maker	accession	maker_id	clone_origin	RIKEN_cloneid	vector	TUID	Related_TUID	gene	GeneID	protein_id	unigene_id	unigene_title	cell_type	tissue_type	clone_lib	lab_host	refseq_nuc	refseq_nuc	refseq_pep	refseq_status	status	ident	gident	overlap	q_len	q_start	q_stop	s_len	s_start	s_stop
RIKEN	BC029516	IRAK048D22	MGC	W01A001A07	pENTR-TOPO	14285		TNP1	7141	AAH29516.1	Hs.3017	Transition protein 1 (during histone to protamine replacement)			Testis	NIH_MGC_97	DH10B	NM_003284.3	NP_003275.1	VALIDATED	OK	1.000	1.000	55	168	1	165	55	1	55
RIKEN	BC001109	IRAL003P09	MGC	W01A001A08	pENTR-TOPO	2143		CRABP2	1382	AAH01109.1	Hs.405662	Cellular retinoic acid binding protein 2			Colon, adenocarcinoma	NIH_MGC_15		NM_001878.2	NP_001869.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
RIKEN	BC018157	IRAK021E04	MGC	W01A001A13	pENTR-TOPO	22769		POLR2K	5440	AAH18157.1	Hs.351475	Polymerase (RNA) II (DNA directed) polypeptide K, 7.0kDa			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005034.3	NP_005025.1	REVIEWED	OK	1.000	1.000	58	177	1	174	58	1	58
RIKEN	BC017205	IRAL012L15	MGC	W01A001A14	pENTR-TOPO	14258		POLR2D	5433	AAH17205.1	Hs.554831	Polymerase (RNA) II (DNA directed) polypeptide D			Skin, melanotic melanoma.	NIH_MGC_20		NM_004805.3	NP_004796.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC008380	IRAL016P10	MGC	W01A001A20	pENTR-TOPO	5585		MED21	9412	AAH08380.1	Hs.286145	Mediator complex subunit 21			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004264.3	NP_004255.2	PROVISIONAL	C	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC014300	IRAL025E04	MGC	W01A001A23	pENTR-TOPO	1392		CTNNBIP1	56998	AAH14300.1	Hs.463759	Catenin, beta interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_020248.2	NP_064633.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	BC008380	IRAL016P10	MGC	W01A001A24	pENTR-TOPO	5585		MED21	9412	AAH08380.1	Hs.286145	Mediator complex subunit 21			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004264.3	NP_004255.2	PROVISIONAL	C	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC016759	IRAL003B09	MGC	W01A001B01	pENTR-TOPO	6094		BTG1	694	AAH16759.1	Hs.255935	B-cell translocation gene 1, anti-proliferative			Colon, adenocarcinoma	NIH_MGC_15		NM_001731.2	NP_001722.1	REVIEWED	C	1.000	1.000	171	516	1	513	171	1	171
RIKEN	BC016759	IRAL003B09	MGC	W01A001B03	pENTR-TOPO	6094		BTG1	694	AAH16759.1	Hs.255935	B-cell translocation gene 1, anti-proliferative			Colon, adenocarcinoma	NIH_MGC_15		NM_001731.2	NP_001722.1	REVIEWED	C	1.000	1.000	171	516	1	513	171	1	171
RIKEN	BC016759	IRAL003B09	MGC	W01A001B05	pENTR-TOPO	6094		BTG1	694	AAH16759.1	Hs.255935	B-cell translocation gene 1, anti-proliferative			Colon, adenocarcinoma	NIH_MGC_15		NM_001731.2	NP_001722.1	REVIEWED	C	1.000	1.000	171	516	1	513	171	1	171
RIKEN	BC028566	IRAL025A01	MGC	W01A001B06	pENTR-TOPO	510		LIN28	79727	AAH28566.1	Hs.86154	Lin-28 homolog (C. elegans)			Placenta, choriocarcinoma	NIH_MGC_21		NM_024674.4	NP_078950.1	VALIDATED	OK	1.000	1.000	209	630	1	627	209	1	209
RIKEN	BC016759	IRAL003B09	MGC	W01A001B07	pENTR-TOPO	6094		BTG1	694	AAH16759.1	Hs.255935	B-cell translocation gene 1, anti-proliferative			Colon, adenocarcinoma	NIH_MGC_15		NM_001731.2	NP_001722.1	REVIEWED	C	1.000	1.000	171	516	1	513	171	1	171
RIKEN	BC000901	IRAK003G11	MGC	W01A001B11	pENTR-TOPO	11509		CIRBP	1153	AAH00901.1	Hs.634522	Cold inducible RNA binding protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001280.2	NP_001271.1	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	BC000901	IRAK003G11	MGC	W01A001B13	pENTR-TOPO	11509		CIRBP	1153	AAH00901.1	Hs.634522	Cold inducible RNA binding protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001280.2	NP_001271.1	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	BC002809	IRAL012D06	MGC	W01A001B19	pENTR-TOPO	673		DR1	1810	AAH02809.1	Hs.348418	Down-regulator of transcription 1, TBP-binding (negative cofactor 2)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001938.2	NP_001929.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
RIKEN	BC002809	IRAL012D06	MGC	W01A001B21	pENTR-TOPO	673		DR1	1810	AAH02809.1	Hs.348418	Down-regulator of transcription 1, TBP-binding (negative cofactor 2)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001938.2	NP_001929.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
RIKEN	BC004252	IRAL013E08	MGC	W01A001B22	pENTR-TOPO	9957		CBX2	84733	AAH04252.1	Hs.368410	Chromobox homolog 2 (Pc class homolog, Drosophila)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_032647.2	NP_116036.1	VALIDATED	C	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC002809	IRAL012D06	MGC	W01A001B23	pENTR-TOPO	673		DR1	1810	AAH02809.1	Hs.348418	Down-regulator of transcription 1, TBP-binding (negative cofactor 2)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001938.2	NP_001929.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
RIKEN	BC005948	IRAL021A04	MGC	W01A001C05	pENTR-TOPO	25188		SMPX	23676	AAH05948.1	Hs.86492	Small muscle protein, X-linked			Skeletal Muscle	NIH_MGC_81	DH10B	NM_014332.1	NP_055147.1	PROVISIONAL	C	1.000	1.000	88	267	1	264	88	1	88
RIKEN	BC001282	IRAK004M15	MGC	W01A001C11	pENTR-TOPO	20066		HMGN4	10473	AAH01282.1	Hs.236774	High mobility group nucleosomal binding domain 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006353.2	NP_006344.1	REVIEWED	C	1.000	1.000	90	273	1	270	90	1	90
RIKEN	BC008686	IRAK013J16	MGC	W01A001C19	pENTR-TOPO	1338		MYCBP	26292	AAH08686.1	Hs.591506	C-myc binding protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_012333.3	NP_036465.2	VALIDATED	C	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC003166	IRAL002F01	MGC	W01A001C22	pENTR-TOPO	24071		POLE3	54107	AAH03166.1	Hs.108112	Polymerase (DNA directed), epsilon 3 (p17 subunit)			Lung, small cell carcinoma	NIH_MGC_7		NM_017443.4	NP_059139.3	VALIDATED	OK	1.000	1.000	147	444	1	441	147	1	147
RIKEN	BC008686	IRAK013J16	MGC	W01A001C23	pENTR-TOPO	1338		MYCBP	26292	AAH08686.1	Hs.591506	C-myc binding protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_012333.3	NP_036465.2	VALIDATED	C	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC003166	IRAL002F01	MGC	W01A001C24	pENTR-TOPO	24071		POLE3	54107	AAH03166.1	Hs.108112	Polymerase (DNA directed), epsilon 3 (p17 subunit)			Lung, small cell carcinoma	NIH_MGC_7		NM_017443.4	NP_059139.3	VALIDATED	OK	1.000	1.000	147	444	1	441	147	1	147
RIKEN	BC008226	IRAK013H11	MGC	W01A001D01	pENTR-TOPO	22757		MED30	90390	AAH08226.1	Hs.492612	Mediator complex subunit 30			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080651.2	NP_542382.1	VALIDATED	C	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC008226	IRAK013H11	MGC	W01A001D03	pENTR-TOPO	22757		MED30	90390	AAH08226.1	Hs.492612	Mediator complex subunit 30			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080651.2	NP_542382.1	VALIDATED	C	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC021972	IRAL025C20	MGC	W01A001D04	pENTR-TOPO	20490		TAF11	6882	AAH21972.1	Hs.112444	TAF11 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 28kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_005643.2	NP_005634.1	REVIEWED	C	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC008226	IRAK013H11	MGC	W01A001D07	pENTR-TOPO	22757		MED30	90390	AAH08226.1	Hs.492612	Mediator complex subunit 30			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080651.2	NP_542382.1	VALIDATED	C	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC025697	IRAK049K07	MGC	W01A001D09	pENTR-TOPO	19765		TCF21	6943	AAH25697.1	Hs.78061	Transcription factor 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_198392.2	NP_938206.1	REVIEWED	OK	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC009720	IRAK014M23	MGC	W01A001D10	pENTR-TOPO	20079		EDN1	1906	AAH09720.1	Hs.713645	Endothelin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001955.3	NP_001946.3	VALIDATED	Cs	0.995	0.995	212	639	1	636	212	1	212
RIKEN	BC009720	IRAK014M23	MGC	W01A001D12	pENTR-TOPO	20079		EDN1	1906	AAH09720.1	Hs.713645	Endothelin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001955.3	NP_001946.3	VALIDATED	Cs	0.995	0.995	212	639	1	636	212	1	212
RIKEN	BC009720	IRAK014M23	MGC	W01A001D14	pENTR-TOPO	20079		EDN1	1906	AAH09720.1	Hs.713645	Endothelin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001955.3	NP_001946.3	VALIDATED	Cs	0.995	0.995	212	639	1	636	212	1	212
RIKEN	BC040950	IRAK084N14	MGC	W01A001D22	pENTR-TOPO	20480		MED20	9477	AAH40950.1	Hs.278434	Mediator complex subunit 20			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004275.3	NP_004266.2	VALIDATED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC040950	IRAK084N14	MGC	W01A001D24	pENTR-TOPO	20480		MED20	9477	AAH40950.1	Hs.278434	Mediator complex subunit 20			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004275.3	NP_004266.2	VALIDATED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC005147	IRAL007E23	MGC	W01A001E09	pENTR-TOPO	15079		FKBP1A	2280	AAH05147.1	Hs.471933	FK506 binding protein 1A, 12kDa			Placenta, choriocarcinoma	NIH_MGC_21		NM_000801.3	NP_000792.1	REVIEWED	OK	1.000	1.000	108	327	1	324	108	1	108
RIKEN	BC000287	IRAL001A01	MGC	W01A001E21	pENTR-TOPO	8355		GTF2A2	2958	AAH00287.1	Hs.512934	General transcription factor IIA, 2, 12kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_004492.2	NP_004483.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
RIKEN	BC005034	IRAL018M03	MGC	W01A001E24	pENTR-TOPO	4521		PHLDA2	7262	AAH05034.1	Hs.154036	Pleckstrin homology-like domain, family A, member 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_003311.3	NP_003302.1	REVIEWED	OK	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC000426	IRAL001B05	MGC	W01A001F02	pENTR-TOPO	17171		H1FX	8971	AAH00426.1	Hs.75307	H1 histone family, member X			Lung, small cell carcinoma	NIH_MGC_7		NM_006026.3	NP_006017.1	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
RIKEN	BC000785	IRAL007F04	MGC	W01A001F03	pENTR-TOPO	14964		SCAND1	51282	AAH00785.1	Hs.584909	SCAN domain containing 1			Brain, neuroblastoma	NIH_MGC_19		NM_033630.1	NP_361012.1	REVIEWED	OK	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC000426	IRAL001B05	MGC	W01A001F04	pENTR-TOPO	17171		H1FX	8971	AAH00426.1	Hs.75307	H1 histone family, member X			Lung, small cell carcinoma	NIH_MGC_7		NM_006026.3	NP_006017.1	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
RIKEN	BC002649	IRAL012E13	MGC	W01A001F12	pENTR-TOPO	20758		HIST1H1C	3006	AAH02649	Hs.7644	Histone cluster 1, H1c			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005319.3	NP_005310.1	REVIEWED	C	1.000	1.000	213	642	1	639	213	1	213
RIKEN	BC006322	IRAL017K09	MGC	W01A001F15	pENTR-TOPO	181		ATF3	467	AAH06322.1	Hs.460	Activating transcription factor 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001674.2	NP_001665.1	REVIEWED	C	1.000	1.000	181	546	1	543	181	1	181
RIKEN	BC066889	IRAK167M22	MGC	W01A001F22	pENTR-TOPO	6673		HMGB1	3146	AAH66889.1	Hs.644368	High-mobility group box 1			Testis	NIH_MGC_97	DH10B	NM_002128.4	NP_002119.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC066889	IRAK167M22	MGC	W01A001F24	pENTR-TOPO	6673		HMGB1	3146	AAH66889.1	Hs.644368	High-mobility group box 1			Testis	NIH_MGC_97	DH10B	NM_002128.4	NP_002119.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC030836	IRAK032D08	MGC	W01A001G08	pENTR-TOPO	6477		SAP18	10284	AAH30836.1	Hs.524899	Sin3A-associated protein, 18kDa			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005870.4	NP_005861.2	REVIEWED	Ps	0.993	0.993	153	462	1	459	172	20	172
RIKEN	BC013809	IRAK026D05	MGC	W01A001G11	pENTR-TOPO	23148		TCEB1	6921	AAH13809.1	Hs.554594	Transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005648.2	NP_005639.1	REVIEWED	C	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC013809	IRAK026D05	MGC	W01A001G15	pENTR-TOPO	23148		TCEB1	6921	AAH13809.1	Hs.554594	Transcription elongation factor B (SIII), polypeptide 1 (15kDa, elongin C)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005648.2	NP_005639.1	REVIEWED	C	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC002531	IRAL004K20	MGC	W01A001G17	pENTR-TOPO	14707		PPDPF	79144	AAH02531.1	Hs.79625	Chromosome 20 open reading frame 149			Placenta, choriocarcinoma	NIH_MGC_21		NM_024299.2	NP_077275.1	PROVISIONAL	OK	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC017890	IRAL036P21	MGC	W01A001G18	pENTR-TOPO	13492		SNRNP27	11017	AAH17890.1	Hs.54649	Small nuclear ribonucleoprotein 27kDa (U4/U6.U5)			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006857.1	NP_006848.1	PROVISIONAL	OK	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC017890	IRAL036P21	MGC	W01A001G24	pENTR-TOPO	13492		SNRNP27	11017	AAH17890.1	Hs.54649	Small nuclear ribonucleoprotein 27kDa (U4/U6.U5)			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006857.1	NP_006848.1	PROVISIONAL	OK	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC003378	IRAK003J01	MGC	W01A001H02	pENTR-TOPO	6673		HMGB1	3146	AAH03378.1	Hs.644368	High-mobility group box 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_002128.4	NP_002119.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC003378	IRAK003J01	MGC	W01A001H08	pENTR-TOPO	6673		HMGB1	3146	AAH03378.1	Hs.644368	High-mobility group box 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_002128.4	NP_002119.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC015961	IRAL007J23	MGC	W01A001H11	pENTR-TOPO	4105		ADM	133	AAH15961.1	Hs.441047	Adrenomedullin			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001124.1	NP_001115.1	REVIEWED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC015961	IRAL007J23	MGC	W01A001H13	pENTR-TOPO	4105		ADM	133	AAH15961.1	Hs.441047	Adrenomedullin			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001124.1	NP_001115.1	REVIEWED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC030981	IRAL041A13	MGC	W01A001H14	pENTR-TOPO	6673		HMGB1	3146	AAH30981.1	Hs.644368	High-mobility group box 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_002128.4	NP_002119.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC030981	IRAL041A13	MGC	W01A001H16	pENTR-TOPO	6673		HMGB1	3146	AAH30981.1	Hs.644368	High-mobility group box 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_002128.4	NP_002119.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC001003	IRAK003F23	MGC	W01A001H19	pENTR-TOPO	24826		SSX1	6756	AAH01003.1	Hs.713144	Synovial sarcoma, X breakpoint 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005635.2	NP_005626.1	REVIEWED	C	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC001003	IRAK003F23	MGC	W01A001H21	pENTR-TOPO	24826		SSX1	6756	AAH01003.1	Hs.713144	Synovial sarcoma, X breakpoint 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005635.2	NP_005626.1	REVIEWED	C	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC021190	IRAL005E01	MGC	W01A001H22	pENTR-TOPO	19185		HAND1	9421	AAH21190.1	Hs.152531	Heart and neural crest derivatives expressed 1			Brain, neuroblastoma	NIH_MGC_19		NM_004821.2	NP_004812.1	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC021190	IRAL005E01	MGC	W01A001H24	pENTR-TOPO	19185		HAND1	9421	AAH21190.1	Hs.152531	Heart and neural crest derivatives expressed 1			Brain, neuroblastoma	NIH_MGC_19		NM_004821.2	NP_004812.1	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC019267	IRAL009G14	MGC	W01A001I05	pENTR-TOPO	886		ZNF593	51042	AAH19267.1	Hs.477273	Zinc finger protein 593			Lung, small cell carcinoma	NIH_MGC_7		NM_015871.4	NP_056955.2	VALIDATED	P	1.000	1.000	116	351	1	348	134	19	134
RIKEN	BC035607	IRAK068L11	MGC	W01A001I06	pENTR-TOPO	4641		LMO2	4005	AAH35607.1	Hs.34560	LIM domain only 2 (rhombotin-like 1)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001142315.1	NP_001135787.1	REVIEWED	C	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC019267	IRAL009G14	MGC	W01A001I07	pENTR-TOPO	886		ZNF593	51042	AAH19267.1	Hs.477273	Zinc finger protein 593			Lung, small cell carcinoma	NIH_MGC_7		NM_015871.4	NP_056955.2	VALIDATED	P	1.000	1.000	116	351	1	348	134	19	134
RIKEN	BC003107	IRAL008A24	MGC	W01A001I09	pENTR-TOPO	1327		ID3	3399	AAH03107.1	Hs.76884	Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_002167.3	NP_002158.3	VALIDATED	Cs	0.992	0.992	119	360	1	357	119	1	119
RIKEN	BC000809	IRAK004C17	MGC	W01A001I10	pENTR-TOPO	24825		TCEAL1	9338	AAH00809.1	Hs.95243	Transcription elongation factor A (SII)-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004780.2	NP_004771.2	REVIEWED	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC000809	IRAK004C17	MGC	W01A001I14	pENTR-TOPO	24825		TCEAL1	9338	AAH00809.1	Hs.95243	Transcription elongation factor A (SII)-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004780.2	NP_004771.2	REVIEWED	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC003107	IRAL008A24	MGC	W01A001I15	pENTR-TOPO	1327		ID3	3399	AAH03107.1	Hs.76884	Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_002167.3	NP_002158.3	VALIDATED	Cs	0.992	0.992	119	360	1	357	119	1	119
RIKEN	BC000809	IRAK004C17	MGC	W01A001I16	pENTR-TOPO	24825		TCEAL1	9338	AAH00809.1	Hs.95243	Transcription elongation factor A (SII)-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004780.2	NP_004771.2	REVIEWED	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC011869	IRAL028A02	MGC	W01A001I17	pENTR-TOPO	19350		PFDN1	5201	AAH11869.1	Hs.483564	Prefoldin subunit 1			Colon, adenocarcinoma	NIH_MGC_15		NM_002622.4	NP_002613.2	REVIEWED	C	1.000	1.000	122	369	1	366	122	1	122
RIKEN	BC011869	IRAL028A02	MGC	W01A001I21	pENTR-TOPO	19350		PFDN1	5201	AAH11869.1	Hs.483564	Prefoldin subunit 1			Colon, adenocarcinoma	NIH_MGC_15		NM_002622.4	NP_002613.2	REVIEWED	C	1.000	1.000	122	369	1	366	122	1	122
RIKEN	BC011869	IRAL028A02	MGC	W01A001I23	pENTR-TOPO	19350		PFDN1	5201	AAH11869.1	Hs.483564	Prefoldin subunit 1			Colon, adenocarcinoma	NIH_MGC_15		NM_002622.4	NP_002613.2	REVIEWED	C	1.000	1.000	122	369	1	366	122	1	122
RIKEN	BC017907	IRAL035I24	MGC	W01A001I24	pENTR-TOPO	13493		TWIST2	117581	AAH17907.1	Hs.708196	Twist homolog 2 (Drosophila)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_057179.1	NP_476527.1	REVIEWED	C	1.000	1.000	160	483	1	480	160	1	160
RIKEN	BC013348	IRAL007N24	MGC	W01A001J02	pENTR-TOPO	7739		RAB11A	8766	AAH13348.1	Hs.321541	RAB11A, member RAS oncogene family			Brain, neuroblastoma	NIH_MGC_19		NM_004663.3	NP_004654.1	REVIEWED	C	1.000	1.000	216	651	1	648	216	1	216
RIKEN	BC013348	IRAL007N24	MGC	W01A001J04	pENTR-TOPO	7739		RAB11A	8766	AAH13348.1	Hs.321541	RAB11A, member RAS oncogene family			Brain, neuroblastoma	NIH_MGC_19		NM_004663.3	NP_004654.1	REVIEWED	C	1.000	1.000	216	651	1	648	216	1	216
RIKEN	BC005325	IRAL016M20	MGC	W01A001J05	pENTR-TOPO	24836		SSX4	6759	AAH05325.1	Hs.558402	Synovial sarcoma, X breakpoint 4			Bladder, carcinoma	NIH_MGC_53	DH10B	XM_001725018.1	XP_001725070.1	MODEL	C	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC013348	IRAL007N24	MGC	W01A001J06	pENTR-TOPO	7739		RAB11A	8766	AAH13348.1	Hs.321541	RAB11A, member RAS oncogene family			Brain, neuroblastoma	NIH_MGC_19		NM_004663.3	NP_004654.1	REVIEWED	C	1.000	1.000	216	651	1	648	216	1	216
RIKEN	BC005325	IRAL016M20	MGC	W01A001J07	pENTR-TOPO	24836		SSX4	6759	AAH05325.1	Hs.558402	Synovial sarcoma, X breakpoint 4			Bladder, carcinoma	NIH_MGC_53	DH10B	XM_001725018.1	XP_001725070.1	MODEL	C	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC015345	IRAK027H14	MGC	W01A001J10	pENTR-TOPO	10657		HOXB7	3217	AAH15345.1	Hs.436181	Homeobox B7			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_004502.3	NP_004493.3	REVIEWED	Cs	0.995	0.995	217	654	1	651	217	1	217
RIKEN	BC021671	IRAL031A21	MGC	W01A001J11	pENTR-TOPO	3413		ANKRD22	118932	AAH21671.1	Hs.217484	Ankyrin repeat domain 22			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_144590.2	NP_653191.2	VALIDATED	Cs	0.995	0.995	191	576	1	573	191	1	191
RIKEN	BC015345	IRAK027H14	MGC	W01A001J16	pENTR-TOPO	10657		HOXB7	3217	AAH15345.1	Hs.436181	Homeobox B7			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_004502.3	NP_004493.3	REVIEWED	Cs	0.995	0.995	217	654	1	651	217	1	217
RIKEN	BC001361	IRAL004C03	MGC	W01A001J17	pENTR-TOPO	9125		ZNF747	65988	AAH01361.1	Hs.592032	Zinc finger protein 747			Skin, melanotic melanoma.	NIH_MGC_20		NM_023931.2	NP_076420.1	PROVISIONAL	OK	1.000	1.000	191	576	1	573	191	1	191
RIKEN	BC003536	IRAL013E17	MGC	W01A001J18	pENTR-TOPO	17179		ZBED2	79413	AAH03536.1	Hs.136912	Zinc finger, BED-type containing 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_024508.3	NP_078784.2	VALIDATED	P	1.000	1.000	217	654	1	651	218	2	218
RIKEN	BC003536	IRAL013E17	MGC	W01A001J22	pENTR-TOPO	17179		ZBED2	79413	AAH03536.1	Hs.136912	Zinc finger, BED-type containing 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_024508.3	NP_078784.2	VALIDATED	P	1.000	1.000	217	654	1	651	218	2	218
RIKEN	BC032294	IRAK064A07	MGC	W01A001K01	pENTR-TOPO	7221		BATF	10538	AAH32294.1	Hs.509964	Basic leucine zipper transcription factor, ATF-like			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006399.3	NP_006390.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC032294	IRAK064A07	MGC	W01A001K05	pENTR-TOPO	7221		BATF	10538	AAH32294.1	Hs.509964	Basic leucine zipper transcription factor, ATF-like			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006399.3	NP_006390.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC032294	IRAK064A07	MGC	W01A001K07	pENTR-TOPO	7221		BATF	10538	AAH32294.1	Hs.509964	Basic leucine zipper transcription factor, ATF-like			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006399.3	NP_006390.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC011986	IRAK021O17	MGC	W01A001K08	pENTR-TOPO	2175		TAF12	6883	AAH11986.1	Hs.530251	TAF12 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 20kDa			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001135218.1	NP_001128690.1	REVIEWED	C	1.000	1.000	161	486	1	483	161	1	161
RIKEN	BC017112	IRAL023O07	MGC	W01A001K09	pENTR-TOPO	12693		POLR2I	5438	AAH17112.1	Hs.47062	Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_006233.4	NP_006224.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC017112	IRAL023O07	MGC	W01A001K11	pENTR-TOPO	12693		POLR2I	5438	AAH17112.1	Hs.47062	Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_006233.4	NP_006224.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC051303	IRAL047C12	MGC	W01A001K14	pENTR-TOPO	6978		JDP2	122953	AAH51303.1	Hs.196482	Jun dimerization protein 2			Colon, adenocarcinoma	NIH_MGC_15		NM_001135048.1	NP_001128520.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	BC017112	IRAL023O07	MGC	W01A001K15	pENTR-TOPO	12693		POLR2I	5438	AAH17112.1	Hs.47062	Polymerase (RNA) II (DNA directed) polypeptide I, 14.5kDa			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_006233.4	NP_006224.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC009783	IRAL019F02	MGC	W01A001K17	pENTR-TOPO	20080		HIST1H2BN	8341	AAH09783	Hs.673851	Histone cluster 1, H2bn			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003520.3	NP_003511.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	BC015037	IRAK015O24	MGC	W01A001K18	pENTR-TOPO	15495		MAFF	23764	AAH15037.1	Hs.517617	V-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152878.1	NP_690617.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC015037	IRAK015O24	MGC	W01A001K22	pENTR-TOPO	15495		MAFF	23764	AAH15037.1	Hs.517617	V-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152878.1	NP_690617.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC009783	IRAL019F02	MGC	W01A001K23	pENTR-TOPO	20080		HIST1H2BN	8341	AAH09783	Hs.673851	Histone cluster 1, H2bn			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003520.3	NP_003511.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	BC015037	IRAK015O24	MGC	W01A001K24	pENTR-TOPO	15495		MAFF	23764	AAH15037.1	Hs.517617	V-maf musculoaponeurotic fibrosarcoma oncogene homolog F (avian)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152878.1	NP_690617.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC004240	IRAL013O08	MGC	W01A001L01	pENTR-TOPO	25389		CITED1	4435	AAH04240.1	Hs.40403	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1			Brain, neuroblastoma	NIH_MGC_19		NM_004143.3	NP_004134.2	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
RIKEN	BC004240	IRAL013O08	MGC	W01A001L03	pENTR-TOPO	25389		CITED1	4435	AAH04240.1	Hs.40403	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 1			Brain, neuroblastoma	NIH_MGC_19		NM_004143.3	NP_004134.2	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
RIKEN	BC012088	IRAL029F07	MGC	W01A001L06	pENTR-TOPO	4896		TAF10	6881	AAH12088.1	Hs.5158	TAF10 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 30kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006284.2	NP_006275.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
RIKEN	BC000682	IRAL005J18	MGC	W01A001L10	pENTR-TOPO	15855		DGCR6L	85359	AAH00682.1	Hs.410965	DiGeorge syndrome critical region gene 6-like			Colon, adenocarcinoma	NIH_MGC_15		NM_033257.2	NP_150282.1	REVIEWED	Cs	0.995	0.995	220	663	1	660	220	1	220
RIKEN	BC032799	IRAK068I22	MGC	W01A001L13	pENTR-TOPO	21417		ANKRD7	56311	AAH32799.1	Hs.657737	Ankyrin repeat domain 7			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019644.3	NP_062618.2	VALIDATED	P	1.000	1.000	201	606	1	603	254	54	254
RIKEN	BC009610	IRAL021D22	MGC	W01A001M03	pENTR-TOPO	18567		SUB1	10923	AAH09610.1	Hs.229641	SUB1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_006713.3	NP_006704.3	VALIDATED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	BC009610	IRAL021D22	MGC	W01A001M05	pENTR-TOPO	18567		SUB1	10923	AAH09610.1	Hs.229641	SUB1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_006713.3	NP_006704.3	VALIDATED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	BC000914	IRAK003L21	MGC	W01A001M06	pENTR-TOPO	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003017.4	NP_003008.1	VALIDATED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC000914	IRAK003L21	MGC	W01A001M08	pENTR-TOPO	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003017.4	NP_003008.1	VALIDATED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC017673	IRAK014G05	MGC	W01A001M12	pENTR-TOPO	893		LMO4	8543	AAH17673.1	Hs.436792	LIM domain only 4				NIH_MGC_69	DH10B	NM_006769.3	NP_006760.1	REVIEWED	C	1.000	1.000	165	498	1	495	165	1	165
RIKEN	BC015891	IRAK015D08	MGC	W01A001M15	pENTR-TOPO	22580		CHRAC1	54108	AAH15891.1	Hs.279704	Chromatin accessibility complex 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017444.4	NP_059140.1	VALIDATED	C	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC021176	IRAK047P16	MGC	W01A001M18	pENTR-TOPO	24857		ZCCHC13	389874	AAH21176.1	Hs.157231	Zinc finger, CCHC domain containing 13			Testis	NIH_MGC_97	DH10B	NM_203303.2	NP_976048.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
RIKEN	BC012539	IRAL019H08	MGC	W01A001M19	pENTR-TOPO	10394		MED31	51003	AAH12539.1	Hs.567493	Mediator complex subunit 31			Prostate	NIH_MGC_83	DH10B	NM_016060.2	NP_057144.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC021176	IRAK047P16	MGC	W01A001M22	pENTR-TOPO	24857		ZCCHC13	389874	AAH21176.1	Hs.157231	Zinc finger, CCHC domain containing 13			Testis	NIH_MGC_97	DH10B	NM_203303.2	NP_976048.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
RIKEN	BC011864	IRAL028O01	MGC	W01A001N05	pENTR-TOPO	2174		MYCL1	4610	AAH11864.1	Hs.437922	V-myc myelocytomatosis viral oncogene homolog 1, lung carcinoma derived (avian)			Placenta, choriocarcinoma	NIH_MGC_21		NM_005376.3	NP_005367.1	VALIDATED	OK	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC019079	IRAL039D06	MGC	W01A001N09	pENTR-TOPO	11404		NAT14	57106	AAH19079.1	Hs.719312	N-acetyltransferase 14 (GCN5-related, putative)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_020378.2	NP_065111.1	PROVISIONAL	OK	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC019079	IRAL039D06	MGC	W01A001N11	pENTR-TOPO	11404		NAT14	57106	AAH19079.1	Hs.719312	N-acetyltransferase 14 (GCN5-related, putative)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_020378.2	NP_065111.1	PROVISIONAL	OK	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC019079	IRAL039D06	MGC	W01A001N15	pENTR-TOPO	11404		NAT14	57106	AAH19079.1	Hs.719312	N-acetyltransferase 14 (GCN5-related, putative)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_020378.2	NP_065111.1	PROVISIONAL	OK	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC007939	IRAL020H04	MGC	W01A001N18	pENTR-TOPO	13785		HES6	55502	AAH07939.1	Hs.42949	Hairy and enhancer of split 6 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018645.4	NP_061115.2	REVIEWED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC007939	IRAL020H04	MGC	W01A001N20	pENTR-TOPO	13785		HES6	55502	AAH07939.1	Hs.42949	Hairy and enhancer of split 6 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018645.4	NP_061115.2	REVIEWED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC020654	IRAL037A09	MGC	W01A001N23	pENTR-TOPO	7702		RAB8B	51762	AAH20654.1	Hs.389733	RAB8B, member RAS oncogene family			Lung	NIH_MGC_77	DH10B	NM_016530.2	NP_057614.1	VALIDATED	OK	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC013789	IRAK013F20	MGC	W01A001O03	pENTR-TOPO	912		NHLH1	4807	AAH13789.1	Hs.30956	Nescient helix loop helix 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005598.3	NP_005589.1	VALIDATED	OK	1.000	1.000	133	402	1	399	133	1	133
RIKEN	BC058035	IRAL048J16	MGC	W01A001O09	pENTR-TOPO	6027		PRR4	11272	AAH58035.1	Hs.408153	Proline rich 4 (lacrimal)			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_007244.2	NP_009175.2	VALIDATED	Cs	0.985	0.985	134	405	1	402	134	1	134
RIKEN	BC058035	IRAL048J16	MGC	W01A001O13	pENTR-TOPO	6027		PRR4	11272	AAH58035.1	Hs.408153	Proline rich 4 (lacrimal)			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_007244.2	NP_009175.2	VALIDATED	Cs	0.985	0.985	134	405	1	402	134	1	134
RIKEN	BC006245	IRAL015F13	MGC	W01A001P03	pENTR-TOPO	18482		FGF18	8817	AAH06245.1	Hs.87191	Fibroblast growth factor 18			Ovary, adenocarcinoma	NIH_MGC_9		NM_003862.1	NP_003853.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC006245	IRAL015F13	MGC	W01A001P05	pENTR-TOPO	18482		FGF18	8817	AAH06245.1	Hs.87191	Fibroblast growth factor 18			Ovary, adenocarcinoma	NIH_MGC_9		NM_003862.1	NP_003853.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC006245	IRAL015F13	MGC	W01A001P07	pENTR-TOPO	18482		FGF18	8817	AAH06245.1	Hs.87191	Fibroblast growth factor 18			Ovary, adenocarcinoma	NIH_MGC_9		NM_003862.1	NP_003853.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC033097	IRAL043L23	MGC	W01A001P15	pENTR-TOPO	19392		HBEGF	1839	AAH33097.1	Hs.799	Heparin-binding EGF-like growth factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001945.2	NP_001936.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC001063	IRAL002L16	MGC	W01A001P19	pENTR-TOPO	18254		HMGB2	3148	AAH01063.1	Hs.434953	High-mobility group box 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_001130689.1	NP_001124161.1	REVIEWED	C	1.000	1.000	209	630	1	627	209	1	209
RIKEN	BC000994	IRAK003I05	MGC	W01A002A05	pENTR-TOPO	5379		YEATS4	8089	AAH00994.1	Hs.4029	YEATS domain containing 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006530.2	NP_006521.1	REVIEWED	C	1.000	1.000	227	684	1	681	227	1	227
RIKEN	AK098063	flj0039j16	FLJ	W01A002A09	pENTR-TOPO	6093		NRIP2	83714	BAG53573.1	Hs.530816	Nuclear receptor interacting protein 2				TRACH2	EK1	NM_031474.2	NP_113662.1	VALIDATED	P	1.000	1.000	231	696	1	693	281	51	281
RIKEN	BC010264	IRAK003E05	MGC	W01A002A12	pENTR-TOPO	10263		SFRS1	6426	AAH10264.1	Hs.68714	Splicing factor, arginine/serine-rich 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006924.4	NP_008855.1	REVIEWED	C	1.000	1.000	248	747	1	744	248	1	248
RIKEN	AK098063	flj0039j16	FLJ	W01A002A13	pENTR-TOPO	6093		NRIP2	83714	BAG53573.1	Hs.530816	Nuclear receptor interacting protein 2				TRACH2	EK1	NM_031474.2	NP_113662.1	VALIDATED	P	1.000	1.000	231	696	1	693	281	51	281
RIKEN	BC000985	IRAK003K16	MGC	W01A002A17	pENTR-TOPO	10195		SOX15	6665	AAH00985.1	Hs.95582	SRY (sex determining region Y)-box 15			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006942.1	NP_008873.1	REVIEWED	C	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC012910	IRAK028K01	MGC	W01A002B03	pENTR-TOPO	14623		SNAI1	6615	AAH12910.1	Hs.48029	Snail homolog 1 (Drosophila)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005985.2	NP_005976.2	REVIEWED	OK	1.000	1.000	264	795	1	792	264	1	264
RIKEN	BC011707	IRAL027H09	MGC	W01A002B10	pENTR-TOPO	2703		NRBF2	29982	AAH11707.1	Hs.449628	Nuclear receptor binding factor 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_030759.3	NP_110386.2	VALIDATED	C	1.000	1.000	287	864	1	861	287	1	287
RIKEN	BC014666	IRAL034I02	MGC	W01A002B11	pENTR-TOPO	11932		ZNF524	147807	AAH14666.1	Hs.440291	Zinc finger protein 524			Colon, adenocarcinoma	NIH_MGC_15		NM_153219.2	NP_694951.1	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
RIKEN	BC011707	IRAL027H09	MGC	W01A002B12	pENTR-TOPO	2703		NRBF2	29982	AAH11707.1	Hs.449628	Nuclear receptor binding factor 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_030759.3	NP_110386.2	VALIDATED	C	1.000	1.000	287	864	1	861	287	1	287
RIKEN	BC014666	IRAL034I02	MGC	W01A002B15	pENTR-TOPO	11932		ZNF524	147807	AAH14666.1	Hs.440291	Zinc finger protein 524			Colon, adenocarcinoma	NIH_MGC_15		NM_153219.2	NP_694951.1	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
RIKEN	BC011707	IRAL027H09	MGC	W01A002B16	pENTR-TOPO	2703		NRBF2	29982	AAH11707.1	Hs.449628	Nuclear receptor binding factor 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_030759.3	NP_110386.2	VALIDATED	C	1.000	1.000	287	864	1	861	287	1	287
RIKEN	BC000617	IRAL005K10	MGC	W01A002B17	pENTR-TOPO	3763		NDUFS3	4722	AAH00617.1	Hs.502528	NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)			Skin, melanotic melanoma.	NIH_MGC_20		NM_004551.2	NP_004542.1	REVIEWED	C	1.000	1.000	264	795	1	792	264	1	264
RIKEN	BC000617	IRAL005K10	MGC	W01A002B19	pENTR-TOPO	3763		NDUFS3	4722	AAH00617.1	Hs.502528	NADH dehydrogenase (ubiquinone) Fe-S protein 3, 30kDa (NADH-coenzyme Q reductase)			Skin, melanotic melanoma.	NIH_MGC_20		NM_004551.2	NP_004542.1	REVIEWED	C	1.000	1.000	264	795	1	792	264	1	264
RIKEN	BC025354	IRAL042K17	MGC	W01A002C02	pENTR-TOPO	8739		CMTM2	146225	AAH25354.1	Hs.195685	CKLF-like MARVEL transmembrane domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_144673.2	NP_653274.1	REVIEWED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC025354	IRAL042K17	MGC	W01A002C04	pENTR-TOPO	8739		CMTM2	146225	AAH25354.1	Hs.195685	CKLF-like MARVEL transmembrane domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_144673.2	NP_653274.1	REVIEWED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC025354	IRAL042K17	MGC	W01A002C06	pENTR-TOPO	8739		CMTM2	146225	AAH25354.1	Hs.195685	CKLF-like MARVEL transmembrane domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_144673.2	NP_653274.1	REVIEWED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC001771	IRAL006I09	MGC	W01A002C10	pENTR-TOPO	6552		GTF2F2	2963	AAH01771.1	Hs.654582	General transcription factor IIF, polypeptide 2, 30kDa			Eye, retinoblastoma	NIH_MGC_16		NM_004128.2	NP_004119.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC001771	IRAL006I09	MGC	W01A002C14	pENTR-TOPO	6552		GTF2F2	2963	AAH01771.1	Hs.654582	General transcription factor IIF, polypeptide 2, 30kDa			Eye, retinoblastoma	NIH_MGC_16		NM_004128.2	NP_004119.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC001771	IRAL006I09	MGC	W01A002C16	pENTR-TOPO	6552		GTF2F2	2963	AAH01771.1	Hs.654582	General transcription factor IIF, polypeptide 2, 30kDa			Eye, retinoblastoma	NIH_MGC_16		NM_004128.2	NP_004119.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC020832	IRAL037M23	MGC	W01A002C17	pENTR-TOPO	17033		RABL3	285282	AAH20832.1	Hs.444360	RAB, member of RAS oncogene family-like 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_173825.3	NP_776186.2	VALIDATED	Cs	0.992	0.992	236	711	1	708	236	1	236
RIKEN	BC015565	IRAL017K21	MGC	W01A002C18	pENTR-TOPO	10537		HOXB9	3219	AAH15565.1	Hs.463350	Homeobox B9			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024017.4	NP_076922.1	REVIEWED	C	1.000	1.000	250	753	1	750	250	1	250
RIKEN	BC020832	IRAL037M23	MGC	W01A002C19	pENTR-TOPO	17033		RABL3	285282	AAH20832.1	Hs.444360	RAB, member of RAS oncogene family-like 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_173825.3	NP_776186.2	VALIDATED	Cs	0.992	0.992	236	711	1	708	236	1	236
RIKEN	BC015565	IRAL017K21	MGC	W01A002C20	pENTR-TOPO	10537		HOXB9	3219	AAH15565.1	Hs.463350	Homeobox B9			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024017.4	NP_076922.1	REVIEWED	C	1.000	1.000	250	753	1	750	250	1	250
RIKEN	BC015565	IRAL017K21	MGC	W01A002C22	pENTR-TOPO	10537		HOXB9	3219	AAH15565.1	Hs.463350	Homeobox B9			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024017.4	NP_076922.1	REVIEWED	C	1.000	1.000	250	753	1	750	250	1	250
RIKEN	BC025712	IRAK049O01	MGC	W01A002D01	pENTR-TOPO	13832		OSR1	130497	AAH25712.1	Hs.123933	Odd-skipped related 1 (Drosophila)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_145260.2	NP_660303.1	VALIDATED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC038709	IRAL036G13	MGC	W01A002D02	pENTR-TOPO	13526		HOXD8	3234	AAH38709.1	Hs.301963	Homeobox D8			Kidney	NIH_MGC_75	DH10B	NM_019558.2	NP_062458.1	REVIEWED	Cg	0.997	1.000	290	870	1	867	290	1	290
RIKEN	BC025712	IRAK049O01	MGC	W01A002D05	pENTR-TOPO	13832		OSR1	130497	AAH25712.1	Hs.123933	Odd-skipped related 1 (Drosophila)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_145260.2	NP_660303.1	VALIDATED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC038709	IRAL036G13	MGC	W01A002D06	pENTR-TOPO	13526		HOXD8	3234	AAH38709.1	Hs.301963	Homeobox D8			Kidney	NIH_MGC_75	DH10B	NM_019558.2	NP_062458.1	REVIEWED	Cg	0.997	1.000	290	870	1	867	290	1	290
RIKEN	BC025712	IRAK049O01	MGC	W01A002D07	pENTR-TOPO	13832		OSR1	130497	AAH25712.1	Hs.123933	Odd-skipped related 1 (Drosophila)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_145260.2	NP_660303.1	VALIDATED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC038709	IRAL036G13	MGC	W01A002D08	pENTR-TOPO	13526		HOXD8	3234	AAH38709.1	Hs.301963	Homeobox D8			Kidney	NIH_MGC_75	DH10B	NM_019558.2	NP_062458.1	REVIEWED	Cg	0.997	1.000	290	870	1	867	290	1	290
RIKEN	BC006226	IRAL015K11	MGC	W01A002D14	pENTR-TOPO	22014		DLX5	1749	AAH06226.1	Hs.99348	Distal-less homeobox 5			Lung, small cell carcinoma	NIH_MGC_7		NM_005221.5	NP_005212.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC006226	IRAL015K11	MGC	W01A002D16	pENTR-TOPO	22014		DLX5	1749	AAH06226.1	Hs.99348	Distal-less homeobox 5			Lung, small cell carcinoma	NIH_MGC_7		NM_005221.5	NP_005212.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC006219	IRAL015A21	MGC	W01A002D17	pENTR-TOPO	8343		MESP1	55897	AAH06219.1	Hs.447531	Mesoderm posterior 1 homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7		NM_018670.3	NP_061140.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC002517	IRAL004C18	MGC	W01A002D20	pENTR-TOPO	25253		PIR	8544	AAH02517.1	Hs.495728	Pirin (iron-binding nuclear protein)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001018109.1	NP_001018119.1	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
RIKEN	BC002670	IRAL012I23	MGC	W01A002E03	pENTR-TOPO	12301		SERTAD1	29950	AAH02670.1	Hs.269898	SERTA domain containing 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_013376.3	NP_037508.2	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
RIKEN	BC002670	IRAL012I23	MGC	W01A002E05	pENTR-TOPO	12301		SERTAD1	29950	AAH02670.1	Hs.269898	SERTA domain containing 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_013376.3	NP_037508.2	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
RIKEN	BC002670	IRAL012I23	MGC	W01A002E07	pENTR-TOPO	12301		SERTAD1	29950	AAH02670.1	Hs.269898	SERTA domain containing 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_013376.3	NP_037508.2	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
RIKEN	AK055041	flj0001c08	FLJ	W01A002E10	pENTR-TOPO	2712		EMX2	2018	BAB70842.1	Hs.202095	Empty spiracles homeobox 2				BRAWH1	EK1	NM_004098.3	NP_004089.1	VALIDATED	Cs	0.996	0.996	252	759	1	756	252	1	252
RIKEN	AK092184	flj0011m18	FLJ	W01A002E22	pENTR-TOPO	15381		RCAN1	1827	BAG52494.1	Hs.282326	Regulator of calcineurin 1	NT2	teratocarcinoma		NT2NE2	EK1	NM_004414.5	NP_004405.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
RIKEN	BC012395	IRAK021L17	MGC	W01A002E23	pENTR-TOPO	7571		NRL	4901	AAH12395.1	Hs.652297	Neural retina leucine zipper			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006177.3	NP_006168.1	REVIEWED	OK	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC017291	IRAL039K16	MGC	W01A002F02	pENTR-TOPO	18884		TLX3	30012	AAH17291.1	Hs.249125	T-cell leukemia homeobox 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021025.2	NP_066305.2	PROVISIONAL	OK	1.000	1.000	291	876	1	873	291	1	291
RIKEN	BC017291	IRAL039K16	MGC	W01A002F04	pENTR-TOPO	18884		TLX3	30012	AAH17291.1	Hs.249125	T-cell leukemia homeobox 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021025.2	NP_066305.2	PROVISIONAL	OK	1.000	1.000	291	876	1	873	291	1	291
RIKEN	BC017291	IRAL039K16	MGC	W01A002F08	pENTR-TOPO	18884		TLX3	30012	AAH17291.1	Hs.249125	T-cell leukemia homeobox 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021025.2	NP_066305.2	PROVISIONAL	OK	1.000	1.000	291	876	1	873	291	1	291
RIKEN	BC005189	IRAL016L05	MGC	W01A002F11	pENTR-TOPO	6712		MED4	29079	AAH05189.1	Hs.181112	Mediator complex subunit 4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014166.2	NP_054885.1	PROVISIONAL	Cs	0.993	0.993	270	813	1	810	270	1	270
RIKEN	BC030572	IRAL025K09	MGC	W01A002F12	pENTR-TOPO	23226		GTF2E2	2961	AAH30572.1	Hs.77100	General transcription factor IIE, polypeptide 2, beta 34kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_002095.4	NP_002086.1	VALIDATED	C	1.000	1.000	291	876	1	873	291	1	291
RIKEN	BC005189	IRAL016L05	MGC	W01A002F13	pENTR-TOPO	6712		MED4	29079	AAH05189.1	Hs.181112	Mediator complex subunit 4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014166.2	NP_054885.1	PROVISIONAL	Cs	0.993	0.993	270	813	1	810	270	1	270
RIKEN	BC030572	IRAL025K09	MGC	W01A002F16	pENTR-TOPO	23226		GTF2E2	2961	AAH30572.1	Hs.77100	General transcription factor IIE, polypeptide 2, beta 34kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_002095.4	NP_002086.1	VALIDATED	C	1.000	1.000	291	876	1	873	291	1	291
RIKEN	BC015110	IRAL031O05	MGC	W01A002F17	pENTR-TOPO	2894		HHEX	3087	AAH15110.1	Hs.118651	Hematopoietically expressed homeobox			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_002729.4	NP_002720.1	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC015110	IRAL031O05	MGC	W01A002F19	pENTR-TOPO	2894		HHEX	3087	AAH15110.1	Hs.118651	Hematopoietically expressed homeobox			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_002729.4	NP_002720.1	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC025788	IRAK049P23	MGC	W01A002F20	pENTR-TOPO	2906		NKX2-3	159296	AAH25788.1	Hs.243272	NK2 transcription factor related, locus 3 (Drosophila)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_145285.2	NP_660328.2	VALIDATED	Pfs	0.902	1.000	326	882	1	881	364	1	326
RIKEN	BC015110	IRAL031O05	MGC	W01A002F23	pENTR-TOPO	2894		HHEX	3087	AAH15110.1	Hs.118651	Hematopoietically expressed homeobox			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_002729.4	NP_002720.1	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	AK000077	flj0065i08	FLJ	W01A002G02	pENTR-TOPO	11443		ZNF586	54807	BAA90930.1	Hs.709730	Zinc finger protein 586				COL	EK1	NM_001077426.1	NP_001070894.1	VALIDATED	Pfs	0.990	0.990	201	759	155	756	210	10	210
RIKEN	BC012816	IRAL010P23	MGC	W01A002G05	pENTR-TOPO	14569		TGIF2	60436	AAH12816.1	Hs.632264	TGFB-induced factor homeobox 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021809.5	NP_068581.1	REVIEWED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	AK000077	flj0065i08	FLJ	W01A002G06	pENTR-TOPO	11443		ZNF586	54807	BAA90930.1	Hs.709730	Zinc finger protein 586				COL	EK1	NM_001077426.1	NP_001070894.1	VALIDATED	Pfs	0.990	0.990	201	759	155	756	210	10	210
RIKEN	BC012816	IRAL010P23	MGC	W01A002G07	pENTR-TOPO	14569		TGIF2	60436	AAH12816.1	Hs.632264	TGFB-induced factor homeobox 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021809.5	NP_068581.1	REVIEWED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	AK000077	flj0065i08	FLJ	W01A002G08	pENTR-TOPO	11443		ZNF586	54807	BAA90930.1	Hs.709730	Zinc finger protein 586				COL	EK1	NM_001077426.1	NP_001070894.1	VALIDATED	Pfs	0.990	0.990	201	759	155	756	210	10	210
RIKEN	BC004281	IRAL013P07	MGC	W01A002G18	pENTR-TOPO	12266		TFPT	29844	AAH04281.1	Hs.590939	TCF3 (E2A) fusion partner (in childhood Leukemia)			Skin, melanotic melanoma.	NIH_MGC_20		NM_013342.3	NP_037474.1	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC004281	IRAL013P07	MGC	W01A002G22	pENTR-TOPO	12266		TFPT	29844	AAH04281.1	Hs.590939	TCF3 (E2A) fusion partner (in childhood Leukemia)			Skin, melanotic melanoma.	NIH_MGC_20		NM_013342.3	NP_037474.1	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC051352	IRAL047O02	MGC	W01A002H03	pENTR-TOPO	20687		OLIG3	167826	AAH51352.1	Hs.195398	Oligodendrocyte transcription factor 3			Ovary, teratocarcinoma	NIH_MGC_109		NM_175747.2	NP_786923.1	PROVISIONAL	OK	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC051352	IRAL047O02	MGC	W01A002H07	pENTR-TOPO	20687		OLIG3	167826	AAH51352.1	Hs.195398	Oligodendrocyte transcription factor 3			Ovary, teratocarcinoma	NIH_MGC_109		NM_175747.2	NP_786923.1	PROVISIONAL	OK	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC003159	IRAL009L18	MGC	W01A002H09	pENTR-TOPO	8629		POLR2C	5432	AAH03159.1	Hs.79402	Polymerase (RNA) II (DNA directed) polypeptide C, 33kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_032940.2	NP_116558.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC003159	IRAL009L18	MGC	W01A002H11	pENTR-TOPO	8629		POLR2C	5432	AAH03159.1	Hs.79402	Polymerase (RNA) II (DNA directed) polypeptide C, 33kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_032940.2	NP_116558.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC003159	IRAL009L18	MGC	W01A002H15	pENTR-TOPO	8629		POLR2C	5432	AAH03159.1	Hs.79402	Polymerase (RNA) II (DNA directed) polypeptide C, 33kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_032940.2	NP_116558.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC024238	IRAK046B19	MGC	W01A002H16	pENTR-TOPO	13801		MKI67IP	84365	AAH24238.1	Hs.367842	MKI67 (FHA domain) interacting nucleolar phosphoprotein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032390.4	NP_115766.3	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
RIKEN	AK021857	flj0029a22	FLJ	W01A002H18	pENTR-TOPO	19296		ANKRD55	79722	BAB13916.1	Hs.436214	Ankyrin repeat domain 55				HEMBA1	EK1	NM_024669.2	NP_078945.2	VALIDATED	P	1.000	1.000	293	888	7	885	614	322	614
RIKEN	BC006148	IRAL018N19	MGC	W01A002H21	pENTR-TOPO	15005		OVOL2	58495	AAH06148.1	Hs.710157	Ovo-like 2 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_021220.2	NP_067043.2	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
RIKEN	AK021857	flj0029a22	FLJ	W01A002H22	pENTR-TOPO	19296		ANKRD55	79722	BAB13916.1	Hs.436214	Ankyrin repeat domain 55				HEMBA1	EK1	NM_024669.2	NP_078945.2	VALIDATED	P	1.000	1.000	293	888	7	885	614	322	614
RIKEN	AK021857	flj0029a22	FLJ	W01A002H24	pENTR-TOPO	19296		ANKRD55	79722	BAB13916.1	Hs.436214	Ankyrin repeat domain 55				HEMBA1	EK1	NM_024669.2	NP_078945.2	VALIDATED	P	1.000	1.000	293	888	7	885	614	322	614
RIKEN	BC041090	IRAK079M23	MGC	W01A002I05	pENTR-TOPO	7381		NKX2-8	26257	AAH41090.1	Hs.234763	NK2 homeobox 8			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_014360.2	NP_055175.2	PROVISIONAL	OK	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC017798	IRAL036H01	MGC	W01A002I09	pENTR-TOPO	3745		ANKRD49	54851	AAH17798.1	Hs.29052	Ankyrin repeat domain 49			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_017704.2	NP_060174.2	VALIDATED	C	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC017798	IRAL036H01	MGC	W01A002I11	pENTR-TOPO	3745		ANKRD49	54851	AAH17798.1	Hs.29052	Ankyrin repeat domain 49			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_017704.2	NP_060174.2	VALIDATED	C	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC016763	IRAL032O02	MGC	W01A002I14	pENTR-TOPO	13491		HOXD4	3233	AAH16763.1	Hs.591609	Homeobox D4			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_014621.2	NP_055436.2	REVIEWED	C	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC017798	IRAL036H01	MGC	W01A002I15	pENTR-TOPO	3745		ANKRD49	54851	AAH17798.1	Hs.29052	Ankyrin repeat domain 49			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_017704.2	NP_060174.2	VALIDATED	C	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC030207	IRAK049K20	MGC	W01A002I18	pENTR-TOPO	2195		NR0B2	8431	AAH30207.1	Hs.427055	Nuclear receptor subfamily 0, group B, member 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_021969.2	NP_068804.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC018991	IRAL028B14	MGC	W01A002I19	pENTR-TOPO	1996		HDGF	3068	AAH18991.1	Hs.506748	Hepatoma-derived growth factor (high-mobility group protein 1-like)			Brain, neuroblastoma	NIH_MGC_19		NM_004494.2	NP_004485.1	REVIEWED	C	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC030207	IRAK049K20	MGC	W01A002I22	pENTR-TOPO	2195		NR0B2	8431	AAH30207.1	Hs.427055	Nuclear receptor subfamily 0, group B, member 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_021969.2	NP_068804.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC018991	IRAL028B14	MGC	W01A002I23	pENTR-TOPO	1996		HDGF	3068	AAH18991.1	Hs.506748	Hepatoma-derived growth factor (high-mobility group protein 1-like)			Brain, neuroblastoma	NIH_MGC_19		NM_004494.2	NP_004485.1	REVIEWED	C	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC030207	IRAK049K20	MGC	W01A002I24	pENTR-TOPO	2195		NR0B2	8431	AAH30207.1	Hs.427055	Nuclear receptor subfamily 0, group B, member 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_021969.2	NP_068804.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC005240	IRAL016F11	MGC	W01A002J01	pENTR-TOPO	895		HAX1	10456	AAH05240.1	Hs.199625	HCLS1 associated protein X-1			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006118.3	NP_006109.2	REVIEWED	C	1.000	1.000	279	840	1	837	279	1	279
RIKEN	BC004222	IRAL011D13	MGC	W01A002J02	pENTR-TOPO	14583		FAM110A	83541	AAH04222.1	Hs.574822	Family with sequence similarity 110, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_207121.3	NP_997004.1	VALIDATED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	BC005240	IRAL016F11	MGC	W01A002J03	pENTR-TOPO	895		HAX1	10456	AAH05240.1	Hs.199625	HCLS1 associated protein X-1			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006118.3	NP_006109.2	REVIEWED	C	1.000	1.000	279	840	1	837	279	1	279
RIKEN	BC004222	IRAL011D13	MGC	W01A002J04	pENTR-TOPO	14583		FAM110A	83541	AAH04222.1	Hs.574822	Family with sequence similarity 110, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_207121.3	NP_997004.1	VALIDATED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	BC014397	IRAL008D16	MGC	W01A002J11	pENTR-TOPO	13838		FHL2	2274	AAH14397.1	Hs.443687	Four and a half LIM domains 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_201555.1	NP_963849.1	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
RIKEN	AK056091	flj0002c22	FLJ	W01A002J12	pENTR-TOPO	8810		ZNF75A	7627	BAB71092.1	Hs.513292	Zinc finger protein 75a	NT2	teratocarcinoma		NT2RI2	EK1	NM_153028.2	NP_694573.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC014397	IRAL008D16	MGC	W01A002J13	pENTR-TOPO	13838		FHL2	2274	AAH14397.1	Hs.443687	Four and a half LIM domains 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_201555.1	NP_963849.1	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
RIKEN	AK056091	flj0002c22	FLJ	W01A002J14	pENTR-TOPO	8810		ZNF75A	7627	BAB71092.1	Hs.513292	Zinc finger protein 75a	NT2	teratocarcinoma		NT2RI2	EK1	NM_153028.2	NP_694573.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC014397	IRAL008D16	MGC	W01A002J15	pENTR-TOPO	13838		FHL2	2274	AAH14397.1	Hs.443687	Four and a half LIM domains 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_201555.1	NP_963849.1	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
RIKEN	AK056091	flj0002c22	FLJ	W01A002J16	pENTR-TOPO	8810		ZNF75A	7627	BAB71092.1	Hs.513292	Zinc finger protein 75a	NT2	teratocarcinoma		NT2RI2	EK1	NM_153028.2	NP_694573.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC036460	IRAK046E10	MGC	W01A002J17	pENTR-TOPO	6970		TMX1	81542	AAH36460.1	Hs.125221	Thioredoxin-related transmembrane protein 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_030755.4	NP_110382.3	VALIDATED	Cs	0.989	0.989	280	843	1	840	280	1	280
RIKEN	BC032579	IRAK069E14	MGC	W01A002J18	pENTR-TOPO	7413		OTX2	5015	AAH32579.1	Hs.288655	Orthodenticle homeobox 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021728.2	NP_068374.1	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC036460	IRAK046E10	MGC	W01A002J19	pENTR-TOPO	6970		TMX1	81542	AAH36460.1	Hs.125221	Thioredoxin-related transmembrane protein 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_030755.4	NP_110382.3	VALIDATED	Cs	0.989	0.989	280	843	1	840	280	1	280
RIKEN	BC036460	IRAK046E10	MGC	W01A002J21	pENTR-TOPO	6970		TMX1	81542	AAH36460.1	Hs.125221	Thioredoxin-related transmembrane protein 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_030755.4	NP_110382.3	VALIDATED	Cs	0.989	0.989	280	843	1	840	280	1	280
RIKEN	BC036460	IRAK046E10	MGC	W01A002J23	pENTR-TOPO	6970		TMX1	81542	AAH36460.1	Hs.125221	Thioredoxin-related transmembrane protein 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_030755.4	NP_110382.3	VALIDATED	Cs	0.989	0.989	280	843	1	840	280	1	280
RIKEN	BC001923	IRAL009M04	MGC	W01A002K09	pENTR-TOPO	15383		U2AF1	7307	AAH01923.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006758.2	NP_006749.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC001923	IRAL009M04	MGC	W01A002K11	pENTR-TOPO	15383		U2AF1	7307	AAH01923.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006758.2	NP_006749.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC001923	IRAL009M04	MGC	W01A002K13	pENTR-TOPO	15383		U2AF1	7307	AAH01923.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006758.2	NP_006749.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC045762	IRAK090M08	MGC	W01A002K20	pENTR-TOPO	13536		EMX1	2016	AAH45762.2	Hs.516090	Empty spiracles homeobox 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004097.2	NP_004088.2	VALIDATED	P	1.000	1.000	257	774	1	771	290	34	290
RIKEN	BC001177	IRAL008A17	MGC	W01A002K23	pENTR-TOPO	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006758.2	NP_006749.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC045762	IRAK090M08	MGC	W01A002K24	pENTR-TOPO	13536		EMX1	2016	AAH45762.2	Hs.516090	Empty spiracles homeobox 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004097.2	NP_004088.2	VALIDATED	P	1.000	1.000	257	774	1	771	290	34	290
RIKEN	BC002796	IRAL012P17	MGC	W01A002L03	pENTR-TOPO	12666		LYL1	4066	AAH02796.2	Hs.46446	Lymphoblastic leukemia derived sequence 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_005583.3	NP_005574.2	PROVISIONAL	OK	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC067353	IRAL054E19	MGC	W01A002L04	pENTR-TOPO	17732		MSX1	4487	AAH67353.1	Hs.424414	Msh homeobox 1			Brain, neuroblastoma	NIH_MGC_19		NM_002448.3	NP_002439.2	REVIEWED	P	1.000	1.000	297	894	1	891	303	7	303
RIKEN	BC002796	IRAL012P17	MGC	W01A002L05	pENTR-TOPO	12666		LYL1	4066	AAH02796.2	Hs.46446	Lymphoblastic leukemia derived sequence 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_005583.3	NP_005574.2	PROVISIONAL	OK	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC067353	IRAL054E19	MGC	W01A002L06	pENTR-TOPO	17732		MSX1	4487	AAH67353.1	Hs.424414	Msh homeobox 1			Brain, neuroblastoma	NIH_MGC_19		NM_002448.3	NP_002439.2	REVIEWED	P	1.000	1.000	297	894	1	891	303	7	303
RIKEN	BC030128	IRAL015M11	MGC	W01A002L11	pENTR-TOPO	17396		ING2	3622	AAH30128.1	Hs.107153	Inhibitor of growth family, member 2			Lung, small cell carcinoma	NIH_MGC_7		NM_001564.2	NP_001555.1	VALIDATED	C	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC030128	IRAL015M11	MGC	W01A002L15	pENTR-TOPO	17396		ING2	3622	AAH30128.1	Hs.107153	Inhibitor of growth family, member 2			Lung, small cell carcinoma	NIH_MGC_7		NM_001564.2	NP_001555.1	VALIDATED	C	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC008348	IRAL023J20	MGC	W01A002L19	pENTR-TOPO	13903		E2F6	1876	AAH08348.1	Hs.603093	E2F transcription factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_198256.2	NP_937987.2	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC008348	IRAL023J20	MGC	W01A002L21	pENTR-TOPO	13903		E2F6	1876	AAH08348.1	Hs.603093	E2F transcription factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_198256.2	NP_937987.2	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
RIKEN	AK001859	flj0036n24	FLJ	W01A002L22	pENTR-TOPO	16340		ZNF654	55279	BAA91946.1	Hs.661116	Zinc finger protein 654				PLACE1	EK1	NM_018293.2	NP_060763.2	VALIDATED	Ps	0.993	0.993	299	900	1	897	581	40	338
RIKEN	AK001859	flj0036n24	FLJ	W01A002L24	pENTR-TOPO	16340		ZNF654	55279	BAA91946.1	Hs.661116	Zinc finger protein 654				PLACE1	EK1	NM_018293.2	NP_060763.2	VALIDATED	Ps	0.993	0.993	299	900	1	897	581	40	338
RIKEN	BC017834	IRAL036A09	MGC	W01A002M07	pENTR-TOPO	5604		MYF6	4618	AAH17834.1	Hs.35937	Myogenic factor 6 (herculin)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_002469.1	NP_002460.1	PROVISIONAL	C	1.000	1.000	242	729	1	726	242	1	242
RIKEN	BC002439	IRAL005I18	MGC	W01A002M09	pENTR-TOPO	3751		HTATIP2	10553	AAH02439.2	Hs.90753	HIV-1 Tat interactive protein 2, 30kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_006410.4	NP_006401.3	VALIDATED	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC057806	IRAK133C13	MGC	W01A002M12	pENTR-TOPO	21452		IGFBP1	3484	AAH57806.1	Hs.642938	Insulin-like growth factor binding protein 1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_000596.2	NP_000587.1	REVIEWED	Cs	0.996	0.996	259	780	1	777	259	1	259
RIKEN	BC002439	IRAL005I18	MGC	W01A002M13	pENTR-TOPO	3751		HTATIP2	10553	AAH02439.2	Hs.90753	HIV-1 Tat interactive protein 2, 30kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_006410.4	NP_006401.3	VALIDATED	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC057806	IRAK133C13	MGC	W01A002M14	pENTR-TOPO	21452		IGFBP1	3484	AAH57806.1	Hs.642938	Insulin-like growth factor binding protein 1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_000596.2	NP_000587.1	REVIEWED	Cs	0.996	0.996	259	780	1	777	259	1	259
RIKEN	BC002439	IRAL005I18	MGC	W01A002M15	pENTR-TOPO	3751		HTATIP2	10553	AAH02439.2	Hs.90753	HIV-1 Tat interactive protein 2, 30kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_006410.4	NP_006401.3	VALIDATED	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC035263	IRAK042F06	MGC	W01A002M18	pENTR-TOPO	21452		IGFBP1	3484	AAH35263.2	Hs.642938	Insulin-like growth factor binding protein 1			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_000596.2	NP_000587.1	REVIEWED	Cs	0.996	0.996	259	780	1	777	259	1	259
RIKEN	AK096222	flj0035e20	FLJ	W01A002M19	pENTR-TOPO	10611		HOXB8	3218	BAC04730.1	Hs.514292	Homeobox B8	NT2	teratocarcinoma		NT2NE2	EK1	NM_024016.3	NP_076921.1	REVIEWED	Cs	0.992	0.992	243	732	1	729	243	1	243
RIKEN	BC035263	IRAK042F06	MGC	W01A002M20	pENTR-TOPO	21452		IGFBP1	3484	AAH35263.2	Hs.642938	Insulin-like growth factor binding protein 1			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_000596.2	NP_000587.1	REVIEWED	Cs	0.996	0.996	259	780	1	777	259	1	259
RIKEN	BC035263	IRAK042F06	MGC	W01A002M22	pENTR-TOPO	21452		IGFBP1	3484	AAH35263.2	Hs.642938	Insulin-like growth factor binding protein 1			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_000596.2	NP_000587.1	REVIEWED	Cs	0.996	0.996	259	780	1	777	259	1	259
RIKEN	AK096222	flj0035e20	FLJ	W01A002M23	pENTR-TOPO	10611		HOXB8	3218	BAC04730.1	Hs.514292	Homeobox B8	NT2	teratocarcinoma		NT2NE2	EK1	NM_024016.3	NP_076921.1	REVIEWED	Cs	0.992	0.992	243	732	1	729	243	1	243
RIKEN	BC035263	IRAK042F06	MGC	W01A002M24	pENTR-TOPO	21452		IGFBP1	3484	AAH35263.2	Hs.642938	Insulin-like growth factor binding protein 1			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_000596.2	NP_000587.1	REVIEWED	Cs	0.996	0.996	259	780	1	777	259	1	259
RIKEN	BC014766	IRAK019K19	MGC	W01A002N02	pENTR-TOPO	5940		PHB2	11331	AAH14766.1	Hs.504620	Prohibitin 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001144831.1	NP_001138303.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC014766	IRAK019K19	MGC	W01A002N06	pENTR-TOPO	5940		PHB2	11331	AAH14766.1	Hs.504620	Prohibitin 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001144831.1	NP_001138303.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC038516	IRAK073P01	MGC	W01A002N12	pENTR-TOPO	238		PHF13	148479	AAH38516.1	Hs.516079	PHD finger protein 13			Testis	NIH_MGC_97	DH10B	NM_153812.2	NP_722519.2	VALIDATED	Cs	0.997	0.997	300	903	1	900	300	1	300
RIKEN	BC038516	IRAK073P01	MGC	W01A002N14	pENTR-TOPO	238		PHF13	148479	AAH38516.1	Hs.516079	PHD finger protein 13			Testis	NIH_MGC_97	DH10B	NM_153812.2	NP_722519.2	VALIDATED	Cs	0.997	0.997	300	903	1	900	300	1	300
RIKEN	BC005174	IRAL007K21	MGC	W01A002N15	pENTR-TOPO	11386		ATF5	22809	AAH05174.1	Hs.9754	Activating transcription factor 5			Placenta, choriocarcinoma	NIH_MGC_21		NM_012068.4	NP_036200.2	VALIDATED	Cs	0.996	0.996	282	849	1	846	282	1	282
RIKEN	BC038516	IRAK073P01	MGC	W01A002N16	pENTR-TOPO	238		PHF13	148479	AAH38516.1	Hs.516079	PHD finger protein 13			Testis	NIH_MGC_97	DH10B	NM_153812.2	NP_722519.2	VALIDATED	Cs	0.997	0.997	300	903	1	900	300	1	300
RIKEN	BC014641	IRAL022D10	MGC	W01A002N18	pENTR-TOPO	15941		ANKRD54	129138	AAH14641.1	Hs.135259	Ankyrin repeat domain 54			Colon, adenocarcinoma	NIH_MGC_15		NM_138797.1	NP_620152.1	PROVISIONAL	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC014641	IRAL022D10	MGC	W01A002N20	pENTR-TOPO	15941		ANKRD54	129138	AAH14641.1	Hs.135259	Ankyrin repeat domain 54			Colon, adenocarcinoma	NIH_MGC_15		NM_138797.1	NP_620152.1	PROVISIONAL	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	AK025645	flj0065b14	FLJ	W01A002O02	pENTR-TOPO	14970		SLA2	84174	BAB15201.1	Hs.713578	Src-like-adaptor 2	HepG2	hepatoma		HEP	EK1	NM_032214.2	NP_115590.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC042441	IRAK072I11	MGC	W01A002O03	pENTR-TOPO	21996		JAZF1	221895	AAH42441.1	Hs.368944	JAZF zinc finger 1			Testis	NIH_MGC_97	DH10B	NM_175061.3	NP_778231.2	REVIEWED	Cs	0.996	0.996	243	732	1	729	243	1	243
RIKEN	BC062299	IRAL050M19	MGC	W01A002O09	pENTR-TOPO	5265		SSPN	8082	AAH62299.1	Hs.183428	Sarcospan (Kras oncogene-associated gene)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001135823.1	NP_001129295.1	REVIEWED	C	1.000	1.000	140	732	310	729	140	1	140
RIKEN	BC062299	IRAL050M19	MGC	W01A002O11	pENTR-TOPO	5265		SSPN	8082	AAH62299.1	Hs.183428	Sarcospan (Kras oncogene-associated gene)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001135823.1	NP_001129295.1	REVIEWED	C	1.000	1.000	140	732	310	729	140	1	140
RIKEN	BC043611	IRAK089L17	MGC	W01A002O19	pENTR-TOPO	11750		ZNF575	284346	AAH43611.1	Hs.213534	Zinc finger protein 575			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_174945.2	NP_777605.1	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
RIKEN	BC043611	IRAK089L17	MGC	W01A002O21	pENTR-TOPO	11750		ZNF575	284346	AAH43611.1	Hs.213534	Zinc finger protein 575			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_174945.2	NP_777605.1	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
RIKEN	BC007092	IRAL021M10	MGC	W01A002P03	pENTR-TOPO	10683		HOXB13	10481	AAH07092.1	Hs.66731	Homeobox B13			Prostate	NIH_MGC_83	DH10B	NM_006361.5	NP_006352.2	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC007092	IRAL021M10	MGC	W01A002P05	pENTR-TOPO	10683		HOXB13	10481	AAH07092.1	Hs.66731	Homeobox B13			Prostate	NIH_MGC_83	DH10B	NM_006361.5	NP_006352.2	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC007092	IRAL021M10	MGC	W01A002P07	pENTR-TOPO	10683		HOXB13	10481	AAH07092.1	Hs.66731	Homeobox B13			Prostate	NIH_MGC_83	DH10B	NM_006361.5	NP_006352.2	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC006356	IRAL017G14	MGC	W01A002P09	pENTR-TOPO	12888		TLX2	3196	AAH06356.1	Hs.168586	T-cell leukemia homeobox 2			Brain, neuroblastoma	NIH_MGC_19		NM_016170.3	NP_057254.1	PROVISIONAL	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC006356	IRAL017G14	MGC	W01A002P13	pENTR-TOPO	12888		TLX2	3196	AAH06356.1	Hs.168586	T-cell leukemia homeobox 2			Brain, neuroblastoma	NIH_MGC_19		NM_016170.3	NP_057254.1	PROVISIONAL	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC008451	IRAL021P21	MGC	W01A003A01	pENTR-TOPO	290		PPIE	10450	AAH08451.1	Hs.524690	Peptidylprolyl isomerase E (cyclophilin E)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_006112.2	NP_006103.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
RIKEN	BC037322	IRAK073C05	MGC	W01A003A06	pENTR-TOPO	18170		LCORL	254251	AAH37322.3	Hs.677572	Ligand dependent nuclear receptor corepressor-like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_153686.6	NP_710153.2	VALIDATED	C	1.000	1.000	318	957	1	954	318	1	318
RIKEN	AK096896	flj0046k19	FLJ	W01A003A10	pENTR-TOPO	25240		ASB12	142689	BAC04888.1	Hs.56281	Ankyrin repeat and SOCS box-containing 12				SKMUS2	EK1	NM_130388.2	NP_569059.2	REVIEWED	Cs	0.997	0.997	309	957	28	954	309	1	309
RIKEN	BC011642	IRAL017I15	MGC	W01A003A13	pENTR-TOPO	3178		PITX3	5309	AAH11642.1	Hs.137568	Paired-like homeodomain 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005029.3	NP_005020.1	REVIEWED	C	1.000	1.000	302	909	1	906	302	1	302
RIKEN	BC011642	IRAL017I15	MGC	W01A003A15	pENTR-TOPO	3178		PITX3	5309	AAH11642.1	Hs.137568	Paired-like homeodomain 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005029.3	NP_005020.1	REVIEWED	C	1.000	1.000	302	909	1	906	302	1	302
RIKEN	AK096896	flj0046k19	FLJ	W01A003A16	pENTR-TOPO	25240		ASB12	142689	BAC04888.1	Hs.56281	Ankyrin repeat and SOCS box-containing 12				SKMUS2	EK1	NM_130388.2	NP_569059.2	REVIEWED	Cs	0.997	0.997	309	957	28	954	309	1	309
RIKEN	BC012012	IRAK028G18	MGC	W01A003A18	pENTR-TOPO	11444		ZNF177	7730	AAH12012.1	Hs.172979	Zinc finger protein 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_003451.1	NP_003442.1	PROVISIONAL	Cs	0.991	0.991	321	966	1	963	321	1	321
RIKEN	BC042476	IRAK029M19	MGC	W01A003A19	pENTR-TOPO	15514		TEF	7008	AAH42476.1	Hs.181159	Thyrotrophic embryonic factor				NCI_CGAP_Brn67	DH10B	NM_003216.2	NP_003207.1	REVIEWED	C	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC042476	IRAK029M19	MGC	W01A003A21	pENTR-TOPO	15514		TEF	7008	AAH42476.1	Hs.181159	Thyrotrophic embryonic factor				NCI_CGAP_Brn67	DH10B	NM_003216.2	NP_003207.1	REVIEWED	C	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC012012	IRAK028G18	MGC	W01A003A22	pENTR-TOPO	11444		ZNF177	7730	AAH12012.1	Hs.172979	Zinc finger protein 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_003451.1	NP_003442.1	PROVISIONAL	Cs	0.991	0.991	321	966	1	963	321	1	321
RIKEN	BC002754	IRAL012M10	MGC	W01A003B11	pENTR-TOPO	5348		HOXC13	3229	AAH02754	Hs.118608	Homeobox C13			Placenta, choriocarcinoma	NIH_MGC_21		NM_017410.2	NP_059106.2	REVIEWED	OK	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC013964	IRAL002H22	MGC	W01A003B17	pENTR-TOPO	22503		NEIL2	252969	AAH13964.1	Hs.293818	Nei like 2 (E. coli)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001135747.1	NP_001129219.1	VALIDATED	C	1.000	1.000	271	999	184	996	271	1	271
RIKEN	BC013964	IRAL002H22	MGC	W01A003B21	pENTR-TOPO	22503		NEIL2	252969	AAH13964.1	Hs.293818	Nei like 2 (E. coli)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001135747.1	NP_001129219.1	VALIDATED	C	1.000	1.000	271	999	184	996	271	1	271
RIKEN	BC018549	IRAK026J07	MGC	W01A003B22	pENTR-TOPO	13018		PLEK	5341	AAH18549.1	Hs.468840	Pleckstrin			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002664.2	NP_002655.2	VALIDATED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
RIKEN	BC003644	IRAL011D17	MGC	W01A003C07	pENTR-TOPO	6217		CDK4	1019	AAH03644.1	Hs.95577	Cyclin-dependent kinase 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000075.2	NP_000066.1	REVIEWED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC033687	IRAK068M21	MGC	W01A003C11	pENTR-TOPO	8274		MTFMT	123263	AAH33687.1	Hs.531615	Mitochondrial methionyl-tRNA formyltransferase			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_139242.3	NP_640335.2	VALIDATED	P	1.000	1.000	304	915	1	912	389	86	389
RIKEN	AK022643	flj0032a24	FLJ	W01A003C19	pENTR-TOPO	5238		NANOG	79923	BAB14151.1	Hs.661360	Nanog homeobox	NT2	teratocarcinoma		NT2RM4	EK1	NM_024865.2	NP_079141.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	AK022643	flj0032a24	FLJ	W01A003C21	pENTR-TOPO	5238		NANOG	79923	BAB14151.1	Hs.661360	Nanog homeobox	NT2	teratocarcinoma		NT2RM4	EK1	NM_024865.2	NP_079141.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC065822	IRAK141D05	MGC	W01A003C22	pENTR-TOPO	12284		ZNF784	147808	AAH65822.1	Hs.53996	Zinc finger protein 784				Lupski_dorsal_root_ganglion	DH10B	NM_203374.1	NP_976308.1	VALIDATED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC008090	IRAK012A12	MGC	W01A003D04	pENTR-TOPO	15623		ATF4	468	AAH08090.1	Hs.496487	Activating transcription factor 4 (tax-responsive enhancer element B67)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001675.2	NP_001666.2	REVIEWED	Cs	0.997	0.997	351	1056	1	1053	351	1	351
RIKEN	BC000153	IRAK003B13	MGC	W01A003D05	pENTR-TOPO	15314		HSF2BP	11077	AAH00153.1	Hs.406157	Heat shock transcription factor 2 binding protein			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_007031.1	NP_008962.1	REVIEWED	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC008090	IRAK012A12	MGC	W01A003D08	pENTR-TOPO	15623		ATF4	468	AAH08090.1	Hs.496487	Activating transcription factor 4 (tax-responsive enhancer element B67)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001675.2	NP_001666.2	REVIEWED	Cs	0.997	0.997	351	1056	1	1053	351	1	351
RIKEN	BC022088	IRAL010J16	MGC	W01A003D10	pENTR-TOPO	15623		ATF4	468	AAH22088.1	Hs.496487	Activating transcription factor 4 (tax-responsive enhancer element B67)			Ovary, adenocarcinoma	NIH_MGC_9		NM_001675.2	NP_001666.2	REVIEWED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC022088	IRAL010J16	MGC	W01A003D12	pENTR-TOPO	15623		ATF4	468	AAH22088.1	Hs.496487	Activating transcription factor 4 (tax-responsive enhancer element B67)			Ovary, adenocarcinoma	NIH_MGC_9		NM_001675.2	NP_001666.2	REVIEWED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC022088	IRAL010J16	MGC	W01A003D16	pENTR-TOPO	15623		ATF4	468	AAH22088.1	Hs.496487	Activating transcription factor 4 (tax-responsive enhancer element B67)			Ovary, adenocarcinoma	NIH_MGC_9		NM_001675.2	NP_001666.2	REVIEWED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC032547	IRAK069K17	MGC	W01A003D19	pENTR-TOPO	22172		HOXA1	3198	AAH32547.1	Hs.67397	Homeobox A1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005522.4	NP_005513.1	REVIEWED	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	AK094761	flj0046k14	FLJ	W01A003D20	pENTR-TOPO	8832		ZFP1	162239	BAC04417.1	Hs.388813	Zinc finger protein 1 homolog (mouse)				BRAWH2	EK1	NM_153688.2	NP_710155.2	VALIDATED	P	1.000	1.000	352	1059	1	1056	407	56	407
RIKEN	AK094761	flj0046k14	FLJ	W01A003D22	pENTR-TOPO	8832		ZFP1	162239	BAC04417.1	Hs.388813	Zinc finger protein 1 homolog (mouse)				BRAWH2	EK1	NM_153688.2	NP_710155.2	VALIDATED	P	1.000	1.000	352	1059	1	1056	407	56	407
RIKEN	BC008506	IRAK004A09	MGC	W01A003E05	pENTR-TOPO	10688		CRK	1398	AAH08506.1	Hs.638121	V-crk sarcoma virus CT10 oncogene homolog (avian)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016823.2	NP_058431.2	REVIEWED	C	1.000	1.000	304	915	1	912	304	1	304
RIKEN	BC053999	IRAK115H11	MGC	W01A003E11	pENTR-TOPO	8228		NDNL2	56160	AAH53999.1	Hs.719283	Necdin-like 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138704.2	NP_619649.1	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
RIKEN	BC053999	IRAK115H11	MGC	W01A003E15	pENTR-TOPO	8228		NDNL2	56160	AAH53999.1	Hs.719283	Necdin-like 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138704.2	NP_619649.1	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
RIKEN	BC038384	IRAK003J08	MGC	W01A003E16	pENTR-TOPO	868		YBX1	4904	AAH38384.1	Hs.473583	Y box binding protein 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004559.3	NP_004550.2	VALIDATED	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC025711	IRAK049M21	MGC	W01A003E18	pENTR-TOPO	19103		NKX2-5	1482	AAH25711.1	Hs.54473	NK2 transcription factor related, locus 5 (Drosophila)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004387.2	NP_004378.1	VALIDATED	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC025711	IRAK049M21	MGC	W01A003E22	pENTR-TOPO	19103		NKX2-5	1482	AAH25711.1	Hs.54473	NK2 transcription factor related, locus 5 (Drosophila)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004387.2	NP_004378.1	VALIDATED	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC007906	IRAL020L03	MGC	W01A003F01	pENTR-TOPO	4397		B3GAT3	26229	AAH07906.1	Hs.502759	Beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_012200.2	NP_036332.2	REVIEWED	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC010235	IRAK019B17	MGC	W01A003F02	pENTR-TOPO	3128		PCGF6	84108	AAH10235.1	Hs.719328	Polycomb group ring finger 6			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001011663.1	NP_001011663.1	REVIEWED	Cg	0.994	1.000	352	1059	1	1056	350	1	350
RIKEN	BC007906	IRAL020L03	MGC	W01A003F03	pENTR-TOPO	4397		B3GAT3	26229	AAH07906.1	Hs.502759	Beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_012200.2	NP_036332.2	REVIEWED	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC007906	IRAL020L03	MGC	W01A003F05	pENTR-TOPO	4397		B3GAT3	26229	AAH07906.1	Hs.502759	Beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_012200.2	NP_036332.2	REVIEWED	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC021299	IRAL039D22	MGC	W01A003F09	pENTR-TOPO	20367		SPDEF	25803	AAH21299.1	Hs.485158	SAM pointed domain containing ets transcription factor			Colon, adenocarcinoma	NIH_MGC_15		NM_012391.1	NP_036523.1	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC001226	IRAK004I04	MGC	W01A003F10	pENTR-TOPO	7433		PLEK2	26499	AAH01226.1	Hs.170473	Pleckstrin 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016445.1	NP_057529.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC001226	IRAK004I04	MGC	W01A003F14	pENTR-TOPO	7433		PLEK2	26499	AAH01226.1	Hs.170473	Pleckstrin 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016445.1	NP_057529.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC001226	IRAK004I04	MGC	W01A003F16	pENTR-TOPO	7433		PLEK2	26499	AAH01226.1	Hs.170473	Pleckstrin 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016445.1	NP_057529.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	AK000086	flj0063d11	FLJ	W01A003F20	pENTR-TOPO	12406		ZNF562	54811	BAA90935.1	Hs.371107	Zinc finger protein 562				COL	EK1	NM_017656.3	NP_060126.2	VALIDATED	Cs	0.992	0.992	354	1065	1	1062	354	1	354
RIKEN	AK000086	flj0063d11	FLJ	W01A003F22	pENTR-TOPO	12406		ZNF562	54811	BAA90935.1	Hs.371107	Zinc finger protein 562				COL	EK1	NM_017656.3	NP_060126.2	VALIDATED	Cs	0.992	0.992	354	1065	1	1062	354	1	354
RIKEN	AK000086	flj0063d11	FLJ	W01A003F24	pENTR-TOPO	12406		ZNF562	54811	BAA90935.1	Hs.371107	Zinc finger protein 562				COL	EK1	NM_017656.3	NP_060126.2	VALIDATED	Cs	0.992	0.992	354	1065	1	1062	354	1	354
RIKEN	BC001268	IRAK004C15	MGC	W01A003G01	pENTR-TOPO	14254		NMI	9111	AAH01268.1	Hs.54483	N-myc (and STAT) interactor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004688.2	NP_004679.2	REVIEWED	C	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC001268	IRAK004C15	MGC	W01A003G03	pENTR-TOPO	14254		NMI	9111	AAH01268.1	Hs.54483	N-myc (and STAT) interactor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004688.2	NP_004679.2	REVIEWED	C	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC012022	IRAK028B13	MGC	W01A003G09	pENTR-TOPO	23082		PPP2CB	5516	AAH12022.1	Hs.491440	Protein phosphatase 2 (formerly 2A), catalytic subunit, beta isoform			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_001009552.1	NP_001009552.1	REVIEWED	C	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC013998	IRAL028F01	MGC	W01A003G10	pENTR-TOPO	18056		PITX2	5308	AAH13998.1	Hs.643588	Paired-like homeodomain 2			Lung, small cell carcinoma	NIH_MGC_7		NM_000325.5	NP_000316.2	REVIEWED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC013998	IRAL028F01	MGC	W01A003G14	pENTR-TOPO	18056		PITX2	5308	AAH13998.1	Hs.643588	Paired-like homeodomain 2			Lung, small cell carcinoma	NIH_MGC_7		NM_000325.5	NP_000316.2	REVIEWED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC013998	IRAL028F01	MGC	W01A003G16	pENTR-TOPO	18056		PITX2	5308	AAH13998.1	Hs.643588	Paired-like homeodomain 2			Lung, small cell carcinoma	NIH_MGC_7		NM_000325.5	NP_000316.2	REVIEWED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC000820	IRAK004O23	MGC	W01A003G17	pENTR-TOPO	7195		MNAT1	4331	AAH00820.1	Hs.509523	Menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002431.2	NP_002422.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC000820	IRAK004O23	MGC	W01A003G19	pENTR-TOPO	7195		MNAT1	4331	AAH00820.1	Hs.509523	Menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002431.2	NP_002422.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC000820	IRAK004O23	MGC	W01A003G21	pENTR-TOPO	7195		MNAT1	4331	AAH00820.1	Hs.509523	Menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002431.2	NP_002422.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC005026	IRAL018A05	MGC	W01A003H02	pENTR-TOPO	12333		SIRT6	51548	AAH05026.1	Hs.423756	Sirtuin (silent mating type information regulation 2 homolog) 6 (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_016539.1	NP_057623.1	REVIEWED	Cs	0.997	0.997	355	1068	1	1065	355	1	355
RIKEN	AK056374	flj0003c21	FLJ	W01A003H09	pENTR-TOPO	25307		ZDHHC15	158866	BAB71168.1	Hs.253211	Zinc finger, DHHC-type containing 15	NT2	teratocarcinoma		NT2RI2	EK1	NM_144969.2	NP_659406.1	VALIDATED	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	AK056374	flj0003c21	FLJ	W01A003H11	pENTR-TOPO	25307		ZDHHC15	158866	BAB71168.1	Hs.253211	Zinc finger, DHHC-type containing 15	NT2	teratocarcinoma		NT2RI2	EK1	NM_144969.2	NP_659406.1	VALIDATED	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC009046	IRAK013M21	MGC	W01A003H12	pENTR-TOPO	14039		NEUROD1	4760	AAH09046.1	Hs.709709	Neurogenic differentiation 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002500.2	NP_002491.2	REVIEWED	C	1.000	1.000	356	1071	1	1068	356	1	356
RIKEN	AK056374	flj0003c21	FLJ	W01A003H15	pENTR-TOPO	25307		ZDHHC15	158866	BAB71168.1	Hs.253211	Zinc finger, DHHC-type containing 15	NT2	teratocarcinoma		NT2RI2	EK1	NM_144969.2	NP_659406.1	VALIDATED	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC051323	IRAL047G24	MGC	W01A003H17	pENTR-TOPO	2782		ZNF488	118738	AAH51323.1	Hs.27788	Zinc finger protein 488			Pancreas, ductal carcinoma	NIH_MGC_110		NM_153034.2	NP_694579.1	PROVISIONAL	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC006460	IRAL008D01	MGC	W01A003H18	pENTR-TOPO	9558		HEXIM1	10614	AAH06460.1	Hs.716487	Hexamethylene bis-acetamide inducible 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006460.2	NP_006451.1	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC006460	IRAL008D01	MGC	W01A003H20	pENTR-TOPO	9558		HEXIM1	10614	AAH06460.1	Hs.716487	Hexamethylene bis-acetamide inducible 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006460.2	NP_006451.1	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC002657	IRAL012G09	MGC	W01A003I01	pENTR-TOPO	19328		PPP2CA	5515	AAH02657.1	Hs.105818	Protein phosphatase 2 (formerly 2A), catalytic subunit, alpha isoform			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002715.2	NP_002706.1	REVIEWED	C	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC010430	IRAL023D03	MGC	W01A003I08	pENTR-TOPO	868		YBX1	4904	AAH10430.1	Hs.473583	Y box binding protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004559.3	NP_004550.2	VALIDATED	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC009483	IRAL024I19	MGC	W01A003I10	pENTR-TOPO	19141		IRF1	3659	AAH09483.1	Hs.436061	Interferon regulatory factor 1			Pancreas, adenocarcinoma	NIH_MGC_39		NM_002198.2	NP_002189.1	REVIEWED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	AK056719	flj0013k05	FLJ	W01A003I13	pENTR-TOPO	17554		ZFP42	132625	BAB71264.1	Hs.335787	Zinc finger protein 42 homolog (mouse)				PLACE6	EK1	NM_174900.3	NP_777560.2	VALIDATED	Cs	0.997	0.997	310	933	1	930	310	1	310
RIKEN	BC009483	IRAL024I19	MGC	W01A003I14	pENTR-TOPO	19141		IRF1	3659	AAH09483.1	Hs.436061	Interferon regulatory factor 1			Pancreas, adenocarcinoma	NIH_MGC_39		NM_002198.2	NP_002189.1	REVIEWED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC000126	IRAL006A19	MGC	W01A003I19	pENTR-TOPO	19782		SIRT5	23408	AAH00126.1	Hs.594133	Sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_012241.3	NP_036373.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC009693	IRAK014M06	MGC	W01A003I20	pENTR-TOPO	11941		ZFP36	7538	AAH09693.1	Hs.534052	Zinc finger protein 36, C3H type, homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_003407.2	NP_003398.1	PROVISIONAL	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC000126	IRAL006A19	MGC	W01A003I21	pENTR-TOPO	19782		SIRT5	23408	AAH00126.1	Hs.594133	Sirtuin (silent mating type information regulation 2 homolog) 5 (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_012241.3	NP_036373.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC009693	IRAK014M06	MGC	W01A003I24	pENTR-TOPO	11941		ZFP36	7538	AAH09693.1	Hs.534052	Zinc finger protein 36, C3H type, homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_003407.2	NP_003398.1	PROVISIONAL	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC001159	IRAL008G17	MGC	W01A003J01	pENTR-TOPO	6994		PAX9	5083	AAH01159.1	Hs.132576	Paired box 9			Lung, small cell carcinoma	NIH_MGC_7		NM_006194.2	NP_006185.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC012136	IRAL029D07	MGC	W01A003J02	pENTR-TOPO	7827		ISL2	64843	AAH12136.1	Hs.444677	ISL LIM homeobox 2			Eye, retinoblastoma	NIH_MGC_16		NM_145805.1	NP_665804.1	PROVISIONAL	OK	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC001159	IRAL008G17	MGC	W01A003J03	pENTR-TOPO	6994		PAX9	5083	AAH01159.1	Hs.132576	Paired box 9			Lung, small cell carcinoma	NIH_MGC_7		NM_006194.2	NP_006185.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC001293	IRAK004E06	MGC	W01A003J11	pENTR-TOPO	5347		HOXC10	3226	AAH01293.1	Hs.44276	Homeobox C10			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_017409.3	NP_059105.2	REVIEWED	OK	1.000	1.000	342	1029	1	1026	342	1	342
RIKEN	BC017553	IRAK015M16	MGC	W01A003J18	pENTR-TOPO	20527		TTRAP	51567	AAH17553.1	Hs.716397	TRAF and TNF receptor associated protein			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016614.2	NP_057698.2	REVIEWED	C	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	BC035853	IRAK079N24	MGC	W01A003J19	pENTR-TOPO	20489		ETV7	51513	AAH35853.1	Hs.272398	Ets variant 7			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_016135.2	NP_057219.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC017553	IRAK015M16	MGC	W01A003J24	pENTR-TOPO	20527		TTRAP	51567	AAH17553.1	Hs.716397	TRAF and TNF receptor associated protein			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016614.2	NP_057698.2	REVIEWED	C	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	BC064608	IRAK139B18	MGC	W01A003K01	pENTR-TOPO	19480		MED27	9442	AAH64608.1	Hs.374262	Mediator complex subunit 27			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004269.2	NP_004260.2	REVIEWED	C	1.000	1.000	311	936	1	933	311	1	311
RIKEN	BC064608	IRAK139B18	MGC	W01A003K03	pENTR-TOPO	19480		MED27	9442	AAH64608.1	Hs.374262	Mediator complex subunit 27			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004269.2	NP_004260.2	REVIEWED	C	1.000	1.000	311	936	1	933	311	1	311
RIKEN	BC027930	IRAK049B18	MGC	W01A003K04	pENTR-TOPO	12382		DEDD2	162989	AAH27930.1	Hs.515432	Death effector domain containing 2			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_133328.2	NP_579874.1	PROVISIONAL	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC027930	IRAK049B18	MGC	W01A003K06	pENTR-TOPO	12382		DEDD2	162989	AAH27930.1	Hs.515432	Death effector domain containing 2			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_133328.2	NP_579874.1	PROVISIONAL	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC027930	IRAK049B18	MGC	W01A003K08	pENTR-TOPO	12382		DEDD2	162989	AAH27930.1	Hs.515432	Death effector domain containing 2			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_133328.2	NP_579874.1	PROVISIONAL	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC028035	IRAK062M15	MGC	W01A003K10	pENTR-TOPO	15684		MPPED1	758	AAH28035.1	Hs.592198	Metallophosphoesterase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001044370.1	NP_001037835.1	VALIDATED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC040948	IRAK084H03	MGC	W01A003K11	pENTR-TOPO	22174		HOXA11	3207	AAH40948.1	Hs.249171	Homeobox A11			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_005523.5	NP_005514.1	REVIEWED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC028035	IRAK062M15	MGC	W01A003K14	pENTR-TOPO	15684		MPPED1	758	AAH28035.1	Hs.592198	Metallophosphoesterase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001044370.1	NP_001037835.1	VALIDATED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC010923	IRAL019K10	MGC	W01A003K20	pENTR-TOPO	5592		ALX1	8092	AAH10923.1	Hs.41683	ALX homeobox 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006982.2	NP_008913.2	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC010923	IRAL019K10	MGC	W01A003K22	pENTR-TOPO	5592		ALX1	8092	AAH10923.1	Hs.41683	ALX homeobox 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006982.2	NP_008913.2	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC031406	IRAK050M15	MGC	W01A003L01	pENTR-TOPO	9997		TOB1	10140	AAH31406.1	Hs.719207	Transducer of ERBB2, 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005749.2	NP_005740.1	REVIEWED	C	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC031406	IRAK050M15	MGC	W01A003L03	pENTR-TOPO	9997		TOB1	10140	AAH31406.1	Hs.719207	Transducer of ERBB2, 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005749.2	NP_005740.1	REVIEWED	C	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC003151	IRAL009B24	MGC	W01A003L06	pENTR-TOPO	2072		VPS72	6944	AAH03151.1	Hs.2430	Vacuolar protein sorting 72 homolog (S. cerevisiae)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_005997.1	NP_005988.1	PROVISIONAL	OK	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC001811	IRAL002F21	MGC	W01A003L10	pENTR-TOPO	22663		RRS1	23212	AAH01811.1	Hs.71827	RRS1 ribosome biogenesis regulator homolog (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_015169.3	NP_055984.1	VALIDATED	C	1.000	1.000	365	1098	1	1095	365	1	365
RIKEN	BC039253	IRAK048N03	MGC	W01A003L18	pENTR-TOPO	22480		ZDHHC2	51201	AAH39253.1	Hs.443852	Zinc finger, DHHC-type containing 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_016353.4	NP_057437.1	VALIDATED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC001036	IRAL004C12	MGC	W01A003L19	pENTR-TOPO	7391		XRCC3	7517	AAH01036.1	Hs.719391	X-ray repair complementing defective repair in Chinese hamster cells 3			Placenta, choriocarcinoma	NIH_MGC_21		NM_005432.3	NP_005423.1	REVIEWED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC039253	IRAK048N03	MGC	W01A003L20	pENTR-TOPO	22480		ZDHHC2	51201	AAH39253.1	Hs.443852	Zinc finger, DHHC-type containing 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_016353.4	NP_057437.1	VALIDATED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC039253	IRAK048N03	MGC	W01A003L22	pENTR-TOPO	22480		ZDHHC2	51201	AAH39253.1	Hs.443852	Zinc finger, DHHC-type containing 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_016353.4	NP_057437.1	VALIDATED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC000643	IRAL005H17	MGC	W01A003M03	pENTR-TOPO	15077		DDRGK1	65992	AAH00643.1	Hs.471975	DDRGK domain containing 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_023935.1	NP_076424.1	PROVISIONAL	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC000643	IRAL005H17	MGC	W01A003M05	pENTR-TOPO	15077		DDRGK1	65992	AAH00643.1	Hs.471975	DDRGK domain containing 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_023935.1	NP_076424.1	PROVISIONAL	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC020597	IRAL037O23	MGC	W01A003M09	pENTR-TOPO	2187		GTF2B	2959	AAH20597.1	Hs.481852	General transcription factor IIB			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001514.5	NP_001505.1	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
RIKEN	BC020597	IRAL037O23	MGC	W01A003M15	pENTR-TOPO	2187		GTF2B	2959	AAH20597.1	Hs.481852	General transcription factor IIB			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001514.5	NP_001505.1	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
RIKEN	BC006087	IRAL018B15	MGC	W01A003M16	pENTR-TOPO	1721		HEYL	26508	AAH06087.1	Hs.472566	Hairy/enhancer-of-split related with YRPW motif-like			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_014571.3	NP_055386.1	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC014477	IRAL034L21	MGC	W01A003M24	pENTR-TOPO	13167		HOXD1	3231	AAH14477.1	Hs.83465	Homeobox D1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_024501.1	NP_078777.1	REVIEWED	Cs	0.997	0.997	328	987	1	984	328	1	328
RIKEN	BC021959	IRAK015D03	MGC	W01A003N01	pENTR-TOPO	7779		HMG20A	10363	AAH21959.1	Hs.69594	High-mobility group 20A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018200.2	NP_060670.1	PROVISIONAL	C	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC021959	IRAK015D03	MGC	W01A003N03	pENTR-TOPO	7779		HMG20A	10363	AAH21959.1	Hs.69594	High-mobility group 20A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018200.2	NP_060670.1	PROVISIONAL	C	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC039266	IRAK048N09	MGC	W01A003N06	pENTR-TOPO	11673		DMRTC2	63946	AAH39266.1	Hs.350507	DMRT-like family C2			Testis	NIH_MGC_97	DH10B	NM_001040283.1	NP_001035373.1	VALIDATED	Cs	0.997	0.997	367	1104	1	1101	367	1	367
RIKEN	BC021959	IRAK015D03	MGC	W01A003N07	pENTR-TOPO	7779		HMG20A	10363	AAH21959.1	Hs.69594	High-mobility group 20A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018200.2	NP_060670.1	PROVISIONAL	C	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC009466	IRAL023P11	MGC	W01A003N09	pENTR-TOPO	11867		JUNB	3726	AAH09466.1	Hs.25292	Jun B proto-oncogene			Pancreas, adenocarcinoma	NIH_MGC_39		NM_002229.2	NP_002220.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC019285	IRAL009A10	MGC	W01A003N10	pENTR-TOPO	15555		DRG1	4733	AAH19285.1	Hs.115242	Developmentally regulated GTP binding protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004147.3	NP_004138.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC009466	IRAL023P11	MGC	W01A003N11	pENTR-TOPO	11867		JUNB	3726	AAH09466.1	Hs.25292	Jun B proto-oncogene			Pancreas, adenocarcinoma	NIH_MGC_39		NM_002229.2	NP_002220.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC019285	IRAL009A10	MGC	W01A003N14	pENTR-TOPO	15555		DRG1	4733	AAH19285.1	Hs.115242	Developmentally regulated GTP binding protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004147.3	NP_004138.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC003566	IRAL008J11	MGC	W01A003N20	pENTR-TOPO	11193		ZNF24	7572	AAH03566.1	Hs.514802	Zinc finger protein 24			Lung, small cell carcinoma	NIH_MGC_7		NM_006965.2	NP_008896.2	VALIDATED	Cs	0.997	0.997	368	1107	1	1104	368	1	368
RIKEN	AK025890	flj0061k08	FLJ	W01A003N21	pENTR-TOPO	16388		HDAC11	79885	BAB15272.1	Hs.404802	Histone deacetylase 11				HRC	EK1	NM_024827.3	NP_079103.2	REVIEWED	Cs	0.997	0.997	347	1044	1	1041	347	1	347
RIKEN	AK025890	flj0061k08	FLJ	W01A003N23	pENTR-TOPO	16388		HDAC11	79885	BAB15272.1	Hs.404802	Histone deacetylase 11				HRC	EK1	NM_024827.3	NP_079103.2	REVIEWED	Cs	0.997	0.997	347	1044	1	1041	347	1	347
RIKEN	BC003566	IRAL008J11	MGC	W01A003N24	pENTR-TOPO	11193		ZNF24	7572	AAH03566.1	Hs.514802	Zinc finger protein 24			Lung, small cell carcinoma	NIH_MGC_7		NM_006965.2	NP_008896.2	VALIDATED	Cs	0.997	0.997	368	1107	1	1104	368	1	368
RIKEN	BC013923	IRAL002B15	MGC	W01A003O03	pENTR-TOPO	16549		SOX2	6657	AAH13923.1	Hs.518438	SRY (sex determining region Y)-box 2			Lung, small cell carcinoma	NIH_MGC_7		NM_003106.2	NP_003097.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC013923	IRAL002B15	MGC	W01A003O05	pENTR-TOPO	16549		SOX2	6657	AAH13923.1	Hs.518438	SRY (sex determining region Y)-box 2			Lung, small cell carcinoma	NIH_MGC_7		NM_003106.2	NP_003097.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC000915	IRAK003L07	MGC	W01A003O08	pENTR-TOPO	3263		PDLIM1	9124	AAH00915.1	Hs.368525	PDZ and LIM domain 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_020992.2	NP_066272.1	PROVISIONAL	OK	1.000	1.000	329	990	1	987	329	1	329
RIKEN	BC040261	IRAK051J11	MGC	W01A003O10	pENTR-TOPO	16580		CD86	942	AAH40261.1	Hs.171182	CD86 molecule			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006889.3	NP_008820.2	REVIEWED	Cs	0.994	0.994	323	990	19	987	323	1	323
RIKEN	BC040261	IRAK051J11	MGC	W01A003O16	pENTR-TOPO	16580		CD86	942	AAH40261.1	Hs.171182	CD86 molecule			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006889.3	NP_008820.2	REVIEWED	Cs	0.994	0.994	323	990	19	987	323	1	323
RIKEN	BC035663	IRAK079G13	MGC	W01A003O18	pENTR-TOPO	7141		REM2	161253	AAH35663.1	Hs.444911	RAS (RAD and GEM)-like GTP binding 2			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_173527.2	NP_775798.2	VALIDATED	P	1.000	1.000	330	993	1	990	340	11	340
RIKEN	BC011870	IRAL028A04	MGC	W01A003O21	pENTR-TOPO	8705		ZNF771	51333	AAH11870.2	Hs.148584	Zinc finger protein 771			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001142305.1	NP_001135777.1	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC031213	IRAK063H24	MGC	W01A003P03	pENTR-TOPO	18882		ISL1	3670	AAH31213.1	Hs.505	ISL LIM homeobox 1			Testis	NIH_MGC_97	DH10B	NM_002202.2	NP_002193.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC034043	IRAK032F22	MGC	W01A003P11	pENTR-TOPO	20736		KHDRBS2	202559	AAH34043.1	Hs.716024	KH domain containing, RNA binding, signal transduction associated 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152688.2	NP_689901.2	VALIDATED	Cs	0.997	0.997	349	1050	1	1047	349	1	349
RIKEN	BC019038	IRAL030L11	MGC	W01A004A03	pENTR-TOPO	7210		SNAPC1	6617	AAH19038.1	Hs.179312	Small nuclear RNA activating complex, polypeptide 1, 43kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003082.3	NP_003073.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
RIKEN	BC007435	IRAL003D02	MGC	W01A004A12	pENTR-TOPO	25318		RBMX	27316	AAH07435.1	Hs.380118	RNA binding motif protein, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002139.2	NP_002130.2	REVIEWED	C	1.000	1.000	391	1176	1	1173	391	1	391
RIKEN	BC014984	IRAL034L06	MGC	W01A004A13	pENTR-TOPO	7210		SNAPC1	6617	AAH14984.1	Hs.179312	Small nuclear RNA activating complex, polypeptide 1, 43kDa			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_003082.3	NP_003073.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
RIKEN	BC014894	IRAK015G08	MGC	W01A004A17	pENTR-TOPO	22640		ZNF707	286075	AAH14894.1	Hs.521922	Zinc finger protein 707			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173831.3	NP_776192.2	VALIDATED	Ps	0.997	0.997	369	1110	1	1107	371	3	371
RIKEN	BC014894	IRAK015G08	MGC	W01A004A19	pENTR-TOPO	22640		ZNF707	286075	AAH14894.1	Hs.521922	Zinc finger protein 707			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173831.3	NP_776192.2	VALIDATED	Ps	0.997	0.997	369	1110	1	1107	371	3	371
RIKEN	BC014894	IRAK015G08	MGC	W01A004A21	pENTR-TOPO	22640		ZNF707	286075	AAH14894.1	Hs.521922	Zinc finger protein 707			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173831.3	NP_776192.2	VALIDATED	Ps	0.997	0.997	369	1110	1	1107	371	3	371
RIKEN	BC067286	IRAK141N17	MGC	W01A004B01	pENTR-TOPO	24758		MAGEB6	158809	AAH67286.1	Hs.376011	Melanoma antigen family B, 6			Testis	NIH_MGC_180	DH10B	NM_173523.2	NP_775794.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC067286	IRAK141N17	MGC	W01A004B03	pENTR-TOPO	24758		MAGEB6	158809	AAH67286.1	Hs.376011	Melanoma antigen family B, 6			Testis	NIH_MGC_180	DH10B	NM_173523.2	NP_775794.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC067286	IRAK141N17	MGC	W01A004B05	pENTR-TOPO	24758		MAGEB6	158809	AAH67286.1	Hs.376011	Melanoma antigen family B, 6			Testis	NIH_MGC_180	DH10B	NM_173523.2	NP_775794.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC060832	IRAK133G16	MGC	W01A004B06	pENTR-TOPO	5889		VDR	7421	AAH60832.1	Hs.524368	Vitamin D (1,25- dihydroxyvitamin D3) receptor			Placenta, normal	NIH_MGC_147	DH10B	NM_001017535.1	NP_001017535.1	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	BC067286	IRAK141N17	MGC	W01A004B07	pENTR-TOPO	24758		MAGEB6	158809	AAH67286.1	Hs.376011	Melanoma antigen family B, 6			Testis	NIH_MGC_180	DH10B	NM_173523.2	NP_775794.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC033798	IRAK068J13	MGC	W01A004B12	pENTR-TOPO	18689		SPZ1	84654	AAH33798.1	Hs.519403	Spermatogenic leucine zipper 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032567.3	NP_115956.3	VALIDATED	Cs	0.998	0.998	430	1293	1	1290	430	1	430
RIKEN	BC033798	IRAK068J13	MGC	W01A004B14	pENTR-TOPO	18689		SPZ1	84654	AAH33798.1	Hs.519403	Spermatogenic leucine zipper 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032567.3	NP_115956.3	VALIDATED	Cs	0.998	0.998	430	1293	1	1290	430	1	430
RIKEN	BC008821	IRAL017I09	MGC	W01A004B17	pENTR-TOPO	9314		ZNF764	92595	AAH08821.1	Hs.132227	Zinc finger protein 764			Brain, neuroblastoma	NIH_MGC_19		NM_033410.2	NP_219363.1	PROVISIONAL	OK	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	AK027609	flj0034b02	FLJ	W01A004B18	pENTR-TOPO	10543		HOXB3	3213	BAG51359.1	Hs.654560	Homeobox B3	NT2	teratocarcinoma		NT2RP3	EK1	NM_002146.4	NP_002137.4	REVIEWED	Cs	0.995	0.995	431	1296	1	1293	431	1	431
RIKEN	BC008821	IRAL017I09	MGC	W01A004B19	pENTR-TOPO	9314		ZNF764	92595	AAH08821.1	Hs.132227	Zinc finger protein 764			Brain, neuroblastoma	NIH_MGC_19		NM_033410.2	NP_219363.1	PROVISIONAL	OK	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	AK027609	flj0034b02	FLJ	W01A004B20	pENTR-TOPO	10543		HOXB3	3213	BAG51359.1	Hs.654560	Homeobox B3	NT2	teratocarcinoma		NT2RP3	EK1	NM_002146.4	NP_002137.4	REVIEWED	Cs	0.995	0.995	431	1296	1	1293	431	1	431
RIKEN	BC003569	IRAL008J17	MGC	W01A004C09	pENTR-TOPO	265		ELF3	1999	AAH03569.1	Hs.67928	E74-like factor 3 (ets domain transcription factor, epithelial-specific )			Lung, small cell carcinoma	NIH_MGC_7		NM_004433.4	NP_004424.3	VALIDATED	OK	1.000	1.000	371	1116	1	1113	371	1	371
RIKEN	BC035716	IRAK079E12	MGC	W01A004C10	pENTR-TOPO	7079		IRF9	10379	AAH35716.1	Hs.1706	Interferon regulatory factor 9			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_006084.4	NP_006075.3	VALIDATED	C	1.000	1.000	393	1182	1	1179	393	1	393
RIKEN	BC003569	IRAL008J17	MGC	W01A004C15	pENTR-TOPO	265		ELF3	1999	AAH03569.1	Hs.67928	E74-like factor 3 (ets domain transcription factor, epithelial-specific )			Lung, small cell carcinoma	NIH_MGC_7		NM_004433.4	NP_004424.3	VALIDATED	OK	1.000	1.000	371	1116	1	1113	371	1	371
RIKEN	BC000404	IRAL001K04	MGC	W01A004D06	pENTR-TOPO	18862		TRIP13	9319	AAH00404.1	Hs.436187	Thyroid hormone receptor interactor 13			Lung, small cell carcinoma	NIH_MGC_7		NM_004237.2	NP_004228.1	PROVISIONAL	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC011685	IRAL027M07	MGC	W01A004D09	pENTR-TOPO	6553		TFDP1	7027	AAH11685.1	Hs.79353	Transcription factor Dp-1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007111.4	NP_009042.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC011685	IRAL027M07	MGC	W01A004D11	pENTR-TOPO	6553		TFDP1	7027	AAH11685.1	Hs.79353	Transcription factor Dp-1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007111.4	NP_009042.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC011685	IRAL027M07	MGC	W01A004D13	pENTR-TOPO	6553		TFDP1	7027	AAH11685.1	Hs.79353	Transcription factor Dp-1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007111.4	NP_009042.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC011685	IRAL027M07	MGC	W01A004D15	pENTR-TOPO	6553		TFDP1	7027	AAH11685.1	Hs.79353	Transcription factor Dp-1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007111.4	NP_009042.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC017498	IRAL029H01	MGC	W01A004D20	pENTR-TOPO	697		ZNF643	65243	AAH17498.1	Hs.133034	Zinc finger protein 643			Primary B-Cells from Tonsils	NIH_MGC_48		NM_023070.1	NP_075558.1	PROVISIONAL	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC017498	IRAL029H01	MGC	W01A004D22	pENTR-TOPO	697		ZNF643	65243	AAH17498.1	Hs.133034	Zinc finger protein 643			Primary B-Cells from Tonsils	NIH_MGC_48		NM_023070.1	NP_075558.1	PROVISIONAL	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC005044	IRAL018O19	MGC	W01A004E01	pENTR-TOPO	6218		NFE2	4778	AAH05044.1	Hs.75643	Nuclear factor (erythroid-derived 2), 45kDa			Lung, large cell carcinoma	NIH_MGC_18		NM_006163.1	NP_006154.1	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	AK022425	flj0031c02	FLJ	W01A004E09	pENTR-TOPO	8772		RUNDC2A	84127	BAB14033.1	Hs.458401	RUN domain containing 2A				MAMMA1	EK1	NM_032167.2	NP_115543.2	VALIDATED	Cs	0.995	0.995	375	1128	1	1125	375	1	375
RIKEN	BC010374	IRAL019G04	MGC	W01A004E10	pENTR-TOPO	20058		ZNF193	7746	AAH10374.1	Hs.100921	Zinc finger protein 193			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_006299.3	NP_006290.1	PROVISIONAL	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	AK022425	flj0031c02	FLJ	W01A004E11	pENTR-TOPO	8772		RUNDC2A	84127	BAB14033.1	Hs.458401	RUN domain containing 2A				MAMMA1	EK1	NM_032167.2	NP_115543.2	VALIDATED	Cs	0.995	0.995	375	1128	1	1125	375	1	375
RIKEN	BC010374	IRAL019G04	MGC	W01A004E12	pENTR-TOPO	20058		ZNF193	7746	AAH10374.1	Hs.100921	Zinc finger protein 193			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_006299.3	NP_006290.1	PROVISIONAL	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	AK022425	flj0031c02	FLJ	W01A004E13	pENTR-TOPO	8772		RUNDC2A	84127	BAB14033.1	Hs.458401	RUN domain containing 2A				MAMMA1	EK1	NM_032167.2	NP_115543.2	VALIDATED	Cs	0.995	0.995	375	1128	1	1125	375	1	375
RIKEN	BC010374	IRAL019G04	MGC	W01A004E14	pENTR-TOPO	20058		ZNF193	7746	AAH10374.1	Hs.100921	Zinc finger protein 193			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_006299.3	NP_006290.1	PROVISIONAL	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC010374	IRAL019G04	MGC	W01A004E16	pENTR-TOPO	20058		ZNF193	7746	AAH10374.1	Hs.100921	Zinc finger protein 193			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_006299.3	NP_006290.1	PROVISIONAL	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC003020	IRAL002N07	MGC	W01A004E17	pENTR-TOPO	11804		ZNF557	79230	AAH03020.1	Hs.591380	Zinc finger protein 557			Lung, small cell carcinoma	NIH_MGC_7		NM_001044387.1	NP_001037852.1	VALIDATED	P	1.000	1.000	375	1128	1	1125	430	1	375
RIKEN	BC038962	IRAK082O13	MGC	W01A004E18	pENTR-TOPO	166		CREB3L4	148327	AAH38962.1	Hs.372924	CAMP responsive element binding protein 3-like 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_130898.2	NP_570968.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
RIKEN	BC003020	IRAL002N07	MGC	W01A004E21	pENTR-TOPO	11804		ZNF557	79230	AAH03020.1	Hs.591380	Zinc finger protein 557			Lung, small cell carcinoma	NIH_MGC_7		NM_001044387.1	NP_001037852.1	VALIDATED	P	1.000	1.000	375	1128	1	1125	430	1	375
RIKEN	BC028595	IRAK047P02	MGC	W01A004F02	pENTR-TOPO	633		MAEL	84944	AAH28595.1	Hs.651245	Maelstrom homolog (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032858.1	NP_116247.1	VALIDATED	C	1.000	1.000	434	1305	1	1302	434	1	434
RIKEN	BC028595	IRAK047P02	MGC	W01A004F04	pENTR-TOPO	633		MAEL	84944	AAH28595.1	Hs.651245	Maelstrom homolog (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032858.1	NP_116247.1	VALIDATED	C	1.000	1.000	434	1305	1	1302	434	1	434
RIKEN	BC028595	IRAK047P02	MGC	W01A004F08	pENTR-TOPO	633		MAEL	84944	AAH28595.1	Hs.651245	Maelstrom homolog (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032858.1	NP_116247.1	VALIDATED	C	1.000	1.000	434	1305	1	1302	434	1	434
RIKEN	BC001964	IRAK004B14	MGC	W01A004F09	pENTR-TOPO	3694		ACAD8	27034	AAH01964.1	Hs.14791	Acyl-Coenzyme A dehydrogenase family, member 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014384.2	NP_055199.1	VALIDATED	Cs	0.998	0.998	415	1248	1	1245	415	1	415
RIKEN	BC001964	IRAK004B14	MGC	W01A004F11	pENTR-TOPO	3694		ACAD8	27034	AAH01964.1	Hs.14791	Acyl-Coenzyme A dehydrogenase family, member 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014384.2	NP_055199.1	VALIDATED	Cs	0.998	0.998	415	1248	1	1245	415	1	415
RIKEN	BC001964	IRAK004B14	MGC	W01A004F15	pENTR-TOPO	3694		ACAD8	27034	AAH01964.1	Hs.14791	Acyl-Coenzyme A dehydrogenase family, member 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014384.2	NP_055199.1	VALIDATED	Cs	0.998	0.998	415	1248	1	1245	415	1	415
RIKEN	BC001810	IRAL002J23	MGC	W01A004F18	pENTR-TOPO	1550		ENO1	2023	AAH01810.1	Hs.517145	Enolase 1, (alpha)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001428.2	NP_001419.1	REVIEWED	C	1.000	1.000	434	1305	1	1302	434	1	434
RIKEN	BC001810	IRAL002J23	MGC	W01A004F22	pENTR-TOPO	1550		ENO1	2023	AAH01810.1	Hs.517145	Enolase 1, (alpha)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001428.2	NP_001419.1	REVIEWED	C	1.000	1.000	434	1305	1	1302	434	1	434
RIKEN	BC000482	IRAL001P21	MGC	W01A004G05	pENTR-TOPO	3091		LDB1	8861	AAH00482.1	Hs.454418	LIM domain binding 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003893.4	NP_003884.1	VALIDATED	C	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC001486	IRAL003I13	MGC	W01A004G06	pENTR-TOPO	21978		TSC22D4	81628	AAH01486.1	Hs.719125	TSC22 domain family, member 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_030935.3	NP_112197.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
RIKEN	BC001486	IRAL003I13	MGC	W01A004G08	pENTR-TOPO	21978		TSC22D4	81628	AAH01486.1	Hs.719125	TSC22 domain family, member 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_030935.3	NP_112197.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
RIKEN	BC002603	IRAL004L12	MGC	W01A004G14	pENTR-TOPO	22604		POLR3D	661	AAH02603.1	Hs.148342	Polymerase (RNA) III (DNA directed) polypeptide D, 44kDa			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001722.2	NP_001713.2	REVIEWED	C	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	BC050632	IRAK110I08	MGC	W01A004G18	pENTR-TOPO	18070		LEF1	51176	AAH50632.1	Hs.719332	Lymphoid enhancer-binding factor 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016269.3	NP_057353.1	VALIDATED	OK	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC050632	IRAK110I08	MGC	W01A004G24	pENTR-TOPO	18070		LEF1	51176	AAH50632.1	Hs.719332	Lymphoid enhancer-binding factor 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016269.3	NP_057353.1	VALIDATED	OK	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC035804	IRAK079L09	MGC	W01A004H02	pENTR-TOPO	7522		ZBTB25	7597	AAH35804.1	Hs.654571	Zinc finger and BTB domain containing 25			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006977.2	NP_008908.2	VALIDATED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC036733	IRAK069I04	MGC	W01A004H03	pENTR-TOPO	16758		KLF15	28999	AAH36733.1	Hs.272215	Kruppel-like factor 15			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014079.3	NP_054798.1	VALIDATED	OK	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC035804	IRAK079L09	MGC	W01A004H04	pENTR-TOPO	7522		ZBTB25	7597	AAH35804.1	Hs.654571	Zinc finger and BTB domain containing 25			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006977.2	NP_008908.2	VALIDATED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC035804	IRAK079L09	MGC	W01A004H06	pENTR-TOPO	7522		ZBTB25	7597	AAH35804.1	Hs.654571	Zinc finger and BTB domain containing 25			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006977.2	NP_008908.2	VALIDATED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	AK092261	flj0004j18	FLJ	W01A004H10	pENTR-TOPO	12189		ZNF154	7710	BAC03839.1	Hs.649031	Zinc finger protein 154	NT2	teratocarcinoma		NT2RP7	EK1	NM_001085384.1	NP_001078853.1	VALIDATED	Cs	0.995	0.995	437	1314	1	1311	437	1	437
RIKEN	BC016472	IRAK012I07	MGC	W01A004H15	pENTR-TOPO	13972		PREB	10113	AAH16472.1	Hs.279784	Prolactin regulatory element binding				NCI_CGAP_Brn67	DH10B	NM_013388.4	NP_037520.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC036285	IRAK012P03	MGC	W01A004I03	pENTR-TOPO	9528		PRKAR1A	5573	AAH36285.1	Hs.280342	Protein kinase, cAMP-dependent, regulatory, type I, alpha (tissue specific extinguisher 1)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_212472.1	NP_997637.1	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	BC001042	IRAL002J19	MGC	W01A004I08	pENTR-TOPO	4571		SIRT3	23410	AAH01042.1	Hs.716456	Sirtuin (silent mating type information regulation 2 homolog) 3 (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_001017524.2	NP_001017524.1	VALIDATED	C	1.000	1.000	257	1200	427	1197	257	1	257
RIKEN	BC020716	IRAL037G09	MGC	W01A004I24	pENTR-TOPO	451		BLZF1	8548	AAH20716.1	Hs.130746	Basic leucine zipper nuclear factor 1			Liver	NIH_MGC_76	DH10B	NM_003666.2	NP_003657.1	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	AK055857	flj0014i04	FLJ	W01A004J04	pENTR-TOPO	6096		ZNF641	121274	BAB71031.1	Hs.23492	Zinc finger protein 641				KIDNE2	EK1	NM_152320.1	NP_689533.1	PROVISIONAL	OK	1.000	1.000	438	1317	1	1314	438	1	438
RIKEN	BC002579	IRAL004D12	MGC	W01A004J10	pENTR-TOPO	11823		GCDH	2639	AAH02579.1	Hs.532699	Glutaryl-Coenzyme A dehydrogenase			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_000159.2	NP_000150.1	REVIEWED	OK	1.000	1.000	438	1317	1	1314	438	1	438
RIKEN	BC002579	IRAL004D12	MGC	W01A004J12	pENTR-TOPO	11823		GCDH	2639	AAH02579.1	Hs.532699	Glutaryl-Coenzyme A dehydrogenase			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_000159.2	NP_000150.1	REVIEWED	OK	1.000	1.000	438	1317	1	1314	438	1	438
RIKEN	BC007911	IRAL020L13	MGC	W01A004J15	pENTR-TOPO	11559		CALR	811	AAH07911.1	Hs.515162	Calreticulin			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_004343.3	NP_004334.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC002527	IRAL004I14	MGC	W01A004J21	pENTR-TOPO	7934		FAH	2184	AAH02527.1	Hs.73875	Fumarylacetoacetate hydrolase (fumarylacetoacetase)			Placenta, choriocarcinoma	NIH_MGC_21		NM_000137.1	NP_000128.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC002527	IRAL004I14	MGC	W01A004J23	pENTR-TOPO	7934		FAH	2184	AAH02527.1	Hs.73875	Fumarylacetoacetate hydrolase (fumarylacetoacetase)			Placenta, choriocarcinoma	NIH_MGC_21		NM_000137.1	NP_000128.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC036567	IRAK076N05	MGC	W01A004K10	pENTR-TOPO	25653		HSFY1	86614	AAH36567.1	Hs.662281	Heat shock transcription factor, Y-linked 1			Testis	NIH_MGC_97	DH10B	NM_033108.2	NP_149099.2	REVIEWED	OK	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC036567	IRAK076N05	MGC	W01A004K12	pENTR-TOPO	25653		HSFY1	86614	AAH36567.1	Hs.662281	Heat shock transcription factor, Y-linked 1			Testis	NIH_MGC_97	DH10B	NM_033108.2	NP_149099.2	REVIEWED	OK	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC036567	IRAK076N05	MGC	W01A004K16	pENTR-TOPO	25653		HSFY1	86614	AAH36567.1	Hs.662281	Heat shock transcription factor, Y-linked 1			Testis	NIH_MGC_97	DH10B	NM_033108.2	NP_149099.2	REVIEWED	OK	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC000274	IRAL006M04	MGC	W01A004K19	pENTR-TOPO	11824		SSBP4	170463	AAH00274.1	Hs.515259	Single stranded DNA binding protein 4			Eye, retinoblastoma	NIH_MGC_16		NM_032627.2	NP_116016.1	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
RIKEN	BC064356	IRAK134P06	MGC	W01A004K24	pENTR-TOPO	12478		ZNF558	148156	AAH64356.1	Hs.659797	Zinc finger protein 558			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_144693.1	NP_653294.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	BC017222	IRAL020K01	MGC	W01A004L04	pENTR-TOPO	1014		SQSTM1	8878	AAH17222.1	Hs.437277	Sequestosome 1			Uterus, leiomyosarcoma	NIH_MGC_46		NM_003900.4	NP_003891.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC033149	IRAL043D21	MGC	W01A004L13	pENTR-TOPO	11812		ZNF584	201514	AAH33149.1	Hs.439551	Zinc finger protein 584			Brain, neuroblastoma	NIH_MGC_19		NM_173548.1	NP_775819.1	PROVISIONAL	C	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	BC005167	IRAL011G08	MGC	W01A004L14	pENTR-TOPO	11751		ZNF773	374928	AAH05167.1	Hs.579576	Zinc finger protein 773			Lung, small cell carcinoma	NIH_MGC_7		NM_198542.1	NP_940944.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
RIKEN	BC009274	IRAL015L08	MGC	W01A004L17	pENTR-TOPO	24128		REXO4	57109	AAH09274.1	Hs.438409	REX4, RNA exonuclease 4 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_020385.2	NP_065118.2	VALIDATED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC009274	IRAL015L08	MGC	W01A004L19	pENTR-TOPO	24128		REXO4	57109	AAH09274.1	Hs.438409	REX4, RNA exonuclease 4 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_020385.2	NP_065118.2	VALIDATED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC009274	IRAL015L08	MGC	W01A004L23	pENTR-TOPO	24128		REXO4	57109	AAH09274.1	Hs.438409	REX4, RNA exonuclease 4 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_020385.2	NP_065118.2	VALIDATED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC039574	IRAK084N13	MGC	W01A004N06	pENTR-TOPO	11192		VPS4B	9525	AAH39574.1	Hs.126550	Vacuolar protein sorting 4 homolog B (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004869.3	NP_004860.2	REVIEWED	C	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC040161	IRAK084G14	MGC	W01A004N18	pENTR-TOPO	15932		ZNF70	7621	AAH40161.1	Hs.382874	Zinc finger protein 70			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021916.2	NP_068735.1	PROVISIONAL	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC037282	IRAK047K16	MGC	W01A004N19	pENTR-TOPO	24310		ZBTB6	10773	AAH37282.1	Hs.654596	Zinc finger and BTB domain containing 6			Testis	NIH_MGC_97	DH10B	NM_006626.4	NP_006617.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC040161	IRAK084G14	MGC	W01A004N20	pENTR-TOPO	15932		ZNF70	7621	AAH40161.1	Hs.382874	Zinc finger protein 70			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021916.2	NP_068735.1	PROVISIONAL	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC037282	IRAK047K16	MGC	W01A004N23	pENTR-TOPO	24310		ZBTB6	10773	AAH37282.1	Hs.654596	Zinc finger and BTB domain containing 6			Testis	NIH_MGC_97	DH10B	NM_006626.4	NP_006617.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC001932	IRAL009I15	MGC	W01A004O04	pENTR-TOPO	9661		PSMC5	5705	AAH01932.1	Hs.79387	Proteasome (prosome, macropain) 26S subunit, ATPase, 5			Lung, small cell carcinoma	NIH_MGC_7		NM_002805.4	NP_002796.4	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	BC002487	IRAL005P24	MGC	W01A004O05	pENTR-TOPO	4834		TSG101	7251	AAH02487.1	Hs.523512	Tumor susceptibility gene 101			Eye, retinoblastoma	NIH_MGC_16		NM_006292.2	NP_006283.1	REVIEWED	Cs	0.997	0.997	390	1173	1	1170	390	1	390
RIKEN	BC001932	IRAL009I15	MGC	W01A004O06	pENTR-TOPO	9661		PSMC5	5705	AAH01932.1	Hs.79387	Proteasome (prosome, macropain) 26S subunit, ATPase, 5			Lung, small cell carcinoma	NIH_MGC_7		NM_002805.4	NP_002796.4	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	BC032319	IRAK064O05	MGC	W01A004O18	pENTR-TOPO	932		MNDA	4332	AAH32319.1	Hs.153837	Myeloid cell nuclear differentiation antigen			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002432.1	NP_002423.1	REVIEWED	OK	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC032319	IRAK064O05	MGC	W01A004O20	pENTR-TOPO	932		MNDA	4332	AAH32319.1	Hs.153837	Myeloid cell nuclear differentiation antigen			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002432.1	NP_002423.1	REVIEWED	OK	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC032319	IRAK064O05	MGC	W01A004O24	pENTR-TOPO	932		MNDA	4332	AAH32319.1	Hs.153837	Myeloid cell nuclear differentiation antigen			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002432.1	NP_002423.1	REVIEWED	OK	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC003092	IRAL006K08	MGC	W01A004P01	pENTR-TOPO	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Eye, retinoblastoma	NIH_MGC_16		NM_001135256.1	NP_001128728.1	REVIEWED	C	1.000	1.000	390	1278	106	1275	390	1	390
RIKEN	BC003092	IRAL006K08	MGC	W01A004P03	pENTR-TOPO	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Eye, retinoblastoma	NIH_MGC_16		NM_001135256.1	NP_001128728.1	REVIEWED	C	1.000	1.000	390	1278	106	1275	390	1	390
RIKEN	BC003092	IRAL006K08	MGC	W01A004P05	pENTR-TOPO	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Eye, retinoblastoma	NIH_MGC_16		NM_001135256.1	NP_001128728.1	REVIEWED	C	1.000	1.000	390	1278	106	1275	390	1	390
RIKEN	BC000093	IRAL007D04	MGC	W01A004P23	pENTR-TOPO	3672		DDB2	1643	AAH00093.1	Hs.700338	Damage-specific DNA binding protein 2, 48kDa			Brain, neuroblastoma	NIH_MGC_19		NM_000107.2	NP_000098.1	REVIEWED	C	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	BC037225	IRAK028M05	MGC	W01A005A03	pENTR-TOPO	20105		TFAP2B	7021	AAH37225.2	Hs.33102	Transcription factor AP-2 beta (activating enhancer binding protein 2 beta)			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003221.3	NP_003212.2	REVIEWED	P	1.000	1.000	449	1350	1	1347	460	12	460
RIKEN	BC037225	IRAK028M05	MGC	W01A005A05	pENTR-TOPO	20105		TFAP2B	7021	AAH37225.2	Hs.33102	Transcription factor AP-2 beta (activating enhancer binding protein 2 beta)			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003221.3	NP_003212.2	REVIEWED	P	1.000	1.000	449	1350	1	1347	460	12	460
RIKEN	AK022668	flj0032p05	FLJ	W01A005A06	pENTR-TOPO	1858		ZNF669	79862	BAB14166.1	Hs.163754	Zinc finger protein 669	NT2	teratocarcinoma		NT2RM4	EK1	NM_024804.2	NP_079080.2	VALIDATED	Cs	0.996	0.996	464	1395	1	1392	464	1	464
RIKEN	AK022668	flj0032p05	FLJ	W01A005A08	pENTR-TOPO	1858		ZNF669	79862	BAB14166.1	Hs.163754	Zinc finger protein 669	NT2	teratocarcinoma		NT2RM4	EK1	NM_024804.2	NP_079080.2	VALIDATED	Cs	0.996	0.996	464	1395	1	1392	464	1	464
RIKEN	BC001060	IRAL002B20	MGC	W01A005A09	pENTR-TOPO	14064		PAX8	7849	AAH01060.1	Hs.469728	Paired box 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003466.3	NP_003457.1	REVIEWED	C	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	BC001060	IRAL002B20	MGC	W01A005A15	pENTR-TOPO	14064		PAX8	7849	AAH01060.1	Hs.469728	Paired box 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003466.3	NP_003457.1	REVIEWED	C	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	AK001753	flj0020g21	FLJ	W01A005A18	pENTR-TOPO	11694		ZNF701	55762	BAA91884.1	Hs.710468	Zinc finger protein 701	NT2	teratocarcinoma		NT2RP4	EK1	NM_018260.1	NP_060730.1	PROVISIONAL	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC013808	IRAK026B05	MGC	W01A005A19	pENTR-TOPO	1829		TAF1A	9015	AAH13808.1	Hs.153088	TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005681.2	NP_005672.1	REVIEWED	C	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	AK001753	flj0020g21	FLJ	W01A005A22	pENTR-TOPO	11694		ZNF701	55762	BAA91884.1	Hs.710468	Zinc finger protein 701	NT2	teratocarcinoma		NT2RP4	EK1	NM_018260.1	NP_060730.1	PROVISIONAL	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC013808	IRAK026B05	MGC	W01A005A23	pENTR-TOPO	1829		TAF1A	9015	AAH13808.1	Hs.153088	TATA box binding protein (TBP)-associated factor, RNA polymerase I, A, 48kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005681.2	NP_005672.1	REVIEWED	C	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	BC016623	IRAK013B05	MGC	W01A005B01	pENTR-TOPO	10705		ETV4	2118	AAH16623.1	Hs.434059	Ets variant 4			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001986.2	NP_001977.1	VALIDATED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	BC016623	IRAK013B05	MGC	W01A005B03	pENTR-TOPO	10705		ETV4	2118	AAH16623.1	Hs.434059	Ets variant 4			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001986.2	NP_001977.1	VALIDATED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	BC003634	IRAL011O13	MGC	W01A005B04	pENTR-TOPO	6215		TFCP2	7024	AAH03634.1	Hs.48849	Transcription factor CP2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005653.3	NP_005644.2	PROVISIONAL	C	1.000	1.000	502	1509	1	1506	502	1	502
RIKEN	BC016623	IRAK013B05	MGC	W01A005B05	pENTR-TOPO	10705		ETV4	2118	AAH16623.1	Hs.434059	Ets variant 4			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001986.2	NP_001977.1	VALIDATED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	BC016623	IRAK013B05	MGC	W01A005B07	pENTR-TOPO	10705		ETV4	2118	AAH16623.1	Hs.434059	Ets variant 4			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001986.2	NP_001977.1	VALIDATED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	AK096011	flj0045e22	FLJ	W01A005B14	pENTR-TOPO	23611		DMRTA1	63951	BAC04672.1	Hs.371976	DMRT-like family A1				KIDNE2	EK1	NM_022160.2	NP_071443.2	VALIDATED	Cs	0.996	0.996	504	1515	1	1512	504	1	504
RIKEN	BC013291	IRAL011L19	MGC	W01A005B15	pENTR-TOPO	2684		SUFU	51684	AAH13291.1	Hs.404089	Suppressor of fused homolog (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016169.2	NP_057253.2	PROVISIONAL	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	AK096011	flj0045e22	FLJ	W01A005B16	pENTR-TOPO	23611		DMRTA1	63951	BAC04672.1	Hs.371976	DMRT-like family A1				KIDNE2	EK1	NM_022160.2	NP_071443.2	VALIDATED	Cs	0.996	0.996	504	1515	1	1512	504	1	504
RIKEN	BC006495	IRAL002H19	MGC	W01A005B18	pENTR-TOPO	12261		FARSA	2193	AAH06495.1	Hs.23111	Phenylalanyl-tRNA synthetase, alpha subunit			Lung, small cell carcinoma	NIH_MGC_7		NM_004461.2	NP_004452.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC006495	IRAL002H19	MGC	W01A005B22	pENTR-TOPO	12261		FARSA	2193	AAH06495.1	Hs.23111	Phenylalanyl-tRNA synthetase, alpha subunit			Lung, small cell carcinoma	NIH_MGC_7		NM_004461.2	NP_004452.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC051829	IRAK110K11	MGC	W01A005C03	pENTR-TOPO	14811		TFAP2C	7022	AAH51829.2	Hs.473152	Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003222.3	NP_003213.1	REVIEWED	C	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	BC051829	IRAK110K11	MGC	W01A005C07	pENTR-TOPO	14811		TFAP2C	7022	AAH51829.2	Hs.473152	Transcription factor AP-2 gamma (activating enhancer binding protein 2 gamma)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003222.3	NP_003213.1	REVIEWED	C	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	BC015752	IRAL034G16	MGC	W01A005C13	pENTR-TOPO	20087		IRF4	3662	AAH15752.1	Hs.401013	Interferon regulatory factor 4			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002460.2	NP_002451.2	VALIDATED	C	1.000	1.000	451	1356	1	1353	451	1	451
RIKEN	BC047286	IRAK093G05	MGC	W01A005C16	pENTR-TOPO	23242		LRRC6	23639	AAH47286.1	Hs.591865	Leucine rich repeat containing 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012472.3	NP_036604.2	PROVISIONAL	OK	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	BC035594	IRAK069P24	MGC	W01A005D02	pENTR-TOPO	13289		UBXN4	23190	AAH35594.1	Hs.591242	UBX domain protein 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014607.3	NP_055422.1	VALIDATED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC035594	IRAK069P24	MGC	W01A005D04	pENTR-TOPO	13289		UBXN4	23190	AAH35594.1	Hs.591242	UBX domain protein 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014607.3	NP_055422.1	VALIDATED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC035594	IRAK069P24	MGC	W01A005D06	pENTR-TOPO	13289		UBXN4	23190	AAH35594.1	Hs.591242	UBX domain protein 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014607.3	NP_055422.1	VALIDATED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC016758	IRAL003I05	MGC	W01A005D07	pENTR-TOPO	17113		HCLS1	3059	AAH16758.1	Hs.14601	Hematopoietic cell-specific Lyn substrate 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_005335.4	NP_005326.2	VALIDATED	Cs	0.998	0.998	486	1461	1	1458	486	1	486
RIKEN	BC035594	IRAK069P24	MGC	W01A005D08	pENTR-TOPO	13289		UBXN4	23190	AAH35594.1	Hs.591242	UBX domain protein 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014607.3	NP_055422.1	VALIDATED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC024259	IRAL023N19	MGC	W01A005D12	pENTR-TOPO	11475		ZNF419	79744	AAH24259.1	Hs.710285	Zinc finger protein 419			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_024691.3	NP_078967.3	VALIDATED	Cs	0.996	0.996	510	1533	1	1530	510	1	510
RIKEN	BC024259	IRAL023N19	MGC	W01A005D14	pENTR-TOPO	11475		ZNF419	79744	AAH24259.1	Hs.710285	Zinc finger protein 419			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_024691.3	NP_078967.3	VALIDATED	Cs	0.996	0.996	510	1533	1	1530	510	1	510
RIKEN	BC008297	IRAL023L01	MGC	W01A005D22	pENTR-TOPO	11475		ZNF419	79744	AAH08297.1	Hs.710285	Zinc finger protein 419			Skin, melanotic melanoma.	NIH_MGC_20		NM_024691.3	NP_078967.3	VALIDATED	Cs	0.996	0.996	510	1533	1	1530	510	1	510
RIKEN	BC035031	IRAK047I09	MGC	W01A005E03	pENTR-TOPO	15256		GABPA	2551	AAH35031.1	Hs.473470	GA binding protein transcription factor, alpha subunit 60kDa			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002040.3	NP_002031.2	VALIDATED	Cs	0.998	0.998	454	1365	1	1362	454	1	454
RIKEN	BC008828	IRAL017F06	MGC	W01A005E04	pENTR-TOPO	23438		ZBTB43	23099	AAH08828.1	Hs.718657	Zinc finger and BTB domain containing 43			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_014007.3	NP_054726.1	VALIDATED	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC008053	IRAL024B12	MGC	W01A005E12	pENTR-TOPO	129		DMAP1	55929	AAH08053.1	Hs.8008	DNA methyltransferase 1 associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001034024.1	NP_001029196.1	REVIEWED	OK	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC008053	IRAL024B12	MGC	W01A005E14	pENTR-TOPO	129		DMAP1	55929	AAH08053.1	Hs.8008	DNA methyltransferase 1 associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001034024.1	NP_001029196.1	REVIEWED	OK	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC056400	IRAK089C20	MGC	W01A005E18	pENTR-TOPO	1439		ZNF436	80818	AAH56400.1	Hs.293798	Zinc finger protein 436			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001077195.1	NP_001070663.1	VALIDATED	C	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC056400	IRAK089C20	MGC	W01A005E24	pENTR-TOPO	1439		ZNF436	80818	AAH56400.1	Hs.293798	Zinc finger protein 436			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001077195.1	NP_001070663.1	VALIDATED	C	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC032707	IRAK069F10	MGC	W01A005F08	pENTR-TOPO	10387		IKZF3	22806	AAH32707.1	Hs.444388	IKAROS family zinc finger 3 (Aiolos)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_012481.3	NP_036613.2	REVIEWED	OK	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC009364	IRAL026O22	MGC	W01A005F18	pENTR-TOPO	593		TOE1	114034	AAH09364.1	Hs.525091	Target of EGR1, member 1 (nuclear)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_025077.3	NP_079353.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
RIKEN	BC009364	IRAL026O22	MGC	W01A005F20	pENTR-TOPO	593		TOE1	114034	AAH09364.1	Hs.525091	Target of EGR1, member 1 (nuclear)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_025077.3	NP_079353.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
RIKEN	BC009364	IRAL026O22	MGC	W01A005F22	pENTR-TOPO	593		TOE1	114034	AAH09364.1	Hs.525091	Target of EGR1, member 1 (nuclear)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_025077.3	NP_079353.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
RIKEN	BC009364	IRAL026O22	MGC	W01A005F24	pENTR-TOPO	593		TOE1	114034	AAH09364.1	Hs.525091	Target of EGR1, member 1 (nuclear)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_025077.3	NP_079353.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
RIKEN	AK096138	flj0041k16	FLJ	W01A005G19	pENTR-TOPO	8853		ANKS4B	257629	BAC04707.1	Hs.115959	Ankyrin repeat and sterile alpha motif domain containing 4B				LIVER2	EK1	NM_145865.2	NP_665872.2	VALIDATED	C	1.000	1.000	417	1383	1	1251	417	1	417
RIKEN	AK096138	flj0041k16	FLJ	W01A005G23	pENTR-TOPO	8853		ANKS4B	257629	BAC04707.1	Hs.115959	Ankyrin repeat and sterile alpha motif domain containing 4B				LIVER2	EK1	NM_145865.2	NP_665872.2	VALIDATED	C	1.000	1.000	417	1383	1	1251	417	1	417
RIKEN	AK091724	flj0001p09	FLJ	W01A005H03	pENTR-TOPO	13100		SMYD1	150572	BAC03732.1	Hs.516176	SET and MYND domain containing 1				HEART1	EK1	NM_198274.2	NP_938015.1	PROVISIONAL	C	1.000	1.000	490	1473	1	1470	490	1	490
RIKEN	AK091724	flj0001p09	FLJ	W01A005H05	pENTR-TOPO	13100		SMYD1	150572	BAC03732.1	Hs.516176	SET and MYND domain containing 1				HEART1	EK1	NM_198274.2	NP_938015.1	PROVISIONAL	C	1.000	1.000	490	1473	1	1470	490	1	490
RIKEN	AK091724	flj0001p09	FLJ	W01A005H07	pENTR-TOPO	13100		SMYD1	150572	BAC03732.1	Hs.516176	SET and MYND domain containing 1				HEART1	EK1	NM_198274.2	NP_938015.1	PROVISIONAL	C	1.000	1.000	490	1473	1	1470	490	1	490
RIKEN	AK092326	flj0010e12	FLJ	W01A005H22	pENTR-TOPO	512		ZBTB8A	653121	BAC03863	Hs.546479	Zinc finger and BTB domain containing 8A				OCBBF2	EK1	NM_001040441.1	NP_001035531.1	VALIDATED		0.360	0.427	467	1539	1	1383	441	1	399
RIKEN	BC033890	IRAK047O19	MGC	W01A005I02	pENTR-TOPO	7582		FOXA1	3169	AAH33890.1	Hs.163484	Forkhead box A1			Testis	NIH_MGC_97	DH10B	NM_004496.2	NP_004487.2	REVIEWED	C	1.000	1.000	472	1419	1	1416	472	1	472
RIKEN	AK074846	flj0018a14	FLJ	W01A005I05	pENTR-TOPO	11511		ZNF627	199692	BAC11240.1	Hs.526665	Zinc finger protein 627	NT2	teratocarcinoma		NT2RP2	EK1	NM_145295.3	NP_660338.1	VALIDATED	OK	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	AK098183	flj0024o07	FLJ	W01A005I09	pENTR-TOPO	11446		ZNF17	7565	BAC05252.1	Hs.710278	Zinc finger protein 17				TRACH2	EK1	NM_006959.2	NP_008890.2	VALIDATED	Ps	0.998	0.998	460	1383	1	1380	662	1	460
RIKEN	BC047309	IRAK093E24	MGC	W01A005I10	pENTR-TOPO	21173		ZSCAN21	7589	AAH47309.1	Hs.632294	Zinc finger and SCAN domain containing 21			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_145914.2	NP_666019.1	VALIDATED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	AK098183	flj0024o07	FLJ	W01A005I11	pENTR-TOPO	11446		ZNF17	7565	BAC05252.1	Hs.710278	Zinc finger protein 17				TRACH2	EK1	NM_006959.2	NP_008890.2	VALIDATED	Ps	0.998	0.998	460	1383	1	1380	662	1	460
RIKEN	BC047309	IRAK093E24	MGC	W01A005I12	pENTR-TOPO	21173		ZSCAN21	7589	AAH47309.1	Hs.632294	Zinc finger and SCAN domain containing 21			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_145914.2	NP_666019.1	VALIDATED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	AK098183	flj0024o07	FLJ	W01A005I13	pENTR-TOPO	11446		ZNF17	7565	BAC05252.1	Hs.710278	Zinc finger protein 17				TRACH2	EK1	NM_006959.2	NP_008890.2	VALIDATED	Ps	0.998	0.998	460	1383	1	1380	662	1	460
RIKEN	AK093445	flj0016i22	FLJ	W01A005I24	pENTR-TOPO	21962		ASZ1	136991	BAC04167.1	Hs.352412	Ankyrin repeat, SAM and basic leucine zipper domain containing 1				TESTI2	EK1	NM_130768.2	NP_570124.1	VALIDATED	C	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC037869	IRAK075D11	MGC	W01A005J08	pENTR-TOPO	18182		TIGD4	201798	AAH37869.1	Hs.301243	Tigger transposable element derived 4			Testis	NIH_MGC_97	DH10B	NM_145720.2	NP_663772.1	REVIEWED	Cs	0.998	0.998	512	1539	1	1536	512	1	512
RIKEN	BC002636	IRAL012C07	MGC	W01A005J11	pENTR-TOPO	12563		ZSCAN5A	79149	AAH02636.1	Hs.177688	Zinc finger and SCAN domain containing 5A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_024303.1	NP_077279.1	PROVISIONAL	OK	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC002636	IRAL012C07	MGC	W01A005J13	pENTR-TOPO	12563		ZSCAN5A	79149	AAH02636.1	Hs.177688	Zinc finger and SCAN domain containing 5A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_024303.1	NP_077279.1	PROVISIONAL	OK	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC064912	IRAK140G03	MGC	W01A005J20	pENTR-TOPO	3706		KAT5	10524	AAH64912.1	Hs.397010	K(lysine) acetyltransferase 5			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006388.2	NP_006379.2	REVIEWED	OK	1.000	1.000	513	1542	1	1539	513	1	513
RIKEN	BC007790	IRAL020A19	MGC	W01A005K03	pENTR-TOPO	11772		NR1H2	7376	AAH07790.1	Hs.432976	Nuclear receptor subfamily 1, group H, member 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_007121.4	NP_009052.3	VALIDATED	C	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	AK098623	flj0053g24	FLJ	W01A005K09	pENTR-TOPO	20515		EEF1A1	1915	-	Hs.713109	Eukaryotic translation elongation factor 1 alpha 1				TST	EK1	NM_001402.5	NP_001393.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	AK098623	flj0053g24	FLJ	W01A005K13	pENTR-TOPO	20515		EEF1A1	1915	-	Hs.713109	Eukaryotic translation elongation factor 1 alpha 1				TST	EK1	NM_001402.5	NP_001393.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC000397	IRAL001I04	MGC	W01A005K16	pENTR-TOPO	25157		GPKOW	27238	AAH00397.1	Hs.503666	G patch domain and KOW motifs			Lung, small cell carcinoma	NIH_MGC_7		NM_015698.3	NP_056513.2	PROVISIONAL	OK	1.000	1.000	476	1431	1	1428	476	1	476
RIKEN	BC066893	IRAK167E02	MGC	W01A005K23	pENTR-TOPO	20515		EEF1A1	1915	AAH66893.1	Hs.713109	Eukaryotic translation elongation factor 1 alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001402.5	NP_001393.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC035582	IRAK069P11	MGC	W01A005L01	pENTR-TOPO	4041		TRIM22	10346	AAH35582.1	Hs.684559	Tripartite motif-containing 22			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006074.3	NP_006065.2	REVIEWED	C	1.000	1.000	498	1497	1	1494	498	1	498
RIKEN	BC035582	IRAK069P11	MGC	W01A005L03	pENTR-TOPO	4041		TRIM22	10346	AAH35582.1	Hs.684559	Tripartite motif-containing 22			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006074.3	NP_006065.2	REVIEWED	C	1.000	1.000	498	1497	1	1494	498	1	498
RIKEN	BC022329	IRAL035K09	MGC	W01A005L04	pENTR-TOPO	21109		HBP1	26959	AAH22329.1	Hs.162032	HMG-box transcription factor 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_012257.3	NP_036389.2	VALIDATED	Cs	0.996	0.996	514	1545	1	1542	514	1	514
RIKEN	BC035582	IRAK069P11	MGC	W01A005L05	pENTR-TOPO	4041		TRIM22	10346	AAH35582.1	Hs.684559	Tripartite motif-containing 22			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006074.3	NP_006065.2	REVIEWED	C	1.000	1.000	498	1497	1	1494	498	1	498
RIKEN	BC035582	IRAK069P11	MGC	W01A005L07	pENTR-TOPO	4041		TRIM22	10346	AAH35582.1	Hs.684559	Tripartite motif-containing 22			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006074.3	NP_006065.2	REVIEWED	C	1.000	1.000	498	1497	1	1494	498	1	498
RIKEN	BC020172	IRAL029I09	MGC	W01A005L12	pENTR-TOPO	20380		ZBTB2	57621	AAH20172.1	Hs.520073	Zinc finger and BTB domain containing 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_020861.1	NP_065912.1	PROVISIONAL	OK	1.000	1.000	514	1545	1	1542	514	1	514
RIKEN	BC026190	IRAK047D14	MGC	W01A005L17	pENTR-TOPO	22710		ZNF596	169270	AAH26190.2	Hs.591388	Zinc finger protein 596			Testis	NIH_MGC_97	DH10B	NM_001042416.1	NP_001035881.1	VALIDATED	Ps	0.998	0.998	498	1497	1	1494	504	7	504
RIKEN	BC026190	IRAK047D14	MGC	W01A005L19	pENTR-TOPO	22710		ZNF596	169270	AAH26190.2	Hs.591388	Zinc finger protein 596			Testis	NIH_MGC_97	DH10B	NM_001042416.1	NP_001035881.1	VALIDATED	Ps	0.998	0.998	498	1497	1	1494	504	7	504
RIKEN	BC026190	IRAK047D14	MGC	W01A005L21	pENTR-TOPO	22710		ZNF596	169270	AAH26190.2	Hs.591388	Zinc finger protein 596			Testis	NIH_MGC_97	DH10B	NM_001042416.1	NP_001035881.1	VALIDATED	Ps	0.998	0.998	498	1497	1	1494	504	7	504
RIKEN	BC009733	IRAK014B15	MGC	W01A005M01	pENTR-TOPO	20515		EEF1A1	1915	AAH09733.1	Hs.713109	Eukaryotic translation elongation factor 1 alpha 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001402.5	NP_001393.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC004992	IRAL009D02	MGC	W01A005M02	pENTR-TOPO	12615		ZNF577	84765	AAH04992.1	Hs.148322	Zinc finger protein 577			Skin, melanotic melanoma.	NIH_MGC_20		NM_032679.2	NP_116068.2	VALIDATED	Ps	0.994	0.994	478	1437	1	1434	485	8	485
RIKEN	BC004992	IRAL009D02	MGC	W01A005M06	pENTR-TOPO	12615		ZNF577	84765	AAH04992.1	Hs.148322	Zinc finger protein 577			Skin, melanotic melanoma.	NIH_MGC_20		NM_032679.2	NP_116068.2	VALIDATED	Ps	0.994	0.994	478	1437	1	1434	485	8	485
RIKEN	BC014442	IRAL034J14	MGC	W01A005M09	pENTR-TOPO	18099		INTS12	57117	AAH14442.1	Hs.480454	Integrator complex subunit 12			Colon, adenocarcinoma	NIH_MGC_15		NM_001142471.1	NP_001135943.1	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC064698	IRAK133J20	MGC	W01A005M10	pENTR-TOPO	13969		TFCP2L1	29842	AAH64698.1	Hs.156471	Transcription factor CP2-like 1			Placenta, normal	NIH_MGC_147	DH10B	NM_014553.2	NP_055368.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	BC014442	IRAL034J14	MGC	W01A005M11	pENTR-TOPO	18099		INTS12	57117	AAH14442.1	Hs.480454	Integrator complex subunit 12			Colon, adenocarcinoma	NIH_MGC_15		NM_001142471.1	NP_001135943.1	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC014442	IRAL034J14	MGC	W01A005M15	pENTR-TOPO	18099		INTS12	57117	AAH14442.1	Hs.480454	Integrator complex subunit 12			Colon, adenocarcinoma	NIH_MGC_15		NM_001142471.1	NP_001135943.1	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC009433	IRAL022P01	MGC	W01A005M21	pENTR-TOPO	11616		ZNF331	55422	AAH09433.1	Hs.185674	Zinc finger protein 331			Eye, retinoblastoma	NIH_MGC_16		NM_001079906.1	NP_001073375.1	VALIDATED	Cs	0.998	0.998	463	1392	1	1389	463	1	463
RIKEN	BC022264	IRAL035G18	MGC	W01A005N03	pENTR-TOPO	130		NFIA	4774	AAH22264.1	Hs.594180	Nuclear factor I/A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_005595.4	NP_005586.1	REVIEWED	C	1.000	1.000	498	1497	1	1494	498	1	498
RIKEN	BC009368	IRAL026B15	MGC	W01A005N04	pENTR-TOPO	5306		SMARCD1	6602	AAH09368.3	Hs.79335	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003076.4	NP_003067.3	REVIEWED	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC062309	IRAL050C02	MGC	W01A005N09	pENTR-TOPO	23646		ZNF79	7633	AAH62309.1	Hs.522399	Zinc finger protein 79			Lung, small cell carcinoma	NIH_MGC_7		NM_007135.2	NP_009066.2	VALIDATED	Cs	0.996	0.996	498	1497	1	1494	498	1	498
RIKEN	BC062309	IRAL050C02	MGC	W01A005N11	pENTR-TOPO	23646		ZNF79	7633	AAH62309.1	Hs.522399	Zinc finger protein 79			Lung, small cell carcinoma	NIH_MGC_7		NM_007135.2	NP_009066.2	VALIDATED	Cs	0.996	0.996	498	1497	1	1494	498	1	498
RIKEN	AK096559	flj0041b06	FLJ	W01A005N16	pENTR-TOPO	11808		ZNF480	147657	BAC04817.1	Hs.147025	Zinc finger protein 480				OCBBF2	EK1	NM_144684.2	NP_653285.2	VALIDATED	P	1.000	1.000	516	1551	1	1548	535	20	535
RIKEN	BC001970	IRAK004A14	MGC	W01A005N17	pENTR-TOPO	11483		PPP5C	5536	AAH01970.1	Hs.654604	Protein phosphatase 5, catalytic subunit			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006247.2	NP_006238.1	PROVISIONAL	OK	1.000	1.000	499	1500	1	1497	499	1	499
RIKEN	AK055489	flj0013j12	FLJ	W01A005N18	pENTR-TOPO	12477		ZNF582	147948	BAB70931.1	Hs.244391	Zinc finger protein 582				FEBRA2	EK1	NM_144690.1	NP_653291.1	PROVISIONAL	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC001970	IRAK004A14	MGC	W01A005N19	pENTR-TOPO	11483		PPP5C	5536	AAH01970.1	Hs.654604	Protein phosphatase 5, catalytic subunit			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006247.2	NP_006238.1	PROVISIONAL	OK	1.000	1.000	499	1500	1	1497	499	1	499
RIKEN	BC001970	IRAK004A14	MGC	W01A005N21	pENTR-TOPO	11483		PPP5C	5536	AAH01970.1	Hs.654604	Protein phosphatase 5, catalytic subunit			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006247.2	NP_006238.1	PROVISIONAL	OK	1.000	1.000	499	1500	1	1497	499	1	499
RIKEN	BC001970	IRAK004A14	MGC	W01A005N23	pENTR-TOPO	11483		PPP5C	5536	AAH01970.1	Hs.654604	Protein phosphatase 5, catalytic subunit			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006247.2	NP_006238.1	PROVISIONAL	OK	1.000	1.000	499	1500	1	1497	499	1	499
RIKEN	AK055489	flj0013j12	FLJ	W01A005N24	pENTR-TOPO	12477		ZNF582	147948	BAB70931.1	Hs.244391	Zinc finger protein 582				FEBRA2	EK1	NM_144690.1	NP_653291.1	PROVISIONAL	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC015613	IRAL033M11	MGC	W01A005O04	pENTR-TOPO	17175		GATA2	2624	AAH15613.1	Hs.367725	GATA binding protein 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_001145661.1	NP_001139133.1	REVIEWED	C	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC022466	IRAK032C09	MGC	W01A005O14	pENTR-TOPO	11602		ZNF223	7766	AAH22466.1					Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013361.4	NP_037493.3	VALIDATED	Cs	0.998	0.998	482	1449	1	1446	482	1	482
RIKEN	BC012063	IRAL029J10	MGC	W01A005O17	pENTR-TOPO	2033		RXRG	6258	AAH12063.1	Hs.26550	Retinoid X receptor, gamma			Eye, retinoblastoma	NIH_MGC_16		NM_006917.3	NP_008848.1	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
RIKEN	BC012063	IRAL029J10	MGC	W01A005O19	pENTR-TOPO	2033		RXRG	6258	AAH12063.1	Hs.26550	Retinoid X receptor, gamma			Eye, retinoblastoma	NIH_MGC_16		NM_006917.3	NP_008848.1	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
RIKEN	BC000301	IRAL001C09	MGC	W01A005O22	pENTR-TOPO	860		HDAC1	3065	AAH00301.1	Hs.88556	Histone deacetylase 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004964.2	NP_004955.2	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
RIKEN	BC014000	IRAL028F05	MGC	W01A005P01	pENTR-TOPO	9106		ZNF689	115509	AAH14000.1	Hs.454685	Zinc finger protein 689			Lung, small cell carcinoma	NIH_MGC_7		NM_138447.1	NP_612456.1	PROVISIONAL	C	1.000	1.000	500	1503	1	1500	500	1	500
RIKEN	BC023667	IRAL039N22	MGC	W01A005P15	pENTR-TOPO	9358		IRX3	79191	AAH23667.1	Hs.499205	Iroquois homeobox 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024336.2	NP_077312.2	VALIDATED	Cs	0.998	0.998	501	1506	1	1503	501	1	501
RIKEN	BC001652	IRAL002G04	MGC	W01A005P19	pENTR-TOPO	5535		PWP1	11137	AAH01652.1	Hs.506652	PWP1 homolog (S. cerevisiae)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_007062.1	NP_008993.1	PROVISIONAL	Cs	0.994	0.994	501	1506	1	1503	501	1	501
RIKEN	BC001652	IRAL002G04	MGC	W01A005P21	pENTR-TOPO	5535		PWP1	11137	AAH01652.1	Hs.506652	PWP1 homolog (S. cerevisiae)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_007062.1	NP_008993.1	PROVISIONAL	Cs	0.994	0.994	501	1506	1	1503	501	1	501
RIKEN	BC013007	IRAL010G14	MGC	W01A006A09	pENTR-TOPO	12656		GTF2F1	2962	AAH13007.1	Hs.68257	General transcription factor IIF, polypeptide 1, 74kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002096.2	NP_002087.2	VALIDATED	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC013007	IRAL010G14	MGC	W01A006A11	pENTR-TOPO	12656		GTF2F1	2962	AAH13007.1	Hs.68257	General transcription factor IIF, polypeptide 1, 74kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002096.2	NP_002087.2	VALIDATED	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC013007	IRAL010G14	MGC	W01A006A15	pENTR-TOPO	12656		GTF2F1	2962	AAH13007.1	Hs.68257	General transcription factor IIF, polypeptide 1, 74kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002096.2	NP_002087.2	VALIDATED	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC062584	IRAK135I05	MGC	W01A006A19	pENTR-TOPO	7422		RIPK3	11035	AAH62584.1	Hs.268551	Receptor-interacting serine-threonine kinase 3			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006871.3	NP_006862.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC062584	IRAK135I05	MGC	W01A006A23	pENTR-TOPO	7422		RIPK3	11035	AAH62584.1	Hs.268551	Receptor-interacting serine-threonine kinase 3			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006871.3	NP_006862.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC050038	IRAK091D12	MGC	W01A006B04	pENTR-TOPO	12713		ZNF677	342926	AAH50038.1	Hs.20506	Zinc finger protein 677			Testis	NIH_MGC_97	DH10B	NM_182609.2	NP_872415.1	PROVISIONAL	C	1.000	1.000	584	1755	1	1752	584	1	584
RIKEN	BC050038	IRAK091D12	MGC	W01A006B06	pENTR-TOPO	12713		ZNF677	342926	AAH50038.1	Hs.20506	Zinc finger protein 677			Testis	NIH_MGC_97	DH10B	NM_182609.2	NP_872415.1	PROVISIONAL	C	1.000	1.000	584	1755	1	1752	584	1	584
RIKEN	AK002053	flj0020m04	FLJ	W01A006B11	pENTR-TOPO	12423		ZNF415	55786	BAA92059.1	Hs.147765	Zinc finger protein 415				PLACE1	EK1	NM_018355.2	NP_060825.2	VALIDATED	Cs	0.996	0.996	555	1668	1	1665	555	1	555
RIKEN	AK002053	flj0020m04	FLJ	W01A006B13	pENTR-TOPO	12423		ZNF415	55786	BAA92059.1	Hs.147765	Zinc finger protein 415				PLACE1	EK1	NM_018355.2	NP_060825.2	VALIDATED	Cs	0.996	0.996	555	1668	1	1665	555	1	555
RIKEN	AK002053	flj0020m04	FLJ	W01A006B15	pENTR-TOPO	12423		ZNF415	55786	BAA92059.1	Hs.147765	Zinc finger protein 415				PLACE1	EK1	NM_018355.2	NP_060825.2	VALIDATED	Cs	0.996	0.996	555	1668	1	1665	555	1	555
RIKEN	BC040594	IRAK074J17	MGC	W01A006B16	pENTR-TOPO	21325		ZNF92	168374	AAH40594.1	Hs.9521	Zinc finger protein 92			Testis	NIH_MGC_97	DH10B	NM_152626.2	NP_689839.1	VALIDATED	OK	1.000	1.000	586	1761	1	1758	586	1	586
RIKEN	BC025728	IRAK049E06	MGC	W01A006B21	pENTR-TOPO	12458		ZNF671	79891	AAH25728.1	Hs.180402	Zinc finger protein 671			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_024833.2	NP_079109.2	VALIDATED	C	1.000	1.000	534	1671	1	1602	534	1	534
RIKEN	BC025728	IRAK049E06	MGC	W01A006B23	pENTR-TOPO	12458		ZNF671	79891	AAH25728.1	Hs.180402	Zinc finger protein 671			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_024833.2	NP_079109.2	VALIDATED	C	1.000	1.000	534	1671	1	1602	534	1	534
RIKEN	BC060768	IRAK133I17	MGC	W01A006C01	pENTR-TOPO	24736		ZNF449	203523	AAH60768.1	Hs.28780	Zinc finger protein 449			Placenta, normal	NIH_MGC_147	DH10B	NM_152695.5	NP_689908.3	VALIDATED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	AK023467	flj0036l12	FLJ	W01A006C02	pENTR-TOPO	12352		ZNF350	59348	BAB14583.1	Hs.407694	Zinc finger protein 350				PLACE1	EK1	NM_021632.3	NP_067645.3	VALIDATED	Cs	0.996	0.996	532	1599	1	1596	532	1	532
RIKEN	BC060768	IRAK133I17	MGC	W01A006C03	pENTR-TOPO	24736		ZNF449	203523	AAH60768.1	Hs.28780	Zinc finger protein 449			Placenta, normal	NIH_MGC_147	DH10B	NM_152695.5	NP_689908.3	VALIDATED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	AK023467	flj0036l12	FLJ	W01A006C04	pENTR-TOPO	12352		ZNF350	59348	BAB14583.1	Hs.407694	Zinc finger protein 350				PLACE1	EK1	NM_021632.3	NP_067645.3	VALIDATED	Cs	0.996	0.996	532	1599	1	1596	532	1	532
RIKEN	BC060768	IRAK133I17	MGC	W01A006C05	pENTR-TOPO	24736		ZNF449	203523	AAH60768.1	Hs.28780	Zinc finger protein 449			Placenta, normal	NIH_MGC_147	DH10B	NM_152695.5	NP_689908.3	VALIDATED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	AK023467	flj0036l12	FLJ	W01A006C06	pENTR-TOPO	12352		ZNF350	59348	BAB14583.1	Hs.407694	Zinc finger protein 350				PLACE1	EK1	NM_021632.3	NP_067645.3	VALIDATED	Cs	0.996	0.996	532	1599	1	1596	532	1	532
RIKEN	BC013597	IRAK012M06	MGC	W01A006C09	pENTR-TOPO	16548		ZNF35	7584	AAH13597.2	Hs.288658	Zinc finger protein 35			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_003420.3	NP_003411.3	VALIDATED	P	1.000	1.000	519	1560	1	1557	527	9	527
RIKEN	BC032577	IRAK069E10	MGC	W01A006C10	pENTR-TOPO	12182		ZFP82	284406	AAH32577.1	Hs.558734	Zinc finger protein 82 homolog (mouse)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133466.2	NP_597723.1	PROVISIONAL	C	1.000	1.000	532	1599	1	1596	532	1	532
RIKEN	BC013597	IRAK012M06	MGC	W01A006C11	pENTR-TOPO	16548		ZNF35	7584	AAH13597.2	Hs.288658	Zinc finger protein 35			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_003420.3	NP_003411.3	VALIDATED	P	1.000	1.000	519	1560	1	1557	527	9	527
RIKEN	BC032577	IRAK069E10	MGC	W01A006C14	pENTR-TOPO	12182		ZFP82	284406	AAH32577.1	Hs.558734	Zinc finger protein 82 homolog (mouse)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133466.2	NP_597723.1	PROVISIONAL	C	1.000	1.000	532	1599	1	1596	532	1	532
RIKEN	BC017337	IRAL039H03	MGC	W01A006C17	pENTR-TOPO	23564		GTF3C5	9328	AAH17337.1	Hs.495417	General transcription factor IIIC, polypeptide 5, 63kDa			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_012087.3	NP_036219.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
RIKEN	BC017337	IRAL039H03	MGC	W01A006C19	pENTR-TOPO	23564		GTF3C5	9328	AAH17337.1	Hs.495417	General transcription factor IIIC, polypeptide 5, 63kDa			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_012087.3	NP_036219.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
RIKEN	BC017337	IRAL039H03	MGC	W01A006C23	pENTR-TOPO	23564		GTF3C5	9328	AAH17337.1	Hs.495417	General transcription factor IIIC, polypeptide 5, 63kDa			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_012087.3	NP_036219.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
RIKEN	BC017714	IRAK027I02	MGC	W01A006D03	pENTR-TOPO	10717		HNF1B	6928	AAH17714.1	Hs.191144	HNF1 homeobox B			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_000458.2	NP_000449.1	VALIDATED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC017714	IRAK027I02	MGC	W01A006D05	pENTR-TOPO	10717		HNF1B	6928	AAH17714.1	Hs.191144	HNF1 homeobox B			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_000458.2	NP_000449.1	VALIDATED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC064393	IRAK139M01	MGC	W01A006D08	pENTR-TOPO	23657		FPGS	2356	AAH64393.1	Hs.335084	Folylpolyglutamate synthase			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004957.4	NP_004948.4	REVIEWED	Cs	0.997	0.997	587	1764	1	1761	587	1	587
RIKEN	BC017091	IRAK020M20	MGC	W01A006D09	pENTR-TOPO	22977		ZNF250	58500	AAH17091.2	Hs.532277	Zinc finger protein 250			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_021061.3	NP_066405.1	VALIDATED	C	1.000	1.000	560	1683	1	1680	560	1	560
RIKEN	BC017352	IRAL039L19	MGC	W01A006D12	pENTR-TOPO	4632		TRIM29	23650	AAH17352.1	Hs.504115	Tripartite motif-containing 29			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_012101.3	NP_036233.2	REVIEWED	C	1.000	1.000	588	1767	1	1764	588	1	588
RIKEN	BC017091	IRAK020M20	MGC	W01A006D13	pENTR-TOPO	22977		ZNF250	58500	AAH17091.2	Hs.532277	Zinc finger protein 250			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_021061.3	NP_066405.1	VALIDATED	C	1.000	1.000	560	1683	1	1680	560	1	560
RIKEN	BC017352	IRAL039L19	MGC	W01A006D14	pENTR-TOPO	4632		TRIM29	23650	AAH17352.1	Hs.504115	Tripartite motif-containing 29			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_012101.3	NP_036233.2	REVIEWED	C	1.000	1.000	588	1767	1	1764	588	1	588
RIKEN	BC017091	IRAK020M20	MGC	W01A006D15	pENTR-TOPO	22977		ZNF250	58500	AAH17091.2	Hs.532277	Zinc finger protein 250			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_021061.3	NP_066405.1	VALIDATED	C	1.000	1.000	560	1683	1	1680	560	1	560
RIKEN	BC051847	IRAK110G23	MGC	W01A006D21	pENTR-TOPO	21982		ZNF394	84124	AAH51847.1	Hs.386324	Zinc finger protein 394			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_032164.2	NP_115540.2	PROVISIONAL	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	BC018137	IRAK020G23	MGC	W01A006D22	pENTR-TOPO	13281		TAF1B	9014	AAH18137.1	Hs.584833	TATA box binding protein (TBP)-associated factor, RNA polymerase I, B, 63kDa			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_005680.2	NP_005671.2	REVIEWED	Cs	0.995	0.995	588	1767	1	1764	588	1	588
RIKEN	BC051847	IRAK110G23	MGC	W01A006D23	pENTR-TOPO	21982		ZNF394	84124	AAH51847.1	Hs.386324	Zinc finger protein 394			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_032164.2	NP_115540.2	PROVISIONAL	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	BC002586	IRAL004F04	MGC	W01A006E06	pENTR-TOPO	2076		POLR3C	10623	AAH02586.1	Hs.591457	Polymerase (RNA) III (DNA directed) polypeptide C (62kD)			Ovary, adenocarcinoma	NIH_MGC_9		NM_006468.6	NP_006459.3	PROVISIONAL	OK	1.000	1.000	534	1605	1	1602	534	1	534
RIKEN	BC002948	IRAL008O11	MGC	W01A006E07	pENTR-TOPO	1516		ZNF692	55657	AAH02948.1	Hs.377705	Zinc finger protein 692			Lung, small cell carcinoma	NIH_MGC_7		NM_017865.2	NP_060335.2	PROVISIONAL	OK	1.000	1.000	519	1560	1	1557	519	1	519
RIKEN	BC014097	IRAL028P16	MGC	W01A006E09	pENTR-TOPO	3648		CREB3L1	90993	AAH14097.1	Hs.405961	CAMP responsive element binding protein 3-like 1			Colon, adenocarcinoma	NIH_MGC_15		NM_052854.2	NP_443086.1	VALIDATED	Cs	0.998	0.998	519	1560	1	1557	519	1	519
RIKEN	AK023094	flj0034l16	FLJ	W01A006E14	pENTR-TOPO	12434		ZNF20	7568	BAB14401.1	Hs.709334	Zinc finger protein 20	NT2	teratocarcinoma		NT2RP3	EK1	NM_021143.2	NP_066966.2	VALIDATED	Cfs	0.994	0.994	532	1611	1	1595	532	1	532
RIKEN	BC013760	IRAK013D07	MGC	W01A006E21	pENTR-TOPO	9276		ZNF768	79724	AAH13760.1	Hs.85658	Zinc finger protein 768			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_024671.3	NP_078947.3	VALIDATED	Ps	0.998	0.998	520	1563	1	1560	540	21	540
RIKEN	BC052269	IRAL047N21	MGC	W01A006F04	pENTR-TOPO	15009		ZBTB46	140685	AAH52269.1	Hs.585028	Zinc finger and BTB domain containing 46			Prostate, carcinoma	NIH_MGC_40		NM_025224.2	NP_079500.1	PROVISIONAL	Cs	0.997	0.997	589	1770	1	1767	589	1	589
RIKEN	BC047702	IRAK098A09	MGC	W01A006F14	pENTR-TOPO	23686		ZNF169	169841	AAH47702.1	Hs.387623	Zinc finger protein 169			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194320.2	NP_919301.2	VALIDATED	P	1.000	1.000	590	1773	1	1770	603	14	603
RIKEN	BC022378	IRAL036K04	MGC	W01A006F19	pENTR-TOPO	21232		ZKSCAN1	7586	AAH22378.1	Hs.615360	Zinc finger with KRAB and SCAN domains 1			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_003439.1	NP_003430.1	VALIDATED	Cs	0.998	0.998	563	1692	1	1689	563	1	563
RIKEN	BC022378	IRAL036K04	MGC	W01A006F23	pENTR-TOPO	21232		ZKSCAN1	7586	AAH22378.1	Hs.615360	Zinc finger with KRAB and SCAN domains 1			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_003439.1	NP_003430.1	VALIDATED	Cs	0.998	0.998	563	1692	1	1689	563	1	563
RIKEN	BC014952	IRAL034G11	MGC	W01A006F24	pENTR-TOPO	14632		TH1L	51497	AAH14952.1	Hs.517148	TH1-like (Drosophila)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_198976.1	NP_945327.1	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC014194	IRAL030B13	MGC	W01A006G01	pENTR-TOPO	24647		TBX22	50945	AAH14194.2	Hs.374253	T-box 22			Skin, melanotic melanoma.	NIH_MGC_20		NM_016954.2	NP_058650.1	REVIEWED	C	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC014194	IRAL030B13	MGC	W01A006G03	pENTR-TOPO	24647		TBX22	50945	AAH14194.2	Hs.374253	T-box 22			Skin, melanotic melanoma.	NIH_MGC_20		NM_016954.2	NP_058650.1	REVIEWED	C	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC014194	IRAL030B13	MGC	W01A006G05	pENTR-TOPO	24647		TBX22	50945	AAH14194.2	Hs.374253	T-box 22			Skin, melanotic melanoma.	NIH_MGC_20		NM_016954.2	NP_058650.1	REVIEWED	C	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC014194	IRAL030B13	MGC	W01A006G07	pENTR-TOPO	24647		TBX22	50945	AAH14194.2	Hs.374253	T-box 22			Skin, melanotic melanoma.	NIH_MGC_20		NM_016954.2	NP_058650.1	REVIEWED	C	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC026070	IRAK034M11	MGC	W01A006G09	pENTR-TOPO	12704		TULP2	7288	AAH26070.1	Hs.104636	Tubby like protein 2			Testis	NIH_MGC_97	DH10B	NM_003323.2	NP_003314.2	VALIDATED	C	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC006118	IRAL018D04	MGC	W01A006G10	pENTR-TOPO	20014		ZKSCAN3	80317	AAH06118.1	Hs.485004	Zinc finger with KRAB and SCAN domains 3			Placenta, choriocarcinoma	NIH_MGC_21		NM_024493.2	NP_077819.2	VALIDATED	Cs	0.996	0.996	538	1617	1	1614	538	1	538
RIKEN	BC006118	IRAL018D04	MGC	W01A006G12	pENTR-TOPO	20014		ZKSCAN3	80317	AAH06118.1	Hs.485004	Zinc finger with KRAB and SCAN domains 3			Placenta, choriocarcinoma	NIH_MGC_21		NM_024493.2	NP_077819.2	VALIDATED	Cs	0.996	0.996	538	1617	1	1614	538	1	538
RIKEN	BC006118	IRAL018D04	MGC	W01A006G14	pENTR-TOPO	20014		ZKSCAN3	80317	AAH06118.1	Hs.485004	Zinc finger with KRAB and SCAN domains 3			Placenta, choriocarcinoma	NIH_MGC_21		NM_024493.2	NP_077819.2	VALIDATED	Cs	0.996	0.996	538	1617	1	1614	538	1	538
RIKEN	BC041348	IRAK075A14	MGC	W01A006G19	pENTR-TOPO	19294		MIER3	166968	AAH41348.2	Hs.657594	Mesoderm induction early response 1, family member 3			Testis	NIH_MGC_97	DH10B	NM_152622.3	NP_689835.3	VALIDATED	Ps	0.998	0.998	522	1569	1	1566	549	28	549
RIKEN	BC006436	IRAL018M14	MGC	W01A006G20	pENTR-TOPO	11444		ZNF559	84527	AAH06436.1	Hs.655107	Zinc finger protein 559			Placenta, choriocarcinoma	NIH_MGC_21		NM_032497.1	NP_115886.1	PROVISIONAL	OK	1.000	1.000	538	1617	1	1614	538	1	538
RIKEN	BC006436	IRAL018M14	MGC	W01A006G22	pENTR-TOPO	11444		ZNF559	84527	AAH06436.1	Hs.655107	Zinc finger protein 559			Placenta, choriocarcinoma	NIH_MGC_21		NM_032497.1	NP_115886.1	PROVISIONAL	OK	1.000	1.000	538	1617	1	1614	538	1	538
RIKEN	BC053514	IRAL047H08	MGC	W01A006H03	pENTR-TOPO	10372		TRIM16	10626	AAH53514.1	Hs.123534	Tripartite motif-containing 16			Skin, melanoma, melanotic	NIH_MGC_112		NM_006470.3	NP_006461.3	REVIEWED	Cs	0.998	0.998	564	1695	1	1692	564	1	564
RIKEN	BC053514	IRAL047H08	MGC	W01A006H05	pENTR-TOPO	10372		TRIM16	10626	AAH53514.1	Hs.123534	Tripartite motif-containing 16			Skin, melanoma, melanotic	NIH_MGC_112		NM_006470.3	NP_006461.3	REVIEWED	Cs	0.998	0.998	564	1695	1	1692	564	1	564
RIKEN	BC060828	IRAK133E22	MGC	W01A006H12	pENTR-TOPO	11888		ARID3A	1820	AAH60828.1	Hs.501296	AT rich interactive domain 3A (BRIGHT-like)			Placenta, normal	NIH_MGC_147	DH10B	NM_005224.2	NP_005215.1	REVIEWED	Cs	0.995	0.995	593	1782	1	1779	593	1	593
RIKEN	BC060828	IRAK133E22	MGC	W01A006H16	pENTR-TOPO	11888		ARID3A	1820	AAH60828.1	Hs.501296	AT rich interactive domain 3A (BRIGHT-like)			Placenta, normal	NIH_MGC_147	DH10B	NM_005224.2	NP_005215.1	REVIEWED	Cs	0.995	0.995	593	1782	1	1779	593	1	593
RIKEN	BC001760	IRAL006F01	MGC	W01A006H21	pENTR-TOPO	21187		REPIN1	29803	AAH01760.1	Hs.647086	Replication initiator 1			Eye, retinoblastoma	NIH_MGC_16		NM_013400.3	NP_037532.2	VALIDATED	Cs	0.998	0.998	567	1704	1	1701	567	1	567
RIKEN	BC060865	IRAK133F06	MGC	W01A006H22	pENTR-TOPO	11406		ZNF530	348327	AAH60865.1	Hs.97111	Zinc finger protein 530			Placenta, normal	NIH_MGC_147	DH10B	NM_020880.3	NP_065931.3	VALIDATED	Cs	0.997	0.997	599	1800	1	1797	599	1	599
RIKEN	BC024227	IRAL038P03	MGC	W01A006I02	pENTR-TOPO	11182		ZNF519	162655	AAH24227.1	Hs.352635	Zinc finger protein 519			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_145287.2	NP_660330.1	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
RIKEN	BC024227	IRAL038P03	MGC	W01A006I04	pENTR-TOPO	11182		ZNF519	162655	AAH24227.1	Hs.352635	Zinc finger protein 519			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_145287.2	NP_660330.1	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
RIKEN	BC054520	IRAK110J06	MGC	W01A006I05	pENTR-TOPO	1528		MEF2D	4209	AAH54520.1	Hs.314327	Myocyte enhancer factor 2D			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005920.2	NP_005911.1	PROVISIONAL	OK	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC047235	IRAK106H01	MGC	W01A006I10	pENTR-TOPO	16936		UBP1	7342	AAH47235.1	Hs.643744	Upstream binding protein 1 (LBP-1a)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001128161.1	NP_001121633.1	VALIDATED	Cs	0.998	0.998	540	1623	1	1620	540	1	540
RIKEN	BC047235	IRAK106H01	MGC	W01A006I12	pENTR-TOPO	16936		UBP1	7342	AAH47235.1	Hs.643744	Upstream binding protein 1 (LBP-1a)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001128161.1	NP_001121633.1	VALIDATED	Cs	0.998	0.998	540	1623	1	1620	540	1	540
RIKEN	BC016925	IRAK027D18	MGC	W01A006I13	pENTR-TOPO	21428		NRF1	4899	AAH16925.1	Hs.654363	Nuclear respiratory factor 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_005011.3	NP_005002.3	REVIEWED	Cg	0.964	1.000	522	1569	1	1566	503	1	503
RIKEN	BC016925	IRAK027D18	MGC	W01A006I15	pENTR-TOPO	21428		NRF1	4899	AAH16925.1	Hs.654363	Nuclear respiratory factor 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_005011.3	NP_005002.3	REVIEWED	Cg	0.964	1.000	522	1569	1	1566	503	1	503
RIKEN	BC008361	IRAL023P19	MGC	W01A006I19	pENTR-TOPO	15565		FBXO7	25793	AAH08361.1	Hs.5912	F-box protein 7			Pancreas, adenocarcinoma	NIH_MGC_39		NM_012179.3	NP_036311.3	REVIEWED	Cs	0.998	0.998	522	1569	1	1566	522	1	522
RIKEN	BC002597	IRAL004J14	MGC	W01A006I20	pENTR-TOPO	5277		CNOT2	4848	AAH02597.1	Hs.719156	CCR4-NOT transcription complex, subunit 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_014515.4	NP_055330.1	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
RIKEN	BC002549	IRAL004H11	MGC	W01A006J03	pENTR-TOPO	20062		ZNF76	7629	AAH02549.1	Hs.388024	Zinc finger protein 76 (expressed in testis)			Placenta, choriocarcinoma	NIH_MGC_21		NM_003427.3	NP_003418.2	PROVISIONAL	OK	1.000	1.000	570	1713	1	1710	570	1	570
RIKEN	BC052311	IRAL047P10	MGC	W01A006J09	pENTR-TOPO	23071		PRDM14	63978	AAH52311.1	Hs.287532	PR domain containing 14			Ovary, teratocarcinoma	NIH_MGC_109		NM_024504.2	NP_078780.1	VALIDATED	Cs	0.998	0.998	571	1716	1	1713	571	1	571
RIKEN	BC052311	IRAL047P10	MGC	W01A006J11	pENTR-TOPO	23071		PRDM14	63978	AAH52311.1	Hs.287532	PR domain containing 14			Ovary, teratocarcinoma	NIH_MGC_109		NM_024504.2	NP_078780.1	VALIDATED	Cs	0.998	0.998	571	1716	1	1713	571	1	571
RIKEN	BC052311	IRAL047P10	MGC	W01A006J15	pENTR-TOPO	23071		PRDM14	63978	AAH52311.1	Hs.287532	PR domain containing 14			Ovary, teratocarcinoma	NIH_MGC_109		NM_024504.2	NP_078780.1	VALIDATED	Cs	0.998	0.998	571	1716	1	1713	571	1	571
RIKEN	BC025249	IRAL042P23	MGC	W01A006J17	pENTR-TOPO	4742		ZBTB3	79842	AAH25249.1	Hs.147554	Zinc finger and BTB domain containing 3			Skin, melanoma, amelanotic	NIH_MGC_41		NM_024784.3	NP_079060.1	VALIDATED	C	1.000	1.000	574	1725	1	1722	574	1	574
RIKEN	BC009288	IRAL020L22	MGC	W01A006J20	pENTR-TOPO	14215		NR4A2	4929	AAH09288.1	Hs.563344	Nuclear receptor subfamily 4, group A, member 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_173173.1	NP_775265.1	REVIEWED	C	1.000	1.000	535	1797	190	1794	535	1	535
RIKEN	BC009288	IRAL020L22	MGC	W01A006J22	pENTR-TOPO	14215		NR4A2	4929	AAH09288.1	Hs.563344	Nuclear receptor subfamily 4, group A, member 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_173173.1	NP_775265.1	REVIEWED	C	1.000	1.000	535	1797	190	1794	535	1	535
RIKEN	BC009288	IRAL020L22	MGC	W01A006J24	pENTR-TOPO	14215		NR4A2	4929	AAH09288.1	Hs.563344	Nuclear receptor subfamily 4, group A, member 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_173173.1	NP_775265.1	REVIEWED	C	1.000	1.000	535	1797	190	1794	535	1	535
RIKEN	BC047501	IRAK091A03	MGC	W01A006K04	pENTR-TOPO	12428		ZNF329	79673	AAH47501.1	Hs.458377	Zinc finger protein 329			Testis	NIH_MGC_97	DH10B	NM_024620.3	NP_078896.3	VALIDATED	Cs	0.998	0.998	541	1626	1	1623	541	1	541
RIKEN	BC047501	IRAK091A03	MGC	W01A006K06	pENTR-TOPO	12428		ZNF329	79673	AAH47501.1	Hs.458377	Zinc finger protein 329			Testis	NIH_MGC_97	DH10B	NM_024620.3	NP_078896.3	VALIDATED	Cs	0.998	0.998	541	1626	1	1623	541	1	541
RIKEN	BC052282	IRAL047D02	MGC	W01A006K16	pENTR-TOPO	13829		ZNF513	130557	AAH52282.1	Hs.515872	Zinc finger protein 513			Skin, melanoma, amelanotic	NIH_MGC_41		NM_144631.4	NP_653232.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
RIKEN	BC042500	IRAK071H14	MGC	W01A006K19	pENTR-TOPO	902		ZNF678	339500	AAH42500.1	Hs.30323	Zinc finger protein 678			Testis	NIH_MGC_97	DH10B	NM_178549.2	NP_848644.1	PROVISIONAL	C	1.000	1.000	525	1578	1	1575	525	1	525
RIKEN	BC026027	IRAL042E05	MGC	W01A006L09	pENTR-TOPO	25357		TFE3	7030	AAH26027.1	Hs.274184	Transcription factor binding to IGHM enhancer 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_006521.3	NP_006512.2	PROVISIONAL	OK	1.000	1.000	575	1728	1	1725	575	1	575
RIKEN	BC026027	IRAL042E05	MGC	W01A006L11	pENTR-TOPO	25357		TFE3	7030	AAH26027.1	Hs.274184	Transcription factor binding to IGHM enhancer 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_006521.3	NP_006512.2	PROVISIONAL	OK	1.000	1.000	575	1728	1	1725	575	1	575
RIKEN	BC042146	IRAL044P20	MGC	W01A006L14	pENTR-TOPO	10937		KIAA0427	9811	AAH42146.1	Hs.145230	KIAA0427			Brain, neuroblastoma	NIH_MGC_47		NM_001142397.1	NP_001135869.1	VALIDATED	C	1.000	1.000	600	1803	1	1800	600	1	600
RIKEN	BC011558	IRAL029A18	MGC	W01A006L20	pENTR-TOPO	13843		NFE2L2	4780	AAH11558.1	Hs.715540	Nuclear factor (erythroid-derived 2)-like 2			Lung, large cell carcinoma	NIH_MGC_18		NM_001145412.1	NP_001138884.1	VALIDATED	C	1.000	1.000	589	1818	49	1815	589	1	589
RIKEN	AK023133	flj0035k11	FLJ	W01A006L21	pENTR-TOPO	8114		MYEF2	50804	BAB14421.1	Hs.6638	Myelin expression factor 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_016132.3	NP_057216.2	VALIDATED	Cgs	0.957	0.997	600	1731	1	1728	600	1	600
RIKEN	BC011558	IRAL029A18	MGC	W01A006L22	pENTR-TOPO	13843		NFE2L2	4780	AAH11558.1	Hs.715540	Nuclear factor (erythroid-derived 2)-like 2			Lung, large cell carcinoma	NIH_MGC_18		NM_001145412.1	NP_001138884.1	VALIDATED	C	1.000	1.000	589	1818	49	1815	589	1	589
RIKEN	AK023133	flj0035k11	FLJ	W01A006L23	pENTR-TOPO	8114		MYEF2	50804	BAB14421.1	Hs.6638	Myelin expression factor 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_016132.3	NP_057216.2	VALIDATED	Cgs	0.957	0.997	600	1731	1	1728	600	1	600
RIKEN	BC011558	IRAL029A18	MGC	W01A006L24	pENTR-TOPO	13843		NFE2L2	4780	AAH11558.1	Hs.715540	Nuclear factor (erythroid-derived 2)-like 2			Lung, large cell carcinoma	NIH_MGC_18		NM_001145412.1	NP_001138884.1	VALIDATED	C	1.000	1.000	589	1818	49	1815	589	1	589
RIKEN	BC014031	IRAL028N07	MGC	W01A006M02	pENTR-TOPO	20660		ZKSCAN4	387032	AAH14031.1	Hs.44720	Zinc finger with KRAB and SCAN domains 4			Primary B-Cells from Tonsils	NIH_MGC_48		NM_019110.3	NP_061983.2	PROVISIONAL	OK	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC028049	IRAK062C02	MGC	W01A006M03	pENTR-TOPO	3266		PPP3CB	5532	AAH28049.1	Hs.500067	Protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142353.1	NP_001135825.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
RIKEN	BC014031	IRAL028N07	MGC	W01A006M04	pENTR-TOPO	20660		ZKSCAN4	387032	AAH14031.1	Hs.44720	Zinc finger with KRAB and SCAN domains 4			Primary B-Cells from Tonsils	NIH_MGC_48		NM_019110.3	NP_061983.2	PROVISIONAL	OK	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC028049	IRAK062C02	MGC	W01A006M05	pENTR-TOPO	3266		PPP3CB	5532	AAH28049.1	Hs.500067	Protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142353.1	NP_001135825.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
RIKEN	BC014031	IRAL028N07	MGC	W01A006M06	pENTR-TOPO	20660		ZKSCAN4	387032	AAH14031.1	Hs.44720	Zinc finger with KRAB and SCAN domains 4			Primary B-Cells from Tonsils	NIH_MGC_48		NM_019110.3	NP_061983.2	PROVISIONAL	OK	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC028049	IRAK062C02	MGC	W01A006M07	pENTR-TOPO	3266		PPP3CB	5532	AAH28049.1	Hs.500067	Protein phosphatase 3 (formerly 2B), catalytic subunit, beta isoform			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142353.1	NP_001135825.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
RIKEN	BC016665	IRAK026K08	MGC	W01A006M11	pENTR-TOPO	22932		TOX	9760	AAH16665.1	Hs.491805	Thymocyte selection-associated high mobility group box			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014729.2	NP_055544.1	REVIEWED	Cs	0.998	0.998	526	1581	1	1578	526	1	526
RIKEN	BC024185	IRAK033H08	MGC	W01A006M19	pENTR-TOPO	19239		GMCL1L	64396	AAH24185	Hs.591738	Germ cell-less homolog 1 (Drosophila)-like			Testis	NIH_MGC_97	DH10B			
RIKEN	BC022231	IRAK027D13	MGC	W01A006M20	pENTR-TOPO	12213		ERF	2077	AAH22231.1	Hs.655969	Ets2 repressor factor			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_006494.2	NP_006485.2	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
RIKEN	BC024185	IRAK033H08	MGC	W01A006M23	pENTR-TOPO	19239		GMCL1L	64396	AAH24185	Hs.591738	Germ cell-less homolog 1 (Drosophila)-like			Testis	NIH_MGC_97	DH10B			
RIKEN	BC022231	IRAK027D13	MGC	W01A006M24	pENTR-TOPO	12213		ERF	2077	AAH22231.1	Hs.655969	Ets2 repressor factor			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_006494.2	NP_006485.2	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
RIKEN	BC016680	IRAK026H05	MGC	W01A006N02	pENTR-TOPO	9982		SP2	6668	AAH16680.1	Hs.514276	Sp2 transcription factor			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003110.5	NP_003101.3	REVIEWED	P	1.000	1.000	606	1821	1	1818	613	8	613
RIKEN	BC016680	IRAK026H05	MGC	W01A006N04	pENTR-TOPO	9982		SP2	6668	AAH16680.1	Hs.514276	Sp2 transcription factor			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003110.5	NP_003101.3	REVIEWED	P	1.000	1.000	606	1821	1	1818	613	8	613
RIKEN	BC016680	IRAK026H05	MGC	W01A006N06	pENTR-TOPO	9982		SP2	6668	AAH16680.1	Hs.514276	Sp2 transcription factor			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003110.5	NP_003101.3	REVIEWED	P	1.000	1.000	606	1821	1	1818	613	8	613
RIKEN	BC008343	IRAL023F04	MGC	W01A006N10	pENTR-TOPO	15617		XRCC6	2547	AAH08343.1	Hs.292493	X-ray repair complementing defective repair in Chinese hamster cells 6			Brain, neuroblastoma	NIH_MGC_19		NM_001469.3	NP_001460.1	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
RIKEN	BC045613	IRAK048F10	MGC	W01A006N13	pENTR-TOPO	16175		NR1D2	9975	AAH45613.1	Hs.37288	Nuclear receptor subfamily 1, group D, member 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001145425.1	NP_001138897.1	REVIEWED	Cs	0.996	0.996	504	1740	226	1737	504	1	504
RIKEN	BC012154	IRAL029F24	MGC	W01A006N18	pENTR-TOPO	15617		XRCC6	2547	AAH12154.1	Hs.292493	X-ray repair complementing defective repair in Chinese hamster cells 6			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001469.3	NP_001460.1	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
RIKEN	BC012154	IRAL029F24	MGC	W01A006N20	pENTR-TOPO	15617		XRCC6	2547	AAH12154.1	Hs.292493	X-ray repair complementing defective repair in Chinese hamster cells 6			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001469.3	NP_001460.1	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
RIKEN	BC012154	IRAL029F24	MGC	W01A006N22	pENTR-TOPO	15617		XRCC6	2547	AAH12154.1	Hs.292493	X-ray repair complementing defective repair in Chinese hamster cells 6			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001469.3	NP_001460.1	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
RIKEN	BC000365	IRAL001A02	MGC	W01A006O08	pENTR-TOPO	3934		GTF2H1	2965	AAH00365.1	Hs.577202	General transcription factor IIH, polypeptide 1, 62kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_005316.3	NP_005307.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
RIKEN	BC002379	IRAL001L17	MGC	W01A006O10	pENTR-TOPO	11070		SMAD4	4089	AAH02379.1	Hs.75862	SMAD family member 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005359.5	NP_005350.1	VALIDATED	OK	1.000	1.000	552	1659	1	1656	552	1	552
RIKEN	BC038586	IRAK079D03	MGC	W01A006O11	pENTR-TOPO	12148		ZNF490	57474	AAH38586.1	Hs.655860	Zinc finger protein 490			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020714.2	NP_065765.1	VALIDATED	C	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC002379	IRAL001L17	MGC	W01A006O12	pENTR-TOPO	11070		SMAD4	4089	AAH02379.1	Hs.75862	SMAD family member 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005359.5	NP_005350.1	VALIDATED	OK	1.000	1.000	552	1659	1	1656	552	1	552
RIKEN	BC038586	IRAK079D03	MGC	W01A006O13	pENTR-TOPO	12148		ZNF490	57474	AAH38586.1	Hs.655860	Zinc finger protein 490			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020714.2	NP_065765.1	VALIDATED	C	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC038586	IRAK079D03	MGC	W01A006O15	pENTR-TOPO	12148		ZNF490	57474	AAH38586.1	Hs.655860	Zinc finger protein 490			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020714.2	NP_065765.1	VALIDATED	C	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC002379	IRAL001L17	MGC	W01A006O16	pENTR-TOPO	11070		SMAD4	4089	AAH02379.1	Hs.75862	SMAD family member 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005359.5	NP_005350.1	VALIDATED	OK	1.000	1.000	552	1659	1	1656	552	1	552
RIKEN	AK027263	flj0019b01	FLJ	W01A006O18	pENTR-TOPO	3248		DNAJC1	64215	BAB55004.1	Hs.499000	DnaJ (Hsp40) homolog, subfamily C, member 1				HEMBA1	EK1	NM_022365.3	NP_071760.2	PROVISIONAL	OK	1.000	1.000	554	1665	1	1662	554	1	554
RIKEN	BC019075	IRAL039P23	MGC	W01A006O19	pENTR-TOPO	19254		DEPDC1B	55789	AAH19075.1	Hs.677180	DEP domain containing 1B			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_018369.2	NP_060839.2	VALIDATED	Cs	0.996	0.996	529	1590	1	1587	529	1	529
RIKEN	AK027263	flj0019b01	FLJ	W01A006O20	pENTR-TOPO	3248		DNAJC1	64215	BAB55004.1	Hs.499000	DnaJ (Hsp40) homolog, subfamily C, member 1				HEMBA1	EK1	NM_022365.3	NP_071760.2	PROVISIONAL	OK	1.000	1.000	554	1665	1	1662	554	1	554
RIKEN	AK027263	flj0019b01	FLJ	W01A006O24	pENTR-TOPO	3248		DNAJC1	64215	BAB55004.1	Hs.499000	DnaJ (Hsp40) homolog, subfamily C, member 1				HEMBA1	EK1	NM_022365.3	NP_071760.2	PROVISIONAL	OK	1.000	1.000	554	1665	1	1662	554	1	554
RIKEN	BC007439	IRAL010J08	MGC	W01A006P09	pENTR-TOPO	16809		DCP1A	55802	AAH07439.1	Hs.476353	DCP1 decapping enzyme homolog A (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018403.4	NP_060873.3	REVIEWED	Cs	0.998	0.998	582	1749	1	1746	582	1	582
RIKEN	BC038222	IRAK064E15	MGC	W01A006P23	pENTR-TOPO	12518		IRF2BP1	26145	AAH38222.1	Hs.515477	Interferon regulatory factor 2 binding protein 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015649.1	NP_056464.1	PROVISIONAL	C	1.000	1.000	584	1755	1	1752	584	1	584
RIKEN	BC013382	IRAL007N04	MGC	W01A007A02	pENTR-TOPO	4538		ZNF202	7753	AAH13382.1	Hs.112556	Zinc finger protein 202			Brain, neuroblastoma	NIH_MGC_19		NM_003455.2	NP_003446.2	VALIDATED	Cs	0.998	0.998	648	1947	1	1944	648	1	648
RIKEN	BC040344	IRAK013N15	MGC	W01A007A11	pENTR-TOPO	14586		CBFA2T2	9139	AAH40344.1	Hs.153934	Core-binding factor, runt domain, alpha subunit 2; translocated to, 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001039709.1	NP_001034798.1	REVIEWED	C	1.000	1.000	575	1845	118	1842	575	1	575
RIKEN	BC001562	IRAK004J01	MGC	W01A007A17	pENTR-TOPO	2607		NCOA4	8031	AAH01562.1	Hs.709644	Nuclear receptor coactivator 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005437.3	NP_005428.1	REVIEWED	OK	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC001562	IRAK004J01	MGC	W01A007A19	pENTR-TOPO	2607		NCOA4	8031	AAH01562.1	Hs.709644	Nuclear receptor coactivator 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005437.3	NP_005428.1	REVIEWED	OK	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC007303	IRAL022O07	MGC	W01A007B09	pENTR-TOPO	11519		ZNF234	10780	AAH07303.1	Hs.235992	Zinc finger protein 234			Eye, retinoblastoma	NIH_MGC_16		NM_001144824.1	NP_001138296.1	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
RIKEN	BC022992	IRAK042K24	MGC	W01A007B10	pENTR-TOPO	20702		ZNF184	7738	AAH22992.1	Hs.158174	Zinc finger protein 184			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007149.2	NP_009080.2	VALIDATED	Cs	0.999	0.999	751	2256	1	2253	751	1	751
RIKEN	BC022992	IRAK042K24	MGC	W01A007B12	pENTR-TOPO	20702		ZNF184	7738	AAH22992.1	Hs.158174	Zinc finger protein 184			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007149.2	NP_009080.2	VALIDATED	Cs	0.999	0.999	751	2256	1	2253	751	1	751
RIKEN	BC022992	IRAK042K24	MGC	W01A007B16	pENTR-TOPO	20702		ZNF184	7738	AAH22992.1	Hs.158174	Zinc finger protein 184			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007149.2	NP_009080.2	VALIDATED	Cs	0.999	0.999	751	2256	1	2253	751	1	751
RIKEN	BC056148	IRAK119O17	MGC	W01A007C03	pENTR-TOPO	10675		NR1D1	9572	AAH56148.1	Hs.592130	Nuclear receptor subfamily 1, group D, member 1				Lupski_sympathetic_trunk	DH10B	NM_021724.2	NP_068370.1	PROVISIONAL	OK	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	AK074919	flj0018d07	FLJ	W01A007C18	pENTR-TOPO	15026		C20orf151	140893	BAC11293.1	Hs.180374	Chromosome 20 open reading frame 151	NT2	teratocarcinoma		NT2RP3	EK1	NM_080833.1	NP_543023.1	PREDICTED	C	1.000	1.000	664	1995	1	1992	664	1	664
RIKEN	BC051902	IRAK110L19	MGC	W01A007D13	pENTR-TOPO	11539		ZNF224	7767	AAH51902.1	Hs.585869	Zinc finger protein 224			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_013398.1	NP_037530.1	PROVISIONAL	Cs	0.997	0.997	707	2124	1	2121	707	1	707
RIKEN	BC051902	IRAK110L19	MGC	W01A007D15	pENTR-TOPO	11539		ZNF224	7767	AAH51902.1	Hs.585869	Zinc finger protein 224			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_013398.1	NP_037530.1	PROVISIONAL	Cs	0.997	0.997	707	2124	1	2121	707	1	707
RIKEN	BC006404	IRAL017P21	MGC	W01A007D19	pENTR-TOPO	4722		CLPB	81570	AAH06404.1	Hs.523877	ClpB caseinolytic peptidase B homolog (E. coli)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_030813.3	NP_110440.1	PROVISIONAL	C	1.000	1.000	707	2124	1	2121	707	1	707
RIKEN	BC033849	IRAK068F22	MGC	W01A007E11	pENTR-TOPO	11787		ZNF567	163081	AAH33849.2	Hs.412517	Zinc finger protein 567			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_152603.2	NP_689816.2	PROVISIONAL	C	1.000	1.000	616	1851	1	1848	616	1	616
RIKEN	BC004988	IRAL009H12	MGC	W01A007E12	pENTR-TOPO	11675		FEM1A	55527	AAH04988.1	Hs.515082	Fem-1 homolog a (C. elegans)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_018708.2	NP_061178.1	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
RIKEN	BC033849	IRAK068F22	MGC	W01A007E13	pENTR-TOPO	11787		ZNF567	163081	AAH33849.2	Hs.412517	Zinc finger protein 567			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_152603.2	NP_689816.2	PROVISIONAL	C	1.000	1.000	616	1851	1	1848	616	1	616
RIKEN	BC004988	IRAL009H12	MGC	W01A007E16	pENTR-TOPO	11675		FEM1A	55527	AAH04988.1	Hs.515082	Fem-1 homolog a (C. elegans)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_018708.2	NP_061178.1	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
RIKEN	BC003064	IRAL007M07	MGC	W01A007F02	pENTR-TOPO	19237		DAB2	1601	AAH03064.1	Hs.481980	Disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001343.2	NP_001334.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
RIKEN	BC005116	IRAL008P01	MGC	W01A007F07	pENTR-TOPO	4493		SSRP1	6749	AAH05116.1	Hs.523680	Structure specific recognition protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_003146.2	NP_003137.1	REVIEWED	C	1.000	1.000	709	2130	1	2127	709	1	709
RIKEN	BC052997	IRAK110N22	MGC	W01A007F09	pENTR-TOPO	11935		ZNF175	7728	AAH52997.1	Hs.119014	Zinc finger protein 175			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_007147.2	NP_009078.1	VALIDATED	OK	1.000	1.000	711	2136	1	2133	711	1	711
RIKEN	BC015747	IRAL034E15	MGC	W01A007F10	pENTR-TOPO	24032		TLE1	7088	AAH15747.1	Hs.689805	Transducin-like enhancer of split 1 (E(sp1) homolog, Drosophila)			Colon, adenocarcinoma	NIH_MGC_15		NM_005077.3	NP_005068.2	PROVISIONAL	C	1.000	1.000	770	2313	1	2310	770	1	770
RIKEN	BC060800	IRAK133H20	MGC	W01A007F19	pENTR-TOPO	16125		NFKBIZ	64332	AAH60800.1	Hs.319171	Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, zeta			Placenta, normal	NIH_MGC_147	DH10B	NM_031419.2	NP_113607.1	REVIEWED	C	1.000	1.000	718	2157	1	2154	718	1	718
RIKEN	BC030507	IRAK064A17	MGC	W01A007G03	pENTR-TOPO	6781		ELF1	1997	AAH30507.1	Hs.135646	E74-like factor 1 (ets domain transcription factor)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_172373.3	NP_758961.1	REVIEWED	C	1.000	1.000	619	1860	1	1857	619	1	619
RIKEN	BC042753	IRAK072D21	MGC	W01A007G04	pENTR-TOPO	24800		ZBTB33	10009	AAH42753.1	Hs.143604	Zinc finger and BTB domain containing 33			Testis	NIH_MGC_97	DH10B	NM_006777.3	NP_006768.1	VALIDATED	Cg	0.999	1.000	673	2022	1	2019	672	1	672
RIKEN	BC001154	IRAL008G09	MGC	W01A007G11	pENTR-TOPO	88		PIAS3	10401	AAH01154.2	Hs.435761	Protein inhibitor of activated STAT, 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006099.3	NP_006090.2	REVIEWED	P	1.000	1.000	619	1860	1	1857	628	10	628
RIKEN	BC020090	IRAK026O08	MGC	W01A007G12	pENTR-TOPO	10720		FXR2	9513	AAH20090.1	Hs.52788	Fragile X mental retardation, autosomal homolog 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004860.2	NP_004851.1	REVIEWED	Cs	0.997	0.997	673	2022	1	2019	673	1	673
RIKEN	BC020090	IRAK026O08	MGC	W01A007G14	pENTR-TOPO	10720		FXR2	9513	AAH20090.1	Hs.52788	Fragile X mental retardation, autosomal homolog 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004860.2	NP_004851.1	REVIEWED	Cs	0.997	0.997	673	2022	1	2019	673	1	673
RIKEN	BC001154	IRAL008G09	MGC	W01A007G15	pENTR-TOPO	88		PIAS3	10401	AAH01154.2	Hs.435761	Protein inhibitor of activated STAT, 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006099.3	NP_006090.2	REVIEWED	P	1.000	1.000	619	1860	1	1857	628	10	628
RIKEN	BC021997	IRAL003O19	MGC	W01A007G23	pENTR-TOPO	8958		ZNF668	79759	AAH21997.1	Hs.707346	Zinc finger protein 668			Skin, melanotic melanoma.	NIH_MGC_20		NM_024706.3	NP_078982.2	PROVISIONAL	OK	1.000	1.000	619	1860	1	1857	619	1	619
RIKEN	BC039820	IRAK084D06	MGC	W01A007H02	pENTR-TOPO	14542		L3MBTL	26013	AAH39820.1	Hs.709356	L(3)mbt-like (Drosophila)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015478.5	NP_056293.4	REVIEWED	Cs	0.999	0.999	772	2319	1	2316	772	1	772
RIKEN	BC015708	IRAK015I12	MGC	W01A007H07	pENTR-TOPO	3852		ZNF408	79797	AAH15708.1	Hs.656931	Zinc finger protein 408			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024741.1	NP_079017.1	PROVISIONAL	C	1.000	1.000	720	2163	1	2160	720	1	720
RIKEN	BC039820	IRAK084D06	MGC	W01A007H08	pENTR-TOPO	14542		L3MBTL	26013	AAH39820.1	Hs.709356	L(3)mbt-like (Drosophila)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015478.5	NP_056293.4	REVIEWED	Cs	0.999	0.999	772	2319	1	2316	772	1	772
RIKEN	BC015023	IRAK015D23	MGC	W01A007H10	pENTR-TOPO	25154		ZNF41	7592	AAH15023.1	Hs.496074	Zinc finger protein 41			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_007130.2	NP_009061.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
RIKEN	BC015023	IRAK015D23	MGC	W01A007H14	pENTR-TOPO	25154		ZNF41	7592	AAH15023.1	Hs.496074	Zinc finger protein 41			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_007130.2	NP_009061.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
RIKEN	BC024157	IRAL025J16	MGC	W01A007H18	pENTR-TOPO	12204		PLEKHA4	57664	AAH24157.1	Hs.9469	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_020904.2	NP_065955.2	VALIDATED	C	1.000	1.000	779	2340	1	2337	779	1	779
RIKEN	AK074321	flj0066d20	FLJ	W01A007I10	pENTR-TOPO	16796		FOXP1	27086	BAB85050.1	Hs.431498	Forkhead box P1	HepG2	hepatoma		HEP	EK1	NM_032682.4	NP_116071.2	REVIEWED	Cs	0.997	0.997	677	2034	1	2031	677	1	677
RIKEN	BC013689	IRAK021M13	MGC	W01A007I13	pENTR-TOPO	6942		TOX4	9878	AAH13689.1	Hs.555910	TOX high mobility group box family member 4			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014828.2	NP_055643.1	VALIDATED	C	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	AK074321	flj0066d20	FLJ	W01A007I14	pENTR-TOPO	16796		FOXP1	27086	BAB85050.1	Hs.431498	Forkhead box P1	HepG2	hepatoma		HEP	EK1	NM_032682.4	NP_116071.2	REVIEWED	Cs	0.997	0.997	677	2034	1	2031	677	1	677
RIKEN	BC013689	IRAK021M13	MGC	W01A007I15	pENTR-TOPO	6942		TOX4	9878	AAH13689.1	Hs.555910	TOX high mobility group box family member 4			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014828.2	NP_055643.1	VALIDATED	C	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	AK074321	flj0066d20	FLJ	W01A007I16	pENTR-TOPO	16796		FOXP1	27086	BAB85050.1	Hs.431498	Forkhead box P1	HepG2	hepatoma		HEP	EK1	NM_032682.4	NP_116071.2	REVIEWED	Cs	0.997	0.997	677	2034	1	2031	677	1	677
RIKEN	BC056152	IRAK119N09	MGC	W01A007I17	pENTR-TOPO	3611		ZDHHC13	54503	AAH56152.1	Hs.188569	Zinc finger, DHHC-type containing 13			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_019028.2	NP_061901.2	VALIDATED	OK	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC056152	IRAK119N09	MGC	W01A007I19	pENTR-TOPO	3611		ZDHHC13	54503	AAH56152.1	Hs.188569	Zinc finger, DHHC-type containing 13			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_019028.2	NP_061901.2	VALIDATED	OK	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC000375	IRAL001C08	MGC	W01A007I20	pENTR-TOPO	14593		CHGB	1114	AAH00375.1	Hs.516874	Chromogranin B (secretogranin 1)			Lung, small cell carcinoma	NIH_MGC_7		NM_001819.2	NP_001810.2	REVIEWED	Cs	0.999	0.999	677	2034	1	2031	677	1	677
RIKEN	BC058926	IRAK119M14	MGC	W01A007J04	pENTR-TOPO	16142		CTNNB1	1499	AAH58926.1	Hs.476018	Catenin (cadherin-associated protein), beta 1, 88kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001098210.1	NP_001091680.1	VALIDATED	C	1.000	1.000	781	2346	1	2343	781	1	781
RIKEN	BC008948	IRAL010K05	MGC	W01A007J07	pENTR-TOPO	13190		ANKZF1	55139	AAH08948.1	Hs.437647	Ankyrin repeat and zinc finger domain containing 1			Colon, adenocarcinoma	NIH_MGC_15		NM_018089.2	NP_060559.2	VALIDATED	OK	1.000	1.000	726	2181	1	2178	726	1	726
RIKEN	BC039815	IRAK084G16	MGC	W01A007K10	pENTR-TOPO	16075		TP63	8626	AAH39815.1	Hs.137569	Tumor protein p63			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003722.4	NP_003713.3	REVIEWED	OK	1.000	1.000	680	2043	1	2040	680	1	680
RIKEN	BC039815	IRAK084G16	MGC	W01A007K14	pENTR-TOPO	16075		TP63	8626	AAH39815.1	Hs.137569	Tumor protein p63			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003722.4	NP_003713.3	REVIEWED	OK	1.000	1.000	680	2043	1	2040	680	1	680
RIKEN	BC016924	IRAK027I24	MGC	W01A007K15	pENTR-TOPO	10289		TRIM25	7706	AAH16924.1	Hs.528952	Tripartite motif-containing 25			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_005082.4	NP_005073.2	REVIEWED	Cs	0.998	0.998	630	1893	1	1890	630	1	630
RIKEN	BC039815	IRAK084G16	MGC	W01A007K16	pENTR-TOPO	16075		TP63	8626	AAH39815.1	Hs.137569	Tumor protein p63			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003722.4	NP_003713.3	REVIEWED	OK	1.000	1.000	680	2043	1	2040	680	1	680
RIKEN	BC009503	IRAL002H11	MGC	W01A007K19	pENTR-TOPO	9316		GSPT1	2935	AAH09503.2	Hs.528780	G1 to S phase transition 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001130007.1	NP_001123479.1	VALIDATED	Cg	0.998	1.000	499	1902	406	1899	499	1	499
RIKEN	BC009503	IRAL002H11	MGC	W01A007K23	pENTR-TOPO	9316		GSPT1	2935	AAH09503.2	Hs.528780	G1 to S phase transition 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001130007.1	NP_001123479.1	VALIDATED	Cg	0.998	1.000	499	1902	406	1899	499	1	499
RIKEN	BC033799	IRAK068J17	MGC	W01A007L08	pENTR-TOPO	5314		HCFC2	29915	AAH33799.1	Hs.506558	Host cell factor C2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_013320.2	NP_037452.1	REVIEWED	OK	1.000	1.000	792	2379	1	2376	792	1	792
RIKEN	BC007777	IRAL017N14	MGC	W01A007L13	pENTR-TOPO	12270		MZF1	7593	AAH07777.1	Hs.399810	Myeloid zinc finger 1			Uterus, leiomyosarcoma	NIH_MGC_46		NM_003422.2	NP_003413.2	VALIDATED	C	1.000	1.000	734	2205	1	2202	734	1	734
RIKEN	BC001449	IRAL004F13	MGC	W01A007M01	pENTR-TOPO	1532		HNRNPR	10236	AAH01449.1	Hs.373763	Heterogeneous nuclear ribonucleoprotein R			Placenta, choriocarcinoma	NIH_MGC_21		NM_001102398.1	NP_001095868.1	REVIEWED	C	1.000	1.000	636	1911	1	1908	636	1	636
RIKEN	BC001449	IRAL004F13	MGC	W01A007M03	pENTR-TOPO	1532		HNRNPR	10236	AAH01449.1	Hs.373763	Heterogeneous nuclear ribonucleoprotein R			Placenta, choriocarcinoma	NIH_MGC_21		NM_001102398.1	NP_001095868.1	REVIEWED	C	1.000	1.000	636	1911	1	1908	636	1	636
RIKEN	BC037575	IRAK069L14	MGC	W01A007M04	pENTR-TOPO	12583		ZNF45	7596	AAH37575.1	Hs.381285	Zinc finger protein 45			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003425.2	NP_003416.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
RIKEN	BC037575	IRAK069L14	MGC	W01A007M06	pENTR-TOPO	12583		ZNF45	7596	AAH37575.1	Hs.381285	Zinc finger protein 45			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003425.2	NP_003416.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
RIKEN	BC001621	IRAL006I22	MGC	W01A007M09	pENTR-TOPO	5809		WBP11	51729	AAH01621.1	Hs.655138	WW domain binding protein 11			Eye, retinoblastoma	NIH_MGC_16		NM_016312.2	NP_057396.1	REVIEWED	OK	1.000	1.000	641	1926	1	1923	641	1	641
RIKEN	BC058923	IRAK119B10	MGC	W01A007M18	pENTR-TOPO	22524		ZNF7	7553	AAH58923.1	Hs.493218	Zinc finger protein 7			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_003416.2	NP_003407.1	VALIDATED	C	1.000	1.000	686	2061	1	2058	686	1	686
RIKEN	BC007256	IRAL022E23	MGC	W01A007M21	pENTR-TOPO	9137		ZNF23	7571	AAH07256.1	Hs.656643	Zinc finger protein 23 (KOX 16)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_145911.1	NP_666016.1	PROVISIONAL	C	1.000	1.000	643	1932	1	1929	643	1	643
RIKEN	BC058923	IRAK119B10	MGC	W01A007M22	pENTR-TOPO	22524		ZNF7	7553	AAH58923.1	Hs.493218	Zinc finger protein 7			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_003416.2	NP_003407.1	VALIDATED	C	1.000	1.000	686	2061	1	2058	686	1	686
RIKEN	BC062552	IRAL050N10	MGC	W01A007N03	pENTR-TOPO	5626		ZNF84	7637	AAH62552.1	Hs.445019	Zinc finger protein 84			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_003428.4	NP_003419.3	VALIDATED	C	1.000	1.000	738	2217	1	2214	738	1	738
RIKEN	BC062552	IRAL050N10	MGC	W01A007N05	pENTR-TOPO	5626		ZNF84	7637	AAH62552.1	Hs.445019	Zinc finger protein 84			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_003428.4	NP_003419.3	VALIDATED	C	1.000	1.000	738	2217	1	2214	738	1	738
RIKEN	BC018543	IRAK026K24	MGC	W01A007N17	pENTR-TOPO	9867		ACAP1	9744	AAH18543.1	Hs.337242	ArfGAP with coiled-coil, ankyrin repeat and PH domains 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014716.3	NP_055531.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
RIKEN	BC000721	IRAL007K17	MGC	W01A007O01	pENTR-TOPO	3286		ECD	11319	AAH00721.1	Hs.631822	Ecdysoneless homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_007265.2	NP_009196.1	VALIDATED	C	1.000	1.000	644	1935	1	1932	644	1	644
RIKEN	BC026210	IRAL010L06	MGC	W01A007O10	pENTR-TOPO	11747		ZNF420	147923	AAH26210.1	Hs.444992	Zinc finger protein 420			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_144689.3	NP_653290.2	PROVISIONAL	OK	1.000	1.000	688	2067	1	2064	688	1	688
RIKEN	BC013395	IRAL010O24	MGC	W01A007O13	pENTR-TOPO	15536		ZNF74	7625	AAH13395.1	Hs.517418	Zinc finger protein 74			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003426.2	NP_003417.2	VALIDATED	Cs	0.998	0.998	644	1935	1	1932	644	1	644
RIKEN	BC026210	IRAL010L06	MGC	W01A007O14	pENTR-TOPO	11747		ZNF420	147923	AAH26210.1	Hs.444992	Zinc finger protein 420			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_144689.3	NP_653290.2	PROVISIONAL	OK	1.000	1.000	688	2067	1	2064	688	1	688
RIKEN	BC036367	IRAK034D11	MGC	W01A007P01	pENTR-TOPO	8700		ZNF267	10308	AAH36367.1	Hs.460645	Zinc finger protein 267			Testis	NIH_MGC_97	DH10B	NM_003414.4	NP_003405.3	VALIDATED	Cs	0.999	0.999	743	2232	1	2229	743	1	743
RIKEN	BC015882	IRAK015D05	MGC	W01A007P21	pENTR-TOPO	10189		EZH1	2145	AAH15882.1	Hs.194669	Enhancer of zeste homolog 1 (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001991.3	NP_001982.2	VALIDATED	C	1.000	1.000	747	2244	1	2241	747	1	747
RIKEN	BC043347	IRAK089D11	MGC	W01A008A02	pENTR-TOPO	13929		GTF3C3	9330	AAH43347.1	Hs.470996	General transcription factor IIIC, polypeptide 3, 102kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_012086.2	NP_036218.1	PROVISIONAL	Cs	0.999	0.999	886	2661	1	2658	886	1	886
RIKEN	BC032374	IRAK064D11	MGC	W01A008A07	pENTR-TOPO	14268		MCM6	4175	AAH32374.1	Hs.444118	Minichromosome maintenance complex component 6			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005915.4	NP_005906.2	REVIEWED	C	1.000	1.000	821	2466	1	2463	821	1	821
RIKEN	BC043347	IRAK089D11	MGC	W01A008A08	pENTR-TOPO	13929		GTF3C3	9330	AAH43347.1	Hs.470996	General transcription factor IIIC, polypeptide 3, 102kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_012086.2	NP_036218.1	PROVISIONAL	Cs	0.999	0.999	886	2661	1	2658	886	1	886
RIKEN	BC043347	IRAK089D11	MGC	W01A008A10	pENTR-TOPO	13929		GTF3C3	9330	AAH43347.1	Hs.470996	General transcription factor IIIC, polypeptide 3, 102kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_012086.2	NP_036218.1	PROVISIONAL	Cs	0.999	0.999	886	2661	1	2658	886	1	886
RIKEN	BC043347	IRAK089D11	MGC	W01A008A14	pENTR-TOPO	13929		GTF3C3	9330	AAH43347.1	Hs.470996	General transcription factor IIIC, polypeptide 3, 102kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_012086.2	NP_036218.1	PROVISIONAL	Cs	0.999	0.999	886	2661	1	2658	886	1	886
RIKEN	BC060872	IRAK133J23	MGC	W01A008A19	pENTR-TOPO	12992		FAM171B	165215	AAH60872.1	Hs.28872	Family with sequence similarity 171, member B			Placenta, normal	NIH_MGC_147	DH10B	NM_177454.3	NP_803237.3	VALIDATED	Cgs	0.996	0.999	828	2487	1	2484	826	1	826
RIKEN	BC014272	IRAL014B20	MGC	W01A008A20	pENTR-TOPO	16480		MCM2	4171	AAH14272.2	Hs.477481	Minichromosome maintenance complex component 2			Lung, small cell carcinoma	NIH_MGC_7		NM_004526.2	NP_004517.2	REVIEWED	C	1.000	1.000	904	2715	1	2712	904	1	904
RIKEN	BC014272	IRAL014B20	MGC	W01A008A22	pENTR-TOPO	16480		MCM2	4171	AAH14272.2	Hs.477481	Minichromosome maintenance complex component 2			Lung, small cell carcinoma	NIH_MGC_7		NM_004526.2	NP_004517.2	REVIEWED	C	1.000	1.000	904	2715	1	2712	904	1	904
RIKEN	AK095391	flj0023f08	FLJ	W01A008B09	pENTR-TOPO	18701		PPARGC1B	133522	BAC04541.1	Hs.591261	Peroxisome proliferator-activated receptor gamma, coactivator 1 beta				CTONG2	EK1	NM_133263.2	NP_573570.2	PROVISIONAL	Cs	0.998	0.998	1023	3072	1	3069	1023	1	1023
RIKEN	BC011686	IRAL027I22	MGC	W01A008B16	pENTR-TOPO	4687		DDB1	1642	AAH11686.1	Hs.290758	Damage-specific DNA binding protein 1, 127kDa			Placenta, choriocarcinoma	NIH_MGC_21		NM_001923.3	NP_001914.3	VALIDATED	C	1.000	1.000	1140	3423	1	3420	1140	1	1140
RIKEN	BC040361	IRAK026B11	MGC	W01A008B18	pENTR-TOPO	15415		NRIP1	8204	AAH40361.1	Hs.155017	Nuclear receptor interacting protein 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003489.3	NP_003480.2	REVIEWED	Cs	0.999	0.999	1158	3477	1	3474	1158	1	1158
RIKEN	BC053861	IRAK115B08	MGC	W01A008B21	pENTR-TOPO	25113		PHF8	23133	AAH53861.1	Hs.133352	PHD finger protein 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015107.2	NP_055922.1	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
RIKEN	BC040361	IRAK026B11	MGC	W01A008B22	pENTR-TOPO	15415		NRIP1	8204	AAH40361.1	Hs.155017	Nuclear receptor interacting protein 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003489.3	NP_003480.2	REVIEWED	Cs	0.999	0.999	1158	3477	1	3474	1158	1	1158
RIKEN	BC014272	IRAL014B20	MGC	W01A008C04	pENTR-TOPO	16480		MCM2	4171	AAH14272.2	Hs.477481	Minichromosome maintenance complex component 2			Lung, small cell carcinoma	NIH_MGC_7		NM_004526.2	NP_004517.2	REVIEWED	C	1.000	1.000	904	2715	1	2712	904	1	904
RIKEN	BC014272	IRAL014B20	MGC	W01A008C08	pENTR-TOPO	16480		MCM2	4171	AAH14272.2	Hs.477481	Minichromosome maintenance complex component 2			Lung, small cell carcinoma	NIH_MGC_7		NM_004526.2	NP_004517.2	REVIEWED	C	1.000	1.000	904	2715	1	2712	904	1	904
RIKEN	BC039248	IRAK048C20	MGC	W01A008C14	pENTR-TOPO	20108		RFX6	222546	AAH39248.1	Hs.352276	Regulatory factor X, 6			Testis	NIH_MGC_97	DH10B	NM_173560.1	NP_775831.1	PROVISIONAL	C	1.000	1.000	928	2787	1	2784	928	1	928
RIKEN	BC039248	IRAK048C20	MGC	W01A008C16	pENTR-TOPO	20108		RFX6	222546	AAH39248.1	Hs.352276	Regulatory factor X, 6			Testis	NIH_MGC_97	DH10B	NM_173560.1	NP_775831.1	PROVISIONAL	C	1.000	1.000	928	2787	1	2784	928	1	928
RIKEN	BC039248	IRAK048C20	MGC	W01A008C18	pENTR-TOPO	20108		RFX6	222546	AAH39248.1	Hs.352276	Regulatory factor X, 6			Testis	NIH_MGC_97	DH10B	NM_173560.1	NP_775831.1	PROVISIONAL	C	1.000	1.000	928	2787	1	2784	928	1	928
RIKEN	BC039248	IRAK048C20	MGC	W01A008C20	pENTR-TOPO	20108		RFX6	222546	AAH39248.1	Hs.352276	Regulatory factor X, 6			Testis	NIH_MGC_97	DH10B	NM_173560.1	NP_775831.1	PROVISIONAL	C	1.000	1.000	928	2787	1	2784	928	1	928
RIKEN	BC040361	IRAK026B11	MGC	W01A008D04	pENTR-TOPO	15415		NRIP1	8204	AAH40361.1	Hs.155017	Nuclear receptor interacting protein 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003489.3	NP_003480.2	REVIEWED	Cs	0.999	0.999	1158	3477	1	3474	1158	1	1158
RIKEN	BC040361	IRAK026B11	MGC	W01A008D06	pENTR-TOPO	15415		NRIP1	8204	AAH40361.1	Hs.155017	Nuclear receptor interacting protein 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003489.3	NP_003480.2	REVIEWED	Cs	0.999	0.999	1158	3477	1	3474	1158	1	1158
RIKEN	BC040361	IRAK026B11	MGC	W01A008D08	pENTR-TOPO	15415		NRIP1	8204	AAH40361.1	Hs.155017	Nuclear receptor interacting protein 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003489.3	NP_003480.2	REVIEWED	Cs	0.999	0.999	1158	3477	1	3474	1158	1	1158
RIKEN	BC045649	IRAK074G07	MGC	W01A008E17	pENTR-TOPO	11828		ZNF546	339327	AAH45649.1	Hs.709400	Zinc finger protein 546			Testis	NIH_MGC_97	DH10B	NM_178544.3	NP_848639.2	VALIDATED	Cs	0.999	0.999	836	2511	1	2508	836	1	836
RIKEN	BC045649	IRAK074G07	MGC	W01A008G03	pENTR-TOPO	11828		ZNF546	339327	AAH45649.1	Hs.709400	Zinc finger protein 546			Testis	NIH_MGC_97	DH10B	NM_178544.3	NP_848639.2	VALIDATED	Cs	0.999	0.999	836	2511	1	2508	836	1	836
RIKEN	BC045649	IRAK074G07	MGC	W01A008G05	pENTR-TOPO	11828		ZNF546	339327	AAH45649.1	Hs.709400	Zinc finger protein 546			Testis	NIH_MGC_97	DH10B	NM_178544.3	NP_848639.2	VALIDATED	Cs	0.999	0.999	836	2511	1	2508	836	1	836
RIKEN	BC045649	IRAK074G07	MGC	W01A008G07	pENTR-TOPO	11828		ZNF546	339327	AAH45649.1	Hs.709400	Zinc finger protein 546			Testis	NIH_MGC_97	DH10B	NM_178544.3	NP_848639.2	VALIDATED	Cs	0.999	0.999	836	2511	1	2508	836	1	836
RIKEN	BC039907	IRAK082P15	MGC	W01A008G13	pENTR-TOPO	10326		KAT2A	2648	AAH39907.1	Hs.463045	K(lysine) acetyltransferase 2A			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_021078.2	NP_066564.2	VALIDATED	C	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC049826	IRAK082N17	MGC	W01A008G18	pENTR-TOPO	12109		RFX1	5989	AAH49826.1	Hs.655215	Regulatory factor X, 1 (influences HLA class II expression)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002918.4	NP_002909.4	VALIDATED	Cs	0.999	0.999	979	2940	1	2937	979	1	979
RIKEN	BC008782	IRAL012C08	MGC	W01A008H18	pENTR-TOPO	22986		NFKBIL2	4796	AAH08782.1	Hs.675285	Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2			Brain, neuroblastoma	NIH_MGC_19		NM_013432.4	NP_038460.4	REVIEWED	Ps	0.999	0.999	1219	3660	1	3657	1378	160	1378
RIKEN	BC008782	IRAL012C08	MGC	W01A008H20	pENTR-TOPO	22986		NFKBIL2	4796	AAH08782.1	Hs.675285	Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor-like 2			Brain, neuroblastoma	NIH_MGC_19		NM_013432.4	NP_038460.4	REVIEWED	Ps	0.999	0.999	1219	3660	1	3657	1378	160	1378
RIKEN	BC042145	IRAL044P18	MGC	W01A008I01	pENTR-TOPO	22477		ZHX2	22882	AAH42145.1	Hs.719079	Zinc fingers and homeoboxes 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014943.3	NP_055758.1	REVIEWED	C	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC042145	IRAL044P18	MGC	W01A008I05	pENTR-TOPO	22477		ZHX2	22882	AAH42145.1	Hs.719079	Zinc fingers and homeoboxes 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014943.3	NP_055758.1	REVIEWED	C	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC042145	IRAL044P18	MGC	W01A008I11	pENTR-TOPO	22477		ZHX2	22882	AAH42145.1	Hs.719079	Zinc fingers and homeoboxes 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014943.3	NP_055758.1	REVIEWED	C	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC024203	IRAL011F11	MGC	W01A008J09	pENTR-TOPO	11354		SUPT5H	6829	AAH24203.1	Hs.631604	Suppressor of Ty 5 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001111020.2	NP_001104490.1	VALIDATED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
RIKEN	BC032639	IRAK069F15	MGC	W01A008J10	pENTR-TOPO	12904		EIF5B	9669	AAH32639.1	Hs.158688	Eukaryotic translation initiation factor 5B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015904.3	NP_056988.3	REVIEWED	Cs	0.998	0.998	1220	3663	1	3660	1220	1	1220
RIKEN	BC032639	IRAK069F15	MGC	W01A008J14	pENTR-TOPO	12904		EIF5B	9669	AAH32639.1	Hs.158688	Eukaryotic translation initiation factor 5B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015904.3	NP_056988.3	REVIEWED	Cs	0.998	0.998	1220	3663	1	3660	1220	1	1220
RIKEN	BC032639	IRAK069F15	MGC	W01A008J16	pENTR-TOPO	12904		EIF5B	9669	AAH32639.1	Hs.158688	Eukaryotic translation initiation factor 5B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015904.3	NP_056988.3	REVIEWED	Cs	0.998	0.998	1220	3663	1	3660	1220	1	1220
RIKEN	BC013000	IRAL011H07	MGC	W01A008J19	pENTR-TOPO	5596		GLI1	2735	AAH13000.1	Hs.632702	GLI family zinc finger 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001160045.1	NP_001153517.1	REVIEWED	C	1.000	1.000	978	3321	385	3318	978	1	978
RIKEN	AK000314	flj0051o24	FLJ	W01A008K02	pENTR-TOPO	10961		ZNF407	55628	BAA91077.1	Hs.536490	Zinc finger protein 407	HepG2	hepatoma		HEP	EK1	NM_001146190.1	NP_001139662.1	VALIDATED	Ps	0.994	0.994	812	3006	1	2436	1660	815	1626
RIKEN	BC007208	IRAL022A10	MGC	W01A008K03	pENTR-TOPO	12136		XAB2	56949	AAH07208.1	Hs.9822	XPA binding protein 2			Lung, small cell carcinoma	NIH_MGC_7		NM_020196.2	NP_064581.2	VALIDATED	OK	1.000	1.000	855	2568	1	2565	855	1	855
RIKEN	BC007208	IRAL022A10	MGC	W01A008K07	pENTR-TOPO	12136		XAB2	56949	AAH07208.1	Hs.9822	XPA binding protein 2			Lung, small cell carcinoma	NIH_MGC_7		NM_020196.2	NP_064581.2	VALIDATED	OK	1.000	1.000	855	2568	1	2565	855	1	855
RIKEN	BC031061	IRAK048F21	MGC	W01A008K19	pENTR-TOPO	22653		MCM4	4173	AAH31061.1	Hs.460184	Minichromosome maintenance complex component 4			Testis	NIH_MGC_97	DH10B	NM_182746.1	NP_877423.1	REVIEWED	Cs	0.999	0.999	863	2592	1	2589	863	1	863
RIKEN	BC013000	IRAL011H07	MGC	W01A008L07	pENTR-TOPO	5596		GLI1	2735	AAH13000.1	Hs.632702	GLI family zinc finger 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001160045.1	NP_001153517.1	REVIEWED	C	1.000	1.000	978	3321	385	3318	978	1	978
RIKEN	BC024004	IRAK033G24	MGC	W01A008M04	pENTR-TOPO	12921		RAPGEF4	11069	AAH24004.1	Hs.470646	Rap guanine nucleotide exchange factor (GEF) 4			Testis	NIH_MGC_97	DH10B	NM_007023.3	NP_008954.2	VALIDATED	Cs	0.998	0.998	1011	3036	1	3033	1011	1	1011
RIKEN	BC024004	IRAK033G24	MGC	W01A008M06	pENTR-TOPO	12921		RAPGEF4	11069	AAH24004.1	Hs.470646	Rap guanine nucleotide exchange factor (GEF) 4			Testis	NIH_MGC_97	DH10B	NM_007023.3	NP_008954.2	VALIDATED	Cs	0.998	0.998	1011	3036	1	3033	1011	1	1011
RIKEN	BC054501	IRAK107P05	MGC	W01A008M09	pENTR-TOPO	11628		DNM2	1785	AAH54501.1	Hs.211463	Dynamin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004945.2	NP_004936.2	REVIEWED	C	1.000	1.000	866	2601	1	2598	866	1	866
RIKEN	BC024004	IRAK033G24	MGC	W01A008M10	pENTR-TOPO	12921		RAPGEF4	11069	AAH24004.1	Hs.470646	Rap guanine nucleotide exchange factor (GEF) 4			Testis	NIH_MGC_97	DH10B	NM_007023.3	NP_008954.2	VALIDATED	Cs	0.998	0.998	1011	3036	1	3033	1011	1	1011
RIKEN	BC054501	IRAK107P05	MGC	W01A008M15	pENTR-TOPO	11628		DNM2	1785	AAH54501.1	Hs.211463	Dynamin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004945.2	NP_004936.2	REVIEWED	C	1.000	1.000	866	2601	1	2598	866	1	866
RIKEN	BC065544	IRAK140B12	MGC	W01A008N01	pENTR-TOPO	7363		C14orf106	55320	AAH65544.1	Hs.437941	Chromosome 14 open reading frame 106			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_018353.4	NP_060823.3	VALIDATED	C	1.000	1.000	1132	3399	1	3396	1132	1	1132
RIKEN	BC050546	IRAK107F23	MGC	W01A008N02	pENTR-TOPO	10393		MYBBP1A	10514	AAH50546.1	Hs.22824	MYB binding protein (P160) 1a			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014520.3	NP_055335.2	VALIDATED	Cs	0.999	0.999	1328	3987	1	3984	1328	1	1328
RIKEN	BC065544	IRAK140B12	MGC	W01A008N07	pENTR-TOPO	7363		C14orf106	55320	AAH65544.1	Hs.437941	Chromosome 14 open reading frame 106			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_018353.4	NP_060823.3	VALIDATED	C	1.000	1.000	1132	3399	1	3396	1132	1	1132
RIKEN	BC040481	IRAK048B09	MGC	W01A008O03	pENTR-TOPO	23023		ZHX1	11244	AAH40481.1	Hs.612084	Zinc fingers and homeoboxes 1			Testis	NIH_MGC_97	DH10B	NM_007222.3	NP_009153.3	REVIEWED	Cs	0.998	0.998	873	2622	1	2619	873	1	873
RIKEN	BC017728	IRAK027I05	MGC	W01A008O13	pENTR-TOPO	5923		RAPGEF3	10411	AAH17728.2	Hs.8578	Rap guanine nucleotide exchange factor (GEF) 3			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_001098532.2	NP_001092002.1	VALIDATED	OK	1.000	1.000	881	2646	1	2643	881	1	881
RIKEN	BC050530	IRAK107G11	MGC	W01A008P21	pENTR-TOPO	4687		DDB1	1642	AAH50530.1	Hs.290758	Damage-specific DNA binding protein 1, 127kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001923.3	NP_001914.3	VALIDATED	C	1.000	1.000	1140	3423	1	3420	1140	1	1140
RIKEN	BC010744	IRAK014F24	MGC	W01A009A20	pENTR-TOPO	9691		DYNLL2	140735	AAH10744.1	Hs.514368	Dynein, light chain, LC8-type 2				NIH_MGC_69	DH10B	NM_080677.2	NP_542408.1	VALIDATED	C	1.000	1.000	89	270	1	267	89	1	89
RIKEN	BC000462	IRAL001J01	MGC	W01A009A21	pENTR-TOPO	12657		UQCR	10975	AAH00462.1	Hs.8372	Ubiquinol-cytochrome c reductase, 6.4kDa subunit			Lung, small cell carcinoma	NIH_MGC_7		NM_006830.2	NP_006821.1	PROVISIONAL	C	1.000	1.000	56	171	1	168	56	1	56
RIKEN	BC002837	IRAL012L06	MGC	W01A009B02	pENTR-TOPO	22135		C7orf23	79161	AAH02837.1	Hs.719226	Chromosome 7 open reading frame 23			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_024315.2	NP_077291.1	PROVISIONAL	OK	1.000	1.000	118	357	1	354	118	1	118
RIKEN	BC001410	IRAL004G12	MGC	W01A009B05	pENTR-TOPO	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Placenta, choriocarcinoma	NIH_MGC_21		NM_005620.1	NP_005611.1	REVIEWED	OK	1.000	1.000	105	318	1	315	105	1	105
RIKEN	BC002837	IRAL012L06	MGC	W01A009B06	pENTR-TOPO	22135		C7orf23	79161	AAH02837.1	Hs.719226	Chromosome 7 open reading frame 23			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_024315.2	NP_077291.1	PROVISIONAL	OK	1.000	1.000	118	357	1	354	118	1	118
RIKEN	BC061912	IRAK134J21	MGC	W01A009B09	pENTR-TOPO	12273		C19orf56	51398	AAH61912.1	Hs.108969	Chromosome 19 open reading frame 56			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_016145.3	NP_057229.1	VALIDATED	OK	1.000	1.000	106	321	1	318	106	1	106
RIKEN	BC011976	IRAK021A07	MGC	W01A009B17	pENTR-TOPO	17719		CXCL1	2919	AAH11976.1	Hs.789	Chemokine (C-X-C motif) ligand 1 (melanoma growth stimulating activity, alpha)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001511.1	NP_001502.1	PROVISIONAL	OK	1.000	1.000	107	324	1	321	107	1	107
RIKEN	BC033746	IRAK068M14	MGC	W01A009B20	pENTR-TOPO	25416		PNCK	139728	AAH33746	Hs.436667	Pregnancy up-regulated non-ubiquitously expressed CaM kinase			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001039582.3	NP_001034671.3	VALIDATED	Pg	0.760	1.000	121	366	1	363	426	84	175
RIKEN	BC033746	IRAK068M14	MGC	W01A009B22	pENTR-TOPO	25416		PNCK	139728	AAH33746	Hs.436667	Pregnancy up-regulated non-ubiquitously expressed CaM kinase			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001039582.3	NP_001034671.3	VALIDATED	Pg	0.760	1.000	121	366	1	363	426	84	175
RIKEN	BC030950	IRAL041O06	MGC	W01A009C01	pENTR-TOPO	10435		PRAC	84366	AAH30950.1	Hs.116467	Prostate cancer susceptibility candidate			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_032391.2	NP_115767.1	REVIEWED	OK	1.000	1.000	57	174	1	171	57	1	57
RIKEN	BC001863	IRAL008E23	MGC	W01A009C15	pENTR-TOPO	21166		C7orf68	29923	AAH01863.1	Hs.710088	Chromosome 7 open reading frame 68			Lung, small cell carcinoma	NIH_MGC_7		NM_001098786.1	NP_001092256.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
RIKEN	BC063023	IRAK140C05	MGC	W01A009C21	pENTR-TOPO	8120		NOP10	55505	AAH63023.1	Hs.14317	NOP10 ribonucleoprotein homolog (yeast)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_018648.3	NP_061118.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
RIKEN	AK024728	flj0057h23	FLJ	W01A009D08	pENTR-TOPO	21282		C7orf69	80099	BAB14977.1	Hs.287647	Chromosome 7 open reading frame 69				CAS	EK1	NM_025031.2	NP_079307.2	VALIDATED	Cs	0.984	0.984	122	369	1	366	122	1	122
RIKEN	AK097056	flj0025g13	FLJ	W01A009D14	pENTR-TOPO	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D				SMINT2	EK1	NM_182635.1	NP_872441.1	VALIDATED	C	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC020666	IRAL037N23	MGC	W01A009D22	pENTR-TOPO	15852		VPREB3	29802	AAH20666.1	Hs.136713	Pre-B lymphocyte 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013378.2	NP_037510.1	REVIEWED	C	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC008886	IRAL027O09	MGC	W01A009E01	pENTR-TOPO	8120		NOP10	55505	AAH08886.1	Hs.14317	NOP10 ribonucleoprotein homolog (yeast)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_018648.3	NP_061118.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
RIKEN	BC027888	IRAK049K18	MGC	W01A009E14	pENTR-TOPO	10728		CCL3L1	6349	AAH27888.1	Hs.512683	Chemokine (C-C motif) ligand 3-like 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_021006.4	NP_066286.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC030241	IRAK062C23	MGC	W01A009F14	pENTR-TOPO	3774		GAL	51083	AAH30241.1	Hs.278959	Galanin prepropeptide			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015973.3	NP_057057.2	VALIDATED	C	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC000897	IRAK004B24	MGC	W01A009F18	pENTR-TOPO	4077		IFITM1	8519	AAH00897.1	Hs.458414	Interferon induced transmembrane protein 1 (9-27)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003641.3	NP_003632.3	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC002647	IRAL012E07	MGC	W01A009F23	pENTR-TOPO	16960		UCN2	90226	AAH02647.2	Hs.631914	Urocortin 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_033199.3	NP_149976.1	REVIEWED	OK	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC022440	IRAL035M22	MGC	W01A009G10	pENTR-TOPO	21184		LSM8	51691	AAH22440.1	Hs.709757	LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_016200.3	NP_057284.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
RIKEN	BC022440	IRAL035M22	MGC	W01A009G14	pENTR-TOPO	21184		LSM8	51691	AAH22440.1	Hs.709757	LSM8 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_016200.3	NP_057284.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
RIKEN	BC015463	IRAK022M11	MGC	W01A009H16	pENTR-TOPO	13958		SF3B14	51639	AAH15463.1	Hs.177861	Splicing factor 3B, 14 kDa subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016047.3	NP_057131.1	REVIEWED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	AK091220	flj0015c19	FLJ	W01A009H18	pENTR-TOPO	695		HIST3H2BB	128312	BAC03613.1	Hs.376691	Histone cluster 3, H2bb				CTONG2	EK1	NM_175055.2	NP_778225.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	AK091220	flj0015c19	FLJ	W01A009H20	pENTR-TOPO	695		HIST3H2BB	128312	BAC03613.1	Hs.376691	Histone cluster 3, H2bb				CTONG2	EK1	NM_175055.2	NP_778225.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	AK091220	flj0015c19	FLJ	W01A009H22	pENTR-TOPO	695		HIST3H2BB	128312	BAC03613.1	Hs.376691	Histone cluster 3, H2bb				CTONG2	EK1	NM_175055.2	NP_778225.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	BC029367	IRAL041E23	MGC	W01A009I01	pENTR-TOPO	21234		GNGT1	2792	AAH29367.1	Hs.702084	Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1			Placenta	NIH_MGC_79	DH10B	NM_021955.3	NP_068774.1	VALIDATED	C	1.000	1.000	74	225	1	222	74	1	74
RIKEN	BC029367	IRAL041E23	MGC	W01A009I03	pENTR-TOPO	21234		GNGT1	2792	AAH29367.1	Hs.702084	Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 1			Placenta	NIH_MGC_79	DH10B	NM_021955.3	NP_068774.1	VALIDATED	C	1.000	1.000	74	225	1	222	74	1	74
RIKEN	BC013643	IRAK019G22	MGC	W01A009I14	pENTR-TOPO	18707		C5orf32	84418	AAH13643.1	Hs.529798	Chromosome 5 open reading frame 32			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_032412.3	NP_115788.1	VALIDATED	OK	1.000	1.000	97	294	1	291	97	1	97
RIKEN	BC022485	IRAK032H10	MGC	W01A009I15	pENTR-TOPO	1760		GNG4	2786	AAH22485.1	Hs.159711	Guanine nucleotide binding protein (G protein), gamma 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004485.3	NP_004476.1	VALIDATED	C	1.000	1.000	75	228	1	225	75	1	75
RIKEN	BC054023	IRAL048L10	MGC	W01A009I18	pENTR-TOPO	25261		SPANXC	64663	AAH54023.1	Hs.558533	SPANX family, member C			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_022661.2	NP_073152.1	REVIEWED	C	1.000	1.000	97	294	1	291	97	1	97
RIKEN	BC015563	IRAL017G09	MGC	W01A009I19	pENTR-TOPO	3773		GNG3	2785	AAH15563.1	Hs.179915	Guanine nucleotide binding protein (G protein), gamma 3			Brain, neuroblastoma	NIH_MGC_19		NM_012202.3	NP_036334.1	VALIDATED	OK	1.000	1.000	75	228	1	225	75	1	75
RIKEN	BC054023	IRAL048L10	MGC	W01A009I20	pENTR-TOPO	25261		SPANXC	64663	AAH54023.1	Hs.558533	SPANX family, member C			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_022661.2	NP_073152.1	REVIEWED	C	1.000	1.000	97	294	1	291	97	1	97
RIKEN	BC015563	IRAL017G09	MGC	W01A009I21	pENTR-TOPO	3773		GNG3	2785	AAH15563.1	Hs.179915	Guanine nucleotide binding protein (G protein), gamma 3			Brain, neuroblastoma	NIH_MGC_19		NM_012202.3	NP_036334.1	VALIDATED	OK	1.000	1.000	75	228	1	225	75	1	75
RIKEN	BC054023	IRAL048L10	MGC	W01A009I22	pENTR-TOPO	25261		SPANXC	64663	AAH54023.1	Hs.558533	SPANX family, member C			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_022661.2	NP_073152.1	REVIEWED	C	1.000	1.000	97	294	1	291	97	1	97
RIKEN	BC066240	IRAK172G20	MGC	W01A009J04	pENTR-TOPO	20121		HIST1H2BA	255626	AAH66240.1	Hs.591786	Histone cluster 1, H2ba			PCR rescued clones	NIH_MGC_195	DH10B	NM_170610.2	NP_733759.1	REVIEWED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	BC066240	IRAK172G20	MGC	W01A009J06	pENTR-TOPO	20121		HIST1H2BA	255626	AAH66240.1	Hs.591786	Histone cluster 1, H2ba			PCR rescued clones	NIH_MGC_195	DH10B	NM_170610.2	NP_733759.1	REVIEWED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	BC002348	IRAL001A06	MGC	W01A009J12	pENTR-TOPO	8910		NUTF2	10204	AAH02348.1	Hs.719219	Nuclear transport factor 2			Lung, small cell carcinoma	NIH_MGC_7		NM_005796.1	NP_005787.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
RIKEN	BC011175	IRAK019A14	MGC	W01A009J15	pENTR-TOPO	12247		TYROBP	7305	AAH11175.1	Hs.515369	TYRO protein tyrosine kinase binding protein			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_003332.2	NP_003323.1	REVIEWED	OK	1.000	1.000	113	342	1	339	113	1	113
RIKEN	BC002348	IRAL001A06	MGC	W01A009J16	pENTR-TOPO	8910		NUTF2	10204	AAH02348.1	Hs.719219	Nuclear transport factor 2			Lung, small cell carcinoma	NIH_MGC_7		NM_005796.1	NP_005787.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
RIKEN	BC009798	IRAL019M05	MGC	W01A009J19	pENTR-TOPO	7543		DAD1	1603	AAH09798.1	Hs.82890	Defender against cell death 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001344.2	NP_001335.1	REVIEWED	Cs	0.991	0.991	113	342	1	339	113	1	113
RIKEN	BC028217	IRAK062H24	MGC	W01A009J22	pENTR-TOPO	18282		PPBP	5473	AAH28217.1	Hs.2164	Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_002704.2	NP_002695.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC028217	IRAK062H24	MGC	W01A009J24	pENTR-TOPO	18282		PPBP	5473	AAH28217.1	Hs.2164	Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_002704.2	NP_002695.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC015925	IRAK015F18	MGC	W01A009K01	pENTR-TOPO	23031		ZNF706	51123	AAH15925.1	Hs.374485	Zinc finger protein 706			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001042511.1	NP_001035976.1	VALIDATED	C	1.000	1.000	76	231	1	228	76	1	76
RIKEN	BC008621	IRAK012L08	MGC	W01A009K06	pENTR-TOPO	9789		CCL13	6357	AAH08621.1	Hs.414629	Chemokine (C-C motif) ligand 13			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_005408.2	NP_005399.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC015925	IRAK015F18	MGC	W01A009K07	pENTR-TOPO	23031		ZNF706	51123	AAH15925.1	Hs.374485	Zinc finger protein 706			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001042511.1	NP_001035976.1	VALIDATED	C	1.000	1.000	76	231	1	228	76	1	76
RIKEN	BC008621	IRAK012L08	MGC	W01A009K08	pENTR-TOPO	9789		CCL13	6357	AAH08621.1	Hs.414629	Chemokine (C-C motif) ligand 13			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_005408.2	NP_005399.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC027968	IRAK049N18	MGC	W01A009K10	pENTR-TOPO	23947		CCL19	6363	AAH27968.1	Hs.50002	Chemokine (C-C motif) ligand 19			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006274.2	NP_006265.1	REVIEWED	C	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC000070	IRAL007I05	MGC	W01A009K17	pENTR-TOPO	14253		SNRPG	6637	AAH00070.1	Hs.654528	Small nuclear ribonucleoprotein polypeptide G			Placenta, choriocarcinoma	NIH_MGC_21		NM_003096.2	NP_003087.1	PROVISIONAL	C	1.000	1.000	76	231	1	228	76	1	76
RIKEN	BC009716	IRAK014O01	MGC	W01A009K20	pENTR-TOPO	9990		CCL2	6347	AAH09716.1	Hs.303649	Chemokine (C-C motif) ligand 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002982.3	NP_002973.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC009716	IRAK014O01	MGC	W01A009K22	pENTR-TOPO	9990		CCL2	6347	AAH09716.1	Hs.303649	Chemokine (C-C motif) ligand 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002982.3	NP_002973.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC009716	IRAK014O01	MGC	W01A009K24	pENTR-TOPO	9990		CCL2	6347	AAH09716.1	Hs.303649	Chemokine (C-C motif) ligand 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002982.3	NP_002973.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC020732	IRAL037B21	MGC	W01A009L04	pENTR-TOPO	24595		SH2D1A	4068	AAH20732.1	Hs.349094	SH2 domain protein 1A			Lung	NIH_MGC_77	DH10B	NM_002351.3	NP_002342.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC020732	IRAL037B21	MGC	W01A009L08	pENTR-TOPO	24595		SH2D1A	4068	AAH20732.1	Hs.349094	SH2 domain protein 1A			Lung	NIH_MGC_77	DH10B	NM_002351.3	NP_002342.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC016709	IRAL032D19	MGC	W01A009L13	pENTR-TOPO	24582		SH3BGRL	6451	AAH16709.1	Hs.108029	SH3 domain binding glutamic acid-rich protein like			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_003022.2	NP_003013.1	VALIDATED	OK	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC001033	IRAL004A10	MGC	W01A009L19	pENTR-TOPO	20064		TMEM14B	81853	AAH01033.1	Hs.95600	Transmembrane protein 14B			Placenta, choriocarcinoma	NIH_MGC_21		NM_030969.3	NP_112231.3	VALIDATED	Cs	0.991	0.991	114	345	1	342	114	1	114
RIKEN	BC032626	IRAK069B19	MGC	W01A009L20	pENTR-TOPO	7428		IFI27L2	83982	AAH32626.1	Hs.94695	Interferon, alpha-inducible protein 27-like 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_032036.2	NP_114425.1	VALIDATED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC032626	IRAK069B19	MGC	W01A009L24	pENTR-TOPO	7428		IFI27L2	83982	AAH32626.1	Hs.94695	Interferon, alpha-inducible protein 27-like 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_032036.2	NP_114425.1	VALIDATED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC008488	IRAL021D19	MGC	W01A009M05	pENTR-TOPO	14695		ROMO1	140823	AAH08488.1	Hs.472564	Reactive oxygen species modulator 1			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_080748.2	NP_542786.1	VALIDATED	C	1.000	1.000	79	240	1	237	79	1	79
RIKEN	BC015097	IRAL031C11	MGC	W01A009M06	pENTR-TOPO	19778		TMEM14A	28978	AAH15097.1	Hs.94896	Transmembrane protein 14A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014051.3	NP_054770.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC015970	IRAL032K24	MGC	W01A009M10	pENTR-TOPO	13977		DPY30	84661	AAH15970.1	Hs.531788	Dpy-30 homolog (C. elegans)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_032574.2	NP_115963.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC019328	IRAL008G19	MGC	W01A009M20	pENTR-TOPO	19778		TMEM14A	28978	AAH19328.1	Hs.94896	Transmembrane protein 14A			Lung, small cell carcinoma	NIH_MGC_7		NM_014051.3	NP_054770.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC010888	IRAL019M15	MGC	W01A009M23	pENTR-TOPO	10990		IER3IP1	51124	AAH10888.1	Hs.653122	Immediate early response 3 interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_016097.3	NP_057181.1	VALIDATED	OK	1.000	1.000	82	249	1	246	82	1	82
RIKEN	BC012303	IRAK028B06	MGC	W01A009N01	pENTR-TOPO	2176		PDZK1IP1	10158	AAH12303.1	Hs.431099	PDZK1 interacting protein 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_005764.3	NP_005755.1	VALIDATED	Cs	0.982	0.982	114	345	1	342	114	1	114
RIKEN	BC034717	IRAK028N22	MGC	W01A009N09	pENTR-TOPO	5778		CDK2AP1	8099	AAH34717.1	Hs.719107	Cyclin-dependent kinase 2 associated protein 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_004642.2	NP_004633.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC022554	IRAK032P01	MGC	W01A009N16	pENTR-TOPO	732		PEA15	8682	AAH22554.1	Hs.517216	Phosphoprotein enriched in astrocytes 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003768.3	NP_003759.1	VALIDATED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC010957	IRAL019B18	MGC	W01A009N17	pENTR-TOPO	19662		CGA	1081	AAH10957.1	Hs.119689	Glycoprotein hormones, alpha polypeptide			Placenta	NIH_MGC_79	DH10B	NM_000735.2	NP_000726.1	REVIEWED	Cs	0.991	0.991	116	351	1	348	116	1	116
RIKEN	BC001193	IRAL006B15	MGC	W01A009N20	pENTR-TOPO	2145		HIST3H2A	92815	AAH01193	Hs.700190	Histone cluster 3, H2a			Eye, retinoblastoma	NIH_MGC_16		NM_033445.2	NP_254280.1	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC010957	IRAL019B18	MGC	W01A009N21	pENTR-TOPO	19662		CGA	1081	AAH10957.1	Hs.119689	Glycoprotein hormones, alpha polypeptide			Placenta	NIH_MGC_79	DH10B	NM_000735.2	NP_000726.1	REVIEWED	Cs	0.991	0.991	116	351	1	348	116	1	116
RIKEN	BC010957	IRAL019B18	MGC	W01A009N23	pENTR-TOPO	19662		CGA	1081	AAH10957.1	Hs.119689	Glycoprotein hormones, alpha polypeptide			Placenta	NIH_MGC_79	DH10B	NM_000735.2	NP_000726.1	REVIEWED	Cs	0.991	0.991	116	351	1	348	116	1	116
RIKEN	BC016336	IRAL032F13	MGC	W01A009O02	pENTR-TOPO	20088		HIST1H4I	8294	AAH16336	Hs.248172	Histone cluster 1, H4i			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003495.2	NP_003486.1	REVIEWED	C	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC016336	IRAL032F13	MGC	W01A009O06	pENTR-TOPO	20088		HIST1H4I	8294	AAH16336	Hs.248172	Histone cluster 1, H4i			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003495.2	NP_003486.1	REVIEWED	C	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC066248	IRAK172F02	MGC	W01A009O10	pENTR-TOPO	20124		HIST1H4A	8359	AAH66248.1	Hs.248178	Histone cluster 1, H4a			PCR rescued clones	NIH_MGC_195	DH10B	NM_003538.3	NP_003529.1	REVIEWED	C	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC025399	IRAK033O06	MGC	W01A009O18	pENTR-TOPO	472		PROK1	84432	AAH25399.1	Hs.514793	Prokineticin 1			Testis	NIH_MGC_97	DH10B	NM_032414.2	NP_115790.1	VALIDATED	Cs	0.990	0.990	105	318	1	315	105	1	105
RIKEN	BC017568	IRAL032N09	MGC	W01A009P03	pENTR-TOPO	8369		NRG4	145957	AAH17568.1	Hs.696574	Neuregulin 4			Liver	NIH_MGC_76	DH10B	NM_138573.2	NP_612640.1	PROVISIONAL	OK	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC025791	IRAK062G11	MGC	W01A009P21	pENTR-TOPO	16759		GHRL	51738	AAH25791.1	Hs.590080	Ghrelin/obestatin prepropeptide			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_016362.3	NP_057446.1	REVIEWED	Cs	0.991	0.991	117	354	1	351	117	1	117
RIKEN	BC005974	IRAL021F09	MGC	W01A010A02	pENTR-TOPO	1559		VAMP4	8674	AAH05974.1	Hs.6651	Vesicle-associated membrane protein 4			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003762.3	NP_003753.2	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
RIKEN	BC001629	IRAL008N11	MGC	W01A010A05	pENTR-TOPO	881		HIST2H2AA3	8337	AAH01629	Hs.530461	Histone cluster 2, H2aa3			Lung, small cell carcinoma	NIH_MGC_7		NM_003516.2	NP_003507.1	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC005974	IRAL021F09	MGC	W01A010A06	pENTR-TOPO	1559		VAMP4	8674	AAH05974.1	Hs.6651	Vesicle-associated membrane protein 4			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003762.3	NP_003753.2	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
RIKEN	BC001629	IRAL008N11	MGC	W01A010A07	pENTR-TOPO	881		HIST2H2AA3	8337	AAH01629	Hs.530461	Histone cluster 2, H2aa3			Lung, small cell carcinoma	NIH_MGC_7		NM_003516.2	NP_003507.1	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC035330	IRAK050O12	MGC	W01A010A12	pENTR-TOPO	25180		KCNE1L	23630	AAH35330.1	Hs.522753	KCNE1-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012282.2	NP_036414.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC035330	IRAK050O12	MGC	W01A010A14	pENTR-TOPO	25180		KCNE1L	23630	AAH35330.1	Hs.522753	KCNE1-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012282.2	NP_036414.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC035330	IRAK050O12	MGC	W01A010A16	pENTR-TOPO	25180		KCNE1L	23630	AAH35330.1	Hs.522753	KCNE1-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012282.2	NP_036414.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC019272	IRAL002F15	MGC	W01A010A24	pENTR-TOPO	11189		TXNL4A	10907	AAH19272.1	Hs.465498	Thioredoxin-like 4A			Lung, small cell carcinoma	NIH_MGC_7		NM_006701.2	NP_006692.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC016650	IRAK026K11	MGC	W01A010B04	pENTR-TOPO	482		ECOP	81552	AAH16650.1	Hs.488307	EGFR-coamplified and overexpressed protein			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_030796.3	NP_110423.3	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	BC016650	IRAK026K11	MGC	W01A010B06	pENTR-TOPO	482		ECOP	81552	AAH16650.1	Hs.488307	EGFR-coamplified and overexpressed protein			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_030796.3	NP_110423.3	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	BC010142	IRAL027O02	MGC	W01A010B10	pENTR-TOPO	25164		TIMM17B	10245	AAH10142.1	Hs.30570	Translocase of inner mitochondrial membrane 17 homolog B (yeast)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_005834.2	NP_005825.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
RIKEN	AK024359	flj0038i05	FLJ	W01A010B13	pENTR-TOPO	18015		ABCA11P	79963	BAB14895.1						PLACE1	EK1			
RIKEN	BC010142	IRAL027O02	MGC	W01A010B14	pENTR-TOPO	25164		TIMM17B	10245	AAH10142.1	Hs.30570	Translocase of inner mitochondrial membrane 17 homolog B (yeast)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_005834.2	NP_005825.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
RIKEN	BC033861	IRAK068J22	MGC	W01A010B18	pENTR-TOPO	10468		LSMD1	84316	AAH33861.1	Hs.565094	LSM domain containing 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032356.3	NP_115732.2	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
RIKEN	BC001255	IRAK004K10	MGC	W01A010B19	pENTR-TOPO	17086		NCBP2	22916	AAH01255.1	Hs.591671	Nuclear cap binding protein subunit 2, 20kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_007362.3	NP_031388.2	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	BC001255	IRAK004K10	MGC	W01A010B21	pENTR-TOPO	17086		NCBP2	22916	AAH01255.1	Hs.591671	Nuclear cap binding protein subunit 2, 20kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_007362.3	NP_031388.2	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	BC007793	IRAL020C03	MGC	W01A010C09	pENTR-TOPO	11708		GEMIN7	79760	AAH07793.1	Hs.466919	Gem (nuclear organelle) associated protein 7			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001007269.1	NP_001007270.1	REVIEWED	C	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC011704	IRAL027F21	MGC	W01A010C12	pENTR-TOPO	4033		MDK	4192	AAH11704.1	Hs.82045	Midkine (neurite growth-promoting factor 2)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001012334.1	NP_001012334.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
RIKEN	BC009363	IRAL026O20	MGC	W01A010C18	pENTR-TOPO	15505		TOMM22	56993	AAH09363.1	Hs.595072	Translocase of outer mitochondrial membrane 22 homolog (yeast)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_020243.4	NP_064628.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
RIKEN	AK055561	flj0001n13	FLJ	W01A010C19	pENTR-TOPO	10302		ERN1	2081	BAB70956	Hs.700027	Endoplasmic reticulum to nucleus signaling 1				HLUNG1	EK1	NM_001433.3	NP_001424.3	REVIEWED		0.545	0.545	11	402	289	321	977	965	975
RIKEN	AK055561	flj0001n13	FLJ	W01A010C23	pENTR-TOPO	10302		ERN1	2081	BAB70956	Hs.700027	Endoplasmic reticulum to nucleus signaling 1				HLUNG1	EK1	NM_001433.3	NP_001424.3	REVIEWED		0.545	0.545	11	402	289	321	977	965	975
RIKEN	BC047300	IRAK093C10	MGC	W01A010D01	pENTR-TOPO	5605		EMP1	2012	AAH47300.1	Hs.707901	Epithelial membrane protein 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001423.2	NP_001414.1	VALIDATED	C	1.000	1.000	157	474	1	471	157	1	157
RIKEN	BC047300	IRAK093C10	MGC	W01A010D03	pENTR-TOPO	5605		EMP1	2012	AAH47300.1	Hs.707901	Epithelial membrane protein 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001423.2	NP_001414.1	VALIDATED	C	1.000	1.000	157	474	1	471	157	1	157
RIKEN	BC003371	IRAK003A19	MGC	W01A010D06	pENTR-TOPO	5651		SSR4	6748	AAH03371.1	Hs.409223	Signal sequence receptor, delta (translocon-associated protein delta)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006280.1	NP_006271.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
RIKEN	BC023975	IRAL002K20	MGC	W01A010D10	pENTR-TOPO	19893		PTP4A1	7803	AAH23975.1	Hs.227777	Protein tyrosine phosphatase type IVA, member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003463.3	NP_003454.1	REVIEWED	C	1.000	1.000	173	522	1	519	173	1	173
RIKEN	BC023975	IRAL002K20	MGC	W01A010D12	pENTR-TOPO	19893		PTP4A1	7803	AAH23975.1	Hs.227777	Protein tyrosine phosphatase type IVA, member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003463.3	NP_003454.1	REVIEWED	C	1.000	1.000	173	522	1	519	173	1	173
RIKEN	BC017784	IRAL036H06	MGC	W01A010D13	pENTR-TOPO	5981		KLRC4	8302	AAH17784.1					Lung	NIH_MGC_77	DH10B	NM_013431.2	NP_038459.1	REVIEWED	C	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC023975	IRAL002K20	MGC	W01A010D14	pENTR-TOPO	19893		PTP4A1	7803	AAH23975.1	Hs.227777	Protein tyrosine phosphatase type IVA, member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003463.3	NP_003454.1	REVIEWED	C	1.000	1.000	173	522	1	519	173	1	173
RIKEN	BC041390	IRAK075J15	MGC	W01A010D18	pENTR-TOPO	16329		CMTM8	152189	AAH41390.1	Hs.154986	CKLF-like MARVEL transmembrane domain containing 8			Brain, hippocampus	NIH_MGC_95	DH10B	NM_178868.3	NP_849199.2	REVIEWED	Cs	0.988	0.988	173	522	1	519	173	1	173
RIKEN	BC000569	IRAL005I23	MGC	W01A010D19	pENTR-TOPO	15363		TMEM50B	757	AAH00569.1	Hs.433668	Transmembrane protein 50B			Eye, retinoblastoma	NIH_MGC_16		NM_006134.5	NP_006125.2	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	AK021845	flj0029a18	FLJ	W01A010E01	pENTR-TOPO	3693		MLL	4297	BAB13909	Hs.258855	Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)				HEMBA1	EK1	NM_005933.2	NP_005924.2	VALIDATED	Pfs	0.299	0.333	67	408	331	146	3969	1281	1345
RIKEN	BC010561	IRAK019E24	MGC	W01A010E02	pENTR-TOPO	16752		FAM107A	11170	AAH10561.1	Hs.506357	Family with sequence similarity 107, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_001076778.1	NP_001070246.1	VALIDATED	C	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC010561	IRAK019E24	MGC	W01A010E04	pENTR-TOPO	16752		FAM107A	11170	AAH10561.1	Hs.506357	Family with sequence similarity 107, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_001076778.1	NP_001070246.1	VALIDATED	C	1.000	1.000	144	435	1	432	144	1	144
RIKEN	AK021845	flj0029a18	FLJ	W01A010E05	pENTR-TOPO	3693		MLL	4297	BAB13909	Hs.258855	Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)				HEMBA1	EK1	NM_005933.2	NP_005924.2	VALIDATED	Pfs	0.299	0.333	67	408	331	146	3969	1281	1345
RIKEN	AK021845	flj0029a18	FLJ	W01A010E07	pENTR-TOPO	3693		MLL	4297	BAB13909	Hs.258855	Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)				HEMBA1	EK1	NM_005933.2	NP_005924.2	VALIDATED	Pfs	0.299	0.333	67	408	331	146	3969	1281	1345
RIKEN	BC001693	IRAL003E19	MGC	W01A010E09	pENTR-TOPO	15524		LGALS1	3956	AAH01693.1	Hs.445351	Lectin, galactoside-binding, soluble, 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_002305.3	NP_002296.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	BC000882	IRAK004F12	MGC	W01A010E10	pENTR-TOPO	2142		TOMM20	9804	AAH00882.1	Hs.533192	Translocase of outer mitochondrial membrane 20 homolog (yeast)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014765.2	NP_055580.1	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC001693	IRAL003E19	MGC	W01A010E11	pENTR-TOPO	15524		LGALS1	3956	AAH01693.1	Hs.445351	Lectin, galactoside-binding, soluble, 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_002305.3	NP_002296.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	BC001693	IRAL003E19	MGC	W01A010E13	pENTR-TOPO	15524		LGALS1	3956	AAH01693.1	Hs.445351	Lectin, galactoside-binding, soluble, 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_002305.3	NP_002296.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	BC000882	IRAK004F12	MGC	W01A010E14	pENTR-TOPO	2142		TOMM20	9804	AAH00882.1	Hs.533192	Translocase of outer mitochondrial membrane 20 homolog (yeast)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014765.2	NP_055580.1	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC001693	IRAL003E19	MGC	W01A010E15	pENTR-TOPO	15524		LGALS1	3956	AAH01693.1	Hs.445351	Lectin, galactoside-binding, soluble, 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_002305.3	NP_002296.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	BC000882	IRAK004F12	MGC	W01A010E16	pENTR-TOPO	2142		TOMM20	9804	AAH00882.1	Hs.533192	Translocase of outer mitochondrial membrane 20 homolog (yeast)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014765.2	NP_055580.1	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC042038	IRAK090I16	MGC	W01A010E19	pENTR-TOPO	16581		C3orf46	255330	AAH42038.1	Hs.145435	Chromosome 3 open reading frame 46			Testis	NIH_MGC_97	DH10B													
RIKEN	BC016667	IRAK026I10	MGC	W01A010F05	pENTR-TOPO	276		RGS13	6003	AAH16667.1	Hs.497220	Regulator of G-protein signaling 13			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002927.3	NP_002918.1	REVIEWED	OK	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC016667	IRAK026I10	MGC	W01A010F07	pENTR-TOPO	276		RGS13	6003	AAH16667.1	Hs.497220	Regulator of G-protein signaling 13			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002927.3	NP_002918.1	REVIEWED	OK	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC014448	IRAL034P24	MGC	W01A010F09	pENTR-TOPO	22550		C8orf44	56260	AAH14448.1	Hs.661238	Chromosome 8 open reading frame 44			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_019607.1	NP_062553.1	PREDICTED	Cs	0.994	0.994	159	480	1	477	159	1	159
RIKEN	BC014448	IRAL034P24	MGC	W01A010F11	pENTR-TOPO	22550		C8orf44	56260	AAH14448.1	Hs.661238	Chromosome 8 open reading frame 44			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_019607.1	NP_062553.1	PREDICTED	Cs	0.994	0.994	159	480	1	477	159	1	159
RIKEN	BC014448	IRAL034P24	MGC	W01A010F13	pENTR-TOPO	22550		C8orf44	56260	AAH14448.1	Hs.661238	Chromosome 8 open reading frame 44			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_019607.1	NP_062553.1	PREDICTED	Cs	0.994	0.994	159	480	1	477	159	1	159
RIKEN	BC012908	IRAK021J24	MGC	W01A010F14	pENTR-TOPO	18132		NMU	10874	AAH12908.1	Hs.418367	Neuromedin U			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_006681.2	NP_006672.1	VALIDATED	C	1.000	1.000	174	525	1	522	174	1	174
RIKEN	BC011020	IRAL019N21	MGC	W01A010F21	pENTR-TOPO	9343		MPHOSPH6	10200	AAH11020.1	Hs.344400	M-phase phosphoprotein 6			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005792.2	NP_005783.2	VALIDATED	Cs	0.994	0.994	160	483	1	480	160	1	160
RIKEN	BC011020	IRAL019N21	MGC	W01A010F23	pENTR-TOPO	9343		MPHOSPH6	10200	AAH11020.1	Hs.344400	M-phase phosphoprotein 6			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005792.2	NP_005783.2	VALIDATED	Cs	0.994	0.994	160	483	1	480	160	1	160
RIKEN	BC007704	IRAL015D21	MGC	W01A010G04	pENTR-TOPO	7475		SYNJ2BP	55333	AAH07704.1	Hs.704691	Synaptojanin 2 binding protein			Ovary, adenocarcinoma	NIH_MGC_9		NM_018373.2	NP_060843.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC007704	IRAL015D21	MGC	W01A010G06	pENTR-TOPO	7475		SYNJ2BP	55333	AAH07704.1	Hs.704691	Synaptojanin 2 binding protein			Ovary, adenocarcinoma	NIH_MGC_9		NM_018373.2	NP_060843.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC017558	IRAK015G04	MGC	W01A010G13	pENTR-TOPO	10413		H3F3B	3021	AAH17558.1	Hs.180877	H3 histone, family 3B (H3.3B)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005324.3	NP_005315.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC003104	IRAL006N16	MGC	W01A010G16	pENTR-TOPO	25107		LDOC1	23641	AAH03104.1	Hs.45231	Leucine zipper, down-regulated in cancer 1			Brain, neuroblastoma	NIH_MGC_19		NM_012317.2	NP_036449.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	BC022304	IRAL037E13	MGC	W01A010G18	pENTR-TOPO	21245		RAMP3	10268	AAH22304.1	Hs.25691	Receptor (G protein-coupled) activity modifying protein 3			Lung	NIH_MGC_77	DH10B	NM_005856.2	NP_005847.1	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC031391	IRAK050G03	MGC	W01A010G19	pENTR-TOPO	18092		CYTL1	54360	AAH31391.1	Hs.13872	Cytokine-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018659.2	NP_061129.1	VALIDATED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC022304	IRAL037E13	MGC	W01A010G24	pENTR-TOPO	21245		RAMP3	10268	AAH22304.1	Hs.25691	Receptor (G protein-coupled) activity modifying protein 3			Lung	NIH_MGC_77	DH10B	NM_005856.2	NP_005847.1	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC017088	IRAK020L06	MGC	W01A010H02	pENTR-TOPO	375		RBM8A	9939	AAH17088.1	Hs.356873	RNA binding motif protein 8A			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_005105.2	NP_005096.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
RIKEN	BC005242	IRAL016F06	MGC	W01A010H03	pENTR-TOPO	9343		MPHOSPH6	10200	AAH05242.1	Hs.344400	M-phase phosphoprotein 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005792.2	NP_005783.2	VALIDATED	Cs	0.994	0.994	160	483	1	480	160	1	160
RIKEN	BC017088	IRAK020L06	MGC	W01A010H06	pENTR-TOPO	375		RBM8A	9939	AAH17088.1	Hs.356873	RNA binding motif protein 8A			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_005105.2	NP_005096.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
RIKEN	BC005242	IRAL016F06	MGC	W01A010H07	pENTR-TOPO	9343		MPHOSPH6	10200	AAH05242.1	Hs.344400	M-phase phosphoprotein 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005792.2	NP_005783.2	VALIDATED	Cs	0.994	0.994	160	483	1	480	160	1	160
RIKEN	BC010116	IRAL027G18	MGC	W01A010H10	pENTR-TOPO	16330		CMTM7	112616	AAH10116.1	Hs.440494	CKLF-like MARVEL transmembrane domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21		NM_138410.2	NP_612419.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC010116	IRAL027G18	MGC	W01A010H12	pENTR-TOPO	16330		CMTM7	112616	AAH10116.1	Hs.440494	CKLF-like MARVEL transmembrane domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21		NM_138410.2	NP_612419.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC001599	IRAL008O10	MGC	W01A010H13	pENTR-TOPO	15672		BIK	638	AAH01599.1	Hs.475055	BCL2-interacting killer (apoptosis-inducing)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001197.3	NP_001188.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
RIKEN	BC010116	IRAL027G18	MGC	W01A010H14	pENTR-TOPO	16330		CMTM7	112616	AAH10116.1	Hs.440494	CKLF-like MARVEL transmembrane domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21		NM_138410.2	NP_612419.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC010116	IRAL027G18	MGC	W01A010H16	pENTR-TOPO	16330		CMTM7	112616	AAH10116.1	Hs.440494	CKLF-like MARVEL transmembrane domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21		NM_138410.2	NP_612419.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC018149	IRAK020N22	MGC	W01A010H17	pENTR-TOPO	17480		IL15	3600	AAH18149.1	Hs.654378	Interleukin 15			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_172174.2	NP_751914.1	REVIEWED	OK	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC027975	IRAK049P18	MGC	W01A010H22	pENTR-TOPO	9788		RAMP2	10266	AAH27975.1	Hs.514193	Receptor (G protein-coupled) activity modifying protein 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_005854.2	NP_005845.2	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC027975	IRAK049P18	MGC	W01A010H24	pENTR-TOPO	9788		RAMP2	10266	AAH27975.1	Hs.514193	Receptor (G protein-coupled) activity modifying protein 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_005854.2	NP_005845.2	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC010905	IRAL019L09	MGC	W01A010I04	pENTR-TOPO	5959		MAGOHB	55110	AAH10905.1	Hs.104650	Mago-nashi homolog B (Drosophila)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_018048.2	NP_060518.1	PROVISIONAL	C	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC029405	IRAL041B22	MGC	W01A010I05	pENTR-TOPO	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002107.3	NP_002098.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC000548	IRAL005C15	MGC	W01A010I12	pENTR-TOPO	13217		RAMP1	10267	AAH00548.1	Hs.471783	Receptor (G protein-coupled) activity modifying protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_005855.2	NP_005846.1	REVIEWED	C	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC006497	IRAL010C09	MGC	W01A010I17	pENTR-TOPO	10413		H3F3B	3021	AAH06497.1	Hs.180877	H3 histone, family 3B (H3.3B)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005324.3	NP_005315.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC009646	IRAK004K08	MGC	W01A010I18	pENTR-TOPO	9243		TXNL4B	54957	AAH09646.1	Hs.134406	Thioredoxin-like 4B			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001142317.1	NP_001135789.1	VALIDATED	C	1.000	1.000	149	450	1	447	149	1	149
RIKEN	BC006497	IRAL010C09	MGC	W01A010I19	pENTR-TOPO	10413		H3F3B	3021	AAH06497.1	Hs.180877	H3 histone, family 3B (H3.3B)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005324.3	NP_005315.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC009646	IRAK004K08	MGC	W01A010I20	pENTR-TOPO	9243		TXNL4B	54957	AAH09646.1	Hs.134406	Thioredoxin-like 4B			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001142317.1	NP_001135789.1	VALIDATED	C	1.000	1.000	149	450	1	447	149	1	149
RIKEN	BC006497	IRAL010C09	MGC	W01A010I21	pENTR-TOPO	10413		H3F3B	3021	AAH06497.1	Hs.180877	H3 histone, family 3B (H3.3B)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005324.3	NP_005315.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC009646	IRAK004K08	MGC	W01A010I22	pENTR-TOPO	9243		TXNL4B	54957	AAH09646.1	Hs.134406	Thioredoxin-like 4B			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001142317.1	NP_001135789.1	VALIDATED	C	1.000	1.000	149	450	1	447	149	1	149
RIKEN	BC006497	IRAL010C09	MGC	W01A010I23	pENTR-TOPO	10413		H3F3B	3021	AAH06497.1	Hs.180877	H3 histone, family 3B (H3.3B)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005324.3	NP_005315.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC018538	IRAK026K02	MGC	W01A010J05	pENTR-TOPO	6555		ALOX5AP	241	AAH18538.1	Hs.507658	Arachidonate 5-lipoxygenase-activating protein			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001629.2	NP_001620.2	REVIEWED	C	1.000	1.000	161	486	1	483	161	1	161
RIKEN	BC038846	IRAK082M15	MGC	W01A010J11	pENTR-TOPO	19664		LY86	9450	AAH38846.1	Hs.653138	Lymphocyte antigen 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004271.3	NP_004262.1	VALIDATED	OK	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC038846	IRAK082M15	MGC	W01A010J13	pENTR-TOPO	19664		LY86	9450	AAH38846.1	Hs.653138	Lymphocyte antigen 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004271.3	NP_004262.1	VALIDATED	OK	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC001115	IRAL003I19	MGC	W01A010J16	pENTR-TOPO	13933		MPV17	4358	AAH01115.1	Hs.75659	MpV17 mitochondrial inner membrane protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_002437.4	NP_002428.1	REVIEWED	C	1.000	1.000	176	531	1	528	176	1	176
RIKEN	BC022001	IRAK033H21	MGC	W01A010J18	pENTR-TOPO	16120		PCNP	57092	AAH22001.1	Hs.654949	PEST proteolytic signal containing nuclear protein			Testis	NIH_MGC_97	DH10B	NM_020357.1	NP_065090.1	PROVISIONAL	Cs	0.994	0.994	178	537	1	534	178	1	178
RIKEN	BC009718	IRAK014E12	MGC	W01A010J23	pENTR-TOPO	11942		EMP3	2014	AAH09718.1	Hs.9999	Epithelial membrane protein 3				NIH_MGC_69	DH10B	NM_001425.2	NP_001416.1	VALIDATED	C	1.000	1.000	163	492	1	489	163	1	163
RIKEN	BC020628	IRAL036I04	MGC	W01A010K06	pENTR-TOPO	3885		C11orf1	64776	AAH20628.1	Hs.17546	Chromosome 11 open reading frame 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_022761.2	NP_073598.1	VALIDATED	C	1.000	1.000	150	453	1	450	150	1	150
RIKEN	BC012592	IRAL019E23	MGC	W01A010K13	pENTR-TOPO	23232		HRSP12	10247	AAH12592.1	Hs.18426	Heat-responsive protein 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_005836.2	NP_005827.1	VALIDATED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC012592	IRAL019E23	MGC	W01A010K15	pENTR-TOPO	23232		HRSP12	10247	AAH12592.1	Hs.18426	Heat-responsive protein 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_005836.2	NP_005827.1	VALIDATED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC022257	IRAL037M02	MGC	W01A010K17	pENTR-TOPO	11569		LGALS14	56891	AAH22257.1	Hs.24236	Lectin, galactoside-binding, soluble, 14			Placenta	NIH_MGC_79	DH10B	NM_020129.2	NP_064514.1	REVIEWED	Cs	0.986	0.986	139	420	1	417	139	1	139
RIKEN	BC004440	IRAL009A15	MGC	W01A010K24	pENTR-TOPO	24222		NINJ1	4814	AAH04440.1	Hs.494457	Ninjurin 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004148.3	NP_004139.2	VALIDATED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC054868	IRAL048I24	MGC	W01A010L02	pENTR-TOPO	3191		NPM3	10360	AAH54868.1	Hs.90691	Nucleophosmin/nucleoplasmin, 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006993.2	NP_008924.1	REVIEWED	C	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC002899	IRAL015M09	MGC	W01A010L03	pENTR-TOPO	11555		PIN1	5300	AAH02899.1	Hs.465849	Peptidylprolyl cis/trans isomerase, NIMA-interacting 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006221.2	NP_006212.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	BC002899	IRAL015M09	MGC	W01A010L07	pENTR-TOPO	11555		PIN1	5300	AAH02899.1	Hs.465849	Peptidylprolyl cis/trans isomerase, NIMA-interacting 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006221.2	NP_006212.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	BC021666	IRAL031B23	MGC	W01A010L17	pENTR-TOPO	18889		STK32A	202374	AAH21666.1	Hs.585069	Serine/threonine kinase 32A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_145001.3	NP_659438.1	VALIDATED	C	1.000	1.000	166	501	1	498	166	1	166
RIKEN	BC005278	IRAL016K10	MGC	W01A010L18	pENTR-TOPO	14263		GCG	2641	AAH05278.1	Hs.516494	Glucagon			Pancreas	NIH_MGC_78	DH10B	NM_002054.2	NP_002045.1	REVIEWED	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC005278	IRAL016K10	MGC	W01A010L24	pENTR-TOPO	14263		GCG	2641	AAH05278.1	Hs.516494	Glucagon			Pancreas	NIH_MGC_78	DH10B	NM_002054.2	NP_002045.1	REVIEWED	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC001959	IRAL008H13	MGC	W01A010M03	pENTR-TOPO	30166		PNRC2	55629	AAH01959.1	Hs.7862	Proline-rich nuclear receptor coactivator 2			Lung, small cell carcinoma	NIH_MGC_7		XM_001713881.1	XP_001713933.1	MODEL	C	1.000	1.000	139	420	1	417	139	1	139
RIKEN	BC005964	IRAL021K13	MGC	W01A010M08	pENTR-TOPO	271		MGST3	4259	AAH05964.1	Hs.191734	Microsomal glutathione S-transferase 3			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004528.2	NP_004519.1	REVIEWED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC003410	IRAK003P18	MGC	W01A010M11	pENTR-TOPO	14631		NXT1	29107	AAH03410.1	Hs.516933	NTF2-like export factor 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_013248.2	NP_037380.1	REVIEWED	C	1.000	1.000	140	423	1	420	140	1	140
RIKEN	BC003540	IRAL013K19	MGC	W01A010M12	pENTR-TOPO	21909		FIS1	51024	AAH03540.1	Hs.423968	Fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_016068.2	NP_057152.2	VALIDATED	OK	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC002444	IRAL005M24	MGC	W01A010M19	pENTR-TOPO	7418		C14orf1	11161	AAH02444.1	Hs.15106	Chromosome 14 open reading frame 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_007176.2	NP_009107.1	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
RIKEN	BC002444	IRAL005M24	MGC	W01A010M21	pENTR-TOPO	7418		C14orf1	11161	AAH02444.1	Hs.15106	Chromosome 14 open reading frame 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_007176.2	NP_009107.1	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
RIKEN	BC003034	IRAL009H13	MGC	W01A010M22	pENTR-TOPO	271		MGST3	4259	AAH03034.1	Hs.191734	Microsomal glutathione S-transferase 3			Lung, small cell carcinoma	NIH_MGC_7		NM_004528.2	NP_004519.1	REVIEWED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC007662	IRAL004O17	MGC	W01A010N04	pENTR-TOPO	1556		TRAPPC3	27095	AAH07662.1	Hs.523131	Trafficking protein particle complex 3			Colon, adenocarcinoma	NIH_MGC_15		NM_014408.3	NP_055223.1	PROVISIONAL	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC007662	IRAL004O17	MGC	W01A010N06	pENTR-TOPO	1556		TRAPPC3	27095	AAH07662.1	Hs.523131	Trafficking protein particle complex 3			Colon, adenocarcinoma	NIH_MGC_15		NM_014408.3	NP_055223.1	PROVISIONAL	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC010918	IRAL019M13	MGC	W01A010N09	pENTR-TOPO	5326		NTS	4922	AAH10918.1	Hs.80962	Neurotensin			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006183.3	NP_006174.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
RIKEN	BC007922	IRAL020P05	MGC	W01A010N12	pENTR-TOPO	7737		ISG20	3669	AAH07922.1	Hs.459265	Interferon stimulated exonuclease gene 20kDa			Primary B-Cells from Tonsils	NIH_MGC_48		NM_002201.4	NP_002192.2	PROVISIONAL	OK	1.000	1.000	181	546	1	543	181	1	181
RIKEN	BC010918	IRAL019M13	MGC	W01A010N15	pENTR-TOPO	5326		NTS	4922	AAH10918.1	Hs.80962	Neurotensin			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006183.3	NP_006174.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
RIKEN	BC001110	IRAL003O04	MGC	W01A010N19	pENTR-TOPO	15551		TSPO	706	AAH01110.1	Hs.202	Translocator protein (18kDa)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_000714.4	NP_000705.2	REVIEWED	Cs	0.988	0.988	169	510	1	507	169	1	169
RIKEN	BC004380	IRAL013F14	MGC	W01A010O06	pENTR-TOPO	8645		CKLF	51192	AAH04380.1	Hs.15159	Chemokine-like factor			Pancreas, adenocarcinoma	NIH_MGC_39		NM_016951.2	NP_058647.1	REVIEWED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC000759	IRAL002I17	MGC	W01A010O07	pENTR-TOPO	14631		NXT1	29107	AAH00759.1	Hs.516933	NTF2-like export factor 1			Lung, small cell carcinoma	NIH_MGC_7		NM_013248.2	NP_037380.1	REVIEWED	C	1.000	1.000	140	423	1	420	140	1	140
RIKEN	BC012543	IRAL019I22	MGC	W01A010O10	pENTR-TOPO	5228		ORMDL2	29095	AAH12543.1	Hs.534450	ORM1-like 2 (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_014182.4	NP_054901.1	VALIDATED	C	1.000	1.000	153	462	1	459	153	1	153
RIKEN	BC001430	IRAL004B03	MGC	W01A010O11	pENTR-TOPO	21406		POP7	10248	AAH01430.1	Hs.416994	Processing of precursor 7, ribonuclease P/MRP subunit (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_005837.2	NP_005828.2	VALIDATED	C	1.000	1.000	140	423	1	420	140	1	140
RIKEN	BC012543	IRAL019I22	MGC	W01A010O16	pENTR-TOPO	5228		ORMDL2	29095	AAH12543.1	Hs.534450	ORM1-like 2 (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_014182.4	NP_054901.1	VALIDATED	C	1.000	1.000	153	462	1	459	153	1	153
RIKEN	BC031264	IRAK063J05	MGC	W01A010O19	pENTR-TOPO	1559		VAMP4	8674	AAH31264.1	Hs.6651	Vesicle-associated membrane protein 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003762.3	NP_003753.2	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
RIKEN	BC000250	IRAL006C18	MGC	W01A010P01	pENTR-TOPO	9367		NME3	4832	AAH00250.1	Hs.514065	Non-metastatic cells 3, protein expressed in			Eye, retinoblastoma	NIH_MGC_16		NM_002513.2	NP_002504.2	VALIDATED	C	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC014429	IRAL029A02	MGC	W01A010P09	pENTR-TOPO	13435		KCNE4	23704	AAH14429.1	Hs.348522	Potassium voltage-gated channel, Isk-related family, member 4			Lung, large cell carcinoma	NIH_MGC_18		NM_080671.2	NP_542402.2	VALIDATED	Cs	0.994	0.994	170	513	1	510	170	1	170
RIKEN	BC014429	IRAL029A02	MGC	W01A010P11	pENTR-TOPO	13435		KCNE4	23704	AAH14429.1	Hs.348522	Potassium voltage-gated channel, Isk-related family, member 4			Lung, large cell carcinoma	NIH_MGC_18		NM_080671.2	NP_542402.2	VALIDATED	Cs	0.994	0.994	170	513	1	510	170	1	170
RIKEN	BC014429	IRAL029A02	MGC	W01A010P13	pENTR-TOPO	13435		KCNE4	23704	AAH14429.1	Hs.348522	Potassium voltage-gated channel, Isk-related family, member 4			Lung, large cell carcinoma	NIH_MGC_18		NM_080671.2	NP_542402.2	VALIDATED	Cs	0.994	0.994	170	513	1	510	170	1	170
RIKEN	BC001422	IRAL004M06	MGC	W01A010P17	pENTR-TOPO	7312		PGF	5228	AAH01422.1	Hs.252820	Placental growth factor			Placenta, choriocarcinoma	NIH_MGC_21		NM_002632.4	NP_002623.2	VALIDATED	C	1.000	1.000	170	513	1	510	170	1	170
RIKEN	BC001777	IRAL006P17	MGC	W01A011A12	pENTR-TOPO	883		HPCA	3208	AAH01777.1	Hs.632391	Hippocalcin			Eye, retinoblastoma	NIH_MGC_16		NM_002143.2	NP_002134.2	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC002797	IRAL012B02	MGC	W01A011A17	pENTR-TOPO	16906		CMTM6	54918	AAH02797.1	Hs.380627	CKLF-like MARVEL transmembrane domain containing 6			Ovary, adenocarcinoma	NIH_MGC_9		NM_017801.2	NP_060271.1	REVIEWED	C	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC022067	IRAK046F10	MGC	W01A011A22	pENTR-TOPO	3211		EXOSC1	51013	AAH22067.1	Hs.632089	Exosome component 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016046.3	NP_057130.1	VALIDATED	C	1.000	1.000	195	588	1	585	195	1	195
RIKEN	BC035000	IRAK047O08	MGC	W01A011B02	pENTR-TOPO	12938		DUSP19	142679	AAH35000.1	Hs.132237	Dual specificity phosphatase 19			Testis	NIH_MGC_97	DH10B	NM_080876.3	NP_543152.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC040176	IRAK070C20	MGC	W01A011B03	pENTR-TOPO	13198		LYPD6B	130576	AAH40176.2	Hs.357567	LY6/PLAUR domain containing 6B			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_177964.3	NP_808879.2	PROVISIONAL	OK	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC035000	IRAK047O08	MGC	W01A011B04	pENTR-TOPO	12938		DUSP19	142679	AAH35000.1	Hs.132237	Dual specificity phosphatase 19			Testis	NIH_MGC_97	DH10B	NM_080876.3	NP_543152.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC035000	IRAK047O08	MGC	W01A011B06	pENTR-TOPO	12938		DUSP19	142679	AAH35000.1	Hs.132237	Dual specificity phosphatase 19			Testis	NIH_MGC_97	DH10B	NM_080876.3	NP_543152.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC000824	IRAK004F03	MGC	W01A011B09	pENTR-TOPO	2874		MGMT	4255	AAH00824.1	Hs.501522	O-6-methylguanine-DNA methyltransferase			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002412.3	NP_002403.2	VALIDATED	P	1.000	1.000	207	624	1	621	238	32	238
RIKEN	BC017495	IRAK015O05	MGC	W01A011B10	pENTR-TOPO	7815		TMED3	23423	AAH17495.1	Hs.513058	Transmembrane emp24 protein transport domain containing 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007364.2	NP_031390.1	VALIDATED	C	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC017495	IRAK015O05	MGC	W01A011B14	pENTR-TOPO	7815		TMED3	23423	AAH17495.1	Hs.513058	Transmembrane emp24 protein transport domain containing 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007364.2	NP_031390.1	VALIDATED	C	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC009681	IRAK014C09	MGC	W01A011B21	pENTR-TOPO	840		IL24	11009	AAH09681.1	Hs.719320	Interleukin 24			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_181339.1	NP_851936.1	REVIEWED	C	1.000	1.000	48	624	478	621	48	1	48
RIKEN	BC002673	IRAL012K07	MGC	W01A011C04	pENTR-TOPO	5318		HSPB8	26353	AAH02673.1	Hs.400095	Heat shock 22kDa protein 8			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_014365.2	NP_055180.1	REVIEWED	OK	1.000	1.000	196	591	1	588	196	1	196
RIKEN	BC011989	IRAK021O21	MGC	W01A011C05	pENTR-TOPO	19282		ESM1	11082	AAH11989.1	Hs.129944	Endothelial cell-specific molecule 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_007036.4	NP_008967.1	REVIEWED	Cs	0.995	0.995	184	555	1	552	184	1	184
RIKEN	BC016327	IRAL032F03	MGC	W01A011C11	pENTR-TOPO	25270		NUP62CL	54830	AAH16327.1	Hs.163629	Nucleoporin 62kDa C-terminal like			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_017681.2	NP_060151.2	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC040124	IRAK084O11	MGC	W01A011C18	pENTR-TOPO	4477		TMEM9B	56674	AAH40124.1	Hs.501853	TMEM9 domain family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_020644.1	NP_065695.1	PROVISIONAL	C	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC040124	IRAK084O11	MGC	W01A011C20	pENTR-TOPO	4477		TMEM9B	56674	AAH40124.1	Hs.501853	TMEM9 domain family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_020644.1	NP_065695.1	PROVISIONAL	C	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC020637	IRAL037H22	MGC	W01A011D02	pENTR-TOPO	13144		IL1F7	27178	AAH20637.1	Hs.166371	Interleukin 1 family, member 7 (zeta)			Placenta	NIH_MGC_79	DH10B	NM_014439.3	NP_055254.2	REVIEWED	Cs	0.991	0.991	218	657	1	654	218	1	218
RIKEN	BC020637	IRAL037H22	MGC	W01A011D06	pENTR-TOPO	13144		IL1F7	27178	AAH20637.1	Hs.166371	Interleukin 1 family, member 7 (zeta)			Placenta	NIH_MGC_79	DH10B	NM_014439.3	NP_055254.2	REVIEWED	Cs	0.991	0.991	218	657	1	654	218	1	218
RIKEN	BC020637	IRAL037H22	MGC	W01A011D08	pENTR-TOPO	13144		IL1F7	27178	AAH20637.1	Hs.166371	Interleukin 1 family, member 7 (zeta)			Placenta	NIH_MGC_79	DH10B	NM_014439.3	NP_055254.2	REVIEWED	Cs	0.991	0.991	218	657	1	654	218	1	218
RIKEN	BC010866	IRAK014A15	MGC	W01A011D12	pENTR-TOPO	3777		TRAPPC4	51399	AAH10866.1	Hs.132760	Trafficking protein particle complex 4			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_016146.4	NP_057230.1	VALIDATED	C	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC013113	IRAK026F22	MGC	W01A011D21	pENTR-TOPO	16934		TM4SF19	116211	AAH13113	Hs.710321	Transmembrane 4 L six family member 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138461.2	NP_612470.2	VALIDATED	Cs	0.995	0.995	209	630	1	627	209	1	209
RIKEN	BC003658	IRAL011B14	MGC	W01A011E06	pENTR-TOPO	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20		NM_020150.4	NP_064535.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC002530	IRAL004K18	MGC	W01A011E09	pENTR-TOPO	3690		ARL2	402	AAH02530.1	Hs.502836	ADP-ribosylation factor-like 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_001667.2	NP_001658.2	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC002530	IRAL004K18	MGC	W01A011E13	pENTR-TOPO	3690		ARL2	402	AAH02530.1	Hs.502836	ADP-ribosylation factor-like 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_001667.2	NP_001658.2	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC022847	IRAL025F07	MGC	W01A011E17	pENTR-TOPO	19819		DUSP22	56940	AAH22847.1	Hs.29106	Dual specificity phosphatase 22			Lung, small cell carcinoma	NIH_MGC_7		NM_020185.3	NP_064570.1	PROVISIONAL	C	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC007037	IRAL016A12	MGC	W01A011E18	pENTR-TOPO	6202		CD69	969	AAH07037.1	Hs.208854	CD69 molecule			Pancreas	NIH_MGC_78	DH10B	NM_001781.2	NP_001772.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC022847	IRAL025F07	MGC	W01A011E19	pENTR-TOPO	19819		DUSP22	56940	AAH22847.1	Hs.29106	Dual specificity phosphatase 22			Lung, small cell carcinoma	NIH_MGC_7		NM_020185.3	NP_064570.1	PROVISIONAL	C	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC022847	IRAL025F07	MGC	W01A011E23	pENTR-TOPO	19819		DUSP22	56940	AAH22847.1	Hs.29106	Dual specificity phosphatase 22			Lung, small cell carcinoma	NIH_MGC_7		NM_020185.3	NP_064570.1	PROVISIONAL	C	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC007037	IRAL016A12	MGC	W01A011E24	pENTR-TOPO	6202		CD69	969	AAH07037.1	Hs.208854	CD69 molecule			Pancreas	NIH_MGC_78	DH10B	NM_001781.2	NP_001772.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC029408	IRAL041H04	MGC	W01A011F04	pENTR-TOPO	14278		PIGF	5281	AAH29408.1	Hs.468415	Phosphatidylinositol glycan anchor biosynthesis, class F			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_002643.3	NP_002634.1	REVIEWED	C	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC012421	IRAK021K09	MGC	W01A011F09	pENTR-TOPO	12684		NTF4	4909	AAH12421.1	Hs.266902	Neurotrophin 4			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_006179.4	NP_006170.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC008934	IRAL002F16	MGC	W01A011F10	pENTR-TOPO	9170		CLDN6	9074	AAH08934.1	Hs.533779	Claudin 6			Placenta, choriocarcinoma	NIH_MGC_21		NM_021195.4	NP_067018.2	VALIDATED	Cs	0.995	0.995	220	663	1	660	220	1	220
RIKEN	BC008934	IRAL002F16	MGC	W01A011F16	pENTR-TOPO	9170		CLDN6	9074	AAH08934.1	Hs.533779	Claudin 6			Placenta, choriocarcinoma	NIH_MGC_21		NM_021195.4	NP_067018.2	VALIDATED	Cs	0.995	0.995	220	663	1	660	220	1	220
RIKEN	BC018404	IRAK021N16	MGC	W01A011F19	pENTR-TOPO	11389		FGF21	26291	AAH18404.1	Hs.283015	Fibroblast growth factor 21			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_019113.2	NP_061986.1	REVIEWED	Cs	0.995	0.995	209	630	1	627	209	1	209
RIKEN	BC006098	IRAL018B13	MGC	W01A011F20	pENTR-TOPO	11495		POP4	10775	AAH06098.1	Hs.412870	Processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006627.2	NP_006618.1	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC006098	IRAL018B13	MGC	W01A011F22	pENTR-TOPO	11495		POP4	10775	AAH06098.1	Hs.412870	Processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006627.2	NP_006618.1	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC018404	IRAK021N16	MGC	W01A011F23	pENTR-TOPO	11389		FGF21	26291	AAH18404.1	Hs.283015	Fibroblast growth factor 21			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_019113.2	NP_061986.1	REVIEWED	Cs	0.995	0.995	209	630	1	627	209	1	209
RIKEN	BC006098	IRAL018B13	MGC	W01A011F24	pENTR-TOPO	11495		POP4	10775	AAH06098.1	Hs.412870	Processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006627.2	NP_006618.1	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC062333	IRAL050K06	MGC	W01A011G06	pENTR-TOPO	1440		AURKAIP1	54998	AAH62333.1	Hs.658138	Aurora kinase A interacting protein 1			Prostate, carcinoma	NIH_MGC_111		NM_017900.2	NP_060370.1	VALIDATED	OK	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC005956	IRAL021N20	MGC	W01A011G11	pENTR-TOPO	23942		RLN1	6013	AAH05956.1	Hs.368996	Relaxin 1			Prostate	NIH_MGC_83	DH10B	NM_006911.2	NP_008842.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC005956	IRAL021N20	MGC	W01A011G13	pENTR-TOPO	23942		RLN1	6013	AAH05956.1	Hs.368996	Relaxin 1			Prostate	NIH_MGC_83	DH10B	NM_006911.2	NP_008842.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC007997	IRAL023A16	MGC	W01A011G14	pENTR-TOPO	5998		RERG	85004	AAH07997.1	Hs.199487	RAS-like, estrogen-regulated, growth inhibitor			Eye, retinoblastoma	NIH_MGC_16		NM_032918.1	NP_116307.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC007997	IRAL023A16	MGC	W01A011G16	pENTR-TOPO	5998		RERG	85004	AAH07997.1	Hs.199487	RAS-like, estrogen-regulated, growth inhibitor			Eye, retinoblastoma	NIH_MGC_16		NM_032918.1	NP_116307.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC003186	IRAL006D16	MGC	W01A011G17	pENTR-TOPO	9168		GINS2	51659	AAH03186.1	Hs.433180	GINS complex subunit 2 (Psf2 homolog)			Brain, neuroblastoma	NIH_MGC_19		NM_016095.2	NP_057179.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC056668	IRAL048G04	MGC	W01A011G24	pENTR-TOPO	18759		ZMAT2	153527	AAH56668.1	Hs.350194	Zinc finger, matrin type 2			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144723.1	NP_653324.1	PROVISIONAL	OK	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC004438	IRAL009C21	MGC	W01A011H02	pENTR-TOPO	11495		POP4	10775	AAH04438.1	Hs.412870	Processing of precursor 4, ribonuclease P/MRP subunit (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_006627.2	NP_006618.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC002833	IRAL012J20	MGC	W01A011H15	pENTR-TOPO	25259		CTAG2	30848	AAH02833.1	Hs.87225	Cancer/testis antigen 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_020994.2	NP_066274.1	VALIDATED	Cs	0.990	0.990	210	633	1	630	210	1	210
RIKEN	BC007049	IRAL016A03	MGC	W01A011H19	pENTR-TOPO	503		RGS2	5997	AAH07049.1	Hs.78944	Regulator of G-protein signaling 2, 24kDa			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_002923.2	NP_002914.1	PROVISIONAL	OK	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC017203	IRAL012B17	MGC	W01A011I05	pENTR-TOPO	16892		SSR3	6747	AAH17203.1	Hs.518346	Signal sequence receptor, gamma (translocon-associated protein gamma)			Skin, melanotic melanoma.	NIH_MGC_20		NM_007107.2	NP_009038.1	REVIEWED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC017203	IRAL012B17	MGC	W01A011I07	pENTR-TOPO	16892		SSR3	6747	AAH17203.1	Hs.518346	Signal sequence receptor, gamma (translocon-associated protein gamma)			Skin, melanotic melanoma.	NIH_MGC_20		NM_007107.2	NP_009038.1	REVIEWED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC014339	IRAL031D14	MGC	W01A011I10	pENTR-TOPO	17150		TM4SF18	116441	AAH14339.1	Hs.22026	Transmembrane 4 L six family member 18			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_138786.2	NP_620141.1	PROVISIONAL	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC014339	IRAL031D14	MGC	W01A011I12	pENTR-TOPO	17150		TM4SF18	116441	AAH14339.1	Hs.22026	Transmembrane 4 L six family member 18			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_138786.2	NP_620141.1	PROVISIONAL	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC014339	IRAL031D14	MGC	W01A011I14	pENTR-TOPO	17150		TM4SF18	116441	AAH14339.1	Hs.22026	Transmembrane 4 L six family member 18			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_138786.2	NP_620141.1	PROVISIONAL	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC014339	IRAL031D14	MGC	W01A011I16	pENTR-TOPO	17150		TM4SF18	116441	AAH14339.1	Hs.22026	Transmembrane 4 L six family member 18			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_138786.2	NP_620141.1	PROVISIONAL	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC000339	IRAL001K01	MGC	W01A011J02	pENTR-TOPO	10590		SFRS2	6427	AAH00339.1	Hs.713672	Splicing factor, arginine/serine-rich 2			Lung, small cell carcinoma	NIH_MGC_7		NM_003016.3	NP_003007.2	PROVISIONAL	C	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC001055	IRAL007O15	MGC	W01A011J07	pENTR-TOPO	10370		CLDN7	1366	AAH01055.1	Hs.513915	Claudin 7			Placenta, choriocarcinoma	NIH_MGC_21		NM_001307.4	NP_001298.3	VALIDATED	Cs	0.991	0.991	211	636	1	633	211	1	211
RIKEN	BC047691	IRAK098K05	MGC	W01A011J12	pENTR-TOPO	16218		CYB561D2	11068	AAH47691.1	Hs.149443	Cytochrome b-561 domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_007022.3	NP_008953.1	PROVISIONAL	OK	1.000	1.000	222	669	1	666	222	1	222
RIKEN	BC047691	IRAK098K05	MGC	W01A011J14	pENTR-TOPO	16218		CYB561D2	11068	AAH47691.1	Hs.149443	Cytochrome b-561 domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_007022.3	NP_008953.1	PROVISIONAL	OK	1.000	1.000	222	669	1	666	222	1	222
RIKEN	BC004431	IRAL009K03	MGC	W01A011J15	pENTR-TOPO	20578		BAK1	578	AAH04431.1	Hs.485139	BCL2-antagonist/killer 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001188.3	NP_001179.1	REVIEWED	OK	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC005206	IRAL016J12	MGC	W01A011J19	pENTR-TOPO	21997		FKBP14	55033	AAH05206.1	Hs.571333	FK506 binding protein 14, 22 kDa			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_017946.2	NP_060416.1	VALIDATED	C	1.000	1.000	211	636	1	633	211	1	211
RIKEN	AK130502	flj0055b12	FLJ	W01A011J20	pENTR-TOPO	24118		SIGMAR1	10280	-	Hs.522087	Sigma non-opioid intracellular receptor 1				SLV	EK1	NM_005866.2	NP_005857.1	REVIEWED	OK	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC005206	IRAL016J12	MGC	W01A011J21	pENTR-TOPO	21997		FKBP14	55033	AAH05206.1	Hs.571333	FK506 binding protein 14, 22 kDa			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_017946.2	NP_060416.1	VALIDATED	C	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC021186	IRAK047F20	MGC	W01A011K02	pENTR-TOPO	12521		U2AF1L4	199746	AAH21186.1	Hs.351558	U2 small nuclear RNA auxiliary factor 1-like 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144987.2	NP_659424.2	VALIDATED	Cs	0.995	0.995	202	609	1	606	202	1	202
RIKEN	BC025713	IRAK049O03	MGC	W01A011K11	pENTR-TOPO	16276		TRAT1	50852	AAH25713.1	Hs.138701	T cell receptor associated transmembrane adaptor 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_016388.2	NP_057472.2	VALIDATED	C	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC025713	IRAK049O03	MGC	W01A011K13	pENTR-TOPO	16276		TRAT1	50852	AAH25713.1	Hs.138701	T cell receptor associated transmembrane adaptor 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_016388.2	NP_057472.2	VALIDATED	C	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC010281	IRAK003P17	MGC	W01A011K20	pENTR-TOPO	9384		ARL6IP1	23204	AAH10281.1	Hs.634882	ADP-ribosylation factor-like 6 interacting protein 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015161.1	NP_055976.1	PROVISIONAL	OK	1.000	1.000	203	612	1	609	203	1	203
RIKEN	BC015511	IRAK022B10	MGC	W01A011L05	pENTR-TOPO	21000		IL6	3569	AAH15511.1	Hs.654458	Interleukin 6 (interferon, beta 2)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000600.3	NP_000591.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC015511	IRAK022B10	MGC	W01A011L07	pENTR-TOPO	21000		IL6	3569	AAH15511.1	Hs.654458	Interleukin 6 (interferon, beta 2)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000600.3	NP_000591.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC000600	IRAL005E08	MGC	W01A011L09	pENTR-TOPO	7432		CINP	51550	AAH00600.1	Hs.129634	Cyclin-dependent kinase 2-interacting protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_032630.2	NP_116019.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC000600	IRAL005E08	MGC	W01A011L11	pENTR-TOPO	7432		CINP	51550	AAH00600.1	Hs.129634	Cyclin-dependent kinase 2-interacting protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_032630.2	NP_116019.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC000600	IRAL005E08	MGC	W01A011L13	pENTR-TOPO	7432		CINP	51550	AAH00600.1	Hs.129634	Cyclin-dependent kinase 2-interacting protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_032630.2	NP_116019.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC001827	IRAL011P19	MGC	W01A011L17	pENTR-TOPO	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_012145.2	NP_036277.2	VALIDATED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	AK023070	flj0034l23	FLJ	W01A011L20	pENTR-TOPO	22977		COMMD5	28991	BAB14389.1	Hs.631856	COMM domain containing 5	NT2	teratocarcinoma		NT2RP3	EK1	NM_014066.3	NP_054785.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	AK023070	flj0034l23	FLJ	W01A011L24	pENTR-TOPO	22977		COMMD5	28991	BAB14389.1	Hs.631856	COMM domain containing 5	NT2	teratocarcinoma		NT2RP3	EK1	NM_014066.3	NP_054785.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC001963	IRAK004P07	MGC	W01A011M06	pENTR-TOPO	14718		NRSN2	80023	AAH01963.1	Hs.416024	Neurensin 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_024958.2	NP_079234.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
RIKEN	BC030987	IRAL041M12	MGC	W01A011M09	pENTR-TOPO	15872		DUSP18	150290	AAH30987.1	Hs.517544	Dual specificity phosphatase 18			Placenta	NIH_MGC_79	DH10B	NM_152511.3	NP_689724.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC019921	IRAK042B20	MGC	W01A011M22	pENTR-TOPO	8210		MTHFS	10588	AAH19921.1	Hs.459049	5,10-methenyltetrahydrofolate synthetase (5-formyltetrahydrofolate cyclo-ligase)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006441.2	NP_006432.1	VALIDATED	C	1.000	1.000	203	612	1	609	203	1	203
RIKEN	BC008487	IRAL021N07	MGC	W01A011N05	pENTR-TOPO	4054		MS4A3	932	AAH08487.1	Hs.99960	Membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_001031666.1	NP_001026836.1	REVIEWED	C	1.000	1.000	91	645	370	642	91	1	91
RIKEN	BC008487	IRAL021N07	MGC	W01A011N07	pENTR-TOPO	4054		MS4A3	932	AAH08487.1	Hs.99960	Membrane-spanning 4-domains, subfamily A, member 3 (hematopoietic cell-specific)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_001031666.1	NP_001026836.1	REVIEWED	C	1.000	1.000	91	645	370	642	91	1	91
RIKEN	BC032313	IRAK064M07	MGC	W01A011N09	pENTR-TOPO	5367		CLEC4D	338339	AAH32313.1	Hs.351811	C-type lectin domain family 4, member D			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_080387.4	NP_525126.2	REVIEWED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC016288	IRAK015L19	MGC	W01A011N10	pENTR-TOPO	7542		FKBP3	2287	AAH16288.1	Hs.509226	FK506 binding protein 3, 25kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002013.3	NP_002004.1	REVIEWED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC032313	IRAK064M07	MGC	W01A011N15	pENTR-TOPO	5367		CLEC4D	338339	AAH32313.1	Hs.351811	C-type lectin domain family 4, member D			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_080387.4	NP_525126.2	REVIEWED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC016288	IRAK015L19	MGC	W01A011N16	pENTR-TOPO	7542		FKBP3	2287	AAH16288.1	Hs.509226	FK506 binding protein 3, 25kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002013.3	NP_002004.1	REVIEWED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC036793	IRAK079P23	MGC	W01A011N19	pENTR-TOPO	4529		SCN2B	6327	AAH36793.1	Hs.129783	Sodium channel, voltage-gated, type II, beta			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_004588.4	NP_004579.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC036793	IRAK079P23	MGC	W01A011N21	pENTR-TOPO	4529		SCN2B	6327	AAH36793.1	Hs.129783	Sodium channel, voltage-gated, type II, beta			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_004588.4	NP_004579.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC015359	IRAK020N05	MGC	W01A011N22	pENTR-TOPO	16979		FAM3D	131177	AAH15359.1	Hs.61265	Family with sequence similarity 3, member D			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138805.2	NP_620160.1	VALIDATED	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC036793	IRAK079P23	MGC	W01A011N23	pENTR-TOPO	4529		SCN2B	6327	AAH36793.1	Hs.129783	Sodium channel, voltage-gated, type II, beta			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_004588.4	NP_004579.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC005219	IRAL016A17	MGC	W01A011O05	pENTR-TOPO	1387		NRAS	4893	AAH05219.1	Hs.486502	Neuroblastoma RAS viral (v-ras) oncogene homolog			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002524.3	NP_002515.1	REVIEWED	C	1.000	1.000	189	570	1	567	189	1	189
RIKEN	BC010878	IRAL008L14	MGC	W01A011O06	pENTR-TOPO	19675		ASF1A	25842	AAH10878.1	Hs.292316	ASF1 anti-silencing function 1 homolog A (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_014034.2	NP_054753.1	REVIEWED	OK	1.000	1.000	204	615	1	612	204	1	204
RIKEN	BC013008	IRAL010C18	MGC	W01A011O12	pENTR-TOPO	9980		PSMB3	5691	AAH13008.1	Hs.82793	Proteasome (prosome, macropain) subunit, beta type, 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002795.2	NP_002786.2	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC013008	IRAL010C18	MGC	W01A011O14	pENTR-TOPO	9980		PSMB3	5691	AAH13008.1	Hs.82793	Proteasome (prosome, macropain) subunit, beta type, 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002795.2	NP_002786.2	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC006821	IRAK003F04	MGC	W01A011O15	pENTR-TOPO	5950		CBX5	23468	AAH06821.1	Hs.349283	Chromobox homolog 5 (HP1 alpha homolog, Drosophila)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001127321.1	NP_001120793.1	REVIEWED	C	1.000	1.000	191	576	1	573	191	1	191
RIKEN	BC002819	IRAL012F12	MGC	W01A011O17	pENTR-TOPO	10693		TMEM11	8834	AAH02819.1	Hs.719186	Transmembrane protein 11			Placenta, choriocarcinoma	NIH_MGC_21		NM_003876.2	NP_003867.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
RIKEN	BC002819	IRAL012F12	MGC	W01A011O19	pENTR-TOPO	10693		TMEM11	8834	AAH02819.1	Hs.719186	Transmembrane protein 11			Placenta, choriocarcinoma	NIH_MGC_21		NM_003876.2	NP_003867.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
RIKEN	BC018478	IRAK028D15	MGC	W01A011O22	pENTR-TOPO	6718		EBPL	84650	AAH18478.1	Hs.433278	Emopamil binding protein-like			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_032565.3	NP_115954.1	VALIDATED	OK	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC017774	IRAL036M13	MGC	W01A011P03	pENTR-TOPO	4541		MPZL2	10205	AAH17774.1	Hs.116651	Myelin protein zero-like 2			Lung	NIH_MGC_77	DH10B	NM_005797.2	NP_005788.1	REVIEWED	C	1.000	1.000	215	648	1	645	215	1	215
RIKEN	BC020839	IRAL036D11	MGC	W01A011P11	pENTR-TOPO	7411		RAB2B	84932	AAH20839.1	Hs.22399	RAB2B, member RAS oncogene family			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_032846.2	NP_116235.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
RIKEN	BC002672	IRAL012K05	MGC	W01A012A01	pENTR-TOPO	22977		COMMD5	28991	AAH02672.1	Hs.631856	COMM domain containing 5			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_014066.3	NP_054785.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC017773	IRAL036M14	MGC	W01A012A04	pENTR-TOPO	20525		TREM1	54210	AAH17773.1	Hs.283022	Triggering receptor expressed on myeloid cells 1			Lung	NIH_MGC_77	DH10B	NM_018643.2	NP_061113.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC002672	IRAL012K05	MGC	W01A012A05	pENTR-TOPO	22977		COMMD5	28991	AAH02672.1	Hs.631856	COMM domain containing 5			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_014066.3	NP_054785.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC017773	IRAL036M14	MGC	W01A012A06	pENTR-TOPO	20525		TREM1	54210	AAH17773.1	Hs.283022	Triggering receptor expressed on myeloid cells 1			Lung	NIH_MGC_77	DH10B	NM_018643.2	NP_061113.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC007986	IRAL010K06	MGC	W01A012A10	pENTR-TOPO	10704		TK1	7083	AAH07986.1	Hs.515122	Thymidine kinase 1, soluble			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003258.4	NP_003249.3	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC022279	IRAL036M06	MGC	W01A012A13	pENTR-TOPO	10722		CD300C	10871	AAH22279.1	Hs.2605	CD300c molecule			Lung	NIH_MGC_77	DH10B	NM_006678.3	NP_006669.1	PROVISIONAL	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC011589	IRAL029A21	MGC	W01A012B06	pENTR-TOPO	15969		OSM	5008	AAH11589.1	Hs.248156	Oncostatin M			Lung, large cell carcinoma	NIH_MGC_18		NM_020530.3	NP_065391.1	REVIEWED	C	1.000	1.000	252	759	1	756	252	1	252
RIKEN	BC036754	IRAK068N18	MGC	W01A012B11	pENTR-TOPO	21381		CLDN12	9069	AAH36754.1	Hs.258576	Claudin 12			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_012129.2	NP_036261.1	PROVISIONAL	C	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC013610	IRAK021L13	MGC	W01A012B14	pENTR-TOPO	4590		CLDND1	56650	AAH13610.1	Hs.709386	Claudin domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001040199.1	NP_001035289.1	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC017871	IRAL035K13	MGC	W01A012B17	pENTR-TOPO	20785		RPP40	10799	AAH17871.1	Hs.511756	Ribonuclease P/MRP 40kDa subunit			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006638.2	NP_006629.2	VALIDATED	Pg	0.914	1.000	266	735	1	729	363	61	326
RIKEN	BC005182	IRAL016I22	MGC	W01A012B18	pENTR-TOPO	313		UTP11L	51118	AAH05182.1	Hs.472038	UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016037.3	NP_057121.2	VALIDATED	C	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC017871	IRAL035K13	MGC	W01A012B19	pENTR-TOPO	20785		RPP40	10799	AAH17871.1	Hs.511756	Ribonuclease P/MRP 40kDa subunit			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006638.2	NP_006629.2	VALIDATED	Pg	0.914	1.000	266	735	1	729	363	61	326
RIKEN	BC005182	IRAL016I22	MGC	W01A012B20	pENTR-TOPO	313		UTP11L	51118	AAH05182.1	Hs.472038	UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016037.3	NP_057121.2	VALIDATED	C	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC005182	IRAL016I22	MGC	W01A012B22	pENTR-TOPO	313		UTP11L	51118	AAH05182.1	Hs.472038	UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016037.3	NP_057121.2	VALIDATED	C	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC017871	IRAL035K13	MGC	W01A012B23	pENTR-TOPO	20785		RPP40	10799	AAH17871.1	Hs.511756	Ribonuclease P/MRP 40kDa subunit			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006638.2	NP_006629.2	VALIDATED	Pg	0.914	1.000	266	735	1	729	363	61	326
RIKEN	BC005182	IRAL016I22	MGC	W01A012B24	pENTR-TOPO	313		UTP11L	51118	AAH05182.1	Hs.472038	UTP11-like, U3 small nucleolar ribonucleoprotein, (yeast)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016037.3	NP_057121.2	VALIDATED	C	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC001118	IRAL003I16	MGC	W01A012C03	pENTR-TOPO	11909		TMEM147	10430	AAH01118.1	Hs.9234	Transmembrane protein 147			Ovary, adenocarcinoma	NIH_MGC_9		NM_032635.2	NP_116024.1	PROVISIONAL	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	AK097501	flj0040l22	FLJ	W01A012C11	pENTR-TOPO	25249		FAM9B	171483	BAC05078.1	Hs.371894	Family with sequence similarity 9, member B				TESTI2	EK1	NM_205849.2	NP_995321.1	VALIDATED		0.844	0.867	186	681	136	678	186	1	186
RIKEN	AK097501	flj0040l22	FLJ	W01A012C13	pENTR-TOPO	25249		FAM9B	171483	BAC05078.1	Hs.371894	Family with sequence similarity 9, member B				TESTI2	EK1	NM_205849.2	NP_995321.1	VALIDATED		0.844	0.867	186	681	136	678	186	1	186
RIKEN	AK097501	flj0040l22	FLJ	W01A012C15	pENTR-TOPO	25249		FAM9B	171483	BAC05078.1	Hs.371894	Family with sequence similarity 9, member B				TESTI2	EK1	NM_205849.2	NP_995321.1	VALIDATED		0.844	0.867	186	681	136	678	186	1	186
RIKEN	BC003640	IRAL011I03	MGC	W01A012D12	pENTR-TOPO	8609		C16orf53	79447	AAH03640.1	Hs.702841	Chromosome 16 open reading frame 53			Eye, retinoblastoma	NIH_MGC_16		NM_024516.3	NP_078792.1	VALIDATED	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC003640	IRAL011I03	MGC	W01A012D16	pENTR-TOPO	8609		C16orf53	79447	AAH03640.1	Hs.702841	Chromosome 16 open reading frame 53			Eye, retinoblastoma	NIH_MGC_16		NM_024516.3	NP_078792.1	VALIDATED	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC013161	IRAK026C17	MGC	W01A012D21	pENTR-TOPO	16346		RTP4	64108	AAH13161.1	Hs.43388	Receptor (chemosensory) transporter protein 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022147.2	NP_071430.2	VALIDATED	Cs	0.988	0.988	246	741	1	738	246	1	246
RIKEN	BC009850	IRAL025G05	MGC	W01A012E02	pENTR-TOPO	11913		CDC34	997	AAH09850.1	Hs.514997	Cell division cycle 34 homolog (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_004359.1	NP_004350.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
RIKEN	BC010052	IRAL027I15	MGC	W01A012E11	pENTR-TOPO	3848		PRRG4	79056	AAH10052.1	Hs.471695	Proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)			Placenta, choriocarcinoma	NIH_MGC_21		NM_024081.4	NP_076986.1	PROVISIONAL	C	1.000	1.000	226	681	1	678	226	1	226
RIKEN	BC010052	IRAL027I15	MGC	W01A012E13	pENTR-TOPO	3848		PRRG4	79056	AAH10052.1	Hs.471695	Proline rich Gla (G-carboxyglutamic acid) 4 (transmembrane)			Placenta, choriocarcinoma	NIH_MGC_21		NM_024081.4	NP_076986.1	PROVISIONAL	C	1.000	1.000	226	681	1	678	226	1	226
RIKEN	BC000916	IRAK003K07	MGC	W01A012E14	pENTR-TOPO	5271		TMBIM6	7009	AAH00916.1	Hs.708025	Transmembrane BAX inhibitor motif containing 6			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003217.2	NP_003208.2	VALIDATED	OK	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC052641	IRAK115E08	MGC	W01A012E19	pENTR-TOPO	21407		TMED4	222068	AAH52641.1	Hs.715273	Transmembrane emp24 protein transport domain containing 4			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_182547.2	NP_872353.2	PROVISIONAL	C	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC034689	IRAK028M17	MGC	W01A012F05	pENTR-TOPO	19696		ULBP2	80328	AAH34689.1	Hs.656778	UL16 binding protein 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_025217.2	NP_079493.1	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC034689	IRAK028M17	MGC	W01A012F07	pENTR-TOPO	19696		ULBP2	80328	AAH34689.1	Hs.656778	UL16 binding protein 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_025217.2	NP_079493.1	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC023659	IRAL039H10	MGC	W01A012F09	pENTR-TOPO	6932		PSMA6	5687	AAH23659.1	Hs.446260	Proteasome (prosome, macropain) subunit, alpha type, 6			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002791.1	NP_002782.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC023659	IRAL039H10	MGC	W01A012F15	pENTR-TOPO	6932		PSMA6	5687	AAH23659.1	Hs.446260	Proteasome (prosome, macropain) subunit, alpha type, 6			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002791.1	NP_002782.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC006196	IRAL002C04	MGC	W01A012F18	pENTR-TOPO	2159		TNFRSF9	3604	AAH06196.1	Hs.654459	Tumor necrosis factor receptor superfamily, member 9			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001561.4	NP_001552.2	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	AK001387	flj0033m12	FLJ	W01A012F19	pENTR-TOPO	17582		TMEM33	55161	BAA91665.1	Hs.31082	Transmembrane protein 33	NT2	teratocarcinoma		NT2RP2	EK1	NM_018126.2	NP_060596.2	VALIDATED	Cs	0.996	0.996	247	744	1	741	247	1	247
RIKEN	BC006196	IRAL002C04	MGC	W01A012F20	pENTR-TOPO	2159		TNFRSF9	3604	AAH06196.1	Hs.654459	Tumor necrosis factor receptor superfamily, member 9			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001561.4	NP_001552.2	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC006196	IRAL002C04	MGC	W01A012F22	pENTR-TOPO	2159		TNFRSF9	3604	AAH06196.1	Hs.654459	Tumor necrosis factor receptor superfamily, member 9			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001561.4	NP_001552.2	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC006196	IRAL002C04	MGC	W01A012F24	pENTR-TOPO	2159		TNFRSF9	3604	AAH06196.1	Hs.654459	Tumor necrosis factor receptor superfamily, member 9			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001561.4	NP_001552.2	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC013948	IRAL007D16	MGC	W01A012G08	pENTR-TOPO	9289		RNF166	115992	AAH13948.1	Hs.513804	Ring finger protein 166			Brain, neuroblastoma	NIH_MGC_19		NM_178841.2	NP_849163.1	PROVISIONAL	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC015850	IRAL038F08	MGC	W01A012G09	pENTR-TOPO	20779		PRL	5617	AAH15850.1	Hs.1905	Prolactin			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_000948.3	NP_000939.1	PROVISIONAL	C	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC015850	IRAL038F08	MGC	W01A012G13	pENTR-TOPO	20779		PRL	5617	AAH15850.1	Hs.1905	Prolactin			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_000948.3	NP_000939.1	PROVISIONAL	C	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC015850	IRAL038F08	MGC	W01A012G15	pENTR-TOPO	20779		PRL	5617	AAH15850.1	Hs.1905	Prolactin			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_000948.3	NP_000939.1	PROVISIONAL	C	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC017722	IRAK027D19	MGC	W01A012G16	pENTR-TOPO	928		EFNA3	1944	AAH17722.1	Hs.516656	Ephrin-A3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_004952.4	NP_004943.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC002349	IRAL001A18	MGC	W01A012G18	pENTR-TOPO	6023		CD63	967	AAH02349.1	Hs.445570	CD63 molecule			Lung, small cell carcinoma	NIH_MGC_7		NM_001780.4	NP_001771.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC013771	IRAK026O03	MGC	W01A012G19	pENTR-TOPO	23966		AK3	50808	AAH13771.1	Hs.719257	Adenylate kinase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016282.2	NP_057366.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC013771	IRAK026O03	MGC	W01A012G21	pENTR-TOPO	23966		AK3	50808	AAH13771.1	Hs.719257	Adenylate kinase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016282.2	NP_057366.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC000948	IRAK003L02	MGC	W01A012H01	pENTR-TOPO	17582		TMEM33	55161	AAH00948.2	Hs.31082	Transmembrane protein 33			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_018126.2	NP_060596.2	VALIDATED	C	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC020905	IRAL037F15	MGC	W01A012H12	pENTR-TOPO	7722		APH1B	83464	AAH20905.1	Hs.511703	Anterior pharynx defective 1 homolog B (C. elegans)			Placenta	NIH_MGC_79	DH10B	NM_031301.3	NP_112591.2	VALIDATED	C	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC029044	IRAK050K05	MGC	W01A012H17	pENTR-TOPO	23247		STC1	6781	AAH29044.1	Hs.25590	Stanniocalcin 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_003155.2	NP_003146.1	REVIEWED	C	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC029044	IRAK050K05	MGC	W01A012H19	pENTR-TOPO	23247		STC1	6781	AAH29044.1	Hs.25590	Stanniocalcin 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_003155.2	NP_003146.1	REVIEWED	C	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC005912	IRAL021H16	MGC	W01A012H22	pENTR-TOPO	896		FCER1A	2205	AAH05912.1	Hs.897	Fc fragment of IgE, high affinity I, receptor for; alpha polypeptide			Prostate	NIH_MGC_83	DH10B	NM_002001.2	NP_001992.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC066919	IRAK167K21	MGC	W01A012I01	pENTR-TOPO	14624		RNF114	55905	AAH66919.1	Hs.144949	Ring finger protein 114			Brain, hippocampus	NIH_MGC_95	DH10B	NM_018683.3	NP_061153.1	VALIDATED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC013017	IRAL010M18	MGC	W01A012I04	pENTR-TOPO	6023		CD63	967	AAH13017.1	Hs.445570	CD63 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001780.4	NP_001771.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC013695	IRAK021C21	MGC	W01A012I13	pENTR-TOPO	14624		RNF114	55905	AAH13695.1	Hs.144949	Ring finger protein 114			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_018683.3	NP_061153.1	VALIDATED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC000835	IRAK004P15	MGC	W01A012I14	pENTR-TOPO	9976		PSMB6	5694	AAH00835.1	Hs.77060	Proteasome (prosome, macropain) subunit, beta type, 6			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_002798.1	NP_002789.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
RIKEN	AK025273	flj0056f02	FLJ	W01A012I18	pENTR-TOPO	7462		EGLN3	112399	BAB15101.1	Hs.135507	Egl nine homolog 3 (C. elegans)				COL	EK1	NM_022073.3	NP_071356.1	VALIDATED	OK	1.000	1.000	239	720	1	717	239	1	239
RIKEN	AK025273	flj0056f02	FLJ	W01A012I20	pENTR-TOPO	7462		EGLN3	112399	BAB15101.1	Hs.135507	Egl nine homolog 3 (C. elegans)				COL	EK1	NM_022073.3	NP_071356.1	VALIDATED	OK	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC007438	IRAL010B08	MGC	W01A012J04	pENTR-TOPO	10279		TMEM101	84336	AAH07438.1	Hs.514211	Transmembrane protein 101			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032376.2	NP_115752.1	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC001898	IRAL008P05	MGC	W01A012J05	pENTR-TOPO	9664		MPDU1	9526	AAH01898.1	Hs.632249	Mannose-P-dolichol utilization defect 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004870.3	NP_004861.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
RIKEN	BC007438	IRAL010B08	MGC	W01A012J06	pENTR-TOPO	10279		TMEM101	84336	AAH07438.1	Hs.514211	Transmembrane protein 101			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032376.2	NP_115752.1	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC007438	IRAL010B08	MGC	W01A012J08	pENTR-TOPO	10279		TMEM101	84336	AAH07438.1	Hs.514211	Transmembrane protein 101			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032376.2	NP_115752.1	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC003047	IRAL008G20	MGC	W01A012J09	pENTR-TOPO	15666		YWHAH	7533	AAH03047.1	Hs.226755	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003405.3	NP_003396.1	REVIEWED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC002947	IRAL015O24	MGC	W01A012J12	pENTR-TOPO	3720		FOLR1	2348	AAH02947.1	Hs.73769	Folate receptor 1 (adult)			Placenta, choriocarcinoma	NIH_MGC_21		NM_016724.1	NP_057936.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC003047	IRAL008G20	MGC	W01A012J15	pENTR-TOPO	15666		YWHAH	7533	AAH03047.1	Hs.226755	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, eta polypeptide			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003405.3	NP_003396.1	REVIEWED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC002947	IRAL015O24	MGC	W01A012J16	pENTR-TOPO	3720		FOLR1	2348	AAH02947.1	Hs.73769	Folate receptor 1 (adult)			Placenta, choriocarcinoma	NIH_MGC_21		NM_016724.1	NP_057936.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC000898	IRAK003K03	MGC	W01A012J19	pENTR-TOPO	5907		MLF2	8079	AAH00898.1	Hs.524214	Myeloid leukemia factor 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005439.2	NP_005430.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC000898	IRAK003K03	MGC	W01A012J21	pENTR-TOPO	5907		MLF2	8079	AAH00898.1	Hs.524214	Myeloid leukemia factor 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005439.2	NP_005430.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC000898	IRAK003K03	MGC	W01A012J23	pENTR-TOPO	5907		MLF2	8079	AAH00898.1	Hs.524214	Myeloid leukemia factor 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005439.2	NP_005430.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	AK096354	flj0040a15	FLJ	W01A012K03	pENTR-TOPO	739		CYB561D1	284613	BAC04767.1	Hs.514682	Cytochrome b-561 domain containing 1	NT2	teratocarcinoma		NT2RP7	EK1	NM_182580.2	NP_872386.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
RIKEN	AK096354	flj0040a15	FLJ	W01A012K07	pENTR-TOPO	739		CYB561D1	284613	BAC04767.1	Hs.514682	Cytochrome b-561 domain containing 1	NT2	teratocarcinoma		NT2RP7	EK1	NM_182580.2	NP_872386.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
RIKEN	BC015364	IRAK022F18	MGC	W01A012K13	pENTR-TOPO	11949		EBI3	10148	AAH15364.1	Hs.501452	Epstein-Barr virus induced 3			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_005755.2	NP_005746.2	REVIEWED	C	1.000	1.000	229	690	1	687	229	1	229
RIKEN	BC027176	IRAK026J16	MGC	W01A012K22	pENTR-TOPO	10323		UNC119	9094	AAH27176.1	Hs.410455	Unc-119 homolog (C. elegans)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_005148.3	NP_005139.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC027176	IRAK026J16	MGC	W01A012K24	pENTR-TOPO	10323		UNC119	9094	AAH27176.1	Hs.410455	Unc-119 homolog (C. elegans)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_005148.3	NP_005139.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC007033	IRAL016K07	MGC	W01A012L02	pENTR-TOPO	18598		SRD5A1	6715	AAH07033.1	Hs.552	Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001047.2	NP_001038.1	VALIDATED	C	1.000	1.000	259	780	1	777	259	1	259
RIKEN	BC017716	IRAK027H10	MGC	W01A012L03	pENTR-TOPO	10655		SECTM1	6398	AAH17716.1	Hs.558009	Secreted and transmembrane 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_003004.2	NP_002995.1	REVIEWED	Cs	0.996	0.996	248	747	1	744	248	1	248
RIKEN	BC017716	IRAK027H10	MGC	W01A012L05	pENTR-TOPO	10655		SECTM1	6398	AAH17716.1	Hs.558009	Secreted and transmembrane 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_003004.2	NP_002995.1	REVIEWED	Cs	0.996	0.996	248	747	1	744	248	1	248
RIKEN	BC007033	IRAL016K07	MGC	W01A012L06	pENTR-TOPO	18598		SRD5A1	6715	AAH07033.1	Hs.552	Steroid-5-alpha-reductase, alpha polypeptide 1 (3-oxo-5 alpha-steroid delta 4-dehydrogenase alpha 1)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001047.2	NP_001038.1	VALIDATED	C	1.000	1.000	259	780	1	777	259	1	259
RIKEN	BC017716	IRAK027H10	MGC	W01A012L07	pENTR-TOPO	10655		SECTM1	6398	AAH17716.1	Hs.558009	Secreted and transmembrane 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_003004.2	NP_002995.1	REVIEWED	Cs	0.996	0.996	248	747	1	744	248	1	248
RIKEN	BC063568	IRAK134C02	MGC	W01A012L10	pENTR-TOPO	16066		UPK1B	7348	AAH63568.1	Hs.271580	Uroplakin 1B			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_006952.3	NP_008883.2	REVIEWED	Cs	0.996	0.996	260	783	1	780	260	1	260
RIKEN	BC002340	IRAL001C11	MGC	W01A012L13	pENTR-TOPO	5907		MLF2	8079	AAH02340.1	Hs.524214	Myeloid leukemia factor 2			Lung, small cell carcinoma	NIH_MGC_7		NM_005439.2	NP_005430.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC063568	IRAK134C02	MGC	W01A012L14	pENTR-TOPO	16066		UPK1B	7348	AAH63568.1	Hs.271580	Uroplakin 1B			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_006952.3	NP_008883.2	REVIEWED	Cs	0.996	0.996	260	783	1	780	260	1	260
RIKEN	BC002340	IRAL001C11	MGC	W01A012L15	pENTR-TOPO	5907		MLF2	8079	AAH02340.1	Hs.524214	Myeloid leukemia factor 2			Lung, small cell carcinoma	NIH_MGC_7		NM_005439.2	NP_005430.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC063568	IRAK134C02	MGC	W01A012L16	pENTR-TOPO	16066		UPK1B	7348	AAH63568.1	Hs.271580	Uroplakin 1B			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_006952.3	NP_008883.2	REVIEWED	Cs	0.996	0.996	260	783	1	780	260	1	260
RIKEN	BC007073	IRAL016N08	MGC	W01A012L22	pENTR-TOPO	14921		DPM1	8813	AAH07073.1	Hs.654951	Dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003859.1	NP_003850.1	REVIEWED	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC004427	IRAL009E13	MGC	W01A012L23	pENTR-TOPO	14925		PSMA7	5688	AAH04427.1	Hs.233952	Proteasome (prosome, macropain) subunit, alpha type, 7			Lung, small cell carcinoma	NIH_MGC_7		NM_002792.2	NP_002783.1	REVIEWED	C	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC007073	IRAL016N08	MGC	W01A012L24	pENTR-TOPO	14921		DPM1	8813	AAH07073.1	Hs.654951	Dolichyl-phosphate mannosyltransferase polypeptide 1, catalytic subunit			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003859.1	NP_003850.1	REVIEWED	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC029822	IRAK051K05	MGC	W01A012M02	pENTR-TOPO	15891		PDGFB	5155	AAH29822.1	Hs.1976	Platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002608.2	NP_002599.1	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC029822	IRAK051K05	MGC	W01A012M04	pENTR-TOPO	15891		PDGFB	5155	AAH29822.1	Hs.1976	Platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002608.2	NP_002599.1	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC016509	IRAK012J02	MGC	W01A012M05	pENTR-TOPO	11564		SCAMP4	113178	AAH16509.1	Hs.144980	Secretory carrier membrane protein 4				NCI_CGAP_Brn67	DH10B	NM_079834.2	NP_524558.1	VALIDATED	C	1.000	1.000	229	690	1	687	229	1	229
RIKEN	BC029822	IRAK051K05	MGC	W01A012M08	pENTR-TOPO	15891		PDGFB	5155	AAH29822.1	Hs.1976	Platelet-derived growth factor beta polypeptide (simian sarcoma viral (v-sis) oncogene homolog)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002608.2	NP_002599.1	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	AK026453	flj0060p11	FLJ	W01A012M09	pENTR-TOPO	14082		TM4SF20	79853	BAB15488.1	Hs.156652	Transmembrane 4 L six family member 20				kaia	EK1	NM_024795.3	NP_079071.2	VALIDATED	Cs	0.996	0.996	229	690	1	687	229	1	229
RIKEN	AK026453	flj0060p11	FLJ	W01A012M11	pENTR-TOPO	14082		TM4SF20	79853	BAB15488.1	Hs.156652	Transmembrane 4 L six family member 20				kaia	EK1	NM_024795.3	NP_079071.2	VALIDATED	Cs	0.996	0.996	229	690	1	687	229	1	229
RIKEN	AK026453	flj0060p11	FLJ	W01A012M15	pENTR-TOPO	14082		TM4SF20	79853	BAB15488.1	Hs.156652	Transmembrane 4 L six family member 20				kaia	EK1	NM_024795.3	NP_079071.2	VALIDATED	Cs	0.996	0.996	229	690	1	687	229	1	229
RIKEN	BC007290	IRAL022M14	MGC	W01A012M18	pENTR-TOPO	304		TSPAN1	10103	AAH07290.1	Hs.38972	Tetraspanin 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005727.2	NP_005718.2	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC031053	IRAK048D09	MGC	W01A012M19	pENTR-TOPO	17493		LRAT	9227	AAH31053.1	Hs.658427	Lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)			Testis	NIH_MGC_97	DH10B	NM_004744.3	NP_004735.2	REVIEWED	C	1.000	1.000	230	693	1	690	230	1	230
RIKEN	BC007290	IRAL022M14	MGC	W01A012M22	pENTR-TOPO	304		TSPAN1	10103	AAH07290.1	Hs.38972	Tetraspanin 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005727.2	NP_005718.2	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC007290	IRAL022M14	MGC	W01A012M24	pENTR-TOPO	304		TSPAN1	10103	AAH07290.1	Hs.38972	Tetraspanin 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005727.2	NP_005718.2	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC005288	IRAL016C09	MGC	W01A012N02	pENTR-TOPO	18610		TINP1	10412	AAH05288.1	Hs.482526	TGF beta-inducible nuclear protein 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014886.3	NP_055701.1	PROVISIONAL	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC005288	IRAL016C09	MGC	W01A012N04	pENTR-TOPO	18610		TINP1	10412	AAH05288.1	Hs.482526	TGF beta-inducible nuclear protein 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014886.3	NP_055701.1	PROVISIONAL	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC005288	IRAL016C09	MGC	W01A012N06	pENTR-TOPO	18610		TINP1	10412	AAH05288.1	Hs.482526	TGF beta-inducible nuclear protein 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014886.3	NP_055701.1	PROVISIONAL	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC005288	IRAL016C09	MGC	W01A012N08	pENTR-TOPO	18610		TINP1	10412	AAH05288.1	Hs.482526	TGF beta-inducible nuclear protein 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014886.3	NP_055701.1	PROVISIONAL	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC002851	IRAL012N24	MGC	W01A012N10	pENTR-TOPO	25199		PCSK1N	27344	AAH02851.1	Hs.522640	Proprotein convertase subtilisin/kexin type 1 inhibitor			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_013271.2	NP_037403.1	REVIEWED	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC002851	IRAL012N24	MGC	W01A012N12	pENTR-TOPO	25199		PCSK1N	27344	AAH02851.1	Hs.522640	Proprotein convertase subtilisin/kexin type 1 inhibitor			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_013271.2	NP_037403.1	REVIEWED	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC047400	IRAK091J05	MGC	W01A012N19	pENTR-TOPO	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.992	0.992	250	753	1	750	250	1	250
RIKEN	BC047400	IRAK091J05	MGC	W01A012N21	pENTR-TOPO	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.992	0.992	250	753	1	750	250	1	250
RIKEN	BC047400	IRAK091J05	MGC	W01A012N23	pENTR-TOPO	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.992	0.992	250	753	1	750	250	1	250
RIKEN	BC013404	IRAL010M05	MGC	W01A012O02	pENTR-TOPO	304		TSPAN1	10103	AAH13404.1	Hs.38972	Tetraspanin 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005727.2	NP_005718.2	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC013404	IRAL010M05	MGC	W01A012O06	pENTR-TOPO	304		TSPAN1	10103	AAH13404.1	Hs.38972	Tetraspanin 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005727.2	NP_005718.2	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC013404	IRAL010M05	MGC	W01A012O08	pENTR-TOPO	304		TSPAN1	10103	AAH13404.1	Hs.38972	Tetraspanin 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005727.2	NP_005718.2	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	AK074574	flj0017b17	FLJ	W01A012O09	pENTR-TOPO	24658		PRRG3	79057	BAC11069.1	Hs.592236	Proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane)				HEMBA1	EK1	NM_024082.2	NP_076987.2	PROVISIONAL	C	1.000	1.000	231	696	1	693	231	1	231
RIKEN	AK075441	flj0027h07	FLJ	W01A012O10	pENTR-TOPO	16815		SHISA5	51246	BAC11623.1	Hs.414579	Shisa homolog 5 (Xenopus laevis)				PLACE1	EK1	NM_016479.3	NP_057563.3	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	AK075441	flj0027h07	FLJ	W01A012O12	pENTR-TOPO	16815		SHISA5	51246	BAC11623.1	Hs.414579	Shisa homolog 5 (Xenopus laevis)				PLACE1	EK1	NM_016479.3	NP_057563.3	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	AK075441	flj0027h07	FLJ	W01A012O14	pENTR-TOPO	16815		SHISA5	51246	BAC11623.1	Hs.414579	Shisa homolog 5 (Xenopus laevis)				PLACE1	EK1	NM_016479.3	NP_057563.3	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	AK074574	flj0017b17	FLJ	W01A012O15	pENTR-TOPO	24658		PRRG3	79057	BAC11069.1	Hs.592236	Proline rich Gla (G-carboxyglutamic acid) 3 (transmembrane)				HEMBA1	EK1	NM_024082.2	NP_076987.2	PROVISIONAL	C	1.000	1.000	231	696	1	693	231	1	231
RIKEN	AK075441	flj0027h07	FLJ	W01A012O16	pENTR-TOPO	16815		SHISA5	51246	BAC11623.1	Hs.414579	Shisa homolog 5 (Xenopus laevis)				PLACE1	EK1	NM_016479.3	NP_057563.3	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC053617	IRAK115K22	MGC	W01A012O21	pENTR-TOPO	1571		BCL10	8915	AAH53617.1	Hs.193516	B-cell CLL/lymphoma 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003921.3	NP_003912.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC013183	IRAK026I20	MGC	W01A012P01	pENTR-TOPO	20615		HLA-DOA	3111	AAH13183.1	Hs.631991	Major histocompatibility complex, class II, DO alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002119.3	NP_002110.1	REVIEWED	C	1.000	1.000	250	753	1	750	250	1	250
RIKEN	BC063565	IRAK134A14	MGC	W01A012P09	pENTR-TOPO	8678		ORC6L	23594	AAH63565.1	Hs.49760	Origin recognition complex, subunit 6 like (yeast)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014321.2	NP_055136.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
RIKEN	BC001668	IRAL002I14	MGC	W01A012P21	pENTR-TOPO	11362		SPINT2	10653	AAH01668.1	Hs.31439	Serine peptidase inhibitor, Kunitz type, 2			Colon, adenocarcinoma	NIH_MGC_15		NM_021102.2	NP_066925.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
RIKEN	BC032343	IRAK064I16	MGC	W01A013A18	pENTR-TOPO	6463		KCNRG	283518	AAH32343.1	Hs.660161	Potassium channel regulator			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_173605.1	NP_775876.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC005361	IRAL016K13	MGC	W01A013A23	pENTR-TOPO	7851		PSMA4	5685	AAH05361.1	Hs.251531	Proteasome (prosome, macropain) subunit, alpha type, 4			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001102668.1	NP_001096138.1	VALIDATED	C	1.000	1.000	190	786	214	783	190	1	190
RIKEN	BC032343	IRAK064I16	MGC	W01A013A24	pENTR-TOPO	6463		KCNRG	283518	AAH32343.1	Hs.660161	Potassium channel regulator			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_173605.1	NP_775876.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC044244	IRAK089I03	MGC	W01A013B03	pENTR-TOPO	21203		TSPAN33	340348	AAH44244.1	Hs.27267	Tetraspanin 33			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_178562.2	NP_848657.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC039198	IRAL037C07	MGC	W01A013B11	pENTR-TOPO	24832		GJB1	2705	AAH39198.1	Hs.333303	Gap junction protein, beta 1, 32kDa			Liver	NIH_MGC_76	DH10B	NM_001097642.2	NP_001091111.1	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC039198	IRAL037C07	MGC	W01A013B13	pENTR-TOPO	24832		GJB1	2705	AAH39198.1	Hs.333303	Gap junction protein, beta 1, 32kDa			Liver	NIH_MGC_76	DH10B	NM_001097642.2	NP_001091111.1	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC008500	IRAL021D10	MGC	W01A013B14	pENTR-TOPO	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC039198	IRAL037C07	MGC	W01A013B15	pENTR-TOPO	24832		GJB1	2705	AAH39198.1	Hs.333303	Gap junction protein, beta 1, 32kDa			Liver	NIH_MGC_76	DH10B	NM_001097642.2	NP_001091111.1	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC008500	IRAL021D10	MGC	W01A013B16	pENTR-TOPO	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC038934	IRAK068M22	MGC	W01A013C01	pENTR-TOPO	6768		GJB6	10804	AAH38934.1	Hs.716216	Gap junction protein, beta 6, 30kDa			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001110220.2	NP_001103690.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC038934	IRAK068M22	MGC	W01A013C03	pENTR-TOPO	6768		GJB6	10804	AAH38934.1	Hs.716216	Gap junction protein, beta 6, 30kDa			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001110220.2	NP_001103690.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC009418	IRAL023F05	MGC	W01A013C04	pENTR-TOPO	15209		CHODL	140578	AAH09418.1	Hs.283725	Chondrolectin			Brain, neuroblastoma	NIH_MGC_19		NM_024944.2	NP_079220.2	REVIEWED	C	1.000	1.000	273	822	1	819	273	1	273
RIKEN	BC038934	IRAK068M22	MGC	W01A013C05	pENTR-TOPO	6768		GJB6	10804	AAH38934.1	Hs.716216	Gap junction protein, beta 6, 30kDa			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001110220.2	NP_001103690.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC009418	IRAL023F05	MGC	W01A013C08	pENTR-TOPO	15209		CHODL	140578	AAH09418.1	Hs.283725	Chondrolectin			Brain, neuroblastoma	NIH_MGC_19		NM_024944.2	NP_079220.2	REVIEWED	C	1.000	1.000	273	822	1	819	273	1	273
RIKEN	AK056404	flj0004f21	FLJ	W01A013C09	pENTR-TOPO	649		TMEM56	148534	BAB71177.1	Hs.483512	Transmembrane protein 56	NT2	teratocarcinoma		NT2RP7	EK1	NM_152487.2	NP_689700.1	VALIDATED	C	1.000	1.000	263	792	1	789	263	1	263
RIKEN	AK056404	flj0004f21	FLJ	W01A013C13	pENTR-TOPO	649		TMEM56	148534	BAB71177.1	Hs.483512	Transmembrane protein 56	NT2	teratocarcinoma		NT2RP7	EK1	NM_152487.2	NP_689700.1	VALIDATED	C	1.000	1.000	263	792	1	789	263	1	263
RIKEN	BC057840	IRAK133K17	MGC	W01A013C19	pENTR-TOPO	7589		PSMB5	5693	AAH57840.1	Hs.422990	Proteasome (prosome, macropain) subunit, beta type, 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002797.3	NP_002788.1	REVIEWED	C	1.000	1.000	263	792	1	789	263	1	263
RIKEN	AK057735	flj0051l02	FLJ	W01A013C22	pENTR-TOPO	10570		FLJ25006	124923	BAB71555.1	Hs.657973	Uncharacterized serine/threonine-protein kinase SgK494				CBL	EK1	NM_144610.1	NP_653211.1	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
RIKEN	BC002436	IRAL005I06	MGC	W01A013D10	pENTR-TOPO	8631		STX4	6810	AAH02436.1	Hs.83734	Syntaxin 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_004604.3	NP_004595.2	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC002436	IRAL005I06	MGC	W01A013D16	pENTR-TOPO	8631		STX4	6810	AAH02436.1	Hs.83734	Syntaxin 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_004604.3	NP_004595.2	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC060840	IRAK133N02	MGC	W01A013D18	pENTR-TOPO	15007		NAPB	63908	AAH60840.1	Hs.269471	N-ethylmaleimide-sensitive factor attachment protein, beta			Brain, hippocampus	NIH_MGC_95	DH10B	NM_022080.2	NP_071363.1	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
RIKEN	BC060840	IRAK133N02	MGC	W01A013D20	pENTR-TOPO	15007		NAPB	63908	AAH60840.1	Hs.269471	N-ethylmaleimide-sensitive factor attachment protein, beta			Brain, hippocampus	NIH_MGC_95	DH10B	NM_022080.2	NP_071363.1	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
RIKEN	BC060840	IRAK133N02	MGC	W01A013D24	pENTR-TOPO	15007		NAPB	63908	AAH60840.1	Hs.269471	N-ethylmaleimide-sensitive factor attachment protein, beta			Brain, hippocampus	NIH_MGC_95	DH10B	NM_022080.2	NP_071363.1	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
RIKEN	BC012160	IRAL029H11	MGC	W01A013E01	pENTR-TOPO	5594		CD27	939	AAH12160.1	Hs.355307	CD27 molecule			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001242.4	NP_001233.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC012160	IRAL029H11	MGC	W01A013E03	pENTR-TOPO	5594		CD27	939	AAH12160.1	Hs.355307	CD27 molecule			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001242.4	NP_001233.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC012160	IRAL029H11	MGC	W01A013E05	pENTR-TOPO	5594		CD27	939	AAH12160.1	Hs.355307	CD27 molecule			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001242.4	NP_001233.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC012160	IRAL029H11	MGC	W01A013E07	pENTR-TOPO	5594		CD27	939	AAH12160.1	Hs.355307	CD27 molecule			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001242.4	NP_001233.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC017451	IRAL023L02	MGC	W01A013E09	pENTR-TOPO	871		PSMB4	5692	AAH17451	Hs.89545	Proteasome (prosome, macropain) subunit, beta type, 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_002796.2	NP_002787.2	REVIEWED	Cs	0.996	0.996	264	795	1	792	264	1	264
RIKEN	BC000331	IRAL001I09	MGC	W01A013E21	pENTR-TOPO	871		PSMB4	5692	AAH00331	Hs.89545	Proteasome (prosome, macropain) subunit, beta type, 4			Lung, small cell carcinoma	NIH_MGC_7		NM_002796.2	NP_002787.2	REVIEWED	Cs	0.996	0.996	264	795	1	792	264	1	264
RIKEN	BC028059	IRAK062E08	MGC	W01A013E22	pENTR-TOPO	34065		TPSAB1	7177	AAH28059.1	Hs.405479	Tryptase alpha/beta 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	XM_001720740.1	XP_001720792.1	MODEL	OK	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC033830	IRAK068B10	MGC	W01A013F06	pENTR-TOPO	22139		AZGP1	563	AAH33830.1	Hs.546239	Alpha-2-glycoprotein 1, zinc-binding			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001185.2	NP_001176.1	VALIDATED	C	1.000	1.000	298	897	1	894	298	1	298
RIKEN	BC065290	IRAK140F14	MGC	W01A013F07	pENTR-TOPO	13292		CYBRD1	79901	AAH65290.1	Hs.715531	Cytochrome b reductase 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024843.3	NP_079119.3	VALIDATED	Cs	0.997	0.997	286	861	1	858	286	1	286
RIKEN	BC007710	IRAL015P22	MGC	W01A013F17	pENTR-TOPO	20510		SSR1	6745	AAH07710.1	Hs.114033	Signal sequence receptor, alpha			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003144.3	NP_003135.2	REVIEWED	C	1.000	1.000	286	861	1	858	286	1	286
RIKEN	BC007710	IRAL015P22	MGC	W01A013F19	pENTR-TOPO	20510		SSR1	6745	AAH07710.1	Hs.114033	Signal sequence receptor, alpha			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003144.3	NP_003135.2	REVIEWED	C	1.000	1.000	286	861	1	858	286	1	286
RIKEN	BC007710	IRAL015P22	MGC	W01A013F23	pENTR-TOPO	20510		SSR1	6745	AAH07710.1	Hs.114033	Signal sequence receptor, alpha			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003144.3	NP_003135.2	REVIEWED	C	1.000	1.000	286	861	1	858	286	1	286
RIKEN	BC022518	IRAK032A16	MGC	W01A013G03	pENTR-TOPO	16320		SYNPR	132204	AAH22518.1	Hs.648668	Synaptoporin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144642.4	NP_653243.1	VALIDATED	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC022518	IRAK032A16	MGC	W01A013G05	pENTR-TOPO	16320		SYNPR	132204	AAH22518.1	Hs.648668	Synaptoporin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144642.4	NP_653243.1	VALIDATED	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC001305	IRAK004M09	MGC	W01A013G11	pENTR-TOPO	18163		ELOVL6	79071	AAH01305.1	Hs.412939	ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001130721.1	NP_001124193.1	VALIDATED	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC020773	IRAL037P19	MGC	W01A013G12	pENTR-TOPO	6454		EXOSC8	11340	AAH20773.1	Hs.294041	Exosome component 8			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_181503.2	NP_852480.1	REVIEWED	C	1.000	1.000	276	831	1	828	276	1	276
RIKEN	BC020773	IRAL037P19	MGC	W01A013G14	pENTR-TOPO	6454		EXOSC8	11340	AAH20773.1	Hs.294041	Exosome component 8			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_181503.2	NP_852480.1	REVIEWED	C	1.000	1.000	276	831	1	828	276	1	276
RIKEN	BC001305	IRAK004M09	MGC	W01A013G15	pENTR-TOPO	18163		ELOVL6	79071	AAH01305.1	Hs.412939	ELOVL family member 6, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001130721.1	NP_001124193.1	VALIDATED	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC020875	IRAL036G01	MGC	W01A013G19	pENTR-TOPO	19173		C5orf15	56951	AAH20875.1	Hs.716457	Chromosome 5 open reading frame 15			Kidney	NIH_MGC_75	DH10B	NM_020199.2	NP_064584.1	VALIDATED	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC020875	IRAL036G01	MGC	W01A013G21	pENTR-TOPO	19173		C5orf15	56951	AAH20875.1	Hs.716457	Chromosome 5 open reading frame 15			Kidney	NIH_MGC_75	DH10B	NM_020199.2	NP_064584.1	VALIDATED	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC020875	IRAL036G01	MGC	W01A013G23	pENTR-TOPO	19173		C5orf15	56951	AAH20875.1	Hs.716457	Chromosome 5 open reading frame 15			Kidney	NIH_MGC_75	DH10B	NM_020199.2	NP_064584.1	VALIDATED	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC020947	IRAK032M15	MGC	W01A013G24	pENTR-TOPO	7544		TMEM55B	90809	AAH20947.1	Hs.7001	Transmembrane protein 55B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144568.2	NP_653169.2	VALIDATED	Cs	0.996	0.996	277	834	1	831	277	1	277
RIKEN	BC056899	IRAK119A11	MGC	W01A013H03	pENTR-TOPO	25130		MORF4L2	9643	AAH56899.1	Hs.597035	Mortality factor 4 like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142430.1	NP_001135902.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC000509	IRAL001H18	MGC	W01A013I02	pENTR-TOPO	23655		PSMB7	5695	AAH00509.1	Hs.213470	Proteasome (prosome, macropain) subunit, beta type, 7			Lung, small cell carcinoma	NIH_MGC_7		NM_002799.2	NP_002790.1	REVIEWED	Cs	0.996	0.996	277	834	1	831	277	1	277
RIKEN	BC034709	IRAK028P08	MGC	W01A013I05	pENTR-TOPO	675		GJB4	127534	AAH34709.1	Hs.715288	Gap junction protein, beta 4, 30.3kDa			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_153212.1	NP_694944.1	VALIDATED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC034709	IRAK028P08	MGC	W01A013I07	pENTR-TOPO	675		GJB4	127534	AAH34709.1	Hs.715288	Gap junction protein, beta 4, 30.3kDa			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_153212.1	NP_694944.1	VALIDATED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC000618	IRAL005K22	MGC	W01A013I14	pENTR-TOPO	1654		ELOVL1	64834	AAH00618.1	Hs.25597	Elongation of very long chain fatty acids (FEN1/Elo2, SUR4/Elo3, yeast)-like 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_022821.2	NP_073732.1	VALIDATED	OK	1.000	1.000	279	840	1	837	279	1	279
RIKEN	BC039072	IRAK051O12	MGC	W01A013I18	pENTR-TOPO	5966		CLEC1A	51267	AAH39072.1	Hs.29549	C-type lectin domain family 1, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_016511.2	NP_057595.2	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC032505	IRAK069C11	MGC	W01A013I19	pENTR-TOPO	23252		PENK	5179	AAH32505.1	Hs.339831	Proenkephalin			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006211.3	NP_006202.1	VALIDATED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	BC039072	IRAK051O12	MGC	W01A013I22	pENTR-TOPO	5966		CLEC1A	51267	AAH39072.1	Hs.29549	C-type lectin domain family 1, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_016511.2	NP_057595.2	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC032505	IRAK069C11	MGC	W01A013I23	pENTR-TOPO	23252		PENK	5179	AAH32505.1	Hs.339831	Proenkephalin			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006211.3	NP_006202.1	VALIDATED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	AK074889	flj0018g24	FLJ	W01A013J06	pENTR-TOPO	20430		ELOVL5	60481	BAC11270.1	Hs.713560	ELOVL family member 5, elongation of long chain fatty acids (FEN1/Elo2, SUR4/Elo3-like, yeast)	NT2	teratocarcinoma		NT2RP2	EK1	NM_021814.3	NP_068586.1	PROVISIONAL	C	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC001356	IRAL004A03	MGC	W01A013J07	pENTR-TOPO	9845		IFI35	3430	AAH01356.1	Hs.632258	Interferon-induced protein 35			Skin, melanotic melanoma.	NIH_MGC_20		NM_005533.3	NP_005524.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC000496	IRAL001D10	MGC	W01A013J10	pENTR-TOPO	1381		PEX19	5824	AAH00496.1	Hs.517232	Peroxisomal biogenesis factor 19			Lung, small cell carcinoma	NIH_MGC_7		NM_002857.3	NP_002848.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC002896	IRAL015K17	MGC	W01A013J11	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC000496	IRAL001D10	MGC	W01A013J12	pENTR-TOPO	1381		PEX19	5824	AAH00496.1	Hs.517232	Peroxisomal biogenesis factor 19			Lung, small cell carcinoma	NIH_MGC_7		NM_002857.3	NP_002848.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC036785	IRAK079L21	MGC	W01A013J17	pENTR-TOPO	14873		TP53TG5	27296	AAH36785.1	Hs.401982	TP53 target 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_014477.2	NP_055292.1	VALIDATED	C	1.000	1.000	290	873	1	870	290	1	290
RIKEN	BC014943	IRAL034M10	MGC	W01A013K02	pENTR-TOPO	464		NMNAT1	64802	AAH14943.1	Hs.633762	Nicotinamide nucleotide adenylyltransferase 1			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_022787.3	NP_073624.2	PROVISIONAL	C	1.000	1.000	279	840	1	837	279	1	279
RIKEN	BC014943	IRAL034M10	MGC	W01A013K04	pENTR-TOPO	464		NMNAT1	64802	AAH14943.1	Hs.633762	Nicotinamide nucleotide adenylyltransferase 1			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_022787.3	NP_073624.2	PROVISIONAL	C	1.000	1.000	279	840	1	837	279	1	279
RIKEN	BC014943	IRAL034M10	MGC	W01A013K06	pENTR-TOPO	464		NMNAT1	64802	AAH14943.1	Hs.633762	Nicotinamide nucleotide adenylyltransferase 1			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_022787.3	NP_073624.2	PROVISIONAL	C	1.000	1.000	279	840	1	837	279	1	279
RIKEN	BC001861	IRAL011O16	MGC	W01A013K07	pENTR-TOPO	11614		TEX101	83639	AAH01861.2	Hs.97978	Testis expressed 101			Lung, small cell carcinoma	NIH_MGC_7		NM_001130011.1	NP_001123483.1	VALIDATED	C	1.000	1.000	249	804	55	801	249	1	249
RIKEN	BC014943	IRAL034M10	MGC	W01A013K08	pENTR-TOPO	464		NMNAT1	64802	AAH14943.1	Hs.633762	Nicotinamide nucleotide adenylyltransferase 1			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_022787.3	NP_073624.2	PROVISIONAL	C	1.000	1.000	279	840	1	837	279	1	279
RIKEN	BC029059	IRAK050G15	MGC	W01A013L03	pENTR-TOPO	6817		ATP4B	496	AAH29059.1	Hs.434202	ATPase, H+/K+ exchanging, beta polypeptide			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000705.2	NP_000696.1	REVIEWED	C	1.000	1.000	291	876	1	873	291	1	291
RIKEN	BC010958	IRAL019G11	MGC	W01A013L13	pENTR-TOPO	5539		CCND2	894	AAH10958.1	Hs.376071	Cyclin D2			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_001759.3	NP_001750.1	VALIDATED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC010958	IRAL019G11	MGC	W01A013L15	pENTR-TOPO	5539		CCND2	894	AAH10958.1	Hs.376071	Cyclin D2			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_001759.3	NP_001750.1	VALIDATED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC012831	IRAL011O03	MGC	W01A013L17	pENTR-TOPO	16485		EXOSC7	23016	AAH12831.1					Brain, neuroblastoma	NIH_MGC_19		NM_015004.3	NP_055819.2	VALIDATED	Cs	0.997	0.997	291	876	1	873	291	1	291
RIKEN	BC036705	IRAL017P06	MGC	W01A013L24	pENTR-TOPO	23980		ST6GALNAC4	27090	AAH36705.1	Hs.3972	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 4			Primary B-Cells from Tonsils	NIH_MGC_48		NM_175040.3	NP_778205.1	REVIEWED	C	1.000	1.000	218	909	253	906	218	1	218
RIKEN	BC009704	IRAK014H04	MGC	W01A013M01	pENTR-TOPO	18062		TSPAN5	10098	AAH09704.1	Hs.591706	Tetraspanin 5			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_005723.2	NP_005714.2	REVIEWED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC022078	IRAK046P17	MGC	W01A013M08	pENTR-TOPO	17111		ZDHHC19	131540	AAH22078.1	Hs.111591	Zinc finger, DHHC-type containing 19			Testis	NIH_MGC_97	DH10B	NM_001039617.1	NP_001034706.1	VALIDATED		0.977	0.977	266	849	1	798	309	1	266
RIKEN	BC064697	IRAK133G23	MGC	W01A013N06	pENTR-TOPO	7234		KIAA0247	9766	AAH64697.1	Hs.440025	KIAA0247			Placenta, normal	NIH_MGC_147	DH10B	NM_014734.3	NP_055549.1	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC000747	IRAL002A23	MGC	W01A013N15	pENTR-TOPO	23630		EXOSC2	23404	AAH00747.1	Hs.654643	Exosome component 2			Lung, small cell carcinoma	NIH_MGC_7		NM_014285.5	NP_055100.2	VALIDATED	C	1.000	1.000	293	882	1	879	293	1	293
RIKEN	BC013194	IRAK026B09	MGC	W01A013N18	pENTR-TOPO	16368		SLC25A38	54977	AAH13194.1	Hs.369615	Solute carrier family 25, member 38			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017875.2	NP_060345.2	VALIDATED	C	1.000	1.000	304	915	1	912	304	1	304
RIKEN	AK023028	flj0034c24	FLJ	W01A013O05	pENTR-TOPO	14900		TMEM189	387521	BAB14364.1			NT2	teratocarcinoma		NT2RP2	EK1	NM_199129.1	NP_954580.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	AK023028	flj0034c24	FLJ	W01A013O07	pENTR-TOPO	14900		TMEM189	387521	BAB14364.1			NT2	teratocarcinoma		NT2RP2	EK1	NM_199129.1	NP_954580.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC012918	IRAK028E17	MGC	W01A013O11	pENTR-TOPO	300		GJB3	2707	AAH12918.1	Hs.522561	Gap junction protein, beta 3, 31kDa			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001005752.1	NP_001005752.1	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC000405	IRAL001K06	MGC	W01A013O16	pENTR-TOPO	11906		SNRPA	6626	AAH00405.1	Hs.466775	Small nuclear ribonucleoprotein polypeptide A			Lung, small cell carcinoma	NIH_MGC_7		NM_004596.3	NP_004587.1	PROVISIONAL	C	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC021257	IRAL039C01	MGC	W01A013O17	pENTR-TOPO	2148		RPA2	6118	AAH21257.1	Hs.79411	Replication protein A2, 32kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002946.3	NP_002937.1	PROVISIONAL	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC021257	IRAL039C01	MGC	W01A013O21	pENTR-TOPO	2148		RPA2	6118	AAH21257.1	Hs.79411	Replication protein A2, 32kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002946.3	NP_002937.1	PROVISIONAL	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC012625	IRAL019H22	MGC	W01A014A02	pENTR-TOPO	3196		PPP1R3C	5507	AAH12625.1	Hs.303090	Protein phosphatase 1, regulatory (inhibitor) subunit 3C			Skeletal Muscle	NIH_MGC_81	DH10B	NM_005398.4	NP_005389.1	PROVISIONAL	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC005375	IRAL016H19	MGC	W01A014A11	pENTR-TOPO	23223		PXMP3	5828	AAH05375.1	Hs.437966	Peroxisomal membrane protein 3, 35kDa			Liver	NIH_MGC_76	DH10B	NM_000318.2	NP_000309.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC031562	IRAK050E18	MGC	W01A014B02	pENTR-TOPO	1555		AKR7A3	22977	AAH31562.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.997	0.997	331	996	1	993	331	1	331
RIKEN	BC031562	IRAK050E18	MGC	W01A014B06	pENTR-TOPO	1555		AKR7A3	22977	AAH31562.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.997	0.997	331	996	1	993	331	1	331
RIKEN	BC027889	IRAK049K22	MGC	W01A014B20	pENTR-TOPO	413		GJA4	2701	AAH27889.1	Hs.296310	Gap junction protein, alpha 4, 37kDa			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002060.2	NP_002051.2	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	BC009074	IRAK013H12	MGC	W01A014B21	pENTR-TOPO	22568		FAM164A	51101	AAH09074.1	Hs.271876	Family with sequence similarity 164, member A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_016010.2	NP_057094.2	VALIDATED	Cs	0.997	0.997	325	978	1	975	325	1	325
RIKEN	BC027889	IRAK049K22	MGC	W01A014B24	pENTR-TOPO	413		GJA4	2701	AAH27889.1	Hs.296310	Gap junction protein, alpha 4, 37kDa			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002060.2	NP_002051.2	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	BC006990	IRAL016G09	MGC	W01A014C05	pENTR-TOPO	24056		PPP6C	5537	AAH06990.1	Hs.715605	Protein phosphatase 6, catalytic subunit			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_002721.4	NP_002712.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC035314	IRAK028L03	MGC	W01A014C13	pENTR-TOPO	19933		BXDC1	84154	AAH35314.1	Hs.372265	Brix domain containing 1			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_032194.1	NP_115570.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC035314	IRAK028L03	MGC	W01A014C15	pENTR-TOPO	19933		BXDC1	84154	AAH35314.1	Hs.372265	Brix domain containing 1			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_032194.1	NP_115570.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC032718	IRAK069H12	MGC	W01A014C18	pENTR-TOPO	16722		PLSCR1	5359	AAH32718.1	Hs.130759	Phospholipid scramblase 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_021105.2	NP_066928.1	VALIDATED	C	1.000	1.000	318	957	1	954	318	1	318
RIKEN	BC009175	IRAL003O11	MGC	W01A014C23	pENTR-TOPO	2077		EBNA1BP2	10969	AAH09175.1	Hs.346868	EBNA1 binding protein 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_006824.2	NP_006815.2	VALIDATED	C	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC020566	IRAK020C21	MGC	W01A014D11	pENTR-TOPO	22669		CYC1	1537	AAH20566.1	Hs.289271	Cytochrome c-1				NCI_CGAP_Brn67	DH10B	NM_001916.3	NP_001907.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC014241	IRAL030J18	MGC	W01A014D14	pENTR-TOPO	21396		GPR146	115330	AAH14241.1	Hs.718624	G protein-coupled receptor 146			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_138445.2	NP_612454.1	PROVISIONAL	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	BC014241	IRAL030J18	MGC	W01A014D16	pENTR-TOPO	21396		GPR146	115330	AAH14241.1	Hs.718624	G protein-coupled receptor 146			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_138445.2	NP_612454.1	PROVISIONAL	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	BC001006	IRAL001G16	MGC	W01A014D19	pENTR-TOPO	22669		CYC1	1537	AAH01006.1	Hs.289271	Cytochrome c-1			Lung, small cell carcinoma	NIH_MGC_7		NM_001916.3	NP_001907.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC001006	IRAL001G16	MGC	W01A014D23	pENTR-TOPO	22669		CYC1	1537	AAH01006.1	Hs.289271	Cytochrome c-1			Lung, small cell carcinoma	NIH_MGC_7		NM_001916.3	NP_001907.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC020580	IRAK027B20	MGC	W01A014E01	pENTR-TOPO	9914		CDK5R1	8851	AAH20580.1	Hs.500015	Cyclin-dependent kinase 5, regulatory subunit 1 (p35)			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_003885.2	NP_003876.1	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC002480	IRAL005L24	MGC	W01A014E02	pENTR-TOPO	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Eye, retinoblastoma	NIH_MGC_16		NM_024592.3	NP_078868.1	VALIDATED	C	1.000	1.000	318	957	1	954	318	1	318
RIKEN	BC020580	IRAK027B20	MGC	W01A014E03	pENTR-TOPO	9914		CDK5R1	8851	AAH20580.1	Hs.500015	Cyclin-dependent kinase 5, regulatory subunit 1 (p35)			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_003885.2	NP_003876.1	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC002480	IRAL005L24	MGC	W01A014E04	pENTR-TOPO	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Eye, retinoblastoma	NIH_MGC_16		NM_024592.3	NP_078868.1	VALIDATED	C	1.000	1.000	318	957	1	954	318	1	318
RIKEN	BC020580	IRAK027B20	MGC	W01A014E07	pENTR-TOPO	9914		CDK5R1	8851	AAH20580.1	Hs.500015	Cyclin-dependent kinase 5, regulatory subunit 1 (p35)			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_003885.2	NP_003876.1	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC026274	IRAL035E15	MGC	W01A014E12	pENTR-TOPO	7373		RDH11	51109	AAH26274.1	Hs.226007	Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)			Prostate	NIH_MGC_83	DH10B	NM_016026.3	NP_057110.3	VALIDATED	Cs	0.997	0.997	318	957	1	954	318	1	318
RIKEN	BC008962	IRAL010I12	MGC	W01A014E13	pENTR-TOPO	11355		GDF15	9518	AAH08962.1	Hs.616962	Growth differentiation factor 15			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004864.2	NP_004855.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
RIKEN	BC026274	IRAL035E15	MGC	W01A014E14	pENTR-TOPO	7373		RDH11	51109	AAH26274.1	Hs.226007	Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)			Prostate	NIH_MGC_83	DH10B	NM_016026.3	NP_057110.3	VALIDATED	Cs	0.997	0.997	318	957	1	954	318	1	318
RIKEN	BC008962	IRAL010I12	MGC	W01A014E15	pENTR-TOPO	11355		GDF15	9518	AAH08962.1	Hs.616962	Growth differentiation factor 15			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004864.2	NP_004855.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
RIKEN	BC032694	IRAK069B22	MGC	W01A014E18	pENTR-TOPO	14291		GPR55	9290	AAH32694.1	Hs.114545	G protein-coupled receptor 55			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_005683.3	NP_005674.2	VALIDATED	C	1.000	1.000	319	960	1	957	319	1	319
RIKEN	BC007611	IRAL022N03	MGC	W01A014E19	pENTR-TOPO	9833		FN3KRP	79672	AAH07611.1	Hs.31431	Fructosamine 3 kinase related protein			Eye, retinoblastoma	NIH_MGC_16		NM_024619.3	NP_078895.2	VALIDATED	OK	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC032694	IRAK069B22	MGC	W01A014E20	pENTR-TOPO	14291		GPR55	9290	AAH32694.1	Hs.114545	G protein-coupled receptor 55			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_005683.3	NP_005674.2	VALIDATED	C	1.000	1.000	319	960	1	957	319	1	319
RIKEN	BC007611	IRAL022N03	MGC	W01A014E21	pENTR-TOPO	9833		FN3KRP	79672	AAH07611.1	Hs.31431	Fructosamine 3 kinase related protein			Eye, retinoblastoma	NIH_MGC_16		NM_024619.3	NP_078895.2	VALIDATED	OK	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC007611	IRAL022N03	MGC	W01A014E23	pENTR-TOPO	9833		FN3KRP	79672	AAH07611.1	Hs.31431	Fructosamine 3 kinase related protein			Eye, retinoblastoma	NIH_MGC_16		NM_024619.3	NP_078895.2	VALIDATED	OK	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC030948	IRAL041E17	MGC	W01A014F02	pENTR-TOPO	16315		SUCNR1	56670	AAH30948.3	Hs.279575	Succinate receptor 1			Kidney	NIH_MGC_75	DH10B	NM_033050.3	NP_149039.2	PROVISIONAL	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC030948	IRAL041E17	MGC	W01A014F04	pENTR-TOPO	16315		SUCNR1	56670	AAH30948.3	Hs.279575	Succinate receptor 1			Kidney	NIH_MGC_75	DH10B	NM_033050.3	NP_149039.2	PROVISIONAL	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC030948	IRAL041E17	MGC	W01A014F06	pENTR-TOPO	16315		SUCNR1	56670	AAH30948.3	Hs.279575	Succinate receptor 1			Kidney	NIH_MGC_75	DH10B	NM_033050.3	NP_149039.2	PROVISIONAL	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	AK057811	flj0051p24	FLJ	W01A014F07	pENTR-TOPO	2788		SAMD8	142891	BAB71586.1	Hs.663616	Sterile alpha motif domain containing 8				CBL	EK1	NM_144660.1	NP_653261.1	PROVISIONAL	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC026340	IRAK032F16	MGC	W01A014F15	pENTR-TOPO	20		ADORA1	134	AAH26340.1	Hs.77867	Adenosine A1 receptor			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001048230.1	NP_001041695.1	REVIEWED	Cs	0.988	0.988	326	981	1	978	326	1	326
RIKEN	BC047029	IRAK093O19	MGC	W01A014F19	pENTR-TOPO	13196		NUP35	129401	AAH47029.1	Hs.180591	Nucleoporin 35kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138285.3	NP_612142.2	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC047029	IRAK093O19	MGC	W01A014F23	pENTR-TOPO	13196		NUP35	129401	AAH47029.1	Hs.180591	Nucleoporin 35kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138285.3	NP_612142.2	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC036815	IRAK079L06	MGC	W01A014G02	pENTR-TOPO	16852		GPR171	29909	AAH36815.1	Hs.549152	G protein-coupled receptor 171			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_013308.3	NP_037440.3	VALIDATED	Cs	0.997	0.997	319	960	1	957	319	1	319
RIKEN	BC036815	IRAK079L06	MGC	W01A014G04	pENTR-TOPO	16852		GPR171	29909	AAH36815.1	Hs.549152	G protein-coupled receptor 171			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_013308.3	NP_037440.3	VALIDATED	Cs	0.997	0.997	319	960	1	957	319	1	319
RIKEN	BC036815	IRAK079L06	MGC	W01A014G06	pENTR-TOPO	16852		GPR171	29909	AAH36815.1	Hs.549152	G protein-coupled receptor 171			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_013308.3	NP_037440.3	VALIDATED	Cs	0.997	0.997	319	960	1	957	319	1	319
RIKEN	BC036815	IRAK079L06	MGC	W01A014G08	pENTR-TOPO	16852		GPR171	29909	AAH36815.1	Hs.549152	G protein-coupled receptor 171			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_013308.3	NP_037440.3	VALIDATED	Cs	0.997	0.997	319	960	1	957	319	1	319
RIKEN	BC008061	IRAL002I08	MGC	W01A014G11	pENTR-TOPO	990		SLC25A1	6576	AAH08061.1	Hs.719167	Solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_005984.2	NP_005975.1	VALIDATED	C	1.000	1.000	311	936	1	933	311	1	311
RIKEN	BC020768	IRAL035D02	MGC	W01A014G12	pENTR-TOPO	4665		OR51E2	81285	AAH20768.1	Hs.606330	Olfactory receptor, family 51, subfamily E, member 2			Prostate	NIH_MGC_83	DH10B	NM_030774.3	NP_110401.1	VALIDATED	C	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC020768	IRAL035D02	MGC	W01A014G14	pENTR-TOPO	4665		OR51E2	81285	AAH20768.1	Hs.606330	Olfactory receptor, family 51, subfamily E, member 2			Prostate	NIH_MGC_83	DH10B	NM_030774.3	NP_110401.1	VALIDATED	C	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC009196	IRAL025M07	MGC	W01A014G17	pENTR-TOPO	1329		PPAP2B	8613	AAH09196.1	Hs.715848	Phosphatidic acid phosphatase type 2B			Placenta, choriocarcinoma	NIH_MGC_21		NM_003713.3	NP_003704.3	REVIEWED	Cs	0.997	0.997	311	936	1	933	311	1	311
RIKEN	BC001075	IRAL002C19	MGC	W01A014G18	pENTR-TOPO	10008		SLC25A19	60386	AAH01075.1	Hs.514470	Solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19			Lung, small cell carcinoma	NIH_MGC_7		NM_001126122.1	NP_001119594.1	REVIEWED	C	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC001075	IRAL002C19	MGC	W01A014G20	pENTR-TOPO	10008		SLC25A19	60386	AAH01075.1	Hs.514470	Solute carrier family 25 (mitochondrial thiamine pyrophosphate carrier), member 19			Lung, small cell carcinoma	NIH_MGC_7		NM_001126122.1	NP_001119594.1	REVIEWED	C	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC009196	IRAL025M07	MGC	W01A014G21	pENTR-TOPO	1329		PPAP2B	8613	AAH09196.1	Hs.715848	Phosphatidic acid phosphatase type 2B			Placenta, choriocarcinoma	NIH_MGC_21		NM_003713.3	NP_003704.3	REVIEWED	Cs	0.997	0.997	311	936	1	933	311	1	311
RIKEN	BC009196	IRAL025M07	MGC	W01A014G23	pENTR-TOPO	1329		PPAP2B	8613	AAH09196.1	Hs.715848	Phosphatidic acid phosphatase type 2B			Placenta, choriocarcinoma	NIH_MGC_21		NM_003713.3	NP_003704.3	REVIEWED	Cs	0.997	0.997	311	936	1	933	311	1	311
RIKEN	BC034412	IRAK051L20	MGC	W01A014H06	pENTR-TOPO	97		CA14	23632	AAH34412.1	Hs.528988	Carbonic anhydrase XIV			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_012113.1	NP_036245.1	REVIEWED	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC034412	IRAK051L20	MGC	W01A014H08	pENTR-TOPO	97		CA14	23632	AAH34412.1	Hs.528988	Carbonic anhydrase XIV			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_012113.1	NP_036245.1	REVIEWED	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC001540	IRAL003H15	MGC	W01A014H09	pENTR-TOPO	9215		DOK4	55715	AAH01540.1	Hs.279832	Docking protein 4			Colon, adenocarcinoma	NIH_MGC_15		NM_018110.3	NP_060580.2	VALIDATED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC035633	IRAK068P10	MGC	W01A014H10	pENTR-TOPO	7226		GPR65	8477	AAH35633.1	Hs.513440	G protein-coupled receptor 65			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_003608.2	NP_003599.2	PROVISIONAL	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC001540	IRAL003H15	MGC	W01A014H11	pENTR-TOPO	9215		DOK4	55715	AAH01540.1	Hs.279832	Docking protein 4			Colon, adenocarcinoma	NIH_MGC_15		NM_018110.3	NP_060580.2	VALIDATED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC035633	IRAK068P10	MGC	W01A014H12	pENTR-TOPO	7226		GPR65	8477	AAH35633.1	Hs.513440	G protein-coupled receptor 65			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_003608.2	NP_003599.2	PROVISIONAL	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC001540	IRAL003H15	MGC	W01A014H13	pENTR-TOPO	9215		DOK4	55715	AAH01540.1	Hs.279832	Docking protein 4			Colon, adenocarcinoma	NIH_MGC_15		NM_018110.3	NP_060580.2	VALIDATED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC001540	IRAL003H15	MGC	W01A014H15	pENTR-TOPO	9215		DOK4	55715	AAH01540.1	Hs.279832	Docking protein 4			Colon, adenocarcinoma	NIH_MGC_15		NM_018110.3	NP_060580.2	VALIDATED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC008717	IRAL001H15	MGC	W01A014H20	pENTR-TOPO	19242		CSNK1A1	1452	AAH08717.1	Hs.712555	Casein kinase 1, alpha 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001892.4	NP_001883.4	VALIDATED	Cs	0.997	0.997	337	1014	1	1011	337	1	337
RIKEN	BC022505	IRAK032H19	MGC	W01A014H23	pENTR-TOPO	2653		VPS26A	9559	AAH22505.1	Hs.499925	Vacuolar protein sorting 26 homolog A (S. pombe)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004896.3	NP_004887.2	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC008717	IRAL001H15	MGC	W01A014H24	pENTR-TOPO	19242		CSNK1A1	1452	AAH08717.1	Hs.712555	Casein kinase 1, alpha 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001892.4	NP_001883.4	VALIDATED	Cs	0.997	0.997	337	1014	1	1011	337	1	337
RIKEN	BC014064	IRAL028F18	MGC	W01A014I01	pENTR-TOPO	16375		SLC25A36	55186	AAH14064.1	Hs.144130	Solute carrier family 25, member 36			Placenta, choriocarcinoma	NIH_MGC_21		NM_001104647.1	NP_001098117.1	VALIDATED	C	1.000	1.000	311	936	1	933	311	1	311
RIKEN	BC019260	IRAL006P24	MGC	W01A014I02	pENTR-TOPO	12688		FBL	2091	AAH19260.1	Hs.299002	Fibrillarin			Placenta, choriocarcinoma	NIH_MGC_21		NM_001436.3	NP_001427.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
RIKEN	BC019260	IRAL006P24	MGC	W01A014I04	pENTR-TOPO	12688		FBL	2091	AAH19260.1	Hs.299002	Fibrillarin			Placenta, choriocarcinoma	NIH_MGC_21		NM_001436.3	NP_001427.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
RIKEN	AK095468	flj0042j24	FLJ	W01A014I11	pENTR-TOPO	11803		OR7D2	162998	BAC04554.1	Hs.531755	Olfactory receptor, family 7, subfamily D, member 2				D9OST2	EK1	NM_175883.1	NP_787079.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
RIKEN	BC028158	IRAK062L13	MGC	W01A014I23	pENTR-TOPO	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
RIKEN	BC048797	IRAK093I21	MGC	W01A014J02	pENTR-TOPO	57		DFFB	1677	AAH48797.1	Hs.133089	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004402.2	NP_004393.1	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	BC000861	IRAK004A18	MGC	W01A014J03	pENTR-TOPO	6024		NUP37	79023	AAH00861.2	Hs.444276	Nucleoporin 37kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_024057.2	NP_076962.2	PROVISIONAL	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC013436	IRAK014D12	MGC	W01A014J13	pENTR-TOPO	11596		RCN3	57333	AAH13436.1	Hs.567550	Reticulocalbin 3, EF-hand calcium binding domain				NIH_MGC_69	DH10B	NM_020650.2	NP_065701.2	PROVISIONAL	OK	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC027322	IRAK026M12	MGC	W01A014J16	pENTR-TOPO	21900		SLC25A40	55972	AAH27322.1	Hs.208414	Solute carrier family 25, member 40			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_018843.2	NP_061331.2	VALIDATED	C	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	BC062983	IRAL050D14	MGC	W01A014J19	pENTR-TOPO	18506		B4GALT7	11285	AAH62983.1	Hs.455109	Xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)			Skin, melanotic melanoma.	NIH_MGC_20		NM_007255.1	NP_009186.1	REVIEWED	C	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC015191	IRAL021C23	MGC	W01A014K06	pENTR-TOPO	22936		PBK	55872	AAH15191.1	Hs.104741	PDZ binding kinase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_018492.2	NP_060962.2	REVIEWED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC004367	IRAL013L14	MGC	W01A014K15	pENTR-TOPO	11568		KCNK6	9424	AAH04367.1	Hs.240395	Potassium channel, subfamily K, member 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_004823.1	NP_004814.1	REVIEWED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC009990	IRAL026H12	MGC	W01A014K17	pENTR-TOPO	23761		RRAGA	10670	AAH09990.1	Hs.432330	Ras-related GTP binding A			Brain, neuroblastoma	NIH_MGC_19		NM_006570.4	NP_006561.1	VALIDATED	OK	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC013995	IRAL028D19	MGC	W01A014K18	pENTR-TOPO	11558		MYADM	91663	AAH13995.1	Hs.380906	Myeloid-associated differentiation marker			Brain, neuroblastoma	NIH_MGC_19		NM_001020820.1	NP_001018656.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC009990	IRAL026H12	MGC	W01A014K21	pENTR-TOPO	23761		RRAGA	10670	AAH09990.1	Hs.432330	Ras-related GTP binding A			Brain, neuroblastoma	NIH_MGC_19		NM_006570.4	NP_006561.1	VALIDATED	OK	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC036796	IRAK079F04	MGC	W01A014L02	pENTR-TOPO	22175		SVOPL	136306	AAH36796.1	Hs.99414	SVOP-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_174959.2	NP_777619.1	VALIDATED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC007317	IRAL003B20	MGC	W01A014L05	pENTR-TOPO	18506		B4GALT7	11285	AAH07317.1	Hs.455109	Xylosylprotein beta 1,4-galactosyltransferase, polypeptide 7 (galactosyltransferase I)			Skin, melanotic melanoma.	NIH_MGC_20		NM_007255.1	NP_009186.1	REVIEWED	C	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC005138	IRAL007I07	MGC	W01A014L19	pENTR-TOPO	2649		BUB3	9184	AAH05138.1	Hs.418533	Budding uninhibited by benzimidazoles 3 homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21		NM_004725.3	NP_004716.1	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC012182	IRAL029C22	MGC	W01A014M01	pENTR-TOPO	8539		THAP11	57215	AAH12182.1	Hs.632200	THAP domain containing 11			Uterus, leiomyosarcoma	NIH_MGC_46		NM_020457.2	NP_065190.2	REVIEWED	Cg	0.997	1.000	314	942	1	939	314	1	314
RIKEN	BC012182	IRAL029C22	MGC	W01A014M03	pENTR-TOPO	8539		THAP11	57215	AAH12182.1	Hs.632200	THAP domain containing 11			Uterus, leiomyosarcoma	NIH_MGC_46		NM_020457.2	NP_065190.2	REVIEWED	Cg	0.997	1.000	314	942	1	939	314	1	314
RIKEN	BC039725	IRAK082F20	MGC	W01A014M10	pENTR-TOPO	6		AMPH	273		Hs.592182	Amphiphysin			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_139316.1	NP_647477.1	REVIEWED		0.346	0.346	26	972	945	868	653	18	43
RIKEN	BC006433	IRAL018K13	MGC	W01A014M13	pENTR-TOPO	23761		RRAGA	10670	AAH06433.1	Hs.432330	Ras-related GTP binding A			Ovary, adenocarcinoma	NIH_MGC_9		NM_006570.4	NP_006561.1	VALIDATED	OK	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC014785	IRAK021G03	MGC	W01A014M17	pENTR-TOPO	13282		EPCAM	4072	AAH14785.1	Hs.542050	Epithelial cell adhesion molecule			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_002354.2	NP_002345.2	REVIEWED	Cs	0.997	0.997	314	945	1	942	314	1	314
RIKEN	BC005810	IRAL014L03	MGC	W01A014M22	pENTR-TOPO	11365		CLEC11A	6320	AAH05810.1	Hs.512680	C-type lectin domain family 11, member A			Skin, melanotic melanoma.	NIH_MGC_20		NM_002975.2	NP_002966.1	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC065246	IRAK140F15	MGC	W01A014N04	pENTR-TOPO	345		HSD17B7	51478	AAH65246.1	Hs.492925	Hydroxysteroid (17-beta) dehydrogenase 7			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016371.2	NP_057455.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC024290	IRAL042C04	MGC	W01A014N05	pENTR-TOPO	14565		DNTTIP1	116092	AAH24290.1	Hs.472852	Deoxynucleotidyltransferase, terminal, interacting protein 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_052951.2	NP_443183.1	VALIDATED	C	1.000	1.000	329	990	1	987	329	1	329
RIKEN	BC065246	IRAK140F15	MGC	W01A014N06	pENTR-TOPO	345		HSD17B7	51478	AAH65246.1	Hs.492925	Hydroxysteroid (17-beta) dehydrogenase 7			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016371.2	NP_057455.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC065246	IRAK140F15	MGC	W01A014N08	pENTR-TOPO	345		HSD17B7	51478	AAH65246.1	Hs.492925	Hydroxysteroid (17-beta) dehydrogenase 7			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016371.2	NP_057455.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC032340	IRAK064G22	MGC	W01A014N11	pENTR-TOPO	25106		DHRSX	207063	AAH32340.1	Hs.131452	Dehydrogenase/reductase (SDR family) X-linked			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_145177.2	NP_660160.2	VALIDATED	Cs	0.994	0.994	330	993	1	990	330	1	330
RIKEN	BC032340	IRAK064G22	MGC	W01A014N15	pENTR-TOPO	25106		DHRSX	207063	AAH32340.1	Hs.131452	Dehydrogenase/reductase (SDR family) X-linked			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_145177.2	NP_660160.2	VALIDATED	Cs	0.994	0.994	330	993	1	990	330	1	330
RIKEN	BC007068	IRAL016N06	MGC	W01A014N16	pENTR-TOPO	345		HSD17B7	51478	AAH07068.1	Hs.492925	Hydroxysteroid (17-beta) dehydrogenase 7			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016371.2	NP_057455.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC032702	IRAK069D20	MGC	W01A014N17	pENTR-TOPO	959		GPR3	2827	AAH32702.1	Hs.66542	G protein-coupled receptor 3			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_005281.2	NP_005272.1	PROVISIONAL	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC032702	IRAK069D20	MGC	W01A014N19	pENTR-TOPO	959		GPR3	2827	AAH32702.1	Hs.66542	G protein-coupled receptor 3			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_005281.2	NP_005272.1	PROVISIONAL	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC012531	IRAL019J17	MGC	W01A014O08	pENTR-TOPO	6702		ALG5	29880	AAH12531.1	Hs.507769	Asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_013338.4	NP_037470.1	REVIEWED	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC022032	IRAK033D15	MGC	W01A014O11	pENTR-TOPO	17575		SLC25A31	83447	AAH22032.1	Hs.149030	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31			Testis	NIH_MGC_97	DH10B	NM_031291.2	NP_112581.1	VALIDATED	C	1.000	1.000	315	948	1	945	315	1	315
RIKEN	BC016374	IRAL038E10	MGC	W01A014O14	pENTR-TOPO	1560		TMEM59	9528	AAH16374.1	Hs.523262	Transmembrane protein 59			Lung	NIH_MGC_77	DH10B	NM_004872.3	NP_004863.2	PROVISIONAL	Cgs	0.994	0.997	324	975	1	972	323	1	323
RIKEN	BC022032	IRAK033D15	MGC	W01A014O15	pENTR-TOPO	17575		SLC25A31	83447	AAH22032.1	Hs.149030	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31			Testis	NIH_MGC_97	DH10B	NM_031291.2	NP_112581.1	VALIDATED	C	1.000	1.000	315	948	1	945	315	1	315
RIKEN	BC016374	IRAL038E10	MGC	W01A014O16	pENTR-TOPO	1560		TMEM59	9528	AAH16374.1	Hs.523262	Transmembrane protein 59			Lung	NIH_MGC_77	DH10B	NM_004872.3	NP_004863.2	PROVISIONAL	Cgs	0.994	0.997	324	975	1	972	323	1	323
RIKEN	BC013383	IRAL007A24	MGC	W01A014O17	pENTR-TOPO	21103		CALU	813	AAH13383.1	Hs.718425	Calumenin			Brain, neuroblastoma	NIH_MGC_19		NM_001219.3	NP_001210.1	REVIEWED	OK	1.000	1.000	315	948	1	945	315	1	315
RIKEN	BC009906	IRAL002D12	MGC	W01A014O18	pENTR-TOPO	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_080670.2	NP_542401.1	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC036015	IRAK048E18	MGC	W01A014P07	pENTR-TOPO	1363		EXTL2	2135	AAH36015.1	Hs.357637	Exostoses (multiple)-like 2			Testis	NIH_MGC_97	DH10B	NM_001033025.1	NP_001028197.1	VALIDATED	Cs	0.997	0.997	330	993	1	990	330	1	330
RIKEN	BC039234	IRAL041F16	MGC	W01A014P11	pENTR-TOPO	7821		PAQR5	54852	AAH39234.1	Hs.591096	Progestin and adipoQ receptor family member V			Kidney	NIH_MGC_75	DH10B	NM_001104554.1	NP_001098024.1	VALIDATED	Cs	0.997	0.997	330	993	1	990	330	1	330
RIKEN	BC039234	IRAL041F16	MGC	W01A014P13	pENTR-TOPO	7821		PAQR5	54852	AAH39234.1	Hs.591096	Progestin and adipoQ receptor family member V			Kidney	NIH_MGC_75	DH10B	NM_001104554.1	NP_001098024.1	VALIDATED	Cs	0.997	0.997	330	993	1	990	330	1	330
RIKEN	BC039234	IRAL041F16	MGC	W01A014P15	pENTR-TOPO	7821		PAQR5	54852	AAH39234.1	Hs.591096	Progestin and adipoQ receptor family member V			Kidney	NIH_MGC_75	DH10B	NM_001104554.1	NP_001098024.1	VALIDATED	Cs	0.997	0.997	330	993	1	990	330	1	330
RIKEN	BC006849	IRAK003F24	MGC	W01A015A02	pENTR-TOPO	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032361.2	NP_115737.1	VALIDATED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC051850	IRAK110O05	MGC	W01A015A03	pENTR-TOPO	21942		TMEM120A	83862	AAH51850.1	Hs.488835	Transmembrane protein 120A				Lupski_sympathetic_trunk	DH10B	NM_031925.2	NP_114131.1	VALIDATED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
RIKEN	BC006849	IRAK003F24	MGC	W01A015A04	pENTR-TOPO	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032361.2	NP_115737.1	VALIDATED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC051850	IRAK110O05	MGC	W01A015A05	pENTR-TOPO	21942		TMEM120A	83862	AAH51850.1	Hs.488835	Transmembrane protein 120A				Lupski_sympathetic_trunk	DH10B	NM_031925.2	NP_114131.1	VALIDATED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
RIKEN	BC039846	IRAK084P06	MGC	W01A015A12	pENTR-TOPO	12326		PRKACA	5566	AAH39846.1	Hs.631630	Protein kinase, cAMP-dependent, catalytic, alpha			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002730.3	NP_002721.1	REVIEWED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC001239	IRAK004K12	MGC	W01A015A13	pENTR-TOPO	21188		ZDHHC4	55146	AAH01239.1	Hs.5268	Zinc finger, DHHC-type containing 4			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134387.1	NP_001127859.1	VALIDATED	OK	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	BC001239	IRAK004K12	MGC	W01A015A15	pENTR-TOPO	21188		ZDHHC4	55146	AAH01239.1	Hs.5268	Zinc finger, DHHC-type containing 4			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134387.1	NP_001127859.1	VALIDATED	OK	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	BC039846	IRAK084P06	MGC	W01A015A16	pENTR-TOPO	12326		PRKACA	5566	AAH39846.1	Hs.631630	Protein kinase, cAMP-dependent, catalytic, alpha			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002730.3	NP_002721.1	REVIEWED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC038957	IRAK082M07	MGC	W01A015A23	pENTR-TOPO	15786		TOB2	10766	AAH38957.1	Hs.719120	Transducer of ERBB2, 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016272.3	NP_057356.1	VALIDATED	C	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	BC004203	IRAL011N24	MGC	W01A015B07	pENTR-TOPO	8167		SNUPN	10073	AAH04203.1	Hs.21577	Snurportin 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005701.3	NP_005692.1	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC036661	IRAK047L04	MGC	W01A015B13	pENTR-TOPO	13057		CXCR7	57007	AAH36661.1	Hs.471751	Chemokine (C-X-C motif) receptor 7			Testis	NIH_MGC_97	DH10B	NM_020311.2	NP_064707.1	REVIEWED	Cs	0.997	0.997	362	1089	1	1086	362	1	362
RIKEN	BC036661	IRAK047L04	MGC	W01A015B15	pENTR-TOPO	13057		CXCR7	57007	AAH36661.1	Hs.471751	Chemokine (C-X-C motif) receptor 7			Testis	NIH_MGC_97	DH10B	NM_020311.2	NP_064707.1	REVIEWED	Cs	0.997	0.997	362	1089	1	1086	362	1	362
RIKEN	BC001025	IRAL005P05	MGC	W01A015B16	pENTR-TOPO	23536		RCL1	10171	AAH01025.1	Hs.194121	RNA terminal phosphate cyclase-like 1			Eye, retinoblastoma	NIH_MGC_16		NM_005772.3	NP_005763.3	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC009861	IRAL025C22	MGC	W01A015B18	pENTR-TOPO	24523		GPR173	54328	AAH09861.1	Hs.661815	G protein-coupled receptor 173			Lung, small cell carcinoma	NIH_MGC_7		NM_018969.4	NP_061842.1	VALIDATED	C	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC024022	IRAL038F06	MGC	W01A015B21	pENTR-TOPO	17202		RFC4	5984	AAH24022.1	Hs.714318	Replication factor C (activator 1) 4, 37kDa			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_181573.2	NP_853551.1	REVIEWED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC024022	IRAL038F06	MGC	W01A015B23	pENTR-TOPO	17202		RFC4	5984	AAH24022.1	Hs.714318	Replication factor C (activator 1) 4, 37kDa			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_181573.2	NP_853551.1	REVIEWED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC062618	IRAK135E22	MGC	W01A015C03	pENTR-TOPO	16753		B4GALT4	8702	AAH62618.1	Hs.13225	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_212543.1	NP_997708.1	REVIEWED	Cs	0.997	0.997	344	1035	1	1032	344	1	344
RIKEN	BC062618	IRAK135E22	MGC	W01A015C05	pENTR-TOPO	16753		B4GALT4	8702	AAH62618.1	Hs.13225	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_212543.1	NP_997708.1	REVIEWED	Cs	0.997	0.997	344	1035	1	1032	344	1	344
RIKEN	BC062618	IRAK135E22	MGC	W01A015C07	pENTR-TOPO	16753		B4GALT4	8702	AAH62618.1	Hs.13225	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_212543.1	NP_997708.1	REVIEWED	Cs	0.997	0.997	344	1035	1	1032	344	1	344
RIKEN	BC004523	IRAL011B07	MGC	W01A015C13	pENTR-TOPO	16753		B4GALT4	8702	AAH04523.1	Hs.13225	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_212543.1	NP_997708.1	REVIEWED	Cs	0.997	0.997	344	1035	1	1032	344	1	344
RIKEN	BC010101	IRAL027C24	MGC	W01A015C16	pENTR-TOPO	1476		MUL1	79594	AAH10101.1	Hs.10101	Mitochondrial E3 ubiquitin ligase 1			Brain, neuroblastoma	NIH_MGC_19		NM_024544.2	NP_078820.2	VALIDATED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC004107	IRAL014I19	MGC	W01A015C19	pENTR-TOPO	18866		FST	10468	AAH04107.1	Hs.9914	Follistatin			Pancreas, adenocarcinoma	NIH_MGC_39		NM_013409.1	NP_037541.1	REVIEWED	C	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	BC004107	IRAL014I19	MGC	W01A015C23	pENTR-TOPO	18866		FST	10468	AAH04107.1	Hs.9914	Follistatin			Pancreas, adenocarcinoma	NIH_MGC_39		NM_013409.1	NP_037541.1	REVIEWED	C	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	AK056942	flj0003p05	FLJ	W01A015C24	pENTR-TOPO	1735		TRIM63	84676	BAB71318.1	Hs.279709	Tripartite motif-containing 63				SKMUS1	EK1	NM_032588.2	NP_115977.2	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC016040	IRAL029H13	MGC	W01A015D06	pENTR-TOPO	13751		STK17B	9262	AAH16040.1	Hs.88297	Serine/threonine kinase 17b			Primary B-Cells from Tonsils	NIH_MGC_48		NM_004226.3	NP_004217.1	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC016040	IRAL029H13	MGC	W01A015D08	pENTR-TOPO	13751		STK17B	9262	AAH16040.1	Hs.88297	Serine/threonine kinase 17b			Primary B-Cells from Tonsils	NIH_MGC_48		NM_004226.3	NP_004217.1	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC003385	IRAK003I04	MGC	W01A015D10	pENTR-TOPO	10472		SPOP	8405	AAH03385.1	Hs.718421	Speckle-type POZ protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001007228.1	NP_001007229.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC017452	IRAL008L17	MGC	W01A015D11	pENTR-TOPO	17202		RFC4	5984	AAH17452.1	Hs.714318	Replication factor C (activator 1) 4, 37kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_181573.2	NP_853551.1	REVIEWED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC003385	IRAK003I04	MGC	W01A015D14	pENTR-TOPO	10472		SPOP	8405	AAH03385.1	Hs.718421	Speckle-type POZ protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001007228.1	NP_001007229.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC017452	IRAL008L17	MGC	W01A015D15	pENTR-TOPO	17202		RFC4	5984	AAH17452.1	Hs.714318	Replication factor C (activator 1) 4, 37kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_181573.2	NP_853551.1	REVIEWED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC001269	IRAK004L06	MGC	W01A015D18	pENTR-TOPO	10472		SPOP	8405	AAH01269.1	Hs.718421	Speckle-type POZ protein			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001007228.1	NP_001007229.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC001269	IRAK004L06	MGC	W01A015D20	pENTR-TOPO	10472		SPOP	8405	AAH01269.1	Hs.718421	Speckle-type POZ protein			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001007228.1	NP_001007229.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC001269	IRAK004L06	MGC	W01A015D22	pENTR-TOPO	10472		SPOP	8405	AAH01269.1	Hs.718421	Speckle-type POZ protein			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001007228.1	NP_001007229.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC030959	IRAL041F06	MGC	W01A015D23	pENTR-TOPO	5924		GDF3	9573	AAH30959.1	Hs.86232	Growth differentiation factor 3			Kidney	NIH_MGC_75	DH10B	NM_020634.1	NP_065685.1	REVIEWED	Cs	0.997	0.997	364	1095	1	1092	364	1	364
RIKEN	BC032606	IRAK069K18	MGC	W01A015E01	pENTR-TOPO	22541		KHDRBS3	10656	AAH32606.1	Hs.444558	KH domain containing, RNA binding, signal transduction associated 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006558.1	NP_006549.1	PROVISIONAL	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC032606	IRAK069K18	MGC	W01A015E03	pENTR-TOPO	22541		KHDRBS3	10656	AAH32606.1	Hs.444558	KH domain containing, RNA binding, signal transduction associated 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006558.1	NP_006549.1	PROVISIONAL	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC032606	IRAK069K18	MGC	W01A015E05	pENTR-TOPO	22541		KHDRBS3	10656	AAH32606.1	Hs.444558	KH domain containing, RNA binding, signal transduction associated 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006558.1	NP_006549.1	PROVISIONAL	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC059388	IRAK133A19	MGC	W01A015E06	pENTR-TOPO	11831		FPR3	2359	AAH59388.1	Hs.445466	Formyl peptide receptor 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_002030.3	NP_002021.3	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC001275	IRAK004G18	MGC	W01A015E09	pENTR-TOPO	23665		ANXA1	301	AAH01275.1	Hs.494173	Annexin A1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000700.1	NP_000691.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC000575	IRAL005M05	MGC	W01A015E12	pENTR-TOPO	1851		ISG20L2	81875	AAH00575.1	Hs.301904	Interferon stimulated exonuclease gene 20kDa-like 2			Brain, neuroblastoma	NIH_MGC_19		NM_030980.1	NP_112242.1	PROVISIONAL	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC015557	IRAL004A05	MGC	W01A015E18	pENTR-TOPO	9635		CD68	968	AAH15557.1	Hs.647419	CD68 molecule			Skin, melanotic melanoma.	NIH_MGC_20		NM_001251.2	NP_001242.2	REVIEWED	OK	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	BC015557	IRAL004A05	MGC	W01A015E20	pENTR-TOPO	9635		CD68	968	AAH15557.1	Hs.647419	CD68 molecule			Skin, melanotic melanoma.	NIH_MGC_20		NM_001251.2	NP_001242.2	REVIEWED	OK	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	BC015557	IRAL004A05	MGC	W01A015E22	pENTR-TOPO	9635		CD68	968	AAH15557.1	Hs.647419	CD68 molecule			Skin, melanotic melanoma.	NIH_MGC_20		NM_001251.2	NP_001242.2	REVIEWED	OK	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	BC015557	IRAL004A05	MGC	W01A015E24	pENTR-TOPO	9635		CD68	968	AAH15557.1	Hs.647419	CD68 molecule			Skin, melanotic melanoma.	NIH_MGC_20		NM_001251.2	NP_001242.2	REVIEWED	OK	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	BC032735	IRAK069L10	MGC	W01A015F03	pENTR-TOPO	4002		RBM4	5936	AAH32735.1	Hs.533712	RNA binding motif protein 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002896.2	NP_002887.2	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC032735	IRAK069L10	MGC	W01A015F05	pENTR-TOPO	4002		RBM4	5936	AAH32735.1	Hs.533712	RNA binding motif protein 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002896.2	NP_002887.2	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC035871	IRAK078K05	MGC	W01A015F09	pENTR-TOPO	19306		CCNJL	79616	AAH35871.3	Hs.14070	Cyclin J-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_024565.5	NP_078841.3	VALIDATED	P	1.000	1.000	365	1098	1	1095	435	71	435
RIKEN	BC013585	IRAK014C17	MGC	W01A015F12	pENTR-TOPO	11652		GNA15	2769	AAH13585.1	Hs.73797	Guanine nucleotide binding protein (G protein), alpha 15 (Gq class)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002068.2	NP_002059.2	VALIDATED	Cs	0.997	0.997	374	1125	1	1122	374	1	374
RIKEN	BC013585	IRAK014C17	MGC	W01A015F14	pENTR-TOPO	11652		GNA15	2769	AAH13585.1	Hs.73797	Guanine nucleotide binding protein (G protein), alpha 15 (Gq class)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002068.2	NP_002059.2	VALIDATED	Cs	0.997	0.997	374	1125	1	1122	374	1	374
RIKEN	BC014624	IRAL010O13	MGC	W01A015F23	pENTR-TOPO	10951		ELAC1	55520	AAH14624.1	Hs.657360	ElaC homolog 1 (E. coli)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018696.2	NP_061166.1	VALIDATED	OK	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC000344	IRAL001K11	MGC	W01A015G01	pENTR-TOPO	11527		SAE1	10055	AAH00344.1	Hs.515500	SUMO1 activating enzyme subunit 1			Lung, small cell carcinoma	NIH_MGC_7		NM_005500.2	NP_005491.1	VALIDATED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC002442	IRAL005M08	MGC	W01A015G14	pENTR-TOPO	24109		STOML2	30968	AAH02442.1	Hs.3439	Stomatin (EPB72)-like 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_013442.1	NP_038470.1	PROVISIONAL	C	1.000	1.000	356	1071	1	1068	356	1	356
RIKEN	BC003611	IRAL003F15	MGC	W01A015G19	pENTR-TOPO	11527		SAE1	10055	AAH03611.1	Hs.515500	SUMO1 activating enzyme subunit 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005500.2	NP_005491.1	VALIDATED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC001594	IRAL003M02	MGC	W01A015H06	pENTR-TOPO	1631		ADIPOR1	51094	AAH01594.1	Hs.5298	Adiponectin receptor 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_015999.3	NP_057083.2	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC004329	IRAL013C16	MGC	W01A015H07	pENTR-TOPO	12972		WNT6	7475	AAH04329.1	Hs.29764	Wingless-type MMTV integration site family, member 6			Placenta, choriocarcinoma	NIH_MGC_21		NM_006522.3	NP_006513.1	REVIEWED	C	1.000	1.000	365	1098	1	1095	365	1	365
RIKEN	BC001594	IRAL003M02	MGC	W01A015H08	pENTR-TOPO	1631		ADIPOR1	51094	AAH01594.1	Hs.5298	Adiponectin receptor 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_015999.3	NP_057083.2	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC027883	IRAK049K02	MGC	W01A015H11	pENTR-TOPO	1589		LEFTY1	10637	AAH27883.1	Hs.656214	Left-right determination factor 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020997.2	NP_066277.1	REVIEWED	C	1.000	1.000	366	1101	1	1098	366	1	366
RIKEN	BC054517	IRAK110B03	MGC	W01A015H12	pENTR-TOPO	14050		FANCL	55120	AAH54517.1	Hs.631890	Fanconi anemia, complementation group L			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018062.3	NP_060532.2	REVIEWED	C	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC054517	IRAK110B03	MGC	W01A015H14	pENTR-TOPO	14050		FANCL	55120	AAH54517.1	Hs.631890	Fanconi anemia, complementation group L			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018062.3	NP_060532.2	REVIEWED	C	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC054517	IRAK110B03	MGC	W01A015H16	pENTR-TOPO	14050		FANCL	55120	AAH54517.1	Hs.631890	Fanconi anemia, complementation group L			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018062.3	NP_060532.2	REVIEWED	C	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC010507	IRAK019M04	MGC	W01A015H18	pENTR-TOPO	19205		CD14	929	AAH10507.1	Hs.163867	CD14 molecule			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_001040021.1	NP_001035110.1	REVIEWED	C	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC014476	IRAL034H09	MGC	W01A015H19	pENTR-TOPO	23979		GKAP1	80318	AAH14476.1	Hs.522255	G kinase anchoring protein 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_025211.3	NP_079487.2	REVIEWED	OK	1.000	1.000	366	1101	1	1098	366	1	366
RIKEN	BC010507	IRAK019M04	MGC	W01A015H20	pENTR-TOPO	19205		CD14	929	AAH10507.1	Hs.163867	CD14 molecule			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_001040021.1	NP_001035110.1	REVIEWED	C	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC014476	IRAL034H09	MGC	W01A015H21	pENTR-TOPO	23979		GKAP1	80318	AAH14476.1	Hs.522255	G kinase anchoring protein 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_025211.3	NP_079487.2	REVIEWED	OK	1.000	1.000	366	1101	1	1098	366	1	366
RIKEN	BC001494	IRAL007K13	MGC	W01A015I04	pENTR-TOPO	1606		SNRNP40	9410	AAH01494.1	Hs.33962	Small nuclear ribonucleoprotein 40kDa (U5)			Placenta, choriocarcinoma	NIH_MGC_21		NM_004814.2	NP_004805.2	REVIEWED	OK	1.000	1.000	357	1074	1	1071	357	1	357
RIKEN	BC001144	IRAL008E19	MGC	W01A015I10	pENTR-TOPO	16108		DNAJB11	51726	AAH01144.1	Hs.317192	DnaJ (Hsp40) homolog, subfamily B, member 11			Lung, small cell carcinoma	NIH_MGC_7		NM_016306.4	NP_057390.1	VALIDATED	OK	1.000	1.000	358	1077	1	1074	358	1	358
RIKEN	BC033586	IRAK049N16	MGC	W01A015I13	pENTR-TOPO	1540		CD5L	922	AAH33586.1	Hs.134035	CD5 molecule-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_005894.2	NP_005885.1	VALIDATED	C	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC001144	IRAL008E19	MGC	W01A015I16	pENTR-TOPO	16108		DNAJB11	51726	AAH01144.1	Hs.317192	DnaJ (Hsp40) homolog, subfamily B, member 11			Lung, small cell carcinoma	NIH_MGC_7		NM_016306.4	NP_057390.1	VALIDATED	OK	1.000	1.000	358	1077	1	1074	358	1	358
RIKEN	BC003665	IRAL003L11	MGC	W01A015I18	pENTR-TOPO	5303		GPRC5A	9052	AAH03665.1	Hs.631733	G protein-coupled receptor, family C, group 5, member A			Colon, adenocarcinoma	NIH_MGC_15		NM_003979.3	NP_003970.1	REVIEWED	C	1.000	1.000	357	1074	1	1071	357	1	357
RIKEN	BC030831	IRAK032F24	MGC	W01A015J03	pENTR-TOPO	18186		TRAM1L1	133022	AAH30831.1	Hs.570737	Translocation associated membrane protein 1-like 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152402.2	NP_689615.2	VALIDATED	Cs	0.997	0.997	369	1110	1	1107	369	1	369
RIKEN	BC030831	IRAK032F24	MGC	W01A015J05	pENTR-TOPO	18186		TRAM1L1	133022	AAH30831.1	Hs.570737	Translocation associated membrane protein 1-like 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152402.2	NP_689615.2	VALIDATED	Cs	0.997	0.997	369	1110	1	1107	369	1	369
RIKEN	BC030831	IRAK032F24	MGC	W01A015J07	pENTR-TOPO	18186		TRAM1L1	133022	AAH30831.1	Hs.570737	Translocation associated membrane protein 1-like 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152402.2	NP_689615.2	VALIDATED	Cs	0.997	0.997	369	1110	1	1107	369	1	369
RIKEN	BC014972	IRAL034N17	MGC	W01A015J09	pENTR-TOPO	25147		IL2RG	3561	AAH14972.1	Hs.84	Interleukin 2 receptor, gamma (severe combined immunodeficiency)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_000206.1	NP_000197.1	REVIEWED	OK	1.000	1.000	369	1110	1	1107	369	1	369
RIKEN	BC049214	IRAK093N06	MGC	W01A015J10	pENTR-TOPO	7714		CHST14	113189	AAH49214.1	Hs.442449	Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_130468.2	NP_569735.1	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC014972	IRAL034N17	MGC	W01A015J11	pENTR-TOPO	25147		IL2RG	3561	AAH14972.1	Hs.84	Interleukin 2 receptor, gamma (severe combined immunodeficiency)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_000206.1	NP_000197.1	REVIEWED	OK	1.000	1.000	369	1110	1	1107	369	1	369
RIKEN	BC049214	IRAK093N06	MGC	W01A015J14	pENTR-TOPO	7714		CHST14	113189	AAH49214.1	Hs.442449	Carbohydrate (N-acetylgalactosamine 4-0) sulfotransferase 14			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_130468.2	NP_569735.1	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC014972	IRAL034N17	MGC	W01A015J15	pENTR-TOPO	25147		IL2RG	3561	AAH14972.1	Hs.84	Interleukin 2 receptor, gamma (severe combined immunodeficiency)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_000206.1	NP_000197.1	REVIEWED	OK	1.000	1.000	369	1110	1	1107	369	1	369
RIKEN	BC030577	IRAK033G13	MGC	W01A015J21	pENTR-TOPO	21817		GPR85	54329	AAH30577.1	Hs.152009	G protein-coupled receptor 85			Testis	NIH_MGC_97	DH10B	NM_001146266.1	NP_001139738.1	VALIDATED	Cs	0.997	0.997	370	1113	1	1110	370	1	370
RIKEN	BC002538	IRAL004O20	MGC	W01A015J24	pENTR-TOPO	20393		SERPINB9	5272	AAH02538.1	Hs.104879	Serpin peptidase inhibitor, clade B (ovalbumin), member 9			Placenta, choriocarcinoma	NIH_MGC_21		NM_004155.4	NP_004146.1	VALIDATED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC002798	IRAL012B04	MGC	W01A015K01	pENTR-TOPO	15494		NCF4	4689	AAH02798.1	Hs.474781	Neutrophil cytosolic factor 4, 40kDa			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_013416.3	NP_038202.2	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
RIKEN	BC002798	IRAL012B04	MGC	W01A015K03	pENTR-TOPO	15494		NCF4	4689	AAH02798.1	Hs.474781	Neutrophil cytosolic factor 4, 40kDa			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_013416.3	NP_038202.2	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
RIKEN	BC008141	IRAK019D20	MGC	W01A015K10	pENTR-TOPO	25194		HAUS7	55559	AAH08141.3	Hs.170835	HAUS augmin-like complex, subunit 7				NCI_CGAP_Brn67	DH10B	NM_017518.5	NP_059988.3	REVIEWED	P	1.000	1.000	358	1077	1	1074	368	11	368
RIKEN	BC008141	IRAK019D20	MGC	W01A015K14	pENTR-TOPO	25194		HAUS7	55559	AAH08141.3	Hs.170835	HAUS augmin-like complex, subunit 7				NCI_CGAP_Brn67	DH10B	NM_017518.5	NP_059988.3	REVIEWED	P	1.000	1.000	358	1077	1	1074	368	11	368
RIKEN	AK027784	flj0037k13	FLJ	W01A015K18	pENTR-TOPO	16764		GPR87	53836	BAB55366.1	Hs.591292	G protein-coupled receptor 87				PLACE1	EK1	NM_023915.3	NP_076404.3	VALIDATED	Cs	0.997	0.997	358	1077	1	1074	358	1	358
RIKEN	AK027784	flj0037k13	FLJ	W01A015K22	pENTR-TOPO	16764		GPR87	53836	BAB55366.1	Hs.591292	G protein-coupled receptor 87				PLACE1	EK1	NM_023915.3	NP_076404.3	VALIDATED	Cs	0.997	0.997	358	1077	1	1074	358	1	358
RIKEN	AK027784	flj0037k13	FLJ	W01A015K24	pENTR-TOPO	16764		GPR87	53836	BAB55366.1	Hs.591292	G protein-coupled receptor 87				PLACE1	EK1	NM_023915.3	NP_076404.3	VALIDATED	Cs	0.997	0.997	358	1077	1	1074	358	1	358
RIKEN	BC034621	IRAK072P06	MGC	W01A015L01	pENTR-TOPO	2130		LPGAT1	9926	AAH34621.1	Hs.497674	Lysophosphatidylglycerol acyltransferase 1			Testis	NIH_MGC_97	DH10B	NM_014873.2	NP_055688.1	VALIDATED	C	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC001747	IRAL008J03	MGC	W01A015L02	pENTR-TOPO	3583		PSMD13	5719	AAH01747.1	Hs.134688	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 13			Lung, small cell carcinoma	NIH_MGC_7		NM_002817.3	NP_002808.3	VALIDATED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
RIKEN	BC034621	IRAK072P06	MGC	W01A015L03	pENTR-TOPO	2130		LPGAT1	9926	AAH34621.1	Hs.497674	Lysophosphatidylglycerol acyltransferase 1			Testis	NIH_MGC_97	DH10B	NM_014873.2	NP_055688.1	VALIDATED	C	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC013188	IRAK026B03	MGC	W01A015L11	pENTR-TOPO	21115		TPST1	8460	AAH13188.1	Hs.421194	Tyrosylprotein sulfotransferase 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003596.3	NP_003587.1	VALIDATED	C	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC004374	IRAL013L08	MGC	W01A015L18	pENTR-TOPO	14259		ACTR1B	10120	AAH04374.1	Hs.98791	ARP1 actin-related protein 1 homolog B, centractin beta (yeast)			Placenta, choriocarcinoma	NIH_MGC_21		NM_005735.3	NP_005726.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC004374	IRAL013L08	MGC	W01A015L20	pENTR-TOPO	14259		ACTR1B	10120	AAH04374.1	Hs.98791	ARP1 actin-related protein 1 homolog B, centractin beta (yeast)			Placenta, choriocarcinoma	NIH_MGC_21		NM_005735.3	NP_005726.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC028121	IRAK062D05	MGC	W01A015L23	pENTR-TOPO	20781		TRAM2	9697	AAH28121.1	Hs.520182	Translocation associated membrane protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012288.3	NP_036420.1	REVIEWED	C	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC004374	IRAL013L08	MGC	W01A015L24	pENTR-TOPO	14259		ACTR1B	10120	AAH04374.1	Hs.98791	ARP1 actin-related protein 1 homolog B, centractin beta (yeast)			Placenta, choriocarcinoma	NIH_MGC_21		NM_005735.3	NP_005726.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC031085	IRAK048L17	MGC	W01A015M02	pENTR-TOPO	10192		PEX12	5193	AAH31085.1	Hs.591190	Peroxisomal biogenesis factor 12			Testis	NIH_MGC_97	DH10B	NM_000286.2	NP_000277.1	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC043610	IRAK089K08	MGC	W01A015M12	pENTR-TOPO	25322		P2RY8	286530	AAH43610.1	Hs.111377	Purinergic receptor P2Y, G-protein coupled, 8			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_178129.4	NP_835230.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC001749	IRAL008M07	MGC	W01A015M20	pENTR-TOPO	5222		WNT5B	81029	AAH01749.1	Hs.306051	Wingless-type MMTV integration site family, member 5B			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_030775.2	NP_110402.2	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC028425	IRAK046F07	MGC	W01A015N10	pENTR-TOPO	15866		MLC1	23209	AAH28425.1	Hs.517729	Megalencephalic leukoencephalopathy with subcortical cysts 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015166.3	NP_055981.1	REVIEWED	Cs	0.997	0.997	377	1134	1	1131	377	1	377
RIKEN	BC002365	IRAL001D17	MGC	W01A015N20	pENTR-TOPO	116		PSMD4	5710	AAH02365.1	Hs.505059	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 4			Lung, small cell carcinoma	NIH_MGC_7		NM_002810.2	NP_002801.1	REVIEWED	OK	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	BC037552	IRAK064O11	MGC	W01A015N21	pENTR-TOPO	18112		PPM1K	152926	AAH37552.1	Hs.291000	Protein phosphatase 1K (PP2C domain containing)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152542.3	NP_689755.3	VALIDATED	Cs	0.997	0.997	372	1119	1	1116	372	1	372
RIKEN	BC037552	IRAK064O11	MGC	W01A015N23	pENTR-TOPO	18112		PPM1K	152926	AAH37552.1	Hs.291000	Protein phosphatase 1K (PP2C domain containing)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152542.3	NP_689755.3	VALIDATED	Cs	0.997	0.997	372	1119	1	1116	372	1	372
RIKEN	BC008812	IRAL015N17	MGC	W01A015O01	pENTR-TOPO	9380		CSNK2A2	1459	AAH08812.1	Hs.82201	Casein kinase 2, alpha prime polypeptide			Ovary, adenocarcinoma	NIH_MGC_9		NM_001896.2	NP_001887.1	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC030227	IRAK049N06	MGC	W01A015O04	pENTR-TOPO	24025		CD72	971	AAH30227.1	Hs.116481	CD72 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001782.2	NP_001773.1	VALIDATED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC030227	IRAK049N06	MGC	W01A015O06	pENTR-TOPO	24025		CD72	971	AAH30227.1	Hs.116481	CD72 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001782.2	NP_001773.1	VALIDATED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC030227	IRAK049N06	MGC	W01A015O08	pENTR-TOPO	24025		CD72	971	AAH30227.1	Hs.116481	CD72 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001782.2	NP_001773.1	VALIDATED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC037290	IRAK046F04	MGC	W01A015O10	pENTR-TOPO	13918		KCNJ13	3769	AAH37290.1	Hs.467338	Potassium inwardly-rectifying channel, subfamily J, member 13			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002242.3	NP_002233.2	VALIDATED	Cs	0.992	0.992	360	1083	1	1080	360	1	360
RIKEN	BC037290	IRAK046F04	MGC	W01A015O12	pENTR-TOPO	13918		KCNJ13	3769	AAH37290.1	Hs.467338	Potassium inwardly-rectifying channel, subfamily J, member 13			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002242.3	NP_002233.2	VALIDATED	Cs	0.992	0.992	360	1083	1	1080	360	1	360
RIKEN	BC037290	IRAK046F04	MGC	W01A015O16	pENTR-TOPO	13918		KCNJ13	3769	AAH37290.1	Hs.467338	Potassium inwardly-rectifying channel, subfamily J, member 13			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002242.3	NP_002233.2	VALIDATED	Cs	0.992	0.992	360	1083	1	1080	360	1	360
RIKEN	AK075382	flj0027i08	FLJ	W01A015O17	pENTR-TOPO	24605		ATP6AP2	10159	BAC11582.1	Hs.495960	ATPase, H+ transporting, lysosomal accessory protein 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_005765.2	NP_005756.2	REVIEWED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
RIKEN	BC013318	IRAL019G08	MGC	W01A015P03	pENTR-TOPO	25184		MAGEC2	51438	AAH13318.1	Hs.123536	Melanoma antigen family C, 2			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_016249.2	NP_057333.1	REVIEWED	Cs	0.997	0.997	373	1122	1	1119	373	1	373
RIKEN	BC013318	IRAL019G08	MGC	W01A015P05	pENTR-TOPO	25184		MAGEC2	51438	AAH13318.1	Hs.123536	Melanoma antigen family C, 2			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_016249.2	NP_057333.1	REVIEWED	Cs	0.997	0.997	373	1122	1	1119	373	1	373
RIKEN	BC013331	IRAL019D20	MGC	W01A015P13	pENTR-TOPO	18914		H2AFY	9555	AAH13331.1	Hs.599225	H2A histone family, member Y			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_138610.2	NP_613258.2	REVIEWED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC005891	IRAL003F20	MGC	W01A015P17	pENTR-TOPO	25184		MAGEC2	51438	AAH05891.1	Hs.123536	Melanoma antigen family C, 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_016249.2	NP_057333.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC005891	IRAL003F20	MGC	W01A015P21	pENTR-TOPO	25184		MAGEC2	51438	AAH05891.1	Hs.123536	Melanoma antigen family C, 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_016249.2	NP_057333.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC025312	IRAL042D01	MGC	W01A016A02	pENTR-TOPO	14719		SLC17A9	63910	AAH25312	Hs.512686	Solute carrier family 17, member 9			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_022082.3	NP_071365.3	VALIDATED	Ps	0.992	0.992	380	1167	25	1164	436	15	394
RIKEN	BC025312	IRAL042D01	MGC	W01A016A08	pENTR-TOPO	14719		SLC17A9	63910	AAH25312	Hs.512686	Solute carrier family 17, member 9			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_022082.3	NP_071365.3	VALIDATED	Ps	0.992	0.992	380	1167	25	1164	436	15	394
RIKEN	BC005390	IRAL016L02	MGC	W01A016A10	pENTR-TOPO	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_002806.3	NP_002797.3	REVIEWED	P	1.000	1.000	389	1170	1	1167	403	15	403
RIKEN	BC005390	IRAL016L02	MGC	W01A016A14	pENTR-TOPO	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_002806.3	NP_002797.3	REVIEWED	P	1.000	1.000	389	1170	1	1167	403	15	403
RIKEN	BC005390	IRAL016L02	MGC	W01A016A16	pENTR-TOPO	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_002806.3	NP_002797.3	REVIEWED	P	1.000	1.000	389	1170	1	1167	403	15	403
RIKEN	BC000693	IRAL005N08	MGC	W01A016A19	pENTR-TOPO	3343		ACTR1A	10121	AAH00693.1	Hs.153961	ARP1 actin-related protein 1 homolog A, centractin alpha (yeast)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_005736.3	NP_005727.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC012369	IRAK021C08	MGC	W01A016A20	pENTR-TOPO	16940		PSMD6	9861	AAH12369.1	Hs.152536	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014814.1	NP_055629.1	PROVISIONAL	C	1.000	1.000	389	1170	1	1167	389	1	389
RIKEN	BC000693	IRAL005N08	MGC	W01A016A21	pENTR-TOPO	3343		ACTR1A	10121	AAH00693.1	Hs.153961	ARP1 actin-related protein 1 homolog A, centractin alpha (yeast)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_005736.3	NP_005727.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC012369	IRAK021C08	MGC	W01A016A24	pENTR-TOPO	16940		PSMD6	9861	AAH12369.1	Hs.152536	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014814.1	NP_055629.1	PROVISIONAL	C	1.000	1.000	389	1170	1	1167	389	1	389
RIKEN	BC001746	IRAL008I16	MGC	W01A016B11	pENTR-TOPO	1744		PTPN7	5778	AAH01746.2	Hs.402773	Protein tyrosine phosphatase, non-receptor type 7			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_080588.1	NP_542155.1	REVIEWED	OK	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC007363	IRAL024B05	MGC	W01A016B14	pENTR-TOPO	8632		BCKDK	10295	AAH07363.1	Hs.513520	Branched chain ketoacid dehydrogenase kinase			Placenta, choriocarcinoma	NIH_MGC_21		NM_005881.2	NP_005872.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	BC001746	IRAL008I16	MGC	W01A016B15	pENTR-TOPO	1744		PTPN7	5778	AAH01746.2	Hs.402773	Protein tyrosine phosphatase, non-receptor type 7			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_080588.1	NP_542155.1	REVIEWED	OK	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC007363	IRAL024B05	MGC	W01A016B16	pENTR-TOPO	8632		BCKDK	10295	AAH07363.1	Hs.513520	Branched chain ketoacid dehydrogenase kinase			Placenta, choriocarcinoma	NIH_MGC_21		NM_005881.2	NP_005872.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	BC038713	IRAK074I10	MGC	W01A016B19	pENTR-TOPO	11482		CYTH2	9266	AAH38713.1	Hs.144011	Cytohesin 2			Testis	NIH_MGC_97	DH10B	NM_017457.4	NP_059431.1	REVIEWED	Cs	0.998	0.998	400	1203	1	1200	400	1	400
RIKEN	BC038713	IRAK074I10	MGC	W01A016B23	pENTR-TOPO	11482		CYTH2	9266	AAH38713.1	Hs.144011	Cytohesin 2			Testis	NIH_MGC_97	DH10B	NM_017457.4	NP_059431.1	REVIEWED	Cs	0.998	0.998	400	1203	1	1200	400	1	400
RIKEN	BC006238	IRAL015D03	MGC	W01A016B24	pENTR-TOPO	24571		SUV39H1	6839	AAH06238.1	Hs.522639	Suppressor of variegation 3-9 homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7		NM_003173.2	NP_003164.1	REVIEWED	C	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	BC000944	IRAK003M04	MGC	W01A016C02	pENTR-TOPO	11610		TSEN34	79042	AAH00944	Hs.15580	TRNA splicing endonuclease 34 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_024075.2	NP_076980.2	VALIDATED	Cfs	0.994	0.994	310	1173	1	929	310	1	310
RIKEN	BC000944	IRAK003M04	MGC	W01A016C04	pENTR-TOPO	11610		TSEN34	79042	AAH00944	Hs.15580	TRNA splicing endonuclease 34 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_024075.2	NP_076980.2	VALIDATED	Cfs	0.994	0.994	310	1173	1	929	310	1	310
RIKEN	BC000944	IRAK003M04	MGC	W01A016C08	pENTR-TOPO	11610		TSEN34	79042	AAH00944	Hs.15580	TRNA splicing endonuclease 34 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_024075.2	NP_076980.2	VALIDATED	Cfs	0.994	0.994	310	1173	1	929	310	1	310
RIKEN	BC035343	IRAK050B15	MGC	W01A016C09	pENTR-TOPO	10642		CCR7	1236	AAH35343.1	Hs.370036	Chemokine (C-C motif) receptor 7			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001838.2	NP_001829.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
RIKEN	BC002816	IRAL012F02	MGC	W01A016C18	pENTR-TOPO	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_000265.4	NP_000256.3	REVIEWED	Cs	0.997	0.997	390	1173	1	1170	390	1	390
RIKEN	BC020209	IRAL040I15	MGC	W01A016C19	pENTR-TOPO	20509		AGPAT4	56895	AAH20209.1	Hs.353175	1-acylglycerol-3-phosphate O-acyltransferase 4 (lysophosphatidic acid acyltransferase, delta)			Spleen	NIH_MGC_113		NM_020133.2	NP_064518.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
RIKEN	BC002816	IRAL012F02	MGC	W01A016C20	pENTR-TOPO	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_000265.4	NP_000256.3	REVIEWED	Cs	0.997	0.997	390	1173	1	1170	390	1	390
RIKEN	BC002816	IRAL012F02	MGC	W01A016C22	pENTR-TOPO	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_000265.4	NP_000256.3	REVIEWED	Cs	0.997	0.997	390	1173	1	1170	390	1	390
RIKEN	BC002816	IRAL012F02	MGC	W01A016C24	pENTR-TOPO	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_000265.4	NP_000256.3	REVIEWED	Cs	0.997	0.997	390	1173	1	1170	390	1	390
RIKEN	BC013780	IRAK026O11	MGC	W01A016D02	pENTR-TOPO	15480		ADORA2A	135	AAH13780.1	Hs.197029	Adenosine A2a receptor			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000675.4	NP_000666.2	REVIEWED	C	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	BC013780	IRAK026O11	MGC	W01A016D04	pENTR-TOPO	15480		ADORA2A	135	AAH13780.1	Hs.197029	Adenosine A2a receptor			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000675.4	NP_000666.2	REVIEWED	C	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	BC012846	IRAK021M16	MGC	W01A016D16	pENTR-TOPO	13886		IDH1	3417	AAH12846.1	Hs.593422	Isocitrate dehydrogenase 1 (NADP+), soluble			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_005896.2	NP_005887.2	REVIEWED	C	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	BC004361	IRAL008D23	MGC	W01A016D17	pENTR-TOPO	11482		CYTH2	9266	AAH04361.1	Hs.144011	Cytohesin 2			Lung, small cell carcinoma	NIH_MGC_7		NM_017457.4	NP_059431.1	REVIEWED	OK	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC016938	IRAK020N03	MGC	W01A016D20	pENTR-TOPO	19121		NMUR2	56923	AAH16938.1	Hs.283093	Neuromedin U receptor 2			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_020167.4	NP_064552.3	REVIEWED	Cs	0.995	0.995	415	1248	1	1245	415	1	415
RIKEN	BC016938	IRAK020N03	MGC	W01A016D24	pENTR-TOPO	19121		NMUR2	56923	AAH16938.1	Hs.283093	Neuromedin U receptor 2			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_020167.4	NP_064552.3	REVIEWED	Cs	0.995	0.995	415	1248	1	1245	415	1	415
RIKEN	BC064694	IRAK133I11	MGC	W01A016E01	pENTR-TOPO	17017		WNT5A	7474	AAH64694.1	Hs.696364	Wingless-type MMTV integration site family, member 5A			Placenta, normal	NIH_MGC_147	DH10B	NM_003392.3	NP_003383.2	REVIEWED	C	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC064694	IRAK133I11	MGC	W01A016E03	pENTR-TOPO	17017		WNT5A	7474	AAH64694.1	Hs.696364	Wingless-type MMTV integration site family, member 5A			Placenta, normal	NIH_MGC_147	DH10B	NM_003392.3	NP_003383.2	REVIEWED	C	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC064694	IRAK133I11	MGC	W01A016E05	pENTR-TOPO	17017		WNT5A	7474	AAH64694.1	Hs.696364	Wingless-type MMTV integration site family, member 5A			Placenta, normal	NIH_MGC_147	DH10B	NM_003392.3	NP_003383.2	REVIEWED	C	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC064694	IRAK133I11	MGC	W01A016E07	pENTR-TOPO	17017		WNT5A	7474	AAH64694.1	Hs.696364	Wingless-type MMTV integration site family, member 5A			Placenta, normal	NIH_MGC_147	DH10B	NM_003392.3	NP_003383.2	REVIEWED	C	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC020739	IRAL037O24	MGC	W01A016E09	pENTR-TOPO	25406		IL13RA2	3598	AAH20739.1	Hs.336046	Interleukin 13 receptor, alpha 2			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_000640.2	NP_000631.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC047733	IRAK098P13	MGC	W01A016E10	pENTR-TOPO	3167		TRDMT1	1787	AAH47733.1	Hs.351665	TRNA aspartic acid methyltransferase 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004412.4	NP_004403.1	REVIEWED	Cs	0.997	0.997	391	1176	1	1173	391	1	391
RIKEN	BC020739	IRAL037O24	MGC	W01A016E11	pENTR-TOPO	25406		IL13RA2	3598	AAH20739.1	Hs.336046	Interleukin 13 receptor, alpha 2			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_000640.2	NP_000631.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC047733	IRAK098P13	MGC	W01A016E12	pENTR-TOPO	3167		TRDMT1	1787	AAH47733.1	Hs.351665	TRNA aspartic acid methyltransferase 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004412.4	NP_004403.1	REVIEWED	Cs	0.997	0.997	391	1176	1	1173	391	1	391
RIKEN	BC020739	IRAL037O24	MGC	W01A016E13	pENTR-TOPO	25406		IL13RA2	3598	AAH20739.1	Hs.336046	Interleukin 13 receptor, alpha 2			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_000640.2	NP_000631.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC047733	IRAK098P13	MGC	W01A016E14	pENTR-TOPO	3167		TRDMT1	1787	AAH47733.1	Hs.351665	TRNA aspartic acid methyltransferase 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004412.4	NP_004403.1	REVIEWED	Cs	0.997	0.997	391	1176	1	1173	391	1	391
RIKEN	BC020739	IRAL037O24	MGC	W01A016E15	pENTR-TOPO	25406		IL13RA2	3598	AAH20739.1	Hs.336046	Interleukin 13 receptor, alpha 2			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_000640.2	NP_000631.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC047733	IRAK098P13	MGC	W01A016E16	pENTR-TOPO	3167		TRDMT1	1787	AAH47733.1	Hs.351665	TRNA aspartic acid methyltransferase 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004412.4	NP_004403.1	REVIEWED	Cs	0.997	0.997	391	1176	1	1173	391	1	391
RIKEN	BC018650	IRAL032N14	MGC	W01A016E17	pENTR-TOPO	270		S1PR1	1901	AAH18650.1	Hs.154210	Sphingosine-1-phosphate receptor 1			Lung	NIH_MGC_77	DH10B	NM_001400.4	NP_001391.2	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC018650	IRAL032N14	MGC	W01A016E19	pENTR-TOPO	270		S1PR1	1901	AAH18650.1	Hs.154210	Sphingosine-1-phosphate receptor 1			Lung	NIH_MGC_77	DH10B	NM_001400.4	NP_001391.2	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC018650	IRAL032N14	MGC	W01A016E21	pENTR-TOPO	270		S1PR1	1901	AAH18650.1	Hs.154210	Sphingosine-1-phosphate receptor 1			Lung	NIH_MGC_77	DH10B	NM_001400.4	NP_001391.2	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC018650	IRAL032N14	MGC	W01A016E23	pENTR-TOPO	270		S1PR1	1901	AAH18650.1	Hs.154210	Sphingosine-1-phosphate receptor 1			Lung	NIH_MGC_77	DH10B	NM_001400.4	NP_001391.2	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC020972	IRAK020N18	MGC	W01A016F02	pENTR-TOPO	11496		CSNK1G2	1455	AAH20972.1	Hs.651905	Casein kinase 1, gamma 2			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001319.6	NP_001310.3	VALIDATED	Cs	0.998	0.998	415	1248	1	1245	415	1	415
RIKEN	BC012350	IRAL029G21	MGC	W01A016F03	pENTR-TOPO	8922		SPN	6693	AAH12350.1	Hs.632188	Sialophorin			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001030288.1	NP_001025459.1	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC012350	IRAL029G21	MGC	W01A016F07	pENTR-TOPO	8922		SPN	6693	AAH12350.1	Hs.632188	Sialophorin			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001030288.1	NP_001025459.1	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC017655	IRAK014K24	MGC	W01A016F09	pENTR-TOPO	10278		CANT1	124583	AAH17655.1	Hs.8859	Calcium activated nucleotidase 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001159772.1	NP_001153244.1	VALIDATED	C	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC018699	IRAL003D06	MGC	W01A016F10	pENTR-TOPO	11496		CSNK1G2	1455	AAH18699.1	Hs.651905	Casein kinase 1, gamma 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001319.6	NP_001310.3	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
RIKEN	BC017655	IRAK014K24	MGC	W01A016F15	pENTR-TOPO	10278		CANT1	124583	AAH17655.1	Hs.8859	Calcium activated nucleotidase 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001159772.1	NP_001153244.1	VALIDATED	C	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC007871	IRAL020O16	MGC	W01A016F19	pENTR-TOPO	2737		RBM17	84991	AAH07871.1	Hs.498548	RNA binding motif protein 17			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001145547.1	NP_001139019.1	REVIEWED	OK	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC007871	IRAL020O16	MGC	W01A016F21	pENTR-TOPO	2737		RBM17	84991	AAH07871.1	Hs.498548	RNA binding motif protein 17			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001145547.1	NP_001139019.1	REVIEWED	OK	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC007871	IRAL020O16	MGC	W01A016F23	pENTR-TOPO	2737		RBM17	84991	AAH07871.1	Hs.498548	RNA binding motif protein 17			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001145547.1	NP_001139019.1	REVIEWED	OK	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	BC001662	IRAL003D19	MGC	W01A016G01	pENTR-TOPO	16534		MAPKAPK3	7867	AAH01662.1	Hs.234521	Mitogen-activated protein kinase-activated protein kinase 3			Colon, adenocarcinoma	NIH_MGC_15		NM_004635.3	NP_004626.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC001662	IRAL003D19	MGC	W01A016G03	pENTR-TOPO	16534		MAPKAPK3	7867	AAH01662.1	Hs.234521	Mitogen-activated protein kinase-activated protein kinase 3			Colon, adenocarcinoma	NIH_MGC_15		NM_004635.3	NP_004626.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC001662	IRAL003D19	MGC	W01A016G05	pENTR-TOPO	16534		MAPKAPK3	7867	AAH01662.1	Hs.234521	Mitogen-activated protein kinase-activated protein kinase 3			Colon, adenocarcinoma	NIH_MGC_15		NM_004635.3	NP_004626.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC001662	IRAL003D19	MGC	W01A016G07	pENTR-TOPO	16534		MAPKAPK3	7867	AAH01662.1	Hs.234521	Mitogen-activated protein kinase-activated protein kinase 3			Colon, adenocarcinoma	NIH_MGC_15		NM_004635.3	NP_004626.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC000259	IRAL006G14	MGC	W01A016G12	pENTR-TOPO	18672		FAM53C	51307	AAH00259.1	Hs.716415	Family with sequence similarity 53, member C			Eye, retinoblastoma	NIH_MGC_16		NM_001135647.1	NP_001129119.1	VALIDATED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC000259	IRAL006G14	MGC	W01A016G16	pENTR-TOPO	18672		FAM53C	51307	AAH00259.1	Hs.716415	Family with sequence similarity 53, member C			Eye, retinoblastoma	NIH_MGC_16		NM_001135647.1	NP_001129119.1	VALIDATED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC006576	IRAL011H20	MGC	W01A016G18	pENTR-TOPO	14049		ILKAP	80895	AAH06576.1	Hs.92033	Integrin-linked kinase-associated serine/threonine phosphatase 2C			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_030768.2	NP_110395.1	REVIEWED	OK	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC049196	IRAK093K19	MGC	W01A016H06	pENTR-TOPO	314		CEPT1	10390	AAH49196.1	Hs.363572	Choline/ethanolamine phosphotransferase 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001007794.1	NP_001007795.1	REVIEWED	C	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC017876	IRAL036P23	MGC	W01A016H10	pENTR-TOPO	24014		ALG2	85365	AAH17876.1	Hs.40919	Asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_033087.3	NP_149078.1	REVIEWED	C	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC008492	IRAL021O12	MGC	W01A016H11	pENTR-TOPO	15803		RPL3	6122	AAH08492.1	Hs.119598	Ribosomal protein L3			Prostate	NIH_MGC_83	DH10B	NM_000967.3	NP_000958.1	REVIEWED	Cs	0.995	0.995	403	1212	1	1209	403	1	403
RIKEN	BC008492	IRAL021O12	MGC	W01A016H13	pENTR-TOPO	15803		RPL3	6122	AAH08492.1	Hs.119598	Ribosomal protein L3			Prostate	NIH_MGC_83	DH10B	NM_000967.3	NP_000958.1	REVIEWED	Cs	0.995	0.995	403	1212	1	1209	403	1	403
RIKEN	BC017876	IRAL036P23	MGC	W01A016H14	pENTR-TOPO	24014		ALG2	85365	AAH17876.1	Hs.40919	Asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_033087.3	NP_149078.1	REVIEWED	C	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC017876	IRAL036P23	MGC	W01A016H16	pENTR-TOPO	24014		ALG2	85365	AAH17876.1	Hs.40919	Asparagine-linked glycosylation 2, alpha-1,3-mannosyltransferase homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_033087.3	NP_149078.1	REVIEWED	C	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC038843	IRAK082I21	MGC	W01A016H18	pENTR-TOPO	20810		PGK2	5232	AAH38843.1	Hs.367727	Phosphoglycerate kinase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138733.3	NP_620061.2	PROVISIONAL	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC011631	IRAL015L10	MGC	W01A016I03	pENTR-TOPO	16539		CCBP2	1238	AAH11631.1	Hs.146346	Chemokine binding protein 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_001296.4	NP_001287.2	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC008725	IRAL005E11	MGC	W01A016I04	pENTR-TOPO	10512		VAT1	10493	AAH08725.2	Hs.514199	Vesicle amine transport protein 1 homolog (T. californica)			Brain, neuroblastoma	NIH_MGC_19		NM_006373.3	NP_006364.2	VALIDATED	C	1.000	1.000	393	1182	1	1179	393	1	393
RIKEN	BC008725	IRAL005E11	MGC	W01A016I06	pENTR-TOPO	10512		VAT1	10493	AAH08725.2	Hs.514199	Vesicle amine transport protein 1 homolog (T. californica)			Brain, neuroblastoma	NIH_MGC_19		NM_006373.3	NP_006364.2	VALIDATED	C	1.000	1.000	393	1182	1	1179	393	1	393
RIKEN	BC011631	IRAL015L10	MGC	W01A016I07	pENTR-TOPO	16539		CCBP2	1238	AAH11631.1	Hs.146346	Chemokine binding protein 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_001296.4	NP_001287.2	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC012055	IRAL029J22	MGC	W01A016I11	pENTR-TOPO	10334		AIPL1	23746	AAH12055.1	Hs.279887	Aryl hydrocarbon receptor interacting protein-like 1			Eye, retinoblastoma	NIH_MGC_16		NM_014336.3	NP_055151.3	REVIEWED	C	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC012055	IRAL029J22	MGC	W01A016I13	pENTR-TOPO	10334		AIPL1	23746	AAH12055.1	Hs.279887	Aryl hydrocarbon receptor interacting protein-like 1			Eye, retinoblastoma	NIH_MGC_16		NM_014336.3	NP_055151.3	REVIEWED	C	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC007561	IRAL022D06	MGC	W01A016I14	pENTR-TOPO	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_006191.2	NP_006182.2	REVIEWED	OK	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC012055	IRAL029J22	MGC	W01A016I15	pENTR-TOPO	10334		AIPL1	23746	AAH12055.1	Hs.279887	Aryl hydrocarbon receptor interacting protein-like 1			Eye, retinoblastoma	NIH_MGC_16		NM_014336.3	NP_055151.3	REVIEWED	C	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC001951	IRAL009O10	MGC	W01A016I18	pENTR-TOPO	5569		PA2G4	5036	AAH01951.1	Hs.715674	Proliferation-associated 2G4, 38kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_006191.2	NP_006182.2	REVIEWED	OK	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC001951	IRAL009O10	MGC	W01A016I20	pENTR-TOPO	5569		PA2G4	5036	AAH01951.1	Hs.715674	Proliferation-associated 2G4, 38kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_006191.2	NP_006182.2	REVIEWED	OK	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC067090	IRAL050M03	MGC	W01A016J01	pENTR-TOPO	12913		PEX13	5194	AAH67090.1	Hs.161377	Peroxisomal biogenesis factor 13			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_002618.3	NP_002609.1	REVIEWED	OK	1.000	1.000	403	1212	1	1209	403	1	403
RIKEN	BC015542	IRAK014O20	MGC	W01A016J02	pENTR-TOPO	11793		PVR	5817	AAH15542.1	Hs.171844	Poliovirus receptor			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006505.3	NP_006496.3	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
RIKEN	BC067090	IRAL050M03	MGC	W01A016J03	pENTR-TOPO	12913		PEX13	5194	AAH67090.1	Hs.161377	Peroxisomal biogenesis factor 13			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_002618.3	NP_002609.1	REVIEWED	OK	1.000	1.000	403	1212	1	1209	403	1	403
RIKEN	BC037958	IRAK079O12	MGC	W01A016J10	pENTR-TOPO	4913		GIF	2694	AAH37958.1	Hs.110014	Gastric intrinsic factor (vitamin B synthesis)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005142.2	NP_005133.2	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC037958	IRAK079O12	MGC	W01A016J12	pENTR-TOPO	4913		GIF	2694	AAH37958.1	Hs.110014	Gastric intrinsic factor (vitamin B synthesis)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005142.2	NP_005133.2	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC018951	IRAL026M07	MGC	W01A016J15	pENTR-TOPO	14193		RBMS1	5937	AAH18951.1	Hs.470412	RNA binding motif, single stranded interacting protein 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016836.3	NP_058520.1	REVIEWED	C	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	BC009251	IRAL010P11	MGC	W01A016J24	pENTR-TOPO	22688		FDFT1	2222	AAH09251.1	Hs.593928	Farnesyl-diphosphate farnesyltransferase 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004462.3	NP_004453.3	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
RIKEN	BC014595	IRAK033C13	MGC	W01A016K03	pENTR-TOPO	12226		CALR3	125972	AAH14595.1	Hs.304020	Calreticulin 3			Testis	NIH_MGC_97	DH10B	NM_145046.3	NP_659483.2	VALIDATED	Cs	0.997	0.997	384	1155	1	1152	384	1	384
RIKEN	BC038711	IRAK048K08	MGC	W01A016K04	pENTR-TOPO	23614		UGCG	7357	AAH38711.1	Hs.593014	UDP-glucose ceramide glucosyltransferase			Testis	NIH_MGC_97	DH10B	NM_003358.1	NP_003349.1	REVIEWED	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC007212	IRAL022M07	MGC	W01A016K14	pENTR-TOPO	17035		ZNF385D	79750	AAH07212.1	Hs.21026	Zinc finger protein 385D			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_024697.1	NP_078973.1	PROVISIONAL	C	1.000	1.000	395	1188	1	1185	395	1	395
RIKEN	BC030594	IRAK033E21	MGC	W01A016K17	pENTR-TOPO	11		CD46	4179	AAH30594.1	Hs.510402	CD46 molecule, complement regulatory protein			Testis	NIH_MGC_97	DH10B	NM_153826.2	NP_722548.1	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC020614	IRAL035K17	MGC	W01A016K18	pENTR-TOPO	5973		GPR84	53831	AAH20614.1	Hs.306199	G protein-coupled receptor 84			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020370.1	NP_065103.1	PROVISIONAL	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	BC020614	IRAL035K17	MGC	W01A016K20	pENTR-TOPO	5973		GPR84	53831	AAH20614.1	Hs.306199	G protein-coupled receptor 84			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020370.1	NP_065103.1	PROVISIONAL	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	BC030594	IRAK033E21	MGC	W01A016K23	pENTR-TOPO	11		CD46	4179	AAH30594.1	Hs.510402	CD46 molecule, complement regulatory protein			Testis	NIH_MGC_97	DH10B	NM_153826.2	NP_722548.1	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC020614	IRAL035K17	MGC	W01A016K24	pENTR-TOPO	5973		GPR84	53831	AAH20614.1	Hs.306199	G protein-coupled receptor 84			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020370.1	NP_065103.1	PROVISIONAL	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	BC015489	IRAK014I15	MGC	W01A016L09	pENTR-TOPO	15808		TMEM184B	25829	AAH15489.2	Hs.716419	Transmembrane protein 184B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_012264.3	NP_036396.2	VALIDATED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC008302	IRAL023N23	MGC	W01A016L10	pENTR-TOPO	12940		STRADB	55437	AAH08302.1	Hs.652338	STE20-related kinase adaptor beta			Placenta, choriocarcinoma	NIH_MGC_21		NM_018571.5	NP_061041.2	REVIEWED	C	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC015489	IRAK014I15	MGC	W01A016L13	pENTR-TOPO	15808		TMEM184B	25829	AAH15489.2	Hs.716419	Transmembrane protein 184B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_012264.3	NP_036396.2	VALIDATED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC008302	IRAL023N23	MGC	W01A016L14	pENTR-TOPO	12940		STRADB	55437	AAH08302.1	Hs.652338	STE20-related kinase adaptor beta			Placenta, choriocarcinoma	NIH_MGC_21		NM_018571.5	NP_061041.2	REVIEWED	C	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC008302	IRAL023N23	MGC	W01A016L16	pENTR-TOPO	12940		STRADB	55437	AAH08302.1	Hs.652338	STE20-related kinase adaptor beta			Placenta, choriocarcinoma	NIH_MGC_21		NM_018571.5	NP_061041.2	REVIEWED	C	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC024268	IRAL042I06	MGC	W01A016M03	pENTR-TOPO	15574		APOBEC3G	60489	AAH24268.1	Hs.660143	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3G			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_021822.2	NP_068594.1	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC001163	IRAL006D20	MGC	W01A016M08	pENTR-TOPO	8607		CX3CL1	6376	AAH01163.1	Hs.531668	Chemokine (C-X3-C motif) ligand 1			Brain, neuroblastoma	NIH_MGC_19		NM_002996.3	NP_002987.1	PROVISIONAL	OK	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC018130	IRAK014H12	MGC	W01A016M10	pENTR-TOPO	18850		F2RL1	2150	AAH18130.1	Hs.154299	Coagulation factor II (thrombin) receptor-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_005242.4	NP_005233.3	VALIDATED	Cs	0.997	0.997	397	1194	1	1191	397	1	397
RIKEN	BC005889	IRAL003I23	MGC	W01A016M11	pENTR-TOPO	18631		PELO	53918	AAH05889.1	Hs.644352	Pelota homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_20		NM_015946.4	NP_057030.3	REVIEWED	Cs	0.997	0.997	385	1158	1	1155	385	1	385
RIKEN	BC018130	IRAK014H12	MGC	W01A016M12	pENTR-TOPO	18850		F2RL1	2150	AAH18130.1	Hs.154299	Coagulation factor II (thrombin) receptor-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_005242.4	NP_005233.3	VALIDATED	Cs	0.997	0.997	397	1194	1	1191	397	1	397
RIKEN	BC051858	IRAK110P10	MGC	W01A016M17	pENTR-TOPO	5416		ADIPOR2	79602	AAH51858.1	Hs.371642	Adiponectin receptor 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024551.2	NP_078827.2	VALIDATED	OK	1.000	1.000	386	1161	1	1158	386	1	386
RIKEN	BC051858	IRAK110P10	MGC	W01A016M21	pENTR-TOPO	5416		ADIPOR2	79602	AAH51858.1	Hs.371642	Adiponectin receptor 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024551.2	NP_078827.2	VALIDATED	OK	1.000	1.000	386	1161	1	1158	386	1	386
RIKEN	BC054510	IRAK110K05	MGC	W01A016M24	pENTR-TOPO	18503		HRH2	3274	AAH54510.1	Hs.716212	Histamine receptor H2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001131055.1	NP_001124527.1	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC000343	IRAL001K09	MGC	W01A016N06	pENTR-TOPO	11508		PSMC4	5704	AAH00343.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Lung, small cell carcinoma	NIH_MGC_7		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC000343	IRAL001K09	MGC	W01A016N08	pENTR-TOPO	11508		PSMC4	5704	AAH00343.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Lung, small cell carcinoma	NIH_MGC_7		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC020818	IRAL036E10	MGC	W01A016N09	pENTR-TOPO	13460		SSB	6741	AAH20818.1	Hs.632535	Sjogren syndrome antigen B (autoantigen La)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_003142.3	NP_003133.1	PROVISIONAL	C	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	BC012779	IRAL025F11	MGC	W01A016N17	pENTR-TOPO	7050		KCNK13	56659	AAH12779.1	Hs.510191	Potassium channel, subfamily K, member 13			Lung, small cell carcinoma	NIH_MGC_7		NM_022054.2	NP_071337.2	REVIEWED	C	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	BC012779	IRAL025F11	MGC	W01A016N23	pENTR-TOPO	7050		KCNK13	56659	AAH12779.1	Hs.510191	Potassium channel, subfamily K, member 13			Lung, small cell carcinoma	NIH_MGC_7		NM_022054.2	NP_071337.2	REVIEWED	C	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	BC052270	IRAL047N23	MGC	W01A016O05	pENTR-TOPO	23000		TNFRSF10D	8793	AAH52270.1	Hs.213467	Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain			Prostate, carcinoma	NIH_MGC_40		NM_003840.3	NP_003831.2	REVIEWED	Cs	0.997	0.997	386	1161	1	1158	386	1	386
RIKEN	BC052270	IRAL047N23	MGC	W01A016O07	pENTR-TOPO	23000		TNFRSF10D	8793	AAH52270.1	Hs.213467	Tumor necrosis factor receptor superfamily, member 10d, decoy with truncated death domain			Prostate, carcinoma	NIH_MGC_40		NM_003840.3	NP_003831.2	REVIEWED	Cs	0.997	0.997	386	1161	1	1158	386	1	386
RIKEN	AK001404	flj0033m22	FLJ	W01A016O08	pENTR-TOPO	7684		CCNB2	9133	BAG50905.1	Hs.194698	Cyclin B2	NT2	teratocarcinoma		NT2RP2	EK1	NM_004701.2	NP_004692.1	REVIEWED	C	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	BC064532	IRAK139E16	MGC	W01A016O11	pENTR-TOPO	14899		SIRPG	55423	AAH64532.1	Hs.590883	Signal-regulatory protein gamma			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_018556.3	NP_061026.2	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC039031	IRAK082H06	MGC	W01A016O16	pENTR-TOPO	13414		IL1R2	7850	AAH39031.1	Hs.25333	Interleukin 1 receptor, type II			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_173343.1	NP_775465.1	REVIEWED	OK	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	BC038851	IRAK082C10	MGC	W01A016O22	pENTR-TOPO	11379		CLEC4M	10332	AAH38851.1	Hs.421437	C-type lectin domain family 4, member M			Brain, adult medulla	NIH_MGC_119	DH10B	NM_014257.4	NP_055072.3	REVIEWED	C	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC035498	IRAL028F21	MGC	W01A016P07	pENTR-TOPO	11970		CCNE1	898	AAH35498.1	Hs.244723	Cyclin E1			Placenta, choriocarcinoma	NIH_MGC_21		NM_001238.1	NP_001229.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC026183	IRAK047K13	MGC	W01A016P09	pENTR-TOPO	25412		TEX28	1527	AAH26183.1	Hs.672606	Testis expressed 28			Testis	NIH_MGC_97	DH10B	NM_001586.1	NP_001577.1	PROVISIONAL	C	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC026183	IRAK047K13	MGC	W01A016P13	pENTR-TOPO	25412		TEX28	1527	AAH26183.1	Hs.672606	Testis expressed 28			Testis	NIH_MGC_97	DH10B	NM_001586.1	NP_001577.1	PROVISIONAL	C	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC026183	IRAK047K13	MGC	W01A016P15	pENTR-TOPO	25412		TEX28	1527	AAH26183.1	Hs.672606	Testis expressed 28			Testis	NIH_MGC_97	DH10B	NM_001586.1	NP_001577.1	PROVISIONAL	C	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC042525	IRAK071K04	MGC	W01A016P17	pENTR-TOPO	7041		BTBD6	90135	AAH42525.1	Hs.7367	BTB (POZ) domain containing 6			Testis	NIH_MGC_97	DH10B	NM_033271.2	NP_150374.2	VALIDATED	Ps	0.998	0.998	410	1233	1	1230	485	76	485
RIKEN	BC039205	IRAK032P19	MGC	W01A017A12	pENTR-TOPO	630		SYT11	23208	AAH39205.1	Hs.32984	Synaptotagmin XI			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152280.3	NP_689493.3	VALIDATED	Cs	0.995	0.995	431	1296	1	1293	431	1	431
RIKEN	BC039205	IRAK032P19	MGC	W01A017A14	pENTR-TOPO	630		SYT11	23208	AAH39205.1	Hs.32984	Synaptotagmin XI			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152280.3	NP_689493.3	VALIDATED	Cs	0.995	0.995	431	1296	1	1293	431	1	431
RIKEN	BC035757	IRAK079O22	MGC	W01A017B01	pENTR-TOPO	14102		SCTR	6344	AAH35757.2	Hs.42091	Secretin receptor			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_002980.2	NP_002971.2	REVIEWED	Cs	0.998	0.998	440	1323	1	1320	440	1	440
RIKEN	BC035757	IRAK079O22	MGC	W01A017B03	pENTR-TOPO	14102		SCTR	6344	AAH35757.2	Hs.42091	Secretin receptor			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_002980.2	NP_002971.2	REVIEWED	Cs	0.998	0.998	440	1323	1	1320	440	1	440
RIKEN	BC035757	IRAK079O22	MGC	W01A017B07	pENTR-TOPO	14102		SCTR	6344	AAH35757.2	Hs.42091	Secretin receptor			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_002980.2	NP_002971.2	REVIEWED	Cs	0.998	0.998	440	1323	1	1320	440	1	440
RIKEN	BC007449	IRAL003P02	MGC	W01A017B08	pENTR-TOPO	17442		METTL14	57721	AAH07449.1	Hs.657806	Methyltransferase like 14			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_020961.2	NP_066012.1	PROVISIONAL	C	1.000	1.000	456	1371	1	1368	456	1	456
RIKEN	BC065375	IRAL050P04	MGC	W01A017B14	pENTR-TOPO	4690		SERGEF	26297	AAH65375.1	Hs.32470	Secretion regulating guanine nucleotide exchange factor			Ovary, teratocarcinoma	NIH_MGC_109		NM_012139.2	NP_036271.1	VALIDATED	OK	1.000	1.000	458	1377	1	1374	458	1	458
RIKEN	BC063839	IRAK141D10	MGC	W01A017B17	pENTR-TOPO	7444		SGPP1	81537	AAH63839.1	Hs.24678	Sphingosine-1-phosphate phosphatase 1				Lupski_dorsal_root_ganglion	DH10B	NM_030791.2	NP_110418.1	PROVISIONAL	OK	1.000	1.000	441	1326	1	1323	441	1	441
RIKEN	BC063839	IRAK141D10	MGC	W01A017B21	pENTR-TOPO	7444		SGPP1	81537	AAH63839.1	Hs.24678	Sphingosine-1-phosphate phosphatase 1				Lupski_dorsal_root_ganglion	DH10B	NM_030791.2	NP_110418.1	PROVISIONAL	OK	1.000	1.000	441	1326	1	1323	441	1	441
RIKEN	BC001786	IRAL008A04	MGC	W01A017B22	pENTR-TOPO	5568		FKBP4	2288	AAH01786.1	Hs.524183	FK506 binding protein 4, 59kDa			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002014.3	NP_002005.1	REVIEWED	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC063839	IRAK141D10	MGC	W01A017B23	pENTR-TOPO	7444		SGPP1	81537	AAH63839.1	Hs.24678	Sphingosine-1-phosphate phosphatase 1				Lupski_dorsal_root_ganglion	DH10B	NM_030791.2	NP_110418.1	PROVISIONAL	OK	1.000	1.000	441	1326	1	1323	441	1	441
RIKEN	BC004291	IRAL013J19	MGC	W01A017C08	pENTR-TOPO	630		SYT11	23208	AAH04291.1	Hs.32984	Synaptotagmin XI			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_152280.3	NP_689493.3	VALIDATED	Cs	0.998	0.998	431	1296	1	1293	431	1	431
RIKEN	BC003160	IRAL009P16	MGC	W01A017C11	pENTR-TOPO	4847		ACP2	53	AAH03160.1	Hs.532492	Acid phosphatase 2, lysosomal			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001610.2	NP_001601.1	REVIEWED	Cs	0.998	0.998	423	1272	1	1269	423	1	423
RIKEN	BC031559	IRAK050I14	MGC	W01A017C17	pENTR-TOPO	10733		KRT20	54474	AAH31559.1	Hs.84905	Keratin 20			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_019010.1	NP_061883.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC001263	IRAK004A12	MGC	W01A017C20	pENTR-TOPO	20507		SGK1	6446	AAH01263.1	Hs.510078	Serum/glucocorticoid regulated kinase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005627.3	NP_005618.2	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC031559	IRAK050I14	MGC	W01A017C21	pENTR-TOPO	10733		KRT20	54474	AAH31559.1	Hs.84905	Keratin 20			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_019010.1	NP_061883.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC001263	IRAK004A12	MGC	W01A017C22	pENTR-TOPO	20507		SGK1	6446	AAH01263.1	Hs.510078	Serum/glucocorticoid regulated kinase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005627.3	NP_005618.2	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC010456	IRAK012K22	MGC	W01A017D01	pENTR-TOPO	4424		EFEMP2	30008	AAH10456.1	Hs.170622	EGF-containing fibulin-like extracellular matrix protein 2			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_016938.3	NP_058634.3	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC014950	IRAL034I18	MGC	W01A017D04	pENTR-TOPO	23601		CA9	768	AAH14950.1	Hs.63287	Carbonic anhydrase IX			Colon, adenocarcinoma	NIH_MGC_15		NM_001216.2	NP_001207.2	REVIEWED	Cs	0.998	0.998	459	1380	1	1377	459	1	459
RIKEN	BC010456	IRAK012K22	MGC	W01A017D07	pENTR-TOPO	4424		EFEMP2	30008	AAH10456.1	Hs.170622	EGF-containing fibulin-like extracellular matrix protein 2			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_016938.3	NP_058634.3	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	AK095417	flj0041k08	FLJ	W01A017D09	pENTR-TOPO	22586		TM7SF4	81501	BAG53050.1	Hs.652230	Transmembrane 7 superfamily member 4				D3OST1	EK1	NM_030788.2	NP_110415.1	REVIEWED	Ps	0.998	0.998	444	1335	1	1332	470	27	470
RIKEN	AK095417	flj0041k08	FLJ	W01A017D13	pENTR-TOPO	22586		TM7SF4	81501	BAG53050.1	Hs.652230	Transmembrane 7 superfamily member 4				D3OST1	EK1	NM_030788.2	NP_110415.1	REVIEWED	Ps	0.998	0.998	444	1335	1	1332	470	27	470
RIKEN	AK095417	flj0041k08	FLJ	W01A017D15	pENTR-TOPO	22586		TM7SF4	81501	BAG53050.1	Hs.652230	Transmembrane 7 superfamily member 4				D3OST1	EK1	NM_030788.2	NP_110415.1	REVIEWED	Ps	0.998	0.998	444	1335	1	1332	470	27	470
RIKEN	BC017349	IRAL039L13	MGC	W01A017D16	pENTR-TOPO	4535		ZNF259	8882	AAH17349.1	Hs.7165	Zinc finger protein 259			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_003904.3	NP_003895.1	PROVISIONAL	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC010307	IRAK003N18	MGC	W01A017E01	pENTR-TOPO	16370		SLC35A5	55032	AAH10307.1	Hs.237480	Solute carrier family 35, member A5			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017945.2	NP_060415.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC001011	IRAL001P16	MGC	W01A017E02	pENTR-TOPO	14778		CSTF1	1477	AAH01011.1	Hs.172865	Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001033521.1	NP_001028693.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC010307	IRAK003N18	MGC	W01A017E03	pENTR-TOPO	16370		SLC35A5	55032	AAH10307.1	Hs.237480	Solute carrier family 35, member A5			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017945.2	NP_060415.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC001011	IRAL001P16	MGC	W01A017E04	pENTR-TOPO	14778		CSTF1	1477	AAH01011.1	Hs.172865	Cleavage stimulation factor, 3' pre-RNA, subunit 1, 50kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001033521.1	NP_001028693.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC010307	IRAK003N18	MGC	W01A017E05	pENTR-TOPO	16370		SLC35A5	55032	AAH10307.1	Hs.237480	Solute carrier family 35, member A5			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017945.2	NP_060415.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC032539	IRAK069I21	MGC	W01A017E09	pENTR-TOPO	19442		MAPK9	5601	AAH32539.1	Hs.484371	Mitogen-activated protein kinase 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002752.4	NP_002743.3	REVIEWED	OK	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC041765	IRAK020F19	MGC	W01A017E12	pENTR-TOPO	10450		GFAP	2670	AAH41765.1	Hs.514227	Glial fibrillary acidic protein			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_002055.3	NP_002046.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC032539	IRAK069I21	MGC	W01A017E15	pENTR-TOPO	19442		MAPK9	5601	AAH32539.1	Hs.484371	Mitogen-activated protein kinase 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002752.4	NP_002743.3	REVIEWED	OK	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC004273	IRAL013J03	MGC	W01A017E17	pENTR-TOPO	2008		SF3B4	10262	AAH04273.1	Hs.516160	Splicing factor 3b, subunit 4, 49kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_005850.3	NP_005841.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC004273	IRAL013J03	MGC	W01A017E23	pENTR-TOPO	2008		SF3B4	10262	AAH04273.1	Hs.516160	Splicing factor 3b, subunit 4, 49kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_005850.3	NP_005841.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC007740	IRAL017H03	MGC	W01A017F04	pENTR-TOPO	4667		CHRM1	1128	AAH07740.1	Hs.632119	Cholinergic receptor, muscarinic 1			Brain, neuroblastoma	NIH_MGC_19		NM_000738.2	NP_000729.2	REVIEWED	OK	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	BC007740	IRAL017H03	MGC	W01A017F08	pENTR-TOPO	4667		CHRM1	1128	AAH07740.1	Hs.632119	Cholinergic receptor, muscarinic 1			Brain, neuroblastoma	NIH_MGC_19		NM_000738.2	NP_000729.2	REVIEWED	OK	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	BC025751	IRAK049B21	MGC	W01A017F09	pENTR-TOPO	14607		CDS2	8760	AAH25751.1	Hs.719252	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_003818.2	NP_003809.1	REVIEWED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC026323	IRAK032L12	MGC	W01A017F14	pENTR-TOPO	19226		DCTN4	51164	AAH26323.1	Hs.675564	Dynactin 4 (p62)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016221.3	NP_057305.1	VALIDATED	Cs	0.998	0.998	460	1383	1	1380	460	1	460
RIKEN	BC025751	IRAK049B21	MGC	W01A017F15	pENTR-TOPO	14607		CDS2	8760	AAH25751.1	Hs.719252	CDP-diacylglycerol synthase (phosphatidate cytidylyltransferase) 2			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_003818.2	NP_003809.1	REVIEWED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC052977	IRAK110N02	MGC	W01A017F18	pENTR-TOPO	837		TNFRSF1B	7133	AAH52977.1	Hs.256278	Tumor necrosis factor receptor superfamily, member 1B				Lupski_sympathetic_trunk	DH10B	NM_001066.2	NP_001057.1	REVIEWED	C	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	BC052977	IRAK110N02	MGC	W01A017F24	pENTR-TOPO	837		TNFRSF1B	7133	AAH52977.1	Hs.256278	Tumor necrosis factor receptor superfamily, member 1B				Lupski_sympathetic_trunk	DH10B	NM_001066.2	NP_001057.1	REVIEWED	C	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	BC024288	IRAL042I14	MGC	W01A017G14	pENTR-TOPO	20404		SLC35B2	347734	AAH24288.1	Hs.182885	Solute carrier family 35, member B2			Brain, neuroblastoma	NIH_MGC_19		NM_178148.2	NP_835361.1	VALIDATED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC031095	IRAK048G14	MGC	W01A017H04	pENTR-TOPO	8543		ALG1	56052	AAH31095.1	Hs.592086	Asparagine-linked glycosylation 1, beta-1,4-mannosyltransferase homolog (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019109.4	NP_061982.3	REVIEWED	Cs	0.996	0.996	464	1395	1	1392	464	1	464
RIKEN	BC004434	IRAL009M21	MGC	W01A017H10	pENTR-TOPO	11920		SF3A2	8175	AAH04434.1	Hs.115232	Splicing factor 3a, subunit 2, 66kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_007165.4	NP_009096.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
RIKEN	BC008747	IRAL005K04	MGC	W01A017H13	pENTR-TOPO	9641		STARD3	10948	AAH08747.1	Hs.77628	StAR-related lipid transfer (START) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_006804.2	NP_006795.2	PROVISIONAL	Cs	0.996	0.996	445	1338	1	1335	445	1	445
RIKEN	BC031589	IRAK050F12	MGC	W01A017I12	pENTR-TOPO	5902		RASSF9	9182	AAH31589.1	Hs.527881	Ras association (RalGDS/AF-6) domain family (N-terminal) member 9			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005447.3	NP_005438.2	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC031589	IRAK050F12	MGC	W01A017I16	pENTR-TOPO	5902		RASSF9	9182	AAH31589.1	Hs.527881	Ras association (RalGDS/AF-6) domain family (N-terminal) member 9			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005447.3	NP_005438.2	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC029451	IRAL041P03	MGC	W01A017I21	pENTR-TOPO	1530		RBM34	23029	AAH29451.1	Hs.535224	RNA binding motif protein 34			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_015014.2	NP_055829.2	VALIDATED	P	1.000	1.000	425	1278	1	1275	430	6	430
RIKEN	BC002440	IRAL005I22	MGC	W01A017J01	pENTR-TOPO	11445		GRWD1	83743	AAH02440.1	Hs.400625	Glutamate-rich WD repeat containing 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_031485.3	NP_113673.3	VALIDATED	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC019582	IRAK029A11	MGC	W01A017J02	pENTR-TOPO	16404		TSEN2	80746	AAH19582.1	Hs.335550	TRNA splicing endonuclease 2 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001145392.1	NP_001138864.1	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC002440	IRAL005I22	MGC	W01A017J03	pENTR-TOPO	11445		GRWD1	83743	AAH02440.1	Hs.400625	Glutamate-rich WD repeat containing 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_031485.3	NP_113673.3	VALIDATED	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC019582	IRAK029A11	MGC	W01A017J04	pENTR-TOPO	16404		TSEN2	80746	AAH19582.1	Hs.335550	TRNA splicing endonuclease 2 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001145392.1	NP_001138864.1	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC019582	IRAK029A11	MGC	W01A017J06	pENTR-TOPO	16404		TSEN2	80746	AAH19582.1	Hs.335550	TRNA splicing endonuclease 2 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001145392.1	NP_001138864.1	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC019582	IRAK029A11	MGC	W01A017J08	pENTR-TOPO	16404		TSEN2	80746	AAH19582.1	Hs.335550	TRNA splicing endonuclease 2 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001145392.1	NP_001138864.1	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC004362	IRAL006J11	MGC	W01A017J09	pENTR-TOPO	10237		INPP5K	51763	AAH04362.1	Hs.632238	Inositol polyphosphate-5-phosphatase K			Eye, retinoblastoma	NIH_MGC_16		NM_016532.3	NP_057616.2	REVIEWED	OK	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC012085	IRAL029D22	MGC	W01A017J10	pENTR-TOPO	20448		STK38	11329	AAH12085.1	Hs.409578	Serine/threonine kinase 38			Uterus, leiomyosarcoma	NIH_MGC_46		NM_007271.2	NP_009202.1	PROVISIONAL	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC004362	IRAL006J11	MGC	W01A017J13	pENTR-TOPO	10237		INPP5K	51763	AAH04362.1	Hs.632238	Inositol polyphosphate-5-phosphatase K			Eye, retinoblastoma	NIH_MGC_16		NM_016532.3	NP_057616.2	REVIEWED	OK	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC012085	IRAL029D22	MGC	W01A017J14	pENTR-TOPO	20448		STK38	11329	AAH12085.1	Hs.409578	Serine/threonine kinase 38			Uterus, leiomyosarcoma	NIH_MGC_46		NM_007271.2	NP_009202.1	PROVISIONAL	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC004362	IRAL006J11	MGC	W01A017J15	pENTR-TOPO	10237		INPP5K	51763	AAH04362.1	Hs.632238	Inositol polyphosphate-5-phosphatase K			Eye, retinoblastoma	NIH_MGC_16		NM_016532.3	NP_057616.2	REVIEWED	OK	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC000163	IRAK003F09	MGC	W01A017J18	pENTR-TOPO	2720		VIM	7431	AAH00163.2	Hs.708825	Vimentin			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003380.2	NP_003371.2	VALIDATED	C	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	BC006365	IRAL017I14	MGC	W01A017J19	pENTR-TOPO	488		PSEN2	5664	AAH06365.1	Hs.25363	Presenilin 2 (Alzheimer disease 4)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000447.2	NP_000438.2	REVIEWED	C	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC000163	IRAK003F09	MGC	W01A017J20	pENTR-TOPO	2720		VIM	7431	AAH00163.2	Hs.708825	Vimentin			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003380.2	NP_003371.2	VALIDATED	C	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	BC006365	IRAL017I14	MGC	W01A017J21	pENTR-TOPO	488		PSEN2	5664	AAH06365.1	Hs.25363	Presenilin 2 (Alzheimer disease 4)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000447.2	NP_000438.2	REVIEWED	C	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC000446	IRAL001F01	MGC	W01A017K01	pENTR-TOPO	4076		CLP1	10978	AAH00446.1	Hs.523687	CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_006831.2	NP_006822.1	VALIDATED	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC009249	IRAL010J12	MGC	W01A017K02	pENTR-TOPO	12294		KPTN	11133	AAH09249.1	Hs.25441	Kaptin (actin binding protein)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007059.2	NP_008990.2	VALIDATED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	BC000446	IRAL001F01	MGC	W01A017K03	pENTR-TOPO	4076		CLP1	10978	AAH00446.1	Hs.523687	CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_006831.2	NP_006822.1	VALIDATED	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC000446	IRAL001F01	MGC	W01A017K05	pENTR-TOPO	4076		CLP1	10978	AAH00446.1	Hs.523687	CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_006831.2	NP_006822.1	VALIDATED	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC009249	IRAL010J12	MGC	W01A017K06	pENTR-TOPO	12294		KPTN	11133	AAH09249.1	Hs.25441	Kaptin (actin binding protein)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007059.2	NP_008990.2	VALIDATED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	BC000446	IRAL001F01	MGC	W01A017K07	pENTR-TOPO	4076		CLP1	10978	AAH00446.1	Hs.523687	CLP1, cleavage and polyadenylation factor I subunit, homolog (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_006831.2	NP_006822.1	VALIDATED	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC036422	IRAK070G19	MGC	W01A017K20	pENTR-TOPO	18816		MGC42105	167359	AAH36422.1	Hs.25845	Serine/threonine-protein kinase NIM1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153361.2	NP_699192.1	PROVISIONAL	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	BC044573	IRAK106K11	MGC	W01A017L02	pENTR-TOPO	1693		ERO1LB	56605	AAH44573.1	Hs.558519	ERO1-like beta (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_019891.2	NP_063944.2	PROVISIONAL	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC044573	IRAK106K11	MGC	W01A017L04	pENTR-TOPO	1693		ERO1LB	56605	AAH44573.1	Hs.558519	ERO1-like beta (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_019891.2	NP_063944.2	PROVISIONAL	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC044573	IRAK106K11	MGC	W01A017L06	pENTR-TOPO	1693		ERO1LB	56605	AAH44573.1	Hs.558519	ERO1-like beta (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_019891.2	NP_063944.2	PROVISIONAL	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC000619	IRAL005M02	MGC	W01A017L07	pENTR-TOPO	9975		TUBG1	7283	AAH00619.1	Hs.279669	Tubulin, gamma 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001070.4	NP_001061.2	REVIEWED	OK	1.000	1.000	451	1356	1	1353	451	1	451
RIKEN	BC032823	IRAK034G07	MGC	W01A017L12	pENTR-TOPO	1693		ERO1LB	56605	AAH32823.2	Hs.558519	ERO1-like beta (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_019891.2	NP_063944.2	PROVISIONAL	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC001554	IRAK004A06	MGC	W01A017L23	pENTR-TOPO	3689		ILK	3611	AAH01554.1	Hs.706355	Integrin-linked kinase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_004517.2	NP_004508.1	REVIEWED	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC036543	IRAK073N15	MGC	W01A017M05	pENTR-TOPO	13986		NMUR1	10316	AAH36543.1	Hs.471619	Neuromedin U receptor 1			Testis	NIH_MGC_97	DH10B	NM_006056.4	NP_006047.3	VALIDATED	Cs	0.998	0.998	426	1281	1	1278	426	1	426
RIKEN	BC001315	IRAK004B09	MGC	W01A017M08	pENTR-TOPO	11730		SNRNP70	6625	AAH01315.1	Hs.467097	Small nuclear ribonucleoprotein 70kDa (U1)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003089.4	NP_003080.2	VALIDATED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC029167	IRAK050D12	MGC	W01A017M12	pENTR-TOPO	11579		CD177	57126	AAH29167.1	Hs.232165	CD177 molecule			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020406.2	NP_065139.2	VALIDATED	Cs	0.989	0.989	437	1314	1	1311	437	1	437
RIKEN	BC029167	IRAK050D12	MGC	W01A017M14	pENTR-TOPO	11579		CD177	57126	AAH29167.1	Hs.232165	CD177 molecule			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020406.2	NP_065139.2	VALIDATED	Cs	0.989	0.989	437	1314	1	1311	437	1	437
RIKEN	BC029167	IRAK050D12	MGC	W01A017M16	pENTR-TOPO	11579		CD177	57126	AAH29167.1	Hs.232165	CD177 molecule			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020406.2	NP_065139.2	VALIDATED	Cs	0.989	0.989	437	1314	1	1311	437	1	437
RIKEN	BC007858	IRAL020M08	MGC	W01A017M19	pENTR-TOPO	21921		INHBA	3624	AAH07858.1	Hs.583348	Inhibin, beta A			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_002192.2	NP_002183.1	REVIEWED	C	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC007858	IRAL020M08	MGC	W01A017M21	pENTR-TOPO	21921		INHBA	3624	AAH07858.1	Hs.583348	Inhibin, beta A			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_002192.2	NP_002183.1	REVIEWED	C	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC031012	IRAL041H24	MGC	W01A017M22	pENTR-TOPO	4732		EEF1G	1937	AAH31012.1	Hs.144835	Eukaryotic translation elongation factor 1 gamma			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001404.4	NP_001395.1	REVIEWED	OK	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC033639	IRAK069G12	MGC	W01A017N02	pENTR-TOPO	7804		CHRNA5	1138	AAH33639.1	Hs.719767	Cholinergic receptor, nicotinic, alpha 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000745.2	NP_000736.2	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC033801	IRAK068J21	MGC	W01A017N03	pENTR-TOPO	267		GABRD	2563	AAH33801.1	Hs.113882	Gamma-aminobutyric acid (GABA) A receptor, delta			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000815.4	NP_000806.2	REVIEWED	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC033801	IRAK068J21	MGC	W01A017N05	pENTR-TOPO	267		GABRD	2563	AAH33801.1	Hs.113882	Gamma-aminobutyric acid (GABA) A receptor, delta			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000815.4	NP_000806.2	REVIEWED	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC033801	IRAK068J21	MGC	W01A017N07	pENTR-TOPO	267		GABRD	2563	AAH33801.1	Hs.113882	Gamma-aminobutyric acid (GABA) A receptor, delta			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000815.4	NP_000806.2	REVIEWED	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC014539	IRAL019L10	MGC	W01A017N12	pENTR-TOPO	7761		SCG3	29106	AAH14539.1	Hs.232618	Secretogranin III			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_013243.2	NP_037375.2	REVIEWED	Cs	0.998	0.998	468	1407	1	1404	468	1	468
RIKEN	BC014539	IRAL019L10	MGC	W01A017N14	pENTR-TOPO	7761		SCG3	29106	AAH14539.1	Hs.232618	Secretogranin III			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_013243.2	NP_037375.2	REVIEWED	Cs	0.998	0.998	468	1407	1	1404	468	1	468
RIKEN	BC007830	IRAL020A18	MGC	W01A017N22	pENTR-TOPO	15569		SAMM50	25813	AAH07830.1	Hs.505824	Sorting and assembly machinery component 50 homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_015380.4	NP_056195.3	VALIDATED	Cgs	0.996	0.998	469	1407	1	1404	469	1	469
RIKEN	BC010569	IRAK012I01	MGC	W01A017O02	pENTR-TOPO	22105		VIPR2	7434	AAH10569.1	Hs.585052	Vasoactive intestinal peptide receptor 2				NCI_CGAP_Brn67	DH10B	NM_003382.4	NP_003373.2	VALIDATED	C	1.000	1.000	438	1317	1	1314	438	1	438
RIKEN	BC015337	IRAK027O05	MGC	W01A017O05	pENTR-TOPO	12238		KCNN4	3783	AAH15337.1	Hs.10082	Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 4			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_002250.2	NP_002241.1	REVIEWED	C	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	BC002839	IRAL012L12	MGC	W01A017O14	pENTR-TOPO	17177		ALG3	10195	AAH02839.1	Hs.478481	Asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_005787.5	NP_005778.1	REVIEWED	OK	1.000	1.000	438	1317	1	1314	438	1	438
RIKEN	BC002839	IRAL012L12	MGC	W01A017O16	pENTR-TOPO	17177		ALG3	10195	AAH02839.1	Hs.478481	Asparagine-linked glycosylation 3, alpha-1,3- mannosyltransferase homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_005787.5	NP_005778.1	REVIEWED	OK	1.000	1.000	438	1317	1	1314	438	1	438
RIKEN	BC048969	IRAK106P20	MGC	W01A017O18	pENTR-TOPO	20458		TSPYL1	7259	AAH48969.1	Hs.458358	TSPY-like 1			Testis	NIH_MGC_97	DH10B	NM_003309.2	NP_003300.1	VALIDATED	Cg	0.998	1.000	438	1317	1	1314	437	1	437
RIKEN	BC001391	IRAL004M05	MGC	W01A017O19	pENTR-TOPO	16091		ACTL6A	86	AAH01391.1	Hs.435326	Actin-like 6A			Skin, melanotic melanoma.	NIH_MGC_20		NM_004301.3	NP_004292.1	REVIEWED	C	1.000	1.000	429	1290	1	1287	429	1	429
RIKEN	BC048969	IRAK106P20	MGC	W01A017O20	pENTR-TOPO	20458		TSPYL1	7259	AAH48969.1	Hs.458358	TSPY-like 1			Testis	NIH_MGC_97	DH10B	NM_003309.2	NP_003300.1	VALIDATED	Cg	0.998	1.000	438	1317	1	1314	437	1	437
RIKEN	BC003187	IRAL008J19	MGC	W01A017P15	pENTR-TOPO	387		GPR89A	653519	AAH03187.1	Hs.645432	G protein-coupled receptor 89A			Lung, small cell carcinoma	NIH_MGC_7		NM_001097612.1	NP_001091081.1	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
RIKEN	BC001502	IRAL003L03	MGC	W01A017P19	pENTR-TOPO	18256		MFSD10	10227	AAH01502.1	Hs.632581	Major facilitator superfamily domain containing 10			Colon, adenocarcinoma	NIH_MGC_15		NM_001146069.1	NP_001139541.1	REVIEWED	C	1.000	1.000	455	1368	1	1365	455	1	455
RIKEN	BC003091	IRAL006F16	MGC	W01A018A12	pENTR-TOPO	11535		PVRL2	5819	AAH03091.1	Hs.655455	Poliovirus receptor-related 2 (herpesvirus entry mediator B)			Brain, neuroblastoma	NIH_MGC_19		NM_002856.2	NP_002847.1	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	BC000459	IRAL001H09	MGC	W01A018A15	pENTR-TOPO	22128		POLD2	5425	AAH00459.1	Hs.306791	Polymerase (DNA directed), delta 2, regulatory subunit 50kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_001127218.1	NP_001120690.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
RIKEN	BC013304	IRAL010O11	MGC	W01A018A18	pENTR-TOPO	610		SESN2	83667	AAH13304.1	Hs.469543	Sestrin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031459.3	NP_113647.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC009750	IRAL014I21	MGC	W01A018A19	pENTR-TOPO	15025		C20orf54	113278	AAH09750.2	Hs.283865	Chromosome 20 open reading frame 54			Pancreas, adenocarcinoma	NIH_MGC_39		NM_033409.3	NP_212134.3	VALIDATED	Cs	0.994	0.994	469	1410	1	1407	469	1	469
RIKEN	BC013304	IRAL010O11	MGC	W01A018A20	pENTR-TOPO	610		SESN2	83667	AAH13304.1	Hs.469543	Sestrin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031459.3	NP_113647.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC009750	IRAL014I21	MGC	W01A018A21	pENTR-TOPO	15025		C20orf54	113278	AAH09750.2	Hs.283865	Chromosome 20 open reading frame 54			Pancreas, adenocarcinoma	NIH_MGC_39		NM_033409.3	NP_212134.3	VALIDATED	Cs	0.994	0.994	469	1410	1	1407	469	1	469
RIKEN	BC014018	IRAL028J13	MGC	W01A018B01	pENTR-TOPO	8225		LARP6	55323	AAH14018.1	Hs.416755	La ribonucleoprotein domain family, member 6			Brain, neuroblastoma	NIH_MGC_19		NM_018357.2	NP_060827.2	VALIDATED	C	1.000	1.000	491	1476	1	1473	491	1	491
RIKEN	BC011371	IRAK013O09	MGC	W01A018B02	pENTR-TOPO	9632		CHRNB1	1140	AAH11371.1	Hs.330386	Cholinergic receptor, nicotinic, beta 1 (muscle)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000747.2	NP_000738.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC014018	IRAL028J13	MGC	W01A018B05	pENTR-TOPO	8225		LARP6	55323	AAH14018.1	Hs.416755	La ribonucleoprotein domain family, member 6			Brain, neuroblastoma	NIH_MGC_19		NM_018357.2	NP_060827.2	VALIDATED	C	1.000	1.000	491	1476	1	1473	491	1	491
RIKEN	BC011371	IRAK013O09	MGC	W01A018B06	pENTR-TOPO	9632		CHRNB1	1140	AAH11371.1	Hs.330386	Cholinergic receptor, nicotinic, beta 1 (muscle)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000747.2	NP_000738.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC006082	IRAL018B21	MGC	W01A018B09	pENTR-TOPO	8225		LARP6	55323	AAH06082.1	Hs.416755	La ribonucleoprotein domain family, member 6			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018357.2	NP_060827.2	VALIDATED	C	1.000	1.000	491	1476	1	1473	491	1	491
RIKEN	BC033862	IRAK068L02	MGC	W01A018B12	pENTR-TOPO	21914		CYP3A5	1577	AAH33862.1	Hs.695915	Cytochrome P450, family 3, subfamily A, polypeptide 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000777.2	NP_000768.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
RIKEN	BC032594	IRAK069I14	MGC	W01A018B18	pENTR-TOPO	1471		CYP2J2	1573	AAH32594.1	Hs.152096	Cytochrome P450, family 2, subfamily J, polypeptide 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000775.2	NP_000766.2	REVIEWED	C	1.000	1.000	502	1509	1	1506	502	1	502
RIKEN	BC028629	IRAK047F05	MGC	W01A018B21	pENTR-TOPO	25094		GABRA3	2556	AAH28629.1	Hs.123024	Gamma-aminobutyric acid (GABA) A receptor, alpha 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000808.3	NP_000799.1	REVIEWED	Cs	0.998	0.998	492	1479	1	1476	492	1	492
RIKEN	BC001602	IRAL008I12	MGC	W01A018C06	pENTR-TOPO	13041		CFLAR	8837	AAH01602.1	Hs.390736	CASP8 and FADD-like apoptosis regulator			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001127183.1	NP_001120655.1	VALIDATED	C	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC011681	IRAL027A21	MGC	W01A018C07	pENTR-TOPO	15569		SAMM50	25813	AAH11681.1	Hs.505824	Sorting and assembly machinery component 50 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_015380.4	NP_056195.3	VALIDATED	Cs	0.998	0.998	469	1410	1	1407	469	1	469
RIKEN	BC017329	IRAL039F01	MGC	W01A018C18	pENTR-TOPO	21104		AGFG2	3268	AAH17329.1	Hs.521083	ArfGAP with FG repeats 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_006076.4	NP_006067.3	REVIEWED	Cs	0.998	0.998	481	1446	1	1443	481	1	481
RIKEN	BC017329	IRAL039F01	MGC	W01A018C20	pENTR-TOPO	21104		AGFG2	3268	AAH17329.1	Hs.521083	ArfGAP with FG repeats 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_006076.4	NP_006067.3	REVIEWED	Cs	0.998	0.998	481	1446	1	1443	481	1	481
RIKEN	BC017329	IRAL039F01	MGC	W01A018C22	pENTR-TOPO	21104		AGFG2	3268	AAH17329.1	Hs.521083	ArfGAP with FG repeats 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_006076.4	NP_006067.3	REVIEWED	Cs	0.998	0.998	481	1446	1	1443	481	1	481
RIKEN	BC051839	IRAK110O03	MGC	W01A018D03	pENTR-TOPO	15367		TMPRSS2	7113	AAH51839.1	Hs.439309	Transmembrane protease, serine 2				Lupski_sympathetic_trunk	DH10B	NM_005656.3	NP_005647.3	REVIEWED	C	1.000	1.000	492	1479	1	1476	492	1	492
RIKEN	BC022529	IRAK032H03	MGC	W01A018D10	pENTR-TOPO	16768		HHATL	57467	AAH22529.1	Hs.476041	Hedgehog acyltransferase-like			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020707.2	NP_065758.2	PROVISIONAL	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC022529	IRAK032H03	MGC	W01A018D12	pENTR-TOPO	16768		HHATL	57467	AAH22529.1	Hs.476041	Hedgehog acyltransferase-like			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020707.2	NP_065758.2	PROVISIONAL	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC022530	IRAK032I09	MGC	W01A018D15	pENTR-TOPO	14019		ACVR1C	130399	AAH22530.1	Hs.562901	Activin A receptor, type IC			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001111031.1	NP_001104501.1	VALIDATED	Cs	0.995	0.995	443	1482	151	1479	443	1	443
RIKEN	BC040879	IRAK088I18	MGC	W01A018D17	pENTR-TOPO	1414		AMIGO1	57463	AAH40879.1	Hs.709892	Adhesion molecule with Ig-like domain 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_020703.2	NP_065754.2	VALIDATED	Cs	0.998	0.998	493	1482	1	1479	493	1	493
RIKEN	BC042875	IRAK051K02	MGC	W01A018D18	pENTR-TOPO	16299		SLC38A3	10991	AAH42875.1	Hs.76460	Solute carrier family 38, member 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006841.4	NP_006832.1	VALIDATED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC040879	IRAK088I18	MGC	W01A018D23	pENTR-TOPO	1414		AMIGO1	57463	AAH40879.1	Hs.709892	Adhesion molecule with Ig-like domain 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_020703.2	NP_065754.2	VALIDATED	Cs	0.998	0.998	493	1482	1	1479	493	1	493
RIKEN	BC046110	IRAK107F04	MGC	W01A018E01	pENTR-TOPO	4491		FBXO3	26273	AAH46110.1	Hs.406787	F-box protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012175.3	NP_036307.2	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC046110	IRAK107F04	MGC	W01A018E03	pENTR-TOPO	4491		FBXO3	26273	AAH46110.1	Hs.406787	F-box protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012175.3	NP_036307.2	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC031405	IRAK050C17	MGC	W01A018E08	pENTR-TOPO	1400		DUSP10	11221	AAH31405.1	Hs.497822	Dual specificity phosphatase 10			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_007207.3	NP_009138.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
RIKEN	AK074674	flj0017j18	FLJ	W01A018E15	pENTR-TOPO	10578		SLC16A11	162515	BAC11128.1	Hs.336564	Solute carrier family 16, member 11 (monocarboxylic acid transporter 11)				MAMMA1	EK1	NM_153357.1	NP_699188.1	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC008406	IRAL021P23	MGC	W01A018E19	pENTR-TOPO	21308		CD36	948	AAH08406.1	Hs.120949	CD36 molecule (thrombospondin receptor)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001001548.2	NP_001001548.1	REVIEWED	C	1.000	1.000	472	1419	1	1416	472	1	472
RIKEN	BC018160	IRAK021M06	MGC	W01A018E20	pENTR-TOPO	15906		TYMP	1890	AAH18160.1	Hs.592212	Thymidine phosphorylase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001953.3	NP_001944.1	REVIEWED	Cs	0.998	0.998	482	1449	1	1446	482	1	482
RIKEN	BC008406	IRAL021P23	MGC	W01A018E21	pENTR-TOPO	21308		CD36	948	AAH08406.1	Hs.120949	CD36 molecule (thrombospondin receptor)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001001548.2	NP_001001548.1	REVIEWED	C	1.000	1.000	472	1419	1	1416	472	1	472
RIKEN	BC018160	IRAK021M06	MGC	W01A018E22	pENTR-TOPO	15906		TYMP	1890	AAH18160.1	Hs.592212	Thymidine phosphorylase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001953.3	NP_001944.1	REVIEWED	Cs	0.998	0.998	482	1449	1	1446	482	1	482
RIKEN	BC046151	IRAK107P13	MGC	W01A018F07	pENTR-TOPO	15543		TOM1	10043	AAH46151.1	Hs.474705	Target of myb1 (chicken)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001135732.1	NP_001129204.1	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
RIKEN	BC014478	IRAL034N19	MGC	W01A018F08	pENTR-TOPO	24173		PSMD5	5711	AAH14478.1	Hs.193725	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_005047.2	NP_005038.1	REVIEWED	OK	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC040531	IRAK063D22	MGC	W01A018F14	pENTR-TOPO	5562		ACVR1B	91	AAH40531.1	Hs.438918	Activin A receptor, type IB			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004302.3	NP_004293.1	REVIEWED	C	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC002781	IRAL012F19	MGC	W01A018F23	pENTR-TOPO	1523		SFRS4	6429	AAH02781.1	Hs.469970	Splicing factor, arginine/serine-rich 4			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_005626.4	NP_005617.2	REVIEWED	C	1.000	1.000	494	1485	1	1482	494	1	494
RIKEN	BC065007	IRAK140M23	MGC	W01A018G12	pENTR-TOPO	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004397.4	NP_004388.2	REVIEWED	C	1.000	1.000	483	1452	1	1449	483	1	483
RIKEN	BC002690	IRAL012M19	MGC	W01A018G13	pENTR-TOPO	10691		KRT14	3861	AAH02690.1	Hs.654380	Keratin 14			Pancreas, adenocarcinoma	NIH_MGC_39		NM_000526.4	NP_000517.2	REVIEWED	Cs	0.998	0.998	472	1419	1	1416	472	1	472
RIKEN	BC012075	IRAL029O21	MGC	W01A018G20	pENTR-TOPO	10292		NLE1	54475	AAH12075.1	Hs.85570	Notchless homolog 1 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001014445.1	NP_001014445.1	VALIDATED	C	1.000	1.000	193	1458	877	1455	193	1	193
RIKEN	BC012075	IRAL029O21	MGC	W01A018G22	pENTR-TOPO	10292		NLE1	54475	AAH12075.1	Hs.85570	Notchless homolog 1 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001014445.1	NP_001014445.1	VALIDATED	C	1.000	1.000	193	1458	877	1455	193	1	193
RIKEN	BC004192	IRAL007D14	MGC	W01A018G23	pENTR-TOPO	22770		PTDSS1	9791	AAH04192.1	Hs.292579	Phosphatidylserine synthase 1			Brain, neuroblastoma	NIH_MGC_19		NM_014754.1	NP_055569.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC014433	IRAL008M06	MGC	W01A018H04	pENTR-TOPO	7865		PDIA3	2923	AAH14433.1	Hs.591095	Protein disulfide isomerase family A, member 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_005313.4	NP_005304.3	REVIEWED	C	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	AK074823	flj0018c08	FLJ	W01A018H15	pENTR-TOPO	22056		SLC37A3	84255	BAC11231.1	Hs.446021	Solute carrier family 37 (glycerol-3-phosphate transporter), member 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_207113.1	NP_996996.1	VALIDATED	Cs	0.996	0.996	494	1485	1	1482	494	1	494
RIKEN	BC027901	IRAK049O18	MGC	W01A018H19	pENTR-TOPO	4067		CD5	921	AAH27901.1	Hs.58685	CD5 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014207.3	NP_055022.2	VALIDATED	Cs	0.996	0.996	495	1488	1	1485	495	1	495
RIKEN	BC027901	IRAK049O18	MGC	W01A018H23	pENTR-TOPO	4067		CD5	921	AAH27901.1	Hs.58685	CD5 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014207.3	NP_055022.2	VALIDATED	Cs	0.996	0.996	495	1488	1	1485	495	1	495
RIKEN	BC011519	IRAK012N22	MGC	W01A018I04	pENTR-TOPO	1519		AGT	183	AAH11519.1	Hs.19383	Angiotensinogen (serpin peptidase inhibitor, clade A, member 8)			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000029.3	NP_000020.1	REVIEWED	Cs	0.996	0.996	485	1458	1	1455	485	1	485
RIKEN	BC012976	IRAL024F17	MGC	W01A018I12	pENTR-TOPO	21936		GAL3ST4	79690	AAH12976.1	Hs.44856	Galactose-3-O-sulfotransferase 4			Placenta, choriocarcinoma	NIH_MGC_21		NM_024637.4	NP_078913.3	REVIEWED	Cs	0.998	0.998	486	1461	1	1458	486	1	486
RIKEN	AK129827	flj0054f22	FLJ	W01A018I20	pENTR-TOPO	10499		KRT28	162605	BAC85240.1	Hs.59736	Keratin 28				DMC	EK1	NM_181535.3	NP_853513.2	VALIDATED	C	1.000	1.000	464	1461	67	1458	464	1	464
RIKEN	AK129827	flj0054f22	FLJ	W01A018I22	pENTR-TOPO	10499		KRT28	162605	BAC85240.1	Hs.59736	Keratin 28				DMC	EK1	NM_181535.3	NP_853513.2	VALIDATED	C	1.000	1.000	464	1461	67	1458	464	1	464
RIKEN	BC002612	IRAL004N16	MGC	W01A018J01	pENTR-TOPO	11678		FKRP	79147	AAH02612.1	Hs.515493	Fukutin related protein			Brain, neuroblastoma	NIH_MGC_19		NM_001039885.2	NP_001034974.1	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
RIKEN	BC002612	IRAL004N16	MGC	W01A018J03	pENTR-TOPO	11678		FKRP	79147	AAH02612.1	Hs.515493	Fukutin related protein			Brain, neuroblastoma	NIH_MGC_19		NM_001039885.2	NP_001034974.1	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
RIKEN	BC042600	IRAK029C13	MGC	W01A018J10	pENTR-TOPO	9073		SLC7A5	8140	AAH42600.1	Hs.513797	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_003486.5	NP_003477.4	VALIDATED	C	1.000	1.000	507	1524	1	1521	507	1	507
RIKEN	BC042600	IRAK029C13	MGC	W01A018J12	pENTR-TOPO	9073		SLC7A5	8140	AAH42600.1	Hs.513797	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_003486.5	NP_003477.4	VALIDATED	C	1.000	1.000	507	1524	1	1521	507	1	507
RIKEN	BC042600	IRAK029C13	MGC	W01A018J14	pENTR-TOPO	9073		SLC7A5	8140	AAH42600.1	Hs.513797	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_003486.5	NP_003477.4	VALIDATED	C	1.000	1.000	507	1524	1	1521	507	1	507
RIKEN	BC039196	IRAK027C22	MGC	W01A018J19	pENTR-TOPO	5873		SLC2A3	6515	AAH39196.1	Hs.419240	Solute carrier family 2 (facilitated glucose transporter), member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_006931.2	NP_008862.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC010859	IRAK014D17	MGC	W01A018J20	pENTR-TOPO	10264		P4HB	5034	AAH10859.1	Hs.464336	Prolyl 4-hydroxylase, beta polypeptide			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000918.3	NP_000909.2	REVIEWED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC039196	IRAK027C22	MGC	W01A018J21	pENTR-TOPO	5873		SLC2A3	6515	AAH39196.1	Hs.419240	Solute carrier family 2 (facilitated glucose transporter), member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_006931.2	NP_008862.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC010859	IRAK014D17	MGC	W01A018J22	pENTR-TOPO	10264		P4HB	5034	AAH10859.1	Hs.464336	Prolyl 4-hydroxylase, beta polypeptide			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000918.3	NP_000909.2	REVIEWED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC039196	IRAK027C22	MGC	W01A018J23	pENTR-TOPO	5873		SLC2A3	6515	AAH39196.1	Hs.419240	Solute carrier family 2 (facilitated glucose transporter), member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_006931.2	NP_008862.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC002680	IRAL012K21	MGC	W01A018K05	pENTR-TOPO	21098		TRIP6	7205	AAH02680.1	Hs.534360	Thyroid hormone receptor interactor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_003302.2	NP_003293.2	REVIEWED	Cgs	0.994	0.998	476	1425	1	1422	476	1	476
RIKEN	BC000054	IRAL007E18	MGC	W01A018K09	pENTR-TOPO	4543		DHCR7	1717	AAH00054.1	Hs.503134	7-dehydrocholesterol reductase			Brain, neuroblastoma	NIH_MGC_19		NM_001360.2	NP_001351.2	VALIDATED	C	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC000054	IRAL007E18	MGC	W01A018K11	pENTR-TOPO	4543		DHCR7	1717	AAH00054.1	Hs.503134	7-dehydrocholesterol reductase			Brain, neuroblastoma	NIH_MGC_19		NM_001360.2	NP_001351.2	VALIDATED	C	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC000054	IRAL007E18	MGC	W01A018K15	pENTR-TOPO	4543		DHCR7	1717	AAH00054.1	Hs.503134	7-dehydrocholesterol reductase			Brain, neuroblastoma	NIH_MGC_19		NM_001360.2	NP_001351.2	VALIDATED	C	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC005333	IRAL016K12	MGC	W01A018K20	pENTR-TOPO	20462		IFNGR1	3459	AAH05333.1	Hs.520414	Interferon gamma receptor 1			Prostate	NIH_MGC_83	DH10B	NM_000416.2	NP_000407.1	REVIEWED	OK	1.000	1.000	489	1470	1	1467	489	1	489
RIKEN	BC005333	IRAL016K12	MGC	W01A018K24	pENTR-TOPO	20462		IFNGR1	3459	AAH05333.1	Hs.520414	Interferon gamma receptor 1			Prostate	NIH_MGC_83	DH10B	NM_000416.2	NP_000407.1	REVIEWED	OK	1.000	1.000	489	1470	1	1467	489	1	489
RIKEN	BC012920	IRAK028G21	MGC	W01A018L06	pENTR-TOPO	2592		DNTT	1791	AAH12920.1	Hs.534206	Deoxynucleotidyltransferase, terminal			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004088.3	NP_004079.3	REVIEWED	Cs	0.998	0.998	509	1530	1	1527	509	1	509
RIKEN	BC012920	IRAK028G21	MGC	W01A018L08	pENTR-TOPO	2592		DNTT	1791	AAH12920.1	Hs.534206	Deoxynucleotidyltransferase, terminal			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004088.3	NP_004079.3	REVIEWED	Cs	0.998	0.998	509	1530	1	1527	509	1	509
RIKEN	AK027729	flj0036g17	FLJ	W01A018L09	pENTR-TOPO	9539		GRB7	2886	BAG51372.1	Hs.86859	Growth factor receptor-bound protein 7				OVARC1	EK1	NM_005310.2	NP_005301.2	REVIEWED	Cgs	0.934	0.998	532	1497	1	1494	532	1	532
RIKEN	AK027729	flj0036g17	FLJ	W01A018L13	pENTR-TOPO	9539		GRB7	2886	BAG51372.1	Hs.86859	Growth factor receptor-bound protein 7				OVARC1	EK1	NM_005310.2	NP_005301.2	REVIEWED	Cgs	0.934	0.998	532	1497	1	1494	532	1	532
RIKEN	AK027729	flj0036g17	FLJ	W01A018L15	pENTR-TOPO	9539		GRB7	2886	BAG51372.1	Hs.86859	Growth factor receptor-bound protein 7				OVARC1	EK1	NM_005310.2	NP_005301.2	REVIEWED	Cgs	0.934	0.998	532	1497	1	1494	532	1	532
RIKEN	BC022539	IRAK032P05	MGC	W01A018L19	pENTR-TOPO	7016		CYP46A1	10858	AAH22539.1	Hs.25121	Cytochrome P450, family 46, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006668.1	NP_006659.1	REVIEWED	OK	1.000	1.000	500	1503	1	1500	500	1	500
RIKEN	BC032330	IRAK064E10	MGC	W01A018L22	pENTR-TOPO	11266		LMAN1	3998	AAH32330.1	Hs.465295	Lectin, mannose-binding, 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005570.3	NP_005561.1	REVIEWED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC032330	IRAK064E10	MGC	W01A018L24	pENTR-TOPO	11266		LMAN1	3998	AAH32330.1	Hs.465295	Lectin, mannose-binding, 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005570.3	NP_005561.1	REVIEWED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC008752	IRAL005M04	MGC	W01A018M01	pENTR-TOPO	19400		ZNF622	90441	AAH08752.1	Hs.60300	Zinc finger protein 622			Skin, melanotic melanoma.	NIH_MGC_20		NM_033414.2	NP_219482.1	PROVISIONAL	OK	1.000	1.000	477	1434	1	1431	477	1	477
RIKEN	BC008752	IRAL005M04	MGC	W01A018M03	pENTR-TOPO	19400		ZNF622	90441	AAH08752.1	Hs.60300	Zinc finger protein 622			Skin, melanotic melanoma.	NIH_MGC_20		NM_033414.2	NP_219482.1	PROVISIONAL	OK	1.000	1.000	477	1434	1	1431	477	1	477
RIKEN	BC040503	IRAK048N12	MGC	W01A018M04	pENTR-TOPO	7513		TC2N	123036	AAH40503.1	Hs.510262	Tandem C2 domains, nuclear			Testis	NIH_MGC_97	DH10B	NM_001128595.1	NP_001122067.1	VALIDATED	OK	1.000	1.000	490	1473	1	1470	490	1	490
RIKEN	BC020596	IRAL037K09	MGC	W01A018M10	pENTR-TOPO	3411		CYP2C8	1558	AAH20596.1	Hs.709188	Cytochrome P450, family 2, subfamily C, polypeptide 8			Liver	NIH_MGC_76	DH10B	NM_000770.3	NP_000761.3	REVIEWED	Cs	0.998	0.998	490	1473	1	1470	490	1	490
RIKEN	BC020596	IRAL037K09	MGC	W01A018M14	pENTR-TOPO	3411		CYP2C8	1558	AAH20596.1	Hs.709188	Cytochrome P450, family 2, subfamily C, polypeptide 8			Liver	NIH_MGC_76	DH10B	NM_000770.3	NP_000761.3	REVIEWED	Cs	0.998	0.998	490	1473	1	1470	490	1	490
RIKEN	BC020596	IRAL037K09	MGC	W01A018M16	pENTR-TOPO	3411		CYP2C8	1558	AAH20596.1	Hs.709188	Cytochrome P450, family 2, subfamily C, polypeptide 8			Liver	NIH_MGC_76	DH10B	NM_000770.3	NP_000761.3	REVIEWED	Cs	0.998	0.998	490	1473	1	1470	490	1	490
RIKEN	BC067299	IRAK141O18	MGC	W01A018M20	pENTR-TOPO	235		MDM4	4194	AAH67299.1	Hs.497492	Mdm4 p53 binding protein homolog (mouse)			Testis	NIH_MGC_180	DH10B	NM_002393.3	NP_002384.2	VALIDATED	C	1.000	1.000	490	1473	1	1470	490	1	490
RIKEN	BC017758	IRAL036M17	MGC	W01A018N02	pENTR-TOPO	500		CYP4B1	1580	AAH17758.1	Hs.436317	Cytochrome P450, family 4, subfamily B, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_001099772.1	NP_001093242.1	REVIEWED	C	1.000	1.000	512	1539	1	1536	512	1	512
RIKEN	BC036059	IRAK048N22	MGC	W01A018N07	pENTR-TOPO	10423		PLXDC1	57125	AAH36059.1	Hs.125036	Plexin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_020405.4	NP_065138.2	VALIDATED	Cs	0.998	0.998	500	1503	1	1500	500	1	500
RIKEN	BC004864	IRAL014G01	MGC	W01A018N10	pENTR-TOPO	22675		PPP3CC	5533	AAH04864.1	Hs.655661	Protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_005605.3	NP_005596.2	PROVISIONAL	OK	1.000	1.000	512	1539	1	1536	512	1	512
RIKEN	BC004864	IRAL014G01	MGC	W01A018N14	pENTR-TOPO	22675		PPP3CC	5533	AAH04864.1	Hs.655661	Protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_005605.3	NP_005596.2	PROVISIONAL	OK	1.000	1.000	512	1539	1	1536	512	1	512
RIKEN	BC032410	IRAK064L07	MGC	W01A018N17	pENTR-TOPO	23648		TRAF2	7186	AAH32410.1	Hs.522506	TNF receptor-associated factor 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021138.3	NP_066961.2	REVIEWED	C	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	AK026762	flj0058j19	FLJ	W01A018O02	pENTR-TOPO	21290		CBLL1	79872	BAB15544.1	Hs.592271	Cas-Br-M (murine) ecotropic retroviral transforming sequence-like 1				LNG	EK1	NM_024814.2	NP_079090.2	VALIDATED	Cs	0.998	0.998	491	1476	1	1473	491	1	491
RIKEN	BC006311	IRAL017E09	MGC	W01A018O05	pENTR-TOPO	11593		GLTSCR2	29997	AAH06311.1	Hs.421907	Glioma tumor suppressor candidate region gene 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_015710.3	NP_056525.1	PROVISIONAL	C	1.000	1.000	478	1437	1	1434	478	1	478
RIKEN	BC015947	IRAK015L20	MGC	W01A018O10	pENTR-TOPO	13071		KCNS3	3790	AAH15947.1	Hs.414489	Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002252.3	NP_002243.3	REVIEWED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	BC015947	IRAK015L20	MGC	W01A018O14	pENTR-TOPO	13071		KCNS3	3790	AAH15947.1	Hs.414489	Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002252.3	NP_002243.3	REVIEWED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	BC030693	IRAK034A13	MGC	W01A018O15	pENTR-TOPO	5281		SLC16A7	9194	AAH30693.1	Hs.439643	Solute carrier family 16, member 7 (monocarboxylic acid transporter 2)			Testis	NIH_MGC_97	DH10B	NM_004731.3	NP_004722.2	PROVISIONAL	C	1.000	1.000	478	1437	1	1434	478	1	478
RIKEN	BC032495	IRAK064P24	MGC	W01A018P03	pENTR-TOPO	15091		GDF5	8200	AAH32495.1	Hs.1573	Growth differentiation factor 5			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000557.2	NP_000548.1	REVIEWED	C	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC032495	IRAK064P24	MGC	W01A018P05	pENTR-TOPO	15091		GDF5	8200	AAH32495.1	Hs.1573	Growth differentiation factor 5			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000557.2	NP_000548.1	REVIEWED	C	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC032495	IRAK064P24	MGC	W01A018P07	pENTR-TOPO	15091		GDF5	8200	AAH32495.1	Hs.1573	Growth differentiation factor 5			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000557.2	NP_000548.1	REVIEWED	C	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC002395	IRAL001F04	MGC	W01A018P11	pENTR-TOPO	2050		SF3A3	10946	AAH02395.1	Hs.77897	Splicing factor 3a, subunit 3, 60kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_006802.2	NP_006793.1	REVIEWED	C	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC002395	IRAL001F04	MGC	W01A018P13	pENTR-TOPO	2050		SF3A3	10946	AAH02395.1	Hs.77897	Splicing factor 3a, subunit 3, 60kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_006802.2	NP_006793.1	REVIEWED	C	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC001820	IRAL003G07	MGC	W01A018P21	pENTR-TOPO	1754		SLC2A5	6518	AAH01820.1	Hs.530003	Solute carrier family 2 (facilitated glucose/fructose transporter), member 5			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003039.2	NP_003030.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
RIKEN	BC008768	IRAL004K09	MGC	W01A019A01	pENTR-TOPO	14618		OGFR	11054	AAH08768.1	Hs.67896	Opioid growth factor receptor			Skin, melanotic melanoma.	NIH_MGC_20		NM_007346.2	NP_031372.2	REVIEWED	Pfs	0.962	1.000	532	1542	3	1539	677	146	677
RIKEN	BC008768	IRAL004K09	MGC	W01A019A07	pENTR-TOPO	14618		OGFR	11054	AAH08768.1	Hs.67896	Opioid growth factor receptor			Skin, melanotic melanoma.	NIH_MGC_20		NM_007346.2	NP_031372.2	REVIEWED	Pfs	0.962	1.000	532	1542	3	1539	677	146	677
RIKEN	BC031231	IRAK063M21	MGC	W01A019A11	pENTR-TOPO	4700		STK33	65975	AAH31231.1	Hs.501833	Serine/threonine kinase 33			Testis	NIH_MGC_97	DH10B	NM_030906.2	NP_112168.1	VALIDATED	Cs	0.994	0.994	514	1545	1	1542	514	1	514
RIKEN	BC065235	IRAK140M14	MGC	W01A019A12	pENTR-TOPO	8618		SPNS1	83985	AAH65235.1	Hs.632181	Spinster homolog 1 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142448.1	NP_001135920.1	VALIDATED	Cs	0.998	0.998	528	1587	1	1584	528	1	528
RIKEN	BC031231	IRAK063M21	MGC	W01A019A15	pENTR-TOPO	4700		STK33	65975	AAH31231.1	Hs.501833	Serine/threonine kinase 33			Testis	NIH_MGC_97	DH10B	NM_030906.2	NP_112168.1	VALIDATED	Cs	0.994	0.994	514	1545	1	1542	514	1	514
RIKEN	BC011669	IRAL026J02	MGC	W01A019A19	pENTR-TOPO	1464		DHCR24	1718	AAH11669.1	Hs.498727	24-dehydrocholesterol reductase			Brain, neuroblastoma	NIH_MGC_19		NM_014762.3	NP_055577.1	REVIEWED	C	1.000	1.000	516	1551	1	1548	516	1	516
RIKEN	BC017480	IRAL023B08	MGC	W01A019B01	pENTR-TOPO	14042		HNRPLL	92906	AAH17480.1	Hs.445497	Heterogeneous nuclear ribonucleoprotein L-like			Brain, neuroblastoma	NIH_MGC_19		NM_138394.3	NP_612403.2	VALIDATED	C	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC002780	IRAL012F17	MGC	W01A019B02	pENTR-TOPO	889		FMO4	2329	AAH02780.1	Hs.386502	Flavin containing monooxygenase 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_002022.1	NP_002013.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
RIKEN	BC017480	IRAL023B08	MGC	W01A019B05	pENTR-TOPO	14042		HNRPLL	92906	AAH17480.1	Hs.445497	Heterogeneous nuclear ribonucleoprotein L-like			Brain, neuroblastoma	NIH_MGC_19		NM_138394.3	NP_612403.2	VALIDATED	C	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC002780	IRAL012F17	MGC	W01A019B06	pENTR-TOPO	889		FMO4	2329	AAH02780.1	Hs.386502	Flavin containing monooxygenase 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_002022.1	NP_002013.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
RIKEN	BC017480	IRAL023B08	MGC	W01A019B07	pENTR-TOPO	14042		HNRPLL	92906	AAH17480.1	Hs.445497	Heterogeneous nuclear ribonucleoprotein L-like			Brain, neuroblastoma	NIH_MGC_19		NM_138394.3	NP_612403.2	VALIDATED	C	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC002987	IRAL009G08	MGC	W01A019B13	pENTR-TOPO	4082		STIP1	10963	AAH02987.1	Hs.337295	Stress-induced-phosphoprotein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006819.2	NP_006810.1	VALIDATED	OK	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	BC015748	IRAL034I13	MGC	W01A019B16	pENTR-TOPO	23790		FANCC	2176	AAH15748.1	Hs.494529	Fanconi anemia, complementation group C			Colon, adenocarcinoma	NIH_MGC_15		NM_000136.2	NP_000127.2	REVIEWED	C	1.000	1.000	558	1677	1	1674	558	1	558
RIKEN	BC005122	IRAL014L22	MGC	W01A019C01	pENTR-TOPO	15843		ARFGAP3	26286	AAH05122.1	Hs.162877	ADP-ribosylation factor GTPase activating protein 3			Lung, small cell carcinoma	NIH_MGC_7		NM_014570.4	NP_055385.3	REVIEWED	Cs	0.998	0.998	516	1551	1	1548	516	1	516
RIKEN	BC005122	IRAL014L22	MGC	W01A019C05	pENTR-TOPO	15843		ARFGAP3	26286	AAH05122.1	Hs.162877	ADP-ribosylation factor GTPase activating protein 3			Lung, small cell carcinoma	NIH_MGC_7		NM_014570.4	NP_055385.3	REVIEWED	Cs	0.998	0.998	516	1551	1	1548	516	1	516
RIKEN	BC066985	IRAK167G21	MGC	W01A019C11	pENTR-TOPO	19701		SLC16A10	117247	AAH66985.1	Hs.591327	Solute carrier family 16, member 10 (aromatic amino acid transporter)			Testis	NIH_MGC_97	DH10B	NM_018593.4	NP_061063.2	VALIDATED	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC066985	IRAK167G21	MGC	W01A019C13	pENTR-TOPO	19701		SLC16A10	117247	AAH66985.1	Hs.591327	Solute carrier family 16, member 10 (aromatic amino acid transporter)			Testis	NIH_MGC_97	DH10B	NM_018593.4	NP_061063.2	VALIDATED	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC053343	IRAK115A21	MGC	W01A019C14	pENTR-TOPO	9841		KPNA2	3838	AAH53343.1	Hs.594238	Karyopherin alpha 2 (RAG cohort 1, importin alpha 1)			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_002266.2	NP_002257.1	REVIEWED	Cs	0.998	0.998	529	1590	1	1587	529	1	529
RIKEN	BC028030	IRAK062M03	MGC	W01A019C22	pENTR-TOPO	8564		PDP2	57546	AAH28030.1	Hs.654693	Pyruvate dehydrogenase phosphatase isoenzyme 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020786.1	NP_065837.1	VALIDATED	C	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC028030	IRAK062M03	MGC	W01A019C24	pENTR-TOPO	8564		PDP2	57546	AAH28030.1	Hs.654693	Pyruvate dehydrogenase phosphatase isoenzyme 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020786.1	NP_065837.1	VALIDATED	C	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC001595	IRAL008C16	MGC	W01A019D18	pENTR-TOPO	3375		NT5C2	22978	AAH01595.1	Hs.97439	5'-nucleotidase, cytosolic II			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001134373.1	NP_001127845.1	VALIDATED	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	BC001595	IRAL008C16	MGC	W01A019D20	pENTR-TOPO	3375		NT5C2	22978	AAH01595.1	Hs.97439	5'-nucleotidase, cytosolic II			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001134373.1	NP_001127845.1	VALIDATED	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	BC002957	IRAL008H19	MGC	W01A019D21	pENTR-TOPO	16165		RBM5	10181	AAH02957					Lung, small cell carcinoma	NIH_MGC_7		NM_005778.1	NP_005769.1	PROVISIONAL	P	1.000	1.000	546	1641	1	1638	815	1	546
RIKEN	BC003000	IRAL009N11	MGC	W01A019E02	pENTR-TOPO	3599		SLC3A2	6520	AAH03000.2	Hs.502769	Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2			Lung, small cell carcinoma	NIH_MGC_7		NM_001013251.1	NP_001013269.1	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC003000	IRAL009N11	MGC	W01A019E04	pENTR-TOPO	3599		SLC3A2	6520	AAH03000.2	Hs.502769	Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2			Lung, small cell carcinoma	NIH_MGC_7		NM_001013251.1	NP_001013269.1	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC029503	IRAK048D03	MGC	W01A019E05	pENTR-TOPO	18185		MFSD8	256471	AAH29503.1	Hs.480701	Major facilitator superfamily domain containing 8			Testis	NIH_MGC_97	DH10B	NM_152778.2	NP_689991.1	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC014453	IRAL034L22	MGC	W01A019E11	pENTR-TOPO	15196		BACE2	25825	AAH14453.1	Hs.529408	Beta-site APP-cleaving enzyme 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_012105.3	NP_036237.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC001061	IRAL007H11	MGC	W01A019E14	pENTR-TOPO	3599		SLC3A2	6520	AAH01061.2	Hs.502769	Solute carrier family 3 (activators of dibasic and neutral amino acid transport), member 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_001013251.1	NP_001013269.1	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC014453	IRAL034L22	MGC	W01A019E15	pENTR-TOPO	15196		BACE2	25825	AAH14453.1	Hs.529408	Beta-site APP-cleaving enzyme 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_012105.3	NP_036237.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC040482	IRAK048C16	MGC	W01A019E17	pENTR-TOPO	2654		PFKFB3	5209	AAH40482.1	Hs.719094	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3			Testis	NIH_MGC_97	DH10B	NM_004566.3	NP_004557.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC033100	IRAL043P19	MGC	W01A019F03	pENTR-TOPO	13147		EHD3	30845	AAH33100	Hs.368808	EH-domain containing 3			Brain, neuroblastoma	NIH_MGC_47		NM_014600.2	NP_055415.1	VALIDATED	Cfs	1.000	1.000	535	1641	1	1604	535	1	535
RIKEN	BC010887	IRAL008B01	MGC	W01A019F17	pENTR-TOPO	6995		REC8	9985	AAH10887.1	Hs.419259	REC8 homolog (yeast)			Lung, small cell carcinoma	NIH_MGC_7		NM_001048205.1	NP_001041670.1	REVIEWED	OK	1.000	1.000	547	1644	1	1641	547	1	547
RIKEN	BC010887	IRAL008B01	MGC	W01A019F19	pENTR-TOPO	6995		REC8	9985	AAH10887.1	Hs.419259	REC8 homolog (yeast)			Lung, small cell carcinoma	NIH_MGC_7		NM_001048205.1	NP_001041670.1	REVIEWED	OK	1.000	1.000	547	1644	1	1641	547	1	547
RIKEN	BC008807	IRAL015J09	MGC	W01A019F22	pENTR-TOPO	6229		KRT6A	3853	AAH08807.1	Hs.700779	Keratin 6A			Ovary, adenocarcinoma	NIH_MGC_9		NM_005554.3	NP_005545.1	REVIEWED	C	1.000	1.000	564	1695	1	1692	564	1	564
RIKEN	BC010887	IRAL008B01	MGC	W01A019F23	pENTR-TOPO	6995		REC8	9985	AAH10887.1	Hs.419259	REC8 homolog (yeast)			Lung, small cell carcinoma	NIH_MGC_7		NM_001048205.1	NP_001041670.1	REVIEWED	OK	1.000	1.000	547	1644	1	1641	547	1	547
RIKEN	BC028383	IRAK046M04	MGC	W01A019G02	pENTR-TOPO	2908		BMPR1A	657	AAH28383.1	Hs.524477	Bone morphogenetic protein receptor, type IA			Testis	NIH_MGC_97	DH10B	NM_004329.2	NP_004320.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
RIKEN	BC028383	IRAK046M04	MGC	W01A019G04	pENTR-TOPO	2908		BMPR1A	657	AAH28383.1	Hs.524477	Bone morphogenetic protein receptor, type IA			Testis	NIH_MGC_97	DH10B	NM_004329.2	NP_004320.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
RIKEN	BC006232	IRAL015B07	MGC	W01A019H04	pENTR-TOPO	15546		CDC45L	8318	AAH06232.1	Hs.474217	CDC45 cell division cycle 45-like (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_003504.3	NP_003495.1	REVIEWED	C	1.000	1.000	566	1701	1	1698	566	1	566
RIKEN	AK094619	flj0022c24	FLJ	W01A019H11	pENTR-TOPO	9617		KIF19	124602	BAC04386.1	Hs.372773	Kinesin family member 19				BRAMY2	EK1	NM_153209.3	NP_694941.2	VALIDATED		0.976	0.976	544	1647	1	1632	998	1	544
RIKEN	BC052991	IRAK110K18	MGC	W01A019H18	pENTR-TOPO	2582		SGPL1	8879	AAH52991.1	Hs.499984	Sphingosine-1-phosphate lyase 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003901.3	NP_003892.2	VALIDATED	C	1.000	1.000	568	1707	1	1704	568	1	568
RIKEN	AK000524	flj0060l18	FLJ	W01A019H19	pENTR-TOPO	14993		UCKL1	54963	BAA91230.1	Hs.504998	Uridine-cytidine kinase 1-like 1				KAT	EK1	NM_017859.2	NP_060329.2	VALIDATED	Cs	0.998	0.998	548	1647	1	1644	548	1	548
RIKEN	BC052991	IRAK110K18	MGC	W01A019H22	pENTR-TOPO	2582		SGPL1	8879	AAH52991.1	Hs.499984	Sphingosine-1-phosphate lyase 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003901.3	NP_003892.2	VALIDATED	C	1.000	1.000	568	1707	1	1704	568	1	568
RIKEN	AK000524	flj0060l18	FLJ	W01A019H23	pENTR-TOPO	14993		UCKL1	54963	BAA91230.1	Hs.504998	Uridine-cytidine kinase 1-like 1				KAT	EK1	NM_017859.2	NP_060329.2	VALIDATED	Cs	0.998	0.998	548	1647	1	1644	548	1	548
RIKEN	BC001588	IRAL003N15	MGC	W01A019I01	pENTR-TOPO	23513		PRPF4	9128	AAH01588.1	Hs.530284	PRP4 pre-mRNA processing factor 4 homolog (yeast)			Colon, adenocarcinoma	NIH_MGC_15		NM_004697.3	NP_004688.2	PROVISIONAL	C	1.000	1.000	522	1569	1	1566	522	1	522
RIKEN	BC001588	IRAL003N15	MGC	W01A019I03	pENTR-TOPO	23513		PRPF4	9128	AAH01588.1	Hs.530284	PRP4 pre-mRNA processing factor 4 homolog (yeast)			Colon, adenocarcinoma	NIH_MGC_15		NM_004697.3	NP_004688.2	PROVISIONAL	C	1.000	1.000	522	1569	1	1566	522	1	522
RIKEN	AK022896	flj0033d10	FLJ	W01A019I04	pENTR-TOPO	9696		PSMD3	5709	BAG51131.1	Hs.12970	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_002809.2	NP_002800.2	REVIEWED	OK	1.000	1.000	534	1605	1	1602	534	1	534
RIKEN	BC001588	IRAL003N15	MGC	W01A019I07	pENTR-TOPO	23513		PRPF4	9128	AAH01588.1	Hs.530284	PRP4 pre-mRNA processing factor 4 homolog (yeast)			Colon, adenocarcinoma	NIH_MGC_15		NM_004697.3	NP_004688.2	PROVISIONAL	C	1.000	1.000	522	1569	1	1566	522	1	522
RIKEN	AK022896	flj0033d10	FLJ	W01A019I08	pENTR-TOPO	9696		PSMD3	5709	BAG51131.1	Hs.12970	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_002809.2	NP_002800.2	REVIEWED	OK	1.000	1.000	534	1605	1	1602	534	1	534
RIKEN	BC064508	IRAL050N21	MGC	W01A019J03	pENTR-TOPO	8574		GPR97	222487	AAH64508.1	Hs.383403	G protein-coupled receptor 97			Lung, large cell carcinoma	NIH_MGC_18		NM_170776.4	NP_740746.4	VALIDATED	Cs	0.998	0.998	549	1650	1	1647	549	1	549
RIKEN	BC006104	IRAL018F21	MGC	W01A019J08	pENTR-TOPO	19835		RIOK1	83732	AAH06104.2	Hs.437474	RIO kinase 1 (yeast)			Lung, small cell carcinoma	NIH_MGC_7		NM_153005.1	NP_694550.1	REVIEWED	C	1.000	1.000	327	1707	724	1704	327	1	327
RIKEN	BC029896	IRAK051P21	MGC	W01A019J21	pENTR-TOPO	12318		SIGLEC5	8778	AAH29896.1	Hs.310333	Sialic acid binding Ig-like lectin 5			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003830.2	NP_003821.1	VALIDATED	Cs	0.998	0.998	551	1656	1	1653	551	1	551
RIKEN	AK026935	flj0066b10	FLJ	W01A019K04	pENTR-TOPO	9274		RABEP2	79874	BAB15594.1	Hs.555978	Rabaptin, RAB GTPase binding effector protein 2	HepG2	hepatoma		HEP	EK1	NM_024816.2	NP_079092.2	VALIDATED	Pfs	1.000	1.000	539	1617	1	1616	569	1	539
RIKEN	BC035090	IRAK073E08	MGC	W01A019K05	pENTR-TOPO	6680		KPNA3	3839	AAH35090.1	Hs.527919	Karyopherin alpha 3 (importin alpha 4)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002267.3	NP_002258.2	REVIEWED	Cs	0.992	0.992	521	1566	1	1563	521	1	521
RIKEN	BC035090	IRAK073E08	MGC	W01A019K07	pENTR-TOPO	6680		KPNA3	3839	AAH35090.1	Hs.527919	Karyopherin alpha 3 (importin alpha 4)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002267.3	NP_002258.2	REVIEWED	Cs	0.992	0.992	521	1566	1	1563	521	1	521
RIKEN	BC024202	IRAL011J01	MGC	W01A019K17	pENTR-TOPO	6680		KPNA3	3839	AAH24202.1	Hs.527919	Karyopherin alpha 3 (importin alpha 4)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002267.3	NP_002258.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC044952	IRAK089H19	MGC	W01A019K18	pENTR-TOPO	14564		MAVS	57506	AAH44952.1	Hs.570362	Mitochondrial antiviral signaling protein			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020746.3	NP_065797.2	VALIDATED	Cs	0.994	0.994	540	1623	1	1620	540	1	540
RIKEN	BC044952	IRAK089H19	MGC	W01A019K20	pENTR-TOPO	14564		MAVS	57506	AAH44952.1	Hs.570362	Mitochondrial antiviral signaling protein			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020746.3	NP_065797.2	VALIDATED	Cs	0.994	0.994	540	1623	1	1620	540	1	540
RIKEN	BC024202	IRAL011J01	MGC	W01A019K21	pENTR-TOPO	6680		KPNA3	3839	AAH24202.1	Hs.527919	Karyopherin alpha 3 (importin alpha 4)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002267.3	NP_002258.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC044952	IRAK089H19	MGC	W01A019K24	pENTR-TOPO	14564		MAVS	57506	AAH44952.1	Hs.570362	Mitochondrial antiviral signaling protein			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020746.3	NP_065797.2	VALIDATED	Cs	0.994	0.994	540	1623	1	1620	540	1	540
RIKEN	BC017033	IRAK020G13	MGC	W01A019L02	pENTR-TOPO	22557		SQLE	6713	AAH17033.1	Hs.71465	Squalene epoxidase			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_003129.3	NP_003120.2	REVIEWED	C	1.000	1.000	574	1725	1	1722	574	1	574
RIKEN	BC017033	IRAK020G13	MGC	W01A019L08	pENTR-TOPO	22557		SQLE	6713	AAH17033.1	Hs.71465	Squalene epoxidase			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_003129.3	NP_003120.2	REVIEWED	C	1.000	1.000	574	1725	1	1722	574	1	574
RIKEN	AK092706	flj0003d06	FLJ	W01A019L14	pENTR-TOPO	11786		ANKLE1	126549	BAC03953.1				neuroepithelioma		SKNMC1	EK1	NM_152363.4	NP_689576.4	VALIDATED	Pfs	0.947	0.993	602	1728	3	1725	615	14	615
RIKEN	AK092706	flj0003d06	FLJ	W01A019L16	pENTR-TOPO	11786		ANKLE1	126549	BAC03953.1				neuroepithelioma		SKNMC1	EK1	NM_152363.4	NP_689576.4	VALIDATED	Pfs	0.947	0.993	602	1728	3	1725	615	14	615
RIKEN	BC025698	IRAK049K09	MGC	W01A019L22	pENTR-TOPO	22111		AOAH	313	AAH25698.1	Hs.488007	Acyloxyacyl hydrolase (neutrophil)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001637.2	NP_001628.1	REVIEWED	C	1.000	1.000	575	1728	1	1725	575	1	575
RIKEN	BC053559	IRAK115M17	MGC	W01A019M06	pENTR-TOPO	14136		GRB14	2888	AAH53559.1	Hs.411881	Growth factor receptor-bound protein 14			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004490.2	NP_004481.2	REVIEWED	C	1.000	1.000	540	1623	1	1620	540	1	540
RIKEN	BC053559	IRAK115M17	MGC	W01A019M08	pENTR-TOPO	14136		GRB14	2888	AAH53559.1	Hs.411881	Growth factor receptor-bound protein 14			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004490.2	NP_004481.2	REVIEWED	C	1.000	1.000	540	1623	1	1620	540	1	540
RIKEN	BC043595	IRAK089J15	MGC	W01A019M24	pENTR-TOPO	16996		RFT1	91869	AAH43595.1	Hs.631910	RFT1 homolog (S. cerevisiae)			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_052859.3	NP_443091.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
RIKEN	BC047565	IRAK090K18	MGC	W01A019N02	pENTR-TOPO	20390		SLC22A16	85413	AAH47565.1	Hs.520319	Solute carrier family 22 (organic cation/carnitine transporter), member 16			Testis	NIH_MGC_97	DH10B	NM_033125.2	NP_149116.2	PROVISIONAL	C	1.000	1.000	577	1734	1	1731	577	1	577
RIKEN	BC029820	IRAK051C03	MGC	W01A019N03	pENTR-TOPO	18280		GK2	2712	AAH29820.1	Hs.98008	Glycerol kinase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_033214.2	NP_149991.2	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
RIKEN	BC063416	IRAK135J05	MGC	W01A019O08	pENTR-TOPO	12271		PLA2G4C	8605	AAH63416.1	Hs.631562	Phospholipase A2, group IVC (cytosolic, calcium-independent)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001159323.1	NP_001152795.1	REVIEWED	C	1.000	1.000	527	1626	1	1581	527	1	527
RIKEN	BC022397	IRAL036I05	MGC	W01A019O15	pENTR-TOPO	4569		RAG2	5897	AAH22397.1	Hs.714519	Recombination activating gene 2			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_000536.2	NP_000527.2	REVIEWED	Cs	0.996	0.996	527	1584	1	1581	527	1	527
RIKEN	BC037310	IRAK073I17	MGC	W01A019O22	pENTR-TOPO	18770		SLC1A3	6507	AAH37310.1	Hs.481918	Solute carrier family 1 (glial high affinity glutamate transporter), member 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004172.4	NP_004163.3	VALIDATED	Cs	0.998	0.998	542	1629	1	1626	542	1	542
RIKEN	BC012325	IRAL029A13	MGC	W01A019P19	pENTR-TOPO	18488		SLC22A5	6584	AAH12325.1	Hs.443572	Solute carrier family 22 (organic cation/carnitine transporter), member 5			Lung, large cell carcinoma	NIH_MGC_18		NM_003060.3	NP_003051.1	REVIEWED	Cs	0.998	0.998	557	1674	1	1671	557	1	557
RIKEN	BC001347	IRAL001I10	MGC	W01A020A08	pENTR-TOPO	3924		POLA2	23649	AAH01347.1	Hs.201897	Polymerase (DNA directed), alpha 2 (70kD subunit)			Lung, small cell carcinoma	NIH_MGC_7		NM_002689.2	NP_002680.2	PROVISIONAL	OK	1.000	1.000	598	1797	1	1794	598	1	598
RIKEN	AK055132	flj0014j17	FLJ	W01A020A09	pENTR-TOPO	4457		MFRP	83552	BAB70859.1	Hs.679518	Membrane frizzled-related protein				BRAWH2	EK1	NM_031433.2	NP_113621.1	REVIEWED	Cs	0.998	0.998	579	1740	1	1737	579	1	579
RIKEN	BC050261	IRAK093H17	MGC	W01A020A10	pENTR-TOPO	19183		SLC23A1	9963	AAH50261.1	Hs.643467	Solute carrier family 23 (nucleobase transporters), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152685.3	NP_689898.2	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
RIKEN	AK055132	flj0014j17	FLJ	W01A020A13	pENTR-TOPO	4457		MFRP	83552	BAB70859.1	Hs.679518	Membrane frizzled-related protein				BRAWH2	EK1	NM_031433.2	NP_113621.1	REVIEWED	Cs	0.998	0.998	579	1740	1	1737	579	1	579
RIKEN	BC050261	IRAK093H17	MGC	W01A020A14	pENTR-TOPO	19183		SLC23A1	9963	AAH50261.1	Hs.643467	Solute carrier family 23 (nucleobase transporters), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152685.3	NP_689898.2	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
RIKEN	BC050261	IRAK093H17	MGC	W01A020A16	pENTR-TOPO	19183		SLC23A1	9963	AAH50261.1	Hs.643467	Solute carrier family 23 (nucleobase transporters), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152685.3	NP_689898.2	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
RIKEN	BC003031	IRAL002O19	MGC	W01A020A17	pENTR-TOPO	7467		METTL3	56339	AAH03031.1	Hs.168799	Methyltransferase like 3			Lung, small cell carcinoma	NIH_MGC_7		NM_019852.3	NP_062826.2	REVIEWED	C	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	BC003031	IRAL002O19	MGC	W01A020A19	pENTR-TOPO	7467		METTL3	56339	AAH03031.1	Hs.168799	Methyltransferase like 3			Lung, small cell carcinoma	NIH_MGC_7		NM_019852.3	NP_062826.2	REVIEWED	C	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	BC035966	IRAL041F09	MGC	W01A020A24	pENTR-TOPO	14872		SLC13A3	64849	AAH35966.1	Hs.655498	Solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 3			Kidney	NIH_MGC_75	DH10B	NM_001011554.1	NP_001011554.1	REVIEWED	Cs	0.998	0.998	555	1809	142	1806	555	1	555
RIKEN	BC016932	IRAK027J09	MGC	W01A020B04	pENTR-TOPO	14033		SLC25A12	8604	AAH16932.1	Hs.470608	Solute carrier family 25 (mitochondrial carrier, Aralar), member 12			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003705.3	NP_003696.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
RIKEN	BC038984	IRAK082K22	MGC	W01A020B10	pENTR-TOPO	6536		GAS6	2621	AAH38984.1	Hs.646346	Growth arrest-specific 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001143945.1	NP_001137417.1	REVIEWED	C	1.000	1.000	405	2037	820	2034	405	1	405
RIKEN	BC003560	IRAL008B18	MGC	W01A020B11	pENTR-TOPO	14748		RPN2	6185	AAH03560.1	Hs.370895	Ribophorin II			Placenta, choriocarcinoma	NIH_MGC_21		NM_002951.3	NP_002942.2	REVIEWED	C	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC038984	IRAK082K22	MGC	W01A020B12	pENTR-TOPO	6536		GAS6	2621	AAH38984.1	Hs.646346	Growth arrest-specific 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001143945.1	NP_001137417.1	REVIEWED	C	1.000	1.000	405	2037	820	2034	405	1	405
RIKEN	BC003560	IRAL008B18	MGC	W01A020B13	pENTR-TOPO	14748		RPN2	6185	AAH03560.1	Hs.370895	Ribophorin II			Placenta, choriocarcinoma	NIH_MGC_21		NM_002951.3	NP_002942.2	REVIEWED	C	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC031828	IRAK029N10	MGC	W01A020B18	pENTR-TOPO	18626		KIF2A	3796	AAH31828.1	Hs.558351	Kinesin heavy chain member 2A				NCI_CGAP_Brn67	DH10B	NM_004520.3	NP_004511.2	VALIDATED	P	1.000	1.000	679	2040	1	2037	706	28	706
RIKEN	BC023593	IRAL033F09	MGC	W01A020B19	pENTR-TOPO	12198		XRCC1	7515	AAH23593.1	Hs.98493	X-ray repair complementing defective repair in Chinese hamster cells 1			Eye, retinoblastoma	NIH_MGC_16		NM_006297.2	NP_006288.2	REVIEWED	C	1.000	1.000	633	1902	1	1899	633	1	633
RIKEN	BC005149	IRAL007C22	MGC	W01A020C07	pENTR-TOPO	11588		MCOLN1	57192	AAH05149.1	Hs.631858	Mucolipin 1			Brain, neuroblastoma	NIH_MGC_19		NM_020533.1	NP_065394.1	VALIDATED	OK	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	BC030779	IRAK033H06	MGC	W01A020C14	pENTR-TOPO	24798		MTM1	4534	AAH30779.1	Hs.655056	Myotubularin 1			Testis	NIH_MGC_97	DH10B	NM_000252.2	NP_000243.1	REVIEWED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
RIKEN	BC003002	IRAL009M18	MGC	W01A020C24	pENTR-TOPO	8593		PLK1	5347	AAH03002.1	Hs.592049	Polo-like kinase 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7		NM_005030.3	NP_005021.2	PROVISIONAL	C	1.000	1.000	603	1812	1	1809	603	1	603
RIKEN	AK055882	flj0002i07	FLJ	W01A020D09	pENTR-TOPO	12180		PGLYRP2	114770	BAB71034.1	Hs.282244	Peptidoglycan recognition protein 2				LIVER1	EK1	NM_052890.3	NP_443122.3	VALIDATED	Cfs	0.959	0.965	580	1905	1	1741	576	1	576
RIKEN	AK055882	flj0002i07	FLJ	W01A020D11	pENTR-TOPO	12180		PGLYRP2	114770	BAB71034.1	Hs.282244	Peptidoglycan recognition protein 2				LIVER1	EK1	NM_052890.3	NP_443122.3	VALIDATED	Cfs	0.959	0.965	580	1905	1	1741	576	1	576
RIKEN	BC002962	IRAL008C12	MGC	W01A020D19	pENTR-TOPO	23667		SYK	6850	AAH02962.1	Hs.371720	Spleen tyrosine kinase			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003177.4	NP_003168.2	VALIDATED	C	1.000	1.000	635	1908	1	1905	635	1	635
RIKEN	BC002962	IRAL008C12	MGC	W01A020D21	pENTR-TOPO	23667		SYK	6850	AAH02962.1	Hs.371720	Spleen tyrosine kinase			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003177.4	NP_003168.2	VALIDATED	C	1.000	1.000	635	1908	1	1905	635	1	635
RIKEN	BC010634	IRAK013K19	MGC	W01A020E03	pENTR-TOPO	19207		SLU7	10569	AAH10634.1	Hs.435342	SLU7 splicing factor homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006425.4	NP_006416.3	REVIEWED	Cs	0.997	0.997	586	1761	1	1758	586	1	586
RIKEN	BC010856	IRAK014L19	MGC	W01A020E08	pENTR-TOPO	7370		TM9SF1	10548	AAH10856.1	Hs.91586	Transmembrane 9 superfamily member 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006405.5	NP_006396.2	VALIDATED	OK	1.000	1.000	606	1821	1	1818	606	1	606
RIKEN	BC012815	IRAL010K13	MGC	W01A020E12	pENTR-TOPO	7384		ABCD4	5826	AAH12815.1	Hs.94395	ATP-binding cassette, sub-family D (ALD), member 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005050.3	NP_005041.1	REVIEWED	Cs	0.997	0.997	606	1821	1	1818	606	1	606
RIKEN	BC064506	IRAL050N13	MGC	W01A020E17	pENTR-TOPO	2901		GRK5	2869	AAH64506.1	Hs.524625	G protein-coupled receptor kinase 5			Prostate, carcinoma	NIH_MGC_40		NM_005308.2	NP_005299.1	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC064506	IRAL050N13	MGC	W01A020E21	pENTR-TOPO	2901		GRK5	2869	AAH64506.1	Hs.524625	G protein-coupled receptor kinase 5			Prostate, carcinoma	NIH_MGC_40		NM_005308.2	NP_005299.1	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC001954	IRAL009K20	MGC	W01A020F04	pENTR-TOPO	252		PRPF3	9129	AAH01954.1	Hs.11776	PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20		NM_004698.2	NP_004689.1	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC001954	IRAL009K20	MGC	W01A020F08	pENTR-TOPO	252		PRPF3	9129	AAH01954.1	Hs.11776	PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20		NM_004698.2	NP_004689.1	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC001162	IRAL008G07	MGC	W01A020F13	pENTR-TOPO	4833		SRPR	6734	AAH01162.1	Hs.368376	Signal recognition particle receptor (docking protein)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003139.2	NP_003130.2	PROVISIONAL	C	1.000	1.000	638	1917	1	1914	638	1	638
RIKEN	BC035617	IRAK068H12	MGC	W01A020F19	pENTR-TOPO	10942		NDC80	10403	AAH35617.1	Hs.414407	NDC80 homolog, kinetochore complex component (S. cerevisiae)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006101.2	NP_006092.1	VALIDATED	OK	1.000	1.000	642	1929	1	1926	642	1	642
RIKEN	BC035617	IRAK068H12	MGC	W01A020F21	pENTR-TOPO	10942		NDC80	10403	AAH35617.1	Hs.414407	NDC80 homolog, kinetochore complex component (S. cerevisiae)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006101.2	NP_006092.1	VALIDATED	OK	1.000	1.000	642	1929	1	1926	642	1	642
RIKEN	BC028357	IRAK034H10	MGC	W01A020G12	pENTR-TOPO	18195		CLGN	1047	AAH28357.1	Hs.86368	Calmegin			Testis	NIH_MGC_97	DH10B	NM_004362.2	NP_004353.1	REVIEWED	C	1.000	1.000	610	1833	1	1830	610	1	610
RIKEN	BC025704	IRAK049M01	MGC	W01A020G13	pENTR-TOPO	12251		LILRB5	10990	AAH25704.1	Hs.655338	Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 5			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006840.3	NP_006831.1	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC028357	IRAK034H10	MGC	W01A020G16	pENTR-TOPO	18195		CLGN	1047	AAH28357.1	Hs.86368	Calmegin			Testis	NIH_MGC_97	DH10B	NM_004362.2	NP_004353.1	REVIEWED	C	1.000	1.000	610	1833	1	1830	610	1	610
RIKEN	BC024292	IRAL042O02	MGC	W01A020G19	pENTR-TOPO	6140		KRT5	3852	AAH24292.1	Hs.433845	Keratin 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_000424.3	NP_000415.2	REVIEWED	Cs	0.997	0.997	590	1773	1	1770	590	1	590
RIKEN	BC016027	IRAL008C05	MGC	W01A020G20	pENTR-TOPO	10305		DDX5	1655	AAH16027.1	Hs.279806	DEAD (Asp-Glu-Ala-Asp) box polypeptide 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004396.3	NP_004387.1	VALIDATED	C	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC016027	IRAL008C05	MGC	W01A020G24	pENTR-TOPO	10305		DDX5	1655	AAH16027.1	Hs.279806	DEAD (Asp-Glu-Ala-Asp) box polypeptide 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004396.3	NP_004387.1	VALIDATED	C	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC045639	IRAK077A11	MGC	W01A020H03	pENTR-TOPO	5951		SENP1	29843	AAH45639.2	Hs.719362	SUMO1/sentrin specific peptidase 1			Testis	NIH_MGC_97	DH10B	NM_014554.2	NP_055369.1	VALIDATED	Cgs	0.995	0.997	644	1935	1	1932	643	1	643
RIKEN	BC045639	IRAK077A11	MGC	W01A020H05	pENTR-TOPO	5951		SENP1	29843	AAH45639.2	Hs.719362	SUMO1/sentrin specific peptidase 1			Testis	NIH_MGC_97	DH10B	NM_014554.2	NP_055369.1	VALIDATED	Cgs	0.995	0.997	644	1935	1	1932	643	1	643
RIKEN	BC013879	IRAL014L09	MGC	W01A020H12	pENTR-TOPO	19184		PLK2	10769	AAH13879.1	Hs.398157	Polo-like kinase 2 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_20		NM_006622.2	NP_006613.2	VALIDATED	C	1.000	1.000	685	2058	1	2055	685	1	685
RIKEN	BC041091	IRAK079O23	MGC	W01A020H13	pENTR-TOPO	3889		ABCG4	64137	AAH41091.1	Hs.126378	ATP-binding cassette, sub-family G (WHITE), member 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001142505.1	NP_001135977.1	REVIEWED	C	1.000	1.000	646	1941	1	1938	646	1	646
RIKEN	BC013879	IRAL014L09	MGC	W01A020H16	pENTR-TOPO	19184		PLK2	10769	AAH13879.1	Hs.398157	Polo-like kinase 2 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_20		NM_006622.2	NP_006613.2	VALIDATED	C	1.000	1.000	685	2058	1	2055	685	1	685
RIKEN	BC012889	IRAK021K13	MGC	W01A020H17	pENTR-TOPO	11780		APLP1	333	AAH12889.1	Hs.74565	Amyloid beta (A4) precursor-like protein 1			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005166.3	NP_005157.1	REVIEWED	OK	1.000	1.000	650	1953	1	1950	650	1	650
RIKEN	BC009348	IRAL026K22	MGC	W01A020H18	pENTR-TOPO	8590		CIRH1A	84916	AAH09348.1	Hs.461113	Cirrhosis, autosomal recessive 1A (cirhin)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032830.2	NP_116219.2	REVIEWED	C	1.000	1.000	686	2061	1	2058	686	1	686
RIKEN	BC012889	IRAK021K13	MGC	W01A020H19	pENTR-TOPO	11780		APLP1	333	AAH12889.1	Hs.74565	Amyloid beta (A4) precursor-like protein 1			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005166.3	NP_005157.1	REVIEWED	OK	1.000	1.000	650	1953	1	1950	650	1	650
RIKEN	BC009348	IRAL026K22	MGC	W01A020H24	pENTR-TOPO	8590		CIRH1A	84916	AAH09348.1	Hs.461113	Cirrhosis, autosomal recessive 1A (cirhin)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032830.2	NP_116219.2	REVIEWED	C	1.000	1.000	686	2061	1	2058	686	1	686
RIKEN	BC017713	IRAK027E03	MGC	W01A020I01	pENTR-TOPO	19084		CDC23	8697	AAH17713.1	Hs.73625	Cell division cycle 23 homolog (S. cerevisiae)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_004661.3	NP_004652.2	REVIEWED	P	1.000	1.000	591	1776	1	1773	597	7	597
RIKEN	BC018126	IRAK022J06	MGC	W01A020I02	pENTR-TOPO	9640		RPA1	6117	AAH18126.1	Hs.461925	Replication protein A1, 70kDa			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002945.3	NP_002936.1	VALIDATED	C	1.000	1.000	616	1851	1	1848	616	1	616
RIKEN	BC017713	IRAK027E03	MGC	W01A020I03	pENTR-TOPO	19084		CDC23	8697	AAH17713.1	Hs.73625	Cell division cycle 23 homolog (S. cerevisiae)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_004661.3	NP_004652.2	REVIEWED	P	1.000	1.000	591	1776	1	1773	597	7	597
RIKEN	BC017713	IRAK027E03	MGC	W01A020I07	pENTR-TOPO	19084		CDC23	8697	AAH17713.1	Hs.73625	Cell division cycle 23 homolog (S. cerevisiae)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_004661.3	NP_004652.2	REVIEWED	P	1.000	1.000	591	1776	1	1773	597	7	597
RIKEN	BC018126	IRAK022J06	MGC	W01A020I08	pENTR-TOPO	9640		RPA1	6117	AAH18126.1	Hs.461925	Replication protein A1, 70kDa			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002945.3	NP_002936.1	VALIDATED	C	1.000	1.000	616	1851	1	1848	616	1	616
RIKEN	BC011890	IRAL028G04	MGC	W01A020I12	pENTR-TOPO	17718		ETFDH	2110	AAH11890.1	Hs.155729	Electron-transferring-flavoprotein dehydrogenase			Lung, small cell carcinoma	NIH_MGC_7		NM_004453.2	NP_004444.2	REVIEWED	Cs	0.998	0.998	617	1854	1	1851	617	1	617
RIKEN	BC016174	IRAK015D21	MGC	W01A020I24	pENTR-TOPO	4106		BIRC2	329	AAH16174.1	Hs.696238	Baculoviral IAP repeat-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001166.3	NP_001157.1	REVIEWED	C	1.000	1.000	618	1857	1	1854	618	1	618
RIKEN	BC001211	IRAL006F22	MGC	W01A020J02	pENTR-TOPO	9124		KIFC3	3801	AAH01211.2	Hs.495080	Kinesin family member C3			Brain, neuroblastoma	NIH_MGC_19		NM_001130100.1	NP_001123572.1	VALIDATED	P	1.000	1.000	686	2085	1	2058	826	140	825
RIKEN	BC043147	IRAK076N24	MGC	W01A020J07	pENTR-TOPO	11531		ZNF254	9534	AAH43147.2	Hs.434406	Zinc finger protein 254			Testis	NIH_MGC_97	DH10B	NM_203282.2	NP_975011.3	VALIDATED	Ps	0.997	0.997	650	1953	1	1950	659	10	659
RIKEN	BC024270	IRAL042A02	MGC	W01A020J10	pENTR-TOPO	24504		TSPYL2	64061	AAH24270.1	Hs.136164	TSPY-like 2			Lung, small cell carcinoma	NIH_MGC_7		NM_022117.2	NP_071400.1	VALIDATED	C	1.000	1.000	693	2082	1	2079	693	1	693
RIKEN	BC024270	IRAL042A02	MGC	W01A020J14	pENTR-TOPO	24504		TSPYL2	64061	AAH24270.1	Hs.136164	TSPY-like 2			Lung, small cell carcinoma	NIH_MGC_7		NM_022117.2	NP_071400.1	VALIDATED	C	1.000	1.000	693	2082	1	2079	693	1	693
RIKEN	BC032726	IRAK069J10	MGC	W01A020J18	pENTR-TOPO	17462		DCLK2	166614	AAH32726	Hs.591683	Doublecortin-like kinase 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001040261.3	NP_001035351.3	VALIDATED	P	1.000	1.000	690	2088	1	2070	765	1	690
RIKEN	BC032726	IRAK069J10	MGC	W01A020J24	pENTR-TOPO	17462		DCLK2	166614	AAH32726	Hs.591683	Doublecortin-like kinase 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001040261.3	NP_001035351.3	VALIDATED	P	1.000	1.000	690	2088	1	2070	765	1	690
RIKEN	BC047620	IRAK090O17	MGC	W01A020K06	pENTR-TOPO	17477		GUCY1B3	2983	AAH47620.2	Hs.77890	Guanylate cyclase 1, soluble, beta 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000857.2	NP_000848.1	VALIDATED	C	1.000	1.000	619	1860	1	1857	619	1	619
RIKEN	BC041799	IRAK077A01	MGC	W01A020K09	pENTR-TOPO	19200		CDKL3	51265	AAH41799.1					Testis	NIH_MGC_97	DH10B	NM_001113575.1	NP_001107047.1	REVIEWED	C	1.000	1.000	592	1779	1	1776	592	1	592
RIKEN	BC041799	IRAK077A01	MGC	W01A020K11	pENTR-TOPO	19200		CDKL3	51265	AAH41799.1					Testis	NIH_MGC_97	DH10B	NM_001113575.1	NP_001107047.1	REVIEWED	C	1.000	1.000	592	1779	1	1776	592	1	592
RIKEN	BC033816	IRAK068N09	MGC	W01A020K12	pENTR-TOPO	25232		SLC7A3	84889	AAH33816.1	Hs.175220	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001048164.1	NP_001041629.1	VALIDATED	Cs	0.997	0.997	619	1860	1	1857	619	1	619
RIKEN	BC033816	IRAK068N09	MGC	W01A020K14	pENTR-TOPO	25232		SLC7A3	84889	AAH33816.1	Hs.175220	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001048164.1	NP_001041629.1	VALIDATED	Cs	0.997	0.997	619	1860	1	1857	619	1	619
RIKEN	BC041799	IRAK077A01	MGC	W01A020K15	pENTR-TOPO	19200		CDKL3	51265	AAH41799.1					Testis	NIH_MGC_97	DH10B	NM_001113575.1	NP_001107047.1	REVIEWED	C	1.000	1.000	592	1779	1	1776	592	1	592
RIKEN	BC033816	IRAK068N09	MGC	W01A020K16	pENTR-TOPO	25232		SLC7A3	84889	AAH33816.1	Hs.175220	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001048164.1	NP_001041629.1	VALIDATED	Cs	0.997	0.997	619	1860	1	1857	619	1	619
RIKEN	BC004904	IRAL011I05	MGC	W01A020K20	pENTR-TOPO	4510		NXF1	10482	AAH04904.1	Hs.523739	Nuclear RNA export factor 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006362.4	NP_006353.2	REVIEWED	OK	1.000	1.000	619	1860	1	1857	619	1	619
RIKEN	BC004904	IRAL011I05	MGC	W01A020K22	pENTR-TOPO	4510		NXF1	10482	AAH04904.1	Hs.523739	Nuclear RNA export factor 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006362.4	NP_006353.2	REVIEWED	OK	1.000	1.000	619	1860	1	1857	619	1	619
RIKEN	AK056792	flj0006b23	FLJ	W01A020K23	pENTR-TOPO	15020		FAM65C	140876	BAB71286.1	Hs.372578	Family with sequence similarity 65, member C				PLACE6	EK1	NM_080829.2	NP_543019.2	PREDICTED	Ps	0.995	0.995	593	1782	1	1779	946	1	593
RIKEN	BC001883	IRAL008A11	MGC	W01A020L02	pENTR-TOPO	2783		NOLC1	9221	AAH01883.1	Hs.523238	Nucleolar and coiled-body phosphoprotein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004741.3	NP_004732.2	VALIDATED	Cgs	0.997	0.999	700	2103	1	2100	699	1	699
RIKEN	BC006161	IRAL018J08	MGC	W01A020L03	pENTR-TOPO	11457		SPHK2	56848	AAH06161.1					Lymph, Burkitt lymphoma	NIH_MGC_8		NM_020126.3	NP_064511.2	PROVISIONAL	OK	1.000	1.000	654	1965	1	1962	654	1	654
RIKEN	BC001883	IRAL008A11	MGC	W01A020L04	pENTR-TOPO	2783		NOLC1	9221	AAH01883.1	Hs.523238	Nucleolar and coiled-body phosphoprotein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004741.3	NP_004732.2	VALIDATED	Cgs	0.997	0.999	700	2103	1	2100	699	1	699
RIKEN	BC001883	IRAL008A11	MGC	W01A020L06	pENTR-TOPO	2783		NOLC1	9221	AAH01883.1	Hs.523238	Nucleolar and coiled-body phosphoprotein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004741.3	NP_004732.2	VALIDATED	Cgs	0.997	0.999	700	2103	1	2100	699	1	699
RIKEN	BC001883	IRAL008A11	MGC	W01A020L08	pENTR-TOPO	2783		NOLC1	9221	AAH01883.1	Hs.523238	Nucleolar and coiled-body phosphoprotein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004741.3	NP_004732.2	VALIDATED	Cgs	0.997	0.999	700	2103	1	2100	699	1	699
RIKEN	BC021281	IRAL039K21	MGC	W01A020L11	pENTR-TOPO	18004		ABCG2	9429	AAH21281.1	Hs.480218	ATP-binding cassette, sub-family G (WHITE), member 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_004827.2	NP_004818.2	REVIEWED	C	1.000	1.000	655	1968	1	1965	655	1	655
RIKEN	BC021281	IRAL039K21	MGC	W01A020L15	pENTR-TOPO	18004		ABCG2	9429	AAH21281.1	Hs.480218	ATP-binding cassette, sub-family G (WHITE), member 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_004827.2	NP_004818.2	REVIEWED	C	1.000	1.000	655	1968	1	1965	655	1	655
RIKEN	BC045542	IRAK106P17	MGC	W01A020L16	pENTR-TOPO	19161		KIF3A	11127	AAH45542.1	Hs.43670	Kinesin family member 3A			Testis	NIH_MGC_97	DH10B	NM_007054.5	NP_008985.3	VALIDATED	Cgs	0.993	0.997	702	2109	1	2106	699	1	699
RIKEN	AK000607	flj0064h08	FLJ	W01A020M03	pENTR-TOPO	9670		GRN	2896	-	Hs.514220	Granulin				KAT	EK1	NM_002087.2	NP_002078.1	REVIEWED	C	1.000	1.000	593	1782	1	1779	593	1	593
RIKEN	BC000032	IRAL007C12	MGC	W01A020M10	pENTR-TOPO	24151		FANCG	2189	AAH00032.1	Hs.591084	Fanconi anemia, complementation group G			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004629.1	NP_004620.1	REVIEWED	C	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC000032	IRAL007C12	MGC	W01A020M14	pENTR-TOPO	24151		FANCG	2189	AAH00032.1	Hs.591084	Fanconi anemia, complementation group G			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004629.1	NP_004620.1	REVIEWED	C	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC049203	IRAK093M18	MGC	W01A020N01	pENTR-TOPO	23608		SLC44A1	23446	AAH49203.1	Hs.573495	Solute carrier family 44, member 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080546.3	NP_536856.2	VALIDATED	OK	1.000	1.000	657	1974	1	1971	657	1	657
RIKEN	BC012399	IRAK021J23	MGC	W01A020N02	pENTR-TOPO	25269		MTMR8	55613	AAH12399.1	Hs.442892	Myotubularin related protein 8			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_017677.2	NP_060147.2	PROVISIONAL	OK	1.000	1.000	704	2115	1	2112	704	1	704
RIKEN	BC012399	IRAK021J23	MGC	W01A020N04	pENTR-TOPO	25269		MTMR8	55613	AAH12399.1	Hs.442892	Myotubularin related protein 8			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_017677.2	NP_060147.2	PROVISIONAL	OK	1.000	1.000	704	2115	1	2112	704	1	704
RIKEN	BC049203	IRAK093M18	MGC	W01A020N07	pENTR-TOPO	23608		SLC44A1	23446	AAH49203.1	Hs.573495	Solute carrier family 44, member 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080546.3	NP_536856.2	VALIDATED	OK	1.000	1.000	657	1974	1	1971	657	1	657
RIKEN	BC012399	IRAK021J23	MGC	W01A020N08	pENTR-TOPO	25269		MTMR8	55613	AAH12399.1	Hs.442892	Myotubularin related protein 8			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_017677.2	NP_060147.2	PROVISIONAL	OK	1.000	1.000	704	2115	1	2112	704	1	704
RIKEN	BC001257	IRAK004P01	MGC	W01A020O01	pENTR-TOPO	1798		GLMN	11146	AAH01257.1	Hs.666341	Glomulin, FKBP associated protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_053274.2	NP_444504.1	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
RIKEN	BC015020	IRAK015N20	MGC	W01A020O04	pENTR-TOPO	24676		NXF2	56001	AAH15020.1	Hs.530358	Nuclear RNA export factor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022053.1	NP_071336.1	REVIEWED	C	1.000	1.000	626	1881	1	1878	626	1	626
RIKEN	AK026413	flj0060j03	FLJ	W01A020O11	pENTR-TOPO	21930		SLC13A1	6561	BAB15477.1	Hs.489849	Solute carrier family 13 (sodium/sulfate symporters), member 1				kaia	EK1	NM_022444.3	NP_071889.2	VALIDATED	Cs	0.998	0.998	595	1788	1	1785	595	1	595
RIKEN	BC053347	IRAK115C15	MGC	W01A020O12	pENTR-TOPO	11469		MAG	4099	AAH53347.1	Hs.643440	Myelin associated glycoprotein			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002361.2	NP_002352.1	REVIEWED	C	1.000	1.000	626	1881	1	1878	626	1	626
RIKEN	AK026413	flj0060j03	FLJ	W01A020O13	pENTR-TOPO	21930		SLC13A1	6561	BAB15477.1	Hs.489849	Solute carrier family 13 (sodium/sulfate symporters), member 1				kaia	EK1	NM_022444.3	NP_071889.2	VALIDATED	Cs	0.998	0.998	595	1788	1	1785	595	1	595
RIKEN	BC053347	IRAK115C15	MGC	W01A020O14	pENTR-TOPO	11469		MAG	4099	AAH53347.1	Hs.643440	Myelin associated glycoprotein			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002361.2	NP_002352.1	REVIEWED	C	1.000	1.000	626	1881	1	1878	626	1	626
RIKEN	BC053347	IRAK115C15	MGC	W01A020O16	pENTR-TOPO	11469		MAG	4099	AAH53347.1	Hs.643440	Myelin associated glycoprotein			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002361.2	NP_002352.1	REVIEWED	C	1.000	1.000	626	1881	1	1878	626	1	626
RIKEN	BC027955	IRAK049J16	MGC	W01A020O22	pENTR-TOPO	10012		GP1BA	2811	AAH27955.1	Hs.1472	Glycoprotein Ib (platelet), alpha polypeptide			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000173.4	NP_000164.4	REVIEWED	Cgs	0.978	0.998	639	1881	1	1878	639	1	639
RIKEN	BC025358	IRAL042L14	MGC	W01A021A08	pENTR-TOPO	24810		ABCD1	215	AAH25358.1	Hs.159546	ATP-binding cassette, sub-family D (ALD), member 1			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_000033.3	NP_000024.2	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
RIKEN	BC034047	IRAK032G18	MGC	W01A021A17	pENTR-TOPO	1548		LRRN2	10446	AAH34047.1	Hs.26312	Leucine rich repeat neuronal 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006338.2	NP_006329.2	REVIEWED	Cs	0.997	0.997	713	2142	1	2139	713	1	713
RIKEN	BC031651	IRAK051B04	MGC	W01A021A18	pENTR-TOPO	7372		POMT2	29954	AAH31651.1	Hs.132989	Protein-O-mannosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_013382.5	NP_037514.2	REVIEWED	C	1.000	1.000	750	2253	1	2250	750	1	750
RIKEN	BC026169	IRAK034G03	MGC	W01A021B01	pENTR-TOPO	22726		ADAM32	203102	AAH26169.1	Hs.521545	ADAM metallopeptidase domain 32			Testis	NIH_MGC_97	DH10B	NM_145004.5	NP_659441.3	VALIDATED	C	1.000	1.000	787	2364	1	2361	787	1	787
RIKEN	BC028702	IRAK034G02	MGC	W01A021B11	pENTR-TOPO	22726		ADAM32	203102	AAH28702.1	Hs.521545	ADAM metallopeptidase domain 32			Testis	NIH_MGC_97	DH10B	NM_145004.5	NP_659441.3	VALIDATED	C	1.000	1.000	787	2364	1	2361	787	1	787
RIKEN	BC011656	IRAL017N22	MGC	W01A021B16	pENTR-TOPO	10711		CDC27	996	AAH11656.1	Hs.463295	Cell division cycle 27 homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001114091.1	NP_001107563.1	REVIEWED	Cs	0.999	0.999	830	2493	1	2490	830	1	830
RIKEN	BC050358	IRAK098J06	MGC	W01A021B17	pENTR-TOPO	21143		TAX1BP1	8887	AAH50358.1	Hs.34576	Tax1 (human T-cell leukemia virus type I) binding protein 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006024.5	NP_006015.4	VALIDATED	Cs	0.999	0.999	789	2370	1	2367	789	1	789
RIKEN	BC040207	IRAK071C02	MGC	W01A021B22	pENTR-TOPO	20787		NEDD9	4739	AAH40207.1	Hs.37982	Neural precursor cell expressed, developmentally down-regulated 9			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006403.3	NP_006394.1	VALIDATED	C	1.000	1.000	834	2505	1	2502	834	1	834
RIKEN	BC040207	IRAK071C02	MGC	W01A021B24	pENTR-TOPO	20787		NEDD9	4739	AAH40207.1	Hs.37982	Neural precursor cell expressed, developmentally down-regulated 9			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006403.3	NP_006394.1	VALIDATED	C	1.000	1.000	834	2505	1	2502	834	1	834
RIKEN	BC028355	IRAK034B23	MGC	W01A021C01	pENTR-TOPO	5885		MDM1	56890	AAH28355.1	Hs.655702	Mdm1 nuclear protein homolog (mouse)			Testis	NIH_MGC_97	DH10B	NM_017440.4	NP_059136.2	REVIEWED	Cs	0.996	0.996	714	2145	1	2142	714	1	714
RIKEN	BC006301	IRAL017C01	MGC	W01A021C10	pENTR-TOPO	5964		ANAPC5	51433	AAH06301.1	Hs.7101	Anaphase promoting complex subunit 5			Brain, neuroblastoma	NIH_MGC_19		NM_016237.4	NP_057321.2	REVIEWED	C	1.000	1.000	755	2268	1	2265	755	1	755
RIKEN	BC043165	IRAK076B13	MGC	W01A021C13	pENTR-TOPO	7109		LRFN5	145581	AAH43165.1	Hs.715685	Leucine rich repeat and fibronectin type III domain containing 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152447.3	NP_689660.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
RIKEN	BC028372	IRAK034J01	MGC	W01A021D01	pENTR-TOPO	1666		ADAM30	11085	AAH28372.1	Hs.283011	ADAM metallopeptidase domain 30			Testis	NIH_MGC_97	DH10B	NM_021794.2	NP_068566.2	REVIEWED	Cs	0.999	0.999	790	2373	1	2370	790	1	790
RIKEN	BC032398	IRAK064H23	MGC	W01A021D02	pENTR-TOPO	9950		ATP6V0A1	535	AAH32398.1	Hs.463074	ATPase, H+ transporting, lysosomal V0 subunit a1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001130021.1	NP_001123493.1	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC028372	IRAK034J01	MGC	W01A021D07	pENTR-TOPO	1666		ADAM30	11085	AAH28372.1	Hs.283011	ADAM metallopeptidase domain 30			Testis	NIH_MGC_97	DH10B	NM_021794.2	NP_068566.2	REVIEWED	Cs	0.999	0.999	790	2373	1	2370	790	1	790
RIKEN	BC040986	IRAK070L18	MGC	W01A021D12	pENTR-TOPO	25312		SLITRK4	139065	AAH40986.1	Hs.272284	SLIT and NTRK-like family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173078.2	NP_775101.1	VALIDATED	C	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC031051	IRAK048H03	MGC	W01A021D15	pENTR-TOPO	19439		CDH18	1016	AAH31051.1	Hs.317632	Cadherin 18, type 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004934.2	NP_004925.1	REVIEWED	Cs	0.995	0.995	790	2373	1	2370	790	1	790
RIKEN	BC001450	IRAL004F17	MGC	W01A021D17	pENTR-TOPO	23506		NCBP1	4686	AAH01450.1	Hs.595669	Nuclear cap binding protein subunit 1, 80kDa			Placenta, choriocarcinoma	NIH_MGC_21		NM_002486.4	NP_002477.1	REVIEWED	C	1.000	1.000	790	2373	1	2370	790	1	790
RIKEN	BC001450	IRAL004F17	MGC	W01A021D21	pENTR-TOPO	23506		NCBP1	4686	AAH01450.1	Hs.595669	Nuclear cap binding protein subunit 1, 80kDa			Placenta, choriocarcinoma	NIH_MGC_21		NM_002486.4	NP_002477.1	REVIEWED	C	1.000	1.000	790	2373	1	2370	790	1	790
RIKEN	BC047719	IRAK098D19	MGC	W01A021E01	pENTR-TOPO	8793		TMC7	79905	AAH47719.1	Hs.187377	Transmembrane channel-like 7			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001160364.1	NP_001153836.1	VALIDATED	C	1.000	1.000	613	2172	331	2169	613	1	613
RIKEN	BC032665	IRAK069L03	MGC	W01A021E11	pENTR-TOPO	8774		EEF2K	29904	AAH32665.1	Hs.498892	Eukaryotic elongation factor-2 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_013302.3	NP_037434.1	REVIEWED	Cs	0.999	0.999	725	2178	1	2175	725	1	725
RIKEN	BC008764	IRAL005H04	MGC	W01A021E21	pENTR-TOPO	831		KIF2C	11004	AAH08764.1	Hs.69360	Kinesin family member 2C			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006845.3	NP_006836.2	VALIDATED	Cs	0.999	0.999	725	2178	1	2175	725	1	725
RIKEN	BC047608	IRAK088N08	MGC	W01A021F07	pENTR-TOPO	19344		CDH12	1010	AAH47608.1	Hs.113684	Cadherin 12, type 2 (N-cadherin 2)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004061.3	NP_004052.2	REVIEWED	C	1.000	1.000	794	2385	1	2382	794	1	794
RIKEN	BC011599	IRAL004M07	MGC	W01A021F08	pENTR-TOPO	15834		TFIP11	24144	AAH11599.1	Hs.20225	Tuftelin interacting protein 11			Skin, melanotic melanoma.	NIH_MGC_20		NM_012143.2	NP_036275.1	VALIDATED	C	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC013979	IRAL027M19	MGC	W01A021G02	pENTR-TOPO	14209		GGCX	2677	AAH13979.1	Hs.77719	Gamma-glutamyl carboxylase			Brain, neuroblastoma	NIH_MGC_19		NM_000821.4	NP_000812.2	REVIEWED	OK	1.000	1.000	758	2277	1	2274	758	1	758
RIKEN	BC016657	IRAK026A02	MGC	W01A021G03	pENTR-TOPO	922		PLOD1	5351	AAH16657.1	Hs.75093	Procollagen-lysine 1, 2-oxoglutarate 5-dioxygenase 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000302.2	NP_000293.2	REVIEWED	Cs	0.997	0.997	727	2184	1	2181	727	1	727
RIKEN	BC034950	IRAK033K04	MGC	W01A021G09	pENTR-TOPO	5332		TBK1	29110	AAH34950.1	Hs.607889	TANK-binding kinase 1			Testis	NIH_MGC_97	DH10B	NM_013254.2	NP_037386.1	REVIEWED	Cs	0.997	0.997	729	2190	1	2187	729	1	729
RIKEN	BC026250	IRAL037H15	MGC	W01A021G10	pENTR-TOPO	13878		FAP	2191	AAH26250.1	Hs.654370	Fibroblast activation protein, alpha			Placenta	NIH_MGC_79	DH10B	NM_004460.2	NP_004451.2	REVIEWED	C	1.000	1.000	760	2283	1	2280	760	1	760
RIKEN	BC050549	IRAK107N01	MGC	W01A021G18	pENTR-TOPO	9669		AOC3	8639	AAH50549.1	Hs.198241	Amine oxidase, copper containing 3 (vascular adhesion protein 1)				Lupski_sympathetic_trunk	DH10B	NM_003734.2	NP_003725.1	REVIEWED	C	1.000	1.000	763	2292	1	2289	763	1	763
RIKEN	BC050549	IRAK107N01	MGC	W01A021G20	pENTR-TOPO	9669		AOC3	8639	AAH50549.1	Hs.198241	Amine oxidase, copper containing 3 (vascular adhesion protein 1)				Lupski_sympathetic_trunk	DH10B	NM_003734.2	NP_003725.1	REVIEWED	C	1.000	1.000	763	2292	1	2289	763	1	763
RIKEN	BC001186	IRAL008O05	MGC	W01A021H01	pENTR-TOPO	18569		PCDHB5	26167	AAH01186.1	Hs.119693	Protocadherin beta 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_015669.2	NP_056484.1	REVIEWED	Cs	0.999	0.999	795	2388	1	2385	795	1	795
RIKEN	BC001186	IRAL008O05	MGC	W01A021H05	pENTR-TOPO	18569		PCDHB5	26167	AAH01186.1	Hs.119693	Protocadherin beta 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_015669.2	NP_056484.1	REVIEWED	Cs	0.999	0.999	795	2388	1	2385	795	1	795
RIKEN	AK027360	flj0030k17	FLJ	W01A021H21	pENTR-TOPO	16399		GPR128	84873	BAB55061.1	Hs.334511	G protein-coupled receptor 128				HEMBB1	EK1	NM_032787.2	NP_116176.2	VALIDATED	Cs	0.999	0.999	797	2394	1	2391	797	1	797
RIKEN	BC036109	IRAK048L23	MGC	W01A021H22	pENTR-TOPO	23501		SECISBP2	79048	AAH36109.1	Hs.59804	SECIS binding protein 2			Testis	NIH_MGC_97	DH10B	NM_024077.3	NP_076982.3	REVIEWED	Cs	0.999	0.999	854	2565	1	2562	854	1	854
RIKEN	BC002363	IRAL001M20	MGC	W01A021I05	pENTR-TOPO	20416		RPS6KA2	6196	AAH02363.1	Hs.719131	Ribosomal protein S6 kinase, 90kDa, polypeptide 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021135.4	NP_066958.2	REVIEWED	C	1.000	1.000	733	2202	1	2199	733	1	733
RIKEN	BC007413	IRAL003G24	MGC	W01A021I12	pENTR-TOPO	14877		FASTKD5	60493	AAH07413.1					Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021826.4	NP_068598.1	VALIDATED	C	1.000	1.000	764	2295	1	2292	764	1	764
RIKEN	BC014966	IRAL034K03	MGC	W01A021I15	pENTR-TOPO	709		RPS6KA1	6195	AAH14966.1	Hs.149957	Ribosomal protein S6 kinase, 90kDa, polypeptide 1			Colon, adenocarcinoma	NIH_MGC_15		NM_002953.3	NP_002944.2	REVIEWED	C	1.000	1.000	735	2208	1	2205	735	1	735
RIKEN	BC051728	IRAK090I14	MGC	W01A021I21	pENTR-TOPO	25267		ZNF280C	55609	AAH51728.1	Hs.308418	Zinc finger protein 280C			Testis	NIH_MGC_97	DH10B	NM_017666.3	NP_060136.1	VALIDATED	C	1.000	1.000	737	2214	1	2211	737	1	737
RIKEN	BC020548	IRAK027J08	MGC	W01A021J10	pENTR-TOPO	13890		TGFBRAP1	9392	AAH20548.1	Hs.446350	Transforming growth factor, beta receptor associated protein 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004257.4	NP_004248.2	VALIDATED	C	1.000	1.000	860	2583	1	2580	860	1	860
RIKEN	BC020548	IRAK027J08	MGC	W01A021J14	pENTR-TOPO	13890		TGFBRAP1	9392	AAH20548.1	Hs.446350	Transforming growth factor, beta receptor associated protein 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004257.4	NP_004248.2	VALIDATED	C	1.000	1.000	860	2583	1	2580	860	1	860
RIKEN	BC000081	IRAL007O09	MGC	W01A021J15	pENTR-TOPO	3755		PKP3	11187	AAH00081.1	Hs.534395	Plakophilin 3			Placenta, choriocarcinoma	NIH_MGC_21		NM_007183.2	NP_009114.1	REVIEWED	C	1.000	1.000	797	2394	1	2391	797	1	797
RIKEN	BC020548	IRAK027J08	MGC	W01A021J16	pENTR-TOPO	13890		TGFBRAP1	9392	AAH20548.1	Hs.446350	Transforming growth factor, beta receptor associated protein 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004257.4	NP_004248.2	VALIDATED	C	1.000	1.000	860	2583	1	2580	860	1	860
RIKEN	BC011539	IRAK013J04	MGC	W01A021J18	pENTR-TOPO	2172		ORC1L	4998	AAH11539.1	Hs.17908	Origin recognition complex, subunit 1-like (yeast)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004153.2	NP_004144.2	REVIEWED	Cs	0.999	0.999	861	2586	1	2583	861	1	861
RIKEN	BC065265	IRAK140L09	MGC	W01A021K04	pENTR-TOPO	14246		DPP4	1803	AAH65265.1	Hs.368912	Dipeptidyl-peptidase 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001935.3	NP_001926.2	REVIEWED	C	1.000	1.000	766	2301	1	2298	766	1	766
RIKEN	BC035009	IRAK046H22	MGC	W01A021K07	pENTR-TOPO	14006		DNER	92737	AAH35009.1	Hs.234074	Delta/notch-like EGF repeat containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_139072.3	NP_620711.3	VALIDATED	Cs	0.999	0.999	737	2214	1	2211	737	1	737
RIKEN	BC005404	IRAK004B02	MGC	W01A021K12	pENTR-TOPO	14779		SEC23B	10483	AAH05404.1	Hs.369373	Sec23 homolog B (S. cerevisiae)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006363.4	NP_006354.2	REVIEWED	Cs	0.997	0.997	767	2304	1	2301	767	1	767
RIKEN	BC005404	IRAK004B02	MGC	W01A021K16	pENTR-TOPO	14779		SEC23B	10483	AAH05404.1	Hs.369373	Sec23 homolog B (S. cerevisiae)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006363.4	NP_006354.2	REVIEWED	Cs	0.997	0.997	767	2304	1	2301	767	1	767
RIKEN	BC031837	IRAK029N18	MGC	W01A021L05	pENTR-TOPO	18629		PCDHB10	56126	AAH31837.1	Hs.657953	Protocadherin beta 10				NCI_CGAP_Brn67	DH10B	NM_018930.3	NP_061753.1	REVIEWED	C	1.000	1.000	800	2403	1	2400	800	1	800
RIKEN	BC054500	IRAK107F02	MGC	W01A021L12	pENTR-TOPO	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006378.3	NP_006369.3	VALIDATED	Cs	0.999	0.999	862	2589	1	2586	862	1	862
RIKEN	BC011674	IRAL026N12	MGC	W01A021M01	pENTR-TOPO	21868		PLOD3	8985	AAH11674.1	Hs.153357	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_001084.4	NP_001075.1	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
RIKEN	BC027720	IRAL030L14	MGC	W01A021M09	pENTR-TOPO	15053		LRRN4	164312	AAH27720.1	Hs.716060	Leucine rich repeat neuronal 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_152611.3	NP_689824.2	VALIDATED	Cs	0.999	0.999	740	2223	1	2220	740	1	740
RIKEN	BC027720	IRAL030L14	MGC	W01A021M11	pENTR-TOPO	15053		LRRN4	164312	AAH27720.1	Hs.716060	Leucine rich repeat neuronal 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_152611.3	NP_689824.2	VALIDATED	Cs	0.999	0.999	740	2223	1	2220	740	1	740
RIKEN	BC027720	IRAL030L14	MGC	W01A021M13	pENTR-TOPO	15053		LRRN4	164312	AAH27720.1	Hs.716060	Leucine rich repeat neuronal 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_152611.3	NP_689824.2	VALIDATED	Cs	0.999	0.999	740	2223	1	2220	740	1	740
RIKEN	BC033043	IRAK046H02	MGC	W01A021N21	pENTR-TOPO	7094		EML1	2009	AAH33043.1	Hs.12451	Echinoderm microtubule associated protein like 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004434.2	NP_004425.2	REVIEWED	Cs	0.999	0.999	815	2448	1	2445	815	1	815
RIKEN	BC024211	IRAL011M05	MGC	W01A021O13	pENTR-TOPO	13504		NCAPH	23397	AAH24211.1	Hs.308045	Non-SMC condensin I complex, subunit H			Placenta, choriocarcinoma	NIH_MGC_21		NM_015341.3	NP_056156.2	REVIEWED	Cs	0.999	0.999	741	2226	1	2223	741	1	741
RIKEN	BC024211	IRAL011M05	MGC	W01A021O15	pENTR-TOPO	13504		NCAPH	23397	AAH24211.1	Hs.308045	Non-SMC condensin I complex, subunit H			Placenta, choriocarcinoma	NIH_MGC_21		NM_015341.3	NP_056156.2	REVIEWED	Cs	0.999	0.999	741	2226	1	2223	741	1	741
RIKEN	BC030613	IRAK046D19	MGC	W01A021O17	pENTR-TOPO	9699		NSF	4905	AAH30613.1	Hs.431279	N-ethylmaleimide-sensitive factor			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006178.2	NP_006169.2	VALIDATED	C	1.000	1.000	744	2235	1	2232	744	1	744
RIKEN	BC030613	IRAK046D19	MGC	W01A021O21	pENTR-TOPO	9699		NSF	4905	AAH30613.1	Hs.431279	N-ethylmaleimide-sensitive factor			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006178.2	NP_006169.2	VALIDATED	C	1.000	1.000	744	2235	1	2232	744	1	744
RIKEN	BC032541	IRAK069K03	MGC	W01A021P01	pENTR-TOPO	7094		EML1	2009	AAH32541.1	Hs.12451	Echinoderm microtubule associated protein like 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004434.2	NP_004425.2	REVIEWED	Cs	0.999	0.999	815	2448	1	2445	815	1	815
RIKEN	BC032541	IRAK069K03	MGC	W01A021P03	pENTR-TOPO	7094		EML1	2009	AAH32541.1	Hs.12451	Echinoderm microtubule associated protein like 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004434.2	NP_004425.2	REVIEWED	Cs	0.999	0.999	815	2448	1	2445	815	1	815
RIKEN	BC062558	IRAL050P08	MGC	W01A022A01	pENTR-TOPO	23447		PKN3	29941	AAH62558.1	Hs.300485	Protein kinase N3			Ovary, teratocarcinoma	NIH_MGC_109		NM_013355.3	NP_037487.2	VALIDATED	OK	1.000	1.000	889	2670	1	2667	889	1	889
RIKEN	BC012999	IRAL011L18	MGC	W01A022A11	pENTR-TOPO	18608		KIF20A	10112	AAH12999.1	Hs.718626	Kinesin family member 20A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005733.2	NP_005724.1	VALIDATED	C	1.000	1.000	890	2673	1	2670	890	1	890
RIKEN	BC012999	IRAL011L18	MGC	W01A022A15	pENTR-TOPO	18608		KIF20A	10112	AAH12999.1	Hs.718626	Kinesin family member 20A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005733.2	NP_005724.1	VALIDATED	C	1.000	1.000	890	2673	1	2670	890	1	890
RIKEN	BC046363	IRAK089E04	MGC	W01A022A18	pENTR-TOPO	9172		ZC3H7A	29066	AAH46363.1	Hs.371856	Zinc finger CCCH-type containing 7A			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014153.2	NP_054872.2	PROVISIONAL	C	1.000	1.000	971	2916	1	2913	971	1	971
RIKEN	BC040340	IRAK012I12	MGC	W01A022A19	pENTR-TOPO	18908		TNPO1	3842	AAH40340.1	Hs.482497	Transportin 1				NCI_CGAP_Brn67	DH10B	NM_153188.2	NP_694858.1	REVIEWED	C	1.000	1.000	890	2673	1	2670	890	1	890
RIKEN	BC046363	IRAK089E04	MGC	W01A022A20	pENTR-TOPO	9172		ZC3H7A	29066	AAH46363.1	Hs.371856	Zinc finger CCCH-type containing 7A			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014153.2	NP_054872.2	PROVISIONAL	C	1.000	1.000	971	2916	1	2913	971	1	971
RIKEN	BC033094	IRAL043E18	MGC	W01A022B02	pENTR-TOPO	24036		IKBKAP	8518	AAH33094.1	Hs.494738	Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003640.3	NP_003631.2	REVIEWED	Cs	0.998	0.998	1332	3999	1	3996	1332	1	1332
RIKEN	AK000283	flj0051a18	FLJ	W01A022B05	pENTR-TOPO	23620		CNTLN	54875	BAA91052.1	Hs.435381	Centlein, centrosomal protein	HepG2	hepatoma		HEP	EK1	NM_001114395.1	NP_001107867.1	VALIDATED	Ps	0.984	0.984	62	3255	1	186	391	322	383
RIKEN	BC033094	IRAL043E18	MGC	W01A022B10	pENTR-TOPO	24036		IKBKAP	8518	AAH33094.1	Hs.494738	Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003640.3	NP_003631.2	REVIEWED	Cs	0.998	0.998	1332	3999	1	3996	1332	1	1332
RIKEN	AK000283	flj0051a18	FLJ	W01A022B13	pENTR-TOPO	23620		CNTLN	54875	BAA91052.1	Hs.435381	Centlein, centrosomal protein	HepG2	hepatoma		HEP	EK1	NM_001114395.1	NP_001107867.1	VALIDATED	Ps	0.984	0.984	62	3255	1	186	391	322	383
RIKEN	BC033094	IRAL043E18	MGC	W01A022B16	pENTR-TOPO	24036		IKBKAP	8518	AAH33094.1	Hs.494738	Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003640.3	NP_003631.2	REVIEWED	Cs	0.998	0.998	1332	3999	1	3996	1332	1	1332
RIKEN	BC033094	IRAL043E18	MGC	W01A022B22	pENTR-TOPO	24036		IKBKAP	8518	AAH33094.1	Hs.494738	Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase complex-associated protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003640.3	NP_003631.2	REVIEWED	Cs	0.998	0.998	1332	3999	1	3996	1332	1	1332
RIKEN	BC046363	IRAK089E04	MGC	W01A022C02	pENTR-TOPO	9172		ZC3H7A	29066	AAH46363.1	Hs.371856	Zinc finger CCCH-type containing 7A			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014153.2	NP_054872.2	PROVISIONAL	C	1.000	1.000	971	2916	1	2913	971	1	971
RIKEN	BC046363	IRAK089E04	MGC	W01A022C06	pENTR-TOPO	9172		ZC3H7A	29066	AAH46363.1	Hs.371856	Zinc finger CCCH-type containing 7A			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014153.2	NP_054872.2	PROVISIONAL	C	1.000	1.000	971	2916	1	2913	971	1	971
RIKEN	BC014616	IRAL010J23	MGC	W01A022C11	pENTR-TOPO	16547		DAG1	1605	AAH14616.1	Hs.76111	Dystroglycan 1 (dystrophin-associated glycoprotein 1)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004393.2	NP_004384.2	REVIEWED	C	1.000	1.000	895	2688	1	2685	895	1	895
RIKEN	BC014616	IRAL010J23	MGC	W01A022C13	pENTR-TOPO	16547		DAG1	1605	AAH14616.1	Hs.76111	Dystroglycan 1 (dystrophin-associated glycoprotein 1)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004393.2	NP_004384.2	REVIEWED	C	1.000	1.000	895	2688	1	2685	895	1	895
RIKEN	BC048347	IRAK093P02	MGC	W01A022C21	pENTR-TOPO	4466		KIF18A	81930	AAH48347.1	Hs.301052	Kinesin family member 18A			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_031217.3	NP_112494.3	VALIDATED	Cs	0.999	0.999	898	2697	1	2694	898	1	898
RIKEN	BC048347	IRAK093P02	MGC	W01A022C23	pENTR-TOPO	4466		KIF18A	81930	AAH48347.1	Hs.301052	Kinesin family member 18A			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_031217.3	NP_112494.3	VALIDATED	Cs	0.999	0.999	898	2697	1	2694	898	1	898
RIKEN	BC034993	IRAK047K20	MGC	W01A022D09	pENTR-TOPO	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	OK	1.000	1.000	1103	3312	1	3309	1103	1	1103
RIKEN	BC037166	IRAL039O23	MGC	W01A022E02	pENTR-TOPO	2168		EPHA2	1969	AAH37166.1	Hs.171596	EPH receptor A2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_004431.2	NP_004422.2	REVIEWED	OK	1.000	1.000	976	2931	1	2928	976	1	976
RIKEN	BC002756	IRAL012M14	MGC	W01A022E07	pENTR-TOPO	5943		TAOK3	51347	AAH02756.1	Hs.644420	TAO kinase 3			Placenta, choriocarcinoma	NIH_MGC_21		NM_016281.3	NP_057365.3	VALIDATED	OK	1.000	1.000	898	2697	1	2694	898	1	898
RIKEN	BC033028	IRAK047D10	MGC	W01A022E18	pENTR-TOPO	15858		EIF4ENIF1	56478	AAH33028.1	Hs.517559	Eukaryotic translation initiation factor 4E nuclear import factor 1			Testis	NIH_MGC_97	DH10B	NM_019843.2	NP_062817.1	REVIEWED	Cs	0.998	0.998	985	2958	1	2955	985	1	985
RIKEN	BC060786	IRAK133P19	MGC	W01A022E19	pENTR-TOPO	1446		ASAP3	55616	AAH60786.1	Hs.437379	ArfGAP with SH3 domain, ankyrin repeat and PH domain 3			Testis	NIH_MGC_97	DH10B	NM_017707.3	NP_060177.2	REVIEWED	Cs	0.999	0.999	903	2712	1	2709	903	1	903
RIKEN	BC060786	IRAK133P19	MGC	W01A022E23	pENTR-TOPO	1446		ASAP3	55616	AAH60786.1	Hs.437379	ArfGAP with SH3 domain, ankyrin repeat and PH domain 3			Testis	NIH_MGC_97	DH10B	NM_017707.3	NP_060177.2	REVIEWED	Cs	0.999	0.999	903	2712	1	2709	903	1	903
RIKEN	BC033028	IRAK047D10	MGC	W01A022E24	pENTR-TOPO	15858		EIF4ENIF1	56478	AAH33028.1	Hs.517559	Eukaryotic translation initiation factor 4E nuclear import factor 1			Testis	NIH_MGC_97	DH10B	NM_019843.2	NP_062817.1	REVIEWED	Cs	0.998	0.998	985	2958	1	2955	985	1	985
RIKEN	BC008800	IRAL012J04	MGC	W01A022F03	pENTR-TOPO	11481		POLD1	5424	AAH08800.1	Hs.279413	Polymerase (DNA directed), delta 1, catalytic subunit 125kDa			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002691.2	NP_002682.2	VALIDATED	Cs	0.999	0.999	1107	3324	1	3321	1107	1	1107
RIKEN	BC039257	IRAK048K10	MGC	W01A022F14	pENTR-TOPO	19098		NUP155	9631	AAH39257.1	Hs.547696	Nucleoporin 155kDa			Testis	NIH_MGC_97	DH10B	NM_004298.2	NP_004289.1	REVIEWED	C	1.000	1.000	1332	4176	178	4173	1332	1	1332
RIKEN	BC033028	IRAK047D10	MGC	W01A022G06	pENTR-TOPO	15858		EIF4ENIF1	56478	AAH33028.1	Hs.517559	Eukaryotic translation initiation factor 4E nuclear import factor 1			Testis	NIH_MGC_97	DH10B	NM_019843.2	NP_062817.1	REVIEWED	Cs	0.998	0.998	985	2958	1	2955	985	1	985
RIKEN	BC041124	IRAK082M03	MGC	W01A022G07	pENTR-TOPO	23263		NSMAF	8439	AAH41124.1	Hs.372000	Neutral sphingomyelinase (N-SMase) activation associated factor			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003580.3	NP_003571.2	REVIEWED	C	1.000	1.000	917	2754	1	2751	917	1	917
RIKEN	BC033028	IRAK047D10	MGC	W01A022G08	pENTR-TOPO	15858		EIF4ENIF1	56478	AAH33028.1	Hs.517559	Eukaryotic translation initiation factor 4E nuclear import factor 1			Testis	NIH_MGC_97	DH10B	NM_019843.2	NP_062817.1	REVIEWED	Cs	0.998	0.998	985	2958	1	2955	985	1	985
RIKEN	BC052968	IRAK098P21	MGC	W01A022G12	pENTR-TOPO	16584		EPHB3	2049	AAH52968.1	Hs.2913	EPH receptor B3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004443.3	NP_004434.2	REVIEWED	OK	1.000	1.000	998	2997	1	2994	998	1	998
RIKEN	BC006567	IRAL002P18	MGC	W01A022H05	pENTR-TOPO	11950		SYMPK	8189	AAH06567.2	Hs.515475	Symplekin			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004819.2	NP_004810.2	REVIEWED	P	1.000	1.000	1142	3429	1	3426	1274	133	1274
RIKEN	BC006567	IRAL002P18	MGC	W01A022H07	pENTR-TOPO	11950		SYMPK	8189	AAH06567.2	Hs.515475	Symplekin			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004819.2	NP_004810.2	REVIEWED	P	1.000	1.000	1142	3429	1	3426	1274	133	1274
RIKEN	BC033084	IRAL043O15	MGC	W01A022H11	pENTR-TOPO	9095		FHOD1	29109	AAH33084.1	Hs.95231	Formin homology 2 domain containing 1			Prostate, carcinoma	NIH_MGC_40		NM_013241.2	NP_037373.2	REVIEWED	C	1.000	1.000	1164	3495	1	3492	1164	1	1164
RIKEN	BC035761	IRAK079B11	MGC	W01A022I02	pENTR-TOPO	17967		SEC24D	9871	AAH35761.1	Hs.189641	SEC24 family, member D (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014822.2	NP_055637.2	REVIEWED	Cg	0.999	1.000	1033	3102	1	3099	1032	1	1032
RIKEN	BC035761	IRAK079B11	MGC	W01A022I04	pENTR-TOPO	17967		SEC24D	9871	AAH35761.1	Hs.189641	SEC24 family, member D (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014822.2	NP_055637.2	REVIEWED	Cg	0.999	1.000	1033	3102	1	3099	1032	1	1032
RIKEN	BC035761	IRAK079B11	MGC	W01A022I10	pENTR-TOPO	17967		SEC24D	9871	AAH35761.1	Hs.189641	SEC24 family, member D (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014822.2	NP_055637.2	REVIEWED	Cg	0.999	1.000	1033	3102	1	3099	1032	1	1032
RIKEN	BC035761	IRAK079B11	MGC	W01A022I12	pENTR-TOPO	17967		SEC24D	9871	AAH35761.1	Hs.189641	SEC24 family, member D (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014822.2	NP_055637.2	REVIEWED	Cg	0.999	1.000	1033	3102	1	3099	1032	1	1032
RIKEN	BC010492	IRAK019A03	MGC	W01A022I18	pENTR-TOPO	3578		SIPA1	6494	AAH10492.1	Hs.530477	Signal-induced proliferation-associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006747.3	NP_006738.3	REVIEWED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
RIKEN	BC043343	IRAK089K03	MGC	W01A022I23	pENTR-TOPO	5382		NUP107	57122	AAH43343.1	Hs.524574	Nucleoporin 107kDa			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020401.2	NP_065134.1	REVIEWED	Cs	0.999	0.999	925	2778	1	2775	925	1	925
RIKEN	BC033030	IRAK047L24	MGC	W01A022K19	pENTR-TOPO	348		MSH4	4438	AAH33030.1	Hs.216639	MutS homolog 4 (E. coli)			Testis	NIH_MGC_97	DH10B	NM_002440.2	NP_002431.2	VALIDATED	Cs	0.999	0.999	936	2811	1	2808	936	1	936
RIKEN	BC033030	IRAK047L24	MGC	W01A022K21	pENTR-TOPO	348		MSH4	4438	AAH33030.1	Hs.216639	MutS homolog 4 (E. coli)			Testis	NIH_MGC_97	DH10B	NM_002440.2	NP_002431.2	VALIDATED	Cs	0.999	0.999	936	2811	1	2808	936	1	936
RIKEN	BC033030	IRAK047L24	MGC	W01A022K23	pENTR-TOPO	348		MSH4	4438	AAH33030.1	Hs.216639	MutS homolog 4 (E. coli)			Testis	NIH_MGC_97	DH10B	NM_002440.2	NP_002431.2	VALIDATED	Cs	0.999	0.999	936	2811	1	2808	936	1	936
RIKEN	BC033651	IRAK069P16	MGC	W01A022M08	pENTR-TOPO	24643		TLR7	51284	AAH33651.1	Hs.659215	Toll-like receptor 7			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_016562.3	NP_057646.1	REVIEWED	C	1.000	1.000	1049	3150	1	3147	1049	1	1049
RIKEN	BC035576	IRAK069F09	MGC	W01A022M09	pENTR-TOPO	10650		MAP3K14	9020	AAH35576.1	Hs.404183	Mitogen-activated protein kinase kinase kinase 14			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003954.2	NP_003945.2	REVIEWED	C	1.000	1.000	947	2844	1	2841	947	1	947
RIKEN	BC033651	IRAK069P16	MGC	W01A022M12	pENTR-TOPO	24643		TLR7	51284	AAH33651.1	Hs.659215	Toll-like receptor 7			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_016562.3	NP_057646.1	REVIEWED	C	1.000	1.000	1049	3150	1	3147	1049	1	1049
RIKEN	BC033651	IRAK069P16	MGC	W01A022M14	pENTR-TOPO	24643		TLR7	51284	AAH33651.1	Hs.659215	Toll-like receptor 7			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_016562.3	NP_057646.1	REVIEWED	C	1.000	1.000	1049	3150	1	3147	1049	1	1049
RIKEN	BC035576	IRAK069F09	MGC	W01A022M15	pENTR-TOPO	10650		MAP3K14	9020	AAH35576.1	Hs.404183	Mitogen-activated protein kinase kinase kinase 14			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003954.2	NP_003945.2	REVIEWED	C	1.000	1.000	947	2844	1	2841	947	1	947
RIKEN	BC064981	IRAL050O21	MGC	W01A022M17	pENTR-TOPO	11455		CC2D1A	54862	AAH64981.1	Hs.269592	Coiled-coil and C2 domain containing 1A			Ovary, teratocarcinoma	NIH_MGC_109		NM_017721.4	NP_060191.3	VALIDATED	OK	1.000	1.000	951	2856	1	2853	951	1	951
RIKEN	BC064981	IRAL050O21	MGC	W01A022M21	pENTR-TOPO	11455		CC2D1A	54862	AAH64981.1	Hs.269592	Coiled-coil and C2 domain containing 1A			Ovary, teratocarcinoma	NIH_MGC_109		NM_017721.4	NP_060191.3	VALIDATED	OK	1.000	1.000	951	2856	1	2853	951	1	951
RIKEN	BC047324	IRAK093M22	MGC	W01A022N09	pENTR-TOPO	2642		SMC3	9126	AAH47324.1	Hs.24485	Structural maintenance of chromosomes 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005445.3	NP_005436.1	REVIEWED	Cs	0.999	0.999	1217	3654	1	3651	1217	1	1217
RIKEN	BC047324	IRAK093M22	MGC	W01A022N13	pENTR-TOPO	2642		SMC3	9126	AAH47324.1	Hs.24485	Structural maintenance of chromosomes 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005445.3	NP_005436.1	REVIEWED	Cs	0.999	0.999	1217	3654	1	3651	1217	1	1217
RIKEN	BC037280	IRAK047D18	MGC	W01A022O01	pENTR-TOPO	4573		COPB1	1315	AAH37280.1	Hs.339278	Coatomer protein complex, subunit beta 1			Testis	NIH_MGC_97	DH10B	NM_001144061.1	NP_001137533.1	REVIEWED	C	1.000	1.000	953	2862	1	2859	953	1	953
RIKEN	BC008786	IRAL012I12	MGC	W01A022O02	pENTR-TOPO	6206		ITGA5	3678	AAH08786.1	Hs.505654	Integrin, alpha 5 (fibronectin receptor, alpha polypeptide)			Placenta, choriocarcinoma	NIH_MGC_21		NM_002205.2	NP_002196.2	REVIEWED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
RIKEN	BC037280	IRAK047D18	MGC	W01A022O03	pENTR-TOPO	4573		COPB1	1315	AAH37280.1	Hs.339278	Coatomer protein complex, subunit beta 1			Testis	NIH_MGC_97	DH10B	NM_001144061.1	NP_001137533.1	REVIEWED	C	1.000	1.000	953	2862	1	2859	953	1	953
RIKEN	BC008786	IRAL012I12	MGC	W01A022O04	pENTR-TOPO	6206		ITGA5	3678	AAH08786.1	Hs.505654	Integrin, alpha 5 (fibronectin receptor, alpha polypeptide)			Placenta, choriocarcinoma	NIH_MGC_21		NM_002205.2	NP_002196.2	REVIEWED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
RIKEN	BC020062	IRAK026I19	MGC	W01A022O12	pENTR-TOPO	10404		GEMIN4	50628	AAH20062.1	Hs.499620	Gem (nuclear organelle) associated protein 4			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015721.2	NP_056536.2	REVIEWED	Cs	0.993	0.993	1058	3177	1	3174	1058	1	1058
RIKEN	BC007459	IRAL016D18	MGC	W01A023A06	pENTR-TOPO	23730		OSTF1	26578	AAH07459.1	Hs.494192	Osteoclast stimulating factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_012383.4	NP_036515.4	VALIDATED	Cgs	0.982	0.995	217	654	1	651	214	1	214
RIKEN	BC002614	IRAL004N24	MGC	W01A023A07	pENTR-TOPO	13185		FKBP1B	2281	AAH02614.1	Hs.709461	FK506 binding protein 1B, 12.6 kDa			Brain, neuroblastoma	NIH_MGC_19		NM_054033.2	NP_473374.1	REVIEWED	C	1.000	1.000	80	243	1	240	80	1	80
RIKEN	NM_006205	X01Y001A13	RIKEN_rt-pcr	W01A023A09	pENTR-TOPO	5644		PDE6H	5149	NP_006196.1	Hs.54471	Phosphodiesterase 6H, cGMP-specific, cone, gamma						NM_006205.1	NP_006196.1	PROVISIONAL	OK	1.000	1.000	83	252	1	249	83	1	83
RIKEN	BC001727	IRAL006B09	MGC	W01A023A12	pENTR-TOPO	6742		ANKRD10	55608	AAH01727.1	Hs.525163	Ankyrin repeat domain 10			Eye, retinoblastoma	NIH_MGC_16		NM_017664.2	NP_060134.2	VALIDATED	Pfs	0.855	0.995	220	663	1	661	420	1	189
RIKEN	NM_006205	X01Y001A13	RIKEN_rt-pcr	W01A023A13	pENTR-TOPO	5644		PDE6H	5149	NP_006196.1	Hs.54471	Phosphodiesterase 6H, cGMP-specific, cone, gamma						NM_006205.1	NP_006196.1	PROVISIONAL	OK	1.000	1.000	83	252	1	249	83	1	83
RIKEN	BC001727	IRAL006B09	MGC	W01A023A16	pENTR-TOPO	6742		ANKRD10	55608	AAH01727.1	Hs.525163	Ankyrin repeat domain 10			Eye, retinoblastoma	NIH_MGC_16		NM_017664.2	NP_060134.2	VALIDATED	Pfs	0.855	0.995	220	663	1	661	420	1	189
RIKEN	BC069193	X01Y051A05	MGC	W01A023A17	pENTR-TOPO	1982		HIST2H2BE	8349	AAH69193.1	Hs.2178	Histone cluster 2, H2be			Lung, small cell carcinoma	NIH_MGC_7		NM_003528.2	NP_003519.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	BC069193	X01Y051A05	MGC	W01A023A21	pENTR-TOPO	1982		HIST2H2BE	8349	AAH69193.1	Hs.2178	Histone cluster 2, H2be			Lung, small cell carcinoma	NIH_MGC_7		NM_003528.2	NP_003519.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	BC069193	X01Y051A05	MGC	W01A023A23	pENTR-TOPO	1982		HIST2H2BE	8349	AAH69193.1	Hs.2178	Histone cluster 2, H2be			Lung, small cell carcinoma	NIH_MGC_7		NM_003528.2	NP_003519.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	BC024181	IRAK033M07	MGC	W01A023B01	pENTR-TOPO	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Testis	NIH_MGC_97	DH10B	NM_001437.2	NP_001428.1	REVIEWED	P	1.000	1.000	318	972	1	954	530	1	318
RIKEN	BC017801	IRAL036E06	MGC	W01A023B15	pENTR-TOPO	1629		BPNT1	10380	AAH17801.1	Hs.406134	3'(2'), 5'-bisphosphate nucleotidase 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_006085.4	NP_006076.4	VALIDATED	Ps	0.993	0.993	278	978	1	834	308	1	278
RIKEN	BC036038	IRAK048D04	MGC	W01A023B18	pENTR-TOPO	3268		ZNF25	219749	AAH36038.1	Hs.499429	Zinc finger protein 25			Testis	NIH_MGC_97	DH10B	NM_145011.2	NP_659448.1	PROVISIONAL	Ps	0.998	0.998	420	1263	1	1260	456	37	456
RIKEN	BC011652	IRAL017K18	MGC	W01A023B19	pENTR-TOPO	2891		BMI1	648	AAH11652.1	Hs.380403	BMI1 polycomb ring finger oncogene			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005180.6	NP_005171.4	VALIDATED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC036038	IRAK048D04	MGC	W01A023B20	pENTR-TOPO	3268		ZNF25	219749	AAH36038.1	Hs.499429	Zinc finger protein 25			Testis	NIH_MGC_97	DH10B	NM_145011.2	NP_659448.1	PROVISIONAL	Ps	0.998	0.998	420	1263	1	1260	456	37	456
RIKEN	BC002818	IRAL012F10	MGC	W01A023C02	pENTR-TOPO	24635		SSX2	6757	AAH02818.1	Hs.661107	Synovial sarcoma, X breakpoint 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_003147.4	NP_003138.3	REVIEWED	OK	1.000	1.000	223	672	1	669	223	1	223
RIKEN	NM_018664	X01Y001G17	RIKEN_rt-pcr	W01A023C03	pENTR-TOPO	1695		BATF3	55509	NP_061134.1	Hs.62919	Basic leucine zipper transcription factor, ATF-like 3						NM_018664.2	NP_061134.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
RIKEN	BC002818	IRAL012F10	MGC	W01A023C04	pENTR-TOPO	24635		SSX2	6757	AAH02818.1	Hs.661107	Synovial sarcoma, X breakpoint 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_003147.4	NP_003138.3	REVIEWED	OK	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC053351	IRAK115E13	MGC	W01A023C09	pENTR-TOPO	13357		DLX1	1745	AAH53351.1	Hs.407015	Distal-less homeobox 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001038493.1	NP_001033582.1	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
RIKEN	BC053351	IRAK115E13	MGC	W01A023C13	pENTR-TOPO	13357		DLX1	1745	AAH53351.1	Hs.407015	Distal-less homeobox 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001038493.1	NP_001033582.1	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
RIKEN	BC053351	IRAK115E13	MGC	W01A023C15	pENTR-TOPO	13357		DLX1	1745	AAH53351.1	Hs.407015	Distal-less homeobox 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001038493.1	NP_001033582.1	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
RIKEN	BC016640	IRAK026E03	MGC	W01A023C16	pENTR-TOPO	25403		SSX5	6758	AAH16640.1	Hs.166198	Synovial sarcoma, X breakpoint 5			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_021015.3	NP_066295.3	REVIEWED	Cs	0.996	0.996	229	690	1	687	229	1	229
RIKEN	AK096973	flj0021f19	FLJ	W01A023C21	pENTR-TOPO	14750		HNF4A	3172	BAC04917	Hs.116462	Hepatocyte nuclear factor 4, alpha				SMINT2	EK1	NM_175914.3	NP_787110.2	REVIEWED	P	1.000	1.000	16	399	1	48	452	1	16
RIKEN	AK096973	flj0021f19	FLJ	W01A023C23	pENTR-TOPO	14750		HNF4A	3172	BAC04917	Hs.116462	Hepatocyte nuclear factor 4, alpha				SMINT2	EK1	NM_175914.3	NP_787110.2	REVIEWED	P	1.000	1.000	16	399	1	48	452	1	16
RIKEN	NM_006896	X01Y034G09	RIKEN_rt-pcr	W01A023C24	pENTR-TOPO	21863		HOXA7	3204	NP_008827.2	Hs.660918	Homeobox A7						NM_006896.3	NP_008827.2	REVIEWED	OK	1.000	1.000	230	693	1	690	230	1	230
RIKEN	BC017206	IRAL012D10	MGC	W01A023D04	pENTR-TOPO	11686		ZNF446	55663	AAH17206.1	Hs.710284	Zinc finger protein 446			Placenta, choriocarcinoma	NIH_MGC_21		NM_017908.2	NP_060378.1	PROVISIONAL	Ps	0.995	0.995	417	1269	1	1251	450	1	417
RIKEN	AK056262	flj0002b18	FLJ	W01A023D05	pENTR-TOPO	16964		ZIC4	84107	BAG51660.1	Hs.415766	Zic family member 4	NT2	teratocarcinoma		NT2RI2	EK1	NM_032153.3	NP_115529.2	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	AK056262	flj0002b18	FLJ	W01A023D07	pENTR-TOPO	16964		ZIC4	84107	BAG51660.1	Hs.415766	Zic family member 4	NT2	teratocarcinoma		NT2RI2	EK1	NM_032153.3	NP_115529.2	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC017206	IRAL012D10	MGC	W01A023D08	pENTR-TOPO	11686		ZNF446	55663	AAH17206.1	Hs.710284	Zinc finger protein 446			Placenta, choriocarcinoma	NIH_MGC_21		NM_017908.2	NP_060378.1	PROVISIONAL	Ps	0.995	0.995	417	1269	1	1251	450	1	417
RIKEN	BC007621	IRAL022P04	MGC	W01A023D17	pENTR-TOPO	13360		OTX1	5013	AAH07621.1	Hs.445340	Orthodenticle homeobox 1			Eye, retinoblastoma	NIH_MGC_16		NM_014562.2	NP_055377.1	REVIEWED	C	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	BC000876	IRAK004H08	MGC	W01A023E06	pENTR-TOPO	8748		ZNF174	7727	AAH00876.1	Hs.155204	Zinc finger protein 174			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001032292.2	NP_001027463.1	VALIDATED	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC000876	IRAK004H08	MGC	W01A023E08	pENTR-TOPO	8748		ZNF174	7727	AAH00876.1	Hs.155204	Zinc finger protein 174			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001032292.2	NP_001027463.1	VALIDATED	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	NM_138960	X01Y003K07	RIKEN_rt-pcr	W01A023E10	pENTR-TOPO	24667		TGIF2LX	90316	NP_620410.3	Hs.592220	TGFB-induced factor homeobox 2-like, X-linked						NM_138960.3	NP_620410.3	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
RIKEN	NM_138960	X01Y003K07	RIKEN_rt-pcr	W01A023E12	pENTR-TOPO	24667		TGIF2LX	90316	NP_620410.3	Hs.592220	TGFB-induced factor homeobox 2-like, X-linked						NM_138960.3	NP_620410.3	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
RIKEN	AK091701	flj0017k13	FLJ	W01A023E17	pENTR-TOPO	9072		RGS11	8786	BAC03726	Hs.65756	Regulator of G-protein signaling 11				FEBRA2	EK1	NM_003834.1	NP_003825.1	REVIEWED	Pg	0.858	1.000	162	420	1	417	446	141	302
RIKEN	AK092424	flj0006p08	FLJ	W01A023F02	pENTR-TOPO	11782		ZSCAN4	201516	BAC03886.1	Hs.469663	Zinc finger and SCAN domain containing 4				PLACE6	EK1	NM_152677.2	NP_689890.1	VALIDATED	C	1.000	1.000	433	1302	1	1299	433	1	433
RIKEN	BC000527	IRAL001L22	MGC	W01A023F05	pENTR-TOPO	15610		EWSR1	2130	AAH00527.1	Hs.374477	Ewing sarcoma breakpoint region 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005243.2	NP_005234.1	REVIEWED	Ps	0.991	0.991	329	1065	1	987	656	1	329
RIKEN	AK092424	flj0006p08	FLJ	W01A023F06	pENTR-TOPO	11782		ZSCAN4	201516	BAC03886.1	Hs.469663	Zinc finger and SCAN domain containing 4				PLACE6	EK1	NM_152677.2	NP_689890.1	VALIDATED	C	1.000	1.000	433	1302	1	1299	433	1	433
RIKEN	BC000527	IRAL001L22	MGC	W01A023F07	pENTR-TOPO	15610		EWSR1	2130	AAH00527.1	Hs.374477	Ewing sarcoma breakpoint region 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005243.2	NP_005234.1	REVIEWED	Ps	0.991	0.991	329	1065	1	987	656	1	329
RIKEN	AK092424	flj0006p08	FLJ	W01A023F08	pENTR-TOPO	11782		ZSCAN4	201516	BAC03886.1	Hs.469663	Zinc finger and SCAN domain containing 4				PLACE6	EK1	NM_152677.2	NP_689890.1	VALIDATED	C	1.000	1.000	433	1302	1	1299	433	1	433
RIKEN	NM_002501	X01Y007M07	RIKEN_rt-pcr	W01A023F18	pENTR-TOPO	12002		NFIX	4784	NP_002492.2	Hs.257970	Nuclear factor I/X (CCAAT-binding transcription factor)						NM_002501.2	NP_002492.2	VALIDATED	Cs	0.998	0.998	441	1326	1	1323	441	1	441
RIKEN	NM_002501	X01Y007M07	RIKEN_rt-pcr	W01A023F20	pENTR-TOPO	12002		NFIX	4784	NP_002492.2	Hs.257970	Nuclear factor I/X (CCAAT-binding transcription factor)						NM_002501.2	NP_002492.2	VALIDATED	Cs	0.998	0.998	441	1326	1	1323	441	1	441
RIKEN	NM_002501	X01Y007M07	RIKEN_rt-pcr	W01A023F22	pENTR-TOPO	12002		NFIX	4784	NP_002492.2	Hs.257970	Nuclear factor I/X (CCAAT-binding transcription factor)						NM_002501.2	NP_002492.2	VALIDATED	Cs	0.998	0.998	441	1326	1	1323	441	1	441
RIKEN	AK095595	flj0024d13	FLJ	W01A023G01	pENTR-TOPO	5837		LMO3	55885	BAC04582.1	Hs.504908	LIM domain only 3 (rhombotin-like 2)				FCBBF3	EK1	NM_001001395.1	NP_001001395.1	VALIDATED	Cs	0.993	0.993	145	438	1	435	145	1	145
RIKEN	NM_005593	X01Y027I23	RIKEN_rt-pcr	W01A023G02	pENTR-TOPO	5642		MYF5	4617	NP_005584.2	Hs.178023	Myogenic factor 5						NM_005593.2	NP_005584.2	VALIDATED	Cs	0.996	0.996	255	768	1	765	255	1	255
RIKEN	AK095595	flj0024d13	FLJ	W01A023G07	pENTR-TOPO	5837		LMO3	55885	BAC04582.1	Hs.504908	LIM domain only 3 (rhombotin-like 2)				FCBBF3	EK1	NM_001001395.1	NP_001001395.1	VALIDATED	Cs	0.993	0.993	145	438	1	435	145	1	145
RIKEN	NM_005593	X01Y027I23	RIKEN_rt-pcr	W01A023G08	pENTR-TOPO	5642		MYF5	4617	NP_005584.2	Hs.178023	Myogenic factor 5						NM_005593.2	NP_005584.2	VALIDATED	Cs	0.996	0.996	255	768	1	765	255	1	255
RIKEN	XM_291704	X01Y027G23	RIKEN_rt-pcr	W01A023G19	pENTR-TOPO															
RIKEN	XM_291704	X01Y027G23	RIKEN_rt-pcr	W01A023G21	pENTR-TOPO															
RIKEN	BC015497	IRAK022L01	MGC	W01A023H01	pENTR-TOPO	5533		TEAD4	7004	AAH15497.2	Hs.94865	TEA domain family member 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201443.1	NP_958851.1	REVIEWED	C	1.000	1.000	305	1086	169	1083	305	1	305
RIKEN	BC015497	IRAK022L01	MGC	W01A023H03	pENTR-TOPO	5533		TEAD4	7004	AAH15497.2	Hs.94865	TEA domain family member 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201443.1	NP_958851.1	REVIEWED	C	1.000	1.000	305	1086	169	1083	305	1	305
RIKEN	BC015497	IRAK022L01	MGC	W01A023H07	pENTR-TOPO	5533		TEAD4	7004	AAH15497.2	Hs.94865	TEA domain family member 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201443.1	NP_958851.1	REVIEWED	C	1.000	1.000	305	1086	169	1083	305	1	305
RIKEN	BC012826	IRAL002D24	MGC	W01A023H09	pENTR-TOPO	25158		ZDHHC9	51114	AAH12826.1	Hs.719122	Zinc finger, DHHC-type containing 9			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016032.2	NP_057116.2	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	NM_001002920	X01Y036O03	RIKEN_rt-pcr	W01A023H10	pENTR-TOPO	22763		POTEA	340441	NP_001002920.1	Hs.531579	POTE ankyrin domain family, member A						NM_001002920.1	NP_001002920.1	PROVISIONAL	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC012826	IRAL002D24	MGC	W01A023H11	pENTR-TOPO	25158		ZDHHC9	51114	AAH12826.1	Hs.719122	Zinc finger, DHHC-type containing 9			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016032.2	NP_057116.2	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC012826	IRAL002D24	MGC	W01A023H13	pENTR-TOPO	25158		ZDHHC9	51114	AAH12826.1	Hs.719122	Zinc finger, DHHC-type containing 9			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016032.2	NP_057116.2	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	NM_001002920	X01Y036O03	RIKEN_rt-pcr	W01A023H16	pENTR-TOPO	22763		POTEA	340441	NP_001002920.1	Hs.531579	POTE ankyrin domain family, member A						NM_001002920.1	NP_001002920.1	PROVISIONAL	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC033711	IRAK068E02	MGC	W01A023H17	pENTR-TOPO	7353		ATXN3	4287	AAH33711.1	Hs.532632	Ataxin 3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001127696.1	NP_001121168.1	REVIEWED	Cg	0.935	1.000	370	1113	1	1110	346	1	346
RIKEN	BC009395	IRAL026L09	MGC	W01A023H20	pENTR-TOPO	12192		IRF3	3661	AAH09395.1	Hs.75254	Interferon regulatory factor 3			Brain, neuroblastoma	NIH_MGC_19		NM_001571.4	NP_001562.1	VALIDATED	Cfs	0.986	0.998	432	1359	1	1297	427	1	427
RIKEN	BC033711	IRAK068E02	MGC	W01A023H21	pENTR-TOPO	7353		ATXN3	4287	AAH33711.1	Hs.532632	Ataxin 3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001127696.1	NP_001121168.1	REVIEWED	Cg	0.935	1.000	370	1113	1	1110	346	1	346
RIKEN	AK023379	flj0036c22	FLJ	W01A023I10	pENTR-TOPO	3747		SFRS2B	10929	BAG51186.1	Hs.713908	Splicing factor, arginine/serine-rich 2B				OVARC1	EK1	NM_032102.2	NP_115285.1	REVIEWED	C	1.000	1.000	282	849	1	846	282	1	282
RIKEN	NM_199231	X01Y023C05	RIKEN_rt-pcr	W01A023I13	pENTR-TOPO	19181		GDNF	2668	NP_954701.1	Hs.248114	Glial cell derived neurotrophic factor						NM_199231.1	NP_954701.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	AK023379	flj0036c22	FLJ	W01A023I16	pENTR-TOPO	3747		SFRS2B	10929	BAG51186.1	Hs.713908	Splicing factor, arginine/serine-rich 2B				OVARC1	EK1	NM_032102.2	NP_115285.1	REVIEWED	C	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC001003	IRAK003F23	MGC	W01A023I19	pENTR-TOPO	24826		SSX1	6756	AAH01003.1	Hs.713144	Synovial sarcoma, X breakpoint 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005635.2	NP_005626.1	REVIEWED	C	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC001003	IRAK003F23	MGC	W01A023I23	pENTR-TOPO	24826		SSX1	6756	AAH01003.1	Hs.713144	Synovial sarcoma, X breakpoint 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005635.2	NP_005626.1	REVIEWED	C	1.000	1.000	188	567	1	564	188	1	188
RIKEN	AK093431	flj0016o07	FLJ	W01A023I24	pENTR-TOPO	21011		SSPO	23145	BAC04161.1	Hs.632022	SCO-spondin homolog (Bos taurus)				TESTI2	EK1	NM_198455.2	NP_940857.2	PROVISIONAL	Pfs	0.972	0.984	249	852	2	749	5147	4616	4861
RIKEN	NM_000966	X01Y007O13	RIKEN_rt-pcr	W01A023J02	pENTR-TOPO	6238		RARG	5916	NP_000957.1	Hs.1497	Retinoic acid receptor, gamma						NM_000966.4	NP_000957.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
RIKEN	AK056581	flj0003a06	FLJ	W01A023J03	pENTR-TOPO	3165		MMS19	64210	BAB71223.1	Hs.500721	MMS19 nucleotide excision repair homolog (S. cerevisiae)				NTONG1	EK1	NM_022362.4	NP_071757.4	VALIDATED	Pg	0.995	1.000	366	1128	1	1098	1030	365	728
RIKEN	AK056581	flj0003a06	FLJ	W01A023J05	pENTR-TOPO	3165		MMS19	64210	BAB71223.1	Hs.500721	MMS19 nucleotide excision repair homolog (S. cerevisiae)				NTONG1	EK1	NM_022362.4	NP_071757.4	VALIDATED	Pg	0.995	1.000	366	1128	1	1098	1030	365	728
RIKEN	AK056581	flj0003a06	FLJ	W01A023J07	pENTR-TOPO	3165		MMS19	64210	BAB71223.1	Hs.500721	MMS19 nucleotide excision repair homolog (S. cerevisiae)				NTONG1	EK1	NM_022362.4	NP_071757.4	VALIDATED	Pg	0.995	1.000	366	1128	1	1098	1030	365	728
RIKEN	BC053675	IRAK115N09	MGC	W01A023J16	pENTR-TOPO	5252		TMPO	7112	AAH53675.1	Hs.11355	Thymopoietin			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001032283.1	NP_001027454.1	PROVISIONAL	OK	1.000	1.000	454	1365	1	1362	454	1	454
RIKEN	AK098610	flj0053i20	FLJ	W01A023J17	pENTR-TOPO	5853		SOX5	6660	BAC05353.1	Hs.657542	SRY (sex determining region Y)-box 5				TST	EK1	NM_178010.1	NP_821078.1	REVIEWED	Cs	0.997	0.997	377	1134	1	1131	377	1	377
RIKEN	AK025574	flj0065p02	FLJ	W01A023J18	pENTR-TOPO	13245		POLR1B	84172	BAB15175.1	Hs.86337	Polymerase (RNA) I polypeptide B, 128kDa	HepG2	hepatoma		HEP	EK1	NM_001137604.1	NP_001131076.1	VALIDATED	Pfs	0.996	0.998	460	1380	1	1378	1079	586	1045
RIKEN	NM_005193	X01Y027K23	RIKEN_rt-pcr	W01A023K02	pENTR-TOPO	24933		CDX4	1046	NP_005184.1	Hs.553488	Caudal type homeobox 4						NM_005193.1	NP_005184.1	PROVISIONAL	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC005325	IRAL016M20	MGC	W01A023K03	pENTR-TOPO	24836		SSX4	6759	AAH05325.1	Hs.558402	Synovial sarcoma, X breakpoint 4			Bladder, carcinoma	NIH_MGC_53	DH10B	XM_001725018.1	XP_001725070.1	MODEL	C	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC021719	IRAK047O18	MGC	W01A023K12	pENTR-TOPO	24656		RHOXF2	84528	AAH21719.1	Hs.567620	Rhox homeobox family, member 2			Testis	NIH_MGC_97	DH10B	NM_032498.1	NP_115887.1	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	XM_292850	X01Y002G07	RIKEN_rt-pcr	W01A023K15	pENTR-TOPO	13576		MSGN1	343930	XP_292850	Hs.705359	Mesogenin 1						NM_001105569.1	NP_001099039.1	INFERRED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	NM_005342	X01Y002I21	RIKEN_rt-pcr	W01A023K19	pENTR-TOPO	24878		HMGB3	3149	NP_005333.2	Hs.19114	High-mobility group box 3						NM_005342.2	NP_005333.2	VALIDATED	Cs	0.985	0.985	200	603	1	600	200	1	200
RIKEN	BC008279	IRAL013N14	MGC	W01A023K20	pENTR-TOPO	12336		ECSIT	51295	AAH08279.1	Hs.515146	ECSIT homolog (Drosophila)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001142464.1	NP_001135936.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
RIKEN	NM_032607	X01Y008A05	RIKEN_rt-pcr	W01A023L02	pENTR-TOPO	11418		CREB3L3	84699	NP_115996.1	Hs.247744	CAMP responsive element binding protein 3-like 3						NM_032607.1	NP_115996.1	PROVISIONAL	OK	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	BC025281	IRAL042D08	MGC	W01A023L03	pENTR-TOPO	15856		RBM9	23543	AAH25281.1	Hs.282998	RNA binding motif protein 9			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001031695.2	NP_001026865.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	NM_032607	X01Y008A05	RIKEN_rt-pcr	W01A023L04	pENTR-TOPO	11418		CREB3L3	84699	NP_115996.1	Hs.247744	CAMP responsive element binding protein 3-like 3						NM_032607.1	NP_115996.1	PROVISIONAL	OK	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	BC025281	IRAL042D08	MGC	W01A023L07	pENTR-TOPO	15856		RBM9	23543	AAH25281.1	Hs.282998	RNA binding motif protein 9			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001031695.2	NP_001026865.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	NM_003413	X01Y037G11	RIKEN_rt-pcr	W01A023L10	pENTR-TOPO	24573		ZIC3	7547	NP_003404.1	Hs.111227	Zic family member 3 (odd-paired homolog, Drosophila)						NM_003413.3	NP_003404.1	REVIEWED	OK	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	NM_002750	X01Y035M07	RIKEN_rt-pcr	W01A023L15	pENTR-TOPO	2853		MAPK8	5599	NP_002741.1	Hs.138211	Mitogen-activated protein kinase 8						NM_002750.2	NP_002741.1	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	NM_003413	X01Y037G11	RIKEN_rt-pcr	W01A023L16	pENTR-TOPO	24573		ZIC3	7547	NP_003404.1	Hs.111227	Zic family member 3 (odd-paired homolog, Drosophila)						NM_003413.3	NP_003404.1	REVIEWED	OK	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	NM_020063	X01Y006A05	RIKEN_rt-pcr	W01A023L19	pENTR-TOPO	2120		BARHL2	343472	NP_064447.1	Hs.451956	BarH-like homeobox 2						NM_020063.1	NP_064447.1	VALIDATED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC050600	IRAK110O21	MGC	W01A023M01	pENTR-TOPO	17408		UBE2K	3093	AAH50600.1	Hs.714332	Ubiquitin-conjugating enzyme E2K (UBC1 homolog, yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005339.4	NP_005330.1	REVIEWED	OK	1.000	1.000	200	603	1	600	200	1	200
RIKEN	NM_002144	X01Y004I07	RIKEN_rt-pcr	W01A023M12	pENTR-TOPO	10766		HOXB1	3211	NP_002135.2	Hs.99992	Homeobox B1						NM_002144.3	NP_002135.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
RIKEN	NM_030981	X01Y034C07	RIKEN_rt-pcr	W01A023M15	pENTR-TOPO	3789		RAB1B	81876	NP_112243.1	Hs.300816	RAB1B, member RAS oncogene family						NM_030981.2	NP_112243.1	VALIDATED	C	1.000	1.000	201	606	1	603	201	1	201
RIKEN	NM_002144	X01Y004I07	RIKEN_rt-pcr	W01A023M16	pENTR-TOPO	10766		HOXB1	3211	NP_002135.2	Hs.99992	Homeobox B1						NM_002144.3	NP_002135.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
RIKEN	BC037777	IRAK075J17	MGC	W01A023M17	pENTR-TOPO	6176		YAF2	10138	AAH37777.1	Hs.708084	YY1 associated factor 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005748.3	NP_005739.2	REVIEWED	Cg	0.882	1.000	204	615	1	612	180	1	180
RIKEN	BC007592	IRAL022L15	MGC	W01A023M22	pENTR-TOPO	9694		SAP30BP	29115	AAH07592.1	Hs.655088	SAP30 binding protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_013260.6	NP_037392.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
RIKEN	BC022523	IRAK032D14	MGC	W01A023N04	pENTR-TOPO	12517		ZNF563	147837	AAH22523.1	Hs.663510	Zinc finger protein 563			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145276.2	NP_660319.1	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
RIKEN	BC032476	IRAK064L16	MGC	W01A023N12	pENTR-TOPO	8694		OSGIN1	29948	AAH32476.1	Hs.128055	Oxidative stress induced growth inhibitor 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_182980.2	NP_892025.1	VALIDATED	C	1.000	1.000	477	1434	1	1431	477	1	477
RIKEN	BC008819	IRAL015F06	MGC	W01A023N15	pENTR-TOPO	4009		NR1H3	10062	AAH08819.1	Hs.438863	Nuclear receptor subfamily 1, group H, member 3			Placenta, choriocarcinoma	NIH_MGC_21		NM_001130101.1	NP_001123573.1	VALIDATED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC032476	IRAK064L16	MGC	W01A023N16	pENTR-TOPO	8694		OSGIN1	29948	AAH32476.1	Hs.128055	Oxidative stress induced growth inhibitor 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_182980.2	NP_892025.1	VALIDATED	C	1.000	1.000	477	1434	1	1431	477	1	477
RIKEN	AK129992	flj0054i17	FLJ	W01A023N17	pENTR-TOPO	12286		ZNF320	162967	BAC85270.1	Hs.446907	Zinc finger protein 320				KDN	EK1	NM_207333.2	NP_997216.2	VALIDATED	P	1.000	1.000	397	1194	1	1191	509	113	509
RIKEN	BC011612	IRAL015O20	MGC	W01A023N18	pENTR-TOPO	24556		MECP2	4204	AAH11612.1	Hs.200716	Methyl CpG binding protein 2 (Rett syndrome)			Placenta, choriocarcinoma	NIH_MGC_21		NM_004992.3	NP_004983.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
RIKEN	AK129992	flj0054i17	FLJ	W01A023N23	pENTR-TOPO	12286		ZNF320	162967	BAC85270.1	Hs.446907	Zinc finger protein 320				KDN	EK1	NM_207333.2	NP_997216.2	VALIDATED	P	1.000	1.000	397	1194	1	1191	509	113	509
RIKEN	BC012176	IRAL029N10	MGC	W01A023O06	pENTR-TOPO	18539		NKD2	85409	AAH12176.1	Hs.240951	Naked cuticle homolog 2 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_033120.2	NP_149111.1	PROVISIONAL		0.943	0.943	283	936	1	849	451	1	283
RIKEN	NM_003438	X01Y002M17	RIKEN_rt-pcr	W01A023O09	pENTR-TOPO	35079		ZNF137	7696	NP_003429.1								NM_003438.2	NP_003429.1	VALIDATED	OK	1.000	1.000	207	624	1	621	207	1	207
RIKEN	NM_003438	X01Y002M17	RIKEN_rt-pcr	W01A023O11	pENTR-TOPO	35079		ZNF137	7696	NP_003429.1								NM_003438.2	NP_003429.1	VALIDATED	OK	1.000	1.000	207	624	1	621	207	1	207
RIKEN	NM_003438	X01Y002M17	RIKEN_rt-pcr	W01A023O15	pENTR-TOPO	35079		ZNF137	7696	NP_003429.1								NM_003438.2	NP_003429.1	VALIDATED	OK	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC009831	IRAL025B08	MGC	W01A023O19	pENTR-TOPO	330		RAB25	57111	AAH09831.1	Hs.632469	RAB25, member RAS oncogene family			Ovary, adenocarcinoma	NIH_MGC_9		NM_020387.2	NP_065120.2	PROVISIONAL	OK	1.000	1.000	213	642	1	639	213	1	213
RIKEN	BC004408	IRAL013J10	MGC	W01A023O22	pENTR-TOPO	11542		HMG20B	10362	AAH04408.2	Hs.406534	High-mobility group 20B			Pancreas, adenocarcinoma	NIH_MGC_39		NM_006339.2	NP_006330.2	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC050425	IRAK098P16	MGC	W01A023P01	pENTR-TOPO	20643		ZNF322A	79692	AAH50425.2	Hs.530271	Zinc finger protein 322A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024639.3	NP_078915.2	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	BC050425	IRAK098P16	MGC	W01A023P03	pENTR-TOPO	20643		ZNF322A	79692	AAH50425.2	Hs.530271	Zinc finger protein 322A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024639.3	NP_078915.2	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	BC050425	IRAK098P16	MGC	W01A023P05	pENTR-TOPO	20643		ZNF322A	79692	AAH50425.2	Hs.530271	Zinc finger protein 322A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024639.3	NP_078915.2	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	AK097041	flj0025i09	FLJ	W01A023P11	pENTR-TOPO	12444		ZNF552	79818	BAG53411.1	Hs.560727	Zinc finger protein 552				SMINT2	EK1	NM_024762.3	NP_079038.2	VALIDATED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC034810	IRAK071I10	MGC	W01A023P17	pENTR-TOPO	12566		ZNF550	162972	AAH34810.1	Hs.180257	Zinc finger protein 550			Testis	NIH_MGC_97	DH10B	NM_001039654.1	NP_001034743.1	PROVISIONAL	Cgs	0.918	0.995	413	1242	1	1239	381	1	381
RIKEN	BC002417	IRAL005C19	MGC	W01A024A08	pENTR-TOPO	12367		KEAP1	9817	AAH02417.1	Hs.465870	Kelch-like ECH-associated protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_203500.1	NP_987096.1	REVIEWED	OK	1.000	1.000	624	1875	1	1872	624	1	624
RIKEN	BC002417	IRAL005C19	MGC	W01A024A12	pENTR-TOPO	12367		KEAP1	9817	AAH02417.1	Hs.465870	Kelch-like ECH-associated protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_203500.1	NP_987096.1	REVIEWED	OK	1.000	1.000	624	1875	1	1872	624	1	624
RIKEN	BC002417	IRAL005C19	MGC	W01A024A16	pENTR-TOPO	12367		KEAP1	9817	AAH02417.1	Hs.465870	Kelch-like ECH-associated protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_203500.1	NP_987096.1	REVIEWED	OK	1.000	1.000	624	1875	1	1872	624	1	624
RIKEN	BC035724	IRAK079G06	MGC	W01A024A17	pENTR-TOPO	13072		NAB1	4664	AAH35724.1	Hs.570078	NGFI-A binding protein 1 (EGR1 binding protein 1)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_005966.3	NP_005957.2	VALIDATED	C	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC047412	IRAK091H03	MGC	W01A024A20	pENTR-TOPO	12559		ZNF433	163059	AAH47412.1	Hs.667776	Zinc finger protein 433			Testis	NIH_MGC_97	DH10B	NM_001080411.1	NP_001073880.1	PROVISIONAL	P	1.000	1.000	638	1917	1	1914	673	36	673
RIKEN	BC050719	IRAK110J17	MGC	W01A024B11	pENTR-TOPO	6947		ZBTB1	22890	AAH50719.1	Hs.655536	Zinc finger and BTB domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001123329.1	NP_001116801.1	VALIDATED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
RIKEN	BC050719	IRAK110J17	MGC	W01A024B13	pENTR-TOPO	6947		ZBTB1	22890	AAH50719.1	Hs.655536	Zinc finger and BTB domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001123329.1	NP_001116801.1	VALIDATED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
RIKEN	BC035724	IRAK079G06	MGC	W01A024C03	pENTR-TOPO	13072		NAB1	4664	AAH35724.1	Hs.570078	NGFI-A binding protein 1 (EGR1 binding protein 1)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_005966.3	NP_005957.2	VALIDATED	C	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC065261	IRAK140J23	MGC	W01A024C09	pENTR-TOPO	20796		TULP1	7287	AAH65261.1	Hs.485208	Tubby like protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003322.3	NP_003313.3	REVIEWED	Cgs	0.900	0.998	542	1470	1	1467	542	1	542
RIKEN	BC060863	IRAK133E01	MGC	W01A024C14	pENTR-TOPO	11777		ZNF549	256051	AAH60863.1	Hs.564295	Zinc finger protein 549			Placenta, normal	NIH_MGC_147	DH10B	NM_153263.1	NP_694995.1	PROVISIONAL	Cgs	0.978	0.998	640	1923	1	1920	627	1	627
RIKEN	BC065261	IRAK140J23	MGC	W01A024C15	pENTR-TOPO	20796		TULP1	7287	AAH65261.1	Hs.485208	Tubby like protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003322.3	NP_003313.3	REVIEWED	Cgs	0.900	0.998	542	1470	1	1467	542	1	542
RIKEN	BC065261	IRAK140J23	MGC	W01A024C19	pENTR-TOPO	20796		TULP1	7287	AAH65261.1	Hs.485208	Tubby like protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003322.3	NP_003313.3	REVIEWED	Cgs	0.900	0.998	542	1470	1	1467	542	1	542
RIKEN	ENST00000026952	X01Y053G23	RIKEN_rt-pcr	W01A024D06	pENTR-TOPO	14642		C20orf95	343578	ENSP00000026952	Hs.451997	Chromosome 20 open reading frame 95						XM_937379.3	XP_942472.3	MODEL	Pfs	0.327	0.354	52	3042	2839	2684	744	158	205
RIKEN	BC036099	IRAK048G07	MGC	W01A024D07	pENTR-TOPO	7669		ARNT2	9915	AAH36099.1	Hs.459070	Aryl-hydrocarbon receptor nuclear translocator 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014862.3	NP_055677.3	REVIEWED	P	1.000	1.000	694	2151	1	2082	717	1	694
RIKEN	BC036099	IRAK048G07	MGC	W01A024D21	pENTR-TOPO	7669		ARNT2	9915	AAH36099.1	Hs.459070	Aryl-hydrocarbon receptor nuclear translocator 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014862.3	NP_055677.3	REVIEWED	P	1.000	1.000	694	2151	1	2082	717	1	694
RIKEN	AK022560	flj0032m07	FLJ	W01A024E16	pENTR-TOPO	23062		WHSC1L1	54904	BAB14099.1	Hs.700599	Wolf-Hirschhorn syndrome candidate 1-like 1	NT2	teratocarcinoma		NT2RM2	EK1	NM_017778.2	NP_060248.2	REVIEWED	OK	1.000	1.000	645	1938	1	1935	645	1	645
RIKEN	AK095351	flj0023j21	FLJ	W01A024E24	pENTR-TOPO	11741		ZNF233	353355	BAG53032.1	Hs.466891	Zinc finger protein 233				CTONG2	EK1	NM_181756.1	NP_861421.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
RIKEN	BC063838	IRAK141D02	MGC	W01A024F01	pENTR-TOPO	24522		MAGED4B	81557	AAH63838.1	Hs.522650	Melanoma antigen family D, 4B				Lupski_dorsal_root_ganglion	DH10B	NM_177535.1	NP_803879.1	REVIEWED	OK	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	BC063838	IRAK141D02	MGC	W01A024F07	pENTR-TOPO	24522		MAGED4B	81557	AAH63838.1	Hs.522650	Melanoma antigen family D, 4B				Lupski_dorsal_root_ganglion	DH10B	NM_177535.1	NP_803879.1	REVIEWED	OK	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	AK091206	flj0015g15	FLJ	W01A024F10	pENTR-TOPO	14643		TSHZ2	128553	BAC03610.1	Hs.649877	Teashirt zinc finger homeobox 2				CTONG2	EK1	NM_173485.4	NP_775756.3	VALIDATED	Cs	0.999	0.999	1034	3105	1	3102	1034	1	1034
RIKEN	BC011684	IRAL027K13	MGC	W01A024G01	pENTR-TOPO	11683		GATAD2A	54815	AAH11684.1	Hs.709287	GATA zinc finger domain containing 2A			Skin, melanotic melanoma.	NIH_MGC_20		NM_017660.3	NP_060130.3	PROVISIONAL	P	1.000	1.000	490	1473	1	1470	633	144	633
RIKEN	BC011684	IRAL027K13	MGC	W01A024G03	pENTR-TOPO	11683		GATAD2A	54815	AAH11684.1	Hs.709287	GATA zinc finger domain containing 2A			Skin, melanotic melanoma.	NIH_MGC_20		NM_017660.3	NP_060130.3	PROVISIONAL	P	1.000	1.000	490	1473	1	1470	633	144	633
RIKEN	BC026902	IRAK029P02	MGC	W01A024G20	pENTR-TOPO	3680		ZBTB16	7704	AAH26902.1	Hs.682144	Zinc finger and BTB domain containing 16				NCI_CGAP_Brn67	DH10B	NM_006006.4	NP_005997.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
RIKEN	BC001664	IRAL003A05	MGC	W01A024H07	pENTR-TOPO	696		POU2F1	5451	AAH01664.1	Hs.493649	POU class 2 homeobox 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002697.2	NP_002688.2	PROVISIONAL	OK	1.000	1.000	743	2232	1	2229	743	1	743
RIKEN	BC001664	IRAL003A05	MGC	W01A024H11	pENTR-TOPO	696		POU2F1	5451	AAH01664.1	Hs.493649	POU class 2 homeobox 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002697.2	NP_002688.2	PROVISIONAL	OK	1.000	1.000	743	2232	1	2229	743	1	743
RIKEN	BC013045	IRAK012K02	MGC	W01A024H16	pENTR-TOPO	5862		SMARCC2	6601	AAH13045.1	Hs.236030	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 2				NCI_CGAP_Brn67	DH10B	NM_139067.2	NP_620706.1	REVIEWED	Cs	0.999	0.999	1130	3393	1	3390	1130	1	1130
RIKEN	BC001664	IRAL003A05	MGC	W01A024H19	pENTR-TOPO	696		POU2F1	5451	AAH01664.1	Hs.493649	POU class 2 homeobox 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002697.2	NP_002688.2	PROVISIONAL	OK	1.000	1.000	743	2232	1	2229	743	1	743
RIKEN	BC035875	IRAK078O03	MGC	W01A024I01	pENTR-TOPO	18766		ZNF131	7690	AAH35875.1	Hs.535804	Zinc finger protein 131			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003432.1	NP_003423.1	VALIDATED	P	1.000	1.000	510	1533	1	1530	589	80	589
RIKEN	BC035875	IRAK078O03	MGC	W01A024I03	pENTR-TOPO	18766		ZNF131	7690	AAH35875.1	Hs.535804	Zinc finger protein 131			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003432.1	NP_003423.1	VALIDATED	P	1.000	1.000	510	1533	1	1530	589	80	589
RIKEN	BC020095	IRAK026G12	MGC	W01A024I06	pENTR-TOPO	41310		TCEANC	170082	-	Hs.222855	Transcription elongation factor A (SII) N-terminal and central domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152634.2	NP_689847.2	VALIDATED	P	1.000	1.000	320	2019	2	961	381	62	381
RIKEN	BC025262	IRAL042G03	MGC	W01A024I17	pENTR-TOPO	358		IQWD1	55827	AAH25262.2	Hs.435741	IQ motif and WD repeats 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001017977.1	NP_001017977.1	VALIDATED	Ps	0.998	0.998	513	1542	1	1539	860	348	860
RIKEN	BC025262	IRAL042G03	MGC	W01A024I21	pENTR-TOPO	358		IQWD1	55827	AAH25262.2	Hs.435741	IQ motif and WD repeats 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001017977.1	NP_001017977.1	VALIDATED	Ps	0.998	0.998	513	1542	1	1539	860	348	860
RIKEN	BC025262	IRAL042G03	MGC	W01A024I23	pENTR-TOPO	358		IQWD1	55827	AAH25262.2	Hs.435741	IQ motif and WD repeats 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001017977.1	NP_001017977.1	VALIDATED	Ps	0.998	0.998	513	1542	1	1539	860	348	860
RIKEN	AK001331	flj0033k13	FLJ	W01A024I24	pENTR-TOPO	14998		ZNF334	55713	BAA91630.1	Hs.584933	Zinc finger protein 334	NT2	teratocarcinoma		NT2RP2	EK1	NM_018102.3	NP_060572.3	VALIDATED	Cs	0.997	0.997	680	2043	1	2040	680	1	680
RIKEN	BC063280	IRAK133N18	MGC	W01A024J04	pENTR-TOPO	4430		NFRKB	4798	AAH63280.1	Hs.530539	Nuclear factor related to kappaB binding protein			Testis	NIH_MGC_97	DH10B	NM_001143835.1	NP_001137307.1	VALIDATED	Cs	0.998	0.998	1299	3900	1	3897	1299	1	1299
RIKEN	AK001331	flj0033k13	FLJ	W01A024K04	pENTR-TOPO	14998		ZNF334	55713	BAA91630.1	Hs.584933	Zinc finger protein 334	NT2	teratocarcinoma		NT2RP2	EK1	NM_018102.3	NP_060572.3	VALIDATED	Cs	0.997	0.997	680	2043	1	2040	680	1	680
RIKEN	BC014070	IRAL028H08	MGC	W01A024L19	pENTR-TOPO	24609		MAGED1	9500	AAH14070.1	Hs.5258	Melanoma antigen family D, 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001005333.1	NP_001005333.1	REVIEWED	OK	1.000	1.000	834	2505	1	2502	834	1	834
RIKEN	BC014070	IRAL028H08	MGC	W01A024L23	pENTR-TOPO	24609		MAGED1	9500	AAH14070.1	Hs.5258	Melanoma antigen family D, 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001005333.1	NP_001005333.1	REVIEWED	OK	1.000	1.000	834	2505	1	2502	834	1	834
RIKEN	AK027440	flj0031h16	FLJ	W01A024M02	pENTR-TOPO	5813		KDM2B	84678	BAB55112.1	Hs.524800	Lysine (K)-specific demethylase 2B	NT2	teratocarcinoma		NT2RM2	EK1	NM_032590.4	NP_115979.3	REVIEWED	P	1.000	1.000	704	2115	1	2112	1336	633	1336
RIKEN	BC041667	IRAK082J24	MGC	W01A024M07	pENTR-TOPO	1776		EYA3	2140	AAH41667.1	Hs.185774	Eyes absent homolog 3 (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001990.2	NP_001981.2	REVIEWED	Pgs	0.914	0.998	548	1611	1	1506	573	1	548
RIKEN	AK027440	flj0031h16	FLJ	W01A024M16	pENTR-TOPO	5813		KDM2B	84678	BAB55112.1	Hs.524800	Lysine (K)-specific demethylase 2B	NT2	teratocarcinoma		NT2RM2	EK1	NM_032590.4	NP_115979.3	REVIEWED	P	1.000	1.000	704	2115	1	2112	1336	633	1336
RIKEN	AK057460	flj0005f23	FLJ	W01A024M20	pENTR-TOPO	12498		ZNF132	7691	BAG51916.1	Hs.156169	Zinc finger protein 132				TESTI2	EK1	NM_003433.3	NP_003424.3	VALIDATED	Cs	0.999	0.999	706	2121	1	2118	706	1	706
RIKEN	AF275255	X01Y052C07	RIKEN_rt-pcr	W01A024M23	pENTR-TOPO	11411		ZNF317	57693	AAL29188.1	Hs.465829	Zinc finger protein 317						NM_020933.3	NP_065984.3	PROVISIONAL	Cs	0.998	0.998	595	1788	1	1785	595	1	595
RIKEN	AK057460	flj0005f23	FLJ	W01A024O04	pENTR-TOPO	12498		ZNF132	7691	BAG51916.1	Hs.156169	Zinc finger protein 132				TESTI2	EK1	NM_003433.3	NP_003424.3	VALIDATED	Cs	0.999	0.999	706	2121	1	2118	706	1	706
RIKEN	AK096465	flj0039d04	FLJ	W01A024O15	pENTR-TOPO	19261		ZNF300	91975	BAG53297.1	Hs.134885	Zinc finger protein 300				OCBBF1	EK1	NM_052860.1	NP_443092.1	PROVISIONAL	C	1.000	1.000	604	1815	1	1812	604	1	604
RIKEN	AK091406	flj0016d20	FLJ	W01A024O16	pENTR-TOPO	22547		PCM1	5108	BAC03656.1	Hs.491148	Pericentriolar material 1				FCBBF3	EK1	NM_006197.3	NP_006188.3	VALIDATED	Pgs	0.922	0.994	761	2121	1	2118	2024	1264	2024
RIKEN	AK122788	flj0043i16	FLJ	W01A024P19	pENTR-TOPO	8231		ZSCAN29	146050	BAG53731.1	Hs.418287	Zinc finger and SCAN domain containing 29				TESTI2	EK1	NM_152455.3	NP_689668.3	VALIDATED	Ps	0.998	0.998	851	2556	1	2553	852	2	852
RIKEN	ENST00000259608	X01Y146K19	RIKEN_rt-pcr	W01A025A08	pENTR-TOPO	24152		SIT1	27240	ENSP00000259608	Hs.88012	Signaling threshold regulating transmembrane adaptor 1						NM_014450.2	NP_055265.1	VALIDATED	C	1.000	1.000	196	597	3	590	196	1	196
RIKEN	AK090539	flj0011f09	FLJ	W01A025A12	pENTR-TOPO	40713		LOC100129034	100129034	BAC03472	Hs.654980	Hypothetical protein LOC100129034				ASTRO2	EK1	XM_001720357.1	XP_001720409.1	MODEL	C	1.000	1.000	198	597	1	594	198	1	198
RIKEN	AK090539	flj0011f09	FLJ	W01A025A14	pENTR-TOPO	40713		LOC100129034	100129034	BAC03472	Hs.654980	Hypothetical protein LOC100129034				ASTRO2	EK1	XM_001720357.1	XP_001720409.1	MODEL	C	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC010384	X01Y101A11	MGC	W01A025A15	pENTR-TOPO	4949		GNG10	2790	AAH10384.1	Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED	OK	1.000	1.000	68	207	1	204	68	1	68
RIKEN	AK092744	flj0008p19	FLJ	W01A025B01	pENTR-TOPO	20378		NHSL1	57224		Hs.652741	NHS-like 1				SMINT2	EK1	NM_001144060.1	NP_001137532.1	INFERRED		0.346	0.346	26	765	165	88	1606	1462	1487
RIKEN	AK092744	flj0008p19	FLJ	W01A025B07	pENTR-TOPO	20378		NHSL1	57224		Hs.652741	NHS-like 1				SMINT2	EK1	NM_001144060.1	NP_001137532.1	INFERRED		0.346	0.346	26	765	165	88	1606	1462	1487
RIKEN	AK131042	flj0053m20	FLJ	W01A025B08	pENTR-TOPO	7069		TSSK4	283629	BAC85482.1	Hs.314432	Testis-specific serine kinase 4				TST	EK1	NM_174944.2	NP_777604.2	PROVISIONAL	Cgs	0.967	0.997	338	1017	1	1014	328	1	328
RIKEN	AK098474	flj0052n18	FLJ	W01A025B09	pENTR-TOPO	16294		CLDN18	51208	-	Hs.655324	Claudin 18				STM	EK1	NM_001002026.2	NP_001002026.1	VALIDATED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	AK122669	flj0024g13	FLJ	W01A025B14	pENTR-TOPO	4775		MRGPRF	116535	BAG53655.1	Hs.118513	MAS-related GPR, member F				UTERU2	EK1	NM_001098515.1	NP_001091985.1	VALIDATED	C	1.000	1.000	343	1032	1	1029	343	1	343
RIKEN	U24186	X01Y104I19	RIKEN_rt-pcr	W01A025B21	pENTR-TOPO	24895		RPA4	29935	AAB08488.2	Hs.659349	Replication protein A4, 34kDa						NM_013347.3	NP_037479.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC034726	IRAK026C14	MGC	W01A025B22	pENTR-TOPO	24796		RRAGB	10325	AAH34726.1	Hs.50282	Ras-related GTP binding B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006064.4	NP_006055.3	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	AK026170	flj0063n16	FLJ	W01A025C01	pENTR-TOPO	24495		LOC440552	440552							HRC	EK1			
RIKEN	AK022001	flj0019j24	FLJ	W01A025C06	pENTR-TOPO	12127		LPHN1	22859	BAB13950.1	Hs.654658	Latrophilin 1				HEMBB1	EK1	NM_014921.4	NP_055736.2	REVIEWED		0.400	0.414	30	606	176	87	1469	438	466
RIKEN	BC000702	IRAL005P06	MGC	W01A025D02	pENTR-TOPO	20503		MTCH1	23787	AAH00702.2	Hs.485262	Mitochondrial carrier homolog 1 (C. elegans)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014341.1	NP_055156.1	PROVISIONAL	P	1.000	1.000	347	1046	3	1043	372	26	372
RIKEN	BC020590	X01Y103E15	MGC	W01A025D03	pENTR-TOPO	1653		APH1A	51107	AAH20590.1	Hs.108408	Anterior pharynx defective 1 homolog A (C. elegans)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001077628.1	NP_001071096.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC000702	IRAL005P06	MGC	W01A025D08	pENTR-TOPO	20503		MTCH1	23787	AAH00702.2	Hs.485262	Mitochondrial carrier homolog 1 (C. elegans)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014341.1	NP_055156.1	PROVISIONAL	P	1.000	1.000	347	1046	3	1043	372	26	372
RIKEN	AF327353	X01Y147M19	RIKEN_rt-pcr	W01A025D17	pENTR-TOPO	3822		ACER3	55331	AAL56013.1	Hs.23862	Alkaline ceramidase 3						NM_018367.5	NP_060837.3	VALIDATED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	AK027009	flj0064a23	FLJ	W01A025D18	pENTR-TOPO	22800		SGK196	84197	BAB15623	Hs.491646	Protein kinase-like protein SgK196	HepG2	hepatoma		HEP	EK1	NM_032237.3	NP_115613.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	AF327353	X01Y147M19	RIKEN_rt-pcr	W01A025D19	pENTR-TOPO	3822		ACER3	55331	AAL56013.1	Hs.23862	Alkaline ceramidase 3						NM_018367.5	NP_060837.3	VALIDATED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	U65410	X01Y104M01	RIKEN_rt-pcr	W01A025E02	pENTR-TOPO	18115		MAD2L1	4085	AAC50781.1	Hs.591697	MAD2 mitotic arrest deficient-like 1 (yeast)						NM_002358.3	NP_002349.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	U65410	X01Y104M01	RIKEN_rt-pcr	W01A025E08	pENTR-TOPO	18115		MAD2L1	4085	AAC50781.1	Hs.591697	MAD2 mitotic arrest deficient-like 1 (yeast)						NM_002358.3	NP_002349.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC008430	IRAL021B14	MGC	W01A025E12	pENTR-TOPO	9721		FAM18B	51030	AAH08430.1	Hs.87295	Family with sequence similarity 18, member B			Skeletal Muscle	NIH_MGC_81	DH10B	NM_016078.4	NP_057162.4	PREDICTED	OK	1.000	1.000	205	618	1	615	205	1	205
RIKEN	ENST00000267017	X01Y140E05	RIKEN_rt-pcr	W01A025E13	pENTR-TOPO	5884		NPFF	8620	ENSP00000267017	Hs.719390	Neuropeptide FF-amide peptide precursor						NM_003717.2	NP_003708.1	REVIEWED	C	1.000	1.000	113	346	2	340	113	1	113
RIKEN	BC005257	IRAL016K14	MGC	W01A025E19	pENTR-TOPO	2881		MSMB	4477	AAH05257.1	Hs.255462	Microseminoprotein, beta-			Prostate	NIH_MGC_83	DH10B	NM_002443.2	NP_002434.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	ENST00000168712	X01Y146O17	RIKEN_rt-pcr	W01A025E24	pENTR-TOPO	4954		FGF4	2249	ENSP00000168712	Hs.1755	Fibroblast growth factor 4						NM_002007.2	NP_001998.1	REVIEWED	C	1.000	1.000	206	624	1	618	206	1	206
RIKEN	BC038398	IRAK050G06	MGC	W01A025F02	pENTR-TOPO	16203		CCR5	1234	AAH38398.1	Hs.536735	Chemokine (C-C motif) receptor 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000579.3	NP_000570.1	REVIEWED	OK	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC009280	IRAL017N06	MGC	W01A025F03	pENTR-TOPO	24187		ZDHHC12	84885	AAH09280.1	Hs.133122	Zinc finger, DHHC-type containing 12			Uterus, leiomyosarcoma	NIH_MGC_46		NM_032799.4	NP_116188.2	VALIDATED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	BC038398	IRAK050G06	MGC	W01A025F04	pENTR-TOPO	16203		CCR5	1234	AAH38398.1	Hs.536735	Chemokine (C-C motif) receptor 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000579.3	NP_000570.1	REVIEWED	OK	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC009280	IRAL017N06	MGC	W01A025F05	pENTR-TOPO	24187		ZDHHC12	84885	AAH09280.1	Hs.133122	Zinc finger, DHHC-type containing 12			Uterus, leiomyosarcoma	NIH_MGC_46		NM_032799.4	NP_116188.2	VALIDATED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	BC038398	IRAK050G06	MGC	W01A025F08	pENTR-TOPO	16203		CCR5	1234	AAH38398.1	Hs.536735	Chemokine (C-C motif) receptor 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000579.3	NP_000570.1	REVIEWED	OK	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	AK094452	flj0024a02	FLJ	W01A025F10	pENTR-TOPO	12340		VN1R1	57191	BAG52867.1	Hs.677423	Vomeronasal 1 receptor 1				BRACE2	EK1	NM_020633.2	NP_065684.1	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC039847	IRAK084M06	MGC	W01A025F11	pENTR-TOPO	19075		PPAP2A	8611	AAH39847.1	Hs.696231	Phosphatidic acid phosphatase type 2A			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_003711.2	NP_003702.2	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	AK094452	flj0024a02	FLJ	W01A025F12	pENTR-TOPO	12340		VN1R1	57191	BAG52867.1	Hs.677423	Vomeronasal 1 receptor 1				BRACE2	EK1	NM_020633.2	NP_065684.1	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC039847	IRAK084M06	MGC	W01A025F15	pENTR-TOPO	19075		PPAP2A	8611	AAH39847.1	Hs.696231	Phosphatidic acid phosphatase type 2A			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_003711.2	NP_003702.2	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	AK094452	flj0024a02	FLJ	W01A025F16	pENTR-TOPO	12340		VN1R1	57191	BAG52867.1	Hs.677423	Vomeronasal 1 receptor 1				BRACE2	EK1	NM_020633.2	NP_065684.1	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	NM_023920	X01Y105O09	RIKEN_rt-pcr	W01A025F17	pENTR-TOPO	6275		TAS2R13	50838	NP_076409.1	Hs.679407	Taste receptor, type 2, member 13						NM_023920.2	NP_076409.1	REVIEWED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC036741	IRAK068G21	MGC	W01A025F20	pENTR-TOPO	18691		BXDC2	55299	AAH36741.1	Hs.718510	Brix domain containing 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_018321.3	NP_060791.3	VALIDATED	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	AK096737	flj0023l16	FLJ	W01A025F23	pENTR-TOPO	12629		PTGIR	5739		Hs.458324	Prostaglandin I2 (prostacyclin) receptor (IP)				PLACE6	EK1	NM_000960.3	NP_000951.1	REVIEWED	Ps	0.992	0.992	257	870	1	771	386	1	257
RIKEN	BC008392	IRAL021F12	MGC	W01A025G02	pENTR-TOPO	4524		UCP3	7352	AAH08392.1	Hs.101337	Uncoupling protein 3 (mitochondrial, proton carrier)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_022803.2	NP_073714.1	REVIEWED	Cg	0.625	1.000	275	630	1	516	275	1	275
RIKEN	AK091247	flj0015i02	FLJ	W01A025G03	pENTR-TOPO	23672		CENPP	401541	BAG52317.1	Hs.713775	Centromere protein P				CTONG2	EK1	NM_001012267.1	NP_001012267.1	VALIDATED	Ps	0.990	0.990	101	348	43	345	288	188	288
RIKEN	BC008392	IRAL021F12	MGC	W01A025G06	pENTR-TOPO	4524		UCP3	7352	AAH08392.1	Hs.101337	Uncoupling protein 3 (mitochondrial, proton carrier)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_022803.2	NP_073714.1	REVIEWED	Cg	0.625	1.000	275	630	1	516	275	1	275
RIKEN	BC040107	IRAK084H07	MGC	W01A025G09	pENTR-TOPO	21135		CRCP	27297	AAH40107.1	Hs.300684	CGRP receptor component			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001040647.1	NP_001035737.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC002833	IRAL012J20	MGC	W01A025G12	pENTR-TOPO	25259		CTAG2	30848	AAH02833.1	Hs.87225	Cancer/testis antigen 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_020994.2	NP_066274.1	VALIDATED	Cs	0.990	0.990	210	633	1	630	210	1	210
RIKEN	BC040107	IRAK084H07	MGC	W01A025G15	pENTR-TOPO	21135		CRCP	27297	AAH40107.1	Hs.300684	CGRP receptor component			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001040647.1	NP_001035737.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC002833	IRAL012J20	MGC	W01A025G16	pENTR-TOPO	25259		CTAG2	30848	AAH02833.1	Hs.87225	Cancer/testis antigen 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_020994.2	NP_066274.1	VALIDATED	Cs	0.990	0.990	210	633	1	630	210	1	210
RIKEN	BC001827	IRAL011P19	MGC	W01A025G18	pENTR-TOPO	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_012145.2	NP_036277.2	VALIDATED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC001827	IRAL011P19	MGC	W01A025G20	pENTR-TOPO	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_012145.2	NP_036277.2	VALIDATED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC001827	IRAL011P19	MGC	W01A025G22	pENTR-TOPO	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_012145.2	NP_036277.2	VALIDATED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC056508	IRAL048H09	MGC	W01A025G23	pENTR-TOPO	25677		VCY1B	353513	AAH56508.1					Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC008930	IRAL002B21	MGC	W01A025H03	pENTR-TOPO	12177		ERCC1	2067	AAH08930.1	Hs.435981	Excision repair cross-complementing rodent repair deficiency, complementation group 1 (includes overlapping antisense sequence)			Lung, small cell carcinoma	NIH_MGC_7		NM_001983.2	NP_001974.1	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC011387	IRAK013M06	MGC	W01A025H04	pENTR-TOPO	4539		SLC29A2	3177	AAH11387.1	Hs.569017	Solute carrier family 29 (nucleoside transporters), member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001532.2	NP_001523.2	VALIDATED	Pfs	0.884	0.994	406	1086	1	1084	456	1	406
RIKEN	BC003548	IRAL008D07	MGC	W01A025H09	pENTR-TOPO	3214		POLL	27343	AAH03548.2	Hs.523230	Polymerase (DNA directed), lambda			Lung, small cell carcinoma	NIH_MGC_7		NM_013274.2	NP_037406.1	VALIDATED	Ps	0.996	0.996	279	897	58	894	575	297	575
RIKEN	BC003548	IRAL008D07	MGC	W01A025H11	pENTR-TOPO	3214		POLL	27343	AAH03548.2	Hs.523230	Polymerase (DNA directed), lambda			Lung, small cell carcinoma	NIH_MGC_7		NM_013274.2	NP_037406.1	VALIDATED	Ps	0.996	0.996	279	897	58	894	575	297	575
RIKEN	BC003548	IRAL008D07	MGC	W01A025H13	pENTR-TOPO	3214		POLL	27343	AAH03548.2	Hs.523230	Polymerase (DNA directed), lambda			Lung, small cell carcinoma	NIH_MGC_7		NM_013274.2	NP_037406.1	VALIDATED	Ps	0.996	0.996	279	897	58	894	575	297	575
RIKEN	BC001620	IRAL006O08	MGC	W01A025H17	pENTR-TOPO	24829		ASMT	438	AAH01620.1					Eye, retinoblastoma	NIH_MGC_16		NM_004043.2	NP_004034.2	VALIDATED	Cg	0.799	1.000	373	897	1	894	373	1	373
RIKEN	BC041788	IRAL041O03	MGC	W01A025H18	pENTR-TOPO	22508		GRINA	2907	AAH41788.2	Hs.594634	Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001009184.1	NP_001009184.1	VALIDATED	Cs	0.997	0.997	371	1116	1	1113	371	1	371
RIKEN	BC041788	IRAL041O03	MGC	W01A025H20	pENTR-TOPO	22508		GRINA	2907	AAH41788.2	Hs.594634	Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001009184.1	NP_001009184.1	VALIDATED	Cs	0.997	0.997	371	1116	1	1113	371	1	371
RIKEN	BC041788	IRAL041O03	MGC	W01A025H22	pENTR-TOPO	22508		GRINA	2907	AAH41788.2	Hs.594634	Glutamate receptor, ionotropic, N-methyl D-aspartate-associated protein 1 (glutamate binding)			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001009184.1	NP_001009184.1	VALIDATED	Cs	0.997	0.997	371	1116	1	1113	371	1	371
RIKEN	AK096693	flj0042b14	FLJ	W01A025I02	pENTR-TOPO	4504		TOLLIP	54472	BAC04844.1	Hs.368527	Toll interacting protein				PEBLM2	EK1	NM_019009.2	NP_061882.2	PROVISIONAL	Cgs	0.774	0.995	274	642	1	639	274	1	274
RIKEN	BC000893	IRAK004F22	MGC	W01A025I03	pENTR-TOPO	20586		HIST1H2BK	85236	AAH00893.1	Hs.689116	Histone cluster 1, H2bk			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080593.1	NP_542160.1	REVIEWED	C	1.000	1.000	126	381	1	378	126	1	126
RIKEN	AK096693	flj0042b14	FLJ	W01A025I04	pENTR-TOPO	4504		TOLLIP	54472	BAC04844.1	Hs.368527	Toll interacting protein				PEBLM2	EK1	NM_019009.2	NP_061882.2	PROVISIONAL	Cgs	0.774	0.995	274	642	1	639	274	1	274
RIKEN	AK096693	flj0042b14	FLJ	W01A025I06	pENTR-TOPO	4504		TOLLIP	54472	BAC04844.1	Hs.368527	Toll interacting protein				PEBLM2	EK1	NM_019009.2	NP_061882.2	PROVISIONAL	Cgs	0.774	0.995	274	642	1	639	274	1	274
RIKEN	NM_003513	X01Y145O09	RIKEN_rt-pcr	W01A025I09	pENTR-TOPO	20857		HIST1H2AB	8335	NP_003504.2	Hs.248174	Histone cluster 1, H2ab						NM_003513.2	NP_003504.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	AK092182	flj0011i18	FLJ	W01A025I17	pENTR-TOPO	16152		SEMA3B	7869	BAC03823.1	Hs.82222	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B	NT2	teratocarcinoma		NT2NE2	EK1	NM_001005914.1	NP_001005914.1	REVIEWED	Pfs	0.714	1.000	185	399	1	397	748	407	591
RIKEN	AK092182	flj0011i18	FLJ	W01A025I21	pENTR-TOPO	16152		SEMA3B	7869	BAC03823.1	Hs.82222	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B	NT2	teratocarcinoma		NT2NE2	EK1	NM_001005914.1	NP_001005914.1	REVIEWED	Pfs	0.714	1.000	185	399	1	397	748	407	591
RIKEN	BC021675	IRAL031K19	MGC	W01A025I22	pENTR-TOPO	1568		TSPAN2	10100	AAH21675.1	Hs.310458	Tetraspanin 2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_005725.3	NP_005716.2	REVIEWED	C	1.000	1.000	221	666	1	663	221	1	221
RIKEN	NM_023920	X01Y105O09	RIKEN_rt-pcr	W01A025J03	pENTR-TOPO	6275		TAS2R13	50838	NP_076409.1	Hs.679407	Taste receptor, type 2, member 13						NM_023920.2	NP_076409.1	REVIEWED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC001492	IRAL007D18	MGC	W01A025J04	pENTR-TOPO	24241		CNTFR	1271	AAH01492.1	Hs.129966	Ciliary neurotrophic factor receptor			Brain, neuroblastoma	NIH_MGC_19		NM_001842.3	NP_001833.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	NM_023920	X01Y105O09	RIKEN_rt-pcr	W01A025J07	pENTR-TOPO	6275		TAS2R13	50838	NP_076409.1	Hs.679407	Taste receptor, type 2, member 13						NM_023920.2	NP_076409.1	REVIEWED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	AK098566	flj0053m04	FLJ	W01A025J10	pENTR-TOPO	20428		SERPINB6	5269	-	Hs.519523	Serpin peptidase inhibitor, clade B (ovalbumin), member 6				TST	EK1	NM_004568.4	NP_004559.4	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC002862	IRAL015A11	MGC	W01A025J11	pENTR-TOPO	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lung, small cell carcinoma	NIH_MGC_7		NM_001040177.1	NP_001035267.1	PROVISIONAL	Ps	0.997	0.997	307	924	1	921	320	1	307
RIKEN	AK098566	flj0053m04	FLJ	W01A025J12	pENTR-TOPO	20428		SERPINB6	5269	-	Hs.519523	Serpin peptidase inhibitor, clade B (ovalbumin), member 6				TST	EK1	NM_004568.4	NP_004559.4	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC002862	IRAL015A11	MGC	W01A025J13	pENTR-TOPO	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lung, small cell carcinoma	NIH_MGC_7		NM_001040177.1	NP_001035267.1	PROVISIONAL	Ps	0.997	0.997	307	924	1	921	320	1	307
RIKEN	BC002862	IRAL015A11	MGC	W01A025J15	pENTR-TOPO	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lung, small cell carcinoma	NIH_MGC_7		NM_001040177.1	NP_001035267.1	PROVISIONAL	Ps	0.997	0.997	307	924	1	921	320	1	307
RIKEN	BC011971	IRAK019A04	MGC	W01A025J18	pENTR-TOPO	15169		AGPAT3	56894	AAH11971.1	Hs.248785	1-acylglycerol-3-phosphate O-acyltransferase 3			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_020132.4	NP_064517.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	NM_176885	X01Y106A23	RIKEN_rt-pcr	W01A025J19	pENTR-TOPO	6306		TAS2R31	259290	NP_795366.2	Hs.688197	Taste receptor, type 2, member 31						NM_176885.2	NP_795366.2	PROVISIONAL	Cs	0.997	0.997	309	930	1	927	309	1	309
RIKEN	NM_176885	X01Y106A23	RIKEN_rt-pcr	W01A025J23	pENTR-TOPO	6306		TAS2R31	259290	NP_795366.2	Hs.688197	Taste receptor, type 2, member 31						NM_176885.2	NP_795366.2	PROVISIONAL	Cs	0.997	0.997	309	930	1	927	309	1	309
RIKEN	BC011971	IRAK019A04	MGC	W01A025J24	pENTR-TOPO	15169		AGPAT3	56894	AAH11971.1	Hs.248785	1-acylglycerol-3-phosphate O-acyltransferase 3			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_020132.4	NP_064517.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	AK000158	flj0050p01	FLJ	W01A025K07	pENTR-TOPO	8166		CA12	771	BAA90981.1	Hs.210995	Carbonic anhydrase XII				COL	EK1	NM_001218.3	NP_001209.1	REVIEWED		0.538	0.583	13	426	362	327	354	236	248
RIKEN	BC009739	IRAL021J03	MGC	W01A025K14	pENTR-TOPO	8560		HERPUD1	9709	AAH09739.1	Hs.146393	Homocysteine-inducible, endoplasmic reticulum stress-inducible, ubiquitin-like domain member 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001010990.1	NP_001010990.1	REVIEWED	Cg	0.533	1.000	390	699	1	696	366	1	366
RIKEN	BC011563	IRAL029M05	MGC	W01A025K18	pENTR-TOPO	8618		LAT	27040	AAH11563.1	Hs.632179	Linker for activation of T cells			Colon, adenocarcinoma	NIH_MGC_15		NM_001014987.1	NP_001014987.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC011563	IRAL029M05	MGC	W01A025K20	pENTR-TOPO	8618		LAT	27040	AAH11563.1	Hs.632179	Linker for activation of T cells			Colon, adenocarcinoma	NIH_MGC_15		NM_001014987.1	NP_001014987.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC029908	IRAK051B14	MGC	W01A025K23	pENTR-TOPO	11962		TSPAN16	26526	AAH29908.1	Hs.579784	Tetraspanin 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012466.2	NP_036598.1	REVIEWED	P	1.000	1.000	150	483	1	450	245	1	150
RIKEN	BC003622	IRAL010K18	MGC	W01A025L09	pENTR-TOPO	7437		ITPK1	3705	AAH03622.1	Hs.308122	Inositol 1,3,4-triphosphate 5/6 kinase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001142594.1	NP_001136066.1	VALIDATED	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC043493	IRAK089M03	MGC	W01A025L12	pENTR-TOPO	16073		MBNL1	4154	AAH43493.1	Hs.478000	Muscleblind-like (Drosophila)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021038.3	NP_066368.2	VALIDATED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC043493	IRAK089M03	MGC	W01A025L16	pENTR-TOPO	16073		MBNL1	4154	AAH43493.1	Hs.478000	Muscleblind-like (Drosophila)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021038.3	NP_066368.2	VALIDATED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	AF040630	X01Y109E23	RIKEN_rt-pcr	W01A025L18	pENTR-TOPO	9665		GALR2	8811	AAC39634.1	Hs.666366	Galanin receptor 2						NM_003857.2	NP_003848.1	REVIEWED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	ENST00000259205	X01Y146G21	RIKEN_rt-pcr	W01A025M01	pENTR-TOPO	13154		IL1F9	56300	ENSP00000259205	Hs.211238	Interleukin 1 family, member 9						NM_019618.2	NP_062564.1	REVIEWED	C	1.000	1.000	169	513	1	507	169	1	169
RIKEN	BC036364	IRAK071B13	MGC	W01A025M02	pENTR-TOPO	15828		BID	637	AAH36364.2	Hs.591054	BH3 interacting domain death agonist			Brain, hippocampus	NIH_MGC_95	DH10B	NM_197966.1	NP_932070.1	REVIEWED	Cs	0.996	0.996	241	726	1	723	241	1	241
RIKEN	ENST00000259205	X01Y146G21	RIKEN_rt-pcr	W01A025M07	pENTR-TOPO	13154		IL1F9	56300	ENSP00000259205	Hs.211238	Interleukin 1 family, member 9						NM_019618.2	NP_062564.1	REVIEWED	C	1.000	1.000	169	513	1	507	169	1	169
RIKEN	BC012620	IRAL019I07	MGC	W01A025M11	pENTR-TOPO	9667		GOSR1	9527	AAH12620.1	Hs.462680	Golgi SNAP receptor complex member 1			Prostate	NIH_MGC_83	DH10B	NM_004871.2	NP_004862.1	REVIEWED	P	1.000	1.000	116	528	1	348	250	1	116
RIKEN	AF285592	X01Y101I13	RIKEN_rt-pcr	W01A025M19	pENTR-TOPO	25218		FTHL17	53940	AAK31971.1	Hs.333125	Ferritin, heavy polypeptide-like 17						NM_031894.1	NP_114100.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC001119	IRAL003A20	MGC	W01A025M20	pENTR-TOPO	14910		EIF6	3692	AAH01119.1	Hs.654848	Eukaryotic translation initiation factor 6			Ovary, adenocarcinoma	NIH_MGC_9		NM_181468.1	NP_852133.1	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
RIKEN	AF285592	X01Y101I13	RIKEN_rt-pcr	W01A025M21	pENTR-TOPO	25218		FTHL17	53940	AAK31971.1	Hs.333125	Ferritin, heavy polypeptide-like 17						NM_031894.1	NP_114100.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC001119	IRAL003A20	MGC	W01A025M22	pENTR-TOPO	14910		EIF6	3692	AAH01119.1	Hs.654848	Eukaryotic translation initiation factor 6			Ovary, adenocarcinoma	NIH_MGC_9		NM_181468.1	NP_852133.1	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
RIKEN	AK124339	flj0041a17	FLJ	W01A025N08	pENTR-TOPO	10628		GJC1	10052	BAG54030.1	Hs.712052	Gap junction protein, gamma 1, 45kDa				UTERU2	EK1	NM_005497.3	NP_005488.2	REVIEWED	Cs	0.997	0.997	396	1191	1	1188	396	1	396
RIKEN	BC069148	X01Y148M15	MGC	W01A025N13	pENTR-TOPO	6027		TAS2R14	50840	AAH69148.1	Hs.679406	Taste receptor, type 2, member 14						NM_023922.1	NP_076411.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC033864	IRAK068L12	MGC	W01A025N19	pENTR-TOPO	6073		BCAT1	586	AAH33864	Hs.438993	Branched chain aminotransferase 1, cytosolic			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005504.5	NP_005495.2	REVIEWED	P	1.000	1.000	299	963	4	900	386	3	301
RIKEN	BC033864	IRAK068L12	MGC	W01A025N21	pENTR-TOPO	6073		BCAT1	586	AAH33864	Hs.438993	Branched chain aminotransferase 1, cytosolic			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005504.5	NP_005495.2	REVIEWED	P	1.000	1.000	299	963	4	900	386	3	301
RIKEN	BC033864	IRAK068L12	MGC	W01A025N23	pENTR-TOPO	6073		BCAT1	586	AAH33864	Hs.438993	Branched chain aminotransferase 1, cytosolic			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005504.5	NP_005495.2	REVIEWED	P	1.000	1.000	299	963	4	900	386	3	301
RIKEN	BC063487	IRAK135L10	MGC	W01A025O03	pENTR-TOPO	7792		TM6SF1	53346	AAH63487.1	Hs.513094	Transmembrane 6 superfamily member 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_023003.3	NP_075379.2	VALIDATED	Pfs	0.907	0.917	183	567	1	542	370	1	183
RIKEN	BC014851	IRAK028A22	MGC	W01A025O08	pENTR-TOPO	21186		LFNG	3955	AAH14851.1	Hs.159142	LFNG O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_001040167.1	NP_001035257.1	REVIEWED	P	1.000	1.000	235	753	46	750	379	145	379
RIKEN	M11568	X01Y103G19	RIKEN_rt-pcr	W01A025O09	pENTR-TOPO	5865		IGF1	3479	AAA52539.1	Hs.160562	Insulin-like growth factor 1 (somatomedin C)						NM_001111285.1	NP_001104755.1	REVIEWED	OK	1.000	1.000	195	588	1	585	195	1	195
RIKEN	BC012621	IRAL019F08	MGC	W01A025O17	pENTR-TOPO	5272		KLRG1	10219	AAH12621.1	Hs.558446	Killer cell lectin-like receptor subfamily G, member 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_005810.3	NP_005801.3	REVIEWED	P	1.000	1.000	186	588	1	558	189	1	186
RIKEN	BC012621	IRAL019F08	MGC	W01A025O19	pENTR-TOPO	5272		KLRG1	10219	AAH12621.1	Hs.558446	Killer cell lectin-like receptor subfamily G, member 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_005810.3	NP_005801.3	REVIEWED	P	1.000	1.000	186	588	1	558	189	1	186
RIKEN	BC012621	IRAL019F08	MGC	W01A025O21	pENTR-TOPO	5272		KLRG1	10219	AAH12621.1	Hs.558446	Killer cell lectin-like receptor subfamily G, member 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_005810.3	NP_005801.3	REVIEWED	P	1.000	1.000	186	588	1	558	189	1	186
RIKEN	NM_176882	X01Y106E05	RIKEN_rt-pcr	W01A025P05	pENTR-TOPO	21476		TAS2R40	259286	NP_795363.1	Hs.352241	Taste receptor, type 2, member 40						NM_176882.1	NP_795363.1	PROVISIONAL	OK	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC069075	X01Y140E23	MGC	W01A025P21	pENTR-TOPO	16822		XCR1	2829	AAH69075.1	Hs.248116	Chemokine (C motif) receptor 1						NM_001024644.1	NP_001019815.1	REVIEWED	OK	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	AK096737	flj0023l16	FLJ	W01A025P22	pENTR-TOPO	12629		PTGIR	5739		Hs.458324	Prostaglandin I2 (prostacyclin) receptor (IP)				PLACE6	EK1	NM_000960.3	NP_000951.1	REVIEWED	Ps	0.992	0.992	257	870	1	771	386	1	257
RIKEN	BC044581	IRAK106F13	MGC	W01A026A02	pENTR-TOPO	18624		PKD2L2	27039	AAH44581.1	Hs.716884	Polycystic kidney disease 2-like 2			Testis	NIH_MGC_97	DH10B	NM_014386.2	NP_055201.2	VALIDATED	Pgs	0.827	0.996	595	1572	1	1482	613	1	595
RIKEN	BC044581	IRAK106F13	MGC	W01A026A04	pENTR-TOPO	18624		PKD2L2	27039	AAH44581.1	Hs.716884	Polycystic kidney disease 2-like 2			Testis	NIH_MGC_97	DH10B	NM_014386.2	NP_055201.2	VALIDATED	Pgs	0.827	0.996	595	1572	1	1482	613	1	595
RIKEN	X86570	X01Y149O23	RIKEN_rt-pcr	W01A026A09	pENTR-TOPO	10770		KRT31	3881	CAA60378.1	Hs.41696	Keratin 31						NM_002277.2	NP_002268.2	REVIEWED	Cs	0.995	0.995	416	1251	1	1248	416	1	416
RIKEN	AK131391	X01Y113E21	FLJ	W01A026A20	pENTR-TOPO	7165		PPP2R5C	5527	BAD18542.1	Hs.368264	Protein phosphatase 2, regulatory subunit B', gamma isoform				BRHIP3	EK1	NM_178588.1	NP_848703.1	REVIEWED	Ps	0.994	0.994	355	1623	253	1317	384	30	384
RIKEN	BC045630	IRAK063J16	MGC	W01A026A21	pENTR-TOPO	22954		TSPYL5	85453	AAH45630.1	Hs.173094	TSPY-like 5			Testis	NIH_MGC_97	DH10B	NM_033512.2	NP_277047.2	VALIDATED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
RIKEN	BC035404	IRAK052E20	MGC	W01A026B04	pENTR-TOPO	22985		PTK2	5747	AAH35404.1	Hs.395482	PTK2 protein tyrosine kinase 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_153831.2	NP_722560.1	REVIEWED	Cg	0.956	1.000	1052	3021	1	3018	1052	1	1052
RIKEN	BC023021	IRAK042L14	MGC	W01A026B11	pENTR-TOPO	7010		GOLGA5	9950	AAH23021.1	Hs.104320	Golgi autoantigen, golgin subfamily a, 5			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005113.2	NP_005104.2	REVIEWED	Cs	0.997	0.997	731	2196	1	2193	731	1	731
RIKEN	AK056638	flj0003e12	FLJ	W01A026B17	pENTR-TOPO	13772		SATB2	23314	BAG51771.1	Hs.516617	SATB homeobox 2				OCBBF1	EK1	NM_015265.2	NP_056080.1	VALIDATED	Cs	0.999	0.999	733	2202	1	2199	733	1	733
RIKEN	NM_006158	X01Y114I23	RIKEN_rt-pcr	W01A026C04	pENTR-TOPO	23146		NEFL	4747	NP_006149.2	Hs.521461	Neurofilament, light polypeptide						NM_006158.3	NP_006149.2	REVIEWED	Cgs	0.987	0.993	545	1635	1	1632	543	1	543
RIKEN	BC007679	IRAL012G06	MGC	W01A026C09	pENTR-TOPO	5258		P2RX7	5027	AAH07679.1	Hs.507102	Purinergic receptor P2X, ligand-gated ion channel, 7			Brain, neuroblastoma	NIH_MGC_19		NM_002562.4	NP_002553.2	REVIEWED	Ps	0.995	0.995	418	1278	22	1275	595	178	595
RIKEN	BC048960	IRAK106H12	MGC	W01A026C10	pENTR-TOPO	11280		YES1	7525	AAH48960.1	Hs.194148	V-yes-1 Yamaguchi sarcoma viral oncogene homolog 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005433.3	NP_005424.1	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	BC048960	IRAK106H12	MGC	W01A026C12	pENTR-TOPO	11280		YES1	7525	AAH48960.1	Hs.194148	V-yes-1 Yamaguchi sarcoma viral oncogene homolog 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005433.3	NP_005424.1	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	BC042147	IRAL044B20	MGC	W01A026C19	pENTR-TOPO	1549		KCNN3	3782	AAH42147.1	Hs.490765	Potassium intermediate/small conductance calcium-activated channel, subfamily N, member 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_170782.1	NP_740752.1	REVIEWED	C	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC030587	IRAK033E22	MGC	W01A026C22	pENTR-TOPO	23784		PIP5K1B	8395	AAH30587.1	Hs.534371	Phosphatidylinositol-4-phosphate 5-kinase, type I, beta			Testis	NIH_MGC_97	DH10B	NM_003558.2	NP_003549.1	VALIDATED	Pgs	0.914	0.986	547	1650	1	1641	540	1	507
RIKEN	BC041098	IRAK078M15	MGC	W01A026D02	pENTR-TOPO	13164		UGCGL1	56886	AAH41098.1	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001025777.1	NP_001020948.1	VALIDATED	C	1.000	1.000	1531	4596	1	4593	1531	1	1531
RIKEN	AK075390	flj0027e12	FLJ	W01A026D03	pENTR-TOPO	3879		NAALAD2	10003	BAG52126.1	Hs.503560	N-acetylated alpha-linked acidic dipeptidase 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_005467.3	NP_005458.1	REVIEWED	C	1.000	1.000	740	2223	1	2220	740	1	740
RIKEN	BC041098	IRAK078M15	MGC	W01A026D04	pENTR-TOPO	13164		UGCGL1	56886	AAH41098.1	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001025777.1	NP_001020948.1	VALIDATED	C	1.000	1.000	1531	4596	1	4593	1531	1	1531
RIKEN	BC041098	IRAK078M15	MGC	W01A026D06	pENTR-TOPO	13164		UGCGL1	56886	AAH41098.1	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001025777.1	NP_001020948.1	VALIDATED	C	1.000	1.000	1531	4596	1	4593	1531	1	1531
RIKEN	AK075390	flj0027e12	FLJ	W01A026D07	pENTR-TOPO	3879		NAALAD2	10003	BAG52126.1	Hs.503560	N-acetylated alpha-linked acidic dipeptidase 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_005467.3	NP_005458.1	REVIEWED	C	1.000	1.000	740	2223	1	2220	740	1	740
RIKEN	BC028933	IRAK052B12	MGC	W01A026D13	pENTR-TOPO	1750		FCRL3	115352	AAH28933.1	Hs.292449	Fc receptor-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_052939.3	NP_443171.2	REVIEWED	Ps	0.999	0.999	725	2229	1	2175	734	1	725
RIKEN	BC028933	IRAK052B12	MGC	W01A026D15	pENTR-TOPO	1750		FCRL3	115352	AAH28933.1	Hs.292449	Fc receptor-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_052939.3	NP_443171.2	REVIEWED	Ps	0.999	0.999	725	2229	1	2175	734	1	725
RIKEN	BC001174	IRAL006L06	MGC	W01A026D19	pENTR-TOPO	23193		EXT1	2131	AAH01174.1	Hs.492618	Exostoses (multiple) 1			Brain, neuroblastoma	NIH_MGC_19		NM_000127.2	NP_000118.2	REVIEWED	OK	1.000	1.000	746	2241	1	2238	746	1	746
RIKEN	XM_496653	X01Y111O09	RIKEN_rt-pcr	W01A026E05	pENTR-TOPO	16634		EPHA6	285220	XP_496653	Hs.653244	EPH receptor A6						NM_173655.2	NP_775926.1	PROVISIONAL	P	1.000	1.000	320	1308	1	960	334	1	320
RIKEN	XM_496653	X01Y111O09	RIKEN_rt-pcr	W01A026E07	pENTR-TOPO	16634		EPHA6	285220	XP_496653	Hs.653244	EPH receptor A6						NM_173655.2	NP_775926.1	PROVISIONAL	P	1.000	1.000	320	1308	1	960	334	1	320
RIKEN	AF532859	X01Y111C01	RIKEN_rt-pcr	W01A026E11	pENTR-TOPO	10469		RTN4RL1	146760	AAP21836.1	Hs.22917	Reticulon 4 receptor-like 1						NM_178568.2	NP_848663.1	VALIDATED	C	1.000	1.000	441	1326	1	1323	441	1	441
RIKEN	AF532859	X01Y111C01	RIKEN_rt-pcr	W01A026E13	pENTR-TOPO	10469		RTN4RL1	146760	AAP21836.1	Hs.22917	Reticulon 4 receptor-like 1						NM_178568.2	NP_848663.1	VALIDATED	C	1.000	1.000	441	1326	1	1323	441	1	441
RIKEN	BC007933	IRAL020D24	MGC	W01A026E16	pENTR-TOPO	16303		EEFSEC	60678	AAH07933.1	Hs.477498	Eukaryotic elongation factor, selenocysteine-tRNA-specific			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021937.3	NP_068756.2	VALIDATED	Ps	0.996	0.996	567	1710	7	1707	596	30	596
RIKEN	AK094130	flj0045l01	FLJ	W01A026E21	pENTR-TOPO	19150		MGAT1	4245	BAG52821.1	Hs.519818	Mannosyl (alpha-1,3-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase				ASTRO2	EK1	NM_002406.3	NP_002397.2	REVIEWED	Cs	0.998	0.998	445	1338	1	1335	445	1	445
RIKEN	BC025777	IRAK049L15	MGC	W01A026F03	pENTR-TOPO	20589		MAP7	9053	AAH25777.1	Hs.486548	Microtubule-associated protein 7			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003980.3	NP_003971.1	REVIEWED	Cs	0.999	0.999	749	2250	1	2247	749	1	749
RIKEN	BC025777	IRAK049L15	MGC	W01A026F05	pENTR-TOPO	20589		MAP7	9053	AAH25777.1	Hs.486548	Microtubule-associated protein 7			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003980.3	NP_003971.1	REVIEWED	Cs	0.999	0.999	749	2250	1	2247	749	1	749
RIKEN	BC025777	IRAK049L15	MGC	W01A026F07	pENTR-TOPO	20589		MAP7	9053	AAH25777.1	Hs.486548	Microtubule-associated protein 7			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003980.3	NP_003971.1	REVIEWED	Cs	0.999	0.999	749	2250	1	2247	749	1	749
RIKEN	AK122647	flj0023b14	FLJ	W01A026F15	pENTR-TOPO	17461		RXFP1	59350	BAG53639.1	Hs.591686	Relaxin/insulin-like family peptide receptor 1				MESAN2	EK1	NM_021634.2	NP_067647.2	PROVISIONAL	P	1.000	1.000	740	2307	85	2304	757	18	757
RIKEN	BC020057	IRAK026E17	MGC	W01A026F17	pENTR-TOPO	3410		ITGB1	3688	AAH20057.1	Hs.643813	Integrin, beta 1 (fibronectin receptor, beta polypeptide, antigen CD29 includes MDF2, MSK12)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_133376.2	NP_596867.1	REVIEWED	C	1.000	1.000	798	2397	1	2394	798	1	798
RIKEN	BC045711	IRAK090M23	MGC	W01A026G05	pENTR-TOPO	11186		BRUNOL4	56853	AAH45711.1	Hs.435976	Bruno-like 4, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001025089.1	NP_001020260.1	REVIEWED	OK	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC011794	IRAL027N06	MGC	W01A026G09	pENTR-TOPO	5887		MCRS1	10445	AAH11794.1	Hs.25313	Microspherule protein 1			Uterus, leiomyosarcoma	NIH_MGC_46		NM_006337.3	NP_006328.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC041664	IRAK082D04	MGC	W01A026G12	pENTR-TOPO	3692		BEST1	7439	AAH41664.1	Hs.712676	Bestrophin 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001139443.1	NP_001132915.1	REVIEWED	Cs	0.998	0.998	604	1815	1	1812	604	1	604
RIKEN	BC041664	IRAK082D04	MGC	W01A026G16	pENTR-TOPO	3692		BEST1	7439	AAH41664.1	Hs.712676	Bestrophin 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001139443.1	NP_001132915.1	REVIEWED	Cs	0.998	0.998	604	1815	1	1812	604	1	604
RIKEN	BC007737	IRAL017F15	MGC	W01A026G24	pENTR-TOPO	3157		NRP1	8829	AAH07737.1	Hs.131704	Neuropilin 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001024629.2	NP_001019800.1	VALIDATED	C	1.000	1.000	609	1830	1	1827	609	1	609
RIKEN	BC012097	IRAL029L19	MGC	W01A026H07	pENTR-TOPO	8366		OCA2	4948	AAH12097.1	Hs.654411	Oculocutaneous albinism II			Skin, melanotic melanoma.	NIH_MGC_20		NM_000275.2	NP_000266.2	REVIEWED	Cg	0.971	1.000	838	2445	1	2442	838	1	838
RIKEN	AY345972	X01Y130I21	RIKEN_rt-pcr	W01A026H19	pENTR-TOPO	6164		KSR2	283455	AAQ24226.1	Hs.375836	Kinase suppressor of ras 2						NM_173598.4	NP_775869.3	VALIDATED	P	1.000	1.000	829	2490	1	2487	921	93	921
RIKEN	AY345972	X01Y130I21	RIKEN_rt-pcr	W01A026H21	pENTR-TOPO	6164		KSR2	283455	AAQ24226.1	Hs.375836	Kinase suppressor of ras 2						NM_173598.4	NP_775869.3	VALIDATED	P	1.000	1.000	829	2490	1	2487	921	93	921
RIKEN	BC023978	IRAL031K22	MGC	W01A026I04	pENTR-TOPO	14801		PCK1	5105	AAH23978.1	Hs.1872	Phosphoenolpyruvate carboxykinase 1 (soluble)			Kidney	NIH_MGC_75	DH10B	NM_002591.3	NP_002582.3	REVIEWED	Cs	0.997	0.997	622	1869	1	1866	622	1	622
RIKEN	AK098052	flj0047i19	FLJ	W01A026I05	pENTR-TOPO	9107		PKD1L2	114780	BAC05222.1	Hs.413525	Polycystic kidney disease 1-like 2				TKIDN2	EK1	NM_001076780.1	NP_001070248.1	REVIEWED	Ps	0.996	0.996	471	1416	1	1413	991	521	991
RIKEN	NM_203351	X01Y116M01	RIKEN_rt-pcr	W01A026I10	pENTR-TOPO	9731		MAP3K3	4215	NP_976226.1	Hs.29282	Mitogen-activated protein kinase kinase kinase 3						NM_203351.1	NP_976226.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
RIKEN	BC027932	IRAK049B22	MGC	W01A026I11	pENTR-TOPO	22483		KCNS2	3788	AAH27932.1	Hs.388045	Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 2			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_020697.2	NP_065748.1	PROVISIONAL	C	1.000	1.000	477	1434	1	1431	477	1	477
RIKEN	BC015020	IRAK015N20	MGC	W01A026I20	pENTR-TOPO	24676		NXF2	56001	AAH15020.1	Hs.530358	Nuclear RNA export factor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022053.1	NP_071336.1	REVIEWED	C	1.000	1.000	626	1881	1	1878	626	1	626
RIKEN	NM_014646	X01Y144I09	RIKEN_rt-pcr	W01A026J09	pENTR-TOPO	11291		LPIN2	9663	NP_055461.1	Hs.132342	Lipin 2						NM_014646.2	NP_055461.1	REVIEWED	OK	1.000	1.000	896	2691	1	2688	896	1	896
RIKEN	NM_014646	X01Y144I09	RIKEN_rt-pcr	W01A026J11	pENTR-TOPO	11291		LPIN2	9663	NP_055461.1	Hs.132342	Lipin 2						NM_014646.2	NP_055461.1	REVIEWED	OK	1.000	1.000	896	2691	1	2688	896	1	896
RIKEN	NM_014646	X01Y144I09	RIKEN_rt-pcr	W01A026J13	pENTR-TOPO	11291		LPIN2	9663	NP_055461.1	Hs.132342	Lipin 2						NM_014646.2	NP_055461.1	REVIEWED	OK	1.000	1.000	896	2691	1	2688	896	1	896
RIKEN	AL136868	X01Y163A03	RIKEN_rt-pcr	W01A026J21	pENTR-TOPO	13021		RGPD5	84220	CAB66802.1	Hs.469630	RANBP2-like and GRIP domain containing 5						NM_032260.2	NP_115636.1	REVIEWED	OK	1.000	1.000	904	2715	1	2712	904	1	904
RIKEN	AL136868	X01Y163A03	RIKEN_rt-pcr	W01A026J23	pENTR-TOPO	13021		RGPD5	84220	CAB66802.1	Hs.469630	RANBP2-like and GRIP domain containing 5						NM_032260.2	NP_115636.1	REVIEWED	OK	1.000	1.000	904	2715	1	2712	904	1	904
RIKEN	BC031079	IRAK048L08	MGC	W01A026K01	pENTR-TOPO	4513		CUGBP1	10658	AAH31079.1	Hs.632137	CUG triplet repeat, RNA binding protein 1			Testis	NIH_MGC_97	DH10B	NM_198700.1	NP_941989.1	REVIEWED	OK	1.000	1.000	483	1452	1	1449	483	1	483
RIKEN	BC050381	IRAK098I23	MGC	W01A026K02	pENTR-TOPO	23180		RAD21	5885	AAH50381.1	Hs.81848	RAD21 homolog (S. pombe)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006265.2	NP_006256.1	REVIEWED	C	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC050381	IRAK098I23	MGC	W01A026K04	pENTR-TOPO	23180		RAD21	5885	AAH50381.1	Hs.81848	RAD21 homolog (S. pombe)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006265.2	NP_006256.1	REVIEWED	C	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC029868	IRAK051G14	MGC	W01A026K11	pENTR-TOPO	17508		SNX25	83891	AAH29868.2	Hs.369091	Sorting nexin 25			Brain, adult medulla	NIH_MGC_119	DH10B	NM_031953.2	NP_114159.2	VALIDATED	Pg	0.898	1.000	538	1452	1	1449	840	303	840
RIKEN	AK057247	flj0005a03	FLJ	W01A026K23	pENTR-TOPO	17056		NEK10	152110	BAB71395.1	Hs.506115	NIMA (never in mitosis gene a)- related kinase 10				TESTI2	EK1	NM_001031741.1	NP_001026911.1	VALIDATED	Cg	0.979	1.000	484	1455	1	1452	474	1	474
RIKEN	BC015231	IRAK014L03	MGC	W01A026L21	pENTR-TOPO	1377		PLEKHG5	57449	AAH15231.1	Hs.284232	Pleckstrin homology domain containing, family G (with RhoGef domain) member 5			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001042663.1	NP_001036128.1	REVIEWED	Pgs	0.987	0.989	928	2793	1	2778	1062	57	984
RIKEN	BC006317	IRAL017G17	MGC	W01A026M13	pENTR-TOPO	23230		SLC18A1	6570	AAH06317.1	Hs.158322	Solute carrier family 18 (vesicular monoamine), member 1			Brain, neuroblastoma	NIH_MGC_19		NM_001142324.1	NP_001135796.1	VALIDATED	Cs	0.996	0.996	493	1482	1	1479	493	1	493
RIKEN	AK123036	flj0035c15	FLJ	W01A026O04	pENTR-TOPO	12274		SLC27A5	10998	BAG53858.1	Hs.292177	Solute carrier family 27 (fatty acid transporter), member 5				LIVER1	EK1	NM_012254.2	NP_036386.1	REVIEWED	C	1.000	1.000	690	2073	1	2070	690	1	690
RIKEN	BC049169	IRAK106P06	MGC	W01A026O10	pENTR-TOPO	24537		SLC9A6	10479	AAH49169.1	Hs.62185	Solute carrier family 9 (sodium/hydrogen exchanger), member 6			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001042537.1	NP_001036002.1	VALIDATED	C	1.000	1.000	701	2106	1	2103	701	1	701
RIKEN	BC049169	IRAK106P06	MGC	W01A026O14	pENTR-TOPO	24537		SLC9A6	10479	AAH49169.1	Hs.62185	Solute carrier family 9 (sodium/hydrogen exchanger), member 6			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001042537.1	NP_001036002.1	VALIDATED	C	1.000	1.000	701	2106	1	2103	701	1	701
RIKEN	AL161971	X01Y112I17	RIKEN_rt-pcr	W01A026O15	pENTR-TOPO	22619		SNTG1	54212	CAB82311.1	Hs.584914	Syntrophin, gamma 1						NM_018967.2	NP_061840.1	REVIEWED	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	AK056291	flj0002l24	FLJ	W01A026O18	pENTR-TOPO	7075		C14orf101	54916	BAG51667.1	Hs.497253	Chromosome 14 open reading frame 101	NT2	teratocarcinoma		NT2RI2	EK1	NM_017799.3	NP_060269.3	VALIDATED	Cs	0.999	0.999	707	2124	1	2121	707	1	707
RIKEN	AK027057	flj0064o13	FLJ	W01A027A02	pENTR-TOPO	2655		ZNF33A	7581	BAB15642.1	Hs.435774	Zinc finger protein 33A	HepG2	hepatoma		HEP	EK1	NM_006954.1	NP_008885.1	VALIDATED	P	1.000	1.000	129	417	1	387	811	1	129
RIKEN	AK027057	flj0064o13	FLJ	W01A027A08	pENTR-TOPO	2655		ZNF33A	7581	BAB15642.1	Hs.435774	Zinc finger protein 33A	HepG2	hepatoma		HEP	EK1	NM_006954.1	NP_008885.1	VALIDATED	P	1.000	1.000	129	417	1	387	811	1	129
RIKEN	BC010025	IRAL027A23	MGC	W01A027B13	pENTR-TOPO	4099		DRAP1	10589	AAH10025.1	Hs.356742	DR1-associated protein 1 (negative cofactor 2 alpha)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006442.2	NP_006433.2	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC015500	IRAK022G23	MGC	W01A027C24	pENTR-TOPO	23950		EDF1	8721	AAH15500.1	Hs.174050	Endothelial differentiation-related factor 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_003792.2	NP_003783.1	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC007099	IRAL021G18	MGC	W01A027D15	pENTR-TOPO	5955		SARNP	84324	AAH07099.1	Hs.505676	Cytokine induced protein 29 kDa			Prostate	NIH_MGC_83	DH10B	NM_033082.3	NP_149073.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC003525	IRAL013E11	MGC	W01A027E04	pENTR-TOPO	7545		MAX	4149	AAH03525.1	Hs.285354	MYC associated factor X			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_145112.1	NP_660087.1	REVIEWED	C	1.000	1.000	151	456	1	453	151	1	151
RIKEN	AK000018	flj0063i20	FLJ	W01A027E22	pENTR-TOPO	11466		ILF3	3609	BAA90887.1	Hs.465885	Interleukin enhancer binding factor 3, 90kDa				ad	EK1	NM_012218.3	NP_036350.2	REVIEWED		0.348	0.348	23	477	337	269	894	626	648
RIKEN	BC006537	IRAL003N09	MGC	W01A027F06	pENTR-TOPO	22145		HOXA9	3205	AAH06537.1	Hs.659350	Homeobox A9			Colon, adenocarcinoma	NIH_MGC_15		NM_152739.3	NP_689952.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC004272	IRAL013H03	MGC	W01A027F13	pENTR-TOPO	5225		RAN	5901	AAH04272.3	Hs.10842	RAN, member RAS oncogene family			Skin, melanotic melanoma.	NIH_MGC_20		NM_006325.3	NP_006316.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
RIKEN	BC084565	IRAL059L08	MGC	W01A027G11	pENTR-TOPO	44491		ZNF717	100131827	AAH84565	Hs.556877	Zinc finger protein 717			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	XM_001719561.1	XP_001719613.1	MODEL	OK	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC084565	IRAL059L08	MGC	W01A027G15	pENTR-TOPO	44491		ZNF717	100131827	AAH84565	Hs.556877	Zinc finger protein 717			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	XM_001719561.1	XP_001719613.1	MODEL	OK	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC010074	IRAL027O03	MGC	W01A027G18	pENTR-TOPO	12866		FUSIP1	10772	AAH10074.1	Hs.652334	FUS interacting protein (serine/arginine-rich) 1			Uterus, leiomyosarcoma	NIH_MGC_46		NM_054016.1	NP_473357.1	REVIEWED	P	1.000	1.000	163	522	1	489	262	1	163
RIKEN	BC010074	IRAL027O03	MGC	W01A027G22	pENTR-TOPO	12866		FUSIP1	10772	AAH10074.1	Hs.652334	FUS interacting protein (serine/arginine-rich) 1			Uterus, leiomyosarcoma	NIH_MGC_46		NM_054016.1	NP_473357.1	REVIEWED	P	1.000	1.000	163	522	1	489	262	1	163
RIKEN	BC010074	IRAL027O03	MGC	W01A027G24	pENTR-TOPO	12866		FUSIP1	10772	AAH10074.1	Hs.652334	FUS interacting protein (serine/arginine-rich) 1			Uterus, leiomyosarcoma	NIH_MGC_46		NM_054016.1	NP_473357.1	REVIEWED	P	1.000	1.000	163	522	1	489	262	1	163
RIKEN	AK092110	flj0008n05	FLJ	W01A027H10	pENTR-TOPO	11774		ZNF491	126069	BAC03809.1	Hs.631634	Zinc finger protein 491	NT2	teratocarcinoma		NT2NE2	EK1	NM_152356.3	NP_689569.2	VALIDATED	P	1.000	1.000	286	861	1	858	437	122	407
RIKEN	BC012423	IRAK021M11	MGC	W01A027H11	pENTR-TOPO	20693		SOD2	6648	AAH12423.1	Hs.487046	Superoxide dismutase 2, mitochondrial			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001024465.1	NP_001019636.1	REVIEWED	C	1.000	1.000	222	669	1	666	222	1	222
RIKEN	BC033165	IRAL043E03	MGC	W01A027H17	pENTR-TOPO	8588		ZFP90	146198	AAH33165.2	Hs.709017	Zinc finger protein 90 homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_20		NM_133458.2	NP_597715.2	PROVISIONAL	P	1.000	1.000	224	675	1	672	636	413	636
RIKEN	AK002096	flj0020i22	FLJ	W01A027H20	pENTR-TOPO	20547		TRERF1	55809	BAA92082.1	Hs.485392	Transcriptional regulating factor 1				PLACE1	EK1	NM_033502.2	NP_277037.1	REVIEWED	P	1.000	1.000	286	861	1	858	1200	915	1200
RIKEN	BC009929	IRAL007B13	MGC	W01A027I02	pENTR-TOPO	1669		ITGB3BP	23421	AAH09929.1	Hs.166539	Integrin beta 3 binding protein (beta3-endonexin)			Placenta, choriocarcinoma	NIH_MGC_21		NM_014288.3	NP_055103.3	PROVISIONAL	OK	1.000	1.000	177	534	1	531	177	1	177
RIKEN	BC009929	IRAL007B13	MGC	W01A027I04	pENTR-TOPO	1669		ITGB3BP	23421	AAH09929.1	Hs.166539	Integrin beta 3 binding protein (beta3-endonexin)			Placenta, choriocarcinoma	NIH_MGC_21		NM_014288.3	NP_055103.3	PROVISIONAL	OK	1.000	1.000	177	534	1	531	177	1	177
RIKEN	AK126949	flj0077m19	FLJ	W01A027I13	pENTR-TOPO	24777		ZNF81	347344	BAC86759.1	Hs.114246	Zinc finger protein 81				BRAWH3	EK1	NM_007137.2	NP_009068.2	VALIDATED	P	1.000	1.000	120	369	1	360	661	1	120
RIKEN	AK128256	flj0076m22	FLJ	W01A027I18	pENTR-TOPO	12489		LOC729991	729991	BAC87356	Hs.153629	Hypothetical protein LOC729991				THYMU3	EK1	NM_001145783.1	NP_001139255.1	VALIDATED		0.571	0.571	7	540	214	234	109	55	61
RIKEN	BC022475	IRAK032D05	MGC	W01A027J03	pENTR-TOPO	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_016133.2	NP_057217.2	REVIEWED	OK	1.000	1.000	225	678	1	675	225	1	225
RIKEN	BC064622	IRAK139H02	MGC	W01A027J21	pENTR-TOPO	20072		HSF2	3298	AAH64622.1	Hs.158195	Heat shock transcription factor 2			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001135564.1	NP_001129036.1	VALIDATED	P	1.000	1.000	228	693	1	684	518	1	228
RIKEN	AK092300	flj0006o20	FLJ	W01A027K14	pENTR-TOPO	3978		CBL	867	BAC03854	Hs.504096	Cas-Br-M (murine) ecotropic retroviral transforming sequence				OCBBF2	EK1	NM_005188.2	NP_005179.2	REVIEWED		0.348	0.348	23	543	389	457	906	524	546
RIKEN	AK057245	flj0005m01	FLJ	W01A027K23	pENTR-TOPO	21291		ZNF655	79027	BAB71394.1	Hs.696221	Zinc finger protein 655				TESTI2	EK1	NM_001009958.1	NP_001009958.1	REVIEWED	P	1.000	1.000	65	396	199	393	110	46	110
RIKEN	BC071612	IRAK167O13	MGC	W01A027M08	pENTR-TOPO	13774		MYT1L	23040	AAH71612.1	Hs.669852	Myelin transcription factor 1-like			Testis	NIH_MGC_97	DH10B	NM_015025.2	NP_055840.2	VALIDATED	Pg	0.989	1.000	184	555	1	552	1184	1003	1184
RIKEN	AK127095	flj0078d09	FLJ	W01A027M12	pENTR-TOPO	3371		VAX1	11023	BAC86826.1	Hs.441536	Ventral anterior homeobox 1				BRAWH3	EK1	NM_199131.2	NP_954582.1	REVIEWED	C	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC000889	IRAK004F18	MGC	W01A027M17	pENTR-TOPO	6461		POLR1D	51082	AAH00889.1	Hs.507584	Polymerase (RNA) I polypeptide D, 16kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015972.2	NP_057056.1	PROVISIONAL	C	1.000	1.000	133	402	1	399	133	1	133
RIKEN	BC000889	IRAK004F18	MGC	W01A027M19	pENTR-TOPO	6461		POLR1D	51082	AAH00889.1	Hs.507584	Polymerase (RNA) I polypeptide D, 16kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015972.2	NP_057056.1	PROVISIONAL	C	1.000	1.000	133	402	1	399	133	1	133
RIKEN	BC000381	IRAL001C20	MGC	W01A027M24	pENTR-TOPO	19667		TBPL1	9519	AAH00381.1	Hs.486507	TBP-like 1			Lung, small cell carcinoma	NIH_MGC_7		NM_004865.2	NP_004856.1	REVIEWED	Cs	0.995	0.995	186	561	1	558	186	1	186
RIKEN	BC072460	IRAK174O14	MGC	W01A027N10	pENTR-TOPO	23132		TCEA1	6917	AAH72460.1	Hs.491745	Transcription elongation factor A (SII), 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006756.2	NP_006747.1	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
RIKEN	BC072460	IRAK174O14	MGC	W01A027N12	pENTR-TOPO	23132		TCEA1	6917	AAH72460.1	Hs.491745	Transcription elongation factor A (SII), 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006756.2	NP_006747.1	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
RIKEN	BC072460	IRAK174O14	MGC	W01A027N14	pENTR-TOPO	23132		TCEA1	6917	AAH72460.1	Hs.491745	Transcription elongation factor A (SII), 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006756.2	NP_006747.1	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
RIKEN	AK092811	flj0008f14	FLJ	W01A027N15	pENTR-TOPO	23485		ZNF483	158399	BAC03981.1	Hs.660784	Zinc finger protein 483				SMINT2	EK1	NM_001007169.2	NP_001007170.1	VALIDATED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC014082	IRAL028L08	MGC	W01A027N19	pENTR-TOPO	22745		MAF1	84232	AAH14082.1	Hs.19673	MAF1 homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_032272.4	NP_115648.2	REVIEWED	Cs	0.996	0.996	256	771	1	768	256	1	256
RIKEN	BC008849	IRAL020J12	MGC	W01A027O14	pENTR-TOPO	10310		PTRF	284119	AAH08849.1	Hs.437191	Polymerase I and transcript release factor			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_012232.4	NP_036364.2	VALIDATED	P	1.000	1.000	197	597	4	594	390	194	390
RIKEN	BC014209	IRAL030P07	MGC	W01A027P13	pENTR-TOPO	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Primary B-Cells from Tonsils	NIH_MGC_48		NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	AK055644	flj0001l04	FLJ	W01A027P19	pENTR-TOPO	21292		ZNF138	7697	BAG51547.1	Hs.184080	Zinc finger protein 138				HSYRA2	EK1	NM_006524.2	NP_006515.2	VALIDATED	Ps	0.996	0.996	250	789	37	786	293	44	293
RIKEN	BC001838	IRAL002K18	MGC	W01A028A03	pENTR-TOPO	8971		RNPS1	10921	AAH01838.1	Hs.355643	RNA binding protein S1, serine-rich domain			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006711.2	NP_006702.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC065250	IRAK140H01	MGC	W01A028A17	pENTR-TOPO	5597		GTF2H3	2967	AAH65250.1	Hs.355348	General transcription factor IIH, polypeptide 3, 34kDa			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001516.3	NP_001507.2	PROVISIONAL	C	1.000	1.000	308	927	1	924	308	1	308
RIKEN	BC065250	IRAK140H01	MGC	W01A028A19	pENTR-TOPO	5597		GTF2H3	2967	AAH65250.1	Hs.355348	General transcription factor IIH, polypeptide 3, 34kDa			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001516.3	NP_001507.2	PROVISIONAL	C	1.000	1.000	308	927	1	924	308	1	308
RIKEN	BC065250	IRAK140H01	MGC	W01A028A23	pENTR-TOPO	5597		GTF2H3	2967	AAH65250.1	Hs.355348	General transcription factor IIH, polypeptide 3, 34kDa			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001516.3	NP_001507.2	PROVISIONAL	C	1.000	1.000	308	927	1	924	308	1	308
RIKEN	AK022691	flj0032j13	FLJ	W01A028B06	pENTR-TOPO	21798		ZNF12	7559	BAB14183.1	Hs.431471	Zinc finger protein 12	NT2	teratocarcinoma		NT2RM4	EK1	NM_006956.2	NP_008887.2	REVIEWED	Ps	0.998	0.998	462	1389	1	1386	659	198	659
RIKEN	BC001878	IRAL008D18	MGC	W01A028B18	pENTR-TOPO	17648		SMAD1	4086	AAH01878.1	Hs.604588	SMAD family member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_001003688.1	NP_001003688.1	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC001152	IRAL006L05	MGC	W01A028B19	pENTR-TOPO	10198		GAS7	8522	AAH01152.1	Hs.462214	Growth arrest-specific 7			Eye, retinoblastoma	NIH_MGC_16		NM_001130831.1	NP_001124303.1	REVIEWED	C	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	BC001878	IRAL008D18	MGC	W01A028B22	pENTR-TOPO	17648		SMAD1	4086	AAH01878.1	Hs.604588	SMAD family member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_001003688.1	NP_001003688.1	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC040321	IRAK072P09	MGC	W01A028C06	pENTR-TOPO	724		LHX8	431707	AAH40321.1	Hs.403934	LIM homeobox 8			Testis	NIH_MGC_97	DH10B	NM_001001933.1	NP_001001933.1	VALIDATED	Cs	0.997	0.997	356	1071	1	1068	356	1	356
RIKEN	BC040321	IRAK072P09	MGC	W01A028C08	pENTR-TOPO	724		LHX8	431707	AAH40321.1	Hs.403934	LIM homeobox 8			Testis	NIH_MGC_97	DH10B	NM_001001933.1	NP_001001933.1	VALIDATED	Cs	0.997	0.997	356	1071	1	1068	356	1	356
RIKEN	BC012814	IRAL002G20	MGC	W01A028C09	pENTR-TOPO	3726		ZFPL1	7542	AAH12814.1	Hs.98170	Zinc finger protein-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006782.3	NP_006773.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC012814	IRAL002G20	MGC	W01A028C15	pENTR-TOPO	3726		ZFPL1	7542	AAH12814.1	Hs.98170	Zinc finger protein-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006782.3	NP_006773.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC011538	IRAK013H19	MGC	W01A028D02	pENTR-TOPO	23233		KLF10	7071	AAH11538.1	Hs.435001	Kruppel-like factor 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001032282.2	NP_001027453.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
RIKEN	BC008750	IRAL005K18	MGC	W01A028E03	pENTR-TOPO	8326		NDN	4692	AAH08750.1	Hs.50130	Necdin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_20		NM_002487.2	NP_002478.1	REVIEWED	C	1.000	1.000	321	966	1	963	321	1	321
RIKEN	BC029752	IRAK028D16	MGC	W01A028E24	pENTR-TOPO	5994		ZNF385A	25946	AAH29752.1	Hs.505653	Zinc finger protein 385A			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_015481.1	NP_056296.1	VALIDATED	C	1.000	1.000	366	1101	1	1098	366	1	366
RIKEN	BC025404	IRAK046N10	MGC	W01A028F03	pENTR-TOPO	12220		MEIS3	56917	AAH25404.1	Hs.380923	Meis homeobox 3			Testis	NIH_MGC_97	DH10B	NM_020160.1	NP_064545.1	VALIDATED	C	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	BC012837	IRAK021C04	MGC	W01A028F18	pENTR-TOPO	16274		BBX	56987	AAH12837.2	Hs.124366	Bobby sox homolog (Drosophila)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001142568.1	NP_001136040.1	VALIDATED	P	1.000	1.000	483	1452	1	1449	941	459	941
RIKEN	AK131266	flj0073b09	FLJ	W01A028G02	pENTR-TOPO	21139		FOXP2	93986	BAD18444.1	Hs.656280	Forkhead box P2				CTONG2	EK1	NM_148899.2	NP_683697.1	REVIEWED	Pg	0.951	1.000	347	1113	1	1041	623	1	330
RIKEN	BC018112	IRAK022P10	MGC	W01A028G05	pENTR-TOPO	19840		PNRC1	10957	AAH18112.1	Hs.75969	Proline-rich nuclear receptor coactivator 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006813.2	NP_006804.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC009402	IRAL026N05	MGC	W01A028G12	pENTR-TOPO	23520		CREB3	10488	AAH09402.1	Hs.522110	CAMP responsive element binding protein 3			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006368.4	NP_006359.3	REVIEWED	Cs	0.997	0.997	371	1116	1	1113	371	1	371
RIKEN	BC009402	IRAL026N05	MGC	W01A028G14	pENTR-TOPO	23520		CREB3	10488	AAH09402.1	Hs.522110	CAMP responsive element binding protein 3			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006368.4	NP_006359.3	REVIEWED	Cs	0.997	0.997	371	1116	1	1113	371	1	371
RIKEN	AK098546	flj0061j22	FLJ	W01A028G17	pENTR-TOPO	19368		POU5F2	134187	BAC05328.1	Hs.678995	POU domain class 5, transcription factor 2				TST	EK1	NM_153216.1	NP_694948.1	PROVISIONAL	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	AK098546	flj0061j22	FLJ	W01A028G19	pENTR-TOPO	19368		POU5F2	134187	BAC05328.1	Hs.678995	POU domain class 5, transcription factor 2				TST	EK1	NM_153216.1	NP_694948.1	PROVISIONAL	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC063795	IRAK141L24	MGC	W01A028H05	pENTR-TOPO	3772		ESRRA	2101	AAH63795.2	Hs.110849	Estrogen-related receptor alpha			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004451.3	NP_004442.3	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
RIKEN	BC082261	IRAL059L09	MGC	W01A028H09	pENTR-TOPO	20760		PBX2	5089	AAH82261.1	Hs.509545	Pre-B-cell leukemia homeobox 2			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_002586.4	NP_002577.2	REVIEWED	OK	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC063312	IRAK133E18	MGC	W01A028H14	pENTR-TOPO	18695		ZNF354C	30832	AAH63312.1	Hs.445740	Zinc finger protein 354C			Placenta, normal	NIH_MGC_147	DH10B	NM_014594.1	NP_055409.1	PROVISIONAL	Pfs	0.996	0.998	486	1458	1	1456	554	1	486
RIKEN	AK055309	flj0012b01	FLJ	W01A028H21	pENTR-TOPO	12474		ZNF285A	26974	BAB70901.1	Hs.709428	Zinc finger protein 285A				FEBRA2	EK1	NM_152354.3	NP_689567.3	VALIDATED	Ps	0.995	0.995	435	1308	1	1305	590	156	590
RIKEN	BC048254	IRAK093I20	MGC	W01A028I05	pENTR-TOPO	23540		GFI1B	8328	-	Hs.553160	Growth factor independent 1B transcription repressor			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004188.4	NP_004179.3	VALIDATED	OK	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC035259	IRAK042N15	MGC	W01A028I14	pENTR-TOPO	20612		DEK	7913	AAH35259.1	Hs.484813	DEK oncogene			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003472.3	NP_003463.1	REVIEWED	OK	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC032587	IRAK069G14	MGC	W01A028J15	pENTR-TOPO	5278		TULP3	7289	AAH32587.1	Hs.655333	Tubby like protein 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003324.4	NP_003315.2	REVIEWED	Cs	0.998	0.998	442	1329	1	1326	442	1	442
RIKEN	BC000717	IRAL007F05	MGC	W01A028J21	pENTR-TOPO	875		KHDRBS1	10657	AAH00717.1	Hs.709204	KH domain containing, RNA binding, signal transduction associated 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006559.1	NP_006550.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	AK001877	flj0037e15	FLJ	W01A028J22	pENTR-TOPO	3220		ZNF83	55769	BAA91956.1	Hs.710125	Zinc finger protein 83				PLACE1	EK1	NM_001105554.1	NP_001099024.1	VALIDATED	Cs	0.996	0.996	488	1467	1	1464	488	1	488
RIKEN	BC000717	IRAL007F05	MGC	W01A028J23	pENTR-TOPO	875		KHDRBS1	10657	AAH00717.1	Hs.709204	KH domain containing, RNA binding, signal transduction associated 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006559.1	NP_006550.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC036724	IRAK062G14	MGC	W01A028K13	pENTR-TOPO	11972		FOSB	2354	AAH36724.1	Hs.590958	FBJ murine osteosarcoma viral oncogene homolog B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006732.2	NP_006723.2	REVIEWED	P	1.000	1.000	337	1014	1	1011	338	1	337
RIKEN	AK027782	flj0037i07	FLJ	W01A028L04	pENTR-TOPO	35284		ZNF83	55769	BAB55364.1	Hs.710125	Zinc finger protein 83				PLACE1	EK1	NM_001105554.1	NP_001099024.1	VALIDATED	Cs	0.996	0.996	488	1467	1	1464	488	1	488
RIKEN	BC001830	IRAL003D10	MGC	W01A028L11	pENTR-TOPO	8525		TGFB1I1	7041	AAH01830.1	Hs.513530	Transforming growth factor beta 1 induced transcript 1			Ovary, adenocarcinoma	NIH_MGC_9		NM_015927.3	NP_057011.2	PROVISIONAL	OK	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC001830	IRAL003D10	MGC	W01A028L13	pENTR-TOPO	8525		TGFB1I1	7041	AAH01830.1	Hs.513530	Transforming growth factor beta 1 induced transcript 1			Ovary, adenocarcinoma	NIH_MGC_9		NM_015927.3	NP_057011.2	PROVISIONAL	OK	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	AK128716	flj0074f19	FLJ	W01A028L16	pENTR-TOPO	11851		ZSCAN22	342945	BAC87588.1	Hs.388162	Zinc finger and SCAN domain containing 22				UTERU3	EK1	NM_181846.2	NP_862829.1	VALIDATED	C	1.000	1.000	491	1476	1	1473	491	1	491
RIKEN	AK025568	flj0065d02	FLJ	W01A028L24	pENTR-TOPO	14077		POLR1A	25885	BAB15171.1	Hs.531818	Polymerase (RNA) I polypeptide A, 194kDa	HepG2	hepatoma		HEP	EK1	NM_015425.3	NP_056240.2	VALIDATED	Ps	0.998	0.998	495	1488	1	1485	1720	1226	1720
RIKEN	AK097971	flj0026h19	FLJ	W01A028M05	pENTR-TOPO	15909		NFAM1	150372	BAC05207	Hs.436677	NFAT activating protein with ITAM motif 1				THYMU2	EK1	NM_145912.5	NP_666017.1	REVIEWED	Pfs	0.225	0.259	129	1035	365	742	270	17	131
RIKEN	AK026693	flj0061o13	FLJ	W01A028M15	pENTR-TOPO	1431		GON4L	54856	BAB15528.1	Hs.656361	Gon-4-like (C. elegans)				LNG	EK1	NM_032292.4	NP_115668.4	VALIDATED	Ps	0.983	0.983	294	1035	1	882	1529	307	600
RIKEN	AK125053	flj0069f23	FLJ	W01A028N05	pENTR-TOPO	8868		IRX6	79190	BAC86033.1	Hs.369907	Iroquois homeobox 6				BRTHA3	EK1	NM_024335.2	NP_077311.2	VALIDATED	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC040642	IRAK070L20	MGC	W01A028O20	pENTR-TOPO	9286		ZNF785	146540	AAH40642.1	Hs.513509	Zinc finger protein 785			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152458.5	NP_689671.2	PROVISIONAL	OK	1.000	1.000	405	1218	1	1215	405	1	405
RIKEN	BC026030	IRAL042P03	MGC	W01A028P11	pENTR-TOPO	3419		ZNF239	8187	AAH26030.1	Hs.25040	Zinc finger protein 239			Brain, neuroblastoma	NIH_MGC_47		NM_005674.2	NP_005665.2	VALIDATED	C	1.000	1.000	458	1377	1	1374	458	1	458
RIKEN	BC063815	IRAK141B07	MGC	W01A029B07	pENTR-TOPO	20508		NOTCH4	4855	AAH63815.1	Hs.436100	Notch homolog 4 (Drosophila)				Lupski_dorsal_root_ganglion	DH10B	NM_004557.3	NP_004548.3	REVIEWED	P	1.000	1.000	621	1944	1	1863	2003	1	621
RIKEN	BC062583	IRAK135G21	MGC	W01A029E24	pENTR-TOPO	21130		MLL5	55904	AAH62583.1	Hs.592262	Myeloid/lymphoid or mixed-lineage leukemia 5 (trithorax homolog, Drosophila)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_018682.3	NP_061152.3	REVIEWED	Ps	0.995	0.995	578	1830	1	1734	1858	1	578
RIKEN	AK056113	flj0002d03	FLJ	W01A029F23	pENTR-TOPO	12183		ZNF418	147686	BAB71096.1	Hs.660728	Zinc finger protein 418	NT2	teratocarcinoma		NT2RI2	EK1	NM_133460.1	NP_597717.1	PROVISIONAL	Cs	0.999	0.999	676	2031	1	2028	676	1	676
RIKEN	BC065227	IRAK139B04	MGC	W01A029H14	pENTR-TOPO	10286		STAT5B	6777	AAH65227.1	Hs.719121	Signal transducer and activator of transcription 5B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_012448.3	NP_036580.2	REVIEWED	OK	1.000	1.000	787	2364	1	2361	787	1	787
RIKEN	BC065227	IRAK139B04	MGC	W01A029H16	pENTR-TOPO	10286		STAT5B	6777	AAH65227.1	Hs.719121	Signal transducer and activator of transcription 5B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_012448.3	NP_036580.2	REVIEWED	OK	1.000	1.000	787	2364	1	2361	787	1	787
RIKEN	AK093139	flj0005f12	FLJ	W01A029I11	pENTR-TOPO	19984		PNLDC1	154197	BAC04070.1	Hs.349077	Poly(A)-specific ribonuclease (PARN)-like domain containing 1				TESTI2	EK1	NM_173516.1	NP_775787.1	PROVISIONAL	Ps	0.996	0.996	508	1596	70	1593	520	13	520
RIKEN	BC064836	IRAK141J12	MGC	W01A029L21	pENTR-TOPO	11466		ILF3	3609	AAH64836.1	Hs.465885	Interleukin enhancer binding factor 3, 90kDa			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001137673.1	NP_001131145.1	REVIEWED	C	1.000	1.000	706	2121	1	2118	706	1	706
RIKEN	BC050029	IRAK071M01	MGC	W01A029M08	pENTR-TOPO	9223		PARN	5073	AAH50029.1	Hs.253197	Poly(A)-specific ribonuclease (deadenylation nuclease)			Testis	NIH_MGC_97	DH10B	NM_001134477.1	NP_001127949.1	REVIEWED	C	1.000	1.000	578	1920	184	1917	578	1	578
RIKEN	AK095600	flj0024n13	FLJ	W01A029M16	pENTR-TOPO	12148		ZNF564	163050	BAC04584	Hs.655615	Zinc finger protein 564				FCBBF3	EK1	NM_144976.3	NP_659413.1	VALIDATED		0.654	0.692	540	1926	1	1533	553	1	539
RIKEN	BC075852	IRAK166O15	MGC	W01A029N12	pENTR-TOPO	5857		STAT6	6778	AAH75852.1	Hs.524518	Signal transducer and activator of transcription 6, interleukin-4 induced			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003153.3	NP_003144.3	REVIEWED	OK	1.000	1.000	847	2544	1	2541	847	1	847
RIKEN	BC075852	IRAK166O15	MGC	W01A029N14	pENTR-TOPO	5857		STAT6	6778	AAH75852.1	Hs.524518	Signal transducer and activator of transcription 6, interleukin-4 induced			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003153.3	NP_003144.3	REVIEWED	OK	1.000	1.000	847	2544	1	2541	847	1	847
RIKEN	BC068569	IRAK168C21	MGC	W01A030A04	pENTR-TOPO	14863		ZHX3	23051	AAH68569.1	Hs.380133	Zinc fingers and homeoboxes 3			Testis	NIH_MGC_97	DH10B	NM_015035.3	NP_055850.1	REVIEWED	Ps	0.994	0.994	883	2910	1	2649	956	1	883
RIKEN	BC068569	IRAK168C21	MGC	W01A030A06	pENTR-TOPO	14863		ZHX3	23051	AAH68569.1	Hs.380133	Zinc fingers and homeoboxes 3			Testis	NIH_MGC_97	DH10B	NM_015035.3	NP_055850.1	REVIEWED	Ps	0.994	0.994	883	2910	1	2649	956	1	883
RIKEN	BC075794	IRAK168L03	MGC	W01A030D03	pENTR-TOPO	14875		ADNP	23394	AAH75794.1	Hs.570355	Activity-dependent neuroprotector homeobox			Placenta, normal	NIH_MGC_147	DH10B	NM_015339.2	NP_056154.1	REVIEWED	Cs	0.998	0.998	1102	3309	1	3306	1102	1	1102
RIKEN	BC075794	IRAK168L03	MGC	W01A030D13	pENTR-TOPO	14875		ADNP	23394	AAH75794.1	Hs.570355	Activity-dependent neuroprotector homeobox			Placenta, normal	NIH_MGC_147	DH10B	NM_015339.2	NP_056154.1	REVIEWED	Cs	0.998	0.998	1102	3309	1	3306	1102	1	1102
RIKEN	BC052988	IRAK110L03	MGC	W01A030E02	pENTR-TOPO	18524		RAI14	26064	AAH52988.1	Hs.431400	Retinoic acid induced 14			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001145520.1	NP_001138992.1	VALIDATED	Cs	0.999	0.999	980	2943	1	2940	980	1	980
RIKEN	BC052988	IRAK110L03	MGC	W01A030E08	pENTR-TOPO	18524		RAI14	26064	AAH52988.1	Hs.431400	Retinoic acid induced 14			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001145520.1	NP_001138992.1	VALIDATED	Cs	0.999	0.999	980	2943	1	2940	980	1	980
RIKEN	BC052988	IRAK110L03	MGC	W01A030E18	pENTR-TOPO	18524		RAI14	26064	AAH52988.1	Hs.431400	Retinoic acid induced 14			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001145520.1	NP_001138992.1	VALIDATED	Cs	0.999	0.999	980	2943	1	2940	980	1	980
RIKEN	BC058918	IRAK119B04	MGC	W01A030F01	pENTR-TOPO	1801		TP53BP2	7159	AAH58918.2	Hs.523968	Tumor protein p53 binding protein, 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005426.2	NP_005417.1	REVIEWED	C	1.000	1.000	1005	3387	370	3384	1005	1	1005
RIKEN	BC058918	IRAK119B04	MGC	W01A030F03	pENTR-TOPO	1801		TP53BP2	7159	AAH58918.2	Hs.523968	Tumor protein p53 binding protein, 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005426.2	NP_005417.1	REVIEWED	C	1.000	1.000	1005	3387	370	3384	1005	1	1005
RIKEN	BC070071	IRAK167A07	MGC	W01A030F10	pENTR-TOPO	19676		RBM16	22828	AAH70071.1	Hs.591329	RNA binding motif protein 16			Testis	NIH_MGC_97	DH10B	NM_014892.3	NP_055707.3	VALIDATED	Cs	0.999	0.999	1271	3816	1	3813	1271	1	1271
RIKEN	BC058918	IRAK119B04	MGC	W01A030F13	pENTR-TOPO	1801		TP53BP2	7159	AAH58918.2	Hs.523968	Tumor protein p53 binding protein, 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005426.2	NP_005417.1	REVIEWED	C	1.000	1.000	1005	3387	370	3384	1005	1	1005
RIKEN	BC040668	IRAK070N20	MGC	W01A030G05	pENTR-TOPO	13746		TRAK2	66008	AAH40668.1	Hs.152774	Trafficking protein, kinesin binding 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015049.2	NP_055864.2	VALIDATED	Cs	0.995	0.995	914	2745	1	2742	914	1	914
RIKEN	BC032247	IRAK062B02	MGC	W01A030G08	pENTR-TOPO	14797		RBL1	5933	AAH32247.1	Hs.617220	Retinoblastoma-like 1 (p107)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_183404.1	NP_899662.1	REVIEWED	OK	1.000	1.000	1014	3045	1	3042	1014	1	1014
RIKEN	AK000234	flj0062j09	FLJ	W01A030M13	pENTR-TOPO	4430		PRDM10	56980	BAA91026.1	Hs.275086	PR domain containing 10				ColF	EK1	NM_199437.1	NP_955469.1	REVIEWED	Ps	0.998	0.998	857	2796	1	2571	1156	284	1140
RIKEN	BC051765	IRAK098P09	MGC	W01A030O13	pENTR-TOPO	17654		NFKB1	4790	AAH51765.1	Hs.654408	Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003998.2	NP_003989.2	REVIEWED	C	1.000	1.000	969	2910	1	2907	969	1	969
RIKEN	BC071781	IRAL057D23	MGC	W01A031A09	pENTR-TOPO	13781		ATAD2B	54454	AAH71781	Hs.467862	ATPase family, AAA domain containing 2B			Kidney	NIH_MGC_75	DH10B	NM_017552.1	NP_060022.1	VALIDATED		0.977	0.977	44	141	1	132	1458	1003	1046
RIKEN	AK096622	flj0022c19	FLJ	W01A031B02	pENTR-TOPO	12544		FLJ39303	400706	-	Hs.630811	Hypothetical gene supported by AK096622				OCBBF2	EK1	XM_001716813.1	XP_001716865.1	MODEL		0.273	0.286	44	321	97	228	186	101	142
RIKEN	BC005282	IRAL016J21	MGC	W01A031B07	pENTR-TOPO	2154		APOA2	336	AAH05282.1	Hs.237658	Apolipoprotein A-II			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001643.1	NP_001634.1	REVIEWED	OK	1.000	1.000	100	303	1	300	100	1	100
RIKEN	AK094674	flj0022n15	FLJ	W01A031B09	pENTR-TOPO	31472										BRAMY2	EK1			
RIKEN	AK128161	flj0076n19	FLJ	W01A031B20	pENTR-TOPO	23191		FLJ46284	441369	-	Hs.521683	Hypothetical gene supported by AK128161				TESTI4	EK1													
RIKEN	BC051808	IRAK107M11	MGC	W01A031C10	pENTR-TOPO	992		LOC400768	400768	-	Hs.12422	Hypothetical gene supported by BC051808			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	XM_378883.2	XP_378883.2	MODEL
RIKEN	BC070203	IRAL057B04	MGC	W01A031C23	pENTR-TOPO	25380		COL4A6	1288	AAH70203.1	Hs.145586	Collagen, type IV, alpha 6			Prostate	NIH_MGC_83	DH10B	NM_033641.2	NP_378667.1	REVIEWED	P	1.000	1.000	48	219	1	144	1690	1	48
RIKEN	BC040489	IRAK048I12	MGC	W01A031D08	pENTR-TOPO	19849		SH3BGRL2	83699	AAH40489.2	Hs.302772	SH3 domain binding glutamic acid-rich protein like 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031469.2	NP_113657.1	PROVISIONAL	Cs	0.991	0.991	107	324	1	321	107	1	107
RIKEN	AK091900	flj0015j21	FLJ	W01A031D10	pENTR-TOPO	19975		LOC285733	285733	-	Hs.388715	Hypothetical LOC285733				KIDNE2	EK1	XM_944838.2	XP_949931.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
RIKEN	AK091900	flj0015j21	FLJ	W01A031D14	pENTR-TOPO	19975		LOC285733	285733	-	Hs.388715	Hypothetical LOC285733				KIDNE2	EK1	XM_944838.2	XP_949931.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
RIKEN	AK093452	flj0016g24	FLJ	W01A031D15	pENTR-TOPO	11249		C18orf62	284274	-	Hs.666744	Chromosome 18 open reading frame 62				TESTI2	EK1	NM_001037331.2	NP_001032408.1	PREDICTED	Cs	0.990	0.990	101	306	1	303	101	1	101
RIKEN	AK001520	flj0034l03	FLJ	W01A031E18	pENTR-TOPO	18722		SPINK5L3	153218	-	Hs.483771	Serine PI Kazal type 5-like 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_001040129.2	NP_001035218.1	PROVISIONAL	C	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC067772	IRAK168H07	MGC	W01A031F02	pENTR-TOPO	11580		FTL	2512	AAH67772	Hs.713706	Ferritin, light polypeptide			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000146.3	NP_000137.2	REVIEWED	P	1.000	1.000	83	324	1	249	175	1	83
RIKEN	AK057311	flj0005k19	FLJ	W01A031F13	pENTR-TOPO	26109										TESTI2	EK1			
RIKEN	BC036876	IRAK078J01	MGC	W01A031F22	pENTR-TOPO	15903		LOC284898	284898	-	Hs.350813	Hypothetical protein LOC284898			Brain, fetal, whole pooled	NIH_MGC_121	DH10B			
RIKEN	BC005193	IRAL016I23	MGC	W01A031G19	pENTR-TOPO	6447		UFM1	51569	AAH05193.1	Hs.719178	Ubiquitin-fold modifier 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_016617.2	NP_057701.1	VALIDATED	C	1.000	1.000	85	258	1	255	85	1	85
RIKEN	AK098696	flj0053h21	FLJ	W01A031H05	pENTR-TOPO	34485										TST	EK1			
RIKEN	AK095077	flj0025p23	FLJ	W01A031H22	pENTR-TOPO	20180			401284							BRHIP2	EK1			
RIKEN	AK096398	flj0042f02	FLJ	W01A031I08	pENTR-TOPO	22563		C8orf83	286144	-	Hs.440643	Chromosome 8 open reading frame 83	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	BC006819	IRAK003C24	MGC	W01A031I12	pENTR-TOPO	17559		S100P	6286	AAH06819.1	Hs.2962	S100 calcium binding protein P			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005980.2	NP_005971.1	REVIEWED	OK	1.000	1.000	95	288	1	285	95	1	95
RIKEN	BC039105	IRAK072E21	MGC	W01A031J08	pENTR-TOPO	26548									Testis	NIH_MGC_97	DH10B			
RIKEN	BC033880	IRAK079A14	MGC	W01A031J19	pENTR-TOPO	16103		ATP11B	23200	AAH33880.1	Hs.478429	ATPase, class VI, type 11B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014616.1	NP_055431.1	VALIDATED	P	1.000	1.000	93	315	1	279	1177	1059	1151
RIKEN	AK023254	flj0035d15	FLJ	W01A031K05	pENTR-TOPO	8262		LOC145845	145845	-	Hs.302693	Hypothetical LOC145845	NT2	teratocarcinoma		NT2RP3	EK1													
RIKEN	BC037850	IRAK070O14	MGC	W01A031K15	pENTR-TOPO	26896									Brain, hippocampus	NIH_MGC_95	DH10B			
RIKEN	AK096414	flj0042f06	FLJ	W01A031K17	pENTR-TOPO	741		FLJ39095	400812	-	Hs.558907	Hypothetical gene supported by AK096414	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	BC005272	IRAL016H07	MGC	W01A031L05	pENTR-TOPO	6209		MGP	4256	AAH05272.1	Hs.365706	Matrix Gla protein			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_000900.2	NP_000891.2	VALIDATED	Cs	0.990	0.990	103	312	1	309	103	1	103
RIKEN	BC005272	IRAL016H07	MGC	W01A031L07	pENTR-TOPO	6209		MGP	4256	AAH05272.1	Hs.365706	Matrix Gla protein			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_000900.2	NP_000891.2	VALIDATED	Cs	0.990	0.990	103	312	1	309	103	1	103
RIKEN	BC005230	IRAL016K18	MGC	W01A031L12	pENTR-TOPO	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_006294.3	NP_006285.1	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
RIKEN	BC038743	IRAK074F15	MGC	W01A031M06	pENTR-TOPO	6261		LOC283403	283403	-	Hs.667179	Hypothetical protein LOC283403			Testis	NIH_MGC_97	DH10B			
RIKEN	BC037382	IRAK072O02	MGC	W01A031M16	pENTR-TOPO	28236									Testis	NIH_MGC_97	DH10B			
RIKEN	AK098532	flj0061p14	FLJ	W01A031N04	pENTR-TOPO	24231		LOC286238	286238	-	Hs.434185	Hypothetical protein LOC286238				TST	EK1	NM_001100111.1	NP_001093581.1	VALIDATED	OK	1.000	1.000	112	339	1	336	112	1	112
RIKEN	AK055518	flj0006m05	FLJ	W01A031N13	pENTR-TOPO	17611		LOC152742	152742	-	Hs.135435	Hypothetical protein LOC152742				HCASM2	EK1	XM_001723200.1	XP_001723252.1	MODEL	Cs	0.990	0.990	105	318	1	315	105	1	105
RIKEN	AK055518	flj0006m05	FLJ	W01A031N15	pENTR-TOPO	17611		LOC152742	152742	-	Hs.135435	Hypothetical protein LOC152742				HCASM2	EK1	XM_001723200.1	XP_001723252.1	MODEL	Cs	0.990	0.990	105	318	1	315	105	1	105
RIKEN	BC040315	IRAK072K22	MGC	W01A031O20	pENTR-TOPO	19451		LOC340107	340107	-	Hs.145181	Hypothetical protein LOC340107			Testis	NIH_MGC_97	DH10B			
RIKEN	AK094097	flj0024k02	FLJ	W01A031P07	pENTR-TOPO	7136		C14orf70	283601	-	Hs.379802	Chromosome 14 open reading frame 70				ADRGL2	EK1	NM_001007560.1	NP_001007561.1	PREDICTED										
RIKEN	BC033979	IRAK076I01	MGC	W01A031P21	pENTR-TOPO	7928		SPATA8	145946	AAH33979.1	Hs.326528	Spermatogenesis associated 8			Testis	NIH_MGC_97	DH10B	NM_173499.3	NP_775770.1	PROVISIONAL	C	1.000	1.000	105	318	1	315	105	1	105
RIKEN	AK093215	flj0007f11	FLJ	W01A032A13	pENTR-TOPO	6137		LOC283332	283332	-	Hs.127688	Hypothetical LOC283332				TESTI2	EK1													
RIKEN	AK093215	flj0007f11	FLJ	W01A032A15	pENTR-TOPO	6137		LOC283332	283332	-	Hs.127688	Hypothetical LOC283332				TESTI2	EK1													
RIKEN	AK127365	flj0077h05	FLJ	W01A032B23	pENTR-TOPO	219		PDE4B	5142	BAC86945	Hs.198072	Phosphodiesterase 4B, cAMP-specific (phosphodiesterase E4 dunce homolog, Drosophila)				BRSSN2	EK1	NM_002600.3	NP_002591.2	REVIEWED	Ps	0.992	0.992	122	390	22	387	736	615	736
RIKEN	BC058012	IRAL048H05	MGC	W01A032C03	pENTR-TOPO	9848		LOC388436	388436	-	Hs.712017	Hypothetical gene supported by BC058012			Pooled, 40 cell lines	NIH_MGC_142	DH10B			
RIKEN	AK091087	flj0008i04	FLJ	W01A032C10	pENTR-TOPO	7869		TMEM84	283673	BAC03580.1	Hs.177927	Transmembrane protein 84				BRHIP2	EK1	NM_173610.1	NP_775881.1	VALIDATED										
RIKEN	AK091027	flj0014d23	FLJ	W01A032E14	pENTR-TOPO	20673		RP3-398D13.1	285780	BAC03570.1	Hs.655737	Hypothetical LOC285780				BRAWH2	EK1	NM_173675.1	NP_775946.1	VALIDATED										
RIKEN	AK124959	flj0073e11	FLJ	W01A032E15	pENTR-TOPO	22730		FLJ42969	441374	-	Hs.652045	Hypothetical gene supported by AK124959				BRSTN2	EK1			
RIKEN	AK056383	flj0003e23	FLJ	W01A032E22	pENTR-TOPO	9070		N4BP1	9683	BAB71172	Hs.511839	NEDD4 binding protein 1	NT2	teratocarcinoma		NT2RP6	EK1	NM_153029.3	NP_694574.3	VALIDATED		0.280	0.280	25	375	228	154	896	802	826
RIKEN	AK056383	flj0003e23	FLJ	W01A032E24	pENTR-TOPO	9070		N4BP1	9683	BAB71172	Hs.511839	NEDD4 binding protein 1	NT2	teratocarcinoma		NT2RP6	EK1	NM_153029.3	NP_694574.3	VALIDATED		0.280	0.280	25	375	228	154	896	802	826
RIKEN	BC025707	IRAK049M13	MGC	W01A032F07	pENTR-TOPO	19170		KCNMB1	3779	AAH25707.1	Hs.484099	Potassium large conductance calcium-activated channel, subfamily M, beta member 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004137.2	NP_004128.1	REVIEWED	P	1.000	1.000	102	393	1	306	191	1	102
RIKEN	AK131322	flj0073a10	FLJ	W01A032F08	pENTR-TOPO	23728			441390	BAD18483						SPLEN2	EK1			
RIKEN	BC031410	IRAK050O17	MGC	W01A032F12	pENTR-TOPO	13511		C2orf58	285154	AAH31410	Hs.353894	Chromosome 2 open reading frame 58			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B													
RIKEN	AK098249	flj0041o23	FLJ	W01A032G04	pENTR-TOPO	3353		LOC283050	283050	-	Hs.309176	Hypothetical LOC283050				UTERU2	EK1	XM_944265.1	XP_949358.1	MODEL										
RIKEN	BC044935	IRAK087F18	MGC	W01A032G15	pENTR-TOPO	18913		LOC340113	340113	-	Hs.434404	Hypothetical protein LOC340113			Brain, adult medulla	NIH_MGC_119	DH10B	XM_379324.3	XP_379324.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
RIKEN	AK075506	flj0049a11	FLJ	W01A032H02	pENTR-TOPO	11765		MIDN	90007	BAC11659	Hs.465529	Midnolin				HEMBA1	EK1	NM_177401.4	NP_796375.3	VALIDATED	Pfs	0.345	0.385	58	429	180	335	468	193	250
RIKEN	AK022670	flj0032d07	FLJ	W01A032H20	pENTR-TOPO	14940		ESF1	51575	BAB14167.1	Hs.369284	ESF1, nucleolar pre-rRNA processing protein, homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RM4	EK1	NM_016649.3	NP_057733.2	PROVISIONAL	Ps	0.993	0.993	144	435	1	432	851	708	851
RIKEN	AK126833	flj0073p24	FLJ	W01A032H23	pENTR-TOPO	2040		LOC284475	284475	-	Hs.196026	Hypothetical protein LOC284475				BRAMY2	EK1			
RIKEN	BC029901	IRAK051P06	MGC	W01A032J05	pENTR-TOPO	25414		NDP	4693	AAH29901.1	Hs.522615	Norrie disease (pseudoglioma)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000266.3	NP_000257.1	REVIEWED	OK	1.000	1.000	133	402	1	399	133	1	133
RIKEN	AK123995	flj0068a22	FLJ	W01A032J10	pENTR-TOPO	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684				SPLEN2	EK1													
RIKEN	BC001767	IRAL006H05	MGC	W01A032J15	pENTR-TOPO	22992		LSM1	27257	AAH01767.1	Hs.425311	LSM1 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_014462.1	NP_055277.1	PROVISIONAL	C	1.000	1.000	133	402	1	399	133	1	133
RIKEN	AK123995	flj0068a22	FLJ	W01A032J16	pENTR-TOPO	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684				SPLEN2	EK1													
RIKEN	BC001392	IRAL004M11	MGC	W01A033A12	pENTR-TOPO	13347		RPS27A	6233	AAH01392.1	Hs.546292	Ribosomal protein S27a			Skin, melanotic melanoma.	NIH_MGC_20		NM_002954.4	NP_002945.1	REVIEWED	C	1.000	1.000	156	471	1	468	156	1	156
RIKEN	BC009474	IRAL019I01	MGC	W01A033A19	pENTR-TOPO	19788		AIF1	199	AAH09474.1	Hs.76364	Allograft inflammatory factor 1			Prostate	NIH_MGC_83	DH10B	NM_001623.3	NP_001614.3	REVIEWED	OK	1.000	1.000	147	444	1	441	147	1	147
RIKEN	AK092728	flj0015b22	FLJ	W01A033B06	pENTR-TOPO	1972		FLJ35409	400765	BAC03958.1	Hs.451802	FLJ35409 protein		neuroblastoma		SKNSH2	EK1													
RIKEN	AK125618	flj0068e22	FLJ	W01A033B13	pENTR-TOPO	9183		VKORC1	79001	BAC86222.1	Hs.324844	Vitamin K epoxide reductase complex, subunit 1				SPLEN2	EK1	NM_024006.4	NP_076869.1	REVIEWED	P	1.000	1.000	5	495	410	424	163	57	61
RIKEN	AK025280	flj0056b04	FLJ	W01A033B14	pENTR-TOPO	5808		MED13L	23389	BAB15103.1	Hs.715095	Mediator complex subunit 13-like				COL	EK1	NM_015335.3	NP_056150.1	VALIDATED	P	1.000	1.000	173	522	1	519	2210	499	671
RIKEN	AK127131	flj0078b17	FLJ	W01A033B24	pENTR-TOPO	8325		LOC440313	440313	BAC86843	Hs.534903	Hypothetical gene supported by AK127131				BRAWH3	EK1													
RIKEN	AK094866	flj0046h04	FLJ	W01A033C06	pENTR-TOPO	21946		HIP1	3092	BAC04441	Hs.329266	Huntingtin interacting protein 1				BRCAN2	EK1	NM_005338.4	NP_005329.3	REVIEWED	Pfs	0.355	0.355	31	474	44	136	1037	750	780
RIKEN	AK092109	flj0008j05	FLJ	W01A033C15	pENTR-TOPO	10587		C17orf44	284029	BAC03808.1	Hs.121692	Chromosome 17 open reading frame 44	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	AK131382	flj0073j10	FLJ	W01A033D09	pENTR-TOPO	19967		PRR3	80742	BAD18533	Hs.118354	Proline rich 3				BRAWH3	EK1	NM_025263.2	NP_079539.2	VALIDATED	P	1.000	1.000	132	498	100	495	188	57	188
RIKEN	BC005270	IRAL016M03	MGC	W01A033D10	pENTR-TOPO	18583		NDUFS4	4724	AAH05270.1	Hs.528222	NADH dehydrogenase (ubiquinone) Fe-S protein 4, 18kDa (NADH-coenzyme Q reductase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_002495.2	NP_002486.1	REVIEWED	Cs	0.994	0.994	175	528	1	525	175	1	175
RIKEN	AK131382	flj0073j10	FLJ	W01A033D11	pENTR-TOPO	19967		PRR3	80742	BAD18533	Hs.118354	Proline rich 3				BRAWH3	EK1	NM_025263.2	NP_079539.2	VALIDATED	P	1.000	1.000	132	498	100	495	188	57	188
RIKEN	AK125737	flj0070a06	FLJ	W01A033D18	pENTR-TOPO	775		LOC440570	440570	BAC86267.1	Hs.710283	Hypothetical LOC440570				TESTI2	EK1													
RIKEN	BC065522	IRAK140A07	MGC	W01A033E11	pENTR-TOPO	19668		VEGFA	7422	AAH65522.2	Hs.73793	Vascular endothelial growth factor A			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001025370.1	NP_001020541.2	REVIEWED	P	1.000	1.000	147	444	1	441	327	181	327
RIKEN	BC065522	IRAK140A07	MGC	W01A033E15	pENTR-TOPO	19668		VEGFA	7422	AAH65522.2	Hs.73793	Vascular endothelial growth factor A			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001025370.1	NP_001020541.2	REVIEWED	P	1.000	1.000	147	444	1	441	327	181	327
RIKEN	AK098607	flj0053o18	FLJ	W01A033E16	pENTR-TOPO	23595		TMC1	117531	BAC05351.1	Hs.670211	Transmembrane channel-like 1				TST	EK1	NM_138691.2	NP_619636.2	REVIEWED	Ps	0.981	0.981	158	477	1	474	760	586	743
RIKEN	BC007075	IRAL021P12	MGC	W01A033E17	pENTR-TOPO	4591		HBB	3043	AAH07075.1	Hs.523443	Hemoglobin, beta			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000518.4	NP_000509.1	REVIEWED	C	1.000	1.000	147	444	1	441	147	1	147
RIKEN	AK001632	flj0035h02	FLJ	W01A033F05	pENTR-TOPO	146		RAVER2	55225	BAA91798.1	Hs.591443	Ribonucleoprotein, PTB-binding 2	NT2	teratocarcinoma		NT2RP4	EK1	NM_018211.3	NP_060681.2	VALIDATED	Ps	0.988	0.988	164	501	1	492	678	295	458
RIKEN	AK001632	flj0035h02	FLJ	W01A033F07	pENTR-TOPO	146		RAVER2	55225	BAA91798.1	Hs.591443	Ribonucleoprotein, PTB-binding 2	NT2	teratocarcinoma		NT2RP4	EK1	NM_018211.3	NP_060681.2	VALIDATED	Ps	0.988	0.988	164	501	1	492	678	295	458
RIKEN	BC007008	IRAL016J15	MGC	W01A033F12	pENTR-TOPO	4527		CRYAB	1410	AAH07008.1	Hs.408767	Crystallin, alpha B			Heart	NIH_MGC_74	DH10B	NM_001885.1	NP_001876.1	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC007008	IRAL016J15	MGC	W01A033F14	pENTR-TOPO	4527		CRYAB	1410	AAH07008.1	Hs.408767	Crystallin, alpha B			Heart	NIH_MGC_74	DH10B	NM_001885.1	NP_001876.1	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	AK127518	flj0075e15	FLJ	W01A033F18	pENTR-TOPO	16725		MAGI1	9223	BAC87015	Hs.651939	Membrane associated guanylate kinase, WW and PDZ domain containing 1				BRTHA3	EK1	NM_001033057.1	NP_001028229.1	REVIEWED	Ps	0.994	0.994	178	537	3	536	1462	1257	1434
RIKEN	AK125816	flj0072p14	FLJ	W01A033F19	pENTR-TOPO	24240			387873	BAC86305						TESTI4	EK1			
RIKEN	BC004147	IRAL002G16	MGC	W01A033G05	pENTR-TOPO	5526		LYZ	4069	AAH04147.1	Hs.524579	Lysozyme (renal amyloidosis)			Colon, adenocarcinoma	NIH_MGC_15		NM_000239.2	NP_000230.1	REVIEWED	C	1.000	1.000	148	447	1	444	148	1	148
RIKEN	AK124161	flj0068m23	FLJ	W01A033G12	pENTR-TOPO	10281		MYO18A	399687	BAC85790	Hs.708160	Myosin XVIIIA				THYMU2	EK1	NM_203318.1	NP_976063.1	VALIDATED		0.667	0.667	9	480	50	24	2039	1046	1054
RIKEN	BC000926	IRAK003M16	MGC	W01A033G21	pENTR-TOPO	4782		AHNAK	79026	AAH00926.1	Hs.502756	AHNAK nucleoprotein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_024060.2	NP_076965.2	VALIDATED	Ps	0.986	0.986	148	453	7	450	149	2	149
RIKEN	BC000926	IRAK003M16	MGC	W01A033G23	pENTR-TOPO	4782		AHNAK	79026	AAH00926.1	Hs.502756	AHNAK nucleoprotein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_024060.2	NP_076965.2	VALIDATED	Ps	0.986	0.986	148	453	7	450	149	2	149
RIKEN	BC050644	IRAK110B16	MGC	W01A033H03	pENTR-TOPO	13031		RPL12	6136	AAH50644.1	Hs.408054	Ribosomal protein L12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000976.2	NP_000967.1	REVIEWED	C	1.000	1.000	165	498	1	495	165	1	165
RIKEN	BC050644	IRAK110B16	MGC	W01A033H05	pENTR-TOPO	13031		RPL12	6136	AAH50644.1	Hs.408054	Ribosomal protein L12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000976.2	NP_000967.1	REVIEWED	C	1.000	1.000	165	498	1	495	165	1	165
RIKEN	AK130369	flj0060e12	FLJ	W01A033H22	pENTR-TOPO	3756		CD151	977	BAC85335.1	Hs.654379	CD151 molecule (Raph blood group)				PRS	EK1	NM_001039490.1	NP_001034579.1	REVIEWED	P	1.000	1.000	92	540	1	276	253	1	92
RIKEN	AK130369	flj0060e12	FLJ	W01A033H24	pENTR-TOPO	3756		CD151	977	BAC85335.1	Hs.654379	CD151 molecule (Raph blood group)				PRS	EK1	NM_001039490.1	NP_001034579.1	REVIEWED	P	1.000	1.000	92	540	1	276	253	1	92
RIKEN	AK024943	flj0066b05	FLJ	W01A033I01	pENTR-TOPO	4392		USH1C	10083	BAB15040.1	Hs.502072	Usher syndrome 1C (autosomal recessive, severe)				COL	EK1	NM_153676.3	NP_710142.1	REVIEWED		0.381	0.432	42	456	128	6	899	575	612
RIKEN	BC005263	IRAL016P09	MGC	W01A033I04	pENTR-TOPO	3580		SDHD	6392	AAH05263.1	Hs.719164	Succinate dehydrogenase complex, subunit D, integral membrane protein			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_003002.2	NP_002993.1	REVIEWED	OK	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC032457	IRAK064F24	MGC	W01A033I09	pENTR-TOPO	3850		SPA17	53340	AAH32457.1	Hs.286233	Sperm autoantigenic protein 17			Brain, adult medulla	NIH_MGC_119	DH10B	NM_017425.3	NP_059121.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
RIKEN	BC009745	IRAL014G21	MGC	W01A033I18	pENTR-TOPO	13070		IL1RN	3557	AAH09745.1	Hs.81134	Interleukin 1 receptor antagonist			Pancreas, adenocarcinoma	NIH_MGC_39		NM_000577.3	NP_000568.1	REVIEWED	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC009745	IRAL014G21	MGC	W01A033I20	pENTR-TOPO	13070		IL1RN	3557	AAH09745.1	Hs.81134	Interleukin 1 receptor antagonist			Pancreas, adenocarcinoma	NIH_MGC_39		NM_000577.3	NP_000568.1	REVIEWED	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	AK124156	flj0067l21	FLJ	W01A033I21	pENTR-TOPO	14167		CD8A	925	BAC85789.1	Hs.85258	CD8a molecule				THYMU2	EK1	NM_171827.3	NP_741969.1	REVIEWED	P	1.000	1.000	111	459	124	456	198	1	111
RIKEN	BC009745	IRAL014G21	MGC	W01A033I22	pENTR-TOPO	13070		IL1RN	3557	AAH09745.1	Hs.81134	Interleukin 1 receptor antagonist			Pancreas, adenocarcinoma	NIH_MGC_39		NM_000577.3	NP_000568.1	REVIEWED	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	AK093321	flj0009l07	FLJ	W01A033J11	pENTR-TOPO	21333		LOC285941	285941	-	Hs.413394	Hypothetical protein LOC285941				TESTI2	EK1	XM_938991.3	XP_944084.1	MODEL	C	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC015941	IRAK015P20	MGC	W01A033J16	pENTR-TOPO	8583		NIP7	51388	AAH15941.1	Hs.719308	Nuclear import 7 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016101.3	NP_057185.1	VALIDATED	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC008280	IRAL013C04	MGC	W01A033K09	pENTR-TOPO	24044		PTGES	9536	AAH08280.1	Hs.146688	Prostaglandin E synthase			Pancreas, adenocarcinoma	NIH_MGC_39		NM_004878.4	NP_004869.1	REVIEWED	OK	1.000	1.000	152	459	1	456	152	1	152
RIKEN	AK074590	flj0017b21	FLJ	W01A033K12	pENTR-TOPO	11524		SFRS16	11129	BAC11078	Hs.466917	Splicing factor, arginine/serine-rich 16				HEMBA1	EK1	NM_007056.2	NP_008987.2	VALIDATED	Pfs	0.698	0.760	159	480	40	478	674	359	517
RIKEN	BC008280	IRAL013C04	MGC	W01A033K15	pENTR-TOPO	24044		PTGES	9536	AAH08280.1	Hs.146688	Prostaglandin E synthase			Pancreas, adenocarcinoma	NIH_MGC_39		NM_004878.4	NP_004869.1	REVIEWED	OK	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC005979	IRAL021F13	MGC	W01A033K17	pENTR-TOPO	18871		UBE2B	7320	AAH05979.1	Hs.644421	Ubiquitin-conjugating enzyme E2B (RAD6 homolog)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_003337.2	NP_003328.1	REVIEWED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	AK022255	flj0030b21	FLJ	W01A033K24	pENTR-TOPO	22651		C8orf60	619426	BAB13998						MAMMA1	EK1			
RIKEN	AK092973	flj0009k04	FLJ	W01A033L04	pENTR-TOPO	37251										SPLEN2	EK1			
RIKEN	AK092973	flj0009k04	FLJ	W01A033L06	pENTR-TOPO	37251										SPLEN2	EK1			
RIKEN	AK127771	flj0077p04	FLJ	W01A033L09	pENTR-TOPO	23190		FLJ45872	401478	BAC87124.1	Hs.654931	FLJ45872 protein				OCBBF3	EK1													
RIKEN	BC022524	IRAK032D12	MGC	W01A033L10	pENTR-TOPO	17116		FGF12	2257	AAH22524.1	Hs.584758	Fibroblast growth factor 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004113.4	NP_004104.3	REVIEWED	Cs	0.994	0.994	181	546	1	543	181	1	181
RIKEN	BC022524	IRAK032D12	MGC	W01A033L14	pENTR-TOPO	17116		FGF12	2257	AAH22524.1	Hs.584758	Fibroblast growth factor 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004113.4	NP_004104.3	REVIEWED	Cs	0.994	0.994	181	546	1	543	181	1	181
RIKEN	BC022524	IRAK032D12	MGC	W01A033L16	pENTR-TOPO	17116		FGF12	2257	AAH22524.1	Hs.584758	Fibroblast growth factor 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004113.4	NP_004104.3	REVIEWED	Cs	0.994	0.994	181	546	1	543	181	1	181
RIKEN	BC045817	IRAK090K06	MGC	W01A033L17	pENTR-TOPO	22793		LOC286094	286094	-	Hs.440978	Hypothetical LOC286094			Testis	NIH_MGC_97	DH10B	XM_001725668.1	XP_001725720.1	MODEL	C	1.000	1.000	94	513	229	510	94	1	94
RIKEN	AK124614	flj0070i07	FLJ	W01A033M08	pENTR-TOPO	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614				BRACE3	EK1													
RIKEN	BC070317	IRAL057G04	MGC	W01A033M14	pENTR-TOPO	2903		CYP2C9	1559	AAH70317.1	Hs.282624	Cytochrome P450, family 2, subfamily C, polypeptide 9			Liver	NIH_MGC_76	DH10B	NM_000771.3	NP_000762.2	REVIEWED	Ps	0.994	0.994	160	489	1	480	490	1	160
RIKEN	BC070317	IRAL057G04	MGC	W01A033M16	pENTR-TOPO	2903		CYP2C9	1559	AAH70317.1	Hs.282624	Cytochrome P450, family 2, subfamily C, polypeptide 9			Liver	NIH_MGC_76	DH10B	NM_000771.3	NP_000762.2	REVIEWED	Ps	0.994	0.994	160	489	1	480	490	1	160
RIKEN	BC006499	IRAL002G09	MGC	W01A033N01	pENTR-TOPO	4678		HRAS	3265	AAH06499.1	Hs.37003	V-Ha-ras Harvey rat sarcoma viral oncogene homolog			Lung, small cell carcinoma	NIH_MGC_7		NM_176795.3	NP_789765.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
RIKEN	BC006499	IRAL002G09	MGC	W01A033N03	pENTR-TOPO	4678		HRAS	3265	AAH06499.1	Hs.37003	V-Ha-ras Harvey rat sarcoma viral oncogene homolog			Lung, small cell carcinoma	NIH_MGC_7		NM_176795.3	NP_789765.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
RIKEN	BC070321	IRAL057P24	MGC	W01A033N09	pENTR-TOPO	4915		CD3D	915	AAH70321.1	Hs.504048	CD3d molecule, delta (CD3-TCR complex)				NIH_MGC_191	DH10B	NM_000732.4	NP_000723.1	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
RIKEN	BC070321	IRAL057P24	MGC	W01A033N11	pENTR-TOPO	4915		CD3D	915	AAH70321.1	Hs.504048	CD3d molecule, delta (CD3-TCR complex)				NIH_MGC_191	DH10B	NM_000732.4	NP_000723.1	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
RIKEN	BC022030	IRAK033H20	MGC	W01A033N23	pENTR-TOPO	453		TSEN15	116461	AAH22030.1	Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
RIKEN	AK097847	flj0023m05	FLJ	W01A033O03	pENTR-TOPO	24229		hCG_2045089	286359	BAC05182	Hs.132262	Hypothetical LOC286359				TESTI2	EK1													
RIKEN	AK097847	flj0023m05	FLJ	W01A033O05	pENTR-TOPO	24229		hCG_2045089	286359	BAC05182	Hs.132262	Hypothetical LOC286359				TESTI2	EK1													
RIKEN	AK123041	flj0067d17	FLJ	W01A033O17	pENTR-TOPO	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	AK128747	flj0074d22	FLJ	W01A033P13	pENTR-TOPO	8869		FLJ44674	400535	BAC87597	Hs.711995	FLJ44674 protein				BRACE3	EK1													
RIKEN	BC043363	IRAK087D21	MGC	W01A033P21	pENTR-TOPO	5635		C12orf74	338809	-	Hs.326303	Chromosome 12 open reading frame 74			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001037671.1	NP_001032760.1	PREDICTED	Ps	0.983	0.983	173	522	1	519	190	1	173
RIKEN	BC064527	IRAK139E06	MGC	W01A034B04	pENTR-TOPO	20450		CLIC1	1192	AAH64527.1	Hs.414565	Chloride intracellular channel 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001288.4	NP_001279.2	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC014961	IRAL034O06	MGC	W01A034B21	pENTR-TOPO	316		CMPK1	51727	AAH14961.1	Hs.714325	Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016308.2	NP_057392.1	VALIDATED	Cs	0.996	0.996	228	687	1	684	228	1	228
RIKEN	BC014961	IRAL034O06	MGC	W01A034B23	pENTR-TOPO	316		CMPK1	51727	AAH14961.1	Hs.714325	Cytidine monophosphate (UMP-CMP) kinase 1, cytosolic			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016308.2	NP_057392.1	VALIDATED	Cs	0.996	0.996	228	687	1	684	228	1	228
RIKEN	AK055636	flj0008o11	FLJ	W01A034D12	pENTR-TOPO	18035		ANTXR2	118429	BAB70976.1	Hs.162963	Anthrax toxin receptor 2				HSYRA2	EK1	NM_001145794.1	NP_001139266.1	REVIEWED	P	1.000	1.000	212	738	1	636	489	78	289
RIKEN	BC032624	IRAK069B07	MGC	W01A034D20	pENTR-TOPO	11461		MARCH2	51257	AAH32624.1	Hs.631861	Membrane-associated ring finger (C3HC4) 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_016496.4	NP_057580.3	VALIDATED	Cs	0.996	0.996	246	741	1	738	246	1	246
RIKEN	AK131212	flj0073j07	FLJ	W01A034E18	pENTR-TOPO	15324		TMPRSS3	64699	BAD18402	Hs.208600	Transmembrane protease, serine 3				PROST2	EK1	NM_032405.1	NP_115781.1	REVIEWED		0.750	0.750	80	636	7	246	344	245	324
RIKEN	BC005939	IRAL021J18	MGC	W01A034E19	pENTR-TOPO	23668		PTGDS	5730	AAH05939.1	Hs.446429	Prostaglandin D2 synthase 21kDa (brain)			Prostate	NIH_MGC_83	DH10B	NM_000954.5	NP_000945.3	REVIEWED	C	1.000	1.000	190	573	1	570	190	1	190
RIKEN	BC005939	IRAL021J18	MGC	W01A034E23	pENTR-TOPO	23668		PTGDS	5730	AAH05939.1	Hs.446429	Prostaglandin D2 synthase 21kDa (brain)			Prostate	NIH_MGC_83	DH10B	NM_000954.5	NP_000945.3	REVIEWED	C	1.000	1.000	190	573	1	570	190	1	190
RIKEN	BC029795	IRAK050L02	MGC	W01A034F10	pENTR-TOPO	4437		BDNF	627	AAH29795.1	Hs.502182	Brain-derived neurotrophic factor			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001143807.1	NP_001137279.1	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
RIKEN	BC029795	IRAK050L02	MGC	W01A034F16	pENTR-TOPO	4437		BDNF	627	AAH29795.1	Hs.502182	Brain-derived neurotrophic factor			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001143807.1	NP_001137279.1	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
RIKEN	BC012471	IRAK028E19	MGC	W01A034G02	pENTR-TOPO	16889		CLDN1	9076	AAH12471.1	Hs.439060	Claudin 1			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_021101.3	NP_066924.1	REVIEWED	C	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC009822	IRAL025J08	MGC	W01A034G07	pENTR-TOPO	4734		NUP160	23279	AAH09822.1	Hs.643526	Nucleoporin 160kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_015231.1	NP_056046.1	VALIDATED	P	1.000	1.000	141	573	1	423	1436	35	175
RIKEN	AK091754	flj0015g14	FLJ	W01A034G14	pENTR-TOPO	15518		CECR2	27443	BAC03740	Hs.658723	Cat eye syndrome chromosome region, candidate 2				HLUNG2	EK1	NM_031413.2	NP_113601.2	VALIDATED	Ps	0.989	0.989	186	642	1	558	1484	1263	1448
RIKEN	BC027178	IRAK026L18	MGC	W01A034G20	pENTR-TOPO	13908		PRPF40A	55660	AAH27178.1	Hs.643580	PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_017892.3	NP_060362.3	VALIDATED	P	1.000	1.000	215	648	1	645	930	716	930
RIKEN	BC027178	IRAK026L18	MGC	W01A034G22	pENTR-TOPO	13908		PRPF40A	55660	AAH27178.1	Hs.643580	PRP40 pre-mRNA processing factor 40 homolog A (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_017892.3	NP_060362.3	VALIDATED	P	1.000	1.000	215	648	1	645	930	716	930
RIKEN	BC001485	IRAL007L10	MGC	W01A034G23	pENTR-TOPO	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Brain, neuroblastoma	NIH_MGC_19		NM_002872.3	NP_002863.1	REVIEWED	C	1.000	1.000	192	579	1	576	192	1	192
RIKEN	BC001120	IRAL003N24	MGC	W01A034H04	pENTR-TOPO	6934		LGALS3	3958	AAH01120.1	Hs.531081	Lectin, galactoside-binding, soluble, 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_002306.2	NP_002297.2	VALIDATED	C	1.000	1.000	250	753	1	750	250	1	250
RIKEN	AK124252	flj0070p20	FLJ	W01A034H05	pENTR-TOPO	4823		FLJ42258	440049	BAC85817.1	Hs.712208	FLJ42258 protein				TKIDN2	EK1													
RIKEN	BC001120	IRAL003N24	MGC	W01A034H06	pENTR-TOPO	6934		LGALS3	3958	AAH01120.1	Hs.531081	Lectin, galactoside-binding, soluble, 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_002306.2	NP_002297.2	VALIDATED	C	1.000	1.000	250	753	1	750	250	1	250
RIKEN	AK124252	flj0070p20	FLJ	W01A034H07	pENTR-TOPO	4823		FLJ42258	440049	BAC85817.1	Hs.712208	FLJ42258 protein				TKIDN2	EK1													
RIKEN	BC028148	IRAK062J09	MGC	W01A034H09	pENTR-TOPO	19769		TNF	7124	AAH28148.1	Hs.241570	Tumor necrosis factor (TNF superfamily, member 2)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_000594.2	NP_000585.2	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	AK123643	flj0068o08	FLJ	W01A034H12	pENTR-TOPO	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260				FEBRA2	EK1													
RIKEN	BC028148	IRAK062J09	MGC	W01A034H13	pENTR-TOPO	19769		TNF	7124	AAH28148.1	Hs.241570	Tumor necrosis factor (TNF superfamily, member 2)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_000594.2	NP_000585.2	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC028148	IRAK062J09	MGC	W01A034H15	pENTR-TOPO	19769		TNF	7124	AAH28148.1	Hs.241570	Tumor necrosis factor (TNF superfamily, member 2)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_000594.2	NP_000585.2	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	AK123908	flj0071m23	FLJ	W01A034H22	pENTR-TOPO	6147		LRRC10	376132	BAC85724.1	Hs.448708	Leucine rich repeat containing 10				PERIC2	EK1	NM_201550.2	NP_963844.2	PROVISIONAL	P	1.000	1.000	250	753	1	750	277	28	277
RIKEN	BC057829	IRAK133D20	MGC	W01A034H23	pENTR-TOPO	15214		FAM3B	54097	AAH57829.1	Hs.473877	Family with sequence similarity 3, member B			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_058186.3	NP_478066.3	VALIDATED	C	1.000	1.000	235	708	1	705	235	1	235
RIKEN	AK074349	flj0064m08	FLJ	W01A034I03	pENTR-TOPO	13235		RIF1	55183	BAB85058.1	Hs.655671	RAP1 interacting factor homolog (yeast)	HepG2	hepatoma		HEP	EK1	NM_018151.3	NP_060621.3	VALIDATED		0.969	0.969	194	585	1	582	2472	2279	2472
RIKEN	AK074349	flj0064m08	FLJ	W01A034I05	pENTR-TOPO	13235		RIF1	55183	BAB85058.1	Hs.655671	RAP1 interacting factor homolog (yeast)	HepG2	hepatoma		HEP	EK1	NM_018151.3	NP_060621.3	VALIDATED		0.969	0.969	194	585	1	582	2472	2279	2472
RIKEN	AK127642	flj0075g23	FLJ	W01A034I12	pENTR-TOPO	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642				KIDNE2	EK1													
RIKEN	AK125766	flj0069h12	FLJ	W01A034I15	pENTR-TOPO	22092		LOC401296	401296	BAC86279.1	Hs.520617	Hypothetical LOC401296				TESTI2	EK1													
RIKEN	BC025415	IRAL017H01	MGC	W01A034J12	pENTR-TOPO	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Brain, neuroblastoma	NIH_MGC_19		NM_000161.2	NP_000152.1	REVIEWED	OK	1.000	1.000	250	753	1	750	250	1	250
RIKEN	BC025415	IRAL017H01	MGC	W01A034J14	pENTR-TOPO	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Brain, neuroblastoma	NIH_MGC_19		NM_000161.2	NP_000152.1	REVIEWED	OK	1.000	1.000	250	753	1	750	250	1	250
RIKEN	AK127026	flj0078d24	FLJ	W01A034K07	pENTR-TOPO	21355		POM121C	100101267	BAC86794	Hs.712563	POM121 membrane glycoprotein C				BRAWH3	EK1	NM_001099415.1	NP_001092885.1	VALIDATED	P	1.000	1.000	73	591	137	355	987	915	987
RIKEN	AK127861	flj0078j10	FLJ	W01A034K09	pENTR-TOPO	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964				PLACE7	EK1													
RIKEN	AK127861	flj0078j10	FLJ	W01A034K13	pENTR-TOPO	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964				PLACE7	EK1													
RIKEN	BC075799	IRAK168B16	MGC	W01A034L01	pENTR-TOPO	6991		ARHGAP5	394	AAH75799.1	Hs.592313	Rho GTPase activating protein 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001173.2	NP_001164.2	REVIEWED		0.943	0.943	230	714	22	711	1501	1272	1501
RIKEN	BC063613	IRAK134B01	MGC	W01A034L02	pENTR-TOPO	6983		TSHR	7253	AAH63613.1	Hs.160411	Thyroid stimulating hormone receptor			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001018036.1	NP_001018046.1	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC075799	IRAK168B16	MGC	W01A034L05	pENTR-TOPO	6991		ARHGAP5	394	AAH75799.1	Hs.592313	Rho GTPase activating protein 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001173.2	NP_001164.2	REVIEWED		0.943	0.943	230	714	22	711	1501	1272	1501
RIKEN	BC003530	IRAL013I13	MGC	W01A034L11	pENTR-TOPO	15073		SNRPB	6628	AAH03530	Hs.83753	Small nuclear ribonucleoprotein polypeptides B and B1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_003091.3	NP_003082.1	REVIEWED	P	1.000	1.000	229	705	1	687	231	1	229
RIKEN	BC000738	IRAL007H09	MGC	W01A034L18	pENTR-TOPO	24824		EMD	2010	AAH00738.1	Hs.522823	Emerin			Placenta, choriocarcinoma	NIH_MGC_21		NM_000117.2	NP_000108.1	REVIEWED	C	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC007012	IRAL016P02	MGC	W01A034L19	pENTR-TOPO	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	C	1.000	1.000	236	711	1	708	236	1	236
RIKEN	BC000738	IRAL007H09	MGC	W01A034L20	pENTR-TOPO	24824		EMD	2010	AAH00738.1	Hs.522823	Emerin			Placenta, choriocarcinoma	NIH_MGC_21		NM_000117.2	NP_000108.1	REVIEWED	C	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC069200	IRAL054G07	MGC	W01A034M12	pENTR-TOPO	12378		GADD45GIP1	90480	AAH69200.1	Hs.515164	Growth arrest and DNA-damage-inducible, gamma interacting protein 1			Skin, melanoma, amelanotic	NIH_MGC_41		NM_052850.2	NP_443082.2	PROVISIONAL	OK	1.000	1.000	222	669	1	666	222	1	222
RIKEN	BC005913	IRAL021G03	MGC	W01A034M17	pENTR-TOPO	22690		SFTPC	6440	AAH05913.1	Hs.1074	Surfactant protein C			Lung	NIH_MGC_77	DH10B	NM_003018.3	NP_003009.2	VALIDATED	Cs	0.990	0.990	197	594	1	591	197	1	197
RIKEN	BC006491	IRAL014N02	MGC	W01A034N18	pENTR-TOPO	2161		MPZ	4359	AAH06491.1	Hs.591486	Myelin protein zero			Skin, melanotic melanoma.	NIH_MGC_20		NM_000530.5	NP_000521.1	REVIEWED	C	1.000	1.000	258	777	1	774	258	1	258
RIKEN	AK126747	flj0075g01	FLJ	W01A034N23	pENTR-TOPO	44796		GNAZ	2781	BAC86669	Hs.584760	Guanine nucleotide binding protein (G protein), alpha z polypeptide				BRACE3	EK1	NM_002073.2	NP_002064.1	REVIEWED	Pfs	0.417	0.417	12	723	109	74	355	258	269
RIKEN	BC000607	IRAL005G04	MGC	W01A034O01	pENTR-TOPO	9717		ANAPC11	51529	AAH00607.2	Hs.534456	Anaphase promoting complex subunit 11			Skin, melanotic melanoma.	NIH_MGC_20		NM_001002244.1	NP_001002244.1	VALIDATED	OK	1.000	1.000	196	591	1	588	196	1	196
RIKEN	BC000607	IRAL005G04	MGC	W01A034O07	pENTR-TOPO	9717		ANAPC11	51529	AAH00607.2	Hs.534456	Anaphase promoting complex subunit 11			Skin, melanotic melanoma.	NIH_MGC_20		NM_001002244.1	NP_001002244.1	VALIDATED	OK	1.000	1.000	196	591	1	588	196	1	196
RIKEN	BC068030	IRAK141P08	MGC	W01A034O15	pENTR-TOPO	3644		CNTF	1270	AAH68030.1	Hs.715806	Ciliary neurotrophic factor				NIH_MGC_181	DH10B	NM_000614.3	NP_000605.1	REVIEWED	C	1.000	1.000	200	603	1	600	200	1	200
RIKEN	AK126903	flj0077o13	FLJ	W01A034O17	pENTR-TOPO	20714			401278	BAC86744						BRAWH2	EK1			
RIKEN	AK097543	flj0026l05	FLJ	W01A034P19	pENTR-TOPO	4001		PRR10	283165	BAC05095.1	Hs.376015	Proline rich 10				TESTI2	EK1													
RIKEN	AK128613	flj0075j21	FLJ	W01A035A03	pENTR-TOPO	6179		ATXN2	6311	BAC87528.1	Hs.76253	Ataxin 2				TRACH3	EK1	NM_002973.3	NP_002964.3	REVIEWED		0.906	0.975	256	777	34	747	1313	993	1248
RIKEN	AK128613	flj0075j21	FLJ	W01A035A05	pENTR-TOPO	6179		ATXN2	6311	BAC87528.1	Hs.76253	Ataxin 2				TRACH3	EK1	NM_002973.3	NP_002964.3	REVIEWED		0.906	0.975	256	777	34	747	1313	993	1248
RIKEN	AK128613	flj0075j21	FLJ	W01A035A07	pENTR-TOPO	6179		ATXN2	6311	BAC87528.1	Hs.76253	Ataxin 2				TRACH3	EK1	NM_002973.3	NP_002964.3	REVIEWED		0.906	0.975	256	777	34	747	1313	993	1248
RIKEN	BC010376	IRAL019L04	MGC	W01A035B05	pENTR-TOPO	870		TSNAX	7257	AAH10376.1	Hs.96247	Translin-associated factor X			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005999.2	NP_005990.1	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
RIKEN	BC025394	IRAK034H03	MGC	W01A035B13	pENTR-TOPO	3294		MARCH8	220972	AAH25394.1	Hs.499489	Membrane-associated ring finger (C3HC4) 8			Testis	NIH_MGC_97	DH10B	NM_001002265.1	NP_001002265.1	VALIDATED	Cs	0.997	0.997	291	876	1	873	291	1	291
RIKEN	AK124283	flj0071o12	FLJ	W01A035B18	pENTR-TOPO	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182				TLIVE2	EK1													
RIKEN	BC050373	IRAK098B20	MGC	W01A035B21	pENTR-TOPO	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014746.3	NP_055561.2	REVIEWED	Cs	0.997	0.997	292	879	1	876	292	1	292
RIKEN	AK124283	flj0071o12	FLJ	W01A035B22	pENTR-TOPO	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182				TLIVE2	EK1													
RIKEN	BC000372	IRAL001A24	MGC	W01A035C09	pENTR-TOPO	25166		HSD17B10	3028	AAH00372.1	Hs.171280	Hydroxysteroid (17-beta) dehydrogenase 10			Lung, small cell carcinoma	NIH_MGC_7		NM_004493.2	NP_004484.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC013401	IRAL010K16	MGC	W01A035C12	pENTR-TOPO	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002634.2	NP_002625.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC013401	IRAL010K16	MGC	W01A035C16	pENTR-TOPO	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002634.2	NP_002625.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC013566	IRAK014A21	MGC	W01A035D13	pENTR-TOPO	23948		AQP3	360	AAH13566.1	Hs.234642	Aquaporin 3 (Gill blood group)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004925.3	NP_004916.1	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
RIKEN	BC001416	IRAL004I20	MGC	W01A035D14	pENTR-TOPO	8659		PPP4C	5531	AAH01416.1	Hs.534338	Protein phosphatase 4 (formerly X), catalytic subunit			Placenta, choriocarcinoma	NIH_MGC_21		NM_002720.1	NP_002711.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
RIKEN	AK127759	flj0074d20	FLJ	W01A035D21	pENTR-TOPO	11537		NDUFS7	374291	BAC87117.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)				OCBBF2	EK1	NM_024407.4	NP_077718.3	REVIEWED	Ps	0.987	0.987	78	885	1	234	213	1	78
RIKEN	AK024697	flj0063m19	FLJ	W01A035D22	pENTR-TOPO	3922		ROBO3	64221	BAB14966.1	Hs.435621	Roundabout, axon guidance receptor, homolog 3 (Drosophila)				CAE	EK1	NM_022370.2	NP_071765.2	VALIDATED	Pg	0.994	1.000	311	930	1	927	1386	1076	1386
RIKEN	BC071754	IRAL057P02	MGC	W01A035E07	pENTR-TOPO	24672		CD40LG	959	AAH71754.1	Hs.592244	CD40 ligand				NIH_MGC_191	DH10B	NM_000074.2	NP_000065.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC011515	IRAK012P06	MGC	W01A035E17	pENTR-TOPO	24807		TAZ	6901	AAH11515.1	Hs.409911	Tafazzin			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_181312.2	NP_851829.1	REVIEWED		0.659	0.937	317	789	1	786	278	1	278
RIKEN	AK075320	flj0049k14	FLJ	W01A035E22	pENTR-TOPO	20538		SLC17A5	26503	BAC11546.1	Hs.597422	Solute carrier family 17 (anion/sugar transporter), member 5	Y79	retinoblastoma		Y79AA1	EK1	NM_012434.4	NP_036566.1	REVIEWED	Ps	0.989	0.989	277	834	1	831	495	1	277
RIKEN	BC011737	IRAL027P19	MGC	W01A035F14	pENTR-TOPO	4731		UCP2	7351	AAH11737.1	Hs.80658	Uncoupling protein 2 (mitochondrial, proton carrier)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003355.2	NP_003346.2	REVIEWED	OK	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC011737	IRAL027P19	MGC	W01A035F16	pENTR-TOPO	4731		UCP2	7351	AAH11737.1	Hs.80658	Uncoupling protein 2 (mitochondrial, proton carrier)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003355.2	NP_003346.2	REVIEWED	OK	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC015739	IRAL034A03	MGC	W01A035G03	pENTR-TOPO	18881		GZMA	3001	AAH15739.1	Hs.90708	Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)			Blood, natural killer cell	NIH_MGC_106		NM_006144.3	NP_006135.1	REVIEWED	C	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC015739	IRAL034A03	MGC	W01A035G07	pENTR-TOPO	18881		GZMA	3001	AAH15739.1	Hs.90708	Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)			Blood, natural killer cell	NIH_MGC_106		NM_006144.3	NP_006135.1	REVIEWED	C	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC039865	IRAK084N06	MGC	W01A035G11	pENTR-TOPO	20499		NRM	11270	AAH39865.1	Hs.519993	Nurim (nuclear envelope membrane protein)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_007243.1	NP_009174.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC039865	IRAK084N06	MGC	W01A035G15	pENTR-TOPO	20499		NRM	11270	AAH39865.1	Hs.519993	Nurim (nuclear envelope membrane protein)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_007243.1	NP_009174.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
RIKEN	AK021791	flj0029m23	FLJ	W01A035G24	pENTR-TOPO	14676		PANK2	80025	BAB13897.1	Hs.516859	Pantothenate kinase 2				HEMBA1	EK1	NM_024960.4	NP_079236.3	REVIEWED	Cs	0.993	0.993	279	840	1	837	279	1	279
RIKEN	AK027000	flj0064g17	FLJ	W01A035H01	pENTR-TOPO	1343		CDC42BPA	8476	BAB15619.1	Hs.35433	CDC42 binding protein kinase alpha (DMPK-like)	HepG2	hepatoma		HEP	EK1	NM_003607.3	NP_003598.2	REVIEWED	P	1.000	1.000	272	894	1	816	1719	1352	1623
RIKEN	AK027000	flj0064g17	FLJ	W01A035H03	pENTR-TOPO	1343		CDC42BPA	8476	BAB15619.1	Hs.35433	CDC42 binding protein kinase alpha (DMPK-like)	HepG2	hepatoma		HEP	EK1	NM_003607.3	NP_003598.2	REVIEWED	P	1.000	1.000	272	894	1	816	1719	1352	1623
RIKEN	BC032001	IRAK028N11	MGC	W01A035H13	pENTR-TOPO	13997		ZC3H8	84524	AAH32001.1	Hs.418416	Zinc finger CCCH-type containing 8			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_032494.2	NP_115883.2	VALIDATED	P	1.000	1.000	290	894	1	870	291	1	290
RIKEN	AK129976	flj0054o15	FLJ	W01A035I04	pENTR-TOPO	14039		CERKL	375298	BAC85266.1	Hs.715753	Ceramide kinase-like				KDN	EK1	NM_001160277.1	NP_001153749.1	VALIDATED	P	1.000	1.000	280	843	1	840	514	235	514
RIKEN	AK091044	flj0016o02	FLJ	W01A035I05	pENTR-TOPO	21064		KIAA1908	114796	BAC03573	Hs.639814	Hypothetical LOC114796				BRAWH2	EK1	XM_001716897.1	XP_001716949.1	MODEL	OK	1.000	1.000	264	795	1	792	264	1	264
RIKEN	AK091044	flj0016o02	FLJ	W01A035I07	pENTR-TOPO	21064		KIAA1908	114796	BAC03573	Hs.639814	Hypothetical LOC114796				BRAWH2	EK1	XM_001716897.1	XP_001716949.1	MODEL	OK	1.000	1.000	264	795	1	792	264	1	264
RIKEN	BC000491	IRAL001B22	MGC	W01A035I11	pENTR-TOPO	15076		PCNA	5111	AAH00491.1	Hs.147433	Proliferating cell nuclear antigen			Lung, small cell carcinoma	NIH_MGC_7		NM_002592.2	NP_002583.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC000491	IRAL001B22	MGC	W01A035I13	pENTR-TOPO	15076		PCNA	5111	AAH00491.1	Hs.147433	Proliferating cell nuclear antigen			Lung, small cell carcinoma	NIH_MGC_7		NM_002592.2	NP_002583.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC007840	IRAL020E10	MGC	W01A035I22	pENTR-TOPO	2167		SDHB	6390	AAH07840.1	Hs.465924	Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)			Brain, neuroblastoma	NIH_MGC_19		NM_003000.2	NP_002991.2	REVIEWED	C	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC007840	IRAL020E10	MGC	W01A035I24	pENTR-TOPO	2167		SDHB	6390	AAH07840.1	Hs.465924	Succinate dehydrogenase complex, subunit B, iron sulfur (Ip)			Brain, neuroblastoma	NIH_MGC_19		NM_003000.2	NP_002991.2	REVIEWED	C	1.000	1.000	280	843	1	840	280	1	280
RIKEN	AK092682	flj0003f15	FLJ	W01A035J06	pENTR-TOPO	707		HFE2	148738	BAC03944.1	Hs.632436	Hemochromatosis type 2 (juvenile)				SKMUS2	EK1	NM_202004.3	NP_973733.1	REVIEWED	Cs	0.995	0.995	200	942	340	939	200	1	200
RIKEN	AK096889	flj0046m17	FLJ	W01A035J07	pENTR-TOPO	16423		MLF1	4291	BAC04885.1	Hs.85195	Myeloid leukemia factor 1				SKMUS2	EK1	NM_001130157.1	NP_001123629.1	VALIDATED	Cg	0.942	1.000	258	900	124	897	243	1	243
RIKEN	AK092682	flj0003f15	FLJ	W01A035J08	pENTR-TOPO	707		HFE2	148738	BAC03944.1	Hs.632436	Hemochromatosis type 2 (juvenile)				SKMUS2	EK1	NM_202004.3	NP_973733.1	REVIEWED	Cs	0.995	0.995	200	942	340	939	200	1	200
RIKEN	BC073173	IRAK174N24	MGC	W01A035J17	pENTR-TOPO	24512		RGN	9104	AAH73173.1	Hs.77854	Regucalcin (senescence marker protein-30)				Lupski_dorsal_root_ganglion	DH10B	NM_004683.4	NP_004674.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC000101	IRAL007G12	MGC	W01A035J18	pENTR-TOPO	23455		NEK6	10783	AAH00101.2	Hs.197071	NIMA (never in mitosis gene a)-related kinase 6			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014397.4	NP_055212.2	VALIDATED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC073173	IRAK174N24	MGC	W01A035J19	pENTR-TOPO	24512		RGN	9104	AAH73173.1	Hs.77854	Regucalcin (senescence marker protein-30)				Lupski_dorsal_root_ganglion	DH10B	NM_004683.4	NP_004674.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC000101	IRAL007G12	MGC	W01A035J22	pENTR-TOPO	23455		NEK6	10783	AAH00101.2	Hs.197071	NIMA (never in mitosis gene a)-related kinase 6			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014397.4	NP_055212.2	VALIDATED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC000101	IRAL007G12	MGC	W01A035J24	pENTR-TOPO	23455		NEK6	10783	AAH00101.2	Hs.197071	NIMA (never in mitosis gene a)-related kinase 6			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014397.4	NP_055212.2	VALIDATED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC029382	IRAL041C02	MGC	W01A035K01	pENTR-TOPO	18721		AGGF1	55109	AAH29382.2	Hs.634849	Angiogenic factor with G patch and FHA domains 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_018046.3	NP_060516.2	VALIDATED	Ps	0.996	0.996	266	801	1	798	714	442	707
RIKEN	BC029382	IRAL041C02	MGC	W01A035K05	pENTR-TOPO	18721		AGGF1	55109	AAH29382.2	Hs.634849	Angiogenic factor with G patch and FHA domains 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_018046.3	NP_060516.2	VALIDATED	Ps	0.996	0.996	266	801	1	798	714	442	707
RIKEN	AK124189	flj0068f21	FLJ	W01A035K10	pENTR-TOPO	13616		D2HGDH	728294	BAC85798.1	Hs.535639	D-2-hydroxyglutarate dehydrogenase				THYMU2	EK1	NM_152783.3	NP_689996.4	REVIEWED		0.278	0.282	72	849	182	394	521	27	98
RIKEN	BC002577	IRAL004D02	MGC	W01A035K13	pENTR-TOPO	4876		PSMA1	5682	AAH02577.1	Hs.102798	Proteasome (prosome, macropain) subunit, alpha type, 1			Ovary, adenocarcinoma	NIH_MGC_9		NM_002786.3	NP_002777.1	REVIEWED	C	1.000	1.000	263	792	1	789	263	1	263
RIKEN	AK124189	flj0068f21	FLJ	W01A035K14	pENTR-TOPO	13616		D2HGDH	728294	BAC85798.1	Hs.535639	D-2-hydroxyglutarate dehydrogenase				THYMU2	EK1	NM_152783.3	NP_689996.4	REVIEWED		0.278	0.282	72	849	182	394	521	27	98
RIKEN	BC017342	IRAL039H17	MGC	W01A035K22	pENTR-TOPO	8624		CDK10	8558	AAH17342.1	Hs.699177	Cyclin-dependent kinase 10			Colon, adenocarcinoma	NIH_MGC_15		NM_001098533.2	NP_001092003.2	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC034709	IRAK028P08	MGC	W01A035K23	pENTR-TOPO	675		GJB4	127534	AAH34709.1	Hs.715288	Gap junction protein, beta 4, 30.3kDa			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_153212.1	NP_694944.1	VALIDATED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC047771	IRAK098E02	MGC	W01A035L11	pENTR-TOPO	4805		DPAGT1	1798	AAH47771.1	Hs.524081	Dolichyl-phosphate (UDP-N-acetylglucosamine) N-acetylglucosaminephosphotransferase 1 (GlcNAc-1-P transferase)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_203316.1	NP_976061.1	REVIEWED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	BC009470	IRAL006D22	MGC	W01A035L14	pENTR-TOPO	13925		PRKRA	8575	AAH09470.1	Hs.570274	Protein kinase, interferon-inducible double stranded RNA dependent activator			Brain, neuroblastoma	NIH_MGC_19		NM_001139518.1	NP_001132990.1	REVIEWED	C	1.000	1.000	288	942	76	939	288	1	288
RIKEN	BC002702	IRAL012O23	MGC	W01A035L23	pENTR-TOPO	6471		SLC25A15	10166	AAH02702.1	Hs.646645	Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 15			Skin, melanotic melanoma.	NIH_MGC_20		NM_014252.3	NP_055067.1	REVIEWED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	BC000160	IRAK003B07	MGC	W01A035M06	pENTR-TOPO	17093		TRA2B	6434	AAH00160.1	Hs.533122	Transformer 2 beta homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004593.2	NP_004584.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	AK001926	flj0037a22	FLJ	W01A035M10	pENTR-TOPO	16929		PBRM1	55193	BAA91982.1	Hs.189920	Polybromo 1				PLACE1	EK1	NM_181042.3	NP_851385.1	VALIDATED	P	1.000	1.000	286	870	1	858	1582	844	1129
RIKEN	BC001821	IRAL002M16	MGC	W01A035M13	pENTR-TOPO	4060		CD82	3732	AAH01821.1	Hs.527778	CD82 molecule			Colon, adenocarcinoma	NIH_MGC_15		NM_002231.3	NP_002222.1	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	BC036723	IRAK049H17	MGC	W01A035M18	pENTR-TOPO	2073		FCGR3A	2214	AAH36723.1	Hs.372679	Fc fragment of IgG, low affinity IIIa, receptor (CD16a)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001127595.1	NP_001121067.1	REVIEWED	Cs	0.996	0.996	254	873	109	870	254	1	254
RIKEN	BC036723	IRAK049H17	MGC	W01A035M24	pENTR-TOPO	2073		FCGR3A	2214	AAH36723.1	Hs.372679	Fc fragment of IgG, low affinity IIIa, receptor (CD16a)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001127595.1	NP_001121067.1	REVIEWED	Cs	0.996	0.996	254	873	109	870	254	1	254
RIKEN	BC064806	IRAK119E20	MGC	W01A035N03	pENTR-TOPO	11664		NCR1	9437	AAH64806.1	Hs.97084	Natural cytotoxicity triggering receptor 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001145457.1	NP_001138929.1	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC064806	IRAK119E20	MGC	W01A035N05	pENTR-TOPO	11664		NCR1	9437	AAH64806.1	Hs.97084	Natural cytotoxicity triggering receptor 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001145457.1	NP_001138929.1	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC003014	IRAL001E24	MGC	W01A035N17	pENTR-TOPO	9058		NTHL1	4913	AAH03014.1	Hs.66196	Nth endonuclease III-like 1 (E. coli)			Lung, small cell carcinoma	NIH_MGC_7		NM_002528.5	NP_002519.1	REVIEWED	P	1.000	1.000	304	915	1	912	312	9	312
RIKEN	BC003014	IRAL001E24	MGC	W01A035N19	pENTR-TOPO	9058		NTHL1	4913	AAH03014.1	Hs.66196	Nth endonuclease III-like 1 (E. coli)			Lung, small cell carcinoma	NIH_MGC_7		NM_002528.5	NP_002519.1	REVIEWED	P	1.000	1.000	304	915	1	912	312	9	312
RIKEN	BC003014	IRAL001E24	MGC	W01A035N21	pENTR-TOPO	9058		NTHL1	4913	AAH03014.1	Hs.66196	Nth endonuclease III-like 1 (E. coli)			Lung, small cell carcinoma	NIH_MGC_7		NM_002528.5	NP_002519.1	REVIEWED	P	1.000	1.000	304	915	1	912	312	9	312
RIKEN	BC009040	IRAK013G03	MGC	W01A035O05	pENTR-TOPO	11440		BSG	682	AAH09040.1	Hs.501293	Basigin (Ok blood group)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198590.1	NP_940992.1	REVIEWED	C	1.000	1.000	176	810	280	807	176	1	176
RIKEN	BC063853	IRAK141C12	MGC	W01A035O08	pENTR-TOPO	4101		ACAT1	38	AAH63853	Hs.232375	Acetyl-Coenzyme A acetyltransferase 1				Lupski_dorsal_root_ganglion	DH10B	NM_000019.3	NP_000010.1	REVIEWED	Pfs	0.883	0.989	316	870	1	846	427	1	316
RIKEN	BC001823	IRAL001L23	MGC	W01A035O11	pENTR-TOPO	5267		PRKAB1	5564	AAH01823.1	Hs.715515	Protein kinase, AMP-activated, beta 1 non-catalytic subunit			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006253.4	NP_006244.2	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC001823	IRAL001L23	MGC	W01A035O15	pENTR-TOPO	5267		PRKAB1	5564	AAH01823.1	Hs.715515	Protein kinase, AMP-activated, beta 1 non-catalytic subunit			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006253.4	NP_006244.2	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC006314	IRAL017G03	MGC	W01A035O17	pENTR-TOPO	14265		CHRNA1	1134	AAH06314	Hs.434479	Cholinergic receptor, nicotinic, alpha 1 (muscle)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000079.3	NP_000070.1	REVIEWED	P	1.000	1.000	260	810	1	780	457	1	260
RIKEN	BC006314	IRAL017G03	MGC	W01A035O19	pENTR-TOPO	14265		CHRNA1	1134	AAH06314	Hs.434479	Cholinergic receptor, nicotinic, alpha 1 (muscle)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000079.3	NP_000070.1	REVIEWED	P	1.000	1.000	260	810	1	780	457	1	260
RIKEN	BC024939	IRAK026D11	MGC	W01A035O22	pENTR-TOPO	22783		GDAP1	54332	AAH24939.1	Hs.168950	Ganglioside-induced differentiation-associated protein 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001040875.1	NP_001035808.1	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
RIKEN	BC016280	IRAK015G18	MGC	W01A035P07	pENTR-TOPO	15523		PEX26	55670	AAH16280.1	Hs.517400	Peroxisomal biogenesis factor 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017929.4	NP_060399.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC008656	IRAK013C08	MGC	W01A035P09	pENTR-TOPO	7031		SPATA7	55812	AAH08656.2	Hs.525518	Spermatogenesis associated 7			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001040428.2	NP_001035518.1	VALIDATED	P	1.000	1.000	305	918	1	915	567	263	567
RIKEN	BC000306	IRAL001C23	MGC	W01A036A07	pENTR-TOPO	17471		HADH	3033	AAH00306.1	Hs.438289	Hydroxyacyl-Coenzyme A dehydrogenase			Lung, small cell carcinoma	NIH_MGC_7		NM_005327.2	NP_005318.2	REVIEWED	Cs	0.997	0.997	314	945	1	942	314	1	314
RIKEN	BC068581	IRAK168E22	MGC	W01A036A24	pENTR-TOPO	20470		OSTM1	28962	AAH68581.1	Hs.719130	Osteopetrosis associated transmembrane protein 1			Testis	NIH_MGC_97	DH10B	NM_014028.3	NP_054747.2	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC070032	IRAK167O15	MGC	W01A036B06	pENTR-TOPO	24016		TSC1	7248	AAH70032.1	Hs.370854	Tuberous sclerosis 1			Testis	NIH_MGC_97	DH10B	NM_001008567.1	NP_001008567.1	VALIDATED	C	1.000	1.000	366	1101	1	1098	366	1	366
RIKEN	BC032667	IRAK069L09	MGC	W01A036B07	pENTR-TOPO	5905		KERA	11081	AAH32667.1	Hs.125750	Keratocan			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_007035.3	NP_008966.1	VALIDATED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC022488	IRAK032J10	MGC	W01A036B10	pENTR-TOPO	17947		GABRA2	2555	AAH22488.1	Hs.116250	Gamma-aminobutyric acid (GABA) A receptor, alpha 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000807.2	NP_000798.2	REVIEWED	Ps	0.981	0.981	362	1104	1	1086	451	1	362
RIKEN	BC067742	IRAK168H06	MGC	W01A036B17	pENTR-TOPO	21323		PHTF2	57157	AAH67742.1	Hs.203965	Putative homeodomain transcription factor 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001127360.1	NP_001120832.1	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC067742	IRAK168H06	MGC	W01A036B21	pENTR-TOPO	21323		PHTF2	57157	AAH67742.1	Hs.203965	Putative homeodomain transcription factor 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001127360.1	NP_001120832.1	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC006540	IRAL002N01	MGC	W01A036C05	pENTR-TOPO	24813		BRCC3	79184	AAH06540.1	Hs.558537	BRCA1/BRCA2-containing complex, subunit 3			Lung, small cell carcinoma	NIH_MGC_7		NM_024332.2	NP_077308.1	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
RIKEN	BC006540	IRAL002N01	MGC	W01A036C07	pENTR-TOPO	24813		BRCC3	79184	AAH06540.1	Hs.558537	BRCA1/BRCA2-containing complex, subunit 3			Lung, small cell carcinoma	NIH_MGC_7		NM_024332.2	NP_077308.1	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
RIKEN	BC015526	IRAK020O07	MGC	W01A036C08	pENTR-TOPO	8368		ETFA	2108	AAH15526.1	Hs.39925	Electron-transfer-flavoprotein, alpha polypeptide			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000126.3	NP_000117.1	REVIEWED	OK	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	AK093762	flj0021e05	FLJ	W01A036C12	pENTR-TOPO	9122		ANKRD11	29123	BAC04221	Hs.335003	Ankyrin repeat domain 11				THYMU2	EK1	NM_013275.4	NP_037407.4	VALIDATED		0.951	0.951	163	1005	1	489	2663	2336	2498
RIKEN	AK093762	flj0021e05	FLJ	W01A036C14	pENTR-TOPO	9122		ANKRD11	29123	BAC04221	Hs.335003	Ankyrin repeat domain 11				THYMU2	EK1	NM_013275.4	NP_037407.4	VALIDATED		0.951	0.951	163	1005	1	489	2663	2336	2498
RIKEN	BC046355	IRAK089G13	MGC	W01A036D02	pENTR-TOPO	17225		PCYT1A	5130	AAH46355.1	Hs.435767	Phosphate cytidylyltransferase 1, choline, alpha			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005017.2	NP_005008.2	PROVISIONAL	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC046355	IRAK089G13	MGC	W01A036D04	pENTR-TOPO	17225		PCYT1A	5130	AAH46355.1	Hs.435767	Phosphate cytidylyltransferase 1, choline, alpha			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005017.2	NP_005008.2	PROVISIONAL	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC020968	IRAK020G12	MGC	W01A036D05	pENTR-TOPO	13894		CXCR4	7852	AAH20968.1	Hs.593413	Chemokine (C-X-C motif) receptor 4			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_003467.2	NP_003458.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC020968	IRAK020G12	MGC	W01A036D07	pENTR-TOPO	13894		CXCR4	7852	AAH20968.1	Hs.593413	Chemokine (C-X-C motif) receptor 4			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_003467.2	NP_003458.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC046355	IRAK089G13	MGC	W01A036D08	pENTR-TOPO	17225		PCYT1A	5130	AAH46355.1	Hs.435767	Phosphate cytidylyltransferase 1, choline, alpha			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005017.2	NP_005008.2	PROVISIONAL	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	AK022977	flj0034c15	FLJ	W01A036D10	pENTR-TOPO	52		KIF1B	23095	BAB14341.1	Hs.97858	Kinesin family member 1B	NT2	teratocarcinoma		NT2RP2	EK1	NM_015074.3	NP_055889.2	REVIEWED	P	1.000	1.000	368	1107	1	1104	1770	1403	1770
RIKEN	BC004196	IRAL011O21	MGC	W01A036D15	pENTR-TOPO	4676		RAPSN	5913	AAH04196.1	Hs.81218	Receptor-associated protein of the synapse			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032645.3	NP_116034.2	REVIEWED	Cs	0.997	0.997	353	1062	1	1059	353	1	353
RIKEN	BC020709	IRAL037M06	MGC	W01A036E01	pENTR-TOPO	18199		SGCB	6443	AAH20709.1	Hs.438953	Sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)			Placenta	NIH_MGC_79	DH10B	NM_000232.4	NP_000223.1	REVIEWED	C	1.000	1.000	318	957	1	954	318	1	318
RIKEN	BC020709	IRAL037M06	MGC	W01A036E03	pENTR-TOPO	18199		SGCB	6443	AAH20709.1	Hs.438953	Sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)			Placenta	NIH_MGC_79	DH10B	NM_000232.4	NP_000223.1	REVIEWED	C	1.000	1.000	318	957	1	954	318	1	318
RIKEN	BC028298	IRAK029P14	MGC	W01A036E13	pENTR-TOPO	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)				NCI_CGAP_Brn67	DH10B	NM_002905.3	NP_002896.2	REVIEWED	Cs	0.997	0.997	318	957	1	954	318	1	318
RIKEN	AK027580	flj0034c03	FLJ	W01A036E21	pENTR-TOPO	18009		NEK1	4750	BAB55209.1	Hs.481181	NIMA (never in mitosis gene a)-related kinase 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_012224.1	NP_036356.1	VALIDATED	P	1.000	1.000	314	963	1	942	1258	208	521
RIKEN	BC003624	IRAL003K17	MGC	W01A036E24	pENTR-TOPO	15270		IFNGR2	3460	AAH03624.1	Hs.634632	Interferon gamma receptor 2 (interferon gamma transducer 1)			Skin, melanotic melanoma.	NIH_MGC_20		NM_005534.3	NP_005525.2	REVIEWED	OK	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC017068	IRAK022L03	MGC	W01A036F01	pENTR-TOPO	15788		A4GALT	53947	AAH17068.1	Hs.105956	Alpha 1,4-galactosyltransferase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017436.4	NP_059132.1	REVIEWED	OK	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	AK095003	flj0025l05	FLJ	W01A036F02	pENTR-TOPO	23449		PALM2	114299	BAC04472.1						BRHIP2	EK1	NM_001037293.1	NP_001032370.1	VALIDATED	Cg	0.974	1.000	379	1110	1	1107	379	1	379
RIKEN	BC017068	IRAK022L03	MGC	W01A036F05	pENTR-TOPO	15788		A4GALT	53947	AAH17068.1	Hs.105956	Alpha 1,4-galactosyltransferase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017436.4	NP_059132.1	REVIEWED	OK	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC004929	IRAL013C08	MGC	W01A036F10	pENTR-TOPO	8710		HSD3B7	80270	AAH04929.1	Hs.709632	Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 7			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_025193.3	NP_079469.2	REVIEWED	C	1.000	1.000	369	1110	1	1107	369	1	369
RIKEN	AK092276	flj0010a02	FLJ	W01A036F13	pENTR-TOPO	10588		KRT13	3860	BAC03847.1	Hs.654550	Keratin 13				NTONG2	EK1	NM_153490.2	NP_705694.2	REVIEWED	Pfs	0.934	0.997	379	1068	1	1066	458	1	379
RIKEN	BC021708	IRAK033D09	MGC	W01A036G02	pENTR-TOPO	19733		HLA-G	3135	AAH21708.1	Hs.512152	Major histocompatibility complex, class I, G			Testis	NIH_MGC_97	DH10B	NM_002127.4	NP_002118.1	REVIEWED	Cs	0.991	0.991	338	1017	1	1014	338	1	338
RIKEN	BC021708	IRAK033D09	MGC	W01A036G04	pENTR-TOPO	19733		HLA-G	3135	AAH21708.1	Hs.512152	Major histocompatibility complex, class I, G			Testis	NIH_MGC_97	DH10B	NM_002127.4	NP_002118.1	REVIEWED	Cs	0.991	0.991	338	1017	1	1014	338	1	338
RIKEN	BC019033	IRAL030J05	MGC	W01A036G09	pENTR-TOPO	4704		SLC25A22	79751	AAH19033.1	Hs.99486	Solute carrier family 25 (mitochondrial carrier: glutamate), member 22			Skin, melanotic melanoma.	NIH_MGC_20		NM_024698.4	NP_078974.1	PROVISIONAL	OK	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC019033	IRAL030J05	MGC	W01A036G15	pENTR-TOPO	4704		SLC25A22	79751	AAH19033.1	Hs.99486	Solute carrier family 25 (mitochondrial carrier: glutamate), member 22			Skin, melanotic melanoma.	NIH_MGC_20		NM_024698.4	NP_078974.1	PROVISIONAL	OK	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC004395	IRAL013H04	MGC	W01A036G20	pENTR-TOPO	15811		APOL2	23780	AAH04395.1	Hs.474740	Apolipoprotein L, 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_030882.2	NP_112092.1	REVIEWED	Cs	0.997	0.997	337	1014	1	1011	337	1	337
RIKEN	AK027713	flj0020c15	FLJ	W01A036H11	pENTR-TOPO	16373		ECT2	1894	BAB55317.1	Hs.518299	Epithelial cell transforming sequence 2 oncogene	NT2	teratocarcinoma		NT2RP4	EK1	NM_018098.4	NP_060568.3	REVIEWED	P	1.000	1.000	359	1080	1	1077	883	525	883
RIKEN	AK027713	flj0020c15	FLJ	W01A036H15	pENTR-TOPO	16373		ECT2	1894	BAB55317.1	Hs.518299	Epithelial cell transforming sequence 2 oncogene	NT2	teratocarcinoma		NT2RP4	EK1	NM_018098.4	NP_060568.3	REVIEWED	P	1.000	1.000	359	1080	1	1077	883	525	883
RIKEN	BC018198	IRAK021P09	MGC	W01A036I09	pENTR-TOPO	1369		PEX10	5192	AAH18198.1	Hs.591454	Peroxisomal biogenesis factor 10			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002617.3	NP_002608.1	REVIEWED	OK	1.000	1.000	326	981	1	978	326	1	326
RIKEN	AK000421	flj0064l05	FLJ	W01A036I18	pENTR-TOPO	21878		TFR2	7036	BAA91153.1	Hs.544932	Transferrin receptor 2				KAT	EK1	NM_003227.3	NP_003218.2	REVIEWED	P	1.000	1.000	342	1029	1	1026	801	460	801
RIKEN	AK000421	flj0064l05	FLJ	W01A036I22	pENTR-TOPO	21878		TFR2	7036	BAA91153.1	Hs.544932	Transferrin receptor 2				KAT	EK1	NM_003227.3	NP_003218.2	REVIEWED	P	1.000	1.000	342	1029	1	1026	801	460	801
RIKEN	BC000349	IRAL001M05	MGC	W01A036J03	pENTR-TOPO	1952		GBAP	2630	AAH00349					Muscle, rhabdomyosarcoma	NIH_MGC_17														
RIKEN	BC000245	IRAL006G02	MGC	W01A036J04	pENTR-TOPO	24712		NSDHL	50814	AAH00245.1	Hs.57698	NAD(P) dependent steroid dehydrogenase-like			Eye, retinoblastoma	NIH_MGC_16		NM_015922.2	NP_057006.1	REVIEWED	C	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC000245	IRAL006G02	MGC	W01A036J06	pENTR-TOPO	24712		NSDHL	50814	AAH00245.1	Hs.57698	NAD(P) dependent steroid dehydrogenase-like			Eye, retinoblastoma	NIH_MGC_16		NM_015922.2	NP_057006.1	REVIEWED	C	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC040968	IRAK084M12	MGC	W01A036J11	pENTR-TOPO	7103		PTGDR	5729	AAH40968.1	Hs.306831	Prostaglandin D2 receptor (DP)			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000953.2	NP_000944.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC007826	IRAL020A06	MGC	W01A036J14	pENTR-TOPO	5235		RNF34	80196	AAH07826.1	Hs.292804	Ring finger protein 34			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_025126.2	NP_079402.2	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC001936	IRAL009A12	MGC	W01A036K02	pENTR-TOPO	24049		BAG1	573	AAH01936.2	Hs.377484	BCL2-associated athanogene			Lung, small cell carcinoma	NIH_MGC_7		NM_004323.4	NP_004314.4	REVIEWED	Ps	0.997	0.997	344	1035	1	1032	345	2	345
RIKEN	BC001936	IRAL009A12	MGC	W01A036K04	pENTR-TOPO	24049		BAG1	573	AAH01936.2	Hs.377484	BCL2-associated athanogene			Lung, small cell carcinoma	NIH_MGC_7		NM_004323.4	NP_004314.4	REVIEWED	Ps	0.997	0.997	344	1035	1	1032	345	2	345
RIKEN	BC067498	IRAK172D13	MGC	W01A036K05	pENTR-TOPO	19236		IL12B	3593	AAH67498.1	Hs.674	Interleukin 12B (natural killer cell stimulatory factor 2, cytotoxic lymphocyte maturation factor 2, p40)			PCR rescued clones	NIH_MGC_195	DH10B	NM_002187.2	NP_002178.2	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC001936	IRAL009A12	MGC	W01A036K06	pENTR-TOPO	24049		BAG1	573	AAH01936.2	Hs.377484	BCL2-associated athanogene			Lung, small cell carcinoma	NIH_MGC_7		NM_004323.4	NP_004314.4	REVIEWED	Ps	0.997	0.997	344	1035	1	1032	345	2	345
RIKEN	BC001936	IRAL009A12	MGC	W01A036K08	pENTR-TOPO	24049		BAG1	573	AAH01936.2	Hs.377484	BCL2-associated athanogene			Lung, small cell carcinoma	NIH_MGC_7		NM_004323.4	NP_004314.4	REVIEWED	Ps	0.997	0.997	344	1035	1	1032	345	2	345
RIKEN	BC000605	IRAL005E24	MGC	W01A036K13	pENTR-TOPO	23558		GRHPR	9380	AAH00605.1	Hs.155742	Glyoxylate reductase/hydroxypyruvate reductase			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_012203.1	NP_036335.1	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC000605	IRAL005E24	MGC	W01A036K15	pENTR-TOPO	23558		GRHPR	9380	AAH00605.1	Hs.155742	Glyoxylate reductase/hydroxypyruvate reductase			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_012203.1	NP_036335.1	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	AK090599	flj0014c20	FLJ	W01A036K17	pENTR-TOPO	6654		SACS	26278	BAC03486.1	Hs.159492	Spastic ataxia of Charlevoix-Saguenay (sacsin)				ASTRO2	EK1	NM_014363.4	NP_055178.3	VALIDATED	P	1.000	1.000	306	984	1	918	4579	424	729
RIKEN	AK055285	flj0008k14	FLJ	W01A036K18	pENTR-TOPO	12371		ETFB	2109	BAG51494.1	Hs.348531	Electron-transfer-flavoprotein, beta polypeptide				FCBBF4	EK1	NM_001014763.1	NP_001014763.1	REVIEWED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	AK055285	flj0008k14	FLJ	W01A036K22	pENTR-TOPO	12371		ETFB	2109	BAG51494.1	Hs.348531	Electron-transfer-flavoprotein, beta polypeptide				FCBBF4	EK1	NM_001014763.1	NP_001014763.1	REVIEWED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	AK090599	flj0014c20	FLJ	W01A036K23	pENTR-TOPO	6654		SACS	26278	BAC03486.1	Hs.159492	Spastic ataxia of Charlevoix-Saguenay (sacsin)				ASTRO2	EK1	NM_014363.4	NP_055178.3	VALIDATED	P	1.000	1.000	306	984	1	918	4579	424	729
RIKEN	BC024229	IRAL038G06	MGC	W01A036L02	pENTR-TOPO	1095		PTGER3	5733	AAH24229.1	Hs.445000	Prostaglandin E receptor 3 (subtype EP3)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_198716.1	NP_942009.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC024229	IRAL038G06	MGC	W01A036L06	pENTR-TOPO	1095		PTGER3	5733	AAH24229.1	Hs.445000	Prostaglandin E receptor 3 (subtype EP3)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_198716.1	NP_942009.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	AK001514	flj0034j01	FLJ	W01A036L11	pENTR-TOPO	5208		C12orf35	55196	BAA91734.1	Hs.445129	Chromosome 12 open reading frame 35	NT2	teratocarcinoma		NT2RP2	EK1	NM_018169.2	NP_060639.2	VALIDATED	Ps	0.997	0.997	363	1092	1	1089	1747	1385	1747
RIKEN	BC010927	IRAL019K12	MGC	W01A036L12	pENTR-TOPO	22772		PDGFRL	5157	AAH10927.1	Hs.458573	Platelet-derived growth factor receptor-like			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006207.1	NP_006198.1	REVIEWED	OK	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	AK095201	flj0024h05	FLJ	W01A036L18	pENTR-TOPO	8112		DYX1C1	161582	BAC04498.1	Hs.126403	Dyslexia susceptibility 1 candidate 1				BRSTN2	EK1	NM_001033559.1	NP_001028731.1	VALIDATED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	AK024328	flj0036l24	FLJ	W01A036L19	pENTR-TOPO	23987		ABCA1	19	BAB14887	Hs.719214	ATP-binding cassette, sub-family A (ABC1), member 1				PLACE1	EK1	NM_005502.2	NP_005493.2	REVIEWED	Ps	0.996	0.996	240	1092	1	720	2261	1	240
RIKEN	AK095201	flj0024h05	FLJ	W01A036L20	pENTR-TOPO	8112		DYX1C1	161582	BAC04498.1	Hs.126403	Dyslexia susceptibility 1 candidate 1				BRSTN2	EK1	NM_001033559.1	NP_001028731.1	VALIDATED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC016649	IRAK013F12	MGC	W01A036M02	pENTR-TOPO	24849		EFNB1	1947	AAH16649.1	Hs.144700	Ephrin-B1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004429.4	NP_004420.1	REVIEWED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC058911	IRAK119E22	MGC	W01A036M14	pENTR-TOPO	21864		SFRP4	6424	AAH58911.1	Hs.658169	Secreted frizzled-related protein 4			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003014.3	NP_003005.2	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC036228	IRAK063K01	MGC	W01A036M15	pENTR-TOPO	9202		KCTD13	253980	AAH36228.1	Hs.534590	Potassium channel tetramerisation domain containing 13			Brain, hippocampus	NIH_MGC_95	DH10B	NM_178863.2	NP_849194.1	PROVISIONAL	OK	1.000	1.000	329	990	1	987	329	1	329
RIKEN	BC058911	IRAK119E22	MGC	W01A036M16	pENTR-TOPO	21864		SFRP4	6424	AAH58911.1	Hs.658169	Secreted frizzled-related protein 4			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003014.3	NP_003005.2	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	AK127850	flj0078h08	FLJ	W01A036N02	pENTR-TOPO	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor				PLACE7	EK1	NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	AK098547	flj0061l22	FLJ	W01A036N13	pENTR-TOPO	11629		PRPF31	26121	BAC05329.1	Hs.515598	PRP31 pre-mRNA processing factor 31 homolog (S. cerevisiae)				TST	EK1	NM_015629.3	NP_056444.3	REVIEWED		0.949	0.952	354	1095	1	1062	499	1	353
RIKEN	AK098547	flj0061l22	FLJ	W01A036N15	pENTR-TOPO	11629		PRPF31	26121	BAC05329.1	Hs.515598	PRP31 pre-mRNA processing factor 31 homolog (S. cerevisiae)				TST	EK1	NM_015629.3	NP_056444.3	REVIEWED		0.949	0.952	354	1095	1	1062	499	1	353
RIKEN	BC006327	IRAL017K19	MGC	W01A036N20	pENTR-TOPO	70		PEX14	5195	AAH06327.1	Hs.149983	Peroxisomal biogenesis factor 14			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004565.2	NP_004556.1	REVIEWED	C	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	BC006327	IRAL017K19	MGC	W01A036N24	pENTR-TOPO	70		PEX14	5195	AAH06327.1	Hs.149983	Peroxisomal biogenesis factor 14			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004565.2	NP_004556.1	REVIEWED	C	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	BC002399	IRAL001H08	MGC	W01A036O05	pENTR-TOPO	82		NUDC	10726	AAH02399.1	Hs.263812	Nuclear distribution gene C homolog (A. nidulans)			Lung, small cell carcinoma	NIH_MGC_7		NM_006600.2	NP_006591.1	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
RIKEN	BC047618	IRAK090L04	MGC	W01A036O13	pENTR-TOPO	16788		B3GALNT1	8706	AAH47618.1	Hs.418062	Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003781.3	NP_003772.1	REVIEWED	C	1.000	1.000	331	996	1	993	331	1	331
RIKEN	AK002182	flj0038c08	FLJ	W01A036O20	pENTR-TOPO	3846		SLC35C1	55343	BAA92126.1	Hs.12211	Solute carrier family 35, member C1				PLACE1	EK1	NM_001145266.1	NP_001138738.1	REVIEWED	Cs	0.997	0.997	351	1056	1	1053	351	1	351
RIKEN	AK002182	flj0038c08	FLJ	W01A036O22	pENTR-TOPO	3846		SLC35C1	55343	BAA92126.1	Hs.12211	Solute carrier family 35, member C1				PLACE1	EK1	NM_001145266.1	NP_001138738.1	REVIEWED	Cs	0.997	0.997	351	1056	1	1053	351	1	351
RIKEN	BC041164	IRAK084M05	MGC	W01A036P01	pENTR-TOPO	3705		SMPD1	6609	AAH41164.1	Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000543.3	NP_000534.3	REVIEWED	Pg	0.995	1.000	364	1095	1	1086	631	1	364
RIKEN	BC041164	IRAK084M05	MGC	W01A036P05	pENTR-TOPO	3705		SMPD1	6609	AAH41164.1	Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000543.3	NP_000534.3	REVIEWED	Pg	0.995	1.000	364	1095	1	1086	631	1	364
RIKEN	AK024131	flj0030o07	FLJ	W01A037B01	pENTR-TOPO	10215		SMG6	23293	BAB14835.1	Hs.448342	Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans)				HEMBB1	EK1	NM_017575.4	NP_060045.4	VALIDATED	Ps	0.998	0.998	402	1236	1	1206	1419	32	433
RIKEN	AK024131	flj0030o07	FLJ	W01A037B05	pENTR-TOPO	10215		SMG6	23293	BAB14835.1	Hs.448342	Smg-6 homolog, nonsense mediated mRNA decay factor (C. elegans)				HEMBB1	EK1	NM_017575.4	NP_060045.4	VALIDATED	Ps	0.998	0.998	402	1236	1	1206	1419	32	433
RIKEN	BC009781	IRAL019A03	MGC	W01A037C03	pENTR-TOPO	16216		RNF13	11342	AAH09781.1	Hs.12333	Ring finger protein 13			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_183381.2	NP_899237.1	REVIEWED	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	BC027040	IRAK042D20	MGC	W01A037C12	pENTR-TOPO	1857		SNIP1	79753	AAH27040.1	Hs.471951	Smad nuclear interacting protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_024700.2	NP_078976.2	PROVISIONAL	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	BC069192	IRAL054D11	MGC	W01A037C18	pENTR-TOPO	19838		WTAP	9589	AAH69192.1	Hs.710715	Wilms tumor 1 associated protein			Placenta, choriocarcinoma	NIH_MGC_21		NM_004906.3	NP_004897.2	REVIEWED	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	BC069192	IRAL054D11	MGC	W01A037C20	pENTR-TOPO	19838		WTAP	9589	AAH69192.1	Hs.710715	Wilms tumor 1 associated protein			Placenta, choriocarcinoma	NIH_MGC_21		NM_004906.3	NP_004897.2	REVIEWED	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	BC029121	IRAK050I08	MGC	W01A037C21	pENTR-TOPO	12709		IL12RB1	3594	AAH29121.1	Hs.567294	Interleukin 12 receptor, beta 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153701.1	NP_714912.1	REVIEWED	Cs	0.997	0.997	381	1146	1	1143	381	1	381
RIKEN	AK022927	flj0033f22	FLJ	W01A037D12	pENTR-TOPO	5351		CMAS	55907	BAB14311.1	Hs.311346	Cytidine monophosphate N-acetylneuraminic acid synthetase	NT2	teratocarcinoma		NT2RP2	EK1	NM_018686.3	NP_061156.1	REVIEWED	C	1.000	1.000	434	1305	1	1302	434	1	434
RIKEN	BC026329	IRAK032D24	MGC	W01A037E01	pENTR-TOPO	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000165.3	NP_000156.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC026329	IRAK032D24	MGC	W01A037E03	pENTR-TOPO	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000165.3	NP_000156.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC026329	IRAK032D24	MGC	W01A037E07	pENTR-TOPO	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000165.3	NP_000156.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC013586	IRAK014F17	MGC	W01A037E12	pENTR-TOPO	11577		PRKCSH	5589	AAH13586.2	Hs.610830	Protein kinase C substrate 80K-H				NIH_MGC_69	DH10B	NM_001001329.1	NP_001001329.1	REVIEWED	Pgs	0.972	0.982	399	1197	1	1194	525	130	525
RIKEN	BC032850	IRAK047N13	MGC	W01A037E20	pENTR-TOPO	9794		CTNS	1497	AAH32850.1	Hs.187667	Cystinosis, nephropathic			Testis	NIH_MGC_97	DH10B	NM_001031681.2	NP_001026851.2	VALIDATED	Cs	0.998	0.998	400	1203	1	1200	400	1	400
RIKEN	BC032850	IRAK047N13	MGC	W01A037E24	pENTR-TOPO	9794		CTNS	1497	AAH32850.1	Hs.187667	Cystinosis, nephropathic			Testis	NIH_MGC_97	DH10B	NM_001031681.2	NP_001026851.2	VALIDATED	Cs	0.998	0.998	400	1203	1	1200	400	1	400
RIKEN	AK131568	flj0079g05	FLJ	W01A037F06	pENTR-TOPO	9562		ERBB2	2064	BAD18701	Hs.446352	V-erb-b2 erythroblastic leukemia viral oncogene homolog 2, neuro/glioblastoma derived oncogene homolog (avian)				TRACH3	EK1	NM_001005862.1	NP_001005862.1	REVIEWED	Pgs	0.929	0.995	407	1308	82	1302	1225	475	854
RIKEN	AK000046	flj0050l23	FLJ	W01A037F07	pENTR-TOPO	4606		SUV420H1	51111	BAA90905.1	Hs.632120	Suppressor of variegation 4-20 homolog 1 (Drosophila)				COL	EK1	NM_017635.3	NP_060105.3	REVIEWED	Ps	0.998	0.998	414	1245	1	1242	885	472	885
RIKEN	AK000302	flj0051g22	FLJ	W01A037F12	pENTR-TOPO	13783		ITSN2	50618	BAA91068.1	Hs.432562	Intersectin 2	HepG2	hepatoma		HEP	EK1	NM_019595.3	NP_062541.3	REVIEWED	P	1.000	1.000	436	1311	1	1308	1670	1235	1670
RIKEN	AK000302	flj0051g22	FLJ	W01A037F14	pENTR-TOPO	13783		ITSN2	50618	BAA91068.1	Hs.432562	Intersectin 2	HepG2	hepatoma		HEP	EK1	NM_019595.3	NP_062541.3	REVIEWED	P	1.000	1.000	436	1311	1	1308	1670	1235	1670
RIKEN	AK000302	flj0051g22	FLJ	W01A037F16	pENTR-TOPO	13783		ITSN2	50618	BAA91068.1	Hs.432562	Intersectin 2	HepG2	hepatoma		HEP	EK1	NM_019595.3	NP_062541.3	REVIEWED	P	1.000	1.000	436	1311	1	1308	1670	1235	1670
RIKEN	BC000722	IRAL007O04	MGC	W01A037F17	pENTR-TOPO	20412		NEU1	4758	AAH00722.1	Hs.520037	Sialidase 1 (lysosomal sialidase)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000434.3	NP_000425.1	REVIEWED	OK	1.000	1.000	415	1248	1	1245	415	1	415
RIKEN	BC035695	IRAK079O17	MGC	W01A037F20	pENTR-TOPO	16910		HYAL1	3373	AAH35695.1	Hs.75619	Hyaluronoglucosaminidase 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153281.1	NP_695013.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC036457	IRAK046B20	MGC	W01A037G03	pENTR-TOPO	12930		PNKD	25953	AAH36457.1	Hs.98475	Paroxysmal nonkinesigenic dyskinesia			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015488.4	NP_056303.3	VALIDATED	Cs	0.992	0.992	385	1158	1	1155	385	1	385
RIKEN	BC036457	IRAK046B20	MGC	W01A037G05	pENTR-TOPO	12930		PNKD	25953	AAH36457.1	Hs.98475	Paroxysmal nonkinesigenic dyskinesia			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015488.4	NP_056303.3	VALIDATED	Cs	0.992	0.992	385	1158	1	1155	385	1	385
RIKEN	BC036457	IRAK046B20	MGC	W01A037G07	pENTR-TOPO	12930		PNKD	25953	AAH36457.1	Hs.98475	Paroxysmal nonkinesigenic dyskinesia			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015488.4	NP_056303.3	VALIDATED	Cs	0.992	0.992	385	1158	1	1155	385	1	385
RIKEN	BC017299	IRAL039M14	MGC	W01A037G08	pENTR-TOPO	10668		TRIM47	91107	AAH17299.1	Hs.293660	Tripartite motif-containing 47			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_033452.2	NP_258411.2	VALIDATED	P	1.000	1.000	400	1203	1	1200	638	239	638
RIKEN	BC035745	IRAK079M02	MGC	W01A037G17	pENTR-TOPO	2613		CAMK1D	57118	AAH35745.1	Hs.659517	Calcium/calmodulin-dependent protein kinase ID			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153498.2	NP_705718.1	REVIEWED	C	1.000	1.000	385	1158	1	1155	385	1	385
RIKEN	BC035745	IRAK079M02	MGC	W01A037G19	pENTR-TOPO	2613		CAMK1D	57118	AAH35745.1	Hs.659517	Calcium/calmodulin-dependent protein kinase ID			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153498.2	NP_705718.1	REVIEWED	C	1.000	1.000	385	1158	1	1155	385	1	385
RIKEN	BC035745	IRAK079M02	MGC	W01A037G21	pENTR-TOPO	2613		CAMK1D	57118	AAH35745.1	Hs.659517	Calcium/calmodulin-dependent protein kinase ID			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153498.2	NP_705718.1	REVIEWED	C	1.000	1.000	385	1158	1	1155	385	1	385
RIKEN	BC021709	IRAK033D23	MGC	W01A037H06	pENTR-TOPO	21844		SGCE	8910	AAH21709.1	Hs.371199	Sarcoglycan, epsilon			Testis	NIH_MGC_97	DH10B	NM_003919.2	NP_003910.1	REVIEWED	Cs	0.995	0.995	437	1314	1	1311	437	1	437
RIKEN	BC005896	IRAL021L11	MGC	W01A037H09	pENTR-TOPO	16861		HYAL3	8372	AAH05896.1	Hs.129910	Hyaluronoglucosaminidase 3			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_003549.2	NP_003540.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
RIKEN	BC004433	IRAL001D22	MGC	W01A037H18	pENTR-TOPO	9134		CLN3	1201	AAH04433.1	Hs.628393	Ceroid-lipofuscinosis, neuronal 3			Lung, small cell carcinoma	NIH_MGC_7		NM_001042432.1	NP_001035897.1	REVIEWED	OK	1.000	1.000	438	1317	1	1314	438	1	438
RIKEN	AK090579	flj0014k14	FLJ	W01A037I07	pENTR-TOPO	11173		ESCO1	114799	BAC03483.1	Hs.464733	Establishment of cohesion 1 homolog 1 (S. cerevisiae)				ASTRO2	EK1	NM_052911.2	NP_443143.2	VALIDATED	Ps	0.997	0.997	386	1161	1	1158	840	455	840
RIKEN	BC001280	IRAK004B17	MGC	W01A037I14	pENTR-TOPO	14922		AURKA	6790	AAH01280.1	Hs.250822	Aurora kinase A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198435.1	NP_940837.1	REVIEWED	Cs	0.998	0.998	403	1212	1	1209	403	1	403
RIKEN	AK024883	flj0065m02	FLJ	W01A037I15	pENTR-TOPO	9708		GGNBP2	79893	BAB15031.1	Hs.514116	Gametogenetin binding protein 2				COL	EK1	NM_024835.2	NP_079111.1	VALIDATED	P	1.000	1.000	386	1161	1	1158	697	1	386
RIKEN	BC032449	IRAK064F04	MGC	W01A037I21	pENTR-TOPO	11702		PALM	5064	AAH32449.1	Hs.631841	Paralemmin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002579.2	NP_002570.2	REVIEWED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC032449	IRAK064F04	MGC	W01A037I23	pENTR-TOPO	11702		PALM	5064	AAH32449.1	Hs.631841	Paralemmin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002579.2	NP_002570.2	REVIEWED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC025987	IRAK033G20	MGC	W01A037J01	pENTR-TOPO	21065		SEPT7	989	AAH25987.3	Hs.191346	Septin 7			Testis	NIH_MGC_97	DH10B	NM_001011553.2	NP_001011553.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	436	20	436
RIKEN	AK131432	flj0073k10	FLJ	W01A037J11	pENTR-TOPO	14131		ZNF385B	151126	BAD18578.1	Hs.655005	Zinc finger protein 385B				SYNOV2	EK1	NM_001113397.1	NP_001106868.1	VALIDATED	Ps	0.993	0.993	305	1266	292	1206	395	7	311
RIKEN	AK091227	flj0015a21	FLJ	W01A037K02	pENTR-TOPO	13027		DDX18	8886	BAC03616.1	Hs.363492	DEAD (Asp-Glu-Ala-Asp) box polypeptide 18				CTONG2	EK1	NM_006773.3	NP_006764.3	REVIEWED	Ps	0.985	0.985	408	1227	1	1224	670	263	670
RIKEN	AK091227	flj0015a21	FLJ	W01A037K04	pENTR-TOPO	13027		DDX18	8886	BAC03616.1	Hs.363492	DEAD (Asp-Glu-Ala-Asp) box polypeptide 18				CTONG2	EK1	NM_006773.3	NP_006764.3	REVIEWED	Ps	0.985	0.985	408	1227	1	1224	670	263	670
RIKEN	BC022014	IRAK033J06	MGC	W01A037K11	pENTR-TOPO	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
RIKEN	BC012605	IRAL019C11	MGC	W01A037K20	pENTR-TOPO	20445		RHAG	6005	AAH12605.1	Hs.120950	Rh-associated glycoprotein			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_000324.2	NP_000315.2	REVIEWED	Cs	0.995	0.995	409	1230	1	1227	409	1	409
RIKEN	AK023651	flj0038o11	FLJ	W01A037L03	pENTR-TOPO	3825		C11orf30	56946	BAB14627.1	Hs.352588	Chromosome 11 open reading frame 30				PLACE1	EK1	NM_020193.3	NP_064578.2	VALIDATED	P	1.000	1.000	422	1269	1	1266	1322	901	1322
RIKEN	AK023651	flj0038o11	FLJ	W01A037L05	pENTR-TOPO	3825		C11orf30	56946	BAB14627.1	Hs.352588	Chromosome 11 open reading frame 30				PLACE1	EK1	NM_020193.3	NP_064578.2	VALIDATED	P	1.000	1.000	422	1269	1	1266	1322	901	1322
RIKEN	BC014472	IRAL034L23	MGC	W01A037L06	pENTR-TOPO	6675		EDNRB	1910	AAH14472.1	Hs.82002	Endothelin receptor type B			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_001122659.1	NP_001116131.1	REVIEWED	C	1.000	1.000	442	1329	1	1326	442	1	442
RIKEN	BC062616	IRAK135E18	MGC	W01A037L23	pENTR-TOPO	8754		PSKH1	5681	AAH62616.1	Hs.513683	Protein serine kinase H1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_006742.2	NP_006733.1	VALIDATED	OK	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	AK131460	flj0073f14	FLJ	W01A037M01	pENTR-TOPO	1663		C1orf25	81627	BAD18605.1	Hs.107149	Chromosome 1 open reading frame 25				TESTI4	EK1	NM_030934.4	NP_112196.3	REVIEWED	Pfs	0.934	0.989	391	1173	1	1172	733	157	525
RIKEN	BC065936	IRAK140N22	MGC	W01A037M09	pENTR-TOPO	13766		ST3GAL5	8869	AAH65936.2	Hs.415117	ST3 beta-galactoside alpha-2,3-sialyltransferase 5			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003896.3	NP_003887.3	REVIEWED	Ps	0.997	0.997	390	1173	1	1170	418	29	418
RIKEN	BC013403	IRAL001N01	MGC	W01A037M18	pENTR-TOPO	3173		COX15	1355	AAH13403.1	Hs.28326	COX15 homolog, cytochrome c oxidase assembly protein (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_078470.4	NP_510870.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC022261	IRAL037C11	MGC	W01A037N02	pENTR-TOPO	7425		SERPINA10	51156	AAH22261.1	Hs.118620	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10			Liver	NIH_MGC_76	DH10B	NM_001100607.1	NP_001094077.1	VALIDATED	C	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC022261	IRAL037C11	MGC	W01A037N06	pENTR-TOPO	7425		SERPINA10	51156	AAH22261.1	Hs.118620	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 10			Liver	NIH_MGC_76	DH10B	NM_001100607.1	NP_001094077.1	VALIDATED	C	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC022511	IRAK032J07	MGC	W01A037N09	pENTR-TOPO	17476		EDNRA	1909	AAH22511.1	Hs.183713	Endothelin receptor type A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001957.2	NP_001948.1	VALIDATED	Cs	0.993	0.993	427	1284	1	1281	427	1	427
RIKEN	BC006390	IRAL017H15	MGC	W01A037N10	pENTR-TOPO	7114		MGAT2	4247	AAH06390.1	Hs.93338	Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase			Brain, neuroblastoma	NIH_MGC_19		NM_002408.3	NP_002399.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
RIKEN	BC022511	IRAK032J07	MGC	W01A037N11	pENTR-TOPO	17476		EDNRA	1909	AAH22511.1	Hs.183713	Endothelin receptor type A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001957.2	NP_001948.1	VALIDATED	Cs	0.993	0.993	427	1284	1	1281	427	1	427
RIKEN	BC022511	IRAK032J07	MGC	W01A037N15	pENTR-TOPO	17476		EDNRA	1909	AAH22511.1	Hs.183713	Endothelin receptor type A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001957.2	NP_001948.1	VALIDATED	Cs	0.993	0.993	427	1284	1	1281	427	1	427
RIKEN	BC006390	IRAL017H15	MGC	W01A037N16	pENTR-TOPO	7114		MGAT2	4247	AAH06390.1	Hs.93338	Mannosyl (alpha-1,6-)-glycoprotein beta-1,2-N-acetylglucosaminyltransferase			Brain, neuroblastoma	NIH_MGC_19		NM_002408.3	NP_002399.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
RIKEN	BC022280	IRAL036N23	MGC	W01A037N18	pENTR-TOPO	7412		FBLN5	10516	AAH22280.1	Hs.332708	Fibulin 5			Lung	NIH_MGC_77	DH10B	NM_006329.3	NP_006320.2	REVIEWED	C	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC022280	IRAL036N23	MGC	W01A037N22	pENTR-TOPO	7412		FBLN5	10516	AAH22280.1	Hs.332708	Fibulin 5			Lung	NIH_MGC_77	DH10B	NM_006329.3	NP_006320.2	REVIEWED	C	1.000	1.000	448	1347	1	1344	448	1	448
RIKEN	BC001441	IRAL004D17	MGC	W01A037O02	pENTR-TOPO	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21		NM_032637.2	NP_116026.1	REVIEWED	C	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC009545	IRAK014J17	MGC	W01A037O05	pENTR-TOPO	4889		FEZ1	9638	AAH09545.1	Hs.224008	Fasciculation and elongation protein zeta 1 (zygin I)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_022549.2	NP_072043.1	REVIEWED	C	1.000	1.000	104	1179	1	312	104	1	104
RIKEN	BC009545	IRAK014J17	MGC	W01A037O07	pENTR-TOPO	4889		FEZ1	9638	AAH09545.1	Hs.224008	Fasciculation and elongation protein zeta 1 (zygin I)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_022549.2	NP_072043.1	REVIEWED	C	1.000	1.000	104	1179	1	312	104	1	104
RIKEN	BC002965	IRAL008I10	MGC	W01A037O12	pENTR-TOPO	25371		LAMP2	3920	AAH02965.1	Hs.496684	Lysosomal-associated membrane protein 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_013995.2	NP_054701.1	REVIEWED	C	1.000	1.000	410	1233	1	1230	410	1	410
RIKEN	BC000095	IRAL007O01	MGC	W01A037O20	pENTR-TOPO	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Placenta, choriocarcinoma	NIH_MGC_21		NM_000262.2	NP_000253.1	REVIEWED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	AK075278	flj0049g04	FLJ	W01A037P11	pENTR-TOPO	17399		BMP2K	55589	BAC11515.1	Hs.146551	BMP2 inducible kinase				THYRO1	EK1	NM_017593.3	NP_060063.2	REVIEWED	P	1.000	1.000	429	1290	1	1287	662	234	662
RIKEN	BC015645	IRAL033G10	MGC	W01A038A02	pENTR-TOPO	3754		NDUFV1	4723	AAH15645.1	Hs.7744	NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa			Eye, retinoblastoma	NIH_MGC_16		NM_007103.3	NP_009034.2	VALIDATED	C	1.000	1.000	464	1395	1	1392	464	1	464
RIKEN	BC028138	IRAK062H09	MGC	W01A038A03	pENTR-TOPO	15231		UBASH3A	53347	AAH28138.1	Hs.473912	Ubiquitin associated and SH3 domain containing, A			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001001895.1	NP_001001895.1	VALIDATED	Ps	0.995	0.995	427	1356	1	1281	623	1	427
RIKEN	BC015645	IRAL033G10	MGC	W01A038A04	pENTR-TOPO	3754		NDUFV1	4723	AAH15645.1	Hs.7744	NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa			Eye, retinoblastoma	NIH_MGC_16		NM_007103.3	NP_009034.2	VALIDATED	C	1.000	1.000	464	1395	1	1392	464	1	464
RIKEN	BC015645	IRAL033G10	MGC	W01A038A06	pENTR-TOPO	3754		NDUFV1	4723	AAH15645.1	Hs.7744	NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa			Eye, retinoblastoma	NIH_MGC_16		NM_007103.3	NP_009034.2	VALIDATED	C	1.000	1.000	464	1395	1	1392	464	1	464
RIKEN	AK001072	flj0029h01	FLJ	W01A038A19	pENTR-TOPO	3112		FRMD4A	55691	BAA91492.1	Hs.656573	FERM domain containing 4A				HEMBA1	EK1	NM_018027.3	NP_060497.3	VALIDATED	Ps	0.994	0.994	360	1353	94	1173	1039	16	375
RIKEN	BC042637	IRAK051P13	MGC	W01A038B06	pENTR-TOPO	5633		ACVRL1	94	AAH42637.1	Hs.591026	Activin A receptor type II-like 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001077401.1	NP_001070869.1	REVIEWED	C	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	BC073760	IRAL058A10	MGC	W01A038B07	pENTR-TOPO	6185		KRT8	3856	AAH73760.1	Hs.708445	Keratin 8			Placenta, choriocarcinoma	NIH_MGC_21		NM_002273.3	NP_002264.1	REVIEWED	Cs	0.998	0.998	483	1452	1	1449	483	1	483
RIKEN	BC042637	IRAK051P13	MGC	W01A038B08	pENTR-TOPO	5633		ACVRL1	94	AAH42637.1	Hs.591026	Activin A receptor type II-like 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001077401.1	NP_001070869.1	REVIEWED	C	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	BC080579	IRAL059O17	MGC	W01A038B09	pENTR-TOPO	24623		WDR13	64743	AAH80579.1	Hs.521973	WD repeat domain 13			Ovary, teratocarcinoma	NIH_MGC_109		NM_017883.3	NP_060353.2	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC080574	IRAL059M23	MGC	W01A038B20	pENTR-TOPO	20339		TAPBP	6892	AAH80574.1	Hs.714746	TAP binding protein (tapasin)			Prostate, carcinoma	NIH_MGC_40		NM_172209.1	NP_757346.1	REVIEWED	Ps	0.993	0.993	406	1515	1	1218	412	1	406
RIKEN	BC013875	IRAL014H19	MGC	W01A038C04	pENTR-TOPO	4727		MMP1	4312	AAH13875.1	Hs.83169	Matrix metallopeptidase 1 (interstitial collagenase)			Ovary, adenocarcinoma	NIH_MGC_9		NM_002421.3	NP_002412.1	REVIEWED	C	1.000	1.000	469	1410	1	1407	469	1	469
RIKEN	BC063878	IRAK141M16	MGC	W01A038C05	pENTR-TOPO	23007		MSR1	4481	AAH63878.1	Hs.147635	Macrophage scavenger receptor 1			Testis	NIH_MGC_180	DH10B	NM_138715.2	NP_619729.1	REVIEWED	C	1.000	1.000	451	1356	1	1353	451	1	451
RIKEN	BC013875	IRAL014H19	MGC	W01A038C06	pENTR-TOPO	4727		MMP1	4312	AAH13875.1	Hs.83169	Matrix metallopeptidase 1 (interstitial collagenase)			Ovary, adenocarcinoma	NIH_MGC_9		NM_002421.3	NP_002412.1	REVIEWED	C	1.000	1.000	469	1410	1	1407	469	1	469
RIKEN	BC013875	IRAL014H19	MGC	W01A038C08	pENTR-TOPO	4727		MMP1	4312	AAH13875.1	Hs.83169	Matrix metallopeptidase 1 (interstitial collagenase)			Ovary, adenocarcinoma	NIH_MGC_9		NM_002421.3	NP_002412.1	REVIEWED	C	1.000	1.000	469	1410	1	1407	469	1	469
RIKEN	AK022687	flj0032p11	FLJ	W01A038C09	pENTR-TOPO	21818		MLL3	58508	BAB14179	Hs.647120	Myeloid/lymphoid or mixed-lineage leukemia 3	NT2	teratocarcinoma		NT2RM4	EK1	NM_170606.2	NP_733751.2	REVIEWED	Ps	0.996	0.996	452	1359	1	1356	4911	4460	4911
RIKEN	AK022687	flj0032p11	FLJ	W01A038C13	pENTR-TOPO	21818		MLL3	58508	BAB14179	Hs.647120	Myeloid/lymphoid or mixed-lineage leukemia 3	NT2	teratocarcinoma		NT2RM4	EK1	NM_170606.2	NP_733751.2	REVIEWED	Ps	0.996	0.996	452	1359	1	1356	4911	4460	4911
RIKEN	AK022687	flj0032p11	FLJ	W01A038C15	pENTR-TOPO	21818		MLL3	58508	BAB14179	Hs.647120	Myeloid/lymphoid or mixed-lineage leukemia 3	NT2	teratocarcinoma		NT2RM4	EK1	NM_170606.2	NP_733751.2	REVIEWED	Ps	0.996	0.996	452	1359	1	1356	4911	4460	4911
RIKEN	BC017709	IRAK027J21	MGC	W01A038D02	pENTR-TOPO	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_006595.3	NP_006586.1	VALIDATED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC017709	IRAK027J21	MGC	W01A038D04	pENTR-TOPO	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_006595.3	NP_006586.1	VALIDATED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC003044	IRAL002L09	MGC	W01A038D05	pENTR-TOPO	24254		MAPKAP1	79109	AAH03044.1	Hs.495138	Mitogen-activated protein kinase associated protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_024117.3	NP_077022.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
RIKEN	BC017709	IRAK027J21	MGC	W01A038D08	pENTR-TOPO	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_006595.3	NP_006586.1	VALIDATED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC017962	IRAL036F08	MGC	W01A038D13	pENTR-TOPO	12151		SLC7A9	11136	AAH17962.1	Hs.719221	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 9			Kidney	NIH_MGC_75	DH10B	NM_001126335.1	NP_001119807.1	REVIEWED	C	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	AK093818	flj0021e19	FLJ	W01A038E11	pENTR-TOPO	2598		CDH23	64072	BAC04231.1	Hs.656032	Cadherin-like 23				THYMU2	EK1	NM_022124.4	NP_071407.4	REVIEWED	Pgs	0.979	0.981	428	1368	31	1311	3354	1190	1617
RIKEN	AK027495	flj0032h15	FLJ	W01A038E14	pENTR-TOPO	23463		LRRC8A	56262	BAB55153.1	Hs.643600	Leucine rich repeat containing 8 family, member A	NT2	teratocarcinoma		NT2RM4	EK1	NM_019594.3	NP_062540.2	REVIEWED	P	1.000	1.000	474	1425	1	1422	810	337	810
RIKEN	AK093818	flj0021e19	FLJ	W01A038E15	pENTR-TOPO	2598		CDH23	64072	BAC04231.1	Hs.656032	Cadherin-like 23				THYMU2	EK1	NM_022124.4	NP_071407.4	REVIEWED	Pgs	0.979	0.981	428	1368	31	1311	3354	1190	1617
RIKEN	AK127947	flj0075o14	FLJ	W01A038E17	pENTR-TOPO	15167		SON	6651	BAC87202.1	Hs.517262	SON DNA binding protein				T1ESE2	EK1	NM_032195.1	NP_115571.1	REVIEWED	P	1.000	1.000	166	1365	244	741	2303	2054	2219
RIKEN	BC064391	IRAK139K21	MGC	W01A038E24	pENTR-TOPO	3415		CCDC6	8030	AAH64391.1	Hs.591360	Coiled-coil domain containing 6			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005436.3	NP_005427.2	VALIDATED	Cs	0.998	0.998	474	1425	1	1422	474	1	474
RIKEN	BC001729	IRAL006D01	MGC	W01A038F01	pENTR-TOPO	15859		ALG12	79087	AAH01729.1	Hs.526711	Asparagine-linked glycosylation 12, alpha-1,6-mannosyltransferase homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_024105.3	NP_077010.1	REVIEWED	OK	1.000	1.000	488	1467	1	1464	488	1	488
RIKEN	BC014210	IRAL030P15	MGC	W01A038F10	pENTR-TOPO	15919		ARSA	410	AAH14210.2	Hs.88251	Arylsulfatase A			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001085427.1	NP_001078896.1	REVIEWED	Cs	0.998	0.998	507	1524	1	1521	507	1	507
RIKEN	BC010640	IRAK013I06	MGC	W01A038F17	pENTR-TOPO	23152		STK3	6788	AAH10640.1	Hs.492333	Serine/threonine kinase 3 (STE20 homolog, yeast)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006281.2	NP_006272.2	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
RIKEN	BC044217	IRAK089G16	MGC	W01A038F18	pENTR-TOPO	2217		HMGCS2	3158	AAH44217.1	Hs.59889	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005518.2	NP_005509.1	VALIDATED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC010640	IRAK013I06	MGC	W01A038F21	pENTR-TOPO	23152		STK3	6788	AAH10640.1	Hs.492333	Serine/threonine kinase 3 (STE20 homolog, yeast)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006281.2	NP_006272.2	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
RIKEN	BC044217	IRAK089G16	MGC	W01A038F24	pENTR-TOPO	2217		HMGCS2	3158	AAH44217.1	Hs.59889	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005518.2	NP_005509.1	VALIDATED	C	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC059389	IRAK133O06	MGC	W01A038G06	pENTR-TOPO	18818		GABRG2	2566	AAH59389.1	Hs.7195	Gamma-aminobutyric acid (GABA) A receptor, gamma 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198904.2	NP_944494.1	REVIEWED	Cs	0.998	0.998	475	1428	1	1425	475	1	475
RIKEN	BC010140	IRAL027M22	MGC	W01A038G07	pENTR-TOPO	5771		TNFRSF1A	7132	AAH10140.1	Hs.279594	Tumor necrosis factor receptor superfamily, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001065.2	NP_001056.1	REVIEWED	OK	1.000	1.000	455	1368	1	1365	455	1	455
RIKEN	BC030696	IRAK033A15	MGC	W01A038G09	pENTR-TOPO	18831		GABRA1	2554	AAH30696.1	Hs.175934	Gamma-aminobutyric acid (GABA) A receptor, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000806.5	NP_000797.2	REVIEWED	C	1.000	1.000	456	1371	1	1368	456	1	456
RIKEN	AK095943	flj0024n08	FLJ	W01A038G19	pENTR-TOPO	15506		MYO18B	84700	BAC04656.1	Hs.417959	Myosin XVIIIB				HEART2	EK1	NM_032608.5	NP_115997.5	REVIEWED	P	1.000	1.000	457	1374	1	1371	2567	2111	2567
RIKEN	AK095943	flj0024n08	FLJ	W01A038G23	pENTR-TOPO	15506		MYO18B	84700	BAC04656.1	Hs.417959	Myosin XVIIIB				HEART2	EK1	NM_032608.5	NP_115997.5	REVIEWED	P	1.000	1.000	457	1374	1	1371	2567	2111	2567
RIKEN	BC066549	IRAK139L19	MGC	W01A038G24	pENTR-TOPO	12936		RBM45	129831	AAH66549.1	Hs.377257	RNA binding motif protein 45			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152945.2	NP_694453.2	PROVISIONAL	OK	1.000	1.000	474	1425	1	1422	474	1	474
RIKEN	BC002430	IRAL005C20	MGC	W01A038H04	pENTR-TOPO	9619		ALDH3A2	224	AAH02430.1	Hs.499886	Aldehyde dehydrogenase 3 family, member A2			Skin, melanotic melanoma.	NIH_MGC_20		NM_001031806.1	NP_001026976.1	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC002430	IRAL005C20	MGC	W01A038H06	pENTR-TOPO	9619		ALDH3A2	224	AAH02430.1	Hs.499886	Aldehyde dehydrogenase 3 family, member A2			Skin, melanotic melanoma.	NIH_MGC_20		NM_001031806.1	NP_001026976.1	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC009835	IRAL025B06	MGC	W01A038H15	pENTR-TOPO	19123		ANKH	56172	AAH09835.1	Hs.156727	Ankylosis, progressive homolog (mouse)			Ovary, adenocarcinoma	NIH_MGC_9		NM_054027.4	NP_473368.1	REVIEWED	C	1.000	1.000	492	1479	1	1476	492	1	492
RIKEN	BC004202	IRAL011G21	MGC	W01A038I02	pENTR-TOPO	3739		CHEK1	1111	AAH04202.1	Hs.24529	CHK1 checkpoint homolog (S. pombe)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001274.4	NP_001265.2	VALIDATED	Cs	0.998	0.998	476	1431	1	1428	476	1	476
RIKEN	BC062590	IRAK135I19	MGC	W01A038I09	pENTR-TOPO	21913		POLM	27434	AAH62590.1	Hs.596982	Polymerase (DNA directed), mu			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_013284.2	NP_037416.1	VALIDATED	Cfs	0.925	1.000	494	1374	1	1371	494	1	494
RIKEN	AK094792	flj0045n04	FLJ	W01A038I12	pENTR-TOPO	3836		PRDM11	56981	BAC04425.1	Hs.178715	PR domain containing 11				BRAWH2	EK1	NM_020229.2	NP_064614.2	VALIDATED	Ps	0.998	0.998	477	1434	1	1431	511	35	511
RIKEN	BC002357	IRAL001G20	MGC	W01A038I22	pENTR-TOPO	727		PPOX	5498	AAH02357.1	Hs.517373	Protoporphyrinogen oxidase			Lung, small cell carcinoma	NIH_MGC_7		NM_001122764.1	NP_001116236.1	REVIEWED	OK	1.000	1.000	477	1434	1	1431	477	1	477
RIKEN	BC003062	IRAL007K15	MGC	W01A038J02	pENTR-TOPO	7321		SLC7A7	9056	AAH03062.1	Hs.513147	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7			Placenta, choriocarcinoma	NIH_MGC_21		NM_001126106.1	NP_001119578.1	REVIEWED	C	1.000	1.000	511	1536	1	1533	511	1	511
RIKEN	BC003062	IRAL007K15	MGC	W01A038J06	pENTR-TOPO	7321		SLC7A7	9056	AAH03062.1	Hs.513147	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 7			Placenta, choriocarcinoma	NIH_MGC_21		NM_001126106.1	NP_001119578.1	REVIEWED	C	1.000	1.000	511	1536	1	1533	511	1	511
RIKEN	BC069226	IRAL054N06	MGC	W01A038J11	pENTR-TOPO	22938		TRIM35	23087	AAH69226.1	Hs.104223	Tripartite motif-containing 35			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_171982.3	NP_741983.2	VALIDATED	OK	1.000	1.000	493	1482	1	1479	493	1	493
RIKEN	AK055789	flj0014m11	FLJ	W01A038J12	pENTR-TOPO	21927		ATP6V0A4	50617	BAB71014.1	Hs.98967	ATPase, H+ transporting, lysosomal V0 subunit a4				KIDNE2	EK1	NM_130840.2	NP_570855.2	REVIEWED	Pg	0.760	1.000	675	1542	1	1539	840	166	840
RIKEN	BC069226	IRAL054N06	MGC	W01A038J15	pENTR-TOPO	22938		TRIM35	23087	AAH69226.1	Hs.104223	Tripartite motif-containing 35			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_171982.3	NP_741983.2	VALIDATED	OK	1.000	1.000	493	1482	1	1479	493	1	493
RIKEN	BC068537	IRAK167I18	MGC	W01A038J20	pENTR-TOPO	24029		SPTLC1	10558	AAH68537.1	Hs.90458	Serine palmitoyltransferase, long chain base subunit 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_178324.1	NP_847894.1	REVIEWED	Cs	0.993	0.993	143	1542	1	429	143	1	143
RIKEN	BC068537	IRAK167I18	MGC	W01A038J22	pENTR-TOPO	24029		SPTLC1	10558	AAH68537.1	Hs.90458	Serine palmitoyltransferase, long chain base subunit 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_178324.1	NP_847894.1	REVIEWED	Cs	0.993	0.993	143	1542	1	429	143	1	143
RIKEN	BC068537	IRAK167I18	MGC	W01A038J24	pENTR-TOPO	24029		SPTLC1	10558	AAH68537.1	Hs.90458	Serine palmitoyltransferase, long chain base subunit 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_178324.1	NP_847894.1	REVIEWED	Cs	0.993	0.993	143	1542	1	429	143	1	143
RIKEN	BC039821	IRAK084P16	MGC	W01A038K08	pENTR-TOPO	16402		DIRC2	84925	AAH39821.1	Hs.477346	Disrupted in renal carcinoma 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032839.2	NP_116228.1	REVIEWED	C	1.000	1.000	478	1437	1	1434	478	1	478
RIKEN	BC008692	IRAK013K23	MGC	W01A038K11	pENTR-TOPO	5582		PTPN11	5781	AAH08692.1	Hs.506852	Protein tyrosine phosphatase, non-receptor type 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002834.3	NP_002825.3	REVIEWED	P	1.000	1.000	459	1383	1	1377	593	1	459
RIKEN	BC008692	IRAK013K23	MGC	W01A038K13	pENTR-TOPO	5582		PTPN11	5781	AAH08692.1	Hs.506852	Protein tyrosine phosphatase, non-receptor type 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002834.3	NP_002825.3	REVIEWED	P	1.000	1.000	459	1383	1	1377	593	1	459
RIKEN	BC035882	IRAK078C12	MGC	W01A038L03	pENTR-TOPO	14915		FERMT1	55612	AAH35882.1	Hs.472054	Fermitin family homolog 1 (Drosophila)				NCI_CGAP_Brn67	DH10B	NM_017671.4	NP_060141.3	VALIDATED	P	1.000	1.000	457	1488	1	1371	677	1	457
RIKEN	BC035882	IRAK078C12	MGC	W01A038L07	pENTR-TOPO	14915		FERMT1	55612	AAH35882.1	Hs.472054	Fermitin family homolog 1 (Drosophila)				NCI_CGAP_Brn67	DH10B	NM_017671.4	NP_060141.3	VALIDATED	P	1.000	1.000	457	1488	1	1371	677	1	457
RIKEN	BC001191	IRAL006H15	MGC	W01A038L12	pENTR-TOPO	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_024078.1	NP_076983.1	PROVISIONAL	OK	1.000	1.000	516	1551	1	1548	516	1	516
RIKEN	BC032014	IRAK051N01	MGC	W01A038L13	pENTR-TOPO	13984		SLC19A3	80704	AAH32014.1	Hs.221597	Solute carrier family 19, member 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_025243.3	NP_079519.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC001191	IRAL006H15	MGC	W01A038L14	pENTR-TOPO	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_024078.1	NP_076983.1	PROVISIONAL	OK	1.000	1.000	516	1551	1	1548	516	1	516
RIKEN	BC001191	IRAL006H15	MGC	W01A038L16	pENTR-TOPO	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_024078.1	NP_076983.1	PROVISIONAL	OK	1.000	1.000	516	1551	1	1548	516	1	516
RIKEN	BC036319	IRAK072D10	MGC	W01A038L20	pENTR-TOPO	19167		PDE4D	5144	AAH36319.1	Hs.117545	Phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila)			Testis	NIH_MGC_97	DH10B	NM_001104631.1	NP_001098101.1	VALIDATED	Ps	0.998	0.998	503	1557	46	1554	809	307	809
RIKEN	BC036319	IRAK072D10	MGC	W01A038L22	pENTR-TOPO	19167		PDE4D	5144	AAH36319.1	Hs.117545	Phosphodiesterase 4D, cAMP-specific (phosphodiesterase E3 dunce homolog, Drosophila)			Testis	NIH_MGC_97	DH10B	NM_001104631.1	NP_001098101.1	VALIDATED	Ps	0.998	0.998	503	1557	46	1554	809	307	809
RIKEN	BC008366	IRAL001B06	MGC	W01A038M18	pENTR-TOPO	21983		DDC	1644	AAH08366.1	Hs.359698	Dopa decarboxylase (aromatic L-amino acid decarboxylase)			Lung, small cell carcinoma	NIH_MGC_7		NM_000790.3	NP_000781.1	REVIEWED	C	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC023247	IRAK029A01	MGC	W01A038M23	pENTR-TOPO	572		TOR1AIP1	26092	AAH23247.1	Hs.496459	Torsin A interacting protein 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015602.2	NP_056417.2	VALIDATED	Ps	0.996	0.996	462	1389	1	1386	583	122	583
RIKEN	BC008366	IRAL001B06	MGC	W01A038M24	pENTR-TOPO	21983		DDC	1644	AAH08366.1	Hs.359698	Dopa decarboxylase (aromatic L-amino acid decarboxylase)			Lung, small cell carcinoma	NIH_MGC_7		NM_000790.3	NP_000781.1	REVIEWED	C	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC002959	IRAL008B17	MGC	W01A038N06	pENTR-TOPO	24509		APEX2	27301	AAH02959.1	Hs.659558	APEX nuclease (apurinic/apyrimidinic endonuclease) 2			Lung, small cell carcinoma	NIH_MGC_7		NM_014481.2	NP_055296.2	REVIEWED	OK	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC001233	IRAK004M05	MGC	W01A038N07	pENTR-TOPO	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
RIKEN	BC027624	IRAK046L03	MGC	W01A038N10	pENTR-TOPO	7802		BBS4	585	AAH27624.1	Hs.208681	Bardet-Biedl syndrome 4			Testis	NIH_MGC_97	DH10B	NM_033028.3	NP_149017.2	REVIEWED	Cs	0.996	0.996	519	1560	1	1557	519	1	519
RIKEN	BC027624	IRAK046L03	MGC	W01A038N12	pENTR-TOPO	7802		BBS4	585	AAH27624.1	Hs.208681	Bardet-Biedl syndrome 4			Testis	NIH_MGC_97	DH10B	NM_033028.3	NP_149017.2	REVIEWED	Cs	0.996	0.996	519	1560	1	1557	519	1	519
RIKEN	BC019247	IRAK033K15	MGC	W01A038N13	pENTR-TOPO	24290		SPAG8	26206	AAH19247.1	Hs.256747	Sperm associated antigen 8			Testis	NIH_MGC_97	DH10B	NM_172312.1	NP_758516.1	REVIEWED	Cs	0.996	0.996	501	1506	1	1503	501	1	501
RIKEN	BC027624	IRAK046L03	MGC	W01A038N14	pENTR-TOPO	7802		BBS4	585	AAH27624.1	Hs.208681	Bardet-Biedl syndrome 4			Testis	NIH_MGC_97	DH10B	NM_033028.3	NP_149017.2	REVIEWED	Cs	0.996	0.996	519	1560	1	1557	519	1	519
RIKEN	BC048324	IRAK093F02	MGC	W01A038O12	pENTR-TOPO	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Brain, adult medulla	NIH_MGC_119	DH10B	NM_197978.1	NP_932095.1	VALIDATED	Cgs	0.996	0.998	484	1452	1	1449	484	1	484
RIKEN	BC048324	IRAK093F02	MGC	W01A038O14	pENTR-TOPO	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Brain, adult medulla	NIH_MGC_119	DH10B	NM_197978.1	NP_932095.1	VALIDATED	Cgs	0.996	0.998	484	1452	1	1449	484	1	484
RIKEN	BC027587	IRAK034F05	MGC	W01A038O15	pENTR-TOPO	6661		SUCLA2	8803	AAH27587.1	Hs.546323	Succinate-CoA ligase, ADP-forming, beta subunit			Testis	NIH_MGC_97	DH10B	NM_003850.2	NP_003841.1	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
RIKEN	BC048324	IRAK093F02	MGC	W01A038O16	pENTR-TOPO	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Brain, adult medulla	NIH_MGC_119	DH10B	NM_197978.1	NP_932095.1	VALIDATED	Cgs	0.996	0.998	484	1452	1	1449	484	1	484
RIKEN	AK022677	flj0032h09	FLJ	W01A038P15	pENTR-TOPO	7089		MPP5	64398	BAB14172.1	Hs.652312	Membrane protein, palmitoylated 5 (MAGUK p55 subfamily member 5)	NT2	teratocarcinoma		NT2RM4	EK1	NM_022474.2	NP_071919.2	VALIDATED	Ps	0.998	0.998	503	1512	1	1509	675	173	675
RIKEN	AK074628	flj0017n06	FLJ	W01A039A01	pENTR-TOPO	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18				HEMBB1	EK1	NM_032870.2	NP_116259.2	VALIDATED	P	1.000	1.000	518	1563	1	1554	805	1	518
RIKEN	AK074628	flj0017n06	FLJ	W01A039A05	pENTR-TOPO	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18				HEMBB1	EK1	NM_032870.2	NP_116259.2	VALIDATED	P	1.000	1.000	518	1563	1	1554	805	1	518
RIKEN	BC031244	IRAK063F23	MGC	W01A039A13	pENTR-TOPO	5349		DYRK4	8798	AAH31244.1	Hs.439530	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4			Testis	NIH_MGC_97	DH10B	NM_003845.1	NP_003836.1	PROVISIONAL	OK	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC031244	IRAK063F23	MGC	W01A039A15	pENTR-TOPO	5349		DYRK4	8798	AAH31244.1	Hs.439530	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 4			Testis	NIH_MGC_97	DH10B	NM_003845.1	NP_003836.1	PROVISIONAL	OK	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	BC002676	IRAL012K13	MGC	W01A039B22	pENTR-TOPO	14255		HSPD1	3329	AAH02676.1	Hs.719142	Heat shock 60kDa protein 1 (chaperonin)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_199440.1	NP_955472.1	REVIEWED	C	1.000	1.000	573	1722	1	1719	573	1	573
RIKEN	BC003356	IRAK003G05	MGC	W01A039C10	pENTR-TOPO	1952		GBA	2629	AAH03356.1	Hs.282997	Glucosidase, beta; acid (includes glucosylceramidase)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001005749.1	NP_001005749.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC003663	IRAL003B22	MGC	W01A039C11	pENTR-TOPO	12351		NUP62	23636	AAH03663.1	Hs.574492	Nucleoporin 62kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_153719.2	NP_714941.1	REVIEWED	Cs	0.998	0.998	522	1569	1	1566	522	1	522
RIKEN	BC003356	IRAK003G05	MGC	W01A039C12	pENTR-TOPO	1952		GBA	2629	AAH03356.1	Hs.282997	Glucosidase, beta; acid (includes glucosylceramidase)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001005749.1	NP_001005749.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC003356	IRAK003G05	MGC	W01A039C16	pENTR-TOPO	1952		GBA	2629	AAH03356.1	Hs.282997	Glucosidase, beta; acid (includes glucosylceramidase)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001005749.1	NP_001005749.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	AK131550	flj0079i03	FLJ	W01A039C17	pENTR-TOPO	8664		GPR56	9289	BAD18684.1	Hs.513633	G protein-coupled receptor 56				PROST2	EK1	NM_005682.5	NP_005673.3	REVIEWED	Ps	0.994	0.994	488	1572	106	1569	693	206	693
RIKEN	BC022510	IRAK032J23	MGC	W01A039D08	pENTR-TOPO	19245		TRIM23	373	AAH22510.1	Hs.792	Tripartite motif-containing 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001656.3	NP_001647.1	REVIEWED	OK	1.000	1.000	574	1725	1	1722	574	1	574
RIKEN	AK022854	flj0033l09	FLJ	W01A039D17	pENTR-TOPO	23989		DFNB31	25861	BAB14275.1	Hs.93836	Deafness, autosomal recessive 31	NT2	teratocarcinoma		NT2RP2	EK1	NM_001083885.1	NP_001077354.1	VALIDATED	Ps	0.992	0.992	518	1671	115	1668	524	7	524
RIKEN	BC005140	IRAL007C23	MGC	W01A039D22	pENTR-TOPO	8169		PRC1	9055	AAH05140.1	Hs.567385	Protein regulator of cytokinesis 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_199413.1	NP_955445.1	REVIEWED	Cg	0.950	1.000	606	1731	1	1728	606	1	606
RIKEN	AK022555	flj0032o05	FLJ	W01A039E09	pENTR-TOPO	21013		POM121	9883	BAB14097.1	Hs.655217	POM121 membrane glycoprotein (rat)	NT2	teratocarcinoma		NT2RM2	EK1	NM_172020.1	NP_742017.1	REVIEWED	Ps	0.994	0.994	523	1572	1	1569	984	462	984
RIKEN	BC052608	IRAL047H16	MGC	W01A039E10	pENTR-TOPO	23800		TYRP1	7306	AAH52608.1	Hs.270279	Tyrosinase-related protein 1			Skin, melanoma, melanotic	NIH_MGC_112		NM_000550.2	NP_000541.1	REVIEWED	C	1.000	1.000	537	1614	1	1611	537	1	537
RIKEN	BC052608	IRAL047H16	MGC	W01A039E12	pENTR-TOPO	23800		TYRP1	7306	AAH52608.1	Hs.270279	Tyrosinase-related protein 1			Skin, melanoma, melanotic	NIH_MGC_112		NM_000550.2	NP_000541.1	REVIEWED	C	1.000	1.000	537	1614	1	1611	537	1	537
RIKEN	AK027511	flj0032n16	FLJ	W01A039E17	pENTR-TOPO	17397		NCAPG	64151	BAB55165.1	Hs.567567	Non-SMC condensin I complex, subunit G	NT2	teratocarcinoma		NT2RP1	EK1	NM_022346.3	NP_071741.2	VALIDATED	Ps	0.996	0.996	524	1575	1	1572	1015	492	1015
RIKEN	BC055427	IRAK090L17	MGC	W01A039E18	pENTR-TOPO	16727		TNIK	23043	AAH55427.1	Hs.34024	TRAF2 and NCK interacting kinase			Testis	NIH_MGC_97	DH10B	NM_015028.1	NP_055843.1	PROVISIONAL	Ps	0.998	0.998	538	1617	1	1614	1360	823	1360
RIKEN	AK027511	flj0032n16	FLJ	W01A039E19	pENTR-TOPO	17397		NCAPG	64151	BAB55165.1	Hs.567567	Non-SMC condensin I complex, subunit G	NT2	teratocarcinoma		NT2RP1	EK1	NM_022346.3	NP_071741.2	VALIDATED	Ps	0.996	0.996	524	1575	1	1572	1015	492	1015
RIKEN	AK027511	flj0032n16	FLJ	W01A039E21	pENTR-TOPO	17397		NCAPG	64151	BAB55165.1	Hs.567567	Non-SMC condensin I complex, subunit G	NT2	teratocarcinoma		NT2RP1	EK1	NM_022346.3	NP_071741.2	VALIDATED	Ps	0.996	0.996	524	1575	1	1572	1015	492	1015
RIKEN	AK027511	flj0032n16	FLJ	W01A039E23	pENTR-TOPO	17397		NCAPG	64151	BAB55165.1	Hs.567567	Non-SMC condensin I complex, subunit G	NT2	teratocarcinoma		NT2RP1	EK1	NM_022346.3	NP_071741.2	VALIDATED	Ps	0.996	0.996	524	1575	1	1572	1015	492	1015
RIKEN	BC055427	IRAK090L17	MGC	W01A039E24	pENTR-TOPO	16727		TNIK	23043	AAH55427.1	Hs.34024	TRAF2 and NCK interacting kinase			Testis	NIH_MGC_97	DH10B	NM_015028.1	NP_055843.1	PROVISIONAL	Ps	0.998	0.998	538	1617	1	1614	1360	823	1360
RIKEN	AK023243	flj0035d09	FLJ	W01A039F02	pENTR-TOPO	1863		TRIM45	80263	BAB14484.1	Hs.301526	Tripartite motif-containing 45	NT2	teratocarcinoma		NT2RP3	EK1	NM_025188.3	NP_079464.2	REVIEWED	Cs	0.998	0.998	580	1743	1	1740	580	1	580
RIKEN	BC035972	IRAL041E20	MGC	W01A039F10	pENTR-TOPO	25349		GPC3	2719	AAH35972.1	Hs.644108	Glypican 3			Placenta	NIH_MGC_79	DH10B	NM_004484.2	NP_004475.1	REVIEWED	Cs	0.998	0.998	580	1743	1	1740	580	1	580
RIKEN	BC035972	IRAL041E20	MGC	W01A039F12	pENTR-TOPO	25349		GPC3	2719	AAH35972.1	Hs.644108	Glypican 3			Placenta	NIH_MGC_79	DH10B	NM_004484.2	NP_004475.1	REVIEWED	Cs	0.998	0.998	580	1743	1	1740	580	1	580
RIKEN	BC035972	IRAL041E20	MGC	W01A039F16	pENTR-TOPO	25349		GPC3	2719	AAH35972.1	Hs.644108	Glypican 3			Placenta	NIH_MGC_79	DH10B	NM_004484.2	NP_004475.1	REVIEWED	Cs	0.998	0.998	580	1743	1	1740	580	1	580
RIKEN	BC045642	IRAK077B21	MGC	W01A039F18	pENTR-TOPO	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	Cs	0.997	0.997	582	1749	1	1746	582	1	582
RIKEN	BC060857	IRAK133B19	MGC	W01A039G01	pENTR-TOPO	17590		CYP4V2	285440	AAH60857.1					Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207352.3	NP_997235.3	REVIEWED	Cs	0.998	0.998	525	1578	1	1575	525	1	525
RIKEN	BC068598	IRAK167I17	MGC	W01A039G09	pENTR-TOPO	21803		PRKAG2	51422	AAH68598.1	Hs.647072	Protein kinase, AMP-activated, gamma 2 non-catalytic subunit			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024429.1	NP_077747.1	REVIEWED	C	1.000	1.000	328	1578	592	1575	328	1	328
RIKEN	BC068598	IRAK167I17	MGC	W01A039G11	pENTR-TOPO	21803		PRKAG2	51422	AAH68598.1	Hs.647072	Protein kinase, AMP-activated, gamma 2 non-catalytic subunit			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024429.1	NP_077747.1	REVIEWED	C	1.000	1.000	328	1578	592	1575	328	1	328
RIKEN	BC028983	IRAK042N17	MGC	W01A039G12	pENTR-TOPO	16521		FXR1	8087	AAH28983.1	Hs.478407	Fragile X mental retardation, autosomal homolog 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001013438.1	NP_001013456.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
RIKEN	BC028983	IRAK042N17	MGC	W01A039G16	pENTR-TOPO	16521		FXR1	8087	AAH28983.1	Hs.478407	Fragile X mental retardation, autosomal homolog 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001013438.1	NP_001013456.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
RIKEN	AK074743	flj0018c11	FLJ	W01A039G21	pENTR-TOPO	7370		IPO4	79711	BAC11174.1	Hs.411865	Importin 4	NT2	teratocarcinoma		NT2RM4	EK1	NM_024658.3	NP_078934.3	VALIDATED	Pg	0.996	1.000	525	1578	1	1575	1081	559	1081
RIKEN	AK027484	flj0032i24	FLJ	W01A039H18	pENTR-TOPO	24135		DDX31	64794	BAB55146.1	Hs.660767	DEAD (Asp-Glu-Ala-Asp) box polypeptide 31	NT2	teratocarcinoma		NT2RM4	EK1	NM_138620.1	NP_619526.1	REVIEWED	Cs	0.998	0.998	585	1758	1	1755	585	1	585
RIKEN	AK027484	flj0032i24	FLJ	W01A039H20	pENTR-TOPO	24135		DDX31	64794	BAB55146.1	Hs.660767	DEAD (Asp-Glu-Ala-Asp) box polypeptide 31	NT2	teratocarcinoma		NT2RM4	EK1	NM_138620.1	NP_619526.1	REVIEWED	Cs	0.998	0.998	585	1758	1	1755	585	1	585
RIKEN	BC012099	IRAL029E06	MGC	W01A039I12	pENTR-TOPO	16544		BTD	686	AAH12099.1	Hs.517830	Biotinidase			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000060.2	NP_000051.1	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	BC004207	IRAL011F17	MGC	W01A039I24	pENTR-TOPO	15789		CHEK2	11200	AAH04207.1	Hs.291363	CHK2 checkpoint homolog (S. pombe)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007194.3	NP_009125.1	REVIEWED	OK	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	AK091632	flj0013n20	FLJ	W01A039J13	pENTR-TOPO	14579		PHACTR3	116154	BAG52395.1	Hs.473218	Phosphatase and actin regulator 3				FEBRA2	EK1	NM_183244.1	NP_899067.1	REVIEWED	Cs	0.998	0.998	518	1680	124	1677	518	1	518
RIKEN	BC014044	IRAL028B06	MGC	W01A039J20	pENTR-TOPO	15802		RANGAP1	5905	AAH14044.1	Hs.183800	Ran GTPase activating protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_002883.2	NP_002874.1	REVIEWED	C	1.000	1.000	587	1764	1	1761	587	1	587
RIKEN	BC010708	IRAK013J23	MGC	W01A039J23	pENTR-TOPO	7028		ATL1	51062	AAH10708.2	Hs.584905	Atlastin GTPase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015915.4	NP_056999.2	REVIEWED	Cs	0.996	0.996	558	1677	1	1674	558	1	558
RIKEN	AK056157	flj0002p13	FLJ	W01A039K06	pENTR-TOPO	12965		PARD3B	117583	BAB71106.1	Hs.657382	Par-3 partitioning defective 3 homolog B (C. elegans)	NT2	teratocarcinoma		NT2RI2	EK1	NM_152526.4	NP_689739.4	VALIDATED	Ps	0.994	0.994	480	1638	1	1440	1143	1	480
RIKEN	BC018927	IRAL020A07	MGC	W01A039K13	pENTR-TOPO	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Eye, retinoblastoma	NIH_MGC_16		NM_000520.4	NP_000511.2	REVIEWED	Cs	0.998	0.998	529	1590	1	1587	529	1	529
RIKEN	BC042421	IRAK071C10	MGC	W01A039K17	pENTR-TOPO	24854		GK	2710	AAH42421.1	Hs.1466	Glycerol kinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203391.2	NP_976325.1	REVIEWED	Cs	0.996	0.996	530	1593	1	1590	530	1	530
RIKEN	BC042421	IRAK071C10	MGC	W01A039K21	pENTR-TOPO	24854		GK	2710	AAH42421.1	Hs.1466	Glycerol kinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203391.2	NP_976325.1	REVIEWED	Cs	0.996	0.996	530	1593	1	1590	530	1	530
RIKEN	BC042421	IRAK071C10	MGC	W01A039K23	pENTR-TOPO	24854		GK	2710	AAH42421.1	Hs.1466	Glycerol kinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203391.2	NP_976325.1	REVIEWED	Cs	0.996	0.996	530	1593	1	1590	530	1	530
RIKEN	AK056122	flj0002f05	FLJ	W01A039L09	pENTR-TOPO	20352		SYNE1	23345	BAB71097.1	Hs.12967	Spectrin repeat containing, nuclear envelope 1	NT2	teratocarcinoma		NT2RI2	EK1	NM_033071.2	NP_149062.1	REVIEWED	Ps	0.996	0.996	559	1683	1	1677	8749	2926	3484
RIKEN	BC040609	IRAK088C07	MGC	W01A039L18	pENTR-TOPO	16269		SENP2	59343	AAH40609.1	Hs.401388	SUMO1/sentrin/SMT3 specific peptidase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021627.2	NP_067640.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
RIKEN	BC073963	IRAK174A04	MGC	W01A039M08	pENTR-TOPO	9675		SUPT6H	6830	AAH73963.1	Hs.250429	Suppressor of Ty 6 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_003170.3	NP_003161.2	VALIDATED	Ps	0.998	0.998	517	1638	85	1635	1726	1210	1726
RIKEN	BC002592	IRAL004H16	MGC	W01A039N09	pENTR-TOPO	5776		SLC11A2	4891	AAH02592.1	Hs.505545	Solute carrier family 11 (proton-coupled divalent metal ion transporters), member 2			Brain, neuroblastoma	NIH_MGC_19		NM_000617.2	NP_000608.1	VALIDATED	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	AK094715	flj0042k02	FLJ	W01A039N16	pENTR-TOPO	19993		FLJ37396	285754	BAC04406.1	Hs.652880	Hypothetical protein FLJ37396				BRAMY2	EK1	XM_001722396.1	XP_001722448.1	MODEL	Pgs	0.979	0.984	567	1779	85	1776	1151	585	1151
RIKEN	BC030592	IRAK034K17	MGC	W01A039N17	pENTR-TOPO	13372		AGFG1	3267	AAH30592.1	Hs.352962	ArfGAP with FG repeats 1			Testis	NIH_MGC_97	DH10B	NM_004504.4	NP_004495.2	REVIEWED	C	1.000	1.000	562	1689	1	1686	562	1	562
RIKEN	BC030592	IRAK034K17	MGC	W01A039N23	pENTR-TOPO	13372		AGFG1	3267	AAH30592.1	Hs.352962	ArfGAP with FG repeats 1			Testis	NIH_MGC_97	DH10B	NM_004504.4	NP_004495.2	REVIEWED	C	1.000	1.000	562	1689	1	1686	562	1	562
RIKEN	AK074663	flj0017d16	FLJ	W01A039P09	pENTR-TOPO	14612		CTNNBL1	56259	BAC11121.1	Hs.472667	Catenin, beta like 1				MAMMA1	EK1	NM_030877.3	NP_110517.2	REVIEWED	Cs	0.998	0.998	563	1692	1	1689	563	1	563
RIKEN	AK024189	flj0031e08	FLJ	W01A040A08	pENTR-TOPO	18511		ANKHD1	54882	BAB14849.1	Hs.594084	Ankyrin repeat and KH domain containing 1				MAMMA1	EK1	NM_017747.1	NP_060217.1	REVIEWED	P	1.000	1.000	602	1860	1	1806	2542	1566	2167
RIKEN	AK092765	flj0008j02	FLJ	W01A040A20	pENTR-TOPO	19263		CLINT1	9685	BAC03971.1	Hs.711787	Clathrin interactor 1				SMINT2	EK1	NM_014666.2	NP_055481.1	VALIDATED	Pgs	0.970	0.998	625	1878	1	1875	625	19	625
RIKEN	AK127248	flj0074m15	FLJ	W01A040A21	pENTR-TOPO	19134		SH3TC2	79628	BAC86899.1	Hs.483784	SH3 domain and tetratricopeptide repeats 2				BRHIP3	EK1	NM_024577.3	NP_078853.2	REVIEWED	Pfs	0.940	1.000	597	1791	1	1790	1288	454	1014
RIKEN	AK127248	flj0074m15	FLJ	W01A040A23	pENTR-TOPO	19134		SH3TC2	79628	BAC86899.1	Hs.483784	SH3 domain and tetratricopeptide repeats 2				BRHIP3	EK1	NM_024577.3	NP_078853.2	REVIEWED	Pfs	0.940	1.000	597	1791	1	1790	1288	454	1014
RIKEN	BC030977	IRAL041F01	MGC	W01A040B01	pENTR-TOPO	17472		SLC4A4	8671	AAH30977.1	Hs.5462	Solute carrier family 4, sodium bicarbonate cotransporter, member 4			Kidney	NIH_MGC_75	DH10B	NM_003759.3	NP_003750.1	REVIEWED	P	1.000	1.000	590	1941	1	1770	1035	1	590
RIKEN	BC030977	IRAL041F01	MGC	W01A040B05	pENTR-TOPO	17472		SLC4A4	8671	AAH30977.1	Hs.5462	Solute carrier family 4, sodium bicarbonate cotransporter, member 4			Kidney	NIH_MGC_75	DH10B	NM_003759.3	NP_003750.1	REVIEWED	P	1.000	1.000	590	1941	1	1770	1035	1	590
RIKEN	BC030977	IRAL041F01	MGC	W01A040B07	pENTR-TOPO	17472		SLC4A4	8671	AAH30977.1	Hs.5462	Solute carrier family 4, sodium bicarbonate cotransporter, member 4			Kidney	NIH_MGC_75	DH10B	NM_003759.3	NP_003750.1	REVIEWED	P	1.000	1.000	590	1941	1	1770	1035	1	590
RIKEN	AK057403	flj0005i22	FLJ	W01A040B13	pENTR-TOPO	9759		ASPSCR1	79058	BAB71472.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1				TESTI2	EK1	NM_024083.2	NP_076988.1	REVIEWED	Cg	0.855	1.000	647	1944	1	1941	553	1	553
RIKEN	BC036472	IRAK073C09	MGC	W01A040B20	pENTR-TOPO	8950		PRKCB	5579	AAH36472.1	Hs.460355	Protein kinase C, beta			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002738.6	NP_002729.2	REVIEWED	C	1.000	1.000	673	2022	1	2019	673	1	673
RIKEN	AK001617	flj0035n19	FLJ	W01A040C15	pENTR-TOPO	18554		SNCAIP	9627	BAA91791.1	Hs.426463	Synuclein, alpha interacting protein	NT2	teratocarcinoma		NT2RP3	EK1	NM_005460.2	NP_005451.2	REVIEWED	Ps	0.998	0.998	546	1794	1	1638	919	373	918
RIKEN	AK092883	flj0009g05	FLJ	W01A040C18	pENTR-TOPO	3331		PIK3AP1	118788	BAC03996.1	Hs.310456	Phosphoinositide-3-kinase adaptor protein 1				SPLEN2	EK1	NM_152309.2	NP_689522.2	VALIDATED	Ps	0.998	0.998	627	1884	1	1881	805	179	805
RIKEN	AK092883	flj0009g05	FLJ	W01A040C20	pENTR-TOPO	3331		PIK3AP1	118788	BAC03996.1	Hs.310456	Phosphoinositide-3-kinase adaptor protein 1				SPLEN2	EK1	NM_152309.2	NP_689522.2	VALIDATED	Ps	0.998	0.998	627	1884	1	1881	805	179	805
RIKEN	AK092883	flj0009g05	FLJ	W01A040C22	pENTR-TOPO	3331		PIK3AP1	118788	BAC03996.1	Hs.310456	Phosphoinositide-3-kinase adaptor protein 1				SPLEN2	EK1	NM_152309.2	NP_689522.2	VALIDATED	Ps	0.998	0.998	627	1884	1	1881	805	179	805
RIKEN	BC001052	IRAL002D13	MGC	W01A040D07	pENTR-TOPO	6199		RECQL	5965	AAH01052.1	Hs.235069	RecQ protein-like (DNA helicase Q1-like)			Lung, small cell carcinoma	NIH_MGC_7		NM_002907.3	NP_002898.2	REVIEWED	Cs	0.998	0.998	649	1950	1	1947	649	1	649
RIKEN	BC013277	IRAL024D13	MGC	W01A040D19	pENTR-TOPO	22920		RECQL4	9401	AAH13277.2	Hs.31442	RecQ protein-like 4			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_004260.2	NP_004251.2	VALIDATED	P	1.000	1.000	652	1959	1	1956	1208	557	1208
RIKEN	BC001104	IRAL007G15	MGC	W01A040E07	pENTR-TOPO	6415		NUPL1	9818	AAH01104.1	Hs.719291	Nucleoporin like 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014089.3	NP_054808.1	REVIEWED	C	1.000	1.000	599	1800	1	1797	599	1	599
RIKEN	BC029840	IRAK051K17	MGC	W01A040E11	pENTR-TOPO	23782		PTGS1	5742	AAH29840.1	Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000962.2	NP_000953.2	REVIEWED	Cs	0.998	0.998	599	1800	1	1797	599	1	599
RIKEN	BC000450	IRAL001F09	MGC	W01A040F02	pENTR-TOPO	246		GNPAT	8443	AAH00450.1	Hs.498028	Glyceronephosphate O-acyltransferase			Lung, small cell carcinoma	NIH_MGC_7		NM_014236.3	NP_055051.1	REVIEWED	Cs	0.999	0.999	680	2043	1	2040	680	1	680
RIKEN	BC000450	IRAL001F09	MGC	W01A040F06	pENTR-TOPO	246		GNPAT	8443	AAH00450.1	Hs.498028	Glyceronephosphate O-acyltransferase			Lung, small cell carcinoma	NIH_MGC_7		NM_014236.3	NP_055051.1	REVIEWED	Cs	0.999	0.999	680	2043	1	2040	680	1	680
RIKEN	BC038292	IRAK033H04	MGC	W01A040F17	pENTR-TOPO	20598		SRPK1	6732	AAH38292.1	Hs.443861	SFRS protein kinase 1			Testis	NIH_MGC_97	DH10B	NM_003137.3	NP_003128.3	REVIEWED	Cs	0.998	0.998	655	1968	1	1965	655	1	655
RIKEN	BC042612	IRAK071E06	MGC	W01A040G04	pENTR-TOPO	3094		SORBS1	10580	AAH42612.1	Hs.719081	Sorbin and SH3 domain containing 1			Testis	NIH_MGC_97	DH10B	NM_006434.2	NP_006425.2	VALIDATED	Pg	0.783	1.000	567	1887	1	1701	684	1	444
RIKEN	BC006551	IRAL002H02	MGC	W01A040G05	pENTR-TOPO	12676		LMNB2	84823	AAH06551.1	Hs.538286	Lamin B2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032737.2	NP_116126.2	REVIEWED	OK	1.000	1.000	600	1803	1	1800	600	1	600
RIKEN	BC010621	IRAK013M05	MGC	W01A040G22	pENTR-TOPO	5590		PEX5	5830	AAH10621.1	Hs.567327	Peroxisomal biogenesis factor 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000319.4	NP_000310.2	REVIEWED	OK	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC002445	IRAL005O02	MGC	W01A040H01	pENTR-TOPO	809		CPT2	1376	AAH02445.1	Hs.713535	Carnitine palmitoyltransferase 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_000098.2	NP_000089.1	REVIEWED	Cs	0.995	0.995	658	1977	1	1974	658	1	658
RIKEN	BC022386	IRAL036E15	MGC	W01A040H10	pENTR-TOPO	12935		SLC3A1	6519	AAH22386.1	Hs.112916	Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1			Kidney	NIH_MGC_75	DH10B	NM_000341.3	NP_000332.2	REVIEWED	Cs	0.999	0.999	685	2058	1	2055	685	1	685
RIKEN	BC014271	IRAL014I16	MGC	W01A040H13	pENTR-TOPO	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Placenta, choriocarcinoma	NIH_MGC_21		NM_001114753.1	NP_001108225.1	REVIEWED	Cs	0.998	0.998	658	1977	1	1974	658	1	658
RIKEN	BC014271	IRAL014I16	MGC	W01A040H15	pENTR-TOPO	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Placenta, choriocarcinoma	NIH_MGC_21		NM_001114753.1	NP_001108225.1	REVIEWED	Cs	0.998	0.998	658	1977	1	1974	658	1	658
RIKEN	BC022386	IRAL036E15	MGC	W01A040H16	pENTR-TOPO	12935		SLC3A1	6519	AAH22386.1	Hs.112916	Solute carrier family 3 (cystine, dibasic and neutral amino acid transporters, activator of cystine, dibasic and neutral amino acid transport), member 1			Kidney	NIH_MGC_75	DH10B	NM_000341.3	NP_000332.2	REVIEWED	Cs	0.999	0.999	685	2058	1	2055	685	1	685
RIKEN	AK125448	flj0069k12	FLJ	W01A040I14	pENTR-TOPO	23962		SETX	23064	BAC86166.1	Hs.460317	Senataxin				OCBBF2	EK1	NM_015046.5	NP_055861.3	REVIEWED	Ps	0.997	0.997	624	1908	1	1872	2677	1	624
RIKEN	BC068530	IRAK168G06	MGC	W01A040I15	pENTR-TOPO	21904		TNPO3	23534	AAH68530	Hs.193613	Transportin 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_012470.2	NP_036602.1	VALIDATED	P	1.000	1.000	605	1818	1	1815	923	1	605
RIKEN	BC035214	IRAK029L11	MGC	W01A040J10	pENTR-TOPO	22063		SRPK2	6733	AAH35214.1	Hs.285197	SFRS protein kinase 2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_182691.1	NP_872633.1	VALIDATED	C	1.000	1.000	688	2067	1	2064	688	1	688
RIKEN	BC036809	IRAK079J04	MGC	W01A040J11	pENTR-TOPO	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.939	0.998	674	1983	10	1911	1344	227	900
RIKEN	BC036809	IRAK079J04	MGC	W01A040J13	pENTR-TOPO	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.939	0.998	674	1983	10	1911	1344	227	900
RIKEN	BC035214	IRAK029L11	MGC	W01A040J16	pENTR-TOPO	22063		SRPK2	6733	AAH35214.1	Hs.285197	SFRS protein kinase 2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_182691.1	NP_872633.1	VALIDATED	C	1.000	1.000	688	2067	1	2064	688	1	688
RIKEN	BC007610	IRAL022N04	MGC	W01A040K08	pENTR-TOPO	4075		SF3B2	10992	AAH07610.1	Hs.406423	Splicing factor 3b, subunit 2, 145kDa			Eye, retinoblastoma	NIH_MGC_16		NM_006842.2	NP_006833.2	REVIEWED	P	1.000	1.000	636	1911	1	1908	895	260	895
RIKEN	BC033637	IRAK069O09	MGC	W01A040K09	pENTR-TOPO	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
RIKEN	BC033637	IRAK069O09	MGC	W01A040K11	pENTR-TOPO	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
RIKEN	AK021452	flj0019j17	FLJ	W01A040L16	pENTR-TOPO	11201		ZNF521	25925	BAB13829.1	Hs.116935	Zinc finger protein 521				HEMBA1	EK1	NM_015461.2	NP_056276.1	VALIDATED	P	1.000	1.000	693	2082	1	2079	1311	619	1311
RIKEN	BC020079	IRAK026G04	MGC	W01A040M01	pENTR-TOPO	1508		LBR	3930	AAH20079.1	Hs.435166	Lamin B receptor			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_194442.1	NP_919424.1	REVIEWED	C	1.000	1.000	615	1848	1	1845	615	1	615
RIKEN	BC020079	IRAK026G04	MGC	W01A040M03	pENTR-TOPO	1508		LBR	3930	AAH20079.1	Hs.435166	Lamin B receptor			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_194442.1	NP_919424.1	REVIEWED	C	1.000	1.000	615	1848	1	1845	615	1	615
RIKEN	BC030530	IRAK064K05	MGC	W01A040M11	pENTR-TOPO	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_172230.2	NP_757385.1	REVIEWED	OK	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	BC030530	IRAK064K05	MGC	W01A040M13	pENTR-TOPO	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_172230.2	NP_757385.1	REVIEWED	OK	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	AK024113	flj0029l17	FLJ	W01A040N02	pENTR-TOPO	7469		C14orf102	55051	BAB14830.1	Hs.528131	Chromosome 14 open reading frame 102				HEMBA1	EK1	NM_017970.2	NP_060440.2	VALIDATED	Ps	0.997	0.997	696	2091	1	2088	1164	469	1164
RIKEN	BC001380	IRAL004I15	MGC	W01A040N03	pENTR-TOPO	18561		SDHA	6389	AAH01380.1	Hs.440475	Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)			Colon, adenocarcinoma	NIH_MGC_15		NM_004168.2	NP_004159.2	REVIEWED	C	1.000	1.000	664	1995	1	1992	664	1	664
RIKEN	AK024113	flj0029l17	FLJ	W01A040N06	pENTR-TOPO	7469		C14orf102	55051	BAB14830.1	Hs.528131	Chromosome 14 open reading frame 102				HEMBA1	EK1	NM_017970.2	NP_060440.2	VALIDATED	Ps	0.997	0.997	696	2091	1	2088	1164	469	1164
RIKEN	AK024113	flj0029l17	FLJ	W01A040N08	pENTR-TOPO	7469		C14orf102	55051	BAB14830.1	Hs.528131	Chromosome 14 open reading frame 102				HEMBA1	EK1	NM_017970.2	NP_060440.2	VALIDATED	Ps	0.997	0.997	696	2091	1	2088	1164	469	1164
RIKEN	BC052990	IRAK110O14	MGC	W01A040O06	pENTR-TOPO	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201281.2	NP_958438.1	REVIEWED	C	1.000	1.000	571	1932	217	1929	571	1	571
RIKEN	AK025916	flj0058i19	FLJ	W01A041A01	pENTR-TOPO	18614		NSD1	64324	BAB15281.1	Hs.106861	Nuclear receptor binding SET domain protein 1				HRC	EK1	NM_172349.2	NP_758859.1	REVIEWED	P	1.000	1.000	699	2100	1	2097	2427	1729	2427
RIKEN	AK025916	flj0058i19	FLJ	W01A041A03	pENTR-TOPO	18614		NSD1	64324	BAB15281.1	Hs.106861	Nuclear receptor binding SET domain protein 1				HRC	EK1	NM_172349.2	NP_758859.1	REVIEWED	P	1.000	1.000	699	2100	1	2097	2427	1729	2427
RIKEN	AK127721	flj0076n05	FLJ	W01A041A06	pENTR-TOPO	6928		TECPR2	9895	BAC87100.1	Hs.195667	Tectonin beta-propeller repeat containing 2	NT2	teratocarcinoma		NT2RP8	EK1	NM_014844.2	NP_055659.1	VALIDATED	Ps	0.998	0.998	611	2202	1	1833	1411	1	611
RIKEN	BC059390	IRAK133E16	MGC	W01A041A22	pENTR-TOPO	18662		SLC26A2	1836	AAH59390.1	Hs.302738	Solute carrier family 26 (sulfate transporter), member 2			Placenta, normal	NIH_MGC_147	DH10B	NM_000112.3	NP_000103.2	REVIEWED	Cs	0.999	0.999	739	2220	1	2217	739	1	739
RIKEN	AK001754	flj0020m21	FLJ	W01A041B05	pENTR-TOPO	1565		NUP133	55746	BAA91885.1	Hs.12457	Nucleoporin 133kDa	NT2	teratocarcinoma		NT2RP4	EK1	NM_018230.2	NP_060700.2	REVIEWED	Ps	0.999	0.999	775	2328	1	2325	1156	382	1156
RIKEN	BC068533	IRAK168P06	MGC	W01A041B10	pENTR-TOPO	2125		SELP	6403	AAH68533.1	Hs.73800	Selectin P (granule membrane protein 140kDa, antigen CD62)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003005.3	NP_002996.2	REVIEWED	Cgs	0.996	0.998	830	2490	1	2487	830	1	830
RIKEN	BC018133	IRAK022I15	MGC	W01A041D08	pENTR-TOPO	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
RIKEN	BC036091	IRAK048K01	MGC	W01A041D14	pENTR-TOPO	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	Ps	0.999	0.999	831	2496	1	2493	1030	1	831
RIKEN	BC070095	IRAK167M15	MGC	W01A041D23	pENTR-TOPO	6963		CPSF2	53981	AAH70095.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	Cs	0.997	0.997	782	2349	1	2346	782	1	782
RIKEN	BC038456	IRAK078I14	MGC	W01A041D24	pENTR-TOPO	6792		RASA3	22821	AAH38456.1	Hs.593075	RAS p21 protein activator 3			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_007368.2	NP_031394.2	REVIEWED	C	1.000	1.000	834	2505	1	2502	834	1	834
RIKEN	BC063458	IRAK135D08	MGC	W01A041E01	pENTR-TOPO	4536		MRE11A	4361	AAH63458.1	Hs.192649	MRE11 meiotic recombination 11 homolog A (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_005591.3	NP_005582.1	REVIEWED	C	1.000	1.000	708	2127	1	2124	708	1	708
RIKEN	BC063458	IRAK135D08	MGC	W01A041E05	pENTR-TOPO	4536		MRE11A	4361	AAH63458.1	Hs.192649	MRE11 meiotic recombination 11 homolog A (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_005591.3	NP_005582.1	REVIEWED	C	1.000	1.000	708	2127	1	2124	708	1	708
RIKEN	BC071670	IRAK166N03	MGC	W01A041E20	pENTR-TOPO	1534		PTPN22	26191	AAH71670.1	Hs.535276	Protein tyrosine phosphatase, non-receptor type 22 (lymphoid)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015967.4	NP_057051.3	REVIEWED	Cgs	0.931	0.999	807	2259	1	2256	807	1	807
RIKEN	BC072681	IRAK174K22	MGC	W01A041F16	pENTR-TOPO	1793		OTUD7B	56957	AAH72681.1	Hs.98322	OTU domain containing 7B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020205.2	NP_064590.2	VALIDATED	OK	1.000	1.000	843	2532	1	2529	843	1	843
RIKEN	BC016276	IRAL008N17	MGC	W01A041F24	pENTR-TOPO	7364		DLGAP5	9787	AAH16276.2	Hs.77695	Discs, large (Drosophila) homolog-associated protein 5			Lung, small cell carcinoma	NIH_MGC_7		NM_014750.4	NP_055565.3	VALIDATED	C	1.000	1.000	846	2541	1	2538	846	1	846
RIKEN	AK127571	flj0077j23	FLJ	W01A041G08	pENTR-TOPO	6537		FREM2	341640	BAC87040.1	Hs.253994	FRAS1 related extracellular matrix protein 2				CTONG2	EK1	NM_207361.4	NP_997244.3	REVIEWED	Ps	0.993	0.993	748	2262	1	2244	3169	1915	2662
RIKEN	BC016052	IRAL034H16	MGC	W01A041G09	pENTR-TOPO	16729		NCKIPSD	51517	AAH16052.1	Hs.655006	NCK interacting protein with SH3 domain			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_184231.1	NP_909119.1	REVIEWED	C	1.000	1.000	715	2148	1	2145	715	1	715
RIKEN	AK092381	flj0010d01	FLJ	W01A041G10	pENTR-TOPO	23497		VLDLR	7436	BAC03874.1	Hs.370422	Very low density lipoprotein receptor				OCBBF2	EK1	NM_003383.3	NP_003374.3	VALIDATED	Cg	0.861	1.000	873	2259	1	2256	873	1	873
RIKEN	AK092381	flj0010d01	FLJ	W01A041G14	pENTR-TOPO	23497		VLDLR	7436	BAC03874.1	Hs.370422	Very low density lipoprotein receptor				OCBBF2	EK1	NM_003383.3	NP_003374.3	VALIDATED	Cg	0.861	1.000	873	2259	1	2256	873	1	873
RIKEN	AK092381	flj0010d01	FLJ	W01A041G16	pENTR-TOPO	23497		VLDLR	7436	BAC03874.1	Hs.370422	Very low density lipoprotein receptor				OCBBF2	EK1	NM_003383.3	NP_003374.3	VALIDATED	Cg	0.861	1.000	873	2259	1	2256	873	1	873
RIKEN	BC006323	IRAL017K11	MGC	W01A041G18	pENTR-TOPO	25167		ABCB7	22	AAH06323.1	Hs.370480	ATP-binding cassette, sub-family B (MDR/TAP), member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004299.3	NP_004290.2	REVIEWED	C	1.000	1.000	753	2262	1	2259	753	1	753
RIKEN	BC006323	IRAL017K11	MGC	W01A041G20	pENTR-TOPO	25167		ABCB7	22	AAH06323.1	Hs.370480	ATP-binding cassette, sub-family B (MDR/TAP), member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004299.3	NP_004290.2	REVIEWED	C	1.000	1.000	753	2262	1	2259	753	1	753
RIKEN	BC015031	IRAK015N04	MGC	W01A041H02	pENTR-TOPO	18491		MATR3	9782	AAH15031.1	Hs.268939	Matrin 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199189.1	NP_954659.1	REVIEWED	C	1.000	1.000	847	2544	1	2541	847	1	847
RIKEN	AK027648	flj0035o04	FLJ	W01A041H09	pENTR-TOPO	1611		LEPRE1	64175	BAB55264.1	Hs.437656	Leucine proline-enriched proteoglycan (leprecan) 1	NT2	teratocarcinoma		NT2RP3	EK1	NM_001146289.1	NP_001139761.1	REVIEWED	Ps	0.994	0.994	695	2415	1	2085	697	1	695
RIKEN	BC012737	IRAL025N15	MGC	W01A041H17	pENTR-TOPO	9191		CLCN7	1186	AAH12737.1	Hs.459649	Chloride channel 7			Skin, melanotic melanoma.	NIH_MGC_20		NM_001287.4	NP_001278.1	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
RIKEN	BC000249	IRAL006G06	MGC	W01A041H20	pENTR-TOPO	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16		NM_001145291.1	NP_001138763.1	REVIEWED	Cs	0.999	0.999	853	2562	1	2559	853	1	853
RIKEN	BC000249	IRAL006G06	MGC	W01A041H22	pENTR-TOPO	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16		NM_001145291.1	NP_001138763.1	REVIEWED	Cs	0.999	0.999	853	2562	1	2559	853	1	853
RIKEN	AK026022	flj0058m14	FLJ	W01A041I10	pENTR-TOPO	14892		CHD6	84181	BAB15325.1	Hs.371979	Chromodomain helicase DNA binding protein 6				HRC	EK1	NM_032221.3	NP_115597.3	REVIEWED	P	1.000	1.000	750	2274	1	2250	2715	778	1527
RIKEN	AK026022	flj0058m14	FLJ	W01A041I14	pENTR-TOPO	14892		CHD6	84181	BAB15325.1	Hs.371979	Chromodomain helicase DNA binding protein 6				HRC	EK1	NM_032221.3	NP_115597.3	REVIEWED	P	1.000	1.000	750	2274	1	2250	2715	778	1527
RIKEN	BC037169	IRAK068G14	MGC	W01A041I18	pENTR-TOPO	16848		PLOD2	5352	AAH37169.1	Hs.477866	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_182943.2	NP_891988.1	REVIEWED	C	1.000	1.000	758	2277	1	2274	758	1	758
RIKEN	BC026035	IRAL042I09	MGC	W01A041J03	pENTR-TOPO	17949		NOP14	8602	AAH26035.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Colon, adenocarcinoma	NIH_MGC_15		NM_003703.1	NP_003694.1	VALIDATED	P	1.000	1.000	771	2421	1	2313	857	1	771
RIKEN	AK127729	flj0076l07	FLJ	W01A041J20	pENTR-TOPO	5422		LRRK2	120892	BAC87105	Hs.187636	Leucine-rich repeat kinase 2	NT2	teratocarcinoma		NT2RP8	EK1	NM_198578.3	NP_940980.3	REVIEWED	Ps	0.999	0.999	859	2613	1	2577	2527	402	1260
RIKEN	BC068555	IRAK168M19	MGC	W01A041K08	pENTR-TOPO	18486		ARHGAP26	23092	AAH68555.1	Hs.654668	Rho GTPase activating protein 26			Placenta, normal	NIH_MGC_147	DH10B	NM_001135608.1	NP_001129080.1	VALIDATED	C	1.000	1.000	759	2280	1	2277	759	1	759
RIKEN	BC039243	IRAK048H18	MGC	W01A041K09	pENTR-TOPO	3107		FGFR2	2263	AAH39243.2	Hs.533683	Fibroblast growth factor receptor 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001144918.1	NP_001138390.1	REVIEWED	C	1.000	1.000	704	2172	58	2169	704	1	704
RIKEN	BC039243	IRAK048H18	MGC	W01A041K13	pENTR-TOPO	3107		FGFR2	2263	AAH39243.2	Hs.533683	Fibroblast growth factor receptor 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001144918.1	NP_001138390.1	REVIEWED	C	1.000	1.000	704	2172	58	2169	704	1	704
RIKEN	BC039243	IRAK048H18	MGC	W01A041K15	pENTR-TOPO	3107		FGFR2	2263	AAH39243.2	Hs.533683	Fibroblast growth factor receptor 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001144918.1	NP_001138390.1	REVIEWED	C	1.000	1.000	704	2172	58	2169	704	1	704
RIKEN	BC035071	IRAK073B06	MGC	W01A041L12	pENTR-TOPO	24068		GABBR2	9568	AAH35071.2	Hs.198612	Gamma-aminobutyric acid (GABA) B receptor, 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005458.6	NP_005449.5	VALIDATED	Ps	0.999	0.999	883	2652	1	2649	941	59	941
RIKEN	AK092284	flj0010a04	FLJ	W01A041L18	pENTR-TOPO	13994		TTN	7273	BAC03850.1	Hs.134602	Titin				NTONG2	EK1	NM_133379.2	NP_596870.2	REVIEWED	Pgs	0.962	0.998	918	2658	1	2655	5604	4687	5604
RIKEN	BC014153	IRAL030A22	MGC	W01A041M02	pENTR-TOPO	16268		ATRIP	84126	AAH14153.2	Hs.694840	ATR interacting protein			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032166.2	NP_115542.2	REVIEWED	Cs	0.999	0.999	764	2295	1	2292	764	1	764
RIKEN	BC030016	IRAK046O14	MGC	W01A041M20	pENTR-TOPO	6964		GPHN	10243	AAH30016.1	Hs.208765	Gephyrin			Testis	NIH_MGC_97	DH10B	NM_020806.4	NP_065857.1	REVIEWED	C	1.000	1.000	769	2310	1	2307	769	1	769
RIKEN	AK001411	flj0033d09	FLJ	W01A041O01	pENTR-TOPO	1770		ASPM	259266	BAA91676.1	Hs.121028	Asp (abnormal spindle) homolog, microcephaly associated (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_018136.4	NP_060606.3	VALIDATED	Ps	0.997	0.997	726	2181	1	2178	3477	2752	3477
RIKEN	AK001411	flj0033d09	FLJ	W01A041O07	pENTR-TOPO	1770		ASPM	259266	BAA91676.1	Hs.121028	Asp (abnormal spindle) homolog, microcephaly associated (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_018136.4	NP_060606.3	VALIDATED	Ps	0.997	0.997	726	2181	1	2178	3477	2752	3477
RIKEN	BC000549	IRAL005C17	MGC	W01A041O14	pENTR-TOPO	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Brain, neuroblastoma	NIH_MGC_19		NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
RIKEN	BC018128	IRAK014I02	MGC	W01A041P09	pENTR-TOPO	22980		FGFR1	2260	AAH18128.1	Hs.264887	Fibroblast growth factor receptor 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015850.3	NP_056934.2	REVIEWED	Cs	0.999	0.999	820	2463	1	2460	820	1	820
RIKEN	BC018128	IRAK014I02	MGC	W01A041P13	pENTR-TOPO	22980		FGFR1	2260	AAH18128.1	Hs.264887	Fibroblast growth factor receptor 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015850.3	NP_056934.2	REVIEWED	Cs	0.999	0.999	820	2463	1	2460	820	1	820
RIKEN	BC038443	IRAK064M01	MGC	W01A042A07	pENTR-TOPO	15226		DIP2A	23181	AAH38443.1	Hs.189585	DIP2 disco-interacting protein 2 homolog A (Drosophila)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_206889.2	NP_996772.1	REVIEWED	C	1.000	1.000	889	2670	1	2667	889	1	889
RIKEN	AK098212	flj0041c13	FLJ	W01A042A17	pENTR-TOPO	1833		HEATR1	55127	BAC05261.1	Hs.708114	HEAT repeat containing 1				UTERU2	EK1	NM_018072.4	NP_060542.4	VALIDATED	Ps	0.992	0.992	897	2694	1	2691	2144	1248	2144
RIKEN	BC069057	IRAK135P21	MGC	W01A042B24	pENTR-TOPO	25097		ZMYM3	9203	AAH69057.1	Hs.522684	Zinc finger, MYM-type 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_005096.2	NP_005087.1	VALIDATED	C	1.000	1.000	1370	4113	1	4110	1370	1	1370
RIKEN	BC040520	IRAK063L07	MGC	W01A042C23	pENTR-TOPO	1372		NPHP4	261734	AAH40520.1	Hs.462348	Nephronophthisis 4			Testis	NIH_MGC_97	DH10B	NM_015102.2	NP_055917.1	REVIEWED	Pg	0.999	1.000	871	2736	1	2610	1426	1	871
RIKEN	AK125781	flj0068h11	FLJ	W01A042D10	pENTR-TOPO	13909		LRPPRC	10128	BAC86287.1	Hs.368084	Leucine-rich PPR-motif containing				TESTI4	EK1	NM_133259.3	NP_573566.2	REVIEWED	Cs	0.998	0.998	1394	4185	1	4182	1394	1	1394
RIKEN	AK098394	flj0052d01	FLJ	W01A042E07	pENTR-TOPO	24536		USP11	8237	-	Hs.171501	Ubiquitin specific peptidase 11				CBR	EK1	NM_004651.3	NP_004642.2	REVIEWED	Ps	0.997	0.997	920	2763	1	2760	963	44	963
RIKEN	BC012787	IRAL025K17	MGC	W01A042G01	pENTR-TOPO	14870		RBM12	10137	AAH12787.1	Hs.246413	RNA binding motif protein 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_006047.4	NP_006038.2	REVIEWED	C	1.000	1.000	932	2799	1	2796	932	1	932
RIKEN	BC012787	IRAL025K17	MGC	W01A042G07	pENTR-TOPO	14870		RBM12	10137	AAH12787.1	Hs.246413	RNA binding motif protein 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_006047.4	NP_006038.2	REVIEWED	C	1.000	1.000	932	2799	1	2796	932	1	932
RIKEN	BC044586	IRAK106N12	MGC	W01A042H07	pENTR-TOPO	10006		DHX8	1659	AAH44586.2	Hs.463105	DEAH (Asp-Glu-Ala-His) box polypeptide 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004941.1	NP_004932.1	REVIEWED	Ps	0.999	0.999	1214	3645	1	3642	1220	7	1220
RIKEN	BC064699	IRAK133F13	MGC	W01A042H19	pENTR-TOPO	16851		STAG1	10274	AAH64699.1	Hs.412586	Stromal antigen 1			Placenta, normal	NIH_MGC_147	DH10B	NM_005862.2	NP_005853.2	REVIEWED	Cg	0.971	1.000	1258	3666	1	3663	1258	1	1258
RIKEN	BC056143	IRAK119F04	MGC	W01A042I09	pENTR-TOPO	6658		DIS3	22894	AAH56143.1	Hs.643464	DIS3 mitotic control homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014953.3	NP_055768.3	VALIDATED	Cs	0.999	0.999	958	2877	1	2874	958	1	958
RIKEN	BC056143	IRAK119F04	MGC	W01A042I11	pENTR-TOPO	6658		DIS3	22894	AAH56143.1	Hs.643464	DIS3 mitotic control homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014953.3	NP_055768.3	VALIDATED	Cs	0.999	0.999	958	2877	1	2874	958	1	958
RIKEN	BC030785	IRAK047O13	MGC	W01A042I18	pENTR-TOPO	22474		XPO7	23039	AAH30785.1	Hs.172685	Exportin 7			Testis	NIH_MGC_97	DH10B	NM_015024.4	NP_055839.3	VALIDATED	Cs	0.998	0.998	1087	3264	1	3261	1087	1	1087
RIKEN	BC033647	IRAK069O18	MGC	W01A042J06	pENTR-TOPO	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	Cs	0.999	0.999	1698	5097	1	5094	1698	1	1698
RIKEN	BC033647	IRAK069O18	MGC	W01A042J08	pENTR-TOPO	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	Cs	0.999	0.999	1698	5097	1	5094	1698	1	1698
RIKEN	BC033647	IRAK069O18	MGC	W01A042J20	pENTR-TOPO	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	Cs	0.999	0.999	1698	5097	1	5094	1698	1	1698
RIKEN	BC035514	IRAK049O22	MGC	W01A042K10	pENTR-TOPO	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Ps	0.998	0.998	1101	3306	1	3303	1124	24	1124
RIKEN	BC035514	IRAK049O22	MGC	W01A042K16	pENTR-TOPO	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Ps	0.998	0.998	1101	3306	1	3303	1124	24	1124
RIKEN	AK126804	flj0075d16	FLJ	W01A042K23	pENTR-TOPO	18494		NIPBL	25836	BAC86701.1	Hs.481927	Nipped-B homolog (Drosophila)				BRACE3	EK1	NM_015384.4	NP_056199.2	REVIEWED	Ps	0.999	0.999	969	2910	1	2907	2697	133	1101
RIKEN	BC032224	IRAK049P01	MGC	W01A042K24	pENTR-TOPO	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide				NCI_CGAP_Brn67	DH10B	NM_002609.3	NP_002600.1	REVIEWED	Cs	0.999	0.999	1106	3321	1	3318	1106	1	1106
RIKEN	AK022967	flj0034i11	FLJ	W01A042M05	pENTR-TOPO	23451		VPS13A	23230	BAB14337.1	Hs.459790	Vacuolar protein sorting 13 homolog A (S. cerevisiae)	NT2	teratocarcinoma		NT2RP2	EK1	NM_001018038.2	NP_001018048.1	REVIEWED	Ps	0.997	0.997	864	2928	1	2592	3069	2200	3063
RIKEN	BC033454	IRAK028H20	MGC	W01A042M06	pENTR-TOPO	18659		FBXO38	81545	AAH33454.1	Hs.483772	F-box protein 38			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_030793.3	NP_110420.3	VALIDATED	Cs	0.997	0.997	1113	3342	1	3339	1113	1	1113
RIKEN	AK022967	flj0034i11	FLJ	W01A042M07	pENTR-TOPO	23451		VPS13A	23230	BAB14337.1	Hs.459790	Vacuolar protein sorting 13 homolog A (S. cerevisiae)	NT2	teratocarcinoma		NT2RP2	EK1	NM_001018038.2	NP_001018048.1	REVIEWED	Ps	0.997	0.997	864	2928	1	2592	3069	2200	3063
RIKEN	BC033776	IRAK068F03	MGC	W01A042M21	pENTR-TOPO	18621		IPO11	51194	AAH33776.1	Hs.482269	Importin 11			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_016338.4	NP_057422.3	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
RIKEN	BC035575	IRAK069F03	MGC	W01A042N21	pENTR-TOPO	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000466.2	NP_000457.1	REVIEWED	C	1.000	1.000	1283	3852	1	3849	1283	1	1283
RIKEN	BC032851	IRAK047O02	MGC	W01A042O05	pENTR-TOPO	16808		CBLB	868	AAH32851.1	Hs.430589	Cas-Br-M (murine) ecotropic retroviral transforming sequence b			Testis	NIH_MGC_97	DH10B	NM_170662.3	NP_733762.2	VALIDATED	Cs	0.999	0.999	982	2949	1	2946	982	1	982
RIKEN	AK026281	flj0059o15	FLJ	W01A042O08	pENTR-TOPO	24136		TRPM6	140803	BAB15429.1	Hs.272225	Transient receptor potential cation channel, subfamily M, member 6				HSI	EK1	NM_017662.4	NP_060132.3	VALIDATED	Ps	0.995	0.995	1107	3402	1	3321	2022	338	1444
RIKEN	BC069268	IRAL054M08	MGC	W01A042O15	pENTR-TOPO	24121		GOLGA2	2801	AAH69268.1	Hs.155827	Golgi autoantigen, golgin subfamily a, 2			Brain, neuroblastoma	NIH_MGC_47		NM_004486.4	NP_004477.3	REVIEWED	P	1.000	1.000	990	2973	1	2970	1002	13	1002
RIKEN	BC032722	IRAK069H20	MGC	W01A043A08	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032722	IRAK069H20	MGC	W01A043A10	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC017502	IRAL034A12	MGC	W01A043A16	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC001472	IRAL004P03	MGC	W01A043B02	pENTR-TOPO	9132		COX4NB	10328	AAH01472.1	Hs.173162	COX4 neighbor			Placenta, choriocarcinoma	NIH_MGC_21		NM_006067.4	NP_006058.1	VALIDATED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC001472	IRAL004P03	MGC	W01A043B04	pENTR-TOPO	9132		COX4NB	10328	AAH01472.1	Hs.173162	COX4 neighbor			Placenta, choriocarcinoma	NIH_MGC_21		NM_006067.4	NP_006058.1	VALIDATED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC002794	IRAL012P03	MGC	W01A043B07	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC020838	IRAL035B23	MGC	W01A043B10	pENTR-TOPO	20096		CLDN20	49861	AAH20838.1	Hs.567491	Claudin 20			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001001346.2	NP_001001346.1	PROVISIONAL	C	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC000666	IRAL005D22	MGC	W01A043B15	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC020838	IRAL035B23	MGC	W01A043B16	pENTR-TOPO	20096		CLDN20	49861	AAH20838.1	Hs.567491	Claudin 20			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001001346.2	NP_001001346.1	PROVISIONAL	C	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC000666	IRAL005D22	MGC	W01A043B17	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC000666	IRAL005D22	MGC	W01A043B19	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC066336	IRAK168D07	MGC	W01A043B22	pENTR-TOPO	13023		PSMD14	10213	AAH66336.1	Hs.567410	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14			Testis	NIH_MGC_97	DH10B	NM_005805.4	NP_005796.1	VALIDATED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC000666	IRAL005D22	MGC	W01A043B23	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC008687	IRAK013L18	MGC	W01A043C01	pENTR-TOPO	19422		NEUROG1	4762	AAH08687.1	Hs.248149	Neurogenin 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006161.2	NP_006152.2	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC017502	IRAL034A12	MGC	W01A043C02	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC017502	IRAL034A12	MGC	W01A043C04	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC017502	IRAL034A12	MGC	W01A043C06	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC008687	IRAK013L18	MGC	W01A043C09	pENTR-TOPO	19422		NEUROG1	4762	AAH08687.1	Hs.248149	Neurogenin 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006161.2	NP_006152.2	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC008687	IRAK013L18	MGC	W01A043C11	pENTR-TOPO	19422		NEUROG1	4762	AAH08687.1	Hs.248149	Neurogenin 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006161.2	NP_006152.2	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC008687	IRAK013L18	MGC	W01A043C13	pENTR-TOPO	19422		NEUROG1	4762	AAH08687.1	Hs.248149	Neurogenin 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006161.2	NP_006152.2	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC008687	IRAK013L18	MGC	W01A043C15	pENTR-TOPO	19422		NEUROG1	4762	AAH08687.1	Hs.248149	Neurogenin 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006161.2	NP_006152.2	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC008687	IRAK013L18	MGC	W01A043C17	pENTR-TOPO	19422		NEUROG1	4762	AAH08687.1	Hs.248149	Neurogenin 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006161.2	NP_006152.2	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC017502	IRAL034A12	MGC	W01A043C18	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC000363	IRAL001O21	MGC	W01A043C19	pENTR-TOPO	21187		REPIN1	29803	AAH00363.2	Hs.647086	Replication initiator 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_013400.3	NP_037532.2	VALIDATED	OK	1.000	1.000	567	1704	1	1701	567	1	567
RIKEN	BC000363	IRAL001O21	MGC	W01A043C23	pENTR-TOPO	21187		REPIN1	29803	AAH00363.2	Hs.647086	Replication initiator 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_013400.3	NP_037532.2	VALIDATED	OK	1.000	1.000	567	1704	1	1701	567	1	567
RIKEN	BC066336	IRAK168D07	MGC	W01A043D02	pENTR-TOPO	13023		PSMD14	10213	AAH66336.1	Hs.567410	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14			Testis	NIH_MGC_97	DH10B	NM_005805.4	NP_005796.1	VALIDATED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC000666	IRAL005D22	MGC	W01A043D05	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC066336	IRAK168D07	MGC	W01A043D06	pENTR-TOPO	13023		PSMD14	10213	AAH66336.1	Hs.567410	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14			Testis	NIH_MGC_97	DH10B	NM_005805.4	NP_005796.1	VALIDATED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC066336	IRAK168D07	MGC	W01A043D08	pENTR-TOPO	13023		PSMD14	10213	AAH66336.1	Hs.567410	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14			Testis	NIH_MGC_97	DH10B	NM_005805.4	NP_005796.1	VALIDATED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC000666	IRAL005D22	MGC	W01A043D09	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC066336	IRAK168D07	MGC	W01A043D10	pENTR-TOPO	13023		PSMD14	10213	AAH66336.1	Hs.567410	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 14			Testis	NIH_MGC_97	DH10B	NM_005805.4	NP_005796.1	VALIDATED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC002443	IRAL005M10	MGC	W01A043D12	pENTR-TOPO	12663		TMED1	11018	AAH02443.1	Hs.515139	Transmembrane emp24 protein transport domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_006858.2	NP_006849.1	REVIEWED	C	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC000666	IRAL005D22	MGC	W01A043D13	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC035657	IRAK079E17	MGC	W01A043D16	pENTR-TOPO	11971		FFAR3	2865	AAH35657.1	Hs.248055	Free fatty acid receptor 3			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_005304.3	NP_005295.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC000666	IRAL005D22	MGC	W01A043D17	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC000666	IRAL005D22	MGC	W01A043D19	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC035657	IRAK079E17	MGC	W01A043D20	pENTR-TOPO	11971		FFAR3	2865	AAH35657.1	Hs.248055	Free fatty acid receptor 3			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_005304.3	NP_005295.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	AK096878	flj0039l06	FLJ	W01A043E01	pENTR-TOPO	19908		VGLL2	245806	BAC04881.1	Hs.99324	Vestigial like 2 (Drosophila)				SKMUS2	EK1	NM_182645.2	NP_872586.1	PROVISIONAL	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC017502	IRAL034A12	MGC	W01A043E04	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032354	IRAK064M16	MGC	W01A043E07	pENTR-TOPO	7358		ASB2	51676	AAH32354.1	Hs.510327	Ankyrin repeat and SOCS box-containing 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_016150.3	NP_057234.2	REVIEWED	C	1.000	1.000	587	1764	1	1761	587	1	587
RIKEN	BC017502	IRAL034A12	MGC	W01A043E08	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032354	IRAK064M16	MGC	W01A043E09	pENTR-TOPO	7358		ASB2	51676	AAH32354.1	Hs.510327	Ankyrin repeat and SOCS box-containing 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_016150.3	NP_057234.2	REVIEWED	C	1.000	1.000	587	1764	1	1761	587	1	587
RIKEN	BC032354	IRAK064M16	MGC	W01A043E11	pENTR-TOPO	7358		ASB2	51676	AAH32354.1	Hs.510327	Ankyrin repeat and SOCS box-containing 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_016150.3	NP_057234.2	REVIEWED	C	1.000	1.000	587	1764	1	1761	587	1	587
RIKEN	BC017502	IRAL034A12	MGC	W01A043E12	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC014187	IRAL030M24	MGC	W01A043E19	pENTR-TOPO	12596		ZNF653	115950	AAH14187.1	Hs.465928	Zinc finger protein 653			Eye, retinoblastoma	NIH_MGC_16		NM_138783.2	NP_620138.1	PROVISIONAL	Cs	0.998	0.998	615	1848	1	1845	615	1	615
RIKEN	BC017502	IRAL034A12	MGC	W01A043E20	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC014187	IRAL030M24	MGC	W01A043E21	pENTR-TOPO	12596		ZNF653	115950	AAH14187.1	Hs.465928	Zinc finger protein 653			Eye, retinoblastoma	NIH_MGC_16		NM_138783.2	NP_620138.1	PROVISIONAL	Cs	0.998	0.998	615	1848	1	1845	615	1	615
RIKEN	BC017502	IRAL034A12	MGC	W01A043E22	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC000666	IRAL005D22	MGC	W01A043F03	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC000666	IRAL005D22	MGC	W01A043F05	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC000666	IRAL005D22	MGC	W01A043F09	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC000666	IRAL005D22	MGC	W01A043F21	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC017502	IRAL034A12	MGC	W01A043G04	pENTR-TOPO	455		FASLG	356	AAH17502.1	Hs.2007	Fas ligand (TNF superfamily, member 6)			Blood, natural killer cell	NIH_MGC_106		NM_000639.1	NP_000630.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC006837	IRAK003B16	MGC	W01A043G06	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC007707	IRAL015P01	MGC	W01A043G07	pENTR-TOPO	19691		HEY2	23493	AAH07707.1	Hs.144287	Hairy/enhancer-of-split related with YRPW motif 2			Lung, small cell carcinoma	NIH_MGC_7		NM_012259.2	NP_036391.1	REVIEWED	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC015922	IRAL029F01	MGC	W01A043G09	pENTR-TOPO	16109		TRAK1	22906	AAH15922.1	Hs.535711	Trafficking protein, kinesin binding 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014965.3	NP_055780.2	VALIDATED	Cg	0.997	1.000	688	2067	1	2064	686	1	686
RIKEN	BC006837	IRAK003B16	MGC	W01A043G10	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC006837	IRAK003B16	MGC	W01A043G14	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC005868	IRAL011F01	MGC	W01A043G15	pENTR-TOPO	11443		ZNF551	90233	AAH05868.1					Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_138347.3	NP_612356.1	VALIDATED	C	1.000	1.000	654	1965	1	1962	654	1	654
RIKEN	BC006837	IRAK003B16	MGC	W01A043G16	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC005868	IRAL011F01	MGC	W01A043G17	pENTR-TOPO	11443		ZNF551	90233	AAH05868.1					Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_138347.3	NP_612356.1	VALIDATED	C	1.000	1.000	654	1965	1	1962	654	1	654
RIKEN	BC016556	IRAK003F21	MGC	W01A043H02	pENTR-TOPO	1655		TMED5	50999	AAH16556.1	Hs.482873	Transmembrane emp24 protein transport domain containing 5			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016040.3	NP_057124.2	PROVISIONAL	C	1.000	1.000	229	690	1	687	229	1	229
RIKEN	BC000666	IRAL005D22	MGC	W01A043H03	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC016556	IRAK003F21	MGC	W01A043H04	pENTR-TOPO	1655		TMED5	50999	AAH16556.1	Hs.482873	Transmembrane emp24 protein transport domain containing 5			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016040.3	NP_057124.2	PROVISIONAL	C	1.000	1.000	229	690	1	687	229	1	229
RIKEN	BC008100	IRAK012H19	MGC	W01A043H10	pENTR-TOPO	4092		ROM1	6094	AAH08100.1	Hs.281564	Retinal outer segment membrane protein 1				NCI_CGAP_Brn67	DH10B	NM_000327.3	NP_000318.1	REVIEWED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC000666	IRAL005D22	MGC	W01A043H11	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC000666	IRAL005D22	MGC	W01A043H13	pENTR-TOPO	3760		TMX2	51075	AAH00666.1	Hs.654965	Thioredoxin-related transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_015959.2	NP_057043.1	VALIDATED	C	1.000	1.000	296	891	1	888	296	1	296
RIKEN	BC035008	IRAK047O07	MGC	W01A043H16	pENTR-TOPO	12393		GGN	199720	AAH35008.1	Hs.447948	Gametogenetin			Testis	NIH_MGC_97	DH10B	NM_152657.3	NP_689870.3	REVIEWED	C	1.000	1.000	652	1959	1	1956	652	1	652
RIKEN	BC002896	IRAL015K17	MGC	W01A043H21	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC006837	IRAK003B16	MGC	W01A043I02	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC006837	IRAK003B16	MGC	W01A043I08	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC017194	IRAL004L09	MGC	W01A043I09	pENTR-TOPO	25159		ELF4	2000	AAH17194.1	Hs.271940	E74-like factor 4 (ets domain transcription factor)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001421.3	NP_001412.1	VALIDATED	C	1.000	1.000	663	1992	1	1989	663	1	663
RIKEN	BC019352	IRAL018L12	MGC	W01A043I11	pENTR-TOPO	12383		ZNF296	162979	AAH19352.1	Hs.192237	Zinc finger protein 296			Lung, small cell carcinoma	NIH_MGC_7		NM_145288.1	NP_660331.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC019352	IRAL018L12	MGC	W01A043I15	pENTR-TOPO	12383		ZNF296	162979	AAH19352.1	Hs.192237	Zinc finger protein 296			Lung, small cell carcinoma	NIH_MGC_7		NM_145288.1	NP_660331.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC006837	IRAK003B16	MGC	W01A043I16	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC019352	IRAL018L12	MGC	W01A043I17	pENTR-TOPO	12383		ZNF296	162979	AAH19352.1	Hs.192237	Zinc finger protein 296			Lung, small cell carcinoma	NIH_MGC_7		NM_145288.1	NP_660331.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC019352	IRAL018L12	MGC	W01A043I19	pENTR-TOPO	12383		ZNF296	162979	AAH19352.1	Hs.192237	Zinc finger protein 296			Lung, small cell carcinoma	NIH_MGC_7		NM_145288.1	NP_660331.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC015030	IRAK015D20	MGC	W01A043I23	pENTR-TOPO	25106		ZBED1	9189	AAH15030.1					Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004729.3	NP_004720.1	VALIDATED	Cs	0.999	0.999	694	2085	1	2082	694	1	694
RIKEN	BC006837	IRAK003B16	MGC	W01A043I24	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC002896	IRAL015K17	MGC	W01A043J03	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC002896	IRAL015K17	MGC	W01A043J05	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC002896	IRAL015K17	MGC	W01A043J07	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC065528	IRAK140K11	MGC	W01A043J12	pENTR-TOPO	999		EXTL1	2134	AAH65528.1	Hs.150956	Exostoses (multiple)-like 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004455.2	NP_004446.2	REVIEWED	C	1.000	1.000	676	2031	1	2028	676	1	676
RIKEN	BC002896	IRAL015K17	MGC	W01A043J13	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC002896	IRAL015K17	MGC	W01A043J15	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC002896	IRAL015K17	MGC	W01A043J17	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC015030	IRAK015D20	MGC	W01A043K05	pENTR-TOPO	25106		ZBED1	9189	AAH15030.1					Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004729.3	NP_004720.1	VALIDATED	Cs	0.999	0.999	694	2085	1	2082	694	1	694
RIKEN	BC006837	IRAK003B16	MGC	W01A043K08	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC032722	IRAK069H20	MGC	W01A043K17	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032722	IRAK069H20	MGC	W01A043K19	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032722	IRAK069H20	MGC	W01A043K21	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC006837	IRAK003B16	MGC	W01A043K22	pENTR-TOPO	19166		RAD1	5810	AAH06837.1	Hs.38114	RAD1 homolog (S. pombe)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002853.3	NP_002844.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC002896	IRAL015K17	MGC	W01A043L01	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC002896	IRAL015K17	MGC	W01A043L09	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC002896	IRAL015K17	MGC	W01A043L11	pENTR-TOPO	16967		ZMAT3	64393	AAH02896.1	Hs.386299	Zinc finger, matrin type 3			Lung, small cell carcinoma	NIH_MGC_7		NM_022470.2	NP_071915.1	REVIEWED	C	1.000	1.000	289	870	1	867	289	1	289
RIKEN	BC050526	IRAK107G09	MGC	W01A043L14	pENTR-TOPO	10015		CASC3	22794	AAH50526.1	Hs.719152	Cancer susceptibility candidate 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_007359.4	NP_031385.2	REVIEWED	C	1.000	1.000	703	2112	1	2109	703	1	703
RIKEN	BC009828	IRAL025D14	MGC	W01A043L19	pENTR-TOPO	11697		LASS4	79603	AAH09828.1	Hs.515111	LAG1 homolog, ceramide synthase 4			Lung, small cell carcinoma	NIH_MGC_7		NM_024552.2	NP_078828.2	VALIDATED	Cs	0.995	0.995	394	1185	1	1182	394	1	394
RIKEN	BC022512	IRAK032N22	MGC	W01A043L22	pENTR-TOPO	10424		PECAM1	5175	AAH22512.1	Hs.514412	Platelet/endothelial cell adhesion molecule			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000442.3	NP_000433.3	PROVISIONAL	Cs	0.996	0.996	738	2217	1	2214	738	1	738
RIKEN	BC032722	IRAK069H20	MGC	W01A043M01	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032722	IRAK069H20	MGC	W01A043M03	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032722	IRAK069H20	MGC	W01A043M05	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC002794	IRAL012P03	MGC	W01A043M10	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC032722	IRAK069H20	MGC	W01A043M11	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC002794	IRAL012P03	MGC	W01A043M12	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC032722	IRAK069H20	MGC	W01A043M17	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC002794	IRAL012P03	MGC	W01A043M18	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC032722	IRAK069H20	MGC	W01A043M19	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC009828	IRAL025D14	MGC	W01A043N01	pENTR-TOPO	11697		LASS4	79603	AAH09828.1	Hs.515111	LAG1 homolog, ceramide synthase 4			Lung, small cell carcinoma	NIH_MGC_7		NM_024552.2	NP_078828.2	VALIDATED	Cs	0.995	0.995	394	1185	1	1182	394	1	394
RIKEN	BC032373	IRAK064D09	MGC	W01A043N11	pENTR-TOPO	3753		FAM89B	23625	AAH32373.1	Hs.25723	Family with sequence similarity 89, member B			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152832.2	NP_690045.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
RIKEN	BC003555	IRAL008B14	MGC	W01A043N12	pENTR-TOPO	1860		NOC2L	26155	AAH03555.1	Hs.405987	Nucleolar complex associated 2 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_015658.3	NP_056473.2	VALIDATED	C	1.000	1.000	749	2250	1	2247	749	1	749
RIKEN	BC003555	IRAL008B14	MGC	W01A043N16	pENTR-TOPO	1860		NOC2L	26155	AAH03555.1	Hs.405987	Nucleolar complex associated 2 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_015658.3	NP_056473.2	VALIDATED	C	1.000	1.000	749	2250	1	2247	749	1	749
RIKEN	AK097536	flj0023b20	FLJ	W01A043N17	pENTR-TOPO	10617		SLC25A35	399512	BAC05091.1	Hs.118918	Solute carrier family 25, member 35				TESTI2	EK1	NM_201520.1	NP_958928.1	PROVISIONAL	OK	1.000	1.000	295	888	1	885	295	1	295
RIKEN	BC003555	IRAL008B14	MGC	W01A043N18	pENTR-TOPO	1860		NOC2L	26155	AAH03555.1	Hs.405987	Nucleolar complex associated 2 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_015658.3	NP_056473.2	VALIDATED	C	1.000	1.000	749	2250	1	2247	749	1	749
RIKEN	BC003555	IRAL008B14	MGC	W01A043N20	pENTR-TOPO	1860		NOC2L	26155	AAH03555.1	Hs.405987	Nucleolar complex associated 2 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_015658.3	NP_056473.2	VALIDATED	C	1.000	1.000	749	2250	1	2247	749	1	749
RIKEN	BC003555	IRAL008B14	MGC	W01A043N22	pENTR-TOPO	1860		NOC2L	26155	AAH03555.1	Hs.405987	Nucleolar complex associated 2 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_015658.3	NP_056473.2	VALIDATED	C	1.000	1.000	749	2250	1	2247	749	1	749
RIKEN	BC004100	IRAL014H14	MGC	W01A043N23	pENTR-TOPO	7566		PIGH	5283	AAH04100.1	Hs.553497	Phosphatidylinositol glycan anchor biosynthesis, class H			Lung, small cell carcinoma	NIH_MGC_7		NM_004569.3	NP_004560.1	REVIEWED	OK	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC003555	IRAL008B14	MGC	W01A043N24	pENTR-TOPO	1860		NOC2L	26155	AAH03555.1	Hs.405987	Nucleolar complex associated 2 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_015658.3	NP_056473.2	VALIDATED	C	1.000	1.000	749	2250	1	2247	749	1	749
RIKEN	BC002794	IRAL012P03	MGC	W01A043O02	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC032722	IRAK069H20	MGC	W01A043O05	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC002794	IRAL012P03	MGC	W01A043O06	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC032722	IRAK069H20	MGC	W01A043O07	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC002794	IRAL012P03	MGC	W01A043O10	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC032722	IRAK069H20	MGC	W01A043O11	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032722	IRAK069H20	MGC	W01A043O17	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC002794	IRAL012P03	MGC	W01A043O18	pENTR-TOPO	1486		TNFRSF14	8764	AAH02794.1	Hs.512898	Tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator)			Skin, melanotic melanoma.	NIH_MGC_20		NM_003820.2	NP_003811.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
RIKEN	BC032722	IRAK069H20	MGC	W01A043O19	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC032722	IRAK069H20	MGC	W01A043O23	pENTR-TOPO	17189		TNFSF10	8743	AAH32722.1	Hs.478275	Tumor necrosis factor (ligand) superfamily, member 10			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003810.2	NP_003801.1	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC065529	IRAK140K21	MGC	W01A043P02	pENTR-TOPO	15309		APP	351	AAH65529.1	Hs.434980	Amyloid beta (A4) precursor protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_201413.2	NP_958816.1	REVIEWED	C	1.000	1.000	751	2256	1	2253	751	1	751
RIKEN	BC004100	IRAL014H14	MGC	W01A043P05	pENTR-TOPO	7566		PIGH	5283	AAH04100.1	Hs.553497	Phosphatidylinositol glycan anchor biosynthesis, class H			Lung, small cell carcinoma	NIH_MGC_7		NM_004569.3	NP_004560.1	REVIEWED	OK	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC004100	IRAL014H14	MGC	W01A043P07	pENTR-TOPO	7566		PIGH	5283	AAH04100.1	Hs.553497	Phosphatidylinositol glycan anchor biosynthesis, class H			Lung, small cell carcinoma	NIH_MGC_7		NM_004569.3	NP_004560.1	REVIEWED	OK	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC004100	IRAL014H14	MGC	W01A043P09	pENTR-TOPO	7566		PIGH	5283	AAH04100.1	Hs.553497	Phosphatidylinositol glycan anchor biosynthesis, class H			Lung, small cell carcinoma	NIH_MGC_7		NM_004569.3	NP_004560.1	REVIEWED	OK	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC065529	IRAK140K21	MGC	W01A043P10	pENTR-TOPO	15309		APP	351	AAH65529.1	Hs.434980	Amyloid beta (A4) precursor protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_201413.2	NP_958816.1	REVIEWED	C	1.000	1.000	751	2256	1	2253	751	1	751
RIKEN	BC004100	IRAL014H14	MGC	W01A043P11	pENTR-TOPO	7566		PIGH	5283	AAH04100.1	Hs.553497	Phosphatidylinositol glycan anchor biosynthesis, class H			Lung, small cell carcinoma	NIH_MGC_7		NM_004569.3	NP_004560.1	REVIEWED	OK	1.000	1.000	188	567	1	564	188	1	188
RIKEN	BC065529	IRAK140K21	MGC	W01A043P14	pENTR-TOPO	15309		APP	351	AAH65529.1	Hs.434980	Amyloid beta (A4) precursor protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_201413.2	NP_958816.1	REVIEWED	C	1.000	1.000	751	2256	1	2253	751	1	751
RIKEN	BC065529	IRAK140K21	MGC	W01A043P22	pENTR-TOPO	15309		APP	351	AAH65529.1	Hs.434980	Amyloid beta (A4) precursor protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_201413.2	NP_958816.1	REVIEWED	C	1.000	1.000	751	2256	1	2253	751	1	751
RIKEN	BC017191	IRAL004B05	MGC	W01A044A05	pENTR-TOPO	15595		L3MBTL2	83746	AAH17191.1	Hs.517641	L(3)mbt-like 2 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_031488.4	NP_113676.2	VALIDATED	C	1.000	1.000	705	2118	1	2115	705	1	705
RIKEN	BC001757	IRAL007F18	MGC	W01A044A10	pENTR-TOPO	4590		CLDND1	56650	AAH01757.2	Hs.709386	Claudin domain containing 1			Brain, neuroblastoma	NIH_MGC_19		NM_001040199.1	NP_001035289.1	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC059404	IRAK133E24	MGC	W01A044A15	pENTR-TOPO	9607		BCL6B	255877	AAH59404.1	Hs.22575	B-cell CLL/lymphoma 6, member B (zinc finger protein)			Placenta, normal	NIH_MGC_147	DH10B	NM_181844.3	NP_862827.1	VALIDATED	Cs	0.998	0.998	480	1443	1	1440	480	1	480
RIKEN	BC002387	IRAL001P07	MGC	W01A044A16	pENTR-TOPO	5920		NAP1L1	4673	AAH02387.1	Hs.695185	Nucleosome assembly protein 1-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_139207.2	NP_631946.1	REVIEWED	C	1.000	1.000	391	1176	1	1173	391	1	391
RIKEN	BC059404	IRAK133E24	MGC	W01A044A19	pENTR-TOPO	9607		BCL6B	255877	AAH59404.1	Hs.22575	B-cell CLL/lymphoma 6, member B (zinc finger protein)			Placenta, normal	NIH_MGC_147	DH10B	NM_181844.3	NP_862827.1	VALIDATED	Cs	0.998	0.998	480	1443	1	1440	480	1	480
RIKEN	BC002387	IRAL001P07	MGC	W01A044A20	pENTR-TOPO	5920		NAP1L1	4673	AAH02387.1	Hs.695185	Nucleosome assembly protein 1-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_139207.2	NP_631946.1	REVIEWED	C	1.000	1.000	391	1176	1	1173	391	1	391
RIKEN	BC002387	IRAL001P07	MGC	W01A044A22	pENTR-TOPO	5920		NAP1L1	4673	AAH02387.1	Hs.695185	Nucleosome assembly protein 1-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_139207.2	NP_631946.1	REVIEWED	C	1.000	1.000	391	1176	1	1173	391	1	391
RIKEN	BC059404	IRAK133E24	MGC	W01A044A23	pENTR-TOPO	9607		BCL6B	255877	AAH59404.1	Hs.22575	B-cell CLL/lymphoma 6, member B (zinc finger protein)			Placenta, normal	NIH_MGC_147	DH10B	NM_181844.3	NP_862827.1	VALIDATED	Cs	0.998	0.998	480	1443	1	1440	480	1	480
RIKEN	BC008678	IRAK013P06	MGC	W01A044A24	pENTR-TOPO	13906		IL1B	3553	AAH08678.1	Hs.126256	Interleukin 1, beta			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000576.2	NP_000567.1	REVIEWED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC013362	IRAL024A05	MGC	W01A044B11	pENTR-TOPO	1541		RUNX3	864	AAH13362.1	Hs.170019	Runt-related transcription factor 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_001031680.2	NP_001026850.1	REVIEWED	OK	1.000	1.000	429	1290	1	1287	429	1	429
RIKEN	BC033747	IRAK068M16	MGC	W01A044B12	pENTR-TOPO	21840		ADAP1	11033	AAH33747.1	Hs.644629	ArfGAP with dual PH domains 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_006869.2	NP_006860.1	VALIDATED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC033747	IRAK068M16	MGC	W01A044B14	pENTR-TOPO	21840		ADAP1	11033	AAH33747.1	Hs.644629	ArfGAP with dual PH domains 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_006869.2	NP_006860.1	VALIDATED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC013362	IRAL024A05	MGC	W01A044B15	pENTR-TOPO	1541		RUNX3	864	AAH13362.1	Hs.170019	Runt-related transcription factor 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_001031680.2	NP_001026850.1	REVIEWED	OK	1.000	1.000	429	1290	1	1287	429	1	429
RIKEN	BC035589	IRAK069J12	MGC	W01A044B19	pENTR-TOPO	8518		ZNF646	9726	AAH35589.1	Hs.119273	Zinc finger protein 646			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014699.3	NP_055514.3	VALIDATED	Cs	0.999	0.999	1832	5499	1	5496	1832	1	1832
RIKEN	BC033747	IRAK068M16	MGC	W01A044B20	pENTR-TOPO	21840		ADAP1	11033	AAH33747.1	Hs.644629	ArfGAP with dual PH domains 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_006869.2	NP_006860.1	VALIDATED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	AK095572	flj0024f07	FLJ	W01A044B21	pENTR-TOPO	9842		GTF2IRD2	84163	BAC04576.1	Hs.647039	GTF2I repeat domain containing 2				FCBBF3	EK1	NM_173537.2	NP_775808.2	VALIDATED	Ps	0.989	0.989	702	2109	1	2106	949	248	949
RIKEN	BC033747	IRAK068M16	MGC	W01A044B22	pENTR-TOPO	21840		ADAP1	11033	AAH33747.1	Hs.644629	ArfGAP with dual PH domains 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_006869.2	NP_006860.1	VALIDATED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC014072	IRAL028H16	MGC	W01A044B23	pENTR-TOPO	10713		TLCD1	116238	AAH14072.1	Hs.499952	TLC domain containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_138463.3	NP_612472.1	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC008678	IRAK013P06	MGC	W01A044C02	pENTR-TOPO	13906		IL1B	3553	AAH08678.1	Hs.126256	Interleukin 1, beta			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000576.2	NP_000567.1	REVIEWED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC015704	IRAK015C13	MGC	W01A044C07	pENTR-TOPO	9882		SUZ12	23512	AAH15704.1	Hs.462732	Suppressor of zeste 12 homolog (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015355.2	NP_056170.2	REVIEWED	OK	1.000	1.000	739	2220	1	2217	739	1	739
RIKEN	BC008678	IRAK013P06	MGC	W01A044C08	pENTR-TOPO	13906		IL1B	3553	AAH08678.1	Hs.126256	Interleukin 1, beta			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000576.2	NP_000567.1	REVIEWED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC008678	IRAK013P06	MGC	W01A044C10	pENTR-TOPO	13906		IL1B	3553	AAH08678.1	Hs.126256	Interleukin 1, beta			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000576.2	NP_000567.1	REVIEWED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC015704	IRAK015C13	MGC	W01A044C11	pENTR-TOPO	9882		SUZ12	23512	AAH15704.1	Hs.462732	Suppressor of zeste 12 homolog (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015355.2	NP_056170.2	REVIEWED	OK	1.000	1.000	739	2220	1	2217	739	1	739
RIKEN	BC009971	IRAL026P07	MGC	W01A044C16	pENTR-TOPO	10709		KRT33B	3884	AAH09971.1	Hs.32950	Keratin 33B			Kidney, renal carcinoma (ascites)	NIH_MGC_45		NM_002279.3	NP_002270.1	REVIEWED	C	1.000	1.000	404	1215	1	1212	404	1	404
RIKEN	BC009971	IRAL026P07	MGC	W01A044C20	pENTR-TOPO	10709		KRT33B	3884	AAH09971.1	Hs.32950	Keratin 33B			Kidney, renal carcinoma (ascites)	NIH_MGC_45		NM_002279.3	NP_002270.1	REVIEWED	C	1.000	1.000	404	1215	1	1212	404	1	404
RIKEN	BC022785	IRAK020L20	MGC	W01A044C21	pENTR-TOPO	21314		ZNF212	7988	AAH22785.2	Hs.490510	Zinc finger protein 212			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_012256.2	NP_036388.2	REVIEWED	C	1.000	1.000	495	1488	1	1485	495	1	495
RIKEN	BC009971	IRAL026P07	MGC	W01A044C22	pENTR-TOPO	10709		KRT33B	3884	AAH09971.1	Hs.32950	Keratin 33B			Kidney, renal carcinoma (ascites)	NIH_MGC_45		NM_002279.3	NP_002270.1	REVIEWED	C	1.000	1.000	404	1215	1	1212	404	1	404
RIKEN	BC009971	IRAL026P07	MGC	W01A044C24	pENTR-TOPO	10709		KRT33B	3884	AAH09971.1	Hs.32950	Keratin 33B			Kidney, renal carcinoma (ascites)	NIH_MGC_45		NM_002279.3	NP_002270.1	REVIEWED	C	1.000	1.000	404	1215	1	1212	404	1	404
RIKEN	BC014072	IRAL028H16	MGC	W01A044D01	pENTR-TOPO	10713		TLCD1	116238	AAH14072.1	Hs.499952	TLC domain containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_138463.3	NP_612472.1	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC014072	IRAL028H16	MGC	W01A044D03	pENTR-TOPO	10713		TLCD1	116238	AAH14072.1	Hs.499952	TLC domain containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_138463.3	NP_612472.1	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC014072	IRAL028H16	MGC	W01A044D09	pENTR-TOPO	10713		TLCD1	116238	AAH14072.1	Hs.499952	TLC domain containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_138463.3	NP_612472.1	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC014072	IRAL028H16	MGC	W01A044D13	pENTR-TOPO	10713		TLCD1	116238	AAH14072.1	Hs.499952	TLC domain containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_138463.3	NP_612472.1	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC014072	IRAL028H16	MGC	W01A044D17	pENTR-TOPO	10713		TLCD1	116238	AAH14072.1	Hs.499952	TLC domain containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_138463.3	NP_612472.1	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
RIKEN	BC022481	IRAK032M16	MGC	W01A044D22	pENTR-TOPO	10220		NEUROD2	4761	AAH22481.1	Hs.322431	Neurogenic differentiation 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006160.3	NP_006151.3	REVIEWED	Cs	0.997	0.997	382	1149	1	1146	382	1	382
RIKEN	AK000456	flj0057g18	FLJ	W01A044D23	pENTR-TOPO	6743		SOHLH2	54937	BAA91175.1	Hs.656745	Spermatogenesis and oogenesis specific basic helix-loop-helix 2				KAT	EK1	NM_017826.1	NP_060296.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC022481	IRAK032M16	MGC	W01A044D24	pENTR-TOPO	10220		NEUROD2	4761	AAH22481.1	Hs.322431	Neurogenic differentiation 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006160.3	NP_006151.3	REVIEWED	Cs	0.997	0.997	382	1149	1	1146	382	1	382
RIKEN	BC022785	IRAK020L20	MGC	W01A044E01	pENTR-TOPO	21314		ZNF212	7988	AAH22785.2	Hs.490510	Zinc finger protein 212			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_012256.2	NP_036388.2	REVIEWED	C	1.000	1.000	495	1488	1	1485	495	1	495
RIKEN	BC022191	IRAL011J03	MGC	W01A044E03	pENTR-TOPO	24294		RFX3	5991	AAH22191.1	Hs.136829	Regulatory factor X, 3 (influences HLA class II expression)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_134428.1	NP_602304.1	REVIEWED	C	1.000	1.000	749	2250	1	2247	749	1	749
RIKEN	BC001630	IRAL008H21	MGC	W01A044E04	pENTR-TOPO	2148		RPA2	6118	AAH01630.1	Hs.79411	Replication protein A2, 32kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002946.3	NP_002937.1	PROVISIONAL	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC005010	IRAL013P16	MGC	W01A044E05	pENTR-TOPO	14261		ZFP36L2	678	AAH05010.1	Hs.503093	Zinc finger protein 36, C3H type-like 2			Pancreas, adenocarcinoma	NIH_MGC_39		NM_006887.4	NP_008818.3	REVIEWED	Cg	0.994	1.000	497	1494	1	1491	494	1	494
RIKEN	BC001630	IRAL008H21	MGC	W01A044E06	pENTR-TOPO	2148		RPA2	6118	AAH01630.1	Hs.79411	Replication protein A2, 32kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002946.3	NP_002937.1	PROVISIONAL	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC005010	IRAL013P16	MGC	W01A044E09	pENTR-TOPO	14261		ZFP36L2	678	AAH05010.1	Hs.503093	Zinc finger protein 36, C3H type-like 2			Pancreas, adenocarcinoma	NIH_MGC_39		NM_006887.4	NP_008818.3	REVIEWED	Cg	0.994	1.000	497	1494	1	1491	494	1	494
RIKEN	BC005010	IRAL013P16	MGC	W01A044E15	pENTR-TOPO	14261		ZFP36L2	678	AAH05010.1	Hs.503093	Zinc finger protein 36, C3H type-like 2			Pancreas, adenocarcinoma	NIH_MGC_39		NM_006887.4	NP_008818.3	REVIEWED	Cg	0.994	1.000	497	1494	1	1491	494	1	494
RIKEN	BC005010	IRAL013P16	MGC	W01A044E17	pENTR-TOPO	14261		ZFP36L2	678	AAH05010.1	Hs.503093	Zinc finger protein 36, C3H type-like 2			Pancreas, adenocarcinoma	NIH_MGC_39		NM_006887.4	NP_008818.3	REVIEWED	Cg	0.994	1.000	497	1494	1	1491	494	1	494
RIKEN	BC021962	IRAL014J03	MGC	W01A044E23	pENTR-TOPO	18708		PHF15	23338	AAH21962.2	Hs.483419	PHD finger protein 15			Skin, melanotic melanoma.	NIH_MGC_20		NM_015288.4	NP_056103.4	PROVISIONAL	Cg	0.999	1.000	791	2376	1	2373	790	1	790
RIKEN	AK000456	flj0057g18	FLJ	W01A044F01	pENTR-TOPO	6743		SOHLH2	54937	BAA91175.1	Hs.656745	Spermatogenesis and oogenesis specific basic helix-loop-helix 2				KAT	EK1	NM_017826.1	NP_060296.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC022481	IRAK032M16	MGC	W01A044F02	pENTR-TOPO	10220		NEUROD2	4761	AAH22481.1	Hs.322431	Neurogenic differentiation 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006160.3	NP_006151.3	REVIEWED	Cs	0.997	0.997	382	1149	1	1146	382	1	382
RIKEN	AK000456	flj0057g18	FLJ	W01A044F03	pENTR-TOPO	6743		SOHLH2	54937	BAA91175.1	Hs.656745	Spermatogenesis and oogenesis specific basic helix-loop-helix 2				KAT	EK1	NM_017826.1	NP_060296.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	AK000456	flj0057g18	FLJ	W01A044F05	pENTR-TOPO	6743		SOHLH2	54937	BAA91175.1	Hs.656745	Spermatogenesis and oogenesis specific basic helix-loop-helix 2				KAT	EK1	NM_017826.1	NP_060296.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	AK000456	flj0057g18	FLJ	W01A044F11	pENTR-TOPO	6743		SOHLH2	54937	BAA91175.1	Hs.656745	Spermatogenesis and oogenesis specific basic helix-loop-helix 2				KAT	EK1	NM_017826.1	NP_060296.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC031067	IRAK048G03	MGC	W01A044F12	pENTR-TOPO	12315		SYT3	84258	AAH31067.1	Hs.515554	Synaptotagmin III			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001160329.1	NP_001153801.1	VALIDATED	Cs	0.998	0.998	590	1773	1	1770	590	1	590
RIKEN	AK000456	flj0057g18	FLJ	W01A044F13	pENTR-TOPO	6743		SOHLH2	54937	BAA91175.1	Hs.656745	Spermatogenesis and oogenesis specific basic helix-loop-helix 2				KAT	EK1	NM_017826.1	NP_060296.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC031067	IRAK048G03	MGC	W01A044F14	pENTR-TOPO	12315		SYT3	84258	AAH31067.1	Hs.515554	Synaptotagmin III			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001160329.1	NP_001153801.1	VALIDATED	Cs	0.998	0.998	590	1773	1	1770	590	1	590
RIKEN	AK000456	flj0057g18	FLJ	W01A044F15	pENTR-TOPO	6743		SOHLH2	54937	BAA91175.1	Hs.656745	Spermatogenesis and oogenesis specific basic helix-loop-helix 2				KAT	EK1	NM_017826.1	NP_060296.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	AK098601	flj0053o16	FLJ	W01A044G06	pENTR-TOPO	24763		ZNF645	158506	BAC05348.1	Hs.132485	Zinc finger protein 645				TST	EK1	NM_152577.2	NP_689790.1	PROVISIONAL	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC021962	IRAL014J03	MGC	W01A044G07	pENTR-TOPO	18708		PHF15	23338	AAH21962.2	Hs.483419	PHD finger protein 15			Skin, melanotic melanoma.	NIH_MGC_20		NM_015288.4	NP_056103.4	PROVISIONAL	Cg	0.999	1.000	791	2376	1	2373	790	1	790
RIKEN	BC021962	IRAL014J03	MGC	W01A044G09	pENTR-TOPO	18708		PHF15	23338	AAH21962.2	Hs.483419	PHD finger protein 15			Skin, melanotic melanoma.	NIH_MGC_20		NM_015288.4	NP_056103.4	PROVISIONAL	Cg	0.999	1.000	791	2376	1	2373	790	1	790
RIKEN	BC013153	IRAK013L10	MGC	W01A044G14	pENTR-TOPO	2897		LOXL4	84171	AAH13153.1	Hs.671890	Lysyl oxidase-like 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032211.6	NP_115587.6	REVIEWED	Cs	0.996	0.996	756	2271	1	2268	756	1	756
RIKEN	BC056240	IRAL048I17	MGC	W01A044G19	pENTR-TOPO	994		SPRR1B	6699	AAH56240.1	Hs.1076	Small proline-rich protein 1B (cornifin)			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_003125.2	NP_003116.2	PROVISIONAL	Cs	0.989	0.989	89	270	1	267	89	1	89
RIKEN	BC056240	IRAL048I17	MGC	W01A044G23	pENTR-TOPO	994		SPRR1B	6699	AAH56240.1	Hs.1076	Small proline-rich protein 1B (cornifin)			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_003125.2	NP_003116.2	PROVISIONAL	Cs	0.989	0.989	89	270	1	267	89	1	89
RIKEN	AK095343	flj0023j19	FLJ	W01A044G24	pENTR-TOPO	2727		FBXO18	84893	BAC04535.1	Hs.498543	F-box protein, helicase, 18				CTONG2	EK1	NM_178150.1	NP_835363.1	REVIEWED	Cs	0.998	0.998	1043	3132	1	3129	1043	1	1043
RIKEN	BC023511	IRAL017I05	MGC	W01A044H17	pENTR-TOPO	14281		FEV	54738	AAH23511.1	Hs.234759	FEV (ETS oncogene family)			Brain, neuroblastoma	NIH_MGC_19		NM_017521.2	NP_059991.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC060837	IRAK133D10	MGC	W01A044H18	pENTR-TOPO	24874		DUSP9	1852	AAH60837.1	Hs.719154	Dual specificity phosphatase 9			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001395.2	NP_001386.1	REVIEWED	Cs	0.995	0.995	384	1155	1	1152	384	1	384
RIKEN	BC023511	IRAL017I05	MGC	W01A044H19	pENTR-TOPO	14281		FEV	54738	AAH23511.1	Hs.234759	FEV (ETS oncogene family)			Brain, neuroblastoma	NIH_MGC_19		NM_017521.2	NP_059991.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC025671	IRAK049E03	MGC	W01A044I02	pENTR-TOPO	22160		SLC26A3	1811	AAH25671.1	Hs.1650	Solute carrier family 26, member 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000111.2	NP_000102.1	REVIEWED	C	1.000	1.000	764	2295	1	2292	764	1	764
RIKEN	BC039739	IRAK082P08	MGC	W01A044I05	pENTR-TOPO	9697		TBX21	30009	AAH39739.1	Hs.272409	T-box 21			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_013351.1	NP_037483.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
RIKEN	BC039739	IRAK082P08	MGC	W01A044I07	pENTR-TOPO	9697		TBX21	30009	AAH39739.1	Hs.272409	T-box 21			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_013351.1	NP_037483.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
RIKEN	BC021193	IRAL005D20	MGC	W01A044I10	pENTR-TOPO	9140		SLC12A4	6560	AAH21193.1	Hs.10094	Solute carrier family 12 (potassium/chloride transporters), member 4			Eye, retinoblastoma	NIH_MGC_16		NM_005072.4	NP_005063.1	VALIDATED	C	1.000	1.000	1085	3258	1	3255	1085	1	1085
RIKEN	BC021193	IRAL005D20	MGC	W01A044I12	pENTR-TOPO	9140		SLC12A4	6560	AAH21193.1	Hs.10094	Solute carrier family 12 (potassium/chloride transporters), member 4			Eye, retinoblastoma	NIH_MGC_16		NM_005072.4	NP_005063.1	VALIDATED	C	1.000	1.000	1085	3258	1	3255	1085	1	1085
RIKEN	BC067266	IRAK141A19	MGC	W01A044I24	pENTR-TOPO	12163		PRX	57716	AAH67266.1	Hs.205457	Periaxin				Lupski_dorsal_root_ganglion	DH10B	NM_181882.2	NP_870998.2	REVIEWED	Cs	0.999	0.999	1461	4386	1	4383	1461	1	1461
RIKEN	BC026314	IRAK032O18	MGC	W01A044J20	pENTR-TOPO	24295		SHC3	53358	AAH26314.1	Hs.656806	SHC (Src homology 2 domain containing) transforming protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016848.4	NP_058544.3	VALIDATED	Cs	0.995	0.995	594	1785	1	1782	594	1	594
RIKEN	BC023511	IRAL017I05	MGC	W01A044J21	pENTR-TOPO	14281		FEV	54738	AAH23511.1	Hs.234759	FEV (ETS oncogene family)			Brain, neuroblastoma	NIH_MGC_19		NM_017521.2	NP_059991.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC067266	IRAK141A19	MGC	W01A044K02	pENTR-TOPO	12163		PRX	57716	AAH67266.1	Hs.205457	Periaxin				Lupski_dorsal_root_ganglion	DH10B	NM_181882.2	NP_870998.2	REVIEWED	Cs	0.999	0.999	1461	4386	1	4383	1461	1	1461
RIKEN	BC002496	IRAL004E05	MGC	W01A044K03	pENTR-TOPO	19810		TMEM14C	51522	AAH02496.1	Hs.519557	Transmembrane protein 14C			Skin, melanotic melanoma.	NIH_MGC_20		NM_016462.2	NP_057546.1	PROVISIONAL	C	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC003565	IRAL008P02	MGC	W01A044K06	pENTR-TOPO	9752		HGS	9146	AAH03565.1	Hs.719305	Hepatocyte growth factor-regulated tyrosine kinase substrate			Skin, melanotic melanoma.	NIH_MGC_20		NM_004712.3	NP_004703.1	PROVISIONAL	OK	1.000	1.000	777	2334	1	2331	777	1	777
RIKEN	BC001549	IRAK004L22	MGC	W01A044K07	pENTR-TOPO	24828		EBP	10682	AAH01549.1	Hs.30619	Emopamil binding protein (sterol isomerase)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006579.2	NP_006570.1	REVIEWED	OK	1.000	1.000	230	693	1	690	230	1	230
RIKEN	BC003565	IRAL008P02	MGC	W01A044K10	pENTR-TOPO	9752		HGS	9146	AAH03565.1	Hs.719305	Hepatocyte growth factor-regulated tyrosine kinase substrate			Skin, melanotic melanoma.	NIH_MGC_20		NM_004712.3	NP_004703.1	PROVISIONAL	OK	1.000	1.000	777	2334	1	2331	777	1	777
RIKEN	BC015028	IRAK015K16	MGC	W01A044K11	pENTR-TOPO	22756		NOV	4856	AAH15028.1	Hs.235935	Nephroblastoma overexpressed gene			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002514.3	NP_002505.1	REVIEWED	Cs	0.997	0.997	357	1074	1	1071	357	1	357
RIKEN	BC020632	IRAL037D18	MGC	W01A044K17	pENTR-TOPO	327		RGS18	64407	AAH20632.1	Hs.440890	Regulator of G-protein signaling 18			Liver	NIH_MGC_76	DH10B	NM_130782.2	NP_570138.1	REVIEWED	C	1.000	1.000	235	708	1	705	235	1	235
RIKEN	AK001557	flj0034p21	FLJ	W01A044K21	pENTR-TOPO	6460		WBP4	11193	BAG50940.1	Hs.411300	WW domain binding protein 4 (formin binding protein 21)	NT2	teratocarcinoma		NT2RP3	EK1	NM_007187.3	NP_009118.1	REVIEWED	Cs	0.995	0.995	376	1131	1	1128	376	1	376
RIKEN	BC023511	IRAL017I05	MGC	W01A044L01	pENTR-TOPO	14281		FEV	54738	AAH23511.1	Hs.234759	FEV (ETS oncogene family)			Brain, neuroblastoma	NIH_MGC_19		NM_017521.2	NP_059991.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC051286	IRAL047O09	MGC	W01A044L24	pENTR-TOPO	12632		PTGER1	5731	AAH51286.1	Hs.159360	Prostaglandin E receptor 1 (subtype EP1), 42kDa			Ovary, teratocarcinoma	NIH_MGC_109		NM_000955.2	NP_000946.2	REVIEWED	C	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	AK001557	flj0034p21	FLJ	W01A044M03	pENTR-TOPO	6460		WBP4	11193	BAG50940.1	Hs.411300	WW domain binding protein 4 (formin binding protein 21)	NT2	teratocarcinoma		NT2RP3	EK1	NM_007187.3	NP_009118.1	REVIEWED	Cs	0.995	0.995	376	1131	1	1128	376	1	376
RIKEN	BC033126	IRAL043A07	MGC	W01A044M04	pENTR-TOPO	1900		ZNF697	90874	AAH33126.1	Hs.381105	Zinc finger protein 697			Skin, melanotic melanoma.	NIH_MGC_20		NM_001080470.1	NP_001073939.1	PROVISIONAL	P	1.000	1.000	136	411	1	408	545	410	545
RIKEN	BC012181	IRAL029B09	MGC	W01A044M08	pENTR-TOPO	7938		FURIN	5045	AAH12181.1	Hs.513153	Furin (paired basic amino acid cleaving enzyme)			Lung, large cell carcinoma	NIH_MGC_18		NM_002569.2	NP_002560.1	REVIEWED	C	1.000	1.000	794	2385	1	2382	794	1	794
RIKEN	AK001557	flj0034p21	FLJ	W01A044M09	pENTR-TOPO	6460		WBP4	11193	BAG50940.1	Hs.411300	WW domain binding protein 4 (formin binding protein 21)	NT2	teratocarcinoma		NT2RP3	EK1	NM_007187.3	NP_009118.1	REVIEWED	Cs	0.995	0.995	376	1131	1	1128	376	1	376
RIKEN	AK001557	flj0034p21	FLJ	W01A044M15	pENTR-TOPO	6460		WBP4	11193	BAG50940.1	Hs.411300	WW domain binding protein 4 (formin binding protein 21)	NT2	teratocarcinoma		NT2RP3	EK1	NM_007187.3	NP_009118.1	REVIEWED	Cs	0.995	0.995	376	1131	1	1128	376	1	376
RIKEN	BC002401	IRAL001H14	MGC	W01A044M16	pENTR-TOPO	18049		HNRNPD	3184	AAH02401.1	Hs.480073	Heterogeneous nuclear ribonucleoprotein D (AU-rich element RNA binding protein 1, 37kDa)			Lung, small cell carcinoma	NIH_MGC_7		NM_031370.2	NP_112738.1	REVIEWED	C	1.000	1.000	355	1068	1	1065	355	1	355
RIKEN	BC052302	IRAL047L16	MGC	W01A044N01	pENTR-TOPO	10342		THOC4	10189	AAH52302.1	Hs.534385	THO complex 4			Lung, large cell carcinoma	NIH_MGC_18		NM_005782.3	NP_005773.3	REVIEWED	P	1.000	1.000	257	774	1	771	264	8	264
RIKEN	BC052302	IRAL047L16	MGC	W01A044N07	pENTR-TOPO	10342		THOC4	10189	AAH52302.1	Hs.534385	THO complex 4			Lung, large cell carcinoma	NIH_MGC_18		NM_005782.3	NP_005773.3	REVIEWED	P	1.000	1.000	257	774	1	771	264	8	264
RIKEN	BC052302	IRAL047L16	MGC	W01A044N09	pENTR-TOPO	10342		THOC4	10189	AAH52302.1	Hs.534385	THO complex 4			Lung, large cell carcinoma	NIH_MGC_18		NM_005782.3	NP_005773.3	REVIEWED	P	1.000	1.000	257	774	1	771	264	8	264
RIKEN	BC039735	IRAK082N20	MGC	W01A044N16	pENTR-TOPO	10257		SCARF1	8578	AAH39735.1	Hs.647430	Scavenger receptor class F, member 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_145351.1	NP_663326.1	REVIEWED	C	1.000	1.000	337	2493	1	1011	337	1	337
RIKEN	BC002777	IRAL012F01	MGC	W01A044O11	pENTR-TOPO	22587		EXOSC4	54512	AAH02777.1	Hs.632041	Exosome component 4			Skin, melanotic melanoma.	NIH_MGC_20		NM_019037.2	NP_061910.1	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
RIKEN	BC014848	IRAK028G12	MGC	W01A044O13	pENTR-TOPO	4104		RAD9A	5883	AAH14848.1	Hs.655354	RAD9 homolog A (S. pombe)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004584.2	NP_004575.1	REVIEWED	Cs	0.997	0.997	391	1176	1	1173	391	1	391
RIKEN	BC014848	IRAK028G12	MGC	W01A044O17	pENTR-TOPO	4104		RAD9A	5883	AAH14848.1	Hs.655354	RAD9 homolog A (S. pombe)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004584.2	NP_004575.1	REVIEWED	Cs	0.997	0.997	391	1176	1	1173	391	1	391
RIKEN	BC024197	IRAL011D11	MGC	W01A044O18	pENTR-TOPO	11514		ZNF226	7769	AAH24197.1	Hs.145956	Zinc finger protein 226			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001032373.1	NP_001027545.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
RIKEN	BC024197	IRAL011D11	MGC	W01A044O20	pENTR-TOPO	11514		ZNF226	7769	AAH24197.1	Hs.145956	Zinc finger protein 226			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001032373.1	NP_001027545.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
RIKEN	BC024197	IRAL011D11	MGC	W01A044O22	pENTR-TOPO	11514		ZNF226	7769	AAH24197.1	Hs.145956	Zinc finger protein 226			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001032373.1	NP_001027545.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
RIKEN	BC023597	IRAL033B02	MGC	W01A044O24	pENTR-TOPO	10190		TMC6	11322	AAH23597.1	Hs.632227	Transmembrane channel-like 6			Primary B-Cells from Tonsils	NIH_MGC_48		NM_007267.6	NP_009198.4	REVIEWED	Cs	0.999	0.999	805	2418	1	2415	805	1	805
RIKEN	BC052302	IRAL047L16	MGC	W01A044P05	pENTR-TOPO	10342		THOC4	10189	AAH52302.1	Hs.534385	THO complex 4			Lung, large cell carcinoma	NIH_MGC_18		NM_005782.3	NP_005773.3	REVIEWED	P	1.000	1.000	257	774	1	771	264	8	264
RIKEN	BC052302	IRAL047L16	MGC	W01A044P11	pENTR-TOPO	10342		THOC4	10189	AAH52302.1	Hs.534385	THO complex 4			Lung, large cell carcinoma	NIH_MGC_18		NM_005782.3	NP_005773.3	REVIEWED	P	1.000	1.000	257	774	1	771	264	8	264
RIKEN	AK091098	flj0017e23	FLJ	W01A044P16	pENTR-TOPO	11771		ZSCAN1	284312	BAC03582.1	Hs.643437	Zinc finger and SCAN domain containing 1				BRSSN2	EK1	NM_182572.3	NP_872378.3	VALIDATED	Cs	0.998	0.998	408	1227	1	1224	408	1	408
RIKEN	BC062375	IRAL050H10	MGC	W01A045A18	pENTR-TOPO	353		ARTN	9048	AAH62375.1	Hs.632404	Artemin			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_057090.2	NP_476431.2	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC017199	IRAL004N18	MGC	W01A045B01	pENTR-TOPO	18273		PHOX2B	8929	AAH17199.1	Hs.87202	Paired-like homeobox 2b			Brain, neuroblastoma	NIH_MGC_19		NM_003924.3	NP_003915.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC017199	IRAL004N18	MGC	W01A045B07	pENTR-TOPO	18273		PHOX2B	8929	AAH17199.1	Hs.87202	Paired-like homeobox 2b			Brain, neuroblastoma	NIH_MGC_19		NM_003924.3	NP_003915.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC005124	IRAL014F14	MGC	W01A045B17	pENTR-TOPO	13470		HOXD3	3232	AAH05124.1	Hs.93574	Homeobox D3			Lung, small cell carcinoma	NIH_MGC_7		NM_006898.4	NP_008829.3	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC005124	IRAL014F14	MGC	W01A045B23	pENTR-TOPO	13470		HOXD3	3232	AAH05124.1	Hs.93574	Homeobox D3			Lung, small cell carcinoma	NIH_MGC_7		NM_006898.4	NP_008829.3	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC025927	IRAL029A17	MGC	W01A045C05	pENTR-TOPO	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Lung, large cell carcinoma	NIH_MGC_18		NM_001032365.1	NP_001027537.1	REVIEWED	OK	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	BC062375	IRAL050H10	MGC	W01A045C06	pENTR-TOPO	353		ARTN	9048	AAH62375.1	Hs.632404	Artemin			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_057090.2	NP_476431.2	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC062375	IRAL050H10	MGC	W01A045C14	pENTR-TOPO	353		ARTN	9048	AAH62375.1	Hs.632404	Artemin			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_057090.2	NP_476431.2	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC062375	IRAL050H10	MGC	W01A045C16	pENTR-TOPO	353		ARTN	9048	AAH62375.1	Hs.632404	Artemin			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_057090.2	NP_476431.2	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	AK095194	flj0046j12	FLJ	W01A045C21	pENTR-TOPO	23170		PABPC1	26986	BAG53005.1	Hs.387804	Poly(A) binding protein, cytoplasmic 1				BRSSN2	EK1	NM_002568.3	NP_002559.2	VALIDATED	Cs	0.995	0.995	636	1911	1	1908	636	1	636
RIKEN	AK095194	flj0046j12	FLJ	W01A045C23	pENTR-TOPO	23170		PABPC1	26986	BAG53005.1	Hs.387804	Poly(A) binding protein, cytoplasmic 1				BRSSN2	EK1	NM_002568.3	NP_002559.2	VALIDATED	Cs	0.995	0.995	636	1911	1	1908	636	1	636
RIKEN	BC007239	IRAL022A20	MGC	W01A045C24	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC005124	IRAL014F14	MGC	W01A045D03	pENTR-TOPO	13470		HOXD3	3232	AAH05124.1	Hs.93574	Homeobox D3			Lung, small cell carcinoma	NIH_MGC_7		NM_006898.4	NP_008829.3	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC005124	IRAL014F14	MGC	W01A045D05	pENTR-TOPO	13470		HOXD3	3232	AAH05124.1	Hs.93574	Homeobox D3			Lung, small cell carcinoma	NIH_MGC_7		NM_006898.4	NP_008829.3	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC013082	IRAK019L02	MGC	W01A045D09	pENTR-TOPO	17047		SIAH2	6478	AAH13082.1	Hs.477959	Seven in absentia homolog 2 (Drosophila)			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_005067.5	NP_005058.3	REVIEWED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC013082	IRAK019L02	MGC	W01A045D15	pENTR-TOPO	17047		SIAH2	6478	AAH13082.1	Hs.477959	Seven in absentia homolog 2 (Drosophila)			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_005067.5	NP_005058.3	REVIEWED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC013082	IRAK019L02	MGC	W01A045D19	pENTR-TOPO	17047		SIAH2	6478	AAH13082.1	Hs.477959	Seven in absentia homolog 2 (Drosophila)			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_005067.5	NP_005058.3	REVIEWED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	AK095194	flj0046j12	FLJ	W01A045E01	pENTR-TOPO	23170		PABPC1	26986	BAG53005.1	Hs.387804	Poly(A) binding protein, cytoplasmic 1				BRSSN2	EK1	NM_002568.3	NP_002559.2	VALIDATED	Cs	0.995	0.995	636	1911	1	1908	636	1	636
RIKEN	AK095194	flj0046j12	FLJ	W01A045E03	pENTR-TOPO	23170		PABPC1	26986	BAG53005.1	Hs.387804	Poly(A) binding protein, cytoplasmic 1				BRSSN2	EK1	NM_002568.3	NP_002559.2	VALIDATED	Cs	0.995	0.995	636	1911	1	1908	636	1	636
RIKEN	BC007239	IRAL022A20	MGC	W01A045E04	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC007239	IRAL022A20	MGC	W01A045E10	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC007239	IRAL022A20	MGC	W01A045E12	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	AK025599	flj0065n06	FLJ	W01A045E13	pENTR-TOPO	20638		MAN1A1	4121	-	Hs.102788	Mannosidase, alpha, class 1A, member 1	HepG2	hepatoma		HEP	EK1	NM_005907.2	NP_005898.2	REVIEWED	C	1.000	1.000	653	1962	1	1959	653	1	653
RIKEN	BC007239	IRAL022A20	MGC	W01A045E22	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	AK025599	flj0065n06	FLJ	W01A045E23	pENTR-TOPO	20638		MAN1A1	4121	-	Hs.102788	Mannosidase, alpha, class 1A, member 1	HepG2	hepatoma		HEP	EK1	NM_005907.2	NP_005898.2	REVIEWED	C	1.000	1.000	653	1962	1	1959	653	1	653
RIKEN	BC041175	IRAK084M23	MGC	W01A045F07	pENTR-TOPO	848		TFAP2E	339488	AAH41175.1	Hs.567844	Transcription factor AP-2 epsilon (activating enhancer binding protein 2 epsilon)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178548.3	NP_848643.2	VALIDATED	P	1.000	1.000	434	1305	1	1302	442	9	442
RIKEN	BC007239	IRAL022A20	MGC	W01A045G02	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC007239	IRAL022A20	MGC	W01A045G08	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC000973	IRAK003H14	MGC	W01A045G11	pENTR-TOPO	6962		G2E3	55632	AAH00973.2	Hs.509008	G2/M-phase specific E3 ubiquitin ligase			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017769.3	NP_060239.2	VALIDATED	C	1.000	1.000	706	2121	1	2118	706	1	706
RIKEN	BC000973	IRAK003H14	MGC	W01A045G13	pENTR-TOPO	6962		G2E3	55632	AAH00973.2	Hs.509008	G2/M-phase specific E3 ubiquitin ligase			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017769.3	NP_060239.2	VALIDATED	C	1.000	1.000	706	2121	1	2118	706	1	706
RIKEN	BC007239	IRAL022A20	MGC	W01A045G14	pENTR-TOPO	19393		ZBED3	84327	AAH07239.1	Hs.584988	Zinc finger, BED-type containing 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_032367.2	NP_115743.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC000973	IRAK003H14	MGC	W01A045G15	pENTR-TOPO	6962		G2E3	55632	AAH00973.2	Hs.509008	G2/M-phase specific E3 ubiquitin ligase			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017769.3	NP_060239.2	VALIDATED	C	1.000	1.000	706	2121	1	2118	706	1	706
RIKEN	ENST00000305428	X01Y144I19	RIKEN_rt-pcr	W01A045G19	pENTR-TOPO	7690		KIAA1024	23251	ENSP00000307461	Hs.301654	KIAA1024						NM_015206.2	NP_056021.1	VALIDATED	C	1.000	1.000	916	2756	2	2749	916	1	916
RIKEN	BC050369	IRAK098I17	MGC	W01A045H15	pENTR-TOPO	14948		E2F1	1869	AAH50369.1	Hs.654393	E2F transcription factor 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_005225.2	NP_005216.1	REVIEWED	OK	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC014267	IRAL014M08	MGC	W01A045I01	pENTR-TOPO	8621		CTCF	10664	AAH14267.1	Hs.368367	CCCTC-binding factor (zinc finger protein)			Placenta, choriocarcinoma	NIH_MGC_21		NM_006565.2	NP_006556.1	REVIEWED	OK	1.000	1.000	727	2184	1	2181	727	1	727
RIKEN	BC063308	IRAK133H11	MGC	W01A045I05	pENTR-TOPO	12885		ASAP2	8853	AAH63308.1	Hs.555902	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2			Placenta, normal	NIH_MGC_147	DH10B	NM_001135191.1	NP_001128663.1	REVIEWED	Cs	0.998	0.998	961	2886	1	2883	961	1	961
RIKEN	BC036243	IRAK063O24	MGC	W01A045I06	pENTR-TOPO	6496		IL17D	53342	AAH36243.1	Hs.655142	Interleukin 17D			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138284.1	NP_612141.1	REVIEWED	OK	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC063308	IRAK133H11	MGC	W01A045I07	pENTR-TOPO	12885		ASAP2	8853	AAH63308.1	Hs.555902	ArfGAP with SH3 domain, ankyrin repeat and PH domain 2			Placenta, normal	NIH_MGC_147	DH10B	NM_001135191.1	NP_001128663.1	REVIEWED	Cs	0.998	0.998	961	2886	1	2883	961	1	961
RIKEN	BC036243	IRAK063O24	MGC	W01A045I08	pENTR-TOPO	6496		IL17D	53342	AAH36243.1	Hs.655142	Interleukin 17D			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138284.1	NP_612141.1	REVIEWED	OK	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC036243	IRAK063O24	MGC	W01A045I12	pENTR-TOPO	6496		IL17D	53342	AAH36243.1	Hs.655142	Interleukin 17D			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138284.1	NP_612141.1	REVIEWED	OK	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC036243	IRAK063O24	MGC	W01A045I16	pENTR-TOPO	6496		IL17D	53342	AAH36243.1	Hs.655142	Interleukin 17D			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138284.1	NP_612141.1	REVIEWED	OK	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC064567	IRAK139D21	MGC	W01A045I21	pENTR-TOPO	8875		EDC4	23644	AAH64567.1	Hs.75682	Enhancer of mRNA decapping 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_014329.3	NP_055144.3	VALIDATED	C	1.000	1.000	1401	4206	1	4203	1401	1	1401
RIKEN	BC002883	IRAL015G11	MGC	W01A045I23	pENTR-TOPO	359		TCEB3	6924	AAH02883.1					Lung, small cell carcinoma	NIH_MGC_7		NM_003198.2	NP_003189.2	REVIEWED	P	1.000	1.000	772	2319	1	2316	798	27	798
RIKEN	BC031797	IRAK029O06	MGC	W01A045J17	pENTR-TOPO	8686		SOX8	30812	AAH31797.1	Hs.243678	SRY (sex determining region Y)-box 8				NCI_CGAP_Brn67	DH10B	NM_014587.3	NP_055402.2	REVIEWED	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC031797	IRAK029O06	MGC	W01A045J19	pENTR-TOPO	8686		SOX8	30812	AAH31797.1	Hs.243678	SRY (sex determining region Y)-box 8				NCI_CGAP_Brn67	DH10B	NM_014587.3	NP_055402.2	REVIEWED	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC014664	IRAL034A18	MGC	W01A045K06	pENTR-TOPO	7942		NR2F2	7026	AAH14664.1	Hs.657455	Nuclear receptor subfamily 2, group F, member 2			Spleen	NIH_MGC_113		NM_001145156.1	NP_001138628.1	VALIDATED	C	1.000	1.000	261	1245	460	1242	261	1	261
RIKEN	BC002883	IRAL015G11	MGC	W01A045K09	pENTR-TOPO	359		TCEB3	6924	AAH02883.1					Lung, small cell carcinoma	NIH_MGC_7		NM_003198.2	NP_003189.2	REVIEWED	P	1.000	1.000	772	2319	1	2316	798	27	798
RIKEN	BC002883	IRAL015G11	MGC	W01A045K13	pENTR-TOPO	359		TCEB3	6924	AAH02883.1					Lung, small cell carcinoma	NIH_MGC_7		NM_003198.2	NP_003189.2	REVIEWED	P	1.000	1.000	772	2319	1	2316	798	27	798
RIKEN	BC035812	IRAK079N09	MGC	W01A045K19	pENTR-TOPO	19332		PCDH1	5097	AAH35812.1	Hs.79769	Protocadherin 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002587.3	NP_002578.2	REVIEWED	C	1.000	1.000	1060	3183	1	3180	1060	1	1060
RIKEN	BC031797	IRAK029O06	MGC	W01A045L03	pENTR-TOPO	8686		SOX8	30812	AAH31797.1	Hs.243678	SRY (sex determining region Y)-box 8				NCI_CGAP_Brn67	DH10B	NM_014587.3	NP_055402.2	REVIEWED	C	1.000	1.000	446	1341	1	1338	446	1	446
RIKEN	BC007538	IRAL022F17	MGC	W01A045L13	pENTR-TOPO	14655		CEBPB	1051	AAH07538.1	Hs.719041	CCAAT/enhancer binding protein (C/EBP), beta			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005194.2	NP_005185.2	REVIEWED	C	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC007538	IRAL022F17	MGC	W01A045L15	pENTR-TOPO	14655		CEBPB	1051	AAH07538.1	Hs.719041	CCAAT/enhancer binding protein (C/EBP), beta			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005194.2	NP_005185.2	REVIEWED	C	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC059356	IRAK133I22	MGC	W01A045M01	pENTR-TOPO	25338		ZXDA	7789	AAH59356.1	Hs.591214	Zinc finger, X-linked, duplicated A			Placenta, normal	NIH_MGC_147	DH10B	NM_007156.3	NP_009087.1	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
RIKEN	BC062375	IRAL050H10	MGC	W01A045M07	pENTR-TOPO	353		ARTN	9048	AAH62375.1	Hs.632404	Artemin			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_057090.2	NP_476431.2	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC004377	IRAL013P18	MGC	W01A045M12	pENTR-TOPO	20485		CITED2	10370	AAH04377.1	Hs.82071	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 2			Pancreas, adenocarcinoma	NIH_MGC_39		NM_006079.3	NP_006070.2	VALIDATED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC014965	IRAL034N16	MGC	W01A045M15	pENTR-TOPO	24287		XPA	7507	AAH14965.1	Hs.654364	Xeroderma pigmentosum, complementation group A			Primary B-Cells from Tonsils	NIH_MGC_48		NM_000380.3	NP_000371.1	REVIEWED	OK	1.000	1.000	273	822	1	819	273	1	273
RIKEN	BC014965	IRAL034N16	MGC	W01A045M17	pENTR-TOPO	24287		XPA	7507	AAH14965.1	Hs.654364	Xeroderma pigmentosum, complementation group A			Primary B-Cells from Tonsils	NIH_MGC_48		NM_000380.3	NP_000371.1	REVIEWED	OK	1.000	1.000	273	822	1	819	273	1	273
RIKEN	BC032751	IRAK069P06	MGC	W01A045M18	pENTR-TOPO	1512		GFI1	2672	AAH32751.1	Hs.73172	Growth factor independent 1 transcription repressor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001127216.1	NP_001120688.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC032751	IRAK069P06	MGC	W01A045M20	pENTR-TOPO	1512		GFI1	2672	AAH32751.1	Hs.73172	Growth factor independent 1 transcription repressor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001127216.1	NP_001120688.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC014965	IRAL034N16	MGC	W01A045M23	pENTR-TOPO	24287		XPA	7507	AAH14965.1	Hs.654364	Xeroderma pigmentosum, complementation group A			Primary B-Cells from Tonsils	NIH_MGC_48		NM_000380.3	NP_000371.1	REVIEWED	OK	1.000	1.000	273	822	1	819	273	1	273
RIKEN	BC032751	IRAK069P06	MGC	W01A045M24	pENTR-TOPO	1512		GFI1	2672	AAH32751.1	Hs.73172	Growth factor independent 1 transcription repressor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001127216.1	NP_001120688.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC032751	IRAK069P06	MGC	W01A045O10	pENTR-TOPO	1512		GFI1	2672	AAH32751.1	Hs.73172	Growth factor independent 1 transcription repressor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001127216.1	NP_001120688.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC017199	IRAL004N18	MGC	W01A045O12	pENTR-TOPO	18273		PHOX2B	8929	AAH17199.1	Hs.87202	Paired-like homeobox 2b			Brain, neuroblastoma	NIH_MGC_19		NM_003924.3	NP_003915.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC017199	IRAL004N18	MGC	W01A045O14	pENTR-TOPO	18273		PHOX2B	8929	AAH17199.1	Hs.87202	Paired-like homeobox 2b			Brain, neuroblastoma	NIH_MGC_19		NM_003924.3	NP_003915.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC017199	IRAL004N18	MGC	W01A045O18	pENTR-TOPO	18273		PHOX2B	8929	AAH17199.1	Hs.87202	Paired-like homeobox 2b			Brain, neuroblastoma	NIH_MGC_19		NM_003924.3	NP_003915.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC014965	IRAL034N16	MGC	W01A045O23	pENTR-TOPO	24287		XPA	7507	AAH14965.1	Hs.654364	Xeroderma pigmentosum, complementation group A			Primary B-Cells from Tonsils	NIH_MGC_48		NM_000380.3	NP_000371.1	REVIEWED	OK	1.000	1.000	273	822	1	819	273	1	273
RIKEN	BC012986	IRAL024B11	MGC	W01A046A03	pENTR-TOPO	7745		SMAD6	4091	AAH12986.1	Hs.153863	SMAD family member 6			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005585.4	NP_005576.3	REVIEWED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC034475	IRAK033E04	MGC	W01A046A04	pENTR-TOPO	14297		CEBPZ	10153	AAH34475.1	Hs.135406	CCAAT/enhancer binding protein (C/EBP), zeta			Testis	NIH_MGC_97	DH10B	NM_005760.2	NP_005751.2	VALIDATED	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
RIKEN	BC012986	IRAL024B11	MGC	W01A046A05	pENTR-TOPO	7745		SMAD6	4091	AAH12986.1	Hs.153863	SMAD family member 6			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005585.4	NP_005576.3	REVIEWED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC034475	IRAK033E04	MGC	W01A046A06	pENTR-TOPO	14297		CEBPZ	10153	AAH34475.1	Hs.135406	CCAAT/enhancer binding protein (C/EBP), zeta			Testis	NIH_MGC_97	DH10B	NM_005760.2	NP_005751.2	VALIDATED	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
RIKEN	BC012333	IRAL008P13	MGC	W01A046A08	pENTR-TOPO	3764		SC5DL	6309	AAH12333.1	Hs.287749	Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001024956.2	NP_001020127.1	REVIEWED	C	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC012986	IRAL024B11	MGC	W01A046A09	pENTR-TOPO	7745		SMAD6	4091	AAH12986.1	Hs.153863	SMAD family member 6			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005585.4	NP_005576.3	REVIEWED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC012333	IRAL008P13	MGC	W01A046A10	pENTR-TOPO	3764		SC5DL	6309	AAH12333.1	Hs.287749	Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001024956.2	NP_001020127.1	REVIEWED	C	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC012333	IRAL008P13	MGC	W01A046A14	pENTR-TOPO	3764		SC5DL	6309	AAH12333.1	Hs.287749	Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001024956.2	NP_001020127.1	REVIEWED	C	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC007951	IRAL020L12	MGC	W01A046A15	pENTR-TOPO	9984		SOX9	6662	AAH07951.1	Hs.647409	SRY (sex determining region Y)-box 9			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_000346.3	NP_000337.1	VALIDATED	OK	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC012333	IRAL008P13	MGC	W01A046A18	pENTR-TOPO	3764		SC5DL	6309	AAH12333.1	Hs.287749	Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001024956.2	NP_001020127.1	REVIEWED	C	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC007951	IRAL020L12	MGC	W01A046A21	pENTR-TOPO	9984		SOX9	6662	AAH07951.1	Hs.647409	SRY (sex determining region Y)-box 9			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_000346.3	NP_000337.1	VALIDATED	OK	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC007951	IRAL020L12	MGC	W01A046A23	pENTR-TOPO	9984		SOX9	6662	AAH07951.1	Hs.647409	SRY (sex determining region Y)-box 9			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_000346.3	NP_000337.1	VALIDATED	OK	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC017305	IRAL039O08	MGC	W01A046B02	pENTR-TOPO	10416		SIRT7	51547	AAH17305.1	Hs.528641	Sirtuin (silent mating type information regulation 2 homolog) 7 (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_016538.1	NP_057622.1	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC017305	IRAL039O08	MGC	W01A046B20	pENTR-TOPO	10416		SIRT7	51547	AAH17305.1	Hs.528641	Sirtuin (silent mating type information regulation 2 homolog) 7 (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_016538.1	NP_057622.1	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC007717	IRAL017O07	MGC	W01A046B24	pENTR-TOPO	11536		ZNF324	25799	AAH07717.1	Hs.515660	Zinc finger protein 324			Uterus, leiomyosarcoma	NIH_MGC_46		NM_014347.1	NP_055162.1	PROVISIONAL	P	1.000	1.000	278	861	1	834	553	1	278
RIKEN	BC007951	IRAL020L12	MGC	W01A046C03	pENTR-TOPO	9984		SOX9	6662	AAH07951.1	Hs.647409	SRY (sex determining region Y)-box 9			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_000346.3	NP_000337.1	VALIDATED	OK	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC012333	IRAL008P13	MGC	W01A046C04	pENTR-TOPO	3764		SC5DL	6309	AAH12333.1	Hs.287749	Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001024956.2	NP_001020127.1	REVIEWED	C	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC012333	IRAL008P13	MGC	W01A046C06	pENTR-TOPO	3764		SC5DL	6309	AAH12333.1	Hs.287749	Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001024956.2	NP_001020127.1	REVIEWED	C	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC004978	IRAL009H10	MGC	W01A046C09	pENTR-TOPO	11858		TRIM28	10155	AAH04978.1	Hs.467408	Tripartite motif-containing 28			Skin, melanotic melanoma.	NIH_MGC_20		NM_005762.2	NP_005753.1	REVIEWED	OK	1.000	1.000	835	2508	1	2505	835	1	835
RIKEN	BC004978	IRAL009H10	MGC	W01A046C11	pENTR-TOPO	11858		TRIM28	10155	AAH04978.1	Hs.467408	Tripartite motif-containing 28			Skin, melanotic melanoma.	NIH_MGC_20		NM_005762.2	NP_005753.1	REVIEWED	OK	1.000	1.000	835	2508	1	2505	835	1	835
RIKEN	BC026338	IRAK032L22	MGC	W01A046C15	pENTR-TOPO	11958		ICAM5	7087	AAH26338.1	Hs.465862	Intercellular adhesion molecule 5, telencephalin			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003259.3	NP_003250.3	REVIEWED	Cs	0.998	0.998	924	2775	1	2772	924	1	924
RIKEN	BC002651	IRAL012E17	MGC	W01A046C18	pENTR-TOPO	11528		ASNA1	439	AAH02651.1	Hs.465985	ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_004317.2	NP_004308.2	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC002651	IRAL012E17	MGC	W01A046C20	pENTR-TOPO	11528		ASNA1	439	AAH02651.1	Hs.465985	ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_004317.2	NP_004308.2	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC002651	IRAL012E17	MGC	W01A046C24	pENTR-TOPO	11528		ASNA1	439	AAH02651.1	Hs.465985	ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_004317.2	NP_004308.2	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC007717	IRAL017O07	MGC	W01A046D04	pENTR-TOPO	11536		ZNF324	25799	AAH07717.1	Hs.515660	Zinc finger protein 324			Uterus, leiomyosarcoma	NIH_MGC_46		NM_014347.1	NP_055162.1	PROVISIONAL	P	1.000	1.000	278	861	1	834	553	1	278
RIKEN	BC007717	IRAL017O07	MGC	W01A046D06	pENTR-TOPO	11536		ZNF324	25799	AAH07717.1	Hs.515660	Zinc finger protein 324			Uterus, leiomyosarcoma	NIH_MGC_46		NM_014347.1	NP_055162.1	PROVISIONAL	P	1.000	1.000	278	861	1	834	553	1	278
RIKEN	BC007717	IRAL017O07	MGC	W01A046D08	pENTR-TOPO	11536		ZNF324	25799	AAH07717.1	Hs.515660	Zinc finger protein 324			Uterus, leiomyosarcoma	NIH_MGC_46		NM_014347.1	NP_055162.1	PROVISIONAL	P	1.000	1.000	278	861	1	834	553	1	278
RIKEN	BC002509	IRAL004M15	MGC	W01A046D22	pENTR-TOPO	10538		PHF23	79142	AAH02509.1	Hs.647432	PHD finger protein 23			Colon, adenocarcinoma	NIH_MGC_15		NM_024297.2	NP_077273.2	VALIDATED	OK	1.000	1.000	403	1212	1	1209	403	1	403
RIKEN	BC002651	IRAL012E17	MGC	W01A046E02	pENTR-TOPO	11528		ASNA1	439	AAH02651.1	Hs.465985	ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_004317.2	NP_004308.2	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC002651	IRAL012E17	MGC	W01A046E04	pENTR-TOPO	11528		ASNA1	439	AAH02651.1	Hs.465985	ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_004317.2	NP_004308.2	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC028168	IRAK062N11	MGC	W01A046E05	pENTR-TOPO	1576		ICMT	23463	AAH28168.1	Hs.515688	Isoprenylcysteine carboxyl methyltransferase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_012405.3	NP_036537.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC002651	IRAL012E17	MGC	W01A046E06	pENTR-TOPO	11528		ASNA1	439	AAH02651.1	Hs.465985	ArsA arsenite transporter, ATP-binding, homolog 1 (bacterial)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_004317.2	NP_004308.2	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC028168	IRAK062N11	MGC	W01A046E09	pENTR-TOPO	1576		ICMT	23463	AAH28168.1	Hs.515688	Isoprenylcysteine carboxyl methyltransferase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_012405.3	NP_036537.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC017094	IRAK015B14	MGC	W01A046E10	pENTR-TOPO	21839		TRA2A	29896	AAH17094.1	Hs.445652	Transformer 2 alpha homolog (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_013293.3	NP_037425.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC017094	IRAK015B14	MGC	W01A046E14	pENTR-TOPO	21839		TRA2A	29896	AAH17094.1	Hs.445652	Transformer 2 alpha homolog (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_013293.3	NP_037425.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC028168	IRAK062N11	MGC	W01A046E15	pENTR-TOPO	1576		ICMT	23463	AAH28168.1	Hs.515688	Isoprenylcysteine carboxyl methyltransferase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_012405.3	NP_036537.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC017094	IRAK015B14	MGC	W01A046E16	pENTR-TOPO	21839		TRA2A	29896	AAH17094.1	Hs.445652	Transformer 2 alpha homolog (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_013293.3	NP_037425.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC017094	IRAK015B14	MGC	W01A046E18	pENTR-TOPO	21839		TRA2A	29896	AAH17094.1	Hs.445652	Transformer 2 alpha homolog (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_013293.3	NP_037425.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC017094	IRAK015B14	MGC	W01A046E20	pENTR-TOPO	21839		TRA2A	29896	AAH17094.1	Hs.445652	Transformer 2 alpha homolog (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_013293.3	NP_037425.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC010123	IRAL027I14	MGC	W01A046E24	pENTR-TOPO	16719		SH3BP5	9467	AAH10123.2	Hs.719150	SH3-domain binding protein 5 (BTK-associated)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001018009.2	NP_001018009.2	VALIDATED	C	1.000	1.000	298	1278	382	1275	298	1	298
RIKEN	BC002509	IRAL004M15	MGC	W01A046F04	pENTR-TOPO	10538		PHF23	79142	AAH02509.1	Hs.647432	PHD finger protein 23			Colon, adenocarcinoma	NIH_MGC_15		NM_024297.2	NP_077273.2	VALIDATED	OK	1.000	1.000	403	1212	1	1209	403	1	403
RIKEN	BC000428	IRAL001B09	MGC	W01A046F06	pENTR-TOPO	11391		RUVBL2	10856	AAH00428.1	Hs.515846	RuvB-like 2 (E. coli)			Lung, small cell carcinoma	NIH_MGC_7		NM_006666.1	NP_006657.1	REVIEWED	C	1.000	1.000	463	1392	1	1389	463	1	463
RIKEN	BC000428	IRAL001B09	MGC	W01A046F08	pENTR-TOPO	11391		RUVBL2	10856	AAH00428.1	Hs.515846	RuvB-like 2 (E. coli)			Lung, small cell carcinoma	NIH_MGC_7		NM_006666.1	NP_006657.1	REVIEWED	C	1.000	1.000	463	1392	1	1389	463	1	463
RIKEN	BC000428	IRAL001B09	MGC	W01A046F12	pENTR-TOPO	11391		RUVBL2	10856	AAH00428.1	Hs.515846	RuvB-like 2 (E. coli)			Lung, small cell carcinoma	NIH_MGC_7		NM_006666.1	NP_006657.1	REVIEWED	C	1.000	1.000	463	1392	1	1389	463	1	463
RIKEN	BC000428	IRAL001B09	MGC	W01A046F18	pENTR-TOPO	11391		RUVBL2	10856	AAH00428.1	Hs.515846	RuvB-like 2 (E. coli)			Lung, small cell carcinoma	NIH_MGC_7		NM_006666.1	NP_006657.1	REVIEWED	C	1.000	1.000	463	1392	1	1389	463	1	463
RIKEN	BC028168	IRAK062N11	MGC	W01A046G01	pENTR-TOPO	1576		ICMT	23463	AAH28168.1	Hs.515688	Isoprenylcysteine carboxyl methyltransferase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_012405.3	NP_036537.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC010123	IRAL027I14	MGC	W01A046G02	pENTR-TOPO	16719		SH3BP5	9467	AAH10123.2	Hs.719150	SH3-domain binding protein 5 (BTK-associated)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001018009.2	NP_001018009.2	VALIDATED	C	1.000	1.000	298	1278	382	1275	298	1	298
RIKEN	AK000576	flj0057i17	FLJ	W01A046G03	pENTR-TOPO	15576		MIOX	55586	BAA91266.1	Hs.129227	Myo-inositol oxygenase				REC	EK1	NM_017584.5	NP_060054.4	VALIDATED	C	1.000	1.000	285	858	1	855	285	1	285
RIKEN	BC010123	IRAL027I14	MGC	W01A046G04	pENTR-TOPO	16719		SH3BP5	9467	AAH10123.2	Hs.719150	SH3-domain binding protein 5 (BTK-associated)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001018009.2	NP_001018009.2	VALIDATED	C	1.000	1.000	298	1278	382	1275	298	1	298
RIKEN	AK000576	flj0057i17	FLJ	W01A046G05	pENTR-TOPO	15576		MIOX	55586	BAA91266.1	Hs.129227	Myo-inositol oxygenase				REC	EK1	NM_017584.5	NP_060054.4	VALIDATED	C	1.000	1.000	285	858	1	855	285	1	285
RIKEN	AK000576	flj0057i17	FLJ	W01A046G07	pENTR-TOPO	15576		MIOX	55586	BAA91266.1	Hs.129227	Myo-inositol oxygenase				REC	EK1	NM_017584.5	NP_060054.4	VALIDATED	C	1.000	1.000	285	858	1	855	285	1	285
RIKEN	BC010123	IRAL027I14	MGC	W01A046G08	pENTR-TOPO	16719		SH3BP5	9467	AAH10123.2	Hs.719150	SH3-domain binding protein 5 (BTK-associated)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001018009.2	NP_001018009.2	VALIDATED	C	1.000	1.000	298	1278	382	1275	298	1	298
RIKEN	BC027982	IRAK062A17	MGC	W01A046G16	pENTR-TOPO	9616		KCNJ12	3768	AAH27982.1					Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021012.4	NP_066292.2	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
RIKEN	AK000576	flj0057i17	FLJ	W01A046G17	pENTR-TOPO	15576		MIOX	55586	BAA91266.1	Hs.129227	Myo-inositol oxygenase				REC	EK1	NM_017584.5	NP_060054.4	VALIDATED	C	1.000	1.000	285	858	1	855	285	1	285
RIKEN	AK054574	flj0001k03	FLJ	W01A046G20	pENTR-TOPO	5295		DDX47	51202	BAB70762.1	Hs.23388	DEAD (Asp-Glu-Ala-Asp) box polypeptide 47	NB69	neuroblastoma		3NB692	EK1	NM_016355.3	NP_057439.2	REVIEWED	Cs	0.998	0.998	455	1368	1	1365	455	1	455
RIKEN	AK054574	flj0001k03	FLJ	W01A046G24	pENTR-TOPO	5295		DDX47	51202	BAB70762.1	Hs.23388	DEAD (Asp-Glu-Ala-Asp) box polypeptide 47	NB69	neuroblastoma		3NB692	EK1	NM_016355.3	NP_057439.2	REVIEWED	Cs	0.998	0.998	455	1368	1	1365	455	1	455
RIKEN	BC007595	IRAL022L10	MGC	W01A046H20	pENTR-TOPO	15878		SOX10	6663	AAH07595.1	Hs.376984	SRY (sex determining region Y)-box 10			Skin, melanotic melanoma.	NIH_MGC_20		NM_006941.3	NP_008872.1	REVIEWED	C	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	BC007595	IRAL022L10	MGC	W01A046H24	pENTR-TOPO	15878		SOX10	6663	AAH07595.1	Hs.376984	SRY (sex determining region Y)-box 10			Skin, melanotic melanoma.	NIH_MGC_20		NM_006941.3	NP_008872.1	REVIEWED	C	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	AK000576	flj0057i17	FLJ	W01A046I01	pENTR-TOPO	15576		MIOX	55586	BAA91266.1	Hs.129227	Myo-inositol oxygenase				REC	EK1	NM_017584.5	NP_060054.4	VALIDATED	C	1.000	1.000	285	858	1	855	285	1	285
RIKEN	BC047064	IRAK091B08	MGC	W01A046I03	pENTR-TOPO	4652		SOX6	55553	AAH47064.2	Hs.368226	SRY (sex determining region Y)-box 6			Testis	NIH_MGC_97	DH10B	NM_001145819.1	NP_001139291.1	REVIEWED	C	1.000	1.000	841	2526	1	2523	841	1	841
RIKEN	BC047064	IRAK091B08	MGC	W01A046I05	pENTR-TOPO	4652		SOX6	55553	AAH47064.2	Hs.368226	SRY (sex determining region Y)-box 6			Testis	NIH_MGC_97	DH10B	NM_001145819.1	NP_001139291.1	REVIEWED	C	1.000	1.000	841	2526	1	2523	841	1	841
RIKEN	BC009903	IRAL002G10	MGC	W01A046I06	pENTR-TOPO	11920		SF3A2	8175	AAH09903.1	Hs.115232	Splicing factor 3a, subunit 2, 66kDa			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_007165.4	NP_009096.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
RIKEN	BC011735	IRAL027P15	MGC	W01A046I07	pENTR-TOPO	10400		PLSCR3	57048	AAH11735.1	Hs.655161	Phospholipid scramblase 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020360.2	NP_065093.2	PROVISIONAL	Cs	0.993	0.993	295	888	1	885	295	1	295
RIKEN	BC009903	IRAL002G10	MGC	W01A046I08	pENTR-TOPO	11920		SF3A2	8175	AAH09903.1	Hs.115232	Splicing factor 3a, subunit 2, 66kDa			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_007165.4	NP_009096.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
RIKEN	BC011735	IRAL027P15	MGC	W01A046I13	pENTR-TOPO	10400		PLSCR3	57048	AAH11735.1	Hs.655161	Phospholipid scramblase 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020360.2	NP_065093.2	PROVISIONAL	Cs	0.993	0.993	295	888	1	885	295	1	295
RIKEN	BC036680	IRAK047G11	MGC	W01A046I14	pENTR-TOPO	9304		FBXL16	146330	AAH36680.1	Hs.513244	F-box and leucine-rich repeat protein 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_153350.2	NP_699181.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	BC011735	IRAL027P15	MGC	W01A046I15	pENTR-TOPO	10400		PLSCR3	57048	AAH11735.1	Hs.655161	Phospholipid scramblase 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020360.2	NP_065093.2	PROVISIONAL	Cs	0.993	0.993	295	888	1	885	295	1	295
RIKEN	BC036680	IRAK047G11	MGC	W01A046I16	pENTR-TOPO	9304		FBXL16	146330	AAH36680.1	Hs.513244	F-box and leucine-rich repeat protein 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_153350.2	NP_699181.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	BC036680	IRAK047G11	MGC	W01A046I18	pENTR-TOPO	9304		FBXL16	146330	AAH36680.1	Hs.513244	F-box and leucine-rich repeat protein 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_153350.2	NP_699181.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	BC036680	IRAK047G11	MGC	W01A046I22	pENTR-TOPO	9304		FBXL16	146330	AAH36680.1	Hs.513244	F-box and leucine-rich repeat protein 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_153350.2	NP_699181.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	BC036680	IRAK047G11	MGC	W01A046I24	pENTR-TOPO	9304		FBXL16	146330	AAH36680.1	Hs.513244	F-box and leucine-rich repeat protein 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_153350.2	NP_699181.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	BC007595	IRAL022L10	MGC	W01A046J06	pENTR-TOPO	15878		SOX10	6663	AAH07595.1	Hs.376984	SRY (sex determining region Y)-box 10			Skin, melanotic melanoma.	NIH_MGC_20		NM_006941.3	NP_008872.1	REVIEWED	C	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	BC022009	IRAK033G19	MGC	W01A046J08	pENTR-TOPO	1605		RGS7	6000	AAH22009.1	Hs.655739	Regulator of G-protein signaling 7			Testis	NIH_MGC_97	DH10B	NM_002924.4	NP_002915.3	VALIDATED	Cs	0.998	0.998	487	1464	1	1461	487	1	487
RIKEN	BC022009	IRAK033G19	MGC	W01A046J10	pENTR-TOPO	1605		RGS7	6000	AAH22009.1	Hs.655739	Regulator of G-protein signaling 7			Testis	NIH_MGC_97	DH10B	NM_002924.4	NP_002915.3	VALIDATED	Cs	0.998	0.998	487	1464	1	1461	487	1	487
RIKEN	BC022009	IRAK033G19	MGC	W01A046J16	pENTR-TOPO	1605		RGS7	6000	AAH22009.1	Hs.655739	Regulator of G-protein signaling 7			Testis	NIH_MGC_97	DH10B	NM_002924.4	NP_002915.3	VALIDATED	Cs	0.998	0.998	487	1464	1	1461	487	1	487
RIKEN	BC022846	IRAL025B10	MGC	W01A046J20	pENTR-TOPO	12430		ZSCAN18	65982	AAH22846.1	Hs.235390	Zinc finger and SCAN domain containing 18			Skin, melanotic melanoma.	NIH_MGC_20		NM_023926.4	NP_076415.3	VALIDATED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC022846	IRAL025B10	MGC	W01A046J24	pENTR-TOPO	12430		ZSCAN18	65982	AAH22846.1	Hs.235390	Zinc finger and SCAN domain containing 18			Skin, melanotic melanoma.	NIH_MGC_20		NM_023926.4	NP_076415.3	VALIDATED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC036680	IRAK047G11	MGC	W01A046K02	pENTR-TOPO	9304		FBXL16	146330	AAH36680.1	Hs.513244	F-box and leucine-rich repeat protein 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_153350.2	NP_699181.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	AK024251	flj0034l05	FLJ	W01A046K03	pENTR-TOPO	6425		SLITRK5	26050	BAG51280.1	Hs.591208	SLIT and NTRK-like family, member 5	NT2	teratocarcinoma		NT2RP2	EK1	NM_015567.1	NP_056382.1	VALIDATED	P	1.000	1.000	941	2826	1	2823	958	18	958
RIKEN	BC033822	IRAK068P09	MGC	W01A046K04	pENTR-TOPO	12302		PNKP	11284	AAH33822.1	Hs.78016	Polynucleotide kinase 3'-phosphatase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007254.2	NP_009185.2	PROVISIONAL	OK	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	AK024251	flj0034l05	FLJ	W01A046K09	pENTR-TOPO	6425		SLITRK5	26050	BAG51280.1	Hs.591208	SLIT and NTRK-like family, member 5	NT2	teratocarcinoma		NT2RP2	EK1	NM_015567.1	NP_056382.1	VALIDATED	P	1.000	1.000	941	2826	1	2823	958	18	958
RIKEN	BC033822	IRAK068P09	MGC	W01A046K14	pENTR-TOPO	12302		PNKP	11284	AAH33822.1	Hs.78016	Polynucleotide kinase 3'-phosphatase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007254.2	NP_009185.2	PROVISIONAL	OK	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC021667	IRAL031B22	MGC	W01A046K15	pENTR-TOPO	22687		TTC35	9694	AAH21667.1	Hs.654351	Tetratricopeptide repeat domain 35			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014673.3	NP_055488.1	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC000588	IRAL005A04	MGC	W01A046K16	pENTR-TOPO	9225		HIRIP3	8479	AAH00588.1	Hs.592046	HIRA interacting protein 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_003609.2	NP_003600.2	REVIEWED	OK	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC000588	IRAL005A04	MGC	W01A046K18	pENTR-TOPO	9225		HIRIP3	8479	AAH00588.1	Hs.592046	HIRA interacting protein 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_003609.2	NP_003600.2	REVIEWED	OK	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC021667	IRAL031B22	MGC	W01A046K19	pENTR-TOPO	22687		TTC35	9694	AAH21667.1	Hs.654351	Tetratricopeptide repeat domain 35			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014673.3	NP_055488.1	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC000588	IRAL005A04	MGC	W01A046K22	pENTR-TOPO	9225		HIRIP3	8479	AAH00588.1	Hs.592046	HIRA interacting protein 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_003609.2	NP_003600.2	REVIEWED	OK	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC021667	IRAL031B22	MGC	W01A046K23	pENTR-TOPO	22687		TTC35	9694	AAH21667.1	Hs.654351	Tetratricopeptide repeat domain 35			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014673.3	NP_055488.1	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC022846	IRAL025B10	MGC	W01A046L02	pENTR-TOPO	12430		ZSCAN18	65982	AAH22846.1	Hs.235390	Zinc finger and SCAN domain containing 18			Skin, melanotic melanoma.	NIH_MGC_20		NM_023926.4	NP_076415.3	VALIDATED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC022846	IRAL025B10	MGC	W01A046L06	pENTR-TOPO	12430		ZSCAN18	65982	AAH22846.1	Hs.235390	Zinc finger and SCAN domain containing 18			Skin, melanotic melanoma.	NIH_MGC_20		NM_023926.4	NP_076415.3	VALIDATED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC022846	IRAL025B10	MGC	W01A046L08	pENTR-TOPO	12430		ZSCAN18	65982	AAH22846.1	Hs.235390	Zinc finger and SCAN domain containing 18			Skin, melanotic melanoma.	NIH_MGC_20		NM_023926.4	NP_076415.3	VALIDATED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC022846	IRAL025B10	MGC	W01A046L14	pENTR-TOPO	12430		ZSCAN18	65982	AAH22846.1	Hs.235390	Zinc finger and SCAN domain containing 18			Skin, melanotic melanoma.	NIH_MGC_20		NM_023926.4	NP_076415.3	VALIDATED	Cs	0.998	0.998	510	1533	1	1530	510	1	510
RIKEN	BC029505	IRAK048F19	MGC	W01A046L16	pENTR-TOPO	2192		ZNF683	257101	AAH29505.1	Hs.353208	Zinc finger protein 683			Testis	NIH_MGC_97	DH10B	NM_173574.2	NP_775845.2	VALIDATED	Pgs	0.959	0.998	509	1530	1	1527	504	16	504
RIKEN	BC029505	IRAK048F19	MGC	W01A046L18	pENTR-TOPO	2192		ZNF683	257101	AAH29505.1	Hs.353208	Zinc finger protein 683			Testis	NIH_MGC_97	DH10B	NM_173574.2	NP_775845.2	VALIDATED	Pgs	0.959	0.998	509	1530	1	1527	504	16	504
RIKEN	BC029505	IRAK048F19	MGC	W01A046L22	pENTR-TOPO	2192		ZNF683	257101	AAH29505.1	Hs.353208	Zinc finger protein 683			Testis	NIH_MGC_97	DH10B	NM_173574.2	NP_775845.2	VALIDATED	Pgs	0.959	0.998	509	1530	1	1527	504	16	504
RIKEN	BC000588	IRAL005A04	MGC	W01A046M02	pENTR-TOPO	9225		HIRIP3	8479	AAH00588.1	Hs.592046	HIRA interacting protein 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_003609.2	NP_003600.2	REVIEWED	OK	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC021667	IRAL031B22	MGC	W01A046M03	pENTR-TOPO	22687		TTC35	9694	AAH21667.1	Hs.654351	Tetratricopeptide repeat domain 35			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014673.3	NP_055488.1	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC000588	IRAL005A04	MGC	W01A046M04	pENTR-TOPO	9225		HIRIP3	8479	AAH00588.1	Hs.592046	HIRA interacting protein 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_003609.2	NP_003600.2	REVIEWED	OK	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC000588	IRAL005A04	MGC	W01A046M06	pENTR-TOPO	9225		HIRIP3	8479	AAH00588.1	Hs.592046	HIRA interacting protein 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_003609.2	NP_003600.2	REVIEWED	OK	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC021667	IRAL031B22	MGC	W01A046M07	pENTR-TOPO	22687		TTC35	9694	AAH21667.1	Hs.654351	Tetratricopeptide repeat domain 35			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_014673.3	NP_055488.1	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC000588	IRAL005A04	MGC	W01A046M08	pENTR-TOPO	9225		HIRIP3	8479	AAH00588.1	Hs.592046	HIRA interacting protein 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_003609.2	NP_003600.2	REVIEWED	OK	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC005250	IRAL016O20	MGC	W01A046M12	pENTR-TOPO	19172		MED7	9443	AAH05250	Hs.719330	Mediator complex subunit 7			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001100816.1	NP_001094286.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC005250	IRAL016O20	MGC	W01A046M16	pENTR-TOPO	19172		MED7	9443	AAH05250	Hs.719330	Mediator complex subunit 7			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001100816.1	NP_001094286.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC008935	IRAL002N21	MGC	W01A046M21	pENTR-TOPO	17770		SLC25A6	293	AAH08935.1	Hs.350927	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001636.2	NP_001627.2	VALIDATED	C	1.000	1.000	298	897	1	894	298	1	298
RIKEN	BC005250	IRAL016O20	MGC	W01A046M22	pENTR-TOPO	19172		MED7	9443	AAH05250	Hs.719330	Mediator complex subunit 7			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001100816.1	NP_001094286.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
RIKEN	BC029505	IRAK048F19	MGC	W01A046N02	pENTR-TOPO	2192		ZNF683	257101	AAH29505.1	Hs.353208	Zinc finger protein 683			Testis	NIH_MGC_97	DH10B	NM_173574.2	NP_775845.2	VALIDATED	Pgs	0.959	0.998	509	1530	1	1527	504	16	504
RIKEN	BC004227	IRAL011G20	MGC	W01A046N06	pENTR-TOPO	12932		MTA3	57504	AAH04227.1	Hs.435413	Metastasis associated 1 family, member 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_020744.2	NP_065795.1	PROVISIONAL	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC004227	IRAL011G20	MGC	W01A046N08	pENTR-TOPO	12932		MTA3	57504	AAH04227.1	Hs.435413	Metastasis associated 1 family, member 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_020744.2	NP_065795.1	PROVISIONAL	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC004227	IRAL011G20	MGC	W01A046N12	pENTR-TOPO	12932		MTA3	57504	AAH04227.1	Hs.435413	Metastasis associated 1 family, member 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_020744.2	NP_065795.1	PROVISIONAL	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC004227	IRAL011G20	MGC	W01A046N18	pENTR-TOPO	12932		MTA3	57504	AAH04227.1	Hs.435413	Metastasis associated 1 family, member 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_020744.2	NP_065795.1	PROVISIONAL	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC004227	IRAL011G20	MGC	W01A046N22	pENTR-TOPO	12932		MTA3	57504	AAH04227.1	Hs.435413	Metastasis associated 1 family, member 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_020744.2	NP_065795.1	PROVISIONAL	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC008935	IRAL002N21	MGC	W01A046O01	pENTR-TOPO	17770		SLC25A6	293	AAH08935.1	Hs.350927	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001636.2	NP_001627.2	VALIDATED	C	1.000	1.000	298	897	1	894	298	1	298
RIKEN	BC000162	IRAK003E15	MGC	W01A046O02	pENTR-TOPO	5180		STRAP	11171	AAH00162.1	Hs.719087	Serine/threonine kinase receptor associated protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007178.3	NP_009109.3	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC008935	IRAL002N21	MGC	W01A046O05	pENTR-TOPO	17770		SLC25A6	293	AAH08935.1	Hs.350927	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001636.2	NP_001627.2	VALIDATED	C	1.000	1.000	298	897	1	894	298	1	298
RIKEN	BC000162	IRAK003E15	MGC	W01A046O06	pENTR-TOPO	5180		STRAP	11171	AAH00162.1	Hs.719087	Serine/threonine kinase receptor associated protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007178.3	NP_009109.3	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC000162	IRAK003E15	MGC	W01A046O08	pENTR-TOPO	5180		STRAP	11171	AAH00162.1	Hs.719087	Serine/threonine kinase receptor associated protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007178.3	NP_009109.3	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC000162	IRAK003E15	MGC	W01A046O10	pENTR-TOPO	5180		STRAP	11171	AAH00162.1	Hs.719087	Serine/threonine kinase receptor associated protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007178.3	NP_009109.3	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC000162	IRAK003E15	MGC	W01A046O12	pENTR-TOPO	5180		STRAP	11171	AAH00162.1	Hs.719087	Serine/threonine kinase receptor associated protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007178.3	NP_009109.3	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC000162	IRAK003E15	MGC	W01A046O16	pENTR-TOPO	5180		STRAP	11171	AAH00162.1	Hs.719087	Serine/threonine kinase receptor associated protein			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007178.3	NP_009109.3	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC018070	IRAK032N16	MGC	W01A046O17	pENTR-TOPO	17159		DPPA2	151871	AAH18070.1	Hs.351113	Developmental pluripotency associated 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_138815.2	NP_620170.2	PROVISIONAL	Cs	0.997	0.997	298	897	1	894	298	1	298
RIKEN	BC018070	IRAK032N16	MGC	W01A046O21	pENTR-TOPO	17159		DPPA2	151871	AAH18070.1	Hs.351113	Developmental pluripotency associated 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_138815.2	NP_620170.2	PROVISIONAL	Cs	0.997	0.997	298	897	1	894	298	1	298
RIKEN	BC012126	IRAL029P02	MGC	W01A046O24	pENTR-TOPO	15382		CLDN14	23562	AAH12126.1	Hs.660278	Claudin 14			Skin, melanoma, amelanotic	NIH_MGC_41		NM_001146079.1	NP_001139551.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC029897	IRAK051J23	MGC	W01A046P02	pENTR-TOPO	15615		TBC1D22A	25771	AAH29897.1	Hs.435044	TBC1 domain family, member 22A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_014346.1	NP_055161.1	PROVISIONAL	OK	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC029897	IRAK051J23	MGC	W01A046P04	pENTR-TOPO	15615		TBC1D22A	25771	AAH29897.1	Hs.435044	TBC1 domain family, member 22A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_014346.1	NP_055161.1	PROVISIONAL	OK	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC029897	IRAK051J23	MGC	W01A046P06	pENTR-TOPO	15615		TBC1D22A	25771	AAH29897.1	Hs.435044	TBC1 domain family, member 22A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_014346.1	NP_055161.1	PROVISIONAL	OK	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC001543	IRAK004D16	MGC	W01A047A04	pENTR-TOPO	5377		HOXC11	3227	AAH01543.1	Hs.127562	Homeobox C11			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014212.3	NP_055027.1	REVIEWED	Cs	0.997	0.997	304	915	1	912	304	1	304
RIKEN	BC001543	IRAK004D16	MGC	W01A047A08	pENTR-TOPO	5377		HOXC11	3227	AAH01543.1	Hs.127562	Homeobox C11			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014212.3	NP_055027.1	REVIEWED	Cs	0.997	0.997	304	915	1	912	304	1	304
RIKEN	AK097640	flj0043c02	FLJ	W01A047A11	pENTR-TOPO	12553		TPRX1	284355	BAC05130.1	Hs.629812	Tetra-peptide repeat homeobox 1				TESTI2	EK1	NM_198479.2	NP_940881.2	VALIDATED	Cs	0.995	0.995	411	1236	1	1233	411	1	411
RIKEN	AK097640	flj0043c02	FLJ	W01A047A13	pENTR-TOPO	12553		TPRX1	284355	BAC05130.1	Hs.629812	Tetra-peptide repeat homeobox 1				TESTI2	EK1	NM_198479.2	NP_940881.2	VALIDATED	Cs	0.995	0.995	411	1236	1	1233	411	1	411
RIKEN	AK097640	flj0043c02	FLJ	W01A047A15	pENTR-TOPO	12553		TPRX1	284355	BAC05130.1	Hs.629812	Tetra-peptide repeat homeobox 1				TESTI2	EK1	NM_198479.2	NP_940881.2	VALIDATED	Cs	0.995	0.995	411	1236	1	1233	411	1	411
RIKEN	AK097640	flj0043c02	FLJ	W01A047A19	pENTR-TOPO	12553		TPRX1	284355	BAC05130.1	Hs.629812	Tetra-peptide repeat homeobox 1				TESTI2	EK1	NM_198479.2	NP_940881.2	VALIDATED	Cs	0.995	0.995	411	1236	1	1233	411	1	411
RIKEN	AK097640	flj0043c02	FLJ	W01A047A21	pENTR-TOPO	12553		TPRX1	284355	BAC05130.1	Hs.629812	Tetra-peptide repeat homeobox 1				TESTI2	EK1	NM_198479.2	NP_940881.2	VALIDATED	Cs	0.995	0.995	411	1236	1	1233	411	1	411
RIKEN	AK094073	flj0016f04	FLJ	W01A047A24	pENTR-TOPO	19351		SFRS12IP1	285672	BAC04279.1	Hs.69504	SFRS12-interacting protein 1				UTERU2	EK1	NM_173829.3	NP_776190.1	VALIDATED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC011932	IRAL028L09	MGC	W01A047B03	pENTR-TOPO	9142		POLR3K	51728	AAH11932.1	Hs.632223	Polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016310.2	NP_057394.1	REVIEWED	C	1.000	1.000	108	327	1	324	108	1	108
RIKEN	BC011932	IRAL028L09	MGC	W01A047B05	pENTR-TOPO	9142		POLR3K	51728	AAH11932.1	Hs.632223	Polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016310.2	NP_057394.1	REVIEWED	C	1.000	1.000	108	327	1	324	108	1	108
RIKEN	BC011932	IRAL028L09	MGC	W01A047B09	pENTR-TOPO	9142		POLR3K	51728	AAH11932.1	Hs.632223	Polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016310.2	NP_057394.1	REVIEWED	C	1.000	1.000	108	327	1	324	108	1	108
RIKEN	BC032099	IRAL028J17	MGC	W01A047B19	pENTR-TOPO	1713		PYGO2	90780	AAH32099.1	Hs.533597	Pygopus homolog 2 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_138300.3	NP_612157.1	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	AK094073	flj0016f04	FLJ	W01A047C06	pENTR-TOPO	19351		SFRS12IP1	285672	BAC04279.1	Hs.69504	SFRS12-interacting protein 1				UTERU2	EK1	NM_173829.3	NP_776190.1	VALIDATED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC002601	IRAL004J22	MGC	W01A047C12	pENTR-TOPO	7546		NFKBIA	4792	AAH02601.1	Hs.81328	Nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha			Brain, neuroblastoma	NIH_MGC_19		NM_020529.2	NP_065390.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC026265	IRAL036P11	MGC	W01A047C20	pENTR-TOPO	22163		C7orf11	136647	AAH26265.1	Hs.654989	Chromosome 7 open reading frame 11			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_138701.2	NP_619646.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC032099	IRAL028J17	MGC	W01A047D01	pENTR-TOPO	1713		PYGO2	90780	AAH32099.1	Hs.533597	Pygopus homolog 2 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_138300.3	NP_612157.1	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	BC032099	IRAL028J17	MGC	W01A047D03	pENTR-TOPO	1713		PYGO2	90780	AAH32099.1	Hs.533597	Pygopus homolog 2 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_138300.3	NP_612157.1	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	BC025265	IRAL042E23	MGC	W01A047D19	pENTR-TOPO	21865		ZNF3	7551	AAH25265	Hs.435302	Zinc finger protein 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_017715.2	NP_060185.2	VALIDATED	P	1.000	1.000	55	1233	1	165	131	37	91
RIKEN	BC025265	IRAL042E23	MGC	W01A047D23	pENTR-TOPO	21865		ZNF3	7551	AAH25265	Hs.435302	Zinc finger protein 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_017715.2	NP_060185.2	VALIDATED	P	1.000	1.000	55	1233	1	165	131	37	91
RIKEN	BC026265	IRAL036P11	MGC	W01A047E04	pENTR-TOPO	22163		C7orf11	136647	AAH26265.1	Hs.654989	Chromosome 7 open reading frame 11			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_138701.2	NP_619646.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC026265	IRAL036P11	MGC	W01A047E06	pENTR-TOPO	22163		C7orf11	136647	AAH26265.1	Hs.654989	Chromosome 7 open reading frame 11			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_138701.2	NP_619646.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC005146	IRAL003L13	MGC	W01A047E14	pENTR-TOPO	12114		LGALS4	3960	AAH05146.1	Hs.5302	Lectin, galactoside-binding, soluble, 4			Colon, adenocarcinoma	NIH_MGC_15		NM_006149.3	NP_006140.1	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC005146	IRAL003L13	MGC	W01A047E16	pENTR-TOPO	12114		LGALS4	3960	AAH05146.1	Hs.5302	Lectin, galactoside-binding, soluble, 4			Colon, adenocarcinoma	NIH_MGC_15		NM_006149.3	NP_006140.1	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC005146	IRAL003L13	MGC	W01A047E18	pENTR-TOPO	12114		LGALS4	3960	AAH05146.1	Hs.5302	Lectin, galactoside-binding, soluble, 4			Colon, adenocarcinoma	NIH_MGC_15		NM_006149.3	NP_006140.1	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC005146	IRAL003L13	MGC	W01A047E24	pENTR-TOPO	12114		LGALS4	3960	AAH05146.1	Hs.5302	Lectin, galactoside-binding, soluble, 4			Colon, adenocarcinoma	NIH_MGC_15		NM_006149.3	NP_006140.1	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC015014	IRAK015O09	MGC	W01A047G02	pENTR-TOPO	2631		RAB18	22931	AAH15014.1	Hs.406799	RAB18, member RAS oncogene family			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_021252.3	NP_067075.1	PROVISIONAL	C	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC015014	IRAK015O09	MGC	W01A047G14	pENTR-TOPO	2631		RAB18	22931	AAH15014.1	Hs.406799	RAB18, member RAS oncogene family			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_021252.3	NP_067075.1	PROVISIONAL	C	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC015014	IRAK015O09	MGC	W01A047G16	pENTR-TOPO	2631		RAB18	22931	AAH15014.1	Hs.406799	RAB18, member RAS oncogene family			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_021252.3	NP_067075.1	PROVISIONAL	C	1.000	1.000	206	621	1	618	206	1	206
RIKEN	BC022821	IRAL042M20	MGC	W01A047G19	pENTR-TOPO	21437		BUD31	8896	AAH22821.1	Hs.380233	BUD31 homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_003910.3	NP_003901.2	VALIDATED	OK	1.000	1.000	144	435	1	432	144	1	144
RIKEN	AK054797	flj0011b18	FLJ	W01A047G22	pENTR-TOPO	23587		BARHL1	56751	BAB70807.1	Hs.283809	BarH-like homeobox 1				BRACE2	EK1	NM_020064.3	NP_064448.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC011655	IRAL017H06	MGC	W01A047H03	pENTR-TOPO	18074		CTBP1	1487	AAH11655.1	Hs.208597	C-terminal binding protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_001328.2	NP_001319.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC011655	IRAL017H06	MGC	W01A047H05	pENTR-TOPO	18074		CTBP1	1487	AAH11655.1	Hs.208597	C-terminal binding protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_001328.2	NP_001319.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC011655	IRAL017H06	MGC	W01A047H09	pENTR-TOPO	18074		CTBP1	1487	AAH11655.1	Hs.208597	C-terminal binding protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_001328.2	NP_001319.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC022821	IRAL042M20	MGC	W01A047I01	pENTR-TOPO	21437		BUD31	8896	AAH22821.1	Hs.380233	BUD31 homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_003910.3	NP_003901.2	VALIDATED	OK	1.000	1.000	144	435	1	432	144	1	144
RIKEN	AK054797	flj0011b18	FLJ	W01A047I02	pENTR-TOPO	23587		BARHL1	56751	BAB70807.1	Hs.283809	BarH-like homeobox 1				BRACE2	EK1	NM_020064.3	NP_064448.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC022821	IRAL042M20	MGC	W01A047I07	pENTR-TOPO	21437		BUD31	8896	AAH22821.1	Hs.380233	BUD31 homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_003910.3	NP_003901.2	VALIDATED	OK	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC004441	IRAL009O17	MGC	W01A047I08	pENTR-TOPO	12565		POLR2E	5434	AAH04441.1	Hs.24301	Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002695.3	NP_002686.2	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC004441	IRAL009O17	MGC	W01A047I10	pENTR-TOPO	12565		POLR2E	5434	AAH04441.1	Hs.24301	Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002695.3	NP_002686.2	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC022821	IRAL042M20	MGC	W01A047I13	pENTR-TOPO	21437		BUD31	8896	AAH22821.1	Hs.380233	BUD31 homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_003910.3	NP_003901.2	VALIDATED	OK	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC004441	IRAL009O17	MGC	W01A047I14	pENTR-TOPO	12565		POLR2E	5434	AAH04441.1	Hs.24301	Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002695.3	NP_002686.2	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC022821	IRAL042M20	MGC	W01A047I15	pENTR-TOPO	21437		BUD31	8896	AAH22821.1	Hs.380233	BUD31 homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_003910.3	NP_003901.2	VALIDATED	OK	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC021719	IRAK047O18	MGC	W01A047I17	pENTR-TOPO	24656		RHOXF2	84528	AAH21719.1	Hs.567620	Rhox homeobox family, member 2			Testis	NIH_MGC_97	DH10B	NM_032498.1	NP_115887.1	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC021719	IRAK047O18	MGC	W01A047I19	pENTR-TOPO	24656		RHOXF2	84528	AAH21719.1	Hs.567620	Rhox homeobox family, member 2			Testis	NIH_MGC_97	DH10B	NM_032498.1	NP_115887.1	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC021719	IRAK047O18	MGC	W01A047I21	pENTR-TOPO	24656		RHOXF2	84528	AAH21719.1	Hs.567620	Rhox homeobox family, member 2			Testis	NIH_MGC_97	DH10B	NM_032498.1	NP_115887.1	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC021719	IRAK047O18	MGC	W01A047I23	pENTR-TOPO	24656		RHOXF2	84528	AAH21719.1	Hs.567620	Rhox homeobox family, member 2			Testis	NIH_MGC_97	DH10B	NM_032498.1	NP_115887.1	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC004441	IRAL009O17	MGC	W01A047I24	pENTR-TOPO	12565		POLR2E	5434	AAH04441.1	Hs.24301	Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002695.3	NP_002686.2	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC004441	IRAL009O17	MGC	W01A047K02	pENTR-TOPO	12565		POLR2E	5434	AAH04441.1	Hs.24301	Polymerase (RNA) II (DNA directed) polypeptide E, 25kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002695.3	NP_002686.2	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC035048	IRAK073E13	MGC	W01A047K04	pENTR-TOPO	21877		NEUROD6	63974	AAH35048.1	Hs.45152	Neurogenic differentiation 6			Brain, hippocampus	NIH_MGC_95	DH10B	NM_022728.2	NP_073565.2	PROVISIONAL	Cs	0.997	0.997	337	1014	1	1011	337	1	337
RIKEN	BC021719	IRAK047O18	MGC	W01A047K13	pENTR-TOPO	24656		RHOXF2	84528	AAH21719.1	Hs.567620	Rhox homeobox family, member 2			Testis	NIH_MGC_97	DH10B	NM_032498.1	NP_115887.1	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC035048	IRAK073E13	MGC	W01A047K18	pENTR-TOPO	21877		NEUROD6	63974	AAH35048.1	Hs.45152	Neurogenic differentiation 6			Brain, hippocampus	NIH_MGC_95	DH10B	NM_022728.2	NP_073565.2	PROVISIONAL	Cs	0.997	0.997	337	1014	1	1011	337	1	337
RIKEN	BC035048	IRAK073E13	MGC	W01A047K20	pENTR-TOPO	21877		NEUROD6	63974	AAH35048.1	Hs.45152	Neurogenic differentiation 6			Brain, hippocampus	NIH_MGC_95	DH10B	NM_022728.2	NP_073565.2	PROVISIONAL	Cs	0.997	0.997	337	1014	1	1011	337	1	337
RIKEN	BC013949	IRAL002K17	MGC	W01A047K24	pENTR-TOPO	11947		CCDC124	115098	AAH13949.1	Hs.100043	Coiled-coil domain containing 124			Lung, small cell carcinoma	NIH_MGC_7		NM_138442.3	NP_612451.1	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC013949	IRAL002K17	MGC	W01A047M02	pENTR-TOPO	11947		CCDC124	115098	AAH13949.1	Hs.100043	Coiled-coil domain containing 124			Lung, small cell carcinoma	NIH_MGC_7		NM_138442.3	NP_612451.1	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC039172	IRAK028P23	MGC	W01A047M03	pENTR-TOPO	3215		CALML5	51806	AAH39172.1	Hs.180142	Calmodulin-like 5			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_017422.4	NP_059118.2	REVIEWED	Cs	0.986	0.986	146	441	1	438	146	1	146
RIKEN	BC013949	IRAL002K17	MGC	W01A047M04	pENTR-TOPO	11947		CCDC124	115098	AAH13949.1	Hs.100043	Coiled-coil domain containing 124			Lung, small cell carcinoma	NIH_MGC_7		NM_138442.3	NP_612451.1	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC013949	IRAL002K17	MGC	W01A047M06	pENTR-TOPO	11947		CCDC124	115098	AAH13949.1	Hs.100043	Coiled-coil domain containing 124			Lung, small cell carcinoma	NIH_MGC_7		NM_138442.3	NP_612451.1	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC013949	IRAL002K17	MGC	W01A047M08	pENTR-TOPO	11947		CCDC124	115098	AAH13949.1	Hs.100043	Coiled-coil domain containing 124			Lung, small cell carcinoma	NIH_MGC_7		NM_138442.3	NP_612451.1	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC039172	IRAK028P23	MGC	W01A047M13	pENTR-TOPO	3215		CALML5	51806	AAH39172.1	Hs.180142	Calmodulin-like 5			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_017422.4	NP_059118.2	REVIEWED	Cs	0.986	0.986	146	441	1	438	146	1	146
RIKEN	BC013949	IRAL002K17	MGC	W01A047M14	pENTR-TOPO	11947		CCDC124	115098	AAH13949.1	Hs.100043	Coiled-coil domain containing 124			Lung, small cell carcinoma	NIH_MGC_7		NM_138442.3	NP_612451.1	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC007754	IRAL017D18	MGC	W01A047M20	pENTR-TOPO	2771		SUV39H2	79723	AAH07754.1	Hs.554883	Suppressor of variegation 3-9 homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024670.3	NP_078946.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC007754	IRAL017D18	MGC	W01A047M22	pENTR-TOPO	2771		SUV39H2	79723	AAH07754.1	Hs.554883	Suppressor of variegation 3-9 homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024670.3	NP_078946.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC007754	IRAL017D18	MGC	W01A047O02	pENTR-TOPO	2771		SUV39H2	79723	AAH07754.1	Hs.554883	Suppressor of variegation 3-9 homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024670.3	NP_078946.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC017366	IRAL007F15	MGC	W01A047O03	pENTR-TOPO	18600		CNOT8	9337	AAH17366.1	Hs.26703	CCR4-NOT transcription complex, subunit 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004779.4	NP_004770.4	PROVISIONAL	OK	1.000	1.000	292	879	1	876	292	1	292
RIKEN	BC007754	IRAL017D18	MGC	W01A047O04	pENTR-TOPO	2771		SUV39H2	79723	AAH07754.1	Hs.554883	Suppressor of variegation 3-9 homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024670.3	NP_078946.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC007754	IRAL017D18	MGC	W01A047O08	pENTR-TOPO	2771		SUV39H2	79723	AAH07754.1	Hs.554883	Suppressor of variegation 3-9 homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024670.3	NP_078946.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC007754	IRAL017D18	MGC	W01A047O12	pENTR-TOPO	2771		SUV39H2	79723	AAH07754.1	Hs.554883	Suppressor of variegation 3-9 homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024670.3	NP_078946.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC007754	IRAL017D18	MGC	W01A047O14	pENTR-TOPO	2771		SUV39H2	79723	AAH07754.1	Hs.554883	Suppressor of variegation 3-9 homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024670.3	NP_078946.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC000739	IRAL007O23	MGC	W01A047O15	pENTR-TOPO	16533		POLR2H	5437	AAH00739.1	Hs.432574	Polymerase (RNA) II (DNA directed) polypeptide H			Placenta, choriocarcinoma	NIH_MGC_21		NM_006232.2	NP_006223.2	REVIEWED	C	1.000	1.000	150	453	1	450	150	1	150
RIKEN	BC000739	IRAL007O23	MGC	W01A047O19	pENTR-TOPO	16533		POLR2H	5437	AAH00739.1	Hs.432574	Polymerase (RNA) II (DNA directed) polypeptide H			Placenta, choriocarcinoma	NIH_MGC_21		NM_006232.2	NP_006223.2	REVIEWED	C	1.000	1.000	150	453	1	450	150	1	150
RIKEN	BC011932	IRAL028L09	MGC	W01A047O22	pENTR-TOPO	9142		POLR3K	51728	AAH11932.1	Hs.632223	Polymerase (RNA) III (DNA directed) polypeptide K, 12.3 kDa			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016310.2	NP_057394.1	REVIEWED	C	1.000	1.000	108	327	1	324	108	1	108
RIKEN	BC017589	IRAK034D24	MGC	W01A048A12	pENTR-TOPO	23660		TPD52L3	89882	AAH17589.1	Hs.351815	Tumor protein D52-like 3			Testis	NIH_MGC_97	DH10B	NM_001001875.2	NP_001001875.1	VALIDATED	C	1.000	1.000	132	399	1	396	132	1	132
RIKEN	BC017589	IRAK034D24	MGC	W01A048A16	pENTR-TOPO	23660		TPD52L3	89882	AAH17589.1	Hs.351815	Tumor protein D52-like 3			Testis	NIH_MGC_97	DH10B	NM_001001875.2	NP_001001875.1	VALIDATED	C	1.000	1.000	132	399	1	396	132	1	132
RIKEN	H033076C15	H033076C15	RIKEN	W01A048A18	pENTR-TOPO		9658	RAD51C	5889		Hs.412587	RAD51 homolog C (S. cerevisiae)	-	-	hypothalamus	hypothalamus	DH10B	NM_002876.2	NP_002867.1	REVIEWED	P	1.000	1.000	134	405	1	402	135	1	134
RIKEN	AK090933	flj0011i17	FLJ	W01A048A21	pENTR-TOPO	16748		SERP1	27230	-	Hs.709270	Stress-associated endoplasmic reticulum protein 1				BRAMY2	EK1	NM_014445.3	NP_055260.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
RIKEN	AK023020	flj0034k14	FLJ	W01A048B02	pENTR-TOPO	1386		IVNS1ABP	10625	BAG51150.1	Hs.497183	Influenza virus NS1A binding protein	NT2	teratocarcinoma		NT2RP2	EK1	NM_006469.4	NP_006460.2	VALIDATED	P	1.000	1.000	220	666	1	660	642	1	220
RIKEN	AK023020	flj0034k14	FLJ	W01A048B08	pENTR-TOPO	1386		IVNS1ABP	10625	BAG51150.1	Hs.497183	Influenza virus NS1A binding protein	NT2	teratocarcinoma		NT2RP2	EK1	NM_006469.4	NP_006460.2	VALIDATED	P	1.000	1.000	220	666	1	660	642	1	220
RIKEN	AK096828	flj0042i01	FLJ	W01A048B11	pENTR-TOPO	12545		ZNF321	399669	BAC04871.1	Hs.675715	Zinc finger protein 321				PROST2	EK1	NM_203307.2	NP_976052.2	VALIDATED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	AK096828	flj0042i01	FLJ	W01A048B13	pENTR-TOPO	12545		ZNF321	399669	BAC04871.1	Hs.675715	Zinc finger protein 321				PROST2	EK1	NM_203307.2	NP_976052.2	VALIDATED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	AK096828	flj0042i01	FLJ	W01A048B15	pENTR-TOPO	12545		ZNF321	399669	BAC04871.1	Hs.675715	Zinc finger protein 321				PROST2	EK1	NM_203307.2	NP_976052.2	VALIDATED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	AK074962	flj0018j17	FLJ	W01A048B22	pENTR-TOPO	19139		TMED7	51014	BAC11318.1	Hs.642817	Transmembrane emp24 protein transport domain containing 7	NT2	teratocarcinoma		NT2RP3	EK1	NM_181836.4	NP_861974.1	VALIDATED	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC066282	IRAK172A18	MGC	W01A048C12	pENTR-TOPO	19462		IL5	3567	AAH66282.1	Hs.2247	Interleukin 5 (colony-stimulating factor, eosinophil)			PCR rescued clones	NIH_MGC_195	DH10B	NM_000879.2	NP_000870.1	REVIEWED	OK	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC066282	IRAK172A18	MGC	W01A048C14	pENTR-TOPO	19462		IL5	3567	AAH66282.1	Hs.2247	Interleukin 5 (colony-stimulating factor, eosinophil)			PCR rescued clones	NIH_MGC_195	DH10B	NM_000879.2	NP_000870.1	REVIEWED	OK	1.000	1.000	134	405	1	402	134	1	134
RIKEN	AK128250	flj0074h21	FLJ	W01A048C24	pENTR-TOPO	11848		ZNF818P	390963	BAC87353.1	Hs.444446	Zinc finger protein 818 pseudogene				THYMU2	EK1													
RIKEN	AK000351	flj0051f09	FLJ	W01A048D01	pENTR-TOPO	24692		ZNF673	55634	BAA91104.1	Hs.632800	Zinc finger family member 673	HepG2	hepatoma		HEP	EK1	NM_017776.2	NP_060246.2	VALIDATED	Cs	0.994	0.994	166	501	1	498	166	1	166
RIKEN	AK000351	flj0051f09	FLJ	W01A048D05	pENTR-TOPO	24692		ZNF673	55634	BAA91104.1	Hs.632800	Zinc finger family member 673	HepG2	hepatoma		HEP	EK1	NM_017776.2	NP_060246.2	VALIDATED	Cs	0.994	0.994	166	501	1	498	166	1	166
RIKEN	H023066A05	H023066A05	RIKEN	W01A048D06	pENTR-TOPO		25100						-	-	hippocampus	hippocampus	DH10B			
RIKEN	AK056412	flj0006c09	FLJ	W01A048D18	pENTR-TOPO	21177		PILRB	29990	BAG51701.1	Hs.632314	Paired immunoglobin-like type 2 receptor beta	NT2	teratocarcinoma		NT2RP7	EK1	NM_178238.1	NP_839956.1	REVIEWED	OK	1.000	1.000	227	684	1	681	227	1	227
RIKEN	AK056412	flj0006c09	FLJ	W01A048D20	pENTR-TOPO	21177		PILRB	29990	BAG51701.1	Hs.632314	Paired immunoglobin-like type 2 receptor beta	NT2	teratocarcinoma		NT2RP7	EK1	NM_178238.1	NP_839956.1	REVIEWED	OK	1.000	1.000	227	684	1	681	227	1	227
RIKEN	H013064O20	H013064O20	RIKEN	W01A048E08	pENTR-TOPO		17984						-	-	testis	testis	DH10B			
RIKEN	AK074781	flj0018o19	FLJ	W01A048E12	pENTR-TOPO	7402		CNIH	10175	BAG52000.1	Hs.294603	Cornichon homolog (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_005776.2	NP_005767.1	VALIDATED	C	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC066283	IRAK172C12	MGC	W01A048E24	pENTR-TOPO	19463		IL9	3578	AAH66283.1	Hs.960	Interleukin 9			PCR rescued clones	NIH_MGC_195	DH10B	NM_000590.1	NP_000581.1	REVIEWED	OK	1.000	1.000	144	435	1	432	144	1	144
RIKEN	BC066270	IRAK172F11	MGC	W01A048F13	pENTR-TOPO	6034		IL26	55801	AAH66270.1	Hs.272350	Interleukin 26			PCR rescued clones	NIH_MGC_195	DH10B	NM_018402.1	NP_060872.1	REVIEWED	C	1.000	1.000	171	516	1	513	171	1	171
RIKEN	BC035572	IRAK069B17	MGC	W01A048F16	pENTR-TOPO	10738		EVI2A	2123	AAH35572.2	Hs.591198	Ecotropic viral integration site 2A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014210.2	NP_055025.2	VALIDATED	C	1.000	1.000	236	711	1	708	236	1	236
RIKEN	AK124976	flj0071l08	FLJ	W01A048F19	pENTR-TOPO	14183		hCG_1645516	731220	BAC86013.1	Hs.662488	Hypothetical protein LOC731220				BRTHA2	EK1	NM_001145664.1	NP_001139136.1	VALIDATED	Ps	0.994	0.994	173	522	1	519	473	301	473
RIKEN	H023038L13	H023038L13	RIKEN	W01A048F20	pENTR-TOPO		23742	DOLPP1	57171		Hs.21701	Dolichyl pyrophosphate phosphatase 1	-	-	hippocampus	hippocampus	DH10B	NM_020438.4	NP_065171.2	VALIDATED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	H023038L13	H023038L13	RIKEN	W01A048F24	pENTR-TOPO		23742	DOLPP1	57171		Hs.21701	Dolichyl pyrophosphate phosphatase 1	-	-	hippocampus	hippocampus	DH10B	NM_020438.4	NP_065171.2	VALIDATED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC032223	IRAK049L23	MGC	W01A048G05	pENTR-TOPO	1403		DPM3	54344	AAH32223.2	Hs.110477	Dolichyl-phosphate mannosyltransferase polypeptide 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153741.1	NP_714963.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC031610	IRAK051M19	MGC	W01A048G06	pENTR-TOPO	3977		MS4A15	219995	AAH31610.1	Hs.207465	Membrane-spanning 4-domains, subfamily A, member 15			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152717.2	NP_689930.1	VALIDATED	OK	1.000	1.000	147	444	1	441	147	1	147
RIKEN	BC032223	IRAK049L23	MGC	W01A048G07	pENTR-TOPO	1403		DPM3	54344	AAH32223.2	Hs.110477	Dolichyl-phosphate mannosyltransferase polypeptide 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153741.1	NP_714963.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
RIKEN	AK125233	flj0067l05	FLJ	W01A048G12	pENTR-TOPO	21224		CHRM2	1129	BAC86092	Hs.535891	Cholinergic receptor, muscarinic 2				HEART1	EK1	NM_001006628.1	NP_001006629.1	REVIEWED	Pfs	0.281	0.281	32	450	126	221	466	348	379
RIKEN	AK025906	flj0061k10	FLJ	W01A048G21	pENTR-TOPO	15893		THAP7	80764	-	Hs.512756	THAP domain containing 7				HRC	EK1	NM_030573.2	NP_085050.2	VALIDATED	P	1.000	1.000	95	288	1	285	309	215	309
RIKEN	AK025906	flj0061k10	FLJ	W01A048G23	pENTR-TOPO	15893		THAP7	80764	-	Hs.512756	THAP domain containing 7				HRC	EK1	NM_030573.2	NP_085050.2	VALIDATED	P	1.000	1.000	95	288	1	285	309	215	309
RIKEN	BC031476	IRAK012O24	MGC	W01A048H03	pENTR-TOPO	16063		ST6GAL1	6480	AAH31476.1	Hs.207459	ST6 beta-galactosamide alpha-2,6-sialyltranferase 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173217.1	NP_775324.1	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC031476	IRAK012O24	MGC	W01A048H05	pENTR-TOPO	16063		ST6GAL1	6480	AAH31476.1	Hs.207459	ST6 beta-galactosamide alpha-2,6-sialyltranferase 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173217.1	NP_775324.1	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC031476	IRAK012O24	MGC	W01A048H07	pENTR-TOPO	16063		ST6GAL1	6480	AAH31476.1	Hs.207459	ST6 beta-galactosamide alpha-2,6-sialyltranferase 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173217.1	NP_775324.1	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC022328	IRAL035E24	MGC	W01A048H10	pENTR-TOPO	13914		SFRS7	6432	AAH22328.1	Hs.309090	Splicing factor, arginine/serine-rich 7, 35kDa			Prostate	NIH_MGC_83	DH10B	NM_001031684.2	NP_001026854.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC034393	IRAK050F24	MGC	W01A048H17	pENTR-TOPO	2200		EDN2	1907	AAH34393.1	Hs.1407	Endothelin 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001956.3	NP_001947.1	REVIEWED	C	1.000	1.000	178	537	1	534	178	1	178
RIKEN	H033037O17	H033037O17	RIKEN	W01A048I05	pENTR-TOPO		8185						-	-	hypothalamus	hypothalamus	DH10B			
RIKEN	BC003401	IRAK003P02	MGC	W01A048I08	pENTR-TOPO	19411		RPS14	6208	AAH03401.1	Hs.719080	Ribosomal protein S14			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001025070.1	NP_001020241.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
RIKEN	BC029430	IRAL041A19	MGC	W01A048I15	pENTR-TOPO	14		APITD1	378708	AAH29430.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_199295.1	NP_954992.1	REVIEWED	C	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC067514	IRAK172A03	MGC	W01A048I16	pENTR-TOPO	18552		IL4	3565	AAH67514.1	Hs.73917	Interleukin 4			PCR rescued clones	NIH_MGC_195	DH10B	NM_000589.2	NP_000580.1	REVIEWED	OK	1.000	1.000	153	462	1	459	153	1	153
RIKEN	BC020807	IRAL035L09	MGC	W01A048J04	pENTR-TOPO	20632		PSMB1	5689	AAH20807.1	Hs.352768	Proteasome (prosome, macropain) subunit, beta type, 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_002793.3	NP_002784.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC039015	IRAK082L03	MGC	W01A048J07	pENTR-TOPO	10316		P2RX5	5026	AAH39015.1	Hs.408615	Purinergic receptor P2X, ligand-gated ion channel, 5			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_175081.1	NP_778256.1	REVIEWED	OK	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC047698	IRAK098D02	MGC	W01A048J11	pENTR-TOPO	22970		IL7	3574	AAH47698.1	Hs.591873	Interleukin 7			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000880.2	NP_000871.1	REVIEWED	OK	1.000	1.000	177	534	1	531	177	1	177
RIKEN	BC047698	IRAK098D02	MGC	W01A048J15	pENTR-TOPO	22970		IL7	3574	AAH47698.1	Hs.591873	Interleukin 7			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000880.2	NP_000871.1	REVIEWED	OK	1.000	1.000	177	534	1	531	177	1	177
RIKEN	BC066263	IRAK172D08	MGC	W01A048J19	pENTR-TOPO	5990		IL22	50616	AAH66263.1	Hs.287369	Interleukin 22			PCR rescued clones	NIH_MGC_195	DH10B	NM_020525.4	NP_065386.1	VALIDATED	OK	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC029497	IRAK048H04	MGC	W01A048K01	pENTR-TOPO	21445		NPY	4852	AAH29497.1	Hs.1832	Neuropeptide Y			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000905.2	NP_000896.1	PROVISIONAL	C	1.000	1.000	97	294	1	291	97	1	97
RIKEN	BC029497	IRAK048H04	MGC	W01A048K07	pENTR-TOPO	21445		NPY	4852	AAH29497.1	Hs.1832	Neuropeptide Y			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000905.2	NP_000896.1	PROVISIONAL	C	1.000	1.000	97	294	1	291	97	1	97
RIKEN	AK129864	flj0055c02	FLJ	W01A048K12	pENTR-TOPO	22990		ANK1	286	-	Hs.654438	Ankyrin 1, erythrocytic				HRT	EK1	NM_020478.4	NP_065211.2	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC015994	IRAL038L06	MGC	W01A048K15	pENTR-TOPO	2698		C10orf32	119032	AAH15994.1					Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144591.3	NP_653192.2	VALIDATED	P	1.000	1.000	105	318	1	315	106	2	106
RIKEN	H013060M18	H013060M18	RIKEN	W01A048K19	pENTR-TOPO		16933	PROK2	60675		Hs.528665	Prokineticin 2	-	-	testis	testis	DH10B	NM_021935.3	NP_068754.1	REVIEWED	C	1.000	1.000	108	327	1	324	108	1	108
RIKEN	H023077M14	H023077M14	RIKEN	W01A048L11	pENTR-TOPO		4681						-	-	hippocampus	hippocampus	DH10B			
RIKEN	H023077M14	H023077M14	RIKEN	W01A048L15	pENTR-TOPO		4681						-	-	hippocampus	hippocampus	DH10B			
RIKEN	BC009799	IRAL019K06	MGC	W01A048L20	pENTR-TOPO	17713		AREG	374	AAH09799.1	Hs.270833	Amphiregulin			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001657.2	NP_001648.1	REVIEWED	C	1.000	1.000	252	759	1	756	252	1	252
RIKEN	AK098255	flj0041k02	FLJ	W01A048L21	pENTR-TOPO	3603		IL18BP	10068	BAG53602.1	Hs.591967	Interleukin 18 binding protein				UTERU2	EK1	NM_173042.2	NP_766630.2	REVIEWED	C	1.000	1.000	194	586	2	583	194	1	194
RIKEN	AK027114	flj0061p01	FLJ	W01A048M05	pENTR-TOPO	21291		ZNF655	79027	-	Hs.696221	Zinc finger protein 655				HSI	EK1	NM_001009958.1	NP_001009958.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
RIKEN	BC015065	IRAL019F19	MGC	W01A048M10	pENTR-TOPO	18580		SCAMP1	9522	AAH15065.1	Hs.482587	Secretory carrier membrane protein 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_004866.4	NP_004857.4	REVIEWED	P	1.000	1.000	157	474	1	471	338	1	157
RIKEN	BC015065	IRAL019F19	MGC	W01A048M12	pENTR-TOPO	18580		SCAMP1	9522	AAH15065.1	Hs.482587	Secretory carrier membrane protein 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_004866.4	NP_004857.4	REVIEWED	P	1.000	1.000	157	474	1	471	338	1	157
RIKEN	BC034562	IRAK021E11	MGC	W01A048M13	pENTR-TOPO	6999		SIVA1	10572	AAH34562.1	Hs.112058	SIVA1, apoptosis-inducing factor			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_021709.2	NP_068355.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
RIKEN	BC015065	IRAL019F19	MGC	W01A048M14	pENTR-TOPO	18580		SCAMP1	9522	AAH15065.1	Hs.482587	Secretory carrier membrane protein 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_004866.4	NP_004857.4	REVIEWED	P	1.000	1.000	157	474	1	471	338	1	157
RIKEN	BC034562	IRAK021E11	MGC	W01A048M15	pENTR-TOPO	6999		SIVA1	10572	AAH34562.1	Hs.112058	SIVA1, apoptosis-inducing factor			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_021709.2	NP_068355.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
RIKEN	H013032N15	H013032N15	RIKEN	W01A048M18	pENTR-TOPO		17690	ANKRD37	353322		Hs.508154	Ankyrin repeat domain 37	-	-	testis	testis	DH10B	NM_181726.2	NP_859077.1	PROVISIONAL	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC031268	IRAK063K16	MGC	W01A048N02	pENTR-TOPO	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174886.1	NP_777480.1	REVIEWED	C	1.000	1.000	252	760	2	757	252	1	252
RIKEN	BC031268	IRAK063K16	MGC	W01A048N04	pENTR-TOPO	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174886.1	NP_777480.1	REVIEWED	C	1.000	1.000	252	760	2	757	252	1	252
RIKEN	BC021989	IRAL032P12	MGC	W01A048N07	pENTR-TOPO	3162		BNIP3	664	AAH21989.1	Hs.144873	BCL2/adenovirus E1B 19kDa interacting protein 3			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_004052.2	NP_004043.2	REVIEWED	C	1.000	1.000	194	585	1	582	194	1	194
RIKEN	BC062475	IRAK141P19	MGC	W01A048N11	pENTR-TOPO	10182		GH1	2688	AAH62475.1	Hs.655229	Growth hormone 1			Pituitary	NIH_MGC_179	DH10B	NM_022559.2	NP_072053.1	REVIEWED	C	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC068098	IRAL054M02	MGC	W01A048O02	pENTR-TOPO	517		SFT2D2	375035	AAH68098.1	Hs.645435	SFT2 domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_199344.2	NP_955376.1	VALIDATED	C	1.000	1.000	160	483	1	480	160	1	160
RIKEN	BC068098	IRAL054M02	MGC	W01A048O04	pENTR-TOPO	517		SFT2D2	375035	AAH68098.1	Hs.645435	SFT2 domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_199344.2	NP_955376.1	VALIDATED	C	1.000	1.000	160	483	1	480	160	1	160
RIKEN	AK096312	flj0039b02	FLJ	W01A048O10	pENTR-TOPO	317		CNIH3	149111	BAC04760.1	Hs.28659	Cornichon homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RI2	EK1	NM_152495.1	NP_689708.1	PROVISIONAL	C	1.000	1.000	160	483	1	480	160	1	160
RIKEN	BC067486	IRAK172G09	MGC	W01A048O13	pENTR-TOPO	20122		HIST1H2BM	8342	AAH67486.1	Hs.182432	Histone cluster 1, H2bm			PCR rescued clones	NIH_MGC_195	DH10B	NM_003521.2	NP_003512.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	AK096312	flj0039b02	FLJ	W01A048O16	pENTR-TOPO	317		CNIH3	149111	BAC04760.1	Hs.28659	Cornichon homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RI2	EK1	NM_152495.1	NP_689708.1	PROVISIONAL	C	1.000	1.000	160	483	1	480	160	1	160
RIKEN	H033066D15	H033066D15	RIKEN	W01A048O19	pENTR-TOPO		21121	TAC1	6863		Hs.2563	Tachykinin, precursor 1	-	-	hypothalamus	hypothalamus	DH10B	NM_003182.2	NP_003173.1	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
RIKEN	H033066D15	H033066D15	RIKEN	W01A048O23	pENTR-TOPO		21121	TAC1	6863		Hs.2563	Tachykinin, precursor 1	-	-	hypothalamus	hypothalamus	DH10B	NM_003182.2	NP_003173.1	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
RIKEN	BC017052	IRAK022C06	MGC	W01A048P01	pENTR-TOPO	2899		VTI1A	143187	AAH17052.1	Hs.194554	Vesicle transport through interaction with t-SNAREs homolog 1A (yeast)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_145206.2	NP_660207.2	VALIDATED	P	1.000	1.000	187	612	1	561	217	1	187
RIKEN	AK126315	flj0072l01	FLJ	W01A048P13	pENTR-TOPO	21002		CLDN4	1364	BAG54307.1	Hs.699253	Claudin 4				TRACH3	EK1	NM_001305.3	NP_001296.1	REVIEWED	C	1.000	1.000	209	630	1	627	209	1	209
RIKEN	BC017664	IRAK020K21	MGC	W01A048P21	pENTR-TOPO	4405		FGF19	9965	AAH17664.1	Hs.249200	Fibroblast growth factor 19			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_005117.2	NP_005108.1	REVIEWED	C	1.000	1.000	216	651	1	648	216	1	216
RIKEN	AK024685	flj0063a17	FLJ	W01A049A01	pENTR-TOPO	18114		SCD5	79966	BAB14961.1	Hs.379191	Stearoyl-CoA desaturase 5				CAE	EK1	NM_024906.2	NP_079182.2	VALIDATED	Cs	0.992	0.992	256	771	1	768	256	1	256
RIKEN	BC064637	IRAK139N02	MGC	W01A049A06	pENTR-TOPO	15316		ICOSLG	23308	AAH64637.1	Hs.14155	Inducible T-cell co-stimulator ligand			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_015259.4	NP_056074.1	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
RIKEN	AK024685	flj0063a17	FLJ	W01A049A07	pENTR-TOPO	18114		SCD5	79966	BAB14961.1	Hs.379191	Stearoyl-CoA desaturase 5				CAE	EK1	NM_024906.2	NP_079182.2	VALIDATED	Cs	0.992	0.992	256	771	1	768	256	1	256
RIKEN	H013055M11	H013055M11	RIKEN	W01A049A12	pENTR-TOPO		15599	MED13	9969		Hs.282678	Mediator complex subunit 13	-	-	testis	testis	DH10B	NM_005121.2	NP_005112.2	REVIEWED		0.364	0.364	22	912	172	107	2174	1004	1025
RIKEN	H013055M11	H013055M11	RIKEN	W01A049A16	pENTR-TOPO		15599	MED13	9969		Hs.282678	Mediator complex subunit 13	-	-	testis	testis	DH10B	NM_005121.2	NP_005112.2	REVIEWED		0.364	0.364	22	912	172	107	2174	1004	1025
RIKEN	BC067461	IRAK172E07	MGC	W01A049A24	pENTR-TOPO	20752		TAAR2	9287	AAH67461.1	Hs.272382	Trace amine associated receptor 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_014626.3	NP_055441.2	VALIDATED	C	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC032634	IRAK069D17	MGC	W01A049B10	pENTR-TOPO	958		FCGR1A	2209	AAH32634.1	Hs.77424	Fc fragment of IgG, high affinity Ia, receptor (CD64)			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000566.3	NP_000557.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC030662	IRAK047G19	MGC	W01A049B11	pENTR-TOPO	17414		KLF3	51274	AAH30662.1	Hs.298658	Kruppel-like factor 3 (basic)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016531.5	NP_057615.3	VALIDATED	Cs	0.997	0.997	345	1038	1	1035	345	1	345
RIKEN	BC032634	IRAK069D17	MGC	W01A049B12	pENTR-TOPO	958		FCGR1A	2209	AAH32634.1	Hs.77424	Fc fragment of IgG, high affinity Ia, receptor (CD64)			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000566.3	NP_000557.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC030662	IRAK047G19	MGC	W01A049B13	pENTR-TOPO	17414		KLF3	51274	AAH30662.1	Hs.298658	Kruppel-like factor 3 (basic)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016531.5	NP_057615.3	VALIDATED	Cs	0.997	0.997	345	1038	1	1035	345	1	345
RIKEN	BC050380	IRAK098H13	MGC	W01A049D04	pENTR-TOPO	492		ST3GAL3	6487	AAH50380.1	Hs.597915	ST3 beta-galactoside alpha-2,3-sialyltransferase 3			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006279.2	NP_006270.1	REVIEWED	OK	1.000	1.000	375	1128	1	1125	375	1	375
RIKEN	BC035279	IRAK050G01	MGC	W01A049D05	pENTR-TOPO	22746		ERI1	90459	AAH35279.1	Hs.20000	Exoribonuclease 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153332.3	NP_699163.2	VALIDATED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC035279	IRAK050G01	MGC	W01A049D07	pENTR-TOPO	22746		ERI1	90459	AAH35279.1	Hs.20000	Exoribonuclease 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153332.3	NP_699163.2	VALIDATED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC066885	IRAK172B07	MGC	W01A049D09	pENTR-TOPO	23804		GPR21	2844	AAH66885.2					PCR rescued clones	NIH_MGC_195	DH10B	NM_005294.1	NP_005285.1	PROVISIONAL	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	AK094072	flj0016d04	FLJ	W01A049D10	pENTR-TOPO	720		ZNF684	127396	BAG52807.1	Hs.524767	Zinc finger protein 684				UTERU2	EK1	NM_152373.2	NP_689586.2	PROVISIONAL	C	1.000	1.000	378	1137	1	1134	378	1	378
RIKEN	BC066885	IRAK172B07	MGC	W01A049D11	pENTR-TOPO	23804		GPR21	2844	AAH66885.2					PCR rescued clones	NIH_MGC_195	DH10B	NM_005294.1	NP_005285.1	PROVISIONAL	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	AK094072	flj0016d04	FLJ	W01A049D12	pENTR-TOPO	720		ZNF684	127396	BAG52807.1	Hs.524767	Zinc finger protein 684				UTERU2	EK1	NM_152373.2	NP_689586.2	PROVISIONAL	C	1.000	1.000	378	1137	1	1134	378	1	378
RIKEN	BC066885	IRAK172B07	MGC	W01A049D13	pENTR-TOPO	23804		GPR21	2844	AAH66885.2					PCR rescued clones	NIH_MGC_195	DH10B	NM_005294.1	NP_005285.1	PROVISIONAL	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC033583	IRAK049N01	MGC	W01A049D21	pENTR-TOPO	815		CD2	914	AAH33583.1	Hs.523500	CD2 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001767.3	NP_001758.2	VALIDATED	Cs	0.997	0.997	351	1056	1	1053	351	1	351
RIKEN	BC019680	IRAK029P13	MGC	W01A049E03	pENTR-TOPO	6707		KLF12	11278	AAH19680.1	Hs.373857	Kruppel-like factor 12				NCI_CGAP_Brn67	DH10B	NM_007249.4	NP_009180.3	VALIDATED	P	1.000	1.000	269	810	1	807	402	1	269
RIKEN	AK027531	flj0033c23	FLJ	W01A049E04	pENTR-TOPO	23066		SLC25A32	81034	BAB55180.1	Hs.607819	Solute carrier family 25, member 32	NT2	teratocarcinoma		NT2RP2	EK1	NM_030780.3	NP_110407.2	VALIDATED	C	1.000	1.000	315	948	1	945	315	1	315
RIKEN	AK055028	flj0001i04	FLJ	W01A049E11	pENTR-TOPO	10975		C18orf1	753	BAG51451.1	Hs.149363	Chromosome 18 open reading frame 1				BRAWH1	EK1	NM_001003674.2	NP_001003674.1	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
RIKEN	AK055028	flj0001i04	FLJ	W01A049E15	pENTR-TOPO	10975		C18orf1	753	BAG51451.1	Hs.149363	Chromosome 18 open reading frame 1				BRAWH1	EK1	NM_001003674.2	NP_001003674.1	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
RIKEN	AK095197	flj0024p03	FLJ	W01A049F07	pENTR-TOPO	1755		PAQR6	79957	BAC04497.1	Hs.235873	Progestin and adipoQ receptor family member VI				BRSTN2	EK1	NM_024897.2	NP_079173.2	PROVISIONAL	OK	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	H013034G23	H013034G23	RIKEN	W01A049F09	pENTR-TOPO		8155	GNB5	10681		Hs.155090	Guanine nucleotide binding protein (G protein), beta 5	-	-	testis	testis	DH10B	NM_006578.3	NP_006569.1	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC036657	IRAK047I23	MGC	W01A049F10	pENTR-TOPO	17946		NPY1R	4886	AAH36657.1	Hs.519057	Neuropeptide Y receptor Y1			Testis	NIH_MGC_97	DH10B	NM_000909.4	NP_000900.1	VALIDATED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC036657	IRAK047I23	MGC	W01A049F12	pENTR-TOPO	17946		NPY1R	4886	AAH36657.1	Hs.519057	Neuropeptide Y receptor Y1			Testis	NIH_MGC_97	DH10B	NM_000909.4	NP_000900.1	VALIDATED	OK	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	H013034G23	H013034G23	RIKEN	W01A049F15	pENTR-TOPO		8155	GNB5	10681		Hs.155090	Guanine nucleotide binding protein (G protein), beta 5	-	-	testis	testis	DH10B	NM_006578.3	NP_006569.1	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
RIKEN	BC039146	IRAK028M09	MGC	W01A049F18	pENTR-TOPO	1678		CD34	947	AAH39146.2	Hs.374990	CD34 molecule			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_001025109.1	NP_001020280.1	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
RIKEN	BC025285	IRAL042O11	MGC	W01A049F19	pENTR-TOPO	501		GNAI3	2773	AAH25285.1	Hs.73799	Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 3			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006496.2	NP_006487.1	VALIDATED	OK	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	AK075443	flj0027l07	FLJ	W01A049G06	pENTR-TOPO	4593		LYVE1	10894	BAG52138.1	Hs.655332	Lymphatic vessel endothelial hyaluronan receptor 1				PLACE1	EK1	NM_006691.3	NP_006682.2	REVIEWED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC007024	IRAL016A05	MGC	W01A049G14	pENTR-TOPO	3095		AKR1C2	1646	AAH07024.1	Hs.567256	Aldo-keto reductase family 1, member C2 (dihydrodiol dehydrogenase 2; bile acid binding protein; 3-alpha hydroxysteroid dehydrogenase, type III)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001354.4	NP_001345.1	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC068573	IRAK168K12	MGC	W01A049G18	pENTR-TOPO	1781		PHC2	1912	AAH68573.1	Hs.524271	Polyhomeotic homolog 2 (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_004427.3	NP_004418.2	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC068573	IRAK168K12	MGC	W01A049G20	pENTR-TOPO	1781		PHC2	1912	AAH68573.1	Hs.524271	Polyhomeotic homolog 2 (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_004427.3	NP_004418.2	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC068573	IRAK168K12	MGC	W01A049G22	pENTR-TOPO	1781		PHC2	1912	AAH68573.1	Hs.524271	Polyhomeotic homolog 2 (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_004427.3	NP_004418.2	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC068573	IRAK168K12	MGC	W01A049G24	pENTR-TOPO	1781		PHC2	1912	AAH68573.1	Hs.524271	Polyhomeotic homolog 2 (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_004427.3	NP_004418.2	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC067454	IRAK172B23	MGC	W01A049H05	pENTR-TOPO	11986		GPR32	2854	AAH67454.1	Hs.515555	G protein-coupled receptor 32			PCR rescued clones	NIH_MGC_195	DH10B	NM_001506.1	NP_001497.1	PROVISIONAL	OK	1.000	1.000	356	1071	1	1068	356	1	356
RIKEN	BC067454	IRAK172B23	MGC	W01A049H07	pENTR-TOPO	11986		GPR32	2854	AAH67454.1	Hs.515555	G protein-coupled receptor 32			PCR rescued clones	NIH_MGC_195	DH10B	NM_001506.1	NP_001497.1	PROVISIONAL	OK	1.000	1.000	356	1071	1	1068	356	1	356
RIKEN	H023092E15	H023092E15	RIKEN	W01A049H08	pENTR-TOPO		14609	ERGIC3	51614		Hs.472558	ERGIC and golgi 3	-	-	hippocampus	hippocampus	DH10B	NM_198398.1	NP_938408.1	VALIDATED	C	1.000	1.000	388	1167	1	1164	388	1	388
RIKEN	AK026564	flj0057c22	FLJ	W01A049H12	pENTR-TOPO	14604		GNAS	2778	-	Hs.125898	GNAS complex locus				KAT	EK1	NM_000516.4	NP_000507.1	REVIEWED	C	1.000	1.000	394	1188	3	1184	394	1	394
RIKEN	BC037781	IRAK075D05	MGC	W01A049H13	pENTR-TOPO	15586		TSSK2	23617	AAH37781.1	Hs.694070	Testis-specific serine kinase 2			Testis	NIH_MGC_97	DH10B	NM_053006.4	NP_443732.3	VALIDATED	Cs	0.997	0.997	358	1077	1	1074	358	1	358
RIKEN	BC037961	IRAK079N23	MGC	W01A049H21	pENTR-TOPO	13524		IL8RB	3579	AAH37961.2	Hs.846	Interleukin 8 receptor, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001557.2	NP_001548.1	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC037961	IRAK079N23	MGC	W01A049H23	pENTR-TOPO	13524		IL8RB	3579	AAH37961.2	Hs.846	Interleukin 8 receptor, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001557.2	NP_001548.1	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	AK074661	flj0017p14	FLJ	W01A049H24	pENTR-TOPO	12290		S1PR5	53637	BAC11119.1	Hs.501561	Sphingosine-1-phosphate receptor 5				MAMMA1	EK1	NM_030760.3	NP_110387.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	AK027624	flj0035a03	FLJ	W01A049I07	pENTR-TOPO	5832		ABCB9	23457	BAG51360.1	Hs.511951	ATP-binding cassette, sub-family B (MDR/TAP), member 9	NT2	teratocarcinoma		NT2RP3	EK1	NM_019625.3	NP_062571.1	REVIEWED	Pfs	0.978	0.996	277	819	1	817	766	1	277
RIKEN	AK093756	flj0021i03	FLJ	W01A049I17	pENTR-TOPO	23079		EEF1D	1936	-	Hs.686554	Eukaryotic translation elongation factor 1 delta (guanine nucleotide exchange protein)				THYMU2	EK1	NM_001130055.1	NP_001123527.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC026002	IRAL038I15	MGC	W01A049I24	pENTR-TOPO	15544		GRAP2	9402	AAH26002.1	Hs.517499	GRB2-related adaptor protein 2			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_004810.2	NP_004801.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	AK092689	flj0008g15	FLJ	W01A049J03	pENTR-TOPO	5227		SLC25A3	5250	BAG52596.1	Hs.290404	Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3				SKMUS2	EK1	NM_005888.3	NP_005879.1	REVIEWED	C	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	AK092689	flj0008g15	FLJ	W01A049J07	pENTR-TOPO	5227		SLC25A3	5250	BAG52596.1	Hs.290404	Solute carrier family 25 (mitochondrial carrier; phosphate carrier), member 3				SKMUS2	EK1	NM_005888.3	NP_005879.1	REVIEWED	C	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	BC044311	IRAK084L09	MGC	W01A049J16	pENTR-TOPO	12723		MYPOP	339344	AAH44311.2	Hs.515478	Myb-related transcription factor, partner of profilin			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001012643.2	NP_001012661.1	PROVISIONAL	OK	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	AK075249	flj0019g18	FLJ	W01A049K03	pENTR-TOPO	9792		SLC25A10	1468	BAC11497.1	Hs.548187	Solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10				THYRO1	EK1	NM_012140.3	NP_036272.2	PROVISIONAL	C	1.000	1.000	287	864	1	861	287	1	287
RIKEN	AK075249	flj0019g18	FLJ	W01A049K07	pENTR-TOPO	9792		SLC25A10	1468	BAC11497.1	Hs.548187	Solute carrier family 25 (mitochondrial carrier; dicarboxylate transporter), member 10				THYRO1	EK1	NM_012140.3	NP_036272.2	PROVISIONAL	C	1.000	1.000	287	864	1	861	287	1	287
RIKEN	BC066927	IRAK167A05	MGC	W01A049K08	pENTR-TOPO	6719		GPR18	2841	AAH66927.1	Hs.631765	G protein-coupled receptor 18			Testis	NIH_MGC_97	DH10B	NM_001098200.1	NP_001091670.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
RIKEN	AK128391	flj0078a10	FLJ	W01A049K10	pENTR-TOPO	20111		LOC401233	401233	BAC87416.1	Hs.441039	Similar to HIV TAT specific factor 1; cofactor required for Tat activation of HIV-1 transcription				THYMU3	EK1													
RIKEN	AK128391	flj0078a10	FLJ	W01A049K12	pENTR-TOPO	20111		LOC401233	401233	BAC87416.1	Hs.441039	Similar to HIV TAT specific factor 1; cofactor required for Tat activation of HIV-1 transcription				THYMU3	EK1													
RIKEN	AK128391	flj0078a10	FLJ	W01A049K14	pENTR-TOPO	20111		LOC401233	401233	BAC87416.1	Hs.441039	Similar to HIV TAT specific factor 1; cofactor required for Tat activation of HIV-1 transcription				THYMU3	EK1													
RIKEN	BC027926	IRAK049P13	MGC	W01A049K22	pENTR-TOPO	943		CD1D	912	AAH27926.1	Hs.1799	CD1d molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001766.3	NP_001757.1	REVIEWED	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC067536	IRAK172B17	MGC	W01A049L03	pENTR-TOPO	12720		GPR4	2828	AAH67536.1	Hs.17170	G protein-coupled receptor 4			PCR rescued clones	NIH_MGC_195	DH10B	NM_005282.2	NP_005273.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	BC034761	IRAK050F08	MGC	W01A049L06	pENTR-TOPO	5619		GPR182	11318	AAH34761.1	Hs.483909	G protein-coupled receptor 182			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_007264.3	NP_009195.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
RIKEN	H023037J07	H023037J07	RIKEN	W01A049L11	pENTR-TOPO		21171	WNT16	51384		Hs.272375	Wingless-type MMTV integration site family, member 16	-	-	hippocampus	hippocampus	DH10B	NM_057168.1	NP_476509.1	REVIEWED	C	1.000	1.000	365	1098	1	1095	365	1	365
RIKEN	H023037J07	H023037J07	RIKEN	W01A049L15	pENTR-TOPO		21171	WNT16	51384		Hs.272375	Wingless-type MMTV integration site family, member 16	-	-	hippocampus	hippocampus	DH10B	NM_057168.1	NP_476509.1	REVIEWED	C	1.000	1.000	365	1098	1	1095	365	1	365
RIKEN	AK125398	flj0069e04	FLJ	W01A049L20	pENTR-TOPO	13202		FOXD4L1	200350	BAG54193.1	Hs.591554	Forkhead box D4-like 1				OCBBF2	EK1	NM_012184.4	NP_036316.1	REVIEWED	C	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	BC041100	IRAK078A08	MGC	W01A049M04	pENTR-TOPO	4776		SLC25A45	283130	AAH41100	Hs.661604	Solute carrier family 25, member 45			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_182556.2	NP_872362.2	VALIDATED	Cfs	0.913	0.996	288	1008	1	793	288	1	288
RIKEN	BC011349	IRAK012F04	MGC	W01A049M11	pENTR-TOPO	2888		RGR	5995	AAH11349.1	Hs.1544	Retinal G protein coupled receptor				NCI_CGAP_Brn67	DH10B	NM_002921.3	NP_002912.2	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	BC011349	IRAK012F04	MGC	W01A049M15	pENTR-TOPO	2888		RGR	5995	AAH11349.1	Hs.1544	Retinal G protein coupled receptor				NCI_CGAP_Brn67	DH10B	NM_002921.3	NP_002912.2	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	AK075532	flj0049a17	FLJ	W01A049N01	pENTR-TOPO	11760		FCGRT	2217	BAG52164.1	Hs.111903	Fc fragment of IgG, receptor, transporter, alpha				HEMBA1	EK1	NM_004107.4	NP_004098.1	REVIEWED	OK	1.000	1.000	365	1098	1	1095	365	1	365
RIKEN	BC032623	IRAK069B01	MGC	W01A049N02	pENTR-TOPO	23004		DOK2	9046	AAH32623.1	Hs.71215	Docking protein 2, 56kDa			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003974.2	NP_003965.2	REVIEWED	C	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	BC041369	IRAK075E15	MGC	W01A049N09	pENTR-TOPO	17555		SGMS2	166929	AAH41369.1	Hs.595423	Sphingomyelin synthase 2			Testis	NIH_MGC_97	DH10B	NM_152621.5	NP_689834.1	REVIEWED	OK	1.000	1.000	365	1098	1	1095	365	1	365
RIKEN	AK026683	flj0061i11	FLJ	W01A049N10	pENTR-TOPO	3144		SGMS1	259230	-	Hs.654698	Sphingomyelin synthase 1				LNG	EK1	NM_147156.3	NP_671512.1	REVIEWED	C	1.000	1.000	413	1242	1	1239	413	1	413
RIKEN	AK055690	flj0001h16	FLJ	W01A049N17	pENTR-TOPO	5323		PPHLN1	51535	BAB70985.1	Hs.444157	Periphilin 1	IMR32	neuroblastoma		IMR322	EK1	NM_201439.1	NP_958847.1	REVIEWED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	AK055690	flj0001h16	FLJ	W01A049N19	pENTR-TOPO	5323		PPHLN1	51535	BAB70985.1	Hs.444157	Periphilin 1	IMR32	neuroblastoma		IMR322	EK1	NM_201439.1	NP_958847.1	REVIEWED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	AK025605	flj0065f08	FLJ	W01A049N20	pENTR-TOPO	3227		ZDHHC6	64429	BAB15187.1	Hs.196990	Zinc finger, DHHC-type containing 6	HepG2	hepatoma		HEP	EK1	NM_022494.1	NP_071939.1	PROVISIONAL	C	1.000	1.000	413	1242	1	1239	413	1	413
RIKEN	BC007016	IRAL016J18	MGC	W01A049O05	pENTR-TOPO	1		SPP1	6696	AAH07016.1	Hs.313	Secreted phosphoprotein 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_000582.2	NP_000573.1	VALIDATED	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC007016	IRAL016J18	MGC	W01A049O07	pENTR-TOPO	1		SPP1	6696	AAH07016.1	Hs.313	Secreted phosphoprotein 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_000582.2	NP_000573.1	VALIDATED	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC034989	IRAK047J21	MGC	W01A049O12	pENTR-TOPO	17218		P2RY14	9934	AAH34989.1	Hs.2465	Purinergic receptor P2Y, G-protein coupled, 14			Testis	NIH_MGC_97	DH10B	NM_014879.3	NP_055694.3	REVIEWED	Cs	0.997	0.997	338	1017	1	1014	338	1	338
RIKEN	AK097621	flj0043m19	FLJ	W01A049O17	pENTR-TOPO	2011		RHBDL2	54933	BAG53496.1	Hs.524626	Rhomboid, veinlet-like 2 (Drosophila)				TESTI2	EK1	NM_017821.3	NP_060291.2	REVIEWED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC011405	IRAK013H15	MGC	W01A049O20	pENTR-TOPO	8824		PRRT2	112476	AAH11405.1	Hs.655071	Proline-rich transmembrane protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_145239.2	NP_660282.2	VALIDATED	Cs	0.997	0.997	340	1023	1	1020	340	1	340
RIKEN	BC065511	IRAK139H11	MGC	W01A049P01	pENTR-TOPO	14542		SGK2	10110	AAH65511.1	Hs.300863	Serum/glucocorticoid regulated kinase 2			Brain, hippocampus	NIH_MGC_124	DH10B	NM_170693.1	NP_733794.1	REVIEWED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC032864	IRAK047H15	MGC	W01A050A02	pENTR-TOPO	24812		GLRA2	2742	AAH32864.1	Hs.2700	Glycine receptor, alpha 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001118885.1	NP_001112357.1	VALIDATED	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC026961	IRAK052B18	MGC	W01A050A05	pENTR-TOPO	16072		MITF	4286	AAH26961.1	Hs.166017	Microphthalmia-associated transcription factor			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198158.1	NP_937801.1	REVIEWED	C	1.000	1.000	413	1242	1	1239	413	1	413
RIKEN	H023062D15	H023062D15	RIKEN	W01A050A09	pENTR-TOPO		6130	PTPRR	5801		Hs.506076	Protein tyrosine phosphatase, receptor type, R	-	-	hippocampus	hippocampus	DH10B	NM_130846.1	NP_570897.1	REVIEWED	OK	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	H033077J21	H033077J21	RIKEN	W01A050A10	pENTR-TOPO		4748	CHKA	1119		Hs.77221	Choline kinase alpha	-	-	hypothalamus	hypothalamus	DH10B	NM_001277.2	NP_001268.2	REVIEWED	C	1.000	1.000	457	1374	1	1371	457	1	457
RIKEN	H023062D15	H023062D15	RIKEN	W01A050A13	pENTR-TOPO		6130	PTPRR	5801		Hs.506076	Protein tyrosine phosphatase, receptor type, R	-	-	hippocampus	hippocampus	DH10B	NM_130846.1	NP_570897.1	REVIEWED	OK	1.000	1.000	412	1239	1	1236	412	1	412
RIKEN	H033077J21	H033077J21	RIKEN	W01A050A16	pENTR-TOPO		4748	CHKA	1119		Hs.77221	Choline kinase alpha	-	-	hypothalamus	hypothalamus	DH10B	NM_001277.2	NP_001268.2	REVIEWED	C	1.000	1.000	457	1374	1	1371	457	1	457
RIKEN	BC071657	IRAK166N02	MGC	W01A050A17	pENTR-TOPO	463		TARDBP	23435	AAH71657.1	Hs.300624	TAR DNA binding protein			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_007375.3	NP_031401.1	REVIEWED	C	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	BC011393	IRAK013K18	MGC	W01A050A18	pENTR-TOPO	13872		CHN1	1123	AAH11393.1	Hs.654534	Chimerin (chimaerin) 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001822.4	NP_001813.1	REVIEWED	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC071657	IRAK166N02	MGC	W01A050A19	pENTR-TOPO	463		TARDBP	23435	AAH71657.1	Hs.300624	TAR DNA binding protein			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_007375.3	NP_031401.1	REVIEWED	C	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	BC011393	IRAK013K18	MGC	W01A050A24	pENTR-TOPO	13872		CHN1	1123	AAH11393.1	Hs.654534	Chimerin (chimaerin) 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001822.4	NP_001813.1	REVIEWED	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC012368	IRAK021K02	MGC	W01A050B05	pENTR-TOPO	24094		ANGPTL2	23452	AAH12368.1	Hs.653262	Angiopoietin-like 2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_012098.2	NP_036230.1	REVIEWED	C	1.000	1.000	493	1482	1	1479	493	1	493
RIKEN	BC032831	IRAK033M04	MGC	W01A050B15	pENTR-TOPO	7553		GPR135	64582	AAH32831.2	Hs.647573	G protein-coupled receptor 135			Testis	NIH_MGC_97	DH10B	NM_022571.5	NP_072093.2	VALIDATED	C	1.000	1.000	494	1485	1	1482	494	1	494
RIKEN	BC047447	IRAK091I15	MGC	W01A050B22	pENTR-TOPO	18229		NHEDC2	133308	AAH47447.2	Hs.546482	Na+/H+ exchanger domain containing 2			Testis	NIH_MGC_97	DH10B	NM_178833.4	NP_849155.2	VALIDATED	C	1.000	1.000	537	1614	1	1611	537	1	537
RIKEN	AK001738	flj0020o15	FLJ	W01A050B23	pENTR-TOPO	126		RCOR3	55758	BAA91872.1	Hs.356399	REST corepressor 3	NT2	teratocarcinoma		NT2RP4	EK1	NM_018254.3	NP_060724.1	VALIDATED	C	1.000	1.000	495	1488	1	1485	495	1	495
RIKEN	BC025782	IRAK049N09	MGC	W01A050C02	pENTR-TOPO	5608		CD4	920	AAH25782.1	Hs.631659	CD4 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000616.3	NP_000607.1	VALIDATED	C	1.000	1.000	458	1377	1	1374	458	1	458
RIKEN	BC068585	IRAK168O15	MGC	W01A050D04	pENTR-TOPO	20668		HERV-FRD	405754	AAH68585.1	Hs.631996	HERV-FRD provirus ancestral Env polyprotein			Placenta, normal	NIH_MGC_147	DH10B	NM_207582.1	NP_997465.1	PROVISIONAL	C	1.000	1.000	538	1617	1	1614	538	1	538
RIKEN	AK127750	flj0075e08	FLJ	W01A050D14	pENTR-TOPO	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B				OCBBF2	EK1	NM_207395.2	NP_997278.2	VALIDATED	Cs	0.998	0.998	544	1635	1	1632	544	1	544
RIKEN	AK127536	flj0075a19	FLJ	W01A050D15	pENTR-TOPO	1995		TBX15	6913	BAG54518.1	Hs.146196	T-box 15		chondrocytes		CHONS2	EK1	NM_152380.2	NP_689593.2	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	AK127750	flj0075e08	FLJ	W01A050D16	pENTR-TOPO	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B				OCBBF2	EK1	NM_207395.2	NP_997278.2	VALIDATED	Cs	0.998	0.998	544	1635	1	1632	544	1	544
RIKEN	BC050432	IRAK098J15	MGC	W01A050D21	pENTR-TOPO	14916		STAU1	6780	AAH50432.1	Hs.596704	Staufen, RNA binding protein, homolog 1 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017454.2	NP_059348.2	REVIEWED	OK	1.000	1.000	496	1492	2	1489	496	1	496
RIKEN	BC050432	IRAK098J15	MGC	W01A050D23	pENTR-TOPO	14916		STAU1	6780	AAH50432.1	Hs.596704	Staufen, RNA binding protein, homolog 1 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017454.2	NP_059348.2	REVIEWED	OK	1.000	1.000	496	1492	2	1489	496	1	496
RIKEN	AK131232	flj0073c16	FLJ	W01A050E03	pENTR-TOPO	16449		ZNF620	253639	BAD18415.1	Hs.581541	Zinc finger protein 620				BRAMY2	EK1	NM_175888.2	NP_787084.1	VALIDATED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	AK096628	flj0022o19	FLJ	W01A050E08	pENTR-TOPO	17099		THRB	7068	BAG53341.1	Hs.187861	Thyroid hormone receptor, beta (erythroblastic leukemia viral (v-erb-a) oncogene homolog 2, avian)				OCBBF2	EK1	NM_000461.4	NP_000452.2	REVIEWED	C	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	AK127779	flj0078d02	FLJ	W01A050E17	pENTR-TOPO	16407		ZNF662	389114	BAC87129.1						OCBBF3	EK1	NM_207404.3	NP_997287.2	VALIDATED	C	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC036026	IRAK048E22	MGC	W01A050F01	pENTR-TOPO	24572		PPEF1	5475	AAH36026.1	Hs.211589	Protein phosphatase, EF-hand calcium binding domain 1			Testis	NIH_MGC_97	DH10B	NM_006240.2	NP_006231.2	REVIEWED	P	1.000	1.000	501	1506	1	1503	653	153	653
RIKEN	BC053626	IRAK115M22	MGC	W01A050F06	pENTR-TOPO	25165		MID1	4281	AAH53626.1	Hs.27695	Midline 1 (Opitz/BBB syndrome)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_033290.2	NP_150632.1	REVIEWED	P	1.000	1.000	552	1657	1	1656	667	1	552
RIKEN	BC036026	IRAK048E22	MGC	W01A050F07	pENTR-TOPO	24572		PPEF1	5475	AAH36026.1	Hs.211589	Protein phosphatase, EF-hand calcium binding domain 1			Testis	NIH_MGC_97	DH10B	NM_006240.2	NP_006231.2	REVIEWED	P	1.000	1.000	501	1506	1	1503	653	153	653
RIKEN	BC053626	IRAK115M22	MGC	W01A050F08	pENTR-TOPO	25165		MID1	4281	AAH53626.1	Hs.27695	Midline 1 (Opitz/BBB syndrome)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_033290.2	NP_150632.1	REVIEWED	P	1.000	1.000	552	1657	1	1656	667	1	552
RIKEN	AK129884	flj0055o04	FLJ	W01A050F16	pENTR-TOPO	11721		GPI	2821	-	Hs.466471	Glucose phosphate isomerase				HRT	EK1	NM_000175.2	NP_000166.2	REVIEWED	C	1.000	1.000	558	1677	1	1674	558	1	558
RIKEN	AK090923	flj0011e15	FLJ	W01A050F18	pENTR-TOPO	4745		PTPN5	84867	BAC03548.1	Hs.79092	Protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)				BRAMY2	EK1	NM_032781.3	NP_116170.3	VALIDATED	Cs	0.996	0.996	565	1698	1	1695	565	1	565
RIKEN	AK090923	flj0011e15	FLJ	W01A050F22	pENTR-TOPO	4745		PTPN5	84867	BAC03548.1	Hs.79092	Protein tyrosine phosphatase, non-receptor type 5 (striatum-enriched)				BRAMY2	EK1	NM_032781.3	NP_116170.3	VALIDATED	Cs	0.996	0.996	565	1698	1	1695	565	1	565
RIKEN	H033077F17	H033077F17	RIKEN	W01A050G04	pENTR-TOPO		21288	CHN2	1124		Hs.663145	Chimerin (chimaerin) 2	-	-	hypothalamus	hypothalamus	DH10B	NM_004067.2	NP_004058.1	REVIEWED	C	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	H033077F17	H033077F17	RIKEN	W01A050G08	pENTR-TOPO		21288	CHN2	1124		Hs.663145	Chimerin (chimaerin) 2	-	-	hypothalamus	hypothalamus	DH10B	NM_004067.2	NP_004058.1	REVIEWED	C	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC030553	IRAK064K16	MGC	W01A050G18	pENTR-TOPO	9736		SPHK1	8877	AAH30553.1	Hs.68061	Sphingosine kinase 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142601.1	NP_001136073.1	VALIDATED	C	1.000	1.000	384	1413	259	1410	384	1	384
RIKEN	BC030553	IRAK064K16	MGC	W01A050G20	pENTR-TOPO	9736		SPHK1	8877	AAH30553.1	Hs.68061	Sphingosine kinase 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142601.1	NP_001136073.1	VALIDATED	C	1.000	1.000	384	1413	259	1410	384	1	384
RIKEN	AK058199	flj0053f14	FLJ	W01A050H03	pENTR-TOPO	12879		VRK2	7444	-	Hs.666703	Vaccinia related kinase 2				TST	EK1	NM_001136027.1	NP_001129499.1	REVIEWED	C	1.000	1.000	390	1527	355	1524	390	1	390
RIKEN	BC053357	IRAK115I09	MGC	W01A050H10	pENTR-TOPO	15032		THBD	7056	AAH53357.1	Hs.2030	Thrombomodulin			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000361.2	NP_000352.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
RIKEN	BC053357	IRAK115I09	MGC	W01A050H12	pENTR-TOPO	15032		THBD	7056	AAH53357.1	Hs.2030	Thrombomodulin			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000361.2	NP_000352.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
RIKEN	BC013645	IRAK019B01	MGC	W01A050I05	pENTR-TOPO	8750		WWP2	11060	AAH13645.1	Hs.408458	WW domain containing E3 ubiquitin protein ligase 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_199424.1	NP_955456.1	REVIEWED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	H023084C16	H023084C16	RIKEN	W01A050I12	pENTR-TOPO		8364	GABRB3	2562		Hs.302352	Gamma-aminobutyric acid (GABA) A receptor, beta 3	-	-	hippocampus	hippocampus	DH10B	NM_000814.4	NP_000805.1	REVIEWED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	H023084C16	H023084C16	RIKEN	W01A050I14	pENTR-TOPO		8364	GABRB3	2562		Hs.302352	Gamma-aminobutyric acid (GABA) A receptor, beta 3	-	-	hippocampus	hippocampus	DH10B	NM_000814.4	NP_000805.1	REVIEWED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC013433	IRAK014J09	MGC	W01A050K01	pENTR-TOPO	16878		TADA3L	10474	AAH13433.1	Hs.386390	Transcriptional adaptor 3 (NGG1 homolog, yeast)-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006354.2	NP_006345.1	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	AK057266	flj0005i07	FLJ	W01A050K02	pENTR-TOPO	24200		C9orf98	158067	BAB71402.1	Hs.421340	Chromosome 9 open reading frame 98				TESTI2	EK1	NM_152572.2	NP_689785.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	H04D015A07	H04D015A07	RIKEN	W01A050K10	pENTR-TOPO		6264						-	-	testis	testis	DH10B			
RIKEN	BC033786	IRAK068H03	MGC	W01A050K13	pENTR-TOPO	24142		RNF38	152006	AAH33786.2	Hs.333503	Ring finger protein 38			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194328.2	NP_919309.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	AK126026	flj0072n17	FLJ	W01A050L09	pENTR-TOPO	6015		SLC2A14	144195	BAG54279.1	Hs.655169	Solute carrier family 2 (facilitated glucose transporter), member 14				TESTI4	EK1	NM_153449.2	NP_703150.1	PROVISIONAL	C	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	AK126026	flj0072n17	FLJ	W01A050L13	pENTR-TOPO	6015		SLC2A14	144195	BAG54279.1	Hs.655169	Solute carrier family 2 (facilitated glucose transporter), member 14				TESTI4	EK1	NM_153449.2	NP_703150.1	PROVISIONAL	C	1.000	1.000	520	1563	1	1560	520	1	520
RIKEN	AK093074	flj0005b15	FLJ	W01A050L24	pENTR-TOPO	16973		IL17RD	54756	-	Hs.150725	Interleukin 17 receptor D				TESTI2	EK1	NM_001080973.1	NP_001074442.1	VALIDATED	Ps	0.998	0.998	595	1788	1	1785	739	145	739
RIKEN	AK127181	flj0076i10	FLJ	W01A050M03	pENTR-TOPO	16435		ZNF621	285268	BAC86873.1	Hs.19977	Zinc finger protein 621				BRCOC2	EK1	NM_198484.3	NP_940886.1	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
RIKEN	BC026092	IRAK034L20	MGC	W01A050M04	pENTR-TOPO	20046		ZNF165	7718	AAH26092.1	Hs.535177	Zinc finger protein 165			Testis	NIH_MGC_97	DH10B	NM_003447.2	NP_003438.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC042416	IRAK050K08	MGC	W01A050M15	pENTR-TOPO	17747		NPY5R	4889	AAH42416.1	Hs.598503	Neuropeptide Y receptor Y5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_006174.2	NP_006165.1	PROVISIONAL	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC009569	IRAL016N18	MGC	W01A050M17	pENTR-TOPO	13874		ASB3	51130	AAH09569.1	Hs.40763	Ankyrin repeat and SOCS box-containing 3			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145863.1	NP_665862.1	REVIEWED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	AK092136	flj0011g10	FLJ	W01A050M20	pENTR-TOPO	11736		ZNF554	115196	BAC03814.1	Hs.307043	Zinc finger protein 554	NT2	teratocarcinoma		NT2NE2	EK1	NM_001102651.1	NP_001096121.1	VALIDATED	Ps	0.998	0.998	487	1464	1	1461	538	52	538
RIKEN	AK021646	flj0028d19	FLJ	W01A050N16	pENTR-TOPO	16151		MYNN	55892	BAB13862.1	Hs.507025	Myoneurin				HEMBA1	EK1	NM_018657.3	NP_061127.1	PROVISIONAL	C	1.000	1.000	610	1833	1	1830	610	1	610
RIKEN	BC053881	IRAK115H14	MGC	W01A050N24	pENTR-TOPO	1722		IGSF8	93185	AAH53881.1	Hs.332012	Immunoglobulin superfamily, member 8			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_052868.2	NP_443100.1	PROVISIONAL	C	1.000	1.000	613	1842	1	1839	613	1	613
RIKEN	AK128401	flj0078c12	FLJ	W01A050O03	pENTR-TOPO	16872		COLQ	8292	BAG54671.1	Hs.146735	Collagen-like tail subunit (single strand of homotrimer) of asymmetric acetylcholinesterase				THYMU3	EK1	NM_080538.2	NP_536799.1	REVIEWED	OK	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	AK024071	flj0049i16	FLJ	W01A050O13	pENTR-TOPO	11709		TLE6	79816	BAB14815.1	Hs.334507	Transducin-like enhancer of split 6 (E(sp1) homolog, Drosophila)	Y79	retinoblastoma		Y79AA1	EK1	NM_024760.2	NP_079036.1	VALIDATED	OK	1.000	1.000	449	1350	1	1347	449	1	449
RIKEN	AK027593	flj0034a02	FLJ	W01A050O24	pENTR-TOPO	4631		TRIM5	85363	BAB55218.1	Hs.370515	Tripartite motif-containing 5	NT2	teratocarcinoma		NT2RP2	EK1	NM_033034.1	NP_149023.1	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
RIKEN	BC040007	IRAK084C20	MGC	W01A051A03	pENTR-TOPO	21861		GPR37	2861	AAH40007.1	Hs.406094	G protein-coupled receptor 37 (endothelin receptor type B-like)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_005302.2	NP_005293.1	PROVISIONAL	OK	1.000	1.000	613	1842	1	1839	613	1	613
RIKEN	AK023130	flj0035e11	FLJ	W01A051A06	pENTR-TOPO	3642		ZDHHC5	25921	BAB14420.1	Hs.27239	Zinc finger, DHHC-type containing 5	NT2	teratocarcinoma		NT2RP3	EK1	NM_015457.2	NP_056272.2	VALIDATED	OK	1.000	1.000	715	2148	1	2145	715	1	715
RIKEN	BC070149	IRAL057O13	MGC	W01A051A15	pENTR-TOPO	20658		SLC2A12	154091	AAH70149.1	Hs.486508	Solute carrier family 2 (facilitated glucose transporter), member 12				NIH_MGC_186	DH10B	NM_145176.2	NP_660159.1	VALIDATED	C	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	BC070149	IRAL057O13	MGC	W01A051A19	pENTR-TOPO	20658		SLC2A12	154091	AAH70149.1	Hs.486508	Solute carrier family 2 (facilitated glucose transporter), member 12				NIH_MGC_186	DH10B	NM_145176.2	NP_660159.1	VALIDATED	C	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	BC070149	IRAL057O13	MGC	W01A051A21	pENTR-TOPO	20658		SLC2A12	154091	AAH70149.1	Hs.486508	Solute carrier family 2 (facilitated glucose transporter), member 12				NIH_MGC_186	DH10B	NM_145176.2	NP_660159.1	VALIDATED	C	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	BC070149	IRAL057O13	MGC	W01A051A23	pENTR-TOPO	20658		SLC2A12	154091	AAH70149.1	Hs.486508	Solute carrier family 2 (facilitated glucose transporter), member 12				NIH_MGC_186	DH10B	NM_145176.2	NP_660159.1	VALIDATED	C	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	BC064848	IRAK141N09	MGC	W01A051A24	pENTR-TOPO	17591		GAB1	2549	AAH64848.1	Hs.80720	GRB2-associated binding protein 1			Testis	NIH_MGC_180	DH10B	NM_207123.2	NP_997006.1	REVIEWED	OK	1.000	1.000	724	2175	1	2172	724	1	724
RIKEN	BC031522	IRAK013J22	MGC	W01A051B02	pENTR-TOPO	6486		ERCC5	2073	AAH31522.1	Hs.258429	Excision repair cross-complementing rodent repair deficiency, complementation group 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000123.2	NP_000114.2	REVIEWED	C	1.000	1.000	1186	3561	1	3558	1186	1	1186
RIKEN	BC031522	IRAK013J22	MGC	W01A051B08	pENTR-TOPO	6486		ERCC5	2073	AAH31522.1	Hs.258429	Excision repair cross-complementing rodent repair deficiency, complementation group 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000123.2	NP_000114.2	REVIEWED	C	1.000	1.000	1186	3561	1	3558	1186	1	1186
RIKEN	AK124594	flj0070g03	FLJ	W01A051B11	pENTR-TOPO	3699		DGKZ	8525	BAC85894.1	Hs.502461	Diacylglycerol kinase, zeta 104kDa				BRACE3	EK1	NM_201532.1	NP_963290.1	REVIEWED	C	1.000	1.000	945	2838	1	2835	945	1	945
RIKEN	BC031522	IRAK013J22	MGC	W01A051B12	pENTR-TOPO	6486		ERCC5	2073	AAH31522.1	Hs.258429	Excision repair cross-complementing rodent repair deficiency, complementation group 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000123.2	NP_000114.2	REVIEWED	C	1.000	1.000	1186	3561	1	3558	1186	1	1186
RIKEN	BC031522	IRAK013J22	MGC	W01A051B14	pENTR-TOPO	6486		ERCC5	2073	AAH31522.1	Hs.258429	Excision repair cross-complementing rodent repair deficiency, complementation group 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000123.2	NP_000114.2	REVIEWED	C	1.000	1.000	1186	3561	1	3558	1186	1	1186
RIKEN	BC057396	IRAK110J23	MGC	W01A051B17	pENTR-TOPO	13047		SH3BP4	23677	AAH57396.1	Hs.516777	SH3-domain binding protein 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014521.2	NP_055336.1	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
RIKEN	AK001699	flj0020o01	FLJ	W01A051C01	pENTR-TOPO	5801		FBXO21	23014	BAG50962.1	Hs.719089	F-box protein 21	NT2	teratocarcinoma		NT2RP4	EK1	NM_015002.2	NP_055817.1	REVIEWED	C	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	BC031832	IRAK029B16	MGC	W01A051C02	pENTR-TOPO	21842		PMS2	5395	AAH31832	Hs.632637	PMS2 postmeiotic segregation increased 2 (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000535.5	NP_000526.1	REVIEWED	P	1.000	1.000	727	2184	1	2181	862	136	862
RIKEN	AK001699	flj0020o01	FLJ	W01A051C07	pENTR-TOPO	5801		FBXO21	23014	BAG50962.1	Hs.719089	F-box protein 21	NT2	teratocarcinoma		NT2RP4	EK1	NM_015002.2	NP_055817.1	REVIEWED	C	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	BC031832	IRAK029B16	MGC	W01A051C10	pENTR-TOPO	21842		PMS2	5395	AAH31832	Hs.632637	PMS2 postmeiotic segregation increased 2 (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000535.5	NP_000526.1	REVIEWED	P	1.000	1.000	727	2184	1	2181	862	136	862
RIKEN	AK001699	flj0020o01	FLJ	W01A051C11	pENTR-TOPO	5801		FBXO21	23014	BAG50962.1	Hs.719089	F-box protein 21	NT2	teratocarcinoma		NT2RP4	EK1	NM_015002.2	NP_055817.1	REVIEWED	C	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	BC031832	IRAK029B16	MGC	W01A051C12	pENTR-TOPO	21842		PMS2	5395	AAH31832	Hs.632637	PMS2 postmeiotic segregation increased 2 (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000535.5	NP_000526.1	REVIEWED	P	1.000	1.000	727	2184	1	2181	862	136	862
RIKEN	AK126051	flj0072f23	FLJ	W01A051D01	pENTR-TOPO	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein				TESTI4	EK1	NM_207482.2	NP_997365.2	MODEL	Ps	0.994	0.994	975	2937	1	2925	1605	197	1171
RIKEN	BC053851	IRAK115K14	MGC	W01A051D02	pENTR-TOPO	16200		BRPF1	7862	AAH53851.1	Hs.1004	Bromodomain and PHD finger containing, 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001003694.1	NP_001003694.1	REVIEWED	OK	1.000	1.000	1220	3663	1	3660	1220	1	1220
RIKEN	BC068490	IRAK168K19	MGC	W01A051E04	pENTR-TOPO	812		VCAM1	7412	AAH68490.2	Hs.109225	Vascular cell adhesion molecule 1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001078.2	NP_001069.1	REVIEWED	C	1.000	1.000	739	2220	1	2217	739	1	739
RIKEN	BC050450	IRAK098E21	MGC	W01A051E11	pENTR-TOPO	11973		BCAM	4059	AAH50450.1	Hs.625725	Basal cell adhesion molecule (Lutheran blood group)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_005581.3	NP_005572.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	AK130533	flj0054j11	FLJ	W01A051E16	pENTR-TOPO	19851		CFB	629	-	Hs.69771	Complement factor B				SLV	EK1	NM_001710.5	NP_001701.2	REVIEWED	C	1.000	1.000	764	2295	1	2292	764	1	764
RIKEN	AK130533	flj0054j11	FLJ	W01A051E22	pENTR-TOPO	19851		CFB	629	-	Hs.69771	Complement factor B				SLV	EK1	NM_001710.5	NP_001701.2	REVIEWED	C	1.000	1.000	764	2295	1	2292	764	1	764
RIKEN	H013069L07	H013069L07	RIKEN	W01A051F04	pENTR-TOPO		16097						-	-	testis	testis	DH10B			
RIKEN	BC028600	IRAK046H19	MGC	W01A051G05	pENTR-TOPO	23245		SLC20A2	6575	AAH28600.1	Hs.653173	Solute carrier family 20 (phosphate transporter), member 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006749.3	NP_006740.1	PROVISIONAL	OK	1.000	1.000	652	1959	1	1956	652	1	652
RIKEN	BC028600	IRAK046H19	MGC	W01A051G07	pENTR-TOPO	23245		SLC20A2	6575	AAH28600.1	Hs.653173	Solute carrier family 20 (phosphate transporter), member 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006749.3	NP_006740.1	PROVISIONAL	OK	1.000	1.000	652	1959	1	1956	652	1	652
RIKEN	BC017730	IRAK020I01	MGC	W01A051G15	pENTR-TOPO	20424		TNFRSF21	27242	AAH17730.1	Hs.443577	Tumor necrosis factor receptor superfamily, member 21			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014452.3	NP_055267.1	REVIEWED	C	1.000	1.000	655	1968	1	1965	655	1	655
RIKEN	AK097689	flj0043a14	FLJ	W01A051G16	pENTR-TOPO	14709		ANKRD5	63926	BAG53512.1	Hs.70903	Ankyrin repeat domain 5				TESTI2	EK1	NM_022096.4	NP_071379.3	VALIDATED	C	1.000	1.000	776	2331	1	2328	776	1	776
RIKEN	BC017730	IRAK020I01	MGC	W01A051G21	pENTR-TOPO	20424		TNFRSF21	27242	AAH17730.1	Hs.443577	Tumor necrosis factor receptor superfamily, member 21			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014452.3	NP_055267.1	REVIEWED	C	1.000	1.000	655	1968	1	1965	655	1	655
RIKEN	AK097689	flj0043a14	FLJ	W01A051G24	pENTR-TOPO	14709		ANKRD5	63926	BAG53512.1	Hs.70903	Ankyrin repeat domain 5				TESTI2	EK1	NM_022096.4	NP_071379.3	VALIDATED	C	1.000	1.000	776	2331	1	2328	776	1	776
RIKEN	BC032542	IRAK069K05	MGC	W01A051H21	pENTR-TOPO	8757		FUK	197258	AAH32542.2	Hs.7907	Fucokinase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145059.2	NP_659496.2	REVIEWED	OK	1.000	1.000	1084	3255	1	3252	1084	1	1084
RIKEN	AK123496	flj0070b12	FLJ	W01A051I01	pENTR-TOPO	9112		ANKS3	124401	BAC85629.1	Hs.654859	Ankyrin repeat and sterile alpha motif domain containing 3				BRTHA2	EK1	NM_133450.2	NP_597707.1	PROVISIONAL	C	1.000	1.000	656	1971	1	1968	656	1	656
RIKEN	BC040187	IRAK070K22	MGC	W01A051I02	pENTR-TOPO	2682		HECTD2	143279	AAH40187.1	Hs.596096	HECT domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_182765.3	NP_877497.2	VALIDATED	Cs	0.995	0.995	776	2331	1	2328	776	1	776
RIKEN	AK123496	flj0070b12	FLJ	W01A051I05	pENTR-TOPO	9112		ANKS3	124401	BAC85629.1	Hs.654859	Ankyrin repeat and sterile alpha motif domain containing 3				BRTHA2	EK1	NM_133450.2	NP_597707.1	PROVISIONAL	C	1.000	1.000	656	1971	1	1968	656	1	656
RIKEN	BC037268	IRAK033C21	MGC	W01A051I13	pENTR-TOPO	7129		PRKCH	5583	AAH37268.1	Hs.333907	Protein kinase C, eta			Testis	NIH_MGC_97	DH10B	NM_006255.3	NP_006246.2	REVIEWED	C	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC030657	IRAK047C13	MGC	W01A051I14	pENTR-TOPO	16958		KIF9	64147	AAH30657.1	Hs.373947	Kinesin family member 9			Testis	NIH_MGC_97	DH10B	NM_182902.3	NP_878905.2	VALIDATED	Cs	0.999	0.999	790	2373	1	2370	790	1	790
RIKEN	BC037268	IRAK033C21	MGC	W01A051I23	pENTR-TOPO	7129		PRKCH	5583	AAH37268.1	Hs.333907	Protein kinase C, eta			Testis	NIH_MGC_97	DH10B	NM_006255.3	NP_006246.2	REVIEWED	C	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	AK131398	flj0073l08	FLJ	W01A051J03	pENTR-TOPO	24165		BNC2	54796	BAD18545.1	Hs.693437	Basonuclin 2				CTONG2	EK1	NM_017637.5	NP_060107.3	VALIDATED	C	1.000	1.000	1099	3300	1	3297	1099	1	1099
RIKEN	AK131398	flj0073l08	FLJ	W01A051J05	pENTR-TOPO	24165		BNC2	54796	BAD18545.1	Hs.693437	Basonuclin 2				CTONG2	EK1	NM_017637.5	NP_060107.3	VALIDATED	C	1.000	1.000	1099	3300	1	3297	1099	1	1099
RIKEN	BC013051	IRAK021F07	MGC	W01A051K05	pENTR-TOPO	15634		LIMK2	3985	AAH13051.1	Hs.474596	LIM domain kinase 2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001031801.1	NP_001026971.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
RIKEN	AK124734	flj0047f19	FLJ	W01A051K06	pENTR-TOPO	9088		CDH8	1006	BAG54083.1	Hs.368322	Cadherin 8, type 2				BRAWH3	EK1	NM_001796.2	NP_001787.2	REVIEWED	OK	1.000	1.000	799	2403	4	2400	799	1	799
RIKEN	AK124734	flj0047f19	FLJ	W01A051K08	pENTR-TOPO	9088		CDH8	1006	BAG54083.1	Hs.368322	Cadherin 8, type 2				BRAWH3	EK1	NM_001796.2	NP_001787.2	REVIEWED	OK	1.000	1.000	799	2403	4	2400	799	1	799
RIKEN	AK124734	flj0047f19	FLJ	W01A051K12	pENTR-TOPO	9088		CDH8	1006	BAG54083.1	Hs.368322	Cadherin 8, type 2				BRAWH3	EK1	NM_001796.2	NP_001787.2	REVIEWED	OK	1.000	1.000	799	2403	4	2400	799	1	799
RIKEN	BC032680	IRAK069P05	MGC	W01A051L02	pENTR-TOPO	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004799.2	NP_004790.2	REVIEWED	C	1.000	1.000	1425	4278	1	4275	1425	1	1425
RIKEN	BC032680	IRAK069P05	MGC	W01A051L04	pENTR-TOPO	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004799.2	NP_004790.2	REVIEWED	C	1.000	1.000	1425	4278	1	4275	1425	1	1425
RIKEN	AK131447	flj0073e12	FLJ	W01A051L11	pENTR-TOPO	1935		SPOCD1	90853	BAD18592.1	Hs.62604	SPOC domain containing 1				TESTI4	EK1	NM_144569.4	NP_653170.3	PROVISIONAL	OK	1.000	1.000	1216	3651	1	3648	1216	1	1216
RIKEN	BC032680	IRAK069P05	MGC	W01A051L14	pENTR-TOPO	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004799.2	NP_004790.2	REVIEWED	C	1.000	1.000	1425	4278	1	4275	1425	1	1425
RIKEN	BC032680	IRAK069P05	MGC	W01A051L18	pENTR-TOPO	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004799.2	NP_004790.2	REVIEWED	C	1.000	1.000	1425	4278	1	4275	1425	1	1425
RIKEN	BC032680	IRAK069P05	MGC	W01A051L20	pENTR-TOPO	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004799.2	NP_004790.2	REVIEWED	C	1.000	1.000	1425	4278	1	4275	1425	1	1425
RIKEN	BC032680	IRAK069P05	MGC	W01A051L22	pENTR-TOPO	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004799.2	NP_004790.2	REVIEWED	C	1.000	1.000	1425	4278	1	4275	1425	1	1425
RIKEN	AK131447	flj0073e12	FLJ	W01A051L23	pENTR-TOPO	1935		SPOCD1	90853	BAD18592.1	Hs.62604	SPOC domain containing 1				TESTI4	EK1	NM_144569.4	NP_653170.3	PROVISIONAL	OK	1.000	1.000	1216	3651	1	3648	1216	1	1216
RIKEN	H013039K11	H013039K11	RIKEN	W01A051M17	pENTR-TOPO		23960	ECM2	1842		Hs.117060	Extracellular matrix protein 2, female organ and adipocyte specific	-	-	testis	testis	DH10B	NM_001393.2	NP_001384.1	REVIEWED	C	1.000	1.000	699	2100	1	2097	699	1	699
RIKEN	H013062J03	H013062J03	RIKEN	W01A051N15	pENTR-TOPO		17190	PIK3R4	30849		Hs.149032	Phosphoinositide-3-kinase, regulatory subunit 4	-	-	testis	testis	DH10B	NM_014602.2	NP_055417.1	VALIDATED	C	1.000	1.000	1358	4077	1	4074	1358	1	1358
RIKEN	AK056430	flj0006k09	FLJ	W01A051O07	pENTR-TOPO	18014		YTHDC1	91746	BAB71181.1	Hs.175955	YTH domain containing 1	NT2	teratocarcinoma		NT2RP7	EK1	NM_133370.2	NP_588611.2	VALIDATED	Cs	0.997	0.997	709	2132	3	2129	709	1	709
RIKEN	AK131419	flj0073o22	FLJ	W01A051O15	pENTR-TOPO	16		TMCC2	9911	BAD18566.1	Hs.6360	Transmembrane and coiled-coil domain family 2				OCBBF2	EK1	NM_014858.2	NP_055673.2	VALIDATED	OK	1.000	1.000	709	2130	1	2127	709	1	709
RIKEN	BC034013	IRAK020A19	MGC	W01A051O18	pENTR-TOPO	11727		ARHGEF1	9138	AAH34013.2	Hs.631550	Rho guanine nucleotide exchange factor (GEF) 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_199002.1	NP_945353.1	REVIEWED	OK	1.000	1.000	927	2784	1	2781	927	1	927
RIKEN	BC053630	IRAK115O16	MGC	W01A052A05	pENTR-TOPO	12117		GNG7	2788	AAH53630.1	Hs.515544	Guanine nucleotide binding protein (G protein), gamma 7			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_052847.2	NP_443079.1	VALIDATED	C	1.000	1.000	68	207	1	204	68	1	68
RIKEN	BC008663	IRAK013E22	MGC	W01A052A13	pENTR-TOPO	10442		GNGT2	2793	AAH08663.1	Hs.181781	Guanine nucleotide binding protein (G protein), gamma transducing activity polypeptide 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_031498.2	NP_113686.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
RIKEN	BC016026	IRAK015H19	MGC	W01A052A23	pENTR-TOPO	17526		LSM6	11157	AAH16026.1	Hs.190520	LSM6 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_007080.2	NP_009011.1	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
RIKEN	BC009794	IRAL019O02	MGC	W01A052B04	pENTR-TOPO	20081		VIP	7432	AAH09794.1	Hs.53973	Vasoactive intestinal peptide			Prostate	NIH_MGC_83	DH10B	NM_194435.1	NP_919416.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC005904	IRAL021K11	MGC	W01A052B14	pENTR-TOPO	25392		SSX3	10214	AAH05904.1	Hs.558445	Synovial sarcoma, X breakpoint 3			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_175711.1	NP_783642.1	REVIEWED	C	1.000	1.000	170	513	1	510	170	1	170
RIKEN	BC009717	IRAK014E05	MGC	W01A052B18	pENTR-TOPO	15956		ZMAT5	55954	AAH09717.1	Hs.713647	Zinc finger, matrin type 5				NIH_MGC_69	DH10B	NM_019103.2	NP_061976.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
RIKEN	H013040B20	H013040B20	RIKEN	W01A052B19	pENTR-TOPO		402	CNIH4	29097		Hs.445890	Cornichon homolog 4 (Drosophila)	-	-	testis	testis	DH10B	NM_014184.2	NP_054903.1	PROVISIONAL	OK	1.000	1.000	139	420	1	417	139	1	139
RIKEN	AK056225	flj0002h08	FLJ	W01A052C02	pENTR-TOPO	21890		MTPN	136319	BAG51651.1	Hs.654894	Myotrophin	NT2	teratocarcinoma		NT2RI2	EK1	NM_145808.3	NP_665807.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
RIKEN	AK056225	flj0002h08	FLJ	W01A052C06	pENTR-TOPO	21890		MTPN	136319	BAG51651.1	Hs.654894	Myotrophin	NT2	teratocarcinoma		NT2RI2	EK1	NM_145808.3	NP_665807.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
RIKEN	H013056E07	H013056E07	RIKEN	W01A052C14	pENTR-TOPO		11026	SNRPD1	6632		Hs.464734	Small nuclear ribonucleoprotein D1 polypeptide 16kDa	-	-	testis	testis	DH10B	NM_006938.2	NP_008869.1	REVIEWED	C	1.000	1.000	119	360	1	357	119	1	119
RIKEN	AK124822	flj0046l21	FLJ	W01A052C19	pENTR-TOPO	14937		BLCAP	10904	-	Hs.718404	Bladder cancer associated protein				BRCAN2	EK1	NM_006698.2	NP_006689.1	REVIEWED	C	1.000	1.000	87	264	1	261	87	1	87
RIKEN	AK124822	flj0046l21	FLJ	W01A052C21	pENTR-TOPO	14937		BLCAP	10904	-	Hs.718404	Bladder cancer associated protein				BRCAN2	EK1	NM_006698.2	NP_006689.1	REVIEWED	C	1.000	1.000	87	264	1	261	87	1	87
RIKEN	BC003384	IRAK003J23	MGC	W01A052D01	pENTR-TOPO	4083		FKBP2	2286	AAH03384.1	Hs.227729	FK506 binding protein 2, 13kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_057092.2	NP_476433.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC003384	IRAK003J23	MGC	W01A052D05	pENTR-TOPO	4083		FKBP2	2286	AAH03384.1	Hs.227729	FK506 binding protein 2, 13kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_057092.2	NP_476433.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC022868	IRAL032C07	MGC	W01A052D15	pENTR-TOPO	1682		ETV3	2117	AAH22868.1	Hs.105636	Ets variant 3			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_005240.1	NP_005231.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
RIKEN	BC008600	IRAK012M01	MGC	W01A052E05	pENTR-TOPO	10339		CCL5	6352	AAH08600.1	Hs.514821	Chemokine (C-C motif) ligand 5			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_002985.2	NP_002976.2	REVIEWED	C	1.000	1.000	91	276	1	273	91	1	91
RIKEN	BC075837	IRAL058J02	MGC	W01A052E17	pENTR-TOPO	618		HMGN2	3151	AAH75837.1	Hs.181163	High-mobility group nucleosomal binding domain 2			Salivary gland, epidermoid carcinoma	NIH_MGC_102	DH10B	NM_005517.3	NP_005508.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
RIKEN	BC075837	IRAL058J02	MGC	W01A052E21	pENTR-TOPO	618		HMGN2	3151	AAH75837.1	Hs.181163	High-mobility group nucleosomal binding domain 2			Salivary gland, epidermoid carcinoma	NIH_MGC_102	DH10B	NM_005517.3	NP_005508.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
RIKEN	BC005961	IRAL021C11	MGC	W01A052F04	pENTR-TOPO	6223		PTHLH	5744	AAH05961.1	Hs.591159	Parathyroid hormone-like hormone			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_198964.1	NP_945315.1	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
RIKEN	AK000602	flj0064p17	FLJ	W01A052F07	pENTR-TOPO	7824		ZSCAN2	54993	BAA91283.1	Hs.594023	Zinc finger and SCAN domain containing 2				KAT	EK1	NM_017894.5	NP_060364.4	REVIEWED	Cs	0.993	0.993	150	453	1	450	150	1	150
RIKEN	AK022844	flj0033n05	FLJ	W01A052F21	pENTR-TOPO	7790		SCAND2	54581	BAB14268.1	Hs.658114	SCAN domain containing 2 pseudogene	NT2	teratocarcinoma		NT2RP2	EK1	NM_033635.2	NP_378661.1	VALIDATED										
RIKEN	BC003412	IRAK003J20	MGC	W01A052F22	pENTR-TOPO	266		PPIH	10465	AAH03412.1	Hs.256639	Peptidylprolyl isomerase H (cyclophilin H)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006347.3	NP_006338.1	REVIEWED	C	1.000	1.000	177	534	1	531	177	1	177
RIKEN	BC038289	IRAK082F24	MGC	W01A052G03	pENTR-TOPO	10327		CCL14	6358	AAH38289.1	Hs.714858	Chemokine (C-C motif) ligand 14			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_032963.3	NP_116739.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC038289	IRAK082F24	MGC	W01A052G05	pENTR-TOPO	10327		CCL14	6358	AAH38289.1	Hs.714858	Chemokine (C-C motif) ligand 14			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_032963.3	NP_116739.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC023980	IRAL032O12	MGC	W01A052G10	pENTR-TOPO	10316		TAX1BP3	30851	AAH23980.1	Hs.12956	Tax1 (human T-cell leukemia virus type I) binding protein 3			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_014604.2	NP_055419.1	VALIDATED	C	1.000	1.000	124	375	1	372	124	1	124
RIKEN	BC023980	IRAL032O12	MGC	W01A052G16	pENTR-TOPO	10316		TAX1BP3	30851	AAH23980.1	Hs.12956	Tax1 (human T-cell leukemia virus type I) binding protein 3			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_014604.2	NP_055419.1	VALIDATED	C	1.000	1.000	124	375	1	372	124	1	124
RIKEN	BC020795	IRAL037K20	MGC	W01A052G22	pENTR-TOPO	4167		SAA2	6289	AAH20795.1	Hs.1955	Serum amyloid A2			Liver	NIH_MGC_76	DH10B	NM_030754.3	NP_110381.2	VALIDATED	Cs	0.992	0.992	122	369	1	366	122	1	122
RIKEN	BC020795	IRAL037K20	MGC	W01A052G24	pENTR-TOPO	4167		SAA2	6289	AAH20795.1	Hs.1955	Serum amyloid A2			Liver	NIH_MGC_76	DH10B	NM_030754.3	NP_110381.2	VALIDATED	Cs	0.992	0.992	122	369	1	366	122	1	122
RIKEN	BC006807	IRAK003C10	MGC	W01A052H02	pENTR-TOPO	10396		PTRH2	51651	AAH06807.1	Hs.12677	Peptidyl-tRNA hydrolase 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016077.3	NP_057161.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC066255	IRAK172C17	MGC	W01A052H03	pENTR-TOPO	17945		IL2	3558	AAH66255.1	Hs.89679	Interleukin 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_000586.3	NP_000577.2	REVIEWED	OK	1.000	1.000	153	462	1	459	153	1	153
RIKEN	AK054581	flj0001i05	FLJ	W01A052H11	pENTR-TOPO	15385		CYYR1	116159	BAB70764.1	Hs.37445	Cysteine/tyrosine-rich 1	NB69	neuroblastoma		3NB692	EK1	NM_052954.2	NP_443186.1	VALIDATED	C	1.000	1.000	154	465	1	462	154	1	154
RIKEN	AK125647	flj0069n04	FLJ	W01A052H17	pENTR-TOPO	14115		MALL	7851	BAG54228.1	Hs.185055	Mal, T-cell differentiation protein-like				SYNOV4	EK1	NM_005434.4	NP_005425.1	VALIDATED	OK	1.000	1.000	153	462	1	459	153	1	153
RIKEN	AK125647	flj0069n04	FLJ	W01A052H21	pENTR-TOPO	14115		MALL	7851	BAG54228.1	Hs.185055	Mal, T-cell differentiation protein-like				SYNOV4	EK1	NM_005434.4	NP_005425.1	VALIDATED	OK	1.000	1.000	153	462	1	459	153	1	153
RIKEN	BC018509	IRAK013F11	MGC	W01A052H22	pENTR-TOPO	8714		CBFB	865	AAH18509.1	Hs.460988	Core-binding factor, beta subunit			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001755.2	NP_001746.1	REVIEWED	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	BC015519	IRAK022E05	MGC	W01A052I02	pENTR-TOPO	11504		PDCD5	9141	AAH15519.1	Hs.443831	Programmed cell death 5				NIH_MGC_69	DH10B	NM_004708.2	NP_004699.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC017850	IRAL036H08	MGC	W01A052I03	pENTR-TOPO	10002		CCL11	6356	AAH17850.1	Hs.54460	Chemokine (C-C motif) ligand 11			Lung	NIH_MGC_77	DH10B	NM_002986.2	NP_002977.1	REVIEWED	C	1.000	1.000	97	294	1	291	97	1	97
RIKEN	BC012290	IRAK021J18	MGC	W01A052I09	pENTR-TOPO	13484		ACYP2	98	AAH12290.1	Hs.516173	Acylphosphatase 2, muscle type			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138448.3	NP_612457.1	REVIEWED	C	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC012290	IRAK021J18	MGC	W01A052I11	pENTR-TOPO	13484		ACYP2	98	AAH12290.1	Hs.516173	Acylphosphatase 2, muscle type			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138448.3	NP_612457.1	REVIEWED	C	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC012290	IRAK021J18	MGC	W01A052I15	pENTR-TOPO	13484		ACYP2	98	AAH12290.1	Hs.516173	Acylphosphatase 2, muscle type			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138448.3	NP_612457.1	REVIEWED	C	1.000	1.000	99	300	1	297	99	1	99
RIKEN	BC007050	IRAL016O03	MGC	W01A052I21	pENTR-TOPO	892		VAMP3	9341	AAH07050.1	Hs.66708	Vesicle-associated membrane protein 3 (cellubrevin)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004781.3	NP_004772.1	REVIEWED	OK	1.000	1.000	100	303	1	300	100	1	100
RIKEN	H033072A04	H033072A04	RIKEN	W01A052J03	pENTR-TOPO		5217						-	-	hypothalamus	hypothalamus	DH10B			
RIKEN	BC012420	IRAK021G09	MGC	W01A052J13	pENTR-TOPO	14776		ID1	3397	AAH12420.1	Hs.504609	Inhibitor of DNA binding 1, dominant negative helix-loop-helix protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_002165.2	NP_002156.2	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
RIKEN	AK091726	flj0008o13	FLJ	W01A052J20	pENTR-TOPO	1370		TMEM9	252839	-	Hs.181444	Transmembrane protein 9				HEART1	EK1	NM_016456.3	NP_057540.1	VALIDATED	C	1.000	1.000	183	552	1	549	183	1	183
RIKEN	AK091726	flj0008o13	FLJ	W01A052J22	pENTR-TOPO	1370		TMEM9	252839	-	Hs.181444	Transmembrane protein 9				HEART1	EK1	NM_016456.3	NP_057540.1	VALIDATED	C	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC066353	IRAK167G02	MGC	W01A052K01	pENTR-TOPO	2019		LMX1A	4009	AAH66353.1	Hs.667312	LIM homeobox transcription factor 1, alpha			Testis	NIH_MGC_97	DH10B	NM_001033507.1	NP_001028679.1	PROVISIONAL	OK	1.000	1.000	100	303	1	300	100	1	100
RIKEN	AK098031	flj0023k23	FLJ	W01A052K02	pENTR-TOPO	13379		FLJ40712	401044	BAC05218	Hs.683800	FLJ40712 protein				THYMU2	EK1													
RIKEN	AK098031	flj0023k23	FLJ	W01A052K04	pENTR-TOPO	13379		FLJ40712	401044	BAC05218	Hs.683800	FLJ40712 protein				THYMU2	EK1													
RIKEN	BC066353	IRAK167G02	MGC	W01A052K07	pENTR-TOPO	2019		LMX1A	4009	AAH66353.1	Hs.667312	LIM homeobox transcription factor 1, alpha			Testis	NIH_MGC_97	DH10B	NM_001033507.1	NP_001028679.1	PROVISIONAL	OK	1.000	1.000	100	303	1	300	100	1	100
RIKEN	H033047A16	H033047A16	RIKEN	W01A052K15	pENTR-TOPO		12320	LSM7	51690		Hs.512610	LSM7 homolog, U6 small nuclear RNA associated (S. cerevisiae)	-	-	hypothalamus	hypothalamus	DH10B	NM_016199.2	NP_057283.1	VALIDATED	C	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC005303	IRAL016G02	MGC	W01A052K19	pENTR-TOPO	9340		PRM2	5620	AAH05303.1	Hs.2324	Protamine 2			Testis	NIH_MGC_82	DH10B	NM_002762.2	NP_002753.2	VALIDATED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC005303	IRAL016G02	MGC	W01A052K21	pENTR-TOPO	9340		PRM2	5620	AAH05303.1	Hs.2324	Protamine 2			Testis	NIH_MGC_82	DH10B	NM_002762.2	NP_002753.2	VALIDATED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC047445	IRAK091H09	MGC	W01A052K24	pENTR-TOPO	21049		MRPS17	51373	AAH47445.2	Hs.44298	Mitochondrial ribosomal protein S17			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015969.2	NP_057053.1	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	AK122818	flj0044j02	FLJ	W01A052L04	pENTR-TOPO	5464		BTBD11	121551	BAG53742.1	Hs.271272	BTB (POZ) domain containing 11				BRACE3	EK1	NM_001017523.1	NP_001017523.1	VALIDATED	P	1.000	1.000	183	552	1	549	641	459	641
RIKEN	BC013109	IRAK026H18	MGC	W01A052L05	pENTR-TOPO	7063		CMTM5	116173	AAH13109.1	Hs.99272	CKLF-like MARVEL transmembrane domain containing 5				NCI_CGAP_Brn67	DH10B	NM_138460.2	NP_612469.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	BC070250	IRAL057I07	MGC	W01A052M21	pENTR-TOPO	4499		POLD4	57804	AAH70250.1	Hs.523829	Polymerase (DNA-directed), delta 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_021173.2	NP_066996.2	PROVISIONAL	OK	1.000	1.000	107	324	1	321	107	1	107
RIKEN	BC010953	IRAL019J18	MGC	W01A052M22	pENTR-TOPO	14791		PFDN4	5203	AAH10953.1	Hs.91161	Prefoldin subunit 4			Prostate	NIH_MGC_83	DH10B	NM_002623.3	NP_002614.2	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	AK130859	flj0053m06	FLJ	W01A052N10	pENTR-TOPO	749		HMGB4	127540	-	Hs.568628	High-mobility group box 4				TST	EK1	NM_145205.3	NP_660206.2	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC014591	IRAK033B15	MGC	W01A052N13	pENTR-TOPO	14761		C20orf141	128653	AAH14591.1	Hs.664180	Chromosome 20 open reading frame 141			Testis	NIH_MGC_97	DH10B	NM_080739.2	NP_542777.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
RIKEN	BC070309	IRAL057P15	MGC	W01A052O01	pENTR-TOPO	1008		XCL1	6375	AAH70309.1	Hs.546295	Chemokine (C motif) ligand 1				NIH_MGC_191	DH10B	NM_002995.1	NP_002986.1	PROVISIONAL	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC070308	IRAL057P22	MGC	W01A052O15	pENTR-TOPO	2230		XCL2	6846	AAH70308.1	Hs.458346	Chemokine (C motif) ligand 2				NIH_MGC_191	DH10B	NM_003175.3	NP_003166.1	VALIDATED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC008376	IRAL016K17	MGC	W01A052O19	pENTR-TOPO	18160		CXCL5	6374	AAH08376.1	Hs.89714	Chemokine (C-X-C motif) ligand 5			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002994.3	NP_002985.1	REVIEWED	OK	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC052980	IRAK110H15	MGC	W01A052P01	pENTR-TOPO	16984		CGGBP1	8545	AAH52980.1	Hs.444818	CGG triplet repeat binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_003663.3	NP_003654.3	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
RIKEN	AK024593	flj0064h18	FLJ	W01A052P23	pENTR-TOPO	9747		PPP1R1B	84152	BAB14931.1	Hs.286192	Protein phosphatase 1, regulatory (inhibitor) subunit 1B				ad	EK1	NM_181505.2	NP_852606.1	PROVISIONAL	C	1.000	1.000	168	507	1	504	168	1	168
RIKEN	BC009710	IRAK014D02	MGC	W01A053A02	pENTR-TOPO	9646		GOSR2	9570	AAH09710.1	Hs.463278	Golgi SNAP receptor complex member 2				NIH_MGC_69	DH10B	NM_004287.3	NP_004278.2	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
RIKEN	AK097691	flj0043e14	FLJ	W01A053A12	pENTR-TOPO	9133		CDIPT	10423	BAG53514.1	Hs.719143	CDP-diacylglycerol--inositol 3-phosphatidyltransferase (phosphatidylinositol synthase)				TESTI2	EK1	NM_006319.3	NP_006310.1	VALIDATED	OK	1.000	1.000	213	642	1	639	213	1	213
RIKEN	H023067P15	H023067P15	RIKEN	W01A053A20	pENTR-TOPO		5901						-	-	hippocampus	hippocampus	DH10B			
RIKEN	H023067P15	H023067P15	RIKEN	W01A053A22	pENTR-TOPO		5901						-	-	hippocampus	hippocampus	DH10B			
RIKEN	BC034340	IRAK026B04	MGC	W01A053B03	pENTR-TOPO	25181		FGF13	2258	AAH34340.1	Hs.711551	Fibroblast growth factor 13			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004114.3	NP_004105.1	REVIEWED	C	1.000	1.000	245	738	1	735	245	1	245
RIKEN	BC066313	IRAK167O09	MGC	W01A053B04	pENTR-TOPO	19674		ABT1	29777	AAH66313.1	Hs.254406	Activator of basal transcription 1			Testis	NIH_MGC_97	DH10B	NM_013375.2	NP_037507.1	REVIEWED	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC034340	IRAK026B04	MGC	W01A053B05	pENTR-TOPO	25181		FGF13	2258	AAH34340.1	Hs.711551	Fibroblast growth factor 13			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004114.3	NP_004105.1	REVIEWED	C	1.000	1.000	245	738	1	735	245	1	245
RIKEN	BC066313	IRAK167O09	MGC	W01A053B06	pENTR-TOPO	19674		ABT1	29777	AAH66313.1	Hs.254406	Activator of basal transcription 1			Testis	NIH_MGC_97	DH10B	NM_013375.2	NP_037507.1	REVIEWED	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	H013022O12	H013022O12	RIKEN	W01A053C01	pENTR-TOPO		11884	MBD3L1	85509		Hs.133912	Methyl-CpG binding domain protein 3-like 1	-	-	testis	testis	DH10B	NM_145208.2	NP_660209.2	REVIEWED	Cs	0.995	0.995	194	585	1	582	194	1	194
RIKEN	BC056423	IRAK119E21	MGC	W01A053C04	pENTR-TOPO	8288		ULK3	25989	AAH56423	Hs.513034	Unc-51-like kinase 3 (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001099436.1	NP_001092906.1	VALIDATED	P	1.000	1.000	204	645	1	612	472	1	204
RIKEN	BC001277	IRAK004N12	MGC	W01A053C10	pENTR-TOPO	15654		KDELR3	11015	AAH01277.1	Hs.528305	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006855.2	NP_006846.1	REVIEWED	OK	1.000	1.000	214	645	1	642	214	1	214
RIKEN	BC001277	IRAK004N12	MGC	W01A053C16	pENTR-TOPO	15654		KDELR3	11015	AAH01277.1	Hs.528305	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006855.2	NP_006846.1	REVIEWED	OK	1.000	1.000	214	645	1	642	214	1	214
RIKEN	H023076G23	H023076G23	RIKEN	W01A053D06	pENTR-TOPO		14589	CD40	958		Hs.472860	CD40 molecule, TNF receptor superfamily member 5	-	-	hippocampus	hippocampus	DH10B	NM_001250.4	NP_001241.1	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
RIKEN	AK128785	flj0049l14	FLJ	W01A053D17	pENTR-TOPO	10644		YWHAE	7531	BAG54733.1	Hs.513851	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, epsilon polypeptide				BRSTN2	EK1	NM_006761.4	NP_006752.1	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC040496	IRAK048O21	MGC	W01A053E04	pENTR-TOPO	19095		TPPP	11076	AAH40496.1	Hs.481466	Tubulin polymerization promoting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_007030.2	NP_008961.1	VALIDATED	C	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC000145	IRAK003B21	MGC	W01A053E13	pENTR-TOPO	15627		H1F0	3005	AAH00145.1	Hs.715673	H1 histone family, member 0			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005318.3	NP_005309.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
RIKEN	AK092561	flj0007e03	FLJ	W01A053E14	pENTR-TOPO	15822		CLDN5	7122	BAG52573.1	Hs.505337	Claudin 5				PROST2	EK1	NM_003277.3	NP_003268.2	REVIEWED	P	1.000	1.000	218	657	1	654	303	86	303
RIKEN	BC009711	IRAK014E13	MGC	W01A053E18	pENTR-TOPO	13934		FKBP7	51661	AAH09711.1	Hs.410378	FK506 binding protein 7				NIH_MGC_69	DH10B	NM_181342.2	NP_851939.1	REVIEWED	C	1.000	1.000	222	669	1	666	222	1	222
RIKEN	BC009711	IRAK014E13	MGC	W01A053E20	pENTR-TOPO	13934		FKBP7	51661	AAH09711.1	Hs.410378	FK506 binding protein 7				NIH_MGC_69	DH10B	NM_181342.2	NP_851939.1	REVIEWED	C	1.000	1.000	222	669	1	666	222	1	222
RIKEN	BC010399	IRAL019K04	MGC	W01A053E21	pENTR-TOPO	5151		SOCS2	8835	AAH10399.1	Hs.485572	Suppressor of cytokine signaling 2			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003877.3	NP_003868.1	REVIEWED	C	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC009711	IRAK014E13	MGC	W01A053E22	pENTR-TOPO	13934		FKBP7	51661	AAH09711.1	Hs.410378	FK506 binding protein 7				NIH_MGC_69	DH10B	NM_181342.2	NP_851939.1	REVIEWED	C	1.000	1.000	222	669	1	666	222	1	222
RIKEN	H013037B06	H013037B06	RIKEN	W01A053F04	pENTR-TOPO		6960	SIP1	8487		Hs.708127	Survival of motor neuron protein interacting protein 1	-	-	testis	testis	DH10B	NM_003616.2	NP_003607.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
RIKEN	H013037B06	H013037B06	RIKEN	W01A053F06	pENTR-TOPO		6960	SIP1	8487		Hs.708127	Survival of motor neuron protein interacting protein 1	-	-	testis	testis	DH10B	NM_003616.2	NP_003607.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC007062	IRAL016A18	MGC	W01A053F07	pENTR-TOPO	3202		PRDX3	10935	AAH07062.1	Hs.604267	Peroxiredoxin 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_006793.2	NP_006784.1	REVIEWED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC035797	IRAK079J09	MGC	W01A053F10	pENTR-TOPO	7585		CEBPE	1053	AAH35797.2	Hs.558308	CCAAT/enhancer binding protein (C/EBP), epsilon			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001805.2	NP_001796.2	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
RIKEN	BC016285	IRAK015K14	MGC	W01A053F19	pENTR-TOPO	227		PRKACB	5567	AAH16285.1	Hs.487325	Protein kinase, cAMP-dependent, catalytic, beta			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_207578.1	NP_997461.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC016692	IRAL032P01	MGC	W01A053G14	pENTR-TOPO	18124		PGRMC2	10424	AAH16692.1	Hs.507910	Progesterone receptor membrane component 2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006320.2	NP_006311.1	PROVISIONAL	OK	1.000	1.000	223	672	1	669	223	1	223
RIKEN	BC018022	IRAL035P21	MGC	W01A053G18	pENTR-TOPO	14787		SNRPB2	6629	AAH18022.1	Hs.280378	Small nuclear ribonucleoprotein polypeptide B''			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003092.3	NP_003083.1	REVIEWED	C	1.000	1.000	225	678	1	675	225	1	225
RIKEN	AK096024	flj0045i24	FLJ	W01A053G23	pENTR-TOPO	22648		ZFP41	286128	BAC04676.1	Hs.668016	Zinc finger protein 41 homolog (mouse)				KIDNE2	EK1	NM_173832.3	NP_776193.1	PROVISIONAL	C	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC018022	IRAL035P21	MGC	W01A053G24	pENTR-TOPO	14787		SNRPB2	6629	AAH18022.1	Hs.280378	Small nuclear ribonucleoprotein polypeptide B''			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003092.3	NP_003083.1	REVIEWED	C	1.000	1.000	225	678	1	675	225	1	225
RIKEN	AK058175	flj0053p02	FLJ	W01A053H02	pENTR-TOPO	19839		FHL5	9457	-	Hs.632608	Four and a half LIM domains 5				TST	EK1	NM_020482.3	NP_065228.3	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
RIKEN	AK058175	flj0053p02	FLJ	W01A053H04	pENTR-TOPO	19839		FHL5	9457	-	Hs.632608	Four and a half LIM domains 5				TST	EK1	NM_020482.3	NP_065228.3	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC053894	IRAK115L22	MGC	W01A053H05	pENTR-TOPO	5393		HOXC9	3225	AAH53894.1	Hs.658823	Homeobox C9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_006897.1	NP_008828.1	REVIEWED	C	1.000	1.000	260	783	1	780	260	1	260
RIKEN	AK058175	flj0053p02	FLJ	W01A053H06	pENTR-TOPO	19839		FHL5	9457	-	Hs.632608	Four and a half LIM domains 5				TST	EK1	NM_020482.3	NP_065228.3	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
RIKEN	AK058175	flj0053p02	FLJ	W01A053H08	pENTR-TOPO	19839		FHL5	9457	-	Hs.632608	Four and a half LIM domains 5				TST	EK1	NM_020482.3	NP_065228.3	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
RIKEN	H013088G12	H013088G12	RIKEN	W01A053H09	pENTR-TOPO		17761	DCK	1633		Hs.709	Deoxycytidine kinase	-	-	testis	testis	DH10B	NM_000788.2	NP_000779.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC020674	IRAL037E22	MGC	W01A053H22	pENTR-TOPO	6472		TNFSF13B	10673	AAH20674.1	Hs.525157	Tumor necrosis factor (ligand) superfamily, member 13b			Placenta	NIH_MGC_79	DH10B	NM_006573.3	NP_006564.1	REVIEWED	OK	1.000	1.000	285	858	1	855	285	1	285
RIKEN	BC020674	IRAL037E22	MGC	W01A053H24	pENTR-TOPO	6472		TNFSF13B	10673	AAH20674.1	Hs.525157	Tumor necrosis factor (ligand) superfamily, member 13b			Placenta	NIH_MGC_79	DH10B	NM_006573.3	NP_006564.1	REVIEWED	OK	1.000	1.000	285	858	1	855	285	1	285
RIKEN	AK056034	flj0002i12	FLJ	W01A053J03	pENTR-TOPO	5409		ZNF664	144348	BAG51609.1	Hs.524828	Zinc finger protein 664	NT2	teratocarcinoma		NT2NE2	EK1	NM_152437.1	NP_689650.1	PROVISIONAL	C	1.000	1.000	261	786	1	783	261	1	261
RIKEN	BC028171	IRAK062N17	MGC	W01A053J09	pENTR-TOPO	15844		SULT4A1	25830	AAH28171	Hs.189810	Sulfotransferase family 4A, member 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_014351.3	NP_055166.1	REVIEWED		0.969	0.969	257	783	1	771	284	1	257
RIKEN	BC027953	IRAK049J04	MGC	W01A053J14	pENTR-TOPO	11959		FCAR	2204	AAH27953.1	Hs.659872	Fc fragment of IgA, receptor for			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_002000.2	NP_001991.1	REVIEWED	C	1.000	1.000	287	864	1	861	287	1	287
RIKEN	AK130199	flj0060o07	FLJ	W01A053J18	pENTR-TOPO	12338		OSCAR	126014	-	Hs.347655	Osteoclast associated, immunoglobulin-like receptor		macrophage		MPG	EK1	NM_206818.1	NP_996554.1	REVIEWED	C	1.000	1.000	286	861	1	858	286	1	286
RIKEN	BC040437	IRAK084K21	MGC	W01A053J23	pENTR-TOPO	25168		ITM2A	9452	AAH40437.1	Hs.694944	Integral membrane protein 2A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004867.3	NP_004858.1	VALIDATED	C	1.000	1.000	263	792	1	789	263	1	263
RIKEN	AK130199	flj0060o07	FLJ	W01A053J24	pENTR-TOPO	12338		OSCAR	126014	-	Hs.347655	Osteoclast associated, immunoglobulin-like receptor		macrophage		MPG	EK1	NM_206818.1	NP_996554.1	REVIEWED	C	1.000	1.000	286	861	1	858	286	1	286
RIKEN	BC009713	IRAK014L08	MGC	W01A053K06	pENTR-TOPO	10330		STX8	9482	AAH09713.1	Hs.431109	Syntaxin 8			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004853.1	NP_004844.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
RIKEN	AK075412	flj0027i12	FLJ	W01A053K10	pENTR-TOPO	3704		RTN3	10313	BAG52134.1	Hs.719090	Reticulon 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_006054.2	NP_006045.1	VALIDATED	C	1.000	1.000	236	711	1	708	236	1	236
RIKEN	BC000905	IRAK003K21	MGC	W01A053K11	pENTR-TOPO	14015		RAB1A	5861	AAH00905.1	Hs.310645	RAB1A, member RAS oncogene family			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_004161.4	NP_004152.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC022374	IRAL037O22	MGC	W01A053K17	pENTR-TOPO	24234		PHF19	26147	AAH22374.1	Hs.460124	PHD finger protein 19			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001009936.1	NP_001009936.1	VALIDATED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC022374	IRAL037O22	MGC	W01A053K19	pENTR-TOPO	24234		PHF19	26147	AAH22374.1	Hs.460124	PHD finger protein 19			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001009936.1	NP_001009936.1	VALIDATED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC022374	IRAL037O22	MGC	W01A053K23	pENTR-TOPO	24234		PHF19	26147	AAH22374.1	Hs.460124	PHD finger protein 19			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_001009936.1	NP_001009936.1	VALIDATED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC042558	IRAK072K04	MGC	W01A053L07	pENTR-TOPO	24108		ZDHHC21	340481	AAH42558.1	Hs.649522	Zinc finger, DHHC-type containing 21			Testis	NIH_MGC_97	DH10B	NM_178566.3	NP_848661.1	PROVISIONAL	C	1.000	1.000	265	798	1	795	265	1	265
RIKEN	AK024908	flj0050l09	FLJ	W01A053L10	pENTR-TOPO	6011		ASB8	140461	BAB15033.1	Hs.432699	Ankyrin repeat and SOCS box-containing 8				COL	EK1	NM_024095.3	NP_077000.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	AK024908	flj0050l09	FLJ	W01A053L14	pENTR-TOPO	6011		ASB8	140461	BAB15033.1	Hs.432699	Ankyrin repeat and SOCS box-containing 8				COL	EK1	NM_024095.3	NP_077000.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	AK024908	flj0050l09	FLJ	W01A053L16	pENTR-TOPO	6011		ASB8	140461	BAB15033.1	Hs.432699	Ankyrin repeat and SOCS box-containing 8				COL	EK1	NM_024095.3	NP_077000.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	AK127170	flj0076c23	FLJ	W01A053L17	pENTR-TOPO	2041		ANKRD45	339416	BAC86865.1	Hs.130054	Ankyrin repeat domain 45				BRCAN2	EK1	NM_198493.2	NP_940895.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
RIKEN	AK023553	flj0037a10	FLJ	W01A053L20	pENTR-TOPO	5193		OGFOD2	79676	BAB14610.1	Hs.524817	2-oxoglutarate and iron-dependent oxygenase domain containing 2				PLACE1	EK1	NM_024623.1	NP_078899.1	PROVISIONAL	OK	1.000	1.000	290	873	1	870	290	1	290
RIKEN	AK127170	flj0076c23	FLJ	W01A053L21	pENTR-TOPO	2041		ANKRD45	339416	BAC86865.1	Hs.130054	Ankyrin repeat domain 45				BRCAN2	EK1	NM_198493.2	NP_940895.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
RIKEN	AK096294	flj0037d13	FLJ	W01A053M02	pENTR-TOPO	7518		SLC25A29	123096	BAC04751.1	Hs.578109	Solute carrier family 25, member 29	NT2	teratocarcinoma		NT2RI2	EK1	NM_001039355.1	NP_001034444.1	VALIDATED	P	1.000	1.000	237	714	1	711	303	67	303
RIKEN	AK025165	flj0063h19	FLJ	W01A053M03	pENTR-TOPO	11656		RAB8A	4218	-	Hs.642874	RAB8A, member RAS oncogene family				COL	EK1	NM_005370.4	NP_005361.2	VALIDATED	OK	1.000	1.000	207	624	1	621	207	1	207
RIKEN	AK025165	flj0063h19	FLJ	W01A053M05	pENTR-TOPO	11656		RAB8A	4218	-	Hs.642874	RAB8A, member RAS oncogene family				COL	EK1	NM_005370.4	NP_005361.2	VALIDATED	OK	1.000	1.000	207	624	1	621	207	1	207
RIKEN	AK096294	flj0037d13	FLJ	W01A053M08	pENTR-TOPO	7518		SLC25A29	123096	BAC04751.1	Hs.578109	Solute carrier family 25, member 29	NT2	teratocarcinoma		NT2RI2	EK1	NM_001039355.1	NP_001034444.1	VALIDATED	P	1.000	1.000	237	714	1	711	303	67	303
RIKEN	BC020673	IRAL037F22	MGC	W01A053M14	pENTR-TOPO	3612		MS4A7	58475	AAH20673.1	Hs.530735	Membrane-spanning 4-domains, subfamily A, member 7			Placenta	NIH_MGC_79	DH10B	NM_021201.4	NP_067024.1	REVIEWED	C	1.000	1.000	240	723	1	720	240	1	240
RIKEN	AK056760	flj0006b15	FLJ	W01A053N05	pENTR-TOPO	21302		UPK3B	80761	BAG51807.1	Hs.488861	Uroplakin 3B				PLACE6	EK1	NM_030570.2	NP_085047.1	VALIDATED	Cg	0.828	1.000	320	798	1	795	320	1	320
RIKEN	AK122633	flj0070g18	FLJ	W01A053N09	pENTR-TOPO	4008		MS4A10	341116	BAC85498.1	Hs.591956	Membrane-spanning 4-domains, subfamily A, member 10				SMINT2	EK1	NM_206893.3	NP_996776.2	VALIDATED	Cs	0.993	0.993	267	804	1	801	267	1	267
RIKEN	BC038969	IRAK082C04	MGC	W01A053N14	pENTR-TOPO	3664		FOXR1	283150	AAH38969.2	Hs.116679	Forkhead box R1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181721.2	NP_859072.1	REVIEWED	C	1.000	1.000	292	879	1	876	292	1	292
RIKEN	AK122633	flj0070g18	FLJ	W01A053N15	pENTR-TOPO	4008		MS4A10	341116	BAC85498.1	Hs.591956	Membrane-spanning 4-domains, subfamily A, member 10				SMINT2	EK1	NM_206893.3	NP_996776.2	VALIDATED	Cs	0.993	0.993	267	804	1	801	267	1	267
RIKEN	BC010653	IRAK013E16	MGC	W01A053N20	pENTR-TOPO	17716		SC4MOL	6307	AAH10653.1	Hs.105269	Sterol-C4-methyl oxidase-like			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001017369.1	NP_001017369.1	REVIEWED	C	1.000	1.000	162	882	394	879	162	1	162
RIKEN	BC010653	IRAK013E16	MGC	W01A053N22	pENTR-TOPO	17716		SC4MOL	6307	AAH10653.1	Hs.105269	Sterol-C4-methyl oxidase-like			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001017369.1	NP_001017369.1	REVIEWED	C	1.000	1.000	162	882	394	879	162	1	162
RIKEN	AK098653	flj0053f09	FLJ	W01A053O03	pENTR-TOPO	7044		CDKN3	1033	-	Hs.84113	Cyclin-dependent kinase inhibitor 3				TST	EK1	NM_005192.3	NP_005183.2	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC067804	IRAK167J06	MGC	W01A053O09	pENTR-TOPO	22971		DUSP26	78986	AAH67804.1	Hs.8719	Dual specificity phosphatase 26 (putative)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024025.1	NP_076930.1	PROVISIONAL	C	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC055314	IRAL048F14	MGC	W01A053O10	pENTR-TOPO	5638		EMG1	10436	AAH55314.1	Hs.558447	EMG1 nucleolar protein homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006331.6	NP_006322.4	VALIDATED	OK	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC012389	IRAK021B11	MGC	W01A053O20	pENTR-TOPO	25142		TSPAN6	7105	AAH12389.1	Hs.43233	Tetraspanin 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003270.2	NP_003261.1	REVIEWED	C	1.000	1.000	245	738	1	735	245	1	245
RIKEN	BC013682	IRAK021I09	MGC	W01A053P01	pENTR-TOPO	22150		HOXA5	3202	AAH13682.1	Hs.655218	Homeobox A5			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_019102.2	NP_061975.2	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC029619	IRAL041B15	MGC	W01A053P09	pENTR-TOPO	5614		ATF1	466	AAH29619.1	Hs.648565	Activating transcription factor 1			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_005171.3	NP_005162.1	VALIDATED	C	1.000	1.000	271	816	1	813	271	1	271
RIKEN	BC016648	IRAK026G09	MGC	W01A053P19	pENTR-TOPO	4838		FOSL1	8061	AAH16648.1	Hs.283565	FOS-like antigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005438.3	NP_005429.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
RIKEN	AK098588	flj0053m12	FLJ	W01A054A04	pENTR-TOPO	7150		APEX1	328	-	Hs.73722	APEX nuclease (multifunctional DNA repair enzyme) 1				TST	EK1	NM_080648.1	NP_542379.1	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
RIKEN	AK098588	flj0053m12	FLJ	W01A054A08	pENTR-TOPO	7150		APEX1	328	-	Hs.73722	APEX nuclease (multifunctional DNA repair enzyme) 1				TST	EK1	NM_080648.1	NP_542379.1	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
RIKEN	AK090824	flj0010p14	FLJ	W01A054A23	pENTR-TOPO	6127		DEPDC4	120863	BAC03525.1	Hs.653118	DEP domain containing 4				BRAMY2	EK1	NM_152317.2	NP_689530.1	PROVISIONAL	C	1.000	1.000	294	885	1	882	294	1	294
RIKEN	AK131519	flj0073d11	FLJ	W01A054B01	pENTR-TOPO	6004		FOXN4	121643	BAD18661.1	Hs.528316	Forkhead box N4				FCBBF3	EK1	NM_213596.2	NP_998761.2	VALIDATED	Ps	0.985	0.985	326	1014	34	1011	517	192	517
RIKEN	AK055665	flj0001f10	FLJ	W01A054B04	pENTR-TOPO	17537		MAB21L2	10586	BAG51549.1	Hs.584852	Mab-21-like 2 (C. elegans)	IMR32	neuroblastoma		IMR322	EK1	NM_006439.4	NP_006430.1	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	AK122639	flj0067d10	FLJ	W01A054B15	pENTR-TOPO	6728		OXGR1	27199	BAG53633.1	Hs.352218	Oxoglutarate (alpha-ketoglutarate) receptor 1				TRACH2	EK1	NM_080818.3	NP_543008.3	REVIEWED	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	H033096P22	H033096P22	RIKEN	W01A054B16	pENTR-TOPO		7337	NDRG2	57447		Hs.525205	NDRG family member 2	-	-	hypothalamus	hypothalamus	DH10B	NM_016250.2	NP_057334.1	REVIEWED	OK	1.000	1.000	357	1074	1	1071	357	1	357
RIKEN	BC028234	IRAK062N04	MGC	W01A054C01	pENTR-TOPO	12560		NAPA	8775	AAH28234.1	Hs.719083	N-ethylmaleimide-sensitive factor attachment protein, alpha			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003827.2	NP_003818.2	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	BC018667	IRAL038A16	MGC	W01A054C02	pENTR-TOPO	3397		ANKRD1	27063	AAH18667.1	Hs.448589	Ankyrin repeat domain 1 (cardiac muscle)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_014391.2	NP_055206.2	REVIEWED	OK	1.000	1.000	319	960	1	957	319	1	319
RIKEN	BC028234	IRAK062N04	MGC	W01A054C03	pENTR-TOPO	12560		NAPA	8775	AAH28234.1	Hs.719083	N-ethylmaleimide-sensitive factor attachment protein, alpha			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003827.2	NP_003818.2	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	BC012606	IRAL019P07	MGC	W01A054C16	pENTR-TOPO	8906		PSMD7	5713	AAH12606.1	Hs.440604	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 7			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_002811.3	NP_002802.2	REVIEWED	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	AK128645	flj0075f06	FLJ	W01A054C19	pENTR-TOPO	22528		SDCBP	6386	-	Hs.200804	Syndecan binding protein (syntenin)				TRACH3	EK1	NM_001007070.1	NP_001007071.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC036689	IRAK073D13	MGC	W01A054C20	pENTR-TOPO	14947		MAFB	9935	AAH36689.1	Hs.169487	V-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005461.3	NP_005452.2	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	AK128645	flj0075f06	FLJ	W01A054C21	pENTR-TOPO	22528		SDCBP	6386	-	Hs.200804	Syndecan binding protein (syntenin)				TRACH3	EK1	NM_001007070.1	NP_001007071.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC036689	IRAK073D13	MGC	W01A054C22	pENTR-TOPO	14947		MAFB	9935	AAH36689.1	Hs.169487	V-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005461.3	NP_005452.2	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC016910	IRAK027M22	MGC	W01A054D02	pENTR-TOPO	7935		GABPB1	2553	AAH16910.1	Hs.654350	GA binding protein transcription factor, beta subunit 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_002041.4	NP_002032.2	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC016910	IRAK027M22	MGC	W01A054D04	pENTR-TOPO	7935		GABPB1	2553	AAH16910.1	Hs.654350	GA binding protein transcription factor, beta subunit 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_002041.4	NP_002032.2	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC016910	IRAK027M22	MGC	W01A054D06	pENTR-TOPO	7935		GABPB1	2553	AAH16910.1	Hs.654350	GA binding protein transcription factor, beta subunit 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_002041.4	NP_002032.2	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC016910	IRAK027M22	MGC	W01A054D08	pENTR-TOPO	7935		GABPB1	2553	AAH16910.1	Hs.654350	GA binding protein transcription factor, beta subunit 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_002041.4	NP_002032.2	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	AK001890	flj0037m06	FLJ	W01A054D15	pENTR-TOPO	16954		GNB4	59345	BAG50987.1	Hs.173030	Guanine nucleotide binding protein (G protein), beta polypeptide 4				PLACE1	EK1	NM_021629.3	NP_067642.1	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC000794	IRAK004O01	MGC	W01A054D17	pENTR-TOPO	2670		PRPF18	8559	AAH00794.1	Hs.161181	PRP18 pre-mRNA processing factor 18 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003675.3	NP_003666.1	REVIEWED	C	1.000	1.000	342	1029	1	1026	342	1	342
RIKEN	AK095592	flj0024n11	FLJ	W01A054D22	pENTR-TOPO	18800		LSM11	134353	BAC04581.1	Hs.631954	LSM11, U7 small nuclear RNA associated				FCBBF3	EK1	NM_173491.2	NP_775762.1	PROVISIONAL	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	AK026665	flj0061k05	FLJ	W01A054E03	pENTR-TOPO	1614		F11R	50848	-	Hs.517293	F11 receptor				LNG	EK1	NM_144503.1	NP_653086.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	AK000658	flj0059f03	FLJ	W01A054E17	pENTR-TOPO	23625		STX17	55014	BAA91311.1	Hs.709465	Syntaxin 17				KAT	EK1	NM_017919.2	NP_060389.2	VALIDATED	Cs	0.990	0.990	302	909	1	906	302	1	302
RIKEN	BC038950	IRAK082G13	MGC	W01A054F03	pENTR-TOPO	15594		APOL6	80830	AAH38950.2	Hs.257352	Apolipoprotein L, 6			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_030641.3	NP_085144.1	REVIEWED	OK	1.000	1.000	343	1032	1	1029	343	1	343
RIKEN	AK001745	flj0020a19	FLJ	W01A054F16	pENTR-TOPO	14550		PCMTD2	55251	BAA91877.1	Hs.473317	Protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 2	NT2	teratocarcinoma		NT2RP4	EK1	NM_018257.2	NP_060727.2	VALIDATED	Cs	0.997	0.997	361	1086	1	1083	361	1	361
RIKEN	BC027965	IRAK049L24	MGC	W01A054F20	pENTR-TOPO	6198		NIACR1	338442	AAH27965.1	Hs.524812	Niacin receptor 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_177551.3	NP_808219.1	VALIDATED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	AK075406	flj0027g08	FLJ	W01A054G03	pENTR-TOPO	19087		STC2	8614	BAG52131.1	Hs.233160	Stanniocalcin 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_003714.2	NP_003705.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
RIKEN	BC043494	IRAK089N20	MGC	W01A054G04	pENTR-TOPO	17015		WDR5B	54554	AAH43494.1	Hs.567513	WD repeat domain 5B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019069.3	NP_061942.2	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	AK125624	flj0068h03	FLJ	W01A054G14	pENTR-TOPO	1788		SLAMF6	114836	BAG54223.1	Hs.492348	SLAM family member 6				SPLEN2	EK1	NM_052931.3	NP_443163.1	REVIEWED	C	1.000	1.000	331	996	1	993	331	1	331
RIKEN	AK125624	flj0068h03	FLJ	W01A054G16	pENTR-TOPO	1788		SLAMF6	114836	BAG54223.1	Hs.492348	SLAM family member 6				SPLEN2	EK1	NM_052931.3	NP_443163.1	REVIEWED	C	1.000	1.000	331	996	1	993	331	1	331
RIKEN	AK023136	flj0035e13	FLJ	W01A054G19	pENTR-TOPO	3649		PKNOX2	63876	BAB14422.1	Hs.719275	PBX/knotted 1 homeobox 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_022062.2	NP_071345.2	VALIDATED	Pfs	0.993	0.997	307	921	1	919	472	13	319
RIKEN	H013088G16	H013088G16	RIKEN	W01A054H05	pENTR-TOPO		1328	MKNK1	8569		Hs.371594	MAP kinase interacting serine/threonine kinase 1	-	-	testis	testis	DH10B	NM_198973.2	NP_945324.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC067265	IRAK141I16	MGC	W01A054H21	pENTR-TOPO	14036		LMAN2L	81562	AAH67265.1	Hs.655743	Lectin, mannose-binding 2-like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_030805.3	NP_110432.1	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC067265	IRAK141I16	MGC	W01A054H23	pENTR-TOPO	14036		LMAN2L	81562	AAH67265.1	Hs.655743	Lectin, mannose-binding 2-like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_030805.3	NP_110432.1	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	AK096823	flj0041n24	FLJ	W01A054I01	pENTR-TOPO	18044		HS3ST1	9957	BAG53368.1	Hs.507348	Heparan sulfate (glucosamine) 3-O-sulfotransferase 1				PROST2	EK1	NM_005114.2	NP_005105.1	REVIEWED	C	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC030266	IRAK062L05	MGC	W01A054I04	pENTR-TOPO	3398		SLC25A16	8034	AAH30266.1	Hs.180408	Solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152707.2	NP_689920.1	REVIEWED	C	1.000	1.000	332	999	1	996	332	1	332
RIKEN	AK096823	flj0041n24	FLJ	W01A054I07	pENTR-TOPO	18044		HS3ST1	9957	BAG53368.1	Hs.507348	Heparan sulfate (glucosamine) 3-O-sulfotransferase 1				PROST2	EK1	NM_005114.2	NP_005105.1	REVIEWED	C	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC030266	IRAK062L05	MGC	W01A054I08	pENTR-TOPO	3398		SLC25A16	8034	AAH30266.1	Hs.180408	Solute carrier family 25 (mitochondrial carrier; Graves disease autoantigen), member 16			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152707.2	NP_689920.1	REVIEWED	C	1.000	1.000	332	999	1	996	332	1	332
RIKEN	AK000594	flj0064j08	FLJ	W01A054I09	pENTR-TOPO	14996		TOMM34	10953	-	Hs.517066	Translocase of outer mitochondrial membrane 34				KAT	EK1	NM_006809.4	NP_006800.2	REVIEWED	C	1.000	1.000	309	930	1	927	309	1	309
RIKEN	BC051337	IRAL047K10	MGC	W01A054I12	pENTR-TOPO	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_176786.1	NP_789743.1	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
RIKEN	AK000594	flj0064j08	FLJ	W01A054I13	pENTR-TOPO	14996		TOMM34	10953	-	Hs.517066	Translocase of outer mitochondrial membrane 34				KAT	EK1	NM_006809.4	NP_006800.2	REVIEWED	C	1.000	1.000	309	930	1	927	309	1	309
RIKEN	AK055775	flj0014a09	FLJ	W01A054I20	pENTR-TOPO	11218		ZNF396	252884	BAB71010.1	Hs.351005	Zinc finger protein 396				KIDNE2	EK1	NM_145756.2	NP_665699.1	VALIDATED	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	AK000286	flj0051g18	FLJ	W01A054I21	pENTR-TOPO	9241		ZDHHC7	55625	BAA91055.1	Hs.592065	Zinc finger, DHHC-type containing 7	HepG2	hepatoma		HEP	EK1	NM_017740.2	NP_060210.2	VALIDATED	Cs	0.997	0.997	308	927	1	924	308	1	308
RIKEN	AK055775	flj0014a09	FLJ	W01A054I24	pENTR-TOPO	11218		ZNF396	252884	BAB71010.1	Hs.351005	Zinc finger protein 396				KIDNE2	EK1	NM_145756.2	NP_665699.1	VALIDATED	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	BC020691	IRAL037E04	MGC	W01A054J08	pENTR-TOPO	22013		NAMPT	10135	AAH20691	Hs.489615	Nicotinamide phosphoribosyltransferase			Lung	NIH_MGC_77	DH10B	NM_005746.2	NP_005737.1	REVIEWED	Ps	0.997	0.997	364	1107	1	1092	491	1	364
RIKEN	H023046F18	H023046F18	RIKEN	W01A054J13	pENTR-TOPO		1624	MCL1	4170		Hs.719112	Myeloid cell leukemia sequence 1 (BCL2-related)	-	-	hippocampus	hippocampus	DH10B	NM_021960.3	NP_068779.1	REVIEWED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	H013074K15	H013074K15	RIKEN	W01A054J14	pENTR-TOPO		14724	RAE1	8480		Hs.371698	RAE1 RNA export 1 homolog (S. pombe)	-	-	testis	testis	DH10B	NM_003610.3	NP_003601.1	REVIEWED	C	1.000	1.000	368	1107	1	1104	368	1	368
RIKEN	H023046F18	H023046F18	RIKEN	W01A054J15	pENTR-TOPO		1624	MCL1	4170		Hs.719112	Myeloid cell leukemia sequence 1 (BCL2-related)	-	-	hippocampus	hippocampus	DH10B	NM_021960.3	NP_068779.1	REVIEWED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	AK074955	flj0018l15	FLJ	W01A054J24	pENTR-TOPO	7766		GRINL1A	81488	BAC11313.1			NT2	teratocarcinoma		NT2RP3	EK1	NM_015532.3	NP_056347.1	REVIEWED	C	1.000	1.000	368	1107	1	1104	368	1	368
RIKEN	AK095951	flj0024d10	FLJ	W01A054K13	pENTR-TOPO	17646		AIMP1	9255	BAG53174.1	Hs.591680	Small inducible cytokine subfamily E, member 1 (endothelial monocyte-activating)				HHDPC2	EK1	NM_001142415.1	NP_001135887.1	REVIEWED	C	1.000	1.000	312	939	1	936	312	1	312
RIKEN	BC067481	IRAK172E14	MGC	W01A054K16	pENTR-TOPO	15108		NPBWR2	2832	AAH67481.1	Hs.248118	Neuropeptides B/W receptor 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_005286.2	NP_005277.2	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	AK093389	flj0015l22	FLJ	W01A054K17	pENTR-TOPO	12527		MAMSTR	284358	BAC04152.1	Hs.191815	Likely ortholog of MEF2-activating SAP transcriptional regulator				TESTI2	EK1	NM_182574.2	NP_872380.1	VALIDATED	C	1.000	1.000	312	939	1	936	312	1	312
RIKEN	AK093389	flj0015l22	FLJ	W01A054K19	pENTR-TOPO	12527		MAMSTR	284358	BAC04152.1	Hs.191815	Likely ortholog of MEF2-activating SAP transcriptional regulator				TESTI2	EK1	NM_182574.2	NP_872380.1	VALIDATED	C	1.000	1.000	312	939	1	936	312	1	312
RIKEN	BC067448	IRAK172C09	MGC	W01A054K24	pENTR-TOPO	6758		GPR12	2835	AAH67448.1	Hs.719715	G protein-coupled receptor 12			PCR rescued clones	NIH_MGC_195	DH10B	NM_005288.3	NP_005279.1	VALIDATED	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	AK025876	flj0061g06	FLJ	W01A054L09	pENTR-TOPO	12282		SIRT2	22933	-	Hs.466693	Sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae)				HRC	EK1	NM_030593.1	NP_085096.1	REVIEWED	OK	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	AK025876	flj0061g06	FLJ	W01A054L11	pENTR-TOPO	12282		SIRT2	22933	-	Hs.466693	Sirtuin (silent mating type information regulation 2 homolog) 2 (S. cerevisiae)				HRC	EK1	NM_030593.1	NP_085096.1	REVIEWED	OK	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC021855	IRAK042I12	MGC	W01A054L14	pENTR-TOPO	16114		ZBTB47	92999	AAH21855.1	Hs.409561	Zinc finger and BTB domain containing 47				NCI_CGAP_Brn67	DH10B	NM_145166.2	NP_660149.1	VALIDATED	C	1.000	1.000	371	1116	1	1113	371	1	371
RIKEN	BC036207	IRAK063D07	MGC	W01A054L19	pENTR-TOPO	3362		MKX	283078	AAH36207.1	Hs.128193	Mohawk homeobox			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173576.2	NP_775847.2	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC036207	IRAK063D07	MGC	W01A054L23	pENTR-TOPO	3362		MKX	283078	AAH36207.1	Hs.128193	Mohawk homeobox			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173576.2	NP_775847.2	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC003685	IRAK004E15	MGC	W01A054M07	pENTR-TOPO	19417		PITX1	5307	AAH03685.1	Hs.84136	Paired-like homeodomain 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002653.4	NP_002644.4	REVIEWED	Cs	0.997	0.997	314	945	1	942	314	1	314
RIKEN	BC018051	IRAK032N12	MGC	W01A054M14	pENTR-TOPO	694		KCNK1	3775	AAH18051.1	Hs.208544	Potassium channel, subfamily K, member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002245.3	NP_002236.1	REVIEWED	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC018051	IRAK032N12	MGC	W01A054M16	pENTR-TOPO	694		KCNK1	3775	AAH18051.1	Hs.208544	Potassium channel, subfamily K, member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002245.3	NP_002236.1	REVIEWED	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC067478	IRAK172E18	MGC	W01A054M20	pENTR-TOPO	11402		GPR77	27202	AAH67478.1	Hs.534412	G protein-coupled receptor 77			PCR rescued clones	NIH_MGC_195	DH10B	NM_018485.1	NP_060955.1	PROVISIONAL	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC067478	IRAK172E18	MGC	W01A054M22	pENTR-TOPO	11402		GPR77	27202	AAH67478.1	Hs.534412	G protein-coupled receptor 77			PCR rescued clones	NIH_MGC_195	DH10B	NM_018485.1	NP_060955.1	PROVISIONAL	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	BC015935	IRAK015B09	MGC	W01A054N03	pENTR-TOPO	6987		CCNK	8812	AAH15935.1	Hs.510409	Cyclin K			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003858.3	NP_003849.2	REVIEWED	OK	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	AK127353	flj0076g01	FLJ	W01A054N04	pENTR-TOPO	3240		AIFM2	84883	BAG54492.1	Hs.655377	Apoptosis-inducing factor, mitochondrion-associated, 2				BRHIP3	EK1	NM_032797.4	NP_116186.1	REVIEWED	C	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	AK129806	flj0062i13	FLJ	W01A054N12	pENTR-TOPO	13760		RTN4	57142	-	Hs.704007	Reticulon 4				DMC	EK1	NM_153828.2	NP_722550.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	AK025480	flj0063p24	FLJ	W01A054N15	pENTR-TOPO	4691		C11orf60	56912	BAB15146.1	Hs.533738	Chromosome 11 open reading frame 60	HepG2	hepatoma		HEP	EK1	NM_020153.2	NP_064538.2	PROVISIONAL	OK	1.000	1.000	355	1068	1	1065	355	1	355
RIKEN	AK023153	flj0035k19	FLJ	W01A054N18	pENTR-TOPO	4087		FANCF	2188	BAB14433.1	Hs.713574	Fanconi anemia, complementation group F	NT2	teratocarcinoma		NT2RP3	EK1	NM_022725.3	NP_073562.1	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC053621	IRAK115M08	MGC	W01A054N19	pENTR-TOPO	16071		IL1RAP	3556	AAH53621.1	Hs.478673	Interleukin 1 receptor accessory protein			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_134470.2	NP_608273.1	REVIEWED	OK	1.000	1.000	356	1071	1	1068	356	1	356
RIKEN	AK001421	flj0033p21	FLJ	W01A054O01	pENTR-TOPO	566		PRMT6	55170	BAA91681.1	Hs.26006	Protein arginine methyltransferase 6	NT2	teratocarcinoma		NT2RP2	EK1	NM_018137.2	NP_060607.2	VALIDATED	P	1.000	1.000	316	951	1	948	375	60	375
RIKEN	AK001421	flj0033p21	FLJ	W01A054O05	pENTR-TOPO	566		PRMT6	55170	BAA91681.1	Hs.26006	Protein arginine methyltransferase 6	NT2	teratocarcinoma		NT2RP2	EK1	NM_018137.2	NP_060607.2	VALIDATED	P	1.000	1.000	316	951	1	948	375	60	375
RIKEN	BC006992	IRAL016P06	MGC	W01A054O16	pENTR-TOPO	5264		RAD51AP1	10635	AAH06992.1	Hs.719194	RAD51 associated protein 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_006479.4	NP_006470.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC057777	IRAK133C21	MGC	W01A054P19	pENTR-TOPO	24045		GNAQ	2776	AAH57777.1	Hs.269782	Guanine nucleotide binding protein (G protein), q polypeptide			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_002072.2	NP_002063.2	PROVISIONAL	C	1.000	1.000	359	1080	1	1077	359	1	359
RIKEN	BC073827	IRAK166H09	MGC	W01A055A01	pENTR-TOPO	11655		P2RY11	5032	AAH73827.1					Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002566.4	NP_002557.2	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	AK026290	flj0059g19	FLJ	W01A055A04	pENTR-TOPO	7975		ELL3	80237	BAB15432.1	Hs.706346	Elongation factor RNA polymerase II-like 3				HSI	EK1	NM_025165.2	NP_079441.1	VALIDATED	OK	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC073827	IRAK166H09	MGC	W01A055A05	pENTR-TOPO	11655		P2RY11	5032	AAH73827.1					Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002566.4	NP_002557.2	REVIEWED	C	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC064920	IRAK140G19	MGC	W01A055A17	pENTR-TOPO	3275		DNAJB12	54788	AAH64920.1	Hs.696014	DnaJ (Hsp40) homolog, subfamily B, member 12			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_017626.4	NP_060096.3	VALIDATED	P	1.000	1.000	375	1128	1	1125	409	35	409
RIKEN	BC064920	IRAK140G19	MGC	W01A055A19	pENTR-TOPO	3275		DNAJB12	54788	AAH64920.1	Hs.696014	DnaJ (Hsp40) homolog, subfamily B, member 12			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_017626.4	NP_060096.3	VALIDATED	P	1.000	1.000	375	1128	1	1125	409	35	409
RIKEN	BC064920	IRAK140G19	MGC	W01A055A23	pENTR-TOPO	3275		DNAJB12	54788	AAH64920.1	Hs.696014	DnaJ (Hsp40) homolog, subfamily B, member 12			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_017626.4	NP_060096.3	VALIDATED	P	1.000	1.000	375	1128	1	1125	409	35	409
RIKEN	BC007064	IRAL016M18	MGC	W01A055B01	pENTR-TOPO	12464		ZNF566	84924	AAH07064.1	Hs.533939	Zinc finger protein 566			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001145345.1	NP_001138817.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC007064	IRAL016M18	MGC	W01A055B05	pENTR-TOPO	12464		ZNF566	84924	AAH07064.1	Hs.533939	Zinc finger protein 566			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001145345.1	NP_001138817.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC022874	IRAL032C18	MGC	W01A055B06	pENTR-TOPO	10317		SHMT1	6470	AAH22874.1	Hs.636044	Serine hydroxymethyltransferase 1 (soluble)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_148918.1	NP_683718.1	REVIEWED	C	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC007064	IRAL016M18	MGC	W01A055B07	pENTR-TOPO	12464		ZNF566	84924	AAH07064.1	Hs.533939	Zinc finger protein 566			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001145345.1	NP_001138817.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	AK090672	flj0012o15	FLJ	W01A055B09	pENTR-TOPO	1956		SYT2	127833	BAC03500.1	Hs.25422	Synaptotagmin II				BRACE2	EK1	NM_001136504.1	NP_001129976.1	VALIDATED	C	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC046098	IRAK107F22	MGC	W01A055B18	pENTR-TOPO	13937		CIR	9541	AAH46098.1	Hs.632531	CBF1 interacting corepressor			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004882.3	NP_004873.3	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	AK027669	flj0035f01	FLJ	W01A055B23	pENTR-TOPO	8594		KREMEN2	79412	BAB55281.1	Hs.661128	Kringle containing transmembrane protein 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_024507.2	NP_078783.1	REVIEWED	OK	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	AK056270	flj0002b20	FLJ	W01A055C01	pENTR-TOPO	11240		ST8SIA5	29906	BAG51661.1	Hs.465025	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 5	NT2	teratocarcinoma		NT2RI2	EK1	NM_013305.4	NP_037437.2	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	AK022036	flj0029f22	FLJ	W01A055C08	pENTR-TOPO	16993		WWTR1	25937	BAB13957.1	Hs.719249	WW domain containing transcription regulator 1				HEMBB1	EK1	NM_015472.3	NP_056287.1	PROVISIONAL	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC036756	IRAK079A15	MGC	W01A055C09	pENTR-TOPO	10458		GNA13	10672	AAH36756.1	Hs.515018	Guanine nucleotide binding protein (G protein), alpha 13			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006572.4	NP_006563.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	AK127672	flj0050i16	FLJ	W01A055D02	pENTR-TOPO	7903		CSK	1445	BAG54548.1	Hs.77793	C-src tyrosine kinase		neutrophils		NETRP2	EK1	NM_001127190.1	NP_001120662.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
RIKEN	BC011953	IRAK021M18	MGC	W01A055D09	pENTR-TOPO	4496		PAX6	5080	AAH11953.1	Hs.270303	Paired box 6			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000280.3	NP_000271.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC011953	IRAK021M18	MGC	W01A055D11	pENTR-TOPO	4496		PAX6	5080	AAH11953.1	Hs.270303	Paired box 6			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000280.3	NP_000271.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC021706	IRAK033L17	MGC	W01A055D19	pENTR-TOPO	24616		HSFX1	51402	AAH21706.1	Hs.709146	Heat shock transcription factor family, X linked 1			Testis	NIH_MGC_97	DH10B	NM_016153.1	NP_057237.1	PROVISIONAL	C	1.000	1.000	423	1272	1	1269	423	1	423
RIKEN	BC065028	IRAK140D23	MGC	W01A055E01	pENTR-TOPO	20576		NUP43	348995	AAH65028.1	Hs.510375	Nucleoporin 43kDa			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198887.1	NP_942590.1	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC065028	IRAK140D23	MGC	W01A055E05	pENTR-TOPO	20576		NUP43	348995	AAH65028.1	Hs.510375	Nucleoporin 43kDa			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198887.1	NP_942590.1	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC039733	IRAK082L18	MGC	W01A055E17	pENTR-TOPO	16562		PTX3	5806	AAH39733.1	Hs.591286	Pentraxin-related gene, rapidly induced by IL-1 beta			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002852.3	NP_002843.2	VALIDATED	Cs	0.997	0.997	381	1146	1	1143	381	1	381
RIKEN	BC017371	IRAL019N20	MGC	W01A055E20	pENTR-TOPO	5603		ELK3	2004	AAH17371.1	Hs.46523	ELK3, ETS-domain protein (SRF accessory protein 2)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005230.2	NP_005221.2	REVIEWED	OK	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC039733	IRAK082L18	MGC	W01A055E21	pENTR-TOPO	16562		PTX3	5806	AAH39733.1	Hs.591286	Pentraxin-related gene, rapidly induced by IL-1 beta			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002852.3	NP_002843.2	VALIDATED	Cs	0.997	0.997	381	1146	1	1143	381	1	381
RIKEN	BC039733	IRAK082L18	MGC	W01A055E23	pENTR-TOPO	16562		PTX3	5806	AAH39733.1	Hs.591286	Pentraxin-related gene, rapidly induced by IL-1 beta			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002852.3	NP_002843.2	VALIDATED	Cs	0.997	0.997	381	1146	1	1143	381	1	381
RIKEN	BC033690	IRAK068O05	MGC	W01A055F13	pENTR-TOPO	1727		FCRL1	115350	AAH33690.1	Hs.656112	Fc receptor-like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_052938.4	NP_443170.1	REVIEWED	C	1.000	1.000	429	1290	1	1287	429	1	429
RIKEN	AK074799	flj0018c02	FLJ	W01A055F16	pENTR-TOPO	12115		DAPK3	1613	BAG52004.1	Hs.631844	Death-associated protein kinase 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_001348.1	NP_001339.1	REVIEWED	C	1.000	1.000	454	1365	1	1362	454	1	454
RIKEN	BC000178	IRAK003P13	MGC	W01A055G15	pENTR-TOPO	12995		KCMF1	56888	AAH00178.1	Hs.654968	Potassium channel modulatory factor 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020122.4	NP_064507.3	VALIDATED	OK	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	AK000062	flj0050f09	FLJ	W01A055G22	pENTR-TOPO	10509		MBTD1	54799	BAA90919.1	Hs.656803	Mbt domain containing 1				COL	EK1	NM_017643.2	NP_060113.2	VALIDATED	P	1.000	1.000	399	1233	1	1197	628	165	563
RIKEN	AK026933	flj0066p08	FLJ	W01A055H01	pENTR-TOPO	7106		EIF5	1983	BAB15593.1	Hs.433702	Eukaryotic translation initiation factor 5	HepG2	hepatoma		HEP	EK1	NM_183004.3	NP_892116.2	VALIDATED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	AK056310	flj0003a05	FLJ	W01A055H02	pENTR-TOPO	12926		ZAK	51776	BAG51674.1	Hs.444451	Sterile alpha motif and leucine zipper containing kinase AZK	NT2	teratocarcinoma		NT2RI2	EK1	NM_133646.2	NP_598407.1	REVIEWED	OK	1.000	1.000	455	1368	1	1365	455	1	455
RIKEN	BC017754	IRAK027O11	MGC	W01A055H17	pENTR-TOPO	20784		TFAP2A	7020	AAH17754.1	Hs.519880	Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001032280.2	NP_001027451.1	VALIDATED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC017754	IRAK027O11	MGC	W01A055H23	pENTR-TOPO	20784		TFAP2A	7020	AAH17754.1	Hs.519880	Transcription factor AP-2 alpha (activating enhancer binding protein 2 alpha)			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001032280.2	NP_001027451.1	VALIDATED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC026691	IRAK020I15	MGC	W01A055I01	pENTR-TOPO	7008		PPM1A	5494	AAH26691.1	Hs.130036	Protein phosphatase 1A (formerly 2C), magnesium-dependent, alpha isoform			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_021003.4	NP_066283.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC037236	IRAK050D07	MGC	W01A055I13	pENTR-TOPO	5788		DUSP6	1848	AAH37236.1	Hs.718640	Dual specificity phosphatase 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001946.2	NP_001937.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	BC037236	IRAK050D07	MGC	W01A055I15	pENTR-TOPO	5788		DUSP6	1848	AAH37236.1	Hs.718640	Dual specificity phosphatase 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001946.2	NP_001937.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	BC010960	IRAL019F09	MGC	W01A055I17	pENTR-TOPO	22634		ATP6V1C1	528	AAH10960.1	Hs.86905	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001695.4	NP_001686.1	REVIEWED	OK	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	AK023672	flj0038k14	FLJ	W01A055J03	pENTR-TOPO	9673		CROP	51747	BAG51216.1	Hs.130293	Cisplatin resistance-associated overexpressed protein				PLACE1	EK1	NM_006107.2	NP_006098.2	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	AK001470	flj0034g06	FLJ	W01A055J08	pENTR-TOPO	14949		NFS1	9054	BAG50917.1	Hs.194692	NFS1 nitrogen fixation 1 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RP2	EK1	NM_021100.3	NP_066923.3	REVIEWED	C	1.000	1.000	457	1374	1	1371	457	1	457
RIKEN	AK091198	flj0015g13	FLJ	W01A055J09	pENTR-TOPO	10191		PSMD12	5718	BAG52303.1	Hs.646575	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 12				CTONG2	EK1	NM_174871.2	NP_777360.1	REVIEWED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	AK091198	flj0015g13	FLJ	W01A055J11	pENTR-TOPO	10191		PSMD12	5718	BAG52303.1	Hs.646575	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 12				CTONG2	EK1	NM_174871.2	NP_777360.1	REVIEWED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	AK091198	flj0015g13	FLJ	W01A055J15	pENTR-TOPO	10191		PSMD12	5718	BAG52303.1	Hs.646575	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 12				CTONG2	EK1	NM_174871.2	NP_777360.1	REVIEWED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	AK021559	flj0028a17	FLJ	W01A055J21	pENTR-TOPO	19746		FBXO9	26268	BAG51038.1	Hs.216653	F-box protein 9				HEMBA1	EK1	NM_033480.2	NP_258441.1	REVIEWED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	AK000616	flj0064f13	FLJ	W01A055K14	pENTR-TOPO	13764		SUPT7L	9913	-	Hs.6232	Suppressor of Ty 7 (S. cerevisiae)-like				KAT	EK1	NM_014860.1	NP_055675.1	PROVISIONAL	C	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	AK056038	flj0002a14	FLJ	W01A055K21	pENTR-TOPO	8154		MEIS2	4212	BAG51610.1	Hs.510989	Meis homeobox 2	NT2	teratocarcinoma		NT2NE2	EK1	NM_172315.1	NP_758526.1	REVIEWED	C	1.000	1.000	388	1167	1	1164	388	1	388
RIKEN	BC073140	IRAK174P09	MGC	W01A055K22	pENTR-TOPO	12208		MKNK2	2872	AAH73140.1	Hs.515032	MAP kinase interacting serine/threonine kinase 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017572.3	NP_060042.2	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	AK172766	flj0079c19	FLJ	W01A055L05	pENTR-TOPO	3819		TMPRSS4	56649	BAD18749.1	Hs.161985	Transmembrane protease, serine 4				COL	EK1	NM_019894.3	NP_063947.1	REVIEWED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	AK054669	flj0001i21	FLJ	W01A055L06	pENTR-TOPO	10545		SLC46A1	113235	BAB70789.1	Hs.446689	Solute carrier family 46 (folate transporter), member 1	H4	neuroglioma		BNGH41	EK1	NM_080669.3	NP_542400.2	VALIDATED	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	AK172766	flj0079c19	FLJ	W01A055L07	pENTR-TOPO	3819		TMPRSS4	56649	BAD18749.1	Hs.161985	Transmembrane protease, serine 4				COL	EK1	NM_019894.3	NP_063947.1	REVIEWED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC058287	IRAL048F01	MGC	W01A055L10	pENTR-TOPO	397		ANGPTL3	27329	AAH58287.1	Hs.209153	Angiopoietin-like 3			Liver	NIH_MGC_76	DH10B	NM_014495.2	NP_055310.1	REVIEWED	OK	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	BC058287	IRAL048F01	MGC	W01A055L12	pENTR-TOPO	397		ANGPTL3	27329	AAH58287.1	Hs.209153	Angiopoietin-like 3			Liver	NIH_MGC_76	DH10B	NM_014495.2	NP_055310.1	REVIEWED	OK	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	BC058287	IRAL048F01	MGC	W01A055L16	pENTR-TOPO	397		ANGPTL3	27329	AAH58287.1	Hs.209153	Angiopoietin-like 3			Liver	NIH_MGC_76	DH10B	NM_014495.2	NP_055310.1	REVIEWED	OK	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	BC008197	IRAK003N17	MGC	W01A055L20	pENTR-TOPO	24281		NFIL3	4783	AAH08197.1	Hs.79334	Nuclear factor, interleukin 3 regulated			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005384.2	NP_005375.2	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC008197	IRAK003N17	MGC	W01A055L22	pENTR-TOPO	24281		NFIL3	4783	AAH08197.1	Hs.79334	Nuclear factor, interleukin 3 regulated			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005384.2	NP_005375.2	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC073165	IRAK174N08	MGC	W01A055L23	pENTR-TOPO	4835		PSMC3	5702	AAH73165.3	Hs.250758	Proteasome (prosome, macropain) 26S subunit, ATPase, 3				Lupski_sympathetic_trunk	DH10B	NM_002804.4	NP_002795.2	REVIEWED	C	1.000	1.000	439	1320	1	1317	439	1	439
RIKEN	BC008197	IRAK003N17	MGC	W01A055L24	pENTR-TOPO	24281		NFIL3	4783	AAH08197.1	Hs.79334	Nuclear factor, interleukin 3 regulated			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005384.2	NP_005375.2	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC043503	IRAK089E01	MGC	W01A055M21	pENTR-TOPO	13381		MEIS1	4211	AAH43503.1	Hs.526754	Meis homeobox 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002398.2	NP_002389.1	REVIEWED	C	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	AK056437	flj0006i11	FLJ	W01A055N03	pENTR-TOPO	8813		ZNF778	197320	BAB71183.1	Hs.647385	Zinc finger protein 778	NT2	teratocarcinoma		NT2RP7	EK1	NM_182531.2	NP_872337.2	VALIDATED	Pfs	0.995	0.995	440	1320	1	1319	729	1	440
RIKEN	AK122845	flj0048j09	FLJ	W01A055N06	pENTR-TOPO	18216		GABRG1	2565	BAG53758.1	Hs.375051	Gamma-aminobutyric acid (GABA) A receptor, gamma 1				BRAWH3	EK1	NM_173536.3	NP_775807.2	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC054001	IRAK115F10	MGC	W01A055N13	pENTR-TOPO	23490		OLFML2A	169611	AAH54001.1	Hs.357004	Olfactomedin-like 2A			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_182487.2	NP_872293.2	VALIDATED	Ps	0.995	0.995	430	1317	25	1314	652	223	652
RIKEN	BC006997	IRAL016M12	MGC	W01A055N14	pENTR-TOPO	18785		G3BP1	10146	AAH06997.1	Hs.587054	GTPase activating protein (SH3 domain) binding protein 1			Prostate	NIH_MGC_83	DH10B	NM_005754.2	NP_005745.1	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	AK023483	flj0036j22	FLJ	W01A055N21	pENTR-TOPO	7767		NUSAP1	51203	BAB14586.1	Hs.615092	Nucleolar and spindle associated protein 1				PLACE1	EK1	NM_018454.6	NP_060924.4	VALIDATED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC028150	IRAK062J17	MGC	W01A055N22	pENTR-TOPO	11587		SIGLEC7	27036	AAH28150.1	Hs.655393	Sialic acid binding Ig-like lectin 7			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014385.2	NP_055200.1	VALIDATED	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	AK122936	flj0048p16	FLJ	W01A055O02	pENTR-TOPO	3631		SERPINH1	871	BAG53805.1	Hs.596449	Serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)				TESTI4	EK1	NM_001235.2	NP_001226.2	REVIEWED	C	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	AK122936	flj0048p16	FLJ	W01A055O04	pENTR-TOPO	3631		SERPINH1	871	BAG53805.1	Hs.596449	Serpin peptidase inhibitor, clade H (heat shock protein 47), member 1, (collagen binding protein 1)				TESTI4	EK1	NM_001235.2	NP_001226.2	REVIEWED	C	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC017169	IRAK015P01	MGC	W01A055O14	pENTR-TOPO	18784		SLC25A46	91137	AAH17169.1	Hs.75639	Solute carrier family 25, member 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138773.1	NP_620128.1	PROVISIONAL	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	AK026835	flj0050p24	FLJ	W01A055O17	pENTR-TOPO	1774		TFB2M	64216	BAB15566.1	Hs.715652	Transcription factor B2, mitochondrial				LNG	EK1	NM_022366.2	NP_071761.1	VALIDATED	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	AK023452	flj0036f06	FLJ	W01A055O18	pENTR-TOPO	23637		POLR1E	64425	BAB14579.1	Hs.591087	Polymerase (RNA) I polypeptide E, 53kDa				PLACE1	EK1	NM_022490.1	NP_071935.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	AK026835	flj0050p24	FLJ	W01A055O19	pENTR-TOPO	1774		TFB2M	64216	BAB15566.1	Hs.715652	Transcription factor B2, mitochondrial				LNG	EK1	NM_022366.2	NP_071761.1	VALIDATED	C	1.000	1.000	396	1191	1	1188	396	1	396
RIKEN	AK023452	flj0036f06	FLJ	W01A055O22	pENTR-TOPO	23637		POLR1E	64425	BAB14579.1	Hs.591087	Polymerase (RNA) I polypeptide E, 53kDa				PLACE1	EK1	NM_022490.1	NP_071935.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	AK023452	flj0036f06	FLJ	W01A055O24	pENTR-TOPO	23637		POLR1E	64425	BAB14579.1	Hs.591087	Polymerase (RNA) I polypeptide E, 53kDa				PLACE1	EK1	NM_022490.1	NP_071935.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC060790	IRAK133D19	MGC	W01A055P01	pENTR-TOPO	7060		SOCS4	122809	AAH60790.1	Hs.708344	Suppressor of cytokine signaling 4			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_199421.1	NP_955453.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC001281	IRAK004A08	MGC	W01A055P13	pENTR-TOPO	22997		TNFRSF10B	8795	AAH01281.1	Hs.521456	Tumor necrosis factor receptor superfamily, member 10b			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003842.4	NP_003833.4	REVIEWED	Cs	0.995	0.995	440	1323	1	1320	440	1	440
RIKEN	BC001281	IRAK004A08	MGC	W01A055P15	pENTR-TOPO	22997		TNFRSF10B	8795	AAH01281.1	Hs.521456	Tumor necrosis factor receptor superfamily, member 10b			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003842.4	NP_003833.4	REVIEWED	Cs	0.995	0.995	440	1323	1	1320	440	1	440
RIKEN	AK000139	flj0063j21	FLJ	W01A056A03	pENTR-TOPO	11647		BEST2	54831	BAA90970.1	Hs.435611	Bestrophin 2				COL	EK1	NM_017682.2	NP_060152.2	REVIEWED	Ps	0.998	0.998	466	1401	1	1398	509	44	509
RIKEN	BC067442	IRAK172H01	MGC	W01A056A04	pENTR-TOPO	16893		CYP8B1	1582	AAH67442.1	Hs.447793	Cytochrome P450, family 8, subfamily B, polypeptide 1			PCR rescued clones	NIH_MGC_195	DH10B	NM_004391.2	NP_004382.2	REVIEWED	Cs	0.998	0.998	501	1506	1	1503	501	1	501
RIKEN	AK000139	flj0063j21	FLJ	W01A056A07	pENTR-TOPO	11647		BEST2	54831	BAA90970.1	Hs.435611	Bestrophin 2				COL	EK1	NM_017682.2	NP_060152.2	REVIEWED	Ps	0.998	0.998	466	1401	1	1398	509	44	509
RIKEN	AK025267	flj0066p17	FLJ	W01A056A11	pENTR-TOPO	18495		BTNL3	10917	-	Hs.225949	Butyrophilin-like 3				COL	EK1	NM_197975.1	NP_932079.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	AK025267	flj0066p17	FLJ	W01A056A13	pENTR-TOPO	18495		BTNL3	10917	-	Hs.225949	Butyrophilin-like 3				COL	EK1	NM_197975.1	NP_932079.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	AK025267	flj0066p17	FLJ	W01A056A15	pENTR-TOPO	18495		BTNL3	10917	-	Hs.225949	Butyrophilin-like 3				COL	EK1	NM_197975.1	NP_932079.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	BC016695	IRAL032E21	MGC	W01A056A19	pENTR-TOPO	18840		CAMK4	814	AAH16695.2	Hs.591269	Calcium/calmodulin-dependent protein kinase IV			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001744.3	NP_001735.1	REVIEWED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC015190	IRAL021C21	MGC	W01A056B02	pENTR-TOPO	11197		PIAS2	9063	AAH15190.1	Hs.658013	Protein inhibitor of activated STAT, 2			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_173206.2	NP_775298.1	VALIDATED	OK	1.000	1.000	572	1719	1	1716	572	1	572
RIKEN	BC039316	IRAK063O04	MGC	W01A056B05	pENTR-TOPO	11248		L3MBTL4	91133	AAH39316.1	Hs.128279	L(3)mbt-like 4 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_173464.3	NP_775735.2	VALIDATED	P	1.000	1.000	481	1605	1	1443	623	1	481
RIKEN	AK130179	flj0060a05	FLJ	W01A056B20	pENTR-TOPO	479		LMNA	4000	-	Hs.594444	Lamin A/C		macrophage		MPG	EK1	NM_005572.3	NP_005563.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
RIKEN	AK122644	flj0034l24	FLJ	W01A056C01	pENTR-TOPO	19988		ZBTB9	221504	BAG53637.1	Hs.591805	Zinc finger and BTB domain containing 9	IMR32	neuroblastoma		IMR321	EK1	NM_152735.3	NP_689948.1	VALIDATED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC019916	IRAK042L10	MGC	W01A056C02	pENTR-TOPO	6667		NEK3	4752	AAH19916.2	Hs.409989	NIMA (never in mitosis gene a)-related kinase 3			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_002498.2	NP_002489.1	REVIEWED	C	1.000	1.000	506	1521	1	1518	506	1	506
RIKEN	BC052955	IRAK090O23	MGC	W01A056C10	pENTR-TOPO	22015		WASL	8976	AAH52955.1	Hs.708402	Wiskott-Aldrich syndrome-like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003941.2	NP_003932.3	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC052955	IRAK090O23	MGC	W01A056C14	pENTR-TOPO	22015		WASL	8976	AAH52955.1	Hs.708402	Wiskott-Aldrich syndrome-like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003941.2	NP_003932.3	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC052955	IRAK090O23	MGC	W01A056C16	pENTR-TOPO	22015		WASL	8976	AAH52955.1	Hs.708402	Wiskott-Aldrich syndrome-like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003941.2	NP_003932.3	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC035556	IRAK064O07	MGC	W01A056D03	pENTR-TOPO	23974		DOLK	22845	AAH35556.1	Hs.531563	Dolichol kinase			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014908.3	NP_055723.1	VALIDATED	C	1.000	1.000	538	1617	1	1614	538	1	538
RIKEN	BC036658	IRAK046I19	MGC	W01A056D13	pENTR-TOPO	839		TROVE2	6738	AAH36658.1	Hs.288178	TROVE domain family, member 2			Testis	NIH_MGC_97	DH10B	NM_001042370.1	NP_001035829.1	VALIDATED	C	1.000	1.000	263	1617	826	1614	263	1	263
RIKEN	AK074877	flj0018o20	FLJ	W01A056D14	pENTR-TOPO	11761		ZNF791	163049	BAC11261.1	Hs.522545	Zinc finger protein 791	NT2	teratocarcinoma		NT2RP2	EK1	NM_153358.2	NP_699189.2	VALIDATED	Cs	0.998	0.998	576	1731	1	1728	576	1	576
RIKEN	BC020565	IRAK020C16	MGC	W01A056D21	pENTR-TOPO	7459		SLC22A17	51310	AAH20565.1	Hs.373498	Solute carrier family 22, member 17				NCI_CGAP_Brn67	DH10B	NM_020372.2	NP_065105.2	PROVISIONAL	OK	1.000	1.000	538	1617	1	1614	538	1	538
RIKEN	BC020565	IRAK020C16	MGC	W01A056D23	pENTR-TOPO	7459		SLC22A17	51310	AAH20565.1	Hs.373498	Solute carrier family 22, member 17				NCI_CGAP_Brn67	DH10B	NM_020372.2	NP_065105.2	PROVISIONAL	OK	1.000	1.000	538	1617	1	1614	538	1	538
RIKEN	AK027620	flj0034n14	FLJ	W01A056E02	pENTR-TOPO	17448		PHF17	79960	BAB55239.1	Hs.12420	PHD finger protein 17	NT2	teratocarcinoma		NT2RP3	EK1	NM_024900.3	NP_079176.2	VALIDATED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	AK027620	flj0034n14	FLJ	W01A056E08	pENTR-TOPO	17448		PHF17	79960	BAB55239.1	Hs.12420	PHD finger protein 17	NT2	teratocarcinoma		NT2RP3	EK1	NM_024900.3	NP_079176.2	VALIDATED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	AK055642	flj0001h04	FLJ	W01A056E13	pENTR-TOPO	18027		CAMK2D	817	BAG51545.1	Hs.144114	Calcium/calmodulin-dependent protein kinase II delta				HSYRA2	EK1	NM_172128.2	NP_742126.1	REVIEWED	C	1.000	1.000	478	1437	1	1434	478	1	478
RIKEN	BC023019	IRAK042N10	MGC	W01A056E14	pENTR-TOPO	8168		CYP1A1	1543	AAH23019.1	Hs.72912	Cytochrome P450, family 1, subfamily A, polypeptide 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000499.3	NP_000490.1	REVIEWED	C	1.000	1.000	512	1539	1	1536	512	1	512
RIKEN	AK055642	flj0001h04	FLJ	W01A056E15	pENTR-TOPO	18027		CAMK2D	817	BAG51545.1	Hs.144114	Calcium/calmodulin-dependent protein kinase II delta				HSYRA2	EK1	NM_172128.2	NP_742126.1	REVIEWED	C	1.000	1.000	478	1437	1	1434	478	1	478
RIKEN	AK055403	flj0013h05	FLJ	W01A056F04	pENTR-TOPO	2650		OPTN	10133	BAG51512.1	Hs.332706	Optineurin				FEBRA2	EK1	NM_001008213.1	NP_001008214.1	REVIEWED	C	1.000	1.000	577	1734	1	1731	577	1	577
RIKEN	AK074984	flj0018f23	FLJ	W01A056F11	pENTR-TOPO	1477		GPR177	79971	BAC11333.1	Hs.647659	G protein-coupled receptor 177	NT2	teratocarcinoma		NT2RP3	EK1	NM_024911.4	NP_079187.3	VALIDATED	C	1.000	1.000	541	1626	1	1623	541	1	541
RIKEN	AK074984	flj0018f23	FLJ	W01A056F13	pENTR-TOPO	1477		GPR177	79971	BAC11333.1	Hs.647659	G protein-coupled receptor 177	NT2	teratocarcinoma		NT2RP3	EK1	NM_024911.4	NP_079187.3	VALIDATED	C	1.000	1.000	541	1626	1	1623	541	1	541
RIKEN	AK002108	flj0038i01	FLJ	W01A056G02	pENTR-TOPO	18053		PLRG1	5356	BAG51016.1	Hs.249996	Pleiotropic regulator 1 (PRL1 homolog, Arabidopsis)				PLACE1	EK1	NM_002669.2	NP_002660.1	PROVISIONAL	C	1.000	1.000	514	1545	1	1542	514	1	514
RIKEN	AK098452	flj0052f06	FLJ	W01A056G11	pENTR-TOPO	9323		PKMYT1	9088	-	Hs.77783	Protein kinase, membrane associated tyrosine/threonine 1	JCR			JTH	EK1	NM_182687.1	NP_872629.1	REVIEWED	C	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	AK098452	flj0052f06	FLJ	W01A056G15	pENTR-TOPO	9323		PKMYT1	9088	-	Hs.77783	Protein kinase, membrane associated tyrosine/threonine 1	JCR			JTH	EK1	NM_182687.1	NP_872629.1	REVIEWED	C	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	AK056362	flj0003i17	FLJ	W01A056G20	pENTR-TOPO	3950		HINFP	25988	BAG51688.1	Hs.504091	Histone H4 transcription factor	NT2	teratocarcinoma		NT2RI2	EK1	NM_198971.1	NP_945322.1	VALIDATED	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC032496	IRAK069A01	MGC	W01A056G21	pENTR-TOPO	20661		FYN	2534	AAH32496.1	Hs.390567	FYN oncogene related to SRC, FGR, YES			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_153048.1	NP_694593.1	REVIEWED	C	1.000	1.000	482	1449	1	1446	482	1	482
RIKEN	AK056362	flj0003i17	FLJ	W01A056G24	pENTR-TOPO	3950		HINFP	25988	BAG51688.1	Hs.504091	Histone H4 transcription factor	NT2	teratocarcinoma		NT2RI2	EK1	NM_198971.1	NP_945322.1	VALIDATED	C	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	AK056655	flj0006m20	FLJ	W01A056H18	pENTR-TOPO	12977		CSRNP3	80034	BAG51776.1	Hs.470479	Cysteine-serine-rich nuclear protein 3				OCBBF2	EK1	NM_024969.2	NP_079245.2	PROVISIONAL	C	1.000	1.000	585	1758	1	1755	585	1	585
RIKEN	AK095759	flj0024h23	FLJ	W01A056H19	pENTR-TOPO	12229		ZNF426	79088	BAG53124.1	Hs.594011	Zinc finger protein 426				FEBRA2	EK1	NM_024106.1	NP_077011.1	PROVISIONAL	C	1.000	1.000	554	1665	1	1662	554	1	554
RIKEN	AK056655	flj0006m20	FLJ	W01A056H20	pENTR-TOPO	12977		CSRNP3	80034	BAG51776.1	Hs.470479	Cysteine-serine-rich nuclear protein 3				OCBBF2	EK1	NM_024969.2	NP_079245.2	PROVISIONAL	C	1.000	1.000	585	1758	1	1755	585	1	585
RIKEN	AK056655	flj0006m20	FLJ	W01A056H22	pENTR-TOPO	12977		CSRNP3	80034	BAG51776.1	Hs.470479	Cysteine-serine-rich nuclear protein 3				OCBBF2	EK1	NM_024969.2	NP_079245.2	PROVISIONAL	C	1.000	1.000	585	1758	1	1755	585	1	585
RIKEN	AK095759	flj0024h23	FLJ	W01A056H23	pENTR-TOPO	12229		ZNF426	79088	BAG53124.1	Hs.594011	Zinc finger protein 426				FEBRA2	EK1	NM_024106.1	NP_077011.1	PROVISIONAL	C	1.000	1.000	554	1665	1	1662	554	1	554
RIKEN	BC029600	IRAK063M10	MGC	W01A056J09	pENTR-TOPO	15		TRAF5	7188	AAH29600.1	Hs.523930	TNF receptor-associated factor 5			Testis	NIH_MGC_97	DH10B	NM_004619.3	NP_004610.1	REVIEWED	C	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC029600	IRAK063M10	MGC	W01A056J11	pENTR-TOPO	15		TRAF5	7188	AAH29600.1	Hs.523930	TNF receptor-associated factor 5			Testis	NIH_MGC_97	DH10B	NM_004619.3	NP_004610.1	REVIEWED	C	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	AK128319	flj0078o15	FLJ	W01A056J12	pENTR-TOPO	5387		SLC17A8	246213	BAG54658.1	Hs.116871	Solute carrier family 17 (sodium-dependent inorganic phosphate cotransporter), member 8				THYMU3	EK1	NM_139319.2	NP_647480.1	VALIDATED	C	1.000	1.000	589	1770	1	1767	589	1	589
RIKEN	BC029600	IRAK063M10	MGC	W01A056J15	pENTR-TOPO	15		TRAF5	7188	AAH29600.1	Hs.523930	TNF receptor-associated factor 5			Testis	NIH_MGC_97	DH10B	NM_004619.3	NP_004610.1	REVIEWED	C	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	AK074575	flj0017d17	FLJ	W01A056J18	pENTR-TOPO	450		CHRM3	1131	-	Hs.7138	Cholinergic receptor, muscarinic 3				HEMBA1	EK1	NM_000740.2	NP_000731.1	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC017166	IRAK015P17	MGC	W01A056J23	pENTR-TOPO	25162		GPC4	2239	AAH17166.1	Hs.58367	Glypican 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001448.2	NP_001439.2	REVIEWED	C	1.000	1.000	556	1671	1	1668	556	1	556
RIKEN	BC014842	IRAK028E15	MGC	W01A056K02	pENTR-TOPO	12351		NUP62	23636	AAH14842.1	Hs.574492	Nucleoporin 62kDa			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_153719.2	NP_714941.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
RIKEN	BC032504	IRAK069C09	MGC	W01A056K11	pENTR-TOPO	2636		MINPP1	9562	AAH32504.1	Hs.121260	Multiple inositol polyphosphate histidine phosphatase, 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004897.3	NP_004888.2	VALIDATED	OK	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC065272	IRAK140N05	MGC	W01A056K16	pENTR-TOPO	171		VANGL1	81839	AAH65272.1	Hs.515130	Vang-like 1 (van gogh, Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138959.2	NP_620409.1	VALIDATED	C	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	BC036037	IRAK048C02	MGC	W01A056K19	pENTR-TOPO	2812		FUT11	170384	AAH36037.1	Hs.588854	Fucosyltransferase 11 (alpha (1,3) fucosyltransferase)			Testis	NIH_MGC_97	DH10B	NM_173540.2	NP_775811.2	VALIDATED	Cs	0.998	0.998	492	1479	1	1476	492	1	492
RIKEN	BC021825	IRAK029N17	MGC	W01A056L01	pENTR-TOPO	15250		IFNAR1	3454	AAH21825.1	Hs.529400	Interferon (alpha, beta and omega) receptor 1				NCI_CGAP_Brn67	DH10B	NM_000629.2	NP_000620.2	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC016147	IRAK015N17	MGC	W01A056L20	pENTR-TOPO	5458		NR4A1	3164	AAH16147.1	Hs.524430	Nuclear receptor subfamily 4, group A, member 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002135.3	NP_002126.2	REVIEWED	OK	1.000	1.000	598	1797	1	1794	598	1	598
RIKEN	BC016147	IRAK015N17	MGC	W01A056L24	pENTR-TOPO	5458		NR4A1	3164	AAH16147.1	Hs.524430	Nuclear receptor subfamily 4, group A, member 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002135.3	NP_002126.2	REVIEWED	OK	1.000	1.000	598	1797	1	1794	598	1	598
RIKEN	AK055051	flj0001g10	FLJ	W01A056M02	pENTR-TOPO	14606		SLC32A1	140679	BAB70846.1	Hs.179080	Solute carrier family 32 (GABA vesicular transporter), member 1				BRAWH2	EK1	NM_080552.2	NP_542119.1	REVIEWED	C	1.000	1.000	525	1578	1	1575	525	1	525
RIKEN	AK055051	flj0001g10	FLJ	W01A056M06	pENTR-TOPO	14606		SLC32A1	140679	BAB70846.1	Hs.179080	Solute carrier family 32 (GABA vesicular transporter), member 1				BRAWH2	EK1	NM_080552.2	NP_542119.1	REVIEWED	C	1.000	1.000	525	1578	1	1575	525	1	525
RIKEN	BC035788	IRAK079H05	MGC	W01A056M09	pENTR-TOPO	14538		SNPH	9751	AAH35788.1	Hs.323833	Syntaphilin			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014723.2	NP_055538.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
RIKEN	AK128298	flj0078g13	FLJ	W01A056M10	pENTR-TOPO	8874		GPR114	221188	BAG54657.1	Hs.187884	G protein-coupled receptor 114				THYMU3	EK1	NM_153837.1	NP_722579.1	PROVISIONAL	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	AK023075	flj0034d04	FLJ	W01A056M23	pENTR-TOPO	16771		RAD18	56852	BAB14392.1	Hs.375684	RAD18 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RP3	EK1	NM_020165.2	NP_064550.2	REVIEWED	C	1.000	1.000	495	1488	1	1485	495	1	495
RIKEN	AK057229	flj0004e23	FLJ	W01A056N05	pENTR-TOPO	9683		AATF	26574	BAG51888.1	Hs.195740	Apoptosis antagonizing transcription factor				TESTI1	EK1	NM_012138.3	NP_036270.1	REVIEWED	C	1.000	1.000	560	1683	1	1680	560	1	560
RIKEN	BC015858	IRAL038I11	MGC	W01A056N09	pENTR-TOPO	2746		ZNF37A	7587	AAH15858.1	Hs.292575	Zinc finger protein 37A			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_001007094.1	NP_001007095.1	VALIDATED	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	BC015858	IRAL038I11	MGC	W01A056N11	pENTR-TOPO	2746		ZNF37A	7587	AAH15858.1	Hs.292575	Zinc finger protein 37A			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_001007094.1	NP_001007095.1	VALIDATED	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	BC015858	IRAL038I11	MGC	W01A056N13	pENTR-TOPO	2746		ZNF37A	7587	AAH15858.1	Hs.292575	Zinc finger protein 37A			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_001007094.1	NP_001007095.1	VALIDATED	C	1.000	1.000	561	1686	1	1683	561	1	561
RIKEN	AK055035	flj0001g06	FLJ	W01A056N20	pENTR-TOPO	15614		AIFM3	150209	BAB70841.1	Hs.163543	Apoptosis-inducing factor, mitochondrion-associated, 3				BRAWH1	EK1	NM_144704.2	NP_653305.1	VALIDATED	C	1.000	1.000	605	1818	1	1815	605	1	605
RIKEN	BC032729	IRAK069J18	MGC	W01A056O01	pENTR-TOPO	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED	C	1.000	1.000	497	1494	1	1491	497	1	497
RIKEN	BC032729	IRAK069J18	MGC	W01A056O03	pENTR-TOPO	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED	C	1.000	1.000	497	1494	1	1491	497	1	497
RIKEN	AK055288	flj0008m16	FLJ	W01A056O09	pENTR-TOPO	9857		ZFP3	124961	BAB70898.1	Hs.48832	Zinc finger protein 3 homolog (mouse)				FCBBF5	EK1	NM_153018.2	NP_694563.1	VALIDATED	C	1.000	1.000	502	1509	1	1506	502	1	502
RIKEN	AK055288	flj0008m16	FLJ	W01A056O11	pENTR-TOPO	9857		ZFP3	124961	BAB70898.1	Hs.48832	Zinc finger protein 3 homolog (mouse)				FCBBF5	EK1	NM_153018.2	NP_694563.1	VALIDATED	C	1.000	1.000	502	1509	1	1506	502	1	502
RIKEN	BC030788	IRAK047K12	MGC	W01A056O20	pENTR-TOPO	11753		ZNF548	147694	AAH30788.1	Hs.657353	Zinc finger protein 548			Testis	NIH_MGC_97	DH10B	NM_152909.2	NP_690873.1	PROVISIONAL	OK	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	BC030788	IRAK047K12	MGC	W01A056O24	pENTR-TOPO	11753		ZNF548	147694	AAH30788.1	Hs.657353	Zinc finger protein 548			Testis	NIH_MGC_97	DH10B	NM_152909.2	NP_690873.1	PROVISIONAL	OK	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	AK023085	flj0034n08	FLJ	W01A056P21	pENTR-TOPO	5815		TM7SF3	51768	BAG51155.1	Hs.438641	Transmembrane 7 superfamily member 3	NT2	teratocarcinoma		NT2RP3	EK1	NM_016551.2	NP_057635.1	VALIDATED	C	1.000	1.000	570	1713	1	1710	570	1	570
RIKEN	BC053650	IRAK115F15	MGC	W01A057A02	pENTR-TOPO	4404		MTA2	9219	AAH53650.1	Hs.173043	Metastasis associated 1 family, member 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004739.2	NP_004730.2	REVIEWED	OK	1.000	1.000	668	2007	1	2004	668	1	668
RIKEN	BC015474	IRAK014L04	MGC	W01A057A03	pENTR-TOPO	7042		TDP1	55775	AAH15474.1	Hs.209945	Tyrosyl-DNA phosphodiesterase 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_018319.3	NP_060789.2	REVIEWED	OK	1.000	1.000	608	1827	1	1824	608	1	608
RIKEN	BC013693	IRAK012K17	MGC	W01A057A19	pENTR-TOPO	8170		NTRK3	4916	AAH13693.1	Hs.410969	Neurotrophic tyrosine kinase, receptor, type 3				NCI_CGAP_Brn67	DH10B	NM_001007156.1	NP_001007157.1	REVIEWED	C	1.000	1.000	612	1839	1	1836	612	1	612
RIKEN	BC034688	IRAK028G13	MGC	W01A057A20	pENTR-TOPO	6722		RNF6	6049	AAH34688.1	Hs.136885	Ring finger protein (C3H2C3 type) 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005977.3	NP_005968.1	REVIEWED	C	1.000	1.000	685	2058	1	2055	685	1	685
RIKEN	AK127242	flj0074c15	FLJ	W01A057B01	pENTR-TOPO	16844		SATB1	6304	BAG54463.1	Hs.517717	SATB homeobox 1				BRHIP3	EK1	NM_002971.3	NP_002962.1	VALIDATED	C	1.000	1.000	763	2292	1	2289	763	1	763
RIKEN	AK127242	flj0074c15	FLJ	W01A057B03	pENTR-TOPO	16844		SATB1	6304	BAG54463.1	Hs.517717	SATB homeobox 1				BRHIP3	EK1	NM_002971.3	NP_002962.1	VALIDATED	C	1.000	1.000	763	2292	1	2289	763	1	763
RIKEN	H013072H20	H013072H20	RIKEN	W01A057B09	pENTR-TOPO		13754	CUL3	8452		Hs.372286	Cullin 3	-	-	testis	testis	DH10B	NM_003590.3	NP_003581.1	VALIDATED	C	1.000	1.000	768	2307	1	2304	768	1	768
RIKEN	AK027719	flj0020o21	FLJ	W01A057B18	pENTR-TOPO	2775		MASTL	84930	BAB55321.1	Hs.276905	Microtubule associated serine/threonine kinase-like	NT2	teratocarcinoma		NT2RP4	EK1	NM_032844.2	NP_116233.2	VALIDATED	Cs	0.998	0.998	878	2637	1	2634	878	1	878
RIKEN	AK097552	flj0024i08	FLJ	W01A057B19	pENTR-TOPO	24757		PASD1	139135	BAC05097.1	Hs.160594	PAS domain containing 1				TESTI2	EK1	NM_173493.2	NP_775764.2	VALIDATED	Cs	0.999	0.999	773	2322	1	2319	773	1	773
RIKEN	BC053562	IRAK115O01	MGC	W01A057C04	pENTR-TOPO	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2				Lupski_sympathetic_trunk	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	OK	1.000	1.000	693	2082	1	2079	693	1	693
RIKEN	AK057737	flj0051p02	FLJ	W01A057C05	pENTR-TOPO	18769		ZNF354B	117608	BAB71556.1	Hs.591734	Zinc finger protein 354B				CBL	EK1	NM_058230.2	NP_478137.1	VALIDATED	C	1.000	1.000	612	1839	1	1836	612	1	612
RIKEN	AK000775	flj0066l15	FLJ	W01A057C15	pENTR-TOPO	25183		AIFM1	9131	-	Hs.424932	Apoptosis-inducing factor, mitochondrion-associated, 1				COL	EK1	NM_004208.2	NP_004199.1	REVIEWED	C	1.000	1.000	613	1842	1	1839	613	1	613
RIKEN	BC041125	IRAK082M05	MGC	W01A057D17	pENTR-TOPO	19693		KIAA1586	57691	AAH41125.1	Hs.709521	KIAA1586			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020931.2	NP_065982.1	VALIDATED	C	1.000	1.000	787	2364	1	2361	787	1	787
RIKEN	AK131468	flj0079g22	FLJ	W01A057E04	pENTR-TOPO	24249		ZNF782	158431	BAD18613.1	Hs.592420	Zinc finger protein 782				TESTI4	EK1	NM_001001662.1	NP_001001662.1	PROVISIONAL	C	1.000	1.000	699	2100	1	2097	699	1	699
RIKEN	BC017471	IRAK015E07	MGC	W01A057E13	pENTR-TOPO	2079		RFX5	5993	AAH17471.1	Hs.632472	Regulatory factor X, 5 (influences HLA class II expression)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025603.1	NP_001020774.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
RIKEN	BC051913	IRAK110P13	MGC	W01A057E16	pENTR-TOPO	25290		SCML2	10389	AAH51913.1	Hs.495774	Sex comb on midleg-like 2 (Drosophila)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006089.2	NP_006080.1	VALIDATED	C	1.000	1.000	700	2103	1	2100	700	1	700
RIKEN	BC028369	IRAK033N17	MGC	W01A057E17	pENTR-TOPO	19127		FEM1C	56929	AAH28369.1	Hs.47367	Fem-1 homolog c (C. elegans)			Testis	NIH_MGC_97	DH10B	NM_020177.2	NP_064562.1	VALIDATED	C	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	BC028369	IRAK033N17	MGC	W01A057E19	pENTR-TOPO	19127		FEM1C	56929	AAH28369.1	Hs.47367	Fem-1 homolog c (C. elegans)			Testis	NIH_MGC_97	DH10B	NM_020177.2	NP_064562.1	VALIDATED	C	1.000	1.000	617	1854	1	1851	617	1	617
RIKEN	BC053555	IRAK115K11	MGC	W01A057E22	pENTR-TOPO	14764		MYBL2	4605	AAH53555.1	Hs.179718	V-myb myeloblastosis viral oncogene homolog (avian)-like 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002466.2	NP_002457.1	REVIEWED	C	1.000	1.000	700	2103	1	2100	700	1	700
RIKEN	BC001965	IRAK004O13	MGC	W01A057F18	pENTR-TOPO	22996		RAD54B	25788	AAH01965.1	Hs.710768	RAD54 homolog B (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012415.2	NP_036547.1	REVIEWED	C	1.000	1.000	910	2733	1	2730	910	1	910
RIKEN	BC047570	IRAK090L21	MGC	W01A057F19	pENTR-TOPO	11779		ZNF227	7770	AAH47570.1	Hs.371335	Zinc finger protein 227			Testis	NIH_MGC_97	DH10B	NM_182490.1	NP_872296.1	PROVISIONAL	C	1.000	1.000	799	2400	1	2397	799	1	799
RIKEN	BC001965	IRAK004O13	MGC	W01A057F20	pENTR-TOPO	22996		RAD54B	25788	AAH01965.1	Hs.710768	RAD54 homolog B (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012415.2	NP_036547.1	REVIEWED	C	1.000	1.000	910	2733	1	2730	910	1	910
RIKEN	BC040012	IRAK084F18	MGC	W01A057G01	pENTR-TOPO	6695		MTMR6	9107	AAH40012.1	Hs.643702	Myotubularin related protein 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004685.3	NP_004676.3	VALIDATED	Cs	0.998	0.998	621	1866	1	1863	621	1	621
RIKEN	BC049195	IRAK093G07	MGC	W01A057G11	pENTR-TOPO	12200		ELL	8178	AAH49195.1	Hs.515260	Elongation factor RNA polymerase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006532.3	NP_006523.1	VALIDATED	C	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	BC049195	IRAK093G07	MGC	W01A057G13	pENTR-TOPO	12200		ELL	8178	AAH49195.1	Hs.515260	Elongation factor RNA polymerase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006532.3	NP_006523.1	VALIDATED	C	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	AK001371	flj0033o06	FLJ	W01A057G14	pENTR-TOPO	8566		POLR3E	55718	BAA91655.1	Hs.460298	Polymerase (RNA) III (DNA directed) polypeptide E (80kD)	NT2	teratocarcinoma		NT2RP2	EK1	NM_018119.2	NP_060589.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
RIKEN	BC047905	IRAK107D11	MGC	W01A057H02	pENTR-TOPO	154		LGR6	59352	AAH47905.2	Hs.497402	Leucine-rich repeat-containing G protein-coupled receptor 6			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021636.2	NP_067649.2	REVIEWED	C	1.000	1.000	915	2748	1	2745	915	1	915
RIKEN	BC035581	IRAK069P01	MGC	W01A057H03	pENTR-TOPO	5948		PRDM4	11108	AAH35581.1	Hs.506655	PR domain containing 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_012406.3	NP_036538.3	REVIEWED	C	1.000	1.000	801	2406	1	2403	801	1	801
RIKEN	BC047905	IRAK107D11	MGC	W01A057H06	pENTR-TOPO	154		LGR6	59352	AAH47905.2	Hs.497402	Leucine-rich repeat-containing G protein-coupled receptor 6			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021636.2	NP_067649.2	REVIEWED	C	1.000	1.000	915	2748	1	2745	915	1	915
RIKEN	AK128132	flj0077n22	FLJ	W01A057H12	pENTR-TOPO	2619		UNC5B	219699	BAG54634.1	Hs.522997	Unc-5 homolog B (C. elegans)				TESTI4	EK1	NM_170744.3	NP_734465.2	VALIDATED	C	1.000	1.000	945	2838	1	2835	945	1	945
RIKEN	AK128132	flj0077n22	FLJ	W01A057H16	pENTR-TOPO	2619		UNC5B	219699	BAG54634.1	Hs.522997	Unc-5 homolog B (C. elegans)				TESTI4	EK1	NM_170744.3	NP_734465.2	VALIDATED	C	1.000	1.000	945	2838	1	2835	945	1	945
RIKEN	AK056208	flj0002f04	FLJ	W01A057H21	pENTR-TOPO	6100		NOP2	4839	BAG51648.1	Hs.534334	NOP2 nucleolar protein homolog (yeast)	NT2	teratocarcinoma		NT2RI2	EK1	NM_006170.2	NP_006161.2	VALIDATED	C	1.000	1.000	808	2427	1	2424	808	1	808
RIKEN	BC063440	IRAK135P01	MGC	W01A057H24	pENTR-TOPO	10194		RECQL5	9400	AAH63440.1	Hs.632229	RecQ protein-like 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001003716.2	NP_001003716.1	VALIDATED	Cg	0.934	1.000	410	2895	1	1149	410	1	410
RIKEN	AK001658	flj0035l12	FLJ	W01A057I15	pENTR-TOPO	5960		CHFR	55743	BAA91817.1	Hs.656770	Checkpoint with forkhead and ring finger domains	NT2	teratocarcinoma		NT2RP4	EK1	NM_018223.1	NP_060693.1	PROVISIONAL	C	1.000	1.000	623	1872	1	1869	623	1	623
RIKEN	H013066G05	H013066G05	RIKEN	W01A057J02	pENTR-TOPO		14600	CSE1L	1434		Hs.90073	CSE1 chromosome segregation 1-like (yeast)	-	-	testis	testis	DH10B	NM_001316.2	NP_001307.2	REVIEWED	C	1.000	1.000	971	2916	1	2913	971	1	971
RIKEN	AK091203	flj0015a15	FLJ	W01A057J05	pENTR-TOPO	24170		ZNF484	83744	BAG52305.1	Hs.668378	Zinc finger protein 484				CTONG2	EK1	NM_001007101.1	NP_001007102.1	PROVISIONAL	C	1.000	1.000	816	2451	1	2448	816	1	816
RIKEN	BC050307	IRAK090K14	MGC	W01A057J14	pENTR-TOPO	16884		MORC1	27136	AAH50307.1	Hs.591296	MORC family CW-type zinc finger 1			Testis	NIH_MGC_97	DH10B	NM_014429.3	NP_055244.3	REVIEWED	Cs	0.999	0.999	984	2955	1	2952	984	1	984
RIKEN	BC063303	IRAK133E07	MGC	W01A057K01	pENTR-TOPO	6700		SLC7A1	6541	AAH63303.1	Hs.14846	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 1			Placenta, normal	NIH_MGC_147	DH10B	NM_003045.4	NP_003036.1	VALIDATED	OK	1.000	1.000	629	1890	1	1887	629	1	629
RIKEN	BC040557	IRAK074K07	MGC	W01A057K02	pENTR-TOPO	16129		MFN1	55669	AAH40557.1	Hs.478383	Mitofusin 1			Testis	NIH_MGC_97	DH10B	NM_033540.2	NP_284941.2	REVIEWED	C	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	BC040557	IRAK074K07	MGC	W01A057K06	pENTR-TOPO	16129		MFN1	55669	AAH40557.1	Hs.478383	Mitofusin 1			Testis	NIH_MGC_97	DH10B	NM_033540.2	NP_284941.2	REVIEWED	C	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	BC040557	IRAK074K07	MGC	W01A057K08	pENTR-TOPO	16129		MFN1	55669	AAH40557.1	Hs.478383	Mitofusin 1			Testis	NIH_MGC_97	DH10B	NM_033540.2	NP_284941.2	REVIEWED	C	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	BC031212	IRAK063A24	MGC	W01A057K18	pENTR-TOPO	13850		STAT4	6775	AAH31212.1	Hs.80642	Signal transducer and activator of transcription 4			Testis	NIH_MGC_97	DH10B	NM_003151.2	NP_003142.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
RIKEN	BC028003	IRAK062G03	MGC	W01A057K19	pENTR-TOPO	11452		IL27RA	9466	AAH28003.1	Hs.132781	Interleukin 27 receptor, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004843.2	NP_004834.1	REVIEWED	OK	1.000	1.000	636	1911	1	1908	636	1	636
RIKEN	BC027912	IRAK049H11	MGC	W01A057L01	pENTR-TOPO	9135		CDH16	1014	AAH27912.1	Hs.513660	Cadherin 16, KSP-cadherin			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004062.2	NP_004053.1	REVIEWED	OK	1.000	1.000	829	2490	1	2487	829	1	829
RIKEN	BC048964	IRAK106P21	MGC	W01A057L14	pENTR-TOPO	7831		IQCH	64799	AAH48964.1	Hs.657894	IQ motif containing H			Testis	NIH_MGC_97	DH10B	NM_001031715.1	NP_001026885.1	PROVISIONAL	OK	1.000	1.000	1027	3084	1	3081	1027	1	1027
RIKEN	BC028020	IRAK062K03	MGC	W01A057L17	pENTR-TOPO	6001		AGAP2	116986	AAH28020.1	Hs.302435	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014770.2	NP_055585.1	VALIDATED	C	1.000	1.000	836	2511	1	2508	836	1	836
RIKEN	BC028020	IRAK062K03	MGC	W01A057L23	pENTR-TOPO	6001		AGAP2	116986	AAH28020.1	Hs.302435	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014770.2	NP_055585.1	VALIDATED	C	1.000	1.000	836	2511	1	2508	836	1	836
RIKEN	BC030644	IRAK033K10	MGC	W01A057M07	pENTR-TOPO	5204		RFX4	5992	AAH30644.1	Hs.388827	Regulatory factor X, 4 (influences HLA class II expression)			Testis	NIH_MGC_97	DH10B	NM_032491.4	NP_115880.2	REVIEWED	OK	1.000	1.000	641	1926	1	1923	641	1	641
RIKEN	BC064955	IRAK140G08	MGC	W01A057M15	pENTR-TOPO	19801		MYB	4602	AAH64955.1	Hs.654446	V-myb myeloblastosis viral oncogene homolog (avian)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005375.2	NP_005366.2	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
RIKEN	AK022863	flj0033d13	FLJ	W01A057M16	pENTR-TOPO	11668		HNRNPUL1	11100	BAG51129.1	Hs.155218	Heterogeneous nuclear ribonucleoprotein U-like 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_144732.2	NP_653333.1	REVIEWED	C	1.000	1.000	756	2271	1	2268	756	1	756
RIKEN	H023084C01	H023084C01	RIKEN	W01A057M21	pENTR-TOPO		11618	SLC5A5	6528		Hs.584804	Solute carrier family 5 (sodium iodide symporter), member 5	-	-	hippocampus	hippocampus	DH10B	NM_000453.2	NP_000444.1	VALIDATED	C	1.000	1.000	643	1932	1	1929	643	1	643
RIKEN	BC036013	IRAK048C23	MGC	W01A057N03	pENTR-TOPO	7532		MAP4K5	11183	AAH36013.1	Hs.130491	Mitogen-activated protein kinase kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_198794.1	NP_942089.1	REVIEWED	C	1.000	1.000	846	2541	1	2538	846	1	846
RIKEN	AK122714	flj0046p14	FLJ	W01A057N06	pENTR-TOPO	7408		ADCY4	196883	BAG53686.1	Hs.443428	Adenylate cyclase 4				CTONG2	EK1	NM_139247.2	NP_640340.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
RIKEN	BC051751	IRAK098L23	MGC	W01A057N20	pENTR-TOPO	18050		RFC1	5981	AAH51751.1	Hs.507475	Replication factor C (activator 1) 1, 145kDa			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002913.3	NP_002904.3	REVIEWED	OK	1.000	1.000	1147	3444	1	3441	1147	1	1147
RIKEN	BC020974	IRAK020I24	MGC	W01A057O14	pENTR-TOPO	108		SEMA4A	64218	AAH20974.1	Hs.408846	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4A			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_022367.2	NP_071762.2	PROVISIONAL	C	1.000	1.000	761	2286	1	2283	761	1	761
RIKEN	AK092881	flj0009c05	FLJ	W01A057O17	pENTR-TOPO	6134		SILV	6490	BAG52619.1	Hs.95972	Silver homolog (mouse)				SPLEN2	EK1	NM_006928.3	NP_008859.1	VALIDATED	C	1.000	1.000	661	1986	1	1983	661	1	661
RIKEN	BC012863	IRAK021N17	MGC	W01A057O18	pENTR-TOPO	6210		FOXM1	2305	AAH12863.1	Hs.239	Forkhead box M1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_021953.2	NP_068772.2	VALIDATED	C	1.000	1.000	763	2292	1	2289	763	1	763
RIKEN	BC012863	IRAK021N17	MGC	W01A057O20	pENTR-TOPO	6210		FOXM1	2305	AAH12863.1	Hs.239	Forkhead box M1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_021953.2	NP_068772.2	VALIDATED	C	1.000	1.000	763	2292	1	2289	763	1	763
RIKEN	BC068531	IRAK168N20	MGC	W01A057P09	pENTR-TOPO	5310		ATP6V0A2	23545	AAH68531.1	Hs.201939	ATPase, H+ transporting, lysosomal V0 subunit a2			Placenta, normal	NIH_MGC_147	DH10B	NM_012463.2	NP_036595.2	VALIDATED	C	1.000	1.000	856	2571	1	2568	856	1	856
RIKEN	BC068531	IRAK168N20	MGC	W01A057P11	pENTR-TOPO	5310		ATP6V0A2	23545	AAH68531.1	Hs.201939	ATPase, H+ transporting, lysosomal V0 subunit a2			Placenta, normal	NIH_MGC_147	DH10B	NM_012463.2	NP_036595.2	VALIDATED	C	1.000	1.000	856	2571	1	2568	856	1	856
RIKEN	BC002806	IRAL012B24	MGC	W01A058A04	pENTR-TOPO	12225		PPAP2C	8612	AAH02806.1	Hs.465506	Phosphatidic acid phosphatase type 2C			Ovary, adenocarcinoma	NIH_MGC_9		NM_177526.1	NP_803545.1	REVIEWED	OK	1.000	1.000	232	700	2	697	232	1	232
RIKEN	BC014315	IRAL031J01	MGC	W01A058A05	pENTR-TOPO	8185		SNAPC5	10302	AAH14315.1	Hs.30174	Small nuclear RNA activating complex, polypeptide 5, 19kDa			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_006049.2	NP_006040.1	VALIDATED	Cg	0.694	1.000	98	207	1	204	98	1	98
RIKEN	BC002806	IRAL012B24	MGC	W01A058A06	pENTR-TOPO	12225		PPAP2C	8612	AAH02806.1	Hs.465506	Phosphatidic acid phosphatase type 2C			Ovary, adenocarcinoma	NIH_MGC_9		NM_177526.1	NP_803545.1	REVIEWED	OK	1.000	1.000	232	700	2	697	232	1	232
RIKEN	BC014315	IRAL031J01	MGC	W01A058A07	pENTR-TOPO	8185		SNAPC5	10302	AAH14315.1	Hs.30174	Small nuclear RNA activating complex, polypeptide 5, 19kDa			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_006049.2	NP_006040.1	VALIDATED	Cg	0.694	1.000	98	207	1	204	98	1	98
RIKEN	H04D005F24	H04D005F24	RIKEN	W01A058A11	pENTR-TOPO		17971						-	-	testis	testis	DH10B			
RIKEN	BC010175	IRAL028A12	MGC	W01A058A19	pENTR-TOPO	24791		UBE2A	7319	AAH10175.1	Hs.379466	Ubiquitin-conjugating enzyme E2A (RAD6 homolog)			Skin, melanotic melanoma.	NIH_MGC_20		NM_181777.1	NP_861442.1	REVIEWED	OK	1.000	1.000	77	234	1	231	77	1	77
RIKEN	BC030029	IRAK047E09	MGC	W01A058B04	pENTR-TOPO	13509		INHBB	3625	AAH30029.1	Hs.1735	Inhibin, beta B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002193.2	NP_002184.2	REVIEWED	Cs	0.995	0.995	407	1224	1	1221	407	1	407
RIKEN	BC000571	IRAL005K07	MGC	W01A058B07	pENTR-TOPO	3733		P2RY6	5031	AAH00571.1	Hs.16362	Pyrimidinergic receptor P2Y, G-protein coupled, 6			Brain, neuroblastoma	NIH_MGC_19		NM_176796.1	NP_789766.1	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC016765	IRAL032A04	MGC	W01A058B09	pENTR-TOPO	18651		PDLIM4	8572	AAH16765.1	Hs.424312	PDZ and LIM domain 4			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003687.3	NP_003678.2	VALIDATED	Cs	0.997	0.997	330	993	1	990	330	1	330
RIKEN	BC016765	IRAL032A04	MGC	W01A058B15	pENTR-TOPO	18651		PDLIM4	8572	AAH16765.1	Hs.424312	PDZ and LIM domain 4			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003687.3	NP_003678.2	VALIDATED	Cs	0.997	0.997	330	993	1	990	330	1	330
RIKEN	BC017292	IRAL039K18	MGC	W01A058B16	pENTR-TOPO	10697		FLOT2	2319	AAH17292.2	Hs.514038	Flotillin 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_004475.2	NP_004466.2	REVIEWED	P	1.000	1.000	408	1227	1	1224	428	21	428
RIKEN	AK092346	flj0010m16	FLJ	W01A058B18	pENTR-TOPO	4459		ALX4	60529	-	Hs.436055	ALX homeobox 4				OCBBF2	EK1	NM_021926.2	NP_068745.2	VALIDATED	P	1.000	1.000	410	1235	3	1232	411	2	411
RIKEN	AK092346	flj0010m16	FLJ	W01A058B20	pENTR-TOPO	4459		ALX4	60529	-	Hs.436055	ALX homeobox 4				OCBBF2	EK1	NM_021926.2	NP_068745.2	VALIDATED	P	1.000	1.000	410	1235	3	1232	411	2	411
RIKEN	BC027599	IRAK034F16	MGC	W01A058B21	pENTR-TOPO	17208		IL5RA	3568	AAH27599.1	Hs.68876	Interleukin 5 receptor, alpha			Testis	NIH_MGC_97	DH10B	NM_175728.2	NP_783855.1	REVIEWED	Cs	0.997	0.997	335	1008	1	1005	335	1	335
RIKEN	BC027599	IRAK034F16	MGC	W01A058B23	pENTR-TOPO	17208		IL5RA	3568	AAH27599.1	Hs.68876	Interleukin 5 receptor, alpha			Testis	NIH_MGC_97	DH10B	NM_175728.2	NP_783855.1	REVIEWED	Cs	0.997	0.997	335	1008	1	1005	335	1	335
RIKEN	AK092346	flj0010m16	FLJ	W01A058B24	pENTR-TOPO	4459		ALX4	60529	-	Hs.436055	ALX homeobox 4				OCBBF2	EK1	NM_021926.2	NP_068745.2	VALIDATED	P	1.000	1.000	410	1235	3	1232	411	2	411
RIKEN	BC035505	IRAL033B06	MGC	W01A058C02	pENTR-TOPO	1478		USF1	7391	AAH35505.1	Hs.414880	Upstream transcription factor 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_207005.1	NP_996888.1	REVIEWED	C	1.000	1.000	251	756	1	753	251	1	251
RIKEN	BC010954	IRAL019J07	MGC	W01A058C09	pENTR-TOPO	18263		CXCL10	3627	AAH10954.1	Hs.632586	Chemokine (C-X-C motif) ligand 10			Prostate	NIH_MGC_83	DH10B	NM_001565.2	NP_001556.2	REVIEWED	C	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC003558	IRAL008H18	MGC	W01A058D02	pENTR-TOPO	10277		CSNK1D	1453	AAH03558.1	Hs.631725	Casein kinase 1, delta			Placenta, choriocarcinoma	NIH_MGC_21		NM_001893.3	NP_001884.2	REVIEWED	C	1.000	1.000	415	1248	1	1245	415	1	415
RIKEN	BC033038	IRAK047G10	MGC	W01A058D12	pENTR-TOPO	9722		KCNJ16	3773	AAH33038.1	Hs.463985	Potassium inwardly-rectifying channel, subfamily J, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_018658.1	NP_061128.1	REVIEWED	Cs	0.998	0.998	418	1257	1	1254	418	1	418
RIKEN	BC000233	IRAL006G05	MGC	W01A058D19	pENTR-TOPO	1761		GNAT2	2780	AAH00233.1	Hs.36973	Guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2			Eye, retinoblastoma	NIH_MGC_16		NM_005272.3	NP_005263.1	REVIEWED	C	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	BC000233	IRAL006G05	MGC	W01A058D21	pENTR-TOPO	1761		GNAT2	2780	AAH00233.1	Hs.36973	Guanine nucleotide binding protein (G protein), alpha transducing activity polypeptide 2			Eye, retinoblastoma	NIH_MGC_16		NM_005272.3	NP_005263.1	REVIEWED	C	1.000	1.000	354	1065	1	1062	354	1	354
RIKEN	BC069242	IRAL054H23	MGC	W01A058D24	pENTR-TOPO	22665		HMBOX1	79618	AAH69242.1	Hs.591836	Homeobox containing 1			Brain, neuroblastoma	NIH_MGC_47		NM_001135726.1	NP_001129198.1	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	BC002718	IRAL012C22	MGC	W01A058E09	pENTR-TOPO	8562		TNFRSF12A	51330	AAH02718.1	Hs.355899	Tumor necrosis factor receptor superfamily, member 12A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_016639.2	NP_057723.1	VALIDATED	OK	1.000	1.000	129	390	1	387	129	1	129
RIKEN	BC002718	IRAL012C22	MGC	W01A058E11	pENTR-TOPO	8562		TNFRSF12A	51330	AAH02718.1	Hs.355899	Tumor necrosis factor receptor superfamily, member 12A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_016639.2	NP_057723.1	VALIDATED	OK	1.000	1.000	129	390	1	387	129	1	129
RIKEN	BC030664	IRAK047E23	MGC	W01A058F03	pENTR-TOPO	19846		PAQR8	85315	AAH30664.2	Hs.239388	Progestin and adipoQ receptor family member VIII			Brain, hippocampus	NIH_MGC_95	DH10B	NM_133367.4	NP_588608.1	VALIDATED	Cs	0.994	0.994	354	1065	1	1062	354	1	354
RIKEN	H023086I23	H023086I23	RIKEN	W01A058F04	pENTR-TOPO		15397	KCNJ6	3763		Hs.658533	Potassium inwardly-rectifying channel, subfamily J, member 6	-	-	hippocampus	hippocampus	DH10B	NM_002240.2	NP_002231.1	REVIEWED	Cs	0.998	0.998	423	1272	1	1269	423	1	423
RIKEN	BC030664	IRAK047E23	MGC	W01A058F05	pENTR-TOPO	19846		PAQR8	85315	AAH30664.2	Hs.239388	Progestin and adipoQ receptor family member VIII			Brain, hippocampus	NIH_MGC_95	DH10B	NM_133367.4	NP_588608.1	VALIDATED	Cs	0.994	0.994	354	1065	1	1062	354	1	354
RIKEN	BC068995	IRAL054D24	MGC	W01A058F18	pENTR-TOPO	3767		EED	8726	AAH68995.1	Hs.503510	Embryonic ectoderm development			Lung, large cell carcinoma	NIH_MGC_18		NM_152991.1	NP_694536.1	REVIEWED	Cg	0.941	1.000	425	1278	1	1275	400	1	400
RIKEN	BC068995	IRAL054D24	MGC	W01A058F20	pENTR-TOPO	3767		EED	8726	AAH68995.1	Hs.503510	Embryonic ectoderm development			Lung, large cell carcinoma	NIH_MGC_18		NM_152991.1	NP_694536.1	REVIEWED	Cg	0.941	1.000	425	1278	1	1275	400	1	400
RIKEN	BC027459	IRAK052A21	MGC	W01A058G12	pENTR-TOPO	10726		PIP4K2B	8396	AAH27459.1	Hs.260603	Phosphatidylinositol-5-phosphate 4-kinase, type II, beta			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_003559.4	NP_003550.1	REVIEWED	P	1.000	1.000	269	846	1	807	416	1	269
RIKEN	BC066272	IRAK172A20	MGC	W01A058G19	pENTR-TOPO	18919		IL3	3562	AAH66272.1	Hs.694	Interleukin 3 (colony-stimulating factor, multiple)			PCR rescued clones	NIH_MGC_195	DH10B	NM_000588.3	NP_000579.2	REVIEWED	Cs	0.993	0.993	152	459	1	456	152	1	152
RIKEN	BC067456	IRAK172B18	MGC	W01A058H05	pENTR-TOPO	1000		GPR52	9293	AAH67456.1	Hs.673850	G protein-coupled receptor 52			PCR rescued clones	NIH_MGC_195	DH10B	NM_005684.4	NP_005675.3	VALIDATED	C	1.000	1.000	361	1086	1	1083	361	1	361
RIKEN	BC017304	IRAL039O04	MGC	W01A058H22	pENTR-TOPO	16223		NR1I2	8856	AAH17304.2	Hs.7303	Nuclear receptor subfamily 1, group I, member 2			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_003889.3	NP_003880.3	REVIEWED	Pg	0.998	1.000	433	1301	3	1298	434	2	434
RIKEN	BC017304	IRAL039O04	MGC	W01A058H24	pENTR-TOPO	16223		NR1I2	8856	AAH17304.2	Hs.7303	Nuclear receptor subfamily 1, group I, member 2			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_003889.3	NP_003880.3	REVIEWED	Pg	0.998	1.000	433	1301	3	1298	434	2	434
RIKEN	AK094141	flj0045h03	FLJ	W01A058I02	pENTR-TOPO	25133		ZMAT1	84460	-	Hs.496512	Zinc finger, matrin type 1				ASTRO2	EK1	NM_001011657.1	NP_001011657.1	VALIDATED	Pfs	0.942	0.942	139	867	292	707	638	41	179
RIKEN	BC005308	IRAL016K19	MGC	W01A058I03	pENTR-TOPO	13955		TGFA	7039	AAH05308.1	Hs.170009	Transforming growth factor, alpha			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001099691.1	NP_001093161.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC005308	IRAL016K19	MGC	W01A058I05	pENTR-TOPO	13955		TGFA	7039	AAH05308.1	Hs.170009	Transforming growth factor, alpha			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001099691.1	NP_001093161.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC005308	IRAL016K19	MGC	W01A058I07	pENTR-TOPO	13955		TGFA	7039	AAH05308.1	Hs.170009	Transforming growth factor, alpha			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001099691.1	NP_001093161.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
RIKEN	AK098383	flj0052m18	FLJ	W01A058I09	pENTR-TOPO	7769		EID1	23741	BAC05296.1	Hs.714048	EP300 interacting inhibitor of differentiation 1				CBR	EK1	NM_014335.2	NP_055150.1	VALIDATED	Cg	0.877	1.000	187	495	1	492	187	1	187
RIKEN	AK098383	flj0052m18	FLJ	W01A058I15	pENTR-TOPO	7769		EID1	23741	BAC05296.1	Hs.714048	EP300 interacting inhibitor of differentiation 1				CBR	EK1	NM_014335.2	NP_055150.1	VALIDATED	Cg	0.877	1.000	187	495	1	492	187	1	187
RIKEN	BC002619	IRAL004P16	MGC	W01A058I17	pENTR-TOPO	18622		HMP19	51617	AAH02619.1	Hs.559412	HMP19 protein			Brain, neuroblastoma	NIH_MGC_19		NM_015980.3	NP_057064.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
RIKEN	AK097427	flj0040c11	FLJ	W01A058J05	pENTR-TOPO	12399		PBX4	80714	BAG53471.1	Hs.466257	Pre-B-cell leukemia homeobox 4				TESTI2	EK1	NM_025245.1	NP_079521.1	REVIEWED	Cs	0.997	0.997	374	1125	1	1122	374	1	374
RIKEN	AK056857	flj0006l24	FLJ	W01A058J06	pENTR-TOPO	22052		SP8	221833	BAB71297.1	Hs.195922	Sp8 transcription factor				PROST2	EK1	NM_198956.2	NP_945194.1	VALIDATED	Cg	0.886	1.000	490	1305	1	1302	490	1	490
RIKEN	AK055135	flj0014b19	FLJ	W01A058J16	pENTR-TOPO	14723		TOX2	84969	BAB70860.1	Hs.26608	TOX high mobility group box family member 2				BRAWH2	EK1	NM_001098796.1	NP_001092266.1	VALIDATED	Cgs	0.940	0.998	464	1314	1	1311	464	1	464
RIKEN	BC013992	IRAL028D11	MGC	W01A058J19	pENTR-TOPO	9303		MAPK3	5595	AAH13992.1	Hs.861	Mitogen-activated protein kinase 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002746.2	NP_002737.2	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
RIKEN	H013055M23	H013055M23	RIKEN	W01A058K02	pENTR-TOPO		19258	SLC25A2	83884		Hs.97647	Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2	-	-	testis	testis	DH10B	NM_031947.2	NP_114153.1	REVIEWED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	H013055M23	H013055M23	RIKEN	W01A058K04	pENTR-TOPO		19258	SLC25A2	83884		Hs.97647	Solute carrier family 25 (mitochondrial carrier; ornithine transporter) member 2	-	-	testis	testis	DH10B	NM_031947.2	NP_114153.1	REVIEWED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	BC014175	IRAL030K04	MGC	W01A058K11	pENTR-TOPO	11500		BAX	581	AAH14175.1	Hs.624291	BCL2-associated X protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_138761.3	NP_620116.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
RIKEN	AK023668	flj0038o10	FLJ	W01A058K18	pENTR-TOPO	13091		GULP1	51454	BAG51214.1	Hs.470887	GULP, engulfment adaptor PTB domain containing 1				PLACE1	EK1	NM_016315.2	NP_057399.1	VALIDATED	Cs	0.997	0.997	304	915	1	912	304	1	304
RIKEN	BC018037	IRAK032I06	MGC	W01A058L03	pENTR-TOPO	5934		WIF1	11197	AAH18037.1	Hs.284122	WNT inhibitory factor 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_007191.3	NP_009122.2	REVIEWED	Cs	0.997	0.997	379	1140	1	1137	379	1	379
RIKEN	H07D023C13	H07D023C13	RIKEN	W01A058L04	pENTR-TOPO		17569						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	H07D023C13	H07D023C13	RIKEN	W01A058L06	pENTR-TOPO		17569						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	BC018037	IRAK032I06	MGC	W01A058L07	pENTR-TOPO	5934		WIF1	11197	AAH18037.1	Hs.284122	WNT inhibitory factor 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_007191.3	NP_009122.2	REVIEWED	Cs	0.997	0.997	379	1140	1	1137	379	1	379
RIKEN	BC000295	IRAL001A19	MGC	W01A058L23	pENTR-TOPO	19698		KLHDC3	116138	AAH00295.1	Hs.412468	Kelch domain containing 3			Lung, small cell carcinoma	NIH_MGC_7		NM_057161.2	NP_476502.1	REVIEWED	C	1.000	1.000	382	1149	1	1146	382	1	382
RIKEN	BC071989	IRAL058F11	MGC	W01A058L24	pENTR-TOPO	15864		PPM1F	9647	AAH71989.1	Hs.112728	Protein phosphatase 1F (PP2C domain containing)			Pancreas, ductal carcinoma	NIH_MGC_110		NM_014634.2	NP_055449.1	REVIEWED	Cg	0.998	1.000	454	1362	1	1359	454	1	454
RIKEN	H04D030I23	H04D030I23	RIKEN	W01A058M11	pENTR-TOPO		9200						-	-	testis	testis	DH10B			
RIKEN	BC073876	IRAK166C17	MGC	W01A058M12	pENTR-TOPO	14578		STX16	8675	AAH73876.1	Hs.307913	Syntaxin 16			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_001134772.1	NP_001128244.1	REVIEWED	C	1.000	1.000	321	966	1	963	321	1	321
RIKEN	BC073874	IRAK166M09	MGC	W01A058M17	pENTR-TOPO	12239		RTN2	6253	AAH73874.1	Hs.47517	Reticulon 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_206901.1	NP_996784.1	REVIEWED	Cs	0.995	0.995	205	618	1	615	205	1	205
RIKEN	BC073874	IRAK166M09	MGC	W01A058M19	pENTR-TOPO	12239		RTN2	6253	AAH73874.1	Hs.47517	Reticulon 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_206901.1	NP_996784.1	REVIEWED	Cs	0.995	0.995	205	618	1	615	205	1	205
RIKEN	H023005O22	H023005O22	RIKEN	W01A058M20	pENTR-TOPO		19803	SLC25A27	9481		Hs.40510	Solute carrier family 25, member 27	-	-	hippocampus	hippocampus	DH10B	NM_004277.3	NP_004268.3	REVIEWED	Cs	0.994	0.994	323	972	1	969	323	1	323
RIKEN	BC073874	IRAK166M09	MGC	W01A058M23	pENTR-TOPO	12239		RTN2	6253	AAH73874.1	Hs.47517	Reticulon 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_206901.1	NP_996784.1	REVIEWED	Cs	0.995	0.995	205	618	1	615	205	1	205
RIKEN	BC000141	IRAK003D09	MGC	W01A058N04	pENTR-TOPO	22768		MYC	4609	AAH00141.2					Cervix, carcinoma	NIH_MGC_12	DH10B	NM_002467.3	NP_002458.2	REVIEWED	P	1.000	1.000	453	1364	3	1361	454	2	454
RIKEN	BC000141	IRAK003D09	MGC	W01A058N08	pENTR-TOPO	22768		MYC	4609	AAH00141.2					Cervix, carcinoma	NIH_MGC_12	DH10B	NM_002467.3	NP_002458.2	REVIEWED	P	1.000	1.000	453	1364	3	1361	454	2	454
RIKEN	BC008493	IRAL021M14	MGC	W01A058N11	pENTR-TOPO	16159		ACPP	55	AAH08493.1	Hs.433060	Acid phosphatase, prostate			Prostate	NIH_MGC_83	DH10B	NM_001099.4	NP_001090.2	REVIEWED	Cs	0.992	0.992	386	1161	1	1158	386	1	386
RIKEN	BC052310	IRAL047P08	MGC	W01A058N21	pENTR-TOPO	20564		TXNDC5	81567	AAH52310.1	Hs.150837	Thioredoxin domain containing 5 (endoplasmic reticulum)			Ovary, teratocarcinoma	NIH_MGC_109		NM_022085.3	NP_071368.3	REVIEWED	C	1.000	1.000	389	1172	3	1169	389	1	389
RIKEN	BC008818	IRAL015B24	MGC	W01A058O01	pENTR-TOPO	4096		VEGFB	7423	AAH08818.1	Hs.78781	Vascular endothelial growth factor B			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003377.3	NP_003368.1	PROVISIONAL	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	AK126017	flj0072b17	FLJ	W01A058O04	pENTR-TOPO	9536		LGALS9	3965	BAG54277.1	Hs.81337	Lectin, galactoside-binding, soluble, 9				TESTI4	EK1	NM_002308.3	NP_002299.2	REVIEWED	Cs	0.997	0.997	323	972	1	969	323	1	323
RIKEN	BC008818	IRAL015B24	MGC	W01A058O05	pENTR-TOPO	4096		VEGFB	7423	AAH08818.1	Hs.78781	Vascular endothelial growth factor B			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003377.3	NP_003368.1	PROVISIONAL	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC008818	IRAL015B24	MGC	W01A058O07	pENTR-TOPO	4096		VEGFB	7423	AAH08818.1	Hs.78781	Vascular endothelial growth factor B			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003377.3	NP_003368.1	PROVISIONAL	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	AK126017	flj0072b17	FLJ	W01A058O08	pENTR-TOPO	9536		LGALS9	3965	BAG54277.1	Hs.81337	Lectin, galactoside-binding, soluble, 9				TESTI4	EK1	NM_002308.3	NP_002299.2	REVIEWED	Cs	0.997	0.997	323	972	1	969	323	1	323
RIKEN	AK002047	flj0020o02	FLJ	W01A058O09	pENTR-TOPO	10375		KRT23	25984	BAA92054.1	Hs.9029	Keratin 23 (histone deacetylase inducible)				PLACE1	EK1	NM_015515.3	NP_056330.3	REVIEWED	Ps	0.990	0.990	209	630	1	627	422	214	422
RIKEN	AK002047	flj0020o02	FLJ	W01A058O11	pENTR-TOPO	10375		KRT23	25984	BAA92054.1	Hs.9029	Keratin 23 (histone deacetylase inducible)				PLACE1	EK1	NM_015515.3	NP_056330.3	REVIEWED	Ps	0.990	0.990	209	630	1	627	422	214	422
RIKEN	AK000463	flj0057o20	FLJ	W01A058O17	pENTR-TOPO	11027		RNF125	54941	BAA91182.1	Hs.633703	Ring finger protein 125				KAT	EK1	NM_017831.3	NP_060301.2	REVIEWED	Cs	0.996	0.996	232	699	1	696	232	1	232
RIKEN	H023057P12	H023057P12	RIKEN	W01A058O18	pENTR-TOPO		15986	DMC1	11144		Hs.339396	DMC1 dosage suppressor of mck1 homolog, meiosis-specific homologous recombination (yeast)	-	-	hippocampus	hippocampus	DH10B	NM_007068.2	NP_008999.2	REVIEWED	Cg	0.959	1.000	340	981	1	978	340	1	340
RIKEN	AK000463	flj0057o20	FLJ	W01A058O21	pENTR-TOPO	11027		RNF125	54941	BAA91182.1	Hs.633703	Ring finger protein 125				KAT	EK1	NM_017831.3	NP_060301.2	REVIEWED	Cs	0.996	0.996	232	699	1	696	232	1	232
RIKEN	BC082263	IRAL059L13	MGC	W01A058P09	pENTR-TOPO	15682		CHKB	1120	AAH82263.1	Hs.654827	Choline kinase beta			Lung, large cell carcinoma	NIH_MGC_18		NM_005198.3	NP_005189.2	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
RIKEN	H05D087C16	H05D087C16	RIKEN	W01A059A01	pENTR-TOPO		20536						-	-	thymus	thymus	DH10B			
RIKEN	H05D087C16	H05D087C16	RIKEN	W01A059A03	pENTR-TOPO		20536						-	-	thymus	thymus	DH10B			
RIKEN	BC026930	IRAK021M05	MGC	W01A059A09	pENTR-TOPO	19750		TRIM38	10475	AAH26930.1	Hs.584851	Tripartite motif-containing 38			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_006355.2	NP_006346.1	REVIEWED	Cs	0.998	0.998	465	1398	1	1395	465	1	465
RIKEN	BC026930	IRAK021M05	MGC	W01A059A13	pENTR-TOPO	19750		TRIM38	10475	AAH26930.1	Hs.584851	Tripartite motif-containing 38			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_006355.2	NP_006346.1	REVIEWED	Cs	0.998	0.998	465	1398	1	1395	465	1	465
RIKEN	BC032855	IRAK047J23	MGC	W01A059A14	pENTR-TOPO	9190		N-PAC	84656	AAH32855.1	Hs.387255	Cytokine-like nuclear factor n-pac			Testis	NIH_MGC_97	DH10B	NM_032569.3	NP_115958.2	VALIDATED	Cs	0.998	0.998	553	1662	1	1659	553	1	553
RIKEN	BC032855	IRAK047J23	MGC	W01A059A16	pENTR-TOPO	9190		N-PAC	84656	AAH32855.1	Hs.387255	Cytokine-like nuclear factor n-pac			Testis	NIH_MGC_97	DH10B	NM_032569.3	NP_115958.2	VALIDATED	Cs	0.998	0.998	553	1662	1	1659	553	1	553
RIKEN	BC011526	IRAK013C19	MGC	W01A059A21	pENTR-TOPO	232		PCTK3	5129	AAH11526.1	Hs.445402	PCTAIRE protein kinase 3			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_212502.1	NP_997667.1	VALIDATED	Cs	0.998	0.998	474	1425	1	1422	474	1	474
RIKEN	BC013899	IRAL025P19	MGC	W01A059B07	pENTR-TOPO	245		PLK3	1263	AAH13899.1	Hs.632415	Polo-like kinase 3 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_004073.2	NP_004064.2	VALIDATED	Cs	0.998	0.998	646	1941	1	1938	646	1	646
RIKEN	BC000567	IRAL005I19	MGC	W01A059B12	pENTR-TOPO	9227		SEZ6L2	26470	AAH00567.1	Hs.6314	Seizure related 6 homolog (mouse)-like 2			Brain, neuroblastoma	NIH_MGC_19		NM_001114100.1	NP_001107572.1	VALIDATED	Cs	0.999	0.999	809	2430	1	2427	809	1	809
RIKEN	AK128419	flj0078e16	FLJ	W01A059B13	pENTR-TOPO	4030		CD6	923	-	Hs.643167	CD6 molecule				THYMU3	EK1	NM_006725.3	NP_006716.3	VALIDATED	Cg	0.972	1.000	668	1950	1	1947	668	1	668
RIKEN	BC000567	IRAL005I19	MGC	W01A059B16	pENTR-TOPO	9227		SEZ6L2	26470	AAH00567.1	Hs.6314	Seizure related 6 homolog (mouse)-like 2			Brain, neuroblastoma	NIH_MGC_19		NM_001114100.1	NP_001107572.1	VALIDATED	Cs	0.999	0.999	809	2430	1	2427	809	1	809
RIKEN	H023083C23	H023083C23	RIKEN	W01A059B19	pENTR-TOPO		11442	ZNF540	163255		Hs.121283	Zinc finger protein 540	-	-	hippocampus	hippocampus	DH10B	NM_152606.2	NP_689819.1	PROVISIONAL	Cs	0.998	0.998	660	1983	1	1980	660	1	660
RIKEN	H05D020B18	H05D020B18	RIKEN	W01A059B20	pENTR-TOPO		11080						-	-	thymus	thymus	DH10B			
RIKEN	H07D002K20	H07D002K20	RIKEN	W01A059C03	pENTR-TOPO		2564						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	AK025175	flj0062o08	FLJ	W01A059C04	pENTR-TOPO	1881		EPS8L3	79574	BAB15081.1	Hs.485352	EPS8-like 3				COL	EK1	NM_024526.2	NP_078802.2	REVIEWED	Cs	0.998	0.998	563	1692	1	1689	563	1	563
RIKEN	BC007658	IRAL005P07	MGC	W01A059C09	pENTR-TOPO	15559		BCL2L13	23786	AAH07658.1	Hs.631672	BCL2-like 13 (apoptosis facilitator)			Eye, retinoblastoma	NIH_MGC_16		NM_015367.2	NP_056182.2	VALIDATED	Cs	0.998	0.998	485	1458	1	1455	485	1	485
RIKEN	AK001652	flj0035h10	FLJ	W01A059C19	pENTR-TOPO	10287		DDX52	11056	BAA91812.1	Hs.590937	DEAD (Asp-Glu-Ala-Asp) box polypeptide 52	NT2	teratocarcinoma		NT2RP4	EK1	NM_152300.2	NP_689513.2	VALIDATED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	AK001652	flj0035h10	FLJ	W01A059C21	pENTR-TOPO	10287		DDX52	11056	BAA91812.1	Hs.590937	DEAD (Asp-Glu-Ala-Asp) box polypeptide 52	NT2	teratocarcinoma		NT2RP4	EK1	NM_152300.2	NP_689513.2	VALIDATED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	AK001652	flj0035h10	FLJ	W01A059C23	pENTR-TOPO	10287		DDX52	11056	BAA91812.1	Hs.590937	DEAD (Asp-Glu-Ala-Asp) box polypeptide 52	NT2	teratocarcinoma		NT2RP4	EK1	NM_152300.2	NP_689513.2	VALIDATED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	AK122765	flj0046m09	FLJ	W01A059D01	pENTR-TOPO	11185		TCF4	6925	BAG53716.1	Hs.605153	Transcription factor 4				PUAEN2	EK1	NM_003199.2	NP_003190.1	REVIEWED	Cs	0.999	0.999	667	2004	1	2001	667	1	667
RIKEN	AK131562	flj0079m09	FLJ	W01A059D12	pENTR-TOPO	11865		EMR1	2015	BAD18695.1	Hs.2375	Egf-like module containing, mucin-like, hormone receptor-like 1				THYMU3	EK1	NM_001974.3	NP_001965.3	REVIEWED	Cgs	0.904	0.996	919	2604	1	2601	886	1	886
RIKEN	BC033891	IRAK047J07	MGC	W01A059D17	pENTR-TOPO	8777		ATF7IP2	80063	AAH33891.1	Hs.513343	Activating transcription factor 7 interacting protein 2			Testis	NIH_MGC_97	DH10B	NM_024997.2	NP_079273.2	VALIDATED	Cg	0.999	1.000	682	2046	1	2043	682	1	682
RIKEN	BC033891	IRAK047J07	MGC	W01A059D19	pENTR-TOPO	8777		ATF7IP2	80063	AAH33891.1	Hs.513343	Activating transcription factor 7 interacting protein 2			Testis	NIH_MGC_97	DH10B	NM_024997.2	NP_079273.2	VALIDATED	Cg	0.999	1.000	682	2046	1	2043	682	1	682
RIKEN	BC033891	IRAK047J07	MGC	W01A059D21	pENTR-TOPO	8777		ATF7IP2	80063	AAH33891.1	Hs.513343	Activating transcription factor 7 interacting protein 2			Testis	NIH_MGC_97	DH10B	NM_024997.2	NP_079273.2	VALIDATED	Cg	0.999	1.000	682	2046	1	2043	682	1	682
RIKEN	BC033891	IRAK047J07	MGC	W01A059D23	pENTR-TOPO	8777		ATF7IP2	80063	AAH33891.1	Hs.513343	Activating transcription factor 7 interacting protein 2			Testis	NIH_MGC_97	DH10B	NM_024997.2	NP_079273.2	VALIDATED	Cg	0.999	1.000	682	2046	1	2043	682	1	682
RIKEN	H04D018P13	H04D018P13	RIKEN	W01A059E01	pENTR-TOPO		15591						-	-	testis	testis	DH10B			
RIKEN	BC015501	IRAK022L18	MGC	W01A059E02	pENTR-TOPO	414		DYRK3	8444	AAH15501.1	Hs.164267	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001004023.1	NP_001004023.1	REVIEWED	Cs	0.998	0.998	568	1707	1	1704	568	1	568
RIKEN	H04D018P13	H04D018P13	RIKEN	W01A059E03	pENTR-TOPO		15591						-	-	testis	testis	DH10B			
RIKEN	BC015501	IRAK022L18	MGC	W01A059E06	pENTR-TOPO	414		DYRK3	8444	AAH15501.1	Hs.164267	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001004023.1	NP_001004023.1	REVIEWED	Cs	0.998	0.998	568	1707	1	1704	568	1	568
RIKEN	BC015501	IRAK022L18	MGC	W01A059E08	pENTR-TOPO	414		DYRK3	8444	AAH15501.1	Hs.164267	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001004023.1	NP_001004023.1	REVIEWED	Cs	0.998	0.998	568	1707	1	1704	568	1	568
RIKEN	BC084540	IRAL059D23	MGC	W01A059F01	pENTR-TOPO	3679		MARK2	2011	AAH84540.1	Hs.567261	MAP/microtubule affinity-regulating kinase 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004954.3	NP_004945.3	REVIEWED	C	1.000	1.000	691	2076	1	2073	691	1	691
RIKEN	BC071579	IRAK168D15	MGC	W01A059F02	pENTR-TOPO	14055		MAP4K3	8491	AAH71579.1	Hs.655750	Mitogen-activated protein kinase kinase kinase kinase 3			Testis	NIH_MGC_97	DH10B	NM_003618.2	NP_003609.2	REVIEWED	Cg	0.977	1.000	894	2622	1	2619	894	1	894
RIKEN	BC071579	IRAK168D15	MGC	W01A059F04	pENTR-TOPO	14055		MAP4K3	8491	AAH71579.1	Hs.655750	Mitogen-activated protein kinase kinase kinase kinase 3			Testis	NIH_MGC_97	DH10B	NM_003618.2	NP_003609.2	REVIEWED	Cg	0.977	1.000	894	2622	1	2619	894	1	894
RIKEN	BC071579	IRAK168D15	MGC	W01A059F08	pENTR-TOPO	14055		MAP4K3	8491	AAH71579.1	Hs.655750	Mitogen-activated protein kinase kinase kinase kinase 3			Testis	NIH_MGC_97	DH10B	NM_003618.2	NP_003609.2	REVIEWED	Cg	0.977	1.000	894	2622	1	2619	894	1	894
RIKEN	AK027702	flj0020k01	FLJ	W01A059F11	pENTR-TOPO	6084		ZCCHC8	55596	BAB55308.1	Hs.37706	Zinc finger, CCHC domain containing 8	NT2	teratocarcinoma		NT2RP4	EK1	NM_017612.2	NP_060082.2	VALIDATED	Cs	0.997	0.997	707	2124	1	2121	707	1	707
RIKEN	AK074305	flj0051i10	FLJ	W01A059F18	pENTR-TOPO	18085		TBCKL	93627	BAB85045.1	Hs.292986	TBC domain-containing protein kinase-like	HepG2	hepatoma		HEP	EK1	NM_033115.2	NP_149106.2	PROVISIONAL	Cgs	0.928	0.999	893	2682	1	2679	830	1	830
RIKEN	H033027P04	H033027P04	RIKEN	W01A059G01	pENTR-TOPO		1494	SLC2A1	6513		Hs.706748	Solute carrier family 2 (facilitated glucose transporter), member 1	-	-	hypothalamus	hypothalamus	DH10B	NM_006516.2	NP_006507.2	REVIEWED	OK	1.000	1.000	492	1481	3	1478	492	1	492
RIKEN	BC011362	IRAK012J23	MGC	W01A059G02	pENTR-TOPO	15954		GGT5	2687	AAH11362.1	Hs.437156	Gamma-glutamyltransferase 5				NCI_CGAP_Brn67	DH10B	NM_004121.2	NP_004112.2	REVIEWED	C	1.000	1.000	586	1761	1	1758	586	1	586
RIKEN	BC067433	IRAK172I17	MGC	W01A059G11	pENTR-TOPO	2666		CYP2E1	1571	AAH67433.1	Hs.12907	Cytochrome P450, family 2, subfamily E, polypeptide 1			PCR rescued clones	NIH_MGC_195	DH10B	NM_000773.3	NP_000764.1	REVIEWED	Cs	0.996	0.996	493	1482	1	1479	493	1	493
RIKEN	AK001868	flj0037g11	FLJ	W01A059G19	pENTR-TOPO	1758		MCOLN3	55283	BAA91951.1	Hs.535239	Mucolipin 3				PLACE1	EK1	NM_018298.9	NP_060768.8	VALIDATED	Cgs	0.897	0.998	553	1494	1	1491	553	1	553
RIKEN	AK001868	flj0037g11	FLJ	W01A059G23	pENTR-TOPO	1758		MCOLN3	55283	BAA91951.1	Hs.535239	Mucolipin 3				PLACE1	EK1	NM_018298.9	NP_060768.8	VALIDATED	Cgs	0.897	0.998	553	1494	1	1491	553	1	553
RIKEN	BC024179	IRAK033A23	MGC	W01A059H09	pENTR-TOPO	14887		PAK7	57144	AAH24179.1	Hs.32539	P21 protein (Cdc42/Rac)-activated kinase 7			Brain, hippocampus	NIH_MGC_95	DH10B	NM_177990.2	NP_817127.1	REVIEWED	Cs	0.997	0.997	719	2160	1	2157	719	1	719
RIKEN	BC024179	IRAK033A23	MGC	W01A059H11	pENTR-TOPO	14887		PAK7	57144	AAH24179.1	Hs.32539	P21 protein (Cdc42/Rac)-activated kinase 7			Brain, hippocampus	NIH_MGC_95	DH10B	NM_177990.2	NP_817127.1	REVIEWED	Cs	0.997	0.997	719	2160	1	2157	719	1	719
RIKEN	BC051836	IRAK110J05	MGC	W01A059H12	pENTR-TOPO	1999		LRP8	7804	AAH51836.2	Hs.719248	Low density lipoprotein receptor-related protein 8, apolipoprotein e receptor			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001018054.1	NP_001018064.1	REVIEWED	Cs	0.998	0.998	904	2715	1	2712	904	1	904
RIKEN	BC019954	IRAK026D18	MGC	W01A059I06	pENTR-TOPO	20336		RNGTT	8732	AAH19954.1	Hs.567378	RNA guanylyltransferase and 5'-phosphatase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003800.3	NP_003791.3	VALIDATED	Cs	0.997	0.997	597	1794	1	1791	597	1	597
RIKEN	AK131209	flj0073e19	FLJ	W01A059I15	pENTR-TOPO	12181		ZNF497	162968	BAD18400.1	Hs.447840	Zinc finger protein 497	NT2	teratocarcinoma		NT2RI2	EK1	NM_198458.1	NP_940860.1	PROVISIONAL	Cs	0.998	0.998	498	1497	1	1494	498	1	498
RIKEN	BC002523	IRAL004E22	MGC	W01A059I16	pENTR-TOPO	5335		PTPN6	5777	AAH02523.1	Hs.63489	Protein tyrosine phosphatase, non-receptor type 6			Placenta, choriocarcinoma	NIH_MGC_21		NM_080548.4	NP_536858.1	REVIEWED	OK	1.000	1.000	597	1794	1	1791	597	1	597
RIKEN	BC019070	IRAL039L09	MGC	W01A059I21	pENTR-TOPO	21881		CAMK2B	816	AAH19070.1	Hs.351887	Calcium/calmodulin-dependent protein kinase II beta			Lung, small cell carcinoma	NIH_MGC_7		NM_172081.2	NP_742078.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	BC064840	IRAK141B13	MGC	W01A059J06	pENTR-TOPO	5976		HDAC7	51564	AAH64840.1	Hs.200063	Histone deacetylase 7				Lupski_dorsal_root_ganglion	DH10B	NM_016596.3	NP_057680.3	REVIEWED	C	1.000	1.000	915	2750	3	2747	915	1	915
RIKEN	H013079H02	H013079H02	RIKEN	W01A059J17	pENTR-TOPO		25146	RPS6KA3	6197		Hs.445387	Ribosomal protein S6 kinase, 90kDa, polypeptide 3	-	-	testis	testis	DH10B	NM_004586.2	NP_004577.1	REVIEWED	Cg	0.999	1.000	740	2220	1	2217	740	1	740
RIKEN	BC040339	IRAK012O19	MGC	W01A059J18	pENTR-TOPO	21893		NOD1	10392	AAH40339.1	Hs.405153	Nucleotide-binding oligomerization domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_006092.2	NP_006083.1	VALIDATED	Cs	0.999	0.999	953	2862	1	2859	953	1	953
RIKEN	H013079H02	H013079H02	RIKEN	W01A059J19	pENTR-TOPO		25146	RPS6KA3	6197		Hs.445387	Ribosomal protein S6 kinase, 90kDa, polypeptide 3	-	-	testis	testis	DH10B	NM_004586.2	NP_004577.1	REVIEWED	Cg	0.999	1.000	740	2220	1	2217	740	1	740
RIKEN	H013079H02	H013079H02	RIKEN	W01A059J23	pENTR-TOPO		25146	RPS6KA3	6197		Hs.445387	Ribosomal protein S6 kinase, 90kDa, polypeptide 3	-	-	testis	testis	DH10B	NM_004586.2	NP_004577.1	REVIEWED	Cg	0.999	1.000	740	2220	1	2217	740	1	740
RIKEN	AK091274	flj0015o08	FLJ	W01A059K02	pENTR-TOPO	12513		ZNF780A	284323	-	Hs.115140	Zinc finger protein 780A				CTONG2	EK1	NM_001142578.1	NP_001136050.1	VALIDATED	Ps	0.998	0.998	607	1824	1	1821	641	35	641
RIKEN	BC080647	IRAL059N19	MGC	W01A059K09	pENTR-TOPO	5868		SCARB1	949	AAH80647.1	Hs.709216	Scavenger receptor class B, member 1			Prostate, carcinoma	NIH_MGC_40		NM_005505.4	NP_005496.4	VALIDATED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC080647	IRAL059N19	MGC	W01A059K11	pENTR-TOPO	5868		SCARB1	949	AAH80647.1	Hs.709216	Scavenger receptor class B, member 1			Prostate, carcinoma	NIH_MGC_40		NM_005505.4	NP_005496.4	VALIDATED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC080647	IRAL059N19	MGC	W01A059K13	pENTR-TOPO	5868		SCARB1	949	AAH80647.1	Hs.709216	Scavenger receptor class B, member 1			Prostate, carcinoma	NIH_MGC_40		NM_005505.4	NP_005496.4	VALIDATED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC080647	IRAL059N19	MGC	W01A059K15	pENTR-TOPO	5868		SCARB1	949	AAH80647.1	Hs.709216	Scavenger receptor class B, member 1			Prostate, carcinoma	NIH_MGC_40		NM_005505.4	NP_005496.4	VALIDATED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	AK092882	flj0009e05	FLJ	W01A059K18	pENTR-TOPO	4547		RASGRP2	10235	BAG52620.1	Hs.99491	RAS guanyl releasing protein 2 (calcium and DAG-regulated)				SPLEN2	EK1	NM_001098671.1	NP_001092141.1	REVIEWED	Cg	0.998	1.000	610	1833	1	1830	609	1	609
RIKEN	AK123693	flj0068a09	FLJ	W01A059K19	pENTR-TOPO	6167		CKAP4	10970	BAG53938.1	Hs.74368	Cytoskeleton-associated protein 4				HCHON2	EK1	NM_006825.3	NP_006816.2	VALIDATED	Cgs	0.864	0.998	602	1566	1	1563	602	1	602
RIKEN	AK092882	flj0009e05	FLJ	W01A059K20	pENTR-TOPO	4547		RASGRP2	10235	BAG52620.1	Hs.99491	RAS guanyl releasing protein 2 (calcium and DAG-regulated)				SPLEN2	EK1	NM_001098671.1	NP_001092141.1	REVIEWED	Cg	0.998	1.000	610	1833	1	1830	609	1	609
RIKEN	BC067120	IRAK139A16	MGC	W01A059L01	pENTR-TOPO	23690		PTPDC1	138639	AAH67120.1	Hs.437943	Protein tyrosine phosphatase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_177995.1	NP_818931.1	REVIEWED	Cs	0.999	0.999	754	2265	1	2262	754	1	754
RIKEN	BC067120	IRAK139A16	MGC	W01A059L05	pENTR-TOPO	23690		PTPDC1	138639	AAH67120.1	Hs.437943	Protein tyrosine phosphatase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_177995.1	NP_818931.1	REVIEWED	Cs	0.999	0.999	754	2265	1	2262	754	1	754
RIKEN	BC073964	IRAK174E12	MGC	W01A059L12	pENTR-TOPO	5249		PHC1	1911	AAH73964.1	Hs.305985	Polyhomeotic homolog 1 (Drosophila)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004426.2	NP_004417.2	REVIEWED	Cgs	0.952	0.999	1004	2874	1	2871	1004	1	1004
RIKEN	H04D046M21	H04D046M21	RIKEN	W01A059M06	pENTR-TOPO		15499						-	-	testis	testis	DH10B			
RIKEN	BC066979	IRAK167E09	MGC	W01A059M18	pENTR-TOPO	19676		TIAM2	26230	AAH66979.1	Hs.586279	T-cell lymphoma invasion and metastasis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001010927.2	NP_001010927.1	REVIEWED	Cs	0.992	0.992	626	1881	1	1878	626	1	626
RIKEN	BC066979	IRAK167E09	MGC	W01A059M20	pENTR-TOPO	19676		TIAM2	26230	AAH66979.1	Hs.586279	T-cell lymphoma invasion and metastasis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001010927.2	NP_001010927.1	REVIEWED	Cs	0.992	0.992	626	1881	1	1878	626	1	626
RIKEN	BC066979	IRAK167E09	MGC	W01A059M24	pENTR-TOPO	19676		TIAM2	26230	AAH66979.1	Hs.586279	T-cell lymphoma invasion and metastasis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001010927.2	NP_001010927.1	REVIEWED	Cs	0.992	0.992	626	1881	1	1878	626	1	626
RIKEN	BC071567	IRAK167B13	MGC	W01A059N09	pENTR-TOPO	16364		SNRK	54861	AAH71567.1	Hs.476052	SNF related kinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001100594.1	NP_001094064.1	VALIDATED	Cs	0.996	0.996	765	2298	1	2295	765	1	765
RIKEN	H023045K08	H023045K08	RIKEN	W01A059N17	pENTR-TOPO		4952	ZW10	9183		Hs.503886	ZW10, kinetochore associated, homolog (Drosophila)	-	-	hippocampus	hippocampus	DH10B	NM_004724.2	NP_004715.1	REVIEWED	Cs	0.995	0.995	779	2340	1	2337	779	1	779
RIKEN	BC034988	IRAK047M11	MGC	W01A059N18	pENTR-TOPO	10210		ULK2	9706	AAH34988.1	Hs.168762	Unc-51-like kinase 2 (C. elegans)			Testis	NIH_MGC_97	DH10B	NM_014683.3	NP_055498.3	REVIEWED	Cs	0.999	0.999	1036	3111	1	3108	1036	1	1036
RIKEN	H023045K08	H023045K08	RIKEN	W01A059N23	pENTR-TOPO		4952	ZW10	9183		Hs.503886	ZW10, kinetochore associated, homolog (Drosophila)	-	-	hippocampus	hippocampus	DH10B	NM_004724.2	NP_004715.1	REVIEWED	Cs	0.995	0.995	779	2340	1	2337	779	1	779
RIKEN	AK124565	flj0069d07	FLJ	W01A059O02	pENTR-TOPO	7753		IL16	3603	BAC85888.1	Hs.459095	Interleukin 16 (lymphocyte chemoattractant factor)				BRACE3	EK1	NM_004513.4	NP_004504.3	REVIEWED	Cg	0.998	1.000	631	1893	1	1890	631	1	631
RIKEN	AK056694	flj0006d05	FLJ	W01A059O03	pENTR-TOPO	11541		ZNF257	113835	BAG51786.1	Hs.283900	Zinc finger protein 257				PEBLM2	EK1	NM_033468.2	NP_258429.2	PROVISIONAL	Cg	0.941	1.000	563	1593	1	1590	563	1	563
RIKEN	H013054K20	H013054K20	RIKEN	W01A059O10	pENTR-TOPO		21033	KCND2	3751		Hs.654739	Potassium voltage-gated channel, Shal-related subfamily, member 2	-	-	testis	testis	DH10B	NM_012281.2	NP_036413.1	REVIEWED	Cs	0.998	0.998	630	1893	1	1890	630	1	630
RIKEN	BC069197	IRAL054P10	MGC	W01A059O24	pENTR-TOPO	9167		AMFR	267	AAH69197.1	Hs.295137	Autocrine motility factor receptor			Ovary, teratocarcinoma	NIH_MGC_109		NM_001144.4	NP_001135.3	REVIEWED	C	1.000	1.000	643	1932	1	1929	643	1	643
RIKEN	BC064559	IRAK139B21	MGC	W01A059P01	pENTR-TOPO	13771		C2orf3	6936	AAH64559.1	Hs.303808	Chromosome 2 open reading frame 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003203.3	NP_003194.3	VALIDATED	Cs	0.999	0.999	781	2346	1	2343	781	1	781
RIKEN	BC064559	IRAK139B21	MGC	W01A059P03	pENTR-TOPO	13771		C2orf3	6936	AAH64559.1	Hs.303808	Chromosome 2 open reading frame 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003203.3	NP_003194.3	VALIDATED	Cs	0.999	0.999	781	2346	1	2343	781	1	781
RIKEN	BC064559	IRAK139B21	MGC	W01A059P07	pENTR-TOPO	13771		C2orf3	6936	AAH64559.1	Hs.303808	Chromosome 2 open reading frame 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003203.3	NP_003194.3	VALIDATED	Cs	0.999	0.999	781	2346	1	2343	781	1	781
RIKEN	H023084C04	H023084C04	RIKEN	W01A059P15	pENTR-TOPO		18546	PDE8B	8622		Hs.584830	Phosphodiesterase 8B	-	-	hippocampus	hippocampus	DH10B	NM_001029851.1	NP_001025022.1	VALIDATED	Cs	0.996	0.996	788	2367	1	2364	788	1	788
RIKEN	AK093285	flj0009i22	FLJ	W01A059P17	pENTR-TOPO	9196		PMFBP1	83449	BAC04121.1	Hs.714939	Polyamine modulated factor 1 binding protein 1				TESTI2	EK1	NM_031293.2	NP_112583.2	VALIDATED	Cgs	0.790	0.999	1007	2394	1	2391	1007	1	1007
RIKEN	BC028604	IRAK046G23	MGC	W01A060A01	pENTR-TOPO	18879		SKIV2L2	23517	AAH28604.3	Hs.274531	Superkiller viralicidic activity 2-like 2 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015360.4	NP_056175.3	VALIDATED	Cs	0.999	0.999	1042	3129	1	3126	1042	1	1042
RIKEN	BC028604	IRAK046G23	MGC	W01A060A03	pENTR-TOPO	18879		SKIV2L2	23517	AAH28604.3	Hs.274531	Superkiller viralicidic activity 2-like 2 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015360.4	NP_056175.3	VALIDATED	Cs	0.999	0.999	1042	3129	1	3126	1042	1	1042
RIKEN	H04D010C09	H04D010C09	RIKEN	W01A060A09	pENTR-TOPO		6659						-	-	testis	testis	DH10B			
RIKEN	BC032229	IRAK049H20	MGC	W01A060A12	pENTR-TOPO	11965		AXL	558	AAH32229.1	Hs.590970	AXL receptor tyrosine kinase			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_021913.3	NP_068713.2	REVIEWED	Cs	0.999	0.999	894	2685	1	2682	894	1	894
RIKEN	BC032229	IRAK049H20	MGC	W01A060A14	pENTR-TOPO	11965		AXL	558	AAH32229.1	Hs.590970	AXL receptor tyrosine kinase			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_021913.3	NP_068713.2	REVIEWED	Cs	0.999	0.999	894	2685	1	2682	894	1	894
RIKEN	BC032229	IRAK049H20	MGC	W01A060A16	pENTR-TOPO	11965		AXL	558	AAH32229.1	Hs.590970	AXL receptor tyrosine kinase			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_021913.3	NP_068713.2	REVIEWED	Cs	0.999	0.999	894	2685	1	2682	894	1	894
RIKEN	BC000729	IRAL007L12	MGC	W01A060A24	pENTR-TOPO	9650		AKAP1	8165	AAH00729.1	Hs.463506	A kinase (PRKA) anchor protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_003488.3	NP_003479.1	REVIEWED	Cs	0.999	0.999	903	2712	1	2709	903	1	903
RIKEN	BC044659	IRAK082M14	MGC	W01A060B03	pENTR-TOPO	16828		HLTF	6596	AAH44659.1	Hs.3068	Helicase-like transcription factor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_139048.2	NP_620636.1	REVIEWED	Cg	0.999	1.000	1009	3027	1	3024	1009	1	1009
RIKEN	BC071582	IRAK168N06	MGC	W01A060C05	pENTR-TOPO	10242		USP36	57602	AAH71582.1	Hs.464243	Ubiquitin specific peptidase 36			Placenta, normal	NIH_MGC_147	DH10B	NM_025090.3	NP_079366.3	VALIDATED	Cs	0.999	0.999	1123	3372	1	3369	1123	1	1123
RIKEN	BC036470	IRAK073K13	MGC	W01A060C06	pENTR-TOPO	11278		CDH2	1000	AAH36470.1	Hs.464829	Cadherin 2, type 1, N-cadherin (neuronal)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001792.3	NP_001783.2	REVIEWED	Cs	0.994	0.994	906	2721	1	2718	906	1	906
RIKEN	BC071582	IRAK168N06	MGC	W01A060C07	pENTR-TOPO	10242		USP36	57602	AAH71582.1	Hs.464243	Ubiquitin specific peptidase 36			Placenta, normal	NIH_MGC_147	DH10B	NM_025090.3	NP_079366.3	VALIDATED	Cs	0.999	0.999	1123	3372	1	3369	1123	1	1123
RIKEN	BC035788	IRAK079H05	MGC	W01A060D02	pENTR-TOPO	14538		SNPH	9751	AAH35788.1	Hs.323833	Syntaphilin			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014723.2	NP_055538.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
RIKEN	AK131405	flj0073k02	FLJ	W01A060D03	pENTR-TOPO	804		ZSCAN20	7579	BAD18552.1	Hs.442705	Zinc finger and SCAN domain containing 20				HCHON2	EK1	NM_145238.3	NP_660281.2	VALIDATED	Cs	0.999	0.999	1043	3132	1	3129	1043	1	1043
RIKEN	BC023144	IRAK026I18	MGC	W01A060D15	pENTR-TOPO	17394		SMARCA5	8467	AAH23144.1	Hs.558422	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003601.2	NP_003592.2	REVIEWED	Cs	0.999	0.999	1052	3159	1	3156	1052	1	1052
RIKEN	BC002558	IRAL004L19	MGC	W01A060D17	pENTR-TOPO	61		KDM4A	9682	AAH02558.1	Hs.155983	Lysine (K)-specific demethylase 4A			Placenta, choriocarcinoma	NIH_MGC_21		NM_014663.2	NP_055478.2	REVIEWED	Cs	0.999	0.999	1064	3195	1	3192	1064	1	1064
RIKEN	BC035788	IRAK079H05	MGC	W01A060D20	pENTR-TOPO	14538		SNPH	9751	AAH35788.1	Hs.323833	Syntaphilin			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014723.2	NP_055538.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
RIKEN	BC002558	IRAL004L19	MGC	W01A060D21	pENTR-TOPO	61		KDM4A	9682	AAH02558.1	Hs.155983	Lysine (K)-specific demethylase 4A			Placenta, choriocarcinoma	NIH_MGC_21		NM_014663.2	NP_055478.2	REVIEWED	Cs	0.999	0.999	1064	3195	1	3192	1064	1	1064
RIKEN	BC002558	IRAL004L19	MGC	W01A060D23	pENTR-TOPO	61		KDM4A	9682	AAH02558.1	Hs.155983	Lysine (K)-specific demethylase 4A			Placenta, choriocarcinoma	NIH_MGC_21		NM_014663.2	NP_055478.2	REVIEWED	Cs	0.999	0.999	1064	3195	1	3192	1064	1	1064
RIKEN	AK025510	flj0065l13	FLJ	W01A060E04	pENTR-TOPO	9750		BCAS3	54828	BAB15156.1	Hs.655028	Breast carcinoma amplified sequence 3	HepG2	hepatoma		HEP	EK1	NM_001099432.1	NP_001092902.1	VALIDATED	Cs	0.995	0.995	928	2787	1	2784	928	1	928
RIKEN	AK025510	flj0065l13	FLJ	W01A060E08	pENTR-TOPO	9750		BCAS3	54828	BAB15156.1	Hs.655028	Breast carcinoma amplified sequence 3	HepG2	hepatoma		HEP	EK1	NM_001099432.1	NP_001092902.1	VALIDATED	Cs	0.995	0.995	928	2787	1	2784	928	1	928
RIKEN	AK128298	flj0078g13	FLJ	W01A060F02	pENTR-TOPO	8874		GPR114	221188	BAG54657.1	Hs.187884	G protein-coupled receptor 114				THYMU3	EK1	NM_153837.1	NP_722579.1	PROVISIONAL	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	AK091478	flj0017k12	FLJ	W01A060F05	pENTR-TOPO	2796		ZEB1	6935	BAC03673.1	Hs.124503	Zinc finger E-box binding homeobox 1				FCBBF3	EK1	NM_030751.4	NP_110378.3	VALIDATED	Cgs	0.977	0.995	1124	3315	1	3312	1124	1	1124
RIKEN	AK128298	flj0078g13	FLJ	W01A060F16	pENTR-TOPO	8874		GPR114	221188	BAG54657.1	Hs.187884	G protein-coupled receptor 114				THYMU3	EK1	NM_153837.1	NP_722579.1	PROVISIONAL	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	BC045640	IRAK077B10	MGC	W01A060F21	pENTR-TOPO	6490		IPO5	3843	AAH45640.1	Hs.712598	Importin 5			Testis	NIH_MGC_97	DH10B	NM_002271.4	NP_002262.3	REVIEWED	Cs	0.999	0.999	1115	3348	1	3345	1115	1	1115
RIKEN	AK001573	flj0034f12	FLJ	W01A060G02	pENTR-TOPO	14605		XRN2	22803	BAG50941.1	Hs.255932	5'-3' exoribonuclease 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_012255.3	NP_036387.2	REVIEWED	Cs	0.999	0.999	950	2853	1	2850	950	1	950
RIKEN	H013055M05	H013055M05	RIKEN	W01A060G09	pENTR-TOPO		7599	PTPN21	11099		Hs.437040	Protein tyrosine phosphatase, non-receptor type 21	-	-	testis	testis	DH10B	NM_007039.3	NP_008970.2	REVIEWED	Cs	0.999	0.999	1174	3525	1	3522	1174	1	1174
RIKEN	H013055M05	H013055M05	RIKEN	W01A060G11	pENTR-TOPO		7599	PTPN21	11099		Hs.437040	Protein tyrosine phosphatase, non-receptor type 21	-	-	testis	testis	DH10B	NM_007039.3	NP_008970.2	REVIEWED	Cs	0.999	0.999	1174	3525	1	3522	1174	1	1174
RIKEN	BC068974	IRAK140O13	MGC	W01A060G19	pENTR-TOPO	8749		SF3B3	23450	AAH68974.1	Hs.514435	Splicing factor 3b, subunit 3, 130kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_012426.4	NP_036558.3	REVIEWED	Cs	0.999	0.999	1217	3654	1	3651	1217	1	1217
RIKEN	BC006201	IRAL011F13	MGC	W01A060G24	pENTR-TOPO	9965		AP2B1	163	AAH06201.1	Hs.514819	Adaptor-related protein complex 2, beta 1 subunit			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001030006.1	NP_001025177.1	REVIEWED	C	1.000	1.000	951	2856	1	2853	951	1	951
RIKEN	AK075245	flj0019o16	FLJ	W01A060H04	pENTR-TOPO	16436		ZNF619	285267	BAC11495.1	Hs.407159	Zinc finger protein 619				THYRO1	EK1	NM_173656.2	NP_775927.1	VALIDATED	C	1.000	1.000	560	1683	1	1680	560	1	560
RIKEN	H013090H03	H013090H03	RIKEN	W01A060H13	pENTR-TOPO		1408	TRIM33	51592		Hs.26837	Tripartite motif-containing 33	-	-	testis	testis	DH10B	NM_015906.3	NP_056990.3	REVIEWED	Cs	0.999	0.999	1127	3384	1	3381	1127	1	1127
RIKEN	H013090H03	H013090H03	RIKEN	W01A060H15	pENTR-TOPO		1408	TRIM33	51592		Hs.26837	Tripartite motif-containing 33	-	-	testis	testis	DH10B	NM_015906.3	NP_056990.3	REVIEWED	Cs	0.999	0.999	1127	3384	1	3381	1127	1	1127
RIKEN	AK075245	flj0019o16	FLJ	W01A060H18	pENTR-TOPO	16436		ZNF619	285267	BAC11495.1	Hs.407159	Zinc finger protein 619				THYRO1	EK1	NM_173656.2	NP_775927.1	VALIDATED	C	1.000	1.000	560	1683	1	1680	560	1	560
RIKEN	AK075245	flj0019o16	FLJ	W01A060H24	pENTR-TOPO	16436		ZNF619	285267	BAC11495.1	Hs.407159	Zinc finger protein 619				THYRO1	EK1	NM_173656.2	NP_775927.1	VALIDATED	C	1.000	1.000	560	1683	1	1680	560	1	560
RIKEN	H04D004G24	H04D004G24	RIKEN	W01A060I02	pENTR-TOPO		361						-	-	testis	testis	DH10B			
RIKEN	H04D004G24	H04D004G24	RIKEN	W01A060I08	pENTR-TOPO		361						-	-	testis	testis	DH10B			
RIKEN	BC045667	IRAK077A18	MGC	W01A060I10	pENTR-TOPO	21792		SNX13	23161	AAH45667.1	Hs.487648	Sorting nexin 13			Testis	NIH_MGC_97	DH10B	NM_015132.4	NP_055947.1	REVIEWED	Cs	0.999	0.999	957	2874	1	2871	957	1	957
RIKEN	BC045667	IRAK077A18	MGC	W01A060I12	pENTR-TOPO	21792		SNX13	23161	AAH45667.1	Hs.487648	Sorting nexin 13			Testis	NIH_MGC_97	DH10B	NM_015132.4	NP_055947.1	REVIEWED	Cs	0.999	0.999	957	2874	1	2871	957	1	957
RIKEN	BC011764	IRAL027F14	MGC	W01A060I20	pENTR-TOPO	18568		TCOF1	6949	AAH11764.1	Hs.519672	Treacher Collins-Franceschetti syndrome 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001008657.2	NP_001008657.1	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
RIKEN	BC015757	IRAL034C17	MGC	W01A060J10	pENTR-TOPO	13459		DGUOK	1716	AAH15757.1	Hs.469022	Deoxyguanosine kinase			Primary B-Cells from Tonsils	NIH_MGC_48		NM_080916.1	NP_550438.1	REVIEWED	C	1.000	1.000	277	834	1	831	277	1	277
RIKEN	BC015757	IRAL034C17	MGC	W01A060J12	pENTR-TOPO	13459		DGUOK	1716	AAH15757.1	Hs.469022	Deoxyguanosine kinase			Primary B-Cells from Tonsils	NIH_MGC_48		NM_080916.1	NP_550438.1	REVIEWED	C	1.000	1.000	277	834	1	831	277	1	277
RIKEN	BC051281	IRAL047I17	MGC	W01A060J17	pENTR-TOPO	6265		CD163	9332	AAH51281.1	Hs.504641	CD163 molecule			Spleen	NIH_MGC_113		NM_004244.4	NP_004235.3	VALIDATED	C	1.000	1.000	1156	3471	1	3468	1156	1	1156
RIKEN	BC051281	IRAL047I17	MGC	W01A060J19	pENTR-TOPO	6265		CD163	9332	AAH51281.1	Hs.504641	CD163 molecule			Spleen	NIH_MGC_113		NM_004244.4	NP_004235.3	VALIDATED	C	1.000	1.000	1156	3471	1	3468	1156	1	1156
RIKEN	BC051281	IRAL047I17	MGC	W01A060J23	pENTR-TOPO	6265		CD163	9332	AAH51281.1	Hs.504641	CD163 molecule			Spleen	NIH_MGC_113		NM_004244.4	NP_004235.3	VALIDATED	C	1.000	1.000	1156	3471	1	3468	1156	1	1156
RIKEN	BC040523	IRAK063F19	MGC	W01A060K01	pENTR-TOPO	9079		CNOT1	23019	AAH40523.1	Hs.716474	CCR4-NOT transcription complex, subunit 1			Testis	NIH_MGC_97	DH10B	NM_206999.1	NP_996882.1	VALIDATED	Cs	0.999	0.999	1551	4656	1	4653	1551	1	1551
RIKEN	AK126464	flj0069h16	FLJ	W01A060K06	pENTR-TOPO	10495		EFTUD2	9343	BAG54331.1	Hs.151787	Elongation factor Tu GTP binding domain containing 2				UTERU3	EK1	NM_004247.3	NP_004238.3	VALIDATED	Cg	0.990	1.000	972	2889	1	2886	972	1	972
RIKEN	AK126464	flj0069h16	FLJ	W01A060K08	pENTR-TOPO	10495		EFTUD2	9343	BAG54331.1	Hs.151787	Elongation factor Tu GTP binding domain containing 2				UTERU3	EK1	NM_004247.3	NP_004238.3	VALIDATED	Cg	0.990	1.000	972	2889	1	2886	972	1	972
RIKEN	BC036023	IRAK048E15	MGC	W01A060K12	pENTR-TOPO	17393		PLK4	10733	AAH36023.1	Hs.172052	Polo-like kinase 4 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_014264.3	NP_055079.3	REVIEWED	OK	1.000	1.000	970	2913	1	2910	970	1	970
RIKEN	BC083513	IRAK166O23	MGC	W01A060K19	pENTR-TOPO	13173		ZNF638	27332	AAH83513.1	Hs.434401	Zinc finger protein 638			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014497.3	NP_055312.2	REVIEWED	Cg	0.989	1.000	1978	5874	1	5871	1978	1	1978
RIKEN	BC083513	IRAK166O23	MGC	W01A060K21	pENTR-TOPO	13173		ZNF638	27332	AAH83513.1	Hs.434401	Zinc finger protein 638			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014497.3	NP_055312.2	REVIEWED	Cg	0.989	1.000	1978	5874	1	5871	1978	1	1978
RIKEN	BC021825	IRAK029N17	MGC	W01A060L06	pENTR-TOPO	15250		IFNAR1	3454	AAH21825.1	Hs.529400	Interferon (alpha, beta and omega) receptor 1				NCI_CGAP_Brn67	DH10B	NM_000629.2	NP_000620.2	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC021825	IRAK029N17	MGC	W01A060L14	pENTR-TOPO	15250		IFNAR1	3454	AAH21825.1	Hs.529400	Interferon (alpha, beta and omega) receptor 1				NCI_CGAP_Brn67	DH10B	NM_000629.2	NP_000620.2	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC062556	IRAL050N20	MGC	W01A060M17	pENTR-TOPO	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014567.2	NP_055382.2	VALIDATED	Cs	0.998	0.998	870	2613	1	2610	870	1	870
RIKEN	AK127324	flj0074b02	FLJ	W01A060M22	pENTR-TOPO	4827		HYOU1	10525	BAG54482.1	Hs.277704	Hypoxia up-regulated 1				BRHIP3	EK1	NM_006389.3	NP_006380.1	REVIEWED	Cgs	0.989	0.999	1000	2976	1	2973	999	1	999
RIKEN	BC075798	IRAK168I21	MGC	W01A060N07	pENTR-TOPO	19725		GPR126	57211	AAH75798.1	Hs.715560	G protein-coupled receptor 126			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001032395.2	NP_001027567.1	REVIEWED	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
RIKEN	BC050341	IRAK090P14	MGC	W01A060N09	pENTR-TOPO	5171		CAND1	55832	AAH50341.1	Hs.546407	Cullin-associated and neddylation-dissociated 1			Testis	NIH_MGC_97	DH10B	NM_018448.3	NP_060918.2	VALIDATED	Cs	0.999	0.999	1230	3693	1	3690	1230	1	1230
RIKEN	BC018612	IRAL029I24	MGC	W01A060O05	pENTR-TOPO	11396		ZNF473	25888	AAH18612.1	Hs.440553	Zinc finger protein 473			Eye, retinoblastoma	NIH_MGC_16		NM_015428.1	NP_056243.1	VALIDATED	C	1.000	1.000	871	2616	1	2613	871	1	871
RIKEN	BC016490	IRAK026J22	MGC	W01A060O20	pENTR-TOPO	179		MIB2	142678	AAH16490.1	Hs.593430	Mindbomb homolog 2 (Drosophila)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080875.1	NP_543151.1	PROVISIONAL	Cgs	0.985	0.999	1013	3000	1	2997	1013	1	1013
RIKEN	BC016490	IRAK026J22	MGC	W01A060O24	pENTR-TOPO	179		MIB2	142678	AAH16490.1	Hs.593430	Mindbomb homolog 2 (Drosophila)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080875.1	NP_543151.1	PROVISIONAL	Cgs	0.985	0.999	1013	3000	1	2997	1013	1	1013
RIKEN	BC007228	IRAL022A03	MGC	W01A061A01	pENTR-TOPO	24598		CSAG2	728461	AAH07228.1					Lung, small cell carcinoma	NIH_MGC_7		NM_004909.3	NP_004900.2	VALIDATED	Pg	0.896	1.000	48	147	1	144	110	68	110
RIKEN	AK054592	flj0001o07	FLJ	W01A061A02	pENTR-TOPO	17042		CNBP	7555	BAB70769.1	Hs.518249	CCHC-type zinc finger, nucleic acid binding protein	NB69	neuroblastoma		3NB692	EK1	NM_001127192.1	NP_001120664.1	REVIEWED	Cg	0.933	1.000	179	504	1	501	179	1	179
RIKEN	BC007228	IRAL022A03	MGC	W01A061A03	pENTR-TOPO	24598		CSAG2	728461	AAH07228.1					Lung, small cell carcinoma	NIH_MGC_7		NM_004909.3	NP_004900.2	VALIDATED	Pg	0.896	1.000	48	147	1	144	110	68	110
RIKEN	AK054592	flj0001o07	FLJ	W01A061A04	pENTR-TOPO	17042		CNBP	7555	BAB70769.1	Hs.518249	CCHC-type zinc finger, nucleic acid binding protein	NB69	neuroblastoma		3NB692	EK1	NM_001127192.1	NP_001120664.1	REVIEWED	Cg	0.933	1.000	179	504	1	501	179	1	179
RIKEN	AK054592	flj0001o07	FLJ	W01A061A08	pENTR-TOPO	17042		CNBP	7555	BAB70769.1	Hs.518249	CCHC-type zinc finger, nucleic acid binding protein	NB69	neuroblastoma		3NB692	EK1	NM_001127192.1	NP_001120664.1	REVIEWED	Cg	0.933	1.000	179	504	1	501	179	1	179
RIKEN	BC003563	IRAL006D14	MGC	W01A061A11	pENTR-TOPO	1554		GNG5	2787	AAH03563.1	Hs.645427	Guanine nucleotide binding protein (G protein), gamma 5			Brain, neuroblastoma	NIH_MGC_19		NM_005274.2	NP_005265.1	VALIDATED	C	1.000	1.000	68	207	1	204	68	1	68
RIKEN	BC002434	IRAL005E22	MGC	W01A061A17	pENTR-TOPO	9147		NUPR1	26471	AAH02434.1	Hs.513463	Nuclear protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_012385.2	NP_036517.1	VALIDATED	OK	1.000	1.000	82	249	1	246	82	1	82
RIKEN	BC006282	IRAL015D18	MGC	W01A061A18	pENTR-TOPO	9550		VPS25	84313	AAH06282.1	Hs.500165	Vacuolar protein sorting 25 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20		NM_032353.2	NP_115729.1	PROVISIONAL	C	1.000	1.000	176	531	1	528	176	1	176
RIKEN	BC002434	IRAL005E22	MGC	W01A061A23	pENTR-TOPO	9147		NUPR1	26471	AAH02434.1	Hs.513463	Nuclear protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_012385.2	NP_036517.1	VALIDATED	OK	1.000	1.000	82	249	1	246	82	1	82
RIKEN	BC050442	IRAK098L14	MGC	W01A061B08	pENTR-TOPO	5620		HOXC4	3221	AAH50442.1						Lupski_sympathetic_trunk	DH10B	NM_014620.4	NP_055435.2	REVIEWED	Cs	0.996	0.996	264	795	1	792	264	1	264
RIKEN	BC008929	IRAL003C11	MGC	W01A061B11	pENTR-TOPO	22549		RAB2A	5862	AAH08929.1	Hs.369017	RAB2A, member RAS oncogene family			Skin, melanotic melanoma.	NIH_MGC_20		NM_002865.1	NP_002856.1	PROVISIONAL	OK	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC008929	IRAL003C11	MGC	W01A061B15	pENTR-TOPO	22549		RAB2A	5862	AAH08929.1	Hs.369017	RAB2A, member RAS oncogene family			Skin, melanotic melanoma.	NIH_MGC_20		NM_002865.1	NP_002856.1	PROVISIONAL	OK	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC041329	IRAK075M10	MGC	W01A061B20	pENTR-TOPO	16304		EAF1	85403	AAH41329.1	Hs.716733	ELL associated factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033083.6	NP_149074.3	VALIDATED	Cs	0.993	0.993	268	807	1	804	268	1	268
RIKEN	BC000631	IRAL005B21	MGC	W01A061B23	pENTR-TOPO	10403		GRB2	2885	AAH00631.1	Hs.444356	Growth factor receptor-bound protein 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002086.4	NP_002077.1	REVIEWED	C	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC070310	IRAL057M05	MGC	W01A061C03	pENTR-TOPO	9971		CCL4L1	9560	AAH70310.1	Hs.661942	Chemokine (C-C motif) ligand 4-like 1			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_001001435.2	NP_001001435.1	REVIEWED	Cs	0.989	0.989	92	279	1	276	92	1	92
RIKEN	BC070310	IRAL057M05	MGC	W01A061C05	pENTR-TOPO	9971		CCL4L1	9560	AAH70310.1	Hs.661942	Chemokine (C-C motif) ligand 4-like 1			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_001001435.2	NP_001001435.1	REVIEWED	Cs	0.989	0.989	92	279	1	276	92	1	92
RIKEN	BC040106	IRAK084P11	MGC	W01A061C08	pENTR-TOPO	19223		NOP16	51491	AAH40106.1	Hs.696283	NOP16 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016391.4	NP_057475.2	PROVISIONAL	OK	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC009642	IRAK014N19	MGC	W01A061C12	pENTR-TOPO	11439		FXYD5	53827	AAH09642.1	Hs.333418	FXYD domain containing ion transport regulator 5			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144779.1	NP_659003.1	REVIEWED	Cs	0.994	0.994	178	537	1	534	178	1	178
RIKEN	BC020698	IRAL037C16	MGC	W01A061C13	pENTR-TOPO	13497		CCL20	6364	AAH20698.1	Hs.75498	Chemokine (C-C motif) ligand 20			Liver	NIH_MGC_76	DH10B	NM_001130046.1	NP_001123518.1	VALIDATED	C	1.000	1.000	95	288	1	285	95	1	95
RIKEN	BC020698	IRAL037C16	MGC	W01A061C15	pENTR-TOPO	13497		CCL20	6364	AAH20698.1	Hs.75498	Chemokine (C-C motif) ligand 20			Liver	NIH_MGC_76	DH10B	NM_001130046.1	NP_001123518.1	VALIDATED	C	1.000	1.000	95	288	1	285	95	1	95
RIKEN	BC030059	IRAL042C03	MGC	W01A061C18	pENTR-TOPO	1362		RGS5	8490	AAH30059.1	Hs.24950	Regulator of G-protein signaling 5			Brain, neuroblastoma	NIH_MGC_19		NM_003617.2	NP_003608.1	VALIDATED	C	1.000	1.000	181	546	1	543	181	1	181
RIKEN	BC030059	IRAL042C03	MGC	W01A061C20	pENTR-TOPO	1362		RGS5	8490	AAH30059.1	Hs.24950	Regulator of G-protein signaling 5			Brain, neuroblastoma	NIH_MGC_19		NM_003617.2	NP_003608.1	VALIDATED	C	1.000	1.000	181	546	1	543	181	1	181
RIKEN	BC018652	IRAL002J07	MGC	W01A061C23	pENTR-TOPO	4752		FXYD6	53826	AAH18652.1	Hs.713034	FXYD domain containing ion transport regulator 6			Lung, small cell carcinoma	NIH_MGC_7		NM_022003.1	NP_071286.1	REVIEWED	OK	1.000	1.000	95	288	1	285	95	1	95
RIKEN	BC002437	IRAL005I10	MGC	W01A061D02	pENTR-TOPO	24026		EXOSC3	51010	AAH02437.1	Hs.713483	Exosome component 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_016042.2	NP_057126.2	VALIDATED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC001682	IRAL002J22	MGC	W01A061D03	pENTR-TOPO	7691		NGRN	51335	AAH01682.1	Hs.716378	Neugrin, neurite outgrowth associated			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016645.2	NP_057729.1	PROVISIONAL	OK	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC001682	IRAL002J22	MGC	W01A061D05	pENTR-TOPO	7691		NGRN	51335	AAH01682.1	Hs.716378	Neugrin, neurite outgrowth associated			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016645.2	NP_057729.1	PROVISIONAL	OK	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC001682	IRAL002J22	MGC	W01A061D07	pENTR-TOPO	7691		NGRN	51335	AAH01682.1	Hs.716378	Neugrin, neurite outgrowth associated			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_016645.2	NP_057729.1	PROVISIONAL	OK	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC002437	IRAL005I10	MGC	W01A061D08	pENTR-TOPO	24026		EXOSC3	51010	AAH02437.1	Hs.713483	Exosome component 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_016042.2	NP_057126.2	VALIDATED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC016936	IRAK027L06	MGC	W01A061D12	pENTR-TOPO	22693		OSR2	116039	AAH16936.1	Hs.253247	Odd-skipped related 2 (Drosophila)			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_053001.2	NP_443727.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
RIKEN	AK000387	flj0063k22	FLJ	W01A061D13	pENTR-TOPO	7426		CIDEB	27141	BAA91132.1	Hs.708040	Cell death-inducing DFFA-like effector b				kaia	EK1	NM_014430.2	NP_055245.2	VALIDATED	C	1.000	1.000	219	660	1	657	219	1	219
RIKEN	BC016936	IRAK027L06	MGC	W01A061D16	pENTR-TOPO	22693		OSR2	116039	AAH16936.1	Hs.253247	Odd-skipped related 2 (Drosophila)			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_053001.2	NP_443727.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
RIKEN	BC004317	IRAL013O10	MGC	W01A061D21	pENTR-TOPO	18551		NDFIP1	80762	AAH04317.1	Hs.9788	Nedd4 family interacting protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_030571.3	NP_085048.1	REVIEWED	C	1.000	1.000	221	666	1	663	221	1	221
RIKEN	H013091F03	H013091F03	RIKEN	W01A061D22	pENTR-TOPO		23734	SET	6418		Hs.609454	SET nuclear oncogene	-	-	testis	testis	DH10B	NM_003011.3	NP_003002.2	VALIDATED	C	1.000	1.000	277	834	1	831	277	1	277
RIKEN	H013091F03	H013091F03	RIKEN	W01A061D24	pENTR-TOPO		23734	SET	6418		Hs.609454	SET nuclear oncogene	-	-	testis	testis	DH10B	NM_003011.3	NP_003002.2	VALIDATED	C	1.000	1.000	277	834	1	831	277	1	277
RIKEN	BC006324	IRAL017K13	MGC	W01A061E03	pENTR-TOPO	3192		PCBD1	5092	AAH06324.1	Hs.3192	Pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000281.2	NP_000272.1	REVIEWED	C	1.000	1.000	104	315	1	312	104	1	104
RIKEN	BC005064	IRAL018C13	MGC	W01A061E04	pENTR-TOPO	11634		MPV17L2	84769	AAH05064.1	Hs.515254	MPV17 mitochondrial membrane protein-like 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_032683.2	NP_116072.2	VALIDATED	Cg	0.879	1.000	206	546	1	543	206	1	206
RIKEN	BC006324	IRAL017K13	MGC	W01A061E05	pENTR-TOPO	3192		PCBD1	5092	AAH06324.1	Hs.3192	Pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000281.2	NP_000272.1	REVIEWED	C	1.000	1.000	104	315	1	312	104	1	104
RIKEN	BC006324	IRAL017K13	MGC	W01A061E07	pENTR-TOPO	3192		PCBD1	5092	AAH06324.1	Hs.3192	Pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000281.2	NP_000272.1	REVIEWED	C	1.000	1.000	104	315	1	312	104	1	104
RIKEN	BC002802	IRAL012B12	MGC	W01A061E11	pENTR-TOPO	10274		SUPT4H1	6827	AAH02802.1	Hs.439481	Suppressor of Ty 4 homolog 1 (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_003168.1	NP_003159.1	PROVISIONAL	C	1.000	1.000	117	354	1	351	117	1	117
RIKEN	BC009841	IRAL025B12	MGC	W01A061E14	pENTR-TOPO	3176		ARL3	403	AAH09841.1	Hs.182215	ADP-ribosylation factor-like 3			Skin, melanotic melanoma.	NIH_MGC_20		NM_004311.2	NP_004302.1	REVIEWED	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	BC009361	IRAL026O14	MGC	W01A061E18	pENTR-TOPO	3182		RGS10	6001	AAH09361.1	Hs.501200	Regulator of G-protein signaling 10			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001005339.1	NP_001005339.1	REVIEWED	OK	1.000	1.000	181	546	1	543	181	1	181
RIKEN	BC025928	IRAL034O11	MGC	W01A061F05	pENTR-TOPO	22161		RP9	6100	AAH25928.2	Hs.326805	Retinitis pigmentosa 9 (autosomal dominant)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_203288.1	NP_976033.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC025928	IRAL034O11	MGC	W01A061F07	pENTR-TOPO	22161		RP9	6100	AAH25928.2	Hs.326805	Retinitis pigmentosa 9 (autosomal dominant)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_203288.1	NP_976033.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC014651	IRAL029A06	MGC	W01A061F11	pENTR-TOPO	10714		HOXB6	3216	AAH14651.1	Hs.98428	Homeobox B6			Lung, large cell carcinoma	NIH_MGC_18		NM_018952.4	NP_061825.2	REVIEWED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC008874	IRAL026M09	MGC	W01A061F12	pENTR-TOPO	7570		SIX1	6495	AAH08874.1	Hs.716658	SIX homeobox 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005982.3	NP_005973.1	REVIEWED	Cs	0.996	0.996	284	855	1	852	284	1	284
RIKEN	BC014651	IRAL029A06	MGC	W01A061F13	pENTR-TOPO	10714		HOXB6	3216	AAH14651.1	Hs.98428	Homeobox B6			Lung, large cell carcinoma	NIH_MGC_18		NM_018952.4	NP_061825.2	REVIEWED	OK	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC014967	IRAL034D01	MGC	W01A061F18	pENTR-TOPO	10314		CBX4	8535	AAH14967.1	Hs.714363	Chromobox homolog 4 (Pc class homolog, Drosophila)			Colon, adenocarcinoma	NIH_MGC_15		NM_003655.2	NP_003646.2	VALIDATED	Cg	0.518	1.000	560	873	1	870	560	1	560
RIKEN	BC014967	IRAL034D01	MGC	W01A061F20	pENTR-TOPO	10314		CBX4	8535	AAH14967.1	Hs.714363	Chromobox homolog 4 (Pc class homolog, Drosophila)			Colon, adenocarcinoma	NIH_MGC_15		NM_003655.2	NP_003646.2	VALIDATED	Cg	0.518	1.000	560	873	1	870	560	1	560
RIKEN	BC014261	IRAL030P22	MGC	W01A061G02	pENTR-TOPO	17557		RHOH	399	AAH14261.1	Hs.654594	Ras homolog gene family, member H			Primary B-Cells from Tonsils	NIH_MGC_48		NM_004310.3	NP_004301.1	VALIDATED	C	1.000	1.000	191	576	1	573	191	1	191
RIKEN	BC003582	IRAL008J14	MGC	W01A061G03	pENTR-TOPO	15674		POLR2F	5435	AAH03582.1	Hs.436578	Polymerase (RNA) II (DNA directed) polypeptide F			Placenta, choriocarcinoma	NIH_MGC_21		NM_021974.3	NP_068809.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
RIKEN	BC014261	IRAL030P22	MGC	W01A061G06	pENTR-TOPO	17557		RHOH	399	AAH14261.1	Hs.654594	Ras homolog gene family, member H			Primary B-Cells from Tonsils	NIH_MGC_48		NM_004310.3	NP_004301.1	VALIDATED	C	1.000	1.000	191	576	1	573	191	1	191
RIKEN	BC014261	IRAL030P22	MGC	W01A061G08	pENTR-TOPO	17557		RHOH	399	AAH14261.1	Hs.654594	Ras homolog gene family, member H			Primary B-Cells from Tonsils	NIH_MGC_48		NM_004310.3	NP_004301.1	VALIDATED	C	1.000	1.000	191	576	1	573	191	1	191
RIKEN	BC054021	IRAL048H16	MGC	W01A061G09	pENTR-TOPO	18696		PCBD2	84105	AAH54021.1	Hs.710014	Pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_032151.4	NP_115527.3	VALIDATED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC054021	IRAL048H16	MGC	W01A061G11	pENTR-TOPO	18696		PCBD2	84105	AAH54021.1	Hs.710014	Pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_032151.4	NP_115527.3	VALIDATED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC054021	IRAL048H16	MGC	W01A061G13	pENTR-TOPO	18696		PCBD2	84105	AAH54021.1	Hs.710014	Pterin-4 alpha-carbinolamine dehydratase/dimerization cofactor of hepatocyte nuclear factor 1 alpha (TCF1) 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_032151.4	NP_115527.3	VALIDATED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	H023062E23	H023062E23	RIKEN	W01A061G16	pENTR-TOPO		13762	ARL4C	10123		Hs.719190	ADP-ribosylation factor-like 4C	-	-	hippocampus	hippocampus	DH10B	NM_005737.3	NP_005728.2	REVIEWED	Cs	0.995	0.995	192	579	1	576	192	1	192
RIKEN	BC014469	IRAL034L10	MGC	W01A061G19	pENTR-TOPO	24041		CDKN2B	1030	AAH14469.1	Hs.72901	Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_004936.3	NP_004927.2	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
RIKEN	AK055073	flj0001c16	FLJ	W01A061G20	pENTR-TOPO	22983		NCALD	83988	BAG51461.1	Hs.680132	Neurocalcin delta				BRAWH2	EK1	NM_001040625.1	NP_001035715.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	AK055073	flj0001c16	FLJ	W01A061G22	pENTR-TOPO	22983		NCALD	83988	BAG51461.1	Hs.680132	Neurocalcin delta				BRAWH2	EK1	NM_001040625.1	NP_001035715.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC014469	IRAL034L10	MGC	W01A061G23	pENTR-TOPO	24041		CDKN2B	1030	AAH14469.1	Hs.72901	Cyclin-dependent kinase inhibitor 2B (p15, inhibits CDK4)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_004936.3	NP_004927.2	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
RIKEN	AK055073	flj0001c16	FLJ	W01A061G24	pENTR-TOPO	22983		NCALD	83988	BAG51461.1	Hs.680132	Neurocalcin delta				BRAWH2	EK1	NM_001040625.1	NP_001035715.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC014451	IRAL034P14	MGC	W01A061H09	pENTR-TOPO	14793		PROCR	10544	AAH14451.1	Hs.647450	Protein C receptor, endothelial (EPCR)			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006404.3	NP_006395.2	REVIEWED	Cs	0.996	0.996	238	717	1	714	238	1	238
RIKEN	BC014451	IRAL034P14	MGC	W01A061H13	pENTR-TOPO	14793		PROCR	10544	AAH14451.1	Hs.647450	Protein C receptor, endothelial (EPCR)			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006404.3	NP_006395.2	REVIEWED	Cs	0.996	0.996	238	717	1	714	238	1	238
RIKEN	BC014991	IRAL034P03	MGC	W01A061H16	pENTR-TOPO	8898		MPG	4350	AAH14991.1	Hs.459596	N-methylpurine-DNA glycosylase			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_001015052.1	NP_001015052.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
RIKEN	BC001116	IRAL003P13	MGC	W01A061I06	pENTR-TOPO	23967		AK1	203	AAH01116.1	Hs.175473	Adenylate kinase 1			Colon, adenocarcinoma	NIH_MGC_15		NM_000476.2	NP_000467.1	REVIEWED	Cs	0.995	0.995	194	585	1	582	194	1	194
RIKEN	BC080180	IRAL059F20	MGC	W01A061I09	pENTR-TOPO	12110		GMFG	9535	AAH80180.1	Hs.5210	Glia maturation factor, gamma			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_004877.2	NP_004868.1	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
RIKEN	BC029554	IRAK063G23	MGC	W01A061I14	pENTR-TOPO	5937		CLEC1B	51266	AAH29554.1	Hs.409794	C-type lectin domain family 1, member B			Testis	NIH_MGC_97	DH10B	NM_001099431.1	NP_001092901.1	VALIDATED	Cs	0.990	0.990	196	591	1	588	196	1	196
RIKEN	BC029554	IRAK063G23	MGC	W01A061I16	pENTR-TOPO	5937		CLEC1B	51266	AAH29554.1	Hs.409794	C-type lectin domain family 1, member B			Testis	NIH_MGC_97	DH10B	NM_001099431.1	NP_001092901.1	VALIDATED	Cs	0.990	0.990	196	591	1	588	196	1	196
RIKEN	BC010947	IRAL019M11	MGC	W01A061I19	pENTR-TOPO	18860		SRP19	6728	AAH10947.1	Hs.637001	Signal recognition particle 19kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003135.1	NP_003126.1	PROVISIONAL	Cs	0.993	0.993	144	435	1	432	144	1	144
RIKEN	BC010947	IRAL019M11	MGC	W01A061I23	pENTR-TOPO	18860		SRP19	6728	AAH10947.1	Hs.637001	Signal recognition particle 19kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003135.1	NP_003126.1	PROVISIONAL	Cs	0.993	0.993	144	435	1	432	144	1	144
RIKEN	BC001459	IRAL004H19	MGC	W01A061J01	pENTR-TOPO	7912		RAD51	5888	AAH01459.1	Hs.631709	RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_133487.2	NP_597994.2	REVIEWED	Cs	0.992	0.992	242	729	1	726	242	1	242
RIKEN	BC001459	IRAL004H19	MGC	W01A061J07	pENTR-TOPO	7912		RAD51	5888	AAH01459.1	Hs.631709	RAD51 homolog (RecA homolog, E. coli) (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_21		NM_133487.2	NP_597994.2	REVIEWED	Cs	0.992	0.992	242	729	1	726	242	1	242
RIKEN	BC003101	IRAL006I06	MGC	W01A061J11	pENTR-TOPO	21409		CPSF4	10898	AAH03101.1	Hs.489287	Cleavage and polyadenylation specific factor 4, 30kDa			Eye, retinoblastoma	NIH_MGC_16		NM_001081559.1	NP_001075028.1	VALIDATED	OK	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC064540	IRAK139G20	MGC	W01A061J14	pENTR-TOPO	9382		FANCA	2175	AAH64540.1	Hs.719210	Fanconi anemia, complementation group A			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001018112.1	NP_001018122.1	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
RIKEN	BC003101	IRAL006I06	MGC	W01A061J15	pENTR-TOPO	21409		CPSF4	10898	AAH03101.1	Hs.489287	Cleavage and polyadenylation specific factor 4, 30kDa			Eye, retinoblastoma	NIH_MGC_16		NM_001081559.1	NP_001075028.1	VALIDATED	OK	1.000	1.000	244	735	1	732	244	1	244
RIKEN	AK027384	flj0030b22	FLJ	W01A061J17	pENTR-TOPO	11020		ZNF397	84307	BAB55075.1	Hs.591061	Zinc finger protein 397				MAMMA1	EK1	NM_032347.1	NP_115723.1	VALIDATED	Cgs	0.887	0.996	275	738	1	735	275	1	275
RIKEN	BC015467	IRAK020O12	MGC	W01A061J20	pENTR-TOPO	16945		ZDHHC3	51304	AAH15467.1	Hs.61430	Zinc finger, DHHC-type containing 3			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135179.1	NP_001128651.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC015467	IRAK020O12	MGC	W01A061J22	pENTR-TOPO	16945		ZDHHC3	51304	AAH15467.1	Hs.61430	Zinc finger, DHHC-type containing 3			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135179.1	NP_001128651.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	AK027384	flj0030b22	FLJ	W01A061J23	pENTR-TOPO	11020		ZNF397	84307	BAB55075.1	Hs.591061	Zinc finger protein 397				MAMMA1	EK1	NM_032347.1	NP_115723.1	VALIDATED	Cgs	0.887	0.996	275	738	1	735	275	1	275
RIKEN	BC003366	IRAK003A15	MGC	W01A061K05	pENTR-TOPO	9165		CARHSP1	23589	AAH03366.1	Hs.632184	Calcium regulated heat stable protein 1, 24kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001042476.1	NP_001035941.1	VALIDATED	C	1.000	1.000	147	444	1	441	147	1	147
RIKEN	BC007319	IRAL003E12	MGC	W01A061K06	pENTR-TOPO	21145		YKT6	10652	AAH07319.1	Hs.520794	YKT6 v-SNARE homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006555.3	NP_006546.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC007319	IRAL003E12	MGC	W01A061K08	pENTR-TOPO	21145		YKT6	10652	AAH07319.1	Hs.520794	YKT6 v-SNARE homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006555.3	NP_006546.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC003105	IRAL006A14	MGC	W01A061K09	pENTR-TOPO	22537		PTP4A3	11156	AAH03105.1	Hs.43666	Protein tyrosine phosphatase type IVA, member 3			Eye, retinoblastoma	NIH_MGC_16		NM_007079.2	NP_009010.2	REVIEWED	C	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC012506	IRAK028D14	MGC	W01A061K10	pENTR-TOPO	12685		IL11	3589	AAH12506.1	Hs.467304	Interleukin 11			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_000641.2	NP_000632.1	REVIEWED	Cs	0.995	0.995	199	600	1	597	199	1	199
RIKEN	BC003105	IRAL006A14	MGC	W01A061K11	pENTR-TOPO	22537		PTP4A3	11156	AAH03105.1	Hs.43666	Protein tyrosine phosphatase type IVA, member 3			Eye, retinoblastoma	NIH_MGC_16		NM_007079.2	NP_009010.2	REVIEWED	C	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC012506	IRAK028D14	MGC	W01A061K12	pENTR-TOPO	12685		IL11	3589	AAH12506.1	Hs.467304	Interleukin 11			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_000641.2	NP_000632.1	REVIEWED	Cs	0.995	0.995	199	600	1	597	199	1	199
RIKEN	BC003105	IRAL006A14	MGC	W01A061K13	pENTR-TOPO	22537		PTP4A3	11156	AAH03105.1	Hs.43666	Protein tyrosine phosphatase type IVA, member 3			Eye, retinoblastoma	NIH_MGC_16		NM_007079.2	NP_009010.2	REVIEWED	C	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC012506	IRAK028D14	MGC	W01A061K14	pENTR-TOPO	12685		IL11	3589	AAH12506.1	Hs.467304	Interleukin 11			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_000641.2	NP_000632.1	REVIEWED	Cs	0.995	0.995	199	600	1	597	199	1	199
RIKEN	BC003105	IRAL006A14	MGC	W01A061K15	pENTR-TOPO	22537		PTP4A3	11156	AAH03105.1	Hs.43666	Protein tyrosine phosphatase type IVA, member 3			Eye, retinoblastoma	NIH_MGC_16		NM_007079.2	NP_009010.2	REVIEWED	C	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC065831	IRAK141L11	MGC	W01A061L01	pENTR-TOPO	7070		SIX6	4990	AAH65831.1	Hs.194756	SIX homeobox 6			Pituitary	NIH_MGC_179	DH10B	NM_007374.2	NP_031400.2	REVIEWED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC002730	IRAL012G16	MGC	W01A061L02	pENTR-TOPO	1574		DHRS3	9249	AAH02730.1	Hs.289347	Dehydrogenase/reductase (SDR family) member 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_004753.4	NP_004744.2	VALIDATED	C	1.000	1.000	302	909	1	906	302	1	302
RIKEN	BC065831	IRAK141L11	MGC	W01A061L03	pENTR-TOPO	7070		SIX6	4990	AAH65831.1	Hs.194756	SIX homeobox 6			Pituitary	NIH_MGC_179	DH10B	NM_007374.2	NP_031400.2	REVIEWED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC065831	IRAK141L11	MGC	W01A061L07	pENTR-TOPO	7070		SIX6	4990	AAH65831.1	Hs.194756	SIX homeobox 6			Pituitary	NIH_MGC_179	DH10B	NM_007374.2	NP_031400.2	REVIEWED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC007781	IRAL017P04	MGC	W01A061L11	pENTR-TOPO	5906		ING4	51147	AAH07781.1	Hs.524210	Inhibitor of growth family, member 4			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001127582.1	NP_001121054.1	REVIEWED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC017227	IRAL020B04	MGC	W01A061L12	pENTR-TOPO	24053		PDCL	5082	AAH17227.1	Hs.271749	Phosducin-like			Ovary, adenocarcinoma	NIH_MGC_9		NM_005388.3	NP_005379.3	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
RIKEN	BC007781	IRAL017P04	MGC	W01A061L15	pENTR-TOPO	5906		ING4	51147	AAH07781.1	Hs.524210	Inhibitor of growth family, member 4			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001127582.1	NP_001121054.1	REVIEWED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	AK074641	flj0017h10	FLJ	W01A061L22	pENTR-TOPO	23035		HEY1	23462	BAG51980.1	Hs.234434	Hairy/enhancer-of-split related with YRPW motif 1				HEMBB1	EK1	NM_012258.3	NP_036390.3	REVIEWED	Cs	0.997	0.997	304	915	1	912	304	1	304
RIKEN	AK074641	flj0017h10	FLJ	W01A061L24	pENTR-TOPO	23035		HEY1	23462	BAG51980.1	Hs.234434	Hairy/enhancer-of-split related with YRPW motif 1				HEMBB1	EK1	NM_012258.3	NP_036390.3	REVIEWED	Cs	0.997	0.997	304	915	1	912	304	1	304
RIKEN	BC005319	IRAL016N07	MGC	W01A061M01	pENTR-TOPO	18248		GYPA	2993	AAH05319.1	Hs.434973	Glycophorin A (MNS blood group)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_002099.4	NP_002090.2	REVIEWED	Cs	0.993	0.993	150	453	1	450	150	1	150
RIKEN	BC008796	IRAL012P13	MGC	W01A061M04	pENTR-TOPO	4095		CCDC85B	11007	AAH08796.1	Hs.66713	Coiled-coil domain containing 85B			Skin, melanotic melanoma.	NIH_MGC_20		NM_006848.2	NP_006839.2	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC005319	IRAL016N07	MGC	W01A061M05	pENTR-TOPO	18248		GYPA	2993	AAH05319.1	Hs.434973	Glycophorin A (MNS blood group)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_002099.4	NP_002090.2	REVIEWED	Cs	0.993	0.993	150	453	1	450	150	1	150
RIKEN	BC008796	IRAL012P13	MGC	W01A061M06	pENTR-TOPO	4095		CCDC85B	11007	AAH08796.1	Hs.66713	Coiled-coil domain containing 85B			Skin, melanotic melanoma.	NIH_MGC_20		NM_006848.2	NP_006839.2	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC005319	IRAL016N07	MGC	W01A061M07	pENTR-TOPO	18248		GYPA	2993	AAH05319.1	Hs.434973	Glycophorin A (MNS blood group)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_002099.4	NP_002090.2	REVIEWED	Cs	0.993	0.993	150	453	1	450	150	1	150
RIKEN	AK000501	flj0060p10	FLJ	W01A061M09	pENTR-TOPO	25169		NDUFB11	54539	BAA91208.1	Hs.521969	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa				KAT	EK1	NM_001135998.1	NP_001129470.1	VALIDATED	OK	1.000	1.000	153	462	1	459	153	1	153
RIKEN	AK000501	flj0060p10	FLJ	W01A061M13	pENTR-TOPO	25169		NDUFB11	54539	BAA91208.1	Hs.521969	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 11, 17.3kDa				KAT	EK1	NM_001135998.1	NP_001129470.1	VALIDATED	OK	1.000	1.000	153	462	1	459	153	1	153
RIKEN	BC007422	IRAL010C24	MGC	W01A061M17	pENTR-TOPO	13039		ACP1	52	AAH07422.1	Hs.558296	Acid phosphatase 1, soluble			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007099.3	NP_009030.1	REVIEWED	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC007422	IRAL010C24	MGC	W01A061M19	pENTR-TOPO	13039		ACP1	52	AAH07422.1	Hs.558296	Acid phosphatase 1, soluble			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007099.3	NP_009030.1	REVIEWED	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC007422	IRAL010C24	MGC	W01A061M21	pENTR-TOPO	13039		ACP1	52	AAH07422.1	Hs.558296	Acid phosphatase 1, soluble			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007099.3	NP_009030.1	REVIEWED	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC008792	IRAL012B23	MGC	W01A061M22	pENTR-TOPO	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC008792	IRAL012B23	MGC	W01A061M24	pENTR-TOPO	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC011732	IRAL027P09	MGC	W01A061N04	pENTR-TOPO	21273		GIMAP5	55340	AAH11732.1	Hs.647079	GTPase, IMAP family member 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_018384.3	NP_060854.2	REVIEWED	C	1.000	1.000	307	924	1	921	307	1	307
RIKEN	BC032549	IRAK069M03	MGC	W01A061N07	pENTR-TOPO	4907		POU2AF1	5450	AAH32549.1	Hs.654525	POU class 2 associating factor 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_006235.2	NP_006226.2	VALIDATED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC066913	IRAK167J01	MGC	W01A061N11	pENTR-TOPO	8552		RAB26	25837	AAH66913.1	Hs.3797	RAB26, member RAS oncogene family			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014353.4	NP_055168.2	VALIDATED	Cs	0.996	0.996	256	771	1	768	256	1	256
RIKEN	BC066913	IRAK167J01	MGC	W01A061N13	pENTR-TOPO	8552		RAB26	25837	AAH66913.1	Hs.3797	RAB26, member RAS oncogene family			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014353.4	NP_055168.2	VALIDATED	Cs	0.996	0.996	256	771	1	768	256	1	256
RIKEN	BC000052	IRAL007B07	MGC	W01A061N17	pENTR-TOPO	15521		PPARA	5465	AAH00052	Hs.710044	Peroxisome proliferator-activated receptor alpha			Placenta, choriocarcinoma	NIH_MGC_21		NM_001001928.2	NP_001001928.1	REVIEWED	P	1.000	1.000	237	777	1	711	468	1	237
RIKEN	BC018788	IRAL006D06	MGC	W01A061N18	pENTR-TOPO	23582		HABP4	22927	AAH18788.1	Hs.494567	Hyaluronan binding protein 4			Brain, neuroblastoma	NIH_MGC_19		NM_014282.2	NP_055097.2	VALIDATED	Cg	0.746	1.000	413	927	1	924	413	1	413
RIKEN	BC000052	IRAL007B07	MGC	W01A061N19	pENTR-TOPO	15521		PPARA	5465	AAH00052	Hs.710044	Peroxisome proliferator-activated receptor alpha			Placenta, choriocarcinoma	NIH_MGC_21		NM_001001928.2	NP_001001928.1	REVIEWED	P	1.000	1.000	237	777	1	711	468	1	237
RIKEN	BC018788	IRAL006D06	MGC	W01A061N20	pENTR-TOPO	23582		HABP4	22927	AAH18788.1	Hs.494567	Hyaluronan binding protein 4			Brain, neuroblastoma	NIH_MGC_19		NM_014282.2	NP_055097.2	VALIDATED	Cg	0.746	1.000	413	927	1	924	413	1	413
RIKEN	BC000052	IRAL007B07	MGC	W01A061N21	pENTR-TOPO	15521		PPARA	5465	AAH00052	Hs.710044	Peroxisome proliferator-activated receptor alpha			Placenta, choriocarcinoma	NIH_MGC_21		NM_001001928.2	NP_001001928.1	REVIEWED	P	1.000	1.000	237	777	1	711	468	1	237
RIKEN	BC018788	IRAL006D06	MGC	W01A061N22	pENTR-TOPO	23582		HABP4	22927	AAH18788.1	Hs.494567	Hyaluronan binding protein 4			Brain, neuroblastoma	NIH_MGC_19		NM_014282.2	NP_055097.2	VALIDATED	Cg	0.746	1.000	413	927	1	924	413	1	413
RIKEN	AK075420	flj0027m14	FLJ	W01A061O02	pENTR-TOPO	4738		TMEM123	114908	BAC11610.1	Hs.503709	Transmembrane protein 123	NT2	teratocarcinoma		NT2RP2	EK1	NM_052932.2	NP_443164.2	REVIEWED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC014941	IRAL029B02	MGC	W01A061O03	pENTR-TOPO	20086		ID4	3400	AAH14941.1	Hs.519601	Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001546.2	NP_001537.1	PROVISIONAL	OK	1.000	1.000	161	486	1	483	161	1	161
RIKEN	AK075420	flj0027m14	FLJ	W01A061O06	pENTR-TOPO	4738		TMEM123	114908	BAC11610.1	Hs.503709	Transmembrane protein 123	NT2	teratocarcinoma		NT2RP2	EK1	NM_052932.2	NP_443164.2	REVIEWED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC014941	IRAL029B02	MGC	W01A061O07	pENTR-TOPO	20086		ID4	3400	AAH14941.1	Hs.519601	Inhibitor of DNA binding 4, dominant negative helix-loop-helix protein			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001546.2	NP_001537.1	PROVISIONAL	OK	1.000	1.000	161	486	1	483	161	1	161
RIKEN	BC012327	IRAL029K02	MGC	W01A061O09	pENTR-TOPO	10348		MAFG	4097	AAH12327.1	Hs.252229	V-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)			Lung, large cell carcinoma	NIH_MGC_18		NM_032711.2	NP_116100.2	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC012798	IRAL007P17	MGC	W01A061O10	pENTR-TOPO	8640		NOL3	8996	AAH12798.1	Hs.513667	Nucleolar protein 3 (apoptosis repressor with CARD domain)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003946.3	NP_003937.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC012798	IRAL007P17	MGC	W01A061O12	pENTR-TOPO	8640		NOL3	8996	AAH12798.1	Hs.513667	Nucleolar protein 3 (apoptosis repressor with CARD domain)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003946.3	NP_003937.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC012798	IRAL007P17	MGC	W01A061O14	pENTR-TOPO	8640		NOL3	8996	AAH12798.1	Hs.513667	Nucleolar protein 3 (apoptosis repressor with CARD domain)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003946.3	NP_003937.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC012327	IRAL029K02	MGC	W01A061O15	pENTR-TOPO	10348		MAFG	4097	AAH12327.1	Hs.252229	V-maf musculoaponeurotic fibrosarcoma oncogene homolog G (avian)			Lung, large cell carcinoma	NIH_MGC_18		NM_032711.2	NP_116100.2	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC012798	IRAL007P17	MGC	W01A061O16	pENTR-TOPO	8640		NOL3	8996	AAH12798.1	Hs.513667	Nucleolar protein 3 (apoptosis repressor with CARD domain)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003946.3	NP_003937.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC000334	IRAL001I15	MGC	W01A061O22	pENTR-TOPO	4063		FADD	8772	AAH00334.1	Hs.86131	Fas (TNFRSF6)-associated via death domain			Lung, small cell carcinoma	NIH_MGC_7		NM_003824.3	NP_003815.1	REVIEWED	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC001822	IRAL011M13	MGC	W01A061O23	pENTR-TOPO	12661		CDKN2D	1032	AAH01822.1	Hs.435051	Cyclin-dependent kinase inhibitor 2D (p19, inhibits CDK4)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001800.3	NP_001791.1	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
RIKEN	AK057521	flj0007b03	FLJ	W01A061P09	pENTR-TOPO	7838		MAP2K5	5607	BAG51927.1	Hs.114198	Mitogen-activated protein kinase kinase 5				TESTI2	EK1	NM_145160.1	NP_660143.1	REVIEWED	Ps	0.992	0.992	254	777	13	774	448	195	448
RIKEN	AK057521	flj0007b03	FLJ	W01A061P11	pENTR-TOPO	7838		MAP2K5	5607	BAG51927.1	Hs.114198	Mitogen-activated protein kinase kinase 5				TESTI2	EK1	NM_145160.1	NP_660143.1	REVIEWED	Ps	0.992	0.992	254	777	13	774	448	195	448
RIKEN	BC012460	IRAK028C03	MGC	W01A061P17	pENTR-TOPO	9915		LASP1	3927	AAH12460.1					Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006148.2	NP_006139.1	VALIDATED	Cs	0.989	0.989	261	786	1	783	261	1	261
RIKEN	BC012460	IRAK028C03	MGC	W01A061P23	pENTR-TOPO	9915		LASP1	3927	AAH12460.1					Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006148.2	NP_006139.1	VALIDATED	Cs	0.989	0.989	261	786	1	783	261	1	261
RIKEN	BC067361	IRAL050N15	MGC	W01A062A05	pENTR-TOPO	14803		SOX12	6666	AAH67361.1	Hs.43627	SRY (sex determining region Y)-box 12			Prostate, carcinoma	NIH_MGC_40		NM_006943.2	NP_008874.2	REVIEWED	OK	1.000	1.000	315	948	1	945	315	1	315
RIKEN	BC067361	IRAL050N15	MGC	W01A062A07	pENTR-TOPO	14803		SOX12	6666	AAH67361.1	Hs.43627	SRY (sex determining region Y)-box 12			Prostate, carcinoma	NIH_MGC_40		NM_006943.2	NP_008874.2	REVIEWED	OK	1.000	1.000	315	948	1	945	315	1	315
RIKEN	BC014191	IRAL030O16	MGC	W01A062A08	pENTR-TOPO	14955		SLC35C2	51006	AAH14191.1	Hs.655501	Solute carrier family 35, member C2			Brain, neuroblastoma	NIH_MGC_47		NM_173073.2	NP_775096.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	BC000657	IRAL005B24	MGC	W01A062A12	pENTR-TOPO	16064		OGG1	4968	AAH00657.1	Hs.380271	8-oxoguanine DNA glycosylase			Eye, retinoblastoma	NIH_MGC_16		NM_002542.5	NP_002533.1	REVIEWED	Cs	0.997	0.997	345	1038	1	1035	345	1	345
RIKEN	AK094301	flj0023k12	FLJ	W01A062A15	pENTR-TOPO	15205		PCBP3	54039	BAC04327.2	Hs.474049	Poly(rC) binding protein 3				BRACE2	EK1	NM_020528.2	NP_065389.2	REVIEWED	Pg	0.941	1.000	339	960	1	957	371	33	371
RIKEN	AK057441	flj0005p07	FLJ	W01A062A20	pENTR-TOPO	24733		MAGEB3	4114	BAG51914.1	Hs.113290	Melanoma antigen family B, 3				TESTI2	EK1	NM_002365.3	NP_002356.2	REVIEWED	Cs	0.994	0.994	346	1041	1	1038	346	1	346
RIKEN	AK057441	flj0005p07	FLJ	W01A062A24	pENTR-TOPO	24733		MAGEB3	4114	BAG51914.1	Hs.113290	Melanoma antigen family B, 3				TESTI2	EK1	NM_002365.3	NP_002356.2	REVIEWED	Cs	0.994	0.994	346	1041	1	1038	346	1	346
RIKEN	BC012604	IRAL019L24	MGC	W01A062B03	pENTR-TOPO	911		RTCD1	8634	AAH12604.1	Hs.484222	RNA terminal phosphate cyclase domain 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001130841.1	NP_001124313.1	VALIDATED	Cs	0.997	0.997	379	1140	1	1137	379	1	379
RIKEN	BC038238	IRAK079L20	MGC	W01A062B04	pENTR-TOPO	17566		STK32B	55351	AAH38238.1	Hs.133062	Serine/threonine kinase 32B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018401.1	NP_060871.1	PROVISIONAL	Cs	0.998	0.998	414	1245	1	1242	414	1	414
RIKEN	AK091687	flj0017o09	FLJ	W01A062B10	pENTR-TOPO	25319		ZNF75D	7626	BAG52399.1	Hs.533540	Zinc finger protein 75D				FEBRA2	EK1	NM_007131.2	NP_009062.2	VALIDATED	Cgs	0.812	0.998	510	1248	1	1245	510	1	510
RIKEN	AK091687	flj0017o09	FLJ	W01A062B12	pENTR-TOPO	25319		ZNF75D	7626	BAG52399.1	Hs.533540	Zinc finger protein 75D				FEBRA2	EK1	NM_007131.2	NP_009062.2	VALIDATED	Cgs	0.812	0.998	510	1248	1	1245	510	1	510
RIKEN	AK129503	flj0062c05	FLJ	W01A062B13	pENTR-TOPO	10497		KRT25	147183	BAC85169.1	Hs.55412	Keratin 25				DMC	EK1	NM_181534.3	NP_853512.1	VALIDATED	Cgs	0.840	0.997	450	1140	1	1137	450	1	450
RIKEN	AK091687	flj0017o09	FLJ	W01A062B14	pENTR-TOPO	25319		ZNF75D	7626	BAG52399.1	Hs.533540	Zinc finger protein 75D				FEBRA2	EK1	NM_007131.2	NP_009062.2	VALIDATED	Cgs	0.812	0.998	510	1248	1	1245	510	1	510
RIKEN	BC004490	IRAL014O17	MGC	W01A062B19	pENTR-TOPO	7146		FOS	2353	AAH04490.1	Hs.707896	V-fos FBJ murine osteosarcoma viral oncogene homolog			Pancreas, adenocarcinoma	NIH_MGC_39		NM_005252.2	NP_005243.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC004490	IRAL014O17	MGC	W01A062B21	pENTR-TOPO	7146		FOS	2353	AAH04490.1	Hs.707896	V-fos FBJ murine osteosarcoma viral oncogene homolog			Pancreas, adenocarcinoma	NIH_MGC_39		NM_005252.2	NP_005243.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC004490	IRAL014O17	MGC	W01A062B23	pENTR-TOPO	7146		FOS	2353	AAH04490.1	Hs.707896	V-fos FBJ murine osteosarcoma viral oncogene homolog			Pancreas, adenocarcinoma	NIH_MGC_39		NM_005252.2	NP_005243.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC004421	IRAL006A21	MGC	W01A062C01	pENTR-TOPO	17562		ZNF330	27309	AAH04421.1	Hs.120766	Zinc finger protein 330			Eye, retinoblastoma	NIH_MGC_16		NM_014487.4	NP_055302.1	VALIDATED	C	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC030692	IRAK033M21	MGC	W01A062C04	pENTR-TOPO	24023		ELAVL2	1993	AAH30692.1	Hs.166109	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 2 (Hu antigen B)			Testis	NIH_MGC_97	DH10B	NM_004432.2	NP_004423.2	VALIDATED	Cg	0.964	1.000	359	1041	1	1038	359	1	359
RIKEN	BC004421	IRAL006A21	MGC	W01A062C07	pENTR-TOPO	17562		ZNF330	27309	AAH04421.1	Hs.120766	Zinc finger protein 330			Eye, retinoblastoma	NIH_MGC_16		NM_014487.4	NP_055302.1	VALIDATED	C	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC039814	IRAK084P17	MGC	W01A062C09	pENTR-TOPO	1510		ZRANB2	9406	AAH39814.1	Hs.194718	Zinc finger, RAN-binding domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005455.3	NP_005446.2	VALIDATED	Cs	0.997	0.997	320	963	1	960	320	1	320
RIKEN	BC039814	IRAK084P17	MGC	W01A062C11	pENTR-TOPO	1510		ZRANB2	9406	AAH39814.1	Hs.194718	Zinc finger, RAN-binding domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005455.3	NP_005446.2	VALIDATED	Cs	0.997	0.997	320	963	1	960	320	1	320
RIKEN	BC039814	IRAK084P17	MGC	W01A062C13	pENTR-TOPO	1510		ZRANB2	9406	AAH39814.1	Hs.194718	Zinc finger, RAN-binding domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005455.3	NP_005446.2	VALIDATED	Cs	0.997	0.997	320	963	1	960	320	1	320
RIKEN	BC064493	IRAL050F05	MGC	W01A062C17	pENTR-TOPO	4137		MYOD1	4654	AAH64493.1	Hs.181768	Myogenic differentiation 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002478.4	NP_002469.2	REVIEWED	OK	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC015803	IRAK015M21	MGC	W01A062C20	pENTR-TOPO	18269		IRF2	3660	AAH15803.1	Hs.654566	Interferon regulatory factor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002199.3	NP_002190.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC015803	IRAK015M21	MGC	W01A062C22	pENTR-TOPO	18269		IRF2	3660	AAH15803.1	Hs.654566	Interferon regulatory factor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002199.3	NP_002190.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC064493	IRAL050F05	MGC	W01A062C23	pENTR-TOPO	4137		MYOD1	4654	AAH64493.1	Hs.181768	Myogenic differentiation 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002478.4	NP_002469.2	REVIEWED	OK	1.000	1.000	320	963	1	960	320	1	320
RIKEN	BC015803	IRAK015M21	MGC	W01A062C24	pENTR-TOPO	18269		IRF2	3660	AAH15803.1	Hs.654566	Interferon regulatory factor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002199.3	NP_002190.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC009567	IRAL016P20	MGC	W01A062D06	pENTR-TOPO	24284		BAAT	570	AAH09567.1	Hs.284712	Bile acid Coenzyme A: amino acid N-acyltransferase (glycine N-choloyltransferase)			Liver	NIH_MGC_76	DH10B	NM_001701.3	NP_001692.1	REVIEWED	Cs	0.998	0.998	418	1257	1	1254	418	1	418
RIKEN	BC002763	IRAL012O12	MGC	W01A062D11	pENTR-TOPO	17176		PRKAR2A	5576	AAH02763.1	Hs.631923	Protein kinase, cAMP-dependent, regulatory, type II, alpha			Placenta, choriocarcinoma	NIH_MGC_21		NM_004157.2	NP_004148.1	REVIEWED	Cg	0.946	1.000	404	1149	1	1146	404	1	404
RIKEN	BC001283	IRAK004B16	MGC	W01A062D20	pENTR-TOPO	24248		NFIB	4781	AAH01283.1	Hs.644095	Nuclear factor I/B			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005596.2	NP_005587.2	VALIDATED	C	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	BC002560	IRAL004N01	MGC	W01A062D21	pENTR-TOPO	15373		DNMT3L	29947	AAH02560.1	Hs.592165	DNA (cytosine-5-)-methyltransferase 3-like			Placenta, choriocarcinoma	NIH_MGC_21		NM_175867.1	NP_787063.1	REVIEWED	Cs	0.997	0.997	386	1161	1	1158	386	1	386
RIKEN	BC002560	IRAL004N01	MGC	W01A062D23	pENTR-TOPO	15373		DNMT3L	29947	AAH02560.1	Hs.592165	DNA (cytosine-5-)-methyltransferase 3-like			Placenta, choriocarcinoma	NIH_MGC_21		NM_175867.1	NP_787063.1	REVIEWED	Cs	0.997	0.997	386	1161	1	1158	386	1	386
RIKEN	BC001283	IRAK004B16	MGC	W01A062D24	pENTR-TOPO	24248		NFIB	4781	AAH01283.1	Hs.644095	Nuclear factor I/B			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005596.2	NP_005587.2	VALIDATED	C	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	AK126349	flj0070g02	FLJ	W01A062E03	pENTR-TOPO	16948		CD200R1	131450	BAG54311.1	Hs.309158	CD200 receptor 1				TRACH3	EK1	NM_170780.2	NP_740750.1	REVIEWED	Cs	0.988	0.988	325	978	1	975	325	1	325
RIKEN	BC001800	IRAL006F13	MGC	W01A062E11	pENTR-TOPO	19412		OTP	23440	AAH01800.1	Hs.202247	Orthopedia homeobox			Eye, retinoblastoma	NIH_MGC_16		NM_032109.2	NP_115485.1	REVIEWED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	AK075130	flj0019i11	FLJ	W01A062E12	pENTR-TOPO	14138		GPR1	2825	BAG52070.1	Hs.184907	G protein-coupled receptor 1				PLACE1	EK1	NM_001098199.1	NP_001091669.1	VALIDATED	Cs	0.997	0.997	355	1068	1	1065	355	1	355
RIKEN	BC001800	IRAL006F13	MGC	W01A062E15	pENTR-TOPO	19412		OTP	23440	AAH01800.1	Hs.202247	Orthopedia homeobox			Eye, retinoblastoma	NIH_MGC_16		NM_032109.2	NP_115485.1	REVIEWED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	AK075130	flj0019i11	FLJ	W01A062E16	pENTR-TOPO	14138		GPR1	2825	BAG52070.1	Hs.184907	G protein-coupled receptor 1				PLACE1	EK1	NM_001098199.1	NP_001091669.1	VALIDATED	Cs	0.997	0.997	355	1068	1	1065	355	1	355
RIKEN	BC000313	IRAL001E13	MGC	W01A062F12	pENTR-TOPO	11159		NOL4	8715	AAH00313.1	Hs.514795	Nucleolar protein 4			Lung, small cell carcinoma	NIH_MGC_7		NM_003787.3	NP_003778.2	VALIDATED	Pg	0.805	1.000	524	1269	1	1266	638	115	638
RIKEN	BC000313	IRAL001E13	MGC	W01A062F16	pENTR-TOPO	11159		NOL4	8715	AAH00313.1	Hs.514795	Nucleolar protein 4			Lung, small cell carcinoma	NIH_MGC_7		NM_003787.3	NP_003778.2	VALIDATED	Pg	0.805	1.000	524	1269	1	1266	638	115	638
RIKEN	BC009376	IRAL026D17	MGC	W01A062F19	pENTR-TOPO	10405		CBX8	57332	AAH09376.1	Hs.387258	Chromobox homolog 8 (Pc class homolog, Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_020649.1	NP_065700.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
RIKEN	BC009376	IRAL026D17	MGC	W01A062F21	pENTR-TOPO	10405		CBX8	57332	AAH09376.1	Hs.387258	Chromobox homolog 8 (Pc class homolog, Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_020649.1	NP_065700.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
RIKEN	BC024208	IRAL010A15	MGC	W01A062F22	pENTR-TOPO	7410		RBM23	55147	AAH24208.1	Hs.4997	RNA binding motif protein 23			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018107.4	NP_060577.3	REVIEWED	C	1.000	1.000	423	1272	1	1269	423	1	423
RIKEN	BC009376	IRAL026D17	MGC	W01A062F23	pENTR-TOPO	10405		CBX8	57332	AAH09376.1	Hs.387258	Chromobox homolog 8 (Pc class homolog, Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_020649.1	NP_065700.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
RIKEN	BC047870	IRAK107I07	MGC	W01A062G02	pENTR-TOPO	10742		SKAP1	8631	AAH47870.1	Hs.316931	Src kinase associated phosphoprotein 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001075099.1	NP_001068567.1	REVIEWED	OK	1.000	1.000	358	1077	1	1074	358	1	358
RIKEN	BC047870	IRAK107I07	MGC	W01A062G08	pENTR-TOPO	10742		SKAP1	8631	AAH47870.1	Hs.316931	Src kinase associated phosphoprotein 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001075099.1	NP_001068567.1	REVIEWED	OK	1.000	1.000	358	1077	1	1074	358	1	358
RIKEN	BC014388	IRAL007M23	MGC	W01A062G10	pENTR-TOPO	4531		FIBP	9158	AAH14388.1	Hs.7768	Fibroblast growth factor (acidic) intracellular binding protein			Placenta, choriocarcinoma	NIH_MGC_21		NM_004214.4	NP_004205.2	REVIEWED	OK	1.000	1.000	357	1074	1	1071	357	1	357
RIKEN	BC022791	IRAL029K04	MGC	W01A062G15	pENTR-TOPO	13288		FOSL2	2355	AAH22791.1	Hs.220971	FOS-like antigen 2			Lung, large cell carcinoma	NIH_MGC_18		NM_005253.3	NP_005244.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC014388	IRAL007M23	MGC	W01A062G16	pENTR-TOPO	4531		FIBP	9158	AAH14388.1	Hs.7768	Fibroblast growth factor (acidic) intracellular binding protein			Placenta, choriocarcinoma	NIH_MGC_21		NM_004214.4	NP_004205.2	REVIEWED	OK	1.000	1.000	357	1074	1	1071	357	1	357
RIKEN	BC028354	IRAK034K06	MGC	W01A062G19	pENTR-TOPO	16891		PLSCR4	57088	AAH28354.1	Hs.477869	Phospholipid scramblase 4			Testis	NIH_MGC_97	DH10B	NM_020353.2	NP_065086.2	VALIDATED	C	1.000	1.000	329	990	1	987	329	1	329
RIKEN	BC047567	IRAK090E13	MGC	W01A062H02	pENTR-TOPO	18597		CSNK1G3	1456	AAH47567.1	Hs.129206	Casein kinase 1, gamma 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001031812.2	NP_001026982.1	VALIDATED	Cs	0.998	0.998	423	1272	1	1269	423	1	423
RIKEN	BC047567	IRAK090E13	MGC	W01A062H04	pENTR-TOPO	18597		CSNK1G3	1456	AAH47567.1	Hs.129206	Casein kinase 1, gamma 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001031812.2	NP_001026982.1	VALIDATED	Cs	0.998	0.998	423	1272	1	1269	423	1	423
RIKEN	BC047567	IRAK090E13	MGC	W01A062H06	pENTR-TOPO	18597		CSNK1G3	1456	AAH47567.1	Hs.129206	Casein kinase 1, gamma 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001031812.2	NP_001026982.1	VALIDATED	Cs	0.998	0.998	423	1272	1	1269	423	1	423
RIKEN	BC047567	IRAK090E13	MGC	W01A062H08	pENTR-TOPO	18597		CSNK1G3	1456	AAH47567.1	Hs.129206	Casein kinase 1, gamma 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001031812.2	NP_001026982.1	VALIDATED	Cs	0.998	0.998	423	1272	1	1269	423	1	423
RIKEN	AK075150	flj0019a17	FLJ	W01A062H11	pENTR-TOPO	24521		RP6-213H19.1	51765	BAC11435.1	Hs.444247	Serine/threonine protein kinase MST4				PLACE1	EK1	NM_016542.3	NP_057626.2	REVIEWED	Cg	0.942	1.000	416	1179	1	1176	416	1	416
RIKEN	BC000544	IRAL005C01	MGC	W01A062H20	pENTR-TOPO	6213		KCNJ8	3764	AAH00544.1	Hs.102308	Potassium inwardly-rectifying channel, subfamily J, member 8			Brain, neuroblastoma	NIH_MGC_19		NM_004982.2	NP_004973.1	REVIEWED	OK	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC001166	IRAL006I24	MGC	W01A062H21	pENTR-TOPO	10647		GALK1	2584	AAH01166.1	Hs.407966	Galactokinase 1			Brain, neuroblastoma	NIH_MGC_19		NM_000154.1	NP_000145.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	AK024751	flj0057l06	FLJ	W01A062I05	pENTR-TOPO	1649		UCHL5	51377	-	Hs.591458	Ubiquitin carboxyl-terminal hydrolase L5				CAS	EK1	NM_015984.2	NP_057068.1	VALIDATED	Cg	0.997	1.000	329	987	1	984	329	1	329
RIKEN	BC023550	IRAL027M20	MGC	W01A062I06	pENTR-TOPO	22608		AGPAT5	55326	AAH23550.1	Hs.624002	1-acylglycerol-3-phosphate O-acyltransferase 5 (lysophosphatidic acid acyltransferase, epsilon)			Brain, neuroblastoma	NIH_MGC_19		NM_018361.3	NP_060831.2	REVIEWED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	AK024751	flj0057l06	FLJ	W01A062I07	pENTR-TOPO	1649		UCHL5	51377	-	Hs.591458	Ubiquitin carboxyl-terminal hydrolase L5				CAS	EK1	NM_015984.2	NP_057068.1	VALIDATED	Cg	0.997	1.000	329	987	1	984	329	1	329
RIKEN	BC014026	IRAL028L17	MGC	W01A062I10	pENTR-TOPO	11486		RAD23A	5886	AAH14026.1	Hs.643267	RAD23 homolog A (S. cerevisiae)			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_005053.2	NP_005044.1	REVIEWED	OK	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	H023030K12	H023030K12	RIKEN	W01A062I11	pENTR-TOPO		4148						-	-	hippocampus	hippocampus	DH10B			
RIKEN	BC014026	IRAL028L17	MGC	W01A062I12	pENTR-TOPO	11486		RAD23A	5886	AAH14026.1	Hs.643267	RAD23 homolog A (S. cerevisiae)			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_005053.2	NP_005044.1	REVIEWED	OK	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC006391	IRAL017H17	MGC	W01A062I20	pENTR-TOPO	12937		INHA	3623	AAH06391.1	Hs.407506	Inhibin, alpha			Brain, neuroblastoma	NIH_MGC_19		NM_002191.2	NP_002182.1	REVIEWED	C	1.000	1.000	366	1101	1	1098	366	1	366
RIKEN	BC002671	IRAL012K03	MGC	W01A062J01	pENTR-TOPO	23204		DUSP4	1846	AAH02671.1	Hs.417962	Dual specificity phosphatase 4			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001394.5	NP_001385.1	REVIEWED	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC002464	IRAL005P03	MGC	W01A062J02	pENTR-TOPO	18865		F2R	2149	AAH02464.1	Hs.482562	Coagulation factor II (thrombin) receptor			Eye, retinoblastoma	NIH_MGC_16		NM_001992.3	NP_001983.2	REVIEWED	Cs	0.998	0.998	425	1278	1	1275	425	1	425
RIKEN	BC002671	IRAL012K03	MGC	W01A062J03	pENTR-TOPO	23204		DUSP4	1846	AAH02671.1	Hs.417962	Dual specificity phosphatase 4			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001394.5	NP_001385.1	REVIEWED	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC002464	IRAL005P03	MGC	W01A062J06	pENTR-TOPO	18865		F2R	2149	AAH02464.1	Hs.482562	Coagulation factor II (thrombin) receptor			Eye, retinoblastoma	NIH_MGC_16		NM_001992.3	NP_001983.2	REVIEWED	Cs	0.998	0.998	425	1278	1	1275	425	1	425
RIKEN	BC002671	IRAL012K03	MGC	W01A062J07	pENTR-TOPO	23204		DUSP4	1846	AAH02671.1	Hs.417962	Dual specificity phosphatase 4			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001394.5	NP_001385.1	REVIEWED	C	1.000	1.000	394	1185	1	1182	394	1	394
RIKEN	BC008023	IRAL023K16	MGC	W01A062J13	pENTR-TOPO	9623		ZNF207	7756	AAH08023.1	Hs.500775	Zinc finger protein 207			Lung, small cell carcinoma	NIH_MGC_7		NM_001032293.2	NP_001027464.1	VALIDATED	Cg	0.737	1.000	494	1188	1	1185	463	1	463
RIKEN	BC008023	IRAL023K16	MGC	W01A062J15	pENTR-TOPO	9623		ZNF207	7756	AAH08023.1	Hs.500775	Zinc finger protein 207			Lung, small cell carcinoma	NIH_MGC_7		NM_001032293.2	NP_001027464.1	VALIDATED	Cg	0.737	1.000	494	1188	1	1185	463	1	463
RIKEN	H05D004B16	H05D004B16	RIKEN	W01A062J16	pENTR-TOPO		8969						-	-	thymus	thymus	DH10B			
RIKEN	H033066P15	H033066P15	RIKEN	W01A062J19	pENTR-TOPO		6927	VRK1	7443		Hs.422662	Vaccinia related kinase 1	-	-	hypothalamus	hypothalamus	DH10B	NM_003384.2	NP_003375.1	REVIEWED	Cs	0.997	0.997	396	1191	1	1188	396	1	396
RIKEN	BC019248	IRAK033P13	MGC	W01A062J20	pENTR-TOPO	7813		ABHD2	11057	AAH19248.1	Hs.705984	Abhydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_007011.6	NP_008942.3	REVIEWED	Cs	0.998	0.998	425	1278	1	1275	425	1	425
RIKEN	BC019248	IRAK033P13	MGC	W01A062J22	pENTR-TOPO	7813		ABHD2	11057	AAH19248.1	Hs.705984	Abhydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_007011.6	NP_008942.3	REVIEWED	Cs	0.998	0.998	425	1278	1	1275	425	1	425
RIKEN	BC019248	IRAK033P13	MGC	W01A062J24	pENTR-TOPO	7813		ABHD2	11057	AAH19248.1	Hs.705984	Abhydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_007011.6	NP_008942.3	REVIEWED	Cs	0.998	0.998	425	1278	1	1275	425	1	425
RIKEN	BC012074	IRAL029G03	MGC	W01A062K07	pENTR-TOPO	13108		ANTXR1	84168	AAH12074.1	Hs.165859	Anthrax toxin receptor 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_018153.3	NP_060623.2	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
RIKEN	BC005860	IRAL010A17	MGC	W01A062K08	pENTR-TOPO	5570		TARBP2	6895	AAH05860.1	Hs.326	TAR (HIV-1) RNA binding protein 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_134323.1	NP_599150.1	REVIEWED	OK	1.000	1.000	366	1101	1	1098	366	1	366
RIKEN	BC002832	IRAL012J18	MGC	W01A062K13	pENTR-TOPO	19834		BTN3A2	11118	AAH02832.3	Hs.376046	Butyrophilin, subfamily 3, member A2			Placenta, choriocarcinoma	NIH_MGC_21		NM_007047.3	NP_008978.2	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC034494	IRAK033F09	MGC	W01A062L03	pENTR-TOPO	14543		SS18L1	26039	AAH34494	Hs.154429	Synovial sarcoma translocation gene on chromosome 18-like 1			Testis	NIH_MGC_97	DH10B	NM_198935.1	NP_945173.1	VALIDATED	Cs	0.997	0.997	396	1191	1	1188	396	1	396
RIKEN	BC001176	IRAL006B01	MGC	W01A062L04	pENTR-TOPO	15671		TCN2	6948	AAH01176.1	Hs.417948	Transcobalamin II; macrocytic anemia			Eye, retinoblastoma	NIH_MGC_16		NM_000355.2	NP_000346.2	REVIEWED	Cs	0.998	0.998	427	1284	1	1281	427	1	427
RIKEN	BC034494	IRAK033F09	MGC	W01A062L05	pENTR-TOPO	14543		SS18L1	26039	AAH34494	Hs.154429	Synovial sarcoma translocation gene on chromosome 18-like 1			Testis	NIH_MGC_97	DH10B	NM_198935.1	NP_945173.1	VALIDATED	Cs	0.997	0.997	396	1191	1	1188	396	1	396
RIKEN	BC001176	IRAL006B01	MGC	W01A062L06	pENTR-TOPO	15671		TCN2	6948	AAH01176.1	Hs.417948	Transcobalamin II; macrocytic anemia			Eye, retinoblastoma	NIH_MGC_16		NM_000355.2	NP_000346.2	REVIEWED	Cs	0.998	0.998	427	1284	1	1281	427	1	427
RIKEN	BC030155	IRAL039I04	MGC	W01A062L09	pENTR-TOPO	22918		TNFRSF11B	4982	AAH30155.1	Hs.81791	Tumor necrosis factor receptor superfamily, member 11b			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_002546.3	NP_002537.3	REVIEWED	C	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	AK093001	flj0010l17	FLJ	W01A062L12	pENTR-TOPO	17985		CLNK	116449	BAG52635.1	Hs.678910	Cytokine-dependent hematopoietic cell linker				SPLEN2	EK1	NM_052964.2	NP_443196.2	VALIDATED	C	1.000	1.000	428	1287	1	1284	428	1	428
RIKEN	BC030155	IRAL039I04	MGC	W01A062L13	pENTR-TOPO	22918		TNFRSF11B	4982	AAH30155.1	Hs.81791	Tumor necrosis factor receptor superfamily, member 11b			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_002546.3	NP_002537.3	REVIEWED	C	1.000	1.000	401	1206	1	1203	401	1	401
RIKEN	AK093001	flj0010l17	FLJ	W01A062L14	pENTR-TOPO	17985		CLNK	116449	BAG52635.1	Hs.678910	Cytokine-dependent hematopoietic cell linker				SPLEN2	EK1	NM_052964.2	NP_443196.2	VALIDATED	C	1.000	1.000	428	1287	1	1284	428	1	428
RIKEN	H013089P22	H013089P22	RIKEN	W01A062L19	pENTR-TOPO		14639	STK35	140901		Hs.100057	Serine/threonine kinase 35	-	-	testis	testis	DH10B	NM_080836.2	NP_543026.1	REVIEWED	Cs	0.998	0.998	401	1206	1	1203	401	1	401
RIKEN	BC012120	IRAL029C24	MGC	W01A062L20	pENTR-TOPO	11945		NFIC	4782	AAH12120.1	Hs.170131	Nuclear factor I/C (CCAAT-binding transcription factor)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_005597.2	NP_005588.2	VALIDATED	C	1.000	1.000	428	1287	1	1284	428	1	428
RIKEN	BC014528	IRAL014O12	MGC	W01A062M03	pENTR-TOPO	12929		ASB1	51665	AAH14528.1	Hs.516788	Ankyrin repeat and SOCS box-containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_001040445.1	NP_001035535.1	REVIEWED	C	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC014528	IRAL014O12	MGC	W01A062M07	pENTR-TOPO	12929		ASB1	51665	AAH14528.1	Hs.516788	Ankyrin repeat and SOCS box-containing 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_001040445.1	NP_001035535.1	REVIEWED	C	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	H033059H10	H033059H10	RIKEN	W01A062M08	pENTR-TOPO		17237	CAMK1	8536		Hs.434875	Calcium/calmodulin-dependent protein kinase I	-	-	hypothalamus	hypothalamus	DH10B	NM_003656.3	NP_003647.1	REVIEWED	Cs	0.997	0.997	370	1113	1	1110	370	1	370
RIKEN	BC069996	IRAK172B13	MGC	W01A062M10	pENTR-TOPO	24896		LPAR4	2846	AAH69996.1	Hs.522701	Lysophosphatidic acid receptor 4			PCR rescued clones	NIH_MGC_195	DH10B	NM_005296.2	NP_005287.1	REVIEWED	Cs	0.997	0.997	370	1113	1	1110	370	1	370
RIKEN	BC069996	IRAK172B13	MGC	W01A062M12	pENTR-TOPO	24896		LPAR4	2846	AAH69996.1	Hs.522701	Lysophosphatidic acid receptor 4			PCR rescued clones	NIH_MGC_195	DH10B	NM_005296.2	NP_005287.1	REVIEWED	Cs	0.997	0.997	370	1113	1	1110	370	1	370
RIKEN	BC069996	IRAK172B13	MGC	W01A062M14	pENTR-TOPO	24896		LPAR4	2846	AAH69996.1	Hs.522701	Lysophosphatidic acid receptor 4			PCR rescued clones	NIH_MGC_195	DH10B	NM_005296.2	NP_005287.1	REVIEWED	Cs	0.997	0.997	370	1113	1	1110	370	1	370
RIKEN	AK091850	flj0015h13	FLJ	W01A062M18	pENTR-TOPO	24570		YY2	404281	BAG52427.1	Hs.673601	YY2 transcription factor				HLUNG2	EK1	NM_206923.2	NP_996806.2	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC035750	IRAK079M14	MGC	W01A062M19	pENTR-TOPO	25186		CYSLTR1	10800	AAH35750.1	Hs.201300	Cysteinyl leukotriene receptor 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006639.2	NP_006630.1	REVIEWED	Cs	0.997	0.997	337	1014	1	1011	337	1	337
RIKEN	AK091850	flj0015h13	FLJ	W01A062M22	pENTR-TOPO	24570		YY2	404281	BAG52427.1	Hs.673601	YY2 transcription factor				HLUNG2	EK1	NM_206923.2	NP_996806.2	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	AK091850	flj0015h13	FLJ	W01A062M24	pENTR-TOPO	24570		YY2	404281	BAG52427.1	Hs.673601	YY2 transcription factor				HLUNG2	EK1	NM_206923.2	NP_996806.2	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	AK027560	flj0033l15	FLJ	W01A062N02	pENTR-TOPO	2639		CYP26A1	1592	BAG51346.1	Hs.150595	Cytochrome P450, family 26, subfamily A, polypeptide 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_057157.2	NP_476498.1	REVIEWED	Cs	0.998	0.998	428	1287	1	1284	428	1	428
RIKEN	AK027560	flj0033l15	FLJ	W01A062N04	pENTR-TOPO	2639		CYP26A1	1592	BAG51346.1	Hs.150595	Cytochrome P450, family 26, subfamily A, polypeptide 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_057157.2	NP_476498.1	REVIEWED	Cs	0.998	0.998	428	1287	1	1284	428	1	428
RIKEN	BC014983	IRAL034H21	MGC	W01A062N09	pENTR-TOPO	15015		TBC1D20	128637	AAH14983.1	Hs.590876	TBC1 domain family, member 20			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_144628.2	NP_653229.1	VALIDATED	OK	1.000	1.000	403	1212	1	1209	403	1	403
RIKEN	AK027597	flj0034g08	FLJ	W01A062N17	pENTR-TOPO	23645		LHX2	9355	BAG51357.1	Hs.696425	LIM homeobox 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_004789.3	NP_004780.3	REVIEWED	Cs	0.998	0.998	406	1221	1	1218	406	1	406
RIKEN	BC011559	IRAL029E02	MGC	W01A062N18	pENTR-TOPO	6808		SMAD9	4093	AAH11559.1	Hs.123119	SMAD family member 9			Eye, retinoblastoma	NIH_MGC_16		NM_005905.4	NP_005896.1	VALIDATED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	AK027597	flj0034g08	FLJ	W01A062N23	pENTR-TOPO	23645		LHX2	9355	BAG51357.1	Hs.696425	LIM homeobox 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_004789.3	NP_004780.3	REVIEWED	Cs	0.998	0.998	406	1221	1	1218	406	1	406
RIKEN	BC011559	IRAL029E02	MGC	W01A062N24	pENTR-TOPO	6808		SMAD9	4093	AAH11559.1	Hs.123119	SMAD family member 9			Eye, retinoblastoma	NIH_MGC_16		NM_005905.4	NP_005896.1	VALIDATED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	AK075459	flj0027n11	FLJ	W01A062O06	pENTR-TOPO	17066		SUMF1	285362	BAC11634.1	Hs.350475	Sulfatase modifying factor 1				PLACE1	EK1	NM_182760.2	NP_877437.2	VALIDATED	Cs	0.995	0.995	374	1125	1	1122	374	1	374
RIKEN	BC006521	IRAL011C01	MGC	W01A062O10	pENTR-TOPO	471		FCRLA	84824	AAH06521.2	Hs.266331	Fc receptor-like A			Skin, melanotic melanoma.	NIH_MGC_20		NM_032738.3	NP_116127.3	VALIDATED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
RIKEN	BC006521	IRAL011C01	MGC	W01A062O12	pENTR-TOPO	471		FCRLA	84824	AAH06521.2	Hs.266331	Fc receptor-like A			Skin, melanotic melanoma.	NIH_MGC_20		NM_032738.3	NP_116127.3	VALIDATED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
RIKEN	BC001029	IRAL005B02	MGC	W01A062O13	pENTR-TOPO	13224		NAGK	55577	AAH01029.1	Hs.7036	N-acetylglucosamine kinase			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_017567.3	NP_060037.2	VALIDATED	C	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	BC001029	IRAL005B02	MGC	W01A062O15	pENTR-TOPO	13224		NAGK	55577	AAH01029.1	Hs.7036	N-acetylglucosamine kinase			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_017567.3	NP_060037.2	VALIDATED	C	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	BC050433	IRAK098G04	MGC	W01A062O18	pENTR-TOPO	25204		HDAC8	55869	AAH50433.1	Hs.310536	Histone deacetylase 8			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_018486.1	NP_060956.1	REVIEWED	Cs	0.997	0.997	377	1134	1	1131	377	1	377
RIKEN	BC050433	IRAK098G04	MGC	W01A062O20	pENTR-TOPO	25204		HDAC8	55869	AAH50433.1	Hs.310536	Histone deacetylase 8			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_018486.1	NP_060956.1	REVIEWED	Cs	0.997	0.997	377	1134	1	1131	377	1	377
RIKEN	BC050433	IRAK098G04	MGC	W01A062O24	pENTR-TOPO	25204		HDAC8	55869	AAH50433.1	Hs.310536	Histone deacetylase 8			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_018486.1	NP_060956.1	REVIEWED	Cs	0.997	0.997	377	1134	1	1131	377	1	377
RIKEN	BC012062	IRAL029B21	MGC	W01A062P01	pENTR-TOPO	11592		DAZAP1	26528	AAH12062.1	Hs.222510	DAZ associated protein 1			Lung, large cell carcinoma	NIH_MGC_18		NM_018959.2	NP_061832.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC012062	IRAL029B21	MGC	W01A062P03	pENTR-TOPO	11592		DAZAP1	26528	AAH12062.1	Hs.222510	DAZ associated protein 1			Lung, large cell carcinoma	NIH_MGC_18		NM_018959.2	NP_061832.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC012062	IRAL029B21	MGC	W01A062P05	pENTR-TOPO	11592		DAZAP1	26528	AAH12062.1	Hs.222510	DAZ associated protein 1			Lung, large cell carcinoma	NIH_MGC_18		NM_018959.2	NP_061832.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC012062	IRAL029B21	MGC	W01A062P07	pENTR-TOPO	11592		DAZAP1	26528	AAH12062.1	Hs.222510	DAZ associated protein 1			Lung, large cell carcinoma	NIH_MGC_18		NM_018959.2	NP_061832.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC033180	IRAL043F15	MGC	W01A062P21	pENTR-TOPO	8933		E2F4	1874	AAH33180.1	Hs.108371	E2F transcription factor 4, p107/p130-binding			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001950.3	NP_001941.2	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
RIKEN	BC000355	IRAL001O03	MGC	W01A063A04	pENTR-TOPO	24024		HNRNPK	3190	AAH00355.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031263.2	NP_112553.1	REVIEWED	C	1.000	1.000	464	1395	1	1392	464	1	464
RIKEN	BC038585	IRAK079O08	MGC	W01A063A10	pENTR-TOPO	19831		TRIM15	89870	AAH38585.1	Hs.591789	Tripartite motif-containing 15			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_033229.2	NP_150232.2	REVIEWED	Cs	0.998	0.998	465	1398	1	1395	465	1	465
RIKEN	BC008461	IRAL021O14	MGC	W01A063A11	pENTR-TOPO	13896		TGOLN2	10618	AAH08461.1	Hs.593382	Trans-golgi network protein 2			Prostate	NIH_MGC_83	DH10B	NM_006464.2	NP_006455.2	VALIDATED	Cs	0.998	0.998	437	1314	1	1311	437	1	437
RIKEN	BC038585	IRAK079O08	MGC	W01A063A12	pENTR-TOPO	19831		TRIM15	89870	AAH38585.1	Hs.591789	Tripartite motif-containing 15			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_033229.2	NP_150232.2	REVIEWED	Cs	0.998	0.998	465	1398	1	1395	465	1	465
RIKEN	BC038585	IRAK079O08	MGC	W01A063A14	pENTR-TOPO	19831		TRIM15	89870	AAH38585.1	Hs.591789	Tripartite motif-containing 15			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_033229.2	NP_150232.2	REVIEWED	Cs	0.998	0.998	465	1398	1	1395	465	1	465
RIKEN	BC008461	IRAL021O14	MGC	W01A063A15	pENTR-TOPO	13896		TGOLN2	10618	AAH08461.1	Hs.593382	Trans-golgi network protein 2			Prostate	NIH_MGC_83	DH10B	NM_006464.2	NP_006455.2	VALIDATED	Cs	0.998	0.998	437	1314	1	1311	437	1	437
RIKEN	BC038585	IRAK079O08	MGC	W01A063A16	pENTR-TOPO	19831		TRIM15	89870	AAH38585.1	Hs.591789	Tripartite motif-containing 15			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_033229.2	NP_150232.2	REVIEWED	Cs	0.998	0.998	465	1398	1	1395	465	1	465
RIKEN	BC008763	IRAL005F22	MGC	W01A063A18	pENTR-TOPO	23524		OLFM1	10439	AAH08763.2	Hs.522484	Olfactomedin 1			Eye, retinoblastoma	NIH_MGC_16		NM_014279.4	NP_055094.1	REVIEWED	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC005127	IRAL014G22	MGC	W01A063A21	pENTR-TOPO	24146		ADFP	123	AAH05127.1	Hs.3416	Adipose differentiation-related protein			Placenta, choriocarcinoma	NIH_MGC_21		NM_001122.2	NP_001113.2	REVIEWED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC008763	IRAL005F22	MGC	W01A063A24	pENTR-TOPO	23524		OLFM1	10439	AAH08763.2	Hs.522484	Olfactomedin 1			Eye, retinoblastoma	NIH_MGC_16		NM_014279.4	NP_055094.1	REVIEWED	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC084567	IRAL059L14	MGC	W01A063B02	pENTR-TOPO	18481		POLS	11044	AAH84567.2	Hs.481542	Polymerase (DNA directed) sigma			Lung, large cell carcinoma	NIH_MGC_18		NM_006999.3	NP_008930.1	REVIEWED	C	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC084567	IRAL059L14	MGC	W01A063B04	pENTR-TOPO	18481		POLS	11044	AAH84567.2	Hs.481542	Polymerase (DNA directed) sigma			Lung, large cell carcinoma	NIH_MGC_18		NM_006999.3	NP_008930.1	REVIEWED	C	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC035625	IRAK068N04	MGC	W01A063B05	pENTR-TOPO	3208		EGR2	1959	AAH35625.1	Hs.1395	Early growth response 2 (Krox-20 homolog, Drosophila)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001136179.1	NP_001129651.1	REVIEWED	Cg	0.949	1.000	449	1500	151	1497	426	1	426
RIKEN	AK093108	flj0007g12	FLJ	W01A063B10	pENTR-TOPO	15920		ZNF280A	129025	BAG52655.1	Hs.178665	Zinc finger protein 280A				TESTI2	EK1	NM_080740.3	NP_542778.1	REVIEWED	Cs	0.998	0.998	542	1629	1	1626	542	1	542
RIKEN	AK093108	flj0007g12	FLJ	W01A063B12	pENTR-TOPO	15920		ZNF280A	129025	BAG52655.1	Hs.178665	Zinc finger protein 280A				TESTI2	EK1	NM_080740.3	NP_542778.1	REVIEWED	Cs	0.998	0.998	542	1629	1	1626	542	1	542
RIKEN	AK055548	flj0012d04	FLJ	W01A063B18	pENTR-TOPO	14646		SLC2A10	81031	BAG51534.1	Hs.305971	Solute carrier family 2 (facilitated glucose transporter), member 10				HHDPC2	EK1	NM_030777.3	NP_110404.1	VALIDATED	Cs	0.998	0.998	541	1626	1	1623	541	1	541
RIKEN	H033084H01	H033084H01	RIKEN	W01A063B19	pENTR-TOPO		18083	NUP54	53371		Hs.430435	Nucleoporin 54kDa	-	-	hypothalamus	hypothalamus	DH10B	NM_017426.2	NP_059122.2	REVIEWED	Cs	0.998	0.998	507	1524	1	1521	507	1	507
RIKEN	AK055548	flj0012d04	FLJ	W01A063B22	pENTR-TOPO	14646		SLC2A10	81031	BAG51534.1	Hs.305971	Solute carrier family 2 (facilitated glucose transporter), member 10				HHDPC2	EK1	NM_030777.3	NP_110404.1	VALIDATED	Cs	0.998	0.998	541	1626	1	1623	541	1	541
RIKEN	BC010358	IRAL019P06	MGC	W01A063C02	pENTR-TOPO	20534		CYP39A1	51302	AAH10358.1	Hs.387367	Cytochrome P450, family 39, subfamily A, polypeptide 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_016593.3	NP_057677.2	REVIEWED	Cs	0.996	0.996	469	1410	1	1407	469	1	469
RIKEN	BC007746	IRAL017B18	MGC	W01A063C03	pENTR-TOPO	15255		PKNOX1	5316	AAH07746.1	Hs.431043	PBX/knotted 1 homeobox 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004571.3	NP_004562.2	VALIDATED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	BC007746	IRAL017B18	MGC	W01A063C05	pENTR-TOPO	15255		PKNOX1	5316	AAH07746.1	Hs.431043	PBX/knotted 1 homeobox 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004571.3	NP_004562.2	VALIDATED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	BC053676	IRAK115N11	MGC	W01A063C09	pENTR-TOPO	1600		E2F2	1870	AAH53676.1	Hs.194333	E2F transcription factor 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004091.2	NP_004082.1	REVIEWED	Cs	0.998	0.998	437	1314	1	1311	437	1	437
RIKEN	BC030574	IRAL024M16	MGC	W01A063C18	pENTR-TOPO	11939		U2AF2	11338	AAH30574.1	Hs.528007	U2 small nuclear RNA auxiliary factor 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001012478.1	NP_001012496.1	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC008875	IRAL026M13	MGC	W01A063D02	pENTR-TOPO	23026		PUF60	22827	AAH08875.1	Hs.521924	Poly-U binding splicing factor 60KDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_014281.3	NP_055096.2	REVIEWED	OK	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC008875	IRAL026M13	MGC	W01A063D04	pENTR-TOPO	23026		PUF60	22827	AAH08875.1	Hs.521924	Poly-U binding splicing factor 60KDa			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_014281.3	NP_055096.2	REVIEWED	OK	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC033092	IRAL043F07	MGC	W01A063D05	pENTR-TOPO	14556		SIRPA	140885	AAH33092.1	Hs.581021	Signal-regulatory protein alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_080792.2	NP_542970.1	REVIEWED	Cg	0.992	1.000	508	1527	1	1524	504	1	504
RIKEN	BC007333	IRAL003N20	MGC	W01A063D09	pENTR-TOPO	17181		ETV5	2119	AAH07333.1	Hs.43697	Ets variant 5			Skin, melanotic melanoma.	NIH_MGC_20		NM_004454.2	NP_004445.1	VALIDATED	C	1.000	1.000	510	1533	1	1530	510	1	510
RIKEN	BC007333	IRAL003N20	MGC	W01A063D15	pENTR-TOPO	17181		ETV5	2119	AAH07333.1	Hs.43697	Ets variant 5			Skin, melanotic melanoma.	NIH_MGC_20		NM_004454.2	NP_004445.1	VALIDATED	C	1.000	1.000	510	1533	1	1530	510	1	510
RIKEN	BC026060	IRAL025A14	MGC	W01A063D18	pENTR-TOPO	5800		CAMKK2	10645	AAH26060.1	Hs.297343	Calcium/calmodulin-dependent protein kinase kinase 2, beta			Placenta, choriocarcinoma	NIH_MGC_21		NM_153499.2	NP_705719.2	REVIEWED	Cs	0.998	0.998	541	1626	1	1623	541	1	541
RIKEN	BC026060	IRAL025A14	MGC	W01A063D20	pENTR-TOPO	5800		CAMKK2	10645	AAH26060.1	Hs.297343	Calcium/calmodulin-dependent protein kinase kinase 2, beta			Placenta, choriocarcinoma	NIH_MGC_21		NM_153499.2	NP_705719.2	REVIEWED	Cs	0.998	0.998	541	1626	1	1623	541	1	541
RIKEN	BC026060	IRAL025A14	MGC	W01A063D22	pENTR-TOPO	5800		CAMKK2	10645	AAH26060.1	Hs.297343	Calcium/calmodulin-dependent protein kinase kinase 2, beta			Placenta, choriocarcinoma	NIH_MGC_21		NM_153499.2	NP_705719.2	REVIEWED	Cs	0.998	0.998	541	1626	1	1623	541	1	541
RIKEN	BC064700	IRAK133H16	MGC	W01A063E01	pENTR-TOPO	1384		ESRRG	2104	AAH64700.1	Hs.444225	Estrogen-related receptor gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_206594.1	NP_996317.1	VALIDATED	Cgs	0.982	0.998	442	1329	1	1326	435	1	435
RIKEN	AK092449	flj0006b16	FLJ	W01A063E04	pENTR-TOPO	16879		HYAL2	8692	BAG52554.1	Hs.76873	Hyaluronoglucosaminidase 2				PLACE6	EK1	NM_033158.3	NP_149348.2	REVIEWED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
RIKEN	AK092449	flj0006b16	FLJ	W01A063E06	pENTR-TOPO	16879		HYAL2	8692	BAG52554.1	Hs.76873	Hyaluronoglucosaminidase 2				PLACE6	EK1	NM_033158.3	NP_149348.2	REVIEWED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
RIKEN	BC019089	IRAL039H24	MGC	W01A063E10	pENTR-TOPO	19196		CDC25C	995	AAH19089.1	Hs.656	Cell division cycle 25 homolog C (S. pombe)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_001790.3	NP_001781.2	REVIEWED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
RIKEN	BC019089	IRAL039H24	MGC	W01A063E12	pENTR-TOPO	19196		CDC25C	995	AAH19089.1	Hs.656	Cell division cycle 25 homolog C (S. pombe)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_001790.3	NP_001781.2	REVIEWED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
RIKEN	BC019089	IRAL039H24	MGC	W01A063E16	pENTR-TOPO	19196		CDC25C	995	AAH19089.1	Hs.656	Cell division cycle 25 homolog C (S. pombe)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_001790.3	NP_001781.2	REVIEWED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
RIKEN	BC000060	IRAL007B04	MGC	W01A063E19	pENTR-TOPO	9974		COX10	1352	AAH00060.1	Hs.462278	COX10 homolog, cytochrome c oxidase assembly protein, heme A: farnesyltransferase (yeast)			Brain, neuroblastoma	NIH_MGC_19		NM_001303.3	NP_001294.2	REVIEWED	Cs	0.998	0.998	443	1332	1	1329	443	1	443
RIKEN	BC008803	IRAL015I21	MGC	W01A063F03	pENTR-TOPO	14601		EYA2	2139	AAH08803.1	Hs.472877	Eyes absent homolog 2 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7		NM_172110.2	NP_742108.1	REVIEWED	Cs	0.998	0.998	514	1545	1	1542	514	1	514
RIKEN	BC008803	IRAL015I21	MGC	W01A063F05	pENTR-TOPO	14601		EYA2	2139	AAH08803.1	Hs.472877	Eyes absent homolog 2 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7		NM_172110.2	NP_742108.1	REVIEWED	Cs	0.998	0.998	514	1545	1	1542	514	1	514
RIKEN	AK095734	flj0045i18	FLJ	W01A063F13	pENTR-TOPO	6146		ZNF384	171017	BAC04618.1	Hs.714839	Zinc finger protein 384				FEBRA2	EK1	NM_001039919.1	NP_001035008.1	REVIEWED	Cg	0.967	1.000	516	1548	1	1545	500	1	500
RIKEN	AK023119	flj0035e05	FLJ	W01A063F17	pENTR-TOPO	13264		GMCL1	64395	BAB14416.1	Hs.293971	Germ cell-less homolog 1 (Drosophila)	NT2	teratocarcinoma		NT2RP3	EK1	NM_178439.3	NP_848526.1	PROVISIONAL	Cs	0.998	0.998	515	1548	1	1545	515	1	515
RIKEN	BC017187	IRAL004A02	MGC	W01A063F18	pENTR-TOPO	7403		RPS6KA5	9252	AAH17187.1	Hs.510225	Ribosomal protein S6 kinase, 90kDa, polypeptide 5			Placenta, choriocarcinoma	NIH_MGC_21		NM_182398.1	NP_872198.1	VALIDATED	C	1.000	1.000	549	1650	1	1647	549	1	549
RIKEN	AK023119	flj0035e05	FLJ	W01A063F19	pENTR-TOPO	13264		GMCL1	64395	BAB14416.1	Hs.293971	Germ cell-less homolog 1 (Drosophila)	NT2	teratocarcinoma		NT2RP3	EK1	NM_178439.3	NP_848526.1	PROVISIONAL	Cs	0.998	0.998	515	1548	1	1545	515	1	515
RIKEN	AK023119	flj0035e05	FLJ	W01A063F21	pENTR-TOPO	13264		GMCL1	64395	BAB14416.1	Hs.293971	Germ cell-less homolog 1 (Drosophila)	NT2	teratocarcinoma		NT2RP3	EK1	NM_178439.3	NP_848526.1	PROVISIONAL	Cs	0.998	0.998	515	1548	1	1545	515	1	515
RIKEN	BC017187	IRAL004A02	MGC	W01A063F22	pENTR-TOPO	7403		RPS6KA5	9252	AAH17187.1	Hs.510225	Ribosomal protein S6 kinase, 90kDa, polypeptide 5			Placenta, choriocarcinoma	NIH_MGC_21		NM_182398.1	NP_872198.1	VALIDATED	C	1.000	1.000	549	1650	1	1647	549	1	549
RIKEN	AK023119	flj0035e05	FLJ	W01A063F23	pENTR-TOPO	13264		GMCL1	64395	BAB14416.1	Hs.293971	Germ cell-less homolog 1 (Drosophila)	NT2	teratocarcinoma		NT2RP3	EK1	NM_178439.3	NP_848526.1	PROVISIONAL	Cs	0.998	0.998	515	1548	1	1545	515	1	515
RIKEN	BC017187	IRAL004A02	MGC	W01A063F24	pENTR-TOPO	7403		RPS6KA5	9252	AAH17187.1	Hs.510225	Ribosomal protein S6 kinase, 90kDa, polypeptide 5			Placenta, choriocarcinoma	NIH_MGC_21		NM_182398.1	NP_872198.1	VALIDATED	C	1.000	1.000	549	1650	1	1647	549	1	549
RIKEN	BC006088	IRAL018J19	MGC	W01A063G06	pENTR-TOPO	14950		SERINC3	10955	AAH06088.1	Hs.272168	Serine incorporator 3			Pancreas, adenocarcinoma	NIH_MGC_39		NM_198941.1	NP_945179.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC016039	IRAL029J08	MGC	W01A063G07	pENTR-TOPO	10569		ZNF232	7775	AAH16039.2	Hs.279914	Zinc finger protein 232			Eye, retinoblastoma	NIH_MGC_16		NM_014519.2	NP_055334.2	VALIDATED	OK	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC000597	IRAL005C10	MGC	W01A063G16	pENTR-TOPO	14592		CTSA	5476	AAH00597.1	Hs.609336	Cathepsin A			Skin, melanotic melanoma.	NIH_MGC_20		NM_001127695.1	NP_001121167.1	REVIEWED	Cg	0.998	1.000	480	1440	1	1437	480	1	480
RIKEN	BC050451	IRAK098P07	MGC	W01A063G20	pENTR-TOPO	24738		ZRSR2	8233	AAH50451.2	Hs.171909	Zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005089.3	NP_005080.1	REVIEWED	Cs	0.998	0.998	482	1449	1	1446	482	1	482
RIKEN	BC050451	IRAK098P07	MGC	W01A063G24	pENTR-TOPO	24738		ZRSR2	8233	AAH50451.2	Hs.171909	Zinc finger (CCCH type), RNA-binding motif and serine/arginine rich 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005089.3	NP_005080.1	REVIEWED	Cs	0.998	0.998	482	1449	1	1446	482	1	482
RIKEN	H013055K02	H013055K02	RIKEN	W01A063H08	pENTR-TOPO		15359	TPTE	7179		Hs.122986	Transmembrane phosphatase with tensin homology	-	-	testis	testis	DH10B	NM_199261.2	NP_954870.2	VALIDATED	Cs	0.998	0.998	551	1656	1	1653	551	1	551
RIKEN	BC001503	IRAL007B06	MGC	W01A063H13	pENTR-TOPO	3159		PSAP	5660	AAH01503.1	Hs.523004	Prosaposin			Brain, neuroblastoma	NIH_MGC_19		NM_002778.2	NP_002769.1	REVIEWED	C	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	BC007708	IRAL015P03	MGC	W01A063H24	pENTR-TOPO	22581		EPHX2	2053	AAH07708.1	Hs.212088	Epoxide hydrolase 2, cytoplasmic			Lung, small cell carcinoma	NIH_MGC_7		NM_001979.4	NP_001970.2	REVIEWED	C	1.000	1.000	555	1668	1	1665	555	1	555
RIKEN	AK025665	flj0066a18	FLJ	W01A063I04	pENTR-TOPO	15608		PNPLA3	80339	-	Hs.654800	Patatin-like phospholipase domain containing 3	HepG2	hepatoma		HEP	EK1	NM_025225.2	NP_079501.2	REVIEWED	Cs	0.994	0.994	481	1446	1	1443	481	1	481
RIKEN	BC000740	IRAL007G01	MGC	W01A063I05	pENTR-TOPO	3830		CCKBR	887	AAH00740.1	Hs.203	Cholecystokinin B receptor			Placenta, choriocarcinoma	NIH_MGC_21		NM_176875.2	NP_795344.1	REVIEWED	C	1.000	1.000	447	1344	1	1341	447	1	447
RIKEN	AK025665	flj0066a18	FLJ	W01A063I08	pENTR-TOPO	15608		PNPLA3	80339	-	Hs.654800	Patatin-like phospholipase domain containing 3	HepG2	hepatoma		HEP	EK1	NM_025225.2	NP_079501.2	REVIEWED	Cs	0.994	0.994	481	1446	1	1443	481	1	481
RIKEN	AK057105	flj0003l24	FLJ	W01A063I12	pENTR-TOPO	25195		BTK	695	BAG51864.1	Hs.159494	Bruton agammaglobulinemia tyrosine kinase				SMINT2	EK1	NM_000061.2	NP_000052.1	REVIEWED	Cg	0.733	1.000	659	1452	1	1449	659	1	659
RIKEN	BC011731	IRAL027P07	MGC	W01A063I19	pENTR-TOPO	17960		G3BP2	9908	AAH11731.1	Hs.303676	GTPase activating protein (SH3 domain) binding protein 2			Primary B-Cells from Tonsils	NIH_MGC_48		NM_203504.2	NP_987100.1	VALIDATED	OK	1.000	1.000	449	1350	1	1347	449	1	449
RIKEN	AK095720	flj0023m24	FLJ	W01A063J02	pENTR-TOPO	4505		ZNF195	7748	BAG53114.1	Hs.386294	Zinc finger protein 195				FEBRA2	EK1	NM_007152.3	NP_009083.2	VALIDATED	Cs	0.998	0.998	557	1674	1	1671	557	1	557
RIKEN	BC007401	IRAL003G06	MGC	W01A063J11	pENTR-TOPO	16946		CDC25A	993	AAH07401.1	Hs.437705	Cell division cycle 25 homolog A (S. pombe)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001789.2	NP_001780.2	REVIEWED	OK	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	BC004237	IRAL002O16	MGC	W01A063J16	pENTR-TOPO	14860		DIDO1	11083	AAH04237.1	Hs.517172	Death inducer-obliterator 1			Colon, adenocarcinoma	NIH_MGC_15		NM_080796.2	NP_542986.1	REVIEWED	C	1.000	1.000	562	1689	1	1686	562	1	562
RIKEN	BC021289	IRAL039O09	MGC	W01A063J21	pENTR-TOPO	55		ALPL	249	AAH21289.3	Hs.75431	Alkaline phosphatase, liver/bone/kidney			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001127501.1	NP_001120973.1	REVIEWED	OK	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	AK000892	flj0027h02	FLJ	W01A063J22	pENTR-TOPO	346		GMEB1	10691	BAA91410.1	Hs.632373	Glucocorticoid modulatory element binding protein 1				HEMBA1	EK1	NM_024482.1	NP_077808.1	REVIEWED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
RIKEN	AK000892	flj0027h02	FLJ	W01A063J24	pENTR-TOPO	346		GMEB1	10691	BAA91410.1	Hs.632373	Glucocorticoid modulatory element binding protein 1				HEMBA1	EK1	NM_024482.1	NP_077808.1	REVIEWED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
RIKEN	BC007517	IRAL010P04	MGC	W01A063K02	pENTR-TOPO	19653		RNF8	9025	AAH07517.1	Hs.485278	Ring finger protein 8			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003958.3	NP_003949.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC007517	IRAL010P04	MGC	W01A063K06	pENTR-TOPO	19653		RNF8	9025	AAH07517.1	Hs.485278	Ring finger protein 8			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003958.3	NP_003949.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC034784	IRAK051F14	MGC	W01A063L01	pENTR-TOPO	2871		ZMYND11	10771	AAH34784.1	Hs.292265	Zinc finger, MYND domain containing 11			Brain, adult medulla	NIH_MGC_119	DH10B	NM_212479.2	NP_997644.2	REVIEWED	P	1.000	1.000	527	1584	1	1581	567	41	567
RIKEN	BC002823	IRAL012H04	MGC	W01A063L02	pENTR-TOPO	20475		TRAF3IP2	10758	AAH02823.1	Hs.654708	TRAF3 interacting protein 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_147686.1	NP_679211.1	REVIEWED	OK	1.000	1.000	565	1698	1	1695	565	1	565
RIKEN	BC002823	IRAL012H04	MGC	W01A063L08	pENTR-TOPO	20475		TRAF3IP2	10758	AAH02823.1	Hs.654708	TRAF3 interacting protein 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_147686.1	NP_679211.1	REVIEWED	OK	1.000	1.000	565	1698	1	1695	565	1	565
RIKEN	AK024833	flj0058a05	FLJ	W01A063L09	pENTR-TOPO	27334		KPNA2	3838	-	Hs.594238	Karyopherin alpha 2 (RAG cohort 1, importin alpha 1)				CAS	EK1	NM_002266.2	NP_002257.1	REVIEWED	Cs	0.998	0.998	529	1590	1	1587	529	1	529
RIKEN	AK057028	flj0003d08	FLJ	W01A063L10	pENTR-TOPO	12967		ZNF512	84450	BAB71348.1	Hs.529178	Zinc finger protein 512		neuroepithelioma		SKNMC2	EK1	NM_032434.2	NP_115810.2	VALIDATED	Cs	0.998	0.998	567	1704	1	1701	567	1	567
RIKEN	AK057028	flj0003d08	FLJ	W01A063L14	pENTR-TOPO	12967		ZNF512	84450	BAB71348.1	Hs.529178	Zinc finger protein 512		neuroepithelioma		SKNMC2	EK1	NM_032434.2	NP_115810.2	VALIDATED	Cs	0.998	0.998	567	1704	1	1701	567	1	567
RIKEN	AK024833	flj0058a05	FLJ	W01A063L15	pENTR-TOPO	27334		KPNA2	3838	-	Hs.594238	Karyopherin alpha 2 (RAG cohort 1, importin alpha 1)				CAS	EK1	NM_002266.2	NP_002257.1	REVIEWED	Cs	0.998	0.998	529	1590	1	1587	529	1	529
RIKEN	AK096654	flj0041d10	FLJ	W01A063L17	pENTR-TOPO	6676		RCBTB1	55213	BAC04833.1	Hs.508021	Regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1				OCBBF2	EK1	NM_018191.3	NP_060661.3	REVIEWED	Cs	0.998	0.998	531	1596	1	1593	531	1	531
RIKEN	BC057770	IRAK133J14	MGC	W01A063L18	pENTR-TOPO	7771		SLC27A2	11001	AAH57770.1	Hs.11729	Solute carrier family 27 (fatty acid transporter), member 2			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001159629.1	NP_001153101.1	REVIEWED	OK	1.000	1.000	567	1704	1	1701	567	1	567
RIKEN	BC057770	IRAK133J14	MGC	W01A063L20	pENTR-TOPO	7771		SLC27A2	11001	AAH57770.1	Hs.11729	Solute carrier family 27 (fatty acid transporter), member 2			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001159629.1	NP_001153101.1	REVIEWED	OK	1.000	1.000	567	1704	1	1701	567	1	567
RIKEN	AK096654	flj0041d10	FLJ	W01A063L21	pENTR-TOPO	6676		RCBTB1	55213	BAC04833.1	Hs.508021	Regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 1				OCBBF2	EK1	NM_018191.3	NP_060661.3	REVIEWED	Cs	0.998	0.998	531	1596	1	1593	531	1	531
RIKEN	BC057770	IRAK133J14	MGC	W01A063L22	pENTR-TOPO	7771		SLC27A2	11001	AAH57770.1	Hs.11729	Solute carrier family 27 (fatty acid transporter), member 2			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001159629.1	NP_001153101.1	REVIEWED	OK	1.000	1.000	567	1704	1	1701	567	1	567
RIKEN	BC000422	IRAL001O14	MGC	W01A063M16	pENTR-TOPO	16167		ARIH2	10425	AAH00422.1	Hs.633601	Ariadne homolog 2 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006321.2	NP_006312.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
RIKEN	BC000096	IRAL007F10	MGC	W01A063M17	pENTR-TOPO	13051		HTRA2	27429	AAH00096.1	Hs.716372	HtrA serine peptidase 2			Brain, neuroblastoma	NIH_MGC_19		NM_013247.4	NP_037379.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
RIKEN	AK001437	flj0033f14	FLJ	W01A063M22	pENTR-TOPO	11562		C19orf2	8725	BAG50914.1	Hs.466391	Chromosome 19 open reading frame 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_134447.1	NP_604431.1	REVIEWED	Cg	0.998	1.000	495	1485	1	1482	495	1	495
RIKEN	BC007640	IRAL023I11	MGC	W01A063N05	pENTR-TOPO	8158		PKM2	5315	AAH07640.1	Hs.534770	Pyruvate kinase, muscle			Lung, small cell carcinoma	NIH_MGC_7		NM_002654.3	NP_002645.3	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
RIKEN	BC001167	IRAL006H12	MGC	W01A063N15	pENTR-TOPO	20420		RXRB	6257	AAH01167.1	Hs.388034	Retinoid X receptor, beta			Brain, neuroblastoma	NIH_MGC_19		NM_021976.3	NP_068811.1	REVIEWED	C	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	AK000528	flj0060f20	FLJ	W01A063O01	pENTR-TOPO	5324		IRAK4	51135	BAA91232.1	Hs.138499	Interleukin-1 receptor-associated kinase 4				KAT	EK1	NM_016123.3	NP_057207.2	REVIEWED	C	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	AK000528	flj0060f20	FLJ	W01A063O05	pENTR-TOPO	5324		IRAK4	51135	BAA91232.1	Hs.138499	Interleukin-1 receptor-associated kinase 4				KAT	EK1	NM_016123.3	NP_057207.2	REVIEWED	C	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	BC001048	IRAL007G07	MGC	W01A063O08	pENTR-TOPO	24557		PCTK1	5127	AAH01048.1	Hs.496068	PCTAIRE protein kinase 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006201.3	NP_006192.1	REVIEWED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC013437	IRAK014I06	MGC	W01A063O12	pENTR-TOPO	7726		MEF2A	4205	AAH13437.1	Hs.268675	Myocyte enhancer factor 2A			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_005587.2	NP_005578.2	VALIDATED	C	1.000	1.000	499	1500	1	1497	499	1	499
RIKEN	BC014962	IRAL034M09	MGC	W01A063O13	pENTR-TOPO	3177		GFRA1	2674	AAH14962.1	Hs.388347	GDNF family receptor alpha 1			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_145793.3	NP_665736.1	REVIEWED	C	1.000	1.000	460	1383	1	1380	460	1	460
RIKEN	BC013437	IRAK014I06	MGC	W01A063O16	pENTR-TOPO	7726		MEF2A	4205	AAH13437.1	Hs.268675	Myocyte enhancer factor 2A			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_005587.2	NP_005578.2	VALIDATED	C	1.000	1.000	499	1500	1	1497	499	1	499
RIKEN	BC028936	IRAK052D22	MGC	W01A063O20	pENTR-TOPO	13947		IKZF2	22807	AAH28936.1	Hs.604950	IKAROS family zinc finger 2 (Helios)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079526.1	NP_001072994.1	REVIEWED	C	1.000	1.000	500	1503	1	1500	500	1	500
RIKEN	BC028936	IRAK052D22	MGC	W01A063O22	pENTR-TOPO	13947		IKZF2	22807	AAH28936.1	Hs.604950	IKAROS family zinc finger 2 (Helios)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079526.1	NP_001072994.1	REVIEWED	C	1.000	1.000	500	1503	1	1500	500	1	500
RIKEN	BC028936	IRAK052D22	MGC	W01A063O24	pENTR-TOPO	13947		IKZF2	22807	AAH28936.1	Hs.604950	IKAROS family zinc finger 2 (Helios)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079526.1	NP_001072994.1	REVIEWED	C	1.000	1.000	500	1503	1	1500	500	1	500
RIKEN	BC010013	IRAL026P14	MGC	W01A063P03	pENTR-TOPO	323		MTF2	22823	AAH10013.1	Hs.31016	Metal response element binding transcription factor 2			Primary B-Cells from Tonsils	NIH_MGC_48		NM_007358.3	NP_031384.1	VALIDATED	Cg	0.904	1.000	593	1611	1	1608	593	1	593
RIKEN	AK022875	flj0033n19	FLJ	W01A063P13	pENTR-TOPO	11599		ZNF155	7711	BAB14287.1	Hs.502127	Zinc finger protein 155	NT2	teratocarcinoma		NT2RP2	EK1	NM_198089.1	NP_932355.1	VALIDATED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
RIKEN	BC012070	IRAL029B04	MGC	W01A063P21	pENTR-TOPO	261		ZBTB7B	51043	AAH12070.1	Hs.700874	Zinc finger and BTB domain containing 7B			Uterus, leiomyosarcoma	NIH_MGC_46		NM_015872.2	NP_056956.2	VALIDATED	C	1.000	1.000	539	1620	1	1617	539	1	539
RIKEN	BC012070	IRAL029B04	MGC	W01A063P23	pENTR-TOPO	261		ZBTB7B	51043	AAH12070.1	Hs.700874	Zinc finger and BTB domain containing 7B			Uterus, leiomyosarcoma	NIH_MGC_46		NM_015872.2	NP_056956.2	VALIDATED	C	1.000	1.000	539	1620	1	1617	539	1	539
RIKEN	BC050324	IRAK090P06	MGC	W01A064A02	pENTR-TOPO	5176		ZDHHC17	23390	AAH50324.1	Hs.4014	Zinc finger, DHHC-type containing 17			Testis	NIH_MGC_97	DH10B	NM_015336.2	NP_056151.2	VALIDATED	C	1.000	1.000	632	1899	1	1896	632	1	632
RIKEN	BC002544	IRAL004F07	MGC	W01A064A03	pENTR-TOPO	4699		MEN1	4221	AAH02544.1	Hs.423348	Multiple endocrine neoplasia I			Placenta, choriocarcinoma	NIH_MGC_21		NM_000244.3	NP_000235.2	REVIEWED	Cg	0.935	1.000	615	1728	1	1725	615	1	615
RIKEN	BC050324	IRAK090P06	MGC	W01A064A08	pENTR-TOPO	5176		ZDHHC17	23390	AAH50324.1	Hs.4014	Zinc finger, DHHC-type containing 17			Testis	NIH_MGC_97	DH10B	NM_015336.2	NP_056151.2	VALIDATED	C	1.000	1.000	632	1899	1	1896	632	1	632
RIKEN	AK074892	flj0018m24	FLJ	W01A064A10	pENTR-TOPO	20355		ICK	22858	BAG52026.1	Hs.417022	Intestinal cell (MAK-like) kinase	NT2	teratocarcinoma		NT2RP3	EK1	NM_014920.3	NP_055735.1	REVIEWED	Cs	0.998	0.998	632	1899	1	1896	632	1	632
RIKEN	AK074892	flj0018m24	FLJ	W01A064A12	pENTR-TOPO	20355		ICK	22858	BAG52026.1	Hs.417022	Intestinal cell (MAK-like) kinase	NT2	teratocarcinoma		NT2RP3	EK1	NM_014920.3	NP_055735.1	REVIEWED	Cs	0.998	0.998	632	1899	1	1896	632	1	632
RIKEN	AK125112	flj0069m01	FLJ	W01A064A17	pENTR-TOPO	16803		LRRC15	131578	BAG54146.1	Hs.719456	Leucine rich repeat containing 15				CTONG3	EK1	NM_130830.3	NP_570843.1	VALIDATED	Cs	0.995	0.995	581	1746	1	1743	581	1	581
RIKEN	AK125112	flj0069m01	FLJ	W01A064A19	pENTR-TOPO	16803		LRRC15	131578	BAG54146.1	Hs.719456	Leucine rich repeat containing 15				CTONG3	EK1	NM_130830.3	NP_570843.1	VALIDATED	Cs	0.995	0.995	581	1746	1	1743	581	1	581
RIKEN	AK125112	flj0069m01	FLJ	W01A064A21	pENTR-TOPO	16803		LRRC15	131578	BAG54146.1	Hs.719456	Leucine rich repeat containing 15				CTONG3	EK1	NM_130830.3	NP_570843.1	VALIDATED	Cs	0.995	0.995	581	1746	1	1743	581	1	581
RIKEN	AK056530	flj0004d20	FLJ	W01A064A22	pENTR-TOPO	6943		NRXN3	9369	BAG51739.1	Hs.368307	Neurexin 3	NT2	teratocarcinoma		NT2RP7	EK1	NM_001105250.1	NP_001098720.1	REVIEWED	Cg	0.643	1.000	667	1914	1	1911	459	1	459
RIKEN	H013053K14	H013053K14	RIKEN	W01A064B20	pENTR-TOPO		9581	GSG2	83903		Hs.534059	Germ cell associated 2 (haspin)	-	-	testis	testis	DH10B	NM_031965.2	NP_114171.2	VALIDATED	Cs	0.999	0.999	798	2397	1	2394	798	1	798
RIKEN	H013053K14	H013053K14	RIKEN	W01A064B24	pENTR-TOPO		9581	GSG2	83903		Hs.534059	Germ cell associated 2 (haspin)	-	-	testis	testis	DH10B	NM_031965.2	NP_114171.2	VALIDATED	Cs	0.999	0.999	798	2397	1	2394	798	1	798
RIKEN	BC051271	IRAL047C21	MGC	W01A064C14	pENTR-TOPO	21019		FZD1	8321	AAH51271.1	Hs.94234	Frizzled homolog 1 (Drosophila)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_003505.1	NP_003496.1	REVIEWED	OK	1.000	1.000	647	1944	1	1941	647	1	647
RIKEN	BC001058	IRAL007E21	MGC	W01A064D08	pENTR-TOPO	3579		SART1	9092	AAH01058.1	Hs.502883	Squamous cell carcinoma antigen recognized by T cells			Placenta, choriocarcinoma	NIH_MGC_21		NM_005146.4	NP_005137.1	REVIEWED	C	1.000	1.000	800	2403	1	2400	800	1	800
RIKEN	AK094687	flj0022h19	FLJ	W01A064D12	pENTR-TOPO	10429		ELAC2	60528	BAG52912.1	Hs.434232	ElaC homolog 2 (E. coli)				BRAMY2	EK1	NM_018127.5	NP_060597.4	VALIDATED	Cgs	0.975	0.998	826	2424	1	2421	826	1	826
RIKEN	BC001626	IRAL008P23	MGC	W01A064D18	pENTR-TOPO	20723		MCM3	4172	AAH01626.1	Hs.179565	Minichromosome maintenance complex component 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002388.3	NP_002379.2	REVIEWED	OK	1.000	1.000	808	2427	1	2424	808	1	808
RIKEN	BC001626	IRAL008P23	MGC	W01A064D22	pENTR-TOPO	20723		MCM3	4172	AAH01626.1	Hs.179565	Minichromosome maintenance complex component 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002388.3	NP_002379.2	REVIEWED	OK	1.000	1.000	808	2427	1	2424	808	1	808
RIKEN	H06D069O10	H06D069O10	RIKEN	W01A064E01	pENTR-TOPO		13538						-	-	brain	brain	DH10B			
RIKEN	H06D069O10	H06D069O10	RIKEN	W01A064E03	pENTR-TOPO		13538						-	-	brain	brain	DH10B			
RIKEN	H06D069O10	H06D069O10	RIKEN	W01A064E07	pENTR-TOPO		13538						-	-	brain	brain	DH10B			
RIKEN	BC009763	IRAL003E09	MGC	W01A064E10	pENTR-TOPO	11395		ZNF274	10782	AAH09763.1	Hs.83761	Zinc finger protein 274			Skin, melanotic melanoma.	NIH_MGC_20		NM_016324.2	NP_057408.2	REVIEWED	Cs	0.998	0.998	548	1962	316	1959	548	1	548
RIKEN	BC000714	IRAL007C02	MGC	W01A064E13	pENTR-TOPO	5538		CPSF6	11052	AAH00714.1	Hs.369606	Cleavage and polyadenylation specific factor 6, 68kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_007007.2	NP_008938.2	VALIDATED	Cg	0.937	1.000	588	1767	1	1764	551	1	551
RIKEN	BC009763	IRAL003E09	MGC	W01A064E16	pENTR-TOPO	11395		ZNF274	10782	AAH09763.1	Hs.83761	Zinc finger protein 274			Skin, melanotic melanoma.	NIH_MGC_20		NM_016324.2	NP_057408.2	REVIEWED	Cs	0.998	0.998	548	1962	316	1959	548	1	548
RIKEN	BC007263	IRAL022G17	MGC	W01A064E19	pENTR-TOPO	2165		ZNF496	84838	AAH07263.1	Hs.654803	Zinc finger protein 496			Colon, adenocarcinoma	NIH_MGC_15		NM_032752.1	NP_116141.1	PROVISIONAL	OK	1.000	1.000	587	1764	1	1761	587	1	587
RIKEN	BC034957	IRAK033O08	MGC	W01A064F05	pENTR-TOPO	23091		ADAM2	2515	AAH34957.1	Hs.177959	ADAM metallopeptidase domain 2			Testis	NIH_MGC_97	DH10B	NM_001464.3	NP_001455.3	REVIEWED	Cg	0.974	1.000	735	2151	1	2148	735	1	735
RIKEN	BC034957	IRAK033O08	MGC	W01A064F07	pENTR-TOPO	23091		ADAM2	2515	AAH34957.1	Hs.177959	ADAM metallopeptidase domain 2			Testis	NIH_MGC_97	DH10B	NM_001464.3	NP_001455.3	REVIEWED	Cg	0.974	1.000	735	2151	1	2148	735	1	735
RIKEN	BC056202	IRAK091F24	MGC	W01A064F10	pENTR-TOPO	16107		CAPN7	23473	AAH56202.1	Hs.631920	Calpain 7			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014296.2	NP_055111.1	REVIEWED	Cs	0.996	0.996	813	2442	1	2439	813	1	813
RIKEN	BC056202	IRAK091F24	MGC	W01A064F14	pENTR-TOPO	16107		CAPN7	23473	AAH56202.1	Hs.631920	Calpain 7			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014296.2	NP_055111.1	REVIEWED	Cs	0.996	0.996	813	2442	1	2439	813	1	813
RIKEN	AK131231	flj0073a16	FLJ	W01A064F21	pENTR-TOPO	12504		ZNF600	162966	BAD18414.1	Hs.696848	Zinc finger protein 600				BRAMY2	EK1	NM_198457.2	NP_940859.2	VALIDATED	Cs	0.999	0.999	722	2169	1	2166	722	1	722
RIKEN	BC014940	IRAK015P02	MGC	W01A064G06	pENTR-TOPO	11164		CXXC1	30827	AAH14940.1	Hs.180933	CXXC finger 1 (PHD domain)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014593.3	NP_055408.2	VALIDATED	OK	1.000	1.000	656	1971	1	1968	656	1	656
RIKEN	AK056649	flj0005c01	FLJ	W01A064G10	pENTR-TOPO	7039		FLRT2	23768	BAG51774.1	Hs.719261	Fibronectin leucine rich transmembrane protein 2				OCBBF2	EK1	NM_013231.4	NP_037363.1	REVIEWED	Cs	0.995	0.995	660	1983	1	1980	660	1	660
RIKEN	BC000418	IRAL001O02	MGC	W01A064G13	pENTR-TOPO	19163		ENC1	8507	AAH00418.1	Hs.104925	Ectodermal-neural cortex (with BTB-like domain)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003633.2	NP_003624.1	VALIDATED	C	1.000	1.000	589	1770	1	1767	589	1	589
RIKEN	AK056649	flj0005c01	FLJ	W01A064G14	pENTR-TOPO	7039		FLRT2	23768	BAG51774.1	Hs.719261	Fibronectin leucine rich transmembrane protein 2				OCBBF2	EK1	NM_013231.4	NP_037363.1	REVIEWED	Cs	0.995	0.995	660	1983	1	1980	660	1	660
RIKEN	BC009752	IRAL003F02	MGC	W01A064G18	pENTR-TOPO	1650		SCMH1	22955	AAH09752.1	Hs.571874	Sex comb on midleg homolog 1 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001031694.1	NP_001026864.1	PROVISIONAL	OK	1.000	1.000	660	1983	1	1980	660	1	660
RIKEN	BC009752	IRAL003F02	MGC	W01A064G20	pENTR-TOPO	1650		SCMH1	22955	AAH09752.1	Hs.571874	Sex comb on midleg homolog 1 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001031694.1	NP_001026864.1	PROVISIONAL	OK	1.000	1.000	660	1983	1	1980	660	1	660
RIKEN	BC009752	IRAL003F02	MGC	W01A064G24	pENTR-TOPO	1650		SCMH1	22955	AAH09752.1	Hs.571874	Sex comb on midleg homolog 1 (Drosophila)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001031694.1	NP_001026864.1	PROVISIONAL	OK	1.000	1.000	660	1983	1	1980	660	1	660
RIKEN	H04D018C18	H04D018C18	RIKEN	W01A064H12	pENTR-TOPO		23566						-	-	testis	testis	DH10B			
RIKEN	H033064J08	H033064J08	RIKEN	W01A064H17	pENTR-TOPO		217	IFI16	3428		Hs.380250	Interferon, gamma-inducible protein 16	-	-	hypothalamus	hypothalamus	DH10B	NM_005531.2	NP_005522.2	REVIEWED	Cs	0.992	0.992	729	2190	1	2187	729	1	729
RIKEN	H033064J08	H033064J08	RIKEN	W01A064H19	pENTR-TOPO		217	IFI16	3428		Hs.380250	Interferon, gamma-inducible protein 16	-	-	hypothalamus	hypothalamus	DH10B	NM_005531.2	NP_005522.2	REVIEWED	Cs	0.992	0.992	729	2190	1	2187	729	1	729
RIKEN	AK055973	flj0002o19	FLJ	W01A064I04	pENTR-TOPO	5841		DUSP16	80824	BAB71060.1	Hs.536535	Dual specificity phosphatase 16	NT2	teratocarcinoma		NT2NE2	EK1	NM_030640.1	NP_085143.1	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
RIKEN	AK055973	flj0002o19	FLJ	W01A064I06	pENTR-TOPO	5841		DUSP16	80824	BAB71060.1	Hs.536535	Dual specificity phosphatase 16	NT2	teratocarcinoma		NT2NE2	EK1	NM_030640.1	NP_085143.1	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
RIKEN	BC029041	IRAK050E07	MGC	W01A064I16	pENTR-TOPO	16917		ZBTB20	26137	AAH29041.1	Hs.655108	Zinc finger and BTB domain containing 20			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_015642.3	NP_056457.2	PROVISIONAL	Cs	0.997	0.997	668	2007	1	2004	668	1	668
RIKEN	AK090624	flj0014g24	FLJ	W01A064I20	pENTR-TOPO	8828		TRAF7	84231	BAG52199.1	Hs.713632	TNF receptor-associated factor 7	H4	neuroglioma		BNGH42	EK1	NM_032271.2	NP_115647.2	VALIDATED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
RIKEN	AK001506	flj0034g22	FLJ	W01A064J04	pENTR-TOPO	351		DDX20	11218	BAA91727.1	Hs.591405	DEAD (Asp-Glu-Ala-Asp) box polypeptide 20	NT2	teratocarcinoma		NT2RP2	EK1	NM_007204.3	NP_009135.3	REVIEWED	Cs	0.998	0.998	824	2475	1	2472	824	1	824
RIKEN	AK001506	flj0034g22	FLJ	W01A064J06	pENTR-TOPO	351		DDX20	11218	BAA91727.1	Hs.591405	DEAD (Asp-Glu-Ala-Asp) box polypeptide 20	NT2	teratocarcinoma		NT2RP2	EK1	NM_007204.3	NP_009135.3	REVIEWED	Cs	0.998	0.998	824	2475	1	2472	824	1	824
RIKEN	BC023542	IRAL026E13	MGC	W01A064J10	pENTR-TOPO	1865		SORT1	6272	AAH23542.1	Hs.485195	Sortilin 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_002959.4	NP_002950.3	REVIEWED	C	1.000	1.000	831	2496	1	2493	831	1	831
RIKEN	BC010623	IRAK013K07	MGC	W01A064J11	pENTR-TOPO	9886		NFE2L1	4779	AAH10623.1	Hs.514284	Nuclear factor (erythroid-derived 2)-like 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003204.2	NP_003195.1	VALIDATED	Cg	0.961	1.000	772	2229	1	2226	772	1	772
RIKEN	BC033692	IRAK068O13	MGC	W01A064J18	pENTR-TOPO	18856		HMGCR	3156	AAH33692.1	Hs.713530	3-hydroxy-3-methylglutaryl-Coenzyme A reductase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001130996.1	NP_001124468.1	REVIEWED	OK	1.000	1.000	835	2508	1	2505	835	1	835
RIKEN	BC033692	IRAK068O13	MGC	W01A064J20	pENTR-TOPO	18856		HMGCR	3156	AAH33692.1	Hs.713530	3-hydroxy-3-methylglutaryl-Coenzyme A reductase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001130996.1	NP_001124468.1	REVIEWED	OK	1.000	1.000	835	2508	1	2505	835	1	835
RIKEN	H06D012C04	H06D012C04	RIKEN	W01A064K05	pENTR-TOPO		23030						-	-	brain	brain	DH10B			
RIKEN	BC000755	IRAL007M12	MGC	W01A064K06	pENTR-TOPO	11464		HDGF2	84717	AAH00755.1	Hs.43071	Hepatoma-derived growth factor-related protein 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_032631.2	NP_116020.1	REVIEWED	C	1.000	1.000	670	2013	1	2010	670	1	670
RIKEN	BC047105	IRAK091M11	MGC	W01A064K17	pENTR-TOPO	19216		ZNF354A	6940	AAH47105.1	Hs.484324	Zinc finger protein 354A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005649.2	NP_005640.2	VALIDATED	Cs	0.998	0.998	605	1818	1	1815	605	1	605
RIKEN	BC047105	IRAK091M11	MGC	W01A064K21	pENTR-TOPO	19216		ZNF354A	6940	AAH47105.1	Hs.484324	Zinc finger protein 354A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005649.2	NP_005640.2	VALIDATED	Cs	0.998	0.998	605	1818	1	1815	605	1	605
RIKEN	H013001M19	H013001M19	RIKEN	W01A064L06	pENTR-TOPO		6277	PKP2	5318		Hs.164384	Plakophilin 2	-	-	testis	testis	DH10B	NM_001005242.2	NP_001005242.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
RIKEN	BC004136	IRAL007B16	MGC	W01A064L07	pENTR-TOPO	14557		TPX2	22974	AAH04136.1	Hs.719145	TPX2, microtubule-associated, homolog (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012112.4	NP_036244.2	VALIDATED	C	1.000	1.000	747	2244	1	2241	747	1	747
RIKEN	BC041878	IRAK074P05	MGC	W01A064L12	pENTR-TOPO	17952		CLOCK	9575	AAH41878.1	Hs.436975	Clock homolog (mouse)			Testis	NIH_MGC_97	DH10B	NM_004898.2	NP_004889.1	REVIEWED	Cs	0.999	0.999	846	2541	1	2538	846	1	846
RIKEN	BC044851	IRAK071E11	MGC	W01A064L18	pENTR-TOPO	21901		VPS41	27072	AAH44851.1	Hs.592184	Vacuolar protein sorting 41 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014396.3	NP_055211.2	REVIEWED	C	1.000	1.000	854	2565	1	2562	854	1	854
RIKEN	BC044851	IRAK071E11	MGC	W01A064L20	pENTR-TOPO	21901		VPS41	27072	AAH44851.1	Hs.592184	Vacuolar protein sorting 41 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014396.3	NP_055211.2	REVIEWED	C	1.000	1.000	854	2565	1	2562	854	1	854
RIKEN	BC040591	IRAK074I11	MGC	W01A064M01	pENTR-TOPO	12134		ZNF571	51276	AAH40591.1	Hs.590944	Zinc finger protein 571			Testis	NIH_MGC_97	DH10B	NM_016536.3	NP_057620.3	VALIDATED	Cs	0.997	0.997	609	1830	1	1827	609	1	609
RIKEN	BC040591	IRAK074I11	MGC	W01A064M05	pENTR-TOPO	12134		ZNF571	51276	AAH40591.1	Hs.590944	Zinc finger protein 571			Testis	NIH_MGC_97	DH10B	NM_016536.3	NP_057620.3	VALIDATED	Cs	0.997	0.997	609	1830	1	1827	609	1	609
RIKEN	BC014662	IRAL034C04	MGC	W01A064M06	pENTR-TOPO	1775		SCYL3	57147	AAH14662.1	Hs.435560	SCY1-like 3 (S. cerevisiae)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020423.5	NP_065156.5	VALIDATED	Cs	0.999	0.999	688	2067	1	2064	688	1	688
RIKEN	BC040591	IRAK074I11	MGC	W01A064M07	pENTR-TOPO	12134		ZNF571	51276	AAH40591.1	Hs.590944	Zinc finger protein 571			Testis	NIH_MGC_97	DH10B	NM_016536.3	NP_057620.3	VALIDATED	Cs	0.997	0.997	609	1830	1	1827	609	1	609
RIKEN	BC037963	IRAK079D08	MGC	W01A064M10	pENTR-TOPO	3696		ADRBK1	156	AAH37963.1	Hs.83636	Adrenergic, beta, receptor kinase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001619.3	NP_001610.2	REVIEWED	C	1.000	1.000	689	2070	1	2067	689	1	689
RIKEN	BC013357	IRAL024B14	MGC	W01A064M13	pENTR-TOPO	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Ovary, adenocarcinoma	NIH_MGC_9		NM_016120.3	NP_057204.2	REVIEWED	C	1.000	1.000	624	1875	1	1872	624	1	624
RIKEN	BC037963	IRAK079D08	MGC	W01A064M16	pENTR-TOPO	3696		ADRBK1	156	AAH37963.1	Hs.83636	Adrenergic, beta, receptor kinase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001619.3	NP_001610.2	REVIEWED	C	1.000	1.000	689	2070	1	2067	689	1	689
RIKEN	BC069237	IRAL054C04	MGC	W01A064M17	pENTR-TOPO	24503		UBQLN2	29978	AAH69237.1	Hs.179309	Ubiquilin 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_013444.2	NP_038472.2	REVIEWED	C	1.000	1.000	624	1875	1	1872	624	1	624
RIKEN	BC069237	IRAL054C04	MGC	W01A064M21	pENTR-TOPO	24503		UBQLN2	29978	AAH69237.1	Hs.179309	Ubiquilin 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_013444.2	NP_038472.2	REVIEWED	C	1.000	1.000	624	1875	1	1872	624	1	624
RIKEN	BC069237	IRAL054C04	MGC	W01A064M23	pENTR-TOPO	24503		UBQLN2	29978	AAH69237.1	Hs.179309	Ubiquilin 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_013444.2	NP_038472.2	REVIEWED	C	1.000	1.000	624	1875	1	1872	624	1	624
RIKEN	BC032109	IRAL033N05	MGC	W01A064N04	pENTR-TOPO	22981		LRP12	29967	AAH32109.1	Hs.600630	Low density lipoprotein-related protein 12			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_013437.3	NP_038465.1	REVIEWED	C	1.000	1.000	859	2580	1	2577	859	1	859
RIKEN	BC032109	IRAL033N05	MGC	W01A064N08	pENTR-TOPO	22981		LRP12	29967	AAH32109.1	Hs.600630	Low density lipoprotein-related protein 12			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_013437.3	NP_038465.1	REVIEWED	C	1.000	1.000	859	2580	1	2577	859	1	859
RIKEN	BC000185	IRAL006C19	MGC	W01A064N11	pENTR-TOPO	4703		CPT1A	1374	AAH00185.1	Hs.503043	Carnitine palmitoyltransferase 1A (liver)			Eye, retinoblastoma	NIH_MGC_16		NM_001031847.2	NP_001027017.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
RIKEN	BC000185	IRAL006C19	MGC	W01A064N15	pENTR-TOPO	4703		CPT1A	1374	AAH00185.1	Hs.503043	Carnitine palmitoyltransferase 1A (liver)			Eye, retinoblastoma	NIH_MGC_16		NM_001031847.2	NP_001027017.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
RIKEN	H013081M16	H013081M16	RIKEN	W01A064N19	pENTR-TOPO		1778	PHTF1	10745		Hs.655824	Putative homeodomain transcription factor 1	-	-	testis	testis	DH10B	NM_006608.2	NP_006599.2	VALIDATED	Cs	0.999	0.999	762	2289	1	2286	762	1	762
RIKEN	BC059174	IRAK098M05	MGC	W01A064O05	pENTR-TOPO	13165		TRAF3IP1	26146	AAH59174.1	Hs.631898	TNF receptor-associated factor 3 interacting protein 1				Lupski_sympathetic_trunk	DH10B	NM_001139490.1	NP_001132962.1	VALIDATED	Cs	0.998	0.998	625	1878	1	1875	625	1	625
RIKEN	BC059174	IRAK098M05	MGC	W01A064O07	pENTR-TOPO	13165		TRAF3IP1	26146	AAH59174.1	Hs.631898	TNF receptor-associated factor 3 interacting protein 1				Lupski_sympathetic_trunk	DH10B	NM_001139490.1	NP_001132962.1	VALIDATED	Cs	0.998	0.998	625	1878	1	1875	625	1	625
RIKEN	BC004372	IRAL013P10	MGC	W01A064O12	pENTR-TOPO	3654		CD44	960	AAH04372.1	Hs.502328	CD44 molecule (Indian blood group)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001001389.1	NP_001001389.1	REVIEWED	Cs	0.997	0.997	699	2100	1	2097	699	1	699
RIKEN	BC001438	IRAL004D07	MGC	W01A064O13	pENTR-TOPO	12275		ZNF256	10172	AAH01438.2	Hs.596242	Zinc finger protein 256			Placenta, choriocarcinoma	NIH_MGC_21		NM_005773.2	NP_005764.2	VALIDATED	C	1.000	1.000	627	1884	1	1881	627	1	627
RIKEN	BC004372	IRAL013P10	MGC	W01A064O16	pENTR-TOPO	3654		CD44	960	AAH04372.1	Hs.502328	CD44 molecule (Indian blood group)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001001389.1	NP_001001389.1	REVIEWED	Cs	0.997	0.997	699	2100	1	2097	699	1	699
RIKEN	BC065545	IRAK140B16	MGC	W01A064O18	pENTR-TOPO	15189		ADARB1	104	AAH65545.1	Hs.474018	Adenosine deaminase, RNA-specific, B1 (RED1 homolog rat)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001112.3	NP_001103.1	VALIDATED	Cs	0.999	0.999	701	2106	1	2103	701	1	701
RIKEN	BC008071	IRAL003D03	MGC	W01A064P09	pENTR-TOPO	2606		DDX21	9188	AAH08071.2	Hs.223141	DEAD (Asp-Glu-Ala-Asp) box polypeptide 21			Colon, adenocarcinoma	NIH_MGC_15		NM_004728.2	NP_004719.2	REVIEWED	C	1.000	1.000	783	2352	1	2349	783	1	783
RIKEN	BC062539	IRAL050J02	MGC	W01A064P17	pENTR-TOPO	5257		SP1	6667	AAH62539.1	Hs.649191	Sp1 transcription factor			Brain, neuroblastoma	NIH_MGC_47		NM_138473.2	NP_612482.2	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
RIKEN	BC062539	IRAL050J02	MGC	W01A064P21	pENTR-TOPO	5257		SP1	6667	AAH62539.1	Hs.649191	Sp1 transcription factor			Brain, neuroblastoma	NIH_MGC_47		NM_138473.2	NP_612482.2	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
RIKEN	BC062539	IRAL050J02	MGC	W01A064P23	pENTR-TOPO	5257		SP1	6667	AAH62539.1	Hs.649191	Sp1 transcription factor			Brain, neuroblastoma	NIH_MGC_47		NM_138473.2	NP_612482.2	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
RIKEN	AK090673	flj0012a17	FLJ	W01A065A15	pENTR-TOPO	9302		TRADD	8717	BAG52211.1	Hs.460996	TNFRSF1A-associated via death domain				BRACE2	EK1	NM_003789.3	NP_003780.1	REVIEWED	P	1.000	1.000	252	759	1	756	312	61	312
RIKEN	AK090673	flj0012a17	FLJ	W01A065A19	pENTR-TOPO	9302		TRADD	8717	BAG52211.1	Hs.460996	TNFRSF1A-associated via death domain				BRACE2	EK1	NM_003789.3	NP_003780.1	REVIEWED	P	1.000	1.000	252	759	1	756	312	61	312
RIKEN	AK090673	flj0012a17	FLJ	W01A065A23	pENTR-TOPO	9302		TRADD	8717	BAG52211.1	Hs.460996	TNFRSF1A-associated via death domain				BRACE2	EK1	NM_003789.3	NP_003780.1	REVIEWED	P	1.000	1.000	252	759	1	756	312	61	312
RIKEN	AK096346	flj0039p24	FLJ	W01A065B18	pENTR-TOPO	6442		ZNF828	283489	BAG53268.1	Hs.7542	Zinc finger protein 828	NT2	teratocarcinoma		NT2RP7	EK1	NM_032436.1	NP_115812.1	PROVISIONAL	C	1.000	1.000	812	2439	1	2436	812	1	812
RIKEN	BC029364	IRAL041H13	MGC	W01A065C11	pENTR-TOPO	11904		ICAM4	3386	AAH29364.1	Hs.706750	Intercellular adhesion molecule 4 (Landsteiner-Wiener blood group)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_001544.3	NP_001535.1	REVIEWED	C	1.000	1.000	271	816	1	813	271	1	271
RIKEN	H023099I02	H023099I02	RIKEN	W01A065C21	pENTR-TOPO		4546	CREBZF	58487		Hs.595940	CREB/ATF bZIP transcription factor	-	-	hippocampus	hippocampus	DH10B	NM_001039618.1	NP_001034707.1	VALIDATED	P	1.000	1.000	272	819	1	816	354	83	354
RIKEN	AK026627	flj0060n24	FLJ	W01A065D18	pENTR-TOPO	18612		ZNF346	23567	-	Hs.484259	Zinc finger protein 346				KAT	EK1	NM_012279.2	NP_036411.1	REVIEWED	C	1.000	1.000	294	885	1	882	294	1	294
RIKEN	BC005957	IRAL021A07	MGC	W01A065E01	pENTR-TOPO	15922		SLC25A17	10478	AAH05957.1	Hs.474938	Solute carrier family 25 (mitochondrial carrier; peroxisomal membrane protein, 34kDa), member 17			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006358.2	NP_006349.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
RIKEN	AK097439	flj0040k06	FLJ	W01A065G01	pENTR-TOPO	11494		ETV2	2116	BAG53472.1	Hs.194061	Ets variant 2				TESTI2	EK1	NM_014209.2	NP_055024.2	VALIDATED	Cgs	0.922	0.997	370	1113	1	1110	342	1	342
RIKEN	BC035212	IRAK029K22	MGC	W01A065G13	pENTR-TOPO	18286		VEGFC	7424	AAH35212.1	Hs.435215	Vascular endothelial growth factor C			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_005429.2	NP_005420.1	REVIEWED	C	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC042636	IRAK071N09	MGC	W01A065I01	pENTR-TOPO	11471		ZNF134	7693	AAH42636.1	Hs.469694	Zinc finger protein 134			Testis	NIH_MGC_97	DH10B	NM_003435.3	NP_003426.3	PROVISIONAL	Cs	0.998	0.998	427	1284	1	1281	427	1	427
RIKEN	AK125791	flj0072i07	FLJ	W01A065K09	pENTR-TOPO	3363		SLC16A9	220963	BAC86293.1	Hs.499709	Solute carrier family 16, member 9 (monocarboxylic acid transporter 9)				TESTI4	EK1	NM_194298.2	NP_919274.1	VALIDATED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	AK055556	flj0001d13	FLJ	W01A065L12	pENTR-TOPO	23103		SOX7	83595	BAB70955.1	Hs.709543	SRY (sex determining region Y)-box 7				HLUNG1	EK1	NM_031439.2	NP_113627.1	REVIEWED	C	1.000	1.000	388	1167	1	1164	388	1	388
RIKEN	BC033867	IRAK068N02	MGC	W01A065M07	pENTR-TOPO	14296		ACVR1	90	AAH33867.1	Hs.470316	Activin A receptor, type I			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001111067.2	NP_001104537.1	REVIEWED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	BC033867	IRAK068N02	MGC	W01A065M11	pENTR-TOPO	14296		ACVR1	90	AAH33867.1	Hs.470316	Activin A receptor, type I			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001111067.2	NP_001104537.1	REVIEWED	C	1.000	1.000	509	1530	1	1527	509	1	509
RIKEN	AK125188	flj0070m18	FLJ	W01A065M17	pENTR-TOPO	22943		MTUS1	57509	BAG54161.1	Hs.7946	Mitochondrial tumor suppressor 1				FEBRA2	EK1	NM_001001931.2	NP_001001931.1	REVIEWED	OK	1.000	1.000	517	1554	1	1551	517	1	517
RIKEN	BC051866	IRAK110J10	MGC	W01A065N04	pENTR-TOPO	20069		RING1	6015	AAH51866.1	Hs.631989	Ring finger protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002931.3	NP_002922.2	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	AK024191	flj0031a10	FLJ	W01A066A13	pENTR-TOPO	22656		ZNF696	79943	BAB14850.1	Hs.512740	Zinc finger protein 696				MAMMA1	EK1	NM_030895.2	NP_112157.2	VALIDATED	Cs	0.997	0.997	374	1125	1	1122	374	1	374
RIKEN	AK024191	flj0031a10	FLJ	W01A066A19	pENTR-TOPO	22656		ZNF696	79943	BAB14850.1	Hs.512740	Zinc finger protein 696				MAMMA1	EK1	NM_030895.2	NP_112157.2	VALIDATED	Cs	0.997	0.997	374	1125	1	1122	374	1	374
RIKEN	AK024191	flj0031a10	FLJ	W01A066A23	pENTR-TOPO	22656		ZNF696	79943	BAB14850.1	Hs.512740	Zinc finger protein 696				MAMMA1	EK1	NM_030895.2	NP_112157.2	VALIDATED	Cs	0.997	0.997	374	1125	1	1122	374	1	374
RIKEN	AK074686	flj0017b22	FLJ	W01A066C01	pENTR-TOPO	14636		HM13	81502	BAC11138.1	Hs.373741	Histocompatibility (minor) 13				MAMMA1	EK1	NM_178582.1	NP_848697.1	REVIEWED	OK	1.000	1.000	143	432	1	429	143	1	143
RIKEN	AK074686	flj0017b22	FLJ	W01A066C05	pENTR-TOPO	14636		HM13	81502	BAC11138.1	Hs.373741	Histocompatibility (minor) 13				MAMMA1	EK1	NM_178582.1	NP_848697.1	REVIEWED	OK	1.000	1.000	143	432	1	429	143	1	143
RIKEN	BC017698	IRAK027O09	MGC	W01A066C19	pENTR-TOPO	11581		ZNF580	51157	AAH17698.1	Hs.631551	Zinc finger protein 580			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_016202.2	NP_057286.1	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	BC017698	IRAK027O09	MGC	W01A066C21	pENTR-TOPO	11581		ZNF580	51157	AAH17698.1	Hs.631551	Zinc finger protein 580			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_016202.2	NP_057286.1	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	AK128854	flj0077k01	FLJ	W01A066D08	pENTR-TOPO	18625		SLCO4C1	353189	BAC87647.1	Hs.127648	Solute carrier organic anion transporter family, member 4C1				TRACH3	EK1	NM_180991.4	NP_851322.3	VALIDATED	C	1.000	1.000	724	2175	1	2172	724	1	724
RIKEN	BC016474	IRAK012K11	MGC	W01A066D20	pENTR-TOPO	11376		CNOT3	4849	AAH16474.1	Hs.343571	CCR4-NOT transcription complex, subunit 3				NCI_CGAP_Brn67	DH10B	NM_014516.2	NP_055331.1	VALIDATED	C	1.000	1.000	753	2262	1	2259	753	1	753
RIKEN	BC032651	IRAK069H19	MGC	W01A066E09	pENTR-TOPO	10654		CD79B	974	AAH32651.1	Hs.89575	CD79b molecule, immunoglobulin-associated beta			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000626.2	NP_000617.1	REVIEWED	C	1.000	1.000	229	690	1	687	229	1	229
RIKEN	BC047510	IRAK091J18	MGC	W01A066G03	pENTR-TOPO	18175		PAQR3	152559	AAH47510.1	Hs.657312	Progestin and adipoQ receptor family member III			Testis	NIH_MGC_97	DH10B	NM_001040202.1	NP_001035292.1	VALIDATED	Ps	0.993	0.993	267	810	1	801	311	1	267
RIKEN	AK093182	flj0009i06	FLJ	W01A066G21	pENTR-TOPO	11773		ZNF383	163087	BAC04086.1	Hs.590975	Zinc finger protein 383				TESTI2	EK1	NM_152604.1	NP_689817.1	PROVISIONAL	C	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC036742	IRAK068I01	MGC	W01A066H12	pENTR-TOPO	15833		PLA2G6	8398	AAH36742.2	Hs.170479	Phospholipase A2, group VI (cytosolic, calcium-independent)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003560.2	NP_003551.2	REVIEWED	OK	1.000	1.000	806	2421	1	2418	806	1	806
RIKEN	BC000980	IRAK003N07	MGC	W01A066I13	pENTR-TOPO	16288		IL17RB	55540	AAH00980.1	Hs.654970	Interleukin 17 receptor B			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_018725.3	NP_061195.2	REVIEWED	C	1.000	1.000	502	1509	1	1506	502	1	502
RIKEN	BC011263	IRAK012O07	MGC	W01A066J12	pENTR-TOPO	4765		MAP3K11	4296	AAH11263.1	Hs.502872	Mitogen-activated protein kinase kinase kinase 11				NCI_CGAP_Brn67	DH10B	NM_002419.3	NP_002410.1	REVIEWED	C	1.000	1.000	847	2544	1	2541	847	1	847
RIKEN	AK122795	flj0043d24	FLJ	W01A066K15	pENTR-TOPO	6038		KRT71	112802	BAG53733.1	Hs.660007	Keratin 71				THYMU2	EK1	NM_033448.2	NP_258259.1	VALIDATED	C	1.000	1.000	523	1572	1	1569	523	1	523
RIKEN	BC041804	IRAK074O03	MGC	W01A066L02	pENTR-TOPO	6657		DZIP1	22873	AAH41804.1	Hs.656580	DAZ interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_198968.2	NP_945319.1	VALIDATED	C	1.000	1.000	867	2604	1	2601	867	1	867
RIKEN	BC041804	IRAK074O03	MGC	W01A066L12	pENTR-TOPO	6657		DZIP1	22873	AAH41804.1	Hs.656580	DAZ interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_198968.2	NP_945319.1	VALIDATED	C	1.000	1.000	867	2604	1	2601	867	1	867
RIKEN	BC072420	IRAK174M13	MGC	W01A066L14	pENTR-TOPO	12232		TNPO2	30000	AAH72420.1	Hs.416049	Transportin 2				Lupski_dorsal_root_ganglion	DH10B	NM_001136195.1	NP_001129667.1	VALIDATED	C	1.000	1.000	887	2664	1	2661	887	1	887
RIKEN	BC072420	IRAK174M13	MGC	W01A066L22	pENTR-TOPO	12232		TNPO2	30000	AAH72420.1	Hs.416049	Transportin 2				Lupski_dorsal_root_ganglion	DH10B	NM_001136195.1	NP_001129667.1	VALIDATED	C	1.000	1.000	887	2664	1	2661	887	1	887
RIKEN	BC067476	IRAK172F13	MGC	W01A066M01	pENTR-TOPO	13874		GPR75	10936	AAH67476.1					PCR rescued clones	NIH_MGC_195	DH10B	NM_006794.2	NP_006785.1	VALIDATED	C	1.000	1.000	540	1623	1	1620	540	1	540
RIKEN	AK093808	flj0021a17	FLJ	W01A067A07	pENTR-TOPO	3187		ZWINT	11130	BAG52767.1	Hs.591363	ZW10 interactor				THYMU2	EK1	NM_007057.3	NP_008988.2	REVIEWED	P	1.000	1.000	44	147	1	132	277	1	44
RIKEN	AK000479	flj0060h04	FLJ	W01A067A17	pENTR-TOPO	7752		SERF2	10169	-	Hs.424126	Small EDRK-rich factor 2				KAT	EK1	NM_001018108.2	NP_001018118.1	VALIDATED	C	1.000	1.000	59	180	1	177	59	1	59
RIKEN	BC018048	IRAK032D13	MGC	W01A067B04	pENTR-TOPO	6237		PMCH	5367	AAH18048.1	Hs.707990	Pro-melanin-concentrating hormone			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002674.2	NP_002665.2	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
RIKEN	BC066270	IRAK172F11	MGC	W01A067B24	pENTR-TOPO	6034		IL26	55801	AAH66270.1	Hs.272350	Interleukin 26			PCR rescued clones	NIH_MGC_195	DH10B	NM_018402.1	NP_060872.1	REVIEWED	C	1.000	1.000	171	516	1	513	171	1	171
RIKEN	AK098563	flj0053c04	FLJ	W01A067C03	pENTR-TOPO	7742		SNURF	8926	-						TST	EK1	NM_005678.3	NP_005669.2	REVIEWED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	H023015C21	H023015C21	RIKEN	W01A067C19	pENTR-TOPO		5988						-	-	hippocampus	hippocampus	DH10B			
RIKEN	AK055195	flj0014p16	FLJ	W01A067D08	pENTR-TOPO	8250		SLTM	79811	BAG51484.1	Hs.512932	SAFB-like, transcription modulator				CTONG2	EK1	NM_001013843.1	NP_001013865.1	VALIDATED		0.701	0.736	167	534	1	480	1016	1	166
RIKEN	BC066323	IRAK167C17	MGC	W01A067D14	pENTR-TOPO	11177		RPL17	6139	AAH66323.1	Hs.485090	Ribosomal protein L17			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000985.3	NP_000976.1	REVIEWED	C	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC066323	IRAK167C17	MGC	W01A067D24	pENTR-TOPO	11177		RPL17	6139	AAH66323.1	Hs.485090	Ribosomal protein L17			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_000985.3	NP_000976.1	REVIEWED	C	1.000	1.000	184	555	1	552	184	1	184
RIKEN	H033071E11	H033071E11	RIKEN	W01A067E03	pENTR-TOPO		1192	NEDD8	4738		Hs.531064	Neural precursor cell expressed, developmentally down-regulated 8	-	-	hypothalamus	hypothalamus	DH10B	NM_006156.2	NP_006147.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
RIKEN	H033071E11	H033071E11	RIKEN	W01A067E09	pENTR-TOPO		1192	NEDD8	4738		Hs.531064	Neural precursor cell expressed, developmentally down-regulated 8	-	-	hypothalamus	hypothalamus	DH10B	NM_006156.2	NP_006147.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
RIKEN	H023078L09	H023078L09	RIKEN	W01A067E13	pENTR-TOPO		19813	AKAP7	9465		Hs.486483	A kinase (PRKA) anchor protein 7	-	-	hippocampus	hippocampus	DH10B	NM_004842.2	NP_004833.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	H023078L09	H023078L09	RIKEN	W01A067E17	pENTR-TOPO		19813	AKAP7	9465		Hs.486483	A kinase (PRKA) anchor protein 7	-	-	hippocampus	hippocampus	DH10B	NM_004842.2	NP_004833.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	AK056321	flj0003g07	FLJ	W01A067F14	pENTR-TOPO	12883		ITM2C	81618	BAG51676.1	Hs.111577	Integral membrane protein 2C	NT2	teratocarcinoma		NT2RI2	EK1	NM_001012514.1	NP_001012532.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC032811	IRAK068L07	MGC	W01A067G03	pENTR-TOPO	15437		TFF1	7031	AAH32811.1	Hs.162807	Trefoil factor 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_003225.2	NP_003216.1	REVIEWED	C	1.000	1.000	84	255	1	252	84	1	84
RIKEN	BC068535	IRAK167C16	MGC	W01A067G13	pENTR-TOPO	21776		TP53TG1	11257	AAH68535	Hs.274329	TP53 target 1 (non-protein coding)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_007233.1	NP_009164.1	PREDICTED										
RIKEN	BC068535	IRAK167C16	MGC	W01A067G19	pENTR-TOPO	21776		TP53TG1	11257	AAH68535	Hs.274329	TP53 target 1 (non-protein coding)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_007233.1	NP_009164.1	PREDICTED										
RIKEN	BC039607	IRAK084C18	MGC	W01A067H12	pENTR-TOPO	15096		C20orf165	128497	AAH39607.1	Hs.128235	Chromosome 20 open reading frame 165			Brain, adult medulla	NIH_MGC_119	DH10B	NM_080608.3	NP_542175.1	VALIDATED	C	1.000	1.000	227	684	1	681	227	1	227
RIKEN	BC020648	IRAL037F21	MGC	W01A067H18	pENTR-TOPO	3587		MS4A4A	51338	AAH20648.1	Hs.325960	Membrane-spanning 4-domains, subfamily A, member 4			Placenta	NIH_MGC_79	DH10B	NM_148975.1	NP_683876.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC020648	IRAL037F21	MGC	W01A067H24	pENTR-TOPO	3587		MS4A4A	51338	AAH20648.1	Hs.325960	Membrane-spanning 4-domains, subfamily A, member 4			Placenta	NIH_MGC_79	DH10B	NM_148975.1	NP_683876.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC047681	IRAK098K02	MGC	W01A067I01	pENTR-TOPO	333		S100A9	6280	AAH47681.1	Hs.112405	S100 calcium binding protein A9			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002965.3	NP_002956.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC047681	IRAK098K02	MGC	W01A067I05	pENTR-TOPO	333		S100A9	6280	AAH47681.1	Hs.112405	S100 calcium binding protein A9			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002965.3	NP_002956.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC056250	IRAL048C18	MGC	W01A067I15	pENTR-TOPO	553		LEPROT	54741	AAH56250.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_017526.2	NP_059996.1	VALIDATED	C	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC056250	IRAL048C18	MGC	W01A067I23	pENTR-TOPO	553		LEPROT	54741	AAH56250.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_017526.2	NP_059996.1	VALIDATED	C	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC035416	IRAK071F19	MGC	W01A067J02	pENTR-TOPO	19697		ULBP1	80329	AAH35416.1	Hs.653255	UL16 binding protein 1			Testis	NIH_MGC_97	DH10B	NM_025218.2	NP_079494.1	PROVISIONAL	OK	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC035416	IRAK071F19	MGC	W01A067J08	pENTR-TOPO	19697		ULBP1	80329	AAH35416.1	Hs.653255	UL16 binding protein 1			Testis	NIH_MGC_97	DH10B	NM_025218.2	NP_079494.1	PROVISIONAL	OK	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC035416	IRAK071F19	MGC	W01A067J10	pENTR-TOPO	19697		ULBP1	80329	AAH35416.1	Hs.653255	UL16 binding protein 1			Testis	NIH_MGC_97	DH10B	NM_025218.2	NP_079494.1	PROVISIONAL	OK	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC035416	IRAK071F19	MGC	W01A067J12	pENTR-TOPO	19697		ULBP1	80329	AAH35416.1	Hs.653255	UL16 binding protein 1			Testis	NIH_MGC_97	DH10B	NM_025218.2	NP_079494.1	PROVISIONAL	OK	1.000	1.000	244	735	1	732	244	1	244
RIKEN	AK057613	flj0004g16	FLJ	W01A067J22	pENTR-TOPO	25311		BCAP31	10134	BAG51941.1	Hs.522817	B-cell receptor-associated protein 31				TRACH1	EK1	NM_001139441.1	NP_001132913.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	AK090635	flj0014n01	FLJ	W01A067K03	pENTR-TOPO	15526		ADM2	79924	-	Hs.449099	Adrenomedullin 2	H4	neuroglioma		BNGH42	EK1	NM_024866.4	NP_079142.2	VALIDATED	OK	1.000	1.000	148	447	1	444	148	1	148
RIKEN	AK090635	flj0014n01	FLJ	W01A067K05	pENTR-TOPO	15526		ADM2	79924	-	Hs.449099	Adrenomedullin 2	H4	neuroglioma		BNGH42	EK1	NM_024866.4	NP_079142.2	VALIDATED	OK	1.000	1.000	148	447	1	444	148	1	148
RIKEN	AK090635	flj0014n01	FLJ	W01A067K11	pENTR-TOPO	15526		ADM2	79924	-	Hs.449099	Adrenomedullin 2	H4	neuroglioma		BNGH42	EK1	NM_024866.4	NP_079142.2	VALIDATED	OK	1.000	1.000	148	447	1	444	148	1	148
RIKEN	BC024747	IRAK042K16	MGC	W01A067K17	pENTR-TOPO	13149		IL1F5	26525	AAH24747.1	Hs.516301	Interleukin 1 family, member 5 (delta)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173170.1	NP_775262.1	REVIEWED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC024747	IRAK042K16	MGC	W01A067K19	pENTR-TOPO	13149		IL1F5	26525	AAH24747.1	Hs.516301	Interleukin 1 family, member 5 (delta)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173170.1	NP_775262.1	REVIEWED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC032697	IRAK069D04	MGC	W01A067M01	pENTR-TOPO	19241		FGF1	2246	AAH32697.1	Hs.483635	Fibroblast growth factor 1 (acidic)			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001144935.1	NP_001138407.1	REVIEWED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC032697	IRAK069D04	MGC	W01A067M09	pENTR-TOPO	19241		FGF1	2246	AAH32697.1	Hs.483635	Fibroblast growth factor 1 (acidic)			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001144935.1	NP_001138407.1	REVIEWED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	AK094575	flj0022g12	FLJ	W01A067N06	pENTR-TOPO	5246		RFC5	5985	BAG52890.1	Hs.506989	Replication factor C (activator 1) 5, 36.5kDa				BRAMY2	EK1	NM_001130112.1	NP_001123584.1	REVIEWED	C	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC068484	IRAK168N03	MGC	W01A067N24	pENTR-TOPO	13800		WDR33	55339	AAH68484.1	Hs.620490	WD repeat domain 33			Placenta, normal	NIH_MGC_147	DH10B	NM_001006623.1	NP_001006624.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC036499	IRAK073J11	MGC	W01A067O01	pENTR-TOPO	13465		COPS8	10920	AAH36499.1	Hs.531713	COP9 constitutive photomorphogenic homolog subunit 8 (Arabidopsis)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198189.2	NP_937832.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
RIKEN	BC025703	IRAK049K23	MGC	W01A067O19	pENTR-TOPO	1686		CD247	919	AAH25703.1	Hs.156445	CD247 molecule			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_198053.2	NP_932170.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	AK000643	flj0064p07	FLJ	W01A067P02	pENTR-TOPO	25278		ASB9	140462	BAA91302.1	Hs.19404	Ankyrin repeat and SOCS box-containing 9				KAT	EK1	NM_024087.1	NP_076992.1	PROVISIONAL	C	1.000	1.000	262	789	1	786	262	1	262
RIKEN	AK000643	flj0064p07	FLJ	W01A067P04	pENTR-TOPO	25278		ASB9	140462	BAA91302.1	Hs.19404	Ankyrin repeat and SOCS box-containing 9				KAT	EK1	NM_024087.1	NP_076992.1	PROVISIONAL	C	1.000	1.000	262	789	1	786	262	1	262
RIKEN	AK000643	flj0064p07	FLJ	W01A067P08	pENTR-TOPO	25278		ASB9	140462	BAA91302.1	Hs.19404	Ankyrin repeat and SOCS box-containing 9				KAT	EK1	NM_024087.1	NP_076992.1	PROVISIONAL	C	1.000	1.000	262	789	1	786	262	1	262
RIKEN	AK000643	flj0064p07	FLJ	W01A067P10	pENTR-TOPO	25278		ASB9	140462	BAA91302.1	Hs.19404	Ankyrin repeat and SOCS box-containing 9				KAT	EK1	NM_024087.1	NP_076992.1	PROVISIONAL	C	1.000	1.000	262	789	1	786	262	1	262
RIKEN	AK000643	flj0064p07	FLJ	W01A067P12	pENTR-TOPO	25278		ASB9	140462	BAA91302.1	Hs.19404	Ankyrin repeat and SOCS box-containing 9				KAT	EK1	NM_024087.1	NP_076992.1	PROVISIONAL	C	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC032225	IRAK049P19	MGC	W01A068A05	pENTR-TOPO	10734		PPY	5539	AAH32225.1	Hs.719454	Pancreatic polypeptide			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002722.3	NP_002713.1	REVIEWED	C	1.000	1.000	95	288	1	285	95	1	95
RIKEN	BC032225	IRAK049P19	MGC	W01A068A07	pENTR-TOPO	10734		PPY	5539	AAH32225.1	Hs.719454	Pancreatic polypeptide			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002722.3	NP_002713.1	REVIEWED	C	1.000	1.000	95	288	1	285	95	1	95
RIKEN	BC032225	IRAK049P19	MGC	W01A068A09	pENTR-TOPO	10734		PPY	5539	AAH32225.1	Hs.719454	Pancreatic polypeptide			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002722.3	NP_002713.1	REVIEWED	C	1.000	1.000	95	288	1	285	95	1	95
RIKEN	AK131067	flj0062c13	FLJ	W01A068A15	pENTR-TOPO	17565		IL8	3576	-	Hs.624	Interleukin 8				DMC	EK1	NM_000584.2	NP_000575.1	REVIEWED	C	1.000	1.000	99	300	1	297	99	1	99
RIKEN	AK131067	flj0062c13	FLJ	W01A068A21	pENTR-TOPO	17565		IL8	3576	-	Hs.624	Interleukin 8				DMC	EK1	NM_000584.2	NP_000575.1	REVIEWED	C	1.000	1.000	99	300	1	297	99	1	99
RIKEN	AK131067	flj0062c13	FLJ	W01A068A23	pENTR-TOPO	17565		IL8	3576	-	Hs.624	Interleukin 8				DMC	EK1	NM_000584.2	NP_000575.1	REVIEWED	C	1.000	1.000	99	300	1	297	99	1	99
RIKEN	AK131339	flj0073c12	FLJ	W01A068B04	pENTR-TOPO	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A				TESTI4	EK1	NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
RIKEN	AK131339	flj0073c12	FLJ	W01A068B08	pENTR-TOPO	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A				TESTI4	EK1	NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC025785	IRAK049P15	MGC	W01A068C09	pENTR-TOPO	2191		NPPB	4879	AAH25785.1	Hs.219140	Natriuretic peptide precursor B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002521.2	NP_002512.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC066252	IRAK172C24	MGC	W01A068C21	pENTR-TOPO	20125		IL17A	3605	AAH66252.1	Hs.41724	Interleukin 17A			PCR rescued clones	NIH_MGC_195	DH10B	NM_002190.2	NP_002181.1	REVIEWED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	H013082K13	H013082K13	RIKEN	W01A068D02	pENTR-TOPO		19781						-	-	testis	testis	DH10B			
RIKEN	H013082K13	H013082K13	RIKEN	W01A068D10	pENTR-TOPO		19781						-	-	testis	testis	DH10B			
RIKEN	AK055387	flj0012j19	FLJ	W01A068E15	pENTR-TOPO	12937		SPEG	10290	-	Hs.21639	SPEG complex locus				FEBRA2	EK1	NM_005876.4	NP_005867.3	VALIDATED	P	1.000	1.000	168	511	1	504	3267	793	960
RIKEN	AK055387	flj0012j19	FLJ	W01A068E23	pENTR-TOPO	12937		SPEG	10290	-	Hs.21639	SPEG complex locus				FEBRA2	EK1	NM_005876.4	NP_005867.3	VALIDATED	P	1.000	1.000	168	511	1	504	3267	793	960
RIKEN	H033072K15	H033072K15	RIKEN	W01A068F06	pENTR-TOPO		20467	SUPT3H	8464		Hs.368325	Suppressor of Ty 3 homolog (S. cerevisiae)	-	-	hypothalamus	hypothalamus	DH10B	NM_003599.2	NP_003590.1	PROVISIONAL	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	H033072K15	H033072K15	RIKEN	W01A068F12	pENTR-TOPO		20467	SUPT3H	8464		Hs.368325	Suppressor of Ty 3 homolog (S. cerevisiae)	-	-	hypothalamus	hypothalamus	DH10B	NM_003599.2	NP_003590.1	PROVISIONAL	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC029831	IRAK051M11	MGC	W01A068F24	pENTR-TOPO	2110		ADORA3	140	AAH29831.1	Hs.281342	Adenosine A3 receptor			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000677.3	NP_000668.1	REVIEWED	C	1.000	1.000	318	957	1	954	318	1	318
RIKEN	AK023149	flj0035c19	FLJ	W01A068G03	pENTR-TOPO	9772		DBF4B	80174	BAB14431.1	Hs.369998	DBF4 homolog B (S. cerevisiae)	NT2	teratocarcinoma		NT2RP3	EK1	NM_025104.2	NP_079380.1	VALIDATED	C	1.000	1.000	170	513	1	510	170	1	170
RIKEN	AK023149	flj0035c19	FLJ	W01A068G05	pENTR-TOPO	9772		DBF4B	80174	BAB14431.1	Hs.369998	DBF4 homolog B (S. cerevisiae)	NT2	teratocarcinoma		NT2RP3	EK1	NM_025104.2	NP_079380.1	VALIDATED	C	1.000	1.000	170	513	1	510	170	1	170
RIKEN	H05D064J15	H05D064J15	RIKEN	W01A068G13	pENTR-TOPO		12276						-	-	thymus	thymus	DH10B			
RIKEN	H05D064J15	H05D064J15	RIKEN	W01A068G21	pENTR-TOPO		12276						-	-	thymus	thymus	DH10B			
RIKEN	AK095657	flj0026c03	FLJ	W01A068H04	pENTR-TOPO	25155		GPM6B	2824	BAC04600.1	Hs.495710	Glycoprotein M6B				FCBBF3	EK1	NM_001001995.1	NP_001001995.1	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC028723	IRAK047K04	MGC	W01A068H20	pENTR-TOPO	6816		CSNK1A1L	122011	AAH28723.1	Hs.512897	Casein kinase 1, alpha 1-like			Testis	NIH_MGC_97	DH10B	NM_145203.4	NP_660204.1	PROVISIONAL	C	1.000	1.000	337	1014	1	1011	337	1	337
RIKEN	AK000224	flj0062d07	FLJ	W01A068I03	pENTR-TOPO	3895		MS4A12	54860	BAA91020.1	Hs.272789	Membrane-spanning 4-domains, subfamily A, member 12				ColF	EK1	NM_017716.1	NP_060186.1	REVIEWED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	AK000224	flj0062d07	FLJ	W01A068I05	pENTR-TOPO	3895		MS4A12	54860	BAA91020.1	Hs.272789	Membrane-spanning 4-domains, subfamily A, member 12				ColF	EK1	NM_017716.1	NP_060186.1	REVIEWED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	AK000224	flj0062d07	FLJ	W01A068I09	pENTR-TOPO	3895		MS4A12	54860	BAA91020.1	Hs.272789	Membrane-spanning 4-domains, subfamily A, member 12				ColF	EK1	NM_017716.1	NP_060186.1	REVIEWED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	AK000224	flj0062d07	FLJ	W01A068I11	pENTR-TOPO	3895		MS4A12	54860	BAA91020.1	Hs.272789	Membrane-spanning 4-domains, subfamily A, member 12				ColF	EK1	NM_017716.1	NP_060186.1	REVIEWED	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	BC028713	IRAK034F19	MGC	W01A068J16	pENTR-TOPO	485		PDIK1L	149420	AAH28713.1	Hs.468801	PDLIM1 interacting kinase 1 like			Testis	NIH_MGC_97	DH10B	NM_152835.3	NP_690048.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	BC028713	IRAK034F19	MGC	W01A068J18	pENTR-TOPO	485		PDIK1L	149420	AAH28713.1	Hs.468801	PDLIM1 interacting kinase 1 like			Testis	NIH_MGC_97	DH10B	NM_152835.3	NP_690048.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
RIKEN	AK027682	flj0035p02	FLJ	W01A068K19	pENTR-TOPO	15818		CECR1	51816	BAB55293.1	Hs.170310	Cat eye syndrome chromosome region, candidate 1	NT2	teratocarcinoma		NT2RP4	EK1	NM_177405.1	NP_803124.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	AK131392	flj0073p04	FLJ	W01A068L02	pENTR-TOPO	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like				BRSTN2	EK1	NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
RIKEN	AK131392	flj0073p04	FLJ	W01A068L06	pENTR-TOPO	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like				BRSTN2	EK1	NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
RIKEN	AK131392	flj0073p04	FLJ	W01A068L10	pENTR-TOPO	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like				BRSTN2	EK1	NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
RIKEN	BC030645	IRAK033I12	MGC	W01A068L16	pENTR-TOPO	4432		PDGFD	80310	AAH30645.1	Hs.352298	Platelet derived growth factor D			Testis	NIH_MGC_97	DH10B	NM_033135.3	NP_149126.1	REVIEWED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC030645	IRAK033I12	MGC	W01A068L20	pENTR-TOPO	4432		PDGFD	80310	AAH30645.1	Hs.352298	Platelet derived growth factor D			Testis	NIH_MGC_97	DH10B	NM_033135.3	NP_149126.1	REVIEWED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC042665	IRAK050B03	MGC	W01A068M17	pENTR-TOPO	17153		CD80	941	AAH42665.1	Hs.838	CD80 molecule			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_005191.3	NP_005182.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC028152	IRAK062J21	MGC	W01A068N06	pENTR-TOPO	11767		CD33	945	AAH28152.1	Hs.83731	CD33 molecule			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001772.3	NP_001763.3	VALIDATED	Cs	0.997	0.997	364	1095	1	1092	364	1	364
RIKEN	BC028152	IRAK062J21	MGC	W01A068N10	pENTR-TOPO	11767		CD33	945	AAH28152.1	Hs.83731	CD33 molecule			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001772.3	NP_001763.3	VALIDATED	Cs	0.997	0.997	364	1095	1	1092	364	1	364
RIKEN	H023072O14	H023072O14	RIKEN	W01A068O01	pENTR-TOPO		1759	F3	2152		Hs.62192	Coagulation factor III (thromboplastin, tissue factor)	-	-	hippocampus	hippocampus	DH10B	NM_001993.3	NP_001984.1	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	H023072O14	H023072O14	RIKEN	W01A068O03	pENTR-TOPO		1759	F3	2152		Hs.62192	Coagulation factor III (thromboplastin, tissue factor)	-	-	hippocampus	hippocampus	DH10B	NM_001993.3	NP_001984.1	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	AK022330	flj0030n20	FLJ	W01A068O17	pENTR-TOPO	9204		TBX6	6911	BAB14014.1	Hs.198301	T-box 6				MAMMA1	EK1	NM_080758.1	NP_542936.1	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	AK022330	flj0030n20	FLJ	W01A068O23	pENTR-TOPO	9204		TBX6	6911	BAB14014.1	Hs.198301	T-box 6				MAMMA1	EK1	NM_080758.1	NP_542936.1	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
RIKEN	AK001356	flj0033k23	FLJ	W01A069B04	pENTR-TOPO	5820		LMBR1L	55716	BAA91646.1	Hs.272838	Limb region 1 homolog (mouse)-like	NT2	teratocarcinoma		NT2RP2	EK1	NM_018113.2	NP_060583.2	VALIDATED	Ps	0.995	0.995	437	1455	142	1452	489	53	489
RIKEN	AK001356	flj0033k23	FLJ	W01A069B08	pENTR-TOPO	5820		LMBR1L	55716	BAA91646.1	Hs.272838	Limb region 1 homolog (mouse)-like	NT2	teratocarcinoma		NT2RP2	EK1	NM_018113.2	NP_060583.2	VALIDATED	Ps	0.995	0.995	437	1455	142	1452	489	53	489
RIKEN	BC040145	IRAK084F13	MGC	W01A069C09	pENTR-TOPO	2206		ELK4	2005	AAH40145.1	Hs.497520	ELK4, ETS-domain protein (SRF accessory protein 1)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001973.2	NP_001964.2	REVIEWED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	H06D058F14	H06D058F14	RIKEN	W01A069C19	pENTR-TOPO		10005						-	-	brain	brain	DH10B			
RIKEN	H06D058F14	H06D058F14	RIKEN	W01A069C21	pENTR-TOPO		10005						-	-	brain	brain	DH10B			
RIKEN	AK131219	flj0073o14	FLJ	W01A069D18	pENTR-TOPO	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NB69	neuroblastoma		3NB692	EK1	NM_213597.2	NP_998762.1	PROVISIONAL	OK	1.000	1.000	492	1479	1	1476	492	1	492
RIKEN	AK098396	flj0052j01	FLJ	W01A069E01	pENTR-TOPO	4817		HEPACAM	220296	BAC05297.1	Hs.719285	Hepatocyte cell adhesion molecule				CBR	EK1	NM_152722.4	NP_689935.2	VALIDATED	Cs	0.998	0.998	416	1251	1	1248	416	1	416
RIKEN	AK098396	flj0052j01	FLJ	W01A069E03	pENTR-TOPO	4817		HEPACAM	220296	BAC05297.1	Hs.719285	Hepatocyte cell adhesion molecule				CBR	EK1	NM_152722.4	NP_689935.2	VALIDATED	Cs	0.998	0.998	416	1251	1	1248	416	1	416
RIKEN	AK098396	flj0052j01	FLJ	W01A069E11	pENTR-TOPO	4817		HEPACAM	220296	BAC05297.1	Hs.719285	Hepatocyte cell adhesion molecule				CBR	EK1	NM_152722.4	NP_689935.2	VALIDATED	Cs	0.998	0.998	416	1251	1	1248	416	1	416
RIKEN	AK024280	flj0035n03	FLJ	W01A069E13	pENTR-TOPO	3919		SYT12	91683	-	Hs.287636	Synaptotagmin XII	NT2	teratocarcinoma		NT2RP3	EK1	NM_177963.2	NP_808878.1	PROVISIONAL	C	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	AK075467	flj0027p13	FLJ	W01A069F08	pENTR-TOPO	15532		SLC2A11	66035	BAC11637.1	Hs.632772	Solute carrier family 2 (facilitated glucose transporter), member 11				PLACE1	EK1	NM_001024938.2	NP_001020109.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	AK075467	flj0027p13	FLJ	W01A069F10	pENTR-TOPO	15532		SLC2A11	66035	BAC11637.1	Hs.632772	Solute carrier family 2 (facilitated glucose transporter), member 11				PLACE1	EK1	NM_001024938.2	NP_001020109.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC063674	IRAK134F02	MGC	W01A069G01	pENTR-TOPO	18833		ANKRD32	84250	AAH63674.2	Hs.657315	Ankyrin repeat domain 32			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_032290.3	NP_115666.2	VALIDATED	P	1.000	1.000	422	1269	1	1266	1058	637	1058
RIKEN	BC063674	IRAK134F02	MGC	W01A069G05	pENTR-TOPO	18833		ANKRD32	84250	AAH63674.2	Hs.657315	Ankyrin repeat domain 32			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_032290.3	NP_115666.2	VALIDATED	P	1.000	1.000	422	1269	1	1266	1058	637	1058
RIKEN	BC073137	IRAK174N17	MGC	W01A069G13	pENTR-TOPO	7035		ZNF839	55778	AAH73137.2	Hs.106005	Zinc finger protein 839				Lupski_sympathetic_trunk	DH10B	NM_018335.3	NP_060805.3	VALIDATED	Pgs	0.993	0.998	428	1287	1	1284	927	502	927
RIKEN	BC073137	IRAK174N17	MGC	W01A069G17	pENTR-TOPO	7035		ZNF839	55778	AAH73137.2	Hs.106005	Zinc finger protein 839				Lupski_sympathetic_trunk	DH10B	NM_018335.3	NP_060805.3	VALIDATED	Pgs	0.993	0.998	428	1287	1	1284	927	502	927
RIKEN	BC073137	IRAK174N17	MGC	W01A069G21	pENTR-TOPO	7035		ZNF839	55778	AAH73137.2	Hs.106005	Zinc finger protein 839				Lupski_sympathetic_trunk	DH10B	NM_018335.3	NP_060805.3	VALIDATED	Pgs	0.993	0.998	428	1287	1	1284	927	502	927
RIKEN	BC036769	IRAK079K23	MGC	W01A069H06	pENTR-TOPO	17541		FGFRL1	53834	AAH36769.1	Hs.193326	Fibroblast growth factor receptor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001004358.1	NP_001004358.1	REVIEWED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	AK172832	flj0079i08	FLJ	W01A069H18	pENTR-TOPO	9947		SPNS3	201305	BAD18797.1	Hs.657543	Spinster homolog 3 (Drosophila)				HRC	EK1	NM_182538.4	NP_872344.3	VALIDATED	Cs	0.996	0.996	512	1539	1	1536	512	1	512
RIKEN	AK172832	flj0079i08	FLJ	W01A069H20	pENTR-TOPO	9947		SPNS3	201305	BAD18797.1	Hs.657543	Spinster homolog 3 (Drosophila)				HRC	EK1	NM_182538.4	NP_872344.3	VALIDATED	Cs	0.996	0.996	512	1539	1	1536	512	1	512
RIKEN	AK172832	flj0079i08	FLJ	W01A069H24	pENTR-TOPO	9947		SPNS3	201305	BAD18797.1	Hs.657543	Spinster homolog 3 (Drosophila)				HRC	EK1	NM_182538.4	NP_872344.3	VALIDATED	Cs	0.996	0.996	512	1539	1	1536	512	1	512
RIKEN	AK074659	flj0017l14	FLJ	W01A069I01	pENTR-TOPO	5313		PUS1	80324	BAG51983.1	Hs.592004	Pseudouridylate synthase 1				MAMMA1	EK1	NM_025215.4	NP_079491.2	VALIDATED	OK	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	AK074659	flj0017l14	FLJ	W01A069I07	pENTR-TOPO	5313		PUS1	80324	BAG51983.1	Hs.592004	Pseudouridylate synthase 1				MAMMA1	EK1	NM_025215.4	NP_079491.2	VALIDATED	OK	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	BC033005	IRAK033I03	MGC	W01A069J18	pENTR-TOPO	6252		PCTK2	5128	AAH33005.1	Hs.506415	PCTAIRE protein kinase 2			Testis	NIH_MGC_97	DH10B	NM_002595.2	NP_002586.2	REVIEWED	C	1.000	1.000	523	1572	1	1569	523	1	523
RIKEN	BC067540	IRAK172E06	MGC	W01A069K01	pENTR-TOPO	18888		IL7R	3575	AAH67540.1	Hs.635723	Interleukin 7 receptor			PCR rescued clones	NIH_MGC_195	DH10B	NM_002185.2	NP_002176.2	REVIEWED	OK	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC067540	IRAK172E06	MGC	W01A069K09	pENTR-TOPO	18888		IL7R	3575	AAH67540.1	Hs.635723	Interleukin 7 receptor			PCR rescued clones	NIH_MGC_195	DH10B	NM_002185.2	NP_002176.2	REVIEWED	OK	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC067540	IRAK172E06	MGC	W01A069K11	pENTR-TOPO	18888		IL7R	3575	AAH67540.1	Hs.635723	Interleukin 7 receptor			PCR rescued clones	NIH_MGC_195	DH10B	NM_002185.2	NP_002176.2	REVIEWED	OK	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	AK098066	flj0039p16	FLJ	W01A069K17	pENTR-TOPO	19366		NUDT12	83594	BAG53574.1	Hs.434289	Nudix (nucleoside diphosphate linked moiety X)-type motif 12				TRACH2	EK1	NM_031438.2	NP_113626.1	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	AK098066	flj0039p16	FLJ	W01A069K19	pENTR-TOPO	19366		NUDT12	83594	BAG53574.1	Hs.434289	Nudix (nucleoside diphosphate linked moiety X)-type motif 12				TRACH2	EK1	NM_031438.2	NP_113626.1	VALIDATED	C	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	AK000081	flj0050p11	FLJ	W01A069L02	pENTR-TOPO	1341		CDC2L1	984	-	Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)				COL	EK1	NM_033487.1	NP_277022.1	REVIEWED	C	1.000	1.000	526	1581	1	1578	526	1	526
RIKEN	AK000081	flj0050p11	FLJ	W01A069L06	pENTR-TOPO	1341		CDC2L1	984	-	Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)				COL	EK1	NM_033487.1	NP_277022.1	REVIEWED	C	1.000	1.000	526	1581	1	1578	526	1	526
RIKEN	BC042954	IRAK075J14	MGC	W01A069M15	pENTR-TOPO	15235		ETS2	2114	AAH42954.1	Hs.644231	V-ets erythroblastosis virus E26 oncogene homolog 2 (avian)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005239.4	NP_005230.1	VALIDATED	C	1.000	1.000	469	1410	1	1407	469	1	469
RIKEN	BC042954	IRAK075J14	MGC	W01A069M21	pENTR-TOPO	15235		ETS2	2114	AAH42954.1	Hs.644231	V-ets erythroblastosis virus E26 oncogene homolog 2 (avian)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005239.4	NP_005230.1	VALIDATED	C	1.000	1.000	469	1410	1	1407	469	1	469
RIKEN	AK122656	flj0040g17	FLJ	W01A069N06	pENTR-TOPO	1608		GPR161	23432	BAG53646.1	Hs.632453	G protein-coupled receptor 161				OCBBF2	EK1	NM_153832.1	NP_722561.1	PROVISIONAL	OK	1.000	1.000	529	1590	1	1587	529	1	529
RIKEN	BC033034	IRAK046H17	MGC	W01A069O03	pENTR-TOPO	3641		DIXDC1	85458	AAH33034.1	Hs.655626	DIX domain containing 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033425.3	NP_219493.1	VALIDATED	C	1.000	1.000	472	1419	1	1416	472	1	472
RIKEN	BC033034	IRAK046H17	MGC	W01A069O09	pENTR-TOPO	3641		DIXDC1	85458	AAH33034.1	Hs.655626	DIX domain containing 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033425.3	NP_219493.1	VALIDATED	C	1.000	1.000	472	1419	1	1416	472	1	472
RIKEN	BC033034	IRAK046H17	MGC	W01A069O11	pENTR-TOPO	3641		DIXDC1	85458	AAH33034.1	Hs.655626	DIX domain containing 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033425.3	NP_219493.1	VALIDATED	C	1.000	1.000	472	1419	1	1416	472	1	472
RIKEN	BC006811	IRAK003I16	MGC	W01A069O13	pENTR-TOPO	16156		PPARG	5468	AAH06811.1	Hs.162646	Peroxisome proliferator-activated receptor gamma			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005037.5	NP_005028.4	REVIEWED	P	1.000	1.000	476	1431	1	1428	477	2	477
RIKEN	BC044615	IRAK106J15	MGC	W01A069P02	pENTR-TOPO	12472		ZNF599	148103	AAH44615.1	Hs.590961	Zinc finger protein 599			Testis	NIH_MGC_97	DH10B	NM_001007248.2	NP_001007249.1	VALIDATED	Ps	0.998	0.998	551	1656	1	1653	588	38	588
RIKEN	BC044615	IRAK106J15	MGC	W01A069P04	pENTR-TOPO	12472		ZNF599	148103	AAH44615.1	Hs.590961	Zinc finger protein 599			Testis	NIH_MGC_97	DH10B	NM_001007248.2	NP_001007249.1	VALIDATED	Ps	0.998	0.998	551	1656	1	1653	588	38	588
RIKEN	BC044615	IRAK106J15	MGC	W01A069P06	pENTR-TOPO	12472		ZNF599	148103	AAH44615.1	Hs.590961	Zinc finger protein 599			Testis	NIH_MGC_97	DH10B	NM_001007248.2	NP_001007249.1	VALIDATED	Ps	0.998	0.998	551	1656	1	1653	588	38	588
RIKEN	BC044615	IRAK106J15	MGC	W01A069P08	pENTR-TOPO	12472		ZNF599	148103	AAH44615.1	Hs.590961	Zinc finger protein 599			Testis	NIH_MGC_97	DH10B	NM_001007248.2	NP_001007249.1	VALIDATED	Ps	0.998	0.998	551	1656	1	1653	588	38	588
RIKEN	BC044615	IRAK106J15	MGC	W01A069P10	pENTR-TOPO	12472		ZNF599	148103	AAH44615.1	Hs.590961	Zinc finger protein 599			Testis	NIH_MGC_97	DH10B	NM_001007248.2	NP_001007249.1	VALIDATED	Ps	0.998	0.998	551	1656	1	1653	588	38	588
RIKEN	BC044615	IRAK106J15	MGC	W01A069P12	pENTR-TOPO	12472		ZNF599	148103	AAH44615.1	Hs.590961	Zinc finger protein 599			Testis	NIH_MGC_97	DH10B	NM_001007248.2	NP_001007249.1	VALIDATED	Ps	0.998	0.998	551	1656	1	1653	588	38	588
RIKEN	AK025300	flj0050b03	FLJ	W01A069P18	pENTR-TOPO	12445		RANBP3	8498	BAB15106.1	Hs.531752	RAN binding protein 3				COL	EK1	NM_007322.2	NP_015561.1	REVIEWED	C	1.000	1.000	567	1704	1	1701	567	1	567
RIKEN	BC051711	IRAK077G09	MGC	W01A070A05	pENTR-TOPO	14745		CDC25B	994	AAH51711.1	Hs.153752	Cell division cycle 25 homolog B (S. pombe)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021873.2	NP_068659.1	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	AK095749	flj0024d21	FLJ	W01A070A13	pENTR-TOPO	3572		ARNTL	406	BAG53120.1	Hs.65734	Aryl hydrocarbon receptor nuclear translocator-like				FEBRA2	EK1	NM_001030273.1	NP_001025444.1	REVIEWED	C	1.000	1.000	582	1749	1	1746	582	1	582
RIKEN	H023012B13	H023012B13	RIKEN	W01A070B02	pENTR-TOPO		5275	CREBL2	1389		Hs.591156	CAMP responsive element binding protein-like 2	-	-	hippocampus	hippocampus	DH10B	NM_001310.2	NP_001301.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
RIKEN	H023012B13	H023012B13	RIKEN	W01A070B12	pENTR-TOPO		5275	CREBL2	1389		Hs.591156	CAMP responsive element binding protein-like 2	-	-	hippocampus	hippocampus	DH10B	NM_001310.2	NP_001301.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
RIKEN	BC005264	IRAL016C17	MGC	W01A070B14	pENTR-TOPO	22138		RPA3	6119	AAH05264.1	Hs.487540	Replication protein A3, 14kDa			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002947.3	NP_002938.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
RIKEN	BC005264	IRAL016C17	MGC	W01A070B22	pENTR-TOPO	22138		RPA3	6119	AAH05264.1	Hs.487540	Replication protein A3, 14kDa			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002947.3	NP_002938.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
RIKEN	AK000467	flj0057g22	FLJ	W01A070C13	pENTR-TOPO	5894		GLS2	27165	-	Hs.212606	Glutaminase 2 (liver, mitochondrial)				KAT	EK1	NM_013267.2	NP_037399.2	REVIEWED	C	1.000	1.000	602	1810	2	1807	602	1	602
RIKEN	AK000467	flj0057g22	FLJ	W01A070C15	pENTR-TOPO	5894		GLS2	27165	-	Hs.212606	Glutaminase 2 (liver, mitochondrial)				KAT	EK1	NM_013267.2	NP_037399.2	REVIEWED	C	1.000	1.000	602	1810	2	1807	602	1	602
RIKEN	AK000467	flj0057g22	FLJ	W01A070C17	pENTR-TOPO	5894		GLS2	27165	-	Hs.212606	Glutaminase 2 (liver, mitochondrial)				KAT	EK1	NM_013267.2	NP_037399.2	REVIEWED	C	1.000	1.000	602	1810	2	1807	602	1	602
RIKEN	AK000467	flj0057g22	FLJ	W01A070C21	pENTR-TOPO	5894		GLS2	27165	-	Hs.212606	Glutaminase 2 (liver, mitochondrial)				KAT	EK1	NM_013267.2	NP_037399.2	REVIEWED	C	1.000	1.000	602	1810	2	1807	602	1	602
RIKEN	AK001981	flj0037d23	FLJ	W01A070D08	pENTR-TOPO	1577		ENSA	2029	BAG50998.1	Hs.632456	Endosulfine alpha				PLACE1	EK1	NM_004436.2	NP_004427.1	REVIEWED	OK	1.000	1.000	121	366	1	363	121	1	121
RIKEN	BC016139	IRAK015P19	MGC	W01A070D18	pENTR-TOPO	15488		CBY1	25776	AAH16139.1	Hs.596584	Chibby homolog 1 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015373.3	NP_056188.1	REVIEWED	OK	1.000	1.000	126	381	1	378	126	1	126
RIKEN	AK001171	flj0031d10	FLJ	W01A070E03	pENTR-TOPO	12420		ELOF1	84337	-	Hs.631633	Elongation factor 1 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RM2	EK1	NM_032377.3	NP_115753.1	VALIDATED	C	1.000	1.000	83	252	1	249	83	1	83
RIKEN	AK001171	flj0031d10	FLJ	W01A070E05	pENTR-TOPO	12420		ELOF1	84337	-	Hs.631633	Elongation factor 1 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RM2	EK1	NM_032377.3	NP_115753.1	VALIDATED	C	1.000	1.000	83	252	1	249	83	1	83
RIKEN	AK001171	flj0031d10	FLJ	W01A070E11	pENTR-TOPO	12420		ELOF1	84337	-	Hs.631633	Elongation factor 1 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RM2	EK1	NM_032377.3	NP_115753.1	VALIDATED	C	1.000	1.000	83	252	1	249	83	1	83
RIKEN	BC005358	IRAL016I03	MGC	W01A070F04	pENTR-TOPO	15839		NHP2L1	4809	AAH05358.1	Hs.182255	NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005008.2	NP_004999.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC005358	IRAL016I03	MGC	W01A070F08	pENTR-TOPO	15839		NHP2L1	4809	AAH05358.1	Hs.182255	NHP2 non-histone chromosome protein 2-like 1 (S. cerevisiae)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005008.2	NP_004999.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	AK056690	flj0006j03	FLJ	W01A070F14	pENTR-TOPO	7488		TRAPPC6B	122553	BAG51784.1	Hs.13303	Trafficking protein particle complex 6B				PEBLM2	EK1	NM_177452.3	NP_803235.1	VALIDATED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	AK056690	flj0006j03	FLJ	W01A070F24	pENTR-TOPO	7488		TRAPPC6B	122553	BAG51784.1	Hs.13303	Trafficking protein particle complex 6B				PEBLM2	EK1	NM_177452.3	NP_803235.1	VALIDATED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC007116	IRAL021J20	MGC	W01A070G07	pENTR-TOPO	12678		ZNF626	199777	AAH07116.1	Hs.657001	Zinc finger protein 626			Prostate	NIH_MGC_83	DH10B	NM_145297.3	NP_660340.1	VALIDATED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	AK024884	flj0051i01	FLJ	W01A070G19	pENTR-TOPO	435		SH3BGRL3	83442	-	Hs.109051	SH3 domain binding glutamic acid-rich protein like 3				COL	EK1	NM_031286.3	NP_112576.1	VALIDATED	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC005910	IRAL021H24	MGC	W01A070H02	pENTR-TOPO	11557		MIA	8190	AAH05910.1	Hs.646364	Melanoma inhibitory activity			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006533.2	NP_006524.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC005910	IRAL021H24	MGC	W01A070H04	pENTR-TOPO	11557		MIA	8190	AAH05910.1	Hs.646364	Melanoma inhibitory activity			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006533.2	NP_006524.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC005910	IRAL021H24	MGC	W01A070H06	pENTR-TOPO	11557		MIA	8190	AAH05910.1	Hs.646364	Melanoma inhibitory activity			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006533.2	NP_006524.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC005910	IRAL021H24	MGC	W01A070H12	pENTR-TOPO	11557		MIA	8190	AAH05910.1	Hs.646364	Melanoma inhibitory activity			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006533.2	NP_006524.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	BC007021	IRAL016B21	MGC	W01A070H16	pENTR-TOPO	2163		FABP3	2170	AAH07021.1	Hs.657242	Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)			Liver	NIH_MGC_76	DH10B	NM_004102.3	NP_004093.1	REVIEWED	OK	1.000	1.000	133	402	1	399	133	1	133
RIKEN	BC007021	IRAL016B21	MGC	W01A070H18	pENTR-TOPO	2163		FABP3	2170	AAH07021.1	Hs.657242	Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)			Liver	NIH_MGC_76	DH10B	NM_004102.3	NP_004093.1	REVIEWED	OK	1.000	1.000	133	402	1	399	133	1	133
RIKEN	BC007021	IRAL016B21	MGC	W01A070H20	pENTR-TOPO	2163		FABP3	2170	AAH07021.1	Hs.657242	Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)			Liver	NIH_MGC_76	DH10B	NM_004102.3	NP_004093.1	REVIEWED	OK	1.000	1.000	133	402	1	399	133	1	133
RIKEN	BC007021	IRAL016B21	MGC	W01A070H24	pENTR-TOPO	2163		FABP3	2170	AAH07021.1	Hs.657242	Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor)			Liver	NIH_MGC_76	DH10B	NM_004102.3	NP_004093.1	REVIEWED	OK	1.000	1.000	133	402	1	399	133	1	133
RIKEN	BC059948	IRAK135P04	MGC	W01A070I13	pENTR-TOPO	4890		CSTF3	1479	AAH59948.1	Hs.44402	Cleavage stimulation factor, 3' pre-RNA, subunit 3, 77kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001033505.1	NP_001028677.1	REVIEWED	C	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC015423	IRAK027D11	MGC	W01A070K07	pENTR-TOPO	7213		IFI27L1	122509	AAH15423.1	Hs.19414	Interferon, alpha-inducible protein 27-like 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_145249.2	NP_660292.1	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
RIKEN	BC024165	IRAL032O10	MGC	W01A070K15	pENTR-TOPO	22157		POLR2J	5439	AAH24165.1	Hs.654952	Polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006234.4	NP_006225.1	REVIEWED	C	1.000	1.000	117	354	1	351	117	1	117
RIKEN	BC024165	IRAL032O10	MGC	W01A070K17	pENTR-TOPO	22157		POLR2J	5439	AAH24165.1	Hs.654952	Polymerase (RNA) II (DNA directed) polypeptide J, 13.3kDa			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006234.4	NP_006225.1	REVIEWED	C	1.000	1.000	117	354	1	351	117	1	117
RIKEN	H013061M06	H013061M06	RIKEN	W01A070L04	pENTR-TOPO		2229	HIST3H3	8290		Hs.248171	Histone cluster 3, H3	-	-	testis	testis	DH10B	NM_003493.2	NP_003484.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	H013061M06	H013061M06	RIKEN	W01A070L06	pENTR-TOPO		2229	HIST3H3	8290		Hs.248171	Histone cluster 3, H3	-	-	testis	testis	DH10B	NM_003493.2	NP_003484.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	H013061M06	H013061M06	RIKEN	W01A070L12	pENTR-TOPO		2229	HIST3H3	8290		Hs.248171	Histone cluster 3, H3	-	-	testis	testis	DH10B	NM_003493.2	NP_003484.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
RIKEN	BC012455	IRAK021J20	MGC	W01A070L14	pENTR-TOPO	5240		GOLT1B	51026	AAH12455.1	Hs.62275	Golgi transport 1 homolog B (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_016072.4	NP_057156.1	VALIDATED	C	1.000	1.000	138	417	1	414	138	1	138
RIKEN	BC012455	IRAK021J20	MGC	W01A070L18	pENTR-TOPO	5240		GOLT1B	51026	AAH12455.1	Hs.62275	Golgi transport 1 homolog B (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_016072.4	NP_057156.1	VALIDATED	C	1.000	1.000	138	417	1	414	138	1	138
RIKEN	H033067G02	H033067G02	RIKEN	W01A070M07	pENTR-TOPO		13510	POLE4	56655		Hs.469060	Polymerase (DNA-directed), epsilon 4 (p12 subunit)	-	-	hypothalamus	hypothalamus	DH10B	NM_019896.2	NP_063949.2	VALIDATED	C	1.000	1.000	117	354	1	351	117	1	117
RIKEN	BC000899	IRAK003M05	MGC	W01A070M13	pENTR-TOPO	21857		BET1	10282	AAH00899.1	Hs.489132	Blocked early in transport 1 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005868.4	NP_005859.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
RIKEN	BC000899	IRAK003M05	MGC	W01A070M15	pENTR-TOPO	21857		BET1	10282	AAH00899.1	Hs.489132	Blocked early in transport 1 homolog (S. cerevisiae)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005868.4	NP_005859.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
RIKEN	AK000319	flj0051j01	FLJ	W01A070N08	pENTR-TOPO	388		PNRC2	55629	BAA91082.1	Hs.7862	Proline-rich nuclear receptor coactivator 2	HepG2	hepatoma		HEP	EK1	XM_001713881.1	XP_001713933.1	MODEL	C	1.000	1.000	139	420	1	417	139	1	139
RIKEN	BC032589	IRAK069G18	MGC	W01A070O11	pENTR-TOPO	7685		B2M	567	AAH32589.1	Hs.709313	Beta-2-microglobulin			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004048.2	NP_004039.1	VALIDATED	C	1.000	1.000	119	360	1	357	119	1	119
RIKEN	BC015492	IRAK022O07	MGC	W01A070O19	pENTR-TOPO	7073		IFI27	3429	AAH15492.1	Hs.532634	Interferon, alpha-inducible protein 27			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005532.3	NP_005523.3	VALIDATED	C	1.000	1.000	119	360	1	357	119	1	119
RIKEN	BC015492	IRAK022O07	MGC	W01A070O21	pENTR-TOPO	7073		IFI27	3429	AAH15492.1	Hs.532634	Interferon, alpha-inducible protein 27			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005532.3	NP_005523.3	VALIDATED	C	1.000	1.000	119	360	1	357	119	1	119
RIKEN	BC017931	IRAL036J10	MGC	W01A070P02	pENTR-TOPO	9768		ZNHIT3	9326	AAH17931.1	Hs.2210	Zinc finger, HIT type 3			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_004773.2	NP_004764.1	VALIDATED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC017931	IRAL036J10	MGC	W01A070P04	pENTR-TOPO	9768		ZNHIT3	9326	AAH17931.1	Hs.2210	Zinc finger, HIT type 3			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_004773.2	NP_004764.1	VALIDATED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC017931	IRAL036J10	MGC	W01A070P06	pENTR-TOPO	9768		ZNHIT3	9326	AAH17931.1	Hs.2210	Zinc finger, HIT type 3			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_004773.2	NP_004764.1	VALIDATED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC017931	IRAL036J10	MGC	W01A070P12	pENTR-TOPO	9768		ZNHIT3	9326	AAH17931.1	Hs.2210	Zinc finger, HIT type 3			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_004773.2	NP_004764.1	VALIDATED	C	1.000	1.000	155	468	1	465	155	1	155
RIKEN	BC066908	IRAK167D05	MGC	W01A071A01	pENTR-TOPO	328		TMEM50A	23585	AAH66908.1	Hs.523054	Transmembrane protein 50A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014313.2	NP_055128.1	REVIEWED	OK	1.000	1.000	157	474	1	471	157	1	157
RIKEN	BC005900	IRAL021A06	MGC	W01A071B10	pENTR-TOPO	4595		CSRP3	8048	AAH05900.1	Hs.83577	Cysteine and glycine-rich protein 3 (cardiac LIM protein)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001127656.1	NP_001121128.1	REVIEWED	C	1.000	1.000	194	585	1	582	194	1	194
RIKEN	AK000596	flj0059f09	FLJ	W01A071B18	pENTR-TOPO	13089		HPCAL1	3241	-	Hs.580427	Hippocalcin-like 1				KAT	EK1	NM_134421.1	NP_602293.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	AK097690	flj0043c14	FLJ	W01A071C03	pENTR-TOPO	4814		CFL1	1072	BAG53513.1						TESTI2	EK1	NM_005507.2	NP_005498.1	VALIDATED	C	1.000	1.000	166	501	1	498	166	1	166
RIKEN	AK091170	flj0015i05	FLJ	W01A071C15	pENTR-TOPO	288		CDKN2C	1031	BAG52297.1	Hs.716664	Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)				CTONG2	EK1	NM_001262.2	NP_001253.1	REVIEWED	C	1.000	1.000	168	507	1	504	168	1	168
RIKEN	AK091170	flj0015i05	FLJ	W01A071C19	pENTR-TOPO	288		CDKN2C	1031	BAG52297.1	Hs.716664	Cyclin-dependent kinase inhibitor 2C (p18, inhibits CDK4)				CTONG2	EK1	NM_001262.2	NP_001253.1	REVIEWED	C	1.000	1.000	168	507	1	504	168	1	168
RIKEN	AK074604	flj0017n23	FLJ	W01A071D08	pENTR-TOPO	12321		SERTAD3	29946	BAG51975.1	Hs.515412	SERTA domain containing 3				HEMBA1	EK1	NM_013368.3	NP_037500.2	REVIEWED	C	1.000	1.000	196	591	1	588	196	1	196
RIKEN	BC011025	IRAL019L20	MGC	W01A071D24	pENTR-TOPO	22102		SRI	6717	AAH11025.1	Hs.489040	Sorcin			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003130.2	NP_003121.1	VALIDATED	C	1.000	1.000	198	597	1	594	198	1	198
RIKEN	AK056169	flj0002h17	FLJ	W01A071E09	pENTR-TOPO	1635		TXNDC12	51060	-	Hs.476033	Thioredoxin domain containing 12 (endoplasmic reticulum)	NT2	teratocarcinoma		NT2RI2	EK1	NM_015913.2	NP_056997.1	PROVISIONAL	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	AK056169	flj0002h17	FLJ	W01A071E11	pENTR-TOPO	1635		TXNDC12	51060	-	Hs.476033	Thioredoxin domain containing 12 (endoplasmic reticulum)	NT2	teratocarcinoma		NT2RI2	EK1	NM_015913.2	NP_056997.1	PROVISIONAL	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	H013021D09	H013021D09	RIKEN	W01A071E13	pENTR-TOPO		4153						-	-	testis	testis	DH10B			
RIKEN	H013021D09	H013021D09	RIKEN	W01A071E15	pENTR-TOPO		4153						-	-	testis	testis	DH10B			
RIKEN	BC008992	IRAK012L21	MGC	W01A071F02	pENTR-TOPO	14625		DOK5	55816	AAH08992.1	Hs.656582	Docking protein 5			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_018431.3	NP_060901.2	REVIEWED	P	1.000	1.000	198	597	1	594	306	109	306
RIKEN	BC008992	IRAK012L21	MGC	W01A071F08	pENTR-TOPO	14625		DOK5	55816	AAH08992.1	Hs.656582	Docking protein 5			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_018431.3	NP_060901.2	REVIEWED	P	1.000	1.000	198	597	1	594	306	109	306
RIKEN	BC008992	IRAK012L21	MGC	W01A071F12	pENTR-TOPO	14625		DOK5	55816	AAH08992.1	Hs.656582	Docking protein 5			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_018431.3	NP_060901.2	REVIEWED	P	1.000	1.000	198	597	1	594	306	109	306
RIKEN	AK000419	flj0057k02	FLJ	W01A071F14	pENTR-TOPO	10397		NT5C	30833	BAA91151.1	Hs.67201	5', 3'-nucleotidase, cytosolic				KAT	EK1	NM_014595.1	NP_055410.1	PROVISIONAL	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC028009	IRAK062G17	MGC	W01A071G13	pENTR-TOPO	5157		KLRD1	3824	AAH28009.1	Hs.562457	Killer cell lectin-like receptor subfamily D, member 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001114396.1	NP_001107868.1	REVIEWED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC028009	IRAK062G17	MGC	W01A071G15	pENTR-TOPO	5157		KLRD1	3824	AAH28009.1	Hs.562457	Killer cell lectin-like receptor subfamily D, member 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001114396.1	NP_001107868.1	REVIEWED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC028009	IRAK062G17	MGC	W01A071G17	pENTR-TOPO	5157		KLRD1	3824	AAH28009.1	Hs.562457	Killer cell lectin-like receptor subfamily D, member 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001114396.1	NP_001107868.1	REVIEWED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	H013081A10	H013081A10	RIKEN	W01A071H04	pENTR-TOPO		18603	TBC1D1	23216		Hs.176503	TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1	-	-	testis	testis	DH10B	NM_015173.2	NP_055988.2	VALIDATED	Pfs	0.268	0.268	41	609	297	419	1168	1123	1163
RIKEN	H013081A10	H013081A10	RIKEN	W01A071H12	pENTR-TOPO		18603	TBC1D1	23216		Hs.176503	TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1	-	-	testis	testis	DH10B	NM_015173.2	NP_055988.2	VALIDATED	Pfs	0.268	0.268	41	609	297	419	1168	1123	1163
RIKEN	BC012907	IRAK021P18	MGC	W01A071I01	pENTR-TOPO	2892		MXI1	4601	AAH12907.1	Hs.719185	MAX interactor 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008541.1	NP_001008541.1	REVIEWED	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	BC012907	IRAK021P18	MGC	W01A071I11	pENTR-TOPO	2892		MXI1	4601	AAH12907.1	Hs.719185	MAX interactor 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008541.1	NP_001008541.1	REVIEWED	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	BC000954	IRAK003L12	MGC	W01A071I13	pENTR-TOPO	21036		CBX3	11335	AAH00954.1	Hs.381189	Chromobox homolog 3 (HP1 gamma homolog, Drosophila)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016587.2	NP_057671.2	REVIEWED	C	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC000954	IRAK003L12	MGC	W01A071I15	pENTR-TOPO	21036		CBX3	11335	AAH00954.1	Hs.381189	Chromobox homolog 3 (HP1 gamma homolog, Drosophila)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016587.2	NP_057671.2	REVIEWED	C	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC000954	IRAK003L12	MGC	W01A071I21	pENTR-TOPO	21036		CBX3	11335	AAH00954.1	Hs.381189	Chromobox homolog 3 (HP1 gamma homolog, Drosophila)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016587.2	NP_057671.2	REVIEWED	C	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC068060	IRAL054O16	MGC	W01A071J12	pENTR-TOPO	17737		MXD4	10608	AAH68060.1	Hs.655020	MAX dimerization protein 4			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006454.2	NP_006445.1	REVIEWED	C	1.000	1.000	209	630	1	627	209	1	209
RIKEN	AK127621	flj0076m05	FLJ	W01A071J14	pENTR-TOPO	9057		SOCS1	8651	BAG54535.1	Hs.50640	Suppressor of cytokine signaling 1				FELNG2	EK1	NM_003745.1	NP_003736.1	REVIEWED	OK	1.000	1.000	211	636	1	633	211	1	211
RIKEN	AK127621	flj0076m05	FLJ	W01A071J16	pENTR-TOPO	9057		SOCS1	8651	BAG54535.1	Hs.50640	Suppressor of cytokine signaling 1				FELNG2	EK1	NM_003745.1	NP_003736.1	REVIEWED	OK	1.000	1.000	211	636	1	633	211	1	211
RIKEN	BC065926	IRAK140N09	MGC	W01A071K01	pENTR-TOPO	19407		REEP5	7905	AAH65926.1	Hs.429608	Receptor accessory protein 5			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005669.4	NP_005660.4	VALIDATED	P	1.000	1.000	185	558	1	555	189	5	189
RIKEN	BC012852	IRAK021E24	MGC	W01A071K17	pENTR-TOPO	16359		SLC25A26	115286	AAH12852.2	Hs.379386	Solute carrier family 25, member 26			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173471.2	NP_775742.3	VALIDATED	Ps	0.995	0.995	186	561	1	558	274	89	274
RIKEN	BC012852	IRAK021E24	MGC	W01A071K21	pENTR-TOPO	16359		SLC25A26	115286	AAH12852.2	Hs.379386	Solute carrier family 25, member 26			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173471.2	NP_775742.3	VALIDATED	Ps	0.995	0.995	186	561	1	558	274	89	274
RIKEN	AK002191	flj0038g10	FLJ	W01A071L04	pENTR-TOPO	3096		C10orf10	11067	BAG51027.1	Hs.93675	Chromosome 10 open reading frame 10				PLACE1	EK1	NM_007021.3	NP_008952.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	AK002191	flj0038g10	FLJ	W01A071L06	pENTR-TOPO	3096		C10orf10	11067	BAG51027.1	Hs.93675	Chromosome 10 open reading frame 10				PLACE1	EK1	NM_007021.3	NP_008952.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	AK002191	flj0038g10	FLJ	W01A071L08	pENTR-TOPO	3096		C10orf10	11067	BAG51027.1	Hs.93675	Chromosome 10 open reading frame 10				PLACE1	EK1	NM_007021.3	NP_008952.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
RIKEN	BC001318	IRAK004D09	MGC	W01A071L16	pENTR-TOPO	14984		RGS19	10287	AAH01318.1	Hs.422336	Regulator of G-protein signaling 19			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005873.2	NP_005864.1	REVIEWED	C	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC001318	IRAK004D09	MGC	W01A071L22	pENTR-TOPO	14984		RGS19	10287	AAH01318.1	Hs.422336	Regulator of G-protein signaling 19			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005873.2	NP_005864.1	REVIEWED	C	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC000992	IRAK003D04	MGC	W01A071M05	pENTR-TOPO	6204		CSRP2	1466	AAH00992.1	Hs.530904	Cysteine and glycine-rich protein 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001321.1	NP_001312.1	REVIEWED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC000992	IRAK003D04	MGC	W01A071M07	pENTR-TOPO	6204		CSRP2	1466	AAH00992.1	Hs.530904	Cysteine and glycine-rich protein 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001321.1	NP_001312.1	REVIEWED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC007007	IRAL016C13	MGC	W01A071M23	pENTR-TOPO	4566		IL18	3606	AAH07007.1	Hs.83077	Interleukin 18 (interferon-gamma-inducing factor)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001562.2	NP_001553.1	REVIEWED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	H033076L13	H033076L13	RIKEN	W01A071N06	pENTR-TOPO		6280	SFRS9	8683		Hs.706889	Splicing factor, arginine/serine-rich 9	-	-	hypothalamus	hypothalamus	DH10B	NM_003769.2	NP_003760.1	VALIDATED	C	1.000	1.000	221	666	1	663	221	1	221
RIKEN	H033076L13	H033076L13	RIKEN	W01A071N12	pENTR-TOPO		6280	SFRS9	8683		Hs.706889	Splicing factor, arginine/serine-rich 9	-	-	hypothalamus	hypothalamus	DH10B	NM_003769.2	NP_003760.1	VALIDATED	C	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC057801	IRAK133C06	MGC	W01A071O17	pENTR-TOPO	4902		ASCL2	430	AAH57801.2	Hs.152475	Achaete-scute complex homolog 2 (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_005170.2	NP_005161.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	AK096582	flj0022k05	FLJ	W01A071P10	pENTR-TOPO	332		DHX9	1660	BAG53328.1	Hs.191518	DEAH (Asp-Glu-Ala-His) box polypeptide 9				OCBBF2	EK1	NM_001357.3	NP_001348.2	REVIEWED	P	1.000	1.000	235	708	1	705	1270	1036	1270
RIKEN	BC010689	IRAK013L08	MGC	W01A072A13	pENTR-TOPO	9624		MLX	6945	AAH10689.1	Hs.714749	MAX-like protein X			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198204.1	NP_937847.1	REVIEWED	C	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC010689	IRAK013L08	MGC	W01A072A17	pENTR-TOPO	9624		MLX	6945	AAH10689.1	Hs.714749	MAX-like protein X			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198204.1	NP_937847.1	REVIEWED	C	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC010689	IRAK013L08	MGC	W01A072A19	pENTR-TOPO	9624		MLX	6945	AAH10689.1	Hs.714749	MAX-like protein X			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198204.1	NP_937847.1	REVIEWED	C	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC010689	IRAK013L08	MGC	W01A072A21	pENTR-TOPO	9624		MLX	6945	AAH10689.1	Hs.714749	MAX-like protein X			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198204.1	NP_937847.1	REVIEWED	C	1.000	1.000	244	735	1	732	244	1	244
RIKEN	BC022323	IRAL036C01	MGC	W01A072B04	pENTR-TOPO	20529		POPDC3	64208	AAH22323.1	Hs.458336	Popeye domain containing 3			Skeletal Muscle	NIH_MGC_81	DH10B	NM_022361.4	NP_071756.2	REVIEWED	OK	1.000	1.000	291	876	1	873	291	1	291
RIKEN	BC026258	IRAL037J24	MGC	W01A072B18	pENTR-TOPO	7674		AQP9	366	AAH26258.1	Hs.104624	Aquaporin 9			Liver	NIH_MGC_76	DH10B	NM_020980.3	NP_066190.2	REVIEWED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC026258	IRAL037J24	MGC	W01A072B24	pENTR-TOPO	7674		AQP9	366	AAH26258.1	Hs.104624	Aquaporin 9			Liver	NIH_MGC_76	DH10B	NM_020980.3	NP_066190.2	REVIEWED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	H033084M06	H033084M06	RIKEN	W01A072C01	pENTR-TOPO		21889	FTSJ2	29960		Hs.279877	FtsJ homolog 2 (E. coli)	-	-	hypothalamus	hypothalamus	DH10B	NM_013393.1	NP_037525.1	REVIEWED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC005265	IRAL016M24	MGC	W01A072C23	pENTR-TOPO	7202		PSMA3	5684	AAH05265.1	Hs.558799	Proteasome (prosome, macropain) subunit, alpha type, 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_152132.1	NP_687033.1	REVIEWED	C	1.000	1.000	248	747	1	744	248	1	248
RIKEN	AK098028	flj0023e23	FLJ	W01A072D14	pENTR-TOPO	8861		DNASE1L2	1775	BAG53566.1	Hs.103503	Deoxyribonuclease I-like 2				THYMU2	EK1	NM_001374.2	NP_001365.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
RIKEN	BC012850	IRAK012I22	MGC	W01A072E13	pENTR-TOPO	13124		KCNIP3	30818	AAH12850.1	Hs.437376	Kv channel interacting protein 3, calsenilin				NCI_CGAP_Brn67	DH10B	NM_013434.4	NP_038462.1	REVIEWED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC012850	IRAK012I22	MGC	W01A072E23	pENTR-TOPO	13124		KCNIP3	30818	AAH12850.1	Hs.437376	Kv channel interacting protein 3, calsenilin				NCI_CGAP_Brn67	DH10B	NM_013434.4	NP_038462.1	REVIEWED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC062327	IRAL050I02	MGC	W01A072F02	pENTR-TOPO	4478		CASP1	834	AAH62327.1	Hs.2490	Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_033293.2	NP_150635.1	REVIEWED	C	1.000	1.000	311	936	1	933	311	1	311
RIKEN	BC062327	IRAL050I02	MGC	W01A072F10	pENTR-TOPO	4478		CASP1	834	AAH62327.1	Hs.2490	Caspase 1, apoptosis-related cysteine peptidase (interleukin 1, beta, convertase)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_033293.2	NP_150635.1	REVIEWED	C	1.000	1.000	311	936	1	933	311	1	311
RIKEN	BC037899	IRAK075I11	MGC	W01A072F22	pENTR-TOPO	8661		CACNG3	10368	AAH37899.1	Hs.7235	Calcium channel, voltage-dependent, gamma subunit 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006539.2	NP_006530.1	REVIEWED	OK	1.000	1.000	315	948	1	945	315	1	315
RIKEN	BC012588	IRAL019M08	MGC	W01A072H04	pENTR-TOPO	14749		POLR3F	10621	AAH12588.1	Hs.472227	Polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006466.2	NP_006457.2	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
RIKEN	BC012588	IRAL019M08	MGC	W01A072H06	pENTR-TOPO	14749		POLR3F	10621	AAH12588.1	Hs.472227	Polymerase (RNA) III (DNA directed) polypeptide F, 39 kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_006466.2	NP_006457.2	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
RIKEN	BC010455	IRAK012C22	MGC	W01A072H22	pENTR-TOPO	12613		DDX39	10212	AAH10455	Hs.311609	DEAD (Asp-Glu-Ala-Asp) box polypeptide 39				NCI_CGAP_Brn67	DH10B	NM_005804.2	NP_005795.2	REVIEWED	P	1.000	1.000	244	951	1	732	427	1	244
RIKEN	BC033703	IRAK068A22	MGC	W01A072I05	pENTR-TOPO	8803		PAQR4	124222	AAH33703.1	Hs.351474	Progestin and adipoQ receptor family member IV				NCI_CGAP_Brn67	DH10B	NM_152341.3	NP_689554.2	VALIDATED	OK	1.000	1.000	273	822	1	819	273	1	273
RIKEN	AK026233	flj0059e03	FLJ	W01A072I13	pENTR-TOPO	7429		CCNB1IP1	57820	BAB15403.1	Hs.107003	Cyclin B1 interacting protein 1				HSI	EK1	NM_182851.1	NP_878271.1	VALIDATED	C	1.000	1.000	277	834	1	831	277	1	277
RIKEN	AK026233	flj0059e03	FLJ	W01A072I19	pENTR-TOPO	7429		CCNB1IP1	57820	BAB15403.1	Hs.107003	Cyclin B1 interacting protein 1				HSI	EK1	NM_182851.1	NP_878271.1	VALIDATED	C	1.000	1.000	277	834	1	831	277	1	277
RIKEN	AK026233	flj0059e03	FLJ	W01A072I21	pENTR-TOPO	7429		CCNB1IP1	57820	BAB15403.1	Hs.107003	Cyclin B1 interacting protein 1				HSI	EK1	NM_182851.1	NP_878271.1	VALIDATED	C	1.000	1.000	277	834	1	831	277	1	277
RIKEN	H033038H22	H033038H22	RIKEN	W01A072K13	pENTR-TOPO		6429	ING1	3621		Hs.46700	Inhibitor of growth family, member 1	-	-	hypothalamus	hypothalamus	DH10B	NM_198218.1	NP_937861.1	REVIEWED	C	1.000	1.000	210	840	208	837	210	1	210
RIKEN	H033038H22	H033038H22	RIKEN	W01A072K19	pENTR-TOPO		6429	ING1	3621		Hs.46700	Inhibitor of growth family, member 1	-	-	hypothalamus	hypothalamus	DH10B	NM_198218.1	NP_937861.1	REVIEWED	C	1.000	1.000	210	840	208	837	210	1	210
RIKEN	H033038H22	H033038H22	RIKEN	W01A072K21	pENTR-TOPO		6429	ING1	3621		Hs.46700	Inhibitor of growth family, member 1	-	-	hypothalamus	hypothalamus	DH10B	NM_198218.1	NP_937861.1	REVIEWED	C	1.000	1.000	210	840	208	837	210	1	210
RIKEN	BC032558	IRAK069M21	MGC	W01A072L02	pENTR-TOPO	13844		DLX2	1746	AAH32558.1	Hs.419	Distal-less homeobox 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_004405.3	NP_004396.1	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC032558	IRAK069M21	MGC	W01A072L04	pENTR-TOPO	13844		DLX2	1746	AAH32558.1	Hs.419	Distal-less homeobox 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_004405.3	NP_004396.1	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC032558	IRAK069M21	MGC	W01A072L10	pENTR-TOPO	13844		DLX2	1746	AAH32558.1	Hs.419	Distal-less homeobox 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_004405.3	NP_004396.1	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC030975	IRAL041P17	MGC	W01A072L22	pENTR-TOPO	12895		IL1RL1	9173	AAH30975.1	Hs.66	Interleukin 1 receptor-like 1			Placenta	NIH_MGC_79	DH10B	NM_003856.2	NP_003847.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
RIKEN	BC056153	IRAK119M17	MGC	W01A072M09	pENTR-TOPO	20405		CCNC	892	AAH56153.1	Hs.633351	Cyclin C			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001013399.1	NP_001013417.1	REVIEWED	C	1.000	1.000	198	852	256	849	198	1	198
RIKEN	BC000157	IRAK003C23	MGC	W01A072M17	pENTR-TOPO	379		ZNF691	51058	AAH00157.1	Hs.20879	Zinc finger protein 691			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015911.2	NP_056995.1	PROVISIONAL	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC000157	IRAK003C23	MGC	W01A072M23	pENTR-TOPO	379		ZNF691	51058	AAH00157.1	Hs.20879	Zinc finger protein 691			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015911.2	NP_056995.1	PROVISIONAL	OK	1.000	1.000	284	855	1	852	284	1	284
RIKEN	BC025722	IRAK049A04	MGC	W01A072N02	pENTR-TOPO	9960		ADORA2B	136	AAH25722.1	Hs.167046	Adenosine A2b receptor			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_000676.2	NP_000667.1	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
RIKEN	BC016314	IRAL032B13	MGC	W01A072N14	pENTR-TOPO	18490		XRCC4	7518	AAH16314.1	Hs.567359	X-ray repair complementing defective repair in Chinese hamster cells 4			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_022406.2	NP_071801.1	REVIEWED	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC016314	IRAL032B13	MGC	W01A072N16	pENTR-TOPO	18490		XRCC4	7518	AAH16314.1	Hs.567359	X-ray repair complementing defective repair in Chinese hamster cells 4			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_022406.2	NP_071801.1	REVIEWED	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC016314	IRAL032B13	MGC	W01A072N22	pENTR-TOPO	18490		XRCC4	7518	AAH16314.1	Hs.567359	X-ray repair complementing defective repair in Chinese hamster cells 4			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_022406.2	NP_071801.1	REVIEWED	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	AK075167	flj0019c21	FLJ	W01A072O17	pENTR-TOPO	10579		DLX3	1747	BAG52078.1	Hs.134194	Distal-less homeobox 3				PLACE1	EK1	NM_005220.2	NP_005211.1	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
RIKEN	BC012583	IRAL019M10	MGC	W01A072P02	pENTR-TOPO	326		RNF2	6045	AAH12583.1	Hs.591490	Ring finger protein 2			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_007212.3	NP_009143.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC012583	IRAL019M10	MGC	W01A072P04	pENTR-TOPO	326		RNF2	6045	AAH12583.1	Hs.591490	Ring finger protein 2			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_007212.3	NP_009143.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC012583	IRAL019M10	MGC	W01A072P06	pENTR-TOPO	326		RNF2	6045	AAH12583.1	Hs.591490	Ring finger protein 2			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_007212.3	NP_009143.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC018340	IRAK021E09	MGC	W01A073A01	pENTR-TOPO	7579		ZFP36L1	677	AAH18340.1	Hs.85155	Zinc finger protein 36, C3H type-like 1			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_004926.2	NP_004917.2	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	BC018340	IRAK021E09	MGC	W01A073A05	pENTR-TOPO	7579		ZFP36L1	677	AAH18340.1	Hs.85155	Zinc finger protein 36, C3H type-like 1			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_004926.2	NP_004917.2	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	BC010576	IRAK012K15	MGC	W01A073A13	pENTR-TOPO	9121		TFAP4	7023	AAH10576.1	Hs.513305	Transcription factor AP-4 (activating enhancer binding protein 4)				NCI_CGAP_Brn67	DH10B	NM_003223.2	NP_003214.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	BC010576	IRAK012K15	MGC	W01A073A17	pENTR-TOPO	9121		TFAP4	7023	AAH10576.1	Hs.513305	Transcription factor AP-4 (activating enhancer binding protein 4)				NCI_CGAP_Brn67	DH10B	NM_003223.2	NP_003214.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	H013060E05	H013060E05	RIKEN	W01A073B04	pENTR-TOPO		16267	PHF7	51533		Hs.372719	PHD finger protein 7	-	-	testis	testis	DH10B	NM_016483.4	NP_057567.3	REVIEWED	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	H013060E05	H013060E05	RIKEN	W01A073B06	pENTR-TOPO		16267	PHF7	51533		Hs.372719	PHD finger protein 7	-	-	testis	testis	DH10B	NM_016483.4	NP_057567.3	REVIEWED	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	H013060E05	H013060E05	RIKEN	W01A073B08	pENTR-TOPO		16267	PHF7	51533		Hs.372719	PHD finger protein 7	-	-	testis	testis	DH10B	NM_016483.4	NP_057567.3	REVIEWED	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	AK001511	flj0034m24	FLJ	W01A073C09	pENTR-TOPO	14946		NSFL1C	55968	BAA91731.1	Hs.12865	NSFL1 (p97) cofactor (p47)	NT2	teratocarcinoma		NT2RP2	EK1	NM_018839.3	NP_061327.2	REVIEWED	C	1.000	1.000	339	1020	1	1017	339	1	339
RIKEN	BC008378	IRAL016N24	MGC	W01A073C17	pENTR-TOPO	20609		PDCD2	5134	AAH08378.1	Hs.367900	Programmed cell death 2			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_002598.2	NP_002589.2	REVIEWED	C	1.000	1.000	344	1035	1	1032	344	1	344
RIKEN	AK092694	flj0017k19	FLJ	W01A073D06	pENTR-TOPO	23088		ABRA	137735	BAC03948.1	Hs.374668	Actin-binding Rho activating protein				SKMUS2	EK1	NM_139166.4	NP_631905.1	VALIDATED	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	AK092694	flj0017k19	FLJ	W01A073D08	pENTR-TOPO	23088		ABRA	137735	BAC03948.1	Hs.374668	Actin-binding Rho activating protein				SKMUS2	EK1	NM_139166.4	NP_631905.1	VALIDATED	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	BC009581	IRAL021A19	MGC	W01A073D16	pENTR-TOPO	8885		HSD17B2	3294	AAH09581.1	Hs.162795	Hydroxysteroid (17-beta) dehydrogenase 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002153.2	NP_002144.1	VALIDATED	C	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC009581	IRAL021A19	MGC	W01A073D18	pENTR-TOPO	8885		HSD17B2	3294	AAH09581.1	Hs.162795	Hydroxysteroid (17-beta) dehydrogenase 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002153.2	NP_002144.1	VALIDATED	C	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC032737	IRAK069L18	MGC	W01A073E13	pENTR-TOPO	19424		TAF7	6879	AAH32737.1	Hs.438838	TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005642.2	NP_005633.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC032737	IRAK069L18	MGC	W01A073E23	pENTR-TOPO	19424		TAF7	6879	AAH32737.1	Hs.438838	TAF7 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 55kDa			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005642.2	NP_005633.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC020737	IRAL037F02	MGC	W01A073F02	pENTR-TOPO	1542		PIGK	10026	AAH20737.1	Hs.178305	Phosphatidylinositol glycan anchor biosynthesis, class K			Liver	NIH_MGC_76	DH10B	NM_005482.2	NP_005473.1	REVIEWED	C	1.000	1.000	395	1188	1	1185	395	1	395
RIKEN	BC022428	IRAL035G08	MGC	W01A073F22	pENTR-TOPO	8707		TERF2IP	54386	AAH22428.1	Hs.301419	Telomeric repeat binding factor 2, interacting protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_018975.2	NP_061848.2	PROVISIONAL	C	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	H013067B20	H013067B20	RIKEN	W01A073G01	pENTR-TOPO		1779	TCEA3	6920		Hs.446354	Transcription elongation factor A (SII), 3	-	-	testis	testis	DH10B	NM_003196.1	NP_003187.1	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	H013067B20	H013067B20	RIKEN	W01A073G11	pENTR-TOPO		1779	TCEA3	6920		Hs.446354	Transcription elongation factor A (SII), 3	-	-	testis	testis	DH10B	NM_003196.1	NP_003187.1	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC008982	IRAK012G16	MGC	W01A073G15	pENTR-TOPO	11940		C5AR1	728	AAH08982.1	Hs.2161	Complement component 5a receptor 1				NCI_CGAP_Brn67	DH10B	NM_001736.3	NP_001727.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	H033065O08	H033065O08	RIKEN	W01A073H02	pENTR-TOPO		20543	RRAGD	58528		Hs.31712	Ras-related GTP binding D	-	-	hypothalamus	hypothalamus	DH10B	NM_021244.4	NP_067067.1	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	H033065O08	H033065O08	RIKEN	W01A073H04	pENTR-TOPO		20543	RRAGD	58528		Hs.31712	Ras-related GTP binding D	-	-	hypothalamus	hypothalamus	DH10B	NM_021244.4	NP_067067.1	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	H033065O08	H033065O08	RIKEN	W01A073H06	pENTR-TOPO		20543	RRAGD	58528		Hs.31712	Ras-related GTP binding D	-	-	hypothalamus	hypothalamus	DH10B	NM_021244.4	NP_067067.1	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC033591	IRAK062D10	MGC	W01A073I09	pENTR-TOPO	14629		SPO11	23626	AAH33591.1	Hs.159737	SPO11 meiotic protein covalently bound to DSB homolog (S. cerevisiae)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198265.1	NP_937998.1	REVIEWED	C	1.000	1.000	358	1077	1	1074	358	1	358
RIKEN	BC071751	IRAL057P18	MGC	W01A073I19	pENTR-TOPO	16588		CCR4	1233	AAH71751.1	Hs.184926	Chemokine (C-C motif) receptor 4				NIH_MGC_191	DH10B	NM_005508.4	NP_005499.1	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	AK001629	flj0035b02	FLJ	W01A073J06	pENTR-TOPO	14545		ARFGAP1	55738	BAA91796.1	Hs.25584	ADP-ribosylation factor GTPase activating protein 1	NT2	teratocarcinoma		NT2RP4	EK1	NM_018209.2	NP_060679.1	REVIEWED	C	1.000	1.000	406	1221	1	1218	406	1	406
RIKEN	AK056742	flj0006h09	FLJ	W01A073K07	pENTR-TOPO	22051		WNT2	7472	BAG51800.1	Hs.567356	Wingless-type MMTV integration site family member 2				PLACE6	EK1	NM_003391.2	NP_003382.1	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	AK056742	flj0006h09	FLJ	W01A073K09	pENTR-TOPO	22051		WNT2	7472	BAG51800.1	Hs.567356	Wingless-type MMTV integration site family member 2				PLACE6	EK1	NM_003391.2	NP_003382.1	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC031574	IRAK050B07	MGC	W01A073K15	pENTR-TOPO	19714		MAPK14	1432	AAH31574.1	Hs.485233	Mitogen-activated protein kinase 14			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_139012.2	NP_620581.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC031574	IRAK050B07	MGC	W01A073K23	pENTR-TOPO	19714		MAPK14	1432	AAH31574.1	Hs.485233	Mitogen-activated protein kinase 14			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_139012.2	NP_620581.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	AK001532	flj0034p07	FLJ	W01A073L04	pENTR-TOPO	10524		SMARCE1	6605	BAG50933.1	Hs.696086	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_003079.4	NP_003070.3	REVIEWED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	AK001532	flj0034p07	FLJ	W01A073L10	pENTR-TOPO	10524		SMARCE1	6605	BAG50933.1	Hs.696086	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily e, member 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_003079.4	NP_003070.3	REVIEWED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	AK093112	flj0005j04	FLJ	W01A073M15	pENTR-TOPO	10207		RFFL	117584	BAC04059.1	Hs.13680	Ring finger and FYVE-like domain containing 1				TESTI2	EK1	NM_057178.3	NP_476519.1	VALIDATED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	AK025905	flj0058m17	FLJ	W01A073N10	pENTR-TOPO	22499		SOX17	64321	BAB15277.1	Hs.98367	SRY (sex determining region Y)-box 17				HRC	EK1	NM_022454.3	NP_071899.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	BC037308	IRAK073E05	MGC	W01A073N14	pENTR-TOPO	7217		YY1	7528	AAH37308.1	Hs.388927	YY1 transcription factor			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003403.3	NP_003394.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	BC037308	IRAK073E05	MGC	W01A073N22	pENTR-TOPO	7217		YY1	7528	AAH37308.1	Hs.388927	YY1 transcription factor			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003403.3	NP_003394.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
RIKEN	AK124696	flj0044h14	FLJ	W01A073O09	pENTR-TOPO	275		KCNAB2	8514	BAG54071.1	Hs.440497	Potassium voltage-gated channel, shaker-related subfamily, beta member 2				BRAMY3	EK1	NM_003636.2	NP_003627.1	REVIEWED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC063305	IRAK133G04	MGC	W01A074A13	pENTR-TOPO	13387		FOXN2	3344	AAH63305.1	Hs.468478	Forkhead box N2			Placenta, normal	NIH_MGC_147	DH10B	NM_002158.3	NP_002149.2	REVIEWED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC063305	IRAK133G04	MGC	W01A074A21	pENTR-TOPO	13387		FOXN2	3344	AAH63305.1	Hs.468478	Forkhead box N2			Placenta, normal	NIH_MGC_147	DH10B	NM_002158.3	NP_002149.2	REVIEWED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC025991	IRAK033N20	MGC	W01A074B06	pENTR-TOPO	13113		GTF2A1L	11036	AAH25991.1	Hs.44385	General transcription factor IIA, 1-like			Testis	NIH_MGC_97	DH10B	NM_006872.2	NP_006863.2	REVIEWED	C	1.000	1.000	478	1437	1	1434	478	1	478
RIKEN	BC040168	IRAK084O09	MGC	W01A074B14	pENTR-TOPO	15360		ERG	2078	AAH40168.1	Hs.473819	V-ets erythroblastosis virus E26 oncogene homolog (avian)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_182918.3	NP_891548.1	VALIDATED	C	1.000	1.000	479	1440	1	1437	479	1	479
RIKEN	AK128520	flj0075m24	FLJ	W01A074C01	pENTR-TOPO	6012		SP7	121340	BAG54688.1	Hs.209402	Sp7 transcription factor				TRACH3	EK1	NM_152860.1	NP_690599.1	PROVISIONAL	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	AK128520	flj0075m24	FLJ	W01A074C03	pENTR-TOPO	6012		SP7	121340	BAG54688.1	Hs.209402	Sp7 transcription factor				TRACH3	EK1	NM_152860.1	NP_690599.1	PROVISIONAL	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	AK056085	flj0002g20	FLJ	W01A074C21	pENTR-TOPO	10476		SC65	10609	-	Hs.446459	Synaptonemal complex protein SC65	NT2	teratocarcinoma		NT2RI2	EK1	NM_006455.2	NP_006446.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC032504	IRAK069C09	MGC	W01A074D14	pENTR-TOPO	2636		MINPP1	9562	AAH32504.1	Hs.121260	Multiple inositol polyphosphate histidine phosphatase, 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004897.3	NP_004888.2	VALIDATED	OK	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC028074	IRAK062I02	MGC	W01A074E07	pENTR-TOPO	19859		SMAP1	60682	AAH28074.1	Hs.485717	Small ArfGAP 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021940.3	NP_068759.2	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	AK002050	flj0020e04	FLJ	W01A074F18	pENTR-TOPO	22949		ZNF395	55893	BAA92056.1	Hs.699209	Zinc finger protein 395				PLACE1	EK1	NM_018660.2	NP_061130.1	VALIDATED	C	1.000	1.000	513	1542	1	1539	513	1	513
RIKEN	BC043399	IRAK089K18	MGC	W01A074G13	pENTR-TOPO	5353		ETV6	2120	AAH43399.1	Hs.504765	Ets variant 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001987.4	NP_001978.1	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC043399	IRAK089K18	MGC	W01A074G15	pENTR-TOPO	5353		ETV6	2120	AAH43399.1	Hs.504765	Ets variant 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001987.4	NP_001978.1	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC043399	IRAK089K18	MGC	W01A074G17	pENTR-TOPO	5353		ETV6	2120	AAH43399.1	Hs.504765	Ets variant 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001987.4	NP_001978.1	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC043399	IRAK089K18	MGC	W01A074G19	pENTR-TOPO	5353		ETV6	2120	AAH43399.1	Hs.504765	Ets variant 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001987.4	NP_001978.1	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC043399	IRAK089K18	MGC	W01A074G21	pENTR-TOPO	5353		ETV6	2120	AAH43399.1	Hs.504765	Ets variant 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001987.4	NP_001978.1	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC043399	IRAK089K18	MGC	W01A074G23	pENTR-TOPO	5353		ETV6	2120	AAH43399.1	Hs.504765	Ets variant 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001987.4	NP_001978.1	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	AK026122	flj0058p06	FLJ	W01A074H02	pENTR-TOPO	9143		NAGPA	51172	-	Hs.21334	N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase				HRC	EK1	NM_016256.2	NP_057340.2	REVIEWED	C	1.000	1.000	515	1548	1	1545	515	1	515
RIKEN	BC068506	IRAK167F10	MGC	W01A074I01	pENTR-TOPO	615		ZNF672	79894	AAH68506.1	Hs.702427	Zinc finger protein 672			Testis	NIH_MGC_97	DH10B	NM_024836.1	NP_079112.1	PROVISIONAL	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	AK021699	flj0028f16	FLJ	W01A074I23	pENTR-TOPO	11696		ZNF556	80032	BAB13878.1	Hs.287433	Zinc finger protein 556				HEMBA1	EK1	NM_024967.1	NP_079243.1	PROVISIONAL	C	1.000	1.000	456	1371	1	1368	456	1	456
RIKEN	AK000929	flj0028e01	FLJ	W01A074K05	pENTR-TOPO	9709		NARF	26502	BAA91432.1	Hs.256526	Nuclear prelamin A recognition factor				HEMBA1	EK1	NM_012336.3	NP_036468.1	REVIEWED	OK	1.000	1.000	456	1371	1	1368	456	1	456
RIKEN	BC034951	IRAK033B10	MGC	W01A074L12	pENTR-TOPO	18101		ELF2	1998	AAH34951.1	Hs.634040	E74-like factor 2 (ets domain transcription factor)			Testis	NIH_MGC_97	DH10B	NM_006874.2	NP_006865.1	VALIDATED	C	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	BC039316	IRAK063O04	MGC	W01A074L20	pENTR-TOPO	11248		L3MBTL4	91133	AAH39316.1	Hs.128279	L(3)mbt-like 4 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_173464.3	NP_775735.2	VALIDATED	P	1.000	1.000	481	1605	1	1443	623	1	481
RIKEN	AK122644	flj0034l24	FLJ	W01A074M13	pENTR-TOPO	19988		ZBTB9	221504	BAG53637.1	Hs.591805	Zinc finger and BTB domain containing 9	IMR32	neuroblastoma		IMR321	EK1	NM_152735.3	NP_689948.1	VALIDATED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	AK122644	flj0034l24	FLJ	W01A074M17	pENTR-TOPO	19988		ZBTB9	221504	BAG53637.1	Hs.591805	Zinc finger and BTB domain containing 9	IMR32	neuroblastoma		IMR321	EK1	NM_152735.3	NP_689948.1	VALIDATED	C	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC036658	IRAK046I19	MGC	W01A074N20	pENTR-TOPO	839		TROVE2	6738	AAH36658.1	Hs.288178	TROVE domain family, member 2			Testis	NIH_MGC_97	DH10B	NM_001042370.1	NP_001035829.1	VALIDATED	C	1.000	1.000	263	1617	826	1614	263	1	263
RIKEN	BC036658	IRAK046I19	MGC	W01A074N24	pENTR-TOPO	839		TROVE2	6738	AAH36658.1	Hs.288178	TROVE domain family, member 2			Testis	NIH_MGC_97	DH10B	NM_001042370.1	NP_001035829.1	VALIDATED	C	1.000	1.000	263	1617	826	1614	263	1	263
RIKEN	H013081A15	H013081A15	RIKEN	W01A074O13	pENTR-TOPO		23502	SLC2A8	29988		Hs.179522	Solute carrier family 2 (facilitated glucose transporter), member 8	-	-	testis	testis	DH10B	NM_014580.3	NP_055395.2	PROVISIONAL	OK	1.000	1.000	477	1434	1	1431	477	1	477
RIKEN	BC055010	IRAK115K07	MGC	W01A075B20	pENTR-TOPO	20516		FBXL4	26235	AAH55010.1	Hs.536850	F-box and leucine-rich repeat protein 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_012160.3	NP_036292.2	REVIEWED	OK	1.000	1.000	621	1866	1	1863	621	1	621
RIKEN	AK023258	flj0035n15	FLJ	W01A075D16	pENTR-TOPO	4450		PHF21A	51317	BAB14492.1	Hs.502458	PHD finger protein 21A	NT2	teratocarcinoma		NT2RP3	EK1	NM_016621.3	NP_057705.3	VALIDATED	Cs	0.998	0.998	634	1905	1	1902	634	1	634
RIKEN	BC020870	IRAL036F20	MGC	W01A075F16	pENTR-TOPO	14898		FLRT3	23767	AAH20870.1	Hs.41296	Fibronectin leucine rich transmembrane protein 3			Kidney	NIH_MGC_75	DH10B	NM_013281.2	NP_037413.1	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
RIKEN	AK130179	flj0060a05	FLJ	W01A075G01	pENTR-TOPO	479		LMNA	4000	-	Hs.594444	Lamin A/C		macrophage		MPG	EK1	NM_005572.3	NP_005563.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
RIKEN	AK130179	flj0060a05	FLJ	W01A075G09	pENTR-TOPO	479		LMNA	4000	-	Hs.594444	Lamin A/C		macrophage		MPG	EK1	NM_005572.3	NP_005563.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
RIKEN	AK093110	flj0007i12	FLJ	W01A075G13	pENTR-TOPO	11790		ZNF8	7554	BAG52656.1	Hs.713519	Zinc finger protein 8				TESTI2	EK1	NM_021089.2	NP_066575.2	VALIDATED	Cs	0.998	0.998	575	1728	1	1725	575	1	575
RIKEN	BC047876	IRAK107J10	MGC	W01A075H02	pENTR-TOPO	11485		PRKCG	5582	AAH47876.1	Hs.631564	Protein kinase C, gamma			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_002739.3	NP_002730.1	REVIEWED	C	1.000	1.000	697	2094	1	2091	697	1	697
RIKEN	BC047876	IRAK107J10	MGC	W01A075H06	pENTR-TOPO	11485		PRKCG	5582	AAH47876.1	Hs.631564	Protein kinase C, gamma			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_002739.3	NP_002730.1	REVIEWED	C	1.000	1.000	697	2094	1	2091	697	1	697
RIKEN	BC047876	IRAK107J10	MGC	W01A075H12	pENTR-TOPO	11485		PRKCG	5582	AAH47876.1	Hs.631564	Protein kinase C, gamma			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_002739.3	NP_002730.1	REVIEWED	C	1.000	1.000	697	2094	1	2091	697	1	697
RIKEN	AK096686	flj0042b12	FLJ	W01A075J02	pENTR-TOPO	14160		STAT1	6772	-	Hs.715518	Signal transducer and activator of transcription 1, 91kDa				PEBLM2	EK1	NM_139266.2	NP_644671.1	REVIEWED	C	1.000	1.000	712	2139	1	2136	712	1	712
RIKEN	BC068474	IRAK167F08	MGC	W01A075J22	pENTR-TOPO	19837		HSP90AB1	3326	AAH68474.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Testis	NIH_MGC_97	DH10B	NM_007355.2	NP_031381.2	PROVISIONAL	C	1.000	1.000	724	2175	1	2172	724	1	724
RIKEN	BC034479	IRAK033E15	MGC	W01A075K13	pENTR-TOPO	3155		PGBD3	267004	AAH34479.1					Testis	NIH_MGC_97	DH10B	NM_170753.1	NP_736609.1	VALIDATED	C	1.000	1.000	593	1782	1	1779	593	1	593
RIKEN	BC034479	IRAK033E15	MGC	W01A075K21	pENTR-TOPO	3155		PGBD3	267004	AAH34479.1					Testis	NIH_MGC_97	DH10B	NM_170753.1	NP_736609.1	VALIDATED	C	1.000	1.000	593	1782	1	1779	593	1	593
RIKEN	H013051L07	H013051L07	RIKEN	W01A075L16	pENTR-TOPO		15241	RRP1B	23076		Hs.654727	Ribosomal RNA processing 1 homolog B (S. cerevisiae)	-	-	testis	testis	DH10B	NM_015056.2	NP_055871.1	VALIDATED	C	1.000	1.000	758	2277	1	2274	758	1	758
RIKEN	H013051L07	H013051L07	RIKEN	W01A075L18	pENTR-TOPO		15241	RRP1B	23076		Hs.654727	Ribosomal RNA processing 1 homolog B (S. cerevisiae)	-	-	testis	testis	DH10B	NM_015056.2	NP_055871.1	VALIDATED	C	1.000	1.000	758	2277	1	2274	758	1	758
RIKEN	BC016147	IRAK015N17	MGC	W01A075M01	pENTR-TOPO	5458		NR4A1	3164	AAH16147.1	Hs.524430	Nuclear receptor subfamily 4, group A, member 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002135.3	NP_002126.2	REVIEWED	OK	1.000	1.000	598	1797	1	1794	598	1	598
RIKEN	BC033899	IRAK047A21	MGC	W01A075N18	pENTR-TOPO	24004		GLIS3	169792	AAH33899.2	Hs.644570	GLIS family zinc finger 3			Testis	NIH_MGC_97	DH10B	NM_152629.3	NP_689842.3	REVIEWED	Cs	0.996	0.996	775	2328	1	2325	775	1	775
RIKEN	AK131547	flj0079a07	FLJ	W01A075O01	pENTR-TOPO	11512		ZNF543	125919	BAD18681.1	Hs.202544	Zinc finger protein 543				CTONG2	EK1	NM_213598.2	NP_998763.2	VALIDATED	Cs	0.998	0.998	600	1803	1	1800	600	1	600
RIKEN	AK055035	flj0001g06	FLJ	W01A075O17	pENTR-TOPO	15614		AIFM3	150209	BAB70841.1	Hs.163543	Apoptosis-inducing factor, mitochondrion-associated, 3				BRAWH1	EK1	NM_144704.2	NP_653305.1	VALIDATED	C	1.000	1.000	605	1818	1	1815	605	1	605
RIKEN	AK055035	flj0001g06	FLJ	W01A075O21	pENTR-TOPO	15614		AIFM3	150209	BAB70841.1	Hs.163543	Apoptosis-inducing factor, mitochondrion-associated, 3				BRAWH1	EK1	NM_144704.2	NP_653305.1	VALIDATED	C	1.000	1.000	605	1818	1	1815	605	1	605
RIKEN	AK056433	flj0004h04	FLJ	W01A075P06	pENTR-TOPO	9246		VAC14	55697	BAG51707.1	Hs.445061	Vac14 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RP7	EK1	NM_018052.3	NP_060522.3	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
RIKEN	AK056433	flj0004h04	FLJ	W01A075P08	pENTR-TOPO	9246		VAC14	55697	BAG51707.1	Hs.445061	Vac14 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RP7	EK1	NM_018052.3	NP_060522.3	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
RIKEN	AK056433	flj0004h04	FLJ	W01A075P12	pENTR-TOPO	9246		VAC14	55697	BAG51707.1	Hs.445061	Vac14 homolog (S. cerevisiae)	NT2	teratocarcinoma		NT2RP7	EK1	NM_018052.3	NP_060522.3	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
RIKEN	BC033872	IRAK068P04	MGC	W01A076B04	pENTR-TOPO	964		FCER1G	2207	AAH33872.1	Hs.433300	Fc fragment of IgE, high affinity I, receptor for; gamma polypeptide			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004106.1	NP_004097.1	REVIEWED	Cg	0.989	1.000	87	264	1	261	86	1	86
RIKEN	BC015753	IRAL034M16	MGC	W01A076B22	pENTR-TOPO	18052		CXCL2	2920	AAH15753.1	Hs.75765	Chemokine (C-X-C motif) ligand 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_002089.3	NP_002080.1	VALIDATED	OK	1.000	1.000	107	324	1	321	107	1	107
RIKEN	BC051284	IRAL047M07	MGC	W01A076C03	pENTR-TOPO	5793		STAT2	6773	AAH51284.1	Hs.530595	Signal transducer and activator of transcription 2, 113kDa			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_005419.2	NP_005410.1	REVIEWED	C	1.000	1.000	851	2556	1	2553	851	1	851
RIKEN	BC047244	IRAK082H08	MGC	W01A076C15	pENTR-TOPO	3691		NCAM1	4684	AAH47244.1	Hs.503878	Neural cell adhesion molecule 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_181351.3	NP_851996.2	VALIDATED	Cs	0.999	0.999	858	2577	1	2574	858	1	858
RIKEN	BC047244	IRAK082H08	MGC	W01A076C21	pENTR-TOPO	3691		NCAM1	4684	AAH47244.1	Hs.503878	Neural cell adhesion molecule 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_181351.3	NP_851996.2	VALIDATED	Cs	0.999	0.999	858	2577	1	2574	858	1	858
RIKEN	BC047244	IRAK082H08	MGC	W01A076C23	pENTR-TOPO	3691		NCAM1	4684	AAH47244.1	Hs.503878	Neural cell adhesion molecule 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_181351.3	NP_851996.2	VALIDATED	Cs	0.999	0.999	858	2577	1	2574	858	1	858
RIKEN	H023050L01	H023050L01	RIKEN	W01A076D02	pENTR-TOPO		22545	LEPROTL1	23484		Hs.146585	Leptin receptor overlapping transcript-like 1	-	-	hippocampus	hippocampus	DH10B	NM_015344.2	NP_056159.2	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	H023050L01	H023050L01	RIKEN	W01A076D04	pENTR-TOPO		22545	LEPROTL1	23484		Hs.146585	Leptin receptor overlapping transcript-like 1	-	-	hippocampus	hippocampus	DH10B	NM_015344.2	NP_056159.2	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	H023050L01	H023050L01	RIKEN	W01A076D06	pENTR-TOPO		22545	LEPROTL1	23484		Hs.146585	Leptin receptor overlapping transcript-like 1	-	-	hippocampus	hippocampus	DH10B	NM_015344.2	NP_056159.2	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	H023050L01	H023050L01	RIKEN	W01A076D12	pENTR-TOPO		22545	LEPROTL1	23484		Hs.146585	Leptin receptor overlapping transcript-like 1	-	-	hippocampus	hippocampus	DH10B	NM_015344.2	NP_056159.2	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
RIKEN	AK131401	flj0079k20	FLJ	W01A076E01	pENTR-TOPO	10239		ZNF624	57547	BAD18548.1	Hs.128078	Zinc finger protein 624				CTONG3	EK1	NM_020787.2	NP_065838.2	VALIDATED	Cs	0.998	0.998	865	2598	1	2595	865	1	865
RIKEN	AK131401	flj0079k20	FLJ	W01A076E09	pENTR-TOPO	10239		ZNF624	57547	BAD18548.1	Hs.128078	Zinc finger protein 624				CTONG3	EK1	NM_020787.2	NP_065838.2	VALIDATED	Cs	0.998	0.998	865	2598	1	2595	865	1	865
RIKEN	BC071837	IRAL058H05	MGC	W01A076F02	pENTR-TOPO	9659		TNFSF12	8742	AAH71837.1					Blood, natural killer cell	NIH_MGC_106		NM_003809.2	NP_003800.1	REVIEWED	P	1.000	1.000	124	405	1	372	249	1	124
RIKEN	AK128468	flj0078h01	FLJ	W01A076F14	pENTR-TOPO	12586		EID2	163126	BAC87454.1	Hs.18949	EP300 interacting inhibitor of differentiation 2				TKIDN2	EK1	NM_153232.3	NP_694964.3	VALIDATED	Cgs	0.788	0.995	236	564	1	561	236	1	236
RIKEN	AK128468	flj0078h01	FLJ	W01A076F16	pENTR-TOPO	12586		EID2	163126	BAC87454.1	Hs.18949	EP300 interacting inhibitor of differentiation 2				TKIDN2	EK1	NM_153232.3	NP_694964.3	VALIDATED	Cgs	0.788	0.995	236	564	1	561	236	1	236
RIKEN	AK128468	flj0078h01	FLJ	W01A076F24	pENTR-TOPO	12586		EID2	163126	BAC87454.1	Hs.18949	EP300 interacting inhibitor of differentiation 2				TKIDN2	EK1	NM_153232.3	NP_694964.3	VALIDATED	Cgs	0.788	0.995	236	564	1	561	236	1	236
RIKEN	AK131418	flj0073a02	FLJ	W01A076G03	pENTR-TOPO	11650		ZNF574	64763	BAD18565.1	Hs.13323	Zinc finger protein 574				OCBBF2	EK1	NM_022752.5	NP_073589.4	VALIDATED	Cs	0.999	0.999	896	2691	1	2688	896	1	896
RIKEN	AK131418	flj0073a02	FLJ	W01A076G07	pENTR-TOPO	11650		ZNF574	64763	BAD18565.1	Hs.13323	Zinc finger protein 574				OCBBF2	EK1	NM_022752.5	NP_073589.4	VALIDATED	Cs	0.999	0.999	896	2691	1	2688	896	1	896
RIKEN	BC035818	IRAK079B12	MGC	W01A076G15	pENTR-TOPO	1834		ZZZ3	26009	AAH35818.1	Hs.480506	Zinc finger, ZZ-type containing 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015534.4	NP_056349.1	PROVISIONAL	OK	1.000	1.000	903	2712	1	2709	903	1	903
RIKEN	BC035818	IRAK079B12	MGC	W01A076G19	pENTR-TOPO	1834		ZZZ3	26009	AAH35818.1	Hs.480506	Zinc finger, ZZ-type containing 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015534.4	NP_056349.1	PROVISIONAL	OK	1.000	1.000	903	2712	1	2709	903	1	903
RIKEN	BC000725	IRAL007O06	MGC	W01A076H04	pENTR-TOPO	12659		CD70	970	AAH00725.1	Hs.715224	CD70 molecule			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001252.3	NP_001243.1	REVIEWED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC000725	IRAL007O06	MGC	W01A076H08	pENTR-TOPO	12659		CD70	970	AAH00725.1	Hs.715224	CD70 molecule			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001252.3	NP_001243.1	REVIEWED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC000725	IRAL007O06	MGC	W01A076H10	pENTR-TOPO	12659		CD70	970	AAH00725.1	Hs.715224	CD70 molecule			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001252.3	NP_001243.1	REVIEWED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC015918	IRAL029E05	MGC	W01A076H16	pENTR-TOPO	14689		PMEPA1	56937	AAH15918.2	Hs.517155	Prostate transmembrane protein, androgen induced 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_199171.1	NP_954640.1	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC015918	IRAL029E05	MGC	W01A076H20	pENTR-TOPO	14689		PMEPA1	56937	AAH15918.2	Hs.517155	Prostate transmembrane protein, androgen induced 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_199171.1	NP_954640.1	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC009930	IRAL007E06	MGC	W01A076J02	pENTR-TOPO	3814		FRAG1	27315	AAH09930.1	Hs.133968	FGF receptor activating protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014489.2	NP_055304.1	VALIDATED	Cg	0.794	1.000	315	753	1	750	315	1	315
RIKEN	BC009930	IRAL007E06	MGC	W01A076J04	pENTR-TOPO	3814		FRAG1	27315	AAH09930.1	Hs.133968	FGF receptor activating protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014489.2	NP_055304.1	VALIDATED	Cg	0.794	1.000	315	753	1	750	315	1	315
RIKEN	BC009930	IRAL007E06	MGC	W01A076J08	pENTR-TOPO	3814		FRAG1	27315	AAH09930.1	Hs.133968	FGF receptor activating protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014489.2	NP_055304.1	VALIDATED	Cg	0.794	1.000	315	753	1	750	315	1	315
RIKEN	BC009930	IRAL007E06	MGC	W01A076J10	pENTR-TOPO	3814		FRAG1	27315	AAH09930.1	Hs.133968	FGF receptor activating protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014489.2	NP_055304.1	VALIDATED	Cg	0.794	1.000	315	753	1	750	315	1	315
RIKEN	BC009930	IRAL007E06	MGC	W01A076J12	pENTR-TOPO	3814		FRAG1	27315	AAH09930.1	Hs.133968	FGF receptor activating protein 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014489.2	NP_055304.1	VALIDATED	Cg	0.794	1.000	315	753	1	750	315	1	315
RIKEN	BC001539	IRAL007L02	MGC	W01A076J14	pENTR-TOPO	2680		DKK1	22943	AAH01539.1	Hs.40499	Dickkopf homolog 1 (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012242.2	NP_036374.1	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC001539	IRAL007L02	MGC	W01A076J16	pENTR-TOPO	2680		DKK1	22943	AAH01539.1	Hs.40499	Dickkopf homolog 1 (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012242.2	NP_036374.1	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC001539	IRAL007L02	MGC	W01A076J24	pENTR-TOPO	2680		DKK1	22943	AAH01539.1	Hs.40499	Dickkopf homolog 1 (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012242.2	NP_036374.1	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC035815	IRAK079P05	MGC	W01A076K07	pENTR-TOPO	13898		KCNH7	90134	AAH35815.1	Hs.657413	Potassium voltage-gated channel, subfamily H (eag-related), member 7			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173162.1	NP_775185.1	REVIEWED	C	1.000	1.000	732	2199	1	2196	732	1	732
RIKEN	AK027824	flj0037p20	FLJ	W01A076L08	pENTR-TOPO	14693		TCEA2	6919	BAG51383.1	Hs.505004	Transcription elongation factor A (SII), 2				PLACE1	EK1	NM_198723.1	NP_942016.1	REVIEWED	Cs	0.993	0.993	272	819	1	816	272	1	272
RIKEN	AK027824	flj0037p20	FLJ	W01A076L10	pENTR-TOPO	14693		TCEA2	6919	BAG51383.1	Hs.505004	Transcription elongation factor A (SII), 2				PLACE1	EK1	NM_198723.1	NP_942016.1	REVIEWED	Cs	0.993	0.993	272	819	1	816	272	1	272
RIKEN	AK027824	flj0037p20	FLJ	W01A076L12	pENTR-TOPO	14693		TCEA2	6919	BAG51383.1	Hs.505004	Transcription elongation factor A (SII), 2				PLACE1	EK1	NM_198723.1	NP_942016.1	REVIEWED	Cs	0.993	0.993	272	819	1	816	272	1	272
RIKEN	H023012L18	H023012L18	RIKEN	W01A076L20	pENTR-TOPO		11381	AURKC	6795		Hs.98338	Aurora kinase C	-	-	hippocampus	hippocampus	DH10B	NM_003160.2	NP_003151.2	REVIEWED	Cs	0.996	0.996	275	828	1	825	275	1	275
RIKEN	H023012L18	H023012L18	RIKEN	W01A076L22	pENTR-TOPO		11381	AURKC	6795		Hs.98338	Aurora kinase C	-	-	hippocampus	hippocampus	DH10B	NM_003160.2	NP_003151.2	REVIEWED	Cs	0.996	0.996	275	828	1	825	275	1	275
RIKEN	AK055202	flj0014b20	FLJ	W01A076M13	pENTR-TOPO	14635		CDH26	60437	BAG51485.1	Hs.54973	Cadherin-like 26				CTONG2	EK1	NM_177980.1	NP_817089.1	REVIEWED	C	1.000	1.000	832	2499	1	2496	832	1	832
RIKEN	BC007892	IRAL020F15	MGC	W01A076N10	pENTR-TOPO	9209		FAM57B	83723	AAH07892.2	Hs.558560	Family with sequence similarity 57, member B			Brain, neuroblastoma	NIH_MGC_19		NM_031478.4	NP_113666.2	VALIDATED	OK	1.000	1.000	274	831	7	828	274	1	274
RIKEN	AK096553	flj0041f04	FLJ	W01A076N16	pENTR-TOPO	7454		SLC8A3	6547	BAG53321.1	Hs.337696	Solute carrier family 8 (sodium/calcium exchanger), member 3				OCBBF2	EK1	NM_182936.1	NP_891981.1	REVIEWED	Cs	0.996	0.996	284	855	1	852	284	1	284
RIKEN	AK096553	flj0041f04	FLJ	W01A076N18	pENTR-TOPO	7454		SLC8A3	6547	BAG53321.1	Hs.337696	Solute carrier family 8 (sodium/calcium exchanger), member 3				OCBBF2	EK1	NM_182936.1	NP_891981.1	REVIEWED	Cs	0.996	0.996	284	855	1	852	284	1	284
RIKEN	AK096553	flj0041f04	FLJ	W01A076N20	pENTR-TOPO	7454		SLC8A3	6547	BAG53321.1	Hs.337696	Solute carrier family 8 (sodium/calcium exchanger), member 3				OCBBF2	EK1	NM_182936.1	NP_891981.1	REVIEWED	Cs	0.996	0.996	284	855	1	852	284	1	284
RIKEN	AK096553	flj0041f04	FLJ	W01A076N22	pENTR-TOPO	7454		SLC8A3	6547	BAG53321.1	Hs.337696	Solute carrier family 8 (sodium/calcium exchanger), member 3				OCBBF2	EK1	NM_182936.1	NP_891981.1	REVIEWED	Cs	0.996	0.996	284	855	1	852	284	1	284
RIKEN	AK096553	flj0041f04	FLJ	W01A076N24	pENTR-TOPO	7454		SLC8A3	6547	BAG53321.1	Hs.337696	Solute carrier family 8 (sodium/calcium exchanger), member 3				OCBBF2	EK1	NM_182936.1	NP_891981.1	REVIEWED	Cs	0.996	0.996	284	855	1	852	284	1	284
RIKEN	AK095975	flj0024f16	FLJ	W01A076O09	pENTR-TOPO	733		DDR2	4921	BAG53183.1	Hs.593833	Discoidin domain receptor tyrosine kinase 2				HHDPC2	EK1	NM_006182.2	NP_006173.2	REVIEWED	C	1.000	1.000	855	2568	1	2565	855	1	855
RIKEN	AK055691	flj0001j16	FLJ	W01A076P12	pENTR-TOPO	2589		BCCIP	56647	BAG51557.1	Hs.715543	BRCA2 and CDKN1A interacting protein	IMR32	neuroblastoma		IMR322	EK1	NM_078469.2	NP_510869.1	REVIEWED	Cs	0.997	0.997	292	879	1	876	292	1	292
RIKEN	AK027334	flj0029b01	FLJ	W01A077A01	pENTR-TOPO	19248		HAVCR2	84868	BAB55044.1	Hs.710500	Hepatitis A virus cellular receptor 2				HEMBA1	EK1	NM_032782.3	NP_116171.3	VALIDATED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	AK027334	flj0029b01	FLJ	W01A077A03	pENTR-TOPO	19248		HAVCR2	84868	BAB55044.1	Hs.710500	Hepatitis A virus cellular receptor 2				HEMBA1	EK1	NM_032782.3	NP_116171.3	VALIDATED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	AK027334	flj0029b01	FLJ	W01A077A07	pENTR-TOPO	19248		HAVCR2	84868	BAB55044.1	Hs.710500	Hepatitis A virus cellular receptor 2				HEMBA1	EK1	NM_032782.3	NP_116171.3	VALIDATED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	AK027334	flj0029b01	FLJ	W01A077A11	pENTR-TOPO	19248		HAVCR2	84868	BAB55044.1	Hs.710500	Hepatitis A virus cellular receptor 2				HEMBA1	EK1	NM_032782.3	NP_116171.3	VALIDATED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	AK027371	flj0030n05	FLJ	W01A077A15	pENTR-TOPO	13759		KLF7	8609	BAG51308.1	Hs.471221	Kruppel-like factor 7 (ubiquitous)				MAMMA1	EK1	NM_003709.2	NP_003700.1	PROVISIONAL	Cs	0.997	0.997	302	909	1	906	302	1	302
RIKEN	AK027371	flj0030n05	FLJ	W01A077A23	pENTR-TOPO	13759		KLF7	8609	BAG51308.1	Hs.471221	Kruppel-like factor 7 (ubiquitous)				MAMMA1	EK1	NM_003709.2	NP_003700.1	PROVISIONAL	Cs	0.997	0.997	302	909	1	906	302	1	302
RIKEN	AK097169	flj0042k07	FLJ	W01A077B02	pENTR-TOPO	11811		ZNF101	94039	BAG53429.1	Hs.631642	Zinc finger protein 101				SPLEN2	EK1	NM_033204.2	NP_149981.2	PROVISIONAL	Cs	0.998	0.998	436	1311	1	1308	436	1	436
RIKEN	AK097169	flj0042k07	FLJ	W01A077B06	pENTR-TOPO	11811		ZNF101	94039	BAG53429.1	Hs.631642	Zinc finger protein 101				SPLEN2	EK1	NM_033204.2	NP_149981.2	PROVISIONAL	Cs	0.998	0.998	436	1311	1	1308	436	1	436
RIKEN	AK097169	flj0042k07	FLJ	W01A077B10	pENTR-TOPO	11811		ZNF101	94039	BAG53429.1	Hs.631642	Zinc finger protein 101				SPLEN2	EK1	NM_033204.2	NP_149981.2	PROVISIONAL	Cs	0.998	0.998	436	1311	1	1308	436	1	436
RIKEN	H023010D24	H023010D24	RIKEN	W01A077B14	pENTR-TOPO		19268	DRD1	1812		Hs.2624	Dopamine receptor D1	-	-	hippocampus	hippocampus	DH10B	NM_000794.3	NP_000785.1	REVIEWED	Cs	0.998	0.998	446	1341	1	1338	446	1	446
RIKEN	H023010D24	H023010D24	RIKEN	W01A077B20	pENTR-TOPO		19268	DRD1	1812		Hs.2624	Dopamine receptor D1	-	-	hippocampus	hippocampus	DH10B	NM_000794.3	NP_000785.1	REVIEWED	Cs	0.998	0.998	446	1341	1	1338	446	1	446
RIKEN	BC017817	IRAL036O01	MGC	W01A077C19	pENTR-TOPO	278		DARC	2532	AAH17817.1	Hs.153381	Duffy blood group, chemokine receptor			Lung	NIH_MGC_77	DH10B	NM_002036.2	NP_002027.2	REVIEWED	Cs	0.997	0.997	336	1011	1	1008	336	1	336
RIKEN	BC064424	IRAK139M24	MGC	W01A077D20	pENTR-TOPO	16421		VIPR1	7433	AAH64424.1	Hs.348500	Vasoactive intestinal peptide receptor 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004624.3	NP_004615.2	VALIDATED	Cs	0.998	0.998	457	1374	1	1371	457	1	457
RIKEN	BC019268	IRAL009O12	MGC	W01A077E01	pENTR-TOPO	11553		PRMT1	3276	AAH19268.2	Hs.20521	Protein arginine methyltransferase 1			Lung, small cell carcinoma	NIH_MGC_7		NM_198318.2	NP_938074.2	VALIDATED	P	1.000	1.000	343	1032	1	1029	353	11	353
RIKEN	BC019268	IRAL009O12	MGC	W01A077E05	pENTR-TOPO	11553		PRMT1	3276	AAH19268.2	Hs.20521	Protein arginine methyltransferase 1			Lung, small cell carcinoma	NIH_MGC_7		NM_198318.2	NP_938074.2	VALIDATED	P	1.000	1.000	343	1032	1	1029	353	11	353
RIKEN	BC019268	IRAL009O12	MGC	W01A077E09	pENTR-TOPO	11553		PRMT1	3276	AAH19268.2	Hs.20521	Protein arginine methyltransferase 1			Lung, small cell carcinoma	NIH_MGC_7		NM_198318.2	NP_938074.2	VALIDATED	P	1.000	1.000	343	1032	1	1029	353	11	353
RIKEN	BC012137	IRAL029E12	MGC	W01A077E15	pENTR-TOPO	4878		STX5	6811	AAH12137.2	Hs.654602	Syntaxin 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003164.3	NP_003155.2	VALIDATED	OK	1.000	1.000	355	1068	1	1065	355	1	355
RIKEN	BC067430	IRAK172I05	MGC	W01A077F06	pENTR-TOPO	11595		CYP2B6	1555	AAH67430.1	Hs.1360	Cytochrome P450, family 2, subfamily B, polypeptide 6			PCR rescued clones	NIH_MGC_195	DH10B	NM_000767.4	NP_000758.1	REVIEWED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	BC067430	IRAK172I05	MGC	W01A077F12	pENTR-TOPO	11595		CYP2B6	1555	AAH67430.1	Hs.1360	Cytochrome P450, family 2, subfamily B, polypeptide 6			PCR rescued clones	NIH_MGC_195	DH10B	NM_000767.4	NP_000758.1	REVIEWED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	AK096571	flj0022o01	FLJ	W01A077F14	pENTR-TOPO	12466		ZNF682	91120	BAG53326.1	Hs.306298	Zinc finger protein 682				OCBBF2	EK1	NM_033196.2	NP_149973.1	VALIDATED	Cs	0.998	0.998	498	1497	1	1494	498	1	498
RIKEN	AK096571	flj0022o01	FLJ	W01A077F16	pENTR-TOPO	12466		ZNF682	91120	BAG53326.1	Hs.306298	Zinc finger protein 682				OCBBF2	EK1	NM_033196.2	NP_149973.1	VALIDATED	Cs	0.998	0.998	498	1497	1	1494	498	1	498
RIKEN	AK096571	flj0022o01	FLJ	W01A077F20	pENTR-TOPO	12466		ZNF682	91120	BAG53326.1	Hs.306298	Zinc finger protein 682				OCBBF2	EK1	NM_033196.2	NP_149973.1	VALIDATED	Cs	0.998	0.998	498	1497	1	1494	498	1	498
RIKEN	AK096571	flj0022o01	FLJ	W01A077F22	pENTR-TOPO	12466		ZNF682	91120	BAG53326.1	Hs.306298	Zinc finger protein 682				OCBBF2	EK1	NM_033196.2	NP_149973.1	VALIDATED	Cs	0.998	0.998	498	1497	1	1494	498	1	498
RIKEN	AK096571	flj0022o01	FLJ	W01A077F24	pENTR-TOPO	12466		ZNF682	91120	BAG53326.1	Hs.306298	Zinc finger protein 682				OCBBF2	EK1	NM_033196.2	NP_149973.1	VALIDATED	Cs	0.998	0.998	498	1497	1	1494	498	1	498
RIKEN	H013072B17	H013072B17	RIKEN	W01A077G03	pENTR-TOPO		21965	GNA12	2768		Hs.487341	Guanine nucleotide binding protein (G protein) alpha 12	-	-	testis	testis	DH10B	NM_007353.2	NP_031379.2	VALIDATED	Cgs	0.929	0.997	381	1068	1	1065	381	1	381
RIKEN	H013072B17	H013072B17	RIKEN	W01A077G05	pENTR-TOPO		21965	GNA12	2768		Hs.487341	Guanine nucleotide binding protein (G protein) alpha 12	-	-	testis	testis	DH10B	NM_007353.2	NP_031379.2	VALIDATED	Cgs	0.929	0.997	381	1068	1	1065	381	1	381
RIKEN	H013072B17	H013072B17	RIKEN	W01A077G07	pENTR-TOPO		21965	GNA12	2768		Hs.487341	Guanine nucleotide binding protein (G protein) alpha 12	-	-	testis	testis	DH10B	NM_007353.2	NP_031379.2	VALIDATED	Cgs	0.929	0.997	381	1068	1	1065	381	1	381
RIKEN	H013072B17	H013072B17	RIKEN	W01A077G09	pENTR-TOPO		21965	GNA12	2768		Hs.487341	Guanine nucleotide binding protein (G protein) alpha 12	-	-	testis	testis	DH10B	NM_007353.2	NP_031379.2	VALIDATED	Cgs	0.929	0.997	381	1068	1	1065	381	1	381
RIKEN	H013072B17	H013072B17	RIKEN	W01A077G11	pENTR-TOPO		21965	GNA12	2768		Hs.487341	Guanine nucleotide binding protein (G protein) alpha 12	-	-	testis	testis	DH10B	NM_007353.2	NP_031379.2	VALIDATED	Cgs	0.929	0.997	381	1068	1	1065	381	1	381
RIKEN	H013079G09	H013079G09	RIKEN	W01A077G13	pENTR-TOPO		25170	PCYT1B	9468		Hs.660708	Phosphate cytidylyltransferase 1, choline, beta	-	-	testis	testis	DH10B	NM_004845.3	NP_004836.2	PROVISIONAL	Cs	0.997	0.997	369	1110	1	1107	369	1	369
RIKEN	H013079G09	H013079G09	RIKEN	W01A077G15	pENTR-TOPO		25170	PCYT1B	9468		Hs.660708	Phosphate cytidylyltransferase 1, choline, beta	-	-	testis	testis	DH10B	NM_004845.3	NP_004836.2	PROVISIONAL	Cs	0.997	0.997	369	1110	1	1107	369	1	369
RIKEN	H06D079I15	H06D079I15	RIKEN	W01A077H04	pENTR-TOPO		24661						-	-	brain	brain	DH10B			
RIKEN	H06D079I15	H06D079I15	RIKEN	W01A077H06	pENTR-TOPO		24661						-	-	brain	brain	DH10B			
RIKEN	BC050711	IRAK110M11	MGC	W01A077I01	pENTR-TOPO	16773		GPR175	131601	AAH50711.1	Hs.6418	G protein-coupled receptor 175			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016372.2	NP_057456.2	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC050711	IRAK110M11	MGC	W01A077I03	pENTR-TOPO	16773		GPR175	131601	AAH50711.1	Hs.6418	G protein-coupled receptor 175			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016372.2	NP_057456.2	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC012104	IRAL029E23	MGC	W01A077I13	pENTR-TOPO	4056		P2RY2	5029	AAH12104.1	Hs.339	Purinergic receptor P2Y, G-protein coupled, 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_176071.1	NP_788085.1	REVIEWED	Cs	0.995	0.995	377	1134	1	1131	377	1	377
RIKEN	BC005809	IRAL014H11	MGC	W01A077J20	pENTR-TOPO	5575		DYRK2	8445	AAH05809.1	Hs.173135	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_003583.3	NP_003574.1	REVIEWED	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	BC005809	IRAL014H11	MGC	W01A077J22	pENTR-TOPO	5575		DYRK2	8445	AAH05809.1	Hs.173135	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_003583.3	NP_003574.1	REVIEWED	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	BC005809	IRAL014H11	MGC	W01A077J24	pENTR-TOPO	5575		DYRK2	8445	AAH05809.1	Hs.173135	Dual-specificity tyrosine-(Y)-phosphorylation regulated kinase 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_003583.3	NP_003574.1	REVIEWED	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	BC000103	IRAL007J11	MGC	W01A077K07	pENTR-TOPO	13069		NCK2	8440	AAH00103.1	Hs.529244	NCK adaptor protein 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_003581.2	NP_003572.2	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC000103	IRAL007J11	MGC	W01A077K11	pENTR-TOPO	13069		NCK2	8440	AAH00103.1	Hs.529244	NCK adaptor protein 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_003581.2	NP_003572.2	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC000276	IRAL006E14	MGC	W01A077K13	pENTR-TOPO	1397		B4GALT3	8703	AAH00276.1	Hs.321231	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3			Eye, retinoblastoma	NIH_MGC_16		NM_003779.2	NP_003770.1	REVIEWED	C	1.000	1.000	393	1182	1	1179	393	1	393
RIKEN	BC000276	IRAL006E14	MGC	W01A077K17	pENTR-TOPO	1397		B4GALT3	8703	AAH00276.1	Hs.321231	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3			Eye, retinoblastoma	NIH_MGC_16		NM_003779.2	NP_003770.1	REVIEWED	C	1.000	1.000	393	1182	1	1179	393	1	393
RIKEN	BC000276	IRAL006E14	MGC	W01A077K19	pENTR-TOPO	1397		B4GALT3	8703	AAH00276.1	Hs.321231	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3			Eye, retinoblastoma	NIH_MGC_16		NM_003779.2	NP_003770.1	REVIEWED	C	1.000	1.000	393	1182	1	1179	393	1	393
RIKEN	BC000276	IRAL006E14	MGC	W01A077K21	pENTR-TOPO	1397		B4GALT3	8703	AAH00276.1	Hs.321231	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 3			Eye, retinoblastoma	NIH_MGC_16		NM_003779.2	NP_003770.1	REVIEWED	C	1.000	1.000	393	1182	1	1179	393	1	393
RIKEN	BC053892	IRAK115L18	MGC	W01A077L18	pENTR-TOPO	23483		ZNF618	114991	AAH53892.1	Hs.349208	Zinc finger protein 618			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133374.2	NP_588615.2	VALIDATED	P	1.000	1.000	544	1635	1	1632	861	318	861
RIKEN	H033063C23	H033063C23	RIKEN	W01A077M03	pENTR-TOPO		19663	UST	10090		Hs.657370	Uronyl-2-sulfotransferase	-	-	hypothalamus	hypothalamus	DH10B	NM_005715.2	NP_005706.1	VALIDATED	Cs	0.998	0.998	406	1221	1	1218	406	1	406
RIKEN	H033063C23	H033063C23	RIKEN	W01A077M05	pENTR-TOPO		19663	UST	10090		Hs.657370	Uronyl-2-sulfotransferase	-	-	hypothalamus	hypothalamus	DH10B	NM_005715.2	NP_005706.1	VALIDATED	Cs	0.998	0.998	406	1221	1	1218	406	1	406
RIKEN	H033063C23	H033063C23	RIKEN	W01A077M09	pENTR-TOPO		19663	UST	10090		Hs.657370	Uronyl-2-sulfotransferase	-	-	hypothalamus	hypothalamus	DH10B	NM_005715.2	NP_005706.1	VALIDATED	Cs	0.998	0.998	406	1221	1	1218	406	1	406
RIKEN	H033063C23	H033063C23	RIKEN	W01A077M11	pENTR-TOPO		19663	UST	10090		Hs.657370	Uronyl-2-sulfotransferase	-	-	hypothalamus	hypothalamus	DH10B	NM_005715.2	NP_005706.1	VALIDATED	Cs	0.998	0.998	406	1221	1	1218	406	1	406
RIKEN	AK000121	flj0062g04	FLJ	W01A077M15	pENTR-TOPO	18681		PIK3R1	5295	-	Hs.132225	Phosphoinositide-3-kinase, regulatory subunit 1 (alpha)				COL	EK1	NM_181524.1	NP_852665.1	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
RIKEN	AK000121	flj0062g04	FLJ	W01A077M17	pENTR-TOPO	18681		PIK3R1	5295	-	Hs.132225	Phosphoinositide-3-kinase, regulatory subunit 1 (alpha)				COL	EK1	NM_181524.1	NP_852665.1	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
RIKEN	AK000121	flj0062g04	FLJ	W01A077M19	pENTR-TOPO	18681		PIK3R1	5295	-	Hs.132225	Phosphoinositide-3-kinase, regulatory subunit 1 (alpha)				COL	EK1	NM_181524.1	NP_852665.1	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
RIKEN	BC004907	IRAL011G15	MGC	W01A077N02	pENTR-TOPO	11624		EPS8L1	54869	AAH04907.2	Hs.438862	EPS8-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_017729.3	NP_060199.3	REVIEWED	Pgs	0.913	0.992	402	1656	376	1581	596	17	386
RIKEN	BC004907	IRAL011G15	MGC	W01A077N06	pENTR-TOPO	11624		EPS8L1	54869	AAH04907.2	Hs.438862	EPS8-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_017729.3	NP_060199.3	REVIEWED	Pgs	0.913	0.992	402	1656	376	1581	596	17	386
RIKEN	BC051877	IRAK110F06	MGC	W01A077N14	pENTR-TOPO	7681		ARIH1	25820	AAH51877.1	Hs.268787	Ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005744.3	NP_005735.2	VALIDATED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC051877	IRAK110F06	MGC	W01A077N16	pENTR-TOPO	7681		ARIH1	25820	AAH51877.1	Hs.268787	Ariadne homolog, ubiquitin-conjugating enzyme E2 binding protein, 1 (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005744.3	NP_005735.2	VALIDATED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC005068	IRAL018C23	MGC	W01A077O05	pENTR-TOPO	13298		ZNF2	7549	AAH05068.2	Hs.590916	Zinc finger protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_021088.2	NP_066574.2	VALIDATED	Cs	0.998	0.998	425	1278	1	1275	425	1	425
RIKEN	BC005068	IRAL018C23	MGC	W01A077O11	pENTR-TOPO	13298		ZNF2	7549	AAH05068.2	Hs.590916	Zinc finger protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_021088.2	NP_066574.2	VALIDATED	Cs	0.998	0.998	425	1278	1	1275	425	1	425
RIKEN	AK122621	flj0023e16	FLJ	W01A077O17	pENTR-TOPO	21082		GPR22	2845	BAG53625.1	Hs.657277	G protein-coupled receptor 22				BRACE2	EK1	NM_005295.2	NP_005286.2	REVIEWED	Cs	0.998	0.998	433	1302	1	1299	433	1	433
RIKEN	AK122621	flj0023e16	FLJ	W01A077O19	pENTR-TOPO	21082		GPR22	2845	BAG53625.1	Hs.657277	G protein-coupled receptor 22				BRACE2	EK1	NM_005295.2	NP_005286.2	REVIEWED	Cs	0.998	0.998	433	1302	1	1299	433	1	433
RIKEN	H023030N03	H023030N03	RIKEN	W01A078B06	pENTR-TOPO		14886	SULF2	55959		Hs.162016	Sulfatase 2	-	-	hippocampus	hippocampus	DH10B	NM_018837.2	NP_061325.1	VALIDATED	Cs	0.997	0.997	870	2613	1	2610	870	1	870
RIKEN	H023030N03	H023030N03	RIKEN	W01A078B10	pENTR-TOPO		14886	SULF2	55959		Hs.162016	Sulfatase 2	-	-	hippocampus	hippocampus	DH10B	NM_018837.2	NP_061325.1	VALIDATED	Cs	0.997	0.997	870	2613	1	2610	870	1	870
RIKEN	AK000353	flj0051j09	FLJ	W01A078C07	pENTR-TOPO	25203		ENOX2	10495	-	Hs.171458	Ecto-NOX disulfide-thiol exchanger 2	HepG2	hepatoma		HEP	EK1	NM_006375.2	NP_006366.2	REVIEWED	Cs	0.997	0.997	581	1746	1	1743	581	1	581
RIKEN	AK000353	flj0051j09	FLJ	W01A078C09	pENTR-TOPO	25203		ENOX2	10495	-	Hs.171458	Ecto-NOX disulfide-thiol exchanger 2	HepG2	hepatoma		HEP	EK1	NM_006375.2	NP_006366.2	REVIEWED	Cs	0.997	0.997	581	1746	1	1743	581	1	581
RIKEN	BC039311	IRAK063M07	MGC	W01A078F24	pENTR-TOPO	2671		TACC2	10579	AAH39311.1	Hs.713875	Transforming, acidic coiled-coil containing protein 2			Testis	NIH_MGC_97	DH10B	NM_206860.1	NP_996742.1	REVIEWED	Cs	0.999	0.999	996	2991	1	2988	996	1	996
RIKEN	H023057N14	H023057N14	RIKEN	W01A078G13	pENTR-TOPO		16210	IRAK2	3656		Hs.449207	Interleukin-1 receptor-associated kinase 2	-	-	hippocampus	hippocampus	DH10B	NM_001570.3	NP_001561.3	REVIEWED	Cs	0.998	0.998	625	1878	1	1875	625	1	625
RIKEN	H023057N14	H023057N14	RIKEN	W01A078G17	pENTR-TOPO		16210	IRAK2	3656		Hs.449207	Interleukin-1 receptor-associated kinase 2	-	-	hippocampus	hippocampus	DH10B	NM_001570.3	NP_001561.3	REVIEWED	Cs	0.998	0.998	625	1878	1	1875	625	1	625
RIKEN	H023057N14	H023057N14	RIKEN	W01A078G21	pENTR-TOPO		16210	IRAK2	3656		Hs.449207	Interleukin-1 receptor-associated kinase 2	-	-	hippocampus	hippocampus	DH10B	NM_001570.3	NP_001561.3	REVIEWED	Cs	0.998	0.998	625	1878	1	1875	625	1	625
RIKEN	BC071883	IRAL058N01	MGC	W01A078I07	pENTR-TOPO	20413		TNXB	7148	AAH71883.1	Hs.485104	Tenascin XB			Lung, large cell carcinoma	NIH_MGC_18		NM_032470.3	NP_115859.2	REVIEWED	Cs	0.996	0.996	673	2022	1	2019	673	1	673
RIKEN	H023027P03	H023027P03	RIKEN	W01A078I19	pENTR-TOPO		9618	SEC14L1	6397		Hs.464184	SEC14-like 1 (S. cerevisiae)	-	-	hippocampus	hippocampus	DH10B	NM_001143998.1	NP_001137470.1	REVIEWED	Cs	0.999	0.999	715	2148	1	2145	715	1	715
RIKEN	H04D017L21	H04D017L21	RIKEN	W01A078J02	pENTR-TOPO		11384						-	-	testis	testis	DH10B			
RIKEN	H04D017L21	H04D017L21	RIKEN	W01A078J12	pENTR-TOPO		11384						-	-	testis	testis	DH10B			
RIKEN	H013008J09	H013008J09	RIKEN	W01A078K15	pENTR-TOPO		6998	ADAM21	8747		Hs.178748	ADAM metallopeptidase domain 21	-	-	testis	testis	DH10B	NM_003813.2	NP_003804.1	REVIEWED	Cs	0.997	0.997	722	2169	1	2166	722	1	722
RIKEN	H013008J09	H013008J09	RIKEN	W01A078K17	pENTR-TOPO		6998	ADAM21	8747		Hs.178748	ADAM metallopeptidase domain 21	-	-	testis	testis	DH10B	NM_003813.2	NP_003804.1	REVIEWED	Cs	0.997	0.997	722	2169	1	2166	722	1	722
RIKEN	H013008J09	H013008J09	RIKEN	W01A078K23	pENTR-TOPO		6998	ADAM21	8747		Hs.178748	ADAM metallopeptidase domain 21	-	-	testis	testis	DH10B	NM_003813.2	NP_003804.1	REVIEWED	Cs	0.997	0.997	722	2169	1	2166	722	1	722
RIKEN	AK002018	flj0037j16	FLJ	W01A078M05	pENTR-TOPO	21009		ABCB8	11194	BAA92038.1	Hs.647118	ATP-binding cassette, sub-family B (MDR/TAP), member 8				PLACE1	EK1	NM_007188.3	NP_009119.2	REVIEWED	Cgs	0.976	0.999	735	2208	1	2205	718	1	718
RIKEN	AK027015	flj0066p10	FLJ	W01A078O07	pENTR-TOPO	22921		MTSS1	9788	-	Hs.336994	Metastasis suppressor 1	HepG2	hepatoma		HEP	EK1	NM_014751.4	NP_055566.3	VALIDATED	Cgs	0.993	0.999	759	2280	1	2277	755	1	755
RIKEN	BC036665	IRAK047M22	MGC	W01A078P18	pENTR-TOPO	23179		RGS22	26166	AAH36665.2	Hs.120021	Regulator of G-protein signaling 22			Testis	NIH_MGC_97	DH10B	NM_015668.3	NP_056483.3	VALIDATED	Cs	0.999	0.999	1264	3795	1	3792	1264	1	1264
RIKEN	BC036665	IRAK047M22	MGC	W01A078P20	pENTR-TOPO	23179		RGS22	26166	AAH36665.2	Hs.120021	Regulator of G-protein signaling 22			Testis	NIH_MGC_97	DH10B	NM_015668.3	NP_056483.3	VALIDATED	Cs	0.999	0.999	1264	3795	1	3792	1264	1	1264
RIKEN	AK054728	flj0011d23	FLJ	W01A079A15	pENTR-TOPO	3943		CALCB	797	-	Hs.534305	Calcitonin-related polypeptide beta				BRACE2	EK1	NM_000728.3	NP_000719.1	VALIDATED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	AK054728	flj0011d23	FLJ	W01A079A19	pENTR-TOPO	3943		CALCB	797	-	Hs.534305	Calcitonin-related polypeptide beta				BRACE2	EK1	NM_000728.3	NP_000719.1	VALIDATED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	AK054728	flj0011d23	FLJ	W01A079A21	pENTR-TOPO	3943		CALCB	797	-	Hs.534305	Calcitonin-related polypeptide beta				BRACE2	EK1	NM_000728.3	NP_000719.1	VALIDATED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	AK054728	flj0011d23	FLJ	W01A079A23	pENTR-TOPO	3943		CALCB	797	-	Hs.534305	Calcitonin-related polypeptide beta				BRACE2	EK1	NM_000728.3	NP_000719.1	VALIDATED	Cs	0.992	0.992	127	384	1	381	127	1	127
RIKEN	BC000387	IRAL001E16	MGC	W01A079C01	pENTR-TOPO	12300		LSM4	25804	AAH00387.1	Hs.515255	LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_012321.3	NP_036453.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
RIKEN	BC000387	IRAL001E16	MGC	W01A079C07	pENTR-TOPO	12300		LSM4	25804	AAH00387.1	Hs.515255	LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_012321.3	NP_036453.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
RIKEN	BC000387	IRAL001E16	MGC	W01A079C09	pENTR-TOPO	12300		LSM4	25804	AAH00387.1	Hs.515255	LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_012321.3	NP_036453.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
RIKEN	BC000387	IRAL001E16	MGC	W01A079C11	pENTR-TOPO	12300		LSM4	25804	AAH00387.1	Hs.515255	LSM4 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_012321.3	NP_036453.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
RIKEN	BC014353	IRAL031B14	MGC	W01A079C13	pENTR-TOPO	1503		STMN1	3925	AAH14353.1	Hs.209983	Stathmin 1/oncoprotein 18			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_203399.1	NP_981944.1	REVIEWED	Cs	0.993	0.993	149	450	1	447	149	1	149
RIKEN	BC014353	IRAL031B14	MGC	W01A079C23	pENTR-TOPO	1503		STMN1	3925	AAH14353.1	Hs.209983	Stathmin 1/oncoprotein 18			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_203399.1	NP_981944.1	REVIEWED	Cs	0.993	0.993	149	450	1	447	149	1	149
RIKEN	H013085K09	H013085K09	RIKEN	W01A079D04	pENTR-TOPO		14628	RALY	22913		Hs.136947	RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse))	-	-	testis	testis	DH10B	NM_016732.1	NP_057951.1	REVIEWED	Cgs	0.993	0.997	307	924	1	921	306	1	306
RIKEN	H013085K09	H013085K09	RIKEN	W01A079D10	pENTR-TOPO		14628	RALY	22913		Hs.136947	RNA binding protein, autoantigenic (hnRNP-associated with lethal yellow homolog (mouse))	-	-	testis	testis	DH10B	NM_016732.1	NP_057951.1	REVIEWED	Cgs	0.993	0.997	307	924	1	921	306	1	306
RIKEN	BC039244	IRAK048A17	MGC	W01A079D16	pENTR-TOPO	19891		NFYA	4800	AAH39244.1	Hs.10441	Nuclear transcription factor Y, alpha			Testis	NIH_MGC_97	DH10B	NM_021705.3	NP_068351.1	REVIEWED	Cs	0.997	0.997	318	957	1	954	318	1	318
RIKEN	BC039244	IRAK048A17	MGC	W01A079D22	pENTR-TOPO	19891		NFYA	4800	AAH39244.1	Hs.10441	Nuclear transcription factor Y, alpha			Testis	NIH_MGC_97	DH10B	NM_021705.3	NP_068351.1	REVIEWED	Cs	0.997	0.997	318	957	1	954	318	1	318
RIKEN	BC018195	IRAK021H09	MGC	W01A079E05	pENTR-TOPO	13203		GEMIN6	79833	AAH18195.1	Hs.143818	Gem (nuclear organelle) associated protein 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_024775.9	NP_079051.9	VALIDATED	Cs	0.994	0.994	167	504	1	501	167	1	167
RIKEN	BC018195	IRAK021H09	MGC	W01A079E09	pENTR-TOPO	13203		GEMIN6	79833	AAH18195.1	Hs.143818	Gem (nuclear organelle) associated protein 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_024775.9	NP_079051.9	VALIDATED	Cs	0.994	0.994	167	504	1	501	167	1	167
RIKEN	BC018195	IRAK021H09	MGC	W01A079E11	pENTR-TOPO	13203		GEMIN6	79833	AAH18195.1	Hs.143818	Gem (nuclear organelle) associated protein 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_024775.9	NP_079051.9	VALIDATED	Cs	0.994	0.994	167	504	1	501	167	1	167
RIKEN	BC001971	IRAK004C06	MGC	W01A079E13	pENTR-TOPO	5344		CDKN1B	1027	AAH01971.1	Hs.238990	Cyclin-dependent kinase inhibitor 1B (p27, Kip1)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_004064.3	NP_004055.1	VALIDATED	Cs	0.995	0.995	198	597	1	594	198	1	198
RIKEN	BC001971	IRAK004C06	MGC	W01A079E19	pENTR-TOPO	5344		CDKN1B	1027	AAH01971.1	Hs.238990	Cyclin-dependent kinase inhibitor 1B (p27, Kip1)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_004064.3	NP_004055.1	VALIDATED	Cs	0.995	0.995	198	597	1	594	198	1	198
RIKEN	BC011609	IRAL012H19	MGC	W01A079F04	pENTR-TOPO	13482		DNAJB2	3300	AAH11609.1	Hs.77768	DnaJ (Hsp40) homolog, subfamily B, member 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006736.5	NP_006727.2	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC011609	IRAL012H19	MGC	W01A079F12	pENTR-TOPO	13482		DNAJB2	3300	AAH11609.1	Hs.77768	DnaJ (Hsp40) homolog, subfamily B, member 2			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006736.5	NP_006727.2	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
RIKEN	AK057845	flj0052o12	FLJ	W01A079G09	pENTR-TOPO	677		EFNA1	1942	-	Hs.516664	Ephrin-A1				CBR	EK1	NM_004428.2	NP_004419.2	REVIEWED	Cs	0.995	0.995	205	618	1	615	205	1	205
RIKEN	AK057845	flj0052o12	FLJ	W01A079G11	pENTR-TOPO	677		EFNA1	1942	-	Hs.516664	Ephrin-A1				CBR	EK1	NM_004428.2	NP_004419.2	REVIEWED	Cs	0.995	0.995	205	618	1	615	205	1	205
RIKEN	BC001597	IRAL008G02	MGC	W01A079G19	pENTR-TOPO	309		PPP1R8	5511	AAH01597.1	Hs.533474	Protein phosphatase 1, regulatory (inhibitor) subunit 8			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_138558.1	NP_612568.1	REVIEWED	OK	1.000	1.000	209	630	1	627	209	1	209
RIKEN	BC001597	IRAL008G02	MGC	W01A079G21	pENTR-TOPO	309		PPP1R8	5511	AAH01597.1	Hs.533474	Protein phosphatase 1, regulatory (inhibitor) subunit 8			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_138558.1	NP_612568.1	REVIEWED	OK	1.000	1.000	209	630	1	627	209	1	209
RIKEN	BC001888	IRAL008B16	MGC	W01A079H02	pENTR-TOPO	4816		PPP1CA	5499	AAH01888.1	Hs.183994	Protein phosphatase 1, catalytic subunit, alpha isoform			Placenta, choriocarcinoma	NIH_MGC_21		NM_002708.3	NP_002699.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC001888	IRAL008B16	MGC	W01A079H08	pENTR-TOPO	4816		PPP1CA	5499	AAH01888.1	Hs.183994	Protein phosphatase 1, catalytic subunit, alpha isoform			Placenta, choriocarcinoma	NIH_MGC_21		NM_002708.3	NP_002699.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC001888	IRAL008B16	MGC	W01A079H12	pENTR-TOPO	4816		PPP1CA	5499	AAH01888.1	Hs.183994	Protein phosphatase 1, catalytic subunit, alpha isoform			Placenta, choriocarcinoma	NIH_MGC_21		NM_002708.3	NP_002699.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC002788	IRAL012J13	MGC	W01A079H18	pENTR-TOPO	12108		PLAUR	5329	AAH02788.1	Hs.466871	Plasminogen activator, urokinase receptor			Skin, melanotic melanoma.	NIH_MGC_20		NM_002659.2	NP_002650.1	REVIEWED	C	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC005003	IRAL006H14	MGC	W01A079J10	pENTR-TOPO	216		NFYC	4802	AAH05003.1	Hs.233458	Nuclear transcription factor Y, gamma			Brain, neuroblastoma	NIH_MGC_19		NM_014223.4	NP_055038.2	REVIEWED	OK	1.000	1.000	335	1008	1	1005	335	1	335
RIKEN	BC032517	IRAK069E17	MGC	W01A079K07	pENTR-TOPO	1749		NGF	4803	AAH32517.2	Hs.2561	Nerve growth factor (beta polypeptide)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002506.2	NP_002497.2	REVIEWED	Cs	0.996	0.996	241	726	1	723	241	1	241
RIKEN	BC032517	IRAK069E17	MGC	W01A079K09	pENTR-TOPO	1749		NGF	4803	AAH32517.2	Hs.2561	Nerve growth factor (beta polypeptide)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002506.2	NP_002497.2	REVIEWED	Cs	0.996	0.996	241	726	1	723	241	1	241
RIKEN	BC051773	IRAK098M20	MGC	W01A079K21	pENTR-TOPO	15995		CBX7	23492	AAH51773.1	Hs.356416	Chromobox homolog 7				Lupski_sympathetic_trunk	DH10B	NM_175709.3	NP_783640.1	VALIDATED	Cs	0.992	0.992	251	756	1	753	251	1	251
RIKEN	BC001462	IRAL004J03	MGC	W01A079L04	pENTR-TOPO	9371		PRSS8	5652	AAH01462.1	Hs.75799	Protease, serine, 8			Placenta, choriocarcinoma	NIH_MGC_21		NM_002773.3	NP_002764.1	REVIEWED	OK	1.000	1.000	343	1032	1	1029	343	1	343
RIKEN	BC001462	IRAL004J03	MGC	W01A079L06	pENTR-TOPO	9371		PRSS8	5652	AAH01462.1	Hs.75799	Protease, serine, 8			Placenta, choriocarcinoma	NIH_MGC_21		NM_002773.3	NP_002764.1	REVIEWED	OK	1.000	1.000	343	1032	1	1029	343	1	343
RIKEN	BC001462	IRAL004J03	MGC	W01A079L08	pENTR-TOPO	9371		PRSS8	5652	AAH01462.1	Hs.75799	Protease, serine, 8			Placenta, choriocarcinoma	NIH_MGC_21		NM_002773.3	NP_002764.1	REVIEWED	OK	1.000	1.000	343	1032	1	1029	343	1	343
RIKEN	BC001462	IRAL004J03	MGC	W01A079L10	pENTR-TOPO	9371		PRSS8	5652	AAH01462.1	Hs.75799	Protease, serine, 8			Placenta, choriocarcinoma	NIH_MGC_21		NM_002773.3	NP_002764.1	REVIEWED	OK	1.000	1.000	343	1032	1	1029	343	1	343
RIKEN	BC008863	IRAL026I03	MGC	W01A079L14	pENTR-TOPO	19761		POLR1C	9533	AAH08863.1	Hs.719353	Polymerase (RNA) I polypeptide C, 30kDa			Brain, neuroblastoma	NIH_MGC_19		NM_203290.1	NP_976035.1	VALIDATED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC008863	IRAL026I03	MGC	W01A079L22	pENTR-TOPO	19761		POLR1C	9533	AAH08863.1	Hs.719353	Polymerase (RNA) I polypeptide C, 30kDa			Brain, neuroblastoma	NIH_MGC_19		NM_203290.1	NP_976035.1	VALIDATED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC008863	IRAL026I03	MGC	W01A079L24	pENTR-TOPO	19761		POLR1C	9533	AAH08863.1	Hs.719353	Polymerase (RNA) I polypeptide C, 30kDa			Brain, neuroblastoma	NIH_MGC_19		NM_203290.1	NP_976035.1	VALIDATED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC007963	IRAL020P02	MGC	W01A079M09	pENTR-TOPO	20059		HLA-DPB1	3115	AAH07963.1	Hs.485130	Major histocompatibility complex, class II, DP beta 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_002121.4	NP_002112.3	REVIEWED	Cs	0.996	0.996	258	777	1	774	258	1	258
RIKEN	BC007963	IRAL020P02	MGC	W01A079M11	pENTR-TOPO	20059		HLA-DPB1	3115	AAH07963.1	Hs.485130	Major histocompatibility complex, class II, DP beta 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_002121.4	NP_002112.3	REVIEWED	Cs	0.996	0.996	258	777	1	774	258	1	258
RIKEN	BC012358	IRAL029P05	MGC	W01A079M13	pENTR-TOPO	24505		PQBP1	10084	AAH12358.1	Hs.534384	Polyglutamine binding protein 1			Lung, large cell carcinoma	NIH_MGC_18		NM_005710.2	NP_005701.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
RIKEN	BC012358	IRAL029P05	MGC	W01A079M17	pENTR-TOPO	24505		PQBP1	10084	AAH12358.1	Hs.534384	Polyglutamine binding protein 1			Lung, large cell carcinoma	NIH_MGC_18		NM_005710.2	NP_005701.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
RIKEN	AK123050	flj0039j12	FLJ	W01A079N04	pENTR-TOPO	16211		CCR3	1232	BAG53863.1	Hs.506190	Chemokine (C-C motif) receptor 3				SYNOV2	EK1	NM_178329.1	NP_847899.1	REVIEWED	Cs	0.992	0.992	355	1068	1	1065	355	1	355
RIKEN	AK123050	flj0039j12	FLJ	W01A079N08	pENTR-TOPO	16211		CCR3	1232	BAG53863.1	Hs.506190	Chemokine (C-C motif) receptor 3				SYNOV2	EK1	NM_178329.1	NP_847899.1	REVIEWED	Cs	0.992	0.992	355	1068	1	1065	355	1	355
RIKEN	BC012138	IRAL029F10	MGC	W01A079N14	pENTR-TOPO	16332		GNAI2	2771	AAH12138.1	Hs.77269	Guanine nucleotide binding protein (G protein), alpha inhibiting activity polypeptide 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_002070.2	NP_002061.1	VALIDATED	OK	1.000	1.000	355	1068	1	1065	355	1	355
RIKEN	BC001880	IRAL008F22	MGC	W01A079O05	pENTR-TOPO	21142		INSIG1	3638	AAH01880.1	Hs.520819	Insulin induced gene 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_005542.3	NP_005533.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
RIKEN	BC001880	IRAL008F22	MGC	W01A079O07	pENTR-TOPO	21142		INSIG1	3638	AAH01880.1	Hs.520819	Insulin induced gene 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_005542.3	NP_005533.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
RIKEN	BC001880	IRAL008F22	MGC	W01A079O09	pENTR-TOPO	21142		INSIG1	3638	AAH01880.1	Hs.520819	Insulin induced gene 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_005542.3	NP_005533.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
RIKEN	BC000371	IRAL001A20	MGC	W01A079O15	pENTR-TOPO	5508		MLEC	9761	AAH00371.1	Hs.714322	Malectin			Lung, small cell carcinoma	NIH_MGC_7		NM_014730.2	NP_055545.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
RIKEN	BC000371	IRAL001A20	MGC	W01A079O17	pENTR-TOPO	5508		MLEC	9761	AAH00371.1	Hs.714322	Malectin			Lung, small cell carcinoma	NIH_MGC_7		NM_014730.2	NP_055545.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
RIKEN	BC015741	IRAL034P10	MGC	W01A080A05	pENTR-TOPO	15813		MAPK12	6300	AAH15741.1	Hs.432642	Mitogen-activated protein kinase 12			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_002969.3	NP_002960.2	REVIEWED	C	1.000	1.000	367	1104	1	1101	367	1	367
RIKEN	BC001703	IRAL006B04	MGC	W01A080A17	pENTR-TOPO	11633		MRI1	84245	AAH01703.1	Hs.439370	Methylthioribose-1-phosphate isomerase homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19		NM_001031727.2	NP_001026897.1	VALIDATED	C	1.000	1.000	369	1110	1	1107	369	1	369
RIKEN	BC023569	IRAL030B02	MGC	W01A080B06	pENTR-TOPO	6484		UPF3A	65110	AAH23569.1	Hs.533855	UPF3 regulator of nonsense transcripts homolog A (yeast)			Brain, neuroblastoma	NIH_MGC_19		NM_080687.1	NP_542418.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC023569	IRAL030B02	MGC	W01A080B08	pENTR-TOPO	6484		UPF3A	65110	AAH23569.1	Hs.533855	UPF3 regulator of nonsense transcripts homolog A (yeast)			Brain, neuroblastoma	NIH_MGC_19		NM_080687.1	NP_542418.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC001709	IRAL008K02	MGC	W01A080B24	pENTR-TOPO	1691		NADK	65220	AAH01709.1	Hs.654792	NAD kinase			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_023018.3	NP_075394.3	VALIDATED	Cs	0.998	0.998	446	1341	1	1338	446	1	446
RIKEN	BC033758	IRAK068O20	MGC	W01A080C01	pENTR-TOPO	9795		ADAP2	55803	AAH33758.1	Hs.514063	ArfGAP with dual PH domains 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018404.2	NP_060874.1	VALIDATED	Cg	0.997	1.000	381	1143	1	1140	381	1	381
RIKEN	BC033758	IRAK068O20	MGC	W01A080C03	pENTR-TOPO	9795		ADAP2	55803	AAH33758.1	Hs.514063	ArfGAP with dual PH domains 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018404.2	NP_060874.1	VALIDATED	Cg	0.997	1.000	381	1143	1	1140	381	1	381
RIKEN	H013052A13	H013052A13	RIKEN	W01A080D08	pENTR-TOPO		11283	ZFP161	7541		Hs.592340	Zinc finger protein 161 homolog (mouse)	-	-	testis	testis	DH10B	NM_001143823.1	NP_001137295.1	VALIDATED	Cs	0.998	0.998	449	1350	1	1347	449	1	449
RIKEN	H013052A13	H013052A13	RIKEN	W01A080D12	pENTR-TOPO		11283	ZFP161	7541		Hs.592340	Zinc finger protein 161 homolog (mouse)	-	-	testis	testis	DH10B	NM_001143823.1	NP_001137295.1	VALIDATED	Cs	0.998	0.998	449	1350	1	1347	449	1	449
RIKEN	AK000241	flj0062d11	FLJ	W01A080D20	pENTR-TOPO	12395		STAP2	55620	BAA91028.1	Hs.194385	Signal transducing adaptor family member 2				ColF	EK1	NM_017720.2	NP_060190.2	REVIEWED	Cs	0.998	0.998	449	1350	1	1347	449	1	449
RIKEN	AK125182	flj0048i24	FLJ	W01A080E03	pENTR-TOPO	12573		SYT5	6861	BAG54160.1	Hs.631566	Synaptotagmin V				FCBBF3	EK1	NM_003180.2	NP_003171.2	VALIDATED	Cs	0.997	0.997	386	1161	1	1158	386	1	386
RIKEN	AK125182	flj0048i24	FLJ	W01A080E09	pENTR-TOPO	12573		SYT5	6861	BAG54160.1	Hs.631566	Synaptotagmin V				FCBBF3	EK1	NM_003180.2	NP_003171.2	VALIDATED	Cs	0.997	0.997	386	1161	1	1158	386	1	386
RIKEN	BC011759	IRAL027D20	MGC	W01A080E13	pENTR-TOPO	121		LHX4	89884	AAH11759.1	Hs.658487	LIM homeobox 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_033343.2	NP_203129.1	REVIEWED	C	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC011759	IRAL027D20	MGC	W01A080E15	pENTR-TOPO	121		LHX4	89884	AAH11759.1	Hs.658487	LIM homeobox 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_033343.2	NP_203129.1	REVIEWED	C	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC011759	IRAL027D20	MGC	W01A080E17	pENTR-TOPO	121		LHX4	89884	AAH11759.1	Hs.658487	LIM homeobox 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_033343.2	NP_203129.1	REVIEWED	C	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC011759	IRAL027D20	MGC	W01A080E23	pENTR-TOPO	121		LHX4	89884	AAH11759.1	Hs.658487	LIM homeobox 4			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_033343.2	NP_203129.1	REVIEWED	C	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC001670	IRAL003I14	MGC	W01A080F04	pENTR-TOPO	3805		FLI1	2313	AAH01670.1	Hs.504281	Friend leukemia virus integration 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002017.3	NP_002008.2	VALIDATED	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	BC001670	IRAL003I14	MGC	W01A080F08	pENTR-TOPO	3805		FLI1	2313	AAH01670.1	Hs.504281	Friend leukemia virus integration 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_002017.3	NP_002008.2	VALIDATED	C	1.000	1.000	452	1359	1	1356	452	1	452
RIKEN	AK122643	flj0034l15	FLJ	W01A080F14	pENTR-TOPO	13060		GPR39	2863	BAG53636.1	Hs.432395	G protein-coupled receptor 39				HSYRA2	EK1	NM_001508.2	NP_001499.1	VALIDATED	Cs	0.996	0.996	453	1362	1	1359	453	1	453
RIKEN	AK122643	flj0034l15	FLJ	W01A080F18	pENTR-TOPO	13060		GPR39	2863	BAG53636.1	Hs.432395	G protein-coupled receptor 39				HSYRA2	EK1	NM_001508.2	NP_001499.1	VALIDATED	Cs	0.996	0.996	453	1362	1	1359	453	1	453
RIKEN	AK122643	flj0034l15	FLJ	W01A080F20	pENTR-TOPO	13060		GPR39	2863	BAG53636.1	Hs.432395	G protein-coupled receptor 39				HSYRA2	EK1	NM_001508.2	NP_001499.1	VALIDATED	Cs	0.996	0.996	453	1362	1	1359	453	1	453
RIKEN	AK122643	flj0034l15	FLJ	W01A080F24	pENTR-TOPO	13060		GPR39	2863	BAG53636.1	Hs.432395	G protein-coupled receptor 39				HSYRA2	EK1	NM_001508.2	NP_001499.1	VALIDATED	Cs	0.996	0.996	453	1362	1	1359	453	1	453
RIKEN	BC010409	IRAL024K20	MGC	W01A080G01	pENTR-TOPO	10247		KRT19	3880	AAH10409.3	Hs.654568	Keratin 19			Pancreas, adenocarcinoma	NIH_MGC_39		NM_002276.4	NP_002267.2	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	AK000875	flj0019p09	FLJ	W01A080I05	pENTR-TOPO	15496		PICK1	9463	BAG50834.1	Hs.180871	Protein interacting with PRKCA 1				HEMBA1	EK1	NM_001039583.1	NP_001034672.1	REVIEWED	Cs	0.998	0.998	415	1248	1	1245	415	1	415
RIKEN	BC011714	IRAL027J19	MGC	W01A080I15	pENTR-TOPO	17965		HNRPDL	9987	AAH11714.1	Hs.527105	Heterogeneous nuclear ribonucleoprotein D-like			Ovary, adenocarcinoma	NIH_MGC_9		NM_031372.2	NP_112740.1	REVIEWED	C	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	BC011714	IRAL027J19	MGC	W01A080I19	pENTR-TOPO	17965		HNRPDL	9987	AAH11714.1	Hs.527105	Heterogeneous nuclear ribonucleoprotein D-like			Ovary, adenocarcinoma	NIH_MGC_9		NM_031372.2	NP_112740.1	REVIEWED	C	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	BC004935	IRAL013E09	MGC	W01A080J04	pENTR-TOPO	19708		GTF2H4	2968	AAH04935.1	Hs.485070	General transcription factor IIH, polypeptide 4, 52kDa			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001517.4	NP_001508.1	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	BC004935	IRAL013E09	MGC	W01A080J10	pENTR-TOPO	19708		GTF2H4	2968	AAH04935.1	Hs.485070	General transcription factor IIH, polypeptide 4, 52kDa			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001517.4	NP_001508.1	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
RIKEN	AK093728	flj0016b21	FLJ	W01A080J14	pENTR-TOPO	25231		UPF3B	65109	BAG52755.1	Hs.103832	UPF3 regulator of nonsense transcripts homolog B (yeast)				THYMU2	EK1	NM_023010.2	NP_075386.1	REVIEWED	Cs	0.998	0.998	470	1413	1	1410	470	1	470
RIKEN	AK093728	flj0016b21	FLJ	W01A080J16	pENTR-TOPO	25231		UPF3B	65109	BAG52755.1	Hs.103832	UPF3 regulator of nonsense transcripts homolog B (yeast)				THYMU2	EK1	NM_023010.2	NP_075386.1	REVIEWED	Cs	0.998	0.998	470	1413	1	1410	470	1	470
RIKEN	AK093728	flj0016b21	FLJ	W01A080J22	pENTR-TOPO	25231		UPF3B	65109	BAG52755.1	Hs.103832	UPF3 regulator of nonsense transcripts homolog B (yeast)				THYMU2	EK1	NM_023010.2	NP_075386.1	REVIEWED	Cs	0.998	0.998	470	1413	1	1410	470	1	470
RIKEN	AK093728	flj0016b21	FLJ	W01A080J24	pENTR-TOPO	25231		UPF3B	65109	BAG52755.1	Hs.103832	UPF3 regulator of nonsense transcripts homolog B (yeast)				THYMU2	EK1	NM_023010.2	NP_075386.1	REVIEWED	Cs	0.998	0.998	470	1413	1	1410	470	1	470
RIKEN	BC067473	IRAK172E10	MGC	W01A080K01	pENTR-TOPO	4441		GPR83	10888	AAH67473.1	Hs.272385	G protein-coupled receptor 83			PCR rescued clones	NIH_MGC_195	DH10B	NM_016540.3	NP_057624.3	VALIDATED	C	1.000	1.000	423	1272	1	1269	423	1	423
RIKEN	BC067473	IRAK172E10	MGC	W01A080K05	pENTR-TOPO	4441		GPR83	10888	AAH67473.1	Hs.272385	G protein-coupled receptor 83			PCR rescued clones	NIH_MGC_195	DH10B	NM_016540.3	NP_057624.3	VALIDATED	C	1.000	1.000	423	1272	1	1269	423	1	423
RIKEN	BC004141	IRAL003K24	MGC	W01A080K13	pENTR-TOPO	8314		GATM	2628	AAH04141.1	Hs.75335	Glycine amidinotransferase (L-arginine:glycine amidinotransferase)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001482.2	NP_001473.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
RIKEN	BC001439	IRAL004D09	MGC	W01A080L04	pENTR-TOPO	13172		ABI2	10152	AAH01439.1	Hs.471156	Abl interactor 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_005759.4	NP_005750.4	VALIDATED	C	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC001439	IRAL004D09	MGC	W01A080L10	pENTR-TOPO	13172		ABI2	10152	AAH01439.1	Hs.471156	Abl interactor 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_005759.4	NP_005750.4	VALIDATED	C	1.000	1.000	475	1428	1	1425	475	1	475
RIKEN	BC060802	IRAK133D04	MGC	W01A080L14	pENTR-TOPO	16209		HRH1	3269	AAH60802.1	Hs.1570	Histamine receptor H1			Placenta, normal	NIH_MGC_147	DH10B	NM_000861.3	NP_000852.1	REVIEWED	Cs	0.998	0.998	487	1464	1	1461	487	1	487
RIKEN	BC060802	IRAK133D04	MGC	W01A080L20	pENTR-TOPO	16209		HRH1	3269	AAH60802.1	Hs.1570	Histamine receptor H1			Placenta, normal	NIH_MGC_147	DH10B	NM_000861.3	NP_000852.1	REVIEWED	Cs	0.998	0.998	487	1464	1	1461	487	1	487
RIKEN	BC048296	IRAK093L17	MGC	W01A080M01	pENTR-TOPO	25105		ELK1	2002	AAH48296.1	Hs.181128	ELK1, member of ETS oncogene family			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001114123.1	NP_001107595.1	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
RIKEN	BC048296	IRAK093L17	MGC	W01A080M03	pENTR-TOPO	25105		ELK1	2002	AAH48296.1	Hs.181128	ELK1, member of ETS oncogene family			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001114123.1	NP_001107595.1	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
RIKEN	BC048296	IRAK093L17	MGC	W01A080M09	pENTR-TOPO	25105		ELK1	2002	AAH48296.1	Hs.181128	ELK1, member of ETS oncogene family			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001114123.1	NP_001107595.1	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
RIKEN	BC048296	IRAK093L17	MGC	W01A080M11	pENTR-TOPO	25105		ELK1	2002	AAH48296.1	Hs.181128	ELK1, member of ETS oncogene family			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001114123.1	NP_001107595.1	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
RIKEN	AK127595	flj0075c21	FLJ	W01A080M21	pENTR-TOPO	22097		SMARCD3	6604	BAG54531.1	Hs.647067	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3				FCBBF5	EK1	NM_003078.3	NP_003069.2	REVIEWED	Cg	0.926	1.000	470	1308	1	1305	470	1	470
RIKEN	AK057172	flj0004a09	FLJ	W01A080N02	pENTR-TOPO	493		HIAT1	64645	BAB71375.1	Hs.124156	Hippocampus abundant transcript 1				STOMA2	EK1	NM_033055.2	NP_149044.2	VALIDATED	Cs	0.998	0.998	490	1473	1	1470	490	1	490
RIKEN	AK057172	flj0004a09	FLJ	W01A080N04	pENTR-TOPO	493		HIAT1	64645	BAB71375.1	Hs.124156	Hippocampus abundant transcript 1				STOMA2	EK1	NM_033055.2	NP_149044.2	VALIDATED	Cs	0.998	0.998	490	1473	1	1470	490	1	490
RIKEN	AK057172	flj0004a09	FLJ	W01A080N08	pENTR-TOPO	493		HIAT1	64645	BAB71375.1	Hs.124156	Hippocampus abundant transcript 1				STOMA2	EK1	NM_033055.2	NP_149044.2	VALIDATED	Cs	0.998	0.998	490	1473	1	1470	490	1	490
RIKEN	AK091692	flj0017i11	FLJ	W01A080N16	pENTR-TOPO	7735		CLK3	1198	BAG52400.1	Hs.584748	CDC-like kinase 3				FEBRA2	EK1	NM_003992.4	NP_003983.2	REVIEWED	Cs	0.998	0.998	490	1473	1	1470	490	1	490
RIKEN	BC004101	IRAL014K17	MGC	W01A080O01	pENTR-TOPO	13876		BIN1	274	AAH04101.1	Hs.193163	Bridging integrator 1			Pancreas, adenocarcinoma	NIH_MGC_39		NM_139350.1	NP_647600.1	REVIEWED	Cs	0.998	0.998	439	1320	1	1317	439	1	439
RIKEN	BC004101	IRAL014K17	MGC	W01A080O09	pENTR-TOPO	13876		BIN1	274	AAH04101.1	Hs.193163	Bridging integrator 1			Pancreas, adenocarcinoma	NIH_MGC_39		NM_139350.1	NP_647600.1	REVIEWED	Cs	0.998	0.998	439	1320	1	1317	439	1	439
RIKEN	BC004101	IRAL014K17	MGC	W01A080O11	pENTR-TOPO	13876		BIN1	274	AAH04101.1	Hs.193163	Bridging integrator 1			Pancreas, adenocarcinoma	NIH_MGC_39		NM_139350.1	NP_647600.1	REVIEWED	Cs	0.998	0.998	439	1320	1	1317	439	1	439
RIKEN	BC036019	IRAK048E04	MGC	W01A080O19	pENTR-TOPO	24814		XK	7504	AAH36019.1	Hs.78919	X-linked Kx blood group (McLeod syndrome)			Testis	NIH_MGC_97	DH10B	NM_021083.2	NP_066569.1	REVIEWED	Cs	0.998	0.998	444	1335	1	1332	444	1	444
RIKEN	BC018897	IRAL015B17	MGC	W01A081A03	pENTR-TOPO	18094		SLC2A9	56606	AAH18897.1	Hs.677363	Solute carrier family 2 (facilitated glucose transporter), member 9			Ovary, adenocarcinoma	NIH_MGC_9		NM_001001290.1	NP_001001290.1	REVIEWED	Cs	0.998	0.998	511	1536	1	1533	511	1	511
RIKEN	H013056G14	H013056G14	RIKEN	W01A081B08	pENTR-TOPO		12226	MED26	9441		Hs.651587	Mediator complex subunit 26	-	-	testis	testis	DH10B	NM_004831.3	NP_004822.2	VALIDATED	Cs	0.997	0.997	600	1803	1	1800	600	1	600
RIKEN	BC041142	IRAK082H20	MGC	W01A081B14	pENTR-TOPO	338		XPR1	9213	AAH41142.1	Hs.227656	Xenotropic and polytropic retrovirus receptor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001135669.1	NP_001129141.1	VALIDATED	OK	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC041142	IRAK082H20	MGC	W01A081B20	pENTR-TOPO	338		XPR1	9213	AAH41142.1	Hs.227656	Xenotropic and polytropic retrovirus receptor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001135669.1	NP_001129141.1	VALIDATED	OK	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC041142	IRAK082H20	MGC	W01A081B24	pENTR-TOPO	338		XPR1	9213	AAH41142.1	Hs.227656	Xenotropic and polytropic retrovirus receptor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001135669.1	NP_001129141.1	VALIDATED	OK	1.000	1.000	631	1896	1	1893	631	1	631
RIKEN	BC016853	IRAK020G04	MGC	W01A081C19	pENTR-TOPO	12334		CYP4F11	57834	AAH16853.1	Hs.187393	Cytochrome P450, family 4, subfamily F, polypeptide 11			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001128932.1	NP_001122404.1	REVIEWED	Cs	0.996	0.996	524	1575	1	1572	524	1	524
RIKEN	BC015731	IRAL034N13	MGC	W01A081D10	pENTR-TOPO	11499		LILRB1	10859	AAH15731.1	Hs.667388	Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_006669.3	NP_006660.3	REVIEWED	Cs	0.994	0.994	650	1953	1	1950	650	1	650
RIKEN	AK097608	flj0045j16	FLJ	W01A081E13	pENTR-TOPO	15928		ZNF280B	140883	BAG53494.1	Hs.43834	Zinc finger protein 280B				TESTI2	EK1	NM_080764.2	NP_542942.1	REVIEWED	Cs	0.996	0.996	543	1632	1	1629	543	1	543
RIKEN	AK097608	flj0045j16	FLJ	W01A081E15	pENTR-TOPO	15928		ZNF280B	140883	BAG53494.1	Hs.43834	Zinc finger protein 280B				TESTI2	EK1	NM_080764.2	NP_542942.1	REVIEWED	Cs	0.996	0.996	543	1632	1	1629	543	1	543
RIKEN	AK097608	flj0045j16	FLJ	W01A081E17	pENTR-TOPO	15928		ZNF280B	140883	BAG53494.1	Hs.43834	Zinc finger protein 280B				TESTI2	EK1	NM_080764.2	NP_542942.1	REVIEWED	Cs	0.996	0.996	543	1632	1	1629	543	1	543
RIKEN	AK097608	flj0045j16	FLJ	W01A081E19	pENTR-TOPO	15928		ZNF280B	140883	BAG53494.1	Hs.43834	Zinc finger protein 280B				TESTI2	EK1	NM_080764.2	NP_542942.1	REVIEWED	Cs	0.996	0.996	543	1632	1	1629	543	1	543
RIKEN	AK097608	flj0045j16	FLJ	W01A081E21	pENTR-TOPO	15928		ZNF280B	140883	BAG53494.1	Hs.43834	Zinc finger protein 280B				TESTI2	EK1	NM_080764.2	NP_542942.1	REVIEWED	Cs	0.996	0.996	543	1632	1	1629	543	1	543
RIKEN	AK097608	flj0045j16	FLJ	W01A081E23	pENTR-TOPO	15928		ZNF280B	140883	BAG53494.1	Hs.43834	Zinc finger protein 280B				TESTI2	EK1	NM_080764.2	NP_542942.1	REVIEWED	Cs	0.996	0.996	543	1632	1	1629	543	1	543
RIKEN	BC001887	IRAL008H01	MGC	W01A081F06	pENTR-TOPO	14752		ZNF133	7692	AAH01887.1	Hs.472221	Zinc finger protein 133			Lung, small cell carcinoma	NIH_MGC_7		NM_001083330.1	NP_001076799.1	VALIDATED	C	1.000	1.000	653	1962	1	1959	653	1	653
RIKEN	BC001887	IRAL008H01	MGC	W01A081F08	pENTR-TOPO	14752		ZNF133	7692	AAH01887.1	Hs.472221	Zinc finger protein 133			Lung, small cell carcinoma	NIH_MGC_7		NM_001083330.1	NP_001076799.1	VALIDATED	C	1.000	1.000	653	1962	1	1959	653	1	653
RIKEN	BC010007	IRAL026N10	MGC	W01A081F24	pENTR-TOPO	23952		ZBTB5	9925	AAH10007.1	Hs.161276	Zinc finger and BTB domain containing 5			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_014872.2	NP_055687.1	VALIDATED	C	1.000	1.000	677	2034	1	2031	677	1	677
RIKEN	BC036504	IRAK073L05	MGC	W01A081H08	pENTR-TOPO	23729		C9orf96	169436	AAH36504.3					Testis	NIH_MGC_97	DH10B	NM_153710.3	NP_714921.3	VALIDATED	Cs	0.999	0.999	680	2043	1	2040	680	1	680
RIKEN	AK096639	flj0022e23	FLJ	W01A081I17	pENTR-TOPO	6966		INSM2	84684	BAC04830.1	Hs.62813	Insulinoma-associated 2				OCBBF2	EK1	NM_032594.3	NP_115983.3	VALIDATED	Cs	0.996	0.996	566	1701	1	1698	566	1	566
RIKEN	AK027573	flj0033h10	FLJ	W01A081K09	pENTR-TOPO	1449		TESK2	10420	BAG51348.1	Hs.591499	Testis-specific kinase 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_007170.2	NP_009101.2	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
RIKEN	BC016467	IRAK019F14	MGC	W01A081M11	pENTR-TOPO	9587		FKBP10	60681	AAH16467.1	Hs.463035	FK506 binding protein 10, 65 kDa				NCI_CGAP_Brn67	DH10B	NM_021939.3	NP_068758.3	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
RIKEN	AK123001	flj0075c16	FLJ	W01A081N16	pENTR-TOPO	16862		SLC12A8	84561	BAG53843.1	Hs.658514	Solute carrier family 12 (potassium/chloride transporters), member 8				T1ESE2	EK1	NM_024628.5	NP_078904.3	VALIDATED	Cs	0.997	0.997	714	2145	1	2142	714	1	714
RIKEN	AK123001	flj0075c16	FLJ	W01A081N24	pENTR-TOPO	16862		SLC12A8	84561	BAG53843.1	Hs.658514	Solute carrier family 12 (potassium/chloride transporters), member 8				T1ESE2	EK1	NM_024628.5	NP_078904.3	VALIDATED	Cs	0.997	0.997	714	2145	1	2142	714	1	714
RIKEN	H013067O03	H013067O03	RIKEN	W01A081O09	pENTR-TOPO		1413						-	-	testis	testis	DH10B			
RIKEN	BC005022	IRAL018K08	MGC	W01A081O15	pENTR-TOPO	19742		SNX9	51429	AAH05022.1	Hs.191213	Sorting nexin 9			Skin, melanotic melanoma.	NIH_MGC_20		NM_016224.3	NP_057308.1	REVIEWED	Cs	0.998	0.998	595	1788	1	1785	595	1	595
RIKEN	BC005022	IRAL018K08	MGC	W01A081O21	pENTR-TOPO	19742		SNX9	51429	AAH05022.1	Hs.191213	Sorting nexin 9			Skin, melanotic melanoma.	NIH_MGC_20		NM_016224.3	NP_057308.1	REVIEWED	Cs	0.998	0.998	595	1788	1	1785	595	1	595
RIKEN	BC042510	IRAK050H12	MGC	W01A081P02	pENTR-TOPO	23539		CEL	1056	AAH42510.1	Hs.533258	Carboxyl ester lipase (bile salt-stimulated lipase)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001807.3	NP_001798.2	VALIDATED	Cg	0.955	1.000	756	2169	1	2166	756	1	756
RIKEN	BC042510	IRAK050H12	MGC	W01A081P04	pENTR-TOPO	23539		CEL	1056	AAH42510.1	Hs.533258	Carboxyl ester lipase (bile salt-stimulated lipase)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001807.3	NP_001798.2	VALIDATED	Cg	0.955	1.000	756	2169	1	2166	756	1	756
RIKEN	BC042510	IRAK050H12	MGC	W01A081P12	pENTR-TOPO	23539		CEL	1056	AAH42510.1	Hs.533258	Carboxyl ester lipase (bile salt-stimulated lipase)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001807.3	NP_001798.2	VALIDATED	Cg	0.955	1.000	756	2169	1	2166	756	1	756
RIKEN	AK131231	flj0073a16	FLJ	W01A081P16	pENTR-TOPO	12504		ZNF600	162966	BAD18414.1	Hs.696848	Zinc finger protein 600				BRAMY2	EK1	NM_198457.2	NP_940859.2	VALIDATED	Cs	0.999	0.999	722	2169	1	2166	722	1	722
RIKEN	AK091589	flj0013j09	FLJ	W01A082A13	pENTR-TOPO	23547		LRSAM1	90678	BAC03703.1	Hs.495188	Leucine rich repeat and sterile alpha motif containing 1				FEBRA2	EK1	NM_001005374.1	NP_001005374.1	VALIDATED	Cs	0.999	0.999	723	2172	1	2169	723	1	723
RIKEN	AK091589	flj0013j09	FLJ	W01A082A15	pENTR-TOPO	23547		LRSAM1	90678	BAC03703.1	Hs.495188	Leucine rich repeat and sterile alpha motif containing 1				FEBRA2	EK1	NM_001005374.1	NP_001005374.1	VALIDATED	Cs	0.999	0.999	723	2172	1	2169	723	1	723
RIKEN	AK091589	flj0013j09	FLJ	W01A082A23	pENTR-TOPO	23547		LRSAM1	90678	BAC03703.1	Hs.495188	Leucine rich repeat and sterile alpha motif containing 1				FEBRA2	EK1	NM_001005374.1	NP_001005374.1	VALIDATED	Cs	0.999	0.999	723	2172	1	2169	723	1	723
RIKEN	BC001596	IRAL008M20	MGC	W01A082C07	pENTR-TOPO	16718		BAP1	8314	AAH01596.1	Hs.106674	BRCA1 associated protein-1 (ubiquitin carboxy-terminal hydrolase)			Skin, melanotic melanoma.	NIH_MGC_20		NM_004656.2	NP_004647.1	REVIEWED	C	1.000	1.000	729	2190	1	2187	729	1	729
RIKEN	BC013985	IRAL028B05	MGC	W01A082E05	pENTR-TOPO	15547		MED15	51586	AAH13985.1	Hs.517421	Mediator complex subunit 15			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_015889.3	NP_056973.2	REVIEWED	C	1.000	1.000	748	2247	1	2244	748	1	748
RIKEN	AK023099	flj0034l20	FLJ	W01A082F16	pENTR-TOPO	12324		ZFP112	7771	BAG51156.1	Hs.48589	Zinc finger protein 112 homolog (mouse)	NT2	teratocarcinoma		NT2RP3	EK1	NM_013380.3	NP_037512.3	VALIDATED	Cs	0.994	0.994	907	2724	1	2721	907	1	907
RIKEN	AK023099	flj0034l20	FLJ	W01A082F18	pENTR-TOPO	12324		ZFP112	7771	BAG51156.1	Hs.48589	Zinc finger protein 112 homolog (mouse)	NT2	teratocarcinoma		NT2RP3	EK1	NM_013380.3	NP_037512.3	VALIDATED	Cs	0.994	0.994	907	2724	1	2721	907	1	907
RIKEN	H013084J07	H013084J07	RIKEN	W01A082G11	pENTR-TOPO		22518	IKBKB	3551		Hs.597664	Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase beta	-	-	testis	testis	DH10B	NM_001556.1	NP_001547.1	VALIDATED	Cs	0.999	0.999	756	2271	1	2268	756	1	756
RIKEN	H05D057K02	H05D057K02	RIKEN	W01A082G13	pENTR-TOPO		19783						-	-	thymus	thymus	DH10B			
RIKEN	H05D057K02	H05D057K02	RIKEN	W01A082G15	pENTR-TOPO		19783						-	-	thymus	thymus	DH10B			
RIKEN	H05D057K02	H05D057K02	RIKEN	W01A082G17	pENTR-TOPO		19783						-	-	thymus	thymus	DH10B			
RIKEN	AK094687	flj0022h19	FLJ	W01A082I15	pENTR-TOPO	10429		ELAC2	60528	BAG52912.1	Hs.434232	ElaC homolog 2 (E. coli)				BRAMY2	EK1	NM_018127.5	NP_060597.4	VALIDATED	Cgs	0.975	0.998	826	2424	1	2421	826	1	826
RIKEN	AK094687	flj0022h19	FLJ	W01A082I19	pENTR-TOPO	10429		ELAC2	60528	BAG52912.1	Hs.434232	ElaC homolog 2 (E. coli)				BRAMY2	EK1	NM_018127.5	NP_060597.4	VALIDATED	Cgs	0.975	0.998	826	2424	1	2421	826	1	826
RIKEN	AK094687	flj0022h19	FLJ	W01A082I21	pENTR-TOPO	10429		ELAC2	60528	BAG52912.1	Hs.434232	ElaC homolog 2 (E. coli)				BRAMY2	EK1	NM_018127.5	NP_060597.4	VALIDATED	Cgs	0.975	0.998	826	2424	1	2421	826	1	826
RIKEN	H04D090K14	H04D090K14	RIKEN	W01A082K03	pENTR-TOPO		2081						-	-	testis	testis	DH10B			
RIKEN	BC056202	IRAK091F24	MGC	W01A082K17	pENTR-TOPO	16107		CAPN7	23473	AAH56202.1	Hs.631920	Calpain 7			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014296.2	NP_055111.1	REVIEWED	Cs	0.996	0.996	813	2442	1	2439	813	1	813
RIKEN	BC056202	IRAK091F24	MGC	W01A082K19	pENTR-TOPO	16107		CAPN7	23473	AAH56202.1	Hs.631920	Calpain 7			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014296.2	NP_055111.1	REVIEWED	Cs	0.996	0.996	813	2442	1	2439	813	1	813
RIKEN	AK001573	flj0034f12	FLJ	W01A082L06	pENTR-TOPO	14605		XRN2	22803	BAG50941.1	Hs.255932	5'-3' exoribonuclease 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_012255.3	NP_036387.2	REVIEWED	Cs	0.999	0.999	950	2853	1	2850	950	1	950
RIKEN	AK001573	flj0034f12	FLJ	W01A082L08	pENTR-TOPO	14605		XRN2	22803	BAG50941.1	Hs.255932	5'-3' exoribonuclease 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_012255.3	NP_036387.2	REVIEWED	Cs	0.999	0.999	950	2853	1	2850	950	1	950
RIKEN	AK001573	flj0034f12	FLJ	W01A082L12	pENTR-TOPO	14605		XRN2	22803	BAG50941.1	Hs.255932	5'-3' exoribonuclease 2	NT2	teratocarcinoma		NT2RP3	EK1	NM_012255.3	NP_036387.2	REVIEWED	Cs	0.999	0.999	950	2853	1	2850	950	1	950
RIKEN	BC011764	IRAL027F14	MGC	W01A082N02	pENTR-TOPO	18568		TCOF1	6949	AAH11764.1	Hs.519672	Treacher Collins-Franceschetti syndrome 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001008657.2	NP_001008657.1	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
RIKEN	BC036023	IRAK048E15	MGC	W01A082N24	pENTR-TOPO	17393		PLK4	10733	AAH36023.1	Hs.172052	Polo-like kinase 4 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_014264.3	NP_055079.3	REVIEWED	OK	1.000	1.000	970	2913	1	2910	970	1	970
RIKEN	BC014614	IRAL010H10	MGC	W01A082O01	pENTR-TOPO	16823		SFMBT1	51460	AAH14614.1	Hs.343679	Scm-like with four mbt domains 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001005159.1	NP_001005159.1	REVIEWED	C	1.000	1.000	866	2601	1	2598	866	1	866
RIKEN	BC028730	IRAK046D04	MGC	W01A082O17	pENTR-TOPO	14112		GPR155	151556	AAH28730.1	Hs.516604	G protein-coupled receptor 155			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152529.5	NP_689742.4	VALIDATED	Cs	0.997	0.997	870	2613	1	2610	870	1	870
RIKEN	BC033902	IRAK047H20	MGC	W01A082P06	pENTR-TOPO	1390		CLSTN1	22883	AAH33902.1	Hs.29665	Calsyntenin 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014944.3	NP_055759.3	VALIDATED	Cs	0.995	0.995	971	2916	1	2913	971	1	971
RIKEN	BC052263	IRAL047L21	MGC	W01A083A01	pENTR-TOPO	19860		SCUBE3	222663	AAH52263.2	Hs.12923	Signal peptide, CUB domain, EGF-like 3			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_152753.2	NP_689966.2	PROVISIONAL	Cgs	0.998	0.999	993	2979	1	2976	993	1	993
RIKEN	BC044659	IRAK082M14	MGC	W01A083C15	pENTR-TOPO	16828		HLTF	6596	AAH44659.1	Hs.3068	Helicase-like transcription factor			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_139048.2	NP_620636.1	REVIEWED	Cg	0.999	1.000	1009	3027	1	3024	1009	1	1009
RIKEN	BC075798	IRAK168I21	MGC	W01A083D02	pENTR-TOPO	19725		GPR126	57211	AAH75798.1	Hs.715560	G protein-coupled receptor 126			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001032395.2	NP_001027567.1	REVIEWED	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
RIKEN	BC075798	IRAK168I21	MGC	W01A083D08	pENTR-TOPO	19725		GPR126	57211	AAH75798.1	Hs.715560	G protein-coupled receptor 126			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001032395.2	NP_001027567.1	REVIEWED	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
RIKEN	BC075798	IRAK168I21	MGC	W01A083D10	pENTR-TOPO	19725		GPR126	57211	AAH75798.1	Hs.715560	G protein-coupled receptor 126			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001032395.2	NP_001027567.1	REVIEWED	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
RIKEN	BC050341	IRAK090P14	MGC	W01A083D16	pENTR-TOPO	5171		CAND1	55832	AAH50341.1	Hs.546407	Cullin-associated and neddylation-dissociated 1			Testis	NIH_MGC_97	DH10B	NM_018448.3	NP_060918.2	VALIDATED	Cs	0.999	0.999	1230	3693	1	3690	1230	1	1230
RIKEN	BC050341	IRAK090P14	MGC	W01A083D20	pENTR-TOPO	5171		CAND1	55832	AAH50341.1	Hs.546407	Cullin-associated and neddylation-dissociated 1			Testis	NIH_MGC_97	DH10B	NM_018448.3	NP_060918.2	VALIDATED	Cs	0.999	0.999	1230	3693	1	3690	1230	1	1230
RIKEN	BC002558	IRAL004L19	MGC	W01A083G05	pENTR-TOPO	61		KDM4A	9682	AAH02558.1	Hs.155983	Lysine (K)-specific demethylase 4A			Placenta, choriocarcinoma	NIH_MGC_21		NM_014663.2	NP_055478.2	REVIEWED	Cs	0.999	0.999	1064	3195	1	3192	1064	1	1064
RIKEN	BC002558	IRAL004L19	MGC	W01A083G07	pENTR-TOPO	61		KDM4A	9682	AAH02558.1	Hs.155983	Lysine (K)-specific demethylase 4A			Placenta, choriocarcinoma	NIH_MGC_21		NM_014663.2	NP_055478.2	REVIEWED	Cs	0.999	0.999	1064	3195	1	3192	1064	1	1064
RIKEN	BC036372	IRAK033E20	MGC	W01A083H04	pENTR-TOPO	6453		ZMYM2	7750	AAH36372.1	Hs.644041	Zinc finger, MYM-type 2			Testis	NIH_MGC_97	DH10B	NM_003453.2	NP_003444.1	VALIDATED	Cs	0.998	0.998	1377	4134	1	4131	1377	1	1377
RIKEN	BC036372	IRAK033E20	MGC	W01A083H10	pENTR-TOPO	6453		ZMYM2	7750	AAH36372.1	Hs.644041	Zinc finger, MYM-type 2			Testis	NIH_MGC_97	DH10B	NM_003453.2	NP_003444.1	VALIDATED	Cs	0.998	0.998	1377	4134	1	4131	1377	1	1377
RIKEN	H05D091E08	H05D091E08	RIKEN	W01A083I01	pENTR-TOPO		17193						-	-	thymus	thymus	DH10B			
RIKEN	AK000275	flj0051a16	FLJ	W01A083M17	pENTR-TOPO	14882		ZMYND8	23613	-	Hs.668465	Zinc finger, MYND-type containing 8	HepG2	hepatoma		HEP	EK1	NM_183048.1	NP_898869.1	REVIEWED	Cs	0.998	0.998	1135	3408	1	3405	1135	1	1135
RIKEN	BC051281	IRAL047I17	MGC	W01A083O01	pENTR-TOPO	6265		CD163	9332	AAH51281.1	Hs.504641	CD163 molecule			Spleen	NIH_MGC_113		NM_004244.4	NP_004235.3	VALIDATED	C	1.000	1.000	1156	3471	1	3468	1156	1	1156
RIKEN	BC051281	IRAL047I17	MGC	W01A083O03	pENTR-TOPO	6265		CD163	9332	AAH51281.1	Hs.504641	CD163 molecule			Spleen	NIH_MGC_113		NM_004244.4	NP_004235.3	VALIDATED	C	1.000	1.000	1156	3471	1	3468	1156	1	1156
RIKEN	BC051281	IRAL047I17	MGC	W01A083O09	pENTR-TOPO	6265		CD163	9332	AAH51281.1	Hs.504641	CD163 molecule			Spleen	NIH_MGC_113		NM_004244.4	NP_004235.3	VALIDATED	C	1.000	1.000	1156	3471	1	3468	1156	1	1156
RIKEN	BC030007	IRAK033M24	MGC	W01A083O17	pENTR-TOPO	15812		BRD1	23774	AAH30007.1	Hs.127950	Bromodomain containing 1			Testis	NIH_MGC_97	DH10B	NM_014577.1	NP_055392.1	REVIEWED	Cgs	0.888	0.998	1189	3570	1	3567	1058	1	1058
RIKEN	BC030007	IRAK033M24	MGC	W01A083O19	pENTR-TOPO	15812		BRD1	23774	AAH30007.1	Hs.127950	Bromodomain containing 1			Testis	NIH_MGC_97	DH10B	NM_014577.1	NP_055392.1	REVIEWED	Cgs	0.888	0.998	1189	3570	1	3567	1058	1	1058
RIKEN	BC030007	IRAK033M24	MGC	W01A083O23	pENTR-TOPO	15812		BRD1	23774	AAH30007.1	Hs.127950	Bromodomain containing 1			Testis	NIH_MGC_97	DH10B	NM_014577.1	NP_055392.1	REVIEWED	Cgs	0.888	0.998	1189	3570	1	3567	1058	1	1058
RIKEN	AK098563	flj0053c04	FLJ	W01A084A07	pENTR-TOPO	7742		SNURF	8926	-						TST	EK1	NM_005678.3	NP_005669.2	REVIEWED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	AK098563	flj0053c04	FLJ	W01A084A11	pENTR-TOPO	7742		SNURF	8926	-						TST	EK1	NM_005678.3	NP_005669.2	REVIEWED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	AK098563	flj0053c04	FLJ	W01A084A15	pENTR-TOPO	7742		SNURF	8926	-						TST	EK1	NM_005678.3	NP_005669.2	REVIEWED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	AK098563	flj0053c04	FLJ	W01A084A19	pENTR-TOPO	7742		SNURF	8926	-						TST	EK1	NM_005678.3	NP_005669.2	REVIEWED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	AK098563	flj0053c04	FLJ	W01A084A23	pENTR-TOPO	7742		SNURF	8926	-						TST	EK1	NM_005678.3	NP_005669.2	REVIEWED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	BC053657	IRAK115H15	MGC	W01A084B04	pENTR-TOPO	19436		ST8SIA4	7903	AAH53657.1	Hs.308628	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175052.1	NP_778222.1	REVIEWED	OK	1.000	1.000	168	506	1	504	168	1	168
RIKEN	BC053657	IRAK115H15	MGC	W01A084B06	pENTR-TOPO	19436		ST8SIA4	7903	AAH53657.1	Hs.308628	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175052.1	NP_778222.1	REVIEWED	OK	1.000	1.000	168	506	1	504	168	1	168
RIKEN	BC053657	IRAK115H15	MGC	W01A084B08	pENTR-TOPO	19436		ST8SIA4	7903	AAH53657.1	Hs.308628	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175052.1	NP_778222.1	REVIEWED	OK	1.000	1.000	168	506	1	504	168	1	168
RIKEN	BC053657	IRAK115H15	MGC	W01A084B10	pENTR-TOPO	19436		ST8SIA4	7903	AAH53657.1	Hs.308628	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175052.1	NP_778222.1	REVIEWED	OK	1.000	1.000	168	506	1	504	168	1	168
RIKEN	BC053657	IRAK115H15	MGC	W01A084B14	pENTR-TOPO	19436		ST8SIA4	7903	AAH53657.1	Hs.308628	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175052.1	NP_778222.1	REVIEWED	OK	1.000	1.000	168	506	1	504	168	1	168
RIKEN	BC053657	IRAK115H15	MGC	W01A084B22	pENTR-TOPO	19436		ST8SIA4	7903	AAH53657.1	Hs.308628	ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175052.1	NP_778222.1	REVIEWED	OK	1.000	1.000	168	506	1	504	168	1	168
RIKEN	H023015C21	H023015C21	RIKEN	W01A084C01	pENTR-TOPO		5988						-	-	hippocampus	hippocampus	DH10B			
RIKEN	H023015C21	H023015C21	RIKEN	W01A084C03	pENTR-TOPO		5988						-	-	hippocampus	hippocampus	DH10B			
RIKEN	H023015C21	H023015C21	RIKEN	W01A084C05	pENTR-TOPO		5988						-	-	hippocampus	hippocampus	DH10B			
RIKEN	H023015C21	H023015C21	RIKEN	W01A084C15	pENTR-TOPO		5988						-	-	hippocampus	hippocampus	DH10B			
RIKEN	H023015C21	H023015C21	RIKEN	W01A084C21	pENTR-TOPO		5988						-	-	hippocampus	hippocampus	DH10B			
RIKEN	H023015C21	H023015C21	RIKEN	W01A084C23	pENTR-TOPO		5988						-	-	hippocampus	hippocampus	DH10B			
RIKEN	AK025349	flj0050j05	FLJ	W01A084D04	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	AK025349	flj0050j05	FLJ	W01A084D06	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	AK025349	flj0050j05	FLJ	W01A084D08	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	AK025349	flj0050j05	FLJ	W01A084D10	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	AK025349	flj0050j05	FLJ	W01A084D18	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	AK025349	flj0050j05	FLJ	W01A084D20	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	AK025349	flj0050j05	FLJ	W01A084D22	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	AK025349	flj0050j05	FLJ	W01A084D24	pENTR-TOPO	15811		APOL3	80833	-	Hs.474737	Apolipoprotein L, 3				COL	EK1	NM_145642.1	NP_663617.1	REVIEWED	OK	1.000	1.000	202	610	2	607	202	1	202
RIKEN	H023078L09	H023078L09	RIKEN	W01A084E01	pENTR-TOPO		19813	AKAP7	9465		Hs.486483	A kinase (PRKA) anchor protein 7	-	-	hippocampus	hippocampus	DH10B	NM_004842.2	NP_004833.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	H023078L09	H023078L09	RIKEN	W01A084E03	pENTR-TOPO		19813	AKAP7	9465		Hs.486483	A kinase (PRKA) anchor protein 7	-	-	hippocampus	hippocampus	DH10B	NM_004842.2	NP_004833.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	H023078L09	H023078L09	RIKEN	W01A084E05	pENTR-TOPO		19813	AKAP7	9465		Hs.486483	A kinase (PRKA) anchor protein 7	-	-	hippocampus	hippocampus	DH10B	NM_004842.2	NP_004833.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	H023078L09	H023078L09	RIKEN	W01A084E07	pENTR-TOPO		19813	AKAP7	9465		Hs.486483	A kinase (PRKA) anchor protein 7	-	-	hippocampus	hippocampus	DH10B	NM_004842.2	NP_004833.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	H023078L09	H023078L09	RIKEN	W01A084E09	pENTR-TOPO		19813	AKAP7	9465		Hs.486483	A kinase (PRKA) anchor protein 7	-	-	hippocampus	hippocampus	DH10B	NM_004842.2	NP_004833.1	REVIEWED	C	1.000	1.000	81	246	1	243	81	1	81
RIKEN	AK056321	flj0003g07	FLJ	W01A084F02	pENTR-TOPO	12883		ITM2C	81618	BAG51676.1	Hs.111577	Integral membrane protein 2C	NT2	teratocarcinoma		NT2RI2	EK1	NM_001012514.1	NP_001012532.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	AK056321	flj0003g07	FLJ	W01A084F04	pENTR-TOPO	12883		ITM2C	81618	BAG51676.1	Hs.111577	Integral membrane protein 2C	NT2	teratocarcinoma		NT2RI2	EK1	NM_001012514.1	NP_001012532.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	AK056321	flj0003g07	FLJ	W01A084F08	pENTR-TOPO	12883		ITM2C	81618	BAG51676.1	Hs.111577	Integral membrane protein 2C	NT2	teratocarcinoma		NT2RI2	EK1	NM_001012514.1	NP_001012532.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	AK056321	flj0003g07	FLJ	W01A084F10	pENTR-TOPO	12883		ITM2C	81618	BAG51676.1	Hs.111577	Integral membrane protein 2C	NT2	teratocarcinoma		NT2RI2	EK1	NM_001012514.1	NP_001012532.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	AK056321	flj0003g07	FLJ	W01A084F16	pENTR-TOPO	12883		ITM2C	81618	BAG51676.1	Hs.111577	Integral membrane protein 2C	NT2	teratocarcinoma		NT2RI2	EK1	NM_001012514.1	NP_001012532.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	AK056321	flj0003g07	FLJ	W01A084F18	pENTR-TOPO	12883		ITM2C	81618	BAG51676.1	Hs.111577	Integral membrane protein 2C	NT2	teratocarcinoma		NT2RI2	EK1	NM_001012514.1	NP_001012532.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC047681	IRAK098K02	MGC	W01A084G03	pENTR-TOPO	333		S100A9	6280	AAH47681.1	Hs.112405	S100 calcium binding protein A9			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002965.3	NP_002956.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC047681	IRAK098K02	MGC	W01A084G05	pENTR-TOPO	333		S100A9	6280	AAH47681.1	Hs.112405	S100 calcium binding protein A9			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002965.3	NP_002956.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC047681	IRAK098K02	MGC	W01A084G07	pENTR-TOPO	333		S100A9	6280	AAH47681.1	Hs.112405	S100 calcium binding protein A9			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002965.3	NP_002956.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC047681	IRAK098K02	MGC	W01A084G17	pENTR-TOPO	333		S100A9	6280	AAH47681.1	Hs.112405	S100 calcium binding protein A9			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002965.3	NP_002956.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	AK075482	flj0027m22	FLJ	W01A084H16	pENTR-TOPO	8171		TSPAN3	10099	BAG52152.1	Hs.716484	Tetraspanin 3				OVARC1	EK1	NM_198902.1	NP_944492.1	REVIEWED	C	1.000	1.000	228	687	1	684	228	1	228
RIKEN	AK075482	flj0027m22	FLJ	W01A084H24	pENTR-TOPO	8171		TSPAN3	10099	BAG52152.1	Hs.716484	Tetraspanin 3				OVARC1	EK1	NM_198902.1	NP_944492.1	REVIEWED	C	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC053618	IRAK115K24	MGC	W01A084I05	pENTR-TOPO	24319		NRARP	441478	AAH53618.1	Hs.535075	NOTCH-regulated ankyrin repeat protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001004354.2	NP_001004354.1	VALIDATED	OK	1.000	1.000	114	345	1	342	114	1	114
RIKEN	BC053618	IRAK115K24	MGC	W01A084I23	pENTR-TOPO	24319		NRARP	441478	AAH53618.1	Hs.535075	NOTCH-regulated ankyrin repeat protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001004354.2	NP_001004354.1	VALIDATED	OK	1.000	1.000	114	345	1	342	114	1	114
RIKEN	AK095452	flj0041k12	FLJ	W01A084J08	pENTR-TOPO	4891		DNAJC25	548645	BAG53057.1						D9OST2	EK1	NM_001015882.2	NP_001015882.2	PROVISIONAL	P	1.000	1.000	238	717	1	714	360	123	360
RIKEN	AK095452	flj0041k12	FLJ	W01A084J12	pENTR-TOPO	4891		DNAJC25	548645	BAG53057.1						D9OST2	EK1	NM_001015882.2	NP_001015882.2	PROVISIONAL	P	1.000	1.000	238	717	1	714	360	123	360
RIKEN	AK095452	flj0041k12	FLJ	W01A084J14	pENTR-TOPO	4891		DNAJC25	548645	BAG53057.1						D9OST2	EK1	NM_001015882.2	NP_001015882.2	PROVISIONAL	P	1.000	1.000	238	717	1	714	360	123	360
RIKEN	AK095452	flj0041k12	FLJ	W01A084J16	pENTR-TOPO	4891		DNAJC25	548645	BAG53057.1						D9OST2	EK1	NM_001015882.2	NP_001015882.2	PROVISIONAL	P	1.000	1.000	238	717	1	714	360	123	360
RIKEN	AK095452	flj0041k12	FLJ	W01A084J20	pENTR-TOPO	4891		DNAJC25	548645	BAG53057.1						D9OST2	EK1	NM_001015882.2	NP_001015882.2	PROVISIONAL	P	1.000	1.000	238	717	1	714	360	123	360
RIKEN	AK095452	flj0041k12	FLJ	W01A084J22	pENTR-TOPO	4891		DNAJC25	548645	BAG53057.1						D9OST2	EK1	NM_001015882.2	NP_001015882.2	PROVISIONAL	P	1.000	1.000	238	717	1	714	360	123	360
RIKEN	AK095452	flj0041k12	FLJ	W01A084J24	pENTR-TOPO	4891		DNAJC25	548645	BAG53057.1						D9OST2	EK1	NM_001015882.2	NP_001015882.2	PROVISIONAL	P	1.000	1.000	238	717	1	714	360	123	360
RIKEN	AK057613	flj0004g16	FLJ	W01A084L02	pENTR-TOPO	25311		BCAP31	10134	BAG51941.1	Hs.522817	B-cell receptor-associated protein 31				TRACH1	EK1	NM_001139441.1	NP_001132913.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	AK057613	flj0004g16	FLJ	W01A084L04	pENTR-TOPO	25311		BCAP31	10134	BAG51941.1	Hs.522817	B-cell receptor-associated protein 31				TRACH1	EK1	NM_001139441.1	NP_001132913.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	AK057613	flj0004g16	FLJ	W01A084L06	pENTR-TOPO	25311		BCAP31	10134	BAG51941.1	Hs.522817	B-cell receptor-associated protein 31				TRACH1	EK1	NM_001139441.1	NP_001132913.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	AK057613	flj0004g16	FLJ	W01A084L10	pENTR-TOPO	25311		BCAP31	10134	BAG51941.1	Hs.522817	B-cell receptor-associated protein 31				TRACH1	EK1	NM_001139441.1	NP_001132913.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	AK057613	flj0004g16	FLJ	W01A084L16	pENTR-TOPO	25311		BCAP31	10134	BAG51941.1	Hs.522817	B-cell receptor-associated protein 31				TRACH1	EK1	NM_001139441.1	NP_001132913.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC025785	IRAK049P15	MGC	W01A084M03	pENTR-TOPO	2191		NPPB	4879	AAH25785.1	Hs.219140	Natriuretic peptide precursor B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002521.2	NP_002512.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC025785	IRAK049P15	MGC	W01A084M05	pENTR-TOPO	2191		NPPB	4879	AAH25785.1	Hs.219140	Natriuretic peptide precursor B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002521.2	NP_002512.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC025785	IRAK049P15	MGC	W01A084M09	pENTR-TOPO	2191		NPPB	4879	AAH25785.1	Hs.219140	Natriuretic peptide precursor B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002521.2	NP_002512.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC025785	IRAK049P15	MGC	W01A084M19	pENTR-TOPO	2191		NPPB	4879	AAH25785.1	Hs.219140	Natriuretic peptide precursor B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002521.2	NP_002512.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC025785	IRAK049P15	MGC	W01A084M21	pENTR-TOPO	2191		NPPB	4879	AAH25785.1	Hs.219140	Natriuretic peptide precursor B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002521.2	NP_002512.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC025785	IRAK049P15	MGC	W01A084M23	pENTR-TOPO	2191		NPPB	4879	AAH25785.1	Hs.219140	Natriuretic peptide precursor B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002521.2	NP_002512.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	AK131411	flj0073e22	FLJ	W01A084N22	pENTR-TOPO	20028		LIN28B	389421	BAD18558.1	Hs.23616	Lin-28 homolog B (C. elegans)	NT2	teratocarcinoma		NT2RI3	EK1	NM_001004317.2	NP_001004317.1	PROVISIONAL	C	1.000	1.000	250	753	1	750	250	1	250
RIKEN	AK027249	flj0067o17	FLJ	W01A084O01	pENTR-TOPO	7721		CAPN3	825	-	Hs.143261	Calpain 3, (p94)				LNG	EK1	NM_173089.1	NP_775112.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	AK027249	flj0067o17	FLJ	W01A084O03	pENTR-TOPO	7721		CAPN3	825	-	Hs.143261	Calpain 3, (p94)				LNG	EK1	NM_173089.1	NP_775112.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	AK027249	flj0067o17	FLJ	W01A084O05	pENTR-TOPO	7721		CAPN3	825	-	Hs.143261	Calpain 3, (p94)				LNG	EK1	NM_173089.1	NP_775112.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	AK027249	flj0067o17	FLJ	W01A084O07	pENTR-TOPO	7721		CAPN3	825	-	Hs.143261	Calpain 3, (p94)				LNG	EK1	NM_173089.1	NP_775112.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	AK027249	flj0067o17	FLJ	W01A084O09	pENTR-TOPO	7721		CAPN3	825	-	Hs.143261	Calpain 3, (p94)				LNG	EK1	NM_173089.1	NP_775112.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	AK027249	flj0067o17	FLJ	W01A084O19	pENTR-TOPO	7721		CAPN3	825	-	Hs.143261	Calpain 3, (p94)				LNG	EK1	NM_173089.1	NP_775112.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	AK027249	flj0067o17	FLJ	W01A084O23	pENTR-TOPO	7721		CAPN3	825	-	Hs.143261	Calpain 3, (p94)				LNG	EK1	NM_173089.1	NP_775112.1	REVIEWED	OK	1.000	1.000	156	471	1	468	156	1	156
RIKEN	BC026334	IRAK032O14	MGC	W01A084P10	pENTR-TOPO	15088		PDYN	5173	AAH26334.1	Hs.22584	Prodynorphin			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024411.2	NP_077722.1	REVIEWED	C	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC014645	IRAL029C16	MGC	W01A085A01	pENTR-TOPO	23535		PRRX2	51450	AAH14645.1	Hs.660115	Paired related homeobox 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016307.3	NP_057391.1	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC014645	IRAL029C16	MGC	W01A085A03	pENTR-TOPO	23535		PRRX2	51450	AAH14645.1	Hs.660115	Paired related homeobox 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016307.3	NP_057391.1	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC014645	IRAL029C16	MGC	W01A085A05	pENTR-TOPO	23535		PRRX2	51450	AAH14645.1	Hs.660115	Paired related homeobox 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016307.3	NP_057391.1	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC014645	IRAL029C16	MGC	W01A085A07	pENTR-TOPO	23535		PRRX2	51450	AAH14645.1	Hs.660115	Paired related homeobox 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_016307.3	NP_057391.1	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
RIKEN	BC032668	IRAK069L13	MGC	W01A085B14	pENTR-TOPO	12502		ZNF561	93134	AAH32668.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152289.2	NP_689502.2	VALIDATED	P	1.000	1.000	417	1254	1	1251	486	70	486
RIKEN	BC032668	IRAK069L13	MGC	W01A085B20	pENTR-TOPO	12502		ZNF561	93134	AAH32668.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152289.2	NP_689502.2	VALIDATED	P	1.000	1.000	417	1254	1	1251	486	70	486
RIKEN	BC032668	IRAK069L13	MGC	W01A085B22	pENTR-TOPO	12502		ZNF561	93134	AAH32668.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152289.2	NP_689502.2	VALIDATED	P	1.000	1.000	417	1254	1	1251	486	70	486
RIKEN	BC032668	IRAK069L13	MGC	W01A085B24	pENTR-TOPO	12502		ZNF561	93134	AAH32668.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152289.2	NP_689502.2	VALIDATED	P	1.000	1.000	417	1254	1	1251	486	70	486
RIKEN	BC063580	IRAK134G04	MGC	W01A085C01	pENTR-TOPO	7547		GSC	145258	AAH63580.1	Hs.440438	Goosecoid homeobox			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_173849.2	NP_776248.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC063580	IRAK134G04	MGC	W01A085C03	pENTR-TOPO	7547		GSC	145258	AAH63580.1	Hs.440438	Goosecoid homeobox			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_173849.2	NP_776248.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC063580	IRAK134G04	MGC	W01A085C07	pENTR-TOPO	7547		GSC	145258	AAH63580.1	Hs.440438	Goosecoid homeobox			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_173849.2	NP_776248.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC063580	IRAK134G04	MGC	W01A085C11	pENTR-TOPO	7547		GSC	145258	AAH63580.1	Hs.440438	Goosecoid homeobox			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_173849.2	NP_776248.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC063580	IRAK134G04	MGC	W01A085C15	pENTR-TOPO	7547		GSC	145258	AAH63580.1	Hs.440438	Goosecoid homeobox			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_173849.2	NP_776248.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC063580	IRAK134G04	MGC	W01A085C17	pENTR-TOPO	7547		GSC	145258	AAH63580.1	Hs.440438	Goosecoid homeobox			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_173849.2	NP_776248.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC063580	IRAK134G04	MGC	W01A085C19	pENTR-TOPO	7547		GSC	145258	AAH63580.1	Hs.440438	Goosecoid homeobox			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_173849.2	NP_776248.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
RIKEN	BC020493	IRAK014K15	MGC	W01A085D04	pENTR-TOPO	11559		CALR	811	AAH20493.1	Hs.515162	Calreticulin			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004343.3	NP_004334.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC020493	IRAK014K15	MGC	W01A085D10	pENTR-TOPO	11559		CALR	811	AAH20493.1	Hs.515162	Calreticulin			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004343.3	NP_004334.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC020493	IRAK014K15	MGC	W01A085D16	pENTR-TOPO	11559		CALR	811	AAH20493.1	Hs.515162	Calreticulin			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004343.3	NP_004334.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC020493	IRAK014K15	MGC	W01A085D18	pENTR-TOPO	11559		CALR	811	AAH20493.1	Hs.515162	Calreticulin			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004343.3	NP_004334.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC020493	IRAK014K15	MGC	W01A085D20	pENTR-TOPO	11559		CALR	811	AAH20493.1	Hs.515162	Calreticulin			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004343.3	NP_004334.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC000045	IRAL007M13	MGC	W01A085E05	pENTR-TOPO	24615		VGLL1	51442	AAH00045.1	Hs.496843	Vestigial like 1 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_016267.2	NP_057351.1	PROVISIONAL	C	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC000045	IRAL007M13	MGC	W01A085E07	pENTR-TOPO	24615		VGLL1	51442	AAH00045.1	Hs.496843	Vestigial like 1 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_016267.2	NP_057351.1	PROVISIONAL	C	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC000045	IRAL007M13	MGC	W01A085E17	pENTR-TOPO	24615		VGLL1	51442	AAH00045.1	Hs.496843	Vestigial like 1 (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21		NM_016267.2	NP_057351.1	PROVISIONAL	C	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC029899	IRAK051L04	MGC	W01A085F06	pENTR-TOPO	9294		ZNF597	146434	AAH29899.1	Hs.88630	Zinc finger protein 597			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152457.1	NP_689670.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC029899	IRAK051L04	MGC	W01A085F08	pENTR-TOPO	9294		ZNF597	146434	AAH29899.1	Hs.88630	Zinc finger protein 597			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152457.1	NP_689670.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC029899	IRAK051L04	MGC	W01A085F10	pENTR-TOPO	9294		ZNF597	146434	AAH29899.1	Hs.88630	Zinc finger protein 597			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152457.1	NP_689670.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC029899	IRAK051L04	MGC	W01A085F18	pENTR-TOPO	9294		ZNF597	146434	AAH29899.1	Hs.88630	Zinc finger protein 597			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152457.1	NP_689670.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC029899	IRAK051L04	MGC	W01A085F22	pENTR-TOPO	9294		ZNF597	146434	AAH29899.1	Hs.88630	Zinc finger protein 597			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152457.1	NP_689670.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC029899	IRAK051L04	MGC	W01A085F24	pENTR-TOPO	9294		ZNF597	146434	AAH29899.1	Hs.88630	Zinc finger protein 597			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152457.1	NP_689670.1	PROVISIONAL	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC005342	IRAL016N01	MGC	W01A085G03	pENTR-TOPO	25211		NSBP1	79366	AAH05342.1	Hs.282204	Nucleosomal binding protein 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_030763.1	NP_110390.1	PROVISIONAL	C	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC005342	IRAL016N01	MGC	W01A085G07	pENTR-TOPO	25211		NSBP1	79366	AAH05342.1	Hs.282204	Nucleosomal binding protein 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_030763.1	NP_110390.1	PROVISIONAL	C	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC005342	IRAL016N01	MGC	W01A085G19	pENTR-TOPO	25211		NSBP1	79366	AAH05342.1	Hs.282204	Nucleosomal binding protein 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_030763.1	NP_110390.1	PROVISIONAL	C	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC005342	IRAL016N01	MGC	W01A085G21	pENTR-TOPO	25211		NSBP1	79366	AAH05342.1	Hs.282204	Nucleosomal binding protein 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_030763.1	NP_110390.1	PROVISIONAL	C	1.000	1.000	282	849	1	846	282	1	282
RIKEN	BC039016	IRAK082L05	MGC	W01A085H02	pENTR-TOPO	11422		NPAS1	4861	AAH39016.1	Hs.79564	Neuronal PAS domain protein 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002517.2	NP_002508.2	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC039016	IRAK082L05	MGC	W01A085H06	pENTR-TOPO	11422		NPAS1	4861	AAH39016.1	Hs.79564	Neuronal PAS domain protein 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002517.2	NP_002508.2	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC039016	IRAK082L05	MGC	W01A085H10	pENTR-TOPO	11422		NPAS1	4861	AAH39016.1	Hs.79564	Neuronal PAS domain protein 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002517.2	NP_002508.2	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC039016	IRAK082L05	MGC	W01A085H12	pENTR-TOPO	11422		NPAS1	4861	AAH39016.1	Hs.79564	Neuronal PAS domain protein 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002517.2	NP_002508.2	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC039016	IRAK082L05	MGC	W01A085H16	pENTR-TOPO	11422		NPAS1	4861	AAH39016.1	Hs.79564	Neuronal PAS domain protein 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002517.2	NP_002508.2	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC039016	IRAK082L05	MGC	W01A085H18	pENTR-TOPO	11422		NPAS1	4861	AAH39016.1	Hs.79564	Neuronal PAS domain protein 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002517.2	NP_002508.2	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC039016	IRAK082L05	MGC	W01A085H22	pENTR-TOPO	11422		NPAS1	4861	AAH39016.1	Hs.79564	Neuronal PAS domain protein 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_002517.2	NP_002508.2	REVIEWED	C	1.000	1.000	590	1773	1	1770	590	1	590
RIKEN	BC011699	IRAL027D17	MGC	W01A085I01	pENTR-TOPO	19257		C1QTNF2	114898	AAH11699.2	Hs.110062	C1q and tumor necrosis factor related protein 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031908.4	NP_114114.2	VALIDATED	P	1.000	1.000	285	858	1	855	330	46	330
RIKEN	BC011699	IRAL027D17	MGC	W01A085I09	pENTR-TOPO	19257		C1QTNF2	114898	AAH11699.2	Hs.110062	C1q and tumor necrosis factor related protein 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031908.4	NP_114114.2	VALIDATED	P	1.000	1.000	285	858	1	855	330	46	330
RIKEN	BC011699	IRAL027D17	MGC	W01A085I13	pENTR-TOPO	19257		C1QTNF2	114898	AAH11699.2	Hs.110062	C1q and tumor necrosis factor related protein 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031908.4	NP_114114.2	VALIDATED	P	1.000	1.000	285	858	1	855	330	46	330
RIKEN	BC011699	IRAL027D17	MGC	W01A085I15	pENTR-TOPO	19257		C1QTNF2	114898	AAH11699.2	Hs.110062	C1q and tumor necrosis factor related protein 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031908.4	NP_114114.2	VALIDATED	P	1.000	1.000	285	858	1	855	330	46	330
RIKEN	BC011699	IRAL027D17	MGC	W01A085I19	pENTR-TOPO	19257		C1QTNF2	114898	AAH11699.2	Hs.110062	C1q and tumor necrosis factor related protein 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031908.4	NP_114114.2	VALIDATED	P	1.000	1.000	285	858	1	855	330	46	330
RIKEN	BC011699	IRAL027D17	MGC	W01A085I21	pENTR-TOPO	19257		C1QTNF2	114898	AAH11699.2	Hs.110062	C1q and tumor necrosis factor related protein 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031908.4	NP_114114.2	VALIDATED	P	1.000	1.000	285	858	1	855	330	46	330
RIKEN	BC067272	IRAK141H24	MGC	W01A085J06	pENTR-TOPO	10720		FXR2	9513	AAH67272.1	Hs.52788	Fragile X mental retardation, autosomal homolog 2			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_004860.2	NP_004851.1	REVIEWED	Cs	0.997	0.997	673	2022	1	2019	673	1	673
RIKEN	BC067272	IRAK141H24	MGC	W01A085J18	pENTR-TOPO	10720		FXR2	9513	AAH67272.1	Hs.52788	Fragile X mental retardation, autosomal homolog 2			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_004860.2	NP_004851.1	REVIEWED	Cs	0.997	0.997	673	2022	1	2019	673	1	673
RIKEN	BC013408	IRAL010J02	MGC	W01A085K03	pENTR-TOPO	14934		FOXS1	2307	AAH13408.1	Hs.516971	Forkhead box S1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004118.3	NP_004109.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC013408	IRAL010J02	MGC	W01A085K07	pENTR-TOPO	14934		FOXS1	2307	AAH13408.1	Hs.516971	Forkhead box S1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004118.3	NP_004109.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC013408	IRAL010J02	MGC	W01A085K11	pENTR-TOPO	14934		FOXS1	2307	AAH13408.1	Hs.516971	Forkhead box S1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004118.3	NP_004109.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC013408	IRAL010J02	MGC	W01A085K19	pENTR-TOPO	14934		FOXS1	2307	AAH13408.1	Hs.516971	Forkhead box S1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004118.3	NP_004109.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC013408	IRAL010J02	MGC	W01A085K23	pENTR-TOPO	14934		FOXS1	2307	AAH13408.1	Hs.516971	Forkhead box S1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004118.3	NP_004109.1	REVIEWED	C	1.000	1.000	330	993	1	990	330	1	330
RIKEN	BC012759	IRAL024B13	MGC	W01A085L06	pENTR-TOPO	15000		ZFP64	55734	AAH12759.1	Hs.473082	Zinc finger protein 64 homolog (mouse)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_018197.2	NP_060667.2	VALIDATED	Cs	0.999	0.999	681	2046	1	2043	681	1	681
RIKEN	BC012759	IRAL024B13	MGC	W01A085L08	pENTR-TOPO	15000		ZFP64	55734	AAH12759.1	Hs.473082	Zinc finger protein 64 homolog (mouse)			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_018197.2	NP_060667.2	VALIDATED	Cs	0.999	0.999	681	2046	1	2043	681	1	681
RIKEN	AK095193	flj0046h12	FLJ	W01A085M17	pENTR-TOPO	3994		ANKRD42	338699	BAC04496.1	Hs.503438	Ankyrin repeat domain 42				BRSSN2	EK1	NM_182603.2	NP_872409.2	VALIDATED	Cs	0.997	0.997	389	1170	1	1167	389	1	389
RIKEN	AK095193	flj0046h12	FLJ	W01A085M19	pENTR-TOPO	3994		ANKRD42	338699	BAC04496.1	Hs.503438	Ankyrin repeat domain 42				BRSSN2	EK1	NM_182603.2	NP_872409.2	VALIDATED	Cs	0.997	0.997	389	1170	1	1167	389	1	389
RIKEN	AK095193	flj0046h12	FLJ	W01A085M21	pENTR-TOPO	3994		ANKRD42	338699	BAC04496.1	Hs.503438	Ankyrin repeat domain 42				BRSSN2	EK1	NM_182603.2	NP_872409.2	VALIDATED	Cs	0.997	0.997	389	1170	1	1167	389	1	389
RIKEN	BC036022	IRAK048A01	MGC	W01A085N14	pENTR-TOPO	11163		TCEB3B	51224	AAH36022.1	Hs.375035	Transcription elongation factor B polypeptide 3B (elongin A2)			Testis	NIH_MGC_97	DH10B	NM_016427.2	NP_057511.2	REVIEWED	Cs	0.999	0.999	753	2262	1	2259	753	1	753
RIKEN	BC036022	IRAK048A01	MGC	W01A085N16	pENTR-TOPO	11163		TCEB3B	51224	AAH36022.1	Hs.375035	Transcription elongation factor B polypeptide 3B (elongin A2)			Testis	NIH_MGC_97	DH10B	NM_016427.2	NP_057511.2	REVIEWED	Cs	0.999	0.999	753	2262	1	2259	753	1	753
RIKEN	BC036022	IRAK048A01	MGC	W01A085N18	pENTR-TOPO	11163		TCEB3B	51224	AAH36022.1	Hs.375035	Transcription elongation factor B polypeptide 3B (elongin A2)			Testis	NIH_MGC_97	DH10B	NM_016427.2	NP_057511.2	REVIEWED	Cs	0.999	0.999	753	2262	1	2259	753	1	753
RIKEN	BC036022	IRAK048A01	MGC	W01A085N24	pENTR-TOPO	11163		TCEB3B	51224	AAH36022.1	Hs.375035	Transcription elongation factor B polypeptide 3B (elongin A2)			Testis	NIH_MGC_97	DH10B	NM_016427.2	NP_057511.2	REVIEWED	Cs	0.999	0.999	753	2262	1	2259	753	1	753
RIKEN	BC006401	IRAL017P09	MGC	W01A085O01	pENTR-TOPO	1570		FAIM3	9214	AAH06401.1	Hs.58831	Fas apoptotic inhibitory molecule 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001142472.1	NP_001135944.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC006401	IRAL017P09	MGC	W01A085O05	pENTR-TOPO	1570		FAIM3	9214	AAH06401.1	Hs.58831	Fas apoptotic inhibitory molecule 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001142472.1	NP_001135944.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC006401	IRAL017P09	MGC	W01A085O13	pENTR-TOPO	1570		FAIM3	9214	AAH06401.1	Hs.58831	Fas apoptotic inhibitory molecule 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001142472.1	NP_001135944.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC006401	IRAL017P09	MGC	W01A085O15	pENTR-TOPO	1570		FAIM3	9214	AAH06401.1	Hs.58831	Fas apoptotic inhibitory molecule 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001142472.1	NP_001135944.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC006401	IRAL017P09	MGC	W01A085O21	pENTR-TOPO	1570		FAIM3	9214	AAH06401.1	Hs.58831	Fas apoptotic inhibitory molecule 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001142472.1	NP_001135944.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC006401	IRAL017P09	MGC	W01A085O23	pENTR-TOPO	1570		FAIM3	9214	AAH06401.1	Hs.58831	Fas apoptotic inhibitory molecule 3			Primary B-Cells from Tonsils	NIH_MGC_48		NM_001142472.1	NP_001135944.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
RIKEN	BC001491	IRAL007A09	MGC	W01A085P04	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P06	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P08	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P10	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P12	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P14	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P18	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P20	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001491	IRAL007A09	MGC	W01A085P22	pENTR-TOPO	15545		HMOX1	3162	AAH01491.1	Hs.517581	Heme oxygenase (decycling) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_002133.1	NP_002124.1	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
RIKEN	BC001889	IRAL008L09	MGC	W01A086A07	pENTR-TOPO	10991		NAPG	8774	AAH01889.1	Hs.464622	N-ethylmaleimide-sensitive factor attachment protein, gamma			Lung, small cell carcinoma	NIH_MGC_7		NM_003826.2	NP_003817.1	REVIEWED	Cs	0.997	0.997	312	939	1	936	312	1	312
RIKEN	BC001889	IRAL008L09	MGC	W01A086A15	pENTR-TOPO	10991		NAPG	8774	AAH01889.1	Hs.464622	N-ethylmaleimide-sensitive factor attachment protein, gamma			Lung, small cell carcinoma	NIH_MGC_7		NM_003826.2	NP_003817.1	REVIEWED	Cs	0.997	0.997	312	939	1	936	312	1	312
RIKEN	BC001889	IRAL008L09	MGC	W01A086A23	pENTR-TOPO	10991		NAPG	8774	AAH01889.1	Hs.464622	N-ethylmaleimide-sensitive factor attachment protein, gamma			Lung, small cell carcinoma	NIH_MGC_7		NM_003826.2	NP_003817.1	REVIEWED	Cs	0.997	0.997	312	939	1	936	312	1	312
RIKEN	BC047749	IRAK098L15	MGC	W01A086B02	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC047749	IRAK098L15	MGC	W01A086B04	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC047749	IRAK098L15	MGC	W01A086B06	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC047749	IRAK098L15	MGC	W01A086B08	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC047749	IRAK098L15	MGC	W01A086B12	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC047749	IRAK098L15	MGC	W01A086B14	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC047749	IRAK098L15	MGC	W01A086B18	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC047749	IRAK098L15	MGC	W01A086B22	pENTR-TOPO	13990		KCNK12	56660	AAH47749.1	Hs.591586	Potassium channel, subfamily K, member 12				Lupski_sympathetic_trunk	DH10B	NM_022055.1	NP_071338.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
RIKEN	BC004892	IRAL007J05	MGC	W01A086C03	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C05	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C07	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C09	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C11	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C13	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C15	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C17	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C21	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC004892	IRAL007J05	MGC	W01A086C23	pENTR-TOPO	7916		RCN2	5955	AAH04892.1	Hs.79088	Reticulocalbin 2, EF-hand calcium binding domain			Placenta, choriocarcinoma	NIH_MGC_21		NM_002902.2	NP_002893.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC001315	IRAK004B09	MGC	W01A086D06	pENTR-TOPO	11730		SNRNP70	6625	AAH01315.1	Hs.467097	Small nuclear ribonucleoprotein 70kDa (U1)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003089.4	NP_003080.2	VALIDATED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC001315	IRAK004B09	MGC	W01A086D20	pENTR-TOPO	11730		SNRNP70	6625	AAH01315.1	Hs.467097	Small nuclear ribonucleoprotein 70kDa (U1)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003089.4	NP_003080.2	VALIDATED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC001315	IRAK004B09	MGC	W01A086D22	pENTR-TOPO	11730		SNRNP70	6625	AAH01315.1	Hs.467097	Small nuclear ribonucleoprotein 70kDa (U1)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003089.4	NP_003080.2	VALIDATED	C	1.000	1.000	437	1314	1	1311	437	1	437
RIKEN	BC010466	IRAK012F13	MGC	W01A086E01	pENTR-TOPO	4422		B3GAT1	27087	AAH10466.1	Hs.381050	Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)				NCI_CGAP_Brn67	DH10B	NM_054025.2	NP_473366.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC010466	IRAK012F13	MGC	W01A086E03	pENTR-TOPO	4422		B3GAT1	27087	AAH10466.1	Hs.381050	Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)				NCI_CGAP_Brn67	DH10B	NM_054025.2	NP_473366.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC010466	IRAK012F13	MGC	W01A086E05	pENTR-TOPO	4422		B3GAT1	27087	AAH10466.1	Hs.381050	Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)				NCI_CGAP_Brn67	DH10B	NM_054025.2	NP_473366.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC010466	IRAK012F13	MGC	W01A086E11	pENTR-TOPO	4422		B3GAT1	27087	AAH10466.1	Hs.381050	Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)				NCI_CGAP_Brn67	DH10B	NM_054025.2	NP_473366.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC010466	IRAK012F13	MGC	W01A086E13	pENTR-TOPO	4422		B3GAT1	27087	AAH10466.1	Hs.381050	Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)				NCI_CGAP_Brn67	DH10B	NM_054025.2	NP_473366.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC010466	IRAK012F13	MGC	W01A086E17	pENTR-TOPO	4422		B3GAT1	27087	AAH10466.1	Hs.381050	Beta-1,3-glucuronyltransferase 1 (glucuronosyltransferase P)				NCI_CGAP_Brn67	DH10B	NM_054025.2	NP_473366.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC000062	IRAL007J21	MGC	W01A086F02	pENTR-TOPO	12227		SLC1A5	6510	AAH00062.1	Hs.631582	Solute carrier family 1 (neutral amino acid transporter), member 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001145144.1	NP_001138616.1	VALIDATED	Cs	0.997	0.997	313	1626	685	1623	313	1	313
RIKEN	BC000062	IRAL007J21	MGC	W01A086F08	pENTR-TOPO	12227		SLC1A5	6510	AAH00062.1	Hs.631582	Solute carrier family 1 (neutral amino acid transporter), member 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001145144.1	NP_001138616.1	VALIDATED	Cs	0.997	0.997	313	1626	685	1623	313	1	313
RIKEN	BC000062	IRAL007J21	MGC	W01A086F14	pENTR-TOPO	12227		SLC1A5	6510	AAH00062.1	Hs.631582	Solute carrier family 1 (neutral amino acid transporter), member 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001145144.1	NP_001138616.1	VALIDATED	Cs	0.997	0.997	313	1626	685	1623	313	1	313
RIKEN	BC000062	IRAL007J21	MGC	W01A086F18	pENTR-TOPO	12227		SLC1A5	6510	AAH00062.1	Hs.631582	Solute carrier family 1 (neutral amino acid transporter), member 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001145144.1	NP_001138616.1	VALIDATED	Cs	0.997	0.997	313	1626	685	1623	313	1	313
RIKEN	BC001201	IRAL006C10	MGC	W01A086G01	pENTR-TOPO	534		ST6GALNAC5	81849	AAH01201.1	Hs.303609	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5			Eye, retinoblastoma	NIH_MGC_16		NM_030965.1	NP_112227.1	PROVISIONAL	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC001201	IRAL006C10	MGC	W01A086G03	pENTR-TOPO	534		ST6GALNAC5	81849	AAH01201.1	Hs.303609	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5			Eye, retinoblastoma	NIH_MGC_16		NM_030965.1	NP_112227.1	PROVISIONAL	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC001201	IRAL006C10	MGC	W01A086G09	pENTR-TOPO	534		ST6GALNAC5	81849	AAH01201.1	Hs.303609	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5			Eye, retinoblastoma	NIH_MGC_16		NM_030965.1	NP_112227.1	PROVISIONAL	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC001201	IRAL006C10	MGC	W01A086G17	pENTR-TOPO	534		ST6GALNAC5	81849	AAH01201.1	Hs.303609	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5			Eye, retinoblastoma	NIH_MGC_16		NM_030965.1	NP_112227.1	PROVISIONAL	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC001201	IRAL006C10	MGC	W01A086G21	pENTR-TOPO	534		ST6GALNAC5	81849	AAH01201.1	Hs.303609	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 5			Eye, retinoblastoma	NIH_MGC_16		NM_030965.1	NP_112227.1	PROVISIONAL	C	1.000	1.000	336	1011	1	1008	336	1	336
RIKEN	BC042944	IRAK076A09	MGC	W01A086I11	pENTR-TOPO	9852		EFNB3	1949	AAH42944.1	Hs.26988	Ephrin-B3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001406.3	NP_001397.1	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC042944	IRAK076A09	MGC	W01A086I17	pENTR-TOPO	9852		EFNB3	1949	AAH42944.1	Hs.26988	Ephrin-B3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001406.3	NP_001397.1	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC042944	IRAK076A09	MGC	W01A086I19	pENTR-TOPO	9852		EFNB3	1949	AAH42944.1	Hs.26988	Ephrin-B3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001406.3	NP_001397.1	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	AK057646	flj0004a24	FLJ	W01A086J12	pENTR-TOPO	1933		CCDC17	149483	BAB71539.1	Hs.18912	Coiled-coil domain containing 17				TRACH2	EK1	NM_001114938.1	NP_001108410.1	PROVISIONAL	Ps	0.989	0.989	545	1695	1	1635	590	1	545
RIKEN	AK057646	flj0004a24	FLJ	W01A086J14	pENTR-TOPO	1933		CCDC17	149483	BAB71539.1	Hs.18912	Coiled-coil domain containing 17				TRACH2	EK1	NM_001114938.1	NP_001108410.1	PROVISIONAL	Ps	0.989	0.989	545	1695	1	1635	590	1	545
RIKEN	AK057646	flj0004a24	FLJ	W01A086J20	pENTR-TOPO	1933		CCDC17	149483	BAB71539.1	Hs.18912	Coiled-coil domain containing 17				TRACH2	EK1	NM_001114938.1	NP_001108410.1	PROVISIONAL	Ps	0.989	0.989	545	1695	1	1635	590	1	545
RIKEN	BC010073	IRAL027O01	MGC	W01A086K01	pENTR-TOPO	21129		GNB2	2783	AAH10073.1	Hs.185172	Guanine nucleotide binding protein (G protein), beta polypeptide 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_005273.3	NP_005264.2	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC010073	IRAL027O01	MGC	W01A086K03	pENTR-TOPO	21129		GNB2	2783	AAH10073.1	Hs.185172	Guanine nucleotide binding protein (G protein), beta polypeptide 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_005273.3	NP_005264.2	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC010073	IRAL027O01	MGC	W01A086K09	pENTR-TOPO	21129		GNB2	2783	AAH10073.1	Hs.185172	Guanine nucleotide binding protein (G protein), beta polypeptide 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_005273.3	NP_005264.2	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC010073	IRAL027O01	MGC	W01A086K13	pENTR-TOPO	21129		GNB2	2783	AAH10073.1	Hs.185172	Guanine nucleotide binding protein (G protein), beta polypeptide 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_005273.3	NP_005264.2	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC010073	IRAL027O01	MGC	W01A086K21	pENTR-TOPO	21129		GNB2	2783	AAH10073.1	Hs.185172	Guanine nucleotide binding protein (G protein), beta polypeptide 2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_005273.3	NP_005264.2	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC011604	IRAL004K02	MGC	W01A086L12	pENTR-TOPO	233		CNKSR1	10256	AAH11604.1	Hs.16232	Connector enhancer of kinase suppressor of Ras 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006314.2	NP_006305.2	REVIEWED	Cg	0.990	1.000	720	2163	1	2160	713	1	713
RIKEN	BC011604	IRAL004K02	MGC	W01A086L16	pENTR-TOPO	233		CNKSR1	10256	AAH11604.1	Hs.16232	Connector enhancer of kinase suppressor of Ras 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006314.2	NP_006305.2	REVIEWED	Cg	0.990	1.000	720	2163	1	2160	713	1	713
RIKEN	BC011604	IRAL004K02	MGC	W01A086L18	pENTR-TOPO	233		CNKSR1	10256	AAH11604.1	Hs.16232	Connector enhancer of kinase suppressor of Ras 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006314.2	NP_006305.2	REVIEWED	Cg	0.990	1.000	720	2163	1	2160	713	1	713
RIKEN	BC005315	IRAL016O23	MGC	W01A086M01	pENTR-TOPO	12672		FPR1	2357	AAH05315.1	Hs.753	Formyl peptide receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002029.3	NP_002020.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005315	IRAL016O23	MGC	W01A086M07	pENTR-TOPO	12672		FPR1	2357	AAH05315.1	Hs.753	Formyl peptide receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002029.3	NP_002020.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005315	IRAL016O23	MGC	W01A086M11	pENTR-TOPO	12672		FPR1	2357	AAH05315.1	Hs.753	Formyl peptide receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002029.3	NP_002020.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005315	IRAL016O23	MGC	W01A086M17	pENTR-TOPO	12672		FPR1	2357	AAH05315.1	Hs.753	Formyl peptide receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002029.3	NP_002020.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005315	IRAL016O23	MGC	W01A086M19	pENTR-TOPO	12672		FPR1	2357	AAH05315.1	Hs.753	Formyl peptide receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002029.3	NP_002020.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005315	IRAL016O23	MGC	W01A086M21	pENTR-TOPO	12672		FPR1	2357	AAH05315.1	Hs.753	Formyl peptide receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002029.3	NP_002020.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005315	IRAL016O23	MGC	W01A086M23	pENTR-TOPO	12672		FPR1	2357	AAH05315.1	Hs.753	Formyl peptide receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002029.3	NP_002020.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC066656	IRAK140N08	MGC	W01A086N08	pENTR-TOPO	5256		HSP90B1	7184	AAH66656.1	Hs.192374	Heat shock protein 90kDa beta (Grp94), member 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003299.1	NP_003290.1	PROVISIONAL	C	1.000	1.000	803	2412	1	2409	803	1	803
RIKEN	BC066656	IRAK140N08	MGC	W01A086N12	pENTR-TOPO	5256		HSP90B1	7184	AAH66656.1	Hs.192374	Heat shock protein 90kDa beta (Grp94), member 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003299.1	NP_003290.1	PROVISIONAL	C	1.000	1.000	803	2412	1	2409	803	1	803
RIKEN	BC066656	IRAK140N08	MGC	W01A086N18	pENTR-TOPO	5256		HSP90B1	7184	AAH66656.1	Hs.192374	Heat shock protein 90kDa beta (Grp94), member 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003299.1	NP_003290.1	PROVISIONAL	C	1.000	1.000	803	2412	1	2409	803	1	803
RIKEN	BC066656	IRAK140N08	MGC	W01A086N22	pENTR-TOPO	5256		HSP90B1	7184	AAH66656.1	Hs.192374	Heat shock protein 90kDa beta (Grp94), member 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003299.1	NP_003290.1	PROVISIONAL	C	1.000	1.000	803	2412	1	2409	803	1	803
RIKEN	BC063292	IRAK133G01	MGC	W01A086O03	pENTR-TOPO	22578		TRIB1	10221	AAH63292.1	Hs.444947	Tribbles homolog 1 (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_025195.2	NP_079471.1	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC063292	IRAK133G01	MGC	W01A086O19	pENTR-TOPO	22578		TRIB1	10221	AAH63292.1	Hs.444947	Tribbles homolog 1 (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_025195.2	NP_079471.1	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC063292	IRAK133G01	MGC	W01A086O21	pENTR-TOPO	22578		TRIB1	10221	AAH63292.1	Hs.444947	Tribbles homolog 1 (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_025195.2	NP_079471.1	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC063292	IRAK133G01	MGC	W01A086O23	pENTR-TOPO	22578		TRIB1	10221	AAH63292.1	Hs.444947	Tribbles homolog 1 (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_025195.2	NP_079471.1	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC025665	IRAK049C03	MGC	W01A086P02	pENTR-TOPO	3185		PKD2L1	9033	AAH25665.1	Hs.159241	Polycystic kidney disease 2-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_016112.2	NP_057196.2	REVIEWED	C	1.000	1.000	805	2418	1	2415	805	1	805
RIKEN	BC025665	IRAK049C03	MGC	W01A086P08	pENTR-TOPO	3185		PKD2L1	9033	AAH25665.1	Hs.159241	Polycystic kidney disease 2-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_016112.2	NP_057196.2	REVIEWED	C	1.000	1.000	805	2418	1	2415	805	1	805
RIKEN	BC025665	IRAK049C03	MGC	W01A086P10	pENTR-TOPO	3185		PKD2L1	9033	AAH25665.1	Hs.159241	Polycystic kidney disease 2-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_016112.2	NP_057196.2	REVIEWED	C	1.000	1.000	805	2418	1	2415	805	1	805
RIKEN	BC025665	IRAK049C03	MGC	W01A086P16	pENTR-TOPO	3185		PKD2L1	9033	AAH25665.1	Hs.159241	Polycystic kidney disease 2-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_016112.2	NP_057196.2	REVIEWED	C	1.000	1.000	805	2418	1	2415	805	1	805
RIKEN	BC025665	IRAK049C03	MGC	W01A086P22	pENTR-TOPO	3185		PKD2L1	9033	AAH25665.1	Hs.159241	Polycystic kidney disease 2-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_016112.2	NP_057196.2	REVIEWED	C	1.000	1.000	805	2418	1	2415	805	1	805
RIKEN	BC025665	IRAK049C03	MGC	W01A086P24	pENTR-TOPO	3185		PKD2L1	9033	AAH25665.1	Hs.159241	Polycystic kidney disease 2-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_016112.2	NP_057196.2	REVIEWED	C	1.000	1.000	805	2418	1	2415	805	1	805
RIKEN	AK026000	flj0058m10	FLJ	W01A087A13	pENTR-TOPO	4732		TUT1	64852	BAB15314.1	Hs.256184	Terminal uridylyl transferase 1, U6 snRNA-specific				HRC	EK1	NM_022830.2	NP_073741.2	REVIEWED	Ps	0.999	0.999	874	2625	1	2622	912	39	912
RIKEN	AK026000	flj0058m10	FLJ	W01A087A17	pENTR-TOPO	4732		TUT1	64852	BAB15314.1	Hs.256184	Terminal uridylyl transferase 1, U6 snRNA-specific				HRC	EK1	NM_022830.2	NP_073741.2	REVIEWED	Ps	0.999	0.999	874	2625	1	2622	912	39	912
RIKEN	AK026000	flj0058m10	FLJ	W01A087A21	pENTR-TOPO	4732		TUT1	64852	BAB15314.1	Hs.256184	Terminal uridylyl transferase 1, U6 snRNA-specific				HRC	EK1	NM_022830.2	NP_073741.2	REVIEWED	Ps	0.999	0.999	874	2625	1	2622	912	39	912
RIKEN	AK055395	flj0013h03	FLJ	W01A087B18	pENTR-TOPO	12475		MATK	4145	BAG51511.1	Hs.631845	Megakaryocyte-associated tyrosine kinase				FEBRA2	EK1	NM_139354.2	NP_647611.1	REVIEWED	C	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	AK055395	flj0013h03	FLJ	W01A087B22	pENTR-TOPO	12475		MATK	4145	BAG51511.1	Hs.631845	Megakaryocyte-associated tyrosine kinase				FEBRA2	EK1	NM_139354.2	NP_647611.1	REVIEWED	C	1.000	1.000	466	1401	1	1398	466	1	466
RIKEN	BC051795	IRAK107A08	MGC	W01A087C03	pENTR-TOPO	5589		ATN1	1822	AAH51795.1	Hs.143766	Atrophin 1				NCI_CGAP_Brn67	DH10B	NM_001940.3	NP_001931.2	REVIEWED	Cg	0.999	1.000	1191	3576	1	3573	1190	1	1190
RIKEN	BC051795	IRAK107A08	MGC	W01A087C13	pENTR-TOPO	5589		ATN1	1822	AAH51795.1	Hs.143766	Atrophin 1				NCI_CGAP_Brn67	DH10B	NM_001940.3	NP_001931.2	REVIEWED	Cg	0.999	1.000	1191	3576	1	3573	1190	1	1190
RIKEN	BC012885	IRAK021K03	MGC	W01A087D08	pENTR-TOPO	2726		PLXDC2	84898	AAH12885.1	Hs.658134	Plexin domain containing 2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032812.7	NP_116201.7	PROVISIONAL	Cg	0.907	1.000	529	1443	1	1440	529	1	529
RIKEN	BC012885	IRAK021K03	MGC	W01A087D10	pENTR-TOPO	2726		PLXDC2	84898	AAH12885.1	Hs.658134	Plexin domain containing 2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032812.7	NP_116201.7	PROVISIONAL	Cg	0.907	1.000	529	1443	1	1440	529	1	529
RIKEN	NM_005320	X01Y003E07	RIKEN_rt-pcr	W01A087E05	pENTR-TOPO	20837		HIST1H1D	3007	NP_005311.1	Hs.136857	Histone cluster 1, H1d						NM_005320.2	NP_005311.1	REVIEWED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	NM_005320	X01Y003E07	RIKEN_rt-pcr	W01A087E11	pENTR-TOPO	20837		HIST1H1D	3007	NP_005311.1	Hs.136857	Histone cluster 1, H1d						NM_005320.2	NP_005311.1	REVIEWED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	NM_005320	X01Y003E07	RIKEN_rt-pcr	W01A087E17	pENTR-TOPO	20837		HIST1H1D	3007	NP_005311.1	Hs.136857	Histone cluster 1, H1d						NM_005320.2	NP_005311.1	REVIEWED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	NM_005320	X01Y003E07	RIKEN_rt-pcr	W01A087E19	pENTR-TOPO	20837		HIST1H1D	3007	NP_005311.1	Hs.136857	Histone cluster 1, H1d						NM_005320.2	NP_005311.1	REVIEWED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	NM_005320	X01Y003E07	RIKEN_rt-pcr	W01A087E23	pENTR-TOPO	20837		HIST1H1D	3007	NP_005311.1	Hs.136857	Histone cluster 1, H1d						NM_005320.2	NP_005311.1	REVIEWED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC028580	IRAK034D19	MGC	W01A087F02	pENTR-TOPO	20097		MGC26597	206426	AAH28580	Hs.676966	PIP5K1A pseudogene			Testis	NIH_MGC_97	DH10B			
RIKEN	BC028580	IRAK034D19	MGC	W01A087F12	pENTR-TOPO	20097		MGC26597	206426	AAH28580	Hs.676966	PIP5K1A pseudogene			Testis	NIH_MGC_97	DH10B			
RIKEN	BC028580	IRAK034D19	MGC	W01A087F16	pENTR-TOPO	20097		MGC26597	206426	AAH28580	Hs.676966	PIP5K1A pseudogene			Testis	NIH_MGC_97	DH10B			
RIKEN	AK092761	flj0008b02	FLJ	W01A087G03	pENTR-TOPO	4790		BATF2	116071	BAC03968.2	Hs.124840	Basic leucine zipper transcription factor, ATF-like 2				SMINT2	EK1	NM_138456.3	NP_612465.3	VALIDATED		0.979	0.979	234	948	141	842	274	41	274
RIKEN	AK092761	flj0008b02	FLJ	W01A087G19	pENTR-TOPO	4790		BATF2	116071	BAC03968.2	Hs.124840	Basic leucine zipper transcription factor, ATF-like 2				SMINT2	EK1	NM_138456.3	NP_612465.3	VALIDATED		0.979	0.979	234	948	141	842	274	41	274
RIKEN	AK092761	flj0008b02	FLJ	W01A087G21	pENTR-TOPO	4790		BATF2	116071	BAC03968.2	Hs.124840	Basic leucine zipper transcription factor, ATF-like 2				SMINT2	EK1	NM_138456.3	NP_612465.3	VALIDATED		0.979	0.979	234	948	141	842	274	41	274
RIKEN	AK092761	flj0008b02	FLJ	W01A087G23	pENTR-TOPO	4790		BATF2	116071	BAC03968.2	Hs.124840	Basic leucine zipper transcription factor, ATF-like 2				SMINT2	EK1	NM_138456.3	NP_612465.3	VALIDATED		0.979	0.979	234	948	141	842	274	41	274
RIKEN	AL117234	X01Y137O09	RIKEN_rt-pcr	W01A087H04	pENTR-TOPO	25140		MCF2	4168	CAB55301.1	Hs.387262	MCF.2 cell line derived transforming sequence						NM_001099855.1	NP_001093325.1	VALIDATED	OK	1.000	1.000	985	2958	1	2955	985	1	985
RIKEN	BC059356	IRAK133I22	MGC	W01A087I15	pENTR-TOPO	25338		ZXDA	7789	AAH59356.1	Hs.591214	Zinc finger, X-linked, duplicated A			Placenta, normal	NIH_MGC_147	DH10B	NM_007156.3	NP_009087.1	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
RIKEN	BC059356	IRAK133I22	MGC	W01A087I19	pENTR-TOPO	25338		ZXDA	7789	AAH59356.1	Hs.591214	Zinc finger, X-linked, duplicated A			Placenta, normal	NIH_MGC_147	DH10B	NM_007156.3	NP_009087.1	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
RIKEN	BC059356	IRAK133I22	MGC	W01A087I23	pENTR-TOPO	25338		ZXDA	7789	AAH59356.1	Hs.591214	Zinc finger, X-linked, duplicated A			Placenta, normal	NIH_MGC_147	DH10B	NM_007156.3	NP_009087.1	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
RIKEN	BC057764	IRAK133L11	MGC	W01A087K05	pENTR-TOPO	14287		NCRNA00164	554226	-	Hs.380689	Non-protein coding RNA 164			Testis	NIH_MGC_97	DH10B													
RIKEN	BC057764	IRAK133L11	MGC	W01A087K17	pENTR-TOPO	14287		NCRNA00164	554226	-	Hs.380689	Non-protein coding RNA 164			Testis	NIH_MGC_97	DH10B													
RIKEN	BC057764	IRAK133L11	MGC	W01A087K21	pENTR-TOPO	14287		NCRNA00164	554226	-	Hs.380689	Non-protein coding RNA 164			Testis	NIH_MGC_97	DH10B													
RIKEN	BC007321	IRAL003E04	MGC	W01A087L04	pENTR-TOPO	15967		PHF5A	84844	AAH07321.1	Hs.474980	PHD finger protein 5A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032758.3	NP_116147.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
RIKEN	BC007321	IRAL003E04	MGC	W01A087L06	pENTR-TOPO	15967		PHF5A	84844	AAH07321.1	Hs.474980	PHD finger protein 5A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032758.3	NP_116147.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
RIKEN	BC007321	IRAL003E04	MGC	W01A087L14	pENTR-TOPO	15967		PHF5A	84844	AAH07321.1	Hs.474980	PHD finger protein 5A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032758.3	NP_116147.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
RIKEN	BC007321	IRAL003E04	MGC	W01A087L24	pENTR-TOPO	15967		PHF5A	84844	AAH07321.1	Hs.474980	PHD finger protein 5A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032758.3	NP_116147.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
RIKEN	BC019342	IRAL018D15	MGC	W01A087M05	pENTR-TOPO	3940		TSPAN18	90139	AAH19342.1	Hs.638940	Tetraspanin 18			Eye, retinoblastoma	NIH_MGC_16		NM_001031730.1	NP_001026900.1	PROVISIONAL	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	BC019342	IRAL018D15	MGC	W01A087M09	pENTR-TOPO	3940		TSPAN18	90139	AAH19342.1	Hs.638940	Tetraspanin 18			Eye, retinoblastoma	NIH_MGC_16		NM_001031730.1	NP_001026900.1	PROVISIONAL	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	BC019342	IRAL018D15	MGC	W01A087M11	pENTR-TOPO	3940		TSPAN18	90139	AAH19342.1	Hs.638940	Tetraspanin 18			Eye, retinoblastoma	NIH_MGC_16		NM_001031730.1	NP_001026900.1	PROVISIONAL	C	1.000	1.000	267	804	1	801	267	1	267
RIKEN	AK057898	flj0052n07	FLJ	W01A087N06	pENTR-TOPO	23149		NKX6-3	157848	BAB71610.1	Hs.647132	NK6 homeobox 3				CBR	EK1	NM_152568.2	NP_689781.1	PROVISIONAL	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	AK057898	flj0052n07	FLJ	W01A087N08	pENTR-TOPO	23149		NKX6-3	157848	BAB71610.1	Hs.647132	NK6 homeobox 3				CBR	EK1	NM_152568.2	NP_689781.1	PROVISIONAL	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	AK057898	flj0052n07	FLJ	W01A087N10	pENTR-TOPO	23149		NKX6-3	157848	BAB71610.1	Hs.647132	NK6 homeobox 3				CBR	EK1	NM_152568.2	NP_689781.1	PROVISIONAL	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	AK057898	flj0052n07	FLJ	W01A087N14	pENTR-TOPO	23149		NKX6-3	157848	BAB71610.1	Hs.647132	NK6 homeobox 3				CBR	EK1	NM_152568.2	NP_689781.1	PROVISIONAL	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	AK057898	flj0052n07	FLJ	W01A087N16	pENTR-TOPO	23149		NKX6-3	157848	BAB71610.1	Hs.647132	NK6 homeobox 3				CBR	EK1	NM_152568.2	NP_689781.1	PROVISIONAL	OK	1.000	1.000	135	408	1	405	135	1	135
RIKEN	BC033819	IRAK068N23	MGC	W01A087O05	pENTR-TOPO	278		CADM3	57863	AAH33819.1	Hs.365689	Cell adhesion molecule 3			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001127173.1	NP_001120645.1	VALIDATED	C	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	BC033819	IRAK068N23	MGC	W01A087O09	pENTR-TOPO	278		CADM3	57863	AAH33819.1	Hs.365689	Cell adhesion molecule 3			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001127173.1	NP_001120645.1	VALIDATED	C	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	BC033819	IRAK068N23	MGC	W01A087O13	pENTR-TOPO	278		CADM3	57863	AAH33819.1	Hs.365689	Cell adhesion molecule 3			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001127173.1	NP_001120645.1	VALIDATED	C	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	BC033819	IRAK068N23	MGC	W01A087O23	pENTR-TOPO	278		CADM3	57863	AAH33819.1	Hs.365689	Cell adhesion molecule 3			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001127173.1	NP_001120645.1	VALIDATED	C	1.000	1.000	398	1197	1	1194	398	1	398
RIKEN	BC032621	IRAK069O20	MGC	W01A087P04	pENTR-TOPO	3426		ATOH7	220202	AAH32621.1	Hs.175396	Atonal homolog 7 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_145178.2	NP_660161.1	VALIDATED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC032621	IRAK069O20	MGC	W01A087P10	pENTR-TOPO	3426		ATOH7	220202	AAH32621.1	Hs.175396	Atonal homolog 7 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_145178.2	NP_660161.1	VALIDATED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC032621	IRAK069O20	MGC	W01A087P18	pENTR-TOPO	3426		ATOH7	220202	AAH32621.1	Hs.175396	Atonal homolog 7 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_145178.2	NP_660161.1	VALIDATED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC032621	IRAK069O20	MGC	W01A087P20	pENTR-TOPO	3426		ATOH7	220202	AAH32621.1	Hs.175396	Atonal homolog 7 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_145178.2	NP_660161.1	VALIDATED	C	1.000	1.000	152	459	1	456	152	1	152
RIKEN	BC065832	IRAK141P20	MGC	W01A088A07	pENTR-TOPO	14320		POMC	5443	AAH65832.1	Hs.1897	Proopiomelanocortin			Pituitary	NIH_MGC_179	DH10B	NM_001035256.1	NP_001030333.1	REVIEWED	OK	1.000	1.000	267	804	1	801	267	1	267
RIKEN	BC065832	IRAK141P20	MGC	W01A088A19	pENTR-TOPO	14320		POMC	5443	AAH65832.1	Hs.1897	Proopiomelanocortin			Pituitary	NIH_MGC_179	DH10B	NM_001035256.1	NP_001030333.1	REVIEWED	OK	1.000	1.000	267	804	1	801	267	1	267
RIKEN	AK056894	flj0007k15	FLJ	W01A088C03	pENTR-TOPO	16422		PPM1M	132160	BAB71302.1	Hs.373560	Protein phosphatase 1M (PP2C domain containing)				PROST2	EK1	NM_001122870.1	NP_001116342.1	VALIDATED	Ps	0.995	0.995	201	813	154	756	247	1	201
RIKEN	AK056894	flj0007k15	FLJ	W01A088C05	pENTR-TOPO	16422		PPM1M	132160	BAB71302.1	Hs.373560	Protein phosphatase 1M (PP2C domain containing)				PROST2	EK1	NM_001122870.1	NP_001116342.1	VALIDATED	Ps	0.995	0.995	201	813	154	756	247	1	201
RIKEN	AK056894	flj0007k15	FLJ	W01A088C19	pENTR-TOPO	16422		PPM1M	132160	BAB71302.1	Hs.373560	Protein phosphatase 1M (PP2C domain containing)				PROST2	EK1	NM_001122870.1	NP_001116342.1	VALIDATED	Ps	0.995	0.995	201	813	154	756	247	1	201
RIKEN	BC066879	IRAK172A22	MGC	W01A088D08	pENTR-TOPO	13542		GPR45	11250	AAH66879.1	Hs.590903	G protein-coupled receptor 45			PCR rescued clones	NIH_MGC_195	DH10B	NM_007227.3	NP_009158.3	REVIEWED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC066879	IRAK172A22	MGC	W01A088D16	pENTR-TOPO	13542		GPR45	11250	AAH66879.1	Hs.590903	G protein-coupled receptor 45			PCR rescued clones	NIH_MGC_195	DH10B	NM_007227.3	NP_009158.3	REVIEWED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC066879	IRAK172A22	MGC	W01A088D20	pENTR-TOPO	13542		GPR45	11250	AAH66879.1	Hs.590903	G protein-coupled receptor 45			PCR rescued clones	NIH_MGC_195	DH10B	NM_007227.3	NP_009158.3	REVIEWED	C	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC014611	IRAK033N14	MGC	W01A088E01	pENTR-TOPO	12359		TSSK6	83983	AAH14611.1	Hs.532711	Testis-specific serine kinase 6			Testis	NIH_MGC_97	DH10B	NM_032037.2	NP_114426.1	VALIDATED	C	1.000	1.000	273	822	1	819	273	1	273
RIKEN	BC014611	IRAK033N14	MGC	W01A088E17	pENTR-TOPO	12359		TSSK6	83983	AAH14611.1	Hs.532711	Testis-specific serine kinase 6			Testis	NIH_MGC_97	DH10B	NM_032037.2	NP_114426.1	VALIDATED	C	1.000	1.000	273	822	1	819	273	1	273
RIKEN	AK095873	flj0042f05	FLJ	W01A088F02	pENTR-TOPO	94		B4GALT2	8704	BAG53152.1	Hs.632403	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2				HCHON2	EK1	NM_003780.3	NP_003771.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	AK095873	flj0042f05	FLJ	W01A088F04	pENTR-TOPO	94		B4GALT2	8704	BAG53152.1	Hs.632403	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2				HCHON2	EK1	NM_003780.3	NP_003771.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	AK095873	flj0042f05	FLJ	W01A088F06	pENTR-TOPO	94		B4GALT2	8704	BAG53152.1	Hs.632403	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2				HCHON2	EK1	NM_003780.3	NP_003771.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	AK095873	flj0042f05	FLJ	W01A088F20	pENTR-TOPO	94		B4GALT2	8704	BAG53152.1	Hs.632403	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 2				HCHON2	EK1	NM_003780.3	NP_003771.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	AK095191	flj0046d12	FLJ	W01A088G09	pENTR-TOPO	1046		POU6F1	5463	BAG53003.1	Hs.555886	POU class 6 homeobox 1				BRSSN2	EK1	NM_002702.3	NP_002693.3	VALIDATED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	BC035407	IRAK052O22	MGC	W01A088H12	pENTR-TOPO	24876		IL3RA	3563	AAH35407.1	Hs.632790	Interleukin 3 receptor, alpha (low affinity)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002183.2	NP_002174.1	REVIEWED	OK	1.000	1.000	378	1137	1	1134	378	1	378
RIKEN	BC035407	IRAK052O22	MGC	W01A088H14	pENTR-TOPO	24876		IL3RA	3563	AAH35407.1	Hs.632790	Interleukin 3 receptor, alpha (low affinity)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002183.2	NP_002174.1	REVIEWED	OK	1.000	1.000	378	1137	1	1134	378	1	378
RIKEN	BC035407	IRAK052O22	MGC	W01A088H22	pENTR-TOPO	24876		IL3RA	3563	AAH35407.1	Hs.632790	Interleukin 3 receptor, alpha (low affinity)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002183.2	NP_002174.1	REVIEWED	OK	1.000	1.000	378	1137	1	1134	378	1	378
RIKEN	AK022876	flj0033p19	FLJ	W01A088I01	pENTR-TOPO	19246		ANKRA2	57763	BAB14288.1	Hs.239154	Ankyrin repeat, family A (RFXANK-like), 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_023039.3	NP_075526.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	AK022876	flj0033p19	FLJ	W01A088I03	pENTR-TOPO	19246		ANKRA2	57763	BAB14288.1	Hs.239154	Ankyrin repeat, family A (RFXANK-like), 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_023039.3	NP_075526.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	AK022876	flj0033p19	FLJ	W01A088I15	pENTR-TOPO	19246		ANKRA2	57763	BAB14288.1	Hs.239154	Ankyrin repeat, family A (RFXANK-like), 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_023039.3	NP_075526.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	AK022876	flj0033p19	FLJ	W01A088I21	pENTR-TOPO	19246		ANKRA2	57763	BAB14288.1	Hs.239154	Ankyrin repeat, family A (RFXANK-like), 2	NT2	teratocarcinoma		NT2RP2	EK1	NM_023039.3	NP_075526.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	H033031M02	H033031M02	RIKEN	W01A088J02	pENTR-TOPO		17757	NPY2R	4887		Hs.37125	Neuropeptide Y receptor Y2	-	-	hypothalamus	hypothalamus	DH10B	NM_000910.2	NP_000901.1	PROVISIONAL	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	H033031M02	H033031M02	RIKEN	W01A088J04	pENTR-TOPO		17757	NPY2R	4887		Hs.37125	Neuropeptide Y receptor Y2	-	-	hypothalamus	hypothalamus	DH10B	NM_000910.2	NP_000901.1	PROVISIONAL	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	H033031M02	H033031M02	RIKEN	W01A088J12	pENTR-TOPO		17757	NPY2R	4887		Hs.37125	Neuropeptide Y receptor Y2	-	-	hypothalamus	hypothalamus	DH10B	NM_000910.2	NP_000901.1	PROVISIONAL	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	H033031M02	H033031M02	RIKEN	W01A088J18	pENTR-TOPO		17757	NPY2R	4887		Hs.37125	Neuropeptide Y receptor Y2	-	-	hypothalamus	hypothalamus	DH10B	NM_000910.2	NP_000901.1	PROVISIONAL	C	1.000	1.000	381	1146	1	1143	381	1	381
RIKEN	BC067292	IRAK141M20	MGC	W01A088K07	pENTR-TOPO	4140		MRGPRX3	117195	AAH67292.1	Hs.380177	MAS-related GPR, member X3			Testis	NIH_MGC_180	DH10B	NM_054031.2	NP_473372.2	PROVISIONAL	OK	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC067292	IRAK141M20	MGC	W01A088K11	pENTR-TOPO	4140		MRGPRX3	117195	AAH67292.1	Hs.380177	MAS-related GPR, member X3			Testis	NIH_MGC_180	DH10B	NM_054031.2	NP_473372.2	PROVISIONAL	OK	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC067292	IRAK141M20	MGC	W01A088K13	pENTR-TOPO	4140		MRGPRX3	117195	AAH67292.1	Hs.380177	MAS-related GPR, member X3			Testis	NIH_MGC_180	DH10B	NM_054031.2	NP_473372.2	PROVISIONAL	OK	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC067292	IRAK141M20	MGC	W01A088K15	pENTR-TOPO	4140		MRGPRX3	117195	AAH67292.1	Hs.380177	MAS-related GPR, member X3			Testis	NIH_MGC_180	DH10B	NM_054031.2	NP_473372.2	PROVISIONAL	OK	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC067292	IRAK141M20	MGC	W01A088K19	pENTR-TOPO	4140		MRGPRX3	117195	AAH67292.1	Hs.380177	MAS-related GPR, member X3			Testis	NIH_MGC_180	DH10B	NM_054031.2	NP_473372.2	PROVISIONAL	OK	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC067292	IRAK141M20	MGC	W01A088K21	pENTR-TOPO	4140		MRGPRX3	117195	AAH67292.1	Hs.380177	MAS-related GPR, member X3			Testis	NIH_MGC_180	DH10B	NM_054031.2	NP_473372.2	PROVISIONAL	OK	1.000	1.000	322	969	1	966	322	1	322
RIKEN	AK075325	flj0049e16	FLJ	W01A088M17	pENTR-TOPO	24055		CCRK	23552	BAG52110.1	Hs.522274	Cell cycle related kinase	Y79	retinoblastoma		Y79AA1	EK1	NM_178432.2	NP_848519.1	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	BC047526	IRAK048L07	MGC	W01A088N02	pENTR-TOPO	3393		HTR7	3363	AAH47526.1	Hs.73739	5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled)			Testis	NIH_MGC_97	DH10B	NM_019860.3	NP_062874.1	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC047526	IRAK048L07	MGC	W01A088N18	pENTR-TOPO	3393		HTR7	3363	AAH47526.1	Hs.73739	5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled)			Testis	NIH_MGC_97	DH10B	NM_019860.3	NP_062874.1	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC047526	IRAK048L07	MGC	W01A088N24	pENTR-TOPO	3393		HTR7	3363	AAH47526.1	Hs.73739	5-hydroxytryptamine (serotonin) receptor 7 (adenylate cyclase-coupled)			Testis	NIH_MGC_97	DH10B	NM_019860.3	NP_062874.1	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	AK131230	flj0073f15	FLJ	W01A088O09	pENTR-TOPO	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2				BRALZ2	EK1	NM_001004329.2	NP_001004329.2	VALIDATED	Cs	0.997	0.997	339	1020	1	1017	339	1	339
RIKEN	AK131230	flj0073f15	FLJ	W01A088O13	pENTR-TOPO	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2				BRALZ2	EK1	NM_001004329.2	NP_001004329.2	VALIDATED	Cs	0.997	0.997	339	1020	1	1017	339	1	339
RIKEN	AK131230	flj0073f15	FLJ	W01A088O17	pENTR-TOPO	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2				BRALZ2	EK1	NM_001004329.2	NP_001004329.2	VALIDATED	Cs	0.997	0.997	339	1020	1	1017	339	1	339
RIKEN	AK131230	flj0073f15	FLJ	W01A088O19	pENTR-TOPO	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2				BRALZ2	EK1	NM_001004329.2	NP_001004329.2	VALIDATED	Cs	0.997	0.997	339	1020	1	1017	339	1	339
RIKEN	BC067516	IRAK172H18	MGC	W01A088P04	pENTR-TOPO	22469		ZNF623	9831	AAH67516.1	Hs.694018	Zinc finger protein 623			PCR rescued clones	NIH_MGC_195	DH10B	NM_014789.3	NP_055604.3	VALIDATED	C	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC067516	IRAK172H18	MGC	W01A088P10	pENTR-TOPO	22469		ZNF623	9831	AAH67516.1	Hs.694018	Zinc finger protein 623			PCR rescued clones	NIH_MGC_195	DH10B	NM_014789.3	NP_055604.3	VALIDATED	C	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC067516	IRAK172H18	MGC	W01A088P16	pENTR-TOPO	22469		ZNF623	9831	AAH67516.1	Hs.694018	Zinc finger protein 623			PCR rescued clones	NIH_MGC_195	DH10B	NM_014789.3	NP_055604.3	VALIDATED	C	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC067516	IRAK172H18	MGC	W01A088P18	pENTR-TOPO	22469		ZNF623	9831	AAH67516.1	Hs.694018	Zinc finger protein 623			PCR rescued clones	NIH_MGC_195	DH10B	NM_014789.3	NP_055604.3	VALIDATED	C	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC067516	IRAK172H18	MGC	W01A088P22	pENTR-TOPO	22469		ZNF623	9831	AAH67516.1	Hs.694018	Zinc finger protein 623			PCR rescued clones	NIH_MGC_195	DH10B	NM_014789.3	NP_055604.3	VALIDATED	C	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC067516	IRAK172H18	MGC	W01A088P24	pENTR-TOPO	22469		ZNF623	9831	AAH67516.1	Hs.694018	Zinc finger protein 623			PCR rescued clones	NIH_MGC_195	DH10B	NM_014789.3	NP_055604.3	VALIDATED	C	1.000	1.000	536	1611	1	1608	536	1	536
RIKEN	BC003637	IRAL011M21	MGC	W01A089C01	pENTR-TOPO	6216		DDIT3	1649	AAH03637.1	Hs.690217	DNA-damage-inducible transcript 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004083.4	NP_004074.2	VALIDATED	C	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC003637	IRAL011M21	MGC	W01A089C03	pENTR-TOPO	6216		DDIT3	1649	AAH03637.1	Hs.690217	DNA-damage-inducible transcript 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004083.4	NP_004074.2	VALIDATED	C	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC003637	IRAL011M21	MGC	W01A089C05	pENTR-TOPO	6216		DDIT3	1649	AAH03637.1	Hs.690217	DNA-damage-inducible transcript 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004083.4	NP_004074.2	VALIDATED	C	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC003637	IRAL011M21	MGC	W01A089C21	pENTR-TOPO	6216		DDIT3	1649	AAH03637.1	Hs.690217	DNA-damage-inducible transcript 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004083.4	NP_004074.2	VALIDATED	C	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC002981	IRAL008J05	MGC	W01A089E05	pENTR-TOPO	11726		ZNF576	79177	AAH02981.1	Hs.11110	Zinc finger protein 576			Lung, small cell carcinoma	NIH_MGC_7		NM_001145347.1	NP_001138819.1	VALIDATED	Cs	0.994	0.994	170	513	1	510	170	1	170
RIKEN	BC002981	IRAL008J05	MGC	W01A089E13	pENTR-TOPO	11726		ZNF576	79177	AAH02981.1	Hs.11110	Zinc finger protein 576			Lung, small cell carcinoma	NIH_MGC_7		NM_001145347.1	NP_001138819.1	VALIDATED	Cs	0.994	0.994	170	513	1	510	170	1	170
RIKEN	BC002981	IRAL008J05	MGC	W01A089E15	pENTR-TOPO	11726		ZNF576	79177	AAH02981.1	Hs.11110	Zinc finger protein 576			Lung, small cell carcinoma	NIH_MGC_7		NM_001145347.1	NP_001138819.1	VALIDATED	Cs	0.994	0.994	170	513	1	510	170	1	170
RIKEN	BC002981	IRAL008J05	MGC	W01A089E19	pENTR-TOPO	11726		ZNF576	79177	AAH02981.1	Hs.11110	Zinc finger protein 576			Lung, small cell carcinoma	NIH_MGC_7		NM_001145347.1	NP_001138819.1	VALIDATED	Cs	0.994	0.994	170	513	1	510	170	1	170
RIKEN	BC031343	IRAL043O18	MGC	W01A089F06	pENTR-TOPO	3235		FAM24B	196792	AAH31343.1	Hs.114648	Family with sequence similarity 24, member B			Prostate, carcinoma	NIH_MGC_40		NM_152644.2	NP_689857.2	VALIDATED	Cs	0.989	0.989	94	285	1	282	94	1	94
RIKEN	BC031343	IRAL043O18	MGC	W01A089F08	pENTR-TOPO	3235		FAM24B	196792	AAH31343.1	Hs.114648	Family with sequence similarity 24, member B			Prostate, carcinoma	NIH_MGC_40		NM_152644.2	NP_689857.2	VALIDATED	Cs	0.989	0.989	94	285	1	282	94	1	94
RIKEN	BC031343	IRAL043O18	MGC	W01A089F24	pENTR-TOPO	3235		FAM24B	196792	AAH31343.1	Hs.114648	Family with sequence similarity 24, member B			Prostate, carcinoma	NIH_MGC_40		NM_152644.2	NP_689857.2	VALIDATED	Cs	0.989	0.989	94	285	1	282	94	1	94
RIKEN	BC026265	IRAL036P11	MGC	W01A089G19	pENTR-TOPO	22163		C7orf11	136647	AAH26265.1	Hs.654989	Chromosome 7 open reading frame 11			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_138701.2	NP_619646.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC026265	IRAL036P11	MGC	W01A089G21	pENTR-TOPO	22163		C7orf11	136647	AAH26265.1	Hs.654989	Chromosome 7 open reading frame 11			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_138701.2	NP_619646.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC026265	IRAL036P11	MGC	W01A089G23	pENTR-TOPO	22163		C7orf11	136647	AAH26265.1	Hs.654989	Chromosome 7 open reading frame 11			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_138701.2	NP_619646.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC010532	IRAK019L01	MGC	W01A089H04	pENTR-TOPO	15431		CSTB	1476	AAH10532.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC010532	IRAK019L01	MGC	W01A089H10	pENTR-TOPO	15431		CSTB	1476	AAH10532.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC010532	IRAK019L01	MGC	W01A089H14	pENTR-TOPO	15431		CSTB	1476	AAH10532.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC010532	IRAK019L01	MGC	W01A089H20	pENTR-TOPO	15431		CSTB	1476	AAH10532.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC010532	IRAK019L01	MGC	W01A089H22	pENTR-TOPO	15431		CSTB	1476	AAH10532.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC010532	IRAK019L01	MGC	W01A089H24	pENTR-TOPO	15431		CSTB	1476	AAH10532.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC012351	IRAL029F11	MGC	W01A089I01	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I07	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I11	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I13	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I15	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I17	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I19	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I21	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC012351	IRAL029F11	MGC	W01A089I23	pENTR-TOPO	1434		HES4	57801	AAH12351.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021170.3	NP_066993.1	VALIDATED	OK	1.000	1.000	221	666	1	663	221	1	221
RIKEN	BC016308	IRAL032N16	MGC	W01A089J18	pENTR-TOPO	18270		CXCL3	2921	AAH16308.1	Hs.89690	Chemokine (C-X-C motif) ligand 3			Lung	NIH_MGC_77	DH10B	NM_002090.2	NP_002081.2	VALIDATED	OK	1.000	1.000	107	324	1	321	107	1	107
RIKEN	BC016308	IRAL032N16	MGC	W01A089J22	pENTR-TOPO	18270		CXCL3	2921	AAH16308.1	Hs.89690	Chemokine (C-X-C motif) ligand 3			Lung	NIH_MGC_77	DH10B	NM_002090.2	NP_002081.2	VALIDATED	OK	1.000	1.000	107	324	1	321	107	1	107
RIKEN	BC005269	IRAL016P19	MGC	W01A089K15	pENTR-TOPO	20071		PLN	5350	AAH05269.1	Hs.170839	Phospholamban			Liver	NIH_MGC_76	DH10B	NM_002667.3	NP_002658.1	REVIEWED	OK	1.000	1.000	52	159	1	156	52	1	52
RIKEN	BC012589	IRAL019H19	MGC	W01A089L06	pENTR-TOPO	17478		CXCL13	10563	AAH12589.1	Hs.100431	Chemokine (C-X-C motif) ligand 13			Skeletal Muscle	NIH_MGC_81	DH10B	NM_006419.2	NP_006410.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
RIKEN	BC012589	IRAL019H19	MGC	W01A089L10	pENTR-TOPO	17478		CXCL13	10563	AAH12589.1	Hs.100431	Chemokine (C-X-C motif) ligand 13			Skeletal Muscle	NIH_MGC_81	DH10B	NM_006419.2	NP_006410.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
RIKEN	BC012589	IRAL019H19	MGC	W01A089L22	pENTR-TOPO	17478		CXCL13	10563	AAH12589.1	Hs.100431	Chemokine (C-X-C motif) ligand 13			Skeletal Muscle	NIH_MGC_81	DH10B	NM_006419.2	NP_006410.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
RIKEN	BC001732	IRAL006H19	MGC	W01A089M11	pENTR-TOPO	21886		TOMM7	54543	AAH01732.1	Hs.112318	Translocase of outer mitochondrial membrane 7 homolog (yeast)			Eye, retinoblastoma	NIH_MGC_16		NM_019059.2	NP_061932.1	PROVISIONAL	C	1.000	1.000	55	168	1	165	55	1	55
RIKEN	BC001732	IRAL006H19	MGC	W01A089M17	pENTR-TOPO	21886		TOMM7	54543	AAH01732.1	Hs.112318	Translocase of outer mitochondrial membrane 7 homolog (yeast)			Eye, retinoblastoma	NIH_MGC_16		NM_019059.2	NP_061932.1	PROVISIONAL	C	1.000	1.000	55	168	1	165	55	1	55
RIKEN	BC001732	IRAL006H19	MGC	W01A089M21	pENTR-TOPO	21886		TOMM7	54543	AAH01732.1	Hs.112318	Translocase of outer mitochondrial membrane 7 homolog (yeast)			Eye, retinoblastoma	NIH_MGC_16		NM_019059.2	NP_061932.1	PROVISIONAL	C	1.000	1.000	55	168	1	165	55	1	55
RIKEN	BC001732	IRAL006H19	MGC	W01A089M23	pENTR-TOPO	21886		TOMM7	54543	AAH01732.1	Hs.112318	Translocase of outer mitochondrial membrane 7 homolog (yeast)			Eye, retinoblastoma	NIH_MGC_16		NM_019059.2	NP_061932.1	PROVISIONAL	C	1.000	1.000	55	168	1	165	55	1	55
RIKEN	BC007676	IRAL012C03	MGC	W01A089N04	pENTR-TOPO	15588		MIF	4282	AAH07676.1	Hs.407995	Macrophage migration inhibitory factor (glycosylation-inhibiting factor)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002415.1	NP_002406.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC007676	IRAL012C03	MGC	W01A089N14	pENTR-TOPO	15588		MIF	4282	AAH07676.1	Hs.407995	Macrophage migration inhibitory factor (glycosylation-inhibiting factor)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002415.1	NP_002406.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC007676	IRAL012C03	MGC	W01A089N18	pENTR-TOPO	15588		MIF	4282	AAH07676.1	Hs.407995	Macrophage migration inhibitory factor (glycosylation-inhibiting factor)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002415.1	NP_002406.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC007676	IRAL012C03	MGC	W01A089N22	pENTR-TOPO	15588		MIF	4282	AAH07676.1	Hs.407995	Macrophage migration inhibitory factor (glycosylation-inhibiting factor)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002415.1	NP_002406.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC007676	IRAL012C03	MGC	W01A089N24	pENTR-TOPO	15588		MIF	4282	AAH07676.1	Hs.407995	Macrophage migration inhibitory factor (glycosylation-inhibiting factor)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002415.1	NP_002406.1	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC009709	IRAK014D20	MGC	W01A089O01	pENTR-TOPO	21235		GNG11	2791	AAH09709.1	Hs.83381	Guanine nucleotide binding protein (G protein), gamma 11			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004126.3	NP_004117.1	REVIEWED	C	1.000	1.000	73	222	1	219	73	1	73
RIKEN	BC009709	IRAK014D20	MGC	W01A089O03	pENTR-TOPO	21235		GNG11	2791	AAH09709.1	Hs.83381	Guanine nucleotide binding protein (G protein), gamma 11			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004126.3	NP_004117.1	REVIEWED	C	1.000	1.000	73	222	1	219	73	1	73
RIKEN	BC009709	IRAK014D20	MGC	W01A089O05	pENTR-TOPO	21235		GNG11	2791	AAH09709.1	Hs.83381	Guanine nucleotide binding protein (G protein), gamma 11			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004126.3	NP_004117.1	REVIEWED	C	1.000	1.000	73	222	1	219	73	1	73
RIKEN	BC009709	IRAK014D20	MGC	W01A089O07	pENTR-TOPO	21235		GNG11	2791	AAH09709.1	Hs.83381	Guanine nucleotide binding protein (G protein), gamma 11			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004126.3	NP_004117.1	REVIEWED	C	1.000	1.000	73	222	1	219	73	1	73
RIKEN	BC009709	IRAK014D20	MGC	W01A089O09	pENTR-TOPO	21235		GNG11	2791	AAH09709.1	Hs.83381	Guanine nucleotide binding protein (G protein), gamma 11			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004126.3	NP_004117.1	REVIEWED	C	1.000	1.000	73	222	1	219	73	1	73
RIKEN	BC009709	IRAK014D20	MGC	W01A089O19	pENTR-TOPO	21235		GNG11	2791	AAH09709.1	Hs.83381	Guanine nucleotide binding protein (G protein), gamma 11			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004126.3	NP_004117.1	REVIEWED	C	1.000	1.000	73	222	1	219	73	1	73
RIKEN	BC009709	IRAK014D20	MGC	W01A089O23	pENTR-TOPO	21235		GNG11	2791	AAH09709.1	Hs.83381	Guanine nucleotide binding protein (G protein), gamma 11			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004126.3	NP_004117.1	REVIEWED	C	1.000	1.000	73	222	1	219	73	1	73
RIKEN	BC007623	IRAL023A11	MGC	W01A089P02	pENTR-TOPO	1665		LSM10	84967	AAH07623.1	Hs.654622	LSM10, U7 small nuclear RNA associated			Eye, retinoblastoma	NIH_MGC_16		NM_032881.1	NP_116270.1	PROVISIONAL	OK	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC007623	IRAL023A11	MGC	W01A089P10	pENTR-TOPO	1665		LSM10	84967	AAH07623.1	Hs.654622	LSM10, U7 small nuclear RNA associated			Eye, retinoblastoma	NIH_MGC_16		NM_032881.1	NP_116270.1	PROVISIONAL	OK	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC007623	IRAL023A11	MGC	W01A089P14	pENTR-TOPO	1665		LSM10	84967	AAH07623.1	Hs.654622	LSM10, U7 small nuclear RNA associated			Eye, retinoblastoma	NIH_MGC_16		NM_032881.1	NP_116270.1	PROVISIONAL	OK	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC007623	IRAL023A11	MGC	W01A089P18	pENTR-TOPO	1665		LSM10	84967	AAH07623.1	Hs.654622	LSM10, U7 small nuclear RNA associated			Eye, retinoblastoma	NIH_MGC_16		NM_032881.1	NP_116270.1	PROVISIONAL	OK	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC007623	IRAL023A11	MGC	W01A089P20	pENTR-TOPO	1665		LSM10	84967	AAH07623.1	Hs.654622	LSM10, U7 small nuclear RNA associated			Eye, retinoblastoma	NIH_MGC_16		NM_032881.1	NP_116270.1	PROVISIONAL	OK	1.000	1.000	123	372	1	369	123	1	123
RIKEN	BC017379	IRAL003H21	MGC	W01A090A19	pENTR-TOPO	20093		HIST1H2AC	8334	AAH17379	Hs.699831	Histone cluster 1, H2ac			Skin, melanotic melanoma.	NIH_MGC_20		NM_003512.3	NP_003503.1	REVIEWED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC000043	IRAL007J14	MGC	W01A090B16	pENTR-TOPO	9600		ARL4D	379	AAH00043.1	Hs.183153	ADP-ribosylation factor-like 4D			Brain, neuroblastoma	NIH_MGC_19		NM_001661.3	NP_001652.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC002426	IRAL005A08	MGC	W01A090C03	pENTR-TOPO	732		PEA15	8682	AAH02426.1	Hs.517216	Phosphoprotein enriched in astrocytes 15			Skin, melanotic melanoma.	NIH_MGC_20		NM_003768.3	NP_003759.1	VALIDATED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC002426	IRAL005A08	MGC	W01A090C05	pENTR-TOPO	732		PEA15	8682	AAH02426.1	Hs.517216	Phosphoprotein enriched in astrocytes 15			Skin, melanotic melanoma.	NIH_MGC_20		NM_003768.3	NP_003759.1	VALIDATED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC002426	IRAL005A08	MGC	W01A090C21	pENTR-TOPO	732		PEA15	8682	AAH02426.1	Hs.517216	Phosphoprotein enriched in astrocytes 15			Skin, melanotic melanoma.	NIH_MGC_20		NM_003768.3	NP_003759.1	VALIDATED	OK	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC000043	IRAL007J14	MGC	W01A090D08	pENTR-TOPO	9600		ARL4D	379	AAH00043.1	Hs.183153	ADP-ribosylation factor-like 4D			Brain, neuroblastoma	NIH_MGC_19		NM_001661.3	NP_001652.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC000043	IRAL007J14	MGC	W01A090D14	pENTR-TOPO	9600		ARL4D	379	AAH00043.1	Hs.183153	ADP-ribosylation factor-like 4D			Brain, neuroblastoma	NIH_MGC_19		NM_001661.3	NP_001652.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC000043	IRAL007J14	MGC	W01A090D18	pENTR-TOPO	9600		ARL4D	379	AAH00043.1	Hs.183153	ADP-ribosylation factor-like 4D			Brain, neuroblastoma	NIH_MGC_19		NM_001661.3	NP_001652.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
RIKEN	BC032717	IRAK069H08	MGC	W01A090E03	pENTR-TOPO	10723		TRAPPC1	58485	AAH32717.1	Hs.24379	Trafficking protein particle complex 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_021210.3	NP_067033.1	PROVISIONAL	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC032717	IRAK069H08	MGC	W01A090E19	pENTR-TOPO	10723		TRAPPC1	58485	AAH32717.1	Hs.24379	Trafficking protein particle complex 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_021210.3	NP_067033.1	PROVISIONAL	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC032717	IRAK069H08	MGC	W01A090E21	pENTR-TOPO	10723		TRAPPC1	58485	AAH32717.1	Hs.24379	Trafficking protein particle complex 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_021210.3	NP_067033.1	PROVISIONAL	OK	1.000	1.000	145	438	1	435	145	1	145
RIKEN	BC063035	IRAK119I16	MGC	W01A090F04	pENTR-TOPO	10739		GRAP	10750	AAH63035.1	Hs.567416	GRB2-related adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006613.3	NP_006604.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC063035	IRAK119I16	MGC	W01A090F10	pENTR-TOPO	10739		GRAP	10750	AAH63035.1	Hs.567416	GRB2-related adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006613.3	NP_006604.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC063035	IRAK119I16	MGC	W01A090F16	pENTR-TOPO	10739		GRAP	10750	AAH63035.1	Hs.567416	GRB2-related adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006613.3	NP_006604.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC020808	IRAL036B18	MGC	W01A090I03	pENTR-TOPO	206		SDHC	6391	AAH20808.1	Hs.444472	Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa			Skeletal Muscle	NIH_MGC_81	DH10B	NM_003001.3	NP_002992.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC020808	IRAL036B18	MGC	W01A090I05	pENTR-TOPO	206		SDHC	6391	AAH20808.1	Hs.444472	Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa			Skeletal Muscle	NIH_MGC_81	DH10B	NM_003001.3	NP_002992.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC020808	IRAL036B18	MGC	W01A090I11	pENTR-TOPO	206		SDHC	6391	AAH20808.1	Hs.444472	Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa			Skeletal Muscle	NIH_MGC_81	DH10B	NM_003001.3	NP_002992.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC020808	IRAL036B18	MGC	W01A090I19	pENTR-TOPO	206		SDHC	6391	AAH20808.1	Hs.444472	Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa			Skeletal Muscle	NIH_MGC_81	DH10B	NM_003001.3	NP_002992.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
RIKEN	BC063035	IRAK119I16	MGC	W01A090J02	pENTR-TOPO	10739		GRAP	10750	AAH63035.1	Hs.567416	GRB2-related adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006613.3	NP_006604.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC063035	IRAK119I16	MGC	W01A090J04	pENTR-TOPO	10739		GRAP	10750	AAH63035.1	Hs.567416	GRB2-related adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006613.3	NP_006604.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC002760	IRAL012M24	MGC	W01A090K01	pENTR-TOPO	9173		PLLP	51090	AAH02760.1	Hs.632215	Plasma membrane proteolipid (plasmolipin)			Ovary, adenocarcinoma	NIH_MGC_9		NM_015993.1	NP_057077.1	PROVISIONAL	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	BC020929	IRAL035F17	MGC	W01A090L04	pENTR-TOPO	23487		ZBTB34	403341	AAH20929	Hs.177633	Zinc finger and BTB domain containing 34			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001099270.1	NP_001092740.1	VALIDATED	Pfs	0.429	0.429	14	72	67	26	500	323	336
RIKEN	BC058291	IRAL048N11	MGC	W01A090M05	pENTR-TOPO	8904		TNFRSF17	608	AAH58291.1	Hs.2556	Tumor necrosis factor receptor superfamily, member 17			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_001192.2	NP_001183.2	REVIEWED	Cs	0.989	0.989	184	555	1	552	184	1	184
RIKEN	BC058291	IRAL048N11	MGC	W01A090M11	pENTR-TOPO	8904		TNFRSF17	608	AAH58291.1	Hs.2556	Tumor necrosis factor receptor superfamily, member 17			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_001192.2	NP_001183.2	REVIEWED	Cs	0.989	0.989	184	555	1	552	184	1	184
RIKEN	BC058291	IRAL048N11	MGC	W01A090M19	pENTR-TOPO	8904		TNFRSF17	608	AAH58291.1	Hs.2556	Tumor necrosis factor receptor superfamily, member 17			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_001192.2	NP_001183.2	REVIEWED	Cs	0.989	0.989	184	555	1	552	184	1	184
RIKEN	BC006440	IRAL018C11	MGC	W01A090N02	pENTR-TOPO	6005		BEST3	144453	AAH06440.1	Hs.280782	Bestrophin 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032735.2	NP_116124.2	VALIDATED	P	1.000	1.000	54	219	1	162	668	107	160
RIKEN	BC006440	IRAL018C11	MGC	W01A090N08	pENTR-TOPO	6005		BEST3	144453	AAH06440.1	Hs.280782	Bestrophin 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032735.2	NP_116124.2	VALIDATED	P	1.000	1.000	54	219	1	162	668	107	160
RIKEN	BC006440	IRAL018C11	MGC	W01A090N10	pENTR-TOPO	6005		BEST3	144453	AAH06440.1	Hs.280782	Bestrophin 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032735.2	NP_116124.2	VALIDATED	P	1.000	1.000	54	219	1	162	668	107	160
RIKEN	BC006440	IRAL018C11	MGC	W01A090N14	pENTR-TOPO	6005		BEST3	144453	AAH06440.1	Hs.280782	Bestrophin 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032735.2	NP_116124.2	VALIDATED	P	1.000	1.000	54	219	1	162	668	107	160
RIKEN	BC006440	IRAL018C11	MGC	W01A090N16	pENTR-TOPO	6005		BEST3	144453	AAH06440.1	Hs.280782	Bestrophin 3			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_032735.2	NP_116124.2	VALIDATED	P	1.000	1.000	54	219	1	162	668	107	160
RIKEN	BC022393	IRAL036G18	MGC	W01A090O19	pENTR-TOPO	16560		TDGF1	6997	AAH22393.1	Hs.385870	Teratocarcinoma-derived growth factor 1			Kidney	NIH_MGC_75	DH10B	NM_003212.2	NP_003203.1	VALIDATED	Cs	0.995	0.995	188	567	1	564	188	1	188
RIKEN	AK074417	flj0057g02	FLJ	W01A091A05	pENTR-TOPO	20666		SF3B5	83443	-	Hs.110695	Splicing factor 3b, subunit 5, 10kDa				KAT	EK1	NM_031287.2	NP_112577.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
RIKEN	AK074417	flj0057g02	FLJ	W01A091A09	pENTR-TOPO	20666		SF3B5	83443	-	Hs.110695	Splicing factor 3b, subunit 5, 10kDa				KAT	EK1	NM_031287.2	NP_112577.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
RIKEN	AK074417	flj0057g02	FLJ	W01A091A11	pENTR-TOPO	20666		SF3B5	83443	-	Hs.110695	Splicing factor 3b, subunit 5, 10kDa				KAT	EK1	NM_031287.2	NP_112577.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
RIKEN	AK129822	flj0062c19	FLJ	W01A091B04	pENTR-TOPO	10554		DUSP3	1845	-	Hs.181046	Dual specificity phosphatase 3				DMC	EK1	NM_004090.3	NP_004081.1	REVIEWED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	AK129822	flj0062c19	FLJ	W01A091B20	pENTR-TOPO	10554		DUSP3	1845	-	Hs.181046	Dual specificity phosphatase 3				DMC	EK1	NM_004090.3	NP_004081.1	REVIEWED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	AK129822	flj0062c19	FLJ	W01A091B24	pENTR-TOPO	10554		DUSP3	1845	-	Hs.181046	Dual specificity phosphatase 3				DMC	EK1	NM_004090.3	NP_004081.1	REVIEWED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	AK126904	flj0077a15	FLJ	W01A091C01	pENTR-TOPO	783		S100A1	6271	-	Hs.515715	S100 calcium binding protein A1				BRAWH2	EK1	NM_006271.1	NP_006262.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	AK126904	flj0077a15	FLJ	W01A091C07	pENTR-TOPO	783		S100A1	6271	-	Hs.515715	S100 calcium binding protein A1				BRAWH2	EK1	NM_006271.1	NP_006262.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	AK126904	flj0077a15	FLJ	W01A091C17	pENTR-TOPO	783		S100A1	6271	-	Hs.515715	S100 calcium binding protein A1				BRAWH2	EK1	NM_006271.1	NP_006262.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC005976	IRAL021P09	MGC	W01A091D06	pENTR-TOPO	16981		RHOA	387	AAH05976.1	Hs.247077	Ras homolog gene family, member A			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001664.2	NP_001655.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC005976	IRAL021P09	MGC	W01A091D10	pENTR-TOPO	16981		RHOA	387	AAH05976.1	Hs.247077	Ras homolog gene family, member A			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001664.2	NP_001655.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC005976	IRAL021P09	MGC	W01A091D16	pENTR-TOPO	16981		RHOA	387	AAH05976.1	Hs.247077	Ras homolog gene family, member A			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001664.2	NP_001655.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC005976	IRAL021P09	MGC	W01A091D18	pENTR-TOPO	16981		RHOA	387	AAH05976.1	Hs.247077	Ras homolog gene family, member A			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001664.2	NP_001655.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC005976	IRAL021P09	MGC	W01A091D20	pENTR-TOPO	16981		RHOA	387	AAH05976.1	Hs.247077	Ras homolog gene family, member A			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001664.2	NP_001655.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC005976	IRAL021P09	MGC	W01A091D22	pENTR-TOPO	16981		RHOA	387	AAH05976.1	Hs.247077	Ras homolog gene family, member A			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001664.2	NP_001655.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC005976	IRAL021P09	MGC	W01A091D24	pENTR-TOPO	16981		RHOA	387	AAH05976.1	Hs.247077	Ras homolog gene family, member A			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_001664.2	NP_001655.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC027918	IRAK049N05	MGC	W01A091E07	pENTR-TOPO	23955		CCL21	6366	AAH27918.1	Hs.57907	Chemokine (C-C motif) ligand 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002989.2	NP_002980.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC027918	IRAK049N05	MGC	W01A091E13	pENTR-TOPO	23955		CCL21	6366	AAH27918.1	Hs.57907	Chemokine (C-C motif) ligand 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002989.2	NP_002980.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC027918	IRAK049N05	MGC	W01A091E23	pENTR-TOPO	23955		CCL21	6366	AAH27918.1	Hs.57907	Chemokine (C-C motif) ligand 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002989.2	NP_002980.1	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	AK001776	flj0036m07	FLJ	W01A091F04	pENTR-TOPO	14698		C20orf20	55257	BAA91902.1	Hs.590870	Chromosome 20 open reading frame 20				OVARC1	EK1	NM_018270.4	NP_060740.1	VALIDATED	C	1.000	1.000	204	615	1	612	204	1	204
RIKEN	AK001776	flj0036m07	FLJ	W01A091F12	pENTR-TOPO	14698		C20orf20	55257	BAA91902.1	Hs.590870	Chromosome 20 open reading frame 20				OVARC1	EK1	NM_018270.4	NP_060740.1	VALIDATED	C	1.000	1.000	204	615	1	612	204	1	204
RIKEN	AK001776	flj0036m07	FLJ	W01A091F16	pENTR-TOPO	14698		C20orf20	55257	BAA91902.1	Hs.590870	Chromosome 20 open reading frame 20				OVARC1	EK1	NM_018270.4	NP_060740.1	VALIDATED	C	1.000	1.000	204	615	1	612	204	1	204
RIKEN	AK001776	flj0036m07	FLJ	W01A091F22	pENTR-TOPO	14698		C20orf20	55257	BAA91902.1	Hs.590870	Chromosome 20 open reading frame 20				OVARC1	EK1	NM_018270.4	NP_060740.1	VALIDATED	C	1.000	1.000	204	615	1	612	204	1	204
RIKEN	BC005180	IRAL016B05	MGC	W01A091G09	pENTR-TOPO	15322		PIGP	51227	AAH05180.1	Hs.716087	Phosphatidylinositol glycan anchor biosynthesis, class P			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_153682.2	NP_710149.1	REVIEWED	OK	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC005180	IRAL016B05	MGC	W01A091G11	pENTR-TOPO	15322		PIGP	51227	AAH05180.1	Hs.716087	Phosphatidylinositol glycan anchor biosynthesis, class P			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_153682.2	NP_710149.1	REVIEWED	OK	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC005180	IRAL016B05	MGC	W01A091G15	pENTR-TOPO	15322		PIGP	51227	AAH05180.1	Hs.716087	Phosphatidylinositol glycan anchor biosynthesis, class P			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_153682.2	NP_710149.1	REVIEWED	OK	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC047699	IRAK098A02	MGC	W01A091H10	pENTR-TOPO	8745		ARHGDIG	398	AAH47699.1	Hs.647388	Rho GDP dissociation inhibitor (GDI) gamma			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001176.3	NP_001167.2	VALIDATED	OK	1.000	1.000	225	678	1	675	225	1	225
RIKEN	AK021735	flj0029m03	FLJ	W01A091I03	pENTR-TOPO	23119		UBE2W	55284	BAB13883.1	Hs.597486	Ubiquitin-conjugating enzyme E2W (putative)				HEMBA1	EK1	NM_018299.3	NP_060769.3	VALIDATED	Cs	0.993	0.993	151	456	1	453	151	1	151
RIKEN	AK021735	flj0029m03	FLJ	W01A091I15	pENTR-TOPO	23119		UBE2W	55284	BAB13883.1	Hs.597486	Ubiquitin-conjugating enzyme E2W (putative)				HEMBA1	EK1	NM_018299.3	NP_060769.3	VALIDATED	Cs	0.993	0.993	151	456	1	453	151	1	151
RIKEN	AK021735	flj0029m03	FLJ	W01A091I17	pENTR-TOPO	23119		UBE2W	55284	BAB13883.1	Hs.597486	Ubiquitin-conjugating enzyme E2W (putative)				HEMBA1	EK1	NM_018299.3	NP_060769.3	VALIDATED	Cs	0.993	0.993	151	456	1	453	151	1	151
RIKEN	H06D038O20	H06D038O20	RIKEN	W01A091J18	pENTR-TOPO		4526						-	-	brain	brain	DH10B			
RIKEN	H04D027G04	H04D027G04	RIKEN	W01A091K07	pENTR-TOPO		9087						-	-	testis	testis	DH10B			
RIKEN	H04D027G04	H04D027G04	RIKEN	W01A091K09	pENTR-TOPO		9087						-	-	testis	testis	DH10B			
RIKEN	H04D027G04	H04D027G04	RIKEN	W01A091K15	pENTR-TOPO		9087						-	-	testis	testis	DH10B			
RIKEN	H04D027G04	H04D027G04	RIKEN	W01A091K19	pENTR-TOPO		9087						-	-	testis	testis	DH10B			
RIKEN	H04D027G04	H04D027G04	RIKEN	W01A091K21	pENTR-TOPO		9087						-	-	testis	testis	DH10B			
RIKEN	H04D027G04	H04D027G04	RIKEN	W01A091K23	pENTR-TOPO		9087						-	-	testis	testis	DH10B			
RIKEN	BC053898	IRAK115N08	MGC	W01A091L04	pENTR-TOPO	5637		HOXC8	3224	AAH53898.1	Hs.664500	Homeobox C8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_022658.3	NP_073149.1	REVIEWED	C	1.000	1.000	242	729	1	726	242	1	242
RIKEN	BC053898	IRAK115N08	MGC	W01A091L14	pENTR-TOPO	5637		HOXC8	3224	AAH53898.1	Hs.664500	Homeobox C8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_022658.3	NP_073149.1	REVIEWED	C	1.000	1.000	242	729	1	726	242	1	242
RIKEN	BC005256	IRAL016A23	MGC	W01A091M05	pENTR-TOPO	21114		CAV2	858	AAH05256.1	Hs.212332	Caveolin 2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001233.3	NP_001224.1	REVIEWED	OK	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC005256	IRAL016A23	MGC	W01A091M09	pENTR-TOPO	21114		CAV2	858	AAH05256.1	Hs.212332	Caveolin 2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001233.3	NP_001224.1	REVIEWED	OK	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC005256	IRAL016A23	MGC	W01A091M13	pENTR-TOPO	21114		CAV2	858	AAH05256.1	Hs.212332	Caveolin 2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001233.3	NP_001224.1	REVIEWED	OK	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC005256	IRAL016A23	MGC	W01A091M17	pENTR-TOPO	21114		CAV2	858	AAH05256.1	Hs.212332	Caveolin 2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001233.3	NP_001224.1	REVIEWED	OK	1.000	1.000	162	489	1	486	162	1	162
RIKEN	AK075197	flj0019o04	FLJ	W01A091N08	pENTR-TOPO	4549		ELF5	2001	-	Hs.11713	E74-like factor 5 (ets domain transcription factor)				PLACE1	EK1	NM_001422.2	NP_001413.1	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	AK075197	flj0019o04	FLJ	W01A091N12	pENTR-TOPO	4549		ELF5	2001	-	Hs.11713	E74-like factor 5 (ets domain transcription factor)				PLACE1	EK1	NM_001422.2	NP_001413.1	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	AK075197	flj0019o04	FLJ	W01A091N16	pENTR-TOPO	4549		ELF5	2001	-	Hs.11713	E74-like factor 5 (ets domain transcription factor)				PLACE1	EK1	NM_001422.2	NP_001413.1	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	AK075197	flj0019o04	FLJ	W01A091N18	pENTR-TOPO	4549		ELF5	2001	-	Hs.11713	E74-like factor 5 (ets domain transcription factor)				PLACE1	EK1	NM_001422.2	NP_001413.1	REVIEWED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC029492	IRAK048C14	MGC	W01A091O07	pENTR-TOPO	13917		TPRKB	51002	AAH29492.1	Hs.157401	TP53RK binding protein			Testis	NIH_MGC_97	DH10B	NM_016058.2	NP_057142.1	VALIDATED	OK	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC029492	IRAK048C14	MGC	W01A091O13	pENTR-TOPO	13917		TPRKB	51002	AAH29492.1	Hs.157401	TP53RK binding protein			Testis	NIH_MGC_97	DH10B	NM_016058.2	NP_057142.1	VALIDATED	OK	1.000	1.000	175	528	1	525	175	1	175
RIKEN	BC039158	IRAK029L08	MGC	W01A091P06	pENTR-TOPO	13306		PDK1	5163	AAH39158.1	Hs.470633	Pyruvate dehydrogenase kinase, isozyme 1			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_002610.3	NP_002601.1	REVIEWED	C	1.000	1.000	436	1311	1	1308	436	1	436
RIKEN	BC040141	IRAK084D18	MGC	W01A092C15	pENTR-TOPO	6242		NR2C1	7181	AAH40141.1	Hs.108301	Nuclear receptor subfamily 2, group C, member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001032287.2	NP_001027458.1	REVIEWED	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC040141	IRAK084D18	MGC	W01A092C19	pENTR-TOPO	6242		NR2C1	7181	AAH40141.1	Hs.108301	Nuclear receptor subfamily 2, group C, member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001032287.2	NP_001027458.1	REVIEWED	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC040141	IRAK084D18	MGC	W01A092C21	pENTR-TOPO	6242		NR2C1	7181	AAH40141.1	Hs.108301	Nuclear receptor subfamily 2, group C, member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001032287.2	NP_001027458.1	REVIEWED	C	1.000	1.000	467	1404	1	1401	467	1	467
RIKEN	BC020780	IRAL037E20	MGC	W01A092E05	pENTR-TOPO	17616		RBPJ	3516	AAH20780.1	Hs.479396	Recombination signal binding protein for immunoglobulin kappa J region			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_203283.1	NP_976028.1	VALIDATED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC020780	IRAL037E20	MGC	W01A092E07	pENTR-TOPO	17616		RBPJ	3516	AAH20780.1	Hs.479396	Recombination signal binding protein for immunoglobulin kappa J region			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_203283.1	NP_976028.1	VALIDATED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC020780	IRAL037E20	MGC	W01A092E13	pENTR-TOPO	17616		RBPJ	3516	AAH20780.1	Hs.479396	Recombination signal binding protein for immunoglobulin kappa J region			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_203283.1	NP_976028.1	VALIDATED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC020780	IRAL037E20	MGC	W01A092E17	pENTR-TOPO	17616		RBPJ	3516	AAH20780.1	Hs.479396	Recombination signal binding protein for immunoglobulin kappa J region			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_203283.1	NP_976028.1	VALIDATED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC030700	IRAK034L13	MGC	W01A092F14	pENTR-TOPO	22057		ZNF680	340252	AAH30700.1	Hs.520886	Zinc finger protein 680			Testis	NIH_MGC_97	DH10B	NM_178558.4	NP_848653.2	VALIDATED	Cs	0.996	0.996	530	1593	1	1590	530	1	530
RIKEN	BC030700	IRAK034L13	MGC	W01A092F16	pENTR-TOPO	22057		ZNF680	340252	AAH30700.1	Hs.520886	Zinc finger protein 680			Testis	NIH_MGC_97	DH10B	NM_178558.4	NP_848653.2	VALIDATED	Cs	0.996	0.996	530	1593	1	1590	530	1	530
RIKEN	BC030700	IRAK034L13	MGC	W01A092F18	pENTR-TOPO	22057		ZNF680	340252	AAH30700.1	Hs.520886	Zinc finger protein 680			Testis	NIH_MGC_97	DH10B	NM_178558.4	NP_848653.2	VALIDATED	Cs	0.996	0.996	530	1593	1	1590	530	1	530
RIKEN	AK131210	flj0073g19	FLJ	W01A092G11	pENTR-TOPO	9737		GPRC5C	55890	BAG54752.1	Hs.446438	G protein-coupled receptor, family C, group 5, member C	NT2	teratocarcinoma		NT2RI2	EK1	NM_022036.2	NP_071319.2	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
RIKEN	H06D072L22	H06D072L22	RIKEN	W01A092H02	pENTR-TOPO		6468						-	-	brain	brain	DH10B			
RIKEN	H06D072L22	H06D072L22	RIKEN	W01A092H10	pENTR-TOPO		6468						-	-	brain	brain	DH10B			
RIKEN	H06D072L22	H06D072L22	RIKEN	W01A092H24	pENTR-TOPO		6468						-	-	brain	brain	DH10B			
RIKEN	BC067436	IRAK172I19	MGC	W01A092I07	pENTR-TOPO	21939		CYP3A7	1551	AAH67436.1	Hs.111944	Cytochrome P450, family 3, subfamily A, polypeptide 7			PCR rescued clones	NIH_MGC_195	DH10B	NM_000765.2	NP_000756.1	REVIEWED	C	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	BC067436	IRAK172I19	MGC	W01A092I19	pENTR-TOPO	21939		CYP3A7	1551	AAH67436.1	Hs.111944	Cytochrome P450, family 3, subfamily A, polypeptide 7			PCR rescued clones	NIH_MGC_195	DH10B	NM_000765.2	NP_000756.1	REVIEWED	C	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	BC067436	IRAK172I19	MGC	W01A092I21	pENTR-TOPO	21939		CYP3A7	1551	AAH67436.1	Hs.111944	Cytochrome P450, family 3, subfamily A, polypeptide 7			PCR rescued clones	NIH_MGC_195	DH10B	NM_000765.2	NP_000756.1	REVIEWED	C	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	BC067436	IRAK172I19	MGC	W01A092I23	pENTR-TOPO	21939		CYP3A7	1551	AAH67436.1	Hs.111944	Cytochrome P450, family 3, subfamily A, polypeptide 7			PCR rescued clones	NIH_MGC_195	DH10B	NM_000765.2	NP_000756.1	REVIEWED	C	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	BC036890	IRAK078N03	MGC	W01A092K07	pENTR-TOPO	683		GRHL3	57822	AAH36890.1	Hs.657920	Grainyhead-like 3 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198174.1	NP_937817.2	REVIEWED	C	1.000	1.000	509	1531	2	1528	509	1	509
RIKEN	BC036890	IRAK078N03	MGC	W01A092K17	pENTR-TOPO	683		GRHL3	57822	AAH36890.1	Hs.657920	Grainyhead-like 3 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198174.1	NP_937817.2	REVIEWED	C	1.000	1.000	509	1531	2	1528	509	1	509
RIKEN	BC017715	IRAK022I18	MGC	W01A092L02	pENTR-TOPO	20337		MAP3K7	6885	AAH17715.1	Hs.719192	Mitogen-activated protein kinase kinase kinase 7			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003188.2	NP_003179.1	REVIEWED	OK	1.000	1.000	579	1740	1	1737	579	1	579
RIKEN	BC017715	IRAK022I18	MGC	W01A092L06	pENTR-TOPO	20337		MAP3K7	6885	AAH17715.1	Hs.719192	Mitogen-activated protein kinase kinase kinase 7			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003188.2	NP_003179.1	REVIEWED	OK	1.000	1.000	579	1740	1	1737	579	1	579
RIKEN	H013088J02	H013088J02	RIKEN	W01A092M09	pENTR-TOPO		20133	BMP6	654		Hs.285671	Bone morphogenetic protein 6	-	-	testis	testis	DH10B	NM_001718.4	NP_001709.1	REVIEWED	C	1.000	1.000	513	1542	1	1539	513	1	513
RIKEN	H013088J02	H013088J02	RIKEN	W01A092M19	pENTR-TOPO		20133	BMP6	654		Hs.285671	Bone morphogenetic protein 6	-	-	testis	testis	DH10B	NM_001718.4	NP_001709.1	REVIEWED	C	1.000	1.000	513	1542	1	1539	513	1	513
RIKEN	H013088J02	H013088J02	RIKEN	W01A092M23	pENTR-TOPO		20133	BMP6	654		Hs.285671	Bone morphogenetic protein 6	-	-	testis	testis	DH10B	NM_001718.4	NP_001709.1	REVIEWED	C	1.000	1.000	513	1542	1	1539	513	1	513
RIKEN	BC046099	IRAK107L02	MGC	W01A092N10	pENTR-TOPO	10017		TAF15	8148	AAH46099.2	Hs.402752	TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_139215.1	NP_631961.1	REVIEWED	C	1.000	1.000	592	1779	1	1776	592	1	592
RIKEN	BC046099	IRAK107L02	MGC	W01A092N18	pENTR-TOPO	10017		TAF15	8148	AAH46099.2	Hs.402752	TAF15 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 68kDa			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_139215.1	NP_631961.1	REVIEWED	C	1.000	1.000	592	1779	1	1776	592	1	592
RIKEN	AK056319	flj0003c07	FLJ	W01A092O01	pENTR-TOPO	21806		FAM126A	84668	BAB71148.1	Hs.85603	Family with sequence similarity 126, member A	NT2	teratocarcinoma		NT2RI2	EK1	NM_032581.3	NP_115970.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	AK056319	flj0003c07	FLJ	W01A092O15	pENTR-TOPO	21806		FAM126A	84668	BAB71148.1	Hs.85603	Family with sequence similarity 126, member A	NT2	teratocarcinoma		NT2RI2	EK1	NM_032581.3	NP_115970.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	AK056319	flj0003c07	FLJ	W01A092O17	pENTR-TOPO	21806		FAM126A	84668	BAB71148.1	Hs.85603	Family with sequence similarity 126, member A	NT2	teratocarcinoma		NT2RI2	EK1	NM_032581.3	NP_115970.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	AK056319	flj0003c07	FLJ	W01A092O19	pENTR-TOPO	21806		FAM126A	84668	BAB71148.1	Hs.85603	Family with sequence similarity 126, member A	NT2	teratocarcinoma		NT2RI2	EK1	NM_032581.3	NP_115970.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	AK024089	flj0028h23	FLJ	W01A092P08	pENTR-TOPO	11374		CRTC1	23373	BAB14822.1	Hs.371096	CREB regulated transcription coactivator 1				HEMBA1	EK1	NM_015321.2	NP_056136.2	VALIDATED	Pgs	0.935	0.984	586	1782	1	1671	634	1	586
RIKEN	AK024089	flj0028h23	FLJ	W01A092P18	pENTR-TOPO	11374		CRTC1	23373	BAB14822.1	Hs.371096	CREB regulated transcription coactivator 1				HEMBA1	EK1	NM_015321.2	NP_056136.2	VALIDATED	Pgs	0.935	0.984	586	1782	1	1671	634	1	586
RIKEN	AK024089	flj0028h23	FLJ	W01A092P20	pENTR-TOPO	11374		CRTC1	23373	BAB14822.1	Hs.371096	CREB regulated transcription coactivator 1				HEMBA1	EK1	NM_015321.2	NP_056136.2	VALIDATED	Pgs	0.935	0.984	586	1782	1	1671	634	1	586
RIKEN	BC002873	IRAL015C23	MGC	W01A093A04	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC002873	IRAL015C23	MGC	W01A093A06	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC002873	IRAL015C23	MGC	W01A093A08	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC002873	IRAL015C23	MGC	W01A093A10	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC027952	IRAK049J02	MGC	W01A093A11	pENTR-TOPO	8941		CCL22	6367	AAH27952.1	Hs.534347	Chemokine (C-C motif) ligand 22			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002990.3	NP_002981.2	REVIEWED	Cs	0.989	0.989	93	282	1	279	93	1	93
RIKEN	BC002873	IRAL015C23	MGC	W01A093A12	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC014045	IRAL028B12	MGC	W01A093A16	pENTR-TOPO	4728		CYBASC3	220002	AAH14045.2	Hs.22546	Cytochrome b, ascorbate dependent 3			Brain, neuroblastoma	NIH_MGC_19		NM_153611.3	NP_705839.2	PROVISIONAL	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC014045	IRAL028B12	MGC	W01A093A18	pENTR-TOPO	4728		CYBASC3	220002	AAH14045.2	Hs.22546	Cytochrome b, ascorbate dependent 3			Brain, neuroblastoma	NIH_MGC_19		NM_153611.3	NP_705839.2	PROVISIONAL	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC014045	IRAL028B12	MGC	W01A093A20	pENTR-TOPO	4728		CYBASC3	220002	AAH14045.2	Hs.22546	Cytochrome b, ascorbate dependent 3			Brain, neuroblastoma	NIH_MGC_19		NM_153611.3	NP_705839.2	PROVISIONAL	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC003370	IRAK003G17	MGC	W01A093A21	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	AK092672	flj0003l03	FLJ	W01A093B02	pENTR-TOPO	1884		ANP32E	81611	BAC03942.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E				PUAEN1	EK1	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC015831	IRAL038P07	MGC	W01A093B04	pENTR-TOPO	16868		DNASE1L3	1776	AAH15831.1	Hs.476453	Deoxyribonuclease I-like 3			Liver	NIH_MGC_76	DH10B	NM_004944.2	NP_004935.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC022816	IRAL042K18	MGC	W01A093B07	pENTR-TOPO	8235		SNRPA1	6627	AAH22816.1	Hs.528763	Small nuclear ribonucleoprotein polypeptide A'			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003090.2	NP_003081.2	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC015831	IRAL038P07	MGC	W01A093B08	pENTR-TOPO	16868		DNASE1L3	1776	AAH15831.1	Hs.476453	Deoxyribonuclease I-like 3			Liver	NIH_MGC_76	DH10B	NM_004944.2	NP_004935.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC002563	IRAL004N07	MGC	W01A093B10	pENTR-TOPO	1642		SLC39A1	27173	AAH02563.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC002563	IRAL004N07	MGC	W01A093B12	pENTR-TOPO	1642		SLC39A1	27173	AAH02563.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC022816	IRAL042K18	MGC	W01A093B13	pENTR-TOPO	8235		SNRPA1	6627	AAH22816.1	Hs.528763	Small nuclear ribonucleoprotein polypeptide A'			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003090.2	NP_003081.2	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC002563	IRAL004N07	MGC	W01A093B14	pENTR-TOPO	1642		SLC39A1	27173	AAH02563.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC002563	IRAL004N07	MGC	W01A093B18	pENTR-TOPO	1642		SLC39A1	27173	AAH02563.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC022816	IRAL042K18	MGC	W01A093B19	pENTR-TOPO	8235		SNRPA1	6627	AAH22816.1	Hs.528763	Small nuclear ribonucleoprotein polypeptide A'			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003090.2	NP_003081.2	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC002563	IRAL004N07	MGC	W01A093B20	pENTR-TOPO	1642		SLC39A1	27173	AAH02563.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC022816	IRAL042K18	MGC	W01A093B21	pENTR-TOPO	8235		SNRPA1	6627	AAH22816.1	Hs.528763	Small nuclear ribonucleoprotein polypeptide A'			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003090.2	NP_003081.2	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC002563	IRAL004N07	MGC	W01A093B24	pENTR-TOPO	1642		SLC39A1	27173	AAH02563.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC003370	IRAK003G17	MGC	W01A093C01	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC014045	IRAL028B12	MGC	W01A093C02	pENTR-TOPO	4728		CYBASC3	220002	AAH14045.2	Hs.22546	Cytochrome b, ascorbate dependent 3			Brain, neuroblastoma	NIH_MGC_19		NM_153611.3	NP_705839.2	PROVISIONAL	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC005217	IRAL016F05	MGC	W01A093C04	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC003370	IRAK003G17	MGC	W01A093C05	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC005217	IRAL016F05	MGC	W01A093C06	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC005217	IRAL016F05	MGC	W01A093C08	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC005217	IRAL016F05	MGC	W01A093C10	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC005217	IRAL016F05	MGC	W01A093C12	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC003370	IRAK003G17	MGC	W01A093C13	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC003370	IRAK003G17	MGC	W01A093C15	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC003370	IRAK003G17	MGC	W01A093C17	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC005217	IRAL016F05	MGC	W01A093C18	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC003370	IRAK003G17	MGC	W01A093C19	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC005217	IRAL016F05	MGC	W01A093C20	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC022564	IRAK032F19	MGC	W01A093C23	pENTR-TOPO	3223		IKZF5	64376	AAH22564	Hs.501289	IKAROS family zinc finger 5 (Pegasus)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_022466.5	NP_071911.3	PROVISIONAL	Cfs	0.995	0.995	419	1263	1	1256	419	1	419
RIKEN	BC022816	IRAL042K18	MGC	W01A093D01	pENTR-TOPO	8235		SNRPA1	6627	AAH22816.1	Hs.528763	Small nuclear ribonucleoprotein polypeptide A'			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003090.2	NP_003081.2	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	BC003380	IRAK003J13	MGC	W01A093D02	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC010890	IRAL019K17	MGC	W01A093D03	pENTR-TOPO	10389		DERL2	51009	AAH10890.1	Hs.286131	Der1-like domain family, member 2			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_016041.3	NP_057125.2	PROVISIONAL	C	1.000	1.000	239	720	1	717	239	1	239
RIKEN	AK002052	flj0020k04	FLJ	W01A093D09	pENTR-TOPO	15004		C20orf46	55321	BAA92058.1	Hs.516834	Chromosome 20 open reading frame 46				PLACE1	EK1	NM_018354.1	NP_060824.1	PREDICTED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC008843	IRAL020I13	MGC	W01A093D10	pENTR-TOPO	23		SLC25A44	9673	AAH08843.1	Hs.532375	Solute carrier family 25, member 44			Brain, neuroblastoma	NIH_MGC_19		NM_014655.2	NP_055470.1	VALIDATED	C	1.000	1.000	314	945	1	942	314	1	314
RIKEN	AK002052	flj0020k04	FLJ	W01A093D11	pENTR-TOPO	15004		C20orf46	55321	BAA92058.1	Hs.516834	Chromosome 20 open reading frame 46				PLACE1	EK1	NM_018354.1	NP_060824.1	PREDICTED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	AK002052	flj0020k04	FLJ	W01A093D19	pENTR-TOPO	15004		C20orf46	55321	BAA92058.1	Hs.516834	Chromosome 20 open reading frame 46				PLACE1	EK1	NM_018354.1	NP_060824.1	PREDICTED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC003380	IRAK003J13	MGC	W01A093D20	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC063241	IRAK110N15	MGC	W01A093D21	pENTR-TOPO	18687		SFXN1	94081	AAH63241.1	Hs.369440	Sideroflexin 1				Lupski_sympathetic_trunk	DH10B	NM_022754.5	NP_073591.2	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC063241	IRAK110N15	MGC	W01A093D23	pENTR-TOPO	18687		SFXN1	94081	AAH63241.1	Hs.369440	Sideroflexin 1				Lupski_sympathetic_trunk	DH10B	NM_022754.5	NP_073591.2	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC003380	IRAK003J13	MGC	W01A093D24	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC029485	IRAK048H14	MGC	W01A093E06	pENTR-TOPO	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
RIKEN	BC029485	IRAK048H14	MGC	W01A093E08	pENTR-TOPO	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
RIKEN	BC029485	IRAK048H14	MGC	W01A093E10	pENTR-TOPO	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
RIKEN	BC022564	IRAK032F19	MGC	W01A093E15	pENTR-TOPO	3223		IKZF5	64376	AAH22564	Hs.501289	IKAROS family zinc finger 5 (Pegasus)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_022466.5	NP_071911.3	PROVISIONAL	Cfs	0.995	0.995	419	1263	1	1256	419	1	419
RIKEN	BC001745	IRAL008G03	MGC	W01A093E16	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC022564	IRAK032F19	MGC	W01A093E17	pENTR-TOPO	3223		IKZF5	64376	AAH22564	Hs.501289	IKAROS family zinc finger 5 (Pegasus)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_022466.5	NP_071911.3	PROVISIONAL	Cfs	0.995	0.995	419	1263	1	1256	419	1	419
RIKEN	BC001745	IRAL008G03	MGC	W01A093E18	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC001745	IRAL008G03	MGC	W01A093E22	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC001745	IRAL008G03	MGC	W01A093E24	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC003380	IRAK003J13	MGC	W01A093F02	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC063241	IRAK110N15	MGC	W01A093F05	pENTR-TOPO	18687		SFXN1	94081	AAH63241.1	Hs.369440	Sideroflexin 1				Lupski_sympathetic_trunk	DH10B	NM_022754.5	NP_073591.2	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC003380	IRAK003J13	MGC	W01A093F06	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC063241	IRAK110N15	MGC	W01A093F07	pENTR-TOPO	18687		SFXN1	94081	AAH63241.1	Hs.369440	Sideroflexin 1				Lupski_sympathetic_trunk	DH10B	NM_022754.5	NP_073591.2	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC003380	IRAK003J13	MGC	W01A093F10	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC008843	IRAL020I13	MGC	W01A093F12	pENTR-TOPO	23		SLC25A44	9673	AAH08843.1	Hs.532375	Solute carrier family 25, member 44			Brain, neuroblastoma	NIH_MGC_19		NM_014655.2	NP_055470.1	VALIDATED	C	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC009956	IRAL020P04	MGC	W01A093F15	pENTR-TOPO	20767		HLA-DPA1	3113	AAH09956.1	Hs.347270	Major histocompatibility complex, class II, DP alpha 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_033554.2	NP_291032.2	REVIEWED		0.973	0.973	260	783	1	780	260	1	260
RIKEN	AK090974	flj0011k04	FLJ	W01A093F17	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC026257	IRAL037C08	MGC	W01A093F18	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC026257	IRAL037C08	MGC	W01A093F20	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	AK090974	flj0011k04	FLJ	W01A093F21	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC026257	IRAL037C08	MGC	W01A093F22	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC009956	IRAL020P04	MGC	W01A093F23	pENTR-TOPO	20767		HLA-DPA1	3113	AAH09956.1	Hs.347270	Major histocompatibility complex, class II, DP alpha 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_033554.2	NP_291032.2	REVIEWED		0.973	0.973	260	783	1	780	260	1	260
RIKEN	BC026257	IRAL037C08	MGC	W01A093F24	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC001745	IRAL008G03	MGC	W01A093G02	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC001745	IRAL008G03	MGC	W01A093G04	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC000936	IRAK003B12	MGC	W01A093G08	pENTR-TOPO	22115		TMUB1	83590	AAH00936.1	Hs.647096	Transmembrane and ubiquitin-like domain containing 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001136044.1	NP_001129516.1	VALIDATED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC015938	IRAK015O20	MGC	W01A093G12	pENTR-TOPO	14799		RBBP9	10741	AAH15938.1	Hs.69330	Retinoblastoma binding protein 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006606.2	NP_006597.2	REVIEWED	C	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC015938	IRAK015O20	MGC	W01A093G20	pENTR-TOPO	14799		RBBP9	10741	AAH15938.1	Hs.69330	Retinoblastoma binding protein 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006606.2	NP_006597.2	REVIEWED	C	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC031661	IRAK051D18	MGC	W01A093G21	pENTR-TOPO	21195		LOC389458	389458	AAH31661					Brain, adult medulla	NIH_MGC_119	DH10B	NM_203393.1	NP_976327.1	VALIDATED	Cs	0.982	0.982	111	336	1	333	111	1	111
RIKEN	BC026257	IRAL037C08	MGC	W01A093H04	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	AK090974	flj0011k04	FLJ	W01A093H05	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC026257	IRAL037C08	MGC	W01A093H06	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC009956	IRAL020P04	MGC	W01A093H07	pENTR-TOPO	20767		HLA-DPA1	3113	AAH09956.1	Hs.347270	Major histocompatibility complex, class II, DP alpha 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_033554.2	NP_291032.2	REVIEWED		0.973	0.973	260	783	1	780	260	1	260
RIKEN	AK090974	flj0011k04	FLJ	W01A093H09	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC026257	IRAL037C08	MGC	W01A093H10	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC026257	IRAL037C08	MGC	W01A093H12	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	AK090974	flj0011k04	FLJ	W01A093H13	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC009956	IRAL020P04	MGC	W01A093H15	pENTR-TOPO	20767		HLA-DPA1	3113	AAH09956.1	Hs.347270	Major histocompatibility complex, class II, DP alpha 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_033554.2	NP_291032.2	REVIEWED		0.973	0.973	260	783	1	780	260	1	260
RIKEN	BC003557	IRAL006H23	MGC	W01A093H16	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	AK090974	flj0011k04	FLJ	W01A093H17	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC006991	IRAL016E19	MGC	W01A093H18	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC006991	IRAL016E19	MGC	W01A093H20	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC009956	IRAL020P04	MGC	W01A093H21	pENTR-TOPO	20767		HLA-DPA1	3113	AAH09956.1	Hs.347270	Major histocompatibility complex, class II, DP alpha 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_033554.2	NP_291032.2	REVIEWED		0.973	0.973	260	783	1	780	260	1	260
RIKEN	BC003557	IRAL006H23	MGC	W01A093H24	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC007200	IRAL018J10	MGC	W01A093I02	pENTR-TOPO	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC007200	IRAL018J10	MGC	W01A093I08	pENTR-TOPO	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC031661	IRAK051D18	MGC	W01A093I09	pENTR-TOPO	21195		LOC389458	389458	AAH31661					Brain, adult medulla	NIH_MGC_119	DH10B	NM_203393.1	NP_976327.1	VALIDATED	Cs	0.982	0.982	111	336	1	333	111	1	111
RIKEN	BC007200	IRAL018J10	MGC	W01A093I10	pENTR-TOPO	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC007200	IRAL018J10	MGC	W01A093I12	pENTR-TOPO	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC007200	IRAL018J10	MGC	W01A093I16	pENTR-TOPO	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC003513	IRAL013M21	MGC	W01A093I17	pENTR-TOPO	19191		CXCL14	9547	AAH03513.1	Hs.483444	Chemokine (C-X-C motif) ligand 14			Pancreas, adenocarcinoma	NIH_MGC_39		NM_004887.4	NP_004878.2	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
RIKEN	BC000341	IRAL001K05	MGC	W01A093I20	pENTR-TOPO	2070		SSR2	6746	AAH00341.2	Hs.74564	Signal sequence receptor, beta (translocon-associated protein beta)			Lung, small cell carcinoma	NIH_MGC_7		NM_003145.3	NP_003136.1	REVIEWED	OK	1.000	1.000	183	561	10	558	183	1	183
RIKEN	BC010038	IRAL027E21	MGC	W01A093I24	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC003557	IRAL006H23	MGC	W01A093J02	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC006991	IRAL016E19	MGC	W01A093J04	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC003557	IRAL006H23	MGC	W01A093J06	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	AK090974	flj0011k04	FLJ	W01A093J07	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC006991	IRAL016E19	MGC	W01A093J10	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC022091	IRAL010P10	MGC	W01A093J11	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC003557	IRAL006H23	MGC	W01A093J12	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC022091	IRAL010P10	MGC	W01A093J13	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC006991	IRAL016E19	MGC	W01A093J14	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC022091	IRAL010P10	MGC	W01A093J15	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC003557	IRAL006H23	MGC	W01A093J16	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC022091	IRAL010P10	MGC	W01A093J17	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC006991	IRAL016E19	MGC	W01A093J18	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC006991	IRAL016E19	MGC	W01A093J20	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC015479	IRAK022M18	MGC	W01A093J22	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC022091	IRAL010P10	MGC	W01A093J23	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC003513	IRAL013M21	MGC	W01A093K03	pENTR-TOPO	19191		CXCL14	9547	AAH03513.1	Hs.483444	Chemokine (C-X-C motif) ligand 14			Pancreas, adenocarcinoma	NIH_MGC_39		NM_004887.4	NP_004878.2	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
RIKEN	BC020866	IRAL036E23	MGC	W01A093K06	pENTR-TOPO	15403		CLDN8	9073	AAH20866.1	Hs.162209	Claudin 8			Kidney	NIH_MGC_75	DH10B	NM_199328.1	NP_955360.1	VALIDATED	C	1.000	1.000	225	678	1	675	225	1	225
RIKEN	BC003513	IRAL013M21	MGC	W01A093K07	pENTR-TOPO	19191		CXCL14	9547	AAH03513.1	Hs.483444	Chemokine (C-X-C motif) ligand 14			Pancreas, adenocarcinoma	NIH_MGC_39		NM_004887.4	NP_004878.2	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
RIKEN	BC010038	IRAL027E21	MGC	W01A093K08	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC010038	IRAL027E21	MGC	W01A093K12	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC002764	IRAL012O14	MGC	W01A093K15	pENTR-TOPO	17999		WHSC2	7469	AAH02764.2	Hs.21771	Wolf-Hirschhorn syndrome candidate 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_005663.3	NP_005654.3	REVIEWED	P	1.000	1.000	528	1587	1	1584	539	12	539
RIKEN	BC010038	IRAL027E21	MGC	W01A093K16	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC020866	IRAL036E23	MGC	W01A093K18	pENTR-TOPO	15403		CLDN8	9073	AAH20866.1	Hs.162209	Claudin 8			Kidney	NIH_MGC_75	DH10B	NM_199328.1	NP_955360.1	VALIDATED	C	1.000	1.000	225	678	1	675	225	1	225
RIKEN	BC062370	IRAL050P23	MGC	W01A093K19	pENTR-TOPO	21054		BRI3	25798	AAH62370.1	Hs.567438	Brain protein I3			Ovary, teratocarcinoma	NIH_MGC_109		NM_015379.4	NP_056194.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC020866	IRAL036E23	MGC	W01A093K20	pENTR-TOPO	15403		CLDN8	9073	AAH20866.1	Hs.162209	Claudin 8			Kidney	NIH_MGC_75	DH10B	NM_199328.1	NP_955360.1	VALIDATED	C	1.000	1.000	225	678	1	675	225	1	225
RIKEN	BC062370	IRAL050P23	MGC	W01A093K21	pENTR-TOPO	21054		BRI3	25798	AAH62370.1	Hs.567438	Brain protein I3			Ovary, teratocarcinoma	NIH_MGC_109		NM_015379.4	NP_056194.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC010038	IRAL027E21	MGC	W01A093K22	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC015479	IRAK022M18	MGC	W01A093L02	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC022091	IRAL010P10	MGC	W01A093L03	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC015479	IRAK022M18	MGC	W01A093L04	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC015479	IRAK022M18	MGC	W01A093L10	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC031265	IRAK063J01	MGC	W01A093L11	pENTR-TOPO	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC003097	IRAL006B14	MGC	W01A093L14	pENTR-TOPO	10303		ICAM2	3384	AAH03097.1	Hs.431460	Intercellular adhesion molecule 2			Brain, neuroblastoma	NIH_MGC_19		NM_001099786.1	NP_001093256.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC031265	IRAK063J01	MGC	W01A093L15	pENTR-TOPO	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC019252	IRAL006N20	MGC	W01A093L19	pENTR-TOPO	2844		BAMBI	25805	AAH19252.1	Hs.533336	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012342.2	NP_036474.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC003097	IRAL006B14	MGC	W01A093L22	pENTR-TOPO	10303		ICAM2	3384	AAH03097.1	Hs.431460	Intercellular adhesion molecule 2			Brain, neuroblastoma	NIH_MGC_19		NM_001099786.1	NP_001093256.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC019252	IRAL006N20	MGC	W01A093L23	pENTR-TOPO	2844		BAMBI	25805	AAH19252.1	Hs.533336	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012342.2	NP_036474.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC021993	IRAL032J12	MGC	W01A093L24	pENTR-TOPO	19355		GNB2L1	10399	AAH21993.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC062370	IRAL050P23	MGC	W01A093M03	pENTR-TOPO	21054		BRI3	25798	AAH62370.1	Hs.567438	Brain protein I3			Ovary, teratocarcinoma	NIH_MGC_109		NM_015379.4	NP_056194.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC020866	IRAL036E23	MGC	W01A093M04	pENTR-TOPO	15403		CLDN8	9073	AAH20866.1	Hs.162209	Claudin 8			Kidney	NIH_MGC_75	DH10B	NM_199328.1	NP_955360.1	VALIDATED	C	1.000	1.000	225	678	1	675	225	1	225
RIKEN	BC062370	IRAL050P23	MGC	W01A093M05	pENTR-TOPO	21054		BRI3	25798	AAH62370.1	Hs.567438	Brain protein I3			Ovary, teratocarcinoma	NIH_MGC_109		NM_015379.4	NP_056194.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC022064	IRAK046O03	MGC	W01A093M07	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC009177	IRAL003K02	MGC	W01A093M08	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC022064	IRAK046O03	MGC	W01A093M09	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC022064	IRAK046O03	MGC	W01A093M11	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC022064	IRAK046O03	MGC	W01A093M13	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC022064	IRAK046O03	MGC	W01A093M15	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC009177	IRAL003K02	MGC	W01A093M16	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC022064	IRAK046O03	MGC	W01A093M17	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC009177	IRAL003K02	MGC	W01A093M18	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC022064	IRAK046O03	MGC	W01A093M19	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC009177	IRAL003K02	MGC	W01A093M20	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC009177	IRAL003K02	MGC	W01A093M22	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC031265	IRAK063J01	MGC	W01A093N01	pENTR-TOPO	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC021993	IRAL032J12	MGC	W01A093N02	pENTR-TOPO	19355		GNB2L1	10399	AAH21993.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC003097	IRAL006B14	MGC	W01A093N04	pENTR-TOPO	10303		ICAM2	3384	AAH03097.1	Hs.431460	Intercellular adhesion molecule 2			Brain, neuroblastoma	NIH_MGC_19		NM_001099786.1	NP_001093256.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC019252	IRAL006N20	MGC	W01A093N05	pENTR-TOPO	2844		BAMBI	25805	AAH19252.1	Hs.533336	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012342.2	NP_036474.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC021993	IRAL032J12	MGC	W01A093N06	pENTR-TOPO	19355		GNB2L1	10399	AAH21993.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC031265	IRAK063J01	MGC	W01A093N07	pENTR-TOPO	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC019252	IRAL006N20	MGC	W01A093N09	pENTR-TOPO	2844		BAMBI	25805	AAH19252.1	Hs.533336	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012342.2	NP_036474.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC021993	IRAL032J12	MGC	W01A093N10	pENTR-TOPO	19355		GNB2L1	10399	AAH21993.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC031265	IRAK063J01	MGC	W01A093N11	pENTR-TOPO	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC021993	IRAL032J12	MGC	W01A093N12	pENTR-TOPO	19355		GNB2L1	10399	AAH21993.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC003097	IRAL006B14	MGC	W01A093N14	pENTR-TOPO	10303		ICAM2	3384	AAH03097.1	Hs.431460	Intercellular adhesion molecule 2			Brain, neuroblastoma	NIH_MGC_19		NM_001099786.1	NP_001093256.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC021993	IRAL032J12	MGC	W01A093N16	pENTR-TOPO	19355		GNB2L1	10399	AAH21993.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC014303	IRAL025F01	MGC	W01A093N17	pENTR-TOPO	1642		SLC39A1	27173	AAH14303.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Lung, small cell carcinoma	NIH_MGC_7		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC014303	IRAL025F01	MGC	W01A093N21	pENTR-TOPO	1642		SLC39A1	27173	AAH14303.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Lung, small cell carcinoma	NIH_MGC_7		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC000214	IRAL010K01	MGC	W01A093N22	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC022064	IRAK046O03	MGC	W01A093O01	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC022064	IRAK046O03	MGC	W01A093O03	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC013297	IRAL011O15	MGC	W01A093O05	pENTR-TOPO	10658		CD7	924	AAH13297.1	Hs.36972	CD7 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006137.6	NP_006128.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC011678	IRAL026N22	MGC	W01A093O08	pENTR-TOPO	2845		PGAM1	5223	AAH11678.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC013297	IRAL011O15	MGC	W01A093O09	pENTR-TOPO	10658		CD7	924	AAH13297.1	Hs.36972	CD7 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006137.6	NP_006128.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC013297	IRAL011O15	MGC	W01A093O11	pENTR-TOPO	10658		CD7	924	AAH13297.1	Hs.36972	CD7 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006137.6	NP_006128.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC013297	IRAL011O15	MGC	W01A093O13	pENTR-TOPO	10658		CD7	924	AAH13297.1	Hs.36972	CD7 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006137.6	NP_006128.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC011678	IRAL026N22	MGC	W01A093O14	pENTR-TOPO	2845		PGAM1	5223	AAH11678.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC013297	IRAL011O15	MGC	W01A093O15	pENTR-TOPO	10658		CD7	924	AAH13297.1	Hs.36972	CD7 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006137.6	NP_006128.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC011678	IRAL026N22	MGC	W01A093O16	pENTR-TOPO	2845		PGAM1	5223	AAH11678.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC013297	IRAL011O15	MGC	W01A093O17	pENTR-TOPO	10658		CD7	924	AAH13297.1	Hs.36972	CD7 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006137.6	NP_006128.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC013297	IRAL011O15	MGC	W01A093O19	pENTR-TOPO	10658		CD7	924	AAH13297.1	Hs.36972	CD7 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006137.6	NP_006128.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC002873	IRAL015C23	MGC	W01A093O21	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC028210	IRAK062H10	MGC	W01A093O22	pENTR-TOPO	12914		ICOS	29851	AAH28210.1	Hs.56247	Inducible T-cell co-stimulator			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_012092.2	NP_036224.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC002873	IRAL015C23	MGC	W01A093O23	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC000214	IRAL010K01	MGC	W01A093P02	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC000214	IRAL010K01	MGC	W01A093P06	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	AK092672	flj0003l03	FLJ	W01A093P07	pENTR-TOPO	1884		ANP32E	81611	BAC03942.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E				PUAEN1	EK1	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC000214	IRAL010K01	MGC	W01A093P10	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC000214	IRAL010K01	MGC	W01A093P14	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC000214	IRAL010K01	MGC	W01A093P16	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC015831	IRAL038P07	MGC	W01A093P17	pENTR-TOPO	16868		DNASE1L3	1776	AAH15831.1	Hs.476453	Deoxyribonuclease I-like 3			Liver	NIH_MGC_76	DH10B	NM_004944.2	NP_004935.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC007725	IRAL017O04	MGC	W01A093P18	pENTR-TOPO	22562		CLN8	2055	AAH07725.1	Hs.127675	Ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_018941.3	NP_061764.2	REVIEWED	C	1.000	1.000	286	861	1	858	286	1	286
RIKEN	BC000214	IRAL010K01	MGC	W01A093P20	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC015831	IRAL038P07	MGC	W01A093P21	pENTR-TOPO	16868		DNASE1L3	1776	AAH15831.1	Hs.476453	Deoxyribonuclease I-like 3			Liver	NIH_MGC_76	DH10B	NM_004944.2	NP_004935.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	AK092672	flj0003l03	FLJ	W01A093P23	pENTR-TOPO	1884		ANP32E	81611	BAC03942.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E				PUAEN1	EK1	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC006286	IRAL015H08	MGC	W01A094A01	pENTR-TOPO	369		DUSP12	11266	AAH06286.1	Hs.416216	Dual specificity phosphatase 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_007240.1	NP_009171.1	REVIEWED	OK	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC006286	IRAL015H08	MGC	W01A094A03	pENTR-TOPO	369		DUSP12	11266	AAH06286.1	Hs.416216	Dual specificity phosphatase 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_007240.1	NP_009171.1	REVIEWED	OK	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC001289	IRAK004L05	MGC	W01A094A04	pENTR-TOPO	13460		SSB	6741	AAH01289.1	Hs.632535	Sjogren syndrome antigen B (autoantigen La)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003142.3	NP_003133.1	PROVISIONAL	C	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	BC006286	IRAL015H08	MGC	W01A094A05	pENTR-TOPO	369		DUSP12	11266	AAH06286.1	Hs.416216	Dual specificity phosphatase 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_007240.1	NP_009171.1	REVIEWED	OK	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC033571	IRAL017L19	MGC	W01A094A06	pENTR-TOPO	5834		LPAR5	57121	AAH33571.1	Hs.155538	Lysophosphatidic acid receptor 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020400.5	NP_065133.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC006286	IRAL015H08	MGC	W01A094A09	pENTR-TOPO	369		DUSP12	11266	AAH06286.1	Hs.416216	Dual specificity phosphatase 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_007240.1	NP_009171.1	REVIEWED	OK	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC006286	IRAL015H08	MGC	W01A094A11	pENTR-TOPO	369		DUSP12	11266	AAH06286.1	Hs.416216	Dual specificity phosphatase 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_007240.1	NP_009171.1	REVIEWED	OK	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC033571	IRAL017L19	MGC	W01A094A12	pENTR-TOPO	5834		LPAR5	57121	AAH33571.1	Hs.155538	Lysophosphatidic acid receptor 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020400.5	NP_065133.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC006286	IRAL015H08	MGC	W01A094A15	pENTR-TOPO	369		DUSP12	11266	AAH06286.1	Hs.416216	Dual specificity phosphatase 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_007240.1	NP_009171.1	REVIEWED	OK	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC001769	IRAL006P09	MGC	W01A094A16	pENTR-TOPO	9682		TRAF4	9618	AAH01769.1	Hs.8375	TNF receptor-associated factor 4			Eye, retinoblastoma	NIH_MGC_16		NM_004295.3	NP_004286.2	REVIEWED	OK	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC022567	IRAK032K20	MGC	W01A094A20	pENTR-TOPO	4391		CHST1	8534	AAH22567.1	Hs.104576	Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003654.4	NP_003645.1	VALIDATED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	BC022567	IRAK032K20	MGC	W01A094A24	pENTR-TOPO	4391		CHST1	8534	AAH22567.1	Hs.104576	Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003654.4	NP_003645.1	VALIDATED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	BC057800	IRAK133B06	MGC	W01A094B02	pENTR-TOPO	5312		IRAK3	11213	AAH57800.1	Hs.369265	Interleukin-1 receptor-associated kinase 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_007199.2	NP_009130.2	VALIDATED	Cs	0.998	0.998	596	1791	1	1788	596	1	596
RIKEN	BC057800	IRAK133B06	MGC	W01A094B04	pENTR-TOPO	5312		IRAK3	11213	AAH57800.1	Hs.369265	Interleukin-1 receptor-associated kinase 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_007199.2	NP_009130.2	VALIDATED	Cs	0.998	0.998	596	1791	1	1788	596	1	596
RIKEN	BC000479	IRAL001P05	MGC	W01A094B05	pENTR-TOPO	7515		AKT1	207	AAH00479.1	Hs.525622	V-akt murine thymoma viral oncogene homolog 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001014431.1	NP_001014431.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC057800	IRAK133B06	MGC	W01A094B06	pENTR-TOPO	5312		IRAK3	11213	AAH57800.1	Hs.369265	Interleukin-1 receptor-associated kinase 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_007199.2	NP_009130.2	VALIDATED	Cs	0.998	0.998	596	1791	1	1788	596	1	596
RIKEN	BC017380	IRAL003F23	MGC	W01A094B07	pENTR-TOPO	4535		ZNF259	8882	AAH17380.1	Hs.7165	Zinc finger protein 259			Skin, melanotic melanoma.	NIH_MGC_20		NM_003904.3	NP_003895.1	PROVISIONAL	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC057800	IRAK133B06	MGC	W01A094B12	pENTR-TOPO	5312		IRAK3	11213	AAH57800.1	Hs.369265	Interleukin-1 receptor-associated kinase 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_007199.2	NP_009130.2	VALIDATED	Cs	0.998	0.998	596	1791	1	1788	596	1	596
RIKEN	BC053603	IRAK115I08	MGC	W01A094B14	pENTR-TOPO	1959		CLK2	1196	AAH53603.1	Hs.73986	CDC-like kinase 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_003993.2	NP_003984.2	REVIEWED	Cg	0.998	1.000	499	1500	1	1497	498	1	498
RIKEN	BC000479	IRAL001P05	MGC	W01A094B19	pENTR-TOPO	7515		AKT1	207	AAH00479.1	Hs.525622	V-akt murine thymoma viral oncogene homolog 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001014431.1	NP_001014431.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC017380	IRAL003F23	MGC	W01A094B21	pENTR-TOPO	4535		ZNF259	8882	AAH17380.1	Hs.7165	Zinc finger protein 259			Skin, melanotic melanoma.	NIH_MGC_20		NM_003904.3	NP_003895.1	PROVISIONAL	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC023505	IRAL012H03	MGC	W01A094B24	pENTR-TOPO	743		ECM1	1893	AAH23505.1	Hs.81071	Extracellular matrix protein 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_004425.3	NP_004416.2	REVIEWED	Cs	0.996	0.996	540	1623	1	1620	540	1	540
RIKEN	BC017479	IRAL023A15	MGC	W01A094C01	pENTR-TOPO	20783		TBCC	6903	AAH17479.1	Hs.75064	Tubulin folding cofactor C			Eye, retinoblastoma	NIH_MGC_16		NM_003192.2	NP_003183.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC022567	IRAK032K20	MGC	W01A094C02	pENTR-TOPO	4391		CHST1	8534	AAH22567.1	Hs.104576	Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003654.4	NP_003645.1	VALIDATED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	BC017479	IRAL023A15	MGC	W01A094C03	pENTR-TOPO	20783		TBCC	6903	AAH17479.1	Hs.75064	Tubulin folding cofactor C			Eye, retinoblastoma	NIH_MGC_16		NM_003192.2	NP_003183.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC022567	IRAK032K20	MGC	W01A094C04	pENTR-TOPO	4391		CHST1	8534	AAH22567.1	Hs.104576	Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003654.4	NP_003645.1	VALIDATED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	BC022567	IRAK032K20	MGC	W01A094C06	pENTR-TOPO	4391		CHST1	8534	AAH22567.1	Hs.104576	Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003654.4	NP_003645.1	VALIDATED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	BC017479	IRAL023A15	MGC	W01A094C09	pENTR-TOPO	20783		TBCC	6903	AAH17479.1	Hs.75064	Tubulin folding cofactor C			Eye, retinoblastoma	NIH_MGC_16		NM_003192.2	NP_003183.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC022567	IRAK032K20	MGC	W01A094C10	pENTR-TOPO	4391		CHST1	8534	AAH22567.1	Hs.104576	Carbohydrate (keratan sulfate Gal-6) sulfotransferase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003654.4	NP_003645.1	VALIDATED	C	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	BC019097	IRAL039L14	MGC	W01A094C12	pENTR-TOPO	10691		KRT14	3861	AAH19097.1	Hs.654380	Keratin 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_000526.4	NP_000517.2	REVIEWED	Cs	0.998	0.998	472	1419	1	1416	472	1	472
RIKEN	BC008811	IRAL015N15	MGC	W01A094C15	pENTR-TOPO	17186		WNT7A	7476	AAH08811.1	Hs.72290	Wingless-type MMTV integration site family, member 7A			Ovary, adenocarcinoma	NIH_MGC_9		NM_004625.3	NP_004616.2	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC026262	IRAL037B13	MGC	W01A094C16	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC008811	IRAL015N15	MGC	W01A094C17	pENTR-TOPO	17186		WNT7A	7476	AAH08811.1	Hs.72290	Wingless-type MMTV integration site family, member 7A			Ovary, adenocarcinoma	NIH_MGC_9		NM_004625.3	NP_004616.2	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC008811	IRAL015N15	MGC	W01A094C19	pENTR-TOPO	17186		WNT7A	7476	AAH08811.1	Hs.72290	Wingless-type MMTV integration site family, member 7A			Ovary, adenocarcinoma	NIH_MGC_9		NM_004625.3	NP_004616.2	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC026262	IRAL037B13	MGC	W01A094C20	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC019097	IRAL039L14	MGC	W01A094C22	pENTR-TOPO	10691		KRT14	3861	AAH19097.1	Hs.654380	Keratin 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_000526.4	NP_000517.2	REVIEWED	Cs	0.998	0.998	472	1419	1	1416	472	1	472
RIKEN	BC008811	IRAL015N15	MGC	W01A094C23	pENTR-TOPO	17186		WNT7A	7476	AAH08811.1	Hs.72290	Wingless-type MMTV integration site family, member 7A			Ovary, adenocarcinoma	NIH_MGC_9		NM_004625.3	NP_004616.2	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC026262	IRAL037B13	MGC	W01A094C24	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC017380	IRAL003F23	MGC	W01A094D01	pENTR-TOPO	4535		ZNF259	8882	AAH17380.1	Hs.7165	Zinc finger protein 259			Skin, melanotic melanoma.	NIH_MGC_20		NM_003904.3	NP_003895.1	PROVISIONAL	C	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC015571	IRAL033A11	MGC	W01A094D03	pENTR-TOPO	3585		SLC22A18	5002	AAH15571.1	Hs.50868	Solute carrier family 22, member 18			Placenta, choriocarcinoma	NIH_MGC_21		NM_002555.5	NP_002546.3	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
RIKEN	BC015571	IRAL033A11	MGC	W01A094D05	pENTR-TOPO	3585		SLC22A18	5002	AAH15571.1	Hs.50868	Solute carrier family 22, member 18			Placenta, choriocarcinoma	NIH_MGC_21		NM_002555.5	NP_002546.3	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
RIKEN	BC053603	IRAK115I08	MGC	W01A094D10	pENTR-TOPO	1959		CLK2	1196	AAH53603.1	Hs.73986	CDC-like kinase 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_003993.2	NP_003984.2	REVIEWED	Cg	0.998	1.000	499	1500	1	1497	498	1	498
RIKEN	BC023505	IRAL012H03	MGC	W01A094D14	pENTR-TOPO	743		ECM1	1893	AAH23505.1	Hs.81071	Extracellular matrix protein 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_004425.3	NP_004416.2	REVIEWED	Cs	0.996	0.996	540	1623	1	1620	540	1	540
RIKEN	BC015571	IRAL033A11	MGC	W01A094D17	pENTR-TOPO	3585		SLC22A18	5002	AAH15571.1	Hs.50868	Solute carrier family 22, member 18			Placenta, choriocarcinoma	NIH_MGC_21		NM_002555.5	NP_002546.3	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
RIKEN	BC023505	IRAL012H03	MGC	W01A094D20	pENTR-TOPO	743		ECM1	1893	AAH23505.1	Hs.81071	Extracellular matrix protein 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_004425.3	NP_004416.2	REVIEWED	Cs	0.996	0.996	540	1623	1	1620	540	1	540
RIKEN	BC027984	IRAK062A21	MGC	W01A094D21	pENTR-TOPO	12707		GSK3A	2931	AAH27984.1	Hs.466828	Glycogen synthase kinase 3 alpha			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_019884.2	NP_063937.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
RIKEN	BC012866	IRAK021B21	MGC	W01A094D23	pENTR-TOPO	23234		TNFRSF10A	8797	AAH12866.1	Hs.591834	Tumor necrosis factor receptor superfamily, member 10a			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003844.2	NP_003835.2	REVIEWED	OK	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC023505	IRAL012H03	MGC	W01A094D24	pENTR-TOPO	743		ECM1	1893	AAH23505.1	Hs.81071	Extracellular matrix protein 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_004425.3	NP_004416.2	REVIEWED	Cs	0.996	0.996	540	1623	1	1620	540	1	540
RIKEN	BC008811	IRAL015N15	MGC	W01A094E01	pENTR-TOPO	17186		WNT7A	7476	AAH08811.1	Hs.72290	Wingless-type MMTV integration site family, member 7A			Ovary, adenocarcinoma	NIH_MGC_9		NM_004625.3	NP_004616.2	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC026262	IRAL037B13	MGC	W01A094E02	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC008811	IRAL015N15	MGC	W01A094E03	pENTR-TOPO	17186		WNT7A	7476	AAH08811.1	Hs.72290	Wingless-type MMTV integration site family, member 7A			Ovary, adenocarcinoma	NIH_MGC_9		NM_004625.3	NP_004616.2	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	AK056278	flj0002b22	FLJ	W01A094E05	pENTR-TOPO	174		WNT3A	89780	BAB71136.1	Hs.336930	Wingless-type MMTV integration site family, member 3A	NT2	teratocarcinoma		NT2RI2	EK1	NM_033131.2	NP_149122.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC026262	IRAL037B13	MGC	W01A094E06	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC026262	IRAL037B13	MGC	W01A094E08	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	AK056278	flj0002b22	FLJ	W01A094E11	pENTR-TOPO	174		WNT3A	89780	BAB71136.1	Hs.336930	Wingless-type MMTV integration site family, member 3A	NT2	teratocarcinoma		NT2RI2	EK1	NM_033131.2	NP_149122.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	AK056278	flj0002b22	FLJ	W01A094E13	pENTR-TOPO	174		WNT3A	89780	BAB71136.1	Hs.336930	Wingless-type MMTV integration site family, member 3A	NT2	teratocarcinoma		NT2RI2	EK1	NM_033131.2	NP_149122.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC023508	IRAL012B20	MGC	W01A094E14	pENTR-TOPO	21012		STK17A	9263	AAH23508.2	Hs.709489	Serine/threonine kinase 17a			Placenta, choriocarcinoma	NIH_MGC_21		NM_004760.2	NP_004751.2	REVIEWED	Cs	0.998	0.998	414	1245	1	1242	414	1	414
RIKEN	AK056278	flj0002b22	FLJ	W01A094E15	pENTR-TOPO	174		WNT3A	89780	BAB71136.1	Hs.336930	Wingless-type MMTV integration site family, member 3A	NT2	teratocarcinoma		NT2RI2	EK1	NM_033131.2	NP_149122.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC050346	IRAK090K17	MGC	W01A094E17	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC050346	IRAK090K17	MGC	W01A094E19	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC023508	IRAL012B20	MGC	W01A094E20	pENTR-TOPO	21012		STK17A	9263	AAH23508.2	Hs.709489	Serine/threonine kinase 17a			Placenta, choriocarcinoma	NIH_MGC_21		NM_004760.2	NP_004751.2	REVIEWED	Cs	0.998	0.998	414	1245	1	1242	414	1	414
RIKEN	BC050346	IRAK090K17	MGC	W01A094E21	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC050346	IRAK090K17	MGC	W01A094E23	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC012866	IRAK021B21	MGC	W01A094F01	pENTR-TOPO	23234		TNFRSF10A	8797	AAH12866.1	Hs.591834	Tumor necrosis factor receptor superfamily, member 10a			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003844.2	NP_003835.2	REVIEWED	OK	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC001095	IRAL007C14	MGC	W01A094F02	pENTR-TOPO	19640		PPP2R5D	5528	AAH01095.1	Hs.533308	Protein phosphatase 2, regulatory subunit B', delta isoform			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006245.2	NP_006236.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
RIKEN	BC012866	IRAK021B21	MGC	W01A094F07	pENTR-TOPO	23234		TNFRSF10A	8797	AAH12866.1	Hs.591834	Tumor necrosis factor receptor superfamily, member 10a			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003844.2	NP_003835.2	REVIEWED	OK	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC001095	IRAL007C14	MGC	W01A094F08	pENTR-TOPO	19640		PPP2R5D	5528	AAH01095.1	Hs.533308	Protein phosphatase 2, regulatory subunit B', delta isoform			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006245.2	NP_006236.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
RIKEN	BC012866	IRAK021B21	MGC	W01A094F09	pENTR-TOPO	23234		TNFRSF10A	8797	AAH12866.1	Hs.591834	Tumor necrosis factor receptor superfamily, member 10a			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003844.2	NP_003835.2	REVIEWED	OK	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC001483	IRAL007G16	MGC	W01A094F17	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC001483	IRAL007G16	MGC	W01A094F21	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC001483	IRAL007G16	MGC	W01A094F23	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC050346	IRAK090K17	MGC	W01A094G01	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC023508	IRAL012B20	MGC	W01A094G02	pENTR-TOPO	21012		STK17A	9263	AAH23508.2	Hs.709489	Serine/threonine kinase 17a			Placenta, choriocarcinoma	NIH_MGC_21		NM_004760.2	NP_004751.2	REVIEWED	Cs	0.998	0.998	414	1245	1	1242	414	1	414
RIKEN	BC050346	IRAK090K17	MGC	W01A094G05	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC050346	IRAK090K17	MGC	W01A094G07	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC023508	IRAL012B20	MGC	W01A094G08	pENTR-TOPO	21012		STK17A	9263	AAH23508.2	Hs.709489	Serine/threonine kinase 17a			Placenta, choriocarcinoma	NIH_MGC_21		NM_004760.2	NP_004751.2	REVIEWED	Cs	0.998	0.998	414	1245	1	1242	414	1	414
RIKEN	BC050346	IRAK090K17	MGC	W01A094G09	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC032802	IRAK068M06	MGC	W01A094G11	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC023508	IRAL012B20	MGC	W01A094G12	pENTR-TOPO	21012		STK17A	9263	AAH23508.2	Hs.709489	Serine/threonine kinase 17a			Placenta, choriocarcinoma	NIH_MGC_21		NM_004760.2	NP_004751.2	REVIEWED	Cs	0.998	0.998	414	1245	1	1242	414	1	414
RIKEN	BC023508	IRAL012B20	MGC	W01A094G14	pENTR-TOPO	21012		STK17A	9263	AAH23508.2	Hs.709489	Serine/threonine kinase 17a			Placenta, choriocarcinoma	NIH_MGC_21		NM_004760.2	NP_004751.2	REVIEWED	Cs	0.998	0.998	414	1245	1	1242	414	1	414
RIKEN	BC032802	IRAK068M06	MGC	W01A094G15	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC011787	IRAL027L14	MGC	W01A094G16	pENTR-TOPO	15863		RTN4R	65078	AAH11787.1	Hs.30868	Reticulon 4 receptor			Lung, large cell carcinoma	NIH_MGC_18		NM_023004.5	NP_075380.1	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC032802	IRAK068M06	MGC	W01A094G17	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC032802	IRAK068M06	MGC	W01A094G19	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC011787	IRAL027L14	MGC	W01A094G20	pENTR-TOPO	15863		RTN4R	65078	AAH11787.1	Hs.30868	Reticulon 4 receptor			Lung, large cell carcinoma	NIH_MGC_18		NM_023004.5	NP_075380.1	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC015479	IRAK022M18	MGC	W01A094G21	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC011787	IRAL027L14	MGC	W01A094G22	pENTR-TOPO	15863		RTN4R	65078	AAH11787.1	Hs.30868	Reticulon 4 receptor			Lung, large cell carcinoma	NIH_MGC_18		NM_023004.5	NP_075380.1	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC032802	IRAK068M06	MGC	W01A094G23	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC007682	IRAL012L19	MGC	W01A094H01	pENTR-TOPO	13076		STAMBP	10617	AAH07682.1	Hs.657598	STAM binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_213622.1	NP_998787.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC051803	IRAK107E02	MGC	W01A094H02	pENTR-TOPO	20637		LEMD2	221496	AAH51803.1	Hs.444845	LEM domain containing 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001143944.1	NP_001137416.1	VALIDATED	C	1.000	1.000	201	1512	907	1509	201	1	201
RIKEN	BC001483	IRAL007G16	MGC	W01A094H03	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC051803	IRAK107E02	MGC	W01A094H06	pENTR-TOPO	20637		LEMD2	221496	AAH51803.1	Hs.444845	LEM domain containing 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001143944.1	NP_001137416.1	VALIDATED	C	1.000	1.000	201	1512	907	1509	201	1	201
RIKEN	BC001483	IRAL007G16	MGC	W01A094H07	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC051803	IRAK107E02	MGC	W01A094H08	pENTR-TOPO	20637		LEMD2	221496	AAH51803.1	Hs.444845	LEM domain containing 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001143944.1	NP_001137416.1	VALIDATED	C	1.000	1.000	201	1512	907	1509	201	1	201
RIKEN	BC051803	IRAK107E02	MGC	W01A094H10	pENTR-TOPO	20637		LEMD2	221496	AAH51803.1	Hs.444845	LEM domain containing 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001143944.1	NP_001137416.1	VALIDATED	C	1.000	1.000	201	1512	907	1509	201	1	201
RIKEN	BC001483	IRAL007G16	MGC	W01A094H11	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC040500	IRAK048D23	MGC	W01A094H16	pENTR-TOPO	15978		DGCR2	9993	AAH40500.1	Hs.517357	DiGeorge syndrome critical region gene 2			Testis	NIH_MGC_97	DH10B	NM_005137.2	NP_005128.1	VALIDATED	Cs	0.998	0.998	550	1653	1	1650	550	1	550
RIKEN	BC051803	IRAK107E02	MGC	W01A094H18	pENTR-TOPO	20637		LEMD2	221496	AAH51803.1	Hs.444845	LEM domain containing 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001143944.1	NP_001137416.1	VALIDATED	C	1.000	1.000	201	1512	907	1509	201	1	201
RIKEN	BC004148	IRAL002G08	MGC	W01A094H19	pENTR-TOPO	13071		KCNS3	3790	AAH04148.1	Hs.414489	Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_002252.3	NP_002243.3	REVIEWED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	BC005894	IRAL021J14	MGC	W01A094H21	pENTR-TOPO	750		FMO2	2327	AAH05894.1	Hs.144912	Flavin containing monooxygenase 2 (non-functional)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001460.2	NP_001451.1	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC015479	IRAK022M18	MGC	W01A094I01	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC032802	IRAK068M06	MGC	W01A094I03	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC011787	IRAL027L14	MGC	W01A094I04	pENTR-TOPO	15863		RTN4R	65078	AAH11787.1	Hs.30868	Reticulon 4 receptor			Lung, large cell carcinoma	NIH_MGC_18		NM_023004.5	NP_075380.1	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC015479	IRAK022M18	MGC	W01A094I05	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC011787	IRAL027L14	MGC	W01A094I06	pENTR-TOPO	15863		RTN4R	65078	AAH11787.1	Hs.30868	Reticulon 4 receptor			Lung, large cell carcinoma	NIH_MGC_18		NM_023004.5	NP_075380.1	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC011787	IRAL027L14	MGC	W01A094I10	pENTR-TOPO	15863		RTN4R	65078	AAH11787.1	Hs.30868	Reticulon 4 receptor			Lung, large cell carcinoma	NIH_MGC_18		NM_023004.5	NP_075380.1	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC034425	IRAK071D01	MGC	W01A094I11	pENTR-TOPO	20530		BVES	11149	AAH34425.1	Hs.221660	Blood vessel epicardial substance			Testis	NIH_MGC_97	DH10B	NM_147147.2	NP_671488.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC025709	IRAK049M17	MGC	W01A094I13	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC011787	IRAL027L14	MGC	W01A094I14	pENTR-TOPO	15863		RTN4R	65078	AAH11787.1	Hs.30868	Reticulon 4 receptor			Lung, large cell carcinoma	NIH_MGC_18		NM_023004.5	NP_075380.1	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
RIKEN	BC025709	IRAK049M17	MGC	W01A094I17	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC007741	IRAL017H07	MGC	W01A094I18	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC025709	IRAK049M17	MGC	W01A094I19	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC014488	IRAL034N12	MGC	W01A094I20	pENTR-TOPO	11508		PSMC4	5704	AAH14488.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC034425	IRAK071D01	MGC	W01A094I21	pENTR-TOPO	20530		BVES	11149	AAH34425.1	Hs.221660	Blood vessel epicardial substance			Testis	NIH_MGC_97	DH10B	NM_147147.2	NP_671488.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC007741	IRAL017H07	MGC	W01A094I22	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC025709	IRAK049M17	MGC	W01A094I23	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC014488	IRAL034N12	MGC	W01A094I24	pENTR-TOPO	11508		PSMC4	5704	AAH14488.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC005894	IRAL021J14	MGC	W01A094J01	pENTR-TOPO	750		FMO2	2327	AAH05894.1	Hs.144912	Flavin containing monooxygenase 2 (non-functional)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001460.2	NP_001451.1	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC007564	IRAL022D03	MGC	W01A094J02	pENTR-TOPO	3158		ANXA11	311	AAH07564.1	Hs.530291	Annexin A11			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_001157.2	NP_001148.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC005894	IRAL021J14	MGC	W01A094J03	pENTR-TOPO	750		FMO2	2327	AAH05894.1	Hs.144912	Flavin containing monooxygenase 2 (non-functional)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001460.2	NP_001451.1	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC050416	IRAK098N14	MGC	W01A094J06	pENTR-TOPO	2099		SLC45A3	85414	AAH50416.1	Hs.278695	Solute carrier family 45, member 3				Lupski_sympathetic_trunk	DH10B	NM_033102.2	NP_149093.1	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
RIKEN	BC004148	IRAL002G08	MGC	W01A094J09	pENTR-TOPO	13071		KCNS3	3790	AAH04148.1	Hs.414489	Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_002252.3	NP_002243.3	REVIEWED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	BC005894	IRAL021J14	MGC	W01A094J11	pENTR-TOPO	750		FMO2	2327	AAH05894.1	Hs.144912	Flavin containing monooxygenase 2 (non-functional)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001460.2	NP_001451.1	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC051314	IRAL047G04	MGC	W01A094J12	pENTR-TOPO	3843		SLC37A2	219855	AAH51314.1	Hs.352661	Solute carrier family 37 (glycerol-3-phosphate transporter), member 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_198277.2	NP_938018.1	VALIDATED	C	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC051314	IRAL047G04	MGC	W01A094J14	pENTR-TOPO	3843		SLC37A2	219855	AAH51314.1	Hs.352661	Solute carrier family 37 (glycerol-3-phosphate transporter), member 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_198277.2	NP_938018.1	VALIDATED	C	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC005894	IRAL021J14	MGC	W01A094J15	pENTR-TOPO	750		FMO2	2327	AAH05894.1	Hs.144912	Flavin containing monooxygenase 2 (non-functional)			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001460.2	NP_001451.1	REVIEWED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC004148	IRAL002G08	MGC	W01A094J17	pENTR-TOPO	13071		KCNS3	3790	AAH04148.1	Hs.414489	Potassium voltage-gated channel, delayed-rectifier, subfamily S, member 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_002252.3	NP_002243.3	REVIEWED	Cs	0.996	0.996	491	1476	1	1473	491	1	491
RIKEN	BC051314	IRAL047G04	MGC	W01A094J18	pENTR-TOPO	3843		SLC37A2	219855	AAH51314.1	Hs.352661	Solute carrier family 37 (glycerol-3-phosphate transporter), member 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_198277.2	NP_938018.1	VALIDATED	C	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC005811	IRAL014N09	MGC	W01A094J19	pENTR-TOPO	9856		PDK2	5164	AAH05811.1	Hs.256667	Pyruvate dehydrogenase kinase, isozyme 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_002611.3	NP_002602.2	PROVISIONAL	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC051314	IRAL047G04	MGC	W01A094J20	pENTR-TOPO	3843		SLC37A2	219855	AAH51314.1	Hs.352661	Solute carrier family 37 (glycerol-3-phosphate transporter), member 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_198277.2	NP_938018.1	VALIDATED	C	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC007741	IRAL017H07	MGC	W01A094K02	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC014488	IRAL034N12	MGC	W01A094K04	pENTR-TOPO	11508		PSMC4	5704	AAH14488.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC034425	IRAK071D01	MGC	W01A094K05	pENTR-TOPO	20530		BVES	11149	AAH34425.1	Hs.221660	Blood vessel epicardial substance			Testis	NIH_MGC_97	DH10B	NM_147147.2	NP_671488.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC007741	IRAL017H07	MGC	W01A094K06	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC025709	IRAK049M17	MGC	W01A094K07	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC034425	IRAK071D01	MGC	W01A094K09	pENTR-TOPO	20530		BVES	11149	AAH34425.1	Hs.221660	Blood vessel epicardial substance			Testis	NIH_MGC_97	DH10B	NM_147147.2	NP_671488.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC007741	IRAL017H07	MGC	W01A094K10	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC025709	IRAK049M17	MGC	W01A094K11	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC007741	IRAL017H07	MGC	W01A094K12	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC034425	IRAK071D01	MGC	W01A094K13	pENTR-TOPO	20530		BVES	11149	AAH34425.1	Hs.221660	Blood vessel epicardial substance			Testis	NIH_MGC_97	DH10B	NM_147147.2	NP_671488.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC041116	IRAK082C21	MGC	W01A094K15	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	BC003001	IRAL002G17	MGC	W01A094K19	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	BC041116	IRAK082C21	MGC	W01A094K21	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	BC014488	IRAL034N12	MGC	W01A094K22	pENTR-TOPO	11508		PSMC4	5704	AAH14488.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC041116	IRAK082C21	MGC	W01A094K23	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	BC007741	IRAL017H07	MGC	W01A094K24	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC009960	IRAL026N01	MGC	W01A094L01	pENTR-TOPO	24561		IL13RA1	3597	AAH09960.1	Hs.496646	Interleukin 13 receptor, alpha 1			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_001560.2	NP_001551.1	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	BC005811	IRAL014N09	MGC	W01A094L09	pENTR-TOPO	9856		PDK2	5164	AAH05811.1	Hs.256667	Pyruvate dehydrogenase kinase, isozyme 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_002611.3	NP_002602.2	PROVISIONAL	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC005811	IRAL014N09	MGC	W01A094L11	pENTR-TOPO	9856		PDK2	5164	AAH05811.1	Hs.256667	Pyruvate dehydrogenase kinase, isozyme 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_002611.3	NP_002602.2	PROVISIONAL	C	1.000	1.000	407	1224	1	1221	407	1	407
RIKEN	BC039692	IRAK069L08	MGC	W01A094L12	pENTR-TOPO	9073		SLC7A5	8140	AAH39692.1	Hs.513797	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003486.5	NP_003477.4	VALIDATED	Cs	0.998	0.998	507	1524	1	1521	507	1	507
RIKEN	BC009960	IRAL026N01	MGC	W01A094L13	pENTR-TOPO	24561		IL13RA1	3597	AAH09960.1	Hs.496646	Interleukin 13 receptor, alpha 1			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_001560.2	NP_001551.1	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	AK001852	flj0036f20	FLJ	W01A094L16	pENTR-TOPO	1660		LGTN	1939	BAA91942.1	Hs.497581	Ligatin				PLACE1	EK1	NM_006893.2	NP_008824.2	REVIEWED	Cs	0.998	0.998	584	1755	1	1752	584	1	584
RIKEN	BC039692	IRAK069L08	MGC	W01A094L18	pENTR-TOPO	9073		SLC7A5	8140	AAH39692.1	Hs.513797	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003486.5	NP_003477.4	VALIDATED	Cs	0.998	0.998	507	1524	1	1521	507	1	507
RIKEN	BC014456	IRAL034H17	MGC	W01A094L19	pENTR-TOPO	23235		CHRNA6	8973	AAH14456.1	Hs.103128	Cholinergic receptor, nicotinic, alpha 6			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_004198.2	NP_004189.1	PROVISIONAL	C	1.000	1.000	494	1485	1	1482	494	1	494
RIKEN	BC032703	IRAK069D22	MGC	W01A094L21	pENTR-TOPO	5515		PRPH	5630	AAH32703.1	Hs.37044	Peripherin			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006262.3	NP_006253.2	REVIEWED	OK	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC039692	IRAK069L08	MGC	W01A094L22	pENTR-TOPO	9073		SLC7A5	8140	AAH39692.1	Hs.513797	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_003486.5	NP_003477.4	VALIDATED	Cs	0.998	0.998	507	1524	1	1521	507	1	507
RIKEN	BC003001	IRAL002G17	MGC	W01A094M01	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	AK026594	flj0060p08	FLJ	W01A094M02	pENTR-TOPO	23623		TUBB2C	10383	-	Hs.433615	Tubulin, beta 2C				KAT	EK1	NM_006088.5	NP_006079.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC041116	IRAK082C21	MGC	W01A094M03	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	AK026594	flj0060p08	FLJ	W01A094M04	pENTR-TOPO	23623		TUBB2C	10383	-	Hs.433615	Tubulin, beta 2C				KAT	EK1	NM_006088.5	NP_006079.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	AK026594	flj0060p08	FLJ	W01A094M08	pENTR-TOPO	23623		TUBB2C	10383	-	Hs.433615	Tubulin, beta 2C				KAT	EK1	NM_006088.5	NP_006079.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC041116	IRAK082C21	MGC	W01A094M09	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	AK026594	flj0060p08	FLJ	W01A094M18	pENTR-TOPO	23623		TUBB2C	10383	-	Hs.433615	Tubulin, beta 2C				KAT	EK1	NM_006088.5	NP_006079.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC003001	IRAL002G17	MGC	W01A094M19	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	AK026594	flj0060p08	FLJ	W01A094M20	pENTR-TOPO	23623		TUBB2C	10383	-	Hs.433615	Tubulin, beta 2C				KAT	EK1	NM_006088.5	NP_006079.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC000416	IRAL001M22	MGC	W01A094M22	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC041769	IRAK032O15	MGC	W01A094M24	pENTR-TOPO	9406		DOC2A	8448	AAH41769.2	Hs.355281	Double C2-like domains, alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003586.2	NP_003577.2	REVIEWED	P	1.000	1.000	392	1179	1	1176	400	9	400
RIKEN	BC022026	IRAK033K06	MGC	W01A094N04	pENTR-TOPO	3190		ATE1	11101	AAH22026.2	Hs.632080	Arginyltransferase 1			Testis	NIH_MGC_97	DH10B	NM_007041.2	NP_008972.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC022026	IRAK033K06	MGC	W01A094N08	pENTR-TOPO	3190		ATE1	11101	AAH22026.2	Hs.632080	Arginyltransferase 1			Testis	NIH_MGC_97	DH10B	NM_007041.2	NP_008972.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC032703	IRAK069D22	MGC	W01A094N09	pENTR-TOPO	5515		PRPH	5630	AAH32703.1	Hs.37044	Peripherin			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006262.3	NP_006253.2	REVIEWED	OK	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC032489	IRAK064P04	MGC	W01A094N10	pENTR-TOPO	15925		PES1	23481	AAH32489.1	Hs.517543	Pescadillo homolog 1, containing BRCT domain (zebrafish)			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014303.2	NP_055118.1	REVIEWED	OK	1.000	1.000	588	1767	1	1764	588	1	588
RIKEN	BC032703	IRAK069D22	MGC	W01A094N11	pENTR-TOPO	5515		PRPH	5630	AAH32703.1	Hs.37044	Peripherin			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006262.3	NP_006253.2	REVIEWED	OK	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC022026	IRAK033K06	MGC	W01A094N12	pENTR-TOPO	3190		ATE1	11101	AAH22026.2	Hs.632080	Arginyltransferase 1			Testis	NIH_MGC_97	DH10B	NM_007041.2	NP_008972.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC032635	IRAK069D21	MGC	W01A094N13	pENTR-TOPO	17503		GLRB	2743	AAH32635.1	Hs.32973	Glycine receptor, beta			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000824.3	NP_000815.1	VALIDATED	C	1.000	1.000	497	1494	1	1491	497	1	497
RIKEN	BC032489	IRAK064P04	MGC	W01A094N14	pENTR-TOPO	15925		PES1	23481	AAH32489.1	Hs.517543	Pescadillo homolog 1, containing BRCT domain (zebrafish)			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014303.2	NP_055118.1	REVIEWED	OK	1.000	1.000	588	1767	1	1764	588	1	588
RIKEN	BC063648	IRAK134N07	MGC	W01A094N15	pENTR-TOPO	6045		KRT79	338785	AAH63648.1	Hs.711471	Keratin 79			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_175834.2	NP_787028.1	VALIDATED	Cs	0.996	0.996	535	1608	1	1605	535	1	535
RIKEN	BC063648	IRAK134N07	MGC	W01A094N17	pENTR-TOPO	6045		KRT79	338785	AAH63648.1	Hs.711471	Keratin 79			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_175834.2	NP_787028.1	VALIDATED	Cs	0.996	0.996	535	1608	1	1605	535	1	535
RIKEN	BC032489	IRAK064P04	MGC	W01A094N18	pENTR-TOPO	15925		PES1	23481	AAH32489.1	Hs.517543	Pescadillo homolog 1, containing BRCT domain (zebrafish)			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014303.2	NP_055118.1	REVIEWED	OK	1.000	1.000	588	1767	1	1764	588	1	588
RIKEN	BC063648	IRAK134N07	MGC	W01A094N19	pENTR-TOPO	6045		KRT79	338785	AAH63648.1	Hs.711471	Keratin 79			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_175834.2	NP_787028.1	VALIDATED	Cs	0.996	0.996	535	1608	1	1605	535	1	535
RIKEN	BC063648	IRAK134N07	MGC	W01A094N21	pENTR-TOPO	6045		KRT79	338785	AAH63648.1	Hs.711471	Keratin 79			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_175834.2	NP_787028.1	VALIDATED	Cs	0.996	0.996	535	1608	1	1605	535	1	535
RIKEN	BC000416	IRAL001M22	MGC	W01A094O02	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC000416	IRAL001M22	MGC	W01A094O04	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC000416	IRAL001M22	MGC	W01A094O06	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC001289	IRAK004L05	MGC	W01A094O07	pENTR-TOPO	13460		SSB	6741	AAH01289.1	Hs.632535	Sjogren syndrome antigen B (autoantigen La)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003142.3	NP_003133.1	PROVISIONAL	C	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	BC041769	IRAK032O15	MGC	W01A094O08	pENTR-TOPO	9406		DOC2A	8448	AAH41769.2	Hs.355281	Double C2-like domains, alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003586.2	NP_003577.2	REVIEWED	P	1.000	1.000	392	1179	1	1176	400	9	400
RIKEN	BC000416	IRAL001M22	MGC	W01A094O10	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC000416	IRAL001M22	MGC	W01A094O12	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC000416	IRAL001M22	MGC	W01A094O16	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC001289	IRAK004L05	MGC	W01A094O17	pENTR-TOPO	13460		SSB	6741	AAH01289.1	Hs.632535	Sjogren syndrome antigen B (autoantigen La)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003142.3	NP_003133.1	PROVISIONAL	C	1.000	1.000	408	1227	1	1224	408	1	408
RIKEN	BC000416	IRAL001M22	MGC	W01A094O18	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC033571	IRAL017L19	MGC	W01A094O19	pENTR-TOPO	5834		LPAR5	57121	AAH33571.1	Hs.155538	Lysophosphatidic acid receptor 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020400.5	NP_065133.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC000416	IRAL001M22	MGC	W01A094O20	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC000479	IRAL001P05	MGC	W01A094O24	pENTR-TOPO	7515		AKT1	207	AAH00479.1	Hs.525622	V-akt murine thymoma viral oncogene homolog 1			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001014431.1	NP_001014431.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	BC022026	IRAK033K06	MGC	W01A094P02	pENTR-TOPO	3190		ATE1	11101	AAH22026.2	Hs.632080	Arginyltransferase 1			Testis	NIH_MGC_97	DH10B	NM_007041.2	NP_008972.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC063648	IRAK134N07	MGC	W01A094P03	pENTR-TOPO	6045		KRT79	338785	AAH63648.1	Hs.711471	Keratin 79			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_175834.2	NP_787028.1	VALIDATED	Cs	0.996	0.996	535	1608	1	1605	535	1	535
RIKEN	BC032635	IRAK069D21	MGC	W01A094P05	pENTR-TOPO	17503		GLRB	2743	AAH32635.1	Hs.32973	Glycine receptor, beta			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000824.3	NP_000815.1	VALIDATED	C	1.000	1.000	497	1494	1	1491	497	1	497
RIKEN	BC032635	IRAK069D21	MGC	W01A094P07	pENTR-TOPO	17503		GLRB	2743	AAH32635.1	Hs.32973	Glycine receptor, beta			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000824.3	NP_000815.1	VALIDATED	C	1.000	1.000	497	1494	1	1491	497	1	497
RIKEN	BC022026	IRAK033K06	MGC	W01A094P08	pENTR-TOPO	3190		ATE1	11101	AAH22026.2	Hs.632080	Arginyltransferase 1			Testis	NIH_MGC_97	DH10B	NM_007041.2	NP_008972.2	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC063648	IRAK134N07	MGC	W01A094P09	pENTR-TOPO	6045		KRT79	338785	AAH63648.1	Hs.711471	Keratin 79			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_175834.2	NP_787028.1	VALIDATED	Cs	0.996	0.996	535	1608	1	1605	535	1	535
RIKEN	BC032489	IRAK064P04	MGC	W01A094P10	pENTR-TOPO	15925		PES1	23481	AAH32489.1	Hs.517543	Pescadillo homolog 1, containing BRCT domain (zebrafish)			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014303.2	NP_055118.1	REVIEWED	OK	1.000	1.000	588	1767	1	1764	588	1	588
RIKEN	BC063648	IRAK134N07	MGC	W01A094P11	pENTR-TOPO	6045		KRT79	338785	AAH63648.1	Hs.711471	Keratin 79			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_175834.2	NP_787028.1	VALIDATED	Cs	0.996	0.996	535	1608	1	1605	535	1	535
RIKEN	BC032635	IRAK069D21	MGC	W01A094P13	pENTR-TOPO	17503		GLRB	2743	AAH32635.1	Hs.32973	Glycine receptor, beta			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_000824.3	NP_000815.1	VALIDATED	C	1.000	1.000	497	1494	1	1491	497	1	497
RIKEN	BC035809	IRAK079N01	MGC	W01A094P14	pENTR-TOPO	12346		SIGLEC12	89858	AAH35809.2	Hs.249741	Sialic acid binding Ig-like lectin 12			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_053003.2	NP_443729.1	REVIEWED	OK	1.000	1.000	595	1788	1	1785	595	1	595
RIKEN	BC035809	IRAK079N01	MGC	W01A094P16	pENTR-TOPO	12346		SIGLEC12	89858	AAH35809.2	Hs.249741	Sialic acid binding Ig-like lectin 12			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_053003.2	NP_443729.1	REVIEWED	OK	1.000	1.000	595	1788	1	1785	595	1	595
RIKEN	BC035809	IRAK079N01	MGC	W01A094P18	pENTR-TOPO	12346		SIGLEC12	89858	AAH35809.2	Hs.249741	Sialic acid binding Ig-like lectin 12			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_053003.2	NP_443729.1	REVIEWED	OK	1.000	1.000	595	1788	1	1785	595	1	595
RIKEN	BC035809	IRAK079N01	MGC	W01A094P20	pENTR-TOPO	12346		SIGLEC12	89858	AAH35809.2	Hs.249741	Sialic acid binding Ig-like lectin 12			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_053003.2	NP_443729.1	REVIEWED	OK	1.000	1.000	595	1788	1	1785	595	1	595
RIKEN	BC057800	IRAK133B06	MGC	W01A094P21	pENTR-TOPO	5312		IRAK3	11213	AAH57800.1	Hs.369265	Interleukin-1 receptor-associated kinase 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_007199.2	NP_009130.2	VALIDATED	Cs	0.998	0.998	596	1791	1	1788	596	1	596
RIKEN	BC057800	IRAK133B06	MGC	W01A094P23	pENTR-TOPO	5312		IRAK3	11213	AAH57800.1	Hs.369265	Interleukin-1 receptor-associated kinase 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_007199.2	NP_009130.2	VALIDATED	Cs	0.998	0.998	596	1791	1	1788	596	1	596
RIKEN	BC000097	IRAL007L17	MGC	W01A095A01	pENTR-TOPO	18791		TGFBI	7045	AAH00097.1	Hs.369397	Transforming growth factor, beta-induced, 68kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000358.2	NP_000349.1	REVIEWED	C	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC018926	IRAL017L08	MGC	W01A095A02	pENTR-TOPO	9700		TRPV2	51393	AAH18926.1	Hs.279746	Transient receptor potential cation channel, subfamily V, member 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_016113.3	NP_057197.2	REVIEWED	OK	1.000	1.000	764	2295	1	2292	764	1	764
RIKEN	AK098342	flj0051j12	FLJ	W01A095A04	pENTR-TOPO	466		ZNF362	149076	BAC05287.1	Hs.524248	Zinc finger protein 362				CBL	EK1	NM_152493.2	NP_689706.2	VALIDATED		0.317	0.317	41	621	339	217	420	135	175
RIKEN	BC000097	IRAL007L17	MGC	W01A095A05	pENTR-TOPO	18791		TGFBI	7045	AAH00097.1	Hs.369397	Transforming growth factor, beta-induced, 68kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000358.2	NP_000349.1	REVIEWED	C	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	AK098342	flj0051j12	FLJ	W01A095A06	pENTR-TOPO	466		ZNF362	149076	BAC05287.1	Hs.524248	Zinc finger protein 362				CBL	EK1	NM_152493.2	NP_689706.2	VALIDATED		0.317	0.317	41	621	339	217	420	135	175
RIKEN	BC018950	IRAL026K17	MGC	W01A095A07	pENTR-TOPO	9129		TRAP1	10131	AAH18950.1	Hs.30345	TNF receptor-associated protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_016292.2	NP_057376.2	VALIDATED	OK	1.000	1.000	704	2115	1	2112	704	1	704
RIKEN	BC018950	IRAL026K17	MGC	W01A095A09	pENTR-TOPO	9129		TRAP1	10131	AAH18950.1	Hs.30345	TNF receptor-associated protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_016292.2	NP_057376.2	VALIDATED	OK	1.000	1.000	704	2115	1	2112	704	1	704
RIKEN	AK098342	flj0051j12	FLJ	W01A095A10	pENTR-TOPO	466		ZNF362	149076	BAC05287.1	Hs.524248	Zinc finger protein 362				CBL	EK1	NM_152493.2	NP_689706.2	VALIDATED		0.317	0.317	41	621	339	217	420	135	175
RIKEN	AK098342	flj0051j12	FLJ	W01A095A12	pENTR-TOPO	466		ZNF362	149076	BAC05287.1	Hs.524248	Zinc finger protein 362				CBL	EK1	NM_152493.2	NP_689706.2	VALIDATED		0.317	0.317	41	621	339	217	420	135	175
RIKEN	BC018950	IRAL026K17	MGC	W01A095A13	pENTR-TOPO	9129		TRAP1	10131	AAH18950.1	Hs.30345	TNF receptor-associated protein 1			Brain, neuroblastoma	NIH_MGC_19		NM_016292.2	NP_057376.2	VALIDATED	OK	1.000	1.000	704	2115	1	2112	704	1	704
RIKEN	BC001095	IRAL007C14	MGC	W01A095A17	pENTR-TOPO	19640		PPP2R5D	5528	AAH01095.1	Hs.533308	Protein phosphatase 2, regulatory subunit B', delta isoform			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006245.2	NP_006236.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
RIKEN	BC050683	IRAK110G03	MGC	W01A095A22	pENTR-TOPO	7142		ZNF410	57862	AAH50683.1	Hs.270869	Zinc finger protein 410			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_021188.1	NP_067011.1	PROVISIONAL	Cg	0.902	1.000	478	1296	1	1293	478	1	478
RIKEN	BC041095	IRAK079N14	MGC	W01A095A23	pENTR-TOPO	3606		SLCO2B1	11309	AAH41095.1	Hs.7884	Solute carrier organic anion transporter family, member 2B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_007256.3	NP_009187.1	VALIDATED	OK	1.000	1.000	709	2130	1	2127	709	1	709
RIKEN	BC017361	IRAL039F18	MGC	W01A095A24	pENTR-TOPO	20162		HIST1H4J	8363	AAH17361.1					Eye, retinoblastoma	NIH_MGC_16		NM_021968.3	NP_068803.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC015180	IRAK014P19	MGC	W01A095B01	pENTR-TOPO	22050		HOXA3	3200	AAH15180.1	Hs.659337	Homeobox A3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_030661.4	NP_109377.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	NM_199244	X01Y024E05	RIKEN_rt-pcr	W01A095B02	pENTR-TOPO	23832		FOXD4L4	349334	NP_954714.2	Hs.534644	Forkhead box D4-like 4						NM_199244.2	NP_954714.2	PROVISIONAL	Cs	0.998	0.998	416	1251	1	1248	416	1	416
RIKEN	BC041117	IRAK082E17	MGC	W01A095B05	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	BC041117	IRAK082E17	MGC	W01A095B07	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	BC041117	IRAK082E17	MGC	W01A095B09	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	AK055693	flj0001n16	FLJ	W01A095B12	pENTR-TOPO	16392		ZBTB38	253461	BAB70986.1	Hs.715534	Zinc finger and BTB domain containing 38	IMR32	neuroblastoma		IMR322	EK1	NM_001080412.2	NP_001073881.2	VALIDATED	Pfs	0.292	0.304	24	402	246	317	1195	358	380
RIKEN	BC041117	IRAK082E17	MGC	W01A095B13	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	BC026088	IRAK034A23	MGC	W01A095B15	pENTR-TOPO	6557		RFXAP	5994	AAH26088.1	Hs.24422	Regulatory factor X-associated protein			Testis	NIH_MGC_97	DH10B	NM_000538.3	NP_000529.1	REVIEWED	Cs	0.996	0.996	272	819	1	816	272	1	272
RIKEN	AK055693	flj0001n16	FLJ	W01A095B16	pENTR-TOPO	16392		ZBTB38	253461	BAB70986.1	Hs.715534	Zinc finger and BTB domain containing 38	IMR32	neuroblastoma		IMR322	EK1	NM_001080412.2	NP_001073881.2	VALIDATED	Pfs	0.292	0.304	24	402	246	317	1195	358	380
RIKEN	NM_199244	X01Y024E05	RIKEN_rt-pcr	W01A095B18	pENTR-TOPO	23832		FOXD4L4	349334	NP_954714.2	Hs.534644	Forkhead box D4-like 4						NM_199244.2	NP_954714.2	PROVISIONAL	Cs	0.998	0.998	416	1251	1	1248	416	1	416
RIKEN	BC026088	IRAK034A23	MGC	W01A095B19	pENTR-TOPO	6557		RFXAP	5994	AAH26088.1	Hs.24422	Regulatory factor X-associated protein			Testis	NIH_MGC_97	DH10B	NM_000538.3	NP_000529.1	REVIEWED	Cs	0.996	0.996	272	819	1	816	272	1	272
RIKEN	BC011623	IRAL015F20	MGC	W01A095C01	pENTR-TOPO	24151		FANCG	2189	AAH11623.1	Hs.591084	Fanconi anemia, complementation group G			Uterus, leiomyosarcoma	NIH_MGC_46		NM_004629.1	NP_004620.1	REVIEWED	C	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC017361	IRAL039F18	MGC	W01A095C04	pENTR-TOPO	20162		HIST1H4J	8363	AAH17361.1					Eye, retinoblastoma	NIH_MGC_16		NM_021968.3	NP_068803.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC041095	IRAK079N14	MGC	W01A095C05	pENTR-TOPO	3606		SLCO2B1	11309	AAH41095.1	Hs.7884	Solute carrier organic anion transporter family, member 2B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_007256.3	NP_009187.1	VALIDATED	OK	1.000	1.000	709	2130	1	2127	709	1	709
RIKEN	BC050683	IRAK110G03	MGC	W01A095C10	pENTR-TOPO	7142		ZNF410	57862	AAH50683.1	Hs.270869	Zinc finger protein 410			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_021188.1	NP_067011.1	PROVISIONAL	Cg	0.902	1.000	478	1296	1	1293	478	1	478
RIKEN	BC011623	IRAL015F20	MGC	W01A095C11	pENTR-TOPO	24151		FANCG	2189	AAH11623.1	Hs.591084	Fanconi anemia, complementation group G			Uterus, leiomyosarcoma	NIH_MGC_46		NM_004629.1	NP_004620.1	REVIEWED	C	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC050683	IRAK110G03	MGC	W01A095C14	pENTR-TOPO	7142		ZNF410	57862	AAH50683.1	Hs.270869	Zinc finger protein 410			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_021188.1	NP_067011.1	PROVISIONAL	Cg	0.902	1.000	478	1296	1	1293	478	1	478
RIKEN	BC011623	IRAL015F20	MGC	W01A095C15	pENTR-TOPO	24151		FANCG	2189	AAH11623.1	Hs.591084	Fanconi anemia, complementation group G			Uterus, leiomyosarcoma	NIH_MGC_46		NM_004629.1	NP_004620.1	REVIEWED	C	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC017361	IRAL039F18	MGC	W01A095C18	pENTR-TOPO	20162		HIST1H4J	8363	AAH17361.1					Eye, retinoblastoma	NIH_MGC_16		NM_021968.3	NP_068803.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC050683	IRAK110G03	MGC	W01A095C20	pENTR-TOPO	7142		ZNF410	57862	AAH50683.1	Hs.270869	Zinc finger protein 410			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_021188.1	NP_067011.1	PROVISIONAL	Cg	0.902	1.000	478	1296	1	1293	478	1	478
RIKEN	BC017361	IRAL039F18	MGC	W01A095C22	pENTR-TOPO	20162		HIST1H4J	8363	AAH17361.1					Eye, retinoblastoma	NIH_MGC_16		NM_021968.3	NP_068803.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC041095	IRAK079N14	MGC	W01A095C23	pENTR-TOPO	3606		SLCO2B1	11309	AAH41095.1	Hs.7884	Solute carrier organic anion transporter family, member 2B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_007256.3	NP_009187.1	VALIDATED	OK	1.000	1.000	709	2130	1	2127	709	1	709
RIKEN	BC050683	IRAK110G03	MGC	W01A095C24	pENTR-TOPO	7142		ZNF410	57862	AAH50683.1	Hs.270869	Zinc finger protein 410			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_021188.1	NP_067011.1	PROVISIONAL	Cg	0.902	1.000	478	1296	1	1293	478	1	478
RIKEN	BC041117	IRAK082E17	MGC	W01A095D01	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	BC041117	IRAK082E17	MGC	W01A095D03	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	BC069107	X01Y145E01	MGC	W01A095D04	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC041117	IRAK082E17	MGC	W01A095D07	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	NM_033173	X01Y105E07	RIKEN_rt-pcr	W01A095D10	pENTR-TOPO	15165		B3GALT5	10317	NP_149363.1	Hs.655094	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5						NM_033170.1	NP_149360.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC069107	X01Y145E01	MGC	W01A095D12	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC041117	IRAK082E17	MGC	W01A095D17	pENTR-TOPO	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001812.2	NP_001803.2	REVIEWED	Cs	0.999	0.999	943	2832	1	2829	943	1	943
RIKEN	NM_033173	X01Y105E07	RIKEN_rt-pcr	W01A095D18	pENTR-TOPO	15165		B3GALT5	10317	NP_149363.1	Hs.655094	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5						NM_033170.1	NP_149360.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC007506	IRAL010J06	MGC	W01A095D21	pENTR-TOPO	7416		FOXN3	1112	AAH07506.1	Hs.434286	Forkhead box N3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005197.3	NP_005188.2	REVIEWED	C	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	NM_033173	X01Y105E07	RIKEN_rt-pcr	W01A095D22	pENTR-TOPO	15165		B3GALT5	10317	NP_149363.1	Hs.655094	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5						NM_033170.1	NP_149360.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC065830	IRAK141L14	MGC	W01A095D23	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC017361	IRAL039F18	MGC	W01A095E02	pENTR-TOPO	20162		HIST1H4J	8363	AAH17361.1					Eye, retinoblastoma	NIH_MGC_16		NM_021968.3	NP_068803.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC050683	IRAK110G03	MGC	W01A095E04	pENTR-TOPO	7142		ZNF410	57862	AAH50683.1	Hs.270869	Zinc finger protein 410			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_021188.1	NP_067011.1	PROVISIONAL	Cg	0.902	1.000	478	1296	1	1293	478	1	478
RIKEN	AK094068	flj0016l02	FLJ	W01A095E12	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	BC051332	IRAL047I22	MGC	W01A095E13	pENTR-TOPO	3894		F2	2147	AAH51332.1	Hs.655207	Coagulation factor II (thrombin)			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_000506.3	NP_000497.1	REVIEWED	Cs	0.998	0.998	622	1869	1	1866	622	1	622
RIKEN	AK094068	flj0016l02	FLJ	W01A095E18	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	BC051332	IRAL047I22	MGC	W01A095E21	pENTR-TOPO	3894		F2	2147	AAH51332.1	Hs.655207	Coagulation factor II (thrombin)			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_000506.3	NP_000497.1	REVIEWED	Cs	0.998	0.998	622	1869	1	1866	622	1	622
RIKEN	BC017306	IRAL039O12	MGC	W01A095E23	pENTR-TOPO	1942		NUAK2	81788	AAH17306.1	Hs.497512	NUAK family, SNF1-like kinase, 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_030952.1	NP_112214.1	PROVISIONAL	C	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	BC007506	IRAL010J06	MGC	W01A095F01	pENTR-TOPO	7416		FOXN3	1112	AAH07506.1	Hs.434286	Forkhead box N3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005197.3	NP_005188.2	REVIEWED	C	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC065830	IRAK141L14	MGC	W01A095F03	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	NM_033173	X01Y105E07	RIKEN_rt-pcr	W01A095F06	pENTR-TOPO	15165		B3GALT5	10317	NP_149363.1	Hs.655094	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5						NM_033170.1	NP_149360.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC065830	IRAK141L14	MGC	W01A095F07	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC069107	X01Y145E01	MGC	W01A095F08	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC007506	IRAL010J06	MGC	W01A095F09	pENTR-TOPO	7416		FOXN3	1112	AAH07506.1	Hs.434286	Forkhead box N3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005197.3	NP_005188.2	REVIEWED	C	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	BC065830	IRAK141L14	MGC	W01A095F11	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC069107	X01Y145E01	MGC	W01A095F12	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC065830	IRAK141L14	MGC	W01A095F15	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC069107	X01Y145E01	MGC	W01A095F16	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC007506	IRAL010J06	MGC	W01A095F17	pENTR-TOPO	7416		FOXN3	1112	AAH07506.1	Hs.434286	Forkhead box N3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005197.3	NP_005188.2	REVIEWED	C	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	NM_033173	X01Y105E07	RIKEN_rt-pcr	W01A095F18	pENTR-TOPO	15165		B3GALT5	10317	NP_149363.1	Hs.655094	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5						NM_033170.1	NP_149360.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC029378	IRAL041M05	MGC	W01A095F20	pENTR-TOPO	22529		TERF1	7013	AAH29378.1	Hs.442707	Telomeric repeat binding factor (NIMA-interacting) 1			Liver	NIH_MGC_76	DH10B	NM_003218.3	NP_003209.2	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	AK055181	flj0014j12	FLJ	W01A095F22	pENTR-TOPO	5209		ARID2	196528	BAB70867	Hs.317304	AT rich interactive domain 2 (ARID, RFX-like)				CTONG2	EK1	NM_152641.2	NP_689854.2	VALIDATED	P	1.000	1.000	145	441	1	435	1835	355	499
RIKEN	BC029378	IRAL041M05	MGC	W01A095F24	pENTR-TOPO	22529		TERF1	7013	AAH29378.1	Hs.442707	Telomeric repeat binding factor (NIMA-interacting) 1			Liver	NIH_MGC_76	DH10B	NM_003218.3	NP_003209.2	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	AK094068	flj0016l02	FLJ	W01A095G06	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	BC000335	IRAL001I17	MGC	W01A095G07	pENTR-TOPO	10686		NUP88	4927	AAH00335.1	Hs.584784	Nucleoporin 88kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002532.3	NP_002523.2	REVIEWED	OK	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	BC017306	IRAL039O12	MGC	W01A095G11	pENTR-TOPO	1942		NUAK2	81788	AAH17306.1	Hs.497512	NUAK family, SNF1-like kinase, 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_030952.1	NP_112214.1	PROVISIONAL	C	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	BC000335	IRAL001I17	MGC	W01A095G17	pENTR-TOPO	10686		NUP88	4927	AAH00335.1	Hs.584784	Nucleoporin 88kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002532.3	NP_002523.2	REVIEWED	OK	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	AK094068	flj0016l02	FLJ	W01A095G18	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	BC017306	IRAL039O12	MGC	W01A095G19	pENTR-TOPO	1942		NUAK2	81788	AAH17306.1	Hs.497512	NUAK family, SNF1-like kinase, 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_030952.1	NP_112214.1	PROVISIONAL	C	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	BC065830	IRAK141L14	MGC	W01A095H03	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC007506	IRAL010J06	MGC	W01A095H05	pENTR-TOPO	7416		FOXN3	1112	AAH07506.1	Hs.434286	Forkhead box N3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005197.3	NP_005188.2	REVIEWED	C	1.000	1.000	468	1407	1	1404	468	1	468
RIKEN	AK055181	flj0014j12	FLJ	W01A095H06	pENTR-TOPO	5209		ARID2	196528	BAB70867	Hs.317304	AT rich interactive domain 2 (ARID, RFX-like)				CTONG2	EK1	NM_152641.2	NP_689854.2	VALIDATED	P	1.000	1.000	145	441	1	435	1835	355	499
RIKEN	AK055181	flj0014j12	FLJ	W01A095H10	pENTR-TOPO	5209		ARID2	196528	BAB70867	Hs.317304	AT rich interactive domain 2 (ARID, RFX-like)				CTONG2	EK1	NM_152641.2	NP_689854.2	VALIDATED	P	1.000	1.000	145	441	1	435	1835	355	499
RIKEN	BC065830	IRAK141L14	MGC	W01A095H11	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	AK055181	flj0014j12	FLJ	W01A095H12	pENTR-TOPO	5209		ARID2	196528	BAB70867	Hs.317304	AT rich interactive domain 2 (ARID, RFX-like)				CTONG2	EK1	NM_152641.2	NP_689854.2	VALIDATED	P	1.000	1.000	145	441	1	435	1835	355	499
RIKEN	BC039245	IRAK048E06	MGC	W01A095H15	pENTR-TOPO	19797		DSE	29940	AAH39245.1	Hs.486292	Dermatan sulfate epimerase			Testis	NIH_MGC_97	DH10B	NM_013352.2	NP_037484.1	REVIEWED	C	1.000	1.000	958	2877	1	2874	958	1	958
RIKEN	BC029378	IRAL041M05	MGC	W01A095H22	pENTR-TOPO	22529		TERF1	7013	AAH29378.1	Hs.442707	Telomeric repeat binding factor (NIMA-interacting) 1			Liver	NIH_MGC_76	DH10B	NM_003218.3	NP_003209.2	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC017306	IRAL039O12	MGC	W01A095I01	pENTR-TOPO	1942		NUAK2	81788	AAH17306.1	Hs.497512	NUAK family, SNF1-like kinase, 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_030952.1	NP_112214.1	PROVISIONAL	C	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	AK094068	flj0016l02	FLJ	W01A095I02	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	BC000335	IRAL001I17	MGC	W01A095I07	pENTR-TOPO	10686		NUP88	4927	AAH00335.1	Hs.584784	Nucleoporin 88kDa			Lung, small cell carcinoma	NIH_MGC_7		NM_002532.3	NP_002523.2	REVIEWED	OK	1.000	1.000	741	2226	1	2223	741	1	741
RIKEN	BC017306	IRAL039O12	MGC	W01A095I09	pENTR-TOPO	1942		NUAK2	81788	AAH17306.1	Hs.497512	NUAK family, SNF1-like kinase, 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_030952.1	NP_112214.1	PROVISIONAL	C	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	BC033089	IRAL043K14	MGC	W01A095I12	pENTR-TOPO	23788		LCN2	3934	AAH33089.1	Hs.204238	Lipocalin 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_005564.3	NP_005555.2	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC035256	IRAK072D13	MGC	W01A095I19	pENTR-TOPO	7116		AK7	122481	AAH35256	Hs.667462	Adenylate kinase 7			Testis	NIH_MGC_97	DH10B	NM_152327.2	NP_689540.2	VALIDATED	Ps	0.997	0.997	656	1971	1	1968	723	1	656
RIKEN	BC033089	IRAL043K14	MGC	W01A095I20	pENTR-TOPO	23788		LCN2	3934	AAH33089.1	Hs.204238	Lipocalin 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_005564.3	NP_005555.2	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC035723	IRAK079G04	MGC	W01A095I22	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	BC035256	IRAK072D13	MGC	W01A095I23	pENTR-TOPO	7116		AK7	122481	AAH35256	Hs.667462	Adenylate kinase 7			Testis	NIH_MGC_97	DH10B	NM_152327.2	NP_689540.2	VALIDATED	Ps	0.997	0.997	656	1971	1	1968	723	1	656
RIKEN	NM_014468	X01Y023I23	RIKEN_rt-pcr	W01A095I24	pENTR-TOPO	2656		VENTX	27287	NP_055283.1	Hs.125231	VENT homeobox homolog (Xenopus laevis)						NM_014468.2	NP_055283.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC029378	IRAL041M05	MGC	W01A095J02	pENTR-TOPO	22529		TERF1	7013	AAH29378.1	Hs.442707	Telomeric repeat binding factor (NIMA-interacting) 1			Liver	NIH_MGC_76	DH10B	NM_003218.3	NP_003209.2	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC029378	IRAL041M05	MGC	W01A095J06	pENTR-TOPO	22529		TERF1	7013	AAH29378.1	Hs.442707	Telomeric repeat binding factor (NIMA-interacting) 1			Liver	NIH_MGC_76	DH10B	NM_003218.3	NP_003209.2	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC025389	IRAK034H16	MGC	W01A095J09	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC029378	IRAL041M05	MGC	W01A095J10	pENTR-TOPO	22529		TERF1	7013	AAH29378.1	Hs.442707	Telomeric repeat binding factor (NIMA-interacting) 1			Liver	NIH_MGC_76	DH10B	NM_003218.3	NP_003209.2	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	D13899	X01Y145E23	RIKEN_rt-pcr	W01A095J12	pENTR-TOPO	10743		PYY	5697	BAA03000.1	Hs.169249	Peptide YY						NM_004160.3	NP_004151.2	VALIDATED		0.979	0.979	97	294	1	291	97	1	97
RIKEN	BC069414	X01Y106C21	MGC	W01A095J14	pENTR-TOPO	10759		OR3A1	4994	AAH69414.1	Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL	Cs	0.997	0.997	315	948	1	945	315	1	315
RIKEN	BC025389	IRAK034H16	MGC	W01A095J15	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	D13899	X01Y145E23	RIKEN_rt-pcr	W01A095J16	pENTR-TOPO	10743		PYY	5697	BAA03000.1	Hs.169249	Peptide YY						NM_004160.3	NP_004151.2	VALIDATED		0.979	0.979	97	294	1	291	97	1	97
RIKEN	BC025389	IRAK034H16	MGC	W01A095J17	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC025389	IRAK034H16	MGC	W01A095J19	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	D13899	X01Y145E23	RIKEN_rt-pcr	W01A095J22	pENTR-TOPO	10743		PYY	5697	BAA03000.1	Hs.169249	Peptide YY						NM_004160.3	NP_004151.2	VALIDATED		0.979	0.979	97	294	1	291	97	1	97
RIKEN	BC035723	IRAK079G04	MGC	W01A095K02	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	NM_014468	X01Y023I23	RIKEN_rt-pcr	W01A095K08	pENTR-TOPO	2656		VENTX	27287	NP_055283.1	Hs.125231	VENT homeobox homolog (Xenopus laevis)						NM_014468.2	NP_055283.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC035256	IRAK072D13	MGC	W01A095K09	pENTR-TOPO	7116		AK7	122481	AAH35256	Hs.667462	Adenylate kinase 7			Testis	NIH_MGC_97	DH10B	NM_152327.2	NP_689540.2	VALIDATED	Ps	0.997	0.997	656	1971	1	1968	723	1	656
RIKEN	BC035723	IRAK079G04	MGC	W01A095K10	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	BC035723	IRAK079G04	MGC	W01A095K12	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	BC001081	IRAL002P15	MGC	W01A095K13	pENTR-TOPO	5964		ANAPC5	51433	AAH01081.1	Hs.7101	Anaphase promoting complex subunit 5			Lung, small cell carcinoma	NIH_MGC_7		NM_016237.4	NP_057321.2	REVIEWED	C	1.000	1.000	755	2268	1	2265	755	1	755
RIKEN	BC035256	IRAK072D13	MGC	W01A095K17	pENTR-TOPO	7116		AK7	122481	AAH35256	Hs.667462	Adenylate kinase 7			Testis	NIH_MGC_97	DH10B	NM_152327.2	NP_689540.2	VALIDATED	Ps	0.997	0.997	656	1971	1	1968	723	1	656
RIKEN	NM_014468	X01Y023I23	RIKEN_rt-pcr	W01A095K18	pENTR-TOPO	2656		VENTX	27287	NP_055283.1	Hs.125231	VENT homeobox homolog (Xenopus laevis)						NM_014468.2	NP_055283.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC035723	IRAK079G04	MGC	W01A095K20	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	BC035723	IRAK079G04	MGC	W01A095K22	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	BC002412	IRAL001P14	MGC	W01A095K23	pENTR-TOPO	13954		IMMT	10989	AAH02412.1	Hs.148559	Inner membrane protein, mitochondrial (mitofilin)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_006839.2	NP_006830.2	VALIDATED	C	1.000	1.000	758	2277	1	2274	758	1	758
RIKEN	BC025389	IRAK034H16	MGC	W01A095L03	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC069414	X01Y106C21	MGC	W01A095L04	pENTR-TOPO	10759		OR3A1	4994	AAH69414.1	Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL	Cs	0.997	0.997	315	948	1	945	315	1	315
RIKEN	BC025389	IRAK034H16	MGC	W01A095L05	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC025389	IRAK034H16	MGC	W01A095L07	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC069414	X01Y106C21	MGC	W01A095L08	pENTR-TOPO	10759		OR3A1	4994	AAH69414.1	Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL	Cs	0.997	0.997	315	948	1	945	315	1	315
RIKEN	AK092538	flj0006n18	FLJ	W01A095L09	pENTR-TOPO	11785		ZIK1	284307	BAG52570.1	Hs.454830	Zinc finger protein interacting with K protein 1 homolog (mouse)				PROST2	EK1	NM_001010879.2	NP_001010879.2	PROVISIONAL	Cs	0.998	0.998	487	1464	1	1461	487	1	487
RIKEN	AK027467	flj0032g21	FLJ	W01A095L13	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	AK027467	flj0032g21	FLJ	W01A095L15	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	AK027467	flj0032g21	FLJ	W01A095L19	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	BC069414	X01Y106C21	MGC	W01A095L22	pENTR-TOPO	10759		OR3A1	4994	AAH69414.1	Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL	Cs	0.997	0.997	315	948	1	945	315	1	315
RIKEN	AK027467	flj0032g21	FLJ	W01A095L23	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	NM_206880	X01Y148K05	RIKEN_rt-pcr	W01A095L24	pENTR-TOPO	18940		OR2V2	285659	NP_996763.1	Hs.553681	Olfactory receptor, family 2, subfamily V, member 2						NM_206880.1	NP_996763.1	PROVISIONAL	OK	1.000	1.000	315	948	1	945	315	1	315
RIKEN	BC035723	IRAK079G04	MGC	W01A095M02	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	BC035723	IRAK079G04	MGC	W01A095M08	pENTR-TOPO	19142		C6	729	AAH35723.1	Hs.481992	Complement component 6			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000065.2	NP_000056.2	REVIEWED	Cs	0.999	0.999	934	2805	1	2802	934	1	934
RIKEN	NM_014468	X01Y023I23	RIKEN_rt-pcr	W01A095M14	pENTR-TOPO	2656		VENTX	27287	NP_055283.1	Hs.125231	VENT homeobox homolog (Xenopus laevis)						NM_014468.2	NP_055283.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC015547	IRAK020F05	MGC	W01A095M18	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC015547	IRAK020F05	MGC	W01A095M22	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	AK027467	flj0032g21	FLJ	W01A095N01	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	AK027467	flj0032g21	FLJ	W01A095N03	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	NM_206880	X01Y148K05	RIKEN_rt-pcr	W01A095N06	pENTR-TOPO	18940		OR2V2	285659	NP_996763.1	Hs.553681	Olfactory receptor, family 2, subfamily V, member 2						NM_206880.1	NP_996763.1	PROVISIONAL	OK	1.000	1.000	315	948	1	945	315	1	315
RIKEN	NM_206880	X01Y148K05	RIKEN_rt-pcr	W01A095N08	pENTR-TOPO	18940		OR2V2	285659	NP_996763.1	Hs.553681	Olfactory receptor, family 2, subfamily V, member 2						NM_206880.1	NP_996763.1	PROVISIONAL	OK	1.000	1.000	315	948	1	945	315	1	315
RIKEN	AK027467	flj0032g21	FLJ	W01A095N09	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	AK027467	flj0032g21	FLJ	W01A095N13	pENTR-TOPO	17		ARID1A	8289	BAB55132.1	Hs.468972	AT rich interactive domain 1A (SWI-like)	NT2	teratocarcinoma		NT2RM2	EK1	NM_006015.4	NP_006006.3	REVIEWED	P	1.000	1.000	375	1128	1	1125	2285	1911	2285
RIKEN	BC002920	IRAL015E10	MGC	W01A095N19	pENTR-TOPO	2714		TSPAN14	81619	AAH02920.1	Hs.310453	Tetraspanin 14			Skin, melanotic melanoma.	NIH_MGC_20		NM_030927.2	NP_112189.2	VALIDATED	Cg	0.937	1.000	270	762	1	759	270	1	270
RIKEN	BC015547	IRAK020F05	MGC	W01A095O02	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC015180	IRAK014P19	MGC	W01A095O04	pENTR-TOPO	22050		HOXA3	3200	AAH15180.1	Hs.659337	Homeobox A3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_030661.4	NP_109377.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC018926	IRAL017L08	MGC	W01A095O05	pENTR-TOPO	9700		TRPV2	51393	AAH18926.1	Hs.279746	Transient receptor potential cation channel, subfamily V, member 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_016113.3	NP_057197.2	REVIEWED	OK	1.000	1.000	764	2295	1	2292	764	1	764
RIKEN	BC015547	IRAK020F05	MGC	W01A095O06	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC015547	IRAK020F05	MGC	W01A095O10	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC000184	IRAL006I11	MGC	W01A095O11	pENTR-TOPO	252		PRPF3	9129	AAH00184.1	Hs.11776	PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_004698.2	NP_004689.1	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC015180	IRAK014P19	MGC	W01A095O14	pENTR-TOPO	22050		HOXA3	3200	AAH15180.1	Hs.659337	Homeobox A3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_030661.4	NP_109377.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC015180	IRAK014P19	MGC	W01A095O16	pENTR-TOPO	22050		HOXA3	3200	AAH15180.1	Hs.659337	Homeobox A3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_030661.4	NP_109377.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC000184	IRAL006I11	MGC	W01A095O17	pENTR-TOPO	252		PRPF3	9129	AAH00184.1	Hs.11776	PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_004698.2	NP_004689.1	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC015547	IRAK020F05	MGC	W01A095O18	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC015180	IRAK014P19	MGC	W01A095O20	pENTR-TOPO	22050		HOXA3	3200	AAH15180.1	Hs.659337	Homeobox A3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_030661.4	NP_109377.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
RIKEN	BC000184	IRAL006I11	MGC	W01A095O21	pENTR-TOPO	252		PRPF3	9129	AAH00184.1	Hs.11776	PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_004698.2	NP_004689.1	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC000184	IRAL006I11	MGC	W01A095O23	pENTR-TOPO	252		PRPF3	9129	AAH00184.1	Hs.11776	PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16		NM_004698.2	NP_004689.1	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
RIKEN	BC015547	IRAK020F05	MGC	W01A095O24	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC022845	IRAL003L23	MGC	W01A095P02	pENTR-TOPO	7757		MORF4L1	10933	AAH22845.1	Hs.374503	Mortality factor 4 like 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_006791.2	NP_006782.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC022845	IRAL003L23	MGC	W01A095P06	pENTR-TOPO	7757		MORF4L1	10933	AAH22845.1	Hs.374503	Mortality factor 4 like 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_006791.2	NP_006782.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
RIKEN	BC022845	IRAL003L23	MGC	W01A095P12	pENTR-TOPO	7757		MORF4L1	10933	AAH22845.1	Hs.374503	Mortality factor 4 like 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_006791.2	NP_006782.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
RIKEN	NM_199244	X01Y024E05	RIKEN_rt-pcr	W01A095P13	pENTR-TOPO	23832		FOXD4L4	349334	NP_954714.2	Hs.534644	Forkhead box D4-like 4						NM_199244.2	NP_954714.2	PROVISIONAL	Cs	0.998	0.998	416	1251	1	1248	416	1	416
RIKEN	AK026075	flj0058o24	FLJ	W01A095P20	pENTR-TOPO	19311		CCNO	10309	BAB15351.1	Hs.3041	Cyclin O				HRC	EK1	NM_021147.3	NP_066970.3	VALIDATED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
RIKEN	AK055693	flj0001n16	FLJ	W01A095P21	pENTR-TOPO	16392		ZBTB38	253461	BAB70986.1	Hs.715534	Zinc finger and BTB domain containing 38	IMR32	neuroblastoma		IMR322	EK1	NM_001080412.2	NP_001073881.2	VALIDATED	Pfs	0.292	0.304	24	402	246	317	1195	358	380
RIKEN	NM_199244	X01Y024E05	RIKEN_rt-pcr	W01A095P23	pENTR-TOPO	23832		FOXD4L4	349334	NP_954714.2	Hs.534644	Forkhead box D4-like 4						NM_199244.2	NP_954714.2	PROVISIONAL	Cs	0.998	0.998	416	1251	1	1248	416	1	416
RIKEN	AK026075	flj0058o24	FLJ	W01A095P24	pENTR-TOPO	19311		CCNO	10309	BAB15351.1	Hs.3041	Cyclin O				HRC	EK1	NM_021147.3	NP_066970.3	VALIDATED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
RIKEN	AF532858	X01Y150C11	RIKEN_rt-pcr	W01A096A01	pENTR-TOPO	3877		RTN4RL2	349667	AAP21835.1	Hs.502618	Reticulon 4 receptor-like 2						NM_178570.1	NP_848665.1	PROVISIONAL	OK	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	AF532858	X01Y150C11	RIKEN_rt-pcr	W01A096A03	pENTR-TOPO	3877		RTN4RL2	349667	AAP21835.1	Hs.502618	Reticulon 4 receptor-like 2						NM_178570.1	NP_848665.1	PROVISIONAL	OK	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	AF532858	X01Y150C11	RIKEN_rt-pcr	W01A096A07	pENTR-TOPO	3877		RTN4RL2	349667	AAP21835.1	Hs.502618	Reticulon 4 receptor-like 2						NM_178570.1	NP_848665.1	PROVISIONAL	OK	1.000	1.000	420	1263	1	1260	420	1	420
RIKEN	BC060317	IRAK134E16	MGC	W01A096A08	pENTR-TOPO	19912		GTF2H5	404672	AAH60317.1	Hs.356224	General transcription factor IIH, polypeptide 5			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
RIKEN	BC038236	IRAK079J20	MGC	W01A096A13	pENTR-TOPO	25335		PIGA	5277	AAH38236.1	Hs.137154	Phosphatidylinositol glycan anchor biosynthesis, class A			Brain, hippocampus	NIH_MGC_124	DH10B	NM_002641.2	NP_002632.1	REVIEWED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	BC009372	IRAL026D07	MGC	W01A096B02	pENTR-TOPO	12007		MBD3	53615	AAH09372.1	Hs.178728	Methyl-CpG binding domain protein 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003926.5	NP_003917.1	REVIEWED	P	1.000	1.000	255	780	13	777	291	37	291
RIKEN	BC020712	IRAL037E02	MGC	W01A096B10	pENTR-TOPO	20407		POU5F1	5460	AAH20712	Hs.249184	POU class 5 homeobox 1			Lung	NIH_MGC_77	DH10B	NM_203289.3	NP_976034.3	VALIDATED	P	1.000	1.000	263	792	1	789	265	3	265
RIKEN	BC020712	IRAL037E02	MGC	W01A096B16	pENTR-TOPO	20407		POU5F1	5460	AAH20712	Hs.249184	POU class 5 homeobox 1			Lung	NIH_MGC_77	DH10B	NM_203289.3	NP_976034.3	VALIDATED	P	1.000	1.000	263	792	1	789	265	3	265
RIKEN	BC001107	IRAL007K19	MGC	W01A096B17	pENTR-TOPO	1561		FUSIP1	10772	AAH01107.1	Hs.652334	FUS interacting protein (serine/arginine-rich) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006625.3	NP_006616.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC038236	IRAK079J20	MGC	W01A096C01	pENTR-TOPO	25335		PIGA	5277	AAH38236.1	Hs.137154	Phosphatidylinositol glycan anchor biosynthesis, class A			Brain, hippocampus	NIH_MGC_124	DH10B	NM_002641.2	NP_002632.1	REVIEWED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	BC054347	IRAK115F24	MGC	W01A096C02	pENTR-TOPO	14566		EBF4	57593	AAH54347.1	Hs.471955	Early B-cell factor 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001110514.1	NP_001103984.1	VALIDATED	P	1.000	1.000	88	267	1	264	598	511	598
RIKEN	BC038236	IRAK079J20	MGC	W01A096C03	pENTR-TOPO	25335		PIGA	5277	AAH38236.1	Hs.137154	Phosphatidylinositol glycan anchor biosynthesis, class A			Brain, hippocampus	NIH_MGC_124	DH10B	NM_002641.2	NP_002632.1	REVIEWED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	BC054347	IRAK115F24	MGC	W01A096C04	pENTR-TOPO	14566		EBF4	57593	AAH54347.1	Hs.471955	Early B-cell factor 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001110514.1	NP_001103984.1	VALIDATED	P	1.000	1.000	88	267	1	264	598	511	598
RIKEN	BC038236	IRAK079J20	MGC	W01A096C05	pENTR-TOPO	25335		PIGA	5277	AAH38236.1	Hs.137154	Phosphatidylinositol glycan anchor biosynthesis, class A			Brain, hippocampus	NIH_MGC_124	DH10B	NM_002641.2	NP_002632.1	REVIEWED	C	1.000	1.000	484	1455	1	1452	484	1	484
RIKEN	AK128865	flj0076a08	FLJ	W01A096C10	pENTR-TOPO	2840		FOXI2	399823	BAC87649.1	Hs.449674	Forkhead box I2				UTERU2	EK1	NM_207426.2	NP_997309.2	VALIDATED	P	1.000	1.000	134	405	1	402	318	185	318
RIKEN	BC039196	IRAK027C22	MGC	W01A096C19	pENTR-TOPO	5873		SLC2A3	6515	AAH39196.1	Hs.419240	Solute carrier family 2 (facilitated glucose transporter), member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_006931.2	NP_008862.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC039196	IRAK027C22	MGC	W01A096C21	pENTR-TOPO	5873		SLC2A3	6515	AAH39196.1	Hs.419240	Solute carrier family 2 (facilitated glucose transporter), member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_006931.2	NP_008862.1	VALIDATED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	AK130542	flj0055n16	FLJ	W01A096D02	pENTR-TOPO	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)				SLV	EK1	NM_001128221.1	NP_001121693.1	VALIDATED	Cs	0.995	0.995	206	873	253	870	206	1	206
RIKEN	AK130542	flj0055n16	FLJ	W01A096D04	pENTR-TOPO	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)				SLV	EK1	NM_001128221.1	NP_001121693.1	VALIDATED	Cs	0.995	0.995	206	873	253	870	206	1	206
RIKEN	AK130542	flj0055n16	FLJ	W01A096D06	pENTR-TOPO	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)				SLV	EK1	NM_001128221.1	NP_001121693.1	VALIDATED	Cs	0.995	0.995	206	873	253	870	206	1	206
RIKEN	BC001107	IRAL007K19	MGC	W01A096D07	pENTR-TOPO	1561		FUSIP1	10772	AAH01107.1	Hs.652334	FUS interacting protein (serine/arginine-rich) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006625.3	NP_006616.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	AK130542	flj0055n16	FLJ	W01A096D10	pENTR-TOPO	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)				SLV	EK1	NM_001128221.1	NP_001121693.1	VALIDATED	Cs	0.995	0.995	206	873	253	870	206	1	206
RIKEN	BC000582	IRAL005O09	MGC	W01A096D15	pENTR-TOPO	14666		POFUT1	23509	AAH00582.1	Hs.472409	Protein O-fucosyltransferase 1			Brain, neuroblastoma	NIH_MGC_19		NM_172236.1	NP_758436.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
RIKEN	BC034919	IRAL043M05	MGC	W01A096D16	pENTR-TOPO	25226		EDA2R	60401	AAH34919.1	Hs.302017	Ectodysplasin A2 receptor			Brain, neuroblastoma	NIH_MGC_47		NM_021783.2	NP_068555.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC000582	IRAL005O09	MGC	W01A096D17	pENTR-TOPO	14666		POFUT1	23509	AAH00582.1	Hs.472409	Protein O-fucosyltransferase 1			Brain, neuroblastoma	NIH_MGC_19		NM_172236.1	NP_758436.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
RIKEN	BC034919	IRAL043M05	MGC	W01A096D18	pENTR-TOPO	25226		EDA2R	60401	AAH34919.1	Hs.302017	Ectodysplasin A2 receptor			Brain, neuroblastoma	NIH_MGC_47		NM_021783.2	NP_068555.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC034919	IRAL043M05	MGC	W01A096D20	pENTR-TOPO	25226		EDA2R	60401	AAH34919.1	Hs.302017	Ectodysplasin A2 receptor			Brain, neuroblastoma	NIH_MGC_47		NM_021783.2	NP_068555.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC034919	IRAL043M05	MGC	W01A096D24	pENTR-TOPO	25226		EDA2R	60401	AAH34919.1	Hs.302017	Ectodysplasin A2 receptor			Brain, neuroblastoma	NIH_MGC_47		NM_021783.2	NP_068555.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC015960	IRAL025J09	MGC	W01A096E04	pENTR-TOPO	24090		CDKN2A	1029	AAH15960.3	Hs.512599	Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)			Skin, melanotic melanoma.	NIH_MGC_20		NM_000077.3	NP_000068.1	REVIEWED	P	1.000	1.000	105	318	1	315	156	52	156
RIKEN	BC008064	IRAL003G18	MGC	W01A096E09	pENTR-TOPO	24793		MAOA	4128	AAH08064.1	Hs.183109	Monoamine oxidase A			Ovary, adenocarcinoma	NIH_MGC_9		NM_000240.2	NP_000231.1	REVIEWED	OK	1.000	1.000	527	1584	1	1581	527	1	527
RIKEN	AK023513	flj0037c11	FLJ	W01A096E12	pENTR-TOPO	24054		SNAPC4	6621	BAB14595	Hs.113265	Small nuclear RNA activating complex, polypeptide 4, 190kDa				PLACE1	EK1	NM_003086.2	NP_003077.2	VALIDATED		0.917	0.917	48	405	259	402	1469	1422	1469
RIKEN	BC008064	IRAL003G18	MGC	W01A096E13	pENTR-TOPO	24793		MAOA	4128	AAH08064.1	Hs.183109	Monoamine oxidase A			Ovary, adenocarcinoma	NIH_MGC_9		NM_000240.2	NP_000231.1	REVIEWED	OK	1.000	1.000	527	1584	1	1581	527	1	527
RIKEN	AK026075	flj0058o24	FLJ	W01A096E15	pENTR-TOPO	19311		CCNO	10309	BAB15351.1	Hs.3041	Cyclin O				HRC	EK1	NM_021147.3	NP_066970.3	VALIDATED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
RIKEN	BC072446	IRAK174K10	MGC	W01A096E22	pENTR-TOPO	25110		TSC22D3	1831	AAH72446.1	Hs.716410	TSC22 domain family, member 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004089.3	NP_004080.2	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC008064	IRAL003G18	MGC	W01A096E23	pENTR-TOPO	24793		MAOA	4128	AAH08064.1	Hs.183109	Monoamine oxidase A			Ovary, adenocarcinoma	NIH_MGC_9		NM_000240.2	NP_000231.1	REVIEWED	OK	1.000	1.000	527	1584	1	1581	527	1	527
RIKEN	BC000582	IRAL005O09	MGC	W01A096F07	pENTR-TOPO	14666		POFUT1	23509	AAH00582.1	Hs.472409	Protein O-fucosyltransferase 1			Brain, neuroblastoma	NIH_MGC_19		NM_172236.1	NP_758436.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
RIKEN	BC000518	IRAL001J18	MGC	W01A096F11	pENTR-TOPO	18590		BASP1	10409	AAH00518.1	Hs.201641	Brain abundant, membrane attached signal protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006317.3	NP_006308.3	REVIEWED	Cs	0.996	0.996	227	684	1	681	227	1	227
RIKEN	BC000518	IRAL001J18	MGC	W01A096F17	pENTR-TOPO	18590		BASP1	10409	AAH00518.1	Hs.201641	Brain abundant, membrane attached signal protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006317.3	NP_006308.3	REVIEWED	Cs	0.996	0.996	227	684	1	681	227	1	227
RIKEN	BC021282	IRAL039M03	MGC	W01A096F18	pENTR-TOPO	11421		ZNF444	55311	AAH21282.1	Hs.24545	Zinc finger protein 444			Lung, small cell carcinoma	NIH_MGC_7		NM_018337.2	NP_060807.2	VALIDATED	Cg	0.997	1.000	327	981	1	978	327	1	327
RIKEN	BC001187	IRAL006H07	MGC	W01A096F22	pENTR-TOPO	22988		COPS5	10987	AAH01187.1	Hs.491912	COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis)			Eye, retinoblastoma	NIH_MGC_16		NM_006837.2	NP_006828.2	REVIEWED	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC000518	IRAL001J18	MGC	W01A096F23	pENTR-TOPO	18590		BASP1	10409	AAH00518.1	Hs.201641	Brain abundant, membrane attached signal protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006317.3	NP_006308.3	REVIEWED	Cs	0.996	0.996	227	684	1	681	227	1	227
RIKEN	BC008064	IRAL003G18	MGC	W01A096G03	pENTR-TOPO	24793		MAOA	4128	AAH08064.1	Hs.183109	Monoamine oxidase A			Ovary, adenocarcinoma	NIH_MGC_9		NM_000240.2	NP_000231.1	REVIEWED	OK	1.000	1.000	527	1584	1	1581	527	1	527
RIKEN	AB015745	X01Y107K03	RIKEN_rt-pcr	W01A096G05	pENTR-TOPO	3090		PRLHR	2834	BAA31159.1	Hs.248119	Prolactin releasing hormone receptor						NM_004248.2	NP_004239.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	AB015745	X01Y107K03	RIKEN_rt-pcr	W01A096G07	pENTR-TOPO	3090		PRLHR	2834	BAA31159.1	Hs.248119	Prolactin releasing hormone receptor						NM_004248.2	NP_004239.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	AB015745	X01Y107K03	RIKEN_rt-pcr	W01A096G09	pENTR-TOPO	3090		PRLHR	2834	BAA31159.1	Hs.248119	Prolactin releasing hormone receptor						NM_004248.2	NP_004239.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	AB015745	X01Y107K03	RIKEN_rt-pcr	W01A096G13	pENTR-TOPO	3090		PRLHR	2834	BAA31159.1	Hs.248119	Prolactin releasing hormone receptor						NM_004248.2	NP_004239.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	AB015745	X01Y107K03	RIKEN_rt-pcr	W01A096G15	pENTR-TOPO	3090		PRLHR	2834	BAA31159.1	Hs.248119	Prolactin releasing hormone receptor						NM_004248.2	NP_004239.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	AB015745	X01Y107K03	RIKEN_rt-pcr	W01A096G19	pENTR-TOPO	3090		PRLHR	2834	BAA31159.1	Hs.248119	Prolactin releasing hormone receptor						NM_004248.2	NP_004239.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC061584	IRAK141F07	MGC	W01A096G20	pENTR-TOPO	3684		ATM	472	AAH61584.1	Hs.367437	Ataxia telangiectasia mutated				Lupski_sympathetic_trunk	DH10B	NM_000051.3	NP_000042.3	REVIEWED	P	1.000	1.000	110	339	1	330	3056	1	110
RIKEN	AK074484	flj0027n17	FLJ	W01A096G21	pENTR-TOPO	7450		KCNH5	27133	BAC11016.1	Hs.27043	Potassium voltage-gated channel, subfamily H (eag-related), member 5	H4	neuroglioma		BNGH41	EK1	NM_172375.1	NP_758963.1	REVIEWED	P	1.000	1.000	377	1134	1	1131	611	59	435
RIKEN	BC000589	IRAL005A14	MGC	W01A096G22	pENTR-TOPO	11620		NDUFA13	51079	AAH00589.2	Hs.534453	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13			Skin, melanotic melanoma.	NIH_MGC_20		NM_015965.5	NP_057049.4	VALIDATED	P	1.000	1.000	144	435	1	432	227	84	227
RIKEN	BC065282	IRAK140P07	MGC	W01A096G23	pENTR-TOPO	24205		PIGO	84720	AAH65282.1	Hs.522099	Phosphatidylinositol glycan anchor biosynthesis, class O			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152850.2	NP_690577.2	REVIEWED	C	1.000	1.000	672	2019	1	2016	672	1	672
RIKEN	BC000589	IRAL005A14	MGC	W01A096G24	pENTR-TOPO	11620		NDUFA13	51079	AAH00589.2	Hs.534453	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13			Skin, melanotic melanoma.	NIH_MGC_20		NM_015965.5	NP_057049.4	VALIDATED	P	1.000	1.000	144	435	1	432	227	84	227
RIKEN	BC071997	IRAL058M10	MGC	W01A096H05	pENTR-TOPO	66		ATF6	22926	AAH71997.1	Hs.492740	Activating transcription factor 6			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_007348.2	NP_031374.2	VALIDATED		0.975	0.975	202	609	1	606	670	1	202
RIKEN	BC015626	IRAL033O17	MGC	W01A096H12	pENTR-TOPO	8568		PARD6A	50855	AAH15626.1	Hs.112933	Par-6 partitioning defective 6 homolog alpha (C. elegans)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001037281.1	NP_001032358.1	REVIEWED	OK	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC071997	IRAL058M10	MGC	W01A096H13	pENTR-TOPO	66		ATF6	22926	AAH71997.1	Hs.492740	Activating transcription factor 6			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_007348.2	NP_031374.2	VALIDATED		0.975	0.975	202	609	1	606	670	1	202
RIKEN	BC015626	IRAL033O17	MGC	W01A096H22	pENTR-TOPO	8568		PARD6A	50855	AAH15626.1	Hs.112933	Par-6 partitioning defective 6 homolog alpha (C. elegans)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001037281.1	NP_001032358.1	REVIEWED	OK	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC065282	IRAK140P07	MGC	W01A096I05	pENTR-TOPO	24205		PIGO	84720	AAH65282.1	Hs.522099	Phosphatidylinositol glycan anchor biosynthesis, class O			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152850.2	NP_690577.2	REVIEWED	C	1.000	1.000	672	2019	1	2016	672	1	672
RIKEN	BC065282	IRAK140P07	MGC	W01A096I07	pENTR-TOPO	24205		PIGO	84720	AAH65282.1	Hs.522099	Phosphatidylinositol glycan anchor biosynthesis, class O			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152850.2	NP_690577.2	REVIEWED	C	1.000	1.000	672	2019	1	2016	672	1	672
RIKEN	BC031209	IRAK063E04	MGC	W01A096I08	pENTR-TOPO	16204		ZNF197	10168	AAH31209	Hs.157035	Zinc finger protein 197			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006991.3	NP_008922.1	REVIEWED	Pfs	0.991	0.991	117	351	1	350	1029	1	117
RIKEN	BC065282	IRAK140P07	MGC	W01A096I11	pENTR-TOPO	24205		PIGO	84720	AAH65282.1	Hs.522099	Phosphatidylinositol glycan anchor biosynthesis, class O			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152850.2	NP_690577.2	REVIEWED	C	1.000	1.000	672	2019	1	2016	672	1	672
RIKEN	AK074484	flj0027n17	FLJ	W01A096I13	pENTR-TOPO	7450		KCNH5	27133	BAC11016.1	Hs.27043	Potassium voltage-gated channel, subfamily H (eag-related), member 5	H4	neuroglioma		BNGH41	EK1	NM_172375.1	NP_758963.1	REVIEWED	P	1.000	1.000	377	1134	1	1131	611	59	435
RIKEN	BC065282	IRAK140P07	MGC	W01A096I15	pENTR-TOPO	24205		PIGO	84720	AAH65282.1	Hs.522099	Phosphatidylinositol glycan anchor biosynthesis, class O			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152850.2	NP_690577.2	REVIEWED	C	1.000	1.000	672	2019	1	2016	672	1	672
RIKEN	AK074484	flj0027n17	FLJ	W01A096I19	pENTR-TOPO	7450		KCNH5	27133	BAC11016.1	Hs.27043	Potassium voltage-gated channel, subfamily H (eag-related), member 5	H4	neuroglioma		BNGH41	EK1	NM_172375.1	NP_758963.1	REVIEWED	P	1.000	1.000	377	1134	1	1131	611	59	435
RIKEN	AK022800	flj0033g04	FLJ	W01A096I20	pENTR-TOPO	16228		ZNF167	55888	BAB14250.1	Hs.696570	Zinc finger protein 167	NT2	teratocarcinoma		NT2RP2	EK1	NM_025169.1	NP_079445.1	VALIDATED	Ps	0.994	0.994	168	507	1	504	276	1	168
RIKEN	BC065282	IRAK140P07	MGC	W01A096I23	pENTR-TOPO	24205		PIGO	84720	AAH65282.1	Hs.522099	Phosphatidylinositol glycan anchor biosynthesis, class O			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152850.2	NP_690577.2	REVIEWED	C	1.000	1.000	672	2019	1	2016	672	1	672
RIKEN	BC005903	IRAL021M05	MGC	W01A096J04	pENTR-TOPO	4884		POLR2L	5441	AAH05903.1	Hs.441072	Polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_021128.4	NP_066951.1	REVIEWED	OK	1.000	1.000	67	204	1	201	67	1	67
RIKEN	AK000826	flj0066a23	FLJ	W01A096J05	pENTR-TOPO	16335		RAB7A	7879	BAA91390.1	Hs.716392	RAB7A, member RAS oncogene family				ad	EK1	NM_004637.5	NP_004628.4	REVIEWED	P	1.000	1.000	103	696	3	311	207	105	207
RIKEN	AK025680	flj0065n18	FLJ	W01A096J08	pENTR-TOPO	2728		HIF1AN	55662	BAB15213.1	Hs.500788	Hypoxia inducible factor 1, alpha subunit inhibitor	HepG2	hepatoma		HEP	EK1	NM_017902.2	NP_060372.2	VALIDATED		0.333	0.333	21	399	96	158	349	216	236
RIKEN	AK000826	flj0066a23	FLJ	W01A096J09	pENTR-TOPO	16335		RAB7A	7879	BAA91390.1	Hs.716392	RAB7A, member RAS oncogene family				ad	EK1	NM_004637.5	NP_004628.4	REVIEWED	P	1.000	1.000	103	696	3	311	207	105	207
RIKEN	AK000826	flj0066a23	FLJ	W01A096J11	pENTR-TOPO	16335		RAB7A	7879	BAA91390.1	Hs.716392	RAB7A, member RAS oncogene family				ad	EK1	NM_004637.5	NP_004628.4	REVIEWED	P	1.000	1.000	103	696	3	311	207	105	207
RIKEN	AK000826	flj0066a23	FLJ	W01A096J13	pENTR-TOPO	16335		RAB7A	7879	BAA91390.1	Hs.716392	RAB7A, member RAS oncogene family				ad	EK1	NM_004637.5	NP_004628.4	REVIEWED	P	1.000	1.000	103	696	3	311	207	105	207
RIKEN	AK025680	flj0065n18	FLJ	W01A096J14	pENTR-TOPO	2728		HIF1AN	55662	BAB15213.1	Hs.500788	Hypoxia inducible factor 1, alpha subunit inhibitor	HepG2	hepatoma		HEP	EK1	NM_017902.2	NP_060372.2	VALIDATED		0.333	0.333	21	399	96	158	349	216	236
RIKEN	AK025680	flj0065n18	FLJ	W01A096J22	pENTR-TOPO	2728		HIF1AN	55662	BAB15213.1	Hs.500788	Hypoxia inducible factor 1, alpha subunit inhibitor	HepG2	hepatoma		HEP	EK1	NM_017902.2	NP_060372.2	VALIDATED		0.333	0.333	21	399	96	158	349	216	236
RIKEN	BC009793	IRAL019A04	MGC	W01A096J23	pENTR-TOPO	19325		ERCC8	1161	AAH09793.1	Hs.435237	Excision repair cross-complementing rodent repair deficiency, complementation group 8			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001007234.1	NP_001007235.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC047933	IRAK089J21	MGC	W01A096K03	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	AK022800	flj0033g04	FLJ	W01A096K06	pENTR-TOPO	16228		ZNF167	55888	BAB14250.1	Hs.696570	Zinc finger protein 167	NT2	teratocarcinoma		NT2RP2	EK1	NM_025169.1	NP_079445.1	VALIDATED	Ps	0.994	0.994	168	507	1	504	276	1	168
RIKEN	BC047933	IRAK089J21	MGC	W01A096K07	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	AK022800	flj0033g04	FLJ	W01A096K08	pENTR-TOPO	16228		ZNF167	55888	BAB14250.1	Hs.696570	Zinc finger protein 167	NT2	teratocarcinoma		NT2RP2	EK1	NM_025169.1	NP_079445.1	VALIDATED	Ps	0.994	0.994	168	507	1	504	276	1	168
RIKEN	BC051748	IRAK098J23	MGC	W01A096K09	pENTR-TOPO	10363		TOP3A	7156	AAH51748.1	Hs.592115	Topoisomerase (DNA) III alpha			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004618.3	NP_004609.1	REVIEWED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
RIKEN	BC047933	IRAK089J21	MGC	W01A096K11	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC047933	IRAK089J21	MGC	W01A096K13	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	AK023373	flj0036e20	FLJ	W01A096K14	pENTR-TOPO	1338		RRAGC	64121	BAB14548.1	Hs.532461	Ras-related GTP binding C				OVARC1	EK1	NM_022157.2	NP_071440.1	PROVISIONAL	P	1.000	1.000	121	366	1	363	399	279	399
RIKEN	AK023373	flj0036e20	FLJ	W01A096K16	pENTR-TOPO	1338		RRAGC	64121	BAB14548.1	Hs.532461	Ras-related GTP binding C				OVARC1	EK1	NM_022157.2	NP_071440.1	PROVISIONAL	P	1.000	1.000	121	366	1	363	399	279	399
RIKEN	BC047933	IRAK089J21	MGC	W01A096K19	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC047933	IRAK089J21	MGC	W01A096K23	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC011936	IRAL028F04	MGC	W01A096K24	pENTR-TOPO	2093		MED28	80306	AAH11936.1	Hs.644788	Mediator complex subunit 28			Lung, small cell carcinoma	NIH_MGC_7		NM_025205.3	NP_079481.2	PROVISIONAL	OK	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC009793	IRAL019A04	MGC	W01A096L05	pENTR-TOPO	19325		ERCC8	1161	AAH09793.1	Hs.435237	Excision repair cross-complementing rodent repair deficiency, complementation group 8			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001007234.1	NP_001007235.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC050396	IRAK098K16	MGC	W01A096L07	pENTR-TOPO	22966		ANKRD46	157567	AAH50396.1	Hs.530199	Ankyrin repeat domain 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198401.2	NP_940683.1	PROVISIONAL	P	1.000	1.000	212	699	1	636	228	1	212
RIKEN	AK127788	flj0078b04	FLJ	W01A096L08	pENTR-TOPO	5863		NCOR2	9612	BAC87136	Hs.137510	Nuclear receptor co-repressor 2				OCBBF3	EK1	NM_006312.3	NP_006303.3	VALIDATED		0.846	0.846	91	426	1	273	2524	2238	2328
RIKEN	AK127788	flj0078b04	FLJ	W01A096L10	pENTR-TOPO	5863		NCOR2	9612	BAC87136	Hs.137510	Nuclear receptor co-repressor 2				OCBBF3	EK1	NM_006312.3	NP_006303.3	VALIDATED		0.846	0.846	91	426	1	273	2524	2238	2328
RIKEN	BC050396	IRAK098K16	MGC	W01A096L15	pENTR-TOPO	22966		ANKRD46	157567	AAH50396.1	Hs.530199	Ankyrin repeat domain 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198401.2	NP_940683.1	PROVISIONAL	P	1.000	1.000	212	699	1	636	228	1	212
RIKEN	AK127788	flj0078b04	FLJ	W01A096L16	pENTR-TOPO	5863		NCOR2	9612	BAC87136	Hs.137510	Nuclear receptor co-repressor 2				OCBBF3	EK1	NM_006312.3	NP_006303.3	VALIDATED		0.846	0.846	91	426	1	273	2524	2238	2328
RIKEN	BC029778	IRAK050F09	MGC	W01A096L20	pENTR-TOPO	18858		FOXI1	2299	AAH29778.2	Hs.87236	Forkhead box I1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144769.2	NP_658982.1	REVIEWED	C	1.000	1.000	283	853	2	850	283	1	283
RIKEN	BC050396	IRAK098K16	MGC	W01A096L21	pENTR-TOPO	22966		ANKRD46	157567	AAH50396.1	Hs.530199	Ankyrin repeat domain 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198401.2	NP_940683.1	PROVISIONAL	P	1.000	1.000	212	699	1	636	228	1	212
RIKEN	BC050396	IRAK098K16	MGC	W01A096L23	pENTR-TOPO	22966		ANKRD46	157567	AAH50396.1	Hs.530199	Ankyrin repeat domain 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198401.2	NP_940683.1	PROVISIONAL	P	1.000	1.000	212	699	1	636	228	1	212
RIKEN	BC047933	IRAK089J21	MGC	W01A096M01	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC047933	IRAK089J21	MGC	W01A096M05	pENTR-TOPO	12955		B3GNT2	10678	AAH47933.1	Hs.173203	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006577.5	NP_006568.2	REVIEWED	C	1.000	1.000	397	1194	1	1191	397	1	397
RIKEN	BC011936	IRAL028F04	MGC	W01A096M06	pENTR-TOPO	2093		MED28	80306	AAH11936.1	Hs.644788	Mediator complex subunit 28			Lung, small cell carcinoma	NIH_MGC_7		NM_025205.3	NP_079481.2	PROVISIONAL	OK	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC011936	IRAL028F04	MGC	W01A096M10	pENTR-TOPO	2093		MED28	80306	AAH11936.1	Hs.644788	Mediator complex subunit 28			Lung, small cell carcinoma	NIH_MGC_7		NM_025205.3	NP_079481.2	PROVISIONAL	OK	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC000258	IRAL006M22	MGC	W01A096M11	pENTR-TOPO	10233		TUBD1	51174	AAH00258.1	Hs.463638	Tubulin, delta 1			Eye, retinoblastoma	NIH_MGC_16		NM_016261.2	NP_057345.2	VALIDATED	Cg	0.879	1.000	453	1197	1	1194	453	1	453
RIKEN	BC011936	IRAL028F04	MGC	W01A096M12	pENTR-TOPO	2093		MED28	80306	AAH11936.1	Hs.644788	Mediator complex subunit 28			Lung, small cell carcinoma	NIH_MGC_7		NM_025205.3	NP_079481.2	PROVISIONAL	OK	1.000	1.000	178	537	1	534	178	1	178
RIKEN	BC000258	IRAL006M22	MGC	W01A096M13	pENTR-TOPO	10233		TUBD1	51174	AAH00258.1	Hs.463638	Tubulin, delta 1			Eye, retinoblastoma	NIH_MGC_16		NM_016261.2	NP_057345.2	VALIDATED	Cg	0.879	1.000	453	1197	1	1194	453	1	453
RIKEN	BC000258	IRAL006M22	MGC	W01A096M17	pENTR-TOPO	10233		TUBD1	51174	AAH00258.1	Hs.463638	Tubulin, delta 1			Eye, retinoblastoma	NIH_MGC_16		NM_016261.2	NP_057345.2	VALIDATED	Cg	0.879	1.000	453	1197	1	1194	453	1	453
RIKEN	BC010543	IRAK019L17	MGC	W01A096M20	pENTR-TOPO	1773		MED8	112950	AAH10543.2	Hs.301756	Mediator complex subunit 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_201542.3	NP_963836.2	REVIEWED	P	1.000	1.000	179	639	1	537	268	90	268
RIKEN	BC000258	IRAL006M22	MGC	W01A096M21	pENTR-TOPO	10233		TUBD1	51174	AAH00258.1	Hs.463638	Tubulin, delta 1			Eye, retinoblastoma	NIH_MGC_16		NM_016261.2	NP_057345.2	VALIDATED	Cg	0.879	1.000	453	1197	1	1194	453	1	453
RIKEN	BC010543	IRAK019L17	MGC	W01A096M24	pENTR-TOPO	1773		MED8	112950	AAH10543.2	Hs.301756	Mediator complex subunit 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_201542.3	NP_963836.2	REVIEWED	P	1.000	1.000	179	639	1	537	268	90	268
RIKEN	BC029778	IRAK050F09	MGC	W01A096N02	pENTR-TOPO	18858		FOXI1	2299	AAH29778.2	Hs.87236	Forkhead box I1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144769.2	NP_658982.1	REVIEWED	C	1.000	1.000	283	853	2	850	283	1	283
RIKEN	BC029778	IRAK050F09	MGC	W01A096N04	pENTR-TOPO	18858		FOXI1	2299	AAH29778.2	Hs.87236	Forkhead box I1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144769.2	NP_658982.1	REVIEWED	C	1.000	1.000	283	853	2	850	283	1	283
RIKEN	BC029778	IRAK050F09	MGC	W01A096N06	pENTR-TOPO	18858		FOXI1	2299	AAH29778.2	Hs.87236	Forkhead box I1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144769.2	NP_658982.1	REVIEWED	C	1.000	1.000	283	853	2	850	283	1	283
RIKEN	BC072458	IRAK174O02	MGC	W01A096N10	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC072458	IRAK174O02	MGC	W01A096N14	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC072458	IRAK174O02	MGC	W01A096N16	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC035374	IRAK051N16	MGC	W01A096N17	pENTR-TOPO	656		C1orf83	127428	AAH35374.1	Hs.558618	Chromosome 1 open reading frame 83			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153035.1	NP_694580.1	PREDICTED	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC035374	IRAK051N16	MGC	W01A096N19	pENTR-TOPO	656		C1orf83	127428	AAH35374.1	Hs.558618	Chromosome 1 open reading frame 83			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153035.1	NP_694580.1	PREDICTED	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC072458	IRAK174O02	MGC	W01A096N22	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC035374	IRAK051N16	MGC	W01A096N23	pENTR-TOPO	656		C1orf83	127428	AAH35374.1	Hs.558618	Chromosome 1 open reading frame 83			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153035.1	NP_694580.1	PREDICTED	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC072458	IRAK174O02	MGC	W01A096N24	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC000258	IRAL006M22	MGC	W01A096O01	pENTR-TOPO	10233		TUBD1	51174	AAH00258.1	Hs.463638	Tubulin, delta 1			Eye, retinoblastoma	NIH_MGC_16		NM_016261.2	NP_057345.2	VALIDATED	Cg	0.879	1.000	453	1197	1	1194	453	1	453
RIKEN	BC010543	IRAK019L17	MGC	W01A096O02	pENTR-TOPO	1773		MED8	112950	AAH10543.2	Hs.301756	Mediator complex subunit 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_201542.3	NP_963836.2	REVIEWED	P	1.000	1.000	179	639	1	537	268	90	268
RIKEN	BC010543	IRAK019L17	MGC	W01A096O06	pENTR-TOPO	1773		MED8	112950	AAH10543.2	Hs.301756	Mediator complex subunit 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_201542.3	NP_963836.2	REVIEWED	P	1.000	1.000	179	639	1	537	268	90	268
RIKEN	AK000410	flj0062f23	FLJ	W01A096O15	pENTR-TOPO	547		ZNF326	284695	-	Hs.306221	Zinc finger protein 326				KAT	EK1	NM_182975.2	NP_892020.1	VALIDATED	C	1.000	1.000	70	213	1	210	70	1	70
RIKEN	AK000410	flj0062f23	FLJ	W01A096O21	pENTR-TOPO	547		ZNF326	284695	-	Hs.306221	Zinc finger protein 326				KAT	EK1	NM_182975.2	NP_892020.1	VALIDATED	C	1.000	1.000	70	213	1	210	70	1	70
RIKEN	BC002618	IRAL004P14	MGC	W01A096P02	pENTR-TOPO	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003691.2	NP_003682.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC040961	IRAK084F23	MGC	W01A096P03	pENTR-TOPO	5630		NEUROD4	58158	AAH40961.1	Hs.591024	Neurogenic differentiation 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021191.2	NP_067014.2	VALIDATED	P	1.000	1.000	255	768	1	765	331	77	331
RIKEN	BC002618	IRAL004P14	MGC	W01A096P06	pENTR-TOPO	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003691.2	NP_003682.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC040961	IRAK084F23	MGC	W01A096P07	pENTR-TOPO	5630		NEUROD4	58158	AAH40961.1	Hs.591024	Neurogenic differentiation 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021191.2	NP_067014.2	VALIDATED	P	1.000	1.000	255	768	1	765	331	77	331
RIKEN	BC033073	IRAL043D23	MGC	W01A096P12	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	BC040961	IRAK084F23	MGC	W01A096P17	pENTR-TOPO	5630		NEUROD4	58158	AAH40961.1	Hs.591024	Neurogenic differentiation 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021191.2	NP_067014.2	VALIDATED	P	1.000	1.000	255	768	1	765	331	77	331
RIKEN	BC033073	IRAL043D23	MGC	W01A096P18	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	BC033073	IRAL043D23	MGC	W01A096P20	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	AK095562	flj0026g14	FLJ	W01A096P21	pENTR-TOPO	11744		ZNF578	147660	BAC04574.1	Hs.157287	Zinc finger protein 578				FCBBF2	EK1	NM_001099694.1	NP_001093164.1	VALIDATED	Ps	0.991	0.991	212	639	1	636	590	379	590
RIKEN	BC033073	IRAL043D23	MGC	W01A096P22	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	BC009372	IRAL026D07	MGC	W01A096P23	pENTR-TOPO	12007		MBD3	53615	AAH09372.1	Hs.178728	Methyl-CpG binding domain protein 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003926.5	NP_003917.1	REVIEWED	P	1.000	1.000	255	780	13	777	291	37	291
RIKEN	BC004255	IRAL013A17	MGC	W01A097A01	pENTR-TOPO	19941		ZSCAN16	80345	AAH04255.1	Hs.656641	Zinc finger and SCAN domain containing 16			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_025231.1	NP_079507.1	PROVISIONAL	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC026092	IRAK034L20	MGC	W01A097A02	pENTR-TOPO	20046		ZNF165	7718	AAH26092.1	Hs.535177	Zinc finger protein 165			Testis	NIH_MGC_97	DH10B	NM_003447.2	NP_003438.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC026092	IRAK034L20	MGC	W01A097A04	pENTR-TOPO	20046		ZNF165	7718	AAH26092.1	Hs.535177	Zinc finger protein 165			Testis	NIH_MGC_97	DH10B	NM_003447.2	NP_003438.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC046460	IRAK051F06	MGC	W01A097A08	pENTR-TOPO	10748		FOXJ1	2302	AAH46460.1	Hs.651204	Forkhead box J1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001454.2	NP_001445.2	VALIDATED	C	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	BC004255	IRAL013A17	MGC	W01A097A09	pENTR-TOPO	19941		ZSCAN16	80345	AAH04255.1	Hs.656641	Zinc finger and SCAN domain containing 16			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_025231.1	NP_079507.1	PROVISIONAL	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC046460	IRAK051F06	MGC	W01A097A10	pENTR-TOPO	10748		FOXJ1	2302	AAH46460.1	Hs.651204	Forkhead box J1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001454.2	NP_001445.2	VALIDATED	C	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	BC004255	IRAL013A17	MGC	W01A097A13	pENTR-TOPO	19941		ZSCAN16	80345	AAH04255.1	Hs.656641	Zinc finger and SCAN domain containing 16			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_025231.1	NP_079507.1	PROVISIONAL	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC046460	IRAK051F06	MGC	W01A097A14	pENTR-TOPO	10748		FOXJ1	2302	AAH46460.1	Hs.651204	Forkhead box J1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001454.2	NP_001445.2	VALIDATED	C	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	BC052308	IRAL047P02	MGC	W01A097A16	pENTR-TOPO	9889		ANKFY1	51479	AAH52308.1	Hs.696087	Ankyrin repeat and FYVE domain containing 1			Breast, adenocarcinoma	NIH_MGC_107		NM_020740.2	NP_065791.1	VALIDATED	OK	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC052308	IRAL047P02	MGC	W01A097A18	pENTR-TOPO	9889		ANKFY1	51479	AAH52308.1	Hs.696087	Ankyrin repeat and FYVE domain containing 1			Breast, adenocarcinoma	NIH_MGC_107		NM_020740.2	NP_065791.1	VALIDATED	OK	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC052308	IRAL047P02	MGC	W01A097A20	pENTR-TOPO	9889		ANKFY1	51479	AAH52308.1	Hs.696087	Ankyrin repeat and FYVE domain containing 1			Breast, adenocarcinoma	NIH_MGC_107		NM_020740.2	NP_065791.1	VALIDATED	OK	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC073983	IRAK174N21	MGC	W01A097B09	pENTR-TOPO	18909		EGR1	1958	AAH73983.1	Hs.708393	Early growth response 1				Lupski_sympathetic_trunk	DH10B	NM_001964.2	NP_001955.1	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	BC073983	IRAK174N21	MGC	W01A097B17	pENTR-TOPO	18909		EGR1	1958	AAH73983.1	Hs.708393	Early growth response 1				Lupski_sympathetic_trunk	DH10B	NM_001964.2	NP_001955.1	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	BC073983	IRAK174N21	MGC	W01A097B21	pENTR-TOPO	18909		EGR1	1958	AAH73983.1	Hs.708393	Early growth response 1				Lupski_sympathetic_trunk	DH10B	NM_001964.2	NP_001955.1	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
RIKEN	BC007199	IRAL018B16	MGC	W01A097C01	pENTR-TOPO	13159		CNNM3	26505	AAH07199.3	Hs.711617	Cyclin M3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_199078.2	NP_951060.1	VALIDATED	Ps	0.991	0.991	324	1068	1	972	659	326	649
RIKEN	BC052308	IRAL047P02	MGC	W01A097C02	pENTR-TOPO	9889		ANKFY1	51479	AAH52308.1	Hs.696087	Ankyrin repeat and FYVE domain containing 1			Breast, adenocarcinoma	NIH_MGC_107		NM_020740.2	NP_065791.1	VALIDATED	OK	1.000	1.000	487	1464	1	1461	487	1	487
RIKEN	BC007199	IRAL018B16	MGC	W01A097C03	pENTR-TOPO	13159		CNNM3	26505	AAH07199.3	Hs.711617	Cyclin M3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_199078.2	NP_951060.1	VALIDATED	Ps	0.991	0.991	324	1068	1	972	659	326	649
RIKEN	BC058915	IRAK119D22	MGC	W01A097C09	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC058915	IRAK119D22	MGC	W01A097C11	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC058915	IRAK119D22	MGC	W01A097C15	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC058915	IRAK119D22	MGC	W01A097C19	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC058915	IRAK119D22	MGC	W01A097C23	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC033800	IRAK068J19	MGC	W01A097D04	pENTR-TOPO	10283		YBX2	51087	AAH33800.1	Hs.567494	Y box binding protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015982.3	NP_057066.2	VALIDATED	OK	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	AK024290	flj0035h11	FLJ	W01A097D09	pENTR-TOPO	10245		PHF12	57649	BAB14875.1	Hs.714975	PHD finger protein 12	NT2	teratocarcinoma		NT2RP3	EK1	NM_020889.2	NP_065940.1	VALIDATED	P	1.000	1.000	282	1773	1	846	704	415	696
RIKEN	AK125913	flj0072e04	FLJ	W01A097D10	pENTR-TOPO	7326		PPP1R13B	23368	BAC86342.1	Hs.709297	Protein phosphatase 1, regulatory (inhibitor) subunit 13B				TESTI4	EK1	NM_015316.2	NP_056131.2	REVIEWED	Pfs	0.943	0.982	652	1887	1	1885	1090	134	783
RIKEN	AK024290	flj0035h11	FLJ	W01A097D13	pENTR-TOPO	10245		PHF12	57649	BAB14875.1	Hs.714975	PHD finger protein 12	NT2	teratocarcinoma		NT2RP3	EK1	NM_020889.2	NP_065940.1	VALIDATED	P	1.000	1.000	282	1773	1	846	704	415	696
RIKEN	BC042633	IRAK051E08	MGC	W01A097D18	pENTR-TOPO	25332		ESX1	80712	AAH42633.1	Hs.223782	ESX homeobox 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153448.2	NP_703149.1	VALIDATED	Cs	0.993	0.993	406	1221	1	1218	406	1	406
RIKEN	BC041661	IRAK082P19	MGC	W01A097D19	pENTR-TOPO	20332		ZSCAN12	9753	AAH41661.1	Hs.134816	Zinc finger and SCAN domain containing 12			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001145043.1	NP_001138515.1	VALIDATED	C	1.000	1.000	604	1815	1	1812	604	1	604
RIKEN	BC042633	IRAK051E08	MGC	W01A097D20	pENTR-TOPO	25332		ESX1	80712	AAH42633.1	Hs.223782	ESX homeobox 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153448.2	NP_703149.1	VALIDATED	Cs	0.993	0.993	406	1221	1	1218	406	1	406
RIKEN	BC042633	IRAK051E08	MGC	W01A097D22	pENTR-TOPO	25332		ESX1	80712	AAH42633.1	Hs.223782	ESX homeobox 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153448.2	NP_703149.1	VALIDATED	Cs	0.993	0.993	406	1221	1	1218	406	1	406
RIKEN	BC041158	IRAK084D19	MGC	W01A097E02	pENTR-TOPO	1041		CYP4A11	1579	AAH41158.1	Hs.714775	Cytochrome P450, family 4, subfamily A, polypeptide 11			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000778.3	NP_000769.2	REVIEWED	P	1.000	1.000	455	1368	1	1365	519	1	455
RIKEN	BC041158	IRAK084D19	MGC	W01A097E04	pENTR-TOPO	1041		CYP4A11	1579	AAH41158.1	Hs.714775	Cytochrome P450, family 4, subfamily A, polypeptide 11			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000778.3	NP_000769.2	REVIEWED	P	1.000	1.000	455	1368	1	1365	519	1	455
RIKEN	BC000834	IRAK004N15	MGC	W01A097E11	pENTR-TOPO	18748		CDK7	1022	AAH00834.1	Hs.184298	Cyclin-dependent kinase 7			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001799.3	NP_001790.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC000834	IRAK004N15	MGC	W01A097E13	pENTR-TOPO	18748		CDK7	1022	AAH00834.1	Hs.184298	Cyclin-dependent kinase 7			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001799.3	NP_001790.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC000834	IRAK004N15	MGC	W01A097E15	pENTR-TOPO	18748		CDK7	1022	AAH00834.1	Hs.184298	Cyclin-dependent kinase 7			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001799.3	NP_001790.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC030261	IRAK062F07	MGC	W01A097E19	pENTR-TOPO	11601		ZNF222	7673	AAH30261.1	Hs.279840	Zinc finger protein 222			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_013360.2	NP_037492.2	VALIDATED	P	1.000	1.000	397	1194	1	1191	451	55	451
RIKEN	BC023655	IRAL039F04	MGC	W01A097E22	pENTR-TOPO	14920		PLAGL2	5326	AAH23655.1	Hs.154104	Pleiomorphic adenoma gene-like 2			Primary B-Cells from Tonsils	NIH_MGC_48		NM_002657.3	NP_002648.1	REVIEWED	C	1.000	1.000	496	1491	1	1488	496	1	496
RIKEN	BC030261	IRAK062F07	MGC	W01A097E23	pENTR-TOPO	11601		ZNF222	7673	AAH30261.1	Hs.279840	Zinc finger protein 222			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_013360.2	NP_037492.2	VALIDATED	P	1.000	1.000	397	1194	1	1191	451	55	451
RIKEN	BC041661	IRAK082P19	MGC	W01A097F01	pENTR-TOPO	20332		ZSCAN12	9753	AAH41661.1	Hs.134816	Zinc finger and SCAN domain containing 12			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001145043.1	NP_001138515.1	VALIDATED	C	1.000	1.000	604	1815	1	1812	604	1	604
RIKEN	BC041661	IRAK082P19	MGC	W01A097F05	pENTR-TOPO	20332		ZSCAN12	9753	AAH41661.1	Hs.134816	Zinc finger and SCAN domain containing 12			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001145043.1	NP_001138515.1	VALIDATED	C	1.000	1.000	604	1815	1	1812	604	1	604
RIKEN	BC067521	IRAK172B01	MGC	W01A097F10	pENTR-TOPO	13153		GRHL1	29841	AAH67521.1	Hs.418493	Grainyhead-like 1 (Drosophila)			PCR rescued clones	NIH_MGC_195	DH10B	NM_198182.1	NP_937825.1	REVIEWED	Pfs	0.891	0.990	349	1536	491	1535	429	1	314
RIKEN	BC028599	IRAK047C09	MGC	W01A097F13	pENTR-TOPO	16124		APPL1	26060	AAH28599.1	Hs.476415	Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1			Testis	NIH_MGC_97	DH10B	NM_012096.2	NP_036228.1	REVIEWED	C	1.000	1.000	709	2130	1	2127	709	1	709
RIKEN	BC028599	IRAK047C09	MGC	W01A097F17	pENTR-TOPO	16124		APPL1	26060	AAH28599.1	Hs.476415	Adaptor protein, phosphotyrosine interaction, PH domain and leucine zipper containing 1			Testis	NIH_MGC_97	DH10B	NM_012096.2	NP_036228.1	REVIEWED	C	1.000	1.000	709	2130	1	2127	709	1	709
RIKEN	AK128070	flj0076k20	FLJ	W01A097F18	pENTR-TOPO	14974		CTCFL	140690	BAG54626.1	Hs.131543	CCCTC-binding factor (zinc finger protein)-like				TESTI4	EK1	NM_080618.2	NP_542185.2	REVIEWED	Cs	0.998	0.998	663	1992	1	1989	663	1	663
RIKEN	BC063784	IRAK141H21	MGC	W01A097F19	pENTR-TOPO	12392		SF4	57794	AAH63784.1	Hs.515274	Splicing factor 4			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	642	1929	1	1926	645	4	645
RIKEN	AK128070	flj0076k20	FLJ	W01A097F20	pENTR-TOPO	14974		CTCFL	140690	BAG54626.1	Hs.131543	CCCTC-binding factor (zinc finger protein)-like				TESTI4	EK1	NM_080618.2	NP_542185.2	REVIEWED	Cs	0.998	0.998	663	1992	1	1989	663	1	663
RIKEN	AK128070	flj0076k20	FLJ	W01A097F22	pENTR-TOPO	14974		CTCFL	140690	BAG54626.1	Hs.131543	CCCTC-binding factor (zinc finger protein)-like				TESTI4	EK1	NM_080618.2	NP_542185.2	REVIEWED	Cs	0.998	0.998	663	1992	1	1989	663	1	663
RIKEN	AK094170	flj0025g14	FLJ	W01A097G03	pENTR-TOPO	3206		ASCC1	51008	BAC04299.1	Hs.500007	Activating signal cointegrator 1 complex subunit 1				ASTRO2	EK1	NM_015947.2	NP_057031.2	VALIDATED	Pgs	0.914	0.994	349	1203	1	1047	357	1	321
RIKEN	AK094170	flj0025g14	FLJ	W01A097G05	pENTR-TOPO	3206		ASCC1	51008	BAC04299.1	Hs.500007	Activating signal cointegrator 1 complex subunit 1				ASTRO2	EK1	NM_015947.2	NP_057031.2	VALIDATED	Pgs	0.914	0.994	349	1203	1	1047	357	1	321
RIKEN	BC028136	IRAK062H05	MGC	W01A097G12	pENTR-TOPO	23173		ZNF34	80778	AAH28136.1	Hs.631854	Zinc finger protein 34			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_030580.3	NP_085057.3	VALIDATED	Pg	0.924	1.000	529	1650	181	1647	560	32	560
RIKEN	BC028136	IRAK062H05	MGC	W01A097G14	pENTR-TOPO	23173		ZNF34	80778	AAH28136.1	Hs.631854	Zinc finger protein 34			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_030580.3	NP_085057.3	VALIDATED	Pg	0.924	1.000	529	1650	181	1647	560	32	560
RIKEN	BC028136	IRAK062H05	MGC	W01A097G20	pENTR-TOPO	23173		ZNF34	80778	AAH28136.1	Hs.631854	Zinc finger protein 34			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_030580.3	NP_085057.3	VALIDATED	Pg	0.924	1.000	529	1650	181	1647	560	32	560
RIKEN	BC003591	IRAL002M19	MGC	W01A097G21	pENTR-TOPO	4729		SIGIRR	59307	AAH03591.1	Hs.501624	Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain			Lung, small cell carcinoma	NIH_MGC_7		NM_021805.2	NP_068577.2	VALIDATED	Cs	0.998	0.998	410	1233	1	1230	410	1	410
RIKEN	BC037900	IRAK075I14	MGC	W01A097G22	pENTR-TOPO	3168		CTBP2	1488	AAH37900.1	Hs.501345	C-terminal binding protein 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001329.2	NP_001320.1	REVIEWED	Ps	0.998	0.998	426	1542	262	1539	445	20	445
RIKEN	BC037900	IRAK075I14	MGC	W01A097G24	pENTR-TOPO	3168		CTBP2	1488	AAH37900.1	Hs.501345	C-terminal binding protein 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001329.2	NP_001320.1	REVIEWED	Ps	0.998	0.998	426	1542	262	1539	445	20	445
RIKEN	AK128070	flj0076k20	FLJ	W01A097H02	pENTR-TOPO	14974		CTCFL	140690	BAG54626.1	Hs.131543	CCCTC-binding factor (zinc finger protein)-like				TESTI4	EK1	NM_080618.2	NP_542185.2	REVIEWED	Cs	0.998	0.998	663	1992	1	1989	663	1	663
RIKEN	BC062602	IRAK135O07	MGC	W01A097H03	pENTR-TOPO	7168		PNN	5411	AAH62602.1	Hs.409965	Pinin, desmosome associated protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002687.3	NP_002678.2	VALIDATED	C	1.000	1.000	717	2154	1	2151	717	1	717
RIKEN	AK128070	flj0076k20	FLJ	W01A097H04	pENTR-TOPO	14974		CTCFL	140690	BAG54626.1	Hs.131543	CCCTC-binding factor (zinc finger protein)-like				TESTI4	EK1	NM_080618.2	NP_542185.2	REVIEWED	Cs	0.998	0.998	663	1992	1	1989	663	1	663
RIKEN	BC062602	IRAK135O07	MGC	W01A097H05	pENTR-TOPO	7168		PNN	5411	AAH62602.1	Hs.409965	Pinin, desmosome associated protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002687.3	NP_002678.2	VALIDATED	C	1.000	1.000	717	2154	1	2151	717	1	717
RIKEN	BC065931	IRAK140L02	MGC	W01A097H10	pENTR-TOPO	5580		NAB2	4665	AAH65931.1	Hs.159223	NGFI-A binding protein 2 (EGR1 binding protein 2)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005967.3	NP_005958.1	REVIEWED	OK	1.000	1.000	525	1578	1	1575	525	1	525
RIKEN	BC062602	IRAK135O07	MGC	W01A097H11	pENTR-TOPO	7168		PNN	5411	AAH62602.1	Hs.409965	Pinin, desmosome associated protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_002687.3	NP_002678.2	VALIDATED	C	1.000	1.000	717	2154	1	2151	717	1	717
RIKEN	BC059386	IRAK133A21	MGC	W01A097H16	pENTR-TOPO	16585		SKIL	6498	AAH59386.1	Hs.581632	SKI-like oncogene			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001145098.1	NP_001138570.1	VALIDATED	Cs	0.998	0.998	664	2055	61	2052	664	1	664
RIKEN	BC059386	IRAK133A21	MGC	W01A097H18	pENTR-TOPO	16585		SKIL	6498	AAH59386.1	Hs.581632	SKI-like oncogene			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001145098.1	NP_001138570.1	VALIDATED	Cs	0.998	0.998	664	2055	61	2052	664	1	664
RIKEN	BC059386	IRAK133A21	MGC	W01A097H20	pENTR-TOPO	16585		SKIL	6498	AAH59386.1	Hs.581632	SKI-like oncogene			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001145098.1	NP_001138570.1	VALIDATED	Cs	0.998	0.998	664	2055	61	2052	664	1	664
RIKEN	BC059386	IRAK133A21	MGC	W01A097H22	pENTR-TOPO	16585		SKIL	6498	AAH59386.1	Hs.581632	SKI-like oncogene			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001145098.1	NP_001138570.1	VALIDATED	Cs	0.998	0.998	664	2055	61	2052	664	1	664
RIKEN	BC059386	IRAK133A21	MGC	W01A097H24	pENTR-TOPO	16585		SKIL	6498	AAH59386.1	Hs.581632	SKI-like oncogene			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001145098.1	NP_001138570.1	VALIDATED	Cs	0.998	0.998	664	2055	61	2052	664	1	664
RIKEN	BC037900	IRAK075I14	MGC	W01A097I04	pENTR-TOPO	3168		CTBP2	1488	AAH37900.1	Hs.501345	C-terminal binding protein 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001329.2	NP_001320.1	REVIEWED	Ps	0.998	0.998	426	1542	262	1539	445	20	445
RIKEN	AK093577	flj0007d02	FLJ	W01A097I05	pENTR-TOPO	8559		MKL2	57496	BAC04200.1	Hs.49143	MKL/myocardin-like 2				THYMU2	EK1	NM_014048.3	NP_054767.3	VALIDATED		0.940	0.940	332	1386	52	1047	1049	29	360
RIKEN	AK093577	flj0007d02	FLJ	W01A097I07	pENTR-TOPO	8559		MKL2	57496	BAC04200.1	Hs.49143	MKL/myocardin-like 2				THYMU2	EK1	NM_014048.3	NP_054767.3	VALIDATED		0.940	0.940	332	1386	52	1047	1049	29	360
RIKEN	AK093577	flj0007d02	FLJ	W01A097I09	pENTR-TOPO	8559		MKL2	57496	BAC04200.1	Hs.49143	MKL/myocardin-like 2				THYMU2	EK1	NM_014048.3	NP_054767.3	VALIDATED		0.940	0.940	332	1386	52	1047	1049	29	360
RIKEN	BC064663	IRAK110P06	MGC	W01A097I16	pENTR-TOPO	9734		NLK	51701	AAH64663.2	Hs.208759	Nemo-like kinase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016231.4	NP_057315.3	VALIDATED	Ps	0.998	0.998	515	1548	1	1545	527	13	527
RIKEN	BC064663	IRAK110P06	MGC	W01A097I18	pENTR-TOPO	9734		NLK	51701	AAH64663.2	Hs.208759	Nemo-like kinase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016231.4	NP_057315.3	VALIDATED	Ps	0.998	0.998	515	1548	1	1545	527	13	527
RIKEN	AK055611	flj0001l19	FLJ	W01A097I19	pENTR-TOPO	14905		PRIC285	85441	BAB70969.1	Hs.517180	Peroxisomal proliferator-activated receptor A interacting complex 285				HSYRA2	EK1	NM_001037335.2	NP_001032412.2	REVIEWED	P	1.000	1.000	413	1242	1	1239	2649	2237	2649
RIKEN	AK055611	flj0001l19	FLJ	W01A097I21	pENTR-TOPO	14905		PRIC285	85441	BAB70969.1	Hs.517180	Peroxisomal proliferator-activated receptor A interacting complex 285				HSYRA2	EK1	NM_001037335.2	NP_001032412.2	REVIEWED	P	1.000	1.000	413	1242	1	1239	2649	2237	2649
RIKEN	BC053322	IRAL047O01	MGC	W01A097J04	pENTR-TOPO	4508		DEAF1	10522	AAH53322.1	Hs.243994	Deformed epidermal autoregulatory factor 1 (Drosophila)			Ovary, teratocarcinoma	NIH_MGC_109		NM_021008.2	NP_066288.2	VALIDATED	OK	1.000	1.000	565	1698	1	1695	565	1	565
RIKEN	BC027596	IRAK034J14	MGC	W01A097J09	pENTR-TOPO	4580		PPP2R1B	5519	AAH27596.1	Hs.584790	Protein phosphatase 2 (formerly 2A), regulatory subunit A, beta isoform			Testis	NIH_MGC_97	DH10B	NM_181699.2	NP_859050.1	REVIEWED	C	1.000	1.000	667	2004	1	2001	667	1	667
RIKEN	BC037209	IRAK072L10	MGC	W01A097J14	pENTR-TOPO	12172		ZNF606	80095	AAH37209.1	Hs.654967	Zinc finger protein 606			Testis	NIH_MGC_97	DH10B	NM_025027.3	NP_079303.2	VALIDATED	Cs	0.999	0.999	792	2379	1	2376	792	1	792
RIKEN	BC037209	IRAK072L10	MGC	W01A097J22	pENTR-TOPO	12172		ZNF606	80095	AAH37209.1	Hs.654967	Zinc finger protein 606			Testis	NIH_MGC_97	DH10B	NM_025027.3	NP_079303.2	VALIDATED	Cs	0.999	0.999	792	2379	1	2376	792	1	792
RIKEN	AK055611	flj0001l19	FLJ	W01A097K01	pENTR-TOPO	14905		PRIC285	85441	BAB70969.1	Hs.517180	Peroxisomal proliferator-activated receptor A interacting complex 285				HSYRA2	EK1	NM_001037335.2	NP_001032412.2	REVIEWED	P	1.000	1.000	413	1242	1	1239	2649	2237	2649
RIKEN	AK055611	flj0001l19	FLJ	W01A097K05	pENTR-TOPO	14905		PRIC285	85441	BAB70969.1	Hs.517180	Peroxisomal proliferator-activated receptor A interacting complex 285				HSYRA2	EK1	NM_001037335.2	NP_001032412.2	REVIEWED	P	1.000	1.000	413	1242	1	1239	2649	2237	2649
RIKEN	BC064663	IRAK110P06	MGC	W01A097K06	pENTR-TOPO	9734		NLK	51701	AAH64663.2	Hs.208759	Nemo-like kinase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016231.4	NP_057315.3	VALIDATED	Ps	0.998	0.998	515	1548	1	1545	527	13	527
RIKEN	BC064663	IRAK110P06	MGC	W01A097K08	pENTR-TOPO	9734		NLK	51701	AAH64663.2	Hs.208759	Nemo-like kinase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016231.4	NP_057315.3	VALIDATED	Ps	0.998	0.998	515	1548	1	1545	527	13	527
RIKEN	AK055611	flj0001l19	FLJ	W01A097K09	pENTR-TOPO	14905		PRIC285	85441	BAB70969.1	Hs.517180	Peroxisomal proliferator-activated receptor A interacting complex 285				HSYRA2	EK1	NM_001037335.2	NP_001032412.2	REVIEWED	P	1.000	1.000	413	1242	1	1239	2649	2237	2649
RIKEN	AK000847	flj0064h12	FLJ	W01A097K13	pENTR-TOPO	10968		ZNF236	7776	BAA91398	Hs.719137	Zinc finger protein 236				ad	EK1	NM_007345.3	NP_031371.3	VALIDATED	Ps	0.995	0.995	444	1419	49	1380	1845	17	460
RIKEN	AK000847	flj0064h12	FLJ	W01A097K15	pENTR-TOPO	10968		ZNF236	7776	BAA91398	Hs.719137	Zinc finger protein 236				ad	EK1	NM_007345.3	NP_031371.3	VALIDATED	Ps	0.995	0.995	444	1419	49	1380	1845	17	460
RIKEN	AK000847	flj0064h12	FLJ	W01A097K19	pENTR-TOPO	10968		ZNF236	7776	BAA91398	Hs.719137	Zinc finger protein 236				ad	EK1	NM_007345.3	NP_031371.3	VALIDATED	Ps	0.995	0.995	444	1419	49	1380	1845	17	460
RIKEN	AK097224	flj0042g23	FLJ	W01A097K24	pENTR-TOPO	6508		NARG1L	79612	BAC04980	Hs.512914	NMDA receptor regulated 1-like				SPLEN2	EK1	NM_001110798.1	NP_001104268.1	VALIDATED	P	1.000	1.000	419	1551	1	1257	429	1	419
RIKEN	BC024182	IRAK033F24	MGC	W01A097L04	pENTR-TOPO	5540		ZNF10	7556	AAH24182.1	Hs.507355	Zinc finger protein 10			Testis	NIH_MGC_97	DH10B	NM_015394.4	NP_056209.2	REVIEWED	C	1.000	1.000	573	1722	1	1719	573	1	573
RIKEN	BC024182	IRAK033F24	MGC	W01A097L06	pENTR-TOPO	5540		ZNF10	7556	AAH24182.1	Hs.507355	Zinc finger protein 10			Testis	NIH_MGC_97	DH10B	NM_015394.4	NP_056209.2	REVIEWED	C	1.000	1.000	573	1722	1	1719	573	1	573
RIKEN	AK056499	flj0004n14	FLJ	W01A097L10	pENTR-TOPO	5634		PRICKLE1	144165	BAB71198.1	Hs.639400	Prickle homolog 1 (Drosophila)	NT2	teratocarcinoma		NT2RP7	EK1	NM_001144881.1	NP_001138353.1	VALIDATED	Cs	0.999	0.999	831	2496	1	2493	831	1	831
RIKEN	AK097224	flj0042g23	FLJ	W01A097M02	pENTR-TOPO	6508		NARG1L	79612	BAC04980	Hs.512914	NMDA receptor regulated 1-like				SPLEN2	EK1	NM_001110798.1	NP_001104268.1	VALIDATED	P	1.000	1.000	419	1551	1	1257	429	1	419
RIKEN	AK097224	flj0042g23	FLJ	W01A097M04	pENTR-TOPO	6508		NARG1L	79612	BAC04980	Hs.512914	NMDA receptor regulated 1-like				SPLEN2	EK1	NM_001110798.1	NP_001104268.1	VALIDATED	P	1.000	1.000	419	1551	1	1257	429	1	419
RIKEN	BC020584	IRAK027D01	MGC	W01A097M13	pENTR-TOPO	19394		FAM172A	83989	AAH20584.1	Hs.600086	Family with sequence similarity 172, member A			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032042.4	NP_114431.2	VALIDATED	C	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC051743	IRAK090H10	MGC	W01A097M14	pENTR-TOPO	3644		ZFP91	80829	AAH51743.1	Hs.524920	Zinc finger protein 91 homolog (mouse)			Testis	NIH_MGC_97	DH10B	NM_053023.3	NP_444251.1	REVIEWED	Cgs	0.996	0.998	570	1710	1	1707	570	1	570
RIKEN	BC020584	IRAK027D01	MGC	W01A097M15	pENTR-TOPO	19394		FAM172A	83989	AAH20584.1	Hs.600086	Family with sequence similarity 172, member A			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032042.4	NP_114431.2	VALIDATED	C	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC051743	IRAK090H10	MGC	W01A097M16	pENTR-TOPO	3644		ZFP91	80829	AAH51743.1	Hs.524920	Zinc finger protein 91 homolog (mouse)			Testis	NIH_MGC_97	DH10B	NM_053023.3	NP_444251.1	REVIEWED	Cgs	0.996	0.998	570	1710	1	1707	570	1	570
RIKEN	BC020584	IRAK027D01	MGC	W01A097M17	pENTR-TOPO	19394		FAM172A	83989	AAH20584.1	Hs.600086	Family with sequence similarity 172, member A			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032042.4	NP_114431.2	VALIDATED	C	1.000	1.000	416	1251	1	1248	416	1	416
RIKEN	BC018349	IRAK012O17	MGC	W01A097M21	pENTR-TOPO	21154		IKZF1	10320	AAH18349.1	Hs.488251	IKAROS family zinc finger 1 (Ikaros)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_006060.3	NP_006051.1	VALIDATED	Cg	0.919	1.000	519	1434	1	1431	519	1	519
RIKEN	BC051743	IRAK090H10	MGC	W01A097M22	pENTR-TOPO	3644		ZFP91	80829	AAH51743.1	Hs.524920	Zinc finger protein 91 homolog (mouse)			Testis	NIH_MGC_97	DH10B	NM_053023.3	NP_444251.1	REVIEWED	Cgs	0.996	0.998	570	1710	1	1707	570	1	570
RIKEN	AK027424	flj0031j21	FLJ	W01A097N07	pENTR-TOPO	15325		RIPK4	54101	BAB55102.1	Hs.517310	Receptor-interacting serine-threonine kinase 4	NT2	teratocarcinoma		NT2RM1	EK1	NM_020639.2	NP_065690.2	REVIEWED	Cs	0.995	0.995	784	2355	1	2352	784	1	784
RIKEN	AK124681	flj0069h11	FLJ	W01A097N08	pENTR-TOPO	2789		STOX1	219736	BAC85925.1	Hs.37636	Storkhead box 1				BRAMY3	EK1	NM_001130162.1	NP_001123634.1	PROVISIONAL	Cs	0.999	0.999	879	2640	1	2637	879	1	879
RIKEN	AK027424	flj0031j21	FLJ	W01A097N09	pENTR-TOPO	15325		RIPK4	54101	BAB55102.1	Hs.517310	Receptor-interacting serine-threonine kinase 4	NT2	teratocarcinoma		NT2RM1	EK1	NM_020639.2	NP_065690.2	REVIEWED	Cs	0.995	0.995	784	2355	1	2352	784	1	784
RIKEN	BC013361	IRAL025A16	MGC	W01A097N21	pENTR-TOPO	11946		VAV1	7409	AAH13361.2	Hs.116237	Vav 1 guanine nucleotide exchange factor			Placenta, choriocarcinoma	NIH_MGC_21		NM_005428.2	NP_005419.2	REVIEWED	Ps	0.999	0.999	778	2373	37	2370	845	68	845
RIKEN	BC013361	IRAL025A16	MGC	W01A097N23	pENTR-TOPO	11946		VAV1	7409	AAH13361.2	Hs.116237	Vav 1 guanine nucleotide exchange factor			Placenta, choriocarcinoma	NIH_MGC_21		NM_005428.2	NP_005419.2	REVIEWED	Ps	0.999	0.999	778	2373	37	2370	845	68	845
RIKEN	BC030519	IRAK064E17	MGC	W01A097O02	pENTR-TOPO	6162		CRY1	1407	AAH30519.1	Hs.151573	Cryptochrome 1 (photolyase-like)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004075.3	NP_004066.1	VALIDATED	C	1.000	1.000	586	1761	1	1758	586	1	586
RIKEN	BC030519	IRAK064E17	MGC	W01A097O04	pENTR-TOPO	6162		CRY1	1407	AAH30519.1	Hs.151573	Cryptochrome 1 (photolyase-like)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004075.3	NP_004066.1	VALIDATED	C	1.000	1.000	586	1761	1	1758	586	1	586
RIKEN	BC030519	IRAK064E17	MGC	W01A097O06	pENTR-TOPO	6162		CRY1	1407	AAH30519.1	Hs.151573	Cryptochrome 1 (photolyase-like)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004075.3	NP_004066.1	VALIDATED	C	1.000	1.000	586	1761	1	1758	586	1	586
RIKEN	BC026092	IRAK034L20	MGC	W01A097O09	pENTR-TOPO	20046		ZNF165	7718	AAH26092.1	Hs.535177	Zinc finger protein 165			Testis	NIH_MGC_97	DH10B	NM_003447.2	NP_003438.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC030519	IRAK064E17	MGC	W01A097O12	pENTR-TOPO	6162		CRY1	1407	AAH30519.1	Hs.151573	Cryptochrome 1 (photolyase-like)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004075.3	NP_004066.1	VALIDATED	C	1.000	1.000	586	1761	1	1758	586	1	586
RIKEN	BC026092	IRAK034L20	MGC	W01A097O13	pENTR-TOPO	20046		ZNF165	7718	AAH26092.1	Hs.535177	Zinc finger protein 165			Testis	NIH_MGC_97	DH10B	NM_003447.2	NP_003438.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC030519	IRAK064E17	MGC	W01A097O16	pENTR-TOPO	6162		CRY1	1407	AAH30519.1	Hs.151573	Cryptochrome 1 (photolyase-like)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004075.3	NP_004066.1	VALIDATED	C	1.000	1.000	586	1761	1	1758	586	1	586
RIKEN	BC026092	IRAK034L20	MGC	W01A097O17	pENTR-TOPO	20046		ZNF165	7718	AAH26092.1	Hs.535177	Zinc finger protein 165			Testis	NIH_MGC_97	DH10B	NM_003447.2	NP_003438.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC025279	IRAL042N13	MGC	W01A097O18	pENTR-TOPO	12571		SAFB2	9667	AAH25279.1	Hs.655392	Scaffold attachment factor B2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_014649.2	NP_055464.1	VALIDATED	P	1.000	1.000	527	1587	1	1581	953	1	527
RIKEN	BC026092	IRAK034L20	MGC	W01A097O19	pENTR-TOPO	20046		ZNF165	7718	AAH26092.1	Hs.535177	Zinc finger protein 165			Testis	NIH_MGC_97	DH10B	NM_003447.2	NP_003438.1	REVIEWED	C	1.000	1.000	485	1458	1	1455	485	1	485
RIKEN	BC025279	IRAL042N13	MGC	W01A097O20	pENTR-TOPO	12571		SAFB2	9667	AAH25279.1	Hs.655392	Scaffold attachment factor B2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_014649.2	NP_055464.1	VALIDATED	P	1.000	1.000	527	1587	1	1581	953	1	527
RIKEN	BC013361	IRAL025A16	MGC	W01A097P09	pENTR-TOPO	11946		VAV1	7409	AAH13361.2	Hs.116237	Vav 1 guanine nucleotide exchange factor			Placenta, choriocarcinoma	NIH_MGC_21		NM_005428.2	NP_005419.2	REVIEWED	Ps	0.999	0.999	778	2373	37	2370	845	68	845
RIKEN	BC027036	IRAK042P14	MGC	W01A097P11	pENTR-TOPO	9622		STAT5A	6776	AAH27036.1	Hs.437058	Signal transducer and activator of transcription 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003152.3	NP_003143.2	REVIEWED	C	1.000	1.000	794	2385	1	2382	794	1	794
RIKEN	BC063840	IRAK141C10	MGC	W01A097P21	pENTR-TOPO	19931		BRD2	6046	AAH63840.1	Hs.75243	Bromodomain containing 2				Lupski_dorsal_root_ganglion	DH10B	NM_001113182.1	NP_001106653.1	REVIEWED	Cg	0.958	1.000	836	2511	1	2508	801	1	801
RIKEN	BC065270	IRAK140N01	MGC	W01A097P24	pENTR-TOPO	11566		APOC2	344	AAH65270.1	Hs.75615	Apolipoprotein C-II			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000483.3	NP_000474.2	REVIEWED	P	1.000	1.000	72	219	1	216	101	1	72
RIKEN	AK056723	flj0013c07	FLJ	W01A098A07	pENTR-TOPO	23656		LOC158376	158376	-	Hs.302677	Hypothetical LOC158376				PLACE6	EK1	XM_001130949.2	XP_001130949.1	MODEL	Cs	0.987	0.987	75	273	46	270	75	1	75
RIKEN	AK056689	flj0006h03	FLJ	W01A098A08	pENTR-TOPO	26767										PEBLM2	EK1			
RIKEN	AK056723	flj0013c07	FLJ	W01A098A11	pENTR-TOPO	23656		LOC158376	158376	-	Hs.302677	Hypothetical LOC158376				PLACE6	EK1	XM_001130949.2	XP_001130949.1	MODEL	Cs	0.987	0.987	75	273	46	270	75	1	75
RIKEN	AK056689	flj0006h03	FLJ	W01A098A14	pENTR-TOPO	26767										PEBLM2	EK1			
RIKEN	AK056689	flj0006h03	FLJ	W01A098A18	pENTR-TOPO	26767										PEBLM2	EK1			
RIKEN	AK056689	flj0006h03	FLJ	W01A098A20	pENTR-TOPO	26767										PEBLM2	EK1			
RIKEN	BC001766	IRAL008O24	MGC	W01A098A24	pENTR-TOPO	15430		S100B	6285	AAH01766.1	Hs.422181	S100 calcium binding protein B			Skin, melanotic melanoma.	NIH_MGC_20		NM_006272.2	NP_006263.1	REVIEWED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	AK091031	flj0014n23	FLJ	W01A098B05	pENTR-TOPO	30973										BRAWH2	EK1			
RIKEN	BC042734	IRAK072D19	MGC	W01A098B12	pENTR-TOPO	27160									Testis	NIH_MGC_97	DH10B			
RIKEN	BC042734	IRAK072D19	MGC	W01A098B14	pENTR-TOPO	27160									Testis	NIH_MGC_97	DH10B			
RIKEN	BC042734	IRAK072D19	MGC	W01A098B22	pENTR-TOPO	27160									Testis	NIH_MGC_97	DH10B			
RIKEN	BC001766	IRAL008O24	MGC	W01A098C02	pENTR-TOPO	15430		S100B	6285	AAH01766.1	Hs.422181	S100 calcium binding protein B			Skin, melanotic melanoma.	NIH_MGC_20		NM_006272.2	NP_006263.1	REVIEWED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC019009	IRAL030E24	MGC	W01A098C14	pENTR-TOPO	8931		HTA	283902	-	Hs.382776	Hepatoma associated protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_001101347.1	NP_001094817.1	VALIDATED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC065270	IRAK140N01	MGC	W01A098C15	pENTR-TOPO	11566		APOC2	344	AAH65270.1	Hs.75615	Apolipoprotein C-II			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000483.3	NP_000474.2	REVIEWED	P	1.000	1.000	72	219	1	216	101	1	72
RIKEN	BC043553	IRAK087I17	MGC	W01A098C20	pENTR-TOPO	14309		LOC339822	339822	-	Hs.651879	Hypothetical protein LOC339822			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B			
RIKEN	BC043553	IRAK087I17	MGC	W01A098C22	pENTR-TOPO	14309		LOC339822	339822	-	Hs.651879	Hypothetical protein LOC339822			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B			
RIKEN	BC043553	IRAK087I17	MGC	W01A098C24	pENTR-TOPO	14309		LOC339822	339822	-	Hs.651879	Hypothetical protein LOC339822			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B			
RIKEN	BC042734	IRAK072D19	MGC	W01A098D04	pENTR-TOPO	27160									Testis	NIH_MGC_97	DH10B			
RIKEN	BC029583	IRAK063H18	MGC	W01A098D05	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	BC029583	IRAK063H18	MGC	W01A098D15	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	BC029583	IRAK063H18	MGC	W01A098D19	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	AK126569	flj0077o09	FLJ	W01A098D20	pENTR-TOPO	19379		FLJ44606	401207	-	Hs.49573	Hypothetical gene supported by AK126569				BRACE2	EK1	XM_943643.3	XP_948736.1	MODEL	Ps	0.990	0.990	100	330	28	327	138	39	138
RIKEN	AK126569	flj0077o09	FLJ	W01A098D22	pENTR-TOPO	19379		FLJ44606	401207	-	Hs.49573	Hypothetical gene supported by AK126569				BRACE2	EK1	XM_943643.3	XP_948736.1	MODEL	Ps	0.990	0.990	100	330	28	327	138	39	138
RIKEN	BC043553	IRAK087I17	MGC	W01A098E12	pENTR-TOPO	14309		LOC339822	339822	-	Hs.651879	Hypothetical protein LOC339822			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B			
RIKEN	BC018953	IRAL026O23	MGC	W01A098E13	pENTR-TOPO	10381		SMARCD2	6603	AAH18953.2	Hs.250581	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001098426.1	NP_001091896.1	REVIEWED	P	1.000	1.000	77	234	1	231	531	455	531
RIKEN	BC018953	IRAL026O23	MGC	W01A098E21	pENTR-TOPO	10381		SMARCD2	6603	AAH18953.2	Hs.250581	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001098426.1	NP_001091896.1	REVIEWED	P	1.000	1.000	77	234	1	231	531	455	531
RIKEN	BC043524	IRAK087G04	MGC	W01A098F13	pENTR-TOPO	15101		LOC339568	339568	-	Hs.434319	Hypothetical LOC339568			Brain, adult medulla	NIH_MGC_119	DH10B			
RIKEN	BC040895	IRAK088L20	MGC	W01A098F14	pENTR-TOPO	2925		LOC338588	338588	-	Hs.121365	Hypothetical LOC338588			Brain, adult medulla	NIH_MGC_119	DH10B													
RIKEN	BC040895	IRAK088L20	MGC	W01A098F18	pENTR-TOPO	2925		LOC338588	338588	-	Hs.121365	Hypothetical LOC338588			Brain, adult medulla	NIH_MGC_119	DH10B													
RIKEN	BC040895	IRAK088L20	MGC	W01A098F20	pENTR-TOPO	2925		LOC338588	338588	-	Hs.121365	Hypothetical LOC338588			Brain, adult medulla	NIH_MGC_119	DH10B													
RIKEN	AK023501	flj0037k05	FLJ	W01A098F21	pENTR-TOPO	4725		FLJ13439	399876	-	Hs.132600	Hypothetical gene supported by AK023501				PLACE1	EK1			
RIKEN	BC042042	IRAK088D22	MGC	W01A098G06	pENTR-TOPO	981		LOC440704	440704	-	Hs.518802	Hypothetical gene supported by BC042042			Lymph, lymphoma	NIH_MGC_85	DH10B	XM_498826.2	XP_498826.1	MODEL										
RIKEN	BC042042	IRAK088D22	MGC	W01A098G08	pENTR-TOPO	981		LOC440704	440704	-	Hs.518802	Hypothetical gene supported by BC042042			Lymph, lymphoma	NIH_MGC_85	DH10B	XM_498826.2	XP_498826.1	MODEL										
RIKEN	BC042042	IRAK088D22	MGC	W01A098G14	pENTR-TOPO	981		LOC440704	440704	-	Hs.518802	Hypothetical gene supported by BC042042			Lymph, lymphoma	NIH_MGC_85	DH10B	XM_498826.2	XP_498826.1	MODEL										
RIKEN	BC042042	IRAK088D22	MGC	W01A098G16	pENTR-TOPO	981		LOC440704	440704	-	Hs.518802	Hypothetical gene supported by BC042042			Lymph, lymphoma	NIH_MGC_85	DH10B	XM_498826.2	XP_498826.1	MODEL										
RIKEN	AK125573	flj0044b21	FLJ	W01A098G17	pENTR-TOPO	774		FLJ43585	400800	-	Hs.369324	Hypothetical gene supported by AK125573		neuroepithelioma		SKNMC2	EK1			
RIKEN	BC080600	IRAL059E10	MGC	W01A098H08	pENTR-TOPO	7030		FCF1	51077	AAH80600.1	Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19		NM_015962.4	NP_057046.1	VALIDATED	P	1.000	1.000	109	330	1	327	198	90	198
RIKEN	BC080600	IRAL059E10	MGC	W01A098H10	pENTR-TOPO	7030		FCF1	51077	AAH80600.1	Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19		NM_015962.4	NP_057046.1	VALIDATED	P	1.000	1.000	109	330	1	327	198	90	198
RIKEN	BC010897	IRAL019B17	MGC	W01A098H13	pENTR-TOPO	24653		PAGE4	9506	AAH10897.1	Hs.441038	P antigen family, member 4 (prostate associated)			Placenta	NIH_MGC_79	DH10B	NM_007003.2	NP_008934.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	AK057338	flj0005e04	FLJ	W01A098H14	pENTR-TOPO	28310										TESTI2	EK1			
RIKEN	BC010897	IRAL019B17	MGC	W01A098H15	pENTR-TOPO	24653		PAGE4	9506	AAH10897.1	Hs.441038	P antigen family, member 4 (prostate associated)			Placenta	NIH_MGC_79	DH10B	NM_007003.2	NP_008934.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC010897	IRAL019B17	MGC	W01A098H17	pENTR-TOPO	24653		PAGE4	9506	AAH10897.1	Hs.441038	P antigen family, member 4 (prostate associated)			Placenta	NIH_MGC_79	DH10B	NM_007003.2	NP_008934.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	AK057317	flj0005i21	FLJ	W01A098I06	pENTR-TOPO	9874		LOC147004	147004	-	Hs.652871	Hypothetical protein LOC147004				TESTI2	EK1			
RIKEN	BC025790	IRAK049N22	MGC	W01A098I13	pENTR-TOPO	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
RIKEN	BC025790	IRAK049N22	MGC	W01A098I15	pENTR-TOPO	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
RIKEN	AK129756	flj0053d24	FLJ	W01A098I17	pENTR-TOPO	8878		FLJ26245	400533	-	Hs.499135	Hypothetical gene supported by AK129756				DMC	EK1	XM_001718343.1	XP_001718395.1	MODEL	Pfs	0.416	0.420	89	276	13	275	108	1	89
RIKEN	BC039180	IRAK029J10	MGC	W01A098I18	pENTR-TOPO	24311		C9orf148	401550	-	Hs.644347	Chromosome 9 open reading frame 148			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B			
RIKEN	AK129756	flj0053d24	FLJ	W01A098I21	pENTR-TOPO	8878		FLJ26245	400533	-	Hs.499135	Hypothetical gene supported by AK129756				DMC	EK1	XM_001718343.1	XP_001718395.1	MODEL	Pfs	0.416	0.420	89	276	13	275	108	1	89
RIKEN	BC033370	IRAK072H17	MGC	W01A098J14	pENTR-TOPO	17215		LOC285326	285326	-	Hs.145246	Hypothetical protein LOC285326			Testis	NIH_MGC_97	DH10B			
RIKEN	BC033370	IRAK072H17	MGC	W01A098J16	pENTR-TOPO	17215		LOC285326	285326	-	Hs.145246	Hypothetical protein LOC285326			Testis	NIH_MGC_97	DH10B			
RIKEN	BC036452	IRAK047K19	MGC	W01A098J17	pENTR-TOPO	15368		KCNE1	3753	AAH36452.1	Hs.121495	Potassium voltage-gated channel, Isk-related family, member 1			Testis	NIH_MGC_97	DH10B	NM_001127668.1	NP_001121140.1	REVIEWED	Ps	0.981	0.981	105	318	1	315	129	1	105
RIKEN	BC033370	IRAK072H17	MGC	W01A098J20	pENTR-TOPO	17215		LOC285326	285326	-	Hs.145246	Hypothetical protein LOC285326			Testis	NIH_MGC_97	DH10B			
RIKEN	AK130861	flj0053o08	FLJ	W01A098K04	pENTR-TOPO	19388		FLJ27351	389273	-	Hs.519206	Hypothetical gene supported by AK130861				TST	EK1			
RIKEN	AK130861	flj0053o08	FLJ	W01A098K10	pENTR-TOPO	19388		FLJ27351	389273	-	Hs.519206	Hypothetical gene supported by AK130861				TST	EK1			
RIKEN	BC045586	IRAK106J13	MGC	W01A098K24	pENTR-TOPO	17221		LOC151658	151658	-	Hs.159043	Hypothetical LOC151658			Testis	NIH_MGC_97	DH10B													
RIKEN	AK093498	flj0016d11	FLJ	W01A098L06	pENTR-TOPO	717		LOC284661	284661	-	Hs.278112	Hypothetical LOC284661				TESTI2	EK1			
RIKEN	BC036452	IRAK047K19	MGC	W01A098L07	pENTR-TOPO	15368		KCNE1	3753	AAH36452.1	Hs.121495	Potassium voltage-gated channel, Isk-related family, member 1			Testis	NIH_MGC_97	DH10B	NM_001127668.1	NP_001121140.1	REVIEWED	Ps	0.981	0.981	105	318	1	315	129	1	105
RIKEN	AK093498	flj0016d11	FLJ	W01A098L08	pENTR-TOPO	717		LOC284661	284661	-	Hs.278112	Hypothetical LOC284661				TESTI2	EK1			
RIKEN	AK093498	flj0016d11	FLJ	W01A098L14	pENTR-TOPO	717		LOC284661	284661	-	Hs.278112	Hypothetical LOC284661				TESTI2	EK1			
RIKEN	BC043360	IRAK087C01	MGC	W01A098L18	pENTR-TOPO	23266		LOC340357	340357	-	Hs.434302	Hypothetical LOC340357			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
RIKEN	BC043360	IRAK087C01	MGC	W01A098L20	pENTR-TOPO	23266		LOC340357	340357	-	Hs.434302	Hypothetical LOC340357			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
RIKEN	BC043360	IRAK087C01	MGC	W01A098L22	pENTR-TOPO	23266		LOC340357	340357	-	Hs.434302	Hypothetical LOC340357			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
RIKEN	AK090900	flj0011g09	FLJ	W01A098M03	pENTR-TOPO	14741		FLJ33581	400839	-	Hs.651965	Hypothetical gene supported by AK090900				BRAMY2	EK1			
RIKEN	BC045586	IRAK106J13	MGC	W01A098M08	pENTR-TOPO	17221		LOC151658	151658	-	Hs.159043	Hypothetical LOC151658			Testis	NIH_MGC_97	DH10B													
RIKEN	BC024232	IRAL038L24	MGC	W01A098M18	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	AK056224	flj0002f08	FLJ	W01A098M19	pENTR-TOPO	647		FLJ31662	440594	-	Hs.514123	Hypothetical gene supported by AK056224	NT2	teratocarcinoma		NT2RI2	EK1			
RIKEN	BC024232	IRAL038L24	MGC	W01A098M20	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC024232	IRAL038L24	MGC	W01A098M24	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	AK123741	flj0068i12	FLJ	W01A098N01	pENTR-TOPO	6168		HOTAIR	100124700	-	Hs.197076	Hox transcript antisense RNA (non-protein coding)				HSYRA2	EK1			
RIKEN	BC043360	IRAK087C01	MGC	W01A098N08	pENTR-TOPO	23266		LOC340357	340357	-	Hs.434302	Hypothetical LOC340357			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
RIKEN	BC072680	IRAK174I24	MGC	W01A098N10	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	BC072680	IRAK174I24	MGC	W01A098N14	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	BC072680	IRAK174I24	MGC	W01A098N22	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	BC024232	IRAL038L24	MGC	W01A098O06	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC024232	IRAL038L24	MGC	W01A098O10	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC036830	IRAK078O21	MGC	W01A098O18	pENTR-TOPO	971			148756						Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
RIKEN	AK091031	flj0014n23	FLJ	W01A098O24	pENTR-TOPO	30973										BRAWH2	EK1			
RIKEN	BC072680	IRAK174I24	MGC	W01A098P02	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	BC072680	IRAK174I24	MGC	W01A098P06	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	AK000394	flj0060j19	FLJ	W01A098P10	pENTR-TOPO	26088										kaia	EK1			
RIKEN	AK123344	flj0070k12	FLJ	W01A098P13	pENTR-TOPO	2827		FLJ41350	399806	-						BRAWH2	EK1			
RIKEN	AK000394	flj0060j19	FLJ	W01A098P16	pENTR-TOPO	26088										kaia	EK1			
RIKEN	AK000394	flj0060j19	FLJ	W01A098P18	pENTR-TOPO	26088										kaia	EK1			
RIKEN	AK000394	flj0060j19	FLJ	W01A099A01	pENTR-TOPO	26088										kaia	EK1			
RIKEN	BC043561	IRAK087J06	MGC	W01A099A06	pENTR-TOPO	17751		LOC340017	340017	-	Hs.428275	Hypothetical LOC340017			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B			
RIKEN	AK098538	flj0061h18	FLJ	W01A099A17	pENTR-TOPO	6534		LOC283483	283483	-	Hs.651365	Hypothetical protein LOC283483				TST	EK1			
RIKEN	BC035399	IRAK071O06	MGC	W01A099A22	pENTR-TOPO	10026		LOC400620	400620	-	Hs.348644	Hypothetical LOC400620			Testis	NIH_MGC_97	DH10B			
RIKEN	AK000471	flj0057a24	FLJ	W01A099B10	pENTR-TOPO	15600		FLJ20464	54944	BAA91187.1	Hs.648259	Hypothetical protein FLJ20464				KAT	EK1													
RIKEN	AK000471	flj0057a24	FLJ	W01A099B12	pENTR-TOPO	15600		FLJ20464	54944	BAA91187.1	Hs.648259	Hypothetical protein FLJ20464				KAT	EK1													
RIKEN	AK125779	flj0069p14	FLJ	W01A099B13	pENTR-TOPO	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein				TESTI2	EK1			
RIKEN	BC068078	IRAL054H06	MGC	W01A099B18	pENTR-TOPO	22711		NPM2	10361	AAH68078.1	Hs.131055	Nucleophosmin/nucleoplasmin, 2			Skin, melanoma, melanotic	NIH_MGC_112		NM_182795.1	NP_877724.1	VALIDATED	P	1.000	1.000	122	411	1	366	214	1	122
RIKEN	BC068078	IRAL054H06	MGC	W01A099B22	pENTR-TOPO	22711		NPM2	10361	AAH68078.1	Hs.131055	Nucleophosmin/nucleoplasmin, 2			Skin, melanoma, melanotic	NIH_MGC_112		NM_182795.1	NP_877724.1	VALIDATED	P	1.000	1.000	122	411	1	366	214	1	122
RIKEN	AK094349	flj0045n11	FLJ	W01A099B23	pENTR-TOPO	9907		LOC284033	284033	BAC04335	Hs.592124	Hypothetical LOC284033				BRACE2	EK1			
RIKEN	AK054958	flj0020d21	FLJ	W01A099C09	pENTR-TOPO	10281		TIAF1	9220	-	Hs.664319	TGFB1-induced anti-apoptotic factor 1				BRACE2	EK1	NM_004740.3	NP_004731.2	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
RIKEN	AK054958	flj0020d21	FLJ	W01A099C11	pENTR-TOPO	10281		TIAF1	9220	-	Hs.664319	TGFB1-induced anti-apoptotic factor 1				BRACE2	EK1	NM_004740.3	NP_004731.2	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
RIKEN	BC074501	IRAK119C20	MGC	W01A099C12	pENTR-TOPO	15832		YPEL1	29799	AAH74501.1	Hs.517436	Yippee-like 1 (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_013313.3	NP_037445.1	REVIEWED	Cs	0.992	0.992	119	360	1	357	119	1	119
RIKEN	AK056561	flj0006e10	FLJ	W01A099C21	pENTR-TOPO	2781		LOC170425	170425	-	Hs.434131	Hypothetical protein LOC170425	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	BC039682	IRAK087L09	MGC	W01A099C22	pENTR-TOPO	46420		LOC401312	401312	-	Hs.680441	Hypothetical LOC401312			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
RIKEN	AK056561	flj0006e10	FLJ	W01A099C23	pENTR-TOPO	2781		LOC170425	170425	-	Hs.434131	Hypothetical protein LOC170425	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	BC039682	IRAK087L09	MGC	W01A099C24	pENTR-TOPO	46420		LOC401312	401312	-	Hs.680441	Hypothetical LOC401312			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
RIKEN	AK094349	flj0045n11	FLJ	W01A099D05	pENTR-TOPO	9907		LOC284033	284033	BAC04335	Hs.592124	Hypothetical LOC284033				BRACE2	EK1			
RIKEN	AK094349	flj0045n11	FLJ	W01A099D15	pENTR-TOPO	9907		LOC284033	284033	BAC04335	Hs.592124	Hypothetical LOC284033				BRACE2	EK1			
RIKEN	AK057517	flj0007f01	FLJ	W01A099D16	pENTR-TOPO	14125		FLJ32955	150596	BAB71518.1	Hs.470217	Hypothetical protein FLJ32955				TESTI2	EK1	NM_153041.1	NP_694586.1	NA
RIKEN	AK094349	flj0045n11	FLJ	W01A099D17	pENTR-TOPO	9907		LOC284033	284033	BAC04335	Hs.592124	Hypothetical LOC284033				BRACE2	EK1			
RIKEN	BC066232	IRAK172G21	MGC	W01A099D19	pENTR-TOPO	20817		HIST1H2AJ	8331	AAH66232.1	Hs.406691	Histone cluster 1, H2aj			PCR rescued clones	NIH_MGC_195	DH10B	NM_021066.2	NP_066544.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC066232	IRAK172G21	MGC	W01A099D23	pENTR-TOPO	20817		HIST1H2AJ	8331	AAH66232.1	Hs.406691	Histone cluster 1, H2aj			PCR rescued clones	NIH_MGC_195	DH10B	NM_021066.2	NP_066544.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC039682	IRAK087L09	MGC	W01A099E04	pENTR-TOPO	46420		LOC401312	401312	-	Hs.680441	Hypothetical LOC401312			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
RIKEN	AK056561	flj0006e10	FLJ	W01A099E05	pENTR-TOPO	2781		LOC170425	170425	-	Hs.434131	Hypothetical protein LOC170425	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	BC039682	IRAK087L09	MGC	W01A099E06	pENTR-TOPO	46420		LOC401312	401312	-	Hs.680441	Hypothetical LOC401312			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
RIKEN	BC039682	IRAK087L09	MGC	W01A099E08	pENTR-TOPO	46420		LOC401312	401312	-	Hs.680441	Hypothetical LOC401312			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
RIKEN	BC067882	IRAK168P17	MGC	W01A099E11	pENTR-TOPO	4932		LOC387771	387771	-	Hs.652053	Hypothetical LOC387771			Placenta, normal	NIH_MGC_147	DH10B			
RIKEN	BC067882	IRAK168P17	MGC	W01A099E15	pENTR-TOPO	4932		LOC387771	387771	-	Hs.652053	Hypothetical LOC387771			Placenta, normal	NIH_MGC_147	DH10B			
RIKEN	BC067882	IRAK168P17	MGC	W01A099E17	pENTR-TOPO	4932		LOC387771	387771	-	Hs.652053	Hypothetical LOC387771			Placenta, normal	NIH_MGC_147	DH10B			
RIKEN	BC067882	IRAK168P17	MGC	W01A099E19	pENTR-TOPO	4932		LOC387771	387771	-	Hs.652053	Hypothetical LOC387771			Placenta, normal	NIH_MGC_147	DH10B			
RIKEN	BC041423	IRAK087B16	MGC	W01A099E21	pENTR-TOPO	24882		LOC340581	340581	-	Hs.434754	Hypothetical protein LOC340581				NIH_MGC_69	DH10B			
RIKEN	BC041423	IRAK087B16	MGC	W01A099E23	pENTR-TOPO	24882		LOC340581	340581	-	Hs.434754	Hypothetical protein LOC340581				NIH_MGC_69	DH10B			
RIKEN	AK124782	flj0072g01	FLJ	W01A099F06	pENTR-TOPO	9070		N4BP1	9683	BAC85946	Hs.511839	NEDD4 binding protein 1				BRAWH3	EK1	NM_153029.3	NP_694574.3	VALIDATED	Pfs	0.287	0.320	108	399	62	370	896	782	883
RIKEN	BC066232	IRAK172G21	MGC	W01A099F09	pENTR-TOPO	20817		HIST1H2AJ	8331	AAH66232.1	Hs.406691	Histone cluster 1, H2aj			PCR rescued clones	NIH_MGC_195	DH10B	NM_021066.2	NP_066544.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	AK124782	flj0072g01	FLJ	W01A099F14	pENTR-TOPO	9070		N4BP1	9683	BAC85946	Hs.511839	NEDD4 binding protein 1				BRAWH3	EK1	NM_153029.3	NP_694574.3	VALIDATED	Pfs	0.287	0.320	108	399	62	370	896	782	883
RIKEN	AK124782	flj0072g01	FLJ	W01A099F18	pENTR-TOPO	9070		N4BP1	9683	BAC85946	Hs.511839	NEDD4 binding protein 1				BRAWH3	EK1	NM_153029.3	NP_694574.3	VALIDATED	Pfs	0.287	0.320	108	399	62	370	896	782	883
RIKEN	BC002595	IRAL004J02	MGC	W01A099F20	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	AK127913	flj0075i12	FLJ	W01A099F23	pENTR-TOPO	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein				SPLEN2	EK1													
RIKEN	BC043571	IRAK087L02	MGC	W01A099G04	pENTR-TOPO	15048		LOC613266	613266	-	Hs.309149	Hypothetical LOC613266			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001033516.1	NP_001028688.1	NA
RIKEN	BC043571	IRAK087L02	MGC	W01A099G08	pENTR-TOPO	15048		LOC613266	613266	-	Hs.309149	Hypothetical LOC613266			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001033516.1	NP_001028688.1	NA
RIKEN	BC041423	IRAK087B16	MGC	W01A099G13	pENTR-TOPO	24882		LOC340581	340581	-	Hs.434754	Hypothetical protein LOC340581				NIH_MGC_69	DH10B			
RIKEN	AK094171	flj0025i14	FLJ	W01A099G14	pENTR-TOPO	6141		ABCC9	10060	BAC04300.1	Hs.446050	ATP-binding cassette, sub-family C (CFTR/MRP), member 9				ASTRO2	EK1	NM_020297.2	NP_064693.2	REVIEWED	P	1.000	1.000	120	363	1	360	1549	1430	1549
RIKEN	AK094171	flj0025i14	FLJ	W01A099G20	pENTR-TOPO	6141		ABCC9	10060	BAC04300.1	Hs.446050	ATP-binding cassette, sub-family C (CFTR/MRP), member 9				ASTRO2	EK1	NM_020297.2	NP_064693.2	REVIEWED	P	1.000	1.000	120	363	1	360	1549	1430	1549
RIKEN	BC029882	IRAK051F05	MGC	W01A099G23	pENTR-TOPO	18895		CARTPT	9607	AAH29882.1	Hs.1707	CART prepropeptide			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004291.2	NP_004282.1	VALIDATED	OK	1.000	1.000	116	351	1	348	116	1	116
RIKEN	AK127913	flj0075i12	FLJ	W01A099H01	pENTR-TOPO	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein				SPLEN2	EK1													
RIKEN	BC002595	IRAL004J02	MGC	W01A099H04	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC002595	IRAL004J02	MGC	W01A099H06	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	AK092601	flj0007a02	FLJ	W01A099H07	pENTR-TOPO	23677		FLJ35282	441389	-						PROST2	EK1	XM_943852.1	XP_948945.1	MODEL										
RIKEN	BC002595	IRAL004J02	MGC	W01A099H08	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	AK054869	flj0012c11	FLJ	W01A099H12	pENTR-TOPO	11739		FLJ30307	400704	-	Hs.680622	Hypothetical gene supported by AK054869				BRACE2	EK1			
RIKEN	AK054869	flj0012c11	FLJ	W01A099H14	pENTR-TOPO	11739		FLJ30307	400704	-	Hs.680622	Hypothetical gene supported by AK054869				BRACE2	EK1			
RIKEN	AK054869	flj0012c11	FLJ	W01A099H16	pENTR-TOPO	11739		FLJ30307	400704	-	Hs.680622	Hypothetical gene supported by AK054869				BRACE2	EK1			
RIKEN	AK125177	flj0073m09	FLJ	W01A099H21	pENTR-TOPO	586		LOC149134	149134	BAC86072.1	Hs.417972	Hypothetical LOC149134				FCBBF3	EK1													
RIKEN	BC044843	IRAK050G14	MGC	W01A099H22	pENTR-TOPO	2219		LOC339535	339535	-	Hs.532047	Hypothetical LOC339535			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	XM_001132951.1	XP_001132951.1	MODEL										
RIKEN	AK125177	flj0073m09	FLJ	W01A099H23	pENTR-TOPO	586		LOC149134	149134	BAC86072.1	Hs.417972	Hypothetical LOC149134				FCBBF3	EK1													
RIKEN	AK098639	flj0053b05	FLJ	W01A099I08	pENTR-TOPO	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177				TST	EK1	NM_182560.1	NP_872366.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	AK098639	flj0053b05	FLJ	W01A099I10	pENTR-TOPO	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177				TST	EK1	NM_182560.1	NP_872366.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	AK098639	flj0053b05	FLJ	W01A099I12	pENTR-TOPO	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177				TST	EK1	NM_182560.1	NP_872366.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC040297	IRAK071P16	MGC	W01A099I13	pENTR-TOPO	29562									Testis	NIH_MGC_97	DH10B			
RIKEN	BC040297	IRAK071P16	MGC	W01A099I17	pENTR-TOPO	29562									Testis	NIH_MGC_97	DH10B			
RIKEN	AK124409	flj0070l22	FLJ	W01A099I20	pENTR-TOPO	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein				BLADE2	EK1													
RIKEN	AK125177	flj0073m09	FLJ	W01A099J01	pENTR-TOPO	586		LOC149134	149134	BAC86072.1	Hs.417972	Hypothetical LOC149134				FCBBF3	EK1													
RIKEN	BC044843	IRAK050G14	MGC	W01A099J04	pENTR-TOPO	2219		LOC339535	339535	-	Hs.532047	Hypothetical LOC339535			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	XM_001132951.1	XP_001132951.1	MODEL										
RIKEN	AK125177	flj0073m09	FLJ	W01A099J05	pENTR-TOPO	586		LOC149134	149134	BAC86072.1	Hs.417972	Hypothetical LOC149134				FCBBF3	EK1													
RIKEN	AK125177	flj0073m09	FLJ	W01A099J11	pENTR-TOPO	586		LOC149134	149134	BAC86072.1	Hs.417972	Hypothetical LOC149134				FCBBF3	EK1													
RIKEN	AK097829	flj0023g01	FLJ	W01A099J13	pENTR-TOPO	33538										TESTI2	EK1			
RIKEN	AK026312	flj0061h03	FLJ	W01A099J18	pENTR-TOPO	9848		LOC79999	79999	BAB15440.1	Hs.677375	Hypothetical LOC79999				HSI	EK1													
RIKEN	AK054915	flj0020p09	FLJ	W01A099K06	pENTR-TOPO	11412		SPTBN4	57731	BAB70827	Hs.32706	Spectrin, beta, non-erythrocytic 4				BRACE2	EK1	NM_025213.2	NP_079489.2	REVIEWED	Pfs	0.300	0.308	40	363	41	157	678	635	674
RIKEN	AK054915	flj0020p09	FLJ	W01A099K08	pENTR-TOPO	11412		SPTBN4	57731	BAB70827	Hs.32706	Spectrin, beta, non-erythrocytic 4				BRACE2	EK1	NM_025213.2	NP_079489.2	REVIEWED	Pfs	0.300	0.308	40	363	41	157	678	635	674
RIKEN	AK127955	flj0077j12	FLJ	W01A099K13	pENTR-TOPO	17129		FLJ46066	401103	-	Hs.591304	Hypothetical gene supported by AK127955				TESOP2	EK1			
RIKEN	BC005966	IRAL021O13	MGC	W01A099K15	pENTR-TOPO	16242		RNF7	9616	AAH05966.1	Hs.134623	Ring finger protein 7			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_014245.3	NP_055060.1	REVIEWED	C	1.000	1.000	113	342	1	339	113	1	113
RIKEN	AK054915	flj0020p09	FLJ	W01A099K18	pENTR-TOPO	11412		SPTBN4	57731	BAB70827	Hs.32706	Spectrin, beta, non-erythrocytic 4				BRACE2	EK1	NM_025213.2	NP_079489.2	REVIEWED	Pfs	0.300	0.308	40	363	41	157	678	635	674
RIKEN	AK054915	flj0020p09	FLJ	W01A099K20	pENTR-TOPO	11412		SPTBN4	57731	BAB70827	Hs.32706	Spectrin, beta, non-erythrocytic 4				BRACE2	EK1	NM_025213.2	NP_079489.2	REVIEWED	Pfs	0.300	0.308	40	363	41	157	678	635	674
RIKEN	AK096368	flj0042f17	FLJ	W01A099K23	pENTR-TOPO	18205		LOC285547	285547	-	Hs.381892	Hypothetical protein LOC285547	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	AK024509	flj0067c23	FLJ	W01A099L01	pENTR-TOPO	15404		C21orf96	80215	BAB14918.1	Hs.672131	Chromosome 21 open reading frame 96				ad	EK1													
RIKEN	AK098105	flj0041e05	FLJ	W01A099L04	pENTR-TOPO	19719		GCNT2	2651	BAC05234.1	Hs.519884	Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)				TRACH2	EK1	NM_145649.4	NP_663624.1	REVIEWED	P	1.000	1.000	145	438	1	435	402	258	402
RIKEN	AK024509	flj0067c23	FLJ	W01A099L13	pENTR-TOPO	15404		C21orf96	80215	BAB14918.1	Hs.672131	Chromosome 21 open reading frame 96				ad	EK1													
RIKEN	BC043286	IRAK076P22	MGC	W01A099L14	pENTR-TOPO	11980		LOC339316	339316	-	Hs.432564	Hypothetical protein LOC339316			Testis	NIH_MGC_97	DH10B			
RIKEN	AK091757	flj0015m14	FLJ	W01A099L19	pENTR-TOPO	698		MGC27382	149047	-	Hs.352665	Hypothetical MGC27382				HLUNG2	EK1	XM_373850.3	XP_373850.1	MODEL										
RIKEN	AK091757	flj0015m14	FLJ	W01A099L23	pENTR-TOPO	698		MGC27382	149047	-	Hs.352665	Hypothetical MGC27382				HLUNG2	EK1	XM_373850.3	XP_373850.1	MODEL										
RIKEN	AK096368	flj0042f17	FLJ	W01A099M01	pENTR-TOPO	18205		LOC285547	285547	-	Hs.381892	Hypothetical protein LOC285547	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	AK128810	flj0079g01	FLJ	W01A099M02	pENTR-TOPO	3377		FLJ45983	399717	BAC87617.1	Hs.669736	Hypothetical LOC399717				PROST2	EK1	NM_207423.1	NP_997306.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	AK128810	flj0079g01	FLJ	W01A099M04	pENTR-TOPO	3377		FLJ45983	399717	BAC87617.1	Hs.669736	Hypothetical LOC399717				PROST2	EK1	NM_207423.1	NP_997306.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	AK096368	flj0042f17	FLJ	W01A099M07	pENTR-TOPO	18205		LOC285547	285547	-	Hs.381892	Hypothetical protein LOC285547	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	AK096368	flj0042f17	FLJ	W01A099M09	pENTR-TOPO	18205		LOC285547	285547	-	Hs.381892	Hypothetical protein LOC285547	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	AK128810	flj0079g01	FLJ	W01A099M10	pENTR-TOPO	3377		FLJ45983	399717	BAC87617.1	Hs.669736	Hypothetical LOC399717				PROST2	EK1	NM_207423.1	NP_997306.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	AK096368	flj0042f17	FLJ	W01A099M11	pENTR-TOPO	18205		LOC285547	285547	-	Hs.381892	Hypothetical protein LOC285547	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	AK122786	flj0067l06	FLJ	W01A099M15	pENTR-TOPO	14171		FLJ16341	400957	-	Hs.170358	Hypothetical gene supported by AK122786				TESTI2	EK1			
RIKEN	AK122786	flj0067l06	FLJ	W01A099M17	pENTR-TOPO	14171		FLJ16341	400957	-	Hs.170358	Hypothetical gene supported by AK122786				TESTI2	EK1			
RIKEN	AK127732	flj0076b09	FLJ	W01A099M18	pENTR-TOPO	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8	EK1	NM_207470.1	NP_997353.1	NA
RIKEN	AK122786	flj0067l06	FLJ	W01A099M19	pENTR-TOPO	14171		FLJ16341	400957	-	Hs.170358	Hypothetical gene supported by AK122786				TESTI2	EK1			
RIKEN	AK122786	flj0067l06	FLJ	W01A099M21	pENTR-TOPO	14171		FLJ16341	400957	-	Hs.170358	Hypothetical gene supported by AK122786				TESTI2	EK1			
RIKEN	AK127732	flj0076b09	FLJ	W01A099M22	pENTR-TOPO	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8	EK1	NM_207470.1	NP_997353.1	NA
RIKEN	BC002703	IRAL012A02	MGC	W01A099N02	pENTR-TOPO	13236		CENPA	1058	AAH02703.1	Hs.1594	Centromere protein A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001809.3	NP_001800.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
RIKEN	AK091757	flj0015m14	FLJ	W01A099N05	pENTR-TOPO	698		MGC27382	149047	-	Hs.352665	Hypothetical MGC27382				HLUNG2	EK1	XM_373850.3	XP_373850.1	MODEL										
RIKEN	AK091757	flj0015m14	FLJ	W01A099N07	pENTR-TOPO	698		MGC27382	149047	-	Hs.352665	Hypothetical MGC27382				HLUNG2	EK1	XM_373850.3	XP_373850.1	MODEL										
RIKEN	BC002703	IRAL012A02	MGC	W01A099N08	pENTR-TOPO	13236		CENPA	1058	AAH02703.1	Hs.1594	Centromere protein A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001809.3	NP_001800.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
RIKEN	AK127261	flj0074m17	FLJ	W01A099N09	pENTR-TOPO	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557				BRHIP3	EK1	XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
RIKEN	AK127261	flj0074m17	FLJ	W01A099N11	pENTR-TOPO	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557				BRHIP3	EK1	XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
RIKEN	BC013293	IRAL011L20	MGC	W01A099N14	pENTR-TOPO	18242		SNCA	6622	AAH13293.1	Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_000345.3	NP_000336.1	REVIEWED	C	1.000	1.000	140	423	1	420	140	1	140
RIKEN	BC013293	IRAL011L20	MGC	W01A099N18	pENTR-TOPO	18242		SNCA	6622	AAH13293.1	Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_000345.3	NP_000336.1	REVIEWED	C	1.000	1.000	140	423	1	420	140	1	140
RIKEN	AK128250	flj0074h21	FLJ	W01A099N19	pENTR-TOPO	11848		ZNF818P	390963	BAC87353.1	Hs.444446	Zinc finger protein 818 pseudogene				THYMU2	EK1													
RIKEN	BC056246	IRAL048A16	MGC	W01A099N20	pENTR-TOPO	14034		GALNT3	2591	AAH56246.1	Hs.170986	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)			Lung	NIH_MGC_77	DH10B	NM_004482.3	NP_004473.2	REVIEWED		0.976	0.976	125	426	1	375	633	52	176
RIKEN	AK128250	flj0074h21	FLJ	W01A099N21	pENTR-TOPO	11848		ZNF818P	390963	BAC87353.1	Hs.444446	Zinc finger protein 818 pseudogene				THYMU2	EK1													
RIKEN	BC056246	IRAL048A16	MGC	W01A099N22	pENTR-TOPO	14034		GALNT3	2591	AAH56246.1	Hs.170986	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 3 (GalNAc-T3)			Lung	NIH_MGC_77	DH10B	NM_004482.3	NP_004473.2	REVIEWED		0.976	0.976	125	426	1	375	633	52	176
RIKEN	AK122786	flj0067l06	FLJ	W01A099O01	pENTR-TOPO	14171		FLJ16341	400957	-	Hs.170358	Hypothetical gene supported by AK122786				TESTI2	EK1			
RIKEN	BC031811	IRAK029L05	MGC	W01A099O09	pENTR-TOPO	954		LCE1B	353132	-	Hs.375103	Late cornified envelope 1B			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_178349.1	NP_848126.1	VALIDATED	C	1.000	1.000	118	357	1	354	118	1	118
RIKEN	AK128283	flj0078k09	FLJ	W01A099O14	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	BC031811	IRAK029L05	MGC	W01A099O15	pENTR-TOPO	954		LCE1B	353132	-	Hs.375103	Late cornified envelope 1B			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_178349.1	NP_848126.1	VALIDATED	C	1.000	1.000	118	357	1	354	118	1	118
RIKEN	AK128283	flj0078k09	FLJ	W01A099O16	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK128283	flj0078k09	FLJ	W01A099O20	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	BC043561	IRAK087J06	MGC	W01A099O21	pENTR-TOPO	17751		LOC340017	340017	-	Hs.428275	Hypothetical LOC340017			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B			
RIKEN	BC043561	IRAK087J06	MGC	W01A099O23	pENTR-TOPO	17751		LOC340017	340017	-	Hs.428275	Hypothetical LOC340017			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B			
RIKEN	AK128283	flj0078k09	FLJ	W01A099O24	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK093319	flj0009h07	FLJ	W01A099P06	pENTR-TOPO	9899		FLJ36000	284124	BAC04131						TESTI2	EK1			
RIKEN	BC009788	IRAL019G02	MGC	W01A099P07	pENTR-TOPO	2089		MRPS14	63931	AAH09788.1	Hs.702192	Mitochondrial ribosomal protein S14			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_022100.1	NP_071383.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC009788	IRAL019G02	MGC	W01A099P15	pENTR-TOPO	2089		MRPS14	63931	AAH09788.1	Hs.702192	Mitochondrial ribosomal protein S14			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_022100.1	NP_071383.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	AK056023	flj0002c10	FLJ	W01A099P23	pENTR-TOPO	7853		NCRNA00052	145978	BAB71075.1	Hs.350808	Non-protein coding RNA 52	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	BC066258	IRAK172D20	MGC	W01A100A02	pENTR-TOPO	18100		IL21	59067	AAH66258.1	Hs.567559	Interleukin 21			PCR rescued clones	NIH_MGC_195	DH10B	NM_021803.2	NP_068575.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC066258	IRAK172D20	MGC	W01A100A04	pENTR-TOPO	18100		IL21	59067	AAH66258.1	Hs.567559	Interleukin 21			PCR rescued clones	NIH_MGC_195	DH10B	NM_021803.2	NP_068575.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC066258	IRAK172D20	MGC	W01A100A06	pENTR-TOPO	18100		IL21	59067	AAH66258.1	Hs.567559	Interleukin 21			PCR rescued clones	NIH_MGC_195	DH10B	NM_021803.2	NP_068575.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC054036	IRAK119F10	MGC	W01A100A11	pENTR-TOPO	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001785.2	NP_001776.1	REVIEWED	Cs	0.993	0.993	146	441	1	438	146	1	146
RIKEN	BC018211	IRAK021F21	MGC	W01A100A13	pENTR-TOPO	1552		MAGOH	4116	AAH18211.1	Hs.421576	Mago-nashi homolog, proliferation-associated (Drosophila)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_002370.2	NP_002361.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	BC018211	IRAK021F21	MGC	W01A100A17	pENTR-TOPO	1552		MAGOH	4116	AAH18211.1	Hs.421576	Mago-nashi homolog, proliferation-associated (Drosophila)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_002370.2	NP_002361.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	AK130765	flj0056i08	FLJ	W01A100A18	pENTR-TOPO	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281				SYN	EK1	NM_207501.1	NP_997384.1	NA
RIKEN	BC018211	IRAK021F21	MGC	W01A100A19	pENTR-TOPO	1552		MAGOH	4116	AAH18211.1	Hs.421576	Mago-nashi homolog, proliferation-associated (Drosophila)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_002370.2	NP_002361.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	BC018211	IRAK021F21	MGC	W01A100A21	pENTR-TOPO	1552		MAGOH	4116	AAH18211.1	Hs.421576	Mago-nashi homolog, proliferation-associated (Drosophila)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_002370.2	NP_002361.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	AK123849	flj0069a21	FLJ	W01A100A23	pENTR-TOPO	4820		LOC283174	283174	BAC85707.1	Hs.504370	Hypothetical LOC283174	NT2	teratocarcinoma		NT2RI3	EK1													
RIKEN	BC036636	IRAK076L11	MGC	W01A100B05	pENTR-TOPO	1473		LEMD1	93273	AAH36636.1	Hs.655520	LEM domain containing 1			Testis	NIH_MGC_97	DH10B	NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
RIKEN	AK126768	flj0074m18	FLJ	W01A100B09	pENTR-TOPO	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102				BRACE3	EK1	NM_207454.2	NP_997337.2	VALIDATED	Cs	0.982	0.982	167	504	1	501	167	1	167
RIKEN	AK125190	flj0071d16	FLJ	W01A100B12	pENTR-TOPO	19958		LOC441179	441179	BAC86077.1	Hs.719702	Hypothetical gene supported by AK055887; AK125190				FEBRA2	EK1													
RIKEN	AK125190	flj0071d16	FLJ	W01A100B14	pENTR-TOPO	19958		LOC441179	441179	BAC86077.1	Hs.719702	Hypothetical gene supported by AK055887; AK125190				FEBRA2	EK1													
RIKEN	BC007282	IRAL022K10	MGC	W01A100B19	pENTR-TOPO	16538		MANF	7873	AAH07282.1	Hs.436446	Arginine-rich, mutated in early stage tumors			Eye, retinoblastoma	NIH_MGC_16		NM_006010.2	NP_006001.2	REVIEWED	P	1.000	1.000	182	549	1	546	185	4	185
RIKEN	BC007282	IRAL022K10	MGC	W01A100B23	pENTR-TOPO	16538		MANF	7873	AAH07282.1	Hs.436446	Arginine-rich, mutated in early stage tumors			Eye, retinoblastoma	NIH_MGC_16		NM_006010.2	NP_006001.2	REVIEWED	P	1.000	1.000	182	549	1	546	185	4	185
RIKEN	AK123849	flj0069a21	FLJ	W01A100C01	pENTR-TOPO	4820		LOC283174	283174	BAC85707.1	Hs.504370	Hypothetical LOC283174	NT2	teratocarcinoma		NT2RI3	EK1													
RIKEN	AK126293	flj0071c18	FLJ	W01A100C04	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	BC013083	IRAK019P02	MGC	W01A100C07	pENTR-TOPO	15085		CST3	1471	AAH13083.1	Hs.304682	Cystatin C			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000099.2	NP_000090.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	AK126293	flj0071c18	FLJ	W01A100C08	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	AK126293	flj0071c18	FLJ	W01A100C10	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	BC013083	IRAK019P02	MGC	W01A100C11	pENTR-TOPO	15085		CST3	1471	AAH13083.1	Hs.304682	Cystatin C			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000099.2	NP_000090.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	BC013083	IRAK019P02	MGC	W01A100C13	pENTR-TOPO	15085		CST3	1471	AAH13083.1	Hs.304682	Cystatin C			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000099.2	NP_000090.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	AK126293	flj0071c18	FLJ	W01A100C14	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	BC067903	IRAK168G19	MGC	W01A100C16	pENTR-TOPO	22816		LOC401442	401442	-	Hs.678992	Hypothetical gene supported by BC028401			Brain, hypothalamus	NIH_MGC_96	DH10B													
RIKEN	BC013083	IRAK019P02	MGC	W01A100C19	pENTR-TOPO	15085		CST3	1471	AAH13083.1	Hs.304682	Cystatin C			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000099.2	NP_000090.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	BC067903	IRAK168G19	MGC	W01A100C20	pENTR-TOPO	22816		LOC401442	401442	-	Hs.678992	Hypothetical gene supported by BC028401			Brain, hypothalamus	NIH_MGC_96	DH10B													
RIKEN	BC013083	IRAK019P02	MGC	W01A100C21	pENTR-TOPO	15085		CST3	1471	AAH13083.1	Hs.304682	Cystatin C			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000099.2	NP_000090.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	AK075231	flj0019c14	FLJ	W01A100D07	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	AK075231	flj0019c14	FLJ	W01A100D09	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	AK075231	flj0019c14	FLJ	W01A100D21	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	BC013572	IRAK014C23	MGC	W01A100D22	pENTR-TOPO	6019		KRAS	3845	AAH13572.1	Hs.505033	V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004985.3	NP_004976.2	REVIEWED	Cs	0.995	0.995	188	567	1	564	188	1	188
RIKEN	AK075231	flj0019c14	FLJ	W01A100D23	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	AK128422	flj0078k16	FLJ	W01A100E01	pENTR-TOPO	14590		VAPB	9217	BAC87433.1	Hs.182625	VAMP (vesicle-associated membrane protein)-associated protein B and C				THYMU3	EK1	NM_004738.3	NP_004729.1	REVIEWED	P	1.000	1.000	111	444	109	441	243	133	243
RIKEN	AK128422	flj0078k16	FLJ	W01A100E03	pENTR-TOPO	14590		VAPB	9217	BAC87433.1	Hs.182625	VAMP (vesicle-associated membrane protein)-associated protein B and C				THYMU3	EK1	NM_004738.3	NP_004729.1	REVIEWED	P	1.000	1.000	111	444	109	441	243	133	243
RIKEN	BC067903	IRAK168G19	MGC	W01A100E04	pENTR-TOPO	22816		LOC401442	401442	-	Hs.678992	Hypothetical gene supported by BC028401			Brain, hypothalamus	NIH_MGC_96	DH10B													
RIKEN	BC002911	IRAL015O19	MGC	W01A100E10	pENTR-TOPO	9183		VKORC1	79001	AAH02911.1	Hs.324844	Vitamin K epoxide reductase complex, subunit 1			Lung, small cell carcinoma	NIH_MGC_7		NM_024006.4	NP_076869.1	REVIEWED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	AK092503	flj0015l10	FLJ	W01A100E13	pENTR-TOPO	24653		PAGE4	9506	BAC03907	Hs.441038	P antigen family, member 4 (prostate associated)				PLACE6	EK1	NM_007003.2	NP_008934.1	REVIEWED	Pfs	0.222	0.222	36	447	250	143	102	35	70
RIKEN	BC002911	IRAL015O19	MGC	W01A100E18	pENTR-TOPO	9183		VKORC1	79001	AAH02911.1	Hs.324844	Vitamin K epoxide reductase complex, subunit 1			Lung, small cell carcinoma	NIH_MGC_7		NM_024006.4	NP_076869.1	REVIEWED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	BC002911	IRAL015O19	MGC	W01A100E20	pENTR-TOPO	9183		VKORC1	79001	AAH02911.1	Hs.324844	Vitamin K epoxide reductase complex, subunit 1			Lung, small cell carcinoma	NIH_MGC_7		NM_024006.4	NP_076869.1	REVIEWED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	AK125942	flj0072a10	FLJ	W01A100E23	pENTR-TOPO	17120			401072	BAC86353						TESTI4	EK1			
RIKEN	AK075231	flj0019c14	FLJ	W01A100F01	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	BC013572	IRAK014C23	MGC	W01A100F06	pENTR-TOPO	6019		KRAS	3845	AAH13572.1	Hs.505033	V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004985.3	NP_004976.2	REVIEWED	Cs	0.995	0.995	188	567	1	564	188	1	188
RIKEN	BC005867	IRAL001O06	MGC	W01A100F11	pENTR-TOPO	15655		COMT	1312	AAH05867.1	Hs.713616	Catechol-O-methyltransferase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007310.2	NP_009294.1	REVIEWED	Ps	0.995	0.995	182	549	1	546	221	40	221
RIKEN	BC006465	IRAL006F12	MGC	W01A100F12	pENTR-TOPO	9377		CYBA	1535	AAH06465.1	Hs.513803	Cytochrome b-245, alpha polypeptide			Brain, neuroblastoma	NIH_MGC_19		NM_000101.2	NP_000092.2	REVIEWED	Cs	0.995	0.995	195	588	1	585	195	1	195
RIKEN	BC005867	IRAL001O06	MGC	W01A100F13	pENTR-TOPO	15655		COMT	1312	AAH05867.1	Hs.713616	Catechol-O-methyltransferase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007310.2	NP_009294.1	REVIEWED	Ps	0.995	0.995	182	549	1	546	221	40	221
RIKEN	BC006465	IRAL006F12	MGC	W01A100F14	pENTR-TOPO	9377		CYBA	1535	AAH06465.1	Hs.513803	Cytochrome b-245, alpha polypeptide			Brain, neuroblastoma	NIH_MGC_19		NM_000101.2	NP_000092.2	REVIEWED	Cs	0.995	0.995	195	588	1	585	195	1	195
RIKEN	BC005867	IRAL001O06	MGC	W01A100F15	pENTR-TOPO	15655		COMT	1312	AAH05867.1	Hs.713616	Catechol-O-methyltransferase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007310.2	NP_009294.1	REVIEWED	Ps	0.995	0.995	182	549	1	546	221	40	221
RIKEN	BC005867	IRAL001O06	MGC	W01A100F21	pENTR-TOPO	15655		COMT	1312	AAH05867.1	Hs.713616	Catechol-O-methyltransferase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007310.2	NP_009294.1	REVIEWED	Ps	0.995	0.995	182	549	1	546	221	40	221
RIKEN	AK125942	flj0072a10	FLJ	W01A100G03	pENTR-TOPO	17120			401072	BAC86353						TESTI4	EK1			
RIKEN	BC002911	IRAL015O19	MGC	W01A100G04	pENTR-TOPO	9183		VKORC1	79001	AAH02911.1	Hs.324844	Vitamin K epoxide reductase complex, subunit 1			Lung, small cell carcinoma	NIH_MGC_7		NM_024006.4	NP_076869.1	REVIEWED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	AK125942	flj0072a10	FLJ	W01A100G07	pENTR-TOPO	17120			401072	BAC86353						TESTI4	EK1			
RIKEN	AK125942	flj0072a10	FLJ	W01A100G11	pENTR-TOPO	17120			401072	BAC86353						TESTI4	EK1			
RIKEN	AK095018	flj0025j09	FLJ	W01A100G14	pENTR-TOPO	21247		DNAH11	8701	BAC04475	Hs.655326	Dynein, axonemal, heavy chain 11				BRHIP2	EK1	NM_003777.3	NP_003768.2	REVIEWED		0.937	0.937	126	474	1	378	4523	1	126
RIKEN	AK095018	flj0025j09	FLJ	W01A100G16	pENTR-TOPO	21247		DNAH11	8701	BAC04475	Hs.655326	Dynein, axonemal, heavy chain 11				BRHIP2	EK1	NM_003777.3	NP_003768.2	REVIEWED		0.937	0.937	126	474	1	378	4523	1	126
RIKEN	BC006465	IRAL006F12	MGC	W01A100H02	pENTR-TOPO	9377		CYBA	1535	AAH06465.1	Hs.513803	Cytochrome b-245, alpha polypeptide			Brain, neuroblastoma	NIH_MGC_19		NM_000101.2	NP_000092.2	REVIEWED	Cs	0.995	0.995	195	588	1	585	195	1	195
RIKEN	AK128136	flj0077g05	FLJ	W01A100H07	pENTR-TOPO	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein				TESTI4	EK1													
RIKEN	BC015510	IRAK022P23	MGC	W01A100H14	pENTR-TOPO	502		RGS1	5996	AAH15510.1	Hs.75256	Regulator of G-protein signaling 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002922.3	NP_002913.3	REVIEWED	P	1.000	1.000	196	591	1	588	209	14	209
RIKEN	BC015510	IRAK022P23	MGC	W01A100H16	pENTR-TOPO	502		RGS1	5996	AAH15510.1	Hs.75256	Regulator of G-protein signaling 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002922.3	NP_002913.3	REVIEWED	P	1.000	1.000	196	591	1	588	209	14	209
RIKEN	BC015510	IRAK022P23	MGC	W01A100H20	pENTR-TOPO	502		RGS1	5996	AAH15510.1	Hs.75256	Regulator of G-protein signaling 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002922.3	NP_002913.3	REVIEWED	P	1.000	1.000	196	591	1	588	209	14	209
RIKEN	BC021230	IRAL020H07	MGC	W01A100H21	pENTR-TOPO	982		LOC653160	653160	-					Muscle, rhabdomyosarcoma	NIH_MGC_17		XM_945233.2	XP_950326.2	MODEL										
RIKEN	BC021230	IRAL020H07	MGC	W01A100H23	pENTR-TOPO	982		LOC653160	653160	-					Muscle, rhabdomyosarcoma	NIH_MGC_17		XM_945233.2	XP_950326.2	MODEL										
RIKEN	AK123853	flj0068a11	FLJ	W01A100I06	pENTR-TOPO	20706		LOC401286	401286	BAC85709.1	Hs.715358	Hypothetical LOC401286	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	AK094090	flj0040k22	FLJ	W01A100I09	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	AK123853	flj0068a11	FLJ	W01A100I10	pENTR-TOPO	20706		LOC401286	401286	BAC85709.1	Hs.715358	Hypothetical LOC401286	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	AK123853	flj0068a11	FLJ	W01A100I12	pENTR-TOPO	20706		LOC401286	401286	BAC85709.1	Hs.715358	Hypothetical LOC401286	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	AK094090	flj0040k22	FLJ	W01A100I17	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	AK092217	flj0011p01	FLJ	W01A100I20	pENTR-TOPO	35426		LOC729770	729770	-	Hs.591612	Hypothetical protein LOC729770	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	AK094090	flj0040k22	FLJ	W01A100I23	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	BC021230	IRAL020H07	MGC	W01A100J03	pENTR-TOPO	982		LOC653160	653160	-					Muscle, rhabdomyosarcoma	NIH_MGC_17		XM_945233.2	XP_950326.2	MODEL										
RIKEN	BC015510	IRAK022P23	MGC	W01A100J04	pENTR-TOPO	502		RGS1	5996	AAH15510.1	Hs.75256	Regulator of G-protein signaling 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002922.3	NP_002913.3	REVIEWED	P	1.000	1.000	196	591	1	588	209	14	209
RIKEN	BC015510	IRAK022P23	MGC	W01A100J06	pENTR-TOPO	502		RGS1	5996	AAH15510.1	Hs.75256	Regulator of G-protein signaling 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002922.3	NP_002913.3	REVIEWED	P	1.000	1.000	196	591	1	588	209	14	209
RIKEN	BC021230	IRAL020H07	MGC	W01A100J07	pENTR-TOPO	982		LOC653160	653160	-					Muscle, rhabdomyosarcoma	NIH_MGC_17		XM_945233.2	XP_950326.2	MODEL										
RIKEN	AK000947	flj0028e21	FLJ	W01A100J09	pENTR-TOPO	14568		MYH7B	57644	BAA91440.1	Hs.414122	Myosin, heavy chain 7B, cardiac muscle, beta				HEMBA1	EK1	NM_020884.2	NP_065935.2	VALIDATED	P	1.000	1.000	176	531	1	528	1983	43	218
RIKEN	BC002599	IRAL004J18	MGC	W01A100J14	pENTR-TOPO	23154		CRH	1392	AAH02599.1	Hs.75294	Corticotropin releasing hormone			Brain, neuroblastoma	NIH_MGC_19		NM_000756.1	NP_000747.1	REVIEWED	C	1.000	1.000	196	591	1	588	196	1	196
RIKEN	AK000947	flj0028e21	FLJ	W01A100J17	pENTR-TOPO	14568		MYH7B	57644	BAA91440.1	Hs.414122	Myosin, heavy chain 7B, cardiac muscle, beta				HEMBA1	EK1	NM_020884.2	NP_065935.2	VALIDATED	P	1.000	1.000	176	531	1	528	1983	43	218
RIKEN	AK000947	flj0028e21	FLJ	W01A100J19	pENTR-TOPO	14568		MYH7B	57644	BAA91440.1	Hs.414122	Myosin, heavy chain 7B, cardiac muscle, beta				HEMBA1	EK1	NM_020884.2	NP_065935.2	VALIDATED	P	1.000	1.000	176	531	1	528	1983	43	218
RIKEN	BC002599	IRAL004J18	MGC	W01A100J20	pENTR-TOPO	23154		CRH	1392	AAH02599.1	Hs.75294	Corticotropin releasing hormone			Brain, neuroblastoma	NIH_MGC_19		NM_000756.1	NP_000747.1	REVIEWED	C	1.000	1.000	196	591	1	588	196	1	196
RIKEN	AK000947	flj0028e21	FLJ	W01A100J21	pENTR-TOPO	14568		MYH7B	57644	BAA91440.1	Hs.414122	Myosin, heavy chain 7B, cardiac muscle, beta				HEMBA1	EK1	NM_020884.2	NP_065935.2	VALIDATED	P	1.000	1.000	176	531	1	528	1983	43	218
RIKEN	AK094090	flj0040k22	FLJ	W01A100K01	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	AK092217	flj0011p01	FLJ	W01A100K06	pENTR-TOPO	35426		LOC729770	729770	-	Hs.591612	Hypothetical protein LOC729770	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	AK125880	flj0072m21	FLJ	W01A100K14	pENTR-TOPO	22931		TP53INP1	94241	-	Hs.492261	Tumor protein p53 inducible nuclear protein 1				TESTI4	EK1	NM_001135733.1	NP_001129205.1	VALIDATED	Cs	0.994	0.994	164	495	1	492	164	1	164
RIKEN	AK128177	flj0078o01	FLJ	W01A100K15	pENTR-TOPO	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein				TESTI4	EK1													
RIKEN	AK125880	flj0072m21	FLJ	W01A100K22	pENTR-TOPO	22931		TP53INP1	94241	-	Hs.492261	Tumor protein p53 inducible nuclear protein 1				TESTI4	EK1	NM_001135733.1	NP_001129205.1	VALIDATED	Cs	0.994	0.994	164	495	1	492	164	1	164
RIKEN	AK056936	flj0003d05	FLJ	W01A100L14	pENTR-TOPO	20426		EHMT2	10919	BAB71314.1	Hs.709218	Euchromatic histone-lysine N-methyltransferase 2				SALGL1	EK1	NM_006709.3	NP_006700.3	REVIEWED	P	1.000	1.000	194	609	1	582	1210	1	194
RIKEN	AK024726	flj0057d23	FLJ	W01A100L15	pENTR-TOPO	8204		ZFP106	64397	BAB14976.1	Hs.511143	Zinc finger protein 106 homolog (mouse)				CAS	EK1	NM_022473.1	NP_071918.1	PROVISIONAL	P	1.000	1.000	178	537	1	534	1883	1706	1883
RIKEN	AK024726	flj0057d23	FLJ	W01A100L19	pENTR-TOPO	8204		ZFP106	64397	BAB14976.1	Hs.511143	Zinc finger protein 106 homolog (mouse)				CAS	EK1	NM_022473.1	NP_071918.1	PROVISIONAL	P	1.000	1.000	178	537	1	534	1883	1706	1883
RIKEN	BC001034	IRAL004A16	MGC	W01A100M01	pENTR-TOPO	15261		SOD1	6647	AAH01034.1	Hs.443914	Superoxide dismutase 1, soluble			Placenta, choriocarcinoma	NIH_MGC_21		NM_000454.4	NP_000445.1	REVIEWED	C	1.000	1.000	154	465	1	462	154	1	154
RIKEN	BC000275	IRAL006A04	MGC	W01A100M04	pENTR-TOPO	19748		CDKN1A	1026	AAH00275.1	Hs.370771	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)			Eye, retinoblastoma	NIH_MGC_16		NM_078467.1	NP_510867.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC001034	IRAL004A16	MGC	W01A100M07	pENTR-TOPO	15261		SOD1	6647	AAH01034.1	Hs.443914	Superoxide dismutase 1, soluble			Placenta, choriocarcinoma	NIH_MGC_21		NM_000454.4	NP_000445.1	REVIEWED	C	1.000	1.000	154	465	1	462	154	1	154
RIKEN	BC000275	IRAL006A04	MGC	W01A100M12	pENTR-TOPO	19748		CDKN1A	1026	AAH00275.1	Hs.370771	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)			Eye, retinoblastoma	NIH_MGC_16		NM_078467.1	NP_510867.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	AK097327	flj0025o23	FLJ	W01A100M13	pENTR-TOPO	744		FAM87B	400728	BAC04999.1						STOMA2	EK1	XM_001713962.1	XP_001714014.1	MODEL	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC000275	IRAL006A04	MGC	W01A100M14	pENTR-TOPO	19748		CDKN1A	1026	AAH00275.1	Hs.370771	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)			Eye, retinoblastoma	NIH_MGC_16		NM_078467.1	NP_510867.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	AK097327	flj0025o23	FLJ	W01A100M17	pENTR-TOPO	744		FAM87B	400728	BAC04999.1						STOMA2	EK1	XM_001713962.1	XP_001714014.1	MODEL	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	AK097327	flj0025o23	FLJ	W01A100M19	pENTR-TOPO	744		FAM87B	400728	BAC04999.1						STOMA2	EK1	XM_001713962.1	XP_001714014.1	MODEL	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC070256	IRAL057P19	MGC	W01A100M24	pENTR-TOPO	6022		IFNG	3458	AAH70256.1	Hs.856	Interferon, gamma				NIH_MGC_191	DH10B	NM_000619.2	NP_000610.2	VALIDATED	C	1.000	1.000	166	501	1	498	166	1	166
RIKEN	AK056936	flj0003d05	FLJ	W01A100N02	pENTR-TOPO	20426		EHMT2	10919	BAB71314.1	Hs.709218	Euchromatic histone-lysine N-methyltransferase 2				SALGL1	EK1	NM_006709.3	NP_006700.3	REVIEWED	P	1.000	1.000	194	609	1	582	1210	1	194
RIKEN	AK024726	flj0057d23	FLJ	W01A100N07	pENTR-TOPO	8204		ZFP106	64397	BAB14976.1	Hs.511143	Zinc finger protein 106 homolog (mouse)				CAS	EK1	NM_022473.1	NP_071918.1	PROVISIONAL	P	1.000	1.000	178	537	1	534	1883	1706	1883
RIKEN	AK056936	flj0003d05	FLJ	W01A100N08	pENTR-TOPO	20426		EHMT2	10919	BAB71314.1	Hs.709218	Euchromatic histone-lysine N-methyltransferase 2				SALGL1	EK1	NM_006709.3	NP_006700.3	REVIEWED	P	1.000	1.000	194	609	1	582	1210	1	194
RIKEN	AK023029	flj0034g24	FLJ	W01A100N13	pENTR-TOPO	16968		PHC3	80012	BAB14365.1	Hs.694467	Polyhomeotic homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_024947.3	NP_079223.3	VALIDATED	Pgs	0.972	0.994	180	561	1	528	995	13	192
RIKEN	AK027361	flj0030g19	FLJ	W01A100N14	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK027361	flj0030g19	FLJ	W01A100N18	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK023029	flj0034g24	FLJ	W01A100N19	pENTR-TOPO	16968		PHC3	80012	BAB14365.1	Hs.694467	Polyhomeotic homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_024947.3	NP_079223.3	VALIDATED	Pgs	0.972	0.994	180	561	1	528	995	13	192
RIKEN	AK027361	flj0030g19	FLJ	W01A100N20	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK027361	flj0030g19	FLJ	W01A100N22	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK097327	flj0025o23	FLJ	W01A100O05	pENTR-TOPO	744		FAM87B	400728	BAC04999.1						STOMA2	EK1	XM_001713962.1	XP_001714014.1	MODEL	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	BC036636	IRAK076L11	MGC	W01A100O14	pENTR-TOPO	1473		LEMD1	93273	AAH36636.1	Hs.655520	LEM domain containing 1			Testis	NIH_MGC_97	DH10B	NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
RIKEN	BC036636	IRAK076L11	MGC	W01A100O18	pENTR-TOPO	1473		LEMD1	93273	AAH36636.1	Hs.655520	LEM domain containing 1			Testis	NIH_MGC_97	DH10B	NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
RIKEN	BC036636	IRAK076L11	MGC	W01A100O22	pENTR-TOPO	1473		LEMD1	93273	AAH36636.1	Hs.655520	LEM domain containing 1			Testis	NIH_MGC_97	DH10B	NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
RIKEN	BC066258	IRAK172D20	MGC	W01A100O23	pENTR-TOPO	18100		IL21	59067	AAH66258.1	Hs.567559	Interleukin 21			PCR rescued clones	NIH_MGC_195	DH10B	NM_021803.2	NP_068575.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	AK027361	flj0030g19	FLJ	W01A100P02	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK027361	flj0030g19	FLJ	W01A100P04	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK123203	flj0070b23	FLJ	W01A100P13	pENTR-TOPO	18817			441070	BAC85556						BRALZ2	EK1			
RIKEN	BC000510	IRAL001H20	MGC	W01A100P16	pENTR-TOPO	21024		HSPB1	3315	AAH00510.1	Hs.520973	Heat shock 27kDa protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001540.3	NP_001531.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	AK123203	flj0070b23	FLJ	W01A100P17	pENTR-TOPO	18817			441070	BAC85556						BRALZ2	EK1			
RIKEN	AK123203	flj0070b23	FLJ	W01A100P19	pENTR-TOPO	18817			441070	BAC85556						BRALZ2	EK1			
RIKEN	AK128501	flj0076h01	FLJ	W01A101A03	pENTR-TOPO	15537		BCR	613	BAC87471	Hs.715409	Breakpoint cluster region				TRACH3	EK1	NM_021574.2	NP_067585.2	REVIEWED	Ps	0.995	0.995	188	624	1	564	1227	715	902
RIKEN	AK124522	flj0069e24	FLJ	W01A101A06	pENTR-TOPO	2588		BRWD2	55717	BAC85874	Hs.144447	Bromodomain and WD repeat domain containing 2				BRACE3	EK1	NM_018117.10	NP_060587.8	REVIEWED	Pfs	0.991	0.996	225	675	2	672	1224	1000	1224
RIKEN	BC045773	IRAK090K08	MGC	W01A101A16	pENTR-TOPO	23945		B4GALT1	2683	AAH45773.1	Hs.272011	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1			Testis	NIH_MGC_97	DH10B	NM_001497.3	NP_001488.2	REVIEWED	P	1.000	1.000	216	678	1	648	398	1	216
RIKEN	BC045773	IRAK090K08	MGC	W01A101A18	pENTR-TOPO	23945		B4GALT1	2683	AAH45773.1	Hs.272011	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1			Testis	NIH_MGC_97	DH10B	NM_001497.3	NP_001488.2	REVIEWED	P	1.000	1.000	216	678	1	648	398	1	216
RIKEN	AK128501	flj0076h01	FLJ	W01A101A21	pENTR-TOPO	15537		BCR	613	BAC87471	Hs.715409	Breakpoint cluster region				TRACH3	EK1	NM_021574.2	NP_067585.2	REVIEWED	Ps	0.995	0.995	188	624	1	564	1227	715	902
RIKEN	BC045773	IRAK090K08	MGC	W01A101A22	pENTR-TOPO	23945		B4GALT1	2683	AAH45773.1	Hs.272011	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1			Testis	NIH_MGC_97	DH10B	NM_001497.3	NP_001488.2	REVIEWED	P	1.000	1.000	216	678	1	648	398	1	216
RIKEN	BC045773	IRAK090K08	MGC	W01A101A24	pENTR-TOPO	23945		B4GALT1	2683	AAH45773.1	Hs.272011	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1			Testis	NIH_MGC_97	DH10B	NM_001497.3	NP_001488.2	REVIEWED	P	1.000	1.000	216	678	1	648	398	1	216
RIKEN	BC058934	IRAK119B15	MGC	W01A101B04	pENTR-TOPO	4416		HCCA2	81532	-	Hs.370360	HCCA2 protein			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_053005.3	NP_443731.2	PROVISIONAL	P	1.000	1.000	30	768	2	91	237	208	237
RIKEN	AK001975	flj0037l19	FLJ	W01A101B05	pENTR-TOPO	12945		MBD5	55777	BAA92013.1	Hs.458312	Methyl-CpG binding domain protein 5				PLACE1	EK1	NM_018328.3	NP_060798.2	VALIDATED	P	1.000	1.000	218	690	1	654	1494	623	840
RIKEN	BC058934	IRAK119B15	MGC	W01A101B08	pENTR-TOPO	4416		HCCA2	81532	-	Hs.370360	HCCA2 protein			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_053005.3	NP_443731.2	PROVISIONAL	P	1.000	1.000	30	768	2	91	237	208	237
RIKEN	BC058934	IRAK119B15	MGC	W01A101B10	pENTR-TOPO	4416		HCCA2	81532	-	Hs.370360	HCCA2 protein			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_053005.3	NP_443731.2	PROVISIONAL	P	1.000	1.000	30	768	2	91	237	208	237
RIKEN	BC058934	IRAK119B15	MGC	W01A101B14	pENTR-TOPO	4416		HCCA2	81532	-	Hs.370360	HCCA2 protein			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_053005.3	NP_443731.2	PROVISIONAL	P	1.000	1.000	30	768	2	91	237	208	237
RIKEN	BC022486	IRAK032H20	MGC	W01A101B20	pENTR-TOPO	21398		AQP1	358	AAH22486.1	Hs.76152	Aquaporin 1 (Colton blood group)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198098.1	NP_932766.1	REVIEWED	Cs	0.996	0.996	269	810	1	807	269	1	269
RIKEN	BC045773	IRAK090K08	MGC	W01A101C04	pENTR-TOPO	23945		B4GALT1	2683	AAH45773.1	Hs.272011	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1			Testis	NIH_MGC_97	DH10B	NM_001497.3	NP_001488.2	REVIEWED	P	1.000	1.000	216	678	1	648	398	1	216
RIKEN	BC002882	IRAL015G09	MGC	W01A101C07	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	AK094116	flj0026g09	FLJ	W01A101C12	pENTR-TOPO	19987		LOC441177	441177	BAC04291.1	Hs.708964	Hypothetical LOC441177				ADRGL2	EK1	NM_001013720.1	NP_001013742.1	VALIDATED										
RIKEN	BC002882	IRAL015G09	MGC	W01A101C17	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	AK094116	flj0026g09	FLJ	W01A101C20	pENTR-TOPO	19987		LOC441177	441177	BAC04291.1	Hs.708964	Hypothetical LOC441177				ADRGL2	EK1	NM_001013720.1	NP_001013742.1	VALIDATED										
RIKEN	AK094116	flj0026g09	FLJ	W01A101C22	pENTR-TOPO	19987		LOC441177	441177	BAC04291.1	Hs.708964	Hypothetical LOC441177				ADRGL2	EK1	NM_001013720.1	NP_001013742.1	VALIDATED										
RIKEN	BC002665	IRAL012I05	MGC	W01A101D05	pENTR-TOPO	24782		PLP1	5354	AAH02665.1	Hs.1787	Proteolipid protein 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_199478.1	NP_955772.1	REVIEWED	C	1.000	1.000	242	729	1	726	242	1	242
RIKEN	BC002665	IRAL012I05	MGC	W01A101D07	pENTR-TOPO	24782		PLP1	5354	AAH02665.1	Hs.1787	Proteolipid protein 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_199478.1	NP_955772.1	REVIEWED	C	1.000	1.000	242	729	1	726	242	1	242
RIKEN	BC034027	IRAL037J14	MGC	W01A101D11	pENTR-TOPO	10023		NOG	9241	AAH34027.1	Hs.248201	Noggin			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_005450.4	NP_005441.1	REVIEWED	C	1.000	1.000	232	699	1	696	232	1	232
RIKEN	BC032474	IRAK064L12	MGC	W01A101D14	pENTR-TOPO	3854		TIRAP	114609	AAH32474.1	Hs.537126	Toll-interleukin 1 receptor (TIR) domain containing adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001039661.1	NP_001034750.1	REVIEWED	C	1.000	1.000	221	771	1	663	221	1	221
RIKEN	BC034027	IRAL037J14	MGC	W01A101D15	pENTR-TOPO	10023		NOG	9241	AAH34027.1	Hs.248201	Noggin			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_005450.4	NP_005441.1	REVIEWED	C	1.000	1.000	232	699	1	696	232	1	232
RIKEN	BC032474	IRAK064L12	MGC	W01A101D16	pENTR-TOPO	3854		TIRAP	114609	AAH32474.1	Hs.537126	Toll-interleukin 1 receptor (TIR) domain containing adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001039661.1	NP_001034750.1	REVIEWED	C	1.000	1.000	221	771	1	663	221	1	221
RIKEN	BC034027	IRAL037J14	MGC	W01A101D21	pENTR-TOPO	10023		NOG	9241	AAH34027.1	Hs.248201	Noggin			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_005450.4	NP_005441.1	REVIEWED	C	1.000	1.000	232	699	1	696	232	1	232
RIKEN	BC034027	IRAL037J14	MGC	W01A101D23	pENTR-TOPO	10023		NOG	9241	AAH34027.1	Hs.248201	Noggin			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_005450.4	NP_005441.1	REVIEWED	C	1.000	1.000	232	699	1	696	232	1	232
RIKEN	AK090970	flj0011c04	FLJ	W01A101E05	pENTR-TOPO	17079		C3orf53	285322	BAC03560.1	Hs.376725	Chromosome 3 open reading frame 53				BRAMY2	EK1													
RIKEN	AK090970	flj0011c04	FLJ	W01A101E09	pENTR-TOPO	17079		C3orf53	285322	BAC03560.1	Hs.376725	Chromosome 3 open reading frame 53				BRAMY2	EK1													
RIKEN	BC012626	IRAL019B09	MGC	W01A101E10	pENTR-TOPO	13753		NAT8	9027	AAH12626.1	Hs.14637	N-acetyltransferase 8 (GCN5-related, putative)			Kidney	NIH_MGC_75	DH10B	NM_003960.3	NP_003951.3	REVIEWED	P	1.000	1.000	226	678	1	678	227	1	226
RIKEN	BC012626	IRAL019B09	MGC	W01A101E16	pENTR-TOPO	13753		NAT8	9027	AAH12626.1	Hs.14637	N-acetyltransferase 8 (GCN5-related, putative)			Kidney	NIH_MGC_75	DH10B	NM_003960.3	NP_003951.3	REVIEWED	P	1.000	1.000	226	678	1	678	227	1	226
RIKEN	BC034027	IRAL037J14	MGC	W01A101F01	pENTR-TOPO	10023		NOG	9241	AAH34027.1	Hs.248201	Noggin			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_005450.4	NP_005441.1	REVIEWED	C	1.000	1.000	232	699	1	696	232	1	232
RIKEN	BC034027	IRAL037J14	MGC	W01A101F05	pENTR-TOPO	10023		NOG	9241	AAH34027.1	Hs.248201	Noggin			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_005450.4	NP_005441.1	REVIEWED	C	1.000	1.000	232	699	1	696	232	1	232
RIKEN	BC029485	IRAK048H14	MGC	W01A101F09	pENTR-TOPO	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
RIKEN	BC032474	IRAK064L12	MGC	W01A101F10	pENTR-TOPO	3854		TIRAP	114609	AAH32474.1	Hs.537126	Toll-interleukin 1 receptor (TIR) domain containing adaptor protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001039661.1	NP_001034750.1	REVIEWED	C	1.000	1.000	221	771	1	663	221	1	221
RIKEN	AK054593	flj0001a09	FLJ	W01A101F14	pENTR-TOPO	20465		DTNBP1	84062	BAB70770.1	Hs.571148	Dystrobrevin binding protein 1	NB69	neuroblastoma		3NB692	EK1	NM_183041.1	NP_898862.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC029485	IRAK048H14	MGC	W01A101F17	pENTR-TOPO	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
RIKEN	AK054593	flj0001a09	FLJ	W01A101F20	pENTR-TOPO	20465		DTNBP1	84062	BAB70770.1	Hs.571148	Dystrobrevin binding protein 1	NB69	neuroblastoma		3NB692	EK1	NM_183041.1	NP_898862.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	AK054593	flj0001a09	FLJ	W01A101F22	pENTR-TOPO	20465		DTNBP1	84062	BAB70770.1	Hs.571148	Dystrobrevin binding protein 1	NB69	neuroblastoma		3NB692	EK1	NM_183041.1	NP_898862.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	AK054593	flj0001a09	FLJ	W01A101F24	pENTR-TOPO	20465		DTNBP1	84062	BAB70770.1	Hs.571148	Dystrobrevin binding protein 1	NB69	neuroblastoma		3NB692	EK1	NM_183041.1	NP_898862.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC007742	IRAL017P11	MGC	W01A101G06	pENTR-TOPO	12345		EXOSC5	56915	AAH07742.1	Hs.283741	Exosome component 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020158.3	NP_064543.3	VALIDATED	Cs	0.996	0.996	235	708	1	705	235	1	235
RIKEN	AK027243	flj0067e15	FLJ	W01A101G09	pENTR-TOPO	3598		BBS1	582	BAB15704.1	Hs.502915	Bardet-Biedl syndrome 1				LNG	EK1	NM_024649.4	NP_078925.3	REVIEWED	Pfs	0.317	0.339	63	663	268	445	593	2	64
RIKEN	BC007742	IRAL017P11	MGC	W01A101G10	pENTR-TOPO	12345		EXOSC5	56915	AAH07742.1	Hs.283741	Exosome component 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020158.3	NP_064543.3	VALIDATED	Cs	0.996	0.996	235	708	1	705	235	1	235
RIKEN	AK027243	flj0067e15	FLJ	W01A101G11	pENTR-TOPO	3598		BBS1	582	BAB15704.1	Hs.502915	Bardet-Biedl syndrome 1				LNG	EK1	NM_024649.4	NP_078925.3	REVIEWED	Pfs	0.317	0.339	63	663	268	445	593	2	64
RIKEN	AK027243	flj0067e15	FLJ	W01A101G19	pENTR-TOPO	3598		BBS1	582	BAB15704.1	Hs.502915	Bardet-Biedl syndrome 1				LNG	EK1	NM_024649.4	NP_078925.3	REVIEWED	Pfs	0.317	0.339	63	663	268	445	593	2	64
RIKEN	AK021727	flj0029c01	FLJ	W01A101G22	pENTR-TOPO	21875		LMBR1	64327	BAB13880.1	Hs.209989	Limb region 1 homolog (mouse)				HEMBA1	EK1	NM_022458.3	NP_071903.2	REVIEWED	Ps	0.995	0.995	207	687	1	621	490	1	207
RIKEN	BC070259	IRAL057F03	MGC	W01A101H01	pENTR-TOPO	930		CFHR3	10878	AAH70259.1	Hs.709217	Complement factor H-related 3			Liver	NIH_MGC_76	DH10B	NM_021023.4	NP_066303.2	VALIDATED	Ps	0.990	0.990	206	699	1	618	330	1	206
RIKEN	BC009715	IRAK014N17	MGC	W01A101H04	pENTR-TOPO	15563		SNAP29	9342	AAH09715.1	Hs.108002	Synaptosomal-associated protein, 29kDa			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004782.3	NP_004773.1	REVIEWED	C	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC009715	IRAK014N17	MGC	W01A101H14	pENTR-TOPO	15563		SNAP29	9342	AAH09715.1	Hs.108002	Synaptosomal-associated protein, 29kDa			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004782.3	NP_004773.1	REVIEWED	C	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC014908	IRAK015D11	MGC	W01A101H18	pENTR-TOPO	18191		SLBP	7884	AAH14908.1	Hs.298345	Stem-loop binding protein			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006527.2	NP_006518.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC014908	IRAK015D11	MGC	W01A101H20	pENTR-TOPO	18191		SLBP	7884	AAH14908.1	Hs.298345	Stem-loop binding protein			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006527.2	NP_006518.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC030195	IRAK049M07	MGC	W01A101H23	pENTR-TOPO	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004131.4	NP_004122.2	REVIEWED	Cs	0.992	0.992	247	744	1	741	247	1	247
RIKEN	BC032362	IRAK064O16	MGC	W01A101I01	pENTR-TOPO	20394		TREM2	54209	AAH32362.1	Hs.435295	Triggering receptor expressed on myeloid cells 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_018965.2	NP_061838.1	REVIEWED	Pfs	0.941	1.000	222	669	1	667	230	1	209
RIKEN	BC032362	IRAK064O16	MGC	W01A101I09	pENTR-TOPO	20394		TREM2	54209	AAH32362.1	Hs.435295	Triggering receptor expressed on myeloid cells 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_018965.2	NP_061838.1	REVIEWED	Pfs	0.941	1.000	222	669	1	667	230	1	209
RIKEN	AK097878	flj0040a12	FLJ	W01A101I10	pENTR-TOPO	42475		PRDM11	56981	BAC05192.1	Hs.178715	PR domain containing 11				THYMU2	EK1	NM_020229.2	NP_064614.2	VALIDATED		0.349	0.417	43	714	448	558	511	3	44
RIKEN	AK097878	flj0040a12	FLJ	W01A101I12	pENTR-TOPO	42475		PRDM11	56981	BAC05192.1	Hs.178715	PR domain containing 11				THYMU2	EK1	NM_020229.2	NP_064614.2	VALIDATED		0.349	0.417	43	714	448	558	511	3	44
RIKEN	AK097878	flj0040a12	FLJ	W01A101I16	pENTR-TOPO	42475		PRDM11	56981	BAC05192.1	Hs.178715	PR domain containing 11				THYMU2	EK1	NM_020229.2	NP_064614.2	VALIDATED		0.349	0.417	43	714	448	558	511	3	44
RIKEN	BC032362	IRAK064O16	MGC	W01A101I23	pENTR-TOPO	20394		TREM2	54209	AAH32362.1	Hs.435295	Triggering receptor expressed on myeloid cells 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_018965.2	NP_061838.1	REVIEWED	Pfs	0.941	1.000	222	669	1	667	230	1	209
RIKEN	BC014908	IRAK015D11	MGC	W01A101J02	pENTR-TOPO	18191		SLBP	7884	AAH14908.1	Hs.298345	Stem-loop binding protein			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006527.2	NP_006518.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
RIKEN	BC030195	IRAK049M07	MGC	W01A101J07	pENTR-TOPO	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004131.4	NP_004122.2	REVIEWED	Cs	0.992	0.992	247	744	1	741	247	1	247
RIKEN	BC018036	IRAK032I14	MGC	W01A101J13	pENTR-TOPO	24533		TSPAN7	7102	AAH18036.1	Hs.441664	Tetraspanin 7			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004615.3	NP_004606.2	REVIEWED	Cs	0.992	0.992	249	750	1	747	249	1	249
RIKEN	BC018036	IRAK032I14	MGC	W01A101J15	pENTR-TOPO	24533		TSPAN7	7102	AAH18036.1	Hs.441664	Tetraspanin 7			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004615.3	NP_004606.2	REVIEWED	Cs	0.992	0.992	249	750	1	747	249	1	249
RIKEN	BC018036	IRAK032I14	MGC	W01A101J17	pENTR-TOPO	24533		TSPAN7	7102	AAH18036.1	Hs.441664	Tetraspanin 7			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004615.3	NP_004606.2	REVIEWED	Cs	0.992	0.992	249	750	1	747	249	1	249
RIKEN	BC018036	IRAK032I14	MGC	W01A101J19	pENTR-TOPO	24533		TSPAN7	7102	AAH18036.1	Hs.441664	Tetraspanin 7			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004615.3	NP_004606.2	REVIEWED	Cs	0.992	0.992	249	750	1	747	249	1	249
RIKEN	AK092312	flj0010i08	FLJ	W01A101J20	pENTR-TOPO	16841		ZFYVE20	64145	BAC03860.1	Hs.706478	Zinc finger, FYVE domain containing 20				OCBBF2	EK1	NM_022340.2	NP_071735.2	VALIDATED	P	1.000	1.000	261	786	1	783	784	524	784
RIKEN	BC005975	IRAL021H09	MGC	W01A101K06	pENTR-TOPO	307		CACYBP	27101	AAH05975.1	Hs.508524	Calcyclin binding protein			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_014412.2	NP_055227.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC005975	IRAL021H09	MGC	W01A101K10	pENTR-TOPO	307		CACYBP	27101	AAH05975.1	Hs.508524	Calcyclin binding protein			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_014412.2	NP_055227.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC005975	IRAL021H09	MGC	W01A101K14	pENTR-TOPO	307		CACYBP	27101	AAH05975.1	Hs.508524	Calcyclin binding protein			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_014412.2	NP_055227.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC005975	IRAL021H09	MGC	W01A101K16	pENTR-TOPO	307		CACYBP	27101	AAH05975.1	Hs.508524	Calcyclin binding protein			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_014412.2	NP_055227.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC008876	IRAL026M17	MGC	W01A101K24	pENTR-TOPO	14788		EDN3	1908	AAH08876.1	Hs.1408	Endothelin 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000114.2	NP_000105.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	AK092312	flj0010i08	FLJ	W01A101L02	pENTR-TOPO	16841		ZFYVE20	64145	BAC03860.1	Hs.706478	Zinc finger, FYVE domain containing 20				OCBBF2	EK1	NM_022340.2	NP_071735.2	VALIDATED	P	1.000	1.000	261	786	1	783	784	524	784
RIKEN	AK093413	flj0016k03	FLJ	W01A101L05	pENTR-TOPO	25686		LOC728395	728395	BAC04156.1	Hs.647493	Similar to testis specific protein, Y-linked 1				TESTI2	EK1	XM_001126990.2	XP_001126990.2	MODEL		0.973	0.973	112	795	367	702	221	30	141
RIKEN	AK125122	flj0069m03	FLJ	W01A101L10	pENTR-TOPO	590		C1orf226	400793	-	Hs.447011	Chromosome 1 open reading frame 226				CTONG3	EK1	NM_001085375.1	NP_001078844.1	VALIDATED	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	AK125122	flj0069m03	FLJ	W01A101L12	pENTR-TOPO	590		C1orf226	400793	-	Hs.447011	Chromosome 1 open reading frame 226				CTONG3	EK1	NM_001085375.1	NP_001078844.1	VALIDATED	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	AK125122	flj0069m03	FLJ	W01A101L14	pENTR-TOPO	590		C1orf226	400793	-	Hs.447011	Chromosome 1 open reading frame 226				CTONG3	EK1	NM_001085375.1	NP_001078844.1	VALIDATED	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	AK093413	flj0016k03	FLJ	W01A101L15	pENTR-TOPO	25686		LOC728395	728395	BAC04156.1	Hs.647493	Similar to testis specific protein, Y-linked 1				TESTI2	EK1	XM_001126990.2	XP_001126990.2	MODEL		0.973	0.973	112	795	367	702	221	30	141
RIKEN	AK125122	flj0069m03	FLJ	W01A101L22	pENTR-TOPO	590		C1orf226	400793	-	Hs.447011	Chromosome 1 open reading frame 226				CTONG3	EK1	NM_001085375.1	NP_001078844.1	VALIDATED	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	AK125122	flj0069m03	FLJ	W01A101L24	pENTR-TOPO	590		C1orf226	400793	-	Hs.447011	Chromosome 1 open reading frame 226				CTONG3	EK1	NM_001085375.1	NP_001078844.1	VALIDATED	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	BC070162	IRAL057P09	MGC	W01A101M01	pENTR-TOPO	12914		CTLA4	1493	AAH70162.1	Hs.247824	Cytotoxic T-lymphocyte-associated protein 4				NIH_MGC_191	DH10B	NM_005214.3	NP_005205.2	REVIEWED	Cs	0.996	0.996	223	672	1	669	223	1	223
RIKEN	BC008876	IRAL026M17	MGC	W01A101M02	pENTR-TOPO	14788		EDN3	1908	AAH08876.1	Hs.1408	Endothelin 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000114.2	NP_000105.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC070162	IRAL057P09	MGC	W01A101M05	pENTR-TOPO	12914		CTLA4	1493	AAH70162.1	Hs.247824	Cytotoxic T-lymphocyte-associated protein 4				NIH_MGC_191	DH10B	NM_005214.3	NP_005205.2	REVIEWED	Cs	0.996	0.996	223	672	1	669	223	1	223
RIKEN	BC008876	IRAL026M17	MGC	W01A101M06	pENTR-TOPO	14788		EDN3	1908	AAH08876.1	Hs.1408	Endothelin 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000114.2	NP_000105.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC008876	IRAL026M17	MGC	W01A101M08	pENTR-TOPO	14788		EDN3	1908	AAH08876.1	Hs.1408	Endothelin 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000114.2	NP_000105.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC070162	IRAL057P09	MGC	W01A101M09	pENTR-TOPO	12914		CTLA4	1493	AAH70162.1	Hs.247824	Cytotoxic T-lymphocyte-associated protein 4				NIH_MGC_191	DH10B	NM_005214.3	NP_005205.2	REVIEWED	Cs	0.996	0.996	223	672	1	669	223	1	223
RIKEN	AK055534	flj0012h23	FLJ	W01A101M12	pENTR-TOPO	22680		C8orf49	606553	BAB70943	Hs.545529	Chromosome 8 open reading frame 49				HEART2	EK1													
RIKEN	BC070162	IRAL057P09	MGC	W01A101M15	pENTR-TOPO	12914		CTLA4	1493	AAH70162.1	Hs.247824	Cytotoxic T-lymphocyte-associated protein 4				NIH_MGC_191	DH10B	NM_005214.3	NP_005205.2	REVIEWED	Cs	0.996	0.996	223	672	1	669	223	1	223
RIKEN	BC070162	IRAL057P09	MGC	W01A101M17	pENTR-TOPO	12914		CTLA4	1493	AAH70162.1	Hs.247824	Cytotoxic T-lymphocyte-associated protein 4				NIH_MGC_191	DH10B	NM_005214.3	NP_005205.2	REVIEWED	Cs	0.996	0.996	223	672	1	669	223	1	223
RIKEN	AK055534	flj0012h23	FLJ	W01A101M20	pENTR-TOPO	22680		C8orf49	606553	BAB70943	Hs.545529	Chromosome 8 open reading frame 49				HEART2	EK1													
RIKEN	AK094614	flj0022i22	FLJ	W01A101N03	pENTR-TOPO	5483		TPH2	121278	BAC04385.1	Hs.376337	Tryptophan hydroxylase 2				BRAMY2	EK1	NM_173353.3	NP_775489.2	REVIEWED	P	1.000	1.000	204	753	1	612	490	1	204
RIKEN	BC029608	IRAK063P23	MGC	W01A101N09	pENTR-TOPO	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152756.3	NP_689969.2	VALIDATED	P	1.000	1.000	251	798	1	753	1708	1	251
RIKEN	BC029608	IRAK063P23	MGC	W01A101N11	pENTR-TOPO	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152756.3	NP_689969.2	VALIDATED	P	1.000	1.000	251	798	1	753	1708	1	251
RIKEN	BC029608	IRAK063P23	MGC	W01A101N13	pENTR-TOPO	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152756.3	NP_689969.2	VALIDATED	P	1.000	1.000	251	798	1	753	1708	1	251
RIKEN	AK091711	flj0001j07	FLJ	W01A101N14	pENTR-TOPO	2799		ZNF511	118472	BAC03729.1	Hs.422113	Zinc finger protein 511				HCHON2	EK1	NM_145806.2	NP_665805.2	PROVISIONAL	P	1.000	1.000	227	789	1	681	252	1	227
RIKEN	BC029608	IRAK063P23	MGC	W01A101N19	pENTR-TOPO	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152756.3	NP_689969.2	VALIDATED	P	1.000	1.000	251	798	1	753	1708	1	251
RIKEN	BC015046	IRAK015C15	MGC	W01A101N20	pENTR-TOPO	7081		UBR7	55148	AAH15046.1	Hs.648806	Ubiquitin protein ligase E3 component n-recognin 7 (putative)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_175748.3	NP_786924.2	VALIDATED	P	1.000	1.000	274	825	1	822	425	152	425
RIKEN	BC015046	IRAK015C15	MGC	W01A101N22	pENTR-TOPO	7081		UBR7	55148	AAH15046.1	Hs.648806	Ubiquitin protein ligase E3 component n-recognin 7 (putative)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_175748.3	NP_786924.2	VALIDATED	P	1.000	1.000	274	825	1	822	425	152	425
RIKEN	BC029608	IRAK063P23	MGC	W01A101N23	pENTR-TOPO	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152756.3	NP_689969.2	VALIDATED	P	1.000	1.000	251	798	1	753	1708	1	251
RIKEN	BC000510	IRAL001H20	MGC	W01A101O01	pENTR-TOPO	21024		HSPB1	3315	AAH00510.1	Hs.520973	Heat shock 27kDa protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001540.3	NP_001531.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	AK055534	flj0012h23	FLJ	W01A101O02	pENTR-TOPO	22680		C8orf49	606553	BAB70943	Hs.545529	Chromosome 8 open reading frame 49				HEART2	EK1													
RIKEN	BC000510	IRAL001H20	MGC	W01A101O05	pENTR-TOPO	21024		HSPB1	3315	AAH00510.1	Hs.520973	Heat shock 27kDa protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001540.3	NP_001531.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	AK130578	flj0055p20	FLJ	W01A101O06	pENTR-TOPO	8880		LOC400558	400558	BAC85386.1	Hs.513818	FLJ27068 protein				SPL	EK1	XM_001715649.1	XP_001715701.1	MODEL	OK	1.000	1.000	241	726	1	723	241	1	241
RIKEN	AK130578	flj0055p20	FLJ	W01A101O08	pENTR-TOPO	8880		LOC400558	400558	BAC85386.1	Hs.513818	FLJ27068 protein				SPL	EK1	XM_001715649.1	XP_001715701.1	MODEL	OK	1.000	1.000	241	726	1	723	241	1	241
RIKEN	AK124522	flj0069e24	FLJ	W01A101O19	pENTR-TOPO	2588		BRWD2	55717	BAC85874	Hs.144447	Bromodomain and WD repeat domain containing 2				BRACE3	EK1	NM_018117.10	NP_060587.8	REVIEWED	Pfs	0.991	0.996	225	675	2	672	1224	1000	1224
RIKEN	AK130578	flj0055p20	FLJ	W01A101O20	pENTR-TOPO	8880		LOC400558	400558	BAC85386.1	Hs.513818	FLJ27068 protein				SPL	EK1	XM_001715649.1	XP_001715701.1	MODEL	OK	1.000	1.000	241	726	1	723	241	1	241
RIKEN	BC029608	IRAK063P23	MGC	W01A101P01	pENTR-TOPO	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152756.3	NP_689969.2	VALIDATED	P	1.000	1.000	251	798	1	753	1708	1	251
RIKEN	BC015046	IRAK015C15	MGC	W01A101P04	pENTR-TOPO	7081		UBR7	55148	AAH15046.1	Hs.648806	Ubiquitin protein ligase E3 component n-recognin 7 (putative)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_175748.3	NP_786924.2	VALIDATED	P	1.000	1.000	274	825	1	822	425	152	425
RIKEN	BC012844	IRAK021I14	MGC	W01A101P07	pENTR-TOPO	14738		PRNP	5621	AAH12844.1	Hs.714553	Prion protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001080122.1	NP_001073591.1	REVIEWED	Cs	0.996	0.996	253	762	1	759	253	1	253
RIKEN	BC015046	IRAK015C15	MGC	W01A101P12	pENTR-TOPO	7081		UBR7	55148	AAH15046.1	Hs.648806	Ubiquitin protein ligase E3 component n-recognin 7 (putative)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_175748.3	NP_786924.2	VALIDATED	P	1.000	1.000	274	825	1	822	425	152	425
RIKEN	BC003635	IRAL011F08	MGC	W01A101P13	pENTR-TOPO	4839		MMP7	4316	AAH03635.1	Hs.2256	Matrix metallopeptidase 7 (matrilysin, uterine)			Colon, adenocarcinoma	NIH_MGC_15		NM_002423.3	NP_002414.1	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	BC015046	IRAK015C15	MGC	W01A101P16	pENTR-TOPO	7081		UBR7	55148	AAH15046.1	Hs.648806	Ubiquitin protein ligase E3 component n-recognin 7 (putative)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_175748.3	NP_786924.2	VALIDATED	P	1.000	1.000	274	825	1	822	425	152	425
RIKEN	BC070073	IRAK167E16	MGC	W01A101P20	pENTR-TOPO	2568		ZNF365	22891	AAH70073	Hs.22653	Zinc finger protein 365			Brain, hippocampus	NIH_MGC_95	DH10B	NM_199451.2	NP_955523.1	VALIDATED	Ps	0.994	0.994	177	831	1	531	462	132	308
RIKEN	BC070073	IRAK167E16	MGC	W01A102A01	pENTR-TOPO	2568		ZNF365	22891	AAH70073	Hs.22653	Zinc finger protein 365			Brain, hippocampus	NIH_MGC_95	DH10B	NM_199451.2	NP_955523.1	VALIDATED	Ps	0.994	0.994	177	831	1	531	462	132	308
RIKEN	BC057792	IRAK133A13	MGC	W01A102A02	pENTR-TOPO	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
RIKEN	AK128359	flj0078i02	FLJ	W01A102A12	pENTR-TOPO	21018		ZMIZ2	83637	BAC87398	Hs.77978	Zinc finger, MIZ-type containing 2				THYMU3	EK1	NM_031449.3	NP_113637.3	VALIDATED		0.550	0.550	20	885	180	239	920	395	414
RIKEN	AK128359	flj0078i02	FLJ	W01A102A22	pENTR-TOPO	21018		ZMIZ2	83637	BAC87398	Hs.77978	Zinc finger, MIZ-type containing 2				THYMU3	EK1	NM_031449.3	NP_113637.3	VALIDATED		0.550	0.550	20	885	180	239	920	395	414
RIKEN	BC063007	IRAK135I10	MGC	W01A102B02	pENTR-TOPO	19156		AFF4	27125	AAH63007.1	Hs.519313	AF4/FMR2 family, member 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014423.3	NP_055238.1	VALIDATED	Ps	0.994	0.994	353	1062	1	1059	1163	1	353
RIKEN	BC037218	IRAK050O01	MGC	W01A102B10	pENTR-TOPO	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_138375.2	NP_612384.1	VALIDATED	C	1.000	1.000	368	1107	1	1104	368	1	368
RIKEN	BC037218	IRAK050O01	MGC	W01A102B12	pENTR-TOPO	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_138375.2	NP_612384.1	VALIDATED	C	1.000	1.000	368	1107	1	1104	368	1	368
RIKEN	AK096057	flj0021d06	FLJ	W01A102B17	pENTR-TOPO	19111		EPB41L4A	64097	BAC04690.1	Hs.584954	Erythrocyte membrane protein band 4.1 like 4A				KIDNE2	EK1	NM_022140.3	NP_071423.3	VALIDATED	Ps	0.989	0.989	271	1017	1	813	686	374	644
RIKEN	BC037218	IRAK050O01	MGC	W01A102B18	pENTR-TOPO	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_138375.2	NP_612384.1	VALIDATED	C	1.000	1.000	368	1107	1	1104	368	1	368
RIKEN	AK096057	flj0021d06	FLJ	W01A102B19	pENTR-TOPO	19111		EPB41L4A	64097	BAC04690.1	Hs.584954	Erythrocyte membrane protein band 4.1 like 4A				KIDNE2	EK1	NM_022140.3	NP_071423.3	VALIDATED	Ps	0.989	0.989	271	1017	1	813	686	374	644
RIKEN	AK096057	flj0021d06	FLJ	W01A102B21	pENTR-TOPO	19111		EPB41L4A	64097	BAC04690.1	Hs.584954	Erythrocyte membrane protein band 4.1 like 4A				KIDNE2	EK1	NM_022140.3	NP_071423.3	VALIDATED	Ps	0.989	0.989	271	1017	1	813	686	374	644
RIKEN	BC002520	IRAL004E12	MGC	W01A102B23	pENTR-TOPO	21408		COPS6	10980	AAH02520.2	Hs.15591	COP9 constitutive photomorphogenic homolog subunit 6 (Arabidopsis)			Placenta, choriocarcinoma	NIH_MGC_21		NM_006833.4	NP_006824.2	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC022447	IRAK032H05	MGC	W01A102B24	pENTR-TOPO	16561		AGTR1	185	AAH22447.1	Hs.719071	Angiotensin II receptor, type 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032049.2	NP_114438.1	REVIEWED	Cs	0.994	0.994	359	1080	1	1077	359	1	359
RIKEN	BC068050	IRAL054N15	MGC	W01A102C03	pENTR-TOPO	13046		CASP8	841	AAH68050.1	Hs.599762	Caspase 8, apoptosis-related cysteine peptidase			Lung, large cell carcinoma	NIH_MGC_18		NM_033358.3	NP_203522.1	REVIEWED	Cfs	0.926	0.953	242	837	1	725	235	1	235
RIKEN	AK128359	flj0078i02	FLJ	W01A102C04	pENTR-TOPO	21018		ZMIZ2	83637	BAC87398	Hs.77978	Zinc finger, MIZ-type containing 2				THYMU3	EK1	NM_031449.3	NP_113637.3	VALIDATED		0.550	0.550	20	885	180	239	920	395	414
RIKEN	BC068050	IRAL054N15	MGC	W01A102C07	pENTR-TOPO	13046		CASP8	841	AAH68050.1	Hs.599762	Caspase 8, apoptosis-related cysteine peptidase			Lung, large cell carcinoma	NIH_MGC_18		NM_033358.3	NP_203522.1	REVIEWED	Cfs	0.926	0.953	242	837	1	725	235	1	235
RIKEN	BC068050	IRAL054N15	MGC	W01A102C09	pENTR-TOPO	13046		CASP8	841	AAH68050.1	Hs.599762	Caspase 8, apoptosis-related cysteine peptidase			Lung, large cell carcinoma	NIH_MGC_18		NM_033358.3	NP_203522.1	REVIEWED	Cfs	0.926	0.953	242	837	1	725	235	1	235
RIKEN	BC029128	IRAK050A18	MGC	W01A102C10	pENTR-TOPO	9993		ASPA	443	AAH29128.1	Hs.171142	Aspartoacylase (Canavan disease)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001128085.1	NP_001121557.1	REVIEWED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC068050	IRAL054N15	MGC	W01A102C11	pENTR-TOPO	13046		CASP8	841	AAH68050.1	Hs.599762	Caspase 8, apoptosis-related cysteine peptidase			Lung, large cell carcinoma	NIH_MGC_18		NM_033358.3	NP_203522.1	REVIEWED	Cfs	0.926	0.953	242	837	1	725	235	1	235
RIKEN	BC068050	IRAL054N15	MGC	W01A102C17	pENTR-TOPO	13046		CASP8	841	AAH68050.1	Hs.599762	Caspase 8, apoptosis-related cysteine peptidase			Lung, large cell carcinoma	NIH_MGC_18		NM_033358.3	NP_203522.1	REVIEWED	Cfs	0.926	0.953	242	837	1	725	235	1	235
RIKEN	BC029128	IRAK050A18	MGC	W01A102C18	pENTR-TOPO	9993		ASPA	443	AAH29128.1	Hs.171142	Aspartoacylase (Canavan disease)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001128085.1	NP_001121557.1	REVIEWED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	AK130938	flj0056f13	FLJ	W01A102C19	pENTR-TOPO	20721		COL11A2	1302	BAC85467.1	Hs.390171	Collagen, type XI, alpha 2				WMD	EK1	NM_080679.2	NP_542410.2	REVIEWED	Pfs	0.887	0.905	311	921	3	918	1629	1319	1629
RIKEN	BC029128	IRAK050A18	MGC	W01A102C20	pENTR-TOPO	9993		ASPA	443	AAH29128.1	Hs.171142	Aspartoacylase (Canavan disease)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001128085.1	NP_001121557.1	REVIEWED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC029128	IRAK050A18	MGC	W01A102C22	pENTR-TOPO	9993		ASPA	443	AAH29128.1	Hs.171142	Aspartoacylase (Canavan disease)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001128085.1	NP_001121557.1	REVIEWED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	AK130938	flj0056f13	FLJ	W01A102C23	pENTR-TOPO	20721		COL11A2	1302	BAC85467.1	Hs.390171	Collagen, type XI, alpha 2				WMD	EK1	NM_080679.2	NP_542410.2	REVIEWED	Pfs	0.887	0.905	311	921	3	918	1629	1319	1629
RIKEN	BC029128	IRAK050A18	MGC	W01A102C24	pENTR-TOPO	9993		ASPA	443	AAH29128.1	Hs.171142	Aspartoacylase (Canavan disease)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001128085.1	NP_001121557.1	REVIEWED	C	1.000	1.000	313	942	1	939	313	1	313
RIKEN	BC022447	IRAK032H05	MGC	W01A102D02	pENTR-TOPO	16561		AGTR1	185	AAH22447.1	Hs.719071	Angiotensin II receptor, type 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032049.2	NP_114438.1	REVIEWED	Cs	0.994	0.994	359	1080	1	1077	359	1	359
RIKEN	BC002520	IRAL004E12	MGC	W01A102D03	pENTR-TOPO	21408		COPS6	10980	AAH02520.2	Hs.15591	COP9 constitutive photomorphogenic homolog subunit 6 (Arabidopsis)			Placenta, choriocarcinoma	NIH_MGC_21		NM_006833.4	NP_006824.2	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
RIKEN	BC022447	IRAK032H05	MGC	W01A102D08	pENTR-TOPO	16561		AGTR1	185	AAH22447.1	Hs.719071	Angiotensin II receptor, type 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032049.2	NP_114438.1	REVIEWED	Cs	0.994	0.994	359	1080	1	1077	359	1	359
RIKEN	BC002520	IRAL004E12	MGC	W01A102D11	pENTR-TOPO	21408		COPS6	10980	AAH02520.2	Hs.15591	COP9 constitutive photomorphogenic homolog subunit 6 (Arabidopsis)			Placenta, choriocarcinoma	NIH_MGC_21		NM_006833.4	NP_006824.2	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
RIKEN	AK022469	flj0031g18	FLJ	W01A102D13	pENTR-TOPO	21023		UNC84A	23353	BAB14046.1	Hs.438072	Unc-84 homolog A (C. elegans)				MAMMA1	EK1	NM_001130965.1	NP_001124437.1	REVIEWED	Ps	0.995	0.995	220	1026	1	660	785	1	220
RIKEN	BC022447	IRAK032H05	MGC	W01A102D16	pENTR-TOPO	16561		AGTR1	185	AAH22447.1	Hs.719071	Angiotensin II receptor, type 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032049.2	NP_114438.1	REVIEWED	Cs	0.994	0.994	359	1080	1	1077	359	1	359
RIKEN	AK022469	flj0031g18	FLJ	W01A102D17	pENTR-TOPO	21023		UNC84A	23353	BAB14046.1	Hs.438072	Unc-84 homolog A (C. elegans)				MAMMA1	EK1	NM_001130965.1	NP_001124437.1	REVIEWED	Ps	0.995	0.995	220	1026	1	660	785	1	220
RIKEN	AK022469	flj0031g18	FLJ	W01A102D19	pENTR-TOPO	21023		UNC84A	23353	BAB14046.1	Hs.438072	Unc-84 homolog A (C. elegans)				MAMMA1	EK1	NM_001130965.1	NP_001124437.1	REVIEWED	Ps	0.995	0.995	220	1026	1	660	785	1	220
RIKEN	BC005300	IRAL016B17	MGC	W01A102D20	pENTR-TOPO	10971		DTNA	1837	AAH05300.1	Hs.643454	Dystrobrevin, alpha			Heart	NIH_MGC_74	DH10B	NM_001128175.1	NP_001121647.1	REVIEWED	C	1.000	1.000	371	1116	1	1113	371	1	371
RIKEN	AK022469	flj0031g18	FLJ	W01A102D21	pENTR-TOPO	21023		UNC84A	23353	BAB14046.1	Hs.438072	Unc-84 homolog A (C. elegans)				MAMMA1	EK1	NM_001130965.1	NP_001124437.1	REVIEWED	Ps	0.995	0.995	220	1026	1	660	785	1	220
RIKEN	BC000026	IRAL007M10	MGC	W01A102E13	pENTR-TOPO	24039		AGPAT2	10555	AAH00026.1	Hs.320151	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006412.3	NP_006403.2	REVIEWED	Cs	0.996	0.996	278	837	1	834	278	1	278
RIKEN	BC000026	IRAL007M10	MGC	W01A102E15	pENTR-TOPO	24039		AGPAT2	10555	AAH00026.1	Hs.320151	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006412.3	NP_006403.2	REVIEWED	Cs	0.996	0.996	278	837	1	834	278	1	278
RIKEN	BC029141	IRAK050G24	MGC	W01A102E18	pENTR-TOPO	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
RIKEN	BC000026	IRAL007M10	MGC	W01A102E19	pENTR-TOPO	24039		AGPAT2	10555	AAH00026.1	Hs.320151	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006412.3	NP_006403.2	REVIEWED	Cs	0.996	0.996	278	837	1	834	278	1	278
RIKEN	BC000026	IRAL007M10	MGC	W01A102E21	pENTR-TOPO	24039		AGPAT2	10555	AAH00026.1	Hs.320151	1-acylglycerol-3-phosphate O-acyltransferase 2 (lysophosphatidic acid acyltransferase, beta)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_006412.3	NP_006403.2	REVIEWED	Cs	0.996	0.996	278	837	1	834	278	1	278
RIKEN	AK022469	flj0031g18	FLJ	W01A102F03	pENTR-TOPO	21023		UNC84A	23353	BAB14046.1	Hs.438072	Unc-84 homolog A (C. elegans)				MAMMA1	EK1	NM_001130965.1	NP_001124437.1	REVIEWED	Ps	0.995	0.995	220	1026	1	660	785	1	220
RIKEN	BC005300	IRAL016B17	MGC	W01A102F08	pENTR-TOPO	10971		DTNA	1837	AAH05300.1	Hs.643454	Dystrobrevin, alpha			Heart	NIH_MGC_74	DH10B	NM_001128175.1	NP_001121647.1	REVIEWED	C	1.000	1.000	371	1116	1	1113	371	1	371
RIKEN	BC005300	IRAL016B17	MGC	W01A102F10	pENTR-TOPO	10971		DTNA	1837	AAH05300.1	Hs.643454	Dystrobrevin, alpha			Heart	NIH_MGC_74	DH10B	NM_001128175.1	NP_001121647.1	REVIEWED	C	1.000	1.000	371	1116	1	1113	371	1	371
RIKEN	BC016058	IRAL034G12	MGC	W01A102F11	pENTR-TOPO	2059		CTSK	1513	AAH16058.1	Hs.632466	Cathepsin K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_000396.2	NP_000387.1	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
RIKEN	BC016058	IRAL034G12	MGC	W01A102F17	pENTR-TOPO	2059		CTSK	1513	AAH16058.1	Hs.632466	Cathepsin K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_000396.2	NP_000387.1	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
RIKEN	AK126882	flj0075p18	FLJ	W01A102F18	pENTR-TOPO	10629		ABR	29	BAC86734.1	Hs.159306	Active BCR-related gene				BRAMY3	EK1	NM_021962.2	NP_068781.2	REVIEWED	Ps	0.986	0.986	283	1089	1	849	859	117	399
RIKEN	BC016058	IRAL034G12	MGC	W01A102F19	pENTR-TOPO	2059		CTSK	1513	AAH16058.1	Hs.632466	Cathepsin K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_000396.2	NP_000387.1	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
RIKEN	BC016058	IRAL034G12	MGC	W01A102F21	pENTR-TOPO	2059		CTSK	1513	AAH16058.1	Hs.632466	Cathepsin K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_000396.2	NP_000387.1	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
RIKEN	BC065004	IRAK140E05	MGC	W01A102G01	pENTR-TOPO	16353		CCDC50	152137	AAH65004.1	Hs.478682	Coiled-coil domain containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_174908.3	NP_777568.1	REVIEWED	C	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC000674	IRAL005H10	MGC	W01A102G02	pENTR-TOPO	24043		TOR1A	1861	AAH00674.1	Hs.534312	Torsin family 1, member A (torsin A)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000113.2	NP_000104.1	REVIEWED	Cs	0.997	0.997	332	999	1	996	332	1	332
RIKEN	BC065004	IRAK140E05	MGC	W01A102G03	pENTR-TOPO	16353		CCDC50	152137	AAH65004.1	Hs.478682	Coiled-coil domain containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_174908.3	NP_777568.1	REVIEWED	C	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC000674	IRAL005H10	MGC	W01A102G06	pENTR-TOPO	24043		TOR1A	1861	AAH00674.1	Hs.534312	Torsin family 1, member A (torsin A)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000113.2	NP_000104.1	REVIEWED	Cs	0.997	0.997	332	999	1	996	332	1	332
RIKEN	BC065004	IRAK140E05	MGC	W01A102G07	pENTR-TOPO	16353		CCDC50	152137	AAH65004.1	Hs.478682	Coiled-coil domain containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_174908.3	NP_777568.1	REVIEWED	C	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC000674	IRAL005H10	MGC	W01A102G08	pENTR-TOPO	24043		TOR1A	1861	AAH00674.1	Hs.534312	Torsin family 1, member A (torsin A)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000113.2	NP_000104.1	REVIEWED	Cs	0.997	0.997	332	999	1	996	332	1	332
RIKEN	BC065004	IRAK140E05	MGC	W01A102G09	pENTR-TOPO	16353		CCDC50	152137	AAH65004.1	Hs.478682	Coiled-coil domain containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_174908.3	NP_777568.1	REVIEWED	C	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC000674	IRAL005H10	MGC	W01A102G12	pENTR-TOPO	24043		TOR1A	1861	AAH00674.1	Hs.534312	Torsin family 1, member A (torsin A)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000113.2	NP_000104.1	REVIEWED	Cs	0.997	0.997	332	999	1	996	332	1	332
RIKEN	BC065004	IRAK140E05	MGC	W01A102G17	pENTR-TOPO	16353		CCDC50	152137	AAH65004.1	Hs.478682	Coiled-coil domain containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_174908.3	NP_777568.1	REVIEWED	C	1.000	1.000	306	921	1	918	306	1	306
RIKEN	AK026957	flj0064g07	FLJ	W01A102G19	pENTR-TOPO	8119		CSNK1G1	53944	BAB15601.1	Hs.646508	Casein kinase 1, gamma 1	HepG2	hepatoma		HEP	EK1	NM_022048.3	NP_071331.2	VALIDATED	Ps	0.996	0.996	280	843	1	840	422	143	422
RIKEN	AK126882	flj0075p18	FLJ	W01A102H08	pENTR-TOPO	10629		ABR	29	BAC86734.1	Hs.159306	Active BCR-related gene				BRAMY3	EK1	NM_021962.2	NP_068781.2	REVIEWED	Ps	0.986	0.986	283	1089	1	849	859	117	399
RIKEN	BC000346	IRAL001K15	MGC	W01A102H17	pENTR-TOPO	13893		DUSP11	8446	AAH00346.1	Hs.14611	Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003584.2	NP_003575.2	REVIEWED	Ps	0.997	0.997	330	993	1	990	377	48	377
RIKEN	BC014535	IRAL019C18	MGC	W01A102H20	pENTR-TOPO	3828		PARVA	55742	AAH14535.1	Hs.607144	Parvin, alpha			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_018222.3	NP_060692.1	PROVISIONAL	Cs	0.997	0.997	372	1119	1	1116	372	1	372
RIKEN	AK026957	flj0064g07	FLJ	W01A102I03	pENTR-TOPO	8119		CSNK1G1	53944	BAB15601.1	Hs.646508	Casein kinase 1, gamma 1	HepG2	hepatoma		HEP	EK1	NM_022048.3	NP_071331.2	VALIDATED	Ps	0.996	0.996	280	843	1	840	422	143	422
RIKEN	BC025724	IRAK049A12	MGC	W01A102I04	pENTR-TOPO	7108		RDH12	145226	AAH25724.1	Hs.415322	Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152443.2	NP_689656.2	REVIEWED	Cs	0.997	0.997	316	951	1	948	316	1	316
RIKEN	AK026957	flj0064g07	FLJ	W01A102I09	pENTR-TOPO	8119		CSNK1G1	53944	BAB15601.1	Hs.646508	Casein kinase 1, gamma 1	HepG2	hepatoma		HEP	EK1	NM_022048.3	NP_071331.2	VALIDATED	Ps	0.996	0.996	280	843	1	840	422	143	422
RIKEN	BC025724	IRAK049A12	MGC	W01A102I14	pENTR-TOPO	7108		RDH12	145226	AAH25724.1	Hs.415322	Retinol dehydrogenase 12 (all-trans/9-cis/11-cis)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152443.2	NP_689656.2	REVIEWED	Cs	0.997	0.997	316	951	1	948	316	1	316
RIKEN	BC008426	IRAL021G10	MGC	W01A102I15	pENTR-TOPO	1948		PPT1	5538	AAH08426.1	Hs.3873	Palmitoyl-protein thioesterase 1			Prostate	NIH_MGC_83	DH10B	NM_000310.3	NP_000301.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC040499	IRAK048J21	MGC	W01A102I18	pENTR-TOPO	16361		TGFBR2	7048	AAH40499	Hs.82028	Transforming growth factor, beta receptor II (70/80kDa)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003242.5	NP_003233.4	REVIEWED	P	1.000	1.000	334	1005	1	1002	567	1	334
RIKEN	BC008426	IRAL021G10	MGC	W01A102I21	pENTR-TOPO	1948		PPT1	5538	AAH08426.1	Hs.3873	Palmitoyl-protein thioesterase 1			Prostate	NIH_MGC_83	DH10B	NM_000310.3	NP_000301.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC040499	IRAK048J21	MGC	W01A102I24	pENTR-TOPO	16361		TGFBR2	7048	AAH40499	Hs.82028	Transforming growth factor, beta receptor II (70/80kDa)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003242.5	NP_003233.4	REVIEWED	P	1.000	1.000	334	1005	1	1002	567	1	334
RIKEN	BC000346	IRAL001K15	MGC	W01A102J05	pENTR-TOPO	13893		DUSP11	8446	AAH00346.1	Hs.14611	Dual specificity phosphatase 11 (RNA/RNP complex 1-interacting)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003584.2	NP_003575.2	REVIEWED	Ps	0.997	0.997	330	993	1	990	377	48	377
RIKEN	BC033580	IRAK049D17	MGC	W01A102J10	pENTR-TOPO	12716		KLF1	10661	AAH33580.1	Hs.37860	Kruppel-like factor 1 (erythroid)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006563.3	NP_006554.1	VALIDATED	Cs	0.997	0.997	362	1089	1	1086	362	1	362
RIKEN	BC029057	IRAK050E15	MGC	W01A102J11	pENTR-TOPO	5612		DAO	1610	AAH29057.1	Hs.113227	D-amino-acid oxidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001917.4	NP_001908.3	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC033580	IRAK049D17	MGC	W01A102J12	pENTR-TOPO	12716		KLF1	10661	AAH33580.1	Hs.37860	Kruppel-like factor 1 (erythroid)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006563.3	NP_006554.1	VALIDATED	Cs	0.997	0.997	362	1089	1	1086	362	1	362
RIKEN	BC001419	IRAL004K08	MGC	W01A102J16	pENTR-TOPO	1652		MECR	51102	AAH01419.1	Hs.183646	Mitochondrial trans-2-enoyl-CoA reductase			Placenta, choriocarcinoma	NIH_MGC_21		NM_016011.2	NP_057095.2	VALIDATED	Cs	0.997	0.997	373	1122	1	1119	373	1	373
RIKEN	BC029057	IRAK050E15	MGC	W01A102J17	pENTR-TOPO	5612		DAO	1610	AAH29057.1	Hs.113227	D-amino-acid oxidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001917.4	NP_001908.3	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC001419	IRAL004K08	MGC	W01A102J18	pENTR-TOPO	1652		MECR	51102	AAH01419.1	Hs.183646	Mitochondrial trans-2-enoyl-CoA reductase			Placenta, choriocarcinoma	NIH_MGC_21		NM_016011.2	NP_057095.2	VALIDATED	Cs	0.997	0.997	373	1122	1	1119	373	1	373
RIKEN	BC047618	IRAK090L04	MGC	W01A102J21	pENTR-TOPO	16788		B3GALNT1	8706	AAH47618.1	Hs.418062	Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003781.3	NP_003772.1	REVIEWED	C	1.000	1.000	331	996	1	993	331	1	331
RIKEN	AK097394	flj0040c03	FLJ	W01A102J22	pENTR-TOPO	15031		C20orf96	140680	BAC05033.1	Hs.348112	Chromosome 20 open reading frame 96				TESTI2	EK1	NM_153269.1	NP_695001.1	PREDICTED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC047618	IRAK090L04	MGC	W01A102J23	pENTR-TOPO	16788		B3GALNT1	8706	AAH47618.1	Hs.418062	Beta-1,3-N-acetylgalactosaminyltransferase 1 (globoside blood group)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003781.3	NP_003772.1	REVIEWED	C	1.000	1.000	331	996	1	993	331	1	331
RIKEN	AK097394	flj0040c03	FLJ	W01A102J24	pENTR-TOPO	15031		C20orf96	140680	BAC05033.1	Hs.348112	Chromosome 20 open reading frame 96				TESTI2	EK1	NM_153269.1	NP_695001.1	PREDICTED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC008426	IRAL021G10	MGC	W01A102K01	pENTR-TOPO	1948		PPT1	5538	AAH08426.1	Hs.3873	Palmitoyl-protein thioesterase 1			Prostate	NIH_MGC_83	DH10B	NM_000310.3	NP_000301.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC040499	IRAK048J21	MGC	W01A102K04	pENTR-TOPO	16361		TGFBR2	7048	AAH40499	Hs.82028	Transforming growth factor, beta receptor II (70/80kDa)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003242.5	NP_003233.4	REVIEWED	P	1.000	1.000	334	1005	1	1002	567	1	334
RIKEN	BC008426	IRAL021G10	MGC	W01A102K05	pENTR-TOPO	1948		PPT1	5538	AAH08426.1	Hs.3873	Palmitoyl-protein thioesterase 1			Prostate	NIH_MGC_83	DH10B	NM_000310.3	NP_000301.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC008426	IRAL021G10	MGC	W01A102K07	pENTR-TOPO	1948		PPT1	5538	AAH08426.1	Hs.3873	Palmitoyl-protein thioesterase 1			Prostate	NIH_MGC_83	DH10B	NM_000310.3	NP_000301.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC008426	IRAL021G10	MGC	W01A102K09	pENTR-TOPO	1948		PPT1	5538	AAH08426.1	Hs.3873	Palmitoyl-protein thioesterase 1			Prostate	NIH_MGC_83	DH10B	NM_000310.3	NP_000301.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
RIKEN	BC020740	IRAL037B19	MGC	W01A102K15	pENTR-TOPO	18825		SGCD	6444	AAH20740.1	Hs.387207	Sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)			Lung	NIH_MGC_77	DH10B	NM_000337.5	NP_000328.2	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
RIKEN	BC004199	IRAL011P14	MGC	W01A102K18	pENTR-TOPO	8360		RLBP1	6017	AAH04199.1	Hs.1933	Retinaldehyde binding protein 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_000326.4	NP_000317.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC020740	IRAL037B19	MGC	W01A102K21	pENTR-TOPO	18825		SGCD	6444	AAH20740.1	Hs.387207	Sarcoglycan, delta (35kDa dystrophin-associated glycoprotein)			Lung	NIH_MGC_77	DH10B	NM_000337.5	NP_000328.2	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
RIKEN	BC004199	IRAL011P14	MGC	W01A102K24	pENTR-TOPO	8360		RLBP1	6017	AAH04199.1	Hs.1933	Retinaldehyde binding protein 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_000326.4	NP_000317.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	AK097394	flj0040c03	FLJ	W01A102L02	pENTR-TOPO	15031		C20orf96	140680	BAC05033.1	Hs.348112	Chromosome 20 open reading frame 96				TESTI2	EK1	NM_153269.1	NP_695001.1	PREDICTED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	AK097394	flj0040c03	FLJ	W01A102L04	pENTR-TOPO	15031		C20orf96	140680	BAC05033.1	Hs.348112	Chromosome 20 open reading frame 96				TESTI2	EK1	NM_153269.1	NP_695001.1	PREDICTED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC010370	IRAL019P03	MGC	W01A102L09	pENTR-TOPO	22534		TUSC3	7991	AAH10370.1	Hs.591845	Tumor suppressor candidate 3			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_178234.1	NP_839952.1	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	AK097394	flj0040c03	FLJ	W01A102L10	pENTR-TOPO	15031		C20orf96	140680	BAC05033.1	Hs.348112	Chromosome 20 open reading frame 96				TESTI2	EK1	NM_153269.1	NP_695001.1	PREDICTED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC010370	IRAL019P03	MGC	W01A102L11	pENTR-TOPO	22534		TUSC3	7991	AAH10370.1	Hs.591845	Tumor suppressor candidate 3			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_178234.1	NP_839952.1	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	AK097394	flj0040c03	FLJ	W01A102L12	pENTR-TOPO	15031		C20orf96	140680	BAC05033.1	Hs.348112	Chromosome 20 open reading frame 96				TESTI2	EK1	NM_153269.1	NP_695001.1	PREDICTED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC010370	IRAL019P03	MGC	W01A102L15	pENTR-TOPO	22534		TUSC3	7991	AAH10370.1	Hs.591845	Tumor suppressor candidate 3			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_178234.1	NP_839952.1	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	AK097394	flj0040c03	FLJ	W01A102L16	pENTR-TOPO	15031		C20orf96	140680	BAC05033.1	Hs.348112	Chromosome 20 open reading frame 96				TESTI2	EK1	NM_153269.1	NP_695001.1	PREDICTED	C	1.000	1.000	363	1092	1	1089	363	1	363
RIKEN	BC010370	IRAL019P03	MGC	W01A102L19	pENTR-TOPO	22534		TUSC3	7991	AAH10370.1	Hs.591845	Tumor suppressor candidate 3			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_178234.1	NP_839952.1	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC010370	IRAL019P03	MGC	W01A102L21	pENTR-TOPO	22534		TUSC3	7991	AAH10370.1	Hs.591845	Tumor suppressor candidate 3			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_178234.1	NP_839952.1	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC010370	IRAL019P03	MGC	W01A102L23	pENTR-TOPO	22534		TUSC3	7991	AAH10370.1	Hs.591845	Tumor suppressor candidate 3			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_178234.1	NP_839952.1	REVIEWED	OK	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	BC027179	IRAK026D20	MGC	W01A102L24	pENTR-TOPO	4113		TYR	7299	AAH27179.1	Hs.503555	Tyrosinase (oculocutaneous albinism IA)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000372.4	NP_000363.1	REVIEWED	P	1.000	1.000	345	1134	1	1035	529	1	345
RIKEN	BC034281	IRAK052P06	MGC	W01A102M03	pENTR-TOPO	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000197.1	NP_000188.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC034281	IRAK052P06	MGC	W01A102M05	pENTR-TOPO	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000197.1	NP_000188.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC034281	IRAK052P06	MGC	W01A102M07	pENTR-TOPO	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000197.1	NP_000188.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC034281	IRAK052P06	MGC	W01A102M09	pENTR-TOPO	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000197.1	NP_000188.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC034281	IRAK052P06	MGC	W01A102M11	pENTR-TOPO	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000197.1	NP_000188.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	AK074814	flj0018a06	FLJ	W01A102M14	pENTR-TOPO	24524		NLGN3	54413	BAC11226.1	Hs.438877	Neuroligin 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_018977.2	NP_061850.2	VALIDATED	Ps	0.997	0.997	335	1008	1	1005	828	494	828
RIKEN	AK074814	flj0018a06	FLJ	W01A102M16	pENTR-TOPO	24524		NLGN3	54413	BAC11226.1	Hs.438877	Neuroligin 3	NT2	teratocarcinoma		NT2RP2	EK1	NM_018977.2	NP_061850.2	VALIDATED	Ps	0.997	0.997	335	1008	1	1005	828	494	828
RIKEN	BC034281	IRAK052P06	MGC	W01A102M19	pENTR-TOPO	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000197.1	NP_000188.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC034281	IRAK052P06	MGC	W01A102M21	pENTR-TOPO	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000197.1	NP_000188.1	REVIEWED	C	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC027179	IRAK026D20	MGC	W01A102N10	pENTR-TOPO	4113		TYR	7299	AAH27179.1	Hs.503555	Tyrosinase (oculocutaneous albinism IA)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000372.4	NP_000363.1	REVIEWED	P	1.000	1.000	345	1134	1	1035	529	1	345
RIKEN	BC030615	IRAK046E17	MGC	W01A102N15	pENTR-TOPO	24179		LPAR1	1902	AAH30615.1	Hs.126667	Lysophosphatidic acid receptor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001401.3	NP_001392.2	REVIEWED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC036489	IRAK073F13	MGC	W01A102N18	pENTR-TOPO	22933		PNMA2	10687	AAH36489.1	Hs.591838	Paraneoplastic antigen MA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_007257.5	NP_009188.1	VALIDATED	Cs	0.997	0.997	364	1095	1	1092	364	1	364
RIKEN	BC030615	IRAK046E17	MGC	W01A102N23	pENTR-TOPO	24179		LPAR1	1902	AAH30615.1	Hs.126667	Lysophosphatidic acid receptor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001401.3	NP_001392.2	REVIEWED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC027855	IRAK049K05	MGC	W01A102O10	pENTR-TOPO	14206		FRZB	2487	AAH27855.1	Hs.128453	Frizzled-related protein			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001463.2	NP_001454.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC057792	IRAK133A13	MGC	W01A102O15	pENTR-TOPO	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
RIKEN	BC027855	IRAK049K05	MGC	W01A102O18	pENTR-TOPO	14206		FRZB	2487	AAH27855.1	Hs.128453	Frizzled-related protein			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001463.2	NP_001454.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC057792	IRAK133A13	MGC	W01A102O19	pENTR-TOPO	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
RIKEN	BC057792	IRAK133A13	MGC	W01A102O21	pENTR-TOPO	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
RIKEN	BC027855	IRAK049K05	MGC	W01A102O22	pENTR-TOPO	14206		FRZB	2487	AAH27855.1	Hs.128453	Frizzled-related protein			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001463.2	NP_001454.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	AK096057	flj0021d06	FLJ	W01A102O24	pENTR-TOPO	19111		EPB41L4A	64097	BAC04690.1	Hs.584954	Erythrocyte membrane protein band 4.1 like 4A				KIDNE2	EK1	NM_022140.3	NP_071423.3	VALIDATED	Ps	0.989	0.989	271	1017	1	813	686	374	644
RIKEN	BC030615	IRAK046E17	MGC	W01A102P01	pENTR-TOPO	24179		LPAR1	1902	AAH30615.1	Hs.126667	Lysophosphatidic acid receptor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001401.3	NP_001392.2	REVIEWED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC036489	IRAK073F13	MGC	W01A102P06	pENTR-TOPO	22933		PNMA2	10687	AAH36489.1	Hs.591838	Paraneoplastic antigen MA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_007257.5	NP_009188.1	VALIDATED	Cs	0.997	0.997	364	1095	1	1092	364	1	364
RIKEN	BC013325	IRAL019A07	MGC	W01A102P10	pENTR-TOPO	19176		HAVCR1	26762	AAH13325.1	Hs.129711	Hepatitis A virus cellular receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001099414.1	NP_001092884.1	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC063007	IRAK135I10	MGC	W01A102P11	pENTR-TOPO	19156		AFF4	27125	AAH63007.1	Hs.519313	AF4/FMR2 family, member 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014423.3	NP_055238.1	VALIDATED	Ps	0.994	0.994	353	1062	1	1059	1163	1	353
RIKEN	BC063007	IRAK135I10	MGC	W01A102P13	pENTR-TOPO	19156		AFF4	27125	AAH63007.1	Hs.519313	AF4/FMR2 family, member 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014423.3	NP_055238.1	VALIDATED	Ps	0.994	0.994	353	1062	1	1059	1163	1	353
RIKEN	BC013325	IRAL019A07	MGC	W01A102P14	pENTR-TOPO	19176		HAVCR1	26762	AAH13325.1	Hs.129711	Hepatitis A virus cellular receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001099414.1	NP_001092884.1	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC013325	IRAL019A07	MGC	W01A102P22	pENTR-TOPO	19176		HAVCR1	26762	AAH13325.1	Hs.129711	Hepatitis A virus cellular receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001099414.1	NP_001092884.1	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC013325	IRAL019A07	MGC	W01A102P24	pENTR-TOPO	19176		HAVCR1	26762	AAH13325.1	Hs.129711	Hepatitis A virus cellular receptor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_001099414.1	NP_001092884.1	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC027179	IRAK026D20	MGC	W01A103A03	pENTR-TOPO	4113		TYR	7299	AAH27179.1	Hs.503555	Tyrosinase (oculocutaneous albinism IA)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000372.4	NP_000363.1	REVIEWED	P	1.000	1.000	345	1134	1	1035	529	1	345
RIKEN	BC027179	IRAK026D20	MGC	W01A103A05	pENTR-TOPO	4113		TYR	7299	AAH27179.1	Hs.503555	Tyrosinase (oculocutaneous albinism IA)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000372.4	NP_000363.1	REVIEWED	P	1.000	1.000	345	1134	1	1035	529	1	345
RIKEN	BC022500	IRAK032J11	MGC	W01A103A08	pENTR-TOPO	2626		LGI1	9211	AAH22500.1	Hs.533670	Leucine-rich, glioma inactivated 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005097.2	NP_005088.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC014058	IRAL028F02	MGC	W01A103A11	pENTR-TOPO	16905		PARL	55486	AAH14058.1	Hs.478469	Presenilin associated, rhomboid-like			Lung, small cell carcinoma	NIH_MGC_7		NM_018622.5	NP_061092.3	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
RIKEN	BC022500	IRAK032J11	MGC	W01A103A12	pENTR-TOPO	2626		LGI1	9211	AAH22500.1	Hs.533670	Leucine-rich, glioma inactivated 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005097.2	NP_005088.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC014058	IRAL028F02	MGC	W01A103A15	pENTR-TOPO	16905		PARL	55486	AAH14058.1	Hs.478469	Presenilin associated, rhomboid-like			Lung, small cell carcinoma	NIH_MGC_7		NM_018622.5	NP_061092.3	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
RIKEN	BC014058	IRAL028F02	MGC	W01A103A17	pENTR-TOPO	16905		PARL	55486	AAH14058.1	Hs.478469	Presenilin associated, rhomboid-like			Lung, small cell carcinoma	NIH_MGC_7		NM_018622.5	NP_061092.3	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
RIKEN	BC014058	IRAL028F02	MGC	W01A103A19	pENTR-TOPO	16905		PARL	55486	AAH14058.1	Hs.478469	Presenilin associated, rhomboid-like			Lung, small cell carcinoma	NIH_MGC_7		NM_018622.5	NP_061092.3	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
RIKEN	BC022500	IRAK032J11	MGC	W01A103A22	pENTR-TOPO	2626		LGI1	9211	AAH22500.1	Hs.533670	Leucine-rich, glioma inactivated 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005097.2	NP_005088.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
RIKEN	BC014058	IRAL028F02	MGC	W01A103A23	pENTR-TOPO	16905		PARL	55486	AAH14058.1	Hs.478469	Presenilin associated, rhomboid-like			Lung, small cell carcinoma	NIH_MGC_7		NM_018622.5	NP_061092.3	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
RIKEN	BC043437	IRAK076M23	MGC	W01A103B03	pENTR-TOPO	6099		DCP1B	196513	AAH43437.1	Hs.130934	DCP1 decapping enzyme homolog B (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_152640.3	NP_689853.3	VALIDATED	Cgs	0.997	0.998	618	1857	1	1854	617	1	617
RIKEN	BC009255	IRAL010L10	MGC	W01A103B11	pENTR-TOPO	4670		ALG9	79796	AAH09255.1	Hs.503850	Asparagine-linked glycosylation 9, alpha-1,2-mannosyltransferase homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_024740.2	NP_079016.2	REVIEWED	C	1.000	1.000	618	1857	1	1854	618	1	618
RIKEN	BC042998	IRAK076O01	MGC	W01A103B23	pENTR-TOPO	17389		ADD1	118	AAH42998.1	Hs.183706	Adducin 1 (alpha)			Testis	NIH_MGC_97	DH10B	NM_176801.1	NP_789771.1	REVIEWED	Cg	0.911	1.000	693	1989	1	1986	662	1	662
RIKEN	AK094050	flj0021g22	FLJ	W01A103C03	pENTR-TOPO	17092		LAMB2	3913	BAC04272.1	Hs.439726	Laminin, beta 2 (laminin S)				UTERU2	EK1	NM_002292.3	NP_002283.3	REVIEWED	Pfs	0.896	0.997	424	1146	1	1144	1798	1234	1657
RIKEN	BC021218	IRAL017N07	MGC	W01A103C08	pENTR-TOPO	15267		CHAF1B	8208	AAH21218.1	Hs.75238	Chromatin assembly factor 1, subunit B (p60)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_005441.2	NP_005432.1	REVIEWED	OK	1.000	1.000	559	1680	1	1677	559	1	559
RIKEN	BC021218	IRAL017N07	MGC	W01A103C12	pENTR-TOPO	15267		CHAF1B	8208	AAH21218.1	Hs.75238	Chromatin assembly factor 1, subunit B (p60)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_005441.2	NP_005432.1	REVIEWED	OK	1.000	1.000	559	1680	1	1677	559	1	559
RIKEN	AK000010	flj0066k11	FLJ	W01A103C15	pENTR-TOPO	3226		NSMCE4A	54780	BAA90881.1	Hs.258798	Non-SMC element 4 homolog A (S. cerevisiae)				ad	EK1	NM_017615.1	NP_060085.1	PROVISIONAL	OK	1.000	1.000	385	1158	1	1155	385	1	385
RIKEN	AK000010	flj0066k11	FLJ	W01A103C17	pENTR-TOPO	3226		NSMCE4A	54780	BAA90881.1	Hs.258798	Non-SMC element 4 homolog A (S. cerevisiae)				ad	EK1	NM_017615.1	NP_060085.1	PROVISIONAL	OK	1.000	1.000	385	1158	1	1155	385	1	385
RIKEN	BC031262	IRAK063J11	MGC	W01A103C23	pENTR-TOPO	18760		CTNNA1	1495	AAH31262.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001903.2	NP_001894.2	VALIDATED	P	1.000	1.000	536	1611	1	1608	906	371	906
RIKEN	BC042998	IRAK076O01	MGC	W01A103D03	pENTR-TOPO	17389		ADD1	118	AAH42998.1	Hs.183706	Adducin 1 (alpha)			Testis	NIH_MGC_97	DH10B	NM_176801.1	NP_789771.1	REVIEWED	Cg	0.911	1.000	693	1989	1	1986	662	1	662
RIKEN	BC042998	IRAK076O01	MGC	W01A103D05	pENTR-TOPO	17389		ADD1	118	AAH42998.1	Hs.183706	Adducin 1 (alpha)			Testis	NIH_MGC_97	DH10B	NM_176801.1	NP_789771.1	REVIEWED	Cg	0.911	1.000	693	1989	1	1986	662	1	662
RIKEN	BC012355	IRAL029J18	MGC	W01A103D13	pENTR-TOPO	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Eye, retinoblastoma	NIH_MGC_16		NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
RIKEN	BC012355	IRAL029J18	MGC	W01A103D17	pENTR-TOPO	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Eye, retinoblastoma	NIH_MGC_16		NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
RIKEN	BC012355	IRAL029J18	MGC	W01A103D21	pENTR-TOPO	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Eye, retinoblastoma	NIH_MGC_16		NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
RIKEN	BC017055	IRAK022A02	MGC	W01A103D23	pENTR-TOPO	10331		AKAP10	11216	AAH17055.1	Hs.708043	A kinase (PRKA) anchor protein 10			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_007202.2	NP_009133.2	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
RIKEN	BC013734	IRAK021N20	MGC	W01A103E02	pENTR-TOPO	1810		PTGS2	5743	AAH13734.1	Hs.196384	Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000963.2	NP_000954.1	REVIEWED	C	1.000	1.000	604	1815	1	1812	604	1	604
RIKEN	BC025702	IRAK049K21	MGC	W01A103E03	pENTR-TOPO	10010		SGCA	6442	AAH25702.1	Hs.463412	Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000023.2	NP_000014.1	REVIEWED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC013734	IRAK021N20	MGC	W01A103E04	pENTR-TOPO	1810		PTGS2	5743	AAH13734.1	Hs.196384	Prostaglandin-endoperoxide synthase 2 (prostaglandin G/H synthase and cyclooxygenase)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000963.2	NP_000954.1	REVIEWED	C	1.000	1.000	604	1815	1	1812	604	1	604
RIKEN	BC025702	IRAK049K21	MGC	W01A103E05	pENTR-TOPO	10010		SGCA	6442	AAH25702.1	Hs.463412	Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000023.2	NP_000014.1	REVIEWED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC025702	IRAK049K21	MGC	W01A103E07	pENTR-TOPO	10010		SGCA	6442	AAH25702.1	Hs.463412	Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_000023.2	NP_000014.1	REVIEWED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	AK056122	flj0002f05	FLJ	W01A103E08	pENTR-TOPO	20352		SYNE1	23345	BAB71097.1	Hs.12967	Spectrin repeat containing, nuclear envelope 1	NT2	teratocarcinoma		NT2RI2	EK1	NM_033071.2	NP_149062.1	REVIEWED	Ps	0.996	0.996	559	1683	1	1677	8749	2926	3484
RIKEN	AK056122	flj0002f05	FLJ	W01A103E12	pENTR-TOPO	20352		SYNE1	23345	BAB71097.1	Hs.12967	Spectrin repeat containing, nuclear envelope 1	NT2	teratocarcinoma		NT2RI2	EK1	NM_033071.2	NP_149062.1	REVIEWED	Ps	0.996	0.996	559	1683	1	1677	8749	2926	3484
RIKEN	BC064357	IRAK134P10	MGC	W01A103E16	pENTR-TOPO	4512		PICALM	8301	AAH64357.1	Hs.163893	Phosphatidylinositol binding clathrin assembly protein			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001008660.1	NP_001008660.1	VALIDATED	C	1.000	1.000	610	1833	1	1830	610	1	610
RIKEN	BC064357	IRAK134P10	MGC	W01A103E22	pENTR-TOPO	4512		PICALM	8301	AAH64357.1	Hs.163893	Phosphatidylinositol binding clathrin assembly protein			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001008660.1	NP_001008660.1	VALIDATED	C	1.000	1.000	610	1833	1	1830	610	1	610
RIKEN	BC017055	IRAK022A02	MGC	W01A103F01	pENTR-TOPO	10331		AKAP10	11216	AAH17055.1	Hs.708043	A kinase (PRKA) anchor protein 10			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_007202.2	NP_009133.2	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
RIKEN	AK075566	flj0027m20	FLJ	W01A103F17	pENTR-TOPO	15564		FBLN1	2192	BAC11705.1	Hs.24601	Fibulin 1	NT2	teratocarcinoma		NT2RP3	EK1	NM_006486.2	NP_006477.2	REVIEWED	Pfs	0.947	1.000	673	1917	3	1914	703	31	703
RIKEN	AK075566	flj0027m20	FLJ	W01A103F19	pENTR-TOPO	15564		FBLN1	2192	BAC11705.1	Hs.24601	Fibulin 1	NT2	teratocarcinoma		NT2RP3	EK1	NM_006486.2	NP_006477.2	REVIEWED	Pfs	0.947	1.000	673	1917	3	1914	703	31	703
RIKEN	AK075566	flj0027m20	FLJ	W01A103F23	pENTR-TOPO	15564		FBLN1	2192	BAC11705.1	Hs.24601	Fibulin 1	NT2	teratocarcinoma		NT2RP3	EK1	NM_006486.2	NP_006477.2	REVIEWED	Pfs	0.947	1.000	673	1917	3	1914	703	31	703
RIKEN	BC063849	IRAK141E05	MGC	W01A103G01	pENTR-TOPO	20335		RANBP9	10048	AAH63849.1	Hs.708182	RAN binding protein 9				Lupski_dorsal_root_ganglion	DH10B	NM_005493.2	NP_005484.2	REVIEWED	P	1.000	1.000	388	1167	1	1164	729	342	729
RIKEN	BC063849	IRAK141E05	MGC	W01A103G03	pENTR-TOPO	20335		RANBP9	10048	AAH63849.1	Hs.708182	RAN binding protein 9				Lupski_dorsal_root_ganglion	DH10B	NM_005493.2	NP_005484.2	REVIEWED	P	1.000	1.000	388	1167	1	1164	729	342	729
RIKEN	AK096435	flj0041k22	FLJ	W01A103G09	pENTR-TOPO	2815		OIT3	170392	BAC04788.1	Hs.8366	Oncoprotein induced transcript 3				NTONG2	EK1	NM_152635.1	NP_689848.1	PROVISIONAL	C	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC035893	IRAK078G10	MGC	W01A103G12	pENTR-TOPO	13963		SLC40A1	30061	AAH35893.1	Hs.643005	Solute carrier family 40 (iron-regulated transporter), member 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014585.5	NP_055400.1	REVIEWED	Cs	0.998	0.998	571	1716	1	1713	571	1	571
RIKEN	BC035975	IRAL041D02	MGC	W01A103G14	pENTR-TOPO	9280		UMOD	7369	AAH35975.1	Hs.654425	Uromodulin			Kidney	NIH_MGC_75	DH10B	NM_003361.2	NP_003352.2	REVIEWED	Cgs	0.953	0.998	640	1836	1	1833	640	1	640
RIKEN	AK096435	flj0041k22	FLJ	W01A103G15	pENTR-TOPO	2815		OIT3	170392	BAC04788.1	Hs.8366	Oncoprotein induced transcript 3				NTONG2	EK1	NM_152635.1	NP_689848.1	PROVISIONAL	C	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC035975	IRAL041D02	MGC	W01A103G18	pENTR-TOPO	9280		UMOD	7369	AAH35975.1	Hs.654425	Uromodulin			Kidney	NIH_MGC_75	DH10B	NM_003361.2	NP_003352.2	REVIEWED	Cgs	0.953	0.998	640	1836	1	1833	640	1	640
RIKEN	BC002631	IRAL012A19	MGC	W01A103G19	pENTR-TOPO	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1182	1	381	130	1	127
RIKEN	BC002631	IRAL012A19	MGC	W01A103G21	pENTR-TOPO	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1182	1	381	130	1	127
RIKEN	BC035975	IRAL041D02	MGC	W01A103G22	pENTR-TOPO	9280		UMOD	7369	AAH35975.1	Hs.654425	Uromodulin			Kidney	NIH_MGC_75	DH10B	NM_003361.2	NP_003352.2	REVIEWED	Cgs	0.953	0.998	640	1836	1	1833	640	1	640
RIKEN	BC002631	IRAL012A19	MGC	W01A103G23	pENTR-TOPO	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1182	1	381	130	1	127
RIKEN	BC035975	IRAL041D02	MGC	W01A103G24	pENTR-TOPO	9280		UMOD	7369	AAH35975.1	Hs.654425	Uromodulin			Kidney	NIH_MGC_75	DH10B	NM_003361.2	NP_003352.2	REVIEWED	Cgs	0.953	0.998	640	1836	1	1833	640	1	640
RIKEN	BC015806	IRAK015A11	MGC	W01A103H01	pENTR-TOPO	25208		SH3KBP1	30011	AAH15806.1	Hs.719268	SH3-domain kinase binding protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_031892.2	NP_114098.1	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
RIKEN	BC036352	IRAK051O17	MGC	W01A103H09	pENTR-TOPO	8709		SCNN1B	6338	AAH36352.2	Hs.414614	Sodium channel, nonvoltage-gated 1, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000336.2	NP_000327.2	REVIEWED	Cs	0.998	0.998	640	1923	1	1920	640	1	640
RIKEN	BC036352	IRAK051O17	MGC	W01A103H11	pENTR-TOPO	8709		SCNN1B	6338	AAH36352.2	Hs.414614	Sodium channel, nonvoltage-gated 1, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000336.2	NP_000327.2	REVIEWED	Cs	0.998	0.998	640	1923	1	1920	640	1	640
RIKEN	BC036352	IRAK051O17	MGC	W01A103H15	pENTR-TOPO	8709		SCNN1B	6338	AAH36352.2	Hs.414614	Sodium channel, nonvoltage-gated 1, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000336.2	NP_000327.2	REVIEWED	Cs	0.998	0.998	640	1923	1	1920	640	1	640
RIKEN	BC036352	IRAK051O17	MGC	W01A103H19	pENTR-TOPO	8709		SCNN1B	6338	AAH36352.2	Hs.414614	Sodium channel, nonvoltage-gated 1, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000336.2	NP_000327.2	REVIEWED	Cs	0.998	0.998	640	1923	1	1920	640	1	640
RIKEN	BC036352	IRAK051O17	MGC	W01A103H23	pENTR-TOPO	8709		SCNN1B	6338	AAH36352.2	Hs.414614	Sodium channel, nonvoltage-gated 1, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000336.2	NP_000327.2	REVIEWED	Cs	0.998	0.998	640	1923	1	1920	640	1	640
RIKEN	BC002631	IRAL012A19	MGC	W01A103I01	pENTR-TOPO	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1182	1	381	130	1	127
RIKEN	BC035975	IRAL041D02	MGC	W01A103I02	pENTR-TOPO	9280		UMOD	7369	AAH35975.1	Hs.654425	Uromodulin			Kidney	NIH_MGC_75	DH10B	NM_003361.2	NP_003352.2	REVIEWED	Cgs	0.953	0.998	640	1836	1	1833	640	1	640
RIKEN	BC000659	IRAL005D04	MGC	W01A103I03	pENTR-TOPO	5972		AAAS	8086	AAH00659.1	Hs.369144	Achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_015665.5	NP_056480.1	VALIDATED	C	1.000	1.000	546	1641	1	1638	546	1	546
RIKEN	BC032720	IRAK069H16	MGC	W01A103I06	pENTR-TOPO	24871		CYBB	1536	AAH32720.1	Hs.292356	Cytochrome b-245, beta polypeptide			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000397.3	NP_000388.2	REVIEWED	C	1.000	1.000	570	1713	1	1710	570	1	570
RIKEN	BC000659	IRAL005D04	MGC	W01A103I07	pENTR-TOPO	5972		AAAS	8086	AAH00659.1	Hs.369144	Achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_015665.5	NP_056480.1	VALIDATED	C	1.000	1.000	546	1641	1	1638	546	1	546
RIKEN	BC000659	IRAL005D04	MGC	W01A103I11	pENTR-TOPO	5972		AAAS	8086	AAH00659.1	Hs.369144	Achalasia, adrenocortical insufficiency, alacrimia (Allgrove, triple-A)			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_015665.5	NP_056480.1	VALIDATED	C	1.000	1.000	546	1641	1	1638	546	1	546
RIKEN	BC032720	IRAK069H16	MGC	W01A103I12	pENTR-TOPO	24871		CYBB	1536	AAH32720.1	Hs.292356	Cytochrome b-245, beta polypeptide			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000397.3	NP_000388.2	REVIEWED	C	1.000	1.000	570	1713	1	1710	570	1	570
RIKEN	BC031210	IRAK063P05	MGC	W01A103I15	pENTR-TOPO	24607		MSL3	10943	AAH31210.1	Hs.655288	Male-specific lethal 3 homolog (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_078629.2	NP_523353.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC032720	IRAK069H16	MGC	W01A103I16	pENTR-TOPO	24871		CYBB	1536	AAH32720.1	Hs.292356	Cytochrome b-245, beta polypeptide			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000397.3	NP_000388.2	REVIEWED	C	1.000	1.000	570	1713	1	1710	570	1	570
RIKEN	BC032720	IRAK069H16	MGC	W01A103I18	pENTR-TOPO	24871		CYBB	1536	AAH32720.1	Hs.292356	Cytochrome b-245, beta polypeptide			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_000397.3	NP_000388.2	REVIEWED	C	1.000	1.000	570	1713	1	1710	570	1	570
RIKEN	BC031210	IRAK063P05	MGC	W01A103I19	pENTR-TOPO	24607		MSL3	10943	AAH31210.1	Hs.655288	Male-specific lethal 3 homolog (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_078629.2	NP_523353.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC031210	IRAK063P05	MGC	W01A103I23	pENTR-TOPO	24607		MSL3	10943	AAH31210.1	Hs.655288	Male-specific lethal 3 homolog (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_078629.2	NP_523353.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC062574	IRAK135E13	MGC	W01A103I24	pENTR-TOPO	13892		NPHP1	4867	AAH62574.1	Hs.280388	Nephronophthisis 1 (juvenile)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001128179.1	NP_001121651.1	REVIEWED	OK	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC036352	IRAK051O17	MGC	W01A103J01	pENTR-TOPO	8709		SCNN1B	6338	AAH36352.2	Hs.414614	Sodium channel, nonvoltage-gated 1, beta			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000336.2	NP_000327.2	REVIEWED	Cs	0.998	0.998	640	1923	1	1920	640	1	640
RIKEN	BC036518	IRAK047L03	MGC	W01A103J07	pENTR-TOPO	7586		GALC	2581	AAH36518.1	Hs.513439	Galactosylceramidase			Testis	NIH_MGC_97	DH10B	NM_001037525.1	NP_001032614.1	REVIEWED	P	1.000	1.000	371	2010	1	1113	407	17	387
RIKEN	BC036518	IRAK047L03	MGC	W01A103J11	pENTR-TOPO	7586		GALC	2581	AAH36518.1	Hs.513439	Galactosylceramidase			Testis	NIH_MGC_97	DH10B	NM_001037525.1	NP_001032614.1	REVIEWED	P	1.000	1.000	371	2010	1	1113	407	17	387
RIKEN	BC036518	IRAK047L03	MGC	W01A103J13	pENTR-TOPO	7586		GALC	2581	AAH36518.1	Hs.513439	Galactosylceramidase			Testis	NIH_MGC_97	DH10B	NM_001037525.1	NP_001032614.1	REVIEWED	P	1.000	1.000	371	2010	1	1113	407	17	387
RIKEN	BC036518	IRAK047L03	MGC	W01A103J17	pENTR-TOPO	7586		GALC	2581	AAH36518.1	Hs.513439	Galactosylceramidase			Testis	NIH_MGC_97	DH10B	NM_001037525.1	NP_001032614.1	REVIEWED	P	1.000	1.000	371	2010	1	1113	407	17	387
RIKEN	BC036518	IRAK047L03	MGC	W01A103J19	pENTR-TOPO	7586		GALC	2581	AAH36518.1	Hs.513439	Galactosylceramidase			Testis	NIH_MGC_97	DH10B	NM_001037525.1	NP_001032614.1	REVIEWED	P	1.000	1.000	371	2010	1	1113	407	17	387
RIKEN	BC031210	IRAK063P05	MGC	W01A103K01	pENTR-TOPO	24607		MSL3	10943	AAH31210.1	Hs.655288	Male-specific lethal 3 homolog (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_078629.2	NP_523353.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC031210	IRAK063P05	MGC	W01A103K03	pENTR-TOPO	24607		MSL3	10943	AAH31210.1	Hs.655288	Male-specific lethal 3 homolog (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_078629.2	NP_523353.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
RIKEN	BC062574	IRAK135E13	MGC	W01A103K04	pENTR-TOPO	13892		NPHP1	4867	AAH62574.1	Hs.280388	Nephronophthisis 1 (juvenile)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001128179.1	NP_001121651.1	REVIEWED	OK	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC062574	IRAK135E13	MGC	W01A103K06	pENTR-TOPO	13892		NPHP1	4867	AAH62574.1	Hs.280388	Nephronophthisis 1 (juvenile)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001128179.1	NP_001121651.1	REVIEWED	OK	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC062574	IRAK135E13	MGC	W01A103K08	pENTR-TOPO	13892		NPHP1	4867	AAH62574.1	Hs.280388	Nephronophthisis 1 (juvenile)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001128179.1	NP_001121651.1	REVIEWED	OK	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	AK093196	flj0007b05	FLJ	W01A103K09	pENTR-TOPO	15515		OSBP2	23762	BAC04091.1	Hs.517546	Oxysterol binding protein 2				TESTI2	EK1	NM_030758.3	NP_110385.1	REVIEWED	Pg	0.998	1.000	550	1650	1	1647	916	367	916
RIKEN	BC036677	IRAK047E13	MGC	W01A103K15	pENTR-TOPO	514		ZNF238	10472	AAH36677.2	Hs.69997	Zinc finger protein 238			Brain, hippocampus	NIH_MGC_95	DH10B	NM_205768.2	NP_991331.1	VALIDATED	Cs	0.998	0.998	531	1596	1	1593	531	1	531
RIKEN	BC012295	IRAK003N23	MGC	W01A103K16	pENTR-TOPO	18877		LMNB1	4001	AAH12295.1	Hs.89497	Lamin B1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005573.2	NP_005564.1	REVIEWED	Cs	0.998	0.998	586	1761	1	1758	586	1	586
RIKEN	BC012295	IRAK003N23	MGC	W01A103K18	pENTR-TOPO	18877		LMNB1	4001	AAH12295.1	Hs.89497	Lamin B1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005573.2	NP_005564.1	REVIEWED	Cs	0.998	0.998	586	1761	1	1758	586	1	586
RIKEN	BC036677	IRAK047E13	MGC	W01A103K21	pENTR-TOPO	514		ZNF238	10472	AAH36677.2	Hs.69997	Zinc finger protein 238			Brain, hippocampus	NIH_MGC_95	DH10B	NM_205768.2	NP_991331.1	VALIDATED	Cs	0.998	0.998	531	1596	1	1593	531	1	531
RIKEN	BC012295	IRAK003N23	MGC	W01A103K24	pENTR-TOPO	18877		LMNB1	4001	AAH12295.1	Hs.89497	Lamin B1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005573.2	NP_005564.1	REVIEWED	Cs	0.998	0.998	586	1761	1	1758	586	1	586
RIKEN	BC064394	IRAK139M21	MGC	W01A103L05	pENTR-TOPO	11226		DYM	54808	AAH64394.1	Hs.162996	Dymeclin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_017653.3	NP_060123.3	REVIEWED	Cs	0.999	0.999	669	2010	1	2007	669	1	669
RIKEN	BC013277	IRAL024D13	MGC	W01A103L13	pENTR-TOPO	22920		RECQL4	9401	AAH13277.2	Hs.31442	RecQ protein-like 4			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_004260.2	NP_004251.2	VALIDATED	P	1.000	1.000	652	1959	1	1956	1208	557	1208
RIKEN	BC034959	IRAK033H12	MGC	W01A103L17	pENTR-TOPO	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	C	1.000	1.000	670	2013	1	2010	670	1	670
RIKEN	BC034959	IRAK033H12	MGC	W01A103L19	pENTR-TOPO	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	C	1.000	1.000	670	2013	1	2010	670	1	670
RIKEN	BC000399	IRAL001I16	MGC	W01A103L21	pENTR-TOPO	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7		NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
RIKEN	BC000399	IRAL001I16	MGC	W01A103L23	pENTR-TOPO	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7		NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
RIKEN	BC012295	IRAK003N23	MGC	W01A103M02	pENTR-TOPO	18877		LMNB1	4001	AAH12295.1	Hs.89497	Lamin B1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005573.2	NP_005564.1	REVIEWED	Cs	0.998	0.998	586	1761	1	1758	586	1	586
RIKEN	BC012295	IRAK003N23	MGC	W01A103M04	pENTR-TOPO	18877		LMNB1	4001	AAH12295.1	Hs.89497	Lamin B1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_005573.2	NP_005564.1	REVIEWED	Cs	0.998	0.998	586	1761	1	1758	586	1	586
RIKEN	BC012482	IRAK028I08	MGC	W01A103M15	pENTR-TOPO	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_002076.3	NP_002067.1	REVIEWED	C	1.000	1.000	552	1659	1	1656	552	1	552
RIKEN	BC068476	IRAK167F22	MGC	W01A103M16	pENTR-TOPO	7385		NUMB	8650	AAH68476.1	Hs.714879	Numb homolog (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_001005745.1	NP_001005745.1	REVIEWED	Cs	0.998	0.998	592	1779	1	1776	592	1	592
RIKEN	BC000303	IRAL001C15	MGC	W01A103M19	pENTR-TOPO	114		PHGDH	26227	AAH00303.1	Hs.487296	Phosphoglycerate dehydrogenase			Lung, small cell carcinoma	NIH_MGC_7		NM_006623.3	NP_006614.2	REVIEWED	C	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	BC068476	IRAK167F22	MGC	W01A103M22	pENTR-TOPO	7385		NUMB	8650	AAH68476.1	Hs.714879	Numb homolog (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_001005745.1	NP_001005745.1	REVIEWED	Cs	0.998	0.998	592	1779	1	1776	592	1	592
RIKEN	BC080554	IRAL059I15	MGC	W01A103N01	pENTR-TOPO	11524		SFRS16	11129	AAH80554.1	Hs.466917	Splicing factor, arginine/serine-rich 16			Skin, melanoma, melanotic	NIH_MGC_112		NM_007056.2	NP_008987.2	VALIDATED	P	1.000	1.000	659	1980	1	1977	674	16	674
RIKEN	BC080554	IRAL059I15	MGC	W01A103N05	pENTR-TOPO	11524		SFRS16	11129	AAH80554.1	Hs.466917	Splicing factor, arginine/serine-rich 16			Skin, melanoma, melanotic	NIH_MGC_112		NM_007056.2	NP_008987.2	VALIDATED	P	1.000	1.000	659	1980	1	1977	674	16	674
RIKEN	BC002751	IRAL012M04	MGC	W01A103N15	pENTR-TOPO	20398		TAP2	6891	AAH02751	Hs.502	Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)			Brain, neuroblastoma	NIH_MGC_19		NM_018833.2	NP_061313.2	REVIEWED	Ps	0.995	0.995	648	2061	1	1944	653	1	648
RIKEN	BC002751	IRAL012M04	MGC	W01A103N19	pENTR-TOPO	20398		TAP2	6891	AAH02751	Hs.502	Transporter 2, ATP-binding cassette, sub-family B (MDR/TAP)			Brain, neuroblastoma	NIH_MGC_19		NM_018833.2	NP_061313.2	REVIEWED	Ps	0.995	0.995	648	2061	1	1944	653	1	648
RIKEN	BC000303	IRAL001C15	MGC	W01A103O01	pENTR-TOPO	114		PHGDH	26227	AAH00303.1	Hs.487296	Phosphoglycerate dehydrogenase			Lung, small cell carcinoma	NIH_MGC_7		NM_006623.3	NP_006614.2	REVIEWED	C	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	BC000303	IRAL001C15	MGC	W01A103O03	pENTR-TOPO	114		PHGDH	26227	AAH00303.1	Hs.487296	Phosphoglycerate dehydrogenase			Lung, small cell carcinoma	NIH_MGC_7		NM_006623.3	NP_006614.2	REVIEWED	C	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	BC068476	IRAK167F22	MGC	W01A103O06	pENTR-TOPO	7385		NUMB	8650	AAH68476.1	Hs.714879	Numb homolog (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_001005745.1	NP_001005745.1	REVIEWED	Cs	0.998	0.998	592	1779	1	1776	592	1	592
RIKEN	BC053348	IRAK115C21	MGC	W01A103O07	pENTR-TOPO	3637		SLC22A12	116085	AAH53348.1	Hs.174424	Solute carrier family 22 (organic anion/urate transporter), member 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153378.1	NP_700357.1	REVIEWED	C	1.000	1.000	332	1662	664	1659	332	1	332
RIKEN	BC053348	IRAK115C21	MGC	W01A103O11	pENTR-TOPO	3637		SLC22A12	116085	AAH53348.1	Hs.174424	Solute carrier family 22 (organic anion/urate transporter), member 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153378.1	NP_700357.1	REVIEWED	C	1.000	1.000	332	1662	664	1659	332	1	332
RIKEN	AK023345	flj0036m08	FLJ	W01A103O15	pENTR-TOPO	19154		DIAPH1	1729	BAB14533.1	Hs.529451	Diaphanous homolog 1 (Drosophila)				OVARC1	EK1	NM_005219.4	NP_005210.3	REVIEWED	Pfs	1.000	1.000	534	1602	1	1601	1272	234	767
RIKEN	BC048282	IRAK093H23	MGC	W01A103P01	pENTR-TOPO	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004070.3	NP_004061.3	REVIEWED	Cs	0.997	0.997	687	2064	1	2061	687	1	687
RIKEN	BC059367	IRAK133M11	MGC	W01A103P19	pENTR-TOPO	16256		TF	7018	AAH59367.1	Hs.518267	Transferrin			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001063.2	NP_001054.1	REVIEWED	Cs	0.997	0.997	698	2097	1	2094	698	1	698
RIKEN	BC059367	IRAK133M11	MGC	W01A103P21	pENTR-TOPO	16256		TF	7018	AAH59367.1	Hs.518267	Transferrin			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001063.2	NP_001054.1	REVIEWED	Cs	0.997	0.997	698	2097	1	2094	698	1	698
RIKEN	AK027527	flj0033o15	FLJ	W01A104A23	pENTR-TOPO	3939		TBRG1	84897	BAB55177.1	Hs.436410	Transforming growth factor beta regulator 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_032811.2	NP_116200.2	VALIDATED	Pfs	0.849	1.000	305	783	3	780	411	107	411
RIKEN	BC034019	IRAL036N24	MGC	W01A104B06	pENTR-TOPO	18055		LDB2	9079	AAH34019.1	Hs.714330	LIM domain binding 2			Lung	NIH_MGC_77	DH10B	NM_001290.3	NP_001281.1	VALIDATED	C	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC034381	IRAK050B14	MGC	W01A104C09	pENTR-TOPO	3703		RBM7	10179	AAH34381.1					Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_016090.2	NP_057174.1	PROVISIONAL	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC034381	IRAK050B14	MGC	W01A104C11	pENTR-TOPO	3703		RBM7	10179	AAH34381.1					Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_016090.2	NP_057174.1	PROVISIONAL	C	1.000	1.000	266	801	1	798	266	1	266
RIKEN	BC058000	IRAL048D03	MGC	W01A104C15	pENTR-TOPO	23264		TTPA	7274	AAH58000.1	Hs.69049	Tocopherol (alpha) transfer protein			Kidney	NIH_MGC_75	DH10B	NM_000370.2	NP_000361.1	VALIDATED	C	1.000	1.000	278	837	1	834	278	1	278
RIKEN	AK074427	flj0064n21	FLJ	W01A104D04	pENTR-TOPO	2700		ZDHHC16	84287	-	Hs.76662	Zinc finger, DHHC-type containing 16				KAT	EK1	NM_198046.1	NP_932163.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	AK074427	flj0064n21	FLJ	W01A104D08	pENTR-TOPO	2700		ZDHHC16	84287	-	Hs.76662	Zinc finger, DHHC-type containing 16				KAT	EK1	NM_198046.1	NP_932163.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	AK172775	flj0079i06	FLJ	W01A104F08	pENTR-TOPO	13261		LASS6	253782	BAD18757.1	Hs.718403	LAG1 homolog, ceramide synthase 6				ColF	EK1	NM_203463.1	NP_982288.1	VALIDATED	C	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC048098	IRAK106F21	MGC	W01A104F22	pENTR-TOPO	18628		FBXO4	26272	AAH48098.1	Hs.165575	F-box protein 4			Testis	NIH_MGC_97	DH10B	NM_012176.2	NP_036308.1	REVIEWED	OK	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC011972	IRAK019H03	MGC	W01A104G07	pENTR-TOPO	19410		HNRNPA0	10949	AAH11972.1	Hs.96996	Heterogeneous nuclear ribonucleoprotein A0			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006805.3	NP_006796.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC011972	IRAK019H03	MGC	W01A104G09	pENTR-TOPO	19410		HNRNPA0	10949	AAH11972.1	Hs.96996	Heterogeneous nuclear ribonucleoprotein A0			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006805.3	NP_006796.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC050435	IRAK098L06	MGC	W01A104G13	pENTR-TOPO	3169		SFRP5	6425	AAH50435.2	Hs.279565	Secreted frizzled-related protein 5				Lupski_sympathetic_trunk	DH10B	NM_003015.3	NP_003006.2	REVIEWED	Cs	0.997	0.997	317	954	1	951	317	1	317
RIKEN	BC050435	IRAK098L06	MGC	W01A104G15	pENTR-TOPO	3169		SFRP5	6425	AAH50435.2	Hs.279565	Secreted frizzled-related protein 5				Lupski_sympathetic_trunk	DH10B	NM_003015.3	NP_003006.2	REVIEWED	Cs	0.997	0.997	317	954	1	951	317	1	317
RIKEN	BC031658	IRAK051N12	MGC	W01A104H02	pENTR-TOPO	20626		MCM9	254394	AAH31658.1	Hs.486315	Minichromosome maintenance complex component 9			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153255.3	NP_694987.1	REVIEWED	C	1.000	1.000	391	1176	1	1173	391	1	391
RIKEN	BC024176	IRAK033D14	MGC	W01A104H16	pENTR-TOPO	11470		ZNF302	55900	AAH24176.1	Hs.436350	Zinc finger protein 302			Testis	NIH_MGC_97	DH10B	NM_001012320.1	NP_001012320.1	VALIDATED	C	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC024176	IRAK033D14	MGC	W01A104H18	pENTR-TOPO	11470		ZNF302	55900	AAH24176.1	Hs.436350	Zinc finger protein 302			Testis	NIH_MGC_97	DH10B	NM_001012320.1	NP_001012320.1	VALIDATED	C	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC024176	IRAK033D14	MGC	W01A104H22	pENTR-TOPO	11470		ZNF302	55900	AAH24176.1	Hs.436350	Zinc finger protein 302			Testis	NIH_MGC_97	DH10B	NM_001012320.1	NP_001012320.1	VALIDATED	C	1.000	1.000	399	1200	1	1197	399	1	399
RIKEN	BC016724	IRAL032K02	MGC	W01A104I01	pENTR-TOPO	1558		DEDD	9191	AAH16724.1	Hs.146406	Death effector domain containing			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001039712.1	NP_001034801.1	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
RIKEN	BC016724	IRAL032K02	MGC	W01A104I03	pENTR-TOPO	1558		DEDD	9191	AAH16724.1	Hs.146406	Death effector domain containing			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001039712.1	NP_001034801.1	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
RIKEN	BC016724	IRAL032K02	MGC	W01A104I07	pENTR-TOPO	1558		DEDD	9191	AAH16724.1	Hs.146406	Death effector domain containing			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001039712.1	NP_001034801.1	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
RIKEN	AK026319	flj0061h05	FLJ	W01A104I21	pENTR-TOPO	18077		FBXO8	26269	-	Hs.76917	F-box protein 8				HSI	EK1	NM_012180.2	NP_036312.2	REVIEWED	C	1.000	1.000	319	960	1	957	319	1	319
RIKEN	BC036060	IRAK048L24	MGC	W01A104J16	pENTR-TOPO	970		MAPKAPK2	9261	AAH36060.2	Hs.643566	Mitogen-activated protein kinase-activated protein kinase 2			Testis	NIH_MGC_97	DH10B	NM_032960.2	NP_116584.2	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC036060	IRAK048L24	MGC	W01A104J20	pENTR-TOPO	970		MAPKAPK2	9261	AAH36060.2	Hs.643566	Mitogen-activated protein kinase-activated protein kinase 2			Testis	NIH_MGC_97	DH10B	NM_032960.2	NP_116584.2	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC011965	IRAK021B17	MGC	W01A104K01	pENTR-TOPO	12202		DBP	1628	AAH11965.1	Hs.528006	D site of albumin promoter (albumin D-box) binding protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001352.3	NP_001343.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC011965	IRAK021B17	MGC	W01A104K07	pENTR-TOPO	12202		DBP	1628	AAH11965.1	Hs.528006	D site of albumin promoter (albumin D-box) binding protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001352.3	NP_001343.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC011965	IRAK021B17	MGC	W01A104K09	pENTR-TOPO	12202		DBP	1628	AAH11965.1	Hs.528006	D site of albumin promoter (albumin D-box) binding protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001352.3	NP_001343.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
RIKEN	AK001837	flj0036l08	FLJ	W01A104L02	pENTR-TOPO	20604		PHF10	55274	BAA91934.1	Hs.435933	PHD finger protein 10				PLACE1	EK1	NM_018288.3	NP_060758.2	REVIEWED	P	1.000	1.000	410	1233	1	1230	498	89	498
RIKEN	AK001837	flj0036l08	FLJ	W01A104L08	pENTR-TOPO	20604		PHF10	55274	BAA91934.1	Hs.435933	PHD finger protein 10				PLACE1	EK1	NM_018288.3	NP_060758.2	REVIEWED	P	1.000	1.000	410	1233	1	1230	498	89	498
RIKEN	AK001837	flj0036l08	FLJ	W01A104L12	pENTR-TOPO	20604		PHF10	55274	BAA91934.1	Hs.435933	PHD finger protein 10				PLACE1	EK1	NM_018288.3	NP_060758.2	REVIEWED	P	1.000	1.000	410	1233	1	1230	498	89	498
RIKEN	BC020546	IRAK027E07	MGC	W01A104L14	pENTR-TOPO	7580		BMP4	652	AAH20546.1	Hs.68879	Bone morphogenetic protein 4			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_130851.2	NP_570912.2	REVIEWED	Cs	0.998	0.998	408	1227	1	1224	408	1	408
RIKEN	BC020546	IRAK027E07	MGC	W01A104L16	pENTR-TOPO	7580		BMP4	652	AAH20546.1	Hs.68879	Bone morphogenetic protein 4			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_130851.2	NP_570912.2	REVIEWED	Cs	0.998	0.998	408	1227	1	1224	408	1	408
RIKEN	BC020546	IRAK027E07	MGC	W01A104L20	pENTR-TOPO	7580		BMP4	652	AAH20546.1	Hs.68879	Bone morphogenetic protein 4			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_130851.2	NP_570912.2	REVIEWED	Cs	0.998	0.998	408	1227	1	1224	408	1	408
RIKEN	AK026060	flj0058g22	FLJ	W01A104M19	pENTR-TOPO	10297		SLC25A39	51629	BAB15341.1	Hs.514216	Solute carrier family 25, member 39				HRC	EK1	NM_016016.2	NP_057100.1	VALIDATED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	AK026060	flj0058g22	FLJ	W01A104M21	pENTR-TOPO	10297		SLC25A39	51629	BAB15341.1	Hs.514216	Solute carrier family 25, member 39				HRC	EK1	NM_016016.2	NP_057100.1	VALIDATED	C	1.000	1.000	351	1056	1	1053	351	1	351
RIKEN	BC011151	IRAK019G21	MGC	W01A104N10	pENTR-TOPO	10696		EIF4A3	9775	AAH11151.1	Hs.389649	Eukaryotic translation initiation factor 4A, isoform 3			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014740.2	NP_055555.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
RIKEN	AK001364	flj0033e04	FLJ	W01A104N20	pENTR-TOPO	3133		HNRNPF	3185	BAG50896.1	Hs.808	Heterogeneous nuclear ribonucleoprotein F	NT2	teratocarcinoma		NT2RP2	EK1	NM_001098205.1	NP_001091675.1	REVIEWED	C	1.000	1.000	415	1248	1	1245	415	1	415
RIKEN	AK094255	flj0045a16	FLJ	W01A104O09	pENTR-TOPO	21238		HTR5A	3361	BAG52850.1	Hs.65791	5-hydroxytryptamine (serotonin) receptor 5A				BRACE2	EK1	NM_024012.2	NP_076917.1	REVIEWED	C	1.000	1.000	357	1074	1	1071	357	1	357
RIKEN	BC044929	IRAK089A08	MGC	W01A104O19	pENTR-TOPO	16938		POPDC2	64091	AAH44929.1	Hs.656031	Popeye domain containing 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_022135.2	NP_071418.2	REVIEWED	C	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	AK000555	flj0057n05	FLJ	W01A104P04	pENTR-TOPO	24168		ASB6	140459	BAA91250.1	Hs.125037	Ankyrin repeat and SOCS box-containing 6				KAT	EK1	NM_017873.2	NP_060343.1	REVIEWED	OK	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	AK124791	flj0046j11	FLJ	W01A104P20	pENTR-TOPO	17592		MAPK10	5602	BAG54096.1	Hs.125503	Mitogen-activated protein kinase 10				BRCAN2	EK1	NM_138980.1	NP_620446.1	REVIEWED	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	AK124791	flj0046j11	FLJ	W01A104P24	pENTR-TOPO	17592		MAPK10	5602	BAG54096.1	Hs.125503	Mitogen-activated protein kinase 10				BRCAN2	EK1	NM_138980.1	NP_620446.1	REVIEWED	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	AK021918	flj0029d17	FLJ	W01A105A05	pENTR-TOPO	22646		GPR172A	79581	BAB13936.1	Hs.6459	G protein-coupled receptor 172A				HEMBA1	EK1	NM_024531.3	NP_078807.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	AK021918	flj0029d17	FLJ	W01A105A09	pENTR-TOPO	22646		GPR172A	79581	BAB13936.1	Hs.6459	G protein-coupled receptor 172A				HEMBA1	EK1	NM_024531.3	NP_078807.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	AK125517	flj0070j08	FLJ	W01A105A13	pENTR-TOPO	5374		ANKRD33	341405	BAC86190.1	Hs.433492	Ankyrin repeat domain 33				PLACE6	EK1	NM_182608.3	NP_872414.3	VALIDATED	Cs	0.996	0.996	452	1359	1	1356	452	1	452
RIKEN	AK125517	flj0070j08	FLJ	W01A105A17	pENTR-TOPO	5374		ANKRD33	341405	BAC86190.1	Hs.433492	Ankyrin repeat domain 33				PLACE6	EK1	NM_182608.3	NP_872414.3	VALIDATED	Cs	0.996	0.996	452	1359	1	1356	452	1	452
RIKEN	AK125517	flj0070j08	FLJ	W01A105A19	pENTR-TOPO	5374		ANKRD33	341405	BAC86190.1	Hs.433492	Ankyrin repeat domain 33				PLACE6	EK1	NM_182608.3	NP_872414.3	VALIDATED	Cs	0.996	0.996	452	1359	1	1356	452	1	452
RIKEN	AK125517	flj0070j08	FLJ	W01A105A23	pENTR-TOPO	5374		ANKRD33	341405	BAC86190.1	Hs.433492	Ankyrin repeat domain 33				PLACE6	EK1	NM_182608.3	NP_872414.3	VALIDATED	Cs	0.996	0.996	452	1359	1	1356	452	1	452
RIKEN	BC035813	IRAK079N11	MGC	W01A105B02	pENTR-TOPO	19406		P4HA2	8974	AAH35813.1	Hs.519568	Prolyl 4-hydroxylase, alpha polypeptide II			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001142598.1	NP_001136070.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	BC035813	IRAK079N11	MGC	W01A105B08	pENTR-TOPO	19406		P4HA2	8974	AAH35813.1	Hs.519568	Prolyl 4-hydroxylase, alpha polypeptide II			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001142598.1	NP_001136070.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
RIKEN	AK001946	flj0037l05	FLJ	W01A105B20	pENTR-TOPO	13119		NRBP1	29959	BAA91993.1	Hs.515876	Nuclear receptor binding protein 1				PLACE1	EK1	NM_013392.2	NP_037524.1	VALIDATED	C	1.000	1.000	535	1608	1	1605	535	1	535
RIKEN	BC009553	IRAK014K12	MGC	W01A105C05	pENTR-TOPO	20423		GOPC	57120	AAH09553.1	Hs.191539	Golgi associated PDZ and coiled-coil motif containing			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001017408.1	NP_001017408.1	VALIDATED	C	1.000	1.000	454	1365	1	1362	454	1	454
RIKEN	BC009553	IRAK014K12	MGC	W01A105C09	pENTR-TOPO	20423		GOPC	57120	AAH09553.1	Hs.191539	Golgi associated PDZ and coiled-coil motif containing			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001017408.1	NP_001017408.1	VALIDATED	C	1.000	1.000	454	1365	1	1362	454	1	454
RIKEN	BC009553	IRAK014K12	MGC	W01A105C11	pENTR-TOPO	20423		GOPC	57120	AAH09553.1	Hs.191539	Golgi associated PDZ and coiled-coil motif containing			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001017408.1	NP_001017408.1	VALIDATED	C	1.000	1.000	454	1365	1	1362	454	1	454
RIKEN	BC022387	IRAL036F07	MGC	W01A105D02	pENTR-TOPO	4443		SLC22A8	9376	AAH22387.1	Hs.266223	Solute carrier family 22 (organic anion transporter), member 8			Kidney	NIH_MGC_75	DH10B	NM_004254.2	NP_004245.2	REVIEWED	OK	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC022387	IRAL036F07	MGC	W01A105D10	pENTR-TOPO	4443		SLC22A8	9376	AAH22387.1	Hs.266223	Solute carrier family 22 (organic anion transporter), member 8			Kidney	NIH_MGC_75	DH10B	NM_004254.2	NP_004245.2	REVIEWED	OK	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	BC022387	IRAL036F07	MGC	W01A105D12	pENTR-TOPO	4443		SLC22A8	9376	AAH22387.1	Hs.266223	Solute carrier family 22 (organic anion transporter), member 8			Kidney	NIH_MGC_75	DH10B	NM_004254.2	NP_004245.2	REVIEWED	OK	1.000	1.000	542	1629	1	1626	542	1	542
RIKEN	AK024102	flj0029m04	FLJ	W01A105E01	pENTR-TOPO	8698		MYST1	84148	BAB14827.1	Hs.533803	MYST histone acetyltransferase 1				HEMBA1	EK1	NM_032188.2	NP_115564.2	VALIDATED	Cs	0.996	0.996	458	1377	1	1374	458	1	458
RIKEN	AK024102	flj0029m04	FLJ	W01A105E03	pENTR-TOPO	8698		MYST1	84148	BAB14827.1	Hs.533803	MYST histone acetyltransferase 1				HEMBA1	EK1	NM_032188.2	NP_115564.2	VALIDATED	Cs	0.996	0.996	458	1377	1	1374	458	1	458
RIKEN	AK024102	flj0029m04	FLJ	W01A105E05	pENTR-TOPO	8698		MYST1	84148	BAB14827.1	Hs.533803	MYST histone acetyltransferase 1				HEMBA1	EK1	NM_032188.2	NP_115564.2	VALIDATED	Cs	0.996	0.996	458	1377	1	1374	458	1	458
RIKEN	AK024102	flj0029m04	FLJ	W01A105E07	pENTR-TOPO	8698		MYST1	84148	BAB14827.1	Hs.533803	MYST histone acetyltransferase 1				HEMBA1	EK1	NM_032188.2	NP_115564.2	VALIDATED	Cs	0.996	0.996	458	1377	1	1374	458	1	458
RIKEN	AK024102	flj0029m04	FLJ	W01A105E09	pENTR-TOPO	8698		MYST1	84148	BAB14827.1	Hs.533803	MYST histone acetyltransferase 1				HEMBA1	EK1	NM_032188.2	NP_115564.2	VALIDATED	Cs	0.996	0.996	458	1377	1	1374	458	1	458
RIKEN	BC036798	IRAK079F12	MGC	W01A105E13	pENTR-TOPO	10936		RNMT	8731	AAH36798.1	Hs.592347	RNA (guanine-7-) methyltransferase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_003799.1	NP_003790.1	PROVISIONAL	OK	1.000	1.000	476	1431	1	1428	476	1	476
RIKEN	BC036798	IRAK079F12	MGC	W01A105E17	pENTR-TOPO	10936		RNMT	8731	AAH36798.1	Hs.592347	RNA (guanine-7-) methyltransferase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_003799.1	NP_003790.1	PROVISIONAL	OK	1.000	1.000	476	1431	1	1428	476	1	476
RIKEN	BC036798	IRAK079F12	MGC	W01A105E21	pENTR-TOPO	10936		RNMT	8731	AAH36798.1	Hs.592347	RNA (guanine-7-) methyltransferase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_003799.1	NP_003790.1	PROVISIONAL	OK	1.000	1.000	476	1431	1	1428	476	1	476
RIKEN	BC038587	IRAK079P13	MGC	W01A105F06	pENTR-TOPO	24633		EGFL6	25975	AAH38587.1	Hs.12844	EGF-like-domain, multiple 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015507.2	NP_056322.2	REVIEWED	OK	1.000	1.000	553	1662	1	1659	553	1	553
RIKEN	BC038587	IRAK079P13	MGC	W01A105F12	pENTR-TOPO	24633		EGFL6	25975	AAH38587.1	Hs.12844	EGF-like-domain, multiple 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015507.2	NP_056322.2	REVIEWED	OK	1.000	1.000	553	1662	1	1659	553	1	553
RIKEN	BC035055	IRAK073A19	MGC	W01A105F18	pENTR-TOPO	18098		GABRA4	2557	AAH35055.1	Hs.248112	Gamma-aminobutyric acid (GABA) A receptor, alpha 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000809.2	NP_000800.2	REVIEWED	C	1.000	1.000	554	1665	1	1662	554	1	554
RIKEN	BC035055	IRAK073A19	MGC	W01A105F22	pENTR-TOPO	18098		GABRA4	2557	AAH35055.1	Hs.248112	Gamma-aminobutyric acid (GABA) A receptor, alpha 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000809.2	NP_000800.2	REVIEWED	C	1.000	1.000	554	1665	1	1662	554	1	554
RIKEN	AK001252	flj0032a02	FLJ	W01A105G05	pENTR-TOPO	11691		ZNF358	140467	BAA91582.1	Hs.133475	Zinc finger protein 358	NT2	teratocarcinoma		NT2RM4	EK1	NM_018083.4	NP_060553.4	VALIDATED	P	1.000	1.000	481	1446	1	1443	568	88	568
RIKEN	AK131440	flj0073b02	FLJ	W01A105G23	pENTR-TOPO	22721		ZNF517	340385	BAD18586.1	Hs.521942	Zinc finger protein 517				TESOP2	EK1	NM_213605.2	NP_998770.2	VALIDATED	Cs	0.996	0.996	492	1479	1	1476	492	1	492
RIKEN	BC030246	IRAK062I15	MGC	W01A105H10	pENTR-TOPO	18159		MFSD7	84179	AAH30246.1	Hs.567612	Major facilitator superfamily domain containing 7			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_032219.2	NP_115595.2	PROVISIONAL	C	1.000	1.000	559	1680	1	1677	559	1	559
RIKEN	BC067273	IRAK141J07	MGC	W01A105H22	pENTR-TOPO	13127		USP39	10713	AAH67273.1	Hs.654745	Ubiquitin specific peptidase 39			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006590.2	NP_006581.2	VALIDATED	OK	1.000	1.000	565	1698	1	1695	565	1	565
RIKEN	BC033691	IRAK068O11	MGC	W01A105I01	pENTR-TOPO	11636		CYP2S1	29785	AAH33691.1	Hs.98370	Cytochrome P450, family 2, subfamily S, polypeptide 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_030622.6	NP_085125.1	REVIEWED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC033691	IRAK068O11	MGC	W01A105I05	pENTR-TOPO	11636		CYP2S1	29785	AAH33691.1	Hs.98370	Cytochrome P450, family 2, subfamily S, polypeptide 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_030622.6	NP_085125.1	REVIEWED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC033691	IRAK068O11	MGC	W01A105I11	pENTR-TOPO	11636		CYP2S1	29785	AAH33691.1	Hs.98370	Cytochrome P450, family 2, subfamily S, polypeptide 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_030622.6	NP_085125.1	REVIEWED	C	1.000	1.000	504	1515	1	1512	504	1	504
RIKEN	BC005368	IRAL016J09	MGC	W01A105I17	pENTR-TOPO	12417		ZNF649	65251	AAH05368.1	Hs.567573	Zinc finger protein 649			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_023074.2	NP_075562.2	PROVISIONAL	OK	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC005368	IRAL016J09	MGC	W01A105I19	pENTR-TOPO	12417		ZNF649	65251	AAH05368.1	Hs.567573	Zinc finger protein 649			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_023074.2	NP_075562.2	PROVISIONAL	OK	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	BC005368	IRAL016J09	MGC	W01A105I23	pENTR-TOPO	12417		ZNF649	65251	AAH05368.1	Hs.567573	Zinc finger protein 649			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_023074.2	NP_075562.2	PROVISIONAL	OK	1.000	1.000	505	1518	1	1515	505	1	505
RIKEN	AK131424	flj0073l16	FLJ	W01A105J16	pENTR-TOPO	8136		MEX3B	84206	BAD18571.1	Hs.104744	Mex-3 homolog B (C. elegans)				OCBBF3	EK1	NM_032246.3	NP_115622.2	PROVISIONAL	C	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	BC047004	IRAK093A21	MGC	W01A105K01	pENTR-TOPO	13099		UGP2	7360	AAH47004.1	Hs.516217	UDP-glucose pyrophosphorylase 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006759.3	NP_006750.3	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC047004	IRAK093A21	MGC	W01A105K07	pENTR-TOPO	13099		UGP2	7360	AAH47004.1	Hs.516217	UDP-glucose pyrophosphorylase 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006759.3	NP_006750.3	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC047004	IRAK093A21	MGC	W01A105K11	pENTR-TOPO	13099		UGP2	7360	AAH47004.1	Hs.516217	UDP-glucose pyrophosphorylase 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006759.3	NP_006750.3	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
RIKEN	BC031554	IRAK050G10	MGC	W01A105K19	pENTR-TOPO	2013		RORC	6097	AAH31554.1	Hs.256022	RAR-related orphan receptor C			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005060.3	NP_005051.2	REVIEWED	OK	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC031554	IRAK050G10	MGC	W01A105K23	pENTR-TOPO	2013		RORC	6097	AAH31554.1	Hs.256022	RAR-related orphan receptor C			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_005060.3	NP_005051.2	REVIEWED	OK	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC040136	IRAK084P21	MGC	W01A105L08	pENTR-TOPO	1580		C1orf2	10712	AAH40136.2	Hs.348308	Chromosome 1 open reading frame 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198264.1	NP_937995.1	VALIDATED	OK	1.000	1.000	572	1719	1	1716	572	1	572
RIKEN	AK056088	flj0002m20	FLJ	W01A105L18	pENTR-TOPO	12481		ZNF681	148213	BAB71090.1	Hs.399952	Zinc finger protein 681	NT2	teratocarcinoma		NT2RI2	EK1	NM_138286.2	NP_612143.2	VALIDATED	Ps	0.995	0.995	576	1731	1	1728	645	70	645
RIKEN	BC027942	IRAK049F12	MGC	W01A105M05	pENTR-TOPO	5840		TBX5	6910	AAH27942.1	Hs.381715	T-box 5			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_181486.1	NP_852259.1	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC027942	IRAK049F12	MGC	W01A105M07	pENTR-TOPO	5840		TBX5	6910	AAH27942.1	Hs.381715	T-box 5			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_181486.1	NP_852259.1	REVIEWED	C	1.000	1.000	518	1557	1	1554	518	1	518
RIKEN	BC059173	IRAK088J05	MGC	W01A105M21	pENTR-TOPO	8862		FBXL19	54620	AAH59173.1					Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001099784.2	NP_001093254.2	PROVISIONAL	Pg	0.924	1.000	567	1575	1	1572	694	128	694
RIKEN	BC014834	IRAK003A07	MGC	W01A105N06	pENTR-TOPO	14275		ORC2L	4999	AAH14834.1	Hs.444870	Origin recognition complex, subunit 2-like (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006190.3	NP_006181.1	REVIEWED	C	1.000	1.000	577	1734	1	1731	577	1	577
RIKEN	BC014834	IRAK003A07	MGC	W01A105N10	pENTR-TOPO	14275		ORC2L	4999	AAH14834.1	Hs.444870	Origin recognition complex, subunit 2-like (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006190.3	NP_006181.1	REVIEWED	C	1.000	1.000	577	1734	1	1731	577	1	577
RIKEN	H013040E18	H013040E18	RIKEN	W01A105N18	pENTR-TOPO		14903	NCOA5	57727		Hs.654991	Nuclear receptor coactivator 5	-	-	testis	testis	DH10B	NM_020967.2	NP_066018.1	REVIEWED	OK	1.000	1.000	579	1740	1	1737	579	1	579
RIKEN	H013040E18	H013040E18	RIKEN	W01A105N20	pENTR-TOPO		14903	NCOA5	57727		Hs.654991	Nuclear receptor coactivator 5	-	-	testis	testis	DH10B	NM_020967.2	NP_066018.1	REVIEWED	OK	1.000	1.000	579	1740	1	1737	579	1	579
RIKEN	AK125213	flj0068e10	FLJ	W01A105O03	pENTR-TOPO	1896		YARS	8565	BAG54166.1	Hs.706890	Tyrosyl-tRNA synthetase				FEBRA2	EK1	NM_003680.3	NP_003671.1	REVIEWED	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	AK125213	flj0068e10	FLJ	W01A105O07	pENTR-TOPO	1896		YARS	8565	BAG54166.1	Hs.706890	Tyrosyl-tRNA synthetase				FEBRA2	EK1	NM_003680.3	NP_003671.1	REVIEWED	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	AK125213	flj0068e10	FLJ	W01A105O09	pENTR-TOPO	1896		YARS	8565	BAG54166.1	Hs.706890	Tyrosyl-tRNA synthetase				FEBRA2	EK1	NM_003680.3	NP_003671.1	REVIEWED	C	1.000	1.000	528	1587	1	1584	528	1	528
RIKEN	BC067293	IRAK141N23	MGC	W01A105P04	pENTR-TOPO	21182		FBXO24	26261	AAH67293.1	Hs.283764	F-box protein 24			Testis	NIH_MGC_180	DH10B	NM_033506.2	NP_277041.1	REVIEWED	C	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	BC067293	IRAK141N23	MGC	W01A105P06	pENTR-TOPO	21182		FBXO24	26261	AAH67293.1	Hs.283764	F-box protein 24			Testis	NIH_MGC_180	DH10B	NM_033506.2	NP_277041.1	REVIEWED	C	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	BC067293	IRAK141N23	MGC	W01A105P12	pENTR-TOPO	21182		FBXO24	26261	AAH67293.1	Hs.283764	F-box protein 24			Testis	NIH_MGC_180	DH10B	NM_033506.2	NP_277041.1	REVIEWED	C	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	BC015052	IRAK015F06	MGC	W01A106A01	pENTR-TOPO	7943		RTF1	23168	AAH15052.1	Hs.511096	Rtf1, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015138.4	NP_055953.3	VALIDATED	P	1.000	1.000	585	1758	1	1755	710	126	710
RIKEN	AK056329	flj0003g09	FLJ	W01A106A21	pENTR-TOPO	14110		TIGD1	200765	BAB71153.1	Hs.211823	Tigger transposable element derived 1	NT2	teratocarcinoma		NT2RI2	EK1	NM_145702.1	NP_663748.1	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
RIKEN	BC082762	IRAL059M02	MGC	W01A106B24	pENTR-TOPO	12158		KANK2	25959	AAH82762.1	Hs.719195	KN motif and ankyrin repeat domains 2			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_001136191.1	NP_001129663.1	VALIDATED	C	1.000	1.000	851	2556	1	2553	851	1	851
RIKEN	AK091851	flj0015j13	FLJ	W01A106C01	pENTR-TOPO	19222		COL4A3BP	10087	BAC03762.1	Hs.270437	Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein				HLUNG2	EK1	NM_031361.2	NP_112729.1	REVIEWED	C	1.000	1.000	598	1797	1	1794	598	1	598
RIKEN	AK091851	flj0015j13	FLJ	W01A106C09	pENTR-TOPO	19222		COL4A3BP	10087	BAC03762.1	Hs.270437	Collagen, type IV, alpha 3 (Goodpasture antigen) binding protein				HLUNG2	EK1	NM_031361.2	NP_112729.1	REVIEWED	C	1.000	1.000	598	1797	1	1794	598	1	598
RIKEN	AK056711	flj0003k16	FLJ	W01A106C13	pENTR-TOPO	135		POGK	57645	BAG51796.1	Hs.432752	Pogo transposable element with KRAB domain				PLACE5	EK1	NM_017542.3	NP_060012.3	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
RIKEN	AK056711	flj0003k16	FLJ	W01A106C17	pENTR-TOPO	135		POGK	57645	BAG51796.1	Hs.432752	Pogo transposable element with KRAB domain				PLACE5	EK1	NM_017542.3	NP_060012.3	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
RIKEN	BC059392	IRAK133G13	MGC	W01A106E15	pENTR-TOPO	19233		PRLR	5618	AAH59392.1	Hs.368587	Prolactin receptor			Placenta, normal	NIH_MGC_147	DH10B	NM_000949.4	NP_000940.1	VALIDATED	OK	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC059392	IRAK133G13	MGC	W01A106E23	pENTR-TOPO	19233		PRLR	5618	AAH59392.1	Hs.368587	Prolactin receptor			Placenta, normal	NIH_MGC_147	DH10B	NM_000949.4	NP_000940.1	VALIDATED	OK	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	BC042599	IRAK026L19	MGC	W01A106F08	pENTR-TOPO	22517		PTK2B	2185	AAH42599.1	Hs.491322	PTK2B protein tyrosine kinase 2 beta			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004103.3	NP_004094.3	REVIEWED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
RIKEN	AK022241	flj0030l15	FLJ	W01A106F22	pENTR-TOPO	3638		NAT10	55226	BAB13995.1	Hs.577281	N-acetyltransferase 10 (GCN5-related)				MAMMA1	EK1	NM_001144030.1	NP_001137502.1	VALIDATED	Cs	0.998	0.998	953	3078	217	3075	953	1	953
RIKEN	BC022022	IRAK033C22	MGC	W01A106G03	pENTR-TOPO	11746		ZNF555	148254	AAH22022.2	Hs.47712	Zinc finger protein 555			Testis	NIH_MGC_97	DH10B	NM_152791.3	NP_690004.3	PROVISIONAL	OK	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	BC022022	IRAK033C22	MGC	W01A106G05	pENTR-TOPO	11746		ZNF555	148254	AAH22022.2	Hs.47712	Zinc finger protein 555			Testis	NIH_MGC_97	DH10B	NM_152791.3	NP_690004.3	PROVISIONAL	OK	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	BC022022	IRAK033C22	MGC	W01A106G07	pENTR-TOPO	11746		ZNF555	148254	AAH22022.2	Hs.47712	Zinc finger protein 555			Testis	NIH_MGC_97	DH10B	NM_152791.3	NP_690004.3	PROVISIONAL	OK	1.000	1.000	628	1887	1	1884	628	1	628
RIKEN	BC047376	IRAK091D16	MGC	W01A106G17	pENTR-TOPO	11572		LSR	51599	AAH47376.2	Hs.466507	Lipolysis stimulated lipoprotein receptor			Testis	NIH_MGC_97	DH10B	NM_205834.2	NP_991403.1	VALIDATED	OK	1.000	1.000	649	1950	1	1947	649	1	649
RIKEN	BC033657	IRAK068C23	MGC	W01A106H14	pENTR-TOPO	8864		PHKB	5257	AAH33657.1	Hs.78060	Phosphorylase kinase, beta			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001031835.2	NP_001027005.1	VALIDATED	C	1.000	1.000	1086	3261	1	3258	1086	1	1086
RIKEN	BC033657	IRAK068C23	MGC	W01A106H16	pENTR-TOPO	8864		PHKB	5257	AAH33657.1	Hs.78060	Phosphorylase kinase, beta			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001031835.2	NP_001027005.1	VALIDATED	C	1.000	1.000	1086	3261	1	3258	1086	1	1086
RIKEN	BC033657	IRAK068C23	MGC	W01A106H24	pENTR-TOPO	8864		PHKB	5257	AAH33657.1	Hs.78060	Phosphorylase kinase, beta			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001031835.2	NP_001027005.1	VALIDATED	C	1.000	1.000	1086	3261	1	3258	1086	1	1086
RIKEN	BC028366	IRAK034I10	MGC	W01A106I15	pENTR-TOPO	13981		TSGA10	80705	AAH28366.1	Hs.120267	Testis specific, 10			Testis	NIH_MGC_97	DH10B	NM_025244.2	NP_079520.1	VALIDATED	Cs	0.999	0.999	698	2097	1	2094	698	1	698
RIKEN	BC035357	IRAK051E06	MGC	W01A106J16	pENTR-TOPO	7929		FES	2242	AAH35357.1	Hs.7636	Feline sarcoma oncogene			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002005.3	NP_001996.1	REVIEWED	C	1.000	1.000	822	2469	1	2466	822	1	822
RIKEN	BC013787	IRAK013L16	MGC	W01A106K19	pENTR-TOPO	22960		BOP1	23246	AAH13787.1	Hs.535901	Block of proliferation 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015201.3	NP_056016.1	VALIDATED	C	1.000	1.000	746	2241	1	2238	746	1	746
RIKEN	AK127168	flj0077f03	FLJ	W01A106L02	pENTR-TOPO	3110		GRID1	2894	BAG54447.1	Hs.530653	Glutamate receptor, ionotropic, delta 1				BRCAN2	EK1	NM_017551.2	NP_060021.1	REVIEWED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
RIKEN	BC028679	IRAK034F02	MGC	W01A106M15	pENTR-TOPO	1895		KIFAP3	22920	AAH28679.1	Hs.433442	Kinesin-associated protein 3			Testis	NIH_MGC_97	DH10B	NM_014970.2	NP_055785.2	REVIEWED	C	1.000	1.000	792	2379	1	2376	792	1	792
RIKEN	BC028679	IRAK034F02	MGC	W01A106M17	pENTR-TOPO	1895		KIFAP3	22920	AAH28679.1	Hs.433442	Kinesin-associated protein 3			Testis	NIH_MGC_97	DH10B	NM_014970.2	NP_055785.2	REVIEWED	C	1.000	1.000	792	2379	1	2376	792	1	792
RIKEN	BC001976	IRAK004I18	MGC	W01A106O03	pENTR-TOPO	15930		SF3A1	10291	AAH01976.1	Hs.406277	Splicing factor 3a, subunit 1, 120kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005877.4	NP_005868.1	REVIEWED	C	1.000	1.000	793	2382	1	2379	793	1	793
RIKEN	BC009696	IRAK014A11	MGC	W01A107A01	pENTR-TOPO	4098		IFITM2	10581	AAH09696.1	Hs.709321	Interferon induced transmembrane protein 2 (1-8D)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_006435.2	NP_006426.2	VALIDATED		0.977	0.977	132	399	1	396	132	1	132
RIKEN	BC009696	IRAK014A11	MGC	W01A107A03	pENTR-TOPO	4098		IFITM2	10581	AAH09696.1	Hs.709321	Interferon induced transmembrane protein 2 (1-8D)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_006435.2	NP_006426.2	VALIDATED		0.977	0.977	132	399	1	396	132	1	132
RIKEN	H013088O12	H013088O12	RIKEN	W01A107A19	pENTR-TOPO		14690	C20orf108	116151		Hs.593629	Chromosome 20 open reading frame 108	-	-	testis	testis	DH10B	NM_080821.2	NP_543011.2	VALIDATED	Cs	0.990	0.990	192	579	1	576	192	1	192
RIKEN	AK056508	flj0006c23	FLJ	W01A107B12	pENTR-TOPO	12438		ZNF667	63934	BAG51734.1	Hs.712574	Zinc finger protein 667	NT2	teratocarcinoma		NT2RP7	EK1	NM_022103.2	NP_071386.2	PROVISIONAL	Cs	0.997	0.997	610	1833	1	1830	610	1	610
RIKEN	H07D056B01	H07D056B01	RIKEN	W01A107C05	pENTR-TOPO		23277						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	H07D056B01	H07D056B01	RIKEN	W01A107C09	pENTR-TOPO		23277						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	BC052618	IRAL047N02	MGC	W01A107D10	pENTR-TOPO	12003		TRAPPC2	6399	AAH52618.1	Hs.592238	Trafficking protein particle complex 2			Ovary, teratocarcinoma	NIH_MGC_109		NM_001011658.2	NP_001011658.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
RIKEN	BC006982	IRAL016P08	MGC	W01A107D16	pENTR-TOPO	16289		RSRC1	51319	AAH06982.1	Hs.591283	Arginine/serine-rich coiled-coil 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016625.2	NP_057709.2	PROVISIONAL	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC036087	IRAK048I08	MGC	W01A107E07	pENTR-TOPO	18903		PURA	5813	AAH36087.1	Hs.443121	Purine-rich element binding protein A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005859.3	NP_005850.1	REVIEWED	Cs	0.997	0.997	322	969	1	966	322	1	322
RIKEN	BC036087	IRAK048I08	MGC	W01A107E09	pENTR-TOPO	18903		PURA	5813	AAH36087.1	Hs.443121	Purine-rich element binding protein A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005859.3	NP_005850.1	REVIEWED	Cs	0.997	0.997	322	969	1	966	322	1	322
RIKEN	BC039203	IRAK032I18	MGC	W01A107F16	pENTR-TOPO	22113		RAPGEF5	9771	AAH39203.1	Hs.174768	Rap guanine nucleotide exchange factor (GEF) 5			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012294.3	NP_036426.3	VALIDATED	Pgs	0.732	0.997	512	1335	205	1332	730	219	730
RIKEN	BC039203	IRAK032I18	MGC	W01A107F24	pENTR-TOPO	22113		RAPGEF5	9771	AAH39203.1	Hs.174768	Rap guanine nucleotide exchange factor (GEF) 5			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012294.3	NP_036426.3	VALIDATED	Pgs	0.732	0.997	512	1335	205	1332	730	219	730
RIKEN	BC084580	IRAK174O24	MGC	W01A107G03	pENTR-TOPO	474		SERINC2	347735	AAH84580.1	Hs.270655	Serine incorporator 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178865.3	NP_849196.2	VALIDATED	Cg	0.998	1.000	456	1371	1	1368	455	1	455
RIKEN	AK126918	flj0076d16	FLJ	W01A107G13	pENTR-TOPO	8717		GLIS2	84662	BAG54396.1	Hs.592087	GLIS family zinc finger 2				BRAWH3	EK1	NM_032575.2	NP_115964.2	VALIDATED	C	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	AK126918	flj0076d16	FLJ	W01A107G15	pENTR-TOPO	8717		GLIS2	84662	BAG54396.1	Hs.592087	GLIS family zinc finger 2				BRAWH3	EK1	NM_032575.2	NP_115964.2	VALIDATED	C	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	AK126918	flj0076d16	FLJ	W01A107G19	pENTR-TOPO	8717		GLIS2	84662	BAG54396.1	Hs.592087	GLIS family zinc finger 2				BRAWH3	EK1	NM_032575.2	NP_115964.2	VALIDATED	C	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	AK126918	flj0076d16	FLJ	W01A107G23	pENTR-TOPO	8717		GLIS2	84662	BAG54396.1	Hs.592087	GLIS family zinc finger 2				BRAWH3	EK1	NM_032575.2	NP_115964.2	VALIDATED	C	1.000	1.000	524	1575	1	1572	524	1	524
RIKEN	BC009682	IRAK014P10	MGC	W01A107H04	pENTR-TOPO	18581		SMAD5	4090	AAH09682.1	Hs.167700	SMAD family member 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005903.5	NP_005894.3	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC009682	IRAK014P10	MGC	W01A107H10	pENTR-TOPO	18581		SMAD5	4090	AAH09682.1	Hs.167700	SMAD family member 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005903.5	NP_005894.3	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	BC050407	IRAK098N22	MGC	W01A107H24	pENTR-TOPO	35284		ZNF83	55769	AAH50407.1	Hs.710125	Zinc finger protein 83				Lupski_sympathetic_trunk	DH10B	NM_001105550.1	NP_001099020.1	VALIDATED	Cs	0.996	0.996	516	1551	1	1548	516	1	516
RIKEN	BC013200	IRAK026J21	MGC	W01A107I15	pENTR-TOPO	430		LCK	3932	AAH13200.1	Hs.470627	Lymphocyte-specific protein tyrosine kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001042771.1	NP_001036236.1	REVIEWED	Cg	0.944	1.000	539	1620	1	1617	509	1	509
RIKEN	BC013200	IRAK026J21	MGC	W01A107I17	pENTR-TOPO	430		LCK	3932	AAH13200.1	Hs.470627	Lymphocyte-specific protein tyrosine kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001042771.1	NP_001036236.1	REVIEWED	Cg	0.944	1.000	539	1620	1	1617	509	1	509
RIKEN	BC052266	IRAL047N07	MGC	W01A107K19	pENTR-TOPO	9553		FZD2	2535	AAH52266.1	Hs.142912	Frizzled homolog 2 (Drosophila)			Ovary, teratocarcinoma	NIH_MGC_109		NM_001466.2	NP_001457.1	REVIEWED	OK	1.000	1.000	565	1698	1	1695	565	1	565
RIKEN	BC050382	IRAK098H16	MGC	W01A107L18	pENTR-TOPO	16845		PLCD1	5333	AAH50382.2	Hs.80776	Phospholipase C, delta 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_006225.3	NP_006216.2	VALIDATED	C	1.000	1.000	756	2271	1	2268	756	1	756
RIKEN	H06D051C14	H06D051C14	RIKEN	W01A107M17	pENTR-TOPO		11089						-	-	brain	brain	DH10B			
RIKEN	BC001188	IRAL006F07	MGC	W01A107N08	pENTR-TOPO	16831		TFRC	7037	AAH01188.1	Hs.529618	Transferrin receptor (p90, CD71)			Eye, retinoblastoma	NIH_MGC_16		NM_003234.2	NP_003225.2	VALIDATED	C	1.000	1.000	760	2283	1	2280	760	1	760
RIKEN	BC001188	IRAL006F07	MGC	W01A107N10	pENTR-TOPO	16831		TFRC	7037	AAH01188.1	Hs.529618	Transferrin receptor (p90, CD71)			Eye, retinoblastoma	NIH_MGC_16		NM_003234.2	NP_003225.2	VALIDATED	C	1.000	1.000	760	2283	1	2280	760	1	760
RIKEN	H04D022P10	H04D022P10	RIKEN	W01A107N14	pENTR-TOPO		7048						-	-	testis	testis	DH10B			
RIKEN	BC036827	IRAK078G07	MGC	W01A107O17	pENTR-TOPO	12236		LILRB2	10288	AAH36827.1	Hs.655652	Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005874.3	NP_005865.2	REVIEWED	Cs	0.992	0.992	598	1797	1	1794	598	1	598
RIKEN	BC036827	IRAK078G07	MGC	W01A107O19	pENTR-TOPO	12236		LILRB2	10288	AAH36827.1	Hs.655652	Leukocyte immunoglobulin-like receptor, subfamily B (with TM and ITIM domains), member 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005874.3	NP_005865.2	REVIEWED	Cs	0.992	0.992	598	1797	1	1794	598	1	598
RIKEN	BC006422	IRAL018O14	MGC	W01A107P10	pENTR-TOPO	15190		PFKL	5211	AAH06422.1	Hs.255093	Phosphofructokinase, liver			Lung, large cell carcinoma	NIH_MGC_18		NM_001002021.1	NP_001002021.1	REVIEWED	C	1.000	1.000	827	2484	1	2481	827	1	827
RIKEN	H023063C09	H023063C09	RIKEN	W01A108A19	pENTR-TOPO		3811	REXO2	25996		Hs.7527	REX2, RNA exonuclease 2 homolog (S. cerevisiae)	-	-	hippocampus	hippocampus	DH10B	NM_015523.3	NP_056338.2	VALIDATED	OK	1.000	1.000	237	714	1	711	237	1	237
RIKEN	H023063C09	H023063C09	RIKEN	W01A108A23	pENTR-TOPO		3811	REXO2	25996		Hs.7527	REX2, RNA exonuclease 2 homolog (S. cerevisiae)	-	-	hippocampus	hippocampus	DH10B	NM_015523.3	NP_056338.2	VALIDATED	OK	1.000	1.000	237	714	1	711	237	1	237
RIKEN	AK027592	flj0034c23	FLJ	W01A108B06	pENTR-TOPO	11659		ZNF382	84911	BAB55217.1	Hs.631591	Zinc finger protein 382	NT2	teratocarcinoma		NT2RP2	EK1	NM_032825.3	NP_116214.2	VALIDATED	Cg	0.996	1.000	550	1647	1	1644	550	1	550
RIKEN	H05D012N12	H05D012N12	RIKEN	W01A108B14	pENTR-TOPO		13930						-	-	thymus	thymus	DH10B			
RIKEN	BC007093	IRAL021E12	MGC	W01A108C03	pENTR-TOPO	18861		CCNG1	900	AAH07093.1	Hs.79101	Cyclin G1			Prostate	NIH_MGC_83	DH10B	NM_199246.1	NP_954854.1	REVIEWED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC007093	IRAL021E12	MGC	W01A108C07	pENTR-TOPO	18861		CCNG1	900	AAH07093.1	Hs.79101	Cyclin G1			Prostate	NIH_MGC_83	DH10B	NM_199246.1	NP_954854.1	REVIEWED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC011752	IRAL027D06	MGC	W01A108D12	pENTR-TOPO	16880		MBD4	8930	AAH11752.1	Hs.35947	Methyl-CpG binding domain protein 4			Lung, small cell carcinoma	NIH_MGC_7		NM_003925.1	NP_003916.1	REVIEWED	Cg	0.990	1.000	580	1725	1	1722	580	1	580
RIKEN	AK026941	flj0066h10	FLJ	W01A108D16	pENTR-TOPO	11471		ZNF211	10520	-	Hs.590977	Zinc finger protein 211	HepG2	hepatoma		HEP	EK1	NM_006385.3	NP_006376.2	VALIDATED	Cs	0.998	0.998	577	1734	1	1731	577	1	577
RIKEN	AK026941	flj0066h10	FLJ	W01A108D22	pENTR-TOPO	11471		ZNF211	10520	-	Hs.590977	Zinc finger protein 211	HepG2	hepatoma		HEP	EK1	NM_006385.3	NP_006376.2	VALIDATED	Cs	0.998	0.998	577	1734	1	1731	577	1	577
RIKEN	AK026941	flj0066h10	FLJ	W01A108D24	pENTR-TOPO	11471		ZNF211	10520	-	Hs.590977	Zinc finger protein 211	HepG2	hepatoma		HEP	EK1	NM_006385.3	NP_006376.2	VALIDATED	Cs	0.998	0.998	577	1734	1	1731	577	1	577
RIKEN	BC001903	IRAL008B10	MGC	W01A108E07	pENTR-TOPO	15251		IL10RB	3588	AAH01903.1	Hs.654593	Interleukin 10 receptor, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000628.3	NP_000619.3	REVIEWED	C	1.000	1.000	325	978	1	975	325	1	325
RIKEN	AK123634	flj0046g04	FLJ	W01A108E17	pENTR-TOPO	20392		MCHR2	84539	BAG53926.1	Hs.591342	Melanin-concentrating hormone receptor 2				FEBRA2	EK1	NM_032503.2	NP_115892.2	VALIDATED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	AK123634	flj0046g04	FLJ	W01A108E21	pENTR-TOPO	20392		MCHR2	84539	BAG53926.1	Hs.591342	Melanin-concentrating hormone receptor 2				FEBRA2	EK1	NM_032503.2	NP_115892.2	VALIDATED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC001155	IRAL006C06	MGC	W01A108G09	pENTR-TOPO	5242		PCBP2	5094	AAH01155.1	Hs.546271	Poly(rC) binding protein 2			Eye, retinoblastoma	NIH_MGC_16		NM_031989.4	NP_114366.1	REVIEWED	C	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	AK027556	flj0033n13	FLJ	W01A108H14	pENTR-TOPO	23982		UBQLN1	29979	BAG51344.1	Hs.9589	Ubiquilin 1	NT2	teratocarcinoma		NT2RP2	EK1	NM_013438.4	NP_038466.2	REVIEWED	Cs	0.998	0.998	589	1770	1	1767	589	1	589
RIKEN	BC011780	IRAL027J06	MGC	W01A108I17	pENTR-TOPO	14881		FOXA2	3170	AAH11780.1	Hs.155651	Forkhead box A2			Lung, small cell carcinoma	NIH_MGC_7		NM_153675.2	NP_710141.1	REVIEWED	C	1.000	1.000	457	1374	1	1371	457	1	457
RIKEN	BC070052	IRAK168J05	MGC	W01A108J18	pENTR-TOPO	4013		WEE1	7465	AAH70052.1	Hs.249441	WEE1 homolog (S. pombe)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003390.3	NP_003381.1	REVIEWED	Cs	0.998	0.998	646	1941	1	1938	646	1	646
RIKEN	BC040436	IRAK084F09	MGC	W01A108K11	pENTR-TOPO	178		SFRS11	9295	AAH40436.1	Hs.479693	Splicing factor, arginine/serine-rich 11			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004768.2	NP_004759.1	REVIEWED	Cg	0.998	1.000	484	1452	1	1449	484	1	484
RIKEN	BC067100	IRAL050J01	MGC	W01A108L12	pENTR-TOPO	1609		FAF1	11124	AAH67100.1	Hs.530402	Fas (TNFRSF6) associated factor 1			Brain, neuroblastoma	NIH_MGC_47		NM_007051.2	NP_008982.1	REVIEWED	C	1.000	1.000	650	1953	1	1950	650	1	650
RIKEN	BC037545	IRAK064G23	MGC	W01A108L14	pENTR-TOPO	1747		PARP1	142	AAH37545.1	Hs.177766	Poly (ADP-ribose) polymerase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001618.3	NP_001609.2	REVIEWED	Cs	0.999	0.999	1014	3045	1	3042	1014	1	1014
RIKEN	BC037545	IRAK064G23	MGC	W01A108L20	pENTR-TOPO	1747		PARP1	142	AAH37545.1	Hs.177766	Poly (ADP-ribose) polymerase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_001618.3	NP_001609.2	REVIEWED	Cs	0.999	0.999	1014	3045	1	3042	1014	1	1014
RIKEN	BC014020	IRAL028J21	MGC	W01A108M15	pENTR-TOPO	9551		BAIAP2	10458	AAH14020.1	Hs.128316	BAI1-associated protein 2			Brain, neuroblastoma	NIH_MGC_19		NM_017450.2	NP_059344.1	REVIEWED	Cg	0.998	1.000	522	1569	1	1566	521	1	521
RIKEN	BC014020	IRAL028J21	MGC	W01A108M17	pENTR-TOPO	9551		BAIAP2	10458	AAH14020.1	Hs.128316	BAI1-associated protein 2			Brain, neuroblastoma	NIH_MGC_19		NM_017450.2	NP_059344.1	REVIEWED	Cg	0.998	1.000	522	1569	1	1566	521	1	521
RIKEN	BC068482	IRAK167B20	MGC	W01A108N02	pENTR-TOPO	7319		CLMN	79789	AAH68482.1	Hs.301478	Calmin (calponin-like, transmembrane)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024734.3	NP_079010.2	VALIDATED	Cs	0.998	0.998	1002	3009	1	3006	1002	1	1002
RIKEN	BC068482	IRAK167B20	MGC	W01A108N04	pENTR-TOPO	7319		CLMN	79789	AAH68482.1	Hs.301478	Calmin (calponin-like, transmembrane)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024734.3	NP_079010.2	VALIDATED	Cs	0.998	0.998	1002	3009	1	3006	1002	1	1002
RIKEN	BC068482	IRAK167B20	MGC	W01A108N06	pENTR-TOPO	7319		CLMN	79789	AAH68482.1	Hs.301478	Calmin (calponin-like, transmembrane)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024734.3	NP_079010.2	VALIDATED	Cs	0.998	0.998	1002	3009	1	3006	1002	1	1002
RIKEN	BC068482	IRAK167B20	MGC	W01A108N08	pENTR-TOPO	7319		CLMN	79789	AAH68482.1	Hs.301478	Calmin (calponin-like, transmembrane)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024734.3	NP_079010.2	VALIDATED	Cs	0.998	0.998	1002	3009	1	3006	1002	1	1002
RIKEN	AK091877	flj0014k03	FLJ	W01A108N16	pENTR-TOPO	9756		KCNH6	81033	BAC03764.1	Hs.591177	Potassium voltage-gated channel, subfamily H (eag-related), member 6				KIDNE2	EK1	NM_173092.1	NP_775115.1	REVIEWED	Cs	0.998	0.998	905	2718	1	2715	905	1	905
RIKEN	H013074P05	H013074P05	RIKEN	W01A108O01	pENTR-TOPO		7397	SNW1	22938		Hs.445498	SNW domain containing 1	-	-	testis	testis	DH10B	NM_012245.2	NP_036377.1	REVIEWED	Cs	0.998	0.998	536	1611	1	1608	536	1	536
RIKEN	BC000723	IRAL007G05	MGC	W01A108O13	pENTR-TOPO	24275		CRAT	1384	AAH00723.1	Hs.12068	Carnitine acetyltransferase			Placenta, choriocarcinoma	NIH_MGC_21		NM_004003.2	NP_003994.2	REVIEWED	Cg	0.864	1.000	605	1635	64	1632	605	1	605
RIKEN	BC000723	IRAL007G05	MGC	W01A108O17	pENTR-TOPO	24275		CRAT	1384	AAH00723.1	Hs.12068	Carnitine acetyltransferase			Placenta, choriocarcinoma	NIH_MGC_21		NM_004003.2	NP_003994.2	REVIEWED	Cg	0.864	1.000	605	1635	64	1632	605	1	605
RIKEN	BC000723	IRAL007G05	MGC	W01A108O21	pENTR-TOPO	24275		CRAT	1384	AAH00723.1	Hs.12068	Carnitine acetyltransferase			Placenta, choriocarcinoma	NIH_MGC_21		NM_004003.2	NP_003994.2	REVIEWED	Cg	0.864	1.000	605	1635	64	1632	605	1	605
RIKEN	BC017180	IRAL005F19	MGC	W01A108P02	pENTR-TOPO	21092		SND1	27044	AAH17180.3	Hs.122523	Staphylococcal nuclease and tudor domain containing 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_014390.2	NP_055205.2	VALIDATED	C	1.000	1.000	910	2734	2	2731	910	1	910
RIKEN	BC017180	IRAL005F19	MGC	W01A108P08	pENTR-TOPO	21092		SND1	27044	AAH17180.3	Hs.122523	Staphylococcal nuclease and tudor domain containing 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_014390.2	NP_055205.2	VALIDATED	C	1.000	1.000	910	2734	2	2731	910	1	910
RIKEN	BC017180	IRAL005F19	MGC	W01A108P10	pENTR-TOPO	21092		SND1	27044	AAH17180.3	Hs.122523	Staphylococcal nuclease and tudor domain containing 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_014390.2	NP_055205.2	VALIDATED	C	1.000	1.000	910	2734	2	2731	910	1	910
RIKEN	BC017180	IRAL005F19	MGC	W01A108P12	pENTR-TOPO	21092		SND1	27044	AAH17180.3	Hs.122523	Staphylococcal nuclease and tudor domain containing 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_014390.2	NP_055205.2	VALIDATED	C	1.000	1.000	910	2734	2	2731	910	1	910
RIKEN	H07D030K17	H07D030K17	RIKEN	W01A108P14	pENTR-TOPO		3837						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	H07D030K17	H07D030K17	RIKEN	W01A108P16	pENTR-TOPO		3837						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	H07D030K17	H07D030K17	RIKEN	W01A108P22	pENTR-TOPO		3837						-	-	UNKNOWN	UNKNOWN	DH10B			
RIKEN	AK096588	flj0022g09	FLJ	W01A109A01	pENTR-TOPO	17647		GUCY1A3	2982	BAG53331.1	Hs.24258	Guanylate cyclase 1, soluble, alpha 3				OCBBF2	EK1	NM_001130685.1	NP_001124157.1	VALIDATED	Cs	0.998	0.998	455	2073	706	2070	455	1	455
RIKEN	AK096588	flj0022g09	FLJ	W01A109A07	pENTR-TOPO	17647		GUCY1A3	2982	BAG53331.1	Hs.24258	Guanylate cyclase 1, soluble, alpha 3				OCBBF2	EK1	NM_001130685.1	NP_001124157.1	VALIDATED	Cs	0.998	0.998	455	2073	706	2070	455	1	455
RIKEN	BC003177	IRAL009B12	MGC	W01A109A19	pENTR-TOPO	5833		CALCOCO1	57658	AAH03177.1	Hs.156667	Calcium binding and coiled-coil domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_020898.2	NP_065949.1	VALIDATED	OK	1.000	1.000	691	2076	1	2073	691	1	691
RIKEN	BC003177	IRAL009B12	MGC	W01A109A21	pENTR-TOPO	5833		CALCOCO1	57658	AAH03177.1	Hs.156667	Calcium binding and coiled-coil domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_020898.2	NP_065949.1	VALIDATED	OK	1.000	1.000	691	2076	1	2073	691	1	691
RIKEN	BC030537	IRAK064A04	MGC	W01A109B14	pENTR-TOPO	13134		LPIN1	23175	AAH30537.1	Hs.467740	Lipin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145693.1	NP_663731.1	REVIEWED	Cs	0.999	0.999	890	2673	1	2670	890	1	890
RIKEN	BC030537	IRAK064A04	MGC	W01A109B20	pENTR-TOPO	13134		LPIN1	23175	AAH30537.1	Hs.467740	Lipin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145693.1	NP_663731.1	REVIEWED	Cs	0.999	0.999	890	2673	1	2670	890	1	890
RIKEN	BC030537	IRAK064A04	MGC	W01A109B24	pENTR-TOPO	13134		LPIN1	23175	AAH30537.1	Hs.467740	Lipin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145693.1	NP_663731.1	REVIEWED	Cs	0.999	0.999	890	2673	1	2670	890	1	890
RIKEN	H013099I11	H013099I11	RIKEN	W01A109C15	pENTR-TOPO		23460	TLE4	7091		Hs.444213	Transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila)	-	-	testis	testis	DH10B	NM_007005.3	NP_008936.2	VALIDATED	Cg	0.911	1.000	773	2115	1	2112	773	1	773
RIKEN	BC005110	IRAL018M23	MGC	W01A109D02	pENTR-TOPO	20491		SNX14	57231	AAH05110.2	Hs.485871	Sorting nexin 14			Placenta, choriocarcinoma	NIH_MGC_21		NM_020468.3	NP_065201.1	REVIEWED	C	1.000	1.000	893	2682	1	2679	893	1	893
RIKEN	AK025223	flj0062m16	FLJ	W01A109E15	pENTR-TOPO	3581		C2CD2L	9854	-	Hs.26899	C2CD2-like				COL	EK1	NM_014807.3	NP_055622.3	VALIDATED	Cs	0.999	0.999	707	2124	1	2121	707	1	707
RIKEN	AK025223	flj0062m16	FLJ	W01A109E21	pENTR-TOPO	3581		C2CD2L	9854	-	Hs.26899	C2CD2-like				COL	EK1	NM_014807.3	NP_055622.3	VALIDATED	Cs	0.999	0.999	707	2124	1	2121	707	1	707
RIKEN	BC001666	IRAL003D13	MGC	W01A109F02	pENTR-TOPO	14547		PRPF6	24148	AAH01666.1	Hs.31334	PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae)			Colon, adenocarcinoma	NIH_MGC_15		NM_012469.3	NP_036601.2	REVIEWED	OK	1.000	1.000	941	2826	1	2823	941	1	941
RIKEN	BC001666	IRAL003D13	MGC	W01A109F12	pENTR-TOPO	14547		PRPF6	24148	AAH01666.1	Hs.31334	PRP6 pre-mRNA processing factor 6 homolog (S. cerevisiae)			Colon, adenocarcinoma	NIH_MGC_15		NM_012469.3	NP_036601.2	REVIEWED	OK	1.000	1.000	941	2826	1	2823	941	1	941
RIKEN	H04D045D22	H04D045D22	RIKEN	W01A109G05	pENTR-TOPO		9809						-	-	testis	testis	DH10B			
RIKEN	H04D045D22	H04D045D22	RIKEN	W01A109G11	pENTR-TOPO		9809						-	-	testis	testis	DH10B			
RIKEN	BC070053	IRAK168H13	MGC	W01A109H02	pENTR-TOPO	13863		PTPRN	5798	AAH70053.1	Hs.89655	Protein tyrosine phosphatase, receptor type, N			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002846.2	NP_002837.1	REVIEWED	Cgs	0.969	0.999	979	2853	1	2850	979	1	979
RIKEN	BC060845	IRAK133F14	MGC	W01A109I13	pENTR-TOPO	19702		L3MBTL3	84456	AAH60845.1	Hs.658051	L(3)mbt-like 3 (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_001007102.1	NP_001007103.1	VALIDATED	Cs	0.999	0.999	755	2268	1	2265	755	1	755
RIKEN	BC060845	IRAK133F14	MGC	W01A109I17	pENTR-TOPO	19702		L3MBTL3	84456	AAH60845.1	Hs.658051	L(3)mbt-like 3 (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_001007102.1	NP_001007103.1	VALIDATED	Cs	0.999	0.999	755	2268	1	2265	755	1	755
RIKEN	BC052804	IRAL047N01	MGC	W01A109J10	pENTR-TOPO	21853		EPHB4	2050	AAH52804.1	Hs.437008	EPH receptor B4			Ovary, teratocarcinoma	NIH_MGC_109		NM_004444.4	NP_004435.3	REVIEWED	Cs	0.999	0.999	987	2964	1	2961	987	1	987
RIKEN	BC015610	IRAL033M01	MGC	W01A109K01	pENTR-TOPO	19281		NR3C1	2908	AAH15610.1	Hs.122926	Nuclear receptor subfamily 3, group C, member 1 (glucocorticoid receptor)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001018074.1	NP_001018084.1	REVIEWED	OK	1.000	1.000	777	2334	1	2331	777	1	777
RIKEN	BC014566	IRAL002C06	MGC	W01A109M11	pENTR-TOPO	226		ADAM15	8751	AAH14566.1	Hs.312098	ADAM metallopeptidase domain 15			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_003815.3	NP_003806.3	REVIEWED	Cs	0.999	0.999	814	2445	1	2442	814	1	814
RIKEN	BC051338	IRAL047K12	MGC	W01A109O17	pENTR-TOPO	13075		EPAS1	2034	AAH51338.1	Hs.468410	Endothelial PAS domain protein 1			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001430.3	NP_001421.2	VALIDATED	OK	1.000	1.000	870	2613	1	2610	870	1	870
RIKEN	BC051338	IRAL047K12	MGC	W01A109O21	pENTR-TOPO	13075		EPAS1	2034	AAH51338.1	Hs.468410	Endothelial PAS domain protein 1			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001430.3	NP_001421.2	VALIDATED	OK	1.000	1.000	870	2613	1	2610	870	1	870
RIKEN	AK127272	flj0075k09	FLJ	W01A109P22	pENTR-TOPO	23461		KCNT1	57582	BAG54469.1	Hs.104950	Potassium channel, subfamily T, member 1				BRHIP3	EK1	NM_020822.1	NP_065873.1	PROVISIONAL	Cgs	0.956	0.997	1259	3636	1	3633	1256	1	1256
RIKEN	AK025495	flj0066m02	FLJ	W01A110A11	pENTR-TOPO	19659		SASH1	23328	-	Hs.193133	SAM and SH3 domain containing 1	HepG2	hepatoma		HEP	EK1	NM_015278.3	NP_056093.3	VALIDATED	Cs	0.999	0.999	1247	3744	1	3741	1247	1	1247
RIKEN	BC036704	IRAL017G20	MGC	W01A110B04	pENTR-TOPO	21491		TWIST1	7291	AAH36704.1	Hs.66744	Twist homolog 1 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_000474.3	NP_000465.1	REVIEWED	C	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC036704	IRAL017G20	MGC	W01A110B06	pENTR-TOPO	21491		TWIST1	7291	AAH36704.1	Hs.66744	Twist homolog 1 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_000474.3	NP_000465.1	REVIEWED	C	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC036704	IRAL017G20	MGC	W01A110B08	pENTR-TOPO	21491		TWIST1	7291	AAH36704.1	Hs.66744	Twist homolog 1 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_000474.3	NP_000465.1	REVIEWED	C	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC036704	IRAL017G20	MGC	W01A110B10	pENTR-TOPO	21491		TWIST1	7291	AAH36704.1	Hs.66744	Twist homolog 1 (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_000474.3	NP_000465.1	REVIEWED	C	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC040484	IRAK048C10	MGC	W01A110C09	pENTR-TOPO	3576		MADD	8567	AAH40484.1	Hs.82548	MAP-kinase activating death domain			Testis	NIH_MGC_97	DH10B	NM_001135943.1	NP_001129415.1	REVIEWED	Cs	0.998	0.998	1544	4635	1	4632	1544	1	1544
RIKEN	BC066881	IRAK172E22	MGC	W01A110D02	pENTR-TOPO	5999		GPR81	27198	AAH66881.1	Hs.711001	G protein-coupled receptor 81			PCR rescued clones	NIH_MGC_195	DH10B	NM_032554.3	NP_115943.1	VALIDATED	OK	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	H06D004A12	H06D004A12	RIKEN	W01A110E07	pENTR-TOPO		22203						-	-	brain	brain	DH10B			
RIKEN	BC052306	IRAL047N10	MGC	W01A110F06	pENTR-TOPO	14571		SLC2A4RG	56731	AAH52306.1	Hs.435126	SLC2A4 regulator			Prostate, carcinoma	NIH_MGC_40		NM_020062.3	NP_064446.2	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC052306	IRAL047N10	MGC	W01A110F08	pENTR-TOPO	14571		SLC2A4RG	56731	AAH52306.1	Hs.435126	SLC2A4 regulator			Prostate, carcinoma	NIH_MGC_40		NM_020062.3	NP_064446.2	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC052306	IRAL047N10	MGC	W01A110F14	pENTR-TOPO	14571		SLC2A4RG	56731	AAH52306.1	Hs.435126	SLC2A4 regulator			Prostate, carcinoma	NIH_MGC_40		NM_020062.3	NP_064446.2	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	BC052306	IRAL047N10	MGC	W01A110F20	pENTR-TOPO	14571		SLC2A4RG	56731	AAH52306.1	Hs.435126	SLC2A4 regulator			Prostate, carcinoma	NIH_MGC_40		NM_020062.3	NP_064446.2	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
RIKEN	H023078H10	H023078H10	RIKEN	W01A110G17	pENTR-TOPO		18576						-	-	hippocampus	hippocampus	DH10B			
RIKEN	AK056006	flj0002a06	FLJ	W01A110H10	pENTR-TOPO	11745		ZNF714	148206	BAB71072.1	Hs.466291	Zinc finger protein 714	NT2	teratocarcinoma		NT2NE2	EK1	NM_182515.2	NP_872321.2	VALIDATED	Ps	0.998	0.998	400	1204	2	1201	555	156	555
RIKEN	AK056006	flj0002a06	FLJ	W01A110H16	pENTR-TOPO	11745		ZNF714	148206	BAB71072.1	Hs.466291	Zinc finger protein 714	NT2	teratocarcinoma		NT2NE2	EK1	NM_182515.2	NP_872321.2	VALIDATED	Ps	0.998	0.998	400	1204	2	1201	555	156	555
RIKEN	AK056006	flj0002a06	FLJ	W01A110H22	pENTR-TOPO	11745		ZNF714	148206	BAB71072.1	Hs.466291	Zinc finger protein 714	NT2	teratocarcinoma		NT2NE2	EK1	NM_182515.2	NP_872321.2	VALIDATED	Ps	0.998	0.998	400	1204	2	1201	555	156	555
RIKEN	BC035047	IRAK073O16	MGC	W01A110J02	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC035047	IRAK073O16	MGC	W01A110J04	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC035047	IRAK073O16	MGC	W01A110J06	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC035047	IRAK073O16	MGC	W01A110J10	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC035047	IRAK073O16	MGC	W01A110J16	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC035047	IRAK073O16	MGC	W01A110J20	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC035047	IRAK073O16	MGC	W01A110J22	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC035047	IRAK073O16	MGC	W01A110J24	pENTR-TOPO	2708		ADRA2A	150	AAH35047.1	Hs.249159	Adrenergic, alpha-2A-, receptor			Testis	NIH_MGC_97	DH10B	NM_000681.3	NP_000672.3	REVIEWED	P	1.000	1.000	450	1353	1	1350	465	16	465
RIKEN	BC065912	IRAK135C11	MGC	W01A110K07	pENTR-TOPO	2227		ABL2	27	AAH65912.1	Hs.159472	V-abl Abelson murine leukemia viral oncogene homolog 2 (arg, Abelson-related gene)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001100108.1	NP_001093578.1	REVIEWED	C	1.000	1.000	1167	3504	1	3501	1167	1	1167
RIKEN	BC050321	IRAK090N16	MGC	W01A110K23	pENTR-TOPO	17419		TBC1D1	23216	AAH50321.3	Hs.176503	TBC1 (tre-2/USP6, BUB2, cdc16) domain family, member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015173.2	NP_055988.2	VALIDATED	Cs	0.999	0.999	1168	3507	1	3504	1168	1	1168
RIKEN	BC038447	IRAK069J04	MGC	W01A110M21	pENTR-TOPO	2054		COPA	1314	AAH38447.1	Hs.685025	Coatomer protein complex, subunit alpha			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001098398.1	NP_001091868.1	REVIEWED	C	1.000	1.000	1233	3702	1	3699	1233	1	1233
RIKEN	H04D010I24	H04D010I24	RIKEN	W01A110O19	pENTR-TOPO		11474						-	-	testis	testis	DH10B			
RIKEN	BC016145	IRAK015B13	MGC	W01A111A05	pENTR-TOPO	9749		DLX4	1748	AAH16145.1	Hs.591167	Distal-less homeobox 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138281.2	NP_612138.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC016145	IRAK015B13	MGC	W01A111A07	pENTR-TOPO	9749		DLX4	1748	AAH16145.1	Hs.591167	Distal-less homeobox 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138281.2	NP_612138.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC016145	IRAK015B13	MGC	W01A111A09	pENTR-TOPO	9749		DLX4	1748	AAH16145.1	Hs.591167	Distal-less homeobox 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138281.2	NP_612138.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC016145	IRAK015B13	MGC	W01A111A11	pENTR-TOPO	9749		DLX4	1748	AAH16145.1	Hs.591167	Distal-less homeobox 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138281.2	NP_612138.1	REVIEWED	OK	1.000	1.000	240	723	1	720	240	1	240
RIKEN	BC004106	IRAL014P14	MGC	W01A111A13	pENTR-TOPO	7404		MED6	10001	AAH04106.1	Hs.497353	Mediator complex subunit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_005466.2	NP_005457.2	VALIDATED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC004106	IRAL014P14	MGC	W01A111A15	pENTR-TOPO	7404		MED6	10001	AAH04106.1	Hs.497353	Mediator complex subunit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_005466.2	NP_005457.2	VALIDATED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC004106	IRAL014P14	MGC	W01A111A19	pENTR-TOPO	7404		MED6	10001	AAH04106.1	Hs.497353	Mediator complex subunit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_005466.2	NP_005457.2	VALIDATED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC004106	IRAL014P14	MGC	W01A111A21	pENTR-TOPO	7404		MED6	10001	AAH04106.1	Hs.497353	Mediator complex subunit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_005466.2	NP_005457.2	VALIDATED	OK	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC013971	IRAL017C22	MGC	W01A111B02	pENTR-TOPO	22146		HOXA10	3206	AAH13971.1	Hs.110637	Homeobox A10			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018951.3	NP_061824.3	REVIEWED	P	1.000	1.000	393	1182	1	1179	410	18	410
RIKEN	BC013971	IRAL017C22	MGC	W01A111B04	pENTR-TOPO	22146		HOXA10	3206	AAH13971.1	Hs.110637	Homeobox A10			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018951.3	NP_061824.3	REVIEWED	P	1.000	1.000	393	1182	1	1179	410	18	410
RIKEN	BC013971	IRAL017C22	MGC	W01A111B08	pENTR-TOPO	22146		HOXA10	3206	AAH13971.1	Hs.110637	Homeobox A10			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_018951.3	NP_061824.3	REVIEWED	P	1.000	1.000	393	1182	1	1179	410	18	410
RIKEN	AK027363	flj0030m04	FLJ	W01A111B14	pENTR-TOPO	14090		ZNF514	84874	BAB55064.1	Hs.655109	Zinc finger protein 514				HEMBB1	EK1	NM_032788.1	NP_116177.1	PROVISIONAL	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	AK027363	flj0030m04	FLJ	W01A111B16	pENTR-TOPO	14090		ZNF514	84874	BAB55064.1	Hs.655109	Zinc finger protein 514				HEMBB1	EK1	NM_032788.1	NP_116177.1	PROVISIONAL	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC032317	IRAK064O01	MGC	W01A111C01	pENTR-TOPO	5375		SPIC	121599	AAH32317.1	Hs.577097	Spi-C transcription factor (Spi-1/PU.1 related)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152323.1	NP_689536.1	PROVISIONAL	C	1.000	1.000	248	747	1	744	248	1	248
RIKEN	BC050425	IRAK098P16	MGC	W01A111D02	pENTR-TOPO	20643		ZNF322A	79692	AAH50425.2	Hs.530271	Zinc finger protein 322A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024639.3	NP_078915.2	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	BC050425	IRAK098P16	MGC	W01A111D04	pENTR-TOPO	20643		ZNF322A	79692	AAH50425.2	Hs.530271	Zinc finger protein 322A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024639.3	NP_078915.2	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	BC050425	IRAK098P16	MGC	W01A111D10	pENTR-TOPO	20643		ZNF322A	79692	AAH50425.2	Hs.530271	Zinc finger protein 322A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024639.3	NP_078915.2	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	BC050425	IRAK098P16	MGC	W01A111D12	pENTR-TOPO	20643		ZNF322A	79692	AAH50425.2	Hs.530271	Zinc finger protein 322A			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_024639.3	NP_078915.2	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
RIKEN	BC022564	IRAK032F19	MGC	W01A111D16	pENTR-TOPO	3223		IKZF5	64376	AAH22564	Hs.501289	IKAROS family zinc finger 5 (Pegasus)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_022466.5	NP_071911.3	PROVISIONAL	Cfs	0.995	0.995	419	1263	1	1256	419	1	419
RIKEN	BC022564	IRAK032F19	MGC	W01A111D22	pENTR-TOPO	3223		IKZF5	64376	AAH22564	Hs.501289	IKAROS family zinc finger 5 (Pegasus)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_022466.5	NP_071911.3	PROVISIONAL	Cfs	0.995	0.995	419	1263	1	1256	419	1	419
RIKEN	BC007921	IRAL020P03	MGC	W01A111E01	pENTR-TOPO	11936		SPIB	6689	AAH07921.1	Hs.437905	Spi-B transcription factor (Spi-1/PU.1 related)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003121.3	NP_003112.2	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC007921	IRAL020P03	MGC	W01A111E03	pENTR-TOPO	11936		SPIB	6689	AAH07921.1	Hs.437905	Spi-B transcription factor (Spi-1/PU.1 related)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003121.3	NP_003112.2	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC007921	IRAL020P03	MGC	W01A111E07	pENTR-TOPO	11936		SPIB	6689	AAH07921.1	Hs.437905	Spi-B transcription factor (Spi-1/PU.1 related)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003121.3	NP_003112.2	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC007921	IRAL020P03	MGC	W01A111E11	pENTR-TOPO	11936		SPIB	6689	AAH07921.1	Hs.437905	Spi-B transcription factor (Spi-1/PU.1 related)			Primary B-Cells from Tonsils	NIH_MGC_48		NM_003121.3	NP_003112.2	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
RIKEN	BC015509	IRAK022G09	MGC	W01A111E15	pENTR-TOPO	18880		MSX2	4488	AAH15509.1	Hs.89404	Msh homeobox 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002449.4	NP_002440.2	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	BC015509	IRAK022G09	MGC	W01A111E17	pENTR-TOPO	18880		MSX2	4488	AAH15509.1	Hs.89404	Msh homeobox 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002449.4	NP_002440.2	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	BC015509	IRAK022G09	MGC	W01A111E19	pENTR-TOPO	18880		MSX2	4488	AAH15509.1	Hs.89404	Msh homeobox 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002449.4	NP_002440.2	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	BC015509	IRAK022G09	MGC	W01A111E21	pENTR-TOPO	18880		MSX2	4488	AAH15509.1	Hs.89404	Msh homeobox 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002449.4	NP_002440.2	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
RIKEN	BC019350	IRAL018H13	MGC	W01A111G01	pENTR-TOPO	21287		GATAD1	57798	AAH19350.1	Hs.21145	GATA zinc finger domain containing 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_021167.3	NP_066990.3	VALIDATED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC019350	IRAL018H13	MGC	W01A111G07	pENTR-TOPO	21287		GATAD1	57798	AAH19350.1	Hs.21145	GATA zinc finger domain containing 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_021167.3	NP_066990.3	VALIDATED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC019350	IRAL018H13	MGC	W01A111G09	pENTR-TOPO	21287		GATAD1	57798	AAH19350.1	Hs.21145	GATA zinc finger domain containing 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_021167.3	NP_066990.3	VALIDATED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC019350	IRAL018H13	MGC	W01A111G11	pENTR-TOPO	21287		GATAD1	57798	AAH19350.1	Hs.21145	GATA zinc finger domain containing 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_021167.3	NP_066990.3	VALIDATED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	BC024238	IRAK046B19	MGC	W01A111G15	pENTR-TOPO	13801		MKI67IP	84365	AAH24238.1	Hs.367842	MKI67 (FHA domain) interacting nucleolar phosphoprotein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032390.4	NP_115766.3	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
RIKEN	BC024238	IRAK046B19	MGC	W01A111G17	pENTR-TOPO	13801		MKI67IP	84365	AAH24238.1	Hs.367842	MKI67 (FHA domain) interacting nucleolar phosphoprotein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032390.4	NP_115766.3	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
RIKEN	BC024238	IRAK046B19	MGC	W01A111G19	pENTR-TOPO	13801		MKI67IP	84365	AAH24238.1	Hs.367842	MKI67 (FHA domain) interacting nucleolar phosphoprotein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032390.4	NP_115766.3	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
RIKEN	BC024238	IRAK046B19	MGC	W01A111G21	pENTR-TOPO	13801		MKI67IP	84365	AAH24238.1	Hs.367842	MKI67 (FHA domain) interacting nucleolar phosphoprotein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032390.4	NP_115766.3	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
RIKEN	BC024238	IRAK046B19	MGC	W01A111G23	pENTR-TOPO	13801		MKI67IP	84365	AAH24238.1	Hs.367842	MKI67 (FHA domain) interacting nucleolar phosphoprotein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032390.4	NP_115766.3	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
RIKEN	BC007695	IRAL015K20	MGC	W01A111H10	pENTR-TOPO	6431		KLF5	688	AAH07695.1	Hs.508234	Kruppel-like factor 5 (intestinal)			Placenta, choriocarcinoma	NIH_MGC_21		NM_001730.3	NP_001721.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
RIKEN	BC032501	IRAK069A23	MGC	W01A111H18	pENTR-TOPO	24304		NR5A1	2516	AAH32501.1	Hs.495108	Nuclear receptor subfamily 5, group A, member 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004959.4	NP_004950.2	REVIEWED	OK	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	BC032501	IRAK069A23	MGC	W01A111H20	pENTR-TOPO	24304		NR5A1	2516	AAH32501.1	Hs.495108	Nuclear receptor subfamily 5, group A, member 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004959.4	NP_004950.2	REVIEWED	OK	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	BC032501	IRAK069A23	MGC	W01A111H24	pENTR-TOPO	24304		NR5A1	2516	AAH32501.1	Hs.495108	Nuclear receptor subfamily 5, group A, member 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004959.4	NP_004950.2	REVIEWED	OK	1.000	1.000	461	1386	1	1383	461	1	461
RIKEN	BC011868	IRAL028O21	MGC	W01A111I03	pENTR-TOPO	11868		SNAPC2	6618	AAH11868.1	Hs.631860	Small nuclear RNA activating complex, polypeptide 2, 45kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_003083.2	NP_003074.1	PROVISIONAL	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC011868	IRAL028O21	MGC	W01A111I11	pENTR-TOPO	11868		SNAPC2	6618	AAH11868.1	Hs.631860	Small nuclear RNA activating complex, polypeptide 2, 45kDa			Skin, melanotic melanoma.	NIH_MGC_20		NM_003083.2	NP_003074.1	PROVISIONAL	OK	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC016024	IRAK015C16	MGC	W01A111I15	pENTR-TOPO	11874		FOXA3	3171	AAH16024.1	Hs.36137	Forkhead box A3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004497.2	NP_004488.2	REVIEWED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC016024	IRAK015C16	MGC	W01A111I19	pENTR-TOPO	11874		FOXA3	3171	AAH16024.1	Hs.36137	Forkhead box A3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004497.2	NP_004488.2	REVIEWED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC022853	IRAL032M08	MGC	W01A111J06	pENTR-TOPO	16732		UBA3	9039	AAH22853.1	Hs.154320	Ubiquitin-like modifier activating enzyme 3			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_003968.3	NP_003959.3	REVIEWED	Cs	0.998	0.998	463	1392	1	1389	463	1	463
RIKEN	BC022853	IRAL032M08	MGC	W01A111J08	pENTR-TOPO	16732		UBA3	9039	AAH22853.1	Hs.154320	Ubiquitin-like modifier activating enzyme 3			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_003968.3	NP_003959.3	REVIEWED	Cs	0.998	0.998	463	1392	1	1389	463	1	463
RIKEN	BC022853	IRAL032M08	MGC	W01A111J10	pENTR-TOPO	16732		UBA3	9039	AAH22853.1	Hs.154320	Ubiquitin-like modifier activating enzyme 3			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_003968.3	NP_003959.3	REVIEWED	Cs	0.998	0.998	463	1392	1	1389	463	1	463
RIKEN	BC012116	IRAL029C09	MGC	W01A111K03	pENTR-TOPO	9151		ZNF821	55565	AAH12116.1	Hs.643531	Zinc finger protein 821			Uterus, leiomyosarcoma	NIH_MGC_46		NM_017530.1	NP_060000.1	PROVISIONAL	C	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC012116	IRAL029C09	MGC	W01A111K07	pENTR-TOPO	9151		ZNF821	55565	AAH12116.1	Hs.643531	Zinc finger protein 821			Uterus, leiomyosarcoma	NIH_MGC_46		NM_017530.1	NP_060000.1	PROVISIONAL	C	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC012116	IRAL029C09	MGC	W01A111K09	pENTR-TOPO	9151		ZNF821	55565	AAH12116.1	Hs.643531	Zinc finger protein 821			Uterus, leiomyosarcoma	NIH_MGC_46		NM_017530.1	NP_060000.1	PROVISIONAL	C	1.000	1.000	370	1113	1	1110	370	1	370
RIKEN	BC040847	IRAK088C14	MGC	W01A111K13	pENTR-TOPO	23560		DMRT1	1761	AAH40847.1	Hs.98586	Doublesex and mab-3 related transcription factor 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021951.2	NP_068770.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC040847	IRAK088C14	MGC	W01A111K15	pENTR-TOPO	23560		DMRT1	1761	AAH40847.1	Hs.98586	Doublesex and mab-3 related transcription factor 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021951.2	NP_068770.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC040847	IRAK088C14	MGC	W01A111K17	pENTR-TOPO	23560		DMRT1	1761	AAH40847.1	Hs.98586	Doublesex and mab-3 related transcription factor 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021951.2	NP_068770.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
RIKEN	BC011564	IRAL029K03	MGC	W01A111L04	pENTR-TOPO	25399		NR0B1	190	AAH11564.1	Hs.268490	Nuclear receptor subfamily 0, group B, member 1			Lung, large cell carcinoma	NIH_MGC_18		NM_000475.4	NP_000466.2	REVIEWED	C	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC011564	IRAL029K03	MGC	W01A111L06	pENTR-TOPO	25399		NR0B1	190	AAH11564.1	Hs.268490	Nuclear receptor subfamily 0, group B, member 1			Lung, large cell carcinoma	NIH_MGC_18		NM_000475.4	NP_000466.2	REVIEWED	C	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC011564	IRAL029K03	MGC	W01A111L12	pENTR-TOPO	25399		NR0B1	190	AAH11564.1	Hs.268490	Nuclear receptor subfamily 0, group B, member 1			Lung, large cell carcinoma	NIH_MGC_18		NM_000475.4	NP_000466.2	REVIEWED	C	1.000	1.000	470	1413	1	1410	470	1	470
RIKEN	BC062549	IRAL050N02	MGC	W01A111M15	pENTR-TOPO	16955		FOXL2	668	AAH62549.1	Hs.289292	Forkhead box L2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_023067.2	NP_075555.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC062549	IRAL050N02	MGC	W01A111M17	pENTR-TOPO	16955		FOXL2	668	AAH62549.1	Hs.289292	Forkhead box L2			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_023067.2	NP_075555.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
RIKEN	BC032652	IRAK069H21	MGC	W01A111N10	pENTR-TOPO	11737		MPND	84954	AAH32652.1	Hs.321689	MPN domain containing			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032868.4	NP_116257.2	VALIDATED	C	1.000	1.000	471	1416	1	1413	471	1	471
RIKEN	BC007294	IRAL022M19	MGC	W01A111N20	pENTR-TOPO	208		HLX	3142	AAH07294.1	Hs.74870	H2.0-like homeobox			Eye, retinoblastoma	NIH_MGC_16		NM_021958.3	NP_068777.1	VALIDATED	C	1.000	1.000	488	1467	1	1464	488	1	488
RIKEN	BC030219	IRAK049H10	MGC	W01A111O07	pENTR-TOPO	7174		RAD51L1	5890	AAH30219.1	Hs.172587	RAD51-like 1 (S. cerevisiae)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_133509.2	NP_598193.2	REVIEWED	C	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC005360	IRAL016M09	MGC	W01A111O17	pENTR-TOPO	1902		ZNF670	93474	AAH05360.1	Hs.710279	Zinc finger protein 670			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_033213.2	NP_149990.1	VALIDATED	C	1.000	1.000	389	1170	1	1167	389	1	389
RIKEN	BC005360	IRAL016M09	MGC	W01A111O23	pENTR-TOPO	1902		ZNF670	93474	AAH05360.1	Hs.710279	Zinc finger protein 670			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_033213.2	NP_149990.1	VALIDATED	C	1.000	1.000	389	1170	1	1167	389	1	389
RIKEN	H023050B13	H023050B13	RIKEN	W01A111P22	pENTR-TOPO		5167	CLSTN3	9746		Hs.535378	Calsyntenin 3	-	-	hippocampus	hippocampus	DH10B	NM_014718.3	NP_055533.2	VALIDATED	Cs	0.998	0.998	956	2871	1	2868	956	1	956
RIKEN	BC009921	IRAL007M04	MGC	W01A112A03	pENTR-TOPO	12352		ZNF350	59348	AAH09921.1	Hs.407694	Zinc finger protein 350			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021632.3	NP_067645.3	VALIDATED	C	1.000	1.000	532	1599	1	1596	532	1	532
RIKEN	BC009921	IRAL007M04	MGC	W01A112A07	pENTR-TOPO	12352		ZNF350	59348	AAH09921.1	Hs.407694	Zinc finger protein 350			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021632.3	NP_067645.3	VALIDATED	C	1.000	1.000	532	1599	1	1596	532	1	532
RIKEN	BC009921	IRAL007M04	MGC	W01A112A11	pENTR-TOPO	12352		ZNF350	59348	AAH09921.1	Hs.407694	Zinc finger protein 350			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_021632.3	NP_067645.3	VALIDATED	C	1.000	1.000	532	1599	1	1596	532	1	532
RIKEN	BC020612	IRAL037D14	MGC	W01A112B10	pENTR-TOPO	11573		HAMP	57817	AAH20612.1	Hs.8821	Hepcidin antimicrobial peptide			Liver	NIH_MGC_76	DH10B	NM_021175.2	NP_066998.1	REVIEWED	C	1.000	1.000	84	255	1	252	84	1	84
RIKEN	BC022369	IRAL037J15	MGC	W01A112B14	pENTR-TOPO	11526		NDUFA3	4696	AAH22369.1	Hs.198269	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_004542.3	NP_004533.1	VALIDATED	C	1.000	1.000	84	255	1	252	84	1	84
RIKEN	BC043354	IRAK089K20	MGC	W01A112C13	pENTR-TOPO	12609		ZNF77	58492	AAH43354.2	Hs.38004	Zinc finger protein 77			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021217.2	NP_067040.1	VALIDATED	C	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC043354	IRAK089K20	MGC	W01A112C21	pENTR-TOPO	12609		ZNF77	58492	AAH43354.2	Hs.38004	Zinc finger protein 77			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021217.2	NP_067040.1	VALIDATED	C	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC043354	IRAK089K20	MGC	W01A112C23	pENTR-TOPO	12609		ZNF77	58492	AAH43354.2	Hs.38004	Zinc finger protein 77			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021217.2	NP_067040.1	VALIDATED	C	1.000	1.000	545	1638	1	1635	545	1	545
RIKEN	BC014672	IRAL008J01	MGC	W01A112D02	pENTR-TOPO	14715		MANBAL	63905	AAH14672.1	Hs.6126	Mannosidase, beta A, lysosomal-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001003897.1	NP_001003897.1	VALIDATED	C	1.000	1.000	85	258	1	255	85	1	85
RIKEN	BC014672	IRAL008J01	MGC	W01A112D12	pENTR-TOPO	14715		MANBAL	63905	AAH14672.1	Hs.6126	Mannosidase, beta A, lysosomal-like			Lung, small cell carcinoma	NIH_MGC_7		NM_001003897.1	NP_001003897.1	VALIDATED	C	1.000	1.000	85	258	1	255	85	1	85
RIKEN	BC004481	IRAL014A21	MGC	W01A112D14	pENTR-TOPO	4085		SCGB1A1	7356	AAH04481.1	Hs.523732	Secretoglobin, family 1A, member 1 (uteroglobin)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_003357.3	NP_003348.1	PROVISIONAL	C	1.000	1.000	91	276	1	273	91	1	91
RIKEN	BC004481	IRAL014A21	MGC	W01A112D16	pENTR-TOPO	4085		SCGB1A1	7356	AAH04481.1	Hs.523732	Secretoglobin, family 1A, member 1 (uteroglobin)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_003357.3	NP_003348.1	PROVISIONAL	C	1.000	1.000	91	276	1	273	91	1	91
RIKEN	BC004481	IRAL014A21	MGC	W01A112D20	pENTR-TOPO	4085		SCGB1A1	7356	AAH04481.1	Hs.523732	Secretoglobin, family 1A, member 1 (uteroglobin)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_003357.3	NP_003348.1	PROVISIONAL	C	1.000	1.000	91	276	1	273	91	1	91
RIKEN	BC004481	IRAL014A21	MGC	W01A112D22	pENTR-TOPO	4085		SCGB1A1	7356	AAH04481.1	Hs.523732	Secretoglobin, family 1A, member 1 (uteroglobin)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_003357.3	NP_003348.1	PROVISIONAL	C	1.000	1.000	91	276	1	273	91	1	91
RIKEN	BC004481	IRAL014A21	MGC	W01A112D24	pENTR-TOPO	4085		SCGB1A1	7356	AAH04481.1	Hs.523732	Secretoglobin, family 1A, member 1 (uteroglobin)			Pancreas, adenocarcinoma	NIH_MGC_39		NM_003357.3	NP_003348.1	PROVISIONAL	C	1.000	1.000	91	276	1	273	91	1	91
RIKEN	BC002810	IRAL012D08	MGC	W01A112E11	pENTR-TOPO	8646		ZNF205	7755	AAH02810.1	Hs.592088	Zinc finger protein 205			Placenta, choriocarcinoma	NIH_MGC_21		NM_003456.2	NP_003447.2	VALIDATED	Cs	0.998	0.998	554	1665	1	1662	554	1	554
RIKEN	BC041792	IRAK048M09	MGC	W01A112E19	pENTR-TOPO	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Testis	NIH_MGC_97	DH10B	NM_006465.2	NP_006456.1	REVIEWED	Cg	0.996	1.000	562	1689	1	1686	560	1	560
RIKEN	BC041792	IRAK048M09	MGC	W01A112E23	pENTR-TOPO	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Testis	NIH_MGC_97	DH10B	NM_006465.2	NP_006456.1	REVIEWED	Cg	0.996	1.000	562	1689	1	1686	560	1	560
RIKEN	BC027952	IRAK049J02	MGC	W01A112F02	pENTR-TOPO	8941		CCL22	6367	AAH27952.1	Hs.534347	Chemokine (C-C motif) ligand 22			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002990.3	NP_002981.2	REVIEWED	Cs	0.989	0.989	93	282	1	279	93	1	93
RIKEN	BC027952	IRAK049J02	MGC	W01A112F06	pENTR-TOPO	8941		CCL22	6367	AAH27952.1	Hs.534347	Chemokine (C-C motif) ligand 22			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002990.3	NP_002981.2	REVIEWED	Cs	0.989	0.989	93	282	1	279	93	1	93
RIKEN	BC027952	IRAK049J02	MGC	W01A112F08	pENTR-TOPO	8941		CCL22	6367	AAH27952.1	Hs.534347	Chemokine (C-C motif) ligand 22			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002990.3	NP_002981.2	REVIEWED	Cs	0.989	0.989	93	282	1	279	93	1	93
RIKEN	BC005292	IRAL016J19	MGC	W01A112F18	pENTR-TOPO	18038		CXCL11	6373	AAH05292.1	Hs.632592	Chemokine (C-X-C motif) ligand 11			Liver	NIH_MGC_76	DH10B	NM_005409.3	NP_005400.1	REVIEWED	C	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC005292	IRAL016J19	MGC	W01A112F22	pENTR-TOPO	18038		CXCL11	6373	AAH05292.1	Hs.632592	Chemokine (C-X-C motif) ligand 11			Liver	NIH_MGC_76	DH10B	NM_005409.3	NP_005400.1	REVIEWED	C	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC003370	IRAK003G17	MGC	W01A112H02	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC003370	IRAK003G17	MGC	W01A112H04	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC003370	IRAK003G17	MGC	W01A112H06	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC003370	IRAK003G17	MGC	W01A112H12	pENTR-TOPO	15431		CSTB	1476	AAH03370.1	Hs.695	Cystatin B (stefin B)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_000100.2	NP_000091.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
RIKEN	BC001466	IRAL004J15	MGC	W01A112H16	pENTR-TOPO	15556		RBX1	9978	AAH01466.1	Hs.474949	Ring-box 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014248.2	NP_055063.1	REVIEWED	C	1.000	1.000	108	327	1	324	108	1	108
RIKEN	BC001466	IRAL004J15	MGC	W01A112H20	pENTR-TOPO	15556		RBX1	9978	AAH01466.1	Hs.474949	Ring-box 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014248.2	NP_055063.1	REVIEWED	C	1.000	1.000	108	327	1	324	108	1	108
RIKEN	BC012448	IRAK021P12	MGC	W01A112I01	pENTR-TOPO	7822		TRIP4	9325	AAH12448.1	Hs.500340	Thyroid hormone receptor interactor 4			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_016213.3	NP_057297.2	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
RIKEN	BC012448	IRAK021P12	MGC	W01A112I05	pENTR-TOPO	7822		TRIP4	9325	AAH12448.1	Hs.500340	Thyroid hormone receptor interactor 4			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_016213.3	NP_057297.2	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
RIKEN	BC053847	IRAK115O17	MGC	W01A112I21	pENTR-TOPO	14918		CENPB	1059	AAH53847.1	Hs.713340	Centromere protein B, 80kDa			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001810.5	NP_001801.1	REVIEWED	OK	1.000	1.000	599	1800	1	1797	599	1	599
RIKEN	BC031661	IRAK051D18	MGC	W01A112J16	pENTR-TOPO	21195		LOC389458	389458	AAH31661					Brain, adult medulla	NIH_MGC_119	DH10B	NM_203393.1	NP_976327.1	VALIDATED	Cs	0.982	0.982	111	336	1	333	111	1	111
RIKEN	BC031661	IRAK051D18	MGC	W01A112J20	pENTR-TOPO	21195		LOC389458	389458	AAH31661					Brain, adult medulla	NIH_MGC_119	DH10B	NM_203393.1	NP_976327.1	VALIDATED	Cs	0.982	0.982	111	336	1	333	111	1	111
RIKEN	BC063025	IRAK140C06	MGC	W01A112K23	pENTR-TOPO	4136		COX8A	1351	AAH63025.1	Hs.433901	Cytochrome c oxidase subunit 8A (ubiquitous)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004074.2	NP_004065.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
RIKEN	BC003513	IRAL013M21	MGC	W01A112L02	pENTR-TOPO	19191		CXCL14	9547	AAH03513.1	Hs.483444	Chemokine (C-X-C motif) ligand 14			Pancreas, adenocarcinoma	NIH_MGC_39		NM_004887.4	NP_004878.2	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
RIKEN	BC003418	IRAK003P24	MGC	W01A112L18	pENTR-TOPO	8183		ARPP19	10776	AAH03418.1	Hs.512908	Cyclic AMP phosphoprotein, 19 kD			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006628.4	NP_006619.1	VALIDATED	OK	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC003418	IRAK003P24	MGC	W01A112L20	pENTR-TOPO	8183		ARPP19	10776	AAH03418.1	Hs.512908	Cyclic AMP phosphoprotein, 19 kD			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006628.4	NP_006619.1	VALIDATED	OK	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC003418	IRAK003P24	MGC	W01A112L22	pENTR-TOPO	8183		ARPP19	10776	AAH03418.1	Hs.512908	Cyclic AMP phosphoprotein, 19 kD			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006628.4	NP_006619.1	VALIDATED	OK	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC003418	IRAK003P24	MGC	W01A112L24	pENTR-TOPO	8183		ARPP19	10776	AAH03418.1	Hs.512908	Cyclic AMP phosphoprotein, 19 kD			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006628.4	NP_006619.1	VALIDATED	OK	1.000	1.000	112	339	1	336	112	1	112
RIKEN	BC020774	IRAL035A19	MGC	W01A112M07	pENTR-TOPO	7064		GNG2	54331	AAH20774.1	Hs.713545	Guanine nucleotide binding protein (G protein), gamma 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_053064.3	NP_444292.1	VALIDATED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	BC020774	IRAL035A19	MGC	W01A112M09	pENTR-TOPO	7064		GNG2	54331	AAH20774.1	Hs.713545	Guanine nucleotide binding protein (G protein), gamma 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_053064.3	NP_444292.1	VALIDATED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	BC020774	IRAL035A19	MGC	W01A112M11	pENTR-TOPO	7064		GNG2	54331	AAH20774.1	Hs.713545	Guanine nucleotide binding protein (G protein), gamma 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_053064.3	NP_444292.1	VALIDATED	C	1.000	1.000	71	216	1	213	71	1	71
RIKEN	BC005940	IRAL021O09	MGC	W01A112M13	pENTR-TOPO	1626		GNG12	55970	AAH05940.1	Hs.431101	Guanine nucleotide binding protein (G protein), gamma 12			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_018841.4	NP_061329.3	VALIDATED	Cs	0.986	0.986	72	219	1	216	72	1	72
RIKEN	BC005940	IRAL021O09	MGC	W01A112M17	pENTR-TOPO	1626		GNG12	55970	AAH05940.1	Hs.431101	Guanine nucleotide binding protein (G protein), gamma 12			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_018841.4	NP_061329.3	VALIDATED	Cs	0.986	0.986	72	219	1	216	72	1	72
RIKEN	BC005940	IRAL021O09	MGC	W01A112M19	pENTR-TOPO	1626		GNG12	55970	AAH05940.1	Hs.431101	Guanine nucleotide binding protein (G protein), gamma 12			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_018841.4	NP_061329.3	VALIDATED	Cs	0.986	0.986	72	219	1	216	72	1	72
RIKEN	BC005940	IRAL021O09	MGC	W01A112M21	pENTR-TOPO	1626		GNG12	55970	AAH05940.1	Hs.431101	Guanine nucleotide binding protein (G protein), gamma 12			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_018841.4	NP_061329.3	VALIDATED	Cs	0.986	0.986	72	219	1	216	72	1	72
RIKEN	BC030270	IRAK062P01	MGC	W01A112N04	pENTR-TOPO	10400		C17orf61	254863	AAH30270.1	Hs.534591	Chromosome 17 open reading frame 61			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_152766.2	NP_689979.1	PREDICTED	OK	1.000	1.000	113	342	1	339	113	1	113
RIKEN	BC030270	IRAK062P01	MGC	W01A112N12	pENTR-TOPO	10400		C17orf61	254863	AAH30270.1	Hs.534591	Chromosome 17 open reading frame 61			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_152766.2	NP_689979.1	PREDICTED	OK	1.000	1.000	113	342	1	339	113	1	113
RIKEN	BC007403	IRAL003H23	MGC	W01A112N14	pENTR-TOPO	7543		DAD1	1603	AAH07403.1	Hs.82890	Defender against cell death 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001344.2	NP_001335.1	REVIEWED	OK	1.000	1.000	113	342	1	339	113	1	113
RIKEN	BC007403	IRAL003H23	MGC	W01A112N16	pENTR-TOPO	7543		DAD1	1603	AAH07403.1	Hs.82890	Defender against cell death 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001344.2	NP_001335.1	REVIEWED	OK	1.000	1.000	113	342	1	339	113	1	113
RIKEN	BC007403	IRAL003H23	MGC	W01A112N20	pENTR-TOPO	7543		DAD1	1603	AAH07403.1	Hs.82890	Defender against cell death 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_001344.2	NP_001335.1	REVIEWED	OK	1.000	1.000	113	342	1	339	113	1	113
RIKEN	BC022432	IRAL035J14	MGC	W01A112O03	pENTR-TOPO	14253		SNRPG	6637	AAH22432.1	Hs.654528	Small nuclear ribonucleoprotein polypeptide G			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003096.2	NP_003087.1	PROVISIONAL	C	1.000	1.000	76	231	1	228	76	1	76
RIKEN	BC022432	IRAL035J14	MGC	W01A112O05	pENTR-TOPO	14253		SNRPG	6637	AAH22432.1	Hs.654528	Small nuclear ribonucleoprotein polypeptide G			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003096.2	NP_003087.1	PROVISIONAL	C	1.000	1.000	76	231	1	228	76	1	76
RIKEN	BC061644	IRAK139L15	MGC	W01A112O15	pENTR-TOPO	11526		NDUFA3	4696	AAH61644.1	Hs.198269	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004542.3	NP_004533.1	VALIDATED	OK	1.000	1.000	84	255	1	252	84	1	84
RIKEN	BC061644	IRAK139L15	MGC	W01A112O21	pENTR-TOPO	11526		NDUFA3	4696	AAH61644.1	Hs.198269	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 3, 9kDa			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004542.3	NP_004533.1	VALIDATED	OK	1.000	1.000	84	255	1	252	84	1	84
RIKEN	BC062370	IRAL050P23	MGC	W01A112P08	pENTR-TOPO	21054		BRI3	25798	AAH62370.1	Hs.567438	Brain protein I3			Ovary, teratocarcinoma	NIH_MGC_109		NM_015379.4	NP_056194.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC062370	IRAL050P23	MGC	W01A112P10	pENTR-TOPO	21054		BRI3	25798	AAH62370.1	Hs.567438	Brain protein I3			Ovary, teratocarcinoma	NIH_MGC_109		NM_015379.4	NP_056194.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC062370	IRAL050P23	MGC	W01A112P12	pENTR-TOPO	21054		BRI3	25798	AAH62370.1	Hs.567438	Brain protein I3			Ovary, teratocarcinoma	NIH_MGC_109		NM_015379.4	NP_056194.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC060324	IRAK134D22	MGC	W01A112P18	pENTR-TOPO	395		HIST2H2AC	8338	AAH60324.1	Hs.408067	Histone cluster 2, H2ac				NIH_MGC_69	DH10B	NM_003517.2	NP_003508.1	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
RIKEN	AK024814	flj0057l24	FLJ	W01A113A09	pENTR-TOPO	1877		IFI6	2537	-	Hs.523847	Interferon, alpha-inducible protein 6				CAS	EK1	NM_002038.3	NP_002029.3	REVIEWED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	AK024814	flj0057l24	FLJ	W01A113A11	pENTR-TOPO	1877		IFI6	2537	-	Hs.523847	Interferon, alpha-inducible protein 6				CAS	EK1	NM_002038.3	NP_002029.3	REVIEWED	C	1.000	1.000	130	393	1	390	130	1	130
RIKEN	BC066901	IRAK167G20	MGC	W01A113A17	pENTR-TOPO	913		LOC440926	440926	AAH66901					Testis	NIH_MGC_97	DH10B													
RIKEN	BC066901	IRAK167G20	MGC	W01A113A19	pENTR-TOPO	913		LOC440926	440926	AAH66901					Testis	NIH_MGC_97	DH10B													
RIKEN	BC000341	IRAL001K05	MGC	W01A113B08	pENTR-TOPO	2070		SSR2	6746	AAH00341.2	Hs.74564	Signal sequence receptor, beta (translocon-associated protein beta)			Lung, small cell carcinoma	NIH_MGC_7		NM_003145.3	NP_003136.1	REVIEWED	OK	1.000	1.000	183	561	10	558	183	1	183
RIKEN	BC000341	IRAL001K05	MGC	W01A113B12	pENTR-TOPO	2070		SSR2	6746	AAH00341.2	Hs.74564	Signal sequence receptor, beta (translocon-associated protein beta)			Lung, small cell carcinoma	NIH_MGC_7		NM_003145.3	NP_003136.1	REVIEWED	OK	1.000	1.000	183	561	10	558	183	1	183
RIKEN	BC009177	IRAL003K02	MGC	W01A113B16	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC009177	IRAL003K02	MGC	W01A113B18	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC009177	IRAL003K02	MGC	W01A113B20	pENTR-TOPO	1595		RHOC	389	AAH09177.1	Hs.658289	Ras homolog gene family, member C			Skin, melanotic melanoma.	NIH_MGC_20		NM_001042678.1	NP_001036143.1	REVIEWED	OK	1.000	1.000	193	582	1	579	193	1	193
RIKEN	BC007518	IRAL010P18	MGC	W01A113C03	pENTR-TOPO	20075		HIST1H2AI	8329	AAH07518	Hs.534035	Histone cluster 1, H2ai			Ovary, adenocarcinoma	NIH_MGC_9		NM_003509.2	NP_003500.1	REVIEWED		0.391	0.391	23	411	333	265	130	104	126
RIKEN	BC007518	IRAL010P18	MGC	W01A113C09	pENTR-TOPO	20075		HIST1H2AI	8329	AAH07518	Hs.534035	Histone cluster 1, H2ai			Ovary, adenocarcinoma	NIH_MGC_9		NM_003509.2	NP_003500.1	REVIEWED		0.391	0.391	23	411	333	265	130	104	126
RIKEN	BC007518	IRAL010P18	MGC	W01A113C11	pENTR-TOPO	20075		HIST1H2AI	8329	AAH07518	Hs.534035	Histone cluster 1, H2ai			Ovary, adenocarcinoma	NIH_MGC_9		NM_003509.2	NP_003500.1	REVIEWED		0.391	0.391	23	411	333	265	130	104	126
RIKEN	BC010280	IRAK003B17	MGC	W01A113C13	pENTR-TOPO	23232		HRSP12	10247	AAH10280.1	Hs.18426	Heat-responsive protein 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005836.2	NP_005827.1	VALIDATED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC010280	IRAK003B17	MGC	W01A113C15	pENTR-TOPO	23232		HRSP12	10247	AAH10280.1	Hs.18426	Heat-responsive protein 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005836.2	NP_005827.1	VALIDATED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC010280	IRAK003B17	MGC	W01A113C23	pENTR-TOPO	23232		HRSP12	10247	AAH10280.1	Hs.18426	Heat-responsive protein 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005836.2	NP_005827.1	VALIDATED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC028210	IRAK062H10	MGC	W01A113D16	pENTR-TOPO	12914		ICOS	29851	AAH28210.1	Hs.56247	Inducible T-cell co-stimulator			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_012092.2	NP_036224.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC028210	IRAK062H10	MGC	W01A113D18	pENTR-TOPO	12914		ICOS	29851	AAH28210.1	Hs.56247	Inducible T-cell co-stimulator			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_012092.2	NP_036224.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC028210	IRAK062H10	MGC	W01A113D20	pENTR-TOPO	12914		ICOS	29851	AAH28210.1	Hs.56247	Inducible T-cell co-stimulator			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_012092.2	NP_036224.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC028210	IRAK062H10	MGC	W01A113D22	pENTR-TOPO	12914		ICOS	29851	AAH28210.1	Hs.56247	Inducible T-cell co-stimulator			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_012092.2	NP_036224.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
RIKEN	BC007407	IRAL010F18	MGC	W01A113E15	pENTR-TOPO	8339		NMB	4828	AAH07407.1	Hs.386470	Neuromedin B			Ovary, adenocarcinoma	NIH_MGC_9		NM_205858.1	NP_995580.1	VALIDATED	Cs	0.994	0.994	154	465	1	462	154	1	154
RIKEN	BC029884	IRAK051F13	MGC	W01A113F02	pENTR-TOPO	3588		MS4A5	64232	AAH29884.1	Hs.178066	Membrane-spanning 4-domains, subfamily A, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_023945.2	NP_076434.2	REVIEWED	OK	1.000	1.000	200	603	1	600	200	1	200
RIKEN	BC029884	IRAK051F13	MGC	W01A113F04	pENTR-TOPO	3588		MS4A5	64232	AAH29884.1	Hs.178066	Membrane-spanning 4-domains, subfamily A, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_023945.2	NP_076434.2	REVIEWED	OK	1.000	1.000	200	603	1	600	200	1	200
RIKEN	BC029884	IRAK051F13	MGC	W01A113F08	pENTR-TOPO	3588		MS4A5	64232	AAH29884.1	Hs.178066	Membrane-spanning 4-domains, subfamily A, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_023945.2	NP_076434.2	REVIEWED	OK	1.000	1.000	200	603	1	600	200	1	200
RIKEN	BC029884	IRAK051F13	MGC	W01A113F10	pENTR-TOPO	3588		MS4A5	64232	AAH29884.1	Hs.178066	Membrane-spanning 4-domains, subfamily A, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_023945.2	NP_076434.2	REVIEWED	OK	1.000	1.000	200	603	1	600	200	1	200
RIKEN	BC029884	IRAK051F13	MGC	W01A113F12	pENTR-TOPO	3588		MS4A5	64232	AAH29884.1	Hs.178066	Membrane-spanning 4-domains, subfamily A, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_023945.2	NP_076434.2	REVIEWED	OK	1.000	1.000	200	603	1	600	200	1	200
RIKEN	BC015483	IRAK022L15	MGC	W01A113F14	pENTR-TOPO	8111		HDGFRP3	50810	AAH15483.1	Hs.513954	Hepatoma-derived growth factor, related protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016073.2	NP_057157.1	PROVISIONAL	C	1.000	1.000	203	612	1	609	203	1	203
RIKEN	BC015483	IRAK022L15	MGC	W01A113F16	pENTR-TOPO	8111		HDGFRP3	50810	AAH15483.1	Hs.513954	Hepatoma-derived growth factor, related protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016073.2	NP_057157.1	PROVISIONAL	C	1.000	1.000	203	612	1	609	203	1	203
RIKEN	BC011757	IRAL027D16	MGC	W01A113G07	pENTR-TOPO	908		GADD45A	1647	AAH11757.1	Hs.80409	Growth arrest and DNA-damage-inducible, alpha			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001924.2	NP_001915.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
RIKEN	BC011757	IRAL027D16	MGC	W01A113G09	pENTR-TOPO	908		GADD45A	1647	AAH11757.1	Hs.80409	Growth arrest and DNA-damage-inducible, alpha			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001924.2	NP_001915.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
RIKEN	BC012415	IRAK021K05	MGC	W01A113G13	pENTR-TOPO	15273		WRB	7485	AAH12415.1	Hs.198308	Tryptophan rich basic protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001146218.1	NP_001139690.1	REVIEWED	C	1.000	1.000	140	525	103	522	140	1	140
RIKEN	BC012415	IRAK021K05	MGC	W01A113G15	pENTR-TOPO	15273		WRB	7485	AAH12415.1	Hs.198308	Tryptophan rich basic protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001146218.1	NP_001139690.1	REVIEWED	C	1.000	1.000	140	525	103	522	140	1	140
RIKEN	BC012415	IRAK021K05	MGC	W01A113G19	pENTR-TOPO	15273		WRB	7485	AAH12415.1	Hs.198308	Tryptophan rich basic protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001146218.1	NP_001139690.1	REVIEWED	C	1.000	1.000	140	525	103	522	140	1	140
RIKEN	BC012415	IRAK021K05	MGC	W01A113G23	pENTR-TOPO	15273		WRB	7485	AAH12415.1	Hs.198308	Tryptophan rich basic protein			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001146218.1	NP_001139690.1	REVIEWED	C	1.000	1.000	140	525	103	522	140	1	140
RIKEN	BC049847	IRAK093J02	MGC	W01A113H02	pENTR-TOPO	4132		CD3E	916	AAH49847.1	Hs.3003	CD3e molecule, epsilon (CD3-TCR complex)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_000733.3	NP_000724.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC049847	IRAK093J02	MGC	W01A113H06	pENTR-TOPO	4132		CD3E	916	AAH49847.1	Hs.3003	CD3e molecule, epsilon (CD3-TCR complex)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_000733.3	NP_000724.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC049847	IRAK093J02	MGC	W01A113H08	pENTR-TOPO	4132		CD3E	916	AAH49847.1	Hs.3003	CD3e molecule, epsilon (CD3-TCR complex)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_000733.3	NP_000724.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC049847	IRAK093J02	MGC	W01A113H10	pENTR-TOPO	4132		CD3E	916	AAH49847.1	Hs.3003	CD3e molecule, epsilon (CD3-TCR complex)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_000733.3	NP_000724.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
RIKEN	BC041812	IRAK077J01	MGC	W01A113H16	pENTR-TOPO	15050		NKAIN4	128414	AAH41812.1	Hs.46627	Na+/K+ transporting ATPase interacting 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152864.3	NP_690603.3	VALIDATED	Cs	0.995	0.995	208	627	1	624	208	1	208
RIKEN	BC041812	IRAK077J01	MGC	W01A113H22	pENTR-TOPO	15050		NKAIN4	128414	AAH41812.1	Hs.46627	Na+/K+ transporting ATPase interacting 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152864.3	NP_690603.3	VALIDATED	Cs	0.995	0.995	208	627	1	624	208	1	208
RIKEN	BC011683	IRAL027G13	MGC	W01A113I09	pENTR-TOPO	20455		C6orf108	10591	AAH11683.1	Hs.109752	Chromosome 6 open reading frame 108			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_006443.2	NP_006434.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
RIKEN	BC033873	IRAK068P12	MGC	W01A113I13	pENTR-TOPO	12600		BST2	684	AAH33873.1	Hs.118110	Bone marrow stromal cell antigen 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004335.2	NP_004326.1	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC033873	IRAK068P12	MGC	W01A113I15	pENTR-TOPO	12600		BST2	684	AAH33873.1	Hs.118110	Bone marrow stromal cell antigen 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004335.2	NP_004326.1	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC033873	IRAK068P12	MGC	W01A113I17	pENTR-TOPO	12600		BST2	684	AAH33873.1	Hs.118110	Bone marrow stromal cell antigen 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004335.2	NP_004326.1	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC033873	IRAK068P12	MGC	W01A113I19	pENTR-TOPO	12600		BST2	684	AAH33873.1	Hs.118110	Bone marrow stromal cell antigen 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004335.2	NP_004326.1	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC033873	IRAK068P12	MGC	W01A113I21	pENTR-TOPO	12600		BST2	684	AAH33873.1	Hs.118110	Bone marrow stromal cell antigen 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004335.2	NP_004326.1	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC033873	IRAK068P12	MGC	W01A113I23	pENTR-TOPO	12600		BST2	684	AAH33873.1	Hs.118110	Bone marrow stromal cell antigen 2			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004335.2	NP_004326.1	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC013117	IRAK021P04	MGC	W01A113J02	pENTR-TOPO	20528		RGS17	26575	AAH13117.1	Hs.166313	Regulator of G-protein signaling 17			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_012419.4	NP_036551.3	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC013117	IRAK021P04	MGC	W01A113J10	pENTR-TOPO	20528		RGS17	26575	AAH13117.1	Hs.166313	Regulator of G-protein signaling 17			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_012419.4	NP_036551.3	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC013117	IRAK021P04	MGC	W01A113J12	pENTR-TOPO	20528		RGS17	26575	AAH13117.1	Hs.166313	Regulator of G-protein signaling 17			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_012419.4	NP_036551.3	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	BC016056	IRAL034K12	MGC	W01A113J16	pENTR-TOPO	21771		CLDN3	1365	AAH16056.1	Hs.647023	Claudin 3			Colon, adenocarcinoma	NIH_MGC_15		NM_001306.3	NP_001297.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC016056	IRAL034K12	MGC	W01A113J20	pENTR-TOPO	21771		CLDN3	1365	AAH16056.1	Hs.647023	Claudin 3			Colon, adenocarcinoma	NIH_MGC_15		NM_001306.3	NP_001297.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC016056	IRAL034K12	MGC	W01A113J24	pENTR-TOPO	21771		CLDN3	1365	AAH16056.1	Hs.647023	Claudin 3			Colon, adenocarcinoma	NIH_MGC_15		NM_001306.3	NP_001297.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	AK054689	flj0001i02	FLJ	W01A113K05	pENTR-TOPO	18169		NAP1L5	266812	BAB70793.1	Hs.12554	Nucleosome assembly protein 1-like 5				BRACE1	EK1	NM_153757.2	NP_715638.1	VALIDATED	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	AK054689	flj0001i02	FLJ	W01A113K09	pENTR-TOPO	18169		NAP1L5	266812	BAB70793.1	Hs.12554	Nucleosome assembly protein 1-like 5				BRACE1	EK1	NM_153757.2	NP_715638.1	VALIDATED	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	AK054689	flj0001i02	FLJ	W01A113K11	pENTR-TOPO	18169		NAP1L5	266812	BAB70793.1	Hs.12554	Nucleosome assembly protein 1-like 5				BRACE1	EK1	NM_153757.2	NP_715638.1	VALIDATED	C	1.000	1.000	182	549	1	546	182	1	182
RIKEN	BC022064	IRAK046O03	MGC	W01A113K13	pENTR-TOPO	24645		FATE1	89885	AAH22064.1	Hs.301960	Fetal and adult testis expressed 1			Testis	NIH_MGC_97	DH10B	NM_033085.2	NP_149076.1	VALIDATED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC035857	IRAK079P12	MGC	W01A113L02	pENTR-TOPO	541		PRDX6	9588	AAH35857.1	Hs.120	Peroxiredoxin 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004905.2	NP_004896.1	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC035857	IRAK079P12	MGC	W01A113L04	pENTR-TOPO	541		PRDX6	9588	AAH35857.1	Hs.120	Peroxiredoxin 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004905.2	NP_004896.1	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC035857	IRAK079P12	MGC	W01A113L10	pENTR-TOPO	541		PRDX6	9588	AAH35857.1	Hs.120	Peroxiredoxin 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004905.2	NP_004896.1	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	AK056776	flj0006b19	FLJ	W01A113L14	pENTR-TOPO	11748		HERV-V1	147664	BAB71281.1	Hs.44329	Hypothetical LOC147664				PLACE6	EK1	NM_152473.1	NP_689686.1	NA
RIKEN	AK056776	flj0006b19	FLJ	W01A113L16	pENTR-TOPO	11748		HERV-V1	147664	BAB71281.1	Hs.44329	Hypothetical LOC147664				PLACE6	EK1	NM_152473.1	NP_689686.1	NA
RIKEN	AK056776	flj0006b19	FLJ	W01A113L18	pENTR-TOPO	11748		HERV-V1	147664	BAB71281.1	Hs.44329	Hypothetical LOC147664				PLACE6	EK1	NM_152473.1	NP_689686.1	NA
RIKEN	AK056776	flj0006b19	FLJ	W01A113L20	pENTR-TOPO	11748		HERV-V1	147664	BAB71281.1	Hs.44329	Hypothetical LOC147664				PLACE6	EK1	NM_152473.1	NP_689686.1	NA
RIKEN	AK056776	flj0006b19	FLJ	W01A113L22	pENTR-TOPO	11748		HERV-V1	147664	BAB71281.1	Hs.44329	Hypothetical LOC147664				PLACE6	EK1	NM_152473.1	NP_689686.1	NA
RIKEN	BC002873	IRAL015C23	MGC	W01A113M09	pENTR-TOPO	16496		NDUFAF3	25915	AAH02873.1	Hs.31387	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 3			Lung, small cell carcinoma	NIH_MGC_7		NM_199069.1	NP_951032.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC005217	IRAL016F05	MGC	W01A113M15	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC005217	IRAL016F05	MGC	W01A113M17	pENTR-TOPO	17956		ANAPC10	10393	AAH05217.1	Hs.480876	Anaphase promoting complex subunit 10			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_014885.3	NP_055700.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC035789	IRAK079H07	MGC	W01A113N06	pENTR-TOPO	11260		CBLN2	147381	AAH35789.1	Hs.569851	Cerebellin 2 precursor			Brain, hippocampus	NIH_MGC_124	DH10B	NM_182511.3	NP_872317.1	VALIDATED	C	1.000	1.000	224	675	1	672	224	1	224
RIKEN	BC020866	IRAL036E23	MGC	W01A113N16	pENTR-TOPO	15403		CLDN8	9073	AAH20866.1	Hs.162209	Claudin 8			Kidney	NIH_MGC_75	DH10B	NM_199328.1	NP_955360.1	VALIDATED	C	1.000	1.000	225	678	1	675	225	1	225
RIKEN	BC001745	IRAL008G03	MGC	W01A113O01	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC001745	IRAL008G03	MGC	W01A113O07	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC001745	IRAL008G03	MGC	W01A113O11	pENTR-TOPO	17640		D4S234E	27065	AAH01745	Hs.518595	DNA segment on chromosome 4 (unique) 234 expressed sequence			Brain, neuroblastoma	NIH_MGC_19		NM_014392.3	NP_055207.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
RIKEN	BC015938	IRAK015O20	MGC	W01A113O15	pENTR-TOPO	14799		RBBP9	10741	AAH15938.1	Hs.69330	Retinoblastoma binding protein 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006606.2	NP_006597.2	REVIEWED	C	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC015938	IRAK015O20	MGC	W01A113O21	pENTR-TOPO	14799		RBBP9	10741	AAH15938.1	Hs.69330	Retinoblastoma binding protein 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006606.2	NP_006597.2	REVIEWED	C	1.000	1.000	186	561	1	558	186	1	186
RIKEN	BC017048	IRAK020L01	MGC	W01A113P04	pENTR-TOPO	6811		GJB2	2706	AAH17048.1	Hs.719400	Gap junction protein, beta 2, 26kDa			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004004.5	NP_003995.2	REVIEWED	C	1.000	1.000	226	681	1	678	226	1	226
RIKEN	BC017048	IRAK020L01	MGC	W01A113P08	pENTR-TOPO	6811		GJB2	2706	AAH17048.1	Hs.719400	Gap junction protein, beta 2, 26kDa			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004004.5	NP_003995.2	REVIEWED	C	1.000	1.000	226	681	1	678	226	1	226
RIKEN	BC017048	IRAK020L01	MGC	W01A113P10	pENTR-TOPO	6811		GJB2	2706	AAH17048.1	Hs.719400	Gap junction protein, beta 2, 26kDa			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004004.5	NP_003995.2	REVIEWED	C	1.000	1.000	226	681	1	678	226	1	226
RIKEN	BC005959	IRAL021I09	MGC	W01A114A03	pENTR-TOPO	21254		STARD3NL	83930	AAH05959.1	Hs.309753	STARD3 N-terminal like			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_032016.2	NP_114405.1	PROVISIONAL	OK	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC005959	IRAL021I09	MGC	W01A114A05	pENTR-TOPO	21254		STARD3NL	83930	AAH05959.1	Hs.309753	STARD3 N-terminal like			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_032016.2	NP_114405.1	PROVISIONAL	OK	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC005959	IRAL021I09	MGC	W01A114A07	pENTR-TOPO	21254		STARD3NL	83930	AAH05959.1	Hs.309753	STARD3 N-terminal like			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_032016.2	NP_114405.1	PROVISIONAL	OK	1.000	1.000	234	705	1	702	234	1	234
RIKEN	BC000308	IRAL001E03	MGC	W01A114A13	pENTR-TOPO	25364		ARD1A	8260	AAH00308.1	Hs.433291	ARD1 homolog A, N-acetyltransferase (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_003491.2	NP_003482.1	PROVISIONAL	C	1.000	1.000	235	708	1	705	235	1	235
RIKEN	BC000308	IRAL001E03	MGC	W01A114A15	pENTR-TOPO	25364		ARD1A	8260	AAH00308.1	Hs.433291	ARD1 homolog A, N-acetyltransferase (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_003491.2	NP_003482.1	PROVISIONAL	C	1.000	1.000	235	708	1	705	235	1	235
RIKEN	BC000308	IRAL001E03	MGC	W01A114A21	pENTR-TOPO	25364		ARD1A	8260	AAH00308.1	Hs.433291	ARD1 homolog A, N-acetyltransferase (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_003491.2	NP_003482.1	PROVISIONAL	C	1.000	1.000	235	708	1	705	235	1	235
RIKEN	BC000308	IRAL001E03	MGC	W01A114A23	pENTR-TOPO	25364		ARD1A	8260	AAH00308.1	Hs.433291	ARD1 homolog A, N-acetyltransferase (S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7		NM_003491.2	NP_003482.1	PROVISIONAL	C	1.000	1.000	235	708	1	705	235	1	235
RIKEN	BC022816	IRAL042K18	MGC	W01A114B02	pENTR-TOPO	8235		SNRPA1	6627	AAH22816.1	Hs.528763	Small nuclear ribonucleoprotein polypeptide A'			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003090.2	NP_003081.2	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
RIKEN	AK002052	flj0020k04	FLJ	W01A114B18	pENTR-TOPO	15004		C20orf46	55321	BAA92058.1	Hs.516834	Chromosome 20 open reading frame 46				PLACE1	EK1	NM_018354.1	NP_060824.1	PREDICTED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	AK002052	flj0020k04	FLJ	W01A114B20	pENTR-TOPO	15004		C20orf46	55321	BAA92058.1	Hs.516834	Chromosome 20 open reading frame 46				PLACE1	EK1	NM_018354.1	NP_060824.1	PREDICTED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	AK002052	flj0020k04	FLJ	W01A114B22	pENTR-TOPO	15004		C20orf46	55321	BAA92058.1	Hs.516834	Chromosome 20 open reading frame 46				PLACE1	EK1	NM_018354.1	NP_060824.1	PREDICTED	C	1.000	1.000	256	771	1	768	256	1	256
RIKEN	BC003158	IRAL009F24	MGC	W01A114C09	pENTR-TOPO	14205		LAPTM4A	9741	AAH03158.1	Hs.467807	Lysosomal protein transmembrane 4 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_014713.4	NP_055528.1	REVIEWED	Cs	0.996	0.996	233	702	1	699	233	1	233
RIKEN	BC017226	IRAL020M06	MGC	W01A114C13	pENTR-TOPO	9289		RNF166	115992	AAH17226.1	Hs.513804	Ring finger protein 166			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_178841.2	NP_849163.1	PROVISIONAL	OK	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC017226	IRAL020M06	MGC	W01A114C17	pENTR-TOPO	9289		RNF166	115992	AAH17226.1	Hs.513804	Ring finger protein 166			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_178841.2	NP_849163.1	PROVISIONAL	OK	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC017226	IRAL020M06	MGC	W01A114C19	pENTR-TOPO	9289		RNF166	115992	AAH17226.1	Hs.513804	Ring finger protein 166			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_178841.2	NP_849163.1	PROVISIONAL	OK	1.000	1.000	237	714	1	711	237	1	237
RIKEN	BC009956	IRAL020P04	MGC	W01A114D12	pENTR-TOPO	20767		HLA-DPA1	3113	AAH09956.1	Hs.347270	Major histocompatibility complex, class II, DP alpha 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_033554.2	NP_291032.2	REVIEWED		0.973	0.973	260	783	1	780	260	1	260
RIKEN	BC019252	IRAL006N20	MGC	W01A114D18	pENTR-TOPO	2844		BAMBI	25805	AAH19252.1	Hs.533336	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012342.2	NP_036474.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC019252	IRAL006N20	MGC	W01A114D22	pENTR-TOPO	2844		BAMBI	25805	AAH19252.1	Hs.533336	BMP and activin membrane-bound inhibitor homolog (Xenopus laevis)			Brain, neuroblastoma	NIH_MGC_19		NM_012342.2	NP_036474.1	REVIEWED	OK	1.000	1.000	260	783	1	780	260	1	260
RIKEN	BC017844	IRAL036H21	MGC	W01A114E15	pENTR-TOPO	9224		IGSF6	10261	AAH17844.1	Hs.530902	Immunoglobulin superfamily, member 6			Lung	NIH_MGC_77	DH10B	NM_005849.2	NP_005840.2	VALIDATED	Cs	0.992	0.992	241	726	1	723	241	1	241
RIKEN	BC017844	IRAL036H21	MGC	W01A114E17	pENTR-TOPO	9224		IGSF6	10261	AAH17844.1	Hs.530902	Immunoglobulin superfamily, member 6			Lung	NIH_MGC_77	DH10B	NM_005849.2	NP_005840.2	VALIDATED	Cs	0.992	0.992	241	726	1	723	241	1	241
RIKEN	BC017844	IRAL036H21	MGC	W01A114E21	pENTR-TOPO	9224		IGSF6	10261	AAH17844.1	Hs.530902	Immunoglobulin superfamily, member 6			Lung	NIH_MGC_77	DH10B	NM_005849.2	NP_005840.2	VALIDATED	Cs	0.992	0.992	241	726	1	723	241	1	241
RIKEN	AK092672	flj0003l03	FLJ	W01A114F02	pENTR-TOPO	1884		ANP32E	81611	BAC03942.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E				PUAEN1	EK1	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC003380	IRAK003J13	MGC	W01A114F16	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC003380	IRAK003J13	MGC	W01A114F18	pENTR-TOPO	1884		ANP32E	81611	AAH03380.1	Hs.656466	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_030920.3	NP_112182.1	VALIDATED	C	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC000864	IRAK004A20	MGC	W01A114G05	pENTR-TOPO	23750		SSNA1	8636	AAH00864.1	Hs.530314	Sjogren syndrome nuclear autoantigen 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003731.2	NP_003722.2	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
RIKEN	BC000864	IRAK004A20	MGC	W01A114G07	pENTR-TOPO	23750		SSNA1	8636	AAH00864.1	Hs.530314	Sjogren syndrome nuclear autoantigen 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003731.2	NP_003722.2	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
RIKEN	BC013416	IRAL011G02	MGC	W01A114G21	pENTR-TOPO	4881		H2AFX	3014	AAH13416.1	Hs.477879	H2A histone family, member X			Lung, small cell carcinoma	NIH_MGC_7		NM_002105.2	NP_002096.1	REVIEWED	C	1.000	1.000	143	432	1	429	143	1	143
RIKEN	BC006991	IRAL016E19	MGC	W01A114H06	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC006991	IRAL016E19	MGC	W01A114H08	pENTR-TOPO	2813		RPP30	10556	AAH06991.1	Hs.139120	Ribonuclease P/MRP 30kDa subunit			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_006413.4	NP_006404.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
RIKEN	BC040443	IRAK084J24	MGC	W01A114H20	pENTR-TOPO	3615		AQP11	282679	AAH40443.1	Hs.503345	Aquaporin 11			Brain, hippocampus	NIH_MGC_124	DH10B	NM_173039.1	NP_766627.1	PROVISIONAL	C	1.000	1.000	271	816	1	813	271	1	271
RIKEN	BC040443	IRAK084J24	MGC	W01A114H22	pENTR-TOPO	3615		AQP11	282679	AAH40443.1	Hs.503345	Aquaporin 11			Brain, hippocampus	NIH_MGC_124	DH10B	NM_173039.1	NP_766627.1	PROVISIONAL	C	1.000	1.000	271	816	1	813	271	1	271
RIKEN	BC010890	IRAL019K17	MGC	W01A114I19	pENTR-TOPO	10389		DERL2	51009	AAH10890.1	Hs.286131	Der1-like domain family, member 2			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_016041.3	NP_057125.2	PROVISIONAL	C	1.000	1.000	239	720	1	717	239	1	239
RIKEN	BC002904	IRAL015M23	MGC	W01A114J06	pENTR-TOPO	20068		MAD2L1BP	9587	AAH02904.1	Hs.715485	MAD2L1 binding protein			Lung, small cell carcinoma	NIH_MGC_7		NM_014628.2	NP_055443.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
RIKEN	BC002904	IRAL015M23	MGC	W01A114J08	pENTR-TOPO	20068		MAD2L1BP	9587	AAH02904.1	Hs.715485	MAD2L1 binding protein			Lung, small cell carcinoma	NIH_MGC_7		NM_014628.2	NP_055443.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
RIKEN	BC040355	IRAK028N23	MGC	W01A114J14	pENTR-TOPO	16082		TMEM45A	55076	AAH40355.1	Hs.658956	Transmembrane protein 45A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_018004.1	NP_060474.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC040355	IRAK028N23	MGC	W01A114J16	pENTR-TOPO	16082		TMEM45A	55076	AAH40355.1	Hs.658956	Transmembrane protein 45A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_018004.1	NP_060474.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC040355	IRAK028N23	MGC	W01A114J18	pENTR-TOPO	16082		TMEM45A	55076	AAH40355.1	Hs.658956	Transmembrane protein 45A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_018004.1	NP_060474.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC014045	IRAL028B12	MGC	W01A114K05	pENTR-TOPO	4728		CYBASC3	220002	AAH14045.2	Hs.22546	Cytochrome b, ascorbate dependent 3			Brain, neuroblastoma	NIH_MGC_19		NM_153611.3	NP_705839.2	PROVISIONAL	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC014045	IRAL028B12	MGC	W01A114K09	pENTR-TOPO	4728		CYBASC3	220002	AAH14045.2	Hs.22546	Cytochrome b, ascorbate dependent 3			Brain, neuroblastoma	NIH_MGC_19		NM_153611.3	NP_705839.2	PROVISIONAL	Cs	0.996	0.996	242	729	1	726	242	1	242
RIKEN	BC029485	IRAK048H14	MGC	W01A114K19	pENTR-TOPO	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
RIKEN	BC029485	IRAK048H14	MGC	W01A114K23	pENTR-TOPO	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
RIKEN	BC003097	IRAL006B14	MGC	W01A114L04	pENTR-TOPO	10303		ICAM2	3384	AAH03097.1	Hs.431460	Intercellular adhesion molecule 2			Brain, neuroblastoma	NIH_MGC_19		NM_001099786.1	NP_001093256.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC003097	IRAL006B14	MGC	W01A114L08	pENTR-TOPO	10303		ICAM2	3384	AAH03097.1	Hs.431460	Intercellular adhesion molecule 2			Brain, neuroblastoma	NIH_MGC_19		NM_001099786.1	NP_001093256.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC003097	IRAL006B14	MGC	W01A114L12	pENTR-TOPO	10303		ICAM2	3384	AAH03097.1	Hs.431460	Intercellular adhesion molecule 2			Brain, neuroblastoma	NIH_MGC_19		NM_001099786.1	NP_001093256.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
RIKEN	BC000936	IRAK003B12	MGC	W01A114M01	pENTR-TOPO	22115		TMUB1	83590	AAH00936.1	Hs.647096	Transmembrane and ubiquitin-like domain containing 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001136044.1	NP_001129516.1	VALIDATED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC000936	IRAK003B12	MGC	W01A114M03	pENTR-TOPO	22115		TMUB1	83590	AAH00936.1	Hs.647096	Transmembrane and ubiquitin-like domain containing 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001136044.1	NP_001129516.1	VALIDATED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC000936	IRAK003B12	MGC	W01A114M07	pENTR-TOPO	22115		TMUB1	83590	AAH00936.1	Hs.647096	Transmembrane and ubiquitin-like domain containing 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001136044.1	NP_001129516.1	VALIDATED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC000936	IRAK003B12	MGC	W01A114M09	pENTR-TOPO	22115		TMUB1	83590	AAH00936.1	Hs.647096	Transmembrane and ubiquitin-like domain containing 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001136044.1	NP_001129516.1	VALIDATED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC000936	IRAK003B12	MGC	W01A114M11	pENTR-TOPO	22115		TMUB1	83590	AAH00936.1	Hs.647096	Transmembrane and ubiquitin-like domain containing 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001136044.1	NP_001129516.1	VALIDATED	C	1.000	1.000	246	741	1	738	246	1	246
RIKEN	BC007200	IRAL018J10	MGC	W01A114M13	pENTR-TOPO	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC007200	IRAL018J10	MGC	W01A114M15	pENTR-TOPO	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
RIKEN	BC010038	IRAL027E21	MGC	W01A114O01	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC010038	IRAL027E21	MGC	W01A114O05	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC010038	IRAL027E21	MGC	W01A114O11	pENTR-TOPO	2845		PGAM1	5223	AAH10038.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC011678	IRAL026N22	MGC	W01A114O21	pENTR-TOPO	2845		PGAM1	5223	AAH11678.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC011678	IRAL026N22	MGC	W01A114O23	pENTR-TOPO	2845		PGAM1	5223	AAH11678.1	Hs.632918	Phosphoglycerate mutase 1 (brain)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49		NM_002629.2	NP_002620.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
RIKEN	BC064644	IRAK139P20	MGC	W01A114P08	pENTR-TOPO	21836		STX1A	6804	AAH64644.1	Hs.647024	Syntaxin 1A (brain)			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004603.2	NP_004594.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC064644	IRAK139P20	MGC	W01A114P10	pENTR-TOPO	21836		STX1A	6804	AAH64644.1	Hs.647024	Syntaxin 1A (brain)			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004603.2	NP_004594.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
RIKEN	BC056160	IRAK119A07	MGC	W01A114P18	pENTR-TOPO	24890		SLC25A5	292	AAH56160.1	Hs.632282	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001152.3	NP_001143.2	VALIDATED	Cs	0.997	0.997	298	897	1	894	298	1	298
RIKEN	BC056160	IRAK119A07	MGC	W01A114P24	pENTR-TOPO	24890		SLC25A5	292	AAH56160.1	Hs.632282	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001152.3	NP_001143.2	VALIDATED	Cs	0.997	0.997	298	897	1	894	298	1	298
RIKEN	BC028314	IRAK050J06	MGC	W01A115A01	pENTR-TOPO	24297		SURF1	6834	AAH28314.1	Hs.512464	Surfeit 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_003172.2	NP_003163.1	REVIEWED	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC028314	IRAK050J06	MGC	W01A115A03	pENTR-TOPO	24297		SURF1	6834	AAH28314.1	Hs.512464	Surfeit 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_003172.2	NP_003163.1	REVIEWED	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC028314	IRAK050J06	MGC	W01A115A07	pENTR-TOPO	24297		SURF1	6834	AAH28314.1	Hs.512464	Surfeit 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_003172.2	NP_003163.1	REVIEWED	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC028314	IRAK050J06	MGC	W01A115A11	pENTR-TOPO	24297		SURF1	6834	AAH28314.1	Hs.512464	Surfeit 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_003172.2	NP_003163.1	REVIEWED	C	1.000	1.000	300	903	1	900	300	1	300
RIKEN	BC027614	IRAK034O16	MGC	W01A115A23	pENTR-TOPO	24654		CPXCR1	53336	AAH27614.1	Hs.458292	CPX chromosome region, candidate 1			Testis	NIH_MGC_97	DH10B	NM_033048.4	NP_149037.3	VALIDATED	Cs	0.997	0.997	301	906	1	903	301	1	301
RIKEN	BC047881	IRAK107I02	MGC	W01A115B14	pENTR-TOPO	19793		FAM8A1	51439	AAH47881.1	Hs.95260	Family with sequence similarity 8, member A1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016255.2	NP_057339.1	VALIDATED	OK	1.000	1.000	413	1242	1	1239	413	1	413
RIKEN	BC000875	IRAK004J06	MGC	W01A115C01	pENTR-TOPO	4575		MTCH2	23788	AAH00875.1	Hs.269944	Mitochondrial carrier homolog 2 (C. elegans)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014342.3	NP_055157.1	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC031265	IRAK063J01	MGC	W01A115C13	pENTR-TOPO	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC031265	IRAK063J01	MGC	W01A115C17	pENTR-TOPO	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC007287	IRAL022M06	MGC	W01A115D08	pENTR-TOPO	8630		ZNF213	7760	AAH07287.1	Hs.115284	Zinc finger protein 213			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004220.2	NP_004211.1	VALIDATED	OK	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC007287	IRAL022M06	MGC	W01A115D12	pENTR-TOPO	8630		ZNF213	7760	AAH07287.1	Hs.115284	Zinc finger protein 213			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_004220.2	NP_004211.1	VALIDATED	OK	1.000	1.000	459	1380	1	1377	459	1	459
RIKEN	BC011858	IRAL028M03	MGC	W01A115D14	pENTR-TOPO	16138		ABTB1	80325	AAH11858.1	Hs.107812	Ankyrin repeat and BTB (POZ) domain containing 1			Primary B-Cells from Tonsils	NIH_MGC_48		NM_172027.1	NP_742024.1	REVIEWED	OK	1.000	1.000	478	1437	1	1434	478	1	478
RIKEN	BC015831	IRAL038P07	MGC	W01A115E01	pENTR-TOPO	16868		DNASE1L3	1776	AAH15831.1	Hs.476453	Deoxyribonuclease I-like 3			Liver	NIH_MGC_76	DH10B	NM_004944.2	NP_004935.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC015831	IRAL038P07	MGC	W01A115E03	pENTR-TOPO	16868		DNASE1L3	1776	AAH15831.1	Hs.476453	Deoxyribonuclease I-like 3			Liver	NIH_MGC_76	DH10B	NM_004944.2	NP_004935.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC015831	IRAL038P07	MGC	W01A115E05	pENTR-TOPO	16868		DNASE1L3	1776	AAH15831.1	Hs.476453	Deoxyribonuclease I-like 3			Liver	NIH_MGC_76	DH10B	NM_004944.2	NP_004935.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
RIKEN	BC004991	IRAL009N02	MGC	W01A115E13	pENTR-TOPO	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20		NM_032315.2	NP_115691.1	VALIDATED	C	1.000	1.000	321	966	1	963	321	1	321
RIKEN	BC004991	IRAL009N02	MGC	W01A115E15	pENTR-TOPO	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20		NM_032315.2	NP_115691.1	VALIDATED	C	1.000	1.000	321	966	1	963	321	1	321
RIKEN	BC004991	IRAL009N02	MGC	W01A115E23	pENTR-TOPO	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20		NM_032315.2	NP_115691.1	VALIDATED	C	1.000	1.000	321	966	1	963	321	1	321
RIKEN	BC014280	IRAL014K06	MGC	W01A115F02	pENTR-TOPO	11621		ZNF71	58491	AAH14280.1	Hs.301431	Zinc finger protein 71			Placenta, choriocarcinoma	NIH_MGC_21		NM_021216.4	NP_067039.1	VALIDATED	C	1.000	1.000	489	1470	1	1467	489	1	489
RIKEN	AK027674	flj0035d11	FLJ	W01A115F14	pENTR-TOPO	12463		FIZ1	84922	BAB55286.1	Hs.515617	FLT3-interacting zinc finger 1	NT2	teratocarcinoma		NT2RP3	EK1	NM_032836.2	NP_116225.2	REVIEWED	Cs	0.996	0.996	496	1491	1	1488	496	1	496
RIKEN	AK027674	flj0035d11	FLJ	W01A115F18	pENTR-TOPO	12463		FIZ1	84922	BAB55286.1	Hs.515617	FLT3-interacting zinc finger 1	NT2	teratocarcinoma		NT2RP3	EK1	NM_032836.2	NP_116225.2	REVIEWED	Cs	0.996	0.996	496	1491	1	1488	496	1	496
RIKEN	AK027674	flj0035d11	FLJ	W01A115F20	pENTR-TOPO	12463		FIZ1	84922	BAB55286.1	Hs.515617	FLT3-interacting zinc finger 1	NT2	teratocarcinoma		NT2RP3	EK1	NM_032836.2	NP_116225.2	REVIEWED	Cs	0.996	0.996	496	1491	1	1488	496	1	496
RIKEN	BC063241	IRAK110N15	MGC	W01A115G01	pENTR-TOPO	18687		SFXN1	94081	AAH63241.1	Hs.369440	Sideroflexin 1				Lupski_sympathetic_trunk	DH10B	NM_022754.5	NP_073591.2	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC063241	IRAK110N15	MGC	W01A115G05	pENTR-TOPO	18687		SFXN1	94081	AAH63241.1	Hs.369440	Sideroflexin 1				Lupski_sympathetic_trunk	DH10B	NM_022754.5	NP_073591.2	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC022091	IRAL010P10	MGC	W01A115G13	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC022091	IRAL010P10	MGC	W01A115G19	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC022091	IRAL010P10	MGC	W01A115G21	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	BC022091	IRAL010P10	MGC	W01A115G23	pENTR-TOPO	2733		SFXN2	118980	AAH22091.1	Hs.44070	Sideroflexin 2			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
RIKEN	AK091550	flj0021h03	FLJ	W01A115H06	pENTR-TOPO	19396		ZFP62	643836	BAC03691.1	Hs.719290	Zinc finger protein 62 homolog (mouse)				FCBBF3	EK1	NM_152283.3	NP_689496.3	VALIDATED		0.886	0.888	499	1497	1	1494	840	342	840
RIKEN	BC026257	IRAL037C08	MGC	W01A115I05	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC026257	IRAL037C08	MGC	W01A115I11	pENTR-TOPO	6244		APOF	319	AAH26257.1	Hs.534302	Apolipoprotein F			Liver	NIH_MGC_76	DH10B	NM_001638.2	NP_001629.1	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	BC015479	IRAK022M18	MGC	W01A115I13	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC015479	IRAK022M18	MGC	W01A115I19	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC015479	IRAK022M18	MGC	W01A115I21	pENTR-TOPO	22792		PINX1	54984	AAH15479.1	Hs.583894	PIN2-interacting protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017884.4	NP_060354.4	PROVISIONAL	Cs	0.994	0.994	328	987	1	984	328	1	328
RIKEN	BC002764	IRAL012O14	MGC	W01A115J18	pENTR-TOPO	17999		WHSC2	7469	AAH02764.2	Hs.21771	Wolf-Hirschhorn syndrome candidate 2			Placenta, choriocarcinoma	NIH_MGC_21		NM_005663.3	NP_005654.3	REVIEWED	P	1.000	1.000	528	1587	1	1584	539	12	539
RIKEN	BC002334	IRAL007F12	MGC	W01A115K11	pENTR-TOPO	5491		DAZAP2	9802	AAH02334.1	Hs.369761	DAZ associated protein 2			Brain, neuroblastoma	NIH_MGC_19		NM_014764.3	NP_055579.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
RIKEN	BC010488	IRAK019E01	MGC	W01A115K13	pENTR-TOPO	8213		AVEN	57099	AAH10488.1	Hs.555966	Apoptosis, caspase activation inhibitor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_020371.2	NP_065104.1	VALIDATED	C	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	BC010488	IRAK019E01	MGC	W01A115K21	pENTR-TOPO	8213		AVEN	57099	AAH10488.1	Hs.555966	Apoptosis, caspase activation inhibitor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_020371.2	NP_065104.1	VALIDATED	C	1.000	1.000	362	1089	1	1086	362	1	362
RIKEN	BC022784	IRAK020I06	MGC	W01A115L14	pENTR-TOPO	10432		GHDC	84514	AAH22784.1	Hs.38039	GH3 domain containing			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_032484.4	NP_115873.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
RIKEN	BC016778	IRAL032D03	MGC	W01A115M01	pENTR-TOPO	6066		KRR1	11103	AAH16778.1	Hs.645517	KRR1, small subunit (SSU) processome component, homolog (yeast)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_007043.6	NP_008974.5	VALIDATED	Cs	0.997	0.997	381	1146	1	1143	381	1	381
RIKEN	BC016778	IRAL032D03	MGC	W01A115M09	pENTR-TOPO	6066		KRR1	11103	AAH16778.1	Hs.645517	KRR1, small subunit (SSU) processome component, homolog (yeast)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_007043.6	NP_008974.5	VALIDATED	Cs	0.997	0.997	381	1146	1	1143	381	1	381
RIKEN	BC016778	IRAL032D03	MGC	W01A115M11	pENTR-TOPO	6066		KRR1	11103	AAH16778.1	Hs.645517	KRR1, small subunit (SSU) processome component, homolog (yeast)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_007043.6	NP_008974.5	VALIDATED	Cs	0.997	0.997	381	1146	1	1143	381	1	381
RIKEN	AK092772	flj0008h04	FLJ	W01A115N10	pENTR-TOPO	12520		ZNF579	163033	BAC03972.1	Hs.112529	Zinc finger protein 579				SMINT2	EK1	NM_152600.2	NP_689813.2	VALIDATED	Cs	0.998	0.998	562	1689	1	1686	562	1	562
RIKEN	AK090974	flj0011k04	FLJ	W01A115N14	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	AK090974	flj0011k04	FLJ	W01A115N16	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	AK090974	flj0011k04	FLJ	W01A115N20	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	AK090974	flj0011k04	FLJ	W01A115N22	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	AK090974	flj0011k04	FLJ	W01A115N24	pENTR-TOPO	1811		EPHA10	284656	BAC03561.1	Hs.129435	EPH receptor A10				BRAMY2	EK1	NM_173641.2	NP_775912.2	VALIDATED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC014889	IRAK015C19	MGC	W01A115O11	pENTR-TOPO	3722		DPF2	5977	AAH14889.1	Hs.13495	D4, zinc and double PHD fingers family 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006268.3	NP_006259.1	REVIEWED	OK	1.000	1.000	391	1176	1	1173	391	1	391
RIKEN	BC057796	IRAK133M01	MGC	W01A115O17	pENTR-TOPO	3765		RBMXL2	27288	AAH57796.1	Hs.121605	RNA binding motif protein, X-linked-like 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014469.4	NP_055284.3	REVIEWED	Cs	0.992	0.992	392	1179	1	1176	392	1	392
RIKEN	BC057796	IRAK133M01	MGC	W01A115O19	pENTR-TOPO	3765		RBMXL2	27288	AAH57796.1	Hs.121605	RNA binding motif protein, X-linked-like 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014469.4	NP_055284.3	REVIEWED	Cs	0.992	0.992	392	1179	1	1176	392	1	392
RIKEN	BC057796	IRAK133M01	MGC	W01A115O23	pENTR-TOPO	3765		RBMXL2	27288	AAH57796.1	Hs.121605	RNA binding motif protein, X-linked-like 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014469.4	NP_055284.3	REVIEWED	Cs	0.992	0.992	392	1179	1	1176	392	1	392
RIKEN	BC008666	IRAK013N01	MGC	W01A115P02	pENTR-TOPO	18042		SFRP2	6423	AAH08666.1	Hs.481022	Secreted frizzled-related protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003013.2	NP_003004.1	REVIEWED	Cs	0.997	0.997	295	888	1	885	295	1	295
RIKEN	BC023521	IRAL017H20	MGC	W01A115P14	pENTR-TOPO	18716		THG1L	54974	AAH23521.1	Hs.353090	TRNA-histidine guanylyltransferase 1-like (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19		NM_017872.3	NP_060342.2	PROVISIONAL	Cs	0.997	0.997	298	897	1	894	298	1	298
RIKEN	AK075477	flj0027f17	FLJ	W01A116A03	pENTR-TOPO	21318		SUMF2	25870	BAC11643.1	Hs.279696	Sulfatase modifying factor 2				PLACE1	EK1	NM_001146333.1	NP_001139805.1	REVIEWED	C	1.000	1.000	213	906	265	903	213	1	213
RIKEN	AK075477	flj0027f17	FLJ	W01A116A05	pENTR-TOPO	21318		SUMF2	25870	BAC11643.1	Hs.279696	Sulfatase modifying factor 2				PLACE1	EK1	NM_001146333.1	NP_001139805.1	REVIEWED	C	1.000	1.000	213	906	265	903	213	1	213
RIKEN	AK075477	flj0027f17	FLJ	W01A116A09	pENTR-TOPO	21318		SUMF2	25870	BAC11643.1	Hs.279696	Sulfatase modifying factor 2				PLACE1	EK1	NM_001146333.1	NP_001139805.1	REVIEWED	C	1.000	1.000	213	906	265	903	213	1	213
RIKEN	BC008843	IRAL020I13	MGC	W01A116A13	pENTR-TOPO	23		SLC25A44	9673	AAH08843.1	Hs.532375	Solute carrier family 25, member 44			Brain, neuroblastoma	NIH_MGC_19		NM_014655.2	NP_055470.1	VALIDATED	C	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC008843	IRAL020I13	MGC	W01A116A23	pENTR-TOPO	23		SLC25A44	9673	AAH08843.1	Hs.532375	Solute carrier family 25, member 44			Brain, neuroblastoma	NIH_MGC_19		NM_014655.2	NP_055470.1	VALIDATED	C	1.000	1.000	314	945	1	942	314	1	314
RIKEN	BC034923	IRAL043O20	MGC	W01A116B04	pENTR-TOPO	15804		WNT7B	7477	AAH34923.1	Hs.512714	Wingless-type MMTV integration site family, member 7B			Prostate, carcinoma	NIH_MGC_40		NM_058238.2	NP_478679.1	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC034923	IRAL043O20	MGC	W01A116B06	pENTR-TOPO	15804		WNT7B	7477	AAH34923.1	Hs.512714	Wingless-type MMTV integration site family, member 7B			Prostate, carcinoma	NIH_MGC_40		NM_058238.2	NP_478679.1	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC034923	IRAL043O20	MGC	W01A116B10	pENTR-TOPO	15804		WNT7B	7477	AAH34923.1	Hs.512714	Wingless-type MMTV integration site family, member 7B			Prostate, carcinoma	NIH_MGC_40		NM_058238.2	NP_478679.1	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC034923	IRAL043O20	MGC	W01A116B12	pENTR-TOPO	15804		WNT7B	7477	AAH34923.1	Hs.512714	Wingless-type MMTV integration site family, member 7B			Prostate, carcinoma	NIH_MGC_40		NM_058238.2	NP_478679.1	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC005161	IRAL011E13	MGC	W01A116B14	pENTR-TOPO	5368		INHBE	83729	AAH05161.1	Hs.632713	Inhibin, beta E			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031479.3	NP_113667.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005161	IRAL011E13	MGC	W01A116B16	pENTR-TOPO	5368		INHBE	83729	AAH05161.1	Hs.632713	Inhibin, beta E			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031479.3	NP_113667.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005161	IRAL011E13	MGC	W01A116B18	pENTR-TOPO	5368		INHBE	83729	AAH05161.1	Hs.632713	Inhibin, beta E			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031479.3	NP_113667.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC005161	IRAL011E13	MGC	W01A116B20	pENTR-TOPO	5368		INHBE	83729	AAH05161.1	Hs.632713	Inhibin, beta E			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_031479.3	NP_113667.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
RIKEN	BC003557	IRAL006H23	MGC	W01A116C01	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC003557	IRAL006H23	MGC	W01A116C03	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC003557	IRAL006H23	MGC	W01A116C05	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC003557	IRAL006H23	MGC	W01A116C07	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC003557	IRAL006H23	MGC	W01A116C11	pENTR-TOPO	11916		APOE	348	AAH03557.1	Hs.654439	Apolipoprotein E			Eye, retinoblastoma	NIH_MGC_16		NM_000041.2	NP_000032.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC021993	IRAL032J12	MGC	W01A116C13	pENTR-TOPO	19355		GNB2L1	10399	AAH21993.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	AK056278	flj0002b22	FLJ	W01A116D08	pENTR-TOPO	174		WNT3A	89780	BAB71136.1	Hs.336930	Wingless-type MMTV integration site family, member 3A	NT2	teratocarcinoma		NT2RI2	EK1	NM_033131.2	NP_149122.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	AK056278	flj0002b22	FLJ	W01A116D10	pENTR-TOPO	174		WNT3A	89780	BAB71136.1	Hs.336930	Wingless-type MMTV integration site family, member 3A	NT2	teratocarcinoma		NT2RI2	EK1	NM_033131.2	NP_149122.1	REVIEWED	C	1.000	1.000	352	1059	1	1056	352	1	352
RIKEN	BC050346	IRAK090K17	MGC	W01A116D24	pENTR-TOPO	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Testis	NIH_MGC_97	DH10B	NM_020382.3	NP_065115.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
RIKEN	BC000214	IRAL010K01	MGC	W01A116E01	pENTR-TOPO	19355		GNB2L1	10399	AAH00214.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
RIKEN	BC014303	IRAL025F01	MGC	W01A116E19	pENTR-TOPO	1642		SLC39A1	27173	AAH14303.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Lung, small cell carcinoma	NIH_MGC_7		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC032802	IRAK068M06	MGC	W01A116F02	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC032802	IRAK068M06	MGC	W01A116F04	pENTR-TOPO	9761		TSPAN10	83882	AAH32802.1	Hs.208219	Tetraspanin 10			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
RIKEN	BC034425	IRAK071D01	MGC	W01A116F16	pENTR-TOPO	20530		BVES	11149	AAH34425.1	Hs.221660	Blood vessel epicardial substance			Testis	NIH_MGC_97	DH10B	NM_147147.2	NP_671488.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC034425	IRAK071D01	MGC	W01A116F18	pENTR-TOPO	20530		BVES	11149	AAH34425.1	Hs.221660	Blood vessel epicardial substance			Testis	NIH_MGC_97	DH10B	NM_147147.2	NP_671488.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC002563	IRAL004N07	MGC	W01A116G01	pENTR-TOPO	1642		SLC39A1	27173	AAH02563.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_014437.3	NP_055252.2	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
RIKEN	BC025709	IRAK049M17	MGC	W01A116G13	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC025709	IRAK049M17	MGC	W01A116G15	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC025709	IRAK049M17	MGC	W01A116G23	pENTR-TOPO	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Cs	0.994	0.994	331	996	1	993	331	1	331
RIKEN	BC003001	IRAL002G17	MGC	W01A116H02	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	BC003001	IRAL002G17	MGC	W01A116H04	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	BC003001	IRAL002G17	MGC	W01A116H06	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	BC003001	IRAL002G17	MGC	W01A116H10	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	BC003001	IRAL002G17	MGC	W01A116H12	pENTR-TOPO	24190		SURF6	6838	AAH03001.1	Hs.274430	Surfeit 6			Lung, small cell carcinoma	NIH_MGC_7		NM_006753.4	NP_006744.2	REVIEWED	OK	1.000	1.000	361	1089	4	1086	361	1	361
RIKEN	BC043175	IRAK076C12	MGC	W01A116H18	pENTR-TOPO	2752		CCNJ	54619	AAH43175.1	Hs.596479	Cyclin J			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_019084.4	NP_061957.2	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC043175	IRAK076C12	MGC	W01A116H20	pENTR-TOPO	2752		CCNJ	54619	AAH43175.1	Hs.596479	Cyclin J			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_019084.4	NP_061957.2	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC043175	IRAK076C12	MGC	W01A116H24	pENTR-TOPO	2752		CCNJ	54619	AAH43175.1	Hs.596479	Cyclin J			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_019084.4	NP_061957.2	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
RIKEN	BC025726	IRAK049C20	MGC	W01A116I01	pENTR-TOPO	20555		KCNK17	89822	AAH25726.1	Hs.162282	Potassium channel, subfamily K, member 17			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031460.3	NP_113648.2	REVIEWED	Cs	0.997	0.997	332	999	1	996	332	1	332
RIKEN	BC041116	IRAK082C21	MGC	W01A116I15	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	BC041116	IRAK082C21	MGC	W01A116I17	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	BC041116	IRAK082C21	MGC	W01A116I19	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	BC041116	IRAK082C21	MGC	W01A116I21	pENTR-TOPO	16930		P2RY13	53829	AAH41116.2	Hs.546396	Purinergic receptor P2Y, G-protein coupled, 13			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023914.2	NP_076403.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
RIKEN	BC040455	IRAL035G01	MGC	W01A116J18	pENTR-TOPO	10044		ST6GALNAC2	10610	AAH40455.1	Hs.592105	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_006456.2	NP_006447.2	VALIDATED	OK	1.000	1.000	374	1125	1	1122	374	1	374
RIKEN	BC010446	IRAK012K12	MGC	W01A116K23	pENTR-TOPO	11598		TMEM59L	25789	AAH10446.1	Hs.329850	Transmembrane protein 59-like				NCI_CGAP_Brn67	DH10B	NM_012109.2	NP_036241.1	REVIEWED	C	1.000	1.000	342	1029	1	1026	342	1	342
RIKEN	BC006372	IRAL017K16	MGC	W01A116L06	pENTR-TOPO	14259		ACTR1B	10120	AAH06372.1	Hs.98791	ARP1 actin-related protein 1 homolog B, centractin beta (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005735.3	NP_005726.1	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
RIKEN	BC006372	IRAL017K16	MGC	W01A116L10	pENTR-TOPO	14259		ACTR1B	10120	AAH06372.1	Hs.98791	ARP1 actin-related protein 1 homolog B, centractin beta (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_005735.3	NP_005726.1	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
RIKEN	BC001057	IRAL007F16	MGC	W01A116L20	pENTR-TOPO	15830		TPST2	8459	AAH01057.1	Hs.632768	Tyrosylprotein sulfotransferase 2			Brain, neuroblastoma	NIH_MGC_19		NM_001008566.1	NP_001008566.1	REVIEWED	OK	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	BC017479	IRAL023A15	MGC	W01A116M01	pENTR-TOPO	20783		TBCC	6903	AAH17479.1	Hs.75064	Tubulin folding cofactor C			Eye, retinoblastoma	NIH_MGC_16		NM_003192.2	NP_003183.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC017479	IRAL023A15	MGC	W01A116M03	pENTR-TOPO	20783		TBCC	6903	AAH17479.1	Hs.75064	Tubulin folding cofactor C			Eye, retinoblastoma	NIH_MGC_16		NM_003192.2	NP_003183.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC020170	IRAL008P07	MGC	W01A116M23	pENTR-TOPO	20783		TBCC	6903	AAH20170.1	Hs.75064	Tubulin folding cofactor C			Lung, small cell carcinoma	NIH_MGC_7		NM_003192.2	NP_003183.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC007741	IRAL017H07	MGC	W01A116N04	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC007741	IRAL017H07	MGC	W01A116N10	pENTR-TOPO	7204		DLK1	8788	AAH07741.1	Hs.533717	Delta-like 1 homolog (Drosophila)			Brain, neuroblastoma	NIH_MGC_19		NM_003836.4	NP_003827.3	VALIDATED	Cs	0.997	0.997	383	1152	1	1149	383	1	383
RIKEN	BC043148	IRAK076N14	MGC	W01A116N20	pENTR-TOPO	5866		TWF1	5756	AAH43148.2	Hs.189075	Twinfilin, actin-binding protein, homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_002822.3	NP_002813.2	REVIEWED	C	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC043148	IRAK076N14	MGC	W01A116N24	pENTR-TOPO	5866		TWF1	5756	AAH43148.2	Hs.189075	Twinfilin, actin-binding protein, homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_002822.3	NP_002813.2	REVIEWED	C	1.000	1.000	384	1155	1	1152	384	1	384
RIKEN	BC032478	IRAK064L20	MGC	W01A116O01	pENTR-TOPO	9902		MAP2K3	5606	AAH32478.1	Hs.514012	Mitogen-activated protein kinase kinase 3			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_002756.3	NP_002747.2	REVIEWED	C	1.000	1.000	318	1044	88	1041	318	1	318
RIKEN	BC008811	IRAL015N15	MGC	W01A116O17	pENTR-TOPO	17186		WNT7A	7476	AAH08811.1	Hs.72290	Wingless-type MMTV integration site family, member 7A			Ovary, adenocarcinoma	NIH_MGC_9		NM_004625.3	NP_004616.2	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC041769	IRAK032O15	MGC	W01A116P14	pENTR-TOPO	9406		DOC2A	8448	AAH41769.2	Hs.355281	Double C2-like domains, alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003586.2	NP_003577.2	REVIEWED	P	1.000	1.000	392	1179	1	1176	400	9	400
RIKEN	BC018645	IRAL025N20	MGC	W01A117A05	pENTR-TOPO	12525		MAP2K2	5605	AAH18645.1	Hs.465627	Mitogen-activated protein kinase kinase 2			Skin, melanotic melanoma.	NIH_MGC_20		NM_030662.3	NP_109587.1	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC001483	IRAL007G16	MGC	W01A117A15	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC001483	IRAL007G16	MGC	W01A117A17	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC001483	IRAL007G16	MGC	W01A117A19	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC001483	IRAL007G16	MGC	W01A117A21	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC001483	IRAL007G16	MGC	W01A117A23	pENTR-TOPO	16154		TFG	10342	AAH01483.1	Hs.518123	TRK-fused gene			Brain, neuroblastoma	NIH_MGC_19		NM_006070.4	NP_006061.2	VALIDATED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC036032	IRAK048D13	MGC	W01A117B02	pENTR-TOPO	9929		MAP2K4	6416	AAH36032.1	Hs.514681	Mitogen-activated protein kinase kinase 4			Testis	NIH_MGC_97	DH10B	NM_003010.2	NP_003001.1	REVIEWED	Cs	0.997	0.997	399	1200	1	1197	399	1	399
RIKEN	BC036032	IRAK048D13	MGC	W01A117B04	pENTR-TOPO	9929		MAP2K4	6416	AAH36032.1	Hs.514681	Mitogen-activated protein kinase kinase 4			Testis	NIH_MGC_97	DH10B	NM_003010.2	NP_003001.1	REVIEWED	Cs	0.997	0.997	399	1200	1	1197	399	1	399
RIKEN	BC036032	IRAK048D13	MGC	W01A117B06	pENTR-TOPO	9929		MAP2K4	6416	AAH36032.1	Hs.514681	Mitogen-activated protein kinase kinase 4			Testis	NIH_MGC_97	DH10B	NM_003010.2	NP_003001.1	REVIEWED	Cs	0.997	0.997	399	1200	1	1197	399	1	399
RIKEN	BC036032	IRAK048D13	MGC	W01A117B08	pENTR-TOPO	9929		MAP2K4	6416	AAH36032.1	Hs.514681	Mitogen-activated protein kinase kinase 4			Testis	NIH_MGC_97	DH10B	NM_003010.2	NP_003001.1	REVIEWED	Cs	0.997	0.997	399	1200	1	1197	399	1	399
RIKEN	BC036032	IRAK048D13	MGC	W01A117B10	pENTR-TOPO	9929		MAP2K4	6416	AAH36032.1	Hs.514681	Mitogen-activated protein kinase kinase 4			Testis	NIH_MGC_97	DH10B	NM_003010.2	NP_003001.1	REVIEWED	Cs	0.997	0.997	399	1200	1	1197	399	1	399
RIKEN	BC036032	IRAK048D13	MGC	W01A117B12	pENTR-TOPO	9929		MAP2K4	6416	AAH36032.1	Hs.514681	Mitogen-activated protein kinase kinase 4			Testis	NIH_MGC_97	DH10B	NM_003010.2	NP_003001.1	REVIEWED	Cs	0.997	0.997	399	1200	1	1197	399	1	399
RIKEN	BC052234	IRAL047D09	MGC	W01A117D02	pENTR-TOPO	12971		WNT10A	80326	AAH52234.1	Hs.121540	Wingless-type MMTV integration site family, member 10A			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_025216.2	NP_079492.2	REVIEWED	OK	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC052234	IRAL047D09	MGC	W01A117D10	pENTR-TOPO	12971		WNT10A	80326	AAH52234.1	Hs.121540	Wingless-type MMTV integration site family, member 10A			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_025216.2	NP_079492.2	REVIEWED	OK	1.000	1.000	417	1254	1	1251	417	1	417
RIKEN	BC022507	IRAK032B22	MGC	W01A117D14	pENTR-TOPO	1707		B3GALT2	8707	AAH22507.1	Hs.716598	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003783.3	NP_003774.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC022507	IRAK032B22	MGC	W01A117D16	pENTR-TOPO	1707		B3GALT2	8707	AAH22507.1	Hs.716598	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003783.3	NP_003774.1	REVIEWED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC014488	IRAL034N12	MGC	W01A117E15	pENTR-TOPO	11508		PSMC4	5704	AAH14488.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC014488	IRAL034N12	MGC	W01A117E23	pENTR-TOPO	11508		PSMC4	5704	AAH14488.1	Hs.211594	Proteasome (prosome, macropain) 26S subunit, ATPase, 4			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006503.2	NP_006494.1	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
RIKEN	BC020944	IRAK032I05	MGC	W01A117F08	pENTR-TOPO	21789		ACTL6B	51412	AAH20944.1	Hs.259831	Actin-like 6B			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_016188.4	NP_057272.1	REVIEWED	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC020944	IRAK032I05	MGC	W01A117F10	pENTR-TOPO	21789		ACTL6B	51412	AAH20944.1	Hs.259831	Actin-like 6B			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_016188.4	NP_057272.1	REVIEWED	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC007852	IRAL020K02	MGC	W01A117F14	pENTR-TOPO	14145		STK25	10494	AAH07852.1	Hs.516807	Serine/threonine kinase 25 (STE20 homolog, yeast)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_006374.3	NP_006365.2	PROVISIONAL	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC007852	IRAL020K02	MGC	W01A117F16	pENTR-TOPO	14145		STK25	10494	AAH07852.1	Hs.516807	Serine/threonine kinase 25 (STE20 homolog, yeast)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_006374.3	NP_006365.2	PROVISIONAL	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC007852	IRAL020K02	MGC	W01A117F18	pENTR-TOPO	14145		STK25	10494	AAH07852.1	Hs.516807	Serine/threonine kinase 25 (STE20 homolog, yeast)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_006374.3	NP_006365.2	PROVISIONAL	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC007852	IRAL020K02	MGC	W01A117F20	pENTR-TOPO	14145		STK25	10494	AAH07852.1	Hs.516807	Serine/threonine kinase 25 (STE20 homolog, yeast)			Uterus, leiomyosarcoma	NIH_MGC_46		NM_006374.3	NP_006365.2	PROVISIONAL	OK	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC000416	IRAL001M22	MGC	W01A117G05	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC000416	IRAL001M22	MGC	W01A117G07	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC000416	IRAL001M22	MGC	W01A117G11	pENTR-TOPO	13053		BCS1L	617	AAH00416.1	Hs.471401	BCS1-like (yeast)			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_001079866.1	NP_001073335.1	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
RIKEN	BC022031	IRAK033D16	MGC	W01A117G19	pENTR-TOPO	20652		AKD1	221264	AAH22031.1	Hs.486169	Adenylate kinase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_145025.4	NP_659462.1	PROVISIONAL	C	1.000	1.000	421	1266	1	1263	421	1	421
RIKEN	BC009960	IRAL026N01	MGC	W01A117H02	pENTR-TOPO	24561		IL13RA1	3597	AAH09960.1	Hs.496646	Interleukin 13 receptor, alpha 1			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_001560.2	NP_001551.1	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	BC009960	IRAL026N01	MGC	W01A117H08	pENTR-TOPO	24561		IL13RA1	3597	AAH09960.1	Hs.496646	Interleukin 13 receptor, alpha 1			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_001560.2	NP_001551.1	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
RIKEN	BC008584	IRAK012L15	MGC	W01A117H16	pENTR-TOPO	15081		BMP7	655	AAH08584.1	Hs.473163	Bone morphogenetic protein 7			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_001719.2	NP_001710.1	REVIEWED	C	1.000	1.000	431	1296	1	1293	431	1	431
RIKEN	BC058917	IRAK119O04	MGC	W01A117I03	pENTR-TOPO	5484		SYT1	6857	AAH58917.1	Hs.310545	Synaptotagmin I				Lupski_sympathetic_trunk	DH10B	NM_001135806.1	NP_001129278.1	VALIDATED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC058917	IRAK119O04	MGC	W01A117I05	pENTR-TOPO	5484		SYT1	6857	AAH58917.1	Hs.310545	Synaptotagmin I				Lupski_sympathetic_trunk	DH10B	NM_001135806.1	NP_001129278.1	VALIDATED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC058917	IRAK119O04	MGC	W01A117I09	pENTR-TOPO	5484		SYT1	6857	AAH58917.1	Hs.310545	Synaptotagmin I				Lupski_sympathetic_trunk	DH10B	NM_001135806.1	NP_001129278.1	VALIDATED	C	1.000	1.000	422	1269	1	1266	422	1	422
RIKEN	BC001736	IRAL006L16	MGC	W01A117I15	pENTR-TOPO	15520		MCHR1	2847	AAH01736.1	Hs.248122	Melanin-concentrating hormone receptor 1			Brain, neuroblastoma	NIH_MGC_19		NM_005297.3	NP_005288.3	REVIEWED	Cs	0.998	0.998	422	1269	1	1266	422	1	422
RIKEN	BC001736	IRAL006L16	MGC	W01A117I19	pENTR-TOPO	15520		MCHR1	2847	AAH01736.1	Hs.248122	Melanin-concentrating hormone receptor 1			Brain, neuroblastoma	NIH_MGC_19		NM_005297.3	NP_005288.3	REVIEWED	Cs	0.998	0.998	422	1269	1	1266	422	1	422
RIKEN	BC001736	IRAL006L16	MGC	W01A117I21	pENTR-TOPO	15520		MCHR1	2847	AAH01736.1	Hs.248122	Melanin-concentrating hormone receptor 1			Brain, neuroblastoma	NIH_MGC_19		NM_005297.3	NP_005288.3	REVIEWED	Cs	0.998	0.998	422	1269	1	1266	422	1	422
RIKEN	BC000159	IRAK003H11	MGC	W01A117J06	pENTR-TOPO	10606		KRT17	3872	AAH00159.2	Hs.2785	Keratin 17			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000422.2	NP_000413.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC000159	IRAK003H11	MGC	W01A117J08	pENTR-TOPO	10606		KRT17	3872	AAH00159.2	Hs.2785	Keratin 17			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000422.2	NP_000413.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC011901	IRAL028I14	MGC	W01A117J22	pENTR-TOPO	10606		KRT17	3872	AAH11901.1	Hs.2785	Keratin 17			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000422.2	NP_000413.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
RIKEN	BC015571	IRAL033A11	MGC	W01A117K07	pENTR-TOPO	3585		SLC22A18	5002	AAH15571.1	Hs.50868	Solute carrier family 22, member 18			Placenta, choriocarcinoma	NIH_MGC_21		NM_002555.5	NP_002546.3	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
RIKEN	BC007682	IRAL012L19	MGC	W01A117K13	pENTR-TOPO	13076		STAMBP	10617	AAH07682.1	Hs.657598	STAM binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_213622.1	NP_998787.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC007682	IRAL012L19	MGC	W01A117K15	pENTR-TOPO	13076		STAMBP	10617	AAH07682.1	Hs.657598	STAM binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_213622.1	NP_998787.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC007682	IRAL012L19	MGC	W01A117K17	pENTR-TOPO	13076		STAMBP	10617	AAH07682.1	Hs.657598	STAM binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_213622.1	NP_998787.1	REVIEWED	C	1.000	1.000	424	1275	1	1272	424	1	424
RIKEN	BC001590	IRAL003P11	MGC	W01A117L06	pENTR-TOPO	12265		M6PRBP1	10226	AAH01590.1	Hs.140452	Mannose-6-phosphate receptor binding protein 1			Colon, adenocarcinoma	NIH_MGC_15		NM_005817.3	NP_005808.2	REVIEWED	Cs	0.998	0.998	434	1305	1	1302	434	1	434
RIKEN	BC026262	IRAL037B13	MGC	W01A117L14	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC026262	IRAL037B13	MGC	W01A117L16	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC026262	IRAL037B13	MGC	W01A117L20	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC026262	IRAL037B13	MGC	W01A117L22	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC026262	IRAL037B13	MGC	W01A117L24	pENTR-TOPO	5423		LTBR	4055	AAH26262.1	Hs.1116	Lymphotoxin beta receptor (TNFR superfamily, member 3)			Lung	NIH_MGC_77	DH10B	NM_002342.1	NP_002333.1	REVIEWED	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC036538	IRAK047F23	MGC	W01A117M07	pENTR-TOPO	11166		SYT4	6860	AAH36538.1	Hs.8059	Synaptotagmin IV			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020783.3	NP_065834.1	VALIDATED	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC036538	IRAK047F23	MGC	W01A117M11	pENTR-TOPO	11166		SYT4	6860	AAH36538.1	Hs.8059	Synaptotagmin IV			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020783.3	NP_065834.1	VALIDATED	C	1.000	1.000	425	1278	1	1275	425	1	425
RIKEN	BC004217	IRAL011G01	MGC	W01A117M13	pENTR-TOPO	24127		NPDC1	56654	AAH04217.1	Hs.457	Neural proliferation, differentiation and control, 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_015392.3	NP_056207.3	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC004217	IRAL011G01	MGC	W01A117M23	pENTR-TOPO	24127		NPDC1	56654	AAH04217.1	Hs.457	Neural proliferation, differentiation and control, 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_015392.3	NP_056207.3	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
RIKEN	BC007835	IRAL020C10	MGC	W01A117N06	pENTR-TOPO	1824		STK40	83931	AAH07835.2	Hs.471768	Serine/threonine kinase 40			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032017.1	NP_114406.1	PROVISIONAL	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC007835	IRAL020C10	MGC	W01A117N08	pENTR-TOPO	1824		STK40	83931	AAH07835.2	Hs.471768	Serine/threonine kinase 40			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032017.1	NP_114406.1	PROVISIONAL	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC007835	IRAL020C10	MGC	W01A117N12	pENTR-TOPO	1824		STK40	83931	AAH07835.2	Hs.471768	Serine/threonine kinase 40			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_032017.1	NP_114406.1	PROVISIONAL	C	1.000	1.000	435	1308	1	1305	435	1	435
RIKEN	BC014781	IRAK019N20	MGC	W01A117N14	pENTR-TOPO	9140		LCAT	3931	AAH14781.1	Hs.387239	Lecithin-cholesterol acyltransferase				NCI_CGAP_Brn67	DH10B	NM_000229.1	NP_000220.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC014781	IRAK019N20	MGC	W01A117N16	pENTR-TOPO	9140		LCAT	3931	AAH14781.1	Hs.387239	Lecithin-cholesterol acyltransferase				NCI_CGAP_Brn67	DH10B	NM_000229.1	NP_000220.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC014781	IRAK019N20	MGC	W01A117N20	pENTR-TOPO	9140		LCAT	3931	AAH14781.1	Hs.387239	Lecithin-cholesterol acyltransferase				NCI_CGAP_Brn67	DH10B	NM_000229.1	NP_000220.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC014781	IRAK019N20	MGC	W01A117N22	pENTR-TOPO	9140		LCAT	3931	AAH14781.1	Hs.387239	Lecithin-cholesterol acyltransferase				NCI_CGAP_Brn67	DH10B	NM_000229.1	NP_000220.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC014781	IRAK019N20	MGC	W01A117N24	pENTR-TOPO	9140		LCAT	3931	AAH14781.1	Hs.387239	Lecithin-cholesterol acyltransferase				NCI_CGAP_Brn67	DH10B	NM_000229.1	NP_000220.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
RIKEN	BC006286	IRAL015H08	MGC	W01A117O11	pENTR-TOPO	369		DUSP12	11266	AAH06286.1	Hs.416216	Dual specificity phosphatase 12			Placenta, choriocarcinoma	NIH_MGC_21		NM_007240.1	NP_009171.1	REVIEWED	OK	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC007720	IRAL017M14	MGC	W01A117O13	pENTR-TOPO	1766		HTR1D	3352	AAH07720.1	Hs.121482	5-hydroxytryptamine (serotonin) receptor 1D			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_000864.4	NP_000855.1	VALIDATED	C	1.000	1.000	377	1134	1	1131	377	1	377
RIKEN	BC040228	IRAK051J21	MGC	W01A117P10	pENTR-TOPO	19686		PACSIN1	29993	AAH40228.1	Hs.520087	Protein kinase C and casein kinase substrate in neurons 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020804.2	NP_065855.1	VALIDATED	C	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC006570	IRAL011D14	MGC	W01A117P18	pENTR-TOPO	12507		TUBB4	10382	AAH06570.1	Hs.110837	Tubulin, beta 4			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_006087.2	NP_006078.2	PROVISIONAL	C	1.000	1.000	444	1335	1	1332	444	1	444
RIKEN	BC025679	IRAK049E23	MGC	W01A118A01	pENTR-TOPO	9641		STARD3	10948	AAH25679.1	Hs.77628	StAR-related lipid transfer (START) domain containing 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006804.2	NP_006795.2	PROVISIONAL	OK	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC025679	IRAK049E23	MGC	W01A118A05	pENTR-TOPO	9641		STARD3	10948	AAH25679.1	Hs.77628	StAR-related lipid transfer (START) domain containing 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006804.2	NP_006795.2	PROVISIONAL	OK	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC025679	IRAK049E23	MGC	W01A118A07	pENTR-TOPO	9641		STARD3	10948	AAH25679.1	Hs.77628	StAR-related lipid transfer (START) domain containing 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006804.2	NP_006795.2	PROVISIONAL	OK	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC025679	IRAK049E23	MGC	W01A118A09	pENTR-TOPO	9641		STARD3	10948	AAH25679.1	Hs.77628	StAR-related lipid transfer (START) domain containing 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006804.2	NP_006795.2	PROVISIONAL	OK	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC043502	IRAK089E07	MGC	W01A118A13	pENTR-TOPO	2075		NEK2	4751	AAH43502.2	Hs.153704	NIMA (never in mitosis gene a)-related kinase 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002497.2	NP_002488.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC043502	IRAK089E07	MGC	W01A118A15	pENTR-TOPO	2075		NEK2	4751	AAH43502.2	Hs.153704	NIMA (never in mitosis gene a)-related kinase 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002497.2	NP_002488.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC043502	IRAK089E07	MGC	W01A118A21	pENTR-TOPO	2075		NEK2	4751	AAH43502.2	Hs.153704	NIMA (never in mitosis gene a)-related kinase 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002497.2	NP_002488.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC043502	IRAK089E07	MGC	W01A118A23	pENTR-TOPO	2075		NEK2	4751	AAH43502.2	Hs.153704	NIMA (never in mitosis gene a)-related kinase 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002497.2	NP_002488.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	BC015547	IRAK020F05	MGC	W01A118B04	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC015547	IRAK020F05	MGC	W01A118B06	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC015547	IRAK020F05	MGC	W01A118B12	pENTR-TOPO	24093		UCK1	83549	AAH15547.1	Hs.9597	Uridine-cytidine kinase 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001135954.1	NP_001129426.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
RIKEN	BC065830	IRAK141L14	MGC	W01A118B18	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC065830	IRAK141L14	MGC	W01A118B20	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	BC065830	IRAK141L14	MGC	W01A118B24	pENTR-TOPO	8831		CLDN9	9080	AAH65830.1					Pituitary	NIH_MGC_179	DH10B	NM_020982.3	NP_066192.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
RIKEN	AK026594	flj0060p08	FLJ	W01A118C05	pENTR-TOPO	23623		TUBB2C	10383	-	Hs.433615	Tubulin, beta 2C				KAT	EK1	NM_006088.5	NP_006079.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	AK026594	flj0060p08	FLJ	W01A118C09	pENTR-TOPO	23623		TUBB2C	10383	-	Hs.433615	Tubulin, beta 2C				KAT	EK1	NM_006088.5	NP_006079.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
RIKEN	AK055693	flj0001n16	FLJ	W01A118C17	pENTR-TOPO	16392		ZBTB38	253461	BAB70986.1	Hs.715534	Zinc finger and BTB domain containing 38	IMR32	neuroblastoma		IMR322	EK1	NM_001080412.2	NP_001073881.2	VALIDATED	Pfs	0.292	0.304	24	402	246	317	1195	358	380
RIKEN	AK055693	flj0001n16	FLJ	W01A118C19	pENTR-TOPO	16392		ZBTB38	253461	BAB70986.1	Hs.715534	Zinc finger and BTB domain containing 38	IMR32	neuroblastoma		IMR322	EK1	NM_001080412.2	NP_001073881.2	VALIDATED	Pfs	0.292	0.304	24	402	246	317	1195	358	380
RIKEN	AK055693	flj0001n16	FLJ	W01A118C23	pENTR-TOPO	16392		ZBTB38	253461	BAB70986.1	Hs.715534	Zinc finger and BTB domain containing 38	IMR32	neuroblastoma		IMR322	EK1	NM_001080412.2	NP_001073881.2	VALIDATED	Pfs	0.292	0.304	24	402	246	317	1195	358	380
RIKEN	BC025389	IRAK034H16	MGC	W01A118D02	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC025389	IRAK034H16	MGC	W01A118D06	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC025389	IRAK034H16	MGC	W01A118D12	pENTR-TOPO	11076		PSMA8	143471	-	Hs.464813	Proteasome (prosome, macropain) subunit, alpha type, 8			Testis	NIH_MGC_97	DH10B	NM_144662.2	NP_653263.2	VALIDATED	Ps	0.996	0.996	242	729	1	726	256	1	242
RIKEN	BC002920	IRAL015E10	MGC	W01A118D20	pENTR-TOPO	2714		TSPAN14	81619	AAH02920.1	Hs.310453	Tetraspanin 14			Skin, melanotic melanoma.	NIH_MGC_20		NM_030927.2	NP_112189.2	VALIDATED	Cg	0.937	1.000	270	762	1	759	270	1	270
RIKEN	BC002920	IRAL015E10	MGC	W01A118D22	pENTR-TOPO	2714		TSPAN14	81619	AAH02920.1	Hs.310453	Tetraspanin 14			Skin, melanotic melanoma.	NIH_MGC_20		NM_030927.2	NP_112189.2	VALIDATED	Cg	0.937	1.000	270	762	1	759	270	1	270
RIKEN	AK055181	flj0014j12	FLJ	W01A118E03	pENTR-TOPO	5209		ARID2	196528	BAB70867	Hs.317304	AT rich interactive domain 2 (ARID, RFX-like)				CTONG2	EK1	NM_152641.2	NP_689854.2	VALIDATED	P	1.000	1.000	145	441	1	435	1835	355	499
RIKEN	AK098342	flj0051j12	FLJ	W01A118E13	pENTR-TOPO	466		ZNF362	149076	BAC05287.1	Hs.524248	Zinc finger protein 362				CBL	EK1	NM_152493.2	NP_689706.2	VALIDATED		0.317	0.317	41	621	339	217	420	135	175
RIKEN	AK098342	flj0051j12	FLJ	W01A118E21	pENTR-TOPO	466		ZNF362	149076	BAC05287.1	Hs.524248	Zinc finger protein 362				CBL	EK1	NM_152493.2	NP_689706.2	VALIDATED		0.317	0.317	41	621	339	217	420	135	175
RIKEN	NM_033173	X01Y105E07	RIKEN_rt-pcr	W01A118F06	pENTR-TOPO	15165		B3GALT5	10317	NP_149363.1	Hs.655094	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 5						NM_033170.1	NP_149360.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
RIKEN	BC022845	IRAL003L23	MGC	W01A118F20	pENTR-TOPO	7757		MORF4L1	10933	AAH22845.1	Hs.374503	Mortality factor 4 like 1			Skin, melanotic melanoma.	NIH_MGC_20		NM_006791.2	NP_006782.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
RIKEN	AK094068	flj0016l02	FLJ	W01A118G01	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	AK094068	flj0016l02	FLJ	W01A118G03	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	AK094068	flj0016l02	FLJ	W01A118G07	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	AK094068	flj0016l02	FLJ	W01A118G09	pENTR-TOPO	7514		PROX2	283571	BAC04278.1	Hs.675293	Prospero homeobox 2				UTERU2	EK1	NM_001080408.1	NP_001073877.1	PROVISIONAL	Pgs	0.520	0.992	477	753	1	750	592	116	592
RIKEN	NM_014468	X01Y023I23	RIKEN_rt-pcr	W01A118G21	pENTR-TOPO	2656		VENTX	27287	NP_055283.1	Hs.125231	VENT homeobox homolog (Xenopus laevis)						NM_014468.2	NP_055283.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
RIKEN	BC035496	IRAL027F05	MGC	W01A118H02	pENTR-TOPO	2203		CITED4	163732	AAH35496.1	Hs.355820	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4			Pancreas, adenocarcinoma	NIH_MGC_39		NM_133467.2	NP_597724.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC035496	IRAL027F05	MGC	W01A118H06	pENTR-TOPO	2203		CITED4	163732	AAH35496.1	Hs.355820	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4			Pancreas, adenocarcinoma	NIH_MGC_39		NM_133467.2	NP_597724.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC035496	IRAL027F05	MGC	W01A118H10	pENTR-TOPO	2203		CITED4	163732	AAH35496.1	Hs.355820	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4			Pancreas, adenocarcinoma	NIH_MGC_39		NM_133467.2	NP_597724.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC035496	IRAL027F05	MGC	W01A118H12	pENTR-TOPO	2203		CITED4	163732	AAH35496.1	Hs.355820	Cbp/p300-interacting transactivator, with Glu/Asp-rich carboxy-terminal domain, 4			Pancreas, adenocarcinoma	NIH_MGC_39		NM_133467.2	NP_597724.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
RIKEN	BC016757	IRAL019D24	MGC	W01A118H14	pENTR-TOPO	17487		SAP30	8819	AAH16757.1	Hs.591715	Sin3A-associated protein, 30kDa			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_003864.3	NP_003855.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC016757	IRAL019D24	MGC	W01A118H16	pENTR-TOPO	17487		SAP30	8819	AAH16757.1	Hs.591715	Sin3A-associated protein, 30kDa			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_003864.3	NP_003855.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC016757	IRAL019D24	MGC	W01A118H18	pENTR-TOPO	17487		SAP30	8819	AAH16757.1	Hs.591715	Sin3A-associated protein, 30kDa			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_003864.3	NP_003855.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC016757	IRAL019D24	MGC	W01A118H20	pENTR-TOPO	17487		SAP30	8819	AAH16757.1	Hs.591715	Sin3A-associated protein, 30kDa			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_003864.3	NP_003855.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC016757	IRAL019D24	MGC	W01A118H22	pENTR-TOPO	17487		SAP30	8819	AAH16757.1	Hs.591715	Sin3A-associated protein, 30kDa			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_003864.3	NP_003855.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC016757	IRAL019D24	MGC	W01A118H24	pENTR-TOPO	17487		SAP30	8819	AAH16757.1	Hs.591715	Sin3A-associated protein, 30kDa			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_003864.3	NP_003855.1	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
RIKEN	BC026088	IRAK034A23	MGC	W01A118I01	pENTR-TOPO	6557		RFXAP	5994	AAH26088.1	Hs.24422	Regulatory factor X-associated protein			Testis	NIH_MGC_97	DH10B	NM_000538.3	NP_000529.1	REVIEWED	Cs	0.996	0.996	272	819	1	816	272	1	272
RIKEN	BC026088	IRAK034A23	MGC	W01A118I11	pENTR-TOPO	6557		RFXAP	5994	AAH26088.1	Hs.24422	Regulatory factor X-associated protein			Testis	NIH_MGC_97	DH10B	NM_000538.3	NP_000529.1	REVIEWED	Cs	0.996	0.996	272	819	1	816	272	1	272
RIKEN	BC015913	IRAL029G09	MGC	W01A118I15	pENTR-TOPO	5877		CSDA	8531	AAH15913.1	Hs.221889	Cold shock domain protein A			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001145426.1	NP_001138898.1	VALIDATED	C	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC015913	IRAL029G09	MGC	W01A118I17	pENTR-TOPO	5877		CSDA	8531	AAH15913.1	Hs.221889	Cold shock domain protein A			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001145426.1	NP_001138898.1	VALIDATED	C	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC015913	IRAL029G09	MGC	W01A118I23	pENTR-TOPO	5877		CSDA	8531	AAH15913.1	Hs.221889	Cold shock domain protein A			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_001145426.1	NP_001138898.1	VALIDATED	C	1.000	1.000	303	912	1	909	303	1	303
RIKEN	BC005903	IRAL021M05	MGC	W01A118J14	pENTR-TOPO	4884		POLR2L	5441	AAH05903.1	Hs.441072	Polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_021128.4	NP_066951.1	REVIEWED	OK	1.000	1.000	67	204	1	201	67	1	67
RIKEN	BC005903	IRAL021M05	MGC	W01A118J20	pENTR-TOPO	4884		POLR2L	5441	AAH05903.1	Hs.441072	Polymerase (RNA) II (DNA directed) polypeptide L, 7.6kDa			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_021128.4	NP_066951.1	REVIEWED	OK	1.000	1.000	67	204	1	201	67	1	67
RIKEN	NM_006492	X01Y005C11	RIKEN_rt-pcr	W01A118K01	pENTR-TOPO	1538		ALX3	257	NP_006483.2	Hs.669953	ALX homeobox 3						NM_006492.2	NP_006483.2	REVIEWED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
RIKEN	NM_006492	X01Y005C11	RIKEN_rt-pcr	W01A118K03	pENTR-TOPO	1538		ALX3	257	NP_006483.2	Hs.669953	ALX homeobox 3						NM_006492.2	NP_006483.2	REVIEWED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
RIKEN	NM_006492	X01Y005C11	RIKEN_rt-pcr	W01A118K07	pENTR-TOPO	1538		ALX3	257	NP_006483.2	Hs.669953	ALX homeobox 3						NM_006492.2	NP_006483.2	REVIEWED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
RIKEN	NM_006492	X01Y005C11	RIKEN_rt-pcr	W01A118K09	pENTR-TOPO	1538		ALX3	257	NP_006483.2	Hs.669953	ALX homeobox 3						NM_006492.2	NP_006483.2	REVIEWED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
RIKEN	NM_006492	X01Y005C11	RIKEN_rt-pcr	W01A118K11	pENTR-TOPO	1538		ALX3	257	NP_006483.2	Hs.669953	ALX homeobox 3						NM_006492.2	NP_006483.2	REVIEWED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
RIKEN	BC069107	X01Y145E01	MGC	W01A118K13	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC069107	X01Y145E01	MGC	W01A118K17	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC069107	X01Y145E01	MGC	W01A118K21	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	BC069107	X01Y145E01	MGC	W01A118K23	pENTR-TOPO	8962		CCL17	6361	AAH69107.1	Hs.546294	Chemokine (C-C motif) ligand 17						NM_002987.2	NP_002978.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	AK000410	flj0062f23	FLJ	W01A118L04	pENTR-TOPO	547		ZNF326	284695	-	Hs.306221	Zinc finger protein 326				KAT	EK1	NM_182975.2	NP_892020.1	VALIDATED	C	1.000	1.000	70	213	1	210	70	1	70
RIKEN	AK000410	flj0062f23	FLJ	W01A118L06	pENTR-TOPO	547		ZNF326	284695	-	Hs.306221	Zinc finger protein 326				KAT	EK1	NM_182975.2	NP_892020.1	VALIDATED	C	1.000	1.000	70	213	1	210	70	1	70
RIKEN	AK000410	flj0062f23	FLJ	W01A118L08	pENTR-TOPO	547		ZNF326	284695	-	Hs.306221	Zinc finger protein 326				KAT	EK1	NM_182975.2	NP_892020.1	VALIDATED	C	1.000	1.000	70	213	1	210	70	1	70
RIKEN	AK000410	flj0062f23	FLJ	W01A118L10	pENTR-TOPO	547		ZNF326	284695	-	Hs.306221	Zinc finger protein 326				KAT	EK1	NM_182975.2	NP_892020.1	VALIDATED	C	1.000	1.000	70	213	1	210	70	1	70
RIKEN	BC060317	IRAK134E16	MGC	W01A118L14	pENTR-TOPO	19912		GTF2H5	404672	AAH60317.1	Hs.356224	General transcription factor IIH, polypeptide 5			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
RIKEN	BC060317	IRAK134E16	MGC	W01A118L18	pENTR-TOPO	19912		GTF2H5	404672	AAH60317.1	Hs.356224	General transcription factor IIH, polypeptide 5			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
RIKEN	D13899	X01Y145E23	RIKEN_rt-pcr	W01A118M01	pENTR-TOPO	10743		PYY	5697	BAA03000.1	Hs.169249	Peptide YY						NM_004160.3	NP_004151.2	VALIDATED		0.979	0.979	97	294	1	291	97	1	97
RIKEN	D13899	X01Y145E23	RIKEN_rt-pcr	W01A118M03	pENTR-TOPO	10743		PYY	5697	BAA03000.1	Hs.169249	Peptide YY						NM_004160.3	NP_004151.2	VALIDATED		0.979	0.979	97	294	1	291	97	1	97
RIKEN	D13899	X01Y145E23	RIKEN_rt-pcr	W01A118M09	pENTR-TOPO	10743		PYY	5697	BAA03000.1	Hs.169249	Peptide YY						NM_004160.3	NP_004151.2	VALIDATED		0.979	0.979	97	294	1	291	97	1	97
RIKEN	BC017361	IRAL039F18	MGC	W01A118M13	pENTR-TOPO	20162		HIST1H4J	8363	AAH17361.1					Eye, retinoblastoma	NIH_MGC_16		NM_021968.3	NP_068803.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC017361	IRAL039F18	MGC	W01A118M19	pENTR-TOPO	20162		HIST1H4J	8363	AAH17361.1					Eye, retinoblastoma	NIH_MGC_16		NM_021968.3	NP_068803.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
RIKEN	BC054347	IRAK115F24	MGC	W01A118N04	pENTR-TOPO	14566		EBF4	57593	AAH54347.1	Hs.471955	Early B-cell factor 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001110514.1	NP_001103984.1	VALIDATED	P	1.000	1.000	88	267	1	264	598	511	598
RIKEN	BC054347	IRAK115F24	MGC	W01A118N06	pENTR-TOPO	14566		EBF4	57593	AAH54347.1	Hs.471955	Early B-cell factor 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001110514.1	NP_001103984.1	VALIDATED	P	1.000	1.000	88	267	1	264	598	511	598
RIKEN	BC054347	IRAK115F24	MGC	W01A118N08	pENTR-TOPO	14566		EBF4	57593	AAH54347.1	Hs.471955	Early B-cell factor 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001110514.1	NP_001103984.1	VALIDATED	P	1.000	1.000	88	267	1	264	598	511	598
RIKEN	BC054347	IRAK115F24	MGC	W01A118N10	pENTR-TOPO	14566		EBF4	57593	AAH54347.1	Hs.471955	Early B-cell factor 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001110514.1	NP_001103984.1	VALIDATED	P	1.000	1.000	88	267	1	264	598	511	598
RIKEN	BC054347	IRAK115F24	MGC	W01A118N12	pENTR-TOPO	14566		EBF4	57593	AAH54347.1	Hs.471955	Early B-cell factor 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001110514.1	NP_001103984.1	VALIDATED	P	1.000	1.000	88	267	1	264	598	511	598
RIKEN	BC015960	IRAL025J09	MGC	W01A118N14	pENTR-TOPO	24090		CDKN2A	1029	AAH15960.3	Hs.512599	Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)			Skin, melanotic melanoma.	NIH_MGC_20		NM_000077.3	NP_000068.1	REVIEWED	P	1.000	1.000	105	318	1	315	156	52	156
RIKEN	BC015960	IRAL025J09	MGC	W01A118N16	pENTR-TOPO	24090		CDKN2A	1029	AAH15960.3	Hs.512599	Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)			Skin, melanotic melanoma.	NIH_MGC_20		NM_000077.3	NP_000068.1	REVIEWED	P	1.000	1.000	105	318	1	315	156	52	156
RIKEN	BC015960	IRAL025J09	MGC	W01A118N20	pENTR-TOPO	24090		CDKN2A	1029	AAH15960.3	Hs.512599	Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)			Skin, melanotic melanoma.	NIH_MGC_20		NM_000077.3	NP_000068.1	REVIEWED	P	1.000	1.000	105	318	1	315	156	52	156
RIKEN	BC015960	IRAL025J09	MGC	W01A118N22	pENTR-TOPO	24090		CDKN2A	1029	AAH15960.3	Hs.512599	Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)			Skin, melanotic melanoma.	NIH_MGC_20		NM_000077.3	NP_000068.1	REVIEWED	P	1.000	1.000	105	318	1	315	156	52	156
RIKEN	BC015960	IRAL025J09	MGC	W01A118N24	pENTR-TOPO	24090		CDKN2A	1029	AAH15960.3	Hs.512599	Cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4)			Skin, melanotic melanoma.	NIH_MGC_20		NM_000077.3	NP_000068.1	REVIEWED	P	1.000	1.000	105	318	1	315	156	52	156
RIKEN	BC015744	IRAL034N11	MGC	W01A118O05	pENTR-TOPO	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006014.3	NP_006005.2	REVIEWED	C	1.000	1.000	143	432	1	429	143	1	143
RIKEN	BC015744	IRAL034N11	MGC	W01A118O11	pENTR-TOPO	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_006014.3	NP_006005.2	REVIEWED	C	1.000	1.000	143	432	1	429	143	1	143
RIKEN	BC033089	IRAL043K14	MGC	W01A118O13	pENTR-TOPO	23788		LCN2	3934	AAH33089.1	Hs.204238	Lipocalin 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_005564.3	NP_005555.2	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC033089	IRAL043K14	MGC	W01A118O17	pENTR-TOPO	23788		LCN2	3934	AAH33089.1	Hs.204238	Lipocalin 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_005564.3	NP_005555.2	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC033089	IRAL043K14	MGC	W01A118O21	pENTR-TOPO	23788		LCN2	3934	AAH33089.1	Hs.204238	Lipocalin 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_005564.3	NP_005555.2	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC033089	IRAL043K14	MGC	W01A118O23	pENTR-TOPO	23788		LCN2	3934	AAH33089.1	Hs.204238	Lipocalin 2			Pancreas, ductal carcinoma	NIH_MGC_110		NM_005564.3	NP_005555.2	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
RIKEN	BC010178	IRAL028G02	MGC	W01A118P06	pENTR-TOPO	12489		LOC729991	729991	-	Hs.153629	Hypothetical protein LOC729991			Lung, small cell carcinoma	NIH_MGC_7		NM_001145783.1	NP_001139255.1	VALIDATED	C	1.000	1.000	109	330	1	327	109	1	109
RIKEN	BC010178	IRAL028G02	MGC	W01A118P12	pENTR-TOPO	12489		LOC729991	729991	-	Hs.153629	Hypothetical protein LOC729991			Lung, small cell carcinoma	NIH_MGC_7		NM_001145783.1	NP_001139255.1	VALIDATED	C	1.000	1.000	109	330	1	327	109	1	109
RIKEN	BC061584	IRAK141F07	MGC	W01A118P20	pENTR-TOPO	3684		ATM	472	AAH61584.1	Hs.367437	Ataxia telangiectasia mutated				Lupski_sympathetic_trunk	DH10B	NM_000051.3	NP_000042.3	REVIEWED	P	1.000	1.000	110	339	1	330	3056	1	110
RIKEN	BC061584	IRAK141F07	MGC	W01A118P22	pENTR-TOPO	3684		ATM	472	AAH61584.1	Hs.367437	Ataxia telangiectasia mutated				Lupski_sympathetic_trunk	DH10B	NM_000051.3	NP_000042.3	REVIEWED	P	1.000	1.000	110	339	1	330	3056	1	110
RIKEN	BC031209	IRAK063E04	MGC	W01A119A03	pENTR-TOPO	16204		ZNF197	10168	AAH31209	Hs.157035	Zinc finger protein 197			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006991.3	NP_008922.1	REVIEWED	Pfs	0.991	0.991	117	351	1	350	1029	1	117
RIKEN	BC031209	IRAK063E04	MGC	W01A119A05	pENTR-TOPO	16204		ZNF197	10168	AAH31209	Hs.157035	Zinc finger protein 197			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006991.3	NP_008922.1	REVIEWED	Pfs	0.991	0.991	117	351	1	350	1029	1	117
RIKEN	BC031209	IRAK063E04	MGC	W01A119A07	pENTR-TOPO	16204		ZNF197	10168	AAH31209	Hs.157035	Zinc finger protein 197			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006991.3	NP_008922.1	REVIEWED	Pfs	0.991	0.991	117	351	1	350	1029	1	117
RIKEN	BC031209	IRAK063E04	MGC	W01A119A09	pENTR-TOPO	16204		ZNF197	10168	AAH31209	Hs.157035	Zinc finger protein 197			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006991.3	NP_008922.1	REVIEWED	Pfs	0.991	0.991	117	351	1	350	1029	1	117
RIKEN	BC031209	IRAK063E04	MGC	W01A119A11	pENTR-TOPO	16204		ZNF197	10168	AAH31209	Hs.157035	Zinc finger protein 197			Brain, hippocampus	NIH_MGC_95	DH10B	NM_006991.3	NP_008922.1	REVIEWED	Pfs	0.991	0.991	117	351	1	350	1029	1	117
RIKEN	AK023373	flj0036e20	FLJ	W01A119A17	pENTR-TOPO	1338		RRAGC	64121	BAB14548.1	Hs.532461	Ras-related GTP binding C				OVARC1	EK1	NM_022157.2	NP_071440.1	PROVISIONAL	P	1.000	1.000	121	366	1	363	399	279	399
RIKEN	AK023373	flj0036e20	FLJ	W01A119A23	pENTR-TOPO	1338		RRAGC	64121	BAB14548.1	Hs.532461	Ras-related GTP binding C				OVARC1	EK1	NM_022157.2	NP_071440.1	PROVISIONAL	P	1.000	1.000	121	366	1	363	399	279	399
RIKEN	BC009793	IRAL019A04	MGC	W01A119B12	pENTR-TOPO	19325		ERCC8	1161	AAH09793.1	Hs.435237	Excision repair cross-complementing rodent repair deficiency, complementation group 8			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001007234.1	NP_001007235.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC035374	IRAK051N16	MGC	W01A119B24	pENTR-TOPO	656		C1orf83	127428	AAH35374.1	Hs.558618	Chromosome 1 open reading frame 83			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153035.1	NP_694580.1	PREDICTED	OK	1.000	1.000	208	627	1	624	208	1	208
RIKEN	AK001001	flj0028d03	FLJ	W01A119C15	pENTR-TOPO	5370		ATF7IP	55729	BAA91461	Hs.714407	Activating transcription factor 7 interacting protein				HEMBA1	EK1	NM_018179.3	NP_060649.3	VALIDATED	P	1.000	1.000	130	396	1	390	1270	390	519
RIKEN	AK001001	flj0028d03	FLJ	W01A119C21	pENTR-TOPO	5370		ATF7IP	55729	BAA91461	Hs.714407	Activating transcription factor 7 interacting protein				HEMBA1	EK1	NM_018179.3	NP_060649.3	VALIDATED	P	1.000	1.000	130	396	1	390	1270	390	519
RIKEN	BC010543	IRAK019L17	MGC	W01A119D22	pENTR-TOPO	1773		MED8	112950	AAH10543.2	Hs.301756	Mediator complex subunit 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_201542.3	NP_963836.2	REVIEWED	P	1.000	1.000	179	639	1	537	268	90	268
RIKEN	BC010543	IRAK019L17	MGC	W01A119D24	pENTR-TOPO	1773		MED8	112950	AAH10543.2	Hs.301756	Mediator complex subunit 8			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_201542.3	NP_963836.2	REVIEWED	P	1.000	1.000	179	639	1	537	268	90	268
RIKEN	AK025680	flj0065n18	FLJ	W01A119E03	pENTR-TOPO	2728		HIF1AN	55662	BAB15213.1	Hs.500788	Hypoxia inducible factor 1, alpha subunit inhibitor	HepG2	hepatoma		HEP	EK1	NM_017902.2	NP_060372.2	VALIDATED		0.333	0.333	21	399	96	158	349	216	236
RIKEN	AK025680	flj0065n18	FLJ	W01A119E07	pENTR-TOPO	2728		HIF1AN	55662	BAB15213.1	Hs.500788	Hypoxia inducible factor 1, alpha subunit inhibitor	HepG2	hepatoma		HEP	EK1	NM_017902.2	NP_060372.2	VALIDATED		0.333	0.333	21	399	96	158	349	216	236
RIKEN	AK025680	flj0065n18	FLJ	W01A119E11	pENTR-TOPO	2728		HIF1AN	55662	BAB15213.1	Hs.500788	Hypoxia inducible factor 1, alpha subunit inhibitor	HepG2	hepatoma		HEP	EK1	NM_017902.2	NP_060372.2	VALIDATED		0.333	0.333	21	399	96	158	349	216	236
RIKEN	AK055561	flj0001n13	FLJ	W01A119E13	pENTR-TOPO	10302		ERN1	2081	BAB70956	Hs.700027	Endoplasmic reticulum to nucleus signaling 1				HLUNG1	EK1	NM_001433.3	NP_001424.3	REVIEWED		0.545	0.545	11	402	289	321	977	965	975
RIKEN	AK055561	flj0001n13	FLJ	W01A119E21	pENTR-TOPO	10302		ERN1	2081	BAB70956	Hs.700027	Endoplasmic reticulum to nucleus signaling 1				HLUNG1	EK1	NM_001433.3	NP_001424.3	REVIEWED		0.545	0.545	11	402	289	321	977	965	975
RIKEN	AK056767	flj0006p15	FLJ	W01A119F04	pENTR-TOPO	21126		MAFK	7975	BAB71276	Hs.520612	V-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)				PLACE6	EK1	NM_002360.3	NP_002351.1	VALIDATED		0.174	0.174	23	660	330	398	156	6	28
RIKEN	AK056767	flj0006p15	FLJ	W01A119F06	pENTR-TOPO	21126		MAFK	7975	BAB71276	Hs.520612	V-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)				PLACE6	EK1	NM_002360.3	NP_002351.1	VALIDATED		0.174	0.174	23	660	330	398	156	6	28
RIKEN	AK056767	flj0006p15	FLJ	W01A119F08	pENTR-TOPO	21126		MAFK	7975	BAB71276	Hs.520612	V-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)				PLACE6	EK1	NM_002360.3	NP_002351.1	VALIDATED		0.174	0.174	23	660	330	398	156	6	28
RIKEN	AK056767	flj0006p15	FLJ	W01A119F12	pENTR-TOPO	21126		MAFK	7975	BAB71276	Hs.520612	V-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)				PLACE6	EK1	NM_002360.3	NP_002351.1	VALIDATED		0.174	0.174	23	660	330	398	156	6	28
RIKEN	BC000518	IRAL001J18	MGC	W01A119F14	pENTR-TOPO	18590		BASP1	10409	AAH00518.1	Hs.201641	Brain abundant, membrane attached signal protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006317.3	NP_006308.3	REVIEWED	Cs	0.996	0.996	227	684	1	681	227	1	227
RIKEN	BC000518	IRAL001J18	MGC	W01A119F16	pENTR-TOPO	18590		BASP1	10409	AAH00518.1	Hs.201641	Brain abundant, membrane attached signal protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006317.3	NP_006308.3	REVIEWED	Cs	0.996	0.996	227	684	1	681	227	1	227
RIKEN	BC000518	IRAL001J18	MGC	W01A119F22	pENTR-TOPO	18590		BASP1	10409	AAH00518.1	Hs.201641	Brain abundant, membrane attached signal protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006317.3	NP_006308.3	REVIEWED	Cs	0.996	0.996	227	684	1	681	227	1	227
RIKEN	BC000518	IRAL001J18	MGC	W01A119F24	pENTR-TOPO	18590		BASP1	10409	AAH00518.1	Hs.201641	Brain abundant, membrane attached signal protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_006317.3	NP_006308.3	REVIEWED	Cs	0.996	0.996	227	684	1	681	227	1	227
RIKEN	AK128865	flj0076a08	FLJ	W01A119G01	pENTR-TOPO	2840		FOXI2	399823	BAC87649.1	Hs.449674	Forkhead box I2				UTERU2	EK1	NM_207426.2	NP_997309.2	VALIDATED	P	1.000	1.000	134	405	1	402	318	185	318
RIKEN	AK128865	flj0076a08	FLJ	W01A119G11	pENTR-TOPO	2840		FOXI2	399823	BAC87649.1	Hs.449674	Forkhead box I2				UTERU2	EK1	NM_207426.2	NP_997309.2	VALIDATED	P	1.000	1.000	134	405	1	402	318	185	318
RIKEN	BC072446	IRAK174K10	MGC	W01A119G15	pENTR-TOPO	25110		TSC22D3	1831	AAH72446.1	Hs.716410	TSC22 domain family, member 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004089.3	NP_004080.2	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	BC072446	IRAK174K10	MGC	W01A119G23	pENTR-TOPO	25110		TSC22D3	1831	AAH72446.1	Hs.716410	TSC22 domain family, member 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004089.3	NP_004080.2	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
RIKEN	AK000826	flj0066a23	FLJ	W01A119H08	pENTR-TOPO	16335		RAB7A	7879	BAA91390.1	Hs.716392	RAB7A, member RAS oncogene family				ad	EK1	NM_004637.5	NP_004628.4	REVIEWED	P	1.000	1.000	103	696	3	311	207	105	207
RIKEN	BC050396	IRAK098K16	MGC	W01A119H14	pENTR-TOPO	22966		ANKRD46	157567	AAH50396.1	Hs.530199	Ankyrin repeat domain 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198401.2	NP_940683.1	PROVISIONAL	P	1.000	1.000	212	699	1	636	228	1	212
RIKEN	BC050396	IRAK098K16	MGC	W01A119H16	pENTR-TOPO	22966		ANKRD46	157567	AAH50396.1	Hs.530199	Ankyrin repeat domain 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198401.2	NP_940683.1	PROVISIONAL	P	1.000	1.000	212	699	1	636	228	1	212
RIKEN	BC050396	IRAK098K16	MGC	W01A119H20	pENTR-TOPO	22966		ANKRD46	157567	AAH50396.1	Hs.530199	Ankyrin repeat domain 46			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198401.2	NP_940683.1	PROVISIONAL	P	1.000	1.000	212	699	1	636	228	1	212
RIKEN	AK127788	flj0078b04	FLJ	W01A119I13	pENTR-TOPO	5863		NCOR2	9612	BAC87136	Hs.137510	Nuclear receptor co-repressor 2				OCBBF3	EK1	NM_006312.3	NP_006303.3	VALIDATED		0.846	0.846	91	426	1	273	2524	2238	2328
RIKEN	AK127788	flj0078b04	FLJ	W01A119I17	pENTR-TOPO	5863		NCOR2	9612	BAC87136	Hs.137510	Nuclear receptor co-repressor 2				OCBBF3	EK1	NM_006312.3	NP_006303.3	VALIDATED		0.846	0.846	91	426	1	273	2524	2238	2328
RIKEN	BC040961	IRAK084F23	MGC	W01A119J02	pENTR-TOPO	5630		NEUROD4	58158	AAH40961.1	Hs.591024	Neurogenic differentiation 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021191.2	NP_067014.2	VALIDATED	P	1.000	1.000	255	768	1	765	331	77	331
RIKEN	BC040961	IRAK084F23	MGC	W01A119J06	pENTR-TOPO	5630		NEUROD4	58158	AAH40961.1	Hs.591024	Neurogenic differentiation 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021191.2	NP_067014.2	VALIDATED	P	1.000	1.000	255	768	1	765	331	77	331
RIKEN	BC040961	IRAK084F23	MGC	W01A119J12	pENTR-TOPO	5630		NEUROD4	58158	AAH40961.1	Hs.591024	Neurogenic differentiation 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_021191.2	NP_067014.2	VALIDATED	P	1.000	1.000	255	768	1	765	331	77	331
RIKEN	BC009372	IRAL026D07	MGC	W01A119J14	pENTR-TOPO	12007		MBD3	53615	AAH09372.1	Hs.178728	Methyl-CpG binding domain protein 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003926.5	NP_003917.1	REVIEWED	P	1.000	1.000	255	780	13	777	291	37	291
RIKEN	BC009372	IRAL026D07	MGC	W01A119J18	pENTR-TOPO	12007		MBD3	53615	AAH09372.1	Hs.178728	Methyl-CpG binding domain protein 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003926.5	NP_003917.1	REVIEWED	P	1.000	1.000	255	780	13	777	291	37	291
RIKEN	BC009372	IRAL026D07	MGC	W01A119J20	pENTR-TOPO	12007		MBD3	53615	AAH09372.1	Hs.178728	Methyl-CpG binding domain protein 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_003926.5	NP_003917.1	REVIEWED	P	1.000	1.000	255	780	13	777	291	37	291
RIKEN	BC000589	IRAL005A14	MGC	W01A119K03	pENTR-TOPO	11620		NDUFA13	51079	AAH00589.2	Hs.534453	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 13			Skin, melanotic melanoma.	NIH_MGC_20		NM_015965.5	NP_057049.4	VALIDATED	P	1.000	1.000	144	435	1	432	227	84	227
RIKEN	AK022800	flj0033g04	FLJ	W01A119K15	pENTR-TOPO	16228		ZNF167	55888	BAB14250.1	Hs.696570	Zinc finger protein 167	NT2	teratocarcinoma		NT2RP2	EK1	NM_025169.1	NP_079445.1	VALIDATED	Ps	0.994	0.994	168	507	1	504	276	1	168
RIKEN	AK022800	flj0033g04	FLJ	W01A119K23	pENTR-TOPO	16228		ZNF167	55888	BAB14250.1	Hs.696570	Zinc finger protein 167	NT2	teratocarcinoma		NT2RP2	EK1	NM_025169.1	NP_079445.1	VALIDATED	Ps	0.994	0.994	168	507	1	504	276	1	168
RIKEN	BC020712	IRAL037E02	MGC	W01A119L06	pENTR-TOPO	20407		POU5F1	5460	AAH20712	Hs.249184	POU class 5 homeobox 1			Lung	NIH_MGC_77	DH10B	NM_203289.3	NP_976034.3	VALIDATED	P	1.000	1.000	263	792	1	789	265	3	265
RIKEN	BC020712	IRAL037E02	MGC	W01A119L08	pENTR-TOPO	20407		POU5F1	5460	AAH20712	Hs.249184	POU class 5 homeobox 1			Lung	NIH_MGC_77	DH10B	NM_203289.3	NP_976034.3	VALIDATED	P	1.000	1.000	263	792	1	789	265	3	265
RIKEN	BC020712	IRAL037E02	MGC	W01A119L12	pENTR-TOPO	20407		POU5F1	5460	AAH20712	Hs.249184	POU class 5 homeobox 1			Lung	NIH_MGC_77	DH10B	NM_203289.3	NP_976034.3	VALIDATED	P	1.000	1.000	263	792	1	789	265	3	265
RIKEN	BC033290	IRAK029O23	MGC	W01A119L20	pENTR-TOPO	15191		OLIG1	116448	AAH33290.1	Hs.56663	Oligodendrocyte transcription factor 1				NCI_CGAP_Brn67	DH10B	NM_138983.2	NP_620450.2	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
RIKEN	BC033290	IRAK029O23	MGC	W01A119L24	pENTR-TOPO	15191		OLIG1	116448	AAH33290.1	Hs.56663	Oligodendrocyte transcription factor 1				NCI_CGAP_Brn67	DH10B	NM_138983.2	NP_620450.2	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
RIKEN	AK055063	flj0001o12	FLJ	W01A119M01	pENTR-TOPO	5218		IKZF4	64375	BAB70849	Hs.553221	IKAROS family zinc finger 4 (Eos)				BRAWH2	EK1	NM_022465.3	NP_071910.3	VALIDATED	P	1.000	1.000	180	543	1	540	585	406	585
RIKEN	AK055063	flj0001o12	FLJ	W01A119M03	pENTR-TOPO	5218		IKZF4	64375	BAB70849	Hs.553221	IKAROS family zinc finger 4 (Eos)				BRAWH2	EK1	NM_022465.3	NP_071910.3	VALIDATED	P	1.000	1.000	180	543	1	540	585	406	585
RIKEN	BC001107	IRAL007K19	MGC	W01A119M23	pENTR-TOPO	1561		FUSIP1	10772	AAH01107.1	Hs.652334	FUS interacting protein (serine/arginine-rich) 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_006625.3	NP_006616.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
RIKEN	BC036847	IRAK078K16	MGC	W01A119N02	pENTR-TOPO	18289		NEUROG2	63973	AAH36847.1	Hs.567563	Neurogenin 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_024019.2	NP_076924.1	PROVISIONAL	C	1.000	1.000	272	819	1	816	272	1	272
RIKEN	AK094076	flj0016l04	FLJ	W01A119N18	pENTR-TOPO	23688		SMARCA2	6595	BAC04280.1	Hs.298990	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2				UTERU2	EK1	NM_139045.2	NP_620614.2	REVIEWED	Ps	0.984	0.984	246	837	97	834	1572	1327	1572
RIKEN	AK094076	flj0016l04	FLJ	W01A119N20	pENTR-TOPO	23688		SMARCA2	6595	BAC04280.1	Hs.298990	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2				UTERU2	EK1	NM_139045.2	NP_620614.2	REVIEWED	Ps	0.984	0.984	246	837	97	834	1572	1327	1572
RIKEN	AK094076	flj0016l04	FLJ	W01A119N24	pENTR-TOPO	23688		SMARCA2	6595	BAC04280.1	Hs.298990	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 2				UTERU2	EK1	NM_139045.2	NP_620614.2	REVIEWED	Ps	0.984	0.984	246	837	97	834	1572	1327	1572
RIKEN	BC000582	IRAL005O09	MGC	W01A119O03	pENTR-TOPO	14666		POFUT1	23509	AAH00582.1	Hs.472409	Protein O-fucosyltransferase 1			Brain, neuroblastoma	NIH_MGC_19		NM_172236.1	NP_758436.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
RIKEN	BC000582	IRAL005O09	MGC	W01A119O07	pENTR-TOPO	14666		POFUT1	23509	AAH00582.1	Hs.472409	Protein O-fucosyltransferase 1			Brain, neuroblastoma	NIH_MGC_19		NM_172236.1	NP_758436.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
RIKEN	BC071997	IRAL058M10	MGC	W01A119O13	pENTR-TOPO	66		ATF6	22926	AAH71997.1	Hs.492740	Activating transcription factor 6			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_007348.2	NP_031374.2	VALIDATED		0.975	0.975	202	609	1	606	670	1	202
RIKEN	BC071997	IRAL058M10	MGC	W01A119O21	pENTR-TOPO	66		ATF6	22926	AAH71997.1	Hs.492740	Activating transcription factor 6			Pancreas, epithelioid carcinoma	NIH_MGC_42		NM_007348.2	NP_031374.2	VALIDATED		0.975	0.975	202	609	1	606	670	1	202
RIKEN	AK000415	flj0064j03	FLJ	W01A119P08	pENTR-TOPO	16302		HES1	3280	BAA91149.1	Hs.250666	Hairy and enhancer of split 1, (Drosophila)				KAT	EK1	NM_005524.2	NP_005515.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
RIKEN	BC006336	IRAL017O21	MGC	W01A120A05	pENTR-TOPO	13472		VAX2	25806	AAH06336.1	Hs.249170	Ventral anterior homeobox 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_012476.2	NP_036608.1	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
RIKEN	BC072458	IRAK174O02	MGC	W01A120A13	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC072458	IRAK174O02	MGC	W01A120A15	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC072458	IRAK174O02	MGC	W01A120A19	pENTR-TOPO	10186		PER1	5187	AAH72458.1	Hs.445534	Period homolog 1 (Drosophila)				Lupski_sympathetic_trunk	DH10B	NM_002616.2	NP_002607.2	REVIEWED	P	1.000	1.000	285	885	1	855	1290	1	285
RIKEN	BC007719	IRAL017K08	MGC	W01A120B10	pENTR-TOPO	2728		HIF1AN	55662	AAH07719.1	Hs.500788	Hypoxia inducible factor 1, alpha subunit inhibitor			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_017902.2	NP_060372.2	VALIDATED	C	1.000	1.000	349	1050	1	1047	349	1	349
RIKEN	BC007199	IRAL018B16	MGC	W01A120B18	pENTR-TOPO	13159		CNNM3	26505	AAH07199.3	Hs.711617	Cyclin M3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_199078.2	NP_951060.1	VALIDATED	Ps	0.991	0.991	324	1068	1	972	659	326	649
RIKEN	BC007199	IRAL018B16	MGC	W01A120B24	pENTR-TOPO	13159		CNNM3	26505	AAH07199.3	Hs.711617	Cyclin M3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_199078.2	NP_951060.1	VALIDATED	Ps	0.991	0.991	324	1068	1	972	659	326	649
RIKEN	BC034919	IRAL043M05	MGC	W01A120C01	pENTR-TOPO	25226		EDA2R	60401	AAH34919.1	Hs.302017	Ectodysplasin A2 receptor			Brain, neuroblastoma	NIH_MGC_47		NM_021783.2	NP_068555.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC034919	IRAL043M05	MGC	W01A120C07	pENTR-TOPO	25226		EDA2R	60401	AAH34919.1	Hs.302017	Ectodysplasin A2 receptor			Brain, neuroblastoma	NIH_MGC_47		NM_021783.2	NP_068555.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	BC002618	IRAL004P14	MGC	W01A120C15	pENTR-TOPO	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003691.2	NP_003682.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC002618	IRAL004P14	MGC	W01A120C17	pENTR-TOPO	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003691.2	NP_003682.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC002618	IRAL004P14	MGC	W01A120C21	pENTR-TOPO	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003691.2	NP_003682.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC002618	IRAL004P14	MGC	W01A120C23	pENTR-TOPO	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Lymph, Burkitt lymphoma	NIH_MGC_8		NM_003691.2	NP_003682.2	VALIDATED	Cs	0.997	0.997	305	918	1	915	305	1	305
RIKEN	BC017832	IRAL036K01	MGC	W01A120D04	pENTR-TOPO	15900		MAPK1	5594	AAH17832.1	Hs.431850	Mitogen-activated protein kinase 1			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_002745.4	NP_002736.3	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
RIKEN	BC033800	IRAK068J19	MGC	W01A120D14	pENTR-TOPO	10283		YBX2	51087	AAH33800.1	Hs.567494	Y box binding protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015982.3	NP_057066.2	VALIDATED	OK	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	BC033800	IRAK068J19	MGC	W01A120D16	pENTR-TOPO	10283		YBX2	51087	AAH33800.1	Hs.567494	Y box binding protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015982.3	NP_057066.2	VALIDATED	OK	1.000	1.000	364	1095	1	1092	364	1	364
RIKEN	AK057030	flj0003h08	FLJ	W01A120E03	pENTR-TOPO	21304		ZNF498	221785	BAG51846.1	Hs.446297	Zinc finger protein 498		neuroepithelioma		SKNMC2	EK1	NM_145115.2	NP_660090.2	VALIDATED	P	1.000	1.000	310	933	1	930	544	235	544
RIKEN	AK057030	flj0003h08	FLJ	W01A120E05	pENTR-TOPO	21304		ZNF498	221785	BAG51846.1	Hs.446297	Zinc finger protein 498		neuroepithelioma		SKNMC2	EK1	NM_145115.2	NP_660090.2	VALIDATED	P	1.000	1.000	310	933	1	930	544	235	544
RIKEN	AK057030	flj0003h08	FLJ	W01A120E11	pENTR-TOPO	21304		ZNF498	221785	BAG51846.1	Hs.446297	Zinc finger protein 498		neuroepithelioma		SKNMC2	EK1	NM_145115.2	NP_660090.2	VALIDATED	P	1.000	1.000	310	933	1	930	544	235	544
RIKEN	BC033073	IRAL043D23	MGC	W01A120E13	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	BC033073	IRAL043D23	MGC	W01A120E15	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	BC033073	IRAL043D23	MGC	W01A120E17	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	BC033073	IRAL043D23	MGC	W01A120E19	pENTR-TOPO	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_021965.3	NP_068800.2	VALIDATED	P	1.000	1.000	325	981	1	975	567	62	386
RIKEN	AK074713	flj0018g03	FLJ	W01A120F06	pENTR-TOPO	10441		BRIP1	83990	BAC11156.1	Hs.532799	BRCA1 interacting protein C-terminal helicase 1	NT2	teratocarcinoma		NT2RM2	EK1	NM_032043.1	NP_114432.1	REVIEWED	Ps	0.991	0.991	350	1128	1	1050	1249	620	969
RIKEN	AK074713	flj0018g03	FLJ	W01A120F08	pENTR-TOPO	10441		BRIP1	83990	BAC11156.1	Hs.532799	BRCA1 interacting protein C-terminal helicase 1	NT2	teratocarcinoma		NT2RM2	EK1	NM_032043.1	NP_114432.1	REVIEWED	Ps	0.991	0.991	350	1128	1	1050	1249	620	969
RIKEN	AK074713	flj0018g03	FLJ	W01A120F12	pENTR-TOPO	10441		BRIP1	83990	BAC11156.1	Hs.532799	BRCA1 interacting protein C-terminal helicase 1	NT2	teratocarcinoma		NT2RM2	EK1	NM_032043.1	NP_114432.1	REVIEWED	Ps	0.991	0.991	350	1128	1	1050	1249	620	969
RIKEN	AK091597	flj0013p13	FLJ	W01A120F20	pENTR-TOPO	5199		DIP2B	57609	BAC03705.1	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)				FEBRA2	EK1	NM_173602.2	NP_775873.2	VALIDATED	Ps	0.992	0.992	373	1149	1	1119	1576	1	373
RIKEN	AK091597	flj0013p13	FLJ	W01A120F22	pENTR-TOPO	5199		DIP2B	57609	BAC03705.1	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)				FEBRA2	EK1	NM_173602.2	NP_775873.2	VALIDATED	Ps	0.992	0.992	373	1149	1	1119	1576	1	373
RIKEN	AK091597	flj0013p13	FLJ	W01A120F24	pENTR-TOPO	5199		DIP2B	57609	BAC03705.1	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)				FEBRA2	EK1	NM_173602.2	NP_775873.2	VALIDATED	Ps	0.992	0.992	373	1149	1	1119	1576	1	373
RIKEN	BC006982	IRAL016P08	MGC	W01A120G01	pENTR-TOPO	16289		RSRC1	51319	AAH06982.1	Hs.591283	Arginine/serine-rich coiled-coil 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016625.2	NP_057709.2	PROVISIONAL	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC006982	IRAL016P08	MGC	W01A120G03	pENTR-TOPO	16289		RSRC1	51319	AAH06982.1	Hs.591283	Arginine/serine-rich coiled-coil 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016625.2	NP_057709.2	PROVISIONAL	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC006982	IRAL016P08	MGC	W01A120G05	pENTR-TOPO	16289		RSRC1	51319	AAH06982.1	Hs.591283	Arginine/serine-rich coiled-coil 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_016625.2	NP_057709.2	PROVISIONAL	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC001187	IRAL006H07	MGC	W01A120G15	pENTR-TOPO	22988		COPS5	10987	AAH01187.1	Hs.491912	COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis)			Eye, retinoblastoma	NIH_MGC_16		NM_006837.2	NP_006828.2	REVIEWED	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC001187	IRAL006H07	MGC	W01A120G23	pENTR-TOPO	22988		COPS5	10987	AAH01187.1	Hs.491912	COP9 constitutive photomorphogenic homolog subunit 5 (Arabidopsis)			Eye, retinoblastoma	NIH_MGC_16		NM_006837.2	NP_006828.2	REVIEWED	C	1.000	1.000	334	1005	1	1002	334	1	334
RIKEN	BC075791	IRAK168L10	MGC	W01A120H02	pENTR-TOPO	22151		HOXA13	3209	AAH75791.1	Hs.592172	Homeobox A13			Placenta, normal	NIH_MGC_147	DH10B	NM_000522.4	NP_000513.2	REVIEWED	Cs	0.997	0.997	388	1167	1	1164	388	1	388
RIKEN	BC075791	IRAK168L10	MGC	W01A120H04	pENTR-TOPO	22151		HOXA13	3209	AAH75791.1	Hs.592172	Homeobox A13			Placenta, normal	NIH_MGC_147	DH10B	NM_000522.4	NP_000513.2	REVIEWED	Cs	0.997	0.997	388	1167	1	1164	388	1	388
RIKEN	BC075791	IRAK168L10	MGC	W01A120H06	pENTR-TOPO	22151		HOXA13	3209	AAH75791.1	Hs.592172	Homeobox A13			Placenta, normal	NIH_MGC_147	DH10B	NM_000522.4	NP_000513.2	REVIEWED	Cs	0.997	0.997	388	1167	1	1164	388	1	388
RIKEN	BC075791	IRAK168L10	MGC	W01A120H12	pENTR-TOPO	22151		HOXA13	3209	AAH75791.1	Hs.592172	Homeobox A13			Placenta, normal	NIH_MGC_147	DH10B	NM_000522.4	NP_000513.2	REVIEWED	Cs	0.997	0.997	388	1167	1	1164	388	1	388
RIKEN	BC058915	IRAK119D22	MGC	W01A120H20	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC058915	IRAK119D22	MGC	W01A120H22	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC058915	IRAK119D22	MGC	W01A120H24	pENTR-TOPO	15503		SEC14L2	23541	AAH58915.1	Hs.335614	SEC14-like 2 (S. cerevisiae)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_033382.1	NP_203740.1	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
RIKEN	BC007018	IRAL016M19	MGC	W01A120I03	pENTR-TOPO	6225		PAWR	5074	AAH07018.1	Hs.643130	PRKC, apoptosis, WT1, regulator			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002583.2	NP_002574.2	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	BC007018	IRAL016M19	MGC	W01A120I09	pENTR-TOPO	6225		PAWR	5074	AAH07018.1	Hs.643130	PRKC, apoptosis, WT1, regulator			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_002583.2	NP_002574.2	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
RIKEN	AK023513	flj0037c11	FLJ	W01A120I13	pENTR-TOPO	24054		SNAPC4	6621	BAB14595	Hs.113265	Small nuclear RNA activating complex, polypeptide 4, 190kDa				PLACE1	EK1	NM_003086.2	NP_003077.2	VALIDATED		0.917	0.917	48	405	259	402	1469	1422	1469
RIKEN	AK023513	flj0037c11	FLJ	W01A120I23	pENTR-TOPO	24054		SNAPC4	6621	BAB14595	Hs.113265	Small nuclear RNA activating complex, polypeptide 4, 190kDa				PLACE1	EK1	NM_003086.2	NP_003077.2	VALIDATED		0.917	0.917	48	405	259	402	1469	1422	1469
RIKEN	AK027070	flj0066c01	FLJ	W01A120J04	pENTR-TOPO	22939		RNF19A	25897	BAB15647.1	Hs.292882	Ring finger protein 19A	HepG2	hepatoma		HEP	EK1	NM_183419.1	NP_904355.1	REVIEWED	P	1.000	1.000	397	1194	1	1191	838	442	838
RIKEN	AK027070	flj0066c01	FLJ	W01A120J08	pENTR-TOPO	22939		RNF19A	25897	BAB15647.1	Hs.292882	Ring finger protein 19A	HepG2	hepatoma		HEP	EK1	NM_183419.1	NP_904355.1	REVIEWED	P	1.000	1.000	397	1194	1	1191	838	442	838
RIKEN	AK027070	flj0066c01	FLJ	W01A120J10	pENTR-TOPO	22939		RNF19A	25897	BAB15647.1	Hs.292882	Ring finger protein 19A	HepG2	hepatoma		HEP	EK1	NM_183419.1	NP_904355.1	REVIEWED	P	1.000	1.000	397	1194	1	1191	838	442	838
RIKEN	AK027070	flj0066c01	FLJ	W01A120J12	pENTR-TOPO	22939		RNF19A	25897	BAB15647.1	Hs.292882	Ring finger protein 19A	HepG2	hepatoma		HEP	EK1	NM_183419.1	NP_904355.1	REVIEWED	P	1.000	1.000	397	1194	1	1191	838	442	838
RIKEN	BC030261	IRAK062F07	MGC	W01A120J16	pENTR-TOPO	11601		ZNF222	7673	AAH30261.1	Hs.279840	Zinc finger protein 222			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_013360.2	NP_037492.2	VALIDATED	P	1.000	1.000	397	1194	1	1191	451	55	451
RIKEN	AK095562	flj0026g14	FLJ	W01A120K13	pENTR-TOPO	11744		ZNF578	147660	BAC04574.1	Hs.157287	Zinc finger protein 578				FCBBF2	EK1	NM_001099694.1	NP_001093164.1	VALIDATED	Ps	0.991	0.991	212	639	1	636	590	379	590
RIKEN	AK095562	flj0026g14	FLJ	W01A120K23	pENTR-TOPO	11744		ZNF578	147660	BAC04574.1	Hs.157287	Zinc finger protein 578				FCBBF2	EK1	NM_001099694.1	NP_001093164.1	VALIDATED	Ps	0.991	0.991	212	639	1	636	590	379	590
RIKEN	AK094170	flj0025g14	FLJ	W01A120L16	pENTR-TOPO	3206		ASCC1	51008	BAC04299.1	Hs.500007	Activating signal cointegrator 1 complex subunit 1				ASTRO2	EK1	NM_015947.2	NP_057031.2	VALIDATED	Pgs	0.914	0.994	349	1203	1	1047	357	1	321
RIKEN	AK094170	flj0025g14	FLJ	W01A120L18	pENTR-TOPO	3206		ASCC1	51008	BAC04299.1	Hs.500007	Activating signal cointegrator 1 complex subunit 1				ASTRO2	EK1	NM_015947.2	NP_057031.2	VALIDATED	Pgs	0.914	0.994	349	1203	1	1047	357	1	321
RIKEN	AK094170	flj0025g14	FLJ	W01A120L20	pENTR-TOPO	3206		ASCC1	51008	BAC04299.1	Hs.500007	Activating signal cointegrator 1 complex subunit 1				ASTRO2	EK1	NM_015947.2	NP_057031.2	VALIDATED	Pgs	0.914	0.994	349	1203	1	1047	357	1	321
RIKEN	AK094170	flj0025g14	FLJ	W01A120L22	pENTR-TOPO	3206		ASCC1	51008	BAC04299.1	Hs.500007	Activating signal cointegrator 1 complex subunit 1				ASTRO2	EK1	NM_015947.2	NP_057031.2	VALIDATED	Pgs	0.914	0.994	349	1203	1	1047	357	1	321
RIKEN	AK130542	flj0055n16	FLJ	W01A120M11	pENTR-TOPO	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)				SLV	EK1	NM_001128221.1	NP_001121693.1	VALIDATED	Cs	0.995	0.995	206	873	253	870	206	1	206
RIKEN	BC015626	IRAL033O17	MGC	W01A120M15	pENTR-TOPO	8568		PARD6A	50855	AAH15626.1	Hs.112933	Par-6 partitioning defective 6 homolog alpha (C. elegans)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001037281.1	NP_001032358.1	REVIEWED	OK	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC015626	IRAL033O17	MGC	W01A120M19	pENTR-TOPO	8568		PARD6A	50855	AAH15626.1	Hs.112933	Par-6 partitioning defective 6 homolog alpha (C. elegans)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43		NM_001037281.1	NP_001032358.1	REVIEWED	OK	1.000	1.000	345	1038	1	1035	345	1	345
RIKEN	BC002669	IRAL012I13	MGC	W01A120N08	pENTR-TOPO	12664		NR2F6	2063	AAH02669.3	Hs.466148	Nuclear receptor subfamily 2, group F, member 6			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005234.3	NP_005225.2	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
RIKEN	BC002669	IRAL012I13	MGC	W01A120N10	pENTR-TOPO	12664		NR2F6	2063	AAH02669.3	Hs.466148	Nuclear receptor subfamily 2, group F, member 6			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_005234.3	NP_005225.2	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
RIKEN	BC042633	IRAK051E08	MGC	W01A120N24	pENTR-TOPO	25332		ESX1	80712	AAH42633.1	Hs.223782	ESX homeobox 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153448.2	NP_703149.1	VALIDATED	Cs	0.993	0.993	406	1221	1	1218	406	1	406
RIKEN	BC000834	IRAK004N15	MGC	W01A120O01	pENTR-TOPO	18748		CDK7	1022	AAH00834.1	Hs.184298	Cyclin-dependent kinase 7			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001799.3	NP_001790.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC000834	IRAK004N15	MGC	W01A120O05	pENTR-TOPO	18748		CDK7	1022	AAH00834.1	Hs.184298	Cyclin-dependent kinase 7			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001799.3	NP_001790.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC000834	IRAK004N15	MGC	W01A120O09	pENTR-TOPO	18748		CDK7	1022	AAH00834.1	Hs.184298	Cyclin-dependent kinase 7			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001799.3	NP_001790.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
RIKEN	BC004255	IRAL013A17	MGC	W01A120O17	pENTR-TOPO	19941		ZSCAN16	80345	AAH04255.1	Hs.656641	Zinc finger and SCAN domain containing 16			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_025231.1	NP_079507.1	PROVISIONAL	C	1.000	1.000	348	1047	1	1044	348	1	348
RIKEN	BC003591	IRAL002M19	MGC	W01A120P12	pENTR-TOPO	4729		SIGIRR	59307	AAH03591.1	Hs.501624	Single immunoglobulin and toll-interleukin 1 receptor (TIR) domain			Lung, small cell carcinoma	NIH_MGC_7		NM_021805.2	NP_068577.2	VALIDATED	Cs	0.998	0.998	410	1233	1	1230	410	1	410
RIKEN	BC017863	IRAL036N09	MGC	W01A120P22	pENTR-TOPO	856		PTPRC	5788	AAH17863.1	Hs.654514	Protein tyrosine phosphatase, receptor type, C			Lung	NIH_MGC_77	DH10B	NM_080923.2	NP_563580.1	REVIEWED	C	1.000	1.000	34	105	1	102	34	1	34
RIKEN	BC017863	IRAL036N09	MGC	W01A120P24	pENTR-TOPO	856		PTPRC	5788	AAH17863.1	Hs.654514	Protein tyrosine phosphatase, receptor type, C			Lung	NIH_MGC_77	DH10B	NM_080923.2	NP_563580.1	REVIEWED	C	1.000	1.000	34	105	1	102	34	1	34
RIKEN	BC026965	IRAK052F20	MGC	W01A121A03	pENTR-TOPO	22459		ARHGEF10	9639	AAH26965	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pfs	0.348	0.410	46	183	130	2	1344	912	953
RIKEN	BC026965	IRAK052F20	MGC	W01A121A05	pENTR-TOPO	22459		ARHGEF10	9639	AAH26965	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pfs	0.348	0.410	46	183	130	2	1344	912	953
RIKEN	BC026965	IRAK052F20	MGC	W01A121A07	pENTR-TOPO	22459		ARHGEF10	9639	AAH26965	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pfs	0.348	0.410	46	183	130	2	1344	912	953
RIKEN	BC026965	IRAK052F20	MGC	W01A121A09	pENTR-TOPO	22459		ARHGEF10	9639	AAH26965	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pfs	0.348	0.410	46	183	130	2	1344	912	953
RIKEN	BC065270	IRAK140N01	MGC	W01A121A15	pENTR-TOPO	11566		APOC2	344	AAH65270.1	Hs.75615	Apolipoprotein C-II			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000483.3	NP_000474.2	REVIEWED	P	1.000	1.000	72	219	1	216	101	1	72
RIKEN	BC065270	IRAK140N01	MGC	W01A121A19	pENTR-TOPO	11566		APOC2	344	AAH65270.1	Hs.75615	Apolipoprotein C-II			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000483.3	NP_000474.2	REVIEWED	P	1.000	1.000	72	219	1	216	101	1	72
RIKEN	BC065270	IRAK140N01	MGC	W01A121A21	pENTR-TOPO	11566		APOC2	344	AAH65270.1	Hs.75615	Apolipoprotein C-II			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000483.3	NP_000474.2	REVIEWED	P	1.000	1.000	72	219	1	216	101	1	72
RIKEN	BC039371	IRAK074M22	MGC	W01A121B08	pENTR-TOPO	20109		LOC285735	285735	-	Hs.407549	Hypothetical LOC285735			Testis	NIH_MGC_97	DH10B													
RIKEN	AK057317	flj0005i21	FLJ	W01A121B16	pENTR-TOPO	9874		LOC147004	147004	-	Hs.652871	Hypothetical protein LOC147004				TESTI2	EK1			
RIKEN	AK057317	flj0005i21	FLJ	W01A121B24	pENTR-TOPO	9874		LOC147004	147004	-	Hs.652871	Hypothetical protein LOC147004				TESTI2	EK1			
RIKEN	BC018953	IRAL026O23	MGC	W01A121C01	pENTR-TOPO	10381		SMARCD2	6603	AAH18953.2	Hs.250581	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001098426.1	NP_001091896.1	REVIEWED	P	1.000	1.000	77	234	1	231	531	455	531
RIKEN	BC018953	IRAL026O23	MGC	W01A121C07	pENTR-TOPO	10381		SMARCD2	6603	AAH18953.2	Hs.250581	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001098426.1	NP_001091896.1	REVIEWED	P	1.000	1.000	77	234	1	231	531	455	531
RIKEN	BC018953	IRAL026O23	MGC	W01A121C11	pENTR-TOPO	10381		SMARCD2	6603	AAH18953.2	Hs.250581	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 2			Uterus, leiomyosarcoma	NIH_MGC_46		NM_001098426.1	NP_001091896.1	REVIEWED	P	1.000	1.000	77	234	1	231	531	455	531
RIKEN	BC025790	IRAK049N22	MGC	W01A121C15	pENTR-TOPO	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
RIKEN	BC025790	IRAK049N22	MGC	W01A121C19	pENTR-TOPO	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
RIKEN	BC025790	IRAK049N22	MGC	W01A121C21	pENTR-TOPO	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
RIKEN	BC025790	IRAK049N22	MGC	W01A121C23	pENTR-TOPO	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
RIKEN	AK130861	flj0053o08	FLJ	W01A121D02	pENTR-TOPO	19388		FLJ27351	389273	-	Hs.519206	Hypothetical gene supported by AK130861				TST	EK1			
RIKEN	AK130861	flj0053o08	FLJ	W01A121D10	pENTR-TOPO	19388		FLJ27351	389273	-	Hs.519206	Hypothetical gene supported by AK130861				TST	EK1			
RIKEN	BC024232	IRAL038L24	MGC	W01A121D14	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC024232	IRAL038L24	MGC	W01A121D16	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC024232	IRAL038L24	MGC	W01A121D18	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC024232	IRAL038L24	MGC	W01A121D20	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC024232	IRAL038L24	MGC	W01A121D22	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC024232	IRAL038L24	MGC	W01A121D24	pENTR-TOPO	18684		SCGB3A2	117156	AAH24232.1	Hs.483765	Secretoglobin, family 3A, member 2			Lung	NIH_MGC_77	DH10B	NM_054023.3	NP_473364.1	PROVISIONAL	OK	1.000	1.000	93	282	1	279	93	1	93
RIKEN	BC021173	IRAK047O22	MGC	W01A121E05	pENTR-TOPO	7689		C15orf48	84419	AAH21173.1	Hs.112242	Chromosome 15 open reading frame 48			Testis	NIH_MGC_97	DH10B	NM_197955.1	NP_922946.1	VALIDATED	OK	1.000	1.000	83	252	1	249	83	1	83
RIKEN	BC021173	IRAK047O22	MGC	W01A121E09	pENTR-TOPO	7689		C15orf48	84419	AAH21173.1	Hs.112242	Chromosome 15 open reading frame 48			Testis	NIH_MGC_97	DH10B	NM_197955.1	NP_922946.1	VALIDATED	OK	1.000	1.000	83	252	1	249	83	1	83
RIKEN	AK056224	flj0002f08	FLJ	W01A121E13	pENTR-TOPO	647		FLJ31662	440594	-	Hs.514123	Hypothetical gene supported by AK056224	NT2	teratocarcinoma		NT2RI2	EK1			
RIKEN	AK091031	flj0014n23	FLJ	W01A121F04	pENTR-TOPO	30973										BRAWH2	EK1			
RIKEN	BC029583	IRAK063H18	MGC	W01A121F14	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	BC029583	IRAK063H18	MGC	W01A121F16	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	BC029583	IRAK063H18	MGC	W01A121F20	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	BC029583	IRAK063H18	MGC	W01A121F22	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	BC029583	IRAK063H18	MGC	W01A121F24	pENTR-TOPO	3964		C11orf64	283197	AAH29583	Hs.372650	Chromosome 11 open reading frame 64			Testis	NIH_MGC_97	DH10B													
RIKEN	AK056689	flj0006h03	FLJ	W01A121G05	pENTR-TOPO	26767										PEBLM2	EK1			
RIKEN	AK056689	flj0006h03	FLJ	W01A121G07	pENTR-TOPO	26767										PEBLM2	EK1			
RIKEN	AK056723	flj0013c07	FLJ	W01A121G13	pENTR-TOPO	23656		LOC158376	158376	-	Hs.302677	Hypothetical LOC158376				PLACE6	EK1	XM_001130949.2	XP_001130949.1	MODEL	Cs	0.987	0.987	75	273	46	270	75	1	75
RIKEN	AK056723	flj0013c07	FLJ	W01A121G15	pENTR-TOPO	23656		LOC158376	158376	-	Hs.302677	Hypothetical LOC158376				PLACE6	EK1	XM_001130949.2	XP_001130949.1	MODEL	Cs	0.987	0.987	75	273	46	270	75	1	75
RIKEN	AK056723	flj0013c07	FLJ	W01A121G23	pENTR-TOPO	23656		LOC158376	158376	-	Hs.302677	Hypothetical LOC158376				PLACE6	EK1	XM_001130949.2	XP_001130949.1	MODEL	Cs	0.987	0.987	75	273	46	270	75	1	75
RIKEN	AK023501	flj0037k05	FLJ	W01A121H12	pENTR-TOPO	4725		FLJ13439	399876	-	Hs.132600	Hypothetical gene supported by AK023501				PLACE1	EK1			
RIKEN	BC043553	IRAK087I17	MGC	W01A121H18	pENTR-TOPO	14309		LOC339822	339822	-	Hs.651879	Hypothetical protein LOC339822			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B			
RIKEN	BC043553	IRAK087I17	MGC	W01A121H20	pENTR-TOPO	14309		LOC339822	339822	-	Hs.651879	Hypothetical protein LOC339822			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B			
RIKEN	BC043553	IRAK087I17	MGC	W01A121H22	pENTR-TOPO	14309		LOC339822	339822	-	Hs.651879	Hypothetical protein LOC339822			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B			
RIKEN	AK095800	flj0042i24	FLJ	W01A121I07	pENTR-TOPO	15036		LOC284798	284798	-	Hs.334934	Hypothetical LOC284798				FEBRA2	EK1													
RIKEN	BC042042	IRAK088D22	MGC	W01A121J10	pENTR-TOPO	981		LOC440704	440704	-	Hs.518802	Hypothetical gene supported by BC042042			Lymph, lymphoma	NIH_MGC_85	DH10B	XM_498826.2	XP_498826.1	MODEL										
RIKEN	BC039180	IRAK029J10	MGC	W01A121J14	pENTR-TOPO	24311		C9orf148	401550	-	Hs.644347	Chromosome 9 open reading frame 148			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B			
RIKEN	BC039180	IRAK029J10	MGC	W01A121J16	pENTR-TOPO	24311		C9orf148	401550	-	Hs.644347	Chromosome 9 open reading frame 148			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B			
RIKEN	BC039180	IRAK029J10	MGC	W01A121J18	pENTR-TOPO	24311		C9orf148	401550	-	Hs.644347	Chromosome 9 open reading frame 148			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B			
RIKEN	BC039180	IRAK029J10	MGC	W01A121J20	pENTR-TOPO	24311		C9orf148	401550	-	Hs.644347	Chromosome 9 open reading frame 148			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B			
RIKEN	BC039180	IRAK029J10	MGC	W01A121J22	pENTR-TOPO	24311		C9orf148	401550	-	Hs.644347	Chromosome 9 open reading frame 148			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B			
RIKEN	AK125573	flj0044b21	FLJ	W01A121K01	pENTR-TOPO	774		FLJ43585	400800	-	Hs.369324	Hypothetical gene supported by AK125573		neuroepithelioma		SKNMC2	EK1			
RIKEN	AK125573	flj0044b21	FLJ	W01A121K09	pENTR-TOPO	774		FLJ43585	400800	-	Hs.369324	Hypothetical gene supported by AK125573		neuroepithelioma		SKNMC2	EK1			
RIKEN	AK125573	flj0044b21	FLJ	W01A121K11	pENTR-TOPO	774		FLJ43585	400800	-	Hs.369324	Hypothetical gene supported by AK125573		neuroepithelioma		SKNMC2	EK1			
RIKEN	AK129756	flj0053d24	FLJ	W01A121K13	pENTR-TOPO	8878		FLJ26245	400533	-	Hs.499135	Hypothetical gene supported by AK129756				DMC	EK1	XM_001718343.1	XP_001718395.1	MODEL	Pfs	0.416	0.420	89	276	13	275	108	1	89
RIKEN	BC045586	IRAK106J13	MGC	W01A121L04	pENTR-TOPO	17221		LOC151658	151658	-	Hs.159043	Hypothetical LOC151658			Testis	NIH_MGC_97	DH10B													
RIKEN	BC045586	IRAK106J13	MGC	W01A121L06	pENTR-TOPO	17221		LOC151658	151658	-	Hs.159043	Hypothetical LOC151658			Testis	NIH_MGC_97	DH10B													
RIKEN	BC045586	IRAK106J13	MGC	W01A121L12	pENTR-TOPO	17221		LOC151658	151658	-	Hs.159043	Hypothetical LOC151658			Testis	NIH_MGC_97	DH10B													
RIKEN	AK090900	flj0011g09	FLJ	W01A121M01	pENTR-TOPO	14741		FLJ33581	400839	-	Hs.651965	Hypothetical gene supported by AK090900				BRAMY2	EK1			
RIKEN	AK090900	flj0011g09	FLJ	W01A121M03	pENTR-TOPO	14741		FLJ33581	400839	-	Hs.651965	Hypothetical gene supported by AK090900				BRAMY2	EK1			
RIKEN	AK090900	flj0011g09	FLJ	W01A121M09	pENTR-TOPO	14741		FLJ33581	400839	-	Hs.651965	Hypothetical gene supported by AK090900				BRAMY2	EK1			
RIKEN	AK128192	flj0078o03	FLJ	W01A121M13	pENTR-TOPO	36758										TESTI4	EK1			
RIKEN	AK128192	flj0078o03	FLJ	W01A121M15	pENTR-TOPO	36758										TESTI4	EK1			
RIKEN	AK128192	flj0078o03	FLJ	W01A121M23	pENTR-TOPO	36758										TESTI4	EK1			
RIKEN	AK094771	flj0026o21	FLJ	W01A121N10	pENTR-TOPO	36506										BRAWH2	EK1			
RIKEN	BC043524	IRAK087G04	MGC	W01A121N16	pENTR-TOPO	15101		LOC339568	339568	-	Hs.434319	Hypothetical LOC339568			Brain, adult medulla	NIH_MGC_119	DH10B			
RIKEN	BC001766	IRAL008O24	MGC	W01A121O01	pENTR-TOPO	15430		S100B	6285	AAH01766.1	Hs.422181	S100 calcium binding protein B			Skin, melanotic melanoma.	NIH_MGC_20		NM_006272.2	NP_006263.1	REVIEWED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC001766	IRAL008O24	MGC	W01A121O03	pENTR-TOPO	15430		S100B	6285	AAH01766.1	Hs.422181	S100 calcium binding protein B			Skin, melanotic melanoma.	NIH_MGC_20		NM_006272.2	NP_006263.1	REVIEWED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC001766	IRAL008O24	MGC	W01A121O09	pENTR-TOPO	15430		S100B	6285	AAH01766.1	Hs.422181	S100 calcium binding protein B			Skin, melanotic melanoma.	NIH_MGC_20		NM_006272.2	NP_006263.1	REVIEWED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC019009	IRAL030E24	MGC	W01A121O21	pENTR-TOPO	8931		HTA	283902	-	Hs.382776	Hepatoma associated protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_001101347.1	NP_001094817.1	VALIDATED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC019009	IRAL030E24	MGC	W01A121O23	pENTR-TOPO	8931		HTA	283902	-	Hs.382776	Hepatoma associated protein			Skin, melanotic melanoma.	NIH_MGC_20		NM_001101347.1	NP_001094817.1	VALIDATED	C	1.000	1.000	92	279	1	276	92	1	92
RIKEN	BC010897	IRAL019B17	MGC	W01A121P02	pENTR-TOPO	24653		PAGE4	9506	AAH10897.1	Hs.441038	P antigen family, member 4 (prostate associated)			Placenta	NIH_MGC_79	DH10B	NM_007003.2	NP_008934.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC010897	IRAL019B17	MGC	W01A121P04	pENTR-TOPO	24653		PAGE4	9506	AAH10897.1	Hs.441038	P antigen family, member 4 (prostate associated)			Placenta	NIH_MGC_79	DH10B	NM_007003.2	NP_008934.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC010897	IRAL019B17	MGC	W01A121P06	pENTR-TOPO	24653		PAGE4	9506	AAH10897.1	Hs.441038	P antigen family, member 4 (prostate associated)			Placenta	NIH_MGC_79	DH10B	NM_007003.2	NP_008934.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC010897	IRAL019B17	MGC	W01A121P10	pENTR-TOPO	24653		PAGE4	9506	AAH10897.1	Hs.441038	P antigen family, member 4 (prostate associated)			Placenta	NIH_MGC_79	DH10B	NM_007003.2	NP_008934.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC007055	IRAL016O19	MGC	W01A121P14	pENTR-TOPO	16283		LSM3	27258	AAH07055.1	Hs.111632	LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_014463.1	NP_055278.1	VALIDATED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC007055	IRAL016O19	MGC	W01A121P22	pENTR-TOPO	16283		LSM3	27258	AAH07055.1	Hs.111632	LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_014463.1	NP_055278.1	VALIDATED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	BC007055	IRAL016O19	MGC	W01A121P24	pENTR-TOPO	16283		LSM3	27258	AAH07055.1	Hs.111632	LSM3 homolog, U6 small nuclear RNA associated (S. cerevisiae)			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_014463.1	NP_055278.1	VALIDATED	C	1.000	1.000	102	309	1	306	102	1	102
RIKEN	AK058053	flj0053g11	FLJ	W01A122A05	pENTR-TOPO	6518		LOC144920	144920	-	Hs.567700	Hypothetical protein LOC144920				TST	EK1			
RIKEN	AK058053	flj0053g11	FLJ	W01A122A07	pENTR-TOPO	6518		LOC144920	144920	-	Hs.567700	Hypothetical protein LOC144920				TST	EK1			
RIKEN	AK058053	flj0053g11	FLJ	W01A122A09	pENTR-TOPO	6518		LOC144920	144920	-	Hs.567700	Hypothetical protein LOC144920				TST	EK1			
RIKEN	AK058053	flj0053g11	FLJ	W01A122A11	pENTR-TOPO	6518		LOC144920	144920	-	Hs.567700	Hypothetical protein LOC144920				TST	EK1			
RIKEN	AK123344	flj0070k12	FLJ	W01A122A13	pENTR-TOPO	2827		FLJ41350	399806	-						BRAWH2	EK1			
RIKEN	AK123344	flj0070k12	FLJ	W01A122A17	pENTR-TOPO	2827		FLJ41350	399806	-						BRAWH2	EK1			
RIKEN	AK123344	flj0070k12	FLJ	W01A122A21	pENTR-TOPO	2827		FLJ41350	399806	-						BRAWH2	EK1			
RIKEN	AK056561	flj0006e10	FLJ	W01A122B04	pENTR-TOPO	2781		LOC170425	170425	-	Hs.434131	Hypothetical protein LOC170425	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	AK056561	flj0006e10	FLJ	W01A122B08	pENTR-TOPO	2781		LOC170425	170425	-	Hs.434131	Hypothetical protein LOC170425	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	AK056561	flj0006e10	FLJ	W01A122B10	pENTR-TOPO	2781		LOC170425	170425	-	Hs.434131	Hypothetical protein LOC170425	NT2	teratocarcinoma		NT2RP7	EK1			
RIKEN	BC042734	IRAK072D19	MGC	W01A122C05	pENTR-TOPO	27160									Testis	NIH_MGC_97	DH10B			
RIKEN	BC042734	IRAK072D19	MGC	W01A122C07	pENTR-TOPO	27160									Testis	NIH_MGC_97	DH10B			
RIKEN	BC040895	IRAK088L20	MGC	W01A122C13	pENTR-TOPO	2925		LOC338588	338588	-	Hs.121365	Hypothetical LOC338588			Brain, adult medulla	NIH_MGC_119	DH10B													
RIKEN	BC040895	IRAK088L20	MGC	W01A122C21	pENTR-TOPO	2925		LOC338588	338588	-	Hs.121365	Hypothetical LOC338588			Brain, adult medulla	NIH_MGC_119	DH10B													
RIKEN	BC040895	IRAK088L20	MGC	W01A122C23	pENTR-TOPO	2925		LOC338588	338588	-	Hs.121365	Hypothetical LOC338588			Brain, adult medulla	NIH_MGC_119	DH10B													
RIKEN	AK057338	flj0005e04	FLJ	W01A122E03	pENTR-TOPO	28310										TESTI2	EK1			
RIKEN	AK057338	flj0005e04	FLJ	W01A122E07	pENTR-TOPO	28310										TESTI2	EK1			
RIKEN	AK057338	flj0005e04	FLJ	W01A122E09	pENTR-TOPO	28310										TESTI2	EK1			
RIKEN	AK057338	flj0005e04	FLJ	W01A122E11	pENTR-TOPO	28310										TESTI2	EK1			
RIKEN	AK093498	flj0016d11	FLJ	W01A122E21	pENTR-TOPO	717		LOC284661	284661	-	Hs.278112	Hypothetical LOC284661				TESTI2	EK1			
RIKEN	BC043561	IRAK087J06	MGC	W01A122F14	pENTR-TOPO	17751		LOC340017	340017	-	Hs.428275	Hypothetical LOC340017			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B			
RIKEN	BC043561	IRAK087J06	MGC	W01A122F24	pENTR-TOPO	17751		LOC340017	340017	-	Hs.428275	Hypothetical LOC340017			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B			
RIKEN	BC025668	IRAK049C15	MGC	W01A122G11	pENTR-TOPO	3986		C11orf41	25758	AAH25668	Hs.502266	Chromosome 11 open reading frame 41			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012194.1	NP_036326.1	VALIDATED	Pfs	0.312	0.312	32	315	116	21	1855	998	1029
RIKEN	BC072680	IRAK174I24	MGC	W01A122G13	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	BC072680	IRAK174I24	MGC	W01A122G15	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	BC072680	IRAK174I24	MGC	W01A122G19	pENTR-TOPO	16193		NKTR	4820	AAH72680	Hs.529509	Natural killer-tumor recognition sequence			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005385.3	NP_005376.2	REVIEWED		0.924	0.924	105	318	1	315	1462	1	105
RIKEN	BC036452	IRAK047K19	MGC	W01A122I03	pENTR-TOPO	15368		KCNE1	3753	AAH36452.1	Hs.121495	Potassium voltage-gated channel, Isk-related family, member 1			Testis	NIH_MGC_97	DH10B	NM_001127668.1	NP_001121140.1	REVIEWED	Ps	0.981	0.981	105	318	1	315	129	1	105
RIKEN	BC036452	IRAK047K19	MGC	W01A122I05	pENTR-TOPO	15368		KCNE1	3753	AAH36452.1	Hs.121495	Potassium voltage-gated channel, Isk-related family, member 1			Testis	NIH_MGC_97	DH10B	NM_001127668.1	NP_001121140.1	REVIEWED	Ps	0.981	0.981	105	318	1	315	129	1	105
RIKEN	AK123741	flj0068i12	FLJ	W01A122I15	pENTR-TOPO	6168		HOTAIR	100124700	-	Hs.197076	Hox transcript antisense RNA (non-protein coding)				HSYRA2	EK1			
RIKEN	AK123741	flj0068i12	FLJ	W01A122I17	pENTR-TOPO	6168		HOTAIR	100124700	-	Hs.197076	Hox transcript antisense RNA (non-protein coding)				HSYRA2	EK1			
RIKEN	AK123741	flj0068i12	FLJ	W01A122I19	pENTR-TOPO	6168		HOTAIR	100124700	-	Hs.197076	Hox transcript antisense RNA (non-protein coding)				HSYRA2	EK1			
RIKEN	AK123741	flj0068i12	FLJ	W01A122I21	pENTR-TOPO	6168		HOTAIR	100124700	-	Hs.197076	Hox transcript antisense RNA (non-protein coding)				HSYRA2	EK1			
RIKEN	AK090852	flj0010h22	FLJ	W01A122J16	pENTR-TOPO	22060		LOC285889	285889	-	Hs.407095	Hypothetical protein LOC285889				BRAMY2	EK1			
RIKEN	AK057377	flj0005e14	FLJ	W01A122K01	pENTR-TOPO	9876		LOC146795	146795	-	Hs.651743	Hypothetical protein LOC146795				TESTI2	EK1			
RIKEN	AK057377	flj0005e14	FLJ	W01A122K05	pENTR-TOPO	9876		LOC146795	146795	-	Hs.651743	Hypothetical protein LOC146795				TESTI2	EK1			
RIKEN	AK057377	flj0005e14	FLJ	W01A122K07	pENTR-TOPO	9876		LOC146795	146795	-	Hs.651743	Hypothetical protein LOC146795				TESTI2	EK1			
RIKEN	AK057377	flj0005e14	FLJ	W01A122K09	pENTR-TOPO	9876		LOC146795	146795	-	Hs.651743	Hypothetical protein LOC146795				TESTI2	EK1			
RIKEN	AK126569	flj0077o09	FLJ	W01A122K17	pENTR-TOPO	19379		FLJ44606	401207	-	Hs.49573	Hypothetical gene supported by AK126569				BRACE2	EK1	XM_943643.3	XP_948736.1	MODEL	Ps	0.990	0.990	100	330	28	327	138	39	138
RIKEN	AK126569	flj0077o09	FLJ	W01A122K23	pENTR-TOPO	19379		FLJ44606	401207	-	Hs.49573	Hypothetical gene supported by AK126569				BRACE2	EK1	XM_943643.3	XP_948736.1	MODEL	Ps	0.990	0.990	100	330	28	327	138	39	138
RIKEN	BC080600	IRAL059E10	MGC	W01A122M03	pENTR-TOPO	7030		FCF1	51077	AAH80600.1	Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19		NM_015962.4	NP_057046.1	VALIDATED	P	1.000	1.000	109	330	1	327	198	90	198
RIKEN	BC080600	IRAL059E10	MGC	W01A122M09	pENTR-TOPO	7030		FCF1	51077	AAH80600.1	Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19		NM_015962.4	NP_057046.1	VALIDATED	P	1.000	1.000	109	330	1	327	198	90	198
RIKEN	BC038751	IRAK074H20	MGC	W01A122N06	pENTR-TOPO	26838									Testis	NIH_MGC_97	DH10B			
RIKEN	BC038751	IRAK074H20	MGC	W01A122N10	pENTR-TOPO	26838									Testis	NIH_MGC_97	DH10B			
RIKEN	BC038751	IRAK074H20	MGC	W01A122N12	pENTR-TOPO	26838									Testis	NIH_MGC_97	DH10B			
RIKEN	BC031811	IRAK029L05	MGC	W01A122P12	pENTR-TOPO	954		LCE1B	353132	-	Hs.375103	Late cornified envelope 1B			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_178349.1	NP_848126.1	VALIDATED	C	1.000	1.000	118	357	1	354	118	1	118
RIKEN	BC039682	IRAK087L09	MGC	W01A123A23	pENTR-TOPO	46420		LOC401312	401312	-	Hs.680441	Hypothetical LOC401312			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
RIKEN	BC067506	IRAK172F08	MGC	W01A123B04	pENTR-TOPO	13286		IL1R1	3554	AAH67506.1	Hs.701982	Interleukin 1 receptor, type I			PCR rescued clones	NIH_MGC_195	DH10B	NM_000877.2	NP_000868.1	REVIEWED	C	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	BC067506	IRAK172F08	MGC	W01A123B06	pENTR-TOPO	13286		IL1R1	3554	AAH67506.1	Hs.701982	Interleukin 1 receptor, type I			PCR rescued clones	NIH_MGC_195	DH10B	NM_000877.2	NP_000868.1	REVIEWED	C	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	BC067506	IRAK172F08	MGC	W01A123B08	pENTR-TOPO	13286		IL1R1	3554	AAH67506.1	Hs.701982	Interleukin 1 receptor, type I			PCR rescued clones	NIH_MGC_195	DH10B	NM_000877.2	NP_000868.1	REVIEWED	C	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	BC067506	IRAK172F08	MGC	W01A123B10	pENTR-TOPO	13286		IL1R1	3554	AAH67506.1	Hs.701982	Interleukin 1 receptor, type I			PCR rescued clones	NIH_MGC_195	DH10B	NM_000877.2	NP_000868.1	REVIEWED	C	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	BC067506	IRAK172F08	MGC	W01A123B12	pENTR-TOPO	13286		IL1R1	3554	AAH67506.1	Hs.701982	Interleukin 1 receptor, type I			PCR rescued clones	NIH_MGC_195	DH10B	NM_000877.2	NP_000868.1	REVIEWED	C	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	AK091056	flj0016g06	FLJ	W01A123B14	pENTR-TOPO	23458		COBRA1	25920	BAG52272.1	Hs.655043	Cofactor of BRCA1				BRAWH2	EK1	NM_015456.3	NP_056271.2	VALIDATED	C	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	AK094171	flj0025i14	FLJ	W01A123C03	pENTR-TOPO	6141		ABCC9	10060	BAC04300.1	Hs.446050	ATP-binding cassette, sub-family C (CFTR/MRP), member 9				ASTRO2	EK1	NM_020297.2	NP_064693.2	REVIEWED	P	1.000	1.000	120	363	1	360	1549	1430	1549
RIKEN	AK094171	flj0025i14	FLJ	W01A123C05	pENTR-TOPO	6141		ABCC9	10060	BAC04300.1	Hs.446050	ATP-binding cassette, sub-family C (CFTR/MRP), member 9				ASTRO2	EK1	NM_020297.2	NP_064693.2	REVIEWED	P	1.000	1.000	120	363	1	360	1549	1430	1549
RIKEN	AK094171	flj0025i14	FLJ	W01A123C07	pENTR-TOPO	6141		ABCC9	10060	BAC04300.1	Hs.446050	ATP-binding cassette, sub-family C (CFTR/MRP), member 9				ASTRO2	EK1	NM_020297.2	NP_064693.2	REVIEWED	P	1.000	1.000	120	363	1	360	1549	1430	1549
RIKEN	AK094171	flj0025i14	FLJ	W01A123C09	pENTR-TOPO	6141		ABCC9	10060	BAC04300.1	Hs.446050	ATP-binding cassette, sub-family C (CFTR/MRP), member 9				ASTRO2	EK1	NM_020297.2	NP_064693.2	REVIEWED	P	1.000	1.000	120	363	1	360	1549	1430	1549
RIKEN	AK094171	flj0025i14	FLJ	W01A123C11	pENTR-TOPO	6141		ABCC9	10060	BAC04300.1	Hs.446050	ATP-binding cassette, sub-family C (CFTR/MRP), member 9				ASTRO2	EK1	NM_020297.2	NP_064693.2	REVIEWED	P	1.000	1.000	120	363	1	360	1549	1430	1549
RIKEN	H033086L07	H033086L07	RIKEN	W01A123D02	pENTR-TOPO		21943	ACHE	43		Hs.154495	Acetylcholinesterase (Yt blood group)	-	-	hypothalamus	hypothalamus	DH10B	NM_000665.3	NP_000656.1	REVIEWED	C	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	H033086L07	H033086L07	RIKEN	W01A123D04	pENTR-TOPO		21943	ACHE	43		Hs.154495	Acetylcholinesterase (Yt blood group)	-	-	hypothalamus	hypothalamus	DH10B	NM_000665.3	NP_000656.1	REVIEWED	C	1.000	1.000	614	1845	1	1842	614	1	614
RIKEN	BC014844	IRAK013A01	MGC	W01A123D18	pENTR-TOPO	10312		DVL2	1856	AAH14844.1	Hs.118640	Dishevelled, dsh homolog 2 (Drosophila)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004422.2	NP_004413.1	REVIEWED	C	1.000	1.000	736	2211	1	2208	736	1	736
RIKEN	AK128283	flj0078k09	FLJ	W01A123G01	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK128283	flj0078k09	FLJ	W01A123G03	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK128283	flj0078k09	FLJ	W01A123G07	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK025935	flj0058i23	FLJ	W01A123G19	pENTR-TOPO	9779		FAM57A	79850	BAB15286.1	Hs.154396	Family with sequence similarity 57, member A				HRC	EK1	NM_024792.1	NP_079068.1	PROVISIONAL	C	1.000	1.000	257	774	1	771	257	1	257
RIKEN	AK025935	flj0058i23	FLJ	W01A123G23	pENTR-TOPO	9779		FAM57A	79850	BAB15286.1	Hs.154396	Family with sequence similarity 57, member A				HRC	EK1	NM_024792.1	NP_079068.1	PROVISIONAL	C	1.000	1.000	257	774	1	771	257	1	257
RIKEN	AK056510	flj0004j16	FLJ	W01A123H16	pENTR-TOPO	4471		OSBPL5	114879	BAG51735.1	Hs.436166	Oxysterol binding protein-like 5	NT2	teratocarcinoma		NT2RP7	EK1	NM_020896.3	NP_065947.1	REVIEWED	C	1.000	1.000	879	2640	1	2637	879	1	879
RIKEN	AK056510	flj0004j16	FLJ	W01A123H20	pENTR-TOPO	4471		OSBPL5	114879	BAG51735.1	Hs.436166	Oxysterol binding protein-like 5	NT2	teratocarcinoma		NT2RP7	EK1	NM_020896.3	NP_065947.1	REVIEWED	C	1.000	1.000	879	2640	1	2637	879	1	879
RIKEN	BC084546	IRAL059F02	MGC	W01A123M01	pENTR-TOPO	7407		GPR132	29933	AAH84546.1	Hs.532504	G protein-coupled receptor 132			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_013345.2	NP_037477.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC084546	IRAL059F02	MGC	W01A123M07	pENTR-TOPO	7407		GPR132	29933	AAH84546.1	Hs.532504	G protein-coupled receptor 132			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_013345.2	NP_037477.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC084546	IRAL059F02	MGC	W01A123M11	pENTR-TOPO	7407		GPR132	29933	AAH84546.1	Hs.532504	G protein-coupled receptor 132			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_013345.2	NP_037477.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC037951	IRAK069A24	MGC	W01A123M13	pENTR-TOPO	19179		GFRA3	2676	AAH37951.1	Hs.58042	GDNF family receptor alpha 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001496.3	NP_001487.2	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
RIKEN	BC008726	IRAL005G17	MGC	W01A123N06	pENTR-TOPO	16093		OXSR1	9943	AAH08726.1	Hs.475970	Oxidative-stress responsive 1			Brain, neuroblastoma	NIH_MGC_19		NM_005109.2	NP_005100.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
RIKEN	BC008726	IRAL005G17	MGC	W01A123N12	pENTR-TOPO	16093		OXSR1	9943	AAH08726.1	Hs.475970	Oxidative-stress responsive 1			Brain, neuroblastoma	NIH_MGC_19		NM_005109.2	NP_005100.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
RIKEN	BC065037	IRAK140P17	MGC	W01A123O13	pENTR-TOPO	465		CDC73	79577	AAH65037.1	Hs.576497	Cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024529.3	NP_078805.3	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
RIKEN	BC065037	IRAK140P17	MGC	W01A123O21	pENTR-TOPO	465		CDC73	79577	AAH65037.1	Hs.576497	Cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024529.3	NP_078805.3	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
RIKEN	BC065037	IRAK140P17	MGC	W01A123O23	pENTR-TOPO	465		CDC73	79577	AAH65037.1	Hs.576497	Cell division cycle 73, Paf1/RNA polymerase II complex component, homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024529.3	NP_078805.3	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
RIKEN	AK096342	flj0040e13	FLJ	W01A123P04	pENTR-TOPO	11521		ZNF93	81931	BAC04764.1	Hs.301059	Zinc finger protein 93	NT2	teratocarcinoma		NT2RP7	EK1	NM_031218.2	NP_112495.2	VALIDATED	Cgs	0.950	0.995	620	1779	1	1776	620	1	620
RIKEN	AK096342	flj0040e13	FLJ	W01A123P08	pENTR-TOPO	11521		ZNF93	81931	BAC04764.1	Hs.301059	Zinc finger protein 93	NT2	teratocarcinoma		NT2RP7	EK1	NM_031218.2	NP_112495.2	VALIDATED	Cgs	0.950	0.995	620	1779	1	1776	620	1	620
RIKEN	H04D088K01	H04D088K01	RIKEN	W01A123P14	pENTR-TOPO		15777						-	-	testis	testis	DH10B			
RIKEN	H04D088K01	H04D088K01	RIKEN	W01A123P20	pENTR-TOPO		15777						-	-	testis	testis	DH10B			
RIKEN	H04D088K01	H04D088K01	RIKEN	W01A123P22	pENTR-TOPO		15777						-	-	testis	testis	DH10B			
RIKEN	AK091597	flj0013p13	FLJ	W01A124A07	pENTR-TOPO	5199		DIP2B	57609	BAC03705.1	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)				FEBRA2	EK1	NM_173602.2	NP_775873.2	VALIDATED	Ps	0.992	0.992	373	1149	1	1119	1576	1	373
RIKEN	AK091597	flj0013p13	FLJ	W01A124A09	pENTR-TOPO	5199		DIP2B	57609	BAC03705.1	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)				FEBRA2	EK1	NM_173602.2	NP_775873.2	VALIDATED	Ps	0.992	0.992	373	1149	1	1119	1576	1	373
RIKEN	BC070064	IRAK167A01	MGC	W01A124A21	pENTR-TOPO	21080		DMTF1	9988	AAH70064.1	Hs.196129	Cyclin D binding myb-like transcription factor 1			Testis	NIH_MGC_97	DH10B	NM_021145.3	NP_066968.3	REVIEWED	Cs	0.999	0.999	760	2283	1	2280	760	1	760
RIKEN	BC070064	IRAK167A01	MGC	W01A124A23	pENTR-TOPO	21080		DMTF1	9988	AAH70064.1	Hs.196129	Cyclin D binding myb-like transcription factor 1			Testis	NIH_MGC_97	DH10B	NM_021145.3	NP_066968.3	REVIEWED	Cs	0.999	0.999	760	2283	1	2280	760	1	760
RIKEN	AK123604	flj0043l11	FLJ	W01A124B20	pENTR-TOPO	18219		MAML3	55534	BAG53919.1	Hs.586165	Mastermind-like 3 (Drosophila)				CTONG3	EK1	NM_018717.4	NP_061187.2	VALIDATED	Cs	0.999	0.999	1133	3402	1	3399	1133	1	1133
RIKEN	BC002359	IRAL001I14	MGC	W01A124C15	pENTR-TOPO	13337		TSN	7247	AAH02359.1	Hs.75066	Translin			Lung, small cell carcinoma	NIH_MGC_7		NM_004622.2	NP_004613.1	REVIEWED	C	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC002359	IRAL001I14	MGC	W01A124C19	pENTR-TOPO	13337		TSN	7247	AAH02359.1	Hs.75066	Translin			Lung, small cell carcinoma	NIH_MGC_7		NM_004622.2	NP_004613.1	REVIEWED	C	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC002359	IRAL001I14	MGC	W01A124C21	pENTR-TOPO	13337		TSN	7247	AAH02359.1	Hs.75066	Translin			Lung, small cell carcinoma	NIH_MGC_7		NM_004622.2	NP_004613.1	REVIEWED	C	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC002359	IRAL001I14	MGC	W01A124C23	pENTR-TOPO	13337		TSN	7247	AAH02359.1	Hs.75066	Translin			Lung, small cell carcinoma	NIH_MGC_7		NM_004622.2	NP_004613.1	REVIEWED	C	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC054499	IRAK107E21	MGC	W01A124D14	pENTR-TOPO	25423		KDM5C	8242	AAH54499.1	Hs.631768	Lysine (K)-specific demethylase 5C			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004187.3	NP_004178.2	REVIEWED	Cg	0.999	1.000	1560	4680	1	4677	1560	1	1560
RIKEN	BC054499	IRAK107E21	MGC	W01A124D24	pENTR-TOPO	25423		KDM5C	8242	AAH54499.1	Hs.631768	Lysine (K)-specific demethylase 5C			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004187.3	NP_004178.2	REVIEWED	Cg	0.999	1.000	1560	4680	1	4677	1560	1	1560
RIKEN	BC014563	IRAL003M21	MGC	W01A124E09	pENTR-TOPO	2895		CDC2	983	AAH14563.1	Hs.334562	Cell division cycle 2, G1 to S and G2 to M			Skin, melanotic melanoma.	NIH_MGC_20		NM_001786.3	NP_001777.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
RIKEN	AK054600	flj0001o09	FLJ	W01A124F10	pENTR-TOPO	18753		HNRNPAB	3182	BAG51397.1	Hs.591731	Heterogeneous nuclear ribonucleoprotein A/B	NB69	neuroblastoma		3NB692	EK1	NM_004499.3	NP_004490.2	REVIEWED	OK	1.000	1.000	285	858	1	855	285	1	285
RIKEN	BC084546	IRAL059F02	MGC	W01A124H08	pENTR-TOPO	7407		GPR132	29933	AAH84546.1	Hs.532504	G protein-coupled receptor 132			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_013345.2	NP_037477.1	REVIEWED	OK	1.000	1.000	380	1143	1	1140	380	1	380
RIKEN	BC067506	IRAK172F08	MGC	W01A124J06	pENTR-TOPO	13286		IL1R1	3554	AAH67506.1	Hs.701982	Interleukin 1 receptor, type I			PCR rescued clones	NIH_MGC_195	DH10B	NM_000877.2	NP_000868.1	REVIEWED	C	1.000	1.000	569	1710	1	1707	569	1	569
RIKEN	AK091056	flj0016g06	FLJ	W01A124J20	pENTR-TOPO	23458		COBRA1	25920	BAG52272.1	Hs.655043	Cofactor of BRCA1				BRAWH2	EK1	NM_015456.3	NP_056271.2	VALIDATED	C	1.000	1.000	580	1743	1	1740	580	1	580
RIKEN	BC052566	IRAL047K17	MGC	W01A124K05	pENTR-TOPO	9631		TBX2	6909	AAH52566.1	Hs.531085	T-box 2			Brain, neuroblastoma	NIH_MGC_47		NM_005994.3	NP_005985.3	VALIDATED	P	1.000	1.000	702	2109	1	2106	712	11	712
RIKEN	AK095395	flj0023n08	FLJ	W01A124L22	pENTR-TOPO	19999		GPR115	221393	BAG53042.1	Hs.710050	G protein-coupled receptor 115				CTONG2	EK1	NM_153838.3	NP_722580.3	VALIDATED	Cs	0.999	0.999	695	2088	1	2085	695	1	695
RIKEN	AK093490	flj0016d09	FLJ	W01A124M05	pENTR-TOPO	5190		TPCN1	53373	BAG52729.1	Hs.524763	Two pore segment channel 1				TESTI2	EK1	NM_017901.4	NP_060371.2	VALIDATED	Cs	0.999	0.999	816	2451	1	2448	816	1	816
RIKEN	AK096342	flj0040e13	FLJ	W01A124N20	pENTR-TOPO	11521		ZNF93	81931	BAC04764.1	Hs.301059	Zinc finger protein 93	NT2	teratocarcinoma		NT2RP7	EK1	NM_031218.2	NP_112495.2	VALIDATED	Cgs	0.950	0.995	620	1779	1	1776	620	1	620
RIKEN	H04D088K01	H04D088K01	RIKEN	W01A124P08	pENTR-TOPO		15777						-	-	testis	testis	DH10B			
RIKEN	BC000311	IRAL00001E09	MGC	W01A125A03	pENTR-TOPO	3092		KLF6	1316	AAH00311.1	Hs.4055	Kruppel-like factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001300.5	NP_001291.3	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC000311	IRAL00001E09	MGC	W01A125A05	pENTR-TOPO	3092		KLF6	1316	AAH00311.1	Hs.4055	Kruppel-like factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001300.5	NP_001291.3	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC000311	IRAL00001E09	MGC	W01A125A09	pENTR-TOPO	3092		KLF6	1316	AAH00311.1	Hs.4055	Kruppel-like factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001300.5	NP_001291.3	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC000311	IRAL00001E09	MGC	W01A125A11	pENTR-TOPO	3092		KLF6	1316	AAH00311.1	Hs.4055	Kruppel-like factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001300.5	NP_001291.3	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC000311	IRAL00001E09	MGC	W01A125A13	pENTR-TOPO	3092		KLF6	1316	AAH00311.1	Hs.4055	Kruppel-like factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001300.5	NP_001291.3	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC000311	IRAL00001E09	MGC	W01A125A19	pENTR-TOPO	3092		KLF6	1316	AAH00311.1	Hs.4055	Kruppel-like factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001300.5	NP_001291.3	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	BC000311	IRAL00001E09	MGC	W01A125A23	pENTR-TOPO	3092		KLF6	1316	AAH00311.1	Hs.4055	Kruppel-like factor 6			Lung, small cell carcinoma	NIH_MGC_7		NM_001300.5	NP_001291.3	REVIEWED	OK	1.000	1.000	283	852	1	849	283	1	283
RIKEN	AK055986	flj0002i23	FLJ	W01A125B04	pENTR-TOPO	9773		MAPT	4137	BAB71065.1	Hs.101174	Microtubule-associated protein tau	NT2	teratocarcinoma		NT2NE2	EK1	NM_005910.4	NP_005901.2	REVIEWED	Pfs	0.255	0.255	55	378	14	178	441	178	232
RIKEN	AK055986	flj0002i23	FLJ	W01A125B08	pENTR-TOPO	9773		MAPT	4137	BAB71065.1	Hs.101174	Microtubule-associated protein tau	NT2	teratocarcinoma		NT2NE2	EK1	NM_005910.4	NP_005901.2	REVIEWED	Pfs	0.255	0.255	55	378	14	178	441	178	232
RIKEN	AK128810	flj0079g01	FLJ	W01A125B16	pENTR-TOPO	3377		FLJ45983	399717	BAC87617.1	Hs.669736	Hypothetical LOC399717				PROST2	EK1	NM_207423.1	NP_997306.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	AK128810	flj0079g01	FLJ	W01A125B18	pENTR-TOPO	3377		FLJ45983	399717	BAC87617.1	Hs.669736	Hypothetical LOC399717				PROST2	EK1	NM_207423.1	NP_997306.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC004301	IRAL00013G04	MGC	W01A125C01	pENTR-TOPO	3092		KLF6	1316	AAH04301	Hs.4055	Kruppel-like factor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001160125.1	NP_001153597.1	REVIEWED										
RIKEN	BC004301	IRAL00013G04	MGC	W01A125C03	pENTR-TOPO	3092		KLF6	1316	AAH04301	Hs.4055	Kruppel-like factor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001160125.1	NP_001153597.1	REVIEWED										
RIKEN	BC004301	IRAL00013G04	MGC	W01A125C05	pENTR-TOPO	3092		KLF6	1316	AAH04301	Hs.4055	Kruppel-like factor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001160125.1	NP_001153597.1	REVIEWED										
RIKEN	BC004301	IRAL00013G04	MGC	W01A125C07	pENTR-TOPO	3092		KLF6	1316	AAH04301	Hs.4055	Kruppel-like factor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001160125.1	NP_001153597.1	REVIEWED										
RIKEN	BC004301	IRAL00013G04	MGC	W01A125C15	pENTR-TOPO	3092		KLF6	1316	AAH04301	Hs.4055	Kruppel-like factor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001160125.1	NP_001153597.1	REVIEWED										
RIKEN	BC004301	IRAL00013G04	MGC	W01A125C17	pENTR-TOPO	3092		KLF6	1316	AAH04301	Hs.4055	Kruppel-like factor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001160125.1	NP_001153597.1	REVIEWED										
RIKEN	BC004301	IRAL00013G04	MGC	W01A125C23	pENTR-TOPO	3092		KLF6	1316	AAH04301	Hs.4055	Kruppel-like factor 6			Pancreas, adenocarcinoma	NIH_MGC_39		NM_001160125.1	NP_001153597.1	REVIEWED										
RIKEN	AK129567	flj0060k23	FLJ	W01A125D04	pENTR-TOPO	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127				PRS	EK1	XM_001126757.1	XP_001126757.1	MODEL
RIKEN	AK129567	flj0060k23	FLJ	W01A125D08	pENTR-TOPO	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127				PRS	EK1	XM_001126757.1	XP_001126757.1	MODEL
RIKEN	AK129567	flj0060k23	FLJ	W01A125D12	pENTR-TOPO	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127				PRS	EK1	XM_001126757.1	XP_001126757.1	MODEL
RIKEN	BC066232	IRAK172G21	MGC	W01A125F10	pENTR-TOPO	20817		HIST1H2AJ	8331	AAH66232.1	Hs.406691	Histone cluster 1, H2aj			PCR rescued clones	NIH_MGC_195	DH10B	NM_021066.2	NP_066544.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	BC066232	IRAK172G21	MGC	W01A125F12	pENTR-TOPO	20817		HIST1H2AJ	8331	AAH66232.1	Hs.406691	Histone cluster 1, H2aj			PCR rescued clones	NIH_MGC_195	DH10B	NM_021066.2	NP_066544.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	AK092601	flj0007a02	FLJ	W01A125F24	pENTR-TOPO	23677		FLJ35282	441389	-						PROST2	EK1	XM_943852.1	XP_948945.1	MODEL										
RIKEN	AK125177	flj0073m09	FLJ	W01A125H10	pENTR-TOPO	586		LOC149134	149134	BAC86072.1	Hs.417972	Hypothetical LOC149134				FCBBF3	EK1													
RIKEN	AK024509	flj0067c23	FLJ	W01A125H20	pENTR-TOPO	15404		C21orf96	80215	BAB14918.1	Hs.672131	Chromosome 21 open reading frame 96				ad	EK1													
RIKEN	BC009788	IRAL019G02	MGC	W01A125J16	pENTR-TOPO	2089		MRPS14	63931	AAH09788.1	Hs.702192	Mitochondrial ribosomal protein S14			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_022100.1	NP_071383.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
RIKEN	AK128283	flj0078k09	FLJ	W01A125K03	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK128283	flj0078k09	FLJ	W01A125K05	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK128283	flj0078k09	FLJ	W01A125K07	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK128283	flj0078k09	FLJ	W01A125K09	pENTR-TOPO	1191		DISC1	27185	BAC87367	Hs.13318	Disrupted in schizophrenia 1				THYMU3	EK1	NM_001012959.1	NP_001012977.1	REVIEWED		0.391	0.409	23	369	80	148	678	189	210
RIKEN	AK094349	flj0045n11	FLJ	W01A125K15	pENTR-TOPO	9907		LOC284033	284033	BAC04335	Hs.592124	Hypothetical LOC284033				BRACE2	EK1			
RIKEN	AK094349	flj0045n11	FLJ	W01A125K19	pENTR-TOPO	9907		LOC284033	284033	BAC04335	Hs.592124	Hypothetical LOC284033				BRACE2	EK1			
RIKEN	AK055396	flj0013j03	FLJ	W01A125L02	pENTR-TOPO	18173		TMEM155	132332	BAB70915.1	Hs.27524	Transmembrane protein 155				FEBRA2	EK1	NM_152399.2	NP_689612.2	VALIDATED	Cs	0.992	0.992	130	393	1	390	130	1	130
RIKEN	AK055396	flj0013j03	FLJ	W01A125L06	pENTR-TOPO	18173		TMEM155	132332	BAB70915.1	Hs.27524	Transmembrane protein 155				FEBRA2	EK1	NM_152399.2	NP_689612.2	VALIDATED	Cs	0.992	0.992	130	393	1	390	130	1	130
RIKEN	AK055396	flj0013j03	FLJ	W01A125L08	pENTR-TOPO	18173		TMEM155	132332	BAB70915.1	Hs.27524	Transmembrane protein 155				FEBRA2	EK1	NM_152399.2	NP_689612.2	VALIDATED	Cs	0.992	0.992	130	393	1	390	130	1	130
RIKEN	AK055396	flj0013j03	FLJ	W01A125L12	pENTR-TOPO	18173		TMEM155	132332	BAB70915.1	Hs.27524	Transmembrane protein 155				FEBRA2	EK1	NM_152399.2	NP_689612.2	VALIDATED	Cs	0.992	0.992	130	393	1	390	130	1	130
RIKEN	AK000471	flj0057a24	FLJ	W01A125L22	pENTR-TOPO	15600		FLJ20464	54944	BAA91187.1	Hs.648259	Hypothetical protein FLJ20464				KAT	EK1													
RIKEN	BC043571	IRAK087L02	MGC	W01A125M15	pENTR-TOPO	15048		LOC613266	613266	-	Hs.309149	Hypothetical LOC613266			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001033516.1	NP_001028688.1	NA
RIKEN	AK057517	flj0007f01	FLJ	W01A125N02	pENTR-TOPO	14125		FLJ32955	150596	BAB71518.1	Hs.470217	Hypothetical protein FLJ32955				TESTI2	EK1	NM_153041.1	NP_694586.1	NA
RIKEN	AK057517	flj0007f01	FLJ	W01A125N06	pENTR-TOPO	14125		FLJ32955	150596	BAB71518.1	Hs.470217	Hypothetical protein FLJ32955				TESTI2	EK1	NM_153041.1	NP_694586.1	NA
RIKEN	AK124782	flj0072g01	FLJ	W01A125N16	pENTR-TOPO	9070		N4BP1	9683	BAC85946	Hs.511839	NEDD4 binding protein 1				BRAWH3	EK1	NM_153029.3	NP_694574.3	VALIDATED	Pfs	0.287	0.320	108	399	62	370	896	782	883
RIKEN	AK124782	flj0072g01	FLJ	W01A125N18	pENTR-TOPO	9070		N4BP1	9683	BAC85946	Hs.511839	NEDD4 binding protein 1				BRAWH3	EK1	NM_153029.3	NP_694574.3	VALIDATED	Pfs	0.287	0.320	108	399	62	370	896	782	883
RIKEN	AK124782	flj0072g01	FLJ	W01A125N22	pENTR-TOPO	9070		N4BP1	9683	BAC85946	Hs.511839	NEDD4 binding protein 1				BRAWH3	EK1	NM_153029.3	NP_694574.3	VALIDATED	Pfs	0.287	0.320	108	399	62	370	896	782	883
RIKEN	AK098639	flj0053b05	FLJ	W01A125O03	pENTR-TOPO	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177				TST	EK1	NM_182560.1	NP_872366.1	PREDICTED	C	1.000	1.000	125	378	1	375	125	1	125
RIKEN	BC002429	IRAL005C18	MGC	W01A125O17	pENTR-TOPO	8671		GFER	2671	AAH02429.1	Hs.27184	Growth factor, augmenter of liver regeneration			Skin, melanotic melanoma.	NIH_MGC_20		NM_005262.2	NP_005253.3	REVIEWED	P	1.000	1.000	125	378	1	375	205	81	205
RIKEN	BC002429	IRAL005C18	MGC	W01A125O19	pENTR-TOPO	8671		GFER	2671	AAH02429.1	Hs.27184	Growth factor, augmenter of liver regeneration			Skin, melanotic melanoma.	NIH_MGC_20		NM_005262.2	NP_005253.3	REVIEWED	P	1.000	1.000	125	378	1	375	205	81	205
RIKEN	AK054869	flj0012c11	FLJ	W01A125P04	pENTR-TOPO	11739		FLJ30307	400704	-	Hs.680622	Hypothetical gene supported by AK054869				BRACE2	EK1			
RIKEN	AK054869	flj0012c11	FLJ	W01A125P08	pENTR-TOPO	11739		FLJ30307	400704	-	Hs.680622	Hypothetical gene supported by AK054869				BRACE2	EK1			
RIKEN	AK054869	flj0012c11	FLJ	W01A125P10	pENTR-TOPO	11739		FLJ30307	400704	-	Hs.680622	Hypothetical gene supported by AK054869				BRACE2	EK1			
RIKEN	AK054869	flj0012c11	FLJ	W01A125P12	pENTR-TOPO	11739		FLJ30307	400704	-	Hs.680622	Hypothetical gene supported by AK054869				BRACE2	EK1			
RIKEN	AK097829	flj0023g01	FLJ	W01A125P20	pENTR-TOPO	33538										TESTI2	EK1			
RIKEN	BC063286	IRAK00133G17	MGC	W01A126A07	pENTR-TOPO	13055		KLF11	8462	AAH63286.1	Hs.12229	Kruppel-like factor 11			Placenta, normal	NIH_MGC_147	DH10B	NM_003597.4	NP_003588.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
RIKEN	AK098105	flj0041e05	FLJ	W01A126B22	pENTR-TOPO	19719		GCNT2	2651	BAC05234.1	Hs.519884	Glucosaminyl (N-acetyl) transferase 2, I-branching enzyme (I blood group)				TRACH2	EK1	NM_145649.4	NP_663624.1	REVIEWED	P	1.000	1.000	145	438	1	435	402	258	402
RIKEN	AK091757	flj0015m14	FLJ	W01A126C07	pENTR-TOPO	698		MGC27382	149047	-	Hs.352665	Hypothetical MGC27382				HLUNG2	EK1	XM_373850.3	XP_373850.1	MODEL										
RIKEN	AK091757	flj0015m14	FLJ	W01A126C09	pENTR-TOPO	698		MGC27382	149047	-	Hs.352665	Hypothetical MGC27382				HLUNG2	EK1	XM_373850.3	XP_373850.1	MODEL										
RIKEN	AK091757	flj0015m14	FLJ	W01A126C11	pENTR-TOPO	698		MGC27382	149047	-	Hs.352665	Hypothetical MGC27382				HLUNG2	EK1	XM_373850.3	XP_373850.1	MODEL										
RIKEN	AK128250	flj0074h21	FLJ	W01A126C19	pENTR-TOPO	11848		ZNF818P	390963	BAC87353.1	Hs.444446	Zinc finger protein 818 pseudogene				THYMU2	EK1													
RIKEN	BC017229	IRAL020H24	MGC	W01A126D08	pENTR-TOPO	13254			653683						Brain, neuroblastoma	NIH_MGC_19				
RIKEN	BC017229	IRAL020H24	MGC	W01A126D10	pENTR-TOPO	13254			653683						Brain, neuroblastoma	NIH_MGC_19				
RIKEN	BC054036	IRAK119F10	MGC	W01A126D18	pENTR-TOPO	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001785.2	NP_001776.1	REVIEWED	Cs	0.993	0.993	146	441	1	438	146	1	146
RIKEN	BC054036	IRAK119F10	MGC	W01A126D20	pENTR-TOPO	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001785.2	NP_001776.1	REVIEWED	Cs	0.993	0.993	146	441	1	438	146	1	146
RIKEN	AK056023	flj0002c10	FLJ	W01A126E03	pENTR-TOPO	7853		NCRNA00052	145978	BAB71075.1	Hs.350808	Non-protein coding RNA 52	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	AK056023	flj0002c10	FLJ	W01A126E05	pENTR-TOPO	7853		NCRNA00052	145978	BAB71075.1	Hs.350808	Non-protein coding RNA 52	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	AK056023	flj0002c10	FLJ	W01A126E11	pENTR-TOPO	7853		NCRNA00052	145978	BAB71075.1	Hs.350808	Non-protein coding RNA 52	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	BC068078	IRAL054H06	MGC	W01A126E13	pENTR-TOPO	22711		NPM2	10361	AAH68078.1	Hs.131055	Nucleophosmin/nucleoplasmin, 2			Skin, melanoma, melanotic	NIH_MGC_112		NM_182795.1	NP_877724.1	VALIDATED	P	1.000	1.000	122	411	1	366	214	1	122
RIKEN	BC068078	IRAL054H06	MGC	W01A126E19	pENTR-TOPO	22711		NPM2	10361	AAH68078.1	Hs.131055	Nucleophosmin/nucleoplasmin, 2			Skin, melanoma, melanotic	NIH_MGC_112		NM_182795.1	NP_877724.1	VALIDATED	P	1.000	1.000	122	411	1	366	214	1	122
RIKEN	BC068078	IRAL054H06	MGC	W01A126E23	pENTR-TOPO	22711		NPM2	10361	AAH68078.1	Hs.131055	Nucleophosmin/nucleoplasmin, 2			Skin, melanoma, melanotic	NIH_MGC_112		NM_182795.1	NP_877724.1	VALIDATED	P	1.000	1.000	122	411	1	366	214	1	122
RIKEN	BC018211	IRAK021F21	MGC	W01A126F12	pENTR-TOPO	1552		MAGOH	4116	AAH18211.1	Hs.421576	Mago-nashi homolog, proliferation-associated (Drosophila)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_002370.2	NP_002361.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	AK123849	flj0069a21	FLJ	W01A126F16	pENTR-TOPO	4820		LOC283174	283174	BAC85707.1	Hs.504370	Hypothetical LOC283174	NT2	teratocarcinoma		NT2RI3	EK1													
RIKEN	AK128686	flj0074h13	FLJ	W01A126G03	pENTR-TOPO	18475		PDZD2	23037	BAC87571.1	Hs.481819	PDZ domain containing 2				UTERU3	EK1	NM_178140.2	NP_835260.2	REVIEWED		0.840	0.854	125	414	37	411	2839	2717	2839
RIKEN	AK128686	flj0074h13	FLJ	W01A126G05	pENTR-TOPO	18475		PDZD2	23037	BAC87571.1	Hs.481819	PDZ domain containing 2				UTERU3	EK1	NM_178140.2	NP_835260.2	REVIEWED		0.840	0.854	125	414	37	411	2839	2717	2839
RIKEN	AK128686	flj0074h13	FLJ	W01A126G07	pENTR-TOPO	18475		PDZD2	23037	BAC87571.1	Hs.481819	PDZ domain containing 2				UTERU3	EK1	NM_178140.2	NP_835260.2	REVIEWED		0.840	0.854	125	414	37	411	2839	2717	2839
RIKEN	BC002595	IRAL004J02	MGC	W01A126G13	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC002595	IRAL004J02	MGC	W01A126G15	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC002595	IRAL004J02	MGC	W01A126G17	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC002595	IRAL004J02	MGC	W01A126G19	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC002595	IRAL004J02	MGC	W01A126G21	pENTR-TOPO	12296		NDUFB7	4713	AAH02595.1	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa			Ovary, adenocarcinoma	NIH_MGC_9		NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
RIKEN	BC013083	IRAK019P02	MGC	W01A126H02	pENTR-TOPO	15085		CST3	1471	AAH13083.1	Hs.304682	Cystatin C			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000099.2	NP_000090.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	BC013083	IRAK019P02	MGC	W01A126H10	pENTR-TOPO	15085		CST3	1471	AAH13083.1	Hs.304682	Cystatin C			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000099.2	NP_000090.1	REVIEWED	C	1.000	1.000	146	441	1	438	146	1	146
RIKEN	BC044843	IRAK050G14	MGC	W01A126I01	pENTR-TOPO	2219		LOC339535	339535	-	Hs.532047	Hypothetical LOC339535			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	XM_001132951.1	XP_001132951.1	MODEL										
RIKEN	BC044843	IRAK050G14	MGC	W01A126I07	pENTR-TOPO	2219		LOC339535	339535	-	Hs.532047	Hypothetical LOC339535			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	XM_001132951.1	XP_001132951.1	MODEL										
RIKEN	BC044843	IRAK050G14	MGC	W01A126I09	pENTR-TOPO	2219		LOC339535	339535	-	Hs.532047	Hypothetical LOC339535			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	XM_001132951.1	XP_001132951.1	MODEL										
RIKEN	AK092503	flj0015l10	FLJ	W01A126J04	pENTR-TOPO	24653		PAGE4	9506	BAC03907	Hs.441038	P antigen family, member 4 (prostate associated)				PLACE6	EK1	NM_007003.2	NP_008934.1	REVIEWED	Pfs	0.222	0.222	36	447	250	143	102	35	70
RIKEN	AK092503	flj0015l10	FLJ	W01A126J06	pENTR-TOPO	24653		PAGE4	9506	BAC03907	Hs.441038	P antigen family, member 4 (prostate associated)				PLACE6	EK1	NM_007003.2	NP_008934.1	REVIEWED	Pfs	0.222	0.222	36	447	250	143	102	35	70
RIKEN	AK125942	flj0072a10	FLJ	W01A126J16	pENTR-TOPO	17120			401072	BAC86353						TESTI4	EK1			
RIKEN	AK125942	flj0072a10	FLJ	W01A126J18	pENTR-TOPO	17120			401072	BAC86353						TESTI4	EK1			
RIKEN	AK125942	flj0072a10	FLJ	W01A126J24	pENTR-TOPO	17120			401072	BAC86353						TESTI4	EK1			
RIKEN	BC043286	IRAK076P22	MGC	W01A126K01	pENTR-TOPO	11980		LOC339316	339316	-	Hs.432564	Hypothetical protein LOC339316			Testis	NIH_MGC_97	DH10B			
RIKEN	BC043286	IRAK076P22	MGC	W01A126K05	pENTR-TOPO	11980		LOC339316	339316	-	Hs.432564	Hypothetical protein LOC339316			Testis	NIH_MGC_97	DH10B			
RIKEN	BC043286	IRAK076P22	MGC	W01A126K09	pENTR-TOPO	11980		LOC339316	339316	-	Hs.432564	Hypothetical protein LOC339316			Testis	NIH_MGC_97	DH10B			
RIKEN	BC002703	IRAL012A02	MGC	W01A126K21	pENTR-TOPO	13236		CENPA	1058	AAH02703.1	Hs.1594	Centromere protein A			Uterus, endometrium adenocarcinoma	NIH_MGC_44		NM_001809.3	NP_001800.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
RIKEN	AK094090	flj0040k22	FLJ	W01A126L02	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	AK094090	flj0040k22	FLJ	W01A126L04	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	AK094090	flj0040k22	FLJ	W01A126L06	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	AK094090	flj0040k22	FLJ	W01A126L10	pENTR-TOPO	23085		CYP11B1	1584	BAC04283.1	Hs.184927	Cytochrome P450, family 11, subfamily B, polypeptide 1				ADRGL1	EK1	NM_001026213.1	NP_001021384.1	REVIEWED	P	1.000	1.000	119	462	103	459	437	319	437
RIKEN	BC001034	IRAL004A16	MGC	W01A126L14	pENTR-TOPO	15261		SOD1	6647	AAH01034.1	Hs.443914	Superoxide dismutase 1, soluble			Placenta, choriocarcinoma	NIH_MGC_21		NM_000454.4	NP_000445.1	REVIEWED	C	1.000	1.000	154	465	1	462	154	1	154
RIKEN	BC001034	IRAL004A16	MGC	W01A126L20	pENTR-TOPO	15261		SOD1	6647	AAH01034.1	Hs.443914	Superoxide dismutase 1, soluble			Placenta, choriocarcinoma	NIH_MGC_21		NM_000454.4	NP_000445.1	REVIEWED	C	1.000	1.000	154	465	1	462	154	1	154
RIKEN	BC001034	IRAL004A16	MGC	W01A126L24	pENTR-TOPO	15261		SOD1	6647	AAH01034.1	Hs.443914	Superoxide dismutase 1, soluble			Placenta, choriocarcinoma	NIH_MGC_21		NM_000454.4	NP_000445.1	REVIEWED	C	1.000	1.000	154	465	1	462	154	1	154
RIKEN	AK056895	flj0007o15	FLJ	W01A126N02	pENTR-TOPO	15619		MTMR3	8897	BAB71303	Hs.474536	Myotubularin related protein 3				PROST2	EK1	NM_153051.2	NP_694691.1	REVIEWED		0.306	0.306	36	465	167	274	1161	750	785
RIKEN	AK056895	flj0007o15	FLJ	W01A126N06	pENTR-TOPO	15619		MTMR3	8897	BAB71303	Hs.474536	Myotubularin related protein 3				PROST2	EK1	NM_153051.2	NP_694691.1	REVIEWED		0.306	0.306	36	465	167	274	1161	750	785
RIKEN	AK130765	flj0056i08	FLJ	W01A126N14	pENTR-TOPO	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281				SYN	EK1	NM_207501.1	NP_997384.1	NA
RIKEN	AK130765	flj0056i08	FLJ	W01A126N20	pENTR-TOPO	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281				SYN	EK1	NM_207501.1	NP_997384.1	NA
RIKEN	AK130765	flj0056i08	FLJ	W01A126N22	pENTR-TOPO	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281				SYN	EK1	NM_207501.1	NP_997384.1	NA
RIKEN	AK130765	flj0056i08	FLJ	W01A126N24	pENTR-TOPO	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281				SYN	EK1	NM_207501.1	NP_997384.1	NA
RIKEN	AK093319	flj0009h07	FLJ	W01A126O09	pENTR-TOPO	9899		FLJ36000	284124	BAC04131						TESTI2	EK1			
RIKEN	AK056796	flj0006j23	FLJ	W01A126O13	pENTR-TOPO	19900		SNRNP48	154007	BAB71287.1	Hs.13366	Small nuclear ribonucleoprotein 48kDa (U11/U12)				PLACE6	EK1	NM_152551.3	NP_689764.3	VALIDATED		0.972	0.972	141	435	1	423	339	1	141
RIKEN	BC067903	IRAK168G19	MGC	W01A126P10	pENTR-TOPO	22816		LOC401442	401442	-	Hs.678992	Hypothetical gene supported by BC028401			Brain, hypothalamus	NIH_MGC_96	DH10B													
RIKEN	AK095018	flj0025j09	FLJ	W01A126P20	pENTR-TOPO	21247		DNAH11	8701	BAC04475	Hs.655326	Dynein, axonemal, heavy chain 11				BRHIP2	EK1	NM_003777.3	NP_003768.2	REVIEWED		0.937	0.937	126	474	1	378	4523	1	126
RIKEN	AK095018	flj0025j09	FLJ	W01A126P24	pENTR-TOPO	21247		DNAH11	8701	BAC04475	Hs.655326	Dynein, axonemal, heavy chain 11				BRHIP2	EK1	NM_003777.3	NP_003768.2	REVIEWED		0.937	0.937	126	474	1	378	4523	1	126
RIKEN	AK092217	flj0011p01	FLJ	W01A127A05	pENTR-TOPO	35426		LOC729770	729770	-	Hs.591612	Hypothetical protein LOC729770	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	AK092217	flj0011p01	FLJ	W01A127A09	pENTR-TOPO	35426		LOC729770	729770	-	Hs.591612	Hypothetical protein LOC729770	NT2	teratocarcinoma		NT2NE2	EK1													
RIKEN	BC009523	IRAK014D13	MGC	W01A127A13	pENTR-TOPO	25397		CXorf40B	541578	AAH09523.1	Hs.545950	Chromosome X open reading frame 40B				NIH_MGC_69	DH10B	NM_001013845.1	NP_001013867.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC009523	IRAK014D13	MGC	W01A127A17	pENTR-TOPO	25397		CXorf40B	541578	AAH09523.1	Hs.545950	Chromosome X open reading frame 40B				NIH_MGC_69	DH10B	NM_001013845.1	NP_001013867.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	BC009523	IRAK014D13	MGC	W01A127A21	pENTR-TOPO	25397		CXorf40B	541578	AAH09523.1	Hs.545950	Chromosome X open reading frame 40B				NIH_MGC_69	DH10B	NM_001013845.1	NP_001013867.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
RIKEN	AK000947	flj0028e21	FLJ	W01A127B06	pENTR-TOPO	14568		MYH7B	57644	BAA91440.1	Hs.414122	Myosin, heavy chain 7B, cardiac muscle, beta				HEMBA1	EK1	NM_020884.2	NP_065935.2	VALIDATED	P	1.000	1.000	176	531	1	528	1983	43	218
RIKEN	AK000947	flj0028e21	FLJ	W01A127B10	pENTR-TOPO	14568		MYH7B	57644	BAA91440.1	Hs.414122	Myosin, heavy chain 7B, cardiac muscle, beta				HEMBA1	EK1	NM_020884.2	NP_065935.2	VALIDATED	P	1.000	1.000	176	531	1	528	1983	43	218
RIKEN	AK000947	flj0028e21	FLJ	W01A127B12	pENTR-TOPO	14568		MYH7B	57644	BAA91440.1	Hs.414122	Myosin, heavy chain 7B, cardiac muscle, beta				HEMBA1	EK1	NM_020884.2	NP_065935.2	VALIDATED	P	1.000	1.000	176	531	1	528	1983	43	218
RIKEN	AK000012	flj0063o18	FLJ	W01A127B16	pENTR-TOPO	24033		NOTCH1	4851	BAA90883.1	Hs.495473	Notch homolog 1, translocation-associated (Drosophila)				ad	EK1	NM_017617.3	NP_060087.3	REVIEWED	Pfs	0.300	0.300	40	426	80	199	2555	2378	2417
RIKEN	AK123889	flj0069o06	FLJ	W01A127C03	pENTR-TOPO	20011			401252	BAC85716						OCBBF2	EK1			
RIKEN	AK123889	flj0069o06	FLJ	W01A127C09	pENTR-TOPO	20011			401252	BAC85716						OCBBF2	EK1			
RIKEN	AK123889	flj0069o06	FLJ	W01A127C11	pENTR-TOPO	20011			401252	BAC85716						OCBBF2	EK1			
RIKEN	AK128177	flj0078o01	FLJ	W01A127C15	pENTR-TOPO	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein				TESTI4	EK1													
RIKEN	BC066258	IRAK172D20	MGC	W01A127D14	pENTR-TOPO	18100		IL21	59067	AAH66258.1	Hs.567559	Interleukin 21			PCR rescued clones	NIH_MGC_195	DH10B	NM_021803.2	NP_068575.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC066258	IRAK172D20	MGC	W01A127D16	pENTR-TOPO	18100		IL21	59067	AAH66258.1	Hs.567559	Interleukin 21			PCR rescued clones	NIH_MGC_195	DH10B	NM_021803.2	NP_068575.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	BC066258	IRAK172D20	MGC	W01A127D20	pENTR-TOPO	18100		IL21	59067	AAH66258.1	Hs.567559	Interleukin 21			PCR rescued clones	NIH_MGC_195	DH10B	NM_021803.2	NP_068575.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
RIKEN	AK097327	flj0025o23	FLJ	W01A127E15	pENTR-TOPO	744		FAM87B	400728	BAC04999.1						STOMA2	EK1	XM_001713962.1	XP_001714014.1	MODEL	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	AK097327	flj0025o23	FLJ	W01A127E17	pENTR-TOPO	744		FAM87B	400728	BAC04999.1						STOMA2	EK1	XM_001713962.1	XP_001714014.1	MODEL	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	AK097327	flj0025o23	FLJ	W01A127E23	pENTR-TOPO	744		FAM87B	400728	BAC04999.1						STOMA2	EK1	XM_001713962.1	XP_001714014.1	MODEL	C	1.000	1.000	159	480	1	477	159	1	159
RIKEN	AK075231	flj0019c14	FLJ	W01A127F04	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	AK075231	flj0019c14	FLJ	W01A127F10	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	AK075231	flj0019c14	FLJ	W01A127F12	pENTR-TOPO	1401		WASF2	10163	BAC11488.1	Hs.590909	WAS protein family, member 2				PLACE2	EK1	NM_006990.2	NP_008921.1	REVIEWED	Pg	0.994	1.000	170	510	1	507	498	329	498
RIKEN	AK024726	flj0057d23	FLJ	W01A127F14	pENTR-TOPO	8204		ZFP106	64397	BAB14976.1	Hs.511143	Zinc finger protein 106 homolog (mouse)				CAS	EK1	NM_022473.1	NP_071918.1	PROVISIONAL	P	1.000	1.000	178	537	1	534	1883	1706	1883
RIKEN	AK024726	flj0057d23	FLJ	W01A127F16	pENTR-TOPO	8204		ZFP106	64397	BAB14976.1	Hs.511143	Zinc finger protein 106 homolog (mouse)				CAS	EK1	NM_022473.1	NP_071918.1	PROVISIONAL	P	1.000	1.000	178	537	1	534	1883	1706	1883
RIKEN	AK024726	flj0057d23	FLJ	W01A127F20	pENTR-TOPO	8204		ZFP106	64397	BAB14976.1	Hs.511143	Zinc finger protein 106 homolog (mouse)				CAS	EK1	NM_022473.1	NP_071918.1	PROVISIONAL	P	1.000	1.000	178	537	1	534	1883	1706	1883
RIKEN	BC019040	IRAL030L15	MGC	W01A127G01	pENTR-TOPO	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
RIKEN	BC019040	IRAL030L15	MGC	W01A127G07	pENTR-TOPO	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14		NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
RIKEN	AK126293	flj0071c18	FLJ	W01A127G15	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	AK126293	flj0071c18	FLJ	W01A127G17	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	AK126293	flj0071c18	FLJ	W01A127G19	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	AK126293	flj0071c18	FLJ	W01A127G21	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	AK126293	flj0071c18	FLJ	W01A127G23	pENTR-TOPO	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein				TRACH2	EK1													
RIKEN	AK123203	flj0070b23	FLJ	W01A127H02	pENTR-TOPO	18817			441070	BAC85556						BRALZ2	EK1			
RIKEN	BC001467	IRAL004L13	MGC	W01A127H18	pENTR-TOPO	13825		ADI1	55256	AAH01467.1	Hs.502773	Acireductone dioxygenase 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_018269.2	NP_060739.2	REVIEWED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC001467	IRAL004L13	MGC	W01A127H24	pENTR-TOPO	13825		ADI1	55256	AAH01467.1	Hs.502773	Acireductone dioxygenase 1			Placenta, choriocarcinoma	NIH_MGC_21		NM_018269.2	NP_060739.2	REVIEWED	C	1.000	1.000	179	540	1	537	179	1	179
RIKEN	BC002911	IRAL015O19	MGC	W01A127I01	pENTR-TOPO	9183		VKORC1	79001	AAH02911.1	Hs.324844	Vitamin K epoxide reductase complex, subunit 1			Lung, small cell carcinoma	NIH_MGC_7		NM_024006.4	NP_076869.1	REVIEWED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	BC002911	IRAL015O19	MGC	W01A127I07	pENTR-TOPO	9183		VKORC1	79001	AAH02911.1	Hs.324844	Vitamin K epoxide reductase complex, subunit 1			Lung, small cell carcinoma	NIH_MGC_7		NM_024006.4	NP_076869.1	REVIEWED	OK	1.000	1.000	163	492	1	489	163	1	163
RIKEN	AK123853	flj0068a11	FLJ	W01A127I15	pENTR-TOPO	20706		LOC401286	401286	BAC85709.1	Hs.715358	Hypothetical LOC401286	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	AK123853	flj0068a11	FLJ	W01A127I17	pENTR-TOPO	20706		LOC401286	401286	BAC85709.1	Hs.715358	Hypothetical LOC401286	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	AK123853	flj0068a11	FLJ	W01A127I19	pENTR-TOPO	20706		LOC401286	401286	BAC85709.1	Hs.715358	Hypothetical LOC401286	NT2	teratocarcinoma		NT2RP7	EK1													
RIKEN	BC000415	IRAL001M16	MGC	W01A127J04	pENTR-TOPO	15200		PTTG1IP	754	AAH00415.1	Hs.474010	Pituitary tumor-transforming 1 interacting protein			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004339.2	NP_004330.1	REVIEWED	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC000415	IRAL001M16	MGC	W01A127J06	pENTR-TOPO	15200		PTTG1IP	754	AAH00415.1	Hs.474010	Pituitary tumor-transforming 1 interacting protein			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004339.2	NP_004330.1	REVIEWED	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC000415	IRAL001M16	MGC	W01A127J12	pENTR-TOPO	15200		PTTG1IP	754	AAH00415.1	Hs.474010	Pituitary tumor-transforming 1 interacting protein			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_004339.2	NP_004330.1	REVIEWED	C	1.000	1.000	180	543	1	540	180	1	180
RIKEN	BC036636	IRAK076L11	MGC	W01A127J16	pENTR-TOPO	1473		LEMD1	93273	AAH36636.1	Hs.655520	LEM domain containing 1			Testis	NIH_MGC_97	DH10B	NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
RIKEN	BC036636	IRAK076L11	MGC	W01A127J22	pENTR-TOPO	1473		LEMD1	93273	AAH36636.1	Hs.655520	LEM domain containing 1			Testis	NIH_MGC_97	DH10B	NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
RIKEN	BC036636	IRAK076L11	MGC	W01A127J24	pENTR-TOPO	1473		LEMD1	93273	AAH36636.1	Hs.655520	LEM domain containing 1			Testis	NIH_MGC_97	DH10B	NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
RIKEN	AK125880	flj0072m21	FLJ	W01A127K03	pENTR-TOPO	22931		TP53INP1	94241	-	Hs.492261	Tumor protein p53 inducible nuclear protein 1				TESTI4	EK1	NM_001135733.1	NP_001129205.1	VALIDATED	Cs	0.994	0.994	164	495	1	492	164	1	164
RIKEN	AK125880	flj0072m21	FLJ	W01A127K09	pENTR-TOPO	22931		TP53INP1	94241	-	Hs.492261	Tumor protein p53 inducible nuclear protein 1				TESTI4	EK1	NM_001135733.1	NP_001129205.1	VALIDATED	Cs	0.994	0.994	164	495	1	492	164	1	164
RIKEN	AK125880	flj0072m21	FLJ	W01A127K11	pENTR-TOPO	22931		TP53INP1	94241	-	Hs.492261	Tumor protein p53 inducible nuclear protein 1				TESTI4	EK1	NM_001135733.1	NP_001129205.1	VALIDATED	Cs	0.994	0.994	164	495	1	492	164	1	164
RIKEN	BC000275	IRAL006A04	MGC	W01A127K15	pENTR-TOPO	19748		CDKN1A	1026	AAH00275.1	Hs.370771	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)			Eye, retinoblastoma	NIH_MGC_16		NM_078467.1	NP_510867.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC000275	IRAL006A04	MGC	W01A127K19	pENTR-TOPO	19748		CDKN1A	1026	AAH00275.1	Hs.370771	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)			Eye, retinoblastoma	NIH_MGC_16		NM_078467.1	NP_510867.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC000275	IRAL006A04	MGC	W01A127K21	pENTR-TOPO	19748		CDKN1A	1026	AAH00275.1	Hs.370771	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)			Eye, retinoblastoma	NIH_MGC_16		NM_078467.1	NP_510867.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	BC000275	IRAL006A04	MGC	W01A127K23	pENTR-TOPO	19748		CDKN1A	1026	AAH00275.1	Hs.370771	Cyclin-dependent kinase inhibitor 1A (p21, Cip1)			Eye, retinoblastoma	NIH_MGC_16		NM_078467.1	NP_510867.1	REVIEWED	C	1.000	1.000	164	495	1	492	164	1	164
RIKEN	AK055893	flj0002o07	FLJ	W01A127L06	pENTR-TOPO	16799		NPHP3	27031	BAB71038.1	Hs.511991	Nephronophthisis 3 (adolescent)				MAMGL1	EK1	NM_153240.3	NP_694972.3	REVIEWED	P	1.000	1.000	131	546	1	393	1330	1	131
RIKEN	AK055893	flj0002o07	FLJ	W01A127L08	pENTR-TOPO	16799		NPHP3	27031	BAB71038.1	Hs.511991	Nephronophthisis 3 (adolescent)				MAMGL1	EK1	NM_153240.3	NP_694972.3	REVIEWED	P	1.000	1.000	131	546	1	393	1330	1	131
RIKEN	AK055893	flj0002o07	FLJ	W01A127L10	pENTR-TOPO	16799		NPHP3	27031	BAB71038.1	Hs.511991	Nephronophthisis 3 (adolescent)				MAMGL1	EK1	NM_153240.3	NP_694972.3	REVIEWED	P	1.000	1.000	131	546	1	393	1330	1	131
RIKEN	AK055893	flj0002o07	FLJ	W01A127L12	pENTR-TOPO	16799		NPHP3	27031	BAB71038.1	Hs.511991	Nephronophthisis 3 (adolescent)				MAMGL1	EK1	NM_153240.3	NP_694972.3	REVIEWED	P	1.000	1.000	131	546	1	393	1330	1	131
RIKEN	BC007282	IRAL022K10	MGC	W01A127L20	pENTR-TOPO	16538		MANF	7873	AAH07282.1	Hs.436446	Arginine-rich, mutated in early stage tumors			Eye, retinoblastoma	NIH_MGC_16		NM_006010.2	NP_006001.2	REVIEWED	P	1.000	1.000	182	549	1	546	185	4	185
RIKEN	BC007282	IRAL022K10	MGC	W01A127L24	pENTR-TOPO	16538		MANF	7873	AAH07282.1	Hs.436446	Arginine-rich, mutated in early stage tumors			Eye, retinoblastoma	NIH_MGC_16		NM_006010.2	NP_006001.2	REVIEWED	P	1.000	1.000	182	549	1	546	185	4	185
RIKEN	BC070256	IRAL057P19	MGC	W01A127M05	pENTR-TOPO	6022		IFNG	3458	AAH70256.1	Hs.856	Interferon, gamma				NIH_MGC_191	DH10B	NM_000619.2	NP_000610.2	VALIDATED	C	1.000	1.000	166	501	1	498	166	1	166
RIKEN	AK126768	flj0074m18	FLJ	W01A127M13	pENTR-TOPO	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102				BRACE3	EK1	NM_207454.2	NP_997337.2	VALIDATED	Cs	0.982	0.982	167	504	1	501	167	1	167
RIKEN	AK126768	flj0074m18	FLJ	W01A127M15	pENTR-TOPO	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102				BRACE3	EK1	NM_207454.2	NP_997337.2	VALIDATED	Cs	0.982	0.982	167	504	1	501	167	1	167
RIKEN	AK126768	flj0074m18	FLJ	W01A127M17	pENTR-TOPO	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102				BRACE3	EK1	NM_207454.2	NP_997337.2	VALIDATED	Cs	0.982	0.982	167	504	1	501	167	1	167
RIKEN	AK126768	flj0074m18	FLJ	W01A127M19	pENTR-TOPO	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102				BRACE3	EK1	NM_207454.2	NP_997337.2	VALIDATED	Cs	0.982	0.982	167	504	1	501	167	1	167
RIKEN	BC005867	IRAL001O06	MGC	W01A127N02	pENTR-TOPO	15655		COMT	1312	AAH05867.1	Hs.713616	Catechol-O-methyltransferase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007310.2	NP_009294.1	REVIEWED	Ps	0.995	0.995	182	549	1	546	221	40	221
RIKEN	BC005867	IRAL001O06	MGC	W01A127N04	pENTR-TOPO	15655		COMT	1312	AAH05867.1	Hs.713616	Catechol-O-methyltransferase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007310.2	NP_009294.1	REVIEWED	Ps	0.995	0.995	182	549	1	546	221	40	221
RIKEN	BC005867	IRAL001O06	MGC	W01A127N12	pENTR-TOPO	15655		COMT	1312	AAH05867.1	Hs.713616	Catechol-O-methyltransferase			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_007310.2	NP_009294.1	REVIEWED	Ps	0.995	0.995	182	549	1	546	221	40	221
RIKEN	BC021230	IRAL020H07	MGC	W01A127N20	pENTR-TOPO	982		LOC653160	653160	-					Muscle, rhabdomyosarcoma	NIH_MGC_17		XM_945233.2	XP_950326.2	MODEL										
RIKEN	BC021230	IRAL020H07	MGC	W01A127N22	pENTR-TOPO	982		LOC653160	653160	-					Muscle, rhabdomyosarcoma	NIH_MGC_17		XM_945233.2	XP_950326.2	MODEL										
RIKEN	AK000164	flj0066j21	FLJ	W01A127O01	pENTR-TOPO	24162		APTX	54840	BAA90985.1	Hs.20158	Aprataxin				COL	EK1	NM_175071.1	NP_778241.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
RIKEN	AK000164	flj0066j21	FLJ	W01A127O03	pENTR-TOPO	24162		APTX	54840	BAA90985.1	Hs.20158	Aprataxin				COL	EK1	NM_175071.1	NP_778241.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
RIKEN	AK000164	flj0066j21	FLJ	W01A127O05	pENTR-TOPO	24162		APTX	54840	BAA90985.1	Hs.20158	Aprataxin				COL	EK1	NM_175071.1	NP_778241.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
RIKEN	AK000164	flj0066j21	FLJ	W01A127O07	pENTR-TOPO	24162		APTX	54840	BAA90985.1	Hs.20158	Aprataxin				COL	EK1	NM_175071.1	NP_778241.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
RIKEN	AK000164	flj0066j21	FLJ	W01A127O11	pENTR-TOPO	24162		APTX	54840	BAA90985.1	Hs.20158	Aprataxin				COL	EK1	NM_175071.1	NP_778241.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
RIKEN	AK128136	flj0077g05	FLJ	W01A127O13	pENTR-TOPO	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein				TESTI4	EK1													
RIKEN	AK128136	flj0077g05	FLJ	W01A127O15	pENTR-TOPO	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein				TESTI4	EK1													
RIKEN	AK128136	flj0077g05	FLJ	W01A127O17	pENTR-TOPO	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein				TESTI4	EK1													
RIKEN	AK128136	flj0077g05	FLJ	W01A127O23	pENTR-TOPO	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein				TESTI4	EK1													
RIKEN	AK027451	flj0032c05	FLJ	W01A127P04	pENTR-TOPO	10365		NXN	64359	BAB55122.1	Hs.527989	Nucleoredoxin	NT2	teratocarcinoma		NT2RM2	EK1	NM_022463.3	NP_071908.2	VALIDATED	P	1.000	1.000	186	561	1	558	435	250	435
RIKEN	AK027451	flj0032c05	FLJ	W01A127P06	pENTR-TOPO	10365		NXN	64359	BAB55122.1	Hs.527989	Nucleoredoxin	NT2	teratocarcinoma		NT2RM2	EK1	NM_022463.3	NP_071908.2	VALIDATED	P	1.000	1.000	186	561	1	558	435	250	435
RIKEN	AK027451	flj0032c05	FLJ	W01A127P08	pENTR-TOPO	10365		NXN	64359	BAB55122.1	Hs.527989	Nucleoredoxin	NT2	teratocarcinoma		NT2RM2	EK1	NM_022463.3	NP_071908.2	VALIDATED	P	1.000	1.000	186	561	1	558	435	250	435
RIKEN	AK023029	flj0034g24	FLJ	W01A127P14	pENTR-TOPO	16968		PHC3	80012	BAB14365.1	Hs.694467	Polyhomeotic homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_024947.3	NP_079223.3	VALIDATED	Pgs	0.972	0.994	180	561	1	528	995	13	192
RIKEN	AK023029	flj0034g24	FLJ	W01A127P16	pENTR-TOPO	16968		PHC3	80012	BAB14365.1	Hs.694467	Polyhomeotic homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_024947.3	NP_079223.3	VALIDATED	Pgs	0.972	0.994	180	561	1	528	995	13	192
RIKEN	AK023029	flj0034g24	FLJ	W01A127P18	pENTR-TOPO	16968		PHC3	80012	BAB14365.1	Hs.694467	Polyhomeotic homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_024947.3	NP_079223.3	VALIDATED	Pgs	0.972	0.994	180	561	1	528	995	13	192
RIKEN	AK023029	flj0034g24	FLJ	W01A127P22	pENTR-TOPO	16968		PHC3	80012	BAB14365.1	Hs.694467	Polyhomeotic homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_024947.3	NP_079223.3	VALIDATED	Pgs	0.972	0.994	180	561	1	528	995	13	192
RIKEN	AK023029	flj0034g24	FLJ	W01A127P24	pENTR-TOPO	16968		PHC3	80012	BAB14365.1	Hs.694467	Polyhomeotic homolog 3 (Drosophila)	NT2	teratocarcinoma		NT2RP2	EK1	NM_024947.3	NP_079223.3	VALIDATED	Pgs	0.972	0.994	180	561	1	528	995	13	192
RIKEN	AK125190	flj0071d16	FLJ	W01A128A13	pENTR-TOPO	19958		LOC441179	441179	BAC86077.1	Hs.719702	Hypothetical gene supported by AK055887; AK125190				FEBRA2	EK1													
RIKEN	BC032362	IRAK064O16	MGC	W01A128B02	pENTR-TOPO	20394		TREM2	54209	AAH32362.1	Hs.435295	Triggering receptor expressed on myeloid cells 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_018965.2	NP_061838.1	REVIEWED	Pfs	0.941	1.000	222	669	1	667	230	1	209
RIKEN	BC032362	IRAK064O16	MGC	W01A128B06	pENTR-TOPO	20394		TREM2	54209	AAH32362.1	Hs.435295	Triggering receptor expressed on myeloid cells 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_018965.2	NP_061838.1	REVIEWED	Pfs	0.941	1.000	222	669	1	667	230	1	209
RIKEN	BC032362	IRAK064O16	MGC	W01A128B08	pENTR-TOPO	20394		TREM2	54209	AAH32362.1	Hs.435295	Triggering receptor expressed on myeloid cells 2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_018965.2	NP_061838.1	REVIEWED	Pfs	0.941	1.000	222	669	1	667	230	1	209
RIKEN	BC013572	IRAK014C23	MGC	W01A128C03	pENTR-TOPO	6019		KRAS	3845	AAH13572.1	Hs.505033	V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004985.3	NP_004976.2	REVIEWED	Cs	0.995	0.995	188	567	1	564	188	1	188
RIKEN	BC013572	IRAK014C23	MGC	W01A128C05	pENTR-TOPO	6019		KRAS	3845	AAH13572.1	Hs.505033	V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004985.3	NP_004976.2	REVIEWED	Cs	0.995	0.995	188	567	1	564	188	1	188
RIKEN	BC013572	IRAK014C23	MGC	W01A128C09	pENTR-TOPO	6019		KRAS	3845	AAH13572.1	Hs.505033	V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_004985.3	NP_004976.2	REVIEWED	Cs	0.995	0.995	188	567	1	564	188	1	188
RIKEN	AK128232	flj0078n16	FLJ	W01A128C15	pENTR-TOPO	22734		FLJ46365	401459	BAC87342.1						TESTI4	EK1													
RIKEN	AK128232	flj0078n16	FLJ	W01A128C19	pENTR-TOPO	22734		FLJ46365	401459	BAC87342.1						TESTI4	EK1													
RIKEN	AK128232	flj0078n16	FLJ	W01A128C21	pENTR-TOPO	22734		FLJ46365	401459	BAC87342.1						TESTI4	EK1													
RIKEN	AK128232	flj0078n16	FLJ	W01A128C23	pENTR-TOPO	22734		FLJ46365	401459	BAC87342.1						TESTI4	EK1													
RIKEN	BC070162	IRAL057P09	MGC	W01A128D04	pENTR-TOPO	12914		CTLA4	1493	AAH70162.1	Hs.247824	Cytotoxic T-lymphocyte-associated protein 4				NIH_MGC_191	DH10B	NM_005214.3	NP_005205.2	REVIEWED	Cs	0.996	0.996	223	672	1	669	223	1	223
RIKEN	BC070162	IRAL057P09	MGC	W01A128D10	pENTR-TOPO	12914		CTLA4	1493	AAH70162.1	Hs.247824	Cytotoxic T-lymphocyte-associated protein 4				NIH_MGC_191	DH10B	NM_005214.3	NP_005205.2	REVIEWED	Cs	0.996	0.996	223	672	1	669	223	1	223
RIKEN	AK124522	flj0069e24	FLJ	W01A128D18	pENTR-TOPO	2588		BRWD2	55717	BAC85874	Hs.144447	Bromodomain and WD repeat domain containing 2				BRACE3	EK1	NM_018117.10	NP_060587.8	REVIEWED	Pfs	0.991	0.996	225	675	2	672	1224	1000	1224
RIKEN	AK124522	flj0069e24	FLJ	W01A128D20	pENTR-TOPO	2588		BRWD2	55717	BAC85874	Hs.144447	Bromodomain and WD repeat domain containing 2				BRACE3	EK1	NM_018117.10	NP_060587.8	REVIEWED	Pfs	0.991	0.996	225	675	2	672	1224	1000	1224
RIKEN	AK124522	flj0069e24	FLJ	W01A128D24	pENTR-TOPO	2588		BRWD2	55717	BAC85874	Hs.144447	Bromodomain and WD repeat domain containing 2				BRACE3	EK1	NM_018117.10	NP_060587.8	REVIEWED	Pfs	0.991	0.996	225	675	2	672	1224	1000	1224
RIKEN	BC071998	IRAL058B24	MGC	W01A128E07	pENTR-TOPO	15656		RANBP1	5902	AAH71998	Hs.24763	RAN binding protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_002882.2	NP_002873.1	REVIEWED	Pg	0.995	1.000	188	570	7	567	201	14	201
RIKEN	BC071998	IRAL058B24	MGC	W01A128E09	pENTR-TOPO	15656		RANBP1	5902	AAH71998	Hs.24763	RAN binding protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_002882.2	NP_002873.1	REVIEWED	Pg	0.995	1.000	188	570	7	567	201	14	201
RIKEN	BC071998	IRAL058B24	MGC	W01A128E11	pENTR-TOPO	15656		RANBP1	5902	AAH71998	Hs.24763	RAN binding protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_002882.2	NP_002873.1	REVIEWED	Pg	0.995	1.000	188	570	7	567	201	14	201
RIKEN	BC006465	IRAL006F12	MGC	W01A128E13	pENTR-TOPO	9377		CYBA	1535	AAH06465.1	Hs.513803	Cytochrome b-245, alpha polypeptide			Brain, neuroblastoma	NIH_MGC_19		NM_000101.2	NP_000092.2	REVIEWED	Cs	0.995	0.995	195	588	1	585	195	1	195
RIKEN	BC045773	IRAK090K08	MGC	W01A128F02	pENTR-TOPO	23945		B4GALT1	2683	AAH45773.1	Hs.272011	UDP-Gal:betaGlcNAc beta 1,4- galactosyltransferase, polypeptide 1			Testis	NIH_MGC_97	DH10B	NM_001497.3	NP_001488.2	REVIEWED	P	1.000	1.000	216	678	1	648	398	1	216
RIKEN	BC012626	IRAL019B09	MGC	W01A128F16	pENTR-TOPO	13753		NAT8	9027	AAH12626.1	Hs.14637	N-acetyltransferase 8 (GCN5-related, putative)			Kidney	NIH_MGC_75	DH10B	NM_003960.3	NP_003951.3	REVIEWED	P	1.000	1.000	226	678	1	678	227	1	226
RIKEN	BC012626	IRAL019B09	MGC	W01A128F18	pENTR-TOPO	13753		NAT8	9027	AAH12626.1	Hs.14637	N-acetyltransferase 8 (GCN5-related, putative)			Kidney	NIH_MGC_75	DH10B	NM_003960.3	NP_003951.3	REVIEWED	P	1.000	1.000	226	678	1	678	227	1	226
RIKEN	BC012626	IRAL019B09	MGC	W01A128F24	pENTR-TOPO	13753		NAT8	9027	AAH12626.1	Hs.14637	N-acetyltransferase 8 (GCN5-related, putative)			Kidney	NIH_MGC_75	DH10B	NM_003960.3	NP_003951.3	REVIEWED	P	1.000	1.000	226	678	1	678	227	1	226
RIKEN	BC015510	IRAK022P23	MGC	W01A128G05	pENTR-TOPO	502		RGS1	5996	AAH15510.1	Hs.75256	Regulator of G-protein signaling 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002922.3	NP_002913.3	REVIEWED	P	1.000	1.000	196	591	1	588	209	14	209
RIKEN	AK021727	flj0029c01	FLJ	W01A128H04	pENTR-TOPO	21875		LMBR1	64327	BAB13880.1	Hs.209989	Limb region 1 homolog (mouse)				HEMBA1	EK1	NM_022458.3	NP_071903.2	REVIEWED	Ps	0.995	0.995	207	687	1	621	490	1	207
RIKEN	AK021727	flj0029c01	FLJ	W01A128H06	pENTR-TOPO	21875		LMBR1	64327	BAB13880.1	Hs.209989	Limb region 1 homolog (mouse)				HEMBA1	EK1	NM_022458.3	NP_071903.2	REVIEWED	Ps	0.995	0.995	207	687	1	621	490	1	207
RIKEN	BC005975	IRAL021H09	MGC	W01A128H16	pENTR-TOPO	307		CACYBP	27101	AAH05975.1	Hs.508524	Calcyclin binding protein			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_014412.2	NP_055227.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC005975	IRAL021H09	MGC	W01A128H20	pENTR-TOPO	307		CACYBP	27101	AAH05975.1	Hs.508524	Calcyclin binding protein			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_014412.2	NP_055227.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	BC005975	IRAL021H09	MGC	W01A128H24	pENTR-TOPO	307		CACYBP	27101	AAH05975.1	Hs.508524	Calcyclin binding protein			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_014412.2	NP_055227.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
RIKEN	AK056936	flj0003d05	FLJ	W01A128I01	pENTR-TOPO	20426		EHMT2	10919	BAB71314.1	Hs.709218	Euchromatic histone-lysine N-methyltransferase 2				SALGL1	EK1	NM_006709.3	NP_006700.3	REVIEWED	P	1.000	1.000	194	609	1	582	1210	1	194
RIKEN	AK056936	flj0003d05	FLJ	W01A128I11	pENTR-TOPO	20426		EHMT2	10919	BAB71314.1	Hs.709218	Euchromatic histone-lysine N-methyltransferase 2				SALGL1	EK1	NM_006709.3	NP_006700.3	REVIEWED	P	1.000	1.000	194	609	1	582	1210	1	194
RIKEN	AK027361	flj0030g19	FLJ	W01A128I13	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK027361	flj0030g19	FLJ	W01A128I21	pENTR-TOPO	23134		MYST3	7994	BAB55062	Hs.491577	MYST histone acetyltransferase (monocytic leukemia) 3				HEMBB1	EK1	NM_001099413.1	NP_001092883.1	VALIDATED	P	1.000	1.000	176	618	1	528	2004	838	1013
RIKEN	AK055534	flj0012h23	FLJ	W01A128J08	pENTR-TOPO	22680		C8orf49	606553	BAB70943	Hs.545529	Chromosome 8 open reading frame 49				HEART2	EK1													
RIKEN	AK055534	flj0012h23	FLJ	W01A128J10	pENTR-TOPO	22680		C8orf49	606553	BAB70943	Hs.545529	Chromosome 8 open reading frame 49				HEART2	EK1													
RIKEN	AK001975	flj0037l19	FLJ	W01A128J16	pENTR-TOPO	12945		MBD5	55777	BAA92013.1	Hs.458312	Methyl-CpG binding domain protein 5				PLACE1	EK1	NM_018328.3	NP_060798.2	VALIDATED	P	1.000	1.000	218	690	1	654	1494	623	840
RIKEN	AK001975	flj0037l19	FLJ	W01A128J20	pENTR-TOPO	12945		MBD5	55777	BAA92013.1	Hs.458312	Methyl-CpG binding domain protein 5				PLACE1	EK1	NM_018328.3	NP_060798.2	VALIDATED	P	1.000	1.000	218	690	1	654	1494	623	840
RIKEN	AK001975	flj0037l19	FLJ	W01A128J24	pENTR-TOPO	12945		MBD5	55777	BAA92013.1	Hs.458312	Methyl-CpG binding domain protein 5				PLACE1	EK1	NM_018328.3	NP_060798.2	VALIDATED	P	1.000	1.000	218	690	1	654	1494	623	840
RIKEN	BC000510	IRAL001H20	MGC	W01A128K09	pENTR-TOPO	21024		HSPB1	3315	AAH00510.1	Hs.520973	Heat shock 27kDa protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001540.3	NP_001531.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	BC000510	IRAL001H20	MGC	W01A128K11	pENTR-TOPO	21024		HSPB1	3315	AAH00510.1	Hs.520973	Heat shock 27kDa protein 1			Lung, small cell carcinoma	NIH_MGC_7		NM_001540.3	NP_001531.1	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
RIKEN	AK128501	flj0076h01	FLJ	W01A128K21	pENTR-TOPO	15537		BCR	613	BAC87471	Hs.715409	Breakpoint cluster region				TRACH3	EK1	NM_021574.2	NP_067585.2	REVIEWED	Ps	0.995	0.995	188	624	1	564	1227	715	902
RIKEN	BC034027	IRAL037J14	MGC	W01A128L04	pENTR-TOPO	10023		NOG	9241	AAH34027.1	Hs.248201	Noggin			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_005450.4	NP_005441.1	REVIEWED	C	1.000	1.000	232	699	1	696	232	1	232
RIKEN	BC070259	IRAL057F03	MGC	W01A128L18	pENTR-TOPO	930		CFHR3	10878	AAH70259.1	Hs.709217	Complement factor H-related 3			Liver	NIH_MGC_76	DH10B	NM_021023.4	NP_066303.2	VALIDATED	Ps	0.990	0.990	206	699	1	618	330	1	206
RIKEN	BC070259	IRAL057F03	MGC	W01A128L20	pENTR-TOPO	930		CFHR3	10878	AAH70259.1	Hs.709217	Complement factor H-related 3			Liver	NIH_MGC_76	DH10B	NM_021023.4	NP_066303.2	VALIDATED	Ps	0.990	0.990	206	699	1	618	330	1	206
RIKEN	BC070259	IRAL057F03	MGC	W01A128L24	pENTR-TOPO	930		CFHR3	10878	AAH70259.1	Hs.709217	Complement factor H-related 3			Liver	NIH_MGC_76	DH10B	NM_021023.4	NP_066303.2	VALIDATED	Ps	0.990	0.990	206	699	1	618	330	1	206
RIKEN	BC002882	IRAL015G09	MGC	W01A128M01	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC002882	IRAL015G09	MGC	W01A128M03	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC002882	IRAL015G09	MGC	W01A128M05	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC002882	IRAL015G09	MGC	W01A128M07	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC002882	IRAL015G09	MGC	W01A128M09	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	BC002882	IRAL015G09	MGC	W01A128M11	pENTR-TOPO	9171		C16orf5	29965	AAH02882.1	Hs.654653	Chromosome 16 open reading frame 5			Lung, small cell carcinoma	NIH_MGC_7		NM_013399.2	NP_037531.2	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
RIKEN	AK090970	flj0011c04	FLJ	W01A128M13	pENTR-TOPO	17079		C3orf53	285322	BAC03560.1	Hs.376725	Chromosome 3 open reading frame 53				BRAMY2	EK1													
RIKEN	AK090970	flj0011c04	FLJ	W01A128M23	pENTR-TOPO	17079		C3orf53	285322	BAC03560.1	Hs.376725	Chromosome 3 open reading frame 53				BRAMY2	EK1													
RIKEN	AK094116	flj0026g09	FLJ	W01A128N06	pENTR-TOPO	19987		LOC441177	441177	BAC04291.1	Hs.708964	Hypothetical LOC441177				ADRGL2	EK1	NM_001013720.1	NP_001013742.1	VALIDATED										
RIKEN	BC007742	IRAL017P11	MGC	W01A128N14	pENTR-TOPO	12345		EXOSC5	56915	AAH07742.1	Hs.283741	Exosome component 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020158.3	NP_064543.3	VALIDATED	Cs	0.996	0.996	235	708	1	705	235	1	235
RIKEN	BC007742	IRAL017P11	MGC	W01A128N20	pENTR-TOPO	12345		EXOSC5	56915	AAH07742.1	Hs.283741	Exosome component 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020158.3	NP_064543.3	VALIDATED	Cs	0.996	0.996	235	708	1	705	235	1	235
RIKEN	BC007742	IRAL017P11	MGC	W01A128N24	pENTR-TOPO	12345		EXOSC5	56915	AAH07742.1	Hs.283741	Exosome component 5			Primary B-Cells from Tonsils	NIH_MGC_48		NM_020158.3	NP_064543.3	VALIDATED	Cs	0.996	0.996	235	708	1	705	235	1	235
RIKEN	AK027243	flj0067e15	FLJ	W01A128O09	pENTR-TOPO	3598		BBS1	582	BAB15704.1	Hs.502915	Bardet-Biedl syndrome 1				LNG	EK1	NM_024649.4	NP_078925.3	REVIEWED	Pfs	0.317	0.339	63	663	268	445	593	2	64
RIKEN	AK097878	flj0040a12	FLJ	W01A128P08	pENTR-TOPO	42475		PRDM11	56981	BAC05192.1	Hs.178715	PR domain containing 11				THYMU2	EK1	NM_020229.2	NP_064614.2	VALIDATED		0.349	0.417	43	714	448	558	511	3	44
RIKEN	AK097878	flj0040a12	FLJ	W01A128P10	pENTR-TOPO	42475		PRDM11	56981	BAC05192.1	Hs.178715	PR domain containing 11				THYMU2	EK1	NM_020229.2	NP_064614.2	VALIDATED		0.349	0.417	43	714	448	558	511	3	44
RIKEN	AK097878	flj0040a12	FLJ	W01A128P12	pENTR-TOPO	42475		PRDM11	56981	BAC05192.1	Hs.178715	PR domain containing 11				THYMU2	EK1	NM_020229.2	NP_064614.2	VALIDATED		0.349	0.417	43	714	448	558	511	3	44
RIKEN	BC008876	IRAL026M17	MGC	W01A128P14	pENTR-TOPO	14788		EDN3	1908	AAH08876.1	Hs.1408	Endothelin 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000114.2	NP_000105.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC008876	IRAL026M17	MGC	W01A128P18	pENTR-TOPO	14788		EDN3	1908	AAH08876.1	Hs.1408	Endothelin 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000114.2	NP_000105.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
RIKEN	BC008876	IRAL026M17	MGC	W01A128P22	pENTR-TOPO	14788		EDN3	1908	AAH08876.1	Hs.1408	Endothelin 3			Muscle, rhabdomyosarcoma	NIH_MGC_17		NM_000114.2	NP_000105.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
Invitrogen	NM_003404	IOH3955	Invitrogen(on gateway)	W01B001A01	pENTR221	14594		YWHAB	7529	NP_003395.1	Hs.643544	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, beta polypeptide						NM_003404.3	NP_003395.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
Invitrogen	NM_006782	IOH13051	Invitrogen(on gateway)	W01B001A02	pENTR221	3726		ZFPL1	7542	NP_006773.2	Hs.98170	Zinc finger protein-like 1						NM_006782.3	NP_006773.2	VALIDATED	C	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	BC020225	IOH13323	Invitrogen(on gateway)	W01B001A03	pENTR221	15926		PI4KAP2	375133	AAH20225	Hs.592456	Phosphatidylinositol 4-kinase, catalytic, alpha pseudogene 2						XM_001718688.1	XP_001718740.1	MODEL	Pfs	0.996	0.996	277	1734	1	831	354	1	277
Invitrogen	NM_024685	IOH10848	Invitrogen(on gateway)	W01B001A04	pENTR221	6085		BBS10	79738	NP_078961.3	Hs.96322	Bardet-Biedl syndrome 10						NM_024685.3	NP_078961.3	VALIDATED	Ps	0.998	0.998	657	1974	1	1971	723	67	723
Invitrogen	NM_001611	IOH14225	Invitrogen(on gateway)	W01B001A05	pENTR221	12701		ACP5	54	NP_001602.1	Hs.1211	Acid phosphatase 5, tartrate resistant						NM_001111035.1	NP_001104505.1	REVIEWED	C	1.000	1.000	325	978	1	975	325	1	325
Invitrogen	NM_138807	IOH12627	Invitrogen(on gateway)	W01B001A06	pENTR221	17084		C3orf31	132001	NP_620162.1	Hs.475472	Chromosome 3 open reading frame 31						NM_138807.2	NP_620162.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
Invitrogen	NM_014310	IOH12833	Invitrogen(on gateway)	W01B001A07	pENTR221	15582		RASD2	23551	NP_055125.2	Hs.474711	RASD family, member 2						NM_014310.3	NP_055125.2	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
Invitrogen	NM_052873	IOH12238	Invitrogen(on gateway)	W01B001A08	pENTR221	7115		C14orf179	112752	NP_443105.2	Hs.532626	Chromosome 14 open reading frame 179						NM_052873.2	NP_443105.2	VALIDATED	Cs	0.995	0.995	213	642	1	639	213	1	213
Invitrogen	NM_174930	IOH11024	Invitrogen(on gateway)	W01B001A09	pENTR221	21441		PMS2L5	5383	NP_777590.1	Hs.647025	Postmeiotic segregation increased 2-like 5						NM_174930.3	NP_777590.1	VALIDATED	C	1.000	1.000	134	405	1	402	134	1	134
Invitrogen	NM_138777	IOH10791	Invitrogen(on gateway)	W01B001A10	pENTR221	23756		MRRF	92399	NP_620132.1	Hs.368011	Mitochondrial ribosome recycling factor						NM_138777.2	NP_620132.1	VALIDATED	C	1.000	1.000	262	789	1	786	262	1	262
Invitrogen	ENST00000274747	IOH4227	Invitrogen(on gateway)	W01B001A11	pENTR221	19842		MRS2	57380	ENSP00000274747	Hs.719256	MRS2 magnesium homeostasis factor homolog (S. cerevisiae)						NM_020662.2	NP_065713.1	VALIDATED	P	1.000	1.000	86	312	1	258	443	15	100
Invitrogen	NM_031297	IOH10314	Invitrogen(on gateway)	W01B001A12	pENTR221	24144		RNF208	727800	NP_112587.2	Hs.512767	Ring finger protein 208						NM_031297.3	NP_112587.2	VALIDATED	P	1.000	1.000	180	543	1	540	261	82	261
Invitrogen	NM_002046	IOH3380	Invitrogen(on gateway)	W01B001A13	pENTR221	5224		GAPDH	2597	NP_002037.2	Hs.598320	Glyceraldehyde-3-phosphate dehydrogenase						NM_002046.3	NP_002037.2	REVIEWED	C	1.000	1.000	335	1008	1	1005	335	1	335
Invitrogen	NM_013232	IOH10469	Invitrogen(on gateway)	W01B001A14	pENTR221	18519		PDCD6	10016	NP_037364.1	Hs.50823	Programmed cell death 6						NM_013232.3	NP_037364.1	REVIEWED	C	1.000	1.000	191	576	1	573	191	1	191
Invitrogen	BC025950	IOH12400	Invitrogen(on gateway)	W01B001A15	pENTR221	11009		C18orf21	83608	AAH25950.2	Hs.37883	Chromosome 18 open reading frame 21						NM_031446.3	NP_113634.3	VALIDATED	Ps	0.992	0.992	132	399	1	396	220	89	220
Invitrogen	NM_014876	IOH10136	Invitrogen(on gateway)	W01B001A16	pENTR221	15975		JOSD1	9929	NP_055691.1	Hs.3094	Josephin domain containing 1						NM_014876.5	NP_055691.1	VALIDATED	C	1.000	1.000	202	609	1	606	202	1	202
Invitrogen	NM_000817	IOH10888	Invitrogen(on gateway)	W01B001A17	pENTR221	12878		GAD1	2571	NP_000808.2	Hs.420036	Glutamate decarboxylase 1 (brain, 67kDa)						NM_000817.2	NP_000808.2	REVIEWED	C	1.000	1.000	594	1785	1	1782	594	1	594
Invitrogen	BC009618	IOH9961	Invitrogen(on gateway)	W01B001A18	pENTR221	18809		TMCO6	55374	AAH09618.1	Hs.712585	Transmembrane and coiled-coil domains 6						NM_018502.3	NP_060972.3	PROVISIONAL	P	1.000	1.000	253	762	1	759	493	241	493
Invitrogen	NM_002524	IOH1768	Invitrogen(on gateway)	W01B001A19	pENTR221	1387		NRAS	4893	NP_002515.1	Hs.486502	Neuroblastoma RAS viral (v-ras) oncogene homolog						NM_002524.3	NP_002515.1	REVIEWED	C	1.000	1.000	189	570	1	567	189	1	189
Invitrogen	NM_001207	IOH5823	Invitrogen(on gateway)	W01B001A20	pENTR221	18537		BTF3	689	NP_001198.2	Hs.591768	Basic transcription factor 3						NM_001207.4	NP_001198.2	REVIEWED	C	1.000	1.000	162	489	1	486	162	1	162
Invitrogen	NM_001381	IOH2343	Invitrogen(on gateway)	W01B001A21	pENTR221	13062		DOK1	1796	NP_001372.1	Hs.103854	Docking protein 1, 62kDa (downstream of tyrosine kinase 1)						NM_001381.2	NP_001372.1	REVIEWED	C	1.000	1.000	481	1446	1	1443	481	1	481
Invitrogen	NM_145169	IOH14571	Invitrogen(on gateway)	W01B001A22	pENTR221	20457		SFT2D1	113402	NP_660152.1	Hs.487143	SFT2 domain containing 1						NM_145169.1	NP_660152.1	PROVISIONAL	C	1.000	1.000	159	480	1	477	159	1	159
Invitrogen	NM_032601	IOH12757	Invitrogen(on gateway)	W01B001A23	pENTR221	13999		MCEE	84693	NP_115990.3	Hs.94949	Methylmalonyl CoA epimerase						NM_032601.3	NP_115990.3	REVIEWED	Cs	0.994	0.994	176	531	1	528	176	1	176
Invitrogen	NM_021067	IOH14219	Invitrogen(on gateway)	W01B001A24	pENTR221	14792		GINS1	9837	NP_066545.3	Hs.658464	GINS complex subunit 1 (Psf1 homolog)						NM_021067.3	NP_066545.3	VALIDATED	Cs	0.995	0.995	196	591	1	588	196	1	196
Invitrogen	NM_020145	IOH14380	Invitrogen(on gateway)	W01B001B01	pENTR221	24000		SH3GLB2	56904	NP_064530.1	Hs.460238	SH3-domain GRB2-like endophilin B2						NM_020145.2	NP_064530.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
Invitrogen	NM_012427	IOH5874	Invitrogen(on gateway)	W01B001B02	pENTR221	12316		KLK5	25818	NP_036559.1	Hs.50915	Kallikrein-related peptidase 5						NM_001077492.1	NP_001070960.1	REVIEWED	C	1.000	1.000	293	882	1	879	293	1	293
Invitrogen	BC028609	IOH11758	Invitrogen(on gateway)	W01B001B03	pENTR221	13875		CCDC93	54520	AAH28609.2	Hs.107845	Coiled-coil domain containing 93						NM_019044.3	NP_061917.3	VALIDATED	Ps	0.998	0.998	575	1728	1	1725	631	57	631
Invitrogen	NM_016500	IOH4787	Invitrogen(on gateway)	W01B001B04	pENTR221	24820		CXorf26	51260	NP_057584.2	Hs.370100	Chromosome X open reading frame 26						NM_016500.3	NP_057584.2	PREDICTED	C	1.000	1.000	233	702	1	699	233	1	233
Invitrogen	NM_001738	IOH11391	Invitrogen(on gateway)	W01B001B05	pENTR221	23243		CA1	759	NP_001729.1	Hs.23118	Carbonic anhydrase I						NM_001128830.1	NP_001122302.1	VALIDATED	C	1.000	1.000	261	786	1	783	261	1	261
Invitrogen	NM_030578	IOH4997	Invitrogen(on gateway)	W01B001B06	pENTR221	12669		B9D2	80776	NP_085055.2	Hs.567596	B9 protein domain 2						NM_030578.3	NP_085055.2	VALIDATED	Cs	0.994	0.994	175	528	1	525	175	1	175
Invitrogen	NM_138819	IOH13823	Invitrogen(on gateway)	W01B001B07	pENTR221	24850		FAM122C	159091	NP_620174.1	Hs.269127	Family with sequence similarity 122C						NM_138819.2	NP_620174.1	PREDICTED	C	1.000	1.000	152	459	1	456	152	1	152
Invitrogen	NM_030577	IOH5575	Invitrogen(on gateway)	W01B001B08	pENTR221	13367		TMEM177	80775	NP_085054.2	Hs.439991	Transmembrane protein 177						NM_001105198.1	NP_001098668.1	VALIDATED	Cs	0.994	0.994	311	936	1	933	311	1	311
Invitrogen	NM_178861	IOH10760	Invitrogen(on gateway)	W01B001B09	pENTR221	6734		RNF113B	140432	NP_849192.1	Hs.296045	Ring finger protein 113B						NM_178861.4	NP_849192.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
Invitrogen	NM_001161	IOH5534	Invitrogen(on gateway)	W01B001B10	pENTR221	23760		NUDT2	318	NP_001152.1	Hs.493767	Nudix (nucleoside diphosphate linked moiety X)-type motif 2						NM_001161.3	NP_001152.1	REVIEWED	C	1.000	1.000	147	444	1	441	147	1	147
Invitrogen	NM_001011539	IOH10875	Invitrogen(on gateway)	W01B001B11	pENTR221	17735		LOC441046	441046	NP_001011539	Hs.135705	Glucuronidase, beta pseudogene								
Invitrogen	BC004937	IOH5466	Invitrogen(on gateway)	W01B001B12	pENTR221	14751		NOP56	10528	AAH04937.1	Hs.376064	NOP56 ribonucleoprotein homolog (yeast)						NM_006392.2	NP_006383.2	REVIEWED	P	1.000	1.000	174	525	1	522	594	421	594
Invitrogen	BC015674	IOH13800	Invitrogen(on gateway)	W01B001B13	pENTR221	10372		TRIM16	10626	-	Hs.123534	Tripartite motif-containing 16						NM_006470.3	NP_006461.3	REVIEWED	P	1.000	1.000	348	1047	1	1044	564	217	564
Invitrogen	NM_000790	IOH3416	Invitrogen(on gateway)	W01B001B14	pENTR221	21983		DDC	1644	NP_000781.1	Hs.359698	Dopa decarboxylase (aromatic L-amino acid decarboxylase)						NM_000790.3	NP_000781.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
Invitrogen	BC020840	IOH14881	Invitrogen(on gateway)	W01B001B15	pENTR221	4		TRA@	6955	AAH20840.1										
Invitrogen	NM_024571	IOH3996	Invitrogen(on gateway)	W01B001B16	pENTR221	8799		SNRNP25	79622	NP_078847.1	Hs.15277	Small nuclear ribonucleoprotein 25kDa (U11/U12)						NM_024571.3	NP_078847.1	VALIDATED	C	1.000	1.000	132	399	1	396	132	1	132
Invitrogen	NM_001442	IOH7333	Invitrogen(on gateway)	W01B001B17	pENTR221	23228		FABP4	2167	NP_001433.1	Hs.391561	Fatty acid binding protein 4, adipocyte						NM_001442.2	NP_001433.1	REVIEWED	C	1.000	1.000	132	399	1	396	132	1	132
Invitrogen	NM_021130	IOH4329	Invitrogen(on gateway)	W01B001B18	pENTR221	15193		PPIA	5478	NP_066953.1	Hs.598115	Peptidylprolyl isomerase A (cyclophilin A)						NM_021130.3	NP_066953.1	REVIEWED	C	1.000	1.000	165	498	1	495	165	1	165
Invitrogen	BC005339	IOH7206	Invitrogen(on gateway)	W01B001B19	pENTR221	20443		TPMT	7172	AAH05339.1	Hs.444319	Thiopurine S-methyltransferase						NM_000367.2	NP_000358.1	REVIEWED	Cs	0.996	0.996	245	738	1	735	245	1	245
Invitrogen	BC000408	IOH3611	Invitrogen(on gateway)	W01B001B20	pENTR221	19732		ACAT2	39	AAH00408.1	Hs.571037	Acetyl-Coenzyme A acetyltransferase 2						NM_005891.2	NP_005882.2	REVIEWED	Cs	0.997	0.997	397	1194	1	1191	397	1	397
Invitrogen	NM_005030	IOH5070	Invitrogen(on gateway)	W01B001B21	pENTR221	8593		PLK1	5347	NP_005021.2	Hs.592049	Polo-like kinase 1 (Drosophila)						NM_005030.3	NP_005021.2	PROVISIONAL	C	1.000	1.000	603	1812	1	1809	603	1	603
Invitrogen	NM_018064	IOH6070	Invitrogen(on gateway)	W01B001B22	pENTR221	20628		AKIRIN2	55122	NP_060534.1	Hs.485915	Akirin 2						NM_018064.3	NP_060534.1	VALIDATED	C	1.000	1.000	203	612	1	609	203	1	203
Invitrogen	NM_001002000	IOH6998	Invitrogen(on gateway)	W01B001B23	pENTR221	6955		GMPR2	51292	NP_001002000.1	Hs.368855	Guanosine monophosphate reductase 2						NM_001002001.1	NP_001002001.1	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
Invitrogen	NM_017855	IOH23051	Invitrogen(on gateway)	W01B001B24	pENTR221	17579		ODAM	54959	NP_060325.3	Hs.143811	Odontogenic, ameloblast asssociated						NM_017855.3	NP_060325.3	VALIDATED	P	1.000	1.000	153	462	1	459	279	127	279
Invitrogen	NM_002512	IOH4345	Invitrogen(on gateway)	W01B001C01	pENTR221	9780		NME2	4831	NP_002503.1								NM_002512.2	NP_002503.1	VALIDATED	C	1.000	1.000	152	459	1	456	152	1	152
Invitrogen	NM_138453	IOH13462	Invitrogen(on gateway)	W01B001C02	pENTR221	18845		RAB3C	115827	NP_612462.1	Hs.482173	RAB3C, member RAS oncogene family						NM_138453.2	NP_612462.1	PROVISIONAL	OK	1.000	1.000	227	684	1	681	227	1	227
Invitrogen	NM_001002921	IOH13992	Invitrogen(on gateway)	W01B001C03	pENTR221	614		AK3L1	205	NP_001002921.1	Hs.592601	Adenylate kinase 3-like 1						NM_203464.1	NP_982289.1	REVIEWED	C	1.000	1.000	223	672	1	669	223	1	223
Invitrogen	BC022460	IOH11076	Invitrogen(on gateway)	W01B001C04	pENTR221	6662		KLHL1	57626	AAH22460.1	Hs.508201	Kelch-like 1 (Drosophila)						NM_020866.2	NP_065917.1	VALIDATED	Cs	0.999	0.999	748	2247	1	2244	748	1	748
Invitrogen	BC000566	IOH4164	Invitrogen(on gateway)	W01B001C05	pENTR221	15814		RABL4	11020	AAH00566.1	Hs.415172	RAB, member of RAS oncogene family-like 4						NM_006860.2	NP_006851.1	REVIEWED	Cg	0.995	1.000	186	561	1	558	185	1	185
Invitrogen	BC020586	IOH11099	Invitrogen(on gateway)	W01B001C06	pENTR221	12111		SFRS14	10147	AAH20586.1	Hs.515271	Splicing factor, arginine/serine-rich 14						NM_001017392.3	NP_001017392.2	REVIEWED	Pgs	0.947	0.999	991	2967	1	2817	1082	53	1043
Invitrogen	NM_001010935	IOH14475	Invitrogen(on gateway)	W01B001C07	pENTR221	165		RAP1A	5906	NP_001010935.1	Hs.190334	RAP1A, member of RAS oncogene family						NM_002884.2	NP_002875.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
Invitrogen	NM_001444	IOH10514	Invitrogen(on gateway)	W01B001C08	pENTR221	22779		FABP5	2171	NP_001435.1	Hs.408061	Fatty acid binding protein 5 (psoriasis-associated)						NM_001444.1	NP_001435.1	REVIEWED	C	1.000	1.000	135	408	1	405	135	1	135
Invitrogen	NM_001012752	IOH13735	Invitrogen(on gateway)	W01B001C09	pENTR221	3118		ABI1	10006	NP_001012770.1	Hs.508148	Abl-interactor 1						NM_001012752.1	NP_001012770.1	REVIEWED	C	1.000	1.000	476	1431	1	1428	476	1	476
Invitrogen	NM_144710	IOH10821	Invitrogen(on gateway)	W01B001C10	pENTR221	13847		SEPT10	151011	NP_653311.1	Hs.469615	Septin 10						NM_144710.2	NP_653311.1	REVIEWED	C	1.000	1.000	454	1365	1	1362	454	1	454
Invitrogen	NM_024033	IOH2894	Invitrogen(on gateway)	W01B001C11	pENTR221	22024		C7orf49	78996	NP_076938.2	Hs.521213	Chromosome 7 open reading frame 49						NM_024033.2	NP_076938.2	VALIDATED	P	1.000	1.000	129	390	1	387	157	29	157
Invitrogen	NM_053053	IOH10342	Invitrogen(on gateway)	W01B001C12	pENTR221	2179		TADA1L	117143	NP_444281.1	Hs.435967	Transcriptional adaptor 1 (HFI1 homolog, yeast)-like						NM_053053.3	NP_444281.1	VALIDATED	C	1.000	1.000	335	1008	1	1005	335	1	335
Invitrogen	NM_024071	IOH3850	Invitrogen(on gateway)	W01B001C13	pENTR221	7117		ZFYVE21	79038	NP_076976.1	Hs.592322	Zinc finger, FYVE domain containing 21						NM_024071.2	NP_076976.1	PROVISIONAL	C	1.000	1.000	234	705	1	702	234	1	234
Invitrogen	BC012377	IOH10489	Invitrogen(on gateway)	W01B001C14	pENTR221	23491		EGFL7	51162	AAH12377.1	Hs.91481	EGF-like-domain, multiple 7						NM_016215.3	NP_057299.1	VALIDATED	Cs	0.996	0.996	273	822	1	819	273	1	273
Invitrogen	NM_138492	IOH10766	Invitrogen(on gateway)	W01B001C15	pENTR221	19356		PRELID2	153768	NP_612501.3	Hs.314261	PRELI domain containing 2						NM_138492.4	NP_612501.3	VALIDATED	C	1.000	1.000	148	447	1	444	148	1	148
Invitrogen	BC010537	IOH10170	Invitrogen(on gateway)	W01B001C16	pENTR221	18567		SUB1	10923	AAH10537.1	Hs.229641	SUB1 homolog (S. cerevisiae)						NM_006713.3	NP_006704.3	VALIDATED	C	1.000	1.000	127	384	1	381	127	1	127
Invitrogen	NM_138454	IOH12871	Invitrogen(on gateway)	W01B001C17	pENTR221	12687		NXNL1	115861	NP_612463.1	Hs.661836	Nucleoredoxin-like 1						NM_138454.1	NP_612463.1	PROVISIONAL	C	1.000	1.000	212	639	1	636	212	1	212
Invitrogen	NM_000317	IOH9965	Invitrogen(on gateway)	W01B001C18	pENTR221	4097		PTS	5805	NP_000308.1	Hs.503860	6-pyruvoyltetrahydropterin synthase						NM_000317.2	NP_000308.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
Invitrogen	NM_002009	IOH1782	Invitrogen(on gateway)	W01B001C19	pENTR221	7941		FGF7	2252	NP_002000.1	Hs.567268	Fibroblast growth factor 7 (keratinocyte growth factor)						NM_002009.3	NP_002000.1	REVIEWED	C	1.000	1.000	194	585	1	582	194	1	194
Invitrogen	NM_006027	IOH5832	Invitrogen(on gateway)	W01B001C20	pENTR221	289		EXO1	9156	NP_006018.3	Hs.498248	Exonuclease 1						NM_006027.3	NP_006018.3	REVIEWED	C	1.000	1.000	846	2541	1	2538	846	1	846
Invitrogen	NM_138818	IOH13380	Invitrogen(on gateway)	W01B001C21	pENTR221	24289		PRUNE2	158471	NP_620173.1	Hs.262857	Prune homolog 2 (Drosophila)						NM_138818.2	NP_620173.1	VALIDATED	C	1.000	1.000	259	780	1	777	259	1	259
Invitrogen	NM_016274	IOH14460	Invitrogen(on gateway)	W01B001C22	pENTR221	325		PLEKHO1	51177	NP_057358.2	Hs.438824	Pleckstrin homology domain containing, family O member 1						NM_016274.4	NP_057358.2	PROVISIONAL	C	1.000	1.000	409	1230	1	1227	409	1	409
Invitrogen	NM_020675	IOH13511	Invitrogen(on gateway)	W01B001C23	pENTR221	13976		SPC25	57405	NP_065726.1	Hs.421956	SPC25, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_020675.3	NP_065726.1	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	BC008450	IOH13961	Invitrogen(on gateway)	W01B001C24	pENTR221	10532		SUMO2	6613	AAH08450.1	Hs.546298	SMT3 suppressor of mif two 3 homolog 2 (S. cerevisiae)						NM_006937.3	NP_008868.3	REVIEWED	Cs	0.989	0.989	95	288	1	285	95	1	95
Invitrogen	BC017440	IOH14659	Invitrogen(on gateway)	W01B001D01	pENTR221	8655		TRAPPC2L	51693	AAH17440	Hs.461722	Trafficking protein particle complex 2-like						NM_016209.3	NP_057293.1	VALIDATED		0.667	0.667	6	216	15	32	140	116	121
Invitrogen	NM_014752	IOH5878	Invitrogen(on gateway)	W01B001D02	pENTR221	2237		SPCS2	9789	NP_055567.2	Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	P	1.000	1.000	123	372	1	369	226	104	226
Invitrogen	BC028607	IOH11736	Invitrogen(on gateway)	W01B001D03	pENTR221	20372		SERINC1	57515	AAH28607.1	Hs.146668	Serine incorporator 1						NM_020755.2	NP_065806.1	PROVISIONAL	Cs	0.998	0.998	453	1362	1	1359	453	1	453
Invitrogen	NM_006758	IOH4817	Invitrogen(on gateway)	W01B001D04	pENTR221	15383		U2AF1	7307	NP_006749.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1						NM_001025204.1	NP_001020375.1	REVIEWED	C	1.000	1.000	167	723	220	720	167	1	167
Invitrogen	NM_005332	IOH11347	Invitrogen(on gateway)	W01B001D05	pENTR221	8940		HBZ	3050	NP_005323.1	Hs.585357	Hemoglobin, zeta						NM_005332.2	NP_005323.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
Invitrogen	NM_015939	IOH3137	Invitrogen(on gateway)	W01B001D06	pENTR221	14883		TRMT6	51605	NP_057023.2	Hs.128791	TRNA methyltransferase 6 homolog (S. cerevisiae)						NM_015939.3	NP_057023.2	REVIEWED	C	1.000	1.000	497	1494	1	1491	497	1	497
Invitrogen	NM_001225	IOH14345	Invitrogen(on gateway)	W01B001D07	pENTR221	4762		CASP4	837	NP_001216.1	Hs.138378	Caspase 4, apoptosis-related cysteine peptidase						NM_033306.2	NP_150649.1	REVIEWED	C	1.000	1.000	321	1134	169	1131	321	1	321
Invitrogen	NM_032681	IOH5580	Invitrogen(on gateway)	W01B001D08	pENTR221	4086		SPRYD5	84767	NP_116070.2	Hs.326734	SPRY domain containing 5						NM_032681.3	NP_116070.2	VALIDATED	P	1.000	1.000	293	882	1	879	452	160	452
Invitrogen	NM_030924	IOH10748	Invitrogen(on gateway)	W01B001D09	pENTR221	11680		ACSBG2	81616	NP_112186.3	Hs.465720	Acyl-CoA synthetase bubblegum family member 2						NM_030924.3	NP_112186.3	VALIDATED	Cs	0.992	0.992	666	2001	1	1998	666	1	666
Invitrogen	NM_145308	IOH5208	Invitrogen(on gateway)	W01B001D10	pENTR221	4084		C11orf76	220070	NP_660351	Hs.326766	Chromosome 11 open reading frame 76																		
Invitrogen	NM_030979	IOH12034	Invitrogen(on gateway)	W01B001D11	pENTR221	6475		PABPC3	5042	NP_112241.2	Hs.458280	Poly(A) binding protein, cytoplasmic 3						NM_030979.2	NP_112241.2	VALIDATED	C	1.000	1.000	631	1896	1	1893	631	1	631
Invitrogen	NM_001628	IOH4505	Invitrogen(on gateway)	W01B001D12	pENTR221	21855		AKR1B1	231	NP_001619.1	Hs.521212	Aldo-keto reductase family 1, member B1 (aldose reductase)						NM_001628.2	NP_001619.1	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
Invitrogen	NM_000663	IOH13638	Invitrogen(on gateway)	W01B001D13	pENTR221	8704		ABAT	18	NP_000654.2	Hs.336768	4-aminobutyrate aminotransferase						NM_000663.4	NP_000654.2	REVIEWED	C	1.000	1.000	500	1503	1	1500	500	1	500
Invitrogen	NM_003366	IOH3418	Invitrogen(on gateway)	W01B001D14	pENTR221	8843		UQCRC2	7385	NP_003357.2	Hs.528803	Ubiquinol-cytochrome c reductase core protein II						NM_003366.2	NP_003357.2	VALIDATED	C	1.000	1.000	453	1362	1	1359	453	1	453
Invitrogen	BC022867	IOH13277	Invitrogen(on gateway)	W01B001D15	pENTR221	22633		CSPP1	79848	AAH22867.1	Hs.370147	Centrosome and spindle pole associated protein 1						NM_001077204.1	NP_001070672.1	VALIDATED	Ps	0.995	0.995	379	1140	1	1137	1256	878	1256
Invitrogen	BC002553	IOH4036	Invitrogen(on gateway)	W01B001D16	pENTR221	3700		ALDH3B1	221	AAH02553.1	Hs.523841	Aldehyde dehydrogenase 3 family, member B1						NM_001161473.1	NP_001154945.1	REVIEWED	P	1.000	1.000	203	693	1	609	468	1	203
Invitrogen	NM_004681	IOH7358	Invitrogen(on gateway)	W01B001D17	pENTR221	25640		EIF1AY	9086	NP_004672.2	Hs.461178	Eukaryotic translation initiation factor 1A, Y-linked						NM_004681.2	NP_004672.2	REVIEWED	C	1.000	1.000	144	435	1	432	144	1	144
Invitrogen	NM_015964	IOH4341	Invitrogen(on gateway)	W01B001D18	pENTR221	9153		TPPP3	51673	NP_057048.2	Hs.534458	Tubulin polymerization-promoting protein family member 3						NM_015964.2	NP_057048.2	VALIDATED	C	1.000	1.000	176	531	1	528	176	1	176
Invitrogen	NM_019613	IOH6706	Invitrogen(on gateway)	W01B001D19	pENTR221	10369		WDR45L	56270	NP_062559.2	Hs.132161	WDR45-like						NM_019613.3	NP_062559.2	REVIEWED	P	1.000	1.000	286	861	1	858	344	59	344
Invitrogen	NM_004710	IOH3613	Invitrogen(on gateway)	W01B001D20	pENTR221	9790		SYNGR2	9144	NP_004701.1	Hs.464210	Synaptogyrin 2						NM_004710.3	NP_004701.1	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	NM_032328	IOH7232	Invitrogen(on gateway)	W01B001D21	pENTR221	231		EFCAB2	84288	NP_115704.1	Hs.134857	EF-hand calcium binding domain 2						NM_032328.3	NP_115704.1	VALIDATED	C	1.000	1.000	162	489	1	486	162	1	162
Invitrogen	NM_001537	IOH6103	Invitrogen(on gateway)	W01B001D22	pENTR221	8647		HSBP1	3281	NP_001528.1	Hs.250899	Heat shock factor binding protein 1						NM_001537.2	NP_001528.1	REVIEWED	C	1.000	1.000	76	231	1	228	76	1	76
Invitrogen	NM_001659	IOH6999	Invitrogen(on gateway)	W01B001D23	pENTR221	5851		ARF3	377	NP_001650.1	Hs.715625	ADP-ribosylation factor 3						NM_001659.2	NP_001650.1	REVIEWED	C	1.000	1.000	181	546	1	543	181	1	181
Invitrogen	NM_174896	IOH23052	Invitrogen(on gateway)	W01B001D24	pENTR221	929		C1orf162	128346	NP_777556.1	Hs.288010	Chromosome 1 open reading frame 162						NM_174896.2	NP_777556.1	PREDICTED	C	1.000	1.000	155	468	1	465	155	1	155
Invitrogen	NM_002044	IOH4633	Invitrogen(on gateway)	W01B001E01	pENTR221	7808		GALK2	2585	NP_002035.1	Hs.122006	Galactokinase 2						NM_002044.2	NP_002035.1	REVIEWED	C	1.000	1.000	458	1377	1	1374	458	1	458
Invitrogen	BC012106	IOH13202	Invitrogen(on gateway)	W01B001E02	pENTR221	20149		HLA-DQB1	3119	AAH12106.1	Hs.713773	Major histocompatibility complex, class II, DQ beta 1						XM_001723447.1	XP_001723499.1	MODEL		0.927	0.927	261	786	1	783	261	1	261
Invitrogen	BC021992	IOH13921	Invitrogen(on gateway)	W01B001E03	pENTR221	4528		PRKRIR	5612	AAH21992.1	Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	150	453	1	450	761	612	761
Invitrogen	BC021172	IOH10731	Invitrogen(on gateway)	W01B001E04	pENTR221	3859		DDI1	414301	AAH21172.2	Hs.591941	DDI1, DNA-damage inducible 1, homolog 1 (S. cerevisiae)						NM_001001711.2	NP_001001711.1	VALIDATED	Cs	0.995	0.995	396	1191	1	1188	396	1	396
Invitrogen	NM_004794	IOH4780	Invitrogen(on gateway)	W01B001E05	pENTR221	24669		RAB33A	9363	NP_004785.1	Hs.654356	RAB33A, member RAS oncogene family						NM_004794.2	NP_004785.1	REVIEWED	C	1.000	1.000	237	714	1	711	237	1	237
Invitrogen	NM_014504	IOH11262	Invitrogen(on gateway)	W01B001E06	pENTR221	21248		RABGEF1	27342	NP_055319.1	Hs.530053	RAB guanine nucleotide exchange factor (GEF) 1						NM_014504.2	NP_055319.1	VALIDATED	C	1.000	1.000	491	1476	1	1473	491	1	491
Invitrogen	NM_006822	IOH1937	Invitrogen(on gateway)	W01B001E07	pENTR221	10300		RAB40B	10966	NP_006813.1	Hs.484068	RAB40B, member RAS oncogene family						NM_006822.2	NP_006813.1	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
Invitrogen	NM_138414	IOH10524	Invitrogen(on gateway)	W01B001E08	pENTR221	8815		CCDC101	112869	NP_612423.1	Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	C	1.000	1.000	293	882	1	879	293	1	293
Invitrogen	NM_032726	IOH21106	Invitrogen(on gateway)	W01B001E09	pENTR221	13035		PLCD4	84812	NP_116115.1	Hs.632528	Phospholipase C, delta 4						NM_032726.2	NP_116115.1	PROVISIONAL	C	1.000	1.000	762	2289	1	2286	762	1	762
Invitrogen	NM_001005464	IOH11188	Invitrogen(on gateway)	W01B001E10	pENTR221	920		HIST2H3A	333932	NP_001005464.1	Hs.706618	Histone cluster 2, H3a						NM_001005464.2	NP_001005464.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
Invitrogen	BC000902	IOH2899	Invitrogen(on gateway)	W01B001E11	pENTR221	4749		UBXN1	51035	AAH00902.1	Hs.351296	UBX domain protein 1						NM_015853.3	NP_056937.2	PROVISIONAL	Ps	0.996	0.996	283	894	1	849	312	1	283
Invitrogen	BC015214	IOH10370	Invitrogen(on gateway)	W01B001E12	pENTR221	17978		WDFY3	23001	AAH15214.2	Hs.480116	WD repeat and FYVE domain containing 3						NM_178585.2	NP_848700.1	REVIEWED	C	1.000	1.000	281	1263	418	1260	281	1	281
Invitrogen	BC001697	IOH3864	Invitrogen(on gateway)	W01B001E13	pENTR221	9103		RPS15A	6210	AAH01697.1	Hs.370504	Ribosomal protein S15a						NM_001030009.1	NP_001025180.1	REVIEWED	Cs	0.992	0.992	130	393	1	390	130	1	130
Invitrogen	NM_014484	IOH10025	Invitrogen(on gateway)	W01B001E14	pENTR221	14616		MOCS3	27304	NP_055299.1	Hs.159410	Molybdenum cofactor synthesis 3						NM_014484.3	NP_055299.1	REVIEWED	C	1.000	1.000	460	1383	1	1380	460	1	460
Invitrogen	NM_001006637	IOH10688	Invitrogen(on gateway)	W01B001E15	pENTR221	9855		RAB37	326624	NP_001006638	Hs.592097	RAB37, member RAS oncogene family						NM_001006638.1	NP_001006639.1	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
Invitrogen	BC011249	IOH10172	Invitrogen(on gateway)	W01B001E16	pENTR221	12308		NOSIP	51070	AAH11249.1	Hs.7236	Nitric oxide synthase interacting protein						NM_015953.3	NP_057037.1	PROVISIONAL	Cs	0.997	0.997	301	906	1	903	301	1	301
Invitrogen	NM_182476	IOH12954	Invitrogen(on gateway)	W01B001E17	pENTR221	7029		COQ6	51004	NP_872282.1	Hs.632335	Coenzyme Q6 homolog, monooxygenase (S. cerevisiae)						NM_182476.1	NP_872282.1	VALIDATED	C	1.000	1.000	468	1407	1	1404	468	1	468
Invitrogen	NM_006333	IOH9978	Invitrogen(on gateway)	W01B001E18	pENTR221	14262		C1D	10438	NP_006324.1	Hs.602900	C1D nuclear receptor co-repressor						NM_006333.3	NP_006324.1	REVIEWED	C	1.000	1.000	141	426	1	423	141	1	141
Invitrogen	NM_001011	IOH1784	Invitrogen(on gateway)	W01B001E19	pENTR221	13098		RPS7	6201	NP_001002.1	Hs.646582	Ribosomal protein S7						NM_001011.3	NP_001002.1	REVIEWED	C	1.000	1.000	194	585	1	582	194	1	194
Invitrogen	BC021119	IOH14831	Invitrogen(on gateway)	W01B001E20	pENTR221	23466		GAPVD1	26130	AAH21119.1	Hs.495134	GTPase activating protein and VPS9 domains 1						NM_015635.2	NP_056450.2	VALIDATED	Pfs	0.997	0.997	630	1890	1	1889	1487	142	771
Invitrogen	BC017967	IOH12923	Invitrogen(on gateway)	W01B001E21	pENTR221	20094		HLA-DPB2	3116	AAH17967	Hs.665450	Major histocompatibility complex, class II, DP beta 2 (pseudogene)								
Invitrogen	ENST00000238272	IOH13517	Invitrogen(on gateway)	W01B001E22	pENTR221	24277		WDR34	89891	ENSP00000238272	Hs.495240	WD repeat domain 34						NM_052844.3	NP_443076.2	VALIDATED	P	1.000	1.000	419	1260	1	1257	536	118	536
Invitrogen	NM_001031723	IOH12822	Invitrogen(on gateway)	W01B001E23	pENTR221	18152		DNAJB14	79982	NP_001026893.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14						NM_001031723.2	NP_001026893.1	VALIDATED	C	1.000	1.000	379	1140	1	1137	379	1	379
Invitrogen	NM_017869	IOH14424	Invitrogen(on gateway)	W01B001E24	pENTR221	8767		BANP	54971	NP_060339.2	Hs.461705	BTG3 associated nuclear protein						NM_017869.3	NP_060339.2	REVIEWED	C	1.000	1.000	469	1410	1	1407	469	1	469
Invitrogen	NM_000559	IOH13643	Invitrogen(on gateway)	W01B001F01	pENTR221	4585		HBG1	3047	NP_000550.2	Hs.712539	Hemoglobin, gamma A						NM_000559.2	NP_000550.2	REVIEWED	C	1.000	1.000	147	444	1	441	147	1	147
Invitrogen	NM_021107	IOH6073	Invitrogen(on gateway)	W01B001F02	pENTR221	11912		MRPS12	6183	NP_066930.1	Hs.411125	Mitochondrial ribosomal protein S12						NM_033362.2	NP_203526.1	REVIEWED	C	1.000	1.000	138	417	1	414	138	1	138
Invitrogen	ENST00000265840	IOH11761	Invitrogen(on gateway)	W01B001F03	pENTR221	3944		ELMOD1	55531	ENSP00000265840	Hs.495779	ELMO/CED-12 domain containing 1						NM_018712.3	NP_061182.3	VALIDATED	OK	1.000	1.000	334	1005	1	1002	334	1	334
Invitrogen	BC001892	IOH4823	Invitrogen(on gateway)	W01B001F04	pENTR221	1690		C1orf63	57035	AAH01892.1	Hs.259412	Chromosome 1 open reading frame 63						NM_020317.3	NP_064713.3	VALIDATED	Cs	0.997	0.997	290	873	1	870	290	1	290
Invitrogen	NM_001031692	IOH12026	Invitrogen(on gateway)	W01B001F05	pENTR221	21400		LRRC17	10234	NP_001026862.1	Hs.567412	Leucine rich repeat containing 17						NM_001031692.1	NP_001026862.1	PROVISIONAL	C	1.000	1.000	441	1326	1	1323	441	1	441
Invitrogen	NM_018091	IOH3126	Invitrogen(on gateway)	W01B001F06	pENTR221	22641		ELP3	55140	NP_060561.3	Hs.491336	Elongation protein 3 homolog (S. cerevisiae)						NM_018091.5	NP_060561.3	VALIDATED	C	1.000	1.000	547	1644	1	1641	547	1	547
Invitrogen	BC022362	IOH14191	Invitrogen(on gateway)	W01B001F07	pENTR221	1		RPIA	22934	AAH22362	Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.368	0.389	38	720	164	58	311	7	44
Invitrogen	NM_015147	IOH5611	Invitrogen(on gateway)	W01B001F08	pENTR221	12893		CEP68	23177	NP_055962.2	Hs.709257	Centrosomal protein 68kDa						NM_015147.2	NP_055962.2	VALIDATED	Cgs	0.818	0.998	757	1863	1	1860	757	1	757
Invitrogen	NM_001013748	IOH10678	Invitrogen(on gateway)	W01B001F09	pENTR221	21434		LOC541473	541473	NP_001013770	Hs.645394	FK506 binding protein 6, 36kDa pseudogene								
Invitrogen	NM_001030	IOH5265	Invitrogen(on gateway)	W01B001F10	pENTR221	888		RPS27	6232	NP_001021.1	Hs.654475	Ribosomal protein S27						NM_001030.4	NP_001021.1	REVIEWED	C	1.000	1.000	84	255	1	252	84	1	84
Invitrogen	NM_153236	IOH11863	Invitrogen(on gateway)	W01B001F11	pENTR221	21415		GIMAP7	168537	NP_694968.1	Hs.647074	GTPase, IMAP family member 7						NM_153236.3	NP_694968.1	REVIEWED	C	1.000	1.000	300	903	1	900	300	1	300
Invitrogen	NM_016312	IOH4518	Invitrogen(on gateway)	W01B001F12	pENTR221	5809		WBP11	51729	NP_057396.1	Hs.655138	WW domain binding protein 11						NM_016312.2	NP_057396.1	REVIEWED	C	1.000	1.000	641	1926	1	1923	641	1	641
Invitrogen	NM_006144	IOH14828	Invitrogen(on gateway)	W01B001F13	pENTR221	18881		GZMA	3001	NP_006135.1	Hs.90708	Granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3)						NM_006144.3	NP_006135.1	REVIEWED	C	1.000	1.000	262	789	1	786	262	1	262
Invitrogen	NM_014599	IOH3451	Invitrogen(on gateway)	W01B001F14	pENTR221	24611		MAGED2	10916	NP_055414.2	Hs.522665	Melanoma antigen family D, 2						NM_177433.1	NP_803182.1	REVIEWED	C	1.000	1.000	606	1821	1	1818	606	1	606
Invitrogen	NM_021149	IOH12644	Invitrogen(on gateway)	W01B001F15	pENTR221	8970		COTL1	23406	NP_066972.1	Hs.289092	Coactosin-like 1 (Dictyostelium)						NM_021149.2	NP_066972.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
Invitrogen	NM_198431	IOH4058	Invitrogen(on gateway)	W01B001F16	pENTR221	18502		HSPA4	3308	NP_940833	Hs.90093	Heat shock 70kDa protein 4						NM_002154.3	NP_002145.3	VALIDATED	Ps	0.991	0.991	111	447	1	333	840	1	111
Invitrogen	BC005313	IOH7368	Invitrogen(on gateway)	W01B001F17	pENTR221	12645		KLK1	3816	AAH05313.1	Hs.123107	Kallikrein 1						NM_002257.2	NP_002248.1	REVIEWED	Cs	0.992	0.992	262	789	1	786	262	1	262
Invitrogen	NM_024053	IOH4348	Invitrogen(on gateway)	W01B001F18	pENTR221	15935		CENPM	79019	NP_076958.1	Hs.208912	Centromere protein M						NM_024053.3	NP_076958.1	VALIDATED	C	1.000	1.000	180	543	1	540	180	1	180
Invitrogen	NM_014764	IOH6730	Invitrogen(on gateway)	W01B001F19	pENTR221	5491		DAZAP2	9802	NP_055579.1	Hs.369761	DAZ associated protein 2						NM_014764.3	NP_055579.1	REVIEWED	C	1.000	1.000	168	507	1	504	168	1	168
Invitrogen	NM_001970	IOH3811	Invitrogen(on gateway)	W01B001F20	pENTR221	9695		EIF5A	1984	NP_001961.1	Hs.534314	Eukaryotic translation initiation factor 5A						NM_001143762.1	NP_001137234.1	VALIDATED	C	1.000	1.000	154	465	1	462	154	1	154
Invitrogen	NM_032930	IOH6595	Invitrogen(on gateway)	W01B001F21	pENTR221	3990		C11orf70	85016	NP_116319.1	Hs.98328	Chromosome 11 open reading frame 70						NM_032930.1	NP_116319.1	PREDICTED	C	1.000	1.000	229	690	1	687	229	1	229
Invitrogen	NM_030907	IOH6817	Invitrogen(on gateway)	W01B001F22	pENTR221	2151		C1orf89	79363	NP_112169.1	Hs.546430	Chromosome 1 open reading frame 89						NM_030907.2	NP_112169.1	PREDICTED	C	1.000	1.000	258	777	1	774	258	1	258
Invitrogen	NM_006166	IOH7129	Invitrogen(on gateway)	W01B001F23	pENTR221	6220		NFYB	4801	NP_006157.1	Hs.84928	Nuclear transcription factor Y, beta						NM_006166.3	NP_006157.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
Invitrogen	BC030813	IOH23055	Invitrogen(on gateway)	W01B001F24	pENTR221	1		IGK@	50802	AAH30813.1										
Invitrogen	NM_018571	IOH7002	Invitrogen(on gateway)	W01B001G01	pENTR221	12940		STRADB	55437	NP_061041.2	Hs.652338	STE20-related kinase adaptor beta						NM_018571.5	NP_061041.2	REVIEWED	C	1.000	1.000	418	1257	1	1254	418	1	418
Invitrogen	ENST00000360824	IOH12569	Invitrogen(on gateway)	W01B001G02	pENTR221	7772		CASC4	113201	ENSP00000354067	Hs.512867	Cancer susceptibility candidate 4						NM_177974.1	NP_816929.1	REVIEWED	Pfs	0.856	1.000	208	534	1	533	380	1	208
Invitrogen	NM_001625	IOH14360	Invitrogen(on gateway)	W01B001G03	pENTR221	1335		AK2	204	NP_001616.1	Hs.470907	Adenylate kinase 2						NM_001625.2	NP_001616.1	REVIEWED	C	1.000	1.000	239	720	1	717	239	1	239
Invitrogen	NM_020142	IOH12540	Invitrogen(on gateway)	W01B001G04	pENTR221	5958		NDUFA4L2	56901	NP_064527.1	Hs.75069	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 4-like 2						NM_020142.3	NP_064527.1	PROVISIONAL	C	1.000	1.000	87	264	1	261	87	1	87
Invitrogen	BC001956	IOH4856	Invitrogen(on gateway)	W01B001G05	pENTR221	19133		FNIP1	96459	AAH01956.1	Hs.591273	Folliculin interacting protein 1						NM_133372.2	NP_588613.2	VALIDATED	P	1.000	1.000	507	1527	1	1521	1166	1	507
Invitrogen	BC016914	IOH10995	Invitrogen(on gateway)	W01B001G06	pENTR221	17520		ZCCHC4	29063	AAH16914.1	Hs.278945	Zinc finger, CCHC domain containing 4						NM_024936.2	NP_079212.2	VALIDATED	P	1.000	1.000	205	618	1	615	513	25	229
Invitrogen	NM_024076	IOH4559	Invitrogen(on gateway)	W01B001G07	pENTR221	11723		KCTD15	79047	NP_076981.2	Hs.221873	Potassium channel tetramerisation domain containing 15						NM_024076.2	NP_076981.2	VALIDATED	Cs	0.996	0.996	234	705	1	702	234	1	234
Invitrogen	NM_138435	IOH10273	Invitrogen(on gateway)	W01B001G08	pENTR221	15679		FAM83F	113828	NP_612444.2	Hs.197680	Family with sequence similarity 83, member F						NM_138435.2	NP_612444.2	VALIDATED	Ps	0.997	0.997	332	999	1	996	500	169	500
Invitrogen	NM_005130	IOH3926	Invitrogen(on gateway)	W01B001G09	pENTR221	18257		FGFBP1	9982	NP_005121.1	Hs.1690	Fibroblast growth factor binding protein 1						NM_005130.3	NP_005121.1	VALIDATED	C	1.000	1.000	234	705	1	702	234	1	234
Invitrogen	BC016848	IOH10845	Invitrogen(on gateway)	W01B001G10	pENTR221	1985		FAM131C	348487	AAH16848.1	Hs.126825	Family with sequence similarity 131, member C						NM_182623.2	NP_872429.2	VALIDATED	Cs	0.993	0.993	280	843	1	840	280	1	280
Invitrogen	NM_001634	IOH2906	Invitrogen(on gateway)	W01B001G11	pENTR221	19894		AMD1	262	NP_001625.2	Hs.159118	Adenosylmethionine decarboxylase 1						NM_001634.4	NP_001625.2	REVIEWED	C	1.000	1.000	334	1005	1	1002	334	1	334
Invitrogen	NM_002032	IOH10375	Invitrogen(on gateway)	W01B001G12	pENTR221	4465		FTH1	2495	NP_002023.2	Hs.645560	Ferritin, heavy polypeptide 1						NM_002032.2	NP_002023.2	REVIEWED	C	1.000	1.000	183	552	1	549	183	1	183
Invitrogen	BC003615	IOH3872	Invitrogen(on gateway)	W01B001G13	pENTR221	15782		THOC5	8563	AAH03615.1	Hs.75361	THO complex 5						NM_001002879.1	NP_001002879.1	VALIDATED	Cs	0.997	0.997	683	2052	1	2049	683	1	683
Invitrogen	NM_016618	IOH10031	Invitrogen(on gateway)	W01B001G14	pENTR221	13973		KRCC1	51315	NP_057702.1	Hs.469254	Lysine-rich coiled-coil 1						NM_016618.1	NP_057702.1	PROVISIONAL	C	1.000	1.000	259	780	1	777	259	1	259
Invitrogen	NM_138462	IOH10685	Invitrogen(on gateway)	W01B001G15	pENTR221	24156		ZMYND19	116225	NP_612471.1	Hs.128096	Zinc finger, MYND-type containing 19						NM_138462.2	NP_612471.1	VALIDATED	C	1.000	1.000	227	684	1	681	227	1	227
Invitrogen	BC013073	IOH10173	Invitrogen(on gateway)	W01B001G16	pENTR221	318		TMEM183A	92703	AAH13073.1	Hs.497443	Transmembrane protein 183A						NM_138391.4	NP_612400.3	VALIDATED	C	1.000	1.000	376	1131	1	1128	376	1	376
Invitrogen	NM_138785	IOH12456	Invitrogen(on gateway)	W01B001G17	pENTR221	20055		C6orf72	116254	NP_620140.1	Hs.438872	Chromosome 6 open reading frame 72						NM_138785.2	NP_620140.1	PREDICTED	C	1.000	1.000	330	993	1	990	330	1	330
Invitrogen	NM_015987	IOH9993	Invitrogen(on gateway)	W01B001G18	pENTR221	5929		HEBP1	50865	NP_057071.2	Hs.642618	Heme binding protein 1						NM_015987.3	NP_057071.2	REVIEWED	C	1.000	1.000	189	570	1	567	189	1	189
Invitrogen	NM_001002841	IOH1793	Invitrogen(on gateway)	W01B001G19	pENTR221	10016		MYL4	4635	NP_001002841.1	Hs.463300	Myosin, light chain 4, alkali; atrial, embryonic						NM_001002841.1	NP_001002841.1	REVIEWED	C	1.000	1.000	197	594	1	591	197	1	197
Invitrogen	BC021102	IOH14032	Invitrogen(on gateway)	W01B001G20	pENTR221	13114		ZC3H15	55854	AAH21102.1	Hs.368598	Zinc finger CCCH-type containing 15						NM_018471.2	NP_060941.2	VALIDATED	C	1.000	1.000	426	1281	1	1278	426	1	426
Invitrogen	NM_182620	IOH12434	Invitrogen(on gateway)	W01B001G21	pENTR221	10528		FAM33A	348235	NP_872426.1	Hs.463607	Family with sequence similarity 33, member A						NM_182620.3	NP_872426.1	VALIDATED	C	1.000	1.000	121	366	1	363	121	1	121
Invitrogen	NM_058163	IOH14811	Invitrogen(on gateway)	W01B001G22	pENTR221	24839		TSR2	90121	NP_477511.1	Hs.522662	TSR2, 20S rRNA accumulation, homolog (S. cerevisiae)						NM_058163.1	NP_477511.1	PROVISIONAL	C	1.000	1.000	191	576	1	573	191	1	191
Invitrogen	BC020647	IOH12765	Invitrogen(on gateway)	W01B001G23	pENTR221	5956		CCDC59	29080	AAH20647.1	Hs.582627	Coiled-coil domain containing 59						NM_014167.3	NP_054886.2	VALIDATED	C	1.000	1.000	241	726	1	723	241	1	241
Invitrogen	BC012981	IOH13857	Invitrogen(on gateway)	W01B001G24	pENTR221	24218		ANKS6	203286	AAH12981	Hs.406890	Ankyrin repeat and sterile alpha motif domain containing 6						NM_173551.3	NP_775822.3	PROVISIONAL		0.944	0.944	180	726	61	600	871	115	294
Invitrogen	NM_004645	IOH14379	Invitrogen(on gateway)	W01B001H01	pENTR221	10710		COIL	8161	NP_004636.1	Hs.532795	Coilin						NM_004645.2	NP_004636.1	REVIEWED	C	1.000	1.000	576	1731	1	1728	576	1	576
Invitrogen	NM_032140	IOH6250	Invitrogen(on gateway)	W01B001H02	pENTR221	9347		C16orf48	84080	NP_115516.1	Hs.307084	Chromosome 16 open reading frame 48						NM_032140.1	NP_115516.1	PREDICTED	C	1.000	1.000	346	1041	1	1038	346	1	346
Invitrogen	NM_182548	IOH11415	Invitrogen(on gateway)	W01B001H03	pENTR221	20019		LHFPL5	222662	NP_872354.1	Hs.367947	Lipoma HMGIC fusion partner-like 5						NM_182548.3	NP_872354.1	REVIEWED	C	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	NM_015511	IOH4863	Invitrogen(on gateway)	W01B001H04	pENTR221	14619		C20orf4	25980	NP_056326.2	Hs.11314	Chromosome 20 open reading frame 4						NM_015511.3	NP_056326.2	PREDICTED	C	1.000	1.000	384	1155	1	1152	384	1	384
Invitrogen	NM_016594	IOH11881	Invitrogen(on gateway)	W01B001H05	pENTR221	5974		FKBP11	51303	NP_057678.1	Hs.655103	FK506 binding protein 11, 19 kDa						NM_016594.2	NP_057678.1	VALIDATED	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	BC000923	IOH3011	Invitrogen(on gateway)	W01B001H06	pENTR221	9104		SULT1A1	6817	AAH00923.1	Hs.567342	Sulfotransferase family, cytosolic, 1A, phenol-preferring, member 1						NM_177530.1	NP_803566.1	REVIEWED	Cs	0.997	0.997	295	888	1	885	295	1	295
Invitrogen	BC020747	IOH14518	Invitrogen(on gateway)	W01B001H07	pENTR221	25408		SERPINA7	6906	AAH20747.1	Hs.76838	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 7						NM_000354.4	NP_000345.2	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
Invitrogen	NM_020383	IOH5641	Invitrogen(on gateway)	W01B001H08	pENTR221	3218		XPNPEP1	7511	NP_065116.2	Hs.390623	X-prolyl aminopeptidase (aminopeptidase P) 1, soluble						NM_020383.2	NP_065116.2	PROVISIONAL	C	1.000	1.000	623	1872	1	1869	623	1	623
Invitrogen	NM_032257	IOH10785	Invitrogen(on gateway)	W01B001H09	pENTR221	1928		ZMYND12	84217	NP_115633.3	Hs.294009	Zinc finger, MYND-type containing 12						NM_032257.4	NP_115633.3	VALIDATED	Cs	0.997	0.997	365	1098	1	1095	365	1	365
Invitrogen	NM_030940	IOH5279	Invitrogen(on gateway)	W01B001H10	pENTR221	24059		ISCA1	81689	NP_112202.2	Hs.449291	Iron-sulfur cluster assembly 1 homolog (S. cerevisiae)						NM_030940.3	NP_112202.2	VALIDATED	C	1.000	1.000	129	390	1	387	129	1	129
Invitrogen	NM_173501	IOH11653	Invitrogen(on gateway)	W01B001H11	pENTR221															
Invitrogen	NM_001006681	IOH4604	Invitrogen(on gateway)	W01B001H12	pENTR221	25237		SPIN2B	474343	NP_001006682.1	Hs.719343	Spindlin family, member 2B						NM_001006682.1	NP_001006683.1	VALIDATED	C	1.000	1.000	258	777	1	774	258	1	258
Invitrogen	NM_001911	IOH13616	Invitrogen(on gateway)	W01B001H13	pENTR221	7574		CTSG	1511	NP_001902.1	Hs.421724	Cathepsin G						NM_001911.2	NP_001902.1	REVIEWED	C	1.000	1.000	255	768	1	765	255	1	255
Invitrogen	NM_000661	IOH3705	Invitrogen(on gateway)	W01B001H14	pENTR221	8329		RPL9	6133	NP_000652.2	Hs.719072	Ribosomal protein L9						NM_001024921.2	NP_001020092.1	REVIEWED	C	1.000	1.000	192	579	1	576	192	1	192
Invitrogen	BC014441	IOH13328	Invitrogen(on gateway)	W01B001H15	pENTR221	576		NSUN4	387338	AAH14441.1	Hs.163424	NOL1/NOP2/Sun domain family, member 4						NM_199044.2	NP_950245.2	VALIDATED	Cs	0.997	0.997	384	1155	1	1152	384	1	384
Invitrogen	NM_001017956	IOH3696	Invitrogen(on gateway)	W01B001H16	pENTR221	5150		OS9	10956	NP_001017956.1	Hs.527861	Osteosarcoma amplified 9, endoplasmic reticulum associated protein						NM_001017956.1	NP_001017956.1	REVIEWED	C	1.000	1.000	612	1839	1	1836	612	1	612
Invitrogen	NM_005396	IOH7408	Invitrogen(on gateway)	W01B001H17	pENTR221	2883		PNLIPRP2	5408	NP_005387.2	Hs.423598	Pancreatic lipase-related protein 2						NM_005396.4	NP_005387.2	VALIDATED	P	1.000	1.000	469	1410	1	1407	470	2	470
Invitrogen	NM_006743	IOH3158	Invitrogen(on gateway)	W01B001H18	pENTR221	24693		RBM3	5935	NP_006734.1	Hs.301404	RNA binding motif (RNP1, RRM) protein 3						NM_006743.3	NP_006734.1	REVIEWED	C	1.000	1.000	157	474	1	471	157	1	157
Invitrogen	NM_001906	IOH7194	Invitrogen(on gateway)	W01B001H19	pENTR221	8913		CTRB1	1504	NP_001897.4	Hs.610926	Chymotrypsinogen B1						XM_001717935.1	XP_001717987.1	MODEL	P	1.000	1.000	98	792	496	789	101	4	101
Invitrogen	NM_001551	IOH3828	Invitrogen(on gateway)	W01B001H20	pENTR221	24714		IGBP1	3476	NP_001542.1	Hs.496267	Immunoglobulin (CD79A) binding protein 1						NM_001551.2	NP_001542.1	REVIEWED	C	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	NM_032344	IOH6596	Invitrogen(on gateway)	W01B001H21	pENTR221	4089		NUDT22	84304	NP_115720.1	Hs.656074	Nudix (nucleoside diphosphate linked moiety X)-type motif 22						NM_032344.2	NP_115720.1	VALIDATED	C	1.000	1.000	303	912	1	909	303	1	303
Invitrogen	NM_199297	IOH7190	Invitrogen(on gateway)	W01B001H22	pENTR221	4553		THYN1	29087	NP_954994.1	Hs.13645	Thymocyte nuclear protein 1						NM_199297.1	NP_954994.1	REVIEWED	C	1.000	1.000	166	501	1	498	166	1	166
Invitrogen	NM_016495	IOH7137	Invitrogen(on gateway)	W01B001H23	pENTR221	20502		TBC1D7	51256	NP_057579.1	Hs.484678	TBC1 domain family, member 7						NM_001143964.1	NP_001137436.1	VALIDATED	C	1.000	1.000	293	882	1	879	293	1	293
Invitrogen	NM_152516	IOH23070	Invitrogen(on gateway)	W01B001H24	pENTR221	13009		COMMD1	150684	NP_689729.1	Hs.468702	Copper metabolism (Murr1) domain containing 1						NM_152516.2	NP_689729.1	VALIDATED	C	1.000	1.000	190	573	1	570	190	1	190
Invitrogen	NM_020990	IOH5022	Invitrogen(on gateway)	W01B001I01	pENTR221	7884		CKMT1B	1159	NP_066270.1	Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
Invitrogen	NM_016589	IOH12496	Invitrogen(on gateway)	W01B001I02	pENTR221	16262		C3orf1	51300	NP_057673.2	Hs.477287	Chromosome 3 open reading frame 1						NM_016589.3	NP_057673.2	VALIDATED	C	1.000	1.000	285	858	1	855	285	1	285
Invitrogen	NM_022128	IOH14265	Invitrogen(on gateway)	W01B001I03	pENTR221	14031		RBKS	64080	NP_071411.1								NM_022128.1	NP_071411.1	REVIEWED	C	1.000	1.000	322	969	1	966	322	1	322
Invitrogen	BC011916	IOH12850	Invitrogen(on gateway)	W01B001I04	pENTR221	2810		NPL2	112817	AAH11916.1	Hs.180346	N-acetylneuraminate pyruvate lyase 2 (putative)						NM_001134670.1	NP_001128142.1	VALIDATED	C	1.000	1.000	164	495	1	492	164	1	164
Invitrogen	NM_002867	IOH6672	Invitrogen(on gateway)	W01B001I05	pENTR221	1764		RAB3B	5865	NP_002858.2	Hs.123072	RAB3B, member RAS oncogene family						NM_002867.2	NP_002858.2	PROVISIONAL	OK	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	NM_145055	IOH12956	Invitrogen(on gateway)	W01B001I06	pENTR221	11062		C18orf25	147339	NP_659492.1	Hs.116486	Chromosome 18 open reading frame 25						NM_145055.3	NP_659492.1	VALIDATED	C	1.000	1.000	404	1215	1	1212	404	1	404
Invitrogen	BC021578	IOH13563	Invitrogen(on gateway)	W01B001I07	pENTR221	16858		CLCN2	1181	AAH21578.1	Hs.436847	Chloride channel 2						NM_004366.3	NP_004357.3	VALIDATED	Pgs	0.915	0.997	422	1164	1	1161	898	477	898
Invitrogen	NM_024661	IOH10462	Invitrogen(on gateway)	W01B001I08	pENTR221	17021		CCDC51	79714	NP_078937.3	Hs.187657	Coiled-coil domain containing 51						NM_024661.3	NP_078937.3	VALIDATED	P	1.000	1.000	380	1143	1	1140	411	32	411
Invitrogen	NM_016462	IOH3937	Invitrogen(on gateway)	W01B001I09	pENTR221	19810		TMEM14C	51522	NP_057546.1	Hs.519557	Transmembrane protein 14C						NM_016462.2	NP_057546.1	PROVISIONAL	OK	1.000	1.000	112	339	1	336	112	1	112
Invitrogen	NM_007268	IOH10254	Invitrogen(on gateway)	W01B001I10	pENTR221	25260		VSIG4	11326	NP_009199.1	Hs.8904	V-set and immunoglobulin domain containing 4						NM_007268.2	NP_009199.1	VALIDATED	C	1.000	1.000	399	1200	1	1197	399	1	399
Invitrogen	NM_002870	IOH3059	Invitrogen(on gateway)	W01B001I11	pENTR221	1765		RAB13	5872	NP_002861.1	Hs.151536	RAB13, member RAS oncogene family						NM_002870.2	NP_002861.1	PROVISIONAL	C	1.000	1.000	203	612	1	609	203	1	203
Invitrogen	NM_001675	IOH10385	Invitrogen(on gateway)	W01B001I12	pENTR221	15623		ATF4	468	NP_001666.2	Hs.496487	Activating transcription factor 4 (tax-responsive enhancer element B67)						NM_001675.2	NP_001666.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
Invitrogen	BC020197	IOH13293	Invitrogen(on gateway)	W01B001I13	pENTR221	3958		ACCS	84680	AAH20197.1	Hs.126706	1-aminocyclopropane-1-carboxylate synthase homolog (Arabidopsis)(non-functional)						NM_032592.3	NP_115981.1	VALIDATED	Cs	0.998	0.998	501	1506	1	1503	501	1	501
Invitrogen	NM_006082	IOH10061	Invitrogen(on gateway)	W01B001I14	pENTR221	5911		TUBA1B	10376	NP_006073.2	Hs.719075	Tubulin, alpha 1b						NM_006082.2	NP_006073.2	VALIDATED	C	1.000	1.000	451	1356	1	1353	451	1	451
Invitrogen	NM_015918	IOH10987	Invitrogen(on gateway)	W01B001I15	pENTR221	5908		POP5	51367	NP_057002.2	Hs.279913	Processing of precursor 5, ribonuclease P/MRP subunit (S. cerevisiae)						NM_015918.3	NP_057002.2	VALIDATED	C	1.000	1.000	163	492	1	489	163	1	163
Invitrogen	NM_001753	IOH9855	Invitrogen(on gateway)	W01B001I16	pENTR221	21097		CAV1	857	NP_001744.2	Hs.74034	Caveolin 1, caveolae protein, 22kDa						NM_001753.3	NP_001744.2	REVIEWED	OK	1.000	1.000	178	2704	279	812	178	1	178
Invitrogen	NM_178815	IOH12502	Invitrogen(on gateway)	W01B001I17	pENTR221	2735		ARL5B	221079	NP_848930.1	Hs.25362	ADP-ribosylation factor-like 5B						NM_178815.3	NP_848930.1	VALIDATED	C	1.000	1.000	179	540	1	537	179	1	179
Invitrogen	NM_001281	IOH7578	Invitrogen(on gateway)	W01B001I18	pENTR221	11503		TBCB	1155	NP_001272.2	Hs.31053	Tubulin folding cofactor B						NM_001281.2	NP_001272.2	VALIDATED	C	1.000	1.000	244	735	1	732	244	1	244
Invitrogen	NM_001012	IOH1817	Invitrogen(on gateway)	W01B001I19	pENTR221	175		RPS8	6202	NP_001003.1	Hs.512675	Ribosomal protein S8						NM_001012.1	NP_001003.1	REVIEWED	C	1.000	1.000	208	627	1	624	208	1	208
Invitrogen	BC025345	IOH14194	Invitrogen(on gateway)	W01B001I20	pENTR221	36430		hCG_2018279	100127888	AAH25345.1	Hs.671273	Hypothetical protein LOC100127888						XM_001724019.1	XP_001724071.1	MODEL	C	1.000	1.000	79	240	1	237	79	1	79
Invitrogen	ENST00000312635	IOH12152	Invitrogen(on gateway)	W01B001I21	pENTR221	5158		USP15	9958	ENSP00000309240	Hs.434951	Ubiquitin specific peptidase 15						NM_006313.1	NP_006304.1	PROVISIONAL		0.970	0.970	235	708	1	705	952	1	235
Invitrogen	NM_138355	IOH14669	Invitrogen(on gateway)	W01B001I22	pENTR221	10695		SCRN2	90507	NP_612364.2	Hs.239718	Secernin 2						NM_138355.3	NP_612364.2	VALIDATED	Cs	0.993	0.993	425	1278	1	1275	425	1	425
Invitrogen	NM_145050	IOH12883	Invitrogen(on gateway)	W01B001I23	pENTR221	23241		CCDC26	137196	NP_659487.1	Hs.679457	Coiled-coil domain containing 26						NM_145050.2	NP_659487.1	NA
Invitrogen	NM_001031711	IOH13844	Invitrogen(on gateway)	W01B001I24	pENTR221	18515		ERGIC1	57222	NP_001026881.1	Hs.509163	Endoplasmic reticulum-golgi intermediate compartment (ERGIC) 1						NM_001031711.2	NP_001026881.1	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
Invitrogen	BC010895	IOH14241	Invitrogen(on gateway)	W01B001J01	pENTR221	18262		SULT1B1	27284	AAH10895.1	Hs.129742	Sulfotransferase family, cytosolic, 1B, member 1						NM_014465.3	NP_055280.2	REVIEWED	Cs	0.997	0.997	296	891	1	888	296	1	296
Invitrogen	NM_016246	IOH6340	Invitrogen(on gateway)	W01B001J02	pENTR221	12304		HSD17B14	51171	NP_057330.2	Hs.18788	Hydroxysteroid (17-beta) dehydrogenase 14						NM_016246.2	NP_057330.2	VALIDATED	C	1.000	1.000	270	813	1	810	270	1	270
Invitrogen	NM_144602	IOH11852	Invitrogen(on gateway)	W01B001J03	pENTR221	8935		C16orf78	123970	NP_653203.1	Hs.125875	Chromosome 16 open reading frame 78						NM_144602.2	NP_653203.1	PREDICTED	C	1.000	1.000	265	798	1	795	265	1	265
Invitrogen	NM_016334	IOH4877	Invitrogen(on gateway)	W01B001J04	pENTR221	30151		GPR89B	51463	NP_057418.1								NM_016334.3	NP_057418.1	VALIDATED	C	1.000	1.000	455	1368	1	1365	455	1	455
Invitrogen	NM_174891	IOH11682	Invitrogen(on gateway)	W01B001J05	pENTR221	7001		C14orf79	122616	NP_777551.2	Hs.27183	Chromosome 14 open reading frame 79						NM_174891.3	NP_777551.2	VALIDATED	P	1.000	1.000	83	252	1	249	325	243	325
Invitrogen	ENST00000309466	IOH5706	Invitrogen(on gateway)	W01B001J06	pENTR221	19519		LOC441089	441089	ENSP00000336107	Hs.568291	CRSP8 pseudogene								
Invitrogen	NM_006307	IOH13589	Invitrogen(on gateway)	W01B001J07	pENTR221	25343		SRPX	8406	NP_006298.1	Hs.15154	Sushi-repeat-containing protein, X-linked						NM_006307.3	NP_006298.1	PROVISIONAL	C	1.000	1.000	464	1395	1	1392	464	1	464
Invitrogen	ENST00000355220	IOH5645	Invitrogen(on gateway)	W01B001J08	pENTR221	25345		MAGEA11	4110	ENSP00000347358	Hs.670252	Melanoma antigen family A, 11						NM_005366.4	NP_005357.2	REVIEWED	P	1.000	1.000	319	960	1	957	429	111	429
Invitrogen	NM_001001394	IOH10901	Invitrogen(on gateway)	W01B001J09	pENTR221	14229		DNAJB3	414061	NP_001001394.1	Hs.716819	DnaJ (Hsp40) homolog, subfamily B, member 3						NM_001001394.3	NP_001001394.1	VALIDATED	C	1.000	1.000	145	438	1	435	145	1	145
Invitrogen	BC002698	IOH5283	Invitrogen(on gateway)	W01B001J10	pENTR221	10359		CCDC56	28958	AAH02698.1	Hs.16059	Coiled-coil domain containing 56						NM_001040431.1	NP_001035521.1	PROVISIONAL	C	1.000	1.000	106	321	1	318	106	1	106
Invitrogen	NM_001415	IOH11418	Invitrogen(on gateway)	W01B001J11	pENTR221	24652		EIF2S3	1968	NP_001406.1	Hs.539684	Eukaryotic translation initiation factor 2, subunit 3 gamma, 52kDa						NM_001415.3	NP_001406.1	VALIDATED	C	1.000	1.000	472	1419	1	1416	472	1	472
Invitrogen	NM_003755	IOH4627	Invitrogen(on gateway)	W01B001J12	pENTR221	12249		EIF3G	8666	NP_003746.2	Hs.529059	Eukaryotic translation initiation factor 3, subunit G						NM_003755.3	NP_003746.2	VALIDATED	C	1.000	1.000	320	963	1	960	320	1	320
Invitrogen	ENST00000332570	IOH14883	Invitrogen(on gateway)	W01B001J13	pENTR221	2402			645721	ENSP00000333066										
Invitrogen	NM_002402	IOH3706	Invitrogen(on gateway)	W01B001J14	pENTR221	21352		MEST	4232	NP_002393.2	Hs.270978	Mesoderm specific transcript homolog (mouse)						NM_177524.1	NP_803490.1	REVIEWED	C	1.000	1.000	326	1008	28	1005	326	1	326
Invitrogen	NM_001031731	IOH12832	Invitrogen(on gateway)	W01B001J15	pENTR221															
Invitrogen	NM_024043	IOH4354	Invitrogen(on gateway)	W01B001J16	pENTR221	9254		DBNDD1	79007	NP_076948.2	Hs.301394	Dysbindin (dystrobrevin binding protein 1) domain containing 1						NM_024043.2	NP_076948.2	VALIDATED	P	1.000	1.000	156	471	1	468	178	23	178
Invitrogen	NM_000517	IOH7452	Invitrogen(on gateway)	W01B001J17	pENTR221	33868		HBA2	3040	NP_000508.1	Hs.654744	Hemoglobin, alpha 2						NM_000517.4	NP_000508.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
Invitrogen	NM_007104	IOH3185	Invitrogen(on gateway)	W01B001J18	pENTR221	19721		RPL10A	4736	NP_009035.3	Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED	C	1.000	1.000	217	654	1	651	217	1	217
Invitrogen	NM_002156	IOH5036	Invitrogen(on gateway)	W01B001J19	pENTR221	14255		HSPD1	3329	NP_002147.2	Hs.719142	Heat shock 60kDa protein 1 (chaperonin)						NM_199440.1	NP_955472.1	REVIEWED	C	1.000	1.000	573	1722	1	1719	573	1	573
Invitrogen	BC001088	IOH3839	Invitrogen(on gateway)	W01B001J20	pENTR221	347		CDC20	991	AAH01088.1	Hs.524947	Cell division cycle 20 homolog (S. cerevisiae)						NM_001255.2	NP_001246.2	REVIEWED	C	1.000	1.000	499	1500	1	1497	499	1	499
Invitrogen	NM_032709	IOH6597	Invitrogen(on gateway)	W01B001J21	pENTR221	3323		PYROXD2	84795	NP_116098.2	Hs.238303	Pyridine nucleotide-disulphide oxidoreductase domain 2						NM_032709.2	NP_116098.2	VALIDATED	Cs	0.997	0.997	581	1746	1	1743	581	1	581
Invitrogen	NM_002964	IOH7407	Invitrogen(on gateway)	W01B001J22	pENTR221	2156		S100A8	6279	NP_002955.2	Hs.416073	S100 calcium binding protein A8						NM_002964.3	NP_002955.2	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
Invitrogen	BC007014	IOH7141	Invitrogen(on gateway)	W01B001J23	pENTR221	18607		TNFAIP8	25816	AAH07014.1	Hs.656274	Tumor necrosis factor, alpha-induced protein 8						NM_014350.2	NP_055165.2	VALIDATED	C	1.000	1.000	198	597	1	594	198	1	198
Invitrogen	NM_002572	IOH3561	Invitrogen(on gateway)	W01B001J24	pENTR221	4074		PAFAH1B2	5049	NP_002563.1	Hs.718419	Platelet-activating factor acetylhydrolase, isoform Ib, subunit 2 (30kDa)						NM_002572.2	NP_002563.1	PROVISIONAL	C	1.000	1.000	229	690	1	687	229	1	229
Invitrogen	NM_001827	IOH5978	Invitrogen(on gateway)	W01B001K01	pENTR221	23762		CKS2	1164	NP_001818.1	Hs.83758	CDC28 protein kinase regulatory subunit 2						NM_001827.1	NP_001818.1	REVIEWED	C	1.000	1.000	79	240	1	237	79	1	79
Invitrogen	NM_053050	IOH13265	Invitrogen(on gateway)	W01B001K02	pENTR221	14088		MRPL53	116540	NP_444278.1	Hs.534527	Mitochondrial ribosomal protein L53						NM_053050.3	NP_444278.1	REVIEWED	C	1.000	1.000	112	339	1	336	112	1	112
Invitrogen	NM_014954	IOH14025	Invitrogen(on gateway)	W01B001K03	pENTR221	5179		RPH3A	22895	NP_055769.2	Hs.21239	Rabphilin 3A homolog (mouse)						NM_014954.3	NP_055769.2	VALIDATED	C	1.000	1.000	690	2073	1	2070	690	1	690
Invitrogen	BC011923	IOH13453	Invitrogen(on gateway)	W01B001K04	pENTR221	21384		RBM33	155435	AAH11923.1	Hs.591815	RNA binding motif protein 33						NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	246	807	1	738	1180	1	246
Invitrogen	BC013572	IOH9852	Invitrogen(on gateway)	W01B001K05	pENTR221	6019		KRAS	3845	AAH13572.1	Hs.505033	V-Ki-ras2 Kirsten rat sarcoma viral oncogene homolog						NM_004985.3	NP_004976.2	REVIEWED	Cs	0.995	0.995	188	567	1	564	188	1	188
Invitrogen	NM_001033583	IOH12159	Invitrogen(on gateway)	W01B001K06	pENTR221	25190		ACOT9	23597	NP_001028755.2	Hs.298885	Acyl-CoA thioesterase 9						NM_001033583.2	NP_001028755.2	VALIDATED	P	1.000	1.000	212	639	1	636	439	1	212
Invitrogen	BC005825	IOH5866	Invitrogen(on gateway)	W01B001K07	pENTR221	15236		PDXK	8566	AAH05825.1	Hs.284491	Pyridoxal (pyridoxine, vitamin B6) kinase						NM_003681.4	NP_003672.1	REVIEWED	Cg	0.910	1.000	312	855	1	852	312	1	312
Invitrogen	NM_014929	IOH10681	Invitrogen(on gateway)	W01B001K08	pENTR221	12917		FASTKD2	22868	NP_055744.2	Hs.5930	FAST kinase domains 2						NM_014929.3	NP_055744.2	REVIEWED	C	1.000	1.000	710	2133	1	2130	710	1	710
Invitrogen	NM_005620	IOH4079	Invitrogen(on gateway)	W01B001K09	pENTR221	2146		S100A11	6282	NP_005611.1	Hs.417004	S100 calcium binding protein A11						NM_005620.1	NP_005611.1	REVIEWED	C	1.000	1.000	105	318	1	315	105	1	105
Invitrogen	NM_000229	IOH10295	Invitrogen(on gateway)	W01B001K10	pENTR221	9140		LCAT	3931	NP_000220.1	Hs.387239	Lecithin-cholesterol acyltransferase						NM_000229.1	NP_000220.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
Invitrogen	NM_024055	IOH3071	Invitrogen(on gateway)	W01B001K11	pENTR221	18664		SLC30A5	64924	NP_076960.1	Hs.631975	Solute carrier family 30 (zinc transporter), member 5						NM_024055.2	NP_076960.1	PROVISIONAL	C	1.000	1.000	118	357	1	354	118	1	118
Invitrogen	NM_000126	IOH10424	Invitrogen(on gateway)	W01B001K12	pENTR221	8368		ETFA	2108	NP_000117.1	Hs.39925	Electron-transfer-flavoprotein, alpha polypeptide						NM_000126.3	NP_000117.1	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	BC021927	IOH13479	Invitrogen(on gateway)	W01B001K13	pENTR221	15869		GATSL3	652968	AAH21927.1	Hs.444950	GATS protein-like 3						NM_001037666.2	NP_001032755.1	VALIDATED	C	1.000	1.000	329	990	1	987	329	1	329
Invitrogen	NM_171998	IOH9931	Invitrogen(on gateway)	W01B001K14	pENTR221	25305		RAB39B	116442	NP_741995.1	Hs.632832	RAB39B, member RAS oncogene family						NM_171998.2	NP_741995.1	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
Invitrogen	ENST00000331450	IOH10732	Invitrogen(on gateway)	W01B001K15	pENTR221	7874		LRRC28	123355	ENSP00000332035	Hs.578684	Leucine rich repeat containing 28						NM_144598.2	NP_653199.2	PROVISIONAL	P	1.000	1.000	70	282	1	210	367	1	70
Invitrogen	NM_022129	IOH9861	Invitrogen(on gateway)	W01B001K16	pENTR221	3130		PBLD	64081	NP_071412.2	Hs.198158	Phenazine biosynthesis-like protein domain containing						NM_022129.3	NP_071412.2	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
Invitrogen	NM_001018	IOH1683	Invitrogen(on gateway)	W01B001K17	pENTR221	11578		RPS15	6209	NP_001009.1	Hs.406683	Ribosomal protein S15						NM_001018.3	NP_001009.1	REVIEWED	C	1.000	1.000	145	438	1	435	145	1	145
Invitrogen	NM_001673	IOH5751	Invitrogen(on gateway)	W01B001K18	pENTR221	21993		ASNS	440	NP_001664.3	Hs.489207	Asparagine synthetase						NM_133436.2	NP_597680.2	REVIEWED	Cs	0.998	0.998	561	1686	1	1683	561	1	561
Invitrogen	NM_001005	IOH1876	Invitrogen(on gateway)	W01B001K19	pENTR221	3645		RPS3	6188	NP_000996.2	Hs.546286	Ribosomal protein S3						NM_001005.3	NP_000996.2	REVIEWED	C	1.000	1.000	243	732	1	729	243	1	243
Invitrogen	BC025263	IOH13964	Invitrogen(on gateway)	W01B001K20	pENTR221	7443		CDCA4	55038	AAH25263.1	Hs.715701	Cell division cycle associated 4						NM_145701.2	NP_663747.1	REVIEWED	Cs	0.996	0.996	241	726	1	723	241	1	241
Invitrogen	ENST00000343545	IOH12742	Invitrogen(on gateway)	W01B001K21	pENTR221	603		PYHIN1	149628	ENSP00000345945	Hs.710248	Pyrin and HIN domain family, member 1						NM_198929.3	NP_945147.1	VALIDATED	Ps	0.995	0.995	194	738	1	582	461	1	194
Invitrogen	NM_016093	IOH14674	Invitrogen(on gateway)	W01B001K22	pENTR221	4832		RPL26L1	51121	NP_057177.1	Hs.546390	Ribosomal protein L26-like 1						NM_016093.2	NP_057177.1	REVIEWED	C	1.000	1.000	145	438	1	435	145	1	145
Invitrogen	NM_145304	IOH12701	Invitrogen(on gateway)	W01B001K23	pENTR221	21432		C7orf33	202865	NP_660347.1	Hs.352212	Chromosome 7 open reading frame 33						NM_145304.2	NP_660347.1	PREDICTED	C	1.000	1.000	177	534	1	531	177	1	177
Invitrogen	NM_032261	IOH14034	Invitrogen(on gateway)	W01B001K24	pENTR221	15422		C21orf56	84221	NP_115637.3	Hs.381214	Chromosome 21 open reading frame 56						NM_032261.4	NP_115637.3	VALIDATED	C	1.000	1.000	186	561	1	558	186	1	186
Invitrogen	BC012613	IOH13721	Invitrogen(on gateway)	W01B001L01	pENTR221	16546		CPA3	1359	AAH12613.1	Hs.646	Carboxypeptidase A3 (mast cell)						NM_001870.2	NP_001861.2	REVIEWED	Cs	0.995	0.995	417	1254	1	1251	417	1	417
Invitrogen	NM_013237	IOH4636	Invitrogen(on gateway)	W01B001L02	pENTR221	18618		PRELID1	27166	NP_037369.1	Hs.719148	PRELI domain containing 1						NM_013237.2	NP_037369.1	PROVISIONAL	OK	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	BC026012	IOH11830	Invitrogen(on gateway)	W01B001L03	pENTR221	20700		TMEM217	221468	AAH26012.1	Hs.520101	Transmembrane protein 217						NM_145316.2	NP_660359.2	PROVISIONAL	P	1.000	1.000	201	636	1	603	229	1	201
Invitrogen	NM_000982	IOH4926	Invitrogen(on gateway)	W01B001L04	pENTR221	3195		RPL21	6144	NP_000973.2	Hs.535873	Ribosomal protein L21						NM_000982.3	NP_000973.2	REVIEWED	C	1.000	1.000	160	483	1	480	160	1	160
Invitrogen	NM_173472	IOH11568	Invitrogen(on gateway)	W01B001L05	pENTR221	16944		C3orf24	115795	NP_775743.1	Hs.190413	Chromosome 3 open reading frame 24						NM_173472.1	NP_775743.1	VALIDATED	C	1.000	1.000	177	534	1	531	177	1	177
Invitrogen	BC002877	IOH5717	Invitrogen(on gateway)	W01B001L06	pENTR221	11209		MPPE1	65258	AAH02877.1	Hs.712666	Metallophosphoesterase 1						NM_023075.4	NP_075563.3	VALIDATED	Cg	0.841	1.000	396	1002	1	999	396	1	396
Invitrogen	BC020783	IOH14655	Invitrogen(on gateway)	W01B001L07	pENTR221	4619		CCDC90B	60492	AAH20783.1	Hs.368866	Coiled-coil domain containing 90B						NM_021825.3	NP_068597.2	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
Invitrogen	BC003540	IOH5476	Invitrogen(on gateway)	W01B001L08	pENTR221	21909		FIS1	51024	AAH03540.1	Hs.423968	Fission 1 (mitochondrial outer membrane) homolog (S. cerevisiae)						NM_016068.2	NP_057152.2	VALIDATED	C	1.000	1.000	152	459	1	456	152	1	152
Invitrogen	NM_138812	IOH10642	Invitrogen(on gateway)	W01B001L09	pENTR221	3364		DYDC1	143241	NP_620167.1	Hs.407751	DPY30 domain containing 1						NM_138812.2	NP_620167.1	PROVISIONAL	OK	1.000	1.000	177	534	1	531	177	1	177
Invitrogen	NM_032639	IOH5406	Invitrogen(on gateway)	W01B001L10	pENTR221	6247		PLEKHA8	84725	NP_116028.1	Hs.233495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 8						NM_032639.2	NP_116028.1	PROVISIONAL	C	1.000	1.000	440	1323	1	1320	440	1	440
Invitrogen	NM_025198	IOH13879	Invitrogen(on gateway)	W01B001L11	pENTR221	6072		MTERFD3	80298	NP_079474.2	Hs.5009	MTERF domain containing 3						NM_001033050.1	NP_001028222.1	VALIDATED	C	1.000	1.000	385	1158	1	1155	385	1	385
Invitrogen	NM_007363	IOH5111	Invitrogen(on gateway)	W01B001L12	pENTR221	24721		NONO	4841	NP_031389.3	Hs.700344	Non-POU domain containing, octamer-binding						NM_001145410.1	NP_001138882.1	REVIEWED	C	1.000	1.000	382	1416	268	1413	382	1	382
Invitrogen	NM_002106	IOH14825	Invitrogen(on gateway)	W01B001L13	pENTR221	18178		H2AFZ	3015	NP_002097.1	Hs.119192	H2A histone family, member Z						NM_002106.3	NP_002097.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
Invitrogen	NM_004468	IOH3711	Invitrogen(on gateway)	W01B001L14	pENTR221	1644		FHL3	2275	NP_004459.2	Hs.57687	Four and a half LIM domains 3						NM_004468.3	NP_004459.2	VALIDATED	C	1.000	1.000	280	843	1	840	280	1	280
Invitrogen	BC024300	IOH12700	Invitrogen(on gateway)	W01B001L15	pENTR221	19109		FSTL4	23105	AAH24300.1	Hs.483390	Follistatin-like 4						NM_015082.1	NP_055897.1	VALIDATED	Ps	0.997	0.997	603	1818	1	1809	842	1	603
Invitrogen	NM_006169	IOH4357	Invitrogen(on gateway)	W01B001L16	pENTR221	3933		NNMT	4837	NP_006160.1	Hs.503911	Nicotinamide N-methyltransferase						NM_006169.2	NP_006160.1	REVIEWED	C	1.000	1.000	264	795	1	792	264	1	264
Invitrogen	NM_003338	IOH7482	Invitrogen(on gateway)	W01B001L17	pENTR221	2643		UBE2D1	7321	NP_003329.1	Hs.129683	Ubiquitin-conjugating enzyme E2D 1 (UBC4/5 homolog, yeast)						NM_003338.3	NP_003329.1	REVIEWED	C	1.000	1.000	147	444	1	441	147	1	147
Invitrogen	NM_174940	IOH3344	Invitrogen(on gateway)	W01B001L18	pENTR221	4094		TMEM80	283232	NP_777600.2	Hs.448664	Transmembrane protein 80						NM_174940.2	NP_777600.2	PROVISIONAL	P	1.000	1.000	123	372	1	369	160	38	160
Invitrogen	NM_194434	IOH5040	Invitrogen(on gateway)	W01B001L19	pENTR221	10981		VAPA	9218	NP_919415.2	Hs.699980	VAMP (vesicle-associated membrane protein)-associated protein A, 33kDa						NM_194434.2	NP_919415.2	REVIEWED	P	1.000	1.000	242	729	1	726	249	8	249
Invitrogen	NM_001014	IOH4063	Invitrogen(on gateway)	W01B001L20	pENTR221	4495		RPS10	6204	NP_001005.1	Hs.645317	Ribosomal protein S10						NM_001014.3	NP_001005.1	REVIEWED	C	1.000	1.000	165	498	1	495	165	1	165
Invitrogen	BC007206	IOH6600	Invitrogen(on gateway)	W01B001L21	pENTR221	11743		SHD	56961	AAH07206.1	Hs.7423	Src homology 2 domain containing transforming protein D						NM_020209.3	NP_064594.3	VALIDATED	C	1.000	1.000	340	1023	1	1020	340	1	340
Invitrogen	NM_007285	IOH7450	Invitrogen(on gateway)	W01B001L22	pENTR221	8556		GABARAPL2	11345	NP_009216.1	Hs.461379	GABA(A) receptor-associated protein-like 2						NM_007285.6	NP_009216.1	VALIDATED	C	1.000	1.000	117	354	1	351	117	1	117
Invitrogen	NM_020169	IOH7146	Invitrogen(on gateway)	W01B001L23	pENTR221	16890		LXN	56925	NP_064554.3	Hs.478067	Latexin						NM_020169.3	NP_064554.3	REVIEWED	Cs	0.995	0.995	222	669	1	666	222	1	222
Invitrogen	NM_001930	IOH3570	Invitrogen(on gateway)	W01B001L24	pENTR221	12633		DHPS	1725	NP_001921.1	Hs.79064	Deoxyhypusine synthase						NM_001930.2	NP_001921.1	REVIEWED	C	1.000	1.000	369	1110	1	1107	369	1	369
Invitrogen	BC012264	IOH10528	Invitrogen(on gateway)	W01B001M01	pENTR221	13881		ITGB1BP1	9270	AAH12264.1	Hs.467662	Integrin beta 1 binding protein 1						NM_004763.3	NP_004754.1	REVIEWED	Cs	0.995	0.995	200	603	1	600	200	1	200
Invitrogen	NM_002886	IOH12046	Invitrogen(on gateway)	W01B001M02	pENTR221	16334		RAP2B	5912	NP_002877.2	Hs.98643	RAP2B, member of RAS oncogene family						NM_002886.2	NP_002877.2	REVIEWED	C	1.000	1.000	183	552	1	549	183	1	183
Invitrogen	NM_002647	IOH21022	Invitrogen(on gateway)	W01B001M03	pENTR221	11041		PIK3C3	5289	NP_002638.2	Hs.464971	Phosphoinositide-3-kinase, class 3						NM_002647.2	NP_002638.2	VALIDATED	C	1.000	1.000	887	2664	1	2661	887	1	887
Invitrogen	ENST00000301712	IOH12682	Invitrogen(on gateway)	W01B001M04	pENTR221	9255		UNKL	64718	ENSP00000301712	Hs.643536	Unkempt homolog (Drosophila)-like						NM_001037125.1	NP_001032202.1	VALIDATED	C	1.000	1.000	277	834	1	831	277	1	277
Invitrogen	NM_001791	IOH10262	Invitrogen(on gateway)	W01B001M05	pENTR221	507		CDC42	998	NP_001782.1	Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_001791.3	NP_001782.1	REVIEWED	C	1.000	1.000	191	576	1	573	191	1	191
Invitrogen	BC014532	IOH12798	Invitrogen(on gateway)	W01B001M06	pENTR221	3775		DCPS	28960	AAH14532.1	Hs.504249	Decapping enzyme, scavenger						NM_014026.3	NP_054745.1	VALIDATED	Cs	0.997	0.997	337	1014	1	1011	337	1	337
Invitrogen	NM_172016	IOH5913	Invitrogen(on gateway)	W01B001M07	pENTR221	19692		TRIM39	56658	NP_742013.1	Hs.413493	Tripartite motif-containing 39						NM_172016.2	NP_742013.1	REVIEWED	C	1.000	1.000	488	1467	1	1464	488	1	488
Invitrogen	BC011451	IOH10952	Invitrogen(on gateway)	W01B001M08	pENTR221	9344		AARS	16	AAH11451.1	Hs.315137	Alanyl-tRNA synthetase						NM_001605.2	NP_001596.2	REVIEWED	C	1.000	1.000	968	2907	1	2904	968	1	968
Invitrogen	NM_004146	IOH4112	Invitrogen(on gateway)	W01B001M09	pENTR221	12296		NDUFB7	4713	NP_004137.2	Hs.532853	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 7, 18kDa						NM_004146.4	NP_004137.2	REVIEWED	C	1.000	1.000	137	414	1	411	137	1	137
Invitrogen	NM_080678	IOH10298	Invitrogen(on gateway)	W01B001M10	pENTR221	13030		UBE2F	140739	NP_542409.1	Hs.471785	Ubiquitin-conjugating enzyme E2F (putative)						NM_080678.1	NP_542409.1	PROVISIONAL	C	1.000	1.000	185	558	1	555	185	1	185
Invitrogen	NM_014433	IOH3338	Invitrogen(on gateway)	W01B001M11	pENTR221	15849		RTDR1	27156	NP_055248.1	Hs.526920	Rhabdoid tumor deletion region gene 1						NM_014433.2	NP_055248.1	REVIEWED	C	1.000	1.000	348	1047	1	1044	348	1	348
Invitrogen	NM_022110	IOH10458	Invitrogen(on gateway)	W01B001M12	pENTR221	20644		FKBPL	63943	NP_071393.2	Hs.520042	FK506 binding protein like						NM_022110.3	NP_071393.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
Invitrogen	NM_030968	IOH13365	Invitrogen(on gateway)	W01B001M13	pENTR221	9746		C1QTNF1	114897	NP_112230.1	Hs.201398	C1q and tumor necrosis factor related protein 1						NM_198593.2	NP_940995.1	VALIDATED	OK	1.000	1.000	281	846	1	843	281	1	281
Invitrogen	NM_006325	IOH10063	Invitrogen(on gateway)	W01B001M14	pENTR221	5225		RAN	5901	NP_006316.1	Hs.10842	RAN, member RAS oncogene family						NM_006325.3	NP_006316.1	REVIEWED	C	1.000	1.000	216	651	1	648	216	1	216
Invitrogen	NM_203371	IOH10651	Invitrogen(on gateway)	W01B001M15	pENTR221	3971		FIBIN	387758	NP_976249.1	Hs.712718	Fin bud initiation factor homolog (zebrafish)						NM_203371.1	NP_976249.1	VALIDATED	OK	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	NM_000602	IOH9882	Invitrogen(on gateway)	W01B001M16	pENTR221	21414		SERPINE1	5054	NP_000593.1	Hs.414795	Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1						NM_000602.2	NP_000593.1	VALIDATED	C	1.000	1.000	402	1209	1	1206	402	1	402
Invitrogen	NM_000992	IOH1702	Invitrogen(on gateway)	W01B001M17	pENTR221	17187		RPL29	6159	NP_000983.1	Hs.425125	Ribosomal protein L29						NM_000992.2	NP_000983.1	REVIEWED	OK	1.000	1.000	159	480	1	477	159	1	159
Invitrogen	NM_014502	IOH5752	Invitrogen(on gateway)	W01B001M18	pENTR221	4688		PRPF19	27339	NP_055317.1	Hs.502705	PRP19/PSO4 pre-mRNA processing factor 19 homolog (S. cerevisiae)						NM_014502.4	NP_055317.1	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
Invitrogen	NM_001007	IOH1908	Invitrogen(on gateway)	W01B001M19	pENTR221	18813		RPS4X	6191	NP_000998.1	Hs.118076	Ribosomal protein S4, X-linked						NM_001007.4	NP_000998.1	REVIEWED	C	1.000	1.000	263	792	1	789	263	1	263
Invitrogen	NM_022369	IOH13935	Invitrogen(on gateway)	W01B001M20	pENTR221	8218		STRA6	64220	NP_071764.3	Hs.24553	Stimulated by retinoic acid gene 6 homolog (mouse)						NM_001142617.1	NP_001136089.1	REVIEWED	Cs	0.999	0.999	667	2004	1	2001	667	1	667
Invitrogen	NM_014485	IOH13026	Invitrogen(on gateway)	W01B001M21	pENTR221	18275		PGDS	27306	NP_055300.1	Hs.128433	Prostaglandin D2 synthase, hematopoietic						NM_014485.2	NP_055300.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
Invitrogen	NM_007002	IOH13967	Invitrogen(on gateway)	W01B001M22	pENTR221	14722		ADRM1	11047	NP_008933.2	Hs.90107	Adhesion regulating molecule 1						NM_007002.2	NP_008933.2	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
Invitrogen	NM_173474	IOH13254	Invitrogen(on gateway)	W01B001M23	pENTR221	9163		NTAN1	123803	NP_775745.1	Hs.592045	N-terminal asparagine amidase						NM_173474.2	NP_775745.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	NM_170679	IOH13678	Invitrogen(on gateway)	W01B001M24	pENTR221	19327		SKP1	6500	NP_733779.1	Hs.171626	S-phase kinase-associated protein 1						NM_170679.2	NP_733779.1	VALIDATED	C	1.000	1.000	163	492	1	489	163	1	163
Invitrogen	NM_002961	IOH14167	Invitrogen(on gateway)	W01B001N01	pENTR221	2141		S100A4	6275	NP_002952.1	Hs.654444	S100 calcium binding protein A4						NM_019554.2	NP_062427.1	REVIEWED	C	1.000	1.000	101	306	1	303	101	1	101
Invitrogen	NM_153649	IOH4696	Invitrogen(on gateway)	W01B001N02	pENTR221	1457		TPM3	7170	NP_705935.1	Hs.654421	Tropomyosin 3						NM_153649.3	NP_705935.1	REVIEWED	OK	1.000	1.000	248	747	1	744	248	1	248
Invitrogen	NM_152377	IOH11555	Invitrogen(on gateway)	W01B001N03	pENTR221	2027		C1orf87	127795	NP_689590.1	Hs.47385	Chromosome 1 open reading frame 87						NM_152377.1	NP_689590.1	PREDICTED	C	1.000	1.000	546	1641	1	1638	546	1	546
Invitrogen	NM_005740	IOH4940	Invitrogen(on gateway)	W01B001N04	pENTR221	15948		DNAL4	10126	NP_005731.1	Hs.632766	Dynein, axonemal, light chain 4						NM_005740.2	NP_005731.1	VALIDATED	C	1.000	1.000	105	318	1	315	105	1	105
Invitrogen	NM_018997	IOH14006	Invitrogen(on gateway)	W01B001N05	pENTR221	155		MRPS21	54460	NP_061870.1	Hs.405880	Mitochondrial ribosomal protein S21						NM_018997.2	NP_061870.1	REVIEWED	C	1.000	1.000	87	264	1	261	87	1	87
Invitrogen	BC002944	IOH5726	Invitrogen(on gateway)	W01B001N06	pENTR221	10231		B9D1	27077	AAH02944.1	Hs.462445	B9 protein domain 1						NM_015681.3	NP_056496.1	REVIEWED	P	1.000	1.000	135	462	1	405	204	1	135
Invitrogen	NM_144714	IOH11221	Invitrogen(on gateway)	W01B001N07	pENTR221	17068		C3orf48	151649	NP_653315	Hs.710379	Chromosome 3 open reading frame 48						XM_001718092.1	XP_001718144.1	MODEL	Pfs	0.997	0.997	347	1059	19	1058	396	35	381
Invitrogen	NM_021126	IOH5477	Invitrogen(on gateway)	W01B001N08	pENTR221	15529		MPST	4357	NP_066949.2	Hs.248267	Mercaptopyruvate sulfurtransferase						NM_001013436.1	NP_001013454.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
Invitrogen	NM_033105	IOH11096	Invitrogen(on gateway)	W01B001N09	pENTR221	22606		DNAJC5B	85479	NP_149096.2	Hs.491885	DnaJ (Hsp40) homolog, subfamily C, member 5 beta						NM_033105.4	NP_149096.2	VALIDATED	C	1.000	1.000	199	600	1	597	199	1	199
Invitrogen	NM_001236	IOH5424	Invitrogen(on gateway)	W01B001N10	pENTR221	15161		CBR3	874	NP_001227.1	Hs.154510	Carbonyl reductase 3						NM_001236.3	NP_001227.1	REVIEWED	C	1.000	1.000	277	834	1	831	277	1	277
Invitrogen	NM_024540	IOH14529	Invitrogen(on gateway)	W01B001N11	pENTR221	1875		MRPL24	79590	NP_078816.2	Hs.418233	Mitochondrial ribosomal protein L24						NM_024540.3	NP_078816.2	REVIEWED	C	1.000	1.000	216	651	1	648	216	1	216
Invitrogen	NM_031443	IOH5157	Invitrogen(on gateway)	W01B001N12	pENTR221	21222		CCM2	83605	NP_113631.1	Hs.148272	Cerebral cavernous malformation 2						NM_031443.3	NP_113631.1	VALIDATED	C	1.000	1.000	444	1335	1	1332	444	1	444
Invitrogen	NM_005471	IOH13884	Invitrogen(on gateway)	W01B001N13	pENTR221	19171		GNPDA1	10007	NP_005462.1	Hs.633853	Glucosamine-6-phosphate deaminase 1						NM_005471.4	NP_005462.1	VALIDATED	C	1.000	1.000	289	870	1	867	289	1	289
Invitrogen	NM_007219	IOH3774	Invitrogen(on gateway)	W01B001N14	pENTR221	14957		RNF24	11237	NP_009150.1	Hs.589884	Ring finger protein 24						NM_007219.3	NP_009150.1	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
Invitrogen	BC025236	IOH13207	Invitrogen(on gateway)	W01B001N15	pENTR221	23043		ASPH	444	AAH25236.1	Hs.591874	Aspartate beta-hydroxylase						NM_032466.2	NP_115855.1	VALIDATED	Cg	0.863	1.000	313	813	1	810	313	1	313
Invitrogen	NM_016497	IOH4360	Invitrogen(on gateway)	W01B001N16	pENTR221	5839		MRPL51	51258	NP_057581.2	Hs.55847	Mitochondrial ribosomal protein L51						NM_016497.3	NP_057581.2	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
Invitrogen	BC008489	IOH7524	Invitrogen(on gateway)	W01B001N17	pENTR221	156		NUF2	83540	AAH08489.1	Hs.651950	NUF2, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_031423.3	NP_113611.2	REVIEWED	C	1.000	1.000	464	1395	1	1392	464	1	464
Invitrogen	NM_005362	IOH3602	Invitrogen(on gateway)	W01B001N18	pENTR221	24910		MAGEA3	4102	NP_005353.1	Hs.417816	Melanoma antigen family A, 3						NM_005362.3	NP_005353.1	REVIEWED	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	BC003040	IOH5055	Invitrogen(on gateway)	W01B001N19	pENTR221	13877		DNPEP	23549	AAH03040	Hs.258551	Aspartyl aminopeptidase						NM_012100.2	NP_036232.2	REVIEWED	Pfs	1.000	1.000	165	495	1	494	485	76	240
Invitrogen	NM_000995	IOH4459	Invitrogen(on gateway)	W01B001N20	pENTR221	17517		RPL34	6164	NP_000986.2	Hs.438227	Ribosomal protein L34						NM_000995.3	NP_000986.2	REVIEWED	C	1.000	1.000	117	354	1	351	117	1	117
Invitrogen	NM_018487	IOH6987	Invitrogen(on gateway)	W01B001N21	pENTR221	21199		TMEM176A	55365	NP_060957.2	Hs.647116	Transmembrane protein 176A						NM_018487.2	NP_060957.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
Invitrogen	NM_032876	IOH6856	Invitrogen(on gateway)	W01B001N22	pENTR221	7468		JUB	84962	NP_116265.1	Hs.655832	Jub, ajuba homolog (Xenopus laevis)						NM_198086.1	NP_932352.1	VALIDATED	C	1.000	1.000	121	1617	1252	1614	121	1	121
Invitrogen	NM_178012	IOH3691	Invitrogen(on gateway)	W01B001N23	pENTR221	20451		TUBB2B	347733	NP_821080.1	Hs.300701	Tubulin, beta 2B						NM_178012.4	NP_821080.1	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
Invitrogen	NM_005716	IOH3617	Invitrogen(on gateway)	W01B001N24	pENTR221	12254		GIPC1	10755	NP_005707.1	Hs.655012	GIPC PDZ domain containing family, member 1						NM_005716.2	NP_005707.1	VALIDATED	OK	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	NM_032379	IOH11284	Invitrogen(on gateway)	W01B001O01	pENTR221	4446		SYTL2	54843	NP_115755.2	Hs.369520	Synaptotagmin-like 2						NM_206929.1	NP_996812.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
Invitrogen	NM_198404	IOH10722	Invitrogen(on gateway)	W01B001O02	pENTR221	6812		KCTD4	386618	NP_940686.2	Hs.23406	Potassium channel tetramerisation domain containing 4						NM_198404.2	NP_940686.2	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
Invitrogen	NM_014241	IOH12805	Invitrogen(on gateway)	W01B001O03	pENTR221	3200		PTPLA	9200	NP_055056.3	Hs.114062	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member A						NM_014241.3	NP_055056.3	REVIEWED	Cs	0.993	0.993	288	867	1	864	288	1	288
Invitrogen	NM_015878	IOH12717	Invitrogen(on gateway)	W01B001O04	pENTR221	23015		AZIN1	51582	NP_056962.2	Hs.459106	Antizyme inhibitor 1						NM_015878.4	NP_056962.2	REVIEWED	C	1.000	1.000	448	1347	1	1344	448	1	448
Invitrogen	NM_145313	IOH10825	Invitrogen(on gateway)	W01B001O05	pENTR221	3341		RASGEF1A	221002	NP_660356.2	Hs.125293	RasGEF domain family, member 1A						NM_145313.2	NP_660356.2	VALIDATED	Ps	0.998	0.998	428	1287	1	1284	481	54	481
Invitrogen	ENST00000297670	IOH12920	Invitrogen(on gateway)	W01B001O06	pENTR221	41068		SUGT1P	441394	ENSP00000297670																				
Invitrogen	NM_153273	IOH9779	Invitrogen(on gateway)	W01B001O07	pENTR221	17195		IP6K1	9807	NP_695005.1	Hs.386168	Inositol hexakisphosphate kinase 1						NM_153273.3	NP_695005.1	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
Invitrogen	NM_002491	IOH10805	Invitrogen(on gateway)	W01B001O08	pENTR221	13064		NDUFB3	4709	NP_002482.1	Hs.109760	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa						NM_002491.2	NP_002482.1	VALIDATED	C	1.000	1.000	98	297	1	294	98	1	98
Invitrogen	NM_138501	IOH4169	Invitrogen(on gateway)	W01B001O09	pENTR221	11522		GPSN2	9524	NP_612510.1	Hs.515642	Glycoprotein, synaptic 2						NM_138501.4	NP_612510.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
Invitrogen	NM_000977	IOH10301	Invitrogen(on gateway)	W01B001O10	pENTR221	8582		RPL13	6137	NP_000968.2	Hs.410817	Ribosomal protein L13						NM_000977.2	NP_000968.2	REVIEWED	C	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	NM_030963	IOH3374	Invitrogen(on gateway)	W01B001O11	pENTR221	19886		RNF146	81847	NP_112225.2	Hs.267120	Ring finger protein 146						NM_030963.2	NP_112225.2	PROVISIONAL	C	1.000	1.000	358	1077	1	1074	358	1	358
Invitrogen	NM_001402	IOH10464	Invitrogen(on gateway)	W01B001O12	pENTR221	20515		EEF1A1	1915	NP_001393.1	Hs.713109	Eukaryotic translation elongation factor 1 alpha 1						NM_001402.5	NP_001393.1	REVIEWED	C	1.000	1.000	462	1389	1	1386	462	1	462
Invitrogen	NM_001031699	IOH13443	Invitrogen(on gateway)	W01B001O13	pENTR221	20614		MOXD1	26002	NP_001026869	Hs.6909	Monooxygenase, DBH-like 1						NM_015529.2	NP_056344.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
Invitrogen	NM_025106	IOH10100	Invitrogen(on gateway)	W01B001O14	pENTR221	239		SPSB1	80176	NP_079382.2	Hs.8261	SplA/ryanodine receptor domain and SOCS box containing 1						NM_025106.3	NP_079382.2	VALIDATED	C	1.000	1.000	273	822	1	819	273	1	273
Invitrogen	NM_024899	IOH10957	Invitrogen(on gateway)	W01B001O15	pENTR221	11229		CEP76	79959	NP_079175.2	Hs.236940	Centrosomal protein 76kDa						NM_024899.2	NP_079175.2	PROVISIONAL	OK	1.000	1.000	659	1980	1	1977	659	1	659
Invitrogen	NM_145306	IOH9906	Invitrogen(on gateway)	W01B001O16	pENTR221	2893		C10orf35	219738	NP_660349.1	Hs.522992	Chromosome 10 open reading frame 35						NM_145306.2	NP_660349.1	VALIDATED	C	1.000	1.000	121	366	1	363	121	1	121
Invitrogen	NM_022497	IOH1725	Invitrogen(on gateway)	W01B001O17	pENTR221	17030		MRPS25	64432	NP_071942.1	Hs.715617	Mitochondrial ribosomal protein S25						NM_022497.3	NP_071942.1	REVIEWED	C	1.000	1.000	173	522	1	519	173	1	173
Invitrogen	NM_004051	IOH5792	Invitrogen(on gateway)	W01B001O18	pENTR221	17125		BDH1	622	NP_004042.1	Hs.274539	3-hydroxybutyrate dehydrogenase, type 1						NM_203315.2	NP_976060.1	REVIEWED	C	1.000	1.000	343	1032	1	1029	343	1	343
Invitrogen	NM_004375	IOH1929	Invitrogen(on gateway)	W01B001O19	pENTR221	10340		COX11	1353	NP_004366.1	Hs.591171	COX11 homolog, cytochrome c oxidase assembly protein (yeast)						NM_004375.2	NP_004366.1	REVIEWED	C	1.000	1.000	276	831	1	828	276	1	276
Invitrogen	NM_003090	IOH14672	Invitrogen(on gateway)	W01B001O20	pENTR221	8235		SNRPA1	6627	NP_003081.2	Hs.528763	Small nuclear ribonucleoprotein polypeptide A'						NM_003090.2	NP_003081.2	VALIDATED	C	1.000	1.000	255	768	1	765	255	1	255
Invitrogen	NM_001737	IOH12924	Invitrogen(on gateway)	W01B001O21	pENTR221	19432		C9	735	NP_001728.1	Hs.654443	Complement component 9						NM_001737.3	NP_001728.1	REVIEWED	OK	1.000	1.000	559	1680	1	1677	559	1	559
Invitrogen	BC012612	IOH13719	Invitrogen(on gateway)	W01B001O22	pENTR221	23580		CTSL1	1514	AAH12612.1	Hs.716407	Cathepsin L1						NM_001912.4	NP_001903.1	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
Invitrogen	BC009975	IOH12596	Invitrogen(on gateway)	W01B001O23	pENTR221	9542		WSCD1	23302	AAH09975.1	Hs.370166	WSC domain containing 1						NM_015253.1	NP_056068.1	VALIDATED	Cs	0.998	0.998	575	1728	1	1725	575	1	575
Invitrogen	BC009995	IOH14845	Invitrogen(on gateway)	W01B001O24	pENTR221	4614		INTS4	92105	AAH09995.1	Hs.533723	Integrator complex subunit 4						NM_033547.3	NP_291025.3	VALIDATED	P	1.000	1.000	505	1518	1	1515	963	1	505
Invitrogen	BC014546	IOH14333	Invitrogen(on gateway)	W01B001P01	pENTR221	13042		ACTR2	10097	AAH14546.1	Hs.719274	ARP2 actin-related protein 2 homolog (yeast)						NM_005722.3	NP_005713.1	REVIEWED	Cs	0.995	0.995	394	1185	1	1182	394	1	394
Invitrogen	NM_016091	IOH4743	Invitrogen(on gateway)	W01B001P02	pENTR221	15553		EIF3L	51386	NP_057175.1	Hs.446852	Eukaryotic translation initiation factor 3, subunit L						NM_016091.2	NP_057175.1	VALIDATED	C	1.000	1.000	564	1695	1	1692	564	1	564
Invitrogen	NM_152346	IOH11523	Invitrogen(on gateway)	W01B001P03	pENTR221	10280		SLC43A2	124935	NP_689559.1	Hs.160550	Solute carrier family 43, member 2						NM_152346.1	NP_689559.1	PROVISIONAL	OK	1.000	1.000	569	1710	1	1707	569	1	569
Invitrogen	NM_058179	IOH4946	Invitrogen(on gateway)	W01B001P04	pENTR221	23557		PSAT1	29968	NP_478059.1	Hs.494261	Phosphoserine aminotransferase 1						NM_058179.2	NP_478059.1	REVIEWED	C	1.000	1.000	370	1113	1	1110	370	1	370
Invitrogen	NM_000687	IOH14308	Invitrogen(on gateway)	W01B001P05	pENTR221	15041		AHCY	191	NP_000678.1	Hs.388004	S-adenosylhomocysteine hydrolase						NM_000687.1	NP_000678.1	REVIEWED	C	1.000	1.000	432	1299	1	1296	432	1	432
Invitrogen	BC002914	IOH5733	Invitrogen(on gateway)	W01B001P06	pENTR221	13897		WIPF1	7456	AAH02914.1	Hs.128067	WAS/WASL interacting protein family, member 1						NM_003387.4	NP_003378.3	REVIEWED	Cgs	0.708	0.994	503	1077	1	1074	503	1	503
Invitrogen	NM_146421	IOH10710	Invitrogen(on gateway)	W01B001P07	pENTR221	857		GSTM1	2944	NP_666533.1	Hs.301961	Glutathione S-transferase mu 1						NM_146421.2	NP_666533.1	REVIEWED	OK	1.000	1.000	181	546	1	543	181	1	181
Invitrogen	NM_000146	IOH5497	Invitrogen(on gateway)	W01B001P08	pENTR221	11580		FTL	2512	NP_000137.2	Hs.713706	Ferritin, light polypeptide						NM_000146.3	NP_000137.2	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
Invitrogen	NM_144705	IOH11065	Invitrogen(on gateway)	W01B001P09	pENTR221	13371		TEKT4	150483	NP_653306.1	Hs.631517	Tektin 4						NM_144705.2	NP_653306.1	PROVISIONAL	C	1.000	1.000	435	1308	1	1305	435	1	435
Invitrogen	BC003520	IOH5455	Invitrogen(on gateway)	W01B001P10	pENTR221	23642		WDR32	79269	AAH03520.2	Hs.118394	WD repeat domain 32						NM_024345.3	NP_077321.3	VALIDATED	Pgs	0.853	0.995	258	666	1	663	559	302	559
Invitrogen	NM_002966	IOH14651	Invitrogen(on gateway)	W01B001P11	pENTR221	2181		S100A10	6281	NP_002957.1	Hs.143873	S100 calcium binding protein A10						NM_002966.2	NP_002957.1	REVIEWED	OK	1.000	1.000	97	294	1	291	97	1	97
Invitrogen	NM_006275	IOH3168	Invitrogen(on gateway)	W01B001P12	pENTR221	14765		SFRS6	6431	NP_006266.2	Hs.6891	Splicing factor, arginine/serine-rich 6						NM_006275.5	NP_006266.2	REVIEWED	C	1.000	1.000	344	1035	1	1032	344	1	344
Invitrogen	BC017833	IOH13787	Invitrogen(on gateway)	W01B001P13	pENTR221	20031		PRIM2	5558	AAH17833.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)						NM_000947.2	NP_000938.2	REVIEWED	Ps	0.994	0.994	155	477	1	465	509	1	155
Invitrogen	NM_000968	IOH3995	Invitrogen(on gateway)	W01B001P14	pENTR221	8142		RPL4	6124	NP_000959.2	Hs.644628	Ribosomal protein L4						NM_000968.2	NP_000959.2	REVIEWED	C	1.000	1.000	427	1284	1	1281	427	1	427
Invitrogen	NM_017516	IOH11593	Invitrogen(on gateway)	W01B001P15	pENTR221	4115		RAB39	54734	NP_059986.1	Hs.354906	RAB39, member RAS oncogene family						NM_017516.1	NP_059986.1	PROVISIONAL	C	1.000	1.000	217	654	1	651	217	1	217
Invitrogen	NM_024039	IOH4379	Invitrogen(on gateway)	W01B001P16	pENTR221	9864		MIS12	79003	NP_076944.1	Hs.267194	MIS12, MIND kinetochore complex component, homolog (yeast)						NM_024039.1	NP_076944.1	PROVISIONAL	C	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	BC005332	IOH7177	Invitrogen(on gateway)	W01B001P17	pENTR221	1		RPIA	22934	AAH05332	Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.269	0.269	26	711	433	510	311	117	142
Invitrogen	NM_007209	IOH3605	Invitrogen(on gateway)	W01B001P18	pENTR221	24274		RPL35	11224	NP_009140.1	Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	C	1.000	1.000	123	372	1	369	123	1	123
Invitrogen	BC001953	IOH5065	Invitrogen(on gateway)	W01B001P19	pENTR221	18087		BDH2	56898	AAH01953.1	Hs.124696	3-hydroxybutyrate dehydrogenase, type 2						NM_020139.3	NP_064524.3	VALIDATED	Cs	0.996	0.996	245	738	1	735	245	1	245
Invitrogen	NM_014761	IOH6052	Invitrogen(on gateway)	W01B001P20	pENTR221	8595		KIAA0174	9798	NP_055576.2	Hs.232194	KIAA0174						NM_014761.2	NP_055576.2	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
Invitrogen	NM_001952	IOH6989	Invitrogen(on gateway)	W01B001P21	pENTR221	13903		E2F6	1876	NP_001943	Hs.603093	E2F transcription factor 6						NM_198256.2	NP_937987.2	REVIEWED	C	1.000	1.000	281	846	1	843	281	1	281
Invitrogen	NM_178840	IOH23046	Invitrogen(on gateway)	W01B001P22	pENTR221	789		C1orf64	149563	NP_849162.1	Hs.29190	Chromosome 1 open reading frame 64						NM_178840.2	NP_849162.1	PREDICTED	OK	1.000	1.000	169	510	1	507	169	1	169
Invitrogen	NM_000224	IOH2946	Invitrogen(on gateway)	W01B001P23	pENTR221	5524		KRT18	3875	NP_000215.1	Hs.406013	Keratin 18						NM_199187.1	NP_954657.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
Invitrogen	BC011975	IOH10480	Invitrogen(on gateway)	W01B001P24	pENTR221	20772		STX7	8417	AAH11975.1	Hs.593148	Syntaxin 7						NM_003569.2	NP_003560.2	VALIDATED	C	1.000	1.000	261	786	1	783	261	1	261
Invitrogen	NM_152362	IOH10838	Invitrogen(on gateway)	W01B002A01	pENTR221	11711		TNFAIP8L1	126282	NP_689575.1	Hs.465643	Tumor necrosis factor, alpha-induced protein 8-like 1						NM_152362.1	NP_689575.1	PROVISIONAL	C	1.000	1.000	186	561	1	558	186	1	186
Invitrogen	NM_032514	IOH10043	Invitrogen(on gateway)	W01B002A02	pENTR221	14654		MAP1LC3A	84557	NP_115903.1	Hs.632273	Microtubule-associated protein 1 light chain 3 alpha						NM_032514.2	NP_115903.1	REVIEWED	C	1.000	1.000	121	366	1	363	121	1	121
Invitrogen	BC020923	IOH23033	Invitrogen(on gateway)	W01B002A03	pENTR221	20517		CLIC5	53405	AAH20923.1	Hs.485489	Chloride intracellular channel 5						NM_001114086.1	NP_001107558.1	VALIDATED	Pfs	0.533	0.533	15	210	154	110	410	66	80
Invitrogen	NM_138802	IOH10558	Invitrogen(on gateway)	W01B002A04	pENTR221	13324		ZFAND2B	130617	NP_620157.1	Hs.534540	Zinc finger, AN1-type domain 2B						NM_138802.1	NP_620157.1	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
Invitrogen	NM_182639	IOH2926	Invitrogen(on gateway)	W01B002A05	pENTR221	3389		HPS1	3257	NP_872577.1	Hs.404568	Hermansky-Pudlak syndrome 1						NM_182639.1	NP_872577.1	REVIEWED	C	1.000	1.000	324	975	1	972	324	1	324
Invitrogen	NM_182554	IOH11558	Invitrogen(on gateway)	W01B002A06	pENTR221	2800		C10orf53	282966	NP_872360.2	Hs.131287	Chromosome 10 open reading frame 53						NM_182554.2	NP_872360.2	VALIDATED	Cs	0.987	0.987	157	474	1	471	157	1	157
Invitrogen	NM_182504	IOH22296	Invitrogen(on gateway)	W01B002A07	pENTR221	21402		WBSCR28	135886	NP_872310.2	Hs.647026	Williams-Beuren syndrome chromosome region 28						NM_182504.3	NP_872310.2	VALIDATED	Cs	0.989	0.989	265	798	1	795	265	1	265
Invitrogen	BC031875	IOH22873	Invitrogen(on gateway)	W01B002A08	pENTR221	12495		FAM71E2	284418	AAH31875.1	Hs.528319	Family with sequence similarity 71, member E2						NM_001145402.1	NP_001138874.1	PREDICTED	Ps	0.990	0.990	197	603	1	591	922	1	197
Invitrogen	NM_181775	IOH22435	Invitrogen(on gateway)	W01B002A09	pENTR221	21823		PLXNA4	91584	NP_861440.2	Hs.511454	Plexin A4						NM_181775.3	NP_861440.2	VALIDATED	Cs	0.998	0.998	522	1569	1	1566	522	1	522
Invitrogen	NM_032345	IOH6625	Invitrogen(on gateway)	W01B002A10	pENTR221	5583		WIBG	84305	NP_115721.1	Hs.505687	Within bgcn homolog (Drosophila)						NM_032345.2	NP_115721.1	VALIDATED	C	1.000	1.000	204	615	1	612	204	1	204
Invitrogen	NM_001025205	IOH21478	Invitrogen(on gateway)	W01B002A11	pENTR221	16429		AP2M1	1173	NP_001020376.1	Hs.518460	Adaptor-related protein complex 2, mu 1 subunit						NM_001025205.1	NP_001020376.1	REVIEWED	C	1.000	1.000	433	1302	1	1299	433	1	433
Invitrogen	BC022069	IOH10831	Invitrogen(on gateway)	W01B002A12	pENTR221	7919		CRABP1	1381	AAH22069.1	Hs.346950	Cellular retinoic acid binding protein 1						NM_004378.2	NP_004369.1	REVIEWED	Cs	0.993	0.993	137	414	1	411	137	1	137
Invitrogen	NM_001017435	IOH11814	Invitrogen(on gateway)	W01B002A13	pENTR221	24765		CT45A3	441519	NP_001017435.1	Hs.535080	Cancer/testis antigen family 45, member A3						NM_001017435.1	NP_001017435.1	PROVISIONAL	C	1.000	1.000	189	570	1	567	189	1	189
Invitrogen	ENST00000335315	IOH21847	Invitrogen(on gateway)	W01B002A14	pENTR221	21967		TRIM73	375593	ENSP00000335276	Hs.661254	Tripartite motif-containing 73						NM_198924.2	NP_944606.2	PROVISIONAL		0.800	0.800	5	240	213	199	250	52	56
Invitrogen	NM_030811	IOH1810	Invitrogen(on gateway)	W01B002A15	pENTR221	14658		MRPS26	64949	NP_110438.1	Hs.18946	Mitochondrial ribosomal protein S26						NM_030811.3	NP_110438.1	REVIEWED	OK	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	BC027338	IOH22116	Invitrogen(on gateway)	W01B002A16	pENTR221	41031		MGC21881	389741	AAH27338	Hs.459704	Hypothetical locus MGC21881																		
Invitrogen	NM_033281	IOH12649	Invitrogen(on gateway)	W01B002A17	pENTR221	18615		MRPS36	92259	NP_150597.1	Hs.631971	Mitochondrial ribosomal protein S36						NM_033281.5	NP_150597.1	VALIDATED	C	1.000	1.000	103	312	1	309	103	1	103
Invitrogen	ENST00000323543	IOH22760	Invitrogen(on gateway)	W01B002A18	pENTR221	119		C1orf38	9473	ENSP00000325130	Hs.10649	Chromosome 1 open reading frame 38						NM_004848.2	NP_004839.2	VALIDATED	P	1.000	1.000	111	336	1	333	260	150	260
Invitrogen	ENST00000329873	IOH11035	Invitrogen(on gateway)	W01B002A19	pENTR221	7783		DTWD1	56986	ENSP00000329313	Hs.127432	DTW domain containing 1						NM_020234.5	NP_064619.2	VALIDATED		0.978	0.978	91	330	1	273	304	1	91
Invitrogen	NM_005423	IOH21844	Invitrogen(on gateway)	W01B002A20	pENTR221	15438		TFF2	7032	NP_005414.1	Hs.2979	Trefoil factor 2						NM_005423.4	NP_005414.1	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
Invitrogen	NM_014035	IOH12121	Invitrogen(on gateway)	W01B002A21	pENTR221	18633		SNX24	28966	NP_054754.1	Hs.483200	Sorting nexin 24						NM_014035.2	NP_054754.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
Invitrogen	NM_173638	IOH21467	Invitrogen(on gateway)	W01B002A22	pENTR221	478		NBPF15	284565	NP_775909.1	Hs.655246	Neuroblastoma breakpoint family, member 15						NM_173638.2	NP_775909.1	PREDICTED	C	1.000	1.000	670	2013	1	2010	670	1	670
Invitrogen	BC002831	IOH5409	Invitrogen(on gateway)	W01B002A23	pENTR221	14782		MGC4294	79160	AAH02831.1	Hs.280135	Hypothetical protein MGC4294																		
Invitrogen	ENST00000317442	IOH22562	Invitrogen(on gateway)	W01B002A24	pENTR221	10455		CCDC46	201134	ENSP00000320592	Hs.408676	Coiled-coil domain containing 46						NM_001037325.2	NP_001032402.1	VALIDATED	C	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	BC033668	IOH21801	Invitrogen(on gateway)	W01B002B01	pENTR221	10953		ARHGAP28	79822	AAH33668.2	Hs.183114	Rho GTPase activating protein 28						NM_030672.2	NP_109597.2	VALIDATED	P	1.000	1.000	337	1173	1	1011	563	181	517
Invitrogen	BC090948	IOH21803	Invitrogen(on gateway)	W01B002B02	pENTR221	5384		ALG10	84920	AAH90948.1	Hs.719348	Asparagine-linked glycosylation 10, alpha-1,2-glucosyltransferase homolog (S. pombe)						NM_032834.3	NP_116223.3	VALIDATED	C	1.000	1.000	473	1422	1	1419	473	1	473
Invitrogen	BC020722	IOH12927	Invitrogen(on gateway)	W01B002B03	pENTR221	24292		AUH	549	AAH20722.1	Hs.175905	AU RNA binding protein/enoyl-Coenzyme A hydratase						NM_001698.2	NP_001689.1	REVIEWED	Cg	0.914	1.000	339	933	1	930	339	1	339
Invitrogen	NM_153230	IOH22759	Invitrogen(on gateway)	W01B002B04	pENTR221	10025		FBXO39	162517	NP_694962.1	Hs.368364	F-box protein 39						NM_153230.2	NP_694962.1	VALIDATED	C	1.000	1.000	442	1329	1	1326	442	1	442
Invitrogen	NM_144618	IOH10690	Invitrogen(on gateway)	W01B002B05	pENTR221	702		GABPB2	126626	NP_653219.1	Hs.654699	GA binding protein transcription factor, beta subunit 2						NM_144618.2	NP_653219.1	VALIDATED	C	1.000	1.000	448	1347	1	1344	448	1	448
Invitrogen	NM_024588	IOH6887	Invitrogen(on gateway)	W01B002B06	pENTR221	15613			653792	NP_078864										
Invitrogen	BC029536	IOH22568	Invitrogen(on gateway)	W01B002B07	pENTR221	4904		C11orf65	160140	AAH29536.1	Hs.653180	Chromosome 11 open reading frame 65						NM_152587.3	NP_689800.3	VALIDATED	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	NM_152319	IOH22869	Invitrogen(on gateway)	W01B002B08	pENTR221	5552		C12orf54	121273	NP_689532.1	Hs.98202	Chromosome 12 open reading frame 54						NM_152319.2	NP_689532.1	PREDICTED	C	1.000	1.000	127	384	1	381	127	1	127
Invitrogen	NM_007241	IOH3275	Invitrogen(on gateway)	W01B002B09	pENTR221	10399		SNF8	11267	NP_009172.2	Hs.127249	SNF8, ESCRT-II complex subunit, homolog (S. cerevisiae)						NM_007241.2	NP_009172.2	PROVISIONAL	C	1.000	1.000	258	777	1	774	258	1	258
Invitrogen	NM_174889	IOH25846	Invitrogen(on gateway)	W01B002B10	pENTR221	13841		NDUFAF2	91942	NP_777549.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2						NM_174889.4	NP_777549.1	REVIEWED	C	1.000	1.000	169	510	1	507	169	1	169
Invitrogen	NM_032308	IOH5031	Invitrogen(on gateway)	W01B002B11	pENTR221	9916		RPAIN	84268	NP_115684	Hs.462086	RPA interacting protein						NM_001160243.1	NP_001153715.1	VALIDATED	P	1.000	1.000	141	438	1	423	231	1	141
Invitrogen	BC032451	IOH21663	Invitrogen(on gateway)	W01B002B12	pENTR221	1		IGK@	50802	AAH32451.1										
Invitrogen	ENST00000316157	IOH2964	Invitrogen(on gateway)	W01B002B13	pENTR221	3399		LARP5	23185	ENSP00000326128	Hs.681734	La ribonucleoprotein domain family, member 5						NM_015155.1	NP_055970.1	PROVISIONAL		0.290	0.290	31	225	94	186	738	228	258
Invitrogen	NM_133368	IOH11125	Invitrogen(on gateway)	W01B002B14	pENTR221	8589		RSPRY1	89970	NP_588609.1	Hs.460885	Ring finger and SPRY domain containing 1						NM_133368.1	NP_588609.1	PROVISIONAL	C	1.000	1.000	576	1731	1	1728	576	1	576
Invitrogen	NM_002194	IOH10347	Invitrogen(on gateway)	W01B002B15	pENTR221	13346		INPP1	3628	NP_002185.1	Hs.32309	Inositol polyphosphate-1-phosphatase						NM_002194.3	NP_002185.1	REVIEWED	OK	1.000	1.000	399	1200	1	1197	399	1	399
Invitrogen	NM_001005278	IOH28294	Invitrogen(on gateway)	W01B002B16	pENTR221	2288		OR6N2	81442	NP_001005278.1	Hs.554487	Olfactory receptor, family 6, subfamily N, member 2						NM_001005278.1	NP_001005278.1	PROVISIONAL	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_016305	IOH12915	Invitrogen(on gateway)	W01B002B17	pENTR221	16287		SS18L2	51188	NP_057389.1	Hs.534454	Synovial sarcoma translocation gene on chromosome 18-like 2						NM_016305.2	NP_057389.1	VALIDATED	C	1.000	1.000	77	234	1	231	77	1	77
Invitrogen	NM_001004712	IOH28218	Invitrogen(on gateway)	W01B002B18	pENTR221	7601		OR4K14	122740	NP_001004712.1	Hs.626814	Olfactory receptor, family 4, subfamily K, member 14						NM_001004712.1	NP_001004712.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	BC020746	IOH14515	Invitrogen(on gateway)	W01B002B19	pENTR221	25407		PNPLA4	8228	AAH20746.1	Hs.264	Patatin-like phospholipase domain containing 4						NM_004650.2	NP_004641.1	VALIDATED	Cs	0.992	0.992	253	762	1	759	253	1	253
Invitrogen	NM_031274	IOH27435	Invitrogen(on gateway)	W01B002B20	pENTR221	25222		TEX13A	56157	NP_112564.1	Hs.567543	Testis expressed 13A						NM_031274.3	NP_112564.1	REVIEWED	C	1.000	1.000	409	1230	1	1227	409	1	409
Invitrogen	NM_052848	IOH13249	Invitrogen(on gateway)	W01B002B21	pENTR221	11817		CCDC97	90324	NP_443080.1	Hs.437497	Coiled-coil domain containing 97						NM_052848.1	NP_443080.1	PROVISIONAL	C	1.000	1.000	343	1032	1	1029	343	1	343
Invitrogen	BC034318	IOH27668	Invitrogen(on gateway)	W01B002B22	pENTR221	21127		CUL1	8454	-	Hs.146806	Cullin 1						NM_003592.2	NP_003583.2	VALIDATED	Ps	0.995	0.995	415	1389	142	1386	776	362	776
Invitrogen	BC020844	IOH12056	Invitrogen(on gateway)	W01B002B23	pENTR221	5355		SPRYD4	283377	AAH20844.1	Hs.128676	SPRY domain containing 4						NM_207344.3	NP_997227.1	VALIDATED	Cs	0.995	0.995	207	624	1	621	207	1	207
Invitrogen	NM_003878	IOH25778	Invitrogen(on gateway)	W01B002B24	pENTR221	23240		GGH	8836	NP_003869.1	Hs.78619	Gamma-glutamyl hydrolase (conjugase, folylpolygammaglutamyl hydrolase)						NM_003878.2	NP_003869.1	REVIEWED	C	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	NM_024574	IOH22922	Invitrogen(on gateway)	W01B002C01	pENTR221	18161		C4orf31	79625	NP_078850.3	Hs.709520	Chromosome 4 open reading frame 31						NM_024574.3	NP_078850.3	VALIDATED	P	1.000	1.000	331	996	1	993	568	238	568
Invitrogen	NM_032437	IOH10105	Invitrogen(on gateway)	W01B002C02	pENTR221	172		EFCAB7	84455	NP_115813.2	Hs.652324	EF-hand calcium binding domain 7						NM_032437.2	NP_115813.2	VALIDATED	Cs	0.995	0.995	629	1890	1	1887	629	1	629
Invitrogen	ENST00000322340	IOH22490	Invitrogen(on gateway)	W01B002C03	pENTR221	6982		WDR20	91833	ENSP00000314209	Hs.36859	WD repeat domain 20						NM_181308.1	NP_851825.1	REVIEWED	P	1.000	1.000	83	588	1	249	508	1	83
Invitrogen	BC026221	IOH10864	Invitrogen(on gateway)	W01B002C04	pENTR221	16525		FAM131A	131408	AAH26221.1	Hs.591307	Family with sequence similarity 131, member A						NM_144635.3	NP_653236.2	PREDICTED	P	1.000	1.000	258	846	70	843	335	78	335
Invitrogen	BC020967	IOH10378	Invitrogen(on gateway)	W01B002C05	pENTR221	5607		C12orf24	29902	AAH20967.1	Hs.436618	Chromosome 12 open reading frame 24						NM_013300.2	NP_037432.2	VALIDATED	C	1.000	1.000	273	822	1	819	273	1	273
Invitrogen	BC034350	IOH22153	Invitrogen(on gateway)	W01B002C06	pENTR221	195		CA6	765	AAH34350.1	Hs.100322	Carbonic anhydrase VI						NM_001215.2	NP_001206.2	REVIEWED		0.729	0.770	133	540	1	387	308	1	130
Invitrogen	BC036365	IOH22309	Invitrogen(on gateway)	W01B002C07	pENTR221	2772		C10orf81	79949	AAH36365.2	Hs.228320	Chromosome 10 open reading frame 81						NM_024889.3	NP_079165.3	PREDICTED	P	1.000	1.000	177	849	1	531	363	187	363
Invitrogen	BC033736	IOH21824	Invitrogen(on gateway)	W01B002C08	pENTR221	1599		DPT	1805	AAH33736.1	Hs.80552	Dermatopontin						NM_001937.3	NP_001928.2	REVIEWED	Cs	0.995	0.995	201	606	1	603	201	1	201
Invitrogen	NM_203451	IOH22457	Invitrogen(on gateway)	W01B002C09	pENTR221	6569		C13orf36	400120	NP_982276.2	Hs.422375	Chromosome 13 open reading frame 36						NM_203451.2	NP_982276.2	VALIDATED	Cs	0.991	0.991	107	324	1	321	107	1	107
Invitrogen	NM_001007139	IOH13185	Invitrogen(on gateway)	W01B002C10	pENTR221	4109		IGF2	3481	NP_001007140.2	Hs.718427	Insulin-like growth factor 2 (somatomedin A)						NM_000612.4	NP_000603.1	REVIEWED	Pfs	0.226	0.226	31	342	134	226	180	142	172
Invitrogen	NM_020239	IOH21482	Invitrogen(on gateway)	W01B002C11	pENTR221	1673		CDC42SE1	56882	NP_064624.1	Hs.22065	CDC42 small effector 1						NM_001038707.1	NP_001033796.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
Invitrogen	NM_000978	IOH13951	Invitrogen(on gateway)	W01B002C12	pENTR221	10502		RPL23	9349	NP_000969.1	Hs.406300	Ribosomal protein L23						NM_000978.3	NP_000969.1	REVIEWED	C	1.000	1.000	140	423	1	420	140	1	140
Invitrogen	BC021861	IOH11917	Invitrogen(on gateway)	W01B002C13	pENTR221	24238		LOC554202	554202	AAH21861	Hs.458096	Hypothetical LOC554202								
Invitrogen	ENST00000314567	IOH22861	Invitrogen(on gateway)	W01B002C14	pENTR221	15940		C22orf40	150383	ENSP00000325301	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.467	0.467	15	243	84	128	123	74	88
Invitrogen	BC021680	IOH12084	Invitrogen(on gateway)	W01B002C15	pENTR221	19404		C5orf46	389336	AAH21680.1	Hs.660038	Chromosome 5 open reading frame 46						NM_206966.2	NP_996849.2	VALIDATED	Ps	0.986	0.986	72	219	1	216	87	1	72
Invitrogen	NM_001311	IOH5361	Invitrogen(on gateway)	W01B002C16	pENTR221	7200		CRIP1	1396	NP_001302.1	Hs.70327	Cysteine-rich protein 1 (intestinal)						NM_001311.4	NP_001302.1	VALIDATED	C	1.000	1.000	77	234	1	231	77	1	77
Invitrogen	NM_022142	IOH13085	Invitrogen(on gateway)	W01B002C17	pENTR221	11623		ELSPBP1	64100	NP_071425.2	Hs.104894	Epididymal sperm binding protein 1						NM_022142.3	NP_071425.2	REVIEWED	C	1.000	1.000	223	672	1	669	223	1	223
Invitrogen	NM_003094	IOH5272	Invitrogen(on gateway)	W01B002C18	pENTR221	887		SNRPE	6635	NP_003085.1	Hs.654418	Small nuclear ribonucleoprotein polypeptide E						NM_003094.2	NP_003085.1	PROVISIONAL	OK	1.000	1.000	92	279	1	276	92	1	92
Invitrogen	NM_015340	IOH10999	Invitrogen(on gateway)	W01B002C19	pENTR221	16389		LARS2	23395	NP_056155.1	Hs.526975	Leucyl-tRNA synthetase 2, mitochondrial						NM_015340.3	NP_056155.1	REVIEWED	C	1.000	1.000	903	2712	1	2709	903	1	903
Invitrogen	NM_031210	IOH13414	Invitrogen(on gateway)	W01B002C20	pENTR221	7049		C14orf156	81892	NP_112487.1	Hs.655105	Chromosome 14 open reading frame 156						NM_031210.4	NP_112487.1	VALIDATED	C	1.000	1.000	109	330	1	327	109	1	109
Invitrogen	NM_130777	IOH13230	Invitrogen(on gateway)	W01B002C21	pENTR221	24683		XAGE2	9502	NP_570133.1	Hs.522654	X antigen family, member 2						NM_130777.1	NP_570133.1	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
Invitrogen	NM_018397	IOH22286	Invitrogen(on gateway)	W01B002C22	pENTR221	16989		CHDH	55349	NP_060867.2	Hs.126688	Choline dehydrogenase						NM_018397.3	NP_060867.2	VALIDATED	Cs	0.998	0.998	594	1785	1	1782	594	1	594
Invitrogen	NM_024320	IOH5689	Invitrogen(on gateway)	W01B002C23	pENTR221	10694		ATAD4	79170	NP_077296.1	Hs.368260	ATPase family, AAA domain containing 4						NM_024320.2	NP_077296.1	PROVISIONAL	C	1.000	1.000	103	312	1	309	103	1	103
Invitrogen	NM_080675	IOH10614	Invitrogen(on gateway)	W01B002C24	pENTR221	14977		SPAG4L	140732	NP_542406.2	Hs.375186	Sperm associated antigen 4-like						NM_080675.3	NP_542406.2	VALIDATED	C	1.000	1.000	379	1140	1	1137	379	1	379
Invitrogen	BC025407	IOH11128	Invitrogen(on gateway)	W01B002D01	pENTR221	3947		LAYN	143903	AAH25407.1	Hs.503831	Layilin						NM_178834.3	NP_849156.1	PROVISIONAL	Cs	0.997	0.997	374	1125	1	1122	374	1	374
Invitrogen	NM_031991	IOH5495	Invitrogen(on gateway)	W01B002D02	pENTR221	11465		PTBP1	5725	NP_114368.1	Hs.172550	Polypyrimidine tract binding protein 1						NM_031991.3	NP_114368.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
Invitrogen	NM_173525	IOH22770	Invitrogen(on gateway)	W01B002D03	pENTR221	4119		C11orf42	160298	NP_775796.1	Hs.278221	Chromosome 11 open reading frame 42						NM_173525.1	NP_775796.1	PREDICTED	C	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	ENST00000268383	IOH12794	Invitrogen(on gateway)	W01B002D04	pENTR221	9389		CDR2	1039	ENSP00000268383	Hs.513430	Cerebellar degeneration-related protein 2, 62kDa						NM_001802.1	NP_001793.1	VALIDATED	P	1.000	1.000	443	1332	1	1329	454	12	454
Invitrogen	BC003394	IOH2999	Invitrogen(on gateway)	W01B002D05	pENTR221	7246		HNRNPC	3183	AAH03394.1	Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED	C	1.000	1.000	293	882	1	879	293	1	293
Invitrogen	NM_015154	IOH14565	Invitrogen(on gateway)	W01B002D06	pENTR221	8268		MESDC2	23184	NP_055969.1	Hs.578450	Mesoderm development candidate 2						NM_015154.1	NP_055969.1	VALIDATED	C	1.000	1.000	234	705	1	702	234	1	234
Invitrogen	NM_001010942	IOH2916	Invitrogen(on gateway)	W01B002D07	pENTR221	5223		RAP1B	5908	NP_001010942.1	Hs.369920	RAP1B, member of RAS oncogene family						NM_015646.4	NP_056461.1	VALIDATED	C	1.000	1.000	184	555	1	552	184	1	184
Invitrogen	NM_175887	IOH27336	Invitrogen(on gateway)	W01B002D08	pENTR221	21431		PRR15	222171	NP_787083.1	Hs.91109	Proline rich 15						NM_175887.2	NP_787083.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
Invitrogen	NM_003329	IOH2929	Invitrogen(on gateway)	W01B002D09	pENTR221	24080		TXN	7295	NP_003320.2	Hs.435136	Thioredoxin						NM_003329.2	NP_003320.2	VALIDATED	C	1.000	1.000	105	318	1	315	105	1	105
Invitrogen	NM_173492	IOH25909	Invitrogen(on gateway)	W01B002D10	pENTR221	24316		PIP5KL1	138429	NP_775763.1	Hs.445486	Phosphatidylinositol-4-phosphate 5-kinase-like 1						NM_173492.1	NP_775763.1	VALIDATED	C	1.000	1.000	191	576	1	573	191	1	191
Invitrogen	NM_020300	IOH7456	Invitrogen(on gateway)	W01B002D11	pENTR221	5576		MGST1	4257	NP_064696.1	Hs.389700	Microsomal glutathione S-transferase 1						NM_145791.1	NP_665734.1	REVIEWED	C	1.000	1.000	155	468	1	465	155	1	155
Invitrogen	NM_001006606	IOH25910	Invitrogen(on gateway)	W01B002D12	pENTR221	15990		LOC388882	388882	NP_001006607	Hs.542766	Hypothetical LOC388882																		
Invitrogen	BC000868	IOH3251	Invitrogen(on gateway)	W01B002D13	pENTR221	6805		MGC5590	79024	AAH00868.1	Hs.652876	Hypothetical protein MGC5590						XM_930060.1	XP_935153.1	MODEL										
Invitrogen	NM_007189	IOH3871	Invitrogen(on gateway)	W01B002D14	pENTR221	21887		ABCF2	10061	NP_009120.1	Hs.654958	ATP-binding cassette, sub-family F (GCN20), member 2						NM_007189.1	NP_009120.1	REVIEWED	C	1.000	1.000	623	1872	1	1869	623	1	623
Invitrogen	NM_000967	IOH10093	Invitrogen(on gateway)	W01B002D15	pENTR221	15803		RPL3	6122	NP_000958.1	Hs.119598	Ribosomal protein L3						NM_000967.3	NP_000958.1	REVIEWED	C	1.000	1.000	403	1212	1	1209	403	1	403
Invitrogen	NM_001004740	IOH28262	Invitrogen(on gateway)	W01B002D16	pENTR221	4976		OR5M1	390168	NP_001004740.1	Hs.553751	Olfactory receptor, family 5, subfamily M, member 1						NM_001004740.1	NP_001004740.1	PROVISIONAL	OK	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_206831	IOH12592	Invitrogen(on gateway)	W01B002D17	pENTR221	17027		DPH3	285381	NP_996662.1	Hs.388087	DPH3, KTI11 homolog (S. cerevisiae)						NM_206831.2	NP_996662.1	REVIEWED	C	1.000	1.000	82	249	1	246	82	1	82
Invitrogen	NM_001398	IOH13815	Invitrogen(on gateway)	W01B002D18	pENTR221	12159		ECH1	1891	NP_001389.2	Hs.196176	Enoyl Coenzyme A hydratase 1, peroxisomal						NM_001398.2	NP_001389.2	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
Invitrogen	NM_016052	IOH13661	Invitrogen(on gateway)	W01B002D19	pENTR221	48		RRP15	51018	NP_057136.2	Hs.660109	Ribosomal RNA processing 15 homolog (S. cerevisiae)						NM_016052.3	NP_057136.2	REVIEWED	P	1.000	1.000	259	780	1	777	282	24	282
Invitrogen	NM_153359	IOH25813	Invitrogen(on gateway)	W01B002D20	pENTR221	12681		MGC24975	163154	NP_699190.1	Hs.631838	Hypothetical protein MGC24975						NM_153359.1	NP_699190.1	VALIDATED	C	1.000	1.000	420	1263	1	1260	420	1	420
Invitrogen	NM_000984	IOH13591	Invitrogen(on gateway)	W01B002D21	pENTR221	9944		RPL23A	6147	NP_000975.2	Hs.419463	Ribosomal protein L23a						NM_000984.5	NP_000975.2	REVIEWED	C	1.000	1.000	156	471	1	468	156	1	156
Invitrogen	BC021906	IOH25790	Invitrogen(on gateway)	W01B002D22	pENTR221	9771		FMNL1	752	AAH21906.1	Hs.100217	Formin-like 1						NM_005892.3	NP_005883.2	REVIEWED		0.973	0.975	447	1392	1	1341	1100	642	1087
Invitrogen	NM_013234	IOH4065	Invitrogen(on gateway)	W01B002D23	pENTR221	11382		EIF3K	27335	NP_037366.1	Hs.314359	Eukaryotic translation initiation factor 3, subunit K						NM_013234.2	NP_037366.1	VALIDATED	C	1.000	1.000	218	657	1	654	218	1	218
Invitrogen	NM_178863	IOH27502	Invitrogen(on gateway)	W01B002D24	pENTR221	9202		KCTD13	253980	NP_849194.1	Hs.534590	Potassium channel tetramerisation domain containing 13						NM_178863.2	NP_849194.1	PROVISIONAL	C	1.000	1.000	329	990	1	987	329	1	329
Invitrogen	BC014394	IOH22936	Invitrogen(on gateway)	W01B002E01	pENTR221	2032		AHDC1	27245	AAH14394.3	Hs.469280	AT hook, DNA binding motif, containing 1						NM_001029882.2	NP_001025053.1	VALIDATED	P	1.000	1.000	399	1200	1	1197	1603	1205	1603
Invitrogen	BC015904	IOH10110	Invitrogen(on gateway)	W01B002E02	pENTR221	10637		MRPL10	124995	AAH15904.1	Hs.347535	Mitochondrial ribosomal protein L10						NM_145255.2	NP_660298.2	REVIEWED	Cs	0.996	0.996	261	786	1	783	261	1	261
Invitrogen	BC036669	IOH22495	Invitrogen(on gateway)	W01B002E03	pENTR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1						NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.828	0.998	583	1491	1	1489	654	1	571
Invitrogen	NM_152489	IOH22752	Invitrogen(on gateway)	W01B002E04	pENTR221	948		UBE2U	148581	NP_689702.1	Hs.388746	Ubiquitin-conjugating enzyme E2U (putative)						NM_152489.1	NP_689702.1	PROVISIONAL	C	1.000	1.000	226	681	1	678	226	1	226
Invitrogen	ENST00000323617	IOH22224	Invitrogen(on gateway)	W01B002E05	pENTR221															
Invitrogen	NM_001012631	IOH23121	Invitrogen(on gateway)	W01B002E06	pENTR221	8903		IL32	9235	NP_001012649.1	Hs.943	Interleukin 32						NM_001012632.1	NP_001012650.1	REVIEWED	C	1.000	1.000	188	567	1	564	188	1	188
Invitrogen	NM_004504	IOH22341	Invitrogen(on gateway)	W01B002E07	pENTR221	13372		AGFG1	3267	NP_004495.2	Hs.352962	ArfGAP with FG repeats 1						NM_004504.4	NP_004495.2	REVIEWED	C	1.000	1.000	562	1689	1	1686	562	1	562
Invitrogen	BC022393	IOH12918	Invitrogen(on gateway)	W01B002E08	pENTR221	16560		TDGF1	6997	AAH22393.1	Hs.385870	Teratocarcinoma-derived growth factor 1						NM_003212.2	NP_003203.1	VALIDATED	Cs	0.995	0.995	188	567	1	564	188	1	188
Invitrogen	NM_007108	IOH14150	Invitrogen(on gateway)	W01B002E09	pENTR221	9388		TCEB2	6923	NP_009039.1	Hs.172772	Transcription elongation factor B (SIII), polypeptide 2 (18kDa, elongin B)						NM_007108.2	NP_009039.1	REVIEWED	C	1.000	1.000	118	357	1	354	118	1	118
Invitrogen	NM_004888	IOH7535	Invitrogen(on gateway)	W01B002E10	pENTR221	23525		ATP6V1G1	9550	NP_004879.1	Hs.388654	ATPase, H+ transporting, lysosomal 13kDa, V1 subunit G1						NM_004888.3	NP_004879.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
Invitrogen	NM_004576	IOH22211	Invitrogen(on gateway)	W01B002E11	pENTR221	19320		PPP2R2B	5521	NP_004567.1	Hs.655213	Protein phosphatase 2 (formerly 2A), regulatory subunit B, beta isoform						NM_181674.2	NP_858060.1	REVIEWED	OK	1.000	1.000	443	1332	1	1329	443	1	443
Invitrogen	NM_148178	IOH23094	Invitrogen(on gateway)	W01B002E12	pENTR221	24302		C9orf23	138716	NP_680544.1	Hs.15961	Chromosome 9 open reading frame 23						NM_148178.1	NP_680544.1	VALIDATED	C	1.000	1.000	163	492	1	489	163	1	163
Invitrogen	ENST00000317749	IOH11551	Invitrogen(on gateway)	W01B002E13	pENTR221	15953		C22orf43	51233	ENSP00000316137	Hs.517466	Chromosome 22 open reading frame 43						NM_016449.2	NP_057533.2	PREDICTED	P	1.000	1.000	70	387	1	210	229	1	70
Invitrogen	BC030200	IOH22588	Invitrogen(on gateway)	W01B002E14	pENTR221	10730		FAM171A2	284069	AAH30200.1	Hs.154001	Family with sequence similarity 171, member A2						XM_001715615.1	XP_001715667.1	MODEL	P	1.000	1.000	81	246	3	245	654	63	143
Invitrogen	BC014340	IOH13438	Invitrogen(on gateway)	W01B002E15	pENTR221	4036		LDHAL6A	160287	AAH14340.1	Hs.668877	Lactate dehydrogenase A-like 6A						NM_001144071.1	NP_001137543.1	VALIDATED	P	1.000	1.000	233	705	1	699	332	1	233
Invitrogen	BC031676	IOH22866	Invitrogen(on gateway)	W01B002E16	pENTR221	14760		LOC643406	643406	AAH31676.1	Hs.431161	Hypothetical protein LOC643406						XM_001725180.1	XP_001725232.1	MODEL	Cs	0.990	0.990	98	297	1	294	98	1	98
Invitrogen	ENST00000308101	IOH12275	Invitrogen(on gateway)	W01B002E17	pENTR221	5785		ZFC3H1	196441	ENSP00000307825	Hs.527874	Zinc finger, C3H1-type containing						NM_144982.4	NP_659419.3	VALIDATED	Ps	0.997	0.997	340	1077	1	1020	1989	1	340
Invitrogen	NM_152766	IOH21570	Invitrogen(on gateway)	W01B002E18	pENTR221	10400		C17orf61	254863	NP_689979.1	Hs.534591	Chromosome 17 open reading frame 61						NM_152766.2	NP_689979.1	PREDICTED	C	1.000	1.000	113	342	1	339	113	1	113
Invitrogen	NM_031950	IOH10917	Invitrogen(on gateway)	W01B002E19	pENTR221	17977		FGFBP2	83888	NP_114156.1	Hs.98785	Fibroblast growth factor binding protein 2						NM_031950.3	NP_114156.1	REVIEWED	C	1.000	1.000	223	672	1	669	223	1	223
Invitrogen	BC029032	IOH22628	Invitrogen(on gateway)	W01B002E20	pENTR221	10729		ALOX15	246	AAH29032.1	Hs.73809	Arachidonate 15-lipoxygenase						NM_001140.3	NP_001131.3	VALIDATED	Cs	0.998	0.998	662	1989	1	1986	662	1	662
Invitrogen	NM_032775	IOH12694	Invitrogen(on gateway)	W01B002E21	pENTR221	15892		KLHL22	84861	NP_116164.2	Hs.517419	Kelch-like 22 (Drosophila)						NM_032775.2	NP_116164.2	VALIDATED	C	1.000	1.000	634	1905	1	1902	634	1	634
Invitrogen	NM_170696	IOH22316	Invitrogen(on gateway)	W01B002E22	pENTR221	8101		ALDH1A2	8854	NP_733797.1	Hs.643455	Aldehyde dehydrogenase 1 family, member A2						NM_170696.1	NP_733797.1	REVIEWED	C	1.000	1.000	480	1443	1	1440	480	1	480
Invitrogen	NM_032301	IOH5507	Invitrogen(on gateway)	W01B002E23	pENTR221	12568		FBXW9	84261	NP_115677.2	Hs.515154	F-box and WD repeat domain containing 9						NM_032301.2	NP_115677.2	VALIDATED	P	1.000	1.000	135	408	3	407	458	317	451
Invitrogen	P20839	IOH21694	Invitrogen(on gateway)	W01B002E24	pENTR221															
Invitrogen	BC033681	IOH21850	Invitrogen(on gateway)	W01B002F01	pENTR221	9299		C16orf89	146556	AAH33681.1	Hs.11782	Chromosome 16 open reading frame 89						NM_001098514.1	NP_001091984.1	VALIDATED	Cs	0.995	0.995	399	1200	1	1197	399	1	399
Invitrogen	BC036453	IOH22505	Invitrogen(on gateway)	W01B002F02	pENTR221	3433		FAM13C	220965	AAH36453.1	Hs.607594	Family with sequence similarity 13, member C						NM_001143773.1	NP_001137245.1	VALIDATED	C	1.000	1.000	502	1758	250	1755	502	1	502
Invitrogen	BC022316	IOH12290	Invitrogen(on gateway)	W01B002F03	pENTR221	12349		PSG2	5670	AAH22316.1	Hs.709200	Pregnancy specific beta-1-glycoprotein 2						NM_031246.2	NP_112536.2	VALIDATED	Cs	0.997	0.997	335	1008	1	1005	335	1	335
Invitrogen	BC009272	IOH14502	Invitrogen(on gateway)	W01B002F04	pENTR221	8691		MSLN	10232	AAH09272.1	Hs.408488	Mesothelin						NM_005823.4	NP_005814.2	REVIEWED	Cs	0.998	0.998	622	1869	1	1866	622	1	622
Invitrogen	BC001299	IOH3046	Invitrogen(on gateway)	W01B002F05	pENTR221	4525		YIF1A	10897	AAH01299.1	Hs.446445	Yip1 interacting factor homolog A (S. cerevisiae)						NM_020470.2	NP_065203.2	VALIDATED	C	1.000	1.000	293	882	1	879	293	1	293
Invitrogen	BC000158	IOH2949	Invitrogen(on gateway)	W01B002F06	pENTR221	12442		FAM108A1	81926	AAH00158.1	Hs.653679	Family with sequence similarity 108, member A1						NM_001130111.1	NP_001123583.1	VALIDATED	Ps	0.996	0.996	235	711	1	705	310	1	235
Invitrogen	BC005876	IOH6081	Invitrogen(on gateway)	W01B002F07	pENTR221	873		ATP6V0B	533	AAH05876.1	Hs.596514	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b						NM_001039457.1	NP_001034546.1	REVIEWED	Cs	0.994	0.994	158	618	142	615	158	1	158
Invitrogen	BC036094	IOH27258	Invitrogen(on gateway)	W01B002F08	pENTR221	24586		GAGE1	2543	AAH36094.1	Hs.632815	G antigen 1						NM_001468.3	NP_001459.2	REVIEWED	C	1.000	1.000	139	420	1	417	139	1	139
Invitrogen	NM_016468	IOH3847	Invitrogen(on gateway)	W01B002F09	pENTR221	7420		COX16	51241	NP_057552.1	Hs.709581	COX16 cytochrome c oxidase assembly homolog (S. cerevisiae)						NM_016468.5	NP_057552.1	VALIDATED	C	1.000	1.000	106	321	1	318	106	1	106
Invitrogen	NM_203452	IOH27500	Invitrogen(on gateway)	W01B002F10	pENTR221															
Invitrogen	NM_173362	IOH12123	Invitrogen(on gateway)	W01B002F11	pENTR221	18891		RFESD	317671	NP_775498.1	Hs.399758	Rieske (Fe-S) domain containing						NM_173362.3	NP_775498.1	VALIDATED	C	1.000	1.000	157	474	1	471	157	1	157
Invitrogen	BC036231	IOH27510	Invitrogen(on gateway)	W01B002F12	pENTR221	14999		C20orf12	55184	AAH36231	Hs.472225	Chromosome 20 open reading frame 12						NM_001099407.1	NP_001092877.1	VALIDATED	Pfs	0.911	0.996	270	744	1	742	752	1	270
Invitrogen	NM_023937	IOH4594	Invitrogen(on gateway)	W01B002F13	pENTR221	11416		MRPL34	64981	NP_076426.1	Hs.515242	Mitochondrial ribosomal protein L34						NM_023937.3	NP_076426.1	REVIEWED	C	1.000	1.000	92	279	1	276	92	1	92
Invitrogen	BC017261	IOH12715	Invitrogen(on gateway)	W01B002F14	pENTR221	11769		WDR62	284403	AAH17261.1	Hs.116244	WD repeat domain 62						NM_173636.4	NP_775907.4	VALIDATED	Ps	0.995	0.995	630	1893	1	1890	1518	889	1518
Invitrogen	NM_006417	IOH12126	Invitrogen(on gateway)	W01B002F15	pENTR221	938		IFI44	10561	NP_006408.3	Hs.82316	Interferon-induced protein 44						NM_006417.4	NP_006408.3	VALIDATED	Cs	0.998	0.998	444	1335	1	1332	444	1	444
Invitrogen	NM_001005334	IOH28172	Invitrogen(on gateway)	W01B002F16	pENTR221	10079		OR3A4	390756	NP_001005334.1	Hs.632245	Olfactory receptor, family 3, subfamily A, member 4						NM_001005334.1	NP_001005334.1	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
Invitrogen	NM_001001342	IOH9955	Invitrogen(on gateway)	W01B002F17	pENTR221	3305		BLOC1S2	282991	NP_001001342.1	Hs.34906	Biogenesis of lysosomal organelles complex-1, subunit 2						NM_001001342.1	NP_001001342.1	VALIDATED	C	1.000	1.000	99	300	1	297	99	1	99
Invitrogen	NM_001002857	IOH3974	Invitrogen(on gateway)	W01B002F18	pENTR221	8294		ANXA2	302	NP_001002857.1	Hs.511605	Annexin A2						NM_001002857.1	NP_001002857.1	REVIEWED	C	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	NM_007193	IOH5857	Invitrogen(on gateway)	W01B002F19	pENTR221	17529		ANXA10	11199	NP_009124.2	Hs.188401	Annexin A10						NM_007193.3	NP_009124.2	REVIEWED	C	1.000	1.000	324	975	1	972	324	1	324
Invitrogen	BC031222	IOH21615	Invitrogen(on gateway)	W01B002F20	pENTR221	18772		SRFBP1	153443	AAH31222.1	Hs.107622	Serum response factor binding protein 1						NM_152546.2	NP_689759.2	VALIDATED	C	1.000	1.000	429	1290	1	1287	429	1	429
Invitrogen	NM_144716	IOH13356	Invitrogen(on gateway)	W01B002F21	pENTR221	17104		CCDC12	151903	NP_653317.2	Hs.692157	Coiled-coil domain containing 12						NM_144716.3	NP_653317.2	VALIDATED	P	1.000	1.000	166	501	1	498	179	14	179
Invitrogen	NM_000725	IOH25900	Invitrogen(on gateway)	W01B002F22	pENTR221	5504		CACNB3	784	NP_000716.2	Hs.250712	Calcium channel, voltage-dependent, beta 3 subunit						NM_000725.2	NP_000716.2	VALIDATED	C	1.000	1.000	484	1455	1	1452	484	1	484
Invitrogen	NM_001008397	IOH23140	Invitrogen(on gateway)	W01B002F23	pENTR221	18777		GPX8	493869	NP_001008398.2	Hs.289044	Glutathione peroxidase 8 (putative)						NM_001008397.2	NP_001008398.2	VALIDATED	Cs	0.995	0.995	209	630	1	627	209	1	209
Invitrogen	BC012945	IOH25802	Invitrogen(on gateway)	W01B002F24	pENTR221	12549		C19orf57	79173	AAH12945.2	Hs.143288	Chromosome 19 open reading frame 57						NM_024323.3	NP_077299.3	PREDICTED	Pgs	0.901	0.993	333	1002	1	999	637	336	637
Invitrogen	NM_015956	IOH22955	Invitrogen(on gateway)	W01B002G01	pENTR221	11415		MRPL4	51073	NP_057040.2	Hs.279652	Mitochondrial ribosomal protein L4						NM_015956.2	NP_057040.2	REVIEWED	C	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	NM_018704	IOH10131	Invitrogen(on gateway)	W01B002G02	pENTR221	580		CTTNBP2NL	55917	NP_061174.1	Hs.485899	CTTNBP2 N-terminal like						NM_018704.2	NP_061174.1	VALIDATED	C	1.000	1.000	639	1920	1	1917	639	1	639
Invitrogen	NM_001006939	IOH22597	Invitrogen(on gateway)	W01B002G03	pENTR221	3392		LRRC18	474354	NP_001006940.3	Hs.202438	Leucine rich repeat containing 18						NM_001006939.3	NP_001006940.3	VALIDATED	Cs	0.996	0.996	261	786	1	783	261	1	261
Invitrogen	NM_000850	IOH9886	Invitrogen(on gateway)	W01B002G04	pENTR221	919		GSTM4	2948	NP_000841.1	Hs.348387	Glutathione S-transferase mu 4						NM_000850.4	NP_000841.1	REVIEWED	C	1.000	1.000	218	657	1	654	218	1	218
Invitrogen	NM_016544	IOH22234	Invitrogen(on gateway)	W01B002G05	pENTR221	13966		DNAJC27	51277	NP_057628.1	Hs.434993	DnaJ (Hsp40) homolog, subfamily C, member 27						NM_016544.1	NP_057628.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
Invitrogen	NM_003001	IOH14102	Invitrogen(on gateway)	W01B002G06	pENTR221	206		SDHC	6391	NP_002992.1	Hs.444472	Succinate dehydrogenase complex, subunit C, integral membrane protein, 15kDa						NM_003001.3	NP_002992.1	REVIEWED	C	1.000	1.000	169	510	1	507	169	1	169
Invitrogen	ENST00000360847	IOH22367	Invitrogen(on gateway)	W01B002G07	pENTR221	15089		FITM2	128486	ENSP00000354093	Hs.632269	Chromosome 20 open reading frame 142						NM_001080472.1	NP_001073941.1	PROVISIONAL	C	1.000	1.000	262	789	1	786	262	1	262
Invitrogen	NM_144659	IOH21795	Invitrogen(on gateway)	W01B002G08	pENTR221	15366		TCP10L	140290	NP_653260.1	Hs.42034	T-complex 10 (mouse)-like						NM_144659.5	NP_653260.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
Invitrogen	BC013005	IOH13631	Invitrogen(on gateway)	W01B002G09	pENTR221	18660		IK	3550	AAH13005.1	Hs.421245	IK cytokine, down-regulator of HLA II						NM_006083.3	NP_006074.2	REVIEWED	Cs	0.998	0.998	557	1674	1	1671	557	1	557
Invitrogen	NM_175870	IOH5318	Invitrogen(on gateway)	W01B002G10	pENTR221	1		RPIA	22934	NP_787066	Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.351	0.361	37	363	204	94	311	4	39
Invitrogen	NM_001008708	IOH13580	Invitrogen(on gateway)	W01B002G11	pENTR221	13494		CHAC2	494143	NP_001008708.1	Hs.585944	ChaC, cation transport regulator homolog 2 (E. coli)						NM_001008708.2	NP_001008708.1	PROVISIONAL	C	1.000	1.000	184	555	1	552	184	1	184
Invitrogen	NM_000300	IOH7577	Invitrogen(on gateway)	W01B002G12	pENTR221	2134		PLA2G2A	5320	NP_000291.1	Hs.466804	Phospholipase A2, group IIA (platelets, synovial fluid)						NM_000300.2	NP_000291.1	PROVISIONAL	C	1.000	1.000	144	435	1	432	144	1	144
Invitrogen	NM_005217	IOH11891	Invitrogen(on gateway)	W01B002G13	pENTR221	23244		DEFA3	1668	NP_005208.1	Hs.654448	Defensin, alpha 3, neutrophil-specific						NM_005217.2	NP_005208.1	REVIEWED	C	1.000	1.000	94	285	1	282	94	1	94
Invitrogen	BC008699	IOH6051	Invitrogen(on gateway)	W01B002G14	pENTR221	7274			644719	AAH08699										
Invitrogen	BC025985	IOH12558	Invitrogen(on gateway)	W01B002G15	pENTR221	1		IGHG4	3503	AAH25985										
Invitrogen	NM_001826	IOH6416	Invitrogen(on gateway)	W01B002G16	pENTR221	448		CKS1B	1163	NP_001817.1	Hs.374378	CDC28 protein kinase regulatory subunit 1B						NM_001826.2	NP_001817.1	REVIEWED	C	1.000	1.000	79	240	1	237	79	1	79
Invitrogen	ENST00000287653	IOH12288	Invitrogen(on gateway)	W01B002G17	pENTR221	16307		C3orf42	84657	ENSP00000287653	Hs.302131	Chromosome 3 open reading frame 42																		
Invitrogen	BC031827	IOH22190	Invitrogen(on gateway)	W01B002G18	pENTR221	34248				AAH31827										
Invitrogen	BC027473	IOH10955	Invitrogen(on gateway)	W01B002G19	pENTR221	12268		ADCK4	79934	AAH27473.1	Hs.130712	AarF domain containing kinase 4						NM_001142555.1	NP_001136027.1	VALIDATED	C	1.000	1.000	503	1512	1	1509	503	1	503
Invitrogen	NM_138386	IOH3154	Invitrogen(on gateway)	W01B002G20	pENTR221	18260		NAF1	92345	NP_612395.2	Hs.129095	Nuclear assembly factor 1 homolog (S. cerevisiae)						NM_138386.2	NP_612395.2	VALIDATED	Cs	0.998	0.998	494	1485	1	1482	494	1	494
Invitrogen	NM_032014	IOH13283	Invitrogen(on gateway)	W01B002G21	pENTR221	21910		MRPS24	64951	NP_114403.1	Hs.284286	Mitochondrial ribosomal protein S24						NM_032014.2	NP_114403.1	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
Invitrogen	NM_001023571	IOH6266	Invitrogen(on gateway)	W01B002G22	pENTR221	16801		IQCB1	9657	NP_001018865.2	Hs.604110	IQ motif containing B1						NM_001023571.2	NP_001018865.2	VALIDATED	Cs	0.998	0.998	465	1398	1	1395	465	1	465
Invitrogen	NM_032302	IOH5540	Invitrogen(on gateway)	W01B002G23	pENTR221	22058		PSMG3	84262	NP_115678.1	Hs.446311	Proteasome (prosome, macropain) assembly chaperone 3						NM_032302.3	NP_115678.1	VALIDATED	C	1.000	1.000	122	369	1	366	122	1	122
Invitrogen	BC015878	IOH23080	Invitrogen(on gateway)	W01B002G24	pENTR221	22632		NAT2	10	AAH15878.1	Hs.2	N-acetyltransferase 2 (arylamine N-acetyltransferase)						NM_000015.2	NP_000006.2	REVIEWED	Cs	0.993	0.993	290	873	1	870	290	1	290
Invitrogen	NM_032680	IOH5189	Invitrogen(on gateway)	W01B002H01	pENTR221	6065		EFCAB4B	84766	NP_116069.1	Hs.504534	EF-hand calcium binding domain 4B						NM_032680.3	NP_116069.1	VALIDATED	C	1.000	1.000	395	1188	1	1185	395	1	395
Invitrogen	NM_002053	IOH5246	Invitrogen(on gateway)	W01B002H02	pENTR221	1492		GBP1	2633	NP_002044.2	Hs.62661	Guanylate binding protein 1, interferon-inducible, 67kDa						NM_002053.2	NP_002044.2	VALIDATED	Cs	0.997	0.997	592	1779	1	1776	592	1	592
Invitrogen	NM_012449	IOH13052	Invitrogen(on gateway)	W01B002H03	pENTR221	21185		STEAP1	26872	NP_036581.1	Hs.61635	Six transmembrane epithelial antigen of the prostate 1						NM_012449.2	NP_036581.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	NM_145245	IOH12245	Invitrogen(on gateway)	W01B002H04	pENTR221	11948		EVI5L	115704	NP_660288.1	Hs.26870	Ecotropic viral integration site 5-like						NM_145245.3	NP_660288.1	VALIDATED	C	1.000	1.000	794	2385	1	2382	794	1	794
Invitrogen	NM_152288	IOH14638	Invitrogen(on gateway)	W01B002H05	pENTR221	8914		ORAI3	93129	NP_689501.1	Hs.460617	ORAI calcium release-activated calcium modulator 3						NM_152288.2	NP_689501.1	VALIDATED	C	1.000	1.000	295	888	1	885	295	1	295
Invitrogen	BC001346	IOH3051	Invitrogen(on gateway)	W01B002H06	pENTR221	4489		CYB5R2	51700	AAH01346	Hs.414362	Cytochrome b5 reductase 2						NM_016229.3	NP_057313.2	VALIDATED		0.932	0.936	237	714	1	711	276	1	236
Invitrogen	NM_213636	IOH14519	Invitrogen(on gateway)	W01B002H07	pENTR221	19251		PDLIM7	9260	NP_998801.1	Hs.533040	PDZ and LIM domain 7 (enigma)						NM_213636.1	NP_998801.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
Invitrogen	BC033172	IOH23233	Invitrogen(on gateway)	W01B002H08	pENTR221	18153		MGC45800	90768	AAH33172	Hs.175465	Hypothetical LOC90768																		
Invitrogen	NM_014736	IOH5885	Invitrogen(on gateway)	W01B002H09	pENTR221	8232		KIAA0101	9768	NP_055551.1	Hs.81892	KIAA0101						NM_014736.4	NP_055551.1	VALIDATED	OK	1.000	1.000	111	336	1	333	111	1	111
Invitrogen	NM_001004323	IOH27672	Invitrogen(on gateway)	W01B002H10	pENTR221	22171		C7orf61	402573	NP_001004323.1	Hs.632306	Chromosome 7 open reading frame 61						NM_001004323.1	NP_001004323.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
Invitrogen	NM_015610	IOH5656	Invitrogen(on gateway)	W01B002H11	pENTR221	21169		WIPI2	26100	NP_056425.1	Hs.122363	WD repeat domain, phosphoinositide interacting 2						NM_015610.3	NP_056425.1	VALIDATED	C	1.000	1.000	454	1365	1	1362	454	1	454
Invitrogen	NM_015941	IOH14042	Invitrogen(on gateway)	W01B002H12	pENTR221	23025		ATP6V1H	51606	NP_057025.2	Hs.491737	ATPase, H+ transporting, lysosomal 50/57kDa, V1 subunit H						NM_015941.2	NP_057025.2	REVIEWED	C	1.000	1.000	483	1452	1	1449	483	1	483
Invitrogen	NM_021006	IOH11386	Invitrogen(on gateway)	W01B002H13	pENTR221	10728		CCL3L1	6349	NP_066286.1	Hs.512683	Chemokine (C-C motif) ligand 3-like 1						NM_021006.4	NP_066286.1	REVIEWED	C	1.000	1.000	93	282	1	279	93	1	93
Invitrogen	NM_014782	IOH14216	Invitrogen(on gateway)	W01B002H14	pENTR221	25101		ARMCX2	9823	NP_055597.1	Hs.48924	Armadillo repeat containing, X-linked 2						NM_177949.2	NP_808818.1	REVIEWED	C	1.000	1.000	632	1899	1	1896	632	1	632
Invitrogen	BC031094	IOH22572	Invitrogen(on gateway)	W01B002H15	pENTR221	14198		ZSWIM2	151112	AAH31094.1	Hs.375054	Zinc finger, SWIM-type containing 2						NM_182521.2	NP_872327.2	VALIDATED	Cs	0.989	0.989	633	1902	1	1899	633	1	633
Invitrogen	ENST00000334632	IOH28291	Invitrogen(on gateway)	W01B002H16	pENTR221	30695				ENSP00000334721										
Invitrogen	NM_145326	IOH6254	Invitrogen(on gateway)	W01B002H17	pENTR221	11468		ZNF493	284443	NP_663299.2	Hs.656558	Zinc finger protein 493						NM_145326.2	NP_663299.2	VALIDATED	Cs	0.990	0.990	103	312	1	309	103	1	103
Invitrogen	NM_016371	IOH7352	Invitrogen(on gateway)	W01B002H18	pENTR221	345		HSD17B7	51478	NP_057455.1	Hs.492925	Hydroxysteroid (17-beta) dehydrogenase 7						NM_016371.2	NP_057455.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
Invitrogen	NM_006066	IOH4326	Invitrogen(on gateway)	W01B002H19	pENTR221	874		AKR1A1	10327	NP_006057.1	Hs.654435	Aldo-keto reductase family 1, member A1 (aldehyde reductase)						NM_153326.1	NP_697021.1	REVIEWED	C	1.000	1.000	325	978	1	975	325	1	325
Invitrogen	NM_001014436	IOH21501	Invitrogen(on gateway)	W01B002H20	pENTR221	21089		DBNL	28988	NP_001014436.1	Hs.436500	Drebrin-like						NM_001014436.2	NP_001014436.1	VALIDATED	C	1.000	1.000	430	1293	1	1290	430	1	430
Invitrogen	BC009621	IOH9897	Invitrogen(on gateway)	W01B002H21	pENTR221	372		RAG1AP1	55974	AAH09621.1	Hs.292154	Recombination activating gene 1 activating protein 1						NM_001122839.1	NP_001116311.1	VALIDATED	C	1.000	1.000	167	504	1	501	167	1	167
Invitrogen	BC028295	IOH25815	Invitrogen(on gateway)	W01B002H22	pENTR221	12499		PEPD	5184	AAH28295.1	Hs.36473	Peptidase D						NM_000285.2	NP_000276.2	VALIDATED	Cs	0.998	0.998	493	1482	1	1479	493	1	493
Invitrogen	NM_202004	IOH13470	Invitrogen(on gateway)	W01B002H23	pENTR221	707		HFE2	148738	NP_973733.1	Hs.632436	Hemochromatosis type 2 (juvenile)						NM_202004.3	NP_973733.1	REVIEWED	C	1.000	1.000	200	603	1	600	200	1	200
Invitrogen	ENST00000332772	IOH27534	Invitrogen(on gateway)	W01B002H24	pENTR221	18822		C5orf25	375484	ENSP00000331311	Hs.715124	Chromosome 5 open reading frame 25						NM_198567.4	NP_940969.3	VALIDATED	Ps	0.997	0.997	314	1002	58	999	457	144	457
Invitrogen	BC032101	IOH22993	Invitrogen(on gateway)	W01B002I01	pENTR221	16290		JAGN1	84522	AAH32101.1	Hs.24054	Jagunal homolog 1 (Drosophila)						NM_032492.3	NP_115881.3	VALIDATED	C	1.000	1.000	183	552	1	549	183	1	183
Invitrogen	BC008131	IOH10205	Invitrogen(on gateway)	W01B002I02	pENTR221	2889		LOC142937	142937	-	Hs.679824	Hypothetical protein BC008131						XM_495796.2	XP_495796.2	MODEL										
Invitrogen	NM_033423	IOH22624	Invitrogen(on gateway)	W01B002I03	pENTR221	7552		GZMH	2999	NP_219491.1	Hs.348264	Granzyme H (cathepsin G-like 2, protein h-CCPX)						NM_033423.3	NP_219491.1	PROVISIONAL	C	1.000	1.000	246	741	1	738	246	1	246
Invitrogen	NM_001013615	IOH22858	Invitrogen(on gateway)	W01B002I04	pENTR221	679		C1orf190	541468	NP_001013633.1	Hs.568642	Chromosome 1 open reading frame 190						NM_001013615.2	NP_001013633.1	VALIDATED	C	1.000	1.000	239	720	1	717	239	1	239
Invitrogen	NM_004233	IOH22237	Invitrogen(on gateway)	W01B002I05	pENTR221	20033		CD83	9308	NP_004224.1	Hs.595133	CD83 molecule						NM_004233.3	NP_004224.1	VALIDATED	C	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	BC030991	IOH23130	Invitrogen(on gateway)	W01B002I06	pENTR221	13486		OR7E91P	79315	AAH30991	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene								
Invitrogen	NM_001007256	IOH22412	Invitrogen(on gateway)	W01B002I07	pENTR221	713		KLHDC9	126823	NP_001007257.1	Hs.507290	Kelch domain containing 9						NM_001007256.1	NP_001007257.1	VALIDATED	C	1.000	1.000	111	336	1	333	111	1	111
Invitrogen	NM_178034	IOH21503	Invitrogen(on gateway)	W01B002I08	pENTR221	8135		PLA2G4D	283748	NP_828848.3	Hs.380225	Phospholipase A2, group IVD (cytosolic)						NM_178034.3	NP_828848.3	VALIDATED	P	1.000	1.000	174	651	1	522	818	508	681
Invitrogen	NM_005275	IOH14481	Invitrogen(on gateway)	W01B002I09	pENTR221	20640		GNL1	2794	NP_005266.2	Hs.83147	Guanine nucleotide binding protein-like 1						NM_005275.2	NP_005266.2	REVIEWED	C	1.000	1.000	607	1824	1	1821	607	1	607
Invitrogen	NM_152533	IOH22868	Invitrogen(on gateway)	W01B002I10	pENTR221	17211		C3orf22	152065	NP_689746.1	Hs.178210	Chromosome 3 open reading frame 22						NM_152533.1	NP_689746.1	PREDICTED	OK	1.000	1.000	141	426	1	423	141	1	141
Invitrogen	BC024223	IOH14706	Invitrogen(on gateway)	W01B002I11	pENTR221	13743		TXNDC9	10190	AAH24223.2	Hs.536122	Thioredoxin domain containing 9						NM_005783.3	NP_005774.2	REVIEWED	P	1.000	1.000	187	567	1	561	226	1	187
Invitrogen	NM_152353	IOH22553	Invitrogen(on gateway)	W01B002I12	pENTR221	12711		CLDND2	125875	NP_689566.1								NM_152353.2	NP_689566.1	VALIDATED	C	1.000	1.000	167	504	1	501	167	1	167
Invitrogen	NM_000232	IOH12316	Invitrogen(on gateway)	W01B002I13	pENTR221	18199		SGCB	6443	NP_000223.1	Hs.438953	Sarcoglycan, beta (43kDa dystrophin-associated glycoprotein)						NM_000232.4	NP_000223.1	REVIEWED	C	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	BC029526	IOH22575	Invitrogen(on gateway)	W01B002I14	pENTR221	3342		ACBD7	414149	AAH29526.1	Hs.644598	Acyl-Coenzyme A binding domain containing 7						NM_001039844.2	NP_001034933.1	VALIDATED	C	1.000	1.000	88	267	1	264	88	1	88
Invitrogen	ENST00000263070	IOH12119	Invitrogen(on gateway)	W01B002I15	pENTR221	3135		WAPAL	23063	ENSP00000263070	Hs.714876	Wings apart-like homolog (Drosophila)						NM_015045.2	NP_055860.1	VALIDATED	Pg	0.880	1.000	457	1209	1	1206	1190	734	1190
Invitrogen	NM_153220	IOH22700	Invitrogen(on gateway)	W01B002I16	pENTR221	11661		DPY19L3	147991	NP_694952	Hs.194392	Dpy-19-like 3 (C. elegans)						NM_207325.1	NP_997208.1	PROVISIONAL	P	1.000	1.000	79	309	1	237	716	1	79
Invitrogen	NM_002621	IOH12225	Invitrogen(on gateway)	W01B002I17	pENTR221	25339		CFP	5199	NP_002612.1	Hs.53155	Complement factor properdin						NM_001145252.1	NP_001138724.1	REVIEWED	C	1.000	1.000	469	1410	1	1407	469	1	469
Invitrogen	NM_153238	IOH22133	Invitrogen(on gateway)	W01B002I18	pENTR221	8946		TMEM148	197196	NP_694970	Hs.679002	Transmembrane protein 148																		
Invitrogen	NM_052950	IOH13317	Invitrogen(on gateway)	W01B002I19	pENTR221	6493		WDFY2	115825	NP_443182.1	Hs.208550	WD repeat and FYVE domain containing 2						NM_052950.3	NP_443182.1	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
Invitrogen	NM_024844	IOH4332	Invitrogen(on gateway)	W01B002I20	pENTR221	9781		NUP85	79902	NP_079120.1	Hs.362817	Nucleoporin 85kDa						NM_024844.3	NP_079120.1	REVIEWED	C	1.000	1.000	656	1971	1	1968	656	1	656
Invitrogen	NM_001552	IOH12509	Invitrogen(on gateway)	W01B002I21	pENTR221	9999		IGFBP4	3487	NP_001543.2	Hs.462998	Insulin-like growth factor binding protein 4						NM_001552.2	NP_001543.2	REVIEWED	C	1.000	1.000	258	777	1	774	258	1	258
Invitrogen	BC015625	IOH13242	Invitrogen(on gateway)	W01B002I22	pENTR221	5942		YARS2	51067	AAH15625.1	Hs.505231	Tyrosyl-tRNA synthetase 2, mitochondrial						NM_001040436.1	NP_001035526.1	VALIDATED	C	1.000	1.000	477	1434	1	1431	477	1	477
Invitrogen	NM_004965	IOH4772	Invitrogen(on gateway)	W01B002I23	pENTR221	15358		HMGN1	3150	NP_004956.5	Hs.356285	High-mobility group nucleosome binding domain 1						NM_004965.6	NP_004956.5	REVIEWED	C	1.000	1.000	100	303	1	300	100	1	100
Invitrogen	NM_001001850	IOH22151	Invitrogen(on gateway)	W01B002I24	pENTR221	16975		STX19	415117	NP_001001850.1	Hs.679768	Syntaxin 19						NM_001001850.1	NP_001001850.1	PROVISIONAL	C	1.000	1.000	294	885	1	882	294	1	294
Invitrogen	BC021720	IOH10740	Invitrogen(on gateway)	W01B002J01	pENTR221	7774		DNAJA4	55466	AAH21720.1	Hs.513053	DnaJ (Hsp40) homolog, subfamily A, member 4						NM_001130182.1	NP_001123654.1	VALIDATED	C	1.000	1.000	397	1194	1	1191	397	1	397
Invitrogen	BC034360	IOH22167	Invitrogen(on gateway)	W01B002J02	pENTR221	6494		CLYBL	171425	AAH34360.1	Hs.655642	Citrate lyase beta like						NM_206808.1	NP_996531.1	VALIDATED	Cs	0.997	0.997	340	1023	1	1020	340	1	340
Invitrogen	NM_030812	IOH22202	Invitrogen(on gateway)	W01B002J03	pENTR221	664		ACTL8	81569	NP_110439.2	Hs.2149	Actin-like 8						NM_030812.2	NP_110439.2	VALIDATED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
Invitrogen	BC022317	IOH13773	Invitrogen(on gateway)	W01B002J04	pENTR221	4		TRA@	6955	AAH22317.1										
Invitrogen	NM_024713	IOH12799	Invitrogen(on gateway)	W01B002J05	pENTR221	8267		C15orf29	79768	NP_078989.1	Hs.633566	Chromosome 15 open reading frame 29						NM_024713.2	NP_078989.1	VALIDATED	C	1.000	1.000	304	915	1	912	304	1	304
Invitrogen	NM_014214	IOH13690	Invitrogen(on gateway)	W01B002J06	pENTR221	10977		IMPA2	3613	NP_055029.1	Hs.367992	Inositol(myo)-1(or 4)-monophosphatase 2						NM_014214.1	NP_055029.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
Invitrogen	NM_031227	IOH3028	Invitrogen(on gateway)	W01B002J07	pENTR221															
Invitrogen	NM_194279	IOH27677	Invitrogen(on gateway)	W01B002J08	pENTR221	7214		ISCA2	122961	NP_919255.2	Hs.709509	Iron-sulfur cluster assembly 2 homolog (S. cerevisiae)						NM_194279.2	NP_919255.2	VALIDATED	Cs	0.994	0.994	154	465	1	462	154	1	154
Invitrogen	NM_031412	IOH14808	Invitrogen(on gateway)	W01B002J09	pENTR221	5299		GABARAPL1	23710	NP_113600.1	Hs.524250	GABA(A) receptor-associated protein like 1						NM_031412.2	NP_113600.1	VALIDATED	C	1.000	1.000	117	354	1	351	117	1	117
Invitrogen	NM_173554	IOH25890	Invitrogen(on gateway)	W01B002J10	pENTR221	2926		C10orf107	219621	NP_775825.1	Hs.673160	Chromosome 10 open reading frame 107						NM_173554.2	NP_775825.1	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
Invitrogen	NM_021639	IOH10045	Invitrogen(on gateway)	W01B002J11	pENTR221	1671		GPBP1L1	60313	NP_067652.1	Hs.238432	GC-rich promoter binding protein 1-like 1						NM_021639.4	NP_067652.1	VALIDATED	C	1.000	1.000	474	1425	1	1422	474	1	474
Invitrogen	NM_021079	IOH14141	Invitrogen(on gateway)	W01B002J12	pENTR221	9653		NMT1	4836	NP_066565.1	Hs.532790	N-myristoyltransferase 1						NM_021079.3	NP_066565.1	PROVISIONAL	C	1.000	1.000	496	1491	1	1488	496	1	496
Invitrogen	NM_005980	IOH3157	Invitrogen(on gateway)	W01B002J13	pENTR221	17559		S100P	6286	NP_005971.1	Hs.2962	S100 calcium binding protein P						NM_005980.2	NP_005971.1	REVIEWED	C	1.000	1.000	95	288	1	285	95	1	95
Invitrogen	BC015822	IOH13663	Invitrogen(on gateway)	W01B002J14	pENTR221	16963		LTF	4057	AAH15822.1	Hs.529517	Lactotransferrin						NM_002343.2	NP_002334.2	REVIEWED	Cgs	0.997	0.999	711	2136	1	2133	710	1	710
Invitrogen	BC028012	IOH11598	Invitrogen(on gateway)	W01B002J15	pENTR221	12397		PRAM1	84106	AAH28012.1	Hs.465812	PML-RARA regulated adaptor molecule 1						NM_032152.3	NP_115528.3	REVIEWED	Cgs	0.997	0.999	670	2013	1	2010	669	1	669
Invitrogen	ENST00000334579	IOH28476	Invitrogen(on gateway)	W01B002J16	pENTR221	2278		OR10X1	128367	ENSP00000335495	Hs.553589	Olfactory receptor, family 10, subfamily X, member 1						NM_001004477.1	NP_001004477.1	PROVISIONAL	P	1.000	1.000	309	930	1	927	326	18	326
Invitrogen	NM_203298	IOH11615	Invitrogen(on gateway)	W01B002J17	pENTR221	2823		CHCHD1	118487	NP_976043.1	Hs.181174	Coiled-coil-helix-coiled-coil-helix domain containing 1						NM_203298.2	NP_976043.1	VALIDATED	C	1.000	1.000	118	357	1	354	118	1	118
Invitrogen	NM_006877	IOH6246	Invitrogen(on gateway)	W01B002J18	pENTR221	20078		GMPR	2766	NP_006868.3	Hs.484741	Guanosine monophosphate reductase						NM_006877.3	NP_006868.3	VALIDATED	Cs	0.997	0.997	345	1038	1	1035	345	1	345
Invitrogen	BC021092	IOH13243	Invitrogen(on gateway)	W01B002J19	pENTR221	7730		ZFYVE19	84936	AAH21092.1	Hs.121676	Zinc finger, FYVE domain containing 19						NM_001077268.1	NP_001070736.1	VALIDATED	Pgs	0.823	0.994	396	987	1	984	471	76	471
Invitrogen	NM_198845	IOH27405	Invitrogen(on gateway)	W01B002J20	pENTR221	12719		SIGLEC6	946	NP_942142.3	Hs.397255	Sialic acid binding Ig-like lectin 6						NM_198845.3	NP_942142.3	VALIDATED	C	1.000	1.000	437	1314	1	1311	437	1	437
Invitrogen	NM_198066	IOH13394	Invitrogen(on gateway)	W01B002J21	pENTR221	7472		GNPNAT1	64841	NP_932332.1	Hs.702056	Glucosamine-phosphate N-acetyltransferase 1						NM_198066.3	NP_932332.1	VALIDATED	C	1.000	1.000	184	555	1	552	184	1	184
Invitrogen	NM_006244	IOH27509	Invitrogen(on gateway)	W01B002J22	pENTR221	3686		PPP2R5B	5526	NP_006235.1	Hs.75199	Protein phosphatase 2, regulatory subunit B', beta isoform						NM_006244.2	NP_006235.1	REVIEWED	OK	1.000	1.000	497	1494	1	1491	497	1	497
Invitrogen	NM_145030	IOH13246	Invitrogen(on gateway)	W01B002J23	pENTR221	22164		C7orf47	221908	NP_659467.1	Hs.413359	Chromosome 7 open reading frame 47						NM_145030.2	NP_659467.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	NM_153356	IOH27369	Invitrogen(on gateway)	W01B002J24	pENTR221	7955		TBC1D21	161514	NP_699187.1	Hs.124512	TBC1 domain family, member 21						NM_153356.1	NP_699187.1	PROVISIONAL	C	1.000	1.000	336	1011	1	1008	336	1	336
Invitrogen	NM_025078	IOH22999	Invitrogen(on gateway)	W01B002K01	pENTR221	11233		PQLC1	80148	NP_079354.2	Hs.288284	PQ loop repeat containing 1						NM_025078.4	NP_079354.2	VALIDATED	C	1.000	1.000	271	816	1	813	271	1	271
Invitrogen	NM_080388	IOH10271	Invitrogen(on gateway)	W01B002K02	pENTR221	2113		S100A16	140576	NP_525127.1	Hs.515714	S100 calcium binding protein A16						NM_080388.1	NP_525127.1	PROVISIONAL	OK	1.000	1.000	103	312	1	309	103	1	103
Invitrogen	NM_152389	IOH22642	Invitrogen(on gateway)	W01B002K03	pENTR221	14173		CCDC108	255101	NP_689602.2	Hs.147762	Coiled-coil domain containing 108						NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	115	492	1	345	1925	67	181
Invitrogen	NM_173685	IOH21786	Invitrogen(on gateway)	W01B002K04	pENTR221	22686		NSMCE2	286053	NP_775956.1	Hs.388297	Non-SMC element 2, MMS21 homolog (S. cerevisiae)						NM_173685.2	NP_775956.1	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
Invitrogen	NM_002166	IOH22240	Invitrogen(on gateway)	W01B002K05	pENTR221	13420		ID2	3398	NP_002157.2	Hs.180919	Inhibitor of DNA binding 2, dominant negative helix-loop-helix protein						NM_002166.4	NP_002157.2	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
Invitrogen	NM_033546	IOH5094	Invitrogen(on gateway)	W01B002K06	pENTR221	11066		MYL12B	103910	NP_291024.1	Hs.464472	Myosin, light chain 12B, regulatory						NM_001144944.1	NP_001138416.1	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
Invitrogen	NM_004329	IOH22419	Invitrogen(on gateway)	W01B002K07	pENTR221	2908		BMPR1A	657	NP_004320.2	Hs.524477	Bone morphogenetic protein receptor, type IA						NM_004329.2	NP_004320.2	REVIEWED	C	1.000	1.000	532	1599	1	1596	532	1	532
Invitrogen	NM_145280	IOH21779	Invitrogen(on gateway)	W01B002K08	pENTR221	14009		FAM119A	151194	NP_660323.3	Hs.664764	Family with sequence similarity 119, member A						NM_001127395.1	NP_001120867.1	VALIDATED	Cs	0.995	0.995	218	657	1	654	218	1	218
Invitrogen	NM_005052	IOH14547	Invitrogen(on gateway)	W01B002K09	pENTR221	9647		RAC3	5881	NP_005043.1	Hs.45002	Ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)						NM_005052.2	NP_005043.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
Invitrogen	NM_173652	IOH22733	Invitrogen(on gateway)	W01B002K10	pENTR221	13511		C2orf58	285154	NP_775923	Hs.353894	Chromosome 2 open reading frame 58																		
Invitrogen	NM_005601	IOH14227	Invitrogen(on gateway)	W01B002K11	pENTR221	12689		NKG7	4818	NP_005592.1	Hs.10306	Natural killer cell group 7 sequence						NM_005601.3	NP_005592.1	VALIDATED	C	1.000	1.000	165	498	1	495	165	1	165
Invitrogen	NM_173810	IOH23092	Invitrogen(on gateway)	W01B002K12	pENTR221	3840		TTC9C	283237	NP_776171.1	Hs.31704	Tetratricopeptide repeat domain 9C						NM_173810.3	NP_776171.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
Invitrogen	NM_054023	IOH12827	Invitrogen(on gateway)	W01B002K13	pENTR221	18684		SCGB3A2	117156	NP_473364.1	Hs.483765	Secretoglobin, family 3A, member 2						NM_054023.3	NP_473364.1	PROVISIONAL	C	1.000	1.000	93	282	1	279	93	1	93
Invitrogen	NM_012456	IOH23086	Invitrogen(on gateway)	W01B002K14	pENTR221	4604		TIMM10	26519	NP_036588.1	Hs.235750	Translocase of inner mitochondrial membrane 10 homolog (yeast)						NM_012456.2	NP_036588.1	VALIDATED	C	1.000	1.000	90	273	1	270	90	1	90
Invitrogen	NM_022786	IOH13057	Invitrogen(on gateway)	W01B002K15	pENTR221	445		ARV1	64801	NP_073623.1	Hs.275736	ARV1 homolog (S. cerevisiae)						NM_022786.1	NP_073623.1	PROVISIONAL	C	1.000	1.000	271	816	1	813	271	1	271
Invitrogen	ENST00000320662	IOH21575	Invitrogen(on gateway)	W01B002K16	pENTR221	23249		C8orf56	157556	ENSP00000315478	Hs.459124	Chromosome 8 open reading frame 56								
Invitrogen	NM_145300	IOH12242	Invitrogen(on gateway)	W01B002K17	pENTR221	13487		ALMS1P	200420	NP_660343	Hs.278983	Alstrom syndrome 1 pseudogene								
Invitrogen	BC029544	IOH22551	Invitrogen(on gateway)	W01B002K18	pENTR221	3424		NUDT9P1	119369	AAH29544	Hs.441287	Nudix (nucleoside diphosphate linked moiety X)-type motif 9 pseudogene 1								
Invitrogen	BC011906	IOH12531	Invitrogen(on gateway)	W01B002K19	pENTR221	5395		ISCU	23479	AAH11906.1	Hs.615131	Iron-sulfur cluster scaffold homolog (E. coli)						NM_213595.2	NP_998760.1	REVIEWED	Cs	0.988	0.988	167	504	1	501	167	1	167
Invitrogen	NM_018984	IOH20979	Invitrogen(on gateway)	W01B002K20	pENTR221	5822		SSH1	54434	NP_061857.2	Hs.199763	Slingshot homolog 1 (Drosophila)						NM_018984.2	NP_061857.2	PROVISIONAL	Cs	0.999	0.999	1049	3150	1	3147	1049	1	1049
Invitrogen	NM_013242	IOH5166	Invitrogen(on gateway)	W01B002K21	pENTR221	9161		C16orf80	29105	NP_037374.1	Hs.532755	Chromosome 16 open reading frame 80						NM_013242.2	NP_037374.1	VALIDATED	C	1.000	1.000	193	582	1	579	193	1	193
Invitrogen	BC002960	IOH4868	Invitrogen(on gateway)	W01B002K22	pENTR221	10599		FDXR	2232	AAH02960.1	Hs.69745	Ferredoxin reductase						NM_024417.2	NP_077728.2	REVIEWED	C	1.000	1.000	491	1476	1	1473	491	1	491
Invitrogen	NM_003516	IOH4867	Invitrogen(on gateway)	W01B002K23	pENTR221	881		HIST2H2AA3	8337	NP_003507.1	Hs.530461	Histone cluster 2, H2aa3						NM_003516.2	NP_003507.1	REVIEWED	C	1.000	1.000	130	393	1	390	130	1	130
Invitrogen	ENST00000359860	IOH5963	Invitrogen(on gateway)	W01B002K24	pENTR221	2561		FAM21C	253725	ENSP00000352922	Hs.365286	Family with sequence similarity 21, member C						NM_015262.1	NP_056077.1	VALIDATED	P	1.000	1.000	283	852	1	849	1318	1036	1318
Invitrogen	BC015993	IOH14875	Invitrogen(on gateway)	W01B002L01	pENTR221	1965		FAM151A	338094	AAH15993.1	Hs.234786	Family with sequence similarity 151, member A						NM_176782.2	NP_788954.2	VALIDATED	Cg	0.680	1.000	585	1197	1	1194	585	1	585
Invitrogen	NM_173659	IOH23087	Invitrogen(on gateway)	W01B002L02	pENTR221	17081		RPUSD3	285367	NP_775930.2	Hs.33719	RNA pseudouridylate synthase domain containing 3						NM_173659.3	NP_775930.2	VALIDATED	P	1.000	1.000	343	1032	1	1029	351	9	351
Invitrogen	ENST00000313350	IOH22731	Invitrogen(on gateway)	W01B002L03	pENTR221	16735		CLASP2	23122	ENSP00000324364	Hs.108614	Cytoplasmic linker associated protein 2						NM_015097.1	NP_055912.1	VALIDATED	Ps	0.993	0.993	407	1296	25	1245	1506	236	642
Invitrogen	NM_018649	IOH10067	Invitrogen(on gateway)	W01B002L04	pENTR221	2686		H2AFY2	55506	NP_061119.1	Hs.499953	H2A histone family, member Y2						NM_018649.2	NP_061119.1	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
Invitrogen	BC011815	IOH14409	Invitrogen(on gateway)	W01B002L05	pENTR221	3880		MYEOV	26579	AAH11815.1	Hs.523848	Myeloma overexpressed (in a subset of t(11;14) positive multiple myelomas)						NM_138768.2	NP_620123.2	VALIDATED	Cs	0.994	0.994	313	942	1	939	313	1	313
Invitrogen	NM_139286	IOH26784	Invitrogen(on gateway)	W01B002L06	pENTR221	21969		CDC26	246184	NP_644815.1	Hs.718531	Cell division cycle 26 homolog (S. cerevisiae)						NM_139286.3	NP_644815.1	REVIEWED	OK	1.000	1.000	85	258	1	255	85	1	85
Invitrogen	NM_002573	IOH6769	Invitrogen(on gateway)	W01B002L07	pENTR221	12668		PAFAH1B3	5050	NP_002564.1	Hs.466831	Platelet-activating factor acetylhydrolase, isoform Ib, subunit 3 (29kDa)						NM_001145940.1	NP_001139412.1	REVIEWED	C	1.000	1.000	231	696	1	693	231	1	231
Invitrogen	NM_032112	IOH25749	Invitrogen(on gateway)	W01B002L08	pENTR221	3129		MRPL43	84545	NP_115488.2	Hs.421848	Mitochondrial ribosomal protein L43						NM_032112.2	NP_115488.2	REVIEWED	C	1.000	1.000	159	480	1	477	159	1	159
Invitrogen	NM_005340	IOH3136	Invitrogen(on gateway)	W01B002L09	pENTR221	19313		HINT1	3094	NP_005331.1	Hs.483305	Histidine triad nucleotide binding protein 1						NM_005340.5	NP_005331.1	VALIDATED	C	1.000	1.000	126	381	1	378	126	1	126
Invitrogen	NM_152474	IOH25857	Invitrogen(on gateway)	W01B002L10	pENTR221	12717		C19orf18	147685	NP_689687.1	Hs.134209	Chromosome 19 open reading frame 18						NM_152474.3	NP_689687.1	PREDICTED	C	1.000	1.000	215	648	1	645	215	1	215
Invitrogen	BC022495	IOH10633	Invitrogen(on gateway)	W01B002L11	pENTR221	13501		KCNJ3	3760	AAH22495.1	Hs.591606	Potassium inwardly-rectifying channel, subfamily J, member 3						NM_002239.2	NP_002230.1	REVIEWED	Cs	0.996	0.996	501	1506	1	1503	501	1	501
Invitrogen	BC016369	IOH14869	Invitrogen(on gateway)	W01B002L12	pENTR221	1		IGHA1	3493	AAH16369										
Invitrogen	NM_016438	IOH12887	Invitrogen(on gateway)	W01B002L13	pENTR221	9580		HIGD1B	51751	NP_057522.1	Hs.287963	HIG1 hypoxia inducible domain family, member 1B						NM_016438.2	NP_057522.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
Invitrogen	Q8NGY3	IOH28293	Invitrogen(on gateway)	W01B002L14	pENTR221															
Invitrogen	BC032429	IOH21744	Invitrogen(on gateway)	W01B002L15	pENTR221	23618		FGD3	89846	AAH32429.1	Hs.411081	FYVE, RhoGEF and PH domain containing 3						NM_001083536.1	NP_001077005.1	VALIDATED	Cs	0.999	0.999	725	2178	1	2175	725	1	725
Invitrogen	NM_001004693	IOH28479	Invitrogen(on gateway)	W01B002L16	pENTR221	2282		OR2T10	127069	NP_001004693.1	Hs.553585	Olfactory receptor, family 2, subfamily T, member 10						NM_001004693.1	NP_001004693.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	BC014975	IOH14285	Invitrogen(on gateway)	W01B002L17	pENTR221	14092		FAM136A	84908	AAH14975.1	Hs.516077	Family with sequence similarity 136, member A						NM_032822.2	NP_116211.2	VALIDATED	C	1.000	1.000	138	417	1	414	138	1	138
Invitrogen	BC001778	IOH4907	Invitrogen(on gateway)	W01B002L18	pENTR221	349		UROD	7389	AAH01778.1	Hs.78601	Uroporphyrinogen decarboxylase						NM_000374.3	NP_000365.3	REVIEWED	Cs	0.997	0.997	367	1104	1	1101	367	1	367
Invitrogen	BC006091	IOH6616	Invitrogen(on gateway)	W01B002L19	pENTR221	3798		TSSC4	10078	AAH06091.1	Hs.523424	Tumor suppressing subtransferable candidate 4						NM_005706.2	NP_005697.2	REVIEWED	Cs	0.997	0.997	329	990	1	987	329	1	329
Invitrogen	BC034978	IOH26825	Invitrogen(on gateway)	W01B002L20	pENTR221	16160		PDE12	201626	AAH34978	Hs.572993	Phosphodiesterase 12						NM_177966.5	NP_808881.3	VALIDATED	Ps	0.984	0.984	437	1317	1	1311	609	35	471
Invitrogen	NM_014623	IOH4452	Invitrogen(on gateway)	W01B002L21	pENTR221	20757		MEA1	4201	NP_055438.1	Hs.278362	Male-enhanced antigen 1						NM_014623.2	NP_055438.1	VALIDATED	C	1.000	1.000	185	558	1	555	185	1	185
Invitrogen	NM_018976	IOH25744	Invitrogen(on gateway)	W01B002L22	pENTR221	5824		SLC38A2	54407	NP_061849.2	Hs.221847	Solute carrier family 38, member 2						NM_018976.4	NP_061849.2	VALIDATED	C	1.000	1.000	506	1521	1	1518	506	1	506
Invitrogen	NM_152325	IOH21514	Invitrogen(on gateway)	W01B002L23	pENTR221	6562		C13orf26	122046	NP_689538.1	Hs.124463	Chromosome 13 open reading frame 26						NM_152325.1	NP_689538.1	PREDICTED	C	1.000	1.000	289	870	1	867	289	1	289
Invitrogen	NM_001001412	IOH27486	Invitrogen(on gateway)	W01B002L24	pENTR221	3432		CALHM1	255022	NP_001001412.3	Hs.680365	Calcium homeostasis modulator 1						NM_001001412.3	NP_001001412.3	VALIDATED	Cs	0.994	0.994	346	1041	1	1038	346	1	346
Invitrogen	BC013925	IOH23004	Invitrogen(on gateway)	W01B002M01	pENTR221	13927		OLA1	29789	AAH13925.1	Hs.157351	Obg-like ATPase 1						NM_013341.3	NP_037473.3	VALIDATED	Ps	0.992	0.992	246	837	1	738	396	1	246
Invitrogen	NM_001018068	IOH10305	Invitrogen(on gateway)	W01B002M02	pENTR221	1638		SERBP1	26135	NP_001018078.1	Hs.719078	SERPINE1 mRNA binding protein 1						NM_001018068.1	NP_001018078.1	VALIDATED	C	1.000	1.000	402	1209	1	1206	402	1	402
Invitrogen	BC029167	IOH22650	Invitrogen(on gateway)	W01B002M03	pENTR221	11579		CD177	57126	AAH29167.1	Hs.232165	CD177 molecule						NM_020406.2	NP_065139.2	VALIDATED	Cs	0.989	0.989	437	1314	1	1311	437	1	437
Invitrogen	BC033871	IOH21866	Invitrogen(on gateway)	W01B002M04	pENTR221	21967		TRIM74	378108	AAH33871.1	Hs.645328	Tripartite motif-containing 74						NM_198853.1	NP_942150.1	PROVISIONAL	Cgs	0.984	0.988	250	750	1	747	250	1	250
Invitrogen	NM_013270	IOH22253	Invitrogen(on gateway)	W01B002M05	pENTR221	16897		TSP50	29122	NP_037402.1	Hs.120365	Testes-specific protease 50						NM_013270.4	NP_037402.1	VALIDATED	C	1.000	1.000	385	1158	1	1155	385	1	385
Invitrogen	NM_007029	IOH6398	Invitrogen(on gateway)	W01B002M06	pENTR221	22700		STMN2	11075	NP_008960.2	Hs.521651	Stathmin-like 2						NM_007029.2	NP_008960.2	PROVISIONAL	C	1.000	1.000	179	540	1	537	179	1	179
Invitrogen	NM_153706	IOH22427	Invitrogen(on gateway)	W01B002M07	pENTR221	18904		C5orf35	133383	NP_714917.1	Hs.85950	Chromosome 5 open reading frame 35						NM_153706.2	NP_714917.1	PREDICTED	C	1.000	1.000	299	900	1	897	299	1	299
Invitrogen	NM_152552	IOH22758	Invitrogen(on gateway)	W01B002M08	pENTR221	20674		SAMD3	154075	NP_689765.2	Hs.440508	Sterile alpha motif domain containing 3						NM_152552.2	NP_689765.2	VALIDATED	Cs	0.995	0.995	221	666	1	663	221	1	221
Invitrogen	NM_000377	IOH13659	Invitrogen(on gateway)	W01B002M09	pENTR221	24833		WAS	7454	NP_000368.1	Hs.2157	Wiskott-Aldrich syndrome (eczema-thrombocytopenia)						NM_000377.2	NP_000368.1	REVIEWED	C	1.000	1.000	502	1509	1	1506	502	1	502
Invitrogen	ENST00000317882	IOH23158	Invitrogen(on gateway)	W01B002M10	pENTR221	982		LOC653160	653160	ENSP00000323567								XM_945233.2	XP_950326.2	MODEL										
Invitrogen	NM_002960	IOH11798	Invitrogen(on gateway)	W01B002M11	pENTR221	2177		S100A3	6274	NP_002951.1	Hs.557609	S100 calcium binding protein A3						NM_002960.1	NP_002951.1	REVIEWED	C	1.000	1.000	101	306	1	303	101	1	101
Invitrogen	NM_144661	IOH11200	Invitrogen(on gateway)	W01B002M12	pENTR221	3414		C10orf82	143379	NP_653262.1	Hs.121347	Chromosome 10 open reading frame 82						NM_144661.2	NP_653262.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
Invitrogen	ENST00000329097	IOH10767	Invitrogen(on gateway)	W01B002M13	pENTR221	28136				ENSP00000333257										
Invitrogen	NM_032490	IOH11134	Invitrogen(on gateway)	W01B002M14	pENTR221	7436		C14orf142	84520	NP_115879.2	Hs.20142	Chromosome 14 open reading frame 142						NM_032490.4	NP_115879.2	VALIDATED		0.615	0.667	13	216	120	85	100	47	59
Invitrogen	NM_020186	IOH13136	Invitrogen(on gateway)	W01B002M15	pENTR221	21189		ACN9	57001	NP_064571.1	Hs.592269	ACN9 homolog (S. cerevisiae)						NM_020186.2	NP_064571.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
Invitrogen	BC029799	IOH22727	Invitrogen(on gateway)	W01B002M16	pENTR221	24678		DMRTC1B	728656	AAH29799	Hs.712728	DMRT-like family C1B						NM_001080851.1	NP_001074320.1	VALIDATED	P	1.000	1.000	107	333	1	321	192	1	107
Invitrogen	NM_153645	IOH11663	Invitrogen(on gateway)	W01B002M17	pENTR221	15561		NUP50	10762	NP_705931.1	Hs.715672	Nucleoporin 50kDa						NM_153645.2	NP_705931.1	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
Invitrogen	NM_031275	IOH22570	Invitrogen(on gateway)	W01B002M18	pENTR221	3838		TEX12	56158	NP_112565.1	Hs.524039	Testis expressed 12						NM_031275.4	NP_112565.1	REVIEWED	C	1.000	1.000	123	372	1	369	123	1	123
Invitrogen	NM_138439	IOH13426	Invitrogen(on gateway)	W01B002M19	pENTR221	8925		FLYWCH2	114984	NP_612448.1	Hs.534525	FLYWCH family member 2						NM_001142500.1	NP_001135972.1	VALIDATED	C	1.000	1.000	140	423	1	420	140	1	140
Invitrogen	NM_000020	IOH21048	Invitrogen(on gateway)	W01B002M20	pENTR221	5633		ACVRL1	94	NP_000011.2	Hs.591026	Activin A receptor type II-like 1						NM_001077401.1	NP_001070869.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
Invitrogen	NM_024114	IOH5233	Invitrogen(on gateway)	W01B002M21	pENTR221	3875		TRIM48	79097	NP_077019.2	Hs.195715	Tripartite motif-containing 48						NM_024114.3	NP_077019.2	VALIDATED	P	1.000	1.000	208	627	1	624	224	17	224
Invitrogen	NM_002963	IOH22174	Invitrogen(on gateway)	W01B002M22	pENTR221	2201		S100A7	6278	NP_002954.2	Hs.112408	S100 calcium binding protein A7						NM_002963.3	NP_002954.2	REVIEWED	Cs	0.990	0.990	101	306	1	303	101	1	101
Invitrogen	NM_006272	IOH4935	Invitrogen(on gateway)	W01B002M23	pENTR221	15430		S100B	6285	NP_006263.1	Hs.422181	S100 calcium binding protein B						NM_006272.2	NP_006263.1	REVIEWED	C	1.000	1.000	92	279	1	276	92	1	92
Invitrogen	BC020726	IOH12969	Invitrogen(on gateway)	W01B002M24	pENTR221	6457		SCEL	8796	AAH20726.1	Hs.534699	Sciellin						NM_003843.3	NP_003834.3	VALIDATED	Pgs	0.922	0.996	306	852	1	849	668	1	306
Invitrogen	BC021731	IOH11062	Invitrogen(on gateway)	W01B002N01	pENTR221	18241		SPATA4	132851	AAH21731.1	Hs.481235	Spermatogenesis associated 4						NM_144644.2	NP_653245.2	PROVISIONAL	Cs	0.997	0.997	305	918	1	915	305	1	305
Invitrogen	BC005164	IOH5187	Invitrogen(on gateway)	W01B002N02	pENTR221	7731		AEN	64782	AAH05164.1	Hs.436102	Apoptosis enhancing nuclease						NM_022767.3	NP_073604.3	VALIDATED	Pgs	0.987	0.997	308	984	1	924	325	1	305
Invitrogen	BC029272	IOH22856	Invitrogen(on gateway)	W01B002N03	pENTR221	23963		ASTN2	23245	AAH29272.1	Hs.601562	Astrotactin 2						NM_198188.1	NP_937831.1	VALIDATED	Ps	0.997	0.997	385	1323	148	1302	395	1	385
Invitrogen	BC019247	IOH11023	Invitrogen(on gateway)	W01B002N04	pENTR221	24290		SPAG8	26206	AAH19247.1	Hs.256747	Sperm associated antigen 8						NM_172312.1	NP_758516.1	REVIEWED	Cs	0.996	0.996	501	1506	1	1503	501	1	501
Invitrogen	NM_013328	IOH11728	Invitrogen(on gateway)	W01B002N05	pENTR221	1603		PYCR2	29920	NP_037460.2	Hs.654718	Pyrroline-5-carboxylate reductase family, member 2						NM_013328.2	NP_037460.2	PROVISIONAL	C	1.000	1.000	320	963	1	960	320	1	320
Invitrogen	BC038715	IOH27716	Invitrogen(on gateway)	W01B002N06	pENTR221	12592		PCP2	126006	AAH38715.2	Hs.591400	Purkinje cell protein 2						NM_174895.1	NP_777555.1	PROVISIONAL	P	1.000	1.000	99	300	1	297	136	38	136
Invitrogen	NM_004357	IOH3965	Invitrogen(on gateway)	W01B002N07	pENTR221	3756		CD151	977	NP_004348.2	Hs.654379	CD151 molecule (Raph blood group)						NM_001039490.1	NP_001034579.1	REVIEWED	C	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	BC040592	IOH27725	Invitrogen(on gateway)	W01B002N08	pENTR221	18690		TSLP	85480	AAH40592.1	Hs.389874	Thymic stromal lymphopoietin						NM_138551.3	NP_612561.2	REVIEWED	C	1.000	1.000	63	480	289	477	63	1	63
Invitrogen	NM_001016	IOH14179	Invitrogen(on gateway)	W01B002N09	pENTR221	19909		RPS12	6206	NP_001007.2	Hs.546289	Ribosomal protein S12						NM_001016.3	NP_001007.2	REVIEWED	C	1.000	1.000	132	399	1	396	132	1	132
Invitrogen	BC034972	IOH26829	Invitrogen(on gateway)	W01B002N10	pENTR221	708		C1orf49	84066	AAH34972.1	Hs.534501	Chromosome 1 open reading frame 49						NM_032126.3	NP_115502.1	PREDICTED	Pgs	0.956	0.995	204	648	1	612	233	1	196
Invitrogen	NM_001017998	IOH14377	Invitrogen(on gateway)	W01B002N11	pENTR221	4891		GNG10	2790	NP_001017998.1	Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED	C	1.000	1.000	68	1074	27	230	68	1	68
Invitrogen	NM_002109	IOH13898	Invitrogen(on gateway)	W01B002N12	pENTR221	19289		HARS	3035	NP_002100.2	Hs.528050	Histidyl-tRNA synthetase						NM_002109.3	NP_002100.2	REVIEWED	C	1.000	1.000	509	1530	1	1527	509	1	509
Invitrogen	NM_182488	IOH10698	Invitrogen(on gateway)	W01B002N13	pENTR221	6681		USP12	219333	NP_872294.1	Hs.42400	Ubiquitin specific peptidase 12						NM_182488.2	NP_872294.1	PROVISIONAL	C	1.000	1.000	370	1113	1	1110	370	1	370
Invitrogen	ENST00000325756	IOH28454	Invitrogen(on gateway)	W01B002N14	pENTR221	1067		OR6K6	128371	ENSP00000321329	Hs.553591	Olfactory receptor, family 6, subfamily K, member 6						NM_001005184.1	NP_001005184.1	PROVISIONAL	P	1.000	1.000	319	960	1	957	343	25	343
Invitrogen	NM_005954	IOH10247	Invitrogen(on gateway)	W01B002N15	pENTR221	8924		MT3	4504	NP_005945.1	Hs.73133	Metallothionein 3						NM_005954.2	NP_005945.1	VALIDATED	C	1.000	1.000	68	207	1	204	68	1	68
Invitrogen	NM_001001827	IOH28575	Invitrogen(on gateway)	W01B002N16	pENTR221	2270		OR2T35	403244	NP_001001827.1	Hs.534846	Olfactory receptor, family 2, subfamily T, member 35						NM_001001827.1	NP_001001827.1	PROVISIONAL	OK	1.000	1.000	323	972	1	969	323	1	323
Invitrogen	BC005245	IOH7172	Invitrogen(on gateway)	W01B002N17	pENTR221	987		HSPB11	51668	AAH05245.1	Hs.624686	Heat shock protein family B (small), member 11						NM_016126.2	NP_057210.2	PROVISIONAL	C	1.000	1.000	144	435	1	432	144	1	144
Invitrogen	NM_015051	IOH7179	Invitrogen(on gateway)	W01B002N18	pENTR221	23958		ERP44	23071	NP_055866.1	Hs.154023	Endoplasmic reticulum protein 44						NM_015051.1	NP_055866.1	VALIDATED	C	1.000	1.000	406	1221	1	1218	406	1	406
Invitrogen	NM_006600	IOH5147	Invitrogen(on gateway)	W01B002N19	pENTR221	82		NUDC	10726	NP_006591.1	Hs.263812	Nuclear distribution gene C homolog (A. nidulans)						NM_006600.2	NP_006591.1	PROVISIONAL	OK	1.000	1.000	331	996	1	993	331	1	331
Invitrogen	NM_020319	IOH27320	Invitrogen(on gateway)	W01B002N20	pENTR221	22001		ANKMY2	57037	NP_064715.1	Hs.157378	Ankyrin repeat and MYND domain containing 2						NM_020319.1	NP_064715.1	PROVISIONAL	C	1.000	1.000	441	1326	1	1323	441	1	441
Invitrogen	NM_019101	IOH12125	Invitrogen(on gateway)	W01B002N21	pENTR221	19806		APOM	55937	NP_061974.2	Hs.534468	Apolipoprotein M						NM_019101.2	NP_061974.2	REVIEWED	C	1.000	1.000	188	567	1	564	188	1	188
Invitrogen	NM_000167	IOH27543	Invitrogen(on gateway)	W01B002N22	pENTR221	24854		GK	2710	NP_000158.1	Hs.1466	Glycerol kinase						NM_000167.4	NP_000158.1	REVIEWED	C	1.000	1.000	524	1575	1	1572	524	1	524
Invitrogen	NM_152499	IOH21862	Invitrogen(on gateway)	W01B002N23	pENTR221	706		CCDC24	149473	NP_689712.1	Hs.632394	Coiled-coil domain containing 24						NM_152499.1	NP_689712.1	PROVISIONAL	C	1.000	1.000	307	924	1	921	307	1	307
Invitrogen	ENST00000315425	IOH25759	Invitrogen(on gateway)	W01B002N24	pENTR221	14021		TMEM185B	79134	ENSP00000314309	Hs.376722	Transmembrane protein 185B (pseudogene)								
Invitrogen	NM_080423	IOH23012	Invitrogen(on gateway)	W01B002O01	pENTR221	11183		PTPN2	5771	NP_536348.1	Hs.654527	Protein tyrosine phosphatase, non-receptor type 2						NM_080423.1	NP_536348.1	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
Invitrogen	BC018206	IOH10533	Invitrogen(on gateway)	W01B002O02	pENTR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A						NM_001085365.1	NP_001078834.1	VALIDATED	P	1.000	1.000	121	366	1	363	158	38	158
Invitrogen	NM_147194	IOH22655	Invitrogen(on gateway)	W01B002O03	pENTR221	21294		FAM185A	222234	NP_671727	Hs.202543	Family with sequence similarity 185, member A						NM_001145269.1	NP_001138741.1	VALIDATED	P	1.000	1.000	70	435	1	210	275	1	70
Invitrogen	NM_001017929	IOH22805	Invitrogen(on gateway)	W01B002O04	pENTR221	3355		FRMPD2	143162	NP_001017929.1	Hs.664786	FERM and PDZ domain containing 2						NM_001017929.2	NP_001017929.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
Invitrogen	BC030585	IOH22261	Invitrogen(on gateway)	W01B002O05	pENTR221	2664		SPAG6	9576	AAH30585.1	Hs.655170	Sperm associated antigen 6						NM_172242.1	NP_758442.1	REVIEWED	Cs	0.993	0.993	458	1377	1	1374	458	1	458
Invitrogen	BC031674	IOH22857	Invitrogen(on gateway)	W01B002O06	pENTR221	14734		C20orf26	26074	AAH31674.1	Hs.176013	Chromosome 20 open reading frame 26						NM_015585.2	NP_056400.2	PREDICTED	Ps	0.995	0.995	190	603	1	570	1237	645	834
Invitrogen	NM_182581	IOH22428	Invitrogen(on gateway)	W01B002O07	pENTR221	2114		C1orf111	284680	NP_872387.2	Hs.97784	Chromosome 1 open reading frame 111						NM_182581.3	NP_872387.2	VALIDATED	Cs	0.992	0.992	261	786	1	783	261	1	261
Invitrogen	NM_176812	IOH21812	Invitrogen(on gateway)	W01B002O08	pENTR221	14580		CHMP4B	128866	NP_789782.1	Hs.472471	Chromatin modifying protein 4B						NM_176812.3	NP_789782.1	VALIDATED	C	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	NM_173541	IOH21426	Invitrogen(on gateway)	W01B002O09	pENTR221	2912		C10orf91	170393	NP_775812.1	Hs.375059	Chromosome 10 open reading frame 91						NM_173541.2	NP_775812.1	VALIDATED	C	1.000	1.000	145	438	1	435	145	1	145
Invitrogen	BC029785	IOH22702	Invitrogen(on gateway)	W01B002O10	pENTR221	2028		FLJ42875	440556	AAH29785	Hs.531041	Hypothetical LOC440556						XM_932794.1	XP_937887.1	MODEL										
Invitrogen	BC022003	IOH11205	Invitrogen(on gateway)	W01B002O11	pENTR221	22542		MTMR9	66036	AAH22003.1	Hs.591395	Myotubularin related protein 9						NM_015458.3	NP_056273.2	REVIEWED	Cs	0.998	0.998	549	1650	1	1647	549	1	549
Invitrogen	NM_006304	IOH21799	Invitrogen(on gateway)	W01B002O12	pENTR221	22173		SHFM1	7979	NP_006295.1	Hs.489201	Split hand/foot malformation (ectrodactyly) type 1						NM_006304.1	NP_006295.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
Invitrogen	NM_198076	IOH10796	Invitrogen(on gateway)	W01B002O13	pENTR221	331		FAM36A	116228	NP_932342.1	Hs.715571	Family with sequence similarity 36, member A						NM_198076.4	NP_932342.1	VALIDATED	C	1.000	1.000	118	357	1	354	118	1	118
Invitrogen	NM_005031	IOH21828	Invitrogen(on gateway)	W01B002O14	pENTR221	11966		FXYD1	5348	NP_005022.2	Hs.442498	FXYD domain containing ion transport regulator 1						NM_021902.2	NP_068702.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
Invitrogen	NM_001001701	IOH13306	Invitrogen(on gateway)	W01B002O15	pENTR221	18066		C4orf3	401152	NP_001001701.2	Hs.718451	Chromosome 4 open reading frame 3						NM_001001701.3	NP_001001701.2	VALIDATED	Cs	0.985	0.985	66	201	1	198	66	1	66
Invitrogen	ENST00000344607	IOH22749	Invitrogen(on gateway)	W01B002O16	pENTR221															
Invitrogen	NM_015938	IOH12752	Invitrogen(on gateway)	W01B002O17	pENTR221	16261		NMD3	51068	NP_057022.2	Hs.598836	NMD3 homolog (S. cerevisiae)						NM_015938.3	NP_057022.2	PROVISIONAL	C	1.000	1.000	503	1512	1	1509	503	1	503
Invitrogen	NM_001443	IOH21849	Invitrogen(on gateway)	W01B002O18	pENTR221	14279		FABP1	2168	NP_001434.1	Hs.380135	Fatty acid binding protein 1, liver						NM_001443.1	NP_001434.1	REVIEWED	C	1.000	1.000	127	384	1	381	127	1	127
Invitrogen	NM_015193	IOH13023	Invitrogen(on gateway)	W01B002O19	pENTR221	23044		ARC	23237	NP_056008.1	Hs.40888	Activity-regulated cytoskeleton-associated protein						NM_015193.3	NP_056008.1	VALIDATED	C	1.000	1.000	396	1191	1	1188	396	1	396
Invitrogen	ENST00000009606	IOH21412	Invitrogen(on gateway)	W01B002O20	pENTR221	20331		C6orf174	387104	ENSP00000009606	Hs.319247	Chromosome 6 open reading frame 174						NM_001012279.1	NP_001012279.1	VALIDATED		0.258	0.262	66	1734	154	348	947	354	419
Invitrogen	NM_024684	IOH5351	Invitrogen(on gateway)	W01B002O21	pENTR221	3788		C11orf67	28971	NP_078960.1	Hs.503357	Chromosome 11 open reading frame 67						NM_024684.2	NP_078960.1	PREDICTED	C	1.000	1.000	122	369	1	366	122	1	122
Invitrogen	NM_182615	IOH21533	Invitrogen(on gateway)	W01B002O22	pENTR221	4		TRDV2	28517	NP_872421										
Invitrogen	NM_002014	IOH4908	Invitrogen(on gateway)	W01B002O23	pENTR221	5568		FKBP4	2288	NP_002005.1	Hs.524183	FK506 binding protein 4, 59kDa						NM_002014.3	NP_002005.1	REVIEWED	OK	1.000	1.000	459	1380	1	1377	459	1	459
Invitrogen	NM_018527	IOH21729	Invitrogen(on gateway)	W01B002O24	pENTR221	6508		NARG1L	79612	NP_060997.2	Hs.512914	NMDA receptor regulated 1-like						NM_018527.2	NP_060997.2	VALIDATED	C	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	NM_018509	IOH10008	Invitrogen(on gateway)	W01B002P01	pENTR221	10384		LRRC59	55379	NP_060979.2	Hs.370927	Leucine rich repeat containing 59						NM_018509.2	NP_060979.2	PROVISIONAL	C	1.000	1.000	307	924	1	921	307	1	307
Invitrogen	NM_178525	IOH10984	Invitrogen(on gateway)	W01B002P02	pENTR221	12630		ACTL9	284382	NP_848620.2	Hs.209206	Hypothetical protein MGC33407						NM_178525.3	NP_848620.2	VALIDATED	Cs	0.993	0.993	416	1251	1	1248	416	1	416
Invitrogen	BC026185	IOH10939	Invitrogen(on gateway)	W01B002P03	pENTR221	394		SCCPDH	51097	AAH26185.1	Hs.498397	Saccharopine dehydrogenase (putative)						NM_016002.2	NP_057086.2	VALIDATED	Cs	0.995	0.995	429	1290	1	1287	429	1	429
Invitrogen	NM_198289	IOH22361	Invitrogen(on gateway)	W01B002P04	pENTR221	10979		CIDEA	1149	NP_938031.1	Hs.249129	Cell death-inducing DFFA-like effector a						NM_198289.2	NP_938031.1	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	BC005218	IOH7254	Invitrogen(on gateway)	W01B002P05	pENTR221	18542		MAT2B	27430	AAH05218.1	Hs.54642	Methionine adenosyltransferase II, beta						NM_182796.1	NP_877725.1	REVIEWED	Cs	0.997	0.997	323	972	1	969	323	1	323
Invitrogen	NM_001477	IOH27363	Invitrogen(on gateway)	W01B002P06	pENTR221	24586		GAGE12I	26748	NP_001468.1								NM_001477.1	NP_001468.1	REVIEWED	C	1.000	1.000	117	354	1	351	117	1	117
Invitrogen	NM_145006	IOH10868	Invitrogen(on gateway)	W01B002P07	pENTR221	23722		SUSD3	203328	NP_659443.1	Hs.88417	Sushi domain containing 3						NM_145006.2	NP_659443.1	PROVISIONAL	C	1.000	1.000	255	768	1	765	255	1	255
Invitrogen	NM_001004344	IOH25855	Invitrogen(on gateway)	W01B002P08	pENTR221	14808		MGC44328	440757	NP_001004344	Hs.120399	Hypothetical gene supported by BC033985																		
Invitrogen	NM_005324	IOH5791	Invitrogen(on gateway)	W01B002P09	pENTR221	10413		H3F3B	3021	NP_005315.1	Hs.180877	H3 histone, family 3B (H3.3B)						NM_005324.3	NP_005315.1	REVIEWED	C	1.000	1.000	136	411	1	408	136	1	136
Invitrogen	BC035224	IOH27454	Invitrogen(on gateway)	W01B002P10	pENTR221	18212		CCDC158	339965	AAH35224	Hs.529680	Coiled-coil domain containing 158						NM_001042784.1	NP_001036249.1	VALIDATED	Pfs	1.000	1.000	226	678	1	677	1113	1	226
Invitrogen	BC013775	IOH21487	Invitrogen(on gateway)	W01B002P11	pENTR221	17612		C4orf42	92070	AAH13775.1	Hs.646099	Chromosome 4 open reading frame 42						NM_052861.2	NP_443093.2	VALIDATED		0.323	0.333	31	276	94	5	186	15	45
Invitrogen	NM_006038	IOH14383	Invitrogen(on gateway)	W01B002P12	pENTR221	14874		SPATA2	9825	NP_006029.1	Hs.48513	Spermatogenesis associated 2						NM_006038.3	NP_006029.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
Invitrogen	NM_002243	IOH13007	Invitrogen(on gateway)	W01B002P13	pENTR221	15275		KCNJ15	3772	NP_002234.2	Hs.411299	Potassium inwardly-rectifying channel, subfamily J, member 15						NM_170736.1	NP_733932.1	REVIEWED	C	1.000	1.000	375	1128	1	1125	375	1	375
Invitrogen	NM_001005185	IOH28455	Invitrogen(on gateway)	W01B002P14	pENTR221	2286		OR6N1	128372	NP_001005185.1	Hs.553592	Olfactory receptor, family 6, subfamily N, member 1						NM_001005185.1	NP_001005185.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	BC009779	IOH12227	Invitrogen(on gateway)	W01B002P15	pENTR221	1416		ODF2L	57489	AAH09779.1	Hs.149360	Outer dense fiber of sperm tails 2-like						NM_020729.1	NP_065780.1	VALIDATED	Pg	0.655	1.000	113	231	1	222	644	132	244
Invitrogen	NM_001001824	IOH28576	Invitrogen(on gateway)	W01B002P16	pENTR221	2269		OR2T27	403239	NP_001001824.1	Hs.553814	Olfactory receptor, family 2, subfamily T, member 27						NM_001001824.1	NP_001001824.1	PROVISIONAL	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	BC004368	IOH5600	Invitrogen(on gateway)	W01B002P17	pENTR221	7493		PSME2	5721	AAH04368.1	Hs.512410	Proteasome (prosome, macropain) activator subunit 2 (PA28 beta)						NM_002818.2	NP_002809.2	REVIEWED	Cs	0.996	0.996	239	720	1	717	239	1	239
Invitrogen	ENST00000296461	IOH26805	Invitrogen(on gateway)	W01B002P18	pENTR221	17424		INTU	27152	ENSP00000296461	Hs.391481	Inturned planar cell polarity effector homolog (Drosophila)						NM_015693.2	NP_056508.2	PROVISIONAL	Ps	0.995	0.995	398	1227	1	1194	942	1	398
Invitrogen	NM_004881	IOH3658	Invitrogen(on gateway)	W01B002P19	pENTR221	13879		TP53I3	9540	NP_004872.2	Hs.50649	Tumor protein p53 inducible protein 3						NM_004881.2	NP_004872.2	REVIEWED	C	1.000	1.000	332	999	1	996	332	1	332
Invitrogen	NM_173830	IOH25799	Invitrogen(on gateway)	W01B002P20	pENTR221	19979		C6orf182	285753	NP_776191.1	Hs.632616	Chromosome 6 open reading frame 182						NM_173830.4	NP_776191.1	VALIDATED	C	1.000	1.000	460	1383	1	1380	460	1	460
Invitrogen	NM_001013	IOH5840	Invitrogen(on gateway)	W01B002P21	pENTR221	11425		RPS9	6203	NP_001004.2	Hs.546288	Ribosomal protein S9						NM_001013.3	NP_001004.2	REVIEWED	C	1.000	1.000	194	585	1	582	194	1	194
Invitrogen	BC043256	IOH25859	Invitrogen(on gateway)	W01B002P22	pENTR221	2830		C10orf78	119392	AAH43256	Hs.93667	Chromosome 10 open reading frame 78						NM_145247.4	NP_660290.3	VALIDATED	C	1.000	1.000	232	924	226	921	232	1	232
Invitrogen	BC029245	IOH22746	Invitrogen(on gateway)	W01B002P23	pENTR221	5507		LRRC43	254050	AAH29245.1	Hs.374856	Leucine rich repeat containing 43						NM_152759.4	NP_689972.3	VALIDATED	C	1.000	1.000	471	1416	1	1413	471	1	471
Invitrogen	BC039306	IOH27482	Invitrogen(on gateway)	W01B002P24	pENTR221	23449		PALM2	114299	AAH39306.2								NM_001037293.1	NP_001032370.1	VALIDATED	Cs	0.997	0.997	379	1140	1	1137	379	1	379
Invitrogen	ENST00000290426	IOH28334	Invitrogen(on gateway)	W01B003A01	pENTR221	18929		NPY6R	4888	ENSP00000290426	Hs.713225	Neuropeptide Y receptor Y6 (pseudogene)								
Invitrogen	BC046129	IOH26911	Invitrogen(on gateway)	W01B003A02	pENTR221	17561		GALNT7	51809	AAH46129.1	Hs.548088	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7 (GalNAc-T7)						NM_017423.2	NP_059119.2	REVIEWED	C	1.000	1.000	657	1974	1	1971	657	1	657
Invitrogen	NM_001003745	IOH28192	Invitrogen(on gateway)	W01B003A03	pENTR221	4958		OR10A3	26496	NP_001003745.1	Hs.381322	Olfactory receptor, family 10, subfamily A, member 3						NM_001003745.1	NP_001003745.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	Q8NGN8	IOH28260	Invitrogen(on gateway)	W01B003A04	pENTR221															
Invitrogen	NM_001005470	IOH28230	Invitrogen(on gateway)	W01B003A05	pENTR221	4247		OR4B1	119765	NP_001005470.1	Hs.553566	Olfactory receptor, family 4, subfamily B, member 1						NM_001005470.1	NP_001005470.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
Invitrogen	ENST00000359776	IOH28285	Invitrogen(on gateway)	W01B003A06	pENTR221	16612		OR5H6	79295	ENSP00000352823	Hs.554712	Olfactory receptor, family 5, subfamily H, member 6						NM_001005479.1	NP_001005479.1	PROVISIONAL	P	1.000	1.000	309	930	1	927	325	17	325
Invitrogen	ENST00000305456	IOH28205	Invitrogen(on gateway)	W01B003A07	pENTR221	12759		OR7G2	390882	ENSP00000303822	Hs.553774	Olfactory receptor, family 7, subfamily G, member 2						NM_001005193.1	NP_001005193.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	345	22	345
Invitrogen	BC015130	IOH27871	Invitrogen(on gateway)	W01B003A08	pENTR221	22047		CYCS	54205	AAH15130.1	Hs.617193	Cytochrome c, somatic						NM_018947.4	NP_061820.1	REVIEWED	Cs	0.990	0.990	105	318	1	315	105	1	105
Invitrogen	NM_175085	IOH26153	Invitrogen(on gateway)	W01B003A09	pENTR221	15353		GART	2618	NP_780294.1	Hs.473648	Phosphoribosylglycinamide formyltransferase, phosphoribosylglycinamide synthetase, phosphoribosylaminoimidazole synthetase						NM_175085.2	NP_780294.1	REVIEWED	C	1.000	1.000	433	1302	1	1299	433	1	433
Invitrogen	NM_005742	IOH3098	Invitrogen(on gateway)	W01B003A10	pENTR221	7159		PDIA6	10130	NP_005733.1	Hs.212102	Protein disulfide isomerase family A, member 6						NM_005742.2	NP_005733.1	VALIDATED	C	1.000	1.000	440	1323	1	1320	440	1	440
Invitrogen	BC044585	IOH26894	Invitrogen(on gateway)	W01B003A11	pENTR221	23970		ROD1	9991	AAH44585.1	Hs.269988	ROD1 regulator of differentiation 1 (S. pombe)						NM_005156.4	NP_005147.3	VALIDATED	Ps	0.998	0.998	539	1677	58	1674	552	14	552
Invitrogen	NM_001004461	IOH28513	Invitrogen(on gateway)	W01B003A12	pENTR221	4969		OR10A6	390093	NP_001004461.1	Hs.528593	Olfactory receptor, family 10, subfamily A, member 6						NM_001004461.1	NP_001004461.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_000662	IOH26700	Invitrogen(on gateway)	W01B003A13	pENTR221	22631		NAT1	9	NP_000653.3	Hs.591847	N-acetyltransferase 1 (arylamine N-acetyltransferase)						NM_001160170.1	NP_001153642.1	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
Invitrogen	NM_002629	IOH13682	Invitrogen(on gateway)	W01B003A14	pENTR221	2845		PGAM1	5223	NP_002620.1	Hs.632918	Phosphoglycerate mutase 1 (brain)						NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
Invitrogen	NM_001008215	IOH26651	Invitrogen(on gateway)	W01B003A15	pENTR221	13736		C2orf64	493753	NP_001008216.1	Hs.596537	Chromosome 2 open reading frame 64						NM_001008215.1	NP_001008216.1	PREDICTED	C	1.000	1.000	74	225	1	222	74	1	74
Invitrogen	ENST00000270133	IOH28342	Invitrogen(on gateway)	W01B003A16	pENTR221	34303														
Invitrogen	ENST00000360376	IOH26929	Invitrogen(on gateway)	W01B003A17	pENTR221															
Invitrogen	NM_001004719	IOH28571	Invitrogen(on gateway)	W01B003A18	pENTR221	7898		OR4M2	390538	NP_001004719.1	Hs.709063	Olfactory receptor, family 4, subfamily M, member 2						NM_001004719.1	NP_001004719.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	NM_005402	IOH26207	Invitrogen(on gateway)	W01B003A19	pENTR221	21140		RALA	5898	NP_005393.2	Hs.6906	V-ral simian leukemia viral oncogene homolog A (ras related)						NM_005402.2	NP_005393.2	REVIEWED	C	1.000	1.000	206	621	1	618	206	1	206
Invitrogen	NM_001005181	IOH28535	Invitrogen(on gateway)	W01B003A20	pENTR221	4234		OR56B4	196335	NP_001005181.1	Hs.632154	Olfactory receptor, family 56, subfamily B, member 4						NM_001005181.1	NP_001005181.1	PROVISIONAL	C	1.000	1.000	319	960	1	957	319	1	319
Invitrogen	BC023006	IOH22358	Invitrogen(on gateway)	W01B003A21	pENTR221	7388		HSP90AA1	3320	AAH23006.2	Hs.525600	Heat shock protein 90kDa alpha (cytosolic), class A member 1						NM_001017963.2	NP_001017963.2	VALIDATED	P	1.000	1.000	635	1908	1	1905	854	220	854
Invitrogen	NM_001005325	IOH28254	Invitrogen(on gateway)	W01B003A22	pENTR221	5011		OR6M1	390261	NP_001005325.1	Hs.557924	Olfactory receptor, family 6, subfamily M, member 1						NM_001005325.1	NP_001005325.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	BC032129	IOH27947	Invitrogen(on gateway)	W01B003A23	pENTR221	9105		RPS2	6187	AAH32129.1	Hs.709308	Ribosomal protein S2						NM_002952.3	NP_002943.2	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
Invitrogen	BC006530	IOH29310	Invitrogen(on gateway)	W01B003A24	pENTR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33																		
Invitrogen	NM_015350	IOH26836	Invitrogen(on gateway)	W01B003B01	pENTR221	480		LRRC8B	23507	NP_056165.1	Hs.632420	Leucine rich repeat containing 8 family, member B						NM_001134476.1	NP_001127948.1	VALIDATED	C	1.000	1.000	803	2412	1	2409	803	1	803
Invitrogen	NM_152397	IOH21608	Invitrogen(on gateway)	W01B003B02	pENTR221	17141		IQCF1	132141	NP_689610.2	Hs.671210	IQ motif containing F1						NM_152397.2	NP_689610.2	VALIDATED	Cs	0.995	0.995	205	618	1	615	205	1	205
Invitrogen	NM_001008394	IOH11844	Invitrogen(on gateway)	W01B003B03	pENTR221	5501		EID3	493861	NP_001008395.1	Hs.659857	EP300 interacting inhibitor of differentiation 3						NM_001008394.1	NP_001008395.1	PROVISIONAL	C	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	BC017941	IOH13654	Invitrogen(on gateway)	W01B003B04	pENTR221	13494		CHAC2	494143	AAH17941.1	Hs.585944	ChaC, cation transport regulator homolog 2 (E. coli)						NM_001008708.2	NP_001008708.1	PROVISIONAL	Cs	0.995	0.995	184	555	1	552	184	1	184
Invitrogen	NM_012305	IOH6598	Invitrogen(on gateway)	W01B003B05	pENTR221	3607		AP2A2	161	NP_036437.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit						NM_012305.2	NP_036437.1	VALIDATED	OK	1.000	1.000	939	2820	1	2817	939	1	939
Invitrogen	NM_001086	IOH2181	Invitrogen(on gateway)	W01B003B06	pENTR221	16557		AADAC	13	NP_001077.2	Hs.506908	Arylacetamide deacetylase (esterase)						NM_001086.2	NP_001077.2	REVIEWED	Cs	0.987	0.987	399	1200	1	1197	399	1	399
Invitrogen	BC057816	IOH29218	Invitrogen(on gateway)	W01B003B07	pENTR221	12471		LYPD5	284348	AAH57816.2	Hs.44289	LY6/PLAUR domain containing 5						NM_182573.2	NP_872379.2	VALIDATED	Cs	0.995	0.995	208	750	124	747	208	1	208
Invitrogen	NM_017491	IOH3975	Invitrogen(on gateway)	W01B003B08	pENTR221	17954		WDR1	9948	NP_059830.1	Hs.128548	WD repeat domain 1						NM_017491.3	NP_059830.1	REVIEWED	C	1.000	1.000	606	1821	1	1818	606	1	606
Invitrogen	NM_001002913	IOH26561	Invitrogen(on gateway)	W01B003B09	pENTR221	24212		PTRH1	138428	NP_001002913.1	Hs.653265	Peptidyl-tRNA hydrolase 1 homolog (S. cerevisiae)						NM_001002913.1	NP_001002913.1	PROVISIONAL	C	1.000	1.000	214	645	1	642	214	1	214
Invitrogen	BC033159	IOH23223	Invitrogen(on gateway)	W01B003B10	pENTR221	1591		DNAJC8	22826	AAH33159.1	Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	C	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	NM_145170	IOH27151	Invitrogen(on gateway)	W01B003B11	pENTR221	3252		TTC18	118491	NP_660153.3	Hs.591367	Tetratricopeptide repeat domain 18						NM_145170.3	NP_660153.3	VALIDATED	Cs	0.999	0.999	1121	3366	1	3363	1121	1	1121
Invitrogen	NM_016623	IOH4532	Invitrogen(on gateway)	W01B003B12	pENTR221	23049		FAM49B	51571	NP_057707.3	Hs.126941	Family with sequence similarity 49, member B						NM_016623.3	NP_057707.3	PREDICTED	C	1.000	1.000	324	975	1	972	324	1	324
Invitrogen	BC014140	IOH12771	Invitrogen(on gateway)	W01B003B13	pENTR221	9119		BBS2	583	AAH14140.1	Hs.333738	Bardet-Biedl syndrome 2						NM_031885.3	NP_114091.3	REVIEWED	Cs	0.997	0.997	721	2166	1	2163	721	1	721
Invitrogen	NM_001004729	IOH28242	Invitrogen(on gateway)	W01B003B14	pENTR221	4208		OR5AN1	390195	NP_001004729.1	Hs.553755	Olfactory receptor, family 5, subfamily AN, member 1						NM_001004729.1	NP_001004729.1	PROVISIONAL	C	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	BC047578	IOH26427	Invitrogen(on gateway)	W01B003B15	pENTR221	14130		SESTD1	91404	AAH47578.1	Hs.30977	SEC14 and spectrin domains 1						NM_178123.4	NP_835224.3	VALIDATED	Cs	0.999	0.999	696	2091	1	2088	696	1	696
Invitrogen	BC016715	IOH27895	Invitrogen(on gateway)	W01B003B16	pENTR221	11580		FTL	2512	AAH16715.1	Hs.713706	Ferritin, light polypeptide						NM_000146.3	NP_000137.2	REVIEWED	Cs	0.994	0.994	175	528	1	525	175	1	175
Invitrogen	BC035608	IOH27578	Invitrogen(on gateway)	W01B003B17	pENTR221	7457		NID2	22795	AAH35608.1	Hs.369840	Nidogen 2 (osteonidogen)						NM_007361.3	NP_031387.3	VALIDATED	Ps	0.995	0.995	846	2910	370	2907	1375	530	1375
Invitrogen	BC024231	IOH12124	Invitrogen(on gateway)	W01B003B19	pENTR221	22159		MGC27345	157247	AAH24231.1	Hs.552129	Hypothetical protein MGC27345																		
Invitrogen	BC016645	IOH25785	Invitrogen(on gateway)	W01B003B21	pENTR221	23557		PSAT1	29968	AAH16645.1	Hs.494261	Phosphoserine aminotransferase 1						NM_058179.2	NP_478059.1	REVIEWED	Cs	0.997	0.997	370	1113	1	1110	370	1	370
Invitrogen	NM_021197	IOH22666	Invitrogen(on gateway)	W01B003B23	pENTR221	8687		WFDC1	58189	NP_067020.2	Hs.36688	WAP four-disulfide core domain 1						NM_021197.2	NP_067020.2	REVIEWED	C	1.000	1.000	220	663	1	660	220	1	220
Invitrogen	ENST00000319813	IOH28206	Invitrogen(on gateway)	W01B003C01	pENTR221	31879				ENSP00000321338										
Invitrogen	BC047083	IOH26543	Invitrogen(on gateway)	W01B003C02	pENTR221	6652		SPG20	23111	AAH47083.1	Hs.440414	Spastic paraplegia 20 (Troyer syndrome)						NM_001142294.1	NP_001135766.1	REVIEWED	Cs	0.997	0.997	666	2001	1	1998	666	1	666
Invitrogen	NM_001003750	IOH28514	Invitrogen(on gateway)	W01B003C03	pENTR221	4187		OR8I2	120586	NP_001003750.1	Hs.554524	Olfactory receptor, family 8, subfamily I, member 2						NM_001003750.1	NP_001003750.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	NM_001005237	IOH28247	Invitrogen(on gateway)	W01B003C04	pENTR221	5001		OR51G1	79324	NP_001005237.1	Hs.554541	Olfactory receptor, family 51, subfamily G, member 1						NM_001005237.1	NP_001005237.1	PROVISIONAL	C	1.000	1.000	321	966	1	963	321	1	321
Invitrogen	NM_001004726	IOH28307	Invitrogen(on gateway)	W01B003C05	pENTR221	4205		OR4X1	390113	NP_001004726.1	Hs.553742	Olfactory receptor, family 4, subfamily X, member 1						NM_001004726.1	NP_001004726.1	PROVISIONAL	C	1.000	1.000	305	918	1	915	305	1	305
Invitrogen	NM_001005197	IOH28255	Invitrogen(on gateway)	W01B003C06	pENTR221	4236		OR8D4	338662	NP_001005197.1	Hs.449688	Olfactory receptor, family 8, subfamily D, member 4						NM_001005197.1	NP_001005197.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_012364	IOH28152	Invitrogen(on gateway)	W01B003C07	pENTR221	23816		OR1Q1	158131	NP_036496.1	Hs.684864	Olfactory receptor, family 1, subfamily Q, member 1						NM_012364.1	NP_036496.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_002823	IOH27923	Invitrogen(on gateway)	W01B003C08	pENTR221	13188		PTMA	5757	NP_002814.3	Hs.459927	Prothymosin, alpha						NM_002823.4	NP_002814.3	VALIDATED	Cs	0.991	0.991	110	333	1	330	110	1	110
Invitrogen	NM_016004	IOH26290	Invitrogen(on gateway)	W01B003C09	pENTR221	14630		IFT52	51098	NP_057088.2	Hs.444332	Intraflagellar transport 52 homolog (Chlamydomonas)						NM_016004.2	NP_057088.2	VALIDATED	C	1.000	1.000	437	1314	1	1311	437	1	437
Invitrogen	BC008972	IOH3264	Invitrogen(on gateway)	W01B003C10	pENTR221	8699		CENPN	55839	AAH08972.1	Hs.55028	Centromere protein N						NM_001100624.1	NP_001094094.1	VALIDATED	C	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	NM_182756	IOH26877	Invitrogen(on gateway)	W01B003C11	pENTR221	13110		SPDYA	245711	NP_877433.2	Hs.511956	Speedy homolog A (Xenopus laevis)						NM_001008779.1	NP_001008779.1	VALIDATED	P	1.000	1.000	213	732	1	639	286	71	283
Invitrogen	NM_012373	IOH28414	Invitrogen(on gateway)	W01B003C12	pENTR221	10053		OR3A3	8392	NP_036505.1	Hs.532689	Olfactory receptor, family 3, subfamily A, member 3						NM_012373.1	NP_036505.1	PROVISIONAL	Cs	0.997	0.997	321	966	1	963	321	1	321
Invitrogen	BC050428	IOH26675	Invitrogen(on gateway)	W01B003C13	pENTR221	20461		KATNA1	11104	AAH50428.1	Hs.450175	Katanin p60 (ATPase-containing) subunit A 1						NM_007044.2	NP_008975.1	REVIEWED	Pg	0.802	1.000	383	936	1	921	491	1	383
Invitrogen	NM_014759	IOH22215	Invitrogen(on gateway)	W01B003C14	pENTR221	23182		PHYHIP	9796	NP_055574.3	Hs.334688	Phytanoyl-CoA 2-hydroxylase interacting protein						NM_014759.3	NP_055574.3	VALIDATED	Cs	0.988	0.988	330	993	1	990	330	1	330
Invitrogen	NM_016633	IOH26029	Invitrogen(on gateway)	W01B003C15	pENTR221	8667		ERAF	51327	NP_057717.1	Hs.274309	Erythroid associated factor						NM_016633.2	NP_057717.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
Invitrogen	NM_001005491	IOH28302	Invitrogen(on gateway)	W01B003C16	pENTR221	5016		OR10AG1	282770	NP_001005491.1	Hs.554525	Olfactory receptor, family 10, subfamily AG, member 1						NM_001005491.1	NP_001005491.1	PROVISIONAL	C	1.000	1.000	301	906	1	903	301	1	301
Invitrogen	BC048095	IOH26751	Invitrogen(on gateway)	W01B003C17	pENTR221	16112		HRASLS	57110	AAH48095.1	Hs.36761	HRAS-like suppressor						NM_020386.3	NP_065119.1	VALIDATED	Cs	0.994	0.994	168	507	1	504	168	1	168
Invitrogen	NM_001005469	IOH28306	Invitrogen(on gateway)	W01B003C18	pENTR221	5014		OR5B3	441608	NP_001005469.1	Hs.553826	Olfactory receptor, family 5, subfamily B, member 3						NM_001005469.1	NP_001005469.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_002787	IOH26683	Invitrogen(on gateway)	W01B003C19	pENTR221	22108		PSMA2	5683	NP_002778.1	Hs.333786	Proteasome (prosome, macropain) subunit, alpha type, 2						NM_002787.4	NP_002778.1	REVIEWED	C	1.000	1.000	234	705	1	702	234	1	234
Invitrogen	BC057243	IOH29436	Invitrogen(on gateway)	W01B003C20	pENTR221	16360		NAALADL2	254827	AAH57243.1	Hs.660010	N-acetylated alpha-linked acidic dipeptidase-like 2						NM_207015.2	NP_996898.2	VALIDATED	Ps	0.990	0.990	297	963	1	891	795	18	314
Invitrogen	NM_212552	IOH26443	Invitrogen(on gateway)	W01B003C21	pENTR221	14277		BOLA3	388962	NP_997717.2	Hs.61472	BolA homolog 3 (E. coli)						NM_212552.2	NP_997717.2	VALIDATED	P	1.000	1.000	68	207	1	204	107	1	68
Invitrogen	NM_001005226	IOH28438	Invitrogen(on gateway)	W01B003C22	pENTR221	20853		OR2B3	442184	NP_001005226.1	Hs.553835	Olfactory receptor, family 2, subfamily B, member 3						NM_001005226.2	NP_001005226.1	VALIDATED	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	BC016768	IOH27892	Invitrogen(on gateway)	W01B003C23	pENTR221	18526		NPM1	4869	AAH16768.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)						NM_002520.5	NP_002511.1	VALIDATED	Cs	0.993	0.993	294	885	1	882	294	1	294
Invitrogen	NM_000929	IOH28759	Invitrogen(on gateway)	W01B003C24	pENTR221	748		PLA2G5	5322	NP_000920.1	Hs.319438	Phospholipase A2, group V						NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
Invitrogen	NM_003567	IOH26171	Invitrogen(on gateway)	W01B003D01	pENTR221	1628		BCAR3	8412	NP_003558.1	Hs.36958	Breast cancer anti-estrogen resistance 3						NM_003567.2	NP_003558.1	REVIEWED	C	1.000	1.000	825	2478	1	2475	825	1	825
Invitrogen	NM_152318	IOH21631	Invitrogen(on gateway)	W01B003D02	pENTR221	5617		C12orf45	121053	NP_689531.2	Hs.295563	Chromosome 12 open reading frame 45						NM_152318.2	NP_689531.2	VALIDATED	Cs	0.989	0.989	185	567	1	555	185	1	185
Invitrogen	NM_001515	IOH2174	Invitrogen(on gateway)	W01B003D03	pENTR221	18616		GTF2H2	2966	NP_001506.1	Hs.655216	General transcription factor IIH, polypeptide 2, 44kDa						NM_001515.3	NP_001506.1	REVIEWED	C	1.000	1.000	395	1188	1	1185	395	1	395
Invitrogen	NM_006597	IOH11329	Invitrogen(on gateway)	W01B003D04	pENTR221	4433		HSPA8	3312	NP_006588.1	Hs.702021	Heat shock 70kDa protein 8						NM_006597.3	NP_006588.1	REVIEWED	C	1.000	1.000	646	1941	1	1938	646	1	646
Invitrogen	NM_002983	IOH29648	Invitrogen(on gateway)	W01B003D05	pENTR221	10338		CCL3	6348	NP_002974.1	Hs.514107	Chemokine (C-C motif) ligand 3						NM_002983.2	NP_002974.1	VALIDATED	C	1.000	1.000	92	279	1	276	92	1	92
Invitrogen	BC042625	IOH27415	Invitrogen(on gateway)	W01B003D06	pENTR221	21170		LUC7L2	51631	AAH42625.1	Hs.718441	LUC7-like 2 (S. cerevisiae)						NM_016019.2	NP_057103.2	VALIDATED	P	1.000	1.000	371	1176	61	1173	392	22	392
Invitrogen	NM_004477	IOH28959	Invitrogen(on gateway)	W01B003D07	pENTR221	17753		FRG1	2483	NP_004468.1	Hs.203772	FSHD region gene 1						NM_004477.2	NP_004468.1	REVIEWED	C	1.000	1.000	258	777	1	774	258	1	258
Invitrogen	BC022347	IOH13990	Invitrogen(on gateway)	W01B003D08	pENTR221	16963		LTF	4057	AAH22347.1	Hs.529517	Lactotransferrin						NM_002343.2	NP_002334.2	REVIEWED	Cgs	0.996	0.997	711	2136	1	2133	710	1	710
Invitrogen	NM_153345	IOH27468	Invitrogen(on gateway)	W01B003D09	pENTR221	21315		TMEM139	135932	NP_699176.1	Hs.17558	Transmembrane protein 139						NM_153345.1	NP_699176.1	PROVISIONAL	C	1.000	1.000	216	651	1	648	216	1	216
Invitrogen	NM_001004714	IOH28305	Invitrogen(on gateway)	W01B003D10	pENTR221	7602		OR4K13	390433	NP_001004714.1	Hs.553573	Olfactory receptor, family 4, subfamily K, member 13						NM_001004714.1	NP_001004714.1	PROVISIONAL	C	1.000	1.000	304	915	1	912	304	1	304
Invitrogen	NM_145274	IOH10638	Invitrogen(on gateway)	W01B003D11	pENTR221	9921		TMEM99	147184	NP_660317.2	Hs.353163	Transmembrane protein 99						NM_145274.2	NP_660317.2	VALIDATED	Ps	0.995	0.995	189	570	1	567	258	1	189
Invitrogen	NM_018502	IOH4889	Invitrogen(on gateway)	W01B003D12	pENTR221	18809		TMCO6	55374	NP_060972.3	Hs.712585	Transmembrane and coiled-coil domains 6						NM_018502.3	NP_060972.3	PROVISIONAL	Ps	0.996	0.996	253	762	1	759	493	241	493
Invitrogen	BC015735	IOH13400	Invitrogen(on gateway)	W01B003D13	pENTR221	23578		NDOR1	27158	AAH15735.1	Hs.712847	NADPH dependent diflavin oxidoreductase 1						NM_014434.2	NP_055249.1	REVIEWED	Cs	0.998	0.998	597	1794	1	1791	597	1	597
Invitrogen	NM_001005178	IOH28531	Invitrogen(on gateway)	W01B003D14	pENTR221	4233		OR52W1	120787	NP_001005178.1	Hs.553570	Olfactory receptor, family 52, subfamily W, member 1						NM_001005178.1	NP_001005178.1	PROVISIONAL	C	1.000	1.000	320	963	1	960	320	1	320
Invitrogen	NM_014836	IOH27118	Invitrogen(on gateway)	W01B003D15	pENTR221	3093		RHOBTB1	9886	NP_055651.1	Hs.148670	Rho-related BTB domain containing 1						NM_014836.4	NP_055651.1	REVIEWED	C	1.000	1.000	696	2091	1	2088	696	1	696
Invitrogen	NM_001029	IOH4114	Invitrogen(on gateway)	W01B003D16	pENTR221	5572		RPS26	6231	NP_001020.2	Hs.719141	Ribosomal protein S26						NM_001029.3	NP_001020.2	REVIEWED	C	1.000	1.000	115	348	1	345	115	1	115
Invitrogen	BC045695	IOH25894	Invitrogen(on gateway)	W01B003D17	pENTR221	20679		MBOAT1	154141	AAH45695	Hs.377830	Membrane bound O-acyltransferase domain containing 1						NM_001080480.1	NP_001073949.1	PROVISIONAL	Pfs	0.997	0.997	372	1116	1	1115	495	1	372
Invitrogen	NM_001126	IOH14684	Invitrogen(on gateway)	W01B003D19	pENTR221	1882		ADSS	159	NP_001117.2	Hs.498313	Adenylosuccinate synthase						NM_001126.2	NP_001117.2	REVIEWED	C	1.000	1.000	456	1371	1	1368	456	1	456
Invitrogen	NM_006930	IOH11897	Invitrogen(on gateway)	W01B003D21	pENTR221	19327		SKP1	6500	NP_008861.2	Hs.171626	S-phase kinase-associated protein 1						NM_006930.3	NP_008861.2	VALIDATED	C	1.000	1.000	160	483	1	480	160	1	160
Invitrogen	NM_198534	IOH22747	Invitrogen(on gateway)	W01B003D23	pENTR221	11789		C19orf45	374877	NP_940936.2	Hs.631862	Chromosome 19 open reading frame 45						NM_198534.2	NP_940936.2	VALIDATED	P	1.000	1.000	491	1476	1	1473	505	15	505
Invitrogen	NM_001001918	IOH28500	Invitrogen(on gateway)	W01B003E01	pENTR221	1052		OR14C36	127066	NP_001001918.1	Hs.553583	Olfactory receptor, family 14, subfamily C, member 36						NM_001001918.1	NP_001001918.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_021082	IOH26891	Invitrogen(on gateway)	W01B003E02	pENTR221	16558		SLC15A2	6565	NP_066568.3	Hs.656945	Solute carrier family 15 (H+/peptide transporter), member 2						NM_021082.3	NP_066568.3	VALIDATED	Cs	0.999	0.999	729	2190	1	2187	729	1	729
Invitrogen	NM_001005200	IOH28515	Invitrogen(on gateway)	W01B003E03	pENTR221	4237		OR8H2	390151	NP_001005200.1	Hs.553744	Olfactory receptor, family 8, subfamily H, member 2						NM_001005200.1	NP_001005200.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_001004702	IOH28303	Invitrogen(on gateway)	W01B003E04	pENTR221	4198		OR4C3	256144	NP_001004702.1	Hs.553656	Olfactory receptor, family 4, subfamily C, member 3						NM_001004702.1	NP_001004702.1	PROVISIONAL	C	1.000	1.000	329	990	1	987	329	1	329
Invitrogen	NM_001004735	IOH28250	Invitrogen(on gateway)	W01B003E05	pENTR221	4210		OR5D14	219436	NP_001004735.1	Hs.553622	Olfactory receptor, family 5, subfamily D, member 14						NM_001004735.1	NP_001004735.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	ENST00000302622	IOH28157	Invitrogen(on gateway)	W01B003E06	pENTR221	4235		OR6Q1	219952	ENSP00000307734	Hs.690432	Olfactory receptor, family 6, subfamily Q, member 1						NM_001005186.2	NP_001005186.2	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_001004685	IOH28185	Invitrogen(on gateway)	W01B003E07	pENTR221	21498		OR2F2	135948	NP_001004685.1	Hs.553596	Olfactory receptor, family 2, subfamily F, member 2						NM_001004685.1	NP_001004685.1	PROVISIONAL	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_199001	IOH28105	Invitrogen(on gateway)	W01B003E08	pENTR221	24489		C9orf169	375791	NP_945352.1	Hs.512469	Chromosome 9 open reading frame 169						NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
Invitrogen	NM_178126	IOH26767	Invitrogen(on gateway)	W01B003E09	pENTR221	10583		FAM134C	162427	NP_835227.1	Hs.632262	Family with sequence similarity 134, member C						NM_178126.3	NP_835227.1	VALIDATED	C	1.000	1.000	466	1401	1	1398	466	1	466
Invitrogen	NM_001005213	IOH28162	Invitrogen(on gateway)	W01B003E10	pENTR221	4242		OR9G1	390174	NP_001005213.1	Hs.553752	Olfactory receptor, family 9, subfamily G, member 1						NM_001005213.1	NP_001005213.1	PROVISIONAL	C	1.000	1.000	305	918	1	915	305	1	305
Invitrogen	BC050721	IOH27058	Invitrogen(on gateway)	W01B003E11	pENTR221	1364		KIAA0562	9731	AAH50721.1	Hs.509017	KIAA0562						NM_014704.2	NP_055519.1	VALIDATED	P	1.000	1.000	188	735	1	564	925	1	188
Invitrogen	NM_015292	IOH5129	Invitrogen(on gateway)	W01B003E12	pENTR221	5169		FAM62A	23344	NP_056107.1	Hs.632729	Family with sequence similarity 62 (C2 domain containing), member A						NM_015292.1	NP_056107.1	PROVISIONAL	OK	1.000	1.000	1104	3315	1	3312	1104	1	1104
Invitrogen	BC040438	IOH26200	Invitrogen(on gateway)	W01B003E13	pENTR221	6514		C1QTNF9	338872	AAH40438.1	Hs.362854	C1q and tumor necrosis factor related protein 9						NM_178540.3	NP_848635.2	VALIDATED	Cs	0.997	0.997	333	1002	1	999	333	1	333
Invitrogen	NM_017856	IOH3877	Invitrogen(on gateway)	W01B003E14	pENTR221	25275		GEMIN8	54960	NP_060326.1	Hs.592237	Gem (nuclear organelle) associated protein 8						NM_001042480.1	NP_001035945.1	VALIDATED	C	1.000	1.000	242	729	1	726	242	1	242
Invitrogen	BC042386	IOH26892	Invitrogen(on gateway)	W01B003E15	pENTR221	12516		C19orf70	125988	AAH42386.1	Hs.356626	Chromosome 19 open reading frame 70						NM_205767.1	NP_991330.1	VALIDATED	Cs	0.992	0.992	118	357	1	354	118	1	118
Invitrogen	NM_001004059	IOH28314	Invitrogen(on gateway)	W01B003E16	pENTR221	4188		OR4S2	219431	NP_001004059.2	Hs.553621	Olfactory receptor, family 4, subfamily S, member 2						NM_001004059.2	NP_001004059.2	VALIDATED	Cs	0.997	0.997	311	936	1	933	311	1	311
Invitrogen	NM_176815	IOH26763	Invitrogen(on gateway)	W01B003E17	pENTR221	17110		DHFRL1	200895	NP_789785.1	Hs.718516	Dihydrofolate reductase-like 1						NM_176815.3	NP_789785.1	PROVISIONAL	C	1.000	1.000	187	564	1	561	187	1	187
Invitrogen	NM_001005288	IOH28338	Invitrogen(on gateway)	W01B003E18	pENTR221	5008		OR51I1	390063	NP_001005288.1	Hs.553732	Olfactory receptor, family 51, subfamily I, member 1						NM_001005288.1	NP_001005288.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	BC031262	IOH21607	Invitrogen(on gateway)	W01B003E19	pENTR221	18760		CTNNA1	1495	AAH31262.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa						NM_001903.2	NP_001894.2	VALIDATED	P	1.000	1.000	536	1611	1	1608	906	371	906
Invitrogen	BC016368	IOH27882	Invitrogen(on gateway)	W01B003E20	pENTR221	7058		PSMC1	5700	AAH16368.1	Hs.356654	Proteasome (prosome, macropain) 26S subunit, ATPase, 1						NM_002802.2	NP_002793.2	REVIEWED	Cs	0.998	0.998	440	1323	1	1320	440	1	440
Invitrogen	BC016312	IOH27887	Invitrogen(on gateway)	W01B003E21	pENTR221	8173		RSL24D1	51187	AAH16312.1	Hs.274772	Ribosomal L24 domain containing 1						NM_016304.2	NP_057388.1	REVIEWED	Cs	0.994	0.994	163	492	1	489	163	1	163
Invitrogen	NM_001005211	IOH28456	Invitrogen(on gateway)	W01B003E22	pENTR221	4998		OR9I1	219954	NP_001005211.1	Hs.632122	Olfactory receptor, family 9, subfamily I, member 1						NM_001005211.1	NP_001005211.1	PROVISIONAL	OK	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_014239	IOH27837	Invitrogen(on gateway)	W01B003E23	pENTR221	7000		EIF2B2	8892	NP_055054.1	Hs.409137	Eukaryotic translation initiation factor 2B, subunit 2 beta, 39kDa						NM_014239.2	NP_055054.1	VALIDATED	C	1.000	1.000	351	1056	1	1053	351	1	351
Invitrogen	NM_203412	IOH29081	Invitrogen(on gateway)	W01B003E24	pENTR221	756		UBL4B	164153	NP_981957.1	Hs.374027	Ubiquitin-like 4B						NM_203412.1	NP_981957.1	VALIDATED	C	1.000	1.000	174	525	1	522	174	1	174
Invitrogen	NM_030932	IOH26769	Invitrogen(on gateway)	W01B003F01	pENTR221	6774		DIAPH3	81624	NP_112194.2	Hs.283127	Diaphanous homolog 3 (Drosophila)						NM_030932.3	NP_112194.2	VALIDATED	C	1.000	1.000	849	2550	1	2547	849	1	849
Invitrogen	NM_145177	IOH21679	Invitrogen(on gateway)	W01B003F02	pENTR221	25106		DHRSX	207063	NP_660160.2	Hs.131452	Dehydrogenase/reductase (SDR family) X-linked						NM_145177.2	NP_660160.2	VALIDATED	Cs	0.994	0.994	330	993	1	990	330	1	330
Invitrogen	BC035822	IOH28743	Invitrogen(on gateway)	W01B003F03	pENTR221	6079		GALNT6	11226	AAH35822.2	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)						NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
Invitrogen	NM_018376	IOH7251	Invitrogen(on gateway)	W01B003F04	pENTR221	23593		NIPSNAP3B	55335	NP_060846.2	Hs.429294	Nipsnap homolog 3B (C. elegans)						NM_018376.2	NP_060846.2	PROVISIONAL	OK	1.000	1.000	247	744	1	741	247	1	247
Invitrogen	NM_002984	IOH29652	Invitrogen(on gateway)	W01B003F05	pENTR221	9964		CCL4	6351	NP_002975.1	Hs.75703	Chemokine (C-C motif) ligand 4						NM_002984.2	NP_002975.1	VALIDATED	Cs	0.989	0.989	92	279	1	276	92	1	92
Invitrogen	NM_020963	IOH4005	Invitrogen(on gateway)	W01B003F06	pENTR221	150		MOV10	4343	NP_066014.1	Hs.514941	Mov10, Moloney leukemia virus 10, homolog (mouse)						NM_001130079.1	NP_001123551.1	VALIDATED	C	1.000	1.000	1003	3012	1	3009	1003	1	1003
Invitrogen	NM_001001657	IOH28283	Invitrogen(on gateway)	W01B003F07	pENTR221	19481		OR2Y1	134083	NP_001001657.1	Hs.554719	Olfactory receptor, family 2, subfamily Y, member 1						NM_001001657.1	NP_001001657.1	PROVISIONAL	OK	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	NM_145701	IOH12253	Invitrogen(on gateway)	W01B003F08	pENTR221	7443		CDCA4	55038	NP_663747.1	Hs.715701	Cell division cycle associated 4						NM_145701.2	NP_663747.1	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
Invitrogen	NM_001001317	IOH27437	Invitrogen(on gateway)	W01B003F09	pENTR221	22083		TRYX3	136541	NP_001001317.1	Hs.98609	Trypsin X3						NM_001001317.2	NP_001001317.1	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
Invitrogen	NM_001004134	IOH28220	Invitrogen(on gateway)	W01B003F10	pENTR221	6303		OR10AD1	121275	NP_001004134.1	Hs.446790	Olfactory receptor, family 10, subfamily AD, member 1						NM_001004134.1	NP_001004134.1	PROVISIONAL	OK	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_031279	IOH10786	Invitrogen(on gateway)	W01B003F11	pENTR221	18129		AGXT2L1	64850	NP_112569.2	Hs.106576	Alanine-glyoxylate aminotransferase 2-like 1						NM_031279.3	NP_112569.2	VALIDATED	C	1.000	1.000	499	1500	1	1497	499	1	499
Invitrogen	NM_015641	IOH4022	Invitrogen(on gateway)	W01B003F12	pENTR221	21198		TES	26136	NP_056456.1	Hs.664957	Testis derived transcript (3 LIM domains)						NM_015641.2	NP_056456.1	REVIEWED	OK	1.000	1.000	421	1266	1	1263	421	1	421
Invitrogen	NM_198513	IOH11823	Invitrogen(on gateway)	W01B003F13	pENTR221	22569		PHF20L1	51105	NP_940915.1	Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	C	1.000	1.000	285	858	1	855	285	1	285
Invitrogen	BC029560	IOH21582	Invitrogen(on gateway)	W01B003F14	pENTR221	10417		VPS53	55275	AAH29560.2	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)						NM_001128159.1	NP_001121631.1	REVIEWED	P	1.000	1.000	137	423	10	420	832	696	832
Invitrogen	BC043410	IOH26416	Invitrogen(on gateway)	W01B003F15	pENTR221	1419		FBXO42	54455	AAH43410.1	Hs.522384	F-box protein 42						NM_018994.1	NP_061867.1	PROVISIONAL	Cg	0.999	1.000	717	2151	1	2148	717	1	717
Invitrogen	NM_001349	IOH4209	Invitrogen(on gateway)	W01B003F16	pENTR221	14204		DARS	1615	NP_001340.2	Hs.503787	Aspartyl-tRNA synthetase						NM_001349.2	NP_001340.2	VALIDATED	C	1.000	1.000	501	1506	1	1503	501	1	501
Invitrogen	BC023635	IOH27909	Invitrogen(on gateway)	W01B003F17	pENTR221	17564		LIAS	11019	AAH23635.1	Hs.550502	Lipoic acid synthetase						NM_006859.2	NP_006850.2	REVIEWED	Cs	0.997	0.997	372	1119	1	1116	372	1	372
Invitrogen	ENST00000330728	IOH28177	Invitrogen(on gateway)	W01B003F19	pENTR221	4992		OR56A4	120793	ENSP00000328215	Hs.553571	Olfactory receptor, family 56, subfamily A, member 4						NM_001005179.2	NP_001005179.2	PROVISIONAL	P	1.000	1.000	313	942	1	939	365	53	365
Invitrogen	NM_018679	IOH26898	Invitrogen(on gateway)	W01B003F21	pENTR221	20541		TCP11	6954	NP_061149.1	Hs.435371	T-complex 11 homolog (mouse)						NM_018679.4	NP_061149.1	VALIDATED	C	1.000	1.000	441	1326	1	1323	441	1	441
Invitrogen	BC042970	IOH25849	Invitrogen(on gateway)	W01B003F23	pENTR221	8970		COTL1	23406	AAH42970.1	Hs.289092	Coactosin-like 1 (Dictyostelium)						NM_021149.2	NP_066972.1	REVIEWED	Cs	0.993	0.993	142	429	1	426	142	1	142
Invitrogen	ENST00000355929	IOH28298	Invitrogen(on gateway)	W01B003G01	pENTR221	1063		OR2T4	127074	ENSP00000348195	Hs.553586	Olfactory receptor, family 2, subfamily T, member 4						NM_001004696.1	NP_001004696.1	PROVISIONAL	P	1.000	1.000	320	963	1	960	348	29	348
Invitrogen	NM_001005163	IOH28340	Invitrogen(on gateway)	W01B003G02	pENTR221	4224		OR52D1	390066	NP_001005163.1	Hs.553734	Olfactory receptor, family 52, subfamily D, member 1						NM_001005163.1	NP_001005163.1	PROVISIONAL	C	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	ENST00000317834	IOH28527	Invitrogen(on gateway)	W01B003G03	pENTR221	4196		OR2D3	120775	ENSP00000320560	Hs.446766	Olfactory receptor, family 2, subfamily D, member 3						NM_001004684.1	NP_001004684.1	PROVISIONAL	P	1.000	1.000	314	945	1	942	330	17	330
Invitrogen	NM_001005283	IOH28225	Invitrogen(on gateway)	W01B003G04	pENTR221	4245		OR9Q2	219957	NP_001005283.1	Hs.553643	Olfactory receptor, family 9, subfamily Q, member 2						NM_001005283.1	NP_001005283.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_001001965	IOH28256	Invitrogen(on gateway)	W01B003G05	pENTR221	4183		OR4D5	219875	NP_001001965.1	Hs.553639	Olfactory receptor, family 4, subfamily D, member 5						NM_001001965.1	NP_001001965.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	NM_001005501	IOH28215	Invitrogen(on gateway)	W01B003G06	pENTR221	7257		OR4K2	390431	NP_001005501.1	Hs.551345	Olfactory receptor, family 4, subfamily K, member 2						NM_001005501.1	NP_001005501.1	PROVISIONAL	OK	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_001005287	IOH28565	Invitrogen(on gateway)	W01B003G07	pENTR221	21214		OR2A1	346528	NP_001005287.1	Hs.528398	Olfactory receptor, family 2, subfamily A, member 1						NM_001005287.1	NP_001005287.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	BC016790	IOH27885	Invitrogen(on gateway)	W01B003G08	pENTR221	16767		KIAA1143	57456	AAH16790.1	Hs.476082	KIAA1143						NM_020696.3	NP_065747.1	VALIDATED	Cs	0.994	0.994	154	465	1	462	154	1	154
Invitrogen	NM_198943	IOH26580	Invitrogen(on gateway)	W01B003G09	pENTR221	2241		WASH6P	653440	NP_945181								XM_377073.4	XP_377073.3	MODEL		0.966	0.973	416	1407	157	1404	447	35	447
Invitrogen	NM_001004475	IOH28289	Invitrogen(on gateway)	W01B003G10	pENTR221	2276		OR10T2	128360	NP_001004475.1	Hs.553588	Olfactory receptor, family 10, subfamily T, member 2						NM_001004475.1	NP_001004475.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	ENST00000299341	IOH26305	Invitrogen(on gateway)	W01B003G11	pENTR221	9928		STXBP4	252983	ENSP00000299341	Hs.35199	Syntaxin binding protein 4						NM_178509.5	NP_848604.3	VALIDATED	Pg	0.992	1.000	240	738	1	720	553	78	315
Invitrogen	NM_001004753	IOH28492	Invitrogen(on gateway)	W01B003G12	pENTR221	4217		OR51F2	119694	NP_001004753.1	Hs.553562	Olfactory receptor, family 51, subfamily F, member 2						NM_001004753.1	NP_001004753.1	PROVISIONAL	C	1.000	1.000	342	1029	1	1026	342	1	342
Invitrogen	NM_182559	IOH26752	Invitrogen(on gateway)	W01B003G13	pENTR221	5621		TMPRSS12	283471	NP_872365.1	Hs.125571	Transmembrane protease, serine 12						NM_182559.2	NP_872365.1	VALIDATED	C	1.000	1.000	348	1047	1	1044	348	1	348
Invitrogen	NM_012247	IOH3018	Invitrogen(on gateway)	W01B003G14	pENTR221	3361		SEPHS1	22929	NP_036379.2	Hs.124027	Selenophosphate synthetase 1						NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
Invitrogen	NM_133498	IOH26564	Invitrogen(on gateway)	W01B003G15	pENTR221	11640		SPACA4	171169	NP_598005.1	Hs.122599	Sperm acrosome associated 4						NM_133498.2	NP_598005.1	VALIDATED	C	1.000	1.000	124	375	1	372	124	1	124
Invitrogen	NM_001005224	IOH28187	Invitrogen(on gateway)	W01B003G16	pENTR221	1068		OR4F3	26683	NP_001005224.1								NM_001005224.1	NP_001005224.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	ENST00000310269	IOH26487	Invitrogen(on gateway)	W01B003G17	pENTR221	926		DNAH14	127602	ENSP00000310766	Hs.133977	Dynein, axonemal, heavy chain 14						NM_001145154.1	NP_001138626.1	VALIDATED	Ps	0.989	0.989	182	570	1	546	453	16	197
Invitrogen	NM_001004456	IOH28559	Invitrogen(on gateway)	W01B003G18	pENTR221	12010		OR1M1	125963	NP_001004456.1	Hs.553577	Olfactory receptor, family 1, subfamily M, member 1						NM_001004456.1	NP_001004456.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	NM_198075	IOH26810	Invitrogen(on gateway)	W01B003G19	pENTR221	3921		LRRC56	115399	NP_932341.1	Hs.567655	Leucine rich repeat containing 56						NM_198075.3	NP_932341.1	VALIDATED	C	1.000	1.000	542	1629	1	1626	542	1	542
Invitrogen	NM_176880	IOH29210	Invitrogen(on gateway)	W01B003G20	pENTR221	12619		NR2C2AP	126382	NP_795361.1	Hs.708153	Nuclear receptor 2C2-associated protein						NM_176880.4	NP_795361.1	VALIDATED	C	1.000	1.000	139	420	1	417	139	1	139
Invitrogen	BC051362	IOH28072	Invitrogen(on gateway)	W01B003G21	pENTR221	20024		LOC554223	554223	AAH51362.1	Hs.60856	Hypothetical LOC554223																		
Invitrogen	BC057841	IOH29255	Invitrogen(on gateway)	W01B003G22	pENTR221	24768		ZCCHC12	170261	AAH57841.1	Hs.21417	Zinc finger, CCHC domain containing 12						NM_173798.2	NP_776159.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
Invitrogen	BC021984	IOH27893	Invitrogen(on gateway)	W01B003G23	pENTR221	16865		TUSC4	10641	AAH21984.1	Hs.437083	Tumor suppressor candidate 4						NM_006545.4	NP_006536.3	VALIDATED	Cs	0.997	0.997	380	1143	1	1140	380	1	380
Invitrogen	NM_145255	IOH29371	Invitrogen(on gateway)	W01B003G24	pENTR221	10637		MRPL10	124995	NP_660298.2	Hs.347535	Mitochondrial ribosomal protein L10						NM_145255.2	NP_660298.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
Invitrogen	NM_003748	IOH27900	Invitrogen(on gateway)	W01B003H01	pENTR221	2069		ALDH4A1	8659	NP_003739.2	Hs.77448	Aldehyde dehydrogenase 4 family, member A1						NM_170726.2	NP_733844.1	REVIEWED	C	1.000	1.000	563	1692	1	1689	563	1	563
Invitrogen	NM_152789	IOH21683	Invitrogen(on gateway)	W01B003H02	pENTR221	22089		FAM133B	257415	NP_690002.2	Hs.489105	Family with sequence similarity 133, member B						NM_001040057.1	NP_001035146.1	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
Invitrogen	BC056757	IOH28798	Invitrogen(on gateway)	W01B003H03	pENTR221	18761		SLC6A18	348932	AAH56757.1	Hs.213284	Solute carrier family 6, member 18						NM_182632.2	NP_872438.2	VALIDATED	C	1.000	1.000	628	1887	1	1884	628	1	628
Invitrogen	BC016057	IOH12761	Invitrogen(on gateway)	W01B003H04	pENTR221	4392		USH1C	10083	AAH16057.1	Hs.502072	Usher syndrome 1C (autosomal recessive, severe)						NM_005709.3	NP_005700.2	REVIEWED	Cgs	0.964	0.998	552	1602	1	1599	552	1	552
Invitrogen	NM_203411	IOH29129	Invitrogen(on gateway)	W01B003H05	pENTR221	9813		TMEM88	92162	NP_981956.1	Hs.389669	Transmembrane protein 88						NM_203411.1	NP_981956.1	VALIDATED	C	1.000	1.000	159	480	1	477	159	1	159
Invitrogen	NM_203454	IOH10788	Invitrogen(on gateway)	W01B003H06	pENTR221	2016		APOBEC4	403314	NP_982279.1	Hs.97335	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 4 (putative)						NM_203454.2	NP_982279.1	REVIEWED	C	1.000	1.000	367	1104	1	1101	367	1	367
Invitrogen	NM_017504	IOH28482	Invitrogen(on gateway)	W01B003H07	pENTR221	1040		OR2M4	26245	NP_059974.1	Hs.381309	Olfactory receptor, family 2, subfamily M, member 4						NM_017504.1	NP_059974.1	PROVISIONAL	C	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	BC005090	IOH6629	Invitrogen(on gateway)	W01B003H08	pENTR221	2058		AGMAT	79814	AAH05090.1	Hs.567583	Agmatine ureohydrolase (agmatinase)						NM_024758.3	NP_079034.3	VALIDATED	Cs	0.997	0.997	352	1059	1	1056	352	1	352
Invitrogen	BC039540	IOH26329	Invitrogen(on gateway)	W01B003H09	pENTR221	18157		RELL1	768211	AAH39540.1	Hs.283378	RELT-like 1						NM_001085399.1	NP_001078868.1	VALIDATED	C	1.000	1.000	271	816	1	813	271	1	271
Invitrogen	ENST00000317254	IOH28179	Invitrogen(on gateway)	W01B003H10	pENTR221	4232		OR52N4	390072	ENSP00000323224	Hs.553735	Olfactory receptor, family 52, subfamily N, member 4						NM_001005175.2	NP_001005175.2	VALIDATED	Cs	0.991	0.991	321	966	1	963	321	1	321
Invitrogen	BC007685	IOH6220	Invitrogen(on gateway)	W01B003H11	pENTR221	4791		ALDH3B2	222	AAH07685.1	Hs.87539	Aldehyde dehydrogenase 3 family, member B2						NM_000695.3	NP_000686.2	REVIEWED	Cs	0.997	0.997	385	1158	1	1155	385	1	385
Invitrogen	NM_001018067	IOH4999	Invitrogen(on gateway)	W01B003H12	pENTR221	1638		SERBP1	26135	NP_001018077.1	Hs.719078	SERPINE1 mRNA binding protein 1						NM_001018067.1	NP_001018077.1	VALIDATED	C	1.000	1.000	408	1227	1	1224	408	1	408
Invitrogen	NM_002577	IOH29877	Invitrogen(on gateway)	W01B003H13	pENTR221	16567		PAK2	5062	NP_002568.2	Hs.518530	P21 protein (Cdc42/Rac)-activated kinase 2						NM_002577.4	NP_002568.2	REVIEWED	C	1.000	1.000	524	1575	1	1572	524	1	524
Invitrogen	NM_001586	IOH10912	Invitrogen(on gateway)	W01B003H14	pENTR221	25412		TEX28	1527	NP_001577.1	Hs.672606	Testis expressed 28						NM_001586.1	NP_001577.1	PROVISIONAL	C	1.000	1.000	410	1233	1	1230	410	1	410
Invitrogen	NM_203390	IOH27244	Invitrogen(on gateway)	W01B003H15	pENTR221	23262		RBM12B	389677	NP_976324.2	Hs.192788	RNA binding motif protein 12B						NM_203390.2	NP_976324.2	VALIDATED	Pfs	0.861	0.996	886	2298	1	2297	1001	1	886
Invitrogen	NM_133375	IOH13442	Invitrogen(on gateway)	W01B003H16	pENTR221	7717		DIS3L	115752	NP_588616.1	Hs.446251	DIS3 mitotic control homolog (S. cerevisiae)-like						NM_133375.3	NP_588616.1	VALIDATED	C	1.000	1.000	971	2916	1	2913	971	1	971
Invitrogen	BC050097	IOH26495	Invitrogen(on gateway)	W01B003H17	pENTR221	2596		LRRC27	80313	AAH50097.1	Hs.119897	Leucine rich repeat containing 27						NM_001143758.1	NP_001137230.1	VALIDATED	C	1.000	1.000	383	1152	1	1149	383	1	383
Invitrogen	NM_001001914	IOH28295	Invitrogen(on gateway)	W01B003H19	pENTR221	1050		OR2G3	81469	NP_001001914.1	Hs.653227	Olfactory receptor, family 2, subfamily G, member 3						NM_001001914.1	NP_001001914.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
Invitrogen	BC031630	IOH22761	Invitrogen(on gateway)	W01B003H21	pENTR221	23999		ERMP1	79956	AAH31630.2	Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	P	1.000	1.000	317	954	1	951	904	588	904
Invitrogen	NM_014864	IOH27350	Invitrogen(on gateway)	W01B003H23	pENTR221	37		FAM20B	9917	NP_055679.1	Hs.719217	Family with sequence similarity 20, member B						NM_014864.3	NP_055679.1	VALIDATED	C	1.000	1.000	409	1230	1	1227	409	1	409
Invitrogen	NM_001005212	IOH28263	Invitrogen(on gateway)	W01B003I01	pENTR221	4152		OR9Q1	219956	NP_001005212.1	Hs.689841	Olfactory receptor, family 9, subfamily Q, member 1						NM_001005212.2	NP_001005212.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	NM_001004471	IOH28472	Invitrogen(on gateway)	W01B003I02	pENTR221	4971		OR10Q1	219960	NP_001004471.1	Hs.553646	Olfactory receptor, family 10, subfamily Q, member 1						NM_001004471.1	NP_001004471.1	PROVISIONAL	C	1.000	1.000	319	960	1	957	319	1	319
Invitrogen	ENST00000317121	IOH28238	Invitrogen(on gateway)	W01B003I03	pENTR221	4010		OR56B1	387748	ENSP00000322939	Hs.689609	Olfactory receptor, family 56, subfamily B, member 1						NM_001005180.1	NP_001005180.1	PROVISIONAL	P	1.000	1.000	321	966	1	963	324	4	324
Invitrogen	NM_001002907	IOH28510	Invitrogen(on gateway)	W01B003I04	pENTR221	4185		OR8K1	390157	NP_001002907.1	Hs.553748	Olfactory receptor, family 8, subfamily K, member 1						NM_001002907.1	NP_001002907.1	PROVISIONAL	C	1.000	1.000	319	960	1	957	319	1	319
Invitrogen	NM_001004464	IOH28258	Invitrogen(on gateway)	W01B003I05	pENTR221	4194		OR10G8	219869	NP_001004464.1	Hs.553635	Olfactory receptor, family 10, subfamily G, member 8						NM_001004464.1	NP_001004464.1	PROVISIONAL	OK	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	NM_001005234	IOH28319	Invitrogen(on gateway)	W01B003I06	pENTR221	23823		OR1L3	26735	NP_001005234.1	Hs.626839	Olfactory receptor, family 1, subfamily L, member 3						NM_001005234.1	NP_001005234.1	PROVISIONAL	C	1.000	1.000	324	975	1	972	324	1	324
Invitrogen	BC030196	IOH22581	Invitrogen(on gateway)	W01B003I07	pENTR221	15230		RBM11	54033	AAH30196.2	Hs.283828	RNA binding motif protein 11						NM_144770.3	NP_658983.3	VALIDATED	OK	1.000	1.000	281	846	1	843	281	1	281
Invitrogen	NM_000181	IOH29680	Invitrogen(on gateway)	W01B003I08	pENTR221	22110		GUSB	2990	NP_000172.1	Hs.255230	Glucuronidase, beta						NM_000181.2	NP_000172.1	VALIDATED	C	1.000	1.000	651	1956	1	1953	651	1	651
Invitrogen	BC050704	IOH27028	Invitrogen(on gateway)	W01B003I09	pENTR221	20369		DCDC2	51473	AAH50704.1	Hs.61345	Doublecortin domain containing 2						NM_016356.3	NP_057440.2	REVIEWED	Cs	0.996	0.996	476	1431	1	1428	476	1	476
Invitrogen	NM_001004694	IOH28574	Invitrogen(on gateway)	W01B003I10	pENTR221	2283		OR2T29	343563	NP_001004694.1	Hs.553707	Olfactory receptor, family 2, subfamily T, member 29						NM_001004694.1	NP_001004694.1	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
Invitrogen	NM_178450	IOH26430	Invitrogen(on gateway)	W01B003I11	pENTR221	19182		MARCH3	115123	NP_848545.1	Hs.132441	Membrane-associated ring finger (C3HC4) 3						NM_178450.3	NP_848545.1	VALIDATED	C	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	NM_001005275	IOH28252	Invitrogen(on gateway)	W01B003I12	pENTR221	4244		OR4A15	81328	NP_001005275.1	Hs.554529	Olfactory receptor, family 4, subfamily A, member 15						NM_001005275.1	NP_001005275.1	PROVISIONAL	C	1.000	1.000	344	1035	1	1032	344	1	344
Invitrogen	NM_175878	IOH26879	Invitrogen(on gateway)	W01B003I13	pENTR221	15931		XKR3	150165	NP_787074.2	Hs.356069	XK, Kell blood group complex subunit-related family, member 3						NM_175878.3	NP_787074.2	VALIDATED	Pfs	0.997	0.997	362	1089	1	1087	459	1	362
Invitrogen	NM_004047	IOH3682	Invitrogen(on gateway)	W01B003I14	pENTR221	873		ATP6V0B	533	NP_004038.1	Hs.596514	ATPase, H+ transporting, lysosomal 21kDa, V0 subunit b						NM_004047.3	NP_004038.1	REVIEWED	OK	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	NM_194326	IOH26706	Invitrogen(on gateway)	W01B003I15	pENTR221	15897		RPS19BP1	91582	NP_919307.1	Hs.526933	Ribosomal protein S19 binding protein 1						NM_194326.2	NP_919307.1	PROVISIONAL	OK	1.000	1.000	136	411	1	408	136	1	136
Invitrogen	NM_001005165	IOH28236	Invitrogen(on gateway)	W01B003I16	pENTR221	4225		OR52E4	390081	NP_001005165.1	Hs.553739	Olfactory receptor, family 52, subfamily E, member 4						NM_001005165.1	NP_001005165.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_198276	IOH26511	Invitrogen(on gateway)	W01B003I17	pENTR221	14144		TMEM17	200728	NP_938017.2	Hs.308028	Transmembrane protein 17						NM_198276.2	NP_938017.2	VALIDATED	Cs	0.995	0.995	198	597	1	594	198	1	198
Invitrogen	NM_152587	IOH29280	Invitrogen(on gateway)	W01B003I18	pENTR221	4904		C11orf65	160140	NP_689800.3	Hs.653180	Chromosome 11 open reading frame 65						NM_152587.3	NP_689800.3	VALIDATED	Cs	0.994	0.994	313	942	1	939	313	1	313
Invitrogen	NM_001268	IOH22718	Invitrogen(on gateway)	W01B003I19	pENTR221	6565		RCBTB2	1102	NP_001259.1	Hs.657385	Regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2						NM_001268.2	NP_001259.1	REVIEWED	C	1.000	1.000	551	1656	1	1653	551	1	551
Invitrogen	NM_015115	IOH29028	Invitrogen(on gateway)	W01B003I20	pENTR221	17608		DCUN1D4	23142	NP_055930.2	Hs.605388	DCN1, defective in cullin neddylation 1, domain containing 4 (S. cerevisiae)						NM_015115.2	NP_055930.2	VALIDATED	P	1.000	1.000	197	594	1	591	257	61	257
Invitrogen	ENST00000328788	IOH27849	Invitrogen(on gateway)	W01B003I21	pENTR221	24219		FRMD3	257019	ENSP00000328615	Hs.709357	FERM domain containing 3						NM_174938.4	NP_777598.3	VALIDATED	P	1.000	1.000	154	642	166	627	597	399	552
Invitrogen	BC053984	IOH29361	Invitrogen(on gateway)	W01B003I22	pENTR221	1		IGHV4-31	28396	AAH53984										
Invitrogen	ENST00000310858	IOH28074	Invitrogen(on gateway)	W01B003I23	pENTR221	13860		TNS1	7145	ENSP00000308321	Hs.471381	Tensin 1						NM_022648.4	NP_072174.3	REVIEWED	Ps	0.997	0.997	352	1158	1	1056	1735	1	352
Invitrogen	NM_198584	IOH29373	Invitrogen(on gateway)	W01B003I24	pENTR221	22714		CA13	377677	NP_940986.1	Hs.127189	Carbonic anhydrase XIII						NM_198584.2	NP_940986.1	VALIDATED	C	1.000	1.000	262	789	1	786	262	1	262
Invitrogen	NM_001013845	IOH9866	Invitrogen(on gateway)	W01B003J01	pENTR221	25397		CXorf40B	541578	NP_001013867.1	Hs.545950	Chromosome X open reading frame 40B						NM_001013845.1	NP_001013867.1	VALIDATED	C	1.000	1.000	158	477	1	474	158	1	158
Invitrogen	NM_016102	IOH21790	Invitrogen(on gateway)	W01B003J02	pENTR221	1658		TRIM17	51127	NP_057186.1	Hs.121748	Tripartite motif-containing 17						NM_016102.3	NP_057186.1	REVIEWED	OK	1.000	1.000	477	1434	1	1431	477	1	477
Invitrogen	NM_000444	IOH29637	Invitrogen(on gateway)	W01B003J03	pENTR221	24563		PHEX	5251	NP_000435.3	Hs.495834	Phosphate regulating endopeptidase homolog, X-linked						NM_000444.4	NP_000435.3	REVIEWED	OK	1.000	1.000	749	2250	1	2247	749	1	749
Invitrogen	BC044884	IOH26494	Invitrogen(on gateway)	W01B003J04	pENTR221	21421		KLHDC10	23008	AAH44884.1	Hs.520710	Kelch domain containing 10						NM_014997.2	NP_055812.1	VALIDATED	Cs	0.993	0.993	442	1329	1	1326	442	1	442
Invitrogen	NM_003479	IOH29576	Invitrogen(on gateway)	W01B003J05	pENTR221															
Invitrogen	BC030245	IOH21531	Invitrogen(on gateway)	W01B003J06	pENTR221	1356		TMEM63A	9725	AAH30245.1	Hs.119387	Transmembrane protein 63A						NM_014698.1	NP_055513.1	PROVISIONAL	Cs	0.999	0.999	807	2424	1	2421	807	1	807
Invitrogen	NM_003837	IOH29632	Invitrogen(on gateway)	W01B003J07	pENTR221	24344		FBP2	8789	NP_003828.2	Hs.61255	Fructose-1,6-bisphosphatase 2						NM_003837.2	NP_003828.2	REVIEWED	C	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	BC020719	IOH12903	Invitrogen(on gateway)	W01B003J08	pENTR221	4585		HBG1	3047	AAH20719.1	Hs.712539	Hemoglobin, gamma A						NM_000559.2	NP_000550.2	REVIEWED	Cs	0.993	0.993	147	444	1	441	147	1	147
Invitrogen	NM_001004708	IOH28245	Invitrogen(on gateway)	W01B003J09	pENTR221	4202		OR4D6	219983	NP_001004708.1	Hs.553650	Olfactory receptor, family 4, subfamily D, member 6						NM_001004708.1	NP_001004708.1	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	BC009256	IOH14057	Invitrogen(on gateway)	W01B003J10	pENTR221	12442		FAM108A1	81926	AAH09256.1	Hs.653679	Family with sequence similarity 108, member A1						NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	NM_003344	IOH6283	Invitrogen(on gateway)	W01B003J11	pENTR221	22018		UBE2H	7328	NP_003335.1	Hs.643548	Ubiquitin-conjugating enzyme E2H (UBC8 homolog, yeast)						NM_003344.2	NP_003335.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
Invitrogen	BC001785	IOH4909	Invitrogen(on gateway)	W01B003J12	pENTR221	3951		LSP1	4046	AAH01785.1	Hs.56729	Lymphocyte-specific protein 1						NM_002339.2	NP_002330.1	REVIEWED	Cs	0.997	0.997	339	1020	1	1017	339	1	339
Invitrogen	BC001380	IOH3984	Invitrogen(on gateway)	W01B003J13	pENTR221	18561		SDHA	6389	AAH01380.1	Hs.440475	Succinate dehydrogenase complex, subunit A, flavoprotein (Fp)						NM_004168.2	NP_004159.2	REVIEWED	C	1.000	1.000	664	1995	1	1992	664	1	664
Invitrogen	NM_017911	IOH10492	Invitrogen(on gateway)	W01B003J14	pENTR221	15602		FAM118A	55007	NP_060381.2	Hs.265018	Family with sequence similarity 118, member A						NM_001104595.1	NP_001098065.1	VALIDATED	Cs	0.994	0.994	357	1074	1	1071	357	1	357
Invitrogen	BC032950	IOH27092	Invitrogen(on gateway)	W01B003J15	pENTR221	4672		CATSPER1	117144	AAH32950.1	Hs.189105	Cation channel, sperm associated 1						NM_053054.3	NP_444282.3	REVIEWED	Cs	0.996	0.996	780	2343	1	2340	780	1	780
Invitrogen	BC040902	IOH26326	Invitrogen(on gateway)	W01B003J16	pENTR221	821		PRAMEF2	65122	AAH40902.1	Hs.454859	PRAME family member 2						NM_023014.1	NP_075390.1	PROVISIONAL		0.923	0.923	196	690	100	687	474	279	474
Invitrogen	NM_033397	IOH27489	Invitrogen(on gateway)	W01B003J17	pENTR221	3132		ITPRIP	85450	NP_203755.1	Hs.523252	Inositol 1,4,5-triphosphate receptor interacting protein						NM_033397.2	NP_203755.1	PROVISIONAL	C	1.000	1.000	547	1644	1	1641	547	1	547
Invitrogen	NM_170603	IOH39528	Invitrogen(on gateway)	W01B003J19	pENTR221	12384		RASGRP4	115727	NP_733748	Hs.130434	RAS guanyl releasing protein 4						NM_170604.2	NP_733749.1	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
Invitrogen	NM_017711	IOH22171	Invitrogen(on gateway)	W01B003J21	pENTR221	24526		GDPD2	54857	NP_060181.2	Hs.438712	Glycerophosphodiester phosphodiesterase domain containing 2						NM_017711.2	NP_060181.2	PROVISIONAL	C	1.000	1.000	539	1620	1	1617	539	1	539
Invitrogen	BC013740	IOH11082	Invitrogen(on gateway)	W01B003J23	pENTR221	24020		SLC2A6	11182	AAH13740.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6						NM_017585.3	NP_060055.2	VALIDATED	C	1.000	1.000	507	1524	1	1521	507	1	507
Invitrogen	NM_001004734	IOH28503	Invitrogen(on gateway)	W01B003K01	pENTR221	2285		OR14I1	401994	NP_001004734.1	Hs.449973	Olfactory receptor, family 14, subfamily I, member 1						NM_001004734.1	NP_001004734.1	PROVISIONAL	OK	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	NM_001004473	IOH28473	Invitrogen(on gateway)	W01B003K02	pENTR221	1056		OR10K1	391109	NP_001004473.1	Hs.690410	Olfactory receptor, family 10, subfamily K, member 1						NM_001004473.1	NP_001004473.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	NM_001005167	IOH28331	Invitrogen(on gateway)	W01B003K03	pENTR221	4988		OR52E6	390078	NP_001005167.1	Hs.534693	Olfactory receptor, family 52, subfamily E, member 6						NM_001005167.1	NP_001005167.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	NM_001004489	IOH28437	Invitrogen(on gateway)	W01B003K04	pENTR221	4195		OR2AG1	144125	NP_001004489.1	Hs.553608	Olfactory receptor, family 2, subfamily AG, member 1						NM_001004489.1	NP_001004489.1	PROVISIONAL	OK	1.000	1.000	316	951	1	948	316	1	316
Invitrogen	NM_001001915	IOH28296	Invitrogen(on gateway)	W01B003K05	pENTR221	1051		OR2G2	81470	NP_001001915.1	Hs.690208	Olfactory receptor, family 2, subfamily G, member 2						NM_001001915.1	NP_001001915.1	PROVISIONAL	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_001001923	IOH28265	Invitrogen(on gateway)	W01B003K06	pENTR221	23817		OR5C1	392391	NP_001001923.1	Hs.534761	Olfactory receptor, family 5, subfamily C, member 1						NM_001001923.1	NP_001001923.1	PROVISIONAL	C	1.000	1.000	320	963	1	960	320	1	320
Invitrogen	NM_016075	IOH26673	Invitrogen(on gateway)	W01B003K07	pENTR221	6710		VPS36	51028	NP_057159.2	Hs.109520	Vacuolar protein sorting 36 homolog (S. cerevisiae)						NM_016075.2	NP_057159.2	VALIDATED	C	1.000	1.000	386	1161	1	1158	386	1	386
Invitrogen	NM_003161	IOH29907	Invitrogen(on gateway)	W01B003K08	pENTR221	9849		RPS6KB1	6198	NP_003152.1	Hs.463642	Ribosomal protein S6 kinase, 70kDa, polypeptide 1						NM_003161.2	NP_003152.1	REVIEWED	C	1.000	1.000	525	1578	1	1575	525	1	525
Invitrogen	BC047945	IOH26362	Invitrogen(on gateway)	W01B003K09	pENTR221	7796		TRIM69	140691	AAH47945.1	Hs.489254	Tripartite motif-containing 69						NM_182985.3	NP_892030.3	REVIEWED	Cs	0.996	0.996	500	1503	1	1500	500	1	500
Invitrogen	NM_001004705	IOH28240	Invitrogen(on gateway)	W01B003K10	pENTR221	4200		OR4D10	390197	NP_001004705.1	Hs.553756	Olfactory receptor, family 4, subfamily D, member 10						NM_001004705.1	NP_001004705.1	PROVISIONAL	OK	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	BC044239	IOH26369	Invitrogen(on gateway)	W01B003K11	pENTR221	3938		ANKRD13D	338692	AAH44239.1	Hs.438673	Ankyrin repeat domain 13 family, member D						NM_207354.1	NP_997237.1	PROVISIONAL	Ps	0.988	0.988	251	768	13	765	518	268	518
Invitrogen	NM_182640	IOH29467	Invitrogen(on gateway)	W01B003K12	pENTR221	13243		MRPS9	64965	NP_872578.1	Hs.590900	Mitochondrial ribosomal protein S9						NM_182640.2	NP_872578.1	REVIEWED	C	1.000	1.000	396	1191	1	1188	396	1	396
Invitrogen	BC050393	IOH26678	Invitrogen(on gateway)	W01B003K13	pENTR221	22498		FBXO25	26260	AAH50393.1	Hs.438454	F-box protein 25						NM_183421.1	NP_904357.1	REVIEWED	Cs	0.997	0.997	367	1104	1	1101	367	1	367
Invitrogen	NM_001033002	IOH28888	Invitrogen(on gateway)	W01B003K14	pENTR221	9916		RPAIN	84268	NP_001028174.2	Hs.462086	RPA interacting protein						NM_001033002.3	NP_001028174.2	VALIDATED	Cs	0.995	0.995	219	660	1	657	219	1	219
Invitrogen	NM_176791	IOH26363	Invitrogen(on gateway)	W01B003K15	pENTR221	15022		GTSF1L	149699	NP_789761.1	Hs.447626	Gametocyte specific factor 1-like						NM_176791.3	NP_789761.1	VALIDATED	C	1.000	1.000	148	447	1	444	148	1	148
Invitrogen	NM_001004124	IOH28253	Invitrogen(on gateway)	W01B003K16	pENTR221	4189		OR4P4	81300	NP_001004124.1	Hs.626750	Olfactory receptor, family 4, subfamily P, member 4						NM_001004124.1	NP_001004124.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_053041	IOH26500	Invitrogen(on gateway)	W01B003K17	pENTR221	14988		COMMD7	149951	NP_444269.2	Hs.408427	COMM domain containing 7						NM_053041.2	NP_444269.2	VALIDATED	Cs	0.985	0.985	200	603	1	600	200	1	200
Invitrogen	NM_001004728	IOH28244	Invitrogen(on gateway)	W01B003K18	pENTR221	4207		OR5A1	219982	NP_001004728.1	Hs.553649	Olfactory receptor, family 5, subfamily A, member 1						NM_001004728.1	NP_001004728.1	PROVISIONAL	OK	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_174924	IOH27367	Invitrogen(on gateway)	W01B003K19	pENTR221	9321		PDILT	204474	NP_777584.1	Hs.376025	Protein disulfide isomerase-like, testis expressed						NM_174924.1	NP_777584.1	PROVISIONAL	OK	1.000	1.000	584	1755	1	1752	584	1	584
Invitrogen	BC025314	IOH13984	Invitrogen(on gateway)	W01B003K20	pENTR221	1		IGHG1	3500	AAH25314	Hs.510635	Immunoglobulin heavy constant gamma 1 (G1m marker)								
Invitrogen	BC017917	IOH27928	Invitrogen(on gateway)	W01B003K21	pENTR221	5523		TPI1	7167	AAH17917.1	Hs.524219	Triosephosphate isomerase 1						NM_000365.5	NP_000356.1	REVIEWED	Cs	0.996	0.996	249	750	1	747	249	1	249
Invitrogen	BC060879	IOH29289	Invitrogen(on gateway)	W01B003K22	pENTR221	22075		C7orf31	136895	AAH60879.1	Hs.122055	Chromosome 7 open reading frame 31						NM_138811.3	NP_620166.3	VALIDATED	Cs	0.993	0.993	590	1773	1	1770	590	1	590
Invitrogen	NM_016109	IOH27952	Invitrogen(on gateway)	W01B003K23	pENTR221															
Invitrogen	ENST00000326876	IOH28317	Invitrogen(on gateway)	W01B003K24	pENTR221	31595				ENSP00000322824										
Invitrogen	NM_139162	IOH12829	Invitrogen(on gateway)	W01B003L01	pENTR221	9775		SMCR7	125170	NP_631901.2	Hs.655555	Smith-Magenis syndrome chromosome region, candidate 7						NM_139162.3	NP_631901.2	REVIEWED	C	1.000	1.000	454	1365	1	1362	454	1	454
Invitrogen	BC022968	IOH11044	Invitrogen(on gateway)	W01B003L02	pENTR221	16785		SLC7A14	57709	AAH22968.2	Hs.596660	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14						NM_020949.2	NP_066000.2	VALIDATED	P	1.000	1.000	737	2214	1	2211	771	35	771
Invitrogen	NM_007287	IOH29604	Invitrogen(on gateway)	W01B003L03	pENTR221	16595		MME	4311	NP_009218.2	Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	C	1.000	1.000	750	2253	1	2250	750	1	750
Invitrogen	BC027622	IOH26866	Invitrogen(on gateway)	W01B003L04	pENTR221	9712		PIPOX	51268	AAH27622.1	Hs.462585	Pipecolic acid oxidase						NM_016518.2	NP_057602.2	VALIDATED	Cs	0.990	0.990	390	1173	1	1170	390	1	390
Invitrogen	NM_003224	IOH29617	Invitrogen(on gateway)	W01B003L05	pENTR221	15038		ARFRP1	10139	NP_003215.1	Hs.389277	ADP-ribosylation factor related protein 1						NM_003224.3	NP_003215.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	BC033621	IOH21688	Invitrogen(on gateway)	W01B003L06	pENTR221	6131		PUS7L	83448	AAH33621.1	Hs.445814	Pseudouridylate synthase 7 homolog (S. cerevisiae)-like						NM_031292.3	NP_112582.3	VALIDATED	C	1.000	1.000	701	2106	1	2103	701	1	701
Invitrogen	BC027900	IOH27306	Invitrogen(on gateway)	W01B003L07	pENTR221	13287		RHBDD1	84236	AAH27900.1	Hs.471514	Rhomboid domain containing 1						NM_032276.2	NP_115652.2	PROVISIONAL	P	1.000	1.000	97	321	28	318	315	219	315
Invitrogen	BC034142	IOH23177	Invitrogen(on gateway)	W01B003L08	pENTR221	1		IGKV1-5	28299	AAH34142										
Invitrogen	NM_000367	IOH27812	Invitrogen(on gateway)	W01B003L09	pENTR221	20443		TPMT	7172	NP_000358.1	Hs.444319	Thiopurine S-methyltransferase						NM_000367.2	NP_000358.1	REVIEWED	C	1.000	1.000	245	738	1	735	245	1	245
Invitrogen	NM_014063	IOH14322	Invitrogen(on gateway)	W01B003L10	pENTR221	21089		DBNL	28988	NP_054782.2	Hs.436500	Drebrin-like						NM_014063.6	NP_054782.2	VALIDATED	C	1.000	1.000	431	1296	1	1293	431	1	431
Invitrogen	NM_033412	IOH7441	Invitrogen(on gateway)	W01B003L11	pENTR221	24026		MCART1	92014	NP_219480.1	Hs.719380	Mitochondrial carrier triple repeat 1						NM_033412.3	NP_219480.1	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
Invitrogen	NM_014096	IOH5144	Invitrogen(on gateway)	W01B003L12	pENTR221	4417		SLC43A3	29015	NP_054815.2	Hs.99962	Solute carrier family 43, member 3						NM_017611.2	NP_060081.1	VALIDATED	C	1.000	1.000	491	1476	1	1473	491	1	491
Invitrogen	NM_173623	IOH27653	Invitrogen(on gateway)	W01B003L13	pENTR221	10594		TTLL6	284076	NP_775894.2	Hs.91930	Tubulin tyrosine ligase-like family, member 6						NM_001130918.1	NP_001124390.1	VALIDATED	P	1.000	1.000	559	1710	31	1707	891	333	891
Invitrogen	NM_018242	IOH9806	Invitrogen(on gateway)	W01B003L14	pENTR221	9824		SLC47A1	55244	NP_060712.2	Hs.232054	Solute carrier family 47, member 1						NM_018242.2	NP_060712.2	VALIDATED	C	1.000	1.000	570	1713	1	1710	570	1	570
Invitrogen	BC010362	IOH27799	Invitrogen(on gateway)	W01B003L15	pENTR221	9157		VPS35	55737	AAH10362.1	Hs.454528	Vacuolar protein sorting 35 homolog (S. cerevisiae)						NM_018206.4	NP_060676.2	REVIEWED	Cs	0.999	0.999	796	2391	1	2388	796	1	796
Invitrogen	NM_024313	IOH5392	Invitrogen(on gateway)	W01B003L16	pENTR221	15487		NOL12	79159	NP_077289.1	Hs.632778	Nucleolar protein 12						NM_024313.2	NP_077289.1	VALIDATED	C	1.000	1.000	213	642	1	639	213	1	213
Invitrogen	BC014621	IOH27774	Invitrogen(on gateway)	W01B003L17	pENTR221	21993		ASNS	440	AAH14621.1	Hs.489207	Asparagine synthetase						NM_133436.2	NP_597680.2	REVIEWED	OK	1.000	1.000	561	1686	1	1683	561	1	561
Invitrogen	NM_015149	IOH39464	Invitrogen(on gateway)	W01B003L19	pENTR221	91		RGL1	23179	NP_055964.3	Hs.497148	Ral guanine nucleotide dissociation stimulator-like 1						NM_015149.3	NP_055964.3	VALIDATED	C	1.000	1.000	803	2412	1	2409	803	1	803
Invitrogen	NM_173487	IOH21933	Invitrogen(on gateway)	W01B003L21	pENTR221	17625		C4orf33	132321	NP_775758.2	Hs.567679	Chromosome 4 open reading frame 33						NM_001099783.1	NP_001093253.1	VALIDATED	Cs	0.995	0.995	199	600	1	597	199	1	199
Invitrogen	NM_031213	IOH21446	Invitrogen(on gateway)	W01B003L23	pENTR221	12442		FAM108A1	81926	NP_112490.3	Hs.653679	Family with sequence similarity 108, member A1						NM_031213.3	NP_112490.3	VALIDATED	Cs	0.997	0.997	361	1086	1	1083	361	1	361
Invitrogen	NM_001005853	IOH28581	Invitrogen(on gateway)	W01B003M01	pENTR221	14319		OR6B2	389090	NP_001005853.1	Hs.531343	Olfactory receptor, family 6, subfamily B, member 2						NM_001005853.1	NP_001005853.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_001004689	IOH28201	Invitrogen(on gateway)	W01B003M02	pENTR221	1061		OR2M3	127062	NP_001004689.1	Hs.553581	Olfactory receptor, family 2, subfamily M, member 3						NM_001004689.1	NP_001004689.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_001005286	IOH28297	Invitrogen(on gateway)	W01B003M03	pENTR221	2290		OR6F1	343169	NP_001005286.1	Hs.591529	Olfactory receptor, family 6, subfamily F, member 1						NM_001005286.1	NP_001005286.1	PROVISIONAL	C	1.000	1.000	308	927	1	924	308	1	308
Invitrogen	ENST00000317093	IOH28178	Invitrogen(on gateway)	W01B003M04	pENTR221	4961		OR52N5	390075	ENSP00000322866	Hs.690207	Olfactory receptor, family 52, subfamily N, member 5						NM_001001922.1	NP_001001922.1	PROVISIONAL	Cs	0.997	0.997	324	975	1	972	324	1	324
Invitrogen	NM_001005483	IOH28216	Invitrogen(on gateway)	W01B003M05	pENTR221	7254		OR4K5	79317	NP_001005483.1	Hs.554585	Olfactory receptor, family 4, subfamily K, member 5						NM_001005483.1	NP_001005483.1	PROVISIONAL	C	1.000	1.000	323	972	1	969	323	1	323
Invitrogen	NM_030946	IOH28341	Invitrogen(on gateway)	W01B003M06	pENTR221	20163		OR14J1	442191	NP_112208.1	Hs.632004	Olfactory receptor, family 14, subfamily J, member 1						NM_030946.1	NP_112208.1	PROVISIONAL	C	1.000	1.000	321	966	1	963	321	1	321
Invitrogen	NM_178127	IOH26886	Invitrogen(on gateway)	W01B003M07	pENTR221	4852		ANGPTL5	253935	NP_835228.2	Hs.318370	Angiopoietin-like 5						NM_178127.4	NP_835228.2	VALIDATED	Cs	0.997	0.997	388	1167	1	1164	388	1	388
Invitrogen	BC000921	IOH2975	Invitrogen(on gateway)	W01B003M08	pENTR221	13961		METTL5	29081	AAH00921.1	Hs.470553	Methyltransferase like 5						NM_014168.2	NP_054887.2	PROVISIONAL	C	1.000	1.000	209	630	1	627	209	1	209
Invitrogen	NM_173545	IOH26160	Invitrogen(on gateway)	W01B003M09	pENTR221	12997		APLF	200558	NP_775816.1	Hs.258941	Aprataxin and PNKP like factor						NM_173545.2	NP_775816.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
Invitrogen	NM_001004706	IOH28239	Invitrogen(on gateway)	W01B003M10	pENTR221	4201		OR4D11	219986	NP_001004706.1	Hs.553651	Olfactory receptor, family 4, subfamily D, member 11						NM_001004706.1	NP_001004706.1	PROVISIONAL	OK	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	BC047393	IOH26537	Invitrogen(on gateway)	W01B003M11	pENTR221	18025		RCHY1	25898	AAH47393.1	Hs.48297	Ring finger and CHY zinc finger domain containing 1						NM_015436.2	NP_056251.2	REVIEWED	Cs	0.996	0.996	261	786	1	783	261	1	261
Invitrogen	NM_178819	IOH29416	Invitrogen(on gateway)	W01B003M12	pENTR221	22598		AGPAT6	137964	NP_848934.1	Hs.355753	1-acylglycerol-3-phosphate O-acyltransferase 6 (lysophosphatidic acid acyltransferase, zeta)						NM_178819.3	NP_848934.1	VALIDATED	C	1.000	1.000	456	1371	1	1368	456	1	456
Invitrogen	NM_198282	IOH26670	Invitrogen(on gateway)	W01B003M13	pENTR221	19357		TMEM173	340061	NP_938023.1	Hs.379754	Transmembrane protein 173						NM_198282.1	NP_938023.1	PROVISIONAL	C	1.000	1.000	379	1140	1	1137	379	1	379
Invitrogen	NM_182616	IOH28986	Invitrogen(on gateway)	W01B003M14	pENTR221	7917		C15orf38	348110	NP_872422.1	Hs.6734	Chromosome 15 open reading frame 38						NM_182616.2	NP_872422.1	VALIDATED	C	1.000	1.000	226	681	1	678	226	1	226
Invitrogen	BC047919	IOH26982	Invitrogen(on gateway)	W01B003M15	pENTR221	20765		C6orf1	221491	AAH47919.1	Hs.381300	Chromosome 6 open reading frame 1						NM_001008703.1	NP_001008703.1	VALIDATED	Cs	0.994	0.994	159	480	1	477	159	1	159
Invitrogen	NM_001005492	IOH28301	Invitrogen(on gateway)	W01B003M16	pENTR221	4168		OR5J2	282775	NP_001005492.1	Hs.537145	Olfactory receptor, family 5, subfamily J, member 2						NM_001005492.1	NP_001005492.1	PROVISIONAL	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	BC040018	IOH26253	Invitrogen(on gateway)	W01B003M17	pENTR221	2025		C1orf110	339512	AAH40018	Hs.407631	Chromosome 1 open reading frame 110						NM_178550.4	NP_848645.3	VALIDATED	Ps	0.980	0.980	201	606	1	603	302	5	205
Invitrogen	Q8NGR9	IOH28267	Invitrogen(on gateway)	W01B003M18	pENTR221															
Invitrogen	BC037780	IOH27748	Invitrogen(on gateway)	W01B003M19	pENTR221	12878		GAD1	2571	AAH37780.1	Hs.420036	Glutamate decarboxylase 1 (brain, 67kDa)						NM_000817.2	NP_000808.2	REVIEWED	Cs	0.998	0.998	594	1785	1	1782	594	1	594
Invitrogen	NM_005494	IOH2886	Invitrogen(on gateway)	W01B003M20	pENTR221	21016		DNAJB6	10049	NP_005485.1	Hs.719116	DnaJ (Hsp40) homolog, subfamily B, member 6						NM_005494.2	NP_005485.1	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
Invitrogen	BC021933	IOH27956	Invitrogen(on gateway)	W01B003M21	pENTR221	11883		CAPNS1	826	AAH21933.1	Hs.515371	Calpain, small subunit 1						NM_001003962.1	NP_001003962.1	REVIEWED	Cs	0.996	0.996	268	807	1	804	268	1	268
Invitrogen	NM_207118	IOH29297	Invitrogen(on gateway)	W01B003M22	pENTR221	19912		GTF2H5	404672	NP_997001.1	Hs.356224	General transcription factor IIH, polypeptide 5						NM_207118.2	NP_997001.1	REVIEWED	C	1.000	1.000	71	216	1	213	71	1	71
Invitrogen	BC014571	IOH27872	Invitrogen(on gateway)	W01B003M23	pENTR221	21416		CPA2	1358	AAH14571.1	Hs.490038	Carboxypeptidase A2 (pancreatic)						NM_001869.2	NP_001860.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	419	3	419
Invitrogen	BC036923	IOH25928	Invitrogen(on gateway)	W01B003M24	pENTR221	23482		C9orf150	286343	AAH36923.1	Hs.445356	Chromosome 9 open reading frame 150						NM_203403.1	NP_981948.1	VALIDATED	Cgs	0.983	0.996	231	696	1	693	228	1	228
Invitrogen	BC013768	IOH11543	Invitrogen(on gateway)	W01B003N01	pENTR221	16171		PCCB	5096	AAH13768.1	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide						NM_000532.3	NP_000523.2	REVIEWED	C	1.000	1.000	539	1620	1	1617	539	1	539
Invitrogen	NM_001004051	IOH9893	Invitrogen(on gateway)	W01B003N02	pENTR221	24743		GPRASP2	114928	NP_001004051.1	Hs.603154	G protein-coupled receptor associated sorting protein 2						NM_138437.3	NP_612446.1	VALIDATED	C	1.000	1.000	838	2517	1	2514	838	1	838
Invitrogen	BC053670	IOH29013	Invitrogen(on gateway)	W01B003N03	pENTR221	8762		CES3	23491	AAH53670.1	Hs.268700	Carboxylesterase 3						NM_024922.4	NP_079198.2	VALIDATED	Cg	0.995	1.000	571	1707	1	1704	571	1	571
Invitrogen	NM_174939	IOH21601	Invitrogen(on gateway)	W01B003N04	pENTR221	3964		C11orf64	283197	NP_777599	Hs.372650	Chromosome 11 open reading frame 64																		
Invitrogen	NM_030981	IOH29640	Invitrogen(on gateway)	W01B003N05	pENTR221	3789		RAB1B	81876	NP_112243.1	Hs.300816	RAB1B, member RAS oncogene family						NM_030981.2	NP_112243.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	BC008383	IOH7227	Invitrogen(on gateway)	W01B003N06	pENTR221	703		CELA3A	10136	AAH08383.1	Hs.654349	Elastase 3A, pancreatic						NM_005747.4	NP_005738.4	REVIEWED	Cs	0.993	0.993	270	813	1	810	270	1	270
Invitrogen	ENST00000330811	IOH27718	Invitrogen(on gateway)	W01B003N07	pENTR221	13136		DYNC2LI1	51626	ENSP00000330752	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1						NM_016008.2	NP_057092.2	VALIDATED		0.932	0.932	118	435	1	354	351	1	118
Invitrogen	BC029444	IOH23178	Invitrogen(on gateway)	W01B003N08	pENTR221	1		IGKC	3514	AAH29444	Hs.703932	Immunoglobulin kappa constant								
Invitrogen	NM_019616	IOH29718	Invitrogen(on gateway)	W01B003N09	pENTR221	6548		F7	2155	NP_062562.1	Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
Invitrogen	BC007760	IOH6442	Invitrogen(on gateway)	W01B003N10	pENTR221	19208		SLC12A7	10723	AAH07760.1	Hs.172613	Solute carrier family 12 (potassium/chloride transporters), member 7						NM_006598.2	NP_006589.2	VALIDATED	Ps	0.983	0.983	231	801	1	693	1083	1	231
Invitrogen	BC026241	IOH12763	Invitrogen(on gateway)	W01B003N11	pENTR221	21364		UBE3C	9690	AAH26241.1	Hs.118351	Ubiquitin protein ligase E3C						NM_014671.2	NP_055486.2	VALIDATED	Pgs	0.901	0.998	445	1215	1	1206	1083	1	445
Invitrogen	NM_001005465	IOH28209	Invitrogen(on gateway)	W01B003N12	pENTR221	7604		OR10G3	26533	NP_001005465.1	Hs.554581	Olfactory receptor, family 10, subfamily G, member 3						NM_001005465.1	NP_001005465.1	VALIDATED	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	BC030026	IOH27093	Invitrogen(on gateway)	W01B003N13	pENTR221	710		C1orf65	164127	AAH30026.1	Hs.192090	Chromosome 1 open reading frame 65						NM_152610.2	NP_689823.2	VALIDATED	Cs	0.998	0.998	623	1872	1	1869	623	1	623
Invitrogen	BC005065	IOH6560	Invitrogen(on gateway)	W01B003N14	pENTR221	5163		ERC1	23085	AAH05065	Hs.658200	ELKS/RAB6-interacting/CAST family member 1						NM_178037.1	NP_829881.1	REVIEWED		0.500	0.500	10	276	163	192	992	13	22
Invitrogen	BC035621	IOH27568	Invitrogen(on gateway)	W01B003N15	pENTR221	6138		FAM186B	84070	AAH35621.1	Hs.524406	Family with sequence similarity 186, member B						NM_032130.2	NP_115506.1	VALIDATED	Cs	0.999	0.999	893	2682	1	2679	893	1	893
Invitrogen	BC007080	IOH7467	Invitrogen(on gateway)	W01B003N17	pENTR221	20064		TMEM14B	81853	AAH07080.1	Hs.95600	Transmembrane protein 14B						NM_030969.3	NP_112231.3	VALIDATED	Cs	0.982	0.982	114	345	1	342	114	1	114
Invitrogen	ENST00000307229	IOH10339	Invitrogen(on gateway)	W01B003N19	pENTR221	10224		NLRP1	22861	ENSP00000307759	Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
Invitrogen	NM_178821	IOH22298	Invitrogen(on gateway)	W01B003N21	pENTR221	13370		WDR69	164781	NP_849143.1	Hs.424594	WD repeat domain 69						NM_178821.1	NP_849143.1	PROVISIONAL	C	1.000	1.000	415	1248	1	1245	415	1	415
Invitrogen	NM_025238	IOH21551	Invitrogen(on gateway)	W01B003N23	pENTR221	8211		BTBD1	53339	NP_079514.1	Hs.459149	BTB (POZ) domain containing 1						NM_025238.3	NP_079514.1	REVIEWED	C	1.000	1.000	482	1449	1	1446	482	1	482
Invitrogen	NM_173351	IOH28287	Invitrogen(on gateway)	W01B003O01	pENTR221	14347		OR6B3	150681	NP_775486.1	Hs.626616	Olfactory receptor, family 6, subfamily B, member 3						NM_173351.1	NP_775486.1	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
Invitrogen	NM_001004724	IOH28486	Invitrogen(on gateway)	W01B003O02	pENTR221	7253		OR4N5	390437	NP_001004724.1	Hs.553766	Olfactory receptor, family 4, subfamily N, member 5						NM_001004724.1	NP_001004724.1	PROVISIONAL	C	1.000	1.000	308	927	1	924	308	1	308
Invitrogen	NM_001005494	IOH28221	Invitrogen(on gateway)	W01B003O03	pENTR221	5667		OR6C4	341418	NP_001005494.1	Hs.554552	Olfactory receptor, family 6, subfamily C, member 4						NM_001005494.1	NP_001005494.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
Invitrogen	NM_001001656	IOH28281	Invitrogen(on gateway)	W01B003O04	pENTR221	21493		OR9A4	130075	NP_001001656.1	Hs.690171	Olfactory receptor, family 9, subfamily A, member 4						NM_001001656.1	NP_001001656.1	PROVISIONAL	OK	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	Q8NGS6	IOH28271	Invitrogen(on gateway)	W01B003O05	pENTR221															
Invitrogen	NM_002157	IOH27794	Invitrogen(on gateway)	W01B003O06	pENTR221	13502		HSPE1	3336	NP_002148.1	Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	C	1.000	1.000	102	309	1	306	102	1	102
Invitrogen	NM_173850	IOH26319	Invitrogen(on gateway)	W01B003O07	pENTR221	7548		SERPINA12	145264	NP_776249.1	Hs.99476	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 12						NM_173850.2	NP_776249.1	PROVISIONAL	C	1.000	1.000	414	1245	1	1242	414	1	414
Invitrogen	BC000934	IOH2996	Invitrogen(on gateway)	W01B003O08	pENTR221	13552		EIF2S2	8894	AAH00934.1	Hs.429180	Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa						NM_003908.3	NP_003899.2	REVIEWED	Cs	0.997	0.997	333	1002	1	999	333	1	333
Invitrogen	NM_005433	IOH26758	Invitrogen(on gateway)	W01B003O09	pENTR221	11280		YES1	7525	NP_005424.1	Hs.194148	V-yes-1 Yamaguchi sarcoma viral oncogene homolog 1						NM_005433.3	NP_005424.1	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
Invitrogen	NM_031904	IOH26139	Invitrogen(on gateway)	W01B003O10	pENTR221	3851		FRMD8	83786	NP_114110.1	Hs.578433	FERM domain containing 8						NM_031904.3	NP_114110.1	VALIDATED	C	1.000	1.000	464	1395	1	1392	464	1	464
Invitrogen	NM_173802	IOH26328	Invitrogen(on gateway)	W01B003O11	pENTR221	5544		C12orf72	254013	NP_776163.1								NM_001135863.1	NP_001129335.1	VALIDATED	C	1.000	1.000	262	789	1	786	262	1	262
Invitrogen	NM_001031743	IOH28717	Invitrogen(on gateway)	W01B003O12	pENTR221	19913		C6orf165	154313	NP_001026913.1	Hs.82921	Chromosome 6 open reading frame 165						NM_001031743.1	NP_001026913.1	PREDICTED	C	1.000	1.000	622	1869	1	1866	622	1	622
Invitrogen	NM_005218	IOH26662	Invitrogen(on gateway)	W01B003O13	pENTR221	23254		DEFB1	1672	NP_005209.1	Hs.32949	Defensin, beta 1						NM_005218.3	NP_005209.1	REVIEWED	C	1.000	1.000	68	207	1	204	68	1	68
Invitrogen	NM_001024655	IOH29247	Invitrogen(on gateway)	W01B003O14	pENTR221	14287		NCRNA00164	554226	NP_001019826	Hs.380689	Non-protein coding RNA 164																		
Invitrogen	NM_032593	IOH26687	Invitrogen(on gateway)	W01B003O15	pENTR221	24078		HINT2	84681	NP_115982.1	Hs.70573	Histidine triad nucleotide binding protein 2						NM_032593.2	NP_115982.1	VALIDATED	C	1.000	1.000	163	492	1	489	163	1	163
Invitrogen	ENST00000305377	IOH28224	Invitrogen(on gateway)	W01B003O16	pENTR221	5664		OR9K2	441639	ENSP00000307598	Hs.553827	Olfactory receptor, family 9, subfamily K, member 2						NM_001005243.1	NP_001005243.1	PROVISIONAL	P	1.000	1.000	313	942	1	939	335	23	335
Invitrogen	NM_031477	IOH27026	Invitrogen(on gateway)	W01B003O17	pENTR221	9204		YPEL3	83719	NP_113665.3	Hs.513491	Yippee-like 3 (Drosophila)						NM_031477.4	NP_113665.3	VALIDATED	C	1.000	1.000	157	606	133	603	157	1	157
Invitrogen	BC058886	IOH29125	Invitrogen(on gateway)	W01B003O18	pENTR221	8257		FLJ11506	79719	AAH58886.1	Hs.254642	Alpha- and gamma-adaptin-binding protein p34						NM_024666.3	NP_078942.3	VALIDATED	C	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	BC035325	IOH27330	Invitrogen(on gateway)	W01B003O19	pENTR221	10383		UTP6	55813	AAH35325.1	Hs.589862	UTP6, small subunit (SSU) processome component, homolog (yeast)						NM_018428.2	NP_060898.2	VALIDATED	Cs	0.998	0.998	597	1794	1	1791	597	1	597
Invitrogen	NM_030908	IOH28404	Invitrogen(on gateway)	W01B003O20	pENTR221	20862		OR2A4	79541	NP_112170.1	Hs.486488	Olfactory receptor, family 2, subfamily A, member 4						NM_030908.1	NP_112170.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
Invitrogen	BC020679	IOH27930	Invitrogen(on gateway)	W01B003O21	pENTR221	5982		RPL6	6128	AAH20679.1	Hs.546283	Ribosomal protein L6						NM_000970.3	NP_000961.2	REVIEWED	Cs	0.997	0.997	288	867	1	864	288	1	288
Invitrogen	BC040177	IOH28709	Invitrogen(on gateway)	W01B003O22	pENTR221	5819		PPM1H	57460	AAH40177	Hs.435479	Protein phosphatase 1H (PP2C domain containing)						NM_020700.1	NP_065751.1	VALIDATED	P	1.000	1.000	82	249	1	246	514	1	82
Invitrogen	NM_003052	IOH26663	Invitrogen(on gateway)	W01B003O23	pENTR221	18804		SLC34A1	6569	NP_003043.3	Hs.936	Solute carrier family 34 (sodium phosphate), member 1						NM_003052.3	NP_003043.3	VALIDATED	Cs	0.998	0.998	639	1920	1	1917	639	1	639
Invitrogen	NM_052953	IOH27626	Invitrogen(on gateway)	W01B003O24	pENTR221	16319		LRRC3B	116135	NP_443185.1	Hs.517868	Leucine rich repeat containing 3B						NM_052953.2	NP_443185.1	PROVISIONAL	OK	1.000	1.000	259	780	1	777	259	1	259
Invitrogen	BC026270	IOH14666	Invitrogen(on gateway)	W01B003P01	pENTR221	139		PDE4DIP	9659	AAH26270.1	Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED		0.976	0.976	164	534	37	528	310	147	310
Invitrogen	NM_003907	IOH9815	Invitrogen(on gateway)	W01B003P02	pENTR221	16166		EIF2B5	8893	NP_003898.2	Hs.283551	Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa						NM_003907.2	NP_003898.2	VALIDATED	Cs	0.999	0.999	721	2166	1	2163	721	1	721
Invitrogen	BC007897	IOH27806	Invitrogen(on gateway)	W01B003P03	pENTR221	16190		PSMD2	5708	AAH07897.1	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2						NM_002808.3	NP_002799.3	REVIEWED	Cs	0.999	0.999	908	2727	1	2724	908	1	908
Invitrogen	NM_080476	IOH21639	Invitrogen(on gateway)	W01B003P04	pENTR221	14913		PIGU	128869	NP_536724.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U						NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
Invitrogen	BC056889	IOH29084	Invitrogen(on gateway)	W01B003P05	pENTR221	19225		C5orf45	51149	AAH56889	Hs.719346	Chromosome 5 open reading frame 45						NM_001017987.2	NP_001017987.1	VALIDATED	Ps	0.995	0.995	209	630	1	627	288	80	288
Invitrogen	BC002508	IOH3971	Invitrogen(on gateway)	W01B003P06	pENTR221	25280		ASMTL	8623	AAH02508.1	Hs.533514	Acetylserotonin O-methyltransferase-like						NM_004192.2	NP_004183.2	VALIDATED	Cs	0.998	0.998	621	1866	1	1863	621	1	621
Invitrogen	BC023260	IOH25812	Invitrogen(on gateway)	W01B003P07	pENTR221	1367		TMEM54	113452	AAH23260.1	Hs.534521	Transmembrane protein 54						NM_033504.2	NP_277039.1	PROVISIONAL	Cg	0.761	1.000	222	510	1	507	222	1	222
Invitrogen	BC034141	IOH23179	Invitrogen(on gateway)	W01B003P08	pENTR221	2		IGKC	3514	AAH34141	Hs.703932	Immunoglobulin kappa constant								
Invitrogen	NM_203299	IOH25878	Invitrogen(on gateway)	W01B003P09	pENTR221	23703		C9orf131	138724	NP_976044.2	Hs.715099	Chromosome 9 open reading frame 131						NM_001040411.1	NP_001035501.1	VALIDATED	Ps	0.998	0.998	1003	3198	187	3195	1006	4	1006
Invitrogen	NM_014424	IOH6462	Invitrogen(on gateway)	W01B003P10	pENTR221	1657		HSPB7	27129	NP_055239.1	Hs.502612	Heat shock 27kDa protein family, member 7 (cardiovascular)						NM_014424.4	NP_055239.1	VALIDATED	C	1.000	1.000	170	513	1	510	170	1	170
Invitrogen	BC020748	IOH13116	Invitrogen(on gateway)	W01B003P11	pENTR221	20595		GPLD1	2822	AAH20748.1	Hs.533291	Glycosylphosphatidylinositol specific phospholipase D1						NM_177483.1	NP_803436.1	REVIEWED	Cs	0.994	0.994	176	531	1	528	176	1	176
Invitrogen	NM_001004466	IOH28577	Invitrogen(on gateway)	W01B003P12	pENTR221	12012		OR10H5	284433	NP_001004466.1	Hs.553676	Olfactory receptor, family 10, subfamily H, member 5						NM_001004466.1	NP_001004466.1	PROVISIONAL	C	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_001931	IOH27422	Invitrogen(on gateway)	W01B003P13	pENTR221	3842		DLAT	1737	NP_001922.2	Hs.335551	Dihydrolipoamide S-acetyltransferase						NM_001931.3	NP_001922.2	VALIDATED	C	1.000	1.000	647	1944	1	1941	647	1	647
Invitrogen	NM_033316	IOH6835	Invitrogen(on gateway)	W01B003P14	pENTR221	16713		MFI2	4241	NP_201573.1	Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	C	1.000	1.000	302	909	1	906	302	1	302
Invitrogen	NM_020879	IOH27213	Invitrogen(on gateway)	W01B003P15	pENTR221	21045		CCDC146	57639	NP_065930.2	Hs.113940	Coiled-coil domain containing 146						NM_020879.2	NP_065930.2	VALIDATED	Cs	0.999	0.999	955	2868	1	2865	955	1	955
Invitrogen	NM_032318	IOH6525	Invitrogen(on gateway)	W01B003P17	pENTR221															
Invitrogen	BC008457	IOH7433	Invitrogen(on gateway)	W01B003P19	pENTR221	20334		HLA-C	3107	AAH08457.1	Hs.656020	Major histocompatibility complex, class I, C						XM_001717045.1	XP_001717097.1	MODEL	Pfs	0.895	0.910	372	1119	2	1117	437	72	437
Invitrogen	NM_152390	IOH22547	Invitrogen(on gateway)	W01B003P21	pENTR221	13328		TMEM178	130733	NP_689603.1	Hs.40808	Transmembrane protein 178						NM_152390.1	NP_689603.1	PROVISIONAL	C	1.000	1.000	297	894	1	891	297	1	297
Invitrogen	BC031227	IOH21600	Invitrogen(on gateway)	W01B003P23	pENTR221	11863		WDR88	126248	AAH31227.2	Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	Ps	0.993	0.993	417	1281	1	1251	472	1	417
Invitrogen	NM_139201	IOH3954	Invitrogen(on gateway)	W01B004A01	pENTR221	5936		GIT2	9815	NP_631940.2	Hs.434996	G protein-coupled receptor kinase interacting ArfGAP 2						NM_139201.2	NP_631940.2	REVIEWED	Cs	0.998	0.998	471	1416	1	1413	471	1	471
Invitrogen	NM_021101	IOH10602	Invitrogen(on gateway)	W01B004A02	pENTR221	16889		CLDN1	9076	NP_066924.1	Hs.439060	Claudin 1						NM_021101.3	NP_066924.1	REVIEWED	C	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	BC001454	IOH3989	Invitrogen(on gateway)	W01B004A03	pENTR221	7163		PCK2	5106	AAH01454.1	Hs.75812	Phosphoenolpyruvate carboxykinase 2 (mitochondrial)						NM_004563.2	NP_004554.2	REVIEWED	Cs	0.998	0.998	640	1923	1	1920	640	1	640
Invitrogen	NM_144590	IOH12404	Invitrogen(on gateway)	W01B004A04	pENTR221	3413		ANKRD22	118932	NP_653191.2	Hs.217484	Ankyrin repeat domain 22						NM_144590.2	NP_653191.2	VALIDATED	Cs	0.995	0.995	191	576	1	573	191	1	191
Invitrogen	NM_000431	IOH10122	Invitrogen(on gateway)	W01B004A05	pENTR221	5259		MVK	4598	NP_000422.1	Hs.130607	Mevalonate kinase						NM_000431.2	NP_000422.1	REVIEWED	C	1.000	1.000	396	1191	1	1188	396	1	396
Invitrogen	NM_006118	IOH1939	Invitrogen(on gateway)	W01B004A06	pENTR221	895		HAX1	10456	NP_006109.2	Hs.199625	HCLS1 associated protein X-1						NM_006118.3	NP_006109.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
Invitrogen	NM_001798	IOH21140	Invitrogen(on gateway)	W01B004A07	pENTR221	5159		CDK2	1017	NP_001789.2	Hs.19192	Cyclin-dependent kinase 2						NM_001798.3	NP_001789.2	REVIEWED	C	1.000	1.000	298	897	1	894	298	1	298
Invitrogen	NM_000536	IOH12921	Invitrogen(on gateway)	W01B004A08	pENTR221	4569		RAG2	5897	NP_000527.2	Hs.714519	Recombination activating gene 2						NM_000536.2	NP_000527.2	REVIEWED	Cs	0.996	0.996	527	1584	1	1581	527	1	527
Invitrogen	NM_001661	IOH4765	Invitrogen(on gateway)	W01B004A09	pENTR221	9600		ARL4D	379	NP_001652.2	Hs.183153	ADP-ribosylation factor-like 4D						NM_001661.3	NP_001652.2	REVIEWED	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	NM_144676	IOH13348	Invitrogen(on gateway)	W01B004A10	pENTR221	9359		TMED6	146456	NP_653277.1	Hs.658619	Transmembrane emp24 protein transport domain containing 6						NM_144676.2	NP_653277.1	PROVISIONAL	C	1.000	1.000	240	723	1	720	240	1	240
Invitrogen	NM_018969	IOH13239	Invitrogen(on gateway)	W01B004A11	pENTR221	24523		GPR173	54328	NP_061842.1	Hs.661815	G protein-coupled receptor 173						NM_018969.4	NP_061842.1	VALIDATED	C	1.000	1.000	373	1122	1	1119	373	1	373
Invitrogen	BC014616	IOH12528	Invitrogen(on gateway)	W01B004A12	pENTR221	16547		DAG1	1605	AAH14616.1	Hs.76111	Dystroglycan 1 (dystrophin-associated glycoprotein 1)						NM_004393.2	NP_004384.2	REVIEWED	C	1.000	1.000	895	2688	1	2685	895	1	895
Invitrogen	NM_021137	IOH3751	Invitrogen(on gateway)	W01B004A13	pENTR221	9978		TNFAIP1	7126	NP_066960.1	Hs.76090	Tumor necrosis factor, alpha-induced protein 1 (endothelial)						NM_021137.4	NP_066960.1	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
Invitrogen	BC014146	IOH12774	Invitrogen(on gateway)	W01B004A14	pENTR221	1521		AP4B1	10717	AAH14146.1	Hs.515048	Adaptor-related protein complex 4, beta 1 subunit						NM_006594.2	NP_006585.2	VALIDATED	C	1.000	1.000	739	2220	1	2217	739	1	739
Invitrogen	NM_002903	IOH4436	Invitrogen(on gateway)	W01B004A15	pENTR221	10185		RCVRN	5957	NP_002894.1	Hs.80539	Recoverin						NM_002903.2	NP_002894.1	REVIEWED	C	1.000	1.000	200	603	1	600	200	1	200
Invitrogen	BC024002	IOH11100	Invitrogen(on gateway)	W01B004A16	pENTR221	9954		FNDC8	54752	AAH24002.1	Hs.120369	Fibronectin type III domain containing 8						NM_017559.2	NP_060029.1	VALIDATED	Cs	0.997	0.997	324	975	1	972	324	1	324
Invitrogen	BC001120	IOH3920	Invitrogen(on gateway)	W01B004A17	pENTR221	6934		LGALS3	3958	AAH01120.1	Hs.531081	Lectin, galactoside-binding, soluble, 3						NM_002306.2	NP_002297.2	VALIDATED	C	1.000	1.000	250	753	1	750	250	1	250
Invitrogen	NM_016289	IOH10730	Invitrogen(on gateway)	W01B004A18	pENTR221	12989		CAB39	51719	NP_057373.1	Hs.632536	Calcium binding protein 39						NM_001130850.1	NP_001124322.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
Invitrogen	NM_015994	IOH4090	Invitrogen(on gateway)	W01B004A19	pENTR221	7405		ATP6V1D	51382	NP_057078.1	Hs.272630	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D						NM_015994.2	NP_057078.1	REVIEWED	C	1.000	1.000	247	744	1	741	247	1	247
Invitrogen	BC009764	IOH12737	Invitrogen(on gateway)	W01B004A20	pENTR221	3812		MRPL48	51642	AAH09764.1	Hs.503239	Mitochondrial ribosomal protein L48						NM_016055.5	NP_057139.1	REVIEWED	Cs	0.995	0.995	212	639	1	636	212	1	212
Invitrogen	NM_138820	IOH4234	Invitrogen(on gateway)	W01B004A21	pENTR221	18872		HIGD2A	192286	NP_620175.1	Hs.534575	HIG1 hypoxia inducible domain family, member 2A						NM_138820.2	NP_620175.1	PROVISIONAL	C	1.000	1.000	106	321	1	318	106	1	106
Invitrogen	BC012844	IOH10523	Invitrogen(on gateway)	W01B004A22	pENTR221	14738		PRNP	5621	AAH12844.1	Hs.714553	Prion protein						NM_001080122.1	NP_001073591.1	REVIEWED	Cs	0.996	0.996	253	762	1	759	253	1	253
Invitrogen	NM_020445	IOH3354	Invitrogen(on gateway)	W01B004A23	pENTR221	21079		ACTR3B	57180	NP_065178.1	Hs.647117	ARP3 actin-related protein 3 homolog B (yeast)						NM_020445.4	NP_065178.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
Invitrogen	NM_002880	IOH10773	Invitrogen(on gateway)	W01B004A24	pENTR221	17204		RAF1	5894	NP_002871.1	Hs.159130	V-raf-1 murine leukemia viral oncogene homolog 1						NM_002880.3	NP_002871.1	REVIEWED	OK	1.000	1.000	648	1947	1	1944	648	1	648
Invitrogen	NM_003129	IOH10353	Invitrogen(on gateway)	W01B004B01	pENTR221	22557		SQLE	6713	NP_003120.2	Hs.71465	Squalene epoxidase						NM_003129.3	NP_003120.2	REVIEWED	C	1.000	1.000	574	1725	1	1722	574	1	574
Invitrogen	NM_005530	IOH13556	Invitrogen(on gateway)	W01B004B02	pENTR221	7882		IDH3A	3419	NP_005521.1	Hs.591110	Isocitrate dehydrogenase 3 (NAD+) alpha						NM_005530.2	NP_005521.1	REVIEWED	C	1.000	1.000	366	1101	1	1098	366	1	366
Invitrogen	NM_005506	IOH9776	Invitrogen(on gateway)	W01B004B03	pENTR221	18145		SCARB2	950	NP_005497.1	Hs.349656	Scavenger receptor class B, member 2						NM_005506.2	NP_005497.1	REVIEWED	C	1.000	1.000	478	1437	1	1434	478	1	478
Invitrogen	BC017592	IOH11025	Invitrogen(on gateway)	W01B004B04	pENTR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4						NM_181710.3	NP_859061.3	VALIDATED	Ps	0.988	0.988	420	1263	1	1260	429	10	429
Invitrogen	NM_005880	IOH10150	Invitrogen(on gateway)	W01B004B05	pENTR221	9162		DNAJA2	10294	NP_005871.1	Hs.368078	DnaJ (Hsp40) homolog, subfamily A, member 2						NM_005880.3	NP_005871.1	REVIEWED	C	1.000	1.000	412	1239	1	1236	412	1	412
Invitrogen	NM_007103	IOH14470	Invitrogen(on gateway)	W01B004B06	pENTR221	3754		NDUFV1	4723	NP_009034.2	Hs.7744	NADH dehydrogenase (ubiquinone) flavoprotein 1, 51kDa						NM_007103.3	NP_009034.2	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
Invitrogen	NM_138793	IOH9933	Invitrogen(on gateway)	W01B004B07	pENTR221	10278		CANT1	124583	NP_620148.1	Hs.8859	Calcium activated nucleotidase 1						NM_001159772.1	NP_001153244.1	VALIDATED	C	1.000	1.000	401	1206	1	1203	401	1	401
Invitrogen	BC017844	IOH14384	Invitrogen(on gateway)	W01B004B08	pENTR221	9224		IGSF6	10261	AAH17844.1	Hs.530902	Immunoglobulin superfamily, member 6						NM_005849.2	NP_005840.2	VALIDATED	Cs	0.992	0.992	241	726	1	723	241	1	241
Invitrogen	BC005960	IOH7542	Invitrogen(on gateway)	W01B004B09	pENTR221	808		ATP5F1	515	AAH05960.1	Hs.514870	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1						NM_001688.4	NP_001679.2	REVIEWED	Cs	0.992	0.992	256	771	1	768	256	1	256
Invitrogen	NM_000136	IOH12110	Invitrogen(on gateway)	W01B004B10	pENTR221	23790		FANCC	2176	NP_000127.2	Hs.494529	Fanconi anemia, complementation group C						NM_000136.2	NP_000127.2	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
Invitrogen	NM_138387	IOH14855	Invitrogen(on gateway)	W01B004B11	pENTR221	9979		G6PC3	92579	NP_612396.1	Hs.294005	Glucose 6 phosphatase, catalytic, 3						NM_138387.2	NP_612396.1	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
Invitrogen	NM_053004	IOH14758	Invitrogen(on gateway)	W01B004B12	pENTR221	15791		GNB1L	54584	NP_443730.1	Hs.105642	Guanine nucleotide binding protein (G protein), beta polypeptide 1-like						NM_053004.2	NP_443730.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
Invitrogen	NM_006521	IOH14020	Invitrogen(on gateway)	W01B004B13	pENTR221	25357		TFE3	7030	NP_006512.2	Hs.274184	Transcription factor binding to IGHM enhancer 3						NM_006521.3	NP_006512.2	PROVISIONAL	C	1.000	1.000	575	1728	1	1725	575	1	575
Invitrogen	NM_004507	IOH7302	Invitrogen(on gateway)	W01B004B14	pENTR221	21880		HUS1	3364	NP_004498.1	Hs.152983	HUS1 checkpoint homolog (S. pombe)						NM_004507.2	NP_004498.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
Invitrogen	ENST00000246117	IOH14622	Invitrogen(on gateway)	W01B004B15	pENTR221	11700		NCLN	56926	ENSP00000246117	Hs.657032	Nicalin homolog (zebrafish)						NM_020170.3	NP_064555.2	VALIDATED	P	1.000	1.000	552	1659	1	1656	563	12	563
Invitrogen	NM_001012321	IOH7174	Invitrogen(on gateway)	W01B004B16	pENTR221	12005		RPSA	3921	NP_001012321.1	Hs.449909	Ribosomal protein SA						NM_002295.4	NP_002286.2	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
Invitrogen	NM_002267	IOH14046	Invitrogen(on gateway)	W01B004B17	pENTR221	6680		KPNA3	3839	NP_002258.2	Hs.527919	Karyopherin alpha 3 (importin alpha 4)						NM_002267.3	NP_002258.2	REVIEWED	C	1.000	1.000	521	1566	1	1563	521	1	521
Invitrogen	NM_003118	IOH5095	Invitrogen(on gateway)	W01B004B18	pENTR221	19361		SPARC	6678	NP_003109.1	Hs.111779	Secreted protein, acidic, cysteine-rich (osteonectin)						NM_003118.2	NP_003109.1	PROVISIONAL	C	1.000	1.000	303	912	1	909	303	1	303
Invitrogen	NM_006137	IOH14100	Invitrogen(on gateway)	W01B004B19	pENTR221	10658		CD7	924	NP_006128.1	Hs.36972	CD7 molecule						NM_006137.6	NP_006128.1	REVIEWED	C	1.000	1.000	240	723	1	720	240	1	240
Invitrogen	NM_001861	IOH6832	Invitrogen(on gateway)	W01B004B20	pENTR221	8918		COX4I1	1327	NP_001852.1	Hs.433419	Cytochrome c oxidase subunit IV isoform 1						NM_001861.2	NP_001852.1	REVIEWED	C	1.000	1.000	169	510	1	507	169	1	169
Invitrogen	BC010923	IOH13723	Invitrogen(on gateway)	W01B004B21	pENTR221	5592		ALX1	8092	AAH10923.1	Hs.41683	ALX homeobox 1						NM_006982.2	NP_008913.2	REVIEWED	C	1.000	1.000	326	981	1	978	326	1	326
Invitrogen	NM_006923	IOH4099	Invitrogen(on gateway)	W01B004B22	pENTR221	10687		SDF2	6388	NP_008854.2	Hs.514036	Stromal cell-derived factor 2						NM_006923.2	NP_008854.2	REVIEWED	C	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	NM_152697	IOH11708	Invitrogen(on gateway)	W01B004B23	pENTR221	1961		SLC44A5	204962	NP_689910.2	Hs.654821	Solute carrier family 44, member 5						NM_152697.4	NP_689910.2	VALIDATED	Cs	0.999	0.999	719	2160	1	2157	719	1	719
Invitrogen	NM_007065	IOH6219	Invitrogen(on gateway)	W01B004B24	pENTR221	12655		CDC37	11140	NP_008996.1	Hs.160958	Cell division cycle 37 homolog (S. cerevisiae)						NM_007065.3	NP_008996.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
Invitrogen	NM_000294	IOH4032	Invitrogen(on gateway)	W01B004C01	pENTR221	8608		PHKG2	5261	NP_000285.1	Hs.196177	Phosphorylase kinase, gamma 2 (testis)						NM_000294.1	NP_000285.1	PROVISIONAL	OK	1.000	1.000	406	1221	1	1218	406	1	406
Invitrogen	NM_138798	IOH10640	Invitrogen(on gateway)	W01B004C02	pENTR221	14224		MITD1	129531	NP_620153.1	Hs.14222	MIT, microtubule interacting and transport, domain containing 1						NM_138798.1	NP_620153.1	PROVISIONAL	C	1.000	1.000	249	750	1	747	249	1	249
Invitrogen	BC007514	IOH6107	Invitrogen(on gateway)	W01B004C03	pENTR221	24547		ARAF	369	AAH07514.1	Hs.446641	V-raf murine sarcoma 3611 viral oncogene homolog						NM_001654.2	NP_001645.1	VALIDATED	Cg	0.995	1.000	609	1830	1	1827	606	1	606
Invitrogen	NM_012423	IOH1803	Invitrogen(on gateway)	W01B004C04	pENTR221	11453		RPL13A	23521	NP_036555.1	Hs.523185	Ribosomal protein L13a						NM_012423.2	NP_036555.1	REVIEWED	C	1.000	1.000	203	612	1	609	203	1	203
Invitrogen	NM_005391	IOH10145	Invitrogen(on gateway)	W01B004C05	pENTR221	24848		PDK3	5165	NP_005382.1	Hs.658190	Pyruvate dehydrogenase kinase, isozyme 3						NM_005391.3	NP_005382.1	VALIDATED	C	1.000	1.000	406	1221	1	1218	406	1	406
Invitrogen	NM_000387	IOH1973	Invitrogen(on gateway)	W01B004C06	pENTR221	17173		SLC25A20	788	NP_000378.1	Hs.13845	Solute carrier family 25 (carnitine/acylcarnitine translocase), member 20						NM_000387.4	NP_000378.1	REVIEWED	C	1.000	1.000	301	906	1	903	301	1	301
Invitrogen	NM_004226	IOH21114	Invitrogen(on gateway)	W01B004C07	pENTR221	13751		STK17B	9262	NP_004217.1	Hs.88297	Serine/threonine kinase 17b						NM_004226.3	NP_004217.1	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
Invitrogen	NM_138957	IOH12327	Invitrogen(on gateway)	W01B004C08	pENTR221	15900		MAPK1	5594	NP_620407.1	Hs.431850	Mitogen-activated protein kinase 1						NM_002745.4	NP_002736.3	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
Invitrogen	NM_022337	IOH10104	Invitrogen(on gateway)	W01B004C09	pENTR221	4599		RAB38	23682	NP_071732.1	Hs.591975	RAB38, member RAS oncogene family						NM_022337.1	NP_071732.1	PROVISIONAL	OK	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	BC020620	IOH12057	Invitrogen(on gateway)	W01B004C10	pENTR221	16301		NIT2	56954	AAH20620.1	Hs.439152	Nitrilase family, member 2						NM_020202.4	NP_064587.1	VALIDATED	Cs	0.996	0.996	276	831	1	828	276	1	276
Invitrogen	BC022447	IOH10876	Invitrogen(on gateway)	W01B004C11	pENTR221	16561		AGTR1	185	AAH22447.1	Hs.719071	Angiotensin II receptor, type 1						NM_032049.2	NP_114438.1	REVIEWED	Cs	0.994	0.994	359	1080	1	1077	359	1	359
Invitrogen	NM_178858	IOH13450	Invitrogen(on gateway)	W01B004C12	pENTR221	2733		SFXN2	118980	NP_849189.1	Hs.44070	Sideroflexin 2						NM_178858.4	NP_849189.1	VALIDATED	C	1.000	1.000	322	969	1	966	322	1	322
Invitrogen	NM_021950	IOH5399	Invitrogen(on gateway)	W01B004C13	pENTR221	4080		MS4A1	931	NP_068769.2	Hs.712553	Membrane-spanning 4-domains, subfamily A, member 1						NM_152866.2	NP_690605.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
Invitrogen	BC026325	IOH11158	Invitrogen(on gateway)	W01B004C14	pENTR221	25111		NAP1L2	4674	AAH26325.1	Hs.719281	Nucleosome assembly protein 1-like 2						NM_021963.2	NP_068798.1	REVIEWED	Cs	0.998	0.998	460	1383	1	1380	460	1	460
Invitrogen	NM_016301	IOH7464	Invitrogen(on gateway)	W01B004C15	pENTR221	5928		GPN3	51184	NP_057385.2	Hs.634680	GPN-loop GTPase 3						NM_016301.2	NP_057385.2	PROVISIONAL	C	1.000	1.000	284	855	1	852	284	1	284
Invitrogen	NM_031291	IOH10919	Invitrogen(on gateway)	W01B004C16	pENTR221	17575		SLC25A31	83447	NP_112581.1	Hs.149030	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 31						NM_031291.2	NP_112581.1	VALIDATED	C	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_005533	IOH3930	Invitrogen(on gateway)	W01B004C17	pENTR221	9845		IFI35	3430	NP_005524.1	Hs.632258	Interferon-induced protein 35						NM_005533.3	NP_005524.1	VALIDATED	C	1.000	1.000	288	867	1	864	288	1	288
Invitrogen	NM_033644	IOH11042	Invitrogen(on gateway)	W01B004C18	pENTR221	19090		FBXW11	23291	NP_387448.2	Hs.484138	F-box and WD repeat domain containing 11						NM_033644.2	NP_387448.2	REVIEWED	C	1.000	1.000	529	1590	1	1587	529	1	529
Invitrogen	BC002616	IOH4117	Invitrogen(on gateway)	W01B004C19	pENTR221	1610		TAGLN2	8407	AAH02616.1	Hs.517168	Transgelin 2						NM_003564.1	NP_003555.1	REVIEWED	Cs	0.995	0.995	199	600	1	597	199	1	199
Invitrogen	NM_006299	IOH12838	Invitrogen(on gateway)	W01B004C20	pENTR221	20058		ZNF193	7746	NP_006290.1	Hs.100921	Zinc finger protein 193						NM_006299.3	NP_006290.1	PROVISIONAL	OK	1.000	1.000	394	1185	1	1182	394	1	394
Invitrogen	NM_003973	IOH4249	Invitrogen(on gateway)	W01B004C21	pENTR221	5532		RPL14	9045	NP_003964.3	Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED	Cg	0.995	1.000	216	651	1	648	215	1	215
Invitrogen	NM_005412	IOH10529	Invitrogen(on gateway)	W01B004C22	pENTR221	5431		SHMT2	6472	NP_005403.2	Hs.719098	Serine hydroxymethyltransferase 2 (mitochondrial)						NM_005412.4	NP_005403.2	PROVISIONAL	C	1.000	1.000	504	1515	1	1512	504	1	504
Invitrogen	BC002374	IOH3595	Invitrogen(on gateway)	W01B004C23	pENTR221	17117		KPNA1	3836	AAH02374.1	Hs.161008	Karyopherin alpha 1 (importin alpha 5)						NM_002264.3	NP_002255.3	REVIEWED	Cs	0.998	0.998	538	1617	1	1614	538	1	538
Invitrogen	NM_032145	IOH10846	Invitrogen(on gateway)	W01B004C24	pENTR221	20539		FBXO30	84085	NP_115521.3	Hs.421095	F-box protein 30						NM_032145.4	NP_115521.3	REVIEWED	C	1.000	1.000	745	2238	1	2235	745	1	745
Invitrogen	NM_022094	IOH10416	Invitrogen(on gateway)	W01B004D01	pENTR221	16957		CIDEC	63924	NP_071377.2	Hs.635072	Cell death-inducing DFFA-like effector c						NM_022094.2	NP_071377.2	PROVISIONAL	C	1.000	1.000	238	717	1	714	238	1	238
Invitrogen	BC018847	IOH14862	Invitrogen(on gateway)	W01B004D02	pENTR221	4031		TALDO1	6888	AAH18847.2	Hs.438678	Transaldolase 1						NM_006755.1	NP_006746.1	REVIEWED	P	1.000	1.000	327	984	1	981	337	11	337
Invitrogen	NM_002862	IOH9832	Invitrogen(on gateway)	W01B004D03	pENTR221	14585		PYGB	5834	NP_002853.2	Hs.368157	Phosphorylase, glycogen; brain						NM_002862.3	NP_002853.2	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
Invitrogen	BC025394	IOH10856	Invitrogen(on gateway)	W01B004D04	pENTR221	3294		MARCH8	220972	AAH25394.1	Hs.499489	Membrane-associated ring finger (C3HC4) 8						NM_001002265.1	NP_001002265.1	VALIDATED	Cs	0.997	0.997	291	876	1	873	291	1	291
Invitrogen	BC007566	IOH6849	Invitrogen(on gateway)	W01B004D05	pENTR221	12265		M6PRBP1	10226	AAH07566.1	Hs.140452	Mannose-6-phosphate receptor binding protein 1						NM_005817.3	NP_005808.2	REVIEWED	Cs	0.998	0.998	434	1305	1	1302	434	1	434
Invitrogen	NM_000396	IOH14212	Invitrogen(on gateway)	W01B004D06	pENTR221	2059		CTSK	1513	NP_000387.1	Hs.632466	Cathepsin K						NM_000396.2	NP_000387.1	REVIEWED	C	1.000	1.000	329	990	1	987	329	1	329
Invitrogen	NM_004782	IOH9957	Invitrogen(on gateway)	W01B004D07	pENTR221	15563		SNAP29	9342	NP_004773.1	Hs.108002	Synaptosomal-associated protein, 29kDa						NM_004782.3	NP_004773.1	REVIEWED	C	1.000	1.000	258	777	1	774	258	1	258
Invitrogen	NM_020367	IOH13091	Invitrogen(on gateway)	W01B004D08	pENTR221	5984		PARP11	57097	NP_065100.2	Hs.657268	Poly (ADP-ribose) polymerase family, member 11						NM_020367.4	NP_065100.2	VALIDATED	P	1.000	1.000	331	996	1	993	338	8	338
Invitrogen	NM_001561	IOH5753	Invitrogen(on gateway)	W01B004D09	pENTR221	2159		TNFRSF9	3604	NP_001552.2	Hs.654459	Tumor necrosis factor receptor superfamily, member 9						NM_001561.4	NP_001552.2	REVIEWED	C	1.000	1.000	255	768	1	765	255	1	255
Invitrogen	NM_006215	IOH12257	Invitrogen(on gateway)	W01B004D10	pENTR221	7211		SERPINA4	5267	NP_006206.2								NM_006215.2	NP_006206.2	PROVISIONAL	OK	1.000	1.000	427	1284	1	1281	427	1	427
Invitrogen	NM_021105	IOH13995	Invitrogen(on gateway)	W01B004D11	pENTR221	16722		PLSCR1	5359	NP_066928.1	Hs.130759	Phospholipid scramblase 1						NM_021105.2	NP_066928.1	VALIDATED	C	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	BC012133	IOH14580	Invitrogen(on gateway)	W01B004D12	pENTR221	19273		TNIP1	10318	AAH12133.1	Hs.355141	TNFAIP3 interacting protein 1						NM_006058.3	NP_006049.3	VALIDATED	Cs	0.998	0.998	636	1911	1	1908	636	1	636
Invitrogen	BC024269	IOH13934	Invitrogen(on gateway)	W01B004D13	pENTR221	20149		HLA-DRB1	3123	AAH24269.1	Hs.701691	Major histocompatibility complex, class II, DR beta 1						XM_001124749.2	XP_001124749.1	MODEL		0.925	0.925	266	801	1	798	266	1	266
Invitrogen	BC005279	IOH7369	Invitrogen(on gateway)	W01B004D14	pENTR221	21370		CPA1	1357	AAH05279.1	Hs.2879	Carboxypeptidase A1 (pancreatic)						NM_001868.2	NP_001859.1	REVIEWED	Cs	0.998	0.998	419	1260	1	1257	419	1	419
Invitrogen	BC011888	IOH14513	Invitrogen(on gateway)	W01B004D15	pENTR221	10622		SLC35B1	10237	AAH11888.1	Hs.154073	Solute carrier family 35, member B1						NM_005827.1	NP_005818.1	PROVISIONAL	Cs	0.997	0.997	322	969	1	966	322	1	322
Invitrogen	NM_001639	IOH7176	Invitrogen(on gateway)	W01B004D16	pENTR221	901		APCS	325	NP_001630.1	Hs.507080	Amyloid P component, serum						NM_001639.3	NP_001630.1	REVIEWED	C	1.000	1.000	223	672	1	669	223	1	223
Invitrogen	NM_002413	IOH13576	Invitrogen(on gateway)	W01B004D17	pENTR221	17674		MGST2	4258	NP_002404.1	Hs.81874	Microsomal glutathione S-transferase 2						NM_002413.3	NP_002404.1	REVIEWED	C	1.000	1.000	147	444	1	441	147	1	147
Invitrogen	BC003154	IOH5098	Invitrogen(on gateway)	W01B004D18	pENTR221	23758		TRIM32	22954	AAH03154.1	Hs.591910	Tripartite motif-containing 32						NM_001099679.1	NP_001093149.1	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
Invitrogen	NM_138385	IOH13771	Invitrogen(on gateway)	W01B004D19	pENTR221	18211		TMEM129	92305	NP_612394.1	Hs.518562	Transmembrane protein 129						NM_138385.3	NP_612394.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
Invitrogen	NM_138381	IOH6954	Invitrogen(on gateway)	W01B004D20	pENTR221	16186		OXNAD1	92106	NP_612390.1	Hs.655449	Oxidoreductase NAD-binding domain containing 1						NM_138381.2	NP_612390.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	BC012611	IOH13711	Invitrogen(on gateway)	W01B004D21	pENTR221	18266		EIF4E	1977	AAH12611.1	Hs.249718	Eukaryotic translation initiation factor 4E						NM_001968.3	NP_001959.1	VALIDATED	Cs	0.995	0.995	217	654	1	651	217	1	217
Invitrogen	NM_015324	IOH4643	Invitrogen(on gateway)	W01B004D22	pENTR221	4394		RRP8	23378	NP_056139.1	Hs.652255	Ribosomal RNA processing 8, methyltransferase, homolog (yeast)						NM_015324.2	NP_056139.1	PROVISIONAL	C	1.000	1.000	456	1371	1	1368	456	1	456
Invitrogen	BC028740	IOH11456	Invitrogen(on gateway)	W01B004D23	pENTR221	13904		STAM2	10254	AAH28740.1	Hs.17200	Signal transducing adaptor molecule (SH3 domain and ITAM motif) 2						NM_005843.4	NP_005834.4	REVIEWED	OK	1.000	1.000	525	1578	1	1575	525	1	525
Invitrogen	NM_012208	IOH6231	Invitrogen(on gateway)	W01B004D24	pENTR221	18873		HARS2	23438	NP_036340.1	Hs.432560	Histidyl-tRNA synthetase 2, mitochondrial (putative)						NM_012208.2	NP_036340.1	REVIEWED	C	1.000	1.000	506	1521	1	1518	506	1	506
Invitrogen	NM_003639	IOH3445	Invitrogen(on gateway)	W01B004E01	pENTR221	24590		IKBKG	8517	NP_003630.1	Hs.43505	Inhibitor of kappa light polypeptide gene enhancer in B-cells, kinase gamma						NM_003639.3	NP_003630.1	REVIEWED	C	1.000	1.000	419	1260	1	1257	419	1	419
Invitrogen	BC012920	IOH11297	Invitrogen(on gateway)	W01B004E02	pENTR221	2592		DNTT	1791	AAH12920.1	Hs.534206	Deoxynucleotidyltransferase, terminal						NM_004088.3	NP_004079.3	REVIEWED	Cs	0.998	0.998	509	1530	1	1527	509	1	509
Invitrogen	BC006233	IOH6288	Invitrogen(on gateway)	W01B004E03	pENTR221	13413		KHK	3795	AAH06233.1	Hs.567297	Ketohexokinase (fructokinase)						NM_000221.2	NP_000212.1	REVIEWED	Cs	0.997	0.997	298	897	1	894	298	1	298
Invitrogen	NM_078473	IOH1833	Invitrogen(on gateway)	W01B004E04	pENTR221	23075		TM2D2	83877	NP_510882.1	Hs.7471	TM2 domain containing 2						NM_078473.2	NP_510882.1	VALIDATED	C	1.000	1.000	214	645	1	642	214	1	214
Invitrogen	NM_005565	IOH11014	Invitrogen(on gateway)	W01B004E05	pENTR221	19428		LCP2	3937	NP_005556.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)						NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
Invitrogen	NM_002198	IOH2022	Invitrogen(on gateway)	W01B004E06	pENTR221	19141		IRF1	3659	NP_002189.1	Hs.436061	Interferon regulatory factor 1						NM_002198.2	NP_002189.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
Invitrogen	NM_021643	IOH21149	Invitrogen(on gateway)	W01B004E07	pENTR221	13442		TRIB2	28951	NP_067675.1	Hs.467751	Tribbles homolog 2 (Drosophila)						NM_021643.3	NP_067675.1	REVIEWED	C	1.000	1.000	343	1032	1	1029	343	1	343
Invitrogen	NM_005797	IOH12078	Invitrogen(on gateway)	W01B004E08	pENTR221	4541		MPZL2	10205	NP_005788.1	Hs.116651	Myelin protein zero-like 2						NM_005797.2	NP_005788.1	REVIEWED	C	1.000	1.000	215	648	1	645	215	1	215
Invitrogen	NM_004283	IOH10511	Invitrogen(on gateway)	W01B004E09	pENTR221	12246		RAB3D	9545	NP_004274.1	Hs.655274	RAB3D, member RAS oncogene family						NM_004283.2	NP_004274.1	PROVISIONAL	OK	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	NM_012391	IOH12673	Invitrogen(on gateway)	W01B004E10	pENTR221	20367		SPDEF	25803	NP_036523.1	Hs.485158	SAM pointed domain containing ets transcription factor						NM_012391.1	NP_036523.1	PROVISIONAL	C	1.000	1.000	335	1008	1	1005	335	1	335
Invitrogen	NM_004720	IOH11033	Invitrogen(on gateway)	W01B004E11	pENTR221	12241		LPAR2	9170	NP_004711.2	Hs.122575	Lysophosphatidic acid receptor 2						NM_004720.5	NP_004711.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
Invitrogen	NM_014331	IOH13064	Invitrogen(on gateway)	W01B004E12	pENTR221	17980		SLC7A11	23657	NP_055146.1	Hs.390594	Solute carrier family 7, (cationic amino acid transporter, y+ system) member 11						NM_014331.3	NP_055146.1	VALIDATED	C	1.000	1.000	501	1506	1	1503	501	1	501
Invitrogen	NM_000810	IOH9744	Invitrogen(on gateway)	W01B004E13	pENTR221	7665		GABRA5	2558	NP_000801.1	Hs.612087	Gamma-aminobutyric acid (GABA) A receptor, alpha 5						NM_000810.2	NP_000801.1	REVIEWED	C	1.000	1.000	462	1389	1	1386	462	1	462
Invitrogen	NM_002544	IOH10628	Invitrogen(on gateway)	W01B004E14	pENTR221	10653		OMG	4974	NP_002535.3	Hs.113874	Oligodendrocyte myelin glycoprotein						NM_002544.4	NP_002535.3	VALIDATED	C	1.000	1.000	440	1323	1	1320	440	1	440
Invitrogen	NM_024594	IOH10705	Invitrogen(on gateway)	W01B004E15	pENTR221	19300		PANK3	79646	NP_078870.1	Hs.591729	Pantothenate kinase 3						NM_024594.2	NP_078870.1	REVIEWED	C	1.000	1.000	370	1113	1	1110	370	1	370
Invitrogen	NM_021245	IOH11059	Invitrogen(on gateway)	W01B004E16	pENTR221	3224		MYOZ1	58529	NP_067068.1	Hs.238756	Myozenin 1						NM_021245.2	NP_067068.1	PROVISIONAL	C	1.000	1.000	299	900	1	897	299	1	299
Invitrogen	NM_004804	IOH3935	Invitrogen(on gateway)	W01B004E17	pENTR221	11917		CIAO1	9391	NP_004795.1	Hs.12109	Cytosolic iron-sulfur protein assembly 1 homolog (S. cerevisiae)						NM_004804.2	NP_004795.1	VALIDATED	C	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	NM_004346	IOH11204	Invitrogen(on gateway)	W01B004E18	pENTR221	18131		CASP3	836	NP_004337.2	Hs.141125	Caspase 3, apoptosis-related cysteine peptidase						NM_032991.2	NP_116786.1	REVIEWED	C	1.000	1.000	277	834	1	831	277	1	277
Invitrogen	NM_005216	IOH4125	Invitrogen(on gateway)	W01B004E19	pENTR221	1458		DDOST	1650	NP_005207.2	Hs.523145	Dolichyl-diphosphooligosaccharide-protein glycosyltransferase						NM_005216.4	NP_005207.2	REVIEWED	C	1.000	1.000	456	1371	1	1368	456	1	456
Invitrogen	NM_001935	IOH12261	Invitrogen(on gateway)	W01B004E20	pENTR221	14246		DPP4	1803	NP_001926.2	Hs.368912	Dipeptidyl-peptidase 4						NM_001935.3	NP_001926.2	REVIEWED	C	1.000	1.000	766	2301	1	2298	766	1	766
Invitrogen	NM_007176	IOH4267	Invitrogen(on gateway)	W01B004E21	pENTR221	7418		C14orf1	11161	NP_009107.1	Hs.15106	Chromosome 14 open reading frame 1						NM_007176.2	NP_009107.1	VALIDATED	C	1.000	1.000	140	423	1	420	140	1	140
Invitrogen	NM_003766	IOH11006	Invitrogen(on gateway)	W01B004E22	pENTR221	10361		BECN1	8678	NP_003757.1	Hs.716464	Beclin 1, autophagy related						NM_003766.3	NP_003757.1	VALIDATED	C	1.000	1.000	450	1353	1	1350	450	1	450
Invitrogen	NM_004640	IOH3681	Invitrogen(on gateway)	W01B004E23	pENTR221	20419		BAT1	7919	NP_004631.1	Hs.254042	HLA-B associated transcript 1						NM_004640.5	NP_004631.1	REVIEWED	C	1.000	1.000	428	1287	1	1284	428	1	428
Invitrogen	BC013161	IOH10686	Invitrogen(on gateway)	W01B004E24	pENTR221	16346		RTP4	64108	AAH13161.1	Hs.43388	Receptor (chemosensory) transporter protein 4						NM_022147.2	NP_071430.2	VALIDATED	Cs	0.988	0.988	246	741	1	738	246	1	246
Invitrogen	NM_018683	IOH10466	Invitrogen(on gateway)	W01B004F01	pENTR221	14624		RNF114	55905	NP_061153.1	Hs.144949	Ring finger protein 114						NM_018683.3	NP_061153.1	VALIDATED	C	1.000	1.000	228	687	1	684	228	1	228
Invitrogen	NM_002801	IOH13833	Invitrogen(on gateway)	W01B004F02	pENTR221	9300		PSMB10	5699	NP_002792.1	Hs.9661	Proteasome (prosome, macropain) subunit, beta type, 10						NM_002801.2	NP_002792.1	REVIEWED	C	1.000	1.000	273	822	1	819	273	1	273
Invitrogen	NM_014874	IOH9962	Invitrogen(on gateway)	W01B004F03	pENTR221	284		MFN2	9927	NP_055689.1	Hs.376681	Mitofusin 2						NM_014874.3	NP_055689.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
Invitrogen	NM_144634	IOH10858	Invitrogen(on gateway)	W01B004F04	pENTR221	16961		LYZL4	131375	NP_653235.1	Hs.234895	Lysozyme-like 4						NM_144634.2	NP_653235.1	PROVISIONAL	OK	1.000	1.000	146	441	1	438	146	1	146
Invitrogen	NM_134442	IOH9797	Invitrogen(on gateway)	W01B004F05	pENTR221	13446		CREB1	1385	NP_604391.1	Hs.516646	CAMP responsive element binding protein 1						NM_134442.3	NP_604391.1	REVIEWED	C	1.000	1.000	341	1026	1	1023	341	1	341
Invitrogen	NM_005842	IOH13536	Invitrogen(on gateway)	W01B004F06	pENTR221	6685		SPRY2	10253	NP_005833.1	Hs.18676	Sprouty homolog 2 (Drosophila)						NM_005842.2	NP_005833.1	REVIEWED	OK	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_001613	IOH9991	Invitrogen(on gateway)	W01B004F07	pENTR221	3407		ACTA2	59	NP_001604.1	Hs.500483	Actin, alpha 2, smooth muscle, aorta						NM_001613.2	NP_001604.1	REVIEWED	C	1.000	1.000	377	1134	1	1131	377	1	377
Invitrogen	NM_021227	IOH12645	Invitrogen(on gateway)	W01B004F08	pENTR221	17492		OSTC	58505	NP_067050.1	Hs.445803	Oligosaccharyltransferase complex subunit						NM_021227.2	NP_067050.1	VALIDATED	OK	1.000	1.000	149	450	1	447	149	1	149
Invitrogen	NM_004309	IOH5797	Invitrogen(on gateway)	W01B004F09	pENTR221	10459		ARHGDIA	396	NP_004300.1	Hs.159161	Rho GDP dissociation inhibitor (GDI) alpha						NM_004309.3	NP_004300.1	PROVISIONAL	C	1.000	1.000	204	615	1	612	204	1	204
Invitrogen	BC025243	IOH12391	Invitrogen(on gateway)	W01B004F10	pENTR221	12606		CCDC8	83987	AAH25243.1	Hs.97876	Coiled-coil domain containing 8						NM_032040.3	NP_114429.2	VALIDATED	C	1.000	1.000	538	1617	1	1614	538	1	538
Invitrogen	NM_006332	IOH13656	Invitrogen(on gateway)	W01B004F11	pENTR221	11417		IFI30	10437	NP_006323.2	Hs.14623	Interferon, gamma-inducible protein 30						NM_006332.3	NP_006323.2	REVIEWED	C	1.000	1.000	250	753	1	750	250	1	250
Invitrogen	NM_000318	IOH7247	Invitrogen(on gateway)	W01B004F12	pENTR221	23223		PXMP3	5828	NP_000309.1	Hs.437966	Peroxisomal membrane protein 3, 35kDa						NM_000318.2	NP_000309.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
Invitrogen	NM_006815	IOH14559	Invitrogen(on gateway)	W01B004F13	pENTR221	5415		TMED2	10959	NP_006806.1	Hs.75914	Transmembrane emp24 domain trafficking protein 2						NM_006815.3	NP_006806.1	VALIDATED	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	NM_004270	IOH7377	Invitrogen(on gateway)	W01B004F14	pENTR221	19172		MED7	9443	NP_004261.1	Hs.719330	Mediator complex subunit 7						NM_001100816.1	NP_001094286.1	REVIEWED	C	1.000	1.000	233	702	1	699	233	1	233
Invitrogen	NM_001679	IOH13943	Invitrogen(on gateway)	W01B004F15	pENTR221	16452		ATP1B3	483	NP_001670.1	Hs.477789	ATPase, Na+/K+ transporting, beta 3 polypeptide						NM_001679.2	NP_001670.1	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
Invitrogen	NM_021983	IOH7183	Invitrogen(on gateway)	W01B004F16	pENTR221	20149		HLA-DRB4	3126	NP_068818.4	Hs.716081	Major histocompatibility complex, class II, DR beta 4						NM_021983.4	NP_068818.4	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
Invitrogen	BC009433	IOH14713	Invitrogen(on gateway)	W01B004F17	pENTR221	11616		ZNF331	55422	AAH09433.1	Hs.185674	Zinc finger protein 331						NM_001079906.1	NP_001073375.1	VALIDATED	Cs	0.998	0.998	463	1392	1	1389	463	1	463
Invitrogen	NM_002345	IOH7237	Invitrogen(on gateway)	W01B004F18	pENTR221	6187		LUM	4060	NP_002336.1	Hs.406475	Lumican						NM_002345.3	NP_002336.1	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
Invitrogen	NM_002004	IOH14486	Invitrogen(on gateway)	W01B004F19	pENTR221	577		FDPS	2224	NP_001995.1	Hs.335918	Farnesyl diphosphate synthase (farnesyl pyrophosphate synthetase, dimethylallyltranstransferase, geranyltranstransferase)						NM_001135821.1	NP_001129293.1	REVIEWED	C	1.000	1.000	419	1260	1	1257	419	1	419
Invitrogen	BC008019	IOH6983	Invitrogen(on gateway)	W01B004F20	pENTR221	1491		CCT3	7203	AAH08019.1	Hs.491494	Chaperonin containing TCP1, subunit 3 (gamma)						NM_005998.3	NP_005989.3	REVIEWED	P	1.000	1.000	544	1635	1	1632	545	2	545
Invitrogen	BC026106	IOH11661	Invitrogen(on gateway)	W01B004F21	pENTR221	23478		MTAP	4507	AAH26106.1	Hs.193268	Methylthioadenosine phosphorylase						NM_002451.3	NP_002442.2	REVIEWED	Cs	0.996	0.996	283	852	1	849	283	1	283
Invitrogen	NM_004462	IOH4891	Invitrogen(on gateway)	W01B004F22	pENTR221	22688		FDFT1	2222	NP_004453.3	Hs.593928	Farnesyl-diphosphate farnesyltransferase 1						NM_004462.3	NP_004453.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
Invitrogen	NM_004469	IOH11413	Invitrogen(on gateway)	W01B004F23	pENTR221	25253		FIGF	2277	NP_004460.1	Hs.11392	C-fos induced growth factor (vascular endothelial growth factor D)						NM_004469.2	NP_004460.1	REVIEWED	C	1.000	1.000	354	1065	1	1062	354	1	354
Invitrogen	NM_025187	IOH6362	Invitrogen(on gateway)	W01B004F24	pENTR221	8689		C16orf70	80262	NP_079463.2	Hs.513666	Chromosome 16 open reading frame 70						NM_025187.3	NP_079463.2	PROVISIONAL	OK	1.000	1.000	422	1269	1	1266	422	1	422
Invitrogen	NM_006098	IOH4352	Invitrogen(on gateway)	W01B004G01	pENTR221	19355		GNB2L1	10399	NP_006089.1	Hs.5662	Guanine nucleotide binding protein (G protein), beta polypeptide 2-like 1						NM_006098.4	NP_006089.1	VALIDATED	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_006091	IOH11311	Invitrogen(on gateway)	W01B004G02	pENTR221	7675		CORO2B	10391	NP_006082.3	Hs.551213	Coronin, actin binding protein, 2B						NM_006091.3	NP_006082.3	VALIDATED	Ps	0.998	0.998	475	1428	1	1425	480	6	480
Invitrogen	NM_003821	IOH6368	Invitrogen(on gateway)	W01B004G03	pENTR221	22533		RIPK2	8767	NP_003812.1	Hs.103755	Receptor-interacting serine-threonine kinase 2						NM_003821.5	NP_003812.1	REVIEWED	C	1.000	1.000	540	1623	1	1620	540	1	540
Invitrogen	NM_004359	IOH1870	Invitrogen(on gateway)	W01B004G04	pENTR221	11913		CDC34	997	NP_004350.1	Hs.514997	Cell division cycle 34 homolog (S. cerevisiae)						NM_004359.1	NP_004350.1	REVIEWED	C	1.000	1.000	236	711	1	708	236	1	236
Invitrogen	NM_005206	IOH1805	Invitrogen(on gateway)	W01B004G05	pENTR221	10688		CRK	1398	NP_005197.3	Hs.638121	V-crk sarcoma virus CT10 oncogene homolog (avian)						NM_005206.3	NP_005197.3	REVIEWED	C	1.000	1.000	204	615	1	612	204	1	204
Invitrogen	NM_006755	IOH2052	Invitrogen(on gateway)	W01B004G06	pENTR221	4031		TALDO1	6888	NP_006746.1	Hs.438678	Transaldolase 1						NM_006755.1	NP_006746.1	REVIEWED	OK	1.000	1.000	337	1014	1	1011	337	1	337
Invitrogen	NM_033313	IOH20983	Invitrogen(on gateway)	W01B004G07	pENTR221	244		CDC14A	8556	NP_201570.1	Hs.127411	CDC14 cell division cycle 14 homolog A (S. cerevisiae)						NM_033313.2	NP_201570.1	REVIEWED	OK	1.000	1.000	383	1152	1	1149	383	1	383
Invitrogen	BC017842	IOH12945	Invitrogen(on gateway)	W01B004G08	pENTR221	12291		NAPSA	9476	AAH17842.1	Hs.714418	Napsin A aspartic peptidase						NM_004851.1	NP_004842.1	REVIEWED	Cs	0.998	0.998	420	1263	1	1260	420	1	420
Invitrogen	NM_002436	IOH3460	Invitrogen(on gateway)	W01B004G09	pENTR221	25351		MPP1	4354	NP_002427.1	Hs.496984	Membrane protein, palmitoylated 1, 55kDa						NM_002436.2	NP_002427.1	REVIEWED	C	1.000	1.000	466	1401	1	1398	466	1	466
Invitrogen	BC017249	IOH12653	Invitrogen(on gateway)	W01B004G10	pENTR221	9958		ENO3	2027	AAH17249.1	Hs.224171	Enolase 3 (beta, muscle)						NM_053013.2	NP_443739.2	REVIEWED	C	1.000	1.000	434	1305	1	1302	434	1	434
Invitrogen	NM_004951	IOH13127	Invitrogen(on gateway)	W01B004G11	pENTR221	6795		GPR183	1880	NP_004942.1	Hs.784	G protein-coupled receptor 183						NM_004951.4	NP_004942.1	REVIEWED	C	1.000	1.000	361	1086	1	1083	361	1	361
Invitrogen	NM_020375	IOH13360	Invitrogen(on gateway)	W01B004G12	pENTR221	5381		C12orf5	57103	NP_065108.1	Hs.504545	Chromosome 12 open reading frame 5						NM_020375.2	NP_065108.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
Invitrogen	NM_004004	IOH10387	Invitrogen(on gateway)	W01B004G13	pENTR221	6811		GJB2	2706	NP_003995.2	Hs.719400	Gap junction protein, beta 2, 26kDa						NM_004004.5	NP_003995.2	REVIEWED	C	1.000	1.000	226	681	1	678	226	1	226
Invitrogen	BC026317	IOH11060	Invitrogen(on gateway)	W01B004G14	pENTR221	1823		SLC16A1	6566	AAH26317.1	Hs.75231	Solute carrier family 16, member 1 (monocarboxylic acid transporter 1)						NM_003051.3	NP_003042.3	VALIDATED	C	1.000	1.000	500	1503	1	1500	500	1	500
Invitrogen	NM_004811	IOH13601	Invitrogen(on gateway)	W01B004G15	pENTR221	4555		LPXN	9404	NP_004802.1	Hs.125474	Leupaxin						NM_004811.2	NP_004802.1	REVIEWED	C	1.000	1.000	386	1161	1	1158	386	1	386
Invitrogen	NM_000023	IOH10645	Invitrogen(on gateway)	W01B004G16	pENTR221	10010		SGCA	6442	NP_000014.1	Hs.463412	Sarcoglycan, alpha (50kDa dystrophin-associated glycoprotein)						NM_000023.2	NP_000014.1	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
Invitrogen	NM_014064	IOH3939	Invitrogen(on gateway)	W01B004G17	pENTR221	23556		METTL11A	28989	NP_054783.2	Hs.522433	Methyltransferase like 11A						NM_014064.2	NP_054783.2	VALIDATED	C	1.000	1.000	223	672	1	669	223	1	223
Invitrogen	NM_052817	IOH11264	Invitrogen(on gateway)	W01B004G18	pENTR221	24638		MID2	11043	NP_438112.2	Hs.12256	Midline 2						NM_052817.2	NP_438112.2	REVIEWED	P	1.000	1.000	685	2058	1	2055	705	21	705
Invitrogen	NM_002803	IOH4140	Invitrogen(on gateway)	W01B004G19	pENTR221	21067		PSMC2	5701	NP_002794.1	Hs.437366	Proteasome (prosome, macropain) 26S subunit, ATPase, 2						NM_002803.2	NP_002794.1	REVIEWED	C	1.000	1.000	433	1302	1	1299	433	1	433
Invitrogen	NM_013338	IOH12723	Invitrogen(on gateway)	W01B004G20	pENTR221	6702		ALG5	29880	NP_037470.1	Hs.507769	Asparagine-linked glycosylation 5, dolichyl-phosphate beta-glucosyltransferase homolog (S. cerevisiae)						NM_013338.4	NP_037470.1	REVIEWED	OK	1.000	1.000	324	975	1	972	324	1	324
Invitrogen	NM_005884	IOH2475	Invitrogen(on gateway)	W01B004G21	pENTR221	11397		PAK4	10298	NP_005875.1	Hs.20447	P21 protein (Cdc42/Rac)-activated kinase 4						NM_001014831.2	NP_001014831.1	REVIEWED	C	1.000	1.000	591	1776	1	1773	591	1	591
Invitrogen	NM_014061	IOH10824	Invitrogen(on gateway)	W01B004G22	pENTR221	24617		MAGEH1	28986	NP_054780.2	Hs.279819	Melanoma antigen family H, 1						NM_014061.3	NP_054780.2	REVIEWED	C	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	NM_001568	IOH3799	Invitrogen(on gateway)	W01B004G23	pENTR221	23186		EIF3E	3646	NP_001559.1	Hs.405590	Eukaryotic translation initiation factor 3, subunit E						NM_001568.2	NP_001559.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
Invitrogen	BC017723	IOH11259	Invitrogen(on gateway)	W01B004G24	pENTR221	24851		MAGEA4	4103	AAH17723.1	Hs.37107	Melanoma antigen family A, 4						NM_001011550.1	NP_001011550.1	REVIEWED	Cs	0.997	0.997	317	954	1	951	317	1	317
Invitrogen	NM_000027	IOH10474	Invitrogen(on gateway)	W01B004H01	pENTR221	18265		AGA	175	NP_000018.1	Hs.207776	Aspartylglucosaminidase						NM_000027.2	NP_000018.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
Invitrogen	NM_000715	IOH13736	Invitrogen(on gateway)	W01B004H02	pENTR221	936		C4BPA	722	NP_000706.1	Hs.1012	Complement component 4 binding protein, alpha						NM_000715.3	NP_000706.1	REVIEWED	C	1.000	1.000	597	1794	1	1791	597	1	597
Invitrogen	NM_006653	IOH9654	Invitrogen(on gateway)	W01B004H03	pENTR221	20452		FRS3	10817	NP_006644.1	Hs.194208	Fibroblast growth factor receptor substrate 3						NM_006653.3	NP_006644.1	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
Invitrogen	NM_003117	IOH10647	Invitrogen(on gateway)	W01B004H04	pENTR221	21403		SPAM1	6677	NP_003108.2	Hs.121494	Sperm adhesion molecule 1 (PH-20 hyaluronidase, zona pellucida binding)						NM_003117.3	NP_003108.2	REVIEWED	C	1.000	1.000	511	1536	1	1533	511	1	511
Invitrogen	NM_000575	IOH9809	Invitrogen(on gateway)	W01B004H05	pENTR221	14271		IL1A	3552	NP_000566.3	Hs.1722	Interleukin 1, alpha						NM_000575.3	NP_000566.3	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
Invitrogen	NM_002552	IOH11791	Invitrogen(on gateway)	W01B004H06	pENTR221	13888		ORC4L	5000	NP_002543.2	Hs.558364	Origin recognition complex, subunit 4-like (yeast)						NM_181741.1	NP_859525.1	REVIEWED	C	1.000	1.000	436	1311	1	1308	436	1	436
Invitrogen	NM_002825	IOH7539	Invitrogen(on gateway)	W01B004H07	pENTR221	22141		PTN	5764	NP_002816.1	Hs.371249	Pleiotrophin						NM_002825.5	NP_002816.1	VALIDATED	C	1.000	1.000	168	507	1	504	168	1	168
Invitrogen	NM_144606	IOH12359	Invitrogen(on gateway)	W01B004H08	pENTR221	10465		FLCN	201163	NP_653207.1	Hs.513975	Folliculin						NM_144606.5	NP_653207.1	REVIEWED	C	1.000	1.000	342	1029	1	1026	342	1	342
Invitrogen	BC008935	IOH5815	Invitrogen(on gateway)	W01B004H09	pENTR221	17770		SLC25A6	293	AAH08935.1	Hs.350927	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6						NM_001636.2	NP_001627.2	VALIDATED	C	1.000	1.000	298	897	1	894	298	1	298
Invitrogen	NM_024770	IOH12447	Invitrogen(on gateway)	W01B004H10	pENTR221	14069		METTL8	79828	NP_079046.2	Hs.135146	Methyltransferase like 8						NM_024770.3	NP_079046.2	VALIDATED	P	1.000	1.000	237	726	1	711	407	51	287
Invitrogen	NM_014742	IOH14088	Invitrogen(on gateway)	W01B004H11	pENTR221	14756		TM9SF4	9777	NP_055557.2	Hs.654665	Transmembrane 9 superfamily protein member 4						NM_014742.3	NP_055557.2	VALIDATED	P	1.000	1.000	625	1878	1	1875	642	18	642
Invitrogen	NM_005872	IOH7255	Invitrogen(on gateway)	W01B004H12	pENTR221	1383		BCAS2	10286	NP_005863.1	Hs.22960	Breast carcinoma amplified sequence 2						NM_005872.2	NP_005863.1	VALIDATED	C	1.000	1.000	225	678	1	675	225	1	225
Invitrogen	NM_002539	IOH14694	Invitrogen(on gateway)	W01B004H13	pENTR221	14273		ODC1	4953	NP_002530.1	Hs.467701	Ornithine decarboxylase 1						NM_002539.1	NP_002530.1	REVIEWED	OK	1.000	1.000	461	1386	1	1383	461	1	461
Invitrogen	NM_001688	IOH7382	Invitrogen(on gateway)	W01B004H14	pENTR221	808		ATP5F1	515	NP_001679.2	Hs.514870	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1						NM_001688.4	NP_001679.2	REVIEWED	C	1.000	1.000	256	771	1	768	256	1	256
Invitrogen	ENST00000056217	IOH14526	Invitrogen(on gateway)	W01B004H15	pENTR221	21321		ARHGEF5	7984	ENSP00000056217	Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	519	1560	1	1557	1597	1079	1597
Invitrogen	NM_000971	IOH6732	Invitrogen(on gateway)	W01B004H16	pENTR221	23225		RPL7	6129	NP_000962.2	Hs.571841	Ribosomal protein L7						NM_000971.3	NP_000962.2	REVIEWED	C	1.000	1.000	248	747	1	744	248	1	248
Invitrogen	NM_003192	IOH14757	Invitrogen(on gateway)	W01B004H17	pENTR221	20783		TBCC	6903	NP_003183.1	Hs.75064	Tubulin folding cofactor C						NM_003192.2	NP_003183.1	REVIEWED	C	1.000	1.000	346	1041	1	1038	346	1	346
Invitrogen	NM_004625	IOH6371	Invitrogen(on gateway)	W01B004H18	pENTR221	17186		WNT7A	7476	NP_004616.2	Hs.72290	Wingless-type MMTV integration site family, member 7A						NM_004625.3	NP_004616.2	REVIEWED	C	1.000	1.000	349	1080	31	1077	349	1	349
Invitrogen	BC013309	IOH14161	Invitrogen(on gateway)	W01B004H19	pENTR221	15274		PWP2	5822	AAH13309.1	Hs.449076	PWP2 periodic tryptophan protein homolog (yeast)						NM_005049.2	NP_005040.2	VALIDATED	Cs	0.998	0.998	919	2760	1	2757	919	1	919
Invitrogen	NM_001056	IOH7147	Invitrogen(on gateway)	W01B004H20	pENTR221	12887		SULT1C2	6819	NP_001047.1	Hs.436123	Sulfotransferase family, cytosolic, 1C, member 2						NM_001056.3	NP_001047.1	REVIEWED	C	1.000	1.000	296	891	1	888	296	1	296
Invitrogen	BC027624	IOH11340	Invitrogen(on gateway)	W01B004H21	pENTR221	7802		BBS4	585	AAH27624.1	Hs.208681	Bardet-Biedl syndrome 4						NM_033028.3	NP_149017.2	REVIEWED	Cs	0.996	0.996	519	1560	1	1557	519	1	519
Invitrogen	BC003549	IOH4987	Invitrogen(on gateway)	W01B004H22	pENTR221	20532		ECHDC1	55862	AAH03549.1	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1						NM_001002030.1	NP_001002030.1	VALIDATED	C	1.000	1.000	301	906	1	903	301	1	301
Invitrogen	NM_000078	IOH11986	Invitrogen(on gateway)	W01B004H23	pENTR221	8938		CETP	1071	NP_000069.2	Hs.89538	Cholesteryl ester transfer protein, plasma						NM_000078.2	NP_000069.2	REVIEWED	Cs	0.998	0.998	493	1482	1	1479	493	1	493
Invitrogen	NM_000117	IOH4676	Invitrogen(on gateway)	W01B004H24	pENTR221	24824		EMD	2010	NP_000108.1	Hs.522823	Emerin						NM_000117.2	NP_000108.1	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
Invitrogen	NM_002513	IOH4515	Invitrogen(on gateway)	W01B004I01	pENTR221	9367		NME3	4832	NP_002504.2	Hs.514065	Non-metastatic cells 3, protein expressed in						NM_002513.2	NP_002504.2	VALIDATED	C	1.000	1.000	169	510	1	507	169	1	169
Invitrogen	NM_013361	IOH11220	Invitrogen(on gateway)	W01B004I02	pENTR221	11602		ZNF223	7766	NP_037493.3								NM_013361.4	NP_037493.3	VALIDATED	Cs	0.998	0.998	482	1449	1	1446	482	1	482
Invitrogen	NM_006748	IOH7132	Invitrogen(on gateway)	W01B004I03	pENTR221	23092		SLA	6503	NP_006739.2	Hs.75367	Src-like-adaptor						NM_001045556.2	NP_001039021.1	VALIDATED	C	1.000	1.000	276	831	1	828	276	1	276
Invitrogen	NM_015971	IOH1875	Invitrogen(on gateway)	W01B004I04	pENTR221	9680		MRPS7	51081	NP_057055.2	Hs.71787	Mitochondrial ribosomal protein S7						NM_015971.3	NP_057055.2	REVIEWED	Cs	0.996	0.996	242	729	1	726	242	1	242
Invitrogen	NM_001721	IOH11645	Invitrogen(on gateway)	W01B004I05	pENTR221	24583		BMX	660	NP_001712.1	Hs.495731	BMX non-receptor tyrosine kinase						NM_001721.6	NP_001712.1	VALIDATED	C	1.000	1.000	675	2028	1	2025	675	1	675
Invitrogen	NM_012158	IOH2236	Invitrogen(on gateway)	W01B004I06	pENTR221	6708		FBXL3	26224	NP_036290.1	Hs.508284	F-box and leucine-rich repeat protein 3						NM_012158.2	NP_036290.1	REVIEWED	C	1.000	1.000	428	1287	1	1284	428	1	428
Invitrogen	NM_006504	IOH20996	Invitrogen(on gateway)	W01B004I07	pENTR221	2729		PTPRE	5791	NP_006495.1	Hs.127022	Protein tyrosine phosphatase, receptor type, E						NM_006504.4	NP_006495.1	REVIEWED	C	1.000	1.000	700	2103	1	2100	700	1	700
Invitrogen	NM_001136	IOH12890	Invitrogen(on gateway)	W01B004I08	pENTR221	20376		AGER	177	NP_001127.1	Hs.534342	Advanced glycosylation end product-specific receptor						NM_001136.3	NP_001127.1	REVIEWED	C	1.000	1.000	404	1215	1	1212	404	1	404
Invitrogen	NM_003141	IOH9948	Invitrogen(on gateway)	W01B004I09	pENTR221	4870		TRIM21	6737	NP_003132.2	Hs.532357	Tripartite motif-containing 21						NM_003141.3	NP_003132.2	REVIEWED	C	1.000	1.000	475	1428	1	1425	475	1	475
Invitrogen	NM_020191	IOH12268	Invitrogen(on gateway)	W01B004I10	pENTR221	16170		MRPS22	56945	NP_064576.1	Hs.75724	Mitochondrial ribosomal protein S22						NM_020191.2	NP_064576.1	REVIEWED	C	1.000	1.000	360	1083	1	1080	360	1	360
Invitrogen	NM_001400	IOH14201	Invitrogen(on gateway)	W01B004I11	pENTR221	270		S1PR1	1901	NP_001391.2	Hs.154210	Sphingosine-1-phosphate receptor 1						NM_001400.4	NP_001391.2	REVIEWED	OK	1.000	1.000	382	1149	1	1146	382	1	382
Invitrogen	NM_004839	IOH12380	Invitrogen(on gateway)	W01B004I12	pENTR221	8181		HOMER2	9455	NP_004830.2	Hs.578443	Homer homolog 2 (Drosophila)						NM_004839.2	NP_004830.2	REVIEWED	OK	1.000	1.000	343	1032	1	1029	343	1	343
Invitrogen	BC022449	IOH10885	Invitrogen(on gateway)	W01B004I13	pENTR221	17734		GABRB1	2560	AAH22449.1	Hs.27283	Gamma-aminobutyric acid (GABA) A receptor, beta 1						NM_000812.3	NP_000803.2	REVIEWED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
Invitrogen	NM_005097	IOH10604	Invitrogen(on gateway)	W01B004I14	pENTR221	2626		LGI1	9211	NP_005088.1	Hs.533670	Leucine-rich, glioma inactivated 1						NM_005097.2	NP_005088.1	REVIEWED	C	1.000	1.000	557	1674	1	1671	557	1	557
Invitrogen	NM_002469	IOH13806	Invitrogen(on gateway)	W01B004I15	pENTR221	5604		MYF6	4618	NP_002460.1	Hs.35937	Myogenic factor 6 (herculin)						NM_002469.1	NP_002460.1	PROVISIONAL	C	1.000	1.000	242	729	1	726	242	1	242
Invitrogen	NM_020530	IOH13456	Invitrogen(on gateway)	W01B004I16	pENTR221	15969		OSM	5008	NP_065391.1	Hs.248156	Oncostatin M						NM_020530.3	NP_065391.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
Invitrogen	NM_015449	IOH3953	Invitrogen(on gateway)	W01B004I17	pENTR221	1586		C1orf43	25912	NP_056264.1	Hs.287471	Chromosome 1 open reading frame 43						NM_015449.2	NP_056264.1	VALIDATED	C	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	NM_013246	IOH11263	Invitrogen(on gateway)	W01B004I18	pENTR221	4615		CLCF1	23529	NP_037378.1	Hs.502977	Cardiotrophin-like cytokine factor 1						NM_013246.2	NP_037378.1	VALIDATED	C	1.000	1.000	225	678	1	675	225	1	225
Invitrogen	NM_000854	IOH4186	Invitrogen(on gateway)	W01B004I19	pENTR221	15673		GSTT2	2953	NP_000845.1	Hs.654462	Glutathione S-transferase theta 2						NM_000854.3	NP_000845.1	VALIDATED	C	1.000	1.000	244	735	1	732	244	1	244
Invitrogen	BC010935	IOH12932	Invitrogen(on gateway)	W01B004I20	pENTR221	17717		CSN3	1448	AAH10935.1	Hs.54415	Casein kappa						NM_005212.2	NP_005203.2	VALIDATED	Cs	0.995	0.995	182	549	1	546	182	1	182
Invitrogen	NM_002128	IOH2937	Invitrogen(on gateway)	W01B004I21	pENTR221	6673		HMGB1	3146	NP_002119.1	Hs.644368	High-mobility group box 1						NM_002128.4	NP_002119.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
Invitrogen	BC018122	IOH10873	Invitrogen(on gateway)	W01B004I22	pENTR221	5293		TXNRD1	7296	AAH18122.2	Hs.708065	Thioredoxin reductase 1						NM_003330.2	NP_003321.3	REVIEWED	P	1.000	1.000	497	1494	1	1491	550	53	549
Invitrogen	NM_000942	IOH3849	Invitrogen(on gateway)	W01B004I23	pENTR221	8358		PPIB	5479	NP_000933.1	Hs.434937	Peptidylprolyl isomerase B (cyclophilin B)						NM_000942.4	NP_000933.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
Invitrogen	NM_016176	IOH10229	Invitrogen(on gateway)	W01B004I24	pENTR221	1641		SDF4	51150	NP_057260.2	Hs.42806	Stromal cell derived factor 4						NM_016176.3	NP_057260.2	VALIDATED	C	1.000	1.000	362	1089	1	1086	362	1	362
Invitrogen	NM_052886	IOH10481	Invitrogen(on gateway)	W01B004J01	pENTR221	22740		MAL2	114569	NP_443118.1	Hs.201083	Mal, T-cell differentiation protein 2						NM_052886.2	NP_443118.1	REVIEWED	C	1.000	1.000	176	531	1	528	176	1	176
Invitrogen	BC017758	IOH14196	Invitrogen(on gateway)	W01B004J02	pENTR221	500		CYP4B1	1580	AAH17758.1	Hs.436317	Cytochrome P450, family 4, subfamily B, polypeptide 1						NM_001099772.1	NP_001093242.1	REVIEWED	C	1.000	1.000	512	1539	1	1536	512	1	512
Invitrogen	NM_003420	IOH9658	Invitrogen(on gateway)	W01B004J03	pENTR221	16548		ZNF35	7584	NP_003411.3	Hs.288658	Zinc finger protein 35						NM_003420.3	NP_003411.3	VALIDATED	P	1.000	1.000	519	1560	1	1557	527	9	527
Invitrogen	BC019861	IOH11354	Invitrogen(on gateway)	W01B004J04	pENTR221	13058		UGT1A6	54578	AAH19861.1								NM_205862.1	NP_995584.1	REVIEWED	Cs	0.996	0.996	265	1599	802	1596	265	1	265
Invitrogen	NM_003776	IOH9812	Invitrogen(on gateway)	W01B004J05	pENTR221	15541		MRPL40	64976	NP_003767.2	Hs.431307	Mitochondrial ribosomal protein L40						NM_003776.2	NP_003767.2	REVIEWED	OK	1.000	1.000	206	621	1	618	206	1	206
Invitrogen	NM_001024465	IOH11557	Invitrogen(on gateway)	W01B004J06	pENTR221	20693		SOD2	6648	NP_001019636.1	Hs.487046	Superoxide dismutase 2, mitochondrial						NM_001024465.1	NP_001019636.1	REVIEWED	C	1.000	1.000	222	669	1	666	222	1	222
Invitrogen	NM_006361	IOH7543	Invitrogen(on gateway)	W01B004J07	pENTR221	10683		HOXB13	10481	NP_006352.2	Hs.66731	Homeobox B13						NM_006361.5	NP_006352.2	REVIEWED	C	1.000	1.000	284	855	1	852	284	1	284
Invitrogen	BC015626	IOH13367	Invitrogen(on gateway)	W01B004J08	pENTR221	8568		PARD6A	50855	AAH15626.1	Hs.112933	Par-6 partitioning defective 6 homolog alpha (C. elegans)						NM_001037281.1	NP_001032358.1	REVIEWED	C	1.000	1.000	345	1038	1	1035	345	1	345
Invitrogen	BC005830	IOH5817	Invitrogen(on gateway)	W01B004J09	pENTR221	431		ANXA9	8416	AAH05830.2	Hs.3346	Annexin A9						NM_003568.2	NP_003559.2	VALIDATED	C	1.000	1.000	345	1038	1	1035	345	1	345
Invitrogen	NM_015715	IOH12562	Invitrogen(on gateway)	W01B004J10	pENTR221	15854		PLA2G3	50487	NP_056530.2	Hs.149623	Phospholipase A2, group III						NM_015715.3	NP_056530.2	VALIDATED	Cs	0.998	0.998	509	1530	1	1527	509	1	509
Invitrogen	NM_016207	IOH14059	Invitrogen(on gateway)	W01B004J11	pENTR221	13050		CPSF3	51692	NP_057291.1	Hs.515972	Cleavage and polyadenylation specific factor 3, 73kDa						NM_016207.2	NP_057291.1	PROVISIONAL	C	1.000	1.000	684	2055	1	2052	684	1	684
Invitrogen	BC005216	IOH7266	Invitrogen(on gateway)	W01B004J12	pENTR221	703		CELA3B	23436	AAH05216.1	Hs.181289	Elastase 3B, pancreatic						NM_007352.2	NP_031378.1	REVIEWED	Cs	0.996	0.996	270	813	1	810	270	1	270
Invitrogen	NM_016641	IOH14021	Invitrogen(on gateway)	W01B004J13	pENTR221	9189		GDE1	51573	NP_057725.1	Hs.512607	Glycerophosphodiester phosphodiesterase 1						NM_016641.3	NP_057725.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
Invitrogen	BC008430	IOH7411	Invitrogen(on gateway)	W01B004J14	pENTR221	9721		FAM18B	51030	AAH08430.1	Hs.87295	Family with sequence similarity 18, member B						NM_016078.4	NP_057162.4	PREDICTED	C	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	BC014008	IOH13883	Invitrogen(on gateway)	W01B004J15	pENTR221	19273		TNIP1	10318	AAH14008.1	Hs.355141	TNFAIP3 interacting protein 1						NM_006058.3	NP_006049.3	VALIDATED	C	1.000	1.000	636	1911	1	1908	636	1	636
Invitrogen	NM_032346	IOH6633	Invitrogen(on gateway)	W01B004J16	pENTR221	11927		PDCD2L	84306	NP_115722.1	Hs.515344	Programmed cell death 2-like						NM_032346.1	NP_115722.1	PROVISIONAL	OK	1.000	1.000	358	1077	1	1074	358	1	358
Invitrogen	NM_004872	IOH14687	Invitrogen(on gateway)	W01B004J17	pENTR221	1560		TMEM59	9528	NP_004863.2	Hs.523262	Transmembrane protein 59						NM_004872.3	NP_004863.2	PROVISIONAL	C	1.000	1.000	323	972	1	969	323	1	323
Invitrogen	NM_006305	IOH6615	Invitrogen(on gateway)	W01B004J18	pENTR221	8160		ANP32A	8125	NP_006296.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A						NM_006305.3	NP_006296.1	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
Invitrogen	NM_002638	IOH13658	Invitrogen(on gateway)	W01B004J19	pENTR221	14790		PI3	5266	NP_002629.1	Hs.112341	Peptidase inhibitor 3, skin-derived						NM_002638.3	NP_002629.1	REVIEWED	C	1.000	1.000	117	354	1	351	117	1	117
Invitrogen	NM_005747	IOH7155	Invitrogen(on gateway)	W01B004J20	pENTR221	703		CELA3A	10136	NP_005738.4	Hs.654349	Elastase 3A, pancreatic						NM_005747.4	NP_005738.4	REVIEWED	Cs	0.996	0.996	270	813	1	810	270	1	270
Invitrogen	NM_006853	IOH11649	Invitrogen(on gateway)	W01B004J21	pENTR221	12121		KLK11	11012	NP_006844.1	Hs.57771	Kallikrein-related peptidase 11						NM_001136032.1	NP_001129504.1	REVIEWED	OK	1.000	1.000	250	753	1	750	250	1	250
Invitrogen	NM_000120	IOH4991	Invitrogen(on gateway)	W01B004J22	pENTR221	891		EPHX1	2052	NP_000111.1	Hs.89649	Epoxide hydrolase 1, microsomal (xenobiotic)						NM_001136018.2	NP_001129490.1	REVIEWED	C	1.000	1.000	455	1368	1	1365	455	1	455
Invitrogen	NM_001134	IOH11419	Invitrogen(on gateway)	W01B004J23	pENTR221	17736		AFP	174	NP_001125.1	Hs.518808	Alpha-fetoprotein						NM_001134.1	NP_001125.1	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
Invitrogen	NM_002812	IOH4791	Invitrogen(on gateway)	W01B004J24	pENTR221	11910		PSMD8	5714	NP_002803.2	Hs.78466	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 8						NM_002812.4	NP_002803.2	REVIEWED	P	1.000	1.000	257	774	1	771	350	94	350
Invitrogen	NM_014289	IOH4576	Invitrogen(on gateway)	W01B004K01	pENTR221	24915		CAPN6	827	NP_055104.2	Hs.496593	Calpain 6						NM_014289.2	NP_055104.2	REVIEWED	C	1.000	1.000	641	1926	1	1923	641	1	641
Invitrogen	NM_007225	IOH10772	Invitrogen(on gateway)	W01B004K02	pENTR221	9572		NXPH3	11248	NP_009156.2	Hs.55069	Neurexophilin 3						NM_007225.2	NP_009156.2	VALIDATED	Cs	0.996	0.996	252	759	1	756	252	1	252
Invitrogen	BC005197	IOH7159	Invitrogen(on gateway)	W01B004K03	pENTR221	7343		MBIP	51562	AAH05197.1	Hs.368647	MAP3K12 binding inhibitory protein 1						NM_016586.2	NP_057670.2	VALIDATED	Cs	0.991	0.991	344	1035	1	1032	344	1	344
Invitrogen	NM_000973	IOH1898	Invitrogen(on gateway)	W01B004K04	pENTR221	4875		RPL8	6132	NP_000964.1	Hs.178551	Ribosomal protein L8						NM_000973.3	NP_000964.1	REVIEWED	OK	1.000	1.000	257	774	1	771	257	1	257
Invitrogen	NM_024779	IOH11402	Invitrogen(on gateway)	W01B004K05	pENTR221	5420		PIP4K2C	79837	NP_079055.3	Hs.144502	Phosphatidylinositol-5-phosphate 4-kinase, type II, gamma						NM_024779.4	NP_079055.3	VALIDATED	Cs	0.998	0.998	421	1266	1	1263	421	1	421
Invitrogen	NM_001975	IOH2253	Invitrogen(on gateway)	W01B004K06	pENTR221	5509		ENO2	2026	NP_001966.1	Hs.511915	Enolase 2 (gamma, neuronal)						NM_001975.2	NP_001966.1	REVIEWED	C	1.000	1.000	434	1305	1	1302	434	1	434
Invitrogen	NM_002720	IOH4082	Invitrogen(on gateway)	W01B004K07	pENTR221	8659		PPP4C	5531	NP_002711.1	Hs.534338	Protein phosphatase 4 (formerly X), catalytic subunit						NM_002720.1	NP_002711.1	PROVISIONAL	C	1.000	1.000	307	924	1	921	307	1	307
Invitrogen	NM_002059	IOH12292	Invitrogen(on gateway)	W01B004K08	pENTR221	10313		GH2	2689	NP_002050.1	Hs.406754	Growth hormone 2						NM_002059.3	NP_002050.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
Invitrogen	NM_006700	IOH4990	Invitrogen(on gateway)	W01B004K09	pENTR221	5154		TRAFD1	10906	NP_006691.1	Hs.5148	TRAF-type zinc finger domain containing 1						NM_001143906.1	NP_001137378.1	VALIDATED	C	1.000	1.000	582	1749	1	1746	582	1	582
Invitrogen	NM_001084	IOH12981	Invitrogen(on gateway)	W01B004K10	pENTR221	21868		PLOD3	8985	NP_001075.1	Hs.153357	Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3						NM_001084.4	NP_001075.1	REVIEWED	C	1.000	1.000	738	2217	1	2214	738	1	738
Invitrogen	NM_015727	IOH1987	Invitrogen(on gateway)	W01B004K11	pENTR221	14248		TACR1	6869	NP_056542.1	Hs.633301	Tachykinin receptor 1						NM_015727.2	NP_056542.1	REVIEWED	C	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	NM_022464	IOH13140	Invitrogen(on gateway)	W01B004K12	pENTR221	19271		SIL1	64374	NP_071909.1	Hs.483521	SIL1 homolog, endoplasmic reticulum chaperone (S. cerevisiae)						NM_001037633.1	NP_001032722.1	REVIEWED	C	1.000	1.000	461	1386	1	1383	461	1	461
Invitrogen	NM_001289	IOH14446	Invitrogen(on gateway)	W01B004K13	pENTR221	25365		CLIC2	1193	NP_001280.3	Hs.655445	Chloride intracellular channel 2						NM_001289.4	NP_001280.3	REVIEWED	C	1.000	1.000	247	744	1	741	247	1	247
Invitrogen	NM_019863	IOH10704	Invitrogen(on gateway)	W01B004K14	pENTR221	25410		F8	2157	NP_063916.1	Hs.654450	Coagulation factor VIII, procoagulant component						NM_019863.2	NP_063916.1	REVIEWED	C	1.000	1.000	216	651	1	648	216	1	216
Invitrogen	NM_006995	IOH14772	Invitrogen(on gateway)	W01B004K15	pENTR221	20085		BTN2A2	10385	NP_008926.2	Hs.373938	Butyrophilin, subfamily 2, member A2						NM_006995.3	NP_008926.2	REVIEWED	OK	1.000	1.000	523	1572	1	1569	523	1	523
Invitrogen	NM_007198	IOH12511	Invitrogen(on gateway)	W01B004K16	pENTR221	22647		PROSC	11212	NP_009129.1	Hs.304792	Proline synthetase co-transcribed homolog (bacterial)						NM_007198.3	NP_009129.1	VALIDATED	C	1.000	1.000	275	828	1	825	275	1	275
Invitrogen	NM_016049	IOH3959	Invitrogen(on gateway)	W01B004K17	pENTR221	7421		FAM158A	51016	NP_057133.2	Hs.271614	Family with sequence similarity 158, member A						NM_016049.3	NP_057133.2	PREDICTED	C	1.000	1.000	208	627	1	624	208	1	208
Invitrogen	NM_003986	IOH12345	Invitrogen(on gateway)	W01B004K18	pENTR221	3779		BBOX1	8424	NP_003977.1	Hs.591996	Butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1						NM_003986.2	NP_003977.1	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
Invitrogen	NM_004330	IOH4199	Invitrogen(on gateway)	W01B004K19	pENTR221	8359		BNIP2	663	NP_004321.2	Hs.646490	BCL2/adenovirus E1B 19kDa interacting protein 2						NM_004330.2	NP_004321.2	REVIEWED	P	1.000	1.000	314	945	1	942	435	122	435
Invitrogen	NM_005525	IOH12895	Invitrogen(on gateway)	W01B004K20	pENTR221	910		HSD11B1	3290	NP_005516.1	Hs.195040	Hydroxysteroid (11-beta) dehydrogenase 1						NM_181755.1	NP_861420.1	REVIEWED	C	1.000	1.000	292	879	1	876	292	1	292
Invitrogen	NM_006324	IOH3019	Invitrogen(on gateway)	W01B004K21	pENTR221	9062		CFDP1	10428	NP_006315.1	Hs.461361	Craniofacial development protein 1						NM_006324.2	NP_006315.1	VALIDATED	C	1.000	1.000	299	900	1	897	299	1	299
Invitrogen	BC015210	IOH11027	Invitrogen(on gateway)	W01B004K22	pENTR221	16550		C3orf49	132200	AAH15210	Hs.506386	Chromosome 3 open reading frame 49																		
Invitrogen	NM_015955	IOH12624	Invitrogen(on gateway)	W01B004K23	pENTR221	13797		MEMO1	51072	NP_057039.1	Hs.444969	Mediator of cell motility 1						NM_015955.2	NP_057039.1	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
Invitrogen	NM_052877	IOH10269	Invitrogen(on gateway)	W01B004K24	pENTR221	1773		MED8	112950	NP_443109.2	Hs.301756	Mediator complex subunit 8						NM_201542.3	NP_963836.2	REVIEWED	P	1.000	1.000	179	639	1	537	268	90	268
Invitrogen	NM_138644	IOH10485	Invitrogen(on gateway)	W01B004L01	pENTR221	10988		CABYR	26256	NP_619585.1	Hs.511983	Calcium binding tyrosine-(Y)-phosphorylation regulated						NM_153769.1	NP_722453.1	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
Invitrogen	BC020753	IOH13728	Invitrogen(on gateway)	W01B004L02	pENTR221	22687		TTC35	9694	AAH20753.1	Hs.654351	Tetratricopeptide repeat domain 35						NM_014673.3	NP_055488.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
Invitrogen	NM_014039	IOH9689	Invitrogen(on gateway)	W01B004L03	pENTR221	3787		C11orf54	28970	NP_054758.2	Hs.8360	Chromosome 11 open reading frame 54						NM_014039.2	NP_054758.2	PREDICTED	C	1.000	1.000	265	798	1	795	265	1	265
Invitrogen	NM_145167	IOH11441	Invitrogen(on gateway)	W01B004L04	pENTR221	1402		PIGM	93183	NP_660150.1	Hs.552810	Phosphatidylinositol glycan anchor biosynthesis, class M						NM_145167.2	NP_660150.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
Invitrogen	NM_015484	IOH9828	Invitrogen(on gateway)	W01B004L05	pENTR221	1701		SYF2	25949	NP_056299.1	Hs.20013	SYF2 homolog, RNA splicing factor (S. cerevisiae)						NM_015484.4	NP_056299.1	REVIEWED	C	1.000	1.000	243	732	1	729	243	1	243
Invitrogen	NM_005924	IOH11363	Invitrogen(on gateway)	W01B004L06	pENTR221	22152		MEOX2	4223	NP_005915.2	Hs.170355	Mesenchyme homeobox 2						NM_005924.4	NP_005915.2	REVIEWED	Cg	0.997	1.000	304	912	1	909	304	1	304
Invitrogen	BC005994	IOH7544	Invitrogen(on gateway)	W01B004L07	pENTR221	24531		PHF6	84295	AAH05994.1	Hs.356501	PHD finger protein 6						NM_032335.3	NP_115711.2	REVIEWED	Cs	0.997	0.997	312	939	1	936	312	1	312
Invitrogen	NM_012108	IOH13463	Invitrogen(on gateway)	W01B004L08	pENTR221	17413		STAP1	26228	NP_036240.1	Hs.435579	Signal transducing adaptor family member 1						NM_012108.2	NP_036240.1	REVIEWED	C	1.000	1.000	295	888	1	885	295	1	295
Invitrogen	BC008764	IOH5931	Invitrogen(on gateway)	W01B004L09	pENTR221	831		KIF2C	11004	AAH08764.1	Hs.69360	Kinesin family member 2C						NM_006845.3	NP_006836.2	VALIDATED	Cs	0.999	0.999	725	2178	1	2175	725	1	725
Invitrogen	NM_012092	IOH11466	Invitrogen(on gateway)	W01B004L10	pENTR221	12914		ICOS	29851	NP_036224.1	Hs.56247	Inducible T-cell co-stimulator						NM_012092.2	NP_036224.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
Invitrogen	NM_033161	IOH14151	Invitrogen(on gateway)	W01B004L11	pENTR221	24074		SURF4	6836	NP_149351.1	Hs.512465	Surfeit 4						NM_033161.2	NP_149351.1	REVIEWED	C	1.000	1.000	269	810	1	807	269	1	269
Invitrogen	NM_016464	IOH7268	Invitrogen(on gateway)	W01B004L12	pENTR221	3807		TMEM138	51524	NP_057548.1	Hs.406530	Transmembrane protein 138						NM_016464.3	NP_057548.1	PROVISIONAL	C	1.000	1.000	162	489	1	486	162	1	162
Invitrogen	NM_003104	IOH14671	Invitrogen(on gateway)	W01B004L13	pENTR221	7947		SORD	6652	NP_003095.2	Hs.878	Sorbitol dehydrogenase						NM_003104.4	NP_003095.2	VALIDATED	Cs	0.997	0.997	357	1074	1	1071	357	1	357
Invitrogen	BC005996	IOH7443	Invitrogen(on gateway)	W01B004L14	pENTR221	41066		CBWD1	55871	AAH05996.1	Hs.645337	COBW domain containing 1						NM_018491.3	NP_060961.3	VALIDATED	C	1.000	1.000	395	1188	1	1185	395	1	395
Invitrogen	NM_006816	IOH14720	Invitrogen(on gateway)	W01B004L15	pENTR221	19391		LMAN2	10960	NP_006807.1	Hs.75864	Lectin, mannose-binding 2						NM_006816.2	NP_006807.1	REVIEWED	C	1.000	1.000	356	1071	1	1068	356	1	356
Invitrogen	NM_012200	IOH6746	Invitrogen(on gateway)	W01B004L16	pENTR221	4397		B3GAT3	26229	NP_036332.2	Hs.502759	Beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I)						NM_012200.2	NP_036332.2	REVIEWED	C	1.000	1.000	335	1008	1	1005	335	1	335
Invitrogen	NM_022488	IOH13623	Invitrogen(on gateway)	W01B004L17	pENTR221	16812		ATG3	64422	NP_071933.2	Hs.477126	ATG3 autophagy related 3 homolog (S. cerevisiae)						NM_022488.3	NP_071933.2	PROVISIONAL	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_004596	IOH6628	Invitrogen(on gateway)	W01B004L18	pENTR221	11906		SNRPA	6626	NP_004587.1	Hs.466775	Small nuclear ribonucleoprotein polypeptide A						NM_004596.3	NP_004587.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
Invitrogen	NM_002493	IOH13811	Invitrogen(on gateway)	W01B004L19	pENTR221	24057		NDUFB6	4712	NP_002484.1	Hs.493668	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 6, 17kDa						NM_002493.3	NP_002484.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
Invitrogen	NM_014234	IOH3322	Invitrogen(on gateway)	W01B004L20	pENTR221	20077		HSD17B8	7923	NP_055049.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8						NM_014234.3	NP_055049.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
Invitrogen	NM_032390	IOH12035	Invitrogen(on gateway)	W01B004L21	pENTR221	13801		MKI67IP	84365	NP_115766.3	Hs.367842	MKI67 (FHA domain) interacting nucleolar phosphoprotein						NM_032390.4	NP_115766.3	REVIEWED	Cs	0.997	0.997	293	882	1	879	293	1	293
Invitrogen	NM_016219	IOH4801	Invitrogen(on gateway)	W01B004L22	pENTR221	23567		MAN1B1	11253	NP_057303.2	Hs.279881	Mannosidase, alpha, class 1B, member 1						NM_016219.3	NP_057303.2	VALIDATED	Cs	0.999	0.999	699	2100	1	2097	699	1	699
Invitrogen	BC027955	IOH11484	Invitrogen(on gateway)	W01B004L23	pENTR221	10012		GP1BA	2811	AAH27955.1	Hs.1472	Glycoprotein Ib (platelet), alpha polypeptide						NM_000173.4	NP_000164.4	REVIEWED	Cgs	0.978	0.998	639	1881	1	1878	639	1	639
Invitrogen	NM_006194	IOH4822	Invitrogen(on gateway)	W01B004L24	pENTR221	6994		PAX9	5083	NP_006185.1	Hs.132576	Paired box 9						NM_006194.2	NP_006185.1	VALIDATED	C	1.000	1.000	341	1026	1	1023	341	1	341
Invitrogen	NM_001823	IOH5211	Invitrogen(on gateway)	W01B004M01	pENTR221	7562		CKB	1152	NP_001814.2	Hs.173724	Creatine kinase, brain						NM_001823.3	NP_001814.2	REVIEWED	C	1.000	1.000	381	1146	1	1143	381	1	381
Invitrogen	NM_003082	IOH12934	Invitrogen(on gateway)	W01B004M02	pENTR221	7210		SNAPC1	6617	NP_003073.1	Hs.179312	Small nuclear RNA activating complex, polypeptide 1, 43kDa						NM_003082.3	NP_003073.1	VALIDATED	C	1.000	1.000	368	1107	1	1104	368	1	368
Invitrogen	NM_006374	IOH6735	Invitrogen(on gateway)	W01B004M03	pENTR221	14145		STK25	10494	NP_006365.2	Hs.516807	Serine/threonine kinase 25 (STE20 homolog, yeast)						NM_006374.3	NP_006365.2	PROVISIONAL	C	1.000	1.000	426	1281	1	1278	426	1	426
Invitrogen	NM_000067	IOH1900	Invitrogen(on gateway)	W01B004M04	pENTR221	22774		CA2	760	NP_000058.1	Hs.155097	Carbonic anhydrase II						NM_000067.2	NP_000058.1	REVIEWED	C	1.000	1.000	260	783	1	780	260	1	260
Invitrogen	NM_000189	IOH14727	Invitrogen(on gateway)	W01B004M05	pENTR221	13102		HK2	3099	NP_000180.2	Hs.591588	Hexokinase 2						NM_000189.4	NP_000180.2	REVIEWED	C	1.000	1.000	917	2754	1	2751	917	1	917
Invitrogen	NM_000526	IOH2323	Invitrogen(on gateway)	W01B004M06	pENTR221	10691		KRT14	3861	NP_000517.2	Hs.654380	Keratin 14						NM_000526.4	NP_000517.2	REVIEWED	C	1.000	1.000	472	1419	1	1416	472	1	472
Invitrogen	BC003635	IOH5216	Invitrogen(on gateway)	W01B004M07	pENTR221	4839		MMP7	4316	AAH03635.1	Hs.2256	Matrix metallopeptidase 7 (matrilysin, uterine)						NM_002423.3	NP_002414.1	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
Invitrogen	NM_002543	IOH12341	Invitrogen(on gateway)	W01B004M08	pENTR221	5782		OLR1	4973	NP_002534.1	Hs.412484	Oxidized low density lipoprotein (lectin-like) receptor 1						NM_002543.3	NP_002534.1	VALIDATED	C	1.000	1.000	273	822	1	819	273	1	273
Invitrogen	BC018130	IOH9916	Invitrogen(on gateway)	W01B004M09	pENTR221	18850		F2RL1	2150	AAH18130.1	Hs.154299	Coagulation factor II (thrombin) receptor-like 1						NM_005242.4	NP_005233.3	VALIDATED	Cs	0.997	0.997	397	1197	1	1191	397	1	397
Invitrogen	NM_014696	IOH12974	Invitrogen(on gateway)	W01B004M10	pENTR221	2559		GPRIN2	9721	NP_055511.2	Hs.523375	G protein regulated inducer of neurite outgrowth 2						NM_014696.3	NP_055511.2	VALIDATED	Cgs	0.976	0.983	461	1386	1	1383	458	1	458
Invitrogen	NM_005558	IOH13864	Invitrogen(on gateway)	W01B004M11	pENTR221	2171		LAD1	3898	NP_005549.2	Hs.519035	Ladinin 1						NM_005558.3	NP_005549.2	REVIEWED	C	1.000	1.000	517	1554	1	1551	517	1	517
Invitrogen	NM_020384	IOH12584	Invitrogen(on gateway)	W01B004M12	pENTR221	24631		CLDN2	9075	NP_065117.1	Hs.522746	Claudin 2						NM_020384.2	NP_065117.1	VALIDATED	C	1.000	1.000	230	693	1	690	230	1	230
Invitrogen	BC028739	IOH11395	Invitrogen(on gateway)	W01B004M13	pENTR221	23040		KCNV1	27012	AAH28739.1	Hs.13285	Potassium channel, subfamily V, member 1						NM_014379.2	NP_055194.1	REVIEWED	Cs	0.998	0.998	500	1503	1	1500	500	1	500
Invitrogen	NM_032028	IOH10725	Invitrogen(on gateway)	W01B004M14	pENTR221	19259		TSSK1B	83942	NP_114417.1	Hs.701555	Testis-specific serine kinase 1B						NM_032028.3	NP_114417.1	VALIDATED	C	1.000	1.000	367	1104	1	1101	367	1	367
Invitrogen	NM_001654	IOH21137	Invitrogen(on gateway)	W01B004M15	pENTR221	24547		ARAF	369	NP_001645.1	Hs.446641	V-raf murine sarcoma 3611 viral oncogene homolog						NM_001654.2	NP_001645.1	VALIDATED	OK	1.000	1.000	606	1821	1	1818	606	1	606
Invitrogen	NM_001024956	IOH12139	Invitrogen(on gateway)	W01B004M16	pENTR221	3764		SC5DL	6309	NP_001020127.1	Hs.287749	Sterol-C5-desaturase (ERG3 delta-5-desaturase homolog, S. cerevisiae)-like						NM_001024956.2	NP_001020127.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
Invitrogen	NM_005789	IOH4068	Invitrogen(on gateway)	W01B004M17	pENTR221	9872		PSME3	10197	NP_005780.2	Hs.152978	Proteasome (prosome, macropain) activator subunit 3 (PA28 gamma; Ki)						NM_005789.2	NP_005780.2	REVIEWED	C	1.000	1.000	254	765	1	762	254	1	254
Invitrogen	BC013325	IOH12162	Invitrogen(on gateway)	W01B004M18	pENTR221	19176		HAVCR1	26762	AAH13325.1	Hs.129711	Hepatitis A virus cellular receptor 1						NM_001099414.1	NP_001092884.1	VALIDATED	C	1.000	1.000	364	1095	1	1092	364	1	364
Invitrogen	BC001023	IOH4220	Invitrogen(on gateway)	W01B004M19	pENTR221	20149		HLA-DRB3	3125	AAH01023.1								NM_022555.3	NP_072049.2	REVIEWED		0.906	0.906	266	801	1	798	266	1	266
Invitrogen	NM_022104	IOH12306	Invitrogen(on gateway)	W01B004M20	pENTR221	14572		PCIF1	63935	NP_071387.1	Hs.716563	PDX1 C-terminal inhibiting factor 1						NM_022104.3	NP_071387.1	VALIDATED	C	1.000	1.000	704	2115	1	2112	704	1	704
Invitrogen	NM_016192	IOH3302	Invitrogen(on gateway)	W01B004M21	pENTR221	13738		TMEFF2	23671	NP_057276.2	Hs.144513	Transmembrane protein with EGF-like and two follistatin-like domains 2						NM_016192.2	NP_057276.2	PROVISIONAL	C	1.000	1.000	374	1125	1	1122	374	1	374
Invitrogen	BC016842	IOH10739	Invitrogen(on gateway)	W01B004M22	pENTR221	11436		LSM14A	26065	AAH16842.1	Hs.718430	LSM14A, SCD6 homolog A (S. cerevisiae)						NM_015578.2	NP_056393.2	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
Invitrogen	NM_015944	IOH12631	Invitrogen(on gateway)	W01B004M23	pENTR221	8616		AMDHD2	51005	NP_057028.2	Hs.613940	Amidohydrolase domain containing 2						NM_015944.3	NP_057028.2	VALIDATED	C	1.000	1.000	439	1320	1	1317	439	1	439
Invitrogen	NM_001636	IOH10300	Invitrogen(on gateway)	W01B004M24	pENTR221	17770		SLC25A6	293	NP_001627.2	Hs.350927	Solute carrier family 25 (mitochondrial carrier; adenine nucleotide translocator), member 6						NM_001636.2	NP_001627.2	VALIDATED	Cs	0.997	0.997	298	897	1	894	298	1	298
Invitrogen	BC016282	IOH10032	Invitrogen(on gateway)	W01B004N01	pENTR221	20409		MUT	4594	AAH16282.1	Hs.485527	Methylmalonyl Coenzyme A mutase						NM_000255.2	NP_000246.2	REVIEWED	Cs	0.997	0.997	750	2253	1	2250	750	1	750
Invitrogen	NM_138289	IOH10781	Invitrogen(on gateway)	W01B004N02	pENTR221	25242		ACTRT1	139741	NP_612146.1	Hs.680125	Actin-related protein T1						NM_138289.3	NP_612146.1	VALIDATED	C	1.000	1.000	376	1131	1	1128	376	1	376
Invitrogen	NM_014887	IOH9700	Invitrogen(on gateway)	W01B004N03	pENTR221	6733		N4BP2L2	10443	NP_055702.1	Hs.507680	NEDD4 binding protein 2-like 2						NM_014887.2	NP_055702.1	VALIDATED	C	1.000	1.000	583	1752	1	1749	583	1	583
Invitrogen	NM_138392	IOH13855	Invitrogen(on gateway)	W01B004N04	pENTR221	11617		SHKBP1	92799	NP_612401.2	Hs.26506	SH3KBP1 binding protein 1						NM_138392.3	NP_612401.2	VALIDATED	Cs	0.999	0.999	707	2124	1	2121	707	1	707
Invitrogen	BC009681	IOH9846	Invitrogen(on gateway)	W01B004N05	pENTR221	840		IL24	11009	AAH09681.1	Hs.719320	Interleukin 24						NM_181339.1	NP_851936.1	REVIEWED	C	1.000	1.000	48	624	478	621	48	1	48
Invitrogen	BC018549	IOH11692	Invitrogen(on gateway)	W01B004N06	pENTR221	13018		PLEK	5341	AAH18549.1	Hs.468840	Pleckstrin						NM_002664.2	NP_002655.2	VALIDATED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
Invitrogen	BC005902	IOH7553	Invitrogen(on gateway)	W01B004N07	pENTR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A						NM_000712.3	NP_000703.2	VALIDATED	Cs	0.993	0.993	296	891	1	888	296	1	296
Invitrogen	NM_138769	IOH13192	Invitrogen(on gateway)	W01B004N08	pENTR221	8758		RHOT2	89941	NP_620124.1	Hs.513242	Ras homolog gene family, member T2						NM_138769.1	NP_620124.1	PROVISIONAL	C	1.000	1.000	618	1857	1	1854	618	1	618
Invitrogen	NM_145237	IOH6581	Invitrogen(on gateway)	W01B004N09	pENTR221	9330		LOC730092	730092	NP_660280	Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
Invitrogen	NM_007220	IOH11664	Invitrogen(on gateway)	W01B004N10	pENTR221	24510		CA5B	11238	NP_009151.1	Hs.653287	Carbonic anhydrase VB, mitochondrial						NM_007220.3	NP_009151.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_022082	IOH14804	Invitrogen(on gateway)	W01B004N11	pENTR221	14719		SLC17A9	63910	NP_071365.3	Hs.512686	Solute carrier family 17, member 9						NM_022082.3	NP_071365.3	VALIDATED	Ps	0.992	0.992	380	1167	25	1164	436	15	394
Invitrogen	BC005254	IOH7277	Invitrogen(on gateway)	W01B004N12	pENTR221	5797		CLEC2B	9976	AAH05254.1	Hs.85201	C-type lectin domain family 2, member B						NM_005127.2	NP_005118.2	REVIEWED	Cs	0.993	0.993	149	450	1	447	149	1	149
Invitrogen	BC025951	IOH13912	Invitrogen(on gateway)	W01B004N13	pENTR221	9839		PGS1	9489	AAH25951.2	Hs.654671	Phosphatidylglycerophosphate synthase 1						NM_024419.3	NP_077733.3	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	556	110	556
Invitrogen	NM_018844	IOH7457	Invitrogen(on gateway)	W01B004N14	pENTR221	21161		BCAP29	55973	NP_061332.2	Hs.303787	B-cell receptor-associated protein 29						NM_018844.2	NP_061332.2	VALIDATED	C	1.000	1.000	241	726	1	723	241	1	241
Invitrogen	BC017247	IOH14097	Invitrogen(on gateway)	W01B004N15	pENTR221	1504		FUBP1	8880	AAH17247.1	Hs.567380	Far upstream element (FUSE) binding protein 1						NM_003902.3	NP_003893.2	REVIEWED	Pg	0.998	1.000	642	1962	1	1923	644	1	642
Invitrogen	NM_018410	IOH5020	Invitrogen(on gateway)	W01B004N16	pENTR221	13839		HJURP	55355	NP_060880.3	Hs.532968	Holliday junction recognition protein						NM_018410.3	NP_060880.3	VALIDATED	Ps	0.998	0.998	482	1449	1	1446	748	267	748
Invitrogen	NM_024735	IOH13801	Invitrogen(on gateway)	W01B004N17	pENTR221	9205		FBXO31	79791	NP_079011.3	Hs.567582	F-box protein 31						NM_024735.3	NP_079011.3	VALIDATED	P	1.000	1.000	367	1104	1	1101	539	173	539
Invitrogen	BC006079	IOH6653	Invitrogen(on gateway)	W01B004N18	pENTR221	23567		MAN1B1	11253	AAH06079.1	Hs.279881	Mannosidase, alpha, class 1B, member 1						NM_016219.3	NP_057303.2	VALIDATED	C	1.000	1.000	699	2100	1	2097	699	1	699
Invitrogen	BC010940	IOH14392	Invitrogen(on gateway)	W01B004N19	pENTR221	1543		AIM2	9447	AAH10940.1	Hs.281898	Absent in melanoma 2						NM_004833.1	NP_004824.1	REVIEWED	P	1.000	1.000	342	1071	1	1026	343	1	342
Invitrogen	NM_005720	IOH3992	Invitrogen(on gateway)	W01B004N20	pENTR221	21099		ARPC1B	10095	NP_005711.1	Hs.489284	Actin related protein 2/3 complex, subunit 1B, 41kDa						NM_005720.2	NP_005711.1	REVIEWED	C	1.000	1.000	372	1119	1	1116	372	1	372
Invitrogen	BC028385	IOH11739	Invitrogen(on gateway)	W01B004N21	pENTR221	15643		PPIL2	23759	AAH28385.1	Hs.438587	Peptidylprolyl isomerase (cyclophilin)-like 2						NM_014337.3	NP_055152.1	REVIEWED	Cs	0.998	0.998	520	1563	1	1560	520	1	520
Invitrogen	NM_016172	IOH4830	Invitrogen(on gateway)	W01B004N22	pENTR221	24060		UBAC1	10422	NP_057256.2	Hs.9194	UBA domain containing 1						NM_016172.2	NP_057256.2	VALIDATED	C	1.000	1.000	405	1218	1	1215	405	1	405
Invitrogen	BC028206	IOH11618	Invitrogen(on gateway)	W01B004N23	pENTR221	11510		KIR3DL1	3811	AAH28206.1	Hs.645228	Killer cell immunoglobulin-like receptor, three domains, long cytoplasmic tail, 1						NM_013289.2	NP_037421.2	REVIEWED	Cs	0.993	0.993	444	1335	1	1332	444	1	444
Invitrogen	BC001600	IOH4905	Invitrogen(on gateway)	W01B004N24	pENTR221	2875		CDC123	8872	AAH01600.1	Hs.412842	Cell division cycle 123 homolog (S. cerevisiae)						NM_006023.2	NP_006014.2	VALIDATED	C	1.000	1.000	336	1011	1	1008	336	1	336
Invitrogen	NM_003930	IOH5696	Invitrogen(on gateway)	W01B004O01	pENTR221	21782		SKAP2	8935	NP_003921.2	Hs.200770	Src kinase associated phosphoprotein 2						NM_003930.3	NP_003921.2	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
Invitrogen	NM_001420	IOH12115	Invitrogen(on gateway)	W01B004O02	pENTR221	12482		ELAVL3	1995	NP_001411.2	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)						NM_001420.3	NP_001411.2	REVIEWED	C	1.000	1.000	367	1104	1	1101	367	1	367
Invitrogen	NM_001239	IOH7258	Invitrogen(on gateway)	W01B004O03	pENTR221	19152		CCNH	902	NP_001230.1	Hs.292524	Cyclin H						NM_001239.2	NP_001230.1	REVIEWED	C	1.000	1.000	323	972	1	969	323	1	323
Invitrogen	NM_005138	IOH1913	Invitrogen(on gateway)	W01B004O04	pENTR221	15949		SCO2	9997	NP_005129.2	Hs.718545	SCO cytochrome oxidase deficient homolog 2 (yeast)						NM_005138.2	NP_005129.2	VALIDATED	Cs	0.996	0.996	266	801	1	798	266	1	266
Invitrogen	BC026046	IOH14193	Invitrogen(on gateway)	W01B004O05	pENTR221	535		UHMK1	127933	AAH26046.1	Hs.127310	U2AF homology motif (UHM) kinase 1						NM_175866.3	NP_787062.1	PROVISIONAL	Ps	0.997	0.997	341	1035	1	1023	419	1	341
Invitrogen	BC019059	IOH13228	Invitrogen(on gateway)	W01B004O06	pENTR221	13988		SP110	3431	AAH19059.1	Hs.145150	SP110 nuclear body protein						NM_004510.3	NP_004501.3	REVIEWED	Cgs	0.993	0.996	549	1644	1	1641	549	1	549
Invitrogen	NM_005605	IOH5608	Invitrogen(on gateway)	W01B004O07	pENTR221	22675		PPP3CC	5533	NP_005596.2	Hs.655661	Protein phosphatase 3 (formerly 2B), catalytic subunit, gamma isoform						NM_005605.3	NP_005596.2	PROVISIONAL	C	1.000	1.000	512	1539	1	1536	512	1	512
Invitrogen	NM_017614	IOH12877	Invitrogen(on gateway)	W01B004O08	pENTR221	18673		BHMT2	23743	NP_060084.2	Hs.114172	Betaine-homocysteine methyltransferase 2						NM_017614.3	NP_060084.2	REVIEWED	C	1.000	1.000	363	1092	1	1089	363	1	363
Invitrogen	NM_001784	IOH10866	Invitrogen(on gateway)	W01B004O09	pENTR221	11813		CD97	976	NP_001775.2								NM_001784.3	NP_001775.2	REVIEWED	C	1.000	1.000	742	2229	1	2226	742	1	742
Invitrogen	NM_016930	IOH13076	Invitrogen(on gateway)	W01B004O10	pENTR221	17983		STX18	53407	NP_058626.1	Hs.584913	Syntaxin 18						NM_016930.2	NP_058626.1	VALIDATED	C	1.000	1.000	335	1008	1	1005	335	1	335
Invitrogen	BC011634	IOH13516	Invitrogen(on gateway)	W01B004O11	pENTR221	21105		GPER	2852	AAH11634.1	Hs.20961	G protein-coupled estrogen receptor 1						NM_001039966.1	NP_001035055.1	REVIEWED	Cs	0.997	0.997	375	1128	1	1125	375	1	375
Invitrogen	NM_022154	IOH12587	Invitrogen(on gateway)	W01B004O12	pENTR221	17976		SLC39A8	64116	NP_071437.3	Hs.288034	Solute carrier family 39 (zinc transporter), member 8						NM_001135146.1	NP_001128618.1	REVIEWED	C	1.000	1.000	460	1383	1	1380	460	1	460
Invitrogen	NM_002425	IOH4106	Invitrogen(on gateway)	W01B004O13	pENTR221	4836		MMP10	4319	NP_002416.1	Hs.2258	Matrix metallopeptidase 10 (stromelysin 2)						NM_002425.1	NP_002416.1	REVIEWED	C	1.000	1.000	476	1431	1	1428	476	1	476
Invitrogen	NM_000442	IOH10695	Invitrogen(on gateway)	W01B004O14	pENTR221	10424		PECAM1	5175	NP_000433.3	Hs.514412	Platelet/endothelial cell adhesion molecule						NM_000442.3	NP_000433.3	PROVISIONAL	Cs	0.996	0.996	738	2217	1	2214	738	1	738
Invitrogen	NM_032635	IOH3907	Invitrogen(on gateway)	W01B004O15	pENTR221	11909		TMEM147	10430	NP_116024.1	Hs.9234	Transmembrane protein 147						NM_032635.2	NP_116024.1	PROVISIONAL	OK	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	NM_032213	IOH13135	Invitrogen(on gateway)	W01B004O16	pENTR221	13171		ELMOD3	84173	NP_115589.2	Hs.269990	ELMO/CED-12 domain containing 3						NM_032213.4	NP_115589.2	VALIDATED	C	1.000	1.000	391	1176	1	1173	391	1	391
Invitrogen	NM_003662	IOH4076	Invitrogen(on gateway)	W01B004O17	pENTR221	25253		PIR	8544	NP_003653.1	Hs.495728	Pirin (iron-binding nuclear protein)						NM_001018109.1	NP_001018119.1	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
Invitrogen	BC012626	IOH12346	Invitrogen(on gateway)	W01B004O18	pENTR221	13753		NAT8	9027	AAH12626.1	Hs.14637	N-acetyltransferase 8 (GCN5-related, putative)						NM_003960.3	NP_003951.3	REVIEWED	P	1.000	1.000	226	684	1	678	227	1	226
Invitrogen	NM_003883	IOH4233	Invitrogen(on gateway)	W01B004O19	pENTR221	19164		HDAC3	8841	NP_003874.2	Hs.519632	Histone deacetylase 3						NM_003883.3	NP_003874.2	REVIEWED	C	1.000	1.000	428	1287	1	1284	428	1	428
Invitrogen	NM_032331	IOH10505	Invitrogen(on gateway)	W01B004O20	pENTR221	16080		ECE2	9718	NP_115707.2	Hs.146161	Endothelin converting enzyme 2						NM_032331.3	NP_115707.2	VALIDATED	Cs	0.996	0.996	255	768	1	765	255	1	255
Invitrogen	NM_022555	IOH3310	Invitrogen(on gateway)	W01B004O21	pENTR221	20149		HLA-DRB3	3125	NP_072049.2								NM_022555.3	NP_072049.2	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
Invitrogen	NM_032564	IOH10833	Invitrogen(on gateway)	W01B004O22	pENTR221	3635		DGAT2	84649	NP_115953.2	Hs.334305	Diacylglycerol O-acyltransferase homolog 2 (mouse)						NM_032564.3	NP_115953.2	VALIDATED	C	1.000	1.000	388	1167	1	1164	388	1	388
Invitrogen	NM_138421	IOH10769	Invitrogen(on gateway)	W01B004O23	pENTR221	4818		SAAL1	113174	NP_612430.2	Hs.591998	Serum amyloid A-like 1						NM_138421.2	NP_612430.2	VALIDATED	Cg	0.998	1.000	475	1428	1	1425	474	1	474
Invitrogen	NM_007260	IOH10346	Invitrogen(on gateway)	W01B004O24	pENTR221	339		LYPLA2	11313	NP_009191.1	Hs.533479	Lysophospholipase II						NM_007260.2	NP_009191.1	REVIEWED	C	1.000	1.000	231	696	1	693	231	1	231
Invitrogen	NM_003068	IOH10082	Invitrogen(on gateway)	W01B004P01	pENTR221	23199		SNAI2	6591	NP_003059.1	Hs.360174	Snail homolog 2 (Drosophila)						NM_003068.3	NP_003059.1	REVIEWED	C	1.000	1.000	268	807	1	804	268	1	268
Invitrogen	BC025399	IOH11285	Invitrogen(on gateway)	W01B004P02	pENTR221	472		PROK1	84432	AAH25399.1	Hs.514793	Prokineticin 1						NM_032414.2	NP_115790.1	VALIDATED	Cs	0.990	0.990	105	318	1	315	105	1	105
Invitrogen	NM_016006	IOH10127	Invitrogen(on gateway)	W01B004P03	pENTR221	16201		ABHD5	51099	NP_057090.2	Hs.19385	Abhydrolase domain containing 5						NM_016006.4	NP_057090.2	REVIEWED	C	1.000	1.000	349	1050	1	1047	349	1	349
Invitrogen	NM_001516	IOH14507	Invitrogen(on gateway)	W01B004P04	pENTR221	5597		GTF2H3	2967	NP_001507.2	Hs.355348	General transcription factor IIH, polypeptide 3, 34kDa						NM_001516.3	NP_001507.2	PROVISIONAL	C	1.000	1.000	308	927	1	924	308	1	308
Invitrogen	NM_005723	IOH9899	Invitrogen(on gateway)	W01B004P05	pENTR221	18062		TSPAN5	10098	NP_005714.2	Hs.591706	Tetraspanin 5						NM_005723.2	NP_005714.2	REVIEWED	OK	1.000	1.000	268	807	1	804	268	1	268
Invitrogen	NM_001629	IOH11710	Invitrogen(on gateway)	W01B004P06	pENTR221	6555		ALOX5AP	241	NP_001620.2	Hs.507658	Arachidonate 5-lipoxygenase-activating protein						NM_001629.2	NP_001620.2	REVIEWED	C	1.000	1.000	161	486	1	483	161	1	161
Invitrogen	BC005918	IOH7440	Invitrogen(on gateway)	W01B004P07	pENTR221	703		CELA3A	10136	AAH05918.1	Hs.654349	Elastase 3A, pancreatic						NM_005747.4	NP_005738.4	REVIEWED	Cs	0.989	0.989	270	813	1	810	270	1	270
Invitrogen	BC014457	IOH12101	Invitrogen(on gateway)	W01B004P08	pENTR221	15554		GCAT	23464	AAH14457.1	Hs.54609	Glycine C-acetyltransferase (2-amino-3-ketobutyrate coenzyme A ligase)						NM_014291.2	NP_055106.1	REVIEWED	Cs	0.995	0.995	419	1260	1	1257	419	1	419
Invitrogen	BC021290	IOH13968	Invitrogen(on gateway)	W01B004P09	pENTR221	16907		IGF2BP2	10644	AAH21290.1	Hs.35354	Insulin-like growth factor 2 mRNA binding protein 2						NM_006548.4	NP_006539.3	REVIEWED	P	1.000	1.000	598	1797	1	1794	599	2	599
Invitrogen	NM_182614	IOH14243	Invitrogen(on gateway)	W01B004P10	pENTR221	6813		FAM70B	348013	NP_872420.1	Hs.280805	Family with sequence similarity 70, member B						NM_182614.2	NP_872420.1	PROVISIONAL	C	1.000	1.000	326	981	1	978	326	1	326
Invitrogen	NM_001003789	IOH14073	Invitrogen(on gateway)	W01B004P11	pENTR221	15841		RABL2B	11158	NP_001003789.1	Hs.584862	RAB, member of RAS oncogene family-like 2B						NM_001003789.1	NP_001003789.1	REVIEWED	C	1.000	1.000	229	690	1	687	229	1	229
Invitrogen	NM_002789	IOH7299	Invitrogen(on gateway)	W01B004P12	pENTR221	7851		PSMA4	5685	NP_002780.1	Hs.251531	Proteasome (prosome, macropain) subunit, alpha type, 4						NM_001102668.1	NP_001096138.1	VALIDATED	C	1.000	1.000	190	786	214	783	190	1	190
Invitrogen	BC025232	IOH14592	Invitrogen(on gateway)	W01B004P13	pENTR221	9655		CDC6	990	AAH25232.1	Hs.405958	Cell division cycle 6 homolog (S. cerevisiae)						NM_001254.3	NP_001245.1	REVIEWED	Cs	0.998	0.998	560	1683	1	1680	560	1	560
Invitrogen	NM_006495	IOH7477	Invitrogen(on gateway)	W01B004P14	pENTR221	10702		EVI2B	2124	NP_006486.3	Hs.5509	Ecotropic viral integration site 2B						NM_006495.3	NP_006486.3	VALIDATED	Cs	0.998	0.998	448	1347	1	1344	448	1	448
Invitrogen	NM_004765	IOH14041	Invitrogen(on gateway)	W01B004P15	pENTR221	9226		BCL7C	9274	NP_004756.2	Hs.658547	B-cell CLL/lymphoma 7C						NM_004765.2	NP_004756.2	REVIEWED	C	1.000	1.000	217	654	1	651	217	1	217
Invitrogen	NM_005738	IOH5077	Invitrogen(on gateway)	W01B004P16	pENTR221	21237		ARL4A	10124	NP_005729.1	Hs.245540	ADP-ribosylation factor-like 4A						NM_212460.2	NP_997625.1	REVIEWED	C	1.000	1.000	200	603	1	600	200	1	200
Invitrogen	NM_002125	IOH14748	Invitrogen(on gateway)	W01B004P17	pENTR221	20149		HLA-DRB5	3127	NP_002116.2								NM_002125.3	NP_002116.2	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
Invitrogen	NM_024068	IOH6654	Invitrogen(on gateway)	W01B004P18	pENTR221	5549		OBFC2B	79035	NP_076973.1	Hs.240170	Oligonucleotide/oligosaccharide-binding fold containing 2B						NM_024068.3	NP_076973.1	VALIDATED	OK	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	BC015063	IOH14256	Invitrogen(on gateway)	W01B004P19	pENTR221	7212		CGRRF1	10668	AAH15063.1	Hs.59106	Cell growth regulator with ring finger domain 1						NM_006568.2	NP_006559.1	VALIDATED	Cs	0.997	0.997	332	999	1	996	332	1	332
Invitrogen	NM_014748	IOH4097	Invitrogen(on gateway)	W01B004P20	pENTR221	13412		SNX17	9784	NP_055563.1	Hs.278569	Sorting nexin 17						NM_014748.2	NP_055563.1	REVIEWED	C	1.000	1.000	470	1413	1	1410	470	1	470
Invitrogen	NM_182546	IOH11900	Invitrogen(on gateway)	W01B004P21	pENTR221	21443		VSTM2A	222008	NP_872352.2	Hs.335933	V-set and transmembrane domain containing 2A						NM_182546.2	NP_872352.2	VALIDATED	Ps	0.995	0.995	211	732	1	633	236	2	212
Invitrogen	NM_032376	IOH6085	Invitrogen(on gateway)	W01B004P22	pENTR221	10279		TMEM101	84336	NP_115752.1	Hs.514211	Transmembrane protein 101						NM_032376.2	NP_115752.1	PROVISIONAL	C	1.000	1.000	257	774	1	771	257	1	257
Invitrogen	NM_006865	IOH11666	Invitrogen(on gateway)	W01B004P23	pENTR221	12244		LILRA3	11026	NP_006856.2	Hs.113277	Leukocyte immunoglobulin-like receptor, subfamily A (without TM domain), member 3						NM_006865.2	NP_006856.2	PROVISIONAL	C	1.000	1.000	439	1320	1	1317	439	1	439
Invitrogen	NM_002791	IOH4917	Invitrogen(on gateway)	W01B004P24	pENTR221	6932		PSMA6	5687	NP_002782.1	Hs.446260	Proteasome (prosome, macropain) subunit, alpha type, 6						NM_002791.1	NP_002782.1	REVIEWED	C	1.000	1.000	246	741	1	738	246	1	246
Invitrogen	NM_001006	IOH4942	Invitrogen(on gateway)	W01B005A01	pENTR221	8392		RPS3A	6189	NP_000997.1	Hs.356572	Ribosomal protein S3A						NM_001006.3	NP_000997.1	REVIEWED	C	1.000	1.000	264	795	1	792	264	1	264
Invitrogen	BC030807	IOH23037	Invitrogen(on gateway)	W01B005A02	pENTR221	1587		CRNN	49860	AAH30807.1	Hs.242057	Cornulin						NM_016190.2	NP_057274.1	REVIEWED	Cs	0.998	0.998	495	1488	1	1485	495	1	495
Invitrogen	NM_019845	IOH5716	Invitrogen(on gateway)	W01B005A03	pENTR221	13798		RPRM	56475	NP_062819.1	Hs.100890	Reprimo, TP53 dependent G2 arrest mediator candidate						NM_019845.2	NP_062819.1	VALIDATED	C	1.000	1.000	109	330	1	327	109	1	109
Invitrogen	BC029036	IOH22658	Invitrogen(on gateway)	W01B005A04	pENTR221	5532		RPL14	9045	AAH29036.1	Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED	Cg	0.991	1.000	217	654	1	651	215	1	215
Invitrogen	NM_015993	IOH5384	Invitrogen(on gateway)	W01B005A05	pENTR221	9173		PLLP	51090	NP_057077.1	Hs.632215	Plasma membrane proteolipid (plasmolipin)						NM_015993.1	NP_057077.1	PROVISIONAL	C	1.000	1.000	182	549	1	546	182	1	182
Invitrogen	NM_006746	IOH22321	Invitrogen(on gateway)	W01B005A06	pENTR221	24625		SCML1	6322	NP_006737.2	Hs.109655	Sex comb on midleg-like 1 (Drosophila)						NM_001037536.1	NP_001032625.1	VALIDATED	C	1.000	1.000	208	627	1	624	208	1	208
Invitrogen	NM_001313	IOH4496	Invitrogen(on gateway)	W01B005A07	pENTR221	18198		CRMP1	1400	NP_001304.1	Hs.135270	Collapsin response mediator protein 1						NM_001313.3	NP_001304.1	REVIEWED	C	1.000	1.000	572	1719	1	1716	572	1	572
Invitrogen	NM_002287	IOH11793	Invitrogen(on gateway)	W01B005A08	pENTR221	12242		LAIR1	3903	NP_002278.1	Hs.572535	Leukocyte-associated immunoglobulin-like receptor 1						NM_002287.3	NP_002278.1	REVIEWED	C	1.000	1.000	287	864	1	861	287	1	287
Invitrogen	NM_001614	IOH3408	Invitrogen(on gateway)	W01B005A09	pENTR221	10685		ACTG1	71	NP_001605.1	Hs.514581	Actin, gamma 1						NM_001614.2	NP_001605.1	REVIEWED	C	1.000	1.000	375	1128	1	1125	375	1	375
Invitrogen	BC034729	IOH21497	Invitrogen(on gateway)	W01B005A10	pENTR221	19639		LTA	4049	AAH34729.1	Hs.36	Lymphotoxin alpha (TNF superfamily, member 1)						NM_000595.2	NP_000586.2	REVIEWED	Cs	0.995	0.995	205	618	1	615	205	1	205
Invitrogen	NM_031299	IOH4043	Invitrogen(on gateway)	W01B005A11	pENTR221	6214		CDCA3	83461	NP_112589.1	Hs.524216	Cell division cycle associated 3						NM_031299.4	NP_112589.1	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
Invitrogen	NM_152391	IOH11899	Invitrogen(on gateway)	W01B005A12	pENTR221	13242		PQLC3	130814	NP_689604.1	Hs.274415	PQ loop repeat containing 3						NM_152391.3	NP_689604.1	VALIDATED	C	1.000	1.000	202	609	1	606	202	1	202
Invitrogen	NM_001707	IOH3200	Invitrogen(on gateway)	W01B005A13	pENTR221	4815		BCL7B	9275	NP_001698.2	Hs.647051	B-cell CLL/lymphoma 7B						NM_001707.2	NP_001698.2	REVIEWED	OK	1.000	1.000	202	609	1	606	202	1	202
Invitrogen	NM_138786	IOH13412	Invitrogen(on gateway)	W01B005A14	pENTR221	17150		TM4SF18	116441	NP_620141.1	Hs.22026	Transmembrane 4 L six family member 18						NM_138786.2	NP_620141.1	PROVISIONAL	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	NM_058246	IOH4247	Invitrogen(on gateway)	W01B005A15	pENTR221	21016		DNAJB6	10049	NP_490647.1	Hs.719116	DnaJ (Hsp40) homolog, subfamily B, member 6						NM_058246.3	NP_490647.1	REVIEWED	OK	1.000	1.000	326	981	1	978	326	1	326
Invitrogen	NM_144683	IOH12312	Invitrogen(on gateway)	W01B005A16	pENTR221	10672		DHRS13	147015	NP_653284.2	Hs.631760	Dehydrogenase/reductase (SDR family) member 13						NM_144683.3	NP_653284.2	VALIDATED	P	1.000	1.000	327	984	1	981	377	51	377
Invitrogen	NM_031854	IOH3801	Invitrogen(on gateway)	W01B005A17	pENTR221	10490		KRTAP4-12	83755	NP_114060.1	Hs.572443	Keratin associated protein 4-12						NM_031854.2	NP_114060.1	REVIEWED	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	NM_017503	IOH12519	Invitrogen(on gateway)	W01B005A18	pENTR221	23770		SURF2	6835	NP_059973.3	Hs.159448	Surfeit 2						NM_017503.3	NP_059973.3	REVIEWED	Cs	0.996	0.996	256	771	1	768	256	1	256
Invitrogen	NM_001958	IOH3434	Invitrogen(on gateway)	W01B005A19	pENTR221	15075		EEF1A2	1917	NP_001949.1	Hs.433839	Eukaryotic translation elongation factor 1 alpha 2						NM_001958.2	NP_001949.1	REVIEWED	C	1.000	1.000	463	1392	1	1389	463	1	463
Invitrogen	BC000112	IOH4632	Invitrogen(on gateway)	W01B005A20	pENTR221	7373		RDH11	51109	AAH00112.1	Hs.226007	Retinol dehydrogenase 11 (all-trans/9-cis/11-cis)						NM_016026.3	NP_057110.3	VALIDATED	C	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	NM_001014432	IOH3692	Invitrogen(on gateway)	W01B005A21	pENTR221	7515		AKT1	207	NP_001014432.1	Hs.525622	V-akt murine thymoma viral oncogene homolog 1						NM_001014431.1	NP_001014431.1	REVIEWED	C	1.000	1.000	480	1443	1	1440	480	1	480
Invitrogen	NM_004401	IOH4671	Invitrogen(on gateway)	W01B005A22	pENTR221	1601		DFFA	1676	NP_004392.1	Hs.484782	DNA fragmentation factor, 45kDa, alpha polypeptide						NM_004401.2	NP_004392.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
Invitrogen	NM_052820	IOH4591	Invitrogen(on gateway)	W01B005A23	pENTR221	24273		CORO2A	7464	NP_438171.1	Hs.113094	Coronin, actin binding protein, 2A						NM_052820.3	NP_438171.1	REVIEWED	C	1.000	1.000	525	1578	1	1575	525	1	525
Invitrogen	NM_006681	IOH10556	Invitrogen(on gateway)	W01B005A24	pENTR221	18132		NMU	10874	NP_006672.1	Hs.418367	Neuromedin U						NM_006681.2	NP_006672.1	VALIDATED	C	1.000	1.000	174	525	1	522	174	1	174
Invitrogen	NM_004744	IOH22523	Invitrogen(on gateway)	W01B005B01	pENTR221	17493		LRAT	9227	NP_004735.2	Hs.658427	Lecithin retinol acyltransferase (phosphatidylcholine--retinol O-acyltransferase)						NM_004744.3	NP_004735.2	REVIEWED	C	1.000	1.000	230	693	1	690	230	1	230
Invitrogen	BC001917	IOH5075	Invitrogen(on gateway)	W01B005B02	pENTR221	21118		MDH2	4191	AAH01917.1	Hs.520967	Malate dehydrogenase 2, NAD (mitochondrial)						NM_005918.2	NP_005909.2	REVIEWED	Cs	0.997	0.997	338	1017	1	1014	338	1	338
Invitrogen	NM_005182	IOH21843	Invitrogen(on gateway)	W01B005B03	pENTR221	8896		CA7	766	NP_005173.1	Hs.37014	Carbonic anhydrase VII						NM_005182.2	NP_005173.1	REVIEWED	C	1.000	1.000	264	795	1	792	264	1	264
Invitrogen	BC029896	IOH22827	Invitrogen(on gateway)	W01B005B04	pENTR221	12318		SIGLEC5	8778	AAH29896.1	Hs.310333	Sialic acid binding Ig-like lectin 5						NM_003830.2	NP_003821.1	VALIDATED	Cs	0.998	0.998	551	1656	1	1653	551	1	551
Invitrogen	NM_080387	IOH21717	Invitrogen(on gateway)	W01B005B05	pENTR221	5367		CLEC4D	338339	NP_525126.2	Hs.351811	C-type lectin domain family 4, member D						NM_080387.4	NP_525126.2	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
Invitrogen	BC014577	IOH12508	Invitrogen(on gateway)	W01B005B06	pENTR221	4865		ART5	116969	AAH14577.1	Hs.125680	ADP-ribosyltransferase 5						NM_001079536.1	NP_001073004.1	REVIEWED	Cgs	0.993	0.997	292	879	1	876	291	1	291
Invitrogen	NM_032411	IOH10634	Invitrogen(on gateway)	W01B005B07	pENTR221	13186		C2orf40	84417	NP_115787.1	Hs.43125	Chromosome 2 open reading frame 40						NM_032411.2	NP_115787.1	VALIDATED	C	1.000	1.000	148	447	1	444	148	1	148
Invitrogen	NM_031481	IOH22826	Invitrogen(on gateway)	W01B005B08	pENTR221	15597		SLC25A18	83733	NP_113669.1	Hs.282982	Solute carrier family 25 (mitochondrial carrier), member 18						NM_031481.1	NP_113669.1	PROVISIONAL	OK	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_003006	IOH22638	Invitrogen(on gateway)	W01B005B09	pENTR221	6160		SELPLG	6404	NP_002997.1	Hs.591014	Selectin P ligand						NM_003006.3	NP_002997.1	REVIEWED	OK	1.000	1.000	402	1209	1	1206	402	1	402
Invitrogen	NM_004578	IOH5541	Invitrogen(on gateway)	W01B005B10	pENTR221	506		RAB4A	5867	NP_004569.2	Hs.296169	RAB4A, member RAS oncogene family						NM_004578.2	NP_004569.2	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
Invitrogen	BC000450	IOH3506	Invitrogen(on gateway)	W01B005B11	pENTR221	246		GNPAT	8443	AAH00450.1	Hs.498028	Glyceronephosphate O-acyltransferase						NM_014236.3	NP_055051.1	REVIEWED	Cs	0.999	0.999	680	2043	1	2040	680	1	680
Invitrogen	NM_020143	IOH6877	Invitrogen(on gateway)	W01B005B12	pENTR221	13143		PNO1	56902	NP_064528.1	Hs.262858	Partner of NOB1 homolog (S. cerevisiae)						NM_020143.2	NP_064528.1	PROVISIONAL	C	1.000	1.000	252	759	1	756	252	1	252
Invitrogen	NM_002650	IOH21078	Invitrogen(on gateway)	W01B005B13	pENTR221	15821		PI4KA	5297	NP_002641.1	Hs.529438	Phosphatidylinositol 4-kinase, catalytic, alpha						NM_002650.2	NP_002641.1	REVIEWED	C	1.000	1.000	854	2565	1	2562	854	1	854
Invitrogen	NM_000576	IOH9821	Invitrogen(on gateway)	W01B005B14	pENTR221	13906		IL1B	3553	NP_000567.1	Hs.126256	Interleukin 1, beta						NM_000576.2	NP_000567.1	REVIEWED	C	1.000	1.000	269	810	1	807	269	1	269
Invitrogen	BC034047	IOH22225	Invitrogen(on gateway)	W01B005B15	pENTR221	1548		LRRN2	10446	AAH34047.1	Hs.26312	Leucine rich repeat neuronal 2						NM_006338.2	NP_006329.2	REVIEWED	Cs	0.997	0.997	713	2142	1	2139	713	1	713
Invitrogen	BC008892	IOH6264	Invitrogen(on gateway)	W01B005B16	pENTR221	10585		ALDH3A1	218	AAH08892.1	Hs.531682	Aldehyde dehydrogenase 3 family, memberA1						NM_001135167.1	NP_001128639.1	REVIEWED	Cs	0.998	0.998	453	1362	1	1359	453	1	453
Invitrogen	BC025980	IOH12996	Invitrogen(on gateway)	W01B005B17	pENTR221	14599		ENTPD6	955	AAH25980.1	Hs.500375	Ectonucleoside triphosphate diphosphohydrolase 6 (putative function)						NM_001247.2	NP_001238.2	REVIEWED	Cg	0.998	1.000	484	1452	1	1449	484	1	484
Invitrogen	NM_033177	IOH6217	Invitrogen(on gateway)	W01B005B18	pENTR221	20478		BAT4	7918	NP_149417.1	Hs.247478	HLA-B associated transcript 4						NM_033177.2	NP_149417.1	REVIEWED	C	1.000	1.000	356	1071	1	1068	356	1	356
Invitrogen	NM_012265	IOH5339	Invitrogen(on gateway)	W01B005B19	pENTR221	15952		RHBDD3	25807	NP_036397.1	Hs.106730	Rhomboid domain containing 3						NM_012265.1	NP_036397.1	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
Invitrogen	BC020973	IOH9971	Invitrogen(on gateway)	W01B005B20	pENTR221	23710		RAD23B	5887	AAH20973.1	Hs.521640	RAD23 homolog B (S. cerevisiae)						NM_002874.3	NP_002865.1	REVIEWED	Cs	0.998	0.998	409	1230	1	1227	409	1	409
Invitrogen	NM_016023	IOH22119	Invitrogen(on gateway)	W01B005B21	pENTR221	22570		OTUD6B	51633	NP_057107.3	Hs.30532	OTU domain containing 6B						NM_016023.3	NP_057107.3	VALIDATED	P	1.000	1.000	293	882	1	879	323	31	323
Invitrogen	NM_014820	IOH5235	Invitrogen(on gateway)	W01B005B22	pENTR221	16737		TOMM70A	9868	NP_055635.3	Hs.227253	Translocase of outer mitochondrial membrane 70 homolog A (S. cerevisiae)						NM_014820.3	NP_055635.3	VALIDATED	C	1.000	1.000	608	1827	1	1824	608	1	608
Invitrogen	NM_016607	IOH7393	Invitrogen(on gateway)	W01B005B23	pENTR221	24519		ARMCX3	51566	NP_057691.1	Hs.592225	Armadillo repeat containing, X-linked 3						NM_177948.2	NP_808817.1	REVIEWED	C	1.000	1.000	379	1140	1	1137	379	1	379
Invitrogen	BC017865	IOH13793	Invitrogen(on gateway)	W01B005B24	pENTR221	2073		FCGR3A	2214	AAH17865.1	Hs.372679	Fc fragment of IgG, low affinity IIIa, receptor (CD16a)						NM_001127595.1	NP_001121067.1	REVIEWED	Cs	0.996	0.996	254	765	1	762	254	1	254
Invitrogen	NM_003193	IOH3395	Invitrogen(on gateway)	W01B005C01	pENTR221	715		TBCE	6905	NP_003184.1	Hs.498143	Tubulin folding cofactor E						NM_001079515.1	NP_001072983.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
Invitrogen	BC030229	IOH22611	Invitrogen(on gateway)	W01B005C02	pENTR221	16564		GP9	2815	AAH30229.1	Hs.1144	Glycoprotein IX (platelet)						NM_000174.3	NP_000165.1	REVIEWED	Cs	0.994	0.994	177	534	1	531	177	1	177
Invitrogen	ENST00000333656	IOH5737	Invitrogen(on gateway)	W01B005C03	pENTR221															
Invitrogen	NM_174898	IOH22661	Invitrogen(on gateway)	W01B005C04	pENTR221	14241		LYG1	129530	NP_777558.1	Hs.164589	Lysozyme G-like 1						NM_174898.2	NP_777558.1	VALIDATED	C	1.000	1.000	194	585	1	582	194	1	194
Invitrogen	NM_006303	IOH5395	Invitrogen(on gateway)	W01B005C05	pENTR221	21155		AIMP2	7965	NP_006294.2	Hs.301613	JTV1 gene						NM_006303.3	NP_006294.2	VALIDATED	C	1.000	1.000	320	963	1	960	320	1	320
Invitrogen	BC036370	IOH22345	Invitrogen(on gateway)	W01B005C06	pENTR221	15418		HSPA13	6782	AAH36370.1	Hs.352341	Heat shock protein 70kDa family, member 13						NM_006948.4	NP_008879.3	REVIEWED	Cs	0.998	0.998	471	1416	1	1413	471	1	471
Invitrogen	NM_024045	IOH4504	Invitrogen(on gateway)	W01B005C07	pENTR221	2722		DDX50	79009	NP_076950.1	Hs.522984	DEAD (Asp-Glu-Ala-Asp) box polypeptide 50						NM_024045.1	NP_076950.1	REVIEWED	C	1.000	1.000	737	2214	1	2211	737	1	737
Invitrogen	NM_002642	IOH14889	Invitrogen(on gateway)	W01B005C08	pENTR221	2083		PIGC	5279	NP_002633.1	Hs.188456	Phosphatidylinositol glycan anchor biosynthesis, class C						NM_153747.1	NP_714969.1	REVIEWED	C	1.000	1.000	297	894	1	891	297	1	297
Invitrogen	NM_004911	IOH3420	Invitrogen(on gateway)	W01B005C09	pENTR221	22127		PDIA4	9601	NP_004902.1	Hs.93659	Protein disulfide isomerase family A, member 4						NM_004911.4	NP_004902.1	VALIDATED	C	1.000	1.000	645	1938	1	1935	645	1	645
Invitrogen	NM_005115	IOH14742	Invitrogen(on gateway)	W01B005C10	pENTR221	8609		MVP	9961	NP_005106.2	Hs.632177	Major vault protein						NM_005115.3	NP_005106.2	REVIEWED	C	1.000	1.000	893	2682	1	2679	893	1	893
Invitrogen	BC002559	IOH4053	Invitrogen(on gateway)	W01B005C11	pENTR221	399		YTHDF2	51441	AAH02559.1	Hs.532286	YTH domain family, member 2						NM_016258.2	NP_057342.2	VALIDATED	C	1.000	1.000	579	1740	1	1737	579	1	579
Invitrogen	NM_144987	IOH11407	Invitrogen(on gateway)	W01B005C12	pENTR221	12521		U2AF1L4	199746	NP_659424.2	Hs.351558	U2 small nuclear RNA auxiliary factor 1-like 4						NM_144987.2	NP_659424.2	VALIDATED	Cs	0.995	0.995	202	609	1	606	202	1	202
Invitrogen	NM_004547	IOH3212	Invitrogen(on gateway)	W01B005C13	pENTR221	16220		NDUFB4	4710	NP_004538.2	Hs.304613	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 4, 15kDa						NM_004547.4	NP_004538.2	REVIEWED	C	1.000	1.000	129	390	1	387	129	1	129
Invitrogen	BC015128	IOH12337	Invitrogen(on gateway)	W01B005C14	pENTR221	3768		ATP5L	10632	AAH15128.1	Hs.486360	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit G						NM_006476.4	NP_006467.4	REVIEWED	Cs	0.990	0.990	103	312	1	309	103	1	103
Invitrogen	NM_000190	IOH3306	Invitrogen(on gateway)	W01B005C15	pENTR221	3900		HMBS	3145	NP_000181.2	Hs.82609	Hydroxymethylbilane synthase						NM_000190.3	NP_000181.2	REVIEWED	C	1.000	1.000	361	1086	1	1083	361	1	361
Invitrogen	NM_001778	IOH13424	Invitrogen(on gateway)	W01B005C16	pENTR221	2183		CD48	962	NP_001769.2	Hs.243564	CD48 molecule						NM_001778.2	NP_001769.2	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
Invitrogen	NM_007217	IOH3934	Invitrogen(on gateway)	W01B005C17	pENTR221	16856		PDCD10	11235	NP_009148.2	Hs.478150	Programmed cell death 10						NM_145859.1	NP_665858.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
Invitrogen	NM_022054	IOH12476	Invitrogen(on gateway)	W01B005C18	pENTR221	7050		KCNK13	56659	NP_071337.2	Hs.510191	Potassium channel, subfamily K, member 13						NM_022054.2	NP_071337.2	REVIEWED	OK	1.000	1.000	408	1227	1	1224	408	1	408
Invitrogen	NM_002810	IOH3462	Invitrogen(on gateway)	W01B005C19	pENTR221	116		PSMD4	5710	NP_002801.1	Hs.505059	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 4						NM_002810.2	NP_002801.1	REVIEWED	C	1.000	1.000	377	1134	1	1131	377	1	377
Invitrogen	BC001632	IOH4852	Invitrogen(on gateway)	W01B005C20	pENTR221	10995		NDUFV2	4729	AAH01632.1	Hs.464572	NADH dehydrogenase (ubiquinone) flavoprotein 2, 24kDa						NM_021074.3	NP_066552.2	VALIDATED	C	1.000	1.000	249	750	1	747	249	1	249
Invitrogen	BC001648	IOH3702	Invitrogen(on gateway)	W01B005C21	pENTR221	11857		WDR18	57418	AAH01648.1	Hs.325321	WD repeat domain 18						NM_024100.3	NP_077005.2	REVIEWED	Cs	0.998	0.998	432	1299	1	1296	432	1	432
Invitrogen	NM_014358	IOH4717	Invitrogen(on gateway)	W01B005C22	pENTR221	5806		CLEC4E	26253	NP_055173.1	Hs.236516	C-type lectin domain family 4, member E						NM_014358.2	NP_055173.1	REVIEWED	C	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	NM_004699	IOH4655	Invitrogen(on gateway)	W01B005C23	pENTR221	24565		FAM50A	9130	NP_004690.1	Hs.54277	Family with sequence similarity 50, member A						NM_004699.1	NP_004690.1	PROVISIONAL	C	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	NM_144626	IOH10335	Invitrogen(on gateway)	W01B005C24	pENTR221	924		TMEM125	128218	NP_653227.1	Hs.104476	Transmembrane protein 125						NM_144626.1	NP_653227.1	PROVISIONAL	C	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	NM_012129	IOH21868	Invitrogen(on gateway)	W01B005D01	pENTR221	21381		CLDN12	9069	NP_036261.1	Hs.258576	Claudin 12						NM_012129.2	NP_036261.1	PROVISIONAL	C	1.000	1.000	244	735	1	732	244	1	244
Invitrogen	NM_022788	IOH12543	Invitrogen(on gateway)	W01B005D02	pENTR221	16795		P2RY12	64805	NP_073625.1	Hs.591281	Purinergic receptor P2Y, G-protein coupled, 12						NM_022788.3	NP_073625.1	REVIEWED	C	1.000	1.000	342	1029	1	1026	342	1	342
Invitrogen	NM_001651	IOH22503	Invitrogen(on gateway)	W01B005D03	pENTR221	5618		AQP5	362	NP_001642.1	Hs.298023	Aquaporin 5						NM_001651.2	NP_001642.1	REVIEWED	C	1.000	1.000	265	798	1	795	265	1	265
Invitrogen	NM_012193	IOH10607	Invitrogen(on gateway)	W01B005D04	pENTR221	4426		FZD4	8322	NP_036325.2	Hs.591968	Frizzled homolog 4 (Drosophila)						NM_012193.2	NP_036325.2	REVIEWED	C	1.000	1.000	537	1614	1	1611	537	1	537
Invitrogen	NM_000756	IOH4131	Invitrogen(on gateway)	W01B005D05	pENTR221	23154		CRH	1392	NP_000747.1	Hs.75294	Corticotropin releasing hormone						NM_000756.1	NP_000747.1	REVIEWED	C	1.000	1.000	196	591	1	588	196	1	196
Invitrogen	NM_138484	IOH13821	Invitrogen(on gateway)	W01B005D06	pENTR221	16821		SGOL1	151648	NP_612493.1	Hs.105153	Shugoshin-like 1 (S. pombe)						NM_138484.2	NP_612493.1	PROVISIONAL	C	1.000	1.000	292	879	1	876	292	1	292
Invitrogen	NM_032356	IOH21819	Invitrogen(on gateway)	W01B005D07	pENTR221	10468		LSMD1	84316	NP_115732.2	Hs.565094	LSM domain containing 1						NM_032356.3	NP_115732.2	PROVISIONAL	C	1.000	1.000	173	522	1	519	173	1	173
Invitrogen	BC028728	IOH11804	Invitrogen(on gateway)	W01B005D08	pENTR221	8222		CATSPER2	117155	AAH28728.1	Hs.662284	Cation channel, sperm associated 2						NM_172097.1	NP_742095.1	REVIEWED	Cs	0.995	0.995	199	600	1	597	199	1	199
Invitrogen	NM_014224	IOH22660	Invitrogen(on gateway)	W01B005D09	pENTR221	4019		PGA5	5222	NP_055039.1	Hs.432854	Pepsinogen 5, group I (pepsinogen A)						NM_014224.1	NP_055039.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
Invitrogen	BC009294	IOH14145	Invitrogen(on gateway)	W01B005D10	pENTR221	5532		RPL14	9045	AAH09294.1	Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED	Cg	0.986	1.000	218	657	1	654	215	1	215
Invitrogen	NM_020216	IOH3753	Invitrogen(on gateway)	W01B005D11	pENTR221	519		RNPEP	6051	NP_064601.3	Hs.497391	Arginyl aminopeptidase (aminopeptidase B)						NM_020216.3	NP_064601.3	VALIDATED	C	1.000	1.000	650	1953	1	1950	650	1	650
Invitrogen	BC012197	IOH14767	Invitrogen(on gateway)	W01B005D12	pENTR221	4875		RPL8	6132	AAH12197.1	Hs.178551	Ribosomal protein L8						NM_000973.3	NP_000964.1	REVIEWED	Cs	0.996	0.996	257	774	1	771	257	1	257
Invitrogen	NM_001274	IOH21103	Invitrogen(on gateway)	W01B005D13	pENTR221	3739		CHEK1	1111	NP_001265.2	Hs.24529	CHK1 checkpoint homolog (S. pombe)						NM_001274.4	NP_001265.2	VALIDATED	Cs	0.998	0.998	476	1431	1	1428	476	1	476
Invitrogen	NM_006419	IOH14282	Invitrogen(on gateway)	W01B005D14	pENTR221	17478		CXCL13	10563	NP_006410.1	Hs.100431	Chemokine (C-X-C motif) ligand 13						NM_006419.2	NP_006410.1	VALIDATED	C	1.000	1.000	109	330	1	327	109	1	109
Invitrogen	NM_017673	IOH22246	Invitrogen(on gateway)	W01B005D15	pENTR221	452		C1orf26	54823	NP_060143.4	Hs.134183	Chromosome 1 open reading frame 26						NM_017673.6	NP_060143.4	VALIDATED	Cs	0.996	0.996	900	2703	1	2700	900	1	900
Invitrogen	NM_005147	IOH14013	Invitrogen(on gateway)	W01B005D16	pENTR221	8626		DNAJA3	9093	NP_005138.3	Hs.719223	DnaJ (Hsp40) homolog, subfamily A, member 3						NM_005147.4	NP_005138.3	VALIDATED	Cs	0.998	0.998	480	1443	1	1440	480	1	480
Invitrogen	NM_004337	IOH22524	Invitrogen(on gateway)	W01B005D17	pENTR221	22544		OSGIN2	734	NP_004328.1	Hs.436445	Oxidative stress induced growth inhibitor family member 2						NM_004337.2	NP_004328.1	VALIDATED	C	1.000	1.000	505	1518	1	1515	505	1	505
Invitrogen	NM_017518	IOH10197	Invitrogen(on gateway)	W01B005D18	pENTR221	25194		HAUS7	55559	NP_059988.3	Hs.170835	HAUS augmin-like complex, subunit 7						NM_017518.5	NP_059988.3	REVIEWED	OK	1.000	1.000	368	1107	1	1104	368	1	368
Invitrogen	BC031592	IOH22703	Invitrogen(on gateway)	W01B005D19	pENTR221	10019		SERPINF2	5345	AAH31592.1	Hs.159509	Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 2						NM_000934.3	NP_000925.2	VALIDATED	Cs	0.998	0.998	491	1476	1	1473	491	1	491
Invitrogen	BC012609	IOH12212	Invitrogen(on gateway)	W01B005D20	pENTR221	10934		SERPINB2	5055	AAH12609.1	Hs.594481	Serpin peptidase inhibitor, clade B (ovalbumin), member 2						NM_002575.2	NP_002566.1	VALIDATED	Cs	0.998	0.998	415	1248	1	1245	415	1	415
Invitrogen	NM_030960	IOH22506	Invitrogen(on gateway)	W01B005D21	pENTR221	19827		SPACA1	81833	NP_112222.1	Hs.161241	Sperm acrosome associated 1						NM_030960.2	NP_112222.1	REVIEWED	C	1.000	1.000	294	885	1	882	294	1	294
Invitrogen	NM_032725	IOH6409	Invitrogen(on gateway)	W01B005D22	pENTR221	4769		BUD13	84811	NP_116114.1	Hs.437341	BUD13 homolog (S. cerevisiae)						NM_032725.3	NP_116114.1	VALIDATED	C	1.000	1.000	619	1860	1	1857	619	1	619
Invitrogen	NM_018436	IOH22862	Invitrogen(on gateway)	W01B005D23	pENTR221	13158		ALLC	55821	NP_060906.3	Hs.97899	Allantoicase						NM_018436.3	NP_060906.3	VALIDATED	Cgs	0.995	0.997	391	1230	58	1227	391	1	391
Invitrogen	NM_000802	IOH6364	Invitrogen(on gateway)	W01B005D24	pENTR221	3720		FOLR1	2348	NP_000793.1	Hs.73769	Folate receptor 1 (adult)						NM_016724.1	NP_057936.1	REVIEWED	C	1.000	1.000	257	774	1	771	257	1	257
Invitrogen	NM_006184	IOH3531	Invitrogen(on gateway)	W01B005E01	pENTR221	11722		NUCB1	4924	NP_006175.2	Hs.631602	Nucleobindin 1						NM_006184.3	NP_006175.2	PROVISIONAL	C	1.000	1.000	461	1386	1	1383	461	1	461
Invitrogen	NM_006564	IOH22614	Invitrogen(on gateway)	W01B005E02	pENTR221	16202		CXCR6	10663	NP_006555.1	Hs.34526	Chemokine (C-X-C motif) receptor 6						NM_006564.1	NP_006555.1	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
Invitrogen	NM_030579	IOH5585	Invitrogen(on gateway)	W01B005E03	pENTR221	8529		CYB5B	80777	NP_085056.2	Hs.461131	Cytochrome b5 type B (outer mitochondrial membrane)						NM_030579.2	NP_085056.2	VALIDATED	P	1.000	1.000	146	441	1	438	150	5	150
Invitrogen	BC029057	IOH22662	Invitrogen(on gateway)	W01B005E04	pENTR221	5612		DAO	1610	AAH29057.1	Hs.113227	D-amino-acid oxidase						NM_001917.4	NP_001908.3	REVIEWED	C	1.000	1.000	347	1044	1	1041	347	1	347
Invitrogen	NM_020531	IOH5450	Invitrogen(on gateway)	W01B005E05	pENTR221	14890		C20orf3	57136	NP_065392.1	Hs.472330	Chromosome 20 open reading frame 3						NM_020531.2	NP_065392.1	VALIDATED	OK	1.000	1.000	416	1251	1	1248	416	1	416
Invitrogen	NM_014419	IOH22346	Invitrogen(on gateway)	W01B005E06	pENTR221	11590		DKKL1	27120	NP_055234.1	Hs.515855	Dickkopf-like 1 (soggy)						NM_014419.3	NP_055234.1	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
Invitrogen	NM_016630	IOH4511	Invitrogen(on gateway)	W01B005E07	pENTR221	8205		SPG21	51324	NP_057714.1	Hs.242458	Spastic paraplegia 21 (autosomal recessive, Mast syndrome)						NM_001127889.1	NP_001121361.1	REVIEWED	OK	1.000	1.000	308	927	1	924	308	1	308
Invitrogen	BC018696	IOH14215	Invitrogen(on gateway)	W01B005E08	pENTR221	21094		DLD	1738	AAH18696.1	Hs.131711	Dihydrolipoamide dehydrogenase						NM_000108.3	NP_000099.2	REVIEWED	C	1.000	1.000	509	1530	1	1527	509	1	509
Invitrogen	NM_006623	IOH3438	Invitrogen(on gateway)	W01B005E09	pENTR221	114		PHGDH	26227	NP_006614.2	Hs.487296	Phosphoglycerate dehydrogenase						NM_006623.3	NP_006614.2	REVIEWED	C	1.000	1.000	533	1602	1	1599	533	1	533
Invitrogen	NM_139276	IOH14348	Invitrogen(on gateway)	W01B005E10	pENTR221	10325		STAT3	6774	NP_644805.1	Hs.463059	Signal transducer and activator of transcription 3 (acute-phase response factor)						NM_139276.2	NP_644805.1	REVIEWED	C	1.000	1.000	770	2313	1	2310	770	1	770
Invitrogen	NM_004832	IOH4381	Invitrogen(on gateway)	W01B005E11	pENTR221	2691		GSTO1	9446	NP_004823.1	Hs.190028	Glutathione S-transferase omega 1						NM_004832.1	NP_004823.1	REVIEWED	C	1.000	1.000	241	726	1	723	241	1	241
Invitrogen	NM_002729	IOH1918	Invitrogen(on gateway)	W01B005E12	pENTR221	2894		HHEX	3087	NP_002720.1	Hs.118651	Hematopoietically expressed homeobox						NM_002729.4	NP_002720.1	REVIEWED	C	1.000	1.000	270	813	1	810	270	1	270
Invitrogen	NM_001780	IOH3413	Invitrogen(on gateway)	W01B005E13	pENTR221	6023		CD63	967	NP_001771.1	Hs.445570	CD63 molecule						NM_001780.4	NP_001771.1	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
Invitrogen	NM_138789	IOH12092	Invitrogen(on gateway)	W01B005E14	pENTR221	4901		PIH1D2	120379	NP_620144.1	Hs.420662	PIH1 domain containing 2						NM_138789.3	NP_620144.1	VALIDATED	C	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_080655	IOH3321	Invitrogen(on gateway)	W01B005E15	pENTR221	23675		C9orf30	91283	NP_542386.1	Hs.530272	Chromosome 9 open reading frame 30						NM_080655.1	NP_542386.1	PREDICTED	C	1.000	1.000	275	828	1	825	275	1	275
Invitrogen	NM_002704	IOH12030	Invitrogen(on gateway)	W01B005E16	pENTR221	18282		PPBP	5473	NP_002695.1	Hs.2164	Pro-platelet basic protein (chemokine (C-X-C motif) ligand 7)						NM_002704.2	NP_002695.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
Invitrogen	NM_002632	IOH4048	Invitrogen(on gateway)	W01B005E17	pENTR221	7312		PGF	5228	NP_002623.2	Hs.252820	Placental growth factor						NM_002632.4	NP_002623.2	VALIDATED	C	1.000	1.000	170	513	1	510	170	1	170
Invitrogen	NM_023080	IOH13369	Invitrogen(on gateway)	W01B005E18	pENTR221	22552		C8orf33	65265	NP_075568.1	Hs.169615	Chromosome 8 open reading frame 33						NM_023080.2	NP_075568.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
Invitrogen	NM_014449	IOH3494	Invitrogen(on gateway)	W01B005E19	pENTR221	5253		GPR162	27239	NP_055264.1	Hs.631654	G protein-coupled receptor 162						NM_014449.1	NP_055264.1	REVIEWED	C	1.000	1.000	304	915	1	912	304	1	304
Invitrogen	BC003566	IOH4871	Invitrogen(on gateway)	W01B005E20	pENTR221	11193		ZNF24	7572	AAH03566.1	Hs.514802	Zinc finger protein 24						NM_006965.2	NP_008896.2	VALIDATED	Cs	0.997	0.997	368	1107	1	1104	368	1	368
Invitrogen	NM_000239	IOH3791	Invitrogen(on gateway)	W01B005E21	pENTR221	5526		LYZ	4069	NP_000230.1	Hs.524579	Lysozyme (renal amyloidosis)						NM_000239.2	NP_000230.1	REVIEWED	C	1.000	1.000	148	447	1	444	148	1	148
Invitrogen	NM_000290	IOH4832	Invitrogen(on gateway)	W01B005E22	pENTR221	22131		PGAM2	5224	NP_000281.2	Hs.632642	Phosphoglycerate mutase 2 (muscle)						NM_000290.2	NP_000281.2	VALIDATED	C	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	NM_006135	IOH2966	Invitrogen(on gateway)	W01B005E23	pENTR221	811		CAPZA1	829	NP_006126.1	Hs.514934	Capping protein (actin filament) muscle Z-line, alpha 1						NM_006135.2	NP_006126.1	REVIEWED	C	1.000	1.000	286	861	1	858	286	1	286
Invitrogen	NM_002819	IOH10537	Invitrogen(on gateway)	W01B005E24	pENTR221	11465		PTBP1	5725	NP_002810.1	Hs.172550	Polypyrimidine tract binding protein 1						NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
Invitrogen	NM_013445	IOH5444	Invitrogen(on gateway)	W01B005F01	pENTR221	12878		GAD1	2571	NP_038473.2	Hs.420036	Glutamate decarboxylase 1 (brain, 67kDa)						NM_013445.3	NP_038473.2	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	NM_001005783	IOH12277	Invitrogen(on gateway)	W01B005F02	pENTR221	420		HAO2	51179	NP_001005783.1	Hs.659767	Hydroxyacid oxidase 2 (long chain)						NM_001005783.1	NP_001005783.1	REVIEWED	C	1.000	1.000	351	1056	1	1053	351	1	351
Invitrogen	BC033843	IOH21767	Invitrogen(on gateway)	W01B005F03	pENTR221	7091		C14orf135	64430	AAH33843.2	Hs.509499	Chromosome 14 open reading frame 135						NM_022495.5	NP_071940.4	VALIDATED	P	1.000	1.000	279	840	1	837	938	660	938
Invitrogen	NM_024785	IOH11061	Invitrogen(on gateway)	W01B005F04	pENTR221	14081		FAM124B	79843	NP_079061.2	Hs.147585	Family with sequence similarity 124B						NM_024785.2	NP_079061.2	VALIDATED	C	1.000	1.000	272	819	1	816	272	1	272
Invitrogen	BC019651	IOH22189	Invitrogen(on gateway)	W01B005F05	pENTR221	5532		RPL14	9045	AAH19651.1	Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED	Cg	0.982	1.000	219	660	1	657	215	1	215
Invitrogen	BC016789	IOH13602	Invitrogen(on gateway)	W01B005F06	pENTR221	4673		GLYATL2	219970	AAH16789.1	Hs.254271	Glycine-N-acyltransferase-like 2						NM_145016.3	NP_659453.3	VALIDATED	Cs	0.990	0.990	294	885	1	882	294	1	294
Invitrogen	NM_013251	IOH23098	Invitrogen(on gateway)	W01B005F07	pENTR221	5963		TAC3	6866	NP_037383.1	Hs.9730	Tachykinin 3						NM_013251.2	NP_037383.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
Invitrogen	NM_003278	IOH14450	Invitrogen(on gateway)	W01B005F08	pENTR221	16543		CLEC3B	7123	NP_003269.2	Hs.476092	C-type lectin domain family 3, member B						NM_003278.2	NP_003269.2	VALIDATED	Cs	0.995	0.995	202	609	1	606	202	1	202
Invitrogen	BC034671	IOH22663	Invitrogen(on gateway)	W01B005F09	pENTR221	11869		CEACAM5	1048	AAH34671.1	Hs.709196	Carcinoembryonic antigen-related cell adhesion molecule 5						NM_004363.2	NP_004354.2	VALIDATED	Cs	0.997	0.997	702	2109	1	2106	702	1	702
Invitrogen	NM_004181	IOH5072	Invitrogen(on gateway)	W01B005F10	pENTR221	17610		UCHL1	7345	NP_004172.2	Hs.518731	Ubiquitin carboxyl-terminal esterase L1 (ubiquitin thiolesterase)						NM_004181.3	NP_004172.2	PROVISIONAL	C	1.000	1.000	223	672	1	669	223	1	223
Invitrogen	NM_000404	IOH5894	Invitrogen(on gateway)	W01B005F11	pENTR221	17139		GLB1	2720	NP_000395.2	Hs.443031	Galactosidase, beta 1						NM_001079811.1	NP_001073279.1	REVIEWED	C	1.000	1.000	647	2034	91	2031	647	1	647
Invitrogen	NM_016267	IOH2890	Invitrogen(on gateway)	W01B005F12	pENTR221	24615		VGLL1	51442	NP_057351.1	Hs.496843	Vestigial like 1 (Drosophila)						NM_016267.2	NP_057351.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
Invitrogen	NM_003600	IOH21165	Invitrogen(on gateway)	W01B005F13	pENTR221	14922		AURKA	6790	NP_003591.2	Hs.250822	Aurora kinase A						NM_198435.1	NP_940837.1	REVIEWED	Cs	0.998	0.998	403	1212	1	1209	403	1	403
Invitrogen	BC010957	IOH12272	Invitrogen(on gateway)	W01B005F14	pENTR221	19662		CGA	1081	AAH10957.1	Hs.119689	Glycoprotein hormones, alpha polypeptide						NM_000735.2	NP_000726.1	REVIEWED	Cs	0.991	0.991	116	351	1	348	116	1	116
Invitrogen	BC036649	IOH22249	Invitrogen(on gateway)	W01B005F15	pENTR221	7537		SEC23A	10484	AAH36649.1	Hs.272927	Sec23 homolog A (S. cerevisiae)						NM_006364.2	NP_006355.2	REVIEWED	Cs	0.997	0.997	765	2298	1	2295	765	1	765
Invitrogen	NM_004054	IOH13077	Invitrogen(on gateway)	W01B005F16	pENTR221	6189		C3AR1	719	NP_004045.1	Hs.591148	Complement component 3a receptor 1						NM_004054.2	NP_004045.1	VALIDATED	C	1.000	1.000	482	1449	1	1446	482	1	482
Invitrogen	NM_138790	IOH13175	Invitrogen(on gateway)	W01B005F17	pENTR221	7185		PLD4	122618	NP_620145.2	Hs.407101	Phospholipase D family, member 4						NM_138790.2	NP_620145.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	506	18	506
Invitrogen	NM_003596	IOH11639	Invitrogen(on gateway)	W01B005F18	pENTR221	21115		TPST1	8460	NP_003587.1	Hs.421194	Tyrosylprotein sulfotransferase 1						NM_003596.3	NP_003587.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
Invitrogen	NM_020786	IOH21549	Invitrogen(on gateway)	W01B005F19	pENTR221	8564		PDP2	57546	NP_065837.1	Hs.654693	Pyruvate dehydrogenase phosphatase isoenzyme 2						NM_020786.1	NP_065837.1	VALIDATED	C	1.000	1.000	529	1590	1	1587	529	1	529
Invitrogen	NM_013309	IOH11056	Invitrogen(on gateway)	W01B005F20	pENTR221	8157		SLC30A4	7782	NP_037441.2	Hs.162989	Solute carrier family 30 (zinc transporter), member 4						NM_013309.4	NP_037441.2	VALIDATED	C	1.000	1.000	429	1290	1	1287	429	1	429
Invitrogen	NM_144637	IOH11004	Invitrogen(on gateway)	W01B005F21	pENTR221															
Invitrogen	NM_003156	IOH23097	Invitrogen(on gateway)	W01B005F22	pENTR221	4110		STIM1	6786	NP_003147.2	Hs.501735	Stromal interaction molecule 1						NM_003156.3	NP_003147.2	REVIEWED	OK	1.000	1.000	685	2058	1	2055	685	1	685
Invitrogen	NM_017457	IOH4897	Invitrogen(on gateway)	W01B005F23	pENTR221	11482		CYTH2	9266	NP_059431.1	Hs.144011	Cytohesin 2						NM_017457.4	NP_059431.1	REVIEWED	C	1.000	1.000	400	1203	1	1200	400	1	400
Invitrogen	BC009956	IOH12720	Invitrogen(on gateway)	W01B005F24	pENTR221	20767		HLA-DPA1	3113	AAH09956.1	Hs.347270	Major histocompatibility complex, class II, DP alpha 1						NM_033554.2	NP_291032.2	REVIEWED		0.973	0.973	260	783	1	780	260	1	260
Invitrogen	NM_013319	IOH5671	Invitrogen(on gateway)	W01B005G01	pENTR221	360		UBIAD1	29914	NP_037451.1	Hs.522933	UbiA prenyltransferase domain containing 1						NM_013319.2	NP_037451.1	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
Invitrogen	NM_016564	IOH22629	Invitrogen(on gateway)	W01B005G02	pENTR221	4635		CEND1	51286	NP_057648.2	Hs.22140	Cell cycle exit and neuronal differentiation 1						NM_016564.3	NP_057648.2	REVIEWED	C	1.000	1.000	149	450	1	447	149	1	149
Invitrogen	NM_001959	IOH5493	Invitrogen(on gateway)	W01B005G03	pENTR221	13454		EEF1B2	1933	NP_001950.1	Hs.421608	Eukaryotic translation elongation factor 1 beta 2						NM_021121.3	NP_066944.1	REVIEWED	C	1.000	1.000	225	678	1	675	225	1	225
Invitrogen	NM_006147	IOH10956	Invitrogen(on gateway)	W01B005G04	pENTR221	1545		IRF6	3664	NP_006138.1	Hs.719361	Interferon regulatory factor 6						NM_006147.2	NP_006138.1	REVIEWED	C	1.000	1.000	467	1404	1	1401	467	1	467
Invitrogen	BC000120	IOH4407	Invitrogen(on gateway)	W01B005G05	pENTR221	12656		GTF2F1	2962	AAH00120.1	Hs.68257	General transcription factor IIF, polypeptide 1, 74kDa						NM_002096.2	NP_002087.2	VALIDATED	C	1.000	1.000	517	1554	1	1551	517	1	517
Invitrogen	NM_020207	IOH22373	Invitrogen(on gateway)	W01B005G06	pENTR221	23693		C9orf102	375748	NP_064592.1	Hs.432364	Chromosome 9 open reading frame 102						NM_020207.2	NP_064592.1	VALIDATED	C	1.000	1.000	460	1383	1	1380	460	1	460
Invitrogen	NM_007284	IOH5114	Invitrogen(on gateway)	W01B005G07	pENTR221	16783		TWF2	11344	NP_009215.1	Hs.436439	Twinfilin, actin-binding protein, homolog 2 (Drosophila)						NM_007284.3	NP_009215.1	REVIEWED	OK	1.000	1.000	349	1050	1	1047	349	1	349
Invitrogen	NM_013446	IOH14075	Invitrogen(on gateway)	W01B005G08	pENTR221	21851		MKRN1	23608	NP_038474.2	Hs.490347	Makorin ring finger protein 1						NM_001145125.1	NP_001138597.1	VALIDATED	Cs	0.997	0.997	329	1449	1	987	329	1	329
Invitrogen	NM_003683	IOH3452	Invitrogen(on gateway)	W01B005G09	pENTR221	15257		RRP1	8568	NP_003674.1	Hs.110757	Ribosomal RNA processing 1 homolog (S. cerevisiae)						NM_003683.5	NP_003674.1	REVIEWED	C	1.000	1.000	461	1386	1	1383	461	1	461
Invitrogen	BC017788	IOH13645	Invitrogen(on gateway)	W01B005G10	pENTR221	20504		TFB1M	51106	AAH17788.1	Hs.279908	Transcription factor B1, mitochondrial						NM_016020.2	NP_057104.2	VALIDATED	OK	1.000	1.000	346	1041	1	1038	346	1	346
Invitrogen	NM_004698	IOH4383	Invitrogen(on gateway)	W01B005G11	pENTR221	252		PRPF3	9129	NP_004689.1	Hs.11776	PRP3 pre-mRNA processing factor 3 homolog (S. cerevisiae)						NM_004698.2	NP_004689.1	REVIEWED	C	1.000	1.000	683	2052	1	2049	683	1	683
Invitrogen	NM_001463	IOH11489	Invitrogen(on gateway)	W01B005G12	pENTR221	14206		FRZB	2487	NP_001454.2	Hs.128453	Frizzled-related protein						NM_001463.2	NP_001454.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
Invitrogen	NM_004493	IOH3421	Invitrogen(on gateway)	W01B005G13	pENTR221	25166		HSD17B10	3028	NP_004484.1	Hs.171280	Hydroxysteroid (17-beta) dehydrogenase 10						NM_004493.2	NP_004484.1	REVIEWED	C	1.000	1.000	261	786	1	783	261	1	261
Invitrogen	NM_015660	IOH12432	Invitrogen(on gateway)	W01B005G14	pENTR221	21251		GIMAP2	26157	NP_056475.1	Hs.647071	GTPase, IMAP family member 2						NM_015660.2	NP_056475.1	REVIEWED	OK	1.000	1.000	337	1014	1	1011	337	1	337
Invitrogen	NM_080658	IOH3352	Invitrogen(on gateway)	W01B005G15	pENTR221	4661		ACY3	91703	NP_542389.1	Hs.126265	Aspartoacylase (aminocyclase) 3						NM_080658.1	NP_542389.1	VALIDATED	C	1.000	1.000	319	960	1	957	319	1	319
Invitrogen	NM_145254	IOH10884	Invitrogen(on gateway)	W01B005G16	pENTR221	9357		TMEM170A	124491	NP_660297.1	Hs.487510	Transmembrane protein 170A						NM_145254.1	NP_660297.1	PROVISIONAL	OK	1.000	1.000	144	435	1	432	144	1	144
Invitrogen	NM_002794	IOH4386	Invitrogen(on gateway)	W01B005G17	pENTR221	2245		PSMB2	5690	NP_002785.1	Hs.471441	Proteasome (prosome, macropain) subunit, beta type, 2						NM_002794.3	NP_002785.1	REVIEWED	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	NM_021170	IOH13194	Invitrogen(on gateway)	W01B005G18	pENTR221	1434		HES4	57801	NP_066993.1	Hs.154029	Hairy and enhancer of split 4 (Drosophila)						NM_021170.3	NP_066993.1	VALIDATED	C	1.000	1.000	221	666	1	663	221	1	221
Invitrogen	BC000504	IOH3510	Invitrogen(on gateway)	W01B005G19	pENTR221	13941		SUCLG1	8802	AAH00504.1	Hs.270428	Succinate-CoA ligase, alpha subunit						NM_003849.2	NP_003840.2	VALIDATED	P	1.000	1.000	333	1002	1	999	346	14	346
Invitrogen	NM_006335	IOH4995	Invitrogen(on gateway)	W01B005G20	pENTR221	352		TIMM17A	10440	NP_006326.1	Hs.20716	Translocase of inner mitochondrial membrane 17 homolog A (yeast)						NM_006335.2	NP_006326.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
Invitrogen	BC001496	IOH5148	Invitrogen(on gateway)	W01B005G21	pENTR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)						NM_006827.5	NP_006818.3	REVIEWED	C	1.000	1.000	219	660	1	657	219	1	219
Invitrogen	BC011353	IOH9626	Invitrogen(on gateway)	W01B005G22	pENTR221	22705		LPL	4023	AAH11353.1	Hs.180878	Lipoprotein lipase						NM_000237.2	NP_000228.1	REVIEWED	Cs	0.998	0.998	475	1428	1	1425	475	1	475
Invitrogen	NM_019075	IOH10400	Invitrogen(on gateway)	W01B005G23	pENTR221	13058		UGT1A10	54575	NP_061948.1								NM_019075.2	NP_061948.1	REVIEWED	C	1.000	1.000	530	1593	1	1590	530	1	530
Invitrogen	NM_006452	IOH10896	Invitrogen(on gateway)	W01B005G24	pENTR221	17714		PAICS	10606	NP_006443.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase						NM_006452.3	NP_006443.1	REVIEWED	C	1.000	1.000	425	1278	1	1275	425	1	425
Invitrogen	NM_002479	IOH6403	Invitrogen(on gateway)	W01B005H01	pENTR221	2225		MYOG	4656	NP_002470.2	Hs.2830	Myogenin (myogenic factor 4)						NM_002479.4	NP_002470.2	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	NM_022136	IOH22118	Invitrogen(on gateway)	W01B005H02	pENTR221	15375		SAMSN1	64092	NP_071419.3	Hs.473341	SAM domain, SH3 domain and nuclear localization signals 1						NM_022136.3	NP_071419.3	VALIDATED	C	1.000	1.000	373	1122	1	1119	373	1	373
Invitrogen	NM_000972	IOH5681	Invitrogen(on gateway)	W01B005H03	pENTR221	23473		RPL7A	6130	NP_000963.1	Hs.499839	Ribosomal protein L7a						NM_000972.2	NP_000963.1	REVIEWED	C	1.000	1.000	266	801	1	798	266	1	266
Invitrogen	NM_003956	IOH12950	Invitrogen(on gateway)	W01B005H04	pENTR221	3186		CH25H	9023	NP_003947.1	Hs.47357	Cholesterol 25-hydroxylase						NM_003956.3	NP_003947.1	REVIEWED	C	1.000	1.000	272	819	1	816	272	1	272
Invitrogen	BC026238	IOH13560	Invitrogen(on gateway)	W01B005H05	pENTR221	23763		ORM1	5004	AAH26238.1	Hs.522356	Orosomucoid 1						NM_000607.2	NP_000598.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	NM_006711	IOH3798	Invitrogen(on gateway)	W01B005H06	pENTR221	8971		RNPS1	10921	NP_006702.1	Hs.355643	RNA binding protein S1, serine-rich domain						NM_006711.2	NP_006702.1	REVIEWED	C	1.000	1.000	305	918	1	915	305	1	305
Invitrogen	NM_015973	IOH21513	Invitrogen(on gateway)	W01B005H07	pENTR221	3774		GAL	51083	NP_057057.2	Hs.278959	Galanin prepropeptide						NM_015973.3	NP_057057.2	VALIDATED	C	1.000	1.000	123	372	1	369	123	1	123
Invitrogen	NM_006241	IOH5954	Invitrogen(on gateway)	W01B005H08	pENTR221	16986		PPP1R2	5504	NP_006232.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2						NM_006241.4	NP_006232.1	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	NM_024059	IOH2960	Invitrogen(on gateway)	W01B005H09	pENTR221	14758		C20orf195	79025	NP_076964.1	Hs.197755	Chromosome 20 open reading frame 195						NM_024059.2	NP_076964.1	PREDICTED	C	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	NM_006963	IOH9701	Invitrogen(on gateway)	W01B005H10	pENTR221	2890		ZNF22	7570	NP_008894.2	Hs.655124	Zinc finger protein 22 (KOX 15)						NM_006963.4	NP_008894.2	VALIDATED	C	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	BC015969	IOH13766	Invitrogen(on gateway)	W01B005H11	pENTR221	11638		ICAM1	3383	AAH15969.1	Hs.643447	Intercellular adhesion molecule 1						NM_000201.2	NP_000192.2	REVIEWED	C	1.000	1.000	532	1599	1	1596	532	1	532
Invitrogen	NM_005326	IOH3130	Invitrogen(on gateway)	W01B005H12	pENTR221	9369		HAGH	3029	NP_005317.2	Hs.157394	Hydroxyacylglutathione hydrolase						NM_001040427.1	NP_001035517.1	REVIEWED	C	1.000	1.000	260	783	1	780	260	1	260
Invitrogen	NM_014326	IOH21336	Invitrogen(on gateway)	W01B005H13	pENTR221	8103		DAPK2	23604	NP_055141.2	Hs.237886	Death-associated protein kinase 2						NM_014326.3	NP_055141.2	REVIEWED	C	1.000	1.000	370	1113	1	1110	370	1	370
Invitrogen	NM_024315	IOH5389	Invitrogen(on gateway)	W01B005H14	pENTR221	22135		C7orf23	79161	NP_077291.1	Hs.719226	Chromosome 7 open reading frame 23						NM_024315.2	NP_077291.1	PROVISIONAL	C	1.000	1.000	118	357	1	354	118	1	118
Invitrogen	NM_006379	IOH22289	Invitrogen(on gateway)	W01B005H15	pENTR221	21770		SEMA3C	10512	NP_006370.1	Hs.269109	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3C						NM_006379.2	NP_006370.1	VALIDATED	C	1.000	1.000	751	2256	1	2253	751	1	751
Invitrogen	BC004453	IOH4996	Invitrogen(on gateway)	W01B005H16	pENTR221	3872		HTR3A	3359	AAH04453.2	Hs.413899	5-hydroxytryptamine (serotonin) receptor 3A						NM_000869.2	NP_000860.1	REVIEWED	C	1.000	1.000	478	1455	19	1452	478	1	478
Invitrogen	BC029886	IOH22823	Invitrogen(on gateway)	W01B005H17	pENTR221	18896		OCLN	4950	AAH29886.1	Hs.592605	Occludin						NM_002538.2	NP_002529.1	REVIEWED	Cs	0.998	0.998	522	1569	1	1566	522	1	522
Invitrogen	NM_005103	IOH9923	Invitrogen(on gateway)	W01B005H18	pENTR221	4889		FEZ1	9638	NP_005094.1	Hs.224008	Fasciculation and elongation protein zeta 1 (zygin I)						NM_022549.2	NP_072043.1	REVIEWED	C	1.000	1.000	104	1179	1	312	104	1	104
Invitrogen	NM_022052	IOH22767	Invitrogen(on gateway)	W01B005H19	pENTR221	25235		NXF3	56000	NP_071335.1	Hs.60386	Nuclear RNA export factor 3						NM_022052.1	NP_071335.1	REVIEWED	C	1.000	1.000	531	1596	1	1593	531	1	531
Invitrogen	BC010363	IOH13513	Invitrogen(on gateway)	W01B005H20	pENTR221	8133		LINS1	55180	AAH10363	Hs.105633	Lines homolog 1 (Drosophila)						NM_001040616.1	NP_001035706.1	REVIEWED	Ps	0.998	0.998	407	1311	1	1221	757	1	407
Invitrogen	NM_174923	IOH14835	Invitrogen(on gateway)	W01B005H21	pENTR221	23669		CCDC107	203260	NP_777583.1	Hs.719263	Coiled-coil domain containing 107						NM_174923.1	NP_777583.1	PROVISIONAL	C	1.000	1.000	283	852	1	849	283	1	283
Invitrogen	NM_004939	IOH14578	Invitrogen(on gateway)	W01B005H22	pENTR221	13483		DDX1	1653	NP_004930.1	Hs.440599	DEAD (Asp-Glu-Ala-Asp) box polypeptide 1						NM_004939.1	NP_004930.1	REVIEWED	C	1.000	1.000	740	2223	1	2220	740	1	740
Invitrogen	NM_001585	IOH21553	Invitrogen(on gateway)	W01B005H23	pENTR221	15684		MPPED1	758	NP_001576	Hs.592198	Metallophosphoesterase domain containing 1						NM_001044370.1	NP_001037835.1	VALIDATED	C	1.000	1.000	326	981	1	978	326	1	326
Invitrogen	NM_032641	IOH4981	Invitrogen(on gateway)	W01B005H24	pENTR221	6003		SPSB2	84727	NP_116030.1	Hs.479856	SplA/ryanodine receptor domain and SOCS box containing 2						NM_001146316.1	NP_001139788.1	VALIDATED	C	1.000	1.000	263	792	1	789	263	1	263
Invitrogen	NM_005466	IOH5672	Invitrogen(on gateway)	W01B005I01	pENTR221	7404		MED6	10001	NP_005457.2	Hs.497353	Mediator complex subunit 6						NM_005466.2	NP_005457.2	VALIDATED	C	1.000	1.000	246	741	1	738	246	1	246
Invitrogen	NM_001005738	IOH22632	Invitrogen(on gateway)	W01B005I02	pENTR221	11530		FPR2	2358	NP_001005738.1	Hs.99855	Formyl peptide receptor 2						NM_001462.3	NP_001453.1	VALIDATED	C	1.000	1.000	351	1056	1	1053	351	1	351
Invitrogen	BC003641	IOH5172	Invitrogen(on gateway)	W01B005I03	pENTR221	7181		WDR25	79446	AAH03641.1	Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Ps	0.993	0.993	271	864	49	861	544	274	544
Invitrogen	NM_016445	IOH3142	Invitrogen(on gateway)	W01B005I04	pENTR221	7433		PLEK2	26499	NP_057529.1	Hs.170473	Pleckstrin 2						NM_016445.1	NP_057529.1	PROVISIONAL	C	1.000	1.000	353	1062	1	1059	353	1	353
Invitrogen	BC001798	IOH4437	Invitrogen(on gateway)	W01B005I05	pENTR221	7414		SNX6	58533	AAH01798.1	Hs.583855	Sorting nexin 6						NM_021249.3	NP_067072.3	REVIEWED	C	1.000	1.000	290	873	1	870	290	1	290
Invitrogen	NM_173804	IOH22378	Invitrogen(on gateway)	W01B005I06	pENTR221	12577		TMEM86B	255043	NP_776165.2	Hs.135215	Transmembrane protein 86B						NM_173804.3	NP_776165.2	PROVISIONAL	C	1.000	1.000	226	681	1	678	226	1	226
Invitrogen	NM_001384	IOH5134	Invitrogen(on gateway)	W01B005I07	pENTR221	302		DPH2	1802	NP_001375.2	Hs.632398	DPH2 homolog (S. cerevisiae)						NM_001384.4	NP_001375.2	REVIEWED	C	1.000	1.000	489	1470	1	1467	489	1	489
Invitrogen	NM_174926	IOH21428	Invitrogen(on gateway)	W01B005I08	pENTR221	4026		TMEM136	219902	NP_777586.1	Hs.706896	Transmembrane protein 136						NM_174926.1	NP_777586.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
Invitrogen	NM_005452	IOH3486	Invitrogen(on gateway)	W01B005I09	pENTR221	20565		WDR46	9277	NP_005443.2	Hs.520063	WD repeat domain 46						NM_005452.4	NP_005443.2	PROVISIONAL	C	1.000	1.000	610	1833	1	1830	610	1	610
Invitrogen	NM_000371	IOH14065	Invitrogen(on gateway)	W01B005I10	pENTR221	10999		TTR	7276	NP_000362.1	Hs.427202	Transthyretin						NM_000371.3	NP_000362.1	REVIEWED	C	1.000	1.000	147	444	1	441	147	1	147
Invitrogen	Q9BWM7	IOH4390	Invitrogen(on gateway)	W01B005I11	pENTR221															
Invitrogen	NM_002060	IOH11487	Invitrogen(on gateway)	W01B005I12	pENTR221	413		GJA4	2701	NP_002051.2	Hs.296310	Gap junction protein, alpha 4, 37kDa						NM_002060.2	NP_002051.2	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	NM_006802	IOH3503	Invitrogen(on gateway)	W01B005I13	pENTR221	2050		SF3A3	10946	NP_006793.1	Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
Invitrogen	NM_145303	IOH13071	Invitrogen(on gateway)	W01B005I14	pENTR221	20788		OSTCL	202459	NP_660346.1	Hs.487035	Oligosaccharyltransferase complex subunit-like						NM_145303.3	NP_660346.1	PROVISIONAL	OK	1.000	1.000	119	360	1	357	119	1	119
Invitrogen	NM_004237	IOH3603	Invitrogen(on gateway)	W01B005I15	pENTR221	18862		TRIP13	9319	NP_004228.1	Hs.436187	Thyroid hormone receptor interactor 13						NM_004237.2	NP_004228.1	PROVISIONAL	C	1.000	1.000	432	1299	1	1296	432	1	432
Invitrogen	NM_138463	IOH12071	Invitrogen(on gateway)	W01B005I16	pENTR221	10713		TLCD1	116238	NP_612472.1	Hs.499952	TLC domain containing 1						NM_138463.3	NP_612472.1	VALIDATED	C	1.000	1.000	247	744	1	741	247	1	247
Invitrogen	NM_000729	IOH6245	Invitrogen(on gateway)	W01B005I17	pENTR221	17184		CCK	885	NP_000720.1	Hs.458426	Cholecystokinin						NM_000729.3	NP_000720.1	REVIEWED	OK	1.000	1.000	115	348	1	345	115	1	115
Invitrogen	NM_138446	IOH13334	Invitrogen(on gateway)	W01B005I18	pENTR221	21425		C7orf30	115416	NP_612455.1	Hs.87385	Chromosome 7 open reading frame 30						NM_138446.1	NP_612455.1	PREDICTED	C	1.000	1.000	234	705	1	702	234	1	234
Invitrogen	NM_006230	IOH3545	Invitrogen(on gateway)	W01B005I19	pENTR221	22128		POLD2	5425	NP_006221.1	Hs.306791	Polymerase (DNA directed), delta 2, regulatory subunit 50kDa						NM_001127218.1	NP_001120690.1	VALIDATED	C	1.000	1.000	469	1410	1	1407	469	1	469
Invitrogen	NM_024089	IOH3113	Invitrogen(on gateway)	W01B005I20	pENTR221	6767		KDELC1	79070	NP_076994.2	Hs.408629	KDEL (Lys-Asp-Glu-Leu) containing 1						NM_024089.2	NP_076994.2	REVIEWED	Cs	0.998	0.998	502	1509	1	1506	502	1	502
Invitrogen	NM_006854	IOH5849	Invitrogen(on gateway)	W01B005I21	pENTR221	21960		KDELR2	11014	NP_006845.1	Hs.654552	KDEL (Lys-Asp-Glu-Leu) endoplasmic reticulum protein retention receptor 2						NM_006854.3	NP_006845.1	REVIEWED	C	1.000	1.000	212	639	1	636	212	1	212
Invitrogen	BC011519	IOH9674	Invitrogen(on gateway)	W01B005I22	pENTR221	1519		AGT	183	AAH11519.1	Hs.19383	Angiotensinogen (serpin peptidase inhibitor, clade A, member 8)						NM_000029.3	NP_000020.1	REVIEWED	Cs	0.996	0.996	485	1458	1	1455	485	1	485
Invitrogen	NM_019029	IOH10663	Invitrogen(on gateway)	W01B005I23	pENTR221	21891		CPVL	54504	NP_061902.2	Hs.449281	Carboxypeptidase, vitellogenic-like						NM_031311.3	NP_112601.3	REVIEWED	Cs	0.998	0.998	476	1431	1	1428	476	1	476
Invitrogen	BC012295	IOH11078	Invitrogen(on gateway)	W01B005I24	pENTR221	18877		LMNB1	4001	AAH12295.1	Hs.89497	Lamin B1						NM_005573.2	NP_005564.1	REVIEWED	Cs	0.998	0.998	586	1761	1	1758	586	1	586
Invitrogen	NM_003256	IOH10243	Invitrogen(on gateway)	W01B005J01	pENTR221	17191		TIMP4	7079	NP_003247.1	Hs.591665	TIMP metallopeptidase inhibitor 4						NM_003256.2	NP_003247.1	REVIEWED	OK	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	NM_030773	IOH21834	Invitrogen(on gateway)	W01B005J02	pENTR221	14687		TUBB1	81027	NP_110400.1	Hs.303023	Tubulin, beta 1						NM_030773.2	NP_110400.1	VALIDATED	C	1.000	1.000	451	1356	1	1353	451	1	451
Invitrogen	NM_001424	IOH9913	Invitrogen(on gateway)	W01B005J03	pENTR221	8693		EMP2	2013	NP_001415.1	Hs.531561	Epithelial membrane protein 2						NM_001424.4	NP_001415.1	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
Invitrogen	NM_000903	IOH5917	Invitrogen(on gateway)	W01B005J04	pENTR221	2220		NQO1	1728	NP_000894.1	Hs.406515	NAD(P)H dehydrogenase, quinone 1						NM_000903.2	NP_000894.1	REVIEWED	C	1.000	1.000	274	825	1	822	274	1	274
Invitrogen	NM_001175	IOH14469	Invitrogen(on gateway)	W01B005J05	pENTR221	6020		ARHGDIB	397	NP_001166.3	Hs.504877	Rho GDP dissociation inhibitor (GDI) beta						NM_001175.4	NP_001166.3	VALIDATED	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	NM_004467	IOH7319	Invitrogen(on gateway)	W01B005J06	pENTR221	23009		FGL1	2267	NP_004458.3	Hs.491143	Fibrinogen-like 1						NM_004467.3	NP_004458.3	REVIEWED	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_033318	IOH10687	Invitrogen(on gateway)	W01B005J07	pENTR221	15638		C22orf32	91689	NP_201575.2	Hs.306083	Chromosome 22 open reading frame 32						NM_033318.3	NP_201575.2	PREDICTED	C	1.000	1.000	107	324	1	321	107	1	107
Invitrogen	NM_002795	IOH14510	Invitrogen(on gateway)	W01B005J08	pENTR221	9980		PSMB3	5691	NP_002786.2	Hs.82793	Proteasome (prosome, macropain) subunit, beta type, 3						NM_002795.2	NP_002786.2	REVIEWED	C	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	BC016559	IOH11257	Invitrogen(on gateway)	W01B005J09	pENTR221	16100		SACM1L	22908	AAH16559.1	Hs.156509	SAC1 suppressor of actin mutations 1-like (yeast)						NM_014016.3	NP_054735.3	VALIDATED	Cs	0.998	0.998	587	1764	1	1761	587	1	587
Invitrogen	BC010959	IOH13742	Invitrogen(on gateway)	W01B005J10	pENTR221	18613		BNIP1	662	AAH10959.1	Hs.145726	BCL2/adenovirus E1B 19kDa interacting protein 1						NM_001205.2	NP_001196.2	REVIEWED	C	1.000	1.000	228	687	1	684	228	1	228
Invitrogen	NM_014089	IOH4601	Invitrogen(on gateway)	W01B005J11	pENTR221	6415		NUPL1	9818	NP_054808.1	Hs.719291	Nucleoporin like 1						NM_014089.3	NP_054808.1	REVIEWED	C	1.000	1.000	599	1800	1	1797	599	1	599
Invitrogen	NM_018447	IOH13963	Invitrogen(on gateway)	W01B005J12	pENTR221	16921		TMEM111	55831	NP_060917.1	Hs.475392	Transmembrane protein 111						NM_018447.1	NP_060917.1	PROVISIONAL	C	1.000	1.000	261	786	1	783	261	1	261
Invitrogen	NM_016508	IOH21339	Invitrogen(on gateway)	W01B005J13	pENTR221	19200		CDKL3	51265	NP_057592.2								NM_016508.3	NP_057592.2	REVIEWED	C	1.000	1.000	455	1368	1	1365	455	1	455
Invitrogen	NM_053045	IOH14287	Invitrogen(on gateway)	W01B005J14	pENTR221	24282		TMEM203	94107	NP_444273.1	Hs.591886	Transmembrane protein 203						NM_053045.1	NP_444273.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
Invitrogen	BC030776	IOH22290	Invitrogen(on gateway)	W01B005J15	pENTR221	6519		IFT88	8100	AAH30776.2	Hs.187376	Intraflagellar transport 88 homolog (Chlamydomonas)						NM_006531.3	NP_006522.2	REVIEWED	Cs	0.995	0.995	824	2475	1	2472	824	1	824
Invitrogen	NM_032358	IOH6604	Invitrogen(on gateway)	W01B005J16	pENTR221	5429		CCDC77	84318	NP_115734.1	Hs.631656	Coiled-coil domain containing 77						NM_001130148.1	NP_001123620.1	VALIDATED	C	1.000	1.000	456	1467	97	1464	456	1	456
Invitrogen	BC032016	IOH22802	Invitrogen(on gateway)	W01B005J17	pENTR221	810		FMO3	2328	AAH32016.1	Hs.445350	Flavin containing monooxygenase 3						NM_006894.4	NP_008825.4	VALIDATED	Cs	0.998	0.998	532	1599	1	1596	532	1	532
Invitrogen	BC003596	IOH4961	Invitrogen(on gateway)	W01B005J18	pENTR221	10275		TP53	7157	AAH03596.1	Hs.654481	Tumor protein p53						NM_001126115.1	NP_001119587.1	REVIEWED	Cs	0.996	0.996	261	1182	397	1179	261	1	261
Invitrogen	NM_000690	IOH4924	Invitrogen(on gateway)	W01B005J19	pENTR221	5536		ALDH2	217	NP_000681.2	Hs.632733	Aldehyde dehydrogenase 2 family (mitochondrial)						NM_000690.2	NP_000681.2	REVIEWED	C	1.000	1.000	517	1554	1	1551	517	1	517
Invitrogen	NM_001002295	IOH3184	Invitrogen(on gateway)	W01B005J20	pENTR221	2876		GATA3	2625	NP_001002295.1	Hs.524134	GATA binding protein 3						NM_001002295.1	NP_001002295.1	VALIDATED	OK	1.000	1.000	444	1335	1	1332	444	1	444
Invitrogen	NM_032194	IOH22146	Invitrogen(on gateway)	W01B005J21	pENTR221	19933		BXDC1	84154	NP_115570.1	Hs.372265	Brix domain containing 1						NM_032194.1	NP_115570.1	VALIDATED	C	1.000	1.000	306	921	1	918	306	1	306
Invitrogen	NM_021966	IOH4951	Invitrogen(on gateway)	W01B005J22	pENTR221	7565		TCL1A	8115	NP_068801.1	Hs.2484	T-cell leukemia/lymphoma 1A						NM_021966.2	NP_068801.1	VALIDATED	C	1.000	1.000	114	345	1	342	114	1	114
Invitrogen	NM_002431	IOH3100	Invitrogen(on gateway)	W01B005J23	pENTR221	7195		MNAT1	4331	NP_002422.1	Hs.509523	Menage a trois homolog 1, cyclin H assembly factor (Xenopus laevis)						NM_002431.2	NP_002422.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
Invitrogen	NM_032182	IOH10212	Invitrogen(on gateway)	W01B005J24	pENTR221	2766		FAM175B	23172	NP_115558.3	Hs.280695	Family with sequence similarity 175, member B						NM_032182.3	NP_115558.3	VALIDATED	P	1.000	1.000	311	936	1	933	415	105	415
Invitrogen	BC004889	IOH5673	Invitrogen(on gateway)	W01B005K01	pENTR221	5574		USP5	8078	AAH04889.1	Hs.631661	Ubiquitin specific peptidase 5 (isopeptidase T)						NM_003481.2	NP_003472.2	VALIDATED	C	1.000	1.000	835	2508	1	2505	835	1	835
Invitrogen	NM_173662	IOH22640	Invitrogen(on gateway)	W01B005K02	pENTR221	18190		RNF175	285533	NP_775933.1	Hs.388364	Ring finger protein 175						NM_173662.2	NP_775933.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
Invitrogen	NM_005589	IOH5179	Invitrogen(on gateway)	W01B005K03	pENTR221	7394		ALDH6A1	4329	NP_005580.1	Hs.293970	Aldehyde dehydrogenase 6 family, member A1						NM_005589.2	NP_005580.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
Invitrogen	NM_000806	IOH22243	Invitrogen(on gateway)	W01B005K04	pENTR221	18831		GABRA1	2554	NP_000797.2	Hs.175934	Gamma-aminobutyric acid (GABA) A receptor, alpha 1						NM_000806.5	NP_000797.2	REVIEWED	OK	1.000	1.000	456	1371	1	1368	456	1	456
Invitrogen	NM_001069	IOH4465	Invitrogen(on gateway)	W01B005K05	pENTR221	20740		TUBB2A	7280	NP_001060.1	Hs.654543	Tubulin, beta 2A						NM_001069.2	NP_001060.1	VALIDATED	C	1.000	1.000	445	1338	1	1335	445	1	445
Invitrogen	NM_015488	IOH22386	Invitrogen(on gateway)	W01B005K06	pENTR221	12930		PNKD	25953	NP_056303.3	Hs.98475	Paroxysmal nonkinesigenic dyskinesia						NM_015488.4	NP_056303.3	VALIDATED	Cs	0.992	0.992	385	1158	1	1155	385	1	385
Invitrogen	BC003152	IOH5139	Invitrogen(on gateway)	W01B005K07	pENTR221	1642		SLC39A1	27173	AAH03152.1	Hs.719153	Solute carrier family 39 (zinc transporter), member 1						NM_014437.3	NP_055252.2	PROVISIONAL	Cs	0.997	0.997	324	975	1	972	324	1	324
Invitrogen	BC016640	IOH21476	Invitrogen(on gateway)	W01B005K08	pENTR221	25403		SSX5	6758	AAH16640.1	Hs.166198	Synovial sarcoma, X breakpoint 5						NM_021015.3	NP_066295.3	REVIEWED	Cs	0.996	0.996	229	690	1	687	229	1	229
Invitrogen	NM_000612	IOH3689	Invitrogen(on gateway)	W01B005K09	pENTR221	4109		IGF2	3481	NP_000603.1	Hs.718427	Insulin-like growth factor 2 (somatomedin A)						NM_000612.4	NP_000603.1	REVIEWED	C	1.000	1.000	180	543	1	540	180	1	180
Invitrogen	NM_031911	IOH10940	Invitrogen(on gateway)	W01B005K10	pENTR221	17546		C1QTNF7	114905	NP_114117.1	Hs.153714	C1q and tumor necrosis factor related protein 7						NM_001135171.1	NP_001128643.1	VALIDATED	C	1.000	1.000	289	870	1	867	289	1	289
Invitrogen	NM_003150	IOH4288	Invitrogen(on gateway)	W01B005K11	pENTR221	10325		STAT3	6774	NP_003141.2	Hs.463059	Signal transducer and activator of transcription 3 (acute-phase response factor)						NM_003150.3	NP_003141.2	REVIEWED	C	1.000	1.000	769	2310	1	2307	769	1	769
Invitrogen	BC017969	IOH12941	Invitrogen(on gateway)	W01B005K12	pENTR221	13054		RSAD2	91543	AAH17969.1	Hs.17518	Radical S-adenosyl methionine domain containing 2						NM_080657.4	NP_542388.2	VALIDATED	Cs	0.997	0.997	361	1086	1	1083	361	1	361
Invitrogen	NM_003908	IOH3554	Invitrogen(on gateway)	W01B005K13	pENTR221	13552		EIF2S2	8894	NP_003899.2	Hs.429180	Eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa						NM_003908.3	NP_003899.2	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	NM_138794	IOH13353	Invitrogen(on gateway)	W01B005K14	pENTR221	849		LYPLAL1	127018	NP_620149.1	Hs.657617	Lysophospholipase-like 1						NM_138794.3	NP_620149.1	VALIDATED	C	1.000	1.000	237	714	1	711	237	1	237
Invitrogen	NM_000284	IOH3633	Invitrogen(on gateway)	W01B005K15	pENTR221	24784		PDHA1	5160	NP_000275.1	Hs.530331	Pyruvate dehydrogenase (lipoamide) alpha 1						NM_000284.2	NP_000275.1	VALIDATED	C	1.000	1.000	390	1173	1	1170	390	1	390
Invitrogen	NM_032272	IOH12580	Invitrogen(on gateway)	W01B005K16	pENTR221	22745		MAF1	84232	NP_115648.2	Hs.19673	MAF1 homolog (S. cerevisiae)						NM_032272.4	NP_115648.2	REVIEWED	Cs	0.996	0.996	256	771	1	768	256	1	256
Invitrogen	NM_139265	IOH6327	Invitrogen(on gateway)	W01B005K17	pENTR221	8184		EHD4	30844	NP_644670.1	Hs.143703	EH-domain containing 4						NM_139265.3	NP_644670.1	VALIDATED	C	1.000	1.000	541	1626	1	1623	541	1	541
Invitrogen	NM_032522	IOH4570	Invitrogen(on gateway)	W01B005K18	pENTR221	467		ZBTB37	84614	NP_115911.1	Hs.668497	Zinc finger and BTB domain containing 37						NM_032522.3	NP_115911.1	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
Invitrogen	BC002373	IOH3593	Invitrogen(on gateway)	W01B005K19	pENTR221	12126		HSPBP1	23640	AAH02373.1	Hs.53066	HSPA (heat shock 70kDa) binding protein, cytoplasmic cochaperone 1						NM_001130106.1	NP_001123578.1	VALIDATED	C	1.000	1.000	359	1080	1	1077	359	1	359
Invitrogen	NM_005153	IOH4522	Invitrogen(on gateway)	W01B005K20	pENTR221	8890		USP10	9100	NP_005144.2	Hs.136778	Ubiquitin specific peptidase 10						NM_005153.2	NP_005144.2	REVIEWED	Cs	0.997	0.997	798	2397	1	2394	798	1	798
Invitrogen	NM_017594	IOH5904	Invitrogen(on gateway)	W01B005K21	pENTR221	24007		DIRAS2	54769	NP_060064.2	Hs.165636	DIRAS family, GTP-binding RAS-like 2						NM_017594.3	NP_060064.2	VALIDATED	C	1.000	1.000	199	600	1	597	199	1	199
Invitrogen	BC011460	IOH9675	Invitrogen(on gateway)	W01B005K22	pENTR221	813		CHI3L2	1117	AAH11460.1	Hs.514840	Chitinase 3-like 2						NM_004000.2	NP_003991.2	VALIDATED	Cs	0.997	0.997	390	1173	1	1170	390	1	390
Invitrogen	NM_003463	IOH22884	Invitrogen(on gateway)	W01B005K23	pENTR221	19893		PTP4A1	7803	NP_003454.1	Hs.227777	Protein tyrosine phosphatase type IVA, member 1						NM_003463.3	NP_003454.1	REVIEWED	C	1.000	1.000	173	522	1	519	173	1	173
Invitrogen	NM_144563	IOH11053	Invitrogen(on gateway)	W01B005K24	pENTR221	1		RPIA	22934	NP_653164.2	Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	P	1.000	1.000	237	714	1	711	311	75	311
Invitrogen	NM_015991	IOH23091	Invitrogen(on gateway)	W01B005L01	pENTR221	382		C1QA	712	NP_057075.1	Hs.632379	Complement component 1, q subcomponent, A chain						NM_015991.2	NP_057075.1	REVIEWED	C	1.000	1.000	245	738	1	735	245	1	245
Invitrogen	NM_016561	IOH4880	Invitrogen(on gateway)	W01B005L02	pENTR221	8688		BFAR	51283	NP_057645.1	Hs.435556	Bifunctional apoptosis regulator						NM_016561.2	NP_057645.1	VALIDATED	C	1.000	1.000	450	1353	1	1350	450	1	450
Invitrogen	NM_198507	IOH22124	Invitrogen(on gateway)	W01B005L03	pENTR221	18704		FAM174A	345757	NP_940909.1	Hs.716557	Family with sequence similarity 174, member A						NM_198507.1	NP_940909.1	PROVISIONAL	C	1.000	1.000	190	573	1	570	190	1	190
Invitrogen	NM_024331	IOH3905	Invitrogen(on gateway)	W01B005L04	pENTR221	14729		TTPAL	79183	NP_077307.2	Hs.283869	Tocopherol (alpha) transfer protein-like						NM_024331.3	NP_077307.2	VALIDATED	P	1.000	1.000	279	840	1	837	342	64	342
Invitrogen	NM_001832	IOH7303	Invitrogen(on gateway)	W01B005L05	pENTR221	20753		CLPS	1208	NP_001823.1	Hs.1340	Colipase, pancreatic						NM_001832.2	NP_001823.1	REVIEWED	C	1.000	1.000	112	339	1	336	112	1	112
Invitrogen	NM_003106	IOH13706	Invitrogen(on gateway)	W01B005L06	pENTR221	16549		SOX2	6657	NP_003097.1	Hs.518438	SRY (sex determining region Y)-box 2						NM_003106.2	NP_003097.1	REVIEWED	C	1.000	1.000	317	954	1	951	317	1	317
Invitrogen	NM_152913	IOH22469	Invitrogen(on gateway)	W01B005L07	pENTR221	21835		TMEM130	222865	NP_690877.1	Hs.270753	Transmembrane protein 130						NM_152913.2	NP_690877.1	VALIDATED	C	1.000	1.000	423	1272	1	1269	423	1	423
Invitrogen	BC017101	IOH14448	Invitrogen(on gateway)	W01B005L08	pENTR221	22129		POMZP3	22932	AAH17101	Hs.488877	POM (POM121 homolog, rat) and ZP3 fusion						NM_152992.2	NP_694537.1	REVIEWED	Cs	0.991	0.991	115	633	1	345	115	1	115
Invitrogen	NM_004206	IOH11291	Invitrogen(on gateway)	W01B005L09	pENTR221	16863		SEC22C	9117	NP_004197.1	Hs.445892	SEC22 vesicle trafficking protein homolog C (S. cerevisiae)						NM_004206.2	NP_004197.1	REVIEWED	C	1.000	1.000	250	753	1	750	250	1	250
Invitrogen	NM_024093	IOH3089	Invitrogen(on gateway)	W01B005L10	pENTR221	13406		C2orf49	79074	NP_076998.1	Hs.549577	Chromosome 2 open reading frame 49						NM_024093.1	NP_076998.1	PROVISIONAL	C	1.000	1.000	232	699	1	696	232	1	232
Invitrogen	NM_013254	IOH21006	Invitrogen(on gateway)	W01B005L11	pENTR221	5332		TBK1	29110	NP_037386.1	Hs.607889	TANK-binding kinase 1						NM_013254.2	NP_037386.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
Invitrogen	NM_001008	IOH11799	Invitrogen(on gateway)	W01B005L12	pENTR221	25669		RPS4Y1	6192	NP_000999.1	Hs.282376	Ribosomal protein S4, Y-linked 1						NM_001008.3	NP_000999.1	REVIEWED	C	1.000	1.000	263	792	1	789	263	1	263
Invitrogen	NM_031461	IOH21449	Invitrogen(on gateway)	W01B005L13	pENTR221	22566		CRISPLD1	83690	NP_113649.1	Hs.436542	Cysteine-rich secretory protein LCCL domain containing 1						NM_031461.4	NP_113649.1	VALIDATED	C	1.000	1.000	500	1503	1	1500	500	1	500
Invitrogen	NM_152773	IOH11669	Invitrogen(on gateway)	W01B005L14	pENTR221	16934		TCTEX1D2	255758	NP_689986.2								NM_152773.3	NP_689986.2	VALIDATED	Cs	0.993	0.993	142	429	1	426	142	1	142
Invitrogen	BC034483	IOH22297	Invitrogen(on gateway)	W01B005L15	pENTR221	20728		HSPA1L	3305	AAH34483.1	Hs.690634	Heat shock 70kDa protein 1-like						NM_005527.3	NP_005518.3	REVIEWED	Cs	0.995	0.995	641	1926	1	1923	641	1	641
Invitrogen	BC010389	IOH12210	Invitrogen(on gateway)	W01B005L16	pENTR221	3724		PDHX	8050	AAH10389.1	Hs.502315	Pyruvate dehydrogenase complex, component X						NM_003477.2	NP_003468.2	VALIDATED	Cs	0.998	0.998	501	1506	1	1503	501	1	501
Invitrogen	BC001264	IOH3135	Invitrogen(on gateway)	W01B005L17	pENTR221	9831		WDR68	10238	AAH01264.1	Hs.410596	WD repeat domain 68						NM_005828.3	NP_005819.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
Invitrogen	NM_030935	IOH3133	Invitrogen(on gateway)	W01B005L18	pENTR221	21978		TSC22D4	81628	NP_112197.1	Hs.719125	TSC22 domain family, member 4						NM_030935.3	NP_112197.1	PROVISIONAL	C	1.000	1.000	395	1188	1	1185	395	1	395
Invitrogen	NM_005046	IOH22164	Invitrogen(on gateway)	W01B005L19	pENTR221	12376		KLK7	5650	NP_005037.1	Hs.151254	Kallikrein-related peptidase 7						NM_005046.2	NP_005037.1	REVIEWED	C	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	NM_006329	IOH12151	Invitrogen(on gateway)	W01B005L20	pENTR221	7412		FBLN5	10516	NP_006320.2	Hs.332708	Fibulin 5						NM_006329.3	NP_006320.2	REVIEWED	C	1.000	1.000	448	1347	1	1344	448	1	448
Invitrogen	NM_080913	IOH13227	Invitrogen(on gateway)	W01B005L21	pENTR221	10467		ASGR2	433	NP_550435.1	Hs.654440	Asialoglycoprotein receptor 2						NM_080913.2	NP_550435.1	REVIEWED	C	1.000	1.000	287	864	1	861	287	1	287
Invitrogen	NM_002195	IOH12347	Invitrogen(on gateway)	W01B005L22	pENTR221	23780		INSL4	3641	NP_002186.1	Hs.418506	Insulin-like 4 (placenta)						NM_002195.1	NP_002186.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
Invitrogen	NM_006214	IOH22535	Invitrogen(on gateway)	W01B005L23	pENTR221	3171		PHYH	5264	NP_006205.1	Hs.498732	Phytanoyl-CoA 2-hydroxylase						NM_006214.3	NP_006205.1	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
Invitrogen	NM_152430	IOH12973	Invitrogen(on gateway)	W01B005L24	pENTR221	4044		OR51E1	143503	NP_689643.2	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1						NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
Invitrogen	NM_020134	IOH5686	Invitrogen(on gateway)	W01B005M01	pENTR221	13140		DPYSL5	56896	NP_064519.2	Hs.299315	Dihydropyrimidinase-like 5						NM_020134.3	NP_064519.2	VALIDATED	C	1.000	1.000	564	1695	1	1692	564	1	564
Invitrogen	NM_052863	IOH22643	Invitrogen(on gateway)	W01B005M02	pENTR221	19195		SCGB3A1	92304	NP_443095.2	Hs.62492	Secretoglobin, family 3A, member 1						NM_052863.2	NP_443095.2	VALIDATED	C	1.000	1.000	104	315	1	312	104	1	104
Invitrogen	NM_004041	IOH5227	Invitrogen(on gateway)	W01B005M03	pENTR221	4572		ARRB1	408	NP_004032.2	Hs.503284	Arrestin, beta 1						NM_004041.3	NP_004032.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
Invitrogen	NM_005390	IOH22280	Invitrogen(on gateway)	W01B005M04	pENTR221	17742		PDHA2	5161	NP_005381.1	Hs.131361	Pyruvate dehydrogenase (lipoamide) alpha 2						NM_005390.4	NP_005381.1	VALIDATED	C	1.000	1.000	388	1167	1	1164	388	1	388
Invitrogen	BC001172	IOH4467	Invitrogen(on gateway)	W01B005M05	pENTR221	9671		TADA2L	6871	AAH01172.1	Hs.500066	Transcriptional adaptor 2 (ADA2 homolog, yeast)-like						NM_133439.2	NP_597683.2	REVIEWED	Cs	0.993	0.993	305	918	1	915	305	1	305
Invitrogen	NM_005038	IOH22406	Invitrogen(on gateway)	W01B005M06	pENTR221	18268		PPID	5481	NP_005029.1	Hs.581725	Peptidylprolyl isomerase D						NM_005038.2	NP_005029.1	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
Invitrogen	NM_005997	IOH5140	Invitrogen(on gateway)	W01B005M07	pENTR221	2072		VPS72	6944	NP_005988.1	Hs.2430	Vacuolar protein sorting 72 homolog (S. cerevisiae)						NM_005997.1	NP_005988.1	PROVISIONAL	C	1.000	1.000	364	1095	1	1092	364	1	364
Invitrogen	NM_138461	IOH21483	Invitrogen(on gateway)	W01B005M08	pENTR221	16934		TM4SF19	116211	NP_612470.2	Hs.710321	Transmembrane 4 L six family member 19						NM_138461.2	NP_612470.2	VALIDATED	Cs	0.995	0.995	209	630	1	627	209	1	209
Invitrogen	NM_016237	IOH3762	Invitrogen(on gateway)	W01B005M09	pENTR221	5964		ANAPC5	51433	NP_057321.2	Hs.7101	Anaphase promoting complex subunit 5						NM_016237.4	NP_057321.2	REVIEWED	OK	1.000	1.000	755	2268	1	2265	755	1	755
Invitrogen	NM_022165	IOH12041	Invitrogen(on gateway)	W01B005M10	pENTR221	11630		LIN7B	64130	NP_071448.1	Hs.221737	Lin-7 homolog B (C. elegans)						NM_022165.2	NP_071448.1	VALIDATED	C	1.000	1.000	207	624	1	621	207	1	207
Invitrogen	BC006794	IOH3178	Invitrogen(on gateway)	W01B005M11	pENTR221	4886		IFITM3	10410	AAH06794.1	Hs.374650	Interferon induced transmembrane protein 3 (1-8U)						NM_021034.2	NP_066362.2	VALIDATED	OK	1.000	1.000	133	402	1	399	133	1	133
Invitrogen	BC026264	IOH12309	Invitrogen(on gateway)	W01B005M12	pENTR221	18061		UGT2B4	7363	AAH26264.1	Hs.285887	UDP glucuronosyltransferase 2 family, polypeptide B4						NM_021139.2	NP_066962.2	VALIDATED	C	1.000	1.000	528	1587	1	1584	528	1	528
Invitrogen	NM_004632	IOH3569	Invitrogen(on gateway)	W01B005M13	pENTR221	1024		DAP3	7818	NP_004623.1	Hs.516746	Death associated protein 3						NM_033657.1	NP_387506.1	REVIEWED	C	1.000	1.000	398	1197	1	1194	398	1	398
Invitrogen	BC021682	IOH12127	Invitrogen(on gateway)	W01B005M14	pENTR221	4673		GLYATL2	219970	AAH21682.1	Hs.254271	Glycine-N-acyltransferase-like 2						NM_145016.3	NP_659453.3	VALIDATED	C	1.000	1.000	294	885	1	882	294	1	294
Invitrogen	NM_003099	IOH3673	Invitrogen(on gateway)	W01B005M15	pENTR221	7727		SNX1	6642	NP_003090.2	Hs.188634	Sorting nexin 1						NM_003099.3	NP_003090.2	REVIEWED	C	1.000	1.000	522	1569	1	1566	522	1	522
Invitrogen	NM_032125	IOH12648	Invitrogen(on gateway)	W01B005M16	pENTR221	437		TMEM222	84065	NP_115501.2	Hs.469171	Transmembrane protein 222						NM_032125.2	NP_115501.2	VALIDATED	P	1.000	1.000	188	567	1	564	208	21	208
Invitrogen	BC008417	IOH7579	Invitrogen(on gateway)	W01B005M17	pENTR221	4886		IFITM3	10410	AAH08417.1	Hs.374650	Interferon induced transmembrane protein 3 (1-8U)						NM_021034.2	NP_066362.2	VALIDATED	Cs	0.992	0.992	133	402	1	399	133	1	133
Invitrogen	NM_080702	IOH5121	Invitrogen(on gateway)	W01B005M18	pENTR221	20761		BAT3	7917	NP_542433.1	Hs.440900	HLA-B associated transcript 3						NM_080702.2	NP_542433.1	REVIEWED	OK	1.000	1.000	1126	3381	1	3378	1126	1	1126
Invitrogen	NM_002615	IOH3622	Invitrogen(on gateway)	W01B005M19	pENTR221	9767		SERPINF1	5176	NP_002606.3	Hs.694727	Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1						NM_002615.4	NP_002606.3	VALIDATED	C	1.000	1.000	418	1257	1	1254	418	1	418
Invitrogen	BC001129	IOH3851	Invitrogen(on gateway)	W01B005M20	pENTR221	21246		PVRIG	79037	AAH01129.1	Hs.521075	Poliovirus receptor related immunoglobulin domain containing						NM_024070.3	NP_076975.2	VALIDATED	Cs	0.997	0.997	326	981	1	978	326	1	326
Invitrogen	BC000574	IOH4174	Invitrogen(on gateway)	W01B005M21	pENTR221	21007		PCOLCE	5118	AAH00574.1	Hs.202097	Procollagen C-endopeptidase enhancer						NM_002593.3	NP_002584.2	REVIEWED	C	1.000	1.000	449	1350	1	1347	449	1	449
Invitrogen	NM_031450	IOH10181	Invitrogen(on gateway)	W01B005M22	pENTR221	4562		C11orf68	83638	NP_113638.2	Hs.433573	Chromosome 11 open reading frame 68						NM_001135635.1	NP_001129107.1	VALIDATED	Ps	0.996	0.996	251	756	1	753	293	43	293
Invitrogen	NM_014763	IOH23003	Invitrogen(on gateway)	W01B005M23	pENTR221	13499		MRPL19	9801	NP_055578.2	Hs.44024	Mitochondrial ribosomal protein L19						NM_014763.3	NP_055578.2	REVIEWED	P	1.000	1.000	280	843	1	840	292	13	292
Invitrogen	NM_138451	IOH10717	Invitrogen(on gateway)	W01B005M24	pENTR221	6174		IQCD	115811	NP_612460.1	Hs.568276	IQ motif containing D						NM_138451.1	NP_612460.1	PROVISIONAL	C	1.000	1.000	347	1044	1	1041	347	1	347
Invitrogen	NM_019111	IOH21707	Invitrogen(on gateway)	W01B005N01	pENTR221	20099		HLA-DRA	3122	NP_061984.2	Hs.520048	Major histocompatibility complex, class II, DR alpha						NM_019111.3	NP_061984.2	REVIEWED	C	1.000	1.000	254	765	1	762	254	1	254
Invitrogen	NM_002275	IOH5303	Invitrogen(on gateway)	W01B005N02	pENTR221	10580		KRT15	3866	NP_002266.2	Hs.654570	Keratin 15						NM_002275.3	NP_002266.2	REVIEWED	C	1.000	1.000	456	1371	1	1368	456	1	456
Invitrogen	NM_005834	IOH12331	Invitrogen(on gateway)	W01B005N03	pENTR221	25164		TIMM17B	10245	NP_005825.1	Hs.30570	Translocase of inner mitochondrial membrane 17 homolog B (yeast)						NM_005834.2	NP_005825.1	VALIDATED	C	1.000	1.000	172	519	1	516	172	1	172
Invitrogen	NM_004099	IOH9788	Invitrogen(on gateway)	W01B005N04	pENTR221	24286		STOM	2040	NP_004090.4	Hs.253903	Stomatin						NM_004099.4	NP_004090.4	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
Invitrogen	BC018737	IOH12661	Invitrogen(on gateway)	W01B005N05	pENTR221	21054		BRI3	25798	AAH18737.1	Hs.567438	Brain protein I3						NM_015379.4	NP_056194.1	VALIDATED	Cs	0.992	0.992	125	378	1	375	125	1	125
Invitrogen	NM_001154	IOH5099	Invitrogen(on gateway)	W01B005N06	pENTR221	18249		ANXA5	308	NP_001145.1	Hs.480653	Annexin A5						NM_001154.3	NP_001145.1	REVIEWED	C	1.000	1.000	320	963	1	960	320	1	320
Invitrogen	NM_021969	IOH22604	Invitrogen(on gateway)	W01B005N07	pENTR221	2195		NR0B2	8431	NP_068804.1	Hs.427055	Nuclear receptor subfamily 0, group B, member 2						NM_021969.2	NP_068804.1	REVIEWED	C	1.000	1.000	257	774	1	771	257	1	257
Invitrogen	NM_003825	IOH3269	Invitrogen(on gateway)	W01B005N08	pENTR221	7814		SNAP23	8773	NP_003816.2	Hs.719238	Synaptosomal-associated protein, 23kDa						NM_003825.2	NP_003816.2	REVIEWED	C	1.000	1.000	211	636	1	633	211	1	211
Invitrogen	NM_002197	IOH11817	Invitrogen(on gateway)	W01B005N09	pENTR221	23510		ACO1	48	NP_002188.1	Hs.567229	Aconitase 1, soluble						NM_002197.2	NP_002188.1	REVIEWED	OK	1.000	1.000	889	2670	1	2667	889	1	889
Invitrogen	NM_024056	IOH3247	Invitrogen(on gateway)	W01B005N10	pENTR221	5563		TMEM106C	79022	NP_076961.1	Hs.596726	Transmembrane protein 106C						NM_001143842.1	NP_001137314.1	VALIDATED	C	1.000	1.000	250	753	1	750	250	1	250
Invitrogen	NM_004336	IOH21042	Invitrogen(on gateway)	W01B005N11	pENTR221	13880		BUB1	699	NP_004327.1	Hs.469649	Budding uninhibited by benzimidazoles 1 homolog (yeast)						NM_004336.3	NP_004327.1	REVIEWED	C	1.000	1.000	1085	3258	1	3255	1085	1	1085
Invitrogen	BC007920	IOH6782	Invitrogen(on gateway)	W01B005N12	pENTR221	20149		HLA-DRB1	3123	AAH07920.1	Hs.701691	Major histocompatibility complex, class II, DR beta 1						XM_001124749.2	XP_001124749.1	MODEL		0.966	0.966	266	801	1	798	266	1	266
Invitrogen	NM_002296	IOH21485	Invitrogen(on gateway)	W01B005N13	pENTR221	1508		LBR	3930	NP_002287.2	Hs.435166	Lamin B receptor						NM_194442.1	NP_919424.1	REVIEWED	C	1.000	1.000	615	1848	1	1845	615	1	615
Invitrogen	NM_002652	IOH12199	Invitrogen(on gateway)	W01B005N14	pENTR221	21424		PIP	5304	NP_002643.1	Hs.99949	Prolactin-induced protein						NM_002652.2	NP_002643.1	VALIDATED	C	1.000	1.000	146	441	1	438	146	1	146
Invitrogen	ENST00000278064	IOH22303	Invitrogen(on gateway)	W01B005N15	pENTR221	3301		C10orf79	80217	ENSP00000278064	Hs.288927	Chromosome 10 open reading frame 79						NM_025145.5	NP_079421.5	VALIDATED	Pgs	0.998	0.999	868	2613	1	2604	1665	71	937
Invitrogen	NM_172341	IOH14527	Invitrogen(on gateway)	W01B005N16	pENTR221	11586		PSENEN	55851	NP_758844.1	Hs.534465	Presenilin enhancer 2 homolog (C. elegans)						NM_172341.1	NP_758844.1	REVIEWED	C	1.000	1.000	101	306	1	303	101	1	101
Invitrogen	NM_004291	IOH22771	Invitrogen(on gateway)	W01B005N17	pENTR221	18895		CARTPT	9607	NP_004282.1	Hs.1707	CART prepropeptide						NM_004291.2	NP_004282.1	VALIDATED	C	1.000	1.000	116	351	1	348	116	1	116
Invitrogen	BC022037	IOH11002	Invitrogen(on gateway)	W01B005N18	pENTR221	1939		SLFNL1	200172	AAH22037.2	Hs.194609	Schlafen-like 1						NM_144990.2	NP_659427.2	PROVISIONAL	P	1.000	1.000	404	1215	1	1212	407	4	407
Invitrogen	NM_198589	IOH3378	Invitrogen(on gateway)	W01B005N19	pENTR221	11440		BSG	682	NP_940991.1	Hs.501293	Basigin (Ok blood group)						NM_198590.1	NP_940992.1	REVIEWED	C	1.000	1.000	176	810	280	807	176	1	176
Invitrogen	NM_002168	IOH13257	Invitrogen(on gateway)	W01B005N20	pENTR221	8331		IDH2	3418	NP_002159.2	Hs.596461	Isocitrate dehydrogenase 2 (NADP+), mitochondrial						NM_002168.2	NP_002159.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
Invitrogen	BC034293	IOH21505	Invitrogen(on gateway)	W01B005N21	pENTR221	24171		C9orf68	55064	AAH34293	Hs.179615	Chromosome 9 open reading frame 68						NM_001039395.2	NP_001034484.2	VALIDATED	Cs	0.995	0.995	392	1179	1	1176	392	1	392
Invitrogen	NM_012400	IOH11316	Invitrogen(on gateway)	W01B005N22	pENTR221	1615		PLA2G2D	26279	NP_036532.1	Hs.189507	Phospholipase A2, group IID						NM_012400.2	NP_036532.1	PROVISIONAL	OK	1.000	1.000	145	438	1	435	145	1	145
Invitrogen	NM_000710	IOH22183	Invitrogen(on gateway)	W01B005N23	pENTR221	7024		BDKRB1	623	NP_000701.2	Hs.525572	Bradykinin receptor B1						NM_000710.2	NP_000701.2	REVIEWED	C	1.000	1.000	353	1062	1	1059	353	1	353
Invitrogen	NM_014437	IOH4006	Invitrogen(on gateway)	W01B005N24	pENTR221	1642		SLC39A1	27173	NP_055252.2	Hs.719153	Solute carrier family 39 (zinc transporter), member 1						NM_014437.3	NP_055252.2	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
Invitrogen	NM_000846	IOH5711	Invitrogen(on gateway)	W01B005O01	pENTR221	20759		GSTA2	2939	NP_000837.3	Hs.94107	Glutathione S-transferase alpha 2						NM_000846.4	NP_000837.3	REVIEWED	Cs	0.995	0.995	222	669	1	666	222	1	222
Invitrogen	NM_018452	IOH22646	Invitrogen(on gateway)	W01B005O02	pENTR221	20513		C6orf35	729515	NP_060922.2	Hs.535817	Chromosome 6 open reading frame 35						NM_018452.3	NP_060922.2	VALIDATED	C	1.000	1.000	141	426	1	423	141	1	141
Invitrogen	NM_000169	IOH5271	Invitrogen(on gateway)	W01B005O03	pENTR221	25348		GLA	2717	NP_000160.1	Hs.69089	Galactosidase, alpha						NM_000169.2	NP_000160.1	REVIEWED	C	1.000	1.000	429	1290	1	1287	429	1	429
Invitrogen	NM_014364	IOH22295	Invitrogen(on gateway)	W01B005O04	pENTR221	11666		GAPDHS	26330	NP_055179.1	Hs.248017	Glyceraldehyde-3-phosphate dehydrogenase, spermatogenic						NM_014364.4	NP_055179.1	REVIEWED	C	1.000	1.000	408	1227	1	1224	408	1	408
Invitrogen	BC001619	IOH4485	Invitrogen(on gateway)	W01B005O05	pENTR221	23752		ALDH1B1	219	AAH01619.1	Hs.436219	Aldehyde dehydrogenase 1 family, member B1						NM_000692.3	NP_000683.3	REVIEWED	Cs	0.996	0.996	517	1554	1	1551	517	1	517
Invitrogen	NM_018710	IOH22407	Invitrogen(on gateway)	W01B005O06	pENTR221	23255		TMEM55A	55529	NP_061180.1	Hs.202517	Transmembrane protein 55A						NM_018710.2	NP_061180.1	VALIDATED	C	1.000	1.000	257	774	1	771	257	1	257
Invitrogen	NM_024516	IOH5156	Invitrogen(on gateway)	W01B005O07	pENTR221	8609		C16orf53	79447	NP_078792.1	Hs.702841	Chromosome 16 open reading frame 53						NM_024516.3	NP_078792.1	VALIDATED	C	1.000	1.000	254	765	1	762	254	1	254
Invitrogen	NM_007034	IOH21495	Invitrogen(on gateway)	W01B005O08	pENTR221	248		DNAJB4	11080	NP_008965.2	Hs.13852	DnaJ (Hsp40) homolog, subfamily B, member 4						NM_007034.3	NP_008965.2	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
Invitrogen	NM_016286	IOH4017	Invitrogen(on gateway)	W01B005O09	pENTR221	10208		DCXR	51181	NP_057370.1	Hs.9857	Dicarbonyl/L-xylulose reductase						NM_016286.2	NP_057370.1	VALIDATED	C	1.000	1.000	244	735	1	732	244	1	244
Invitrogen	BC024241	IOH11711	Invitrogen(on gateway)	W01B005O10	pENTR221	19387		CDO1	1036	AAH24241.1	Hs.442378	Cysteine dioxygenase, type I						NM_001801.2	NP_001792.2	VALIDATED	Cs	0.995	0.995	200	603	1	600	200	1	200
Invitrogen	NM_003254	IOH3196	Invitrogen(on gateway)	W01B005O11	pENTR221	24496		TIMP1	7076	NP_003245.1	Hs.522632	TIMP metallopeptidase inhibitor 1						NM_003254.2	NP_003245.1	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
Invitrogen	NM_013321	IOH13259	Invitrogen(on gateway)	W01B005O12	pENTR221	21898		SNX8	29886	NP_037453.1	Hs.584900	Sorting nexin 8						NM_013321.1	NP_037453.1	PROVISIONAL	OK	1.000	1.000	465	1398	1	1395	465	1	465
Invitrogen	NM_002802	IOH3591	Invitrogen(on gateway)	W01B005O13	pENTR221	7058		PSMC1	5700	NP_002793.2	Hs.356654	Proteasome (prosome, macropain) 26S subunit, ATPase, 1						NM_002802.2	NP_002793.2	REVIEWED	C	1.000	1.000	440	1323	1	1320	440	1	440
Invitrogen	NM_006216	IOH12816	Invitrogen(on gateway)	W01B005O14	pENTR221	13735		SERPINE2	5270	NP_006207.1	Hs.708453	Serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 2						NM_006216.3	NP_006207.1	VALIDATED	C	1.000	1.000	398	1197	1	1194	398	1	398
Invitrogen	NM_001172	IOH3685	Invitrogen(on gateway)	W01B005O15	pENTR221	7173		ARG2	384	NP_001163.1	Hs.708024	Arginase, type II						NM_001172.3	NP_001163.1	REVIEWED	OK	1.000	1.000	354	1065	1	1062	354	1	354
Invitrogen	BC012325	IOH12445	Invitrogen(on gateway)	W01B005O16	pENTR221	18488		SLC22A5	6584	AAH12325.1	Hs.443572	Solute carrier family 22 (organic cation/carnitine transporter), member 5						NM_003060.3	NP_003051.1	REVIEWED	Cs	0.998	0.998	557	1674	1	1671	557	1	557
Invitrogen	NM_014829	IOH9798	Invitrogen(on gateway)	W01B005O17	pENTR221	18493		DDX46	9879	NP_055644.2	Hs.406549	DEAD (Asp-Glu-Ala-Asp) box polypeptide 46						NM_014829.2	NP_055644.2	REVIEWED	C	1.000	1.000	1031	3096	1	3093	1031	1	1031
Invitrogen	BC003178	IOH5124	Invitrogen(on gateway)	W01B005O18	pENTR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)						NM_001048174.1	NP_001041639.1	REVIEWED	C	1.000	1.000	521	1608	43	1605	521	1	521
Invitrogen	NM_014300	IOH3684	Invitrogen(on gateway)	W01B005O19	pENTR221	8143		SEC11A	23478	NP_055115.1	Hs.9534	SEC11 homolog A (S. cerevisiae)						NM_014300.2	NP_055115.1	PROVISIONAL	C	1.000	1.000	179	540	1	537	179	1	179
Invitrogen	BC000728	IOH4639	Invitrogen(on gateway)	W01B005O20	pENTR221	14208		CAPG	822	AAH00728.1	Hs.516155	Capping protein (actin filament), gelsolin-like						NM_001747.2	NP_001738.2	REVIEWED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
Invitrogen	NM_016532	IOH4433	Invitrogen(on gateway)	W01B005O21	pENTR221	10237		INPP5K	51763	NP_057616.2	Hs.632238	Inositol polyphosphate-5-phosphatase K						NM_130766.2	NP_570122.1	REVIEWED	C	1.000	1.000	372	1347	229	1344	372	1	372
Invitrogen	NM_004627	IOH10553	Invitrogen(on gateway)	W01B005O22	pENTR221	15273		WRB	7485	NP_004618.2	Hs.198308	Tryptophan rich basic protein						NM_001146218.1	NP_001139690.1	REVIEWED	C	1.000	1.000	140	525	103	522	140	1	140
Invitrogen	BC016821	IOH23009	Invitrogen(on gateway)	W01B005O23	pENTR221	7343		MBIP	51562	AAH16821.1	Hs.368647	MAP3K12 binding inhibitory protein 1						NM_001144891.1	NP_001138363.1	VALIDATED	Cs	0.994	0.994	343	1032	1	1029	343	1	343
Invitrogen	BC020569	IOH10736	Invitrogen(on gateway)	W01B005O24	pENTR221	5274		XPOT	11260	AAH20569.1	Hs.85951	Exportin, tRNA (nuclear export receptor for tRNAs)						NM_007235.3	NP_009166.2	REVIEWED	Cs	0.999	0.999	962	2889	1	2886	962	1	962
Invitrogen	NM_032369	IOH6885	Invitrogen(on gateway)	W01B005P01	pENTR221	6226		HVCN1	84329	NP_115745.2	Hs.334637	Hydrogen voltage-gated channel 1						NM_001040107.1	NP_001035196.1	VALIDATED	Cg	0.864	1.000	273	711	1	708	273	1	273
Invitrogen	BC001606	IOH4901	Invitrogen(on gateway)	W01B005P02	pENTR221	1513		NCF2	4688	AAH01606.1	Hs.587558	Neutrophil cytosolic factor 2						NM_000433.3	NP_000424.2	REVIEWED	Cs	0.996	0.996	526	1581	1	1578	526	1	526
Invitrogen	NM_015448	IOH21499	Invitrogen(on gateway)	W01B005P03	pENTR221	2852		RP11-529I10.4	25911	NP_056263.1	Hs.658128	Deleted in a mouse model of primary ciliary dyskinesia						NM_015448.1	NP_056263.1	PROVISIONAL	OK	1.000	1.000	203	612	1	609	203	1	203
Invitrogen	NM_005999	IOH14291	Invitrogen(on gateway)	W01B005P04	pENTR221	870		TSNAX	7257	NP_005990.1	Hs.96247	Translin-associated factor X						NM_005999.2	NP_005990.1	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
Invitrogen	BC034280	IOH22841	Invitrogen(on gateway)	W01B005P05	pENTR221	5300		TSPAN9	10867	AAH34280	Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED		0.318	0.318	22	474	148	83	239	5	26
Invitrogen	NM_033416	IOH12991	Invitrogen(on gateway)	W01B005P06	pENTR221	13081		IMP4	92856	NP_219484.1	Hs.91579	IMP4, U3 small nucleolar ribonucleoprotein, homolog (yeast)						NM_033416.1	NP_219484.1	PROVISIONAL	C	1.000	1.000	291	876	1	873	291	1	291
Invitrogen	NM_005276	IOH22621	Invitrogen(on gateway)	W01B005P07	pENTR221	5527		GPD1	2819	NP_005267.2	Hs.524418	Glycerol-3-phosphate dehydrogenase 1 (soluble)						NM_005276.2	NP_005267.2	PROVISIONAL	C	1.000	1.000	349	1050	1	1047	349	1	349
Invitrogen	NM_012198	IOH7201	Invitrogen(on gateway)	W01B005P08	pENTR221	13038		GCA	25801	NP_036330.1	Hs.377894	Grancalcin, EF-hand calcium binding protein						NM_012198.3	NP_036330.1	VALIDATED	C	1.000	1.000	217	654	1	651	217	1	217
Invitrogen	NM_138376	IOH23031	Invitrogen(on gateway)	W01B005P09	pENTR221	7505		TTC5	91875	NP_612385.2	Hs.102480	Tetratricopeptide repeat domain 5						NM_138376.2	NP_612385.2	VALIDATED	Cs	0.998	0.998	440	1323	1	1320	440	1	440
Invitrogen	NM_015975	IOH14186	Invitrogen(on gateway)	W01B005P10	pENTR221	25206		TAF9B	51616	NP_057059.2	Hs.592248	TAF9B RNA polymerase II, TATA box binding protein (TBP)-associated factor, 31kDa						NM_015975.4	NP_057059.2	REVIEWED	C	1.000	1.000	251	756	1	753	251	1	251
Invitrogen	NM_002830	IOH21070	Invitrogen(on gateway)	W01B005P11	pENTR221	13481		PTPN4	5775	NP_002821.1	Hs.469809	Protein tyrosine phosphatase, non-receptor type 4 (megakaryocyte)						NM_002830.2	NP_002821.1	REVIEWED	C	1.000	1.000	926	2781	1	2778	926	1	926
Invitrogen	NM_007272	IOH12105	Invitrogen(on gateway)	W01B005P12	pENTR221	657		CTRC	11330	NP_009203.2	Hs.631869	Chymotrypsin C (caldecrin)						NM_007272.2	NP_009203.2	REVIEWED	C	1.000	1.000	268	807	1	804	268	1	268
Invitrogen	NM_003783	IOH22216	Invitrogen(on gateway)	W01B005P13	pENTR221	1707		B3GALT2	8707	NP_003774.1	Hs.716598	UDP-Gal:betaGlcNAc beta 1,3-galactosyltransferase, polypeptide 2						NM_003783.3	NP_003774.1	REVIEWED	OK	1.000	1.000	422	1269	1	1266	422	1	422
Invitrogen	BC027975	IOH12007	Invitrogen(on gateway)	W01B005P14	pENTR221	9788		RAMP2	10266	AAH27975.1	Hs.514193	Receptor (G protein-coupled) activity modifying protein 2						NM_005854.2	NP_005845.2	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
Invitrogen	BC030613	IOH22394	Invitrogen(on gateway)	W01B005P15	pENTR221	9699		NSF	4905	AAH30613.1	Hs.431279	N-ethylmaleimide-sensitive factor						NM_006178.2	NP_006169.2	VALIDATED	C	1.000	1.000	744	2235	1	2232	744	1	744
Invitrogen	NM_006643	IOH12301	Invitrogen(on gateway)	W01B005P16	pENTR221	24064		SDCCAG3	10807	NP_006634.3	Hs.94300	Serologically defined colon cancer antigen 3						NM_006643.3	NP_006634.3	VALIDATED	Ps	0.994	0.994	354	1065	1	1062	412	59	412
Invitrogen	NM_000542	IOH21829	Invitrogen(on gateway)	W01B005P17	pENTR221	14292		SFTPB	6439	NP_000533.2	Hs.512690	Surfactant protein B						NM_000542.2	NP_000533.2	VALIDATED	C	1.000	1.000	381	1146	1	1143	381	1	381
Invitrogen	NM_000666	IOH4147	Invitrogen(on gateway)	W01B005P18	pENTR221	16532		ACY1	95	NP_000657.1	Hs.334707	Aminoacylase 1						NM_000666.1	NP_000657.1	REVIEWED	C	1.000	1.000	408	1227	1	1224	408	1	408
Invitrogen	NM_001671	IOH23108	Invitrogen(on gateway)	W01B005P19	pENTR221	10271		ASGR1	432	NP_001662.1	Hs.12056	Asialoglycoprotein receptor 1						NM_001671.3	NP_001662.1	VALIDATED	C	1.000	1.000	291	876	1	873	291	1	291
Invitrogen	NM_002950	IOH11803	Invitrogen(on gateway)	W01B005P20	pENTR221	17146		RPN1	6184	NP_002941.1	Hs.518244	Ribophorin I						NM_002950.3	NP_002941.1	REVIEWED	C	1.000	1.000	607	1824	1	1821	607	1	607
Invitrogen	NM_017414	IOH10075	Invitrogen(on gateway)	W01B005P21	pENTR221	15572		USP18	11274	NP_059110.2	Hs.38260	Ubiquitin specific peptidase 18						NM_017414.3	NP_059110.2	VALIDATED	C	1.000	1.000	372	1119	1	1116	372	1	372
Invitrogen	BC000557	IOH4154	Invitrogen(on gateway)	W01B005P22	pENTR221	10229		PEMT	10400	AAH00557.1	Hs.287717	Phosphatidylethanolamine N-methyltransferase						NM_148173.1	NP_680478.1	REVIEWED	Cs	0.990	0.990	199	711	112	708	199	1	199
Invitrogen	NM_031945	IOH21852	Invitrogen(on gateway)	W01B005P23	pENTR221	9761		TSPAN10	83882	NP_114151.3	Hs.208219	Tetraspanin 10						NM_031945.3	NP_114151.3	VALIDATED	Cs	0.989	0.989	355	1068	1	1065	355	1	355
Invitrogen	NM_003757	IOH3628	Invitrogen(on gateway)	W01B005P24	pENTR221	357		EIF3I	8668	NP_003748.1	Hs.530096	Eukaryotic translation initiation factor 3, subunit I						NM_003757.2	NP_003748.1	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
Invitrogen	NM_004489	IOH10241	Invitrogen(on gateway)	W01B006A01	pENTR221	10261		GPS2	2874	NP_004480.1	Hs.438219	G protein pathway suppressor 2						NM_004489.4	NP_004480.1	REVIEWED	C	1.000	1.000	327	984	1	981	327	1	327
Invitrogen	NM_002898	IOH11398	Invitrogen(on gateway)	W01B006A02	pENTR221	5610		RBMS2	5939	NP_002889.1	Hs.505729	RNA binding motif, single stranded interacting protein 2						NM_002898.3	NP_002889.1	REVIEWED	C	1.000	1.000	407	1224	1	1221	407	1	407
Invitrogen	NM_002881	IOH11519	Invitrogen(on gateway)	W01B006A03	pENTR221	13204		RALB	5899	NP_002872.1	Hs.469820	V-ral simian leukemia viral oncogene homolog B (ras related; GTP binding protein)						NM_002881.2	NP_002872.1	REVIEWED	C	1.000	1.000	206	621	1	618	206	1	206
Invitrogen	NM_015014	IOH23193	Invitrogen(on gateway)	W01B006A04	pENTR221	1530		RBM34	23029	NP_055829.2	Hs.535224	RNA binding motif protein 34						NM_015014.2	NP_055829.2	VALIDATED	P	1.000	1.000	425	1278	1	1275	430	6	430
Invitrogen	NM_006678	IOH14396	Invitrogen(on gateway)	W01B006A05	pENTR221	10722		CD300C	10871	NP_006669.1	Hs.2605	CD300c molecule						NM_006678.3	NP_006669.1	PROVISIONAL	OK	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	BC031265	IOH21605	Invitrogen(on gateway)	W01B006A06	pENTR221	21899		TSPAN12	23554	AAH31265.1	Hs.16529	Tetraspanin 12						NM_012338.3	NP_036470.1	REVIEWED	Cs	0.997	0.997	305	918	1	915	305	1	305
Invitrogen	BC011765	IOH12453	Invitrogen(on gateway)	W01B006A07	pENTR221	4645		C11orf24	53838	AAH11765.1	Hs.303025	Chromosome 11 open reading frame 24						NM_022338.3	NP_071733.1	VALIDATED	Cs	0.998	0.998	449	1350	1	1347	449	1	449
Invitrogen	NM_000286	IOH27257	Invitrogen(on gateway)	W01B006A08	pENTR221	10192		PEX12	5193	NP_000277.1	Hs.591190	Peroxisomal biogenesis factor 12						NM_000286.2	NP_000277.1	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
Invitrogen	BC006281	IOH6301	Invitrogen(on gateway)	W01B006A09	pENTR221	12303		SH2D3A	10045	AAH06281.1	Hs.439645	SH2 domain containing 3A						NM_005490.2	NP_005481.2	VALIDATED	C	1.000	1.000	576	1731	1	1728	576	1	576
Invitrogen	NM_001086	IOH27536	Invitrogen(on gateway)	W01B006A10	pENTR221	16557		AADAC	13	NP_001077.2	Hs.506908	Arylacetamide deacetylase (esterase)						NM_001086.2	NP_001077.2	REVIEWED	OK	1.000	1.000	399	1200	1	1197	399	1	399
Invitrogen	NM_002709	IOH5281	Invitrogen(on gateway)	W01B006A11	pENTR221	13110		PPP1CB	5500	NP_002700.1	Hs.702907	Protein phosphatase 1, catalytic subunit, beta isoform						NM_206876.1	NP_996759.1	REVIEWED	C	1.000	1.000	327	984	1	981	327	1	327
Invitrogen	NM_000312	IOH22689	Invitrogen(on gateway)	W01B006A12	pENTR221	13515		PROC	5624	NP_000303.1	Hs.224698	Protein C (inactivator of coagulation factors Va and VIIIa)						NM_000312.2	NP_000303.1	VALIDATED	C	1.000	1.000	461	1386	1	1383	461	1	461
Invitrogen	NM_021141	IOH12168	Invitrogen(on gateway)	W01B006A13	pENTR221	13279		XRCC5	7520	NP_066964.1	Hs.388739	X-ray repair complementing defective repair in Chinese hamster cells 5 (double-strand-break rejoining)						NM_021141.3	NP_066964.1	REVIEWED	C	1.000	1.000	732	2199	1	2196	732	1	732
Invitrogen	NM_005061	IOH26731	Invitrogen(on gateway)	W01B006A14	pENTR221	9409		RPL3L	6123	NP_005052.1	Hs.657266	Ribosomal protein L3-like						NM_005061.2	NP_005052.1	REVIEWED	OK	1.000	1.000	407	1224	1	1221	407	1	407
Invitrogen	BC010451	IOH9645	Invitrogen(on gateway)	W01B006A15	pENTR221	10248		CDC42EP4	23580	AAH10451.1	Hs.3903	CDC42 effector protein (Rho GTPase binding) 4						NM_012121.4	NP_036253.2	REVIEWED	Cs	0.997	0.997	356	1071	1	1068	356	1	356
Invitrogen	BC050629	IOH27037	Invitrogen(on gateway)	W01B006A16	pENTR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1						NM_030594.3	NP_085097.3	REVIEWED	OK	1.000	1.000	561	1686	1	1683	561	1	561
Invitrogen	NM_006142	IOH2986	Invitrogen(on gateway)	W01B006A17	pENTR221	274		SFN	2810	NP_006133.1	Hs.523718	Stratifin						NM_006142.3	NP_006133.1	VALIDATED	C	1.000	1.000	248	747	1	744	248	1	248
Invitrogen	BC050688	IOH27002	Invitrogen(on gateway)	W01B006A18	pENTR221	12005		RPSA	3921	AAH50688.1	Hs.449909	Ribosomal protein SA						NM_002295.4	NP_002286.2	REVIEWED	Cs	0.997	0.997	295	888	1	885	295	1	295
Invitrogen	BC006338	IOH6383	Invitrogen(on gateway)	W01B006A19	pENTR221	8881		CD19	930	AAH06338.1	Hs.652262	CD19 molecule						NM_001770.4	NP_001761.3	REVIEWED	C	1.000	1.000	556	1671	1	1668	556	1	556
Invitrogen	NM_006927	IOH26039	Invitrogen(on gateway)	W01B006A20	pENTR221	9335		ST3GAL2	6483	NP_008858.1	Hs.368611	ST3 beta-galactoside alpha-2,3-sialyltransferase 2						NM_006927.3	NP_008858.1	REVIEWED	C	1.000	1.000	350	1053	1	1050	350	1	350
Invitrogen	NM_005415	IOH11215	Invitrogen(on gateway)	W01B006A21	pENTR221	13496		SLC20A1	6574	NP_005406.3	Hs.187946	Solute carrier family 20 (phosphate transporter), member 1						NM_005415.3	NP_005406.3	PROVISIONAL	C	1.000	1.000	679	2040	1	2037	679	1	679
Invitrogen	NM_001423	IOH26556	Invitrogen(on gateway)	W01B006A22	pENTR221	5605		EMP1	2012	NP_001414.1	Hs.707901	Epithelial membrane protein 1						NM_001423.2	NP_001414.1	VALIDATED	C	1.000	1.000	157	474	1	471	157	1	157
Invitrogen	NM_007031	IOH2965	Invitrogen(on gateway)	W01B006A23	pENTR221	15314		HSF2BP	11077	NP_008962.1	Hs.406157	Heat shock transcription factor 2 binding protein						NM_007031.1	NP_008962.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
Invitrogen	BC031020	IOH27971	Invitrogen(on gateway)	W01B006A24	pENTR221	11417		IFI30	10437	AAH31020.1	Hs.14623	Interferon, gamma-inducible protein 30						NM_006332.3	NP_006323.2	REVIEWED	Cs	0.996	0.996	250	753	1	750	250	1	250
Invitrogen	BC022351	IOH27922	Invitrogen(on gateway)	W01B006B01	pENTR221	19152		CCNH	902	AAH22351.1	Hs.292524	Cyclin H						NM_001239.2	NP_001230.1	REVIEWED	Cs	0.997	0.997	323	972	1	969	323	1	323
Invitrogen	ENST00000276150	IOH10046	Invitrogen(on gateway)	W01B006B02	pENTR221	24694		BEX4	56271	ENSP00000276150	Hs.184736	Brain expressed, X-linked 4						NM_001080425.2	NP_001073894.1	VALIDATED	C	1.000	1.000	120	363	1	360	120	1	120
Invitrogen	BC047107	IOH26501	Invitrogen(on gateway)	W01B006B03	pENTR221	5413		KBTBD2	25948	AAH47107.1	Hs.372541	Kelch repeat and BTB (POZ) domain containing 2						NM_015483.2	NP_056298.2	VALIDATED	Cs	0.994	0.994	623	1872	1	1869	623	1	623
Invitrogen	NM_001900	IOH40728	Invitrogen(on gateway)	W01B006B04	pENTR221	15104		CST5	1473	NP_001891.2	Hs.121489	Cystatin D						NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
Invitrogen	NM_053278	IOH28355	Invitrogen(on gateway)	W01B006B05	pENTR221	20047		TAAR8	83551	NP_444508.1	Hs.350571	Trace amine associated receptor 8						NM_053278.1	NP_444508.1	PROVISIONAL	C	1.000	1.000	342	1029	1	1026	342	1	342
Invitrogen	NM_006752	IOH26279	Invitrogen(on gateway)	W01B006B06	pENTR221															
Invitrogen	NM_152266	IOH13579	Invitrogen(on gateway)	W01B006B07	pENTR221	11850		C19orf40	91442	NP_689479.1	Hs.579899	Chromosome 19 open reading frame 40						NM_152266.3	NP_689479.1	VALIDATED	C	1.000	1.000	215	648	1	645	215	1	215
Invitrogen	NM_052850	IOH40778	Invitrogen(on gateway)	W01B006B08	pENTR221	12378		GADD45GIP1	90480	NP_443082.2	Hs.515164	Growth arrest and DNA-damage-inducible, gamma interacting protein 1						NM_052850.2	NP_443082.2	PROVISIONAL	C	1.000	1.000	222	669	1	666	222	1	222
Invitrogen	NM_152699	IOH22279	Invitrogen(on gateway)	W01B006B09	pENTR221	16314		SENP5	205564	NP_689912.2	Hs.240770	SUMO1/sentrin specific peptidase 5						NM_152699.4	NP_689912.2	VALIDATED	Cs	0.999	0.999	755	2268	1	2265	755	1	755
Invitrogen	BC007811	IOH40618	Invitrogen(on gateway)	W01B006B10	pENTR221	33627		LOC80154	80154	AAH07811	Hs.546614	Hypothetical LOC80154																		
Invitrogen	NM_001333	IOH27763	Invitrogen(on gateway)	W01B006B11	pENTR221	23949		CTSL2	1515	NP_001324.2	Hs.660866	Cathepsin L2						NM_001333.2	NP_001324.2	REVIEWED	C	1.000	1.000	334	1005	1	1002	334	1	334
Invitrogen	NM_207330	IOH40144	Invitrogen(on gateway)	W01B006B12	pENTR221	17643		NIPAL1	152519	NP_997213.1	Hs.134190	NIPA-like domain containing 1						NM_207330.1	NP_997213.1	PROVISIONAL	C	1.000	1.000	410	1233	1	1230	410	1	410
Invitrogen	NM_001017395	IOH26212	Invitrogen(on gateway)	W01B006B13	pENTR221	16740		TMCC1	23023	NP_001017395.2	Hs.477547	Transmembrane and coiled-coil domain family 1						NM_015008.4	NP_055823.1	VALIDATED	C	1.000	1.000	329	1962	973	1959	329	1	329
Invitrogen	NM_006327	IOH40094	Invitrogen(on gateway)	W01B006B14	pENTR221	2674		TIMM23	10431	NP_006318.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)						NM_006327.2	NP_006318.1	PROVISIONAL	C	1.000	1.000	209	630	1	627	209	1	209
Invitrogen	P50391	IOH28423	Invitrogen(on gateway)	W01B006B15	pENTR221															
Invitrogen	NM_033277	IOH40715	Invitrogen(on gateway)	W01B006B16	pENTR221	5975		LACRT	90070	NP_150593.1	Hs.307096	Lacritin						NM_033277.1	NP_150593.1	REVIEWED	C	1.000	1.000	138	417	1	414	138	1	138
Invitrogen	Q9BU40	IOH5714	Invitrogen(on gateway)	W01B006B17	pENTR221															
Invitrogen	NM_138698	IOH36253	Invitrogen(on gateway)	W01B006B18	pENTR221	18141		C4orf21	55345	NP_619643	Hs.380346	Chromosome 4 open reading frame 21						NM_018392.3	NP_060862.2	PREDICTED	Pfs	0.429	0.429	21	2781	501	439	1062	601	621
Invitrogen	BC031052	IOH22518	Invitrogen(on gateway)	W01B006B19	pENTR221	4905		TRAF6	7189	AAH31052.1	Hs.591983	TNF receptor-associated factor 6						NM_145803.1	NP_665802.1	REVIEWED	Cs	0.998	0.998	522	1569	1	1566	522	1	522
Invitrogen	NM_032572	IOH35124	Invitrogen(on gateway)	W01B006B20	pENTR221	7071		RNASE7	84659	NP_115961.2	Hs.525206	Ribonuclease, RNase A family, 7						NM_032572.3	NP_115961.2	VALIDATED	Cs	0.994	0.994	156	471	1	468	156	1	156
Invitrogen	BC009751	IOH27785	Invitrogen(on gateway)	W01B006B21	pENTR221	10206		AURKB	9212	AAH09751.1	Hs.442658	Aurora kinase B						NM_004217.2	NP_004208.2	VALIDATED	C	1.000	1.000	344	1035	1	1032	344	1	344
Invitrogen	NM_018018	IOH35947	Invitrogen(on gateway)	W01B006B22	pENTR221	5846		SLC38A4	55089	NP_060488.2	Hs.446077	Solute carrier family 38, member 4						NM_018018.4	NP_060488.2	VALIDATED	C	1.000	1.000	547	1644	1	1641	547	1	547
Invitrogen	NM_080546	IOH26608	Invitrogen(on gateway)	W01B006B23	pENTR221	23608		SLC44A1	23446	NP_536856.2	Hs.573495	Solute carrier family 44, member 1						NM_080546.3	NP_536856.2	VALIDATED	C	1.000	1.000	657	1974	1	1971	657	1	657
Invitrogen	NM_147198	IOH34948	Invitrogen(on gateway)	W01B006B24	pENTR221	15065		WFDC9	259240	NP_671731.1	Hs.249828	WAP four-disulfide core domain 9						NM_147198.2	NP_671731.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
Invitrogen	NM_032636	IOH4088	Invitrogen(on gateway)	W01B006C01	pENTR221	1685		PSRC1	84722	NP_116025.1	Hs.405925	Proline/serine-rich coiled-coil 1						NM_032636.6	NP_116025.1	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	BC018632	IOH14451	Invitrogen(on gateway)	W01B006C02	pENTR221	4900		TCN1	6947	AAH18632	Hs.2012	Transcobalamin I (vitamin B12 binding protein, R binder family)						NM_001062.3	NP_001053.2	REVIEWED	P	1.000	1.000	423	1272	1	1269	433	1	423
Invitrogen	NM_005602	IOH9912	Invitrogen(on gateway)	W01B006C03	pENTR221	16344		CLDN11	5010	NP_005593.2	Hs.31595	Claudin 11						NM_005602.5	NP_005593.2	REVIEWED	C	1.000	1.000	207	624	1	621	207	1	207
Invitrogen	NM_006262	IOH21924	Invitrogen(on gateway)	W01B006C04	pENTR221	5515		PRPH	5630	NP_006253.2	Hs.37044	Peripherin						NM_006262.3	NP_006253.2	REVIEWED	C	1.000	1.000	470	1413	1	1410	470	1	470
Invitrogen	NM_023930	IOH3701	Invitrogen(on gateway)	W01B006C05	pENTR221	4873		KCTD14	65987	NP_076419.2	Hs.709780	Potassium channel tetramerisation domain containing 14						NM_023930.3	NP_076419.2	VALIDATED	P	1.000	1.000	225	678	1	675	255	31	255
Invitrogen	BC013098	IOH22115	Invitrogen(on gateway)	W01B006C06	pENTR221	24846		MAGEA2	4101	AAH13098.1	Hs.534597	Melanoma antigen family A, 2						NM_005361.2	NP_005352.1	REVIEWED	Cs	0.997	0.997	314	945	1	942	314	1	314
Invitrogen	NM_001927	IOH23102	Invitrogen(on gateway)	W01B006C07	pENTR221	13083		DES	1674	NP_001918.3	Hs.594952	Desmin						NM_001927.3	NP_001918.3	REVIEWED	C	1.000	1.000	470	1413	1	1410	470	1	470
Invitrogen	NM_002242	IOH26872	Invitrogen(on gateway)	W01B006C08	pENTR221	13918		KCNJ13	3769	NP_002233.2	Hs.467338	Potassium inwardly-rectifying channel, subfamily J, member 13						NM_002242.3	NP_002233.2	VALIDATED	Cs	0.992	0.992	360	1083	1	1080	360	1	360
Invitrogen	NM_001009932	IOH11824	Invitrogen(on gateway)	W01B006C09	pENTR221	25383		DNASE1L1	1774	NP_001009932.1	Hs.401929	Deoxyribonuclease I-like 1						NM_001009932.1	NP_001009932.1	REVIEWED	C	1.000	1.000	302	909	1	906	302	1	302
Invitrogen	NM_153445	IOH28328	Invitrogen(on gateway)	W01B006C10	pENTR221	4608		OR5P3	120066	NP_703146.1	Hs.351825	Olfactory receptor, family 5, subfamily P, member 3						NM_153445.1	NP_703146.1	PROVISIONAL	C	1.000	1.000	311	936	1	933	311	1	311
Invitrogen	NM_014305	IOH21821	Invitrogen(on gateway)	W01B006C11	pENTR221	6688		TGDS	23483	NP_055120.1	Hs.12393	TDP-glucose 4,6-dehydratase						NM_014305.2	NP_055120.1	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
Invitrogen	NM_006219	IOH20965	Invitrogen(on gateway)	W01B006C12	pENTR221	17178		PIK3CB	5291	NP_006210.1	Hs.239818	Phosphoinositide-3-kinase, catalytic, beta polypeptide						NM_006219.1	NP_006210.1	PROVISIONAL	C	1.000	1.000	1070	3213	1	3210	1070	1	1070
Invitrogen	BC024211	IOH12680	Invitrogen(on gateway)	W01B006C13	pENTR221	13504		NCAPH	23397	AAH24211.1	Hs.308045	Non-SMC condensin I complex, subunit H						NM_015341.3	NP_056156.2	REVIEWED	Cs	0.999	0.999	741	2226	1	2223	741	1	741
Invitrogen	BC051688	IOH26513	Invitrogen(on gateway)	W01B006C14	pENTR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1						NM_001103149.1	NP_001096619.1	VALIDATED	P	1.000	1.000	362	1308	1	1086	378	5	366
Invitrogen	NM_002754	IOH3435	Invitrogen(on gateway)	W01B006C15	pENTR221	19738		MAPK13	5603	NP_002745.1	Hs.178695	Mitogen-activated protein kinase 13						NM_002754.3	NP_002745.1	REVIEWED	OK	1.000	1.000	365	1098	1	1095	365	1	365
Invitrogen	NM_003724	IOH26418	Invitrogen(on gateway)	W01B006C16	pENTR221	22982		JRK	8629	NP_003715.2	Hs.683465	Jerky homolog (mouse)						NM_003724.2	NP_003715.2	REVIEWED	Cs	0.998	0.998	568	1707	1	1704	568	1	568
Invitrogen	BC041390	IOH25825	Invitrogen(on gateway)	W01B006C17	pENTR221	16329		CMTM8	152189	AAH41390.1	Hs.154986	CKLF-like MARVEL transmembrane domain containing 8						NM_178868.3	NP_849199.2	REVIEWED	Cs	0.988	0.988	173	522	1	519	173	1	173
Invitrogen	NM_182906	IOH26131	Invitrogen(on gateway)	W01B006C18	pENTR221	10727		CLEC10A	10462	NP_878910.1	Hs.54403	C-type lectin domain family 10, member A						NM_182906.2	NP_878910.1	REVIEWED	C	1.000	1.000	316	951	1	948	316	1	316
Invitrogen	NM_005554	IOH6342	Invitrogen(on gateway)	W01B006C19	pENTR221	6229		KRT6A	3853	NP_005545.1	Hs.700779	Keratin 6A						NM_005554.3	NP_005545.1	REVIEWED	C	1.000	1.000	564	1695	1	1692	564	1	564
Invitrogen	NM_182494	IOH26292	Invitrogen(on gateway)	W01B006C20	pENTR221	3437		CALHM3	119395	NP_872300	Hs.364624	Calcium homeostasis modulator 3						XM_001725818.1	XP_001725870.1	MODEL	Cg	0.983	1.000	350	1053	1	1050	344	1	344
Invitrogen	BC024590	IOH11674	Invitrogen(on gateway)	W01B006C21	pENTR221	5153		DNM1L	10059	AAH24590.1	Hs.556296	Dynamin 1-like						NM_012063.2	NP_036193.2	REVIEWED	C	1.000	1.000	710	2133	1	2130	710	1	710
Invitrogen	NM_182553	IOH26395	Invitrogen(on gateway)	W01B006C22	pENTR221	4069		CNIH2	254263	NP_872359.1	Hs.437072	Cornichon homolog 2 (Drosophila)						NM_182553.1	NP_872359.1	PROVISIONAL	C	1.000	1.000	160	483	1	480	160	1	160
Invitrogen	NM_005698	IOH2938	Invitrogen(on gateway)	W01B006C23	pENTR221	1535		SCAMP3	10067	NP_005689.2	Hs.200600	Secretory carrier membrane protein 3						NM_005698.2	NP_005689.2	REVIEWED	C	1.000	1.000	347	1044	1	1041	347	1	347
Invitrogen	BC031023	IOH27972	Invitrogen(on gateway)	W01B006C24	pENTR221	20149		HLA-DRB1	3123	AAH31023.1	Hs.701691	Major histocompatibility complex, class II, DR beta 1						XM_001124749.2	XP_001124749.1	MODEL		0.951	0.951	266	801	1	798	266	1	266
Invitrogen	NM_153444	IOH28327	Invitrogen(on gateway)	W01B006D01	pENTR221	4616		OR5P2	120065	NP_703145.1	Hs.351824	Olfactory receptor, family 5, subfamily P, member 2						NM_153444.1	NP_703145.1	PROVISIONAL	OK	1.000	1.000	322	969	1	966	322	1	322
Invitrogen	ENST00000256523	IOH10463	Invitrogen(on gateway)	W01B006D02	pENTR221	37393				ENSP00000256523										
Invitrogen	NM_152315	IOH22681	Invitrogen(on gateway)	W01B006D03	pENTR221	4903		FAM55A	120400	NP_689528.2								NM_152315.2	NP_689528.2	VALIDATED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
Invitrogen	NM_174983	IOH22997	Invitrogen(on gateway)	W01B006D04	pENTR221	12331		C19orf28	126321	NP_778148.2	Hs.656901	Chromosome 19 open reading frame 28						NM_001042680.1	NP_001036145.1	VALIDATED	Cg	0.981	1.000	473	1416	1	1392	473	1	473
Invitrogen	NM_152614	IOH22756	Invitrogen(on gateway)	W01B006D05	pENTR221	13505		C2orf57	165100	NP_689827.1	Hs.98104	Chromosome 2 open reading frame 57						NM_152614.1	NP_689827.1	PREDICTED	OK	1.000	1.000	395	1188	1	1185	395	1	395
Invitrogen	NM_152480	IOH12619	Invitrogen(on gateway)	W01B006D06	pENTR221	12703		C19orf23	148046	NP_689693.1	Hs.438829	Chromosome 19 open reading frame 23						NM_152480.1	NP_689693.1	VALIDATED	C	1.000	1.000	109	330	1	327	109	1	109
Invitrogen	NM_016381	IOH27911	Invitrogen(on gateway)	W01B006D07	pENTR221	16268		TREX1	11277	NP_057465.1	Hs.713742	Three prime repair exonuclease 1						NM_016381.3	NP_057465.1	REVIEWED	OK	1.000	1.000	369	1110	1	1107	369	1	369
Invitrogen	NM_021010	IOH40358	Invitrogen(on gateway)	W01B006D08	pENTR221	23273		DEFA5	1670	NP_066290.1	Hs.655233	Defensin, alpha 5, Paneth cell-specific						NM_021010.1	NP_066290.1	REVIEWED	C	1.000	1.000	94	285	1	282	94	1	94
Invitrogen	NM_002535	IOH26613	Invitrogen(on gateway)	W01B006D09	pENTR221	5591		OAS2	4939	NP_002526.2	Hs.414332	2'-5'-oligoadenylate synthetase 2, 69/71kDa						NM_002535.2	NP_002526.2	REVIEWED	C	1.000	1.000	687	2064	1	2061	687	1	687
Invitrogen	BC070109	IOH40086	Invitrogen(on gateway)	W01B006D10	pENTR221	15894		C22orf13	83606	AAH70109.1	Hs.9850	Chromosome 22 open reading frame 13						NM_031444.2	NP_113632.2	VALIDATED	Cgs	0.992	0.996	240	720	1	717	240	1	240
Invitrogen	NM_016568	IOH28381	Invitrogen(on gateway)	W01B006D11	pENTR221	18853		RXFP3	51289	NP_057652.1	Hs.170146	Relaxin/insulin-like family peptide receptor 3						NM_016568.2	NP_057652.1	PROVISIONAL	C	1.000	1.000	469	1410	1	1407	469	1	469
Invitrogen	NM_152596	IOH40199	Invitrogen(on gateway)	W01B006D12	pENTR221	8319		EXD1	161829	NP_689809.2	Hs.307999	Exonuclease 3'-5' domain containing 1						NM_152596.2	NP_689809.2	PROVISIONAL	OK	1.000	1.000	514	1545	1	1542	514	1	514
Invitrogen	BC026104	IOH11605	Invitrogen(on gateway)	W01B006D13	pENTR221	2850		PDCD4	27250	AAH26104.1	Hs.711490	Programmed cell death 4 (neoplastic transformation inhibitor)						NM_014456.3	NP_055271.2	REVIEWED	Cs	0.996	0.996	469	1410	1	1407	469	1	469
Invitrogen	BC017212	IOH13041	Invitrogen(on gateway)	W01B006D14	pENTR221	6418		PHF11	51131	AAH17212.2	Hs.369039	PHD finger protein 11						NM_001040444.1	NP_001035534.1	VALIDATED	C	1.000	1.000	292	879	1	876	292	1	292
Invitrogen	NM_152413	IOH22531	Invitrogen(on gateway)	W01B006D15	pENTR221	23248		GOT1L1	137362	NP_689626.2	Hs.380740	Glutamic-oxaloacetic transaminase 1-like 1						NM_152413.2	NP_689626.2	VALIDATED	Cs	0.998	0.998	421	1266	1	1263	421	1	421
Invitrogen	NM_017784	IOH40854	Invitrogen(on gateway)	W01B006D16	pENTR221	16847		OSBPL10	114884	NP_060254.2	Hs.150122	Oxysterol binding protein-like 10						NM_017784.3	NP_060254.2	REVIEWED	C	1.000	1.000	764	2295	1	2292	764	1	764
Invitrogen	BC009251	IOH27776	Invitrogen(on gateway)	W01B006D17	pENTR221	22688		FDFT1	2222	AAH09251.1	Hs.593928	Farnesyl-diphosphate farnesyltransferase 1						NM_004462.3	NP_004453.3	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
Invitrogen	BC064902	IOH39951	Invitrogen(on gateway)	W01B006D18	pENTR221	19308		MRPS27	23107	AAH64902.1	Hs.482491	Mitochondrial ribosomal protein S27						NM_015084.2	NP_055899.2	REVIEWED	C	1.000	1.000	414	1245	1	1242	414	1	414
Invitrogen	NM_024625	IOH26215	Invitrogen(on gateway)	W01B006D19	pENTR221	21902		ZC3HAV1	56829	NP_078901.3	Hs.133512	Zinc finger CCCH-type, antiviral 1						NM_024625.3	NP_078901.3	REVIEWED	C	1.000	1.000	699	2100	1	2097	699	1	699
Invitrogen	BC093840	IOH35128	Invitrogen(on gateway)	W01B006D20	pENTR221	5449		A2ML1	144568	AAH93840.2	Hs.620532	Alpha-2-macroglobulin-like 1						NM_144670.3	NP_653271.2	VALIDATED	P	1.000	1.000	158	477	1	474	1454	1297	1454
Invitrogen	NM_003406	IOH3874	Invitrogen(on gateway)	W01B006D21	pENTR221	23227		YWHAZ	7534	NP_003397.1	Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED	C	1.000	1.000	245	738	1	735	245	1	245
Invitrogen	NM_001044	IOH36022	Invitrogen(on gateway)	W01B006D22	pENTR221	19475		SLC6A3	6531	NP_001035.1	Hs.406	Solute carrier family 6 (neurotransmitter transporter, dopamine), member 3						NM_001044.3	NP_001035.1	VALIDATED	C	1.000	1.000	620	1863	1	1860	620	1	620
Invitrogen	NM_145271	IOH14111	Invitrogen(on gateway)	W01B006D23	pENTR221	9156		ZNF688	146542	NP_660314.1	Hs.301463	Zinc finger protein 688						NM_145271.3	NP_660314.1	VALIDATED	C	1.000	1.000	276	831	1	828	276	1	276
Invitrogen	NM_181607	IOH34952	Invitrogen(on gateway)	W01B006D24	pENTR221	15340		KRTAP19-1	337882	NP_853638.1	Hs.61552	Keratin associated protein 19-1						NM_181607.1	NP_853638.1	PROVISIONAL	C	1.000	1.000	90	273	1	270	90	1	90
Invitrogen	NM_002074	IOH3287	Invitrogen(on gateway)	W01B006E01	pENTR221	1581		GNB1	2782	NP_002065.1	Hs.709208	Guanine nucleotide binding protein (G protein), beta polypeptide 1						NM_002074.2	NP_002065.1	REVIEWED	C	1.000	1.000	340	1023	1	1020	340	1	340
Invitrogen	NM_000107	IOH4740	Invitrogen(on gateway)	W01B006E02	pENTR221	3672		DDB2	1643	NP_000098.1	Hs.700338	Damage-specific DNA binding protein 2, 48kDa						NM_000107.2	NP_000098.1	REVIEWED	C	1.000	1.000	427	1284	1	1281	427	1	427
Invitrogen	NM_001307	IOH4602	Invitrogen(on gateway)	W01B006E03	pENTR221	10370		CLDN7	1366	NP_001298.3	Hs.513915	Claudin 7						NM_001307.4	NP_001298.3	VALIDATED	Cs	0.991	0.991	211	636	1	633	211	1	211
Invitrogen	NM_000824	IOH21923	Invitrogen(on gateway)	W01B006E04	pENTR221	17503		GLRB	2743	NP_000815.1	Hs.32973	Glycine receptor, beta						NM_000824.3	NP_000815.1	VALIDATED	C	1.000	1.000	497	1494	1	1491	497	1	497
Invitrogen	NM_024040	IOH4411	Invitrogen(on gateway)	W01B006E05	pENTR221	3102		CUEDC2	79004	NP_076945.2	Hs.500874	CUE domain containing 2						NM_024040.2	NP_076945.2	VALIDATED	P	1.000	1.000	226	681	1	678	287	1	226
Invitrogen	BC030958	IOH23152	Invitrogen(on gateway)	W01B006E06	pENTR221	6249		EPYC	1833	AAH30958.1	Hs.435680	Epiphycan						NM_004950.4	NP_004941.2	REVIEWED	Cs	0.997	0.997	322	969	1	966	322	1	322
Invitrogen	BC028915	IOH22198	Invitrogen(on gateway)	W01B006E07	pENTR221	11393		CBLC	23624	AAH28915.1	Hs.466907	Cas-Br-M (murine) ecotropic retroviral transforming sequence c						NM_012116.3	NP_036248.3	VALIDATED	Cs	0.998	0.998	474	1425	1	1422	474	1	474
Invitrogen	BC045611	IOH27279	Invitrogen(on gateway)	W01B006E08	pENTR221	21795		FAM131B	9715	AAH45611.2	Hs.648908	Family with sequence similarity 131, member B						NM_014690.4	NP_055505.3	VALIDATED	Cs	0.991	0.991	332	1083	85	1080	332	1	332
Invitrogen	BC035310	IOH22154	Invitrogen(on gateway)	W01B006E09	pENTR221	18887		TMEM171	134285	AAH35310.1	Hs.162246	Transmembrane protein 171						NM_173490.5	NP_775761.3	PROVISIONAL	Cgs	0.991	0.994	324	972	1	969	324	1	324
Invitrogen	NM_000529	IOH28387	Invitrogen(on gateway)	W01B006E10	pENTR221	11285		MC2R	4158	NP_000520.1	Hs.248144	Melanocortin 2 receptor (adrenocorticotropic hormone)						NM_000529.2	NP_000520.1	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
Invitrogen	BC017810	IOH12948	Invitrogen(on gateway)	W01B006E11	pENTR221	1664		TMOD4	29765	AAH17810.1	Hs.709681	Tropomodulin 4 (muscle)						NM_013353.2	NP_037485.2	VALIDATED	Cs	0.997	0.997	345	1038	1	1035	345	1	345
Invitrogen	NM_000486	IOH27325	Invitrogen(on gateway)	W01B006E12	pENTR221	5618		AQP2	359	NP_000477.1	Hs.130730	Aquaporin 2 (collecting duct)						NM_000486.5	NP_000477.1	REVIEWED	C	1.000	1.000	271	816	1	813	271	1	271
Invitrogen	NM_134428	IOH12663	Invitrogen(on gateway)	W01B006E13	pENTR221	24294		RFX3	5991	NP_602304.1	Hs.136829	Regulatory factor X, 3 (influences HLA class II expression)						NM_134428.1	NP_602304.1	REVIEWED	C	1.000	1.000	749	2250	1	2247	749	1	749
Invitrogen	BC041453	IOH26296	Invitrogen(on gateway)	W01B006E14	pENTR221	9935		ENPP7	339221	AAH41453.2	Hs.114084	Ectonucleotide pyrophosphatase/phosphodiesterase 7						NM_178543.3	NP_848638.2	VALIDATED	Cs	0.998	0.998	458	1377	1	1374	458	1	458
Invitrogen	BC022318	IOH13776	Invitrogen(on gateway)	W01B006E15	pENTR221	3416		SFTPD	6441	AAH22318.1	Hs.253495	Surfactant protein D						NM_003019.4	NP_003010.4	VALIDATED	Cs	0.995	0.995	375	1128	1	1125	375	1	375
Invitrogen	NM_032373	IOH27011	Invitrogen(on gateway)	W01B006E16	pENTR221	2778		PCGF5	84333	NP_115749.2	Hs.500512	Polycomb group ring finger 5						NM_032373.3	NP_115749.2	PROVISIONAL	OK	1.000	1.000	256	771	1	768	256	1	256
Invitrogen	BC043644	IOH27743	Invitrogen(on gateway)	W01B006E17	pENTR221	14613		PRND	23627	AAH43644.1	Hs.406696	Prion protein 2 (dublet)						NM_012409.2	NP_036541.2	REVIEWED	Cs	0.994	0.994	176	531	1	528	176	1	176
Invitrogen	NM_030883	IOH26779	Invitrogen(on gateway)	W01B006E18	pENTR221	19905		OR2H1	26716	NP_112145.1	Hs.714219	Olfactory receptor, family 2, subfamily H, member 1						NM_030883.3	NP_112145.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
Invitrogen	NM_001032364	IOH12493	Invitrogen(on gateway)	W01B006E19	pENTR221	15683		GGT1	2678	NP_001027536.1	Hs.645535	Gamma-glutamyltransferase 1						NM_001032365.1	NP_001027537.1	REVIEWED	C	1.000	1.000	569	1710	1	1707	569	1	569
Invitrogen	NM_006029	IOH26185	Invitrogen(on gateway)	W01B006E20	pENTR221	7393		PNMA1	9240	NP_006020.4	Hs.194709	Paraneoplastic antigen MA1						NM_006029.4	NP_006020.4	VALIDATED	C	1.000	1.000	353	1062	1	1059	353	1	353
Invitrogen	ENST00000322608	IOH28190	Invitrogen(on gateway)	W01B006E21	pENTR221	10782		OR1E1	8387	ENSP00000313384	Hs.278485	Olfactory receptor, family 1, subfamily E, member 1						NM_003553.2	NP_003544.2	VALIDATED	C	1.000	1.000	314	945	1	942	314	1	314
Invitrogen	NM_020644	IOH26276	Invitrogen(on gateway)	W01B006E22	pENTR221	4477		TMEM9B	56674	NP_065695.1	Hs.501853	TMEM9 domain family, member B						NM_020644.1	NP_065695.1	PROVISIONAL	C	1.000	1.000	198	597	1	594	198	1	198
Invitrogen	BC000162	IOH2911	Invitrogen(on gateway)	W01B006E23	pENTR221	5180		STRAP	11171	AAH00162.1	Hs.719087	Serine/threonine kinase receptor associated protein						NM_007178.3	NP_009109.3	VALIDATED	C	1.000	1.000	350	1053	1	1050	350	1	350
Invitrogen	NM_001001723	IOH28065	Invitrogen(on gateway)	W01B006E24	pENTR221	15245		TRAPPC10	7109	NP_001001723.1	Hs.126221	Trafficking protein particle complex 10						NM_001001723.1	NP_001001723.1	REVIEWED	C	1.000	1.000	276	831	1	828	276	1	276
Invitrogen	NM_145312	IOH12248	Invitrogen(on gateway)	W01B006F01	pENTR221	2791		ZNF485	220992	NP_660355.2	Hs.147440	Zinc finger protein 485						NM_145312.3	NP_660355.2	VALIDATED	P	1.000	1.000	402	1209	1	1206	441	40	441
Invitrogen	ENST00000054650	IOH11952	Invitrogen(on gateway)	W01B006F02	pENTR221	334		THAP3	90326	ENSP00000054650	Hs.709655	THAP domain containing, apoptosis associated protein 3						NM_138350.2	NP_612359.2	PROVISIONAL	Pg	0.954	1.000	153	720	1	438	175	1	153
Invitrogen	BC013984	IOH27848	Invitrogen(on gateway)	W01B006F03	pENTR221	9767		SERPINF1	5176	AAH13984.1	Hs.694727	Serpin peptidase inhibitor, clade F (alpha-2 antiplasmin, pigment epithelium derived factor), member 1						NM_002615.4	NP_002606.3	VALIDATED	Cs	0.995	0.995	418	1257	1	1254	418	1	418
Invitrogen	NM_014263	IOH14600	Invitrogen(on gateway)	W01B006F04	pENTR221	3189		YME1L1	10730	NP_055078.1	Hs.499145	YME1-like 1 (S. cerevisiae)						NM_014263.2	NP_055078.1	REVIEWED	C	1.000	1.000	716	2151	1	2148	716	1	716
Invitrogen	BC045542	IOH26900	Invitrogen(on gateway)	W01B006F05	pENTR221	19161		KIF3A	11127	AAH45542.1	Hs.43670	Kinesin family member 3A						NM_007054.5	NP_008985.3	VALIDATED	Cgs	0.993	0.997	702	2109	1	2106	699	1	699
Invitrogen	NM_000884	IOH6586	Invitrogen(on gateway)	W01B006F06	pENTR221	17167		IMPDH2	3615	NP_000875.2	Hs.654400	IMP (inosine monophosphate) dehydrogenase 2						NM_000884.2	NP_000875.2	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
Invitrogen	BC028587	IOH11837	Invitrogen(on gateway)	W01B006F07	pENTR221	16146		NEK11	79858	AAH28587.1	Hs.657336	NIMA (never in mitosis gene a)- related kinase 11						NM_001146003.1	NP_001139475.1	REVIEWED	P	1.000	1.000	466	1449	1	1398	599	1	466
Invitrogen	NM_004164	IOH40388	Invitrogen(on gateway)	W01B006F08	pENTR221	17232		RBP2	5948	NP_004155.2	Hs.655516	Retinol binding protein 2, cellular						NM_004164.2	NP_004155.2	REVIEWED	C	1.000	1.000	134	405	1	402	134	1	134
Invitrogen	NM_152323	IOH21727	Invitrogen(on gateway)	W01B006F09	pENTR221	5375		SPIC	121599	NP_689536.1	Hs.577097	Spi-C transcription factor (Spi-1/PU.1 related)						NM_152323.1	NP_689536.1	PROVISIONAL	C	1.000	1.000	248	747	1	744	248	1	248
Invitrogen	NM_148912	IOH40097	Invitrogen(on gateway)	W01B006F10	pENTR221	21920		ABHD11	83451	NP_683710.1	Hs.647045	Abhydrolase domain containing 11						NM_148912.2	NP_683710.1	REVIEWED	C	1.000	1.000	315	948	1	945	315	1	315
Invitrogen	NM_145288	IOH13425	Invitrogen(on gateway)	W01B006F11	pENTR221	12383		ZNF296	162979	NP_660331.1	Hs.192237	Zinc finger protein 296						NM_145288.1	NP_660331.1	PROVISIONAL	C	1.000	1.000	475	1428	1	1425	475	1	475
Invitrogen	NM_000394	IOH40243	Invitrogen(on gateway)	W01B006F12	pENTR221	15279		CRYAA	1409	NP_000385.1	Hs.184085	Crystallin, alpha A						NM_000394.2	NP_000385.1	REVIEWED	C	1.000	1.000	173	522	1	519	173	1	173
Invitrogen	NM_152685	IOH26574	Invitrogen(on gateway)	W01B006F13	pENTR221	19183		SLC23A1	9963	NP_689898.2	Hs.643467	Solute carrier family 23 (nucleobase transporters), member 1						NM_152685.3	NP_689898.2	REVIEWED	C	1.000	1.000	602	1809	1	1806	602	1	602
Invitrogen	BC060850	IOH39820	Invitrogen(on gateway)	W01B006F14	pENTR221	6723		SLC46A3	283537	AAH60850.1	Hs.117167	Solute carrier family 46, member 3						NM_181785.3	NP_861450.1	VALIDATED	C	1.000	1.000	461	1392	1	1383	461	1	461
Invitrogen	NM_030959	IOH28403	Invitrogen(on gateway)	W01B006F15	pENTR221	20618		OR12D3	81797	NP_112221.1	Hs.272280	Olfactory receptor, family 12, subfamily D, member 3						NM_030959.2	NP_112221.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
Invitrogen	NM_005768	IOH39890	Invitrogen(on gateway)	W01B006F16	pENTR221	6118		LPCAT3	10162	NP_005759.4	Hs.655248	Lysophosphatidylcholine acyltransferase 3						NM_005768.5	NP_005759.4	VALIDATED	C	1.000	1.000	487	1464	1	1461	487	1	487
Invitrogen	NM_145044	IOH10819	Invitrogen(on gateway)	W01B006F17	pENTR221	16405		ZNF501	115560	NP_659481.2	Hs.401045	Zinc finger protein 501						NM_145044.2	NP_659481.2	VALIDATED	P	1.000	1.000	262	789	1	786	271	10	271
Invitrogen	NM_001003937	IOH40055	Invitrogen(on gateway)	W01B006F18	pENTR221	14165		TSPYL6	388951	NP_001003937.2	Hs.620508	TSPY-like 6						NM_001003937.2	NP_001003937.2	VALIDATED	Cs	0.995	0.995	410	1233	1	1230	410	1	410
Invitrogen	NM_152436	IOH21583	Invitrogen(on gateway)	W01B006F19	pENTR221	5476		GLIPR1L2	144321	NP_689649.1	Hs.406728	GLI pathogenesis-related 1 like 2						NM_152436.1	NP_689649.1	PROVISIONAL	C	1.000	1.000	253	762	1	759	253	1	253
Invitrogen	NM_003784	IOH35656	Invitrogen(on gateway)	W01B006F20	pENTR221	10978		SERPINB7	8710	NP_003775.1	Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
Invitrogen	NM_145023	IOH27457	Invitrogen(on gateway)	W01B006F21	pENTR221	2757		CCDC7	221016	NP_659460.3	Hs.585464	Coiled-coil domain containing 7						NM_145023.4	NP_659460.3	VALIDATED	C	1.000	1.000	486	1461	1	1458	486	1	486
Invitrogen	NM_198460	IOH36042	Invitrogen(on gateway)	W01B006F22	pENTR221	803		GBP6	163351	NP_940862.2	Hs.254338	Guanylate binding protein family, member 6						NM_198460.2	NP_940862.2	VALIDATED	Cs	0.994	0.994	633	1902	1	1899	633	1	633
Invitrogen	NM_021151	IOH26097	Invitrogen(on gateway)	W01B006F23	pENTR221	21122		CROT	54677	NP_066974.2	Hs.125039	Carnitine O-octanoyltransferase						NM_021151.3	NP_066974.2	REVIEWED	OK	1.000	1.000	612	1839	1	1836	612	1	612
Invitrogen	NM_175616	IOH34965	Invitrogen(on gateway)	W01B006F24	pENTR221	18805		C5orf27	202299	NP_783315	Hs.8373	Chromosome 5 open reading frame 27																		
Invitrogen	BC026283	IOH14204	Invitrogen(on gateway)	W01B006G01	pENTR221	10721		APOH	350	AAH26283.1	Hs.445358	Apolipoprotein H (beta-2-glycoprotein I)						NM_000042.2	NP_000033.2	REVIEWED	C	1.000	1.000	345	1038	1	1035	345	1	345
Invitrogen	NM_032858	IOH12001	Invitrogen(on gateway)	W01B006G02	pENTR221	633		MAEL	84944	NP_116247.1	Hs.651245	Maelstrom homolog (Drosophila)						NM_032858.1	NP_116247.1	VALIDATED	C	1.000	1.000	434	1305	1	1302	434	1	434
Invitrogen	NM_000600	IOH11642	Invitrogen(on gateway)	W01B006G03	pENTR221	21000		IL6	3569	NP_000591.1	Hs.654458	Interleukin 6 (interferon, beta 2)						NM_000600.3	NP_000591.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
Invitrogen	NM_003486	IOH25817	Invitrogen(on gateway)	W01B006G04	pENTR221	9073		SLC7A5	8140	NP_003477.4	Hs.513797	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 5						NM_003486.5	NP_003477.4	VALIDATED	C	1.000	1.000	507	1524	1	1521	507	1	507
Invitrogen	NM_007006	IOH4064	Invitrogen(on gateway)	W01B006G05	pENTR221	9222		NUDT21	11051	NP_008937.1	Hs.528834	Nudix (nucleoside diphosphate linked moiety X)-type motif 21						NM_007006.2	NP_008937.1	REVIEWED	C	1.000	1.000	227	684	1	681	227	1	227
Invitrogen	NM_005281	IOH21922	Invitrogen(on gateway)	W01B006G06	pENTR221	959		GPR3	2827	NP_005272.1	Hs.66542	G protein-coupled receptor 3						NM_005281.2	NP_005272.1	PROVISIONAL	OK	1.000	1.000	330	993	1	990	330	1	330
Invitrogen	NM_018590	IOH21547	Invitrogen(on gateway)	W01B006G07	pENTR221	2612		CSGALNACT2	55454	NP_061060.3	Hs.657569	Chondroitin sulfate N-acetylgalactosaminyltransferase 2						NM_018590.3	NP_061060.3	PROVISIONAL	C	1.000	1.000	542	1629	1	1626	542	1	542
Invitrogen	BC031999	IOH22178	Invitrogen(on gateway)	W01B006G08	pENTR221	956		HSD3B1	3283	AAH31999.1	Hs.364941	Hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1						NM_000862.2	NP_000853.1	VALIDATED	Cs	0.997	0.997	373	1122	1	1119	373	1	373
Invitrogen	BC016374	IOH23073	Invitrogen(on gateway)	W01B006G09	pENTR221	1560		TMEM59	9528	AAH16374.1	Hs.523262	Transmembrane protein 59						NM_004872.3	NP_004863.2	PROVISIONAL	Cgs	0.994	0.997	324	975	1	972	323	1	323
Invitrogen	NM_001001667	IOH28547	Invitrogen(on gateway)	W01B006G10	pENTR221	21495		OR6V1	346517	NP_001001667.1	Hs.554721	Olfactory receptor, family 6, subfamily V, member 1						NM_001001667.1	NP_001001667.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	NM_003649	IOH21830	Invitrogen(on gateway)	W01B006G11	pENTR221	20715		DDO	8528	NP_003640.2	Hs.591348	D-aspartate oxidase						NM_003649.2	NP_003640.2	REVIEWED	OK	1.000	1.000	369	1110	1	1107	369	1	369
Invitrogen	BC029356	IOH23176	Invitrogen(on gateway)	W01B006G12	pENTR221	8697		TPSB2	64499	AAH29356.1	Hs.592982	Tryptase beta 2						NM_024164.5	NP_077078.5	REVIEWED	Cs	0.985	0.985	275	828	1	825	275	1	275
Invitrogen	BC036522	IOH22496	Invitrogen(on gateway)	W01B006G13	pENTR221	4672		CATSPER1	117144	AAH36522.1	Hs.189105	Cation channel, sperm associated 1						NM_053054.3	NP_444282.3	REVIEWED	Cs	0.999	0.999	780	2343	1	2340	780	1	780
Invitrogen	BC040955	IOH26197	Invitrogen(on gateway)	W01B006G14	pENTR221	14659		BPI	671	AAH40955.1	Hs.529019	Bactericidal/permeability-increasing protein						NM_001725.2	NP_001716.2	REVIEWED	Cs	0.996	0.996	487	1464	1	1461	487	1	487
Invitrogen	NM_002703	IOH5194	Invitrogen(on gateway)	W01B006G15	pENTR221	18026		PPAT	5471	NP_002694.3	Hs.331420	Phosphoribosyl pyrophosphate amidotransferase						NM_002703.3	NP_002694.3	REVIEWED	C	1.000	1.000	517	1554	1	1551	517	1	517
Invitrogen	NM_007243	IOH26267	Invitrogen(on gateway)	W01B006G16	pENTR221	20499		NRM	11270	NP_009174.1	Hs.519993	Nurim (nuclear envelope membrane protein)						NM_007243.1	NP_009174.1	PROVISIONAL	C	1.000	1.000	262	789	1	786	262	1	262
Invitrogen	NM_031442	IOH27230	Invitrogen(on gateway)	W01B006G17	pENTR221	25316		TMEM47	83604	NP_113630.1	Hs.8769	Transmembrane protein 47						NM_031442.3	NP_113630.1	REVIEWED	C	1.000	1.000	181	546	1	543	181	1	181
Invitrogen	NM_032288	IOH26161	Invitrogen(on gateway)	W01B006G18	pENTR221	16352		FYTTD1	84248	NP_115664.2	Hs.277533	Forty-two-three domain containing 1						NM_032288.5	NP_115664.2	VALIDATED	OK	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	NM_001656	IOH10672	Invitrogen(on gateway)	W01B006G19	pENTR221	19245		TRIM23	373	NP_001647.1	Hs.792	Tripartite motif-containing 23						NM_001656.3	NP_001647.1	REVIEWED	C	1.000	1.000	574	1725	1	1722	574	1	574
Invitrogen	NM_178536	IOH26188	Invitrogen(on gateway)	W01B006G20	pENTR221	23746		LCN12	286256	NP_848631.2	Hs.440519	Lipocalin 12						NM_178536.3	NP_848631.2	VALIDATED		0.964	0.964	192	1068	1	576	192	1	192
Invitrogen	NM_052967	IOH28386	Invitrogen(on gateway)	W01B006G21	pENTR221	20822		MAS1L	116511	NP_443199.1	Hs.533297	MAS1 oncogene-like						NM_052967.1	NP_443199.1	PROVISIONAL	C	1.000	1.000	378	1137	1	1134	378	1	378
Invitrogen	BC046131	IOH26912	Invitrogen(on gateway)	W01B006G22	pENTR221	16875		COMMD2	51122	AAH46131.1	Hs.591315	COMM domain containing 2						NM_016094.2	NP_057178.2	VALIDATED	Cs	0.995	0.995	199	600	1	597	199	1	199
Invitrogen	NM_005266	IOH13936	Invitrogen(on gateway)	W01B006G23	pENTR221	1584		GJA5	2702	NP_005257.2	Hs.447968	Gap junction protein, alpha 5, 40kDa						NM_005266.5	NP_005257.2	REVIEWED	C	1.000	1.000	358	1077	1	1074	358	1	358
Invitrogen	BC031024	IOH27973	Invitrogen(on gateway)	W01B006G24	pENTR221	5928		GPN3	51184	AAH31024.1	Hs.634680	GPN-loop GTPase 3						NM_016301.2	NP_057385.2	PROVISIONAL	Cs	0.993	0.993	284	855	1	852	284	1	284
Invitrogen	BC069123	IOH28193	Invitrogen(on gateway)	W01B006H01	pENTR221	20128		OR12D2	26529	AAH69123.1	Hs.247862	Olfactory receptor, family 12, subfamily D, member 2						NM_013936.3	NP_039224.2	REVIEWED	Cs	0.997	0.997	307	924	1	921	307	1	307
Invitrogen	ENST00000314644	IOH28463	Invitrogen(on gateway)	W01B006H02	pENTR221	4178		OR4C15	81309	ENSP00000324958	Hs.589003	Olfactory receptor, family 4, subfamily C, member 15						NM_001001920.1	NP_001001920.1	PROVISIONAL	P	1.000	1.000	316	951	1	948	370	55	370
Invitrogen	NM_001011551	IOH12600	Invitrogen(on gateway)	W01B006H03	pENTR221	25139		C1GALT1C1	29071	NP_001011551.1	Hs.643920	C1GALT1-specific chaperone 1						NM_152692.3	NP_689905.1	VALIDATED	C	1.000	1.000	318	957	1	954	318	1	318
Invitrogen	BC008715	IOH5750	Invitrogen(on gateway)	W01B006H04	pENTR221	16834		MAP4	4134	AAH08715.1	Hs.517949	Microtubule-associated protein 4						NM_002375.4	NP_002366.2	REVIEWED	Cfs	0.514	0.605	1152	2940	1	2936	1152	1	1152
Invitrogen	NM_145204	IOH22722	Invitrogen(on gateway)	W01B006H05	pENTR221	7797		SENP8	123228	NP_660205.2	Hs.513002	SUMO/sentrin specific peptidase family member 8						NM_145204.2	NP_660205.2	PROVISIONAL	OK	1.000	1.000	212	639	1	636	212	1	212
Invitrogen	BC018760	IOH40654	Invitrogen(on gateway)	W01B006H06	pENTR221	637		SNAP47	116841	AAH18760.2	Hs.325081	Synaptosomal-associated protein, 47kDa						NM_053052.3	NP_444280.2	VALIDATED	Cs	0.998	0.998	464	1395	1	1392	464	1	464
Invitrogen	NM_152274	IOH23085	Invitrogen(on gateway)	W01B006H07	pENTR221	25384		FAM58A	92002	NP_689487.2	Hs.659433	Family with sequence similarity 58, member A						NM_152274.3	NP_689487.2	REVIEWED	P	1.000	1.000	214	645	1	642	248	35	248
Invitrogen	NM_032563	IOH40397	Invitrogen(on gateway)	W01B006H08	pENTR221	1432		LCE3D	84648	NP_115952.1	Hs.244349	Late cornified envelope 3D						NM_032563.1	NP_115952.1	VALIDATED	C	1.000	1.000	92	279	1	276	92	1	92
Invitrogen	NM_001013622	IOH40099	Invitrogen(on gateway)	W01B006H10	pENTR221	18222		FAM53A	152877	NP_001013644.1	Hs.143314	Family with sequence similarity 53, member A						NM_001013622.2	NP_001013644.1	VALIDATED	C	1.000	1.000	398	1197	1	1194	398	1	398
Invitrogen	BC069491	IOH40249	Invitrogen(on gateway)	W01B006H12	pENTR221	24143		CER1	9350	AAH69491.1	Hs.248204	Cerberus 1, cysteine knot superfamily, homolog (Xenopus laevis)						NM_005454.2	NP_005445.1	REVIEWED	Cs	0.996	0.996	267	804	1	801	267	1	267
Invitrogen	BC063463	IOH39865	Invitrogen(on gateway)	W01B006H14	pENTR221	20522		COQ3	51805	AAH63463.1	Hs.713623	Coenzyme Q3 homolog, methyltransferase (S. cerevisiae)						NM_017421.3	NP_059117.3	VALIDATED	Cs	0.995	0.995	369	1110	1	1107	369	1	369
Invitrogen	NM_182498	IOH40051	Invitrogen(on gateway)	W01B006H16	pENTR221	12631		ZNF428	126299	NP_872304.2	Hs.719387	Zinc finger protein 428						NM_182498.3	NP_872304.2	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
Invitrogen	NM_001926	IOH40361	Invitrogen(on gateway)	W01B006H18	pENTR221	23272		DEFA6	1671	NP_001917.1	Hs.711	Defensin, alpha 6, Paneth cell-specific						NM_001926.2	NP_001917.1	REVIEWED	C	1.000	1.000	100	303	1	300	100	1	100
Invitrogen	NM_014904	IOH35890	Invitrogen(on gateway)	W01B006H20	pENTR221	3100		RAB11FIP2	22841	NP_055719.1	Hs.173656	RAB11 family interacting protein 2 (class I)						NM_014904.2	NP_055719.1	VALIDATED	C	1.000	1.000	512	1539	1	1536	512	1	512
Invitrogen	NM_000084	IOH36121	Invitrogen(on gateway)	W01B006H22	pENTR221	24708		CLCN5	1184	NP_000075.1	Hs.166486	Chloride channel 5						NM_000084.2	NP_000075.1	REVIEWED	OK	1.000	1.000	746	2241	1	2238	746	1	746
Invitrogen	NM_002407	IOH40725	Invitrogen(on gateway)	W01B006H24	pENTR221	3770		SCGB2A1	4246	NP_002398.1	Hs.97644	Secretoglobin, family 2A, member 1						NM_002407.2	NP_002398.1	VALIDATED	C	1.000	1.000	95	288	1	285	95	1	95
Invitrogen	NM_144646	IOH12964	Invitrogen(on gateway)	W01B006I01	pENTR221	18293		IGJ	3512	NP_653247.1	Hs.643431	Immunoglobulin J polypeptide, linker protein for immunoglobulin alpha and mu polypeptides						NM_144646.3	NP_653247.1	VALIDATED	C	1.000	1.000	159	480	1	477	159	1	159
Invitrogen	NM_004236	IOH13834	Invitrogen(on gateway)	W01B006I02	pENTR221	8146		COPS2	9318	NP_004227.1	Hs.369614	COP9 constitutive photomorphogenic homolog subunit 2 (Arabidopsis)						NM_004236.3	NP_004227.1	VALIDATED	C	1.000	1.000	443	1332	1	1329	443	1	443
Invitrogen	NM_007328	IOH12852	Invitrogen(on gateway)	W01B006I03	pENTR221	6008		KLRC1	3821	NP_015567.1	Hs.512576	Killer cell lectin-like receptor subfamily C, member 1						NM_007328.2	NP_015567.1	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
Invitrogen	NM_004566	IOH27198	Invitrogen(on gateway)	W01B006I04	pENTR221	2654		PFKFB3	5209	NP_004557.1	Hs.719094	6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3						NM_004566.3	NP_004557.1	VALIDATED	C	1.000	1.000	520	1563	1	1560	520	1	520
Invitrogen	NM_024165	IOH6522	Invitrogen(on gateway)	W01B006I05	pENTR221	19764		PHF1	5252	NP_077084.1	Hs.166204	PHD finger protein 1						NM_024165.2	NP_077084.1	REVIEWED	C	1.000	1.000	567	1704	1	1701	567	1	567
Invitrogen	NM_022141	IOH22820	Invitrogen(on gateway)	W01B006I06	pENTR221	15580		PARVG	64098	NP_071424.1	Hs.658995	Parvin, gamma						NM_022141.5	NP_071424.1	VALIDATED	C	1.000	1.000	331	996	1	993	331	1	331
Invitrogen	NM_021798	IOH5566	Invitrogen(on gateway)	W01B006I07	pENTR221	8708		IL21R	50615	NP_068570.1	Hs.210546	Interleukin 21 receptor						NM_181078.1	NP_851564.1	REVIEWED	C	1.000	1.000	538	1617	1	1614	538	1	538
Invitrogen	NM_006869	IOH21856	Invitrogen(on gateway)	W01B006I08	pENTR221	21840		ADAP1	11033	NP_006860.1	Hs.644629	ArfGAP with dual PH domains 1						NM_006869.2	NP_006860.1	VALIDATED	OK	1.000	1.000	374	1125	1	1122	374	1	374
Invitrogen	BC032422	IOH21726	Invitrogen(on gateway)	W01B006I09	pENTR221	11497		KIR2DL3	3804	AAH32422.1								NM_015868.2	NP_056952.2	REVIEWED	Cs	0.994	0.994	341	1026	1	1023	341	1	341
Invitrogen	NM_080817	IOH28375	Invitrogen(on gateway)	W01B006I10	pENTR221	24684		GPR82	27197	NP_543007.1	Hs.664795	G protein-coupled receptor 82						NM_080817.3	NP_543007.1	PROVISIONAL	C	1.000	1.000	336	1011	1	1008	336	1	336
Invitrogen	BC004196	IOH5177	Invitrogen(on gateway)	W01B006I11	pENTR221	4676		RAPSN	5913	AAH04196.1	Hs.81218	Receptor-associated protein of the synapse						NM_032645.3	NP_116034.2	REVIEWED	Cs	0.997	0.997	353	1062	1	1059	353	1	353
Invitrogen	BC039152	IOH25805	Invitrogen(on gateway)	W01B006I12	pENTR221	16302		HES1	3280	AAH39152.1	Hs.250666	Hairy and enhancer of split 1, (Drosophila)						NM_005524.2	NP_005515.1	REVIEWED	Cg	0.989	1.000	280	834	1	831	280	1	280
Invitrogen	NM_003264	IOH21878	Invitrogen(on gateway)	W01B006I13	pENTR221	17484		TLR2	7097	NP_003255.2	Hs.519033	Toll-like receptor 2						NM_003264.3	NP_003255.2	REVIEWED	C	1.000	1.000	784	2355	1	2352	784	1	784
Invitrogen	NM_052913	IOH26380	Invitrogen(on gateway)	W01B006I14	pENTR221	19695		TMEM200A	114801	NP_443145.1	Hs.591341	Transmembrane protein 200A						NM_052913.2	NP_443145.1	PROVISIONAL	C	1.000	1.000	491	1476	1	1473	491	1	491
Invitrogen	BC007742	IOH6517	Invitrogen(on gateway)	W01B006I15	pENTR221	12345		EXOSC5	56915	AAH07742.1	Hs.283741	Exosome component 5						NM_020158.3	NP_064543.3	VALIDATED	Cs	0.996	0.996	235	708	1	705	235	1	235
Invitrogen	NM_002104	IOH26030	Invitrogen(on gateway)	W01B006I16	pENTR221	18902		GZMK	3003	NP_002095.1	Hs.277937	Granzyme K (granzyme 3; tryptase II)						NM_002104.2	NP_002095.1	REVIEWED	C	1.000	1.000	264	795	1	792	264	1	264
Invitrogen	NM_000409	IOH27378	Invitrogen(on gateway)	W01B006I17	pENTR221	20018		GUCA1A	2978	NP_000400.2	Hs.92858	Guanylate cyclase activator 1A (retina)						NM_000409.3	NP_000400.2	REVIEWED	C	1.000	1.000	201	606	1	603	201	1	201
Invitrogen	BC043498	IOH26404	Invitrogen(on gateway)	W01B006I18	pENTR221	22786		MTFR1	9650	AAH43498.1	Hs.584788	Mitochondrial fission regulator 1						NM_014637.3	NP_055452.3	REVIEWED	C	1.000	1.000	333	1002	1	999	333	1	333
Invitrogen	NM_004286	IOH14552	Invitrogen(on gateway)	W01B006I19	pENTR221	15552		GTPBP1	9567	NP_004277.2	Hs.276925	GTP binding protein 1						NM_004286.4	NP_004277.2	REVIEWED	P	1.000	1.000	584	1755	1	1752	669	86	669
Invitrogen	BC039742	IOH26173	Invitrogen(on gateway)	W01B006I20	pENTR221	13415		PCBP1	5093	AAH39742.1	Hs.2853	Poly(rC) binding protein 1						NM_006196.3	NP_006187.2	REVIEWED	OK	1.000	1.000	356	1071	1	1068	356	1	356
Invitrogen	NM_012351	IOH28402	Invitrogen(on gateway)	W01B006I21	pENTR221	1001		OR10J1	26476	NP_036483.1	Hs.532661	Olfactory receptor, family 10, subfamily J, member 1						NM_012351.1	NP_036483.1	PROVISIONAL	Cs	0.994	0.994	320	963	1	960	320	1	320
Invitrogen	NM_007022	IOH26702	Invitrogen(on gateway)	W01B006I22	pENTR221	16218		CYB561D2	11068	NP_008953.1	Hs.149443	Cytochrome b-561 domain containing 2						NM_007022.3	NP_008953.1	PROVISIONAL	C	1.000	1.000	222	669	1	666	222	1	222
Invitrogen	NM_001615	IOH13748	Invitrogen(on gateway)	W01B006I23	pENTR221	13392		ACTG2	72	NP_001606.1	Hs.516105	Actin, gamma 2, smooth muscle, enteric						NM_001615.3	NP_001606.1	REVIEWED	C	1.000	1.000	376	1131	1	1128	376	1	376
Invitrogen	NM_005169	IOH28056	Invitrogen(on gateway)	W01B006I24	pENTR221	4923		PHOX2A	401	NP_005160.2	Hs.707879	Paired-like homeobox 2a						NM_005169.3	NP_005160.2	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
Invitrogen	NM_019107	IOH13900	Invitrogen(on gateway)	W01B006J02	pENTR221	12347		C19orf10	56005	NP_061980.1	Hs.465645	Chromosome 19 open reading frame 10						NM_019107.3	NP_061980.1	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
Invitrogen	BC007660	IOH5946	Invitrogen(on gateway)	W01B006J04	pENTR221	4431		DKK3	27122	AAH07660.1	Hs.292156	Dickkopf homolog 3 (Xenopus laevis)						NM_001018057.1	NP_001018067.1	REVIEWED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
Invitrogen	NM_006552	IOH40719	Invitrogen(on gateway)	W01B006J06	pENTR221	3881		SCGB1D1	10648	NP_006543.1	Hs.202686	Secretoglobin, family 1D, member 1						NM_006552.1	NP_006543.1	REVIEWED	C	1.000	1.000	90	273	1	270	90	1	90
Invitrogen	NM_033375	IOH40479	Invitrogen(on gateway)	W01B006J08	pENTR221	10307		MYO1C	4641	NP_203693.3	Hs.286226	Myosin IC						NM_033375.4	NP_203693.3	REVIEWED	Cs	0.998	0.998	1028	3087	1	3084	1028	1	1028
Invitrogen	NM_053005	IOH40119	Invitrogen(on gateway)	W01B006J10	pENTR221	4416		HCCA2	81532	NP_443731.2	Hs.370360	HCCA2 protein						NM_053005.3	NP_443731.2	PROVISIONAL	C	1.000	1.000	237	714	1	711	237	1	237
Invitrogen	NM_000496	IOH40269	Invitrogen(on gateway)	W01B006J12	pENTR221	15704		CRYBB2	1415	NP_000487.1	Hs.373074	Crystallin, beta B2						NM_000496.2	NP_000487.1	REVIEWED	OK	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	NM_032439	IOH40856	Invitrogen(on gateway)	W01B006J14	pENTR221	2602		PHYHIPL	84457	NP_115815.2	Hs.499704	Phytanoyl-CoA 2-hydroxylase interacting protein-like						NM_032439.3	NP_115815.2	VALIDATED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
Invitrogen	NM_031290	IOH40382	Invitrogen(on gateway)	W01B006J16	pENTR221	6535		CCDC70	83446	NP_112580.2	Hs.120573	Coiled-coil domain containing 70						NM_031290.2	NP_112580.2	VALIDATED	Cs	0.996	0.996	233	702	1	699	233	1	233
Invitrogen	NM_080870	IOH40303	Invitrogen(on gateway)	W01B006J18	pENTR221	19707		DPCR1	135656	NP_543146.2	Hs.631993	Diffuse panbronchiolitis critical region 1						NM_080870.3	NP_543146.2	VALIDATED	P	1.000	1.000	235	708	1	705	1393	1159	1393
Invitrogen	NM_031282	IOH35897	Invitrogen(on gateway)	W01B006J20	pENTR221	1728		FCRL4	83417	NP_112572.1	Hs.120260	Fc receptor-like 4						NM_031282.2	NP_112572.1	REVIEWED	C	1.000	1.000	515	1548	1	1545	515	1	515
Invitrogen	BC060868	IOH29213	Invitrogen(on gateway)	W01B006J22	pENTR221	21070		BMPER	168667	AAH60868.1	Hs.660998	BMP binding endothelial regulator						NM_133468.3	NP_597725.1	VALIDATED	Cs	0.999	0.999	685	2058	1	2055	685	1	685
Invitrogen	NM_004057	IOH34933	Invitrogen(on gateway)	W01B006J24	pENTR221	24906		S100G	795	NP_004048.1	Hs.639	S100 calcium binding protein G						NM_004057.2	NP_004048.1	REVIEWED	C	1.000	1.000	79	240	1	237	79	1	79
Invitrogen	BC005187	IOH7207	Invitrogen(on gateway)	W01B006K01	pENTR221	201		UFC1	51506	AAH05187.1	Hs.301412	Ubiquitin-fold modifier conjugating enzyme 1						NM_016406.3	NP_057490.2	VALIDATED	Cs	0.994	0.994	167	504	1	501	167	1	167
Invitrogen	NM_001308	IOH11355	Invitrogen(on gateway)	W01B006K02	pENTR221	3420		CPN1	1369	NP_001299.1	Hs.2246	Carboxypeptidase N, polypeptide 1						NM_001308.2	NP_001299.1	REVIEWED	C	1.000	1.000	458	1377	1	1374	458	1	458
Invitrogen	BC003536	IOH5459	Invitrogen(on gateway)	W01B006K03	pENTR221	17179		ZBED2	79413	AAH03536.1	Hs.136912	Zinc finger, BED-type containing 2						NM_024508.3	NP_078784.2	VALIDATED	P	1.000	1.000	217	654	1	651	218	2	218
Invitrogen	BC036391	IOH22062	Invitrogen(on gateway)	W01B006K04	pENTR221	2646		CUGBP2	10659	AAH36391.1	Hs.309288	CUG triplet repeat, RNA binding protein 2						NM_001083591.1	NP_001077060.1	REVIEWED	Cgs	0.970	0.998	502	1566	58	1563	488	1	488
Invitrogen	NM_020378	IOH14646	Invitrogen(on gateway)	W01B006K05	pENTR221	11404		NAT14	57106	NP_065111.1	Hs.719312	N-acetyltransferase 14 (GCN5-related, putative)						NM_020378.2	NP_065111.1	PROVISIONAL	C	1.000	1.000	206	621	1	618	206	1	206
Invitrogen	NM_012113	IOH27401	Invitrogen(on gateway)	W01B006K06	pENTR221	97		CA14	23632	NP_036245.1	Hs.528988	Carbonic anhydrase XIV						NM_012113.1	NP_036245.1	REVIEWED	C	1.000	1.000	337	1014	1	1011	337	1	337
Invitrogen	NM_006819	IOH5061	Invitrogen(on gateway)	W01B006K07	pENTR221	4082		STIP1	10963	NP_006810.1	Hs.337295	Stress-induced-phosphoprotein 1						NM_006819.2	NP_006810.1	VALIDATED	C	1.000	1.000	543	1632	1	1629	543	1	543
Invitrogen	NM_002725	IOH21892	Invitrogen(on gateway)	W01B006K08	pENTR221	754		PRELP	5549	NP_002716.1	Hs.632481	Proline/arginine-rich end leucine-rich repeat protein						NM_201348.1	NP_958505.1	REVIEWED	OK	1.000	1.000	382	1149	1	1146	382	1	382
Invitrogen	NM_020437	IOH21841	Invitrogen(on gateway)	W01B006K09	pENTR221	15642		ASPHD2	57168	NP_065170.2	Hs.567547	Aspartate beta-hydroxylase domain containing 2						NM_020437.4	NP_065170.2	VALIDATED	P	1.000	1.000	343	1032	1	1029	369	27	369
Invitrogen	NM_012367	IOH28191	Invitrogen(on gateway)	W01B006K10	pENTR221	20144		OR2B6	26212	NP_036499.1	Hs.532145	Olfactory receptor, family 2, subfamily B, member 6						NM_012367.1	NP_036499.1	PROVISIONAL	C	1.000	1.000	313	942	1	939	313	1	313
Invitrogen	NM_006682	IOH21881	Invitrogen(on gateway)	W01B006K11	pENTR221	22109		FGL2	10875	NP_006673.1	Hs.520989	Fibrinogen-like 2						NM_006682.2	NP_006673.1	REVIEWED	C	1.000	1.000	439	1320	1	1317	439	1	439
Invitrogen	NM_018990	IOH27033	Invitrogen(on gateway)	W01B006K12	pENTR221	24794		SASH3	54440	NP_061863.1	Hs.61469	SAM and SH3 domain containing 3						NM_018990.2	NP_061863.1	PROVISIONAL	C	1.000	1.000	380	1143	1	1140	380	1	380
Invitrogen	NM_013320	IOH21816	Invitrogen(on gateway)	W01B006K13	pENTR221	5314		HCFC2	29915	NP_037452.1	Hs.506558	Host cell factor C2						NM_013320.2	NP_037452.1	REVIEWED	C	1.000	1.000	792	2379	1	2376	792	1	792
Invitrogen	BC051839	IOH27076	Invitrogen(on gateway)	W01B006K14	pENTR221	15367		TMPRSS2	7113	AAH51839.1	Hs.439309	Transmembrane protease, serine 2						NM_005656.3	NP_005647.3	REVIEWED	C	1.000	1.000	492	1479	1	1476	492	1	492
Invitrogen	BC005246	IOH7322	Invitrogen(on gateway)	W01B006K15	pENTR221	6186		TSPAN8	7103	AAH05246.1	Hs.170563	Tetraspanin 8						NM_004616.2	NP_004607.1	REVIEWED	Cs	0.987	0.987	237	714	1	711	237	1	237
Invitrogen	NM_177424	IOH26548	Invitrogen(on gateway)	W01B006K16	pENTR221	320		STX12	23673	NP_803173.1	Hs.523855	Syntaxin 12						NM_177424.2	NP_803173.1	VALIDATED	C	1.000	1.000	276	831	1	828	276	1	276
Invitrogen	NM_012234	IOH26870	Invitrogen(on gateway)	W01B006K17	pENTR221	16761		RYBP	23429	NP_036366.3	Hs.7910	RING1 and YY1 binding protein						NM_012234.4	NP_036366.3	VALIDATED	Cs	0.996	0.996	228	687	1	684	228	1	228
Invitrogen	NM_004402	IOH26584	Invitrogen(on gateway)	W01B006K18	pENTR221	57		DFFB	1677	NP_004393.1	Hs.133089	DNA fragmentation factor, 40kDa, beta polypeptide (caspase-activated DNase)						NM_004402.2	NP_004393.1	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
Invitrogen	NM_001469	IOH6963	Invitrogen(on gateway)	W01B006K19	pENTR221	15617		XRCC6	2547	NP_001460.1	Hs.292493	X-ray repair complementing defective repair in Chinese hamster cells 6						NM_001469.3	NP_001460.1	REVIEWED	C	1.000	1.000	609	1830	1	1827	609	1	609
Invitrogen	NM_000953	IOH26261	Invitrogen(on gateway)	W01B006K20	pENTR221	7103		PTGDR	5729	NP_000944.1	Hs.306831	Prostaglandin D2 receptor (DP)						NM_000953.2	NP_000944.1	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
Invitrogen	NM_138327	IOH28333	Invitrogen(on gateway)	W01B006K21	pENTR221	20742		TAAR1	134864	NP_612200.1	Hs.375030	Trace amine associated receptor 1						NM_138327.1	NP_612200.1	PROVISIONAL	OK	1.000	1.000	339	1020	1	1017	339	1	339
Invitrogen	NM_148172	IOH27053	Invitrogen(on gateway)	W01B006K22	pENTR221	10229		PEMT	10400	NP_680477.1	Hs.287717	Phosphatidylethanolamine N-methyltransferase						NM_148173.1	NP_680478.1	REVIEWED	C	1.000	1.000	199	711	112	708	199	1	199
Invitrogen	NM_001895	IOH13704	Invitrogen(on gateway)	W01B006K23	pENTR221	15072		CSNK2A1	1457	NP_001886.1	Hs.644056	Casein kinase 2, alpha 1 polypeptide						NM_177560.2	NP_808228.1	REVIEWED	C	1.000	1.000	255	1176	409	1173	255	1	255
Invitrogen	NM_004779	IOH27767	Invitrogen(on gateway)	W01B006K24	pENTR221	18600		CNOT8	9337	NP_004770.4	Hs.26703	CCR4-NOT transcription complex, subunit 8						NM_004779.4	NP_004770.4	PROVISIONAL	C	1.000	1.000	292	879	1	876	292	1	292
Invitrogen	NM_006983	IOH11185	Invitrogen(on gateway)	W01B006L02	pENTR221	50		MMP23B	8510	NP_008914.1	Hs.192316	Matrix metallopeptidase 23B						NM_006983.1	NP_008914.1	REVIEWED	C	1.000	1.000	390	1173	1	1170	390	1	390
Invitrogen	BC015505	IOH9981	Invitrogen(on gateway)	W01B006L04	pENTR221	9574		DDX42	11325	AAH15505.1	Hs.702010	DEAD (Asp-Glu-Ala-Asp) box polypeptide 42						NM_203499.1	NP_987095.1	REVIEWED	P	1.000	1.000	819	2460	1	2457	938	120	938
Invitrogen	NM_147197	IOH40750	Invitrogen(on gateway)	W01B006L06	pENTR221	15064		WFDC11	259239	NP_671730.1	Hs.374924	WAP four-disulfide core domain 11						NM_147197.2	NP_671730.1	REVIEWED	C	1.000	1.000	87	264	1	261	87	1	87
Invitrogen	NM_022776	IOH40437	Invitrogen(on gateway)	W01B006L08	pENTR221	16959		OSBPL11	114885	NP_073613.2	Hs.477440	Oxysterol binding protein-like 11						NM_022776.4	NP_073613.2	REVIEWED	C	1.000	1.000	747	2244	1	2241	747	1	747
Invitrogen	BC067755	IOH40120	Invitrogen(on gateway)	W01B006L10	pENTR221	14104		KCTD18	130535	AAH67755.1	Hs.605775	Potassium channel tetramerisation domain containing 18						NM_152387.2	NP_689600.2	VALIDATED	Cs	0.995	0.995	426	1281	1	1278	426	1	426
Invitrogen	NM_003561	IOH40301	Invitrogen(on gateway)	W01B006L12	pENTR221	9412		PLA2G10	8399	NP_003552.1	Hs.567366	Phospholipase A2, group X						NM_003561.1	NP_003552.1	PROVISIONAL	C	1.000	1.000	165	498	1	495	165	1	165
Invitrogen	NM_032300	IOH5512	Invitrogen(on gateway)	W01B006L14	pENTR221	5473		TCHP	84260	NP_115676.1	Hs.410924	Trichoplein, keratin filament binding						NM_032300.4	NP_115676.1	VALIDATED	C	1.000	1.000	498	1497	1	1494	498	1	498
Invitrogen	BC007360	IOH7031	Invitrogen(on gateway)	W01B006L16	pENTR221	25394		MGC16121	84848	AAH07360	Hs.416379	Hypothetical protein MGC16121						XM_001128419.1	XP_001128419.1	MODEL	P	1.000	1.000	54	258	3	164	624	571	624
Invitrogen	BC069468	IOH40402	Invitrogen(on gateway)	W01B006L18	pENTR221	21581		OCM	654231	AAH69468.1	Hs.571315	Oncomodulin						NM_001097622.1	NP_001091091.1	VALIDATED	C	1.000	1.000	109	330	1	327	109	1	109
Invitrogen	NM_004179	IOH35768	Invitrogen(on gateway)	W01B006L20	pENTR221	4853		TPH1	7166	NP_004170.1	Hs.591999	Tryptophan hydroxylase 1						NM_004179.2	NP_004170.1	REVIEWED	C	1.000	1.000	444	1335	1	1332	444	1	444
Invitrogen	BC058020	IOH29494	Invitrogen(on gateway)	W01B006L22	pENTR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1						NM_198486.2	NP_940888.2	PROVISIONAL	Cs	0.996	0.996	246	741	1	738	246	1	246
Invitrogen	NM_001899	IOH40718	Invitrogen(on gateway)	W01B006L24	pENTR221	15106		CST4	1472	NP_001890.1	Hs.654549	Cystatin S						NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
Invitrogen	NM_014488	IOH13538	Invitrogen(on gateway)	W01B006M01	pENTR221	4680		RAB30	27314	NP_055303.2	Hs.40758	RAB30, member RAS oncogene family						NM_014488.3	NP_055303.2	PROVISIONAL	C	1.000	1.000	203	612	1	609	203	1	203
Invitrogen	BC038713	IOH27724	Invitrogen(on gateway)	W01B006M02	pENTR221	11482		CYTH2	9266	AAH38713.1	Hs.144011	Cytohesin 2						NM_017457.4	NP_059431.1	REVIEWED	Cs	0.998	0.998	400	1203	1	1200	400	1	400
Invitrogen	NM_005638	IOH9935	Invitrogen(on gateway)	W01B006M03	pENTR221	24679		VAMP7	6845	NP_005629.1	Hs.24167	Vesicle-associated membrane protein 7						NM_005638.4	NP_005629.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
Invitrogen	NM_014057	IOH27143	Invitrogen(on gateway)	W01B006M04	pENTR221	24082		OGN	4969	NP_054776.1	Hs.109439	Osteoglycin						NM_014057.3	NP_054776.1	REVIEWED	C	1.000	1.000	298	897	1	894	298	1	298
Invitrogen	BC014455	IOH12083	Invitrogen(on gateway)	W01B006M05	pENTR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2						NM_004404.3	NP_004395.1	VALIDATED	Cs	0.997	0.997	361	1086	1	1083	361	1	361
Invitrogen	BC033787	IOH21789	Invitrogen(on gateway)	W01B006M06	pENTR221	14884		TMX4	56255	AAH33787.1	Hs.169358	Thioredoxin-related transmembrane protein 4						NM_021156.2	NP_066979.2	PROVISIONAL	Cs	0.997	0.997	349	1050	1	1047	349	1	349
Invitrogen	NM_014601	IOH13420	Invitrogen(on gateway)	W01B006M07	pENTR221	11591		EHD2	30846	NP_055416.2	Hs.719225	EH-domain containing 2						NM_014601.3	NP_055416.2	REVIEWED	C	1.000	1.000	543	1632	1	1629	543	1	543
Invitrogen	BC033826	IOH21888	Invitrogen(on gateway)	W01B006M08	pENTR221	5263		P2RX4	5025	AAH33826.1	Hs.321709	Purinergic receptor P2X, ligand-gated ion channel, 4						NM_002560.2	NP_002551.2	REVIEWED	Cs	0.997	0.997	388	1167	1	1164	388	1	388
Invitrogen	NM_000191	IOH9623	Invitrogen(on gateway)	W01B006M09	pENTR221	2020		HMGCL	3155	NP_000182.2	Hs.533444	3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase						NM_000191.2	NP_000182.2	VALIDATED	C	1.000	1.000	325	978	1	975	325	1	325
Invitrogen	NM_030784	IOH28369	Invitrogen(on gateway)	W01B006M10	pENTR221	20364		GPR63	81491	NP_110411.1	Hs.632612	G protein-coupled receptor 63						NM_001143957.1	NP_001137429.1	VALIDATED	C	1.000	1.000	419	1260	1	1257	419	1	419
Invitrogen	NM_016510	IOH6707	Invitrogen(on gateway)	W01B006M11	pENTR221	13030		SCLY	51540	NP_057594.3	Hs.709612	Selenocysteine lyase						NM_016510.4	NP_057594.3	VALIDATED	Cs	0.998	0.998	445	1338	1	1335	445	1	445
Invitrogen	NM_024551	IOH27084	Invitrogen(on gateway)	W01B006M12	pENTR221	5416		ADIPOR2	79602	NP_078827.2	Hs.371642	Adiponectin receptor 2						NM_024551.2	NP_078827.2	VALIDATED	C	1.000	1.000	386	1161	1	1158	386	1	386
Invitrogen	NM_005666	IOH13657	Invitrogen(on gateway)	W01B006M13	pENTR221	934		CFHR2	3080	NP_005657.1	Hs.632450	Complement factor H-related 2						NM_005666.2	NP_005657.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
Invitrogen	NM_006990	IOH26184	Invitrogen(on gateway)	W01B006M14	pENTR221	1401		WASF2	10163	NP_008921.1	Hs.590909	WAS protein family, member 2						NM_006990.2	NP_008921.1	REVIEWED	C	1.000	1.000	498	1497	1	1494	498	1	498
Invitrogen	NM_024092	IOH3088	Invitrogen(on gateway)	W01B006M15	pENTR221	3801		TMEM109	79073	NP_076997.1	Hs.13662	Transmembrane protein 109						NM_024092.2	NP_076997.1	VALIDATED	C	1.000	1.000	243	732	1	729	243	1	243
Invitrogen	BC044612	IOH26756	Invitrogen(on gateway)	W01B006M16	pENTR221	18261		GPM6A	2823	AAH44612.1	Hs.75819	Glycoprotein M6A						NM_005277.3	NP_005268.1	VALIDATED	Cs	0.996	0.996	278	837	1	834	278	1	278
Invitrogen	NM_006866	IOH11932	Invitrogen(on gateway)	W01B006M17	pENTR221	11516		LILRA2	11027	NP_006857.1	Hs.655593	Leukocyte immunoglobulin-like receptor, subfamily A (with TM domain), member 2						NM_006866.2	NP_006857.1	VALIDATED	C	1.000	1.000	466	1401	1	1398	466	1	466
Invitrogen	BC051850	IOH27078	Invitrogen(on gateway)	W01B006M18	pENTR221	21942		TMEM120A	83862	AAH51850.1	Hs.488835	Transmembrane protein 120A						NM_031925.2	NP_114131.1	VALIDATED	Cs	0.997	0.997	343	1032	1	1029	343	1	343
Invitrogen	NM_002594	IOH6275	Invitrogen(on gateway)	W01B006M19	pENTR221	14781		PCSK2	5126	NP_002585.2	Hs.315186	Proprotein convertase subtilisin/kexin type 2						NM_002594.2	NP_002585.2	REVIEWED	OK	1.000	1.000	638	1917	1	1914	638	1	638
Invitrogen	NM_178129	IOH26392	Invitrogen(on gateway)	W01B006M20	pENTR221	25322		P2RY8	286530	NP_835230.1	Hs.111377	Purinergic receptor P2Y, G-protein coupled, 8						NM_178129.4	NP_835230.1	REVIEWED	C	1.000	1.000	359	1080	1	1077	359	1	359
Invitrogen	NM_005180	IOH13688	Invitrogen(on gateway)	W01B006M21	pENTR221	2891		BMI1	648	NP_005171.4	Hs.380403	BMI1 polycomb ring finger oncogene						NM_005180.6	NP_005171.4	VALIDATED	C	1.000	1.000	326	981	1	978	326	1	326
Invitrogen	NM_003564	IOH27832	Invitrogen(on gateway)	W01B006M22	pENTR221	1610		TAGLN2	8407	NP_003555.1	Hs.517168	Transgelin 2						NM_003564.1	NP_003555.1	REVIEWED	C	1.000	1.000	199	600	1	597	199	1	199
Invitrogen	NM_032342	IOH6569	Invitrogen(on gateway)	W01B006M23	pENTR221	24279		C9orf125	84302	NP_115718.1	Hs.655738	Chromosome 9 open reading frame 125						NM_032342.1	NP_115718.1	PREDICTED	OK	1.000	1.000	403	1212	1	1209	403	1	403
Invitrogen	NM_016245	IOH27875	Invitrogen(on gateway)	W01B006M24	pENTR221	18079		HSD17B11	51170	NP_057329.2	Hs.594923	Hydroxysteroid (17-beta) dehydrogenase 11						NM_016245.3	NP_057329.2	VALIDATED	Cs	0.997	0.997	300	903	1	900	300	1	300
Invitrogen	BC011705	IOH12425	Invitrogen(on gateway)	W01B006N02	pENTR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3						NM_001853.3	NP_001844.3	VALIDATED	C	1.000	1.000	684	2055	1	2052	684	1	684
Invitrogen	BC015801	IOH10038	Invitrogen(on gateway)	W01B006N04	pENTR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)						NM_000313.3	NP_000304.2	REVIEWED	C	1.000	1.000	676	2031	1	2028	676	1	676
Invitrogen	BC068071	IOH40780	Invitrogen(on gateway)	W01B006N06	pENTR221	11783		C19orf39	126074	AAH68071.1	Hs.631619	Chromosome 19 open reading frame 39						NM_175871.3	NP_787067.2	VALIDATED	C	1.000	1.000	229	690	1	687	229	1	229
Invitrogen	BC070071	IOH40527	Invitrogen(on gateway)	W01B006N08	pENTR221	19676		RBM16	22828	AAH70071.1	Hs.591329	RNA binding motif protein 16						NM_014892.3	NP_055707.3	VALIDATED	Cs	0.999	0.999	1271	3816	1	3813	1271	1	1271
Invitrogen	BC067773	IOH40125	Invitrogen(on gateway)	W01B006N10	pENTR221	5954		RSRC2	65117	AAH67773.1	Hs.432996	Arginine/serine-rich coiled-coil 2						NM_198262.2	NP_937993.1	VALIDATED	C	1.000	1.000	202	1305	697	1302	202	1	202
Invitrogen	NM_014062	IOH39919	Invitrogen(on gateway)	W01B006N12	pENTR221	9082		NOB1	28987	NP_054781.1	Hs.271695	NIN1/RPN12 binding protein 1 homolog (S. cerevisiae)						NM_014062.1	NP_054781.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
Invitrogen	NM_033118	IOH45160	Invitrogen(on gateway)	W01B006N14	pENTR221	14660		MYLK2	85366	NP_149109.1	Hs.86092	Myosin light chain kinase 2						NM_033118.3	NP_149109.1	REVIEWED	C	1.000	1.000	596	1791	1	1788	596	1	596
Invitrogen	NM_004975	IOH36212	Invitrogen(on gateway)	W01B006N16	pENTR221	14926		KCNB1	3745	NP_004966.1	Hs.84244	Potassium voltage-gated channel, Shab-related subfamily, member 1						NM_004975.2	NP_004966.1	REVIEWED	C	1.000	1.000	858	2577	1	2574	858	1	858
Invitrogen	NM_007102	IOH40405	Invitrogen(on gateway)	W01B006N18	pENTR221	1004		GUCA2B	2981	NP_009033.1	Hs.32966	Guanylate cyclase activator 2B (uroguanylin)						NM_007102.2	NP_009033.1	VALIDATED	C	1.000	1.000	112	339	1	336	112	1	112
Invitrogen	NM_152595	IOH35990	Invitrogen(on gateway)	W01B006N20	pENTR221	7858		PGBD4	161779	NP_689808.2	Hs.156317	PiggyBac transposable element derived 4						NM_152595.4	NP_689808.2	VALIDATED	C	1.000	1.000	585	1758	1	1755	585	1	585
Invitrogen	NM_001139	IOH28016	Invitrogen(on gateway)	W01B006N22	pENTR221	10335		ALOX12B	242	NP_001130.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type						NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
Invitrogen	NM_001322	IOH40727	Invitrogen(on gateway)	W01B006N24	pENTR221	15105		CST2	1470	NP_001313.1	Hs.669305	Cystatin SA						NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
Invitrogen	NM_001009	IOH10434	Invitrogen(on gateway)	W01B006O01	pENTR221	11870		RPS5	6193	NP_001000.2	Hs.378103	Ribosomal protein S5						NM_001009.3	NP_001000.2	REVIEWED	C	1.000	1.000	204	615	1	612	204	1	204
Invitrogen	NM_002612	IOH25726	Invitrogen(on gateway)	W01B006O02	pENTR221	21944		PDK4	5166	NP_002603.1	Hs.8364	Pyruvate dehydrogenase kinase, isozyme 4						NM_002612.3	NP_002603.1	REVIEWED	C	1.000	1.000	411	1236	1	1233	411	1	411
Invitrogen	NM_002013	IOH14109	Invitrogen(on gateway)	W01B006O03	pENTR221	7542		FKBP3	2287	NP_002004.1	Hs.509226	FK506 binding protein 3, 25kDa						NM_002013.3	NP_002004.1	REVIEWED	C	1.000	1.000	224	675	1	672	224	1	224
Invitrogen	NM_003216	IOH27235	Invitrogen(on gateway)	W01B006O04	pENTR221	15514		TEF	7008	NP_003207.1	Hs.181159	Thyrotrophic embryonic factor						NM_003216.2	NP_003207.1	REVIEWED	C	1.000	1.000	303	912	1	909	303	1	303
Invitrogen	BC028918	IOH22206	Invitrogen(on gateway)	W01B006O05	pENTR221	24027		TBC1D2	55357	AAH28918.1	Hs.371016	TBC1 domain family, member 2						NM_018421.3	NP_060891.3	VALIDATED	Pg	0.976	1.000	468	1407	1	1404	917	461	917
Invitrogen	NM_139169	IOH22254	Invitrogen(on gateway)	W01B006O06	pENTR221	2731		TRUB1	142940	NP_631908.1	Hs.21187	TruB pseudouridine (psi) synthase homolog 1 (E. coli)						NM_139169.4	NP_631908.1	VALIDATED	C	1.000	1.000	349	1050	1	1047	349	1	349
Invitrogen	BC007581	IOH6857	Invitrogen(on gateway)	W01B006O07	pENTR221	2069		ALDH4A1	8659	AAH07581.1	Hs.77448	Aldehyde dehydrogenase 4 family, member A1						NM_170726.2	NP_733844.1	REVIEWED	Cs	0.998	0.998	563	1692	1	1689	563	1	563
Invitrogen	NM_003358	IOH27248	Invitrogen(on gateway)	W01B006O08	pENTR221	23614		UGCG	7357	NP_003349.1	Hs.593014	UDP-glucose ceramide glucosyltransferase						NM_003358.1	NP_003349.1	REVIEWED	C	1.000	1.000	394	1185	1	1182	394	1	394
Invitrogen	BC034389	IOH22693	Invitrogen(on gateway)	W01B006O09	pENTR221	12179		LRG1	116844	AAH34389.1	Hs.655559	Leucine-rich alpha-2-glycoprotein 1						NM_052972.2	NP_443204.1	VALIDATED	Cs	0.997	0.997	347	1044	1	1041	347	1	347
Invitrogen	BC022231	IOH10619	Invitrogen(on gateway)	W01B006O10	pENTR221	12213		ERF	2077	AAH22231.1	Hs.655969	Ets2 repressor factor						NM_006494.2	NP_006485.2	VALIDATED	C	1.000	1.000	548	1647	1	1644	548	1	548
Invitrogen	BC025681	IOH10631	Invitrogen(on gateway)	W01B006O11	pENTR221	9394		IGFALS	3483	AAH25681.1	Hs.839	Insulin-like growth factor binding protein, acid labile subunit						NM_004970.2	NP_004961.1	REVIEWED	Cs	0.998	0.998	605	1818	1	1815	605	1	605
Invitrogen	NM_016269	IOH27038	Invitrogen(on gateway)	W01B006O12	pENTR221	18070		LEF1	51176	NP_057353.1	Hs.719332	Lymphoid enhancer-binding factor 1						NM_016269.3	NP_057353.1	VALIDATED	C	1.000	1.000	399	1200	1	1197	399	1	399
Invitrogen	NM_005268	IOH5587	Invitrogen(on gateway)	W01B006O13	pENTR221	301		GJB5	2709	NP_005259.1	Hs.198249	Gap junction protein, beta 5, 31.1kDa						NM_005268.2	NP_005259.1	PROVISIONAL	C	1.000	1.000	273	822	1	819	273	1	273
Invitrogen	NM_005518	IOH26365	Invitrogen(on gateway)	W01B006O14	pENTR221	2217		HMGCS2	3158	NP_005509.1	Hs.59889	3-hydroxy-3-methylglutaryl-Coenzyme A synthase 2 (mitochondrial)						NM_005518.2	NP_005509.1	VALIDATED	C	1.000	1.000	508	1527	1	1524	508	1	508
Invitrogen	NM_015343	IOH12711	Invitrogen(on gateway)	W01B006O15	pENTR221	10473		DULLARD	23399	NP_056158.2	Hs.513913	Dullard homolog (Xenopus laevis)						NM_015343.4	NP_056158.2	VALIDATED	C	1.000	1.000	244	735	1	732	244	1	244
Invitrogen	NM_198563	IOH26582	Invitrogen(on gateway)	W01B006O16	pENTR221	16990		TMEM110	375346	NP_940965.1	Hs.705605	Transmembrane protein 110						NM_198563.1	NP_940965.1	PROVISIONAL	C	1.000	1.000	294	885	1	882	294	1	294
Invitrogen	NM_003365	IOH13889	Invitrogen(on gateway)	W01B006O17	pENTR221	17136		UQCRC1	7384	NP_003356.2	Hs.119251	Ubiquinol-cytochrome c reductase core protein I						NM_003365.2	NP_003356.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
Invitrogen	NM_017938	IOH26541	Invitrogen(on gateway)	W01B006O18	pENTR221	25244		FAM70A	55026	NP_060408.3	Hs.437563	Family with sequence similarity 70, member A						NM_017938.3	NP_060408.3	VALIDATED	Cs	0.997	0.997	349	1050	1	1047	349	1	349
Invitrogen	NM_002887	IOH3659	Invitrogen(on gateway)	W01B006O19	pENTR221	18829		RARS	5917	NP_002878.2	Hs.654907	Arginyl-tRNA synthetase						NM_002887.3	NP_002878.2	REVIEWED	C	1.000	1.000	660	1983	1	1980	660	1	660
Invitrogen	NM_173794	IOH26498	Invitrogen(on gateway)	W01B006O20	pENTR221	25418		FUNDC1	139341	NP_776155.1	Hs.7549	FUN14 domain containing 1						NM_173794.3	NP_776155.1	VALIDATED	C	1.000	1.000	155	468	1	465	155	1	155
Invitrogen	NM_138432	IOH12304	Invitrogen(on gateway)	W01B006O21	pENTR221	5320		SDSL	113675	NP_612441.1	Hs.337594	Serine dehydratase-like						NM_138432.2	NP_612441.1	PROVISIONAL	C	1.000	1.000	329	990	1	987	329	1	329
Invitrogen	BC031002	IOH27958	Invitrogen(on gateway)	W01B006O22	pENTR221	7405		ATP6V1D	51382	AAH31002.1	Hs.272630	ATPase, H+ transporting, lysosomal 34kDa, V1 subunit D						NM_015994.2	NP_057078.1	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
Invitrogen	NM_005651	IOH7291	Invitrogen(on gateway)	W01B006O23	pENTR221	17708		TDO2	6999	NP_005642.1	Hs.183671	Tryptophan 2,3-dioxygenase						NM_005651.2	NP_005642.1	VALIDATED	C	1.000	1.000	406	1221	1	1218	406	1	406
Invitrogen	BC018671	IOH27933	Invitrogen(on gateway)	W01B006O24	pENTR221	18249		ANXA5	308	AAH18671.1	Hs.480653	Annexin A5						NM_001154.3	NP_001145.1	REVIEWED	Cs	0.997	0.997	320	963	1	960	320	1	320
Invitrogen	BC050737	IOH4142	Invitrogen(on gateway)	W01B006P02	pENTR221	18793		SMA4	11039	AAH50737	Hs.654588	Glucuronidase, beta pseudogene								
Invitrogen	NM_006640	IOH12164	Invitrogen(on gateway)	W01B006P04	pENTR221	9560		SEPT9	10801	NP_006631.2	Hs.672188	Septin 9						NM_006640.4	NP_006631.2	REVIEWED	Cs	0.998	0.998	568	1707	1	1704	568	1	568
Invitrogen	NM_207365	IOH40762	Invitrogen(on gateway)	W01B006P06	pENTR221	16586		AADACL2	344752	NP_997248.2	Hs.144710	Arylacetamide deacetylase-like 2						NM_207365.3	NP_997248.2	VALIDATED	Ps	0.997	0.997	379	1140	1	1137	401	23	401
Invitrogen	NM_014435	IOH40605	Invitrogen(on gateway)	W01B006P08	pENTR221	18021		NAAA	27163	NP_055250.2	Hs.437365	N-acylethanolamine acid amidase						NM_001042402.1	NP_001035861.1	REVIEWED	P	1.000	1.000	197	600	1	591	323	1	197
Invitrogen	NM_207337	IOH40127	Invitrogen(on gateway)	W01B006P10	pENTR221	6143		AMN1	196394	NP_997220.1	Hs.591146	Antagonist of mitotic exit network 1 homolog (S. cerevisiae)						NM_207337.1	NP_997220.1	VALIDATED	C	1.000	1.000	213	642	1	639	213	1	213
Invitrogen	NM_145716	IOH39990	Invitrogen(on gateway)	W01B006P12	pENTR221	1597		SSBP3	23648	NP_663768.1	Hs.658676	Single stranded DNA binding protein 3						NM_145716.2	NP_663768.1	VALIDATED	C	1.000	1.000	388	1167	1	1164	388	1	388
Invitrogen	NM_178170	IOH45357	Invitrogen(on gateway)	W01B006P14	pENTR221	9944		NEK8	284086	NP_835464.1	Hs.448468	NIMA (never in mitosis gene a)- related kinase 8						NM_178170.2	NP_835464.1	REVIEWED	C	1.000	1.000	692	2079	1	2076	692	1	692
Invitrogen	NM_181783	IOH36245	Invitrogen(on gateway)	W01B006P16	pENTR221	5391		TMTC3	160418	NP_861448.2	Hs.331268	Transmembrane and tetratricopeptide repeat containing 3						NM_181783.3	NP_861448.2	VALIDATED	C	1.000	1.000	914	2745	1	2742	914	1	914
Invitrogen	NM_031273	IOH35487	Invitrogen(on gateway)	W01B006P18	pENTR221	25223		TEX13B	56156	NP_112563.1	Hs.333130	Testis expressed 13B						NM_031273.2	NP_112563.1	REVIEWED	C	1.000	1.000	312	939	1	936	312	1	312
Invitrogen	NM_024743	IOH35920	Invitrogen(on gateway)	W01B006P20	pENTR221	18158		UGT2A3	79799	NP_079019.3	Hs.122583	UDP glucuronosyltransferase 2 family, polypeptide A3						NM_024743.3	NP_079019.3	VALIDATED	Cs	0.998	0.998	527	1584	1	1581	527	1	527
Invitrogen	NM_018661	IOH34916	Invitrogen(on gateway)	W01B006P22	pENTR221	22486		DEFB103A	55894	NP_061131.1	Hs.283082	Defensin, beta 103A						NM_018661.3	NP_061131.1	REVIEWED	C	1.000	1.000	67	204	1	201	67	1	67
Invitrogen	NM_130776	IOH40741	Invitrogen(on gateway)	W01B006P24	pENTR221	25230		XAGE3	170626	NP_570132.1	Hs.43879	X antigen family, member 3						NM_133179.2	NP_573440.1	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
Invitrogen	NM_013349	IOH6506	Invitrogen(on gateway)	W01B007A01	pENTR221	199		NENF	29937	NP_037481.1	Hs.461787	Neuron derived neurotrophic factor						NM_013349.4	NP_037481.1	REVIEWED	C	1.000	1.000	172	519	1	516	172	1	172
RIKEN	NM_005655	IOH41449	Invitrogen(on gateway)	W01B007A02	pENTR221	23233		KLF10	7071	NP_005646.1	Hs.435001	Kruppel-like factor 10						NM_005655.2	NP_005646.1	VALIDATED	C	1.000	1.000	480	1443	1	1440	480	1	480
Invitrogen	NM_016429	IOH13446	Invitrogen(on gateway)	W01B007A03	pENTR221	10241		COPZ2	51226	NP_057513.1	Hs.408434	Coatomer protein complex, subunit zeta 2						NM_016429.2	NP_057513.1	REVIEWED	C	1.000	1.000	210	633	1	630	210	1	210
RIKEN	NM_012482	IOH29217	Invitrogen(on gateway)	W01B007A04	pENTR221	1630		ZNF281	23528	NP_036614.1	Hs.59757	Zinc finger protein 281						NM_012482.3	NP_036614.1	PROVISIONAL	C	1.000	1.000	895	2688	1	2685	895	1	895
Invitrogen	NM_182971	IOH34924	Invitrogen(on gateway)	W01B007A05	pENTR221	7175		COX8C	341947	NP_892016.1	Hs.666459	Cytochrome c oxidase subunit 8C						NM_182971.2	NP_892016.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
RIKEN	NM_006442	IOH14520	Invitrogen(on gateway)	W01B007A06	pENTR221	4099		DRAP1	10589	NP_006433.2	Hs.356742	DR1-associated protein 1 (negative cofactor 2 alpha)						NM_006442.2	NP_006433.2	REVIEWED	OK	1.000	1.000	205	618	1	615	205	1	205
Invitrogen	BC069184	IOH39991	Invitrogen(on gateway)	W01B007A07	pENTR221	12159		HNRNPL	3191	AAH69184.2	Hs.644906	Heterogeneous nuclear ribonucleoprotein L						NM_001005335.1	NP_001005335.1	REVIEWED	C	1.000	1.000	456	1677	307	1674	456	1	456
Invitrogen	BC017870	IOH13890	Invitrogen(on gateway)	W01B007A09	pENTR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.286	0.296	28	723	288	208	311	68	95
Invitrogen	BC002945	IOH5734	Invitrogen(on gateway)	W01B007A11	pENTR221	23486		C9orf86	55684	AAH02945.2	Hs.370555	Chromosome 9 open reading frame 86						NM_017995.1	NP_060465.1	VALIDATED	P	1.000	1.000	405	1218	1	1215	520	116	520
Invitrogen	BC005209	IOH7197	Invitrogen(on gateway)	W01B007A13	pENTR221	21834		PUS7	54517	AAH05209.3	Hs.520619	Pseudouridylate synthase 7 homolog (S. cerevisiae)						NM_019042.3	NP_061915.2	VALIDATED	P	1.000	1.000	205	618	1	615	661	457	661
Invitrogen	BC002829	IOH5445	Invitrogen(on gateway)	W01B007A15	pENTR221	1596		S100A2	6273	AAH02829.3	Hs.516484	S100 calcium binding protein A2						NM_005978.3	NP_005969.1	REVIEWED	C	1.000	1.000	97	297	4	294	97	1	97
Invitrogen	BC005924	IOH7562	Invitrogen(on gateway)	W01B007A17	pENTR221	12673		PSG3	5671	AAH05924.2	Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED	Cs	0.998	0.998	428	1353	67	1350	428	1	428
Invitrogen	BC008883	IOH14763	Invitrogen(on gateway)	W01B007A19	pENTR221	10531		C17orf70	80233	-	Hs.313905	Chromosome 17 open reading frame 70						NM_025161.4	NP_079437.4	VALIDATED	Ps	0.991	0.991	233	702	1	699	730	498	730
Invitrogen	ENST00000311699	IOH28163	Invitrogen(on gateway)	W01B007A21	pENTR221															
Invitrogen	NM_004127	IOH2368	Invitrogen(on gateway)	W01B007A23	pENTR221	9636		GPS1	2873	NP_004118.3	Hs.268530	G protein pathway suppressor 1						NM_004127.4	NP_004118.3	REVIEWED	Cg	0.992	1.000	491	1503	40	1500	491	1	491
Invitrogen	BC018068	IOH10809	Invitrogen(on gateway)	W01B007C01	pENTR221	3409		UCMA	221044	AAH18068.2	Hs.112998	Upper zone of growth plate and cartilage matrix associated						NM_145314.1	NP_660357.2	PROVISIONAL	P	1.000	1.000	85	465	3	257	138	54	138
Invitrogen	BC036527	IOH22504	Invitrogen(on gateway)	W01B007C03	pENTR221	2921		CTAGEP	119437	AAH36527	Hs.620802	CTAGE family pseudogene								
Invitrogen	BC017025	IOH9960	Invitrogen(on gateway)	W01B007C05	pENTR221	5578		PTMS	5763	AAH17025.2	Hs.504613	Parathymosin						NM_002824.4	NP_002815.3	VALIDATED	P	1.000	1.000	15	354	3	47	102	88	102
Invitrogen	BC003397	IOH3007	Invitrogen(on gateway)	W01B007C07	pENTR221	423		C1orf27	54953	AAH03397.2	Hs.371210	Chromosome 1 open reading frame 27						NM_017847.4	NP_060317.3	PREDICTED	P	1.000	1.000	373	1122	1	1119	454	82	454
Invitrogen	BC011636	IOH14389	Invitrogen(on gateway)	W01B007C09	pENTR221	10252		SSH2	85464	AAH11636.2	Hs.654754	Slingshot homolog 2 (Drosophila)						NM_033389.2	NP_203747.2	REVIEWED		0.948	0.948	154	609	130	591	1423	37	190
Invitrogen	BC035936	IOH26809	Invitrogen(on gateway)	W01B007C11	pENTR221	3921		LRRC56	115399	-	Hs.567655	Leucine rich repeat containing 56						NM_198075.3	NP_932341.1	VALIDATED	Pfs	0.998	0.998	409	1227	1	1226	542	1	409
Invitrogen	XM_166707	IOH28521	Invitrogen(on gateway)	W01B007C13	pENTR221			OR13A1	79290		Hs.532435	Olfactory receptor, family 13, subfamily A, member 1						NM_001004297.2	NP_001004297.2	VALIDATED	P	1.000	1.000	309	930	1	927	328	20	328
Invitrogen	BC011832	IOH14124	Invitrogen(on gateway)	W01B007C15	pENTR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3						NM_017952.5	NP_060422.4	VALIDATED	P	1.000	1.000	367	1104	1	1101	689	323	689
Invitrogen	ENST00000319963	IOH28219	Invitrogen(on gateway)	W01B007C17	pENTR221															
Invitrogen	BC024194	IOH11170	Invitrogen(on gateway)	W01B007C19	pENTR221	20495		HMGCLL1	54511	AAH24194.2	Hs.147054	3-hydroxymethyl-3-methylglutaryl-Coenzyme A lyase-like 1						NM_001042406.1	NP_001035865.1	VALIDATED	P	1.000	1.000	234	705	1	702	340	107	340
Invitrogen	XM_291436	IOH28529	Invitrogen(on gateway)	W01B007C21	pENTR221															
Invitrogen	BC002766	IOH5366	Invitrogen(on gateway)	W01B007C23	pENTR221	6948		TTLL5	23093	AAH02766.2	Hs.709609	Tubulin tyrosine ligase-like family, member 5						NM_015072.3	NP_055887.3	VALIDATED	Ps	0.991	0.991	217	720	1	651	1281	31	247
Invitrogen	BC025289	IOH14617	Invitrogen(on gateway)	W01B007E01	pENTR221															
Invitrogen	BC007811	IOH6749	Invitrogen(on gateway)	W01B007E03	pENTR221	33627		LOC80154	80154	AAH07811	Hs.546614	Hypothetical LOC80154																		
Invitrogen	BC028224	IOH11732	Invitrogen(on gateway)	W01B007E05	pENTR221	9377		CYBA	1535	-	Hs.513803	Cytochrome b-245, alpha polypeptide						NM_000101.2	NP_000092.2	REVIEWED		0.767	0.767	30	765	1	90	195	1	30
RIKEN	NM_002163	IOH42114	Invitrogen(on gateway)	W01B007E07	pENTR221	8969		IRF8	3394	NP_002154.1	Hs.137427	Interferon regulatory factor 8						NM_002163.2	NP_002154.1	REVIEWED	C	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	BC036724	IOH62162	Invitrogen(on gateway)	W01B007E09	pENTR221	11972		FOSB	2354	AAH36724.1	Hs.590958	FBJ murine osteosarcoma viral oncogene homolog B						NM_006732.2	NP_006723.2	REVIEWED	C	1.000	1.000	338	1017	1	1014	338	1	338
RIKEN	NM_005762	IOH5106	Invitrogen(on gateway)	W01B007E11	pENTR221	11858		TRIM28	10155	NP_005753.1	Hs.467408	Tripartite motif-containing 28						NM_005762.2	NP_005753.1	REVIEWED	C	1.000	1.000	835	2508	1	2505	835	1	835
RIKEN	NM_001806	IOH6858	Invitrogen(on gateway)	W01B007E13	pENTR221	11933		CEBPG	1054	NP_001797.1	Hs.429666	CCAAT/enhancer binding protein (C/EBP), gamma						NM_001806.2	NP_001797.1	REVIEWED	OK	1.000	1.000	150	453	1	450	150	1	150
RIKEN	NM_002163	IOH42114	Invitrogen(on gateway)	W01B007E15	pENTR221	8969		IRF8	3394	NP_002154.1	Hs.137427	Interferon regulatory factor 8						NM_002163.2	NP_002154.1	REVIEWED	C	1.000	1.000	426	1281	1	1278	426	1	426
RIKEN	NM_005180	IOH13688	Invitrogen(on gateway)	W01B007E17	pENTR221	2891		BMI1	648	NP_005171.4	Hs.380403	BMI1 polycomb ring finger oncogene						NM_005180.6	NP_005171.4	VALIDATED	C	1.000	1.000	326	981	1	978	326	1	326
RIKEN	NM_006352	IOH52188	Invitrogen(on gateway)	W01B007E19	pENTR221	514		ZNF238	10472	NP_006343.2	Hs.69997	Zinc finger protein 238						NM_006352.3	NP_006343.2	VALIDATED	C	1.000	1.000	522	1569	1	1566	522	1	522
RIKEN	NM_001706	IOH36781	Invitrogen(on gateway)	W01B007E21	pENTR221	17238		BCL6	604	NP_001697.2	Hs.478588	B-cell CLL/lymphoma 6						NM_001706.3	NP_001697.2	REVIEWED	C	1.000	1.000	706	2121	1	2118	706	1	706
RIKEN	NM_004219	IOH35264	Invitrogen(on gateway)	W01B007E23	pENTR221	18603		PTTG1	9232	NP_004210.1	Hs.350966	Pituitary tumor-transforming 1						NM_004219.2	NP_004210.1	REVIEWED	C	1.000	1.000	202	609	1	606	202	1	202
RIKEN	BC039244	IOH27185	Invitrogen(on gateway)	W01B007G01	pENTR221	19891		NFYA	4800	AAH39244.1	Hs.10441	Nuclear transcription factor Y, alpha						NM_021705.3	NP_068351.1	REVIEWED	Cs	0.997	0.997	318	957	1	954	318	1	318
RIKEN	NM_002505	IOH41194	Invitrogen(on gateway)	W01B007G03	pENTR221	19891		NFYA	4800	NP_002496.1	Hs.10441	Nuclear transcription factor Y, alpha						NM_002505.4	NP_002496.1	REVIEWED	C	1.000	1.000	347	1044	1	1041	347	1	347
RIKEN	NM_001012505	IOH6528	Invitrogen(on gateway)	W01B007G05	pENTR221	16796		FOXP1	27086	NP_001012523.1	Hs.431498	Forkhead box P1						NM_001012505.1	NP_001012523.1	REVIEWED	C	1.000	1.000	114	345	1	342	114	1	114
RIKEN	NM_005238	IOH46473	Invitrogen(on gateway)	W01B007G07	pENTR221	4715		ETS1	2113	NP_005229.1	Hs.369438	V-ets erythroblastosis virus E26 oncogene homolog 1 (avian)						NM_005238.3	NP_005229.1	VALIDATED	C	1.000	1.000	441	1326	1	1323	441	1	441
RIKEN	NM_004235	IOH22853	Invitrogen(on gateway)	W01B007G09	pENTR221	24048		KLF4	9314	NP_004226.3	Hs.376206	Kruppel-like factor 4 (gut)						NM_004235.4	NP_004226.3	VALIDATED	P	1.000	1.000	470	1413	1	1410	479	10	479
RIKEN	NM_152676	IOH21595	Invitrogen(on gateway)	W01B007G11	pENTR221	11250		FBXO15	201456	NP_689889.1	Hs.664011	F-box protein 15						NM_152676.2	NP_689889.1	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
Invitrogen	NM_004893	IOH41284	Invitrogen(on gateway) 	W01B007G13	pENTR221	18914		H2AFY	9555	NP_004884.1	Hs.599225	H2A histone family, member Y					DH10B	NM_004893.2	NP_004884.1	REVIEWED	OK	1.000	1.000	371	1923	174	1286	371	1	371
Invitrogen	BC074761	IOH34754	Invitrogen(on gateway) 	W01B007G15	pENTR221	21778		PAX4	5078	AAH74761.1	Hs.129706	Paired box 4					DH10B	NM_006193.2	NP_006184.2	REVIEWED	Cs	0.997	0.997	343	1092	34	1062	343	1	343
Invitrogen	NM_003822	IOH46533	Invitrogen(on gateway) 	W01B007G17	pENTR221	81		NR5A2	2494	NP_003813.1	Hs.33446	Nuclear receptor subfamily 5, group A, member 2					DH10B	NM_003822.3	NP_003813.1	VALIDATED	OK	1	1	495	4916	207	1691	495	1	495
Invitrogen	NM_004535	IOH53635	Invitrogen(on gateway) 	W01B007G19	pENTR221	14550		MYT1	4661	NP_004526.1	Hs.279562	Myelin transcription factor 1					DH10B	NM_004535.2	NP_004526.1	REVIEWED	OK	1	1	1121	5550	365	3727	1121	1	1121
Invitrogen	NM_005526	IOH13558	Invitrogen(on gateway) 	W01B007G21	pENTR221	22592		HSF1	3297	NP_005517.1	Hs.530227	Heat shock transcription factor 1					DH10B	NM_005526.2	NP_005517.1	REVIEWED	OK	1	1	529	2166	171	1757	529	1	529
Invitrogen	NM_024014	IOH34820	Invitrogen(on gateway) 	W01B007G23	pENTR221	22190		HOXA6	3203	NP_076919.1	Hs.679517	Homeobox A6					DH10B	NM_024014.2	NP_076919.1	REVIEWED	OK	1	1	233	863	1	699	233	1	233
Invitrogen	NM_006913	IOH3743	Invitrogen(on gateway) 	W01B007I01	pENTR221	19700		RNF5	6048	NP_008844.1	Hs.718462	Ring finger protein 5					DH10B	NM_006913.3	NP_008844.1	REVIEWED	OK	1	1	180	1176	128	667	180	1	180
Invitrogen	NM_001003802	IOH5277	Invitrogen(on gateway) 	W01B007I03	pENTR221	22097		SMARCD3	6604	NP_001003802.1	Hs.647067	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily d, member 3					DH10B	NM_001003802.1	NP_001003802.1	REVIEWED	OK	1	1	470	1689	130	1539	470	1	470
Invitrogen	NM_015094	IOH62687	Invitrogen(on gateway) 	W01B007I05	pENTR221	15499		HIC2	23119	NP_055909.2	Hs.632767	Hypermethylated in cancer 2					DH10B	NM_015094.2	NP_055909.2	VALIDATED	OK	1	1	615	6812	231	2075	615	1	615
Invitrogen	NM_002357	IOH40302	Invitrogen(on gateway) 	W01B007I07	pENTR221	13519		MXD1	4084	NP_002348.1	Hs.468908	MAX dimerization protein 1					DH10B	NM_002357.2	NP_002348.1	REVIEWED	OK	1	1	221	5587	261	923	221	1	221
Invitrogen	NM_014795	IOH53645	Invitrogen(on gateway) 	W01B007I09	pENTR221	13747		ZEB2	9839	NP_055610.1	Hs.34871	Zinc finger E-box binding homeobox 2					DH10B	NM_014795.2	NP_055610.1	VALIDATED	OK	1	1	1214	5583	481	4122	1214	1	1214
Invitrogen	BC036207	IOH27485	Invitrogen(on gateway) 	W01B007I11	pENTR221	3362		MKX	283078	AAH36207.1	Hs.128193	Mohawk homeobox					DH10B	NM_173576.2	NP_775847.2	VALIDATED	Cs	0.997	0.997	352	3619	192	1247	352	1	352
Invitrogen	NM_004554	IOH28955	Invitrogen(on gateway) 	W01B007I13	pENTR221	7206		NFATC4	4776	NP_004545.2	Hs.77810	Nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 4					DH10B	NM_004554.4	NP_004545.2	REVIEWED	OK	1	1	902	4976	322	3027	902	1	902
Invitrogen	NM_006022	IOH3511	Invitrogen(on gateway) 	W01B007I15	pENTR221	6669		TSC22D1	8848	NP_006013.1	Hs.507916	TSC22 domain family, member 1					DH10B	NM_006022.2	NP_006013.1	VALIDATED	OK	1	1	144	1791	216	647	144	1	144
Invitrogen	NM_020813	IOH38075	Invitrogen(on gateway) 	W01B007I17	pENTR221	11400		ZNF471	57573	NP_065864.2	Hs.710590	Zinc finger protein 471					DH10B	NM_020813.2	NP_065864.2	VALIDATED	OK	1	1	626	4967	134	2011	626	1	626
Invitrogen	NM_134262	IOH43547	Invitrogen(on gateway) 	W01B007I19	pENTR221	7960		RORA	6095	NP_599024.1	Hs.655155	RAR-related orphan receptor A					DH10B	NM_134262.2	NP_599024.1	REVIEWED	OK	1	1	468	10669	92	1495	468	1	468
Invitrogen	NM_181054	IOH44105	Invitrogen(on gateway) 	W01B007I21	pENTR221	6976		HIF1A	3091	NP_851397.1	Hs.597216	Hypoxia inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor)					DH10B	NM_181054.2	NP_851397.1	VALIDATED	OK	1.000	1.000	735	3955	405	2609	735	1	735
Invitrogen	NM_014372	IOH11235	Invitrogen(on gateway) 	W01B007I23	pENTR221	95		RNF11	26994	NP_055187.1	Hs.309641	Ring finger protein 11					DH10B	NM_014372.4	NP_055187.1	REVIEWED	OK	1.000	1.000	154	3082	485	946	154	1	154
Invitrogen	NM_007005	IOH52787	Invitrogen(on gateway) 	W01B007K01	pENTR221	23460		TLE4	7091	NP_008936.2	Hs.444213	Transducin-like enhancer of split 4 (E(sp1) homolog, Drosophila)					DH10B	NM_007005.3	NP_008936.2	VALIDATED	OK	1.000	1.000	773	4749	829	3147	773	1	773
IKAKEN	AF508784	GC-T4865	GeneCopoeia	W01B008A01	pENTR221	10461		GAS2L2	246176	AAM34264.1	Hs.591194	Growth arrest-specific 2 like 2						NM_139285.2	NP_644814.1	VALIDATED	Pfs	0.930	1.000	229	642	1	640	880	1	229
IKAKEN	M55513	GC-A0121	GeneCopoeia	W01B008A02	pENTR221	5650		KCNA5	3741	AAA36422.1	Hs.150208	Potassium voltage-gated channel, shaker-related subfamily, member 5						NM_002234.2	NP_002225.2	REVIEWED	Cs	0.993	0.993	613	1842	1	1839	613	1	613
IKAKEN	NM_015370	GC-T1276	GeneCopoeia	W01B008A03	pENTR221	15950		C22orf31	25770	NP_056185.1	Hs.50891	Chromosome 22 open reading frame 31						NM_015370.1	NP_056185.1	PREDICTED	Cs	0.990	0.990	290	873	1	870	290	1	290
IKAKEN	NM_000818	GC-C0017	GeneCopoeia	W01B008A04	pENTR221	2739		GAD2	2572	NP_000809.1	Hs.231829	Glutamate decarboxylase 2 (pancreatic islets and brain, 65kDa)						NM_000818.2	NP_000809.1	REVIEWED	Cs	0.997	0.997	585	1758	1	1755	585	1	585
IKAKEN	NM_016557	GC-N0080	GeneCopoeia	W01B008A05	pENTR221	16252		CCRL1	51554	NP_057641.1	Hs.719388	Chemokine (C-C motif) receptor-like 1						NM_178445.1	NP_848540.1	REVIEWED	Cs	0.997	0.997	350	1053	1	1050	350	1	350
IKAKEN	NM_001966	GC-C0583	GeneCopoeia	W01B008A06	pENTR221	17144		EHHADH	1962	NP_001957.2	Hs.429879	Enoyl-Coenzyme A, hydratase/3-hydroxyacyl Coenzyme A dehydrogenase						NM_001966.2	NP_001957.2	VALIDATED	Cs	0.994	0.994	723	2172	1	2169	723	1	723
IKAKEN	NM_001158	GC-Q0521	GeneCopoeia	W01B008A07	pENTR221	9681		AOC2	314	NP_001149.2	Hs.143102	Amine oxidase, copper containing 2 (retina-specific)						NM_001158.3	NP_001149.2	REVIEWED	Cs	0.989	0.989	729	2190	1	2187	729	1	729
IKAKEN	NM_020989	GC-D0486	GeneCopoeia	W01B008A08	pENTR221	14328		CRYGC	1420	NP_066269.1	Hs.72910	Crystallin, gamma C						NM_020989.3	NP_066269.1	REVIEWED	Cs	0.994	0.994	174	525	1	522	174	1	174
IKAKEN	NM_014459	GC-M0020	GeneCopoeia	W01B008A09	pENTR221	6455		PCDH17	27253	NP_055274	Hs.106511	Protocadherin 17						NM_001040429.2	NP_001035519.1	REVIEWED	Pfs	0.996	0.999	890	2670	1	2669	1159	1	887
IKAKEN	AJ422118	GC-E0472	GeneCopoeia	W01B008A10	pENTR221	13227		CPO	130749	CAD19478.1	Hs.684103	Carboxypeptidase O						NM_173077.2	NP_775100.1	VALIDATED	Cs	0.997	0.997	374	1125	1	1122	374	1	374
IKAKEN	NM_019035	GC-T1568	GeneCopoeia	W01B008A11	pENTR221	18000		PCDH18	54510	NP_061908.1	Hs.591691	Protocadherin 18						NM_019035.3	NP_061908.1	REVIEWED	Cs	0.999	0.999	1135	3408	1	3405	1135	1	1135
IKAKEN	AL080099	GC-E0699	GeneCopoeia	W01B008A12	pENTR221	16141		UMPS	7372	CAB45710.3	Hs.2057	Uridine monophosphate synthetase						NM_000373.2	NP_000364.1	VALIDATED	Ps	0.988	0.988	251	756	1	753	480	179	429
IKAKEN	M55670	GC-G0069	GeneCopoeia	W01B008A14	pENTR221	6577		PROZ	8858	AAA36500.1	Hs.1011	Protein Z, vitamin K-dependent plasma glycoprotein						NM_003891.1	NP_003882.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	NM_024492	GC-I0356	GeneCopoeia	W01B008A16	pENTR221	20710		LPAL2	80350	NP_077818.1	Hs.654503	Lipoprotein, Lp(a)-like 2						NM_024492.2	NP_077818.1	VALIDATED	C	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	NM_014767	GC-M0545	GeneCopoeia	W01B008A18	pENTR221	3258		SPOCK2	9806	NP_055582.1	Hs.523009	Sparc/osteonectin, cwcv and kazal-like domains proteoglycan (testican) 2						NM_014767.2	NP_055582.1	VALIDATED	Cs	0.993	0.993	424	1275	1	1272	424	1	424
IKAKEN	NM_004828	GC-Q0432	GeneCopoeia	W01B008A20	pENTR221	19875		NCR2	9436	NP_004819.2	Hs.194721	Natural cytotoxicity triggering receptor 2						NM_004828.3	NP_004819.2	VALIDATED	Cs	0.986	0.986	276	831	1	828	276	1	276
IKAKEN	NM_005125	GC-S0330	GeneCopoeia	W01B008A22	pENTR221	3728		CCS	9973	NP_005116.1	Hs.502917	Copper chaperone for superoxide dismutase						NM_005125.1	NP_005116.1	REVIEWED	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	NM_014796	GC-T0036	GeneCopoeia	W01B008A24	pENTR221															
IKAKEN	NM_001739	GC-T1017	GeneCopoeia	W01B008B01	pENTR221	9423		CA5A	763	NP_001730.1	Hs.177446	Carbonic anhydrase VA, mitochondrial						NM_001739.1	NP_001730.1	REVIEWED	Cfs	0.980	0.980	305	918	1	915	305	1	305
IKAKEN	NM_015886	GC-U1327	GeneCopoeia	W01B008B02	pENTR221	22737		PI15	51050	NP_056970.1	Hs.98558	Peptidase inhibitor 15						NM_015886.3	NP_056970.1	REVIEWED	C	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	NM_015596	GC-T1297	GeneCopoeia	W01B008B03	pENTR221	12195		KLK13	26085	NP_056411.1	Hs.165296	Kallikrein-related peptidase 13						NM_015596.1	NP_056411.1	REVIEWED	Cs	0.996	0.996	277	834	1	831	277	1	277
IKAKEN	NM_022140	GC-W0070	GeneCopoeia	W01B008B04	pENTR221	19111		EPB41L4A	64097	NP_071423.3	Hs.584954	Erythrocyte membrane protein band 4.1 like 4A						NM_022140.3	NP_071423.3	VALIDATED	Pgs	0.985	0.987	598	1797	1	1794	686	1	597
IKAKEN	NM_019617	GC-T1240	GeneCopoeia	W01B008B05	pENTR221	12941		GKN1	56287	NP_062563.3	Hs.69319	Gastrokine 1						NM_019617.3	NP_062563.3	REVIEWED	Cs	0.995	0.995	199	600	1	597	199	1	199
IKAKEN	NM_017569	GC-W0328	GeneCopoeia	W01B008B06	pENTR221	6703		FAM48A	55578	NP_060039.1	Hs.435815	Family with sequence similarity 48, member A						NM_017569.3	NP_060039.1	VALIDATED	Cs	0.999	0.999	733	2202	1	2199	733	1	733
IKAKEN	BC000044	GC-T2918	GeneCopoeia	W01B008B07	pENTR221	25237		SPIN2B	474343	AAH00044.1	Hs.719343	Spindlin family, member 2B						NM_001006682.1	NP_001006683.1	VALIDATED	C	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AF303046	GC-W1029	GeneCopoeia	W01B008B08	pENTR221	12354		KLK15	55554	AAK62813.1	Hs.567535	Kallikrein-related peptidase 15						NM_017509.2	NP_059979.2	REVIEWED	Cgs	0.992	0.996	256	768	1	765	256	1	256
IKAKEN	NM_058189	GC-T3244	GeneCopoeia	W01B008B09	pENTR221	15384		C21orf67	84536	NP_478069	Hs.710430	Chromosome 21 open reading frame 67						XM_001726357.1	XP_001726409.1	MODEL	C	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	AJ278120	GC-W1337	GeneCopoeia	W01B008B10	pENTR221	9571		TANC2	26115	CAB92314.1	Hs.410889	Tetratricopeptide repeat, ankyrin repeat and coiled-coil containing 2						NM_025185.3	NP_079461.2	VALIDATED	Pgs	0.983	0.992	1101	3306	1	3303	1990	900	1990
IKAKEN	NM_053280	GC-T3337	GeneCopoeia	W01B008B11	pENTR221	3651		ODF3	113746	NP_444510.2	Hs.350949	Outer dense fiber of sperm tails 3						NM_053280.3	NP_444510.2	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	NM_022360	GC-W2862	GeneCopoeia	W01B008B12	pENTR221	7186		FAM12B	64184	NP_071755.1	Hs.525202	Family with sequence similarity 12, member B (epididymal)						NM_022360.4	NP_071755.1	VALIDATED		0.980	0.980	147	444	1	441	147	1	147
IKAKEN	BC029445	GC-T4009	GeneCopoeia	W01B008B13	pENTR221	22633		CSPP1	79848	AAH29445	Hs.370147	Centrosome and spindle pole associated protein 1						NM_024790.5	NP_079066.5	VALIDATED	P	1.000	1.000	206	627	1	618	1221	37	242
IKAKEN	AF465766	GC-T4830	GeneCopoeia	W01B008B15	pENTR221	15873		BPIL2	254240	AAM73984.1	Hs.372939	Bactericidal/permeability-increasing protein-like 2						NM_174932.2	NP_777592.1	VALIDATED	Cs	0.998	0.998	507	1524	1	1521	507	1	507
IKAKEN	AK096820	GC-T6528	GeneCopoeia	W01B008B17	pENTR221	11809		CYP4F22	126410	BAC04868.1	Hs.156452	Cytochrome P450, family 4, subfamily F, polypeptide 22						NM_173483.3	NP_775754.2	REVIEWED	Cs	0.996	0.996	531	1596	1	1593	531	1	531
IKAKEN	BC037281	GC-T7394	GeneCopoeia	W01B008B19	pENTR221	2923		LOC439951	439951	AAH37281.1	Hs.590986	Hypothetical LOC439951																		
IKAKEN	NM_006093	GC-U0366	GeneCopoeia	W01B008B21	pENTR221	4598		PRG3	10394	NP_006084.2	Hs.251386	Proteoglycan 3						NM_006093.3	NP_006084.2	VALIDATED	Cs	0.991	0.991	225	678	1	675	225	1	225
IKAKEN	NM_018945	GC-U0877	GeneCopoeia	W01B008B23	pENTR221	19690		PDE7B	27115	NP_061818.1	Hs.719318	Phosphodiesterase 7B						NM_018945.3	NP_061818.1	REVIEWED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	NM_002235	GC-A0329	GeneCopoeia	W01B008C02	pENTR221	5641		KCNA6	3742	NP_002226.1	Hs.426162	Potassium voltage-gated channel, shaker-related subfamily, member 6						NM_002235.3	NP_002226.1	REVIEWED	Cs	0.994	0.994	529	1590	1	1587	529	1	529
IKAKEN	NM_021097	GC-C0041	GeneCopoeia	W01B008C04	pENTR221	13853		SLC8A1	6546	NP_066920.1	Hs.656261	Solute carrier family 8 (sodium/calcium exchanger), member 1						NM_021097.2	NP_066920.1	VALIDATED	C	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	NM_021957	GC-C0675	GeneCopoeia	W01B008C06	pENTR221	6295		GYS2	2998	NP_068776.2	Hs.82614	Glycogen synthase 2 (liver)						NM_021957.3	NP_068776.2	VALIDATED	Cs	0.999	0.999	703	2112	1	2109	703	1	703
IKAKEN	XM_053074	GC-E0358	GeneCopoeia	W01B008C08	pENTR221			TIMM50	92609		Hs.597106	Translocase of inner mitochondrial membrane 50 homolog (S. cerevisiae)						NM_001001563.1	NP_001001563.1	VALIDATED	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	AY129150	GC-E0479	GeneCopoeia	W01B008C10	pENTR221	11887		IL29	282618	AAN28265.1	Hs.406745	Interleukin 29 (interferon, lambda 1)						NM_172140.1	NP_742152.1	REVIEWED	Cs	0.995	0.995	200	603	1	600	200	1	200
IKAKEN	NM_020939	GC-E0855	GeneCopoeia	W01B008C12	pENTR221	20383		CPNE5	57699	NP_065990.1	Hs.657869	Copine V						NM_020939.1	NP_065990.1	REVIEWED	C	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	NM_001700	GC-G0288	GeneCopoeia	W01B008C14	pENTR221	11982		AZU1	566	NP_001691.1	Hs.72885	Azurocidin 1						NM_001700.3	NP_001691.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	NM_004049	GC-I0365	GeneCopoeia	W01B008C16	pENTR221	8338		BCL2A1	597	NP_004040.1	Hs.227817	BCL2-related protein A1						NM_004049.3	NP_004040.1	REVIEWED	C	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	NM_014760	GC-M0578	GeneCopoeia	W01B008C18	pENTR221	16593		TATDN2	9797	NP_055575.3	Hs.475401	TatD DNase domain containing 2						NM_014760.3	NP_055575.3	VALIDATED	Cs	0.996	0.996	761	2286	1	2283	761	1	761
IKAKEN	AF044323	GC-Q0470	GeneCopoeia	W01B008C20	pENTR221	3173		COX15	1355	AAD08646.1	Hs.28326	COX15 homolog, cytochrome c oxidase assembly protein (yeast)						NM_004376.5	NP_004367.2	REVIEWED	Cs	0.990	0.990	388	1167	1	1164	388	1	388
IKAKEN	NM_014407	GC-S0408	GeneCopoeia	W01B008C22	pENTR221	16918		KCNMB3	27094	NP_055222.3	Hs.591285	Potassium large conductance calcium-activated channel, subfamily M beta member 3						NM_171830.1	NP_741981.1	REVIEWED	C	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	NM_000133	GC-T0161	GeneCopoeia	W01B008C24	pENTR221	24497		F9	2158	NP_000124.1	Hs.522798	Coagulation factor IX						NM_000133.3	NP_000124.1	REVIEWED	Cs	0.993	0.993	461	1386	1	1383	461	1	461
IKAKEN	NM_002289	GC-T1032	GeneCopoeia	W01B008D01	pENTR221	6274		LALBA	3906	NP_002280.1	Hs.72938	Lactalbumin, alpha-						NM_002289.2	NP_002280.1	REVIEWED	C	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	NM_020552	GC-U1345	GeneCopoeia	W01B008D02	pENTR221	6945		TCL6	27004	NP_065577.2	Hs.510368	T-cell leukemia/lymphoma 6						NM_020552.3	NP_065577.2	REVIEWED	Cs	0.990	0.990	105	318	1	315	105	1	105
IKAKEN	NM_004076	GC-T1356	GeneCopoeia	W01B008D03	pENTR221	15702		CRYBB3	1417	NP_004067.1	Hs.533022	Crystallin, beta B3						NM_004076.3	NP_004067.1	REVIEWED	Cs	0.991	0.991	211	636	1	633	211	1	211
IKAKEN	NM_030891	GC-W0168	GeneCopoeia	W01B008D04	pENTR221	15172		LRRC3	81543	NP_112153.1	Hs.326579	Leucine rich repeat containing 3						NM_030891.3	NP_112153.1	VALIDATED	Cs	0.996	0.996	257	774	1	771	257	1	257
IKAKEN	NM_006202	GC-T1902	GeneCopoeia	W01B008D05	pENTR221	11545		PDE4A	5141	NP_006193.1	Hs.89901	Phosphodiesterase 4A, cAMP-specific (phosphodiesterase E2 dunce homolog, Drosophila)						NM_006202.2	NP_006193.1	VALIDATED	Cs	0.998	0.998	647	1944	1	1941	647	1	647
IKAKEN	AF110002	GC-W0355	GeneCopoeia	W01B008D06	pENTR221	16901		GUCA1C	9626	AAD19944.1	Hs.233363	Guanylate cyclase activator 1C						NM_005459.3	NP_005450.3	VALIDATED	Cs	0.995	0.995	209	630	1	627	209	1	209
IKAKEN	BC011873	GC-T3020	GeneCopoeia	W01B008D07	pENTR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like						NM_019041.5	NP_061914.3	VALIDATED	Cs	0.992	0.992	380	1143	1	1140	380	1	380
IKAKEN	NM_015317	GC-W1075	GeneCopoeia	W01B008D08	pENTR221	13985		PUM2	23369	NP_056132.1	Hs.467824	Pumilio homolog 2 (Drosophila)						NM_015317.1	NP_056132.1	PROVISIONAL	C	1.000	1.000	1064	3195	1	3192	1064	1	1064
IKAKEN	NM_138705	GC-T3246	GeneCopoeia	W01B008D09	pENTR221	499		CALML6	163688	NP_619650.2	Hs.85902	Calmodulin-like 6						NM_138705.2	NP_619650.2	VALIDATED		0.969	0.969	161	495	10	492	181	21	181
IKAKEN	NM_022347	GC-W1368	GeneCopoeia	W01B008D10	pENTR221	1796		IFRG15	64163	NP_071742.1	Hs.716051	Interferon responsive gene 15						NM_022347.1	NP_071742.1	PROVISIONAL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	NM_133492	GC-T3353	GeneCopoeia	W01B008D11	pENTR221	12363		ACER1	125981	NP_597999.1	Hs.352609	Alkaline ceramidase 1						NM_133492.2	NP_597999.1	VALIDATED	Cs	0.989	0.989	264	795	1	792	264	1	264
IKAKEN	NM_002935	GC-X0084	GeneCopoeia	W01B008D12	pENTR221	7239		RNASE3	6037	NP_002926.2	Hs.73839	Ribonuclease, RNase A family, 3 (eosinophil cationic protein)						NM_002935.2	NP_002926.2	VALIDATED		0.975	0.975	160	483	1	480	160	1	160
IKAKEN	BC013650	GC-T4078	GeneCopoeia	W01B008D13	pENTR221															
IKAKEN	AF494536	GC-T4850	GeneCopoeia	W01B008D15	pENTR221	14985		CST9	128822	AAM18055.1	Hs.698020	Cystatin 9 (testatin)						NM_001008693.2	NP_001008693.2	REVIEWED	Cs	0.994	0.994	159	480	1	477	159	1	159
IKAKEN	AK096958	GC-T6558	GeneCopoeia	W01B008D17	pENTR221	8857		FLJ39639	283876	BAC04912.1	Hs.592092	Hypothetical protein FLJ39639						XM_370932.4	XP_370932.2	MODEL	P	1.000	1.000	252	759	1	756	284	33	284
IKAKEN	NM_003961	GC-U0171	GeneCopoeia	W01B008D19	pENTR221	8755		RHBDL1	9028	NP_003952.1	Hs.137572	Rhomboid, veinlet-like 1 (Drosophila)						NM_003961.1	NP_003952.1	PROVISIONAL	Cs	0.993	0.993	438	1317	1	1314	438	1	438
IKAKEN	NM_006382	GC-U0384	GeneCopoeia	W01B008D21	pENTR221	10372		CDRT1	374286	NP_006373.2	Hs.632233	CMT1A duplicated region transcript 1						NM_006382.3	NP_006373.2	PROVISIONAL	Ps	0.996	0.996	252	759	1	756	752	501	752
IKAKEN	NM_000793	GC-U0920	GeneCopoeia	W01B008D23	pENTR221	7348		DIO2	1734	NP_000784.2	Hs.202354	Deiodinase, iodothyronine, type II						NM_000793.4	NP_000784.2	REVIEWED	Cfs	0.982	0.989	273	822	1	819	271	1	271
IKAKEN	NM_000406	GC-A0455	GeneCopoeia	W01B008E02	pENTR221	18245		GNRHR	2798	NP_000397.1	Hs.407587	Gonadotropin-releasing hormone receptor						NM_000406.2	NP_000397.1	REVIEWED	C	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	NM_000148	GC-C0165	GeneCopoeia	W01B008E04	pENTR221	5513		FUT1	2523	NP_000139.1	Hs.69747	Fucosyltransferase 1 (galactoside 2-alpha-L-fucosyltransferase, H blood group)						NM_000148.3	NP_000139.1	REVIEWED	C	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	NM_000408	GC-C0699	GeneCopoeia	W01B008E06	pENTR221	13028		GPD2	2820	NP_000399.2	Hs.512382	Glycerol-3-phosphate dehydrogenase 2 (mitochondrial)						NM_001083112.1	NP_001076581.1	VALIDATED	Cs	0.997	0.997	727	2184	1	2181	727	1	727
IKAKEN	AF445455	GC-E0370	GeneCopoeia	W01B008E08	pENTR221	21958		CRYGN	155051	AAL40968.1	Hs.647104	Crystallin, gamma N						NM_144727.1	NP_653328.1	REVIEWED	C	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AF510036	GC-E0511	GeneCopoeia	W01B008E10	pENTR221	9782		B4GALNT2	124872	AAM34756.1	Hs.374679	Beta-1,4-N-acetyl-galactosaminyl transferase 2						NM_001159388.1	NP_001152860.1	VALIDATED	C	1.000	1.000	480	1701	259	1698	480	1	480
IKAKEN	NM_174962	GC-E0895	GeneCopoeia	W01B008E12	pENTR221	25442		SSX9	280660	NP_777622.1	Hs.553667	Synovial sarcoma, X breakpoint 9						NM_174962.3	NP_777622.1	PROVISIONAL		0.872	0.872	188	567	1	564	188	1	188
IKAKEN	NM_012064	GC-G0297	GeneCopoeia	W01B008E14	pENTR221	6278		MIP	4284	NP_036196.1	Hs.574026	Major intrinsic protein of lens fiber						NM_012064.2	NP_036196.1	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	NM_006788	GC-I0496	GeneCopoeia	W01B008E16	pENTR221	10973		RALBP1	10928	NP_006779.1	Hs.719181	RalA binding protein 1						NM_006788.3	NP_006779.1	VALIDATED	Cs	0.998	0.998	655	1968	1	1965	655	1	655
IKAKEN	NM_006378	GC-M0626	GeneCopoeia	W01B008E18	pENTR221	24035		SEMA4D	10507	NP_006369.3	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D						NM_006378.3	NP_006369.3	VALIDATED	Cs	0.992	0.992	862	2589	1	2586	862	1	862
IKAKEN	AF086735	GC-Q0497	GeneCopoeia	W01B008E20	pENTR221	5903		RDH16	8608	AAC72923.1	Hs.134958	Retinol dehydrogenase 16 (all-trans)						NM_003708.3	NP_003699.3	VALIDATED	Cs	0.994	0.994	317	954	1	951	317	1	317
IKAKEN	NM_014471	GC-S0411	GeneCopoeia	W01B008E22	pENTR221	23528		SPINK4	27290	NP_055286.1	Hs.555934	Serine peptidase inhibitor, Kazal type 4						NM_014471.1	NP_055286.1	PROVISIONAL		0.977	0.977	86	261	1	258	86	1	86
IKAKEN	NM_002453	GC-T0185	GeneCopoeia	W01B008E24	pENTR221	14013		MTIF2	4528	NP_002444.2	Hs.149894	Mitochondrial translational initiation factor 2						NM_002453.2	NP_002444.2	REVIEWED	Cs	0.996	0.996	727	2184	1	2181	727	1	727
IKAKEN	NM_001994	GC-T1036	GeneCopoeia	W01B008F01	pENTR221	2256		F13B	2165	NP_001985.2	Hs.435782	Coagulation factor XIII, B polypeptide						NM_001994.2	NP_001985.2	REVIEWED	Cs	0.997	0.997	661	1986	1	1983	661	1	661
IKAKEN	NM_005208	GC-U1347	GeneCopoeia	W01B008F02	pENTR221	10055		CRYBA1	1411	NP_005199.2	Hs.46275	Crystallin, beta A1						NM_005208.4	NP_005199.2	REVIEWED	Cs	0.991	0.991	215	648	1	645	215	1	215
IKAKEN	NM_025261	GC-T1390	GeneCopoeia	W01B008F03	pENTR221	20596		LY6G6C	80740	NP_079537.1	Hs.241586	Lymphocyte antigen 6 complex, locus G6C						NM_025261.1	NP_079537.1	VALIDATED	C	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	NM_006550	GC-W0182	GeneCopoeia	W01B008F04	pENTR221															
IKAKEN	NM_018412	GC-T2028	GeneCopoeia	W01B008F05	pENTR221	21196		ST7	7982	NP_060882.2	Hs.368131	Suppression of tumorigenicity 7						NM_018412.3	NP_060882.2	REVIEWED	Cs	0.996	0.996	554	1665	1	1662	554	1	554
IKAKEN	AF158383	GC-W0501	GeneCopoeia	W01B008F06	pENTR221	24622		ATP1B4	23439	AAD49692.1	Hs.662608	ATPase, (Na+)/K+ transporting, beta 4 polypeptide						NM_001142447.1	NP_001135919.1	VALIDATED	C	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	BC001522	GC-T3081	GeneCopoeia	W01B008F07	pENTR221	25115		GRIPAP1	56850	AAH01522.2	Hs.109929	GRIP1 associated protein 1						NM_020137.3	NP_064522.3	VALIDATED	Ps	0.998	0.998	484	1455	1	1452	841	358	841
IKAKEN	AY029191	GC-W1078	GeneCopoeia	W01B008F08	pENTR221	24133		ASPN	54829	AAK31800.1	Hs.435655	Asporin						NM_017680.3	NP_060150.3	VALIDATED	Cgs	0.995	0.997	381	1146	1	1143	380	1	380
IKAKEN	NM_139172	GC-T3258	GeneCopoeia	W01B008F09	pENTR221	11649		TMEM190	147744	NP_631911.1	Hs.590943	Transmembrane protein 190						NM_139172.1	NP_631911.1	PROVISIONAL	Cs	0.994	0.994	177	534	1	531	177	1	177
IKAKEN	NM_031948	GC-W1378	GeneCopoeia	W01B008F10	pENTR221	9099		PRSS27	83886	NP_114154.1	Hs.332878	Protease, serine 27						NM_031948.3	NP_114154.1	VALIDATED	Cs	0.997	0.997	290	873	1	870	290	1	290
IKAKEN	NM_080878	GC-T3408	GeneCopoeia	W01B008F11	pENTR221	2107		ITLN2	142683	NP_543154.1	Hs.385631	Intelectin 2						NM_080878.2	NP_543154.1	VALIDATED	Cs	0.997	0.997	325	978	1	975	325	1	325
IKAKEN	NM_021870	GC-X0501	GeneCopoeia	W01B008F12	pENTR221	18259		FGG	2266	NP_068656.2	Hs.546255	Fibrinogen gamma chain						NM_021870.2	NP_068656.2	REVIEWED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC015930	GC-T4339	GeneCopoeia	W01B008F13	pENTR221	15204		USP25	29761	AAH15930.1	Hs.473370	Ubiquitin specific peptidase 25						NM_013396.3	NP_037528.3	VALIDATED	Cfs	0.256	0.601	1055	1353	1	1345	1055	1	1055
IKAKEN	AF520569	GC-T4872	GeneCopoeia	W01B008F15	pENTR221	8746		IQCK	124152	AAM77339.1	Hs.460217	IQ motif containing K						NM_153208.1	NP_694940.1	PROVISIONAL	Pfs	0.807	0.995	233	570	1	568	287	1	233
IKAKEN	AK097402	GC-T6633	GeneCopoeia	W01B008F17	pENTR221	16461		CCDC37	348807	BAC05035.1	Hs.591305	Coiled-coil domain containing 37						NM_182628.2	NP_872434.2	VALIDATED	Cs	0.995	0.995	611	1836	1	1833	611	1	611
IKAKEN	NM_005293	GC-U0262	GeneCopoeia	W01B008F19	pENTR221	22984		GPR20	2843	NP_005284.2	Hs.188859	G protein-coupled receptor 20						NM_005293.2	NP_005284.2	VALIDATED	Cs	0.992	0.992	358	1077	1	1074	358	1	358
IKAKEN	NM_014359	GC-U0585	GeneCopoeia	W01B008F21	pENTR221	403		OPTC	26254	NP_055174.1	Hs.632468	Opticin						NM_014359.3	NP_055174.1	REVIEWED	C	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	NM_019893	GC-U1001	GeneCopoeia	W01B008F23	pENTR221	3225		ASAH2	56624	NP_063946.2	Hs.512645	N-acylsphingosine amidohydrolase (non-lysosomal ceramidase) 2						NM_019893.2	NP_063946.2	VALIDATED	Ps	0.995	0.995	761	2286	1	2283	780	20	780
IKAKEN	NM_004441	GC-A0560	GeneCopoeia	W01B008G02	pENTR221	16217		EPHB1	2047	NP_004432.1	Hs.116092	EPH receptor B1						NM_004441.3	NP_004432.1	REVIEWED	Cs	0.992	0.992	984	2955	1	2952	984	1	984
IKAKEN	NM_000372	GC-C0301	GeneCopoeia	W01B008G04	pENTR221	4113		TYR	7299	NP_000363.1	Hs.503555	Tyrosinase (oculocutaneous albinism IA)						NM_000372.4	NP_000363.1	REVIEWED	Cs	0.996	0.996	529	1590	1	1587	529	1	529
IKAKEN	M30647	GC-D0030	GeneCopoeia	W01B008G06	pENTR221	8388		EPB42	2038	AAA36401.1	Hs.368642	Erythrocyte membrane protein band 4.2						NM_000119.2	NP_000110.2	REVIEWED	Cs	0.990	0.990	721	2166	1	2163	721	1	721
IKAKEN	AF445455	GC-E0370	GeneCopoeia	W01B008G08	pENTR221	21958		CRYGN	155051	AAL40968.1	Hs.647104	Crystallin, gamma N						NM_144727.1	NP_653328.1	REVIEWED	C	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	NM_005840	GC-E0538	GeneCopoeia	W01B008G10	pENTR221	24581		SPRY3	10251	NP_005831.1	Hs.381912	Sprouty homolog 3 (Drosophila)						NM_005840.1	NP_005831.1	VALIDATED	Cs	0.993	0.993	288	867	1	864	288	1	288
IKAKEN	AF461155	GC-E0913	GeneCopoeia	W01B008G12	pENTR221	11651		C19orf59	199675	AAO15597.1	Hs.709539	Chromosome 19 open reading frame 59						NM_174918.2	NP_777578.2	REVIEWED	Cs	0.984	0.984	187	564	1	561	187	1	187
IKAKEN	NM_002934	GC-G0318	GeneCopoeia	W01B008G14	pENTR221	7238		RNASE2	6036	NP_002925.1	Hs.728	Ribonuclease, RNase A family, 2 (liver, eosinophil-derived neurotoxin)						NM_002934.2	NP_002925.1	VALIDATED	Cs	0.994	0.994	161	486	1	483	161	1	161
IKAKEN	NM_016299	GC-J0053	GeneCopoeia	W01B008G16	pENTR221	2673		HSPA14	51182	NP_057383.2	Hs.534169	Heat shock 70kDa protein 14						NM_016299.2	NP_057383.2	VALIDATED	Cs	0.992	0.992	509	1530	1	1527	509	1	509
IKAKEN	U30498	GC-M0636	GeneCopoeia	W01B008G18	pENTR221	2247		LAPTM5	7805	AAA74018.1	Hs.371021	Lysosomal multispanning membrane protein 5						NM_006762.2	NP_006753.1	REVIEWED	Cs	0.989	0.989	262	789	1	786	262	1	262
IKAKEN	NM_015185	GC-S0023	GeneCopoeia	W01B008G20	pENTR221	25099		ARHGEF9	23229	NP_056000.1	Hs.54697	Cdc42 guanine nucleotide exchange factor (GEF) 9						NM_015185.2	NP_056000.1	VALIDATED	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	NM_014645	GC-S0417	GeneCopoeia	W01B008G22	pENTR221															
IKAKEN	NM_025241	GC-T0355	GeneCopoeia	W01B008G24	pENTR221	12344		UBXN6	80700	NP_079517.1	Hs.435255	UBX domain protein 6						NM_025241.1	NP_079517.1	PROVISIONAL	Cs	0.998	0.998	441	1326	1	1323	441	1	441
IKAKEN	NM_005383	GC-T1055	GeneCopoeia	W01B008H01	pENTR221	13546		NEU2	4759	NP_005374.2	Hs.532681	Sialidase 2 (cytosolic sialidase)						NM_005383.2	NP_005374.2	REVIEWED	Cs	0.997	0.997	380	1143	1	1140	380	1	380
IKAKEN	NM_001886	GC-U1349	GeneCopoeia	W01B008H02	pENTR221	15701		CRYBA4	1413	NP_001877.1	Hs.57690	Crystallin, beta A4						NM_001886.2	NP_001877.1	REVIEWED	Cs	0.995	0.995	196	591	1	588	196	1	196
IKAKEN	NM_014617	GC-T1392	GeneCopoeia	W01B008H03	pENTR221	14346		CRYGA	1418	NP_055432.2	Hs.122566	Crystallin, gamma A						NM_014617.3	NP_055432.2	VALIDATED	Cs	0.994	0.994	174	525	1	522	174	1	174
IKAKEN	NM_007354	GC-W0183	GeneCopoeia	W01B008H04	pENTR221	16853		C3orf27	23434	NP_031380.1	Hs.194283	Chromosome 3 open reading frame 27						NM_007354.1	NP_031380.1	PROVISIONAL	Cs	0.993	0.993	149	450	1	447	149	1	149
IKAKEN	BC014242	GC-T2183	GeneCopoeia	W01B008H05	pENTR221	38534		C5orf43	643155	-	Hs.508479	Chromosome 5 open reading frame 43						NM_001048249.3	NP_001041714.1	VALIDATED	Cs	0.986	0.986	74	225	1	222	74	1	74
IKAKEN	NM_020250	GC-W0695	GeneCopoeia	W01B008H06	pENTR221															
IKAKEN	NM_052971	GC-T3171	GeneCopoeia	W01B008H07	pENTR221	18634		LEAP2	116842	NP_443203.1	Hs.337588	Liver expressed antimicrobial peptide 2						NM_052971.2	NP_443203.1	VALIDATED	C	1.000	1.000	77	234	1	231	77	1	77
IKAKEN	NM_025239	GC-W1129	GeneCopoeia	W01B008H08	pENTR221	23588		PDCD1LG2	80380	NP_079515.2	Hs.532279	Programmed cell death 1 ligand 2						NM_025239.3	NP_079515.2	VALIDATED	Cs	0.996	0.996	273	822	1	819	273	1	273
IKAKEN	NM_002098	GC-T3278	GeneCopoeia	W01B008H09	pENTR221	20839		GUCA1B	2979	NP_002089.4	Hs.446529	Guanylate cyclase activator 1B (retina)						NM_002098.4	NP_002089.4	VALIDATED	Cs	0.995	0.995	200	603	1	600	200	1	200
IKAKEN	NM_030967	GC-W1396	GeneCopoeia	W01B008H10	pENTR221	10256		KRTAP1-1	81851	NP_112229.1	Hs.247934	Keratin associated protein 1-1						NM_030967.2	NP_112229.1	REVIEWED	Cs	0.989	0.989	177	534	1	531	177	1	177
IKAKEN	NM_058222	GC-T3414	GeneCopoeia	W01B008H11	pENTR221	2715		TECTB	6975	NP_478129.1	Hs.348615	Tectorin beta						NM_058222.1	NP_478129.1	PROVISIONAL	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC007506	GC-Z0314	GeneCopoeia	W01B008H12	pENTR221	7416		FOXN3	1112	AAH07506.1	Hs.434286	Forkhead box N3						NM_005197.3	NP_005188.2	REVIEWED	Cs	0.994	0.994	468	1407	1	1404	468	1	468
IKAKEN	BC028580	GC-T4378	GeneCopoeia	W01B008H13	pENTR221	20097		MGC26597	206426	AAH28580	Hs.676966	PIP5K1A pseudogene								
IKAKEN	AJ278736	GC-T4895	GeneCopoeia	W01B008H15	pENTR221	1791		TMEM52	339456	CAC82104.1	Hs.123423	Transmembrane protein 52						NM_178545.3	NP_848640.1	VALIDATED	C	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AY052562	GC-T7026	GeneCopoeia	W01B008H17	pENTR221	23965		BICD2	23299	AAL12246.1	Hs.436939	Bicaudal D homolog 2 (Drosophila)						NM_015250.3	NP_056065.1	REVIEWED	C	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	NM_005549	GC-U0286	GeneCopoeia	W01B008H19	pENTR221	2235		KCNA10	3744	NP_005540.1	Hs.248140	Potassium voltage-gated channel, shaker-related subfamily, member 10						NM_005549.2	NP_005540.1	REVIEWED	Cs	0.996	0.996	511	1536	1	1533	511	1	511
IKAKEN	NM_014420	GC-U0588	GeneCopoeia	W01B008H21	pENTR221	22930		DKK4	27121	NP_055235.1	Hs.159311	Dickkopf homolog 4 (Xenopus laevis)						NM_014420.2	NP_055235.1	REVIEWED	Cs	0.996	0.996	224	675	1	672	224	1	224
IKAKEN	NM_012269	GC-U1088	GeneCopoeia	W01B008H23	pENTR221	21101		HYAL4	23553	NP_036401.2	Hs.28673	Hyaluronoglucosaminidase 4						NM_012269.2	NP_036401.2	REVIEWED	Cs	0.998	0.998	481	1446	1	1443	481	1	481
IKAKEN	U35398	GC-A0638	GeneCopoeia	W01B008I02	pENTR221	7560		GPR68	8111	AAA79060.1	Hs.8882	G protein-coupled receptor 68						NM_003485.3	NP_003476.2	VALIDATED	Ps	0.995	0.995	365	1098	1	1095	375	11	375
IKAKEN	NM_004306	GC-C0333	GeneCopoeia	W01B008I04	pENTR221	23099		ANXA13	312	NP_004297.2	Hs.181107	Annexin A13						NM_004306.2	NP_004297.2	REVIEWED	Cs	0.991	0.991	316	951	1	948	316	1	316
IKAKEN	NM_000224	GC-D0093	GeneCopoeia	W01B008I06	pENTR221	5524		KRT18	3875	NP_000215.1	Hs.406013	Keratin 18						NM_199187.1	NP_954657.1	REVIEWED	C	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	AJ457189	GC-E0408	GeneCopoeia	W01B008I08	pENTR221	10493		PHOSPHO1	162466	CAD29803.1	Hs.405607	Phosphatase, orphan 1						NM_178500.3	NP_848595.1	VALIDATED	C	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	AF467440	GC-E0542	GeneCopoeia	W01B008I10	pENTR221	9774		SMCR8	140775	AAL78337.1	Hs.707728	Smith-Magenis syndrome chromosome region, candidate 8						NM_144775.2	NP_658988.2	VALIDATED	P	1.000	1.000	787	2364	1	2361	937	1	787
IKAKEN	AF539794	GC-E0922	GeneCopoeia	W01B008I12	pENTR221	9786		UNC45B	146862	AAO13384.1	Hs.379636	Unc-45 homolog B (C. elegans)						NM_173167.2	NP_775259.1	VALIDATED	Cs	0.997	0.997	931	2796	1	2793	931	1	931
IKAKEN	NM_014737	GC-G0423	GeneCopoeia	W01B008I14	pENTR221	15054		RASSF2	9770	NP_055552.1	Hs.631504	Ras association (RalGDS/AF-6) domain family member 2						NM_014737.2	NP_055552.1	REVIEWED	Cs	0.997	0.997	326	981	1	978	326	1	326
IKAKEN	NM_018840	GC-J0056	GeneCopoeia	W01B008I16	pENTR221	14569		C20orf24	55969	NP_061328.1	Hs.584985	Chromosome 20 open reading frame 24						NM_018840.2	NP_061328.1	VALIDATED	C	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	U67932	GC-M0757	GeneCopoeia	W01B008I18	pENTR221	23073		PDE7A	5150	AAB65772.1	Hs.527119	Phosphodiesterase 7A						NM_002603.2	NP_002594.1	VALIDATED	Cs	0.996	0.996	456	1371	1	1368	456	1	456
IKAKEN	NM_004726	GC-S0065	GeneCopoeia	W01B008I20	pENTR221	24568		REPS2	9185	NP_004717.2	Hs.186810	RALBP1 associated Eps domain containing 2						NM_004726.2	NP_004717.2	REVIEWED	Ps	0.992	0.992	521	1566	1	1563	660	140	660
IKAKEN	XM_006610	GC-S0419	GeneCopoeia	W01B008I22	pENTR221															
IKAKEN	NM_004737	GC-T0454	GeneCopoeia	W01B008I24	pENTR221	15776		LARGE	9215	NP_004728.1	Hs.474667	Like-glycosyltransferase						NM_133642.3	NP_598397.1	REVIEWED	Cs	0.997	0.997	756	2271	1	2268	756	1	756
IKAKEN	NM_006944	GC-T1087	GeneCopoeia	W01B008J01	pENTR221	13226		SPP2	6694	NP_008875.1	Hs.444488	Secreted phosphoprotein 2, 24kDa						NM_006944.2	NP_008875.1	REVIEWED	C	1.000	1.000	211	636	1	633	211	1	211
IKAKEN	NM_019855	GC-U1461	GeneCopoeia	W01B008J02	pENTR221	12317		CABP5	56344	NP_062829.1	Hs.117694	Calcium binding protein 5						NM_019855.3	NP_062829.1	REVIEWED	Cs	0.994	0.994	173	522	1	519	173	1	173
IKAKEN	NM_021954	GC-T1412	GeneCopoeia	W01B008J03	pENTR221	6831		GJA3	2700	NP_068773.2	Hs.130313	Gap junction protein, alpha 3, 46kDa						NM_021954.3	NP_068773.2	VALIDATED	Cs	0.998	0.998	435	1308	1	1305	435	1	435
IKAKEN	NM_014059	GC-W0200	GeneCopoeia	W01B008J04	pENTR221	6456		C13orf15	28984	NP_054778.2	Hs.507866	Chromosome 13 open reading frame 15						NM_014059.2	NP_054778.2	REVIEWED	P	1.000	1.000	113	354	13	351	137	25	137
IKAKEN	BC014233	GC-T2229	GeneCopoeia	W01B008J05	pENTR221	15676		MGC20647	91370	AAH14233.2	Hs.658999	Hypothetical protein MGC20647								
IKAKEN	AF251060	GC-W0810	GeneCopoeia	W01B008J06	pENTR221	19244		SPRY4	81848	AAK34950.1	Hs.323308	Sprouty homolog 4 (Drosophila)						NM_001127496.1	NP_001120968.1	VALIDATED	Pfs	0.172	0.172	29	255	157	71	299	24	52
IKAKEN	NM_131915	GC-T3189	GeneCopoeia	W01B008J07	pENTR221															
IKAKEN	NM_032576	GC-W1142	GeneCopoeia	W01B008J08	pENTR221	25652		CYorf15B	84663	NP_115965.1	Hs.592254	Chromosome Y open reading frame 15B						NM_032576.4	NP_115965.1	VALIDATED		0.972	0.972	181	546	1	543	181	1	181
IKAKEN	NM_080617	GC-T3279	GeneCopoeia	W01B008J09	pENTR221	15070		CBLN4	140689	NP_542184.1	Hs.126141	Cerebellin 4 precursor						NM_080617.4	NP_542184.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	NM_030966	GC-W1397	GeneCopoeia	W01B008J10	pENTR221	10256		KRTAP1-3	81850	NP_112228.1	Hs.534495	Keratin associated protein 1-3						NM_030966.1	NP_112228.1	REVIEWED	Cs	0.988	0.988	167	504	1	501	167	1	167
IKAKEN	NM_052958	GC-T3489	GeneCopoeia	W01B008J11	pENTR221	22493		C8orf34	116328	NP_443190.1	Hs.491941	Chromosome 8 open reading frame 34						NM_052958.1	NP_443190.1	PREDICTED	Cs	0.988	0.988	427	1284	1	1281	427	1	427
IKAKEN	NM_199413	GC-Z0759	GeneCopoeia	W01B008J12	pENTR221	8169		PRC1	9055	NP_955445.1	Hs.567385	Protein regulator of cytokinesis 1						NM_199413.1	NP_955445.1	REVIEWED	OK	1.000	1.000	606	1821	1	1818	606	1	606
IKAKEN	BC031065	GC-T4457	GeneCopoeia	W01B008J13	pENTR221	11202		CTAGE1	64693	AAH31065.2	Hs.406709	Cutaneous T-cell lymphoma-associated antigen 1						NM_172241.2	NP_758441.2	VALIDATED	Cs	0.999	0.999	745	2238	1	2235	745	1	745
IKAKEN	AJ301564	GC-T4898	GeneCopoeia	W01B008J15	pENTR221	23096		FAM167A	83648	CAC82740.1	Hs.124299	Family with sequence similarity 167, member A						NM_053279.2	NP_444509.2	VALIDATED	C	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	AY074491	GC-T7032	GeneCopoeia	W01B008J17	pENTR221	5847		CAPRIN2	65981	AAL71550.1	Hs.234355	Caprin family member 2						NM_001002259.1	NP_001002259.1	VALIDATED	Ps	0.996	0.996	269	837	1	807	1127	1	269
IKAKEN	NM_003571	GC-U0290	GeneCopoeia	W01B008J19	pENTR221	16603		BFSP2	8419	NP_003562.1	Hs.659862	Beaded filament structural protein 2, phakinin						NM_003571.2	NP_003562.1	REVIEWED	Cs	0.995	0.995	415	1248	1	1245	415	1	415
IKAKEN	NM_014069	GC-U0764	GeneCopoeia	W01B008J21	pENTR221	20365		PSORS1C2	170680	NP_054788.2	Hs.146824	Psoriasis susceptibility 1 candidate 2						NM_014069.2	NP_054788.2	VALIDATED	Cs	0.993	0.993	136	411	1	408	136	1	136
IKAKEN	NM_002644	GC-U1138	GeneCopoeia	W01B008J23	pENTR221	1700		PIGR	5284	NP_002635.2	Hs.497589	Polymeric immunoglobulin receptor						NM_002644.2	NP_002635.2	PROVISIONAL	Cs	0.992	0.992	764	2295	1	2292	764	1	764
IKAKEN	NM_004967	GC-A0974	GeneCopoeia	W01B008K02	pENTR221	17772		IBSP	3381	NP_004958.2	Hs.518726	Integrin-binding sialoprotein						NM_004967.3	NP_004958.2	REVIEWED	Cs	0.984	0.984	317	954	1	951	317	1	317
IKAKEN	NM_000531	GC-C0370	GeneCopoeia	W01B008K04	pENTR221	24898		OTC	5009	NP_000522.3	Hs.117050	Ornithine carbamoyltransferase						NM_000531.5	NP_000522.3	REVIEWED	Cs	0.997	0.997	354	1065	1	1062	354	1	354
IKAKEN	NM_005562	GC-D0157	GeneCopoeia	W01B008K06	pENTR221	1026		LAMC2	3918	NP_005553.2	Hs.591484	Laminin, gamma 2						NM_005562.2	NP_005553.2	REVIEWED	Cs	0.999	0.999	1193	3582	1	3579	1193	1	1193
IKAKEN	AY158086	GC-E0430	GeneCopoeia	W01B008K08	pENTR221	15947		SEC14L3	266629	AAO21870.1	Hs.505601	SEC14-like 3 (S. cerevisiae)						NM_174975.4	NP_777635.1	REVIEWED	Cs	0.993	0.993	400	1203	1	1200	400	1	400
IKAKEN	AF329433	GC-E0575	GeneCopoeia	W01B008K10	pENTR221	21940		PON3	5446	AAO15365.1	Hs.440967	Paraoxonase 3						NM_000940.2	NP_000931.1	REVIEWED		0.969	0.969	354	1065	1	1062	354	1	354
IKAKEN	AJ508777	GC-E0926	GeneCopoeia	W01B008K12	pENTR221	6042		KRT74	121391	CAD48514.1	Hs.660125	Keratin 74						NM_175053.3	NP_778223.2	VALIDATED	Cs	0.996	0.996	529	1590	1	1587	529	1	529
IKAKEN	NM_014882	GC-G0665	GeneCopoeia	W01B008K14	pENTR221	13512		ARHGAP25	9938	NP_055697.1	Hs.531807	Rho GTPase activating protein 25						NM_014882.2	NP_055697.1	VALIDATED	C	1.000	1.000	638	1917	1	1914	638	1	638
IKAKEN	NM_000368	GC-K2992	GeneCopoeia	W01B008K16	pENTR221	24016		TSC1	7248	NP_000359.1	Hs.370854	Tuberous sclerosis 1						NM_000368.3	NP_000359.1	VALIDATED	Cs	0.998	0.998	1164	3495	1	3492	1164	1	1164
IKAKEN	NM_000599	GC-O0034	GeneCopoeia	W01B008K18	pENTR221	13913		IGFBP5	3488	NP_000590.1	Hs.607212	Insulin-like growth factor binding protein 5						NM_000599.3	NP_000590.1	VALIDATED	Cs	0.993	0.993	272	819	1	816	272	1	272
IKAKEN	NM_003963	GC-S0079	GeneCopoeia	W01B008K20	pENTR221	9656		TM4SF5	9032	NP_003954.2	Hs.184194	Transmembrane 4 L six family member 5						NM_003963.2	NP_003954.2	REVIEWED	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	NM_000329	GC-S0503	GeneCopoeia	W01B008K22	pENTR221	2236		RPE65	6121	NP_000320.1	Hs.2133	Retinal pigment epithelium-specific protein 65kDa						NM_000329.2	NP_000320.1	REVIEWED	C	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	NM_002161	GC-T0584	GeneCopoeia	W01B008K24	pENTR221	24022		IARS	3376	NP_002152.2	Hs.445403	Isoleucyl-tRNA synthetase						NM_013417.2	NP_038203.2	REVIEWED	Cs	0.998	0.998	1262	3789	1	3786	1262	1	1262
IKAKEN	NM_020161	GC-T1244	GeneCopoeia	W01B008L01	pENTR221	14101		C2orf83	56918	NP_064546.2	Hs.283092	Chromosome 2 open reading frame 83						NM_020161.2	NP_064546.2	VALIDATED	Ps	0.993	0.993	140	423	1	420	150	1	140
IKAKEN	BC007391	GC-V1055	GeneCopoeia	W01B008L02	pENTR221	10592		SLC38A10	124565	-	Hs.352240	Solute carrier family 38, member 10						NM_001037984.1	NP_001033073.1	VALIDATED	Pg	0.995	1.000	194	582	1	579	1119	926	1119
IKAKEN	NM_032129	GC-T1523	GeneCopoeia	W01B008L03	pENTR221	826		PLEKHN1	84069	NP_115505.2	Hs.528691	Pleckstrin homology domain containing, family N member 1						NM_032129.2	NP_115505.2	VALIDATED	Cs	0.997	0.997	611	1836	1	1833	611	1	611
IKAKEN	NM_005492	GC-W0217	GeneCopoeia	W01B008L04	pENTR221	14603		CST8	10047	NP_005483.1	Hs.121602	Cystatin 8 (cystatin-related epididymal specific)						NM_005492.2	NP_005483.1	REVIEWED	Cs	0.993	0.993	142	429	1	426	142	1	142
IKAKEN	BC012776	GC-T2461	GeneCopoeia	W01B008L05	pENTR221	5294		XRCC6BP1	91419	AAH12776.3	Hs.61188	XRCC6 binding protein 1						NM_033276.2	NP_150592.1	PROVISIONAL	Cs	0.996	0.996	246	741	1	738	246	1	246
IKAKEN	NM_032566	GC-W0877	GeneCopoeia	W01B008L06	pENTR221	18676		SPINK7	84651	NP_115955.1	Hs.244569	Serine peptidase inhibitor, Kazal type 7 (putative)						NM_032566.2	NP_115955.1	VALIDATED	C	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	NM_080869	GC-T3200	GeneCopoeia	W01B008L07	pENTR221	15062		WFDC12	128488	NP_543145.1	Hs.352180	WAP four-disulfide core domain 12						NM_080869.1	NP_543145.1	REVIEWED	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	AF360991	GC-W1221	GeneCopoeia	W01B008L08	pENTR221	3243		MBL2	4153	AAK52907.1	Hs.499674	Mannose-binding lectin (protein C) 2, soluble (opsonic defect)						NM_000242.2	NP_000233.1	REVIEWED	C	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	NM_139173	GC-T3297	GeneCopoeia	W01B008L09	pENTR221	18118		NHEDC1	150159	NP_631912.2	Hs.666728	Na+/H+ exchanger domain containing 1						NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.986	0.986	219	663	1	657	475	1	219
IKAKEN	AJ406930	GC-W1398	GeneCopoeia	W01B008L10	pENTR221	10479		KRTAP2-4	85294	CAC27569.1	Hs.560502	Keratin associated protein 2-4						NM_033184.2	NP_149440.1	REVIEWED	C	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	NM_052924	GC-T3611	GeneCopoeia	W01B008L11	pENTR221	22497		RHPN1	114822	NP_443156.2	Hs.521912	Rhophilin, Rho GTPase binding protein 1						NM_052924.2	NP_443156.2	VALIDATED	Cgs	0.963	0.999	695	2088	1	2085	670	1	670
IKAKEN	AY336745	GC-Z9978	GeneCopoeia	W01B008L12	pENTR221	15492		RAB36	9609	AAQ16115.1	Hs.369557	RAB36, member RAS oncogene family						NM_004914.2	NP_004905.2	VALIDATED	Cgs	0.931	0.997	333	936	1	933	333	1	333
IKAKEN	BC029447	GC-T4513	GeneCopoeia	W01B008L13	pENTR221	2679		PRAP1	118471	AAH29447.2	Hs.15951	Proline-rich acidic protein 1						NM_145202.4	NP_660203.3	VALIDATED	Cgs	0.974	0.980	152	459	1	456	151	1	151
IKAKEN	AK075445	GC-T5636	GeneCopoeia	W01B008L15	pENTR221	7463		ISM2	145501	BAC11626.1	Hs.29742	Isthmin 2 homolog (zebrafish)						NM_199265.1	NP_954874.1	REVIEWED	Cs	0.998	0.998	483	1716	265	1713	483	1	483
IKAKEN	AY081842	GC-T7037	GeneCopoeia	W01B008L17	pENTR221	16513		TMIE	259236	AAL89820.1	Hs.185777	Transmembrane inner ear						NM_147196.2	NP_671729.2	REVIEWED	Cg	0.994	1.000	156	468	1	465	156	1	156
IKAKEN	NM_004822	GC-U0317	GeneCopoeia	W01B008L19	pENTR221	10067		NTN1	9423	NP_004813.2	Hs.660885	Netrin 1						NM_004822.2	NP_004813.2	REVIEWED	Cs	0.995	0.995	604	1815	1	1812	604	1	604
IKAKEN	NM_016122	GC-U0794	GeneCopoeia	W01B008L21	pENTR221	5953		CCDC41	51134	NP_057206.2	Hs.279209	Coiled-coil domain containing 41						NM_016122.2	NP_057206.2	VALIDATED	Pfs	0.996	0.996	473	1419	1	1418	701	130	602
IKAKEN	NM_018962	GC-U1197	GeneCopoeia	W01B008L23	pENTR221	15168		DSCR6	53820	NP_061835.1	Hs.254560	Down syndrome critical region gene 6						NM_018962.2	NP_061835.1	VALIDATED	Cs	0.989	0.989	190	573	1	570	190	1	190
IKAKEN	NM_000085	GC-A1060	GeneCopoeia	W01B008M02	pENTR221	752		CLCNKB	1188	NP_000076.2	Hs.352243	Chloride channel Kb						NM_000085.2	NP_000076.2	VALIDATED	Cs	0.987	0.987	687	2064	1	2061	687	1	687
IKAKEN	L21934	GC-C0392	GeneCopoeia	W01B008M04	pENTR221	620		SOAT1	6646	AAC37532.2	Hs.496383	Sterol O-acyltransferase 1						NM_003101.4	NP_003092.4	PROVISIONAL	Cs	0.995	0.995	550	1653	1	1650	550	1	550
IKAKEN	NM_004533	GC-D0244	GeneCopoeia	W01B008M06	pENTR221	12008		MYBPC2	4606	NP_004524.3	Hs.85937	Myosin binding protein C, fast type						NM_004533.3	NP_004524.3	VALIDATED	Cgs	0.997	0.998	1142	3429	1	3426	1141	1	1141
IKAKEN	AL133648	GC-E0433	GeneCopoeia	W01B008M08	pENTR221	1359		KIAA0495	57212	CAB63767.1	Hs.49658	KIAA0495						NM_207306.2	NP_997189.1	VALIDATED	Cs	0.995	0.995	201	606	1	603	201	1	201
IKAKEN	AY177732	GC-E0584	GeneCopoeia	W01B008M10	pENTR221	6200		MORN3	283385	AAO18675.1	Hs.434154	MORN repeat containing 3						NM_173855.3	NP_776254.2	PROVISIONAL		0.969	0.969	159	483	1	477	240	1	159
IKAKEN	NM_005058	GC-F0694	GeneCopoeia	W01B008M12	pENTR221	25674		RBMY1A1	5940	NP_005049.1	Hs.380450	RNA binding motif protein, Y-linked, family 1, member A1						NM_001007526.1	NP_001007527.1	REVIEWED	Cs	0.997	0.997	356	1491	421	1488	356	1	356
IKAKEN	XM_010598	GC-G0777	GeneCopoeia	W01B008M14	pENTR221															
IKAKEN	NM_006472	GC-M0226	GeneCopoeia	W01B008M16	pENTR221	859		TXNIP	10628	NP_006463.3	Hs.715525	Thioredoxin interacting protein						NM_006472.3	NP_006463.3	VALIDATED	Cs	0.995	0.995	391	1176	1	1173	391	1	391
IKAKEN	NM_006213	GC-Q0188	GeneCopoeia	W01B008M18	pENTR221	22182		PHKG1	5260	NP_006204.1	Hs.715728	Phosphorylase kinase, gamma 1 (muscle)						NM_006213.3	NP_006204.1	REVIEWED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	NM_001890	GC-S0252	GeneCopoeia	W01B008M20	pENTR221	17769		CSN1S1	1446	NP_001881.1	Hs.3155	Casein alpha s1						NM_001890.1	NP_001881.1	VALIDATED	Cs	0.989	0.989	185	558	1	555	185	1	185
IKAKEN	NM_000273	GC-S0620	GeneCopoeia	W01B008M22	pENTR221	25401		GPR143	4935	NP_000264.1	Hs.74124	G protein-coupled receptor 143						NM_000273.1	NP_000264.1	REVIEWED	Cs	0.998	0.998	424	1275	1	1272	424	1	424
IKAKEN	NM_018968	GC-T0660	GeneCopoeia	W01B008M24	pENTR221	13219		SNTG2	54221	NP_061841.1	Hs.657453	Syntrophin, gamma 2						NM_018968.2	NP_061841.1	REVIEWED	Cs	0.998	0.998	539	1620	1	1617	539	1	539
IKAKEN	NM_015383	GC-T1277	GeneCopoeia	W01B008N01	pENTR221	475		NBPF14	25832	NP_056198.1	Hs.607640	Neuroblastoma breakpoint family, member 14						NM_015383.1	NP_056198.1	PREDICTED	Cs	0.999	0.999	921	2766	1	2763	921	1	921
IKAKEN	NM_033024	GC-V1734	GeneCopoeia	W01B008N02	pENTR221			MACF1	23499		Hs.580782	Microtubule-actin crosslinking factor 1						NM_033044.2	NP_149033.2	REVIEWED	Pg	0.857	1.000	258	777	1	774	5938	5718	5938
IKAKEN	NM_021013	GC-T1642	GeneCopoeia	W01B008N03	pENTR221	10735		KRT34	3885	NP_066293.2	Hs.296942	Keratin 34						NM_021013.3	NP_066293.2	REVIEWED	Cs	0.991	0.991	436	1311	1	1308	436	1	436
IKAKEN	NM_012318	GC-W0230	GeneCopoeia	W01B008N04	pENTR221	18060		LETM1	3954	NP_036450.1	Hs.120165	Leucine zipper-EF-hand containing transmembrane protein 1						NM_012318.2	NP_036450.1	VALIDATED	Cs	0.999	0.999	739	2220	1	2217	739	1	739
IKAKEN	BC022258	GC-T2497	GeneCopoeia	W01B008N05	pENTR221	5916		VWF	7450	AAH22258.1	Hs.440848	Von Willebrand factor						NM_000552.3	NP_000543.2	REVIEWED	P	1.000	1.000	201	822	166	768	2813	19	219
IKAKEN	AF271775	GC-W0891	GeneCopoeia	W01B008N06	pENTR221	9197		LOC440354	440354	AAG44786.1																				
IKAKEN	NM_053000	GC-T3208	GeneCopoeia	W01B008N07	pENTR221	18530		C5orf26	114915	NP_443726	Hs.12082	Chromosome 5 open reading frame 26																		
IKAKEN	AJ224328	GC-W1275	GeneCopoeia	W01B008N08	pENTR221	20449		MOCS1	4337	CAA11898.1	Hs.718492	Molybdenum cofactor synthesis 1						NM_005942.3	NP_005933.2	REVIEWED	P	1.000	1.000	223	672	1	669	636	414	636
IKAKEN	NM_080741	GC-T3308	GeneCopoeia	W01B008N09	pENTR221	12943		NEU4	129807	NP_542779.2	Hs.551747	Sialidase 4						NM_080741.1	NP_542779.2	REVIEWED	P	1.000	1.000	230	693	3	692	496	105	334
IKAKEN	NM_030786	GC-W2332	GeneCopoeia	W01B008N10	pENTR221	1876		SYNC	81493	NP_110413.2	Hs.712631	Syncoilin, intermediate filament protein						NM_030786.2	NP_110413.2	VALIDATED	P	1.000	1.000	151	456	1	453	482	332	482
IKAKEN	NM_021638	GC-T3623	GeneCopoeia	W01B008N11	pENTR221	18030		AFAP1	60312	NP_067651.2	Hs.529369	Actin filament associated protein 1						NM_198595.2	NP_940997.1	REVIEWED	Cs	0.996	0.996	730	2193	1	2190	730	1	730
IKAKEN	AB084917	GC-T4572	GeneCopoeia	W01B008N13	pENTR221	1474		PPIAL4A	164022	BAB92073.1	Hs.573713	Peptidylprolyl isomerase A (cyclophilin A)-like 4A						NM_178230.1	NP_839944.1	PROVISIONAL		0.970	0.970	164	495	1	492	164	1	164
IKAKEN	AK094537	GC-T6215	GeneCopoeia	W01B008N15	pENTR221	23689		LOC389791	389791	BAC04375	Hs.632678	Hypothetical LOC389791																		
IKAKEN	BC031979	GC-T7168	GeneCopoeia	W01B008N17	pENTR221	5050		hCG_2032978	399978																					
IKAKEN	NM_005328	GC-U0330	GeneCopoeia	W01B008N19	pENTR221	23270		HAS2	3037	NP_005319.1	Hs.159226	Hyaluronan synthase 2						NM_005328.2	NP_005319.1	REVIEWED	Cs	0.995	0.995	552	1659	1	1656	552	1	552
IKAKEN	NM_016352	GC-U0805	GeneCopoeia	W01B008N21	pENTR221	21148		CPA4	51200	NP_057436.2	Hs.93764	Carboxypeptidase A4						NM_016352.3	NP_057436.2	REVIEWED	Cs	0.995	0.995	421	1266	1	1263	421	1	421
IKAKEN	NM_005867	GC-U1206	GeneCopoeia	W01B008N23	pENTR221	15310		DSCR4	10281	NP_005858.1	Hs.23251	Down syndrome critical region gene 4						NM_005867.2	NP_005858.1	REVIEWED	Cfs	0.983	0.983	118	357	1	354	118	1	118
IKAKEN	U79143	GC-A1195	GeneCopoeia	W01B008O02	pENTR221	16196		PIK3CA	5290	AAB39753.1	Hs.85701	Phosphoinositide-3-kinase, catalytic, alpha polypeptide						NM_006218.2	NP_006209.2	REVIEWED	Cs	0.999	0.999	1068	3207	1	3204	1068	1	1068
IKAKEN	M60445	GC-C0410	GeneCopoeia	W01B008O04	pENTR221	8270		HDC	3067	AAC41698.1	Hs.1481	Histidine decarboxylase						NM_002112.2	NP_002103.2	VALIDATED	Cs	0.997	0.997	662	1989	1	1986	662	1	662
IKAKEN	Z29074	GC-D0376	GeneCopoeia	W01B008O06	pENTR221	10183		KRT9	3857	CAA82315.1	Hs.654569	Keratin 9						NM_000226.3	NP_000217.2	REVIEWED	Cs	0.995	0.995	623	1872	1	1869	623	1	623
IKAKEN	AJ315733	GC-E0438	GeneCopoeia	W01B008O08	pENTR221	3890		ADAMTS15	170689	CAC86014.1	Hs.681791	ADAM metallopeptidase with thrombospondin type 1 motif, 15						NM_139055.1	NP_620686.1	REVIEWED	Cs	0.997	0.997	950	2853	1	2850	950	1	950
IKAKEN	AF466366	GC-E0677	GeneCopoeia	W01B008O10	pENTR221	6013		C1QL4	338761	AAO33387.1	Hs.380386	Complement component 1, q subcomponent-like 4						NM_001008223.1	NP_001008224.1	PROVISIONAL	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	NM_005337	GC-G0003	GeneCopoeia	W01B008O12	pENTR221	5566		NCKAP1L	3071	NP_005328.2	Hs.182014	NCK-associated protein 1-like						NM_005337.4	NP_005328.2	REVIEWED	Ps	0.997	0.997	613	1842	1	1839	1127	515	1127
IKAKEN	NM_001170	GC-I0013	GeneCopoeia	W01B008O14	pENTR221	23651		AQP7	364	NP_001161.1	Hs.455323	Aquaporin 7						NM_001170.1	NP_001161.1	REVIEWED	C	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	NM_004186	GC-M0428	GeneCopoeia	W01B008O16	pENTR221	16181		SEMA3F	6405	NP_004177.3	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F						NM_004186.3	NP_004177.3	VALIDATED	Cs	0.994	0.994	785	2358	1	2355	785	1	785
IKAKEN	NM_000330	GC-Q0232	GeneCopoeia	W01B008O18	pENTR221	25161		RS1	6247	NP_000321.1	Hs.715725	Retinoschisin 1						NM_000330.3	NP_000321.1	REVIEWED	Cs	0.991	0.991	224	675	1	672	224	1	224
IKAKEN	NM_002411	GC-S0263	GeneCopoeia	W01B008O20	pENTR221	4058		SCGB2A2	4250	NP_002402.1	Hs.46452	Secretoglobin, family 2A, member 2						NM_002411.2	NP_002402.1	PROVISIONAL	C	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	NM_014790	GC-T0019	GeneCopoeia	W01B008O22	pENTR221	19083		JAKMIP2	9832	NP_055605.2	Hs.719177	Janus kinase and microtubule interacting protein 2						NM_014790.3	NP_055605.2	PROVISIONAL	Pgs	0.971	0.997	804	2400	1	2349	810	1	804
IKAKEN	NM_001040	GC-T1010	GeneCopoeia	W01B008O24	pENTR221	10056		SHBG	6462	NP_001031.2	Hs.632235	Sex hormone-binding globulin						NM_001040.3	NP_001031.2	REVIEWED	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	NM_001852	GC-T1294	GeneCopoeia	W01B008P01	pENTR221	2210		COL9A2	1298	NP_001843.1	Hs.418012	Collagen, type IX, alpha 2						NM_001852.3	NP_001843.1	REVIEWED	Cs	0.999	0.999	689	2070	1	2067	689	1	689
IKAKEN	AF297710	GC-W0061	GeneCopoeia	W01B008P02	pENTR221	21804		TPK1	27010	AAK01351.1	Hs.660232	Thiamin pyrophosphokinase 1						NM_022445.3	NP_071890.2	REVIEWED	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	NM_033259	GC-T1680	GeneCopoeia	W01B008P03	pENTR221	17151		CAMK2N2	94032	NP_150284.1	Hs.585003	Calcium/calmodulin-dependent protein kinase II inhibitor 2						NM_033259.2	NP_150284.1	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	NM_013364	GC-W0282	GeneCopoeia	W01B008P04	pENTR221	24599		PNMA3	29944	NP_037496.3	Hs.449627	Paraneoplastic antigen MA3						NM_013364.4	NP_037496.3	REVIEWED	Cs	0.991	0.991	463	1392	1	1389	463	1	463
IKAKEN	BC014107	GC-T2645	GeneCopoeia	W01B008P05	pENTR221	21163		ADCK2	90956	AAH14107.1	Hs.534141	AarF domain containing kinase 2						NM_052853.3	NP_443085.2	VALIDATED	P	1.000	1.000	388	1224	1	1164	626	1	388
IKAKEN	AF302150	GC-W1026	GeneCopoeia	W01B008P06	pENTR221	5213		PLEKHA5	54477	AAG22817.1	Hs.188614	Pleckstrin homology domain containing, family A member 5						NM_019012.3	NP_061885.2	VALIDATED	Cs	0.999	0.999	1116	3351	1	3348	1116	1	1116
IKAKEN	NM_033378	GC-T3217	GeneCopoeia	W01B008P07	pENTR221	11988		CGB2	114336	NP_203696.2	Hs.567650	Chorionic gonadotropin, beta polypeptide 2						NM_033378.1	NP_203696.2	REVIEWED	Ps	0.991	0.991	116	399	50	397	163	1	116
IKAKEN	NM_019060	GC-W1287	GeneCopoeia	W01B008P08	pENTR221	520		CRCT1	54544	NP_061933.1	Hs.110196	Cysteine-rich C-terminal 1						NM_019060.2	NP_061933.1	VALIDATED	C	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	NM_133639	GC-T3316	GeneCopoeia	W01B008P09	pENTR221	8131		RHOV	171177	NP_598378.3	Hs.447901	Ras homolog gene family, member V						NM_133639.3	NP_598378.3	VALIDATED	C	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	NM_033254	GC-W2837	GeneCopoeia	W01B008P10	pENTR221	16418		BOC	91653	NP_150279.1	Hs.591318	Boc homolog (mouse)						NM_033254.2	NP_150279.1	VALIDATED	Cs	0.999	0.999	1114	3345	1	3342	1114	1	1114
IKAKEN	BC029796	GC-T3827	GeneCopoeia	W01B008P11	pENTR221	19425		C5orf55	116349	AAH29796.1	Hs.446702	Chromosome 5 open reading frame 55						NM_138464.2	NP_612473.1	VALIDATED	Cs	0.992	0.992	119	360	1	357	119	1	119
IKAKEN	AF361356	GC-T4748	GeneCopoeia	W01B008P13	pENTR221	13189		TMEM37	140738	AAL50051.1	Hs.26216	Transmembrane protein 37						NM_183240.2	NP_899063.2	VALIDATED	Cgs	0.979	0.989	192	579	1	576	190	1	190
IKAKEN	AK095564	GC-T6352	GeneCopoeia	W01B008P15	pENTR221	545		LOC100131053	100131053	BAC04575	Hs.697104	Hypothetical LOC100131053						XM_001720101.1	XP_001720153.1	MODEL	Cs	0.983	0.983	175	528	1	525	175	1	175
IKAKEN	BC032944	GC-T7233	GeneCopoeia	W01B008P17	pENTR221	7315		KIAA0317	9870	AAH32944.1	Hs.497417	KIAA0317						NM_001039479.1	NP_001034568.1	VALIDATED	Ps	0.996	0.996	789	2370	1	2367	823	1	789
IKAKEN	XM_010071	GC-U0340	GeneCopoeia	W01B008P19	pENTR221															
IKAKEN	NM_016086	GC-U0850	GeneCopoeia	W01B008P21	pENTR221	21879		STYXL1	51657	NP_057170.1	Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	C	1.000	1.000	313	942	1	939	313	1	313
IKAKEN	XM_002585	GC-U1221	GeneCopoeia	W01B008P23	pENTR221															
IKAKEN	NM_002891	GC-A0506	GeneCopoeia	W01B009B01	pENTR221	8296		RASGRF1	5923	NP_002882.3	Hs.459035	Ras protein-specific guanine nucleotide-releasing factor 1						NM_153815.2	NP_722522.1	REVIEWED	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	L36140	GC-M0318	GeneCopoeia	W01B009B03	pENTR221	6199		RECQL	5965	AAA60261.1	Hs.235069	RecQ protein-like (DNA helicase Q1-like)						NM_002907.3	NP_002898.2	REVIEWED	Cfs	0.994	0.994	649	1980	1	1949	649	1	649
IKAKEN	NM_003918	GC-T0830	GeneCopoeia	W01B009B05	pENTR221	24761		GYG2	8908	NP_003909.2	Hs.567381	Glycogenin 2						NM_003918.2	NP_003909.2	VALIDATED	Cs	0.996	0.996	501	1506	1	1503	501	1	501
IKAKEN	BC021726	GC-T4223	GeneCopoeia	W01B009B07	pENTR221	6951		SAMD4A	23034	AAH21726.2	Hs.98259	Sterile alpha motif domain containing 4A						NM_015589.3	NP_056404.2	PROVISIONAL	Pg	0.896	1.000	345	1038	1	1035	717	409	717
IKAKEN	BC030602	GC-T4323	GeneCopoeia	W01B009B09	pENTR221	10214		MYO1D	4642	AAH30602	Hs.658000	Myosin ID						NM_015194.1	NP_056009.1	PROVISIONAL	Ps	0.993	0.993	433	1311	1	1299	1006	1	433
IKAKEN	AK074570	GC-T5494	GeneCopoeia	W01B009B11	pENTR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B						NM_025190.2	NP_079466.2	VALIDATED		0.967	0.967	30	720	629	718	1121	1	30
IKAKEN	AK093919	GC-T6134	GeneCopoeia	W01B009B13	pENTR221	10507		KRT40	125115	BAC04250.1	Hs.567666	Keratin 40						NM_182497.2	NP_872303.2	VALIDATED		0.979	0.979	233	744	1	699	431	1	233
IKAKEN	NM_014824	GC-U0681	GeneCopoeia	W01B009B15	pENTR221	4407		FCHSD2	9873	NP_055639.2	Hs.577053	FCH and double SH3 domains 2						NM_014824.2	NP_055639.2	VALIDATED	Ps	0.996	0.996	684	2055	1	2052	740	57	740
IKAKEN	NM_018667	GC-U1166	GeneCopoeia	W01B009B17	pENTR221	9229		SMPD3	55512	NP_061137.1	Hs.368421	Sphingomyelin phosphodiesterase 3, neutral membrane (neutral sphingomyelinase II)						NM_018667.3	NP_061137.1	VALIDATED	Cs	0.998	0.998	655	1968	1	1965	655	1	655
IKAKEN	AF249745	GC-U1396	GeneCopoeia	W01B009B19	pENTR221	12925		ARHGEF4	50649	AAF79955.1	Hs.469935	Rho guanine nucleotide exchange factor (GEF) 4						NM_015320.2	NP_056135.2	REVIEWED	Pfs	0.998	0.998	657	2163	1	1969	690	34	690
IKAKEN	NM_014841	GC-W0019	GeneCopoeia	W01B009B21	pENTR221	20343		SNAP91	9892	NP_055656.1	Hs.368046	Synaptosomal-associated protein, 91kDa homolog (mouse)						NM_014841.2	NP_055656.1	VALIDATED	C	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	NM_016644	GC-W0787	GeneCopoeia	W01B009B23	pENTR221	18671		PRR16	51334	NP_057728.1	Hs.157461	Proline rich 16						NM_016644.1	NP_057728.1	PROVISIONAL	C	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	AK027852	GC-W2799	GeneCopoeia	W01B009D01	pENTR221	4663		ROBO4	54538	BAB55411.1	Hs.524121	Roundabout homolog 4, magic roundabout (Drosophila)						NM_019055.5	NP_061928.4	VALIDATED	Pfs	0.994	0.994	793	2379	1	2378	1007	1	793
Funakoshi	EU832762	OHS4559-99868993	OpenBiosystems(on_gateway)	W01B010A01	pENTR221			SS18	6760	ACE87773.1	Hs.404263	Synovial sarcoma translocation, chromosome 18					DH10B	NM_001007559.1	NP_001007560.1	VALIDATED	C	1	1	418	1300	23	1276	418	1	418
Funakoshi	EU832157	OHS4559-99868384	OpenBiosystems(on_gateway)	W01B010A03	pENTR221			SMARCC1	6599	ACE87507.1	Hs.476179	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily c, member 1					DH10B	NM_003074.3	NP_003065.3	VALIDATED	Cs	0.999	0.999	1105	3361	23	3337	1105	1	1105
Funakoshi	EU831945	OHS4559-99868181	OpenBiosystems(on_gateway)	W01B010A05	pENTR221			HELLS	3070	ACE87386.1	Hs.655830	Helicase, lymphoid-specific					DH10B	NM_018063.3	NP_060533.2	REVIEWED	Ps	0.998	0.998	822	2512	23	2488	838	17	838
Funakoshi	GQ129403	OHS4559-101036581	OpenBiosystems(on_gateway)	W01B010A07	pENTR221			EBF1	1879	ACT64537.1	Hs.573143	Early B-cell factor 1					DH10B	NM_024007.3	NP_076870.1	VALIDATED	C	1.000	1.000	591	1819	23	1795	591	1	591
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C001A01	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C001A02	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C001A03	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C001A04	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C001A05	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C001A06	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C001A07	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C001A08	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C001A09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C001A10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C001A11	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C001A12	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C001A13	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C001A14	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C001A15	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C001A16	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C001A17	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C001A18	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C001A19	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C001A20	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C001A21	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C001A22	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C001A23	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C001A24	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C001B01	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C001B02	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C001B03	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C001B04	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C001B05	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C001B06	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C001B07	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C001B08	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C001B09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C001B10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C001B11	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C001B12	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C001B13	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C001B14	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C001B15	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C001B16	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C001B17	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C001B18	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C001B19	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C001B20	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C001B21	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C001B22	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C001B23	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C001B24	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C001C01	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C001C02	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C001C03	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C001C04	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C001C05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C001C06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C001C07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C001C08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C001C09	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C001C10	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C001C11	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C001C12	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C001C13	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C001C14	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C001C15	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C001C16	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C001C17	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C001C18	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C001C19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C001C20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C001C21	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C001C22	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C001C23	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C001C24	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C001D01	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C001D02	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C001D03	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C001D04	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C001D05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C001D06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C001D07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C001D08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C001D09	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C001D10	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C001D11	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C001D12	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C001D13	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C001D14	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C001D15	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C001D16	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C001D17	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C001D18	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C001D19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C001D20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C001D21	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C001D22	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C001D23	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C001D24	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C001E01	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C001E02	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C001E03	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C001E04	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C001E05	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C001E06	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C001E07	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C001E08	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C001E09	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C001E10	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C001E11	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C001E12	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C001E13	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C001E14	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C001E15	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C001E16	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C001E17	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C001E18	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C001E19	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C001E20	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C001E21	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C001E22	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C001E23	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C001E24	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C001F01	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C001F02	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C001F03	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C001F04	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C001F05	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C001F06	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C001F07	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C001F08	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C001F09	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C001F10	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C001F11	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C001F12	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C001F13	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C001F14	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C001F15	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C001F16	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C001F17	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C001F18	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C001F19	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C001F20	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C001F21	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C001F22	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C001F23	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C001F24	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C001G01	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C001G02	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C001G03	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C001G04	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C001G05	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C001G06	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C001G07	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C001G08	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C001G09	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C001G10	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C001G11	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C001G12	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C001G13	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C001G14	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C001G15	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C001G16	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C001G17	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C001G18	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C001G19	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C001G20	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C001G21	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C001G22	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C001G23	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C001G24	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C001H01	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C001H02	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C001H03	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C001H04	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C001H05	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C001H06	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C001H07	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C001H08	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C001H09	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C001H10	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C001H11	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C001H12	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C001H13	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C001H14	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C001H15	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C001H16	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C001H17	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C001H18	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C001H19	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C001H20	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C001H21	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C001H22	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C001H23	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C001H24	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C001I01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C001I02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C001I03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C001I04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C001I05	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C001I06	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C001I07	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C001I08	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C001I09	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C001I10	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C001I11	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C001I12	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C001I13	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C001I14	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C001I15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C001I16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C001I17	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C001I18	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C001I19	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C001I20	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C001I21	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C001I22	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C001I23	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C001I24	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C001J01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C001J02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C001J03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C001J04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C001J05	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C001J06	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C001J07	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C001J08	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C001J09	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C001J10	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C001J11	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C001J12	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C001J13	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C001J14	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C001J15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C001J16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C001J17	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C001J18	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C001J19	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C001J20	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C001J21	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C001J22	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C001J23	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C001J24	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C001K01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C001K02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C001K03	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C001K04	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C001K05	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C001K06	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C001K07	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C001K08	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C001K09	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C001K10	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C001K11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C001K12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C001K13	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C001K14	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C001K15	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C001K16	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C001K17	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C001K18	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C001K19	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C001K20	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C001K21	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C001K22	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C001K23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C001K24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C001L01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C001L02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C001L03	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C001L04	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C001L05	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C001L06	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C001L07	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C001L08	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C001L09	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C001L10	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C001L11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C001L12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C001L13	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C001L14	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C001L15	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C001L16	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C001L17	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C001L18	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C001L19	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C001L20	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C001L21	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C001L22	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C001L23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C001L24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C001M01	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C001M02	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C001M03	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C001M04	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C001M05	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C001M06	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C001M07	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C001M08	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C001M09	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C001M10	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C001M11	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C001M12	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C001M13	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C001M14	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C001M15	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C001M16	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C001M17	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C001M18	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C001M19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C001M20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C001M21	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C001M22	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C001M23	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C001M24	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C001N01	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C001N02	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C001N03	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C001N04	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C001N05	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C001N06	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C001N07	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C001N08	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C001N09	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C001N10	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C001N11	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C001N12	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C001N13	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C001N14	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C001N15	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C001N16	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C001N17	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C001N18	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C001N19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C001N20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C001N21	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C001N22	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C001N23	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C001N24	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C001O01	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C001O02	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C001O03	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C001O04	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C001O05	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C001O06	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C001O07	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C001O08	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C001O09	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C001O10	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C001O11	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C001O12	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C001O13	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C001O14	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C001O15	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C001O16	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C001O17	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C001O18	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C001O19	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C001O20	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C001O21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C001O22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C001O23	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C001O24	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C001P01	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C001P02	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C001P03	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C001P04	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C001P05	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C001P06	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C001P07	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C001P08	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C001P09	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C001P10	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C001P11	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C001P12	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C001P13	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C001P14	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C001P15	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C001P16	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C001P17	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C001P18	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C001P19	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C001P20	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C001P21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C001P22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C001P23	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C001P24	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C002A01	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C002A02	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C002A03	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C002A04	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C002A05	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C002A06	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C002A07	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C002A08	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C002A09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C002A10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C002A11	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C002A12	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C002A13	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C002A14	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C002A15	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C002A16	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C002A17	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C002A18	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C002A19	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C002A20	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C002A21	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C002A22	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C002A23	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C002A24	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C002B01	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	04-134-2_1-A01	MGC	W01C002B02	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C002B03	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	04-134-2_1-A02	MGC	W01C002B04	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C002B05	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	04-134-2_1-A03	MGC	W01C002B06	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C002B07	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	04-134-2_1-A04	MGC	W01C002B08	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C002B09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	04-134-2_1-A05	MGC	W01C002B10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C002B11	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	04-134-2_1-A06	MGC	W01C002B12	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C002B13	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	04-134-2_1-A07	MGC	W01C002B14	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C002B15	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	04-134-2_1-A08	MGC	W01C002B16	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C002B17	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	04-134-2_1-A09	MGC	W01C002B18	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C002B19	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	04-134-2_1-A10	MGC	W01C002B20	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C002B21	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	04-134-2_1-A11	MGC	W01C002B22	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C002B23	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	04-134-2_1-A12	MGC	W01C002B24	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C002C01	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C002C02	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C002C03	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C002C04	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C002C05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C002C06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C002C07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C002C08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C002C09	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C002C10	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C002C11	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C002C12	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C002C13	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C002C14	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C002C15	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C002C16	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C002C17	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C002C18	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C002C19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C002C20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C002C21	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C002C22	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C002C23	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C002C24	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C002D01	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	04-134-2_1-B01	MGC	W01C002D02	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C002D03	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	04-134-2_1-B02	MGC	W01C002D04	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C002D05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	04-134-2_1-B03	MGC	W01C002D06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C002D07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	04-134-2_1-B04	MGC	W01C002D08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C002D09	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	04-134-2_1-B05	MGC	W01C002D10	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C002D11	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	04-134-2_1-B06	MGC	W01C002D12	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C002D13	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	04-134-2_1-B07	MGC	W01C002D14	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C002D15	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	04-134-2_1-B08	MGC	W01C002D16	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C002D17	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	04-134-2_1-B09	MGC	W01C002D18	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C002D19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	04-134-2_1-B10	MGC	W01C002D20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C002D21	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	04-134-2_1-B11	MGC	W01C002D22	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C002D23	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	04-134-2_1-B12	MGC	W01C002D24	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C002E01	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C002E02	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C002E03	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C002E04	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C002E05	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C002E06	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C002E07	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C002E08	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C002E09	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C002E10	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C002E11	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C002E12	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C002E13	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C002E14	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C002E15	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C002E16	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C002E17	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C002E18	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C002E19	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C002E20	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C002E21	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C002E22	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C002E23	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C002E24	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C002F01	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	04-134-2_1-C01	MGC	W01C002F02	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C002F03	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	04-134-2_1-C02	MGC	W01C002F04	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C002F05	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	04-134-2_1-C03	MGC	W01C002F06	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C002F07	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	04-134-2_1-C04	MGC	W01C002F08	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C002F09	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	04-134-2_1-C05	MGC	W01C002F10	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C002F11	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	04-134-2_1-C06	MGC	W01C002F12	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C002F13	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	04-134-2_1-C07	MGC	W01C002F14	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C002F15	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	04-134-2_1-C08	MGC	W01C002F16	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C002F17	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	04-134-2_1-C09	MGC	W01C002F18	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C002F19	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	04-134-2_1-C10	MGC	W01C002F20	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C002F21	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	04-134-2_1-C11	MGC	W01C002F22	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C002F23	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	04-134-2_1-C12	MGC	W01C002F24	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C002G01	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C002G02	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C002G03	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C002G04	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C002G05	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C002G06	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C002G07	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C002G08	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C002G09	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C002G10	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C002G11	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C002G12	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C002G13	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C002G14	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C002G15	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C002G16	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C002G17	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C002G18	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C002G19	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C002G20	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C002G21	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C002G22	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C002G23	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C002G24	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C002H01	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	04-134-2_1-D01	MGC	W01C002H02	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C002H03	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	04-134-2_1-D02	MGC	W01C002H04	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C002H05	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	04-134-2_1-D03	MGC	W01C002H06	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C002H07	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	04-134-2_1-D04	MGC	W01C002H08	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C002H09	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	04-134-2_1-D05	MGC	W01C002H10	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C002H11	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	04-134-2_1-D06	MGC	W01C002H12	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C002H13	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	04-134-2_1-D07	MGC	W01C002H14	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C002H15	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	04-134-2_1-D08	MGC	W01C002H16	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C002H17	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	04-134-2_1-D09	MGC	W01C002H18	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C002H19	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	04-134-2_1-D10	MGC	W01C002H20	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C002H21	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	04-134-2_1-D11	MGC	W01C002H22	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C002H23	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	04-134-2_1-D12	MGC	W01C002H24	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C002I01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C002I02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C002I03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C002I04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C002I05	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C002I06	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C002I07	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C002I08	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C002I09	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C002I10	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C002I11	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C002I12	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C002I13	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C002I14	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C002I15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C002I16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C002I17	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C002I18	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C002I19	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C002I20	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C002I21	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C002I22	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C002I23	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C002I24	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C002J01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	04-134-2_1-E01	MGC	W01C002J02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C002J03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	04-134-2_1-E02	MGC	W01C002J04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C002J05	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	04-134-2_1-E03	MGC	W01C002J06	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C002J07	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	04-134-2_1-E04	MGC	W01C002J08	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C002J09	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	04-134-2_1-E05	MGC	W01C002J10	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C002J11	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	04-134-2_1-E06	MGC	W01C002J12	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C002J13	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	04-134-2_1-E07	MGC	W01C002J14	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C002J15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	04-134-2_1-E08	MGC	W01C002J16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C002J17	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	04-134-2_1-E09	MGC	W01C002J18	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C002J19	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	04-134-2_1-E10	MGC	W01C002J20	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C002J21	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	04-134-2_1-E11	MGC	W01C002J22	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C002J23	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	04-134-2_1-E12	MGC	W01C002J24	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C002K01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C002K02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C002K03	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C002K04	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C002K05	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C002K06	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C002K07	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C002K08	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C002K09	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C002K10	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C002K11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C002K12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C002K13	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C002K14	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C002K15	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C002K16	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C002K17	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C002K18	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C002K19	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C002K20	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C002K21	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C002K22	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C002K23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C002K24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C002L01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	04-134-2_1-F01	MGC	W01C002L02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C002L03	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	04-134-2_1-F02	MGC	W01C002L04	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C002L05	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	04-134-2_1-F03	MGC	W01C002L06	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C002L07	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	04-134-2_1-F04	MGC	W01C002L08	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C002L09	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	04-134-2_1-F05	MGC	W01C002L10	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C002L11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	04-134-2_1-F06	MGC	W01C002L12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C002L13	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	04-134-2_1-F07	MGC	W01C002L14	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C002L15	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	04-134-2_1-F08	MGC	W01C002L16	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C002L17	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	04-134-2_1-F09	MGC	W01C002L18	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C002L19	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	04-134-2_1-F10	MGC	W01C002L20	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C002L21	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	04-134-2_1-F11	MGC	W01C002L22	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C002L23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	04-134-2_1-F12	MGC	W01C002L24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C002M01	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C002M02	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C002M03	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C002M04	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C002M05	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C002M06	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C002M07	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C002M08	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C002M09	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C002M10	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C002M11	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C002M12	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C002M13	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C002M14	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C002M15	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C002M16	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C002M17	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C002M18	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C002M19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C002M20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C002M21	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C002M22	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C002M23	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C002M24	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C002N01	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	04-134-2_1-G01	MGC	W01C002N02	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C002N03	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	04-134-2_1-G02	MGC	W01C002N04	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C002N05	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	04-134-2_1-G03	MGC	W01C002N06	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C002N07	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	04-134-2_1-G04	MGC	W01C002N08	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C002N09	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	04-134-2_1-G05	MGC	W01C002N10	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C002N11	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	04-134-2_1-G06	MGC	W01C002N12	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C002N13	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	04-134-2_1-G07	MGC	W01C002N14	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C002N15	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	04-134-2_1-G08	MGC	W01C002N16	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C002N17	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	04-134-2_1-G09	MGC	W01C002N18	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C002N19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	04-134-2_1-G10	MGC	W01C002N20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C002N21	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	04-134-2_1-G11	MGC	W01C002N22	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C002N23	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	04-134-2_1-G12	MGC	W01C002N24	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C002O01	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C002O02	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C002O03	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C002O04	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C002O05	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C002O06	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C002O07	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C002O08	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C002O09	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C002O10	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C002O11	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C002O12	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C002O13	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C002O14	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C002O15	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C002O16	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C002O17	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C002O18	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C002O19	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C002O20	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C002O21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C002O22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C002O23	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C002O24	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C002P01	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	04-134-2_1-H01	MGC	W01C002P02	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C002P03	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	04-134-2_1-H02	MGC	W01C002P04	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C002P05	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	04-134-2_1-H03	MGC	W01C002P06	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C002P07	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	04-134-2_1-H04	MGC	W01C002P08	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C002P09	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	04-134-2_1-H05	MGC	W01C002P10	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C002P11	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	04-134-2_1-H06	MGC	W01C002P12	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C002P13	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	04-134-2_1-H07	MGC	W01C002P14	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C002P15	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	04-134-2_1-H08	MGC	W01C002P16	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C002P17	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	04-134-2_1-H09	MGC	W01C002P18	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C002P19	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	04-134-2_1-H10	MGC	W01C002P20	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C002P21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	04-134-2_1-H11	MGC	W01C002P22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C002P23	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	04-134-2_1-H12	MGC	W01C002P24	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C003A01	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C003A02	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C003A03	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C003A04	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C003A05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C003A06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C003A07	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C003A08	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C003A09	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C003A10	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C003A11	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C003A12	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C003A13	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C003A14	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C003A15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C003A16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C003A17	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C003A18	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C003A19	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C003A20	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C003A21	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C003A22	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C003A23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C003A24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C003B01	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C003B02	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C003B03	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C003B04	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C003B05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C003B06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C003B07	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C003B08	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C003B09	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C003B10	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C003B11	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C003B12	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C003B13	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C003B14	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C003B15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C003B16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C003B17	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C003B18	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C003B19	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C003B20	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C003B21	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C003B22	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C003B23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C003B24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C003C01	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C003C02	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C003C03	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C003C04	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C003C05	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C003C06	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C003C07	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C003C08	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C003C09	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C003C10	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C003C11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C003C12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C003C13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C003C14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C003C15	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C003C16	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C003C17	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C003C18	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C003C19	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C003C20	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C003C21	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C003C22	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C003C23	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C003C24	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C003D01	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C003D02	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C003D03	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C003D04	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C003D05	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C003D06	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C003D07	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C003D08	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C003D09	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C003D10	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C003D11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C003D12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C003D13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C003D14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C003D15	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C003D16	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C003D17	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C003D18	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C003D19	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C003D20	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C003D21	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C003D22	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C003D23	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C003D24	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C003E01	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C003E02	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C003E03	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C003E04	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C003E05	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C003E06	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C003E07	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C003E08	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C003E09	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C003E10	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C003E11	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C003E12	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C003E13	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C003E14	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C003E15	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C003E16	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C003E17	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C003E18	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C003E19	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C003E20	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C003E21	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C003E22	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C003E23	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C003E24	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C003F01	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C003F02	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C003F03	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C003F04	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C003F05	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C003F06	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C003F07	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C003F08	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C003F09	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C003F10	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C003F11	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C003F12	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C003F13	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C003F14	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C003F15	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C003F16	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C003F17	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C003F18	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C003F19	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C003F20	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C003F21	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C003F22	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C003F23	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C003F24	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C003G01	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C003G02	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C003G03	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C003G04	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C003G05	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C003G06	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C003G07	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C003G08	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C003G09	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C003G10	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C003G11	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C003G12	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C003G13	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C003G14	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C003G15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C003G16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C003G17	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C003G18	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C003G19	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C003G20	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C003G21	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C003G22	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C003G23	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C003G24	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C003H01	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C003H02	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C003H03	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C003H04	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C003H05	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C003H06	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C003H07	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C003H08	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C003H09	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C003H10	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C003H11	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C003H12	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C003H13	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C003H14	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C003H15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C003H16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C003H17	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C003H18	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C003H19	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C003H20	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C003H21	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C003H22	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C003H23	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C003H24	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C003I01	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C003I02	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C003I03	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C003I04	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C003I05	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C003I06	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C003I07	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C003I08	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C003I09	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C003I10	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C003I11	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C003I12	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C003I13	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C003I14	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C003I15	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C003I16	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C003I17	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C003I18	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C003I19	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C003I20	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C003I21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C003I22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C003I23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C003I24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C003J01	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C003J02	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C003J03	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C003J04	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C003J05	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C003J06	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C003J07	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C003J08	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C003J09	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C003J10	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C003J11	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C003J12	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C003J13	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C003J14	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C003J15	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C003J16	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C003J17	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C003J18	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C003J19	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C003J20	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C003J21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C003J22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C003J23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C003J24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C003K01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C003K02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C003K03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C003K04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C003K05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C003K06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C003K07	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C003K08	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C003K09	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C003K10	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C003K11	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C003K12	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C003K13	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C003K14	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C003K15	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C003K16	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C003K17	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C003K18	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C003K19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C003K20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C003K21	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C003K22	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C003K23	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C003K24	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C003L01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C003L02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C003L03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C003L04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C003L05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C003L06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C003L07	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C003L08	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C003L09	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C003L10	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C003L11	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C003L12	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C003L13	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C003L14	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C003L15	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C003L16	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C003L17	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C003L18	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C003L19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C003L20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C003L21	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C003L22	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C003L23	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C003L24	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C003M01	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C003M02	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C003M03	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C003M04	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C003M05	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C003M06	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C003M07	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C003M08	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C003M09	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C003M10	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C003M11	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C003M12	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C003M13	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C003M14	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C003M15	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C003M16	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C003M17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C003M18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C003M19	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C003M20	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C003M21	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C003M22	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C003M23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C003M24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C003N01	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C003N02	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C003N03	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C003N04	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C003N05	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C003N06	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C003N07	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C003N08	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C003N09	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C003N10	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C003N11	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C003N12	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C003N13	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C003N14	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C003N15	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C003N16	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C003N17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C003N18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C003N19	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C003N20	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C003N21	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C003N22	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C003N23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C003N24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C003O01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C003O02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C003O03	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C003O04	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C003O05	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C003O06	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C003O07	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C003O08	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C003O09	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C003O10	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C003O11	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C003O12	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C003O13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C003O14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C003O15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C003O16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C003O17	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C003O18	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C003O19	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C003O20	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C003O21	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C003O22	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C003O23	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C003O24	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C003P01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C003P02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C003P03	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C003P04	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C003P05	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C003P06	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C003P07	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C003P08	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C003P09	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C003P10	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C003P11	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C003P12	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C003P13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C003P14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C003P15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C003P16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C003P17	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C003P18	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C003P19	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C003P20	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C003P21	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C003P22	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C003P23	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C003P24	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C004A01	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C004A02	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C004A03	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C004A04	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C004A05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C004A06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C004A07	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C004A08	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C004A09	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C004A10	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C004A11	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C004A12	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C004A13	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C004A14	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C004A15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C004A16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C004A17	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C004A18	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C004A19	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C004A20	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C004A21	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C004A22	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C004A23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C004A24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C004B01	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	04-134-2_2-A01	MGC	W01C004B02	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C004B03	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	04-134-2_2-A02	MGC	W01C004B04	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C004B05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	04-134-2_2-A03	MGC	W01C004B06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C004B07	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	04-134-2_2-A04	MGC	W01C004B08	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C004B09	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	04-134-2_2-A05	MGC	W01C004B10	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C004B11	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	04-134-2_2-A06	MGC	W01C004B12	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C004B13	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	04-134-2_2-A07	MGC	W01C004B14	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C004B15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	04-134-2_2-A08	MGC	W01C004B16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C004B17	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	04-134-2_2-A09	MGC	W01C004B18	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C004B19	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	04-134-2_2-A10	MGC	W01C004B20	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C004B21	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	04-134-2_2-A11	MGC	W01C004B22	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C004B23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	04-134-2_2-A12	MGC	W01C004B24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C004C01	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C004C02	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C004C03	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C004C04	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C004C05	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C004C06	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C004C07	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C004C08	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C004C09	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C004C10	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C004C11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C004C12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C004C13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C004C14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C004C15	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C004C16	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C004C17	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C004C18	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C004C19	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C004C20	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C004C21	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C004C22	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C004C23	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C004C24	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C004D01	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	04-134-2_2-B01	MGC	W01C004D02	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C004D03	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	04-134-2_2-B02	MGC	W01C004D04	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C004D05	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	04-134-2_2-B03	MGC	W01C004D06	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C004D07	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	04-134-2_2-B04	MGC	W01C004D08	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C004D09	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	04-134-2_2-B05	MGC	W01C004D10	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C004D11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	04-134-2_2-B06	MGC	W01C004D12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C004D13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	04-134-2_2-B07	MGC	W01C004D14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C004D15	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	04-134-2_2-B08	MGC	W01C004D16	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C004D17	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	04-134-2_2-B09	MGC	W01C004D18	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C004D19	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	04-134-2_2-B10	MGC	W01C004D20	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C004D21	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	04-134-2_2-B11	MGC	W01C004D22	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C004D23	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	04-134-2_2-B12	MGC	W01C004D24	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C004E01	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C004E02	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C004E03	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C004E04	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C004E05	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C004E06	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C004E07	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C004E08	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C004E09	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C004E10	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C004E11	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C004E12	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C004E13	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C004E14	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C004E15	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C004E16	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C004E17	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C004E18	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C004E19	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C004E20	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C004E21	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C004E22	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C004E23	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C004E24	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C004F01	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	04-134-2_2-C01	MGC	W01C004F02	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C004F03	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	04-134-2_2-C02	MGC	W01C004F04	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C004F05	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	04-134-2_2-C03	MGC	W01C004F06	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C004F07	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	04-134-2_2-C04	MGC	W01C004F08	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C004F09	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	04-134-2_2-C05	MGC	W01C004F10	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C004F11	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	04-134-2_2-C06	MGC	W01C004F12	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C004F13	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	04-134-2_2-C07	MGC	W01C004F14	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C004F15	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	04-134-2_2-C08	MGC	W01C004F16	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C004F17	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	04-134-2_2-C09	MGC	W01C004F18	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C004F19	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	04-134-2_2-C10	MGC	W01C004F20	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C004F21	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	04-134-2_2-C11	MGC	W01C004F22	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C004F23	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	04-134-2_2-C12	MGC	W01C004F24	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C004G01	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C004G02	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C004G03	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C004G04	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C004G05	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C004G06	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C004G07	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C004G08	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C004G09	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C004G10	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C004G11	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C004G12	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C004G13	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C004G14	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C004G15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C004G16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C004G17	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C004G18	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C004G19	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C004G20	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C004G21	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C004G22	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C004G23	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C004G24	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C004H01	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	04-134-2_2-D01	MGC	W01C004H02	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C004H03	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	04-134-2_2-D02	MGC	W01C004H04	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C004H05	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	04-134-2_2-D03	MGC	W01C004H06	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C004H07	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	04-134-2_2-D04	MGC	W01C004H08	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C004H09	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	04-134-2_2-D05	MGC	W01C004H10	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C004H11	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	04-134-2_2-D06	MGC	W01C004H12	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C004H13	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	04-134-2_2-D07	MGC	W01C004H14	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C004H15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	04-134-2_2-D08	MGC	W01C004H16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C004H17	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	04-134-2_2-D09	MGC	W01C004H18	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C004H19	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	04-134-2_2-D10	MGC	W01C004H20	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C004H21	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	04-134-2_2-D11	MGC	W01C004H22	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C004H23	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	04-134-2_2-D12	MGC	W01C004H24	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C004I01	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C004I02	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C004I03	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C004I04	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C004I05	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C004I06	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C004I07	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C004I08	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C004I09	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C004I10	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C004I11	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C004I12	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C004I13	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C004I14	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C004I15	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C004I16	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C004I17	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C004I18	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C004I19	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C004I20	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C004I21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C004I22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C004I23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C004I24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C004J01	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	04-134-2_2-E01	MGC	W01C004J02	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C004J03	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	04-134-2_2-E02	MGC	W01C004J04	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C004J05	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	04-134-2_2-E03	MGC	W01C004J06	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C004J07	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	04-134-2_2-E04	MGC	W01C004J08	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C004J09	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	04-134-2_2-E05	MGC	W01C004J10	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C004J11	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	04-134-2_2-E06	MGC	W01C004J12	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C004J13	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	04-134-2_2-E07	MGC	W01C004J14	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C004J15	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	04-134-2_2-E08	MGC	W01C004J16	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C004J17	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	04-134-2_2-E09	MGC	W01C004J18	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C004J19	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	04-134-2_2-E10	MGC	W01C004J20	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C004J21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	04-134-2_2-E11	MGC	W01C004J22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C004J23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	04-134-2_2-E12	MGC	W01C004J24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C004K01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C004K02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C004K03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C004K04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C004K05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C004K06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C004K07	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C004K08	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C004K09	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C004K10	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C004K11	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C004K12	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C004K13	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C004K14	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C004K15	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C004K16	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C004K17	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C004K18	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C004K19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C004K20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C004K21	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C004K22	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C004K23	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C004K24	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C004L01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	04-134-2_2-F01	MGC	W01C004L02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C004L03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	04-134-2_2-F02	MGC	W01C004L04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C004L05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	04-134-2_2-F03	MGC	W01C004L06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C004L07	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	04-134-2_2-F04	MGC	W01C004L08	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C004L09	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	04-134-2_2-F05	MGC	W01C004L10	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C004L11	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	04-134-2_2-F06	MGC	W01C004L12	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C004L13	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	04-134-2_2-F07	MGC	W01C004L14	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C004L15	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	04-134-2_2-F08	FLJ	W01C004L16	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C004L17	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	04-134-2_2-F09	FLJ	W01C004L18	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C004L19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-F10	FLJ	W01C004L20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C004L21	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	04-134-2_2-F11	FLJ	W01C004L22	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C004L23	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	04-134-2_2-F12	FLJ	W01C004L24	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C004M01	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C004M02	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C004M03	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C004M04	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C004M05	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C004M06	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C004M07	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C004M08	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C004M09	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C004M10	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C004M11	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C004M12	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C004M13	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C004M14	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C004M15	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C004M16	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C004M17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C004M18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C004M19	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C004M20	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C004M21	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C004M22	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C004M23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C004M24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C004N01	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	04-134-2_2-G01	FLJ	W01C004N02	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C004N03	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	04-134-2_2-G02	FLJ	W01C004N04	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C004N05	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	04-134-2_2-G03	FLJ	W01C004N06	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C004N07	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	04-134-2_2-G04	FLJ	W01C004N08	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C004N09	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	04-134-2_2-G05	FLJ	W01C004N10	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C004N11	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	04-134-2_2-G06	FLJ	W01C004N12	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C004N13	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	04-134-2_2-G07	FLJ	W01C004N14	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C004N15	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	04-134-2_2-G08	FLJ	W01C004N16	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C004N17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	04-134-2_2-G09	FLJ	W01C004N18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C004N19	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	04-134-2_2-G10	FLJ	W01C004N20	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C004N21	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	04-134-2_2-G11	FLJ	W01C004N22	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C004N23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-G12	FLJ	W01C004N24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C004O01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C004O02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C004O03	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C004O04	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C004O05	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C004O06	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C004O07	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C004O08	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C004O09	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C004O10	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C004O11	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C004O12	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C004O13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C004O14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C004O15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C004O16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C004O17	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C004O18	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C004O19	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C004O20	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C004O21	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C004O22	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C004O23	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C004O24	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C004P01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	04-134-2_2-H01	FLJ	W01C004P02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C004P03	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	04-134-2_2-H02	FLJ	W01C004P04	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C004P05	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H03	FLJ	W01C004P06	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C004P07	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H04	FLJ	W01C004P08	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C004P09	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	04-134-2_2-H05	FLJ	W01C004P10	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C004P11	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	04-134-2_2-H06	FLJ	W01C004P12	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C004P13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	04-134-2_2-H07	FLJ	W01C004P14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C004P15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	04-134-2_2-H08	FLJ	W01C004P16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C004P17	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	04-134-2_2-H09	FLJ	W01C004P18	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C004P19	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	04-134-2_2-H10	FLJ	W01C004P20	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C004P21	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	04-134-2_2-H11	FLJ	W01C004P22	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C004P23	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	04-134-2_2-H12	FLJ	W01C004P24	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C005A01	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C005A02	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C005A03	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C005A04	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C005A05	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C005A06	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C005A07	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C005A08	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C005A09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C005A10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C005A11	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C005A12	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C005A13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C005A14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C005A15	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C005A16	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C005A17	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C005A18	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C005A19	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C005A20	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C005A21	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C005A22	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C005A23	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C005A24	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C005B01	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C005B02	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C005B03	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C005B04	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C005B05	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C005B06	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C005B07	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C005B08	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C005B09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C005B10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C005B11	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C005B12	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C005B13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C005B14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C005B15	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C005B16	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C005B17	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C005B18	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C005B19	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C005B20	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C005B21	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C005B22	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C005B23	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C005B24	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C005C01	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C005C02	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C005C03	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C005C04	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C005C05	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C005C06	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C005C07	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C005C08	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C005C09	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C005C10	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C005C11	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C005C12	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C005C13	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C005C14	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C005C15	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C005C16	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C005C17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C005C18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C005C19	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C005C20	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C005C21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C005C22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C005C23	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C005C24	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C005D01	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C005D02	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C005D03	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C005D04	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C005D05	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C005D06	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C005D07	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C005D08	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C005D09	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C005D10	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C005D11	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C005D12	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C005D13	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C005D14	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C005D15	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C005D16	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C005D17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C005D18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C005D19	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C005D20	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C005D21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C005D22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C005D23	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C005D24	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C005E01	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C005E02	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C005E03	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C005E04	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C005E05	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C005E06	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C005E07	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C005E08	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C005E09	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C005E10	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C005E11	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C005E12	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C005E13	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C005E14	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C005E15	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C005E16	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C005E17	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C005E18	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C005E19	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C005E20	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C005E21	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C005E22	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C005E23	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C005E24	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C005F01	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C005F02	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C005F03	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C005F04	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C005F05	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C005F06	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C005F07	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C005F08	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C005F09	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C005F10	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C005F11	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C005F12	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C005F13	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C005F14	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C005F15	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C005F16	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C005F17	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C005F18	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C005F19	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C005F20	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C005F21	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C005F22	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C005F23	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C005F24	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C005G01	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C005G02	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C005G03	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C005G04	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C005G05	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C005G06	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C005G07	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C005G08	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C005G09	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C005G10	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C005G11	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C005G12	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C005G13	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C005G14	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C005G15	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C005G16	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C005G17	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C005G18	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C005G19	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C005G20	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C005G21	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C005G22	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C005G23	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C005G24	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C005H01	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C005H02	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C005H03	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C005H04	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C005H05	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C005H06	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C005H07	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C005H08	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C005H09	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C005H10	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C005H11	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C005H12	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C005H13	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C005H14	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C005H15	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C005H16	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C005H17	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C005H18	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C005H19	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C005H20	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C005H21	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C005H22	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C005H23	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C005H24	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C005I01	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C005I02	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C005I03	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C005I04	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C005I05	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C005I06	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C005I07	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C005I08	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C005I09	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C005I10	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C005I11	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C005I12	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C005I13	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C005I14	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C005I15	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C005I16	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C005I17	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C005I18	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C005I19	pDONR221															
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C005I20	pDONR221															
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C005I21	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C005I22	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C005I23	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C005I24	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C005J01	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C005J02	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C005J03	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C005J04	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C005J05	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C005J06	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C005J07	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C005J08	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C005J09	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C005J10	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C005J11	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C005J12	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C005J13	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C005J14	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C005J15	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C005J16	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C005J17	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C005J18	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C005J19	pDONR221															
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C005J20	pDONR221															
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C005J21	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C005J22	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C005J23	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C005J24	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C005K01	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C005K02	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C005K03	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C005K04	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C005K05	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C005K06	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C005K07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C005K08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C005K09	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C005K10	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C005K11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C005K12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C005K13	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C005K14	pDONR221															
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C005K15	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C005K16	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C005K17	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C005K18	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C005K19	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C005K20	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C005K21	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C005K22	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C005K23	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C005K24	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C005L01	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C005L02	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C005L03	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C005L04	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C005L05	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C005L06	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C005L07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C005L08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C005L09	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C005L10	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C005L11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C005L12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C005L13	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C005L14	pDONR221															
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C005L15	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C005L16	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C005L17	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C005L18	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C005L19	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C005L20	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C005L21	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C005L22	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C005L23	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C005L24	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C005M01	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C005M02	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C005M03	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C005M04	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C005M05	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C005M06	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C005M07	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C005M08	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C005M09	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C005M10	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C005M11	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C005M12	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C005M13	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C005M14	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C005M15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C005M16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C005M17	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C005M18	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C005M19	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C005M20	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C005M21	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C005M22	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C005M23	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C005M24	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C005N01	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C005N02	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C005N03	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C005N04	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C005N05	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C005N06	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C005N07	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C005N08	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C005N09	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C005N10	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C005N11	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C005N12	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C005N13	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C005N14	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C005N15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C005N16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C005N17	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C005N18	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C005N19	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C005N20	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C005N21	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C005N22	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C005N23	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C005N24	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C005O01	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C005O02	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C005O03	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C005O04	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C005O05	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C005O06	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C005O07	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C005O08	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C005O09	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C005O10	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C005O11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C005O12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C005O13	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C005O14	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C005O15	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C005O16	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C005O17	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C005O18	pDONR221															
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C005O19	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C005O20	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C005O21	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C005O22	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C005O23	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C005O24	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C005P01	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C005P02	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C005P03	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C005P04	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C005P05	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C005P06	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C005P07	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C005P08	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C005P09	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C005P10	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C005P11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C005P12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C005P13	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C005P14	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C005P15	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C005P16	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C005P17	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C005P18	pDONR221															
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C005P19	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C005P20	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C005P21	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C005P22	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C005P23	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C005P24	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C006A01	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C006A02	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C006A03	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C006A04	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C006A05	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C006A06	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C006A07	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C006A08	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C006A09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C006A10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C006A11	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C006A12	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C006A13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C006A14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C006A15	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C006A16	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C006A17	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C006A18	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C006A19	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C006A20	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C006A21	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C006A22	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C006A23	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C006A24	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C006B01	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	04-134-2_3-A01	FLJ	W01C006B02	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C006B03	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	04-134-2_3-A02	FLJ	W01C006B04	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C006B05	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	04-134-2_3-A03	FLJ	W01C006B06	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C006B07	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	04-134-2_3-A04	FLJ	W01C006B08	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C006B09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A05	FLJ	W01C006B10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C006B11	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	04-134-2_3-A06	FLJ	W01C006B12	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C006B13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	04-134-2_3-A07	FLJ	W01C006B14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C006B15	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	04-134-2_3-A08	FLJ	W01C006B16	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C006B17	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	04-134-2_3-A09	FLJ	W01C006B18	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C006B19	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	04-134-2_3-A10	FLJ	W01C006B20	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C006B21	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	04-134-2_3-A11	FLJ	W01C006B22	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C006B23	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	04-134-2_3-A12	FLJ	W01C006B24	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C006C01	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C006C02	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C006C03	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C006C04	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C006C05	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C006C06	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C006C07	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C006C08	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C006C09	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C006C10	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C006C11	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C006C12	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C006C13	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C006C14	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C006C15	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C006C16	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C006C17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C006C18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C006C19	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C006C20	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C006C21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C006C22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C006C23	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C006C24	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C006D01	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	04-134-2_3-B01	FLJ	W01C006D02	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C006D03	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	04-134-2_3-B02	FLJ	W01C006D04	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C006D05	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	04-134-2_3-B03	FLJ	W01C006D06	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C006D07	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	04-134-2_3-B04	FLJ	W01C006D08	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C006D09	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	04-134-2_3-B05	FLJ	W01C006D10	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C006D11	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	04-134-2_3-B06	FLJ	W01C006D12	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C006D13	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	04-134-2_3-B07	FLJ	W01C006D14	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C006D15	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	04-134-2_3-B08	FLJ	W01C006D16	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C006D17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	04-134-2_3-B09	FLJ	W01C006D18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C006D19	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	04-134-2_3-B10	FLJ	W01C006D20	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C006D21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC051717	04-134-2_3-B11	MGC	W01C006D22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C006D23	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	04-134-2_3-B12	MGC	W01C006D24	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C006E01	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C006E02	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C006E03	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C006E04	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C006E05	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C006E06	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C006E07	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C006E08	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C006E09	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C006E10	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C006E11	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C006E12	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C006E13	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C006E14	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C006E15	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C006E16	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C006E17	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C006E18	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C006E19	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C006E20	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C006E21	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C006E22	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C006E23	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C006E24	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C006F01	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	04-134-2_3-C01	MGC	W01C006F02	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C006F03	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC025689	04-134-2_3-C02	MGC	W01C006F04	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C006F05	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	04-134-2_3-C03	MGC	W01C006F06	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C006F07	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC039065	04-134-2_3-C04	MGC	W01C006F08	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C006F09	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC030275	04-134-2_3-C05	MGC	W01C006F10	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C006F11	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK056707	04-134-2_3-C06	FLJ	W01C006F12	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C006F13	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK022147	04-134-2_3-C07	FLJ	W01C006F14	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C006F15	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096345	04-134-2_3-C08	FLJ	W01C006F16	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C006F17	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122913	04-134-2_3-C09	FLJ	W01C006F18	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C006F19	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C10	FLJ	W01C006F20	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C006F21	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	04-134-2_3-C11	FLJ	W01C006F22	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C006F23	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK001627	04-134-2_3-C12	FLJ	W01C006F24	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C006G01	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C006G02	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C006G03	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C006G04	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C006G05	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C006G06	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C006G07	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C006G08	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C006G09	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C006G10	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C006G11	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C006G12	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C006G13	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C006G14	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C006G15	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C006G16	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C006G17	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C006G18	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C006G19	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C006G20	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C006G21	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C006G22	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C006G23	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C006G24	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C006H01	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	04-134-2_3-D01		W01C006H02	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C006H03	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	04-134-2_3-D02		W01C006H04	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C006H05	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	04-134-2_3-D03		W01C006H06	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C006H07	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	04-134-2_3-D04		W01C006H08	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C006H09	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	04-134-2_3-D05		W01C006H10	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C006H11	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	04-134-2_3-D06		W01C006H12	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C006H13	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	04-134-2_3-D07		W01C006H14	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C006H15	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	04-134-2_3-D08		W01C006H16	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C006H17	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	04-134-2_3-D09		W01C006H18	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C006H19	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	04-134-2_3-D10		W01C006H20	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C006H21	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	04-134-2_3-D11	EST	W01C006H22	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C006H23	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	04-134-2_3-D12	EST	W01C006H24	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C006I01	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C006I02	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C006I03	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C006I04	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C006I05	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C006I06	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C006I07	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C006I08	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C006I09	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C006I10	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C006I11	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C006I12	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C006I13	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C006I14	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C006I15	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C006I16	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C006I17	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C006I18	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C006I19	pDONR221															
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C006I20	pDONR221															
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C006I21	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C006I22	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C006I23	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C006I24	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C006J01	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	04-134-2_3-E01	EST	W01C006J02	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C006J03	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	04-134-2_3-E02	EST	W01C006J04	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C006J05	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	04-134-2_3-E03	EST	W01C006J06	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C006J07	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	04-134-2_3-E04	EST	W01C006J08	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C006J09	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	04-134-2_3-E05	EST	W01C006J10	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C006J11	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	04-134-2_3-E06	EST	W01C006J12	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C006J13	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	04-134-2_3-E07	EST	W01C006J14	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C006J15	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	04-134-2_3-E08	EST(RND)	W01C006J16	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C006J17	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	04-134-2_3-E09	EST(RND)	W01C006J18	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C006J19	pDONR221															
IKAKEN	FBR08580	04-134-2_3-E10	EST(RND)	W01C006J20	pDONR221															
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C006J21	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	04-134-2_3-E11	EST(RND)	W01C006J22	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C006J23	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	04-134-2_3-E12		W01C006J24	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C006K01	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C006K02	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C006K03	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C006K04	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C006K05	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C006K06	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C006K07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C006K08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C006K09	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C006K10	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C006K11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C006K12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C006K13	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C006K14	pDONR221															
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C006K15	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C006K16	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C006K17	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C006K18	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C006K19	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C006K20	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C006K21	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C006K22	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C006K23	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C006K24	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C006L01	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	04-134-2_3-F01	MGC	W01C006L02	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C006L03	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	04-134-2_3-F02	MGC	W01C006L04	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C006L05	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	04-134-2_3-F03	MGC	W01C006L06	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C006L07	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	04-134-2_3-F04	MGC	W01C006L08	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C006L09	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	04-134-2_3-F05	MGC	W01C006L10	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C006L11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	04-134-2_3-F06	MGC	W01C006L12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C006L13	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	04-134-2_3-F07		W01C006L14	pDONR221															
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C006L15	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	04-134-2_3-F08		W01C006L16	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C006L17	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	04-134-2_3-F09		W01C006L18	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C006L19	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	04-134-2_3-F10		W01C006L20	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C006L21	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	04-134-2_3-F11		W01C006L22	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C006L23	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	04-134-2_3-F12		W01C006L24	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C006M01	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C006M02	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C006M03	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C006M04	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C006M05	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C006M06	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C006M07	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C006M08	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C006M09	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C006M10	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C006M11	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C006M12	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C006M13	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C006M14	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C006M15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C006M16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C006M17	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C006M18	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C006M19	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C006M20	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C006M21	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C006M22	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C006M23	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C006M24	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C006N01	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	04-134-2_3-G01		W01C006N02	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C006N03	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	04-134-2_3-G02		W01C006N04	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C006N05	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	04-134-2_3-G03		W01C006N06	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C006N07	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	04-134-2_3-G04		W01C006N08	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C006N09	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	04-134-2_3-G05		W01C006N10	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C006N11	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	04-134-2_3-G06		W01C006N12	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C006N13	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	04-134-2_3-G07		W01C006N14	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C006N15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	04-134-2_3-G08		W01C006N16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C006N17	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	04-134-2_3-G09		W01C006N18	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C006N19	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	04-134-2_3-G10		W01C006N20	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C006N21	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	04-134-2_3-G11		W01C006N22	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C006N23	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	04-134-2_3-G12		W01C006N24	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C006O01	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C006O02	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C006O03	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C006O04	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C006O05	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C006O06	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C006O07	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C006O08	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C006O09	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C006O10	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C006O11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C006O12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C006O13	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C006O14	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C006O15	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C006O16	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C006O17	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C006O18	pDONR221															
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C006O19	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C006O20	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C006O21	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C006O22	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C006O23	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C006O24	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C006P01	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	04-134-2_3-H01		W01C006P02	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C006P03	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	04-134-2_3-H02		W01C006P04	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C006P05	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	04-134-2_3-H03		W01C006P06	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C006P07	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	04-134-2_3-H04		W01C006P08	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C006P09	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	04-134-2_3-H05		W01C006P10	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C006P11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	04-134-2_3-H06		W01C006P12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C006P13	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	04-134-2_3-H07		W01C006P14	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C006P15	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	04-134-2_3-H08		W01C006P16	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C006P17	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	04-134-2_3-H09		W01C006P18	pDONR221															
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C006P19	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	04-134-2_3-H10		W01C006P20	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C006P21	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	04-134-2_3-H11		W01C006P22	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C006P23	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	04-134-2_3-H12		W01C006P24	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C007A01	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C007A02	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C007A03	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C007A04	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C007A05	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C007A06	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C007A07	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C007A08	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C007A09	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C007A10	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C007A11	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C007A12	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C007A13	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C007A14	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C007A15	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C007A16	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C007A17	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C007A18	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C007A19	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C007A20	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C007A21	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C007A22	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C007A23	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C007A24	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C007B01	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C007B02	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C007B03	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C007B04	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C007B05	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C007B06	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C007B07	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C007B08	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C007B09	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C007B10	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C007B11	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C007B12	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C007B13	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C007B14	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C007B15	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C007B16	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C007B17	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C007B18	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C007B19	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C007B20	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C007B21	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C007B22	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C007B23	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C007B24	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C007C01	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C007C02	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C007C03	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C007C04	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C007C05	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C007C06	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C007C07	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C007C08	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C007C09	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C007C10	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C007C11	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C007C12	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C007C13	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C007C14	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C007C15	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C007C16	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C007C17	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C007C18	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C007C19	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C007C20	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C007C21	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C007C22	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C007C23	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C007C24	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C007D01	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C007D02	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C007D03	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C007D04	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C007D05	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C007D06	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C007D07	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C007D08	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C007D09	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C007D10	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C007D11	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C007D12	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C007D13	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C007D14	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C007D15	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C007D16	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C007D17	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C007D18	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C007D19	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C007D20	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C007D21	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C007D22	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C007D23	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C007D24	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C007E01	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C007E02	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C007E03	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C007E04	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C007E05	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C007E06	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C007E07	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C007E08	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C007E09	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C007E10	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C007E11	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C007E12	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C007E13	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C007E14	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C007E15	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C007E16	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C007E17	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C007E18	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C007E19	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C007E20	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C007E21	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C007E22	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C007E23	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C007E24	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C007F01	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C007F02	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C007F03	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C007F04	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C007F05	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C007F06	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C007F07	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C007F08	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C007F09	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C007F10	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C007F11	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C007F12	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C007F13	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C007F14	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C007F15	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C007F16	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C007F17	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C007F18	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C007F19	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C007F20	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C007F21	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C007F22	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C007F23	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C007F24	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C007G01	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C007G02	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C007G03	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C007G04	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C007G05	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C007G06	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C007G07	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C007G08	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C007G09	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C007G10	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C007G11	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C007G12	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C007G13	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C007G14	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C007G15	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C007G16	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK12820	FLJ01-D09		W01C007G17	pDONR221															
IKAKEN	AK12820	FLJ01-D09		W01C007G18	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C007G19	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C007G20	pDONR221															
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C007G21	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C007G22	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C007G23	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C007G24	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C007H01	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C007H02	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C007H03	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C007H04	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C007H05	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C007H06	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C007H07	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C007H08	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C007H09	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C007H10	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C007H11	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C007H12	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C007H13	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C007H14	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C007H15	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C007H16	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK12820	FLJ01-D09		W01C007H17	pDONR221															
IKAKEN	AK12820	FLJ01-D09		W01C007H18	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C007H19	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C007H20	pDONR221															
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C007H21	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C007H22	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C007H23	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C007H24	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C007I01	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C007I02	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C007I03	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C007I04	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C007I05	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C007I06	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C007I07	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C007I08	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C007I09	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C007I10	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C007I11	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C007I12	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C007I13	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C007I14	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C007I15	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C007I16	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C007I17	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C007I18	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C007I19	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C007I20	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C007I21	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C007I22	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C007I23	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C007I24	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C007J01	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C007J02	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C007J03	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C007J04	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C007J05	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C007J06	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C007J07	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C007J08	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C007J09	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C007J10	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C007J11	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C007J12	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C007J13	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C007J14	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C007J15	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C007J16	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C007J17	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C007J18	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C007J19	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C007J20	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C007J21	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C007J22	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C007J23	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C007J24	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C007K01	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C007K02	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C007K03	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C007K04	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C007K05	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C007K06	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C007K07	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C007K08	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C007K09	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C007K10	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C007K11	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C007K12	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C007K13	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C007K14	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C007K17	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C007K18	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C007K19	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C007K20	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C007K21	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C007K22	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C007K23	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C007K24	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C007L01	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C007L02	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C007L03	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C007L04	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C007L05	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C007L06	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C007L07	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C007L08	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C007L09	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C007L10	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C007L11	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C007L12	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C007L13	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C007L14	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C007L17	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C007L18	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C007L19	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C007L20	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C007L21	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C007L22	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C007L23	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C007L24	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C007M01	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C007M02	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C007M03	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C007M04	pDONR221	29398									testis	TESTI2				
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C007M05	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C007M06	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C007M07	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C007M08	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C007M09	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C007M10	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C007M11	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C007M12	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C007M13	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C007M14	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C007M15	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C007M16	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C007M17	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C007M18	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C007M19	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C007M20	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C007M21	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C007M22	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C007M23	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C007M24	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C007N01	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C007N02	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C007N03	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C007N04	pDONR221	29398									testis	TESTI2				
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C007N05	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C007N06	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C007N07	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C007N08	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C007N09	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C007N10	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C007N11	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C007N12	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C007N13	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C007N14	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C007N15	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C007N16	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C007N17	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C007N18	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C007N19	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C007N20	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C007N21	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C007N22	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C007N23	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C007N24	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C007O01	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C007O02	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C007O03	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C007O04	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C007O05	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C007O06	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C007O07	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C007O08	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C007O09	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C007O10	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C007O11	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C007O12	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C007O13	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C007O14	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C007O15	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C007O16	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C007O17	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C007O18	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C007O19	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C007O20	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C007O21	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C007O22	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C007O23	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C007O24	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C007P01	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C007P02	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C007P03	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C007P04	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C007P05	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C007P06	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C007P07	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C007P08	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C007P09	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C007P10	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C007P11	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C007P12	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C007P13	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C007P14	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C007P15	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C007P16	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C007P17	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C007P18	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C007P19	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C007P20	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C007P21	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C007P22	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C007P23	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C007P24	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C008A01	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C008A02	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C008A03	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C008A04	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C008A05	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C008A06	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C008A07	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C008A08	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C008A09	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C008A10	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C008A11	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C008A12	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C008A13	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C008A14	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C008A15	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C008A16	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C008A17	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C008A18	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C008A19	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C008A20	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C008A21	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C008A22	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C008A23	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C008A24	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C008B01	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK096109	FLJ01-A01	FLJ	W01C008B02	pDONR221	1698		LOC339483	339483	-	Hs.471067	Myotubularin related protein 9 pseudogene			kidney	KIDNE2														
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C008B03	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK127582	FLJ01-A02	FLJ	W01C008B04	pDONR221	44262								CD34+ Cells		D9OST2				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C008B05	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK023856	FLJ01-A03	FLJ	W01C008B06	pDONR221	14065		LOC339803	339803	-	Hs.252433	Hypothetical protein LOC339803			ovary, tumor tissue	OVARC1				
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C008B07	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK000827	FLJ01-A04	FLJ	W01C008B08	pDONR221	11688		MGC2752	65996	-	Hs.541177	Hypothetical LOC65996			adipose tissue	ad														
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C008B09	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK125453	FLJ01-A05	FLJ	W01C008B10	pDONR221	4018		RPL27A	6157	-	Hs.523463	Ribosomal protein L27a			brain	OCBBF2		NM_000990.4	NP_000981.1	REVIEWED		0.400	0.400	25	105	7	81	148	2	26
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C008B11	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK094318	FLJ01-A06	FLJ	W01C008B12	pDONR221	722		C1orf151	440574	-	Hs.466662	Chromosome 1 open reading frame 151			cerebellum	BRACE2		NM_001032363.1	NP_001027535.1	VALIDATED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C008B13	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK090585	FLJ01-A07	FLJ	W01C008B14	pDONR221	24164		SNHG7	84973	-					Brain, adult medulla	NIH_MGC_119	DH10B													
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C008B15	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK093685	FLJ01-A08	FLJ	W01C008B16	pDONR221	35959		MGC13005	84771	-	Hs.712940	Hypothetical LOC84771			thymus	THYMU2		XM_376814.4	XP_376814.3	MODEL										
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C008B17	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK097110	FLJ01-A09	FLJ	W01C008B18	pDONR221	18209		MGC24125	439935	-	Hs.673379	Hypothetical protein MGC24125			spleen	SPLEN2														
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C008B19	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK095904	FLJ01-A10	FLJ	W01C008B20	pDONR221	1639		AIDA	64853		Hs.534965	Axin interactor, dorsalization associated		chondrocytes (HC)		HCHON2		NM_022831.2	NP_073742.2	VALIDATED		0.216	0.216	37	132	16	126	306	157	193
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C008B21	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK096570	FLJ01-A11	FLJ	W01C008B22	pDONR221	918		LOC643837	643837	-	Hs.133183	Hypothetical LOC643837			brain	OCBBF2		XM_927114.1	XP_932207.1	MODEL										
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C008B23	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK055615	FLJ01-A12	FLJ	W01C008B24	pDONR221	14725		LOC283788	283788	BAB70972.1	Hs.696627	FSHD region gene 1 pseudogene		synoviocytes from rtheumatioid arthritis		HSYRA1		XM_001721615.1	XP_001721667.1	MODEL		0.968	0.968	124	378	1	372	147	1	124
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C008C01	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C008C02	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C008C03	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C008C04	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C008C05	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C008C06	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C008C07	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C008C08	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C008C09	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C008C10	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C008C11	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C008C12	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C008C13	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C008C14	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C008C15	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C008C16	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C008C17	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C008C18	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C008C19	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C008C20	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C008C21	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C008C22	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C008C23	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C008C24	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C008D01	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK055694	FLJ01-B01	FLJ	W01C008D02	pDONR221	24722			441522	BAB70987			IMR32	neuroblastoma		IMR322				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C008D03	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ01-B02	FLJ	W01C008D04	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C008D05	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096461	FLJ01-B03	FLJ	W01C008D06	pDONR221	7143		FLJ43390	646113	-	Hs.445241	Hypothetical LOC646113	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C008D07	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK026556	FLJ01-B04	FLJ	W01C008D08	pDONR221	14936		ATP5E	514	-	Hs.177530	ATP synthase, H+ transporting, mitochondrial F1 complex, epsilon subunit	KATO III	signet-ring cell carcinoma		KAT		NM_006886.2	NP_008817.1	REVIEWED		0.922	0.922	51	156	1	153	51	1	51
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C008D09	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK055252	FLJ01-B05	FLJ	W01C008D10	pDONR221	26984		LOC100129502	100129502	BAB70890	Hs.709285	Hypothetical protein LOC100129502			tongue, tumor tissue	CTONG2		XM_001721701.1	XP_001721753.1	MODEL	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C008D11	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK056626	FLJ01-B06	FLJ	W01C008D12	pDONR221	19681		LOC202451	202451	-	Hs.194408	Hypothetical protein LOC202451	NT2	teratocarcinoma		NT2RP7		XM_928403.1	XP_933496.1	MODEL										
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C008D13	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK130345	FLJ01-B07	FLJ	W01C008D14	pDONR221	3725		MALAT1	378938	-	Hs.714394	Metastasis associated lung adenocarcinoma transcript 1 (non-protein coding)			prostate	PRS				
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C008D15	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK124137	FLJ01-B08	FLJ	W01C008D16	pDONR221	16143		TRNT1	51095		Hs.567495	TRNA nucleotidyl transferase, CCA-adding, 1			testis	TESTI2		NM_182916.2	NP_886552.2	VALIDATED		0.980	0.980	49	174	1	147	434	1	49
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C008D17	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK075364	FLJ01-B09	FLJ	W01C008D18	pDONR221	18189		SLC10A7	84068	BAC11571.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7	NT2	teratocarcinoma		NT2RP1		NM_001029998.3	NP_001025169.1	VALIDATED	P	1.000	1.000	55	168	1	165	340	286	340
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C008D19	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK024591	FLJ01-B10	FLJ	W01C008D20	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	P	1.000	1.000	52	159	1	156	84	33	84
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C008D21	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK057081	FLJ01-B11	FLJ	W01C008D22	pDONR221	20601		COL12A1	1303	-	Hs.101302	Collagen, type XII, alpha 1			skeletal muscle	SKMUS2		NM_080645.2	NP_542376.2	REVIEWED	Pfs	0.304	0.309	56	192	185	18	1899	1783	1837
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C008D23	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK000450	FLJ01-B12	FLJ	W01C008D24	pDONR221	7076		MRPL52	122704	-	Hs.355935	Mitochondrial ribosomal protein L52	HepG2	hepatoma		HEP		NM_181304.2	NP_851821.1	REVIEWED	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C008E01	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C008E02	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C008E03	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C008E04	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C008E05	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C008E06	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C008E07	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C008E08	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C008E09	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C008E10	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C008E11	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C008E12	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C008E13	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C008E14	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C008E15	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C008E16	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C008E17	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C008E18	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C008E19	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C008E20	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C008E21	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C008E22	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C008E23	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C008E24	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C008F01	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK094815	FLJ01-C01	FLJ	W01C008F02	pDONR221	7376		SPTB	6710	-	Hs.417303	Spectrin, beta, erythrocytic			brain	BRAWH2		NM_001024858.1	NP_001020029.1	VALIDATED	P	1.000	1.000	5	198	75	61	2328	2128	2132
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C008F03	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK095297	FLJ01-C02	FLJ	W01C008F04	pDONR221	1753		C1orf199	284702	-	Hs.657313	Chromosome 1 open reading frame 199			tongue, tumor tissue	CTONG2				
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C008F05	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK092263	FLJ01-C03	FLJ	W01C008F06	pDONR221	9301		NCRNA00095	283932	BAC03841.1	Hs.152149	Non-protein coding RNA 95	NT2	teratocarcinoma		NT2NE2														
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C008F07	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C04	FLJ	W01C008F08	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C008F09	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C05	FLJ	W01C008F10	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C008F11	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C06	FLJ	W01C008F12	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C008F13	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C07	FLJ	W01C008F14	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C008F15	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097631	FLJ01-C08	FLJ	W01C008F16	pDONR221	11324		LOC644669	644669	-					testis	TESTI2														
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C008F17	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	FLJ01-C09	FLJ	W01C008F18	pDONR221	36210									testis	TESTI2				
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C008F19	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK130082	FLJ01-C10	FLJ	W01C008F20	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.768	0.768	69	210	1	207	406	338	406
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C008F21	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	FLJ01-C11	FLJ	W01C008F22	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C008F23	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK000656	FLJ01-C12	FLJ	W01C008F24	pDONR221	17982		ATP5I	521	-	Hs.85539	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit E	KATO III	signet-ring cell carcinoma		KAT		NM_007100.2	NP_009031.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C008G01	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C008G02	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C008G03	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C008G04	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C008G05	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C008G06	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C008G07	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C008G08	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C008G09	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C008G10	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C008G11	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C008G12	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C008G13	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C008G14	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C008G15	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C008G16	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK12820	FLJ01-D09		W01C008G17	pDONR221															
IKAKEN	AK12820	FLJ01-D09		W01C008G18	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C008G19	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C008G20	pDONR221															
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C008G21	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C008G22	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C008G23	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C008G24	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C008H01	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK055106	FLJ01-D01	FLJ	W01C008H02	pDONR221	19912		GTF2H5	404672	-	Hs.356224	General transcription factor IIH, polypeptide 5			brain	BRAWH2		NM_207118.2	NP_997001.1	REVIEWED	OK	1.000	1.000	71	216	1	213	71	1	71
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C008H03	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK095766	FLJ01-D02	FLJ	W01C008H04	pDONR221	10582		LOC284023	284023	-	Hs.718771	Hypothetical protein LOC284023			brain	FEBRA2		XM_941810.3	XP_946903.3	MODEL	P	1.000	1.000	97	294	1	291	277	181	277
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C008H05	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK129498	FLJ01-D03	FLJ	W01C008H06	pDONR221	9942		UBB	7314	-	Hs.719097	Ubiquitin B			brain	CBR		NM_018955.2	NP_061828.1	REVIEWED		0.863	0.863	73	222	1	219	229	1	73
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C008H07	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK026550	FLJ01-D04	FLJ	W01C008H08	pDONR221	16886		ANAPC13	25847	-	Hs.106909	Anaphase promoting complex subunit 13	KATO III	signet-ring cell carcinoma		KAT		NM_015391.3	NP_056206.1	REVIEWED	OK	1.000	1.000	74	225	1	222	74	1	74
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C008H09	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK055184	FLJ01-D05	FLJ	W01C008H10	pDONR221	2744		CASC2	255082	-	Hs.89387	Cancer susceptibility candidate 2			tongue, tumor tissue	CTONG2														
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C008H11	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK097434	FLJ01-D06	FLJ	W01C008H12	pDONR221	12424		ZNF611	81856	BAC05052.1	Hs.143951	Zinc finger protein 611			testis	TESTI2		NM_030972.2	NP_112234.2	PROVISIONAL	Pfs	0.542	0.549	72	231	12	225	705	517	588
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C008H13	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	FLJ01-D07	FLJ	W01C008H14	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C008H15	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK056999	FLJ01-D08	FLJ	W01C008H16	pDONR221	5383		C12orf75	387882	-	Hs.368938	Chromosome 12 open reading frame 75			prostate	PROST2		NM_001145199.1	NP_001138671.1	VALIDATED	P	1.000	1.000	3	243	165	173	63	3	5
IKAKEN	AK12820	FLJ01-D09		W01C008H17	pDONR221															
IKAKEN	AK12820	FLJ01-D09		W01C008H18	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C008H19	pDONR221															
IKAKEN	AK12820	FLJ01-D10		W01C008H20	pDONR221															
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C008H21	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK025416	FLJ01-D11	FLJ	W01C008H22	pDONR221	27659		UGCGL1	56886	-	Hs.719174	UDP-glucose ceramide glucosyltransferase-like 1			colon	COL		NM_001025777.1	NP_001020948.1	VALIDATED		0.194	0.194	31	246	101	9	1531	1477	1507
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C008H23	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK092137	FLJ01-D12	FLJ	W01C008H24	pDONR221	24113		C9orf130	100128782	-	Hs.652504	Chromosome 9 open reading frame 130	NT2	teratocarcinoma		NT2NE2		XM_001732875.1	XP_001732927.1	MODEL	Cfs	0.989	0.989	87	264	1	261	87	1	87
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C008I01	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C008I02	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C008I03	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C008I04	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C008I05	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C008I06	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C008I07	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C008I08	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C008I09	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C008I10	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C008I11	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C008I12	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C008I13	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C008I14	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C008I15	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C008I16	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C008I17	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C008I18	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C008I19	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C008I20	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C008I21	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C008I22	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C008I23	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C008I24	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C008J01	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK093477	FLJ01-E01	FLJ	W01C008J02	pDONR221	17090		RPL32P3	132241	-	Hs.652423	Ribosomal protein L32 pseudogene 3			testis	TESTI2				
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C008J03	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK126818	FLJ01-E02	FLJ	W01C008J04	pDONR221	19156		AFF4	27125	-	Hs.519313	AF4/FMR2 family, member 4			alzheimer cortex	BRALZ2		NM_014423.3	NP_055238.1	VALIDATED		0.375	0.375	16	258	91	138	1163	223	238
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C008J05	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK027125	FLJ01-E03	FLJ	W01C008J06	pDONR221	29010		tcag7.903	729852	-	Hs.652371	Hypothetical protein LOC729852			human small intestine	HSI														
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C008J07	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK129621	FLJ01-E04	FLJ	W01C008J08	pDONR221	4542		UBE2L6	9246	-	Hs.425777	Ubiquitin-conjugating enzyme E2L 6			rectum	RCT		NM_198183.1	NP_937826.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C008J09	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK057730	FLJ01-E05	FLJ	W01C008J10	pDONR221	5447		LYRM5	144363	-	Hs.209151	LYR motif containing 5			uterus	UTERU2		NM_001001660.2	NP_001001660.2	VALIDATED	P	1.000	1.000	88	267	1	264	90	3	90
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C008J11	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK056415	FLJ01-E06	FLJ	W01C008J12	pDONR221	21296		RBM33	155435	-	Hs.591815	RNA binding motif protein 33	NT2	teratocarcinoma		NT2RI2		NM_001008408.3	NP_001008408.2	VALIDATED	P	1.000	1.000	95	288	1	285	1180	1086	1180
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C008J13	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK094014	FLJ01-E07	FLJ	W01C008J14	pDONR221	25224		CXorf36	79742	-	Hs.98321	Chromosome X open reading frame 36			uterus	UTERU2		NM_176819.3	NP_789789.2	VALIDATED		0.875	0.875	8	273	238	261	433	83	90
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C008J15	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK057332	FLJ01-E08	FLJ	W01C008J16	pDONR221	23144		C8orf78	157376	BAB71431.1	Hs.711100	Chromosome 8 open reading frame 78			testis	TESTI2		NM_182525.1	NP_872331.1	NA
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C008J17	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK124398	FLJ01-E09	FLJ	W01C008J18	pDONR221	13206		RHOB	388	BAG54035.1	Hs.502876	Ras homolog gene family, member B			adrenal gland	ADRGL2		NM_004040.2	NP_004031.1	VALIDATED		0.400	0.400	10	273	184	213	196	108	117
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C008J19	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK074850	FLJ01-E10	FLJ	W01C008J20	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Pfs	0.923	0.923	104	315	1	312	464	361	464
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C008J21	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057458	FLJ01-E11	FLJ	W01C008J22	pDONR221	26110		hCG_1994895	729866	BAB71496	Hs.553298	HCG1994895			testis	TESTI2		XM_001134272.1	XP_001134272.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C008J23	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK127437	FLJ01-E12	FLJ	W01C008J24	pDONR221	16774		MYLK	4638	-	Hs.477375	Myosin light chain kinase			thalamus	BRTHA2		NM_053028.3	NP_444256.3	REVIEWED	Pfs	0.500	0.500	16	282	102	55	1794	363	378
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C008K01	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C008K02	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C008K03	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C008K04	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C008K05	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C008K06	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C008K07	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C008K08	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C008K09	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C008K10	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C008K11	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C008K12	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C008K13	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C008K14	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C008K17	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C008K18	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C008K19	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C008K20	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C008K21	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C008K22	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C008K23	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C008K24	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C008L01	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK075168	FLJ01-F01	FLJ	W01C008L02	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C008L03	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK001384	FLJ01-F02	FLJ	W01C008L04	pDONR221	22159		MGC27345	157247		Hs.552129	Hypothetical protein MGC27345	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C008L05	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK000532	FLJ01-F03	FLJ	W01C008L06	pDONR221	16367		NUDT16P	152195	-	Hs.380350	Nudix (nucleoside diphosphate linked moiety X)-type motif 16 pseudogene	KATO III	signet-ring cell carcinoma		KAT				
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C008L07	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK129817	FLJ01-F04	FLJ	W01C008L08	pDONR221	1		RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A			dermoid tumor	DMC		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.294	0.294	17	435	264	314	311	260	276
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C008L09	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094445	FLJ01-F05	FLJ	W01C008L10	pDONR221	22068		CNPY1	285888	-	Hs.710640	Canopy 1 homolog (zebrafish)			cerebellum	BRACE2		NM_001103176.1	NP_001096646.1	VALIDATED	OK	1.000	1.000	92	417	139	414	92	1	92
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C008L11	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK094002	FLJ01-F06	FLJ	W01C008L12	pDONR221	18792		C5orf51	285636	-	Hs.29899	Chromosome 5 open reading frame 51			trachea	TRACH2		NM_175921.4	NP_787117.3	VALIDATED		0.455	0.455	11	306	130	162	294	225	235
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C008L13	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK097673	FLJ01-F07	FLJ	W01C008L14	pDONR221	2818		C10orf139	399706	-					testis	TESTI2														
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C008L17	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK023312	FLJ01-F09	FLJ	W01C008L18	pDONR221	46760		LOC286260	286260	-	Hs.593896	Hypothetical LOC286260	NT2	teratocarcinoma		NT2RP3		XM_001723591.1	XP_001723643.1	MODEL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C008L19	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK000803	FLJ01-F10	FLJ	W01C008L20	pDONR221	18717		LYRM7	90624	-	Hs.115467	Lyrm7 homolog (mouse)	HepG2	hepatoma		HEP		NM_181705.2	NP_859056.2	VALIDATED	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C008L21	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK130555	FLJ01-F11	FLJ	W01C008L22	pDONR221	40525		FGFR1	2260	-	Hs.264887	Fibroblast growth factor receptor 1			salivary gland	SLV		NM_023108.2	NP_075596.1	REVIEWED		0.556	0.556	9	318	18	44	300	1	9
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C008L23	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ01-F12	FLJ	W01C008L24	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C008M01	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C008M02	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C008M03	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C008M04	pDONR221	29398									testis	TESTI2				
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C008M05	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C008M06	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C008M07	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C008M08	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C008M09	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C008M10	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C008M11	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C008M12	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C008M13	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C008M14	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C008M15	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C008M16	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C008M17	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C008M18	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C008M19	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C008M20	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C008M21	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C008M22	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C008M23	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C008M24	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C008N01	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G01	FLJ	W01C008N02	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C008N03	pDONR221	29398									testis	TESTI2				
IKAKEN	AK093358	FLJ01-G02	FLJ	W01C008N04	pDONR221	29398									testis	TESTI2				
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C008N05	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK021522	FLJ01-G03	FLJ	W01C008N06	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C008N07	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK093095	FLJ01-G04	FLJ	W01C008N08	pDONR221	11044		FLJ35776	649446	BAC04052.1	Hs.19872	Hypothetical LOC649446			spleen	SPLEN2		NM_001039796.1	NP_001034885.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C008N09	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK056484	FLJ01-G05	FLJ	W01C008N10	pDONR221	21277		hCG_2009921	441204	BAB71195.1	Hs.587432	Hypothetical locus LOC441204	NT2	teratocarcinoma		NT2RP7		XM_001722132.1	XP_001722184.1	MODEL	P	1.000	1.000	94	390	1	282	195	1	94
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C008N11	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057548	FLJ01-G06	FLJ	W01C008N12	pDONR221	21307		CLEC2L	154790	-	Hs.57806	C-type lectin domain family 2, member L			testis	TESTI2		NM_001080511.2	NP_001073980.2	PROVISIONAL	P	1.000	1.000	126	654	274	651	214	89	214
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C008N13	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK057625	FLJ01-G07	FLJ	W01C008N14	pDONR221	8042			645022						thymus	THYMU1				
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C008N15	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK129556	FLJ01-G08	FLJ	W01C008N16	pDONR221	38148		LOC100130744	100130744	-	Hs.660550	Hypothetical LOC100130744		macrophage		MPG		XM_001721727.1	XP_001721779.1	MODEL	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C008N17	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK057662	FLJ01-G09	FLJ	W01C008N18	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C008N19	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK056876	FLJ01-G10	FLJ	W01C008N20	pDONR221	7777		LOC440248	440248	-	Hs.531509	Hect domain and RLD 2 pseudogene			prostate	PROST1				
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C008N21	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK097442	FLJ01-G11	FLJ	W01C008N22	pDONR221	20009		HCG27	253018	BAC05055	Hs.659818	HLA complex group 27			testis	TESTI2		NM_181717.2	NP_859068.2	VALIDATED	OK	1.000	1.000	96	362	1	288	96	1	96
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C008N23	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK057400	FLJ01-G12	FLJ	W01C008N24	pDONR221	39769		LOC100129427	100129427	BAB71471	Hs.680434	Hypothetical protein LOC100129427			testis	TESTI2		XM_001715918.1	XP_001715970.1	MODEL	OK	1.000	1.000	79	363	57	293	79	1	79
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C008O01	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C008O02	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C008O03	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C008O04	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C008O05	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C008O06	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C008O07	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C008O08	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C008O09	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C008O10	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C008O11	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C008O12	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C008O13	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C008O14	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C008O15	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C008O16	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C008O17	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C008O18	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C008O19	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C008O20	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C008O21	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C008O22	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C008O23	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C008O24	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C008P01	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK057725	FLJ01-H01	FLJ	W01C008P02	pDONR221	30034		LOC100129196	100129196	BAB71552.1	Hs.659751	Similar to hCG2033298			trachea	TRACH2		XM_001724594.1	XP_001724646.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C008P03	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091343	FLJ01-H02	FLJ	W01C008P04	pDONR221	6488		HS6ST3	266722	BAC03640	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3		normal dermal fibroblasts (Neonatal Skin)		DFNES2		NM_153456.2	NP_703157.2	VALIDATED	Pfs	0.281	0.308	57	363	192	22	471	205	256
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C008P05	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK091518	FLJ01-H03	FLJ	W01C008P06	pDONR221	2797		SH2D4B	387694	BAC03683	Hs.147643	SH2 domain containing 4B			brain	FCBBF3		NM_001145719.1	NP_001139191.1	VALIDATED	Pfs	0.935	0.935	31	363	41	133	309	279	309
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C008P07	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK075204	FLJ01-H04	FLJ	W01C008P08	pDONR221	19331		hCG_2039148	100132356	BAC11469	Hs.649468	Hypothetical protein LOC100132356			placenta	PLACE1		XM_001717477.1	XP_001717529.1	MODEL	P	1.000	1.000	33	363	264	362	194	59	91
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C008P09	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK095511	FLJ01-H05	FLJ	W01C008P10	pDONR221	35445		LOC100130761	100130761	BAC04564	Hs.638437	Hypothetical LOC100130761		CD34+ Cells		D3OST2		XM_001720141.1	XP_001720193.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C008P11	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK094244	FLJ01-H06	FLJ	W01C008P12	pDONR221	15741		LOC100130269	100130269	BAC04316	Hs.632773	Similar to Putative uncharacterized protein FLJ36925			adrenal gland	ADRGL2		XM_001726568.1	XP_001726620.1	MODEL	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C008P13	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK025947	FLJ01-H07	FLJ	W01C008P14	pDONR221	14405		LOC644617	644617	BAB15291	Hs.592796	Hypothetical LOC644617	HepG2	hepatoma		HEP		XM_927735.1	XP_932828.1	MODEL
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C008P15	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK074283	FLJ01-H08	FLJ	W01C008P16	pDONR221	1938		C1orf126	200197	BAB85035.1	Hs.701261	Chromosome 1 open reading frame 126			colon	COL		NM_182534.1	NP_872340.1	VALIDATED										
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C008P17	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK056487	FLJ01-H09	FLJ	W01C008P18	pDONR221	281		C1orf21	81563	BAB71196.1	Hs.719188	Chromosome 1 open reading frame 21	NT2	teratocarcinoma		NT2RP7		NM_030806.3	NP_110433.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C008P19	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094299	FLJ01-H10	FLJ	W01C008P20	pDONR221	22712		C8orf79	57604	BAC04326.1	Hs.202521	Chromosome 8 open reading frame 79			cerebellum	BRACE2		NM_020844.2	NP_065895.2	VALIDATED	Pfs	0.391	0.409	23	366	239	307	454	54	75
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C008P21	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK094354	FLJ01-H11	FLJ	W01C008P22	pDONR221	3335		FLJ37035	399821	BAC04337.1	Hs.535286	FLJ37035 protein			cerebellum	BRACE2														
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C008P23	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK129953	FLJ01-H12	FLJ	W01C008P24	pDONR221	6538		C13orf35	400165	BAC85256.1	Hs.591213	Chromosome 13 open reading frame 35			kidney	KDN		NM_207440.1	NP_997323.1	PREDICTED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C009A01	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C009A02	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C009A03	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C009A04	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C009A05	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C009A06	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C009A07	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C009A08	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C009A09	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C009A10	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C009A11	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C009A12	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C009A13	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C009A14	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C009A15	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C009A16	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C009A17	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C009A18	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C009A19	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C009A20	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C009A21	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C009A22	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C009A23	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C009A24	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C009B01	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C009B02	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C009B03	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C009B04	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C009B05	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C009B06	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C009B07	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C009B08	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C009B09	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C009B10	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C009B11	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C009B12	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C009B13	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C009B14	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C009B15	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C009B16	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C009B17	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C009B18	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C009B19	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C009B20	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C009B21	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C009B22	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C009B23	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C009B24	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C009C01	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C009C02	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C009C03	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C009C04	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C009C05	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C009C06	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C009C07	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C009C08	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C009C09	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C009C10	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C009C11	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C009C12	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C009C13	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C009C14	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C009C15	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C009C16	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C009C17	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C009C18	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C009C19	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C009C20	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C009C21	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C009C22	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C009C23	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C009C24	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C009D01	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C009D02	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C009D03	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C009D04	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C009D05	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C009D06	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C009D07	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C009D08	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C009D09	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C009D10	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C009D11	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C009D12	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C009D13	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C009D14	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C009D15	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C009D16	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C009D17	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C009D18	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C009D19	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C009D20	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C009D21	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C009D22	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C009D23	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C009D24	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C009E01	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C009E02	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C009E03	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C009E04	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C009E05	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C009E06	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C009E07	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C009E08	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C009E09	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C009E10	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C009E11	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C009E12	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C009E13	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C009E14	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C009E15	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C009E16	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C009E17	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C009E18	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C009E19	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C009E20	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C009E21	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C009E22	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C009E23	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C009E24	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C009F01	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C009F02	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C009F03	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C009F04	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C009F05	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C009F06	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C009F07	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C009F08	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C009F09	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C009F10	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C009F11	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C009F12	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C009F13	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C009F14	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C009F15	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C009F16	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C009F17	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C009F18	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C009F19	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C009F20	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C009F21	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C009F22	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C009F23	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C009F24	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C009G01	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C009G02	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C009G03	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C009G04	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C009G05	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C009G06	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C009G07	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C009G08	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C009G09	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C009G10	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C009G11	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C009G12	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C009G13	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C009G14	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C009G15	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C009G16	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C009G17	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C009G18	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C009G19	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C009G20	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C009G21	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C009G22	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C009G23	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C009G24	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C009H01	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C009H02	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C009H03	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C009H04	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C009H05	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C009H06	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C009H07	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C009H08	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C009H09	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C009H10	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C009H11	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C009H12	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C009H13	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C009H14	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C009H15	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C009H16	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C009H17	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C009H18	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C009H19	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C009H20	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C009H21	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C009H22	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C009H23	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C009H24	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C009I01	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C009I02	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C009I03	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C009I04	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C009I05	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C009I06	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C009I07	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C009I08	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C009I09	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C009I10	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C009I11	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C009I12	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C009I13	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C009I14	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C009I15	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C009I16	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C009I17	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C009I18	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C009I19	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C009I20	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C009I21	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C009I22	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C009I23	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C009I24	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C009J01	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C009J02	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C009J03	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C009J04	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C009J05	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C009J06	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C009J07	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C009J08	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C009J09	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C009J10	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C009J11	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C009J12	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C009J13	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C009J14	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C009J15	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C009J16	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C009J17	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C009J18	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C009J19	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C009J20	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C009J21	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C009J22	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C009J23	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C009J24	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C009K01	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C009K02	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C009K03	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C009K04	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C009K05	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C009K06	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C009K07	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C009K08	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C009K09	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C009K10	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C009K11	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C009K12	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C009K13	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C009K14	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C009K15	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C009K16	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C009K17	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C009K18	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C009K19	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C009K20	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C009K21	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C009K22	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C009K23	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C009K24	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C009L01	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C009L02	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C009L03	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C009L04	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C009L05	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C009L06	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C009L07	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C009L08	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C009L09	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C009L10	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C009L11	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C009L12	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C009L13	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C009L14	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C009L15	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C009L16	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C009L17	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C009L18	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C009L19	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C009L20	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C009L21	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C009L22	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C009L23	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C009L24	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C009M01	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C009M02	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C009M03	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C009M04	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C009M05	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C009M06	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C009M07	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C009M08	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C009M09	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C009M10	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C009M11	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C009M12	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C009M13	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C009M14	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C009M15	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C009M16	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C009M17	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C009M18	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C009M19	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C009M20	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C009M21	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C009M22	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C009M23	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C009M24	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C009N01	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C009N02	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C009N03	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C009N04	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C009N05	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C009N06	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C009N07	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C009N08	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C009N09	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C009N10	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C009N11	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C009N12	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C009N13	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C009N14	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C009N15	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C009N16	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C009N17	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C009N18	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C009N19	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C009N20	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C009N21	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C009N22	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C009N23	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C009N24	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C009O01	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C009O02	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C009O03	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C009O04	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C009O05	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C009O06	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C009O07	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C009O08	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C009O09	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C009O10	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C009O11	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C009O12	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C009O13	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C009O14	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C009O15	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C009O16	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C009O17	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C009O18	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C009O19	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C009O20	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C009O21	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C009O22	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C009O23	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C009O24	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C009P01	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C009P02	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C009P03	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C009P04	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C009P05	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C009P06	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C009P07	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C009P08	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C009P09	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C009P10	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C009P11	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C009P12	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C009P13	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C009P14	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C009P15	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C009P16	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C009P17	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C009P18	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C009P19	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C009P20	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C009P21	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C009P22	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C009P23	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C009P24	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C010A01	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C010A02	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C010A03	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C010A04	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C010A05	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C010A06	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C010A07	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C010A08	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C010A09	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C010A10	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C010A11	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C010A12	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C010A13	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C010A14	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C010A15	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C010A16	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C010A17	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C010A18	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C010A19	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C010A20	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C010A21	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C010A22	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C010A23	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C010A24	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C010B01	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055096	FLJ02-A01	FLJ	W01C010B02	pDONR221	19949		DKFZP686I15217	401232	BAB70854.1					cerebellum	BRACE2		XM_001717795.1	XP_001717847.1	MODEL	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C010B03	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055593	FLJ02-A02	FLJ	W01C010B04	pDONR221	1757		C1orf86	199990	BAB70965.1	Hs.107101	Chromosome 1 open reading frame 86			lung	HLUNG2		NM_182533.2	NP_872339.2	VALIDATED	Ps	0.994	0.994	179	588	1	537	180	1	179
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C010B05	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK055725	FLJ02-A03	FLJ	W01C010B06	pDONR221	7291		MEG3	55384	BAB70996	Hs.655127	Maternally expressed 3 (non-protein coding)	IMR32	neuroblastoma		IMR322														
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C010B07	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK056283	FLJ02-A04	FLJ	W01C010B08	pDONR221	43038				BAB71137					kidney	KIDNE2				
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C010B09	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK025787	FLJ02-A05	FLJ	W01C010B10	pDONR221	18637		ISOC1	51015	-	Hs.483296	Isochorismatase domain containing 1	HepG2	hepatoma		HEP		NM_016048.2	NP_057132.2	VALIDATED	Pfs	0.990	1.000	199	592	1	590	298	64	262
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C010B11	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK057462	FLJ02-A06	FLJ	W01C010B12	pDONR221	16427		C3orf65	646600	BAB71499.1	Hs.647949	Chromosome 3 open reading frame 65			testis	TESTI2		NM_001039788.1	NP_001034877.1	VALIDATED	OK	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C010B13	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK093158	FLJ02-A07	FLJ	W01C010B14	pDONR221	6776			400145	BAC04078					testis	TESTI2				
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C010B15	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK056449	FLJ02-A08	FLJ	W01C010B16	pDONR221	19226		DCTN4	51164	BAB71185	Hs.675564	Dynactin 4 (p62)	NT2	teratocarcinoma		NT2RP7		NM_001135644.1	NP_001129116.1	VALIDATED	Pfs	0.333	0.333	30	423	172	84	403	129	158
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C010B17	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A09	FLJ	W01C010B18	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C010B19	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092264	FLJ02-A10	FLJ	W01C010B20	pDONR221	33741				BAC03842			NT2	teratocarcinoma		NT2RP7				
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C010B21	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092393	FLJ02-A11	FLJ	W01C010B22	pDONR221	38694		LOC100130275	100130275	BAC03878	Hs.661431	Hypothetical protein LOC100130275			brain	OCBBF2		XM_001720213.1	XP_001720265.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C010B23	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK092432	FLJ02-A12	FLJ	W01C010B24	pDONR221	40535		PSCA	8000	BAC03889	Hs.711174	Prostate stem cell antigen			placenta	PLACE6		NM_005672.3	NP_005663.1	REVIEWED		0.891	0.911	46	396	373	236	123	13	57
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C010C01	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C010C02	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C010C03	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C010C04	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C010C05	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C010C06	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C010C07	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C010C08	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C010C09	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C010C10	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C010C11	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C010C12	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C010C13	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C010C14	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C010C15	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C010C16	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C010C17	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C010C18	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C010C19	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C010C20	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C010C21	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C010C22	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C010C23	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C010C24	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C010D01	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK092544	FLJ02-B01	FLJ	W01C010D02	pDONR221	40285		LOC100131581	100131581	BAC03913	Hs.638992	Hypothetical LOC100131581			placenta	PLACE6		XM_001721737.1	XP_001721789.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C010D03	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK093659	FLJ02-B02	FLJ	W01C010D04	pDONR221	1970		LOC728448	728448	BAC04213.1	Hs.710761	Peptidylprolyl isomerase E pseudogene			testis	TESTI2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C010D05	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092094	FLJ02-B03	FLJ	W01C010D06	pDONR221	29551				BAC03803				normal mesangial cells (NHMC56046-2)		MESAN2				
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C010D07	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092125	FLJ02-B04	FLJ	W01C010D08	pDONR221	5471		CACNA1C	775	-	Hs.118262	Calcium channel, voltage-dependent, L type, alpha 1C subunit	NT2	teratocarcinoma		NT2NE2		NM_001129843.1	NP_001123315.1	REVIEWED		0.538	0.538	13	384	334	372	2138	1274	1286
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C010D09	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK092849	FLJ02-B05	FLJ	W01C010D10	pDONR221	708		C1orf220	400798	BAC03990.1	Hs.668085	Chromosome 1 open reading frame 220			skeletal muscle	SKMUS2		NM_207467.1	NP_997350.1	PREDICTED	Cs	0.993	0.993	134	405	1	402	134	1	134
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C010D11	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	FLJ02-B06	FLJ	W01C010D12	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C010D13	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093340	FLJ02-B07	FLJ	W01C010D14	pDONR221	31050		LOC100132116	100132116	BAC04137.1	Hs.713690	Hypothetical LOC100132116			testis	TESTI2		XM_001724437.1	XP_001724489.1	MODEL	Cg	0.992	1.000	132	396	1	393	132	1	132
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C010D15	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK093351	FLJ02-B08	FLJ	W01C010D16	pDONR221	714		C1orf230	284485	BAC04143	Hs.297967	Non-protein coding RNA 166			testis	TESTI2		XM_371311.6	XP_371311.4	MODEL	Pfs	0.214	0.214	28	414	205	289	102	11	38
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C010D17	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK094021	FLJ02-B09	FLJ	W01C010D18	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C010D19	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK090822	FLJ02-B10	FLJ	W01C010D20	pDONR221	4723		ATL3	25923	BAC03524	Hs.356719	Atlastin GTPase 3		normal astrocytes (NHA5732)		ASTRO2		NM_015459.3	NP_056274.3	VALIDATED	Pfs	0.250	0.250	28	383	122	39	541	262	289
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C010D21	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054626	FLJ02-B11	FLJ	W01C010D22	pDONR221	21293		FLJ30064	644975	BAB70777.1	Hs.632300	Hypothetical protein LOC644975			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001039906.1	NP_001034995.1	NA
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C010D23	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK054738	FLJ02-B12	FLJ	W01C010D24	pDONR221	13982		TMEM163	81615	-	Hs.369471	Transmembrane protein 163	H4	neuroglioma		BNGH41		NM_030923.4	NP_112185.1	VALIDATED	Pfs	0.444	0.444	27	408	327	246	289	22	48
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C010E01	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C010E02	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C010E03	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C010E04	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C010E05	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C010E06	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C010E07	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C010E08	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C010E09	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C010E10	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C010E11	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C010E12	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C010E13	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C010E14	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C010E15	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C010E16	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C010E17	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C010E18	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C010E19	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C010E20	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C010E21	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C010E22	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C010E23	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C010E24	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C010F01	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055583	FLJ02-C01	FLJ	W01C010F02	pDONR221	28488		LOC100129917	100129917	BAB70962.1	Hs.711523	Hypothetical protein LOC100129917			brain	FEBRA2		XM_001721215.1	XP_001721267.1	MODEL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C010F03	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055470	FLJ02-C02	FLJ	W01C010F04	pDONR221	31876		LOC100130507	100130507	BAB70928.1	Hs.680596	Hypothetical LOC100130507			brain	FEBRA2		XM_001720608.1	XP_001720660.1	MODEL	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C010F05	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK055167	FLJ02-C03	FLJ	W01C010F06	pDONR221	15239		C21orf121	150142	-	Hs.143833	Chromosome 21 open reading frame 121			brain	BRAWH2														
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C010F07	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK091129	FLJ02-C04	FLJ	W01C010F08	pDONR221	6128		C12orf36	283422	BAC03590.1	Hs.448717	Chromosome 12 open reading frame 36			substantia nigra	BRSSN2		NM_182558.1	NP_872364.1	PREDICTED	Cs	0.993	0.993	138	417	1	414	138	1	138
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C010F09	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK092517	FLJ02-C05	FLJ	W01C010F10	pDONR221	3329		C10orf55	414236	BAC03908.1	Hs.585453	Chromosome 10 open reading frame 55			placenta	PLACE6		NM_001001791.2	NP_001001791.2	VALIDATED	P	1.000	1.000	127	384	1	381	151	25	151
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C010F11	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	FLJ02-C06	FLJ	W01C010F12	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C010F13	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	FLJ02-C07	FLJ	W01C010F14	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C010F15	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK074989	FLJ02-C08	FLJ	W01C010F16	pDONR221	687		C1orf213	148898	BAC11338.1	Hs.61884	Chromosome 1 open reading frame 213	NT2	teratocarcinoma		NT2RP3		NM_138479.2	NP_612488.2	VALIDATED	OK	1.000	1.000	126	381	1	378	126	1	126
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C010F17	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075168	FLJ02-C09	FLJ	W01C010F18	pDONR221	13469		C2orf88	84281	BAC11447	Hs.389311	Chromosome 2 open reading frame 88			placenta	PLACE1		NM_001042519.1	NP_001035984.1	VALIDATED		0.714	0.714	7	384	256	276	95	31	37
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C010F19	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK075271	FLJ02-C10	FLJ	W01C010F20	pDONR221	14699		SPTLC3	55304	BAC11509.1	Hs.425023	Serine palmitoyltransferase, long chain base subunit 3			thyroid gland	THYRO1		NM_018327.2	NP_060797.2	VALIDATED	P	1.000	1.000	134	405	1	402	552	419	552
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C010F21	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK091913	FLJ02-C11	FLJ	W01C010F22	pDONR221	19976			642728	BAC03771					lung	HLUNG2				
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C010F23	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK092009	FLJ02-C12	FLJ	W01C010F24	pDONR221	9892		FLJ34690	284034	BAC03788.1	Hs.376614	Hypothetical protein FLJ34690			kidney	KIDNE2														
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C010G01	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C010G02	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C010G03	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C010G04	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C010G05	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C010G06	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C010G07	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C010G08	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C010G09	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C010G10	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C010G11	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C010G12	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C010G13	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C010G14	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C010G15	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C010G16	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C010G17	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C010G18	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C010G19	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C010G20	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C010G21	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C010G22	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C010G23	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C010G24	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C010H01	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK093799	FLJ02-D01	FLJ	W01C010H02	pDONR221	34960		LOC100132800	100132800	BAC04224	Hs.534941	Hypothetical protein LOC100132800			thymus	THYMU2		XM_001724784.1	XP_001724836.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C010H03	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK096111	FLJ02-D02	FLJ	W01C010H04	pDONR221	10610		TMEM105	284186	BAC04703.1	Hs.364191	Transmembrane protein 105			liver	LIVER2		NM_178520.2	NP_848615.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C010H05	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097240	FLJ02-D03	FLJ	W01C010H06	pDONR221	22031		LOC222159	222159	BAC04983					spleen	SPLEN2				
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C010H07	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK097056	FLJ02-D04	FLJ	W01C010H08	pDONR221	24035		SEMA4D	10507	BAC04938.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			small intestine	SMINT2		NM_182635.1	NP_872441.1	VALIDATED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C010H09	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK094976	FLJ02-D05	FLJ	W01C010H10	pDONR221	11799		YJEFN3	374887	-	Hs.710444	YjeF N-terminal domain containing 3			caudate nucleus	BRCAN2		NM_198537.2	NP_940939.2	VALIDATED		0.816	0.816	49	411	263	409	299	95	143
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C010H11	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095012	FLJ02-D06	FLJ	W01C010H12	pDONR221	39634		LOC100130456	100130456	BAC04473	Hs.683861	Hypothetical LOC100130456			hippocampus	BRHIP2		XM_001720710.1	XP_001720762.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C010H13	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095052	FLJ02-D07	FLJ	W01C010H14	pDONR221	9907		LOC284033	284033	-	Hs.592124	Hypothetical LOC284033			hippocampus	BRHIP2				
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C010H15	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095054	FLJ02-D08	FLJ	W01C010H16	pDONR221	4803		FAM181B	220382	BAC04483	Hs.448218	Family with sequence similarity 181, member B			hippocampus	BRHIP2		NM_175885.3	NP_787081.2	VALIDATED	Pfs	0.306	0.317	62	396	224	39	426	74	133
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C010H17	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK095105	FLJ02-D09	FLJ	W01C010H18	pDONR221	14390		FLJ37786	642691	BAC04486	Hs.587089	Hypothetical LOC642691			hippocampus	BRHIP2														
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C010H19	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094115	FLJ02-D10	FLJ	W01C010H20	pDONR221	36898		LOC100128262	100128262	BAC04290	Hs.679136	Hypothetical LOC100128262			uterus	UTERU2		XM_001716783.1	XP_001716835.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C010H21	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK096925	FLJ02-D11	FLJ	W01C010H22	pDONR221	31883				BAC04898			SK-N-SH	neuroblastoma		SKNSH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C010H23	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK098147	FLJ02-D12	FLJ	W01C010H24	pDONR221	36639				BAC05242					trachea	TRACH2				
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C010I01	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C010I02	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C010I03	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C010I04	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C010I05	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C010I06	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C010I07	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C010I08	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C010I09	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C010I10	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C010I11	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C010I12	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C010I13	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C010I14	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C010I15	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C010I16	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C010I17	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C010I18	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C010I19	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C010I20	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C010I21	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C010I22	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C010I23	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C010I24	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C010J01	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095683	FLJ02-E01	FLJ	W01C010J02	pDONR221	38810		PSMG4	389362	BAC04606	Hs.207069	Proteasome (prosome, macropain) assembly chaperone 4			brain	FCBBF3		NM_001135750.1	NP_001129222.1	VALIDATED		0.375	0.375	16	366	299	252	104	76	91
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C010J03	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK095177	FLJ02-E02	FLJ	W01C010J04	pDONR221	23058		PAG1	55824	BAC04494	Hs.266175	Phosphoprotein associated with glycosphingolipid microdomains 1			substantia nigra	BRSSN2		NM_018440.3	NP_060910.3	REVIEWED	Pfs	0.364	0.375	33	402	376	278	432	2	33
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C010J05	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK057522	FLJ02-E03	FLJ	W01C010J06	pDONR221	7291		MEG3	55384	BAB71519	Hs.655127	Maternally expressed 3 (non-protein coding)			testis	TESTI2														
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C010J07	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E04	FLJ	W01C010J08	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C010J09	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ02-E05	FLJ	W01C010J10	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C010J11	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK092192	FLJ02-E06	FLJ	W01C010J12	pDONR221	40720		LOC100128501	100128501	BAC03825	Hs.711775	Hypothetical protein LOC100128501	NT2	teratocarcinoma		NT2NE2		XM_001721187.1	XP_001721239.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C010J13	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097099	FLJ02-E07	FLJ	W01C010J14	pDONR221	2901		LOC100131848	100131848	BAC04949	Hs.711375	FP2025			spleen	SPLEN2		XM_001726336.1	XP_001726388.1	MODEL	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C010J15	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK097487	FLJ02-E08	FLJ	W01C010J16	pDONR221	746		TMEM78	677790	BAC05074	Hs.638407	Transmembrane protein 78			testis	TESTI2		NM_001040079.1	NP_001035168.1	NA
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C010J17	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK098238	FLJ02-E09	FLJ	W01C010J18	pDONR221	6533		C13orf30	144809	BAC05268.1	Hs.16970	Chromosome 13 open reading frame 30			trachea	TRACH2		NM_182508.2	NP_872314.1	VALIDATED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C010J19	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK094721	FLJ02-E10	FLJ	W01C010J20	pDONR221	2808		C10orf85	404216	BAC04408.1	Hs.196578	Chromosome 10 open reading frame 85			amygdala	BRAMY2														
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C010J21	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096231	FLJ02-E11	FLJ	W01C010J22	pDONR221	34838				BAC04734					esophagus	NESOP1				
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C010J23	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-E12	FLJ	W01C010J24	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C010K01	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C010K02	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C010K03	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C010K04	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C010K05	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C010K06	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C010K07	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C010K08	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C010K09	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C010K10	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C010K11	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C010K12	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C010K13	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C010K14	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C010K15	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C010K16	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C010K17	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C010K18	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C010K19	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C010K20	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C010K21	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C010K22	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C010K23	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C010K24	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C010L01	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096379	FLJ02-F01	FLJ	W01C010L02	pDONR221	24752		RP11-114H20.1	401589	BAC04772.1	Hs.553803	Hypothetical LOC401589	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C010L03	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK095434	FLJ02-F02	FLJ	W01C010L04	pDONR221	7507		C14orf43	91748	BAC04547	Hs.656506	Chromosome 14 open reading frame 43			tongue, tumor tissue	CTONG2		NM_194278.3	NP_919254.2	VALIDATED	Pfs	0.316	0.333	38	420	261	154	1045	87	124
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C010L05	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097662	FLJ02-F03	FLJ	W01C010L06	pDONR221	2012		C1orf157	284573	BAC05136.1	Hs.406979	Chromosome 1 open reading frame 157			testis	TESTI2		NM_182579.2	NP_872385.2	VALIDATED		0.971	0.971	103	387	1	309	104	1	103
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C010L07	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097693	FLJ02-F04	FLJ	W01C010L08	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C010L09	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK097701	FLJ02-F05	FLJ	W01C010L10	pDONR221	37588		KIAA1109	84162	BAC05145	Hs.408142	KIAA1109			testis	TESTI2		NM_015312.2	NP_056127.2	VALIDATED	Pfs	0.222	0.222	36	402	101	208	5005	960	995
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C010L11	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK122900	FLJ02-F06	FLJ	W01C010L12	pDONR221	13384		KLRAQ1	129285	-	Hs.654619	KLRAQ motif containing 1			prostate	PRS		NM_001135629.1	NP_001129101.1	VALIDATED	P	1.000	1.000	109	330	1	327	780	672	780
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C010L13	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096849	FLJ02-F07	FLJ	W01C010L14	pDONR221	34969				BAC04875					prostate	PROST2				
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C010L15	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096857	FLJ02-F08	FLJ	W01C010L16	pDONR221	21597		LOC646999	646999	BAC04879	Hs.72168	Hypothetical LOC646999		pulmonary artery endothelial cells (HPAEC)		PUAEN2		XM_929979.2	XP_935072.1	MODEL										
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C010L17	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK096894	FLJ02-F09	FLJ	W01C010L18	pDONR221	21345		C7orf53	286006	BAC04886.1	Hs.396189	Chromosome 7 open reading frame 53		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_001134468.1	NP_001127940.1	VALIDATED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C010L19	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK094853	FLJ02-F10	FLJ	W01C010L20	pDONR221	31776		LOC100129775	100129775	BAC04436	Hs.683867	Hypothetical protein LOC100129775			brain	BRAWH2		XM_001724206.1	XP_001724258.1	MODEL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C010L21	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK095225	FLJ02-F11	FLJ	W01C010L22	pDONR221	37059				BAC04503					substantia nigra	BRSSN2				
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C010L23	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK123212	FLJ02-F12	FLJ	W01C010L24	pDONR221	6559		SERP2	387923		Hs.377972	Stress-associated endoplasmic reticulum protein family member 2			alzheimer cortex	BRALZ2		NM_001010897.1	NP_001010897.1	PROVISIONAL		0.692	0.750	26	1053	615	686	65	40	65
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C010M01	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C010M02	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C010M03	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C010M04	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C010M05	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C010M06	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C010M07	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C010M08	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C010M09	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C010M10	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C010M11	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C010M12	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C010M13	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C010M14	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C010M15	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C010M16	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C010M17	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C010M18	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C010M19	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C010M20	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C010M21	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C010M22	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C010M23	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C010M24	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C010N01	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK095412	FLJ02-G01	FLJ	W01C010N02	pDONR221	8756		DNASE1	1773	BAC04544	Hs.629638	Deoxyribonuclease I			tongue, tumor tissue	CTONG2		NM_005223.3	NP_005214.2	REVIEWED	Pfs	0.310	0.321	29	411	349	266	282	194	222
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C010N03	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK124237	FLJ02-G02	FLJ	W01C010N04	pDONR221	13297		PKP4	8502	-	Hs.407580	Plakophilin 4			thymus	THYMU2		NM_003628.3	NP_003619.2	REVIEWED	Ps	0.994	0.994	310	933	1	930	1192	883	1192
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C010N05	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK075350	FLJ02-G03	FLJ	W01C010N06	pDONR221	1946		TMEM77	128338	BAC11562.1	Hs.485606	Transmembrane protein 77	NT2	teratocarcinoma		NT2RP1		NM_178454.4	NP_848549.3	VALIDATED	P	1.000	1.000	136	411	1	408	266	131	266
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C010N07	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098358	FLJ02-G04	FLJ	W01C010N08	pDONR221	38716				BAC05291					uterus	UTERU2				
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C010N09	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098731	FLJ02-G05	FLJ	W01C010N10	pDONR221	10141		LOC100129677	100129677	BAC05395.1	Hs.683782	Hypothetical protein LOC100129677			testis	TST		XM_001721631.1	XP_001721683.1	MODEL	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C010N11	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098579	FLJ02-G06	FLJ	W01C010N12	pDONR221	19573			642853	BAC05341					brain	CBR				
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C010N13	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK098639	FLJ02-G07	FLJ	W01C010N14	pDONR221	7151		C14orf177	283598	BAC05361.1	Hs.448754	Chromosome 14 open reading frame 177			testis	TST		NM_182560.1	NP_872366.1	PREDICTED	Cs	0.992	0.992	125	378	1	375	125	1	125
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C010N15	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK130360	FLJ02-G08	FLJ	W01C010N16	pDONR221	11856		FLJ26850	400710	BAC85332.1	Hs.628968	FLJ26850 protein			prostate	PRS														
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C010N17	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK129695	FLJ02-G09	FLJ	W01C010N18	pDONR221	9338		C16orf47	388289	BAC85221.1	Hs.371893	Chromosome 16 open reading frame 47			spleen	SPL		NM_207385.1	NP_997268.1	NA
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C010N19	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK025079	FLJ02-G10	FLJ	W01C010N20	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C010N21	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK129527	FLJ02-G11	FLJ	W01C010N22	pDONR221	3378		C10orf125	282969	BAC85178.1	Hs.155823	Chromosome 10 open reading frame 125			dermoid tumor	DMC		NM_198472.2	NP_940874.2	VALIDATED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C010N23	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK131059	FLJ02-G12	FLJ	W01C010N24	pDONR221	4034		LOC494141	494141	-	Hs.446327	Mitochondrial carrier triple repeat 1 pseudogene			dermoid tumor	DMC														
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C010O01	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C010O02	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C010O03	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C010O04	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C010O05	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C010O06	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C010O07	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C010O08	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C010O09	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C010O10	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C010O11	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C010O12	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C010O13	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C010O14	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C010O15	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C010O16	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C010O17	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C010O18	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C010O19	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C010O20	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C010O21	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C010O22	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C010O23	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C010O24	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C010P01	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	FLJ02-H01	FLJ	W01C010P02	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C010P03	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129595	FLJ02-H02	FLJ	W01C010P04	pDONR221	11550		GADD45B	4616	-	Hs.110571	Growth arrest and DNA-damage-inducible, beta			rectum	RCT		NM_015675.2	NP_056490.2	REVIEWED		0.950	0.950	40	933	315	434	160	121	160
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C010P05	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK129601	FLJ02-H03	FLJ	W01C010P06	pDONR221	7925		OSTbeta	123264	-	Hs.534533	Organic solute transporter beta			rectum	RCT		NM_178859.2	NP_849190.1	PROVISIONAL	Cs	0.992	0.992	128	387	1	384	128	1	128
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C010P07	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK026408	FLJ02-H04	FLJ	W01C010P08	pDONR221	1		RPIA	22934	BAB15473	Hs.469264	Ribose 5-phosphate isomerase A			human small intestine	HSI		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.269	0.269	26	408	291	368	311	16	41
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C010P09	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK027157	FLJ02-H05	FLJ	W01C010P10	pDONR221	11731		CEACAM19	56971	-	Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19			human small intestine	HSI		NM_001127893.1	NP_001121365.1	VALIDATED	P	1.000	1.000	56	798	1	168	299	244	299
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C010P11	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK058133	FLJ02-H06	FLJ	W01C010P12	pDONR221	8820		C16orf92	146378	BAB71678.1	Hs.651588	Chromosome 16 open reading frame 92			brain	CBR		NM_001109660.1	NP_001103130.1	PREDICTED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C010P13	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129507	FLJ02-H07	FLJ	W01C010P14	pDONR221	16483		FLJ25996	401109	BAC85170.1	Hs.280133	FLJ25996 protein			dermoid tumor	DMC		NM_001001699.1	NP_001001699.1	NA
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C010P15	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK129854	FLJ02-H08	FLJ	W01C010P16	pDONR221	20470		OSTM1	28962	-	Hs.719130	Osteopetrosis associated transmembrane protein 1			dermoid tumor	DMC		NM_014028.3	NP_054747.2	REVIEWED	Pfs	0.992	1.000	127	384	3	381	334	208	334
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C010P17	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131005	FLJ02-H09	FLJ	W01C010P18	pDONR221	5528		LOC255411	255411	-	Hs.404103	Hypothetical LOC255411			testis	TST		XM_170708.8	XP_170708.1	MODEL	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C010P19	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK131015	FLJ02-H10	FLJ	W01C010P20	pDONR221	18826		C5orf48	389320	BAC85477.1	Hs.177983	Chromosome 5 open reading frame 48			testis	TST		NM_207408.1	NP_997291.1	PREDICTED	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C010P21	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK130965	FLJ02-H11	FLJ	W01C010P22	pDONR221	9944		RPL23A	6147	-	Hs.419463	Ribosomal protein L23a			dermoid tumor	DMC		NM_000984.5	NP_000975.2	REVIEWED		0.839	0.839	112	366	4	339	156	43	154
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C010P23	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK054768	FLJ02-H12	FLJ	W01C010P24	pDONR221	30679		LOC646471	646471	BAB70804.1					cerebellum	BRACE2		XM_929392.2	XP_934485.1	MODEL	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C011A01	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C011A02	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C011A03	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C011A04	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C011A05	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C011A06	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C011A07	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C011A08	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C011A09	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C011A10	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C011A11	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C011A12	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C011A13	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C011A14	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C011A15	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C011A16	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C011A17	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C011A18	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C011A19	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C011A20	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C011A21	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C011A22	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C011A23	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C011A24	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C011B01	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C011B02	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C011B03	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C011B04	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C011B05	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C011B06	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C011B07	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C011B08	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C011B09	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C011B10	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C011B11	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C011B12	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C011B13	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C011B14	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C011B15	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C011B16	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C011B17	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C011B18	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C011B19	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C011B20	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C011B21	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C011B22	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C011B23	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C011B24	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C011C01	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C011C02	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C011C03	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C011C04	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C011C05	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C011C06	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C011C07	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C011C08	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C011C09	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C011C10	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C011C11	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C011C12	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C011C13	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C011C14	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C011C15	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C011C16	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C011C17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C011C18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C011C19	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C011C20	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C011C21	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C011C22	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C011C23	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C011C24	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C011D01	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C011D02	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C011D03	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C011D04	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C011D05	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C011D06	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C011D07	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C011D08	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C011D09	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C011D10	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C011D11	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C011D12	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C011D13	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C011D14	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C011D15	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C011D16	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C011D17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C011D18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C011D19	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C011D20	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C011D21	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C011D22	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C011D23	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C011D24	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C011E01	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C011E02	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C011E03	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C011E04	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C011E05	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C011E06	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C011E07	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C011E08	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C011E09	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C011E10	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C011E11	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C011E12	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C011E13	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C011E14	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C011E15	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C011E16	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C011E17	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C011E18	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C011E19	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C011E20	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C011E21	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C011E22	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C011E23	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C011E24	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C011F01	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C011F02	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C011F03	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C011F04	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C011F05	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C011F06	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C011F07	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C011F08	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C011F09	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C011F10	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C011F11	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C011F12	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C011F13	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C011F14	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C011F15	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C011F16	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C011F17	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C011F18	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C011F19	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C011F20	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C011F21	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C011F22	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C011F23	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C011F24	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C011G01	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C011G02	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C011G03	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C011G04	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C011G05	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C011G06	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C011G07	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C011G08	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C011G09	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C011G10	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C011G11	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C011G12	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C011G13	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C011G14	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C011G15	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C011G16	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C011G17	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C011G18	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C011G19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C011G20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C011G21	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C011G22	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C011G23	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C011G24	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C011H01	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C011H02	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C011H03	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C011H04	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C011H05	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C011H06	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C011H07	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C011H08	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C011H09	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C011H10	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C011H11	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C011H12	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C011H13	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C011H14	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C011H15	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C011H16	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C011H17	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C011H18	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C011H19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C011H20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C011H21	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C011H22	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C011H23	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C011H24	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C011I01	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C011I02	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C011I03	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C011I04	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C011I05	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C011I06	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C011I07	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C011I08	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C011I09	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C011I10	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C011I11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C011I12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C011I13	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C011I14	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C011I15	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C011I16	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C011I17	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C011I18	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C011I19	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C011I20	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C011I21	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C011I22	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C011I23	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C011I24	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C011J01	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C011J02	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C011J03	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C011J04	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C011J05	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C011J06	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C011J07	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C011J08	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C011J09	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C011J10	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C011J11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C011J12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C011J13	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C011J14	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C011J15	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C011J16	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C011J17	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C011J18	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C011J19	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C011J20	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C011J21	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C011J22	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C011J23	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C011J24	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C011K01	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C011K02	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C011K03	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C011K04	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C011K05	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C011K06	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C011K07	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C011K08	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C011K09	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C011K10	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C011K11	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C011K12	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C011K13	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C011K14	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C011K15	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C011K16	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C011K17	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C011K18	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C011K19	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C011K20	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C011K21	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C011K22	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C011K23	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C011K24	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C011L01	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C011L02	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C011L03	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C011L04	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C011L05	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C011L06	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C011L07	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C011L08	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C011L09	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C011L10	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C011L11	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C011L12	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C011L13	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C011L14	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C011L15	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C011L16	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C011L17	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C011L18	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C011L19	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C011L20	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C011L21	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C011L22	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C011L23	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C011L24	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C011M01	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C011M02	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C011M03	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C011M04	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C011M05	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C011M06	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C011M07	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C011M08	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C011M09	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C011M10	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C011M11	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C011M12	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C011M13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C011M14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C011M15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C011M16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C011M17	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C011M18	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C011M19	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C011M20	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C011M21	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C011M22	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C011M23	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C011M24	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C011N01	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C011N02	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C011N03	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C011N04	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C011N05	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C011N06	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C011N07	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C011N08	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C011N09	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C011N10	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C011N11	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C011N12	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C011N13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C011N14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C011N15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C011N16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C011N17	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C011N18	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C011N19	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C011N20	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C011N21	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C011N22	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C011N23	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C011N24	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C011O01	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C011O02	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C011O03	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C011O04	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C011O05	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C011O06	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C011O07	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C011O08	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C011O09	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C011O10	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C011O11	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C011O12	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C011O13	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C011O14	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C011O15	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C011O16	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C011O17	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C011O18	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C011O19	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C011O20	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C011O21	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C011O22	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C011O23	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C011O24	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C011P01	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C011P02	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C011P03	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C011P04	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C011P05	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C011P06	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C011P07	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C011P08	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C011P09	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C011P10	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C011P11	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C011P12	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C011P13	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C011P14	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C011P15	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C011P16	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C011P17	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C011P18	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C011P19	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C011P20	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C011P21	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C011P22	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C011P23	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C011P24	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C012A01	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C012A02	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C012A03	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C012A04	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C012A05	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C012A06	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C012A07	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C012A08	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C012A09	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C012A10	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C012A11	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C012A12	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C012A13	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C012A14	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C012A15	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C012A16	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C012A17	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C012A18	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C012A19	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C012A20	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C012A21	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C012A22	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C012A23	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C012A24	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C012B01	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK025796	FLJ03-A01	FLJ	W01C012B02	pDONR221	20532		ECHDC1	55862	-	Hs.486410	Enoyl Coenzyme A hydratase domain containing 1	HepG2	hepatoma		HEP		NM_001105544.1	NP_001099014.1	VALIDATED	Cg	0.991	1.000	228	912	226	909	226	1	226
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C012B03	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	FLJ03-A02	FLJ	W01C012B04	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C012B05	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074548	FLJ03-A03	FLJ	W01C012B06	pDONR221	12442		FAM108A1	81926	BAC11052.1	Hs.653679	Family with sequence similarity 108, member A1			whole embryo, mainly head	HEMBA1		NM_001130111.1	NP_001123583.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C012B07	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074573	FLJ03-A04	FLJ	W01C012B08	pDONR221	16756		PDZRN3	23024	BAC11068.1	Hs.719126	PDZ domain containing ring finger 3			whole embryo, mainly head	HEMBA1		NM_015009.1	NP_055824.1	PROVISIONAL		0.892	0.898	268	957	1	798	1066	410	677
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C012B09	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074672	FLJ03-A05	FLJ	W01C012B10	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C012B11	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074680	FLJ03-A06	FLJ	W01C012B12	pDONR221	9596		MYO15B	80022	BAC11134	Hs.390817	Myosin XVB pseudogene			mammary gland	MAMMA1				
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C012B13	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074684	FLJ03-A07	FLJ	W01C012B14	pDONR221	5455		MFSD5	84975	BAC11137.1	Hs.654660	Major facilitator superfamily domain containing 5			mammary gland	MAMMA1		NM_032889.3	NP_116278.2	PROVISIONAL	Cs	0.998	0.998	450	1353	1	1350	450	1	450
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C012B15	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074688	FLJ03-A08	FLJ	W01C012B16	pDONR221	15876		PIK3IP1	113791	BAC11140.1	Hs.26670	Phosphoinositide-3-kinase interacting protein 1			mammary gland	MAMMA1		NM_052880.4	NP_443112.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C012B17	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A09	FLJ	W01C012B18	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Pfs	0.977	0.993	304	900	1	899	446	1	304
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C012B19	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074773	FLJ03-A10	FLJ	W01C012B20	pDONR221	8734		CLEC18A	348174	BAC11199.1	Hs.592064	C-type lectin domain family 18, member A	NT2	teratocarcinoma		NT2RM4		NM_001136214.1	NP_001129686.1	VALIDATED	Cs	0.989	0.989	446	1341	1	1338	446	1	446
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C012B21	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074777	FLJ03-A11	FLJ	W01C012B22	pDONR221	18635		MRPS30	10884	BAC11202.1	Hs.124165	Mitochondrial ribosomal protein S30	NT2	teratocarcinoma		NT2RP1		NM_016640.3	NP_057724.2	REVIEWED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C012B23	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK074850	FLJ03-A12	FLJ	W01C012B24	pDONR221	3851		FRMD8	83786	BAC11244.1	Hs.578433	FERM domain containing 8	NT2	teratocarcinoma		NT2RP2		NM_031904.3	NP_114110.1	VALIDATED	Cg	0.879	1.000	464	1227	1	1224	464	1	464
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C012C01	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C012C02	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C012C03	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C012C04	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C012C05	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C012C06	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C012C07	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C012C08	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C012C09	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C012C10	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C012C11	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C012C12	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C012C13	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C012C14	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C012C15	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C012C16	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C012C17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C012C18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C012C19	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C012C20	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C012C21	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C012C22	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C012C23	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C012C24	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C012D01	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK055809	FLJ03-B01	FLJ	W01C012D02	pDONR221	644		LOC148709	148709	-	Hs.162880	Actin pseudogene			kidney	KIDNE2				
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C012D03	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091160	FLJ03-B02	FLJ	W01C012D04	pDONR221	10956		KIAA1468	57614	-	Hs.465323	KIAA1468			tongue, tumor tissue	CTONG2		NM_020854.3	NP_065905.2	VALIDATED	Pfs	0.989	0.995	188	564	1	563	1216	1	187
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C012D05	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091161	FLJ03-B03	FLJ	W01C012D06	pDONR221	7442		PP8961	650662	BAC03597	Hs.638530	Hypothetical protein LOC650662			tongue, tumor tissue	CTONG2		NM_001080113.2	NP_001073582.2	VALIDATED	Pfs	0.993	1.000	144	429	1	428	148	1	144
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C012D07	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091177	FLJ03-B04	FLJ	W01C012D08	pDONR221	38692				BAC03601					tongue, tumor tissue	CTONG2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C012D09	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK091697	FLJ03-B05	FLJ	W01C012D10	pDONR221	40534				BAC03724					brain	FEBRA2				
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C012D11	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B06	FLJ	W01C012D12	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C012D13	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074570	FLJ03-B07	FLJ	W01C012D14	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED	P	1.000	1.000	22	699	629	694	1121	1	22
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C012D15	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B08	FLJ	W01C012D16	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C012D17	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK074886	FLJ03-B09	FLJ	W01C012D18	pDONR221	6122		LOC389634	389634	BAC11267.1	Hs.696467	Hypothetical LOC389634	NT2	teratocarcinoma		NT2RP2														
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C012D19	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075061	FLJ03-B10	FLJ	W01C012D20	pDONR221	8687		WFDC1	58189	BAC11377.1	Hs.36688	WAP four-disulfide core domain 1			ovary, tumor tissue	OVARC1		NM_021197.2	NP_067020.2	REVIEWED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C012D21	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075067	FLJ03-B11	FLJ	W01C012D22	pDONR221	21315		TMEM139	135932	BAC11382.1	Hs.17558	Transmembrane protein 139			placenta	PLACE1		NM_153345.1	NP_699176.1	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C012D23	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK075069	FLJ03-B12	FLJ	W01C012D24	pDONR221	5926		TMBIM4	51643	BAC11384.1	Hs.505934	Transmembrane BAX inhibitor motif containing 4			placenta	PLACE1		NM_016056.2	NP_057140.2	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C012E01	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C012E02	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C012E03	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C012E04	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C012E05	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C012E06	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C012E07	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C012E08	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C012E09	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C012E10	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C012E11	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C012E12	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C012E13	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C012E14	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C012E15	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C012E16	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C012E17	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C012E18	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C012E19	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C012E20	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C012E21	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C012E22	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C012E23	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C012E24	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C012F01	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-C01	FLJ	W01C012F02	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C012F03	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075137	FLJ03-C02	FLJ	W01C012F04	pDONR221	3810		SIDT2	51092	BAC11427.1	Hs.712144	SID1 transmembrane family, member 2			placenta	PLACE1		NM_001040455.1	NP_001035545.1	VALIDATED	P	1.000	1.000	242	729	1	726	832	591	832
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C012F05	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075161	FLJ03-C03	FLJ	W01C012F06	pDONR221	15912		FLJ90680	400926	BAC11442	Hs.143856	FLJ90680 protein			placenta	PLACE1														
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C012F07	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK075165	FLJ03-C04	FLJ	W01C012F08	pDONR221	21866		LAMB4	22798	BAC11446	Hs.62022	Laminin, beta 4			placenta	PLACE1		NM_007356.2	NP_031382.2	VALIDATED	P	1.000	1.000	233	702	1	699	1761	1529	1761
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C012F09	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK000880	FLJ03-C05	FLJ	W01C012F10	pDONR221	2673		HSPA14	51182	BAG50835.1	Hs.534169	Heat shock 70kDa protein 14			adipose tissue	ad		NM_016299.2	NP_057383.2	VALIDATED		0.412	0.412	17	753	489	439	509	417	433
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C012F11	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK094629	FLJ03-C06	FLJ	W01C012F12	pDONR221	39103				BAC04390					cerebellum	BRACE2				
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C012F13	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK097767	FLJ03-C07	FLJ	W01C012F14	pDONR221	8859		FLJ40448	339059	BAC05165.1	Hs.449817	Hypothetical protein FLJ40448			testis	TESTI2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C012F15	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095698	FLJ03-C08	FLJ	W01C012F16	pDONR221	13362		FLJ38379	285097	BAC04613.1	Hs.653239	Hypothetical FLJ38379			brain	FEBRA2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C012F17	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK095276	FLJ03-C09	FLJ	W01C012F18	pDONR221	7498		LOC283588	283588	BAC04519.1	Hs.46519	Hypothetical LOC283588			tongue, tumor tissue	CTONG2														
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C012F19	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK094480	FLJ03-C10	FLJ	W01C012F20	pDONR221	16489		LEKR1	389170	BAC04365	Hs.478048	Leucine, glutamate and lysine rich 1			cerebellum	BRACE2		XM_001725985.1	XP_001726037.1	MODEL	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C012F21	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK095915	FLJ03-C11	FLJ	W01C012F22	pDONR221	8307		C15orf56	644809	BAC04647.1	Hs.631718	Chromosome 15 open reading frame 56		chondrocytes (HC)		HCHON2		NM_001039905.1	NP_001034994.1	PREDICTED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C012F23	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK097050	FLJ03-C12	FLJ	W01C012F24	pDONR221	33261		LOC100130857	100130857	BAC04934	Hs.636752	Hypothetical protein LOC100130857	SK-N-SH	neuroblastoma		SKNSH2		XM_001724739.1	XP_001724791.1	MODEL	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C012G01	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C012G02	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C012G03	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C012G04	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C012G05	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C012G06	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C012G07	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C012G08	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C012G09	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C012G10	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C012G11	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C012G12	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C012G13	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C012G14	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C012G15	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C012G16	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C012G17	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C012G18	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C012G19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C012G20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C012G21	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C012G22	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C012G23	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C012G24	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C012H01	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK097332	FLJ03-D01	FLJ	W01C012H02	pDONR221	28827		LOC729603	729603	-	Hs.674810	Calcium binding protein P22 pseudogene			spleen	SPLEN2				
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C012H03	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK094992	FLJ03-D02	FLJ	W01C012H04	pDONR221	18200		LOC285456	285456	BAC04469.1	Hs.683863	Hypothetical LOC285456			hippocampus	BRHIP2														
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C012H05	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK095020	FLJ03-D03	FLJ	W01C012H06	pDONR221	27138		LOC100130894	100130894	BAC04476.1	Hs.678899	Hypothetical LOC100130894			hippocampus	BRHIP2		XM_001724341.1	XP_001724393.1	MODEL	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C012H07	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	FLJ03-D04	FLJ	W01C012H08	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C012H09	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095821	FLJ03-D05	FLJ	W01C012H10	pDONR221	28843				BAC04631					brain	FEBRA2				
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C012H11	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK095834	FLJ03-D06	FLJ	W01C012H12	pDONR221	19117		SH3PXD2B	285590	-	Hs.285666	SH3 and PX domains 2B		chondrocytes (HC)		HCHON2		NM_001017995.2	NP_001017995.1	VALIDATED		0.667	0.667	9	423	405	379	911	339	347
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C012H13	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK027383	FLJ03-D07	FLJ	W01C012H14	pDONR221	22835			84877	BAB55074					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C012H15	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097396	FLJ03-D08	FLJ	W01C012H16	pDONR221	19567		LOC648987	648987	-	Hs.655947	Hypothetical LOC648987			stomach	STOMA2														
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C012H17	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097866	FLJ03-D09	FLJ	W01C012H18	pDONR221	36367		RP11-429E11.3	100128310	BAC05189.1	Hs.683806	Hypothetical LOC100128310			testis	TESTI2		XM_001723870.1	XP_001723922.1	MODEL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C012H19	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D10	FLJ	W01C012H20	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C012H21	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	FLJ03-D11	FLJ	W01C012H22	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C012H23	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK074927	FLJ03-D12	FLJ	W01C012H24	pDONR221	24020		SLC2A6	11182	BAC11297.1	Hs.244378	Solute carrier family 2 (facilitated glucose transporter), member 6	NT2	teratocarcinoma		NT2RP3		NM_017585.3	NP_060055.2	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C012I01	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C012I02	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C012I03	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C012I04	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C012I05	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C012I06	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C012I07	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C012I08	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C012I09	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C012I10	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C012I11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C012I12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C012I13	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C012I14	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C012I15	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C012I16	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C012I17	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C012I18	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C012I19	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C012I20	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C012I21	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C012I22	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C012I23	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C012I24	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C012J01	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK096036	FLJ03-E01	FLJ	W01C012J02	pDONR221	20004		FLJ38717	401261	BAC04683.1	Hs.656652	FLJ38717 protein		dermal papilla cells (HDPC)		HHDPC2														
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C012J03	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK075021	FLJ03-E02	FLJ	W01C012J04	pDONR221	18682		RUFY1	80230	-	Hs.306769	RUN and FYVE domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_001040451.1	NP_001035541.1	VALIDATED	Cfs	0.853	1.000	600	1540	1	1537	600	1	600
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C012J05	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ03-E03	FLJ	W01C012J06	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C012J07	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK096324	FLJ03-E04	FLJ	W01C012J08	pDONR221	12543			284313	BAC04763			NT2	teratocarcinoma		NT2NE2				
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C012J09	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK122797	FLJ03-E05	FLJ	W01C012J10	pDONR221	7153		PSMB11	122706	BAG53735.1	Hs.508918	Proteasome (prosome, macropain) subunit, beta type, 11			brain	OCBBF2		NM_001099780.1	NP_001093250.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C012J11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK125057	FLJ03-E06	FLJ	W01C012J12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Pfs	0.860	0.860	178	537	1	534	254	77	254
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C012J13	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095727	FLJ03-E07	FLJ	W01C012J14	pDONR221	35204		LOC100130856	100130856	BAC04616.1	Hs.634471	Hypothetical LOC100130856			brain	FEBRA2		XM_001723600.1	XP_001723652.1	MODEL	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C012J15	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095950	FLJ03-E08	FLJ	W01C012J16	pDONR221	15552		GTPBP1	9567	-	Hs.276925	GTP binding protein 1			heart	HEART2		NM_004286.4	NP_004277.2	REVIEWED		0.393	0.407	28	501	399	319	669	620	647
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C012J17	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095245	FLJ03-E09	FLJ	W01C012J18	pDONR221	16190		PSMD2	5708	-	Hs.518464	Proteasome (prosome, macropain) 26S subunit, non-ATPase, 2			colon	COLON2		NM_002808.3	NP_002799.3	REVIEWED	Pfs	0.924	0.938	263	780	1	777	908	646	908
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C012J19	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK095409	FLJ03-E10	FLJ	W01C012J20	pDONR221	33078				BAC04543					tongue, tumor tissue	CTONG2				
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C012J21	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122914	FLJ03-E11	FLJ	W01C012J22	pDONR221	17655		WDR21B	285429	BAG53795.1	Hs.213307	WD repeat domain 21B			testis	TESTI4		NM_001029955.3	NP_001025126.2	VALIDATED	P	1.000	1.000	221	666	1	663	396	176	396
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C012J23	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK122940	FLJ03-E12	FLJ	W01C012J24	pDONR221	22083		TRYX3	136541	BAG53808.1	Hs.98609	Trypsin X3			testis	TESTI4		NM_001001317.2	NP_001001317.1	REVIEWED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C012K01	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C012K02	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C012K03	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C012K04	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C012K05	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C012K06	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C012K07	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C012K08	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C012K09	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C012K10	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C012K11	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C012K12	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C012K13	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C012K14	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C012K15	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C012K16	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C012K17	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C012K18	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C012K19	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C012K20	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C012K21	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C012K22	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C012K23	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C012K24	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C012L01	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075525	FLJ03-F01	FLJ	W01C012L02	pDONR221	22032		VWDE	221806	BAC11671.1	Hs.669526	Von Willebrand factor D and EGF domains			whole embryo, mainly head	HEMBA1		XM_001715460.1	XP_001715512.1	MODEL	P	1.000	1.000	158	513	1	474	1590	1	158
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C012L03	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F02	FLJ	W01C012L04	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C012L05	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075282	FLJ03-F03	FLJ	W01C012L06	pDONR221	9885		LRRC37B2	147172	BAC11518.1	Hs.568209	Leucine rich repeat containing 37, member B2			thyroid gland	THYRO1														
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C012L07	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075296	FLJ03-F04	FLJ	W01C012L08	pDONR221	7763		CCNDBP1	23582	BAC11530.1	Hs.36794	Cyclin D-type binding-protein 1	Y79	retinoblastoma		Y79AA1		NM_037370.2	NP_411241.1	REVIEWED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C012L09	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK075023	FLJ03-F05	FLJ	W01C012L10	pDONR221	15027		ABHD12	26090	BAC11357.1	Hs.441550	Abhydrolase domain containing 12			ovary, tumor tissue	OVARC1		NM_001042472.1	NP_001035937.1	VALIDATED	Cg	0.997	1.000	398	1194	1	1191	398	1	398
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C012L11	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F06	FLJ	W01C012L12	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C012L13	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK123006	FLJ03-F07	FLJ	W01C012L14	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL		0.963	0.963	164	495	1	492	164	1	164
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C012L15	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F08	FLJ	W01C012L16	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C012L17	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F09	FLJ	W01C012L18	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C012L19	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F10	FLJ	W01C012L20	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C012L21	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F11	FLJ	W01C012L22	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C012L23	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-F12	FLJ	W01C012L24	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C012M01	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C012M02	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C012M03	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C012M04	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C012M05	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C012M06	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C012M07	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C012M08	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C012M09	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C012M10	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C012M11	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C012M12	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C012M13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C012M14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C012M15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C012M16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C012M17	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C012M18	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C012M19	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C012M20	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C012M21	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C012M22	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C012M23	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C012M24	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C012N01	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK122996	FLJ03-G01	FLJ	W01C012N02	pDONR221	23078		LOC728731	728731	-	Hs.457899	Similar to olfactory receptor 873			testis	TESTI4				
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C012N03	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK128883	FLJ03-G02	FLJ	W01C012N04	pDONR221	16482		IQCF2	389123	-	Hs.412294	IQ motif containing F2	NT2	teratocarcinoma		NT2RP7		NM_203424.1	NP_982248.1	VALIDATED	P	1.000	1.000	158	558	82	555	164	7	164
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C012N05	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	FLJ03-G03	FLJ	W01C012N06	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C012N07	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK057890	FLJ03-G04	FLJ	W01C012N08	pDONR221	17063		FAM19A4	151647	BAB71606.1	Hs.187873	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A4			cerebellum	CBL		NM_001005527.1	NP_001005527.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C012N09	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130865	FLJ03-G05	FLJ	W01C012N10	pDONR221	22602		LRRC69	100130742	BAC85448.1					heart	HEART1		NM_001129890.1	NP_001123362.1	PROVISIONAL	Cg	0.550	1.000	347	576	1	573	347	1	347
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C012N11	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK130867	FLJ03-G06	FLJ	W01C012N12	pDONR221	24787		TMEM31	203562	-	Hs.98843	Transmembrane protein 31			testis	TST		NM_182541.2	NP_872347.2	VALIDATED	Cg	0.988	1.000	168	501	1	498	168	1	168
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C012N13	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK075105	FLJ03-G07	FLJ	W01C012N14	pDONR221	16309		PVRL3	25945	BAC11404.1	Hs.293917	Poliovirus receptor-related 3			placenta	PLACE1		NM_015480.1	NP_056295.1	PROVISIONAL	Ps	0.987	0.987	309	1464	94	1020	549	55	363
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C012N15	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	FLJ03-G08	FLJ	W01C012N16	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C012N17	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	FLJ03-G09	FLJ	W01C012N18	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C012N19	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK075118	FLJ03-G10	FLJ	W01C012N20	pDONR221	1943		C1orf118	374987	BAC11413.1	Hs.632414	Chromosome 1 open reading frame 118			placenta	PLACE1														
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C012N21	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130765	FLJ03-G11	FLJ	W01C012N22	pDONR221	20720		FLJ27255	401281	BAC85424.1	Hs.712508	Hypothetical LOC401281			synovial membrane (knee)	SYN		NM_207501.1	NP_997384.1	NA
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C012N23	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK130777	FLJ03-G12	FLJ	W01C012N24	pDONR221	14763		NCRNA00176	284739	BAC85427.1	Hs.97840	Proline rich 17			synovial membrane (knee)	SYN		NM_207349.1	NP_997232.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C012O01	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C012O02	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C012O03	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C012O04	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C012O05	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C012O06	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C012O07	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C012O08	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C012O09	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C012O10	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C012O11	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C012O12	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C012O13	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C012O14	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C012O15	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C012O16	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C012O17	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C012O18	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C012O19	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C012O20	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C012O21	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C012O22	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C012O23	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C012O24	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C012P01	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130820	FLJ03-H01	FLJ	W01C012P02	pDONR221	11490		TMEM91	641649	BAC85439.1	Hs.709417	Transmembrane protein 91			thymus	TMS		NM_001098821.1	NP_001092291.1	VALIDATED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C012P03	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130875	FLJ03-H02	FLJ	W01C012P04	pDONR221	15605		LOC400931	400931	BAC85451.1	Hs.719424	Hypothetical LOC400931			testis	TST														
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C012P05	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130879	FLJ03-H03	FLJ	W01C012P06	pDONR221	14637		MYL9	10398	-	Hs.504687	Myosin, light chain 9, regulatory			umbilical cord	UBA		NM_006097.3	NP_006088.2	REVIEWED	OK	1.000	1.000	172	519	1	516	172	1	172
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C012P07	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK130316	FLJ03-H04	FLJ	W01C012P08	pDONR221	13376		RBM44	375316	BAC85324.1				fibroblast	lung	LNF		NM_001080504.2	NP_001073973.2	VALIDATED	P	1.000	1.000	234	705	1	702	1052	819	1052
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C012P09	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK027118	FLJ03-H05	FLJ	W01C012P10	pDONR221	22029		ZFAND2A	90637	-	Hs.648111	Zinc finger, AN1-type domain 2A	HepG2	hepatoma		HEP		NM_182491.2	NP_872297.2	VALIDATED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C012P11	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK129752	FLJ03-H06	FLJ	W01C012P12	pDONR221	7818		CHP	11261		Hs.706184	Calcium binding protein P22			adrenal gland	ADG		NM_007236.4	NP_009167.1	REVIEWED		0.308	0.308	26	468	341	264	195	137	162
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C012P13	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK027130	FLJ03-H07	FLJ	W01C012P14	pDONR221	12457		YIF1B	90522	BAB15669.1	Hs.280741	Yip1 interacting factor homolog B (S. cerevisiae)			human small intestine	HSI		NM_033557.3	NP_291035.1	VALIDATED		0.306	0.319	49	429	142	2	283	2	50
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C012P15	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK026965	FLJ03-H08	FLJ	W01C012P16	pDONR221	38096				BAB15606			HepG2	hepatoma		HEP				
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C012P17	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK131018	FLJ03-H09	FLJ	W01C012P18	pDONR221	17141		IQCF1	132141	-	Hs.671210	IQ motif containing F1			testis	TST		NM_152397.2	NP_689610.2	VALIDATED	P	1.000	1.000	183	552	1	549	205	23	205
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C012P19	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130970	FLJ03-H10	FLJ	W01C012P20	pDONR221	14668		C20orf79	140856	-	Hs.112794	Chromosome 20 open reading frame 79			umbilical cord	UBA		NM_178483.2	NP_848578.1	VALIDATED	OK	1.000	1.000	156	471	1	468	156	1	156
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C012P21	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK130962	FLJ03-H11	FLJ	W01C012P22	pDONR221	8383		RPL19	6143	-	Hs.381061	Ribosomal protein L19			pancreas	PNC		NM_000981.3	NP_000972.1	REVIEWED		0.929	0.929	196	591	1	588	196	1	196
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C012P23	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK075120	FLJ03-H12	FLJ	W01C012P24	pDONR221	14087		UXS1	80146	BAC11415.1	Hs.715639	UDP-glucuronate decarboxylase 1			placenta	PLACE1		NM_025076.3	NP_079352.2	VALIDATED	OK	1.000	1.000	420	1263	1	1260	420	1	420
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C013A01	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C013A02	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C013A03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C013A04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C013A05	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C013A06	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C013A07	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C013A08	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C013A09	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C013A10	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C013A11	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C013A12	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C013A13	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C013A14	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C013A15	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C013A16	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C013A17	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C013A18	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C013A19	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C013A20	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C013A21	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C013A22	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C013A23	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C013A24	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C013B01	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C013B02	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C013B03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C013B04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C013B05	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C013B06	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C013B07	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C013B08	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C013B09	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C013B10	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C013B11	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C013B12	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C013B13	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C013B14	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C013B15	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C013B16	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C013B17	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C013B18	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C013B19	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C013B20	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C013B21	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C013B22	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C013B23	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C013B24	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C013C01	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C013C02	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C013C03	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C013C04	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C013C05	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C013C06	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C013C07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C013C08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C013C09	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C013C10	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C013C11	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C013C12	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C013C13	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C013C14	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C013C15	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C013C16	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C013C17	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C013C18	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C013C19	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C013C20	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C013C21	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C013C22	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C013C23	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C013C24	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C013D01	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C013D02	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C013D03	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C013D04	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C013D05	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C013D06	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C013D07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C013D08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C013D09	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C013D10	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C013D11	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C013D12	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C013D13	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C013D14	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C013D15	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C013D16	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C013D17	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C013D18	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C013D19	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C013D20	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C013D21	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C013D22	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C013D23	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C013D24	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C013E01	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C013E02	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C013E03	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C013E04	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C013E05	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C013E06	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C013E07	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C013E08	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C013E09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C013E10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C013E11	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C013E12	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C013E13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C013E14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C013E15	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C013E16	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C013E17	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C013E18	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C013E19	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C013E20	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C013E21	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C013E22	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C013E23	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C013E24	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C013F01	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C013F02	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C013F03	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C013F04	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C013F05	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C013F06	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C013F07	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C013F08	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C013F09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C013F10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C013F11	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C013F12	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C013F13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C013F14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C013F15	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C013F16	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C013F17	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C013F18	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C013F19	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C013F20	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C013F21	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C013F22	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C013F23	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C013F24	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C013G01	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C013G02	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C013G03	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C013G04	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C013G05	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C013G06	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C013G07	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C013G08	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C013G09	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C013G10	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C013G11	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C013G12	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C013G13	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C013G14	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C013G15	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C013G16	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C013G17	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C013G18	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C013G19	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C013G20	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C013G21	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C013G22	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C013G23	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C013G24	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C013H01	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C013H02	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C013H03	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C013H04	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C013H05	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C013H06	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C013H07	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C013H08	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C013H09	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C013H10	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C013H11	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C013H12	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C013H13	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C013H14	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C013H15	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C013H16	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C013H17	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C013H18	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C013H19	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C013H20	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C013H21	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C013H22	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C013H23	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C013H24	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C013I01	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C013I02	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C013I03	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C013I04	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C013I05	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C013I06	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C013I07	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C013I08	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C013I09	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C013I10	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C013I11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C013I12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C013I13	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C013I14	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C013I15	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C013I16	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C013I17	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C013I18	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C013I19	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C013I20	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C013I21	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C013I22	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C013I23	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C013I24	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C013J01	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C013J02	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C013J03	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C013J04	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C013J05	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C013J06	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C013J07	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C013J08	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C013J09	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C013J10	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C013J11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C013J12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C013J13	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C013J14	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C013J15	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C013J16	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C013J17	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C013J18	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C013J19	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C013J20	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C013J21	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C013J22	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C013J23	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C013J24	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C013K01	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C013K02	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C013K03	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C013K04	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C013K05	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C013K06	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C013K07	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C013K08	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C013K09	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C013K10	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C013K11	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C013K12	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C013K13	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C013K14	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C013K15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C013K16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C013K17	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C013K18	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C013K19	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C013K20	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C013K21	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C013K22	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C013K23	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C013K24	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C013L01	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C013L02	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C013L03	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C013L04	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C013L05	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C013L06	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C013L07	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C013L08	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C013L09	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C013L10	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C013L11	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C013L12	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C013L13	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C013L14	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C013L15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C013L16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C013L17	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C013L18	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C013L19	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C013L20	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C013L21	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C013L22	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C013L23	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C013L24	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C013M01	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C013M02	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C013M03	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C013M04	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C013M05	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C013M06	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C013M07	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C013M08	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C013M09	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C013M10	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C013M11	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C013M12	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C013M13	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C013M14	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C013M15	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C013M16	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C013M17	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C013M18	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C013M19	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C013M20	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C013M21	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C013M22	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C013M23	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C013M24	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C013N01	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C013N02	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C013N03	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C013N04	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C013N05	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C013N06	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C013N07	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C013N08	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C013N09	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C013N10	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C013N11	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C013N12	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C013N13	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C013N14	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C013N15	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C013N16	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C013N17	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C013N18	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C013N19	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C013N20	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C013N21	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C013N22	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C013N23	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C013N24	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C013O01	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C013O02	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C013O03	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C013O04	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C013O05	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C013O06	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C013O07	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C013O08	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C013O09	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C013O10	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C013O11	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C013O12	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C013O13	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C013O14	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C013O15	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C013O16	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C013O17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C013O18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C013O19	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C013O20	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C013O21	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C013O22	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C013O23	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C013O24	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C013P01	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C013P02	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C013P03	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C013P04	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C013P05	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C013P06	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C013P07	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C013P08	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C013P09	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C013P10	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C013P11	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C013P12	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C013P13	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C013P14	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C013P15	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C013P16	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C013P17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C013P18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C013P19	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C013P20	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C013P21	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C013P22	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C013P23	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C013P24	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C014A01	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C014A02	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C014A03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C014A04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C014A05	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C014A06	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C014A07	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C014A08	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C014A09	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C014A10	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C014A11	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C014A12	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C014A13	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C014A14	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C014A15	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C014A16	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C014A17	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C014A18	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C014A19	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C014A20	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C014A21	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C014A22	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C014A23	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C014A24	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C014B01	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK074232	FLJ04-A01	FLJ	W01C014B02	pDONR221	11675		FEM1A	55527	-	Hs.515082	Fem-1 homolog a (C. elegans)			adipose tissue	ad		NM_018708.2	NP_061178.1	VALIDATED	Pfs	0.915	0.922	668	2019	27	2016	669	2	669
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C014B03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	FLJ04-A02	FLJ	W01C014B04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C014B05	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074593	FLJ04-A03	FLJ	W01C014B06	pDONR221	14987		MATN4	8785	BAG51974.1	Hs.278489	Matrilin 4			whole embryo, mainly head	HEMBA1		NM_003833.3	NP_003824.2	REVIEWED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C014B07	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074602	FLJ04-A04	FLJ	W01C014B08	pDONR221	24158		NELF	26012	BAC11086.1	Hs.455336	Nasal embryonic LHRH factor			whole embryo, mainly head	HEMBA1		NM_001130971.1	NP_001124443.1	VALIDATED	Cfs	0.956	1.000	528	1586	1	1583	505	1	505
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C014B09	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074658	FLJ04-A05	FLJ	W01C014B10	pDONR221	6079		GALNT6	11226	BAC11118.1	Hs.505575	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 6 (GalNAc-T6)			whole embryo, mainly body	HEMBB1		NM_007210.3	NP_009141.2	REVIEWED	OK	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C014B11	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074741	FLJ04-A06	FLJ	W01C014B12	pDONR221	6469		GPC6	10082	-	Hs.615434	Glypican 6			mammary gland	MAMMA1		NM_005708.3	NP_005699.1	REVIEWED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C014B13	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074867	FLJ04-A07	FLJ	W01C014B14	pDONR221	14091		FAM98A	25940	BAC11255.1	Hs.468140	Family with sequence similarity 98, member A	NT2	teratocarcinoma		NT2RP2		NM_015475.3	NP_056290.3	VALIDATED	OK	1.000	1.000	518	1557	1	1554	518	1	518
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C014B15	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074870	FLJ04-A08	FLJ	W01C014B16	pDONR221	8190		TMEM87A	25963	BAC11256.1	Hs.719196	Transmembrane protein 87A	NT2	teratocarcinoma		NT2RP2		NM_015497.3	NP_056312.2	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C014B17	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK074918	FLJ04-A09	FLJ	W01C014B18	pDONR221	3590		PHLDB1	23187	BAC11292.1	Hs.504062	Pleckstrin homology-like domain, family B, member 1	NT2	teratocarcinoma		NT2RP2		NM_015157.2	NP_055972.1	VALIDATED	Pg	0.851	1.000	670	1839	1	1836	1377	750	1377
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C014B19	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075076	FLJ04-A10	FLJ	W01C014B20	pDONR221	17544		MEPE	56955	BAC11386.1	Hs.676357	Matrix extracellular phosphoglycoprotein			placenta	PLACE1		NM_020203.2	NP_064588.1	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C014B21	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075192	FLJ04-A11	FLJ	W01C014B22	pDONR221	21379		EIF2AK1	27102	BAC11461.1	Hs.719136	Eukaryotic translation initiation factor 2-alpha kinase 1			placenta	PLACE1		NM_014413.3	NP_055228.2	REVIEWED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C014B23	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	FLJ04-A12	FLJ	W01C014B24	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C014C01	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C014C02	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C014C03	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C014C04	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C014C05	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C014C06	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C014C07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C014C08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C014C09	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C014C10	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C014C11	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C014C12	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C014C13	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C014C14	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C014C15	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C014C16	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C014C17	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C014C18	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C014C19	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C014C20	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C014C21	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C014C22	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C014C23	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C014C24	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C014D01	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075262	FLJ04-B01	FLJ	W01C014D02	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C014D03	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK075383	FLJ04-B02	FLJ	W01C014D04	pDONR221	19326		UGT3A2	167127	BAC11583.1	Hs.348941	UDP glycosyltransferase 3 family, polypeptide A2	NT2	teratocarcinoma		NT2RP2		NM_174914.2	NP_777574.1	PROVISIONAL	Cs	0.998	0.998	523	1572	1	1569	523	1	523
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C014D05	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK122724	FLJ04-B03	FLJ	W01C014D06	pDONR221	25120		KLHL13	90293	BAG53690.1	Hs.348262	Kelch-like 13 (Drosophila)			tongue, tumor tissue	CTONG2		NM_033495.2	NP_277030.2	VALIDATED	P	1.000	1.000	604	1815	1	1812	655	52	655
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C014D07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	FLJ04-B04	FLJ	W01C014D08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C014D09	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK125362	FLJ04-B05	FLJ	W01C014D10	pDONR221	13396		CHRNG	1146	BAG54190.1	Hs.248101	Cholinergic receptor, nicotinic, gamma	NT2	teratocarcinoma		NT2RP7		NM_005199.4	NP_005190.4	VALIDATED	Cg	0.975	1.000	527	1575	1	1572	517	1	517
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C014D11	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	FLJ04-B06	FLJ	W01C014D12	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C014D13	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B07	FLJ	W01C014D14	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C014D15	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075331	FLJ04-B08	FLJ	W01C014D16	pDONR221	21083		FKBP9	11328	BAG52112.1	Hs.103934	FK506 binding protein 9, 63 kDa	Y79	retinoblastoma		Y79AA1		NM_007270.3	NP_009201.2	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C014D17	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK075305	FLJ04-B09	FLJ	W01C014D18	pDONR221	1351		KLHL21	9903	BAG52104.1	Hs.7764	Kelch-like 21 (Drosophila)	Y79	retinoblastoma		Y79AA1		NM_014851.2	NP_055666.2	PROVISIONAL	C	1.000	1.000	597	1794	1	1791	597	1	597
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C014D19	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK074446	FLJ04-B10	FLJ	W01C014D20	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C014D21	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK129897	FLJ04-B11	FLJ	W01C014D22	pDONR221	11221		NARS	4677	-	Hs.465224	Asparaginyl-tRNA synthetase			heart	HRT		NM_004539.3	NP_004530.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C014D23	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK130375	FLJ04-B12	FLJ	W01C014D24	pDONR221	18692		HEXB	3074	-	Hs.69293	Hexosaminidase B (beta polypeptide)			prostate	PRS		NM_000521.3	NP_000512.1	REVIEWED	Cs	0.998	0.998	556	1671	1	1668	556	1	556
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C014E01	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C014E02	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C014E03	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C014E04	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C014E05	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C014E06	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C014E07	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C014E08	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C014E09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C014E10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C014E11	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C014E12	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C014E13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C014E14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C014E15	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C014E16	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C014E17	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C014E18	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C014E19	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C014E20	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C014E21	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C014E22	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C014E23	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C014E24	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C014F01	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075135	FLJ04-C01	FLJ	W01C014F02	pDONR221	12349		PSG8	440533	BAC11426	Hs.466843	Pregnancy specific beta-1-glycoprotein 8			placenta	PLACE1		NM_001130168.1	NP_001123640.1	VALIDATED	Pfs	0.671	0.737	322	975	1	966	297	1	293
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C014F03	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075141	FLJ04-C02	FLJ	W01C014F04	pDONR221	14137		RNF149	284996	BAC11430.1	Hs.142074	Ring finger protein 149			placenta	PLACE1		NM_173647.2	NP_775918.1	PROVISIONAL	Cs	0.998	0.998	400	1203	1	1200	400	1	400
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C014F05	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075211	FLJ04-C03	FLJ	W01C014F06	pDONR221	5279		CHPT1	56994	BAG52084.1	Hs.293077	Choline phosphotransferase 1			placenta	PLACE1		NM_020244.2	NP_064629.2	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C014F07	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C04	FLJ	W01C014F08	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C014F09	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	FLJ04-C05	FLJ	W01C014F10	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C014F11	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK095120	FLJ04-C06	FLJ	W01C014F12	pDONR221	2579		GPR158	57512	-	Hs.499108	G protein-coupled receptor 158			hippocampus	BRHIP2		NM_020752.2	NP_065803.2	VALIDATED	Pfs	0.998	1.000	469	1410	1	1405	1215	1	469
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C014F13	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096209	FLJ04-C07	FLJ	W01C014F14	pDONR221	17627		CRIPAK	285464	BAC04725.1	Hs.26410	Cysteine-rich PAK1 inhibitor			liver	LIVER2		NM_175918.3	NP_787114.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C014F15	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK096082	FLJ04-C08	FLJ	W01C014F16	pDONR221	30512		LOC646976	646976	BAC04698.1	Hs.632485	Hypothetical LOC646976			kidney	KIDNE2		XM_939981.2	XP_945074.1	MODEL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C014F17	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075414	FLJ04-C09	FLJ	W01C014F18	pDONR221	18700		PCYOX1L	78991	BAC11604.1	Hs.644397	Prenylcysteine oxidase 1 like	NT2	teratocarcinoma		NT2RP2		NM_024028.3	NP_076933.3	VALIDATED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C014F19	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075421	FLJ04-C10	FLJ	W01C014F20	pDONR221	23643		FAM73B	84895	BAC11611.1	Hs.632693	Family with sequence similarity 73, member B	NT2	teratocarcinoma		NT2RP2		NM_032809.2	NP_116198.2	PREDICTED	P	1.000	1.000	337	1050	1	1011	593	1	337
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C014F21	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075546	FLJ04-C11	FLJ	W01C014F22	pDONR221	3972		LDLRAD3	143458	BAC11689.1	Hs.708347	Low density lipoprotein receptor class A domain containing 3			whole embryo, mainly head	HEMBA1		NM_174902.2	NP_777562.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C014F23	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075549	FLJ04-C12	FLJ	W01C014F24	pDONR221	1		CD276	80381	BAC11692.1	Hs.77873	CD276 molecule	NT2	teratocarcinoma		NT2RP3		NM_001024736.1	NP_001019907.1	VALIDATED	P	1.000	1.000	388	1167	1	1164	534	147	534
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C014G01	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C014G02	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C014G03	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C014G04	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C014G05	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C014G06	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C014G07	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C014G08	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C014G09	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C014G10	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C014G11	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C014G12	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C014G13	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C014G14	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C014G15	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C014G16	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C014G17	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C014G18	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C014G19	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C014G20	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C014G21	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C014G22	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C014G23	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C014G24	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C014H01	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075552	FLJ04-D01	FLJ	W01C014H02	pDONR221	4417		SLC43A3	29015	BAC11695.1	Hs.99962	Solute carrier family 43, member 3	NT2	teratocarcinoma		NT2RP3		NM_199329.1	NP_955361.1	VALIDATED	OK	1.000	1.000	491	1476	1	1473	491	1	491
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C014H03	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075558	FLJ04-D02	FLJ	W01C014H04	pDONR221	690		C1orf187	374946	BAC11697.1	Hs.632364	Chromosome 1 open reading frame 187	NT2	teratocarcinoma		NT2RP3		NM_198545.3	NP_940947.3	VALIDATED	OK	1.000	1.000	349	1050	1	1047	349	1	349
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C014H05	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075440	FLJ04-D03	FLJ	W01C014H06	pDONR221	13328		TMEM178	130733	BAC11622.1	Hs.40808	Transmembrane protein 178	NT2	teratocarcinoma		NT2RP2		NM_152390.1	NP_689603.1	PROVISIONAL	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C014H07	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK075468	FLJ04-D04	FLJ	W01C014H08	pDONR221	18157		RELL1	768211	BAC11638.1	Hs.283378	RELT-like 1			placenta	PLACE1		NM_001085400.1	NP_001078869.1	VALIDATED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C014H09	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK122729	FLJ04-D05	FLJ	W01C014H10	pDONR221	24233		NAIF1	203245	BAG53693.1	Hs.373606	Nuclear apoptosis inducing factor 1			brain	FCBBF1		NM_197956.3	NP_931045.1	VALIDATED	C	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C014H11	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK130549	FLJ04-D06	FLJ	W01C014H12	pDONR221	798		CTPS	1503	-	Hs.473087	CTP synthase			salivary gland	SLV		NM_001905.2	NP_001896.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C014H13	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001347	FLJ04-D07	FLJ	W01C014H14	pDONR221	19812		AIG1	51390	BAA91640.1	Hs.567501	Androgen-induced 1			whole embryo, mainly head	HEMBA1		NM_016108.2	NP_057192.2	VALIDATED	Ps	0.991	0.991	229	720	1	687	238	1	229
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C014H15	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK001369	FLJ04-D08	FLJ	W01C014H16	pDONR221	19922		C6orf70	55780	BAA91653.1	Hs.47546	Chromosome 6 open reading frame 70	NT2	teratocarcinoma		NT2RP2		NM_018341.1	NP_060811.1	VALIDATED		0.882	0.964	552	1518	1	1515	678	127	678
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C014H17	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK000822	FLJ04-D09	FLJ	W01C014H18	pDONR221	9154		RSL1D1	26156	-	Hs.401842	Ribosomal L1 domain containing 1			colon	COL		NM_015659.2	NP_056474.2	VALIDATED	P	1.000	1.000	484	1551	1	1452	490	1	484
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C014H19	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	FLJ04-D10	FLJ	W01C014H20	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C014H21	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK096554	FLJ04-D11	FLJ	W01C014H22	pDONR221	8577		FTO	79068	BAG53322.1	Hs.528833	Fat mass and obesity associated			brain	OCBBF1		NM_001080432.2	NP_001073901.1	VALIDATED	Cg	0.998	1.000	506	1521	1	1518	505	1	505
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C014H23	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK074401	FLJ04-D12	FLJ	W01C014H24	pDONR221	10576		C17orf28	283987	BAB85070.1	Hs.11067	Chromosome 17 open reading frame 28	HepG2	hepatoma		HEP		NM_030630.2	NP_085133.1	VALIDATED	Pfs	0.986	0.997	632	1893	1	1892	788	1	626
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C014I01	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C014I02	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C014I03	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C014I04	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C014I05	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C014I06	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C014I07	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C014I08	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C014I09	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C014I10	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C014I11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C014I12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C014I13	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C014I14	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C014I15	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C014I16	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C014I17	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C014I18	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C014I19	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C014I20	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C014I21	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C014I22	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C014I23	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C014I24	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C014J01	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097684	FLJ04-E01	FLJ	W01C014J02	pDONR221	11818		CCDC105	126402	BAC05142.1	Hs.375985	Coiled-coil domain containing 105			testis	TESTI2		NM_173482.2	NP_775753.2	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C014J03	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097700	FLJ04-E02	FLJ	W01C014J04	pDONR221	10549		LOC646022	646022	-					testis	TESTI2				
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C014J05	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK097724	FLJ04-E03	FLJ	W01C014J06	pDONR221	17303		C3orf71	646450	BAC05151.1					testis	TESTI2		NM_001123040.1	NP_001116512.1	PREDICTED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C014J07	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E04	FLJ	W01C014J08	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.862	0.876	254	753	1	750	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C014J09	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E05	FLJ	W01C014J10	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	C	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C014J11	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E06	FLJ	W01C014J12	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL		0.957	0.957	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C014J13	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK125057	FLJ04-E07	FLJ	W01C014J14	pDONR221	2845		PGAM1	5223		Hs.632918	Phosphoglycerate mutase 1 (brain)			thalamus	BRTHA3		NM_002629.2	NP_002620.1	PROVISIONAL	Cs	0.996	0.996	254	765	1	762	254	1	254
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C014J15	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK122676	FLJ04-E08	FLJ	W01C014J16	pDONR221	24768		ZCCHC12	170261	BAG53660.1	Hs.21417	Zinc finger, CCHC domain containing 12			thymus	THYMU1		NM_173798.2	NP_776159.1	PROVISIONAL	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C014J17	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094752	FLJ04-E09	FLJ	W01C014J18	pDONR221	9613		PIGW	284098	BAC04413.1	Hs.378885	Phosphatidylinositol glycan anchor biosynthesis, class W			amygdala	BRAMY2		NM_178517.3	NP_848612.2	VALIDATED	OK	1.000	1.000	504	1515	1	1512	504	1	504
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C014J19	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	FLJ04-E10	FLJ	W01C014J20	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C014J21	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK130359	FLJ04-E11	FLJ	W01C014J22	pDONR221	16171		PCCB	5096	-	Hs.63788	Propionyl Coenzyme A carboxylase, beta polypeptide			prostate	PRS		NM_000532.3	NP_000523.2	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C014J23	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK122715	FLJ04-E12	FLJ	W01C014J24	pDONR221	11172		TMX3	54495	BAG53687.1	Hs.440534	Thioredoxin-related transmembrane protein 3			tongue, tumor tissue	CTONG2		NM_019022.3	NP_061895.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C014K01	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C014K02	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C014K03	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C014K04	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C014K05	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C014K06	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C014K07	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C014K08	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C014K09	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C014K10	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C014K11	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C014K12	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C014K13	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C014K14	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C014K15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C014K16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C014K17	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C014K18	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C014K19	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C014K20	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C014K21	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C014K22	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C014K23	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C014K24	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C014L01	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK124292	FLJ04-F01	FLJ	W01C014L02	pDONR221	768		PRAMEF15	653619	-					liver, tumor tissue	TLIVE2		NM_001098376.2	NP_001091846.1	PROVISIONAL	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C014L03	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075497	FLJ04-F02	FLJ	W01C014L04	pDONR221	3607		AP2A2	161	BAC11653.1	Hs.19121	Adaptor-related protein complex 2, alpha 2 subunit			placenta	PLACE1		NM_012305.2	NP_036437.1	VALIDATED	Pg	0.996	1.000	251	1407	1	753	939	128	377
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C014L05	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075501	FLJ04-F03	FLJ	W01C014L06	pDONR221	6126		TMEM119	338773	BAC11656.1	Hs.449718	Transmembrane protein 119			whole embryo, mainly head	HEMBA1		NM_181724.2	NP_859075.2	VALIDATED	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C014L07	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075507	FLJ04-F04	FLJ	W01C014L08	pDONR221	14913		PIGU	128869	BAC11660.1	Hs.253319	Phosphatidylinositol glycan anchor biosynthesis, class U			whole embryo, mainly head	HEMBA1		NM_080476.4	NP_536724.1	REVIEWED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C014L09	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075341	FLJ04-F05	FLJ	W01C014L10	pDONR221	9615		TP53I13	90313	BAC11555.1	Hs.514050	Tumor protein p53 inducible protein 13	NT2	teratocarcinoma		NT2RM1		NM_138349.2	NP_612358.3	PROVISIONAL	P	1.000	1.000	368	1107	1	1104	393	26	393
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C014L11	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK075316	FLJ04-F06	FLJ	W01C014L12	pDONR221	688		IGSF21	84966	BAC11542.1	Hs.212511	Immunoglobin superfamily, member 21	Y79	retinoblastoma		Y79AA1		NM_032880.2	NP_116269.2	PROVISIONAL	Cs	0.998	0.998	467	1404	1	1401	467	1	467
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C014L13	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK127727	FLJ04-F07	FLJ	W01C014L14	pDONR221	6177		MGAT4C	25834	BAG54560.1	Hs.589093	Mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative)	NT2	teratocarcinoma		NT2RP8		NM_013244.3	NP_037376.2	VALIDATED	OK	1.000	1.000	478	1437	1	1434	478	1	478
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C014L15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	FLJ04-F08	FLJ	W01C014L16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C014L17	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK000274	FLJ04-F09	FLJ	W01C014L18	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C014L19	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK024619	FLJ04-F10	FLJ	W01C014L20	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C014L21	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK131039	FLJ04-F11	FLJ	W01C014L22	pDONR221	19158		ADAMTS6	11174	BAC85480.1	Hs.482291	ADAM metallopeptidase with thrombospondin type 1 motif, 6			testis	TST		NM_197941.2	NP_922932.2	REVIEWED	P	1.000	1.000	259	867	88	864	1117	859	1117
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C014L23	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK098697	FLJ04-F12	FLJ	W01C014L24	pDONR221	24766		OTUD6A	139562	BAC05384.1	Hs.447381	OTU domain containing 6A			testis	TST		NM_207320.1	NP_997203.1	PROVISIONAL	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C014M01	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C014M02	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C014M03	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C014M04	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C014M05	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C014M06	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C014M07	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C014M08	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C014M09	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C014M10	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C014M11	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C014M12	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C014M13	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C014M14	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C014M15	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C014M16	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C014M17	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C014M18	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C014M19	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C014M20	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C014M21	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C014M22	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C014M23	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C014M24	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C014N01	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129885	FLJ04-G01	FLJ	W01C014N02	pDONR221	4433		HSPA8	3312	-	Hs.702021	Heat shock 70kDa protein 8			heart	HRT		NM_006597.3	NP_006588.1	REVIEWED		0.904	0.910	479	1440	4	1434	646	46	523
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C014N03	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK129960	FLJ04-G02	FLJ	W01C014N04	pDONR221	5525		CCDC64	92558	BAC85259.1	Hs.369763	Coiled-coil domain containing 64			kidney	KDN		NM_207311.2	NP_997194.2	VALIDATED		0.901	0.947	474	1467	1	1353	573	1	474
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C014N05	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130078	FLJ04-G03	FLJ	W01C014N06	pDONR221	13243		MRPS9	64965	-	Hs.590900	Mitochondrial ribosomal protein S9			kidney	KDN		NM_182640.2	NP_872578.1	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C014N07	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G04	FLJ	W01C014N08	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Pfs	0.966	0.966	323	1065	4	971	406	84	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C014N09	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130082	FLJ04-G05	FLJ	W01C014N10	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED	Cfs	0.936	0.936	406	1272	1	1217	406	1	406
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C014N11	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130487	FLJ04-G06	FLJ	W01C014N12	pDONR221	14670		C20orf70	140683		Hs.125960	Chromosome 20 open reading frame 70			prostate	PRS		NM_080574.2	NP_542141.1	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C014N13	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130506	FLJ04-G07	FLJ	W01C014N14	pDONR221	24786		APOOL	139322	-	Hs.706885	Apolipoprotein O-like			salivary gland	SLV		NM_198450.3	NP_940852.3	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C014N15	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130527	FLJ04-G08	FLJ	W01C014N16	pDONR221	7907		C15orf58	390637	BAC85370.1	Hs.304673	Chromosome 15 open reading frame 58			salivary gland	SLV		NM_001013657.2	NP_001013679.2	VALIDATED	Pfs	0.996	1.000	264	792	1	790	385	1	264
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C014N17	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130542	FLJ04-G09	FLJ	W01C014N18	pDONR221	17124		VGLL4	9686	BAC85375.1	Hs.38032	Vestigial like 4 (Drosophila)			salivary gland	SLV		NM_014667.2	NP_055482.2	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C014N19	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130784	FLJ04-G10	FLJ	W01C014N20	pDONR221	8142		RPL4	6124	-	Hs.644628	Ribosomal protein L4			thymus	TMS		NM_000968.2	NP_000959.2	REVIEWED	OK	1.000	1.000	427	1284	1	1281	427	1	427
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C014N21	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	FLJ04-G11	FLJ	W01C014N22	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C014N23	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK129587	FLJ04-G12	FLJ	W01C014N24	pDONR221	5524		KRT18	3875	-	Hs.406013	Keratin 18			prostate	PRS		NM_199187.1	NP_954657.1	REVIEWED		0.796	0.805	357	1062	1	1059	430	74	430
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C014O01	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C014O02	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C014O03	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C014O04	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C014O05	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C014O06	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C014O07	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C014O08	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C014O09	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C014O10	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C014O11	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C014O12	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C014O13	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C014O14	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C014O15	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C014O16	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C014O17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C014O18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C014O19	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C014O20	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C014O21	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C014O22	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C014O23	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C014O24	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C014P01	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	FLJ04-H01	FLJ	W01C014P02	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C014P03	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H02	FLJ	W01C014P04	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.998	0.998	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C014P05	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK131043	FLJ04-H03	FLJ	W01C014P06	pDONR221	14210		TUBA3E	112714	-	Hs.433336	Tubulin, alpha 3e			testis	TST		NM_207312.2	NP_997195.1	VALIDATED	Ps	0.989	0.989	449	1356	7	1353	450	2	450
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C014P07	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK129500	FLJ04-H04	FLJ	W01C014P08	pDONR221	24783		DGAT2L6	347516	BAC85167.1	Hs.454355	Diacylglycerol O-acyltransferase 2-like 6			brain	CBR		NM_198512.1	NP_940914.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C014P09	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK131047	FLJ04-H05	FLJ	W01C014P10	pDONR221	13873		AAMP	14	-	Hs.83347	Angio-associated, migratory cell protein			testis	TST		NM_001087.3	NP_001078.2	REVIEWED	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C014P11	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK024529	FLJ04-H06	FLJ	W01C014P12	pDONR221	9839		PGS1	9489	BAB14921.1	Hs.654671	Phosphatidylglycerophosphate synthase 1			thyroid gland	THYRO1		NM_024419.3	NP_077733.3	PROVISIONAL	Pfs	0.996	1.000	237	858	1	709	556	320	556
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C014P13	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK000635	FLJ04-H07	FLJ	W01C014P14	pDONR221	14219		TRMT61B	55006	BAA91300	Hs.468026	TRNA methyltransferase 61 homolog B (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_017910.3	NP_060380.3	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C014P15	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK026927	FLJ04-H08	FLJ	W01C014P16	pDONR221	19231		FASTKD3	79072	-	Hs.653162	FAST kinase domains 3	KATO III	signet-ring cell carcinoma		KAT		NM_024091.2	NP_076996.2	VALIDATED	C	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C014P17	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	FLJ04-H09	FLJ	W01C014P18	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C014P19	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074191	FLJ04-H10	FLJ	W01C014P20	pDONR221	12501		ZNF414	84330	-	Hs.515114	Zinc finger protein 414			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032370.2	NP_115746.2	VALIDATED	OK	1.000	1.000	312	1041	103	1038	312	1	312
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C014P21	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK074206	FLJ04-H11	FLJ	W01C014P22	pDONR221	13136		DYNC2LI1	51626	-	Hs.371597	Dynein, cytoplasmic 2, light intermediate chain 1			adipose tissue	ad		NM_016008.2	NP_057092.2	VALIDATED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C014P23	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	AK027224	FLJ04-H12	FLJ	W01C014P24	pDONR221	17018		IQCG	84223	BAB15699.1	Hs.591675	IQ motif containing G			human lung	LNG		NM_032263.3	NP_115639.1	VALIDATED	OK	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC039396	FLJ05-A01	MGC	W01C015A01	pDONR221	15567		FAM19A5	25817	AAH39396.2	Hs.632788	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5			Testis	NIH_MGC_97	DH10B	NM_015381.5	NP_056196.2	VALIDATED	P	1.000	1.000	34	933	1	102	125	92	125
IKAKEN	BC039396	FLJ05-A01	MGC	W01C015A02	pDONR221	15567		FAM19A5	25817	AAH39396.2	Hs.632788	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5			Testis	NIH_MGC_97	DH10B	NM_015381.5	NP_056196.2	VALIDATED	P	1.000	1.000	34	933	1	102	125	92	125
IKAKEN	BC045695	FLJ05-A02	MGC	W01C015A03	pDONR221	20679		MBOAT1	154141	AAH45695	Hs.377830	Membrane bound O-acyltransferase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001080480.1	NP_001073949.1	PROVISIONAL	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC045695	FLJ05-A02	MGC	W01C015A04	pDONR221	20679		MBOAT1	154141	AAH45695	Hs.377830	Membrane bound O-acyltransferase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001080480.1	NP_001073949.1	PROVISIONAL	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC045834	FLJ05-A03	MGC	W01C015A05	pDONR221	7502		C14orf145	145508	AAH45834.2	Hs.162889	Chromosome 14 open reading frame 145			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152446.3	NP_689659.2	VALIDATED	Ps	0.990	0.990	408	1308	1	1224	1094	1	408
IKAKEN	BC045834	FLJ05-A03	MGC	W01C015A06	pDONR221	7502		C14orf145	145508	AAH45834.2	Hs.162889	Chromosome 14 open reading frame 145			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152446.3	NP_689659.2	VALIDATED	Ps	0.990	0.990	408	1308	1	1224	1094	1	408
IKAKEN	BC051717	FLJ05-A04	MGC	W01C015A07	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC051717	FLJ05-A04	MGC	W01C015A08	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC047588	FLJ05-A05	MGC	W01C015A09	pDONR221	16776		AADACL1	57552	AAH47588.2	Hs.444099	Arylacetamide deacetylase-like 1			Testis	NIH_MGC_97	DH10B	NM_001146277.1	NP_001139749.1	VALIDATED	C	1.000	1.000	275	1227	400	1224	275	1	275
IKAKEN	BC047588	FLJ05-A05	MGC	W01C015A10	pDONR221	16776		AADACL1	57552	AAH47588.2	Hs.444099	Arylacetamide deacetylase-like 1			Testis	NIH_MGC_97	DH10B	NM_001146277.1	NP_001139749.1	VALIDATED	C	1.000	1.000	275	1227	400	1224	275	1	275
IKAKEN	BC050346	FLJ05-A06	MGC	W01C015A11	pDONR221	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020382.3	NP_065115.3	VALIDATED		0.948	0.956	346	1032	1	1029	352	7	352
IKAKEN	BC050346	FLJ05-A06	MGC	W01C015A12	pDONR221	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020382.3	NP_065115.3	VALIDATED		0.948	0.956	346	1032	1	1029	352	7	352
IKAKEN	BC051650	FLJ05-A07	MGC	W01C015A13	pDONR221	10332		TOM1L2	146691	AAH51650.1	Hs.462379	Target of myb1-like 2 (chicken)			Testis	NIH_MGC_97	DH10B	NM_001033551.2	NP_001028723.1	VALIDATED	P	1.000	1.000	424	1275	1	1272	457	34	457
IKAKEN	BC051650	FLJ05-A07	MGC	W01C015A14	pDONR221	10332		TOM1L2	146691	AAH51650.1	Hs.462379	Target of myb1-like 2 (chicken)			Testis	NIH_MGC_97	DH10B	NM_001033551.2	NP_001028723.1	VALIDATED	P	1.000	1.000	424	1275	1	1272	457	34	457
IKAKEN	BC051690	FLJ05-A08	MGC	W01C015A15	pDONR221	16484		FBLN2	2199	AAH51690.1	Hs.198862	Fibulin 2			Testis	NIH_MGC_97	DH10B	NM_001004019.1	NP_001004019.1	REVIEWED	Cfs	0.962	1.000	1231	3556	1	3553	1231	1	1231
IKAKEN	BC051690	FLJ05-A08	MGC	W01C015A16	pDONR221	16484		FBLN2	2199	AAH51690.1	Hs.198862	Fibulin 2			Testis	NIH_MGC_97	DH10B	NM_001004019.1	NP_001004019.1	REVIEWED	Cfs	0.962	1.000	1231	3556	1	3553	1231	1	1231
IKAKEN	BC044590	FLJ05-A09	MGC	W01C015A17	pDONR221	13026		ACTR3	10096	AAH44590.1	Hs.433512	ARP3 actin-related protein 3 homolog (yeast)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005721.3	NP_005712.1	REVIEWED	Pfs	0.842	0.846	404	1209	4	1206	418	15	418
IKAKEN	BC044590	FLJ05-A09	MGC	W01C015A18	pDONR221	13026		ACTR3	10096	AAH44590.1	Hs.433512	ARP3 actin-related protein 3 homolog (yeast)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005721.3	NP_005712.1	REVIEWED	Pfs	0.842	0.846	404	1209	4	1206	418	15	418
IKAKEN	BC057833	FLJ05-A10	MGC	W01C015A19	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	FLJ05-A10	MGC	W01C015A20	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC066981	FLJ05-A11	MGC	W01C015A21	pDONR221	8352		POTEB	339010	AAH66981.1	Hs.558766	POTE ankyrin domain family, member B			Testis	NIH_MGC_97	DH10B	NM_207355.2	NP_997238.2	VALIDATED		0.968	0.968	281	855	1	843	581	98	378
IKAKEN	BC066981	FLJ05-A11	MGC	W01C015A22	pDONR221	8352		POTEB	339010	AAH66981.1	Hs.558766	POTE ankyrin domain family, member B			Testis	NIH_MGC_97	DH10B	NM_207355.2	NP_997238.2	VALIDATED		0.968	0.968	281	855	1	843	581	98	378
IKAKEN	BC003377	FLJ05-A12	MGC	W01C015A23	pDONR221	24080		TXN	7295	AAH03377.1	Hs.435136	Thioredoxin			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003329.2	NP_003320.2	VALIDATED		0.923	0.923	65	204	1	195	105	37	101
IKAKEN	BC003377	FLJ05-A12	MGC	W01C015A24	pDONR221	24080		TXN	7295	AAH03377.1	Hs.435136	Thioredoxin			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003329.2	NP_003320.2	VALIDATED		0.923	0.923	65	204	1	195	105	37	101
IKAKEN	BC039396	FLJ05-A01	MGC	W01C015B01	pDONR221	15567		FAM19A5	25817	AAH39396.2	Hs.632788	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5			Testis	NIH_MGC_97	DH10B	NM_015381.5	NP_056196.2	VALIDATED	P	1.000	1.000	34	933	1	102	125	92	125
IKAKEN	BC039396	FLJ05-A01	MGC	W01C015B02	pDONR221	15567		FAM19A5	25817	AAH39396.2	Hs.632788	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5			Testis	NIH_MGC_97	DH10B	NM_015381.5	NP_056196.2	VALIDATED	P	1.000	1.000	34	933	1	102	125	92	125
IKAKEN	BC045695	FLJ05-A02	MGC	W01C015B03	pDONR221	20679		MBOAT1	154141	AAH45695	Hs.377830	Membrane bound O-acyltransferase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001080480.1	NP_001073949.1	PROVISIONAL	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC045695	FLJ05-A02	MGC	W01C015B04	pDONR221	20679		MBOAT1	154141	AAH45695	Hs.377830	Membrane bound O-acyltransferase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001080480.1	NP_001073949.1	PROVISIONAL	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC045834	FLJ05-A03	MGC	W01C015B05	pDONR221	7502		C14orf145	145508	AAH45834.2	Hs.162889	Chromosome 14 open reading frame 145			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152446.3	NP_689659.2	VALIDATED	Ps	0.990	0.990	408	1308	1	1224	1094	1	408
IKAKEN	BC045834	FLJ05-A03	MGC	W01C015B06	pDONR221	7502		C14orf145	145508	AAH45834.2	Hs.162889	Chromosome 14 open reading frame 145			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152446.3	NP_689659.2	VALIDATED	Ps	0.990	0.990	408	1308	1	1224	1094	1	408
IKAKEN	BC051717	FLJ05-A04	MGC	W01C015B07	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC051717	FLJ05-A04	MGC	W01C015B08	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC047588	FLJ05-A05	MGC	W01C015B09	pDONR221	16776		AADACL1	57552	AAH47588.2	Hs.444099	Arylacetamide deacetylase-like 1			Testis	NIH_MGC_97	DH10B	NM_001146277.1	NP_001139749.1	VALIDATED	C	1.000	1.000	275	1227	400	1224	275	1	275
IKAKEN	BC047588	FLJ05-A05	MGC	W01C015B10	pDONR221	16776		AADACL1	57552	AAH47588.2	Hs.444099	Arylacetamide deacetylase-like 1			Testis	NIH_MGC_97	DH10B	NM_001146277.1	NP_001139749.1	VALIDATED	C	1.000	1.000	275	1227	400	1224	275	1	275
IKAKEN	BC050346	FLJ05-A06	MGC	W01C015B11	pDONR221	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020382.3	NP_065115.3	VALIDATED		0.948	0.956	346	1032	1	1029	352	7	352
IKAKEN	BC050346	FLJ05-A06	MGC	W01C015B12	pDONR221	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020382.3	NP_065115.3	VALIDATED		0.948	0.956	346	1032	1	1029	352	7	352
IKAKEN	BC051650	FLJ05-A07	MGC	W01C015B13	pDONR221	10332		TOM1L2	146691	AAH51650.1	Hs.462379	Target of myb1-like 2 (chicken)			Testis	NIH_MGC_97	DH10B	NM_001033551.2	NP_001028723.1	VALIDATED	P	1.000	1.000	424	1275	1	1272	457	34	457
IKAKEN	BC051650	FLJ05-A07	MGC	W01C015B14	pDONR221	10332		TOM1L2	146691	AAH51650.1	Hs.462379	Target of myb1-like 2 (chicken)			Testis	NIH_MGC_97	DH10B	NM_001033551.2	NP_001028723.1	VALIDATED	P	1.000	1.000	424	1275	1	1272	457	34	457
IKAKEN	BC051690	FLJ05-A08	MGC	W01C015B15	pDONR221	16484		FBLN2	2199	AAH51690.1	Hs.198862	Fibulin 2			Testis	NIH_MGC_97	DH10B	NM_001004019.1	NP_001004019.1	REVIEWED	Cfs	0.962	1.000	1231	3556	1	3553	1231	1	1231
IKAKEN	BC051690	FLJ05-A08	MGC	W01C015B16	pDONR221	16484		FBLN2	2199	AAH51690.1	Hs.198862	Fibulin 2			Testis	NIH_MGC_97	DH10B	NM_001004019.1	NP_001004019.1	REVIEWED	Cfs	0.962	1.000	1231	3556	1	3553	1231	1	1231
IKAKEN	BC044590	FLJ05-A09	MGC	W01C015B17	pDONR221	13026		ACTR3	10096	AAH44590.1	Hs.433512	ARP3 actin-related protein 3 homolog (yeast)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005721.3	NP_005712.1	REVIEWED	Pfs	0.842	0.846	404	1209	4	1206	418	15	418
IKAKEN	BC044590	FLJ05-A09	MGC	W01C015B18	pDONR221	13026		ACTR3	10096	AAH44590.1	Hs.433512	ARP3 actin-related protein 3 homolog (yeast)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005721.3	NP_005712.1	REVIEWED	Pfs	0.842	0.846	404	1209	4	1206	418	15	418
IKAKEN	BC057833	FLJ05-A10	MGC	W01C015B19	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	FLJ05-A10	MGC	W01C015B20	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC066981	FLJ05-A11	MGC	W01C015B21	pDONR221	8352		POTEB	339010	AAH66981.1	Hs.558766	POTE ankyrin domain family, member B			Testis	NIH_MGC_97	DH10B	NM_207355.2	NP_997238.2	VALIDATED		0.968	0.968	281	855	1	843	581	98	378
IKAKEN	BC066981	FLJ05-A11	MGC	W01C015B22	pDONR221	8352		POTEB	339010	AAH66981.1	Hs.558766	POTE ankyrin domain family, member B			Testis	NIH_MGC_97	DH10B	NM_207355.2	NP_997238.2	VALIDATED		0.968	0.968	281	855	1	843	581	98	378
IKAKEN	BC003377	FLJ05-A12	MGC	W01C015B23	pDONR221	24080		TXN	7295	AAH03377.1	Hs.435136	Thioredoxin			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003329.2	NP_003320.2	VALIDATED		0.923	0.923	65	204	1	195	105	37	101
IKAKEN	BC003377	FLJ05-A12	MGC	W01C015B24	pDONR221	24080		TXN	7295	AAH03377.1	Hs.435136	Thioredoxin			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003329.2	NP_003320.2	VALIDATED		0.923	0.923	65	204	1	195	105	37	101
IKAKEN	BC000914	FLJ05-B01	MGC	W01C015C01	pDONR221	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003017.4	NP_003008.1	VALIDATED	Cfs	0.933	0.933	164	495	1	492	164	1	164
IKAKEN	BC000914	FLJ05-B01	MGC	W01C015C02	pDONR221	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003017.4	NP_003008.1	VALIDATED	Cfs	0.933	0.933	164	495	1	492	164	1	164
IKAKEN	BC006849	FLJ05-B02	MGC	W01C015C03	pDONR221	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	XM_001723779.1	XP_001723831.1	MODEL	C	1.000	1.000	117	1055	702	1052	117	1	117
IKAKEN	BC006849	FLJ05-B02	MGC	W01C015C04	pDONR221	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	XM_001723779.1	XP_001723831.1	MODEL	C	1.000	1.000	117	1055	702	1052	117	1	117
IKAKEN	BC001254	FLJ05-B03	MGC	W01C015C05	pDONR221	13932		ARL5A	26225	AAH01254.1	Hs.470233	ADP-ribosylation factor-like 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001037174.1	NP_001032251.1	REVIEWED		0.866	0.891	142	753	337	750	142	1	142
IKAKEN	BC001254	FLJ05-B03	MGC	W01C015C06	pDONR221	13932		ARL5A	26225	AAH01254.1	Hs.470233	ADP-ribosylation factor-like 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001037174.1	NP_001032251.1	REVIEWED		0.866	0.891	142	753	337	750	142	1	142
IKAKEN	BC015801	FLJ05-B05	MGC	W01C015C09	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED	Cfs	0.997	1.000	678	2036	1	2033	676	1	676
IKAKEN	BC015801	FLJ05-B05	MGC	W01C015C10	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED	Cfs	0.997	1.000	678	2036	1	2033	676	1	676
IKAKEN	BC012846	FLJ05-B06	MGC	W01C015C11	pDONR221	13886		IDH1	3417	AAH12846.1	Hs.593422	Isocitrate dehydrogenase 1 (NADP+), soluble			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005896.2	NP_005887.2	REVIEWED		0.928	0.928	97	399	1	291	414	318	414
IKAKEN	BC012846	FLJ05-B06	MGC	W01C015C12	pDONR221	13886		IDH1	3417	AAH12846.1	Hs.593422	Isocitrate dehydrogenase 1 (NADP+), soluble			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005896.2	NP_005887.2	REVIEWED		0.928	0.928	97	399	1	291	414	318	414
IKAKEN	BC036263	FLJ05-B07	MGC	W01C015C13	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	FLJ05-B07	MGC	W01C015C14	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC040357	FLJ05-B08	MGC	W01C015C15	pDONR221	14011		MCFD2	90411	AAH40357.1	Hs.293689	Multiple coagulation factor deficiency 2			Testis	NIH_MGC_97	DH10B	NM_139279.3	NP_644808.1	VALIDATED		0.900	0.900	80	243	1	240	146	67	146
IKAKEN	BC040357	FLJ05-B08	MGC	W01C015C16	pDONR221	14011		MCFD2	90411	AAH40357.1	Hs.293689	Multiple coagulation factor deficiency 2			Testis	NIH_MGC_97	DH10B	NM_139279.3	NP_644808.1	VALIDATED		0.900	0.900	80	243	1	240	146	67	146
IKAKEN	BC016486	FLJ05-B09	MGC	W01C015C17	pDONR221	247		LGALS8	3964	AAH16486.2	Hs.4082	Lectin, galactoside-binding, soluble, 8			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201544.1	NP_963838.1	REVIEWED	P	1.000	1.000	316	951	1	948	317	2	317
IKAKEN	BC016486	FLJ05-B09	MGC	W01C015C18	pDONR221	247		LGALS8	3964	AAH16486.2	Hs.4082	Lectin, galactoside-binding, soluble, 8			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201544.1	NP_963838.1	REVIEWED	P	1.000	1.000	316	951	1	948	317	2	317
IKAKEN	BC012469	FLJ05-B10	MGC	W01C015C19	pDONR221	24705		YIPF6	286451	AAH12469.1	Hs.82719	Yip1 domain family, member 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173834.2	NP_776195.1	PROVISIONAL	Cs	0.996	0.996	236	711	1	708	236	1	236
IKAKEN	BC012469	FLJ05-B10	MGC	W01C015C20	pDONR221	24705		YIPF6	286451	AAH12469.1	Hs.82719	Yip1 domain family, member 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173834.2	NP_776195.1	PROVISIONAL	Cs	0.996	0.996	236	711	1	708	236	1	236
IKAKEN	BC034525	FLJ05-B11	MGC	W01C015C21	pDONR221	5354		BRI3BP	140707	AAH34525.1	Hs.596464	BRI3 binding protein			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_080626.5	NP_542193.3	VALIDATED	Pfs	0.990	1.000	97	291	3	290	251	101	197
IKAKEN	BC034525	FLJ05-B11	MGC	W01C015C22	pDONR221	5354		BRI3BP	140707	AAH34525.1	Hs.596464	BRI3 binding protein			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_080626.5	NP_542193.3	VALIDATED	Pfs	0.990	1.000	97	291	3	290	251	101	197
IKAKEN	BC019917	FLJ05-B12	MGC	W01C015C23	pDONR221	19711		QKI	9444	AAH19917.1	Hs.593520	Quaking homolog, KH domain RNA binding (mouse)			Testis	NIH_MGC_97	DH10B	NM_206853.1	NP_996735.1	VALIDATED	P	1.000	1.000	121	453	1	363	319	192	312
IKAKEN	BC019917	FLJ05-B12	MGC	W01C015C24	pDONR221	19711		QKI	9444	AAH19917.1	Hs.593520	Quaking homolog, KH domain RNA binding (mouse)			Testis	NIH_MGC_97	DH10B	NM_206853.1	NP_996735.1	VALIDATED	P	1.000	1.000	121	453	1	363	319	192	312
IKAKEN	BC000914	FLJ05-B01	MGC	W01C015D01	pDONR221	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003017.4	NP_003008.1	VALIDATED	Cfs	0.933	0.933	164	495	1	492	164	1	164
IKAKEN	BC000914	FLJ05-B01	MGC	W01C015D02	pDONR221	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003017.4	NP_003008.1	VALIDATED	Cfs	0.933	0.933	164	495	1	492	164	1	164
IKAKEN	BC006849	FLJ05-B02	MGC	W01C015D03	pDONR221	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	XM_001723779.1	XP_001723831.1	MODEL	C	1.000	1.000	117	1055	702	1052	117	1	117
IKAKEN	BC006849	FLJ05-B02	MGC	W01C015D04	pDONR221	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	XM_001723779.1	XP_001723831.1	MODEL	C	1.000	1.000	117	1055	702	1052	117	1	117
IKAKEN	BC001254	FLJ05-B03	MGC	W01C015D05	pDONR221	13932		ARL5A	26225	AAH01254.1	Hs.470233	ADP-ribosylation factor-like 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001037174.1	NP_001032251.1	REVIEWED		0.866	0.891	142	753	337	750	142	1	142
IKAKEN	BC001254	FLJ05-B03	MGC	W01C015D06	pDONR221	13932		ARL5A	26225	AAH01254.1	Hs.470233	ADP-ribosylation factor-like 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001037174.1	NP_001032251.1	REVIEWED		0.866	0.891	142	753	337	750	142	1	142
IKAKEN	BC015801	FLJ05-B05	MGC	W01C015D09	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED	Cfs	0.997	1.000	678	2036	1	2033	676	1	676
IKAKEN	BC015801	FLJ05-B05	MGC	W01C015D10	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED	Cfs	0.997	1.000	678	2036	1	2033	676	1	676
IKAKEN	BC012846	FLJ05-B06	MGC	W01C015D11	pDONR221	13886		IDH1	3417	AAH12846.1	Hs.593422	Isocitrate dehydrogenase 1 (NADP+), soluble			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005896.2	NP_005887.2	REVIEWED		0.928	0.928	97	399	1	291	414	318	414
IKAKEN	BC012846	FLJ05-B06	MGC	W01C015D12	pDONR221	13886		IDH1	3417	AAH12846.1	Hs.593422	Isocitrate dehydrogenase 1 (NADP+), soluble			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005896.2	NP_005887.2	REVIEWED		0.928	0.928	97	399	1	291	414	318	414
IKAKEN	BC036263	FLJ05-B07	MGC	W01C015D13	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	FLJ05-B07	MGC	W01C015D14	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC040357	FLJ05-B08	MGC	W01C015D15	pDONR221	14011		MCFD2	90411	AAH40357.1	Hs.293689	Multiple coagulation factor deficiency 2			Testis	NIH_MGC_97	DH10B	NM_139279.3	NP_644808.1	VALIDATED		0.900	0.900	80	243	1	240	146	67	146
IKAKEN	BC040357	FLJ05-B08	MGC	W01C015D16	pDONR221	14011		MCFD2	90411	AAH40357.1	Hs.293689	Multiple coagulation factor deficiency 2			Testis	NIH_MGC_97	DH10B	NM_139279.3	NP_644808.1	VALIDATED		0.900	0.900	80	243	1	240	146	67	146
IKAKEN	BC016486	FLJ05-B09	MGC	W01C015D17	pDONR221	247		LGALS8	3964	AAH16486.2	Hs.4082	Lectin, galactoside-binding, soluble, 8			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201544.1	NP_963838.1	REVIEWED	P	1.000	1.000	316	951	1	948	317	2	317
IKAKEN	BC016486	FLJ05-B09	MGC	W01C015D18	pDONR221	247		LGALS8	3964	AAH16486.2	Hs.4082	Lectin, galactoside-binding, soluble, 8			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201544.1	NP_963838.1	REVIEWED	P	1.000	1.000	316	951	1	948	317	2	317
IKAKEN	BC012469	FLJ05-B10	MGC	W01C015D19	pDONR221	24705		YIPF6	286451	AAH12469.1	Hs.82719	Yip1 domain family, member 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173834.2	NP_776195.1	PROVISIONAL	Cs	0.996	0.996	236	711	1	708	236	1	236
IKAKEN	BC012469	FLJ05-B10	MGC	W01C015D20	pDONR221	24705		YIPF6	286451	AAH12469.1	Hs.82719	Yip1 domain family, member 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173834.2	NP_776195.1	PROVISIONAL	Cs	0.996	0.996	236	711	1	708	236	1	236
IKAKEN	BC034525	FLJ05-B11	MGC	W01C015D21	pDONR221	5354		BRI3BP	140707	AAH34525.1	Hs.596464	BRI3 binding protein			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_080626.5	NP_542193.3	VALIDATED	Pfs	0.990	1.000	97	291	3	290	251	101	197
IKAKEN	BC034525	FLJ05-B11	MGC	W01C015D22	pDONR221	5354		BRI3BP	140707	AAH34525.1	Hs.596464	BRI3 binding protein			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_080626.5	NP_542193.3	VALIDATED	Pfs	0.990	1.000	97	291	3	290	251	101	197
IKAKEN	BC019917	FLJ05-B12	MGC	W01C015D23	pDONR221	19711		QKI	9444	AAH19917.1	Hs.593520	Quaking homolog, KH domain RNA binding (mouse)			Testis	NIH_MGC_97	DH10B	NM_206853.1	NP_996735.1	VALIDATED	P	1.000	1.000	121	453	1	363	319	192	312
IKAKEN	BC019917	FLJ05-B12	MGC	W01C015D24	pDONR221	19711		QKI	9444	AAH19917.1	Hs.593520	Quaking homolog, KH domain RNA binding (mouse)			Testis	NIH_MGC_97	DH10B	NM_206853.1	NP_996735.1	VALIDATED	P	1.000	1.000	121	453	1	363	319	192	312
IKAKEN	BC025689	FLJ05-C01	MGC	W01C015E01	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC025689	FLJ05-C01	MGC	W01C015E02	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC029775	FLJ05-C02	MGC	W01C015E03	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	FLJ05-C02	MGC	W01C015E04	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC039065	FLJ05-C03	MGC	W01C015E05	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC039065	FLJ05-C03	MGC	W01C015E06	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC035371	FLJ05-C04	MGC	W01C015E07	pDONR221	21911			29060	AAH35371					Testis	NIH_MGC_97	DH10B			
IKAKEN	BC035371	FLJ05-C04	MGC	W01C015E08	pDONR221	21911			29060	AAH35371					Testis	NIH_MGC_97	DH10B			
IKAKEN	BC030275	FLJ05-C06	MGC	W01C015E11	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC030275	FLJ05-C06	MGC	W01C015E12	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC032326	FLJ05-C07	MGC	W01C015E13	pDONR221	5617		C12orf45	121053	AAH32326.1	Hs.295563	Chromosome 12 open reading frame 45			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152318.2	NP_689531.2	VALIDATED	OK	1.000	1.000	185	566	1	555	185	1	185
IKAKEN	BC032326	FLJ05-C07	MGC	W01C015E14	pDONR221	5617		C12orf45	121053	AAH32326.1	Hs.295563	Chromosome 12 open reading frame 45			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152318.2	NP_689531.2	VALIDATED	OK	1.000	1.000	185	566	1	555	185	1	185
IKAKEN	BC035588	FLJ05-C08	MGC	W01C015E15	pDONR221	5624		ATP2A2	488	AAH35588.1	Hs.506759	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_170665.3	NP_733765.1	REVIEWED	Cgs	0.998	0.999	1043	3132	1	3129	1042	1	1042
IKAKEN	BC035588	FLJ05-C08	MGC	W01C015E16	pDONR221	5624		ATP2A2	488	AAH35588.1	Hs.506759	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_170665.3	NP_733765.1	REVIEWED	Cgs	0.998	0.999	1043	3132	1	3129	1042	1	1042
IKAKEN	BC036849	FLJ05-C09	MGC	W01C015E17	pDONR221	691		ATXN7L2	127002	AAH36849.1	Hs.118248	Ataxin 7-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153340.4	NP_699171.3	VALIDATED	P	1.000	1.000	581	1745	1	1743	722	1	581
IKAKEN	BC036849	FLJ05-C09	MGC	W01C015E18	pDONR221	691		ATXN7L2	127002	AAH36849.1	Hs.118248	Ataxin 7-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153340.4	NP_699171.3	VALIDATED	P	1.000	1.000	581	1745	1	1743	722	1	581
IKAKEN	BC041117	FLJ05-C10	MGC	W01C015E19	pDONR221	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001812.2	NP_001803.2	REVIEWED		0.912	0.918	468	1404	1	1401	943	478	943
IKAKEN	BC041117	FLJ05-C10	MGC	W01C015E20	pDONR221	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001812.2	NP_001803.2	REVIEWED		0.912	0.918	468	1404	1	1401	943	478	943
IKAKEN	BC053323	FLJ05-C11	MGC	W01C015E21	pDONR221	18478		N4BP3	23138	AAH53323.2	Hs.101761	Nedd4 binding protein 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_015111.1	NP_055926.1	VALIDATED	OK	1.000	1.000	544	1668	34	1665	544	1	544
IKAKEN	BC053323	FLJ05-C11	MGC	W01C015E22	pDONR221	18478		N4BP3	23138	AAH53323.2	Hs.101761	Nedd4 binding protein 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_015111.1	NP_055926.1	VALIDATED	OK	1.000	1.000	544	1668	34	1665	544	1	544
IKAKEN	BC052605	FLJ05-C12	MGC	W01C015E23	pDONR221	10566		TIMP2	7077	AAH52605.1	Hs.633514	TIMP metallopeptidase inhibitor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003255.4	NP_003246.1	REVIEWED	P	1.000	1.000	218	661	5	658	220	3	220
IKAKEN	BC052605	FLJ05-C12	MGC	W01C015E24	pDONR221	10566		TIMP2	7077	AAH52605.1	Hs.633514	TIMP metallopeptidase inhibitor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003255.4	NP_003246.1	REVIEWED	P	1.000	1.000	218	661	5	658	220	3	220
IKAKEN	BC025689	FLJ05-C01	MGC	W01C015F01	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC025689	FLJ05-C01	MGC	W01C015F02	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC029775	FLJ05-C02	MGC	W01C015F03	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	FLJ05-C02	MGC	W01C015F04	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC039065	FLJ05-C03	MGC	W01C015F05	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC039065	FLJ05-C03	MGC	W01C015F06	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC035371	FLJ05-C04	MGC	W01C015F07	pDONR221	21911			29060	AAH35371					Testis	NIH_MGC_97	DH10B			
IKAKEN	BC035371	FLJ05-C04	MGC	W01C015F08	pDONR221	21911			29060	AAH35371					Testis	NIH_MGC_97	DH10B			
IKAKEN	BC030275	FLJ05-C06	MGC	W01C015F11	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC030275	FLJ05-C06	MGC	W01C015F12	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC032326	FLJ05-C07	MGC	W01C015F13	pDONR221	5617		C12orf45	121053	AAH32326.1	Hs.295563	Chromosome 12 open reading frame 45			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152318.2	NP_689531.2	VALIDATED	OK	1.000	1.000	185	566	1	555	185	1	185
IKAKEN	BC032326	FLJ05-C07	MGC	W01C015F14	pDONR221	5617		C12orf45	121053	AAH32326.1	Hs.295563	Chromosome 12 open reading frame 45			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152318.2	NP_689531.2	VALIDATED	OK	1.000	1.000	185	566	1	555	185	1	185
IKAKEN	BC035588	FLJ05-C08	MGC	W01C015F15	pDONR221	5624		ATP2A2	488	AAH35588.1	Hs.506759	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_170665.3	NP_733765.1	REVIEWED	Cgs	0.998	0.999	1043	3132	1	3129	1042	1	1042
IKAKEN	BC035588	FLJ05-C08	MGC	W01C015F16	pDONR221	5624		ATP2A2	488	AAH35588.1	Hs.506759	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_170665.3	NP_733765.1	REVIEWED	Cgs	0.998	0.999	1043	3132	1	3129	1042	1	1042
IKAKEN	BC036849	FLJ05-C09	MGC	W01C015F17	pDONR221	691		ATXN7L2	127002	AAH36849.1	Hs.118248	Ataxin 7-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153340.4	NP_699171.3	VALIDATED	P	1.000	1.000	581	1745	1	1743	722	1	581
IKAKEN	BC036849	FLJ05-C09	MGC	W01C015F18	pDONR221	691		ATXN7L2	127002	AAH36849.1	Hs.118248	Ataxin 7-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153340.4	NP_699171.3	VALIDATED	P	1.000	1.000	581	1745	1	1743	722	1	581
IKAKEN	BC041117	FLJ05-C10	MGC	W01C015F19	pDONR221	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001812.2	NP_001803.2	REVIEWED		0.912	0.918	468	1404	1	1401	943	478	943
IKAKEN	BC041117	FLJ05-C10	MGC	W01C015F20	pDONR221	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001812.2	NP_001803.2	REVIEWED		0.912	0.918	468	1404	1	1401	943	478	943
IKAKEN	BC053323	FLJ05-C11	MGC	W01C015F21	pDONR221	18478		N4BP3	23138	AAH53323.2	Hs.101761	Nedd4 binding protein 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_015111.1	NP_055926.1	VALIDATED	OK	1.000	1.000	544	1668	34	1665	544	1	544
IKAKEN	BC053323	FLJ05-C11	MGC	W01C015F22	pDONR221	18478		N4BP3	23138	AAH53323.2	Hs.101761	Nedd4 binding protein 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_015111.1	NP_055926.1	VALIDATED	OK	1.000	1.000	544	1668	34	1665	544	1	544
IKAKEN	BC052605	FLJ05-C12	MGC	W01C015F23	pDONR221	10566		TIMP2	7077	AAH52605.1	Hs.633514	TIMP metallopeptidase inhibitor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003255.4	NP_003246.1	REVIEWED	P	1.000	1.000	218	661	5	658	220	3	220
IKAKEN	BC052605	FLJ05-C12	MGC	W01C015F24	pDONR221	10566		TIMP2	7077	AAH52605.1	Hs.633514	TIMP metallopeptidase inhibitor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003255.4	NP_003246.1	REVIEWED	P	1.000	1.000	218	661	5	658	220	3	220
IKAKEN	BC052575	FLJ05-D01	MGC	W01C015G01	pDONR221	15271		COL6A1	1291	AAH52575.1	Hs.474053	Collagen, type VI, alpha 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_001848.2	NP_001839.2	REVIEWED	P	1.000	1.000	428	1287	1	1284	1028	601	1028
IKAKEN	BC052575	FLJ05-D01	MGC	W01C015G02	pDONR221	15271		COL6A1	1291	AAH52575.1	Hs.474053	Collagen, type VI, alpha 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_001848.2	NP_001839.2	REVIEWED	P	1.000	1.000	428	1287	1	1284	1028	601	1028
IKAKEN	BC052304	FLJ05-D02	MGC	W01C015G03	pDONR221	24558		TBL1X	6907	AAH52304.1	Hs.495656	Transducin (beta)-like 1X-linked			Brain, hippocampus	NIH_MGC_124	DH10B	NM_005647.3	NP_005638.1	REVIEWED	Cg	0.998	1.000	578	1737	1	1734	577	1	577
IKAKEN	BC052304	FLJ05-D02	MGC	W01C015G04	pDONR221	24558		TBL1X	6907	AAH52304.1	Hs.495656	Transducin (beta)-like 1X-linked			Brain, hippocampus	NIH_MGC_124	DH10B	NM_005647.3	NP_005638.1	REVIEWED	Cg	0.998	1.000	578	1737	1	1734	577	1	577
IKAKEN	BC051265	FLJ05-D03	MGC	W01C015G05	pDONR221	13188		PTMA	5757	AAH51265.1	Hs.459927	Prothymosin, alpha			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001099285.1	NP_001092755.1	VALIDATED		0.892	0.943	111	345	1	315	111	1	111
IKAKEN	BC051265	FLJ05-D03	MGC	W01C015G06	pDONR221	13188		PTMA	5757	AAH51265.1	Hs.459927	Prothymosin, alpha			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001099285.1	NP_001092755.1	VALIDATED		0.892	0.943	111	345	1	315	111	1	111
IKAKEN	BC062334	FLJ05-D04	MGC	W01C015G07	pDONR221	9221		PRSS33	260429	AAH62334.1	Hs.280658	Protease, serine, 33			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152891.2	NP_690851.2	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC062334	FLJ05-D04	MGC	W01C015G08	pDONR221	9221		PRSS33	260429	AAH62334.1	Hs.280658	Protease, serine, 33			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152891.2	NP_690851.2	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC064990	FLJ05-D05	MGC	W01C015G09	pDONR221	15320		SFRS15	57466	AAH64990.1	Hs.17255	Splicing factor, arginine/serine-rich 15			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020706.2	NP_065757.1	REVIEWED	OK	1.000	1.000	1147	3444	1	3441	1147	1	1147
IKAKEN	BC064990	FLJ05-D05	MGC	W01C015G10	pDONR221	15320		SFRS15	57466	AAH64990.1	Hs.17255	Splicing factor, arginine/serine-rich 15			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020706.2	NP_065757.1	REVIEWED	OK	1.000	1.000	1147	3444	1	3441	1147	1	1147
IKAKEN	BC067351	FLJ05-D06	MGC	W01C015G11	pDONR221	19472		GUSBL1	387036	AAH67351	Hs.675815	Glucuronidase, beta-like 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC067351	FLJ05-D06	MGC	W01C015G12	pDONR221	19472		GUSBL1	387036	AAH67351	Hs.675815	Glucuronidase, beta-like 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	AK055104	FLJ05-D07	FLJ	W01C015G13	pDONR221	8563		SH2B1	25970	BAG51467.1	Hs.15744	SH2B adaptor protein 1			brain	BRAWH2		NM_001145795.1	NP_001139267.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	AK055104	FLJ05-D07	FLJ	W01C015G14	pDONR221	8563		SH2B1	25970	BAG51467.1	Hs.15744	SH2B adaptor protein 1			brain	BRAWH2		NM_001145795.1	NP_001139267.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	AK055595	FLJ05-D08	FLJ	W01C015G15	pDONR221	18151		DDX60L	91351	BAB70966.1	Hs.535011	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like		synoviocytes from rtheumatioid arthritis		HSYRA1		NM_001012967.1	NP_001012985.1	VALIDATED	Ps	0.999	0.999	727	2184	1	2181	1706	438	1164
IKAKEN	AK055595	FLJ05-D08	FLJ	W01C015G16	pDONR221	18151		DDX60L	91351	BAB70966.1	Hs.535011	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like		synoviocytes from rtheumatioid arthritis		HSYRA1		NM_001012967.1	NP_001012985.1	VALIDATED	Ps	0.999	0.999	727	2184	1	2181	1706	438	1164
IKAKEN	AK056707	FLJ05-D09	FLJ	W01C015G17	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK056707	FLJ05-D09	FLJ	W01C015G18	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK055752	FLJ05-D10	FLJ	W01C015G19	pDONR221	8229		NARG2	79664	BAG51567.1	Hs.200943	NMDA receptor regulated 2			kidney	KIDNE1		NM_024611.4	NP_078887.2	VALIDATED	OK	1.000	1.000	982	2949	1	2946	982	1	982
IKAKEN	AK055752	FLJ05-D10	FLJ	W01C015G20	pDONR221	8229		NARG2	79664	BAG51567.1	Hs.200943	NMDA receptor regulated 2			kidney	KIDNE1		NM_024611.4	NP_078887.2	VALIDATED	OK	1.000	1.000	982	2949	1	2946	982	1	982
IKAKEN	AK091646	FLJ05-D11	FLJ	W01C015G21	pDONR221	16166		EIF2B5	8893	BAC03712.1	Hs.283551	Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa			brain	FCBBF3		NM_003907.2	NP_003898.2	VALIDATED	OK	1.000	1.000	721	2166	1	2163	721	1	721
IKAKEN	AK091646	FLJ05-D11	FLJ	W01C015G22	pDONR221	16166		EIF2B5	8893	BAC03712.1	Hs.283551	Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa			brain	FCBBF3		NM_003907.2	NP_003898.2	VALIDATED	OK	1.000	1.000	721	2166	1	2163	721	1	721
IKAKEN	AK074833	FLJ05-D12	FLJ	W01C015G23	pDONR221	21961		LRCH4	4034	BAG52011.1	Hs.125742	Leucine-rich repeats and calponin homology (CH) domain containing 4	NT2	teratocarcinoma		NT2RP2		NM_002319.3	NP_002310.2	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
IKAKEN	AK074833	FLJ05-D12	FLJ	W01C015G24	pDONR221	21961		LRCH4	4034	BAG52011.1	Hs.125742	Leucine-rich repeats and calponin homology (CH) domain containing 4	NT2	teratocarcinoma		NT2RP2		NM_002319.3	NP_002310.2	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
IKAKEN	BC052575	FLJ05-D01	MGC	W01C015H01	pDONR221	15271		COL6A1	1291	AAH52575.1	Hs.474053	Collagen, type VI, alpha 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_001848.2	NP_001839.2	REVIEWED	P	1.000	1.000	428	1287	1	1284	1028	601	1028
IKAKEN	BC052575	FLJ05-D01	MGC	W01C015H02	pDONR221	15271		COL6A1	1291	AAH52575.1	Hs.474053	Collagen, type VI, alpha 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_001848.2	NP_001839.2	REVIEWED	P	1.000	1.000	428	1287	1	1284	1028	601	1028
IKAKEN	BC052304	FLJ05-D02	MGC	W01C015H03	pDONR221	24558		TBL1X	6907	AAH52304.1	Hs.495656	Transducin (beta)-like 1X-linked			Brain, hippocampus	NIH_MGC_124	DH10B	NM_005647.3	NP_005638.1	REVIEWED	Cg	0.998	1.000	578	1737	1	1734	577	1	577
IKAKEN	BC052304	FLJ05-D02	MGC	W01C015H04	pDONR221	24558		TBL1X	6907	AAH52304.1	Hs.495656	Transducin (beta)-like 1X-linked			Brain, hippocampus	NIH_MGC_124	DH10B	NM_005647.3	NP_005638.1	REVIEWED	Cg	0.998	1.000	578	1737	1	1734	577	1	577
IKAKEN	BC051265	FLJ05-D03	MGC	W01C015H05	pDONR221	13188		PTMA	5757	AAH51265.1	Hs.459927	Prothymosin, alpha			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001099285.1	NP_001092755.1	VALIDATED		0.892	0.943	111	345	1	315	111	1	111
IKAKEN	BC051265	FLJ05-D03	MGC	W01C015H06	pDONR221	13188		PTMA	5757	AAH51265.1	Hs.459927	Prothymosin, alpha			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001099285.1	NP_001092755.1	VALIDATED		0.892	0.943	111	345	1	315	111	1	111
IKAKEN	BC062334	FLJ05-D04	MGC	W01C015H07	pDONR221	9221		PRSS33	260429	AAH62334.1	Hs.280658	Protease, serine, 33			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152891.2	NP_690851.2	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC062334	FLJ05-D04	MGC	W01C015H08	pDONR221	9221		PRSS33	260429	AAH62334.1	Hs.280658	Protease, serine, 33			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152891.2	NP_690851.2	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC064990	FLJ05-D05	MGC	W01C015H09	pDONR221	15320		SFRS15	57466	AAH64990.1	Hs.17255	Splicing factor, arginine/serine-rich 15			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020706.2	NP_065757.1	REVIEWED	OK	1.000	1.000	1147	3444	1	3441	1147	1	1147
IKAKEN	BC064990	FLJ05-D05	MGC	W01C015H10	pDONR221	15320		SFRS15	57466	AAH64990.1	Hs.17255	Splicing factor, arginine/serine-rich 15			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020706.2	NP_065757.1	REVIEWED	OK	1.000	1.000	1147	3444	1	3441	1147	1	1147
IKAKEN	BC067351	FLJ05-D06	MGC	W01C015H11	pDONR221	19472		GUSBL1	387036	AAH67351	Hs.675815	Glucuronidase, beta-like 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC067351	FLJ05-D06	MGC	W01C015H12	pDONR221	19472		GUSBL1	387036	AAH67351	Hs.675815	Glucuronidase, beta-like 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	AK055104	FLJ05-D07	FLJ	W01C015H13	pDONR221	8563		SH2B1	25970	BAG51467.1	Hs.15744	SH2B adaptor protein 1			brain	BRAWH2		NM_001145795.1	NP_001139267.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	AK055104	FLJ05-D07	FLJ	W01C015H14	pDONR221	8563		SH2B1	25970	BAG51467.1	Hs.15744	SH2B adaptor protein 1			brain	BRAWH2		NM_001145795.1	NP_001139267.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	AK055595	FLJ05-D08	FLJ	W01C015H15	pDONR221	18151		DDX60L	91351	BAB70966.1	Hs.535011	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like		synoviocytes from rtheumatioid arthritis		HSYRA1		NM_001012967.1	NP_001012985.1	VALIDATED	Ps	0.999	0.999	727	2184	1	2181	1706	438	1164
IKAKEN	AK055595	FLJ05-D08	FLJ	W01C015H16	pDONR221	18151		DDX60L	91351	BAB70966.1	Hs.535011	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like		synoviocytes from rtheumatioid arthritis		HSYRA1		NM_001012967.1	NP_001012985.1	VALIDATED	Ps	0.999	0.999	727	2184	1	2181	1706	438	1164
IKAKEN	AK056707	FLJ05-D09	FLJ	W01C015H17	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK056707	FLJ05-D09	FLJ	W01C015H18	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK055752	FLJ05-D10	FLJ	W01C015H19	pDONR221	8229		NARG2	79664	BAG51567.1	Hs.200943	NMDA receptor regulated 2			kidney	KIDNE1		NM_024611.4	NP_078887.2	VALIDATED	OK	1.000	1.000	982	2949	1	2946	982	1	982
IKAKEN	AK055752	FLJ05-D10	FLJ	W01C015H20	pDONR221	8229		NARG2	79664	BAG51567.1	Hs.200943	NMDA receptor regulated 2			kidney	KIDNE1		NM_024611.4	NP_078887.2	VALIDATED	OK	1.000	1.000	982	2949	1	2946	982	1	982
IKAKEN	AK091646	FLJ05-D11	FLJ	W01C015H21	pDONR221	16166		EIF2B5	8893	BAC03712.1	Hs.283551	Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa			brain	FCBBF3		NM_003907.2	NP_003898.2	VALIDATED	OK	1.000	1.000	721	2166	1	2163	721	1	721
IKAKEN	AK091646	FLJ05-D11	FLJ	W01C015H22	pDONR221	16166		EIF2B5	8893	BAC03712.1	Hs.283551	Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa			brain	FCBBF3		NM_003907.2	NP_003898.2	VALIDATED	OK	1.000	1.000	721	2166	1	2163	721	1	721
IKAKEN	AK074833	FLJ05-D12	FLJ	W01C015H23	pDONR221	21961		LRCH4	4034	BAG52011.1	Hs.125742	Leucine-rich repeats and calponin homology (CH) domain containing 4	NT2	teratocarcinoma		NT2RP2		NM_002319.3	NP_002310.2	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
IKAKEN	AK074833	FLJ05-D12	FLJ	W01C015H24	pDONR221	21961		LRCH4	4034	BAG52011.1	Hs.125742	Leucine-rich repeats and calponin homology (CH) domain containing 4	NT2	teratocarcinoma		NT2RP2		NM_002319.3	NP_002310.2	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
IKAKEN	AK075268	FLJ05-E01	FLJ	W01C015I01	pDONR221	7788		DUOX1	53905	-	Hs.272813	Dual oxidase 1			thyroid gland	THYRO1		NM_017434.3	NP_059130.2	REVIEWED	Cgs	0.997	0.997	1552	4659	1	4656	1551	1	1551
IKAKEN	AK075268	FLJ05-E01	FLJ	W01C015I02	pDONR221	7788		DUOX1	53905	-	Hs.272813	Dual oxidase 1			thyroid gland	THYRO1		NM_017434.3	NP_059130.2	REVIEWED	Cgs	0.997	0.997	1552	4659	1	4656	1551	1	1551
IKAKEN	AK095004	FLJ05-E02	FLJ	W01C015I03	pDONR221	3624		KIAA1377	57562	BAG52970.1	Hs.156352	KIAA1377			hippocampus	BRHIP2		NM_020802.2	NP_065853.2	VALIDATED	P	1.000	1.000	1073	3222	1	3219	1117	45	1117
IKAKEN	AK095004	FLJ05-E02	FLJ	W01C015I04	pDONR221	3624		KIAA1377	57562	BAG52970.1	Hs.156352	KIAA1377			hippocampus	BRHIP2		NM_020802.2	NP_065853.2	VALIDATED	P	1.000	1.000	1073	3222	1	3219	1117	45	1117
IKAKEN	AK075561	FLJ05-E03	FLJ	W01C015I05	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK075561	FLJ05-E03	FLJ	W01C015I06	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK022147	FLJ05-E04	FLJ	W01C015I07	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK022147	FLJ05-E04	FLJ	W01C015I08	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK096345	FLJ05-E05	FLJ	W01C015I09	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096345	FLJ05-E05	FLJ	W01C015I10	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096338	FLJ05-E06	FLJ	W01C015I11	pDONR221	11806		SNX26	115703	BAG53264.1	Hs.515364	Sorting nexin 26	NT2	teratocarcinoma		NT2RI2		NM_052948.2	NP_443180.2	REVIEWED	OK	1.000	1.000	1126	3381	1	3378	1126	1	1126
IKAKEN	AK096338	FLJ05-E06	FLJ	W01C015I12	pDONR221	11806		SNX26	115703	BAG53264.1	Hs.515364	Sorting nexin 26	NT2	teratocarcinoma		NT2RI2		NM_052948.2	NP_443180.2	REVIEWED	OK	1.000	1.000	1126	3381	1	3378	1126	1	1126
IKAKEN	AK122655	FLJ05-E07	FLJ	W01C015I13	pDONR221	16785		SLC7A14	57709	BAG53645.1	Hs.596660	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14			thymus	THYMU2		NM_020949.2	NP_066000.2	VALIDATED	P	1.000	1.000	737	2214	1	2211	771	35	771
IKAKEN	AK122655	FLJ05-E07	FLJ	W01C015I14	pDONR221	16785		SLC7A14	57709	BAG53645.1	Hs.596660	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14			thymus	THYMU2		NM_020949.2	NP_066000.2	VALIDATED	P	1.000	1.000	737	2214	1	2211	771	35	771
IKAKEN	AK122820	FLJ05-E08	FLJ	W01C015I15	pDONR221	22671		KIAA0146	23514	-	Hs.381058	KIAA0146			thymus	THYMU2		NM_001080394.1	NP_001073863.1	PREDICTED	Ps	0.998	0.998	906	3120	400	3117	915	10	915
IKAKEN	AK122820	FLJ05-E08	FLJ	W01C015I16	pDONR221	22671		KIAA0146	23514	-	Hs.381058	KIAA0146			thymus	THYMU2		NM_001080394.1	NP_001073863.1	PREDICTED	Ps	0.998	0.998	906	3120	400	3117	915	10	915
IKAKEN	AK122913	FLJ05-E09	FLJ	W01C015I17	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122913	FLJ05-E09	FLJ	W01C015I18	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122930	FLJ05-E10	FLJ	W01C015I19	pDONR221	6936		SIPA1L1	26037	-	Hs.654657	Signal-induced proliferation-associated 1 like 1			testis	TESTI4		NM_015556.1	NP_056371.1	PROVISIONAL	C	1.000	1.000	1804	5415	1	5412	1804	1	1804
IKAKEN	AK122930	FLJ05-E10	FLJ	W01C015I20	pDONR221	6936		SIPA1L1	26037	-	Hs.654657	Signal-induced proliferation-associated 1 like 1			testis	TESTI4		NM_015556.1	NP_056371.1	PROVISIONAL	C	1.000	1.000	1804	5415	1	5412	1804	1	1804
IKAKEN	AK122948	FLJ05-E11	FLJ	W01C015I21	pDONR221	1357		RC3H1	149041	BAG53813.1	Hs.30258	Ring finger and CCCH-type zinc finger domains 1			testis	TESTI4		NM_172071.2	NP_742068.1	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122948	FLJ05-E11	FLJ	W01C015I22	pDONR221	1357		RC3H1	149041	BAG53813.1	Hs.30258	Ring finger and CCCH-type zinc finger domains 1			testis	TESTI4		NM_172071.2	NP_742068.1	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122916	FLJ05-E12	FLJ	W01C015I23	pDONR221	2709		TDRD1	56165	BAG53796.1	Hs.333132	Tudor domain containing 1			testis	TESTI4		NM_198795.1	NP_942090.1	REVIEWED	OK	1.000	1.000	1189	3570	1	3567	1189	1	1189
IKAKEN	AK122916	FLJ05-E12	FLJ	W01C015I24	pDONR221	2709		TDRD1	56165	BAG53796.1	Hs.333132	Tudor domain containing 1			testis	TESTI4		NM_198795.1	NP_942090.1	REVIEWED	OK	1.000	1.000	1189	3570	1	3567	1189	1	1189
IKAKEN	AK075268	FLJ05-E01	FLJ	W01C015J01	pDONR221	7788		DUOX1	53905	-	Hs.272813	Dual oxidase 1			thyroid gland	THYRO1		NM_017434.3	NP_059130.2	REVIEWED	Cgs	0.997	0.997	1552	4659	1	4656	1551	1	1551
IKAKEN	AK075268	FLJ05-E01	FLJ	W01C015J02	pDONR221	7788		DUOX1	53905	-	Hs.272813	Dual oxidase 1			thyroid gland	THYRO1		NM_017434.3	NP_059130.2	REVIEWED	Cgs	0.997	0.997	1552	4659	1	4656	1551	1	1551
IKAKEN	AK095004	FLJ05-E02	FLJ	W01C015J03	pDONR221	3624		KIAA1377	57562	BAG52970.1	Hs.156352	KIAA1377			hippocampus	BRHIP2		NM_020802.2	NP_065853.2	VALIDATED	P	1.000	1.000	1073	3222	1	3219	1117	45	1117
IKAKEN	AK095004	FLJ05-E02	FLJ	W01C015J04	pDONR221	3624		KIAA1377	57562	BAG52970.1	Hs.156352	KIAA1377			hippocampus	BRHIP2		NM_020802.2	NP_065853.2	VALIDATED	P	1.000	1.000	1073	3222	1	3219	1117	45	1117
IKAKEN	AK075561	FLJ05-E03	FLJ	W01C015J05	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK075561	FLJ05-E03	FLJ	W01C015J06	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK022147	FLJ05-E04	FLJ	W01C015J07	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK022147	FLJ05-E04	FLJ	W01C015J08	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK096345	FLJ05-E05	FLJ	W01C015J09	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096345	FLJ05-E05	FLJ	W01C015J10	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096338	FLJ05-E06	FLJ	W01C015J11	pDONR221	11806		SNX26	115703	BAG53264.1	Hs.515364	Sorting nexin 26	NT2	teratocarcinoma		NT2RI2		NM_052948.2	NP_443180.2	REVIEWED	OK	1.000	1.000	1126	3381	1	3378	1126	1	1126
IKAKEN	AK096338	FLJ05-E06	FLJ	W01C015J12	pDONR221	11806		SNX26	115703	BAG53264.1	Hs.515364	Sorting nexin 26	NT2	teratocarcinoma		NT2RI2		NM_052948.2	NP_443180.2	REVIEWED	OK	1.000	1.000	1126	3381	1	3378	1126	1	1126
IKAKEN	AK122655	FLJ05-E07	FLJ	W01C015J13	pDONR221	16785		SLC7A14	57709	BAG53645.1	Hs.596660	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14			thymus	THYMU2		NM_020949.2	NP_066000.2	VALIDATED	P	1.000	1.000	737	2214	1	2211	771	35	771
IKAKEN	AK122655	FLJ05-E07	FLJ	W01C015J14	pDONR221	16785		SLC7A14	57709	BAG53645.1	Hs.596660	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14			thymus	THYMU2		NM_020949.2	NP_066000.2	VALIDATED	P	1.000	1.000	737	2214	1	2211	771	35	771
IKAKEN	AK122820	FLJ05-E08	FLJ	W01C015J15	pDONR221	22671		KIAA0146	23514	-	Hs.381058	KIAA0146			thymus	THYMU2		NM_001080394.1	NP_001073863.1	PREDICTED	Ps	0.998	0.998	906	3120	400	3117	915	10	915
IKAKEN	AK122820	FLJ05-E08	FLJ	W01C015J16	pDONR221	22671		KIAA0146	23514	-	Hs.381058	KIAA0146			thymus	THYMU2		NM_001080394.1	NP_001073863.1	PREDICTED	Ps	0.998	0.998	906	3120	400	3117	915	10	915
IKAKEN	AK122913	FLJ05-E09	FLJ	W01C015J17	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122913	FLJ05-E09	FLJ	W01C015J18	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122930	FLJ05-E10	FLJ	W01C015J19	pDONR221	6936		SIPA1L1	26037	-	Hs.654657	Signal-induced proliferation-associated 1 like 1			testis	TESTI4		NM_015556.1	NP_056371.1	PROVISIONAL	C	1.000	1.000	1804	5415	1	5412	1804	1	1804
IKAKEN	AK122930	FLJ05-E10	FLJ	W01C015J20	pDONR221	6936		SIPA1L1	26037	-	Hs.654657	Signal-induced proliferation-associated 1 like 1			testis	TESTI4		NM_015556.1	NP_056371.1	PROVISIONAL	C	1.000	1.000	1804	5415	1	5412	1804	1	1804
IKAKEN	AK122948	FLJ05-E11	FLJ	W01C015J21	pDONR221	1357		RC3H1	149041	BAG53813.1	Hs.30258	Ring finger and CCCH-type zinc finger domains 1			testis	TESTI4		NM_172071.2	NP_742068.1	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122948	FLJ05-E11	FLJ	W01C015J22	pDONR221	1357		RC3H1	149041	BAG53813.1	Hs.30258	Ring finger and CCCH-type zinc finger domains 1			testis	TESTI4		NM_172071.2	NP_742068.1	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122916	FLJ05-E12	FLJ	W01C015J23	pDONR221	2709		TDRD1	56165	BAG53796.1	Hs.333132	Tudor domain containing 1			testis	TESTI4		NM_198795.1	NP_942090.1	REVIEWED	OK	1.000	1.000	1189	3570	1	3567	1189	1	1189
IKAKEN	AK122916	FLJ05-E12	FLJ	W01C015J24	pDONR221	2709		TDRD1	56165	BAG53796.1	Hs.333132	Tudor domain containing 1			testis	TESTI4		NM_198795.1	NP_942090.1	REVIEWED	OK	1.000	1.000	1189	3570	1	3567	1189	1	1189
IKAKEN	AK127134	FLJ05-F01	FLJ	W01C015K01	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F01	FLJ	W01C015K02	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F02	FLJ	W01C015K03	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F02	FLJ	W01C015K04	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK000290	FLJ05-F03	FLJ	W01C015K05	pDONR221	8197		DPP8	54878	BAA91059.1	Hs.591106	Dipeptidyl-peptidase 8	HepG2	hepatoma		HEP		NM_017743.4	NP_060213.2	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK000290	FLJ05-F03	FLJ	W01C015K06	pDONR221	8197		DPP8	54878	BAA91059.1	Hs.591106	Dipeptidyl-peptidase 8	HepG2	hepatoma		HEP		NM_017743.4	NP_060213.2	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK129497	FLJ05-F04	FLJ	W01C015K07	pDONR221	11661		DPY19L3	147991	BAC85166.1	Hs.194392	Dpy-19-like 3 (C. elegans)	NT2	teratocarcinoma		NT2RP4		NM_207325.1	NP_997208.1	PROVISIONAL	Cs	0.999	0.999	716	2151	1	2148	716	1	716
IKAKEN	AK129497	FLJ05-F04	FLJ	W01C015K08	pDONR221	11661		DPY19L3	147991	BAC85166.1	Hs.194392	Dpy-19-like 3 (C. elegans)	NT2	teratocarcinoma		NT2RP4		NM_207325.1	NP_997208.1	PROVISIONAL	Cs	0.999	0.999	716	2151	1	2148	716	1	716
IKAKEN	AK026565	FLJ05-F05	FLJ	W01C015K09	pDONR221	10240		TSR1	55720	-	Hs.388170	TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_018128.4	NP_060598.3	VALIDATED	OK	1.000	1.000	804	2415	1	2412	804	1	804
IKAKEN	AK026565	FLJ05-F05	FLJ	W01C015K10	pDONR221	10240		TSR1	55720	-	Hs.388170	TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_018128.4	NP_060598.3	VALIDATED	OK	1.000	1.000	804	2415	1	2412	804	1	804
IKAKEN	AK001627	FLJ05-F06	FLJ	W01C015K11	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK001627	FLJ05-F06	FLJ	W01C015K12	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK122683	FLJ05-F07	FLJ	W01C015K13	pDONR221	16096		RAD54L2	23132	BAG53666.1	Hs.105399	RAD54-like 2 (S. cerevisiae)			cerebellum	BRACE2		NM_015106.2	NP_055921.2	VALIDATED	P	1.000	1.000	1359	4080	1	4077	1467	109	1467
IKAKEN	AK122683	FLJ05-F07	FLJ	W01C015K14	pDONR221	16096		RAD54L2	23132	BAG53666.1	Hs.105399	RAD54-like 2 (S. cerevisiae)			cerebellum	BRACE2		NM_015106.2	NP_055921.2	VALIDATED	P	1.000	1.000	1359	4080	1	4077	1467	109	1467
IKAKEN	AK127134	FLJ05-F01	FLJ	W01C015L01	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F01	FLJ	W01C015L02	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F02	FLJ	W01C015L03	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F02	FLJ	W01C015L04	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK000290	FLJ05-F03	FLJ	W01C015L05	pDONR221	8197		DPP8	54878	BAA91059.1	Hs.591106	Dipeptidyl-peptidase 8	HepG2	hepatoma		HEP		NM_017743.4	NP_060213.2	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK000290	FLJ05-F03	FLJ	W01C015L06	pDONR221	8197		DPP8	54878	BAA91059.1	Hs.591106	Dipeptidyl-peptidase 8	HepG2	hepatoma		HEP		NM_017743.4	NP_060213.2	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK129497	FLJ05-F04	FLJ	W01C015L07	pDONR221	11661		DPY19L3	147991	BAC85166.1	Hs.194392	Dpy-19-like 3 (C. elegans)	NT2	teratocarcinoma		NT2RP4		NM_207325.1	NP_997208.1	PROVISIONAL	Cs	0.999	0.999	716	2151	1	2148	716	1	716
IKAKEN	AK129497	FLJ05-F04	FLJ	W01C015L08	pDONR221	11661		DPY19L3	147991	BAC85166.1	Hs.194392	Dpy-19-like 3 (C. elegans)	NT2	teratocarcinoma		NT2RP4		NM_207325.1	NP_997208.1	PROVISIONAL	Cs	0.999	0.999	716	2151	1	2148	716	1	716
IKAKEN	AK026565	FLJ05-F05	FLJ	W01C015L09	pDONR221	10240		TSR1	55720	-	Hs.388170	TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_018128.4	NP_060598.3	VALIDATED	OK	1.000	1.000	804	2415	1	2412	804	1	804
IKAKEN	AK026565	FLJ05-F05	FLJ	W01C015L10	pDONR221	10240		TSR1	55720	-	Hs.388170	TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_018128.4	NP_060598.3	VALIDATED	OK	1.000	1.000	804	2415	1	2412	804	1	804
IKAKEN	AK001627	FLJ05-F06	FLJ	W01C015L11	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK001627	FLJ05-F06	FLJ	W01C015L12	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK122683	FLJ05-F07	FLJ	W01C015L13	pDONR221	16096		RAD54L2	23132	BAG53666.1	Hs.105399	RAD54-like 2 (S. cerevisiae)			cerebellum	BRACE2		NM_015106.2	NP_055921.2	VALIDATED	P	1.000	1.000	1359	4080	1	4077	1467	109	1467
IKAKEN	AK122683	FLJ05-F07	FLJ	W01C015L14	pDONR221	16096		RAD54L2	23132	BAG53666.1	Hs.105399	RAD54-like 2 (S. cerevisiae)			cerebellum	BRACE2		NM_015106.2	NP_055921.2	VALIDATED	P	1.000	1.000	1359	4080	1	4077	1467	109	1467
IKAKEN	BC039396	FLJ05-A01	MGC	W01C016A01	pDONR221	15567		FAM19A5	25817	AAH39396.2	Hs.632788	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5			Testis	NIH_MGC_97	DH10B	NM_015381.5	NP_056196.2	VALIDATED	P	1.000	1.000	34	933	1	102	125	92	125
IKAKEN	BC039396	FLJ05-A01	MGC	W01C016A02	pDONR221	15567		FAM19A5	25817	AAH39396.2	Hs.632788	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A5			Testis	NIH_MGC_97	DH10B	NM_015381.5	NP_056196.2	VALIDATED	P	1.000	1.000	34	933	1	102	125	92	125
IKAKEN	BC045695	FLJ05-A02	MGC	W01C016A03	pDONR221	20679		MBOAT1	154141	AAH45695	Hs.377830	Membrane bound O-acyltransferase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001080480.1	NP_001073949.1	PROVISIONAL	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC045695	FLJ05-A02	MGC	W01C016A04	pDONR221	20679		MBOAT1	154141	AAH45695	Hs.377830	Membrane bound O-acyltransferase domain containing 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001080480.1	NP_001073949.1	PROVISIONAL	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC045834	FLJ05-A03	MGC	W01C016A05	pDONR221	7502		C14orf145	145508	AAH45834.2	Hs.162889	Chromosome 14 open reading frame 145			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152446.3	NP_689659.2	VALIDATED	Ps	0.990	0.990	408	1308	1	1224	1094	1	408
IKAKEN	BC045834	FLJ05-A03	MGC	W01C016A06	pDONR221	7502		C14orf145	145508	AAH45834.2	Hs.162889	Chromosome 14 open reading frame 145			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152446.3	NP_689659.2	VALIDATED	Ps	0.990	0.990	408	1308	1	1224	1094	1	408
IKAKEN	BC051717	FLJ05-A04	MGC	W01C016A07	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC051717	FLJ05-A04	MGC	W01C016A08	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL	Pgs	0.951	0.986	647	1944	1	1941	663	40	663
IKAKEN	BC047588	FLJ05-A05	MGC	W01C016A09	pDONR221	16776		AADACL1	57552	AAH47588.2	Hs.444099	Arylacetamide deacetylase-like 1			Testis	NIH_MGC_97	DH10B	NM_001146277.1	NP_001139749.1	VALIDATED	C	1.000	1.000	275	1227	400	1224	275	1	275
IKAKEN	BC047588	FLJ05-A05	MGC	W01C016A10	pDONR221	16776		AADACL1	57552	AAH47588.2	Hs.444099	Arylacetamide deacetylase-like 1			Testis	NIH_MGC_97	DH10B	NM_001146277.1	NP_001139749.1	VALIDATED	C	1.000	1.000	275	1227	400	1224	275	1	275
IKAKEN	BC050346	FLJ05-A06	MGC	W01C016A11	pDONR221	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020382.3	NP_065115.3	VALIDATED		0.948	0.956	346	1032	1	1029	352	7	352
IKAKEN	BC050346	FLJ05-A06	MGC	W01C016A12	pDONR221	5547		SETD8	387893	AAH50346.1	Hs.572262	SET domain containing (lysine methyltransferase) 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_020382.3	NP_065115.3	VALIDATED		0.948	0.956	346	1032	1	1029	352	7	352
IKAKEN	BC051650	FLJ05-A07	MGC	W01C016A13	pDONR221	10332		TOM1L2	146691	AAH51650.1	Hs.462379	Target of myb1-like 2 (chicken)			Testis	NIH_MGC_97	DH10B	NM_001033551.2	NP_001028723.1	VALIDATED	P	1.000	1.000	424	1275	1	1272	457	34	457
IKAKEN	BC051650	FLJ05-A07	MGC	W01C016A14	pDONR221	10332		TOM1L2	146691	AAH51650.1	Hs.462379	Target of myb1-like 2 (chicken)			Testis	NIH_MGC_97	DH10B	NM_001033551.2	NP_001028723.1	VALIDATED	P	1.000	1.000	424	1275	1	1272	457	34	457
IKAKEN	BC051690	FLJ05-A08	MGC	W01C016A15	pDONR221	16484		FBLN2	2199	AAH51690.1	Hs.198862	Fibulin 2			Testis	NIH_MGC_97	DH10B	NM_001004019.1	NP_001004019.1	REVIEWED	Cfs	0.962	1.000	1231	3556	1	3553	1231	1	1231
IKAKEN	BC051690	FLJ05-A08	MGC	W01C016A16	pDONR221	16484		FBLN2	2199	AAH51690.1	Hs.198862	Fibulin 2			Testis	NIH_MGC_97	DH10B	NM_001004019.1	NP_001004019.1	REVIEWED	Cfs	0.962	1.000	1231	3556	1	3553	1231	1	1231
IKAKEN	BC044590	FLJ05-A09	MGC	W01C016A17	pDONR221	13026		ACTR3	10096	AAH44590.1	Hs.433512	ARP3 actin-related protein 3 homolog (yeast)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005721.3	NP_005712.1	REVIEWED	Pfs	0.842	0.846	404	1209	4	1206	418	15	418
IKAKEN	BC044590	FLJ05-A09	MGC	W01C016A18	pDONR221	13026		ACTR3	10096	AAH44590.1	Hs.433512	ARP3 actin-related protein 3 homolog (yeast)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_005721.3	NP_005712.1	REVIEWED	Pfs	0.842	0.846	404	1209	4	1206	418	15	418
IKAKEN	BC057833	FLJ05-A10	MGC	W01C016A19	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	FLJ05-A10	MGC	W01C016A20	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC066981	FLJ05-A11	MGC	W01C016A21	pDONR221	8352		POTEB	339010	AAH66981.1	Hs.558766	POTE ankyrin domain family, member B			Testis	NIH_MGC_97	DH10B	NM_207355.2	NP_997238.2	VALIDATED		0.968	0.968	281	855	1	843	581	98	378
IKAKEN	BC066981	FLJ05-A11	MGC	W01C016A22	pDONR221	8352		POTEB	339010	AAH66981.1	Hs.558766	POTE ankyrin domain family, member B			Testis	NIH_MGC_97	DH10B	NM_207355.2	NP_997238.2	VALIDATED		0.968	0.968	281	855	1	843	581	98	378
IKAKEN	BC003377	FLJ05-A12	MGC	W01C016A23	pDONR221	24080		TXN	7295	AAH03377.1	Hs.435136	Thioredoxin			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003329.2	NP_003320.2	VALIDATED		0.923	0.923	65	204	1	195	105	37	101
IKAKEN	BC003377	FLJ05-A12	MGC	W01C016A24	pDONR221	24080		TXN	7295	AAH03377.1	Hs.435136	Thioredoxin			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_003329.2	NP_003320.2	VALIDATED		0.923	0.923	65	204	1	195	105	37	101
IKAKEN	BC000914	FLJ05-B01	MGC	W01C016C01	pDONR221	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003017.4	NP_003008.1	VALIDATED	Cfs	0.933	0.933	164	495	1	492	164	1	164
IKAKEN	BC000914	FLJ05-B01	MGC	W01C016C02	pDONR221	19802		SFRS3	6428	AAH00914.1	Hs.405144	Splicing factor, arginine/serine-rich 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003017.4	NP_003008.1	VALIDATED	Cfs	0.933	0.933	164	495	1	492	164	1	164
IKAKEN	BC006849	FLJ05-B02	MGC	W01C016C03	pDONR221	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	XM_001723779.1	XP_001723831.1	MODEL	C	1.000	1.000	117	1055	702	1052	117	1	117
IKAKEN	BC006849	FLJ05-B02	MGC	W01C016C04	pDONR221	19420		THOC3	84321	AAH06849.1	Hs.484227	THO complex 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	XM_001723779.1	XP_001723831.1	MODEL	C	1.000	1.000	117	1055	702	1052	117	1	117
IKAKEN	BC001254	FLJ05-B03	MGC	W01C016C05	pDONR221	13932		ARL5A	26225	AAH01254.1	Hs.470233	ADP-ribosylation factor-like 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001037174.1	NP_001032251.1	REVIEWED		0.866	0.891	142	753	337	750	142	1	142
IKAKEN	BC001254	FLJ05-B03	MGC	W01C016C06	pDONR221	13932		ARL5A	26225	AAH01254.1	Hs.470233	ADP-ribosylation factor-like 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001037174.1	NP_001032251.1	REVIEWED		0.866	0.891	142	753	337	750	142	1	142
IKAKEN	BC015801	FLJ05-B05	MGC	W01C016C09	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED	Cfs	0.997	1.000	678	2036	1	2033	676	1	676
IKAKEN	BC015801	FLJ05-B05	MGC	W01C016C10	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED	Cfs	0.997	1.000	678	2036	1	2033	676	1	676
IKAKEN	BC012846	FLJ05-B06	MGC	W01C016C11	pDONR221	13886		IDH1	3417	AAH12846.1	Hs.593422	Isocitrate dehydrogenase 1 (NADP+), soluble			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005896.2	NP_005887.2	REVIEWED		0.928	0.928	97	399	1	291	414	318	414
IKAKEN	BC012846	FLJ05-B06	MGC	W01C016C12	pDONR221	13886		IDH1	3417	AAH12846.1	Hs.593422	Isocitrate dehydrogenase 1 (NADP+), soluble			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005896.2	NP_005887.2	REVIEWED		0.928	0.928	97	399	1	291	414	318	414
IKAKEN	BC036263	FLJ05-B07	MGC	W01C016C13	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	FLJ05-B07	MGC	W01C016C14	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC040357	FLJ05-B08	MGC	W01C016C15	pDONR221	14011		MCFD2	90411	AAH40357.1	Hs.293689	Multiple coagulation factor deficiency 2			Testis	NIH_MGC_97	DH10B	NM_139279.3	NP_644808.1	VALIDATED		0.900	0.900	80	243	1	240	146	67	146
IKAKEN	BC040357	FLJ05-B08	MGC	W01C016C16	pDONR221	14011		MCFD2	90411	AAH40357.1	Hs.293689	Multiple coagulation factor deficiency 2			Testis	NIH_MGC_97	DH10B	NM_139279.3	NP_644808.1	VALIDATED		0.900	0.900	80	243	1	240	146	67	146
IKAKEN	BC016486	FLJ05-B09	MGC	W01C016C17	pDONR221	247		LGALS8	3964	AAH16486.2	Hs.4082	Lectin, galactoside-binding, soluble, 8			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201544.1	NP_963838.1	REVIEWED	P	1.000	1.000	316	951	1	948	317	2	317
IKAKEN	BC016486	FLJ05-B09	MGC	W01C016C18	pDONR221	247		LGALS8	3964	AAH16486.2	Hs.4082	Lectin, galactoside-binding, soluble, 8			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201544.1	NP_963838.1	REVIEWED	P	1.000	1.000	316	951	1	948	317	2	317
IKAKEN	BC012469	FLJ05-B10	MGC	W01C016C19	pDONR221	24705		YIPF6	286451	AAH12469.1	Hs.82719	Yip1 domain family, member 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173834.2	NP_776195.1	PROVISIONAL	Cs	0.996	0.996	236	711	1	708	236	1	236
IKAKEN	BC012469	FLJ05-B10	MGC	W01C016C20	pDONR221	24705		YIPF6	286451	AAH12469.1	Hs.82719	Yip1 domain family, member 6			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_173834.2	NP_776195.1	PROVISIONAL	Cs	0.996	0.996	236	711	1	708	236	1	236
IKAKEN	BC034525	FLJ05-B11	MGC	W01C016C21	pDONR221	5354		BRI3BP	140707	AAH34525.1	Hs.596464	BRI3 binding protein			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_080626.5	NP_542193.3	VALIDATED	Pfs	0.990	1.000	97	291	3	290	251	101	197
IKAKEN	BC034525	FLJ05-B11	MGC	W01C016C22	pDONR221	5354		BRI3BP	140707	AAH34525.1	Hs.596464	BRI3 binding protein			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_080626.5	NP_542193.3	VALIDATED	Pfs	0.990	1.000	97	291	3	290	251	101	197
IKAKEN	BC019917	FLJ05-B12	MGC	W01C016C23	pDONR221	19711		QKI	9444	AAH19917.1	Hs.593520	Quaking homolog, KH domain RNA binding (mouse)			Testis	NIH_MGC_97	DH10B	NM_206853.1	NP_996735.1	VALIDATED	P	1.000	1.000	121	453	1	363	319	192	312
IKAKEN	BC019917	FLJ05-B12	MGC	W01C016C24	pDONR221	19711		QKI	9444	AAH19917.1	Hs.593520	Quaking homolog, KH domain RNA binding (mouse)			Testis	NIH_MGC_97	DH10B	NM_206853.1	NP_996735.1	VALIDATED	P	1.000	1.000	121	453	1	363	319	192	312
IKAKEN	BC025689	FLJ05-C01	MGC	W01C016E01	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC025689	FLJ05-C01	MGC	W01C016E02	pDONR221	7843		CCDC33	80125	AAH25689	Hs.621342	Coiled-coil domain containing 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182791.2	NP_877592.2	VALIDATED	P	1.000	1.000	342	1028	1	1026	367	1	342
IKAKEN	BC029775	FLJ05-C02	MGC	W01C016E03	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	FLJ05-C02	MGC	W01C016E04	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC039065	FLJ05-C03	MGC	W01C016E05	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC039065	FLJ05-C03	MGC	W01C016E06	pDONR221	18128		ADH6	130	AAH39065.1	Hs.586161	Alcohol dehydrogenase 6 (class V)			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001102470.1	NP_001095940.1	REVIEWED	Pfs	0.863	0.997	342	891	1	890	375	1	341
IKAKEN	BC035371	FLJ05-C04	MGC	W01C016E07	pDONR221	21911			29060	AAH35371					Testis	NIH_MGC_97	DH10B			
IKAKEN	BC035371	FLJ05-C04	MGC	W01C016E08	pDONR221	21911			29060	AAH35371					Testis	NIH_MGC_97	DH10B			
IKAKEN	BC030275	FLJ05-C06	MGC	W01C016E11	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC030275	FLJ05-C06	MGC	W01C016E12	pDONR221	13940		VPS54	51542	AAH30275.1	Hs.48499	Vacuolar protein sorting 54 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_016516.2	NP_057600.2	REVIEWED	P	1.000	1.000	967	2902	1	2901	977	1	967
IKAKEN	BC032326	FLJ05-C07	MGC	W01C016E13	pDONR221	5617		C12orf45	121053	AAH32326.1	Hs.295563	Chromosome 12 open reading frame 45			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152318.2	NP_689531.2	VALIDATED	OK	1.000	1.000	185	566	1	555	185	1	185
IKAKEN	BC032326	FLJ05-C07	MGC	W01C016E14	pDONR221	5617		C12orf45	121053	AAH32326.1	Hs.295563	Chromosome 12 open reading frame 45			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152318.2	NP_689531.2	VALIDATED	OK	1.000	1.000	185	566	1	555	185	1	185
IKAKEN	BC035588	FLJ05-C08	MGC	W01C016E15	pDONR221	5624		ATP2A2	488	AAH35588.1	Hs.506759	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_170665.3	NP_733765.1	REVIEWED	Cgs	0.998	0.999	1043	3132	1	3129	1042	1	1042
IKAKEN	BC035588	FLJ05-C08	MGC	W01C016E16	pDONR221	5624		ATP2A2	488	AAH35588.1	Hs.506759	ATPase, Ca++ transporting, cardiac muscle, slow twitch 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_170665.3	NP_733765.1	REVIEWED	Cgs	0.998	0.999	1043	3132	1	3129	1042	1	1042
IKAKEN	BC036849	FLJ05-C09	MGC	W01C016E17	pDONR221	691		ATXN7L2	127002	AAH36849.1	Hs.118248	Ataxin 7-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153340.4	NP_699171.3	VALIDATED	P	1.000	1.000	581	1745	1	1743	722	1	581
IKAKEN	BC036849	FLJ05-C09	MGC	W01C016E18	pDONR221	691		ATXN7L2	127002	AAH36849.1	Hs.118248	Ataxin 7-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153340.4	NP_699171.3	VALIDATED	P	1.000	1.000	581	1745	1	1743	722	1	581
IKAKEN	BC041117	FLJ05-C10	MGC	W01C016E19	pDONR221	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001812.2	NP_001803.2	REVIEWED		0.912	0.918	468	1404	1	1401	943	478	943
IKAKEN	BC041117	FLJ05-C10	MGC	W01C016E20	pDONR221	18283		CENPC1	1060	AAH41117.1	Hs.479867	Centromere protein C 1			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001812.2	NP_001803.2	REVIEWED		0.912	0.918	468	1404	1	1401	943	478	943
IKAKEN	BC053323	FLJ05-C11	MGC	W01C016E21	pDONR221	18478		N4BP3	23138	AAH53323.2	Hs.101761	Nedd4 binding protein 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_015111.1	NP_055926.1	VALIDATED	OK	1.000	1.000	544	1668	34	1665	544	1	544
IKAKEN	BC053323	FLJ05-C11	MGC	W01C016E22	pDONR221	18478		N4BP3	23138	AAH53323.2	Hs.101761	Nedd4 binding protein 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_015111.1	NP_055926.1	VALIDATED	OK	1.000	1.000	544	1668	34	1665	544	1	544
IKAKEN	BC052605	FLJ05-C12	MGC	W01C016E23	pDONR221	10566		TIMP2	7077	AAH52605.1	Hs.633514	TIMP metallopeptidase inhibitor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003255.4	NP_003246.1	REVIEWED	P	1.000	1.000	218	661	5	658	220	3	220
IKAKEN	BC052605	FLJ05-C12	MGC	W01C016E24	pDONR221	10566		TIMP2	7077	AAH52605.1	Hs.633514	TIMP metallopeptidase inhibitor 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003255.4	NP_003246.1	REVIEWED	P	1.000	1.000	218	661	5	658	220	3	220
IKAKEN	BC052575	FLJ05-D01	MGC	W01C016G01	pDONR221	15271		COL6A1	1291	AAH52575.1	Hs.474053	Collagen, type VI, alpha 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_001848.2	NP_001839.2	REVIEWED	P	1.000	1.000	428	1287	1	1284	1028	601	1028
IKAKEN	BC052575	FLJ05-D01	MGC	W01C016G02	pDONR221	15271		COL6A1	1291	AAH52575.1	Hs.474053	Collagen, type VI, alpha 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_001848.2	NP_001839.2	REVIEWED	P	1.000	1.000	428	1287	1	1284	1028	601	1028
IKAKEN	BC052304	FLJ05-D02	MGC	W01C016G03	pDONR221	24558		TBL1X	6907	AAH52304.1	Hs.495656	Transducin (beta)-like 1X-linked			Brain, hippocampus	NIH_MGC_124	DH10B	NM_005647.3	NP_005638.1	REVIEWED	Cg	0.998	1.000	578	1737	1	1734	577	1	577
IKAKEN	BC052304	FLJ05-D02	MGC	W01C016G04	pDONR221	24558		TBL1X	6907	AAH52304.1	Hs.495656	Transducin (beta)-like 1X-linked			Brain, hippocampus	NIH_MGC_124	DH10B	NM_005647.3	NP_005638.1	REVIEWED	Cg	0.998	1.000	578	1737	1	1734	577	1	577
IKAKEN	BC051265	FLJ05-D03	MGC	W01C016G05	pDONR221	13188		PTMA	5757	AAH51265.1	Hs.459927	Prothymosin, alpha			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001099285.1	NP_001092755.1	VALIDATED		0.892	0.943	111	345	1	315	111	1	111
IKAKEN	BC051265	FLJ05-D03	MGC	W01C016G06	pDONR221	13188		PTMA	5757	AAH51265.1	Hs.459927	Prothymosin, alpha			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001099285.1	NP_001092755.1	VALIDATED		0.892	0.943	111	345	1	315	111	1	111
IKAKEN	BC062334	FLJ05-D04	MGC	W01C016G07	pDONR221	9221		PRSS33	260429	AAH62334.1	Hs.280658	Protease, serine, 33			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152891.2	NP_690851.2	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC062334	FLJ05-D04	MGC	W01C016G08	pDONR221	9221		PRSS33	260429	AAH62334.1	Hs.280658	Protease, serine, 33			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152891.2	NP_690851.2	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC064990	FLJ05-D05	MGC	W01C016G09	pDONR221	15320		SFRS15	57466	AAH64990.1	Hs.17255	Splicing factor, arginine/serine-rich 15			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020706.2	NP_065757.1	REVIEWED	OK	1.000	1.000	1147	3444	1	3441	1147	1	1147
IKAKEN	BC064990	FLJ05-D05	MGC	W01C016G10	pDONR221	15320		SFRS15	57466	AAH64990.1	Hs.17255	Splicing factor, arginine/serine-rich 15			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020706.2	NP_065757.1	REVIEWED	OK	1.000	1.000	1147	3444	1	3441	1147	1	1147
IKAKEN	BC067351	FLJ05-D06	MGC	W01C016G11	pDONR221	19472		GUSBL1	387036	AAH67351	Hs.675815	Glucuronidase, beta-like 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC067351	FLJ05-D06	MGC	W01C016G12	pDONR221	19472		GUSBL1	387036	AAH67351	Hs.675815	Glucuronidase, beta-like 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	AK055104	FLJ05-D07	FLJ	W01C016G13	pDONR221	8563		SH2B1	25970	BAG51467.1	Hs.15744	SH2B adaptor protein 1			brain	BRAWH2		NM_001145795.1	NP_001139267.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	AK055104	FLJ05-D07	FLJ	W01C016G14	pDONR221	8563		SH2B1	25970	BAG51467.1	Hs.15744	SH2B adaptor protein 1			brain	BRAWH2		NM_001145795.1	NP_001139267.1	REVIEWED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	AK055595	FLJ05-D08	FLJ	W01C016G15	pDONR221	18151		DDX60L	91351	BAB70966.1	Hs.535011	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like		synoviocytes from rtheumatioid arthritis		HSYRA1		NM_001012967.1	NP_001012985.1	VALIDATED	Ps	0.999	0.999	727	2184	1	2181	1706	438	1164
IKAKEN	AK055595	FLJ05-D08	FLJ	W01C016G16	pDONR221	18151		DDX60L	91351	BAB70966.1	Hs.535011	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60-like		synoviocytes from rtheumatioid arthritis		HSYRA1		NM_001012967.1	NP_001012985.1	VALIDATED	Ps	0.999	0.999	727	2184	1	2181	1706	438	1164
IKAKEN	AK056707	FLJ05-D09	FLJ	W01C016G17	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK056707	FLJ05-D09	FLJ	W01C016G18	pDONR221	31		RPRD2	23248	BAG51793.1	Hs.213666	Regulation of nuclear pre-mRNA domain containing 2			brain	OCBBF1		NM_015203.3	NP_056018.2	VALIDATED	OK	1.000	1.000	1461	4386	1	4383	1461	1	1461
IKAKEN	AK055752	FLJ05-D10	FLJ	W01C016G19	pDONR221	8229		NARG2	79664	BAG51567.1	Hs.200943	NMDA receptor regulated 2			kidney	KIDNE1		NM_024611.4	NP_078887.2	VALIDATED	OK	1.000	1.000	982	2949	1	2946	982	1	982
IKAKEN	AK055752	FLJ05-D10	FLJ	W01C016G20	pDONR221	8229		NARG2	79664	BAG51567.1	Hs.200943	NMDA receptor regulated 2			kidney	KIDNE1		NM_024611.4	NP_078887.2	VALIDATED	OK	1.000	1.000	982	2949	1	2946	982	1	982
IKAKEN	AK091646	FLJ05-D11	FLJ	W01C016G21	pDONR221	16166		EIF2B5	8893	BAC03712.1	Hs.283551	Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa			brain	FCBBF3		NM_003907.2	NP_003898.2	VALIDATED	OK	1.000	1.000	721	2166	1	2163	721	1	721
IKAKEN	AK091646	FLJ05-D11	FLJ	W01C016G22	pDONR221	16166		EIF2B5	8893	BAC03712.1	Hs.283551	Eukaryotic translation initiation factor 2B, subunit 5 epsilon, 82kDa			brain	FCBBF3		NM_003907.2	NP_003898.2	VALIDATED	OK	1.000	1.000	721	2166	1	2163	721	1	721
IKAKEN	AK074833	FLJ05-D12	FLJ	W01C016G23	pDONR221	21961		LRCH4	4034	BAG52011.1	Hs.125742	Leucine-rich repeats and calponin homology (CH) domain containing 4	NT2	teratocarcinoma		NT2RP2		NM_002319.3	NP_002310.2	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
IKAKEN	AK074833	FLJ05-D12	FLJ	W01C016G24	pDONR221	21961		LRCH4	4034	BAG52011.1	Hs.125742	Leucine-rich repeats and calponin homology (CH) domain containing 4	NT2	teratocarcinoma		NT2RP2		NM_002319.3	NP_002310.2	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
IKAKEN	AK075268	FLJ05-E01	FLJ	W01C016I01	pDONR221	7788		DUOX1	53905	-	Hs.272813	Dual oxidase 1			thyroid gland	THYRO1		NM_017434.3	NP_059130.2	REVIEWED	Cgs	0.997	0.997	1552	4659	1	4656	1551	1	1551
IKAKEN	AK075268	FLJ05-E01	FLJ	W01C016I02	pDONR221	7788		DUOX1	53905	-	Hs.272813	Dual oxidase 1			thyroid gland	THYRO1		NM_017434.3	NP_059130.2	REVIEWED	Cgs	0.997	0.997	1552	4659	1	4656	1551	1	1551
IKAKEN	AK095004	FLJ05-E02	FLJ	W01C016I03	pDONR221	3624		KIAA1377	57562	BAG52970.1	Hs.156352	KIAA1377			hippocampus	BRHIP2		NM_020802.2	NP_065853.2	VALIDATED	P	1.000	1.000	1073	3222	1	3219	1117	45	1117
IKAKEN	AK095004	FLJ05-E02	FLJ	W01C016I04	pDONR221	3624		KIAA1377	57562	BAG52970.1	Hs.156352	KIAA1377			hippocampus	BRHIP2		NM_020802.2	NP_065853.2	VALIDATED	P	1.000	1.000	1073	3222	1	3219	1117	45	1117
IKAKEN	AK075561	FLJ05-E03	FLJ	W01C016I05	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK075561	FLJ05-E03	FLJ	W01C016I06	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK022147	FLJ05-E04	FLJ	W01C016I07	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK022147	FLJ05-E04	FLJ	W01C016I08	pDONR221	5407		TBC1D15	64786	BAB13971.1	Hs.284630	TBC1 domain family, member 15			whole embryo, mainly head	HEMBA1		NM_022771.4	NP_073608.3	REVIEWED	Pgs	0.967	0.996	694	2034	1	2031	713	23	713
IKAKEN	AK096345	FLJ05-E05	FLJ	W01C016I09	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096345	FLJ05-E05	FLJ	W01C016I10	pDONR221	17594		C4orf41	60684	BAG53267.1	Hs.443240	Chromosome 4 open reading frame 41	NT2	teratocarcinoma		NT2RP7		NM_021942.4	NP_068761.4	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK096338	FLJ05-E06	FLJ	W01C016I11	pDONR221	11806		SNX26	115703	BAG53264.1	Hs.515364	Sorting nexin 26	NT2	teratocarcinoma		NT2RI2		NM_052948.2	NP_443180.2	REVIEWED	OK	1.000	1.000	1126	3381	1	3378	1126	1	1126
IKAKEN	AK096338	FLJ05-E06	FLJ	W01C016I12	pDONR221	11806		SNX26	115703	BAG53264.1	Hs.515364	Sorting nexin 26	NT2	teratocarcinoma		NT2RI2		NM_052948.2	NP_443180.2	REVIEWED	OK	1.000	1.000	1126	3381	1	3378	1126	1	1126
IKAKEN	AK122655	FLJ05-E07	FLJ	W01C016I13	pDONR221	16785		SLC7A14	57709	BAG53645.1	Hs.596660	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14			thymus	THYMU2		NM_020949.2	NP_066000.2	VALIDATED	P	1.000	1.000	737	2214	1	2211	771	35	771
IKAKEN	AK122655	FLJ05-E07	FLJ	W01C016I14	pDONR221	16785		SLC7A14	57709	BAG53645.1	Hs.596660	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 14			thymus	THYMU2		NM_020949.2	NP_066000.2	VALIDATED	P	1.000	1.000	737	2214	1	2211	771	35	771
IKAKEN	AK122820	FLJ05-E08	FLJ	W01C016I15	pDONR221	22671		KIAA0146	23514	-	Hs.381058	KIAA0146			thymus	THYMU2		NM_001080394.1	NP_001073863.1	PREDICTED	Ps	0.998	0.998	906	3120	400	3117	915	10	915
IKAKEN	AK122820	FLJ05-E08	FLJ	W01C016I16	pDONR221	22671		KIAA0146	23514	-	Hs.381058	KIAA0146			thymus	THYMU2		NM_001080394.1	NP_001073863.1	PREDICTED	Ps	0.998	0.998	906	3120	400	3117	915	10	915
IKAKEN	AK122913	FLJ05-E09	FLJ	W01C016I17	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122913	FLJ05-E09	FLJ	W01C016I18	pDONR221	23996		CDK5RAP2	55755	BAG53794.1	Hs.269560	CDK5 regulatory subunit associated protein 2			testis	TESTI2		NM_018249.4	NP_060719.4	REVIEWED	OK	1.000	1.000	1893	5682	1	5679	1893	1	1893
IKAKEN	AK122930	FLJ05-E10	FLJ	W01C016I19	pDONR221	6936		SIPA1L1	26037	-	Hs.654657	Signal-induced proliferation-associated 1 like 1			testis	TESTI4		NM_015556.1	NP_056371.1	PROVISIONAL	C	1.000	1.000	1804	5415	1	5412	1804	1	1804
IKAKEN	AK122930	FLJ05-E10	FLJ	W01C016I20	pDONR221	6936		SIPA1L1	26037	-	Hs.654657	Signal-induced proliferation-associated 1 like 1			testis	TESTI4		NM_015556.1	NP_056371.1	PROVISIONAL	C	1.000	1.000	1804	5415	1	5412	1804	1	1804
IKAKEN	AK122948	FLJ05-E11	FLJ	W01C016I21	pDONR221	1357		RC3H1	149041	BAG53813.1	Hs.30258	Ring finger and CCCH-type zinc finger domains 1			testis	TESTI4		NM_172071.2	NP_742068.1	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122948	FLJ05-E11	FLJ	W01C016I22	pDONR221	1357		RC3H1	149041	BAG53813.1	Hs.30258	Ring finger and CCCH-type zinc finger domains 1			testis	TESTI4		NM_172071.2	NP_742068.1	VALIDATED	OK	1.000	1.000	1133	3402	1	3399	1133	1	1133
IKAKEN	AK122916	FLJ05-E12	FLJ	W01C016I23	pDONR221	2709		TDRD1	56165	BAG53796.1	Hs.333132	Tudor domain containing 1			testis	TESTI4		NM_198795.1	NP_942090.1	REVIEWED	OK	1.000	1.000	1189	3570	1	3567	1189	1	1189
IKAKEN	AK122916	FLJ05-E12	FLJ	W01C016I24	pDONR221	2709		TDRD1	56165	BAG53796.1	Hs.333132	Tudor domain containing 1			testis	TESTI4		NM_198795.1	NP_942090.1	REVIEWED	OK	1.000	1.000	1189	3570	1	3567	1189	1	1189
IKAKEN	AK127134	FLJ05-F01	FLJ	W01C016K01	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F01	FLJ	W01C016K02	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F02	FLJ	W01C016K03	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	FLJ05-F02	FLJ	W01C016K04	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK000290	FLJ05-F03	FLJ	W01C016K05	pDONR221	8197		DPP8	54878	BAA91059.1	Hs.591106	Dipeptidyl-peptidase 8	HepG2	hepatoma		HEP		NM_017743.4	NP_060213.2	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK000290	FLJ05-F03	FLJ	W01C016K06	pDONR221	8197		DPP8	54878	BAA91059.1	Hs.591106	Dipeptidyl-peptidase 8	HepG2	hepatoma		HEP		NM_017743.4	NP_060213.2	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK129497	FLJ05-F04	FLJ	W01C016K07	pDONR221	11661		DPY19L3	147991	BAC85166.1	Hs.194392	Dpy-19-like 3 (C. elegans)	NT2	teratocarcinoma		NT2RP4		NM_207325.1	NP_997208.1	PROVISIONAL	Cs	0.999	0.999	716	2151	1	2148	716	1	716
IKAKEN	AK129497	FLJ05-F04	FLJ	W01C016K08	pDONR221	11661		DPY19L3	147991	BAC85166.1	Hs.194392	Dpy-19-like 3 (C. elegans)	NT2	teratocarcinoma		NT2RP4		NM_207325.1	NP_997208.1	PROVISIONAL	Cs	0.999	0.999	716	2151	1	2148	716	1	716
IKAKEN	AK026565	FLJ05-F05	FLJ	W01C016K09	pDONR221	10240		TSR1	55720	-	Hs.388170	TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_018128.4	NP_060598.3	VALIDATED	OK	1.000	1.000	804	2415	1	2412	804	1	804
IKAKEN	AK026565	FLJ05-F05	FLJ	W01C016K10	pDONR221	10240		TSR1	55720	-	Hs.388170	TSR1, 20S rRNA accumulation, homolog (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_018128.4	NP_060598.3	VALIDATED	OK	1.000	1.000	804	2415	1	2412	804	1	804
IKAKEN	AK001627	FLJ05-F06	FLJ	W01C016K11	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK001627	FLJ05-F06	FLJ	W01C016K12	pDONR221	6963		CPSF2	53981	BAG50953.1	Hs.657632	Cleavage and polyadenylation specific factor 2, 100kDa			Testis	NIH_MGC_97	DH10B	NM_017437.1	NP_059133.1	VALIDATED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	AK122683	FLJ05-F07	FLJ	W01C016K13	pDONR221	16096		RAD54L2	23132	BAG53666.1	Hs.105399	RAD54-like 2 (S. cerevisiae)			cerebellum	BRACE2		NM_015106.2	NP_055921.2	VALIDATED	P	1.000	1.000	1359	4080	1	4077	1467	109	1467
IKAKEN	AK122683	FLJ05-F07	FLJ	W01C016K14	pDONR221	16096		RAD54L2	23132	BAG53666.1	Hs.105399	RAD54-like 2 (S. cerevisiae)			cerebellum	BRACE2		NM_015106.2	NP_055921.2	VALIDATED	P	1.000	1.000	1359	4080	1	4077	1467	109	1467
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C017A01	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C017A02	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C017A03	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C017A04	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C017A05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C017A06	pDONR221															
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C017A07	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C017A08	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C017A09	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C017A10	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C017A11	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C017A12	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C017A13	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C017A14	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C017A15	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C017A16	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C017A17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C017A18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C017A19	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C017A20	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C017A21	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C017A22	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C017A23	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C017A24	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C017B01	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C017B02	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C017B03	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C017B04	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C017B05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C017B06	pDONR221															
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C017B07	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C017B08	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C017B09	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C017B10	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C017B11	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C017B12	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C017B13	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C017B14	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C017B15	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C017B16	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C017B17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C017B18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C017B19	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C017B20	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C017B21	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C017B22	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C017B23	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C017B24	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C017C01	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C017C02	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C017C03	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C017C04	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C017C05	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C017C06	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C017C07	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C017C08	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C017C09	pDONR221															
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C017C10	pDONR221															
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C017C11	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C017C12	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C017C13	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C017C14	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C017C15	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C017C16	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C017C17	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C017C18	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C017C19	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C017C20	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C017C21	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C017C22	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C017C23	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C017C24	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C017D01	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C017D02	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C017D03	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C017D04	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C017D05	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C017D06	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C017D07	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C017D08	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C017D09	pDONR221															
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C017D10	pDONR221															
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C017D11	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C017D12	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C017D13	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C017D14	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C017D15	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C017D16	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C017D17	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C017D18	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C017D19	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C017D20	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C017D21	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C017D22	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C017D23	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C017D24	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C017E01	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C017E02	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C017E03	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C017E04	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C017E05	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C017E06	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C017E07	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C017E08	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C017E09	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C017E10	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C017E11	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C017E12	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C017E13	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C017E14	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C017E15	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C017E16	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C017E17	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C017E18	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C017E19	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C017E20	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C017E21	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C017E22	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C017E23	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C017E24	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C017F01	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C017F02	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C017F03	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C017F04	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C017F05	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C017F06	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C017F07	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C017F08	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C017F09	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C017F10	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C017F11	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C017F12	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C017F13	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C017F14	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C017F15	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C017F16	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C017F17	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C017F18	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C017F19	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C017F20	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C017F21	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C017F22	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C017F23	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C017F24	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C017G01	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C017G02	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C017G03	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C017G04	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C017G05	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C017G06	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C017G07	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C017G08	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C017G09	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C017G10	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C017G11	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C017G12	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C017G13	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C017G14	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C017G15	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C017G16	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C017G17	pDONR221															
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C017G18	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C017G19	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C017G20	pDONR221															
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C017G21	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C017G22	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C017G23	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C017G24	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C017H01	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C017H02	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C017H03	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C017H04	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C017H05	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C017H06	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C017H07	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C017H08	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C017H09	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C017H10	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C017H11	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C017H12	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C017H13	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C017H14	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C017H15	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C017H16	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C017H17	pDONR221															
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C017H18	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C017H19	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C017H20	pDONR221															
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C017H21	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C017H22	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C017H23	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C017H24	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C017I01	pDONR221				440502											
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C017I02	pDONR221				440502											
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C017I03	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C017I04	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C017I05	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C017I06	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C017I07	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C017I08	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C017I09	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C017I10	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C017I11	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C017I12	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C017I13	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C017I14	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C017I15	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C017I16	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C017I17	pDONR221															
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C017I18	pDONR221															
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C017I19	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C017I20	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C017I21	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C017I22	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C017I23	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C017I24	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C017J01	pDONR221				440502											
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C017J02	pDONR221				440502											
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C017J03	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C017J04	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C017J05	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C017J06	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C017J07	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C017J08	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C017J09	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C017J10	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C017J11	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C017J12	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C017J13	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C017J14	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C017J15	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C017J16	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C017J17	pDONR221															
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C017J18	pDONR221															
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C017J19	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C017J20	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C017J21	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C017J22	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C017J23	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C017J24	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C017K01	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C017K02	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C017K03	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C017K04	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C017K05	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C017K06	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C017K07	pDONR221															
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C017K08	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C017K09	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C017K10	pDONR221															
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C017K11	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C017K12	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C017K13	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C017K14	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C017K15	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C017K16	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C017K17	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C017K18	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C017K19	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C017K20	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C017K21	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C017K22	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C017K23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C017K24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C017L01	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C017L02	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C017L03	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C017L04	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C017L05	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C017L06	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C017L07	pDONR221															
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C017L08	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C017L09	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C017L10	pDONR221															
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C017L11	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C017L12	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C017L13	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C017L14	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C017L15	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C017L16	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C017L17	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C017L18	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C017L19	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C017L20	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C017L21	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C017L22	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C017L23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C017L24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C017M01	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C017M02	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C017M03	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C017M04	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C017M05	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C017M06	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C017M07	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C017M08	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C017M09	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C017M10	pDONR221															
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C017M11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C017M12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C017M13	pDONR221															
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C017M14	pDONR221															
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C017M15	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C017M16	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C017M17	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C017M18	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C017M19	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C017M20	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C017M21	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C017M22	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C017M23	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C017M24	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C017N01	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C017N02	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C017N03	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C017N04	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C017N05	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C017N06	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C017N07	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C017N08	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C017N09	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C017N10	pDONR221															
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C017N11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C017N12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C017N13	pDONR221															
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C017N14	pDONR221															
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C017N15	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C017N16	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C017N17	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C017N18	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C017N19	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C017N20	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C017N21	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C017N22	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C017N23	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C017N24	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C017O01	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C017O02	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C017O03	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C017O04	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C017O05	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C017O06	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C017O07	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C017O08	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C017O09	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C017O10	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C017O11	pDONR221															
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C017O12	pDONR221															
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C017O13	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C017O14	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C017O15	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C017O16	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C017O17	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C017O18	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C017O19	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C017O20	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C017O21	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C017O22	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C017O23	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C017O24	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C017P01	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C017P02	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C017P03	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C017P04	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C017P05	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C017P06	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C017P07	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C017P08	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C017P09	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C017P10	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C017P11	pDONR221															
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C017P12	pDONR221															
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C017P13	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C017P14	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C017P15	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C017P16	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C017P17	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C017P18	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C017P19	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C017P20	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C017P21	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C017P22	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C017P23	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C017P24	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C018A01	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C018A02	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C018A03	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C018A04	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C018A05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C018A06	pDONR221															
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C018A07	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C018A08	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C018A09	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C018A10	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C018A11	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C018A12	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C018A13	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C018A14	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C018A15	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C018A16	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C018A17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C018A18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C018A19	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C018A20	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C018A21	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C018A22	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C018A23	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C018A24	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C018B01	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL523988 (5' CS0DC003YB12)	IMS01-A01		W01C018B02	pDONR221			SUSD1	64420		Hs.494827	Sushi domain containing 1						NM_022486.3	NP_071931.2	VALIDATED	OK	1.000	1.000	747	2244	1	2241	747	1	747
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C018B03	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	AL526476 (3' CS0DC014YE10)	IMS01-A02		W01C018B04	pDONR221			LPCAT4	254531		Hs.352614	Lysophosphatidylcholine acyltransferase 4						NM_153613.2	NP_705841.2	VALIDATED	Pfs	0.987	1.000	75	225	1	223	524	293	367
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C018B05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS01-A03		W01C018B06	pDONR221															
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C018B07	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395084 (5' CS0DC029YM17)	IMS01-A04		W01C018B08	pDONR221			HAUS5	23354		Hs.7426	HAUS augmin-like complex, subunit 5						NM_015302.1	NP_056117.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C018B09	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX395449 (5' CS0DD008YB16)	IMS01-A05		W01C018B10	pDONR221			APRT	353		Hs.28914	Adenine phosphoribosyltransferase						NM_000485.2	NP_000476.1	REVIEWED	Cg	0.994	1.000	181	546	1	543	180	1	180
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C018B11	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX440196 (5' CS0DF003YA15)	IMS01-A06		W01C018B12	pDONR221			SPATA7	55812		Hs.525518	Spermatogenesis associated 7						NM_018418.3	NP_060888.2	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C018B13	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX449285 (5' CL0BA011ZD06)	IMS01-A07		W01C018B14	pDONR221			APOBEC3H	164668		Hs.440515	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3H						NM_181773.2	NP_861438.1	VALIDATED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C018B15	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BX366323 (5' CS0DB008YH18)	IMS01-A08		W01C018B16	pDONR221			LOC387787	387787		Hs.591971	Lipoyl(octanoyl) transferase						NM_001144869.1	NP_001138341.1	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C018B17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL523872 (5' CS0DC003YP09)	IMS01-A09		W01C018B18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C018B19	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL538140 (5' CS0DF029YJ09)	IMS01-A10		W01C018B20	pDONR221			TMPRSS5	80975		Hs.46720	Transmembrane protease, serine 5						NM_030770.2	NP_110397.2	REVIEWED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C018B21	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	AL522396 (5' CS0DB008YK20)	IMS01-A11		W01C018B22	pDONR221			SHISA4	149345		Hs.632471	Shisa homolog 4 (Xenopus laevis)						NM_198149.1	NP_937792.1	PROVISIONAL	Cs	0.995	0.995	197	594	1	591	197	1	197
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C018B23	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BX354124 (5' CS0DC015YA16)	IMS01-A12		W01C018B24	pDONR221			CYP2U1	113612		Hs.109087	Cytochrome P450, family 2, subfamily U, polypeptide 1						NM_183075.2	NP_898898.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C018C01	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C018C02	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C018C03	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C018C04	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C018C05	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C018C06	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C018C07	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C018C08	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C018C09	pDONR221															
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C018C10	pDONR221															
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C018C11	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C018C12	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C018C13	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C018C14	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C018C15	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C018C16	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C018C17	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C018C18	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C018C19	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C018C20	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C018C21	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C018C22	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C018C23	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C018C24	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C018D01	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX391524 (3' CS0DC020YN13)	IMS01-B01		W01C018D02	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.885	1.000	330	882	2	880	1080	659	987
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C018D03	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX355208 (5' CS0DD002YL06)	IMS01-B02		W01C018D04	pDONR221			SPC24	147841		Hs.381225	SPC24, NDC80 kinetochore complex component, homolog (S. cerevisiae)						NM_182513.2	NP_872319.1	PROVISIONAL	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C018D05	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX460293 (5' CS0DF012YD16)	IMS01-B03		W01C018D06	pDONR221			PABPC1L	80336		Hs.641481	Poly(A) binding protein, cytoplasmic 1-like						NM_001124756.1	NP_001118228.1	PROVISIONAL	P	1.000	1.000	414	1278	1	1242	614	1	414
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C018D07	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX405260 (5' CS0DH002YC21)	IMS01-B04		W01C018D08	pDONR221			ERP29	10961		Hs.75841	Endoplasmic reticulum protein 29						NM_006817.3	NP_006808.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C018D09	pDONR221															
IKAKEN	AL515280 (5' CL0BB016ZD11)	IMS01-B05		W01C018D10	pDONR221															
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C018D11	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL522830 (5' CS0DB009YL11)	IMS01-B06		W01C018D12	pDONR221			CCDC50	152137		Hs.478682	Coiled-coil domain containing 50						NM_174908.3	NP_777568.1	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C018D13	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX331864 (5' CS0DC004YK11)	IMS01-B07		W01C018D14	pDONR221			TACC3	10460		Hs.104019	Transforming, acidic coiled-coil containing protein 3						NM_006342.1	NP_006333.1	REVIEWED	P	1.000	1.000	101	435	1	303	838	1	101
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C018D15	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX458329 (5' CS0DE001YP06)	IMS01-B08		W01C018D16	pDONR221			GSR	2936		Hs.271510	Glutathione reductase						NM_000637.2	NP_000628.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	522	44	522
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C018D17	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX417811 (5' CS0DE013YC17)	IMS01-B09		W01C018D18	pDONR221			VASN	114990		Hs.372579	Vasorin						NM_138440.2	NP_612449.2	VALIDATED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C018D19	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX455091 (3' CS0DF014YJ20)	IMS01-B10		W01C018D20	pDONR221			LOC730092	730092		Hs.658149	RRN3 RNA polymerase I transcription factor homolog (S. cerevisiae) pseudogene																		
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C018D21	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	IMS01-B11		W01C018D22	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C018D23	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	AL527767 (3' CS0DC026YJ18)	IMS01-B12		W01C018D24	pDONR221			FAM71E1	112703		Hs.448941	Family with sequence similarity 71, member E1						NM_138411.1	NP_612420.1	PREDICTED	Cg	0.935	1.000	247	744	1	741	231	1	231
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C018E01	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C018E02	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C018E03	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C018E04	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C018E05	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C018E06	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C018E07	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C018E08	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C018E09	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C018E10	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C018E11	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C018E12	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C018E13	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C018E14	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C018E15	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C018E16	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C018E17	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C018E18	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C018E19	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C018E20	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C018E21	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C018E22	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C018E23	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C018E24	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C018F01	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX333917 (5' CS0DD003YF17)	IMS01-C01		W01C018F02	pDONR221			TTC6	115669		Hs.670915	Tetratricopeptide repeat domain 6						NM_001007795.1	NP_001007796.1	MODEL	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C018F03	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX374745 (5' CS0DC001YH05)	IMS01-C02		W01C018F04	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C018F05	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BX332835 (5' CS0DC016YK12)	IMS01-C03		W01C018F06	pDONR221			CLU	1191		Hs.436657	Clusterin						NM_001831.2	NP_001822.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C018F07	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	AL529762 (5' CS0DD005YN01)	IMS01-C04		W01C018F08	pDONR221			C8orf76	84933		Hs.521800	Chromosome 8 open reading frame 76						NM_032847.1	NP_116236.1	PREDICTED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C018F09	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	IMS01-C05		W01C018F10	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C018F11	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	IMS01-C06		W01C018F12	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	329	1098	3	988	2190	1862	2190
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C018F13	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	AL524861 (5' CS0DC008YP23)	IMS01-C07		W01C018F14	pDONR221			MAN2B2	23324		Hs.188464	Mannosidase, alpha, class 2B, member 2						NM_015274.1	NP_056089.1	VALIDATED	C	1.000	1.000	1009	3030	1	3027	1009	1	1009
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C018F15	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	BX354339 (5' CS0DC017YF22)	IMS01-C08		W01C018F16	pDONR221			HDLBP	3069		Hs.471851	High density lipoprotein binding protein						NM_005336.3	NP_005327.1	VALIDATED	Pfs	0.204	0.204	49	231	9	155	1268	113	161
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C018F17	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	AL527442 (5' CS0DC021YM09)	IMS01-C09		W01C018F18	pDONR221			NT5DC1	221294		Hs.719198	5'-nucleotidase domain containing 1						NM_152729.2	NP_689942.2	VALIDATED	OK	1.000	1.000	455	1368	1	1365	455	1	455
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C018F19	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	BX333590 (3' CS0DC027YP21)	IMS01-C10		W01C018F20	pDONR221			AWAT1	158833		Hs.407641	Acyl-CoA wax alcohol acyltransferase 1						NM_001013579.1	NP_001013597.1	PROVISIONAL	P	1.000	1.000	92	279	1	276	328	237	328
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C018F21	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL529575 (5' CS0DD006YH03)	IMS01-C11		W01C018F22	pDONR221			TMEM198	130612		Hs.446664	Transmembrane protein 198						NM_001005209.1	NP_001005209.1	PROVISIONAL	C	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C018F23	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	AL541276 (5' CS0DE005YL01)	IMS01-C12		W01C018F24	pDONR221			ENHO	375704		Hs.522085	Energy homeostasis associated						NM_198573.2	NP_940975.2	VALIDATED	Cfs	0.974	0.987	76	261	1	224	76	1	76
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C018G01	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C018G02	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C018G03	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C018G04	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C018G05	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C018G06	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C018G07	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C018G08	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C018G09	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C018G10	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C018G11	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C018G12	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C018G13	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C018G14	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C018G15	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C018G16	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C018G17	pDONR221															
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C018G18	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C018G19	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C018G20	pDONR221															
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C018G21	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C018G22	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C018G23	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C018G24	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C018H01	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX461138 (5' CS0DF023YK11)	IMS01-D01		W01C018H02	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.976	0.976	245	738	1	735	245	1	245
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C018H03	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX331741 (5' CS0DC001YL09)	IMS01-D02		W01C018H04	pDONR221			N-PAC	84656		Hs.387255	Cytokine-like nuclear factor n-pac						NM_032569.3	NP_115958.2	VALIDATED	Pfs	0.213	0.217	61	384	343	161	553	116	175
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C018H05	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	IMS01-D03		W01C018H06	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C018H07	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	AL530405 (5' CS0DD007YG12)	IMS01-D04		W01C018H08	pDONR221			C7orf67	84182		Hs.660192	Chromosome 7 open reading frame 67						NM_032222.2	NP_115598.2	VALIDATED	Cg	0.999	1.000	758	2277	1	2274	757	1	757
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C018H09	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX458589 (5' CS0DE005YO08)	IMS01-D05		W01C018H10	pDONR221			YWHAZ	7534		Hs.492407	Tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation protein, zeta polypeptide						NM_003406.3	NP_003397.1	REVIEWED		0.910	0.914	245	735	1	732	245	1	245
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C018H11	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX465066 (5' CS0DF001YF14)	IMS01-D06		W01C018H12	pDONR221			SYN3	8224		Hs.608750	Synapsin III						NM_003490.3	NP_003481.3	REVIEWED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C018H13	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	IMS01-D07		W01C018H14	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C018H15	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL553953 (3' CS0DI079YI02)	IMS01-D08		W01C018H16	pDONR221			CTAG1A	246100		Hs.719437	Cancer/testis antigen 1A						NM_139250.1	NP_640343.1	PROVISIONAL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C018H17	pDONR221															
IKAKEN	AL556277 (5' CS0DK001YK24)	IMS01-D09		W01C018H18	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C018H19	pDONR221															
IKAKEN	AL555602 (5' CS0DK008YG21)	IMS01-D10		W01C018H20	pDONR221															
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C018H21	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BX406341 (5' CS0DM011YG04)	IMS01-D11		W01C018H22	pDONR221			GC	2638		Hs.418497	Group-specific component (vitamin D binding protein)						NM_000583.2	NP_000574.2	REVIEWED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C018H23	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	IMS01-D12		W01C018H24	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C018I01	pDONR221				440502											
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C018I02	pDONR221				440502											
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C018I03	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C018I04	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C018I05	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C018I06	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C018I07	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C018I08	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C018I09	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C018I10	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C018I11	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C018I12	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C018I13	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C018I14	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C018I15	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C018I16	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C018I17	pDONR221															
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C018I18	pDONR221															
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C018I19	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C018I20	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C018I21	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C018I22	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C018I23	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C018I24	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C018J01	pDONR221				440502											
IKAKEN	BX396050 (3' CS0DI010YL08)	IMS01-E01		W01C018J02	pDONR221				440502											
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C018J03	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	AL546764 (5' CS0DI026YJ10)	IMS01-E02		W01C018J04	pDONR221			LAMB3	3914		Hs.497636	Laminin, beta 3						NM_001017402.1	NP_001017402.1	REVIEWED	OK	1.000	1.000	1172	3519	1	3516	1172	1	1172
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C018J05	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX337298 (5' CS0DI039YD08)	IMS01-E03		W01C018J06	pDONR221			CC2D1B	200014		Hs.591451	Coiled-coil and C2 domain containing 1B						NM_032449.1	NP_115825.1	VALIDATED	P	1.000	1.000	772	2319	1	2316	858	87	858
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C018J07	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX329164 (3' CS0DJ005YH23)	IMS01-E04		W01C018J08	pDONR221			C5orf39	389289		Hs.529385	Chromosome 5 open reading frame 39						NM_001014279.2	NP_001014301.1	VALIDATED	OK	1.000	1.000	193	582	1	579	193	1	193
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C018J09	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BX402903 (5' CS0DK002YA01)	IMS01-E05		W01C018J10	pDONR221			EIF2B1	1967		Hs.716475	Eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa						NM_001414.2	NP_001405.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C018J11	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	AL531727 (5' CS0DM003YI01)	IMS01-E06		W01C018J12	pDONR221			F7	2155		Hs.36989	Coagulation factor VII (serum prothrombin conversion accelerator)						NM_019616.2	NP_062562.1	REVIEWED	OK	1.000	1.000	444	1335	1	1332	444	1	444
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C018J13	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX427572 (5' CS0DM011YG05)	IMS01-E07		W01C018J14	pDONR221			SLC13A5	284111		Hs.399496	Solute carrier family 13 (sodium-dependent citrate transporter), member 5						NM_177550.3	NP_808218.1	VALIDATED	OK	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C018J15	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	IMS01-E08		W01C018J16	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C018J17	pDONR221															
IKAKEN	BX381882 (3' CS0DI071YG23)	IMS01-E09		W01C018J18	pDONR221															
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C018J19	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BX382568 (5' CS0DI082YH11)	IMS01-E10		W01C018J20	pDONR221			NLRP10	338322		Hs.449636	NLR family, pyrin domain containing 10						NM_176821.3	NP_789791.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C018J21	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL555814 (5' CS0DK002YC18)	IMS01-E11		W01C018J22	pDONR221			TUBGCP5	114791		Hs.533898	Tubulin, gamma complex associated protein 5						NM_052903.4	NP_443135.3	VALIDATED	OK	1.000	1.000	1024	3075	1	3072	1024	1	1024
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C018J23	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	AL531789 (3' CS0DM003YM22)	IMS01-E12		W01C018J24	pDONR221			MED11	400569		Hs.513885	Mediator complex subunit 11						NM_001001683.2	NP_001001683.1	PROVISIONAL	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C018K01	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C018K02	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C018K03	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C018K04	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C018K05	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C018K06	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C018K07	pDONR221															
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C018K08	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C018K09	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C018K10	pDONR221															
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C018K11	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C018K12	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C018K13	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C018K14	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C018K15	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C018K16	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C018K17	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C018K18	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C018K19	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C018K20	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C018K21	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C018K22	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C018K23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C018K24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C018L01	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	BX406635 (5' CS0DM013YA17)	IMS01-F01		W01C018L02	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Cs	0.998	0.998	417	1254	1	1251	417	1	417
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C018L03	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AL553008 (5' CS0DI072YN22)	IMS01-F02		W01C018L04	pDONR221			SDS	10993		Hs.439023	Serine dehydratase						NM_006843.2	NP_006834.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C018L05	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	IMS01-F03		W01C018L06	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C018L07	pDONR221															
IKAKEN	AL531940 (5' CS0DM003YP17)	IMS01-F04		W01C018L08	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C018L09	pDONR221															
IKAKEN	BX350065 (3' CS0DI006YN07)	IMS01-F05		W01C018L10	pDONR221															
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C018L11	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	IMS01-F06		W01C018L12	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C018L13	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX426746 (5' CS0DM005YH01)	IMS01-F07		W01C018L14	pDONR221			APBA3	9546		Hs.465607	Amyloid beta (A4) precursor protein-binding, family A, member 3						NM_004886.3	NP_004877.1	REVIEWED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C018L15	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX427915 (5' CS0DM013YI01)	IMS01-F08		W01C018L16	pDONR221			BTG3	10950		Hs.473420	BTG family, member 3						NM_006806.4	NP_006797.3	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C018L17	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX399393 (5' CS0DI075YE02)	IMS01-F09		W01C018L18	pDONR221			LAMP2	3920		Hs.496684	Lysosomal-associated membrane protein 2						NM_002294.2	NP_002285.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C018L19	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BX324942 (3' CS0DI086YP19)	IMS01-F10		W01C018L20	pDONR221			CIB4	130106		Hs.591579	Calcium and integrin binding family member 4						NM_001029881.1	NP_001025052.1	PROVISIONAL	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C018L21	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	AL556703 (5' CS0DK005YI02)	IMS01-F11		W01C018L22	pDONR221			CP	1356		Hs.558314	Ceruloplasmin (ferroxidase)						NM_000096.3	NP_000087.1	REVIEWED	Cs	0.999	0.999	1065	3198	1	3195	1065	1	1065
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C018L23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX405609 (5' CS0DM006YH13)	IMS01-F12		W01C018L24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Cgs	0.988	0.999	864	2595	1	2592	855	1	855
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C018M01	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C018M02	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C018M03	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C018M04	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C018M05	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C018M06	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C018M07	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C018M08	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C018M09	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C018M10	pDONR221															
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C018M11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C018M12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C018M13	pDONR221															
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C018M14	pDONR221															
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C018M15	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C018M16	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C018M17	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C018M18	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C018M19	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C018M20	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C018M21	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C018M22	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C018M23	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C018M24	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C018N01	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX377480 (5' CS0DI007YM17)	IMS01-G01		W01C018N02	pDONR221			KCTD21	283219		Hs.528439	Potassium channel tetramerisation domain containing 21						NM_001029859.1	NP_001025030.1	PROVISIONAL	P	1.000	1.000	233	702	1	699	260	28	260
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C018N03	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX379356 (3' CS0DI033YG11)	IMS01-G02		W01C018N04	pDONR221			FLJ45983	399717		Hs.669736	Hypothetical LOC399717						NM_207423.1	NP_997306.1	PREDICTED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C018N05	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BX338026 (5' CS0DI054YC18)	IMS01-G03		W01C018N06	pDONR221			ANKRD58	347454		Hs.355223	Ankyrin repeat domain 58						NM_001105576.2	NP_001099046.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C018N07	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	AL553558 (5' CS0DI076YK09)	IMS01-G04		W01C018N08	pDONR221			SMPD1	6609		Hs.498173	Sphingomyelin phosphodiesterase 1, acid lysosomal						NM_000543.3	NP_000534.3	REVIEWED	Cg	0.997	1.000	631	1890	1	1887	631	1	631
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C018N09	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	IMS01-G05		W01C018N10	pDONR221															
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C018N11	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AL556620 (5' CS0DK006YH08)	IMS01-G06		W01C018N12	pDONR221			C15orf17	57184		Hs.367690	Chromosome 15 open reading frame 17						NM_020447.3	NP_065180.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C018N13	pDONR221															
IKAKEN	BX405576 (5' CS0DM006YM19)	IMS01-G07		W01C018N14	pDONR221															
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C018N15	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	BX422805 (5' CS0DN001YD02)	IMS01-G08		W01C018N16	pDONR221			MRPL45	84311		Hs.719232	Mitochondrial ribosomal protein L45						NM_032351.3	NP_115727.3	REVIEWED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C018N17	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	AL545743 (5' CS0DI009YK09)	IMS01-G09		W01C018N18	pDONR221			C20orf7	79133		Hs.472165	Chromosome 20 open reading frame 7						NM_024120.3	NP_077025.2	VALIDATED	P	1.000	1.000	259	804	1	777	345	1	259
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C018N19	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	BX365154 (5' CS0DI056YA22)	IMS01-G10		W01C018N20	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.947	0.947	323	972	1	969	323	1	323
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C018N21	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	AL576607 (3' CS0DI078YD04)	IMS01-G11		W01C018N22	pDONR221			LOC283482	283482									XM_001721848.1	XP_001721900.1	MODEL	Pfs	0.314	0.314	35	795	447	551	46	2	36
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C018N23	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	IMS01-G12		W01C018N24	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED		0.965	0.965	201	606	1	603	201	1	201
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C018O01	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C018O02	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C018O03	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C018O04	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C018O05	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C018O06	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C018O07	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C018O08	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C018O09	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C018O10	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C018O11	pDONR221															
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C018O12	pDONR221															
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C018O13	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C018O14	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C018O15	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C018O16	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C018O17	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C018O18	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C018O19	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C018O20	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C018O21	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C018O22	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C018O23	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C018O24	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C018P01	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	IMS01-H01		W01C018P02	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C018P03	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	BX330465 (3' CS0DI054YF15)	IMS01-H02		W01C018P04	pDONR221			WFDC10B	280664		Hs.237392	WAP four-disulfide core domain 10B						NM_172006.2	NP_742003.1	REVIEWED		0.646	0.699	79	240	1	237	73	1	73
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C018P05	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	AL554295 (5' CS0DI082YI16)	IMS01-H03		W01C018P06	pDONR221			TMEM201	199953		Hs.632365	Transmembrane protein 201						NM_001010866.2	NP_001010866.1	VALIDATED	Ps	0.992	0.992	389	1443	1	1167	392	1	389
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C018P07	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	IMS01-H04		W01C018P08	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C018P09	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	BX397757 (5' CS0DI042YK05)	IMS01-H05		W01C018P10	pDONR221			DUSP27	92235		Hs.632462	Dual specificity phosphatase 27 (putative)						NM_001080426.1	NP_001073895.1	PROVISIONAL	Pfs	0.994	0.994	328	990	1	985	1158	84	411
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C018P11	pDONR221															
IKAKEN	AL540229 (3' CS0DF032YJ19)	IMS01-H06		W01C018P12	pDONR221															
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C018P13	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX339692 (5' CS0DI075YF10)	IMS01-H07		W01C018P14	pDONR221			BTN2A1	11120		Hs.159028	Butyrophilin, subfamily 2, member A1						NM_007049.2	NP_008980.1	REVIEWED	C	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C018P15	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX444684 (5' CS0DN005YH08)	IMS01-H08		W01C018P16	pDONR221			PADI2	11240		Hs.33455	Peptidyl arginine deiminase, type II						NM_007365.2	NP_031391.2	REVIEWED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C018P17	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX398773 (5' CS0DI064YK17)	IMS01-H09		W01C018P18	pDONR221			ARD1B	84779		Hs.676048	ARD1 homolog B (S. cerevisiae)						NM_032693.2	NP_116082.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C018P19	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX403408 (5' CS0DK011YA24)	IMS01-H10		W01C018P20	pDONR221			SPIN3	169981		Hs.522672	Spindlin family, member 3						NM_001010862.2	NP_001010862.2	VALIDATED	P	1.000	1.000	232	699	1	696	258	27	258
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C018P21	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX361349 (5' CS0DI083YL22)	IMS01-H11		W01C018P22	pDONR221			FAM109B	150368		Hs.368312	Family with sequence similarity 109, member B						NM_001002034.2	NP_001002034.2	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C018P23	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BX359413 (5' CS0DI057YE16)	IMS01-H12		W01C018P24	pDONR221			SETD3	84193		Hs.510407	SET domain containing 3						NM_032233.2	NP_115609.2	VALIDATED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	ADB02936	IMS02-A01	EST	W01C019A01	pDONR221															
IKAKEN	ADB02936	IMS02-A01	EST	W01C019A02	pDONR221															
IKAKEN	adKA03524	IMS02-A02	EST	W01C019A03	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	adKA03524	IMS02-A02	EST	W01C019A04	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	COL01980	IMS02-A03	EST	W01C019A05	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL01980	IMS02-A03	EST	W01C019A06	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL09744	IMS02-A04	EST	W01C019A07	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	IMS02-A04	EST	W01C019A08	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	DMC05840	IMS02-A05	EST	W01C019A09	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05840	IMS02-A05	EST	W01C019A10	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	HEP00150	IMS02-A06	EST	W01C019A11	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00150	IMS02-A06	EST	W01C019A12	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00535	IMS02-A07	EST	W01C019A13	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	HEP00535	IMS02-A07	EST	W01C019A14	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	KAT03845	IMS02-A08	EST	W01C019A15	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	IMS02-A08	EST	W01C019A16	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	LFL08188	IMS02-A09	EST	W01C019A17	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS02-A09	EST	W01C019A18	pDONR221			HS6ST1P	388605											
IKAKEN	PRS00980	IMS02-A10	EST	W01C019A19	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	IMS02-A10	EST	W01C019A20	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	IMS02-A11	EST	W01C019A21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A11	EST	W01C019A22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C019A23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C019A24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	ADB02936	IMS02-A01	EST	W01C019B01	pDONR221															
IKAKEN	ADB02936	IMS02-A01	EST	W01C019B02	pDONR221															
IKAKEN	adKA03524	IMS02-A02	EST	W01C019B03	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	adKA03524	IMS02-A02	EST	W01C019B04	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	COL01980	IMS02-A03	EST	W01C019B05	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL01980	IMS02-A03	EST	W01C019B06	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL09744	IMS02-A04	EST	W01C019B07	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	IMS02-A04	EST	W01C019B08	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	DMC05840	IMS02-A05	EST	W01C019B09	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05840	IMS02-A05	EST	W01C019B10	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	HEP00150	IMS02-A06	EST	W01C019B11	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00150	IMS02-A06	EST	W01C019B12	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00535	IMS02-A07	EST	W01C019B13	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	HEP00535	IMS02-A07	EST	W01C019B14	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	KAT03845	IMS02-A08	EST	W01C019B15	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	IMS02-A08	EST	W01C019B16	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	LFL08188	IMS02-A09	EST	W01C019B17	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS02-A09	EST	W01C019B18	pDONR221			HS6ST1P	388605											
IKAKEN	PRS00980	IMS02-A10	EST	W01C019B19	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	IMS02-A10	EST	W01C019B20	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	IMS02-A11	EST	W01C019B21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A11	EST	W01C019B22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C019B23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C019B24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	RCT05355	IMS02-B01	EST	W01C019C01	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT05355	IMS02-B01	EST	W01C019C02	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT07566	IMS02-B02	EST	W01C019C03	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	RCT07566	IMS02-B02	EST	W01C019C04	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	SPL06448	IMS02-B03	EST	W01C019C05	pDONR221															
IKAKEN	SPL06448	IMS02-B03	EST	W01C019C06	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C019C07	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C019C08	pDONR221															
IKAKEN	SYN00348	IMS02-B05	EST	W01C019C09	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN00348	IMS02-B05	EST	W01C019C10	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN05553	IMS02-B06	EST	W01C019C11	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	SYN05553	IMS02-B06	EST	W01C019C12	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	TMS01168	IMS02-B07	EST	W01C019C13	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS01168	IMS02-B07	EST	W01C019C14	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS08467	IMS02-B08	EST	W01C019C15	pDONR221															
IKAKEN	TMS08467	IMS02-B08	EST	W01C019C16	pDONR221															
IKAKEN	TST01923	IMS02-B09	EST	W01C019C17	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01923	IMS02-B09	EST	W01C019C18	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01994	IMS02-B10	EST	W01C019C19	pDONR221				402037											
IKAKEN	TST01994	IMS02-B10	EST	W01C019C20	pDONR221				402037											
IKAKEN	TST03079	IMS02-B11	EST	W01C019C21	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST03079	IMS02-B11	EST	W01C019C22	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST05410	IMS02-B12	EST	W01C019C23	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	IMS02-B12	EST	W01C019C24	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	RCT05355	IMS02-B01	EST	W01C019D01	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT05355	IMS02-B01	EST	W01C019D02	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT07566	IMS02-B02	EST	W01C019D03	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	RCT07566	IMS02-B02	EST	W01C019D04	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	SPL06448	IMS02-B03	EST	W01C019D05	pDONR221															
IKAKEN	SPL06448	IMS02-B03	EST	W01C019D06	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C019D07	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C019D08	pDONR221															
IKAKEN	SYN00348	IMS02-B05	EST	W01C019D09	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN00348	IMS02-B05	EST	W01C019D10	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN05553	IMS02-B06	EST	W01C019D11	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	SYN05553	IMS02-B06	EST	W01C019D12	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	TMS01168	IMS02-B07	EST	W01C019D13	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS01168	IMS02-B07	EST	W01C019D14	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS08467	IMS02-B08	EST	W01C019D15	pDONR221															
IKAKEN	TMS08467	IMS02-B08	EST	W01C019D16	pDONR221															
IKAKEN	TST01923	IMS02-B09	EST	W01C019D17	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01923	IMS02-B09	EST	W01C019D18	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01994	IMS02-B10	EST	W01C019D19	pDONR221				402037											
IKAKEN	TST01994	IMS02-B10	EST	W01C019D20	pDONR221				402037											
IKAKEN	TST03079	IMS02-B11	EST	W01C019D21	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST03079	IMS02-B11	EST	W01C019D22	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST05410	IMS02-B12	EST	W01C019D23	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	IMS02-B12	EST	W01C019D24	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST07725	IMS02-C01	EST	W01C019E01	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST07725	IMS02-C01	EST	W01C019E02	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST08264	IMS02-C02	EST	W01C019E03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	IMS02-C02	EST	W01C019E04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	IMS02-C03	EST	W01C019E05	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	IMS02-C03	EST	W01C019E06	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	IMS02-C04	EST	W01C019E07	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	IMS02-C04	EST	W01C019E08	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	IMS02-C05	EST	W01C019E09	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	IMS02-C05	EST	W01C019E10	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C019E11	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C019E12	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C019E13	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C019E14	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C019E15	pDONR221															
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C019E16	pDONR221															
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C019E17	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C019E18	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C019E19	pDONR221															
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C019E20	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C019E21	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C019E22	pDONR221															
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C019E23	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C019E24	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	TST07725	IMS02-C01	EST	W01C019F01	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST07725	IMS02-C01	EST	W01C019F02	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST08264	IMS02-C02	EST	W01C019F03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	IMS02-C02	EST	W01C019F04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	IMS02-C03	EST	W01C019F05	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	IMS02-C03	EST	W01C019F06	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	IMS02-C04	EST	W01C019F07	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	IMS02-C04	EST	W01C019F08	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	IMS02-C05	EST	W01C019F09	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	IMS02-C05	EST	W01C019F10	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C019F11	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C019F12	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C019F13	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C019F14	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C019F15	pDONR221															
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C019F16	pDONR221															
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C019F17	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C019F18	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C019F19	pDONR221															
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C019F20	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C019F21	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C019F22	pDONR221															
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C019F23	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C019F24	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C019G01	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C019G02	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C019G03	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C019G04	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C019G05	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C019G06	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C019G07	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C019G08	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C019G09	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C019G10	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C019G11	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C019G12	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C019G13	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C019G14	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C019G15	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C019G16	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	AK023132	IMS02-D09	FLJ	W01C019G17	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK023132	IMS02-D09	FLJ	W01C019G18	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK075129	IMS02-D10	FLJ	W01C019G19	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AK075129	IMS02-D10	FLJ	W01C019G20	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C019G21	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C019G22	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C019G23	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C019G24	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C019H01	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C019H02	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C019H03	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C019H04	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C019H05	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C019H06	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C019H07	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C019H08	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C019H09	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C019H10	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C019H11	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C019H12	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C019H13	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C019H14	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C019H15	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C019H16	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	AK023132	IMS02-D09	FLJ	W01C019H17	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK023132	IMS02-D09	FLJ	W01C019H18	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK075129	IMS02-D10	FLJ	W01C019H19	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AK075129	IMS02-D10	FLJ	W01C019H20	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C019H21	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C019H22	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C019H23	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C019H24	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C019I01	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C019I02	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C019I03	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C019I04	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C019I05	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C019I06	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C019I07	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C019I08	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C019I09	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C019I10	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C019I11	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C019I12	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C019I13	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C019I14	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C019I15	pDONR221															
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C019I16	pDONR221															
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C019I17	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C019I18	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C019I19	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C019I20	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C019I21	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C019I22	pDONR221															
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C019I23	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C019I24	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C019J01	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C019J02	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C019J03	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C019J04	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C019J05	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C019J06	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C019J07	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C019J08	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C019J09	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C019J10	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C019J11	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C019J12	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C019J13	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C019J14	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C019J15	pDONR221															
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C019J16	pDONR221															
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C019J17	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C019J18	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C019J19	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C019J20	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C019J21	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C019J22	pDONR221															
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C019J23	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C019J24	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C019K01	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C019K02	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C019K03	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C019K04	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C019K05	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C019K06	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C019K07	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C019K08	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C019K09	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C019K10	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C019K11	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C019K12	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C019K13	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C019K14	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C019K15	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C019K16	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C019K17	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C019K18	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C019K19	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C019K20	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C019K21	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C019K22	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C019K23	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C019K24	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C019L01	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C019L02	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C019L03	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C019L04	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C019L05	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C019L06	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C019L07	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C019L08	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C019L09	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C019L10	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C019L11	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C019L12	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C019L13	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C019L14	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C019L15	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C019L16	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C019L17	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C019L18	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C019L19	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C019L20	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C019L21	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C019L22	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C019L23	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C019L24	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C019M01	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C019M02	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C019M03	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C019M04	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C019M05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C019M06	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C019M07	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C019M08	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C019M09	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C019M10	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C019M11	pDONR221				389039											
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C019M12	pDONR221				389039											
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C019M13	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C019M14	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C019M15	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C019M16	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C019M17	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C019M18	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C019M19	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C019M20	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C019M21	pDONR221															
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C019M22	pDONR221															
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C019M23	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C019M24	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C019N01	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C019N02	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C019N03	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C019N04	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C019N05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C019N06	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C019N07	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C019N08	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C019N09	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C019N10	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C019N11	pDONR221				389039											
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C019N12	pDONR221				389039											
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C019N13	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C019N14	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C019N15	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C019N16	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C019N17	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C019N18	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C019N19	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C019N20	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C019N21	pDONR221															
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C019N22	pDONR221															
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C019N23	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C019N24	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C019O01	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C019O02	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C019O03	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C019O04	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C019O05	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C019O06	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC047594	IMS02-H04	MGC	W01C019O07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	IMS02-H04	MGC	W01C019O08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	IMS02-H05	MGC	W01C019O09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	IMS02-H05	MGC	W01C019O10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC012355	IMS02-H06	MGC	W01C019O11	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC012355	IMS02-H06	MGC	W01C019O12	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC043153	IMS02-H07	MGC	W01C019O13	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC043153	IMS02-H07	MGC	W01C019O14	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC036263	IMS02-H08	MGC	W01C019O15	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS02-H08	MGC	W01C019O16	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	IMS02-H09	MGC	W01C019O17	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	IMS02-H09	MGC	W01C019O18	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	IMS02-H10	MGC	W01C019O19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	IMS02-H10	MGC	W01C019O20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC035033	IMS02-H11	MGC	W01C019O21	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC035033	IMS02-H11	MGC	W01C019O22	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC046145	IMS02-H12	MGC	W01C019O23	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	IMS02-H12	MGC	W01C019O24	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C019P01	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C019P02	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C019P03	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C019P04	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C019P05	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C019P06	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC047594	IMS02-H04	MGC	W01C019P07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	IMS02-H04	MGC	W01C019P08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	IMS02-H05	MGC	W01C019P09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	IMS02-H05	MGC	W01C019P10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC012355	IMS02-H06	MGC	W01C019P11	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC012355	IMS02-H06	MGC	W01C019P12	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC043153	IMS02-H07	MGC	W01C019P13	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC043153	IMS02-H07	MGC	W01C019P14	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC036263	IMS02-H08	MGC	W01C019P15	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS02-H08	MGC	W01C019P16	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	IMS02-H09	MGC	W01C019P17	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	IMS02-H09	MGC	W01C019P18	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	IMS02-H10	MGC	W01C019P19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	IMS02-H10	MGC	W01C019P20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC035033	IMS02-H11	MGC	W01C019P21	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC035033	IMS02-H11	MGC	W01C019P22	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC046145	IMS02-H12	MGC	W01C019P23	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	IMS02-H12	MGC	W01C019P24	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	ADB02936	IMS02-A01	EST	W01C020A01	pDONR221															
IKAKEN	ADB02936	IMS02-A01	EST	W01C020A02	pDONR221															
IKAKEN	adKA03524	IMS02-A02	EST	W01C020A03	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	adKA03524	IMS02-A02	EST	W01C020A04	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	COL01980	IMS02-A03	EST	W01C020A05	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL01980	IMS02-A03	EST	W01C020A06	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL09744	IMS02-A04	EST	W01C020A07	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	IMS02-A04	EST	W01C020A08	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	DMC05840	IMS02-A05	EST	W01C020A09	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05840	IMS02-A05	EST	W01C020A10	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	HEP00150	IMS02-A06	EST	W01C020A11	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00150	IMS02-A06	EST	W01C020A12	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00535	IMS02-A07	EST	W01C020A13	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	HEP00535	IMS02-A07	EST	W01C020A14	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	KAT03845	IMS02-A08	EST	W01C020A15	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	IMS02-A08	EST	W01C020A16	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	LFL08188	IMS02-A09	EST	W01C020A17	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS02-A09	EST	W01C020A18	pDONR221			HS6ST1P	388605											
IKAKEN	PRS00980	IMS02-A10	EST	W01C020A19	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	IMS02-A10	EST	W01C020A20	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	IMS02-A11	EST	W01C020A21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A11	EST	W01C020A22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C020A23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C020A24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	ADB02936	IMS02-A01	EST	W01C020B01	pDONR221															
IKAKEN	ADB02936	IMS02-A01	EST	W01C020B02	pDONR221															
IKAKEN	adKA03524	IMS02-A02	EST	W01C020B03	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	adKA03524	IMS02-A02	EST	W01C020B04	pDONR221			RNF216	54476		Hs.689456	Ring finger protein 216						NM_207111.2	NP_996994.1	REVIEWED	P	1.000	1.000	488	1467	1	1464	923	436	923
IKAKEN	COL01980	IMS02-A03	EST	W01C020B05	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL01980	IMS02-A03	EST	W01C020B06	pDONR221			MFI2	4241		Hs.184727	Antigen p97 (melanoma associated) identified by monoclonal antibodies 133.2 and 96.5						NM_033316.3	NP_201573.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	COL09744	IMS02-A04	EST	W01C020B07	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	COL09744	IMS02-A04	EST	W01C020B08	pDONR221			TWISTNB	221830		Hs.353035	TWIST neighbor						NM_001002926.1	NP_001002926.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	DMC05840	IMS02-A05	EST	W01C020B09	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05840	IMS02-A05	EST	W01C020B10	pDONR221			EPDR1	54749		Hs.563491	Ependymin related protein 1 (zebrafish)						NM_017549.3	NP_060019.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	HEP00150	IMS02-A06	EST	W01C020B11	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00150	IMS02-A06	EST	W01C020B12	pDONR221			KLB	152831		Hs.90756	Klotho beta						NM_175737.3	NP_783864.1	VALIDATED	OK	1.000	1.000	1044	3135	1	3132	1044	1	1044
IKAKEN	HEP00535	IMS02-A07	EST	W01C020B13	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	HEP00535	IMS02-A07	EST	W01C020B14	pDONR221			ITIH2	3698		Hs.75285	Inter-alpha (globulin) inhibitor H2						NM_002216.2	NP_002207.2	VALIDATED	Cg	0.997	1.000	948	2844	1	2841	946	1	946
IKAKEN	KAT03845	IMS02-A08	EST	W01C020B15	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	KAT03845	IMS02-A08	EST	W01C020B16	pDONR221			WTAP	9589		Hs.710715	Wilms tumor 1 associated protein						NM_152857.1	NP_690596.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	LFL08188	IMS02-A09	EST	W01C020B17	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS02-A09	EST	W01C020B18	pDONR221			HS6ST1P	388605											
IKAKEN	PRS00980	IMS02-A10	EST	W01C020B19	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS00980	IMS02-A10	EST	W01C020B20	pDONR221			P4HA3	283208		Hs.660541	Prolyl 4-hydroxylase, alpha polypeptide III						NM_182904.3	NP_878907.1	REVIEWED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	PRS03358	IMS02-A11	EST	W01C020B21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A11	EST	W01C020B22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C020B23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS02-A12	EST	W01C020B24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	RCT05355	IMS02-B01	EST	W01C020C01	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT05355	IMS02-B01	EST	W01C020C02	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT07566	IMS02-B02	EST	W01C020C03	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	RCT07566	IMS02-B02	EST	W01C020C04	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	SPL06448	IMS02-B03	EST	W01C020C05	pDONR221															
IKAKEN	SPL06448	IMS02-B03	EST	W01C020C06	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C020C07	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C020C08	pDONR221															
IKAKEN	SYN00348	IMS02-B05	EST	W01C020C09	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN00348	IMS02-B05	EST	W01C020C10	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN05553	IMS02-B06	EST	W01C020C11	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	SYN05553	IMS02-B06	EST	W01C020C12	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	TMS01168	IMS02-B07	EST	W01C020C13	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS01168	IMS02-B07	EST	W01C020C14	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS08467	IMS02-B08	EST	W01C020C15	pDONR221															
IKAKEN	TMS08467	IMS02-B08	EST	W01C020C16	pDONR221															
IKAKEN	TST01923	IMS02-B09	EST	W01C020C17	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01923	IMS02-B09	EST	W01C020C18	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01994	IMS02-B10	EST	W01C020C19	pDONR221				402037											
IKAKEN	TST01994	IMS02-B10	EST	W01C020C20	pDONR221				402037											
IKAKEN	TST03079	IMS02-B11	EST	W01C020C21	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST03079	IMS02-B11	EST	W01C020C22	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST05410	IMS02-B12	EST	W01C020C23	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	IMS02-B12	EST	W01C020C24	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	RCT05355	IMS02-B01	EST	W01C020D01	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT05355	IMS02-B01	EST	W01C020D02	pDONR221			CEACAM21	90273		Hs.655885	Carcinoembryonic antigen-related cell adhesion molecule 21						NM_033543.3	NP_291021.2	VALIDATED	Ps	0.991	0.991	233	708	1	699	292	1	233
IKAKEN	RCT07566	IMS02-B02	EST	W01C020D03	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	RCT07566	IMS02-B02	EST	W01C020D04	pDONR221			REP15	387849		Hs.269836	Rab15 effector protein						NM_001029874.1	NP_001025045.1	PROVISIONAL	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	SPL06448	IMS02-B03	EST	W01C020D05	pDONR221															
IKAKEN	SPL06448	IMS02-B03	EST	W01C020D06	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C020D07	pDONR221															
IKAKEN	STM01511	IMS02-B04	EST	W01C020D08	pDONR221															
IKAKEN	SYN00348	IMS02-B05	EST	W01C020D09	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN00348	IMS02-B05	EST	W01C020D10	pDONR221			FCF1	51077		Hs.711584	FCF1 small subunit (SSU) processome component homolog (S. cerevisiae)						NM_015962.4	NP_057046.1	VALIDATED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	SYN05553	IMS02-B06	EST	W01C020D11	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	SYN05553	IMS02-B06	EST	W01C020D12	pDONR221			MANEA	79694		Hs.533323	Mannosidase, endo-alpha						NM_024641.2	NP_078917.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	TMS01168	IMS02-B07	EST	W01C020D13	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS01168	IMS02-B07	EST	W01C020D14	pDONR221			OR2D2	120776		Hs.690210	Olfactory receptor, family 2, subfamily D, member 2						NM_003700.1	NP_003691.1	PROVISIONAL	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	TMS08467	IMS02-B08	EST	W01C020D15	pDONR221															
IKAKEN	TMS08467	IMS02-B08	EST	W01C020D16	pDONR221															
IKAKEN	TST01923	IMS02-B09	EST	W01C020D17	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01923	IMS02-B09	EST	W01C020D18	pDONR221			CRISP1	167		Hs.109620	Cysteine-rich secretory protein 1						NM_001131.2	NP_001122.2	REVIEWED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	TST01994	IMS02-B10	EST	W01C020D19	pDONR221				402037											
IKAKEN	TST01994	IMS02-B10	EST	W01C020D20	pDONR221				402037											
IKAKEN	TST03079	IMS02-B11	EST	W01C020D21	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST03079	IMS02-B11	EST	W01C020D22	pDONR221			PLAC8L1	153770		Hs.162369	PLAC8-like 1						NM_001029869.1	NP_001025040.1	INFERRED	OK	1.000	1.000	177	534	1	531	177	1	177
IKAKEN	TST05410	IMS02-B12	EST	W01C020D23	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST05410	IMS02-B12	EST	W01C020D24	pDONR221			MORN5	254956		Hs.71428	MORN repeat containing 5						NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	TST07725	IMS02-C01	EST	W01C020E01	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST07725	IMS02-C01	EST	W01C020E02	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST08264	IMS02-C02	EST	W01C020E03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	IMS02-C02	EST	W01C020E04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	IMS02-C03	EST	W01C020E05	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	IMS02-C03	EST	W01C020E06	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	IMS02-C04	EST	W01C020E07	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	IMS02-C04	EST	W01C020E08	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	IMS02-C05	EST	W01C020E09	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	IMS02-C05	EST	W01C020E10	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C020E11	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C020E12	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C020E13	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C020E14	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C020E15	pDONR221															
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C020E16	pDONR221															
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C020E17	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C020E18	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C020E19	pDONR221															
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C020E20	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C020E21	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C020E22	pDONR221															
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C020E23	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C020E24	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	TST07725	IMS02-C01	EST	W01C020F01	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST07725	IMS02-C01	EST	W01C020F02	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	238	717	1	714	290	53	290
IKAKEN	TST08264	IMS02-C02	EST	W01C020F03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	TST08264	IMS02-C02	EST	W01C020F04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Pfs	1.000	1.000	605	1821	3	1818	651	47	651
IKAKEN	UBA03092	IMS02-C03	EST	W01C020F05	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA03092	IMS02-C03	EST	W01C020F06	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	UBA06001	IMS02-C04	EST	W01C020F07	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	IMS02-C04	EST	W01C020F08	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	IMS02-C05	EST	W01C020F09	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	IMS02-C05	EST	W01C020F10	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C020F11	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	IMS02-C06	EST(RND)	W01C020F12	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C020F13	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	IMS02-C07	EST(RND)	W01C020F14	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C020F15	pDONR221															
IKAKEN	FBR08580	IMS02-C08	EST(RND)	W01C020F16	pDONR221															
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C020F17	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	IMS02-C09	EST(RND)	W01C020F18	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C020F19	pDONR221															
IKAKEN	HKR04040	IMS02-C10	EST(RND)	W01C020F20	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C020F21	pDONR221															
IKAKEN	HKR12708	IMS02-C11	EST(RND)	W01C020F22	pDONR221															
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C020F23	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	HPR05162	IMS02-C12	EST(RND)	W01C020F24	pDONR221			SYT13	57586		Hs.436643	Synaptotagmin XIII						NM_020826.2	NP_065877.1	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C020G01	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C020G02	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C020G03	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C020G04	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C020G05	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C020G06	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C020G07	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C020G08	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C020G09	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C020G10	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C020G11	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C020G12	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C020G13	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C020G14	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C020G15	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C020G16	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	AK023132	IMS02-D09	FLJ	W01C020G17	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK023132	IMS02-D09	FLJ	W01C020G18	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK075129	IMS02-D10	FLJ	W01C020G19	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AK075129	IMS02-D10	FLJ	W01C020G20	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C020G21	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C020G22	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C020G23	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C020G24	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C020H01	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KAR01609	IMS02-D01	EST(RND)	W01C020H02	pDONR221			SLC10A2	6555		Hs.194783	Solute carrier family 10 (sodium/bile acid cotransporter family), member 2						NM_000452.2	NP_000443.1	VALIDATED	Cs	0.997	0.997	348	1047	1	1044	348	1	348
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C020H03	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR01315	IMS02-D02	EST(RND)	W01C020H04	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pfs	0.995	1.000	1459	4362	2	4359	1577	120	1577
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C020H05	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR04578	IMS02-D03	EST(RND)	W01C020H06	pDONR221			LPP	4026		Hs.444362	LIM domain containing preferred translocation partner in lipoma						NM_005578.2	NP_005569.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C020H07	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KGR08332	IMS02-D04	EST(RND)	W01C020H08	pDONR221			SLC39A10	57181		Hs.650158	Solute carrier family 39 (zinc transporter), member 10						NM_001127257.1	NP_001120729.1	VALIDATED	OK	1.000	1.000	831	2496	1	2493	831	1	831
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C020H09	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	KMR04674	IMS02-D05	EST(RND)	W01C020H10	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.993	0.998	406	1215	2	1214	1602	300	704
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C020H11	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	PLR04480	IMS02-D06	EST(RND)	W01C020H12	pDONR221				285773		Hs.664539	CDNA FLJ34131 fis, clone FCBBF3010544, moderately similar to Rattus norvegicus ion transporter protein (NRITP) mRNA								
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C020H13	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	SMR00483	IMS02-D07	EST(RND)	W01C020H14	pDONR221			B3GALTL	145173		Hs.13205	Beta 1,3-galactosyltransferase-like						NM_194318.3	NP_919299.3	REVIEWED	OK	1.000	1.000	498	1497	1	1494	498	1	498
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C020H15	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	T7R06358	IMS02-D08	EST(RND)	W01C020H16	pDONR221			UFSP1	402682		Hs.534845	UFM1-specific peptidase 1 (non-functional)						NM_001015072.3	NP_001015072.2	VALIDATED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	AK023132	IMS02-D09	FLJ	W01C020H17	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK023132	IMS02-D09	FLJ	W01C020H18	pDONR221	14703		DNAJC5	80331	-	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5	NT2	teratocarcinoma		NT2RP2		NM_025219.1	NP_079495.1	PROVISIONAL	Pfs	0.355	0.393	31	2460	2110	2203	198	106	133
IKAKEN	AK075129	IMS02-D10	FLJ	W01C020H19	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AK075129	IMS02-D10	FLJ	W01C020H20	pDONR221	3093		RHOBTB1	9886	BAC11421.1	Hs.148670	Rho-related BTB domain containing 1			placenta	PLACE1		NM_198225.1	NP_937868.1	REVIEWED	OK	1.000	1.000	696	2091	1	2088	696	1	696
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C020H21	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	AL564753 (5' CS0DM007YF14)	IMS02-D11		W01C020H22	pDONR221			FGA	2243		Hs.351593	Fibrinogen alpha chain						NM_021871.2	NP_068657.1	REVIEWED	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C020H23	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	BX341536 (3' CS0DK002YI07)	IMS02-D12		W01C020H24	pDONR221			C8orf73	642475		Hs.531406	Chromosome 8 open reading frame 73						NM_001100878.1	NP_001094348.1	VALIDATED	Pfs	0.302	0.327	106	462	13	314	719	7	109
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C020I01	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C020I02	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C020I03	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C020I04	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C020I05	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C020I06	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C020I07	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C020I08	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C020I09	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C020I10	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C020I11	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C020I12	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C020I13	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C020I14	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C020I15	pDONR221															
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C020I16	pDONR221															
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C020I17	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C020I18	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C020I19	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C020I20	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C020I21	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C020I22	pDONR221															
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C020I23	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C020I24	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C020J01	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL551979 (5' CS0DI060YH12)	IMS02-E01		W01C020J02	pDONR221			ALKBH3	221120		Hs.368920	AlkB, alkylation repair homolog 3 (E. coli)						NM_139178.3	NP_631917.1	VALIDATED	C	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C020J03	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AL528504 (5' CS0DC029YG21)	IMS02-E02		W01C020J04	pDONR221			MATN3	4148		Hs.656199	Matrilin 3						NM_002381.4	NP_002372.1	REVIEWED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C020J05	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX395836 (3' CS0DI006YP06)	IMS02-E03		W01C020J06	pDONR221			PRDX5	25824		Hs.502823	Peroxiredoxin 5						NM_012094.3	NP_036226.1	REVIEWED	Cs	0.995	0.995	214	645	1	642	214	1	214
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C020J07	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX453532 (3' CS0DF020YB12)	IMS02-E04		W01C020J08	pDONR221			C18orf51	125704		Hs.371690	Chromosome 18 open reading frame 51						NM_001044369.2	NP_001037834.2	VALIDATED	P	1.000	1.000	270	813	1	810	419	150	419
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C020J09	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX363520 (5' CS0DL001YL10)	IMS02-E05		W01C020J10	pDONR221			TRABD	80305		Hs.592213	TraB domain containing						NM_025204.2	NP_079480.2	PROVISIONAL	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C020J11	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	AL559654 (5' CS0DG001YC18)	IMS02-E06		W01C020J12	pDONR221			C17orf87	388325		Hs.462080	Chromosome 17 open reading frame 87						NM_207103.2	NP_996986.1	PREDICTED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C020J13	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX442572 (5' CS0DF033YD17)	IMS02-E07		W01C020J14	pDONR221			LGI4	163175		Hs.65256	Leucine-rich repeat LGI family, member 4						NM_139284.2	NP_644813.1	VALIDATED	OK	1.000	1.000	537	1614	1	1611	537	1	537
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C020J15	pDONR221															
IKAKEN	BX414077 (3' CS0DG006YJ19)	IMS02-E08		W01C020J16	pDONR221															
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C020J17	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX384034 (3' CS0DK003YO06)	IMS02-E09		W01C020J18	pDONR221			MYO1G	64005		Hs.37617	Myosin IG						NM_033054.1	NP_149043.1	VALIDATED	Ps	0.996	0.996	279	840	1	837	1018	740	1018
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C020J19	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX452210 (5' CS0DF028YP06)	IMS02-E10		W01C020J20	pDONR221			SHH	6469		Hs.164537	Sonic hedgehog homolog (Drosophila)						NM_000193.2	NP_000184.1	REVIEWED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C020J21	pDONR221															
IKAKEN	BX363373 (5' CS0DK012YO09)	IMS02-E11		W01C020J22	pDONR221															
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C020J23	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BX427554 (5' CS0DM011YA03)	IMS02-E12		W01C020J24	pDONR221			A1BG	1		Hs.529161	Alpha-1-B glycoprotein						NM_130786.3	NP_570602.2	REVIEWED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C020K01	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C020K02	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C020K03	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C020K04	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C020K05	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C020K06	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C020K07	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C020K08	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C020K09	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C020K10	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C020K11	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C020K12	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C020K13	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C020K14	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C020K15	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C020K16	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C020K17	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C020K18	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C020K19	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C020K20	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C020K21	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C020K22	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C020K23	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C020K24	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C020L01	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AL530467 (5' CS0DD007YN21)	IMS02-F01		W01C020L02	pDONR221			SLC35D2	11046		Hs.494556	Solute carrier family 35, member D2						NM_007001.2	NP_008932.2	VALIDATED	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C020L03	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX393884 (5' CS0DC005YD07)	IMS02-F02		W01C020L04	pDONR221			MSI1	4440		Hs.158311	Musashi homolog 1 (Drosophila)						NM_002442.2	NP_002433.1	REVIEWED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C020L05	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX459249 (5' CS0DE014YM12)	IMS02-F03		W01C020L06	pDONR221			RAB1C	441400		Hs.651788	RAB1C, member RAS oncogene family pseudogene								
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C020L07	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX354126 (5' CS0DC015YA20)	IMS02-F04		W01C020L08	pDONR221			RCCD1	91433		Hs.655895	RCC1 domain containing 1						NM_033544.2	NP_291022.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C020L09	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX426365 (5' CS0DG006YI08)	IMS02-F05		W01C020L10	pDONR221			AGGF1	55109		Hs.634849	Angiogenic factor with G patch and FHA domains 1						NM_018046.3	NP_060516.2	VALIDATED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C020L11	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX343525 (3' CS0DC024YB10)	IMS02-F06		W01C020L12	pDONR221			MSTO1	55154		Hs.656547	Misato homolog 1 (Drosophila)						NM_018116.2	NP_060586.2	VALIDATED	Pfs	1.000	1.000	174	525	2	522	570	397	570
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C020L13	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX355824 (3' CS0DI004YJ23)	IMS02-F07		W01C020L14	pDONR221			KIAA0040	9674		Hs.518138	KIAA0040						XM_001726215.1	XP_001726267.1	MODEL		0.800	0.800	5	462	452	438	101	4	8
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C020L15	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	BX364684 (5' CS0DI005YA09)	IMS02-F08		W01C020L16	pDONR221			ANGPTL6	83854		Hs.712850	Angiopoietin-like 6						NM_031917.2	NP_114123.2	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C020L17	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	AL522000 (5' CS0DB007YC17)	IMS02-F09		W01C020L18	pDONR221			MESDC1	59274		Hs.513071	Mesoderm development candidate 1						NM_022566.2	NP_072088.1	VALIDATED	OK	1.000	1.000	362	1089	1	1086	362	1	362
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C020L19	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX464377 (3' CS0DN005YB10)	IMS02-F10		W01C020L20	pDONR221			NLRP1	22861		Hs.652273	NLR family, pyrin domain containing 1						NM_033004.3	NP_127497.1	REVIEWED	Pfs	0.340	0.346	53	441	201	357	1473	1302	1354
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C020L21	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX419109 (5' CS0DF013YE11)	IMS02-F11		W01C020L22	pDONR221			LRRC24	441381		Hs.715747	Leucine rich repeat containing 24						NM_001024678.3	NP_001019849.2	VALIDATED	Cgs	0.955	0.998	513	1476	1	1473	513	1	513
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C020L23	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	IMS02-F12		W01C020L24	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C020M01	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C020M02	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C020M03	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C020M04	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C020M05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C020M06	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C020M07	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C020M08	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C020M09	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C020M10	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C020M11	pDONR221				389039											
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C020M12	pDONR221				389039											
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C020M13	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C020M14	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C020M15	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C020M16	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C020M17	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C020M18	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C020M19	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C020M20	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C020M21	pDONR221															
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C020M22	pDONR221															
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C020M23	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C020M24	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C020N01	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	AL531739 (5' CS0DM003YC15)	IMS02-G01		W01C020N02	pDONR221			APOA4	337		Hs.591940	Apolipoprotein A-IV						NM_000482.3	NP_000473.2	REVIEWED	OK	1.000	1.000	396	1191	1	1188	396	1	396
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C020N03	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX388686 (3' CS0DB001YK19)	IMS02-G02		W01C020N04	pDONR221			LGMN	5641		Hs.719135	Legumain						NM_001008530.1	NP_001008530.1	REVIEWED	Cg	0.868	1.000	433	1131	1	1128	433	1	433
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C020N05	pDONR221															
IKAKEN	BX394649 (5' CS0DC019YK21)	IMS02-G03		W01C020N06	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C020N07	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	IMS02-G04		W01C020N08	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pfs	0.999	1.000	1416	4581	2	4245	1564	144	1558
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C020N09	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL540680 (5' CS0DE002YF10)	IMS02-G05		W01C020N10	pDONR221			AQR	9716		Hs.510958	Aquarius homolog (mouse)						NM_014691.2	NP_055506.1	VALIDATED	C	1.000	1.000	1485	4458	1	4455	1485	1	1485
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C020N11	pDONR221				389039											
IKAKEN	AL527437 (5' CS0DC021YL21)	IMS02-G06		W01C020N12	pDONR221				389039											
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C020N13	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX421216 (5' CS0DG002YJ01)	IMS02-G07		W01C020N14	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C020N15	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX358281 (5' CS0DI036YC19)	IMS02-G08		W01C020N16	pDONR221			SHROOM1	134549		Hs.519574	Shroom family member 1						NM_133456.1	NP_597713.1	PROVISIONAL	Cs	0.999	0.999	847	2544	1	2541	847	1	847
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C020N17	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX365735 (5' CS0DL009YA22)	IMS02-G09		W01C020N18	pDONR221			MTMR3	8897		Hs.474536	Myotubularin related protein 3						NM_021090.3	NP_066576.1	REVIEWED	OK	1.000	1.000	1198	3597	1	3594	1198	1	1198
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C020N19	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	IMS02-G10		W01C020N20	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C020N21	pDONR221															
IKAKEN	BX362822 (5' CS0DK004YJ19)	IMS02-G11		W01C020N22	pDONR221															
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C020N23	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BX439278 (5' CS0DE009YM13)	IMS02-G12		W01C020N24	pDONR221			EXOSC6	118460		Hs.719211	Exosome component 6						NM_058219.2	NP_478126.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C020O01	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C020O02	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C020O03	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C020O04	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C020O05	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C020O06	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC047594	IMS02-H04	MGC	W01C020O07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	IMS02-H04	MGC	W01C020O08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	IMS02-H05	MGC	W01C020O09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	IMS02-H05	MGC	W01C020O10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC012355	IMS02-H06	MGC	W01C020O11	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC012355	IMS02-H06	MGC	W01C020O12	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC043153	IMS02-H07	MGC	W01C020O13	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC043153	IMS02-H07	MGC	W01C020O14	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC036263	IMS02-H08	MGC	W01C020O15	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS02-H08	MGC	W01C020O16	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	IMS02-H09	MGC	W01C020O17	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	IMS02-H09	MGC	W01C020O18	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	IMS02-H10	MGC	W01C020O19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	IMS02-H10	MGC	W01C020O20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC035033	IMS02-H11	MGC	W01C020O21	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC035033	IMS02-H11	MGC	W01C020O22	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC046145	IMS02-H12	MGC	W01C020O23	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	IMS02-H12	MGC	W01C020O24	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C020P01	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	AL548359 (5' CS0DI016YP02)	IMS02-H01		W01C020P02	pDONR221			MME	4311		Hs.307734	Membrane metallo-endopeptidase						NM_007289.2	NP_009220.2	REVIEWED	OK	1.000	1.000	750	2253	1	2250	750	1	750
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C020P03	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX342463 (5' CS0DL001YB06)	IMS02-H02		W01C020P04	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL		0.767	0.780	176	525	1	522	175	1	175
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C020P05	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BX385952 (5' CS0DI021YA10)	IMS02-H03		W01C020P06	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC047594	IMS02-H04	MGC	W01C020P07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	IMS02-H04	MGC	W01C020P08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC061631	IMS02-H05	MGC	W01C020P09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	IMS02-H05	MGC	W01C020P10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC012355	IMS02-H06	MGC	W01C020P11	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC012355	IMS02-H06	MGC	W01C020P12	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.950	0.952	378	1287	4	1134	520	143	520
IKAKEN	BC043153	IMS02-H07	MGC	W01C020P13	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC043153	IMS02-H07	MGC	W01C020P14	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED	P	1.000	1.000	732	2200	2	2197	777	46	777
IKAKEN	BC036263	IMS02-H08	MGC	W01C020P15	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS02-H08	MGC	W01C020P16	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC040528	IMS02-H09	MGC	W01C020P17	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC040528	IMS02-H09	MGC	W01C020P18	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED		0.839	0.839	323	972	1	969	1347	966	1288
IKAKEN	BC043345	IMS02-H10	MGC	W01C020P19	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	IMS02-H10	MGC	W01C020P20	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC035033	IMS02-H11	MGC	W01C020P21	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC035033	IMS02-H11	MGC	W01C020P22	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL		0.950	0.969	634	1866	1	1863	634	1	634
IKAKEN	BC046145	IMS02-H12	MGC	W01C020P23	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC046145	IMS02-H12	MGC	W01C020P24	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	Cgs	0.943	0.994	369	1053	1	1050	369	1	369
IKAKEN	BC028364	IMS03-A01	MGC	W01C021A01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	IMS03-A01	MGC	W01C021A02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC063642	IMS03-A02	MGC	W01C021A03	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	IMS03-A02	MGC	W01C021A04	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC015744	IMS03-A03	MGC	W01C021A05	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC015744	IMS03-A03	MGC	W01C021A06	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC004236	IMS03-A04	MGC	W01C021A07	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC004236	IMS03-A04	MGC	W01C021A08	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC061631	IMS03-A05	MGC	W01C021A09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC061631	IMS03-A05	MGC	W01C021A10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC039169	IMS03-A06	MGC	W01C021A11	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC039169	IMS03-A06	MGC	W01C021A12	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC012355	IMS03-A07	MGC	W01C021A13	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC012355	IMS03-A07	MGC	W01C021A14	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC015353	IMS03-A08	MGC	W01C021A15	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC015353	IMS03-A08	MGC	W01C021A16	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC036263	IMS03-A09	MGC	W01C021A17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	IMS03-A09	MGC	W01C021A18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC063703	IMS03-A10	MGC	W01C021A19	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	IMS03-A10	MGC	W01C021A20	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC015801	IMS03-A11	MGC	W01C021A21	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC015801	IMS03-A11	MGC	W01C021A22	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC036263	IMS03-A12	MGC	W01C021A23	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS03-A12	MGC	W01C021A24	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC028364	IMS03-A01	MGC	W01C021B01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	IMS03-A01	MGC	W01C021B02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC063642	IMS03-A02	MGC	W01C021B03	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	IMS03-A02	MGC	W01C021B04	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC015744	IMS03-A03	MGC	W01C021B05	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC015744	IMS03-A03	MGC	W01C021B06	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC004236	IMS03-A04	MGC	W01C021B07	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC004236	IMS03-A04	MGC	W01C021B08	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC061631	IMS03-A05	MGC	W01C021B09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC061631	IMS03-A05	MGC	W01C021B10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC039169	IMS03-A06	MGC	W01C021B11	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC039169	IMS03-A06	MGC	W01C021B12	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC012355	IMS03-A07	MGC	W01C021B13	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC012355	IMS03-A07	MGC	W01C021B14	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC015353	IMS03-A08	MGC	W01C021B15	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC015353	IMS03-A08	MGC	W01C021B16	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC036263	IMS03-A09	MGC	W01C021B17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	IMS03-A09	MGC	W01C021B18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC063703	IMS03-A10	MGC	W01C021B19	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	IMS03-A10	MGC	W01C021B20	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC015801	IMS03-A11	MGC	W01C021B21	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC015801	IMS03-A11	MGC	W01C021B22	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC036263	IMS03-A12	MGC	W01C021B23	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS03-A12	MGC	W01C021B24	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC064361	IMS03-B01	MGC	W01C021C01	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	IMS03-B01	MGC	W01C021C02	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	IMS03-B02	MGC	W01C021C03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B02	MGC	W01C021C04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C021C05	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C021C06	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC065269	IMS03-B04	MGC	W01C021C07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B04	MGC	W01C021C08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC066936	IMS03-B05	MGC	W01C021C09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC066936	IMS03-B05	MGC	W01C021C10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC019300	IMS03-B06	MGC	W01C021C11	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC019300	IMS03-B06	MGC	W01C021C12	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC001909	IMS03-B07	MGC	W01C021C13	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC001909	IMS03-B07	MGC	W01C021C14	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC000385	IMS03-B08	MGC	W01C021C15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	IMS03-B08	MGC	W01C021C16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC028280	IMS03-B09	MGC	W01C021C17	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC028280	IMS03-B09	MGC	W01C021C18	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC065269	IMS03-B10	MGC	W01C021C19	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B10	MGC	W01C021C20	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC040442	IMS03-B11	MGC	W01C021C21	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC040442	IMS03-B11	MGC	W01C021C22	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC014374	IMS03-B12	MGC	W01C021C23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	IMS03-B12	MGC	W01C021C24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC064361	IMS03-B01	MGC	W01C021D01	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	IMS03-B01	MGC	W01C021D02	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	IMS03-B02	MGC	W01C021D03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B02	MGC	W01C021D04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C021D05	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C021D06	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC065269	IMS03-B04	MGC	W01C021D07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B04	MGC	W01C021D08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC066936	IMS03-B05	MGC	W01C021D09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC066936	IMS03-B05	MGC	W01C021D10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC019300	IMS03-B06	MGC	W01C021D11	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC019300	IMS03-B06	MGC	W01C021D12	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC001909	IMS03-B07	MGC	W01C021D13	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC001909	IMS03-B07	MGC	W01C021D14	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC000385	IMS03-B08	MGC	W01C021D15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	IMS03-B08	MGC	W01C021D16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC028280	IMS03-B09	MGC	W01C021D17	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC028280	IMS03-B09	MGC	W01C021D18	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC065269	IMS03-B10	MGC	W01C021D19	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B10	MGC	W01C021D20	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC040442	IMS03-B11	MGC	W01C021D21	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC040442	IMS03-B11	MGC	W01C021D22	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC014374	IMS03-B12	MGC	W01C021D23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	IMS03-B12	MGC	W01C021D24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC002604	IMS03-C01	MGC	W01C021E01	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC002604	IMS03-C01	MGC	W01C021E02	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC066122	IMS03-C02	MGC	W01C021E03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-C02	MGC	W01C021E04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC009898	IMS03-C03	MGC	W01C021E05	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC009898	IMS03-C03	MGC	W01C021E06	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC021730	IMS03-C04	MGC	W01C021E07	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC021730	IMS03-C04	MGC	W01C021E08	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC030607	IMS03-C05	MGC	W01C021E09	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC030607	IMS03-C05	MGC	W01C021E10	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC066122	IMS03-C06	MGC	W01C021E11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	IMS03-C06	MGC	W01C021E12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC025927	IMS03-C07	MGC	W01C021E13	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC025927	IMS03-C07	MGC	W01C021E14	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC020082	IMS03-C08	MGC	W01C021E15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC020082	IMS03-C08	MGC	W01C021E16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC044925	IMS03-C09	MGC	W01C021E17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC044925	IMS03-C09	MGC	W01C021E18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC003079	IMS03-C10	MGC	W01C021E19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C10	MGC	W01C021E20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C021E21	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C021E22	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC055417	IMS03-C12	MGC	W01C021E23	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	IMS03-C12	MGC	W01C021E24	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC002604	IMS03-C01	MGC	W01C021F01	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC002604	IMS03-C01	MGC	W01C021F02	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC066122	IMS03-C02	MGC	W01C021F03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-C02	MGC	W01C021F04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC009898	IMS03-C03	MGC	W01C021F05	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC009898	IMS03-C03	MGC	W01C021F06	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC021730	IMS03-C04	MGC	W01C021F07	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC021730	IMS03-C04	MGC	W01C021F08	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC030607	IMS03-C05	MGC	W01C021F09	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC030607	IMS03-C05	MGC	W01C021F10	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC066122	IMS03-C06	MGC	W01C021F11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	IMS03-C06	MGC	W01C021F12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC025927	IMS03-C07	MGC	W01C021F13	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC025927	IMS03-C07	MGC	W01C021F14	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC020082	IMS03-C08	MGC	W01C021F15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC020082	IMS03-C08	MGC	W01C021F16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC044925	IMS03-C09	MGC	W01C021F17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC044925	IMS03-C09	MGC	W01C021F18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC003079	IMS03-C10	MGC	W01C021F19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C10	MGC	W01C021F20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C021F21	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C021F22	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC055417	IMS03-C12	MGC	W01C021F23	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	IMS03-C12	MGC	W01C021F24	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC000368	IMS03-D01	MGC	W01C021G01	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000368	IMS03-D01	MGC	W01C021G02	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000255	IMS03-D02	MGC	W01C021G03	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC000255	IMS03-D02	MGC	W01C021G04	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC035228	IMS03-D03	MGC	W01C021G05	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	IMS03-D03	MGC	W01C021G06	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC007512	IMS03-D04	MGC	W01C021G07	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	BC007512	IMS03-D04	MGC	W01C021G08	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	LFL00730	IMS03-D05	EST	W01C021G09	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	LFL00730	IMS03-D05	EST	W01C021G10	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	PRS06513	IMS03-D06	EST	W01C021G11	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	PRS06513	IMS03-D06	EST	W01C021G12	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	RCT02931	IMS03-D07	EST	W01C021G13	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	RCT02931	IMS03-D07	EST	W01C021G14	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	SLV06671	IMS03-D08	EST	W01C021G15	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	SLV06671	IMS03-D08	EST	W01C021G16	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C021G17	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C021G18	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C021G19	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C021G20	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C021G21	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C021G22	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C021G23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C021G24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	BC000368	IMS03-D01	MGC	W01C021H01	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000368	IMS03-D01	MGC	W01C021H02	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000255	IMS03-D02	MGC	W01C021H03	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC000255	IMS03-D02	MGC	W01C021H04	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC035228	IMS03-D03	MGC	W01C021H05	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	IMS03-D03	MGC	W01C021H06	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC007512	IMS03-D04	MGC	W01C021H07	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	BC007512	IMS03-D04	MGC	W01C021H08	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	LFL00730	IMS03-D05	EST	W01C021H09	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	LFL00730	IMS03-D05	EST	W01C021H10	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	PRS06513	IMS03-D06	EST	W01C021H11	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	PRS06513	IMS03-D06	EST	W01C021H12	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	RCT02931	IMS03-D07	EST	W01C021H13	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	RCT02931	IMS03-D07	EST	W01C021H14	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	SLV06671	IMS03-D08	EST	W01C021H15	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	SLV06671	IMS03-D08	EST	W01C021H16	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C021H17	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C021H18	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C021H19	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C021H20	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C021H21	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C021H22	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C021H23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C021H24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C021I01	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C021I02	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C021I03	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C021I04	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C021I05	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C021I06	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	CBR02834	IMS03-E04	EST	W01C021I07	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E04	EST	W01C021I08	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E05	EST	W01C021I09	pDONR221															
IKAKEN	CBR07976	IMS03-E05	EST	W01C021I10	pDONR221															
IKAKEN	HEP04787	IMS03-E06	EST	W01C021I11	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	HEP04787	IMS03-E06	EST	W01C021I12	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	PCD02629	IMS03-E07	EST	W01C021I13	pDONR221															
IKAKEN	PCD02629	IMS03-E07	EST	W01C021I14	pDONR221															
IKAKEN	TST00323	IMS03-E08	EST	W01C021I15	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	TST00323	IMS03-E08	EST	W01C021I16	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C021I17	pDONR221															
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C021I18	pDONR221															
IKAKEN	CBR02834	IMS03-E10	EST	W01C021I19	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E10	EST	W01C021I20	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C021I21	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C021I22	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E12	EST	W01C021I23	pDONR221															
IKAKEN	CBR07976	IMS03-E12	EST	W01C021I24	pDONR221															
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C021J01	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C021J02	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C021J03	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C021J04	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C021J05	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C021J06	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	CBR02834	IMS03-E04	EST	W01C021J07	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E04	EST	W01C021J08	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E05	EST	W01C021J09	pDONR221															
IKAKEN	CBR07976	IMS03-E05	EST	W01C021J10	pDONR221															
IKAKEN	HEP04787	IMS03-E06	EST	W01C021J11	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	HEP04787	IMS03-E06	EST	W01C021J12	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	PCD02629	IMS03-E07	EST	W01C021J13	pDONR221															
IKAKEN	PCD02629	IMS03-E07	EST	W01C021J14	pDONR221															
IKAKEN	TST00323	IMS03-E08	EST	W01C021J15	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	TST00323	IMS03-E08	EST	W01C021J16	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C021J17	pDONR221															
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C021J18	pDONR221															
IKAKEN	CBR02834	IMS03-E10	EST	W01C021J19	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E10	EST	W01C021J20	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C021J21	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C021J22	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E12	EST	W01C021J23	pDONR221															
IKAKEN	CBR07976	IMS03-E12	EST	W01C021J24	pDONR221															
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C021K01	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C021K02	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C021K03	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C021K04	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C021K05	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C021K06	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	LFL08188	IMS03-F04	EST	W01C021K07	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS03-F04	EST	W01C021K08	pDONR221			HS6ST1P	388605											
IKAKEN	AK057328	IMS03-F05	FLJ	W01C021K09	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS03-F05	FLJ	W01C021K10	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC042446	IMS03-F06	MGC	W01C021K11	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC042446	IMS03-F06	MGC	W01C021K12	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC009561	IMS03-F07	MGC	W01C021K13	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC009561	IMS03-F07	MGC	W01C021K14	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC015484	IMS03-F08	MGC	W01C021K15	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	IMS03-F08	MGC	W01C021K16	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042125	IMS03-F09	MGC	W01C021K17	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC042125	IMS03-F09	MGC	W01C021K18	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC022782	IMS03-F10	MGC	W01C021K19	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	IMS03-F10	MGC	W01C021K20	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC024591	IMS03-F11	MGC	W01C021K21	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	IMS03-F11	MGC	W01C021K22	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC018141	IMS03-F12	MGC	W01C021K23	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	BC018141	IMS03-F12	MGC	W01C021K24	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C021L01	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C021L02	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C021L03	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C021L04	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C021L05	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C021L06	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	LFL08188	IMS03-F04	EST	W01C021L07	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS03-F04	EST	W01C021L08	pDONR221			HS6ST1P	388605											
IKAKEN	AK057328	IMS03-F05	FLJ	W01C021L09	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS03-F05	FLJ	W01C021L10	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC042446	IMS03-F06	MGC	W01C021L11	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC042446	IMS03-F06	MGC	W01C021L12	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC009561	IMS03-F07	MGC	W01C021L13	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC009561	IMS03-F07	MGC	W01C021L14	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC015484	IMS03-F08	MGC	W01C021L15	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	IMS03-F08	MGC	W01C021L16	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042125	IMS03-F09	MGC	W01C021L17	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC042125	IMS03-F09	MGC	W01C021L18	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC022782	IMS03-F10	MGC	W01C021L19	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	IMS03-F10	MGC	W01C021L20	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC024591	IMS03-F11	MGC	W01C021L21	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	IMS03-F11	MGC	W01C021L22	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC018141	IMS03-F12	MGC	W01C021L23	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	BC018141	IMS03-F12	MGC	W01C021L24	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	BC013136	IMS03-G01	MGC	W01C021M01	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	IMS03-G01	MGC	W01C021M02	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	IMS03-G02	MGC	W01C021M03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS03-G02	MGC	W01C021M04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC037301	IMS03-G03	MGC	W01C021M05	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037301	IMS03-G03	MGC	W01C021M06	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037292	IMS03-G04	MGC	W01C021M07	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC037292	IMS03-G04	MGC	W01C021M08	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC038507	IMS03-G05	MGC	W01C021M09	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038507	IMS03-G05	MGC	W01C021M10	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038100	IMS03-G06	MGC	W01C021M11	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC038100	IMS03-G06	MGC	W01C021M12	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC031567	IMS03-G07	MGC	W01C021M13	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS03-G07	MGC	W01C021M14	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS03-G08	MGC	W01C021M15	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS03-G08	MGC	W01C021M16	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS03-G09	MGC	W01C021M17	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS03-G09	MGC	W01C021M18	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC029780	IMS03-G10	MGC	W01C021M19	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC029780	IMS03-G10	MGC	W01C021M20	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034752	IMS03-G11	MGC	W01C021M21	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS03-G11	MGC	W01C021M22	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC042680	IMS03-G12	MGC	W01C021M23	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	IMS03-G12	MGC	W01C021M24	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC013136	IMS03-G01	MGC	W01C021N01	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	IMS03-G01	MGC	W01C021N02	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	IMS03-G02	MGC	W01C021N03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS03-G02	MGC	W01C021N04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC037301	IMS03-G03	MGC	W01C021N05	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037301	IMS03-G03	MGC	W01C021N06	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037292	IMS03-G04	MGC	W01C021N07	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC037292	IMS03-G04	MGC	W01C021N08	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC038507	IMS03-G05	MGC	W01C021N09	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038507	IMS03-G05	MGC	W01C021N10	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038100	IMS03-G06	MGC	W01C021N11	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC038100	IMS03-G06	MGC	W01C021N12	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC031567	IMS03-G07	MGC	W01C021N13	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS03-G07	MGC	W01C021N14	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS03-G08	MGC	W01C021N15	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS03-G08	MGC	W01C021N16	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS03-G09	MGC	W01C021N17	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS03-G09	MGC	W01C021N18	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC029780	IMS03-G10	MGC	W01C021N19	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC029780	IMS03-G10	MGC	W01C021N20	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034752	IMS03-G11	MGC	W01C021N21	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS03-G11	MGC	W01C021N22	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC042680	IMS03-G12	MGC	W01C021N23	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	IMS03-G12	MGC	W01C021N24	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC037218	IMS03-H01	MGC	W01C021O01	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC037218	IMS03-H01	MGC	W01C021O02	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC031399	IMS03-H02	MGC	W01C021O03	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	IMS03-H02	MGC	W01C021O04	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC038410	IMS03-H03	MGC	W01C021O05	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC038410	IMS03-H03	MGC	W01C021O06	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC031617	IMS03-H04	MGC	W01C021O07	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS03-H04	MGC	W01C021O08	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC042877	IMS03-H05	MGC	W01C021O09	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC042877	IMS03-H05	MGC	W01C021O10	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC033489	IMS03-H06	MGC	W01C021O11	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	IMS03-H06	MGC	W01C021O12	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC036354	IMS03-H07	MGC	W01C021O13	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC036354	IMS03-H07	MGC	W01C021O14	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC034775	IMS03-H08	MGC	W01C021O15	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC034775	IMS03-H08	MGC	W01C021O16	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC031624	IMS03-H09	MGC	W01C021O17	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS03-H09	MGC	W01C021O18	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS03-H10	MGC	W01C021O19	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS03-H10	MGC	W01C021O20	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC042872	IMS03-H11	MGC	W01C021O21	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC042872	IMS03-H11	MGC	W01C021O22	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC034281	IMS03-H12	MGC	W01C021O23	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC034281	IMS03-H12	MGC	W01C021O24	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC037218	IMS03-H01	MGC	W01C021P01	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC037218	IMS03-H01	MGC	W01C021P02	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC031399	IMS03-H02	MGC	W01C021P03	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	IMS03-H02	MGC	W01C021P04	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC038410	IMS03-H03	MGC	W01C021P05	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC038410	IMS03-H03	MGC	W01C021P06	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC031617	IMS03-H04	MGC	W01C021P07	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS03-H04	MGC	W01C021P08	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC042877	IMS03-H05	MGC	W01C021P09	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC042877	IMS03-H05	MGC	W01C021P10	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC033489	IMS03-H06	MGC	W01C021P11	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	IMS03-H06	MGC	W01C021P12	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC036354	IMS03-H07	MGC	W01C021P13	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC036354	IMS03-H07	MGC	W01C021P14	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC034775	IMS03-H08	MGC	W01C021P15	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC034775	IMS03-H08	MGC	W01C021P16	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC031624	IMS03-H09	MGC	W01C021P17	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS03-H09	MGC	W01C021P18	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS03-H10	MGC	W01C021P19	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS03-H10	MGC	W01C021P20	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC042872	IMS03-H11	MGC	W01C021P21	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC042872	IMS03-H11	MGC	W01C021P22	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC034281	IMS03-H12	MGC	W01C021P23	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC034281	IMS03-H12	MGC	W01C021P24	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC028364	IMS03-A01	MGC	W01C022A01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	IMS03-A01	MGC	W01C022A02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC063642	IMS03-A02	MGC	W01C022A03	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	IMS03-A02	MGC	W01C022A04	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC015744	IMS03-A03	MGC	W01C022A05	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC015744	IMS03-A03	MGC	W01C022A06	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC004236	IMS03-A04	MGC	W01C022A07	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC004236	IMS03-A04	MGC	W01C022A08	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC061631	IMS03-A05	MGC	W01C022A09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC061631	IMS03-A05	MGC	W01C022A10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC039169	IMS03-A06	MGC	W01C022A11	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC039169	IMS03-A06	MGC	W01C022A12	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC012355	IMS03-A07	MGC	W01C022A13	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC012355	IMS03-A07	MGC	W01C022A14	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC015353	IMS03-A08	MGC	W01C022A15	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC015353	IMS03-A08	MGC	W01C022A16	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC036263	IMS03-A09	MGC	W01C022A17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	IMS03-A09	MGC	W01C022A18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC063703	IMS03-A10	MGC	W01C022A19	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	IMS03-A10	MGC	W01C022A20	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC015801	IMS03-A11	MGC	W01C022A21	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC015801	IMS03-A11	MGC	W01C022A22	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC036263	IMS03-A12	MGC	W01C022A23	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS03-A12	MGC	W01C022A24	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC028364	IMS03-A01	MGC	W01C022B01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	IMS03-A01	MGC	W01C022B02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC063642	IMS03-A02	MGC	W01C022B03	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	IMS03-A02	MGC	W01C022B04	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC015744	IMS03-A03	MGC	W01C022B05	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC015744	IMS03-A03	MGC	W01C022B06	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Pfs	0.819	0.819	105	318	3	316	143	6	110
IKAKEN	BC004236	IMS03-A04	MGC	W01C022B07	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC004236	IMS03-A04	MGC	W01C022B08	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	28	87	1	84	222	195	222
IKAKEN	BC061631	IMS03-A05	MGC	W01C022B09	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC061631	IMS03-A05	MGC	W01C022B10	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.886	0.890	465	1401	3	1395	1686	1222	1685
IKAKEN	BC039169	IMS03-A06	MGC	W01C022B11	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC039169	IMS03-A06	MGC	W01C022B12	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED		0.844	0.891	473	1347	1	1344	473	1	473
IKAKEN	BC012355	IMS03-A07	MGC	W01C022B13	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC012355	IMS03-A07	MGC	W01C022B14	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001142806.1	NP_001136278.1	REVIEWED		0.939	0.944	378	1284	4	1131	520	143	520
IKAKEN	BC015353	IMS03-A08	MGC	W01C022B15	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC015353	IMS03-A08	MGC	W01C022B16	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL		0.971	0.973	446	1338	1	1335	446	1	446
IKAKEN	BC036263	IMS03-A09	MGC	W01C022B17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	IMS03-A09	MGC	W01C022B18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC063703	IMS03-A10	MGC	W01C022B19	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	IMS03-A10	MGC	W01C022B20	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC015801	IMS03-A11	MGC	W01C022B21	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC015801	IMS03-A11	MGC	W01C022B22	pDONR221	17201		PROS1	5627	AAH15801.1	Hs.64016	Protein S (alpha)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000313.3	NP_000304.2	REVIEWED		0.955	0.955	66	201	1	198	676	611	676
IKAKEN	BC036263	IMS03-A12	MGC	W01C022B23	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	IMS03-A12	MGC	W01C022B24	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC064361	IMS03-B01	MGC	W01C022C01	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	IMS03-B01	MGC	W01C022C02	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	IMS03-B02	MGC	W01C022C03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B02	MGC	W01C022C04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C022C05	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C022C06	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC065269	IMS03-B04	MGC	W01C022C07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B04	MGC	W01C022C08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC066936	IMS03-B05	MGC	W01C022C09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC066936	IMS03-B05	MGC	W01C022C10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC019300	IMS03-B06	MGC	W01C022C11	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC019300	IMS03-B06	MGC	W01C022C12	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC001909	IMS03-B07	MGC	W01C022C13	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC001909	IMS03-B07	MGC	W01C022C14	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC000385	IMS03-B08	MGC	W01C022C15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	IMS03-B08	MGC	W01C022C16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC028280	IMS03-B09	MGC	W01C022C17	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC028280	IMS03-B09	MGC	W01C022C18	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC065269	IMS03-B10	MGC	W01C022C19	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B10	MGC	W01C022C20	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC040442	IMS03-B11	MGC	W01C022C21	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC040442	IMS03-B11	MGC	W01C022C22	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC014374	IMS03-B12	MGC	W01C022C23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	IMS03-B12	MGC	W01C022C24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC064361	IMS03-B01	MGC	W01C022D01	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	IMS03-B01	MGC	W01C022D02	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	IMS03-B02	MGC	W01C022D03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B02	MGC	W01C022D04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C022D05	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC066122	IMS03-B03	MGC	W01C022D06	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.919	0.919	197	594	1	591	1227	1031	1227
IKAKEN	BC065269	IMS03-B04	MGC	W01C022D07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B04	MGC	W01C022D08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.894	0.903	198	591	1	588	579	382	579
IKAKEN	BC066936	IMS03-B05	MGC	W01C022D09	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC066936	IMS03-B05	MGC	W01C022D10	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001142682.1	NP_001136154.1	VALIDATED		0.953	0.960	278	831	1	828	442	165	442
IKAKEN	BC019300	IMS03-B06	MGC	W01C022D11	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC019300	IMS03-B06	MGC	W01C022D12	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001078172.1	NP_001071640.1	VALIDATED	P	1.000	1.000	7	630	2	22	113	107	113
IKAKEN	BC001909	IMS03-B07	MGC	W01C022D13	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC001909	IMS03-B07	MGC	W01C022D14	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED		0.858	0.866	226	681	1	672	248	1	226
IKAKEN	BC000385	IMS03-B08	MGC	W01C022D15	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	IMS03-B08	MGC	W01C022D16	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC028280	IMS03-B09	MGC	W01C022D17	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC028280	IMS03-B09	MGC	W01C022D18	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED		0.850	0.895	60	177	1	171	61	1	60
IKAKEN	BC065269	IMS03-B10	MGC	W01C022D19	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC065269	IMS03-B10	MGC	W01C022D20	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED		0.909	0.918	198	591	1	588	579	382	579
IKAKEN	BC040442	IMS03-B11	MGC	W01C022D21	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC040442	IMS03-B11	MGC	W01C022D22	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED		0.852	0.869	304	897	1	894	304	1	304
IKAKEN	BC014374	IMS03-B12	MGC	W01C022D23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	IMS03-B12	MGC	W01C022D24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC002604	IMS03-C01	MGC	W01C022E01	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC002604	IMS03-C01	MGC	W01C022E02	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC066122	IMS03-C02	MGC	W01C022E03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-C02	MGC	W01C022E04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC009898	IMS03-C03	MGC	W01C022E05	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC009898	IMS03-C03	MGC	W01C022E06	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC021730	IMS03-C04	MGC	W01C022E07	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC021730	IMS03-C04	MGC	W01C022E08	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC030607	IMS03-C05	MGC	W01C022E09	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC030607	IMS03-C05	MGC	W01C022E10	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC066122	IMS03-C06	MGC	W01C022E11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	IMS03-C06	MGC	W01C022E12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC025927	IMS03-C07	MGC	W01C022E13	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC025927	IMS03-C07	MGC	W01C022E14	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC020082	IMS03-C08	MGC	W01C022E15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC020082	IMS03-C08	MGC	W01C022E16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC044925	IMS03-C09	MGC	W01C022E17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC044925	IMS03-C09	MGC	W01C022E18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC003079	IMS03-C10	MGC	W01C022E19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C10	MGC	W01C022E20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C022E21	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C022E22	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC055417	IMS03-C12	MGC	W01C022E23	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	IMS03-C12	MGC	W01C022E24	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC002604	IMS03-C01	MGC	W01C022F01	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC002604	IMS03-C01	MGC	W01C022F02	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.902	0.902	112	345	7	342	115	4	115
IKAKEN	BC066122	IMS03-C02	MGC	W01C022F03	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	IMS03-C02	MGC	W01C022F04	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.921	0.921	189	570	1	567	1227	1039	1227
IKAKEN	BC009898	IMS03-C03	MGC	W01C022F05	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC009898	IMS03-C03	MGC	W01C022F06	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.958	0.958	144	435	1	432	366	1	144
IKAKEN	BC021730	IMS03-C04	MGC	W01C022F07	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC021730	IMS03-C04	MGC	W01C022F08	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED		0.973	0.973	148	447	1	444	194	47	194
IKAKEN	BC030607	IMS03-C05	MGC	W01C022F09	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC030607	IMS03-C05	MGC	W01C022F10	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	Pfs	0.836	0.836	201	618	1	606	803	68	268
IKAKEN	BC066122	IMS03-C06	MGC	W01C022F11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	IMS03-C06	MGC	W01C022F12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC025927	IMS03-C07	MGC	W01C022F13	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC025927	IMS03-C07	MGC	W01C022F14	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED		0.960	0.964	225	675	1	672	569	345	569
IKAKEN	BC020082	IMS03-C08	MGC	W01C022F15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC020082	IMS03-C08	MGC	W01C022F16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED		0.867	0.881	488	1452	1	1449	535	51	535
IKAKEN	BC044925	IMS03-C09	MGC	W01C022F17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC044925	IMS03-C09	MGC	W01C022F18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.904	0.906	311	936	4	933	718	343	653
IKAKEN	BC003079	IMS03-C10	MGC	W01C022F19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C10	MGC	W01C022F20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED	Cfs	0.848	0.865	151	447	1	444	151	1	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C022F21	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC003079	IMS03-C11	MGC	W01C022F22	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.964	0.964	140	423	1	420	151	12	151
IKAKEN	BC055417	IMS03-C12	MGC	W01C022F23	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	IMS03-C12	MGC	W01C022F24	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC000368	IMS03-D01	MGC	W01C022G01	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000368	IMS03-D01	MGC	W01C022G02	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000255	IMS03-D02	MGC	W01C022G03	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC000255	IMS03-D02	MGC	W01C022G04	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC035228	IMS03-D03	MGC	W01C022G05	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	IMS03-D03	MGC	W01C022G06	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC007512	IMS03-D04	MGC	W01C022G07	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	BC007512	IMS03-D04	MGC	W01C022G08	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	LFL00730	IMS03-D05	EST	W01C022G09	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	LFL00730	IMS03-D05	EST	W01C022G10	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	PRS06513	IMS03-D06	EST	W01C022G11	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	PRS06513	IMS03-D06	EST	W01C022G12	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	RCT02931	IMS03-D07	EST	W01C022G13	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	RCT02931	IMS03-D07	EST	W01C022G14	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	SLV06671	IMS03-D08	EST	W01C022G15	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	SLV06671	IMS03-D08	EST	W01C022G16	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C022G17	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C022G18	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C022G19	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C022G20	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C022G21	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C022G22	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C022G23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C022G24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	BC000368	IMS03-D01	MGC	W01C022H01	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000368	IMS03-D01	MGC	W01C022H02	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED	Pgs	0.996	0.998	471	1416	1	1413	483	14	483
IKAKEN	BC000255	IMS03-D02	MGC	W01C022H03	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC000255	IMS03-D02	MGC	W01C022H04	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.921	0.921	151	456	1	453	189	39	189
IKAKEN	BC035228	IMS03-D03	MGC	W01C022H05	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	IMS03-D03	MGC	W01C022H06	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC007512	IMS03-D04	MGC	W01C022H07	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	BC007512	IMS03-D04	MGC	W01C022H08	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED	Pfs	0.869	0.869	84	255	1	252	176	93	176
IKAKEN	LFL00730	IMS03-D05	EST	W01C022H09	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	LFL00730	IMS03-D05	EST	W01C022H10	pDONR221			FAM180A	389558		Hs.55200	Family with sequence similarity 180, member A						NM_205855.2	NP_995327.1	PREDICTED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	PRS06513	IMS03-D06	EST	W01C022H11	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	PRS06513	IMS03-D06	EST	W01C022H12	pDONR221			KIAA0232	9778		Hs.79276	KIAA0232						NM_014743.2	NP_055558.2	VALIDATED		0.500	0.529	18	504	72	122	1395	1090	1107
IKAKEN	RCT02931	IMS03-D07	EST	W01C022H13	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	RCT02931	IMS03-D07	EST	W01C022H14	pDONR221			C20orf112	140688		Hs.516978	Chromosome 20 open reading frame 112						NM_080616.3	NP_542183.2	VALIDATED		0.471	0.471	17	336	325	275	436	91	107
IKAKEN	SLV06671	IMS03-D08	EST	W01C022H15	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	SLV06671	IMS03-D08	EST	W01C022H16	pDONR221			C4orf40	401137		Hs.518795	Chromosome 4 open reading frame 40						NM_214711.3	NP_999876.2	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C022H17	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC114E05	IMS03-D09	TOYOBO	W01C022H18	pDONR221			TNNI3	7137		Hs.709179	Troponin I type 3 (cardiac)						NM_000363.4	NP_000354.4	REVIEWED	P	1.000	1.000	202	630	22	627	210	9	210
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C022H19	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	FCC105D08	IMS03-D10	TOYOBO	W01C022H20	pDONR221			PRSS3	5646		Hs.654513	Protease, serine, 3						NM_002771.3	NP_002762.2	REVIEWED	Cs	0.996	0.996	247	744	1	741	247	1	247
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C022H21	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	IMS03-D11	EST(RND)	W01C022H22	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C022H23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	HCR01185	IMS03-D12	EST(RND)	W01C022H24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C022I01	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C022I02	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C022I03	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C022I04	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C022I05	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C022I06	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	CBR02834	IMS03-E04	EST	W01C022I07	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E04	EST	W01C022I08	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E05	EST	W01C022I09	pDONR221															
IKAKEN	CBR07976	IMS03-E05	EST	W01C022I10	pDONR221															
IKAKEN	HEP04787	IMS03-E06	EST	W01C022I11	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	HEP04787	IMS03-E06	EST	W01C022I12	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	PCD02629	IMS03-E07	EST	W01C022I13	pDONR221															
IKAKEN	PCD02629	IMS03-E07	EST	W01C022I14	pDONR221															
IKAKEN	TST00323	IMS03-E08	EST	W01C022I15	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	TST00323	IMS03-E08	EST	W01C022I16	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C022I17	pDONR221															
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C022I18	pDONR221															
IKAKEN	CBR02834	IMS03-E10	EST	W01C022I19	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E10	EST	W01C022I20	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C022I21	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C022I22	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E12	EST	W01C022I23	pDONR221															
IKAKEN	CBR07976	IMS03-E12	EST	W01C022I24	pDONR221															
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C022J01	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	HKR08933	IMS03-E01	EST(RND)	W01C022J02	pDONR221			ARL13B	200894		Hs.533086	ADP-ribosylation factor-like 13B						NM_182896.1	NP_878899.1	VALIDATED	Pfs	1.000	1.000	181	543	1	541	428	104	284
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C022J03	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	NRR03126	IMS03-E02	EST(RND)	W01C022J04	pDONR221			GLRA4	441509		Hs.533289	Glycine receptor, alpha 4						NM_001024452.2	NP_001019623.2	VALIDATED	P	1.000	1.000	312	1029	1	936	417	1	312
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C022J05	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	THR03892	IMS03-E03	EST(RND)	W01C022J06	pDONR221			NTM	50863		Hs.504352	Neurotrimin						NM_016522.2	NP_057606.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	CBR02834	IMS03-E04	EST	W01C022J07	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E04	EST	W01C022J08	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E05	EST	W01C022J09	pDONR221															
IKAKEN	CBR07976	IMS03-E05	EST	W01C022J10	pDONR221															
IKAKEN	HEP04787	IMS03-E06	EST	W01C022J11	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	HEP04787	IMS03-E06	EST	W01C022J12	pDONR221			UNC93A	54346		Hs.567508	Unc-93 homolog A (C. elegans)						NM_018974.3	NP_061847.2	VALIDATED	OK	1.000	1.000	457	1374	1	1371	457	1	457
IKAKEN	PCD02629	IMS03-E07	EST	W01C022J13	pDONR221															
IKAKEN	PCD02629	IMS03-E07	EST	W01C022J14	pDONR221															
IKAKEN	TST00323	IMS03-E08	EST	W01C022J15	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	TST00323	IMS03-E08	EST	W01C022J16	pDONR221			C12orf42	374470		Hs.534649	Chromosome 12 open reading frame 42						NM_001099336.1	NP_001092806.1	VALIDATED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C022J17	pDONR221															
IKAKEN	ADR02862	IMS03-E09	EST(RND)	W01C022J18	pDONR221															
IKAKEN	CBR02834	IMS03-E10	EST	W01C022J19	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E10	EST	W01C022J20	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C022J21	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR02834	IMS03-E11	EST	W01C022J22	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	P	1.000	1.000	465	1407	1	1395	1756	357	821
IKAKEN	CBR07976	IMS03-E12	EST	W01C022J23	pDONR221															
IKAKEN	CBR07976	IMS03-E12	EST	W01C022J24	pDONR221															
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C022K01	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C022K02	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C022K03	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C022K04	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C022K05	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C022K06	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	LFL08188	IMS03-F04	EST	W01C022K07	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS03-F04	EST	W01C022K08	pDONR221			HS6ST1P	388605											
IKAKEN	AK057328	IMS03-F05	FLJ	W01C022K09	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS03-F05	FLJ	W01C022K10	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC042446	IMS03-F06	MGC	W01C022K11	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC042446	IMS03-F06	MGC	W01C022K12	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC009561	IMS03-F07	MGC	W01C022K13	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC009561	IMS03-F07	MGC	W01C022K14	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC015484	IMS03-F08	MGC	W01C022K15	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	IMS03-F08	MGC	W01C022K16	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042125	IMS03-F09	MGC	W01C022K17	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC042125	IMS03-F09	MGC	W01C022K18	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC022782	IMS03-F10	MGC	W01C022K19	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	IMS03-F10	MGC	W01C022K20	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC024591	IMS03-F11	MGC	W01C022K21	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	IMS03-F11	MGC	W01C022K22	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC018141	IMS03-F12	MGC	W01C022K23	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	BC018141	IMS03-F12	MGC	W01C022K24	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C022L01	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	CNR04534	IMS03-F01	EST(RND)	W01C022L02	pDONR221			SIGLEC16	400709		Hs.568076	Sialic acid binding Ig-like lectin 16 (gene/pseudogene)								
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C022L03	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	FMR03051	IMS03-F02	EST(RND)	W01C022L04	pDONR221			C19orf28	126321		Hs.656901	Chromosome 19 open reading frame 28						NM_021731.2	NP_068377.2	VALIDATED	Pfs	0.333	0.350	63	432	299	113	538	49	109
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C022L05	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	OFR06614	IMS03-F03	EST(RND)	W01C022L06	pDONR221			MUCL1	118430		Hs.348419	Mucin-like 1						NM_058173.2	NP_477521.1	VALIDATED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	LFL08188	IMS03-F04	EST	W01C022L07	pDONR221			HS6ST1P	388605											
IKAKEN	LFL08188	IMS03-F04	EST	W01C022L08	pDONR221			HS6ST1P	388605											
IKAKEN	AK057328	IMS03-F05	FLJ	W01C022L09	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS03-F05	FLJ	W01C022L10	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC042446	IMS03-F06	MGC	W01C022L11	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC042446	IMS03-F06	MGC	W01C022L12	pDONR221	5327		KCNMB4	27345	AAH42446.2	Hs.525529	Potassium large conductance calcium-activated channel, subfamily M, beta member 4			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014505.4	NP_055320.4	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC009561	IMS03-F07	MGC	W01C022L13	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC009561	IMS03-F07	MGC	W01C022L14	pDONR221	3997		C11orf74	119710	AAH09561.1	Hs.159376	Chromosome 11 open reading frame 74			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138787.2	NP_620142.2	PREDICTED	Cg	0.665	1.000	221	444	1	441	221	1	221
IKAKEN	BC015484	IMS03-F08	MGC	W01C022L15	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	IMS03-F08	MGC	W01C022L16	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042125	IMS03-F09	MGC	W01C022L17	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC042125	IMS03-F09	MGC	W01C022L18	pDONR221	11977		C19orf21	126353	AAH42125.1	Hs.439180	Chromosome 19 open reading frame 21			Testis	NIH_MGC_97	DH10B	NM_173481.2	NP_775752.1	PREDICTED	OK	1.000	1.000	679	2040	1	2037	679	1	679
IKAKEN	BC022782	IMS03-F10	MGC	W01C022L19	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	IMS03-F10	MGC	W01C022L20	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC024591	IMS03-F11	MGC	W01C022L21	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	IMS03-F11	MGC	W01C022L22	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC018141	IMS03-F12	MGC	W01C022L23	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	BC018141	IMS03-F12	MGC	W01C022L24	pDONR221	17185		BCHE	590	AAH18141.1	Hs.420483	Butyrylcholinesterase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_000055.2	NP_000046.1	REVIEWED	OK	1.000	1.000	602	1809	1	1806	602	1	602
IKAKEN	BC013136	IMS03-G01	MGC	W01C022M01	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	IMS03-G01	MGC	W01C022M02	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	IMS03-G02	MGC	W01C022M03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS03-G02	MGC	W01C022M04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC037301	IMS03-G03	MGC	W01C022M05	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037301	IMS03-G03	MGC	W01C022M06	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037292	IMS03-G04	MGC	W01C022M07	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC037292	IMS03-G04	MGC	W01C022M08	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC038507	IMS03-G05	MGC	W01C022M09	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038507	IMS03-G05	MGC	W01C022M10	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038100	IMS03-G06	MGC	W01C022M11	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC038100	IMS03-G06	MGC	W01C022M12	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC031567	IMS03-G07	MGC	W01C022M13	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS03-G07	MGC	W01C022M14	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS03-G08	MGC	W01C022M15	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS03-G08	MGC	W01C022M16	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS03-G09	MGC	W01C022M17	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS03-G09	MGC	W01C022M18	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC029780	IMS03-G10	MGC	W01C022M19	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC029780	IMS03-G10	MGC	W01C022M20	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034752	IMS03-G11	MGC	W01C022M21	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS03-G11	MGC	W01C022M22	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC042680	IMS03-G12	MGC	W01C022M23	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	IMS03-G12	MGC	W01C022M24	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC013136	IMS03-G01	MGC	W01C022N01	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	IMS03-G01	MGC	W01C022N02	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	IMS03-G02	MGC	W01C022N03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS03-G02	MGC	W01C022N04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC037301	IMS03-G03	MGC	W01C022N05	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037301	IMS03-G03	MGC	W01C022N06	pDONR221	25347		BEND2	139105	AAH37301.1	Hs.403802	BEN domain containing 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_153346.4	NP_699177.2	VALIDATED	OK	1.000	1.000	799	2400	1	2397	799	1	799
IKAKEN	BC037292	IMS03-G04	MGC	W01C022N07	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC037292	IMS03-G04	MGC	W01C022N08	pDONR221	16348		FAM62C	83850	AAH37292.1	Hs.477711	Family with sequence similarity 62 (C2 domain containing), member C			Testis	NIH_MGC_97	DH10B	NM_031913.3	NP_114119.2	VALIDATED	Pfs	0.996	0.998	501	1506	1	1504	886	1	500
IKAKEN	BC038507	IMS03-G05	MGC	W01C022N09	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038507	IMS03-G05	MGC	W01C022N10	pDONR221	12907		GLS	2744	AAH38507.2	Hs.116448	Glutaminase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014905.3	NP_055720.3	VALIDATED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC038100	IMS03-G06	MGC	W01C022N11	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC038100	IMS03-G06	MGC	W01C022N12	pDONR221	11235		HDHD2	84064	AAH38100.1	Hs.465041	Haloacid dehalogenase-like hydrolase domain containing 2			Testis	NIH_MGC_97	DH10B	NM_032124.4	NP_115500.1	VALIDATED	OK	1.000	1.000	259	780	1	777	259	1	259
IKAKEN	BC031567	IMS03-G07	MGC	W01C022N13	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS03-G07	MGC	W01C022N14	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS03-G08	MGC	W01C022N15	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS03-G08	MGC	W01C022N16	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS03-G09	MGC	W01C022N17	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS03-G09	MGC	W01C022N18	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC029780	IMS03-G10	MGC	W01C022N19	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC029780	IMS03-G10	MGC	W01C022N20	pDONR221	24298		C9orf71	169693	AAH29780.1	Hs.663056	Chromosome 9 open reading frame 71			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_153237.1	NP_694969.1	PREDICTED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034752	IMS03-G11	MGC	W01C022N21	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS03-G11	MGC	W01C022N22	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC042680	IMS03-G12	MGC	W01C022N23	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	IMS03-G12	MGC	W01C022N24	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC037218	IMS03-H01	MGC	W01C022O01	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC037218	IMS03-H01	MGC	W01C022O02	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC031399	IMS03-H02	MGC	W01C022O03	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	IMS03-H02	MGC	W01C022O04	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC038410	IMS03-H03	MGC	W01C022O05	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC038410	IMS03-H03	MGC	W01C022O06	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC031617	IMS03-H04	MGC	W01C022O07	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS03-H04	MGC	W01C022O08	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC042877	IMS03-H05	MGC	W01C022O09	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC042877	IMS03-H05	MGC	W01C022O10	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC033489	IMS03-H06	MGC	W01C022O11	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	IMS03-H06	MGC	W01C022O12	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC036354	IMS03-H07	MGC	W01C022O13	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC036354	IMS03-H07	MGC	W01C022O14	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC034775	IMS03-H08	MGC	W01C022O15	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC034775	IMS03-H08	MGC	W01C022O16	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC031624	IMS03-H09	MGC	W01C022O17	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS03-H09	MGC	W01C022O18	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS03-H10	MGC	W01C022O19	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS03-H10	MGC	W01C022O20	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC042872	IMS03-H11	MGC	W01C022O21	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC042872	IMS03-H11	MGC	W01C022O22	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC034281	IMS03-H12	MGC	W01C022O23	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC034281	IMS03-H12	MGC	W01C022O24	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC037218	IMS03-H01	MGC	W01C022P01	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC037218	IMS03-H01	MGC	W01C022P02	pDONR221	11014		CABLES1	91768	AAH37218.1	Hs.11108	Cdk5 and Abl enzyme substrate 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_138375.2	NP_612384.1	VALIDATED	OK	1.000	1.000	368	1107	1	1104	368	1	368
IKAKEN	BC031399	IMS03-H02	MGC	W01C022P03	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	IMS03-H02	MGC	W01C022P04	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC038410	IMS03-H03	MGC	W01C022P05	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC038410	IMS03-H03	MGC	W01C022P06	pDONR221	819		C1orf105	92346	AAH38410.1	Hs.517991	Chromosome 1 open reading frame 105			Brain, hippocampus	NIH_MGC_124	DH10B	NM_139240.2	NP_640333.2	PREDICTED	Cs	0.995	0.995	183	552	1	549	183	1	183
IKAKEN	BC031617	IMS03-H04	MGC	W01C022P07	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS03-H04	MGC	W01C022P08	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC042877	IMS03-H05	MGC	W01C022P09	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC042877	IMS03-H05	MGC	W01C022P10	pDONR221	23178		C8orf84	157869	AAH42877.1	Hs.439040	Chromosome 8 open reading frame 84			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153225.3	NP_694957.3	VALIDATED	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC033489	IMS03-H06	MGC	W01C022P11	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	IMS03-H06	MGC	W01C022P12	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC036354	IMS03-H07	MGC	W01C022P13	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC036354	IMS03-H07	MGC	W01C022P14	pDONR221	12491		PCSK4	54760	AAH36354.1	Hs.46884	Proprotein convertase subtilisin/kexin type 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017573.3	NP_060043.2	VALIDATED	P	1.000	1.000	242	729	1	726	755	514	755
IKAKEN	BC034775	IMS03-H08	MGC	W01C022P15	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC034775	IMS03-H08	MGC	W01C022P16	pDONR221	20802		PRR18	285800	AAH34775.1	Hs.119062	Proline rich 18			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_175922.3	NP_787118.2	VALIDATED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC031624	IMS03-H09	MGC	W01C022P17	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS03-H09	MGC	W01C022P18	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS03-H10	MGC	W01C022P19	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS03-H10	MGC	W01C022P20	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC042872	IMS03-H11	MGC	W01C022P21	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC042872	IMS03-H11	MGC	W01C022P22	pDONR221	3359		TMEM26	219623	AAH42872.1	Hs.623955	Transmembrane protein 26			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_178505.6	NP_848600.2	VALIDATED	P	1.000	1.000	202	672	1	606	368	1	202
IKAKEN	BC034281	IMS03-H12	MGC	W01C022P23	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC034281	IMS03-H12	MGC	W01C022P24	pDONR221	24306		HSD17B3	3293	AAH34281.1	Hs.477	Hydroxysteroid (17-beta) dehydrogenase 3			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_000197.1	NP_000188.1	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC022543	MGC01-A01	MGC	W01C023A01	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022543	MGC01-A01	MGC	W01C023A02	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018052	MGC01-A02	MGC	W01C023A03	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC018052	MGC01-A02	MGC	W01C023A04	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC026356	MGC01-A03	MGC	W01C023A05	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	MGC01-A03	MGC	W01C023A06	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	MGC01-A04	MGC	W01C023A07	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	MGC01-A04	MGC	W01C023A08	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC018061	MGC01-A05	MGC	W01C023A09	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC018061	MGC01-A05	MGC	W01C023A10	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC022570	MGC01-A06	MGC	W01C023A11	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC022570	MGC01-A06	MGC	W01C023A12	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC026336	MGC01-A07	MGC	W01C023A13	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	MGC01-A07	MGC	W01C023A14	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC022475	MGC01-A08	MGC	W01C023A15	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022475	MGC01-A08	MGC	W01C023A16	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022542	MGC01-A09	MGC	W01C023A17	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022542	MGC01-A09	MGC	W01C023A18	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018038	MGC01-A10	MGC	W01C023A19	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018038	MGC01-A10	MGC	W01C023A20	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018054	MGC01-A11	MGC	W01C023A21	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC018054	MGC01-A11	MGC	W01C023A22	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC022470	MGC01-A12	MGC	W01C023A23	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC022470	MGC01-A12	MGC	W01C023A24	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC022543	MGC01-A01	MGC	W01C023B01	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022543	MGC01-A01	MGC	W01C023B02	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018052	MGC01-A02	MGC	W01C023B03	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC018052	MGC01-A02	MGC	W01C023B04	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC026356	MGC01-A03	MGC	W01C023B05	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	MGC01-A03	MGC	W01C023B06	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	MGC01-A04	MGC	W01C023B07	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	MGC01-A04	MGC	W01C023B08	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC018061	MGC01-A05	MGC	W01C023B09	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC018061	MGC01-A05	MGC	W01C023B10	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC022570	MGC01-A06	MGC	W01C023B11	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC022570	MGC01-A06	MGC	W01C023B12	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC026336	MGC01-A07	MGC	W01C023B13	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	MGC01-A07	MGC	W01C023B14	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC022475	MGC01-A08	MGC	W01C023B15	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022475	MGC01-A08	MGC	W01C023B16	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022542	MGC01-A09	MGC	W01C023B17	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022542	MGC01-A09	MGC	W01C023B18	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018038	MGC01-A10	MGC	W01C023B19	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018038	MGC01-A10	MGC	W01C023B20	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018054	MGC01-A11	MGC	W01C023B21	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC018054	MGC01-A11	MGC	W01C023B22	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC022470	MGC01-A12	MGC	W01C023B23	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC022470	MGC01-A12	MGC	W01C023B24	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC030835	MGC01-B01	MGC	W01C023C01	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030835	MGC01-B01	MGC	W01C023C02	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030825	MGC01-B02	MGC	W01C023C03	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC030825	MGC01-B02	MGC	W01C023C04	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC039204	MGC01-B03	MGC	W01C023C05	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	MGC01-B03	MGC	W01C023C06	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC022497	MGC01-B04	MGC	W01C023C07	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022497	MGC01-B04	MGC	W01C023C08	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022482	MGC01-B05	MGC	W01C023C09	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022482	MGC01-B05	MGC	W01C023C10	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022489	MGC01-B06	MGC	W01C023C11	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC022489	MGC01-B06	MGC	W01C023C12	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC034046	MGC01-B07	MGC	W01C023C13	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC034046	MGC01-B07	MGC	W01C023C14	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC066939	MGC01-B08	MGC	W01C023C15	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066939	MGC01-B08	MGC	W01C023C16	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066936	MGC01-B09	MGC	W01C023C17	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	MGC01-B09	MGC	W01C023C18	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC030826	MGC01-B10	MGC	W01C023C19	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC030826	MGC01-B10	MGC	W01C023C20	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC066960	MGC01-B11	MGC	W01C023C21	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC066960	MGC01-B11	MGC	W01C023C22	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC034965	MGC01-B12	MGC	W01C023C23	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC034965	MGC01-B12	MGC	W01C023C24	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC030835	MGC01-B01	MGC	W01C023D01	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030835	MGC01-B01	MGC	W01C023D02	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030825	MGC01-B02	MGC	W01C023D03	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC030825	MGC01-B02	MGC	W01C023D04	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC039204	MGC01-B03	MGC	W01C023D05	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	MGC01-B03	MGC	W01C023D06	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC022497	MGC01-B04	MGC	W01C023D07	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022497	MGC01-B04	MGC	W01C023D08	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022482	MGC01-B05	MGC	W01C023D09	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022482	MGC01-B05	MGC	W01C023D10	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022489	MGC01-B06	MGC	W01C023D11	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC022489	MGC01-B06	MGC	W01C023D12	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC034046	MGC01-B07	MGC	W01C023D13	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC034046	MGC01-B07	MGC	W01C023D14	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC066939	MGC01-B08	MGC	W01C023D15	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066939	MGC01-B08	MGC	W01C023D16	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066936	MGC01-B09	MGC	W01C023D17	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	MGC01-B09	MGC	W01C023D18	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC030826	MGC01-B10	MGC	W01C023D19	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC030826	MGC01-B10	MGC	W01C023D20	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC066960	MGC01-B11	MGC	W01C023D21	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC066960	MGC01-B11	MGC	W01C023D22	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC034965	MGC01-B12	MGC	W01C023D23	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC034965	MGC01-B12	MGC	W01C023D24	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC022011	MGC01-C01	MGC	W01C023E01	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC022011	MGC01-C01	MGC	W01C023E02	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC037272	MGC01-C02	MGC	W01C023E03	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC037272	MGC01-C02	MGC	W01C023E04	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC033001	MGC01-C03	MGC	W01C023E05	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC033001	MGC01-C03	MGC	W01C023E06	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC034488	MGC01-C04	MGC	W01C023E07	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC034488	MGC01-C04	MGC	W01C023E08	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC028574	MGC01-C05	MGC	W01C023E09	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC028574	MGC01-C05	MGC	W01C023E10	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC032835	MGC01-C06	MGC	W01C023E11	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032835	MGC01-C06	MGC	W01C023E12	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032841	MGC01-C07	MGC	W01C023E13	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC032841	MGC01-C07	MGC	W01C023E14	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC024181	MGC01-C08	MGC	W01C023E15	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC024181	MGC01-C08	MGC	W01C023E16	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC025997	MGC01-C09	MGC	W01C023E17	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC025997	MGC01-C09	MGC	W01C023E18	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC034947	MGC01-C10	MGC	W01C023E19	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC034947	MGC01-C10	MGC	W01C023E20	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC066975	MGC01-C11	MGC	W01C023E21	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC066975	MGC01-C11	MGC	W01C023E22	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC034959	MGC01-C12	MGC	W01C023E23	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC034959	MGC01-C12	MGC	W01C023E24	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC022011	MGC01-C01	MGC	W01C023F01	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC022011	MGC01-C01	MGC	W01C023F02	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC037272	MGC01-C02	MGC	W01C023F03	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC037272	MGC01-C02	MGC	W01C023F04	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC033001	MGC01-C03	MGC	W01C023F05	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC033001	MGC01-C03	MGC	W01C023F06	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC034488	MGC01-C04	MGC	W01C023F07	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC034488	MGC01-C04	MGC	W01C023F08	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC028574	MGC01-C05	MGC	W01C023F09	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC028574	MGC01-C05	MGC	W01C023F10	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC032835	MGC01-C06	MGC	W01C023F11	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032835	MGC01-C06	MGC	W01C023F12	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032841	MGC01-C07	MGC	W01C023F13	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC032841	MGC01-C07	MGC	W01C023F14	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC024181	MGC01-C08	MGC	W01C023F15	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC024181	MGC01-C08	MGC	W01C023F16	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC025997	MGC01-C09	MGC	W01C023F17	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC025997	MGC01-C09	MGC	W01C023F18	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC034947	MGC01-C10	MGC	W01C023F19	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC034947	MGC01-C10	MGC	W01C023F20	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC066975	MGC01-C11	MGC	W01C023F21	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC066975	MGC01-C11	MGC	W01C023F22	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC034959	MGC01-C12	MGC	W01C023F23	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC034959	MGC01-C12	MGC	W01C023F24	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014609	MGC01-D01	MGC	W01C023G01	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC014609	MGC01-D01	MGC	W01C023G02	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC030010	MGC01-D02	MGC	W01C023G03	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC030010	MGC01-D02	MGC	W01C023G04	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC014603	MGC01-D03	MGC	W01C023G05	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC014603	MGC01-D03	MGC	W01C023G06	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC034503	MGC01-D04	MGC	W01C023G07	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC034503	MGC01-D04	MGC	W01C023G08	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC030783	MGC01-D05	MGC	W01C023G09	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC030783	MGC01-D05	MGC	W01C023G10	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC066986	MGC01-D06	MGC	W01C023G11	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC066986	MGC01-D06	MGC	W01C023G12	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC030703	MGC01-D07	MGC	W01C023G13	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC030703	MGC01-D07	MGC	W01C023G14	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC014596	MGC01-D08	MGC	W01C023G15	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC014596	MGC01-D08	MGC	W01C023G16	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC025381	MGC01-D09	MGC	W01C023G17	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC025381	MGC01-D09	MGC	W01C023G18	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC022012	MGC01-D10	MGC	W01C023G19	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC022012	MGC01-D10	MGC	W01C023G20	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC021707	MGC01-D11	MGC	W01C023G21	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC021707	MGC01-D11	MGC	W01C023G22	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC030687	MGC01-D12	MGC	W01C023G23	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC030687	MGC01-D12	MGC	W01C023G24	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC014609	MGC01-D01	MGC	W01C023H01	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC014609	MGC01-D01	MGC	W01C023H02	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC030010	MGC01-D02	MGC	W01C023H03	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC030010	MGC01-D02	MGC	W01C023H04	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC014603	MGC01-D03	MGC	W01C023H05	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC014603	MGC01-D03	MGC	W01C023H06	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC034503	MGC01-D04	MGC	W01C023H07	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC034503	MGC01-D04	MGC	W01C023H08	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC030783	MGC01-D05	MGC	W01C023H09	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC030783	MGC01-D05	MGC	W01C023H10	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC066986	MGC01-D06	MGC	W01C023H11	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC066986	MGC01-D06	MGC	W01C023H12	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC030703	MGC01-D07	MGC	W01C023H13	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC030703	MGC01-D07	MGC	W01C023H14	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC014596	MGC01-D08	MGC	W01C023H15	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC014596	MGC01-D08	MGC	W01C023H16	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC025381	MGC01-D09	MGC	W01C023H17	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC025381	MGC01-D09	MGC	W01C023H18	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC022012	MGC01-D10	MGC	W01C023H19	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC022012	MGC01-D10	MGC	W01C023H20	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC021707	MGC01-D11	MGC	W01C023H21	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC021707	MGC01-D11	MGC	W01C023H22	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC030687	MGC01-D12	MGC	W01C023H23	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC030687	MGC01-D12	MGC	W01C023H24	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC030607	MGC01-E01	MGC	W01C023I01	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC030607	MGC01-E01	MGC	W01C023I02	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC017592	MGC01-E02	MGC	W01C023I03	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC017592	MGC01-E02	MGC	W01C023I04	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC026078	MGC01-E03	MGC	W01C023I05	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC026078	MGC01-E03	MGC	W01C023I06	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC017586	MGC01-E04	MGC	W01C023I07	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC017586	MGC01-E04	MGC	W01C023I08	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC032999	MGC01-E05	MGC	W01C023I09	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC032999	MGC01-E05	MGC	W01C023I10	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC028588	MGC01-E06	MGC	W01C023I11	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC028588	MGC01-E06	MGC	W01C023I12	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC066304	MGC01-E07	MGC	W01C023I13	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC066304	MGC01-E07	MGC	W01C023I14	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC028711	MGC01-E08	MGC	W01C023I15	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	MGC01-E08	MGC	W01C023I16	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028583	MGC01-E09	MGC	W01C023I17	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC028583	MGC01-E09	MGC	W01C023I18	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC026077	MGC01-E10	MGC	W01C023I19	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC026077	MGC01-E10	MGC	W01C023I20	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC028361	MGC01-E11	MGC	W01C023I21	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC028361	MGC01-E11	MGC	W01C023I22	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC030012	MGC01-E12	MGC	W01C023I23	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030012	MGC01-E12	MGC	W01C023I24	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030607	MGC01-E01	MGC	W01C023J01	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC030607	MGC01-E01	MGC	W01C023J02	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC017592	MGC01-E02	MGC	W01C023J03	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC017592	MGC01-E02	MGC	W01C023J04	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC026078	MGC01-E03	MGC	W01C023J05	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC026078	MGC01-E03	MGC	W01C023J06	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC017586	MGC01-E04	MGC	W01C023J07	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC017586	MGC01-E04	MGC	W01C023J08	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC032999	MGC01-E05	MGC	W01C023J09	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC032999	MGC01-E05	MGC	W01C023J10	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC028588	MGC01-E06	MGC	W01C023J11	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC028588	MGC01-E06	MGC	W01C023J12	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC066304	MGC01-E07	MGC	W01C023J13	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC066304	MGC01-E07	MGC	W01C023J14	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC028711	MGC01-E08	MGC	W01C023J15	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	MGC01-E08	MGC	W01C023J16	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028583	MGC01-E09	MGC	W01C023J17	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC028583	MGC01-E09	MGC	W01C023J18	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC026077	MGC01-E10	MGC	W01C023J19	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC026077	MGC01-E10	MGC	W01C023J20	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC028361	MGC01-E11	MGC	W01C023J21	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC028361	MGC01-E11	MGC	W01C023J22	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC030012	MGC01-E12	MGC	W01C023J23	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030012	MGC01-E12	MGC	W01C023J24	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030590	MGC01-F01	MGC	W01C023K01	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC030590	MGC01-F01	MGC	W01C023K02	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC066340	MGC01-F02	MGC	W01C023K03	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC066340	MGC01-F02	MGC	W01C023K04	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC028704	MGC01-F03	MGC	W01C023K05	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028704	MGC01-F03	MGC	W01C023K06	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC027588	MGC01-F04	MGC	W01C023K07	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC027588	MGC01-F04	MGC	W01C023K08	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC063857	MGC01-F05	MGC	W01C023K09	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC063857	MGC01-F05	MGC	W01C023K10	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC028365	MGC01-F06	MGC	W01C023K11	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028365	MGC01-F06	MGC	W01C023K12	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028581	MGC01-F07	MGC	W01C023K13	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC028581	MGC01-F07	MGC	W01C023K14	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC034982	MGC01-F08	MGC	W01C023K15	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	MGC01-F08	MGC	W01C023K16	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028375	MGC01-F09	MGC	W01C023K17	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028375	MGC01-F09	MGC	W01C023K18	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028714	MGC01-F10	MGC	W01C023K19	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	MGC01-F10	MGC	W01C023K20	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC022188	MGC01-F11	MGC	W01C023K21	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC022188	MGC01-F11	MGC	W01C023K22	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC061588	MGC01-F12	MGC	W01C023K23	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC061588	MGC01-F12	MGC	W01C023K24	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC030590	MGC01-F01	MGC	W01C023L01	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC030590	MGC01-F01	MGC	W01C023L02	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC066340	MGC01-F02	MGC	W01C023L03	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC066340	MGC01-F02	MGC	W01C023L04	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC028704	MGC01-F03	MGC	W01C023L05	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028704	MGC01-F03	MGC	W01C023L06	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC027588	MGC01-F04	MGC	W01C023L07	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC027588	MGC01-F04	MGC	W01C023L08	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC063857	MGC01-F05	MGC	W01C023L09	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC063857	MGC01-F05	MGC	W01C023L10	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC028365	MGC01-F06	MGC	W01C023L11	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028365	MGC01-F06	MGC	W01C023L12	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028581	MGC01-F07	MGC	W01C023L13	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC028581	MGC01-F07	MGC	W01C023L14	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC034982	MGC01-F08	MGC	W01C023L15	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	MGC01-F08	MGC	W01C023L16	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028375	MGC01-F09	MGC	W01C023L17	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028375	MGC01-F09	MGC	W01C023L18	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028714	MGC01-F10	MGC	W01C023L19	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	MGC01-F10	MGC	W01C023L20	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC022188	MGC01-F11	MGC	W01C023L21	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC022188	MGC01-F11	MGC	W01C023L22	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC061588	MGC01-F12	MGC	W01C023L23	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC061588	MGC01-F12	MGC	W01C023L24	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC061592	MGC01-G01	MGC	W01C023M01	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	MGC01-G01	MGC	W01C023M02	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC025408	MGC01-G02	MGC	W01C023M03	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC025408	MGC01-G02	MGC	W01C023M04	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC033898	MGC01-G03	MGC	W01C023M05	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC033898	MGC01-G03	MGC	W01C023M06	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC038296	MGC01-G04	MGC	W01C023M07	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC038296	MGC01-G04	MGC	W01C023M08	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC030618	MGC01-G05	MGC	W01C023M09	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC030618	MGC01-G05	MGC	W01C023M10	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC061587	MGC01-G06	MGC	W01C023M11	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC061587	MGC01-G06	MGC	W01C023M12	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC028726	MGC01-G07	MGC	W01C023M13	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC028726	MGC01-G07	MGC	W01C023M14	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC026194	MGC01-G08	MGC	W01C023M15	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC026194	MGC01-G08	MGC	W01C023M16	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC032949	MGC01-G09	MGC	W01C023M17	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC032949	MGC01-G09	MGC	W01C023M18	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC026189	MGC01-G10	MGC	W01C023M19	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC026189	MGC01-G10	MGC	W01C023M20	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC038667	MGC01-G11	MGC	W01C023M21	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	MGC01-G11	MGC	W01C023M22	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC032948	MGC01-G12	MGC	W01C023M23	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	MGC01-G12	MGC	W01C023M24	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC061592	MGC01-G01	MGC	W01C023N01	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	MGC01-G01	MGC	W01C023N02	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC025408	MGC01-G02	MGC	W01C023N03	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC025408	MGC01-G02	MGC	W01C023N04	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC033898	MGC01-G03	MGC	W01C023N05	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC033898	MGC01-G03	MGC	W01C023N06	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC038296	MGC01-G04	MGC	W01C023N07	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC038296	MGC01-G04	MGC	W01C023N08	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC030618	MGC01-G05	MGC	W01C023N09	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC030618	MGC01-G05	MGC	W01C023N10	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC061587	MGC01-G06	MGC	W01C023N11	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC061587	MGC01-G06	MGC	W01C023N12	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC028726	MGC01-G07	MGC	W01C023N13	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC028726	MGC01-G07	MGC	W01C023N14	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC026194	MGC01-G08	MGC	W01C023N15	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC026194	MGC01-G08	MGC	W01C023N16	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC032949	MGC01-G09	MGC	W01C023N17	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC032949	MGC01-G09	MGC	W01C023N18	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC026189	MGC01-G10	MGC	W01C023N19	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC026189	MGC01-G10	MGC	W01C023N20	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC038667	MGC01-G11	MGC	W01C023N21	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	MGC01-G11	MGC	W01C023N22	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC032948	MGC01-G12	MGC	W01C023N23	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	MGC01-G12	MGC	W01C023N24	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC063817	MGC01-H01	MGC	W01C023O01	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	MGC01-H01	MGC	W01C023O02	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063829	MGC01-H02	MGC	W01C023O03	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC063829	MGC01-H02	MGC	W01C023O04	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC036455	MGC01-H03	MGC	W01C023O05	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC036455	MGC01-H03	MGC	W01C023O06	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC035022	MGC01-H04	MGC	W01C023O07	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC035022	MGC01-H04	MGC	W01C023O08	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC028419	MGC01-H05	MGC	W01C023O09	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028419	MGC01-H05	MGC	W01C023O10	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028421	MGC01-H06	MGC	W01C023O11	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC028421	MGC01-H06	MGC	W01C023O12	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC063801	MGC01-H07	MGC	W01C023O13	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	MGC01-H07	MGC	W01C023O14	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	MGC01-H08	MGC	W01C023O15	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	MGC01-H08	MGC	W01C023O16	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC028603	MGC01-H09	MGC	W01C023O17	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC028603	MGC01-H09	MGC	W01C023O18	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC038294	MGC01-H10	MGC	W01C023O19	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC038294	MGC01-H10	MGC	W01C023O20	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC036679	MGC01-H11	MGC	W01C023O21	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC036679	MGC01-H11	MGC	W01C023O22	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC063817	MGC01-H01	MGC	W01C023P01	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	MGC01-H01	MGC	W01C023P02	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063829	MGC01-H02	MGC	W01C023P03	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC063829	MGC01-H02	MGC	W01C023P04	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC036455	MGC01-H03	MGC	W01C023P05	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC036455	MGC01-H03	MGC	W01C023P06	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC035022	MGC01-H04	MGC	W01C023P07	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC035022	MGC01-H04	MGC	W01C023P08	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC028419	MGC01-H05	MGC	W01C023P09	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028419	MGC01-H05	MGC	W01C023P10	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028421	MGC01-H06	MGC	W01C023P11	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC028421	MGC01-H06	MGC	W01C023P12	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC063801	MGC01-H07	MGC	W01C023P13	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	MGC01-H07	MGC	W01C023P14	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	MGC01-H08	MGC	W01C023P15	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	MGC01-H08	MGC	W01C023P16	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC028603	MGC01-H09	MGC	W01C023P17	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC028603	MGC01-H09	MGC	W01C023P18	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC038294	MGC01-H10	MGC	W01C023P19	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC038294	MGC01-H10	MGC	W01C023P20	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC036679	MGC01-H11	MGC	W01C023P21	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC036679	MGC01-H11	MGC	W01C023P22	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC022543	MGC01-A01	MGC	W01C024A01	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022543	MGC01-A01	MGC	W01C024A02	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018052	MGC01-A02	MGC	W01C024A03	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC018052	MGC01-A02	MGC	W01C024A04	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC026356	MGC01-A03	MGC	W01C024A05	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	MGC01-A03	MGC	W01C024A06	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	MGC01-A04	MGC	W01C024A07	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	MGC01-A04	MGC	W01C024A08	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC018061	MGC01-A05	MGC	W01C024A09	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC018061	MGC01-A05	MGC	W01C024A10	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC022570	MGC01-A06	MGC	W01C024A11	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC022570	MGC01-A06	MGC	W01C024A12	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC026336	MGC01-A07	MGC	W01C024A13	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	MGC01-A07	MGC	W01C024A14	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC022475	MGC01-A08	MGC	W01C024A15	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022475	MGC01-A08	MGC	W01C024A16	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022542	MGC01-A09	MGC	W01C024A17	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022542	MGC01-A09	MGC	W01C024A18	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018038	MGC01-A10	MGC	W01C024A19	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018038	MGC01-A10	MGC	W01C024A20	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018054	MGC01-A11	MGC	W01C024A21	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC018054	MGC01-A11	MGC	W01C024A22	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC022470	MGC01-A12	MGC	W01C024A23	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC022470	MGC01-A12	MGC	W01C024A24	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC022543	MGC01-A01	MGC	W01C024B01	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022543	MGC01-A01	MGC	W01C024B02	pDONR221	5849		ZCRB1	85437	AAH22543.1	Hs.496279	Zinc finger CCHC-type and RNA binding motif 1			Lung	NIH_MGC_77	DH10B	NM_033114.3	NP_149105.3	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018052	MGC01-A02	MGC	W01C024B03	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC018052	MGC01-A02	MGC	W01C024B04	pDONR221	24586		GAGE2D	729408	AAH18052.1					Brain, hippocampus	NIH_MGC_95	DH10B	NM_001098407.1	NP_001091877.1	PROVISIONAL	Cgs	0.974	0.983	117	354	1	351	116	1	116
IKAKEN	BC026356	MGC01-A03	MGC	W01C024B05	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC026356	MGC01-A03	MGC	W01C024B06	pDONR221	5826		RND1	27289	AAH26356.1	Hs.124940	Rho family GTPase 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014470.2	NP_055285.1	PROVISIONAL	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC022547	MGC01-A04	MGC	W01C024B07	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC022547	MGC01-A04	MGC	W01C024B08	pDONR221	491		C1orf93	127281	AAH22547.1	Hs.462033	Chromosome 1 open reading frame 93			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152371.2	NP_689584.1	PREDICTED	C	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC018061	MGC01-A05	MGC	W01C024B09	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC018061	MGC01-A05	MGC	W01C024B10	pDONR221	9379		CRYM	1428	AAH18061.1	Hs.924	Crystallin, mu			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001888.2	NP_001879.1	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	BC022570	MGC01-A06	MGC	W01C024B11	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC022570	MGC01-A06	MGC	W01C024B12	pDONR221	19433		C5orf40	408263	AAH22570.1	Hs.437066	Chromosome 5 open reading frame 40			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001001343.3	NP_001001343.2	VALIDATED	OK	1.000	1.000	224	675	1	672	224	1	224
IKAKEN	BC026336	MGC01-A07	MGC	W01C024B13	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	MGC01-A07	MGC	W01C024B14	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC022475	MGC01-A08	MGC	W01C024B15	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022475	MGC01-A08	MGC	W01C024B16	pDONR221	13126		INSIG2	51141	AAH22475.1	Hs.7089	Insulin induced gene 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_016133.2	NP_057217.2	REVIEWED	P	1.000	1.000	219	714	1	657	225	1	219
IKAKEN	BC022542	MGC01-A09	MGC	W01C024B17	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC022542	MGC01-A09	MGC	W01C024B18	pDONR221	16366		PIGX	54965	AAH22542.1	Hs.223296	Phosphatidylinositol glycan anchor biosynthesis, class X			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_017861.2	NP_060331.2	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC018038	MGC01-A10	MGC	W01C024B19	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018038	MGC01-A10	MGC	W01C024B20	pDONR221	18832		CRHBP	1393	AAH18038.1	Hs.115617	Corticotropin releasing hormone binding protein			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_001882.3	NP_001873.2	REVIEWED	OK	1.000	1.000	322	969	1	966	322	1	322
IKAKEN	BC018054	MGC01-A11	MGC	W01C024B21	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC018054	MGC01-A11	MGC	W01C024B22	pDONR221	19666		ENPP4	22875	AAH18054.1	Hs.643497	Ectonucleotide pyrophosphatase/phosphodiesterase 4 (putative function)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014936.4	NP_055751.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC022470	MGC01-A12	MGC	W01C024B23	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC022470	MGC01-A12	MGC	W01C024B24	pDONR221	6196		PPP1R1A	5502	AAH22470.1	Hs.505662	Protein phosphatase 1, regulatory (inhibitor) subunit 1A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_006741.3	NP_006732.3	VALIDATED	Cs	0.994	0.994	171	516	1	513	171	1	171
IKAKEN	BC030835	MGC01-B01	MGC	W01C024C01	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030835	MGC01-B01	MGC	W01C024C02	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030825	MGC01-B02	MGC	W01C024C03	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC030825	MGC01-B02	MGC	W01C024C04	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC039204	MGC01-B03	MGC	W01C024C05	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	MGC01-B03	MGC	W01C024C06	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC022497	MGC01-B04	MGC	W01C024C07	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022497	MGC01-B04	MGC	W01C024C08	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022482	MGC01-B05	MGC	W01C024C09	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022482	MGC01-B05	MGC	W01C024C10	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022489	MGC01-B06	MGC	W01C024C11	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC022489	MGC01-B06	MGC	W01C024C12	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC034046	MGC01-B07	MGC	W01C024C13	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC034046	MGC01-B07	MGC	W01C024C14	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC066939	MGC01-B08	MGC	W01C024C15	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066939	MGC01-B08	MGC	W01C024C16	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066936	MGC01-B09	MGC	W01C024C17	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	MGC01-B09	MGC	W01C024C18	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC030826	MGC01-B10	MGC	W01C024C19	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC030826	MGC01-B10	MGC	W01C024C20	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC066960	MGC01-B11	MGC	W01C024C21	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC066960	MGC01-B11	MGC	W01C024C22	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC034965	MGC01-B12	MGC	W01C024C23	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC034965	MGC01-B12	MGC	W01C024C24	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC030835	MGC01-B01	MGC	W01C024D01	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030835	MGC01-B01	MGC	W01C024D02	pDONR221	7956		BRUNOL6	60677	AAH30835.1	Hs.348342	Bruno-like 6, RNA binding protein (Drosophila)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_052840.4	NP_443072.3	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC030825	MGC01-B02	MGC	W01C024D03	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC030825	MGC01-B02	MGC	W01C024D04	pDONR221	4454		FAM160A2	84067	AAH30825.1	Hs.501793	Family with sequence similarity 160, member A2			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032127.3	NP_115503.2	VALIDATED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC039204	MGC01-B03	MGC	W01C024D05	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC039204	MGC01-B03	MGC	W01C024D06	pDONR221	9538		SGSM2	9905	AAH39204.1	Hs.513861	Small G protein signaling modulator 2			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_014853.2	NP_055668.2	VALIDATED	Cs	0.998	0.998	1051	3156	1	3153	1051	1	1051
IKAKEN	BC022497	MGC01-B04	MGC	W01C024D07	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022497	MGC01-B04	MGC	W01C024D08	pDONR221	15564		FBLN1	2192	AAH22497.1	Hs.24601	Fibulin 1			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001996.2	NP_001987.2	REVIEWED	Cs	0.999	0.999	683	2052	1	2049	683	1	683
IKAKEN	BC022482	MGC01-B05	MGC	W01C024D09	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022482	MGC01-B05	MGC	W01C024D10	pDONR221	25642		TMSB4Y	9087	-	Hs.159201	Thymosin beta 4, Y-linked			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_004202.2	NP_004193.1	REVIEWED	OK	1.000	1.000	44	135	1	132	44	1	44
IKAKEN	BC022489	MGC01-B06	MGC	W01C024D11	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC022489	MGC01-B06	MGC	W01C024D12	pDONR221	18890		FABP6	2172	AAH22489.1	Hs.519719	Fatty acid binding protein 6, ileal			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001445.2	NP_001436.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC034046	MGC01-B07	MGC	W01C024D13	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC034046	MGC01-B07	MGC	W01C024D14	pDONR221	3687		PPFIA1	8500	AAH34046.1	Hs.530749	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003626.2	NP_003617.1	REVIEWED	Cgs	0.996	0.999	1206	3621	1	3618	1202	1	1202
IKAKEN	BC066939	MGC01-B08	MGC	W01C024D15	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066939	MGC01-B08	MGC	W01C024D16	pDONR221	11969		IRGC	56269	AAH66939.1	Hs.515444	Immunity-related GTPase family, cinema			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_019612.3	NP_062558.1	VALIDATED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC066936	MGC01-B09	MGC	W01C024D17	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC066936	MGC01-B09	MGC	W01C024D18	pDONR221	14063		CCDC121	79635	AAH66936.1	Hs.679799	Coiled-coil domain containing 121			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_024584.3	NP_078860.2	VALIDATED	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC030826	MGC01-B10	MGC	W01C024D19	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC030826	MGC01-B10	MGC	W01C024D20	pDONR221	19081		PJA2	9867	AAH30826.1	Hs.483036	Praja ring finger 2			Placenta	NIH_MGC_79	DH10B	NM_014819.4	NP_055634.3	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC066960	MGC01-B11	MGC	W01C024D21	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC066960	MGC01-B11	MGC	W01C024D22	pDONR221	18304		GK3P	2713	AAH66960	Hs.654557	Glycerol kinase 3 pseudogene			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R			
IKAKEN	BC034965	MGC01-B12	MGC	W01C024D23	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC034965	MGC01-B12	MGC	W01C024D24	pDONR221	6772		EFHA1	221154	AAH34965.1	Hs.412103	EF-hand domain family, member A1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_152726.1	NP_689939.1	PROVISIONAL	OK	1.000	1.000	434	1305	1	1302	434	1	434
IKAKEN	BC022011	MGC01-C01	MGC	W01C024E01	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC022011	MGC01-C01	MGC	W01C024E02	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC037272	MGC01-C02	MGC	W01C024E03	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC037272	MGC01-C02	MGC	W01C024E04	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC033001	MGC01-C03	MGC	W01C024E05	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC033001	MGC01-C03	MGC	W01C024E06	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC034488	MGC01-C04	MGC	W01C024E07	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC034488	MGC01-C04	MGC	W01C024E08	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC028574	MGC01-C05	MGC	W01C024E09	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC028574	MGC01-C05	MGC	W01C024E10	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC032835	MGC01-C06	MGC	W01C024E11	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032835	MGC01-C06	MGC	W01C024E12	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032841	MGC01-C07	MGC	W01C024E13	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC032841	MGC01-C07	MGC	W01C024E14	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC024181	MGC01-C08	MGC	W01C024E15	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC024181	MGC01-C08	MGC	W01C024E16	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC025997	MGC01-C09	MGC	W01C024E17	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC025997	MGC01-C09	MGC	W01C024E18	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC034947	MGC01-C10	MGC	W01C024E19	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC034947	MGC01-C10	MGC	W01C024E20	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC066975	MGC01-C11	MGC	W01C024E21	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC066975	MGC01-C11	MGC	W01C024E22	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC034959	MGC01-C12	MGC	W01C024E23	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC034959	MGC01-C12	MGC	W01C024E24	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC022011	MGC01-C01	MGC	W01C024F01	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC022011	MGC01-C01	MGC	W01C024F02	pDONR221	20725		CRISP2	7180	AAH22011.1	Hs.2042	Cysteine-rich secretory protein 2			Testis	NIH_MGC_97	DH10B	NM_001142408.1	NP_001135880.1	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC037272	MGC01-C02	MGC	W01C024F03	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC037272	MGC01-C02	MGC	W01C024F04	pDONR221	13159		CNNM3	26505	AAH37272.1	Hs.711617	Cyclin M3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_017623.4	NP_060093.3	VALIDATED	OK	1.000	1.000	707	2124	1	2121	707	1	707
IKAKEN	BC033001	MGC01-C03	MGC	W01C024F05	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC033001	MGC01-C03	MGC	W01C024F06	pDONR221	8362		SECISBP2L	9728	AAH33001.1	Hs.9997	SECIS binding protein 2-like			Testis	NIH_MGC_97	DH10B	NM_014701.2	NP_055516.2	PROVISIONAL	Cg	0.959	1.000	1101	3306	1	3303	1056	1	1056
IKAKEN	BC034488	MGC01-C04	MGC	W01C024F07	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC034488	MGC01-C04	MGC	W01C024F08	pDONR221	19736		ABCF1	23	AAH34488.1	Hs.655285	ATP-binding cassette, sub-family F (GCN20), member 1			Testis	NIH_MGC_97	DH10B	NM_001025091.1	NP_001020262.1	REVIEWED	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC028574	MGC01-C05	MGC	W01C024F09	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC028574	MGC01-C05	MGC	W01C024F10	pDONR221	12150		THEG	51298	AAH28574.1	Hs.250002	Theg homolog (mouse)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016585.3	NP_057669.1	REVIEWED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC032835	MGC01-C06	MGC	W01C024F11	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032835	MGC01-C06	MGC	W01C024F12	pDONR221	22670		TMEM67	91147	AAH32835.1	Hs.116240	Transmembrane protein 67			Testis	NIH_MGC_97	DH10B	NM_153704.5	NP_714915.3	REVIEWED	P	1.000	1.000	985	2958	1	2955	995	11	995
IKAKEN	BC032841	MGC01-C07	MGC	W01C024F13	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC032841	MGC01-C07	MGC	W01C024F14	pDONR221	17095		LRRC34	151827	AAH32841.1	Hs.591289	Leucine rich repeat containing 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_153353.3	NP_699184.1	PROVISIONAL	Cs	0.998	0.998	419	1260	1	1257	419	1	419
IKAKEN	BC024181	MGC01-C08	MGC	W01C024F15	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC024181	MGC01-C08	MGC	W01C024F16	pDONR221	7318		ESR2	2100	AAH24181.1	Hs.660607	Estrogen receptor 2 (ER beta)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001437.2	NP_001428.1	REVIEWED		0.500	0.500	14	180	160	119	530	6	19
IKAKEN	BC025997	MGC01-C09	MGC	W01C024F17	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC025997	MGC01-C09	MGC	W01C024F18	pDONR221	14190		C2orf65	130951	AAH25997.1	Hs.348645	Chromosome 2 open reading frame 65			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138804.3	NP_620159.2	PREDICTED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC034947	MGC01-C10	MGC	W01C024F19	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC034947	MGC01-C10	MGC	W01C024F20	pDONR221	16128		LRRN1	57633	AAH34947.1	Hs.163244	Leucine rich repeat neuronal 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020873.5	NP_065924.3	VALIDATED	OK	1.000	1.000	716	2151	1	2148	716	1	716
IKAKEN	BC066975	MGC01-C11	MGC	W01C024F21	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC066975	MGC01-C11	MGC	W01C024F22	pDONR221	17100		C3orf25	90288	AAH66975.1	Hs.652347	Chromosome 3 open reading frame 25			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207307.1	NP_997190.1	PREDICTED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC034959	MGC01-C12	MGC	W01C024F23	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC034959	MGC01-C12	MGC	W01C024F24	pDONR221	25134		ACSL4	2182	AAH34959.1	Hs.268785	Acyl-CoA synthetase long-chain family member 4			Testis	NIH_MGC_97	DH10B	NM_004458.2	NP_004449.1	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014609	MGC01-D01	MGC	W01C024G01	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC014609	MGC01-D01	MGC	W01C024G02	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC030010	MGC01-D02	MGC	W01C024G03	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC030010	MGC01-D02	MGC	W01C024G04	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC014603	MGC01-D03	MGC	W01C024G05	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC014603	MGC01-D03	MGC	W01C024G06	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC034503	MGC01-D04	MGC	W01C024G07	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC034503	MGC01-D04	MGC	W01C024G08	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC030783	MGC01-D05	MGC	W01C024G09	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC030783	MGC01-D05	MGC	W01C024G10	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC066986	MGC01-D06	MGC	W01C024G11	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC066986	MGC01-D06	MGC	W01C024G12	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC030703	MGC01-D07	MGC	W01C024G13	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC030703	MGC01-D07	MGC	W01C024G14	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC014596	MGC01-D08	MGC	W01C024G15	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC014596	MGC01-D08	MGC	W01C024G16	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC025381	MGC01-D09	MGC	W01C024G17	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC025381	MGC01-D09	MGC	W01C024G18	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC022012	MGC01-D10	MGC	W01C024G19	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC022012	MGC01-D10	MGC	W01C024G20	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC021707	MGC01-D11	MGC	W01C024G21	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC021707	MGC01-D11	MGC	W01C024G22	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC030687	MGC01-D12	MGC	W01C024G23	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC030687	MGC01-D12	MGC	W01C024G24	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC014609	MGC01-D01	MGC	W01C024H01	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC014609	MGC01-D01	MGC	W01C024H02	pDONR221	11893		C19orf36	113177	AAH14609.1	Hs.424049	Chromosome 19 open reading frame 36			Testis	NIH_MGC_97	DH10B	NM_001031735.2	NP_001026905.2	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC030010	MGC01-D02	MGC	W01C024H03	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC030010	MGC01-D02	MGC	W01C024H04	pDONR221	6222		EPS8	2059	AAH30010.1	Hs.591160	Epidermal growth factor receptor pathway substrate 8			Testis	NIH_MGC_97	DH10B	NM_004447.5	NP_004438.3	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC014603	MGC01-D03	MGC	W01C024H05	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC014603	MGC01-D03	MGC	W01C024H06	pDONR221	5558		GLIPR1L1	256710	AAH14603.1	Hs.567788	GLI pathogenesis-related 1 like 1			Testis	NIH_MGC_97	DH10B	NM_152779.2	NP_689992.1	PROVISIONAL	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC034503	MGC01-D04	MGC	W01C024H07	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC034503	MGC01-D04	MGC	W01C024H08	pDONR221	13516		ITPRIPL1	150771	AAH34503.2	Hs.65009	Inositol 1,4,5-triphosphate receptor interacting protein-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178495.4	NP_848590.3	VALIDATED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC030783	MGC01-D05	MGC	W01C024H09	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC030783	MGC01-D05	MGC	W01C024H10	pDONR221	3124		GPAM	57678	AAH30783.1	Hs.42586	Glycerol-3-phosphate acyltransferase, mitochondrial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020918.4	NP_065969.3	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC066986	MGC01-D06	MGC	W01C024H11	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC066986	MGC01-D06	MGC	W01C024H12	pDONR221	19858		C6orf201	404220	AAH66986.1	Hs.716731	Chromosome 6 open reading frame 201			Testis	NIH_MGC_97	DH10B	NM_001085401.1	NP_001078870.1	VALIDATED	P	1.000	1.000	98	396	97	390	140	30	127
IKAKEN	BC030703	MGC01-D07	MGC	W01C024H13	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC030703	MGC01-D07	MGC	W01C024H14	pDONR221	7355		DDHD1	80821	AAH30703.1	Hs.513260	DDHD domain containing 1			Testis	NIH_MGC_97	DH10B	NM_030637.2	NP_085140.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC014596	MGC01-D08	MGC	W01C024H15	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC014596	MGC01-D08	MGC	W01C024H16	pDONR221	21072		C7orf34	135927	AAH14596.1	Hs.239676	Chromosome 7 open reading frame 34			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_178829.4	NP_849151.2	VALIDATED	P	1.000	1.000	122	369	1	366	147	26	147
IKAKEN	BC025381	MGC01-D09	MGC	W01C024H17	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC025381	MGC01-D09	MGC	W01C024H18	pDONR221	11016		CLUL1	27098	AAH25381.1	Hs.632357	Clusterin-like 1 (retinal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_199167.1	NP_954636.1	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC022012	MGC01-D10	MGC	W01C024H19	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC022012	MGC01-D10	MGC	W01C024H20	pDONR221	12880		VSNL1	7447	AAH22012.1	Hs.444212	Visinin-like 1			Testis	NIH_MGC_97	DH10B	NM_003385.4	NP_003376.2	REVIEWED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC021707	MGC01-D11	MGC	W01C024H21	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC021707	MGC01-D11	MGC	W01C024H22	pDONR221	13430		TTLL4	9654	AAH21707.1	Hs.471405	Tubulin tyrosine ligase-like family, member 4			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014640.4	NP_055455.3	VALIDATED	OK	1.000	1.000	1199	3600	1	3597	1199	1	1199
IKAKEN	BC030687	MGC01-D12	MGC	W01C024H23	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC030687	MGC01-D12	MGC	W01C024H24	pDONR221	20345		ZNF318	24149	AAH30687	Hs.509718	Zinc finger protein 318			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014345.2	NP_055160.2	VALIDATED	P	1.000	1.000	1092	3354	1	3276	2279	1	1092
IKAKEN	BC030607	MGC01-E01	MGC	W01C024I01	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC030607	MGC01-E01	MGC	W01C024I02	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC017592	MGC01-E02	MGC	W01C024I03	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC017592	MGC01-E02	MGC	W01C024I04	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC026078	MGC01-E03	MGC	W01C024I05	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC026078	MGC01-E03	MGC	W01C024I06	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC017586	MGC01-E04	MGC	W01C024I07	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC017586	MGC01-E04	MGC	W01C024I08	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC032999	MGC01-E05	MGC	W01C024I09	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC032999	MGC01-E05	MGC	W01C024I10	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC028588	MGC01-E06	MGC	W01C024I11	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC028588	MGC01-E06	MGC	W01C024I12	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC066304	MGC01-E07	MGC	W01C024I13	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC066304	MGC01-E07	MGC	W01C024I14	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC028711	MGC01-E08	MGC	W01C024I15	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	MGC01-E08	MGC	W01C024I16	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028583	MGC01-E09	MGC	W01C024I17	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC028583	MGC01-E09	MGC	W01C024I18	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC026077	MGC01-E10	MGC	W01C024I19	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC026077	MGC01-E10	MGC	W01C024I20	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC028361	MGC01-E11	MGC	W01C024I21	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC028361	MGC01-E11	MGC	W01C024I22	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC030012	MGC01-E12	MGC	W01C024I23	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030012	MGC01-E12	MGC	W01C024I24	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030607	MGC01-E01	MGC	W01C024J01	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC030607	MGC01-E01	MGC	W01C024J02	pDONR221	480		LRRC8B	23507	AAH30607.1	Hs.632420	Leucine rich repeat containing 8 family, member B			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001134476.1	NP_001127948.1	VALIDATED	OK	1.000	1.000	803	2412	1	2409	803	1	803
IKAKEN	BC017592	MGC01-E02	MGC	W01C024J03	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC017592	MGC01-E02	MGC	W01C024J04	pDONR221	11825		ZNRF4	148066	AAH17592.2	Hs.126496	Zinc and ring finger 4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181710.3	NP_859061.3	VALIDATED	OK	1.000	1.000	429	1290	1	1287	429	1	429
IKAKEN	BC026078	MGC01-E03	MGC	W01C024J05	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC026078	MGC01-E03	MGC	W01C024J06	pDONR221	1805		MOBKL2C	148932	-	Hs.632401	MOB1, Mps One Binder kinase activator-like 2C (yeast)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_201403.2	NP_958805.1	REVIEWED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC017586	MGC01-E04	MGC	W01C024J07	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC017586	MGC01-E04	MGC	W01C024J08	pDONR221	19429		CAPSL	133690	AAH17586.2	Hs.55150	Calcyphosine-like			Testis	NIH_MGC_97	DH10B	NM_001042625.1	NP_001036090.1	VALIDATED	P	1.000	1.000	198	597	1	594	208	11	208
IKAKEN	BC032999	MGC01-E05	MGC	W01C024J09	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC032999	MGC01-E05	MGC	W01C024J10	pDONR221	21820		PNPLA8	50640	AAH32999.1	Hs.617340	Patatin-like phospholipase domain containing 8			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_015723.2	NP_056538.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC028588	MGC01-E06	MGC	W01C024J11	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC028588	MGC01-E06	MGC	W01C024J12	pDONR221	17662		RBM46	166863	AAH28588.1	Hs.133095	RNA binding motif protein 46			Testis	NIH_MGC_97	DH10B	NM_144979.3	NP_659416.1	VALIDATED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC066304	MGC01-E07	MGC	W01C024J13	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC066304	MGC01-E07	MGC	W01C024J14	pDONR221	11567		LGALS13	29124	AAH66304.1	Hs.23671	Lectin, galactoside-binding, soluble, 13			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_013268.2	NP_037400.1	REVIEWED	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	BC028711	MGC01-E08	MGC	W01C024J15	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028711	MGC01-E08	MGC	W01C024J16	pDONR221	24765		CT45A3	441519	AAH28711.1	Hs.535080	Cancer/testis antigen family 45, member A3			Testis	NIH_MGC_97	DH10B	NM_001017435.1	NP_001017435.1	PROVISIONAL	Cs	0.989	0.989	189	570	1	567	189	1	189
IKAKEN	BC028583	MGC01-E09	MGC	W01C024J17	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC028583	MGC01-E09	MGC	W01C024J18	pDONR221	19660		SENP6	26054	AAH28583.1	Hs.485784	SUMO1/sentrin specific peptidase 6			Testis	NIH_MGC_97	DH10B	NM_015571.2	NP_056386.2	VALIDATED	Cg	0.992	1.000	1114	3324	1	3321	1112	1	1112
IKAKEN	BC026077	MGC01-E10	MGC	W01C024J19	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC026077	MGC01-E10	MGC	W01C024J20	pDONR221	25671		RBMY2FP	159162	AAH26077	Hs.711527	RNA binding motif protein, Y-linked, family 2, member F pseudogene			Brain, hippocampus	NIH_MGC_95	DH10B			
IKAKEN	BC028361	MGC01-E11	MGC	W01C024J21	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC028361	MGC01-E11	MGC	W01C024J22	pDONR221	13192		INPP4A	3631	AAH28361.1	Hs.469386	Inositol polyphosphate-4-phosphatase, type I, 107kDa			Testis	NIH_MGC_97	DH10B	NM_001134225.1	NP_001127697.1	REVIEWED	OK	1.000	1.000	972	2919	1	2916	972	1	972
IKAKEN	BC030012	MGC01-E12	MGC	W01C024J23	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030012	MGC01-E12	MGC	W01C024J24	pDONR221	23534		GLE1	2733	AAH30012.1	Hs.522418	GLE1 RNA export mediator homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001003722.1	NP_001003722.1	REVIEWED	OK	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC030590	MGC01-F01	MGC	W01C024K01	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC030590	MGC01-F01	MGC	W01C024K02	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC066340	MGC01-F02	MGC	W01C024K03	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC066340	MGC01-F02	MGC	W01C024K04	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC028704	MGC01-F03	MGC	W01C024K05	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028704	MGC01-F03	MGC	W01C024K06	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC027588	MGC01-F04	MGC	W01C024K07	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC027588	MGC01-F04	MGC	W01C024K08	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC063857	MGC01-F05	MGC	W01C024K09	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC063857	MGC01-F05	MGC	W01C024K10	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC028365	MGC01-F06	MGC	W01C024K11	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028365	MGC01-F06	MGC	W01C024K12	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028581	MGC01-F07	MGC	W01C024K13	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC028581	MGC01-F07	MGC	W01C024K14	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC034982	MGC01-F08	MGC	W01C024K15	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	MGC01-F08	MGC	W01C024K16	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028375	MGC01-F09	MGC	W01C024K17	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028375	MGC01-F09	MGC	W01C024K18	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028714	MGC01-F10	MGC	W01C024K19	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	MGC01-F10	MGC	W01C024K20	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC022188	MGC01-F11	MGC	W01C024K21	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC022188	MGC01-F11	MGC	W01C024K22	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC061588	MGC01-F12	MGC	W01C024K23	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC061588	MGC01-F12	MGC	W01C024K24	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC030590	MGC01-F01	MGC	W01C024L01	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC030590	MGC01-F01	MGC	W01C024L02	pDONR221	10980		RBBP8	5932	AAH30590.1	Hs.546282	Retinoblastoma binding protein 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_203291.1	NP_976036.1	REVIEWED	OK	1.000	1.000	897	2694	1	2691	897	1	897
IKAKEN	BC066340	MGC01-F02	MGC	W01C024L03	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC066340	MGC01-F02	MGC	W01C024L04	pDONR221	5611		BLOC1S1	2647	AAH66340	Hs.94672	Biogenesis of lysosomal organelles complex-1, subunit 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001487.2	NP_001478.1	VALIDATED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC028704	MGC01-F03	MGC	W01C024L05	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028704	MGC01-F03	MGC	W01C024L06	pDONR221	7841		ARRDC4	91947	AAH28704.2	Hs.6093	Arrestin domain containing 4			Testis	NIH_MGC_97	DH10B	NM_183376.2	NP_899232.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC027588	MGC01-F04	MGC	W01C024L07	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC027588	MGC01-F04	MGC	W01C024L08	pDONR221	14896		RP5-1022P6.2	56261	AAH27588.1	Hs.636359	Hypothetical protein KIAA1434			Brain, hippocampus	NIH_MGC_95	DH10B	NM_019593.3	NP_062539.1	VALIDATED	OK	1.000	1.000	672	2019	1	2016	672	1	672
IKAKEN	BC063857	MGC01-F05	MGC	W01C024L09	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC063857	MGC01-F05	MGC	W01C024L10	pDONR221	22554		GPIHBP1	338328	AAH63857.1	Hs.426410	Glycosylphosphatidylinositol anchored high density lipoprotein binding protein 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_178172.3	NP_835466.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC028365	MGC01-F06	MGC	W01C024L11	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028365	MGC01-F06	MGC	W01C024L12	pDONR221	22167		C7orf62	219557	AAH28365.1	Hs.112877	Chromosome 7 open reading frame 62			Testis	NIH_MGC_97	DH10B	NM_152706.2	NP_689919.1	PREDICTED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC028581	MGC01-F07	MGC	W01C024L13	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC028581	MGC01-F07	MGC	W01C024L14	pDONR221	5304		PIWIL1	9271	AAH28581.1	Hs.405659	Piwi-like 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_004764.3	NP_004755.2	REVIEWED	OK	1.000	1.000	861	2586	1	2583	861	1	861
IKAKEN	BC034982	MGC01-F08	MGC	W01C024L15	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC034982	MGC01-F08	MGC	W01C024L16	pDONR221	20377		HACE1	57531	AAH34982.1	Hs.434340	HECT domain and ankyrin repeat containing, E3 ubiquitin protein ligase 1			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_020771.3	NP_065822.2	VALIDATED	OK	1.000	1.000	909	2730	1	2727	909	1	909
IKAKEN	BC028375	MGC01-F09	MGC	W01C024L17	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028375	MGC01-F09	MGC	W01C024L18	pDONR221	3318		PDZD8	118987	AAH28375.1	Hs.501149	PDZ domain containing 8			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_173791.3	NP_776152.1	PROVISIONAL	C	1.000	1.000	1154	3465	1	3462	1154	1	1154
IKAKEN	BC028714	MGC01-F10	MGC	W01C024L19	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	MGC01-F10	MGC	W01C024L20	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC022188	MGC01-F11	MGC	W01C024L21	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC022188	MGC01-F11	MGC	W01C024L22	pDONR221	6797		N4BP2L1	90634	AAH22188.2	Hs.161220	NEDD4 binding protein 2-like 1			Testis	NIH_MGC_97	DH10B	NM_001079691.1	NP_001073159.1	VALIDATED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC061588	MGC01-F12	MGC	W01C024L23	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC061588	MGC01-F12	MGC	W01C024L24	pDONR221	11978		LGALS7B	653499	AAH61588.1	Hs.558355	Lectin, galactoside-binding, soluble, 7B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001042507.3	NP_001035972.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC061592	MGC01-G01	MGC	W01C024M01	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	MGC01-G01	MGC	W01C024M02	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC025408	MGC01-G02	MGC	W01C024M03	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC025408	MGC01-G02	MGC	W01C024M04	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC033898	MGC01-G03	MGC	W01C024M05	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC033898	MGC01-G03	MGC	W01C024M06	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC038296	MGC01-G04	MGC	W01C024M07	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC038296	MGC01-G04	MGC	W01C024M08	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC030618	MGC01-G05	MGC	W01C024M09	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC030618	MGC01-G05	MGC	W01C024M10	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC061587	MGC01-G06	MGC	W01C024M11	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC061587	MGC01-G06	MGC	W01C024M12	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC028726	MGC01-G07	MGC	W01C024M13	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC028726	MGC01-G07	MGC	W01C024M14	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC026194	MGC01-G08	MGC	W01C024M15	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC026194	MGC01-G08	MGC	W01C024M16	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC032949	MGC01-G09	MGC	W01C024M17	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC032949	MGC01-G09	MGC	W01C024M18	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC026189	MGC01-G10	MGC	W01C024M19	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC026189	MGC01-G10	MGC	W01C024M20	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC038667	MGC01-G11	MGC	W01C024M21	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	MGC01-G11	MGC	W01C024M22	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC032948	MGC01-G12	MGC	W01C024M23	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	MGC01-G12	MGC	W01C024M24	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC061592	MGC01-G01	MGC	W01C024N01	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	MGC01-G01	MGC	W01C024N02	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC025408	MGC01-G02	MGC	W01C024N03	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC025408	MGC01-G02	MGC	W01C024N04	pDONR221	20549		SLC26A8	116369	AAH25408.1	Hs.435836	Solute carrier family 26, member 8			Testis	NIH_MGC_97	DH10B	NM_138718.1	NP_619732.1	REVIEWED	Cs	0.999	0.999	865	2598	1	2595	865	1	865
IKAKEN	BC033898	MGC01-G03	MGC	W01C024N05	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC033898	MGC01-G03	MGC	W01C024N06	pDONR221	4047		TMEM151A	256472	AAH33898.1	Hs.399779	Transmembrane protein 151A			Testis	NIH_MGC_97	DH10B	NM_153266.3	NP_694998.1	VALIDATED	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC038296	MGC01-G04	MGC	W01C024N07	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC038296	MGC01-G04	MGC	W01C024N08	pDONR221	1406		SMG5	23381	AAH38296.1	Hs.516837	Smg-5 homolog, nonsense mediated mRNA decay factor (C. elegans)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015327.2	NP_056142.2	VALIDATED	OK	1.000	1.000	1016	3051	1	3048	1016	1	1016
IKAKEN	BC030618	MGC01-G05	MGC	W01C024N09	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC030618	MGC01-G05	MGC	W01C024N10	pDONR221	5615		PLBD2	196463	AAH30618.1	Hs.115896	Phospholipase B domain containing 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173542.3	NP_775813.2	VALIDATED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC061587	MGC01-G06	MGC	W01C024N11	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC061587	MGC01-G06	MGC	W01C024N12	pDONR221	5390		OAS1	4938	AAH61587.1	Hs.524760	2',5'-oligoadenylate synthetase 1, 40/46kDa			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_002534.2	NP_002525.2	REVIEWED	OK	1.000	1.000	364	1095	1	1092	364	1	364
IKAKEN	BC028726	MGC01-G07	MGC	W01C024N13	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC028726	MGC01-G07	MGC	W01C024N14	pDONR221	16433		GPD1L	23171	AAH28726.1	Hs.82432	Glycerol-3-phosphate dehydrogenase 1-like			Testis	NIH_MGC_97	DH10B	NM_015141.2	NP_055956.1	PROVISIONAL	C	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC026194	MGC01-G08	MGC	W01C024N15	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC026194	MGC01-G08	MGC	W01C024N16	pDONR221	20562		CAGE1	285782	AAH26194.1					Testis	NIH_MGC_97	DH10B	NM_205864.2	NP_995586.1	VALIDATED	Ps	0.996	0.996	534	2103	409	2010	641	1	534
IKAKEN	BC032949	MGC01-G09	MGC	W01C024N17	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC032949	MGC01-G09	MGC	W01C024N18	pDONR221	13802		CREG2	200407	AAH32949.2	Hs.30917	Cellular repressor of E1A-stimulated genes 2			Testis	NIH_MGC_97	DH10B	NM_153836.3	NP_722578.1	VALIDATED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC026189	MGC01-G10	MGC	W01C024N19	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC026189	MGC01-G10	MGC	W01C024N20	pDONR221	21957		SUNC1	256979	AAH26189.3	Hs.406741	Sad1 and UNC84 domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_152782.3	NP_689995.3	VALIDATED	Cfs	0.989	1.000	357	1062	1	1059	357	1	357
IKAKEN	BC038667	MGC01-G11	MGC	W01C024N21	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC038667	MGC01-G11	MGC	W01C024N22	pDONR221	17446		KIAA1712	80817	AAH38667.1	Hs.555989	KIAA1712			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001040157.2	NP_001035247.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC032948	MGC01-G12	MGC	W01C024N23	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	MGC01-G12	MGC	W01C024N24	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC063817	MGC01-H01	MGC	W01C024O01	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	MGC01-H01	MGC	W01C024O02	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063829	MGC01-H02	MGC	W01C024O03	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC063829	MGC01-H02	MGC	W01C024O04	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC036455	MGC01-H03	MGC	W01C024O05	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC036455	MGC01-H03	MGC	W01C024O06	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC035022	MGC01-H04	MGC	W01C024O07	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC035022	MGC01-H04	MGC	W01C024O08	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC028419	MGC01-H05	MGC	W01C024O09	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028419	MGC01-H05	MGC	W01C024O10	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028421	MGC01-H06	MGC	W01C024O11	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC028421	MGC01-H06	MGC	W01C024O12	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC063801	MGC01-H07	MGC	W01C024O13	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	MGC01-H07	MGC	W01C024O14	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	MGC01-H08	MGC	W01C024O15	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	MGC01-H08	MGC	W01C024O16	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC028603	MGC01-H09	MGC	W01C024O17	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC028603	MGC01-H09	MGC	W01C024O18	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC038294	MGC01-H10	MGC	W01C024O19	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC038294	MGC01-H10	MGC	W01C024O20	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC036679	MGC01-H11	MGC	W01C024O21	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC036679	MGC01-H11	MGC	W01C024O22	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC063817	MGC01-H01	MGC	W01C024P01	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063817	MGC01-H01	MGC	W01C024P02	pDONR221	1525		WDR26	80232	AAH63817.2	Hs.497873	WD repeat domain 26			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001115113.1	NP_001108585.1	REVIEWED	P	1.000	1.000	404	1215	1	1212	498	95	498
IKAKEN	BC063829	MGC01-H02	MGC	W01C024P03	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC063829	MGC01-H02	MGC	W01C024P04	pDONR221	2562		PPRC1	23082	AAH63829.1	Hs.533551	Peroxisome proliferator-activated receptor gamma, coactivator-related 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015062.3	NP_055877.3	REVIEWED	OK	1.000	1.000	1664	4995	1	4992	1664	1	1664
IKAKEN	BC036455	MGC01-H03	MGC	W01C024P05	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC036455	MGC01-H03	MGC	W01C024P06	pDONR221	5479		MARCH9	92979	AAH36455.2	Hs.632709	Membrane-associated ring finger (C3HC4) 9			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_138396.4	NP_612405.2	VALIDATED	C	1.000	1.000	346	1041	1	1038	346	1	346
IKAKEN	BC035022	MGC01-H04	MGC	W01C024P07	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC035022	MGC01-H04	MGC	W01C024P08	pDONR221	20803		TCTE1	202500	AAH35022.1	Hs.189183	T-complex-associated-testis-expressed 1			Testis	NIH_MGC_97	DH10B	NM_182539.3	NP_872345.2	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC028419	MGC01-H05	MGC	W01C024P09	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028419	MGC01-H05	MGC	W01C024P10	pDONR221	18016		CCDC110	256309	AAH28419.1	Hs.41101	Coiled-coil domain containing 110			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152775.3	NP_689988.1	VALIDATED	C	1.000	1.000	833	2502	1	2499	833	1	833
IKAKEN	BC028421	MGC01-H06	MGC	W01C024P11	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC028421	MGC01-H06	MGC	W01C024P12	pDONR221	5545		WDR66	144406	AAH28421.1	Hs.709837	WD repeat domain 66			Testis	NIH_MGC_97	DH10B	NM_144668.4	NP_653269.3	VALIDATED	OK	1.000	1.000	1149	3450	1	3447	1149	1	1149
IKAKEN	BC063801	MGC01-H07	MGC	W01C024P13	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	MGC01-H07	MGC	W01C024P14	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035024	MGC01-H08	MGC	W01C024P15	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	MGC01-H08	MGC	W01C024P16	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC028603	MGC01-H09	MGC	W01C024P17	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC028603	MGC01-H09	MGC	W01C024P18	pDONR221	5177		STK38L	23012	AAH28603.1	Hs.184523	Serine/threonine kinase 38 like			Testis	NIH_MGC_97	DH10B	NM_015000.3	NP_055815.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC038294	MGC01-H10	MGC	W01C024P19	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC038294	MGC01-H10	MGC	W01C024P20	pDONR221	3270		C10orf46	143384	AAH38294.1	Hs.719193	Chromosome 10 open reading frame 46			Testis	NIH_MGC_97	DH10B	NM_153810.4	NP_722517.3	VALIDATED	P	1.000	1.000	295	912	1	885	369	1	295
IKAKEN	BC036679	MGC01-H11	MGC	W01C024P21	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC036679	MGC01-H11	MGC	W01C024P22	pDONR221	5276		NXPH4	11247	AAH36679.1	Hs.719394	Neurexophilin 4			Lung	NIH_MGC_77	DH10B	NM_007224.3	NP_009155.1	VALIDATED	C	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC036653	MGC02-A01	MGC	W01C025A01	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC036653	MGC02-A01	MGC	W01C025A02	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC035033	MGC02-A03	MGC	W01C025A05	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC035033	MGC02-A03	MGC	W01C025A06	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC033907	MGC02-A04	MGC	W01C025A07	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033907	MGC02-A04	MGC	W01C025A08	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033904	MGC02-A05	MGC	W01C025A09	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC033904	MGC02-A05	MGC	W01C025A10	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC030021	MGC02-A06	MGC	W01C025A11	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC030021	MGC02-A06	MGC	W01C025A12	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC036654	MGC02-A07	MGC	W01C025A13	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC036654	MGC02-A07	MGC	W01C025A14	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC032862	MGC02-A08	MGC	W01C025A15	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC032862	MGC02-A08	MGC	W01C025A16	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC030651	MGC02-A09	MGC	W01C025A17	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC030651	MGC02-A09	MGC	W01C025A18	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC036379	MGC02-A10	MGC	W01C025A19	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC036379	MGC02-A10	MGC	W01C025A20	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC058843	MGC02-A11	MGC	W01C025A21	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	MGC02-A11	MGC	W01C025A22	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC021741	MGC02-A12	MGC	W01C025A23	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC021741	MGC02-A12	MGC	W01C025A24	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC036653	MGC02-A01	MGC	W01C025B01	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC036653	MGC02-A01	MGC	W01C025B02	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC035033	MGC02-A03	MGC	W01C025B05	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC035033	MGC02-A03	MGC	W01C025B06	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC033907	MGC02-A04	MGC	W01C025B07	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033907	MGC02-A04	MGC	W01C025B08	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033904	MGC02-A05	MGC	W01C025B09	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC033904	MGC02-A05	MGC	W01C025B10	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC030021	MGC02-A06	MGC	W01C025B11	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC030021	MGC02-A06	MGC	W01C025B12	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC036654	MGC02-A07	MGC	W01C025B13	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC036654	MGC02-A07	MGC	W01C025B14	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC032862	MGC02-A08	MGC	W01C025B15	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC032862	MGC02-A08	MGC	W01C025B16	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC030651	MGC02-A09	MGC	W01C025B17	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC030651	MGC02-A09	MGC	W01C025B18	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC036379	MGC02-A10	MGC	W01C025B19	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC036379	MGC02-A10	MGC	W01C025B20	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC058843	MGC02-A11	MGC	W01C025B21	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	MGC02-A11	MGC	W01C025B22	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC021741	MGC02-A12	MGC	W01C025B23	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC021741	MGC02-A12	MGC	W01C025B24	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC057219	MGC02-B02	MGC	W01C025C03	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC057219	MGC02-B02	MGC	W01C025C04	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C025C05	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C025C06	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC055413	MGC02-B04	MGC	W01C025C07	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055413	MGC02-B04	MGC	W01C025C08	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055089	MGC02-B05	MGC	W01C025C09	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC055089	MGC02-B05	MGC	W01C025C10	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034999	MGC02-B06	MGC	W01C025C11	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC034999	MGC02-B06	MGC	W01C025C12	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC056508	MGC02-B07	MGC	W01C025C13	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC056508	MGC02-B07	MGC	W01C025C14	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC035013	MGC02-B08	MGC	W01C025C15	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	MGC02-B08	MGC	W01C025C16	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC038860	MGC02-B09	MGC	W01C025C17	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC038860	MGC02-B09	MGC	W01C025C18	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC033895	MGC02-B11	MGC	W01C025C21	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC033895	MGC02-B11	MGC	W01C025C22	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC031084	MGC02-B12	MGC	W01C025C23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	MGC02-B12	MGC	W01C025C24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC057219	MGC02-B02	MGC	W01C025D03	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC057219	MGC02-B02	MGC	W01C025D04	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C025D05	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C025D06	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC055413	MGC02-B04	MGC	W01C025D07	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055413	MGC02-B04	MGC	W01C025D08	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055089	MGC02-B05	MGC	W01C025D09	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC055089	MGC02-B05	MGC	W01C025D10	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034999	MGC02-B06	MGC	W01C025D11	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC034999	MGC02-B06	MGC	W01C025D12	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC056508	MGC02-B07	MGC	W01C025D13	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC056508	MGC02-B07	MGC	W01C025D14	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC035013	MGC02-B08	MGC	W01C025D15	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	MGC02-B08	MGC	W01C025D16	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC038860	MGC02-B09	MGC	W01C025D17	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC038860	MGC02-B09	MGC	W01C025D18	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC033895	MGC02-B11	MGC	W01C025D21	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC033895	MGC02-B11	MGC	W01C025D22	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC031084	MGC02-B12	MGC	W01C025D23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	MGC02-B12	MGC	W01C025D24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC036091	MGC02-C01	MGC	W01C025E01	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036091	MGC02-C01	MGC	W01C025E02	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036112	MGC02-C02	MGC	W01C025E03	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036112	MGC02-C02	MGC	W01C025E04	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036012	MGC02-C03	MGC	W01C025E05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	MGC02-C03	MGC	W01C025E06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC031082	MGC02-C04	MGC	W01C025E07	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC031082	MGC02-C04	MGC	W01C025E08	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC040492	MGC02-C05	MGC	W01C025E09	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC040492	MGC02-C05	MGC	W01C025E10	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC029523	MGC02-C06	MGC	W01C025E11	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	MGC02-C06	MGC	W01C025E12	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	MGC02-C07	MGC	W01C025E13	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	MGC02-C07	MGC	W01C025E14	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029540	MGC02-C08	MGC	W01C025E15	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029540	MGC02-C08	MGC	W01C025E16	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC058832	MGC02-C09	MGC	W01C025E17	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058832	MGC02-C09	MGC	W01C025E18	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058020	MGC02-C10	MGC	W01C025E19	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC058020	MGC02-C10	MGC	W01C025E20	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC029485	MGC02-C11	MGC	W01C025E21	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC029485	MGC02-C11	MGC	W01C025E22	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC040501	MGC02-C12	MGC	W01C025E23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC040501	MGC02-C12	MGC	W01C025E24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC036091	MGC02-C01	MGC	W01C025F01	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036091	MGC02-C01	MGC	W01C025F02	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036112	MGC02-C02	MGC	W01C025F03	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036112	MGC02-C02	MGC	W01C025F04	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036012	MGC02-C03	MGC	W01C025F05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	MGC02-C03	MGC	W01C025F06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC031082	MGC02-C04	MGC	W01C025F07	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC031082	MGC02-C04	MGC	W01C025F08	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC040492	MGC02-C05	MGC	W01C025F09	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC040492	MGC02-C05	MGC	W01C025F10	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC029523	MGC02-C06	MGC	W01C025F11	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	MGC02-C06	MGC	W01C025F12	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	MGC02-C07	MGC	W01C025F13	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	MGC02-C07	MGC	W01C025F14	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029540	MGC02-C08	MGC	W01C025F15	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029540	MGC02-C08	MGC	W01C025F16	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC058832	MGC02-C09	MGC	W01C025F17	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058832	MGC02-C09	MGC	W01C025F18	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058020	MGC02-C10	MGC	W01C025F19	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC058020	MGC02-C10	MGC	W01C025F20	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC029485	MGC02-C11	MGC	W01C025F21	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC029485	MGC02-C11	MGC	W01C025F22	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC040501	MGC02-C12	MGC	W01C025F23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC040501	MGC02-C12	MGC	W01C025F24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC039247	MGC02-D01	MGC	W01C025G01	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC039247	MGC02-D01	MGC	W01C025G02	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC029521	MGC02-D02	MGC	W01C025G03	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC029521	MGC02-D02	MGC	W01C025G04	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC036054	MGC02-D03	MGC	W01C025G05	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC036054	MGC02-D03	MGC	W01C025G06	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC031059	MGC02-D04	MGC	W01C025G07	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC031059	MGC02-D04	MGC	W01C025G08	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC039254	MGC02-D05	MGC	W01C025G09	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC039254	MGC02-D05	MGC	W01C025G10	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC029510	MGC02-D06	MGC	W01C025G11	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC029510	MGC02-D06	MGC	W01C025G12	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC054888	MGC02-D07	MGC	W01C025G13	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC054888	MGC02-D07	MGC	W01C025G14	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC039268	MGC02-D08	MGC	W01C025G15	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC039268	MGC02-D08	MGC	W01C025G16	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC029535	MGC02-D09	MGC	W01C025G17	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC029535	MGC02-D09	MGC	W01C025G18	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC036075	MGC02-D10	MGC	W01C025G19	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036075	MGC02-D10	MGC	W01C025G20	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036027	MGC02-D11	MGC	W01C025G21	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC036027	MGC02-D11	MGC	W01C025G22	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC056673	MGC02-D12	MGC	W01C025G23	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC056673	MGC02-D12	MGC	W01C025G24	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC039247	MGC02-D01	MGC	W01C025H01	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC039247	MGC02-D01	MGC	W01C025H02	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC029521	MGC02-D02	MGC	W01C025H03	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC029521	MGC02-D02	MGC	W01C025H04	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC036054	MGC02-D03	MGC	W01C025H05	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC036054	MGC02-D03	MGC	W01C025H06	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC031059	MGC02-D04	MGC	W01C025H07	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC031059	MGC02-D04	MGC	W01C025H08	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC039254	MGC02-D05	MGC	W01C025H09	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC039254	MGC02-D05	MGC	W01C025H10	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC029510	MGC02-D06	MGC	W01C025H11	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC029510	MGC02-D06	MGC	W01C025H12	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC054888	MGC02-D07	MGC	W01C025H13	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC054888	MGC02-D07	MGC	W01C025H14	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC039268	MGC02-D08	MGC	W01C025H15	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC039268	MGC02-D08	MGC	W01C025H16	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC029535	MGC02-D09	MGC	W01C025H17	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC029535	MGC02-D09	MGC	W01C025H18	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC036075	MGC02-D10	MGC	W01C025H19	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036075	MGC02-D10	MGC	W01C025H20	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036027	MGC02-D11	MGC	W01C025H21	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC036027	MGC02-D11	MGC	W01C025H22	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC056673	MGC02-D12	MGC	W01C025H23	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC056673	MGC02-D12	MGC	W01C025H24	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC029486	MGC02-E01	MGC	W01C025I01	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029486	MGC02-E01	MGC	W01C025I02	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029538	MGC02-E02	MGC	W01C025I03	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	MGC02-E02	MGC	W01C025I04	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040528	MGC02-E03	MGC	W01C025I05	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	MGC02-E03	MGC	W01C025I06	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC031228	MGC02-E04	MGC	W01C025I07	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC031228	MGC02-E04	MGC	W01C025I08	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC029577	MGC02-E05	MGC	W01C025I09	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC029577	MGC02-E05	MGC	W01C025I10	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC040521	MGC02-E06	MGC	W01C025I11	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	MGC02-E06	MGC	W01C025I12	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC036202	MGC02-E07	MGC	W01C025I13	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC036202	MGC02-E07	MGC	W01C025I14	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC031288	MGC02-E08	MGC	W01C025I15	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC031288	MGC02-E08	MGC	W01C025I16	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC029564	MGC02-E09	MGC	W01C025I17	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029564	MGC02-E09	MGC	W01C025I18	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029565	MGC02-E10	MGC	W01C025I19	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029565	MGC02-E10	MGC	W01C025I20	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C025I23	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C025I24	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029486	MGC02-E01	MGC	W01C025J01	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029486	MGC02-E01	MGC	W01C025J02	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029538	MGC02-E02	MGC	W01C025J03	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	MGC02-E02	MGC	W01C025J04	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040528	MGC02-E03	MGC	W01C025J05	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	MGC02-E03	MGC	W01C025J06	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC031228	MGC02-E04	MGC	W01C025J07	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC031228	MGC02-E04	MGC	W01C025J08	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC029577	MGC02-E05	MGC	W01C025J09	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC029577	MGC02-E05	MGC	W01C025J10	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC040521	MGC02-E06	MGC	W01C025J11	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	MGC02-E06	MGC	W01C025J12	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC036202	MGC02-E07	MGC	W01C025J13	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC036202	MGC02-E07	MGC	W01C025J14	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC031288	MGC02-E08	MGC	W01C025J15	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC031288	MGC02-E08	MGC	W01C025J16	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC029564	MGC02-E09	MGC	W01C025J17	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029564	MGC02-E09	MGC	W01C025J18	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029565	MGC02-E10	MGC	W01C025J19	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029565	MGC02-E10	MGC	W01C025J20	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C025J23	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C025J24	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC031268	MGC02-F01	MGC	W01C025K01	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC031268	MGC02-F01	MGC	W01C025K02	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC047534	MGC02-F02	MGC	W01C025K03	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC047534	MGC02-F02	MGC	W01C025K04	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC058284	MGC02-F03	MGC	W01C025K05	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC058284	MGC02-F03	MGC	W01C025K06	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC029609	MGC02-F05	MGC	W01C025K09	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029609	MGC02-F05	MGC	W01C025K10	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC054014	MGC02-F07	MGC	W01C025K13	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054014	MGC02-F07	MGC	W01C025K14	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054481	MGC02-F08	MGC	W01C025K15	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC054481	MGC02-F08	MGC	W01C025K16	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC030104	MGC02-F09	MGC	W01C025K17	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC030104	MGC02-F09	MGC	W01C025K18	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC056256	MGC02-F10	MGC	W01C025K19	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC056256	MGC02-F10	MGC	W01C025K20	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC030111	MGC02-F11	MGC	W01C025K21	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC030111	MGC02-F11	MGC	W01C025K22	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC040290	MGC02-F12	MGC	W01C025K23	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	MGC02-F12	MGC	W01C025K24	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC031268	MGC02-F01	MGC	W01C025L01	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC031268	MGC02-F01	MGC	W01C025L02	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC047534	MGC02-F02	MGC	W01C025L03	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC047534	MGC02-F02	MGC	W01C025L04	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC058284	MGC02-F03	MGC	W01C025L05	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC058284	MGC02-F03	MGC	W01C025L06	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC029609	MGC02-F05	MGC	W01C025L09	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029609	MGC02-F05	MGC	W01C025L10	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC054014	MGC02-F07	MGC	W01C025L13	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054014	MGC02-F07	MGC	W01C025L14	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054481	MGC02-F08	MGC	W01C025L15	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC054481	MGC02-F08	MGC	W01C025L16	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC030104	MGC02-F09	MGC	W01C025L17	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC030104	MGC02-F09	MGC	W01C025L18	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC056256	MGC02-F10	MGC	W01C025L19	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC056256	MGC02-F10	MGC	W01C025L20	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC030111	MGC02-F11	MGC	W01C025L21	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC030111	MGC02-F11	MGC	W01C025L22	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC040290	MGC02-F12	MGC	W01C025L23	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	MGC02-F12	MGC	W01C025L24	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040291	MGC02-G01	MGC	W01C025M01	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC040291	MGC02-G01	MGC	W01C025M02	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC032035	MGC02-G02	MGC	W01C025M03	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC032035	MGC02-G02	MGC	W01C025M04	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC056676	MGC02-G03	MGC	W01C025M05	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC056676	MGC02-G03	MGC	W01C025M06	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC040285	MGC02-G04	MGC	W01C025M07	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	MGC02-G04	MGC	W01C025M08	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035230	MGC02-G05	MGC	W01C025M09	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC035230	MGC02-G05	MGC	W01C025M10	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC034589	MGC02-G06	MGC	W01C025M11	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC034589	MGC02-G06	MGC	W01C025M12	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC031945	MGC02-G07	MGC	W01C025M13	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC031945	MGC02-G07	MGC	W01C025M14	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC042848	MGC02-G08	MGC	W01C025M15	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC042848	MGC02-G08	MGC	W01C025M16	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC031949	MGC02-G09	MGC	W01C025M17	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC031949	MGC02-G09	MGC	W01C025M18	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC034629	MGC02-G10	MGC	W01C025M19	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC034629	MGC02-G10	MGC	W01C025M20	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC042483	MGC02-G11	MGC	W01C025M21	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC042483	MGC02-G11	MGC	W01C025M22	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC063130	MGC02-G12	MGC	W01C025M23	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	MGC02-G12	MGC	W01C025M24	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC040291	MGC02-G01	MGC	W01C025N01	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC040291	MGC02-G01	MGC	W01C025N02	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC032035	MGC02-G02	MGC	W01C025N03	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC032035	MGC02-G02	MGC	W01C025N04	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC056676	MGC02-G03	MGC	W01C025N05	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC056676	MGC02-G03	MGC	W01C025N06	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC040285	MGC02-G04	MGC	W01C025N07	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	MGC02-G04	MGC	W01C025N08	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035230	MGC02-G05	MGC	W01C025N09	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC035230	MGC02-G05	MGC	W01C025N10	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC034589	MGC02-G06	MGC	W01C025N11	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC034589	MGC02-G06	MGC	W01C025N12	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC031945	MGC02-G07	MGC	W01C025N13	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC031945	MGC02-G07	MGC	W01C025N14	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC042848	MGC02-G08	MGC	W01C025N15	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC042848	MGC02-G08	MGC	W01C025N16	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC031949	MGC02-G09	MGC	W01C025N17	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC031949	MGC02-G09	MGC	W01C025N18	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC034629	MGC02-G10	MGC	W01C025N19	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC034629	MGC02-G10	MGC	W01C025N20	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC042483	MGC02-G11	MGC	W01C025N21	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC042483	MGC02-G11	MGC	W01C025N22	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC063130	MGC02-G12	MGC	W01C025N23	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	MGC02-G12	MGC	W01C025N24	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC036392	MGC02-H01	MGC	W01C025O01	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036392	MGC02-H01	MGC	W01C025O02	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036407	MGC02-H02	MGC	W01C025O03	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC036407	MGC02-H02	MGC	W01C025O04	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC035132	MGC02-H03	MGC	W01C025O05	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	MGC02-H03	MGC	W01C025O06	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038116	MGC02-H04	MGC	W01C025O07	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC038116	MGC02-H04	MGC	W01C025O08	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC035133	MGC02-H05	MGC	W01C025O09	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC035133	MGC02-H05	MGC	W01C025O10	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC038115	MGC02-H06	MGC	W01C025O11	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	MGC02-H06	MGC	W01C025O12	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC062746	MGC02-H07	MGC	W01C025O13	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	MGC02-H07	MGC	W01C025O14	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC033054	MGC02-H08	MGC	W01C025O15	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC033054	MGC02-H08	MGC	W01C025O16	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC038670	MGC02-H09	MGC	W01C025O17	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC038670	MGC02-H09	MGC	W01C025O18	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC041814	MGC02-H10	MGC	W01C025O19	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC041814	MGC02-H10	MGC	W01C025O20	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC039349	MGC02-H11	MGC	W01C025O21	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC039349	MGC02-H11	MGC	W01C025O22	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC050291	MGC02-H12	MGC	W01C025O23	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	MGC02-H12	MGC	W01C025O24	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC036392	MGC02-H01	MGC	W01C025P01	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036392	MGC02-H01	MGC	W01C025P02	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036407	MGC02-H02	MGC	W01C025P03	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC036407	MGC02-H02	MGC	W01C025P04	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC035132	MGC02-H03	MGC	W01C025P05	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	MGC02-H03	MGC	W01C025P06	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038116	MGC02-H04	MGC	W01C025P07	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC038116	MGC02-H04	MGC	W01C025P08	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC035133	MGC02-H05	MGC	W01C025P09	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC035133	MGC02-H05	MGC	W01C025P10	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC038115	MGC02-H06	MGC	W01C025P11	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	MGC02-H06	MGC	W01C025P12	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC062746	MGC02-H07	MGC	W01C025P13	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	MGC02-H07	MGC	W01C025P14	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC033054	MGC02-H08	MGC	W01C025P15	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC033054	MGC02-H08	MGC	W01C025P16	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC038670	MGC02-H09	MGC	W01C025P17	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC038670	MGC02-H09	MGC	W01C025P18	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC041814	MGC02-H10	MGC	W01C025P19	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC041814	MGC02-H10	MGC	W01C025P20	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC039349	MGC02-H11	MGC	W01C025P21	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC039349	MGC02-H11	MGC	W01C025P22	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC050291	MGC02-H12	MGC	W01C025P23	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	MGC02-H12	MGC	W01C025P24	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC036653	MGC02-A01	MGC	W01C026A01	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC036653	MGC02-A01	MGC	W01C026A02	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC035033	MGC02-A03	MGC	W01C026A05	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC035033	MGC02-A03	MGC	W01C026A06	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC033907	MGC02-A04	MGC	W01C026A07	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033907	MGC02-A04	MGC	W01C026A08	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033904	MGC02-A05	MGC	W01C026A09	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC033904	MGC02-A05	MGC	W01C026A10	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC030021	MGC02-A06	MGC	W01C026A11	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC030021	MGC02-A06	MGC	W01C026A12	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC036654	MGC02-A07	MGC	W01C026A13	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC036654	MGC02-A07	MGC	W01C026A14	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC032862	MGC02-A08	MGC	W01C026A15	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC032862	MGC02-A08	MGC	W01C026A16	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC030651	MGC02-A09	MGC	W01C026A17	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC030651	MGC02-A09	MGC	W01C026A18	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC036379	MGC02-A10	MGC	W01C026A19	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC036379	MGC02-A10	MGC	W01C026A20	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC058843	MGC02-A11	MGC	W01C026A21	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	MGC02-A11	MGC	W01C026A22	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC021741	MGC02-A12	MGC	W01C026A23	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC021741	MGC02-A12	MGC	W01C026A24	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC036653	MGC02-A01	MGC	W01C026B01	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC036653	MGC02-A01	MGC	W01C026B02	pDONR221	21923		PAPOLB	56903	AAH36653.2	Hs.487409	Poly(A) polymerase beta (testis specific)			Testis	NIH_MGC_97	DH10B	NM_020144.4	NP_064529.4	VALIDATED	OK	1.000	1.000	637	1914	1	1911	637	1	637
IKAKEN	BC035033	MGC02-A03	MGC	W01C026B05	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC035033	MGC02-A03	MGC	W01C026B06	pDONR221	1475		KIAA2013	90231	AAH35033.1	Hs.520094	KIAA2013			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138346.1	NP_612355.1	PROVISIONAL	C	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC033907	MGC02-A04	MGC	W01C026B07	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033907	MGC02-A04	MGC	W01C026B08	pDONR221	8322		SHC4	399694	AAH33907.1	Hs.642615	SHC (Src homology 2 domain containing) family, member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_203349.3	NP_976224.3	VALIDATED	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC033904	MGC02-A05	MGC	W01C026B09	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC033904	MGC02-A05	MGC	W01C026B10	pDONR221	16439		SLC6A1	6529	AAH33904.1	Hs.443874	Solute carrier family 6 (neurotransmitter transporter, GABA), member 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003042.3	NP_003033.3	VALIDATED	OK	1.000	1.000	599	1800	1	1797	599	1	599
IKAKEN	BC030021	MGC02-A06	MGC	W01C026B11	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC030021	MGC02-A06	MGC	W01C026B12	pDONR221	5237		RASSF8	11228	AAH30021.1	Hs.696433	Ras association (RalGDS/AF-6) domain family (N-terminal) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_007211.3	NP_009142.2	PROVISIONAL	OK	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC036654	MGC02-A07	MGC	W01C026B13	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC036654	MGC02-A07	MGC	W01C026B14	pDONR221	8526		CP110	9738	AAH36654.1	Hs.279912	CP110 protein			Testis	NIH_MGC_97	DH10B	NM_014711.4	NP_055526.3	VALIDATED	Cs	0.999	0.999	991	2976	1	2973	991	1	991
IKAKEN	BC032862	MGC02-A08	MGC	W01C026B15	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC032862	MGC02-A08	MGC	W01C026B16	pDONR221	12898		SOCS5	9655	AAH32862.1	Hs.468426	Suppressor of cytokine signaling 5			Testis	NIH_MGC_97	DH10B	NM_014011.4	NP_054730.1	REVIEWED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	BC030651	MGC02-A09	MGC	W01C026B17	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC030651	MGC02-A09	MGC	W01C026B18	pDONR221	21446		AGBL3	340351	AAH30651.1	Hs.648616	ATP/GTP binding protein-like 3			Testis	NIH_MGC_97	DH10B	XM_001726650.1	XP_001726702.1	MODEL	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC036379	MGC02-A10	MGC	W01C026B19	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC036379	MGC02-A10	MGC	W01C026B20	pDONR221	19658		KIAA0776	23376	AAH36379.1	Hs.149367	KIAA0776			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015323.4	NP_056138.1	VALIDATED	OK	1.000	1.000	794	2385	1	2382	794	1	794
IKAKEN	BC058843	MGC02-A11	MGC	W01C026B21	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC058843	MGC02-A11	MGC	W01C026B22	pDONR221	2109		ZBTB8OS	339487	AAH58843.1	Hs.655921	Zinc finger and BTB domain containing 8 opposite strand			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_178547.2	NP_848642.1	PROVISIONAL	Pfs	0.753	0.859	154	408	1	406	179	13	166
IKAKEN	BC021741	MGC02-A12	MGC	W01C026B23	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC021741	MGC02-A12	MGC	W01C026B24	pDONR221	33302									Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC057219	MGC02-B02	MGC	W01C026C03	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC057219	MGC02-B02	MGC	W01C026C04	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C026C05	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C026C06	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC055413	MGC02-B04	MGC	W01C026C07	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055413	MGC02-B04	MGC	W01C026C08	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055089	MGC02-B05	MGC	W01C026C09	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC055089	MGC02-B05	MGC	W01C026C10	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034999	MGC02-B06	MGC	W01C026C11	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC034999	MGC02-B06	MGC	W01C026C12	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC056508	MGC02-B07	MGC	W01C026C13	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC056508	MGC02-B07	MGC	W01C026C14	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC035013	MGC02-B08	MGC	W01C026C15	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	MGC02-B08	MGC	W01C026C16	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC038860	MGC02-B09	MGC	W01C026C17	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC038860	MGC02-B09	MGC	W01C026C18	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC033895	MGC02-B11	MGC	W01C026C21	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC033895	MGC02-B11	MGC	W01C026C22	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC031084	MGC02-B12	MGC	W01C026C23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	MGC02-B12	MGC	W01C026C24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC057219	MGC02-B02	MGC	W01C026D03	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC057219	MGC02-B02	MGC	W01C026D04	pDONR221	17979		PPA2	27068	AAH57219.1	Hs.654957	Pyrophosphatase (inorganic) 2			Lung	NIH_MGC_77	DH10B	NM_006903.4	NP_008834.3	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C026D05	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC037306	MGC02-B03	MGC	W01C026D06	pDONR221	17103		CD47	961	AAH37306.1	Hs.446414	CD47 molecule			Testis	NIH_MGC_97	DH10B	NM_198793.2	NP_942088.1	REVIEWED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC055413	MGC02-B04	MGC	W01C026D07	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055413	MGC02-B04	MGC	W01C026D08	pDONR221	23268		LRRC67	286187	AAH55413.1	Hs.632064	Leucine rich repeat containing 67			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001013626.2	NP_001013648.1	PROVISIONAL	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC055089	MGC02-B05	MGC	W01C026D09	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC055089	MGC02-B05	MGC	W01C026D10	pDONR221	16519		CAMP	820	AAH55089.1	Hs.51120	Cathelicidin antimicrobial peptide			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_004345.3	NP_004336.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC034999	MGC02-B06	MGC	W01C026D11	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC034999	MGC02-B06	MGC	W01C026D12	pDONR221	11061		KATNAL2	83473	AAH34999.2	Hs.404137	Katanin p60 subunit A-like 2			Testis	NIH_MGC_97	DH10B	NM_031303.2	NP_112593.2	VALIDATED	P	1.000	1.000	426	1281	1	1278	466	41	466
IKAKEN	BC056508	MGC02-B07	MGC	W01C026D13	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC056508	MGC02-B07	MGC	W01C026D14	pDONR221	25677		VCY1B	353513	AAH56508.1					Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_181880.1	NP_870996.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC035013	MGC02-B08	MGC	W01C026D15	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	MGC02-B08	MGC	W01C026D16	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC038860	MGC02-B09	MGC	W01C026D17	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC038860	MGC02-B09	MGC	W01C026D18	pDONR221	14866		ProSAPiP1	9762	AAH38860.1	Hs.90232	ProSAPiP1 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014731.2	NP_055546.1	VALIDATED	Cg	0.932	1.000	673	1884	1	1881	673	1	673
IKAKEN	BC033895	MGC02-B11	MGC	W01C026D21	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC033895	MGC02-B11	MGC	W01C026D22	pDONR221	15908		ENTHD1	150350	AAH33895.1	Hs.474869	ENTH domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152512.3	NP_689725.2	PROVISIONAL	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC031084	MGC02-B12	MGC	W01C026D23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	MGC02-B12	MGC	W01C026D24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC036091	MGC02-C01	MGC	W01C026E01	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036091	MGC02-C01	MGC	W01C026E02	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036112	MGC02-C02	MGC	W01C026E03	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036112	MGC02-C02	MGC	W01C026E04	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036012	MGC02-C03	MGC	W01C026E05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	MGC02-C03	MGC	W01C026E06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC031082	MGC02-C04	MGC	W01C026E07	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC031082	MGC02-C04	MGC	W01C026E08	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC040492	MGC02-C05	MGC	W01C026E09	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC040492	MGC02-C05	MGC	W01C026E10	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC029523	MGC02-C06	MGC	W01C026E11	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	MGC02-C06	MGC	W01C026E12	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	MGC02-C07	MGC	W01C026E13	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	MGC02-C07	MGC	W01C026E14	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029540	MGC02-C08	MGC	W01C026E15	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029540	MGC02-C08	MGC	W01C026E16	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC058832	MGC02-C09	MGC	W01C026E17	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058832	MGC02-C09	MGC	W01C026E18	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058020	MGC02-C10	MGC	W01C026E19	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC058020	MGC02-C10	MGC	W01C026E20	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC029485	MGC02-C11	MGC	W01C026E21	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC029485	MGC02-C11	MGC	W01C026E22	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC040501	MGC02-C12	MGC	W01C026E23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC040501	MGC02-C12	MGC	W01C026E24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC036091	MGC02-C01	MGC	W01C026F01	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036091	MGC02-C01	MGC	W01C026F02	pDONR221	24806		CDKL5	6792	AAH36091	Hs.659851	Cyclin-dependent kinase-like 5			Testis	NIH_MGC_97	DH10B	NM_003159.2	NP_003150.1	REVIEWED	OK	1.000	1.000	1030	3093	1	3090	1030	1	1030
IKAKEN	BC036112	MGC02-C02	MGC	W01C026F03	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036112	MGC02-C02	MGC	W01C026F04	pDONR221	2648		SUPV3L1	6832	AAH36112.1	Hs.106469	Suppressor of var1, 3-like 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_003171.3	NP_003162.2	PROVISIONAL	OK	1.000	1.000	786	2361	1	2358	786	1	786
IKAKEN	BC036012	MGC02-C03	MGC	W01C026F05	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	MGC02-C03	MGC	W01C026F06	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC031082	MGC02-C04	MGC	W01C026F07	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC031082	MGC02-C04	MGC	W01C026F08	pDONR221	2658		HTRA1	5654	AAH31082	Hs.501280	HtrA serine peptidase 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002775.4	NP_002766.1	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC040492	MGC02-C05	MGC	W01C026F09	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC040492	MGC02-C05	MGC	W01C026F10	pDONR221	22178		SCRN1	9805	AAH40492.1	Hs.520740	Secernin 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001145513.1	NP_001138985.1	REVIEWED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC029523	MGC02-C06	MGC	W01C026F11	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	MGC02-C06	MGC	W01C026F12	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	MGC02-C07	MGC	W01C026F13	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	MGC02-C07	MGC	W01C026F14	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029540	MGC02-C08	MGC	W01C026F15	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029540	MGC02-C08	MGC	W01C026F16	pDONR221	25413		CT47A11	255313	AAH29540.1	Hs.522775	Cancer/testis antigen family 47, member A11			Testis	NIH_MGC_97	DH10B	NM_173571.2	NP_775842.2	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC058832	MGC02-C09	MGC	W01C026F17	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058832	MGC02-C09	MGC	W01C026F18	pDONR221	2026		GOLT1A	127845	AAH58832.1	Hs.532401	Golgi transport 1 homolog A (S. cerevisiae)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198447.1	NP_940849.1	PROVISIONAL	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC058020	MGC02-C10	MGC	W01C026F19	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC058020	MGC02-C10	MGC	W01C026F20	pDONR221	20116		RPL7L1	285855	AAH58020.1	Hs.520133	Ribosomal protein L7-like 1			Skeletal Muscle	NIH_MGC_81	DH10B	NM_198486.2	NP_940888.2	PROVISIONAL	OK	1.000	1.000	246	741	1	738	246	1	246
IKAKEN	BC029485	MGC02-C11	MGC	W01C026F21	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC029485	MGC02-C11	MGC	W01C026F22	pDONR221	4457		MFRP	83552	AAH29485.1	Hs.679518	Membrane frizzled-related protein			Kidney	NIH_MGC_75	DH10B	NM_031433.2	NP_113621.1	REVIEWED		0.317	0.371	41	732	254	150	579	121	161
IKAKEN	BC040501	MGC02-C12	MGC	W01C026F23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC040501	MGC02-C12	MGC	W01C026F24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Ps	0.989	0.989	870	2613	1	2610	1700	1	870
IKAKEN	BC039247	MGC02-D01	MGC	W01C026G01	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC039247	MGC02-D01	MGC	W01C026G02	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC029521	MGC02-D02	MGC	W01C026G03	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC029521	MGC02-D02	MGC	W01C026G04	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC036054	MGC02-D03	MGC	W01C026G05	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC036054	MGC02-D03	MGC	W01C026G06	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC031059	MGC02-D04	MGC	W01C026G07	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC031059	MGC02-D04	MGC	W01C026G08	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC039254	MGC02-D05	MGC	W01C026G09	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC039254	MGC02-D05	MGC	W01C026G10	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC029510	MGC02-D06	MGC	W01C026G11	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC029510	MGC02-D06	MGC	W01C026G12	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC054888	MGC02-D07	MGC	W01C026G13	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC054888	MGC02-D07	MGC	W01C026G14	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC039268	MGC02-D08	MGC	W01C026G15	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC039268	MGC02-D08	MGC	W01C026G16	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC029535	MGC02-D09	MGC	W01C026G17	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC029535	MGC02-D09	MGC	W01C026G18	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC036075	MGC02-D10	MGC	W01C026G19	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036075	MGC02-D10	MGC	W01C026G20	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036027	MGC02-D11	MGC	W01C026G21	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC036027	MGC02-D11	MGC	W01C026G22	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC056673	MGC02-D12	MGC	W01C026G23	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC056673	MGC02-D12	MGC	W01C026G24	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC039247	MGC02-D01	MGC	W01C026H01	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC039247	MGC02-D01	MGC	W01C026H02	pDONR221	9959		RUNDC1	146923	AAH39247.1	Hs.632255	RUN domain containing 1			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_173079.2	NP_775102.2	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC029521	MGC02-D02	MGC	W01C026H03	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC029521	MGC02-D02	MGC	W01C026H04	pDONR221	17121		DNAJB8	165721	AAH29521.1	Hs.518241	DnaJ (Hsp40) homolog, subfamily B, member 8			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_153330.2	NP_699161.1	VALIDATED	C	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BC036054	MGC02-D03	MGC	W01C026H05	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC036054	MGC02-D03	MGC	W01C026H06	pDONR221	11054		C18orf54	162681	AAH36054.1	Hs.208701	Chromosome 18 open reading frame 54			Testis	NIH_MGC_97	DH10B	NM_173529.4	NP_775800.3	VALIDATED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC031059	MGC02-D04	MGC	W01C026H07	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC031059	MGC02-D04	MGC	W01C026H08	pDONR221	15435		LCA5L	150082	AAH31059.1	Hs.517284	Leber congenital amaurosis 5-like			Testis	NIH_MGC_97	DH10B	NM_152505.3	NP_689718.1	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC039254	MGC02-D05	MGC	W01C026H09	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC039254	MGC02-D05	MGC	W01C026H10	pDONR221	1388		WDR47	22911	AAH39254.1	Hs.654760	WD repeat domain 47			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_001142551.1	NP_001136023.1	VALIDATED	Cg	0.970	1.000	919	2676	1	2673	919	1	919
IKAKEN	BC029510	MGC02-D06	MGC	W01C026H11	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC029510	MGC02-D06	MGC	W01C026H12	pDONR221	14284		HAAO	23498	AAH29510.1	Hs.368805	3-hydroxyanthranilate 3,4-dioxygenase			Liver	NIH_MGC_76	DH10B	NM_012205.2	NP_036337.2	REVIEWED	OK	1.000	1.000	286	861	1	858	286	1	286
IKAKEN	BC054888	MGC02-D07	MGC	W01C026H13	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC054888	MGC02-D07	MGC	W01C026H14	pDONR221	14633		LSM14B	149986	AAH54888	Hs.105379	LSM14B, SCD6 homolog B (S. cerevisiae)			Kidney	NIH_MGC_75	DH10B	NM_144703.2	NP_653304.2	VALIDATED		0.438	0.438	16	237	206	159	385	203	218
IKAKEN	BC039268	MGC02-D08	MGC	W01C026H15	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC039268	MGC02-D08	MGC	W01C026H16	pDONR221	3916		C11orf82	220042	AAH39268.1	Hs.165607	Chromosome 11 open reading frame 82			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_145018.3	NP_659455.3	VALIDATED	OK	1.000	1.000	998	2997	1	2994	998	1	998
IKAKEN	BC029535	MGC02-D09	MGC	W01C026H17	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC029535	MGC02-D09	MGC	W01C026H18	pDONR221	12595		C19orf41	126123	AAH29535.2	Hs.414175	Chromosome 19 open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_152358.2	NP_689571.2	VALIDATED	P	1.000	1.000	164	495	1	492	221	58	221
IKAKEN	BC036075	MGC02-D10	MGC	W01C026H19	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036075	MGC02-D10	MGC	W01C026H20	pDONR221	185		GIPC2	54810	AAH36075.1	Hs.659356	GIPC PDZ domain containing family, member 2			Testis	NIH_MGC_97	DH10B	NM_017655.4	NP_060125.4	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC036027	MGC02-D11	MGC	W01C026H21	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC036027	MGC02-D11	MGC	W01C026H22	pDONR221	6516		USPL1	10208	AAH36027.1	Hs.533831	Ubiquitin specific peptidase like 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_005800.4	NP_005791.3	VALIDATED	OK	1.000	1.000	1092	3279	1	3276	1092	1	1092
IKAKEN	BC056673	MGC02-D12	MGC	W01C026H23	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC056673	MGC02-D12	MGC	W01C026H24	pDONR221	25125		PPP1R2P9	80316	AAH56673	Hs.127689	Protein phosphatase 1, regulatory (inhibitor) subunit 2 pseudogene 9			Pooled, 40 cell lines	NIH_MGC_141	DH10B			
IKAKEN	BC029486	MGC02-E01	MGC	W01C026I01	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029486	MGC02-E01	MGC	W01C026I02	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029538	MGC02-E02	MGC	W01C026I03	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	MGC02-E02	MGC	W01C026I04	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040528	MGC02-E03	MGC	W01C026I05	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	MGC02-E03	MGC	W01C026I06	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC031228	MGC02-E04	MGC	W01C026I07	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC031228	MGC02-E04	MGC	W01C026I08	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC029577	MGC02-E05	MGC	W01C026I09	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC029577	MGC02-E05	MGC	W01C026I10	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC040521	MGC02-E06	MGC	W01C026I11	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	MGC02-E06	MGC	W01C026I12	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC036202	MGC02-E07	MGC	W01C026I13	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC036202	MGC02-E07	MGC	W01C026I14	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC031288	MGC02-E08	MGC	W01C026I15	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC031288	MGC02-E08	MGC	W01C026I16	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC029564	MGC02-E09	MGC	W01C026I17	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029564	MGC02-E09	MGC	W01C026I18	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029565	MGC02-E10	MGC	W01C026I19	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029565	MGC02-E10	MGC	W01C026I20	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C026I23	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C026I24	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029486	MGC02-E01	MGC	W01C026J01	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029486	MGC02-E01	MGC	W01C026J02	pDONR221	1736		TM2D1	83941	AAH29486.1	Hs.656790	TM2 domain containing 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_032027.2	NP_114416.1	REVIEWED	Cgs	0.990	0.995	208	627	1	624	207	1	207
IKAKEN	BC029538	MGC02-E02	MGC	W01C026J03	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	MGC02-E02	MGC	W01C026J04	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040528	MGC02-E03	MGC	W01C026J05	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC040528	MGC02-E03	MGC	W01C026J06	pDONR221	23735		FAM75A7	26165	AAH40528.1	Hs.123004	Family with sequence similarity 75, member A7			Testis	NIH_MGC_97	DH10B	NM_015667.2	NP_056482.2	VALIDATED	Ps	0.998	0.998	1272	3819	1	3816	1347	76	1347
IKAKEN	BC031228	MGC02-E04	MGC	W01C026J07	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC031228	MGC02-E04	MGC	W01C026J08	pDONR221	31536									Brain, hypothalamus	NIH_MGC_96	DH10B			
IKAKEN	BC029577	MGC02-E05	MGC	W01C026J09	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC029577	MGC02-E05	MGC	W01C026J10	pDONR221	17087		C3orf44	131831	AAH29577.1	Hs.147128	Chromosome 3 open reading frame 44			Testis	NIH_MGC_97	DH10B	NM_152394.3	NP_689607.2	VALIDATED	P	1.000	1.000	517	1554	1	1551	663	147	663
IKAKEN	BC040521	MGC02-E06	MGC	W01C026J11	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	MGC02-E06	MGC	W01C026J12	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC036202	MGC02-E07	MGC	W01C026J13	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC036202	MGC02-E07	MGC	W01C026J14	pDONR221	16431		CCDC36	339834	AAH36202.1	Hs.631931	Coiled-coil domain containing 36			Testis	NIH_MGC_97	DH10B	NM_001135197.1	NP_001128669.1	VALIDATED	P	1.000	1.000	584	1755	1	1752	594	11	594
IKAKEN	BC031288	MGC02-E08	MGC	W01C026J15	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC031288	MGC02-E08	MGC	W01C026J16	pDONR221	21448		MBLAC1	255374	AAH31288.1	Hs.632319	Metallo-beta-lactamase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_203397.1	NP_981942.1	VALIDATED	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC029564	MGC02-E09	MGC	W01C026J17	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029564	MGC02-E09	MGC	W01C026J18	pDONR221	1495		B3GALNT2	148789	AAH29564.1	Hs.716571	Beta-1,3-N-acetylgalactosaminyltransferase 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152490.2	NP_689703.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC029565	MGC02-E10	MGC	W01C026J19	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029565	MGC02-E10	MGC	W01C026J20	pDONR221	11268		C18orf20	221241	AAH29565	Hs.567778	Chromosome 18 open reading frame 20			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C026J23	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC034236	MGC02-E12	MGC	W01C026J24	pDONR221	12718		LOC284440	284440	-	Hs.665307	Hypothetical LOC284440			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC031268	MGC02-F01	MGC	W01C026K01	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC031268	MGC02-F01	MGC	W01C026K02	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC047534	MGC02-F02	MGC	W01C026K03	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC047534	MGC02-F02	MGC	W01C026K04	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC058284	MGC02-F03	MGC	W01C026K05	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC058284	MGC02-F03	MGC	W01C026K06	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC029609	MGC02-F05	MGC	W01C026K09	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029609	MGC02-F05	MGC	W01C026K10	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC054014	MGC02-F07	MGC	W01C026K13	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054014	MGC02-F07	MGC	W01C026K14	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054481	MGC02-F08	MGC	W01C026K15	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC054481	MGC02-F08	MGC	W01C026K16	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC030104	MGC02-F09	MGC	W01C026K17	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC030104	MGC02-F09	MGC	W01C026K18	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC056256	MGC02-F10	MGC	W01C026K19	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC056256	MGC02-F10	MGC	W01C026K20	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC030111	MGC02-F11	MGC	W01C026K21	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC030111	MGC02-F11	MGC	W01C026K22	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC040290	MGC02-F12	MGC	W01C026K23	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	MGC02-F12	MGC	W01C026K24	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC031268	MGC02-F01	MGC	W01C026L01	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC031268	MGC02-F01	MGC	W01C026L02	pDONR221	11001		TGIF1	7050	AAH31268.1	Hs.373550	TGFB-induced factor homeobox 1			Testis	NIH_MGC_97	DH10B	NM_174886.1	NP_777480.1	REVIEWED		0.863	0.884	256	825	61	822	252	1	252
IKAKEN	BC047534	MGC02-F02	MGC	W01C026L03	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC047534	MGC02-F02	MGC	W01C026L04	pDONR221	9995		CDR2L	30850	AAH47534.1	Hs.78358	Cerebellar degeneration-related protein 2-like			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014603.2	NP_055418.2	VALIDATED	P	1.000	1.000	459	1380	1	1377	465	7	465
IKAKEN	BC058284	MGC02-F03	MGC	W01C026L05	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC058284	MGC02-F03	MGC	W01C026L06	pDONR221	22116		AGR3	155465	AAH58284.1	Hs.100686	Anterior gradient homolog 3 (Xenopus laevis)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_176813.3	NP_789783.1	VALIDATED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC029609	MGC02-F05	MGC	W01C026L09	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC029609	MGC02-F05	MGC	W01C026L10	pDONR221	8860		LOC554206	554206	-	Hs.552959	Hypothetical LOC554206			Testis	NIH_MGC_97	DH10B													
IKAKEN	BC054014	MGC02-F07	MGC	W01C026L13	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054014	MGC02-F07	MGC	W01C026L14	pDONR221	20160		HIST1H4C	8364	AAH54014.1	Hs.46423	Histone cluster 1, H4c			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_003542.3	NP_003533.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC054481	MGC02-F08	MGC	W01C026L15	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC054481	MGC02-F08	MGC	W01C026L16	pDONR221	10673		LYZL6	57151	AAH54481.1	Hs.97477	Lysozyme-like 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020426.1	NP_065159.1	PROVISIONAL	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC030104	MGC02-F09	MGC	W01C026L17	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC030104	MGC02-F09	MGC	W01C026L18	pDONR221	22170		TMEM196	256130	AAH30104.1	Hs.487670	Transmembrane protein 196			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_152774.3	NP_689987.3	VALIDATED	P	1.000	1.000	85	270	1	255	172	69	153
IKAKEN	BC056256	MGC02-F10	MGC	W01C026L19	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC056256	MGC02-F10	MGC	W01C026L20	pDONR221	2		IGKC	3514	AAH56256	Hs.703932	Immunoglobulin kappa constant			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC030111	MGC02-F11	MGC	W01C026L21	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC030111	MGC02-F11	MGC	W01C026L22	pDONR221	17740		MGC42157	439933	-	Hs.591071	Hypothetical locus MGC42157			Brain, hypothalamus	NIH_MGC_96	DH10B													
IKAKEN	BC040290	MGC02-F12	MGC	W01C026L23	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040290	MGC02-F12	MGC	W01C026L24	pDONR221	24881		UBE2DNL	100131816	AAH40290	Hs.460809	Ubiquitin-conjugating enzyme E2D N-terminal like pseudogene			Testis	NIH_MGC_97	DH10B	XM_001716039.1	XP_001716091.1	MODEL	P	1.000	1.000	75	228	1	225	203	129	203
IKAKEN	BC040291	MGC02-G01	MGC	W01C026M01	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC040291	MGC02-G01	MGC	W01C026M02	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC032035	MGC02-G02	MGC	W01C026M03	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC032035	MGC02-G02	MGC	W01C026M04	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC056676	MGC02-G03	MGC	W01C026M05	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC056676	MGC02-G03	MGC	W01C026M06	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC040285	MGC02-G04	MGC	W01C026M07	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	MGC02-G04	MGC	W01C026M08	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035230	MGC02-G05	MGC	W01C026M09	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC035230	MGC02-G05	MGC	W01C026M10	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC034589	MGC02-G06	MGC	W01C026M11	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC034589	MGC02-G06	MGC	W01C026M12	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC031945	MGC02-G07	MGC	W01C026M13	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC031945	MGC02-G07	MGC	W01C026M14	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC042848	MGC02-G08	MGC	W01C026M15	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC042848	MGC02-G08	MGC	W01C026M16	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC031949	MGC02-G09	MGC	W01C026M17	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC031949	MGC02-G09	MGC	W01C026M18	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC034629	MGC02-G10	MGC	W01C026M19	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC034629	MGC02-G10	MGC	W01C026M20	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC042483	MGC02-G11	MGC	W01C026M21	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC042483	MGC02-G11	MGC	W01C026M22	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC063130	MGC02-G12	MGC	W01C026M23	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	MGC02-G12	MGC	W01C026M24	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC040291	MGC02-G01	MGC	W01C026N01	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC040291	MGC02-G01	MGC	W01C026N02	pDONR221	17070		FAM116A	201627	AAH40291.1	Hs.91085	Family with sequence similarity 116, member A			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_152678.2	NP_689891.1	VALIDATED	OK	1.000	1.000	608	1827	1	1824	608	1	608
IKAKEN	BC032035	MGC02-G02	MGC	W01C026N03	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC032035	MGC02-G02	MGC	W01C026N04	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC056676	MGC02-G03	MGC	W01C026N05	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC056676	MGC02-G03	MGC	W01C026N06	pDONR221	9410		C16orf87	388272	AAH56676.1	Hs.406551	Chromosome 16 open reading frame 87			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001436.2	NP_001001436.1	PREDICTED	OK	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	BC040285	MGC02-G04	MGC	W01C026N07	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC040285	MGC02-G04	MGC	W01C026N08	pDONR221	17026		CCDC14	64770	AAH40285	Hs.645028	Coiled-coil domain containing 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_022757.4	NP_073594.4	VALIDATED	Ps	0.999	0.999	790	2382	10	2379	912	123	912
IKAKEN	BC035230	MGC02-G05	MGC	W01C026N09	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC035230	MGC02-G05	MGC	W01C026N10	pDONR221	16259		ZDHHC23	254887	AAH35230.2	Hs.21902	Zinc finger, DHHC-type containing 23			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_173570.3	NP_775841.2	VALIDATED	P	1.000	1.000	403	1212	1	1209	409	7	409
IKAKEN	BC034589	MGC02-G06	MGC	W01C026N11	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC034589	MGC02-G06	MGC	W01C026N12	pDONR221	1887		KIAA0090	23065	AAH34589.1	Hs.439200	KIAA0090			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015047.1	NP_055862.1	PREDICTED	OK	1.000	1.000	993	2982	1	2979	993	1	993
IKAKEN	BC031945	MGC02-G07	MGC	W01C026N13	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC031945	MGC02-G07	MGC	W01C026N14	pDONR221	14290		C2orf19	394261	AAH31945					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001024676.1	NP_001019847.1	NA
IKAKEN	BC042848	MGC02-G08	MGC	W01C026N15	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC042848	MGC02-G08	MGC	W01C026N16	pDONR221	14068		TTC30A	92104	AAH42848.1	Hs.128384	Tetratricopeptide repeat domain 30A			Testis	NIH_MGC_97	DH10B	NM_152275.3	NP_689488.3	VALIDATED	OK	1.000	1.000	665	1998	1	1995	665	1	665
IKAKEN	BC031949	MGC02-G09	MGC	W01C026N17	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC031949	MGC02-G09	MGC	W01C026N18	pDONR221	14806		C20orf135	140701	AAH31949	Hs.266774	Chromosome 20 open reading frame 135			Testis	NIH_MGC_97	DH10B	NM_080622.3	NP_542189.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC034629	MGC02-G10	MGC	W01C026N19	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC034629	MGC02-G10	MGC	W01C026N20	pDONR221	12641		LYPD4	147719	AAH34629.1	Hs.98660	LY6/PLAUR domain containing 4			Testis	NIH_MGC_97	DH10B	NM_173506.4	NP_775777.3	VALIDATED		0.829	0.967	246	636	1	633	246	1	246
IKAKEN	BC042483	MGC02-G11	MGC	W01C026N21	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC042483	MGC02-G11	MGC	W01C026N22	pDONR221	16992		LZTFL1	54585	AAH42483.1	Hs.30824	Leucine zipper transcription factor-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020347.2	NP_065080.1	VALIDATED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC063130	MGC02-G12	MGC	W01C026N23	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	MGC02-G12	MGC	W01C026N24	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC036392	MGC02-H01	MGC	W01C026O01	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036392	MGC02-H01	MGC	W01C026O02	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036407	MGC02-H02	MGC	W01C026O03	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC036407	MGC02-H02	MGC	W01C026O04	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC035132	MGC02-H03	MGC	W01C026O05	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	MGC02-H03	MGC	W01C026O06	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038116	MGC02-H04	MGC	W01C026O07	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC038116	MGC02-H04	MGC	W01C026O08	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC035133	MGC02-H05	MGC	W01C026O09	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC035133	MGC02-H05	MGC	W01C026O10	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC038115	MGC02-H06	MGC	W01C026O11	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	MGC02-H06	MGC	W01C026O12	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC062746	MGC02-H07	MGC	W01C026O13	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	MGC02-H07	MGC	W01C026O14	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC033054	MGC02-H08	MGC	W01C026O15	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC033054	MGC02-H08	MGC	W01C026O16	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC038670	MGC02-H09	MGC	W01C026O17	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC038670	MGC02-H09	MGC	W01C026O18	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC041814	MGC02-H10	MGC	W01C026O19	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC041814	MGC02-H10	MGC	W01C026O20	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC039349	MGC02-H11	MGC	W01C026O21	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC039349	MGC02-H11	MGC	W01C026O22	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC050291	MGC02-H12	MGC	W01C026O23	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	MGC02-H12	MGC	W01C026O24	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC036392	MGC02-H01	MGC	W01C026P01	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036392	MGC02-H01	MGC	W01C026P02	pDONR221	16111		PLCL2	23228	AAH36392.1	Hs.202010	Phospholipase C-like 2			Testis	NIH_MGC_97	DH10B	NM_015184.5	NP_055999.2	VALIDATED	OK	1.000	1.000	1001	3006	1	3003	1001	1	1001
IKAKEN	BC036407	MGC02-H02	MGC	W01C026P03	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC036407	MGC02-H02	MGC	W01C026P04	pDONR221	9924		C17orf57	124989	AAH36407.1	Hs.463303	Chromosome 17 open reading frame 57			Brain, hippocampus	NIH_MGC_95	DH10B	NM_152347.3	NP_689560.2	PREDICTED	Cs	0.999	0.999	973	2922	1	2919	973	1	973
IKAKEN	BC035132	MGC02-H03	MGC	W01C026P05	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	MGC02-H03	MGC	W01C026P06	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC038116	MGC02-H04	MGC	W01C026P07	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC038116	MGC02-H04	MGC	W01C026P08	pDONR221	23495		KANK1	23189	AAH38116.1	Hs.306764	KN motif and ankyrin repeat domains 1			Testis	NIH_MGC_97	DH10B	NM_153186.3	NP_694856.1	REVIEWED	C	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	BC035133	MGC02-H05	MGC	W01C026P09	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC035133	MGC02-H05	MGC	W01C026P10	pDONR221	21060		LRRN3	54674	AAH35133.1	Hs.3781	Leucine rich repeat neuronal 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001099660.1	NP_001093130.1	VALIDATED	OK	1.000	1.000	708	2127	1	2124	708	1	708
IKAKEN	BC038115	MGC02-H06	MGC	W01C026P11	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC038115	MGC02-H06	MGC	W01C026P12	pDONR221	18134		DDX60	55601	AAH38115.1	Hs.591710	DEAD (Asp-Glu-Ala-Asp) box polypeptide 60			Testis	NIH_MGC_97	DH10B	NM_017631.5	NP_060101.3	VALIDATED	OK	1.000	1.000	1712	5139	1	5136	1712	1	1712
IKAKEN	BC062746	MGC02-H07	MGC	W01C026P13	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	MGC02-H07	MGC	W01C026P14	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC033054	MGC02-H08	MGC	W01C026P15	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC033054	MGC02-H08	MGC	W01C026P16	pDONR221	14294		C2orf52	151477	AAH33054	Hs.375211	Chromosome 2 open reading frame 52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173513.2	NP_775784.1	PREDICTED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC038670	MGC02-H09	MGC	W01C026P17	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC038670	MGC02-H09	MGC	W01C026P18	pDONR221	23257		ZC3H3	23144	AAH38670.1	Hs.521915	Zinc finger CCCH-type containing 3			Testis	NIH_MGC_97	DH10B	NM_015117.2	NP_055932.2	VALIDATED	OK	1.000	1.000	948	2847	1	2844	948	1	948
IKAKEN	BC041814	MGC02-H10	MGC	W01C026P19	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC041814	MGC02-H10	MGC	W01C026P20	pDONR221	3593		CRY2	1408	AAH41814.1	Hs.532491	Cryptochrome 2 (photolyase-like)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_021117.3	NP_066940.2	VALIDATED	P	1.000	1.000	593	1782	1	1779	614	22	614
IKAKEN	BC039349	MGC02-H11	MGC	W01C026P21	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC039349	MGC02-H11	MGC	W01C026P22	pDONR221	20694		C6orf146	222826	AAH39349.1	Hs.657342	Chromosome 6 open reading frame 146			Testis	NIH_MGC_97	DH10B	NM_173563.1	NP_775834.1	PREDICTED	Cs	0.998	0.998	508	1527	1	1524	508	1	508
IKAKEN	BC050291	MGC02-H12	MGC	W01C026P23	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	MGC02-H12	MGC	W01C026P24	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC062682	MGC03-A01	MGC	W01C027A01	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	MGC03-A01	MGC	W01C027A02	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC045655	MGC03-A02	MGC	W01C027A03	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	MGC03-A02	MGC	W01C027A04	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC040567	MGC03-A03	MGC	W01C027A05	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC040567	MGC03-A03	MGC	W01C027A06	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC041337	MGC03-A04	MGC	W01C027A07	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041337	MGC03-A04	MGC	W01C027A08	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041374	MGC03-A05	MGC	W01C027A09	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC041374	MGC03-A05	MGC	W01C027A10	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC033942	MGC03-A06	MGC	W01C027A11	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC033942	MGC03-A06	MGC	W01C027A12	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC041384	MGC03-A07	MGC	W01C027A13	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041384	MGC03-A07	MGC	W01C027A14	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041409	MGC03-A08	MGC	W01C027A15	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC041409	MGC03-A08	MGC	W01C027A16	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC062707	MGC03-A09	MGC	W01C027A17	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	MGC03-A09	MGC	W01C027A18	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC041338	MGC03-A10	MGC	W01C027A19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	MGC03-A10	MGC	W01C027A20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC036604	MGC03-A11	MGC	W01C027A21	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC036604	MGC03-A11	MGC	W01C027A22	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC042951	MGC03-A12	MGC	W01C027A23	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC042951	MGC03-A12	MGC	W01C027A24	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC062682	MGC03-A01	MGC	W01C027B01	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	MGC03-A01	MGC	W01C027B02	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC045655	MGC03-A02	MGC	W01C027B03	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	MGC03-A02	MGC	W01C027B04	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC040567	MGC03-A03	MGC	W01C027B05	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC040567	MGC03-A03	MGC	W01C027B06	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC041337	MGC03-A04	MGC	W01C027B07	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041337	MGC03-A04	MGC	W01C027B08	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041374	MGC03-A05	MGC	W01C027B09	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC041374	MGC03-A05	MGC	W01C027B10	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC033942	MGC03-A06	MGC	W01C027B11	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC033942	MGC03-A06	MGC	W01C027B12	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC041384	MGC03-A07	MGC	W01C027B13	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041384	MGC03-A07	MGC	W01C027B14	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041409	MGC03-A08	MGC	W01C027B15	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC041409	MGC03-A08	MGC	W01C027B16	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC062707	MGC03-A09	MGC	W01C027B17	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	MGC03-A09	MGC	W01C027B18	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC041338	MGC03-A10	MGC	W01C027B19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	MGC03-A10	MGC	W01C027B20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC036604	MGC03-A11	MGC	W01C027B21	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC036604	MGC03-A11	MGC	W01C027B22	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC042951	MGC03-A12	MGC	W01C027B23	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC042951	MGC03-A12	MGC	W01C027B24	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC041379	MGC03-B01	MGC	W01C027C01	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC041379	MGC03-B01	MGC	W01C027C02	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC043144	MGC03-B02	MGC	W01C027C03	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC043144	MGC03-B02	MGC	W01C027C04	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC042999	MGC03-B03	MGC	W01C027C05	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC042999	MGC03-B03	MGC	W01C027C06	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC043216	MGC03-B04	MGC	W01C027C07	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC043216	MGC03-B04	MGC	W01C027C08	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC062712	MGC03-B05	MGC	W01C027C09	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	MGC03-B05	MGC	W01C027C10	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC043153	MGC03-B06	MGC	W01C027C11	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC043153	MGC03-B06	MGC	W01C027C12	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC033935	MGC03-B07	MGC	W01C027C13	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC033935	MGC03-B07	MGC	W01C027C14	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC043005	MGC03-B08	MGC	W01C027C15	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC043005	MGC03-B08	MGC	W01C027C16	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC044925	MGC03-B09	MGC	W01C027C17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC044925	MGC03-B09	MGC	W01C027C18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC041809	MGC03-B10	MGC	W01C027C19	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC041809	MGC03-B10	MGC	W01C027C20	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC063114	MGC03-B11	MGC	W01C027C21	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	MGC03-B11	MGC	W01C027C22	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC041801	MGC03-B12	MGC	W01C027C23	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC041801	MGC03-B12	MGC	W01C027C24	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC041379	MGC03-B01	MGC	W01C027D01	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC041379	MGC03-B01	MGC	W01C027D02	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC043144	MGC03-B02	MGC	W01C027D03	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC043144	MGC03-B02	MGC	W01C027D04	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC042999	MGC03-B03	MGC	W01C027D05	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC042999	MGC03-B03	MGC	W01C027D06	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC043216	MGC03-B04	MGC	W01C027D07	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC043216	MGC03-B04	MGC	W01C027D08	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC062712	MGC03-B05	MGC	W01C027D09	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	MGC03-B05	MGC	W01C027D10	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC043153	MGC03-B06	MGC	W01C027D11	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC043153	MGC03-B06	MGC	W01C027D12	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC033935	MGC03-B07	MGC	W01C027D13	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC033935	MGC03-B07	MGC	W01C027D14	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC043005	MGC03-B08	MGC	W01C027D15	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC043005	MGC03-B08	MGC	W01C027D16	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC044925	MGC03-B09	MGC	W01C027D17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC044925	MGC03-B09	MGC	W01C027D18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC041809	MGC03-B10	MGC	W01C027D19	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC041809	MGC03-B10	MGC	W01C027D20	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC063114	MGC03-B11	MGC	W01C027D21	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	MGC03-B11	MGC	W01C027D22	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC041801	MGC03-B12	MGC	W01C027D23	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC041801	MGC03-B12	MGC	W01C027D24	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC062680	MGC03-C01	MGC	W01C027E01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	MGC03-C01	MGC	W01C027E02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC050283	MGC03-C02	MGC	W01C027E03	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC050283	MGC03-C02	MGC	W01C027E04	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC045642	MGC03-C03	MGC	W01C027E05	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC045642	MGC03-C03	MGC	W01C027E06	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC062662	MGC03-C04	MGC	W01C027E07	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	MGC03-C04	MGC	W01C027E08	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC055429	MGC03-C05	MGC	W01C027E09	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC055429	MGC03-C05	MGC	W01C027E10	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC052957	MGC03-C06	MGC	W01C027E11	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC052957	MGC03-C06	MGC	W01C027E12	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC051723	MGC03-C07	MGC	W01C027E13	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC051723	MGC03-C07	MGC	W01C027E14	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC055424	MGC03-C08	MGC	W01C027E15	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC055424	MGC03-C08	MGC	W01C027E16	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC062218	MGC03-C09	MGC	W01C027E17	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	MGC03-C09	MGC	W01C027E18	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC050327	MGC03-C10	MGC	W01C027E19	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	MGC03-C10	MGC	W01C027E20	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC047590	MGC03-C11	MGC	W01C027E21	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC047590	MGC03-C11	MGC	W01C027E22	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC055426	MGC03-C12	MGC	W01C027E23	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC055426	MGC03-C12	MGC	W01C027E24	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC062680	MGC03-C01	MGC	W01C027F01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	MGC03-C01	MGC	W01C027F02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC050283	MGC03-C02	MGC	W01C027F03	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC050283	MGC03-C02	MGC	W01C027F04	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC045642	MGC03-C03	MGC	W01C027F05	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC045642	MGC03-C03	MGC	W01C027F06	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC062662	MGC03-C04	MGC	W01C027F07	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	MGC03-C04	MGC	W01C027F08	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC055429	MGC03-C05	MGC	W01C027F09	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC055429	MGC03-C05	MGC	W01C027F10	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC052957	MGC03-C06	MGC	W01C027F11	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC052957	MGC03-C06	MGC	W01C027F12	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC051723	MGC03-C07	MGC	W01C027F13	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC051723	MGC03-C07	MGC	W01C027F14	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC055424	MGC03-C08	MGC	W01C027F15	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC055424	MGC03-C08	MGC	W01C027F16	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC062218	MGC03-C09	MGC	W01C027F17	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	MGC03-C09	MGC	W01C027F18	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC050327	MGC03-C10	MGC	W01C027F19	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	MGC03-C10	MGC	W01C027F20	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC047590	MGC03-C11	MGC	W01C027F21	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC047590	MGC03-C11	MGC	W01C027F22	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC055426	MGC03-C12	MGC	W01C027F23	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC055426	MGC03-C12	MGC	W01C027F24	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC050329	MGC03-D01	MGC	W01C027G01	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	MGC03-D01	MGC	W01C027G02	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC062213	MGC03-D02	MGC	W01C027G03	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	MGC03-D02	MGC	W01C027G04	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062423	MGC03-D03	MGC	W01C027G05	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	MGC03-D03	MGC	W01C027G06	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC047594	MGC03-D04	MGC	W01C027G07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	MGC03-D04	MGC	W01C027G08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC065724	MGC03-D06	MGC	W01C027G11	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	MGC03-D06	MGC	W01C027G12	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC051716	MGC03-D07	MGC	W01C027G13	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC051716	MGC03-D07	MGC	W01C027G14	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC055428	MGC03-D08	MGC	W01C027G15	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	MGC03-D08	MGC	W01C027G16	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC062679	MGC03-D09	MGC	W01C027G17	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	MGC03-D09	MGC	W01C027G18	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC050051	MGC03-D10	MGC	W01C027G19	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC050051	MGC03-D10	MGC	W01C027G20	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC047400	MGC03-D11	MGC	W01C027G21	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047400	MGC03-D11	MGC	W01C027G22	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047455	MGC03-D12	MGC	W01C027G23	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC047455	MGC03-D12	MGC	W01C027G24	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC050329	MGC03-D01	MGC	W01C027H01	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	MGC03-D01	MGC	W01C027H02	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC062213	MGC03-D02	MGC	W01C027H03	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	MGC03-D02	MGC	W01C027H04	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062423	MGC03-D03	MGC	W01C027H05	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	MGC03-D03	MGC	W01C027H06	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC047594	MGC03-D04	MGC	W01C027H07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	MGC03-D04	MGC	W01C027H08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC065724	MGC03-D06	MGC	W01C027H11	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	MGC03-D06	MGC	W01C027H12	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC051716	MGC03-D07	MGC	W01C027H13	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC051716	MGC03-D07	MGC	W01C027H14	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC055428	MGC03-D08	MGC	W01C027H15	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	MGC03-D08	MGC	W01C027H16	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC062679	MGC03-D09	MGC	W01C027H17	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	MGC03-D09	MGC	W01C027H18	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC050051	MGC03-D10	MGC	W01C027H19	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC050051	MGC03-D10	MGC	W01C027H20	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC047400	MGC03-D11	MGC	W01C027H21	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047400	MGC03-D11	MGC	W01C027H22	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047455	MGC03-D12	MGC	W01C027H23	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC047455	MGC03-D12	MGC	W01C027H24	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC062217	MGC03-E01	MGC	W01C027I01	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	MGC03-E01	MGC	W01C027I02	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC056219	MGC03-E02	MGC	W01C027I03	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC056219	MGC03-E02	MGC	W01C027I04	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC047502	MGC03-E03	MGC	W01C027I05	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC047502	MGC03-E03	MGC	W01C027I06	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC062678	MGC03-E04	MGC	W01C027I07	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	MGC03-E04	MGC	W01C027I08	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC051688	MGC03-E05	MGC	W01C027I09	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC051688	MGC03-E05	MGC	W01C027I10	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC047482	MGC03-E06	MGC	W01C027I11	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC047482	MGC03-E06	MGC	W01C027I12	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC065714	MGC03-E07	MGC	W01C027I13	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	MGC03-E07	MGC	W01C027I14	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC045553	MGC03-E08	MGC	W01C027I15	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045553	MGC03-E08	MGC	W01C027I16	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045540	MGC03-E09	MGC	W01C027I17	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	MGC03-E09	MGC	W01C027I18	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	MGC03-E10	MGC	W01C027I19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	MGC03-E10	MGC	W01C027I20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC056606	MGC03-E11	MGC	W01C027I21	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC056606	MGC03-E11	MGC	W01C027I22	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC062734	MGC03-E12	MGC	W01C027I23	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	MGC03-E12	MGC	W01C027I24	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062217	MGC03-E01	MGC	W01C027J01	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	MGC03-E01	MGC	W01C027J02	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC056219	MGC03-E02	MGC	W01C027J03	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC056219	MGC03-E02	MGC	W01C027J04	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC047502	MGC03-E03	MGC	W01C027J05	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC047502	MGC03-E03	MGC	W01C027J06	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC062678	MGC03-E04	MGC	W01C027J07	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	MGC03-E04	MGC	W01C027J08	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC051688	MGC03-E05	MGC	W01C027J09	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC051688	MGC03-E05	MGC	W01C027J10	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC047482	MGC03-E06	MGC	W01C027J11	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC047482	MGC03-E06	MGC	W01C027J12	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC065714	MGC03-E07	MGC	W01C027J13	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	MGC03-E07	MGC	W01C027J14	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC045553	MGC03-E08	MGC	W01C027J15	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045553	MGC03-E08	MGC	W01C027J16	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045540	MGC03-E09	MGC	W01C027J17	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	MGC03-E09	MGC	W01C027J18	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	MGC03-E10	MGC	W01C027J19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	MGC03-E10	MGC	W01C027J20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC056606	MGC03-E11	MGC	W01C027J21	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC056606	MGC03-E11	MGC	W01C027J22	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC062734	MGC03-E12	MGC	W01C027J23	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	MGC03-E12	MGC	W01C027J24	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC048097	MGC03-F01	MGC	W01C027K01	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC048097	MGC03-F01	MGC	W01C027K02	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC065721	MGC03-F02	MGC	W01C027K03	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC065721	MGC03-F02	MGC	W01C027K04	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC048134	MGC03-F03	MGC	W01C027K05	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC048134	MGC03-F03	MGC	W01C027K06	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC060862	MGC03-F04	MGC	W01C027K07	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060862	MGC03-F04	MGC	W01C027K08	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060796	MGC03-F05	MGC	W01C027K09	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	MGC03-F05	MGC	W01C027K10	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	MGC03-F06	MGC	W01C027K11	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	MGC03-F06	MGC	W01C027K12	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063295	MGC03-F07	MGC	W01C027K13	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063295	MGC03-F07	MGC	W01C027K14	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063283	MGC03-F08	MGC	W01C027K15	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC063283	MGC03-F08	MGC	W01C027K16	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC057813	MGC03-F09	MGC	W01C027K17	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC057813	MGC03-F09	MGC	W01C027K18	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC059362	MGC03-F10	MGC	W01C027K19	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC059362	MGC03-F10	MGC	W01C027K20	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC066124	MGC03-F11	MGC	W01C027K21	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	MGC03-F11	MGC	W01C027K22	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC060855	MGC03-F12	MGC	W01C027K23	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC060855	MGC03-F12	MGC	W01C027K24	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC048097	MGC03-F01	MGC	W01C027L01	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC048097	MGC03-F01	MGC	W01C027L02	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC065721	MGC03-F02	MGC	W01C027L03	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC065721	MGC03-F02	MGC	W01C027L04	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC048134	MGC03-F03	MGC	W01C027L05	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC048134	MGC03-F03	MGC	W01C027L06	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC060862	MGC03-F04	MGC	W01C027L07	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060862	MGC03-F04	MGC	W01C027L08	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060796	MGC03-F05	MGC	W01C027L09	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	MGC03-F05	MGC	W01C027L10	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	MGC03-F06	MGC	W01C027L11	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	MGC03-F06	MGC	W01C027L12	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063295	MGC03-F07	MGC	W01C027L13	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063295	MGC03-F07	MGC	W01C027L14	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063283	MGC03-F08	MGC	W01C027L15	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC063283	MGC03-F08	MGC	W01C027L16	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC057813	MGC03-F09	MGC	W01C027L17	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC057813	MGC03-F09	MGC	W01C027L18	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC059362	MGC03-F10	MGC	W01C027L19	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC059362	MGC03-F10	MGC	W01C027L20	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC066124	MGC03-F11	MGC	W01C027L21	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	MGC03-F11	MGC	W01C027L22	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC060855	MGC03-F12	MGC	W01C027L23	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC060855	MGC03-F12	MGC	W01C027L24	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC063293	MGC03-G01	MGC	W01C027M01	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	MGC03-G01	MGC	W01C027M02	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	MGC03-G02	MGC	W01C027M03	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	MGC03-G02	MGC	W01C027M04	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	MGC03-G03	MGC	W01C027M05	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	MGC03-G03	MGC	W01C027M06	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	MGC03-G04	MGC	W01C027M07	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	MGC03-G04	MGC	W01C027M08	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC062670	MGC03-G05	MGC	W01C027M09	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	MGC03-G05	MGC	W01C027M10	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC063313	MGC03-G06	MGC	W01C027M11	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063313	MGC03-G06	MGC	W01C027M12	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063306	MGC03-G07	MGC	W01C027M13	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC063306	MGC03-G07	MGC	W01C027M14	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC060882	MGC03-G08	MGC	W01C027M15	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	MGC03-G08	MGC	W01C027M16	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057825	MGC03-G09	MGC	W01C027M17	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057825	MGC03-G09	MGC	W01C027M18	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057779	MGC03-G10	MGC	W01C027M19	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	MGC03-G10	MGC	W01C027M20	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC063595	MGC03-G11	MGC	W01C027M21	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	MGC03-G11	MGC	W01C027M22	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	MGC03-G12	MGC	W01C027M23	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	MGC03-G12	MGC	W01C027M24	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC063293	MGC03-G01	MGC	W01C027N01	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	MGC03-G01	MGC	W01C027N02	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	MGC03-G02	MGC	W01C027N03	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	MGC03-G02	MGC	W01C027N04	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	MGC03-G03	MGC	W01C027N05	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	MGC03-G03	MGC	W01C027N06	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	MGC03-G04	MGC	W01C027N07	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	MGC03-G04	MGC	W01C027N08	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC062670	MGC03-G05	MGC	W01C027N09	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	MGC03-G05	MGC	W01C027N10	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC063313	MGC03-G06	MGC	W01C027N11	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063313	MGC03-G06	MGC	W01C027N12	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063306	MGC03-G07	MGC	W01C027N13	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC063306	MGC03-G07	MGC	W01C027N14	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC060882	MGC03-G08	MGC	W01C027N15	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	MGC03-G08	MGC	W01C027N16	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057825	MGC03-G09	MGC	W01C027N17	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057825	MGC03-G09	MGC	W01C027N18	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057779	MGC03-G10	MGC	W01C027N19	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	MGC03-G10	MGC	W01C027N20	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC063595	MGC03-G11	MGC	W01C027N21	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	MGC03-G11	MGC	W01C027N22	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	MGC03-G12	MGC	W01C027N23	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	MGC03-G12	MGC	W01C027N24	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060797	MGC03-H01	MGC	W01C027O01	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	MGC03-H01	MGC	W01C027O02	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC057792	MGC03-H02	MGC	W01C027O03	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	MGC03-H02	MGC	W01C027O04	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC060847	MGC03-H03	MGC	W01C027O05	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060847	MGC03-H03	MGC	W01C027O06	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060776	MGC03-H04	MGC	W01C027O07	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060776	MGC03-H04	MGC	W01C027O08	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060887	MGC03-H05	MGC	W01C027O09	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060887	MGC03-H05	MGC	W01C027O10	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060841	MGC03-H06	MGC	W01C027O11	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	MGC03-H06	MGC	W01C027O12	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060844	MGC03-H07	MGC	W01C027O13	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC060844	MGC03-H07	MGC	W01C027O14	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC066122	MGC03-H08	MGC	W01C027O15	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	MGC03-H08	MGC	W01C027O16	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC060871	MGC03-H09	MGC	W01C027O17	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC060871	MGC03-H09	MGC	W01C027O18	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC059398	MGC03-H10	MGC	W01C027O19	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	MGC03-H10	MGC	W01C027O20	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	MGC03-H11	MGC	W01C027O21	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	MGC03-H11	MGC	W01C027O22	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC066955	MGC03-H12	MGC	W01C027O23	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066955	MGC03-H12	MGC	W01C027O24	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC060797	MGC03-H01	MGC	W01C027P01	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	MGC03-H01	MGC	W01C027P02	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC057792	MGC03-H02	MGC	W01C027P03	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	MGC03-H02	MGC	W01C027P04	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC060847	MGC03-H03	MGC	W01C027P05	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060847	MGC03-H03	MGC	W01C027P06	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060776	MGC03-H04	MGC	W01C027P07	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060776	MGC03-H04	MGC	W01C027P08	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060887	MGC03-H05	MGC	W01C027P09	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060887	MGC03-H05	MGC	W01C027P10	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060841	MGC03-H06	MGC	W01C027P11	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	MGC03-H06	MGC	W01C027P12	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060844	MGC03-H07	MGC	W01C027P13	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC060844	MGC03-H07	MGC	W01C027P14	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC066122	MGC03-H08	MGC	W01C027P15	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	MGC03-H08	MGC	W01C027P16	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC060871	MGC03-H09	MGC	W01C027P17	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC060871	MGC03-H09	MGC	W01C027P18	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC059398	MGC03-H10	MGC	W01C027P19	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	MGC03-H10	MGC	W01C027P20	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	MGC03-H11	MGC	W01C027P21	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	MGC03-H11	MGC	W01C027P22	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC066955	MGC03-H12	MGC	W01C027P23	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066955	MGC03-H12	MGC	W01C027P24	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC062682	MGC03-A01	MGC	W01C028A01	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	MGC03-A01	MGC	W01C028A02	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC045655	MGC03-A02	MGC	W01C028A03	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	MGC03-A02	MGC	W01C028A04	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC040567	MGC03-A03	MGC	W01C028A05	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC040567	MGC03-A03	MGC	W01C028A06	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC041337	MGC03-A04	MGC	W01C028A07	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041337	MGC03-A04	MGC	W01C028A08	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041374	MGC03-A05	MGC	W01C028A09	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC041374	MGC03-A05	MGC	W01C028A10	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC033942	MGC03-A06	MGC	W01C028A11	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC033942	MGC03-A06	MGC	W01C028A12	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC041384	MGC03-A07	MGC	W01C028A13	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041384	MGC03-A07	MGC	W01C028A14	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041409	MGC03-A08	MGC	W01C028A15	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC041409	MGC03-A08	MGC	W01C028A16	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC062707	MGC03-A09	MGC	W01C028A17	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	MGC03-A09	MGC	W01C028A18	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC041338	MGC03-A10	MGC	W01C028A19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	MGC03-A10	MGC	W01C028A20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC036604	MGC03-A11	MGC	W01C028A21	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC036604	MGC03-A11	MGC	W01C028A22	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC042951	MGC03-A12	MGC	W01C028A23	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC042951	MGC03-A12	MGC	W01C028A24	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC062682	MGC03-A01	MGC	W01C028B01	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	MGC03-A01	MGC	W01C028B02	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC045655	MGC03-A02	MGC	W01C028B03	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	MGC03-A02	MGC	W01C028B04	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC040567	MGC03-A03	MGC	W01C028B05	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC040567	MGC03-A03	MGC	W01C028B06	pDONR221	13253		WDR75	84128	AAH40567.1	Hs.399984	WD repeat domain 75			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032168.1	NP_115544.1	PROVISIONAL	C	1.000	1.000	830	2493	1	2490	830	1	830
IKAKEN	BC041337	MGC03-A04	MGC	W01C028B07	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041337	MGC03-A04	MGC	W01C028B08	pDONR221	18499		RHOBTB3	22836	AAH41337.1	Hs.445030	Rho-related BTB domain containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014899.3	NP_055714.3	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC041374	MGC03-A05	MGC	W01C028B09	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC041374	MGC03-A05	MGC	W01C028B10	pDONR221	4445		LRRC4C	57689	AAH41374.3	Hs.135736	Leucine rich repeat containing 4C			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020929.1	NP_065980.1	VALIDATED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC033942	MGC03-A06	MGC	W01C028B11	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC033942	MGC03-A06	MGC	W01C028B12	pDONR221	10736		RPRML	388394	AAH33942.2	Hs.367999	Reprimo-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203400.3	NP_981945.1	VALIDATED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC041384	MGC03-A07	MGC	W01C028B13	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041384	MGC03-A07	MGC	W01C028B14	pDONR221	17996		KLHL8	57563	AAH41384.1	Hs.106601	Kelch-like 8 (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_020803.3	NP_065854.3	VALIDATED	OK	1.000	1.000	620	1863	1	1860	620	1	620
IKAKEN	BC041409	MGC03-A08	MGC	W01C028B15	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC041409	MGC03-A08	MGC	W01C028B16	pDONR221	24528		BHLHB9	80823	AAH41409.1	Hs.4276	Basic helix-loop-helix domain containing, class B, 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001142528.1	NP_001136000.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC062707	MGC03-A09	MGC	W01C028B17	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	MGC03-A09	MGC	W01C028B18	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC041338	MGC03-A10	MGC	W01C028B19	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC041338	MGC03-A10	MGC	W01C028B20	pDONR221	20029		FIG4	9896	AAH41338.1	Hs.529959	FIG4 homolog (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_014845.5	NP_055660.1	REVIEWED	OK	1.000	1.000	907	2724	1	2721	907	1	907
IKAKEN	BC036604	MGC03-A11	MGC	W01C028B21	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC036604	MGC03-A11	MGC	W01C028B22	pDONR221	13391		D2HGDH	728294	AAH36604.2	Hs.535639	D-2-hydroxyglutarate dehydrogenase			Testis	NIH_MGC_97	DH10B	XM_001720547.1	XP_001720599.1	MODEL	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC042951	MGC03-A12	MGC	W01C028B23	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC042951	MGC03-A12	MGC	W01C028B24	pDONR221	3344		TCERG1L	256536	AAH42951.1	Hs.126575	Transcription elongation regulator 1-like			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_174937.3	NP_777597.2	VALIDATED	P	1.000	1.000	545	1638	1	1635	586	42	586
IKAKEN	BC041379	MGC03-B01	MGC	W01C028C01	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC041379	MGC03-B01	MGC	W01C028C02	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC043144	MGC03-B02	MGC	W01C028C03	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC043144	MGC03-B02	MGC	W01C028C04	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC042999	MGC03-B03	MGC	W01C028C05	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC042999	MGC03-B03	MGC	W01C028C06	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC043216	MGC03-B04	MGC	W01C028C07	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC043216	MGC03-B04	MGC	W01C028C08	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC062712	MGC03-B05	MGC	W01C028C09	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	MGC03-B05	MGC	W01C028C10	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC043153	MGC03-B06	MGC	W01C028C11	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC043153	MGC03-B06	MGC	W01C028C12	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC033935	MGC03-B07	MGC	W01C028C13	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC033935	MGC03-B07	MGC	W01C028C14	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC043005	MGC03-B08	MGC	W01C028C15	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC043005	MGC03-B08	MGC	W01C028C16	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC044925	MGC03-B09	MGC	W01C028C17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC044925	MGC03-B09	MGC	W01C028C18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC041809	MGC03-B10	MGC	W01C028C19	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC041809	MGC03-B10	MGC	W01C028C20	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC063114	MGC03-B11	MGC	W01C028C21	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	MGC03-B11	MGC	W01C028C22	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC041801	MGC03-B12	MGC	W01C028C23	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC041801	MGC03-B12	MGC	W01C028C24	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC041379	MGC03-B01	MGC	W01C028D01	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC041379	MGC03-B01	MGC	W01C028D02	pDONR221	23236		TMEM65	157378	AAH41379.1	Hs.187646	Transmembrane protein 65			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_194291.2	NP_919267.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC043144	MGC03-B02	MGC	W01C028D03	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC043144	MGC03-B02	MGC	W01C028D04	pDONR221	22475		RIMS2	9699	AAH43144.1	Hs.655271	Regulating synaptic membrane exocytosis 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014677.3	NP_055492.3	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC042999	MGC03-B03	MGC	W01C028D05	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC042999	MGC03-B03	MGC	W01C028D06	pDONR221	13809		ASXL2	55252	AAH42999.1	Hs.594386	Additional sex combs like 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_018263.4	NP_060733.4	VALIDATED	Pfs	0.510	0.653	1175	2757	1	2753	1435	261	1435
IKAKEN	BC043216	MGC03-B04	MGC	W01C028D07	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC043216	MGC03-B04	MGC	W01C028D08	pDONR221	24884		VSIG1	340547	AAH43216.1	Hs.177164	V-set and immunoglobulin domain containing 1			Testis	NIH_MGC_97	DH10B	NM_182607.3	NP_872413.1	PROVISIONAL	OK	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC062712	MGC03-B05	MGC	W01C028D09	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	MGC03-B05	MGC	W01C028D10	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC043153	MGC03-B06	MGC	W01C028D11	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC043153	MGC03-B06	MGC	W01C028D12	pDONR221	22179		CTAGE6	340307	AAH43153	Hs.676333	CTAGE family, member 6			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178561.4	NP_848656.2	VALIDATED		0.955	0.955	777	2334	1	2331	777	1	777
IKAKEN	BC033935	MGC03-B07	MGC	W01C028D13	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC033935	MGC03-B07	MGC	W01C028D14	pDONR221	13354		FBXO36	130888	AAH33935.1	Hs.140666	F-box protein 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174899.4	NP_777559.3	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC043005	MGC03-B08	MGC	W01C028D15	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC043005	MGC03-B08	MGC	W01C028D16	pDONR221	11845		TMEM146	257062	AAH43005.2	Hs.631842	Transmembrane protein 146			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152784.3	NP_689997.3	VALIDATED	P	1.000	1.000	724	2175	1	2172	798	75	798
IKAKEN	BC044925	MGC03-B09	MGC	W01C028D17	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC044925	MGC03-B09	MGC	W01C028D18	pDONR221	9534		TLK2	11011	AAH44925.2	Hs.445078	Tousled-like kinase 2			Testis	NIH_MGC_97	DH10B	NM_001112707.1	NP_001106178.1	VALIDATED		0.936	0.979	750	2250	1	2247	718	1	718
IKAKEN	BC041809	MGC03-B10	MGC	W01C028D19	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC041809	MGC03-B10	MGC	W01C028D20	pDONR221	2213		GCLM	2730	AAH41809.1	Hs.315562	Glutamate-cysteine ligase, modifier subunit			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_002061.2	NP_002052.1	REVIEWED	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC063114	MGC03-B11	MGC	W01C028D21	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	MGC03-B11	MGC	W01C028D22	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC041801	MGC03-B12	MGC	W01C028D23	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC041801	MGC03-B12	MGC	W01C028D24	pDONR221	2095		DDX59	83479	AAH41801.1	Hs.497332	DEAD (Asp-Glu-Ala-Asp) box polypeptide 59			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001031725.4	NP_001026895.2	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	BC062680	MGC03-C01	MGC	W01C028E01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	MGC03-C01	MGC	W01C028E02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC050283	MGC03-C02	MGC	W01C028E03	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC050283	MGC03-C02	MGC	W01C028E04	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC045642	MGC03-C03	MGC	W01C028E05	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC045642	MGC03-C03	MGC	W01C028E06	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC062662	MGC03-C04	MGC	W01C028E07	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	MGC03-C04	MGC	W01C028E08	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC055429	MGC03-C05	MGC	W01C028E09	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC055429	MGC03-C05	MGC	W01C028E10	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC052957	MGC03-C06	MGC	W01C028E11	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC052957	MGC03-C06	MGC	W01C028E12	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC051723	MGC03-C07	MGC	W01C028E13	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC051723	MGC03-C07	MGC	W01C028E14	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC055424	MGC03-C08	MGC	W01C028E15	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC055424	MGC03-C08	MGC	W01C028E16	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC062218	MGC03-C09	MGC	W01C028E17	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	MGC03-C09	MGC	W01C028E18	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC050327	MGC03-C10	MGC	W01C028E19	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	MGC03-C10	MGC	W01C028E20	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC047590	MGC03-C11	MGC	W01C028E21	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC047590	MGC03-C11	MGC	W01C028E22	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC055426	MGC03-C12	MGC	W01C028E23	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC055426	MGC03-C12	MGC	W01C028E24	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC062680	MGC03-C01	MGC	W01C028F01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	MGC03-C01	MGC	W01C028F02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC050283	MGC03-C02	MGC	W01C028F03	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC050283	MGC03-C02	MGC	W01C028F04	pDONR221	6424		WASF3	10810	AAH50283.1	Hs.635221	WAS protein family, member 3			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_006646.5	NP_006637.2	REVIEWED		0.905	0.914	503	1500	1	1497	502	1	502
IKAKEN	BC045642	MGC03-C03	MGC	W01C028F05	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC045642	MGC03-C03	MGC	W01C028F06	pDONR221	22611		MTDH	92140	AAH45642.1	Hs.377155	Metadherin			Testis	NIH_MGC_97	DH10B	NM_178812.3	NP_848927.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC062662	MGC03-C04	MGC	W01C028F07	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	MGC03-C04	MGC	W01C028F08	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC055429	MGC03-C05	MGC	W01C028F09	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC055429	MGC03-C05	MGC	W01C028F10	pDONR221	7323		JPH4	84502	AAH55429.1	Hs.597841	Junctophilin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032452.2	NP_115828.2	REVIEWED	OK	1.000	1.000	628	1887	1	1884	628	1	628
IKAKEN	BC052957	MGC03-C06	MGC	W01C028F11	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC052957	MGC03-C06	MGC	W01C028F12	pDONR221	23105		FAM84B	157638	AAH52957.1	Hs.124951	Family with sequence similarity 84, member B			Testis	NIH_MGC_97	DH10B	NM_174911.3	NP_777571.1	PROVISIONAL	C	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC051723	MGC03-C07	MGC	W01C028F13	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC051723	MGC03-C07	MGC	W01C028F14	pDONR221	6432		COG6	57511	AAH51723.1	Hs.507805	Component of oligomeric golgi complex 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020751.2	NP_065802.1	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	BC055424	MGC03-C08	MGC	W01C028F15	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC055424	MGC03-C08	MGC	W01C028F16	pDONR221	13824		TTC21B	79809	AAH55424.1	Hs.310672	Tetratricopeptide repeat domain 21B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_024753.3	NP_079029.3	VALIDATED	OK	1.000	1.000	1316	3951	1	3948	1316	1	1316
IKAKEN	BC062218	MGC03-C09	MGC	W01C028F17	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	MGC03-C09	MGC	W01C028F18	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC050327	MGC03-C10	MGC	W01C028F19	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC050327	MGC03-C10	MGC	W01C028F20	pDONR221	20732		LCA5	167691	AAH50327.1	Hs.21945	Leber congenital amaurosis 5			Testis	NIH_MGC_97	DH10B	NM_001122769.1	NP_001116241.1	VALIDATED	OK	1.000	1.000	697	2094	1	2091	697	1	697
IKAKEN	BC047590	MGC03-C11	MGC	W01C028F21	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC047590	MGC03-C11	MGC	W01C028F22	pDONR221	7512		HEATR4	399671	AAH47590.1	Hs.660774	HEAT repeat containing 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203309.1	NP_976054.1	PROVISIONAL	C	1.000	1.000	979	2940	1	2937	979	1	979
IKAKEN	BC055426	MGC03-C12	MGC	W01C028F23	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC055426	MGC03-C12	MGC	W01C028F24	pDONR221	17630		BBS12	166379	AAH55426.1	Hs.400698	Bardet-Biedl syndrome 12			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152618.2	NP_689831.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC050329	MGC03-D01	MGC	W01C028G01	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	MGC03-D01	MGC	W01C028G02	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC062213	MGC03-D02	MGC	W01C028G03	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	MGC03-D02	MGC	W01C028G04	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062423	MGC03-D03	MGC	W01C028G05	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	MGC03-D03	MGC	W01C028G06	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC047594	MGC03-D04	MGC	W01C028G07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	MGC03-D04	MGC	W01C028G08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC065724	MGC03-D06	MGC	W01C028G11	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	MGC03-D06	MGC	W01C028G12	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC051716	MGC03-D07	MGC	W01C028G13	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC051716	MGC03-D07	MGC	W01C028G14	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC055428	MGC03-D08	MGC	W01C028G15	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	MGC03-D08	MGC	W01C028G16	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC062679	MGC03-D09	MGC	W01C028G17	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	MGC03-D09	MGC	W01C028G18	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC050051	MGC03-D10	MGC	W01C028G19	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC050051	MGC03-D10	MGC	W01C028G20	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC047400	MGC03-D11	MGC	W01C028G21	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047400	MGC03-D11	MGC	W01C028G22	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047455	MGC03-D12	MGC	W01C028G23	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC047455	MGC03-D12	MGC	W01C028G24	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC050329	MGC03-D01	MGC	W01C028H01	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC050329	MGC03-D01	MGC	W01C028H02	pDONR221	11215		NETO1	81832	AAH50329.1	Hs.465407	Neuropilin (NRP) and tolloid (TLL)-like 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_138966.2	NP_620416.1	REVIEWED	Cs	0.998	0.998	533	1602	1	1599	533	1	533
IKAKEN	BC062213	MGC03-D02	MGC	W01C028H03	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	MGC03-D02	MGC	W01C028H04	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062423	MGC03-D03	MGC	W01C028H05	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	MGC03-D03	MGC	W01C028H06	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC047594	MGC03-D04	MGC	W01C028H07	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC047594	MGC03-D04	MGC	W01C028H08	pDONR221	21461		SPDYE8P	389517	AAH47594	Hs.592259	Speedy homolog E8 (Xenopus laevis), pseudogene			Testis	NIH_MGC_97	DH10B			
IKAKEN	BC065724	MGC03-D06	MGC	W01C028H11	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	MGC03-D06	MGC	W01C028H12	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC051716	MGC03-D07	MGC	W01C028H13	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC051716	MGC03-D07	MGC	W01C028H14	pDONR221	17407		RUFY3	22902	AAH51716.1	Hs.713172	RUN and FYVE domain containing 3			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_014961.3	NP_055776.1	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC055428	MGC03-D08	MGC	W01C028H15	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC055428	MGC03-D08	MGC	W01C028H16	pDONR221	8915		MMP15	4324	AAH55428.1	Hs.80343	Matrix metallopeptidase 15 (membrane-inserted)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002428.2	NP_002419.1	REVIEWED	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC062679	MGC03-D09	MGC	W01C028H17	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	MGC03-D09	MGC	W01C028H18	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC050051	MGC03-D10	MGC	W01C028H19	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC050051	MGC03-D10	MGC	W01C028H20	pDONR221	8929		TMEM219	124446	AAH50051.1	Hs.460574	Transmembrane protein 219			Brain, adult medulla	NIH_MGC_119	DH10B	NM_194280.3	NP_919256.1	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC047400	MGC03-D11	MGC	W01C028H21	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047400	MGC03-D11	MGC	W01C028H22	pDONR221	9599		TBC1D26	353149	AAH47400.1	Hs.567880	TBC1 domain family, member 26			Testis	NIH_MGC_97	DH10B	NM_178571.4	NP_848666.2	VALIDATED	Cs	0.996	0.996	250	753	1	750	250	1	250
IKAKEN	BC047455	MGC03-D12	MGC	W01C028H23	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC047455	MGC03-D12	MGC	W01C028H24	pDONR221	18674		DDX4	54514	AAH47455.1	Hs.223581	DEAD (Asp-Glu-Ala-Asp) box polypeptide 4			Testis	NIH_MGC_97	DH10B	NM_001142549.1	NP_001136021.1	VALIDATED	OK	1.000	1.000	690	2073	1	2070	690	1	690
IKAKEN	BC062217	MGC03-E01	MGC	W01C028I01	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	MGC03-E01	MGC	W01C028I02	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC056219	MGC03-E02	MGC	W01C028I03	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC056219	MGC03-E02	MGC	W01C028I04	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC047502	MGC03-E03	MGC	W01C028I05	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC047502	MGC03-E03	MGC	W01C028I06	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC062678	MGC03-E04	MGC	W01C028I07	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	MGC03-E04	MGC	W01C028I08	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC051688	MGC03-E05	MGC	W01C028I09	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC051688	MGC03-E05	MGC	W01C028I10	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC047482	MGC03-E06	MGC	W01C028I11	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC047482	MGC03-E06	MGC	W01C028I12	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC065714	MGC03-E07	MGC	W01C028I13	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	MGC03-E07	MGC	W01C028I14	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC045553	MGC03-E08	MGC	W01C028I15	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045553	MGC03-E08	MGC	W01C028I16	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045540	MGC03-E09	MGC	W01C028I17	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	MGC03-E09	MGC	W01C028I18	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	MGC03-E10	MGC	W01C028I19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	MGC03-E10	MGC	W01C028I20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC056606	MGC03-E11	MGC	W01C028I21	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC056606	MGC03-E11	MGC	W01C028I22	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC062734	MGC03-E12	MGC	W01C028I23	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	MGC03-E12	MGC	W01C028I24	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062217	MGC03-E01	MGC	W01C028J01	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	MGC03-E01	MGC	W01C028J02	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC056219	MGC03-E02	MGC	W01C028J03	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC056219	MGC03-E02	MGC	W01C028J04	pDONR221	19189		DHX29	54505	AAH56219.1	Hs.719180	DEAH (Asp-Glu-Ala-His) box polypeptide 29			Testis	NIH_MGC_97	DH10B	NM_019030.2	NP_061903.2	VALIDATED	OK	1.000	1.000	1369	4110	1	4107	1369	1	1369
IKAKEN	BC047502	MGC03-E03	MGC	W01C028J05	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC047502	MGC03-E03	MGC	W01C028J06	pDONR221	15102		PPP1R3D	5509	AAH47502.1	Hs.42215	Protein phosphatase 1, regulatory (inhibitor) subunit 3D			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_006242.3	NP_006233.1	REVIEWED	OK	1.000	1.000	299	900	1	897	299	1	299
IKAKEN	BC062678	MGC03-E04	MGC	W01C028J07	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	MGC03-E04	MGC	W01C028J08	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC051688	MGC03-E05	MGC	W01C028J09	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC051688	MGC03-E05	MGC	W01C028J10	pDONR221	12422		PNMAL1	55228	AAH51688.2	Hs.8395	PNMA-like 1			Testis	NIH_MGC_97	DH10B	NM_018215.3	NP_060685.2	VALIDATED	OK	1.000	1.000	439	1320	1	1317	439	1	439
IKAKEN	BC047482	MGC03-E06	MGC	W01C028J11	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC047482	MGC03-E06	MGC	W01C028J12	pDONR221	14563		KIAA1219	57148	AAH47482.1	Hs.655758	KIAA1219			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020336.2	NP_065069.1	VALIDATED	OK	1.000	1.000	1494	4485	1	4482	1494	1	1494
IKAKEN	BC065714	MGC03-E07	MGC	W01C028J13	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	MGC03-E07	MGC	W01C028J14	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC045553	MGC03-E08	MGC	W01C028J15	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045553	MGC03-E08	MGC	W01C028J16	pDONR221	22751		EFHA2	286097	AAH45553.1	Hs.403594	EF-hand domain family, member A2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181723.2	NP_859074.1	VALIDATED	OK	1.000	1.000	530	1593	1	1590	530	1	530
IKAKEN	BC045540	MGC03-E09	MGC	W01C028J17	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	MGC03-E09	MGC	W01C028J18	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC044577	MGC03-E10	MGC	W01C028J19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	MGC03-E10	MGC	W01C028J20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC056606	MGC03-E11	MGC	W01C028J21	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC056606	MGC03-E11	MGC	W01C028J22	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL		0.896	0.896	125	378	1	375	172	48	172
IKAKEN	BC062734	MGC03-E12	MGC	W01C028J23	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	MGC03-E12	MGC	W01C028J24	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC048097	MGC03-F01	MGC	W01C028K01	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC048097	MGC03-F01	MGC	W01C028K02	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC065721	MGC03-F02	MGC	W01C028K03	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC065721	MGC03-F02	MGC	W01C028K04	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC048134	MGC03-F03	MGC	W01C028K05	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC048134	MGC03-F03	MGC	W01C028K06	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC060862	MGC03-F04	MGC	W01C028K07	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060862	MGC03-F04	MGC	W01C028K08	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060796	MGC03-F05	MGC	W01C028K09	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	MGC03-F05	MGC	W01C028K10	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	MGC03-F06	MGC	W01C028K11	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	MGC03-F06	MGC	W01C028K12	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063295	MGC03-F07	MGC	W01C028K13	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063295	MGC03-F07	MGC	W01C028K14	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063283	MGC03-F08	MGC	W01C028K15	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC063283	MGC03-F08	MGC	W01C028K16	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC057813	MGC03-F09	MGC	W01C028K17	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC057813	MGC03-F09	MGC	W01C028K18	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC059362	MGC03-F10	MGC	W01C028K19	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC059362	MGC03-F10	MGC	W01C028K20	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC066124	MGC03-F11	MGC	W01C028K21	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	MGC03-F11	MGC	W01C028K22	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC060855	MGC03-F12	MGC	W01C028K23	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC060855	MGC03-F12	MGC	W01C028K24	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC048097	MGC03-F01	MGC	W01C028L01	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC048097	MGC03-F01	MGC	W01C028L02	pDONR221	23778		FXN	2395	AAH48097.1	Hs.29978	Frataxin			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_000144.3	NP_000135.2	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC065721	MGC03-F02	MGC	W01C028L03	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC065721	MGC03-F02	MGC	W01C028L04	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED		0.920	0.920	176	531	1	528	176	1	176
IKAKEN	BC048134	MGC03-F03	MGC	W01C028L05	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC048134	MGC03-F03	MGC	W01C028L06	pDONR221	53		KDM1	23028	AAH48134.2	Hs.656420	Lysine (K)-specific demethylase 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015013.3	NP_055828.2	REVIEWED	P	1.000	1.000	730	2193	1	2190	852	123	852
IKAKEN	BC060862	MGC03-F04	MGC	W01C028L07	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060862	MGC03-F04	MGC	W01C028L08	pDONR221	7886		RNF111	54778	AAH60862.1	Hs.404423	Ring finger protein 111			Placenta, normal	NIH_MGC_147	DH10B	NM_017610.6	NP_060080.6	REVIEWED	OK	1.000	1.000	986	2961	1	2958	986	1	986
IKAKEN	BC060796	MGC03-F05	MGC	W01C028L09	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	MGC03-F05	MGC	W01C028L10	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC064696	MGC03-F06	MGC	W01C028L11	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	MGC03-F06	MGC	W01C028L12	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063295	MGC03-F07	MGC	W01C028L13	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063295	MGC03-F07	MGC	W01C028L14	pDONR221	12953		CNNM4	26504	AAH63295.2	Hs.175043	Cyclin M4			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_020184.3	NP_064569.3	VALIDATED	P	1.000	1.000	727	2184	1	2181	775	49	775
IKAKEN	BC063283	MGC03-F08	MGC	W01C028L15	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC063283	MGC03-F08	MGC	W01C028L16	pDONR221	9158		ADAMTS18	170692	AAH63283.1	Hs.188746	ADAM metallopeptidase with thrombospondin type 1 motif, 18			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_199355.2	NP_955387.1	REVIEWED	C	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC057813	MGC03-F09	MGC	W01C028L17	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC057813	MGC03-F09	MGC	W01C028L18	pDONR221	20716		GJB7	375519	AAH57813.1	Hs.146727	Gap junction protein, beta 7, 25kDa			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198568.2	NP_940970.1	VALIDATED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	BC059362	MGC03-F10	MGC	W01C028L19	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC059362	MGC03-F10	MGC	W01C028L20	pDONR221	23983		RALGDS	5900	AAH59362.1	Hs.106185	Ral guanine nucleotide dissociation stimulator			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_006266.2	NP_006257.1	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC066124	MGC03-F11	MGC	W01C028L21	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC066124	MGC03-F11	MGC	W01C028L22	pDONR221	12588		KANK3	256949	AAH66124.1	Hs.322473	KN motif and ankyrin repeat domains 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198471.2	NP_940873.2	VALIDATED	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC060855	MGC03-F12	MGC	W01C028L23	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC060855	MGC03-F12	MGC	W01C028L24	pDONR221	13791		SMEK2	57223	AAH60855.1	Hs.516182	SMEK homolog 2, suppressor of mek1 (Dictyostelium)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_001122964.1	NP_001116436.1	VALIDATED	Cgs	0.896	0.997	850	2298	1	2295	849	1	849
IKAKEN	BC063293	MGC03-G01	MGC	W01C028M01	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	MGC03-G01	MGC	W01C028M02	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	MGC03-G02	MGC	W01C028M03	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	MGC03-G02	MGC	W01C028M04	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	MGC03-G03	MGC	W01C028M05	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	MGC03-G03	MGC	W01C028M06	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	MGC03-G04	MGC	W01C028M07	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	MGC03-G04	MGC	W01C028M08	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC062670	MGC03-G05	MGC	W01C028M09	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	MGC03-G05	MGC	W01C028M10	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC063313	MGC03-G06	MGC	W01C028M11	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063313	MGC03-G06	MGC	W01C028M12	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063306	MGC03-G07	MGC	W01C028M13	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC063306	MGC03-G07	MGC	W01C028M14	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC060882	MGC03-G08	MGC	W01C028M15	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	MGC03-G08	MGC	W01C028M16	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057825	MGC03-G09	MGC	W01C028M17	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057825	MGC03-G09	MGC	W01C028M18	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057779	MGC03-G10	MGC	W01C028M19	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	MGC03-G10	MGC	W01C028M20	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC063595	MGC03-G11	MGC	W01C028M21	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	MGC03-G11	MGC	W01C028M22	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	MGC03-G12	MGC	W01C028M23	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	MGC03-G12	MGC	W01C028M24	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC063293	MGC03-G01	MGC	W01C028N01	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC063293	MGC03-G01	MGC	W01C028N02	pDONR221	1373		ADAMTS4	9507	AAH63293.1	Hs.211604	ADAM metallopeptidase with thrombospondin type 1 motif, 4			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005099.4	NP_005090.3	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC060867	MGC03-G02	MGC	W01C028N03	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC060867	MGC03-G02	MGC	W01C028N04	pDONR221	17966		KIAA0746	23231	AAH60867.1	Hs.479384	KIAA0746 protein			Placenta, normal	NIH_MGC_147	DH10B	NM_015187.3	NP_056002.2	VALIDATED	P	1.000	1.000	979	2940	1	2937	1132	154	1132
IKAKEN	BC063289	MGC03-G03	MGC	W01C028N05	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	MGC03-G03	MGC	W01C028N06	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC059391	MGC03-G04	MGC	W01C028N07	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC059391	MGC03-G04	MGC	W01C028N08	pDONR221	8960		SCNN1G	6340	AAH59391.1	Hs.371727	Sodium channel, nonvoltage-gated 1, gamma			Placenta, normal	NIH_MGC_147	DH10B	NM_001039.3	NP_001030.2	REVIEWED	OK	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	BC062670	MGC03-G05	MGC	W01C028N09	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	MGC03-G05	MGC	W01C028N10	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC063313	MGC03-G06	MGC	W01C028N11	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063313	MGC03-G06	MGC	W01C028N12	pDONR221	3098		DIP2C	22982	AAH63313.1	Hs.432397	DIP2 disco-interacting protein 2 homolog C (Drosophila)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014974.2	NP_055789.1	REVIEWED	OK	1.000	1.000	1556	4671	1	4668	1556	1	1556
IKAKEN	BC063306	MGC03-G07	MGC	W01C028N13	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC063306	MGC03-G07	MGC	W01C028N14	pDONR221	3740		CUL5	8065	AAH63306.1	Hs.440320	Cullin 5			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003478.3	NP_003469.2	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC060882	MGC03-G08	MGC	W01C028N15	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC060882	MGC03-G08	MGC	W01C028N16	pDONR221	10266		NOTUM	147111	AAH60882.1	Hs.106137	Notum pectinacetylesterase homolog (Drosophila)			Placenta, normal	NIH_MGC_147	DH10B	NM_178493.5	NP_848588.3	VALIDATED	P	1.000	1.000	430	1293	1	1290	496	67	496
IKAKEN	BC057825	MGC03-G09	MGC	W01C028N17	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057825	MGC03-G09	MGC	W01C028N18	pDONR221	15337		KRTAP26-1	388818	AAH57825.1	Hs.28704	Keratin associated protein 26-1			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_203405.1	NP_981950.1	VALIDATED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC057779	MGC03-G10	MGC	W01C028N19	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC057779	MGC03-G10	MGC	W01C028N20	pDONR221	14649		COX4I2	84701	AAH57779.1	Hs.277101	Cytochrome c oxidase subunit IV isoform 2 (lung)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032609.2	NP_115998.2	REVIEWED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC063595	MGC03-G11	MGC	W01C028N21	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	MGC03-G11	MGC	W01C028N22	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC060866	MGC03-G12	MGC	W01C028N23	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060866	MGC03-G12	MGC	W01C028N24	pDONR221	1966		KANK4	163782	AAH60866.1	Hs.283398	KN motif and ankyrin repeat domains 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_181712.4	NP_859063.3	VALIDATED	OK	1.000	1.000	995	2988	1	2985	995	1	995
IKAKEN	BC060797	MGC03-H01	MGC	W01C028O01	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	MGC03-H01	MGC	W01C028O02	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC057792	MGC03-H02	MGC	W01C028O03	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	MGC03-H02	MGC	W01C028O04	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC060847	MGC03-H03	MGC	W01C028O05	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060847	MGC03-H03	MGC	W01C028O06	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060776	MGC03-H04	MGC	W01C028O07	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060776	MGC03-H04	MGC	W01C028O08	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060887	MGC03-H05	MGC	W01C028O09	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060887	MGC03-H05	MGC	W01C028O10	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060841	MGC03-H06	MGC	W01C028O11	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	MGC03-H06	MGC	W01C028O12	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060844	MGC03-H07	MGC	W01C028O13	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC060844	MGC03-H07	MGC	W01C028O14	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC066122	MGC03-H08	MGC	W01C028O15	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	MGC03-H08	MGC	W01C028O16	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC060871	MGC03-H09	MGC	W01C028O17	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC060871	MGC03-H09	MGC	W01C028O18	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC059398	MGC03-H10	MGC	W01C028O19	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	MGC03-H10	MGC	W01C028O20	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	MGC03-H11	MGC	W01C028O21	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	MGC03-H11	MGC	W01C028O22	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC066955	MGC03-H12	MGC	W01C028O23	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066955	MGC03-H12	MGC	W01C028O24	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC060797	MGC03-H01	MGC	W01C028P01	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	MGC03-H01	MGC	W01C028P02	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC057792	MGC03-H02	MGC	W01C028P03	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	MGC03-H02	MGC	W01C028P04	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC060847	MGC03-H03	MGC	W01C028P05	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060847	MGC03-H03	MGC	W01C028P06	pDONR221	14570		PARD6B	84612	AAH60847.1	Hs.589848	Par-6 partitioning defective 6 homolog beta (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032521.2	NP_115910.1	REVIEWED	OK	1.000	1.000	372	1119	1	1116	372	1	372
IKAKEN	BC060776	MGC03-H04	MGC	W01C028P07	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060776	MGC03-H04	MGC	W01C028P08	pDONR221	6443		ARHGEF7	8874	AAH60776.1	Hs.508738	Rho guanine nucleotide exchange factor (GEF) 7			Placenta, normal	NIH_MGC_147	DH10B	NM_145735.2	NP_663788.1	REVIEWED	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC060887	MGC03-H05	MGC	W01C028P09	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060887	MGC03-H05	MGC	W01C028P10	pDONR221	17003		C3orf64	285203	AAH60887.1	Hs.518059	Chromosome 3 open reading frame 64			Placenta, normal	NIH_MGC_147	DH10B	NM_173654.1	NP_775925.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC060841	MGC03-H06	MGC	W01C028P11	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060841	MGC03-H06	MGC	W01C028P12	pDONR221	4451		INTS5	80789	AAH60841.1	Hs.458390	Integrator complex subunit 5			Testis	NIH_MGC_97	DH10B	NM_030628.1	NP_085131.1	PROVISIONAL	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC060844	MGC03-H07	MGC	W01C028P13	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC060844	MGC03-H07	MGC	W01C028P14	pDONR221	9097		KIAA1609	57707	AAH60844.1	Hs.288274	KIAA1609			Placenta, normal	NIH_MGC_147	DH10B	NM_020947.3	NP_065998.3	VALIDATED	OK	1.000	1.000	456	1371	1	1368	456	1	456
IKAKEN	BC066122	MGC03-H08	MGC	W01C028P15	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC066122	MGC03-H08	MGC	W01C028P16	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_004327.3	NP_004318.3	REVIEWED	OK	1.000	1.000	1271	3816	1	3813	1271	1	1271
IKAKEN	BC060871	MGC03-H09	MGC	W01C028P17	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC060871	MGC03-H09	MGC	W01C028P18	pDONR221	8795		PDXDC1	23042	AAH60871.1	Hs.370781	Pyridoxal-dependent decarboxylase domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_015027.2	NP_055842.2	VALIDATED	OK	1.000	1.000	788	2367	1	2364	788	1	788
IKAKEN	BC059398	MGC03-H10	MGC	W01C028P19	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC059398	MGC03-H10	MGC	W01C028P20	pDONR221	19461		EMB	133418	AAH59398.1	Hs.561411	Embigin homolog (mouse)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198449.2	NP_940851.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC063598	MGC03-H11	MGC	W01C028P21	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC063598	MGC03-H11	MGC	W01C028P22	pDONR221	7558		DEGS2	123099	AAH63598.1	Hs.159643	Degenerative spermatocyte homolog 2, lipid desaturase (Drosophila)			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_206918.2	NP_996801.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC066955	MGC03-H12	MGC	W01C028P23	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066955	MGC03-H12	MGC	W01C028P24	pDONR221	8294		ANXA2	302	AAH66955.2	Hs.511605	Annexin A2			Testis	NIH_MGC_97	DH10B	NM_001002857.1	NP_001002857.1	REVIEWED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC063652	MGC04-A01	MGC	W01C029A01	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC04-A01	MGC	W01C029A02	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013121	MGC04-A02	MGC	W01C029A03	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	MGC04-A02	MGC	W01C029A04	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC011514	MGC04-A03	MGC	W01C029A05	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC011514	MGC04-A03	MGC	W01C029A06	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC003403	MGC04-A04	MGC	W01C029A07	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC003403	MGC04-A04	MGC	W01C029A08	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC000972	MGC04-A05	MGC	W01C029A09	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000972	MGC04-A05	MGC	W01C029A10	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000154	MGC04-A06	MGC	W01C029A11	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC000154	MGC04-A06	MGC	W01C029A12	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC016512	MGC04-A07	MGC	W01C029A13	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC016512	MGC04-A07	MGC	W01C029A14	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC000976	MGC04-A08	MGC	W01C029A15	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000976	MGC04-A08	MGC	W01C029A16	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000924	MGC04-A09	MGC	W01C029A17	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000924	MGC04-A09	MGC	W01C029A18	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000941	MGC04-A10	MGC	W01C029A19	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000941	MGC04-A10	MGC	W01C029A20	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000135	MGC04-A11	MGC	W01C029A21	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000135	MGC04-A11	MGC	W01C029A22	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008195	MGC04-A12	MGC	W01C029A23	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC008195	MGC04-A12	MGC	W01C029A24	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC063652	MGC04-A01	MGC	W01C029B01	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC04-A01	MGC	W01C029B02	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013121	MGC04-A02	MGC	W01C029B03	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	MGC04-A02	MGC	W01C029B04	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC011514	MGC04-A03	MGC	W01C029B05	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC011514	MGC04-A03	MGC	W01C029B06	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC003403	MGC04-A04	MGC	W01C029B07	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC003403	MGC04-A04	MGC	W01C029B08	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC000972	MGC04-A05	MGC	W01C029B09	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000972	MGC04-A05	MGC	W01C029B10	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000154	MGC04-A06	MGC	W01C029B11	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC000154	MGC04-A06	MGC	W01C029B12	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC016512	MGC04-A07	MGC	W01C029B13	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC016512	MGC04-A07	MGC	W01C029B14	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC000976	MGC04-A08	MGC	W01C029B15	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000976	MGC04-A08	MGC	W01C029B16	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000924	MGC04-A09	MGC	W01C029B17	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000924	MGC04-A09	MGC	W01C029B18	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000941	MGC04-A10	MGC	W01C029B19	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000941	MGC04-A10	MGC	W01C029B20	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000135	MGC04-A11	MGC	W01C029B21	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000135	MGC04-A11	MGC	W01C029B22	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008195	MGC04-A12	MGC	W01C029B23	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC008195	MGC04-A12	MGC	W01C029B24	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC008196	MGC04-B01	MGC	W01C029C01	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC008196	MGC04-B01	MGC	W01C029C02	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC013124	MGC04-B02	MGC	W01C029C03	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC013124	MGC04-B02	MGC	W01C029C04	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC000137	MGC04-B03	MGC	W01C029C05	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000137	MGC04-B03	MGC	W01C029C06	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC010284	MGC04-B04	MGC	W01C029C07	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC010284	MGC04-B04	MGC	W01C029C08	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC066268	MGC04-B05	MGC	W01C029C09	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066268	MGC04-B05	MGC	W01C029C10	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066884	MGC04-B06	MGC	W01C029C11	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066884	MGC04-B06	MGC	W01C029C12	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC000790	MGC04-B07	MGC	W01C029C13	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC000790	MGC04-B07	MGC	W01C029C14	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001259	MGC04-B08	MGC	W01C029C15	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001259	MGC04-B08	MGC	W01C029C16	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001261	MGC04-B09	MGC	W01C029C17	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001261	MGC04-B09	MGC	W01C029C18	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000846	MGC04-B10	MGC	W01C029C19	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC000846	MGC04-B10	MGC	W01C029C20	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC001233	MGC04-B11	MGC	W01C029C21	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001233	MGC04-B11	MGC	W01C029C22	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001234	MGC04-B12	MGC	W01C029C23	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC001234	MGC04-B12	MGC	W01C029C24	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC008196	MGC04-B01	MGC	W01C029D01	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC008196	MGC04-B01	MGC	W01C029D02	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC013124	MGC04-B02	MGC	W01C029D03	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC013124	MGC04-B02	MGC	W01C029D04	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC000137	MGC04-B03	MGC	W01C029D05	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000137	MGC04-B03	MGC	W01C029D06	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC010284	MGC04-B04	MGC	W01C029D07	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC010284	MGC04-B04	MGC	W01C029D08	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC066268	MGC04-B05	MGC	W01C029D09	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066268	MGC04-B05	MGC	W01C029D10	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066884	MGC04-B06	MGC	W01C029D11	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066884	MGC04-B06	MGC	W01C029D12	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC000790	MGC04-B07	MGC	W01C029D13	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC000790	MGC04-B07	MGC	W01C029D14	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001259	MGC04-B08	MGC	W01C029D15	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001259	MGC04-B08	MGC	W01C029D16	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001261	MGC04-B09	MGC	W01C029D17	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001261	MGC04-B09	MGC	W01C029D18	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000846	MGC04-B10	MGC	W01C029D19	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC000846	MGC04-B10	MGC	W01C029D20	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC001233	MGC04-B11	MGC	W01C029D21	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001233	MGC04-B11	MGC	W01C029D22	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001234	MGC04-B12	MGC	W01C029D23	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC001234	MGC04-B12	MGC	W01C029D24	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC000849	MGC04-C01	MGC	W01C029E01	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC000849	MGC04-C01	MGC	W01C029E02	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC001567	MGC04-C02	MGC	W01C029E03	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001567	MGC04-C02	MGC	W01C029E04	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001338	MGC04-C03	MGC	W01C029E05	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	MGC04-C03	MGC	W01C029E06	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC000878	MGC04-C04	MGC	W01C029E07	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC000878	MGC04-C04	MGC	W01C029E08	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC001294	MGC04-C05	MGC	W01C029E09	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC001294	MGC04-C05	MGC	W01C029E10	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC066246	MGC04-C06	MGC	W01C029E11	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066246	MGC04-C06	MGC	W01C029E12	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC001232	MGC04-C07	MGC	W01C029E13	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC001232	MGC04-C07	MGC	W01C029E14	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC036283	MGC04-C08	MGC	W01C029E15	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC036283	MGC04-C08	MGC	W01C029E16	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC010439	MGC04-C09	MGC	W01C029E17	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC010439	MGC04-C09	MGC	W01C029E18	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC008602	MGC04-C10	MGC	W01C029E19	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC008602	MGC04-C10	MGC	W01C029E20	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC011051	MGC04-C11	MGC	W01C029E21	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC011051	MGC04-C11	MGC	W01C029E22	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC010607	MGC04-C12	MGC	W01C029E23	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC010607	MGC04-C12	MGC	W01C029E24	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC000849	MGC04-C01	MGC	W01C029F01	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC000849	MGC04-C01	MGC	W01C029F02	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC001567	MGC04-C02	MGC	W01C029F03	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001567	MGC04-C02	MGC	W01C029F04	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001338	MGC04-C03	MGC	W01C029F05	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	MGC04-C03	MGC	W01C029F06	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC000878	MGC04-C04	MGC	W01C029F07	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC000878	MGC04-C04	MGC	W01C029F08	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC001294	MGC04-C05	MGC	W01C029F09	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC001294	MGC04-C05	MGC	W01C029F10	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC066246	MGC04-C06	MGC	W01C029F11	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066246	MGC04-C06	MGC	W01C029F12	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC001232	MGC04-C07	MGC	W01C029F13	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC001232	MGC04-C07	MGC	W01C029F14	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC036283	MGC04-C08	MGC	W01C029F15	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC036283	MGC04-C08	MGC	W01C029F16	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC010439	MGC04-C09	MGC	W01C029F17	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC010439	MGC04-C09	MGC	W01C029F18	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC008602	MGC04-C10	MGC	W01C029F19	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC008602	MGC04-C10	MGC	W01C029F20	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC011051	MGC04-C11	MGC	W01C029F21	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC011051	MGC04-C11	MGC	W01C029F22	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC010607	MGC04-C12	MGC	W01C029F23	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC010607	MGC04-C12	MGC	W01C029F24	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC041070	MGC04-D01	MGC	W01C029G01	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	MGC04-D01	MGC	W01C029G02	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC011052	MGC04-D02	MGC	W01C029G03	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC011052	MGC04-D02	MGC	W01C029G04	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC018207	MGC04-D03	MGC	W01C029G05	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC018207	MGC04-D03	MGC	W01C029G06	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC011057	MGC04-D04	MGC	W01C029G07	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC011057	MGC04-D04	MGC	W01C029G08	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC008983	MGC04-D05	MGC	W01C029G09	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008983	MGC04-D05	MGC	W01C029G10	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008185	MGC04-D06	MGC	W01C029G11	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC008185	MGC04-D06	MGC	W01C029G12	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011520	MGC04-D07	MGC	W01C029G13	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC011520	MGC04-D07	MGC	W01C029G14	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC009037	MGC04-D08	MGC	W01C029G15	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC009037	MGC04-D08	MGC	W01C029G16	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC018445	MGC04-D09	MGC	W01C029G17	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC018445	MGC04-D09	MGC	W01C029G18	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC040341	MGC04-D10	MGC	W01C029G19	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC040341	MGC04-D10	MGC	W01C029G20	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC010629	MGC04-D11	MGC	W01C029G21	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC010629	MGC04-D11	MGC	W01C029G22	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC016613	MGC04-D12	MGC	W01C029G23	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC016613	MGC04-D12	MGC	W01C029G24	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC041070	MGC04-D01	MGC	W01C029H01	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	MGC04-D01	MGC	W01C029H02	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC011052	MGC04-D02	MGC	W01C029H03	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC011052	MGC04-D02	MGC	W01C029H04	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC018207	MGC04-D03	MGC	W01C029H05	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC018207	MGC04-D03	MGC	W01C029H06	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC011057	MGC04-D04	MGC	W01C029H07	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC011057	MGC04-D04	MGC	W01C029H08	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC008983	MGC04-D05	MGC	W01C029H09	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008983	MGC04-D05	MGC	W01C029H10	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008185	MGC04-D06	MGC	W01C029H11	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC008185	MGC04-D06	MGC	W01C029H12	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011520	MGC04-D07	MGC	W01C029H13	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC011520	MGC04-D07	MGC	W01C029H14	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC009037	MGC04-D08	MGC	W01C029H15	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC009037	MGC04-D08	MGC	W01C029H16	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC018445	MGC04-D09	MGC	W01C029H17	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC018445	MGC04-D09	MGC	W01C029H18	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC040341	MGC04-D10	MGC	W01C029H19	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC040341	MGC04-D10	MGC	W01C029H20	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC010629	MGC04-D11	MGC	W01C029H21	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC010629	MGC04-D11	MGC	W01C029H22	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC016613	MGC04-D12	MGC	W01C029H23	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC016613	MGC04-D12	MGC	W01C029H24	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC011377	MGC04-E01	MGC	W01C029I01	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011377	MGC04-E01	MGC	W01C029I02	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011379	MGC04-E02	MGC	W01C029I03	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC011379	MGC04-E02	MGC	W01C029I04	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC008674	MGC04-E03	MGC	W01C029I05	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC008674	MGC04-E03	MGC	W01C029I06	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC009078	MGC04-E04	MGC	W01C029I07	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC009078	MGC04-E04	MGC	W01C029I08	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC008253	MGC04-E05	MGC	W01C029I09	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC008253	MGC04-E05	MGC	W01C029I10	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC048194	MGC04-E06	MGC	W01C029I11	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	MGC04-E06	MGC	W01C029I12	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC009679	MGC04-E07	MGC	W01C029I13	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC009679	MGC04-E07	MGC	W01C029I14	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC013421	MGC04-E08	MGC	W01C029I15	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013421	MGC04-E08	MGC	W01C029I16	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013581	MGC04-E09	MGC	W01C029I17	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC013581	MGC04-E09	MGC	W01C029I18	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC009726	MGC04-E11	MGC	W01C029I21	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	MGC04-E11	MGC	W01C029I22	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC024314	MGC04-E12	MGC	W01C029I23	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC024314	MGC04-E12	MGC	W01C029I24	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC011377	MGC04-E01	MGC	W01C029J01	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011377	MGC04-E01	MGC	W01C029J02	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011379	MGC04-E02	MGC	W01C029J03	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC011379	MGC04-E02	MGC	W01C029J04	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC008674	MGC04-E03	MGC	W01C029J05	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC008674	MGC04-E03	MGC	W01C029J06	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC009078	MGC04-E04	MGC	W01C029J07	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC009078	MGC04-E04	MGC	W01C029J08	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC008253	MGC04-E05	MGC	W01C029J09	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC008253	MGC04-E05	MGC	W01C029J10	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC048194	MGC04-E06	MGC	W01C029J11	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	MGC04-E06	MGC	W01C029J12	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC009679	MGC04-E07	MGC	W01C029J13	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC009679	MGC04-E07	MGC	W01C029J14	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC013421	MGC04-E08	MGC	W01C029J15	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013421	MGC04-E08	MGC	W01C029J16	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013581	MGC04-E09	MGC	W01C029J17	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC013581	MGC04-E09	MGC	W01C029J18	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC009726	MGC04-E11	MGC	W01C029J21	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	MGC04-E11	MGC	W01C029J22	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC024314	MGC04-E12	MGC	W01C029J23	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC024314	MGC04-E12	MGC	W01C029J24	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC009694	MGC04-F01	MGC	W01C029K01	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC009694	MGC04-F01	MGC	W01C029K02	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC020965	MGC04-F02	MGC	W01C029K03	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC020965	MGC04-F02	MGC	W01C029K04	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC016279	MGC04-F03	MGC	W01C029K05	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC016279	MGC04-F03	MGC	W01C029K06	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC015722	MGC04-F04	MGC	W01C029K07	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015722	MGC04-F04	MGC	W01C029K08	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015928	MGC04-F05	MGC	W01C029K09	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	MGC04-F05	MGC	W01C029K10	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015050	MGC04-F06	MGC	W01C029K11	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC015050	MGC04-F06	MGC	W01C029K12	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC016028	MGC04-F07	MGC	W01C029K13	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC016028	MGC04-F07	MGC	W01C029K14	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC045108	MGC04-F08	MGC	W01C029K15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	MGC04-F08	MGC	W01C029K16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015887	MGC04-F09	MGC	W01C029K17	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC015887	MGC04-F09	MGC	W01C029K18	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC016146	MGC04-F10	MGC	W01C029K19	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC016146	MGC04-F10	MGC	W01C029K20	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC017469	MGC04-F11	MGC	W01C029K21	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017469	MGC04-F11	MGC	W01C029K22	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017556	MGC04-F12	MGC	W01C029K23	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC017556	MGC04-F12	MGC	W01C029K24	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC009694	MGC04-F01	MGC	W01C029L01	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC009694	MGC04-F01	MGC	W01C029L02	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC020965	MGC04-F02	MGC	W01C029L03	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC020965	MGC04-F02	MGC	W01C029L04	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC016279	MGC04-F03	MGC	W01C029L05	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC016279	MGC04-F03	MGC	W01C029L06	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC015722	MGC04-F04	MGC	W01C029L07	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015722	MGC04-F04	MGC	W01C029L08	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015928	MGC04-F05	MGC	W01C029L09	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	MGC04-F05	MGC	W01C029L10	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015050	MGC04-F06	MGC	W01C029L11	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC015050	MGC04-F06	MGC	W01C029L12	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC016028	MGC04-F07	MGC	W01C029L13	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC016028	MGC04-F07	MGC	W01C029L14	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC045108	MGC04-F08	MGC	W01C029L15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	MGC04-F08	MGC	W01C029L16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015887	MGC04-F09	MGC	W01C029L17	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC015887	MGC04-F09	MGC	W01C029L18	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC016146	MGC04-F10	MGC	W01C029L19	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC016146	MGC04-F10	MGC	W01C029L20	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC017469	MGC04-F11	MGC	W01C029L21	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017469	MGC04-F11	MGC	W01C029L22	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017556	MGC04-F12	MGC	W01C029L23	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC017556	MGC04-F12	MGC	W01C029L24	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC015937	MGC04-G01	MGC	W01C029M01	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC015937	MGC04-G01	MGC	W01C029M02	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC014923	MGC04-G02	MGC	W01C029M03	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014923	MGC04-G02	MGC	W01C029M04	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014895	MGC04-G03	MGC	W01C029M05	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC014895	MGC04-G03	MGC	W01C029M06	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC010230	MGC04-G04	MGC	W01C029M07	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010230	MGC04-G04	MGC	W01C029M08	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010538	MGC04-G05	MGC	W01C029M09	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC010538	MGC04-G05	MGC	W01C029M10	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC016460	MGC04-G06	MGC	W01C029M11	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016460	MGC04-G06	MGC	W01C029M12	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016465	MGC04-G07	MGC	W01C029M13	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC016465	MGC04-G07	MGC	W01C029M14	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC044889	MGC04-G08	MGC	W01C029M15	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC044889	MGC04-G08	MGC	W01C029M16	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC010503	MGC04-G09	MGC	W01C029M17	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC010503	MGC04-G09	MGC	W01C029M18	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC012881	MGC04-G10	MGC	W01C029M19	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC012881	MGC04-G10	MGC	W01C029M20	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC017023	MGC04-G11	MGC	W01C029M21	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017023	MGC04-G11	MGC	W01C029M22	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017089	MGC04-G12	MGC	W01C029M23	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC017089	MGC04-G12	MGC	W01C029M24	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC015937	MGC04-G01	MGC	W01C029N01	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC015937	MGC04-G01	MGC	W01C029N02	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC014923	MGC04-G02	MGC	W01C029N03	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014923	MGC04-G02	MGC	W01C029N04	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014895	MGC04-G03	MGC	W01C029N05	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC014895	MGC04-G03	MGC	W01C029N06	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC010230	MGC04-G04	MGC	W01C029N07	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010230	MGC04-G04	MGC	W01C029N08	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010538	MGC04-G05	MGC	W01C029N09	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC010538	MGC04-G05	MGC	W01C029N10	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC016460	MGC04-G06	MGC	W01C029N11	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016460	MGC04-G06	MGC	W01C029N12	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016465	MGC04-G07	MGC	W01C029N13	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC016465	MGC04-G07	MGC	W01C029N14	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC044889	MGC04-G08	MGC	W01C029N15	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC044889	MGC04-G08	MGC	W01C029N16	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC010503	MGC04-G09	MGC	W01C029N17	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC010503	MGC04-G09	MGC	W01C029N18	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC012881	MGC04-G10	MGC	W01C029N19	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC012881	MGC04-G10	MGC	W01C029N20	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC017023	MGC04-G11	MGC	W01C029N21	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017023	MGC04-G11	MGC	W01C029N22	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017089	MGC04-G12	MGC	W01C029N23	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC017089	MGC04-G12	MGC	W01C029N24	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC015353	MGC04-H01	MGC	W01C029O01	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015353	MGC04-H01	MGC	W01C029O02	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015484	MGC04-H02	MGC	W01C029O03	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	MGC04-H02	MGC	W01C029O04	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	MGC04-H04	MGC	W01C029O07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	MGC04-H04	MGC	W01C029O08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	MGC04-H05	MGC	W01C029O09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	MGC04-H05	MGC	W01C029O10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC016859	MGC04-H06	MGC	W01C029O11	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC016859	MGC04-H06	MGC	W01C029O12	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC017017	MGC04-H07	MGC	W01C029O13	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC017017	MGC04-H07	MGC	W01C029O14	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC020567	MGC04-H08	MGC	W01C029O15	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC020567	MGC04-H08	MGC	W01C029O16	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC018190	MGC04-H09	MGC	W01C029O17	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC018190	MGC04-H09	MGC	W01C029O18	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC012443	MGC04-H10	MGC	W01C029O19	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC012443	MGC04-H10	MGC	W01C029O20	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC034247	MGC04-H11	MGC	W01C029O21	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC034247	MGC04-H11	MGC	W01C029O22	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC012375	MGC04-H12	MGC	W01C029O23	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC012375	MGC04-H12	MGC	W01C029O24	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC015353	MGC04-H01	MGC	W01C029P01	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015353	MGC04-H01	MGC	W01C029P02	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015484	MGC04-H02	MGC	W01C029P03	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	MGC04-H02	MGC	W01C029P04	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	MGC04-H04	MGC	W01C029P07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	MGC04-H04	MGC	W01C029P08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	MGC04-H05	MGC	W01C029P09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	MGC04-H05	MGC	W01C029P10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC016859	MGC04-H06	MGC	W01C029P11	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC016859	MGC04-H06	MGC	W01C029P12	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC017017	MGC04-H07	MGC	W01C029P13	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC017017	MGC04-H07	MGC	W01C029P14	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC020567	MGC04-H08	MGC	W01C029P15	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC020567	MGC04-H08	MGC	W01C029P16	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC018190	MGC04-H09	MGC	W01C029P17	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC018190	MGC04-H09	MGC	W01C029P18	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC012443	MGC04-H10	MGC	W01C029P19	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC012443	MGC04-H10	MGC	W01C029P20	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC034247	MGC04-H11	MGC	W01C029P21	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC034247	MGC04-H11	MGC	W01C029P22	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC012375	MGC04-H12	MGC	W01C029P23	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC012375	MGC04-H12	MGC	W01C029P24	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC063652	MGC04-A01	MGC	W01C030A01	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC04-A01	MGC	W01C030A02	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013121	MGC04-A02	MGC	W01C030A03	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	MGC04-A02	MGC	W01C030A04	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC011514	MGC04-A03	MGC	W01C030A05	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC011514	MGC04-A03	MGC	W01C030A06	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC003403	MGC04-A04	MGC	W01C030A07	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC003403	MGC04-A04	MGC	W01C030A08	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC000972	MGC04-A05	MGC	W01C030A09	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000972	MGC04-A05	MGC	W01C030A10	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000154	MGC04-A06	MGC	W01C030A11	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC000154	MGC04-A06	MGC	W01C030A12	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC016512	MGC04-A07	MGC	W01C030A13	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC016512	MGC04-A07	MGC	W01C030A14	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC000976	MGC04-A08	MGC	W01C030A15	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000976	MGC04-A08	MGC	W01C030A16	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000924	MGC04-A09	MGC	W01C030A17	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000924	MGC04-A09	MGC	W01C030A18	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000941	MGC04-A10	MGC	W01C030A19	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000941	MGC04-A10	MGC	W01C030A20	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000135	MGC04-A11	MGC	W01C030A21	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000135	MGC04-A11	MGC	W01C030A22	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008195	MGC04-A12	MGC	W01C030A23	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC008195	MGC04-A12	MGC	W01C030A24	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC063652	MGC04-A01	MGC	W01C030B01	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC04-A01	MGC	W01C030B02	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013121	MGC04-A02	MGC	W01C030B03	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC013121	MGC04-A02	MGC	W01C030B04	pDONR221	14864		KIAA0406	9675	AAH13121.1	Hs.655481	KIAA0406			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_014657.1	NP_055472.1	PREDICTED	OK	1.000	1.000	1089	3270	1	3267	1089	1	1089
IKAKEN	BC011514	MGC04-A03	MGC	W01C030B05	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC011514	MGC04-A03	MGC	W01C030B06	pDONR221	17000		RPL32	6161	AAH11514.1	Hs.265174	Ribosomal protein L32			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_000994.3	NP_000985.1	REVIEWED		0.963	0.963	135	408	1	405	135	1	135
IKAKEN	BC003403	MGC04-A04	MGC	W01C030B07	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC003403	MGC04-A04	MGC	W01C030B08	pDONR221	25341		RAP2C	57826	AAH03403.1	Hs.119889	RAP2C, member of RAS oncogene family			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_021183.3	NP_067006.3	PROVISIONAL	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC000972	MGC04-A05	MGC	W01C030B09	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000972	MGC04-A05	MGC	W01C030B10	pDONR221	24673		CCDC22	28952	AAH00972.1	Hs.26333	Coiled-coil domain containing 22			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014008.2	NP_054727.1	VALIDATED	OK	1.000	1.000	627	1884	1	1881	627	1	627
IKAKEN	BC000154	MGC04-A06	MGC	W01C030B11	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC000154	MGC04-A06	MGC	W01C030B12	pDONR221	21039		SLC12A9	56996	AAH00154.1	Hs.521087	Solute carrier family 12 (potassium/chloride transporters), member 9			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_020246.2	NP_064631.2	VALIDATED	Pg	0.856	1.000	619	1617	1	1590	914	1	619
IKAKEN	BC016512	MGC04-A07	MGC	W01C030B13	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC016512	MGC04-A07	MGC	W01C030B14	pDONR221	6235		ATP5B	506	AAH16512.1	Hs.406510	ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001686.3	NP_001677.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC000976	MGC04-A08	MGC	W01C030B15	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000976	MGC04-A08	MGC	W01C030B16	pDONR221	15486		SAPS2	9701	AAH00976.2	Hs.449098	SAPS domain family, member 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_014678.3	NP_055493.2	VALIDATED	Cgs	0.963	0.999	967	2904	1	2901	932	1	932
IKAKEN	BC000924	MGC04-A09	MGC	W01C030B17	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000924	MGC04-A09	MGC	W01C030B18	pDONR221	10295		ARL17	641522	AAH00924.2	Hs.559259	ADP-ribosylation factor-like 17			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_001039083.3	NP_001034172.3	VALIDATED	Ps	0.984	0.984	63	249	1	189	177	115	177
IKAKEN	BC000941	MGC04-A10	MGC	W01C030B19	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000941	MGC04-A10	MGC	W01C030B20	pDONR221	3361		SEPHS1	22929	AAH00941.1	Hs.124027	Selenophosphate synthetase 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012247.3	NP_036379.2	REVIEWED	C	1.000	1.000	392	1179	1	1176	392	1	392
IKAKEN	BC000135	MGC04-A11	MGC	W01C030B21	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000135	MGC04-A11	MGC	W01C030B22	pDONR221	11905		THOP1	7064	AAH00135.1	Hs.78769	Thimet oligopeptidase 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_003249.3	NP_003240.1	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008195	MGC04-A12	MGC	W01C030B23	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC008195	MGC04-A12	MGC	W01C030B24	pDONR221	21395		ASL	435	AAH08195.1	Hs.632015	Argininosuccinate lyase			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000048.3	NP_000039.2	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC008196	MGC04-B01	MGC	W01C030C01	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC008196	MGC04-B01	MGC	W01C030C02	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC013124	MGC04-B02	MGC	W01C030C03	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC013124	MGC04-B02	MGC	W01C030C04	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC000137	MGC04-B03	MGC	W01C030C05	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000137	MGC04-B03	MGC	W01C030C06	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC010284	MGC04-B04	MGC	W01C030C07	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC010284	MGC04-B04	MGC	W01C030C08	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC066268	MGC04-B05	MGC	W01C030C09	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066268	MGC04-B05	MGC	W01C030C10	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066884	MGC04-B06	MGC	W01C030C11	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066884	MGC04-B06	MGC	W01C030C12	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC000790	MGC04-B07	MGC	W01C030C13	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC000790	MGC04-B07	MGC	W01C030C14	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001259	MGC04-B08	MGC	W01C030C15	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001259	MGC04-B08	MGC	W01C030C16	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001261	MGC04-B09	MGC	W01C030C17	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001261	MGC04-B09	MGC	W01C030C18	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000846	MGC04-B10	MGC	W01C030C19	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC000846	MGC04-B10	MGC	W01C030C20	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC001233	MGC04-B11	MGC	W01C030C21	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001233	MGC04-B11	MGC	W01C030C22	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001234	MGC04-B12	MGC	W01C030C23	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC001234	MGC04-B12	MGC	W01C030C24	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC008196	MGC04-B01	MGC	W01C030D01	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC008196	MGC04-B01	MGC	W01C030D02	pDONR221	5360		PGAM5	192111	AAH08196.1	Hs.102558	Phosphoglycerate mutase family member 5			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_138575.2	NP_612642.1	PROVISIONAL	Cs	0.996	0.996	255	768	1	765	255	1	255
IKAKEN	BC013124	MGC04-B02	MGC	W01C030D03	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC013124	MGC04-B02	MGC	W01C030D04	pDONR221	3403		DCLRE1A	9937	AAH13124.1	Hs.1560	DNA cross-link repair 1A (PSO2 homolog, S. cerevisiae)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014881.3	NP_055696.3	PROVISIONAL	OK	1.000	1.000	1040	3123	1	3120	1040	1	1040
IKAKEN	BC000137	MGC04-B03	MGC	W01C030D05	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000137	MGC04-B03	MGC	W01C030D06	pDONR221	8579		CDT1	81620	AAH00137.2	Hs.122908	Chromatin licensing and DNA replication factor 1			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_030928.3	NP_112190.2	VALIDATED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC010284	MGC04-B04	MGC	W01C030D07	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC010284	MGC04-B04	MGC	W01C030D08	pDONR221	3669		FDX1	2230	AAH10284.1	Hs.744	Ferredoxin 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004109.3	NP_004100.1	REVIEWED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC066268	MGC04-B05	MGC	W01C030D09	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066268	MGC04-B05	MGC	W01C030D10	pDONR221	5189		IL23A	51561	AAH66268.1	Hs.98309	Interleukin 23, alpha subunit p19			PCR rescued clones	NIH_MGC_195	DH10B	NM_016584.2	NP_057668.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066884	MGC04-B06	MGC	W01C030D11	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066884	MGC04-B06	MGC	W01C030D12	pDONR221	20818		HIST1H3I	8354	AAH66884.1	Hs.132854	Histone cluster 1, H3i			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003533.2	NP_003524.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC000790	MGC04-B07	MGC	W01C030D13	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC000790	MGC04-B07	MGC	W01C030D14	pDONR221	2129		GCSH	2653	AAH00790.1	Hs.546256	Glycine cleavage system protein H (aminomethyl carrier)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004483.3	NP_004474.2	VALIDATED	C	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001259	MGC04-B08	MGC	W01C030D15	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001259	MGC04-B08	MGC	W01C030D16	pDONR221	6953		AP4S1	11154	AAH01259.1	Hs.293411	Adaptor-related protein complex 4, sigma 1 subunit			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_007077.3	NP_009008.2	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC001261	MGC04-B09	MGC	W01C030D17	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001261	MGC04-B09	MGC	W01C030D18	pDONR221	20065		FAM50B	26240	AAH01261.1	Hs.140944	Family with sequence similarity 50, member B			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_012135.1	NP_036267.1	PROVISIONAL	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000846	MGC04-B10	MGC	W01C030D19	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC000846	MGC04-B10	MGC	W01C030D20	pDONR221	8356		CIB1	10519	AAH00846.1	Hs.715556	Calcium and integrin binding 1 (calmyrin)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006384.3	NP_006375.2	VALIDATED	OK	1.000	1.000	191	576	1	573	191	1	191
IKAKEN	BC001233	MGC04-B11	MGC	W01C030D21	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001233	MGC04-B11	MGC	W01C030D22	pDONR221	4005		CEP57	9702	AAH01233.1	Hs.101014	Centrosomal protein 57kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_014679.3	NP_055494.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC001234	MGC04-B12	MGC	W01C030D23	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC001234	MGC04-B12	MGC	W01C030D24	pDONR221	3729		VWA5A	4013	AAH01234.1	Hs.152944	Von Willebrand factor A domain containing 5A			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_198315.2	NP_938057.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC000849	MGC04-C01	MGC	W01C030E01	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC000849	MGC04-C01	MGC	W01C030E02	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC001567	MGC04-C02	MGC	W01C030E03	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001567	MGC04-C02	MGC	W01C030E04	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001338	MGC04-C03	MGC	W01C030E05	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	MGC04-C03	MGC	W01C030E06	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC000878	MGC04-C04	MGC	W01C030E07	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC000878	MGC04-C04	MGC	W01C030E08	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC001294	MGC04-C05	MGC	W01C030E09	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC001294	MGC04-C05	MGC	W01C030E10	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC066246	MGC04-C06	MGC	W01C030E11	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066246	MGC04-C06	MGC	W01C030E12	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC001232	MGC04-C07	MGC	W01C030E13	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC001232	MGC04-C07	MGC	W01C030E14	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC036283	MGC04-C08	MGC	W01C030E15	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC036283	MGC04-C08	MGC	W01C030E16	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC010439	MGC04-C09	MGC	W01C030E17	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC010439	MGC04-C09	MGC	W01C030E18	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC008602	MGC04-C10	MGC	W01C030E19	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC008602	MGC04-C10	MGC	W01C030E20	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC011051	MGC04-C11	MGC	W01C030E21	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC011051	MGC04-C11	MGC	W01C030E22	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC010607	MGC04-C12	MGC	W01C030E23	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC010607	MGC04-C12	MGC	W01C030E24	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC000849	MGC04-C01	MGC	W01C030F01	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC000849	MGC04-C01	MGC	W01C030F02	pDONR221	15078		MGC5566	79015	AAH00849	Hs.255479	Hypothetical protein MGC5566			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_926767.1	XP_931860.1	MODEL										
IKAKEN	BC001567	MGC04-C02	MGC	W01C030F03	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001567	MGC04-C02	MGC	W01C030F04	pDONR221	16911		QARS	5859	AAH01567.1	Hs.79322	Glutaminyl-tRNA synthetase			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_005051.1	NP_005042.1	REVIEWED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC001338	MGC04-C03	MGC	W01C030F05	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC001338	MGC04-C03	MGC	W01C030F06	pDONR221	3871		RHOD	29984	AAH01338.1	Hs.15114	Ras homolog gene family, member D			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_014578.3	NP_055393.1	REVIEWED	Cs	0.995	0.995	210	633	1	630	210	1	210
IKAKEN	BC000878	MGC04-C04	MGC	W01C030F07	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC000878	MGC04-C04	MGC	W01C030F08	pDONR221	23036		LACTB2	51110	AAH00878.1	Hs.118554	Lactamase, beta 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016027.2	NP_057111.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC001294	MGC04-C05	MGC	W01C030F09	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC001294	MGC04-C05	MGC	W01C030F10	pDONR221	9605		C17orf48	56985	AAH01294.1	Hs.47668	Chromosome 17 open reading frame 48			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_020233.4	NP_064618.3	VALIDATED	P	1.000	1.000	201	618	1	603	342	1	201
IKAKEN	BC066246	MGC04-C06	MGC	W01C030F11	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC066246	MGC04-C06	MGC	W01C030F12	pDONR221	20123		HIST1H3A	8350	AAH66246.1	Hs.546315	Histone cluster 1, H3a			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003529.2	NP_003520.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC001232	MGC04-C07	MGC	W01C030F13	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC001232	MGC04-C07	MGC	W01C030F14	pDONR221	20329		FAM65B	9750	AAH01232.1	Hs.559459	Family with sequence similarity 65, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015864.2	NP_056948.2	VALIDATED	OK	1.000	1.000	591	1776	1	1773	591	1	591
IKAKEN	BC036283	MGC04-C08	MGC	W01C030F15	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC036283	MGC04-C08	MGC	W01C030F16	pDONR221	9071		AP1G1	164	AAH36283.1	Hs.461253	Adaptor-related protein complex 1, gamma 1 subunit			Testis	NIH_MGC_97	DH10B	NM_001030007.1	NP_001025178.1	REVIEWED	Cs	0.996	0.996	825	2478	1	2475	825	1	825
IKAKEN	BC010439	MGC04-C09	MGC	W01C030F17	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC010439	MGC04-C09	MGC	W01C030F18	pDONR221	13480		ACCN4	55515	AAH10439.1	Hs.87469	Amiloride-sensitive cation channel 4, pituitary			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182847.1	NP_878267.1	REVIEWED	Cs	0.997	0.997	647	1944	1	1941	647	1	647
IKAKEN	BC008602	MGC04-C10	MGC	W01C030F19	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC008602	MGC04-C10	MGC	W01C030F20	pDONR221	7748		PSTPIP1	9051	AAH08602.1	Hs.129758	Proline-serine-threonine phosphatase interacting protein 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003978.3	NP_003969.2	REVIEWED	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC011051	MGC04-C11	MGC	W01C030F21	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC011051	MGC04-C11	MGC	W01C030F22	pDONR221	19808		MTO1	25821	AAH11051.2	Hs.347614	Mitochondrial translation optimization 1 homolog (S. cerevisiae)			Prostate	NIH_MGC_83	DH10B	NM_012123.3	NP_036255.2	REVIEWED	P	1.000	1.000	618	1857	1	1854	692	75	692
IKAKEN	BC010607	MGC04-C12	MGC	W01C030F23	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC010607	MGC04-C12	MGC	W01C030F24	pDONR221	7940		IGF1R	3480	AAH10607	Hs.643120	Insulin-like growth factor 1 receptor			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_000875.3	NP_000866.1	REVIEWED		0.303	0.370	33	168	156	76	1367	248	280
IKAKEN	BC041070	MGC04-D01	MGC	W01C030G01	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	MGC04-D01	MGC	W01C030G02	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC011052	MGC04-D02	MGC	W01C030G03	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC011052	MGC04-D02	MGC	W01C030G04	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC018207	MGC04-D03	MGC	W01C030G05	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC018207	MGC04-D03	MGC	W01C030G06	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC011057	MGC04-D04	MGC	W01C030G07	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC011057	MGC04-D04	MGC	W01C030G08	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC008983	MGC04-D05	MGC	W01C030G09	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008983	MGC04-D05	MGC	W01C030G10	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008185	MGC04-D06	MGC	W01C030G11	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC008185	MGC04-D06	MGC	W01C030G12	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011520	MGC04-D07	MGC	W01C030G13	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC011520	MGC04-D07	MGC	W01C030G14	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC009037	MGC04-D08	MGC	W01C030G15	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC009037	MGC04-D08	MGC	W01C030G16	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC018445	MGC04-D09	MGC	W01C030G17	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC018445	MGC04-D09	MGC	W01C030G18	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC040341	MGC04-D10	MGC	W01C030G19	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC040341	MGC04-D10	MGC	W01C030G20	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC010629	MGC04-D11	MGC	W01C030G21	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC010629	MGC04-D11	MGC	W01C030G22	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC016613	MGC04-D12	MGC	W01C030G23	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC016613	MGC04-D12	MGC	W01C030G24	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC041070	MGC04-D01	MGC	W01C030H01	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	MGC04-D01	MGC	W01C030H02	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC011052	MGC04-D02	MGC	W01C030H03	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC011052	MGC04-D02	MGC	W01C030H04	pDONR221	17395		TRIM2	23321	AAH11052.1	Hs.435711	Tripartite motif-containing 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001130067.1	NP_001123539.1	VALIDATED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC018207	MGC04-D03	MGC	W01C030H05	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC018207	MGC04-D03	MGC	W01C030H06	pDONR221	22778		GPT	2875	AAH18207.1	Hs.103502	Glutamic-pyruvate transaminase (alanine aminotransferase)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_005309.2	NP_005300.1	VALIDATED	OK	1.000	1.000	496	1491	1	1488	496	1	496
IKAKEN	BC011057	MGC04-D04	MGC	W01C030H07	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC011057	MGC04-D04	MGC	W01C030H08	pDONR221	8272		LINGO1	84894	AAH11057.2	Hs.656765	Leucine rich repeat and Ig domain containing 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032808.5	NP_116197.4	VALIDATED	P	1.000	1.000	614	1845	1	1842	620	7	620
IKAKEN	BC008983	MGC04-D05	MGC	W01C030H09	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008983	MGC04-D05	MGC	W01C030H10	pDONR221	904		C1QB	713	AAH08983.1	Hs.8986	Complement component 1, q subcomponent, B chain			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000491.3	NP_000482.3	REVIEWED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC008185	MGC04-D06	MGC	W01C030H11	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC008185	MGC04-D06	MGC	W01C030H12	pDONR221	20077		HSD17B8	7923	AAH08185.1	Hs.415058	Hydroxysteroid (17-beta) dehydrogenase 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014234.3	NP_055049.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011520	MGC04-D07	MGC	W01C030H13	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC011520	MGC04-D07	MGC	W01C030H14	pDONR221	23097		STMN4	81551	AAH11520.1	Hs.201058	Stathmin-like 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030795.2	NP_110422.2	PROVISIONAL	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC009037	MGC04-D08	MGC	W01C030H15	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC009037	MGC04-D08	MGC	W01C030H16	pDONR221	12682		ATPBD3	90353	AAH09037.1	Hs.148425	ATP binding domain 3			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145232.3	NP_660275.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC018445	MGC04-D09	MGC	W01C030H17	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC018445	MGC04-D09	MGC	W01C030H18	pDONR221	19866		LACE1	246269	AAH18445.2	Hs.259666	Lactation elevated 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_145315.3	NP_660358.2	REVIEWED	OK	1.000	1.000	481	1446	1	1443	481	1	481
IKAKEN	BC040341	MGC04-D10	MGC	W01C030H19	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC040341	MGC04-D10	MGC	W01C030H20	pDONR221	9590		KIAA1618	57714	AAH40341.1	Hs.514554	KIAA1618			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_020954.2	NP_066005.2	VALIDATED	OK	1.000	1.000	1063	3192	1	3189	1063	1	1063
IKAKEN	BC010629	MGC04-D11	MGC	W01C030H21	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC010629	MGC04-D11	MGC	W01C030H22	pDONR221	23521		ODF2	4957	AAH10629.1	Hs.129055	Outer dense fiber of sperm tails 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002540.3	NP_002531.3	REVIEWED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC016613	MGC04-D12	MGC	W01C030H23	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC016613	MGC04-D12	MGC	W01C030H24	pDONR221	8841		C16orf11	146325	AAH16613.1	Hs.632220	Chromosome 16 open reading frame 11			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_145270.1	NP_660313.1	PREDICTED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC011377	MGC04-E01	MGC	W01C030I01	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011377	MGC04-E01	MGC	W01C030I02	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011379	MGC04-E02	MGC	W01C030I03	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC011379	MGC04-E02	MGC	W01C030I04	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC008674	MGC04-E03	MGC	W01C030I05	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC008674	MGC04-E03	MGC	W01C030I06	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC009078	MGC04-E04	MGC	W01C030I07	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC009078	MGC04-E04	MGC	W01C030I08	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC008253	MGC04-E05	MGC	W01C030I09	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC008253	MGC04-E05	MGC	W01C030I10	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC048194	MGC04-E06	MGC	W01C030I11	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	MGC04-E06	MGC	W01C030I12	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC009679	MGC04-E07	MGC	W01C030I13	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC009679	MGC04-E07	MGC	W01C030I14	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC013421	MGC04-E08	MGC	W01C030I15	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013421	MGC04-E08	MGC	W01C030I16	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013581	MGC04-E09	MGC	W01C030I17	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC013581	MGC04-E09	MGC	W01C030I18	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC009726	MGC04-E11	MGC	W01C030I21	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	MGC04-E11	MGC	W01C030I22	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC024314	MGC04-E12	MGC	W01C030I23	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC024314	MGC04-E12	MGC	W01C030I24	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC011377	MGC04-E01	MGC	W01C030J01	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011377	MGC04-E01	MGC	W01C030J02	pDONR221	22773		LRRC14	9684	AAH11377.1	Hs.459391	Leucine rich repeat containing 14			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014665.1	NP_055480.1	PROVISIONAL	C	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC011379	MGC04-E02	MGC	W01C030J03	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC011379	MGC04-E02	MGC	W01C030J04	pDONR221	7756		C15orf39	56905	AAH11379.2	Hs.17936	Chromosome 15 open reading frame 39			Placenta	NIH_MGC_79	DH10B	NM_015492.4	NP_056307.2	VALIDATED	Cs	0.998	0.998	1047	3144	1	3141	1047	1	1047
IKAKEN	BC008674	MGC04-E03	MGC	W01C030J05	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC008674	MGC04-E03	MGC	W01C030J06	pDONR221	7406		ERO1L	30001	AAH08674.1	Hs.592304	ERO1-like (S. cerevisiae)			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014584.1	NP_055399.1	PROVISIONAL	OK	1.000	1.000	468	1407	1	1404	468	1	468
IKAKEN	BC009078	MGC04-E04	MGC	W01C030J07	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC009078	MGC04-E04	MGC	W01C030J08	pDONR221	9383		C16orf74	404550	AAH09078	Hs.461655	Chromosome 16 open reading frame 74			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_206967.2	NP_996850.1	VALIDATED	P	1.000	1.000	64	195	1	192	76	13	76
IKAKEN	BC008253	MGC04-E05	MGC	W01C030J09	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC008253	MGC04-E05	MGC	W01C030J10	pDONR221	22771		NCRNA00051	619434	-	Hs.393308	Non-protein coding RNA 51			Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC048194	MGC04-E06	MGC	W01C030J11	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	MGC04-E06	MGC	W01C030J12	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC009679	MGC04-E07	MGC	W01C030J13	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC009679	MGC04-E07	MGC	W01C030J14	pDONR221	9720		DHRS7B	25979	AAH09679.1	Hs.386989	Dehydrogenase/reductase (SDR family) member 7B			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_015510.3	NP_056325.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC013421	MGC04-E08	MGC	W01C030J15	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013421	MGC04-E08	MGC	W01C030J16	pDONR221	15958		SELM	140606	AAH13421.1	Hs.55940	Selenoprotein M			Lung	NIH_MGC_77	DH10B	NM_080430.2	NP_536355.1	REVIEWED	Cfs	0.993	1.000	145	438	1	435	144	1	144
IKAKEN	BC013581	MGC04-E09	MGC	W01C030J17	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC013581	MGC04-E09	MGC	W01C030J18	pDONR221	16280		COL8A1	1295	AAH13581.1	Hs.654548	Collagen, type VIII, alpha 1			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_001850.3	NP_001841.2	REVIEWED	OK	1.000	1.000	744	2235	1	2232	744	1	744
IKAKEN	BC009726	MGC04-E11	MGC	W01C030J21	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC009726	MGC04-E11	MGC	W01C030J22	pDONR221	9064		PRSS22	64063	AAH09726.1	Hs.459709	Protease, serine, 22			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_022119.3	NP_071402.1	REVIEWED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	BC024314	MGC04-E12	MGC	W01C030J23	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC024314	MGC04-E12	MGC	W01C030J24	pDONR221	3136		AFAP1L2	84632	AAH24314.1	Hs.501106	Actin filament associated protein 1-like 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_032550.2	NP_115939.1	VALIDATED	C	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC009694	MGC04-F01	MGC	W01C030K01	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC009694	MGC04-F01	MGC	W01C030K02	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC020965	MGC04-F02	MGC	W01C030K03	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC020965	MGC04-F02	MGC	W01C030K04	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC016279	MGC04-F03	MGC	W01C030K05	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC016279	MGC04-F03	MGC	W01C030K06	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC015722	MGC04-F04	MGC	W01C030K07	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015722	MGC04-F04	MGC	W01C030K08	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015928	MGC04-F05	MGC	W01C030K09	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	MGC04-F05	MGC	W01C030K10	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015050	MGC04-F06	MGC	W01C030K11	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC015050	MGC04-F06	MGC	W01C030K12	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC016028	MGC04-F07	MGC	W01C030K13	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC016028	MGC04-F07	MGC	W01C030K14	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC045108	MGC04-F08	MGC	W01C030K15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	MGC04-F08	MGC	W01C030K16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015887	MGC04-F09	MGC	W01C030K17	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC015887	MGC04-F09	MGC	W01C030K18	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC016146	MGC04-F10	MGC	W01C030K19	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC016146	MGC04-F10	MGC	W01C030K20	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC017469	MGC04-F11	MGC	W01C030K21	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017469	MGC04-F11	MGC	W01C030K22	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017556	MGC04-F12	MGC	W01C030K23	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC017556	MGC04-F12	MGC	W01C030K24	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC009694	MGC04-F01	MGC	W01C030L01	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC009694	MGC04-F01	MGC	W01C030L02	pDONR221	906		G0S2	50486	AAH09694.1	Hs.715825	G0/G1switch 2			Skin, melanotic melanoma, high MDR.	NIH_MGC_62	DH10B	NM_015714.3	NP_056529.1	VALIDATED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC020965	MGC04-F02	MGC	W01C030L03	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC020965	MGC04-F02	MGC	W01C030L04	pDONR221	4032		STT3A	3703	AAH20965.1	Hs.504237	STT3, subunit of the oligosaccharyltransferase complex, homolog A (S. cerevisiae)			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_152713.3	NP_689926.1	VALIDATED	OK	1.000	1.000	705	2118	1	2115	705	1	705
IKAKEN	BC016279	MGC04-F03	MGC	W01C030L05	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC016279	MGC04-F03	MGC	W01C030L06	pDONR221	19923		CENPQ	55166	AAH16279.2	Hs.88663	Centromere protein Q			testis	TST		NM_018132.3	NP_060602.2	VALIDATED	OK	1.000	1.000	268	807	1	804	268	1	268
IKAKEN	BC015722	MGC04-F04	MGC	W01C030L07	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015722	MGC04-F04	MGC	W01C030L08	pDONR221	22003		C7orf43	55262	AAH15722.2	Hs.533139	Chromosome 7 open reading frame 43			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_018275.3	NP_060745.3	PREDICTED	OK	1.000	1.000	580	1743	1	1740	580	1	580
IKAKEN	BC015928	MGC04-F05	MGC	W01C030L09	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015928	MGC04-F05	MGC	W01C030L10	pDONR221	19120		ARRDC3	57561	AAH15928.1	Hs.718495	Arrestin domain containing 3			Testis	NIH_MGC_97	DH10B	NM_020801.2	NP_065852.1	VALIDATED	OK	1.000	1.000	414	1245	1	1242	414	1	414
IKAKEN	BC015050	MGC04-F06	MGC	W01C030L11	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC015050	MGC04-F06	MGC	W01C030L12	pDONR221	8159		OIP5	11339	AAH15050.1	Hs.661645	Opa interacting protein 5			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_007280.1	NP_009211.1	PROVISIONAL	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC016028	MGC04-F07	MGC	W01C030L13	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC016028	MGC04-F07	MGC	W01C030L14	pDONR221	7096		C14orf80	283643	AAH16028.1					Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_173608.1	NP_775879.1	VALIDATED	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC045108	MGC04-F08	MGC	W01C030L15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	MGC04-F08	MGC	W01C030L16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015887	MGC04-F09	MGC	W01C030L17	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC015887	MGC04-F09	MGC	W01C030L18	pDONR221	5895		WSB2	55884	AAH15887.1	Hs.506985	WD repeat and SOCS box-containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_018639.3	NP_061109.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	BC016146	MGC04-F10	MGC	W01C030L19	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC016146	MGC04-F10	MGC	W01C030L20	pDONR221	16551		USP13	8975	AAH16146.1	Hs.175322	Ubiquitin specific peptidase 13 (isopeptidase T-3)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003940.2	NP_003931.2	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	BC017469	MGC04-F11	MGC	W01C030L21	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017469	MGC04-F11	MGC	W01C030L22	pDONR221	11489		AP1M1	8907	AAH17469.1	Hs.71040	Adaptor-related protein complex 1, mu 1 subunit			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_032493.3	NP_115882.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC017556	MGC04-F12	MGC	W01C030L23	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC017556	MGC04-F12	MGC	W01C030L24	pDONR221	22959		RB1CC1	9821	AAH17556.1	Hs.196102	RB1-inducible coiled-coil 1			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_014781.4	NP_055596.3	VALIDATED	Cgs	0.996	0.998	1597	4794	1	4791	1594	1	1594
IKAKEN	BC015937	MGC04-G01	MGC	W01C030M01	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC015937	MGC04-G01	MGC	W01C030M02	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC014923	MGC04-G02	MGC	W01C030M03	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014923	MGC04-G02	MGC	W01C030M04	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014895	MGC04-G03	MGC	W01C030M05	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC014895	MGC04-G03	MGC	W01C030M06	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC010230	MGC04-G04	MGC	W01C030M07	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010230	MGC04-G04	MGC	W01C030M08	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010538	MGC04-G05	MGC	W01C030M09	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC010538	MGC04-G05	MGC	W01C030M10	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC016460	MGC04-G06	MGC	W01C030M11	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016460	MGC04-G06	MGC	W01C030M12	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016465	MGC04-G07	MGC	W01C030M13	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC016465	MGC04-G07	MGC	W01C030M14	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC044889	MGC04-G08	MGC	W01C030M15	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC044889	MGC04-G08	MGC	W01C030M16	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC010503	MGC04-G09	MGC	W01C030M17	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC010503	MGC04-G09	MGC	W01C030M18	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC012881	MGC04-G10	MGC	W01C030M19	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC012881	MGC04-G10	MGC	W01C030M20	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC017023	MGC04-G11	MGC	W01C030M21	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017023	MGC04-G11	MGC	W01C030M22	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017089	MGC04-G12	MGC	W01C030M23	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC017089	MGC04-G12	MGC	W01C030M24	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC015937	MGC04-G01	MGC	W01C030N01	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC015937	MGC04-G01	MGC	W01C030N02	pDONR221	19168		PAIP1	10605	AAH15937.1	Hs.482038	Poly(A) binding protein interacting protein 1			Testis	NIH_MGC_97	DH10B	NM_006451.4	NP_006442.2	REVIEWED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC014923	MGC04-G02	MGC	W01C030N03	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014923	MGC04-G02	MGC	W01C030N04	pDONR221	890		EFHD2	79180	AAH14923.1	Hs.465374	EF-hand domain family, member D2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_024329.5	NP_077305.2	VALIDATED	OK	1.000	1.000	240	723	1	720	240	1	240
IKAKEN	BC014895	MGC04-G03	MGC	W01C030N05	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC014895	MGC04-G03	MGC	W01C030N06	pDONR221	11712		ALDH16A1	126133	AAH14895.2					Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_153329.3	NP_699160.2	REVIEWED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC010230	MGC04-G04	MGC	W01C030N07	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010230	MGC04-G04	MGC	W01C030N08	pDONR221	3264		MORN4	118812	AAH10230.1	Hs.217409	MORN repeat containing 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178832.3	NP_849154.1	VALIDATED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC010538	MGC04-G05	MGC	W01C030N09	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC010538	MGC04-G05	MGC	W01C030N10	pDONR221	11273		C18orf18	147525	AAH10538	Hs.657197	Chromosome 18 open reading frame 18			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001720671.1	XP_001720723.1	MODEL	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC016460	MGC04-G06	MGC	W01C030N11	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016460	MGC04-G06	MGC	W01C030N12	pDONR221	9337		GSG1L	146395	AAH16460.1	Hs.91910	GSG1-like			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_144675.2	NP_653276.1	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC016465	MGC04-G07	MGC	W01C030N13	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC016465	MGC04-G07	MGC	W01C030N14	pDONR221	15785		TTC28	23331	AAH16465.1	Hs.387856	Tetratricopeptide repeat domain 28			Skeletal Muscle	NIH_MGC_81	DH10B	XM_001726330.1	XP_001726382.1	MODEL	P	1.000	1.000	1254	3765	1	3762	2481	1228	2481
IKAKEN	BC044889	MGC04-G08	MGC	W01C030N15	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC044889	MGC04-G08	MGC	W01C030N16	pDONR221	11627		SUV420H2	84787	AAH44889.1	Hs.590982	Suppressor of variegation 4-20 homolog 2 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_032701.3	NP_116090.2	VALIDATED	OK	1.000	1.000	462	1389	1	1386	462	1	462
IKAKEN	BC010503	MGC04-G09	MGC	W01C030N17	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC010503	MGC04-G09	MGC	W01C030N18	pDONR221	9094		ERI2	112479	AAH10503.1	Hs.248437	Exoribonuclease 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_080663.2	NP_542394.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC012881	MGC04-G10	MGC	W01C030N19	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC012881	MGC04-G10	MGC	W01C030N20	pDONR221	14842			643697	AAH12881					Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R			
IKAKEN	BC017023	MGC04-G11	MGC	W01C030N21	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017023	MGC04-G11	MGC	W01C030N22	pDONR221	8927		DPEP1	1800	AAH17023.1	Hs.109	Dipeptidase 1 (renal)			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_004413.3	NP_004404.1	VALIDATED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC017089	MGC04-G12	MGC	W01C030N23	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC017089	MGC04-G12	MGC	W01C030N24	pDONR221	1694		REG4	83998	AAH17089.1	Hs.660883	Regenerating islet-derived family, member 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001159352.1	NP_001152824.1	VALIDATED	OK	1.000	1.000	158	477	1	474	158	1	158
IKAKEN	BC015353	MGC04-H01	MGC	W01C030O01	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015353	MGC04-H01	MGC	W01C030O02	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015484	MGC04-H02	MGC	W01C030O03	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	MGC04-H02	MGC	W01C030O04	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	MGC04-H04	MGC	W01C030O07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	MGC04-H04	MGC	W01C030O08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	MGC04-H05	MGC	W01C030O09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	MGC04-H05	MGC	W01C030O10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC016859	MGC04-H06	MGC	W01C030O11	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC016859	MGC04-H06	MGC	W01C030O12	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC017017	MGC04-H07	MGC	W01C030O13	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC017017	MGC04-H07	MGC	W01C030O14	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC020567	MGC04-H08	MGC	W01C030O15	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC020567	MGC04-H08	MGC	W01C030O16	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC018190	MGC04-H09	MGC	W01C030O17	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC018190	MGC04-H09	MGC	W01C030O18	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC012443	MGC04-H10	MGC	W01C030O19	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC012443	MGC04-H10	MGC	W01C030O20	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC034247	MGC04-H11	MGC	W01C030O21	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC034247	MGC04-H11	MGC	W01C030O22	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC012375	MGC04-H12	MGC	W01C030O23	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC012375	MGC04-H12	MGC	W01C030O24	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC015353	MGC04-H01	MGC	W01C030P01	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015353	MGC04-H01	MGC	W01C030P02	pDONR221	13489		TRIM43	129868	AAH15353.1	Hs.232026	Tripartite motif-containing 43			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_138800.1	NP_620155.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC015484	MGC04-H02	MGC	W01C030P03	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	MGC04-H02	MGC	W01C030P04	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	MGC04-H04	MGC	W01C030P07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	MGC04-H04	MGC	W01C030P08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	MGC04-H05	MGC	W01C030P09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	MGC04-H05	MGC	W01C030P10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC016859	MGC04-H06	MGC	W01C030P11	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC016859	MGC04-H06	MGC	W01C030P12	pDONR221	550		MOSC2	54996	AAH16859.1	Hs.369042	MOCO sulphurase C-terminal domain containing 2			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_017898.3	NP_060368.2	PROVISIONAL	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC017017	MGC04-H07	MGC	W01C030P13	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC017017	MGC04-H07	MGC	W01C030P14	pDONR221	20533		TRIM31	11074	AAH17017.1	Hs.493275	Tripartite motif-containing 31			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_007028.3	NP_008959.3	REVIEWED	Cs	0.995	0.995	425	1278	1	1275	425	1	425
IKAKEN	BC020567	MGC04-H08	MGC	W01C030P15	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC020567	MGC04-H08	MGC	W01C030P16	pDONR221	1371		ARHGEF2	9181	AAH20567.1	Hs.655209	Rho/rac guanine nucleotide exchange factor (GEF) 2			Testis	NIH_MGC_97	DH10B	NM_004723.2	NP_004714.2	REVIEWED	OK	1.000	1.000	958	2877	1	2874	958	1	958
IKAKEN	BC018190	MGC04-H09	MGC	W01C030P17	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC018190	MGC04-H09	MGC	W01C030P18	pDONR221	8930		MT1X	4501	AAH18190.1	Hs.374950	Metallothionein 1X			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005952.3	NP_005943.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC012443	MGC04-H10	MGC	W01C030P19	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC012443	MGC04-H10	MGC	W01C030P20	pDONR221	12263		HOOK2	29911	AAH12443.1	Hs.30792	Hook homolog 2 (Drosophila)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100176.1	NP_001093646.1	VALIDATED	OK	1.000	1.000	717	2154	1	2151	717	1	717
IKAKEN	BC034247	MGC04-H11	MGC	W01C030P21	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC034247	MGC04-H11	MGC	W01C030P22	pDONR221	24026		TOMM5	401505	AAH34247.1	Hs.130774	Translocase of outer mitochondrial membrane 5 homolog (yeast)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001001790.2	NP_001001790.1	VALIDATED	OK	1.000	1.000	51	156	1	153	51	1	51
IKAKEN	BC012375	MGC04-H12	MGC	W01C030P23	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC012375	MGC04-H12	MGC	W01C030P24	pDONR221	9561		ARSG	22901	AAH12375.1	Hs.437249	Arylsulfatase G			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014960.3	NP_055775.2	VALIDATED	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC011982	MGC05-A01	MGC	W01C031A01	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC011982	MGC05-A01	MGC	W01C031A02	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC018206	MGC05-A02	MGC	W01C031A03	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC018206	MGC05-A02	MGC	W01C031A04	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC013048	MGC05-A03	MGC	W01C031A05	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013048	MGC05-A03	MGC	W01C031A06	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC041608	MGC05-A04	MGC	W01C031A07	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	MGC05-A04	MGC	W01C031A08	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC031469	MGC05-A05	MGC	W01C031A09	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031469	MGC05-A05	MGC	W01C031A10	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC014791	MGC05-A06	MGC	W01C031A11	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC014791	MGC05-A06	MGC	W01C031A12	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC012427	MGC05-A07	MGC	W01C031A13	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC012427	MGC05-A07	MGC	W01C031A14	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC013694	MGC05-A08	MGC	W01C031A15	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC013694	MGC05-A08	MGC	W01C031A16	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC012430	MGC05-A09	MGC	W01C031A17	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC012430	MGC05-A09	MGC	W01C031A18	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC026951	MGC05-A10	MGC	W01C031A19	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	MGC05-A10	MGC	W01C031A20	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC015527	MGC05-A12	MGC	W01C031A23	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC015527	MGC05-A12	MGC	W01C031A24	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC011982	MGC05-A01	MGC	W01C031B01	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC011982	MGC05-A01	MGC	W01C031B02	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC018206	MGC05-A02	MGC	W01C031B03	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC018206	MGC05-A02	MGC	W01C031B04	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC013048	MGC05-A03	MGC	W01C031B05	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013048	MGC05-A03	MGC	W01C031B06	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC041608	MGC05-A04	MGC	W01C031B07	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	MGC05-A04	MGC	W01C031B08	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC031469	MGC05-A05	MGC	W01C031B09	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031469	MGC05-A05	MGC	W01C031B10	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC014791	MGC05-A06	MGC	W01C031B11	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC014791	MGC05-A06	MGC	W01C031B12	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC012427	MGC05-A07	MGC	W01C031B13	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC012427	MGC05-A07	MGC	W01C031B14	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC013694	MGC05-A08	MGC	W01C031B15	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC013694	MGC05-A08	MGC	W01C031B16	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC012430	MGC05-A09	MGC	W01C031B17	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC012430	MGC05-A09	MGC	W01C031B18	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC026951	MGC05-A10	MGC	W01C031B19	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	MGC05-A10	MGC	W01C031B20	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC015527	MGC05-A12	MGC	W01C031B23	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC015527	MGC05-A12	MGC	W01C031B24	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC024592	MGC05-B01	MGC	W01C031C01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	MGC05-B01	MGC	W01C031C02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	MGC05-B02	MGC	W01C031C03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	MGC05-B02	MGC	W01C031C04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018133	MGC05-B03	MGC	W01C031C05	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018133	MGC05-B03	MGC	W01C031C06	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018117	MGC05-B04	MGC	W01C031C07	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	MGC05-B04	MGC	W01C031C08	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC041609	MGC05-B06	MGC	W01C031C11	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	MGC05-B06	MGC	W01C031C12	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC024315	MGC05-B07	MGC	W01C031C13	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	MGC05-B07	MGC	W01C031C14	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	MGC05-B09	MGC	W01C031C17	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	MGC05-B09	MGC	W01C031C18	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	MGC05-B10	MGC	W01C031C19	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	MGC05-B10	MGC	W01C031C20	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	MGC05-B11	MGC	W01C031C21	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	MGC05-B11	MGC	W01C031C22	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC024592	MGC05-B01	MGC	W01C031D01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	MGC05-B01	MGC	W01C031D02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	MGC05-B02	MGC	W01C031D03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	MGC05-B02	MGC	W01C031D04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018133	MGC05-B03	MGC	W01C031D05	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018133	MGC05-B03	MGC	W01C031D06	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018117	MGC05-B04	MGC	W01C031D07	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	MGC05-B04	MGC	W01C031D08	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC041609	MGC05-B06	MGC	W01C031D11	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	MGC05-B06	MGC	W01C031D12	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC024315	MGC05-B07	MGC	W01C031D13	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	MGC05-B07	MGC	W01C031D14	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	MGC05-B09	MGC	W01C031D17	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	MGC05-B09	MGC	W01C031D18	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	MGC05-B10	MGC	W01C031D19	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	MGC05-B10	MGC	W01C031D20	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	MGC05-B11	MGC	W01C031D21	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	MGC05-B11	MGC	W01C031D22	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC017731	MGC05-C01	MGC	W01C031E01	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC017731	MGC05-C01	MGC	W01C031E02	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC015369	MGC05-C02	MGC	W01C031E03	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	MGC05-C02	MGC	W01C031E04	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013171	MGC05-C03	MGC	W01C031E05	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC013171	MGC05-C03	MGC	W01C031E06	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC021898	MGC05-C04	MGC	W01C031E07	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC021898	MGC05-C04	MGC	W01C031E08	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC013770	MGC05-C05	MGC	W01C031E09	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	MGC05-C05	MGC	W01C031E10	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC018359	MGC05-C06	MGC	W01C031E11	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC018359	MGC05-C06	MGC	W01C031E12	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC036335	MGC05-C07	MGC	W01C031E13	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC036335	MGC05-C07	MGC	W01C031E14	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC020082	MGC05-C08	MGC	W01C031E15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	MGC05-C08	MGC	W01C031E16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC041058	MGC05-C09	MGC	W01C031E17	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	MGC05-C09	MGC	W01C031E18	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC021901	MGC05-C10	MGC	W01C031E19	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	MGC05-C10	MGC	W01C031E20	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC042571	MGC05-C11	MGC	W01C031E21	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC042571	MGC05-C11	MGC	W01C031E22	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC041594	MGC05-C12	MGC	W01C031E23	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	MGC05-C12	MGC	W01C031E24	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC017731	MGC05-C01	MGC	W01C031F01	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC017731	MGC05-C01	MGC	W01C031F02	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC015369	MGC05-C02	MGC	W01C031F03	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	MGC05-C02	MGC	W01C031F04	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013171	MGC05-C03	MGC	W01C031F05	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC013171	MGC05-C03	MGC	W01C031F06	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC021898	MGC05-C04	MGC	W01C031F07	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC021898	MGC05-C04	MGC	W01C031F08	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC013770	MGC05-C05	MGC	W01C031F09	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	MGC05-C05	MGC	W01C031F10	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC018359	MGC05-C06	MGC	W01C031F11	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC018359	MGC05-C06	MGC	W01C031F12	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC036335	MGC05-C07	MGC	W01C031F13	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC036335	MGC05-C07	MGC	W01C031F14	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC020082	MGC05-C08	MGC	W01C031F15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	MGC05-C08	MGC	W01C031F16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC041058	MGC05-C09	MGC	W01C031F17	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	MGC05-C09	MGC	W01C031F18	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC021901	MGC05-C10	MGC	W01C031F19	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	MGC05-C10	MGC	W01C031F20	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC042571	MGC05-C11	MGC	W01C031F21	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC042571	MGC05-C11	MGC	W01C031F22	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC041594	MGC05-C12	MGC	W01C031F23	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	MGC05-C12	MGC	W01C031F24	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC039154	MGC05-D01	MGC	W01C031G01	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC039154	MGC05-D01	MGC	W01C031G02	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC040359	MGC05-D02	MGC	W01C031G03	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC040359	MGC05-D02	MGC	W01C031G04	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC034730	MGC05-D03	MGC	W01C031G05	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC034730	MGC05-D03	MGC	W01C031G06	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC022239	MGC05-D04	MGC	W01C031G07	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC022239	MGC05-D04	MGC	W01C031G08	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC024327	MGC05-D05	MGC	W01C031G09	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	MGC05-D05	MGC	W01C031G10	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC026215	MGC05-D06	MGC	W01C031G11	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC026215	MGC05-D06	MGC	W01C031G12	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC042921	MGC05-D07	MGC	W01C031G13	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	MGC05-D07	MGC	W01C031G14	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC017741	MGC05-D08	MGC	W01C031G15	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC017741	MGC05-D08	MGC	W01C031G16	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC026214	MGC05-D09	MGC	W01C031G17	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC026214	MGC05-D09	MGC	W01C031G18	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC015419	MGC05-D10	MGC	W01C031G19	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015419	MGC05-D10	MGC	W01C031G20	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC039145	MGC05-D11	MGC	W01C031G21	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	MGC05-D11	MGC	W01C031G22	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039154	MGC05-D01	MGC	W01C031H01	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC039154	MGC05-D01	MGC	W01C031H02	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC040359	MGC05-D02	MGC	W01C031H03	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC040359	MGC05-D02	MGC	W01C031H04	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC034730	MGC05-D03	MGC	W01C031H05	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC034730	MGC05-D03	MGC	W01C031H06	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC022239	MGC05-D04	MGC	W01C031H07	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC022239	MGC05-D04	MGC	W01C031H08	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC024327	MGC05-D05	MGC	W01C031H09	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	MGC05-D05	MGC	W01C031H10	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC026215	MGC05-D06	MGC	W01C031H11	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC026215	MGC05-D06	MGC	W01C031H12	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC042921	MGC05-D07	MGC	W01C031H13	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	MGC05-D07	MGC	W01C031H14	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC017741	MGC05-D08	MGC	W01C031H15	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC017741	MGC05-D08	MGC	W01C031H16	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC026214	MGC05-D09	MGC	W01C031H17	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC026214	MGC05-D09	MGC	W01C031H18	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC015419	MGC05-D10	MGC	W01C031H19	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015419	MGC05-D10	MGC	W01C031H20	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC039145	MGC05-D11	MGC	W01C031H21	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	MGC05-D11	MGC	W01C031H22	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC027241	MGC05-E01	MGC	W01C031I01	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC027241	MGC05-E01	MGC	W01C031I02	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC012482	MGC05-E02	MGC	W01C031I03	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC012482	MGC05-E02	MGC	W01C031I04	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC013123	MGC05-E03	MGC	W01C031I05	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC013123	MGC05-E03	MGC	W01C031I06	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC032003	MGC05-E05	MGC	W01C031I09	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC032003	MGC05-E05	MGC	W01C031I10	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC012024	MGC05-E06	MGC	W01C031I11	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012024	MGC05-E06	MGC	W01C031I12	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012934	MGC05-E07	MGC	W01C031I13	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC012934	MGC05-E07	MGC	W01C031I14	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC042914	MGC05-E08	MGC	W01C031I15	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	MGC05-E08	MGC	W01C031I16	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC016618	MGC05-E09	MGC	W01C031I17	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC016618	MGC05-E09	MGC	W01C031I18	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC039169	MGC05-E10	MGC	W01C031I19	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC039169	MGC05-E10	MGC	W01C031I20	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC040354	MGC05-E11	MGC	W01C031I21	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	MGC05-E11	MGC	W01C031I22	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC013145	MGC05-E12	MGC	W01C031I23	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC013145	MGC05-E12	MGC	W01C031I24	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC027241	MGC05-E01	MGC	W01C031J01	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC027241	MGC05-E01	MGC	W01C031J02	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC012482	MGC05-E02	MGC	W01C031J03	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC012482	MGC05-E02	MGC	W01C031J04	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC013123	MGC05-E03	MGC	W01C031J05	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC013123	MGC05-E03	MGC	W01C031J06	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC032003	MGC05-E05	MGC	W01C031J09	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC032003	MGC05-E05	MGC	W01C031J10	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC012024	MGC05-E06	MGC	W01C031J11	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012024	MGC05-E06	MGC	W01C031J12	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012934	MGC05-E07	MGC	W01C031J13	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC012934	MGC05-E07	MGC	W01C031J14	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC042914	MGC05-E08	MGC	W01C031J15	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	MGC05-E08	MGC	W01C031J16	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC016618	MGC05-E09	MGC	W01C031J17	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC016618	MGC05-E09	MGC	W01C031J18	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC039169	MGC05-E10	MGC	W01C031J19	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC039169	MGC05-E10	MGC	W01C031J20	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC040354	MGC05-E11	MGC	W01C031J21	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	MGC05-E11	MGC	W01C031J22	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC013145	MGC05-E12	MGC	W01C031J23	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC013145	MGC05-E12	MGC	W01C031J24	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC028290	MGC05-F01	MGC	W01C031K01	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC028290	MGC05-F01	MGC	W01C031K02	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC044634	MGC05-F02	MGC	W01C031K03	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	MGC05-F02	MGC	W01C031K04	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC052289	MGC05-F03	MGC	W01C031K05	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	MGC05-F03	MGC	W01C031K06	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC034530	MGC05-F04	MGC	W01C031K07	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	MGC05-F04	MGC	W01C031K08	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC028298	MGC05-F05	MGC	W01C031K09	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC028298	MGC05-F05	MGC	W01C031K10	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC019823	MGC05-F06	MGC	W01C031K11	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC019823	MGC05-F06	MGC	W01C031K12	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC021853	MGC05-F07	MGC	W01C031K13	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC021853	MGC05-F07	MGC	W01C031K14	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC022967	MGC05-F08	MGC	W01C031K15	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC022967	MGC05-F08	MGC	W01C031K16	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC031890	MGC05-F09	MGC	W01C031K17	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	MGC05-F09	MGC	W01C031K18	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC052285	MGC05-F10	MGC	W01C031K19	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	MGC05-F10	MGC	W01C031K20	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC019851	MGC05-F11	MGC	W01C031K21	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC019851	MGC05-F11	MGC	W01C031K22	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC052581	MGC05-F12	MGC	W01C031K23	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	MGC05-F12	MGC	W01C031K24	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC028290	MGC05-F01	MGC	W01C031L01	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC028290	MGC05-F01	MGC	W01C031L02	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC044634	MGC05-F02	MGC	W01C031L03	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	MGC05-F02	MGC	W01C031L04	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC052289	MGC05-F03	MGC	W01C031L05	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	MGC05-F03	MGC	W01C031L06	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC034530	MGC05-F04	MGC	W01C031L07	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	MGC05-F04	MGC	W01C031L08	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC028298	MGC05-F05	MGC	W01C031L09	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC028298	MGC05-F05	MGC	W01C031L10	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC019823	MGC05-F06	MGC	W01C031L11	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC019823	MGC05-F06	MGC	W01C031L12	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC021853	MGC05-F07	MGC	W01C031L13	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC021853	MGC05-F07	MGC	W01C031L14	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC022967	MGC05-F08	MGC	W01C031L15	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC022967	MGC05-F08	MGC	W01C031L16	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC031890	MGC05-F09	MGC	W01C031L17	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	MGC05-F09	MGC	W01C031L18	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC052285	MGC05-F10	MGC	W01C031L19	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	MGC05-F10	MGC	W01C031L20	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC019851	MGC05-F11	MGC	W01C031L21	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC019851	MGC05-F11	MGC	W01C031L22	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC052581	MGC05-F12	MGC	W01C031L23	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	MGC05-F12	MGC	W01C031L24	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC032224	MGC05-G01	MGC	W01C031M01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	MGC05-G01	MGC	W01C031M02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC027852	MGC05-G02	MGC	W01C031M03	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC027852	MGC05-G02	MGC	W01C031M04	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC030195	MGC05-G03	MGC	W01C031M05	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC030195	MGC05-G03	MGC	W01C031M06	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC025768	MGC05-G04	MGC	W01C031M07	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC025768	MGC05-G04	MGC	W01C031M08	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC030220	MGC05-G05	MGC	W01C031M09	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC030220	MGC05-G05	MGC	W01C031M10	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC032221	MGC05-G06	MGC	W01C031M11	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC032221	MGC05-G06	MGC	W01C031M12	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC027853	MGC05-G07	MGC	W01C031M13	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	MGC05-G07	MGC	W01C031M14	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC030205	MGC05-G08	MGC	W01C031M15	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC030205	MGC05-G08	MGC	W01C031M16	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC025778	MGC05-G09	MGC	W01C031M17	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC025778	MGC05-G09	MGC	W01C031M18	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC053991	MGC05-G10	MGC	W01C031M19	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	MGC05-G10	MGC	W01C031M20	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035515	MGC05-G11	MGC	W01C031M21	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC035515	MGC05-G11	MGC	W01C031M22	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC025787	MGC05-G12	MGC	W01C031M23	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC025787	MGC05-G12	MGC	W01C031M24	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC032224	MGC05-G01	MGC	W01C031N01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	MGC05-G01	MGC	W01C031N02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC027852	MGC05-G02	MGC	W01C031N03	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC027852	MGC05-G02	MGC	W01C031N04	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC030195	MGC05-G03	MGC	W01C031N05	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC030195	MGC05-G03	MGC	W01C031N06	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC025768	MGC05-G04	MGC	W01C031N07	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC025768	MGC05-G04	MGC	W01C031N08	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC030220	MGC05-G05	MGC	W01C031N09	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC030220	MGC05-G05	MGC	W01C031N10	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC032221	MGC05-G06	MGC	W01C031N11	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC032221	MGC05-G06	MGC	W01C031N12	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC027853	MGC05-G07	MGC	W01C031N13	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	MGC05-G07	MGC	W01C031N14	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC030205	MGC05-G08	MGC	W01C031N15	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC030205	MGC05-G08	MGC	W01C031N16	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC025778	MGC05-G09	MGC	W01C031N17	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC025778	MGC05-G09	MGC	W01C031N18	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC053991	MGC05-G10	MGC	W01C031N19	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	MGC05-G10	MGC	W01C031N20	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035515	MGC05-G11	MGC	W01C031N21	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC035515	MGC05-G11	MGC	W01C031N22	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC025787	MGC05-G12	MGC	W01C031N23	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC025787	MGC05-G12	MGC	W01C031N24	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC025790	MGC05-H01	MGC	W01C031O01	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC025790	MGC05-H01	MGC	W01C031O02	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC035514	MGC05-H02	MGC	W01C031O03	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC035514	MGC05-H02	MGC	W01C031O04	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC027977	MGC05-H03	MGC	W01C031O05	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC027977	MGC05-H03	MGC	W01C031O06	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC035281	MGC05-H04	MGC	W01C031O07	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC035281	MGC05-H04	MGC	W01C031O08	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC052293	MGC05-H05	MGC	W01C031O09	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	MGC05-H05	MGC	W01C031O10	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC029158	MGC05-H08	MGC	W01C031O15	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC029158	MGC05-H08	MGC	W01C031O16	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031573	MGC05-H09	MGC	W01C031O17	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC031573	MGC05-H09	MGC	W01C031O18	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC051355	MGC05-H10	MGC	W01C031O19	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC051355	MGC05-H10	MGC	W01C031O20	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC052243	MGC05-H11	MGC	W01C031O21	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC052243	MGC05-H11	MGC	W01C031O22	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC029120	MGC05-H12	MGC	W01C031O23	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC029120	MGC05-H12	MGC	W01C031O24	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC025790	MGC05-H01	MGC	W01C031P01	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC025790	MGC05-H01	MGC	W01C031P02	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC035514	MGC05-H02	MGC	W01C031P03	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC035514	MGC05-H02	MGC	W01C031P04	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC027977	MGC05-H03	MGC	W01C031P05	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC027977	MGC05-H03	MGC	W01C031P06	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC035281	MGC05-H04	MGC	W01C031P07	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC035281	MGC05-H04	MGC	W01C031P08	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC052293	MGC05-H05	MGC	W01C031P09	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	MGC05-H05	MGC	W01C031P10	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC029158	MGC05-H08	MGC	W01C031P15	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC029158	MGC05-H08	MGC	W01C031P16	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031573	MGC05-H09	MGC	W01C031P17	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC031573	MGC05-H09	MGC	W01C031P18	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC051355	MGC05-H10	MGC	W01C031P19	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC051355	MGC05-H10	MGC	W01C031P20	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC052243	MGC05-H11	MGC	W01C031P21	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC052243	MGC05-H11	MGC	W01C031P22	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC029120	MGC05-H12	MGC	W01C031P23	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC029120	MGC05-H12	MGC	W01C031P24	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC011982	MGC05-A01	MGC	W01C032A01	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC011982	MGC05-A01	MGC	W01C032A02	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC018206	MGC05-A02	MGC	W01C032A03	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC018206	MGC05-A02	MGC	W01C032A04	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC013048	MGC05-A03	MGC	W01C032A05	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013048	MGC05-A03	MGC	W01C032A06	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC041608	MGC05-A04	MGC	W01C032A07	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	MGC05-A04	MGC	W01C032A08	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC031469	MGC05-A05	MGC	W01C032A09	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031469	MGC05-A05	MGC	W01C032A10	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC014791	MGC05-A06	MGC	W01C032A11	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC014791	MGC05-A06	MGC	W01C032A12	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC012427	MGC05-A07	MGC	W01C032A13	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC012427	MGC05-A07	MGC	W01C032A14	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC013694	MGC05-A08	MGC	W01C032A15	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC013694	MGC05-A08	MGC	W01C032A16	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC012430	MGC05-A09	MGC	W01C032A17	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC012430	MGC05-A09	MGC	W01C032A18	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC026951	MGC05-A10	MGC	W01C032A19	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	MGC05-A10	MGC	W01C032A20	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC015527	MGC05-A12	MGC	W01C032A23	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC015527	MGC05-A12	MGC	W01C032A24	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC011982	MGC05-A01	MGC	W01C032B01	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC011982	MGC05-A01	MGC	W01C032B02	pDONR221	22775		MFSD3	113655	AAH11982.1	Hs.7678	Major facilitator superfamily domain containing 3			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_138431.1	NP_612440.1	PROVISIONAL	C	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC018206	MGC05-A02	MGC	W01C032B03	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC018206	MGC05-A02	MGC	W01C032B04	pDONR221	14423		FAM128A	653784	AAH18206.2	Hs.655067	Family with sequence similarity 128, member A			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_001085365.1	NP_001078834.1	VALIDATED		0.962	0.962	158	477	1	474	158	1	158
IKAKEN	BC013048	MGC05-A03	MGC	W01C032B05	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC013048	MGC05-A03	MGC	W01C032B06	pDONR221	23054		REEP4	80346	AAH13048.1	Hs.289063	Receptor accessory protein 4			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_025232.2	NP_079508.2	PROVISIONAL	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC041608	MGC05-A04	MGC	W01C032B07	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	MGC05-A04	MGC	W01C032B08	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC031469	MGC05-A05	MGC	W01C032B09	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031469	MGC05-A05	MGC	W01C032B10	pDONR221	7220		LOC554207	554207	AAH31469.1	Hs.375105	Hypothetical LOC554207			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC014791	MGC05-A06	MGC	W01C032B11	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC014791	MGC05-A06	MGC	W01C032B12	pDONR221	3574		SSSCA1	10534	AAH14791.1	Hs.654840	Sjogren syndrome/scleroderma autoantigen 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_006396.1	NP_006387.1	PROVISIONAL	C	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC012427	MGC05-A07	MGC	W01C032B13	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC012427	MGC05-A07	MGC	W01C032B14	pDONR221	21289		CCDC126	90693	AAH12427.2	Hs.232296	Coiled-coil domain containing 126			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_138771.3	NP_620126.2	VALIDATED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC013694	MGC05-A08	MGC	W01C032B15	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC013694	MGC05-A08	MGC	W01C032B16	pDONR221	11465		PTBP1	5725	AAH13694.1	Hs.172550	Polypyrimidine tract binding protein 1			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_002819.4	NP_002810.1	REVIEWED	OK	1.000	1.000	557	1674	1	1671	557	1	557
IKAKEN	BC012430	MGC05-A09	MGC	W01C032B17	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC012430	MGC05-A09	MGC	W01C032B18	pDONR221	10992		SEH1L	81929	AAH12430.1	Hs.301048	SEH1-like (S. cerevisiae)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_031216.3	NP_112493.2	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC026951	MGC05-A10	MGC	W01C032B19	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC026951	MGC05-A10	MGC	W01C032B20	pDONR221	23200		KIAA0196	9897	AAH26951.1	Hs.270043	KIAA0196			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_014846.3	NP_055661.3	VALIDATED	OK	1.000	1.000	1159	3480	1	3477	1159	1	1159
IKAKEN	BC015527	MGC05-A12	MGC	W01C032B23	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC015527	MGC05-A12	MGC	W01C032B24	pDONR221										Skin, melanotic melanoma.	NIH_MGC_72	DH10B			
IKAKEN	BC024592	MGC05-B01	MGC	W01C032C01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	MGC05-B01	MGC	W01C032C02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	MGC05-B02	MGC	W01C032C03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	MGC05-B02	MGC	W01C032C04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018133	MGC05-B03	MGC	W01C032C05	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018133	MGC05-B03	MGC	W01C032C06	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018117	MGC05-B04	MGC	W01C032C07	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	MGC05-B04	MGC	W01C032C08	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC041609	MGC05-B06	MGC	W01C032C11	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	MGC05-B06	MGC	W01C032C12	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC024315	MGC05-B07	MGC	W01C032C13	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	MGC05-B07	MGC	W01C032C14	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	MGC05-B09	MGC	W01C032C17	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	MGC05-B09	MGC	W01C032C18	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	MGC05-B10	MGC	W01C032C19	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	MGC05-B10	MGC	W01C032C20	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	MGC05-B11	MGC	W01C032C21	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	MGC05-B11	MGC	W01C032C22	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC024592	MGC05-B01	MGC	W01C032D01	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC024592	MGC05-B01	MGC	W01C032D02	pDONR221	54		NCDN	23154	AAH24592.1	Hs.121870	Neurochondrin			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001014839.1	NP_001014839.1	REVIEWED	OK	1.000	1.000	729	2190	1	2187	729	1	729
IKAKEN	BC018127	MGC05-B02	MGC	W01C032D03	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	MGC05-B02	MGC	W01C032D04	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018133	MGC05-B03	MGC	W01C032D05	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018133	MGC05-B03	MGC	W01C032D06	pDONR221	3746		TCIRG1	10312	AAH18133.1	Hs.495985	T-cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 subunit A3			Lung, carcinoma, large cell	NIH_MGC_69	DH10B	NM_006053.2	NP_006044.1	REVIEWED	C	1.000	1.000	614	2493	649	2490	614	1	614
IKAKEN	BC018117	MGC05-B04	MGC	W01C032D07	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC018117	MGC05-B04	MGC	W01C032D08	pDONR221	23047		TPD52	7163	AAH18117.1	Hs.368433	Tumor protein D52			Brain, hippocampus	NIH_MGC_95	DH10B	NM_005079.2	NP_005070.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC041609	MGC05-B06	MGC	W01C032D11	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	MGC05-B06	MGC	W01C032D12	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC024315	MGC05-B07	MGC	W01C032D13	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC024315	MGC05-B07	MGC	W01C032D14	pDONR221	2756		C10orf12	26148	AAH24315.1	Hs.427927	Chromosome 10 open reading frame 12			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_015652.2	NP_056467.2	PREDICTED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC017046	MGC05-B09	MGC	W01C032D17	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC017046	MGC05-B09	MGC	W01C032D18	pDONR221	19382		ANXA6	309	AAH17046.1	Hs.412117	Annexin A6			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_001155.3	NP_001146.2	REVIEWED	OK	1.000	1.000	673	2022	1	2019	673	1	673
IKAKEN	BC039563	MGC05-B10	MGC	W01C032D19	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC039563	MGC05-B10	MGC	W01C032D20	pDONR221	7965		ARHGAP11A	9824	AAH39563.1	Hs.591130	Rho GTPase activating protein 11A			Testis	NIH_MGC_97	DH10B	NM_199357.1	NP_955389.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC020499	MGC05-B11	MGC	W01C032D21	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC020499	MGC05-B11	MGC	W01C032D22	pDONR221	8695		MLST8	64223	AAH20499	Hs.29203	G protein beta subunit-like			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_022372.3	NP_071767.3	VALIDATED	P	1.000	1.000	287	984	1	861	326	1	287
IKAKEN	BC017731	MGC05-C01	MGC	W01C032E01	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC017731	MGC05-C01	MGC	W01C032E02	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC015369	MGC05-C02	MGC	W01C032E03	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	MGC05-C02	MGC	W01C032E04	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013171	MGC05-C03	MGC	W01C032E05	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC013171	MGC05-C03	MGC	W01C032E06	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC021898	MGC05-C04	MGC	W01C032E07	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC021898	MGC05-C04	MGC	W01C032E08	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC013770	MGC05-C05	MGC	W01C032E09	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	MGC05-C05	MGC	W01C032E10	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC018359	MGC05-C06	MGC	W01C032E11	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC018359	MGC05-C06	MGC	W01C032E12	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC036335	MGC05-C07	MGC	W01C032E13	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC036335	MGC05-C07	MGC	W01C032E14	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC020082	MGC05-C08	MGC	W01C032E15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	MGC05-C08	MGC	W01C032E16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC041058	MGC05-C09	MGC	W01C032E17	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	MGC05-C09	MGC	W01C032E18	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC021901	MGC05-C10	MGC	W01C032E19	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	MGC05-C10	MGC	W01C032E20	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC042571	MGC05-C11	MGC	W01C032E21	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC042571	MGC05-C11	MGC	W01C032E22	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC041594	MGC05-C12	MGC	W01C032E23	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	MGC05-C12	MGC	W01C032E24	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC017731	MGC05-C01	MGC	W01C032F01	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC017731	MGC05-C01	MGC	W01C032F02	pDONR221	21786		OSBPL3	26031	AAH17731.1	Hs.520259	Oxysterol binding protein-like 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015550.2	NP_056365.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC015369	MGC05-C02	MGC	W01C032F03	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	MGC05-C02	MGC	W01C032F04	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013171	MGC05-C03	MGC	W01C032F05	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC013171	MGC05-C03	MGC	W01C032F06	pDONR221	25386		MAGEA2	4101		Hs.534597	Melanoma antigen family A, 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_005361.2	NP_005352.1	REVIEWED		0.750	0.750	8	132	35	12	314	13	20
IKAKEN	BC021898	MGC05-C04	MGC	W01C032F07	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC021898	MGC05-C04	MGC	W01C032F08	pDONR221	14003		AP1S3	130340	AAH21898.1	Hs.632555	Adaptor-related protein complex 1, sigma 3 subunit			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001039569.1	NP_001034658.1	VALIDATED	P	1.000	1.000	97	315	1	291	154	1	97
IKAKEN	BC013770	MGC05-C05	MGC	W01C032F09	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	MGC05-C05	MGC	W01C032F10	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC018359	MGC05-C06	MGC	W01C032F11	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC018359	MGC05-C06	MGC	W01C032F12	pDONR221	3303		MAT1A	4143	AAH18359.1	Hs.282670	Methionine adenosyltransferase I, alpha			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000429.2	NP_000420.1	REVIEWED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC036335	MGC05-C07	MGC	W01C032F13	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC036335	MGC05-C07	MGC	W01C032F14	pDONR221	9100		BTBD12	84464	AAH36335	Hs.143681	BTB (POZ) domain containing 12			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_032444.2	NP_115820.2	PROVISIONAL	P	1.000	1.000	1151	3456	1	3453	1834	684	1834
IKAKEN	BC020082	MGC05-C08	MGC	W01C032F15	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC020082	MGC05-C08	MGC	W01C032F16	pDONR221	10935		SOCS6	9306	AAH20082.1	Hs.44439	Suppressor of cytokine signaling 6			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004232.3	NP_004223.2	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	BC041058	MGC05-C09	MGC	W01C032F17	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	MGC05-C09	MGC	W01C032F18	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC021901	MGC05-C10	MGC	W01C032F19	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	MGC05-C10	MGC	W01C032F20	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC042571	MGC05-C11	MGC	W01C032F21	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC042571	MGC05-C11	MGC	W01C032F22	pDONR221	8328		POLG	5428	AAH42571.1	Hs.706868	Polymerase (DNA directed), gamma			Testis	NIH_MGC_97	DH10B	NM_002693.2	NP_002684.1	REVIEWED	OK	1.000	1.000	1239	3720	1	3717	1239	1	1239
IKAKEN	BC041594	MGC05-C12	MGC	W01C032F23	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	MGC05-C12	MGC	W01C032F24	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC039154	MGC05-D01	MGC	W01C032G01	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC039154	MGC05-D01	MGC	W01C032G02	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC040359	MGC05-D02	MGC	W01C032G03	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC040359	MGC05-D02	MGC	W01C032G04	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC034730	MGC05-D03	MGC	W01C032G05	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC034730	MGC05-D03	MGC	W01C032G06	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC022239	MGC05-D04	MGC	W01C032G07	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC022239	MGC05-D04	MGC	W01C032G08	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC024327	MGC05-D05	MGC	W01C032G09	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	MGC05-D05	MGC	W01C032G10	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC026215	MGC05-D06	MGC	W01C032G11	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC026215	MGC05-D06	MGC	W01C032G12	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC042921	MGC05-D07	MGC	W01C032G13	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	MGC05-D07	MGC	W01C032G14	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC017741	MGC05-D08	MGC	W01C032G15	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC017741	MGC05-D08	MGC	W01C032G16	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC026214	MGC05-D09	MGC	W01C032G17	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC026214	MGC05-D09	MGC	W01C032G18	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC015419	MGC05-D10	MGC	W01C032G19	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015419	MGC05-D10	MGC	W01C032G20	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC039145	MGC05-D11	MGC	W01C032G21	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	MGC05-D11	MGC	W01C032G22	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039154	MGC05-D01	MGC	W01C032H01	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC039154	MGC05-D01	MGC	W01C032H02	pDONR221	9365		C16orf79	283870	AAH39154.1	Hs.647399	Chromosome 16 open reading frame 79			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_182563.2	NP_872369.1	PREDICTED	Cs	0.991	0.991	228	687	1	684	228	1	228
IKAKEN	BC040359	MGC05-D02	MGC	W01C032H03	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC040359	MGC05-D02	MGC	W01C032H04	pDONR221	16394		HPS3	84343	AAH40359.1	Hs.591311	Hermansky-Pudlak syndrome 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032383.3	NP_115759.2	REVIEWED	OK	1.000	1.000	1004	3015	1	3012	1004	1	1004
IKAKEN	BC034730	MGC05-D03	MGC	W01C032H05	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC034730	MGC05-D03	MGC	W01C032H06	pDONR221	12510		NLRP11	204801	AAH34730.1	Hs.375039	NLR family, pyrin domain containing 11			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_145007.3	NP_659444.2	VALIDATED	OK	1.000	1.000	1033	3102	1	3099	1033	1	1033
IKAKEN	BC022239	MGC05-D04	MGC	W01C032H07	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC022239	MGC05-D04	MGC	W01C032H08	pDONR221	4574		RAB3IL1	5866	AAH22239.1	Hs.13759	RAB3A interacting protein (rabin3)-like 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_013401.2	NP_037533.2	PROVISIONAL	C	1.000	1.000	382	1149	1	1146	382	1	382
IKAKEN	BC024327	MGC05-D05	MGC	W01C032H09	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	MGC05-D05	MGC	W01C032H10	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC026215	MGC05-D06	MGC	W01C032H11	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC026215	MGC05-D06	MGC	W01C032H12	pDONR221	15037		SNTA1	6640	AAH26215.1	Hs.31121	Syntrophin, alpha 1 (dystrophin-associated protein A1, 59kDa, acidic component)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003098.2	NP_003089.1	REVIEWED	OK	1.000	1.000	505	1518	1	1515	505	1	505
IKAKEN	BC042921	MGC05-D07	MGC	W01C032H13	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	MGC05-D07	MGC	W01C032H14	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC017741	MGC05-D08	MGC	W01C032H15	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC017741	MGC05-D08	MGC	W01C032H16	pDONR221	13836		GTDC1	79712	AAH17741.1	Hs.44780	Glycosyltransferase-like domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_024659.2	NP_078935.2	PROVISIONAL	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC026214	MGC05-D09	MGC	W01C032H17	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC026214	MGC05-D09	MGC	W01C032H18	pDONR221	15614		LZTR1	8216	AAH26214.2	Hs.78788	Leucine-zipper-like transcription regulator 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006767.3	NP_006758.2	REVIEWED	Cg	0.984	1.000	854	2565	1	2562	840	1	840
IKAKEN	BC015419	MGC05-D10	MGC	W01C032H19	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015419	MGC05-D10	MGC	W01C032H20	pDONR221	2024		C1orf96	126731	AAH15419.1	Hs.715507	Chromosome 1 open reading frame 96			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145257.3	NP_660300.3	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC039145	MGC05-D11	MGC	W01C032H21	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC039145	MGC05-D11	MGC	W01C032H22	pDONR221	6064		GLT8D3	283464	AAH39145.1	Hs.259347	Glycosyltransferase 8 domain containing 3			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001099650.1	NP_001093120.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC027241	MGC05-E01	MGC	W01C032I01	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC027241	MGC05-E01	MGC	W01C032I02	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC012482	MGC05-E02	MGC	W01C032I03	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC012482	MGC05-E02	MGC	W01C032I04	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC013123	MGC05-E03	MGC	W01C032I05	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC013123	MGC05-E03	MGC	W01C032I06	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC032003	MGC05-E05	MGC	W01C032I09	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC032003	MGC05-E05	MGC	W01C032I10	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC012024	MGC05-E06	MGC	W01C032I11	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012024	MGC05-E06	MGC	W01C032I12	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012934	MGC05-E07	MGC	W01C032I13	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC012934	MGC05-E07	MGC	W01C032I14	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC042914	MGC05-E08	MGC	W01C032I15	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	MGC05-E08	MGC	W01C032I16	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC016618	MGC05-E09	MGC	W01C032I17	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC016618	MGC05-E09	MGC	W01C032I18	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC039169	MGC05-E10	MGC	W01C032I19	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC039169	MGC05-E10	MGC	W01C032I20	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC040354	MGC05-E11	MGC	W01C032I21	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	MGC05-E11	MGC	W01C032I22	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC013145	MGC05-E12	MGC	W01C032I23	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC013145	MGC05-E12	MGC	W01C032I24	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC027241	MGC05-E01	MGC	W01C032J01	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC027241	MGC05-E01	MGC	W01C032J02	pDONR221	16832		ALDH1L1	10840	AAH27241.1	Hs.434435	Aldehyde dehydrogenase 1 family, member L1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_012190.2	NP_036322.2	REVIEWED	P	1.000	1.000	491	1518	1	1473	902	1	491
IKAKEN	BC012482	MGC05-E02	MGC	W01C032J03	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC012482	MGC05-E02	MGC	W01C032J04	pDONR221	6092		GNS	2799	AAH12482.1	Hs.334534	Glucosamine (N-acetyl)-6-sulfatase			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_002076.3	NP_002067.1	REVIEWED	OK	1.000	1.000	552	1659	1	1656	552	1	552
IKAKEN	BC013123	MGC05-E03	MGC	W01C032J05	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC013123	MGC05-E03	MGC	W01C032J06	pDONR221	17050		C3orf59	151963	AAH13123.1	Hs.151443	Chromosome 3 open reading frame 59			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_178496.3	NP_848591.2	VALIDATED	P	1.000	1.000	489	1470	1	1467	491	3	491
IKAKEN	BC032003	MGC05-E05	MGC	W01C032J09	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC032003	MGC05-E05	MGC	W01C032J10	pDONR221	18852		SPINK6	404203	AAH32003.1	Hs.334274	Serine peptidase inhibitor, Kazal type 6			Testis	NIH_MGC_97	DH10B	NM_205841.2	NP_995313.2	VALIDATED	OK	1.000	1.000	80	243	1	240	80	1	80
IKAKEN	BC012024	MGC05-E06	MGC	W01C032J11	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012024	MGC05-E06	MGC	W01C032J12	pDONR221	18521		CENPH	64946	AAH12024.1	Hs.631967	Centromere protein H			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_022909.3	NP_075060.1	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC012934	MGC05-E07	MGC	W01C032J13	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC012934	MGC05-E07	MGC	W01C032J14	pDONR221	24845		FOXR2	139628	AAH12934.1	Hs.364260	Forkhead box R2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_198451.2	NP_940853.1	VALIDATED	OK	1.000	1.000	311	936	1	933	311	1	311
IKAKEN	BC042914	MGC05-E08	MGC	W01C032J15	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	MGC05-E08	MGC	W01C032J16	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC016618	MGC05-E09	MGC	W01C032J17	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC016618	MGC05-E09	MGC	W01C032J18	pDONR221	19428		LCP2	3937	AAH16618.1	Hs.304475	Lymphocyte cytosolic protein 2 (SH2 domain containing leukocyte protein of 76kDa)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_005565.3	NP_005556.1	REVIEWED	OK	1.000	1.000	533	1602	1	1599	533	1	533
IKAKEN	BC039169	MGC05-E10	MGC	W01C032J19	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC039169	MGC05-E10	MGC	W01C032J20	pDONR221	10352		KRT16	3868	AAH39169.1	Hs.655160	Keratin 16			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_005557.3	NP_005548.2	REVIEWED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC040354	MGC05-E11	MGC	W01C032J21	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC040354	MGC05-E11	MGC	W01C032J22	pDONR221	21061		CALD1	800	AAH40354.1	Hs.490203	Caldesmon 1			Testis	NIH_MGC_97	DH10B	NM_004342.5	NP_004333.1	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC013145	MGC05-E12	MGC	W01C032J23	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC013145	MGC05-E12	MGC	W01C032J24	pDONR221	17107		TBC1D5	9779	AAH13145.1	Hs.475629	TBC1 domain family, member 5			Prostate, adenocarcinoma.	NIH_MGC_91	DH10B	NM_001134380.1	NP_001127852.1	VALIDATED	Cs	0.997	0.997	795	2388	1	2385	795	1	795
IKAKEN	BC028290	MGC05-F01	MGC	W01C032K01	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC028290	MGC05-F01	MGC	W01C032K02	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC044634	MGC05-F02	MGC	W01C032K03	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	MGC05-F02	MGC	W01C032K04	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC052289	MGC05-F03	MGC	W01C032K05	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	MGC05-F03	MGC	W01C032K06	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC034530	MGC05-F04	MGC	W01C032K07	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	MGC05-F04	MGC	W01C032K08	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC028298	MGC05-F05	MGC	W01C032K09	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC028298	MGC05-F05	MGC	W01C032K10	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC019823	MGC05-F06	MGC	W01C032K11	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC019823	MGC05-F06	MGC	W01C032K12	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC021853	MGC05-F07	MGC	W01C032K13	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC021853	MGC05-F07	MGC	W01C032K14	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC022967	MGC05-F08	MGC	W01C032K15	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC022967	MGC05-F08	MGC	W01C032K16	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC031890	MGC05-F09	MGC	W01C032K17	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	MGC05-F09	MGC	W01C032K18	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC052285	MGC05-F10	MGC	W01C032K19	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	MGC05-F10	MGC	W01C032K20	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC019851	MGC05-F11	MGC	W01C032K21	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC019851	MGC05-F11	MGC	W01C032K22	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC052581	MGC05-F12	MGC	W01C032K23	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	MGC05-F12	MGC	W01C032K24	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC028290	MGC05-F01	MGC	W01C032L01	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC028290	MGC05-F01	MGC	W01C032L02	pDONR221	10518		TBC1D16	125058	AAH28290.1	Hs.369819	TBC1 domain family, member 16			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_019020.2	NP_061893.2	PROVISIONAL	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	BC044634	MGC05-F02	MGC	W01C032L03	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	MGC05-F02	MGC	W01C032L04	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC052289	MGC05-F03	MGC	W01C032L05	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	MGC05-F03	MGC	W01C032L06	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC034530	MGC05-F04	MGC	W01C032L07	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	MGC05-F04	MGC	W01C032L08	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC028298	MGC05-F05	MGC	W01C032L09	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC028298	MGC05-F05	MGC	W01C032L10	pDONR221	5611		RDH5	5959	AAH28298.1	Hs.600940	Retinol dehydrogenase 5 (11-cis/9-cis)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_002905.3	NP_002896.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC019823	MGC05-F06	MGC	W01C032L11	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC019823	MGC05-F06	MGC	W01C032L12	pDONR221	14650		SNX21	90203	AAH19823.1	Hs.472854	Sorting nexin family member 21			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_152897.1	NP_690857.1	REVIEWED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC021853	MGC05-F07	MGC	W01C032L13	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC021853	MGC05-F07	MGC	W01C032L14	pDONR221	8703		HAS3	3038	AAH21853.1	Hs.592069	Hyaluronan synthase 3			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_138612.1	NP_619515.1	REVIEWED	OK	1.000	1.000	281	846	1	843	281	1	281
IKAKEN	BC022967	MGC05-F08	MGC	W01C032L15	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC022967	MGC05-F08	MGC	W01C032L16	pDONR221	7359		WDR22	8816	AAH22967.1	Hs.509780	WD repeat domain 22			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_003861.2	NP_003852.1	VALIDATED	Ps	0.997	0.997	294	981	1	882	942	1	294
IKAKEN	BC031890	MGC05-F09	MGC	W01C032L17	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	MGC05-F09	MGC	W01C032L18	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC052285	MGC05-F10	MGC	W01C032L19	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	MGC05-F10	MGC	W01C032L20	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC019851	MGC05-F11	MGC	W01C032L21	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC019851	MGC05-F11	MGC	W01C032L22	pDONR221	16510		TMEM42	131616	AAH19851.1					Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_144638.1	NP_653239.1	PROVISIONAL	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC052581	MGC05-F12	MGC	W01C032L23	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	MGC05-F12	MGC	W01C032L24	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC032224	MGC05-G01	MGC	W01C032M01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	MGC05-G01	MGC	W01C032M02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC027852	MGC05-G02	MGC	W01C032M03	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC027852	MGC05-G02	MGC	W01C032M04	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC030195	MGC05-G03	MGC	W01C032M05	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC030195	MGC05-G03	MGC	W01C032M06	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC025768	MGC05-G04	MGC	W01C032M07	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC025768	MGC05-G04	MGC	W01C032M08	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC030220	MGC05-G05	MGC	W01C032M09	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC030220	MGC05-G05	MGC	W01C032M10	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC032221	MGC05-G06	MGC	W01C032M11	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC032221	MGC05-G06	MGC	W01C032M12	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC027853	MGC05-G07	MGC	W01C032M13	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	MGC05-G07	MGC	W01C032M14	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC030205	MGC05-G08	MGC	W01C032M15	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC030205	MGC05-G08	MGC	W01C032M16	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC025778	MGC05-G09	MGC	W01C032M17	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC025778	MGC05-G09	MGC	W01C032M18	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC053991	MGC05-G10	MGC	W01C032M19	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	MGC05-G10	MGC	W01C032M20	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035515	MGC05-G11	MGC	W01C032M21	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC035515	MGC05-G11	MGC	W01C032M22	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC025787	MGC05-G12	MGC	W01C032M23	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC025787	MGC05-G12	MGC	W01C032M24	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC032224	MGC05-G01	MGC	W01C032N01	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC032224	MGC05-G01	MGC	W01C032N02	pDONR221	19146		PDGFRB	5159	AAH32224.1	Hs.509067	Platelet-derived growth factor receptor, beta polypeptide			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_002609.3	NP_002600.1	REVIEWED	Cgs	0.998	0.999	1107	3324	1	3321	1106	1	1106
IKAKEN	BC027852	MGC05-G02	MGC	W01C032N03	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC027852	MGC05-G02	MGC	W01C032N04	pDONR221	21442		RPL13AP17	399670	AAH27852	Hs.568045	Ribosomal protein L13a pseudogene 17			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B			
IKAKEN	BC030195	MGC05-G03	MGC	W01C032N05	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC030195	MGC05-G03	MGC	W01C032N06	pDONR221	7551		GZMB	3002	AAH30195.1	Hs.1051	Granzyme B (granzyme 2, cytotoxic T-lymphocyte-associated serine esterase 1)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004131.4	NP_004122.2	REVIEWED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC025768	MGC05-G04	MGC	W01C032N07	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC025768	MGC05-G04	MGC	W01C032N08	pDONR221	755		FAM76A	199870	AAH25768.1	Hs.469359	Family with sequence similarity 76, member A			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_152660.2	NP_689873.1	VALIDATED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC030220	MGC05-G05	MGC	W01C032N09	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC030220	MGC05-G05	MGC	W01C032N10	pDONR221	93		NTNG1	22854	AAH30220.1	Hs.657434	Netrin G1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_014917.2	NP_055732.2	VALIDATED	Ps	0.997	0.997	363	1095	1	1089	438	1	363
IKAKEN	BC032221	MGC05-G06	MGC	W01C032N11	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC032221	MGC05-G06	MGC	W01C032N12	pDONR221	6932		KIAA0391	9692	AAH32221.1	Hs.458487	KIAA0391			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_014672.2	NP_055487.2	PROVISIONAL	C	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	BC027853	MGC05-G07	MGC	W01C032N13	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	MGC05-G07	MGC	W01C032N14	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC030205	MGC05-G08	MGC	W01C032N15	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC030205	MGC05-G08	MGC	W01C032N16	pDONR221	13103		TNFAIP6	7130	AAH30205.1	Hs.437322	Tumor necrosis factor, alpha-induced protein 6			Testis	NIH_MGC_97	DH10B	NM_007115.2	NP_009046.2	REVIEWED	OK	1.000	1.000	277	834	1	831	277	1	277
IKAKEN	BC025778	MGC05-G09	MGC	W01C032N17	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC025778	MGC05-G09	MGC	W01C032N18	pDONR221	5353		BCL2L14	79370	AAH25778.1	Hs.210343	BCL2-like 14 (apoptosis facilitator)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_138722.1	NP_620048.1	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC053991	MGC05-G10	MGC	W01C032N19	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	MGC05-G10	MGC	W01C032N20	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035515	MGC05-G11	MGC	W01C032N21	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC035515	MGC05-G11	MGC	W01C032N22	pDONR221	19446		C5orf36	285600	AAH35515.1	Hs.425123	Chromosome 5 open reading frame 36			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173665.2	NP_775936.1	VALIDATED	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC025787	MGC05-G12	MGC	W01C032N23	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC025787	MGC05-G12	MGC	W01C032N24	pDONR221	7576		ALKBH1	8846	AAH25787.1	Hs.94542	AlkB, alkylation repair homolog 1 (E. coli)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_006020.2	NP_006011.2	REVIEWED	Pfs	0.993	1.000	298	894	3	892	389	77	374
IKAKEN	BC025790	MGC05-H01	MGC	W01C032O01	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC025790	MGC05-H01	MGC	W01C032O02	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC035514	MGC05-H02	MGC	W01C032O03	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC035514	MGC05-H02	MGC	W01C032O04	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC027977	MGC05-H03	MGC	W01C032O05	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC027977	MGC05-H03	MGC	W01C032O06	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC035281	MGC05-H04	MGC	W01C032O07	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC035281	MGC05-H04	MGC	W01C032O08	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC052293	MGC05-H05	MGC	W01C032O09	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	MGC05-H05	MGC	W01C032O10	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC029158	MGC05-H08	MGC	W01C032O15	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC029158	MGC05-H08	MGC	W01C032O16	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031573	MGC05-H09	MGC	W01C032O17	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC031573	MGC05-H09	MGC	W01C032O18	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC051355	MGC05-H10	MGC	W01C032O19	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC051355	MGC05-H10	MGC	W01C032O20	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC052243	MGC05-H11	MGC	W01C032O21	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC052243	MGC05-H11	MGC	W01C032O22	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC029120	MGC05-H12	MGC	W01C032O23	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC029120	MGC05-H12	MGC	W01C032O24	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC025790	MGC05-H01	MGC	W01C032P01	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC025790	MGC05-H01	MGC	W01C032P02	pDONR221	19435		SPINK1	6690	AAH25790.1	Hs.407856	Serine peptidase inhibitor, Kazal type 1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_003122.3	NP_003113.2	REVIEWED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC035514	MGC05-H02	MGC	W01C032P03	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC035514	MGC05-H02	MGC	W01C032P04	pDONR221	23488		TEK	7010	AAH35514.2	Hs.89640	TEK tyrosine kinase, endothelial			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000459.3	NP_000450.2	REVIEWED	Cs	0.999	0.999	1124	3375	1	3372	1124	1	1124
IKAKEN	BC027977	MGC05-H03	MGC	W01C032P05	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC027977	MGC05-H03	MGC	W01C032P06	pDONR221	4114		APOC3	345	AAH27977.1	Hs.73849	Apolipoprotein C-III			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000040.1	NP_000031.1	REVIEWED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC035281	MGC05-H04	MGC	W01C032P07	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC035281	MGC05-H04	MGC	W01C032P08	pDONR221	1975		FMOD	2331	AAH35281.1	Hs.519168	Fibromodulin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_002023.3	NP_002014.2	REVIEWED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC052293	MGC05-H05	MGC	W01C032P09	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	MGC05-H05	MGC	W01C032P10	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC029158	MGC05-H08	MGC	W01C032P15	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC029158	MGC05-H08	MGC	W01C032P16	pDONR221	15194		ABCG1	9619	AAH29158.2	Hs.124649	ATP-binding cassette, sub-family G (WHITE), member 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_016818.2	NP_058198.2	REVIEWED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031573	MGC05-H09	MGC	W01C032P17	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC031573	MGC05-H09	MGC	W01C032P18	pDONR221	14026		NGEF	25791	AAH31573.1	Hs.97316	Neuronal guanine nucleotide exchange factor			Brain, adult medulla	NIH_MGC_119	DH10B	NM_019850.2	NP_062824.2	VALIDATED	OK	1.000	1.000	710	2133	1	2130	710	1	710
IKAKEN	BC051355	MGC05-H10	MGC	W01C032P19	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC051355	MGC05-H10	MGC	W01C032P20	pDONR221	4133		TMEM179B	374395	AAH51355.1	Hs.381134	Transmembrane protein 179B			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_199337.2	NP_955369.1	VALIDATED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC052243	MGC05-H11	MGC	W01C032P21	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC052243	MGC05-H11	MGC	W01C032P22	pDONR221	6505		GPR180	160897	AAH52243.1	Hs.657472	G protein-coupled receptor 180			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_180989.4	NP_851320.1	REVIEWED	OK	1.000	1.000	440	1323	1	1320	440	1	440
IKAKEN	BC029120	MGC05-H12	MGC	W01C032P23	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC029120	MGC05-H12	MGC	W01C032P24	pDONR221	5421		C12orf26	84190	AAH29120.1	Hs.506222	Chromosome 12 open reading frame 26			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_032230.1	NP_115606.1	PREDICTED	Cs	0.998	0.998	603	1812	1	1809	603	1	603
IKAKEN	BC042674	MGC06-A01	MGC	W01C033A01	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	MGC06-A01	MGC	W01C033A02	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC029051	MGC06-A03	MGC	W01C033A05	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC029051	MGC06-A03	MGC	W01C033A06	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC035284	MGC06-A04	MGC	W01C033A07	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC035284	MGC06-A04	MGC	W01C033A08	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC031399	MGC06-A06	MGC	W01C033A11	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	MGC06-A06	MGC	W01C033A12	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC035344	MGC06-A07	MGC	W01C033A13	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC035344	MGC06-A07	MGC	W01C033A14	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC034374	MGC06-A08	MGC	W01C033A15	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC034374	MGC06-A08	MGC	W01C033A16	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC031564	MGC06-A09	MGC	W01C033A17	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC031564	MGC06-A09	MGC	W01C033A18	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC042680	MGC06-A10	MGC	W01C033A19	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	MGC06-A10	MGC	W01C033A20	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031412	MGC06-A11	MGC	W01C033A21	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC031412	MGC06-A11	MGC	W01C033A22	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC042674	MGC06-A01	MGC	W01C033B01	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	MGC06-A01	MGC	W01C033B02	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC029051	MGC06-A03	MGC	W01C033B05	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC029051	MGC06-A03	MGC	W01C033B06	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC035284	MGC06-A04	MGC	W01C033B07	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC035284	MGC06-A04	MGC	W01C033B08	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC031399	MGC06-A06	MGC	W01C033B11	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	MGC06-A06	MGC	W01C033B12	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC035344	MGC06-A07	MGC	W01C033B13	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC035344	MGC06-A07	MGC	W01C033B14	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC034374	MGC06-A08	MGC	W01C033B15	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC034374	MGC06-A08	MGC	W01C033B16	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC031564	MGC06-A09	MGC	W01C033B17	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC031564	MGC06-A09	MGC	W01C033B18	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC042680	MGC06-A10	MGC	W01C033B19	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	MGC06-A10	MGC	W01C033B20	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031412	MGC06-A11	MGC	W01C033B21	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC031412	MGC06-A11	MGC	W01C033B22	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC029806	MGC06-B01	MGC	W01C033C01	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC029806	MGC06-B01	MGC	W01C033C02	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC037223	MGC06-B02	MGC	W01C033C03	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037223	MGC06-B02	MGC	W01C033C04	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC034764	MGC06-B04	MGC	W01C033C07	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC034764	MGC06-B04	MGC	W01C033C08	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC029141	MGC06-B05	MGC	W01C033C09	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC029141	MGC06-B05	MGC	W01C033C10	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC034395	MGC06-B06	MGC	W01C033C11	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	MGC06-B06	MGC	W01C033C12	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC042635	MGC06-B07	MGC	W01C033C13	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC042635	MGC06-B07	MGC	W01C033C14	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC033489	MGC06-B08	MGC	W01C033C15	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	MGC06-B08	MGC	W01C033C16	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC038406	MGC06-B11	MGC	W01C033C21	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	MGC06-B11	MGC	W01C033C22	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC029806	MGC06-B01	MGC	W01C033D01	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC029806	MGC06-B01	MGC	W01C033D02	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC037223	MGC06-B02	MGC	W01C033D03	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037223	MGC06-B02	MGC	W01C033D04	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC034764	MGC06-B04	MGC	W01C033D07	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC034764	MGC06-B04	MGC	W01C033D08	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC029141	MGC06-B05	MGC	W01C033D09	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC029141	MGC06-B05	MGC	W01C033D10	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC034395	MGC06-B06	MGC	W01C033D11	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	MGC06-B06	MGC	W01C033D12	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC042635	MGC06-B07	MGC	W01C033D13	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC042635	MGC06-B07	MGC	W01C033D14	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC033489	MGC06-B08	MGC	W01C033D15	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	MGC06-B08	MGC	W01C033D16	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC038406	MGC06-B11	MGC	W01C033D21	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	MGC06-B11	MGC	W01C033D22	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC031624	MGC06-C01	MGC	W01C033E01	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	MGC06-C01	MGC	W01C033E02	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC029827	MGC06-C04	MGC	W01C033E07	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC029827	MGC06-C04	MGC	W01C033E08	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033510	MGC06-C05	MGC	W01C033E09	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC033510	MGC06-C05	MGC	W01C033E10	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC029221	MGC06-C06	MGC	W01C033E11	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029221	MGC06-C06	MGC	W01C033E12	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC039077	MGC06-C07	MGC	W01C033E13	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	MGC06-C07	MGC	W01C033E14	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC029829	MGC06-C08	MGC	W01C033E15	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC029829	MGC06-C08	MGC	W01C033E16	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC037246	MGC06-C09	MGC	W01C033E17	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC037246	MGC06-C09	MGC	W01C033E18	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC033496	MGC06-C10	MGC	W01C033E19	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC033496	MGC06-C10	MGC	W01C033E20	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC034411	MGC06-C11	MGC	W01C033E21	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC034411	MGC06-C11	MGC	W01C033E22	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC029889	MGC06-C12	MGC	W01C033E23	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC029889	MGC06-C12	MGC	W01C033E24	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC031624	MGC06-C01	MGC	W01C033F01	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	MGC06-C01	MGC	W01C033F02	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC029827	MGC06-C04	MGC	W01C033F07	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC029827	MGC06-C04	MGC	W01C033F08	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033510	MGC06-C05	MGC	W01C033F09	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC033510	MGC06-C05	MGC	W01C033F10	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC029221	MGC06-C06	MGC	W01C033F11	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029221	MGC06-C06	MGC	W01C033F12	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC039077	MGC06-C07	MGC	W01C033F13	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	MGC06-C07	MGC	W01C033F14	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC029829	MGC06-C08	MGC	W01C033F15	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC029829	MGC06-C08	MGC	W01C033F16	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC037246	MGC06-C09	MGC	W01C033F17	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC037246	MGC06-C09	MGC	W01C033F18	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC033496	MGC06-C10	MGC	W01C033F19	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC033496	MGC06-C10	MGC	W01C033F20	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC034411	MGC06-C11	MGC	W01C033F21	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC034411	MGC06-C11	MGC	W01C033F22	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC029889	MGC06-C12	MGC	W01C033F23	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC029889	MGC06-C12	MGC	W01C033F24	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC033515	MGC06-D01	MGC	W01C033G01	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC033515	MGC06-D01	MGC	W01C033G02	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC052577	MGC06-D02	MGC	W01C033G03	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC052577	MGC06-D02	MGC	W01C033G04	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC051000	MGC06-D03	MGC	W01C033G05	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC051000	MGC06-D03	MGC	W01C033G06	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC029264	MGC06-D04	MGC	W01C033G07	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC029264	MGC06-D04	MGC	W01C033G08	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC033519	MGC06-D05	MGC	W01C033G09	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC033519	MGC06-D05	MGC	W01C033G10	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC044816	MGC06-D06	MGC	W01C033G11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	MGC06-D06	MGC	W01C033G12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC028301	MGC06-D07	MGC	W01C033G13	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC028301	MGC06-D07	MGC	W01C033G14	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC037404	MGC06-D09	MGC	W01C033G17	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC037404	MGC06-D09	MGC	W01C033G18	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC034809	MGC06-D10	MGC	W01C033G19	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034809	MGC06-D10	MGC	W01C033G20	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034431	MGC06-D11	MGC	W01C033G21	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC034431	MGC06-D11	MGC	W01C033G22	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC044830	MGC06-D12	MGC	W01C033G23	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC044830	MGC06-D12	MGC	W01C033G24	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC033515	MGC06-D01	MGC	W01C033H01	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC033515	MGC06-D01	MGC	W01C033H02	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC052577	MGC06-D02	MGC	W01C033H03	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC052577	MGC06-D02	MGC	W01C033H04	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC051000	MGC06-D03	MGC	W01C033H05	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC051000	MGC06-D03	MGC	W01C033H06	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC029264	MGC06-D04	MGC	W01C033H07	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC029264	MGC06-D04	MGC	W01C033H08	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC033519	MGC06-D05	MGC	W01C033H09	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC033519	MGC06-D05	MGC	W01C033H10	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC044816	MGC06-D06	MGC	W01C033H11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	MGC06-D06	MGC	W01C033H12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC028301	MGC06-D07	MGC	W01C033H13	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC028301	MGC06-D07	MGC	W01C033H14	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC037404	MGC06-D09	MGC	W01C033H17	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC037404	MGC06-D09	MGC	W01C033H18	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC034809	MGC06-D10	MGC	W01C033H19	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034809	MGC06-D10	MGC	W01C033H20	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034431	MGC06-D11	MGC	W01C033H21	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC034431	MGC06-D11	MGC	W01C033H22	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC044830	MGC06-D12	MGC	W01C033H23	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC044830	MGC06-D12	MGC	W01C033H24	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC027486	MGC06-E01	MGC	W01C033I01	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC027486	MGC06-E01	MGC	W01C033I02	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC036360	MGC06-E02	MGC	W01C033I03	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC036360	MGC06-E02	MGC	W01C033I04	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC042481	MGC06-E04	MGC	W01C033I07	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC042481	MGC06-E04	MGC	W01C033I08	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC040264	MGC06-E05	MGC	W01C033I09	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC040264	MGC06-E05	MGC	W01C033I10	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC035228	MGC06-E06	MGC	W01C033I11	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	MGC06-E06	MGC	W01C033I12	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC034582	MGC06-E07	MGC	W01C033I13	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	MGC06-E07	MGC	W01C033I14	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC030281	MGC06-E09	MGC	W01C033I17	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030281	MGC06-E09	MGC	W01C033I18	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030242	MGC06-E10	MGC	W01C033I19	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC030242	MGC06-E10	MGC	W01C033I20	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC027986	MGC06-E11	MGC	W01C033I21	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC027986	MGC06-E11	MGC	W01C033I22	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC028156	MGC06-E12	MGC	W01C033I23	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC028156	MGC06-E12	MGC	W01C033I24	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC027486	MGC06-E01	MGC	W01C033J01	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC027486	MGC06-E01	MGC	W01C033J02	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC036360	MGC06-E02	MGC	W01C033J03	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC036360	MGC06-E02	MGC	W01C033J04	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC042481	MGC06-E04	MGC	W01C033J07	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC042481	MGC06-E04	MGC	W01C033J08	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC040264	MGC06-E05	MGC	W01C033J09	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC040264	MGC06-E05	MGC	W01C033J10	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC035228	MGC06-E06	MGC	W01C033J11	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	MGC06-E06	MGC	W01C033J12	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC034582	MGC06-E07	MGC	W01C033J13	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	MGC06-E07	MGC	W01C033J14	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC030281	MGC06-E09	MGC	W01C033J17	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030281	MGC06-E09	MGC	W01C033J18	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030242	MGC06-E10	MGC	W01C033J19	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC030242	MGC06-E10	MGC	W01C033J20	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC027986	MGC06-E11	MGC	W01C033J21	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC027986	MGC06-E11	MGC	W01C033J22	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC028156	MGC06-E12	MGC	W01C033J23	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC028156	MGC06-E12	MGC	W01C033J24	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC028166	MGC06-F01	MGC	W01C033K01	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028166	MGC06-F01	MGC	W01C033K02	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028198	MGC06-F02	MGC	W01C033K03	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	MGC06-F02	MGC	W01C033K04	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028123	MGC06-F03	MGC	W01C033K05	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC028123	MGC06-F03	MGC	W01C033K06	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC027989	MGC06-F04	MGC	W01C033K07	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC027989	MGC06-F04	MGC	W01C033K08	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC028158	MGC06-F05	MGC	W01C033K09	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC028158	MGC06-F05	MGC	W01C033K10	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC032244	MGC06-F06	MGC	W01C033K11	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC032244	MGC06-F06	MGC	W01C033K12	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC030262	MGC06-F07	MGC	W01C033K13	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC030262	MGC06-F07	MGC	W01C033K14	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC028036	MGC06-F08	MGC	W01C033K15	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028036	MGC06-F08	MGC	W01C033K16	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028101	MGC06-F09	MGC	W01C033K17	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028101	MGC06-F09	MGC	W01C033K18	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028118	MGC06-F10	MGC	W01C033K19	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028118	MGC06-F10	MGC	W01C033K20	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028048	MGC06-F11	MGC	W01C033K21	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028048	MGC06-F11	MGC	W01C033K22	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028216	MGC06-F12	MGC	W01C033K23	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC028216	MGC06-F12	MGC	W01C033K24	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC028166	MGC06-F01	MGC	W01C033L01	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028166	MGC06-F01	MGC	W01C033L02	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028198	MGC06-F02	MGC	W01C033L03	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	MGC06-F02	MGC	W01C033L04	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028123	MGC06-F03	MGC	W01C033L05	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC028123	MGC06-F03	MGC	W01C033L06	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC027989	MGC06-F04	MGC	W01C033L07	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC027989	MGC06-F04	MGC	W01C033L08	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC028158	MGC06-F05	MGC	W01C033L09	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC028158	MGC06-F05	MGC	W01C033L10	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC032244	MGC06-F06	MGC	W01C033L11	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC032244	MGC06-F06	MGC	W01C033L12	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC030262	MGC06-F07	MGC	W01C033L13	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC030262	MGC06-F07	MGC	W01C033L14	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC028036	MGC06-F08	MGC	W01C033L15	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028036	MGC06-F08	MGC	W01C033L16	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028101	MGC06-F09	MGC	W01C033L17	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028101	MGC06-F09	MGC	W01C033L18	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028118	MGC06-F10	MGC	W01C033L19	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028118	MGC06-F10	MGC	W01C033L20	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028048	MGC06-F11	MGC	W01C033L21	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028048	MGC06-F11	MGC	W01C033L22	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028216	MGC06-F12	MGC	W01C033L23	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC028216	MGC06-F12	MGC	W01C033L24	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC061631	MGC06-G01	MGC	W01C033M01	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	MGC06-G01	MGC	W01C033M02	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC030279	MGC06-G02	MGC	W01C033M03	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC030279	MGC06-G02	MGC	W01C033M04	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC038225	MGC06-G03	MGC	W01C033M05	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	MGC06-G03	MGC	W01C033M06	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC032329	MGC06-G04	MGC	W01C033M07	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC032329	MGC06-G04	MGC	W01C033M08	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC035561	MGC06-G05	MGC	W01C033M09	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC035561	MGC06-G05	MGC	W01C033M10	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC032358	MGC06-G06	MGC	W01C033M11	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032358	MGC06-G06	MGC	W01C033M12	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032382	MGC06-G07	MGC	W01C033M13	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032382	MGC06-G07	MGC	W01C033M14	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032346	MGC06-G08	MGC	W01C033M15	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032346	MGC06-G08	MGC	W01C033M16	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032306	MGC06-G09	MGC	W01C033M17	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC032306	MGC06-G09	MGC	W01C033M18	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC030530	MGC06-G10	MGC	W01C033M19	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC030530	MGC06-G10	MGC	W01C033M20	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC038444	MGC06-G11	MGC	W01C033M21	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC038444	MGC06-G11	MGC	W01C033M22	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC032308	MGC06-G12	MGC	W01C033M23	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC032308	MGC06-G12	MGC	W01C033M24	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC061631	MGC06-G01	MGC	W01C033N01	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	MGC06-G01	MGC	W01C033N02	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC030279	MGC06-G02	MGC	W01C033N03	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC030279	MGC06-G02	MGC	W01C033N04	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC038225	MGC06-G03	MGC	W01C033N05	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	MGC06-G03	MGC	W01C033N06	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC032329	MGC06-G04	MGC	W01C033N07	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC032329	MGC06-G04	MGC	W01C033N08	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC035561	MGC06-G05	MGC	W01C033N09	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC035561	MGC06-G05	MGC	W01C033N10	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC032358	MGC06-G06	MGC	W01C033N11	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032358	MGC06-G06	MGC	W01C033N12	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032382	MGC06-G07	MGC	W01C033N13	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032382	MGC06-G07	MGC	W01C033N14	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032346	MGC06-G08	MGC	W01C033N15	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032346	MGC06-G08	MGC	W01C033N16	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032306	MGC06-G09	MGC	W01C033N17	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC032306	MGC06-G09	MGC	W01C033N18	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC030530	MGC06-G10	MGC	W01C033N19	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC030530	MGC06-G10	MGC	W01C033N20	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC038444	MGC06-G11	MGC	W01C033N21	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC038444	MGC06-G11	MGC	W01C033N22	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC032308	MGC06-G12	MGC	W01C033N23	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC032308	MGC06-G12	MGC	W01C033N24	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC032412	MGC06-H01	MGC	W01C033O01	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC032412	MGC06-H01	MGC	W01C033O02	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC052297	MGC06-H02	MGC	W01C033O03	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC052297	MGC06-H02	MGC	W01C033O04	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC028280	MGC06-H03	MGC	W01C033O05	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC028280	MGC06-H03	MGC	W01C033O06	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC032300	MGC06-H04	MGC	W01C033O07	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC032300	MGC06-H04	MGC	W01C033O08	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC051360	MGC06-H05	MGC	W01C033O09	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	MGC06-H05	MGC	W01C033O10	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC035604	MGC06-H06	MGC	W01C033O11	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC035604	MGC06-H06	MGC	W01C033O12	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC062353	MGC06-H07	MGC	W01C033O13	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC062353	MGC06-H07	MGC	W01C033O14	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC036746	MGC06-H08	MGC	W01C033O15	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC036746	MGC06-H08	MGC	W01C033O16	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC032778	MGC06-H09	MGC	W01C033O17	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC032778	MGC06-H09	MGC	W01C033O18	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC033797	MGC06-H10	MGC	W01C033O19	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033797	MGC06-H10	MGC	W01C033O20	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033684	MGC06-H11	MGC	W01C033O21	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC033684	MGC06-H11	MGC	W01C033O22	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC032412	MGC06-H01	MGC	W01C033P01	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC032412	MGC06-H01	MGC	W01C033P02	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC052297	MGC06-H02	MGC	W01C033P03	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC052297	MGC06-H02	MGC	W01C033P04	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC028280	MGC06-H03	MGC	W01C033P05	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC028280	MGC06-H03	MGC	W01C033P06	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC032300	MGC06-H04	MGC	W01C033P07	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC032300	MGC06-H04	MGC	W01C033P08	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC051360	MGC06-H05	MGC	W01C033P09	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	MGC06-H05	MGC	W01C033P10	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC035604	MGC06-H06	MGC	W01C033P11	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC035604	MGC06-H06	MGC	W01C033P12	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC062353	MGC06-H07	MGC	W01C033P13	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC062353	MGC06-H07	MGC	W01C033P14	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC036746	MGC06-H08	MGC	W01C033P15	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC036746	MGC06-H08	MGC	W01C033P16	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC032778	MGC06-H09	MGC	W01C033P17	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC032778	MGC06-H09	MGC	W01C033P18	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC033797	MGC06-H10	MGC	W01C033P19	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033797	MGC06-H10	MGC	W01C033P20	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033684	MGC06-H11	MGC	W01C033P21	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC033684	MGC06-H11	MGC	W01C033P22	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC042674	MGC06-A01	MGC	W01C034A01	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	MGC06-A01	MGC	W01C034A02	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC029051	MGC06-A03	MGC	W01C034A05	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC029051	MGC06-A03	MGC	W01C034A06	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC035284	MGC06-A04	MGC	W01C034A07	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC035284	MGC06-A04	MGC	W01C034A08	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC031399	MGC06-A06	MGC	W01C034A11	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	MGC06-A06	MGC	W01C034A12	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC035344	MGC06-A07	MGC	W01C034A13	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC035344	MGC06-A07	MGC	W01C034A14	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC034374	MGC06-A08	MGC	W01C034A15	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC034374	MGC06-A08	MGC	W01C034A16	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC031564	MGC06-A09	MGC	W01C034A17	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC031564	MGC06-A09	MGC	W01C034A18	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC042680	MGC06-A10	MGC	W01C034A19	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	MGC06-A10	MGC	W01C034A20	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031412	MGC06-A11	MGC	W01C034A21	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC031412	MGC06-A11	MGC	W01C034A22	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC042674	MGC06-A01	MGC	W01C034B01	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	MGC06-A01	MGC	W01C034B02	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC029051	MGC06-A03	MGC	W01C034B05	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC029051	MGC06-A03	MGC	W01C034B06	pDONR221	19315		ARSB	411	AAH29051.1	Hs.149103	Arylsulfatase B			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_198709.2	NP_942002.1	REVIEWED	OK	1.000	1.000	413	1242	1	1239	413	1	413
IKAKEN	BC035284	MGC06-A04	MGC	W01C034B07	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC035284	MGC06-A04	MGC	W01C034B08	pDONR221	20747		UNC5CL	222643	AAH35284.1	Hs.158357	Unc-5 homolog C (C. elegans)-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173561.1	NP_775832.1	PROVISIONAL	Cs	0.998	0.998	518	1557	1	1554	518	1	518
IKAKEN	BC031399	MGC06-A06	MGC	W01C034B11	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	MGC06-A06	MGC	W01C034B12	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC035344	MGC06-A07	MGC	W01C034B13	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC035344	MGC06-A07	MGC	W01C034B14	pDONR221	2836		PSTK	118672	AAH35344.1	Hs.281004	Phosphoseryl-tRNA kinase			Testis	NIH_MGC_97	DH10B	NM_153336.2	NP_699167.2	VALIDATED	OK	1.000	1.000	348	1047	1	1044	348	1	348
IKAKEN	BC034374	MGC06-A08	MGC	W01C034B15	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC034374	MGC06-A08	MGC	W01C034B16	pDONR221	16965		NMNAT3	349565	AAH34374.1	Hs.208673	Nicotinamide nucleotide adenylyltransferase 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_178177.2	NP_835471.1	PROVISIONAL	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC031564	MGC06-A09	MGC	W01C034B17	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC031564	MGC06-A09	MGC	W01C034B18	pDONR221	4623		C11orf75	56935	AAH31564.1	Hs.438064	Chromosome 11 open reading frame 75			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_020179.2	NP_064564.1	VALIDATED		0.898	0.898	59	180	1	177	59	1	59
IKAKEN	BC042680	MGC06-A10	MGC	W01C034B19	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	MGC06-A10	MGC	W01C034B20	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031412	MGC06-A11	MGC	W01C034B21	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC031412	MGC06-A11	MGC	W01C034B22	pDONR221	2914		HABP2	3026	AAH31412.1	Hs.422542	Hyaluronan binding protein 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004132.3	NP_004123.1	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC029806	MGC06-B01	MGC	W01C034C01	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC029806	MGC06-B01	MGC	W01C034C02	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC037223	MGC06-B02	MGC	W01C034C03	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037223	MGC06-B02	MGC	W01C034C04	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC034764	MGC06-B04	MGC	W01C034C07	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC034764	MGC06-B04	MGC	W01C034C08	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC029141	MGC06-B05	MGC	W01C034C09	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC029141	MGC06-B05	MGC	W01C034C10	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC034395	MGC06-B06	MGC	W01C034C11	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	MGC06-B06	MGC	W01C034C12	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC042635	MGC06-B07	MGC	W01C034C13	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC042635	MGC06-B07	MGC	W01C034C14	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC033489	MGC06-B08	MGC	W01C034C15	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	MGC06-B08	MGC	W01C034C16	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC038406	MGC06-B11	MGC	W01C034C21	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	MGC06-B11	MGC	W01C034C22	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC029806	MGC06-B01	MGC	W01C034D01	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC029806	MGC06-B01	MGC	W01C034D02	pDONR221	2111		KRTCAP2	200185	AAH29806.1	Hs.704676	Keratinocyte associated protein 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_173852.3	NP_776251.1	VALIDATED	Pfs	0.860	0.883	114	342	1	339	162	51	162
IKAKEN	BC037223	MGC06-B02	MGC	W01C034D03	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037223	MGC06-B02	MGC	W01C034D04	pDONR221	4850		MED19	219541	AAH37223.1	Hs.43619	Mediator complex subunit 19			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153450.1	NP_703151.1	PROVISIONAL	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC034764	MGC06-B04	MGC	W01C034D07	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC034764	MGC06-B04	MGC	W01C034D08	pDONR221	14299		CGREF1	10669	AAH34764.1	Hs.159525	Cell growth regulator with EF-hand domain 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006569.4	NP_006560.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC029141	MGC06-B05	MGC	W01C034D09	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC029141	MGC06-B05	MGC	W01C034D10	pDONR221	1792		NPHS2	7827	AAH29141.1	Hs.412710	Nephrosis 2, idiopathic, steroid-resistant (podocin)			Testis	NIH_MGC_97	DH10B	NM_014625.2	NP_055440.1	REVIEWED	Cg	0.822	1.000	383	948	1	945	383	1	383
IKAKEN	BC034395	MGC06-B06	MGC	W01C034D11	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC034395	MGC06-B06	MGC	W01C034D12	pDONR221	23256		DPYS	1807	AAH34395.1	Hs.443161	Dihydropyrimidinase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001385.2	NP_001376.1	REVIEWED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC042635	MGC06-B07	MGC	W01C034D13	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC042635	MGC06-B07	MGC	W01C034D14	pDONR221	15993		C22orf33	339669	AAH42635.1	Hs.124502	Chromosome 22 open reading frame 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_178552.2	NP_848647.1	PREDICTED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC033489	MGC06-B08	MGC	W01C034D15	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC033489	MGC06-B08	MGC	W01C034D16	pDONR221	24202		FAM154A	158297	AAH33489.1	Hs.98943	Family with sequence similarity 154, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_153707.1	NP_714918.1	PREDICTED	Cs	0.996	0.996	474	1425	1	1422	474	1	474
IKAKEN	BC038406	MGC06-B11	MGC	W01C034D21	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC038406	MGC06-B11	MGC	W01C034D22	pDONR221	16490		C3orf20	84077	AAH38406.2	Hs.661452	Chromosome 3 open reading frame 20			Testis	NIH_MGC_97	DH10B	NM_032137.3	NP_115513.3	PREDICTED	Ps	0.996	0.996	782	2349	1	2346	904	123	904
IKAKEN	BC031624	MGC06-C01	MGC	W01C034E01	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	MGC06-C01	MGC	W01C034E02	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC029827	MGC06-C04	MGC	W01C034E07	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC029827	MGC06-C04	MGC	W01C034E08	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033510	MGC06-C05	MGC	W01C034E09	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC033510	MGC06-C05	MGC	W01C034E10	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC029221	MGC06-C06	MGC	W01C034E11	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029221	MGC06-C06	MGC	W01C034E12	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC039077	MGC06-C07	MGC	W01C034E13	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	MGC06-C07	MGC	W01C034E14	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC029829	MGC06-C08	MGC	W01C034E15	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC029829	MGC06-C08	MGC	W01C034E16	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC037246	MGC06-C09	MGC	W01C034E17	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC037246	MGC06-C09	MGC	W01C034E18	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC033496	MGC06-C10	MGC	W01C034E19	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC033496	MGC06-C10	MGC	W01C034E20	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC034411	MGC06-C11	MGC	W01C034E21	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC034411	MGC06-C11	MGC	W01C034E22	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC029889	MGC06-C12	MGC	W01C034E23	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC029889	MGC06-C12	MGC	W01C034E24	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC031624	MGC06-C01	MGC	W01C034F01	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	MGC06-C01	MGC	W01C034F02	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC029827	MGC06-C04	MGC	W01C034F07	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC029827	MGC06-C04	MGC	W01C034F08	pDONR221	15173		DSCR9	257203	AAH29827	Hs.505159	Down syndrome critical region gene 9 (non-protein coding)			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_148675.3	NP_683516.1	PREDICTED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033510	MGC06-C05	MGC	W01C034F09	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC033510	MGC06-C05	MGC	W01C034F10	pDONR221	24805		CXorf41	139212	AAH33510.1	Hs.128836	Chromosome X open reading frame 41			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_173494.1	NP_775765.1	PREDICTED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC029221	MGC06-C06	MGC	W01C034F11	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC029221	MGC06-C06	MGC	W01C034F12	pDONR221	7880		TMCO5A	145942	AAH29221.2	Hs.179646	Transmembrane and coiled-coil domains 5A			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_152453.2	NP_689666.2	PROVISIONAL	C	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC039077	MGC06-C07	MGC	W01C034F13	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC039077	MGC06-C07	MGC	W01C034F14	pDONR221	4912		C11orf35	256329	AAH39077.1	Hs.669395	Chromosome 11 open reading frame 35			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_173573.1	NP_775844.1	PREDICTED	OK	1.000	1.000	634	1905	1	1902	634	1	634
IKAKEN	BC029829	MGC06-C08	MGC	W01C034F15	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC029829	MGC06-C08	MGC	W01C034F16	pDONR221	9400		C16orf73	254528	AAH29829.1	Hs.662737	Chromosome 16 open reading frame 73			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152764.2	NP_689977.2	VALIDATED	P	1.000	1.000	198	597	1	594	442	245	442
IKAKEN	BC037246	MGC06-C09	MGC	W01C034F17	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC037246	MGC06-C09	MGC	W01C034F18	pDONR221	10031		PNMT	5409	AAH37246.1	Hs.1892	Phenylethanolamine N-methyltransferase			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002686.3	NP_002677.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC033496	MGC06-C10	MGC	W01C034F19	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC033496	MGC06-C10	MGC	W01C034F20	pDONR221	19403		DND1	373863	AAH33496.1	Hs.591262	Dead end homolog 1 (zebrafish)			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_194249.1	NP_919225.1	PROVISIONAL	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC034411	MGC06-C11	MGC	W01C034F21	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC034411	MGC06-C11	MGC	W01C034F22	pDONR221	16804		IGSF11	152404	AAH34411.1	Hs.112873	Immunoglobulin superfamily, member 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152538.2	NP_689751.2	VALIDATED	OK	1.000	1.000	430	1293	1	1290	430	1	430
IKAKEN	BC029889	MGC06-C12	MGC	W01C034F23	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC029889	MGC06-C12	MGC	W01C034F24	pDONR221	6560		C13orf16	121793	AAH29889.1	Hs.210677	Chromosome 13 open reading frame 16			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152324.1	NP_689537.1	PREDICTED	C	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC033515	MGC06-D01	MGC	W01C034G01	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC033515	MGC06-D01	MGC	W01C034G02	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC052577	MGC06-D02	MGC	W01C034G03	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC052577	MGC06-D02	MGC	W01C034G04	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC051000	MGC06-D03	MGC	W01C034G05	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC051000	MGC06-D03	MGC	W01C034G06	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC029264	MGC06-D04	MGC	W01C034G07	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC029264	MGC06-D04	MGC	W01C034G08	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC033519	MGC06-D05	MGC	W01C034G09	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC033519	MGC06-D05	MGC	W01C034G10	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC044816	MGC06-D06	MGC	W01C034G11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	MGC06-D06	MGC	W01C034G12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC028301	MGC06-D07	MGC	W01C034G13	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC028301	MGC06-D07	MGC	W01C034G14	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC037404	MGC06-D09	MGC	W01C034G17	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC037404	MGC06-D09	MGC	W01C034G18	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC034809	MGC06-D10	MGC	W01C034G19	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034809	MGC06-D10	MGC	W01C034G20	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034431	MGC06-D11	MGC	W01C034G21	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC034431	MGC06-D11	MGC	W01C034G22	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC044830	MGC06-D12	MGC	W01C034G23	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC044830	MGC06-D12	MGC	W01C034G24	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC033515	MGC06-D01	MGC	W01C034H01	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC033515	MGC06-D01	MGC	W01C034H02	pDONR221	8327		LYSMD2	256586	AAH33515.1	Hs.631693	LysM, putative peptidoglycan-binding, domain containing 2			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_153374.2	NP_699205.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC052577	MGC06-D02	MGC	W01C034H03	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC052577	MGC06-D02	MGC	W01C034H04	pDONR221	3621		PACS1	55690	AAH52577.1	Hs.644326	Phosphofurin acidic cluster sorting protein 1			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_018026.2	NP_060496.2	REVIEWED	OK	1.000	1.000	963	2892	1	2889	963	1	963
IKAKEN	BC051000	MGC06-D03	MGC	W01C034H05	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC051000	MGC06-D03	MGC	W01C034H06	pDONR221	6945		TCL1B	9623	AAH51000.1	Hs.632346	T-cell leukemia/lymphoma 1B			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_004918.2	NP_004909.1	VALIDATED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC029264	MGC06-D04	MGC	W01C034H07	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC029264	MGC06-D04	MGC	W01C034H08	pDONR221	22054		RNF148	378925	AAH29264.1	Hs.675191	Ring finger protein 148			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_198085.1	NP_932351.1	VALIDATED	OK	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC033519	MGC06-D05	MGC	W01C034H09	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC033519	MGC06-D05	MGC	W01C034H10	pDONR221	19766		STX11	8676	AAH33519.1	Hs.118958	Syntaxin 11			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_003764.3	NP_003755.2	REVIEWED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC044816	MGC06-D06	MGC	W01C034H11	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	MGC06-D06	MGC	W01C034H12	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC028301	MGC06-D07	MGC	W01C034H13	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC028301	MGC06-D07	MGC	W01C034H14	pDONR221	11279		C18orf56	494514	AAH28301.1	Hs.274959	Chromosome 18 open reading frame 56			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001012716.1	NP_001012734.1	PREDICTED	Cs	0.992	0.992	123	372	1	369	123	1	123
IKAKEN	BC037404	MGC06-D09	MGC	W01C034H17	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC037404	MGC06-D09	MGC	W01C034H18	pDONR221	4413		FNBP4	23360	AAH37404.1	Hs.6834	Formin binding protein 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_015308.2	NP_056123.2	VALIDATED	Cg	0.998	1.000	1017	3048	1	3045	1017	1	1017
IKAKEN	BC034809	MGC06-D10	MGC	W01C034H19	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034809	MGC06-D10	MGC	W01C034H20	pDONR221	6106		FAM109A	144717	AAH34809.1	Hs.173088	Family with sequence similarity 109, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_144671.3	NP_653272.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	BC034431	MGC06-D11	MGC	W01C034H21	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC034431	MGC06-D11	MGC	W01C034H22	pDONR221	18285		PDCL2	132954	AAH34431.1	Hs.223712	Phosducin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152401.2	NP_689614.2	REVIEWED	Cs	0.988	0.988	241	750	1	723	241	1	241
IKAKEN	BC044830	MGC06-D12	MGC	W01C034H23	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC044830	MGC06-D12	MGC	W01C034H24	pDONR221	2929		C10orf96	374355	AAH44830.1	Hs.233407	Chromosome 10 open reading frame 96			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_198515.2	NP_940917.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC027486	MGC06-E01	MGC	W01C034I01	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC027486	MGC06-E01	MGC	W01C034I02	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC036360	MGC06-E02	MGC	W01C034I03	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC036360	MGC06-E02	MGC	W01C034I04	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC042481	MGC06-E04	MGC	W01C034I07	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC042481	MGC06-E04	MGC	W01C034I08	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC040264	MGC06-E05	MGC	W01C034I09	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC040264	MGC06-E05	MGC	W01C034I10	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC035228	MGC06-E06	MGC	W01C034I11	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	MGC06-E06	MGC	W01C034I12	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC034582	MGC06-E07	MGC	W01C034I13	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	MGC06-E07	MGC	W01C034I14	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC030281	MGC06-E09	MGC	W01C034I17	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030281	MGC06-E09	MGC	W01C034I18	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030242	MGC06-E10	MGC	W01C034I19	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC030242	MGC06-E10	MGC	W01C034I20	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC027986	MGC06-E11	MGC	W01C034I21	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC027986	MGC06-E11	MGC	W01C034I22	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC028156	MGC06-E12	MGC	W01C034I23	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC028156	MGC06-E12	MGC	W01C034I24	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC027486	MGC06-E01	MGC	W01C034J01	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC027486	MGC06-E01	MGC	W01C034J02	pDONR221	32708		hCG_2020170	728437	AAH27486					Cervix, carcinoma	NIH_MGC_12	DH10B	XM_001129114.1	XP_001129114.1	MODEL
IKAKEN	BC036360	MGC06-E02	MGC	W01C034J03	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC036360	MGC06-E02	MGC	W01C034J04	pDONR221	10446		CHAD	1101	AAH36360.1	Hs.97220	Chondroadherin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001267.2	NP_001258.2	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC042481	MGC06-E04	MGC	W01C034J07	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC042481	MGC06-E04	MGC	W01C034J08	pDONR221	552		KIF26B	55083	AAH42481.1	Hs.368096	Kinesin family member 26B			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_018012.3	NP_060482.2	PROVISIONAL		0.913	0.913	149	489	1	447	2108	201	349
IKAKEN	BC040264	MGC06-E05	MGC	W01C034J09	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC040264	MGC06-E05	MGC	W01C034J10	pDONR221	10574		CCDC57	284001	AAH40264.1	Hs.631724	Coiled-coil domain containing 57			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_198082.2	NP_932348.2	VALIDATED	P	1.000	1.000	747	2256	1	2241	915	1	747
IKAKEN	BC035228	MGC06-E06	MGC	W01C034J11	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035228	MGC06-E06	MGC	W01C034J12	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC034582	MGC06-E07	MGC	W01C034J13	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	MGC06-E07	MGC	W01C034J14	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC030281	MGC06-E09	MGC	W01C034J17	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030281	MGC06-E09	MGC	W01C034J18	pDONR221	12443		RASAL3	64926	AAH30281.1	Hs.136979	RAS protein activator like 3			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_022904.1	NP_075055.1	VALIDATED	P	1.000	1.000	264	795	1	792	1011	748	1011
IKAKEN	BC030242	MGC06-E10	MGC	W01C034J19	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC030242	MGC06-E10	MGC	W01C034J20	pDONR221	3405		TYSND1	219743	AAH30242.1	Hs.533655	Trypsin domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040273.1	NP_001035363.1	VALIDATED	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	BC027986	MGC06-E11	MGC	W01C034J21	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC027986	MGC06-E11	MGC	W01C034J22	pDONR221	9926		C17orf45	125144	AAH27986.1	Hs.368934	Chromosome 17 open reading frame 45			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_152350.2	NP_689563.1	PREDICTED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC028156	MGC06-E12	MGC	W01C034J23	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC028156	MGC06-E12	MGC	W01C034J24	pDONR221	12708		C19orf26	255057	AAH28156.1	Hs.346575	Chromosome 19 open reading frame 26			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152769.2	NP_689982.2	VALIDATED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC028166	MGC06-F01	MGC	W01C034K01	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028166	MGC06-F01	MGC	W01C034K02	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028198	MGC06-F02	MGC	W01C034K03	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	MGC06-F02	MGC	W01C034K04	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028123	MGC06-F03	MGC	W01C034K05	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC028123	MGC06-F03	MGC	W01C034K06	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC027989	MGC06-F04	MGC	W01C034K07	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC027989	MGC06-F04	MGC	W01C034K08	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC028158	MGC06-F05	MGC	W01C034K09	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC028158	MGC06-F05	MGC	W01C034K10	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC032244	MGC06-F06	MGC	W01C034K11	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC032244	MGC06-F06	MGC	W01C034K12	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC030262	MGC06-F07	MGC	W01C034K13	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC030262	MGC06-F07	MGC	W01C034K14	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC028036	MGC06-F08	MGC	W01C034K15	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028036	MGC06-F08	MGC	W01C034K16	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028101	MGC06-F09	MGC	W01C034K17	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028101	MGC06-F09	MGC	W01C034K18	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028118	MGC06-F10	MGC	W01C034K19	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028118	MGC06-F10	MGC	W01C034K20	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028048	MGC06-F11	MGC	W01C034K21	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028048	MGC06-F11	MGC	W01C034K22	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028216	MGC06-F12	MGC	W01C034K23	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC028216	MGC06-F12	MGC	W01C034K24	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC028166	MGC06-F01	MGC	W01C034L01	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028166	MGC06-F01	MGC	W01C034L02	pDONR221	22762		C8orf38	137682	AAH28166.1	Hs.435500	Chromosome 8 open reading frame 38			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152416.2	NP_689629.2	VALIDATED	P	1.000	1.000	99	366	1	297	333	1	99
IKAKEN	BC028198	MGC06-F02	MGC	W01C034L03	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	MGC06-F02	MGC	W01C034L04	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028123	MGC06-F03	MGC	W01C034L05	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC028123	MGC06-F03	MGC	W01C034L06	pDONR221	31593		LOC100129827	100129827	AAH28123.1	Hs.246769	Hypothetical protein LOC100129827			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	XM_001716326.1	XP_001716378.1	MODEL	P	1.000	1.000	29	90	3	89	145	64	92
IKAKEN	BC027989	MGC06-F04	MGC	W01C034L07	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC027989	MGC06-F04	MGC	W01C034L08	pDONR221	21995		CDK6	1021	-	Hs.119882	Cyclin-dependent kinase 6			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_001259.6	NP_001250.1	VALIDATED	Pfs	0.273	0.281	33	189	24	122	326	290	321
IKAKEN	BC028158	MGC06-F05	MGC	W01C034L09	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC028158	MGC06-F05	MGC	W01C034L10	pDONR221	945		OR2L13	284521	AAH28158.1	Hs.372936	Olfactory receptor, family 2, subfamily L, member 13			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_175911.2	NP_787107.1	PROVISIONAL	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC032244	MGC06-F06	MGC	W01C034L11	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC032244	MGC06-F06	MGC	W01C034L12	pDONR221	12146		REXO1	57455	AAH32244.1	Hs.192477	REX1, RNA exonuclease 1 homolog (S. cerevisiae)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_020695.3	NP_065746.3	VALIDATED	OK	1.000	1.000	1221	3666	1	3663	1221	1	1221
IKAKEN	BC030262	MGC06-F07	MGC	W01C034L13	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC030262	MGC06-F07	MGC	W01C034L14	pDONR221	23575		ADAMTSL1	92949	AAH30262.1	Hs.522019	ADAMTS-like 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_052866.3	NP_443098.3	VALIDATED	Pgs	0.960	0.998	450	1320	1	1299	525	1	450
IKAKEN	BC028036	MGC06-F08	MGC	W01C034L15	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028036	MGC06-F08	MGC	W01C034L16	pDONR221	162		FAM5B	57795	AAH28036.1	Hs.495918	Family with sequence similarity 5, member B			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_021165.2	NP_066988.1	PROVISIONAL	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC028101	MGC06-F09	MGC	W01C034L17	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028101	MGC06-F09	MGC	W01C034L18	pDONR221	11467		BRUNOL5	60680	AAH28101.1	Hs.655747	Bruno-like 5, RNA binding protein (Drosophila)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_021938.3	NP_068757.2	REVIEWED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC028118	MGC06-F10	MGC	W01C034L19	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028118	MGC06-F10	MGC	W01C034L20	pDONR221	20780		C6orf218	221718	AAH28118.1	Hs.173337	Chromosome 6 open reading frame 218			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_152738.1	NP_689951.1	PREDICTED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC028048	MGC06-F11	MGC	W01C034L21	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028048	MGC06-F11	MGC	W01C034L22	pDONR221	11435		LENG8	114823	AAH28048.1	Hs.719640	Leukocyte receptor cluster (LRC) member 8			Brain, adult medulla	NIH_MGC_119	DH10B	NM_052925.2	NP_443157.1	VALIDATED	OK	1.000	1.000	800	2403	1	2400	800	1	800
IKAKEN	BC028216	MGC06-F12	MGC	W01C034L23	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC028216	MGC06-F12	MGC	W01C034L24	pDONR221	8942		SLC7A6	9057	AAH28216.1	Hs.653193	Solute carrier family 7 (cationic amino acid transporter, y+ system), member 6			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_003983.4	NP_003974.3	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC061631	MGC06-G01	MGC	W01C034M01	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	MGC06-G01	MGC	W01C034M02	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC030279	MGC06-G02	MGC	W01C034M03	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC030279	MGC06-G02	MGC	W01C034M04	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC038225	MGC06-G03	MGC	W01C034M05	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	MGC06-G03	MGC	W01C034M06	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC032329	MGC06-G04	MGC	W01C034M07	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC032329	MGC06-G04	MGC	W01C034M08	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC035561	MGC06-G05	MGC	W01C034M09	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC035561	MGC06-G05	MGC	W01C034M10	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC032358	MGC06-G06	MGC	W01C034M11	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032358	MGC06-G06	MGC	W01C034M12	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032382	MGC06-G07	MGC	W01C034M13	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032382	MGC06-G07	MGC	W01C034M14	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032346	MGC06-G08	MGC	W01C034M15	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032346	MGC06-G08	MGC	W01C034M16	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032306	MGC06-G09	MGC	W01C034M17	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC032306	MGC06-G09	MGC	W01C034M18	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC030530	MGC06-G10	MGC	W01C034M19	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC030530	MGC06-G10	MGC	W01C034M20	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC038444	MGC06-G11	MGC	W01C034M21	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC038444	MGC06-G11	MGC	W01C034M22	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC032308	MGC06-G12	MGC	W01C034M23	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC032308	MGC06-G12	MGC	W01C034M24	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC061631	MGC06-G01	MGC	W01C034N01	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	MGC06-G01	MGC	W01C034N02	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC030279	MGC06-G02	MGC	W01C034N03	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC030279	MGC06-G02	MGC	W01C034N04	pDONR221	950		C1orf211	148645	AAH30279.1	Hs.719514	Chromosome 1 open reading frame 211			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B													
IKAKEN	BC038225	MGC06-G03	MGC	W01C034N05	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	MGC06-G03	MGC	W01C034N06	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC032329	MGC06-G04	MGC	W01C034N07	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC032329	MGC06-G04	MGC	W01C034N08	pDONR221	8280		CYP11A1	1583	AAH32329.1	Hs.303980	Cytochrome P450, family 11, subfamily A, polypeptide 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_000781.2	NP_000772.2	REVIEWED	OK	1.000	1.000	521	1566	1	1563	521	1	521
IKAKEN	BC035561	MGC06-G05	MGC	W01C034N09	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC035561	MGC06-G05	MGC	W01C034N10	pDONR221	9883		HEXDC	284004	AAH35561.1	Hs.714387	Hexosaminidase (glycosyl hydrolase family 20, catalytic domain) containing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_173620.2	NP_775891.2	VALIDATED	P	1.000	1.000	493	1482	1	1479	585	93	585
IKAKEN	BC032358	MGC06-G06	MGC	W01C034N11	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032358	MGC06-G06	MGC	W01C034N12	pDONR221	7004		EVL	51466	AAH32358.1	Hs.125867	Enah/Vasp-like			Lung	NIH_MGC_77	DH10B	NM_016337.2	NP_057421.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC032382	MGC06-G07	MGC	W01C034N13	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032382	MGC06-G07	MGC	W01C034N14	pDONR221	10549		LOC146880	146880	AAH32382	Hs.117853	Hypothetical LOC146880			Blood, adult leukocytes	NIH_MGC_118	DH10B	XM_001718613.1	XP_001718665.1	MODEL	P	1.000	1.000	143	714	3	431	365	223	365
IKAKEN	BC032346	MGC06-G08	MGC	W01C034N15	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032346	MGC06-G08	MGC	W01C034N16	pDONR221	23511		ARRDC1	92714	AAH32346.1	Hs.12999	Arrestin domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_152285.2	NP_689498.1	VALIDATED	OK	1.000	1.000	433	1302	1	1299	433	1	433
IKAKEN	BC032306	MGC06-G09	MGC	W01C034N17	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC032306	MGC06-G09	MGC	W01C034N18	pDONR221	22967		LYNX1	66004		Hs.158665	Ly6/neurotoxin 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_023946.2	NP_076435.1	REVIEWED	OK	1.000	1.000	131	396	1	393	131	1	131
IKAKEN	BC030530	MGC06-G10	MGC	W01C034N19	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC030530	MGC06-G10	MGC	W01C034N20	pDONR221	4460		SYVN1	84447	AAH30530.1	Hs.715498	Synovial apoptosis inhibitor 1, synoviolin			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_032431.2	NP_115807.1	REVIEWED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	BC038444	MGC06-G11	MGC	W01C034N21	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC038444	MGC06-G11	MGC	W01C034N22	pDONR221	19408		AP3B1	8546	AAH38444.1	Hs.532091	Adaptor-related protein complex 3, beta 1 subunit			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003664.3	NP_003655.3	REVIEWED	OK	1.000	1.000	1094	3285	1	3282	1094	1	1094
IKAKEN	BC032308	MGC06-G12	MGC	W01C034N23	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC032308	MGC06-G12	MGC	W01C034N24	pDONR221	215		FPGT	8790	AAH32308.1	Hs.632389	Fucose-1-phosphate guanylyltransferase			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003838.2	NP_003829.2	REVIEWED	OK	1.000	1.000	594	1785	1	1782	594	1	594
IKAKEN	BC032412	MGC06-H01	MGC	W01C034O01	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC032412	MGC06-H01	MGC	W01C034O02	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC052297	MGC06-H02	MGC	W01C034O03	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC052297	MGC06-H02	MGC	W01C034O04	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC028280	MGC06-H03	MGC	W01C034O05	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC028280	MGC06-H03	MGC	W01C034O06	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC032300	MGC06-H04	MGC	W01C034O07	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC032300	MGC06-H04	MGC	W01C034O08	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC051360	MGC06-H05	MGC	W01C034O09	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	MGC06-H05	MGC	W01C034O10	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC035604	MGC06-H06	MGC	W01C034O11	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC035604	MGC06-H06	MGC	W01C034O12	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC062353	MGC06-H07	MGC	W01C034O13	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC062353	MGC06-H07	MGC	W01C034O14	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC036746	MGC06-H08	MGC	W01C034O15	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC036746	MGC06-H08	MGC	W01C034O16	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC032778	MGC06-H09	MGC	W01C034O17	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC032778	MGC06-H09	MGC	W01C034O18	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC033797	MGC06-H10	MGC	W01C034O19	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033797	MGC06-H10	MGC	W01C034O20	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033684	MGC06-H11	MGC	W01C034O21	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC033684	MGC06-H11	MGC	W01C034O22	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC032412	MGC06-H01	MGC	W01C034P01	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC032412	MGC06-H01	MGC	W01C034P02	pDONR221	13513		LOC100129726	100129726	AAH32412.1	Hs.194480	Hypothetical LOC100129726			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001723922.1	XP_001723974.1	MODEL	P	1.000	1.000	69	210	1	207	101	33	101
IKAKEN	BC052297	MGC06-H02	MGC	W01C034P03	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC052297	MGC06-H02	MGC	W01C034P04	pDONR221	24489		C9orf169	375791	AAH52297.1	Hs.512469	Chromosome 9 open reading frame 169			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_199001.1	NP_945352.1	PREDICTED	OK	1.000	1.000	144	435	1	432	144	1	144
IKAKEN	BC028280	MGC06-H03	MGC	W01C034P05	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC028280	MGC06-H03	MGC	W01C034P06	pDONR221	8677		MT1M	4499	AAH28280.1	Hs.647370	Metallothionein 1M			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_176870.2	NP_789846.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	BC032300	MGC06-H04	MGC	W01C034P07	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC032300	MGC06-H04	MGC	W01C034P08	pDONR221	17731		CISD2	493856	AAH32300.1	Hs.556638	CDGSH iron sulfur domain 2			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001008388.3	NP_001008389.1	REVIEWED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	BC051360	MGC06-H05	MGC	W01C034P09	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	MGC06-H05	MGC	W01C034P10	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC035604	MGC06-H06	MGC	W01C034P11	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC035604	MGC06-H06	MGC	W01C034P12	pDONR221	24125		C9orf97	158427	AAH35604.1	Hs.404289	Chromosome 9 open reading frame 97			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_139246.4	NP_640339.4	VALIDATED	P	1.000	1.000	489	1470	1	1467	516	28	516
IKAKEN	BC062353	MGC06-H07	MGC	W01C034P13	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC062353	MGC06-H07	MGC	W01C034P14	pDONR221	2100		C1orf131	128061	AAH62353.1	Hs.556017	Chromosome 1 open reading frame 131			Lung	NIH_MGC_77	DH10B	NM_152379.2	NP_689592.2	VALIDATED	P	1.000	1.000	249	750	1	747	293	1	249
IKAKEN	BC036746	MGC06-H08	MGC	W01C034P15	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC036746	MGC06-H08	MGC	W01C034P16	pDONR221	23551		FSD1L	83856	AAH36746.1	Hs.136901	Fibronectin type III and SPRY domain containing 1-like			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001145313.1	NP_001138785.1	VALIDATED	P	1.000	1.000	311	936	1	933	530	220	530
IKAKEN	BC032778	MGC06-H09	MGC	W01C034P17	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC032778	MGC06-H09	MGC	W01C034P18	pDONR221	2697		PAOX	196743	AAH32778.1	Hs.532469	Polyamine oxidase (exo-N4-amino)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152911.2	NP_690875.1	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC033797	MGC06-H10	MGC	W01C034P19	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033797	MGC06-H10	MGC	W01C034P20	pDONR221	15979		CCT8L2	150160	AAH33797.1	Hs.128342	Chaperonin containing TCP1, subunit 8 (theta)-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014406.4	NP_055221.1	VALIDATED		0.962	0.962	557	1674	1	1671	557	1	557
IKAKEN	BC033684	MGC06-H11	MGC	W01C034P21	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC033684	MGC06-H11	MGC	W01C034P22	pDONR221	23055		CPA6	57094	AAH33684.1	Hs.658850	Carboxypeptidase A6			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020361.4	NP_065094.3	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC033780	MGC07-A01	MGC	W01C035A01	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC033780	MGC07-A01	MGC	W01C035A02	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036749	MGC07-A02	MGC	W01C035A03	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	MGC07-A02	MGC	W01C035A04	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC032818	MGC07-A03	MGC	W01C035A05	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC032818	MGC07-A03	MGC	W01C035A06	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC033791	MGC07-A04	MGC	W01C035A07	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033791	MGC07-A04	MGC	W01C035A08	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033839	MGC07-A05	MGC	W01C035A09	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033839	MGC07-A05	MGC	W01C035A10	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033866	MGC07-A06	MGC	W01C035A11	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC033866	MGC07-A06	MGC	W01C035A12	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC039878	MGC07-A07	MGC	W01C035A13	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC039878	MGC07-A07	MGC	W01C035A14	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC033793	MGC07-A08	MGC	W01C035A15	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC033793	MGC07-A08	MGC	W01C035A16	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC035628	MGC07-A09	MGC	W01C035A17	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035628	MGC07-A09	MGC	W01C035A18	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC032808	MGC07-A10	MGC	W01C035A19	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC032808	MGC07-A10	MGC	W01C035A20	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC033794	MGC07-A11	MGC	W01C035A21	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033794	MGC07-A11	MGC	W01C035A22	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033759	MGC07-A12	MGC	W01C035A23	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC033759	MGC07-A12	MGC	W01C035A24	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC033780	MGC07-A01	MGC	W01C035B01	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC033780	MGC07-A01	MGC	W01C035B02	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036749	MGC07-A02	MGC	W01C035B03	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	MGC07-A02	MGC	W01C035B04	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC032818	MGC07-A03	MGC	W01C035B05	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC032818	MGC07-A03	MGC	W01C035B06	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC033791	MGC07-A04	MGC	W01C035B07	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033791	MGC07-A04	MGC	W01C035B08	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033839	MGC07-A05	MGC	W01C035B09	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033839	MGC07-A05	MGC	W01C035B10	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033866	MGC07-A06	MGC	W01C035B11	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC033866	MGC07-A06	MGC	W01C035B12	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC039878	MGC07-A07	MGC	W01C035B13	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC039878	MGC07-A07	MGC	W01C035B14	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC033793	MGC07-A08	MGC	W01C035B15	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC033793	MGC07-A08	MGC	W01C035B16	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC035628	MGC07-A09	MGC	W01C035B17	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035628	MGC07-A09	MGC	W01C035B18	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC032808	MGC07-A10	MGC	W01C035B19	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC032808	MGC07-A10	MGC	W01C035B20	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC033794	MGC07-A11	MGC	W01C035B21	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033794	MGC07-A11	MGC	W01C035B22	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033759	MGC07-A12	MGC	W01C035B23	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC033759	MGC07-A12	MGC	W01C035B24	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC035575	MGC07-B01	MGC	W01C035C01	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC035575	MGC07-B01	MGC	W01C035C02	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC032522	MGC07-B02	MGC	W01C035C03	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC032522	MGC07-B02	MGC	W01C035C04	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC035577	MGC07-B03	MGC	W01C035C05	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC035577	MGC07-B03	MGC	W01C035C06	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC037572	MGC07-B04	MGC	W01C035C07	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC037572	MGC07-B04	MGC	W01C035C08	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC032503	MGC07-B05	MGC	W01C035C09	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032503	MGC07-B05	MGC	W01C035C10	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032690	MGC07-B06	MGC	W01C035C11	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032690	MGC07-B06	MGC	W01C035C12	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032631	MGC07-B07	MGC	W01C035C13	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC032631	MGC07-B07	MGC	W01C035C14	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC033637	MGC07-B08	MGC	W01C035C15	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC033637	MGC07-B08	MGC	W01C035C16	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC035587	MGC07-B09	MGC	W01C035C17	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC035587	MGC07-B09	MGC	W01C035C18	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC032593	MGC07-B10	MGC	W01C035C19	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032593	MGC07-B10	MGC	W01C035C20	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032526	MGC07-B11	MGC	W01C035C21	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032526	MGC07-B11	MGC	W01C035C22	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032555	MGC07-B12	MGC	W01C035C23	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC032555	MGC07-B12	MGC	W01C035C24	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC035575	MGC07-B01	MGC	W01C035D01	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC035575	MGC07-B01	MGC	W01C035D02	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC032522	MGC07-B02	MGC	W01C035D03	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC032522	MGC07-B02	MGC	W01C035D04	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC035577	MGC07-B03	MGC	W01C035D05	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC035577	MGC07-B03	MGC	W01C035D06	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC037572	MGC07-B04	MGC	W01C035D07	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC037572	MGC07-B04	MGC	W01C035D08	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC032503	MGC07-B05	MGC	W01C035D09	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032503	MGC07-B05	MGC	W01C035D10	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032690	MGC07-B06	MGC	W01C035D11	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032690	MGC07-B06	MGC	W01C035D12	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032631	MGC07-B07	MGC	W01C035D13	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC032631	MGC07-B07	MGC	W01C035D14	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC033637	MGC07-B08	MGC	W01C035D15	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC033637	MGC07-B08	MGC	W01C035D16	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC035587	MGC07-B09	MGC	W01C035D17	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC035587	MGC07-B09	MGC	W01C035D18	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC032593	MGC07-B10	MGC	W01C035D19	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032593	MGC07-B10	MGC	W01C035D20	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032526	MGC07-B11	MGC	W01C035D21	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032526	MGC07-B11	MGC	W01C035D22	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032555	MGC07-B12	MGC	W01C035D23	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC032555	MGC07-B12	MGC	W01C035D24	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC032710	MGC07-C01	MGC	W01C035E01	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC032710	MGC07-C01	MGC	W01C035E02	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC033630	MGC07-C02	MGC	W01C035E03	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC033630	MGC07-C02	MGC	W01C035E04	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC032729	MGC07-C03	MGC	W01C035E05	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC032729	MGC07-C03	MGC	W01C035E06	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC033647	MGC07-C04	MGC	W01C035E07	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC033647	MGC07-C04	MGC	W01C035E08	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC032528	MGC07-C05	MGC	W01C035E09	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032528	MGC07-C05	MGC	W01C035E10	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032730	MGC07-C06	MGC	W01C035E11	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC032730	MGC07-C06	MGC	W01C035E12	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC033643	MGC07-C07	MGC	W01C035E13	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC033643	MGC07-C07	MGC	W01C035E14	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC032627	MGC07-C08	MGC	W01C035E15	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032627	MGC07-C08	MGC	W01C035E16	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032662	MGC07-C09	MGC	W01C035E17	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC032662	MGC07-C09	MGC	W01C035E18	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC033640	MGC07-C10	MGC	W01C035E19	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC033640	MGC07-C10	MGC	W01C035E20	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC062320	MGC07-C11	MGC	W01C035E21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	MGC07-C11	MGC	W01C035E22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC032597	MGC07-C12	MGC	W01C035E23	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC032597	MGC07-C12	MGC	W01C035E24	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC032710	MGC07-C01	MGC	W01C035F01	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC032710	MGC07-C01	MGC	W01C035F02	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC033630	MGC07-C02	MGC	W01C035F03	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC033630	MGC07-C02	MGC	W01C035F04	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC032729	MGC07-C03	MGC	W01C035F05	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC032729	MGC07-C03	MGC	W01C035F06	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC033647	MGC07-C04	MGC	W01C035F07	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC033647	MGC07-C04	MGC	W01C035F08	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC032528	MGC07-C05	MGC	W01C035F09	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032528	MGC07-C05	MGC	W01C035F10	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032730	MGC07-C06	MGC	W01C035F11	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC032730	MGC07-C06	MGC	W01C035F12	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC033643	MGC07-C07	MGC	W01C035F13	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC033643	MGC07-C07	MGC	W01C035F14	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC032627	MGC07-C08	MGC	W01C035F15	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032627	MGC07-C08	MGC	W01C035F16	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032662	MGC07-C09	MGC	W01C035F17	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC032662	MGC07-C09	MGC	W01C035F18	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC033640	MGC07-C10	MGC	W01C035F19	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC033640	MGC07-C10	MGC	W01C035F20	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC062320	MGC07-C11	MGC	W01C035F21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	MGC07-C11	MGC	W01C035F22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC032597	MGC07-C12	MGC	W01C035F23	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC032597	MGC07-C12	MGC	W01C035F24	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC035923	MGC07-D01	MGC	W01C035G01	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC035923	MGC07-D01	MGC	W01C035G02	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC046243	MGC07-D02	MGC	W01C035G03	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC046243	MGC07-D02	MGC	W01C035G04	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC038808	MGC07-D03	MGC	W01C035G05	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC038808	MGC07-D03	MGC	W01C035G06	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC037974	MGC07-D04	MGC	W01C035G07	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC037974	MGC07-D04	MGC	W01C035G08	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC041097	MGC07-D05	MGC	W01C035G09	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC041097	MGC07-D05	MGC	W01C035G10	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC038799	MGC07-D06	MGC	W01C035G11	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC038799	MGC07-D06	MGC	W01C035G12	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC037969	MGC07-D07	MGC	W01C035G13	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC037969	MGC07-D07	MGC	W01C035G14	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC038452	MGC07-D08	MGC	W01C035G15	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC038452	MGC07-D08	MGC	W01C035G16	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC037420	MGC07-D09	MGC	W01C035G17	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037420	MGC07-D09	MGC	W01C035G18	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037428	MGC07-D10	MGC	W01C035G19	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	MGC07-D10	MGC	W01C035G20	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC036873	MGC07-D11	MGC	W01C035G21	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC036873	MGC07-D11	MGC	W01C035G22	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC062346	MGC07-D12	MGC	W01C035G23	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC062346	MGC07-D12	MGC	W01C035G24	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC035923	MGC07-D01	MGC	W01C035H01	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC035923	MGC07-D01	MGC	W01C035H02	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC046243	MGC07-D02	MGC	W01C035H03	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC046243	MGC07-D02	MGC	W01C035H04	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC038808	MGC07-D03	MGC	W01C035H05	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC038808	MGC07-D03	MGC	W01C035H06	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC037974	MGC07-D04	MGC	W01C035H07	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC037974	MGC07-D04	MGC	W01C035H08	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC041097	MGC07-D05	MGC	W01C035H09	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC041097	MGC07-D05	MGC	W01C035H10	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC038799	MGC07-D06	MGC	W01C035H11	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC038799	MGC07-D06	MGC	W01C035H12	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC037969	MGC07-D07	MGC	W01C035H13	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC037969	MGC07-D07	MGC	W01C035H14	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC038452	MGC07-D08	MGC	W01C035H15	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC038452	MGC07-D08	MGC	W01C035H16	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC037420	MGC07-D09	MGC	W01C035H17	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037420	MGC07-D09	MGC	W01C035H18	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037428	MGC07-D10	MGC	W01C035H19	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	MGC07-D10	MGC	W01C035H20	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC036873	MGC07-D11	MGC	W01C035H21	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC036873	MGC07-D11	MGC	W01C035H22	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC062346	MGC07-D12	MGC	W01C035H23	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC062346	MGC07-D12	MGC	W01C035H24	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC035918	MGC07-E01	MGC	W01C035I01	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC035918	MGC07-E01	MGC	W01C035I02	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC037955	MGC07-E02	MGC	W01C035I03	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC037955	MGC07-E02	MGC	W01C035I04	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC035854	MGC07-E03	MGC	W01C035I05	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035854	MGC07-E03	MGC	W01C035I06	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035638	MGC07-E04	MGC	W01C035I07	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035638	MGC07-E04	MGC	W01C035I08	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035672	MGC07-E05	MGC	W01C035I09	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC035672	MGC07-E05	MGC	W01C035I10	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC036809	MGC07-E06	MGC	W01C035I11	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC036809	MGC07-E06	MGC	W01C035I12	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC035639	MGC07-E07	MGC	W01C035I13	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC035639	MGC07-E07	MGC	W01C035I14	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC041093	MGC07-E08	MGC	W01C035I15	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC041093	MGC07-E08	MGC	W01C035I16	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC035732	MGC07-E09	MGC	W01C035I17	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	MGC07-E09	MGC	W01C035I18	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC037964	MGC07-E10	MGC	W01C035I19	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	MGC07-E10	MGC	W01C035I20	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	MGC07-E11	MGC	W01C035I21	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	MGC07-E11	MGC	W01C035I22	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC035674	MGC07-E12	MGC	W01C035I23	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC035674	MGC07-E12	MGC	W01C035I24	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC035918	MGC07-E01	MGC	W01C035J01	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC035918	MGC07-E01	MGC	W01C035J02	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC037955	MGC07-E02	MGC	W01C035J03	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC037955	MGC07-E02	MGC	W01C035J04	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC035854	MGC07-E03	MGC	W01C035J05	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035854	MGC07-E03	MGC	W01C035J06	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035638	MGC07-E04	MGC	W01C035J07	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035638	MGC07-E04	MGC	W01C035J08	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035672	MGC07-E05	MGC	W01C035J09	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC035672	MGC07-E05	MGC	W01C035J10	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC036809	MGC07-E06	MGC	W01C035J11	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC036809	MGC07-E06	MGC	W01C035J12	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC035639	MGC07-E07	MGC	W01C035J13	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC035639	MGC07-E07	MGC	W01C035J14	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC041093	MGC07-E08	MGC	W01C035J15	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC041093	MGC07-E08	MGC	W01C035J16	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC035732	MGC07-E09	MGC	W01C035J17	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	MGC07-E09	MGC	W01C035J18	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC037964	MGC07-E10	MGC	W01C035J19	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	MGC07-E10	MGC	W01C035J20	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	MGC07-E11	MGC	W01C035J21	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	MGC07-E11	MGC	W01C035J22	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC035674	MGC07-E12	MGC	W01C035J23	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC035674	MGC07-E12	MGC	W01C035J24	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC038230	MGC07-F01	MGC	W01C035K01	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC038230	MGC07-F01	MGC	W01C035K02	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC036776	MGC07-F02	MGC	W01C035K03	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036776	MGC07-F02	MGC	W01C035K04	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036819	MGC07-F03	MGC	W01C035K05	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036819	MGC07-F03	MGC	W01C035K06	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036780	MGC07-F04	MGC	W01C035K07	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC036780	MGC07-F04	MGC	W01C035K08	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC042923	MGC07-F05	MGC	W01C035K09	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	MGC07-F05	MGC	W01C035K10	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC035727	MGC07-F06	MGC	W01C035K11	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC035727	MGC07-F06	MGC	W01C035K12	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC033882	MGC07-F07	MGC	W01C035K13	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC033882	MGC07-F07	MGC	W01C035K14	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC036790	MGC07-F08	MGC	W01C035K15	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036790	MGC07-F08	MGC	W01C035K16	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036817	MGC07-F09	MGC	W01C035K17	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC036817	MGC07-F09	MGC	W01C035K18	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC038233	MGC07-F10	MGC	W01C035K19	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC038233	MGC07-F10	MGC	W01C035K20	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC035837	MGC07-F11	MGC	W01C035K21	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC035837	MGC07-F11	MGC	W01C035K22	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC041092	MGC07-F12	MGC	W01C035K23	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	MGC07-F12	MGC	W01C035K24	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC038230	MGC07-F01	MGC	W01C035L01	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC038230	MGC07-F01	MGC	W01C035L02	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC036776	MGC07-F02	MGC	W01C035L03	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036776	MGC07-F02	MGC	W01C035L04	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036819	MGC07-F03	MGC	W01C035L05	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036819	MGC07-F03	MGC	W01C035L06	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036780	MGC07-F04	MGC	W01C035L07	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC036780	MGC07-F04	MGC	W01C035L08	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC042923	MGC07-F05	MGC	W01C035L09	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	MGC07-F05	MGC	W01C035L10	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC035727	MGC07-F06	MGC	W01C035L11	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC035727	MGC07-F06	MGC	W01C035L12	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC033882	MGC07-F07	MGC	W01C035L13	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC033882	MGC07-F07	MGC	W01C035L14	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC036790	MGC07-F08	MGC	W01C035L15	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036790	MGC07-F08	MGC	W01C035L16	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036817	MGC07-F09	MGC	W01C035L17	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC036817	MGC07-F09	MGC	W01C035L18	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC038233	MGC07-F10	MGC	W01C035L19	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC038233	MGC07-F10	MGC	W01C035L20	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC035837	MGC07-F11	MGC	W01C035L21	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC035837	MGC07-F11	MGC	W01C035L22	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC041092	MGC07-F12	MGC	W01C035L23	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	MGC07-F12	MGC	W01C035L24	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC035744	MGC07-G01	MGC	W01C035M01	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC035744	MGC07-G01	MGC	W01C035M02	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC041118	MGC07-G02	MGC	W01C035M03	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC041118	MGC07-G02	MGC	W01C035M04	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC046248	MGC07-G03	MGC	W01C035M05	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046248	MGC07-G03	MGC	W01C035M06	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046247	MGC07-G04	MGC	W01C035M07	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	MGC07-G04	MGC	W01C035M08	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039888	MGC07-G05	MGC	W01C035M09	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039888	MGC07-G05	MGC	W01C035M10	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039011	MGC07-G06	MGC	W01C035M11	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039011	MGC07-G06	MGC	W01C035M12	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039905	MGC07-G07	MGC	W01C035M13	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC039905	MGC07-G07	MGC	W01C035M14	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC038094	MGC07-G08	MGC	W01C035M15	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038094	MGC07-G08	MGC	W01C035M16	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038978	MGC07-G09	MGC	W01C035M17	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC038978	MGC07-G09	MGC	W01C035M18	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC041130	MGC07-G10	MGC	W01C035M19	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC041130	MGC07-G10	MGC	W01C035M20	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC038836	MGC07-G11	MGC	W01C035M21	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC038836	MGC07-G11	MGC	W01C035M22	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC039899	MGC07-G12	MGC	W01C035M23	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC039899	MGC07-G12	MGC	W01C035M24	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC035744	MGC07-G01	MGC	W01C035N01	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC035744	MGC07-G01	MGC	W01C035N02	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC041118	MGC07-G02	MGC	W01C035N03	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC041118	MGC07-G02	MGC	W01C035N04	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC046248	MGC07-G03	MGC	W01C035N05	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046248	MGC07-G03	MGC	W01C035N06	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046247	MGC07-G04	MGC	W01C035N07	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	MGC07-G04	MGC	W01C035N08	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039888	MGC07-G05	MGC	W01C035N09	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039888	MGC07-G05	MGC	W01C035N10	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039011	MGC07-G06	MGC	W01C035N11	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039011	MGC07-G06	MGC	W01C035N12	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039905	MGC07-G07	MGC	W01C035N13	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC039905	MGC07-G07	MGC	W01C035N14	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC038094	MGC07-G08	MGC	W01C035N15	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038094	MGC07-G08	MGC	W01C035N16	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038978	MGC07-G09	MGC	W01C035N17	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC038978	MGC07-G09	MGC	W01C035N18	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC041130	MGC07-G10	MGC	W01C035N19	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC041130	MGC07-G10	MGC	W01C035N20	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC038836	MGC07-G11	MGC	W01C035N21	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC038836	MGC07-G11	MGC	W01C035N22	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC039899	MGC07-G12	MGC	W01C035N23	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC039899	MGC07-G12	MGC	W01C035N24	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC041120	MGC07-H01	MGC	W01C035O01	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC041120	MGC07-H01	MGC	W01C035O02	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC038970	MGC07-H02	MGC	W01C035O03	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC038970	MGC07-H02	MGC	W01C035O04	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC040076	MGC07-H03	MGC	W01C035O05	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC040076	MGC07-H03	MGC	W01C035O06	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC042191	MGC07-H04	MGC	W01C035O07	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC042191	MGC07-H04	MGC	W01C035O08	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC067362	MGC07-H05	MGC	W01C035O09	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC067362	MGC07-H05	MGC	W01C035O10	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039600	MGC07-H06	MGC	W01C035O11	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC039600	MGC07-H06	MGC	W01C035O12	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC042297	MGC07-H07	MGC	W01C035O13	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC042297	MGC07-H07	MGC	W01C035O14	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC039856	MGC07-H08	MGC	W01C035O15	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	MGC07-H08	MGC	W01C035O16	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039833	MGC07-H09	MGC	W01C035O17	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039833	MGC07-H09	MGC	W01C035O18	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039844	MGC07-H10	MGC	W01C035O19	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	MGC07-H10	MGC	W01C035O20	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC041167	MGC07-H11	MGC	W01C035O21	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC041167	MGC07-H11	MGC	W01C035O22	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC039608	MGC07-H12	MGC	W01C035O23	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC039608	MGC07-H12	MGC	W01C035O24	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC041120	MGC07-H01	MGC	W01C035P01	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC041120	MGC07-H01	MGC	W01C035P02	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC038970	MGC07-H02	MGC	W01C035P03	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC038970	MGC07-H02	MGC	W01C035P04	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC040076	MGC07-H03	MGC	W01C035P05	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC040076	MGC07-H03	MGC	W01C035P06	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC042191	MGC07-H04	MGC	W01C035P07	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC042191	MGC07-H04	MGC	W01C035P08	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC067362	MGC07-H05	MGC	W01C035P09	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC067362	MGC07-H05	MGC	W01C035P10	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039600	MGC07-H06	MGC	W01C035P11	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC039600	MGC07-H06	MGC	W01C035P12	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC042297	MGC07-H07	MGC	W01C035P13	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC042297	MGC07-H07	MGC	W01C035P14	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC039856	MGC07-H08	MGC	W01C035P15	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	MGC07-H08	MGC	W01C035P16	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039833	MGC07-H09	MGC	W01C035P17	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039833	MGC07-H09	MGC	W01C035P18	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039844	MGC07-H10	MGC	W01C035P19	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	MGC07-H10	MGC	W01C035P20	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC041167	MGC07-H11	MGC	W01C035P21	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC041167	MGC07-H11	MGC	W01C035P22	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC039608	MGC07-H12	MGC	W01C035P23	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC039608	MGC07-H12	MGC	W01C035P24	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC033780	MGC07-A01	MGC	W01C036A01	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC033780	MGC07-A01	MGC	W01C036A02	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036749	MGC07-A02	MGC	W01C036A03	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	MGC07-A02	MGC	W01C036A04	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC032818	MGC07-A03	MGC	W01C036A05	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC032818	MGC07-A03	MGC	W01C036A06	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC033791	MGC07-A04	MGC	W01C036A07	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033791	MGC07-A04	MGC	W01C036A08	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033839	MGC07-A05	MGC	W01C036A09	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033839	MGC07-A05	MGC	W01C036A10	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033866	MGC07-A06	MGC	W01C036A11	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC033866	MGC07-A06	MGC	W01C036A12	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC039878	MGC07-A07	MGC	W01C036A13	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC039878	MGC07-A07	MGC	W01C036A14	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC033793	MGC07-A08	MGC	W01C036A15	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC033793	MGC07-A08	MGC	W01C036A16	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC035628	MGC07-A09	MGC	W01C036A17	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035628	MGC07-A09	MGC	W01C036A18	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC032808	MGC07-A10	MGC	W01C036A19	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC032808	MGC07-A10	MGC	W01C036A20	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC033794	MGC07-A11	MGC	W01C036A21	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033794	MGC07-A11	MGC	W01C036A22	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033759	MGC07-A12	MGC	W01C036A23	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC033759	MGC07-A12	MGC	W01C036A24	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC033780	MGC07-A01	MGC	W01C036B01	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC033780	MGC07-A01	MGC	W01C036B02	pDONR221	11274		ZADH2	284273	AAH33780.1	Hs.465433	Zinc binding alcohol dehydrogenase domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_175907.4	NP_787103.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036749	MGC07-A02	MGC	W01C036B03	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	MGC07-A02	MGC	W01C036B04	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC032818	MGC07-A03	MGC	W01C036B05	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC032818	MGC07-A03	MGC	W01C036B06	pDONR221	14807		C20orf144	128864	AAH32818.1	Hs.324104	Chromosome 20 open reading frame 144			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_080825.2	NP_543015.1	PREDICTED	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC033791	MGC07-A04	MGC	W01C036B07	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033791	MGC07-A04	MGC	W01C036B08	pDONR221	17044		RNF168	165918	AAH33791.1	Hs.660132	Ring finger protein 168			Testis	NIH_MGC_97	DH10B	NM_152617.2	NP_689830.2	PROVISIONAL	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC033839	MGC07-A05	MGC	W01C036B09	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033839	MGC07-A05	MGC	W01C036B10	pDONR221	2919		C10orf126	283080	AAH33839					Cervix, carcinoma	NIH_MGC_12	DH10B			
IKAKEN	BC033866	MGC07-A06	MGC	W01C036B11	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC033866	MGC07-A06	MGC	W01C036B12	pDONR221	17623		CPE	1363	AAH33866.1	Hs.75360	Carboxypeptidase E			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001873.2	NP_001864.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC039878	MGC07-A07	MGC	W01C036B13	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC039878	MGC07-A07	MGC	W01C036B14	pDONR221	7530		FSCB	84075	AAH39878.1	Hs.307086	Fibrous sheath CABYR binding protein			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032135.3	NP_115511.3	VALIDATED	OK	1.000	1.000	825	2478	1	2475	825	1	825
IKAKEN	BC033793	MGC07-A08	MGC	W01C036B15	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC033793	MGC07-A08	MGC	W01C036B16	pDONR221	5192		RIMKLB	57494	AAH33793.1	Hs.504670	Ribosomal modification protein rimK-like family member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020734.2	NP_065785.2	VALIDATED	P	1.000	1.000	281	924	1	843	386	1	281
IKAKEN	BC035628	MGC07-A09	MGC	W01C036B17	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC035628	MGC07-A09	MGC	W01C036B18	pDONR221	4657		C1QTNF4	114900	AAH35628.1	Hs.662633	C1q and tumor necrosis factor related protein 4			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_031909.2	NP_114115.2	VALIDATED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	BC032808	MGC07-A10	MGC	W01C036B19	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC032808	MGC07-A10	MGC	W01C036B20	pDONR221	18247		OCIAD2	132299	AAH32808.1	Hs.95835	OCIA domain containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152398.2	NP_689611.1	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC033794	MGC07-A11	MGC	W01C036B21	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033794	MGC07-A11	MGC	W01C036B22	pDONR221	8284		HDDC3	374659	AAH33794.1	Hs.349979	HD domain containing 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_198527.2	NP_940929.1	PROVISIONAL	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC033759	MGC07-A12	MGC	W01C036B23	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC033759	MGC07-A12	MGC	W01C036B24	pDONR221	10415		MIF4GD	57409	AAH33759.1	Hs.325631	MIF4G domain containing			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020679.2	NP_065730.2	VALIDATED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC035575	MGC07-B01	MGC	W01C036C01	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC035575	MGC07-B01	MGC	W01C036C02	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC032522	MGC07-B02	MGC	W01C036C03	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC032522	MGC07-B02	MGC	W01C036C04	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC035577	MGC07-B03	MGC	W01C036C05	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC035577	MGC07-B03	MGC	W01C036C06	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC037572	MGC07-B04	MGC	W01C036C07	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC037572	MGC07-B04	MGC	W01C036C08	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC032503	MGC07-B05	MGC	W01C036C09	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032503	MGC07-B05	MGC	W01C036C10	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032690	MGC07-B06	MGC	W01C036C11	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032690	MGC07-B06	MGC	W01C036C12	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032631	MGC07-B07	MGC	W01C036C13	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC032631	MGC07-B07	MGC	W01C036C14	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC033637	MGC07-B08	MGC	W01C036C15	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC033637	MGC07-B08	MGC	W01C036C16	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC035587	MGC07-B09	MGC	W01C036C17	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC035587	MGC07-B09	MGC	W01C036C18	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC032593	MGC07-B10	MGC	W01C036C19	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032593	MGC07-B10	MGC	W01C036C20	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032526	MGC07-B11	MGC	W01C036C21	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032526	MGC07-B11	MGC	W01C036C22	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032555	MGC07-B12	MGC	W01C036C23	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC032555	MGC07-B12	MGC	W01C036C24	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC035575	MGC07-B01	MGC	W01C036D01	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC035575	MGC07-B01	MGC	W01C036D02	pDONR221	21777		PEX1	5189	AAH35575.1	Hs.164682	Peroxisomal biogenesis factor 1			Testis	NIH_MGC_97	DH10B	NM_000466.2	NP_000457.1	REVIEWED	OK	1.000	1.000	1283	3852	1	3849	1283	1	1283
IKAKEN	BC032522	MGC07-B02	MGC	W01C036D03	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC032522	MGC07-B02	MGC	W01C036D04	pDONR221	17155		MRPL47	57129	AAH32522.1	Hs.283734	Mitochondrial ribosomal protein L47			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_177988.1	NP_817125.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC035577	MGC07-B03	MGC	W01C036D05	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC035577	MGC07-B03	MGC	W01C036D06	pDONR221	9069		IFT140	9742	AAH35577.1	Hs.389438	Intraflagellar transport 140 homolog (Chlamydomonas)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014714.3	NP_055529.2	VALIDATED	OK	1.000	1.000	1462	4389	1	4386	1462	1	1462
IKAKEN	BC037572	MGC07-B04	MGC	W01C036D07	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC037572	MGC07-B04	MGC	W01C036D08	pDONR221	10386		FAM117A	81558	AAH37572.1	Hs.514308	Family with sequence similarity 117, member A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_030802.3	NP_110429.1	VALIDATED	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC032503	MGC07-B05	MGC	W01C036D09	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032503	MGC07-B05	MGC	W01C036D10	pDONR221	23985		ANAPC2	29882	AAH32503.1	Hs.533262	Anaphase promoting complex subunit 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013366.3	NP_037498.1	REVIEWED	OK	1.000	1.000	822	2469	1	2466	822	1	822
IKAKEN	BC032690	MGC07-B06	MGC	W01C036D11	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032690	MGC07-B06	MGC	W01C036D12	pDONR221	1625		TDRKH	11022	AAH32690	Hs.144439	Tudor and KH domain containing			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_001083965.1	NP_001077434.1	VALIDATED	Cg	0.981	1.000	572	1719	1	1716	561	1	561
IKAKEN	BC032631	MGC07-B07	MGC	W01C036D13	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC032631	MGC07-B07	MGC	W01C036D14	pDONR221	9185		C16orf61	56942	AAH32631.1	Hs.388255	Chromosome 16 open reading frame 61			Testis	NIH_MGC_97	DH10B	NM_020188.3	NP_064573.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC033637	MGC07-B08	MGC	W01C036D15	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC033637	MGC07-B08	MGC	W01C036D16	pDONR221	1394		SSX2IP	117178	AAH33637.1	Hs.22587	Synovial sarcoma, X breakpoint 2 interacting protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_014021.2	NP_054740.2	PROVISIONAL	Cs	0.998	0.998	614	1845	1	1842	614	1	614
IKAKEN	BC035587	MGC07-B09	MGC	W01C036D17	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC035587	MGC07-B09	MGC	W01C036D18	pDONR221	24877		STARD8	9754	AAH35587.1	Hs.95140	StAR-related lipid transfer (START) domain containing 8			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001142504.1	NP_001135976.1	VALIDATED	OK	1.000	1.000	1023	3072	1	3069	1023	1	1023
IKAKEN	BC032593	MGC07-B10	MGC	W01C036D19	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032593	MGC07-B10	MGC	W01C036D20	pDONR221	2627		RASSF4	83937	AAH32593.1	Hs.522895	Ras association (RalGDS/AF-6) domain family member 4			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032023.3	NP_114412.2	REVIEWED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	BC032526	MGC07-B11	MGC	W01C036D21	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032526	MGC07-B11	MGC	W01C036D22	pDONR221	25358		MAP3K7IP3	257397	AAH32526.1	Hs.188256	Mitogen-activated protein kinase kinase kinase 7 interacting protein 3			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_152787.3	NP_690000.2	REVIEWED	OK	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC032555	MGC07-B12	MGC	W01C036D23	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC032555	MGC07-B12	MGC	W01C036D24	pDONR221	16110		NLGN1	22871	AAH32555.1	Hs.478289	Neuroligin 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_014932.2	NP_055747.1	REVIEWED	OK	1.000	1.000	823	2472	1	2469	823	1	823
IKAKEN	BC032710	MGC07-C01	MGC	W01C036E01	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC032710	MGC07-C01	MGC	W01C036E02	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC033630	MGC07-C02	MGC	W01C036E03	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC033630	MGC07-C02	MGC	W01C036E04	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC032729	MGC07-C03	MGC	W01C036E05	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC032729	MGC07-C03	MGC	W01C036E06	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC033647	MGC07-C04	MGC	W01C036E07	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC033647	MGC07-C04	MGC	W01C036E08	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC032528	MGC07-C05	MGC	W01C036E09	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032528	MGC07-C05	MGC	W01C036E10	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032730	MGC07-C06	MGC	W01C036E11	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC032730	MGC07-C06	MGC	W01C036E12	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC033643	MGC07-C07	MGC	W01C036E13	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC033643	MGC07-C07	MGC	W01C036E14	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC032627	MGC07-C08	MGC	W01C036E15	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032627	MGC07-C08	MGC	W01C036E16	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032662	MGC07-C09	MGC	W01C036E17	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC032662	MGC07-C09	MGC	W01C036E18	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC033640	MGC07-C10	MGC	W01C036E19	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC033640	MGC07-C10	MGC	W01C036E20	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC062320	MGC07-C11	MGC	W01C036E21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	MGC07-C11	MGC	W01C036E22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC032597	MGC07-C12	MGC	W01C036E23	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC032597	MGC07-C12	MGC	W01C036E24	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC032710	MGC07-C01	MGC	W01C036F01	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC032710	MGC07-C01	MGC	W01C036F02	pDONR221	22500		OXR1	55074	AAH32710.1	Hs.148778	Oxidation resistance 1			Testis	NIH_MGC_97	DH10B	NM_018002.2	NP_060472.2	VALIDATED	P	1.000	1.000	758	2277	1	2274	846	89	846
IKAKEN	BC033630	MGC07-C02	MGC	W01C036F03	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC033630	MGC07-C02	MGC	W01C036F04	pDONR221	23069		SNX16	64089	AAH33630.1	Hs.492121	Sorting nexin 16			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152836.2	NP_690049.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC032729	MGC07-C03	MGC	W01C036F05	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC032729	MGC07-C03	MGC	W01C036F06	pDONR221	24868		XIAP	331	AAH32729.1	Hs.356076	X-linked inhibitor of apoptosis			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001167.2	NP_001158.2	REVIEWED		0.896	0.905	106	321	4	318	497	275	380
IKAKEN	BC033647	MGC07-C04	MGC	W01C036F07	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC033647	MGC07-C04	MGC	W01C036F08	pDONR221	20798		CUL7	9820	AAH33647.1	Hs.520136	Cullin 7			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_014780.3	NP_055595.2	VALIDATED	OK	1.000	1.000	1698	5097	1	5094	1698	1	1698
IKAKEN	BC032528	MGC07-C05	MGC	W01C036F09	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032528	MGC07-C05	MGC	W01C036F10	pDONR221	5876		LTA4H	4048	AAH32528.1	Hs.524648	Leukotriene A4 hydrolase			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_000895.1	NP_000886.1	PROVISIONAL	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC032730	MGC07-C06	MGC	W01C036F11	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC032730	MGC07-C06	MGC	W01C036F12	pDONR221	11388		DHDH	27294	AAH32730.1	Hs.631555	Dihydrodiol dehydrogenase (dimeric)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_014475.3	NP_055290.1	REVIEWED	OK	1.000	1.000	334	1005	1	1002	334	1	334
IKAKEN	BC033643	MGC07-C07	MGC	W01C036F13	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC033643	MGC07-C07	MGC	W01C036F14	pDONR221	32867				AAH33643					Testis, embryonal carcinoma	NIH_MGC_92	DH10B			
IKAKEN	BC032627	MGC07-C08	MGC	W01C036F15	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032627	MGC07-C08	MGC	W01C036F16	pDONR221	19800		GNMT	27232	AAH32627.1	Hs.144914	Glycine N-methyltransferase			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_018960.4	NP_061833.1	REVIEWED	OK	1.000	1.000	295	888	1	885	295	1	295
IKAKEN	BC032662	MGC07-C09	MGC	W01C036F17	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC032662	MGC07-C09	MGC	W01C036F18	pDONR221	10993		POLI	11201	AAH32662.1	Hs.438533	Polymerase (DNA directed) iota			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007195.2	NP_009126.2	VALIDATED	P	1.000	1.000	715	2148	1	2145	740	26	740
IKAKEN	BC033640	MGC07-C10	MGC	W01C036F19	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC033640	MGC07-C10	MGC	W01C036F20	pDONR221	4414		HPS5	11234	AAH33640.1	Hs.437599	Hermansky-Pudlak syndrome 5			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181508.1	NP_852609.1	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC062320	MGC07-C11	MGC	W01C036F21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	MGC07-C11	MGC	W01C036F22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC032597	MGC07-C12	MGC	W01C036F23	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC032597	MGC07-C12	MGC	W01C036F24	pDONR221	10939		NEDD4L	23327	AAH32597.1	Hs.185677	Neural precursor cell expressed, developmentally down-regulated 4-like			Testis	NIH_MGC_97	DH10B	NM_001144970.1	NP_001138442.1	VALIDATED	Cg	0.947	1.000	834	2763	391	2760	834	1	834
IKAKEN	BC035923	MGC07-D01	MGC	W01C036G01	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC035923	MGC07-D01	MGC	W01C036G02	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC046243	MGC07-D02	MGC	W01C036G03	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC046243	MGC07-D02	MGC	W01C036G04	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC038808	MGC07-D03	MGC	W01C036G05	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC038808	MGC07-D03	MGC	W01C036G06	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC037974	MGC07-D04	MGC	W01C036G07	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC037974	MGC07-D04	MGC	W01C036G08	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC041097	MGC07-D05	MGC	W01C036G09	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC041097	MGC07-D05	MGC	W01C036G10	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC038799	MGC07-D06	MGC	W01C036G11	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC038799	MGC07-D06	MGC	W01C036G12	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC037969	MGC07-D07	MGC	W01C036G13	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC037969	MGC07-D07	MGC	W01C036G14	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC038452	MGC07-D08	MGC	W01C036G15	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC038452	MGC07-D08	MGC	W01C036G16	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC037420	MGC07-D09	MGC	W01C036G17	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037420	MGC07-D09	MGC	W01C036G18	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037428	MGC07-D10	MGC	W01C036G19	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	MGC07-D10	MGC	W01C036G20	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC036873	MGC07-D11	MGC	W01C036G21	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC036873	MGC07-D11	MGC	W01C036G22	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC062346	MGC07-D12	MGC	W01C036G23	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC062346	MGC07-D12	MGC	W01C036G24	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC035923	MGC07-D01	MGC	W01C036H01	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC035923	MGC07-D01	MGC	W01C036H02	pDONR221	18078		COX7B2	170712	AAH35923.1	Hs.479656	Cytochrome c oxidase subunit VIIb2			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_130902.2	NP_570972.2	VALIDATED	P	1.000	1.000	80	243	1	240	81	2	81
IKAKEN	BC046243	MGC07-D02	MGC	W01C036H03	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC046243	MGC07-D02	MGC	W01C036H04	pDONR221	23038		ERICH1	157697	AAH46243.1	Hs.655310	Glutamate-rich 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_207332.1	NP_997215.1	PROVISIONAL	C	1.000	1.000	443	1332	1	1329	443	1	443
IKAKEN	BC038808	MGC07-D03	MGC	W01C036H05	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC038808	MGC07-D03	MGC	W01C036H06	pDONR221	15574		APOBEC3F	200316	AAH38808.1	Hs.659809	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_145298.5	NP_660341.2	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC037974	MGC07-D04	MGC	W01C036H07	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC037974	MGC07-D04	MGC	W01C036H08	pDONR221	4410		SLC15A3	51296	AAH37974.1	Hs.237856	Solute carrier family 15, member 3			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_016582.2	NP_057666.1	VALIDATED	C	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	BC041097	MGC07-D05	MGC	W01C036H09	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC041097	MGC07-D05	MGC	W01C036H10	pDONR221	8278		LYSMD4	145748	AAH41097.2	Hs.562568	LysM, putative peptidoglycan-binding, domain containing 4			Brain, hippocampus	NIH_MGC_124	DH10B	NM_152449.2	NP_689662.2	VALIDATED	C	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC038799	MGC07-D06	MGC	W01C036H11	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC038799	MGC07-D06	MGC	W01C036H12	pDONR221	2599		PCDH21	92211	AAH38799.1	Hs.137556	Protocadherin 21			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_033100.1	NP_149091.1	REVIEWED	Pg	0.990	1.000	687	2259	1	2061	859	1	680
IKAKEN	BC037969	MGC07-D07	MGC	W01C036H13	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC037969	MGC07-D07	MGC	W01C036H14	pDONR221	5170		WSCD2	9671	AAH37969.2	Hs.143591	WSC domain containing 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014653.2	NP_055468.2	VALIDATED	Pg	0.922	1.000	255	768	1	765	565	331	565
IKAKEN	BC038452	MGC07-D08	MGC	W01C036H15	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC038452	MGC07-D08	MGC	W01C036H16	pDONR221	20791		PLA2G7	7941	AAH38452.1	Hs.584823	Phospholipase A2, group VII (platelet-activating factor acetylhydrolase, plasma)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005084.3	NP_005075.3	VALIDATED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC037420	MGC07-D09	MGC	W01C036H17	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037420	MGC07-D09	MGC	W01C036H18	pDONR221	3769		BIRC3	330	AAH37420.1	Hs.127799	Baculoviral IAP repeat-containing 3	NT2	teratocarcinoma		NT2RP3		NM_001165.3	NP_001156.1	REVIEWED	OK	1.000	1.000	604	1815	1	1812	604	1	604
IKAKEN	BC037428	MGC07-D10	MGC	W01C036H19	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC037428	MGC07-D10	MGC	W01C036H20	pDONR221	12184		RAVER1	125950	AAH37428	Hs.714339	Ribonucleoprotein, PTB-binding 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_133452.2	NP_597709.2	VALIDATED	Pfs	0.756	1.000	763	1821	1	1820	756	18	750
IKAKEN	BC036873	MGC07-D11	MGC	W01C036H21	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC036873	MGC07-D11	MGC	W01C036H22	pDONR221	4007		TBC1D10C	374403	AAH36873.3	Hs.534648	TBC1 domain family, member 10C			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198517.2	NP_940919.1	PROVISIONAL	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC062346	MGC07-D12	MGC	W01C036H23	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC062346	MGC07-D12	MGC	W01C036H24	pDONR221	3333		ANKRD16	54522	AAH62346.1	Hs.289828	Ankyrin repeat domain 16			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001009941.2	NP_001009941.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC035918	MGC07-E01	MGC	W01C036I01	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC035918	MGC07-E01	MGC	W01C036I02	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC037955	MGC07-E02	MGC	W01C036I03	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC037955	MGC07-E02	MGC	W01C036I04	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC035854	MGC07-E03	MGC	W01C036I05	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035854	MGC07-E03	MGC	W01C036I06	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035638	MGC07-E04	MGC	W01C036I07	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035638	MGC07-E04	MGC	W01C036I08	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035672	MGC07-E05	MGC	W01C036I09	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC035672	MGC07-E05	MGC	W01C036I10	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC036809	MGC07-E06	MGC	W01C036I11	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC036809	MGC07-E06	MGC	W01C036I12	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC035639	MGC07-E07	MGC	W01C036I13	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC035639	MGC07-E07	MGC	W01C036I14	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC041093	MGC07-E08	MGC	W01C036I15	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC041093	MGC07-E08	MGC	W01C036I16	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC035732	MGC07-E09	MGC	W01C036I17	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	MGC07-E09	MGC	W01C036I18	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC037964	MGC07-E10	MGC	W01C036I19	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	MGC07-E10	MGC	W01C036I20	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	MGC07-E11	MGC	W01C036I21	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	MGC07-E11	MGC	W01C036I22	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC035674	MGC07-E12	MGC	W01C036I23	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC035674	MGC07-E12	MGC	W01C036I24	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC035918	MGC07-E01	MGC	W01C036J01	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC035918	MGC07-E01	MGC	W01C036J02	pDONR221	11445		KCNJ14	3770	AAH35918.1	Hs.644912	Potassium inwardly-rectifying channel, subfamily J, member 14			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_013348.2	NP_037480.1	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC037955	MGC07-E02	MGC	W01C036J03	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC037955	MGC07-E02	MGC	W01C036J04	pDONR221	20711		ADAT2	134637	AAH37955.2	Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	144	435	1	432	191	48	191
IKAKEN	BC035854	MGC07-E03	MGC	W01C036J05	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035854	MGC07-E03	MGC	W01C036J06	pDONR221	410		RCAN3	11123	AAH35854.1	Hs.656799	RCAN family member 3			Testis	NIH_MGC_97	DH10B	NM_013441.2	NP_038469.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC035638	MGC07-E04	MGC	W01C036J07	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035638	MGC07-E04	MGC	W01C036J08	pDONR221	15413		LSS	4047	AAH35638.1	Hs.596543	Lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_002340.5	NP_002331.3	REVIEWED	OK	1.000	1.000	732	2199	1	2196	732	1	732
IKAKEN	BC035672	MGC07-E05	MGC	W01C036J09	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC035672	MGC07-E05	MGC	W01C036J10	pDONR221	1365		GLT25D2	23127	AAH35672.1	Hs.387995	Glycosyltransferase 25 domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_015101.2	NP_055916.1	VALIDATED	OK	1.000	1.000	626	1881	1	1878	626	1	626
IKAKEN	BC036809	MGC07-E06	MGC	W01C036J11	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC036809	MGC07-E06	MGC	W01C036J12	pDONR221	22459		ARHGEF10	9639	AAH36809.1	Hs.98594	Rho guanine nucleotide exchange factor (GEF) 10			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014629.2	NP_055444.2	REVIEWED	Pgs	0.941	0.998	674	1986	10	1914	1344	227	900
IKAKEN	BC035639	MGC07-E07	MGC	W01C036J13	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC035639	MGC07-E07	MGC	W01C036J14	pDONR221	14688		TP53INP2	58476	AAH35639.1	Hs.516994	Tumor protein p53 inducible nuclear protein 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_021202.1	NP_067025.1	PROVISIONAL	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC041093	MGC07-E08	MGC	W01C036J15	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC041093	MGC07-E08	MGC	W01C036J16	pDONR221	13290		R3HDM1	23518	AAH41093.1	Hs.412462	R3H domain containing 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015361.2	NP_056176.2	PROVISIONAL	OK	1.000	1.000	1099	3300	1	3297	1099	1	1099
IKAKEN	BC035732	MGC07-E09	MGC	W01C036J17	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	MGC07-E09	MGC	W01C036J18	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC037964	MGC07-E10	MGC	W01C036J19	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC037964	MGC07-E10	MGC	W01C036J20	pDONR221	5831		DHX37	57647	AAH37964.1	Hs.107382	DEAH (Asp-Glu-Ala-His) box polypeptide 37			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_032656.2	NP_116045.2	REVIEWED	OK	1.000	1.000	1157	3474	1	3471	1157	1	1157
IKAKEN	BC039695	MGC07-E11	MGC	W01C036J21	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC039695	MGC07-E11	MGC	W01C036J22	pDONR221	23516		JAK2	3717	AAH39695.1	Hs.656213	Janus kinase 2 (a protein tyrosine kinase)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_004972.3	NP_004963.1	REVIEWED	OK	1.000	1.000	1132	3399	1	3396	1132	1	1132
IKAKEN	BC035674	MGC07-E12	MGC	W01C036J23	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC035674	MGC07-E12	MGC	W01C036J24	pDONR221	25419		WDR40B	139170	AAH35674.1	Hs.120403	WD repeat domain 40B			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178470.3	NP_848565.2	REVIEWED	OK	1.000	1.000	463	1392	1	1389	463	1	463
IKAKEN	BC038230	MGC07-F01	MGC	W01C036K01	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC038230	MGC07-F01	MGC	W01C036K02	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC036776	MGC07-F02	MGC	W01C036K03	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036776	MGC07-F02	MGC	W01C036K04	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036819	MGC07-F03	MGC	W01C036K05	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036819	MGC07-F03	MGC	W01C036K06	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036780	MGC07-F04	MGC	W01C036K07	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC036780	MGC07-F04	MGC	W01C036K08	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC042923	MGC07-F05	MGC	W01C036K09	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	MGC07-F05	MGC	W01C036K10	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC035727	MGC07-F06	MGC	W01C036K11	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC035727	MGC07-F06	MGC	W01C036K12	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC033882	MGC07-F07	MGC	W01C036K13	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC033882	MGC07-F07	MGC	W01C036K14	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC036790	MGC07-F08	MGC	W01C036K15	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036790	MGC07-F08	MGC	W01C036K16	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036817	MGC07-F09	MGC	W01C036K17	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC036817	MGC07-F09	MGC	W01C036K18	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC038233	MGC07-F10	MGC	W01C036K19	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC038233	MGC07-F10	MGC	W01C036K20	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC035837	MGC07-F11	MGC	W01C036K21	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC035837	MGC07-F11	MGC	W01C036K22	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC041092	MGC07-F12	MGC	W01C036K23	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	MGC07-F12	MGC	W01C036K24	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC038230	MGC07-F01	MGC	W01C036L01	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC038230	MGC07-F01	MGC	W01C036L02	pDONR221	19360		MBLAC2	153364	AAH38230.1	Hs.64004	Metallo-beta-lactamase domain containing 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203406.1	NP_981951.1	VALIDATED	Cs	0.996	0.996	279	840	1	837	279	1	279
IKAKEN	BC036776	MGC07-F02	MGC	W01C036L03	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036776	MGC07-F02	MGC	W01C036L04	pDONR221	14250		REG3A	5068	AAH36776.1	Hs.567312	Regenerating islet-derived 3 alpha			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_002580.1	NP_002571.1	REVIEWED	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	BC036819	MGC07-F03	MGC	W01C036L05	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036819	MGC07-F03	MGC	W01C036L06	pDONR221	12985		TTL	150465	AAH36819.1	Hs.358997	Tubulin tyrosine ligase			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153712.4	NP_714923.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC036780	MGC07-F04	MGC	W01C036L07	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC036780	MGC07-F04	MGC	W01C036L08	pDONR221	8951		HSD11B2	3291	AAH36780.1	Hs.1376	Hydroxysteroid (11-beta) dehydrogenase 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_000196.3	NP_000187.3	VALIDATED	OK	1.000	1.000	405	1218	1	1215	405	1	405
IKAKEN	BC042923	MGC07-F05	MGC	W01C036L09	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	MGC07-F05	MGC	W01C036L10	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC035727	MGC07-F06	MGC	W01C036L11	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC035727	MGC07-F06	MGC	W01C036L12	pDONR221	794		LIX1L	128077	AAH35727.1	Hs.632435	Lix1 homolog (mouse)-like			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_153713.1	NP_714924.1	PROVISIONAL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	BC033882	MGC07-F07	MGC	W01C036L13	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC033882	MGC07-F07	MGC	W01C036L14	pDONR221	9632		SPEM1	374768	AAH33882.1	Hs.710599	Spermatid maturation 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_199339.2	NP_955371.2	PROVISIONAL	OK	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC036790	MGC07-F08	MGC	W01C036L15	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036790	MGC07-F08	MGC	W01C036L16	pDONR221	15988		CRYBB1	1414	AAH36790.1	Hs.37135	Crystallin, beta B1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001887.3	NP_001878.1	REVIEWED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC036817	MGC07-F09	MGC	W01C036L17	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC036817	MGC07-F09	MGC	W01C036L18	pDONR221	21116		FKBP6	8468	AAH36817.1	Hs.661266	FK506 binding protein 6, 36kDa			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_003602.3	NP_003593.3	REVIEWED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC038233	MGC07-F10	MGC	W01C036L19	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC038233	MGC07-F10	MGC	W01C036L20	pDONR221	18834		PSD2	84249	AAH38233.1	Hs.21963	Pleckstrin and Sec7 domain containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032289.2	NP_115665.1	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC035837	MGC07-F11	MGC	W01C036L21	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC035837	MGC07-F11	MGC	W01C036L22	pDONR221	12652		HAS1	3036	AAH35837.1	Hs.57697	Hyaluronan synthase 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001523.2	NP_001514.2	REVIEWED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BC041092	MGC07-F12	MGC	W01C036L23	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC041092	MGC07-F12	MGC	W01C036L24	pDONR221	3120		RUFY2	55680	AAH41092.1	Hs.653144	RUN and FYVE domain containing 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001042417.1	NP_001035882.1	VALIDATED	P	1.000	1.000	387	1164	1	1161	403	17	403
IKAKEN	BC035744	MGC07-G01	MGC	W01C036M01	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC035744	MGC07-G01	MGC	W01C036M02	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC041118	MGC07-G02	MGC	W01C036M03	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC041118	MGC07-G02	MGC	W01C036M04	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC046248	MGC07-G03	MGC	W01C036M05	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046248	MGC07-G03	MGC	W01C036M06	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046247	MGC07-G04	MGC	W01C036M07	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	MGC07-G04	MGC	W01C036M08	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039888	MGC07-G05	MGC	W01C036M09	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039888	MGC07-G05	MGC	W01C036M10	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039011	MGC07-G06	MGC	W01C036M11	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039011	MGC07-G06	MGC	W01C036M12	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039905	MGC07-G07	MGC	W01C036M13	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC039905	MGC07-G07	MGC	W01C036M14	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC038094	MGC07-G08	MGC	W01C036M15	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038094	MGC07-G08	MGC	W01C036M16	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038978	MGC07-G09	MGC	W01C036M17	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC038978	MGC07-G09	MGC	W01C036M18	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC041130	MGC07-G10	MGC	W01C036M19	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC041130	MGC07-G10	MGC	W01C036M20	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC038836	MGC07-G11	MGC	W01C036M21	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC038836	MGC07-G11	MGC	W01C036M22	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC039899	MGC07-G12	MGC	W01C036M23	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC039899	MGC07-G12	MGC	W01C036M24	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC035744	MGC07-G01	MGC	W01C036N01	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC035744	MGC07-G01	MGC	W01C036N02	pDONR221	7782		CTDSPL2	51496	AAH35744.1	Hs.497967	CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase like 2			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_016396.2	NP_057480.2	VALIDATED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	BC041118	MGC07-G02	MGC	W01C036N03	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC041118	MGC07-G02	MGC	W01C036N04	pDONR221	4462		KIAA1826	84437	AAH41118.1	Hs.266782	KIAA1826			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_032424.1	NP_115800.1	VALIDATED	Pfs	0.978	1.000	135	402	3	400	345	113	247
IKAKEN	BC046248	MGC07-G03	MGC	W01C036N05	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046248	MGC07-G03	MGC	W01C036N06	pDONR221	24886		CXorf67	340602	AAH46248.1	Hs.97053	Chromosome X open reading frame 67			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_203407.1	NP_981952.1	PREDICTED	C	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC046247	MGC07-G04	MGC	W01C036N07	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC046247	MGC07-G04	MGC	W01C036N08	pDONR221	8109		CHSY1	22856	AAH46247.1	Hs.110488	Chondroitin sulfate synthase 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_014918.3	NP_055733.2	VALIDATED	C	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	BC039888	MGC07-G05	MGC	W01C036N09	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039888	MGC07-G05	MGC	W01C036N10	pDONR221	24314		PRKACG	5568	AAH39888.1	Hs.158029	Protein kinase, cAMP-dependent, catalytic, gamma			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_002732.3	NP_002723.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC039011	MGC07-G06	MGC	W01C036N11	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039011	MGC07-G06	MGC	W01C036N12	pDONR221	10727		CLEC10A	10462	AAH39011.1	Hs.54403	C-type lectin domain family 10, member A			Testis	NIH_MGC_97	DH10B	NM_182906.2	NP_878910.1	REVIEWED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC039905	MGC07-G07	MGC	W01C036N13	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC039905	MGC07-G07	MGC	W01C036N14	pDONR221	6556		TPP2	7174	AAH39905.1	Hs.432424	Tripeptidyl peptidase II			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003291.2	NP_003282.2	REVIEWED	OK	1.000	1.000	1249	3750	1	3747	1249	1	1249
IKAKEN	BC038094	MGC07-G08	MGC	W01C036N15	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038094	MGC07-G08	MGC	W01C036N16	pDONR221	10358		IFT20	90410	AAH38094.1	Hs.705431	Intraflagellar transport 20 homolog (Chlamydomonas)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_174887.2	NP_777547.1	PROVISIONAL	Cfs	0.736	1.000	148	399	1	326	148	1	148
IKAKEN	BC038978	MGC07-G09	MGC	W01C036N17	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC038978	MGC07-G09	MGC	W01C036N18	pDONR221	3221		CALY	50632	AAH38978.1	Hs.148680	Calcyon neuron-specific vesicular protein			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015722.3	NP_056537.1	VALIDATED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC041130	MGC07-G10	MGC	W01C036N19	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC041130	MGC07-G10	MGC	W01C036N20	pDONR221	11363		FCHO1	23149	AAH41130.1	Hs.96485	FCH domain only 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015122.1	NP_055937.1	PROVISIONAL	Cgs	0.984	0.999	902	2709	1	2706	889	1	889
IKAKEN	BC038836	MGC07-G11	MGC	W01C036N21	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC038836	MGC07-G11	MGC	W01C036N22	pDONR221	5601		C12orf60	144608	AAH38836.1	Hs.659951	Chromosome 12 open reading frame 60			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175874.3	NP_787070.2	VALIDATED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC039899	MGC07-G12	MGC	W01C036N23	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC039899	MGC07-G12	MGC	W01C036N24	pDONR221	20401		SLC22A2	6582	AAH39899.1	Hs.436385	Solute carrier family 22 (organic cation transporter), member 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_003058.2	NP_003049.1	REVIEWED	Cs	0.998	0.998	555	1668	1	1665	555	1	555
IKAKEN	BC041120	MGC07-H01	MGC	W01C036O01	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC041120	MGC07-H01	MGC	W01C036O02	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC038970	MGC07-H02	MGC	W01C036O03	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC038970	MGC07-H02	MGC	W01C036O04	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC040076	MGC07-H03	MGC	W01C036O05	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC040076	MGC07-H03	MGC	W01C036O06	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC042191	MGC07-H04	MGC	W01C036O07	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC042191	MGC07-H04	MGC	W01C036O08	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC067362	MGC07-H05	MGC	W01C036O09	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC067362	MGC07-H05	MGC	W01C036O10	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039600	MGC07-H06	MGC	W01C036O11	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC039600	MGC07-H06	MGC	W01C036O12	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC042297	MGC07-H07	MGC	W01C036O13	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC042297	MGC07-H07	MGC	W01C036O14	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC039856	MGC07-H08	MGC	W01C036O15	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	MGC07-H08	MGC	W01C036O16	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039833	MGC07-H09	MGC	W01C036O17	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039833	MGC07-H09	MGC	W01C036O18	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039844	MGC07-H10	MGC	W01C036O19	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	MGC07-H10	MGC	W01C036O20	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC041167	MGC07-H11	MGC	W01C036O21	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC041167	MGC07-H11	MGC	W01C036O22	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC039608	MGC07-H12	MGC	W01C036O23	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC039608	MGC07-H12	MGC	W01C036O24	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC041120	MGC07-H01	MGC	W01C036P01	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC041120	MGC07-H01	MGC	W01C036P02	pDONR221	978		GALNT2	2590	AAH41120.1	Hs.716384	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 2 (GalNAc-T2)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004481.3	NP_004472.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC038970	MGC07-H02	MGC	W01C036P03	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC038970	MGC07-H02	MGC	W01C036P04	pDONR221	7172		TPPP2	122664	AAH38970.1	Hs.406966	Tubulin polymerization-promoting protein family member 2			Testis	NIH_MGC_97	DH10B	NM_173846.4	NP_776245.2	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC040076	MGC07-H03	MGC	W01C036P05	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC040076	MGC07-H03	MGC	W01C036P06	pDONR221	164		RHOU	58480	AAH40076.1	Hs.647774	Ras homolog gene family, member U			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_021205.4	NP_067028.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC042191	MGC07-H04	MGC	W01C036P07	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC042191	MGC07-H04	MGC	W01C036P08	pDONR221	16331		DTX3L	151636	AAH42191.1	Hs.518201	Deltex 3-like (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_138287.3	NP_612144.1	VALIDATED	OK	1.000	1.000	740	2223	1	2220	740	1	740
IKAKEN	BC067362	MGC07-H05	MGC	W01C036P09	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC067362	MGC07-H05	MGC	W01C036P10	pDONR221	15098		SAMD10	140700	AAH67362.1	Hs.27189	Sterile alpha motif domain containing 10			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_080621.4	NP_542188.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039600	MGC07-H06	MGC	W01C036P11	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC039600	MGC07-H06	MGC	W01C036P12	pDONR221	3125		HERC4	26091	AAH39600.1	Hs.51891	Hect domain and RLD 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_015601.3	NP_056416.2	VALIDATED	OK	1.000	1.000	1049	3150	1	3147	1049	1	1049
IKAKEN	BC042297	MGC07-H07	MGC	W01C036P13	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC042297	MGC07-H07	MGC	W01C036P14	pDONR221	10732		UBTF	7343	AAH42297.1	Hs.89781	Upstream binding transcription factor, RNA polymerase I			Testis	NIH_MGC_97	DH10B	NM_001076683.1	NP_001070151.1	VALIDATED		0.500	0.500	12	360	68	103	727	621	632
IKAKEN	BC039856	MGC07-H08	MGC	W01C036P15	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	MGC07-H08	MGC	W01C036P16	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039833	MGC07-H09	MGC	W01C036P17	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039833	MGC07-H09	MGC	W01C036P18	pDONR221	19110		RNF44	22838	AAH39833.1	Hs.434888	Ring finger protein 44			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_014901.4	NP_055716.1	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC039844	MGC07-H10	MGC	W01C036P19	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC039844	MGC07-H10	MGC	W01C036P20	pDONR221	3438		RBP3	5949	AAH39844.1	Hs.591928	Retinol binding protein 3, interstitial			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_002900.2	NP_002891.1	REVIEWED	OK	1.000	1.000	1247	3744	1	3741	1247	1	1247
IKAKEN	BC041167	MGC07-H11	MGC	W01C036P21	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC041167	MGC07-H11	MGC	W01C036P22	pDONR221	17425		TBC1D14	57533	AAH41167.1	Hs.518611	TBC1 domain family, member 14			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001113361.1	NP_001106832.1	VALIDATED	P	1.000	1.000	678	2037	1	2034	693	16	693
IKAKEN	BC039608	MGC07-H12	MGC	W01C036P23	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC039608	MGC07-H12	MGC	W01C036P24	pDONR221	9150		SPATA2L	124044	AAH39608.1	Hs.374556	Spermatogenesis associated 2-like			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_152339.2	NP_689552.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC039593	MGC08-A01	MGC	W01C037A01	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC039593	MGC08-A01	MGC	W01C037A02	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC041709	MGC08-A02	MGC	W01C037A03	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC041709	MGC08-A02	MGC	W01C037A04	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC040431	MGC08-A03	MGC	W01C037A05	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040431	MGC08-A03	MGC	W01C037A06	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040442	MGC08-A04	MGC	W01C037A07	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC040442	MGC08-A04	MGC	W01C037A08	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC039862	MGC08-A05	MGC	W01C037A09	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039862	MGC08-A05	MGC	W01C037A10	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039586	MGC08-A06	MGC	W01C037A11	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039586	MGC08-A06	MGC	W01C037A12	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039829	MGC08-A07	MGC	W01C037A13	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039829	MGC08-A07	MGC	W01C037A14	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039849	MGC08-A08	MGC	W01C037A15	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039849	MGC08-A08	MGC	W01C037A16	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039576	MGC08-A09	MGC	W01C037A17	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039576	MGC08-A09	MGC	W01C037A18	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039594	MGC08-A10	MGC	W01C037A19	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039594	MGC08-A10	MGC	W01C037A20	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039828	MGC08-A11	MGC	W01C037A21	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039828	MGC08-A11	MGC	W01C037A22	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039582	MGC08-A12	MGC	W01C037A23	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC039582	MGC08-A12	MGC	W01C037A24	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC039593	MGC08-A01	MGC	W01C037B01	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC039593	MGC08-A01	MGC	W01C037B02	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC041709	MGC08-A02	MGC	W01C037B03	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC041709	MGC08-A02	MGC	W01C037B04	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC040431	MGC08-A03	MGC	W01C037B05	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040431	MGC08-A03	MGC	W01C037B06	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040442	MGC08-A04	MGC	W01C037B07	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC040442	MGC08-A04	MGC	W01C037B08	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC039862	MGC08-A05	MGC	W01C037B09	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039862	MGC08-A05	MGC	W01C037B10	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039586	MGC08-A06	MGC	W01C037B11	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039586	MGC08-A06	MGC	W01C037B12	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039829	MGC08-A07	MGC	W01C037B13	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039829	MGC08-A07	MGC	W01C037B14	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039849	MGC08-A08	MGC	W01C037B15	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039849	MGC08-A08	MGC	W01C037B16	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039576	MGC08-A09	MGC	W01C037B17	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039576	MGC08-A09	MGC	W01C037B18	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039594	MGC08-A10	MGC	W01C037B19	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039594	MGC08-A10	MGC	W01C037B20	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039828	MGC08-A11	MGC	W01C037B21	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039828	MGC08-A11	MGC	W01C037B22	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039582	MGC08-A12	MGC	W01C037B23	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC039582	MGC08-A12	MGC	W01C037B24	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC067084	MGC08-B01	MGC	W01C037C01	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	MGC08-B01	MGC	W01C037C02	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC039669	MGC08-B02	MGC	W01C037C03	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC039669	MGC08-B02	MGC	W01C037C04	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC040732	MGC08-B03	MGC	W01C037C05	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC040732	MGC08-B03	MGC	W01C037C06	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC043386	MGC08-B04	MGC	W01C037C07	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043386	MGC08-B04	MGC	W01C037C08	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043564	MGC08-B05	MGC	W01C037C09	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043564	MGC08-B05	MGC	W01C037C10	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043584	MGC08-B06	MGC	W01C037C11	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC043584	MGC08-B06	MGC	W01C037C12	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC040859	MGC08-B07	MGC	W01C037C13	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC040859	MGC08-B07	MGC	W01C037C14	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC039562	MGC08-B08	MGC	W01C037C15	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039562	MGC08-B08	MGC	W01C037C16	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC042083	MGC08-B09	MGC	W01C037C17	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042083	MGC08-B09	MGC	W01C037C18	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042054	MGC08-B10	MGC	W01C037C19	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	MGC08-B10	MGC	W01C037C20	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC044226	MGC08-B11	MGC	W01C037C21	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	MGC08-B11	MGC	W01C037C22	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC052750	MGC08-B12	MGC	W01C037C23	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC052750	MGC08-B12	MGC	W01C037C24	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC067084	MGC08-B01	MGC	W01C037D01	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	MGC08-B01	MGC	W01C037D02	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC039669	MGC08-B02	MGC	W01C037D03	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC039669	MGC08-B02	MGC	W01C037D04	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC040732	MGC08-B03	MGC	W01C037D05	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC040732	MGC08-B03	MGC	W01C037D06	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC043386	MGC08-B04	MGC	W01C037D07	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043386	MGC08-B04	MGC	W01C037D08	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043564	MGC08-B05	MGC	W01C037D09	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043564	MGC08-B05	MGC	W01C037D10	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043584	MGC08-B06	MGC	W01C037D11	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC043584	MGC08-B06	MGC	W01C037D12	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC040859	MGC08-B07	MGC	W01C037D13	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC040859	MGC08-B07	MGC	W01C037D14	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC039562	MGC08-B08	MGC	W01C037D15	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039562	MGC08-B08	MGC	W01C037D16	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC042083	MGC08-B09	MGC	W01C037D17	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042083	MGC08-B09	MGC	W01C037D18	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042054	MGC08-B10	MGC	W01C037D19	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	MGC08-B10	MGC	W01C037D20	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC044226	MGC08-B11	MGC	W01C037D21	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	MGC08-B11	MGC	W01C037D22	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC052750	MGC08-B12	MGC	W01C037D23	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC052750	MGC08-B12	MGC	W01C037D24	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC043345	MGC08-C01	MGC	W01C037E01	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	MGC08-C01	MGC	W01C037E02	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	MGC08-C02	MGC	W01C037E03	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	MGC08-C02	MGC	W01C037E04	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC065482	MGC08-C03	MGC	W01C037E05	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC065482	MGC08-C03	MGC	W01C037E06	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC040053	MGC08-C04	MGC	W01C037E07	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC040053	MGC08-C04	MGC	W01C037E08	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC044254	MGC08-C05	MGC	W01C037E09	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC044254	MGC08-C05	MGC	W01C037E10	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC047949	MGC08-C06	MGC	W01C037E11	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC047949	MGC08-C06	MGC	W01C037E12	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC044216	MGC08-C07	MGC	W01C037E13	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC044216	MGC08-C07	MGC	W01C037E14	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC040050	MGC08-C08	MGC	W01C037E15	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC040050	MGC08-C08	MGC	W01C037E16	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC044233	MGC08-C09	MGC	W01C037E17	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC044233	MGC08-C09	MGC	W01C037E18	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC056402	MGC08-C10	MGC	W01C037E19	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC056402	MGC08-C10	MGC	W01C037E20	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC040035	MGC08-C11	MGC	W01C037E21	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC040035	MGC08-C11	MGC	W01C037E22	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC046357	MGC08-C12	MGC	W01C037E23	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC046357	MGC08-C12	MGC	W01C037E24	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC043345	MGC08-C01	MGC	W01C037F01	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	MGC08-C01	MGC	W01C037F02	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	MGC08-C02	MGC	W01C037F03	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	MGC08-C02	MGC	W01C037F04	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC065482	MGC08-C03	MGC	W01C037F05	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC065482	MGC08-C03	MGC	W01C037F06	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC040053	MGC08-C04	MGC	W01C037F07	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC040053	MGC08-C04	MGC	W01C037F08	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC044254	MGC08-C05	MGC	W01C037F09	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC044254	MGC08-C05	MGC	W01C037F10	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC047949	MGC08-C06	MGC	W01C037F11	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC047949	MGC08-C06	MGC	W01C037F12	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC044216	MGC08-C07	MGC	W01C037F13	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC044216	MGC08-C07	MGC	W01C037F14	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC040050	MGC08-C08	MGC	W01C037F15	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC040050	MGC08-C08	MGC	W01C037F16	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC044233	MGC08-C09	MGC	W01C037F17	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC044233	MGC08-C09	MGC	W01C037F18	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC056402	MGC08-C10	MGC	W01C037F19	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC056402	MGC08-C10	MGC	W01C037F20	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC040035	MGC08-C11	MGC	W01C037F21	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC040035	MGC08-C11	MGC	W01C037F22	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC046357	MGC08-C12	MGC	W01C037F23	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC046357	MGC08-C12	MGC	W01C037F24	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC047935	MGC08-D01	MGC	W01C037G01	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	MGC08-D01	MGC	W01C037G02	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC049388	MGC08-D02	MGC	W01C037G03	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC049388	MGC08-D02	MGC	W01C037G04	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC053521	MGC08-D04	MGC	W01C037G07	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	MGC08-D04	MGC	W01C037G08	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC047023	MGC08-D05	MGC	W01C037G09	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC047023	MGC08-D05	MGC	W01C037G10	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC048806	MGC08-D06	MGC	W01C037G11	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC048806	MGC08-D06	MGC	W01C037G12	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC047013	MGC08-D07	MGC	W01C037G13	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC047013	MGC08-D07	MGC	W01C037G14	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC048255	MGC08-D08	MGC	W01C037G15	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC048255	MGC08-D08	MGC	W01C037G16	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC049207	MGC08-D09	MGC	W01C037G17	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC049207	MGC08-D09	MGC	W01C037G18	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC047024	MGC08-D10	MGC	W01C037G19	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047024	MGC08-D10	MGC	W01C037G20	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047318	MGC08-D11	MGC	W01C037G21	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC047318	MGC08-D11	MGC	W01C037G22	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC062298	MGC08-D12	MGC	W01C037G23	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC062298	MGC08-D12	MGC	W01C037G24	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC047935	MGC08-D01	MGC	W01C037H01	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	MGC08-D01	MGC	W01C037H02	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC049388	MGC08-D02	MGC	W01C037H03	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC049388	MGC08-D02	MGC	W01C037H04	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC053521	MGC08-D04	MGC	W01C037H07	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	MGC08-D04	MGC	W01C037H08	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC047023	MGC08-D05	MGC	W01C037H09	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC047023	MGC08-D05	MGC	W01C037H10	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC048806	MGC08-D06	MGC	W01C037H11	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC048806	MGC08-D06	MGC	W01C037H12	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC047013	MGC08-D07	MGC	W01C037H13	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC047013	MGC08-D07	MGC	W01C037H14	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC048255	MGC08-D08	MGC	W01C037H15	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC048255	MGC08-D08	MGC	W01C037H16	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC049207	MGC08-D09	MGC	W01C037H17	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC049207	MGC08-D09	MGC	W01C037H18	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC047024	MGC08-D10	MGC	W01C037H19	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047024	MGC08-D10	MGC	W01C037H20	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047318	MGC08-D11	MGC	W01C037H21	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC047318	MGC08-D11	MGC	W01C037H22	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC062298	MGC08-D12	MGC	W01C037H23	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC062298	MGC08-D12	MGC	W01C037H24	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC048282	MGC08-E01	MGC	W01C037I01	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC048282	MGC08-E01	MGC	W01C037I02	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC047690	MGC08-E02	MGC	W01C037I03	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC047690	MGC08-E02	MGC	W01C037I04	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC050462	MGC08-E03	MGC	W01C037I05	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	MGC08-E03	MGC	W01C037I06	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC047726	MGC08-E04	MGC	W01C037I07	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC047726	MGC08-E04	MGC	W01C037I08	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC050453	MGC08-E05	MGC	W01C037I09	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC050453	MGC08-E05	MGC	W01C037I10	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC047705	MGC08-E06	MGC	W01C037I11	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC047705	MGC08-E06	MGC	W01C037I12	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC050373	MGC08-E07	MGC	W01C037I13	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC050373	MGC08-E07	MGC	W01C037I14	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC047752	MGC08-E08	MGC	W01C037I15	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC047752	MGC08-E08	MGC	W01C037I16	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC050452	MGC08-E09	MGC	W01C037I17	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050452	MGC08-E09	MGC	W01C037I18	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050389	MGC08-E10	MGC	W01C037I19	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050389	MGC08-E10	MGC	W01C037I20	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050445	MGC08-E12	MGC	W01C037I23	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC050445	MGC08-E12	MGC	W01C037I24	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC048282	MGC08-E01	MGC	W01C037J01	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC048282	MGC08-E01	MGC	W01C037J02	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC047690	MGC08-E02	MGC	W01C037J03	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC047690	MGC08-E02	MGC	W01C037J04	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC050462	MGC08-E03	MGC	W01C037J05	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	MGC08-E03	MGC	W01C037J06	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC047726	MGC08-E04	MGC	W01C037J07	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC047726	MGC08-E04	MGC	W01C037J08	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC050453	MGC08-E05	MGC	W01C037J09	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC050453	MGC08-E05	MGC	W01C037J10	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC047705	MGC08-E06	MGC	W01C037J11	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC047705	MGC08-E06	MGC	W01C037J12	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC050373	MGC08-E07	MGC	W01C037J13	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC050373	MGC08-E07	MGC	W01C037J14	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC047752	MGC08-E08	MGC	W01C037J15	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC047752	MGC08-E08	MGC	W01C037J16	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC050452	MGC08-E09	MGC	W01C037J17	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050452	MGC08-E09	MGC	W01C037J18	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050389	MGC08-E10	MGC	W01C037J19	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050389	MGC08-E10	MGC	W01C037J20	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050445	MGC08-E12	MGC	W01C037J23	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC050445	MGC08-E12	MGC	W01C037J24	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC046190	MGC08-F01	MGC	W01C037K01	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC046190	MGC08-F01	MGC	W01C037K02	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC050529	MGC08-F02	MGC	W01C037K03	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC050529	MGC08-F02	MGC	W01C037K04	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC054500	MGC08-F03	MGC	W01C037K05	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	MGC08-F03	MGC	W01C037K06	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC050553	MGC08-F04	MGC	W01C037K07	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC050553	MGC08-F04	MGC	W01C037K08	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC046200	MGC08-F05	MGC	W01C037K09	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046200	MGC08-F05	MGC	W01C037K10	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046145	MGC08-F06	MGC	W01C037K11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	MGC08-F06	MGC	W01C037K12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC050550	MGC08-F07	MGC	W01C037K13	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC050550	MGC08-F07	MGC	W01C037K14	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC046173	MGC08-F08	MGC	W01C037K15	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC046173	MGC08-F08	MGC	W01C037K16	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC051805	MGC08-F09	MGC	W01C037K17	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC051805	MGC08-F09	MGC	W01C037K18	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC060668	MGC08-F10	MGC	W01C037K19	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	MGC08-F10	MGC	W01C037K20	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC050557	MGC08-F11	MGC	W01C037K21	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC050557	MGC08-F11	MGC	W01C037K22	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC064511	MGC08-F12	MGC	W01C037K23	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC064511	MGC08-F12	MGC	W01C037K24	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC046190	MGC08-F01	MGC	W01C037L01	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC046190	MGC08-F01	MGC	W01C037L02	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC050529	MGC08-F02	MGC	W01C037L03	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC050529	MGC08-F02	MGC	W01C037L04	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC054500	MGC08-F03	MGC	W01C037L05	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	MGC08-F03	MGC	W01C037L06	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC050553	MGC08-F04	MGC	W01C037L07	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC050553	MGC08-F04	MGC	W01C037L08	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC046200	MGC08-F05	MGC	W01C037L09	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046200	MGC08-F05	MGC	W01C037L10	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046145	MGC08-F06	MGC	W01C037L11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	MGC08-F06	MGC	W01C037L12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC050550	MGC08-F07	MGC	W01C037L13	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC050550	MGC08-F07	MGC	W01C037L14	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC046173	MGC08-F08	MGC	W01C037L15	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC046173	MGC08-F08	MGC	W01C037L16	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC051805	MGC08-F09	MGC	W01C037L17	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC051805	MGC08-F09	MGC	W01C037L18	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC060668	MGC08-F10	MGC	W01C037L19	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	MGC08-F10	MGC	W01C037L20	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC050557	MGC08-F11	MGC	W01C037L21	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC050557	MGC08-F11	MGC	W01C037L22	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC064511	MGC08-F12	MGC	W01C037L23	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC064511	MGC08-F12	MGC	W01C037L24	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC050588	MGC08-G01	MGC	W01C037M01	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC050588	MGC08-G01	MGC	W01C037M02	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC054503	MGC08-G02	MGC	W01C037M03	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC054503	MGC08-G02	MGC	W01C037M04	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC050659	MGC08-G03	MGC	W01C037M05	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050659	MGC08-G03	MGC	W01C037M06	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050629	MGC08-G04	MGC	W01C037M07	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC050629	MGC08-G04	MGC	W01C037M08	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC051826	MGC08-G05	MGC	W01C037M09	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC051826	MGC08-G05	MGC	W01C037M10	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC057395	MGC08-G06	MGC	W01C037M11	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC057395	MGC08-G06	MGC	W01C037M12	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC051896	MGC08-G07	MGC	W01C037M13	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC051896	MGC08-G07	MGC	W01C037M14	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC052990	MGC08-G08	MGC	W01C037M15	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC052990	MGC08-G08	MGC	W01C037M16	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC051851	MGC08-G09	MGC	W01C037M17	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC051851	MGC08-G09	MGC	W01C037M18	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC050728	MGC08-G10	MGC	W01C037M19	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC050728	MGC08-G10	MGC	W01C037M20	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC051911	MGC08-G11	MGC	W01C037M21	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC051911	MGC08-G11	MGC	W01C037M22	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC063242	MGC08-G12	MGC	W01C037M23	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	MGC08-G12	MGC	W01C037M24	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC050588	MGC08-G01	MGC	W01C037N01	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC050588	MGC08-G01	MGC	W01C037N02	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC054503	MGC08-G02	MGC	W01C037N03	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC054503	MGC08-G02	MGC	W01C037N04	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC050659	MGC08-G03	MGC	W01C037N05	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050659	MGC08-G03	MGC	W01C037N06	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050629	MGC08-G04	MGC	W01C037N07	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC050629	MGC08-G04	MGC	W01C037N08	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC051826	MGC08-G05	MGC	W01C037N09	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC051826	MGC08-G05	MGC	W01C037N10	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC057395	MGC08-G06	MGC	W01C037N11	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC057395	MGC08-G06	MGC	W01C037N12	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC051896	MGC08-G07	MGC	W01C037N13	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC051896	MGC08-G07	MGC	W01C037N14	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC052990	MGC08-G08	MGC	W01C037N15	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC052990	MGC08-G08	MGC	W01C037N16	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC051851	MGC08-G09	MGC	W01C037N17	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC051851	MGC08-G09	MGC	W01C037N18	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC050728	MGC08-G10	MGC	W01C037N19	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC050728	MGC08-G10	MGC	W01C037N20	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC051911	MGC08-G11	MGC	W01C037N21	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC051911	MGC08-G11	MGC	W01C037N22	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC063242	MGC08-G12	MGC	W01C037N23	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	MGC08-G12	MGC	W01C037N24	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC053642	MGC08-H01	MGC	W01C037O01	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053642	MGC08-H01	MGC	W01C037O02	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053562	MGC08-H02	MGC	W01C037O03	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC053562	MGC08-H02	MGC	W01C037O04	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC054002	MGC08-H03	MGC	W01C037O05	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	MGC08-H03	MGC	W01C037O06	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC053610	MGC08-H04	MGC	W01C037O07	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053610	MGC08-H04	MGC	W01C037O08	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053634	MGC08-H05	MGC	W01C037O09	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053634	MGC08-H05	MGC	W01C037O10	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053859	MGC08-H06	MGC	W01C037O11	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053859	MGC08-H06	MGC	W01C037O12	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053578	MGC08-H07	MGC	W01C037O13	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053578	MGC08-H07	MGC	W01C037O14	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053877	MGC08-H08	MGC	W01C037O15	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053877	MGC08-H08	MGC	W01C037O16	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053903	MGC08-H09	MGC	W01C037O17	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053903	MGC08-H09	MGC	W01C037O18	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053856	MGC08-H10	MGC	W01C037O19	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053856	MGC08-H10	MGC	W01C037O20	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053660	MGC08-H11	MGC	W01C037O21	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	MGC08-H11	MGC	W01C037O22	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053666	MGC08-H12	MGC	W01C037O23	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC053666	MGC08-H12	MGC	W01C037O24	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC053642	MGC08-H01	MGC	W01C037P01	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053642	MGC08-H01	MGC	W01C037P02	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053562	MGC08-H02	MGC	W01C037P03	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC053562	MGC08-H02	MGC	W01C037P04	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC054002	MGC08-H03	MGC	W01C037P05	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	MGC08-H03	MGC	W01C037P06	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC053610	MGC08-H04	MGC	W01C037P07	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053610	MGC08-H04	MGC	W01C037P08	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053634	MGC08-H05	MGC	W01C037P09	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053634	MGC08-H05	MGC	W01C037P10	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053859	MGC08-H06	MGC	W01C037P11	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053859	MGC08-H06	MGC	W01C037P12	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053578	MGC08-H07	MGC	W01C037P13	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053578	MGC08-H07	MGC	W01C037P14	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053877	MGC08-H08	MGC	W01C037P15	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053877	MGC08-H08	MGC	W01C037P16	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053903	MGC08-H09	MGC	W01C037P17	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053903	MGC08-H09	MGC	W01C037P18	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053856	MGC08-H10	MGC	W01C037P19	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053856	MGC08-H10	MGC	W01C037P20	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053660	MGC08-H11	MGC	W01C037P21	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	MGC08-H11	MGC	W01C037P22	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053666	MGC08-H12	MGC	W01C037P23	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC053666	MGC08-H12	MGC	W01C037P24	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC039593	MGC08-A01	MGC	W01C038A01	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC039593	MGC08-A01	MGC	W01C038A02	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC041709	MGC08-A02	MGC	W01C038A03	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC041709	MGC08-A02	MGC	W01C038A04	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC040431	MGC08-A03	MGC	W01C038A05	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040431	MGC08-A03	MGC	W01C038A06	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040442	MGC08-A04	MGC	W01C038A07	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC040442	MGC08-A04	MGC	W01C038A08	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC039862	MGC08-A05	MGC	W01C038A09	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039862	MGC08-A05	MGC	W01C038A10	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039586	MGC08-A06	MGC	W01C038A11	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039586	MGC08-A06	MGC	W01C038A12	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039829	MGC08-A07	MGC	W01C038A13	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039829	MGC08-A07	MGC	W01C038A14	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039849	MGC08-A08	MGC	W01C038A15	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039849	MGC08-A08	MGC	W01C038A16	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039576	MGC08-A09	MGC	W01C038A17	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039576	MGC08-A09	MGC	W01C038A18	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039594	MGC08-A10	MGC	W01C038A19	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039594	MGC08-A10	MGC	W01C038A20	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039828	MGC08-A11	MGC	W01C038A21	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039828	MGC08-A11	MGC	W01C038A22	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039582	MGC08-A12	MGC	W01C038A23	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC039582	MGC08-A12	MGC	W01C038A24	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC039593	MGC08-A01	MGC	W01C038B01	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC039593	MGC08-A01	MGC	W01C038B02	pDONR221	23452		USP20	10868	AAH39593.1	Hs.5452	Ubiquitin specific peptidase 20			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_001008563.3	NP_001008563.2	VALIDATED	OK	1.000	1.000	914	2745	1	2742	914	1	914
IKAKEN	BC041709	MGC08-A02	MGC	W01C038B03	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC041709	MGC08-A02	MGC	W01C038B04	pDONR221	18814		C5orf41	153222	AAH41709.1	Hs.484195	Chromosome 5 open reading frame 41			Testis	NIH_MGC_97	DH10B	NM_153607.1	NP_705835.1	PROVISIONAL	OK	1.000	1.000	639	1920	1	1917	639	1	639
IKAKEN	BC040431	MGC08-A03	MGC	W01C038B05	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040431	MGC08-A03	MGC	W01C038B06	pDONR221	9998		GAA	2548	AAH40431.1	Hs.1437	Glucosidase, alpha; acid			Testis	NIH_MGC_97	DH10B	NM_001079803.1	NP_001073271.1	REVIEWED	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC040442	MGC08-A04	MGC	W01C038B07	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC040442	MGC08-A04	MGC	W01C038B08	pDONR221	9094		DCUN1D3	123879	AAH40442.1	Hs.101007	DCN1, defective in cullin neddylation 1, domain containing 3 (S. cerevisiae)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_173475.2	NP_775746.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC039862	MGC08-A05	MGC	W01C038B09	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039862	MGC08-A05	MGC	W01C038B10	pDONR221	7966		ODF3L1	161753	AAH39862.1	Hs.144348	Outer dense fiber of sperm tails 3-like 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_175881.3	NP_787077.1	PROVISIONAL	OK	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC039586	MGC08-A06	MGC	W01C038B11	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039586	MGC08-A06	MGC	W01C038B12	pDONR221	6440		KIAA1704	55425	AAH39586.1	Hs.507922	KIAA1704			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_018559.2	NP_061029.2	PREDICTED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC039829	MGC08-A07	MGC	W01C038B13	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039829	MGC08-A07	MGC	W01C038B14	pDONR221	6704		INTS6	26512	AAH39829.1	Hs.439440	Integrator complex subunit 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012141.2	NP_036273.1	REVIEWED	OK	1.000	1.000	887	2664	1	2661	887	1	887
IKAKEN	BC039849	MGC08-A08	MGC	W01C038B15	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039849	MGC08-A08	MGC	W01C038B16	pDONR221	11943		GPX4	2879	AAH39849.1	Hs.433951	Glutathione peroxidase 4 (phospholipid hydroperoxidase)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002085.3	NP_002076.2	REVIEWED	Cfs	0.995	1.000	197	594	1	591	196	1	196
IKAKEN	BC039576	MGC08-A09	MGC	W01C038B17	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039576	MGC08-A09	MGC	W01C038B18	pDONR221	13325		ABHD1	84696	AAH39576.2	Hs.375791	Abhydrolase domain containing 1			Testis	NIH_MGC_97	DH10B	NM_032604.3	NP_115993.3	REVIEWED	Cs	0.998	0.998	405	1218	1	1215	405	1	405
IKAKEN	BC039594	MGC08-A10	MGC	W01C038B19	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039594	MGC08-A10	MGC	W01C038B20	pDONR221	21077		ARPC1A	10552	AAH39594.2	Hs.124126	Actin related protein 2/3 complex, subunit 1A, 41kDa			Brain, adult medulla	NIH_MGC_119	DH10B	NM_006409.2	NP_006400.2	REVIEWED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC039828	MGC08-A11	MGC	W01C038B21	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039828	MGC08-A11	MGC	W01C038B22	pDONR221	14029		SMC6	79677	AAH39828.1	Hs.526728	Structural maintenance of chromosomes 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001142286.1	NP_001135758.1	VALIDATED	OK	1.000	1.000	1091	3276	1	3273	1091	1	1091
IKAKEN	BC039582	MGC08-A12	MGC	W01C038B23	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC039582	MGC08-A12	MGC	W01C038B24	pDONR221	9748		DNAI2	64446	AAH39582.1	Hs.147472	Dynein, axonemal, intermediate chain 2			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_023036.3	NP_075462.3	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC067084	MGC08-B01	MGC	W01C038C01	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	MGC08-B01	MGC	W01C038C02	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC039669	MGC08-B02	MGC	W01C038C03	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC039669	MGC08-B02	MGC	W01C038C04	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC040732	MGC08-B03	MGC	W01C038C05	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC040732	MGC08-B03	MGC	W01C038C06	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC043386	MGC08-B04	MGC	W01C038C07	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043386	MGC08-B04	MGC	W01C038C08	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043564	MGC08-B05	MGC	W01C038C09	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043564	MGC08-B05	MGC	W01C038C10	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043584	MGC08-B06	MGC	W01C038C11	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC043584	MGC08-B06	MGC	W01C038C12	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC040859	MGC08-B07	MGC	W01C038C13	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC040859	MGC08-B07	MGC	W01C038C14	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC039562	MGC08-B08	MGC	W01C038C15	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039562	MGC08-B08	MGC	W01C038C16	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC042083	MGC08-B09	MGC	W01C038C17	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042083	MGC08-B09	MGC	W01C038C18	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042054	MGC08-B10	MGC	W01C038C19	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	MGC08-B10	MGC	W01C038C20	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC044226	MGC08-B11	MGC	W01C038C21	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	MGC08-B11	MGC	W01C038C22	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC052750	MGC08-B12	MGC	W01C038C23	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC052750	MGC08-B12	MGC	W01C038C24	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC067084	MGC08-B01	MGC	W01C038D01	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC067084	MGC08-B01	MGC	W01C038D02	pDONR221	10500		UNC13D	201294	AAH67084.1	Hs.41045	Unc-13 homolog D (C. elegans)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_199242.2	NP_954712.1	REVIEWED	OK	1.000	1.000	1090	3273	1	3270	1090	1	1090
IKAKEN	BC039669	MGC08-B02	MGC	W01C038D03	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC039669	MGC08-B02	MGC	W01C038D04	pDONR221	4128		C11orf53	341032	AAH39669.1	Hs.298685	Chromosome 11 open reading frame 53			Brain, adult medulla	NIH_MGC_119	DH10B	NM_198498.1	NP_940900.1	PREDICTED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC040732	MGC08-B03	MGC	W01C038D05	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC040732	MGC08-B03	MGC	W01C038D06	pDONR221	16941		LRTM1	57408	AAH40732.1	Hs.591668	Leucine-rich repeats and transmembrane domains 1			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_020678.2	NP_065729.1	PROVISIONAL	OK	1.000	1.000	345	1038	1	1035	345	1	345
IKAKEN	BC043386	MGC08-B04	MGC	W01C038D07	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043386	MGC08-B04	MGC	W01C038D08	pDONR221	11981		C19orf68	374920	AAH43386.1	Hs.664054	Chromosome 19 open reading frame 68			Brain, hippocampus	NIH_MGC_95	DH10B	XM_001713771.1	XP_001713823.1	MODEL	Pfs	1.000	1.000	628	1884	1	1883	632	1	628
IKAKEN	BC043564	MGC08-B05	MGC	W01C038D09	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043564	MGC08-B05	MGC	W01C038D10	pDONR221	2216		KCNA2	3737	AAH43564.1	Hs.657199	Potassium voltage-gated channel, shaker-related subfamily, member 2			Testis	NIH_MGC_97	DH10B	NM_004974.2	NP_004965.1	REVIEWED		0.947	0.953	320	1071	1	954	499	1	320
IKAKEN	BC043584	MGC08-B06	MGC	W01C038D11	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC043584	MGC08-B06	MGC	W01C038D12	pDONR221	14310		C2orf27B	408029	AAH43584.1	Hs.145567	Chromosome 2 open reading frame 27B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_214461.1	NP_999626.1	PREDICTED	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC040859	MGC08-B07	MGC	W01C038D13	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC040859	MGC08-B07	MGC	W01C038D14	pDONR221	15933		C22orf30	253143	AAH40859.1	Hs.438906	Chromosome 22 open reading frame 30			Testis	NIH_MGC_97	DH10B	NM_173566.2	NP_775837.2	VALIDATED		0.908	0.908	238	909	1	714	2151	1848	2085
IKAKEN	BC039562	MGC08-B08	MGC	W01C038D15	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC039562	MGC08-B08	MGC	W01C038D16	pDONR221	9391		C16orf65	255762	AAH39562.1	Hs.98244	Chromosome 16 open reading frame 65			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_173806.2	NP_776167.1	PREDICTED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC042083	MGC08-B09	MGC	W01C038D17	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042083	MGC08-B09	MGC	W01C038D18	pDONR221	5996		TMTC1	83857	AAH42083.1	Hs.401954	Transmembrane and tetratricopeptide repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_175861.2	NP_787057.2	PROVISIONAL	OK	1.000	1.000	774	2325	1	2322	774	1	774
IKAKEN	BC042054	MGC08-B10	MGC	W01C038D19	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC042054	MGC08-B10	MGC	W01C038D20	pDONR221	8175		IGDCC3	9543	AAH42054.1	Hs.128292	Immunoglobulin superfamily, DCC subclass, member 3			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_004884.3	NP_004875.2	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	BC044226	MGC08-B11	MGC	W01C038D21	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	MGC08-B11	MGC	W01C038D22	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC052750	MGC08-B12	MGC	W01C038D23	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC052750	MGC08-B12	MGC	W01C038D24	pDONR221	13539		C2orf62	375307	AAH52750.1	Hs.645453	Chromosome 2 open reading frame 62			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_198559.1	NP_940961.1	PREDICTED	C	1.000	1.000	387	1164	1	1161	387	1	387
IKAKEN	BC043345	MGC08-C01	MGC	W01C038E01	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	MGC08-C01	MGC	W01C038E02	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	MGC08-C02	MGC	W01C038E03	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	MGC08-C02	MGC	W01C038E04	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC065482	MGC08-C03	MGC	W01C038E05	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC065482	MGC08-C03	MGC	W01C038E06	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC040053	MGC08-C04	MGC	W01C038E07	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC040053	MGC08-C04	MGC	W01C038E08	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC044254	MGC08-C05	MGC	W01C038E09	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC044254	MGC08-C05	MGC	W01C038E10	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC047949	MGC08-C06	MGC	W01C038E11	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC047949	MGC08-C06	MGC	W01C038E12	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC044216	MGC08-C07	MGC	W01C038E13	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC044216	MGC08-C07	MGC	W01C038E14	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC040050	MGC08-C08	MGC	W01C038E15	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC040050	MGC08-C08	MGC	W01C038E16	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC044233	MGC08-C09	MGC	W01C038E17	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC044233	MGC08-C09	MGC	W01C038E18	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC056402	MGC08-C10	MGC	W01C038E19	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC056402	MGC08-C10	MGC	W01C038E20	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC040035	MGC08-C11	MGC	W01C038E21	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC040035	MGC08-C11	MGC	W01C038E22	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC046357	MGC08-C12	MGC	W01C038E23	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC046357	MGC08-C12	MGC	W01C038E24	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC043345	MGC08-C01	MGC	W01C038F01	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	MGC08-C01	MGC	W01C038F02	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC046358	MGC08-C02	MGC	W01C038F03	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC046358	MGC08-C02	MGC	W01C038F04	pDONR221	15596		EMID1	129080	AAH46358.1	Hs.289106	EMI domain containing 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_133455.2	NP_597712.2	VALIDATED	Cg	0.995	1.000	443	1326	1	1323	443	1	443
IKAKEN	BC065482	MGC08-C03	MGC	W01C038F05	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC065482	MGC08-C03	MGC	W01C038F06	pDONR221	10285		OSBPL7	114881	AAH65482.1	Hs.463320	Oxysterol binding protein-like 7			Testis	NIH_MGC_97	DH10B	NM_145798.2	NP_665741.1	REVIEWED	OK	1.000	1.000	842	2529	1	2526	842	1	842
IKAKEN	BC040053	MGC08-C04	MGC	W01C038F07	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC040053	MGC08-C04	MGC	W01C038F08	pDONR221	5480		MSRB3	253827	AAH40053.1	Hs.339024	Methionine sulfoxide reductase B3			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_001031679.1	NP_001026849.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC044254	MGC08-C05	MGC	W01C038F09	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC044254	MGC08-C05	MGC	W01C038F10	pDONR221	9266		PALB2	79728	AAH44254.1	Hs.444664	Partner and localizer of BRCA2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_024675.3	NP_078951.2	REVIEWED	Cg	0.998	1.000	1188	3567	1	3564	1186	1	1186
IKAKEN	BC047949	MGC08-C06	MGC	W01C038F11	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC047949	MGC08-C06	MGC	W01C038F12	pDONR221	24204		FAM102A	399665	-	Hs.568044	Family with sequence similarity 102, member A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_203305.2	NP_976050.1	VALIDATED	OK	1.000	1.000	242	729	1	726	242	1	242
IKAKEN	BC044216	MGC08-C07	MGC	W01C038F13	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC044216	MGC08-C07	MGC	W01C038F14	pDONR221	7329		BAG5	9529	AAH44216.2	Hs.5443	BCL2-associated athanogene 5			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004873.2	NP_004864.1	REVIEWED	OK	1.000	1.000	447	1344	1	1341	447	1	447
IKAKEN	BC040050	MGC08-C08	MGC	W01C038F15	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC040050	MGC08-C08	MGC	W01C038F16	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC044233	MGC08-C09	MGC	W01C038F17	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC044233	MGC08-C09	MGC	W01C038F18	pDONR221	16524		LRRC33	375387	AAH44233.1	Hs.709536	Leucine rich repeat containing 33			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198565.1	NP_940967.1	PROVISIONAL	C	1.000	1.000	692	2079	1	2076	692	1	692
IKAKEN	BC056402	MGC08-C10	MGC	W01C038F19	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC056402	MGC08-C10	MGC	W01C038F20	pDONR221	4079		C11orf84	144097	AAH56402.1	Hs.502793	Chromosome 11 open reading frame 84			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_138471.1	NP_612480.1	PREDICTED	C	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC040035	MGC08-C11	MGC	W01C038F21	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC040035	MGC08-C11	MGC	W01C038F22	pDONR221	23743		MRPL41	64975	AAH40035.1	Hs.44017	Mitochondrial ribosomal protein L41			Brain, adult medulla	NIH_MGC_119	DH10B	NM_032477.2	NP_115866.1	REVIEWED	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	BC046357	MGC08-C12	MGC	W01C038F23	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC046357	MGC08-C12	MGC	W01C038F24	pDONR221	7812		MPI	4351	AAH46357.1	Hs.75694	Mannose phosphate isomerase			Neuroblastoma			NM_002435.1	NP_002426.1	REVIEWED	OK	1.000	1.000	423	1272	1	1269	423	1	423
IKAKEN	BC047935	MGC08-D01	MGC	W01C038G01	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	MGC08-D01	MGC	W01C038G02	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC049388	MGC08-D02	MGC	W01C038G03	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC049388	MGC08-D02	MGC	W01C038G04	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC053521	MGC08-D04	MGC	W01C038G07	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	MGC08-D04	MGC	W01C038G08	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC047023	MGC08-D05	MGC	W01C038G09	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC047023	MGC08-D05	MGC	W01C038G10	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC048806	MGC08-D06	MGC	W01C038G11	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC048806	MGC08-D06	MGC	W01C038G12	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC047013	MGC08-D07	MGC	W01C038G13	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC047013	MGC08-D07	MGC	W01C038G14	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC048255	MGC08-D08	MGC	W01C038G15	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC048255	MGC08-D08	MGC	W01C038G16	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC049207	MGC08-D09	MGC	W01C038G17	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC049207	MGC08-D09	MGC	W01C038G18	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC047024	MGC08-D10	MGC	W01C038G19	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047024	MGC08-D10	MGC	W01C038G20	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047318	MGC08-D11	MGC	W01C038G21	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC047318	MGC08-D11	MGC	W01C038G22	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC062298	MGC08-D12	MGC	W01C038G23	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC062298	MGC08-D12	MGC	W01C038G24	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC047935	MGC08-D01	MGC	W01C038H01	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	MGC08-D01	MGC	W01C038H02	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC049388	MGC08-D02	MGC	W01C038H03	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC049388	MGC08-D02	MGC	W01C038H04	pDONR221	24182		FAM78A	286336	AAH49388.1	Hs.704076	Family with sequence similarity 78, member A			Testis	NIH_MGC_97	DH10B	NM_033387.3	NP_203745.2	VALIDATED	P	1.000	1.000	263	792	1	789	283	21	283
IKAKEN	BC053521	MGC08-D04	MGC	W01C038H07	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	MGC08-D04	MGC	W01C038H08	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC047023	MGC08-D05	MGC	W01C038H09	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC047023	MGC08-D05	MGC	W01C038H10	pDONR221	23739		RABEPK	10244	AAH47023.1	Hs.19012	Rab9 effector protein with kelch motifs			Brain, adult medulla	NIH_MGC_119	DH10B	NM_005833.2	NP_005824.2	PROVISIONAL	Cg	0.863	1.000	372	966	1	963	372	1	372
IKAKEN	BC048806	MGC08-D06	MGC	W01C038H11	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC048806	MGC08-D06	MGC	W01C038H12	pDONR221	10029		C17orf64	124773	AAH48806.1	Hs.129312	Chromosome 17 open reading frame 64			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181707.2	NP_859058.2	VALIDATED	P	1.000	1.000	126	381	1	378	236	111	236
IKAKEN	BC047013	MGC08-D07	MGC	W01C038H13	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC047013	MGC08-D07	MGC	W01C038H14	pDONR221	13303		LYPD6	130574	AAH47013.1	Hs.21929	LY6/PLAUR domain containing 6			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_194317.2	NP_919298.1	PROVISIONAL	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC048255	MGC08-D08	MGC	W01C038H15	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC048255	MGC08-D08	MGC	W01C038H16	pDONR221	3735		CTSW	1521	AAH48255.1	Hs.416848	Cathepsin W			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001335.3	NP_001326.2	REVIEWED	Cs	0.997	0.997	376	1131	1	1128	376	1	376
IKAKEN	BC049207	MGC08-D09	MGC	W01C038H17	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC049207	MGC08-D09	MGC	W01C038H18	pDONR221	4922		SLC5A12	159963	AAH49207.1	Hs.148907	Solute carrier family 5 (sodium/glucose cotransporter), member 12			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_178498.3	NP_848593.2	VALIDATED	P	1.000	1.000	385	1191	1	1155	618	1	385
IKAKEN	BC047024	MGC08-D10	MGC	W01C038H19	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047024	MGC08-D10	MGC	W01C038H20	pDONR221	16873		SUCLG2	8801	AAH47024.1	Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_003848.2	NP_003839.2	VALIDATED		0.937	0.939	428	1284	1	1281	432	5	432
IKAKEN	BC047318	MGC08-D11	MGC	W01C038H21	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC047318	MGC08-D11	MGC	W01C038H22	pDONR221	10304		SGSH	6448	AAH47318.1	Hs.31074	N-sulfoglucosamine sulfohydrolase			Testis	NIH_MGC_97	DH10B	NM_000199.3	NP_000190.1	REVIEWED	OK	1.000	1.000	502	1509	1	1506	502	1	502
IKAKEN	BC062298	MGC08-D12	MGC	W01C038H23	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC062298	MGC08-D12	MGC	W01C038H24	pDONR221	9352		STX1B	112755	AAH62298.1	Hs.542230	Syntaxin 1B			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_052874.3	NP_443106.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC048282	MGC08-E01	MGC	W01C038I01	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC048282	MGC08-E01	MGC	W01C038I02	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC047690	MGC08-E02	MGC	W01C038I03	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC047690	MGC08-E02	MGC	W01C038I04	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC050462	MGC08-E03	MGC	W01C038I05	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	MGC08-E03	MGC	W01C038I06	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC047726	MGC08-E04	MGC	W01C038I07	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC047726	MGC08-E04	MGC	W01C038I08	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC050453	MGC08-E05	MGC	W01C038I09	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC050453	MGC08-E05	MGC	W01C038I10	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC047705	MGC08-E06	MGC	W01C038I11	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC047705	MGC08-E06	MGC	W01C038I12	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC050373	MGC08-E07	MGC	W01C038I13	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC050373	MGC08-E07	MGC	W01C038I14	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC047752	MGC08-E08	MGC	W01C038I15	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC047752	MGC08-E08	MGC	W01C038I16	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC050452	MGC08-E09	MGC	W01C038I17	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050452	MGC08-E09	MGC	W01C038I18	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050389	MGC08-E10	MGC	W01C038I19	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050389	MGC08-E10	MGC	W01C038I20	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050445	MGC08-E12	MGC	W01C038I23	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC050445	MGC08-E12	MGC	W01C038I24	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC048282	MGC08-E01	MGC	W01C038J01	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC048282	MGC08-E01	MGC	W01C038J02	pDONR221	752		CLCNKA	1187	AAH48282.1	Hs.591533	Chloride channel Ka			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_004070.3	NP_004061.3	REVIEWED	OK	1.000	1.000	687	2064	1	2061	687	1	687
IKAKEN	BC047690	MGC08-E02	MGC	W01C038J03	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC047690	MGC08-E02	MGC	W01C038J04	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC050462	MGC08-E03	MGC	W01C038J05	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	MGC08-E03	MGC	W01C038J06	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC047726	MGC08-E04	MGC	W01C038J07	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC047726	MGC08-E04	MGC	W01C038J08	pDONR221	4065		OAF	220323	AAH47726.1	Hs.445081	OAF homolog (Drosophila)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_178507.2	NP_848602.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC050453	MGC08-E05	MGC	W01C038J09	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC050453	MGC08-E05	MGC	W01C038J10	pDONR221	13775		ECEL1	9427	AAH50453.2	Hs.26880	Endothelin converting enzyme-like 1			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004826.2	NP_004817.2	VALIDATED	OK	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	BC047705	MGC08-E06	MGC	W01C038J11	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC047705	MGC08-E06	MGC	W01C038J12	pDONR221	1955		C1orf201	90529	AAH47705.1	Hs.403187	Chromosome 1 open reading frame 201			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_178122.3	NP_835223.1	PREDICTED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC050373	MGC08-E07	MGC	W01C038J13	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC050373	MGC08-E07	MGC	W01C038J14	pDONR221	13517		RNF144A	9781	AAH50373.1	Hs.22146	Ring finger protein 144A			Testis	NIH_MGC_97	DH10B	NM_014746.3	NP_055561.2	REVIEWED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC047752	MGC08-E08	MGC	W01C038J15	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC047752	MGC08-E08	MGC	W01C038J16	pDONR221	1623		REN	5972	AAH47752.1	Hs.3210	Renin			Brain, adult medulla	NIH_MGC_119	DH10B	NM_000537.3	NP_000528.1	REVIEWED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC050452	MGC08-E09	MGC	W01C038J17	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050452	MGC08-E09	MGC	W01C038J18	pDONR221	10740		CYTH1	9267	AAH50452.1	Hs.191215	Cytohesin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017456.2	NP_059430.2	REVIEWED	OK	1.000	1.000	397	1194	1	1191	397	1	397
IKAKEN	BC050389	MGC08-E10	MGC	W01C038J19	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050389	MGC08-E10	MGC	W01C038J20	pDONR221	8531		MGRN1	23295	AAH50389.1	Hs.526494	Mahogunin, ring finger 1			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_015246.2	NP_056061.1	VALIDATED	OK	1.000	1.000	576	1731	1	1728	576	1	576
IKAKEN	BC050445	MGC08-E12	MGC	W01C038J23	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC050445	MGC08-E12	MGC	W01C038J24	pDONR221	2569		SHOC2	8036	AAH50445.1	Hs.104315	Soc-2 suppressor of clear homolog (C. elegans)			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_007373.3	NP_031399.2	VALIDATED	OK	1.000	1.000	582	1749	1	1746	582	1	582
IKAKEN	BC046190	MGC08-F01	MGC	W01C038K01	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC046190	MGC08-F01	MGC	W01C038K02	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC050529	MGC08-F02	MGC	W01C038K03	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC050529	MGC08-F02	MGC	W01C038K04	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC054500	MGC08-F03	MGC	W01C038K05	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	MGC08-F03	MGC	W01C038K06	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC050553	MGC08-F04	MGC	W01C038K07	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC050553	MGC08-F04	MGC	W01C038K08	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC046200	MGC08-F05	MGC	W01C038K09	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046200	MGC08-F05	MGC	W01C038K10	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046145	MGC08-F06	MGC	W01C038K11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	MGC08-F06	MGC	W01C038K12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC050550	MGC08-F07	MGC	W01C038K13	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC050550	MGC08-F07	MGC	W01C038K14	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC046173	MGC08-F08	MGC	W01C038K15	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC046173	MGC08-F08	MGC	W01C038K16	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC051805	MGC08-F09	MGC	W01C038K17	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC051805	MGC08-F09	MGC	W01C038K18	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC060668	MGC08-F10	MGC	W01C038K19	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	MGC08-F10	MGC	W01C038K20	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC050557	MGC08-F11	MGC	W01C038K21	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC050557	MGC08-F11	MGC	W01C038K22	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC064511	MGC08-F12	MGC	W01C038K23	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC064511	MGC08-F12	MGC	W01C038K24	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC046190	MGC08-F01	MGC	W01C038L01	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC046190	MGC08-F01	MGC	W01C038L02	pDONR221	6192		OVOS2	144203	AAH46190.1	Hs.524331	Ovostatin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001080502.1	NP_001073971.1	MODEL		0.786	0.786	28	288	1	84	1394	1346	1373
IKAKEN	BC050529	MGC08-F02	MGC	W01C038L03	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC050529	MGC08-F02	MGC	W01C038L04	pDONR221	12467		ANKRD27	84079	AAH50529.1	Hs.59236	Ankyrin repeat domain 27 (VPS9 domain)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_032139.2	NP_115515.2	VALIDATED	OK	1.000	1.000	1050	3216	64	3213	1050	1	1050
IKAKEN	BC054500	MGC08-F03	MGC	W01C038L05	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC054500	MGC08-F03	MGC	W01C038L06	pDONR221	24035		SEMA4D	10507	AAH54500.1	Hs.494406	Sema domain, immunoglobulin domain (Ig), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 4D			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182635.1	NP_872441.1	VALIDATED		0.294	0.294	34	1653	386	285	123	80	113
IKAKEN	BC050553	MGC08-F04	MGC	W01C038L07	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC050553	MGC08-F04	MGC	W01C038L08	pDONR221	11665		PNPLA6	10908	AAH50553.1	Hs.631863	Patatin-like phospholipase domain containing 6			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_006702.3	NP_006693.3	VALIDATED	OK	1.000	1.000	1327	3984	1	3981	1327	1	1327
IKAKEN	BC046200	MGC08-F05	MGC	W01C038L09	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046200	MGC08-F05	MGC	W01C038L10	pDONR221	10045		C17orf82	388407	AAH46200.1	Hs.434459	Chromosome 17 open reading frame 82			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203425.1	NP_982249.1	PREDICTED	Cs	0.996	0.996	251	756	1	753	251	1	251
IKAKEN	BC046145	MGC08-F06	MGC	W01C038L11	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC046145	MGC08-F06	MGC	W01C038L12	pDONR221	8702		LOC339047	339047	AAH46145.1	Hs.648395	Hypothetical protein LOC339047			Testis	NIH_MGC_97	DH10B	NM_178541.1	NP_848636.1	PROVISIONAL	OK	1.000	1.000	369	1110	1	1107	369	1	369
IKAKEN	BC050550	MGC08-F07	MGC	W01C038L13	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC050550	MGC08-F07	MGC	W01C038L14	pDONR221	7939		MAN2C1	4123	AAH50550.1	Hs.598731	Mannosidase, alpha, class 2C, member 1			Testis	NIH_MGC_97	DH10B	NM_006715.2	NP_006706.2	VALIDATED	Cfs	0.994	0.997	1041	3189	1	3118	1040	1	1040
IKAKEN	BC046173	MGC08-F08	MGC	W01C038L15	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC046173	MGC08-F08	MGC	W01C038L16	pDONR221	2851		NUDT13	25961	AAH46173.2	Hs.533657	Nudix (nucleoside diphosphate linked moiety X)-type motif 13			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_015901.4	NP_056985.3	VALIDATED	Cg	0.747	1.000	352	792	1	789	352	1	352
IKAKEN	BC051805	MGC08-F09	MGC	W01C038L17	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC051805	MGC08-F09	MGC	W01C038L18	pDONR221	15697		CABP7	164633	AAH51805.1	Hs.643608	Calcium binding protein 7			Testis	NIH_MGC_97	DH10B	NM_182527.2	NP_872333.1	VALIDATED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC060668	MGC08-F10	MGC	W01C038L19	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC060668	MGC08-F10	MGC	W01C038L20	pDONR221	19754		BAT2	7916	AAH60668.1	Hs.436093	HLA-B associated transcript 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_080686.2	NP_542417.2	REVIEWED	Cs	0.997	0.997	2157	6474	1	6471	2157	1	2157
IKAKEN	BC050557	MGC08-F11	MGC	W01C038L21	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC050557	MGC08-F11	MGC	W01C038L22	pDONR221	5796		TIMELESS	8914	AAH50557.1	Hs.118631	Timeless homolog (Drosophila)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003920.3	NP_003911.2	VALIDATED	OK	1.000	1.000	1208	3627	1	3624	1208	1	1208
IKAKEN	BC064511	MGC08-F12	MGC	W01C038L23	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC064511	MGC08-F12	MGC	W01C038L24	pDONR221	14227		FAHD2B	151313	AAH64511.1					Brain, adult medulla	NIH_MGC_119	DH10B	NM_199336.1	NP_955368.1	PROVISIONAL	Cgs	0.978	0.981	314	942	1	939	314	1	314
IKAKEN	BC050588	MGC08-G01	MGC	W01C038M01	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC050588	MGC08-G01	MGC	W01C038M02	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC054503	MGC08-G02	MGC	W01C038M03	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC054503	MGC08-G02	MGC	W01C038M04	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC050659	MGC08-G03	MGC	W01C038M05	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050659	MGC08-G03	MGC	W01C038M06	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050629	MGC08-G04	MGC	W01C038M07	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC050629	MGC08-G04	MGC	W01C038M08	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC051826	MGC08-G05	MGC	W01C038M09	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC051826	MGC08-G05	MGC	W01C038M10	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC057395	MGC08-G06	MGC	W01C038M11	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC057395	MGC08-G06	MGC	W01C038M12	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC051896	MGC08-G07	MGC	W01C038M13	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC051896	MGC08-G07	MGC	W01C038M14	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC052990	MGC08-G08	MGC	W01C038M15	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC052990	MGC08-G08	MGC	W01C038M16	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC051851	MGC08-G09	MGC	W01C038M17	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC051851	MGC08-G09	MGC	W01C038M18	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC050728	MGC08-G10	MGC	W01C038M19	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC050728	MGC08-G10	MGC	W01C038M20	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC051911	MGC08-G11	MGC	W01C038M21	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC051911	MGC08-G11	MGC	W01C038M22	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC063242	MGC08-G12	MGC	W01C038M23	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	MGC08-G12	MGC	W01C038M24	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC050588	MGC08-G01	MGC	W01C038N01	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC050588	MGC08-G01	MGC	W01C038N02	pDONR221	24525		MAGEE1	57692	AAH50588.1	Hs.8453	Melanoma antigen family E, 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020932.1	NP_065983.1	VALIDATED	OK	1.000	1.000	957	2874	1	2871	957	1	957
IKAKEN	BC054503	MGC08-G02	MGC	W01C038N03	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC054503	MGC08-G02	MGC	W01C038N04	pDONR221	20414		MAP3K5	4217	AAH54503.1	Hs.186486	Mitogen-activated protein kinase kinase kinase 5			Testis	NIH_MGC_97	DH10B	NM_005923.3	NP_005914.1	REVIEWED	OK	1.000	1.000	1374	4125	1	4122	1374	1	1374
IKAKEN	BC050659	MGC08-G03	MGC	W01C038N05	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050659	MGC08-G03	MGC	W01C038N06	pDONR221	21034		PEG10	23089	AAH50659.1	Hs.147492	Paternally expressed 10			Testis	NIH_MGC_97	DH10B	NM_001040152.1	NP_001035242.1	REVIEWED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC050629	MGC08-G04	MGC	W01C038N07	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC050629	MGC08-G04	MGC	W01C038N08	pDONR221	8156		CPEB1	64506	AAH50629.1	Hs.547988	Cytoplasmic polyadenylation element binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001079533.1	NP_001073001.1	REVIEWED	C	1.000	1.000	491	1701	226	1698	491	1	491
IKAKEN	BC051826	MGC08-G05	MGC	W01C038N09	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC051826	MGC08-G05	MGC	W01C038N10	pDONR221	7946		KIF23	9493	AAH51826.1	Hs.270845	Kinesin family member 23			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004856.4	NP_004847.2	REVIEWED	C	1.000	1.000	856	2571	1	2568	856	1	856
IKAKEN	BC057395	MGC08-G06	MGC	W01C038N11	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC057395	MGC08-G06	MGC	W01C038N12	pDONR221	8094		HISPPD2A	9677	AAH57395.1	Hs.156814	Histidine acid phosphatase domain containing 2A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014659.4	NP_055474.3	VALIDATED	OK	1.000	1.000	1408	4227	1	4224	1408	1	1408
IKAKEN	BC051896	MGC08-G07	MGC	W01C038N13	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC051896	MGC08-G07	MGC	W01C038N14	pDONR221	6950		VASH1	22846	AAH51896.1	Hs.525479	Vasohibin 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_014909.4	NP_055724.1	VALIDATED	OK	1.000	1.000	365	1098	1	1095	365	1	365
IKAKEN	BC052990	MGC08-G08	MGC	W01C038N15	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC052990	MGC08-G08	MGC	W01C038N16	pDONR221	4420		MTMR2	8898	AAH52990.1	Hs.181326	Myotubularin related protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_016156.5	NP_057240.3	REVIEWED	OK	1.000	1.000	643	1932	1	1929	643	1	643
IKAKEN	BC051851	MGC08-G09	MGC	W01C038N17	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC051851	MGC08-G09	MGC	W01C038N18	pDONR221	13440		CYP27A1	1593	AAH51851.1	Hs.516700	Cytochrome P450, family 27, subfamily A, polypeptide 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_000784.3	NP_000775.1	REVIEWED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC050728	MGC08-G10	MGC	W01C038N19	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC050728	MGC08-G10	MGC	W01C038N20	pDONR221	9176		BRD7	29117	AAH50728.1	Hs.437894	Bromodomain containing 7			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_013263.2	NP_037395.2	VALIDATED		0.960	0.970	471	1401	1	1398	651	181	651
IKAKEN	BC051911	MGC08-G11	MGC	W01C038N21	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC051911	MGC08-G11	MGC	W01C038N22	pDONR221	6485		PIBF1	10464	AAH51911.1	Hs.441926	Progesterone immunomodulatory binding factor 1			Liver, hepatocellular carcinoma	NIH_MGC_100	DH10B	NM_006346.2	NP_006337.2	VALIDATED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	BC063242	MGC08-G12	MGC	W01C038N23	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	MGC08-G12	MGC	W01C038N24	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC053642	MGC08-H01	MGC	W01C038O01	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053642	MGC08-H01	MGC	W01C038O02	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053562	MGC08-H02	MGC	W01C038O03	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC053562	MGC08-H02	MGC	W01C038O04	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC054002	MGC08-H03	MGC	W01C038O05	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	MGC08-H03	MGC	W01C038O06	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC053610	MGC08-H04	MGC	W01C038O07	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053610	MGC08-H04	MGC	W01C038O08	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053634	MGC08-H05	MGC	W01C038O09	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053634	MGC08-H05	MGC	W01C038O10	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053859	MGC08-H06	MGC	W01C038O11	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053859	MGC08-H06	MGC	W01C038O12	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053578	MGC08-H07	MGC	W01C038O13	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053578	MGC08-H07	MGC	W01C038O14	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053877	MGC08-H08	MGC	W01C038O15	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053877	MGC08-H08	MGC	W01C038O16	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053903	MGC08-H09	MGC	W01C038O17	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053903	MGC08-H09	MGC	W01C038O18	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053856	MGC08-H10	MGC	W01C038O19	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053856	MGC08-H10	MGC	W01C038O20	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053660	MGC08-H11	MGC	W01C038O21	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	MGC08-H11	MGC	W01C038O22	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053666	MGC08-H12	MGC	W01C038O23	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC053666	MGC08-H12	MGC	W01C038O24	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC053642	MGC08-H01	MGC	W01C038P01	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053642	MGC08-H01	MGC	W01C038P02	pDONR221	14703		DNAJC5	80331	AAH53642.1	Hs.164419	DnaJ (Hsp40) homolog, subfamily C, member 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_025219.1	NP_079495.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC053562	MGC08-H02	MGC	W01C038P03	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC053562	MGC08-H02	MGC	W01C038P04	pDONR221	1712		CRTC2	200186	AAH53562.1	Hs.406392	CREB regulated transcription coactivator 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181715.1	NP_859066.1	PROVISIONAL	Cgs	0.986	0.999	702	2109	1	2106	693	1	693
IKAKEN	BC054002	MGC08-H03	MGC	W01C038P05	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	MGC08-H03	MGC	W01C038P06	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC053610	MGC08-H04	MGC	W01C038P07	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053610	MGC08-H04	MGC	W01C038P08	pDONR221	1780		PRKAB2	5565	AAH53610.1	Hs.50732	Protein kinase, AMP-activated, beta 2 non-catalytic subunit			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_005399.3	NP_005390.1	REVIEWED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC053634	MGC08-H05	MGC	W01C038P09	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053634	MGC08-H05	MGC	W01C038P10	pDONR221	22112		THAP5	168451	AAH53634.1					Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001130475.1	NP_001123947.1	VALIDATED	P	1.000	1.000	233	702	1	699	395	163	395
IKAKEN	BC053859	MGC08-H06	MGC	W01C038P11	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053859	MGC08-H06	MGC	W01C038P12	pDONR221	15606		APOBEC3B	9582	AAH53859.1	Hs.226307	Apolipoprotein B mRNA editing enzyme, catalytic polypeptide-like 3B			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004900.3	NP_004891.3	REVIEWED	Pfs	0.827	1.000	295	732	1	731	382	9	303
IKAKEN	BC053578	MGC08-H07	MGC	W01C038P13	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053578	MGC08-H07	MGC	W01C038P14	pDONR221	20749		GSTA1	2938	AAH53578.1	Hs.446309	Glutathione S-transferase alpha 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_145740.3	NP_665683.1	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC053877	MGC08-H08	MGC	W01C038P15	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053877	MGC08-H08	MGC	W01C038P16	pDONR221	854		SLC44A3	126969	AAH53877.1	Hs.483423	Solute carrier family 44, member 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_152369.3	NP_689582.2	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC053903	MGC08-H09	MGC	W01C038P17	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053903	MGC08-H09	MGC	W01C038P18	pDONR221	5194		SRGAP1	57522	AAH53903.1	Hs.210751	SLIT-ROBO Rho GTPase activating protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020762.2	NP_065813.1	VALIDATED	OK	1.000	1.000	1085	3258	1	3255	1085	1	1085
IKAKEN	BC053856	MGC08-H10	MGC	W01C038P19	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053856	MGC08-H10	MGC	W01C038P20	pDONR221	2204		RBBP5	5929	AAH53856.1	Hs.519230	Retinoblastoma binding protein 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005057.2	NP_005048.2	REVIEWED	OK	1.000	1.000	538	1617	1	1614	538	1	538
IKAKEN	BC053660	MGC08-H11	MGC	W01C038P21	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053660	MGC08-H11	MGC	W01C038P22	pDONR221	14032		PNPT1	87178	AAH53660.1	Hs.388733	Polyribonucleotide nucleotidyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_033109.3	NP_149100.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC053666	MGC08-H12	MGC	W01C038P23	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC053666	MGC08-H12	MGC	W01C038P24	pDONR221	5623		GRASP	160622	AAH53666.1	Hs.407202	GRP1 (general receptor for phosphoinositides 1)-associated scaffold protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181711.2	NP_859062.1	PROVISIONAL	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC053635	MGC09-A01	MGC	W01C039A01	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC053635	MGC09-A01	MGC	W01C039A02	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC052806	MGC09-A03	MGC	W01C039A05	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC052806	MGC09-A03	MGC	W01C039A06	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC053368	MGC09-A04	MGC	W01C039A07	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC053368	MGC09-A04	MGC	W01C039A08	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC055396	MGC09-A05	MGC	W01C039A09	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC055396	MGC09-A05	MGC	W01C039A10	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC053671	MGC09-A06	MGC	W01C039A11	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC053671	MGC09-A06	MGC	W01C039A12	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC052644	MGC09-A07	MGC	W01C039A13	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC052644	MGC09-A07	MGC	W01C039A14	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC053908	MGC09-A08	MGC	W01C039A15	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053908	MGC09-A08	MGC	W01C039A16	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053560	MGC09-A09	MGC	W01C039A17	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053560	MGC09-A09	MGC	W01C039A18	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053902	MGC09-A10	MGC	W01C039A19	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053902	MGC09-A10	MGC	W01C039A20	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053857	MGC09-A11	MGC	W01C039A21	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053857	MGC09-A11	MGC	W01C039A22	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053547	MGC09-A12	MGC	W01C039A23	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053547	MGC09-A12	MGC	W01C039A24	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053635	MGC09-A01	MGC	W01C039B01	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC053635	MGC09-A01	MGC	W01C039B02	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC052806	MGC09-A03	MGC	W01C039B05	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC052806	MGC09-A03	MGC	W01C039B06	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC053368	MGC09-A04	MGC	W01C039B07	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC053368	MGC09-A04	MGC	W01C039B08	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC055396	MGC09-A05	MGC	W01C039B09	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC055396	MGC09-A05	MGC	W01C039B10	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC053671	MGC09-A06	MGC	W01C039B11	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC053671	MGC09-A06	MGC	W01C039B12	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC052644	MGC09-A07	MGC	W01C039B13	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC052644	MGC09-A07	MGC	W01C039B14	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC053908	MGC09-A08	MGC	W01C039B15	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053908	MGC09-A08	MGC	W01C039B16	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053560	MGC09-A09	MGC	W01C039B17	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053560	MGC09-A09	MGC	W01C039B18	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053902	MGC09-A10	MGC	W01C039B19	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053902	MGC09-A10	MGC	W01C039B20	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053857	MGC09-A11	MGC	W01C039B21	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053857	MGC09-A11	MGC	W01C039B22	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053547	MGC09-A12	MGC	W01C039B23	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053547	MGC09-A12	MGC	W01C039B24	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053550	MGC09-B01	MGC	W01C039C01	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC053550	MGC09-B01	MGC	W01C039C02	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC055285	MGC09-B02	MGC	W01C039C03	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	MGC09-B02	MGC	W01C039C04	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	MGC09-B03	MGC	W01C039C05	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	MGC09-B03	MGC	W01C039C06	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053591	MGC09-B04	MGC	W01C039C07	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC053591	MGC09-B04	MGC	W01C039C08	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC058928	MGC09-B05	MGC	W01C039C09	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	MGC09-B05	MGC	W01C039C10	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056904	MGC09-B06	MGC	W01C039C11	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056904	MGC09-B06	MGC	W01C039C12	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056408	MGC09-B07	MGC	W01C039C13	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056408	MGC09-B07	MGC	W01C039C14	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056146	MGC09-B08	MGC	W01C039C15	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC056146	MGC09-B08	MGC	W01C039C16	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC054034	MGC09-B09	MGC	W01C039C17	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054034	MGC09-B09	MGC	W01C039C18	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054036	MGC09-B10	MGC	W01C039C19	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	MGC09-B10	MGC	W01C039C20	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC056918	MGC09-B11	MGC	W01C039C21	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC056918	MGC09-B11	MGC	W01C039C22	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC054049	MGC09-B12	MGC	W01C039C23	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC054049	MGC09-B12	MGC	W01C039C24	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC053550	MGC09-B01	MGC	W01C039D01	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC053550	MGC09-B01	MGC	W01C039D02	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC055285	MGC09-B02	MGC	W01C039D03	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	MGC09-B02	MGC	W01C039D04	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	MGC09-B03	MGC	W01C039D05	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	MGC09-B03	MGC	W01C039D06	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053591	MGC09-B04	MGC	W01C039D07	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC053591	MGC09-B04	MGC	W01C039D08	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC058928	MGC09-B05	MGC	W01C039D09	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	MGC09-B05	MGC	W01C039D10	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056904	MGC09-B06	MGC	W01C039D11	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056904	MGC09-B06	MGC	W01C039D12	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056408	MGC09-B07	MGC	W01C039D13	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056408	MGC09-B07	MGC	W01C039D14	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056146	MGC09-B08	MGC	W01C039D15	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC056146	MGC09-B08	MGC	W01C039D16	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC054034	MGC09-B09	MGC	W01C039D17	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054034	MGC09-B09	MGC	W01C039D18	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054036	MGC09-B10	MGC	W01C039D19	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	MGC09-B10	MGC	W01C039D20	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC056918	MGC09-B11	MGC	W01C039D21	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC056918	MGC09-B11	MGC	W01C039D22	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC054049	MGC09-B12	MGC	W01C039D23	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC054049	MGC09-B12	MGC	W01C039D24	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC056911	MGC09-C01	MGC	W01C039E01	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC056911	MGC09-C01	MGC	W01C039E02	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC062555	MGC09-C02	MGC	W01C039E03	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC062555	MGC09-C02	MGC	W01C039E04	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC056878	MGC09-C03	MGC	W01C039E05	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056878	MGC09-C03	MGC	W01C039E06	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056908	MGC09-C04	MGC	W01C039E07	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	MGC09-C04	MGC	W01C039E08	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056893	MGC09-C05	MGC	W01C039E09	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC056893	MGC09-C05	MGC	W01C039E10	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC058077	MGC09-C06	MGC	W01C039E11	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058077	MGC09-C06	MGC	W01C039E12	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058924	MGC09-C07	MGC	W01C039E13	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC058924	MGC09-C07	MGC	W01C039E14	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC063646	MGC09-C08	MGC	W01C039E15	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	MGC09-C08	MGC	W01C039E16	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	MGC09-C09	MGC	W01C039E17	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	MGC09-C09	MGC	W01C039E18	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063633	MGC09-C10	MGC	W01C039E19	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063633	MGC09-C10	MGC	W01C039E20	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063634	MGC09-C11	MGC	W01C039E21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	MGC09-C11	MGC	W01C039E22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063682	MGC09-C12	MGC	W01C039E23	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC063682	MGC09-C12	MGC	W01C039E24	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC056911	MGC09-C01	MGC	W01C039F01	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC056911	MGC09-C01	MGC	W01C039F02	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC062555	MGC09-C02	MGC	W01C039F03	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC062555	MGC09-C02	MGC	W01C039F04	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC056878	MGC09-C03	MGC	W01C039F05	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056878	MGC09-C03	MGC	W01C039F06	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056908	MGC09-C04	MGC	W01C039F07	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	MGC09-C04	MGC	W01C039F08	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056893	MGC09-C05	MGC	W01C039F09	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC056893	MGC09-C05	MGC	W01C039F10	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC058077	MGC09-C06	MGC	W01C039F11	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058077	MGC09-C06	MGC	W01C039F12	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058924	MGC09-C07	MGC	W01C039F13	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC058924	MGC09-C07	MGC	W01C039F14	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC063646	MGC09-C08	MGC	W01C039F15	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	MGC09-C08	MGC	W01C039F16	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	MGC09-C09	MGC	W01C039F17	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	MGC09-C09	MGC	W01C039F18	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063633	MGC09-C10	MGC	W01C039F19	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063633	MGC09-C10	MGC	W01C039F20	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063634	MGC09-C11	MGC	W01C039F21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	MGC09-C11	MGC	W01C039F22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063682	MGC09-C12	MGC	W01C039F23	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC063682	MGC09-C12	MGC	W01C039F24	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC063688	MGC09-D01	MGC	W01C039G01	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063688	MGC09-D01	MGC	W01C039G02	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063644	MGC09-D02	MGC	W01C039G03	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063644	MGC09-D02	MGC	W01C039G04	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063575	MGC09-D03	MGC	W01C039G05	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063575	MGC09-D03	MGC	W01C039G06	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063703	MGC09-D04	MGC	W01C039G07	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	MGC09-D04	MGC	W01C039G08	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063471	MGC09-D06	MGC	W01C039G11	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063471	MGC09-D06	MGC	W01C039G12	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063021	MGC09-D08	MGC	W01C039G15	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063021	MGC09-D08	MGC	W01C039G16	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063451	MGC09-D09	MGC	W01C039G17	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063451	MGC09-D09	MGC	W01C039G18	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063502	MGC09-D10	MGC	W01C039G19	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC063502	MGC09-D10	MGC	W01C039G20	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC062575	MGC09-D11	MGC	W01C039G21	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC062575	MGC09-D11	MGC	W01C039G22	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC063688	MGC09-D01	MGC	W01C039H01	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063688	MGC09-D01	MGC	W01C039H02	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063644	MGC09-D02	MGC	W01C039H03	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063644	MGC09-D02	MGC	W01C039H04	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063575	MGC09-D03	MGC	W01C039H05	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063575	MGC09-D03	MGC	W01C039H06	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063703	MGC09-D04	MGC	W01C039H07	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	MGC09-D04	MGC	W01C039H08	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063471	MGC09-D06	MGC	W01C039H11	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063471	MGC09-D06	MGC	W01C039H12	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063021	MGC09-D08	MGC	W01C039H15	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063021	MGC09-D08	MGC	W01C039H16	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063451	MGC09-D09	MGC	W01C039H17	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063451	MGC09-D09	MGC	W01C039H18	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063502	MGC09-D10	MGC	W01C039H19	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC063502	MGC09-D10	MGC	W01C039H20	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC062575	MGC09-D11	MGC	W01C039H21	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC062575	MGC09-D11	MGC	W01C039H22	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC063406	MGC09-E01	MGC	W01C039I01	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC063406	MGC09-E01	MGC	W01C039I02	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC062619	MGC09-E02	MGC	W01C039I03	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC062619	MGC09-E02	MGC	W01C039I04	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC064553	MGC09-E04	MGC	W01C039I07	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	MGC09-E04	MGC	W01C039I08	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064581	MGC09-E05	MGC	W01C039I09	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC064581	MGC09-E05	MGC	W01C039I10	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC065510	MGC09-E06	MGC	W01C039I11	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	MGC09-E06	MGC	W01C039I12	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065509	MGC09-E07	MGC	W01C039I13	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC065509	MGC09-E07	MGC	W01C039I14	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC064626	MGC09-E08	MGC	W01C039I15	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	MGC09-E08	MGC	W01C039I16	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064361	MGC09-E09	MGC	W01C039I17	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC064361	MGC09-E09	MGC	W01C039I18	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC065223	MGC09-E10	MGC	W01C039I19	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC065223	MGC09-E10	MGC	W01C039I20	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC064999	MGC09-E11	MGC	W01C039I21	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064999	MGC09-E11	MGC	W01C039I22	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064421	MGC09-E12	MGC	W01C039I23	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC064421	MGC09-E12	MGC	W01C039I24	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC063406	MGC09-E01	MGC	W01C039J01	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC063406	MGC09-E01	MGC	W01C039J02	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC062619	MGC09-E02	MGC	W01C039J03	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC062619	MGC09-E02	MGC	W01C039J04	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC064553	MGC09-E04	MGC	W01C039J07	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	MGC09-E04	MGC	W01C039J08	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064581	MGC09-E05	MGC	W01C039J09	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC064581	MGC09-E05	MGC	W01C039J10	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC065510	MGC09-E06	MGC	W01C039J11	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	MGC09-E06	MGC	W01C039J12	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065509	MGC09-E07	MGC	W01C039J13	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC065509	MGC09-E07	MGC	W01C039J14	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC064626	MGC09-E08	MGC	W01C039J15	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	MGC09-E08	MGC	W01C039J16	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064361	MGC09-E09	MGC	W01C039J17	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC064361	MGC09-E09	MGC	W01C039J18	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC065223	MGC09-E10	MGC	W01C039J19	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC065223	MGC09-E10	MGC	W01C039J20	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC064999	MGC09-E11	MGC	W01C039J21	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064999	MGC09-E11	MGC	W01C039J22	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064421	MGC09-E12	MGC	W01C039J23	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC064421	MGC09-E12	MGC	W01C039J24	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC064574	MGC09-F01	MGC	W01C039K01	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC064574	MGC09-F01	MGC	W01C039K02	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC066643	MGC09-F02	MGC	W01C039K03	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	MGC09-F02	MGC	W01C039K04	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	MGC09-F03	MGC	W01C039K05	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	MGC09-F03	MGC	W01C039K06	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC062342	MGC09-F04	MGC	W01C039K07	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC062342	MGC09-F04	MGC	W01C039K08	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC064623	MGC09-F05	MGC	W01C039K09	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064623	MGC09-F05	MGC	W01C039K10	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064994	MGC09-F06	MGC	W01C039K11	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	MGC09-F06	MGC	W01C039K12	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064577	MGC09-F07	MGC	W01C039K13	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064577	MGC09-F07	MGC	W01C039K14	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064403	MGC09-F08	MGC	W01C039K15	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC064403	MGC09-F08	MGC	W01C039K16	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC065232	MGC09-F09	MGC	W01C039K17	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065232	MGC09-F09	MGC	W01C039K18	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064931	MGC09-F10	MGC	W01C039K19	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064931	MGC09-F10	MGC	W01C039K20	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064961	MGC09-F11	MGC	W01C039K21	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC064961	MGC09-F11	MGC	W01C039K22	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC065271	MGC09-F12	MGC	W01C039K23	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC065271	MGC09-F12	MGC	W01C039K24	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC064574	MGC09-F01	MGC	W01C039L01	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC064574	MGC09-F01	MGC	W01C039L02	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC066643	MGC09-F02	MGC	W01C039L03	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	MGC09-F02	MGC	W01C039L04	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	MGC09-F03	MGC	W01C039L05	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	MGC09-F03	MGC	W01C039L06	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC062342	MGC09-F04	MGC	W01C039L07	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC062342	MGC09-F04	MGC	W01C039L08	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC064623	MGC09-F05	MGC	W01C039L09	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064623	MGC09-F05	MGC	W01C039L10	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064994	MGC09-F06	MGC	W01C039L11	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	MGC09-F06	MGC	W01C039L12	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064577	MGC09-F07	MGC	W01C039L13	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064577	MGC09-F07	MGC	W01C039L14	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064403	MGC09-F08	MGC	W01C039L15	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC064403	MGC09-F08	MGC	W01C039L16	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC065232	MGC09-F09	MGC	W01C039L17	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065232	MGC09-F09	MGC	W01C039L18	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064931	MGC09-F10	MGC	W01C039L19	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064931	MGC09-F10	MGC	W01C039L20	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064961	MGC09-F11	MGC	W01C039L21	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC064961	MGC09-F11	MGC	W01C039L22	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC065271	MGC09-F12	MGC	W01C039L23	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC065271	MGC09-F12	MGC	W01C039L24	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC065541	MGC09-G01	MGC	W01C039M01	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC065541	MGC09-G01	MGC	W01C039M02	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC064968	MGC09-G02	MGC	W01C039M03	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC064968	MGC09-G02	MGC	W01C039M04	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC065273	MGC09-G03	MGC	W01C039M05	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065273	MGC09-G03	MGC	W01C039M06	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC063026	MGC09-G04	MGC	W01C039M07	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC063026	MGC09-G04	MGC	W01C039M08	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC067125	MGC09-G05	MGC	W01C039M09	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC067125	MGC09-G05	MGC	W01C039M10	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC065531	MGC09-G06	MGC	W01C039M11	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC065531	MGC09-G06	MGC	W01C039M12	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC064918	MGC09-G07	MGC	W01C039M13	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064918	MGC09-G07	MGC	W01C039M14	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064946	MGC09-G08	MGC	W01C039M15	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC064946	MGC09-G08	MGC	W01C039M16	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC065551	MGC09-G09	MGC	W01C039M17	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	MGC09-G09	MGC	W01C039M18	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065930	MGC09-G10	MGC	W01C039M19	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC065930	MGC09-G10	MGC	W01C039M20	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC062319	MGC09-G11	MGC	W01C039M21	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC062319	MGC09-G11	MGC	W01C039M22	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC065525	MGC09-G12	MGC	W01C039M23	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065525	MGC09-G12	MGC	W01C039M24	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065541	MGC09-G01	MGC	W01C039N01	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC065541	MGC09-G01	MGC	W01C039N02	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC064968	MGC09-G02	MGC	W01C039N03	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC064968	MGC09-G02	MGC	W01C039N04	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC065273	MGC09-G03	MGC	W01C039N05	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065273	MGC09-G03	MGC	W01C039N06	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC063026	MGC09-G04	MGC	W01C039N07	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC063026	MGC09-G04	MGC	W01C039N08	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC067125	MGC09-G05	MGC	W01C039N09	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC067125	MGC09-G05	MGC	W01C039N10	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC065531	MGC09-G06	MGC	W01C039N11	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC065531	MGC09-G06	MGC	W01C039N12	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC064918	MGC09-G07	MGC	W01C039N13	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064918	MGC09-G07	MGC	W01C039N14	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064946	MGC09-G08	MGC	W01C039N15	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC064946	MGC09-G08	MGC	W01C039N16	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC065551	MGC09-G09	MGC	W01C039N17	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	MGC09-G09	MGC	W01C039N18	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065930	MGC09-G10	MGC	W01C039N19	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC065930	MGC09-G10	MGC	W01C039N20	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC062319	MGC09-G11	MGC	W01C039N21	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC062319	MGC09-G11	MGC	W01C039N22	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC065525	MGC09-G12	MGC	W01C039N23	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065525	MGC09-G12	MGC	W01C039N24	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065269	MGC09-H01	MGC	W01C039O01	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	MGC09-H01	MGC	W01C039O02	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC064948	MGC09-H02	MGC	W01C039O03	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC064948	MGC09-H02	MGC	W01C039O04	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066649	MGC09-H03	MGC	W01C039O05	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC066649	MGC09-H03	MGC	W01C039O06	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC067131	MGC09-H04	MGC	W01C039O07	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC067131	MGC09-H04	MGC	W01C039O08	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC065007	MGC09-H05	MGC	W01C039O09	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065007	MGC09-H05	MGC	W01C039O10	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065016	MGC09-H06	MGC	W01C039O11	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	MGC09-H06	MGC	W01C039O12	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065564	MGC09-H07	MGC	W01C039O13	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC065564	MGC09-H07	MGC	W01C039O14	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC064027	MGC09-H09	MGC	W01C039O17	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC064027	MGC09-H09	MGC	W01C039O18	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC062416	MGC09-H10	MGC	W01C039O19	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC062416	MGC09-H10	MGC	W01C039O20	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC064829	MGC09-H11	MGC	W01C039O21	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064829	MGC09-H11	MGC	W01C039O22	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064138	MGC09-H12	MGC	W01C039O23	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064138	MGC09-H12	MGC	W01C039O24	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065269	MGC09-H01	MGC	W01C039P01	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	MGC09-H01	MGC	W01C039P02	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC064948	MGC09-H02	MGC	W01C039P03	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC064948	MGC09-H02	MGC	W01C039P04	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066649	MGC09-H03	MGC	W01C039P05	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC066649	MGC09-H03	MGC	W01C039P06	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC067131	MGC09-H04	MGC	W01C039P07	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC067131	MGC09-H04	MGC	W01C039P08	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC065007	MGC09-H05	MGC	W01C039P09	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065007	MGC09-H05	MGC	W01C039P10	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065016	MGC09-H06	MGC	W01C039P11	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	MGC09-H06	MGC	W01C039P12	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065564	MGC09-H07	MGC	W01C039P13	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC065564	MGC09-H07	MGC	W01C039P14	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC064027	MGC09-H09	MGC	W01C039P17	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC064027	MGC09-H09	MGC	W01C039P18	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC062416	MGC09-H10	MGC	W01C039P19	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC062416	MGC09-H10	MGC	W01C039P20	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC064829	MGC09-H11	MGC	W01C039P21	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064829	MGC09-H11	MGC	W01C039P22	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064138	MGC09-H12	MGC	W01C039P23	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064138	MGC09-H12	MGC	W01C039P24	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC053635	MGC09-A01	MGC	W01C040A01	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC053635	MGC09-A01	MGC	W01C040A02	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC052806	MGC09-A03	MGC	W01C040A05	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC052806	MGC09-A03	MGC	W01C040A06	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC053368	MGC09-A04	MGC	W01C040A07	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC053368	MGC09-A04	MGC	W01C040A08	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC055396	MGC09-A05	MGC	W01C040A09	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC055396	MGC09-A05	MGC	W01C040A10	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC053671	MGC09-A06	MGC	W01C040A11	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC053671	MGC09-A06	MGC	W01C040A12	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC052644	MGC09-A07	MGC	W01C040A13	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC052644	MGC09-A07	MGC	W01C040A14	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC053908	MGC09-A08	MGC	W01C040A15	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053908	MGC09-A08	MGC	W01C040A16	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053560	MGC09-A09	MGC	W01C040A17	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053560	MGC09-A09	MGC	W01C040A18	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053902	MGC09-A10	MGC	W01C040A19	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053902	MGC09-A10	MGC	W01C040A20	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053857	MGC09-A11	MGC	W01C040A21	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053857	MGC09-A11	MGC	W01C040A22	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053547	MGC09-A12	MGC	W01C040A23	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053547	MGC09-A12	MGC	W01C040A24	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053635	MGC09-A01	MGC	W01C040B01	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC053635	MGC09-A01	MGC	W01C040B02	pDONR221	17949		NOP14	8602	AAH53635.1	Hs.627133	NOP14 nucleolar protein homolog (yeast)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_003703.1	NP_003694.1	VALIDATED	OK	1.000	1.000	857	2574	1	2571	857	1	857
IKAKEN	BC052806	MGC09-A03	MGC	W01C040B05	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC052806	MGC09-A03	MGC	W01C040B06	pDONR221	1924		MRPL55	128308	AAH52806.1	Hs.63236	Mitochondrial ribosomal protein L55			Brain, adult medulla	NIH_MGC_119	DH10B	NM_181464.2	NP_852129.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC053368	MGC09-A04	MGC	W01C040B07	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC053368	MGC09-A04	MGC	W01C040B08	pDONR221	15590		UBE2L3	7332	AAH53368.1	Hs.108104	Ubiquitin-conjugating enzyme E2L 3			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_198157.1	NP_937800.1	REVIEWED		0.971	0.971	103	465	1	309	121	1	103
IKAKEN	BC055396	MGC09-A05	MGC	W01C040B09	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC055396	MGC09-A05	MGC	W01C040B10	pDONR221	11644		NACC1	112939	AAH55396.1	Hs.531614	Nucleus accumbens associated 1, BEN and BTB (POZ) domain containing			Testis	NIH_MGC_82	DH10B	NM_052876.2	NP_443108.1	VALIDATED	OK	1.000	1.000	527	1584	1	1581	527	1	527
IKAKEN	BC053671	MGC09-A06	MGC	W01C040B11	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC053671	MGC09-A06	MGC	W01C040B12	pDONR221	17998		SH3RF1	57630	AAH53671.1	Hs.301804	SH3 domain containing ring finger 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_020870.3	NP_065921.2	REVIEWED	Pfs	0.999	1.000	841	2526	2	2523	888	49	888
IKAKEN	BC052644	MGC09-A07	MGC	W01C040B13	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC052644	MGC09-A07	MGC	W01C040B14	pDONR221	16231		CMC1	152100	AAH52644.1	Hs.444724	COX assembly mitochondrial protein homolog (S. cerevisiae)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_182523.1	NP_872329.1	PROVISIONAL	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC053908	MGC09-A08	MGC	W01C040B15	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053908	MGC09-A08	MGC	W01C040B16	pDONR221	1425		RCC2	55920	AAH53908.1	Hs.380857	Regulator of chromosome condensation 2			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_018715.2	NP_061185.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC053560	MGC09-A09	MGC	W01C040B17	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053560	MGC09-A09	MGC	W01C040B18	pDONR221	6263		BCDIN3D	144233	AAH53560.1	Hs.142736	BCDIN3 domain containing			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_181708.2	NP_859059.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC053902	MGC09-A10	MGC	W01C040B19	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053902	MGC09-A10	MGC	W01C040B20	pDONR221	4846		LRRN4CL	221091	AAH53902.1	Hs.427449	LRRN4 C-terminal like			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_203422.1	NP_981967.1	VALIDATED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC053857	MGC09-A11	MGC	W01C040B21	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053857	MGC09-A11	MGC	W01C040B22	pDONR221	1643		DPH5	51611	AAH53857.1	Hs.440776	DPH5 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_015958.2	NP_057042.2	REVIEWED	Cfs	0.989	0.996	285	852	1	849	285	1	285
IKAKEN	BC053547	MGC09-A12	MGC	W01C040B23	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053547	MGC09-A12	MGC	W01C040B24	pDONR221	22507		SPATC1	375686	AAH53547.1	Hs.97726	Spermatogenesis and centriole associated 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001134374.1	NP_001127846.1	VALIDATED	P	1.000	1.000	344	1503	1	1032	441	92	435
IKAKEN	BC053550	MGC09-B01	MGC	W01C040C01	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC053550	MGC09-B01	MGC	W01C040C02	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC055285	MGC09-B02	MGC	W01C040C03	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	MGC09-B02	MGC	W01C040C04	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	MGC09-B03	MGC	W01C040C05	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	MGC09-B03	MGC	W01C040C06	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053591	MGC09-B04	MGC	W01C040C07	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC053591	MGC09-B04	MGC	W01C040C08	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC058928	MGC09-B05	MGC	W01C040C09	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	MGC09-B05	MGC	W01C040C10	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056904	MGC09-B06	MGC	W01C040C11	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056904	MGC09-B06	MGC	W01C040C12	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056408	MGC09-B07	MGC	W01C040C13	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056408	MGC09-B07	MGC	W01C040C14	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056146	MGC09-B08	MGC	W01C040C15	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC056146	MGC09-B08	MGC	W01C040C16	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC054034	MGC09-B09	MGC	W01C040C17	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054034	MGC09-B09	MGC	W01C040C18	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054036	MGC09-B10	MGC	W01C040C19	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	MGC09-B10	MGC	W01C040C20	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC056918	MGC09-B11	MGC	W01C040C21	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC056918	MGC09-B11	MGC	W01C040C22	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC054049	MGC09-B12	MGC	W01C040C23	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC054049	MGC09-B12	MGC	W01C040C24	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC053550	MGC09-B01	MGC	W01C040D01	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC053550	MGC09-B01	MGC	W01C040D02	pDONR221	541		PRDX6	9588	AAH53550.1	Hs.120	Peroxiredoxin 6			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_004905.2	NP_004896.1	REVIEWED		0.879	0.887	224	669	1	666	224	1	224
IKAKEN	BC055285	MGC09-B02	MGC	W01C040D03	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	MGC09-B02	MGC	W01C040D04	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	MGC09-B03	MGC	W01C040D05	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	MGC09-B03	MGC	W01C040D06	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053591	MGC09-B04	MGC	W01C040D07	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC053591	MGC09-B04	MGC	W01C040D08	pDONR221	21813		TECPR1	25851	AAH53591.1	Hs.632303	Tectonin beta-propeller repeat containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015395.1	NP_056210.1	PROVISIONAL	OK	1.000	1.000	1165	3498	1	3495	1165	1	1165
IKAKEN	BC058928	MGC09-B05	MGC	W01C040D09	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC058928	MGC09-B05	MGC	W01C040D10	pDONR221	8149		ANPEP	290	AAH58928.1	Hs.1239	Alanyl (membrane) aminopeptidase			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001150.2	NP_001141.2	REVIEWED	OK	1.000	1.000	967	2904	1	2901	967	1	967
IKAKEN	BC056904	MGC09-B06	MGC	W01C040D11	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056904	MGC09-B06	MGC	W01C040D12	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	BC056408	MGC09-B07	MGC	W01C040D13	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056408	MGC09-B07	MGC	W01C040D14	pDONR221	22521		DPYSL2	1808	AAH56408.1	Hs.173381	Dihydropyrimidinase-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_001386.4	NP_001377.1	VALIDATED	C	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC056146	MGC09-B08	MGC	W01C040D15	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC056146	MGC09-B08	MGC	W01C040D16	pDONR221	22696		HOOK3	84376	AAH56146.1	Hs.162852	Hook homolog 3 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_032410.3	NP_115786.1	VALIDATED	OK	1.000	1.000	718	2157	1	2154	718	1	718
IKAKEN	BC054034	MGC09-B09	MGC	W01C040D17	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054034	MGC09-B09	MGC	W01C040D18	pDONR221	5588		SNRNP35	11066	AAH54034.1	Hs.632738	Small nuclear ribonucleoprotein 35kDa (U11/U12)			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_180703.2	NP_851034.1	REVIEWED	OK	1.000	1.000	251	756	1	753	251	1	251
IKAKEN	BC054036	MGC09-B10	MGC	W01C040D19	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	MGC09-B10	MGC	W01C040D20	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC056918	MGC09-B11	MGC	W01C040D21	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC056918	MGC09-B11	MGC	W01C040D22	pDONR221	2864		GSTO2	119391	AAH56918.1	Hs.203634	Glutathione S-transferase omega 2			Testis	NIH_MGC_97	DH10B	NM_183239.1	NP_899062.1	PROVISIONAL	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC054049	MGC09-B12	MGC	W01C040D23	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC054049	MGC09-B12	MGC	W01C040D24	pDONR221	490		RNF115	27246	AAH54049.1	Hs.523550	Ring finger protein 115			Testis	NIH_MGC_97	DH10B	NM_014455.2	NP_055270.1	VALIDATED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC056911	MGC09-C01	MGC	W01C040E01	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC056911	MGC09-C01	MGC	W01C040E02	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC062555	MGC09-C02	MGC	W01C040E03	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC062555	MGC09-C02	MGC	W01C040E04	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC056878	MGC09-C03	MGC	W01C040E05	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056878	MGC09-C03	MGC	W01C040E06	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056908	MGC09-C04	MGC	W01C040E07	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	MGC09-C04	MGC	W01C040E08	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056893	MGC09-C05	MGC	W01C040E09	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC056893	MGC09-C05	MGC	W01C040E10	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC058077	MGC09-C06	MGC	W01C040E11	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058077	MGC09-C06	MGC	W01C040E12	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058924	MGC09-C07	MGC	W01C040E13	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC058924	MGC09-C07	MGC	W01C040E14	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC063646	MGC09-C08	MGC	W01C040E15	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	MGC09-C08	MGC	W01C040E16	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	MGC09-C09	MGC	W01C040E17	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	MGC09-C09	MGC	W01C040E18	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063633	MGC09-C10	MGC	W01C040E19	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063633	MGC09-C10	MGC	W01C040E20	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063634	MGC09-C11	MGC	W01C040E21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	MGC09-C11	MGC	W01C040E22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063682	MGC09-C12	MGC	W01C040E23	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC063682	MGC09-C12	MGC	W01C040E24	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC056911	MGC09-C01	MGC	W01C040F01	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC056911	MGC09-C01	MGC	W01C040F02	pDONR221	14997		DUSP15	128853	AAH56911.1	Hs.585017	Dual specificity phosphatase 15			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_080611.3	NP_542178.2	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC062555	MGC09-C02	MGC	W01C040F03	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC062555	MGC09-C02	MGC	W01C040F04	pDONR221	8830		GPT2	84706	AAH62555.1	Hs.460693	Glutamic pyruvate transaminase (alanine aminotransferase) 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_133443.2	NP_597700.1	VALIDATED	OK	1.000	1.000	523	1572	1	1569	523	1	523
IKAKEN	BC056878	MGC09-C03	MGC	W01C040F05	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056878	MGC09-C03	MGC	W01C040F06	pDONR221	19825		TRMT11	60487	AAH56878.1	Hs.404186	TRNA methyltransferase 11 homolog (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001031712.2	NP_001026882.2	VALIDATED	Ps	0.988	0.988	257	774	1	771	463	1	257
IKAKEN	BC056908	MGC09-C04	MGC	W01C040F07	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056908	MGC09-C04	MGC	W01C040F08	pDONR221	20608		C6orf145	221749	AAH56908.1	Hs.484500	Chromosome 6 open reading frame 145			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_183373.3	NP_899229.2	VALIDATED	OK	1.000	1.000	231	696	1	693	231	1	231
IKAKEN	BC056893	MGC09-C05	MGC	W01C040F09	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC056893	MGC09-C05	MGC	W01C040F10	pDONR221	19077		TTC37	9652	AAH56893.1	Hs.482868	Tetratricopeptide repeat domain 37			Testis	NIH_MGC_82	DH10B	NM_014639.2	NP_055454.1	PROVISIONAL	OK	1.000	1.000	1564	4695	1	4692	1564	1	1564
IKAKEN	BC058077	MGC09-C06	MGC	W01C040F11	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058077	MGC09-C06	MGC	W01C040F12	pDONR221	15980		RASL10A	10633	AAH58077.1	Hs.73088	RAS-like, family 10, member A			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_006477.3	NP_006468.1	VALIDATED	OK	1.000	1.000	203	612	1	609	203	1	203
IKAKEN	BC058924	MGC09-C07	MGC	W01C040F13	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC058924	MGC09-C07	MGC	W01C040F14	pDONR221	12120		UBE2M	9040	AAH58924.1	Hs.406068	Ubiquitin-conjugating enzyme E2M (UBC12 homolog, yeast)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_003969.3	NP_003960.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	BC063646	MGC09-C08	MGC	W01C040F15	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	MGC09-C08	MGC	W01C040F16	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC064348	MGC09-C09	MGC	W01C040F17	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	MGC09-C09	MGC	W01C040F18	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC063633	MGC09-C10	MGC	W01C040F19	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063633	MGC09-C10	MGC	W01C040F20	pDONR221	9350		PDXDC2	283970	AAH63633	Hs.513695	Pyridoxal-dependent decarboxylase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B			
IKAKEN	BC063634	MGC09-C11	MGC	W01C040F21	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063634	MGC09-C11	MGC	W01C040F22	pDONR221	23774		MAMDC2	256691	AAH63634.1	Hs.547172	MAM domain containing 2			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153267.4	NP_694999.3	VALIDATED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC063682	MGC09-C12	MGC	W01C040F23	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC063682	MGC09-C12	MGC	W01C040F24	pDONR221	1987		WASH6P	653440	AAH63682					Skin, normal	NCI_CGAP_Skn3	DH10B	XM_377073.4	XP_377073.3	MODEL	Pfs	0.977	0.977	264	794	1	791	447	184	447
IKAKEN	BC063688	MGC09-D01	MGC	W01C040G01	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063688	MGC09-D01	MGC	W01C040G02	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063644	MGC09-D02	MGC	W01C040G03	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063644	MGC09-D02	MGC	W01C040G04	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063575	MGC09-D03	MGC	W01C040G05	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063575	MGC09-D03	MGC	W01C040G06	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063703	MGC09-D04	MGC	W01C040G07	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	MGC09-D04	MGC	W01C040G08	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063471	MGC09-D06	MGC	W01C040G11	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063471	MGC09-D06	MGC	W01C040G12	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063021	MGC09-D08	MGC	W01C040G15	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063021	MGC09-D08	MGC	W01C040G16	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063451	MGC09-D09	MGC	W01C040G17	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063451	MGC09-D09	MGC	W01C040G18	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063502	MGC09-D10	MGC	W01C040G19	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC063502	MGC09-D10	MGC	W01C040G20	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC062575	MGC09-D11	MGC	W01C040G21	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC062575	MGC09-D11	MGC	W01C040G22	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC063688	MGC09-D01	MGC	W01C040H01	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063688	MGC09-D01	MGC	W01C040H02	pDONR221	20709		FAM54A	113115	AAH63688.2	Hs.121536	Family with sequence similarity 54, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138419.3	NP_612428.2	VALIDATED	OK	1.000	1.000	385	1158	1	1155	385	1	385
IKAKEN	BC063644	MGC09-D02	MGC	W01C040H03	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063644	MGC09-D02	MGC	W01C040H04	pDONR221	24110		C9orf114	51490	AAH63644.1	Hs.224137	Chromosome 9 open reading frame 114			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_016390.2	NP_057474.2	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC063575	MGC09-D03	MGC	W01C040H05	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063575	MGC09-D03	MGC	W01C040H06	pDONR221	5922		PLEKHA9	51054	AAH63575.1	Hs.558495	Pleckstrin homology domain containing, family A (phosphoinositide binding specific) member 9			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_015899.1	NP_056983.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC063703	MGC09-D04	MGC	W01C040H07	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063703	MGC09-D04	MGC	W01C040H08	pDONR221	9411		LOC595101	595101	AAH63703	Hs.654650	PI-3-kinase-related kinase SMG-1 pseudogene			Skin, normal	NCI_CGAP_Skn3	DH10B			
IKAKEN	BC063471	MGC09-D06	MGC	W01C040H11	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063471	MGC09-D06	MGC	W01C040H12	pDONR221	18189		SLC10A7	84068	AAH63471.1	Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032128.3	NP_115504.1	VALIDATED	OK	1.000	1.000	159	480	1	477	159	1	159
IKAKEN	BC063021	MGC09-D08	MGC	W01C040H15	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063021	MGC09-D08	MGC	W01C040H16	pDONR221	11836		PRR19	284338	AAH63021.1	Hs.585901	Proline rich 19			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_199285.2	NP_954979.2	VALIDATED	Ps	0.990	0.990	204	708	1	612	356	1	204
IKAKEN	BC063451	MGC09-D09	MGC	W01C040H17	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063451	MGC09-D09	MGC	W01C040H18	pDONR221	20799		TCP10	6953	AAH63451.1	Hs.351	T-complex 10 homolog (mouse)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_004610.3	NP_004601.3	VALIDATED		0.969	0.969	326	1062	82	1059	326	1	326
IKAKEN	BC063502	MGC09-D10	MGC	W01C040H19	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC063502	MGC09-D10	MGC	W01C040H20	pDONR221	14154		C2orf60	129450	AAH63502.1	Hs.204619	Chromosome 2 open reading frame 60			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_001039693.2	NP_001034782.1	VALIDATED	P	1.000	1.000	152	459	1	456	315	164	315
IKAKEN	BC062575	MGC09-D11	MGC	W01C040H21	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC062575	MGC09-D11	MGC	W01C040H22	pDONR221	6984		RHOJ	57381	AAH62575.1	Hs.656339	Ras homolog gene family, member J			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020663.3	NP_065714.1	PROVISIONAL	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	BC063406	MGC09-E01	MGC	W01C040I01	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC063406	MGC09-E01	MGC	W01C040I02	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC062619	MGC09-E02	MGC	W01C040I03	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC062619	MGC09-E02	MGC	W01C040I04	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC064553	MGC09-E04	MGC	W01C040I07	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	MGC09-E04	MGC	W01C040I08	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064581	MGC09-E05	MGC	W01C040I09	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC064581	MGC09-E05	MGC	W01C040I10	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC065510	MGC09-E06	MGC	W01C040I11	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	MGC09-E06	MGC	W01C040I12	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065509	MGC09-E07	MGC	W01C040I13	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC065509	MGC09-E07	MGC	W01C040I14	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC064626	MGC09-E08	MGC	W01C040I15	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	MGC09-E08	MGC	W01C040I16	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064361	MGC09-E09	MGC	W01C040I17	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC064361	MGC09-E09	MGC	W01C040I18	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC065223	MGC09-E10	MGC	W01C040I19	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC065223	MGC09-E10	MGC	W01C040I20	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC064999	MGC09-E11	MGC	W01C040I21	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064999	MGC09-E11	MGC	W01C040I22	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064421	MGC09-E12	MGC	W01C040I23	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC064421	MGC09-E12	MGC	W01C040I24	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC063406	MGC09-E01	MGC	W01C040J01	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC063406	MGC09-E01	MGC	W01C040J02	pDONR221	19318		FAM173B	134145	AAH63406.1	Hs.481569	Family with sequence similarity 173, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_199133.2	NP_954584.2	VALIDATED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC062619	MGC09-E02	MGC	W01C040J03	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC062619	MGC09-E02	MGC	W01C040J04	pDONR221	1547		HBXIP	10542	AAH62619.2	Hs.439815	Hepatitis B virus x interacting protein			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_006402.2	NP_006393.2	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC064553	MGC09-E04	MGC	W01C040J07	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064553	MGC09-E04	MGC	W01C040J08	pDONR221	6027		PRH1	5554	AAH64553					Brain, adult medulla	NIH_MGC_119	DH10B	NM_006250.2	NP_006241.2	PROVISIONAL	Cs	0.982	0.982	166	501	1	498	166	1	166
IKAKEN	BC064581	MGC09-E05	MGC	W01C040J09	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC064581	MGC09-E05	MGC	W01C040J10	pDONR221	4046		RNF214	257160	AAH64581	Hs.591934	Ring finger protein 214			Brain, hippocampus	NIH_MGC_124	DH10B	NM_207343.2	NP_997226.2	VALIDATED	P	1.000	1.000	639	1922	3	1919	703	65	703
IKAKEN	BC065510	MGC09-E06	MGC	W01C040J11	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	MGC09-E06	MGC	W01C040J12	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065509	MGC09-E07	MGC	W01C040J13	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC065509	MGC09-E07	MGC	W01C040J14	pDONR221	15206		COL6A2	1292	AAH65509.1	Hs.420269	Collagen, type VI, alpha 2			Placenta	NIH_MGC_79	DH10B	NM_001849.3	NP_001840.3	REVIEWED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC064626	MGC09-E08	MGC	W01C040J15	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064626	MGC09-E08	MGC	W01C040J16	pDONR221	7897		WDR93	56964	AAH64626.1	Hs.177557	WD repeat domain 93			Brain, hippocampus	NIH_MGC_124	DH10B	NM_020212.1	NP_064597.1	PROVISIONAL	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	BC064361	MGC09-E09	MGC	W01C040J17	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC064361	MGC09-E09	MGC	W01C040J18	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	OK	1.000	1.000	1056	3171	1	3168	1056	1	1056
IKAKEN	BC065223	MGC09-E10	MGC	W01C040J19	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC065223	MGC09-E10	MGC	W01C040J20	pDONR221	11827		HMHA1	23526	AAH65223.1	Hs.465521	Histocompatibility (minor) HA-1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012292.2	NP_036424.2	VALIDATED	OK	1.000	1.000	1136	3411	1	3408	1136	1	1136
IKAKEN	BC064999	MGC09-E11	MGC	W01C040J21	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064999	MGC09-E11	MGC	W01C040J22	pDONR221	6941		DAAM1	23002	AAH64999.1	Hs.654934	Dishevelled associated activator of morphogenesis 1			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014992.1	NP_055807.1	REVIEWED	Cg	0.991	1.000	1078	3207	1	3204	1078	1	1078
IKAKEN	BC064421	MGC09-E12	MGC	W01C040J23	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC064421	MGC09-E12	MGC	W01C040J24	pDONR221	13112		C2orf29	55571	AAH64421.1	Hs.715598	Chromosome 2 open reading frame 29			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_017546.4	NP_060016.3	VALIDATED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	BC064574	MGC09-F01	MGC	W01C040K01	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC064574	MGC09-F01	MGC	W01C040K02	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC066643	MGC09-F02	MGC	W01C040K03	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	MGC09-F02	MGC	W01C040K04	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	MGC09-F03	MGC	W01C040K05	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	MGC09-F03	MGC	W01C040K06	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC062342	MGC09-F04	MGC	W01C040K07	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC062342	MGC09-F04	MGC	W01C040K08	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC064623	MGC09-F05	MGC	W01C040K09	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064623	MGC09-F05	MGC	W01C040K10	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064994	MGC09-F06	MGC	W01C040K11	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	MGC09-F06	MGC	W01C040K12	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064577	MGC09-F07	MGC	W01C040K13	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064577	MGC09-F07	MGC	W01C040K14	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064403	MGC09-F08	MGC	W01C040K15	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC064403	MGC09-F08	MGC	W01C040K16	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC065232	MGC09-F09	MGC	W01C040K17	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065232	MGC09-F09	MGC	W01C040K18	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064931	MGC09-F10	MGC	W01C040K19	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064931	MGC09-F10	MGC	W01C040K20	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064961	MGC09-F11	MGC	W01C040K21	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC064961	MGC09-F11	MGC	W01C040K22	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC065271	MGC09-F12	MGC	W01C040K23	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC065271	MGC09-F12	MGC	W01C040K24	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC064574	MGC09-F01	MGC	W01C040L01	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC064574	MGC09-F01	MGC	W01C040L02	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.929	1.000	851	2557	1	2555	795	4	794
IKAKEN	BC066643	MGC09-F02	MGC	W01C040L03	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	MGC09-F02	MGC	W01C040L04	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC067364	MGC09-F03	MGC	W01C040L05	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC067364	MGC09-F03	MGC	W01C040L06	pDONR221	5280		PRPF40B	25766	AAH67364.1	Hs.706827	PRP40 pre-mRNA processing factor 40 homolog B (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_012272.1	NP_036404.1	PROVISIONAL	C	1.000	1.000	858	2577	1	2574	858	1	858
IKAKEN	BC062342	MGC09-F04	MGC	W01C040L07	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC062342	MGC09-F04	MGC	W01C040L08	pDONR221	1345		RERE	473	AAH62342	Hs.463041	Arginine-glutamic acid dipeptide (RE) repeats			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_012102.3	NP_036234.3	REVIEWED	OK	1.000	1.000	1566	4701	1	4698	1566	1	1566
IKAKEN	BC064623	MGC09-F05	MGC	W01C040L09	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064623	MGC09-F05	MGC	W01C040L10	pDONR221	15319		POFUT2	23275	AAH64623.1	Hs.592164	Protein O-fucosyltransferase 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_133634.3	NP_598367.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC064994	MGC09-F06	MGC	W01C040L11	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064994	MGC09-F06	MGC	W01C040L12	pDONR221	9844		LLGL2	3993	AAH64994.1	Hs.514477	Lethal giant larvae homolog 2 (Drosophila)			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_004524.2	NP_004515.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	BC064577	MGC09-F07	MGC	W01C040L13	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064577	MGC09-F07	MGC	W01C040L14	pDONR221	8753		CPNE7	27132	AAH64577.1	Hs.461775	Copine VII			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_153636.2	NP_705900.1	REVIEWED	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	BC064403	MGC09-F08	MGC	W01C040L15	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC064403	MGC09-F08	MGC	W01C040L16	pDONR221	18207		PRMT10	90826	AAH64403.1	Hs.591692	Hypothetical protein BC004337			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138364.2	NP_612373.2	PROVISIONAL	OK	1.000	1.000	845	2538	1	2535	845	1	845
IKAKEN	BC065232	MGC09-F09	MGC	W01C040L17	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065232	MGC09-F09	MGC	W01C040L18	pDONR221	15996		CHCHD10	400916	AAH65232.1	Hs.66915	Coiled-coil-helix-coiled-coil-helix domain containing 10			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_213720.1	NP_998885.1	PROVISIONAL	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064931	MGC09-F10	MGC	W01C040L19	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064931	MGC09-F10	MGC	W01C040L20	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.968	0.968	222	669	1	666	509	125	346
IKAKEN	BC064961	MGC09-F11	MGC	W01C040L21	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC064961	MGC09-F11	MGC	W01C040L22	pDONR221	7784		TMOD2	29767	AAH64961.1	Hs.659839	Tropomodulin 2 (neuronal)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_014548.3	NP_055363.1	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC065271	MGC09-F12	MGC	W01C040L23	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC065271	MGC09-F12	MGC	W01C040L24	pDONR221	13254		ARMC9	80210	AAH65271.1	Hs.471610	Armadillo repeat containing 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_025139.3	NP_079415.3	VALIDATED	Cs	0.998	0.998	665	1998	1	1995	665	1	665
IKAKEN	BC065541	MGC09-G01	MGC	W01C040M01	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC065541	MGC09-G01	MGC	W01C040M02	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC064968	MGC09-G02	MGC	W01C040M03	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC064968	MGC09-G02	MGC	W01C040M04	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC065273	MGC09-G03	MGC	W01C040M05	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065273	MGC09-G03	MGC	W01C040M06	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC063026	MGC09-G04	MGC	W01C040M07	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC063026	MGC09-G04	MGC	W01C040M08	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC067125	MGC09-G05	MGC	W01C040M09	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC067125	MGC09-G05	MGC	W01C040M10	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC065531	MGC09-G06	MGC	W01C040M11	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC065531	MGC09-G06	MGC	W01C040M12	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC064918	MGC09-G07	MGC	W01C040M13	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064918	MGC09-G07	MGC	W01C040M14	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064946	MGC09-G08	MGC	W01C040M15	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC064946	MGC09-G08	MGC	W01C040M16	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC065551	MGC09-G09	MGC	W01C040M17	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	MGC09-G09	MGC	W01C040M18	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065930	MGC09-G10	MGC	W01C040M19	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC065930	MGC09-G10	MGC	W01C040M20	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC062319	MGC09-G11	MGC	W01C040M21	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC062319	MGC09-G11	MGC	W01C040M22	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC065525	MGC09-G12	MGC	W01C040M23	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065525	MGC09-G12	MGC	W01C040M24	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065541	MGC09-G01	MGC	W01C040N01	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC065541	MGC09-G01	MGC	W01C040N02	pDONR221	2112		RD3	343035	AAH65541.1	Hs.632495	Retinal degeneration 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_183059.2	NP_898882.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC064968	MGC09-G02	MGC	W01C040N03	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC064968	MGC09-G02	MGC	W01C040N04	pDONR221	20357		GTPBP2	54676	AAH64968.1	Hs.485449	GTP binding protein 2			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_019096.3	NP_061969.3	VALIDATED	P	1.000	1.000	514	1545	1	1542	602	89	602
IKAKEN	BC065273	MGC09-G03	MGC	W01C040N05	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065273	MGC09-G03	MGC	W01C040N06	pDONR221	11985		MRPL54	116541	AAH65273.1	Hs.356578	Mitochondrial ribosomal protein L54			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_172251.2	NP_758455.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC063026	MGC09-G04	MGC	W01C040N07	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC063026	MGC09-G04	MGC	W01C040N08	pDONR221	21120		NDUFB2	4708	AAH63026.1	Hs.655788	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 2, 8kDa			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_004546.2	NP_004537.1	REVIEWED	P	1.000	1.000	72	288	70	285	105	34	105
IKAKEN	BC067125	MGC09-G05	MGC	W01C040N09	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC067125	MGC09-G05	MGC	W01C040N10	pDONR221	11919		ARMC6	93436	AAH67125.1	Hs.77876	Armadillo repeat containing 6			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_033415.2	NP_219483.1	REVIEWED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	BC065531	MGC09-G06	MGC	W01C040N11	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC065531	MGC09-G06	MGC	W01C040N12	pDONR221	16500		PPP2R3A	5523	AAH65531.1	Hs.518155	Protein phosphatase 2 (formerly 2A), regulatory subunit B'', alpha			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_002718.3	NP_002709.2	REVIEWED	OK	1.000	1.000	1150	3453	1	3450	1150	1	1150
IKAKEN	BC064918	MGC09-G07	MGC	W01C040N13	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064918	MGC09-G07	MGC	W01C040N14	pDONR221	10410		DUS1L	64118	AAH64918.1	Hs.514599	Dihydrouridine synthase 1-like (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_022156.3	NP_071439.3	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	BC064946	MGC09-G08	MGC	W01C040N15	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC064946	MGC09-G08	MGC	W01C040N16	pDONR221	8683		COQ9	57017	AAH64946.1	Hs.513632	Coenzyme Q9 homolog (S. cerevisiae)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020312.1	NP_064708.1	PROVISIONAL	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC065551	MGC09-G09	MGC	W01C040N17	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065551	MGC09-G09	MGC	W01C040N18	pDONR221	9586		WIPF2	147179	AAH65551.1	Hs.421622	WAS/WASL interacting protein family, member 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_133264.4	NP_573571.1	VALIDATED	Cfs	0.261	0.518	440	670	1	666	440	1	440
IKAKEN	BC065930	MGC09-G10	MGC	W01C040N19	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC065930	MGC09-G10	MGC	W01C040N20	pDONR221	21929		TMEM60	85025	AAH65930.1	Hs.19025	Transmembrane protein 60			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_032936.3	NP_116325.1	VALIDATED	Pfs	0.988	1.000	86	258	1	256	133	1	86
IKAKEN	BC062319	MGC09-G11	MGC	W01C040N21	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC062319	MGC09-G11	MGC	W01C040N22	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC065525	MGC09-G12	MGC	W01C040N23	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065525	MGC09-G12	MGC	W01C040N24	pDONR221	13859		ADD2	119	AAH65525.1	Hs.188528	Adducin 2 (beta)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_001617.2	NP_001608.1	REVIEWED	OK	1.000	1.000	726	2181	1	2178	726	1	726
IKAKEN	BC065269	MGC09-H01	MGC	W01C040O01	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	MGC09-H01	MGC	W01C040O02	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC064948	MGC09-H02	MGC	W01C040O03	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC064948	MGC09-H02	MGC	W01C040O04	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066649	MGC09-H03	MGC	W01C040O05	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC066649	MGC09-H03	MGC	W01C040O06	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC067131	MGC09-H04	MGC	W01C040O07	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC067131	MGC09-H04	MGC	W01C040O08	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC065007	MGC09-H05	MGC	W01C040O09	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065007	MGC09-H05	MGC	W01C040O10	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065016	MGC09-H06	MGC	W01C040O11	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	MGC09-H06	MGC	W01C040O12	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065564	MGC09-H07	MGC	W01C040O13	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC065564	MGC09-H07	MGC	W01C040O14	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC064027	MGC09-H09	MGC	W01C040O17	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC064027	MGC09-H09	MGC	W01C040O18	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC062416	MGC09-H10	MGC	W01C040O19	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC062416	MGC09-H10	MGC	W01C040O20	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC064829	MGC09-H11	MGC	W01C040O21	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064829	MGC09-H11	MGC	W01C040O22	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064138	MGC09-H12	MGC	W01C040O23	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064138	MGC09-H12	MGC	W01C040O24	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065269	MGC09-H01	MGC	W01C040P01	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	MGC09-H01	MGC	W01C040P02	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC064948	MGC09-H02	MGC	W01C040P03	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC064948	MGC09-H02	MGC	W01C040P04	pDONR221	12580		TMEM205	374882	AAH64948.1	Hs.8036	Transmembrane protein 205			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_198536.2	NP_940938.1	VALIDATED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	BC066649	MGC09-H03	MGC	W01C040P05	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC066649	MGC09-H03	MGC	W01C040P06	pDONR221	1904		C1orf198	84886	AAH66649.1	Hs.520494	Chromosome 1 open reading frame 198			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_032800.2	NP_116189.1	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC067131	MGC09-H04	MGC	W01C040P07	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC067131	MGC09-H04	MGC	W01C040P08	pDONR221	22614		RDH10	157506	AAH67131.1	Hs.244940	Retinol dehydrogenase 10 (all-trans)			White Matter pool-  5 brain tissues- femoral	NIH_MGC_181	DH10B	NM_172037.3	NP_742034.1	VALIDATED	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	BC065007	MGC09-H05	MGC	W01C040P09	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065007	MGC09-H05	MGC	W01C040P10	pDONR221	4799		DDX6	1656	AAH65007.1	Hs.654366	DEAD (Asp-Glu-Ala-Asp) box polypeptide 6			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_004397.4	NP_004388.2	REVIEWED	Pfs	0.871	0.889	425	1317	1	1256	483	62	483
IKAKEN	BC065016	MGC09-H06	MGC	W01C040P11	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	MGC09-H06	MGC	W01C040P12	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065564	MGC09-H07	MGC	W01C040P13	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC065564	MGC09-H07	MGC	W01C040P14	pDONR221	17488		LAP3	51056	AAH65564.1	Hs.570791	Leucine aminopeptidase 3			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_015907.2	NP_056991.2	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC064027	MGC09-H09	MGC	W01C040P17	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC064027	MGC09-H09	MGC	W01C040P18	pDONR221	1332		DPYD	1806	AAH64027.1	Hs.335034	Dihydropyrimidine dehydrogenase			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001160301.1	NP_001153773.1	REVIEWED	Cgs	0.838	0.993	173	441	1	438	173	1	173
IKAKEN	BC062416	MGC09-H10	MGC	W01C040P19	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC062416	MGC09-H10	MGC	W01C040P20	pDONR221	12337		JOSD2	126119	AAH62416.1	Hs.467151	Josephin domain containing 2			Kidney	NIH_MGC_75	DH10B	NM_138334.2	NP_612207.1	PROVISIONAL	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC064829	MGC09-H11	MGC	W01C040P21	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064829	MGC09-H11	MGC	W01C040P22	pDONR221	22973		C8orf82	414919	AAH64829.1	Hs.105685	Chromosome 8 open reading frame 82			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001001795.1	NP_001001795.1	PREDICTED	OK	1.000	1.000	216	651	1	648	216	1	216
IKAKEN	BC064138	MGC09-H12	MGC	W01C040P23	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC064138	MGC09-H12	MGC	W01C040P24	pDONR221	12427		PRDX2	7001	AAH64138	Hs.432121	Peroxiredoxin 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_181738.1	NP_859428.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC005299	MGC10-A01	MGC	W01C041A01	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC005299	MGC10-A01	MGC	W01C041A02	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC007072	MGC10-A02	MGC	W01C041A03	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC007072	MGC10-A02	MGC	W01C041A04	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC005390	MGC10-A03	MGC	W01C041A05	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005390	MGC10-A03	MGC	W01C041A06	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005382	MGC10-A04	MGC	W01C041A07	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC005382	MGC10-A04	MGC	W01C041A08	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC007012	MGC10-A05	MGC	W01C041A09	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC007012	MGC10-A05	MGC	W01C041A10	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC005400	MGC10-A06	MGC	W01C041A11	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005400	MGC10-A06	MGC	W01C041A12	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005304	MGC10-A07	MGC	W01C041A13	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC005304	MGC10-A07	MGC	W01C041A14	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC067274	MGC10-A08	MGC	W01C041A15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	MGC10-A08	MGC	W01C041A16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC007043	MGC10-A09	MGC	W01C041A17	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC007043	MGC10-A09	MGC	W01C041A18	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC005350	MGC10-A10	MGC	W01C041A19	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005350	MGC10-A10	MGC	W01C041A20	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005291	MGC10-A11	MGC	W01C041A21	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	MGC10-A11	MGC	W01C041A22	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005283	MGC10-A12	MGC	W01C041A23	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC005283	MGC10-A12	MGC	W01C041A24	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC005299	MGC10-A01	MGC	W01C041B01	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC005299	MGC10-A01	MGC	W01C041B02	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC007072	MGC10-A02	MGC	W01C041B03	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC007072	MGC10-A02	MGC	W01C041B04	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC005390	MGC10-A03	MGC	W01C041B05	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005390	MGC10-A03	MGC	W01C041B06	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005382	MGC10-A04	MGC	W01C041B07	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC005382	MGC10-A04	MGC	W01C041B08	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC007012	MGC10-A05	MGC	W01C041B09	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC007012	MGC10-A05	MGC	W01C041B10	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC005400	MGC10-A06	MGC	W01C041B11	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005400	MGC10-A06	MGC	W01C041B12	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005304	MGC10-A07	MGC	W01C041B13	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC005304	MGC10-A07	MGC	W01C041B14	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC067274	MGC10-A08	MGC	W01C041B15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	MGC10-A08	MGC	W01C041B16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC007043	MGC10-A09	MGC	W01C041B17	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC007043	MGC10-A09	MGC	W01C041B18	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC005350	MGC10-A10	MGC	W01C041B19	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005350	MGC10-A10	MGC	W01C041B20	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005291	MGC10-A11	MGC	W01C041B21	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	MGC10-A11	MGC	W01C041B22	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005283	MGC10-A12	MGC	W01C041B23	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC005283	MGC10-A12	MGC	W01C041B24	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC003674	MGC10-B01	MGC	W01C041C01	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC003674	MGC10-B01	MGC	W01C041C02	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC005196	MGC10-B02	MGC	W01C041C03	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005196	MGC10-B02	MGC	W01C041C04	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007034	MGC10-B03	MGC	W01C041C05	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC007034	MGC10-B03	MGC	W01C041C06	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC003678	MGC10-B04	MGC	W01C041C07	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC003678	MGC10-B04	MGC	W01C041C08	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC005322	MGC10-B05	MGC	W01C041C09	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC005322	MGC10-B05	MGC	W01C041C10	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC006980	MGC10-B06	MGC	W01C041C11	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006980	MGC10-B06	MGC	W01C041C12	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC005230	MGC10-B07	MGC	W01C041C13	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC005230	MGC10-B07	MGC	W01C041C14	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC007001	MGC10-B08	MGC	W01C041C15	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC007001	MGC10-B08	MGC	W01C041C16	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC005402	MGC10-B09	MGC	W01C041C17	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005402	MGC10-B09	MGC	W01C041C18	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005321	MGC10-B10	MGC	W01C041C19	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005321	MGC10-B10	MGC	W01C041C20	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005379	MGC10-B11	MGC	W01C041C21	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC005379	MGC10-B11	MGC	W01C041C22	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC010926	MGC10-B12	MGC	W01C041C23	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC010926	MGC10-B12	MGC	W01C041C24	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC003674	MGC10-B01	MGC	W01C041D01	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC003674	MGC10-B01	MGC	W01C041D02	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC005196	MGC10-B02	MGC	W01C041D03	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005196	MGC10-B02	MGC	W01C041D04	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007034	MGC10-B03	MGC	W01C041D05	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC007034	MGC10-B03	MGC	W01C041D06	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC003678	MGC10-B04	MGC	W01C041D07	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC003678	MGC10-B04	MGC	W01C041D08	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC005322	MGC10-B05	MGC	W01C041D09	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC005322	MGC10-B05	MGC	W01C041D10	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC006980	MGC10-B06	MGC	W01C041D11	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006980	MGC10-B06	MGC	W01C041D12	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC005230	MGC10-B07	MGC	W01C041D13	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC005230	MGC10-B07	MGC	W01C041D14	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC007001	MGC10-B08	MGC	W01C041D15	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC007001	MGC10-B08	MGC	W01C041D16	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC005402	MGC10-B09	MGC	W01C041D17	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005402	MGC10-B09	MGC	W01C041D18	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005321	MGC10-B10	MGC	W01C041D19	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005321	MGC10-B10	MGC	W01C041D20	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005379	MGC10-B11	MGC	W01C041D21	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC005379	MGC10-B11	MGC	W01C041D22	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC010926	MGC10-B12	MGC	W01C041D23	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC010926	MGC10-B12	MGC	W01C041D24	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC010379	MGC10-C01	MGC	W01C041E01	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010379	MGC10-C01	MGC	W01C041E02	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010922	MGC10-C02	MGC	W01C041E03	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010922	MGC10-C02	MGC	W01C041E04	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010915	MGC10-C03	MGC	W01C041E05	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC010915	MGC10-C03	MGC	W01C041E06	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC012607	MGC10-C04	MGC	W01C041E07	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012607	MGC10-C04	MGC	W01C041E08	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012549	MGC10-C05	MGC	W01C041E09	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC012549	MGC10-C05	MGC	W01C041E10	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC005902	MGC10-C06	MGC	W01C041E11	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC005902	MGC10-C06	MGC	W01C041E12	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008455	MGC10-C07	MGC	W01C041E13	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	MGC10-C07	MGC	W01C041E14	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC006006	MGC10-C08	MGC	W01C041E15	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC006006	MGC10-C08	MGC	W01C041E16	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC005901	MGC10-C09	MGC	W01C041E17	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005901	MGC10-C09	MGC	W01C041E18	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005991	MGC10-C10	MGC	W01C041E19	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC005991	MGC10-C10	MGC	W01C041E20	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC008443	MGC10-C11	MGC	W01C041E21	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008443	MGC10-C11	MGC	W01C041E22	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008500	MGC10-C12	MGC	W01C041E23	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC008500	MGC10-C12	MGC	W01C041E24	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC010379	MGC10-C01	MGC	W01C041F01	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010379	MGC10-C01	MGC	W01C041F02	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010922	MGC10-C02	MGC	W01C041F03	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010922	MGC10-C02	MGC	W01C041F04	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010915	MGC10-C03	MGC	W01C041F05	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC010915	MGC10-C03	MGC	W01C041F06	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC012607	MGC10-C04	MGC	W01C041F07	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012607	MGC10-C04	MGC	W01C041F08	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012549	MGC10-C05	MGC	W01C041F09	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC012549	MGC10-C05	MGC	W01C041F10	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC005902	MGC10-C06	MGC	W01C041F11	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC005902	MGC10-C06	MGC	W01C041F12	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008455	MGC10-C07	MGC	W01C041F13	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	MGC10-C07	MGC	W01C041F14	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC006006	MGC10-C08	MGC	W01C041F15	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC006006	MGC10-C08	MGC	W01C041F16	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC005901	MGC10-C09	MGC	W01C041F17	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005901	MGC10-C09	MGC	W01C041F18	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005991	MGC10-C10	MGC	W01C041F19	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC005991	MGC10-C10	MGC	W01C041F20	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC008443	MGC10-C11	MGC	W01C041F21	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008443	MGC10-C11	MGC	W01C041F22	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008500	MGC10-C12	MGC	W01C041F23	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC008500	MGC10-C12	MGC	W01C041F24	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC005936	MGC10-D01	MGC	W01C041G01	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005936	MGC10-D01	MGC	W01C041G02	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005942	MGC10-D02	MGC	W01C041G03	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC005942	MGC10-D02	MGC	W01C041G04	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC008408	MGC10-D03	MGC	W01C041G05	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC008408	MGC10-D03	MGC	W01C041G06	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC005922	MGC10-D04	MGC	W01C041G07	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC005922	MGC10-D04	MGC	W01C041G08	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC008496	MGC10-D05	MGC	W01C041G09	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC008496	MGC10-D05	MGC	W01C041G10	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC005954	MGC10-D06	MGC	W01C041G11	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC005954	MGC10-D06	MGC	W01C041G12	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC008467	MGC10-D07	MGC	W01C041G13	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC008467	MGC10-D07	MGC	W01C041G14	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC005946	MGC10-D08	MGC	W01C041G15	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC005946	MGC10-D08	MGC	W01C041G16	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC009571	MGC10-D09	MGC	W01C041G17	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC009571	MGC10-D09	MGC	W01C041G18	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC008412	MGC10-D10	MGC	W01C041G19	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC008412	MGC10-D10	MGC	W01C041G20	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC014341	MGC10-D11	MGC	W01C041G21	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014341	MGC10-D11	MGC	W01C041G22	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C041G23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C041G24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC005936	MGC10-D01	MGC	W01C041H01	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005936	MGC10-D01	MGC	W01C041H02	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005942	MGC10-D02	MGC	W01C041H03	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC005942	MGC10-D02	MGC	W01C041H04	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC008408	MGC10-D03	MGC	W01C041H05	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC008408	MGC10-D03	MGC	W01C041H06	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC005922	MGC10-D04	MGC	W01C041H07	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC005922	MGC10-D04	MGC	W01C041H08	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC008496	MGC10-D05	MGC	W01C041H09	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC008496	MGC10-D05	MGC	W01C041H10	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC005954	MGC10-D06	MGC	W01C041H11	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC005954	MGC10-D06	MGC	W01C041H12	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC008467	MGC10-D07	MGC	W01C041H13	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC008467	MGC10-D07	MGC	W01C041H14	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC005946	MGC10-D08	MGC	W01C041H15	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC005946	MGC10-D08	MGC	W01C041H16	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC009571	MGC10-D09	MGC	W01C041H17	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC009571	MGC10-D09	MGC	W01C041H18	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC008412	MGC10-D10	MGC	W01C041H19	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC008412	MGC10-D10	MGC	W01C041H20	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC014341	MGC10-D11	MGC	W01C041H21	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014341	MGC10-D11	MGC	W01C041H22	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C041H23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C041H24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC015116	MGC10-E01	MGC	W01C041I01	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC015116	MGC10-E01	MGC	W01C041I02	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC023988	MGC10-E02	MGC	W01C041I03	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC023988	MGC10-E02	MGC	W01C041I04	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC017571	MGC10-E03	MGC	W01C041I05	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017571	MGC10-E03	MGC	W01C041I06	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC016701	MGC10-E04	MGC	W01C041I07	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC016701	MGC10-E04	MGC	W01C041I08	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC018658	MGC10-E05	MGC	W01C041I09	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018658	MGC10-E05	MGC	W01C041I10	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018660	MGC10-E06	MGC	W01C041I11	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC018660	MGC10-E06	MGC	W01C041I12	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC017998	MGC10-E07	MGC	W01C041I13	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC017998	MGC10-E07	MGC	W01C041I14	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034033	MGC10-E08	MGC	W01C041I15	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC034033	MGC10-E08	MGC	W01C041I16	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC017981	MGC10-E09	MGC	W01C041I17	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC017981	MGC10-E09	MGC	W01C041I18	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC020779	MGC10-E10	MGC	W01C041I19	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC020779	MGC10-E10	MGC	W01C041I20	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC022320	MGC10-E11	MGC	W01C041I21	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC022320	MGC10-E11	MGC	W01C041I22	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC017864	MGC10-E12	MGC	W01C041I23	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC017864	MGC10-E12	MGC	W01C041I24	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC015116	MGC10-E01	MGC	W01C041J01	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC015116	MGC10-E01	MGC	W01C041J02	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC023988	MGC10-E02	MGC	W01C041J03	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC023988	MGC10-E02	MGC	W01C041J04	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC017571	MGC10-E03	MGC	W01C041J05	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017571	MGC10-E03	MGC	W01C041J06	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC016701	MGC10-E04	MGC	W01C041J07	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC016701	MGC10-E04	MGC	W01C041J08	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC018658	MGC10-E05	MGC	W01C041J09	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018658	MGC10-E05	MGC	W01C041J10	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018660	MGC10-E06	MGC	W01C041J11	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC018660	MGC10-E06	MGC	W01C041J12	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC017998	MGC10-E07	MGC	W01C041J13	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC017998	MGC10-E07	MGC	W01C041J14	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034033	MGC10-E08	MGC	W01C041J15	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC034033	MGC10-E08	MGC	W01C041J16	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC017981	MGC10-E09	MGC	W01C041J17	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC017981	MGC10-E09	MGC	W01C041J18	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC020779	MGC10-E10	MGC	W01C041J19	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC020779	MGC10-E10	MGC	W01C041J20	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC022320	MGC10-E11	MGC	W01C041J21	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC022320	MGC10-E11	MGC	W01C041J22	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC017864	MGC10-E12	MGC	W01C041J23	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC017864	MGC10-E12	MGC	W01C041J24	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC020814	MGC10-F01	MGC	W01C041K01	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC020814	MGC10-F01	MGC	W01C041K02	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC022401	MGC10-F02	MGC	W01C041K03	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC022401	MGC10-F02	MGC	W01C041K04	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC017952	MGC10-F03	MGC	W01C041K05	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017952	MGC10-F03	MGC	W01C041K06	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017922	MGC10-F04	MGC	W01C041K07	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017922	MGC10-F04	MGC	W01C041K08	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017891	MGC10-F05	MGC	W01C041K09	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017891	MGC10-F05	MGC	W01C041K10	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC020778	MGC10-F06	MGC	W01C041K11	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC020778	MGC10-F06	MGC	W01C041K12	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC017783	MGC10-F07	MGC	W01C041K13	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC017783	MGC10-F07	MGC	W01C041K14	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC020790	MGC10-F08	MGC	W01C041K15	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC020790	MGC10-F08	MGC	W01C041K16	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC026285	MGC10-F09	MGC	W01C041K17	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC026285	MGC10-F09	MGC	W01C041K18	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC022371	MGC10-F10	MGC	W01C041K19	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022371	MGC10-F10	MGC	W01C041K20	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022286	MGC10-F11	MGC	W01C041K21	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC022286	MGC10-F11	MGC	W01C041K22	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC020619	MGC10-F12	MGC	W01C041K23	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020619	MGC10-F12	MGC	W01C041K24	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020814	MGC10-F01	MGC	W01C041L01	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC020814	MGC10-F01	MGC	W01C041L02	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC022401	MGC10-F02	MGC	W01C041L03	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC022401	MGC10-F02	MGC	W01C041L04	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC017952	MGC10-F03	MGC	W01C041L05	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017952	MGC10-F03	MGC	W01C041L06	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017922	MGC10-F04	MGC	W01C041L07	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017922	MGC10-F04	MGC	W01C041L08	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017891	MGC10-F05	MGC	W01C041L09	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017891	MGC10-F05	MGC	W01C041L10	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC020778	MGC10-F06	MGC	W01C041L11	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC020778	MGC10-F06	MGC	W01C041L12	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC017783	MGC10-F07	MGC	W01C041L13	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC017783	MGC10-F07	MGC	W01C041L14	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC020790	MGC10-F08	MGC	W01C041L15	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC020790	MGC10-F08	MGC	W01C041L16	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC026285	MGC10-F09	MGC	W01C041L17	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC026285	MGC10-F09	MGC	W01C041L18	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC022371	MGC10-F10	MGC	W01C041L19	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022371	MGC10-F10	MGC	W01C041L20	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022286	MGC10-F11	MGC	W01C041L21	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC022286	MGC10-F11	MGC	W01C041L22	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC020619	MGC10-F12	MGC	W01C041L23	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020619	MGC10-F12	MGC	W01C041L24	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020711	MGC10-G01	MGC	W01C041M01	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC020711	MGC10-G01	MGC	W01C041M02	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC035931	MGC10-G02	MGC	W01C041M03	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC035931	MGC10-G02	MGC	W01C041M04	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC026278	MGC10-G03	MGC	W01C041M05	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	MGC10-G03	MGC	W01C041M06	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC020633	MGC10-G04	MGC	W01C041M07	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC020633	MGC10-G04	MGC	W01C041M08	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC022248	MGC10-G05	MGC	W01C041M09	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC022248	MGC10-G05	MGC	W01C041M10	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC030817	MGC10-G06	MGC	W01C041M11	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC030817	MGC10-G06	MGC	W01C041M12	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC020894	MGC10-G07	MGC	W01C041M13	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020894	MGC10-G07	MGC	W01C041M14	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020757	MGC10-G08	MGC	W01C041M15	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC020757	MGC10-G08	MGC	W01C041M16	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC024233	MGC10-G09	MGC	W01C041M17	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC024233	MGC10-G09	MGC	W01C041M18	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC016372	MGC10-G10	MGC	W01C041M19	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC016372	MGC10-G10	MGC	W01C041M20	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC017422	MGC10-G11	MGC	W01C041M21	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC017422	MGC10-G11	MGC	W01C041M22	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC018688	MGC10-G12	MGC	W01C041M23	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC018688	MGC10-G12	MGC	W01C041M24	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC020711	MGC10-G01	MGC	W01C041N01	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC020711	MGC10-G01	MGC	W01C041N02	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC035931	MGC10-G02	MGC	W01C041N03	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC035931	MGC10-G02	MGC	W01C041N04	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC026278	MGC10-G03	MGC	W01C041N05	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	MGC10-G03	MGC	W01C041N06	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC020633	MGC10-G04	MGC	W01C041N07	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC020633	MGC10-G04	MGC	W01C041N08	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC022248	MGC10-G05	MGC	W01C041N09	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC022248	MGC10-G05	MGC	W01C041N10	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC030817	MGC10-G06	MGC	W01C041N11	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC030817	MGC10-G06	MGC	W01C041N12	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC020894	MGC10-G07	MGC	W01C041N13	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020894	MGC10-G07	MGC	W01C041N14	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020757	MGC10-G08	MGC	W01C041N15	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC020757	MGC10-G08	MGC	W01C041N16	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC024233	MGC10-G09	MGC	W01C041N17	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC024233	MGC10-G09	MGC	W01C041N18	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC016372	MGC10-G10	MGC	W01C041N19	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC016372	MGC10-G10	MGC	W01C041N20	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC017422	MGC10-G11	MGC	W01C041N21	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC017422	MGC10-G11	MGC	W01C041N22	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC018688	MGC10-G12	MGC	W01C041N23	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC018688	MGC10-G12	MGC	W01C041N24	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC029427	MGC10-H01	MGC	W01C041O01	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC029427	MGC10-H01	MGC	W01C041O02	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC055417	MGC10-H02	MGC	W01C041O03	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	MGC10-H02	MGC	W01C041O04	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC029478	MGC10-H03	MGC	W01C041O05	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029478	MGC10-H03	MGC	W01C041O06	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029437	MGC10-H04	MGC	W01C041O07	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC029437	MGC10-H04	MGC	W01C041O08	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC035959	MGC10-H05	MGC	W01C041O09	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC035959	MGC10-H05	MGC	W01C041O10	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC054892	MGC10-H06	MGC	W01C041O11	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC054892	MGC10-H06	MGC	W01C041O12	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC029405	MGC10-H07	MGC	W01C041O13	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	MGC10-H07	MGC	W01C041O14	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC056253	MGC10-H08	MGC	W01C041O15	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC056253	MGC10-H08	MGC	W01C041O16	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC054022	MGC10-H09	MGC	W01C041O17	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054022	MGC10-H09	MGC	W01C041O18	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054876	MGC10-H10	MGC	W01C041O19	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC054876	MGC10-H10	MGC	W01C041O20	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC055088	MGC10-H11	MGC	W01C041O21	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC055088	MGC10-H11	MGC	W01C041O22	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC056686	MGC10-H12	MGC	W01C041O23	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC056686	MGC10-H12	MGC	W01C041O24	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC029427	MGC10-H01	MGC	W01C041P01	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC029427	MGC10-H01	MGC	W01C041P02	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC055417	MGC10-H02	MGC	W01C041P03	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	MGC10-H02	MGC	W01C041P04	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC029478	MGC10-H03	MGC	W01C041P05	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029478	MGC10-H03	MGC	W01C041P06	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029437	MGC10-H04	MGC	W01C041P07	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC029437	MGC10-H04	MGC	W01C041P08	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC035959	MGC10-H05	MGC	W01C041P09	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC035959	MGC10-H05	MGC	W01C041P10	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC054892	MGC10-H06	MGC	W01C041P11	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC054892	MGC10-H06	MGC	W01C041P12	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC029405	MGC10-H07	MGC	W01C041P13	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	MGC10-H07	MGC	W01C041P14	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC056253	MGC10-H08	MGC	W01C041P15	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC056253	MGC10-H08	MGC	W01C041P16	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC054022	MGC10-H09	MGC	W01C041P17	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054022	MGC10-H09	MGC	W01C041P18	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054876	MGC10-H10	MGC	W01C041P19	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC054876	MGC10-H10	MGC	W01C041P20	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC055088	MGC10-H11	MGC	W01C041P21	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC055088	MGC10-H11	MGC	W01C041P22	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC056686	MGC10-H12	MGC	W01C041P23	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC056686	MGC10-H12	MGC	W01C041P24	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC005299	MGC10-A01	MGC	W01C042A01	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC005299	MGC10-A01	MGC	W01C042A02	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC007072	MGC10-A02	MGC	W01C042A03	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC007072	MGC10-A02	MGC	W01C042A04	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC005390	MGC10-A03	MGC	W01C042A05	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005390	MGC10-A03	MGC	W01C042A06	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005382	MGC10-A04	MGC	W01C042A07	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC005382	MGC10-A04	MGC	W01C042A08	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC007012	MGC10-A05	MGC	W01C042A09	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC007012	MGC10-A05	MGC	W01C042A10	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC005400	MGC10-A06	MGC	W01C042A11	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005400	MGC10-A06	MGC	W01C042A12	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005304	MGC10-A07	MGC	W01C042A13	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC005304	MGC10-A07	MGC	W01C042A14	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC067274	MGC10-A08	MGC	W01C042A15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	MGC10-A08	MGC	W01C042A16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC007043	MGC10-A09	MGC	W01C042A17	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC007043	MGC10-A09	MGC	W01C042A18	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC005350	MGC10-A10	MGC	W01C042A19	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005350	MGC10-A10	MGC	W01C042A20	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005291	MGC10-A11	MGC	W01C042A21	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	MGC10-A11	MGC	W01C042A22	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005283	MGC10-A12	MGC	W01C042A23	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC005283	MGC10-A12	MGC	W01C042A24	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC005299	MGC10-A01	MGC	W01C042B01	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC005299	MGC10-A01	MGC	W01C042B02	pDONR221	22047		CYCS	54205	AAH05299.1	Hs.617193	Cytochrome c, somatic			Skeletal Muscle	NIH_MGC_81	DH10B	NM_018947.4	NP_061820.1	REVIEWED		0.914	0.914	105	318	1	315	105	1	105
IKAKEN	BC007072	MGC10-A02	MGC	W01C042B03	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC007072	MGC10-A02	MGC	W01C042B04	pDONR221	2164		ANKRD26L1	84832	AAH07072	Hs.537067	Ankyrin repeat domain 26-like 1			Skeletal Muscle	NIH_MGC_81	DH10B													
IKAKEN	BC005390	MGC10-A03	MGC	W01C042B05	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005390	MGC10-A03	MGC	W01C042B06	pDONR221	6996		PSMC6	5706	AAH05390.1	Hs.156171	Proteasome (prosome, macropain) 26S subunit, ATPase, 6			Testis	NIH_MGC_82	DH10B	NM_002806.3	NP_002797.3	REVIEWED		0.969	0.969	389	1170	1	1167	403	15	403
IKAKEN	BC005382	MGC10-A04	MGC	W01C042B07	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC005382	MGC10-A04	MGC	W01C042B08	pDONR221	25229		SPANXE	171489	AAH05382.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145665.1	NP_663698.1	REVIEWED		0.979	0.979	97	294	1	291	97	1	97
IKAKEN	BC007012	MGC10-A05	MGC	W01C042B09	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC007012	MGC10-A05	MGC	W01C042B10	pDONR221	24087		CLIC3	9022	AAH07012.2	Hs.64746	Chloride intracellular channel 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004669.2	NP_004660.2	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC005400	MGC10-A06	MGC	W01C042B11	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005400	MGC10-A06	MGC	W01C042B12	pDONR221	19255		CENPK	64105	AAH05400.1	Hs.529778	Centromere protein K			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_022145.3	NP_071428.2	VALIDATED	OK	1.000	1.000	269	810	1	807	269	1	269
IKAKEN	BC005304	MGC10-A07	MGC	W01C042B13	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC005304	MGC10-A07	MGC	W01C042B14	pDONR221	19188		GLRX	2745	AAH05304.1	Hs.28988	Glutaredoxin (thioltransferase)			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_001118890.1	NP_001112362.1	VALIDATED		0.915	0.915	106	321	1	318	106	1	106
IKAKEN	BC067274	MGC10-A08	MGC	W01C042B15	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	MGC10-A08	MGC	W01C042B16	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC007043	MGC10-A09	MGC	W01C042B17	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC007043	MGC10-A09	MGC	W01C042B18	pDONR221	2694		CISD1	55847	AAH07043.1	Hs.370102	CDGSH iron sulfur domain 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_018464.3	NP_060934.1	VALIDATED		0.870	0.870	108	327	1	324	108	1	108
IKAKEN	BC005350	MGC10-A10	MGC	W01C042B19	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005350	MGC10-A10	MGC	W01C042B20	pDONR221	13145		REG1A	5967	AAH05350.1	Hs.49407	Regenerating islet-derived 1 alpha			Brain, hippocampus	NIH_MGC_95	DH10B	NM_002909.4	NP_002900.2	REVIEWED	OK	1.000	1.000	166	501	1	498	166	1	166
IKAKEN	BC005291	MGC10-A11	MGC	W01C042B21	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005291	MGC10-A11	MGC	W01C042B22	pDONR221	20340		EEF1E1	9521	AAH05291.1	Hs.719206	Eukaryotic translation elongation factor 1 epsilon 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004280.4	NP_004271.1	REVIEWED	OK	1.000	1.000	174	525	1	522	174	1	174
IKAKEN	BC005283	MGC10-A12	MGC	W01C042B23	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC005283	MGC10-A12	MGC	W01C042B24	pDONR221	7755		ZFAND6	54469	AAH05283.1	Hs.719106	Zinc finger, AN1-type domain 6			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_019006.2	NP_061879.2	PROVISIONAL	Pfs	0.894	0.932	199	573	1	572	208	1	199
IKAKEN	BC003674	MGC10-B01	MGC	W01C042C01	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC003674	MGC10-B01	MGC	W01C042C02	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC005196	MGC10-B02	MGC	W01C042C03	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005196	MGC10-B02	MGC	W01C042C04	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007034	MGC10-B03	MGC	W01C042C05	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC007034	MGC10-B03	MGC	W01C042C06	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC003678	MGC10-B04	MGC	W01C042C07	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC003678	MGC10-B04	MGC	W01C042C08	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC005322	MGC10-B05	MGC	W01C042C09	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC005322	MGC10-B05	MGC	W01C042C10	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC006980	MGC10-B06	MGC	W01C042C11	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006980	MGC10-B06	MGC	W01C042C12	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC005230	MGC10-B07	MGC	W01C042C13	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC005230	MGC10-B07	MGC	W01C042C14	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC007001	MGC10-B08	MGC	W01C042C15	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC007001	MGC10-B08	MGC	W01C042C16	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC005402	MGC10-B09	MGC	W01C042C17	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005402	MGC10-B09	MGC	W01C042C18	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005321	MGC10-B10	MGC	W01C042C19	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005321	MGC10-B10	MGC	W01C042C20	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005379	MGC10-B11	MGC	W01C042C21	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC005379	MGC10-B11	MGC	W01C042C22	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC010926	MGC10-B12	MGC	W01C042C23	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC010926	MGC10-B12	MGC	W01C042C24	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC003674	MGC10-B01	MGC	W01C042D01	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC003674	MGC10-B01	MGC	W01C042D02	pDONR221	19178		NDUFA2	4695	AAH03674.1	Hs.534333	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002488.3	NP_002479.1	PROVISIONAL	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC005196	MGC10-B02	MGC	W01C042D03	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005196	MGC10-B02	MGC	W01C042D04	pDONR221	11604		KLK2	3817	AAH05196.1	Hs.515560	Kallikrein-related peptidase 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005551.3	NP_005542.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007034	MGC10-B03	MGC	W01C042D05	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC007034	MGC10-B03	MGC	W01C042D06	pDONR221	8917		MT2A	4502	AAH07034.1	Hs.647371	Metallothionein 2A			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_005953.3	NP_005944.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC003678	MGC10-B04	MGC	W01C042D07	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC003678	MGC10-B04	MGC	W01C042D08	pDONR221	21869		ATP5J2	9551	AAH03678.1	Hs.656515	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit F2			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_004889.2	NP_004880.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
IKAKEN	BC005322	MGC10-B05	MGC	W01C042D09	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC005322	MGC10-B05	MGC	W01C042D10	pDONR221	5944		DCN	1634	AAH05322.1	Hs.718429	Decorin			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001920.3	NP_001911.1	REVIEWED	OK	1.000	1.000	359	1080	1	1077	359	1	359
IKAKEN	BC006980	MGC10-B06	MGC	W01C042D11	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006980	MGC10-B06	MGC	W01C042D12	pDONR221	13141		CRIPT	9419	AAH06980.1	Hs.133998	Cysteine-rich PDZ-binding protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014171.4	NP_054890.1	VALIDATED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC005230	MGC10-B07	MGC	W01C042D13	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC005230	MGC10-B07	MGC	W01C042D14	pDONR221	23229		UQCRB	7381	AAH05230.1	Hs.131255	Ubiquinol-cytochrome c reductase binding protein			Prostate	NIH_MGC_83	DH10B	NM_006294.3	NP_006285.1	REVIEWED		0.901	0.901	111	336	1	333	111	1	111
IKAKEN	BC007001	MGC10-B08	MGC	W01C042D15	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC007001	MGC10-B08	MGC	W01C042D16	pDONR221	12902		LIPT1	51601	AAH07001.1					Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_145196.2	NP_660197.1	REVIEWED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	BC005402	MGC10-B09	MGC	W01C042D17	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005402	MGC10-B09	MGC	W01C042D18	pDONR221	15498		UCRC	29796	AAH05402.1	Hs.284292	Ubiquinol-cytochrome c reductase complex (7.2 kD)			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_013387.3	NP_037519.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC005321	MGC10-B10	MGC	W01C042D19	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005321	MGC10-B10	MGC	W01C042D20	pDONR221	20025		ARG1	383	AAH05321.1	Hs.440934	Arginase, liver			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_000045.2	NP_000036.2	REVIEWED	Cg	0.736	1.000	322	714	1	711	322	1	322
IKAKEN	BC005379	MGC10-B11	MGC	W01C042D21	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC005379	MGC10-B11	MGC	W01C042D22	pDONR221	13092		PLGLB2	5342	AAH05379.1	Hs.652169	Plasminogen-like B2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_002665.4	NP_002656.1	VALIDATED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC010926	MGC10-B12	MGC	W01C042D23	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC010926	MGC10-B12	MGC	W01C042D24	pDONR221	20769		HIST1H4H	8365	AAH10926	Hs.591790	Histone cluster 1, H4h			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_003543.3	NP_003534.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	BC010379	MGC10-C01	MGC	W01C042E01	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010379	MGC10-C01	MGC	W01C042E02	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010922	MGC10-C02	MGC	W01C042E03	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010922	MGC10-C02	MGC	W01C042E04	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010915	MGC10-C03	MGC	W01C042E05	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC010915	MGC10-C03	MGC	W01C042E06	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC012607	MGC10-C04	MGC	W01C042E07	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012607	MGC10-C04	MGC	W01C042E08	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012549	MGC10-C05	MGC	W01C042E09	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC012549	MGC10-C05	MGC	W01C042E10	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC005902	MGC10-C06	MGC	W01C042E11	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC005902	MGC10-C06	MGC	W01C042E12	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008455	MGC10-C07	MGC	W01C042E13	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	MGC10-C07	MGC	W01C042E14	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC006006	MGC10-C08	MGC	W01C042E15	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC006006	MGC10-C08	MGC	W01C042E16	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC005901	MGC10-C09	MGC	W01C042E17	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005901	MGC10-C09	MGC	W01C042E18	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005991	MGC10-C10	MGC	W01C042E19	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC005991	MGC10-C10	MGC	W01C042E20	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC008443	MGC10-C11	MGC	W01C042E21	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008443	MGC10-C11	MGC	W01C042E22	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008500	MGC10-C12	MGC	W01C042E23	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC008500	MGC10-C12	MGC	W01C042E24	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC010379	MGC10-C01	MGC	W01C042F01	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010379	MGC10-C01	MGC	W01C042F02	pDONR221	16542		CSTA	1475	AAH10379.1	Hs.518198	Cystatin A (stefin A)			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_005213.3	NP_005204.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC010922	MGC10-C02	MGC	W01C042F03	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010922	MGC10-C02	MGC	W01C042F04	pDONR221	373		HHLA3	11147	AAH10922.1	Hs.142245	HERV-H LTR-associating 3			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_001036646.1	NP_001031723.1	VALIDATED	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	BC010915	MGC10-C03	MGC	W01C042F05	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC010915	MGC10-C03	MGC	W01C042F06	pDONR221	4068		GSTP1	2950	AAH10915.1	Hs.523836	Glutathione S-transferase pi 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_000852.3	NP_000843.1	REVIEWED	OK	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC012607	MGC10-C04	MGC	W01C042F07	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012607	MGC10-C04	MGC	W01C042F08	pDONR221	12686		PSG5	5673	AAH12607.1	Hs.654415	Pregnancy specific beta-1-glycoprotein 5			Skeletal Muscle	NIH_MGC_81	DH10B	NM_001130014.1	NP_001123486.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	BC012549	MGC10-C05	MGC	W01C042F09	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC012549	MGC10-C05	MGC	W01C042F10	pDONR221	14558		PLUNC	51297	AAH12549.1	Hs.211092	Palate, lung and nasal epithelium associated			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_130852.2	NP_570913.1	REVIEWED	OK	1.000	1.000	256	771	1	768	256	1	256
IKAKEN	BC005902	MGC10-C06	MGC	W01C042F11	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC005902	MGC10-C06	MGC	W01C042F12	pDONR221	21413		BLVRA	644	AAH05902.1	Hs.488143	Biliverdin reductase A			Skeletal Muscle	NIH_MGC_81	DH10B	NM_000712.3	NP_000703.2	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008455	MGC10-C07	MGC	W01C042F13	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC008455	MGC10-C07	MGC	W01C042F14	pDONR221	11456		USE1	55850	AAH08455.1	Hs.16187	Unconventional SNARE in the ER 1 homolog (S. cerevisiae)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018467.3	NP_060937.1	VALIDATED	Cs	0.996	0.996	259	780	1	777	259	1	259
IKAKEN	BC006006	MGC10-C08	MGC	W01C042F15	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC006006	MGC10-C08	MGC	W01C042F16	pDONR221	10457		C17orf37	84299	AAH06006.1	Hs.333526	Chromosome 17 open reading frame 37			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_032339.3	NP_115715.3	VALIDATED	OK	1.000	1.000	115	348	1	345	115	1	115
IKAKEN	BC005901	MGC10-C09	MGC	W01C042F17	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005901	MGC10-C09	MGC	W01C042F18	pDONR221	6169		MFAP5	8076	AAH05901.1	Hs.512842	Microfibrillar associated protein 5			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003480.2	NP_003471.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC005991	MGC10-C10	MGC	W01C042F19	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC005991	MGC10-C10	MGC	W01C042F20	pDONR221	20621		USP45	85015	AAH05991.1	Hs.143410	Ubiquitin specific peptidase 45			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080481.1	NP_001073950.1	PROVISIONAL	P	1.000	1.000	282	870	1	846	814	1	282
IKAKEN	BC008443	MGC10-C11	MGC	W01C042F21	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008443	MGC10-C11	MGC	W01C042F22	pDONR221	321		SRP9	6726	AAH08443.1	Hs.706900	Signal recognition particle 9kDa			Prostate	NIH_MGC_83	DH10B	NM_003133.5	NP_003124.1	VALIDATED	OK	1.000	1.000	86	261	1	258	86	1	86
IKAKEN	BC008500	MGC10-C12	MGC	W01C042F23	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC008500	MGC10-C12	MGC	W01C042F24	pDONR221	24026		MCART1	92014	AAH08500.1	Hs.719380	Mitochondrial carrier triple repeat 1			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_033412.3	NP_219480.1	VALIDATED		0.872	0.881	296	915	1	879	297	1	296
IKAKEN	BC005936	MGC10-D01	MGC	W01C042G01	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005936	MGC10-D01	MGC	W01C042G02	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005942	MGC10-D02	MGC	W01C042G03	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC005942	MGC10-D02	MGC	W01C042G04	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC008408	MGC10-D03	MGC	W01C042G05	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC008408	MGC10-D03	MGC	W01C042G06	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC005922	MGC10-D04	MGC	W01C042G07	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC005922	MGC10-D04	MGC	W01C042G08	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC008496	MGC10-D05	MGC	W01C042G09	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC008496	MGC10-D05	MGC	W01C042G10	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC005954	MGC10-D06	MGC	W01C042G11	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC005954	MGC10-D06	MGC	W01C042G12	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC008467	MGC10-D07	MGC	W01C042G13	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC008467	MGC10-D07	MGC	W01C042G14	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC005946	MGC10-D08	MGC	W01C042G15	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC005946	MGC10-D08	MGC	W01C042G16	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC009571	MGC10-D09	MGC	W01C042G17	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC009571	MGC10-D09	MGC	W01C042G18	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC008412	MGC10-D10	MGC	W01C042G19	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC008412	MGC10-D10	MGC	W01C042G20	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC014341	MGC10-D11	MGC	W01C042G21	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014341	MGC10-D11	MGC	W01C042G22	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C042G23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C042G24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC005936	MGC10-D01	MGC	W01C042H01	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005936	MGC10-D01	MGC	W01C042H02	pDONR221	5925		NDUFA12	55967	AAH05936.1	Hs.506374	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_018838.3	NP_061326.1	VALIDATED	Pfs	0.969	0.984	65	300	1	191	145	81	145
IKAKEN	BC005942	MGC10-D02	MGC	W01C042H03	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC005942	MGC10-D02	MGC	W01C042H04	pDONR221	3752		BANF1	8815	AAH05942.1	Hs.433759	Barrier to autointegration factor 1			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_003860.3	NP_003851.1	REVIEWED		0.944	0.977	89	261	1	258	89	1	89
IKAKEN	BC008408	MGC10-D03	MGC	W01C042H05	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC008408	MGC10-D03	MGC	W01C042H06	pDONR221	1730		MT1H	4496	AAH08408.1	Hs.438462	Metallothionein 1H			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005951.2	NP_005942.1	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC005922	MGC10-D04	MGC	W01C042H07	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC005922	MGC10-D04	MGC	W01C042H08	pDONR221	22142		ICA1	3382	AAH05922	Hs.487561	Islet cell autoantigen 1, 69kDa			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001136020.1	NP_001129492.1	REVIEWED		0.920	0.930	301	1026	1	900	483	1	299
IKAKEN	BC008496	MGC10-D05	MGC	W01C042H09	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC008496	MGC10-D05	MGC	W01C042H10	pDONR221	4607		CCDC34	91057	AAH08496.1	Hs.143733	Coiled-coil domain containing 34			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_080654.2	NP_542385.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC005954	MGC10-D06	MGC	W01C042H11	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC005954	MGC10-D06	MGC	W01C042H12	pDONR221	11537		NDUFS7	374291	AAH05954.1	Hs.211914	NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase)			Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B	NM_024407.4	NP_077718.3	REVIEWED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	BC008467	MGC10-D07	MGC	W01C042H13	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC008467	MGC10-D07	MGC	W01C042H14	pDONR221	21178		C7orf55	154791	AAH08467.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_197964.3	NP_932068.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC005946	MGC10-D08	MGC	W01C042H15	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC005946	MGC10-D08	MGC	W01C042H16	pDONR221	5534		TUBA1C	84790	AAH05946.1	Hs.719091	Tubulin, alpha 1c			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032704.3	NP_116093.1	PROVISIONAL	C	1.000	1.000	449	1350	1	1347	449	1	449
IKAKEN	BC009571	MGC10-D09	MGC	W01C042H17	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC009571	MGC10-D09	MGC	W01C042H18	pDONR221	10708		STRA13	201254	AAH09571.1	Hs.37616	Stimulated by retinoic acid 13 homolog (mouse)			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_144998.2	NP_659435.2	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	BC008412	MGC10-D10	MGC	W01C042H19	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC008412	MGC10-D10	MGC	W01C042H20	pDONR221	5322		SLC35E3	55508	AAH08412.1	Hs.506011	Solute carrier family 35, member E3			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018656.2	NP_061126.2	VALIDATED	OK	1.000	1.000	313	1066	125	1063	313	1	313
IKAKEN	BC014341	MGC10-D11	MGC	W01C042H21	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014341	MGC10-D11	MGC	W01C042H22	pDONR221	914		FMO9P	116123	AAH14341	Hs.348539	Flavin containing monooxygenase 9 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C042H23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	MGC10-D12	MGC	W01C042H24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC015116	MGC10-E01	MGC	W01C042I01	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC015116	MGC10-E01	MGC	W01C042I02	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC023988	MGC10-E02	MGC	W01C042I03	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC023988	MGC10-E02	MGC	W01C042I04	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC017571	MGC10-E03	MGC	W01C042I05	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017571	MGC10-E03	MGC	W01C042I06	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC016701	MGC10-E04	MGC	W01C042I07	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC016701	MGC10-E04	MGC	W01C042I08	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC018658	MGC10-E05	MGC	W01C042I09	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018658	MGC10-E05	MGC	W01C042I10	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018660	MGC10-E06	MGC	W01C042I11	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC018660	MGC10-E06	MGC	W01C042I12	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC017998	MGC10-E07	MGC	W01C042I13	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC017998	MGC10-E07	MGC	W01C042I14	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034033	MGC10-E08	MGC	W01C042I15	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC034033	MGC10-E08	MGC	W01C042I16	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC017981	MGC10-E09	MGC	W01C042I17	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC017981	MGC10-E09	MGC	W01C042I18	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC020779	MGC10-E10	MGC	W01C042I19	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC020779	MGC10-E10	MGC	W01C042I20	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC022320	MGC10-E11	MGC	W01C042I21	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC022320	MGC10-E11	MGC	W01C042I22	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC017864	MGC10-E12	MGC	W01C042I23	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC017864	MGC10-E12	MGC	W01C042I24	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC015116	MGC10-E01	MGC	W01C042J01	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC015116	MGC10-E01	MGC	W01C042J02	pDONR221	24727		UPRT	139596	AAH15116.1	Hs.91612	Uracil phosphoribosyltransferase (FUR1) homolog (S. cerevisiae)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145052.2	NP_659489.1	PROVISIONAL	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC023988	MGC10-E02	MGC	W01C042J03	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC023988	MGC10-E02	MGC	W01C042J04	pDONR221	194		C1orf144	26099	AAH23988.1	Hs.252967	Chromosome 1 open reading frame 144			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_015609.3	NP_056424.1	PROVISIONAL	OK	1.000	1.000	133	402	1	399	133	1	133
IKAKEN	BC017571	MGC10-E03	MGC	W01C042J05	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017571	MGC10-E03	MGC	W01C042J06	pDONR221	25272		FAM104B	90736	AAH17571.1	Hs.415414	Family with sequence similarity 104, member B			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_138362.2	NP_612371.1	PREDICTED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC016701	MGC10-E04	MGC	W01C042J07	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC016701	MGC10-E04	MGC	W01C042J08	pDONR221	13157		ARHGAP15	55843	AAH16701.1	Hs.171011	Rho GTPase activating protein 15			Testis	NIH_MGC_97	DH10B	NM_018460.3	NP_060930.3	VALIDATED	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC018658	MGC10-E05	MGC	W01C042J09	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018658	MGC10-E05	MGC	W01C042J10	pDONR221	2869		REEP3	221035	AAH18658.1	Hs.499833	Receptor accessory protein 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001330.1	NP_001001330.1	PROVISIONAL	Pfs	0.364	0.364	11	174	16	48	255	207	217
IKAKEN	BC018660	MGC10-E06	MGC	W01C042J11	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC018660	MGC10-E06	MGC	W01C042J12	pDONR221	2774		ADO	84890	AAH18660.3	Hs.99821	2-aminoethanethiol (cysteamine) dioxygenase			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_032804.5	NP_116193.2	VALIDATED	P	1.000	1.000	228	687	1	684	270	43	270
IKAKEN	BC017998	MGC10-E07	MGC	W01C042J13	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC017998	MGC10-E07	MGC	W01C042J14	pDONR221	7794		SPESP1	246777	AAH17998.1					Skeletal Muscle	NIH_MGC_81	DH10B	NM_145658.2	NP_663633.1	PROVISIONAL	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034033	MGC10-E08	MGC	W01C042J15	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC034033	MGC10-E08	MGC	W01C042J16	pDONR221	24232		C9orf41	138199	AAH34033.1	Hs.567688	Chromosome 9 open reading frame 41			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_152420.1	NP_689633.1	PREDICTED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	BC017981	MGC10-E09	MGC	W01C042J17	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC017981	MGC10-E09	MGC	W01C042J18	pDONR221	22624		C8orf22	492307	AAH17981.1	Hs.49890	Chromosome 8 open reading frame 22			Kidney	NIH_MGC_75	DH10B	NM_001007176.3	NP_001007177.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	BC020779	MGC10-E10	MGC	W01C042J19	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC020779	MGC10-E10	MGC	W01C042J20	pDONR221	23210		PEBP4	157310	AAH20779.1	Hs.491242	Phosphatidylethanolamine-binding protein 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_144962.2	NP_659399.2	VALIDATED	OK	1.000	1.000	227	684	1	681	227	1	227
IKAKEN	BC022320	MGC10-E11	MGC	W01C042J21	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC022320	MGC10-E11	MGC	W01C042J22	pDONR221	18697		S100Z	170591	AAH22320.1	Hs.482563	S100 calcium binding protein Z			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_130772.3	NP_570128.2	VALIDATED	OK	1.000	1.000	99	300	1	297	99	1	99
IKAKEN	BC017864	MGC10-E12	MGC	W01C042J23	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC017864	MGC10-E12	MGC	W01C042J24	pDONR221	18069		GYPE	2996	AAH17864.1	Hs.709199	Glycophorin E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_198682.2	NP_941391.2	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC020814	MGC10-F01	MGC	W01C042K01	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC020814	MGC10-F01	MGC	W01C042K02	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC022401	MGC10-F02	MGC	W01C042K03	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC022401	MGC10-F02	MGC	W01C042K04	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC017952	MGC10-F03	MGC	W01C042K05	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017952	MGC10-F03	MGC	W01C042K06	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017922	MGC10-F04	MGC	W01C042K07	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017922	MGC10-F04	MGC	W01C042K08	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017891	MGC10-F05	MGC	W01C042K09	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017891	MGC10-F05	MGC	W01C042K10	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC020778	MGC10-F06	MGC	W01C042K11	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC020778	MGC10-F06	MGC	W01C042K12	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC017783	MGC10-F07	MGC	W01C042K13	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC017783	MGC10-F07	MGC	W01C042K14	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC020790	MGC10-F08	MGC	W01C042K15	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC020790	MGC10-F08	MGC	W01C042K16	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC026285	MGC10-F09	MGC	W01C042K17	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC026285	MGC10-F09	MGC	W01C042K18	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC022371	MGC10-F10	MGC	W01C042K19	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022371	MGC10-F10	MGC	W01C042K20	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022286	MGC10-F11	MGC	W01C042K21	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC022286	MGC10-F11	MGC	W01C042K22	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC020619	MGC10-F12	MGC	W01C042K23	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020619	MGC10-F12	MGC	W01C042K24	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020814	MGC10-F01	MGC	W01C042L01	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC020814	MGC10-F01	MGC	W01C042L02	pDONR221	6777		SUGT1L1	283507	AAH20814	Hs.709973	SGT1, suppressor of G2 allele of SKP1 like 1 (S. cerevisiae)			Skeletal Muscle	NIH_MGC_81	DH10B			
IKAKEN	BC022401	MGC10-F02	MGC	W01C042L03	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC022401	MGC10-F02	MGC	W01C042L04	pDONR221	4044		OR51E1	143503	AAH22401.1	Hs.470038	Olfactory receptor, family 51, subfamily E, member 1			Prostate, adenocarcinoma.	NIH_MGC_60	DH10B	NM_152430.3	NP_689643.2	VALIDATED	P	1.000	1.000	317	954	1	951	318	2	318
IKAKEN	BC017952	MGC10-F03	MGC	W01C042L05	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017952	MGC10-F03	MGC	W01C042L06	pDONR221	20786		SLC17A3	10786	AAH17952.1	Hs.327179	Solute carrier family 17 (sodium phosphate), member 3			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_006632.3	NP_006623.2	VALIDATED	P	1.000	1.000	401	1206	1	1203	420	20	420
IKAKEN	BC017922	MGC10-F04	MGC	W01C042L07	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017922	MGC10-F04	MGC	W01C042L08	pDONR221	15681		VPREB1	7441	AAH17922	Hs.247979	Pre-B lymphocyte 1			Lung	NIH_MGC_77	DH10B	NM_007128.2	NP_009059.1	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC017891	MGC10-F05	MGC	W01C042L09	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC017891	MGC10-F05	MGC	W01C042L10	pDONR221	13080		VAMP5	10791	AAH17891.1	Hs.534373	Vesicle-associated membrane protein 5 (myobrevin)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_006634.2	NP_006625.1	REVIEWED	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC020778	MGC10-F06	MGC	W01C042L11	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC020778	MGC10-F06	MGC	W01C042L12	pDONR221	2068		LRRIQ3	127255	AAH20778.1	Hs.644625	Leucine-rich repeats and IQ motif containing 3			Liver	NIH_MGC_76	DH10B	NM_001105659.1	NP_001099129.1	INFERRED		0.965	0.965	199	600	1	597	624	1	199
IKAKEN	BC017783	MGC10-F07	MGC	W01C042L13	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC017783	MGC10-F07	MGC	W01C042L14	pDONR221	13905		FARSB	10056	AAH17783.1	Hs.471452	Phenylalanyl-tRNA synthetase, beta subunit			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005687.3	NP_005678.3	REVIEWED	OK	1.000	1.000	589	1770	1	1767	589	1	589
IKAKEN	BC020790	MGC10-F08	MGC	W01C042L15	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC020790	MGC10-F08	MGC	W01C042L16	pDONR221	348		RABGGTB	5876	AAH20790.1	Hs.78948	Rab geranylgeranyltransferase, beta subunit			Lung	NIH_MGC_77	DH10B	NM_004582.2	NP_004573.2	PROVISIONAL	C	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC026285	MGC10-F09	MGC	W01C042L17	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC026285	MGC10-F09	MGC	W01C042L18	pDONR221	19287		TMEM167A	153339	AAH26285.1	Hs.355606	Transmembrane protein 167A			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_174909.4	NP_777569.1	VALIDATED	OK	1.000	1.000	72	219	1	216	72	1	72
IKAKEN	BC022371	MGC10-F10	MGC	W01C042L19	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022371	MGC10-F10	MGC	W01C042L20	pDONR221	631		BTF3L4	91408	AAH22371.1	Hs.538093	Basic transcription factor 3-like 4			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001136497.1	NP_001129969.1	VALIDATED		0.970	0.970	99	504	172	468	100	1	99
IKAKEN	BC022286	MGC10-F11	MGC	W01C042L21	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC022286	MGC10-F11	MGC	W01C042L22	pDONR221	11178		AQP4	361	AAH22286.1	Hs.315369	Aquaporin 4			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004028.3	NP_004019.1	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC020619	MGC10-F12	MGC	W01C042L23	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020619	MGC10-F12	MGC	W01C042L24	pDONR221	20441		GSTA3	2940	AAH20619.1	Hs.102484	Glutathione S-transferase alpha 3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_000847.4	NP_000838.3	REVIEWED	OK	1.000	1.000	222	669	1	666	222	1	222
IKAKEN	BC020711	MGC10-G01	MGC	W01C042M01	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC020711	MGC10-G01	MGC	W01C042M02	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC035931	MGC10-G02	MGC	W01C042M03	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC035931	MGC10-G02	MGC	W01C042M04	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC026278	MGC10-G03	MGC	W01C042M05	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	MGC10-G03	MGC	W01C042M06	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC020633	MGC10-G04	MGC	W01C042M07	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC020633	MGC10-G04	MGC	W01C042M08	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC022248	MGC10-G05	MGC	W01C042M09	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC022248	MGC10-G05	MGC	W01C042M10	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC030817	MGC10-G06	MGC	W01C042M11	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC030817	MGC10-G06	MGC	W01C042M12	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC020894	MGC10-G07	MGC	W01C042M13	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020894	MGC10-G07	MGC	W01C042M14	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020757	MGC10-G08	MGC	W01C042M15	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC020757	MGC10-G08	MGC	W01C042M16	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC024233	MGC10-G09	MGC	W01C042M17	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC024233	MGC10-G09	MGC	W01C042M18	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC016372	MGC10-G10	MGC	W01C042M19	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC016372	MGC10-G10	MGC	W01C042M20	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC017422	MGC10-G11	MGC	W01C042M21	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC017422	MGC10-G11	MGC	W01C042M22	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC018688	MGC10-G12	MGC	W01C042M23	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC018688	MGC10-G12	MGC	W01C042M24	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC020711	MGC10-G01	MGC	W01C042N01	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC020711	MGC10-G01	MGC	W01C042N02	pDONR221	12696		PSG11	5680	AAH20711.2	Hs.646353	Pregnancy specific beta-1-glycoprotein 11			Placenta	NIH_MGC_79	DH10B	NM_001113410.1	NP_001106881.1	VALIDATED	OK	1.000	1.000	213	660	19	657	213	1	213
IKAKEN	BC035931	MGC10-G02	MGC	W01C042N03	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC035931	MGC10-G02	MGC	W01C042N04	pDONR221	11543		HCST	10870	AAH35931.1	Hs.117339	Hematopoietic cell signal transducer			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_014266.3	NP_055081.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC026278	MGC10-G03	MGC	W01C042N05	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC026278	MGC10-G03	MGC	W01C042N06	pDONR221	20792		C6orf118	168090	AAH26278.1	Hs.144734	Chromosome 6 open reading frame 118			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_144980.3	NP_659417.2	VALIDATED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC020633	MGC10-G04	MGC	W01C042N07	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC020633	MGC10-G04	MGC	W01C042N08	pDONR221	3412		RBP4	5950	AAH20633.1	Hs.50223	Retinol binding protein 4, plasma			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_006744.3	NP_006735.2	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC022248	MGC10-G05	MGC	W01C042N09	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC022248	MGC10-G05	MGC	W01C042N10	pDONR221	18152		DNAJB14	79982	AAH22248.1	Hs.577426	DnaJ (Hsp40) homolog, subfamily B, member 14			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001031723.2	NP_001026893.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	BC030817	MGC10-G06	MGC	W01C042N11	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC030817	MGC10-G06	MGC	W01C042N12	pDONR221	7088		NGDN	25983	AAH30817.1	Hs.9043	Neuroguidin, EIF4E binding protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001042635.1	NP_001036100.1	VALIDATED	OK	1.000	1.000	315	948	1	945	315	1	315
IKAKEN	BC020894	MGC10-G07	MGC	W01C042N13	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020894	MGC10-G07	MGC	W01C042N14	pDONR221	4295		LOC100132686	100132686	AAH20894.1	Hs.650455	Hypothetical LOC100132686			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	XM_001725819.1	XP_001725871.1	MODEL	OK	1.000	1.000	37	114	1	111	37	1	37
IKAKEN	BC020757	MGC10-G08	MGC	W01C042N15	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC020757	MGC10-G08	MGC	W01C042N16	pDONR221	9376		MT1G	4495	AAH20757.1	Hs.433391	Metallothionein 1G			Placenta	NIH_MGC_79	DH10B	NM_005950.1	NP_005941.1	PROVISIONAL	C	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC024233	MGC10-G09	MGC	W01C042N17	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC024233	MGC10-G09	MGC	W01C042N18	pDONR221	18869		PRR7	80758	AAH24233.2	Hs.534492	Proline rich 7 (synaptic)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_030567.3	NP_085044.2	PROVISIONAL	C	1.000	1.000	274	825	1	822	274	1	274
IKAKEN	BC016372	MGC10-G10	MGC	W01C042N19	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC016372	MGC10-G10	MGC	W01C042N20	pDONR221	11058		MYL12A	10627	AAH16372.1	Hs.190086	Myosin, light chain 12A, regulatory, non-sarcomeric			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_006471.2	NP_006462.1	PROVISIONAL	C	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	BC017422	MGC10-G11	MGC	W01C042N21	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC017422	MGC10-G11	MGC	W01C042N22	pDONR221	18886		C5orf53	492311	AAH17422.2	Hs.696360	Chromosome 5 open reading frame 53			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001007189.1	NP_001007190.1	VALIDATED	P	1.000	1.000	47	144	1	141	53	7	53
IKAKEN	BC018688	MGC10-G12	MGC	W01C042N23	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC018688	MGC10-G12	MGC	W01C042N24	pDONR221	19932		OGFRL1	79627	AAH18688.1	Hs.656091	Opioid growth factor receptor-like 1			Testis	NIH_MGC_97	DH10B	NM_024576.3	NP_078852.3	VALIDATED	OK	1.000	1.000	451	1356	1	1353	451	1	451
IKAKEN	BC029427	MGC10-H01	MGC	W01C042O01	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC029427	MGC10-H01	MGC	W01C042O02	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC055417	MGC10-H02	MGC	W01C042O03	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	MGC10-H02	MGC	W01C042O04	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC029478	MGC10-H03	MGC	W01C042O05	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029478	MGC10-H03	MGC	W01C042O06	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029437	MGC10-H04	MGC	W01C042O07	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC029437	MGC10-H04	MGC	W01C042O08	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC035959	MGC10-H05	MGC	W01C042O09	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC035959	MGC10-H05	MGC	W01C042O10	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC054892	MGC10-H06	MGC	W01C042O11	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC054892	MGC10-H06	MGC	W01C042O12	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC029405	MGC10-H07	MGC	W01C042O13	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	MGC10-H07	MGC	W01C042O14	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC056253	MGC10-H08	MGC	W01C042O15	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC056253	MGC10-H08	MGC	W01C042O16	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC054022	MGC10-H09	MGC	W01C042O17	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054022	MGC10-H09	MGC	W01C042O18	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054876	MGC10-H10	MGC	W01C042O19	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC054876	MGC10-H10	MGC	W01C042O20	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC055088	MGC10-H11	MGC	W01C042O21	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC055088	MGC10-H11	MGC	W01C042O22	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC056686	MGC10-H12	MGC	W01C042O23	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC056686	MGC10-H12	MGC	W01C042O24	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC029427	MGC10-H01	MGC	W01C042P01	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC029427	MGC10-H01	MGC	W01C042P02	pDONR221	2194		CCDC23	374969	AAH29427.1	Hs.113919	Coiled-coil domain containing 23			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_199342.3	NP_955374.1	VALIDATED	OK	1.000	1.000	66	201	1	198	66	1	66
IKAKEN	BC055417	MGC10-H02	MGC	W01C042P03	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	MGC10-H02	MGC	W01C042P04	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC029478	MGC10-H03	MGC	W01C042P05	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029478	MGC10-H03	MGC	W01C042P06	pDONR221	3423		CLRN3	119467	AAH29478.1	Hs.242014	Clarin 3			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_152311.3	NP_689524.1	VALIDATED	OK	1.000	1.000	226	681	1	678	226	1	226
IKAKEN	BC029437	MGC10-H04	MGC	W01C042P07	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC029437	MGC10-H04	MGC	W01C042P08	pDONR221	8756		DNASE1	1773	AAH29437.1	Hs.629638	Deoxyribonuclease I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_005223.3	NP_005214.2	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC035959	MGC10-H05	MGC	W01C042P09	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC035959	MGC10-H05	MGC	W01C042P10	pDONR221	8371		CYP19A1	1588	AAH35959.1	Hs.260074	Cytochrome P450, family 19, subfamily A, polypeptide 1			Lung	NIH_MGC_77	DH10B	NM_031226.2	NP_112503.1	REVIEWED	OK	1.000	1.000	503	1512	1	1509	503	1	503
IKAKEN	BC054892	MGC10-H06	MGC	W01C042P11	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC054892	MGC10-H06	MGC	W01C042P12	pDONR221	8672		DYNLRB2	83657	AAH54892.1	Hs.98849	Dynein, light chain, roadblock-type 2			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_130897.1	NP_570967.1	PROVISIONAL	P	1.000	1.000	25	168	7	81	96	2	26
IKAKEN	BC029405	MGC10-H07	MGC	W01C042P13	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC029405	MGC10-H07	MGC	W01C042P14	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.926	0.926	135	429	1	405	136	1	135
IKAKEN	BC056253	MGC10-H08	MGC	W01C042P15	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC056253	MGC10-H08	MGC	W01C042P16	pDONR221	20027		IYD	389434	AAH56253.1	Hs.310225	Iodotyrosine deiodinase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_203395.1	NP_981932.1	VALIDATED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC054022	MGC10-H09	MGC	W01C042P17	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054022	MGC10-H09	MGC	W01C042P18	pDONR221	24889		PAGE2	203569	AAH54022.1	Hs.662489	P antigen family, member 2 (prostate associated)			Testis	NIH_MGC_82	DH10B	NM_207339.2	NP_997222.1	PROVISIONAL	C	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC054876	MGC10-H10	MGC	W01C042P19	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC054876	MGC10-H10	MGC	W01C042P20	pDONR221	2866		FXYD4	53828	AAH54876.1	Hs.130497	FXYD domain containing ion transport regulator 4			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_173160.2	NP_775183.1	REVIEWED	OK	1.000	1.000	89	270	1	267	89	1	89
IKAKEN	BC055088	MGC10-H11	MGC	W01C042P21	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC055088	MGC10-H11	MGC	W01C042P22	pDONR221	4813		MRPL21	219927	AAH55088.1	Hs.503047	Mitochondrial ribosomal protein L21			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181515.1	NP_852616.1	REVIEWED	OK	1.000	1.000	120	363	1	360	120	1	120
IKAKEN	BC056686	MGC10-H12	MGC	W01C042P23	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC056686	MGC10-H12	MGC	W01C042P24	pDONR221	8959		HBQ1	3049	AAH56686.1	Hs.247921	Hemoglobin, theta 1			Pancreas	NIH_MGC_78	DH10B	NM_005331.3	NP_005322.1	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC000665	MGC11-A01	MGC	W01C043A01	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC000665	MGC11-A01	MGC	W01C043A02	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC017178	MGC11-A02	MGC	W01C043A03	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC017178	MGC11-A02	MGC	W01C043A04	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC007655	MGC11-A03	MGC	W01C043A05	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	MGC11-A03	MGC	W01C043A06	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	MGC11-A04	MGC	W01C043A07	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	MGC11-A04	MGC	W01C043A08	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC062776	MGC11-A05	MGC	W01C043A09	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	MGC11-A05	MGC	W01C043A10	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC017174	MGC11-A06	MGC	W01C043A11	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC017174	MGC11-A06	MGC	W01C043A12	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC000644	MGC11-A07	MGC	W01C043A13	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC000644	MGC11-A07	MGC	W01C043A14	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC002453	MGC11-A08	MGC	W01C043A15	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC002453	MGC11-A08	MGC	W01C043A16	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC000122	MGC11-A09	MGC	W01C043A17	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000122	MGC11-A09	MGC	W01C043A18	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000255	MGC11-A10	MGC	W01C043A19	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC000255	MGC11-A10	MGC	W01C043A20	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC001781	MGC11-A11	MGC	W01C043A21	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC001781	MGC11-A11	MGC	W01C043A22	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC000243	MGC11-A12	MGC	W01C043A23	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000243	MGC11-A12	MGC	W01C043A24	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000665	MGC11-A01	MGC	W01C043B01	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC000665	MGC11-A01	MGC	W01C043B02	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC017178	MGC11-A02	MGC	W01C043B03	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC017178	MGC11-A02	MGC	W01C043B04	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC007655	MGC11-A03	MGC	W01C043B05	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	MGC11-A03	MGC	W01C043B06	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	MGC11-A04	MGC	W01C043B07	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	MGC11-A04	MGC	W01C043B08	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC062776	MGC11-A05	MGC	W01C043B09	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	MGC11-A05	MGC	W01C043B10	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC017174	MGC11-A06	MGC	W01C043B11	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC017174	MGC11-A06	MGC	W01C043B12	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC000644	MGC11-A07	MGC	W01C043B13	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC000644	MGC11-A07	MGC	W01C043B14	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC002453	MGC11-A08	MGC	W01C043B15	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC002453	MGC11-A08	MGC	W01C043B16	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC000122	MGC11-A09	MGC	W01C043B17	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000122	MGC11-A09	MGC	W01C043B18	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000255	MGC11-A10	MGC	W01C043B19	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC000255	MGC11-A10	MGC	W01C043B20	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC001781	MGC11-A11	MGC	W01C043B21	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC001781	MGC11-A11	MGC	W01C043B22	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC000243	MGC11-A12	MGC	W01C043B23	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000243	MGC11-A12	MGC	W01C043B24	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000249	MGC11-B01	MGC	W01C043C01	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	MGC11-B01	MGC	W01C043C02	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC001734	MGC11-B02	MGC	W01C043C03	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC001734	MGC11-B02	MGC	W01C043C04	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC003092	MGC11-B03	MGC	W01C043C05	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC003092	MGC11-B03	MGC	W01C043C06	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC000266	MGC11-B04	MGC	W01C043C07	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC000266	MGC11-B04	MGC	W01C043C08	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC001804	MGC11-B05	MGC	W01C043C09	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001804	MGC11-B05	MGC	W01C043C10	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001182	MGC11-B06	MGC	W01C043C11	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC001182	MGC11-B06	MGC	W01C043C12	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003586	MGC11-B07	MGC	W01C043C13	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003586	MGC11-B07	MGC	W01C043C14	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC001191	MGC11-B08	MGC	W01C043C15	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC001191	MGC11-B08	MGC	W01C043C16	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC000246	MGC11-B09	MGC	W01C043C17	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC000246	MGC11-B09	MGC	W01C043C18	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC001623	MGC11-B10	MGC	W01C043C19	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001623	MGC11-B10	MGC	W01C043C20	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001210	MGC11-B11	MGC	W01C043C21	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001210	MGC11-B11	MGC	W01C043C22	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001181	MGC11-B12	MGC	W01C043C23	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC001181	MGC11-B12	MGC	W01C043C24	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000249	MGC11-B01	MGC	W01C043D01	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	MGC11-B01	MGC	W01C043D02	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC001734	MGC11-B02	MGC	W01C043D03	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC001734	MGC11-B02	MGC	W01C043D04	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC003092	MGC11-B03	MGC	W01C043D05	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC003092	MGC11-B03	MGC	W01C043D06	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC000266	MGC11-B04	MGC	W01C043D07	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC000266	MGC11-B04	MGC	W01C043D08	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC001804	MGC11-B05	MGC	W01C043D09	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001804	MGC11-B05	MGC	W01C043D10	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001182	MGC11-B06	MGC	W01C043D11	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC001182	MGC11-B06	MGC	W01C043D12	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003586	MGC11-B07	MGC	W01C043D13	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003586	MGC11-B07	MGC	W01C043D14	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC001191	MGC11-B08	MGC	W01C043D15	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC001191	MGC11-B08	MGC	W01C043D16	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC000246	MGC11-B09	MGC	W01C043D17	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC000246	MGC11-B09	MGC	W01C043D18	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC001623	MGC11-B10	MGC	W01C043D19	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001623	MGC11-B10	MGC	W01C043D20	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001210	MGC11-B11	MGC	W01C043D21	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001210	MGC11-B11	MGC	W01C043D22	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001181	MGC11-B12	MGC	W01C043D23	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC001181	MGC11-B12	MGC	W01C043D24	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC024043	MGC11-C01	MGC	W01C043E01	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	MGC11-C01	MGC	W01C043E02	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC003103	MGC11-C02	MGC	W01C043E03	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003103	MGC11-C02	MGC	W01C043E04	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC000270	MGC11-C03	MGC	W01C043E05	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000270	MGC11-C03	MGC	W01C043E06	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001731	MGC11-C04	MGC	W01C043E07	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC001731	MGC11-C04	MGC	W01C043E08	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC000121	MGC11-C05	MGC	W01C043E09	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC000121	MGC11-C05	MGC	W01C043E10	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC001149	MGC11-C06	MGC	W01C043E11	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC001149	MGC11-C06	MGC	W01C043E12	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC000004	MGC11-C07	MGC	W01C043E13	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000004	MGC11-C07	MGC	W01C043E14	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000002	MGC11-C08	MGC	W01C043E15	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000002	MGC11-C08	MGC	W01C043E16	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000095	MGC11-C09	MGC	W01C043E17	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000095	MGC11-C09	MGC	W01C043E18	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000056	MGC11-C10	MGC	W01C043E19	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000056	MGC11-C10	MGC	W01C043E20	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC003609	MGC11-C11	MGC	W01C043E21	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC003609	MGC11-C11	MGC	W01C043E22	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC000006	MGC11-C12	MGC	W01C043E23	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC000006	MGC11-C12	MGC	W01C043E24	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC024043	MGC11-C01	MGC	W01C043F01	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	MGC11-C01	MGC	W01C043F02	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC003103	MGC11-C02	MGC	W01C043F03	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003103	MGC11-C02	MGC	W01C043F04	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC000270	MGC11-C03	MGC	W01C043F05	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000270	MGC11-C03	MGC	W01C043F06	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001731	MGC11-C04	MGC	W01C043F07	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC001731	MGC11-C04	MGC	W01C043F08	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC000121	MGC11-C05	MGC	W01C043F09	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC000121	MGC11-C05	MGC	W01C043F10	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC001149	MGC11-C06	MGC	W01C043F11	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC001149	MGC11-C06	MGC	W01C043F12	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC000004	MGC11-C07	MGC	W01C043F13	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000004	MGC11-C07	MGC	W01C043F14	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000002	MGC11-C08	MGC	W01C043F15	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000002	MGC11-C08	MGC	W01C043F16	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000095	MGC11-C09	MGC	W01C043F17	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000095	MGC11-C09	MGC	W01C043F18	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000056	MGC11-C10	MGC	W01C043F19	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000056	MGC11-C10	MGC	W01C043F20	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC003609	MGC11-C11	MGC	W01C043F21	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC003609	MGC11-C11	MGC	W01C043F22	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC000006	MGC11-C12	MGC	W01C043F23	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC000006	MGC11-C12	MGC	W01C043F24	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC000003	MGC11-D01	MGC	W01C043G01	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC000003	MGC11-D01	MGC	W01C043G02	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC003608	MGC11-D02	MGC	W01C043G03	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC003608	MGC11-D02	MGC	W01C043G04	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC001482	MGC11-D03	MGC	W01C043G05	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001482	MGC11-D03	MGC	W01C043G06	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001070	MGC11-D04	MGC	W01C043G07	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001070	MGC11-D04	MGC	W01C043G08	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001485	MGC11-D05	MGC	W01C043G09	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC001485	MGC11-D05	MGC	W01C043G10	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC000029	MGC11-D06	MGC	W01C043G11	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000029	MGC11-D06	MGC	W01C043G12	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000051	MGC11-D07	MGC	W01C043G13	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000051	MGC11-D07	MGC	W01C043G14	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000736	MGC11-D08	MGC	W01C043G15	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000736	MGC11-D08	MGC	W01C043G16	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000780	MGC11-D09	MGC	W01C043G17	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	MGC11-D09	MGC	W01C043G18	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009898	MGC11-D10	MGC	W01C043G19	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC009898	MGC11-D10	MGC	W01C043G20	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC001096	MGC11-D11	MGC	W01C043G21	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC001096	MGC11-D11	MGC	W01C043G22	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC000104	MGC11-D12	MGC	W01C043G23	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC000104	MGC11-D12	MGC	W01C043G24	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC000003	MGC11-D01	MGC	W01C043H01	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC000003	MGC11-D01	MGC	W01C043H02	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC003608	MGC11-D02	MGC	W01C043H03	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC003608	MGC11-D02	MGC	W01C043H04	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC001482	MGC11-D03	MGC	W01C043H05	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001482	MGC11-D03	MGC	W01C043H06	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001070	MGC11-D04	MGC	W01C043H07	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001070	MGC11-D04	MGC	W01C043H08	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001485	MGC11-D05	MGC	W01C043H09	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC001485	MGC11-D05	MGC	W01C043H10	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC000029	MGC11-D06	MGC	W01C043H11	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000029	MGC11-D06	MGC	W01C043H12	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000051	MGC11-D07	MGC	W01C043H13	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000051	MGC11-D07	MGC	W01C043H14	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000736	MGC11-D08	MGC	W01C043H15	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000736	MGC11-D08	MGC	W01C043H16	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000780	MGC11-D09	MGC	W01C043H17	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	MGC11-D09	MGC	W01C043H18	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009898	MGC11-D10	MGC	W01C043H19	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC009898	MGC11-D10	MGC	W01C043H20	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC001096	MGC11-D11	MGC	W01C043H21	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC001096	MGC11-D11	MGC	W01C043H22	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC000104	MGC11-D12	MGC	W01C043H23	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC000104	MGC11-D12	MGC	W01C043H24	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC004191	MGC11-E01	MGC	W01C043I01	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC004191	MGC11-E01	MGC	W01C043I02	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC009902	MGC11-E02	MGC	W01C043I03	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC009902	MGC11-E02	MGC	W01C043I04	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC003082	MGC11-E03	MGC	W01C043I05	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC003082	MGC11-E03	MGC	W01C043I06	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC009924	MGC11-E04	MGC	W01C043I07	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC009924	MGC11-E04	MGC	W01C043I08	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC002978	MGC11-E05	MGC	W01C043I09	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC002978	MGC11-E05	MGC	W01C043I10	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001902	MGC11-E06	MGC	W01C043I11	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC001902	MGC11-E06	MGC	W01C043I12	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC005005	MGC11-E07	MGC	W01C043I13	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC005005	MGC11-E07	MGC	W01C043I14	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC001890	MGC11-E08	MGC	W01C043I15	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001890	MGC11-E08	MGC	W01C043I16	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001884	MGC11-E09	MGC	W01C043I17	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC001884	MGC11-E09	MGC	W01C043I18	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC004963	MGC11-E10	MGC	W01C043I19	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC004963	MGC11-E10	MGC	W01C043I20	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC001738	MGC11-E11	MGC	W01C043I21	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC001738	MGC11-E11	MGC	W01C043I22	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC019255	MGC11-E12	MGC	W01C043I23	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC019255	MGC11-E12	MGC	W01C043I24	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC004191	MGC11-E01	MGC	W01C043J01	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC004191	MGC11-E01	MGC	W01C043J02	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC009902	MGC11-E02	MGC	W01C043J03	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC009902	MGC11-E02	MGC	W01C043J04	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC003082	MGC11-E03	MGC	W01C043J05	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC003082	MGC11-E03	MGC	W01C043J06	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC009924	MGC11-E04	MGC	W01C043J07	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC009924	MGC11-E04	MGC	W01C043J08	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC002978	MGC11-E05	MGC	W01C043J09	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC002978	MGC11-E05	MGC	W01C043J10	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001902	MGC11-E06	MGC	W01C043J11	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC001902	MGC11-E06	MGC	W01C043J12	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC005005	MGC11-E07	MGC	W01C043J13	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC005005	MGC11-E07	MGC	W01C043J14	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC001890	MGC11-E08	MGC	W01C043J15	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001890	MGC11-E08	MGC	W01C043J16	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001884	MGC11-E09	MGC	W01C043J17	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC001884	MGC11-E09	MGC	W01C043J18	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC004963	MGC11-E10	MGC	W01C043J19	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC004963	MGC11-E10	MGC	W01C043J20	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC001738	MGC11-E11	MGC	W01C043J21	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC001738	MGC11-E11	MGC	W01C043J22	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC019255	MGC11-E12	MGC	W01C043J23	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC019255	MGC11-E12	MGC	W01C043J24	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC006462	MGC11-F01	MGC	W01C043K01	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006462	MGC11-F01	MGC	W01C043K02	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC003102	MGC11-F02	MGC	W01C043K03	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC003102	MGC11-F02	MGC	W01C043K04	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC001725	MGC11-F03	MGC	W01C043K05	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC001725	MGC11-F03	MGC	W01C043K06	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC003093	MGC11-F04	MGC	W01C043K07	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC003093	MGC11-F04	MGC	W01C043K08	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC001907	MGC11-F05	MGC	W01C043K09	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001907	MGC11-F05	MGC	W01C043K10	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001909	MGC11-F06	MGC	W01C043K11	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001909	MGC11-F06	MGC	W01C043K12	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001177	MGC11-F07	MGC	W01C043K13	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001177	MGC11-F07	MGC	W01C043K14	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001870	MGC11-F08	MGC	W01C043K15	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001870	MGC11-F08	MGC	W01C043K16	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001711	MGC11-F09	MGC	W01C043K17	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001711	MGC11-F09	MGC	W01C043K18	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001634	MGC11-F10	MGC	W01C043K19	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001634	MGC11-F10	MGC	W01C043K20	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001912	MGC11-F11	MGC	W01C043K21	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC001912	MGC11-F11	MGC	W01C043K22	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC003576	MGC11-F12	MGC	W01C043K23	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC003576	MGC11-F12	MGC	W01C043K24	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC006462	MGC11-F01	MGC	W01C043L01	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006462	MGC11-F01	MGC	W01C043L02	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC003102	MGC11-F02	MGC	W01C043L03	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC003102	MGC11-F02	MGC	W01C043L04	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC001725	MGC11-F03	MGC	W01C043L05	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC001725	MGC11-F03	MGC	W01C043L06	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC003093	MGC11-F04	MGC	W01C043L07	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC003093	MGC11-F04	MGC	W01C043L08	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC001907	MGC11-F05	MGC	W01C043L09	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001907	MGC11-F05	MGC	W01C043L10	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001909	MGC11-F06	MGC	W01C043L11	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001909	MGC11-F06	MGC	W01C043L12	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001177	MGC11-F07	MGC	W01C043L13	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001177	MGC11-F07	MGC	W01C043L14	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001870	MGC11-F08	MGC	W01C043L15	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001870	MGC11-F08	MGC	W01C043L16	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001711	MGC11-F09	MGC	W01C043L17	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001711	MGC11-F09	MGC	W01C043L18	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001634	MGC11-F10	MGC	W01C043L19	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001634	MGC11-F10	MGC	W01C043L20	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001912	MGC11-F11	MGC	W01C043L21	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC001912	MGC11-F11	MGC	W01C043L22	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC003576	MGC11-F12	MGC	W01C043L23	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC003576	MGC11-F12	MGC	W01C043L24	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC019283	MGC11-G01	MGC	W01C043M01	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC019283	MGC11-G01	MGC	W01C043M02	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC003167	MGC11-G02	MGC	W01C043M03	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC003167	MGC11-G02	MGC	W01C043M04	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC004991	MGC11-G03	MGC	W01C043M05	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC004991	MGC11-G03	MGC	W01C043M06	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC019314	MGC11-G04	MGC	W01C043M07	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC019314	MGC11-G04	MGC	W01C043M08	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC004986	MGC11-G05	MGC	W01C043M09	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC004986	MGC11-G05	MGC	W01C043M10	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC063126	MGC11-G06	MGC	W01C043M11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	MGC11-G06	MGC	W01C043M12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC000762	MGC11-G07	MGC	W01C043M13	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC000762	MGC11-G07	MGC	W01C043M14	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC019300	MGC11-G08	MGC	W01C043M15	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC019300	MGC11-G08	MGC	W01C043M16	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC004426	MGC11-G09	MGC	W01C043M17	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC004426	MGC11-G09	MGC	W01C043M18	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC003170	MGC11-G10	MGC	W01C043M19	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC003170	MGC11-G10	MGC	W01C043M20	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC001937	MGC11-G11	MGC	W01C043M21	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001937	MGC11-G11	MGC	W01C043M22	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001930	MGC11-G12	MGC	W01C043M23	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC001930	MGC11-G12	MGC	W01C043M24	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC019283	MGC11-G01	MGC	W01C043N01	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC019283	MGC11-G01	MGC	W01C043N02	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC003167	MGC11-G02	MGC	W01C043N03	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC003167	MGC11-G02	MGC	W01C043N04	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC004991	MGC11-G03	MGC	W01C043N05	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC004991	MGC11-G03	MGC	W01C043N06	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC019314	MGC11-G04	MGC	W01C043N07	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC019314	MGC11-G04	MGC	W01C043N08	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC004986	MGC11-G05	MGC	W01C043N09	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC004986	MGC11-G05	MGC	W01C043N10	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC063126	MGC11-G06	MGC	W01C043N11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	MGC11-G06	MGC	W01C043N12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC000762	MGC11-G07	MGC	W01C043N13	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC000762	MGC11-G07	MGC	W01C043N14	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC019300	MGC11-G08	MGC	W01C043N15	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC019300	MGC11-G08	MGC	W01C043N16	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC004426	MGC11-G09	MGC	W01C043N17	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC004426	MGC11-G09	MGC	W01C043N18	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC003170	MGC11-G10	MGC	W01C043N19	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC003170	MGC11-G10	MGC	W01C043N20	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC001937	MGC11-G11	MGC	W01C043N21	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001937	MGC11-G11	MGC	W01C043N22	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001930	MGC11-G12	MGC	W01C043N23	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC001930	MGC11-G12	MGC	W01C043N24	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC004460	MGC11-H01	MGC	W01C043O01	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC004460	MGC11-H01	MGC	W01C043O02	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC062693	MGC11-H02	MGC	W01C043O03	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	MGC11-H02	MGC	W01C043O04	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC019287	MGC11-H03	MGC	W01C043O05	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC019287	MGC11-H03	MGC	W01C043O06	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003142	MGC11-H04	MGC	W01C043O07	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC003142	MGC11-H04	MGC	W01C043O08	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC004161	MGC11-H05	MGC	W01C043O09	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC004161	MGC11-H05	MGC	W01C043O10	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC009917	MGC11-H06	MGC	W01C043O11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	MGC11-H06	MGC	W01C043O12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC004175	MGC11-H07	MGC	W01C043O13	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC004175	MGC11-H07	MGC	W01C043O14	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC009916	MGC11-H08	MGC	W01C043O15	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC009916	MGC11-H08	MGC	W01C043O16	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC019276	MGC11-H09	MGC	W01C043O17	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC019276	MGC11-H09	MGC	W01C043O18	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC001496	MGC11-H10	MGC	W01C043O19	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC001496	MGC11-H10	MGC	W01C043O20	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC008898	MGC11-H11	MGC	W01C043O21	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC008898	MGC11-H11	MGC	W01C043O22	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC007436	MGC11-H12	MGC	W01C043O23	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	MGC11-H12	MGC	W01C043O24	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC004460	MGC11-H01	MGC	W01C043P01	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC004460	MGC11-H01	MGC	W01C043P02	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC062693	MGC11-H02	MGC	W01C043P03	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	MGC11-H02	MGC	W01C043P04	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC019287	MGC11-H03	MGC	W01C043P05	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC019287	MGC11-H03	MGC	W01C043P06	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003142	MGC11-H04	MGC	W01C043P07	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC003142	MGC11-H04	MGC	W01C043P08	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC004161	MGC11-H05	MGC	W01C043P09	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC004161	MGC11-H05	MGC	W01C043P10	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC009917	MGC11-H06	MGC	W01C043P11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	MGC11-H06	MGC	W01C043P12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC004175	MGC11-H07	MGC	W01C043P13	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC004175	MGC11-H07	MGC	W01C043P14	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC009916	MGC11-H08	MGC	W01C043P15	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC009916	MGC11-H08	MGC	W01C043P16	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC019276	MGC11-H09	MGC	W01C043P17	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC019276	MGC11-H09	MGC	W01C043P18	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC001496	MGC11-H10	MGC	W01C043P19	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC001496	MGC11-H10	MGC	W01C043P20	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC008898	MGC11-H11	MGC	W01C043P21	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC008898	MGC11-H11	MGC	W01C043P22	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC007436	MGC11-H12	MGC	W01C043P23	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	MGC11-H12	MGC	W01C043P24	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC000665	MGC11-A01	MGC	W01C044A01	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC000665	MGC11-A01	MGC	W01C044A02	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC017178	MGC11-A02	MGC	W01C044A03	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC017178	MGC11-A02	MGC	W01C044A04	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC007655	MGC11-A03	MGC	W01C044A05	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	MGC11-A03	MGC	W01C044A06	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	MGC11-A04	MGC	W01C044A07	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	MGC11-A04	MGC	W01C044A08	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC062776	MGC11-A05	MGC	W01C044A09	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	MGC11-A05	MGC	W01C044A10	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC017174	MGC11-A06	MGC	W01C044A11	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC017174	MGC11-A06	MGC	W01C044A12	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC000644	MGC11-A07	MGC	W01C044A13	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC000644	MGC11-A07	MGC	W01C044A14	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC002453	MGC11-A08	MGC	W01C044A15	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC002453	MGC11-A08	MGC	W01C044A16	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC000122	MGC11-A09	MGC	W01C044A17	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000122	MGC11-A09	MGC	W01C044A18	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000255	MGC11-A10	MGC	W01C044A19	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC000255	MGC11-A10	MGC	W01C044A20	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC001781	MGC11-A11	MGC	W01C044A21	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC001781	MGC11-A11	MGC	W01C044A22	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC000243	MGC11-A12	MGC	W01C044A23	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000243	MGC11-A12	MGC	W01C044A24	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000665	MGC11-A01	MGC	W01C044B01	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC000665	MGC11-A01	MGC	W01C044B02	pDONR221	20755		TCP1	6950	AAH00665.1	Hs.363137	T-complex 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001008897.1	NP_001008897.1	REVIEWED	Pfs	0.880	0.886	291	1338	466	1331	401	2	292
IKAKEN	BC017178	MGC11-A02	MGC	W01C044B03	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC017178	MGC11-A02	MGC	W01C044B04	pDONR221	8639		STUB1	10273	AAH17178.1	Hs.592081	STIP1 homology and U-box containing protein 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_005861.2	NP_005852.2	VALIDATED	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	BC007655	MGC11-A03	MGC	W01C044B05	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC007655	MGC11-A03	MGC	W01C044B06	pDONR221	16986		PPP1R2	5504	AAH07655.1	Hs.706920	Protein phosphatase 1, regulatory (inhibitor) subunit 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006241.4	NP_006232.1	VALIDATED		0.839	0.839	161	486	1	483	205	1	161
IKAKEN	BC000549	MGC11-A04	MGC	W01C044B07	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC000549	MGC11-A04	MGC	W01C044B08	pDONR221	9149		COG7	91949	AAH00549.1	Hs.185807	Component of oligomeric golgi complex 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_153603.2	NP_705831.1	VALIDATED	OK	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC062776	MGC11-A05	MGC	W01C044B09	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	MGC11-A05	MGC	W01C044B10	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC017174	MGC11-A06	MGC	W01C044B11	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC017174	MGC11-A06	MGC	W01C044B12	pDONR221	23776		DBH	1621	AAH17174.1	Hs.591890	Dopamine beta-hydroxylase (dopamine beta-monooxygenase)			Pooled, 40 cell lines	NIH_MGC_127	DH10B	NM_000787.3	NP_000778.3	REVIEWED	P	1.000	1.000	603	1812	1	1809	617	15	617
IKAKEN	BC000644	MGC11-A07	MGC	W01C044B13	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC000644	MGC11-A07	MGC	W01C044B14	pDONR221	12		CD52	1043	AAH00644.1	Hs.276770	CD52 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001803.2	NP_001794.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC002453	MGC11-A08	MGC	W01C044B15	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC002453	MGC11-A08	MGC	W01C044B16	pDONR221	38753		HSPA1A	3303	AAH02453.1	Hs.702139	Heat shock 70kDa protein 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005345.5	NP_005336.3	REVIEWED	Cs	0.998	0.998	641	1926	1	1923	641	1	641
IKAKEN	BC000122	MGC11-A09	MGC	W01C044B17	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000122	MGC11-A09	MGC	W01C044B18	pDONR221	23615		FAM125B	89853	AAH00122	Hs.162659	Family with sequence similarity 125, member B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_033446.1	NP_258257.1	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC000255	MGC11-A10	MGC	W01C044B19	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC000255	MGC11-A10	MGC	W01C044B20	pDONR221	18675		FUNDC2	65991	AAH00255.2	Hs.356050	FUN14 domain containing 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023934.3	NP_076423.2	VALIDATED		0.968	0.968	189	570	1	567	189	1	189
IKAKEN	BC001781	MGC11-A11	MGC	W01C044B21	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC001781	MGC11-A11	MGC	W01C044B22	pDONR221	4936		RPL36A	6173	AAH01781.1	Hs.432485	Ribosomal protein L36a			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021029.4	NP_066357.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BC000243	MGC11-A12	MGC	W01C044B23	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000243	MGC11-A12	MGC	W01C044B24	pDONR221	16187		VILL	50853	AAH00243.1	Hs.103665	Villin-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015873.3	NP_056957.3	REVIEWED	P	1.000	1.000	686	2061	1	2058	856	171	856
IKAKEN	BC000249	MGC11-B01	MGC	W01C044C01	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	MGC11-B01	MGC	W01C044C02	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC001734	MGC11-B02	MGC	W01C044C03	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC001734	MGC11-B02	MGC	W01C044C04	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC003092	MGC11-B03	MGC	W01C044C05	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC003092	MGC11-B03	MGC	W01C044C06	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC000266	MGC11-B04	MGC	W01C044C07	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC000266	MGC11-B04	MGC	W01C044C08	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC001804	MGC11-B05	MGC	W01C044C09	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001804	MGC11-B05	MGC	W01C044C10	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001182	MGC11-B06	MGC	W01C044C11	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC001182	MGC11-B06	MGC	W01C044C12	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003586	MGC11-B07	MGC	W01C044C13	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003586	MGC11-B07	MGC	W01C044C14	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC001191	MGC11-B08	MGC	W01C044C15	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC001191	MGC11-B08	MGC	W01C044C16	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC000246	MGC11-B09	MGC	W01C044C17	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC000246	MGC11-B09	MGC	W01C044C18	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC001623	MGC11-B10	MGC	W01C044C19	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001623	MGC11-B10	MGC	W01C044C20	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001210	MGC11-B11	MGC	W01C044C21	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001210	MGC11-B11	MGC	W01C044C22	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001181	MGC11-B12	MGC	W01C044C23	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC001181	MGC11-B12	MGC	W01C044C24	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000249	MGC11-B01	MGC	W01C044D01	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC000249	MGC11-B01	MGC	W01C044D02	pDONR221	17704		PDE6B	5158	AAH00249.1	Hs.654544	Phosphodiesterase 6B, cGMP-specific, rod, beta			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000283.3	NP_000274.2	REVIEWED	Cgs	0.993	0.999	859	2580	1	2577	854	1	854
IKAKEN	BC001734	MGC11-B02	MGC	W01C044D03	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC001734	MGC11-B02	MGC	W01C044D04	pDONR221	23612		SEC61B	10952	AAH01734.1	Hs.191887	Sec61 beta subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006808.2	NP_006799.1	REVIEWED	OK	1.000	1.000	96	291	1	288	96	1	96
IKAKEN	BC003092	MGC11-B03	MGC	W01C044D05	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC003092	MGC11-B03	MGC	W01C044D06	pDONR221	806		RBBP4	5928	AAH03092.1	Hs.16003	Retinoblastoma binding protein 4			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001135256.1	NP_001128728.1	REVIEWED		0.892	0.903	388	1383	103	1251	390	1	388
IKAKEN	BC000266	MGC11-B04	MGC	W01C044D07	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC000266	MGC11-B04	MGC	W01C044D08	pDONR221	24822		NDUFA1	4694	AAH00266.1	Hs.534168	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 1, 7.5kDa			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004541.3	NP_004532.1	REVIEWED	OK	1.000	1.000	70	213	1	210	70	1	70
IKAKEN	BC001804	MGC11-B05	MGC	W01C044D09	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001804	MGC11-B05	MGC	W01C044D10	pDONR221	12990		BZW1	9689	AAH01804.1	Hs.355983	Basic leucine zipper and W2 domains 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014670.2	NP_055485.2	VALIDATED	OK	1.000	1.000	353	1062	1	1059	353	1	353
IKAKEN	BC001182	MGC11-B06	MGC	W01C044D11	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC001182	MGC11-B06	MGC	W01C044D12	pDONR221	9370		MRPS34	65993	AAH01182.1	Hs.157160	Mitochondrial ribosomal protein S34			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_023936.1	NP_076425.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003586	MGC11-B07	MGC	W01C044D13	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003586	MGC11-B07	MGC	W01C044D14	pDONR221	21202		ARMC10	83787	AAH03586.1	Hs.287412	Armadillo repeat containing 10			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001161009.1	NP_001154481.1	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC001191	MGC11-B08	MGC	W01C044D15	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC001191	MGC11-B08	MGC	W01C044D16	pDONR221	5564		NOC4L	79050	AAH01191.1	Hs.558536	Nucleolar complex associated 4 homolog (S. cerevisiae)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_024078.1	NP_076983.1	PROVISIONAL	C	1.000	1.000	516	1551	1	1548	516	1	516
IKAKEN	BC000246	MGC11-B09	MGC	W01C044D17	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC000246	MGC11-B09	MGC	W01C044D18	pDONR221	8116		RPAP1	26015	AAH00246.2	Hs.371045	RNA polymerase II associated protein 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_015540.2	NP_056355.2	REVIEWED	OK	1.000	1.000	1393	4182	1	4179	1393	1	1393
IKAKEN	BC001623	MGC11-B10	MGC	W01C044D19	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001623	MGC11-B10	MGC	W01C044D20	pDONR221	19817		MRPL18	29074	AAH01623.1	Hs.416998	Mitochondrial ribosomal protein L18			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_014161.3	NP_054880.2	REVIEWED	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	BC001210	MGC11-B11	MGC	W01C044D21	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001210	MGC11-B11	MGC	W01C044D22	pDONR221	4045		PTDSS2	81490	AAH01210.1	Hs.12851	Phosphatidylserine synthase 2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_030783.1	NP_110410.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC001181	MGC11-B12	MGC	W01C044D23	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC001181	MGC11-B12	MGC	W01C044D24	pDONR221	8908		FAM173A	65990	AAH01181.1	Hs.166244	Family with sequence similarity 173, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_023933.1	NP_076422.1	PREDICTED	C	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC024043	MGC11-C01	MGC	W01C044E01	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	MGC11-C01	MGC	W01C044E02	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC003103	MGC11-C02	MGC	W01C044E03	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003103	MGC11-C02	MGC	W01C044E04	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC000270	MGC11-C03	MGC	W01C044E05	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000270	MGC11-C03	MGC	W01C044E06	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001731	MGC11-C04	MGC	W01C044E07	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC001731	MGC11-C04	MGC	W01C044E08	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC000121	MGC11-C05	MGC	W01C044E09	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC000121	MGC11-C05	MGC	W01C044E10	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC001149	MGC11-C06	MGC	W01C044E11	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC001149	MGC11-C06	MGC	W01C044E12	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC000004	MGC11-C07	MGC	W01C044E13	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000004	MGC11-C07	MGC	W01C044E14	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000002	MGC11-C08	MGC	W01C044E15	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000002	MGC11-C08	MGC	W01C044E16	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000095	MGC11-C09	MGC	W01C044E17	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000095	MGC11-C09	MGC	W01C044E18	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000056	MGC11-C10	MGC	W01C044E19	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000056	MGC11-C10	MGC	W01C044E20	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC003609	MGC11-C11	MGC	W01C044E21	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC003609	MGC11-C11	MGC	W01C044E22	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC000006	MGC11-C12	MGC	W01C044E23	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC000006	MGC11-C12	MGC	W01C044E24	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC024043	MGC11-C01	MGC	W01C044F01	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	MGC11-C01	MGC	W01C044F02	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC003103	MGC11-C02	MGC	W01C044F03	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC003103	MGC11-C02	MGC	W01C044F04	pDONR221	2119		RIMS3	9783	AAH03103.1	Hs.654808	Regulating synaptic membrane exocytosis 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014747.2	NP_055562.2	VALIDATED	OK	1.000	1.000	308	927	1	924	308	1	308
IKAKEN	BC000270	MGC11-C03	MGC	W01C044F05	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC000270	MGC11-C03	MGC	W01C044F06	pDONR221	4576		MACROD1	28992	AAH00270.2	Hs.602898	MACRO domain containing 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_014067.3	NP_054786.2	VALIDATED	OK	1.000	1.000	325	978	1	975	325	1	325
IKAKEN	BC001731	MGC11-C04	MGC	W01C044F07	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC001731	MGC11-C04	MGC	W01C044F08	pDONR221	4024		CAPRIN1	4076	AAH01731.2	Hs.471818	Cell cycle associated protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203364.2	NP_976240.1	VALIDATED	Pfs	0.992	0.998	639	1956	1	1913	694	54	689
IKAKEN	BC000121	MGC11-C05	MGC	W01C044F09	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC000121	MGC11-C05	MGC	W01C044F10	pDONR221	9826		C17orf53	78995	AAH00121.1	Hs.437059	Chromosome 17 open reading frame 53			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024032.2	NP_076937.2	PREDICTED	Pg	0.871	1.000	590	1572	7	1548	647	2	591
IKAKEN	BC001149	MGC11-C06	MGC	W01C044F11	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC001149	MGC11-C06	MGC	W01C044F12	pDONR221	24579		UTP14A	10813	AAH01149.1	Hs.458598	UTP14, U3 small nucleolar ribonucleoprotein, homolog A (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_006649.2	NP_006640.2	PROVISIONAL	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC000004	MGC11-C07	MGC	W01C044F13	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000004	MGC11-C07	MGC	W01C044F14	pDONR221	15669		HSCB	150274	AAH00004	Hs.632780	HscB iron-sulfur cluster co-chaperone homolog (E. coli)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_172002.3	NP_741999.3	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC000002	MGC11-C08	MGC	W01C044F15	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000002	MGC11-C08	MGC	W01C044F16	pDONR221	6439		MRP63	78988	AAH00002	Hs.458367	Mitochondrial ribosomal protein 63			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024026.4	NP_076931.1	REVIEWED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000095	MGC11-C09	MGC	W01C044F17	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000095	MGC11-C09	MGC	W01C044F18	pDONR221	15961		NAGA	4668	AAH00095.1	Hs.75372	N-acetylgalactosaminidase, alpha-			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000262.2	NP_000253.1	REVIEWED	OK	1.000	1.000	411	1236	1	1233	411	1	411
IKAKEN	BC000056	MGC11-C10	MGC	W01C044F19	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000056	MGC11-C10	MGC	W01C044F20	pDONR221	12654		YIPF2	78992	AAH00056.1	Hs.323213	Yip1 domain family, member 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024029.3	NP_076934.1	PROVISIONAL	C	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC003609	MGC11-C11	MGC	W01C044F21	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC003609	MGC11-C11	MGC	W01C044F22	pDONR221	24834		PRDX4	10549	AAH03609.1	Hs.83383	Peroxiredoxin 4			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006406.1	NP_006397.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC000006	MGC11-C12	MGC	W01C044F23	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC000006	MGC11-C12	MGC	W01C044F24	pDONR221	865		ATP1B1	481	AAH00006.1	Hs.291196	ATPase, Na+/K+ transporting, beta 1 polypeptide			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001677.3	NP_001668.1	REVIEWED	Cgs	0.993	0.997	304	915	1	912	303	1	303
IKAKEN	BC000003	MGC11-D01	MGC	W01C044G01	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC000003	MGC11-D01	MGC	W01C044G02	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC003608	MGC11-D02	MGC	W01C044G03	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC003608	MGC11-D02	MGC	W01C044G04	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC001482	MGC11-D03	MGC	W01C044G05	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001482	MGC11-D03	MGC	W01C044G06	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001070	MGC11-D04	MGC	W01C044G07	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001070	MGC11-D04	MGC	W01C044G08	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001485	MGC11-D05	MGC	W01C044G09	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC001485	MGC11-D05	MGC	W01C044G10	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC000029	MGC11-D06	MGC	W01C044G11	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000029	MGC11-D06	MGC	W01C044G12	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000051	MGC11-D07	MGC	W01C044G13	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000051	MGC11-D07	MGC	W01C044G14	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000736	MGC11-D08	MGC	W01C044G15	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000736	MGC11-D08	MGC	W01C044G16	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000780	MGC11-D09	MGC	W01C044G17	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	MGC11-D09	MGC	W01C044G18	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009898	MGC11-D10	MGC	W01C044G19	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC009898	MGC11-D10	MGC	W01C044G20	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC001096	MGC11-D11	MGC	W01C044G21	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC001096	MGC11-D11	MGC	W01C044G22	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC000104	MGC11-D12	MGC	W01C044G23	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC000104	MGC11-D12	MGC	W01C044G24	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC000003	MGC11-D01	MGC	W01C044H01	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC000003	MGC11-D01	MGC	W01C044H02	pDONR221	16275		GTPBP8	29083	-	Hs.127496	GTP-binding protein 8 (putative)			human lung	LNG		NM_014170.2	NP_054889.2	VALIDATED	Pfs	0.994	1.000	170	510	1	508	284	1	170
IKAKEN	BC003608	MGC11-D02	MGC	W01C044H03	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC003608	MGC11-D02	MGC	W01C044H04	pDONR221	22657		RBPMS	11030	AAH03608.1	Hs.334587	RNA binding protein with multiple splicing			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001008712.1	NP_001008712.1	REVIEWED	OK	1.000	1.000	219	660	1	657	219	1	219
IKAKEN	BC001482	MGC11-D03	MGC	W01C044H05	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001482	MGC11-D03	MGC	W01C044H06	pDONR221	15826		PISD	23761	AAH01482.1	Hs.420559	Phosphatidylserine decarboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014338.3	NP_055153.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC001070	MGC11-D04	MGC	W01C044H07	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001070	MGC11-D04	MGC	W01C044H08	pDONR221	15936		TTLL12	23170	AAH01070.1	Hs.517670	Tubulin tyrosine ligase-like family, member 12			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015140.2	NP_055955.1	PROVISIONAL	OK	1.000	1.000	644	1935	1	1932	644	1	644
IKAKEN	BC001485	MGC11-D05	MGC	W01C044H09	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC001485	MGC11-D05	MGC	W01C044H10	pDONR221	15835		RAC2	5880	AAH01485.1	Hs.517601	Ras-related C3 botulinum toxin substrate 2 (rho family, small GTP binding protein Rac2)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_002872.3	NP_002863.1	REVIEWED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC000029	MGC11-D06	MGC	W01C044H11	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000029	MGC11-D06	MGC	W01C044H12	pDONR221	1336		PI4KB	5298	AAH00029.1	Hs.632465	Phosphatidylinositol 4-kinase, catalytic, beta			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002651.1	NP_002642.1	PROVISIONAL	Pg	0.982	1.000	816	2406	1	2403	828	13	828
IKAKEN	BC000051	MGC11-D07	MGC	W01C044H13	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000051	MGC11-D07	MGC	W01C044H14	pDONR221	5804		FAIM2	23017	AAH00051.1	Hs.567424	Fas apoptotic inhibitory molecule 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012306.2	NP_036438.2	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC000736	MGC11-D08	MGC	W01C044H15	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000736	MGC11-D08	MGC	W01C044H16	pDONR221	12231		MAN2B1	4125	AAH00736.1	Hs.356769	Mannosidase, alpha, class 2B, member 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000528.3	NP_000519.2	REVIEWED	OK	1.000	1.000	1011	3036	1	3033	1011	1	1011
IKAKEN	BC000780	MGC11-D09	MGC	W01C044H17	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC000780	MGC11-D09	MGC	W01C044H18	pDONR221	8193		NDUFAF1	51103	AAH00780.1	Hs.106529	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016013.2	NP_057097.2	VALIDATED	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC009898	MGC11-D10	MGC	W01C044H19	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC009898	MGC11-D10	MGC	W01C044H20	pDONR221	24564		SMS	6611	AAH09898.1	Hs.715555	Spermine synthase			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_004595.2	NP_004586.2	REVIEWED		0.975	0.978	366	1098	1	1095	366	1	366
IKAKEN	BC001096	MGC11-D11	MGC	W01C044H21	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC001096	MGC11-D11	MGC	W01C044H22	pDONR221	17706		FAM114A1	92689	AAH01096.2	Hs.476517	Family with sequence similarity 114, member A1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138389.1	NP_612398.1	PREDICTED	Cs	0.996	0.996	563	1692	1	1689	563	1	563
IKAKEN	BC000104	MGC11-D12	MGC	W01C044H23	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC000104	MGC11-D12	MGC	W01C044H24	pDONR221	1391		TMCO1	54499	AAH00104.1	Hs.715707	Transmembrane and coiled-coil domains 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_019026.3	NP_061899.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC004191	MGC11-E01	MGC	W01C044I01	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC004191	MGC11-E01	MGC	W01C044I02	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC009902	MGC11-E02	MGC	W01C044I03	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC009902	MGC11-E02	MGC	W01C044I04	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC003082	MGC11-E03	MGC	W01C044I05	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC003082	MGC11-E03	MGC	W01C044I06	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC009924	MGC11-E04	MGC	W01C044I07	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC009924	MGC11-E04	MGC	W01C044I08	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC002978	MGC11-E05	MGC	W01C044I09	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC002978	MGC11-E05	MGC	W01C044I10	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001902	MGC11-E06	MGC	W01C044I11	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC001902	MGC11-E06	MGC	W01C044I12	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC005005	MGC11-E07	MGC	W01C044I13	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC005005	MGC11-E07	MGC	W01C044I14	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC001890	MGC11-E08	MGC	W01C044I15	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001890	MGC11-E08	MGC	W01C044I16	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001884	MGC11-E09	MGC	W01C044I17	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC001884	MGC11-E09	MGC	W01C044I18	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC004963	MGC11-E10	MGC	W01C044I19	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC004963	MGC11-E10	MGC	W01C044I20	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC001738	MGC11-E11	MGC	W01C044I21	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC001738	MGC11-E11	MGC	W01C044I22	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC019255	MGC11-E12	MGC	W01C044I23	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC019255	MGC11-E12	MGC	W01C044I24	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC004191	MGC11-E01	MGC	W01C044J01	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC004191	MGC11-E01	MGC	W01C044J02	pDONR221	8801		DCTN5	84516	AAH04191.1	Hs.435941	Dynactin 5 (p25)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032486.2	NP_115875.1	PROVISIONAL	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC009902	MGC11-E02	MGC	W01C044J03	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC009902	MGC11-E02	MGC	W01C044J04	pDONR221	12876		IGFBP2	3485	AAH09902.1	Hs.438102	Insulin-like growth factor binding protein 2, 36kDa			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000597.2	NP_000588.2	VALIDATED	Cg	0.991	1.000	328	978	1	975	328	1	328
IKAKEN	BC003082	MGC11-E03	MGC	W01C044J05	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC003082	MGC11-E03	MGC	W01C044J06	pDONR221	1835		TMEM48	55706	AAH03082.1	Hs.476525	Transmembrane protein 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_018087.3	NP_060557.2	PROVISIONAL	Cs	0.999	0.999	674	2025	1	2022	674	1	674
IKAKEN	BC009924	MGC11-E04	MGC	W01C044J07	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC009924	MGC11-E04	MGC	W01C044J08	pDONR221	21420		NPTX2	4885	AAH09924.1	Hs.3281	Neuronal pentraxin II			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002523.2	NP_002514.1	REVIEWED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC002978	MGC11-E05	MGC	W01C044J09	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC002978	MGC11-E05	MGC	W01C044J10	pDONR221	3688		CD81	975	AAH02978.1	Hs.54457	CD81 molecule			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004356.3	NP_004347.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001902	MGC11-E06	MGC	W01C044J11	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC001902	MGC11-E06	MGC	W01C044J12	pDONR221	25152		IDH3G	3421	AAH01902.1	Hs.410197	Isocitrate dehydrogenase 3 (NAD+) gamma			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004135.2	NP_004126.1	REVIEWED	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC005005	MGC11-E07	MGC	W01C044J13	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC005005	MGC11-E07	MGC	W01C044J14	pDONR221	9820		C17orf80	55028	AAH05005.1	Hs.12929	Chromosome 17 open reading frame 80			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_017941.4	NP_060411.2	VALIDATED	Cs	0.998	0.998	609	1830	1	1827	609	1	609
IKAKEN	BC001890	MGC11-E08	MGC	W01C044J15	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001890	MGC11-E08	MGC	W01C044J16	pDONR221	22082		GCK	2645	AAH01890.1	Hs.1270	Glucokinase (hexokinase 4)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_000162.3	NP_000153.1	REVIEWED	OK	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	BC001884	MGC11-E09	MGC	W01C044J17	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC001884	MGC11-E09	MGC	W01C044J18	pDONR221	269		NDUFS5	4725	AAH01884.1	Hs.632385	NADH dehydrogenase (ubiquinone) Fe-S protein 5, 15kDa (NADH-coenzyme Q reductase)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004552.1	NP_004543.1	PROVISIONAL		0.868	0.868	106	321	1	318	106	1	106
IKAKEN	BC004963	MGC11-E10	MGC	W01C044J19	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC004963	MGC11-E10	MGC	W01C044J20	pDONR221	9913		ATP5G1	516	AAH04963.1	Hs.80986	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit C1 (subunit 9)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005175.2	NP_005166.1	REVIEWED		0.856	0.856	125	378	1	375	136	1	125
IKAKEN	BC001738	MGC11-E11	MGC	W01C044J21	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC001738	MGC11-E11	MGC	W01C044J22	pDONR221	15362		UBE2G2	7327	AAH01738.1	Hs.701398	Ubiquitin-conjugating enzyme E2G 2 (UBC7 homolog, yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003343.4	NP_003334.2	REVIEWED	P	1.000	1.000	124	375	1	372	165	42	165
IKAKEN	BC019255	MGC11-E12	MGC	W01C044J23	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC019255	MGC11-E12	MGC	W01C044J24	pDONR221	17714		PAICS	10606	AAH19255.1	Hs.709570	Phosphoribosylaminoimidazole carboxylase, phosphoribosylaminoimidazole succinocarboxamide synthetase			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_006452.3	NP_006443.1	REVIEWED	OK	1.000	1.000	425	1278	1	1275	425	1	425
IKAKEN	BC006462	MGC11-F01	MGC	W01C044K01	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006462	MGC11-F01	MGC	W01C044K02	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC003102	MGC11-F02	MGC	W01C044K03	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC003102	MGC11-F02	MGC	W01C044K04	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC001725	MGC11-F03	MGC	W01C044K05	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC001725	MGC11-F03	MGC	W01C044K06	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC003093	MGC11-F04	MGC	W01C044K07	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC003093	MGC11-F04	MGC	W01C044K08	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC001907	MGC11-F05	MGC	W01C044K09	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001907	MGC11-F05	MGC	W01C044K10	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001909	MGC11-F06	MGC	W01C044K11	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001909	MGC11-F06	MGC	W01C044K12	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001177	MGC11-F07	MGC	W01C044K13	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001177	MGC11-F07	MGC	W01C044K14	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001870	MGC11-F08	MGC	W01C044K15	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001870	MGC11-F08	MGC	W01C044K16	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001711	MGC11-F09	MGC	W01C044K17	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001711	MGC11-F09	MGC	W01C044K18	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001634	MGC11-F10	MGC	W01C044K19	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001634	MGC11-F10	MGC	W01C044K20	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001912	MGC11-F11	MGC	W01C044K21	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC001912	MGC11-F11	MGC	W01C044K22	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC003576	MGC11-F12	MGC	W01C044K23	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC003576	MGC11-F12	MGC	W01C044K24	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC006462	MGC11-F01	MGC	W01C044L01	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC006462	MGC11-F01	MGC	W01C044L02	pDONR221	1029		SUMO1	7341	AAH06462.1	Hs.81424	SMT3 suppressor of mif two 3 homolog 1 (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001005781.1	NP_001005781.1	REVIEWED	OK	1.000	1.000	101	306	1	303	101	1	101
IKAKEN	BC003102	MGC11-F02	MGC	W01C044L03	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC003102	MGC11-F02	MGC	W01C044L04	pDONR221	12264		NDUFA7	4701	AAH03102.1	Hs.333427	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 7, 14.5kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005001.2	NP_004992.2	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC001725	MGC11-F03	MGC	W01C044L05	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC001725	MGC11-F03	MGC	W01C044L06	pDONR221	23753		RGP1	9827	AAH01725.1	Hs.719327	RGP1 retrograde golgi transport homolog (S. cerevisiae)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001080496.1	NP_001073965.1	PROVISIONAL	P	1.000	1.000	391	1176	1	1173	431	41	431
IKAKEN	BC003093	MGC11-F04	MGC	W01C044L07	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC003093	MGC11-F04	MGC	W01C044L08	pDONR221	7564		RABGGTA	5875	AAH03093.1	Hs.377992	Rab geranylgeranyltransferase, alpha subunit			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004581.3	NP_004572.3	VALIDATED	Cg	0.995	1.000	570	1713	1	1710	567	1	567
IKAKEN	BC001907	MGC11-F05	MGC	W01C044L09	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001907	MGC11-F05	MGC	W01C044L10	pDONR221	12313		TRAPPC6A	79090	AAH01907.1	Hs.466929	Trafficking protein particle complex 6A			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_024108.1	NP_077013.1	PROVISIONAL	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	BC001909	MGC11-F06	MGC	W01C044L11	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001909	MGC11-F06	MGC	W01C044L12	pDONR221	25384		FAM58A	92002	AAH01909.4	Hs.659433	Family with sequence similarity 58, member A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152274.3	NP_689487.2	REVIEWED	Cg	0.992	1.000	248	741	1	738	248	1	248
IKAKEN	BC001177	MGC11-F07	MGC	W01C044L13	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001177	MGC11-F07	MGC	W01C044L14	pDONR221	15383		U2AF1	7307	AAH01177.1	Hs.365116	U2 small nuclear RNA auxiliary factor 1			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001025204.1	NP_001020375.1	REVIEWED		0.878	0.904	172	732	214	729	167	1	167
IKAKEN	BC001870	MGC11-F08	MGC	W01C044L15	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001870	MGC11-F08	MGC	W01C044L16	pDONR221	13866		EIF2B4	8890	AAH01870.1	Hs.169474	Eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015636.3	NP_056451.3	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC001711	MGC11-F09	MGC	W01C044L17	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001711	MGC11-F09	MGC	W01C044L18	pDONR221	879		C1orf50	79078	AAH01711.1	Hs.148845	Chromosome 1 open reading frame 50			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024097.2	NP_077002.2	PREDICTED	OK	1.000	1.000	199	600	1	597	199	1	199
IKAKEN	BC001634	MGC11-F10	MGC	W01C044L19	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001634	MGC11-F10	MGC	W01C044L20	pDONR221	13078		VAMP8	8673	AAH01634.1	Hs.714302	Vesicle-associated membrane protein 8 (endobrevin)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_003761.3	NP_003752.2	VALIDATED	OK	1.000	1.000	100	303	1	300	100	1	100
IKAKEN	BC001912	MGC11-F11	MGC	W01C044L21	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC001912	MGC11-F11	MGC	W01C044L22	pDONR221	8585		C16orf14	84331	AAH01912.2	Hs.417710	Chromosome 16 open reading frame 14			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138418.2	NP_612427.2	PREDICTED	Cfs	0.994	1.000	160	585	1	478	160	1	160
IKAKEN	BC003576	MGC11-F12	MGC	W01C044L23	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC003576	MGC11-F12	MGC	W01C044L24	pDONR221	7464		ACTN1	87	AAH03576.1	Hs.509765	Actinin, alpha 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001102.3	NP_001093.1	REVIEWED	OK	1.000	1.000	892	2679	1	2676	892	1	892
IKAKEN	BC019283	MGC11-G01	MGC	W01C044M01	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC019283	MGC11-G01	MGC	W01C044M02	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC003167	MGC11-G02	MGC	W01C044M03	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC003167	MGC11-G02	MGC	W01C044M04	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC004991	MGC11-G03	MGC	W01C044M05	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC004991	MGC11-G03	MGC	W01C044M06	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC019314	MGC11-G04	MGC	W01C044M07	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC019314	MGC11-G04	MGC	W01C044M08	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC004986	MGC11-G05	MGC	W01C044M09	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC004986	MGC11-G05	MGC	W01C044M10	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC063126	MGC11-G06	MGC	W01C044M11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	MGC11-G06	MGC	W01C044M12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC000762	MGC11-G07	MGC	W01C044M13	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC000762	MGC11-G07	MGC	W01C044M14	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC019300	MGC11-G08	MGC	W01C044M15	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC019300	MGC11-G08	MGC	W01C044M16	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC004426	MGC11-G09	MGC	W01C044M17	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC004426	MGC11-G09	MGC	W01C044M18	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC003170	MGC11-G10	MGC	W01C044M19	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC003170	MGC11-G10	MGC	W01C044M20	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC001937	MGC11-G11	MGC	W01C044M21	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001937	MGC11-G11	MGC	W01C044M22	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001930	MGC11-G12	MGC	W01C044M23	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC001930	MGC11-G12	MGC	W01C044M24	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC019283	MGC11-G01	MGC	W01C044N01	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC019283	MGC11-G01	MGC	W01C044N02	pDONR221	17169		TRAIP	10293	AAH19283.1	Hs.517972	TRAF interacting protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005879.2	NP_005870.2	REVIEWED	OK	1.000	1.000	469	1410	1	1407	469	1	469
IKAKEN	BC003167	MGC11-G02	MGC	W01C044N03	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC003167	MGC11-G02	MGC	W01C044N04	pDONR221	2659		PI4K2A	55361	AAH03167.1	Hs.25300	Phosphatidylinositol 4-kinase type 2 alpha			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018425.2	NP_060895.1	PROVISIONAL	C	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	BC004991	MGC11-G03	MGC	W01C044N05	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC004991	MGC11-G03	MGC	W01C044N06	pDONR221	504		SLC25A33	84275	AAH04991.1	Hs.568613	Solute carrier family 25, member 33			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032315.2	NP_115691.1	VALIDATED	Cs	0.984	0.984	321	966	1	963	321	1	321
IKAKEN	BC019314	MGC11-G04	MGC	W01C044N07	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC019314	MGC11-G04	MGC	W01C044N08	pDONR221	3742		TSPAN4	7106	AAH19314.1	Hs.654836	Tetraspanin 4			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_001025238.1	NP_001020409.1	REVIEWED	C	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC004986	MGC11-G05	MGC	W01C044N09	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC004986	MGC11-G05	MGC	W01C044N10	pDONR221	4879		RPS25	6230	AAH04986.1	Hs.512676	Ribosomal protein S25			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001028.2	NP_001019.1	REVIEWED	Cgs	0.976	0.984	125	375	1	372	125	1	125
IKAKEN	BC063126	MGC11-G06	MGC	W01C044N11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	MGC11-G06	MGC	W01C044N12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC000762	MGC11-G07	MGC	W01C044N13	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC000762	MGC11-G07	MGC	W01C044N14	pDONR221	9368		DCI	1632	AAH00762.1	Hs.403436	Dodecenoyl-Coenzyme A delta isomerase (3,2 trans-enoyl-Coenzyme A isomerase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001919.2	NP_001910.2	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC019300	MGC11-G08	MGC	W01C044N15	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC019300	MGC11-G08	MGC	W01C044N16	pDONR221	25354		FAM127B	26071	AAH19300.1	Hs.719352	Family with sequence similarity 127, member B			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001134321.1	NP_001127793.1	VALIDATED		0.950	0.950	20	348	137	196	83	64	83
IKAKEN	BC004426	MGC11-G09	MGC	W01C044N17	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC004426	MGC11-G09	MGC	W01C044N18	pDONR221	11797		ATP5D	513	AAH04426.1	Hs.418668	ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001001975.1	NP_001001975.1	REVIEWED	OK	1.000	1.000	168	507	1	504	168	1	168
IKAKEN	BC003170	MGC11-G10	MGC	W01C044N19	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC003170	MGC11-G10	MGC	W01C044N20	pDONR221	522		UBAP2L	9898	AAH03170.1	Hs.490551	Ubiquitin associated protein 2-like			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014847.3	NP_055662.3	VALIDATED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	BC001937	MGC11-G11	MGC	W01C044N21	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001937	MGC11-G11	MGC	W01C044N22	pDONR221	15657		NCAPH2	29781	AAH01937.1	Hs.180903	Non-SMC condensin II complex, subunit H2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014551.4	NP_055366.3	VALIDATED	P	1.000	1.000	237	1668	1	711	299	51	287
IKAKEN	BC001930	MGC11-G12	MGC	W01C044N23	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC001930	MGC11-G12	MGC	W01C044N24	pDONR221	12658		SNRPD2	6633	AAH01930.1	Hs.515472	Small nuclear ribonucleoprotein D2 polypeptide 16.5kDa			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177542.2	NP_808210.2	REVIEWED		0.898	0.907	108	354	31	351	108	1	108
IKAKEN	BC004460	MGC11-H01	MGC	W01C044O01	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC004460	MGC11-H01	MGC	W01C044O02	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC062693	MGC11-H02	MGC	W01C044O03	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	MGC11-H02	MGC	W01C044O04	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC019287	MGC11-H03	MGC	W01C044O05	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC019287	MGC11-H03	MGC	W01C044O06	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003142	MGC11-H04	MGC	W01C044O07	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC003142	MGC11-H04	MGC	W01C044O08	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC004161	MGC11-H05	MGC	W01C044O09	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC004161	MGC11-H05	MGC	W01C044O10	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC009917	MGC11-H06	MGC	W01C044O11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	MGC11-H06	MGC	W01C044O12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC004175	MGC11-H07	MGC	W01C044O13	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC004175	MGC11-H07	MGC	W01C044O14	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC009916	MGC11-H08	MGC	W01C044O15	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC009916	MGC11-H08	MGC	W01C044O16	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC019276	MGC11-H09	MGC	W01C044O17	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC019276	MGC11-H09	MGC	W01C044O18	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC001496	MGC11-H10	MGC	W01C044O19	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC001496	MGC11-H10	MGC	W01C044O20	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC008898	MGC11-H11	MGC	W01C044O21	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC008898	MGC11-H11	MGC	W01C044O22	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC007436	MGC11-H12	MGC	W01C044O23	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	MGC11-H12	MGC	W01C044O24	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC004460	MGC11-H01	MGC	W01C044P01	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC004460	MGC11-H01	MGC	W01C044P02	pDONR221	18253		CASP6	839	AAH04460.1	Hs.654616	Caspase 6, apoptosis-related cysteine peptidase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001226.3	NP_001217.2	REVIEWED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC062693	MGC11-H02	MGC	W01C044P03	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	MGC11-H02	MGC	W01C044P04	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC019287	MGC11-H03	MGC	W01C044P05	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC019287	MGC11-H03	MGC	W01C044P06	pDONR221	23766		CLTA	1211	AAH19287.1	Hs.522114	Clathrin, light chain (Lca)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001833.2	NP_001824.1	REVIEWED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC003142	MGC11-H04	MGC	W01C044P07	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC003142	MGC11-H04	MGC	W01C044P08	pDONR221	7392		VTI1B	10490	AAH03142.1					Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006370.2	NP_006361.1	VALIDATED		0.897	0.900	232	696	1	693	232	1	232
IKAKEN	BC004161	MGC11-H05	MGC	W01C044P09	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC004161	MGC11-H05	MGC	W01C044P10	pDONR221	2676		TSPAN15	23555	AAH04161.1	Hs.499941	Tetraspanin 15			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012339.3	NP_036471.1	REVIEWED	OK	1.000	1.000	294	885	1	882	294	1	294
IKAKEN	BC009917	MGC11-H06	MGC	W01C044P11	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	MGC11-H06	MGC	W01C044P12	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC004175	MGC11-H07	MGC	W01C044P13	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC004175	MGC11-H07	MGC	W01C044P14	pDONR221	1676		KLHL12	59349	AAH04175.1	Hs.706793	Kelch-like 12 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021633.2	NP_067646.1	PROVISIONAL	C	1.000	1.000	568	1707	1	1704	568	1	568
IKAKEN	BC009916	MGC11-H08	MGC	W01C044P15	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC009916	MGC11-H08	MGC	W01C044P16	pDONR221	536		SLC27A3	11000	AAH09916.1	Hs.438723	Solute carrier family 27 (fatty acid transporter), member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024330.1	NP_077306.1	PROVISIONAL	OK	1.000	1.000	730	2193	1	2190	730	1	730
IKAKEN	BC019276	MGC11-H09	MGC	W01C044P17	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC019276	MGC11-H09	MGC	W01C044P18	pDONR221	3181		NDUFB8	4714	AAH19276.1	Hs.523215	NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 8, 19kDa			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005004.2	NP_004995.1	VALIDATED	OK	1.000	1.000	186	561	1	558	186	1	186
IKAKEN	BC001496	MGC11-H10	MGC	W01C044P19	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC001496	MGC11-H10	MGC	W01C044P20	pDONR221	7455		TMED10	10972	AAH01496.1	Hs.74137	Transmembrane emp24-like trafficking protein 10 (yeast)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006827.5	NP_006818.3	REVIEWED		0.870	0.874	208	624	1	621	219	1	208
IKAKEN	BC008898	MGC11-H11	MGC	W01C044P21	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC008898	MGC11-H11	MGC	W01C044P22	pDONR221	19815		CNPY3	10695	AAH08898.1	Hs.414099	Canopy 3 homolog (zebrafish)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006586.3	NP_006577.2	VALIDATED	Pfs	0.985	0.992	134	426	1	398	278	145	278
IKAKEN	BC007436	MGC11-H12	MGC	W01C044P23	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	MGC11-H12	MGC	W01C044P24	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007497	MGC12-A01	MGC	W01C045A01	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007497	MGC12-A01	MGC	W01C045A02	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007512	MGC12-A02	MGC	W01C045A03	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007512	MGC12-A02	MGC	W01C045A04	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007433	MGC12-A03	MGC	W01C045A05	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC007433	MGC12-A03	MGC	W01C045A06	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC008950	MGC12-A04	MGC	W01C045A07	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC008950	MGC12-A04	MGC	W01C045A08	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC013401	MGC12-A05	MGC	W01C045A09	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	MGC12-A05	MGC	W01C045A10	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC007504	MGC12-A06	MGC	W01C045A11	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC007504	MGC12-A06	MGC	W01C045A12	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC000354	MGC12-A07	MGC	W01C045A13	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC000354	MGC12-A07	MGC	W01C045A14	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC005156	MGC12-A08	MGC	W01C045A15	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC005156	MGC12-A08	MGC	W01C045A16	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC006494	MGC12-A09	MGC	W01C045A17	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC006494	MGC12-A09	MGC	W01C045A18	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC001683	MGC12-A10	MGC	W01C045A19	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC001683	MGC12-A10	MGC	W01C045A20	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC018654	MGC12-A11	MGC	W01C045A21	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC018654	MGC12-A11	MGC	W01C045A22	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC013026	MGC12-A12	MGC	W01C045A23	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC013026	MGC12-A12	MGC	W01C045A24	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC007497	MGC12-A01	MGC	W01C045B01	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007497	MGC12-A01	MGC	W01C045B02	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007512	MGC12-A02	MGC	W01C045B03	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007512	MGC12-A02	MGC	W01C045B04	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007433	MGC12-A03	MGC	W01C045B05	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC007433	MGC12-A03	MGC	W01C045B06	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC008950	MGC12-A04	MGC	W01C045B07	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC008950	MGC12-A04	MGC	W01C045B08	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC013401	MGC12-A05	MGC	W01C045B09	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	MGC12-A05	MGC	W01C045B10	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC007504	MGC12-A06	MGC	W01C045B11	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC007504	MGC12-A06	MGC	W01C045B12	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC000354	MGC12-A07	MGC	W01C045B13	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC000354	MGC12-A07	MGC	W01C045B14	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC005156	MGC12-A08	MGC	W01C045B15	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC005156	MGC12-A08	MGC	W01C045B16	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC006494	MGC12-A09	MGC	W01C045B17	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC006494	MGC12-A09	MGC	W01C045B18	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC001683	MGC12-A10	MGC	W01C045B19	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC001683	MGC12-A10	MGC	W01C045B20	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC018654	MGC12-A11	MGC	W01C045B21	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC018654	MGC12-A11	MGC	W01C045B22	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC013026	MGC12-A12	MGC	W01C045B23	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC013026	MGC12-A12	MGC	W01C045B24	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC022898	MGC12-B01	MGC	W01C045C01	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC022898	MGC12-B01	MGC	W01C045C02	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC005158	MGC12-B02	MGC	W01C045C03	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC005158	MGC12-B02	MGC	W01C045C04	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC009507	MGC12-B03	MGC	W01C045C05	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC009507	MGC12-B03	MGC	W01C045C06	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC013398	MGC12-B04	MGC	W01C045C07	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC013398	MGC12-B04	MGC	W01C045C08	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC006203	MGC12-B05	MGC	W01C045C09	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC006203	MGC12-B05	MGC	W01C045C10	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC003658	MGC12-B06	MGC	W01C045C11	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	MGC12-B06	MGC	W01C045C12	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC012808	MGC12-B07	MGC	W01C045C13	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012808	MGC12-B07	MGC	W01C045C14	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012995	MGC12-B08	MGC	W01C045C15	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC012995	MGC12-B08	MGC	W01C045C16	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC004204	MGC12-B09	MGC	W01C045C17	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC004204	MGC12-B09	MGC	W01C045C18	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC009508	MGC12-B10	MGC	W01C045C19	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC009508	MGC12-B10	MGC	W01C045C20	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC013040	MGC12-B11	MGC	W01C045C21	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC013040	MGC12-B11	MGC	W01C045C22	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC001827	MGC12-B12	MGC	W01C045C23	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC001827	MGC12-B12	MGC	W01C045C24	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC022898	MGC12-B01	MGC	W01C045D01	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC022898	MGC12-B01	MGC	W01C045D02	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC005158	MGC12-B02	MGC	W01C045D03	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC005158	MGC12-B02	MGC	W01C045D04	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC009507	MGC12-B03	MGC	W01C045D05	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC009507	MGC12-B03	MGC	W01C045D06	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC013398	MGC12-B04	MGC	W01C045D07	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC013398	MGC12-B04	MGC	W01C045D08	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC006203	MGC12-B05	MGC	W01C045D09	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC006203	MGC12-B05	MGC	W01C045D10	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC003658	MGC12-B06	MGC	W01C045D11	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	MGC12-B06	MGC	W01C045D12	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC012808	MGC12-B07	MGC	W01C045D13	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012808	MGC12-B07	MGC	W01C045D14	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012995	MGC12-B08	MGC	W01C045D15	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC012995	MGC12-B08	MGC	W01C045D16	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC004204	MGC12-B09	MGC	W01C045D17	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC004204	MGC12-B09	MGC	W01C045D18	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC009508	MGC12-B10	MGC	W01C045D19	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC009508	MGC12-B10	MGC	W01C045D20	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC013040	MGC12-B11	MGC	W01C045D21	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC013040	MGC12-B11	MGC	W01C045D22	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC001827	MGC12-B12	MGC	W01C045D23	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC001827	MGC12-B12	MGC	W01C045D24	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC009928	MGC12-C01	MGC	W01C045E01	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC009928	MGC12-C01	MGC	W01C045E02	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC013041	MGC12-C02	MGC	W01C045E03	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	MGC12-C02	MGC	W01C045E04	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC004922	MGC12-C03	MGC	W01C045E05	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004922	MGC12-C03	MGC	W01C045E06	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004221	MGC12-C04	MGC	W01C045E07	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC004221	MGC12-C04	MGC	W01C045E08	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC002816	MGC12-C05	MGC	W01C045E09	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002816	MGC12-C05	MGC	W01C045E10	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002843	MGC12-C06	MGC	W01C045E11	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002843	MGC12-C06	MGC	W01C045E12	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002786	MGC12-C07	MGC	W01C045E13	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002786	MGC12-C07	MGC	W01C045E14	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002817	MGC12-C08	MGC	W01C045E15	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC002817	MGC12-C08	MGC	W01C045E16	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC008798	MGC12-C09	MGC	W01C045E17	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC008798	MGC12-C09	MGC	W01C045E18	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC002846	MGC12-C10	MGC	W01C045E19	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002846	MGC12-C10	MGC	W01C045E20	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002762	MGC12-C11	MGC	W01C045E21	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC002762	MGC12-C11	MGC	W01C045E22	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC004536	MGC12-C12	MGC	W01C045E23	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC004536	MGC12-C12	MGC	W01C045E24	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC009928	MGC12-C01	MGC	W01C045F01	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC009928	MGC12-C01	MGC	W01C045F02	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC013041	MGC12-C02	MGC	W01C045F03	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	MGC12-C02	MGC	W01C045F04	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC004922	MGC12-C03	MGC	W01C045F05	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004922	MGC12-C03	MGC	W01C045F06	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004221	MGC12-C04	MGC	W01C045F07	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC004221	MGC12-C04	MGC	W01C045F08	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC002816	MGC12-C05	MGC	W01C045F09	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002816	MGC12-C05	MGC	W01C045F10	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002843	MGC12-C06	MGC	W01C045F11	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002843	MGC12-C06	MGC	W01C045F12	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002786	MGC12-C07	MGC	W01C045F13	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002786	MGC12-C07	MGC	W01C045F14	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002817	MGC12-C08	MGC	W01C045F15	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC002817	MGC12-C08	MGC	W01C045F16	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC008798	MGC12-C09	MGC	W01C045F17	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC008798	MGC12-C09	MGC	W01C045F18	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC002846	MGC12-C10	MGC	W01C045F19	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002846	MGC12-C10	MGC	W01C045F20	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002762	MGC12-C11	MGC	W01C045F21	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC002762	MGC12-C11	MGC	W01C045F22	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC004536	MGC12-C12	MGC	W01C045F23	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC004536	MGC12-C12	MGC	W01C045F24	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC002790	MGC12-D01	MGC	W01C045G01	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC002790	MGC12-D01	MGC	W01C045G02	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC004537	MGC12-D02	MGC	W01C045G03	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC004537	MGC12-D02	MGC	W01C045G04	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC002678	MGC12-D03	MGC	W01C045G05	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002678	MGC12-D03	MGC	W01C045G06	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002738	MGC12-D04	MGC	W01C045G07	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002738	MGC12-D04	MGC	W01C045G08	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002631	MGC12-D05	MGC	W01C045G09	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC002631	MGC12-D05	MGC	W01C045G10	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC008780	MGC12-D06	MGC	W01C045G11	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC008780	MGC12-D06	MGC	W01C045G12	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC002701	MGC12-D07	MGC	W01C045G13	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC002701	MGC12-D07	MGC	W01C045G14	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC017201	MGC12-D08	MGC	W01C045G15	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	MGC12-D08	MGC	W01C045G16	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002662	MGC12-D10	MGC	W01C045G19	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002662	MGC12-D10	MGC	W01C045G20	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002710	MGC12-D11	MGC	W01C045G21	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002710	MGC12-D11	MGC	W01C045G22	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002727	MGC12-D12	MGC	W01C045G23	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002727	MGC12-D12	MGC	W01C045G24	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002790	MGC12-D01	MGC	W01C045H01	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC002790	MGC12-D01	MGC	W01C045H02	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC004537	MGC12-D02	MGC	W01C045H03	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC004537	MGC12-D02	MGC	W01C045H04	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC002678	MGC12-D03	MGC	W01C045H05	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002678	MGC12-D03	MGC	W01C045H06	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002738	MGC12-D04	MGC	W01C045H07	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002738	MGC12-D04	MGC	W01C045H08	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002631	MGC12-D05	MGC	W01C045H09	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC002631	MGC12-D05	MGC	W01C045H10	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC008780	MGC12-D06	MGC	W01C045H11	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC008780	MGC12-D06	MGC	W01C045H12	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC002701	MGC12-D07	MGC	W01C045H13	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC002701	MGC12-D07	MGC	W01C045H14	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC017201	MGC12-D08	MGC	W01C045H15	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	MGC12-D08	MGC	W01C045H16	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002662	MGC12-D10	MGC	W01C045H19	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002662	MGC12-D10	MGC	W01C045H20	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002710	MGC12-D11	MGC	W01C045H21	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002710	MGC12-D11	MGC	W01C045H22	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002727	MGC12-D12	MGC	W01C045H23	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002727	MGC12-D12	MGC	W01C045H24	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002750	MGC12-E01	MGC	W01C045I01	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC002750	MGC12-E01	MGC	W01C045I02	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC004269	MGC12-E02	MGC	W01C045I03	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004269	MGC12-E02	MGC	W01C045I04	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004270	MGC12-E03	MGC	W01C045I05	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	MGC12-E03	MGC	W01C045I06	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	MGC12-E04	MGC	W01C045I07	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	MGC12-E04	MGC	W01C045I08	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC003517	MGC12-E05	MGC	W01C045I09	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC003517	MGC12-E05	MGC	W01C045I10	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC008285	MGC12-E06	MGC	W01C045I11	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	MGC12-E06	MGC	W01C045I12	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC005019	MGC12-E07	MGC	W01C045I13	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC005019	MGC12-E07	MGC	W01C045I14	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC004952	MGC12-E08	MGC	W01C045I15	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004952	MGC12-E08	MGC	W01C045I16	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004343	MGC12-E09	MGC	W01C045I17	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004343	MGC12-E09	MGC	W01C045I18	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC009518	MGC12-E10	MGC	W01C045I19	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC009518	MGC12-E10	MGC	W01C045I20	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC014274	MGC12-E11	MGC	W01C045I21	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC014274	MGC12-E11	MGC	W01C045I22	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC004861	MGC12-E12	MGC	W01C045I23	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC004861	MGC12-E12	MGC	W01C045I24	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC002750	MGC12-E01	MGC	W01C045J01	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC002750	MGC12-E01	MGC	W01C045J02	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC004269	MGC12-E02	MGC	W01C045J03	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004269	MGC12-E02	MGC	W01C045J04	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004270	MGC12-E03	MGC	W01C045J05	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	MGC12-E03	MGC	W01C045J06	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	MGC12-E04	MGC	W01C045J07	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	MGC12-E04	MGC	W01C045J08	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC003517	MGC12-E05	MGC	W01C045J09	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC003517	MGC12-E05	MGC	W01C045J10	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC008285	MGC12-E06	MGC	W01C045J11	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	MGC12-E06	MGC	W01C045J12	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC005019	MGC12-E07	MGC	W01C045J13	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC005019	MGC12-E07	MGC	W01C045J14	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC004952	MGC12-E08	MGC	W01C045J15	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004952	MGC12-E08	MGC	W01C045J16	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004343	MGC12-E09	MGC	W01C045J17	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004343	MGC12-E09	MGC	W01C045J18	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC009518	MGC12-E10	MGC	W01C045J19	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC009518	MGC12-E10	MGC	W01C045J20	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC014274	MGC12-E11	MGC	W01C045J21	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC014274	MGC12-E11	MGC	W01C045J22	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC004861	MGC12-E12	MGC	W01C045J23	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC004861	MGC12-E12	MGC	W01C045J24	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC009755	MGC12-F01	MGC	W01C045K01	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	MGC12-F01	MGC	W01C045K02	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC024146	MGC12-F02	MGC	W01C045K03	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC024146	MGC12-F02	MGC	W01C045K04	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC019221	MGC12-F03	MGC	W01C045K05	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC019221	MGC12-F03	MGC	W01C045K06	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC004856	MGC12-F04	MGC	W01C045K07	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC004856	MGC12-F04	MGC	W01C045K08	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC014527	MGC12-F05	MGC	W01C045K09	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC014527	MGC12-F05	MGC	W01C045K10	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC013888	MGC12-F06	MGC	W01C045K11	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC013888	MGC12-F06	MGC	W01C045K12	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC004868	MGC12-F07	MGC	W01C045K13	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC004868	MGC12-F07	MGC	W01C045K14	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC014271	MGC12-F08	MGC	W01C045K15	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC014271	MGC12-F08	MGC	W01C045K16	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC013885	MGC12-F09	MGC	W01C045K17	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC013885	MGC12-F09	MGC	W01C045K18	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC004518	MGC12-F10	MGC	W01C045K19	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004518	MGC12-F10	MGC	W01C045K20	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004519	MGC12-F11	MGC	W01C045K21	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC004519	MGC12-F11	MGC	W01C045K22	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC006530	MGC12-F12	MGC	W01C045K23	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC006530	MGC12-F12	MGC	W01C045K24	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC009755	MGC12-F01	MGC	W01C045L01	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	MGC12-F01	MGC	W01C045L02	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC024146	MGC12-F02	MGC	W01C045L03	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC024146	MGC12-F02	MGC	W01C045L04	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC019221	MGC12-F03	MGC	W01C045L05	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC019221	MGC12-F03	MGC	W01C045L06	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC004856	MGC12-F04	MGC	W01C045L07	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC004856	MGC12-F04	MGC	W01C045L08	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC014527	MGC12-F05	MGC	W01C045L09	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC014527	MGC12-F05	MGC	W01C045L10	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC013888	MGC12-F06	MGC	W01C045L11	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC013888	MGC12-F06	MGC	W01C045L12	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC004868	MGC12-F07	MGC	W01C045L13	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC004868	MGC12-F07	MGC	W01C045L14	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC014271	MGC12-F08	MGC	W01C045L15	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC014271	MGC12-F08	MGC	W01C045L16	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC013885	MGC12-F09	MGC	W01C045L17	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC013885	MGC12-F09	MGC	W01C045L18	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC004518	MGC12-F10	MGC	W01C045L19	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004518	MGC12-F10	MGC	W01C045L20	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004519	MGC12-F11	MGC	W01C045L21	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC004519	MGC12-F11	MGC	W01C045L22	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC006530	MGC12-F12	MGC	W01C045L23	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC006530	MGC12-F12	MGC	W01C045L24	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC004114	MGC12-G01	MGC	W01C045M01	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC004114	MGC12-G01	MGC	W01C045M02	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC005133	MGC12-G02	MGC	W01C045M03	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC005133	MGC12-G02	MGC	W01C045M04	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006229	MGC12-G03	MGC	W01C045M05	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC006229	MGC12-G03	MGC	W01C045M06	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC002880	MGC12-G04	MGC	W01C045M07	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002880	MGC12-G04	MGC	W01C045M08	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002866	MGC12-G05	MGC	W01C045M09	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	MGC12-G05	MGC	W01C045M10	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC011617	MGC12-G06	MGC	W01C045M11	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	MGC12-G06	MGC	W01C045M12	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002939	MGC12-G07	MGC	W01C045M13	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC002939	MGC12-G07	MGC	W01C045M14	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC004558	MGC12-G08	MGC	W01C045M15	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC004558	MGC12-G08	MGC	W01C045M16	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC002894	MGC12-G09	MGC	W01C045M17	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	MGC12-G09	MGC	W01C045M18	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC006251	MGC12-G10	MGC	W01C045M19	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006251	MGC12-G10	MGC	W01C045M20	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006224	MGC12-G11	MGC	W01C045M21	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC006224	MGC12-G11	MGC	W01C045M22	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC009932	MGC12-G12	MGC	W01C045M23	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC009932	MGC12-G12	MGC	W01C045M24	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC004114	MGC12-G01	MGC	W01C045N01	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC004114	MGC12-G01	MGC	W01C045N02	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC005133	MGC12-G02	MGC	W01C045N03	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC005133	MGC12-G02	MGC	W01C045N04	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006229	MGC12-G03	MGC	W01C045N05	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC006229	MGC12-G03	MGC	W01C045N06	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC002880	MGC12-G04	MGC	W01C045N07	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002880	MGC12-G04	MGC	W01C045N08	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002866	MGC12-G05	MGC	W01C045N09	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	MGC12-G05	MGC	W01C045N10	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC011617	MGC12-G06	MGC	W01C045N11	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	MGC12-G06	MGC	W01C045N12	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002939	MGC12-G07	MGC	W01C045N13	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC002939	MGC12-G07	MGC	W01C045N14	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC004558	MGC12-G08	MGC	W01C045N15	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC004558	MGC12-G08	MGC	W01C045N16	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC002894	MGC12-G09	MGC	W01C045N17	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	MGC12-G09	MGC	W01C045N18	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC006251	MGC12-G10	MGC	W01C045N19	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006251	MGC12-G10	MGC	W01C045N20	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006224	MGC12-G11	MGC	W01C045N21	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC006224	MGC12-G11	MGC	W01C045N22	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC009932	MGC12-G12	MGC	W01C045N23	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC009932	MGC12-G12	MGC	W01C045N24	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC006278	MGC12-H01	MGC	W01C045O01	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC006278	MGC12-H01	MGC	W01C045O02	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC011621	MGC12-H02	MGC	W01C045O03	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC011621	MGC12-H02	MGC	W01C045O04	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC018910	MGC12-H03	MGC	W01C045O05	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC018910	MGC12-H03	MGC	W01C045O06	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC006285	MGC12-H04	MGC	W01C045O07	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC006285	MGC12-H04	MGC	W01C045O08	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC021198	MGC12-H05	MGC	W01C045O09	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC021198	MGC12-H05	MGC	W01C045O10	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC002912	MGC12-H06	MGC	W01C045O11	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC002912	MGC12-H06	MGC	W01C045O12	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC009934	MGC12-H07	MGC	W01C045O13	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC009934	MGC12-H07	MGC	W01C045O14	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC007706	MGC12-H08	MGC	W01C045O15	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC007706	MGC12-H08	MGC	W01C045O16	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC017210	MGC12-H09	MGC	W01C045O17	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC017210	MGC12-H09	MGC	W01C045O18	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC006296	MGC12-H10	MGC	W01C045O19	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC006296	MGC12-H10	MGC	W01C045O20	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC007780	MGC12-H11	MGC	W01C045O21	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC007780	MGC12-H11	MGC	W01C045O22	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC013973	MGC12-H12	MGC	W01C045O23	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC013973	MGC12-H12	MGC	W01C045O24	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC006278	MGC12-H01	MGC	W01C045P01	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC006278	MGC12-H01	MGC	W01C045P02	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC011621	MGC12-H02	MGC	W01C045P03	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC011621	MGC12-H02	MGC	W01C045P04	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC018910	MGC12-H03	MGC	W01C045P05	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC018910	MGC12-H03	MGC	W01C045P06	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC006285	MGC12-H04	MGC	W01C045P07	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC006285	MGC12-H04	MGC	W01C045P08	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC021198	MGC12-H05	MGC	W01C045P09	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC021198	MGC12-H05	MGC	W01C045P10	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC002912	MGC12-H06	MGC	W01C045P11	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC002912	MGC12-H06	MGC	W01C045P12	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC009934	MGC12-H07	MGC	W01C045P13	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC009934	MGC12-H07	MGC	W01C045P14	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC007706	MGC12-H08	MGC	W01C045P15	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC007706	MGC12-H08	MGC	W01C045P16	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC017210	MGC12-H09	MGC	W01C045P17	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC017210	MGC12-H09	MGC	W01C045P18	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC006296	MGC12-H10	MGC	W01C045P19	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC006296	MGC12-H10	MGC	W01C045P20	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC007780	MGC12-H11	MGC	W01C045P21	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC007780	MGC12-H11	MGC	W01C045P22	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC013973	MGC12-H12	MGC	W01C045P23	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC013973	MGC12-H12	MGC	W01C045P24	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC007497	MGC12-A01	MGC	W01C046A01	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007497	MGC12-A01	MGC	W01C046A02	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007512	MGC12-A02	MGC	W01C046A03	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007512	MGC12-A02	MGC	W01C046A04	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007433	MGC12-A03	MGC	W01C046A05	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC007433	MGC12-A03	MGC	W01C046A06	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC008950	MGC12-A04	MGC	W01C046A07	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC008950	MGC12-A04	MGC	W01C046A08	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC013401	MGC12-A05	MGC	W01C046A09	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	MGC12-A05	MGC	W01C046A10	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC007504	MGC12-A06	MGC	W01C046A11	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC007504	MGC12-A06	MGC	W01C046A12	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC000354	MGC12-A07	MGC	W01C046A13	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC000354	MGC12-A07	MGC	W01C046A14	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC005156	MGC12-A08	MGC	W01C046A15	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC005156	MGC12-A08	MGC	W01C046A16	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC006494	MGC12-A09	MGC	W01C046A17	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC006494	MGC12-A09	MGC	W01C046A18	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC001683	MGC12-A10	MGC	W01C046A19	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC001683	MGC12-A10	MGC	W01C046A20	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC018654	MGC12-A11	MGC	W01C046A21	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC018654	MGC12-A11	MGC	W01C046A22	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC013026	MGC12-A12	MGC	W01C046A23	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC013026	MGC12-A12	MGC	W01C046A24	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC007497	MGC12-A01	MGC	W01C046B01	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007497	MGC12-A01	MGC	W01C046B02	pDONR221	9701		MRPL12	6182	AAH07497.1	Hs.109059	Mitochondrial ribosomal protein L12			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_002949.2	NP_002940.2	REVIEWED	Pfs	0.989	1.000	179	531	1	529	198	1	179
IKAKEN	BC007512	MGC12-A02	MGC	W01C046B03	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007512	MGC12-A02	MGC	W01C046B04	pDONR221	5657		RPL18A	6142	AAH07512.1	Hs.337766	Ribosomal protein L18a			Peripheral Nervous System, sciatic nerve	Lupski_sciatic_nerve	DH10B	NM_000980.2	NP_000971.1	REVIEWED		0.915	0.915	176	531	1	528	176	1	176
IKAKEN	BC007433	MGC12-A03	MGC	W01C046B05	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC007433	MGC12-A03	MGC	W01C046B06	pDONR221	7728		TPM1	7168	AAH07433.1	Hs.133892	Tropomyosin 1 (alpha)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000366.5	NP_000357.3	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC008950	MGC12-A04	MGC	W01C046B07	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC008950	MGC12-A04	MGC	W01C046B08	pDONR221	12297		RABAC1	10567	AAH08950.1	Hs.11417	Rab acceptor 1 (prenylated)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_006423.2	NP_006414.2	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC013401	MGC12-A05	MGC	W01C046B09	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	MGC12-A05	MGC	W01C046B10	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC007504	MGC12-A06	MGC	W01C046B11	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC007504	MGC12-A06	MGC	W01C046B12	pDONR221	16413		LRCH3	84859	AAH07504.1	Hs.659335	Leucine-rich repeats and calponin homology (CH) domain containing 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032773.2	NP_116162.1	PROVISIONAL	C	1.000	1.000	712	2139	1	2136	712	1	712
IKAKEN	BC000354	MGC12-A07	MGC	W01C046B13	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC000354	MGC12-A07	MGC	W01C046B14	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	OK	1.000	1.000	69	210	1	207	69	1	69
IKAKEN	BC005156	MGC12-A08	MGC	W01C046B15	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC005156	MGC12-A08	MGC	W01C046B16	pDONR221	4565		C11orf51	25906	AAH05156.1	Hs.38044	Chromosome 11 open reading frame 51			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014042.2	NP_054761.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	BC006494	MGC12-A09	MGC	W01C046B17	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC006494	MGC12-A09	MGC	W01C046B18	pDONR221	14043		NCL	4691	AAH06494.3	Hs.79110	Nucleolin			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005381.2	NP_005372.2	REVIEWED	Cgs	0.685	0.992	710	1473	1	1470	710	1	710
IKAKEN	BC001683	MGC12-A10	MGC	W01C046B19	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC001683	MGC12-A10	MGC	W01C046B20	pDONR221	7933		CHAC1	79094	AAH01683.1	Hs.155569	ChaC, cation transport regulator homolog 1 (E. coli)			Brain, hippocampus	NIH_MGC_124	DH10B	NM_024111.3	NP_077016.2	VALIDATED	P	1.000	1.000	222	669	1	666	264	43	264
IKAKEN	BC018654	MGC12-A11	MGC	W01C046B21	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC018654	MGC12-A11	MGC	W01C046B22	pDONR221	12694		NTN5	126147	AAH18654.2	Hs.326217	Netrin 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145807.1	NP_665806.1	PROVISIONAL	C	1.000	1.000	489	1470	1	1467	489	1	489
IKAKEN	BC013026	MGC12-A12	MGC	W01C046B23	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC013026	MGC12-A12	MGC	W01C046B24	pDONR221	19938		NUS1	116150	AAH13026.1	Hs.289008	Nuclear undecaprenyl pyrophosphate synthase 1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138459.3	NP_612468.1	VALIDATED	Cs	0.997	0.997	293	882	1	879	293	1	293
IKAKEN	BC022898	MGC12-B01	MGC	W01C046C01	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC022898	MGC12-B01	MGC	W01C046C02	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC005158	MGC12-B02	MGC	W01C046C03	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC005158	MGC12-B02	MGC	W01C046C04	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC009507	MGC12-B03	MGC	W01C046C05	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC009507	MGC12-B03	MGC	W01C046C06	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC013398	MGC12-B04	MGC	W01C046C07	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC013398	MGC12-B04	MGC	W01C046C08	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC006203	MGC12-B05	MGC	W01C046C09	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC006203	MGC12-B05	MGC	W01C046C10	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC003658	MGC12-B06	MGC	W01C046C11	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	MGC12-B06	MGC	W01C046C12	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC012808	MGC12-B07	MGC	W01C046C13	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012808	MGC12-B07	MGC	W01C046C14	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012995	MGC12-B08	MGC	W01C046C15	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC012995	MGC12-B08	MGC	W01C046C16	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC004204	MGC12-B09	MGC	W01C046C17	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC004204	MGC12-B09	MGC	W01C046C18	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC009508	MGC12-B10	MGC	W01C046C19	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC009508	MGC12-B10	MGC	W01C046C20	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC013040	MGC12-B11	MGC	W01C046C21	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC013040	MGC12-B11	MGC	W01C046C22	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC001827	MGC12-B12	MGC	W01C046C23	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC001827	MGC12-B12	MGC	W01C046C24	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC022898	MGC12-B01	MGC	W01C046D01	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC022898	MGC12-B01	MGC	W01C046D02	pDONR221	2663		COMMD3	23412	AAH22898.1	Hs.534398	COMM domain containing 3			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_012071.2	NP_036203.1	VALIDATED	OK	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	BC005158	MGC12-B02	MGC	W01C046D03	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC005158	MGC12-B02	MGC	W01C046D04	pDONR221	17683		TMEM175	84286	AAH05158.1	Hs.478936	Transmembrane protein 175			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032326.2	NP_115702.1	PROVISIONAL	Pfs	0.989	0.989	88	399	3	265	504	417	504
IKAKEN	BC009507	MGC12-B03	MGC	W01C046D05	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC009507	MGC12-B03	MGC	W01C046D06	pDONR221	205		ISG15	9636	AAH09507.1	Hs.458485	ISG15 ubiquitin-like modifier			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005101.3	NP_005092.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC013398	MGC12-B04	MGC	W01C046D07	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC013398	MGC12-B04	MGC	W01C046D08	pDONR221	1724		PUM1	9698	AAH13398.1	Hs.281707	Pumilio homolog 1 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014676.2	NP_055491.1	REVIEWED	OK	1.000	1.000	1186	3561	1	3558	1186	1	1186
IKAKEN	BC006203	MGC12-B05	MGC	W01C046D09	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC006203	MGC12-B05	MGC	W01C046D10	pDONR221	13146		BOK	666	AAH06203	Hs.293753	BCL2-related ovarian killer			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032515.3	NP_115904.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC003658	MGC12-B06	MGC	W01C046D11	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC003658	MGC12-B06	MGC	W01C046D12	pDONR221	3194		SAR1A	56681	AAH03658.1	Hs.499960	SAR1 homolog A (S. cerevisiae)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_020150.4	NP_064535.1	VALIDATED		0.894	0.894	85	258	1	255	198	1	85
IKAKEN	BC012808	MGC12-B07	MGC	W01C046D13	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012808	MGC12-B07	MGC	W01C046D14	pDONR221	20774		VARS	7407	AAH12808.1	Hs.520026	Valyl-tRNA synthetase			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_006295.2	NP_006286.1	REVIEWED	C	1.000	1.000	1264	3795	1	3792	1264	1	1264
IKAKEN	BC012995	MGC12-B08	MGC	W01C046D15	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC012995	MGC12-B08	MGC	W01C046D16	pDONR221	23034		MTERFD1	51001	AAH12995.2	Hs.308613	MTERF domain containing 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015942.3	NP_057026.3	PROVISIONAL	OK	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC004204	MGC12-B09	MGC	W01C046D17	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC004204	MGC12-B09	MGC	W01C046D18	pDONR221	11914		RBM42	79171	AAH04204.1	Hs.5086	RNA binding motif protein 42			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024321.3	NP_077297.2	PROVISIONAL	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC009508	MGC12-B10	MGC	W01C046D19	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC009508	MGC12-B10	MGC	W01C046D20	pDONR221	13478		NCRNA00152	112597	AAH09508	Hs.652166	Non-protein coding RNA 152			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R													
IKAKEN	BC013040	MGC12-B11	MGC	W01C046D21	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC013040	MGC12-B11	MGC	W01C046D22	pDONR221	8866		C16orf75	116028	AAH13040.2	Hs.347524	Chromosome 16 open reading frame 75			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152308.1	NP_689521.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	BC001827	MGC12-B12	MGC	W01C046D23	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC001827	MGC12-B12	MGC	W01C046D24	pDONR221	14214		DTYMK	1841	AAH01827.1	Hs.471873	Deoxythymidylate kinase (thymidylate kinase)			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_012145.2	NP_036277.2	VALIDATED	P	1.000	1.000	33	306	3	101	212	180	212
IKAKEN	BC009928	MGC12-C01	MGC	W01C046E01	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC009928	MGC12-C01	MGC	W01C046E02	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC013041	MGC12-C02	MGC	W01C046E03	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	MGC12-C02	MGC	W01C046E04	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC004922	MGC12-C03	MGC	W01C046E05	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004922	MGC12-C03	MGC	W01C046E06	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004221	MGC12-C04	MGC	W01C046E07	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC004221	MGC12-C04	MGC	W01C046E08	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC002816	MGC12-C05	MGC	W01C046E09	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002816	MGC12-C05	MGC	W01C046E10	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002843	MGC12-C06	MGC	W01C046E11	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002843	MGC12-C06	MGC	W01C046E12	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002786	MGC12-C07	MGC	W01C046E13	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002786	MGC12-C07	MGC	W01C046E14	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002817	MGC12-C08	MGC	W01C046E15	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC002817	MGC12-C08	MGC	W01C046E16	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC008798	MGC12-C09	MGC	W01C046E17	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC008798	MGC12-C09	MGC	W01C046E18	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC002846	MGC12-C10	MGC	W01C046E19	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002846	MGC12-C10	MGC	W01C046E20	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002762	MGC12-C11	MGC	W01C046E21	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC002762	MGC12-C11	MGC	W01C046E22	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC004536	MGC12-C12	MGC	W01C046E23	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC004536	MGC12-C12	MGC	W01C046E24	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC009928	MGC12-C01	MGC	W01C046F01	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC009928	MGC12-C01	MGC	W01C046F02	pDONR221	24593		DKC1	1736	AAH09928.1	Hs.4747	Dyskeratosis congenita 1, dyskerin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001363.3	NP_001354.1	REVIEWED	C	1.000	1.000	514	1545	1	1542	514	1	514
IKAKEN	BC013041	MGC12-C02	MGC	W01C046F03	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC013041	MGC12-C02	MGC	W01C046F04	pDONR221	24650		UBA1	7317	AAH13041.1	Hs.533273	Ubiquitin-like modifier activating enzyme 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_003334.3	NP_003325.2	REVIEWED	OK	1.000	1.000	1058	3177	1	3174	1058	1	1058
IKAKEN	BC004922	MGC12-C03	MGC	W01C046F05	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004922	MGC12-C03	MGC	W01C046F06	pDONR221	23727		ENDOG	2021	AAH04922.1	Hs.591905	Endonuclease G			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004435.2	NP_004426.2	REVIEWED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC004221	MGC12-C04	MGC	W01C046F07	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC004221	MGC12-C04	MGC	W01C046F08	pDONR221	7201		TMEM121	80757	AAH04221.1	Hs.157527	Transmembrane protein 121			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_025268.2	NP_079544.1	PROVISIONAL	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	BC002816	MGC12-C05	MGC	W01C046F09	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002816	MGC12-C05	MGC	W01C046F10	pDONR221	21376		NCF1	653361	AAH02816.1	Hs.647047	Neutrophil cytosolic factor 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000265.4	NP_000256.3	REVIEWED	Cgs	0.987	0.995	393	1182	1	1179	390	1	390
IKAKEN	BC002843	MGC12-C06	MGC	W01C046F11	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002843	MGC12-C06	MGC	W01C046F12	pDONR221	2023		C1orf35	79169	AAH02843.1	Hs.715607	Chromosome 1 open reading frame 35			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_024319.2	NP_077295.1	PREDICTED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	BC002786	MGC12-C07	MGC	W01C046F13	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002786	MGC12-C07	MGC	W01C046F14	pDONR221	6990		DHRS2	10202	AAH02786.1	Hs.272499	Dehydrogenase/reductase (SDR family) member 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005794.3	NP_005785.1	VALIDATED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC002817	MGC12-C08	MGC	W01C046F15	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC002817	MGC12-C08	MGC	W01C046F16	pDONR221	12667		DOHH	83475	AAH02817.1	Hs.515064	Deoxyhypusine hydroxylase/monooxygenase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001145165.1	NP_001138637.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC008798	MGC12-C09	MGC	W01C046F17	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC008798	MGC12-C09	MGC	W01C046F18	pDONR221	10371		C1QL1	10882	AAH08798.1	Hs.134012	Complement component 1, q subcomponent-like 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006688.3	NP_006679.1	PROVISIONAL	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC002846	MGC12-C10	MGC	W01C046F19	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002846	MGC12-C10	MGC	W01C046F20	pDONR221	13094		C2orf28	51374	AAH02846.2	Hs.9527	Chromosome 2 open reading frame 28			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_016085.3	NP_057169.2	REVIEWED	Cfs	0.994	1.000	171	621	70	580	171	1	171
IKAKEN	BC002762	MGC12-C11	MGC	W01C046F21	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC002762	MGC12-C11	MGC	W01C046F22	pDONR221	9546		C17orf81	23587	AAH02762.2	Hs.417029	Chromosome 17 open reading frame 81			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015362.3	NP_056177.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	BC004536	MGC12-C12	MGC	W01C046F23	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC004536	MGC12-C12	MGC	W01C046F24	pDONR221	5297		IFT81	28981	AAH04536.2	Hs.528382	Intraflagellar transport 81 homolog (Chlamydomonas)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_031473.3	NP_113661.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC002790	MGC12-D01	MGC	W01C046G01	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC002790	MGC12-D01	MGC	W01C046G02	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC004537	MGC12-D02	MGC	W01C046G03	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC004537	MGC12-D02	MGC	W01C046G04	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC002678	MGC12-D03	MGC	W01C046G05	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002678	MGC12-D03	MGC	W01C046G06	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002738	MGC12-D04	MGC	W01C046G07	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002738	MGC12-D04	MGC	W01C046G08	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002631	MGC12-D05	MGC	W01C046G09	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC002631	MGC12-D05	MGC	W01C046G10	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC008780	MGC12-D06	MGC	W01C046G11	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC008780	MGC12-D06	MGC	W01C046G12	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC002701	MGC12-D07	MGC	W01C046G13	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC002701	MGC12-D07	MGC	W01C046G14	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC017201	MGC12-D08	MGC	W01C046G15	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	MGC12-D08	MGC	W01C046G16	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002662	MGC12-D10	MGC	W01C046G19	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002662	MGC12-D10	MGC	W01C046G20	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002710	MGC12-D11	MGC	W01C046G21	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002710	MGC12-D11	MGC	W01C046G22	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002727	MGC12-D12	MGC	W01C046G23	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002727	MGC12-D12	MGC	W01C046G24	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002790	MGC12-D01	MGC	W01C046H01	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC002790	MGC12-D01	MGC	W01C046H02	pDONR221	8887		ACSM3	6296	AAH02790.3	Hs.706754	Acyl-CoA synthetase medium-chain family member 3			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_202000.2	NP_973729.1	VALIDATED	OK	1.000	1.000	438	1317	1	1314	438	1	438
IKAKEN	BC004537	MGC12-D02	MGC	W01C046H03	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC004537	MGC12-D02	MGC	W01C046H04	pDONR221	8911		ATP6V0C	527	AAH04537.1	Hs.389107	ATPase, H+ transporting, lysosomal 16kDa, V0 subunit c			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001694.2	NP_001685.1	REVIEWED	OK	1.000	1.000	155	468	1	465	155	1	155
IKAKEN	BC002678	MGC12-D03	MGC	W01C046H05	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002678	MGC12-D03	MGC	W01C046H06	pDONR221	19414		PPIC	5480	AAH02678.1	Hs.110364	Peptidylprolyl isomerase C (cyclophilin C)			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_000943.4	NP_000934.1	REVIEWED	OK	1.000	1.000	212	639	1	636	212	1	212
IKAKEN	BC002738	MGC12-D04	MGC	W01C046H07	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002738	MGC12-D04	MGC	W01C046H08	pDONR221	7200		CRIP1	1396	AAH02738.1	Hs.70327	Cysteine-rich protein 1 (intestinal)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001311.4	NP_001302.1	VALIDATED		0.935	0.947	77	231	1	228	77	1	77
IKAKEN	BC002631	MGC12-D05	MGC	W01C046H09	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC002631	MGC12-D05	MGC	W01C046H10	pDONR221	10414		MMP28	79148	AAH02631.1	Hs.380710	Matrix metallopeptidase 28			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001032278.1	NP_001027449.1	REVIEWED	P	1.000	1.000	127	1179	1	381	130	1	127
IKAKEN	BC008780	MGC12-D06	MGC	W01C046H11	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC008780	MGC12-D06	MGC	W01C046H12	pDONR221	12188		PEX11G	92960	AAH08780.1	Hs.515100	Peroxisomal biogenesis factor 11 gamma			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_080662.2	NP_542393.1	PROVISIONAL	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	BC002701	MGC12-D07	MGC	W01C046H13	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC002701	MGC12-D07	MGC	W01C046H14	pDONR221	8528		ATMIN	23300	AAH02701.2	Hs.589959	ATM interactor			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015251.2	NP_056066.2	VALIDATED	P	1.000	1.000	667	2004	1	2001	823	157	823
IKAKEN	BC017201	MGC12-D08	MGC	W01C046H15	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC017201	MGC12-D08	MGC	W01C046H16	pDONR221	18123		IGFBP7	3490	AAH17201.1	Hs.711065	Insulin-like growth factor binding protein 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001553.1	NP_001544.1	PROVISIONAL	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002662	MGC12-D10	MGC	W01C046H19	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002662	MGC12-D10	MGC	W01C046H20	pDONR221	12124		CA11	770	AAH02662.1	Hs.428446	Carbonic anhydrase XI			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001217.3	NP_001208.2	REVIEWED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	BC002710	MGC12-D11	MGC	W01C046H21	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002710	MGC12-D11	MGC	W01C046H22	pDONR221	12250		KLK10	5655	AAH02710.1	Hs.275464	Kallikrein-related peptidase 10			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_145888.2	NP_665895.1	REVIEWED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC002727	MGC12-D12	MGC	W01C046H23	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002727	MGC12-D12	MGC	W01C046H24	pDONR221	14954		SDCBP2	27111	AAH02727.2	Hs.657015	Syndecan binding protein (syntenin) 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080489.3	NP_536737.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC002750	MGC12-E01	MGC	W01C046I01	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC002750	MGC12-E01	MGC	W01C046I02	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC004269	MGC12-E02	MGC	W01C046I03	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004269	MGC12-E02	MGC	W01C046I04	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004270	MGC12-E03	MGC	W01C046I05	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	MGC12-E03	MGC	W01C046I06	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	MGC12-E04	MGC	W01C046I07	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	MGC12-E04	MGC	W01C046I08	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC003517	MGC12-E05	MGC	W01C046I09	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC003517	MGC12-E05	MGC	W01C046I10	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC008285	MGC12-E06	MGC	W01C046I11	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	MGC12-E06	MGC	W01C046I12	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC005019	MGC12-E07	MGC	W01C046I13	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC005019	MGC12-E07	MGC	W01C046I14	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC004952	MGC12-E08	MGC	W01C046I15	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004952	MGC12-E08	MGC	W01C046I16	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004343	MGC12-E09	MGC	W01C046I17	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004343	MGC12-E09	MGC	W01C046I18	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC009518	MGC12-E10	MGC	W01C046I19	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC009518	MGC12-E10	MGC	W01C046I20	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC014274	MGC12-E11	MGC	W01C046I21	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC014274	MGC12-E11	MGC	W01C046I22	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC004861	MGC12-E12	MGC	W01C046I23	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC004861	MGC12-E12	MGC	W01C046I24	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC002750	MGC12-E01	MGC	W01C046J01	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC002750	MGC12-E01	MGC	W01C046J02	pDONR221	4559		C11orf10	746	AAH02750.1	Hs.437779	Chromosome 11 open reading frame 10			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014206.3	NP_055021.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	BC004269	MGC12-E02	MGC	W01C046J03	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004269	MGC12-E02	MGC	W01C046J04	pDONR221	894		FAM167B	84734	AAH04269.2	Hs.18449	Family with sequence similarity 167, member B			Kidney, hypernephroma	NIH_MGC_58	DH10B	NM_032648.2	NP_116037.2	VALIDATED	P	1.000	1.000	74	225	1	222	163	90	163
IKAKEN	BC004270	MGC12-E03	MGC	W01C046J05	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004270	MGC12-E03	MGC	W01C046J06	pDONR221	224		RASSF5	83593	AAH04270.1	Hs.497579	Ras association (RalGDS/AF-6) domain family member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_182664.2	NP_872605.1	REVIEWED	P	1.000	1.000	330	1179	1	990	336	1	330
IKAKEN	BC004397	MGC12-E04	MGC	W01C046J07	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	MGC12-E04	MGC	W01C046J08	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC003517	MGC12-E05	MGC	W01C046J09	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC003517	MGC12-E05	MGC	W01C046J10	pDONR221	21809		ATXN7L1	222255	AAH03517.2	Hs.489603	Ataxin 7-like 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_138495.1	NP_612504.1	VALIDATED	Pg	0.790	1.000	485	1602	1	1455	738	319	701
IKAKEN	BC008285	MGC12-E06	MGC	W01C046J11	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC008285	MGC12-E06	MGC	W01C046J12	pDONR221	9374		CCDC102A	92922	AAH08285.1	Hs.644611	Coiled-coil domain containing 102A			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_033212.3	NP_149989.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC005019	MGC12-E07	MGC	W01C046J13	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC005019	MGC12-E07	MGC	W01C046J14	pDONR221	2101		S100A14	57402	AAH05019.1	Hs.288998	S100 calcium binding protein A14			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020672.1	NP_065723.1	PROVISIONAL	OK	1.000	1.000	104	315	1	312	104	1	104
IKAKEN	BC004952	MGC12-E08	MGC	W01C046J15	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004952	MGC12-E08	MGC	W01C046J16	pDONR221	13931		PCGF1	84759	AAH04952.1	Hs.316750	Polycomb group ring finger 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032673.2	NP_116062.2	VALIDATED	P	1.000	1.000	247	744	1	741	259	13	259
IKAKEN	BC004343	MGC12-E09	MGC	W01C046J17	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004343	MGC12-E09	MGC	W01C046J18	pDONR221	15432		C21orf122	728039	AAH04343	Hs.309203	Chromosome 21 open reading frame 122			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC009518	MGC12-E10	MGC	W01C046J19	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC009518	MGC12-E10	MGC	W01C046J20	pDONR221	9875		CCDC45	90799	AAH09518.1	Hs.569713	Coiled-coil domain containing 45			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_138363.1	NP_612372.1	PROVISIONAL	OK	1.000	1.000	821	2466	1	2463	821	1	821
IKAKEN	BC014274	MGC12-E11	MGC	W01C046J21	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC014274	MGC12-E11	MGC	W01C046J22	pDONR221	13983		STARD7	56910	AAH14274.3	Hs.469331	StAR-related lipid transfer (START) domain containing 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020151.3	NP_064536.2	VALIDATED	P	1.000	1.000	295	888	1	885	370	76	370
IKAKEN	BC004861	MGC12-E12	MGC	W01C046J23	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC004861	MGC12-E12	MGC	W01C046J24	pDONR221	25171		PAGE1	8712	AAH04861.1	Hs.128231	P antigen family, member 1 (prostate associated)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_003785.3	NP_003776.2	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC009755	MGC12-F01	MGC	W01C046K01	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	MGC12-F01	MGC	W01C046K02	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC024146	MGC12-F02	MGC	W01C046K03	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC024146	MGC12-F02	MGC	W01C046K04	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC019221	MGC12-F03	MGC	W01C046K05	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC019221	MGC12-F03	MGC	W01C046K06	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC004856	MGC12-F04	MGC	W01C046K07	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC004856	MGC12-F04	MGC	W01C046K08	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC014527	MGC12-F05	MGC	W01C046K09	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC014527	MGC12-F05	MGC	W01C046K10	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC013888	MGC12-F06	MGC	W01C046K11	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC013888	MGC12-F06	MGC	W01C046K12	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC004868	MGC12-F07	MGC	W01C046K13	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC004868	MGC12-F07	MGC	W01C046K14	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC014271	MGC12-F08	MGC	W01C046K15	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC014271	MGC12-F08	MGC	W01C046K16	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC013885	MGC12-F09	MGC	W01C046K17	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC013885	MGC12-F09	MGC	W01C046K18	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC004518	MGC12-F10	MGC	W01C046K19	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004518	MGC12-F10	MGC	W01C046K20	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004519	MGC12-F11	MGC	W01C046K21	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC004519	MGC12-F11	MGC	W01C046K22	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC006530	MGC12-F12	MGC	W01C046K23	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC006530	MGC12-F12	MGC	W01C046K24	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC009755	MGC12-F01	MGC	W01C046L01	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	MGC12-F01	MGC	W01C046L02	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC024146	MGC12-F02	MGC	W01C046L03	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC024146	MGC12-F02	MGC	W01C046L04	pDONR221	23094		XKR6	286046	AAH24146.1	Hs.666146	XK, Kell blood group complex subunit-related family, member 6			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_173683.3	NP_775954.2	PROVISIONAL	P	1.000	1.000	362	1089	1	1086	641	280	641
IKAKEN	BC019221	MGC12-F03	MGC	W01C046L05	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC019221	MGC12-F03	MGC	W01C046L06	pDONR221	25300		FAM122B	159090	AAH19221.1	Hs.404706	Family with sequence similarity 122B			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_145284.3	NP_660327.2	PROVISIONAL	OK	1.000	1.000	248	747	1	744	248	1	248
IKAKEN	BC004856	MGC12-F04	MGC	W01C046L07	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC004856	MGC12-F04	MGC	W01C046L08	pDONR221	23565		FREQ	23413	AAH04856.1	Hs.642946	Frequenin homolog (Drosophila)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014286.3	NP_055101.2	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	BC014527	MGC12-F05	MGC	W01C046L09	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC014527	MGC12-F05	MGC	W01C046L10	pDONR221	12380		FBXO27	126433	AAH14527.1	Hs.187461	F-box protein 27			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_178820.3	NP_849142.1	PROVISIONAL	OK	1.000	1.000	283	852	1	849	283	1	283
IKAKEN	BC013888	MGC12-F06	MGC	W01C046L11	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC013888	MGC12-F06	MGC	W01C046L12	pDONR221	21897		BAIAP2L1	55971	AAH13888.1	Hs.656063	BAI1-associated protein 2-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_018842.4	NP_061330.2	VALIDATED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	BC004868	MGC12-F07	MGC	W01C046L13	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC004868	MGC12-F07	MGC	W01C046L14	pDONR221	5388		USP30	84749	AAH04868.1	Hs.486434	Ubiquitin specific peptidase 30			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032663.3	NP_116052.2	VALIDATED	P	1.000	1.000	508	1527	1	1524	517	10	517
IKAKEN	BC014271	MGC12-F08	MGC	W01C046L15	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC014271	MGC12-F08	MGC	W01C046L16	pDONR221	24237		ENG	2022	AAH14271.1	Hs.76753	Endoglin			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001114753.1	NP_001108225.1	REVIEWED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	BC013885	MGC12-F09	MGC	W01C046L17	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC013885	MGC12-F09	MGC	W01C046L18	pDONR221	14536		EPB41L1	2036	AAH13885.1	Hs.716399	Erythrocyte membrane protein band 4.1-like 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_177996.1	NP_818932.1	REVIEWED	OK	1.000	1.000	779	2340	1	2337	779	1	779
IKAKEN	BC004518	MGC12-F10	MGC	W01C046L19	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004518	MGC12-F10	MGC	W01C046L20	pDONR221	8701		SYT17	51760	AAH04518.1	Hs.258326	Synaptotagmin XVII			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_016524.2	NP_057608.2	VALIDATED	OK	1.000	1.000	474	1425	1	1422	474	1	474
IKAKEN	BC004519	MGC12-F11	MGC	W01C046L21	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC004519	MGC12-F11	MGC	W01C046L22	pDONR221	9108		WDR59	79726	AAH04519.1	Hs.280951	WD repeat domain 59			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_030581.3	NP_085058.3	VALIDATED	P	1.000	1.000	571	1716	1	1713	974	1	571
IKAKEN	BC006530	MGC12-F12	MGC	W01C046L23	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC006530	MGC12-F12	MGC	W01C046L24	pDONR221	8361		DNM1P33	554175	AAH06530	Hs.646517	DNM1 pseudogene 33			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R													
IKAKEN	BC004114	MGC12-G01	MGC	W01C046M01	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC004114	MGC12-G01	MGC	W01C046M02	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC005133	MGC12-G02	MGC	W01C046M03	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC005133	MGC12-G02	MGC	W01C046M04	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006229	MGC12-G03	MGC	W01C046M05	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC006229	MGC12-G03	MGC	W01C046M06	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC002880	MGC12-G04	MGC	W01C046M07	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002880	MGC12-G04	MGC	W01C046M08	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002866	MGC12-G05	MGC	W01C046M09	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	MGC12-G05	MGC	W01C046M10	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC011617	MGC12-G06	MGC	W01C046M11	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	MGC12-G06	MGC	W01C046M12	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002939	MGC12-G07	MGC	W01C046M13	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC002939	MGC12-G07	MGC	W01C046M14	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC004558	MGC12-G08	MGC	W01C046M15	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC004558	MGC12-G08	MGC	W01C046M16	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC002894	MGC12-G09	MGC	W01C046M17	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	MGC12-G09	MGC	W01C046M18	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC006251	MGC12-G10	MGC	W01C046M19	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006251	MGC12-G10	MGC	W01C046M20	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006224	MGC12-G11	MGC	W01C046M21	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC006224	MGC12-G11	MGC	W01C046M22	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC009932	MGC12-G12	MGC	W01C046M23	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC009932	MGC12-G12	MGC	W01C046M24	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC004114	MGC12-G01	MGC	W01C046N01	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC004114	MGC12-G01	MGC	W01C046N02	pDONR221	10344		ATPAF2	91647	AAH04114.1	Hs.528889	ATP synthase mitochondrial F1 complex assembly factor 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_145691.3	NP_663729.1	REVIEWED	OK	1.000	1.000	289	870	1	867	289	1	289
IKAKEN	BC005133	MGC12-G02	MGC	W01C046N03	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC005133	MGC12-G02	MGC	W01C046N04	pDONR221	4736		TRPT1	83707	AAH05133.1	Hs.326586	TRNA phosphotransferase 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031472.3	NP_113660.1	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006229	MGC12-G03	MGC	W01C046N05	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC006229	MGC12-G03	MGC	W01C046N06	pDONR221	13471		COX5B	1329	AAH06229.1	Hs.1342	Cytochrome c oxidase subunit Vb			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001862.2	NP_001853.2	REVIEWED	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC002880	MGC12-G04	MGC	W01C046N07	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002880	MGC12-G04	MGC	W01C046N08	pDONR221	4486		CARS	833	AAH02880.1	Hs.274873	Cysteinyl-tRNA synthetase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001751.4	NP_001742.1	REVIEWED	OK	1.000	1.000	748	2247	1	2244	748	1	748
IKAKEN	BC002866	MGC12-G05	MGC	W01C046N09	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC002866	MGC12-G05	MGC	W01C046N10	pDONR221	13098		RPS7	6201	AAH02866.1	Hs.646582	Ribosomal protein S7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001011.3	NP_001002.1	REVIEWED		0.974	0.974	194	603	1	582	194	1	194
IKAKEN	BC011617	MGC12-G06	MGC	W01C046N11	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	MGC12-G06	MGC	W01C046N12	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002939	MGC12-G07	MGC	W01C046N13	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC002939	MGC12-G07	MGC	W01C046N14	pDONR221	1379		CLCC1	23155	AAH02939.1	Hs.658489	Chloride channel CLIC-like 1			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_015127.3	NP_055942.1	VALIDATED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	BC004558	MGC12-G08	MGC	W01C046N15	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC004558	MGC12-G08	MGC	W01C046N16	pDONR221	13907		RTKN	6242	AAH04558.2	Hs.192854	Rhotekin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001015055.1	NP_001015055.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	BC002894	MGC12-G09	MGC	W01C046N17	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	MGC12-G09	MGC	W01C046N18	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC006251	MGC12-G10	MGC	W01C046N19	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006251	MGC12-G10	MGC	W01C046N20	pDONR221	1739		SLC30A2	7780	AAH06251.1	Hs.143545	Solute carrier family 30 (zinc transporter), member 2			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_032513.3	NP_115902.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC006224	MGC12-G11	MGC	W01C046N21	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC006224	MGC12-G11	MGC	W01C046N22	pDONR221	21966		C7orf50	84310	AAH06224.1	Hs.653258	Chromosome 7 open reading frame 50			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001134395.1	NP_001127867.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC009932	MGC12-G12	MGC	W01C046N23	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC009932	MGC12-G12	MGC	W01C046N24	pDONR221	5968		GLTP	51228	AAH09932.1	Hs.381256	Glycolipid transfer protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_016433.3	NP_057517.1	REVIEWED		0.933	0.938	209	627	1	624	209	1	209
IKAKEN	BC006278	MGC12-H01	MGC	W01C046O01	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC006278	MGC12-H01	MGC	W01C046O02	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC011621	MGC12-H02	MGC	W01C046O03	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC011621	MGC12-H02	MGC	W01C046O04	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC018910	MGC12-H03	MGC	W01C046O05	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC018910	MGC12-H03	MGC	W01C046O06	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC006285	MGC12-H04	MGC	W01C046O07	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC006285	MGC12-H04	MGC	W01C046O08	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC021198	MGC12-H05	MGC	W01C046O09	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC021198	MGC12-H05	MGC	W01C046O10	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC002912	MGC12-H06	MGC	W01C046O11	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC002912	MGC12-H06	MGC	W01C046O12	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC009934	MGC12-H07	MGC	W01C046O13	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC009934	MGC12-H07	MGC	W01C046O14	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC007706	MGC12-H08	MGC	W01C046O15	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC007706	MGC12-H08	MGC	W01C046O16	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC017210	MGC12-H09	MGC	W01C046O17	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC017210	MGC12-H09	MGC	W01C046O18	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC006296	MGC12-H10	MGC	W01C046O19	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC006296	MGC12-H10	MGC	W01C046O20	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC007780	MGC12-H11	MGC	W01C046O21	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC007780	MGC12-H11	MGC	W01C046O22	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC013973	MGC12-H12	MGC	W01C046O23	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC013973	MGC12-H12	MGC	W01C046O24	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC006278	MGC12-H01	MGC	W01C046P01	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC006278	MGC12-H01	MGC	W01C046P02	pDONR221	8790		CHTF18	63922	AAH06278.2	Hs.153850	CTF18, chromosome transmission fidelity factor 18 homolog (S. cerevisiae)			Blood vessels- blood vessel, aorta, basilar	NIH_MGC_187	DH10B	NM_022092.2	NP_071375.1	VALIDATED	C	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	BC011621	MGC12-H02	MGC	W01C046P03	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC011621	MGC12-H02	MGC	W01C046P04	pDONR221	293		HOOK1	51361	AAH11621.1	Hs.378836	Hook homolog 1 (Drosophila)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_015888.4	NP_056972.1	REVIEWED	OK	1.000	1.000	728	2187	1	2184	728	1	728
IKAKEN	BC018910	MGC12-H03	MGC	W01C046P05	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC018910	MGC12-H03	MGC	W01C046P06	pDONR221	8912		QPRT	23475	AAH18910.1	Hs.513484	Quinolinate phosphoribosyltransferase			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_014298.3	NP_055113.2	REVIEWED	Cs	0.997	0.997	297	894	1	891	297	1	297
IKAKEN	BC006285	MGC12-H04	MGC	W01C046P07	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC006285	MGC12-H04	MGC	W01C046P08	pDONR221	13962		CRYBA2	1412	AAH06285.1	Hs.415790	Crystallin, beta A2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_057093.1	NP_476434.1	REVIEWED	OK	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	BC021198	MGC12-H05	MGC	W01C046P09	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC021198	MGC12-H05	MGC	W01C046P10	pDONR221			BCL2L2	599	AAH21198.1	Hs.410026	BCL2-like 2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_004050.3	NP_004041.1	REVIEWED	Cs	0.995	0.995	193	582	1	579	193	1	193
IKAKEN	BC002912	MGC12-H06	MGC	W01C046P11	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC002912	MGC12-H06	MGC	W01C046P12	pDONR221			FBXL15	79176	AAH02912.1	Hs.380081	F-box and leucine-rich repeat protein 15			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024326.3	NP_077302.3	VALIDATED	P	1.000	1.000	296	891	1	888	300	5	300
IKAKEN	BC009934	MGC12-H07	MGC	W01C046P13	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC009934	MGC12-H07	MGC	W01C046P14	pDONR221	6806		MIPEP	4285	AAH09934.1	Hs.507498	Mitochondrial intermediate peptidase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_005932.2	NP_005923.2	REVIEWED	Cs	0.999	0.999	713	2142	1	2139	713	1	713
IKAKEN	BC007706	MGC12-H08	MGC	W01C046P15	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC007706	MGC12-H08	MGC	W01C046P16	pDONR221	18787		FAM105B	90268	AAH07706.3	Hs.406335	Family with sequence similarity 105, member B			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_138348.4	NP_612357.4	VALIDATED	P	1.000	1.000	214	645	1	642	352	139	352
IKAKEN	BC017210	MGC12-H09	MGC	W01C046P17	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC017210	MGC12-H09	MGC	W01C046P18	pDONR221	17145		CPOX	1371	AAH17210.1	Hs.476982	Coproporphyrinogen oxidase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_000097.4	NP_000088.3	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC006296	MGC12-H10	MGC	W01C046P19	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC006296	MGC12-H10	MGC	W01C046P20	pDONR221	5827		AICDA	57379	AAH06296.1	Hs.149342	Activation-induced cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_020661.2	NP_065712.1	REVIEWED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	BC007780	MGC12-H11	MGC	W01C046P21	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC007780	MGC12-H11	MGC	W01C046P22	pDONR221	9579		ABI3	51225	AAH07780.1	Hs.130719	ABI family, member 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016428.2	NP_057512.1	REVIEWED	Cs	0.997	0.997	366	1101	1	1098	366	1	366
IKAKEN	BC013973	MGC12-H12	MGC	W01C046P23	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC013973	MGC12-H12	MGC	W01C046P24	pDONR221	20501		UBE2J1	51465	AAH13973.1	Hs.163776	Ubiquitin-conjugating enzyme E2, J1 (UBC6 homolog, yeast)			Adrenal cortex, carcinoma	NIH_MGC_84	DH10B	NM_016021.2	NP_057105.2	REVIEWED	OK	1.000	1.000	318	957	1	954	318	1	318
IKAKEN	BC032095	MGC13-A01	MGC	W01C047A01	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC032095	MGC13-A01	MGC	W01C047A02	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC021223	MGC13-A02	MGC	W01C047A03	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	MGC13-A02	MGC	W01C047A04	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	MGC13-A03	MGC	W01C047A05	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	MGC13-A03	MGC	W01C047A06	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006312	MGC13-A04	MGC	W01C047A07	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC006312	MGC13-A04	MGC	W01C047A08	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC007729	MGC13-A06	MGC	W01C047A11	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC007729	MGC13-A06	MGC	W01C047A12	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC006333	MGC13-A07	MGC	W01C047A13	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC006333	MGC13-A07	MGC	W01C047A14	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC015566	MGC13-A08	MGC	W01C047A15	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	MGC13-A08	MGC	W01C047A16	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006359	MGC13-A09	MGC	W01C047A17	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC006359	MGC13-A09	MGC	W01C047A18	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC007723	MGC13-A10	MGC	W01C047A19	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC007723	MGC13-A10	MGC	W01C047A20	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC023523	MGC13-A11	MGC	W01C047A21	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC023523	MGC13-A11	MGC	W01C047A22	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC005042	MGC13-A12	MGC	W01C047A23	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC005042	MGC13-A12	MGC	W01C047A24	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC032095	MGC13-A01	MGC	W01C047B01	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC032095	MGC13-A01	MGC	W01C047B02	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC021223	MGC13-A02	MGC	W01C047B03	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	MGC13-A02	MGC	W01C047B04	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	MGC13-A03	MGC	W01C047B05	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	MGC13-A03	MGC	W01C047B06	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006312	MGC13-A04	MGC	W01C047B07	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC006312	MGC13-A04	MGC	W01C047B08	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC007729	MGC13-A06	MGC	W01C047B11	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC007729	MGC13-A06	MGC	W01C047B12	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC006333	MGC13-A07	MGC	W01C047B13	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC006333	MGC13-A07	MGC	W01C047B14	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC015566	MGC13-A08	MGC	W01C047B15	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	MGC13-A08	MGC	W01C047B16	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006359	MGC13-A09	MGC	W01C047B17	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC006359	MGC13-A09	MGC	W01C047B18	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC007723	MGC13-A10	MGC	W01C047B19	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC007723	MGC13-A10	MGC	W01C047B20	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC023523	MGC13-A11	MGC	W01C047B21	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC023523	MGC13-A11	MGC	W01C047B22	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC005042	MGC13-A12	MGC	W01C047B23	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC005042	MGC13-A12	MGC	W01C047B24	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC006170	MGC13-B01	MGC	W01C047C01	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	MGC13-B01	MGC	W01C047C02	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC019340	MGC13-B02	MGC	W01C047C03	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC019340	MGC13-B02	MGC	W01C047C04	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC005097	MGC13-B03	MGC	W01C047C05	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC005097	MGC13-B03	MGC	W01C047C06	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC006116	MGC13-B04	MGC	W01C047C07	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	MGC13-B04	MGC	W01C047C08	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC067302	MGC13-B05	MGC	W01C047C09	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC067302	MGC13-B05	MGC	W01C047C10	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC005063	MGC13-B06	MGC	W01C047C11	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005063	MGC13-B06	MGC	W01C047C12	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007200	MGC13-B07	MGC	W01C047C13	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC007200	MGC13-B07	MGC	W01C047C14	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC006107	MGC13-B08	MGC	W01C047C15	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC006107	MGC13-B08	MGC	W01C047C16	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC012048	MGC13-B09	MGC	W01C047C17	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC012048	MGC13-B09	MGC	W01C047C18	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC030054	MGC13-B10	MGC	W01C047C19	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	MGC13-B10	MGC	W01C047C20	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC005072	MGC13-B11	MGC	W01C047C21	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005072	MGC13-B11	MGC	W01C047C22	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005073	MGC13-B12	MGC	W01C047C23	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC005073	MGC13-B12	MGC	W01C047C24	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC006170	MGC13-B01	MGC	W01C047D01	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	MGC13-B01	MGC	W01C047D02	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC019340	MGC13-B02	MGC	W01C047D03	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC019340	MGC13-B02	MGC	W01C047D04	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC005097	MGC13-B03	MGC	W01C047D05	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC005097	MGC13-B03	MGC	W01C047D06	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC006116	MGC13-B04	MGC	W01C047D07	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	MGC13-B04	MGC	W01C047D08	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC067302	MGC13-B05	MGC	W01C047D09	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC067302	MGC13-B05	MGC	W01C047D10	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC005063	MGC13-B06	MGC	W01C047D11	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005063	MGC13-B06	MGC	W01C047D12	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007200	MGC13-B07	MGC	W01C047D13	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC007200	MGC13-B07	MGC	W01C047D14	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC006107	MGC13-B08	MGC	W01C047D15	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC006107	MGC13-B08	MGC	W01C047D16	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC012048	MGC13-B09	MGC	W01C047D17	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC012048	MGC13-B09	MGC	W01C047D18	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC030054	MGC13-B10	MGC	W01C047D19	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	MGC13-B10	MGC	W01C047D20	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC005072	MGC13-B11	MGC	W01C047D21	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005072	MGC13-B11	MGC	W01C047D22	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005073	MGC13-B12	MGC	W01C047D23	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC005073	MGC13-B12	MGC	W01C047D24	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC006141	MGC13-C01	MGC	W01C047E01	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC006141	MGC13-C01	MGC	W01C047E02	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC008293	MGC13-C02	MGC	W01C047E03	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC008293	MGC13-C02	MGC	W01C047E04	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC063642	MGC13-C03	MGC	W01C047E05	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	MGC13-C03	MGC	W01C047E06	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC005075	MGC13-C04	MGC	W01C047E07	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC005075	MGC13-C04	MGC	W01C047E08	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC006140	MGC13-C05	MGC	W01C047E09	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006140	MGC13-C05	MGC	W01C047E10	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006151	MGC13-C06	MGC	W01C047E11	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC006151	MGC13-C06	MGC	W01C047E12	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC007947	MGC13-C07	MGC	W01C047E13	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007947	MGC13-C07	MGC	W01C047E14	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007854	MGC13-C08	MGC	W01C047E15	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC007854	MGC13-C08	MGC	W01C047E16	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC018927	MGC13-C09	MGC	W01C047E17	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC018927	MGC13-C09	MGC	W01C047E18	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC007914	MGC13-C10	MGC	W01C047E19	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007914	MGC13-C10	MGC	W01C047E20	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007834	MGC13-C11	MGC	W01C047E21	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007834	MGC13-C11	MGC	W01C047E22	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007855	MGC13-C12	MGC	W01C047E23	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC007855	MGC13-C12	MGC	W01C047E24	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC006141	MGC13-C01	MGC	W01C047F01	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC006141	MGC13-C01	MGC	W01C047F02	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC008293	MGC13-C02	MGC	W01C047F03	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC008293	MGC13-C02	MGC	W01C047F04	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC063642	MGC13-C03	MGC	W01C047F05	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	MGC13-C03	MGC	W01C047F06	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC005075	MGC13-C04	MGC	W01C047F07	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC005075	MGC13-C04	MGC	W01C047F08	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC006140	MGC13-C05	MGC	W01C047F09	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006140	MGC13-C05	MGC	W01C047F10	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006151	MGC13-C06	MGC	W01C047F11	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC006151	MGC13-C06	MGC	W01C047F12	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC007947	MGC13-C07	MGC	W01C047F13	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007947	MGC13-C07	MGC	W01C047F14	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007854	MGC13-C08	MGC	W01C047F15	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC007854	MGC13-C08	MGC	W01C047F16	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC018927	MGC13-C09	MGC	W01C047F17	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC018927	MGC13-C09	MGC	W01C047F18	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC007914	MGC13-C10	MGC	W01C047F19	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007914	MGC13-C10	MGC	W01C047F20	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007834	MGC13-C11	MGC	W01C047F21	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007834	MGC13-C11	MGC	W01C047F22	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007855	MGC13-C12	MGC	W01C047F23	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC007855	MGC13-C12	MGC	W01C047F24	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC007956	MGC13-D01	MGC	W01C047G01	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC007956	MGC13-D01	MGC	W01C047G02	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC008842	MGC13-D02	MGC	W01C047G03	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC008842	MGC13-D02	MGC	W01C047G04	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC007828	MGC13-D03	MGC	W01C047G05	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007828	MGC13-D03	MGC	W01C047G06	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007860	MGC13-D04	MGC	W01C047G07	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC007860	MGC13-D04	MGC	W01C047G08	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC023528	MGC13-D05	MGC	W01C047G09	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023528	MGC13-D05	MGC	W01C047G10	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023539	MGC13-D06	MGC	W01C047G11	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC023539	MGC13-D06	MGC	W01C047G12	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC007883	MGC13-D07	MGC	W01C047G13	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007883	MGC13-D07	MGC	W01C047G14	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007823	MGC13-D08	MGC	W01C047G15	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC007823	MGC13-D08	MGC	W01C047G16	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC014640	MGC13-D09	MGC	W01C047G17	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC014640	MGC13-D09	MGC	W01C047G18	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC007304	MGC13-D10	MGC	W01C047G19	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC007304	MGC13-D10	MGC	W01C047G20	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC014642	MGC13-D11	MGC	W01C047G21	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC014642	MGC13-D11	MGC	W01C047G22	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC010426	MGC13-D12	MGC	W01C047G23	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC010426	MGC13-D12	MGC	W01C047G24	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC007956	MGC13-D01	MGC	W01C047H01	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC007956	MGC13-D01	MGC	W01C047H02	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC008842	MGC13-D02	MGC	W01C047H03	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC008842	MGC13-D02	MGC	W01C047H04	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC007828	MGC13-D03	MGC	W01C047H05	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007828	MGC13-D03	MGC	W01C047H06	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007860	MGC13-D04	MGC	W01C047H07	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC007860	MGC13-D04	MGC	W01C047H08	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC023528	MGC13-D05	MGC	W01C047H09	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023528	MGC13-D05	MGC	W01C047H10	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023539	MGC13-D06	MGC	W01C047H11	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC023539	MGC13-D06	MGC	W01C047H12	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC007883	MGC13-D07	MGC	W01C047H13	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007883	MGC13-D07	MGC	W01C047H14	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007823	MGC13-D08	MGC	W01C047H15	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC007823	MGC13-D08	MGC	W01C047H16	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC014640	MGC13-D09	MGC	W01C047H17	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC014640	MGC13-D09	MGC	W01C047H18	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC007304	MGC13-D10	MGC	W01C047H19	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC007304	MGC13-D10	MGC	W01C047H20	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC014642	MGC13-D11	MGC	W01C047H21	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC014642	MGC13-D11	MGC	W01C047H22	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC010426	MGC13-D12	MGC	W01C047H23	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC010426	MGC13-D12	MGC	W01C047H24	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC007286	MGC13-E01	MGC	W01C047I01	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC007286	MGC13-E01	MGC	W01C047I02	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC016167	MGC13-E02	MGC	W01C047I03	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC016167	MGC13-E02	MGC	W01C047I04	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC008025	MGC13-E03	MGC	W01C047I05	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008025	MGC13-E03	MGC	W01C047I06	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008017	MGC13-E04	MGC	W01C047I07	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008017	MGC13-E04	MGC	W01C047I08	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008900	MGC13-E05	MGC	W01C047I09	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC008900	MGC13-E05	MGC	W01C047I10	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC007366	MGC13-E06	MGC	W01C047I11	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC007366	MGC13-E06	MGC	W01C047I12	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC008915	MGC13-E07	MGC	W01C047I13	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008915	MGC13-E07	MGC	W01C047I14	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008926	MGC13-E08	MGC	W01C047I15	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC008926	MGC13-E08	MGC	W01C047I16	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC063652	MGC13-E09	MGC	W01C047I17	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC13-E09	MGC	W01C047I18	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC011001	MGC13-E10	MGC	W01C047I19	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011001	MGC13-E10	MGC	W01C047I20	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011000	MGC13-E11	MGC	W01C047I21	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC011000	MGC13-E11	MGC	W01C047I22	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC009230	MGC13-E12	MGC	W01C047I23	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC009230	MGC13-E12	MGC	W01C047I24	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC007286	MGC13-E01	MGC	W01C047J01	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC007286	MGC13-E01	MGC	W01C047J02	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC016167	MGC13-E02	MGC	W01C047J03	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC016167	MGC13-E02	MGC	W01C047J04	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC008025	MGC13-E03	MGC	W01C047J05	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008025	MGC13-E03	MGC	W01C047J06	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008017	MGC13-E04	MGC	W01C047J07	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008017	MGC13-E04	MGC	W01C047J08	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008900	MGC13-E05	MGC	W01C047J09	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC008900	MGC13-E05	MGC	W01C047J10	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC007366	MGC13-E06	MGC	W01C047J11	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC007366	MGC13-E06	MGC	W01C047J12	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC008915	MGC13-E07	MGC	W01C047J13	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008915	MGC13-E07	MGC	W01C047J14	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008926	MGC13-E08	MGC	W01C047J15	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC008926	MGC13-E08	MGC	W01C047J16	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC063652	MGC13-E09	MGC	W01C047J17	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC13-E09	MGC	W01C047J18	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC011001	MGC13-E10	MGC	W01C047J19	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011001	MGC13-E10	MGC	W01C047J20	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011000	MGC13-E11	MGC	W01C047J21	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC011000	MGC13-E11	MGC	W01C047J22	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC009230	MGC13-E12	MGC	W01C047J23	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC009230	MGC13-E12	MGC	W01C047J24	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC009855	MGC13-F01	MGC	W01C047K01	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009855	MGC13-F01	MGC	W01C047K02	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009839	MGC13-F02	MGC	W01C047K03	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC009839	MGC13-F02	MGC	W01C047K04	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC018644	MGC13-F03	MGC	W01C047K05	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC018644	MGC13-F03	MGC	W01C047K06	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC025367	MGC13-F04	MGC	W01C047K07	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC025367	MGC13-F04	MGC	W01C047K08	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009194	MGC13-F05	MGC	W01C047K09	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009194	MGC13-F05	MGC	W01C047K10	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009356	MGC13-F06	MGC	W01C047K11	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009356	MGC13-F06	MGC	W01C047K12	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009970	MGC13-F07	MGC	W01C047K13	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009970	MGC13-F07	MGC	W01C047K14	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009993	MGC13-F08	MGC	W01C047K15	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC009993	MGC13-F08	MGC	W01C047K16	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC045110	MGC13-F09	MGC	W01C047K17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	MGC13-F09	MGC	W01C047K18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC009373	MGC13-F10	MGC	W01C047K19	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	MGC13-F10	MGC	W01C047K20	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC010011	MGC13-F11	MGC	W01C047K21	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC010011	MGC13-F11	MGC	W01C047K22	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC009403	MGC13-F12	MGC	W01C047K23	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC009403	MGC13-F12	MGC	W01C047K24	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC009855	MGC13-F01	MGC	W01C047L01	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009855	MGC13-F01	MGC	W01C047L02	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009839	MGC13-F02	MGC	W01C047L03	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC009839	MGC13-F02	MGC	W01C047L04	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC018644	MGC13-F03	MGC	W01C047L05	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC018644	MGC13-F03	MGC	W01C047L06	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC025367	MGC13-F04	MGC	W01C047L07	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC025367	MGC13-F04	MGC	W01C047L08	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009194	MGC13-F05	MGC	W01C047L09	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009194	MGC13-F05	MGC	W01C047L10	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009356	MGC13-F06	MGC	W01C047L11	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009356	MGC13-F06	MGC	W01C047L12	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009970	MGC13-F07	MGC	W01C047L13	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009970	MGC13-F07	MGC	W01C047L14	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009993	MGC13-F08	MGC	W01C047L15	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC009993	MGC13-F08	MGC	W01C047L16	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC045110	MGC13-F09	MGC	W01C047L17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	MGC13-F09	MGC	W01C047L18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC009373	MGC13-F10	MGC	W01C047L19	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	MGC13-F10	MGC	W01C047L20	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC010011	MGC13-F11	MGC	W01C047L21	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC010011	MGC13-F11	MGC	W01C047L22	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC009403	MGC13-F12	MGC	W01C047L23	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC009403	MGC13-F12	MGC	W01C047L24	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC008881	MGC13-G01	MGC	W01C047M01	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC008881	MGC13-G01	MGC	W01C047M02	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC009980	MGC13-G02	MGC	W01C047M03	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009980	MGC13-G02	MGC	W01C047M04	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009311	MGC13-G03	MGC	W01C047M05	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC009311	MGC13-G03	MGC	W01C047M06	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC008869	MGC13-G04	MGC	W01C047M07	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC008869	MGC13-G04	MGC	W01C047M08	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C047M09	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C047M10	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011722	MGC13-G06	MGC	W01C047M11	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	MGC13-G06	MGC	W01C047M12	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011751	MGC13-G08	MGC	W01C047M15	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011751	MGC13-G08	MGC	W01C047M16	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011710	MGC13-G09	MGC	W01C047M17	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC011710	MGC13-G09	MGC	W01C047M18	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC017238	MGC13-G10	MGC	W01C047M19	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC017238	MGC13-G10	MGC	W01C047M20	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC011782	MGC13-G11	MGC	W01C047M21	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011782	MGC13-G11	MGC	W01C047M22	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011783	MGC13-G12	MGC	W01C047M23	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011783	MGC13-G12	MGC	W01C047M24	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC008881	MGC13-G01	MGC	W01C047N01	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC008881	MGC13-G01	MGC	W01C047N02	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC009980	MGC13-G02	MGC	W01C047N03	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009980	MGC13-G02	MGC	W01C047N04	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009311	MGC13-G03	MGC	W01C047N05	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC009311	MGC13-G03	MGC	W01C047N06	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC008869	MGC13-G04	MGC	W01C047N07	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC008869	MGC13-G04	MGC	W01C047N08	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C047N09	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C047N10	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011722	MGC13-G06	MGC	W01C047N11	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	MGC13-G06	MGC	W01C047N12	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011751	MGC13-G08	MGC	W01C047N15	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011751	MGC13-G08	MGC	W01C047N16	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011710	MGC13-G09	MGC	W01C047N17	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC011710	MGC13-G09	MGC	W01C047N18	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC017238	MGC13-G10	MGC	W01C047N19	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC017238	MGC13-G10	MGC	W01C047N20	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC011782	MGC13-G11	MGC	W01C047N21	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011782	MGC13-G11	MGC	W01C047N22	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011783	MGC13-G12	MGC	W01C047N23	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011783	MGC13-G12	MGC	W01C047N24	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC010138	MGC13-H01	MGC	W01C047O01	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010138	MGC13-H01	MGC	W01C047O02	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010130	MGC13-H02	MGC	W01C047O03	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC010130	MGC13-H02	MGC	W01C047O04	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC011785	MGC13-H03	MGC	W01C047O05	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011785	MGC13-H03	MGC	W01C047O06	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011776	MGC13-H04	MGC	W01C047O07	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC011776	MGC13-H04	MGC	W01C047O08	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC014006	MGC13-H05	MGC	W01C047O09	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC014006	MGC13-H05	MGC	W01C047O10	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC011832	MGC13-H06	MGC	W01C047O11	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011832	MGC13-H06	MGC	W01C047O12	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011907	MGC13-H07	MGC	W01C047O13	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011907	MGC13-H07	MGC	W01C047O14	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011873	MGC13-H08	MGC	W01C047O15	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011873	MGC13-H08	MGC	W01C047O16	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011853	MGC13-H09	MGC	W01C047O17	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC011853	MGC13-H09	MGC	W01C047O18	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC032097	MGC13-H10	MGC	W01C047O19	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	MGC13-H10	MGC	W01C047O20	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC011837	MGC13-H11	MGC	W01C047O21	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011837	MGC13-H11	MGC	W01C047O22	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011819	MGC13-H12	MGC	W01C047O23	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC011819	MGC13-H12	MGC	W01C047O24	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC010138	MGC13-H01	MGC	W01C047P01	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010138	MGC13-H01	MGC	W01C047P02	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010130	MGC13-H02	MGC	W01C047P03	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC010130	MGC13-H02	MGC	W01C047P04	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC011785	MGC13-H03	MGC	W01C047P05	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011785	MGC13-H03	MGC	W01C047P06	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011776	MGC13-H04	MGC	W01C047P07	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC011776	MGC13-H04	MGC	W01C047P08	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC014006	MGC13-H05	MGC	W01C047P09	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC014006	MGC13-H05	MGC	W01C047P10	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC011832	MGC13-H06	MGC	W01C047P11	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011832	MGC13-H06	MGC	W01C047P12	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011907	MGC13-H07	MGC	W01C047P13	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011907	MGC13-H07	MGC	W01C047P14	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011873	MGC13-H08	MGC	W01C047P15	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011873	MGC13-H08	MGC	W01C047P16	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011853	MGC13-H09	MGC	W01C047P17	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC011853	MGC13-H09	MGC	W01C047P18	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC032097	MGC13-H10	MGC	W01C047P19	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	MGC13-H10	MGC	W01C047P20	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC011837	MGC13-H11	MGC	W01C047P21	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011837	MGC13-H11	MGC	W01C047P22	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011819	MGC13-H12	MGC	W01C047P23	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC011819	MGC13-H12	MGC	W01C047P24	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC032095	MGC13-A01	MGC	W01C048A01	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC032095	MGC13-A01	MGC	W01C048A02	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC021223	MGC13-A02	MGC	W01C048A03	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	MGC13-A02	MGC	W01C048A04	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	MGC13-A03	MGC	W01C048A05	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	MGC13-A03	MGC	W01C048A06	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006312	MGC13-A04	MGC	W01C048A07	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC006312	MGC13-A04	MGC	W01C048A08	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC007729	MGC13-A06	MGC	W01C048A11	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC007729	MGC13-A06	MGC	W01C048A12	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC006333	MGC13-A07	MGC	W01C048A13	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC006333	MGC13-A07	MGC	W01C048A14	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC015566	MGC13-A08	MGC	W01C048A15	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	MGC13-A08	MGC	W01C048A16	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006359	MGC13-A09	MGC	W01C048A17	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC006359	MGC13-A09	MGC	W01C048A18	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC007723	MGC13-A10	MGC	W01C048A19	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC007723	MGC13-A10	MGC	W01C048A20	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC023523	MGC13-A11	MGC	W01C048A21	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC023523	MGC13-A11	MGC	W01C048A22	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC005042	MGC13-A12	MGC	W01C048A23	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC005042	MGC13-A12	MGC	W01C048A24	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC032095	MGC13-A01	MGC	W01C048B01	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC032095	MGC13-A01	MGC	W01C048B02	pDONR221	8852		CES2	8824	AAH32095.1	Hs.282975	Carboxylesterase 2 (intestine, liver)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003869.4	NP_003860.2	REVIEWED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC021223	MGC13-A02	MGC	W01C048B03	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC021223	MGC13-A02	MGC	W01C048B04	pDONR221	13834		CHPF	79586	AAH21223.2	Hs.516711	Chondroitin polymerizing factor			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_024536.5	NP_078812.2	VALIDATED	Cs	0.999	0.999	775	2328	1	2325	775	1	775
IKAKEN	BC006378	MGC13-A03	MGC	W01C048B05	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006378	MGC13-A03	MGC	W01C048B06	pDONR221	17180		UBA7	7318	AAH06378.1	Hs.16695	Ubiquitin-like modifier activating enzyme 7			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003335.2	NP_003326.2	REVIEWED	Cs	0.986	0.986	1012	3039	1	3036	1012	1	1012
IKAKEN	BC006312	MGC13-A04	MGC	W01C048B07	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC006312	MGC13-A04	MGC	W01C048B08	pDONR221	1908		CROCCL1	84809	AAH06312	Hs.631865	Ciliary rootlet coiled-coil, rootletin-like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R													
IKAKEN	BC007729	MGC13-A06	MGC	W01C048B11	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC007729	MGC13-A06	MGC	W01C048B12	pDONR221	18138		TMEM128	85013	AAH07729.1	Hs.12845	Transmembrane protein 128			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_032927.2	NP_116316.1	PROVISIONAL	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC006333	MGC13-A07	MGC	W01C048B13	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC006333	MGC13-A07	MGC	W01C048B14	pDONR221	24116		TRIM14	9830	AAH06333.1	Hs.575631	Tripartite motif-containing 14			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_033220.1	NP_150089.1	REVIEWED	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	BC015566	MGC13-A08	MGC	W01C048B15	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC015566	MGC13-A08	MGC	W01C048B16	pDONR221	12468		ATP1A3	478	AAH15566.1	Hs.515427	ATPase, Na+/K+ transporting, alpha 3 polypeptide			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_152296.3	NP_689509.1	REVIEWED	OK	1.000	1.000	1013	3042	1	3039	1013	1	1013
IKAKEN	BC006359	MGC13-A09	MGC	W01C048B17	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC006359	MGC13-A09	MGC	W01C048B18	pDONR221	2634		INA	9118	AAH06359.1	Hs.500916	Internexin neuronal intermediate filament protein, alpha			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_032727.3	NP_116116.1	VALIDATED	OK	1.000	1.000	499	1500	1	1497	499	1	499
IKAKEN	BC007723	MGC13-A10	MGC	W01C048B19	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC007723	MGC13-A10	MGC	W01C048B20	pDONR221	5579		COX6A1	1337	AAH07723.1	Hs.497118	Cytochrome c oxidase subunit VIa polypeptide 1			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004373.2	NP_004364.2	REVIEWED	Cs	0.982	0.982	109	330	1	327	109	1	109
IKAKEN	BC023523	MGC13-A11	MGC	W01C048B21	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC023523	MGC13-A11	MGC	W01C048B22	pDONR221	5289		DGKA	1606	AAH23523.1	Hs.524488	Diacylglycerol kinase, alpha 80kDa			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_201554.1	NP_963848.1	REVIEWED	OK	1.000	1.000	735	2208	1	2205	735	1	735
IKAKEN	BC005042	MGC13-A12	MGC	W01C048B23	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC005042	MGC13-A12	MGC	W01C048B24	pDONR221	21411		MOSPD3	64598	AAH05042.1	Hs.521086	Motile sperm domain containing 3			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001040097.1	NP_001035186.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC006170	MGC13-B01	MGC	W01C048C01	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	MGC13-B01	MGC	W01C048C02	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC019340	MGC13-B02	MGC	W01C048C03	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC019340	MGC13-B02	MGC	W01C048C04	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC005097	MGC13-B03	MGC	W01C048C05	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC005097	MGC13-B03	MGC	W01C048C06	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC006116	MGC13-B04	MGC	W01C048C07	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	MGC13-B04	MGC	W01C048C08	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC067302	MGC13-B05	MGC	W01C048C09	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC067302	MGC13-B05	MGC	W01C048C10	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC005063	MGC13-B06	MGC	W01C048C11	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005063	MGC13-B06	MGC	W01C048C12	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007200	MGC13-B07	MGC	W01C048C13	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC007200	MGC13-B07	MGC	W01C048C14	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC006107	MGC13-B08	MGC	W01C048C15	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC006107	MGC13-B08	MGC	W01C048C16	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC012048	MGC13-B09	MGC	W01C048C17	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC012048	MGC13-B09	MGC	W01C048C18	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC030054	MGC13-B10	MGC	W01C048C19	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	MGC13-B10	MGC	W01C048C20	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC005072	MGC13-B11	MGC	W01C048C21	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005072	MGC13-B11	MGC	W01C048C22	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005073	MGC13-B12	MGC	W01C048C23	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC005073	MGC13-B12	MGC	W01C048C24	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC006170	MGC13-B01	MGC	W01C048D01	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	MGC13-B01	MGC	W01C048D02	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC019340	MGC13-B02	MGC	W01C048D03	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC019340	MGC13-B02	MGC	W01C048D04	pDONR221	4107			374408	AAH19340	Hs.82502	CDNA, FLJ79200 complete cds, highly similar to DNA polymerase subunit delta 3			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R			
IKAKEN	BC005097	MGC13-B03	MGC	W01C048D05	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC005097	MGC13-B03	MGC	W01C048D06	pDONR221	7839		CYFIP1	23191	AAH05097.1	Hs.26704	Cytoplasmic FMR1 interacting protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014608.2	NP_055423.1	VALIDATED	OK	1.000	1.000	1253	3762	1	3759	1253	1	1253
IKAKEN	BC006116	MGC13-B04	MGC	W01C048D07	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC006116	MGC13-B04	MGC	W01C048D08	pDONR221	10417		VPS53	55275	AAH06116.1	Hs.461819	Vacuolar protein sorting 53 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_018289.3	NP_060759.2	REVIEWED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC067302	MGC13-B05	MGC	W01C048D09	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC067302	MGC13-B05	MGC	W01C048D10	pDONR221	2030		C1orf174	339448	AAH67302.1	Hs.103939	Chromosome 1 open reading frame 174			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_207356.2	NP_997239.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC005063	MGC13-B06	MGC	W01C048D11	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC005063	MGC13-B06	MGC	W01C048D12	pDONR221	12530		RTBDN	83546	AAH05063.1	Hs.689432	Retbindin			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_031429.1	NP_113617.1	PROVISIONAL	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC007200	MGC13-B07	MGC	W01C048D13	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC007200	MGC13-B07	MGC	W01C048D14	pDONR221	8160		ANP32A	8125	AAH07200.1	Hs.458747	Acidic (leucine-rich) nuclear phosphoprotein 32 family, member A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006305.3	NP_006296.1	VALIDATED		0.861	0.876	238	705	1	702	249	1	238
IKAKEN	BC006107	MGC13-B08	MGC	W01C048D15	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC006107	MGC13-B08	MGC	W01C048D16	pDONR221	5810		ARHGAP9	64333	AAH06107.1	Hs.437126	Rho GTPase activating protein 9			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_001080156.1	NP_001073625.1	REVIEWED	Cg	0.966	1.000	566	2253	553	2250	547	1	547
IKAKEN	BC012048	MGC13-B09	MGC	W01C048D17	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC012048	MGC13-B09	MGC	W01C048D18	pDONR221	17665		SLC10A4	201780	AAH12048.2	Hs.132591	Solute carrier family 10 (sodium/bile acid cotransporter family), member 4			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_152679.3	NP_689892.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	BC030054	MGC13-B10	MGC	W01C048D19	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	MGC13-B10	MGC	W01C048D20	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC005072	MGC13-B11	MGC	W01C048D21	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005072	MGC13-B11	MGC	W01C048D22	pDONR221	10700			84772	AAH05072					Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC005073	MGC13-B12	MGC	W01C048D23	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC005073	MGC13-B12	MGC	W01C048D24	pDONR221	22923		CYHR1	50626	AAH05073.1	Hs.598583	Cysteine/histidine-rich 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032687.3	NP_116076.1	VALIDATED	OK	1.000	1.000	192	579	1	576	192	1	192
IKAKEN	BC006141	MGC13-C01	MGC	W01C048E01	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC006141	MGC13-C01	MGC	W01C048E02	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC008293	MGC13-C02	MGC	W01C048E03	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC008293	MGC13-C02	MGC	W01C048E04	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC063642	MGC13-C03	MGC	W01C048E05	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	MGC13-C03	MGC	W01C048E06	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC005075	MGC13-C04	MGC	W01C048E07	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC005075	MGC13-C04	MGC	W01C048E08	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC006140	MGC13-C05	MGC	W01C048E09	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006140	MGC13-C05	MGC	W01C048E10	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006151	MGC13-C06	MGC	W01C048E11	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC006151	MGC13-C06	MGC	W01C048E12	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC007947	MGC13-C07	MGC	W01C048E13	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007947	MGC13-C07	MGC	W01C048E14	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007854	MGC13-C08	MGC	W01C048E15	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC007854	MGC13-C08	MGC	W01C048E16	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC018927	MGC13-C09	MGC	W01C048E17	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC018927	MGC13-C09	MGC	W01C048E18	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC007914	MGC13-C10	MGC	W01C048E19	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007914	MGC13-C10	MGC	W01C048E20	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007834	MGC13-C11	MGC	W01C048E21	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007834	MGC13-C11	MGC	W01C048E22	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007855	MGC13-C12	MGC	W01C048E23	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC007855	MGC13-C12	MGC	W01C048E24	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC006141	MGC13-C01	MGC	W01C048F01	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC006141	MGC13-C01	MGC	W01C048F02	pDONR221	11160		EPB41L3	23136	AAH06141.1	Hs.213394	Erythrocyte membrane protein band 4.1-like 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_012307.2	NP_036439.2	PROVISIONAL	Cfs	0.471	0.614	1105	2598	1	2594	1087	1	1087
IKAKEN	BC008293	MGC13-C02	MGC	W01C048F03	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC008293	MGC13-C02	MGC	W01C048F04	pDONR221	19421		CDKN2AIPNL	91368	AAH08293.1	Hs.156506	CDKN2A interacting protein N-terminal like			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_080656.1	NP_542387.1	PROVISIONAL	OK	1.000	1.000	116	351	1	348	116	1	116
IKAKEN	BC063642	MGC13-C03	MGC	W01C048F05	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC063642	MGC13-C03	MGC	W01C048F06	pDONR221	139		LOC200025	200025	AAH63642					Lung, large cell carcinoma	NIH_MGC_68	DH10B			
IKAKEN	BC005075	MGC13-C04	MGC	W01C048F07	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC005075	MGC13-C04	MGC	W01C048F08	pDONR221	11923		C19orf52	90580	AAH05075.2	Hs.164026	Chromosome 19 open reading frame 52			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138358.2	NP_612367.1	PREDICTED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC006140	MGC13-C05	MGC	W01C048F09	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006140	MGC13-C05	MGC	W01C048F10	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC006151	MGC13-C06	MGC	W01C048F11	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC006151	MGC13-C06	MGC	W01C048F12	pDONR221	12647		C19orf48	84798	AAH06151.1	Hs.256301	Chromosome 19 open reading frame 48			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_199250.1	NP_954858.1	VALIDATED	OK	1.000	1.000	117	354	1	351	117	1	117
IKAKEN	BC007947	MGC13-C07	MGC	W01C048F13	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007947	MGC13-C07	MGC	W01C048F14	pDONR221	12795		PHLDB3	653583	AAH07947.3	Hs.631581	Pleckstrin homology-like domain, family B, member 3			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_198850.3	NP_942147.3	VALIDATED	P	1.000	1.000	175	528	1	525	640	466	640
IKAKEN	BC007854	MGC13-C08	MGC	W01C048F15	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC007854	MGC13-C08	MGC	W01C048F16	pDONR221	22695		PPP1R16A	84988	AAH07854.1	Hs.521937	Protein phosphatase 1, regulatory (inhibitor) subunit 16A			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_032902.5	NP_116291.1	PROVISIONAL	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BC018927	MGC13-C09	MGC	W01C048F17	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC018927	MGC13-C09	MGC	W01C048F18	pDONR221	7956		HEXA	3073	AAH18927.1	Hs.709495	Hexosaminidase A (alpha polypeptide)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000520.4	NP_000511.2	REVIEWED	OK	1.000	1.000	529	1590	1	1587	529	1	529
IKAKEN	BC007914	MGC13-C10	MGC	W01C048F19	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007914	MGC13-C10	MGC	W01C048F20	pDONR221	4597		PACSIN3	29763	AAH07914.1	Hs.334639	Protein kinase C and casein kinase substrate in neurons 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016223.3	NP_057307.2	PROVISIONAL	OK	1.000	1.000	424	1275	1	1272	424	1	424
IKAKEN	BC007834	MGC13-C11	MGC	W01C048F21	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007834	MGC13-C11	MGC	W01C048F22	pDONR221	23486		TMEM141	85014	AAH07834.1	Hs.356744	Transmembrane protein 141			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032928.3	NP_116317.1	VALIDATED	OK	1.000	1.000	108	327	1	324	108	1	108
IKAKEN	BC007855	MGC13-C12	MGC	W01C048F23	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC007855	MGC13-C12	MGC	W01C048F24	pDONR221	18874		KIAA0141	9812	AAH07855.1	Hs.210532	KIAA0141			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001142603.1	NP_001136075.1	VALIDATED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC007956	MGC13-D01	MGC	W01C048G01	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC007956	MGC13-D01	MGC	W01C048G02	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC008842	MGC13-D02	MGC	W01C048G03	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC008842	MGC13-D02	MGC	W01C048G04	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC007828	MGC13-D03	MGC	W01C048G05	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007828	MGC13-D03	MGC	W01C048G06	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007860	MGC13-D04	MGC	W01C048G07	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC007860	MGC13-D04	MGC	W01C048G08	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC023528	MGC13-D05	MGC	W01C048G09	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023528	MGC13-D05	MGC	W01C048G10	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023539	MGC13-D06	MGC	W01C048G11	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC023539	MGC13-D06	MGC	W01C048G12	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC007883	MGC13-D07	MGC	W01C048G13	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007883	MGC13-D07	MGC	W01C048G14	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007823	MGC13-D08	MGC	W01C048G15	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC007823	MGC13-D08	MGC	W01C048G16	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC014640	MGC13-D09	MGC	W01C048G17	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC014640	MGC13-D09	MGC	W01C048G18	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC007304	MGC13-D10	MGC	W01C048G19	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC007304	MGC13-D10	MGC	W01C048G20	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC014642	MGC13-D11	MGC	W01C048G21	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC014642	MGC13-D11	MGC	W01C048G22	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC010426	MGC13-D12	MGC	W01C048G23	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC010426	MGC13-D12	MGC	W01C048G24	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC007956	MGC13-D01	MGC	W01C048H01	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC007956	MGC13-D01	MGC	W01C048H02	pDONR221	1883		PARS2	25973	AAH07956.2	Hs.380169	Prolyl-tRNA synthetase 2, mitochondrial (putative)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_152268.2	NP_689481.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC008842	MGC13-D02	MGC	W01C048H03	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC008842	MGC13-D02	MGC	W01C048H04	pDONR221	22148		ZC3HAV1L	92092	AAH08842.1	Hs.659143	Zinc finger CCCH-type, antiviral 1-like			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080660.2	NP_542391.1	PROVISIONAL	Cs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC007828	MGC13-D03	MGC	W01C048H05	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007828	MGC13-D03	MGC	W01C048H06	pDONR221	22616		FAM83A	84985	AAH07828.1	Hs.379821	Family with sequence similarity 83, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032899.4	NP_116288.2	VALIDATED	Pgs	0.835	0.993	351	903	1	885	434	1	351
IKAKEN	BC007860	MGC13-D04	MGC	W01C048H07	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC007860	MGC13-D04	MGC	W01C048H08	pDONR221	5161		DENR	8562	AAH07860.1	Hs.22393	Density-regulated protein			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_003677.3	NP_003668.2	REVIEWED	Cgs	0.985	0.995	200	603	1	600	198	1	198
IKAKEN	BC023528	MGC13-D05	MGC	W01C048H09	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023528	MGC13-D05	MGC	W01C048H10	pDONR221	7022		GLRX5	51218	AAH23528.2	Hs.719204	Glutaredoxin 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016417.2	NP_057501.2	VALIDATED	OK	1.000	1.000	157	474	1	471	157	1	157
IKAKEN	BC023539	MGC13-D06	MGC	W01C048H11	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC023539	MGC13-D06	MGC	W01C048H12	pDONR221			SEPSECS	51091	AAH23539.1	Hs.253305	Sep (O-phosphoserine) tRNA:Sec (selenocysteine) tRNA synthase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016955.2	NP_058651.2	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC007883	MGC13-D07	MGC	W01C048H13	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007883	MGC13-D07	MGC	W01C048H14	pDONR221	11749		FAM125A	93343	AAH07883.2	Hs.515243	Family with sequence similarity 125, member A			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_138401.2	NP_612410.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC007823	MGC13-D08	MGC	W01C048H15	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC007823	MGC13-D08	MGC	W01C048H16	pDONR221	21952		WBSCR16	81554	AAH07823.1	Hs.716393	Williams-Beuren syndrome chromosome region 16			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_030798.3	NP_110425.1	REVIEWED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	BC014640	MGC13-D09	MGC	W01C048H17	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC014640	MGC13-D09	MGC	W01C048H18	pDONR221	22649		COL14A1	7373	AAH14640.1	Hs.409662	Collagen, type XIV, alpha 1			Testis	NIH_MGC_97	DH10B	NM_021110.1	NP_066933.1	VALIDATED	Pfs	0.999	1.000	758	2277	3	2274	1796	1039	1796
IKAKEN	BC007304	MGC13-D10	MGC	W01C048H19	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC007304	MGC13-D10	MGC	W01C048H20	pDONR221	15675		MGC15705	84843	AAH07304.1	Hs.652898	Hypothetical protein MGC15705			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC014642	MGC13-D11	MGC	W01C048H21	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC014642	MGC13-D11	MGC	W01C048H22	pDONR221	10592		SLC38A10	124565	AAH14642.1	Hs.352240	Solute carrier family 38, member 10			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138570.2	NP_612637.1	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC010426	MGC13-D12	MGC	W01C048H23	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC010426	MGC13-D12	MGC	W01C048H24	pDONR221	26432				AAH10426					Bone marrow, chronic myelogenous leukemia	NIH_MGC_54	DH10B			
IKAKEN	BC007286	MGC13-E01	MGC	W01C048I01	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC007286	MGC13-E01	MGC	W01C048I02	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC016167	MGC13-E02	MGC	W01C048I03	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC016167	MGC13-E02	MGC	W01C048I04	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC008025	MGC13-E03	MGC	W01C048I05	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008025	MGC13-E03	MGC	W01C048I06	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008017	MGC13-E04	MGC	W01C048I07	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008017	MGC13-E04	MGC	W01C048I08	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008900	MGC13-E05	MGC	W01C048I09	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC008900	MGC13-E05	MGC	W01C048I10	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC007366	MGC13-E06	MGC	W01C048I11	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC007366	MGC13-E06	MGC	W01C048I12	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC008915	MGC13-E07	MGC	W01C048I13	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008915	MGC13-E07	MGC	W01C048I14	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008926	MGC13-E08	MGC	W01C048I15	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC008926	MGC13-E08	MGC	W01C048I16	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC063652	MGC13-E09	MGC	W01C048I17	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC13-E09	MGC	W01C048I18	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC011001	MGC13-E10	MGC	W01C048I19	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011001	MGC13-E10	MGC	W01C048I20	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011000	MGC13-E11	MGC	W01C048I21	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC011000	MGC13-E11	MGC	W01C048I22	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC009230	MGC13-E12	MGC	W01C048I23	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC009230	MGC13-E12	MGC	W01C048I24	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC007286	MGC13-E01	MGC	W01C048J01	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC007286	MGC13-E01	MGC	W01C048J02	pDONR221	902		ZNF678	339500	-	Hs.30323	Zinc finger protein 678			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_178549.2	NP_848644.1	PROVISIONAL	Pfs	0.302	0.317	43	249	191	66	525	390	431
IKAKEN	BC016167	MGC13-E02	MGC	W01C048J03	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC016167	MGC13-E02	MGC	W01C048J04	pDONR221	20021		C6orf136	221545	AAH16167.1	Hs.591787	Chromosome 6 open reading frame 136			human lung	LNG		NM_001109938.2	NP_001103408.1	VALIDATED	P	1.000	1.000	172	519	1	516	315	144	315
IKAKEN	BC008025	MGC13-E03	MGC	W01C048J05	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008025	MGC13-E03	MGC	W01C048J06	pDONR221	9348		WDR24	84219	AAH08025.1	Hs.459632	WD repeat domain 24			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_032259.2	NP_115635.1	PROVISIONAL	C	1.000	1.000	790	2373	1	2370	790	1	790
IKAKEN	BC008017	MGC13-E04	MGC	W01C048J07	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008017	MGC13-E04	MGC	W01C048J08	pDONR221	23472		MRPS2	51116	AAH08017.1	Hs.382044	Mitochondrial ribosomal protein S2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_016034.3	NP_057118.1	REVIEWED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC008900	MGC13-E05	MGC	W01C048J09	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC008900	MGC13-E05	MGC	W01C048J10	pDONR221	10290		MYO19	80179	AAH08900.1	Hs.302051	Myosin XIX			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_025109.4	NP_079385.2	VALIDATED	C	1.000	1.000	770	2313	1	2310	770	1	770
IKAKEN	BC007366	MGC13-E06	MGC	W01C048J11	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC007366	MGC13-E06	MGC	W01C048J12	pDONR221	23764		C9orf70	84850	AAH07366	Hs.676113	Chromosome 9 open reading frame 70			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	XM_001721481.1	XP_001721533.1	MODEL	OK	1.000	1.000	58	177	1	174	58	1	58
IKAKEN	BC008915	MGC13-E07	MGC	W01C048J13	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008915	MGC13-E07	MGC	W01C048J14	pDONR221	6980		SERPINA5	5104	AAH08915.1	Hs.159628	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 5			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000624.4	NP_000615.3	VALIDATED	OK	1.000	1.000	406	1221	1	1218	406	1	406
IKAKEN	BC008926	MGC13-E08	MGC	W01C048J15	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC008926	MGC13-E08	MGC	W01C048J16	pDONR221	17187		RPL29	6159	AAH08926.1	Hs.425125	Ribosomal protein L29			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_000992.2	NP_000983.1	REVIEWED		0.906	0.929	159	468	1	465	159	1	159
IKAKEN	BC063652	MGC13-E09	MGC	W01C048J17	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC063652	MGC13-E09	MGC	W01C048J18	pDONR221	11220		KCTD1	284252	AAH63652.1	Hs.526630	Potassium channel tetramerisation domain containing 1			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_198991.2	NP_945342.1	VALIDATED	OK	1.000	1.000	257	774	1	771	257	1	257
IKAKEN	BC011001	MGC13-E10	MGC	W01C048J19	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011001	MGC13-E10	MGC	W01C048J20	pDONR221	3968		GLB1L3	112937	AAH11001.2					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001080407.2	NP_001073876.2	VALIDATED	P	1.000	1.000	292	942	1	876	653	1	292
IKAKEN	BC011000	MGC13-E11	MGC	W01C048J21	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC011000	MGC13-E11	MGC	W01C048J22	pDONR221	4800		CDCA5	113130	AAH11000.1	Hs.434886	Cell division cycle associated 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_080668.3	NP_542399.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	BC009230	MGC13-E12	MGC	W01C048J23	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC009230	MGC13-E12	MGC	W01C048J24	pDONR221	24685		PAGE5	90737	AAH09230.2	Hs.668491	P antigen family, member 5 (prostate associated)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_130467.3	NP_569734.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	BC009855	MGC13-F01	MGC	W01C048K01	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009855	MGC13-F01	MGC	W01C048K02	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009839	MGC13-F02	MGC	W01C048K03	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC009839	MGC13-F02	MGC	W01C048K04	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC018644	MGC13-F03	MGC	W01C048K05	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC018644	MGC13-F03	MGC	W01C048K06	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC025367	MGC13-F04	MGC	W01C048K07	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC025367	MGC13-F04	MGC	W01C048K08	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009194	MGC13-F05	MGC	W01C048K09	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009194	MGC13-F05	MGC	W01C048K10	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009356	MGC13-F06	MGC	W01C048K11	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009356	MGC13-F06	MGC	W01C048K12	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009970	MGC13-F07	MGC	W01C048K13	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009970	MGC13-F07	MGC	W01C048K14	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009993	MGC13-F08	MGC	W01C048K15	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC009993	MGC13-F08	MGC	W01C048K16	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC045110	MGC13-F09	MGC	W01C048K17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	MGC13-F09	MGC	W01C048K18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC009373	MGC13-F10	MGC	W01C048K19	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	MGC13-F10	MGC	W01C048K20	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC010011	MGC13-F11	MGC	W01C048K21	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC010011	MGC13-F11	MGC	W01C048K22	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC009403	MGC13-F12	MGC	W01C048K23	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC009403	MGC13-F12	MGC	W01C048K24	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC009855	MGC13-F01	MGC	W01C048L01	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009855	MGC13-F01	MGC	W01C048L02	pDONR221	19945		LTV1	84946	AAH09855.1	Hs.185675	LTV1 homolog (S. cerevisiae)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032860.3	NP_116249.2	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	BC009839	MGC13-F02	MGC	W01C048L03	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC009839	MGC13-F02	MGC	W01C048L04	pDONR221	19327		SKP1	6500	AAH09839.1	Hs.171626	S-phase kinase-associated protein 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_170679.2	NP_733779.1	VALIDATED		0.945	0.951	163	489	1	486	163	1	163
IKAKEN	BC018644	MGC13-F03	MGC	W01C048L05	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC018644	MGC13-F03	MGC	W01C048L06	pDONR221	4819		NUDT8	254552	AAH18644.1	Hs.433329	Nudix (nucleoside diphosphate linked moiety X)-type motif 8			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_181843.1	NP_862826.1	PROVISIONAL	C	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC025367	MGC13-F04	MGC	W01C048L07	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC025367	MGC13-F04	MGC	W01C048L08	pDONR221	6509		C13orf34	79866	AAH25367.2	Hs.714340	Chromosome 13 open reading frame 34			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024808.2	NP_079084.2	VALIDATED	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009194	MGC13-F05	MGC	W01C048L09	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009194	MGC13-F05	MGC	W01C048L10	pDONR221	10391		POLG2	11232	AAH09194.1	Hs.437009	Polymerase (DNA directed), gamma 2, accessory subunit			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007215.2	NP_009146.2	VALIDATED	OK	1.000	1.000	485	1458	1	1455	485	1	485
IKAKEN	BC009356	MGC13-F06	MGC	W01C048L11	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009356	MGC13-F06	MGC	W01C048L12	pDONR221	15677		CDC42EP1	11135	AAH09356.1	Hs.225356	CDC42 effector protein (Rho GTPase binding) 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_007061.3	NP_008992.3	REVIEWED	OK	1.000	1.000	384	1155	1	1152	384	1	384
IKAKEN	BC009970	MGC13-F07	MGC	W01C048L13	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009970	MGC13-F07	MGC	W01C048L14	pDONR221	17055		TKT	7086	AAH09970.1	Hs.89643	Transketolase			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_001135055.1	NP_001128527.1	VALIDATED	OK	1.000	1.000	623	1872	1	1869	623	1	623
IKAKEN	BC009993	MGC13-F08	MGC	W01C048L15	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC009993	MGC13-F08	MGC	W01C048L16	pDONR221	16286		C3orf37	56941	AAH09993.1	Hs.458320	Chromosome 3 open reading frame 37			Kidney, renal carcinoma (ascites)	NIH_MGC_45	DH10B-R	NM_001006109.1	NP_001006109.1	VALIDATED	OK	1.000	1.000	354	1115	1	1062	354	1	354
IKAKEN	BC045110	MGC13-F09	MGC	W01C048L17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	MGC13-F09	MGC	W01C048L18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC009373	MGC13-F10	MGC	W01C048L19	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	MGC13-F10	MGC	W01C048L20	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC010011	MGC13-F11	MGC	W01C048L21	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC010011	MGC13-F11	MGC	W01C048L22	pDONR221	13447		CCDC104	112942	AAH10011.1	Hs.264208	Coiled-coil domain containing 104			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_080667.5	NP_542398.3	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	BC009403	MGC13-F12	MGC	W01C048L23	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC009403	MGC13-F12	MGC	W01C048L24	pDONR221	13138		FAHD2A	51011	AAH09403.1	Hs.546387	Fumarylacetoacetate hydrolase domain containing 2A			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_016044.2	NP_057128.2	VALIDATED	Cs	0.981	0.981	314	945	1	942	314	1	314
IKAKEN	BC008881	MGC13-G01	MGC	W01C048M01	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC008881	MGC13-G01	MGC	W01C048M02	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC009980	MGC13-G02	MGC	W01C048M03	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009980	MGC13-G02	MGC	W01C048M04	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009311	MGC13-G03	MGC	W01C048M05	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC009311	MGC13-G03	MGC	W01C048M06	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC008869	MGC13-G04	MGC	W01C048M07	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC008869	MGC13-G04	MGC	W01C048M08	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C048M09	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C048M10	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011722	MGC13-G06	MGC	W01C048M11	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	MGC13-G06	MGC	W01C048M12	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011751	MGC13-G08	MGC	W01C048M15	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011751	MGC13-G08	MGC	W01C048M16	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011710	MGC13-G09	MGC	W01C048M17	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC011710	MGC13-G09	MGC	W01C048M18	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC017238	MGC13-G10	MGC	W01C048M19	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC017238	MGC13-G10	MGC	W01C048M20	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC011782	MGC13-G11	MGC	W01C048M21	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011782	MGC13-G11	MGC	W01C048M22	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011783	MGC13-G12	MGC	W01C048M23	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011783	MGC13-G12	MGC	W01C048M24	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC008881	MGC13-G01	MGC	W01C048N01	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC008881	MGC13-G01	MGC	W01C048N02	pDONR221	7066		KLC1	3831	AAH08881.1	Hs.20107	Kinesin light chain 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005552.4	NP_005543.2	REVIEWED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	BC009980	MGC13-G02	MGC	W01C048N03	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009980	MGC13-G02	MGC	W01C048N04	pDONR221	15678		KLHDC7B	113730	AAH09980.1	Hs.137007	Kelch domain containing 7B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_138433.3	NP_612442.2	VALIDATED	P	1.000	1.000	495	1488	1	1485	594	100	594
IKAKEN	BC009311	MGC13-G03	MGC	W01C048N05	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC009311	MGC13-G03	MGC	W01C048N06	pDONR221	5283		NDUFA9	4704	AAH09311.1	Hs.75227	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 9, 39kDa			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_005002.3	NP_004993.1	PROVISIONAL	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	BC008869	MGC13-G04	MGC	W01C048N07	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC008869	MGC13-G04	MGC	W01C048N08	pDONR221	12429		C19orf61	56006	AAH08869.1	Hs.466875	Chromosome 19 open reading frame 61			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_019108.2	NP_061981.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C048N09	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011680	MGC13-G05	MGC	W01C048N10	pDONR221	9250		KLHDC4	54758	AAH11680.1	Hs.123450	Kelch domain containing 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017566.2	NP_060036.2	PROVISIONAL	Cg	0.940	1.000	520	1470	1	1467	520	1	520
IKAKEN	BC011722	MGC13-G06	MGC	W01C048N11	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	MGC13-G06	MGC	W01C048N12	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011751	MGC13-G08	MGC	W01C048N15	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011751	MGC13-G08	MGC	W01C048N16	pDONR221	10438		SAT2	112483	AAH11751.1	Hs.10846	Spermidine/spermine N1-acetyltransferase family member 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_133491.3	NP_597998.1	VALIDATED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	BC011710	MGC13-G09	MGC	W01C048N17	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC011710	MGC13-G09	MGC	W01C048N18	pDONR221	16365		P4HTM	54681	AAH11710.3	Hs.654944	Prolyl 4-hydroxylase, transmembrane (endoplasmic reticulum)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_177938.2	NP_808807.2	REVIEWED	P	1.000	1.000	499	1500	1	1497	563	65	563
IKAKEN	BC017238	MGC13-G10	MGC	W01C048N19	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC017238	MGC13-G10	MGC	W01C048N20	pDONR221	3816		TTC17	55761	AAH17238.1	Hs.696109	Tetratricopeptide repeat domain 17			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018259.4	NP_060729.2	PROVISIONAL	OK	1.000	1.000	1141	3426	1	3423	1141	1	1141
IKAKEN	BC011782	MGC13-G11	MGC	W01C048N21	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011782	MGC13-G11	MGC	W01C048N22	pDONR221	12339		RAB3A	5864	AAH11782.1	Hs.27744	RAB3A, member RAS oncogene family			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_002866.4	NP_002857.1	VALIDATED	OK	1.000	1.000	220	663	1	660	220	1	220
IKAKEN	BC011783	MGC13-G12	MGC	W01C048N23	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011783	MGC13-G12	MGC	W01C048N24	pDONR221	9386		RPUSD1	113000	AAH11783.1	Hs.101742	RNA pseudouridylate synthase domain containing 1			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_058192.2	NP_478072.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC010138	MGC13-H01	MGC	W01C048O01	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010138	MGC13-H01	MGC	W01C048O02	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010130	MGC13-H02	MGC	W01C048O03	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC010130	MGC13-H02	MGC	W01C048O04	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC011785	MGC13-H03	MGC	W01C048O05	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011785	MGC13-H03	MGC	W01C048O06	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011776	MGC13-H04	MGC	W01C048O07	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC011776	MGC13-H04	MGC	W01C048O08	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC014006	MGC13-H05	MGC	W01C048O09	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC014006	MGC13-H05	MGC	W01C048O10	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC011832	MGC13-H06	MGC	W01C048O11	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011832	MGC13-H06	MGC	W01C048O12	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011907	MGC13-H07	MGC	W01C048O13	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011907	MGC13-H07	MGC	W01C048O14	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011873	MGC13-H08	MGC	W01C048O15	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011873	MGC13-H08	MGC	W01C048O16	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011853	MGC13-H09	MGC	W01C048O17	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC011853	MGC13-H09	MGC	W01C048O18	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC032097	MGC13-H10	MGC	W01C048O19	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	MGC13-H10	MGC	W01C048O20	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC011837	MGC13-H11	MGC	W01C048O21	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011837	MGC13-H11	MGC	W01C048O22	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011819	MGC13-H12	MGC	W01C048O23	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC011819	MGC13-H12	MGC	W01C048O24	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC010138	MGC13-H01	MGC	W01C048P01	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010138	MGC13-H01	MGC	W01C048P02	pDONR221	14576		ITPA	3704	AAH10138.1	Hs.415299	Inosine triphosphatase (nucleoside triphosphate pyrophosphatase)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033453.2	NP_258412.1	REVIEWED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC010130	MGC13-H02	MGC	W01C048P03	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC010130	MGC13-H02	MGC	W01C048P04	pDONR221	21268		C7orf28B	221960	AAH10130.1	Hs.567779	Chromosome 7 open reading frame 28B			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198097.2	NP_932765.1	PREDICTED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC011785	MGC13-H03	MGC	W01C048P05	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011785	MGC13-H03	MGC	W01C048P06	pDONR221	9387		C16orf42	115939	AAH11785	Hs.134846	Chromosome 16 open reading frame 42			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_001001410.2	NP_001001410.1	VALIDATED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC011776	MGC13-H04	MGC	W01C048P07	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC011776	MGC13-H04	MGC	W01C048P08	pDONR221	24246		TPM2	7169	AAH11776.1	Hs.300772	Tropomyosin 2 (beta)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_213674.1	NP_998839.1	REVIEWED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC014006	MGC13-H05	MGC	W01C048P09	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC014006	MGC13-H05	MGC	W01C048P10	pDONR221	11561		PGLS	25796	AAH14006.1	Hs.466165	6-phosphogluconolactonase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012088.2	NP_036220.1	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC011832	MGC13-H06	MGC	W01C048P11	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011832	MGC13-H06	MGC	W01C048P12	pDONR221	13237		PTCD3	55037	AAH11832.3	Hs.323489	Pentatricopeptide repeat domain 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_017952.5	NP_060422.4	VALIDATED	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC011907	MGC13-H07	MGC	W01C048P13	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011907	MGC13-H07	MGC	W01C048P14	pDONR221	24030		DPP7	29952	AAH11907.1	Hs.37916	Dipeptidyl-peptidase 7			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_013379.2	NP_037511.2	REVIEWED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC011873	MGC13-H08	MGC	W01C048P15	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011873	MGC13-H08	MGC	W01C048P16	pDONR221	20645		MTRF1L	54516	AAH11873.1	Hs.304818	Mitochondrial translational release factor 1-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_019041.5	NP_061914.3	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC011853	MGC13-H09	MGC	W01C048P17	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC011853	MGC13-H09	MGC	W01C048P18	pDONR221	6413		MCF2L	23263	AAH11853.1	Hs.597691	MCF.2 cell line derived transforming sequence-like			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_024979.3	NP_079255.3	VALIDATED	P	1.000	1.000	958	2955	73	2946	1129	31	988
IKAKEN	BC032097	MGC13-H10	MGC	W01C048P19	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC032097	MGC13-H10	MGC	W01C048P20	pDONR221	23586		FAM69B	138311	AAH32097.1	Hs.495480	Family with sequence similarity 69, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_152421.3	NP_689634.2	VALIDATED	OK	1.000	1.000	431	1296	1	1293	431	1	431
IKAKEN	BC011837	MGC13-H11	MGC	W01C048P21	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011837	MGC13-H11	MGC	W01C048P22	pDONR221	10301		DNAJC7	7266	AAH11837.2	Hs.500156	DnaJ (Hsp40) homolog, subfamily C, member 7			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001144766.1	NP_001138238.1	VALIDATED	C	1.000	1.000	438	1455	139	1452	438	1	438
IKAKEN	BC011819	MGC13-H12	MGC	W01C048P23	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC011819	MGC13-H12	MGC	W01C048P24	pDONR221	24550		DDX3X	1654	AAH11819.1	Hs.719127	DEAD (Asp-Glu-Ala-Asp) box polypeptide 3, X-linked			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001356.3	NP_001347.3	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	BC026345	MGC14-A01	MGC	W01C049A01	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC026345	MGC14-A01	MGC	W01C049A02	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC034051	MGC14-A02	MGC	W01C049A03	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	MGC14-A02	MGC	W01C049A04	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC000349	MGC14-A03	MGC	W01C049A05	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC000349	MGC14-A03	MGC	W01C049A06	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC026329	MGC14-A04	MGC	W01C049A07	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	MGC14-A04	MGC	W01C049A08	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	MGC14-A05	MGC	W01C049A09	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	MGC14-A05	MGC	W01C049A10	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	MGC14-A06	MGC	W01C049A11	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	MGC14-A06	MGC	W01C049A12	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC026167	MGC14-A07	MGC	W01C049A13	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC026167	MGC14-A07	MGC	W01C049A14	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC001353	MGC14-A08	MGC	W01C049A15	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	MGC14-A08	MGC	W01C049A16	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC032833	MGC14-A09	MGC	W01C049A17	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC032833	MGC14-A09	MGC	W01C049A18	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC000358	MGC14-A10	MGC	W01C049A19	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	MGC14-A10	MGC	W01C049A20	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	MGC14-A11	MGC	W01C049A21	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	MGC14-A11	MGC	W01C049A22	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	MGC14-A12	MGC	W01C049A23	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	MGC14-A12	MGC	W01C049A24	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC026345	MGC14-A01	MGC	W01C049B01	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC026345	MGC14-A01	MGC	W01C049B02	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC034051	MGC14-A02	MGC	W01C049B03	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	MGC14-A02	MGC	W01C049B04	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC000349	MGC14-A03	MGC	W01C049B05	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC000349	MGC14-A03	MGC	W01C049B06	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC026329	MGC14-A04	MGC	W01C049B07	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	MGC14-A04	MGC	W01C049B08	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	MGC14-A05	MGC	W01C049B09	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	MGC14-A05	MGC	W01C049B10	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	MGC14-A06	MGC	W01C049B11	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	MGC14-A06	MGC	W01C049B12	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC026167	MGC14-A07	MGC	W01C049B13	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC026167	MGC14-A07	MGC	W01C049B14	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC001353	MGC14-A08	MGC	W01C049B15	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	MGC14-A08	MGC	W01C049B16	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC032833	MGC14-A09	MGC	W01C049B17	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC032833	MGC14-A09	MGC	W01C049B18	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC000358	MGC14-A10	MGC	W01C049B19	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	MGC14-A10	MGC	W01C049B20	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	MGC14-A11	MGC	W01C049B21	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	MGC14-A11	MGC	W01C049B22	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	MGC14-A12	MGC	W01C049B23	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	MGC14-A12	MGC	W01C049B24	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC002378	MGC14-B01	MGC	W01C049C01	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC002378	MGC14-B01	MGC	W01C049C02	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC000385	MGC14-B02	MGC	W01C049C03	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	MGC14-B02	MGC	W01C049C04	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC002384	MGC14-B03	MGC	W01C049C05	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC002384	MGC14-B03	MGC	W01C049C06	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC000399	MGC14-B04	MGC	W01C049C07	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC000399	MGC14-B04	MGC	W01C049C08	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC021174	MGC14-B05	MGC	W01C049C09	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC021174	MGC14-B05	MGC	W01C049C10	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC022079	MGC14-B06	MGC	W01C049C11	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC022079	MGC14-B06	MGC	W01C049C12	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC026191	MGC14-B07	MGC	W01C049C13	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC026191	MGC14-B07	MGC	W01C049C14	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC000326	MGC14-B08	MGC	W01C049C15	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000326	MGC14-B08	MGC	W01C049C16	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000337	MGC14-B09	MGC	W01C049C17	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000337	MGC14-B09	MGC	W01C049C18	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000435	MGC14-B10	MGC	W01C049C19	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC000435	MGC14-B10	MGC	W01C049C20	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002366	MGC14-B11	MGC	W01C049C21	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC002366	MGC14-B11	MGC	W01C049C22	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC026125	MGC14-B12	MGC	W01C049C23	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC026125	MGC14-B12	MGC	W01C049C24	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC002378	MGC14-B01	MGC	W01C049D01	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC002378	MGC14-B01	MGC	W01C049D02	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC000385	MGC14-B02	MGC	W01C049D03	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	MGC14-B02	MGC	W01C049D04	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC002384	MGC14-B03	MGC	W01C049D05	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC002384	MGC14-B03	MGC	W01C049D06	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC000399	MGC14-B04	MGC	W01C049D07	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC000399	MGC14-B04	MGC	W01C049D08	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC021174	MGC14-B05	MGC	W01C049D09	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC021174	MGC14-B05	MGC	W01C049D10	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC022079	MGC14-B06	MGC	W01C049D11	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC022079	MGC14-B06	MGC	W01C049D12	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC026191	MGC14-B07	MGC	W01C049D13	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC026191	MGC14-B07	MGC	W01C049D14	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC000326	MGC14-B08	MGC	W01C049D15	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000326	MGC14-B08	MGC	W01C049D16	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000337	MGC14-B09	MGC	W01C049D17	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000337	MGC14-B09	MGC	W01C049D18	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000435	MGC14-B10	MGC	W01C049D19	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC000435	MGC14-B10	MGC	W01C049D20	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002366	MGC14-B11	MGC	W01C049D21	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC002366	MGC14-B11	MGC	W01C049D22	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC026125	MGC14-B12	MGC	W01C049D23	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC026125	MGC14-B12	MGC	W01C049D24	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC021740	MGC14-C01	MGC	W01C049E01	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	MGC14-C01	MGC	W01C049E02	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021730	MGC14-C02	MGC	W01C049E03	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC021730	MGC14-C02	MGC	W01C049E04	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037287	MGC14-C03	MGC	W01C049E05	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	MGC14-C03	MGC	W01C049E06	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC021727	MGC14-C04	MGC	W01C049E07	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC021727	MGC14-C04	MGC	W01C049E08	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC036526	MGC14-C05	MGC	W01C049E09	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC036526	MGC14-C05	MGC	W01C049E10	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC009911	MGC14-C06	MGC	W01C049E11	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC009911	MGC14-C06	MGC	W01C049E12	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC032859	MGC14-C07	MGC	W01C049E13	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC032859	MGC14-C07	MGC	W01C049E14	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC001639	MGC14-C08	MGC	W01C049E15	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC001639	MGC14-C08	MGC	W01C049E16	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009906	MGC14-C09	MGC	W01C049E17	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC009906	MGC14-C09	MGC	W01C049E18	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC041792	MGC14-C10	MGC	W01C049E19	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	MGC14-C10	MGC	W01C049E20	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC039260	MGC14-C11	MGC	W01C049E21	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC039260	MGC14-C11	MGC	W01C049E22	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC006559	MGC14-C12	MGC	W01C049E23	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC006559	MGC14-C12	MGC	W01C049E24	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC021740	MGC14-C01	MGC	W01C049F01	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	MGC14-C01	MGC	W01C049F02	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021730	MGC14-C02	MGC	W01C049F03	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC021730	MGC14-C02	MGC	W01C049F04	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037287	MGC14-C03	MGC	W01C049F05	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	MGC14-C03	MGC	W01C049F06	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC021727	MGC14-C04	MGC	W01C049F07	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC021727	MGC14-C04	MGC	W01C049F08	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC036526	MGC14-C05	MGC	W01C049F09	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC036526	MGC14-C05	MGC	W01C049F10	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC009911	MGC14-C06	MGC	W01C049F11	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC009911	MGC14-C06	MGC	W01C049F12	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC032859	MGC14-C07	MGC	W01C049F13	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC032859	MGC14-C07	MGC	W01C049F14	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC001639	MGC14-C08	MGC	W01C049F15	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC001639	MGC14-C08	MGC	W01C049F16	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009906	MGC14-C09	MGC	W01C049F17	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC009906	MGC14-C09	MGC	W01C049F18	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC041792	MGC14-C10	MGC	W01C049F19	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	MGC14-C10	MGC	W01C049F20	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC039260	MGC14-C11	MGC	W01C049F21	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC039260	MGC14-C11	MGC	W01C049F22	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC006559	MGC14-C12	MGC	W01C049F23	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC006559	MGC14-C12	MGC	W01C049F24	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC036065	MGC14-D01	MGC	W01C049G01	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC036065	MGC14-D01	MGC	W01C049G02	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC031108	MGC14-D02	MGC	W01C049G03	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	MGC14-D02	MGC	W01C049G04	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC039312	MGC14-D03	MGC	W01C049G05	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC039312	MGC14-D03	MGC	W01C049G06	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC006543	MGC14-D04	MGC	W01C049G07	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC006543	MGC14-D04	MGC	W01C049G08	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC020998	MGC14-D05	MGC	W01C049G09	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC020998	MGC14-D05	MGC	W01C049G10	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC021985	MGC14-D06	MGC	W01C049G11	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC021985	MGC14-D06	MGC	W01C049G12	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC008906	MGC14-D07	MGC	W01C049G13	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC008906	MGC14-D07	MGC	W01C049G14	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC009235	MGC14-D08	MGC	W01C049G15	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC009235	MGC14-D08	MGC	W01C049G16	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC030767	MGC14-D09	MGC	W01C049G17	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC030767	MGC14-D09	MGC	W01C049G18	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC003079	MGC14-D10	MGC	W01C049G19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC003079	MGC14-D10	MGC	W01C049G20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC006552	MGC14-D11	MGC	W01C049G21	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC006552	MGC14-D11	MGC	W01C049G22	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC007313	MGC14-D12	MGC	W01C049G23	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC007313	MGC14-D12	MGC	W01C049G24	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC036065	MGC14-D01	MGC	W01C049H01	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC036065	MGC14-D01	MGC	W01C049H02	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC031108	MGC14-D02	MGC	W01C049H03	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	MGC14-D02	MGC	W01C049H04	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC039312	MGC14-D03	MGC	W01C049H05	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC039312	MGC14-D03	MGC	W01C049H06	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC006543	MGC14-D04	MGC	W01C049H07	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC006543	MGC14-D04	MGC	W01C049H08	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC020998	MGC14-D05	MGC	W01C049H09	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC020998	MGC14-D05	MGC	W01C049H10	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC021985	MGC14-D06	MGC	W01C049H11	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC021985	MGC14-D06	MGC	W01C049H12	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC008906	MGC14-D07	MGC	W01C049H13	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC008906	MGC14-D07	MGC	W01C049H14	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC009235	MGC14-D08	MGC	W01C049H15	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC009235	MGC14-D08	MGC	W01C049H16	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC030767	MGC14-D09	MGC	W01C049H17	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC030767	MGC14-D09	MGC	W01C049H18	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC003079	MGC14-D10	MGC	W01C049H19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC003079	MGC14-D10	MGC	W01C049H20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC006552	MGC14-D11	MGC	W01C049H21	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC006552	MGC14-D11	MGC	W01C049H22	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC007313	MGC14-D12	MGC	W01C049H23	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC007313	MGC14-D12	MGC	W01C049H24	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC001665	MGC14-E01	MGC	W01C049I01	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC001665	MGC14-E01	MGC	W01C049I02	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC016753	MGC14-E02	MGC	W01C049I03	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	MGC14-E02	MGC	W01C049I04	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016760	MGC14-E03	MGC	W01C049I05	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC016760	MGC14-E03	MGC	W01C049I06	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001672	MGC14-E04	MGC	W01C049I07	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC001672	MGC14-E04	MGC	W01C049I08	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC007412	MGC14-E05	MGC	W01C049I09	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC007412	MGC14-E05	MGC	W01C049I10	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC004236	MGC14-E06	MGC	W01C049I11	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC004236	MGC14-E06	MGC	W01C049I12	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC001111	MGC14-E07	MGC	W01C049I13	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC001111	MGC14-E07	MGC	W01C049I14	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC024225	MGC14-E08	MGC	W01C049I15	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC024225	MGC14-E08	MGC	W01C049I16	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC007415	MGC14-E09	MGC	W01C049I17	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC007415	MGC14-E09	MGC	W01C049I18	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC003080	MGC14-E10	MGC	W01C049I19	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC003080	MGC14-E10	MGC	W01C049I20	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC002525	MGC14-E11	MGC	W01C049I21	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002525	MGC14-E11	MGC	W01C049I22	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002542	MGC14-E12	MGC	W01C049I23	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC002542	MGC14-E12	MGC	W01C049I24	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC001665	MGC14-E01	MGC	W01C049J01	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC001665	MGC14-E01	MGC	W01C049J02	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC016753	MGC14-E02	MGC	W01C049J03	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	MGC14-E02	MGC	W01C049J04	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016760	MGC14-E03	MGC	W01C049J05	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC016760	MGC14-E03	MGC	W01C049J06	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001672	MGC14-E04	MGC	W01C049J07	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC001672	MGC14-E04	MGC	W01C049J08	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC007412	MGC14-E05	MGC	W01C049J09	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC007412	MGC14-E05	MGC	W01C049J10	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC004236	MGC14-E06	MGC	W01C049J11	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC004236	MGC14-E06	MGC	W01C049J12	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC001111	MGC14-E07	MGC	W01C049J13	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC001111	MGC14-E07	MGC	W01C049J14	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC024225	MGC14-E08	MGC	W01C049J15	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC024225	MGC14-E08	MGC	W01C049J16	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC007415	MGC14-E09	MGC	W01C049J17	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC007415	MGC14-E09	MGC	W01C049J18	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC003080	MGC14-E10	MGC	W01C049J19	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC003080	MGC14-E10	MGC	W01C049J20	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC002525	MGC14-E11	MGC	W01C049J21	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002525	MGC14-E11	MGC	W01C049J22	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002542	MGC14-E12	MGC	W01C049J23	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC002542	MGC14-E12	MGC	W01C049J24	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC015558	MGC14-F01	MGC	W01C049K01	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC015558	MGC14-F01	MGC	W01C049K02	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC008769	MGC14-F02	MGC	W01C049K03	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC008769	MGC14-F02	MGC	W01C049K04	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC002545	MGC14-F03	MGC	W01C049K05	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC002545	MGC14-F03	MGC	W01C049K06	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC017188	MGC14-F04	MGC	W01C049K07	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	MGC14-F04	MGC	W01C049K08	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC001410	MGC14-F05	MGC	W01C049K09	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC001410	MGC14-F05	MGC	W01C049K10	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC002617	MGC14-F06	MGC	W01C049K11	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002617	MGC14-F06	MGC	W01C049K12	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002604	MGC14-F07	MGC	W01C049K13	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002604	MGC14-F07	MGC	W01C049K14	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002618	MGC14-F08	MGC	W01C049K15	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC002618	MGC14-F08	MGC	W01C049K16	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC001441	MGC14-F09	MGC	W01C049K17	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001441	MGC14-F09	MGC	W01C049K18	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001405	MGC14-F10	MGC	W01C049K19	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC001405	MGC14-F10	MGC	W01C049K20	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC002600	MGC14-F11	MGC	W01C049K21	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002600	MGC14-F11	MGC	W01C049K22	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002613	MGC14-F12	MGC	W01C049K23	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC002613	MGC14-F12	MGC	W01C049K24	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC015558	MGC14-F01	MGC	W01C049L01	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC015558	MGC14-F01	MGC	W01C049L02	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC008769	MGC14-F02	MGC	W01C049L03	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC008769	MGC14-F02	MGC	W01C049L04	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC002545	MGC14-F03	MGC	W01C049L05	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC002545	MGC14-F03	MGC	W01C049L06	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC017188	MGC14-F04	MGC	W01C049L07	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	MGC14-F04	MGC	W01C049L08	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC001410	MGC14-F05	MGC	W01C049L09	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC001410	MGC14-F05	MGC	W01C049L10	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC002617	MGC14-F06	MGC	W01C049L11	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002617	MGC14-F06	MGC	W01C049L12	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002604	MGC14-F07	MGC	W01C049L13	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002604	MGC14-F07	MGC	W01C049L14	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002618	MGC14-F08	MGC	W01C049L15	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC002618	MGC14-F08	MGC	W01C049L16	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC001441	MGC14-F09	MGC	W01C049L17	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001441	MGC14-F09	MGC	W01C049L18	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001405	MGC14-F10	MGC	W01C049L19	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC001405	MGC14-F10	MGC	W01C049L20	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC002600	MGC14-F11	MGC	W01C049L21	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002600	MGC14-F11	MGC	W01C049L22	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002613	MGC14-F12	MGC	W01C049L23	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC002613	MGC14-F12	MGC	W01C049L24	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC008767	MGC14-G01	MGC	W01C049M01	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	MGC14-G01	MGC	W01C049M02	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	MGC14-G02	MGC	W01C049M03	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	MGC14-G02	MGC	W01C049M04	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC002607	MGC14-G03	MGC	W01C049M05	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002607	MGC14-G03	MGC	W01C049M06	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002489	MGC14-G04	MGC	W01C049M07	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC002489	MGC14-G04	MGC	W01C049M08	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC040679	MGC14-G05	MGC	W01C049M09	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC040679	MGC14-G05	MGC	W01C049M10	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC002532	MGC14-G06	MGC	W01C049M11	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC002532	MGC14-G06	MGC	W01C049M12	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC006212	MGC14-G07	MGC	W01C049M13	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC006212	MGC14-G07	MGC	W01C049M14	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC000606	MGC14-G08	MGC	W01C049M15	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000606	MGC14-G08	MGC	W01C049M16	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000556	MGC14-G09	MGC	W01C049M17	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000556	MGC14-G09	MGC	W01C049M18	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008743	MGC14-G10	MGC	W01C049M19	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC008743	MGC14-G10	MGC	W01C049M20	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC000684	MGC14-G11	MGC	W01C049M21	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC000684	MGC14-G11	MGC	W01C049M22	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC008741	MGC14-G12	MGC	W01C049M23	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC008741	MGC14-G12	MGC	W01C049M24	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC008767	MGC14-G01	MGC	W01C049N01	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	MGC14-G01	MGC	W01C049N02	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	MGC14-G02	MGC	W01C049N03	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	MGC14-G02	MGC	W01C049N04	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC002607	MGC14-G03	MGC	W01C049N05	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002607	MGC14-G03	MGC	W01C049N06	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002489	MGC14-G04	MGC	W01C049N07	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC002489	MGC14-G04	MGC	W01C049N08	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC040679	MGC14-G05	MGC	W01C049N09	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC040679	MGC14-G05	MGC	W01C049N10	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC002532	MGC14-G06	MGC	W01C049N11	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC002532	MGC14-G06	MGC	W01C049N12	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC006212	MGC14-G07	MGC	W01C049N13	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC006212	MGC14-G07	MGC	W01C049N14	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC000606	MGC14-G08	MGC	W01C049N15	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000606	MGC14-G08	MGC	W01C049N16	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000556	MGC14-G09	MGC	W01C049N17	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000556	MGC14-G09	MGC	W01C049N18	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008743	MGC14-G10	MGC	W01C049N19	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC008743	MGC14-G10	MGC	W01C049N20	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC000684	MGC14-G11	MGC	W01C049N21	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC000684	MGC14-G11	MGC	W01C049N22	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC008741	MGC14-G12	MGC	W01C049N23	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC008741	MGC14-G12	MGC	W01C049N24	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC000615	MGC14-H01	MGC	W01C049O01	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000615	MGC14-H01	MGC	W01C049O02	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000576	MGC14-H02	MGC	W01C049O03	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000576	MGC14-H02	MGC	W01C049O04	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000616	MGC14-H03	MGC	W01C049O05	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	MGC14-H03	MGC	W01C049O06	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC008765	MGC14-H04	MGC	W01C049O07	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC008765	MGC14-H04	MGC	W01C049O08	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC000662	MGC14-H05	MGC	W01C049O09	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000662	MGC14-H05	MGC	W01C049O10	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000601	MGC14-H06	MGC	W01C049O11	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC000601	MGC14-H06	MGC	W01C049O12	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC002477	MGC14-H07	MGC	W01C049O13	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC002477	MGC14-H07	MGC	W01C049O14	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC000687	MGC14-H08	MGC	W01C049O15	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC000687	MGC14-H08	MGC	W01C049O16	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC002427	MGC14-H09	MGC	W01C049O17	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC002427	MGC14-H09	MGC	W01C049O18	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC000663	MGC14-H10	MGC	W01C049O19	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC000663	MGC14-H10	MGC	W01C049O20	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC002462	MGC14-H11	MGC	W01C049O21	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC002462	MGC14-H11	MGC	W01C049O22	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC000590	MGC14-H12	MGC	W01C049O23	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	MGC14-H12	MGC	W01C049O24	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000615	MGC14-H01	MGC	W01C049P01	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000615	MGC14-H01	MGC	W01C049P02	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000576	MGC14-H02	MGC	W01C049P03	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000576	MGC14-H02	MGC	W01C049P04	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000616	MGC14-H03	MGC	W01C049P05	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	MGC14-H03	MGC	W01C049P06	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC008765	MGC14-H04	MGC	W01C049P07	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC008765	MGC14-H04	MGC	W01C049P08	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC000662	MGC14-H05	MGC	W01C049P09	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000662	MGC14-H05	MGC	W01C049P10	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000601	MGC14-H06	MGC	W01C049P11	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC000601	MGC14-H06	MGC	W01C049P12	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC002477	MGC14-H07	MGC	W01C049P13	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC002477	MGC14-H07	MGC	W01C049P14	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC000687	MGC14-H08	MGC	W01C049P15	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC000687	MGC14-H08	MGC	W01C049P16	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC002427	MGC14-H09	MGC	W01C049P17	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC002427	MGC14-H09	MGC	W01C049P18	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC000663	MGC14-H10	MGC	W01C049P19	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC000663	MGC14-H10	MGC	W01C049P20	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC002462	MGC14-H11	MGC	W01C049P21	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC002462	MGC14-H11	MGC	W01C049P22	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC000590	MGC14-H12	MGC	W01C049P23	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	MGC14-H12	MGC	W01C049P24	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC026345	MGC14-A01	MGC	W01C050A01	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC026345	MGC14-A01	MGC	W01C050A02	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC034051	MGC14-A02	MGC	W01C050A03	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	MGC14-A02	MGC	W01C050A04	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC000349	MGC14-A03	MGC	W01C050A05	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC000349	MGC14-A03	MGC	W01C050A06	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC026329	MGC14-A04	MGC	W01C050A07	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	MGC14-A04	MGC	W01C050A08	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	MGC14-A05	MGC	W01C050A09	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	MGC14-A05	MGC	W01C050A10	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	MGC14-A06	MGC	W01C050A11	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	MGC14-A06	MGC	W01C050A12	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC026167	MGC14-A07	MGC	W01C050A13	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC026167	MGC14-A07	MGC	W01C050A14	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC001353	MGC14-A08	MGC	W01C050A15	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	MGC14-A08	MGC	W01C050A16	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC032833	MGC14-A09	MGC	W01C050A17	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC032833	MGC14-A09	MGC	W01C050A18	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC000358	MGC14-A10	MGC	W01C050A19	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	MGC14-A10	MGC	W01C050A20	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	MGC14-A11	MGC	W01C050A21	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	MGC14-A11	MGC	W01C050A22	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	MGC14-A12	MGC	W01C050A23	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	MGC14-A12	MGC	W01C050A24	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC026345	MGC14-A01	MGC	W01C050B01	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC026345	MGC14-A01	MGC	W01C050B02	pDONR221	13779		ERMN	57471	AAH26345.1	Hs.443894	Ermin, ERM-like protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_020711.1	NP_065762.1	VALIDATED	OK	1.000	1.000	284	855	1	852	284	1	284
IKAKEN	BC034051	MGC14-A02	MGC	W01C050B03	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	MGC14-A02	MGC	W01C050B04	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC000349	MGC14-A03	MGC	W01C050B05	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC000349	MGC14-A03	MGC	W01C050B06	pDONR221	1952		GBAP	2630	AAH00349					Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC026329	MGC14-A04	MGC	W01C050B07	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC026329	MGC14-A04	MGC	W01C050B08	pDONR221	20032		GJA1	2697	AAH26329.1	Hs.74471	Gap junction protein, alpha 1, 43kDa			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_000165.3	NP_000156.1	REVIEWED		0.940	0.942	382	1365	1	1143	382	1	382
IKAKEN	BC021714	MGC14-A05	MGC	W01C050B09	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	MGC14-A05	MGC	W01C050B10	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC000320	MGC14-A06	MGC	W01C050B11	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC000320	MGC14-A06	MGC	W01C050B12	pDONR221	15621		PDXP	57026	AAH00320.1	Hs.632762	Pyridoxal (pyridoxine, vitamin B6) phosphatase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_020315.4	NP_064711.1	VALIDATED	OK	1.000	1.000	296	891	1	888	296	1	296
IKAKEN	BC026167	MGC14-A07	MGC	W01C050B13	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC026167	MGC14-A07	MGC	W01C050B14	pDONR221	3237		METTL10	399818	AAH26167.1	Hs.714827	Methyltransferase like 10			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_212554.2	NP_997719.2	VALIDATED	P	1.000	1.000	192	578	1	576	291	1	192
IKAKEN	BC001353	MGC14-A08	MGC	W01C050B15	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC001353	MGC14-A08	MGC	W01C050B16	pDONR221	8614		KATNB1	10300	AAH01353.1	Hs.275675	Katanin p80 (WD repeat containing) subunit B 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005886.2	NP_005877.2	REVIEWED	Cgs	0.997	0.998	656	1971	1	1968	655	1	655
IKAKEN	BC032833	MGC14-A09	MGC	W01C050B17	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC032833	MGC14-A09	MGC	W01C050B18	pDONR221	5288		ANKRD13A	88455	AAH32833.2	Hs.528703	Ankyrin repeat domain 13A			Testis	NIH_MGC_97	DH10B	NM_033121.1	NP_149112.1	VALIDATED	Pfs	0.997	1.000	355	1065	1	1063	590	1	355
IKAKEN	BC000358	MGC14-A10	MGC	W01C050B19	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000358	MGC14-A10	MGC	W01C050B20	pDONR221	6157		PRKAG1	5571	AAH00358.1	Hs.530862	Protein kinase, AMP-activated, gamma 1 non-catalytic subunit			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_212461.1	NP_997626.1	REVIEWED	C	1.000	1.000	247	900	157	897	247	1	247
IKAKEN	BC000368	MGC14-A11	MGC	W01C050B21	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC000368	MGC14-A11	MGC	W01C050B22	pDONR221	872		PGD	5226	AAH00368.1	Hs.464071	Phosphogluconate dehydrogenase			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_002631.2	NP_002622.2	REVIEWED		0.882	0.893	483	1434	1	1431	483	1	483
IKAKEN	BC028364	MGC14-A12	MGC	W01C050B23	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC028364	MGC14-A12	MGC	W01C050B24	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED		0.979	0.979	243	732	1	729	1051	809	1051
IKAKEN	BC002378	MGC14-B01	MGC	W01C050C01	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC002378	MGC14-B01	MGC	W01C050C02	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC000385	MGC14-B02	MGC	W01C050C03	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	MGC14-B02	MGC	W01C050C04	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC002384	MGC14-B03	MGC	W01C050C05	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC002384	MGC14-B03	MGC	W01C050C06	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC000399	MGC14-B04	MGC	W01C050C07	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC000399	MGC14-B04	MGC	W01C050C08	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC021174	MGC14-B05	MGC	W01C050C09	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC021174	MGC14-B05	MGC	W01C050C10	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC022079	MGC14-B06	MGC	W01C050C11	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC022079	MGC14-B06	MGC	W01C050C12	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC026191	MGC14-B07	MGC	W01C050C13	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC026191	MGC14-B07	MGC	W01C050C14	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC000326	MGC14-B08	MGC	W01C050C15	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000326	MGC14-B08	MGC	W01C050C16	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000337	MGC14-B09	MGC	W01C050C17	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000337	MGC14-B09	MGC	W01C050C18	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000435	MGC14-B10	MGC	W01C050C19	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC000435	MGC14-B10	MGC	W01C050C20	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002366	MGC14-B11	MGC	W01C050C21	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC002366	MGC14-B11	MGC	W01C050C22	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC026125	MGC14-B12	MGC	W01C050C23	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC026125	MGC14-B12	MGC	W01C050C24	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC002378	MGC14-B01	MGC	W01C050D01	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC002378	MGC14-B01	MGC	W01C050D02	pDONR221	3592		KIAA0652	9776	AAH02378.1	Hs.127403	KIAA0652			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_014741.3	NP_055556.2	VALIDATED	OK	1.000	1.000	480	1443	1	1440	480	1	480
IKAKEN	BC000385	MGC14-B02	MGC	W01C050D03	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000385	MGC14-B02	MGC	W01C050D04	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC002384	MGC14-B03	MGC	W01C050D05	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC002384	MGC14-B03	MGC	W01C050D06	pDONR221	5505		MARS	4141	AAH02384.1	Hs.632707	Methionyl-tRNA synthetase			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004990.2	NP_004981.2	REVIEWED	OK	1.000	1.000	900	2703	1	2700	900	1	900
IKAKEN	BC000399	MGC14-B04	MGC	W01C050D07	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC000399	MGC14-B04	MGC	W01C050D08	pDONR221	9865		ACADVL	37	AAH00399.1	Hs.437178	Acyl-Coenzyme A dehydrogenase, very long chain			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000018.2	NP_000009.1	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC021174	MGC14-B05	MGC	W01C050D09	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC021174	MGC14-B05	MGC	W01C050D10	pDONR221	18609		SERF1A	8293	AAH21174.1	Hs.559428	Small EDRK-rich factor 1A (telomeric)			Prostate	NIH_MGC_83	DH10B	NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	BC022079	MGC14-B06	MGC	W01C050D11	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC022079	MGC14-B06	MGC	W01C050D12	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED	Ps	0.988	0.988	170	696	181	690	475	275	444
IKAKEN	BC026191	MGC14-B07	MGC	W01C050D13	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC026191	MGC14-B07	MGC	W01C050D14	pDONR221	3605		ENDOD1	23052	AAH26191.1	Hs.167115	Endonuclease domain containing 1			Testis	NIH_MGC_97	DH10B	NM_015036.1	NP_055851.1	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
IKAKEN	BC000326	MGC14-B08	MGC	W01C050D15	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000326	MGC14-B08	MGC	W01C050D16	pDONR221	17170		COPB2	9276	AAH00326.1	Hs.719115	Coatomer protein complex, subunit beta 2 (beta prime)			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_004766.2	NP_004757.1	VALIDATED	OK	1.000	1.000	906	2721	1	2718	906	1	906
IKAKEN	BC000337	MGC14-B09	MGC	W01C050D17	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000337	MGC14-B09	MGC	W01C050D18	pDONR221	25378		G6PD	2539	AAH00337.1	Hs.684904	Glucose-6-phosphate dehydrogenase			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001042351.1	NP_001035810.1	REVIEWED	OK	1.000	1.000	515	1548	1	1545	515	1	515
IKAKEN	BC000435	MGC14-B10	MGC	W01C050D19	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC000435	MGC14-B10	MGC	W01C050D20	pDONR221	10422		C1QBP	708	AAH00435.1	Hs.555866	Complement component 1, q subcomponent binding protein			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001212.3	NP_001203.1	REVIEWED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	BC002366	MGC14-B11	MGC	W01C050D21	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC002366	MGC14-B11	MGC	W01C050D22	pDONR221	5890		DDX23	9416	AAH02366.1	Hs.130098	DEAD (Asp-Glu-Ala-Asp) box polypeptide 23			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_004818.2	NP_004809.2	REVIEWED		0.891	0.902	267	795	1	792	820	554	820
IKAKEN	BC026125	MGC14-B12	MGC	W01C050D23	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC026125	MGC14-B12	MGC	W01C050D24	pDONR221	10724		CCT6B	10693	AAH26125.1	Hs.73072	Chaperonin containing TCP1, subunit 6B (zeta 2)			Testis	NIH_MGC_97	DH10B	NM_006584.2	NP_006575.2	REVIEWED	OK	1.000	1.000	530	1628	1	1590	530	1	530
IKAKEN	BC021740	MGC14-C01	MGC	W01C050E01	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	MGC14-C01	MGC	W01C050E02	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021730	MGC14-C02	MGC	W01C050E03	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC021730	MGC14-C02	MGC	W01C050E04	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037287	MGC14-C03	MGC	W01C050E05	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	MGC14-C03	MGC	W01C050E06	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC021727	MGC14-C04	MGC	W01C050E07	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC021727	MGC14-C04	MGC	W01C050E08	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC036526	MGC14-C05	MGC	W01C050E09	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC036526	MGC14-C05	MGC	W01C050E10	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC009911	MGC14-C06	MGC	W01C050E11	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC009911	MGC14-C06	MGC	W01C050E12	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC032859	MGC14-C07	MGC	W01C050E13	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC032859	MGC14-C07	MGC	W01C050E14	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC001639	MGC14-C08	MGC	W01C050E15	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC001639	MGC14-C08	MGC	W01C050E16	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009906	MGC14-C09	MGC	W01C050E17	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC009906	MGC14-C09	MGC	W01C050E18	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC041792	MGC14-C10	MGC	W01C050E19	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	MGC14-C10	MGC	W01C050E20	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC039260	MGC14-C11	MGC	W01C050E21	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC039260	MGC14-C11	MGC	W01C050E22	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC006559	MGC14-C12	MGC	W01C050E23	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC006559	MGC14-C12	MGC	W01C050E24	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC021740	MGC14-C01	MGC	W01C050F01	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021740	MGC14-C01	MGC	W01C050F02	pDONR221	11057		BOD1P	284257	AAH21740	Hs.127882	Biorientation of chromosomes in cell division 1 pseudogene			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R			
IKAKEN	BC021730	MGC14-C02	MGC	W01C050F03	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC021730	MGC14-C02	MGC	W01C050F04	pDONR221	2867		LYZL1	84569	AAH21730.1	Hs.558572	Lysozyme-like 1			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_032517.4	NP_115906.3	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	BC037287	MGC14-C03	MGC	W01C050F05	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	MGC14-C03	MGC	W01C050F06	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC021727	MGC14-C04	MGC	W01C050F07	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC021727	MGC14-C04	MGC	W01C050F08	pDONR221	9968		C17orf50	146853	AAH21727	Hs.127194	Chromosome 17 open reading frame 50			Placenta	NIH_MGC_79	DH10B	NM_145272.3	NP_660315.2	VALIDATED	OK	1.000	1.000	174	746	1	522	174	1	174
IKAKEN	BC036526	MGC14-C05	MGC	W01C050F09	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC036526	MGC14-C05	MGC	W01C050F10	pDONR221	4686		KDELC2	143888	AAH36526.3	Hs.83286	KDEL (Lys-Asp-Glu-Leu) containing 2			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_153705.4	NP_714916.3	VALIDATED	OK	1.000	1.000	507	1524	1	1521	507	1	507
IKAKEN	BC009911	MGC14-C06	MGC	W01C050F11	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC009911	MGC14-C06	MGC	W01C050F12	pDONR221	18745		RMND5B	64777	AAH09911.1	Hs.716508	Required for meiotic nuclear division 5 homolog B (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_022762.3	NP_073599.2	PROVISIONAL	OK	1.000	1.000	393	1182	1	1179	393	1	393
IKAKEN	BC032859	MGC14-C07	MGC	W01C050F13	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC032859	MGC14-C07	MGC	W01C050F14	pDONR221	628		C1orf101	257044	AAH32859.1	Hs.459534	Chromosome 1 open reading frame 101			Testis	NIH_MGC_97	DH10B	NM_173807.4	NP_776168.1	VALIDATED	OK	1.000	1.000	832	2499	1	2496	832	1	832
IKAKEN	BC001639	MGC14-C08	MGC	W01C050F15	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC001639	MGC14-C08	MGC	W01C050F16	pDONR221	4479		SLC43A1	8501	AAH01639.1	Hs.591952	Solute carrier family 43, member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_003627.4	NP_003618.1	PROVISIONAL	OK	1.000	1.000	559	1680	1	1677	559	1	559
IKAKEN	BC009906	MGC14-C09	MGC	W01C050F17	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC009906	MGC14-C09	MGC	W01C050F18	pDONR221	18699		SLC35A4	113829	AAH09906.1	Hs.406840	Solute carrier family 35, member A4			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_080670.2	NP_542401.1	PROVISIONAL	OK	1.000	1.000	324	975	1	972	324	1	324
IKAKEN	BC041792	MGC14-C10	MGC	W01C050F19	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC041792	MGC14-C10	MGC	W01C050F20	pDONR221	7724		ARID3B	10620	AAH41792.1	Hs.655532	AT rich interactive domain 3B (BRIGHT-like)			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_006465.2	NP_006456.1	REVIEWED	Cgs	0.979	0.986	564	1695	1	1692	560	1	560
IKAKEN	BC039260	MGC14-C11	MGC	W01C050F21	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC039260	MGC14-C11	MGC	W01C050F22	pDONR221	23262		RBM12B	389677	AAH39260	Hs.192788	RNA binding motif protein 12B			Testis	NIH_MGC_97	DH10B	NM_203390.2	NP_976324.2	VALIDATED	Pg	0.865	1.000	886	2299	1	2298	1001	1	886
IKAKEN	BC006559	MGC14-C12	MGC	W01C050F23	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC006559	MGC14-C12	MGC	W01C050F24	pDONR221	9105		RPS2	6187	AAH06559.1	Hs.709308	Ribosomal protein S2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_002952.3	NP_002943.2	REVIEWED	Pfs	0.858	0.870	233	693	1	690	293	61	293
IKAKEN	BC036065	MGC14-D01	MGC	W01C050G01	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC036065	MGC14-D01	MGC	W01C050G02	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC031108	MGC14-D02	MGC	W01C050G03	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	MGC14-D02	MGC	W01C050G04	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC039312	MGC14-D03	MGC	W01C050G05	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC039312	MGC14-D03	MGC	W01C050G06	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC006543	MGC14-D04	MGC	W01C050G07	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC006543	MGC14-D04	MGC	W01C050G08	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC020998	MGC14-D05	MGC	W01C050G09	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC020998	MGC14-D05	MGC	W01C050G10	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC021985	MGC14-D06	MGC	W01C050G11	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC021985	MGC14-D06	MGC	W01C050G12	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC008906	MGC14-D07	MGC	W01C050G13	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC008906	MGC14-D07	MGC	W01C050G14	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC009235	MGC14-D08	MGC	W01C050G15	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC009235	MGC14-D08	MGC	W01C050G16	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC030767	MGC14-D09	MGC	W01C050G17	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC030767	MGC14-D09	MGC	W01C050G18	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC003079	MGC14-D10	MGC	W01C050G19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC003079	MGC14-D10	MGC	W01C050G20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC006552	MGC14-D11	MGC	W01C050G21	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC006552	MGC14-D11	MGC	W01C050G22	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC007313	MGC14-D12	MGC	W01C050G23	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC007313	MGC14-D12	MGC	W01C050G24	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC036065	MGC14-D01	MGC	W01C050H01	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC036065	MGC14-D01	MGC	W01C050H02	pDONR221	22742		WWP1	11059	AAH36065.1	Hs.655189	WW domain containing E3 ubiquitin protein ligase 1			Testis	NIH_MGC_97	DH10B	NM_007013.3	NP_008944.1	VALIDATED	Pfs	0.922	0.922	296	891	1	888	922	627	922
IKAKEN	BC031108	MGC14-D02	MGC	W01C050H03	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC031108	MGC14-D02	MGC	W01C050H04	pDONR221	30070									Prostate, carcinoma	NIH_MGC_40	DH10B-R			
IKAKEN	BC039312	MGC14-D03	MGC	W01C050H05	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC039312	MGC14-D03	MGC	W01C050H06	pDONR221	2786		ARMC3	219681	AAH39312.1	Hs.659807	Armadillo repeat containing 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173081.3	NP_775104.2	VALIDATED	OK	1.000	1.000	872	2619	1	2616	872	1	872
IKAKEN	BC006543	MGC14-D04	MGC	W01C050H07	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC006543	MGC14-D04	MGC	W01C050H08	pDONR221	18679		CCT5	22948	AAH06543.1	Hs.1600	Chaperonin containing TCP1, subunit 5 (epsilon)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012073.3	NP_036205.1	REVIEWED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC020998	MGC14-D05	MGC	W01C050H09	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC020998	MGC14-D05	MGC	W01C050H10	pDONR221	1355		NMNAT2	23057	AAH20998.1	Hs.497123	Nicotinamide nucleotide adenylyltransferase 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_170706.2	NP_733820.1	REVIEWED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	BC021985	MGC14-D06	MGC	W01C050H11	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC021985	MGC14-D06	MGC	W01C050H12	pDONR221	9578		COG1	9382	AAH21985.1	Hs.283109	Component of oligomeric golgi complex 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018714.2	NP_061184.1	REVIEWED	OK	1.000	1.000	980	2943	1	2940	980	1	980
IKAKEN	BC008906	MGC14-D07	MGC	W01C050H13	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC008906	MGC14-D07	MGC	W01C050H14	pDONR221	3400		ECHS1	1892	AAH08906.1	Hs.76394	Enoyl Coenzyme A hydratase, short chain, 1, mitochondrial			Pooled, 40 cell lines	NIH_MGC_128	DH10B	NM_004092.3	NP_004083.3	REVIEWED	OK	1.000	1.000	290	873	1	870	290	1	290
IKAKEN	BC009235	MGC14-D08	MGC	W01C050H15	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC009235	MGC14-D08	MGC	W01C050H16	pDONR221	14269		HADHA	3030	AAH09235.1	Hs.516032	Hydroxyacyl-Coenzyme A dehydrogenase/3-ketoacyl-Coenzyme A thiolase/enoyl-Coenzyme A hydratase (trifunctional protein), alpha subunit			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_000182.4	NP_000173.2	REVIEWED		0.887	0.892	408	1221	1	1218	763	340	747
IKAKEN	BC030767	MGC14-D09	MGC	W01C050H17	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC030767	MGC14-D09	MGC	W01C050H18	pDONR221	18898		LOC133874	133874	-	Hs.519749	Hypothetical gene LOC133874			Testis	NIH_MGC_97	DH10B	NM_001102609.1	NP_001096079.1	PREDICTED	P	1.000	1.000	52	165	1	156	102	1	52
IKAKEN	BC003079	MGC14-D10	MGC	W01C050H19	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC003079	MGC14-D10	MGC	W01C050H20	pDONR221	21882		CHCHD2	51142	AAH03079.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			testis	TESTI2		NM_016139.2	NP_057223.1	VALIDATED		0.940	0.940	151	456	1	453	151	1	151
IKAKEN	BC006552	MGC14-D11	MGC	W01C050H21	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC006552	MGC14-D11	MGC	W01C050H22	pDONR221	5343		ITFG2	55846	AAH06552.1	Hs.448720	Integrin alpha FG-GAP repeat containing 2			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018463.2	NP_060933.2	PROVISIONAL	Cs	0.998	0.998	447	1344	1	1341	447	1	447
IKAKEN	BC007313	MGC14-D12	MGC	W01C050H23	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC007313	MGC14-D12	MGC	W01C050H24	pDONR221	4709		VSIG2	23584	AAH07313.1	Hs.112377	V-set and immunoglobulin domain containing 2			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_014312.3	NP_055127.2	PROVISIONAL	OK	1.000	1.000	327	984	1	981	327	1	327
IKAKEN	BC001665	MGC14-E01	MGC	W01C050I01	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC001665	MGC14-E01	MGC	W01C050I02	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC016753	MGC14-E02	MGC	W01C050I03	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	MGC14-E02	MGC	W01C050I04	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016760	MGC14-E03	MGC	W01C050I05	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC016760	MGC14-E03	MGC	W01C050I06	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001672	MGC14-E04	MGC	W01C050I07	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC001672	MGC14-E04	MGC	W01C050I08	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC007412	MGC14-E05	MGC	W01C050I09	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC007412	MGC14-E05	MGC	W01C050I10	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC004236	MGC14-E06	MGC	W01C050I11	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC004236	MGC14-E06	MGC	W01C050I12	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC001111	MGC14-E07	MGC	W01C050I13	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC001111	MGC14-E07	MGC	W01C050I14	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC024225	MGC14-E08	MGC	W01C050I15	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC024225	MGC14-E08	MGC	W01C050I16	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC007415	MGC14-E09	MGC	W01C050I17	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC007415	MGC14-E09	MGC	W01C050I18	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC003080	MGC14-E10	MGC	W01C050I19	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC003080	MGC14-E10	MGC	W01C050I20	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC002525	MGC14-E11	MGC	W01C050I21	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002525	MGC14-E11	MGC	W01C050I22	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002542	MGC14-E12	MGC	W01C050I23	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC002542	MGC14-E12	MGC	W01C050I24	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC001665	MGC14-E01	MGC	W01C050J01	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC001665	MGC14-E01	MGC	W01C050J02	pDONR221	18497		ABLIM3	22885	AAH01665.1	Hs.49688	Actin binding LIM protein family, member 3			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014945.2	NP_055760.1	VALIDATED	Pg	0.828	1.000	646	1635	1	1605	683	1	646
IKAKEN	BC016753	MGC14-E02	MGC	W01C050J03	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	MGC14-E02	MGC	W01C050J04	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016760	MGC14-E03	MGC	W01C050J05	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC016760	MGC14-E03	MGC	W01C050J06	pDONR221	12288		GAMT	2593	AAH16760.1	Hs.81131	Guanidinoacetate N-methyltransferase			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000156.4	NP_000147.1	REVIEWED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC001672	MGC14-E04	MGC	W01C050J07	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC001672	MGC14-E04	MGC	W01C050J08	pDONR221	14780		ZSWIM1	90204	AAH01672.3	Hs.517075	Zinc finger, SWIM-type containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_080603.3	NP_542170.3	PROVISIONAL	P	1.000	1.000	456	1371	1	1368	485	30	485
IKAKEN	BC007412	MGC14-E05	MGC	W01C050J09	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC007412	MGC14-E05	MGC	W01C050J10	pDONR221	7166		C14orf153	84334	AAH07412.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032374.3	NP_115750.2	VALIDATED	P	1.000	1.000	193	582	1	579	206	14	206
IKAKEN	BC004236	MGC14-E06	MGC	W01C050J11	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC004236	MGC14-E06	MGC	W01C050J12	pDONR221	10754		UBE2S	27338	AAH04236.1	Hs.396393	Ubiquitin-conjugating enzyme E2S			Lung	NIH_MGC_77	DH10B	NM_014501.2	NP_055316.2	REVIEWED		0.977	0.977	222	669	1	666	222	1	222
IKAKEN	BC001111	MGC14-E07	MGC	W01C050J13	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC001111	MGC14-E07	MGC	W01C050J14	pDONR221	21237		ARL4A	10124	AAH01111.1	Hs.245540	ADP-ribosylation factor-like 4A			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_212460.2	NP_997625.1	REVIEWED		0.905	0.905	190	705	1	570	200	1	190
IKAKEN	BC024225	MGC14-E08	MGC	W01C050J15	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC024225	MGC14-E08	MGC	W01C050J16	pDONR221	24153		MED22	6837	AAH24225.1	Hs.78354	Mediator complex subunit 22			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_181491.1	NP_852468.1	REVIEWED	OK	1.000	1.000	140	423	1	420	140	1	140
IKAKEN	BC007415	MGC14-E09	MGC	W01C050J17	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC007415	MGC14-E09	MGC	W01C050J18	pDONR221	13269		AGBL5	60509	AAH07415.2	Hs.138207	ATP/GTP binding protein-like 5			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_021831.5	NP_068603.4	VALIDATED	OK	1.000	1.000	886	2661	1	2658	886	1	886
IKAKEN	BC003080	MGC14-E10	MGC	W01C050J19	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC003080	MGC14-E10	MGC	W01C050J20	pDONR221	8684		TMEM208	29100	AAH03080.1	Hs.433203	Transmembrane protein 208			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014187.3	NP_054906.2	VALIDATED	Cs	0.988	0.988	173	528	7	525	173	1	173
IKAKEN	BC002525	MGC14-E11	MGC	W01C050J21	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002525	MGC14-E11	MGC	W01C050J22	pDONR221	1358		KIAA0494	9813	AAH02525.1	Hs.719205	KIAA0494			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_014774.2	NP_055589.1	VALIDATED	OK	1.000	1.000	495	1488	1	1485	495	1	495
IKAKEN	BC002542	MGC14-E12	MGC	W01C050J23	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC002542	MGC14-E12	MGC	W01C050J24	pDONR221	115		ATAD3B	83858	AAH02542.1	Hs.23413	ATPase family, AAA domain containing 3B			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_031921.4	NP_114127.3	PROVISIONAL	OK	1.000	1.000	648	1947	1	1944	648	1	648
IKAKEN	BC015558	MGC14-F01	MGC	W01C050K01	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC015558	MGC14-F01	MGC	W01C050K02	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC008769	MGC14-F02	MGC	W01C050K03	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC008769	MGC14-F02	MGC	W01C050K04	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC002545	MGC14-F03	MGC	W01C050K05	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC002545	MGC14-F03	MGC	W01C050K06	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC017188	MGC14-F04	MGC	W01C050K07	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	MGC14-F04	MGC	W01C050K08	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC001410	MGC14-F05	MGC	W01C050K09	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC001410	MGC14-F05	MGC	W01C050K10	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC002617	MGC14-F06	MGC	W01C050K11	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002617	MGC14-F06	MGC	W01C050K12	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002604	MGC14-F07	MGC	W01C050K13	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002604	MGC14-F07	MGC	W01C050K14	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002618	MGC14-F08	MGC	W01C050K15	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC002618	MGC14-F08	MGC	W01C050K16	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC001441	MGC14-F09	MGC	W01C050K17	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001441	MGC14-F09	MGC	W01C050K18	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001405	MGC14-F10	MGC	W01C050K19	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC001405	MGC14-F10	MGC	W01C050K20	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC002600	MGC14-F11	MGC	W01C050K21	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002600	MGC14-F11	MGC	W01C050K22	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002613	MGC14-F12	MGC	W01C050K23	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC002613	MGC14-F12	MGC	W01C050K24	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC015558	MGC14-F01	MGC	W01C050L01	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC015558	MGC14-F01	MGC	W01C050L02	pDONR221	25400		RENBP	5973	AAH15558.1	Hs.158331	Renin binding protein			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_002910.5	NP_002901.2	REVIEWED	P	1.000	1.000	417	1254	1	1251	427	11	427
IKAKEN	BC008769	MGC14-F02	MGC	W01C050L03	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC008769	MGC14-F02	MGC	W01C050L04	pDONR221	24698		CCDC120	90060	AAH08769.1	Hs.522643	Coiled-coil domain containing 120			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_033626.2	NP_296375.1	PROVISIONAL	OK	1.000	1.000	630	1893	1	1890	630	1	630
IKAKEN	BC002545	MGC14-F03	MGC	W01C050L05	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC002545	MGC14-F03	MGC	W01C050L06	pDONR221	23731		PPP2R4	5524	AAH02545.1	Hs.400740	Protein phosphatase 2A activator, regulatory subunit 4			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_021131.3	NP_066954.2	REVIEWED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BC017188	MGC14-F04	MGC	W01C050L07	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC017188	MGC14-F04	MGC	W01C050L08	pDONR221	8537		TELO2	9894	AAH17188.1	Hs.271044	TEL2, telomere maintenance 2, homolog (S. cerevisiae)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016111.3	NP_057195.2	REVIEWED	OK	1.000	1.000	837	2514	1	2511	837	1	837
IKAKEN	BC001410	MGC14-F05	MGC	W01C050L09	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC001410	MGC14-F05	MGC	W01C050L10	pDONR221	2146		S100A11	6282	AAH01410.1	Hs.417004	S100 calcium binding protein A11			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_005620.1	NP_005611.1	REVIEWED		0.913	0.922	103	309	1	306	105	1	103
IKAKEN	BC002617	MGC14-F06	MGC	W01C050L11	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002617	MGC14-F06	MGC	W01C050L12	pDONR221	12603		GYS1	2997	AAH02617.1	Hs.386225	Glycogen synthase 1 (muscle)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_002103.3	NP_002094.2	PROVISIONAL	OK	1.000	1.000	737	2214	1	2211	737	1	737
IKAKEN	BC002604	MGC14-F07	MGC	W01C050L13	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002604	MGC14-F07	MGC	W01C050L14	pDONR221	5572		RPS26	6231	AAH02604.1	Hs.719141	Ribosomal protein S26			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001029.3	NP_001020.2	REVIEWED		0.948	0.948	115	348	1	345	115	1	115
IKAKEN	BC002618	MGC14-F08	MGC	W01C050L15	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC002618	MGC14-F08	MGC	W01C050L16	pDONR221	12911		STK16	8576	AAH02618.1	Hs.153003	Serine/threonine kinase 16			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_003691.2	NP_003682.2	VALIDATED	C	1.000	1.000	305	918	1	915	305	1	305
IKAKEN	BC001441	MGC14-F09	MGC	W01C050L17	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001441	MGC14-F09	MGC	W01C050L18	pDONR221	18532		SKP2	6502	AAH01441.1	Hs.23348	S-phase kinase-associated protein 2 (p45)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032637.2	NP_116026.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	BC001405	MGC14-F10	MGC	W01C050L19	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC001405	MGC14-F10	MGC	W01C050L20	pDONR221	21341		UPP1	7378	AAH01405.1	Hs.488240	Uridine phosphorylase 1			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_003364.2	NP_003355.1	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC002600	MGC14-F11	MGC	W01C050L21	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002600	MGC14-F11	MGC	W01C050L22	pDONR221	25385		MTCP1NB	100272147	AAH02600.1	Hs.6917	Mature T-cell proliferation 1 neighbor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_001018024.2	NP_001018024.1	REVIEWED	OK	1.000	1.000	68	207	1	204	68	1	68
IKAKEN	BC002613	MGC14-F12	MGC	W01C050L23	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC002613	MGC14-F12	MGC	W01C050L24	pDONR221	23755		C9orf142	286257	AAH02613.2	Hs.409582	Chromosome 9 open reading frame 142			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_183241.1	NP_899064.1	PREDICTED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	BC008767	MGC14-G01	MGC	W01C050M01	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	MGC14-G01	MGC	W01C050M02	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	MGC14-G02	MGC	W01C050M03	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	MGC14-G02	MGC	W01C050M04	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC002607	MGC14-G03	MGC	W01C050M05	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002607	MGC14-G03	MGC	W01C050M06	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002489	MGC14-G04	MGC	W01C050M07	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC002489	MGC14-G04	MGC	W01C050M08	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC040679	MGC14-G05	MGC	W01C050M09	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC040679	MGC14-G05	MGC	W01C050M10	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC002532	MGC14-G06	MGC	W01C050M11	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC002532	MGC14-G06	MGC	W01C050M12	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC006212	MGC14-G07	MGC	W01C050M13	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC006212	MGC14-G07	MGC	W01C050M14	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC000606	MGC14-G08	MGC	W01C050M15	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000606	MGC14-G08	MGC	W01C050M16	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000556	MGC14-G09	MGC	W01C050M17	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000556	MGC14-G09	MGC	W01C050M18	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008743	MGC14-G10	MGC	W01C050M19	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC008743	MGC14-G10	MGC	W01C050M20	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC000684	MGC14-G11	MGC	W01C050M21	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC000684	MGC14-G11	MGC	W01C050M22	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC008741	MGC14-G12	MGC	W01C050M23	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC008741	MGC14-G12	MGC	W01C050M24	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC008767	MGC14-G01	MGC	W01C050N01	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC008767	MGC14-G01	MGC	W01C050N02	pDONR221	10608		ACOX1	51	AAH08767.1	Hs.464137	Acyl-Coenzyme A oxidase 1, palmitoyl			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004035.5	NP_004026.2	REVIEWED	OK	1.000	1.000	660	1983	1	1980	660	1	660
IKAKEN	BC001460	MGC14-G02	MGC	W01C050N03	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC001460	MGC14-G02	MGC	W01C050N04	pDONR221	18492		LARP1	23367	AAH01460.2	Hs.292078	La ribonucleoprotein domain family, member 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_015315.3	NP_056130.2	VALIDATED	OK	1.000	1.000	1019	3060	1	3057	1019	1	1019
IKAKEN	BC002607	MGC14-G03	MGC	W01C050N05	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002607	MGC14-G03	MGC	W01C050N06	pDONR221	7345		BEGAIN	57596	AAH02607.1	Hs.211751	Brain-enriched guanylate kinase-associated homolog (rat)			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001159531.1	NP_001153003.1	VALIDATED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	BC002489	MGC14-G04	MGC	W01C050N07	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC002489	MGC14-G04	MGC	W01C050N08	pDONR221	17954		WDR1	9948	AAH02489.1	Hs.128548	WD repeat domain 1			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005112.4	NP_005103.2	REVIEWED	Ps	0.998	0.998	422	1533	265	1530	466	45	466
IKAKEN	BC040679	MGC14-G05	MGC	W01C050N09	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC040679	MGC14-G05	MGC	W01C050N10	pDONR221	7575		RAB15	376267	AAH40679.2	Hs.512492	RAB15, member RAS onocogene family			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198686.2	NP_941959.1	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC002532	MGC14-G06	MGC	W01C050N11	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC002532	MGC14-G06	MGC	W01C050N12	pDONR221	7541		NPC2	10577	AAH02532.1	Hs.433222	Niemann-Pick disease, type C2			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006432.3	NP_006423.1	REVIEWED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC006212	MGC14-G07	MGC	W01C050N13	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC006212	MGC14-G07	MGC	W01C050N14	pDONR221	2603		LZTS2	84445	AAH06212.2	Hs.523221	Leucine zipper, putative tumor suppressor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_032429.1	NP_115805.1	PROVISIONAL	OK	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	BC000606	MGC14-G08	MGC	W01C050N15	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000606	MGC14-G08	MGC	W01C050N16	pDONR221	5532		RPL14	9045	AAH00606.1	Hs.719095	Ribosomal protein L14			Testis	NIH_MGC_97	DH10B	NM_003973.3	NP_003964.3	REVIEWED	OK	1.000	1.000	215	648	1	645	215	1	215
IKAKEN	BC000556	MGC14-G09	MGC	W01C050N17	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC000556	MGC14-G09	MGC	W01C050N18	pDONR221	21260		MEPCE	56257	AAH00556.2	Hs.178011	Methylphosphate capping enzyme			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_019606.4	NP_062552.2	PROVISIONAL	OK	1.000	1.000	689	2070	1	2067	689	1	689
IKAKEN	BC008743	MGC14-G10	MGC	W01C050N19	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC008743	MGC14-G10	MGC	W01C050N20	pDONR221	21369		ZYX	7791	AAH08743.1	Hs.490415	Zyxin			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001010972.1	NP_001010972.1	REVIEWED	OK	1.000	1.000	572	1719	1	1716	572	1	572
IKAKEN	BC000684	MGC14-G11	MGC	W01C050N21	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC000684	MGC14-G11	MGC	W01C050N22	pDONR221	22130		PDAP1	11333	AAH00684.1	Hs.632296	PDGFA associated protein 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_014891.5	NP_055706.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC008741	MGC14-G12	MGC	W01C050N23	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC008741	MGC14-G12	MGC	W01C050N24	pDONR221	17466		PDLIM5	10611	AAH08741.1	Hs.480311	PDZ and LIM domain 5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_006457.3	NP_006448.3	REVIEWED	OK	1.000	1.000	596	1791	1	1788	596	1	596
IKAKEN	BC000615	MGC14-H01	MGC	W01C050O01	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000615	MGC14-H01	MGC	W01C050O02	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000576	MGC14-H02	MGC	W01C050O03	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000576	MGC14-H02	MGC	W01C050O04	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000616	MGC14-H03	MGC	W01C050O05	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	MGC14-H03	MGC	W01C050O06	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC008765	MGC14-H04	MGC	W01C050O07	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC008765	MGC14-H04	MGC	W01C050O08	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC000662	MGC14-H05	MGC	W01C050O09	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000662	MGC14-H05	MGC	W01C050O10	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000601	MGC14-H06	MGC	W01C050O11	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC000601	MGC14-H06	MGC	W01C050O12	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC002477	MGC14-H07	MGC	W01C050O13	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC002477	MGC14-H07	MGC	W01C050O14	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC000687	MGC14-H08	MGC	W01C050O15	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC000687	MGC14-H08	MGC	W01C050O16	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC002427	MGC14-H09	MGC	W01C050O17	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC002427	MGC14-H09	MGC	W01C050O18	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC000663	MGC14-H10	MGC	W01C050O19	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC000663	MGC14-H10	MGC	W01C050O20	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC002462	MGC14-H11	MGC	W01C050O21	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC002462	MGC14-H11	MGC	W01C050O22	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC000590	MGC14-H12	MGC	W01C050O23	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	MGC14-H12	MGC	W01C050O24	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000615	MGC14-H01	MGC	W01C050P01	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000615	MGC14-H01	MGC	W01C050P02	pDONR221	11900		DDA1	79016	AAH00615.1	Hs.706814	DET1 and DDB1 associated 1			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_024050.5	NP_076955.1	VALIDATED	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	BC000576	MGC14-H02	MGC	W01C050P03	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000576	MGC14-H02	MGC	W01C050P04	pDONR221	18220		QDPR	5860	AAH00576.1	Hs.75438	Quinoid dihydropteridine reductase			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_000320.2	NP_000311.2	REVIEWED	OK	1.000	1.000	244	735	1	732	244	1	244
IKAKEN	BC000616	MGC14-H03	MGC	W01C050P05	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	MGC14-H03	MGC	W01C050P06	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC008765	MGC14-H04	MGC	W01C050P07	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC008765	MGC14-H04	MGC	W01C050P08	pDONR221	14037		SDC1	6382	AAH08765.1	Hs.224607	Syndecan 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002997.4	NP_002988.3	REVIEWED	Cs	0.997	0.997	310	933	1	930	310	1	310
IKAKEN	BC000662	MGC14-H05	MGC	W01C050P09	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000662	MGC14-H05	MGC	W01C050P10	pDONR221	8907		METRN	79006	AAH00662.1	Hs.533772	Meteorin, glial cell differentiation regulator			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_024042.2	NP_076947.1	VALIDATED	OK	1.000	1.000	293	882	1	879	293	1	293
IKAKEN	BC000601	MGC14-H06	MGC	W01C050P11	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC000601	MGC14-H06	MGC	W01C050P12	pDONR221	16882		HIGD1A	25994	AAH00601.1	Hs.719119	HIG1 hypoxia inducible domain family, member 1A			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014056.3	NP_054775.2	VALIDATED		0.978	0.978	93	282	1	279	93	1	93
IKAKEN	BC002477	MGC14-H07	MGC	W01C050P13	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC002477	MGC14-H07	MGC	W01C050P14	pDONR221	2724		DHTKD1	55526	AAH02477.1	Hs.104980	Dehydrogenase E1 and transketolase domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_018706.5	NP_061176.3	VALIDATED	Cs	0.999	0.999	919	2760	1	2757	919	1	919
IKAKEN	BC000687	MGC14-H08	MGC	W01C050P15	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC000687	MGC14-H08	MGC	W01C050P16	pDONR221	23224		TRAM1	23471	AAH00687.1	Hs.491988	Translocation associated membrane protein 1			Kidney	NIH_MGC_75	DH10B	NM_014294.4	NP_055109.1	PROVISIONAL	OK	1.000	1.000	374	1125	1	1122	374	1	374
IKAKEN	BC002427	MGC14-H09	MGC	W01C050P17	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC002427	MGC14-H09	MGC	W01C050P18	pDONR221	21208		CASP2	835	AAH02427.2	Hs.368982	Caspase 2, apoptosis-related cysteine peptidase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_032982.2	NP_116764.2	REVIEWED	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	BC000663	MGC14-H10	MGC	W01C050P19	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC000663	MGC14-H10	MGC	W01C050P20	pDONR221	7194		DHRS4L2	317749	AAH00663.2					Brain, adult medulla	NIH_MGC_119	DH10B	NM_198083.2	NP_932349.2	VALIDATED	P	1.000	1.000	230	693	1	690	232	3	232
IKAKEN	BC002462	MGC14-H11	MGC	W01C050P21	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC002462	MGC14-H11	MGC	W01C050P22	pDONR221	885		CCDC28B	79140	AAH02462	Hs.718470	Coiled-coil domain containing 28B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024296.3	NP_077272.2	REVIEWED	Ps	0.995	0.995	183	726	1	549	200	1	183
IKAKEN	BC000590	MGC14-H12	MGC	W01C050P23	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC000590	MGC14-H12	MGC	W01C050P24	pDONR221	13043		ARPC2	10109	AAH00590.1	Hs.529303	Actin related protein 2/3 complex, subunit 2, 34kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_005731.2	NP_005722.1	REVIEWED	Pfs	0.985	1.000	206	621	1	619	300	56	258
IKAKEN	BC011865	MGC15-A01	MGC	W01C051A01	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC011865	MGC15-A01	MGC	W01C051A02	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC014036	MGC15-A02	MGC	W01C051A03	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC014036	MGC15-A02	MGC	W01C051A04	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC011912	MGC15-A03	MGC	W01C051A05	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC011912	MGC15-A03	MGC	W01C051A06	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC012093	MGC15-A04	MGC	W01C051A07	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012093	MGC15-A04	MGC	W01C051A08	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012332	MGC15-A05	MGC	W01C051A09	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012332	MGC15-A05	MGC	W01C051A10	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012177	MGC15-A06	MGC	W01C051A11	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC012177	MGC15-A06	MGC	W01C051A12	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC011561	MGC15-A07	MGC	W01C051A13	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC011561	MGC15-A07	MGC	W01C051A14	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC015921	MGC15-A08	MGC	W01C051A15	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC015921	MGC15-A08	MGC	W01C051A16	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC012064	MGC15-A09	MGC	W01C051A17	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC012064	MGC15-A09	MGC	W01C051A18	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC014652	MGC15-A10	MGC	W01C051A19	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC014652	MGC15-A10	MGC	W01C051A20	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC012065	MGC15-A11	MGC	W01C051A21	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012065	MGC15-A11	MGC	W01C051A22	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012185	MGC15-A12	MGC	W01C051A23	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC012185	MGC15-A12	MGC	W01C051A24	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC011865	MGC15-A01	MGC	W01C051B01	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC011865	MGC15-A01	MGC	W01C051B02	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC014036	MGC15-A02	MGC	W01C051B03	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC014036	MGC15-A02	MGC	W01C051B04	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC011912	MGC15-A03	MGC	W01C051B05	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC011912	MGC15-A03	MGC	W01C051B06	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC012093	MGC15-A04	MGC	W01C051B07	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012093	MGC15-A04	MGC	W01C051B08	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012332	MGC15-A05	MGC	W01C051B09	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012332	MGC15-A05	MGC	W01C051B10	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012177	MGC15-A06	MGC	W01C051B11	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC012177	MGC15-A06	MGC	W01C051B12	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC011561	MGC15-A07	MGC	W01C051B13	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC011561	MGC15-A07	MGC	W01C051B14	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC015921	MGC15-A08	MGC	W01C051B15	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC015921	MGC15-A08	MGC	W01C051B16	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC012064	MGC15-A09	MGC	W01C051B17	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC012064	MGC15-A09	MGC	W01C051B18	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC014652	MGC15-A10	MGC	W01C051B19	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC014652	MGC15-A10	MGC	W01C051B20	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC012065	MGC15-A11	MGC	W01C051B21	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012065	MGC15-A11	MGC	W01C051B22	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012185	MGC15-A12	MGC	W01C051B23	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC012185	MGC15-A12	MGC	W01C051B24	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC011553	MGC15-B01	MGC	W01C051C01	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC011553	MGC15-B01	MGC	W01C051C02	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC012170	MGC15-B02	MGC	W01C051C03	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012170	MGC15-B02	MGC	W01C051C04	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012180	MGC15-B03	MGC	W01C051C05	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC012180	MGC15-B03	MGC	W01C051C06	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC025927	MGC15-B04	MGC	W01C051C07	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC025927	MGC15-B04	MGC	W01C051C08	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC012355	MGC15-B05	MGC	W01C051C09	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC012355	MGC15-B05	MGC	W01C051C10	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC011585	MGC15-B06	MGC	W01C051C11	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011585	MGC15-B06	MGC	W01C051C12	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011549	MGC15-B07	MGC	W01C051C13	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC011549	MGC15-B07	MGC	W01C051C14	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC012142	MGC15-B08	MGC	W01C051C15	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012142	MGC15-B08	MGC	W01C051C16	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012178	MGC15-B09	MGC	W01C051C17	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC012178	MGC15-B09	MGC	W01C051C18	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC014417	MGC15-B10	MGC	W01C051C19	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC014417	MGC15-B10	MGC	W01C051C20	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC033537	MGC15-B11	MGC	W01C051C21	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC033537	MGC15-B11	MGC	W01C051C22	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC023576	MGC15-B12	MGC	W01C051C23	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC023576	MGC15-B12	MGC	W01C051C24	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC011553	MGC15-B01	MGC	W01C051D01	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC011553	MGC15-B01	MGC	W01C051D02	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC012170	MGC15-B02	MGC	W01C051D03	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012170	MGC15-B02	MGC	W01C051D04	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012180	MGC15-B03	MGC	W01C051D05	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC012180	MGC15-B03	MGC	W01C051D06	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC025927	MGC15-B04	MGC	W01C051D07	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC025927	MGC15-B04	MGC	W01C051D08	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC012355	MGC15-B05	MGC	W01C051D09	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC012355	MGC15-B05	MGC	W01C051D10	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC011585	MGC15-B06	MGC	W01C051D11	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011585	MGC15-B06	MGC	W01C051D12	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011549	MGC15-B07	MGC	W01C051D13	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC011549	MGC15-B07	MGC	W01C051D14	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC012142	MGC15-B08	MGC	W01C051D15	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012142	MGC15-B08	MGC	W01C051D16	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012178	MGC15-B09	MGC	W01C051D17	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC012178	MGC15-B09	MGC	W01C051D18	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC014417	MGC15-B10	MGC	W01C051D19	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC014417	MGC15-B10	MGC	W01C051D20	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC033537	MGC15-B11	MGC	W01C051D21	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC033537	MGC15-B11	MGC	W01C051D22	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC023576	MGC15-B12	MGC	W01C051D23	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC023576	MGC15-B12	MGC	W01C051D24	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC014176	MGC15-C01	MGC	W01C051E01	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014176	MGC15-C01	MGC	W01C051E02	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014132	MGC15-C02	MGC	W01C051E03	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014132	MGC15-C02	MGC	W01C051E04	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014209	MGC15-C03	MGC	W01C051E05	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC014209	MGC15-C03	MGC	W01C051E06	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC035501	MGC15-C04	MGC	W01C051E07	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC035501	MGC15-C04	MGC	W01C051E08	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC014139	MGC15-C05	MGC	W01C051E09	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC014139	MGC15-C05	MGC	W01C051E10	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC030143	MGC15-C06	MGC	W01C051E11	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC030143	MGC15-C06	MGC	W01C051E12	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC019035	MGC15-C07	MGC	W01C051E13	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019035	MGC15-C07	MGC	W01C051E14	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019040	MGC15-C08	MGC	W01C051E15	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC019040	MGC15-C08	MGC	W01C051E16	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC014259	MGC15-C09	MGC	W01C051E17	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014259	MGC15-C09	MGC	W01C051E18	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014245	MGC15-C10	MGC	W01C051E19	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014245	MGC15-C10	MGC	W01C051E20	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014109	MGC15-C11	MGC	W01C051E21	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014109	MGC15-C11	MGC	W01C051E22	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014144	MGC15-C12	MGC	W01C051E23	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC014144	MGC15-C12	MGC	W01C051E24	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC014176	MGC15-C01	MGC	W01C051F01	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014176	MGC15-C01	MGC	W01C051F02	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014132	MGC15-C02	MGC	W01C051F03	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014132	MGC15-C02	MGC	W01C051F04	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014209	MGC15-C03	MGC	W01C051F05	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC014209	MGC15-C03	MGC	W01C051F06	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC035501	MGC15-C04	MGC	W01C051F07	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC035501	MGC15-C04	MGC	W01C051F08	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC014139	MGC15-C05	MGC	W01C051F09	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC014139	MGC15-C05	MGC	W01C051F10	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC030143	MGC15-C06	MGC	W01C051F11	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC030143	MGC15-C06	MGC	W01C051F12	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC019035	MGC15-C07	MGC	W01C051F13	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019035	MGC15-C07	MGC	W01C051F14	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019040	MGC15-C08	MGC	W01C051F15	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC019040	MGC15-C08	MGC	W01C051F16	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC014259	MGC15-C09	MGC	W01C051F17	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014259	MGC15-C09	MGC	W01C051F18	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014245	MGC15-C10	MGC	W01C051F19	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014245	MGC15-C10	MGC	W01C051F20	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014109	MGC15-C11	MGC	W01C051F21	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014109	MGC15-C11	MGC	W01C051F22	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014144	MGC15-C12	MGC	W01C051F23	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC014144	MGC15-C12	MGC	W01C051F24	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC030141	MGC15-D01	MGC	W01C051G01	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC030141	MGC15-D01	MGC	W01C051G02	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC015655	MGC15-D02	MGC	W01C051G03	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC015655	MGC15-D02	MGC	W01C051G04	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC014262	MGC15-D03	MGC	W01C051G05	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC014262	MGC15-D03	MGC	W01C051G06	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC015581	MGC15-D04	MGC	W01C051G07	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	MGC15-D04	MGC	W01C051G08	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	MGC15-D05	MGC	W01C051G09	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	MGC15-D05	MGC	W01C051G10	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	MGC15-D06	MGC	W01C051G11	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	MGC15-D06	MGC	W01C051G12	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015639	MGC15-D07	MGC	W01C051G13	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC015639	MGC15-D07	MGC	W01C051G14	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC032108	MGC15-D08	MGC	W01C051G15	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	MGC15-D08	MGC	W01C051G16	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC023582	MGC15-D09	MGC	W01C051G17	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC023582	MGC15-D09	MGC	W01C051G18	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC015649	MGC15-D10	MGC	W01C051G19	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC015649	MGC15-D10	MGC	W01C051G20	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC023586	MGC15-D11	MGC	W01C051G21	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC023586	MGC15-D11	MGC	W01C051G22	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC014465	MGC15-D12	MGC	W01C051G23	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC014465	MGC15-D12	MGC	W01C051G24	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC030141	MGC15-D01	MGC	W01C051H01	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC030141	MGC15-D01	MGC	W01C051H02	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC015655	MGC15-D02	MGC	W01C051H03	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC015655	MGC15-D02	MGC	W01C051H04	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC014262	MGC15-D03	MGC	W01C051H05	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC014262	MGC15-D03	MGC	W01C051H06	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC015581	MGC15-D04	MGC	W01C051H07	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	MGC15-D04	MGC	W01C051H08	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	MGC15-D05	MGC	W01C051H09	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	MGC15-D05	MGC	W01C051H10	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	MGC15-D06	MGC	W01C051H11	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	MGC15-D06	MGC	W01C051H12	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015639	MGC15-D07	MGC	W01C051H13	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC015639	MGC15-D07	MGC	W01C051H14	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC032108	MGC15-D08	MGC	W01C051H15	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	MGC15-D08	MGC	W01C051H16	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC023582	MGC15-D09	MGC	W01C051H17	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC023582	MGC15-D09	MGC	W01C051H18	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC015649	MGC15-D10	MGC	W01C051H19	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC015649	MGC15-D10	MGC	W01C051H20	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC023586	MGC15-D11	MGC	W01C051H21	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC023586	MGC15-D11	MGC	W01C051H22	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC014465	MGC15-D12	MGC	W01C051H23	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC014465	MGC15-D12	MGC	W01C051H24	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC014945	MGC15-E01	MGC	W01C051I01	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC014945	MGC15-E01	MGC	W01C051I02	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC042592	MGC15-E02	MGC	W01C051I03	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC042592	MGC15-E02	MGC	W01C051I04	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC014474	MGC15-E04	MGC	W01C051I07	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC014474	MGC15-E04	MGC	W01C051I08	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC015744	MGC15-E05	MGC	W01C051I09	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC015744	MGC15-E05	MGC	W01C051I10	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC041860	MGC15-E06	MGC	W01C051I11	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC041860	MGC15-E06	MGC	W01C051I12	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC014668	MGC15-E07	MGC	W01C051I13	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014668	MGC15-E07	MGC	W01C051I14	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014986	MGC15-E08	MGC	W01C051I15	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014986	MGC15-E08	MGC	W01C051I16	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014980	MGC15-E09	MGC	W01C051I17	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	MGC15-E09	MGC	W01C051I18	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014508	MGC15-E10	MGC	W01C051I19	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC014508	MGC15-E10	MGC	W01C051I20	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC015773	MGC15-E11	MGC	W01C051I21	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC015773	MGC15-E11	MGC	W01C051I22	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC014455	MGC15-E12	MGC	W01C051I23	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC014455	MGC15-E12	MGC	W01C051I24	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC014945	MGC15-E01	MGC	W01C051J01	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC014945	MGC15-E01	MGC	W01C051J02	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC042592	MGC15-E02	MGC	W01C051J03	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC042592	MGC15-E02	MGC	W01C051J04	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC014474	MGC15-E04	MGC	W01C051J07	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC014474	MGC15-E04	MGC	W01C051J08	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC015744	MGC15-E05	MGC	W01C051J09	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC015744	MGC15-E05	MGC	W01C051J10	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC041860	MGC15-E06	MGC	W01C051J11	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC041860	MGC15-E06	MGC	W01C051J12	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC014668	MGC15-E07	MGC	W01C051J13	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014668	MGC15-E07	MGC	W01C051J14	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014986	MGC15-E08	MGC	W01C051J15	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014986	MGC15-E08	MGC	W01C051J16	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014980	MGC15-E09	MGC	W01C051J17	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	MGC15-E09	MGC	W01C051J18	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014508	MGC15-E10	MGC	W01C051J19	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC014508	MGC15-E10	MGC	W01C051J20	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC015773	MGC15-E11	MGC	W01C051J21	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC015773	MGC15-E11	MGC	W01C051J22	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC014455	MGC15-E12	MGC	W01C051J23	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC014455	MGC15-E12	MGC	W01C051J24	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC021294	MGC15-F01	MGC	W01C051K01	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC021294	MGC15-F01	MGC	W01C051K02	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC023638	MGC15-F02	MGC	W01C051K03	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC023638	MGC15-F02	MGC	W01C051K04	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC017280	MGC15-F03	MGC	W01C051K05	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC017280	MGC15-F03	MGC	W01C051K06	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC023645	MGC15-F04	MGC	W01C051K07	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC023645	MGC15-F04	MGC	W01C051K08	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC032147	MGC15-F05	MGC	W01C051K09	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC032147	MGC15-F05	MGC	W01C051K10	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC027734	MGC15-F06	MGC	W01C051K11	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC027734	MGC15-F06	MGC	W01C051K12	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC032148	MGC15-F07	MGC	W01C051K13	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC032148	MGC15-F07	MGC	W01C051K14	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC017310	MGC15-F08	MGC	W01C051K15	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC017310	MGC15-F08	MGC	W01C051K16	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC035511	MGC15-F09	MGC	W01C051K17	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC035511	MGC15-F09	MGC	W01C051K18	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC017327	MGC15-F10	MGC	W01C051K19	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC017327	MGC15-F10	MGC	W01C051K20	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC021557	MGC15-F11	MGC	W01C051K21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	MGC15-F11	MGC	W01C051K22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	MGC15-F12	MGC	W01C051K23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	MGC15-F12	MGC	W01C051K24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC021294	MGC15-F01	MGC	W01C051L01	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC021294	MGC15-F01	MGC	W01C051L02	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC023638	MGC15-F02	MGC	W01C051L03	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC023638	MGC15-F02	MGC	W01C051L04	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC017280	MGC15-F03	MGC	W01C051L05	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC017280	MGC15-F03	MGC	W01C051L06	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC023645	MGC15-F04	MGC	W01C051L07	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC023645	MGC15-F04	MGC	W01C051L08	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC032147	MGC15-F05	MGC	W01C051L09	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC032147	MGC15-F05	MGC	W01C051L10	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC027734	MGC15-F06	MGC	W01C051L11	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC027734	MGC15-F06	MGC	W01C051L12	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC032148	MGC15-F07	MGC	W01C051L13	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC032148	MGC15-F07	MGC	W01C051L14	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC017310	MGC15-F08	MGC	W01C051L15	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC017310	MGC15-F08	MGC	W01C051L16	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC035511	MGC15-F09	MGC	W01C051L17	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC035511	MGC15-F09	MGC	W01C051L18	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC017327	MGC15-F10	MGC	W01C051L19	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC017327	MGC15-F10	MGC	W01C051L20	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC021557	MGC15-F11	MGC	W01C051L21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	MGC15-F11	MGC	W01C051L22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	MGC15-F12	MGC	W01C051L23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	MGC15-F12	MGC	W01C051L24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018771	MGC15-G01	MGC	W01C051M01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	MGC15-G01	MGC	W01C051M02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	MGC15-G02	MGC	W01C051M03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	MGC15-G02	MGC	W01C051M04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	MGC15-G03	MGC	W01C051M05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	MGC15-G03	MGC	W01C051M06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC028840	MGC15-G04	MGC	W01C051M07	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC028840	MGC15-G04	MGC	W01C051M08	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC031300	MGC15-G05	MGC	W01C051M09	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC031300	MGC15-G05	MGC	W01C051M10	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC025311	MGC15-G06	MGC	W01C051M11	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC025311	MGC15-G06	MGC	W01C051M12	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC022796	MGC15-G07	MGC	W01C051M13	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC022796	MGC15-G07	MGC	W01C051M14	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC025327	MGC15-G08	MGC	W01C051M15	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025327	MGC15-G08	MGC	W01C051M16	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025959	MGC15-G09	MGC	W01C051M17	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC025959	MGC15-G09	MGC	W01C051M18	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC026041	MGC15-G10	MGC	W01C051M19	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC026041	MGC15-G10	MGC	W01C051M20	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC031301	MGC15-G11	MGC	W01C051M21	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	MGC15-G11	MGC	W01C051M22	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC022819	MGC15-G12	MGC	W01C051M23	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC022819	MGC15-G12	MGC	W01C051M24	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC018771	MGC15-G01	MGC	W01C051N01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	MGC15-G01	MGC	W01C051N02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	MGC15-G02	MGC	W01C051N03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	MGC15-G02	MGC	W01C051N04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	MGC15-G03	MGC	W01C051N05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	MGC15-G03	MGC	W01C051N06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC028840	MGC15-G04	MGC	W01C051N07	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC028840	MGC15-G04	MGC	W01C051N08	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC031300	MGC15-G05	MGC	W01C051N09	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC031300	MGC15-G05	MGC	W01C051N10	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC025311	MGC15-G06	MGC	W01C051N11	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC025311	MGC15-G06	MGC	W01C051N12	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC022796	MGC15-G07	MGC	W01C051N13	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC022796	MGC15-G07	MGC	W01C051N14	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC025327	MGC15-G08	MGC	W01C051N15	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025327	MGC15-G08	MGC	W01C051N16	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025959	MGC15-G09	MGC	W01C051N17	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC025959	MGC15-G09	MGC	W01C051N18	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC026041	MGC15-G10	MGC	W01C051N19	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC026041	MGC15-G10	MGC	W01C051N20	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC031301	MGC15-G11	MGC	W01C051N21	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	MGC15-G11	MGC	W01C051N22	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC022819	MGC15-G12	MGC	W01C051N23	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC022819	MGC15-G12	MGC	W01C051N24	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC033082	MGC15-H01	MGC	W01C051O01	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	MGC15-H01	MGC	W01C051O02	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	MGC15-H02	MGC	W01C051O03	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	MGC15-H02	MGC	W01C051O04	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033239	MGC15-H03	MGC	W01C051O05	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033239	MGC15-H03	MGC	W01C051O06	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033113	MGC15-H04	MGC	W01C051O07	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033113	MGC15-H04	MGC	W01C051O08	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033237	MGC15-H05	MGC	W01C051O09	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033237	MGC15-H05	MGC	W01C051O10	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033154	MGC15-H06	MGC	W01C051O11	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC033154	MGC15-H06	MGC	W01C051O12	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC042943	MGC15-H07	MGC	W01C051O13	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC042943	MGC15-H07	MGC	W01C051O14	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC033103	MGC15-H08	MGC	W01C051O15	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	MGC15-H08	MGC	W01C051O16	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC031334	MGC15-H09	MGC	W01C051O17	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC031334	MGC15-H09	MGC	W01C051O18	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033213	MGC15-H10	MGC	W01C051O19	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033213	MGC15-H10	MGC	W01C051O20	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033195	MGC15-H11	MGC	W01C051O21	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033195	MGC15-H11	MGC	W01C051O22	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033073	MGC15-H12	MGC	W01C051O23	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	BC033073	MGC15-H12	MGC	W01C051O24	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	BC033082	MGC15-H01	MGC	W01C051P01	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	MGC15-H01	MGC	W01C051P02	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	MGC15-H02	MGC	W01C051P03	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	MGC15-H02	MGC	W01C051P04	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033239	MGC15-H03	MGC	W01C051P05	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033239	MGC15-H03	MGC	W01C051P06	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033113	MGC15-H04	MGC	W01C051P07	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033113	MGC15-H04	MGC	W01C051P08	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033237	MGC15-H05	MGC	W01C051P09	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033237	MGC15-H05	MGC	W01C051P10	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033154	MGC15-H06	MGC	W01C051P11	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC033154	MGC15-H06	MGC	W01C051P12	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC042943	MGC15-H07	MGC	W01C051P13	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC042943	MGC15-H07	MGC	W01C051P14	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC033103	MGC15-H08	MGC	W01C051P15	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	MGC15-H08	MGC	W01C051P16	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC031334	MGC15-H09	MGC	W01C051P17	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC031334	MGC15-H09	MGC	W01C051P18	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033213	MGC15-H10	MGC	W01C051P19	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033213	MGC15-H10	MGC	W01C051P20	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033195	MGC15-H11	MGC	W01C051P21	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033195	MGC15-H11	MGC	W01C051P22	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033073	MGC15-H12	MGC	W01C051P23	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	BC033073	MGC15-H12	MGC	W01C051P24	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	BC011865	MGC15-A01	MGC	W01C052A01	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC011865	MGC15-A01	MGC	W01C052A02	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC014036	MGC15-A02	MGC	W01C052A03	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC014036	MGC15-A02	MGC	W01C052A04	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC011912	MGC15-A03	MGC	W01C052A05	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC011912	MGC15-A03	MGC	W01C052A06	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC012093	MGC15-A04	MGC	W01C052A07	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012093	MGC15-A04	MGC	W01C052A08	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012332	MGC15-A05	MGC	W01C052A09	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012332	MGC15-A05	MGC	W01C052A10	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012177	MGC15-A06	MGC	W01C052A11	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC012177	MGC15-A06	MGC	W01C052A12	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC011561	MGC15-A07	MGC	W01C052A13	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC011561	MGC15-A07	MGC	W01C052A14	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC015921	MGC15-A08	MGC	W01C052A15	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC015921	MGC15-A08	MGC	W01C052A16	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC012064	MGC15-A09	MGC	W01C052A17	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC012064	MGC15-A09	MGC	W01C052A18	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC014652	MGC15-A10	MGC	W01C052A19	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC014652	MGC15-A10	MGC	W01C052A20	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC012065	MGC15-A11	MGC	W01C052A21	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012065	MGC15-A11	MGC	W01C052A22	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012185	MGC15-A12	MGC	W01C052A23	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC012185	MGC15-A12	MGC	W01C052A24	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC011865	MGC15-A01	MGC	W01C052B01	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC011865	MGC15-A01	MGC	W01C052B02	pDONR221	10670		JUP	3728	AAH11865.1	Hs.514174	Junction plakoglobin			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_021991.2	NP_068831.1	REVIEWED	OK	1.000	1.000	745	2238	1	2235	745	1	745
IKAKEN	BC014036	MGC15-A02	MGC	W01C052B03	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC014036	MGC15-A02	MGC	W01C052B04	pDONR221	24879		PHKA2	5256	AAH14036.1	Hs.622882	Phosphorylase kinase, alpha 2 (liver)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_000292.2	NP_000283.1	VALIDATED	OK	1.000	1.000	1235	3708	1	3705	1235	1	1235
IKAKEN	BC011912	MGC15-A03	MGC	W01C052B05	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC011912	MGC15-A03	MGC	W01C052B06	pDONR221	20465		DTNBP1	84062	AAH11912.1	Hs.571148	Dystrobrevin binding protein 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_032122.3	NP_115498.2	REVIEWED	OK	1.000	1.000	351	1056	1	1053	351	1	351
IKAKEN	BC012093	MGC15-A04	MGC	W01C052B07	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012093	MGC15-A04	MGC	W01C052B08	pDONR221	21		ZMYM4	9202	AAH12093.2	Hs.269211	Zinc finger, MYM-type 4			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_005095.2	NP_005086.2	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1548	325	1548
IKAKEN	BC012332	MGC15-A05	MGC	W01C052B09	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012332	MGC15-A05	MGC	W01C052B10	pDONR221	10039		FBF1	85302	AAH12332.2	Hs.442609	Fas (TNFRSF6) binding factor 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001080542.1	NP_001074011.1	PROVISIONAL	Pgs	0.995	0.996	805	2418	1	2415	1133	330	1133
IKAKEN	BC012177	MGC15-A06	MGC	W01C052B11	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC012177	MGC15-A06	MGC	W01C052B12	pDONR221	19703		FAM120B	84498	AAH12177.1	Hs.369522	Family with sequence similarity 120B			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_032448.1	NP_115824.1	PROVISIONAL	C	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	BC011561	MGC15-A07	MGC	W01C052B13	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC011561	MGC15-A07	MGC	W01C052B14	pDONR221	24502		HEPH	9843	AAH11561.1	Hs.31720	Hephaestin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_014799.2	NP_055614.1	REVIEWED	C	1.000	1.000	891	3477	802	3474	891	1	891
IKAKEN	BC015921	MGC15-A08	MGC	W01C052B15	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC015921	MGC15-A08	MGC	W01C052B16	pDONR221	12329		LENG9	94059	AAH15921.1	Hs.590976	Leukocyte receptor cluster (LRC) member 9			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_198988.1	NP_945339.2	VALIDATED	P	1.000	1.000	479	1440	1	1437	501	23	501
IKAKEN	BC012064	MGC15-A09	MGC	W01C052B17	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC012064	MGC15-A09	MGC	W01C052B18	pDONR221	23654		PCSK5	5125	AAH12064.1	Hs.368542	Proprotein convertase subtilisin/kexin type 5			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_006200.3	NP_006191.2	REVIEWED	OK	1.000	1.000	913	2742	1	2739	913	1	913
IKAKEN	BC014652	MGC15-A10	MGC	W01C052B19	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC014652	MGC15-A10	MGC	W01C052B20	pDONR221	15946		LMF2	91289	AAH14652.1	Hs.150540	Lipase maturation factor 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_033200.1	NP_149977.1	PROVISIONAL	C	1.000	1.000	682	2049	1	2046	682	1	682
IKAKEN	BC012065	MGC15-A11	MGC	W01C052B21	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012065	MGC15-A11	MGC	W01C052B22	pDONR221	3823		TMEM126B	55863	AAH12065.1	Hs.525063	Transmembrane protein 126B			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_018480.2	NP_060950.2	PROVISIONAL	OK	1.000	1.000	200	603	1	600	200	1	200
IKAKEN	BC012185	MGC15-A12	MGC	W01C052B23	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC012185	MGC15-A12	MGC	W01C052B24	pDONR221	20773		HIST1H3G	8355	AAH12185	Hs.247813	Histone cluster 1, H3g			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_003534.2	NP_003525.1	REVIEWED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BC011553	MGC15-B01	MGC	W01C052C01	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC011553	MGC15-B01	MGC	W01C052C02	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC012170	MGC15-B02	MGC	W01C052C03	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012170	MGC15-B02	MGC	W01C052C04	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012180	MGC15-B03	MGC	W01C052C05	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC012180	MGC15-B03	MGC	W01C052C06	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC025927	MGC15-B04	MGC	W01C052C07	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC025927	MGC15-B04	MGC	W01C052C08	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC012355	MGC15-B05	MGC	W01C052C09	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC012355	MGC15-B05	MGC	W01C052C10	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC011585	MGC15-B06	MGC	W01C052C11	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011585	MGC15-B06	MGC	W01C052C12	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011549	MGC15-B07	MGC	W01C052C13	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC011549	MGC15-B07	MGC	W01C052C14	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC012142	MGC15-B08	MGC	W01C052C15	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012142	MGC15-B08	MGC	W01C052C16	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012178	MGC15-B09	MGC	W01C052C17	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC012178	MGC15-B09	MGC	W01C052C18	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC014417	MGC15-B10	MGC	W01C052C19	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC014417	MGC15-B10	MGC	W01C052C20	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC033537	MGC15-B11	MGC	W01C052C21	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC033537	MGC15-B11	MGC	W01C052C22	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC023576	MGC15-B12	MGC	W01C052C23	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC023576	MGC15-B12	MGC	W01C052C24	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC011553	MGC15-B01	MGC	W01C052D01	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC011553	MGC15-B01	MGC	W01C052D02	pDONR221	11682		QPCTL	54814	AAH11553.1	Hs.719563	Glutaminyl-peptide cyclotransferase-like			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_017659.2	NP_060129.2	VALIDATED	Cg	0.754	1.000	382	867	1	864	382	1	382
IKAKEN	BC012170	MGC15-B02	MGC	W01C052D03	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012170	MGC15-B02	MGC	W01C052D04	pDONR221	16545		C3orf54	389119	AAH12170.2	Hs.86674	Chromosome 3 open reading frame 54			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_203370.1	NP_976248.1	VALIDATED	OK	1.000	1.000	287	864	1	861	287	1	287
IKAKEN	BC012180	MGC15-B03	MGC	W01C052D05	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC012180	MGC15-B03	MGC	W01C052D06	pDONR221	2584		KIAA1279	26128	AAH12180.1	Hs.279580	KIAA1279			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_015634.2	NP_056449.1	VALIDATED	OK	1.000	1.000	621	1866	1	1863	621	1	621
IKAKEN	BC025927	MGC15-B04	MGC	W01C052D07	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC025927	MGC15-B04	MGC	W01C052D08	pDONR221	15683		GGT1	2678	AAH25927.1	Hs.645535	Gamma-glutamyltransferase 1			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_001032365.1	NP_001027537.1	REVIEWED	Pfs	0.969	0.969	225	678	1	675	569	345	569
IKAKEN	BC012355	MGC15-B05	MGC	W01C052D09	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC012355	MGC15-B05	MGC	W01C052D10	pDONR221	24560		SLC6A8	6535	AAH12355.1	Hs.540696	Solute carrier family 6 (neurotransmitter transporter, creatine), member 8			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_005629.3	NP_005620.1	REVIEWED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC011585	MGC15-B06	MGC	W01C052D11	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011585	MGC15-B06	MGC	W01C052D12	pDONR221	4660		PRKCDBP	112464	AAH11585.1	Hs.434044	Protein kinase C, delta binding protein			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_145040.2	NP_659477.2	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC011549	MGC15-B07	MGC	W01C052D13	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC011549	MGC15-B07	MGC	W01C052D14	pDONR221	7003		ATP5S	27109	AAH11549.1	Hs.438489	ATP synthase, H+ transporting, mitochondrial F0 complex, subunit s (factor B)			Lung, large cell carcinoma	NIH_MGC_68	DH10B	NM_001003805.1	NP_001003805.1	REVIEWED	OK	1.000	1.000	127	384	1	381	127	1	127
IKAKEN	BC012142	MGC15-B08	MGC	W01C052D15	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012142	MGC15-B08	MGC	W01C052D16	pDONR221	13407		ATP6V1C2	245973	AAH12142.1	Hs.580464	ATPase, H+ transporting, lysosomal 42kDa, V1 subunit C2			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_144583.3	NP_653184.2	REVIEWED	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC012178	MGC15-B09	MGC	W01C052D17	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC012178	MGC15-B09	MGC	W01C052D18	pDONR221	16493		GMPS	8833	AAH12178.1	Hs.591314	Guanine monphosphate synthetase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003875.2	NP_003866.1	REVIEWED	OK	1.000	1.000	693	2082	1	2079	693	1	693
IKAKEN	BC014417	MGC15-B10	MGC	W01C052D19	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC014417	MGC15-B10	MGC	W01C052D20	pDONR221	4503		RIN1	9610	AAH14417.1	Hs.1030	Ras and Rab interactor 1			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_004292.2	NP_004283.2	VALIDATED	OK	1.000	1.000	783	2352	1	2349	783	1	783
IKAKEN	BC033537	MGC15-B11	MGC	W01C052D21	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC033537	MGC15-B11	MGC	W01C052D22	pDONR221	8572		VAT1L	57687	AAH33537.1	Hs.461405	Vesicle amine transport protein 1 homolog (T. californica)-like			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_020927.1	NP_065978.1	PROVISIONAL	C	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC023576	MGC15-B12	MGC	W01C052D23	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC023576	MGC15-B12	MGC	W01C052D24	pDONR221	13503		GNLY	10578	AAH23576.1	Hs.105806	Granulysin			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_006433.3	NP_006424.2	REVIEWED	OK	1.000	1.000	145	438	1	435	145	1	145
IKAKEN	BC014176	MGC15-C01	MGC	W01C052E01	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014176	MGC15-C01	MGC	W01C052E02	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014132	MGC15-C02	MGC	W01C052E03	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014132	MGC15-C02	MGC	W01C052E04	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014209	MGC15-C03	MGC	W01C052E05	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC014209	MGC15-C03	MGC	W01C052E06	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC035501	MGC15-C04	MGC	W01C052E07	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC035501	MGC15-C04	MGC	W01C052E08	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC014139	MGC15-C05	MGC	W01C052E09	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC014139	MGC15-C05	MGC	W01C052E10	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC030143	MGC15-C06	MGC	W01C052E11	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC030143	MGC15-C06	MGC	W01C052E12	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC019035	MGC15-C07	MGC	W01C052E13	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019035	MGC15-C07	MGC	W01C052E14	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019040	MGC15-C08	MGC	W01C052E15	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC019040	MGC15-C08	MGC	W01C052E16	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC014259	MGC15-C09	MGC	W01C052E17	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014259	MGC15-C09	MGC	W01C052E18	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014245	MGC15-C10	MGC	W01C052E19	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014245	MGC15-C10	MGC	W01C052E20	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014109	MGC15-C11	MGC	W01C052E21	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014109	MGC15-C11	MGC	W01C052E22	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014144	MGC15-C12	MGC	W01C052E23	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC014144	MGC15-C12	MGC	W01C052E24	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC014176	MGC15-C01	MGC	W01C052F01	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014176	MGC15-C01	MGC	W01C052F02	pDONR221	20622		USP49	25862	AAH14176.1	Hs.665742	Ubiquitin specific peptidase 49			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_018561.3	NP_061031.2	PROVISIONAL	C	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	BC014132	MGC15-C02	MGC	W01C052F03	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014132	MGC15-C02	MGC	W01C052F04	pDONR221	10712		NT5C3L	115024	AAH14132.2	Hs.237536	5'-nucleotidase, cytosolic III-like			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_052935.3	NP_443167.3	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
IKAKEN	BC014209	MGC15-C03	MGC	W01C052F05	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC014209	MGC15-C03	MGC	W01C052F06	pDONR221	16292		EAF2	55840	AAH14209.1	Hs.477325	ELL associated factor 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_018456.4	NP_060926.2	VALIDATED	OK	1.000	1.000	260	783	1	780	260	1	260
IKAKEN	BC035501	MGC15-C04	MGC	W01C052F07	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC035501	MGC15-C04	MGC	W01C052F08	pDONR221	65		RP1-21O18.1	23254	AAH35501.3					Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_001018000.3	NP_001018000.1	VALIDATED	OK	1.000	1.000	415	1248	1	1245	415	1	415
IKAKEN	BC014139	MGC15-C05	MGC	W01C052F09	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC014139	MGC15-C05	MGC	W01C052F10	pDONR221	12894		ALPPL2	251	AAH14139.1	Hs.333509	Alkaline phosphatase, placental-like 2			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_031313.2	NP_112603.2	REVIEWED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	BC030143	MGC15-C06	MGC	W01C052F11	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC030143	MGC15-C06	MGC	W01C052F12	pDONR221	10947		MALT1	10892	AAH30143.1	Hs.601217	Mucosa associated lymphoid tissue lymphoma translocation gene 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_006785.2	NP_006776.1	REVIEWED	OK	1.000	1.000	824	2475	1	2472	824	1	824
IKAKEN	BC019035	MGC15-C07	MGC	W01C052F13	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019035	MGC15-C07	MGC	W01C052F14	pDONR221	4555		LPXN	9404	AAH19035.1	Hs.125474	Leupaxin			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_004811.2	NP_004802.1	REVIEWED	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	BC019040	MGC15-C08	MGC	W01C052F15	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC019040	MGC15-C08	MGC	W01C052F16	pDONR221	10719		PMP22	5376	AAH19040.2	Hs.372031	Peripheral myelin protein 22			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000304.2	NP_000295.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	BC014259	MGC15-C09	MGC	W01C052F17	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014259	MGC15-C09	MGC	W01C052F18	pDONR221	18008		TIFA	92610	AAH14259.1	Hs.310640	TRAF-interacting protein with forkhead-associated domain			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_052864.2	NP_443096.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BC014245	MGC15-C10	MGC	W01C052F19	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014245	MGC15-C10	MGC	W01C052F20	pDONR221	22610		CTHRC1	115908	AAH14245.1	Hs.405614	Collagen triple helix repeat containing 1			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_138455.2	NP_612464.1	PROVISIONAL	C	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC014109	MGC15-C11	MGC	W01C052F21	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014109	MGC15-C11	MGC	W01C052F22	pDONR221	9996		LRRC45	201255	AAH14109.1	Hs.143774	Leucine rich repeat containing 45			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_144999.2	NP_659436.1	PROVISIONAL	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC014144	MGC15-C12	MGC	W01C052F23	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC014144	MGC15-C12	MGC	W01C052F24	pDONR221	12482		ELAVL3	1995	AAH14144	Hs.1701	ELAV (embryonic lethal, abnormal vision, Drosophila)-like 3 (Hu antigen C)			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_032281.2	NP_115657.2	REVIEWED	Cfs	1.000	1.000	360	1082	1	1079	360	1	360
IKAKEN	BC030141	MGC15-D01	MGC	W01C052G01	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC030141	MGC15-D01	MGC	W01C052G02	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC015655	MGC15-D02	MGC	W01C052G03	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC015655	MGC15-D02	MGC	W01C052G04	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC014262	MGC15-D03	MGC	W01C052G05	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC014262	MGC15-D03	MGC	W01C052G06	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC015581	MGC15-D04	MGC	W01C052G07	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	MGC15-D04	MGC	W01C052G08	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	MGC15-D05	MGC	W01C052G09	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	MGC15-D05	MGC	W01C052G10	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	MGC15-D06	MGC	W01C052G11	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	MGC15-D06	MGC	W01C052G12	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015639	MGC15-D07	MGC	W01C052G13	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC015639	MGC15-D07	MGC	W01C052G14	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC032108	MGC15-D08	MGC	W01C052G15	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	MGC15-D08	MGC	W01C052G16	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC023582	MGC15-D09	MGC	W01C052G17	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC023582	MGC15-D09	MGC	W01C052G18	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC015649	MGC15-D10	MGC	W01C052G19	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC015649	MGC15-D10	MGC	W01C052G20	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC023586	MGC15-D11	MGC	W01C052G21	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC023586	MGC15-D11	MGC	W01C052G22	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC014465	MGC15-D12	MGC	W01C052G23	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC014465	MGC15-D12	MGC	W01C052G24	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC030141	MGC15-D01	MGC	W01C052H01	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC030141	MGC15-D01	MGC	W01C052H02	pDONR221	1420		IGSF9	57549	AAH30141.1	Hs.591472	Immunoglobulin superfamily, member 9			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_020789.3	NP_065840.2	VALIDATED	OK	1.000	1.000	1163	3492	1	3489	1163	1	1163
IKAKEN	BC015655	MGC15-D02	MGC	W01C052H03	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC015655	MGC15-D02	MGC	W01C052H04	pDONR221	12642		TMIGD2	126259	AAH15655.1	Hs.263928	Transmembrane and immunoglobulin domain containing 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_144615.1	NP_653216.1	PROVISIONAL	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC014262	MGC15-D03	MGC	W01C052H05	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC014262	MGC15-D03	MGC	W01C052H06	pDONR221	13456		RPL37A	6168	AAH14262.1	Hs.433701	Ribosomal protein L37a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000998.4	NP_000989.1	REVIEWED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC015581	MGC15-D04	MGC	W01C052H07	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC015581	MGC15-D04	MGC	W01C052H08	pDONR221	3681		LRFN4	78999	AAH15581.2	Hs.714189	Leucine rich repeat and fibronectin type III domain containing 4			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_024036.4	NP_076941.2	VALIDATED	OK	1.000	1.000	635	1908	1	1905	635	1	635
IKAKEN	BC023594	MGC15-D05	MGC	W01C052H09	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	MGC15-D05	MGC	W01C052H10	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC015632	MGC15-D06	MGC	W01C052H11	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015632	MGC15-D06	MGC	W01C052H12	pDONR221	22017		C7orf27	221927	AAH15632.2	Hs.520623	Chromosome 7 open reading frame 27			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_152743.2	NP_689956.1	PREDICTED	Cs	0.999	0.999	821	2466	1	2463	821	1	821
IKAKEN	BC015639	MGC15-D07	MGC	W01C052H13	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC015639	MGC15-D07	MGC	W01C052H14	pDONR221	21882		CHCHD2	51142	AAH15639.1	Hs.547257	Coiled-coil-helix-coiled-coil-helix domain containing 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_016139.2	NP_057223.1	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	BC032108	MGC15-D08	MGC	W01C052H15	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	MGC15-D08	MGC	W01C052H16	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC023582	MGC15-D09	MGC	W01C052H17	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC023582	MGC15-D09	MGC	W01C052H18	pDONR221	22538		PSCA	8000	AAH23582.1	Hs.711174	Prostate stem cell antigen			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_005672.3	NP_005663.1	REVIEWED	P	1.000	1.000	114	345	1	342	123	10	123
IKAKEN	BC015649	MGC15-D10	MGC	W01C052H19	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC015649	MGC15-D10	MGC	W01C052H20	pDONR221	24288		NACC2	138151	AAH15649.1	Hs.112895	NACC family member 2, BEN and BTB (POZ) domain containing			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_144653.3	NP_653254.1	VALIDATED	OK	1.000	1.000	587	1764	1	1761	587	1	587
IKAKEN	BC023586	MGC15-D11	MGC	W01C052H21	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC023586	MGC15-D11	MGC	W01C052H22	pDONR221	16854		C3orf62	375341	AAH23586.1	Hs.403828	Chromosome 3 open reading frame 62			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_198562.2	NP_940964.1	VALIDATED	OK	1.000	1.000	267	804	1	801	267	1	267
IKAKEN	BC014465	MGC15-D12	MGC	W01C052H23	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC014465	MGC15-D12	MGC	W01C052H24	pDONR221	1573		CD160	11126	AAH14465.1	Hs.488237	CD160 molecule			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007053.2	NP_008984.1	VALIDATED	OK	1.000	1.000	181	546	1	543	181	1	181
IKAKEN	BC014945	MGC15-E01	MGC	W01C052I01	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC014945	MGC15-E01	MGC	W01C052I02	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC042592	MGC15-E02	MGC	W01C052I03	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC042592	MGC15-E02	MGC	W01C052I04	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC014474	MGC15-E04	MGC	W01C052I07	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC014474	MGC15-E04	MGC	W01C052I08	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC015744	MGC15-E05	MGC	W01C052I09	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC015744	MGC15-E05	MGC	W01C052I10	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC041860	MGC15-E06	MGC	W01C052I11	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC041860	MGC15-E06	MGC	W01C052I12	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC014668	MGC15-E07	MGC	W01C052I13	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014668	MGC15-E07	MGC	W01C052I14	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014986	MGC15-E08	MGC	W01C052I15	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014986	MGC15-E08	MGC	W01C052I16	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014980	MGC15-E09	MGC	W01C052I17	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	MGC15-E09	MGC	W01C052I18	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014508	MGC15-E10	MGC	W01C052I19	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC014508	MGC15-E10	MGC	W01C052I20	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC015773	MGC15-E11	MGC	W01C052I21	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC015773	MGC15-E11	MGC	W01C052I22	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC014455	MGC15-E12	MGC	W01C052I23	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC014455	MGC15-E12	MGC	W01C052I24	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC014945	MGC15-E01	MGC	W01C052J01	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC014945	MGC15-E01	MGC	W01C052J02	pDONR221	8780		ARMC5	79798	AAH14945.1	Hs.121915	Armadillo repeat containing 5			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_001105247.1	NP_001098717.1	VALIDATED	P	1.000	1.000	771	2316	1	2313	935	165	935
IKAKEN	BC042592	MGC15-E02	MGC	W01C052J03	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC042592	MGC15-E02	MGC	W01C052J04	pDONR221	2048		SLC9A11	284525	AAH42592.1	Hs.494981	Solute carrier family 9, member 11			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178527.3	NP_848622.2	VALIDATED	OK	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC014474	MGC15-E04	MGC	W01C052J07	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC014474	MGC15-E04	MGC	W01C052J08	pDONR221	16859		ACAA1	30	AAH14474.1	Hs.643487	Acetyl-Coenzyme A acyltransferase 1			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130410.1	NP_001123882.1	REVIEWED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	BC015744	MGC15-E05	MGC	W01C052J09	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC015744	MGC15-E05	MGC	W01C052J10	pDONR221	25402		LAGE3	8270	AAH15744.2	Hs.444619	L antigen family, member 3			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_006014.3	NP_006005.2	REVIEWED	Cg	0.993	1.000	143	429	1	426	143	1	143
IKAKEN	BC041860	MGC15-E06	MGC	W01C052J11	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC041860	MGC15-E06	MGC	W01C052J12	pDONR221	11241		LOXHD1	125336	AAH41860.1	Hs.345877	Lipoxygenase homology domains 1			Testis	NIH_MGC_97	DH10B	NM_001145472.1	NP_001138944.1	INFERRED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	BC014668	MGC15-E07	MGC	W01C052J13	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014668	MGC15-E07	MGC	W01C052J14	pDONR221	200		PDPN	10630	AAH14668.2	Hs.468675	Podoplanin			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_006474.4	NP_006465.3	REVIEWED	OK	1.000	1.000	238	717	1	714	238	1	238
IKAKEN	BC014986	MGC15-E08	MGC	W01C052J15	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014986	MGC15-E08	MGC	W01C052J16	pDONR221	12327		LENG1	79165	AAH14986.1	Hs.590974	Leukocyte receptor cluster (LRC) member 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024316.1	NP_077292.1	PROVISIONAL	OK	1.000	1.000	264	795	1	792	264	1	264
IKAKEN	BC014980	MGC15-E09	MGC	W01C052J17	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	MGC15-E09	MGC	W01C052J18	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014508	MGC15-E10	MGC	W01C052J19	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC014508	MGC15-E10	MGC	W01C052J20	pDONR221	8143		SEC11A	23478	AAH14508.1	Hs.9534	SEC11 homolog A (S. cerevisiae)			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_014300.2	NP_055115.1	PROVISIONAL		0.922	0.928	167	501	1	498	179	13	179
IKAKEN	BC015773	MGC15-E11	MGC	W01C052J21	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC015773	MGC15-E11	MGC	W01C052J22	pDONR221	19844		PPP1R14C	81706	AAH15773.1	Hs.486798	Protein phosphatase 1, regulatory (inhibitor) subunit 14C			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_030949.2	NP_112211.1	VALIDATED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC014455	MGC15-E12	MGC	W01C052J23	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC014455	MGC15-E12	MGC	W01C052J24	pDONR221	13066		SEPT2	4735	AAH14455.1	Hs.716403	Septin 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_004404.3	NP_004395.1	VALIDATED	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	BC021294	MGC15-F01	MGC	W01C052K01	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC021294	MGC15-F01	MGC	W01C052K02	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC023638	MGC15-F02	MGC	W01C052K03	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC023638	MGC15-F02	MGC	W01C052K04	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC017280	MGC15-F03	MGC	W01C052K05	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC017280	MGC15-F03	MGC	W01C052K06	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC023645	MGC15-F04	MGC	W01C052K07	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC023645	MGC15-F04	MGC	W01C052K08	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC032147	MGC15-F05	MGC	W01C052K09	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC032147	MGC15-F05	MGC	W01C052K10	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC027734	MGC15-F06	MGC	W01C052K11	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC027734	MGC15-F06	MGC	W01C052K12	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC032148	MGC15-F07	MGC	W01C052K13	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC032148	MGC15-F07	MGC	W01C052K14	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC017310	MGC15-F08	MGC	W01C052K15	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC017310	MGC15-F08	MGC	W01C052K16	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC035511	MGC15-F09	MGC	W01C052K17	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC035511	MGC15-F09	MGC	W01C052K18	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC017327	MGC15-F10	MGC	W01C052K19	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC017327	MGC15-F10	MGC	W01C052K20	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC021557	MGC15-F11	MGC	W01C052K21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	MGC15-F11	MGC	W01C052K22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	MGC15-F12	MGC	W01C052K23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	MGC15-F12	MGC	W01C052K24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC021294	MGC15-F01	MGC	W01C052L01	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC021294	MGC15-F01	MGC	W01C052L02	pDONR221	12226		CHERP	10523	AAH21294.1	Hs.631627	Calcium homeostasis endoplasmic reticulum protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_006387.5	NP_006378.3	VALIDATED	Pfs	0.998	1.000	459	1377	1	1375	916	1	459
IKAKEN	BC023638	MGC15-F02	MGC	W01C052L03	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC023638	MGC15-F02	MGC	W01C052L04	pDONR221	21181		MPP6	51678	AAH23638.1	Hs.533355	Membrane protein, palmitoylated 6 (MAGUK p55 subfamily member 6)			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_016447.2	NP_057531.2	PROVISIONAL	C	1.000	1.000	540	1623	1	1620	540	1	540
IKAKEN	BC017280	MGC15-F03	MGC	W01C052L05	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC017280	MGC15-F03	MGC	W01C052L06	pDONR221	3756		PNPLA2	57104	AAH17280.1	Hs.654697	Patatin-like phospholipase domain containing 2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_020376.2	NP_065109.1	PROVISIONAL	Cs	0.998	0.998	504	1515	1	1512	504	1	504
IKAKEN	BC023645	MGC15-F04	MGC	W01C052L07	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC023645	MGC15-F04	MGC	W01C052L08	pDONR221	19980		FGD2	221472	AAH23645.1	Hs.509664	FYVE, RhoGEF and PH domain containing 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_173558.3	NP_775829.2	VALIDATED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	BC032147	MGC15-F05	MGC	W01C052L09	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC032147	MGC15-F05	MGC	W01C052L10	pDONR221										Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R			
IKAKEN	BC027734	MGC15-F06	MGC	W01C052L11	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC027734	MGC15-F06	MGC	W01C052L12	pDONR221	21266		VKORC1L1	154807	AAH27734.2	Hs.427232	Vitamin K epoxide reductase complex, subunit 1-like 1			Testis	NIH_MGC_97	DH10B	NM_173517.3	NP_775788.2	VALIDATED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC032148	MGC15-F07	MGC	W01C052L13	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC032148	MGC15-F07	MGC	W01C052L14	pDONR221	4121		TNNI2	7136	AAH32148.1	Hs.523403	Troponin I type 2 (skeletal, fast)			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_003282.3	NP_003273.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC017310	MGC15-F08	MGC	W01C052L15	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC017310	MGC15-F08	MGC	W01C052L16	pDONR221	13422		SPR	6697	AAH17310.1	Hs.301540	Sepiapterin reductase (7,8-dihydrobiopterin:NADP+ oxidoreductase)			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_003124.4	NP_003115.1	REVIEWED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BC035511	MGC15-F09	MGC	W01C052L17	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC035511	MGC15-F09	MGC	W01C052L18	pDONR221	10027		FAM100B	283991	AAH35511.1	Hs.719201	Family with sequence similarity 100, member B			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_182565.3	NP_872371.1	VALIDATED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	BC017327	MGC15-F10	MGC	W01C052L19	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC017327	MGC15-F10	MGC	W01C052L20	pDONR221	7452		FERMT2	10979	AAH17327.1	Hs.509343	Fermitin family homolog 2 (Drosophila)			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_001135000.1	NP_001128472.1	VALIDATED	OK	1.000	1.000	633	1902	1	1899	633	1	633
IKAKEN	BC021557	MGC15-F11	MGC	W01C052L21	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	MGC15-F11	MGC	W01C052L22	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	MGC15-F12	MGC	W01C052L23	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	MGC15-F12	MGC	W01C052L24	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018771	MGC15-G01	MGC	W01C052M01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	MGC15-G01	MGC	W01C052M02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	MGC15-G02	MGC	W01C052M03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	MGC15-G02	MGC	W01C052M04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	MGC15-G03	MGC	W01C052M05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	MGC15-G03	MGC	W01C052M06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC028840	MGC15-G04	MGC	W01C052M07	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC028840	MGC15-G04	MGC	W01C052M08	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC031300	MGC15-G05	MGC	W01C052M09	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC031300	MGC15-G05	MGC	W01C052M10	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC025311	MGC15-G06	MGC	W01C052M11	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC025311	MGC15-G06	MGC	W01C052M12	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC022796	MGC15-G07	MGC	W01C052M13	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC022796	MGC15-G07	MGC	W01C052M14	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC025327	MGC15-G08	MGC	W01C052M15	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025327	MGC15-G08	MGC	W01C052M16	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025959	MGC15-G09	MGC	W01C052M17	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC025959	MGC15-G09	MGC	W01C052M18	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC026041	MGC15-G10	MGC	W01C052M19	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC026041	MGC15-G10	MGC	W01C052M20	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC031301	MGC15-G11	MGC	W01C052M21	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	MGC15-G11	MGC	W01C052M22	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC022819	MGC15-G12	MGC	W01C052M23	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC022819	MGC15-G12	MGC	W01C052M24	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC018771	MGC15-G01	MGC	W01C052N01	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	MGC15-G01	MGC	W01C052N02	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC021134	MGC15-G02	MGC	W01C052N03	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	MGC15-G02	MGC	W01C052N04	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC020235	MGC15-G03	MGC	W01C052N05	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	MGC15-G03	MGC	W01C052N06	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC028840	MGC15-G04	MGC	W01C052N07	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC028840	MGC15-G04	MGC	W01C052N08	pDONR221	2096		ANKRD13C	81573	AAH28840.1	Hs.105016	Ankyrin repeat domain 13C			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_030816.4	NP_110443.3	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	BC031300	MGC15-G05	MGC	W01C052N09	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC031300	MGC15-G05	MGC	W01C052N10	pDONR221	15436		C21orf2	755	AAH31300.1	Hs.517331	Chromosome 21 open reading frame 2			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004928.2	NP_004919.1	VALIDATED	P	1.000	1.000	214	1131	1	642	256	1	214
IKAKEN	BC025311	MGC15-G06	MGC	W01C052N11	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC025311	MGC15-G06	MGC	W01C052N12	pDONR221	17600		HHIP	64399	AAH25311.1	Hs.507991	Hedgehog interacting protein			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_022475.1	NP_071920.1	REVIEWED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC022796	MGC15-G07	MGC	W01C052N13	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC022796	MGC15-G07	MGC	W01C052N14	pDONR221	12715		CGB	1082	AAH22796.1	Hs.446683	Chorionic gonadotropin, beta polypeptide			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000737.2	NP_000728.1	REVIEWED	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	BC025327	MGC15-G08	MGC	W01C052N15	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025327	MGC15-G08	MGC	W01C052N16	pDONR221	9213		FAM100A	124402	AAH25327.1	Hs.513313	Family with sequence similarity 100, member A			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_145253.2	NP_660296.1	VALIDATED	P	1.000	1.000	165	498	1	495	177	13	177
IKAKEN	BC025959	MGC15-G09	MGC	W01C052N17	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC025959	MGC15-G09	MGC	W01C052N18	pDONR221	9138		DYNC1LI2	1783	AAH25959.1	Hs.369068	Dynein, cytoplasmic 1, light intermediate chain 2			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_006141.2	NP_006132.1	VALIDATED	OK	1.000	1.000	492	1479	1	1476	492	1	492
IKAKEN	BC026041	MGC15-G10	MGC	W01C052N19	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC026041	MGC15-G10	MGC	W01C052N20	pDONR221	12703		C19orf23	148046	AAH26041	Hs.438829	Chromosome 19 open reading frame 23			Testis	NIH_MGC_97	DH10B	NM_152480.1	NP_689693.1	VALIDATED	P	1.000	1.000	106	561	1	318	109	1	106
IKAKEN	BC031301	MGC15-G11	MGC	W01C052N21	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC031301	MGC15-G11	MGC	W01C052N22	pDONR221	1415		LRRC47	57470	AAH31301.1	Hs.268488	Leucine rich repeat containing 47			Testis	NIH_MGC_97	DH10B	NM_020710.2	NP_065761.1	VALIDATED	Cfs	1.000	1.000	583	1751	1	1748	583	1	583
IKAKEN	BC022819	MGC15-G12	MGC	W01C052N23	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC022819	MGC15-G12	MGC	W01C052N24	pDONR221	1681		KISS1	3814	AAH22819.1	Hs.95008	KiSS-1 metastasis-suppressor			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002256.3	NP_002247.3	VALIDATED	OK	1.000	1.000	138	439	1	414	138	1	138
IKAKEN	BC033082	MGC15-H01	MGC	W01C052O01	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	MGC15-H01	MGC	W01C052O02	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	MGC15-H02	MGC	W01C052O03	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	MGC15-H02	MGC	W01C052O04	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033239	MGC15-H03	MGC	W01C052O05	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033239	MGC15-H03	MGC	W01C052O06	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033113	MGC15-H04	MGC	W01C052O07	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033113	MGC15-H04	MGC	W01C052O08	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033237	MGC15-H05	MGC	W01C052O09	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033237	MGC15-H05	MGC	W01C052O10	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033154	MGC15-H06	MGC	W01C052O11	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC033154	MGC15-H06	MGC	W01C052O12	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC042943	MGC15-H07	MGC	W01C052O13	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC042943	MGC15-H07	MGC	W01C052O14	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC033103	MGC15-H08	MGC	W01C052O15	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	MGC15-H08	MGC	W01C052O16	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC031334	MGC15-H09	MGC	W01C052O17	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC031334	MGC15-H09	MGC	W01C052O18	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033213	MGC15-H10	MGC	W01C052O19	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033213	MGC15-H10	MGC	W01C052O20	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033195	MGC15-H11	MGC	W01C052O21	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033195	MGC15-H11	MGC	W01C052O22	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033073	MGC15-H12	MGC	W01C052O23	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	BC033073	MGC15-H12	MGC	W01C052O24	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	BC033082	MGC15-H01	MGC	W01C052P01	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	MGC15-H01	MGC	W01C052P02	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC040993	MGC15-H02	MGC	W01C052P03	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC040993	MGC15-H02	MGC	W01C052P04	pDONR221	17434		SLAIN2	57606	-	Hs.479677	SLAIN motif family, member 2			Testis	NIH_MGC_97	DH10B	NM_020846.1	NP_065897.1	VALIDATED	C	1.000	1.000	581	1938	193	1935	581	1	581
IKAKEN	BC033239	MGC15-H03	MGC	W01C052P05	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033239	MGC15-H03	MGC	W01C052P06	pDONR221	4908		PLEKHA7	144100	AAH33239.1	Hs.12332	Pleckstrin homology domain containing, family A member 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_175058.3	NP_778228.2	PROVISIONAL	Pgs	0.997	0.999	748	2247	1	2244	1121	375	1121
IKAKEN	BC033113	MGC15-H04	MGC	W01C052P07	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033113	MGC15-H04	MGC	W01C052P08	pDONR221	9951		TMEM199	147007	AAH33113.1	Hs.709610	Transmembrane protein 199			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152464.1	NP_689677.1	PROVISIONAL	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BC033237	MGC15-H05	MGC	W01C052P09	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033237	MGC15-H05	MGC	W01C052P10	pDONR221	11968		MGC45922	284365	AAH33237.1	Hs.161397	Hypothetical gene MGC45922			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R													
IKAKEN	BC033154	MGC15-H06	MGC	W01C052P11	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC033154	MGC15-H06	MGC	W01C052P12	pDONR221	1916		CENPL	91687	AAH33154.1	Hs.531856	Centromere protein L			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_001127181.1	NP_001120653.1	VALIDATED	OK	1.000	1.000	390	1173	1	1170	390	1	390
IKAKEN	BC042943	MGC15-H07	MGC	W01C052P13	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC042943	MGC15-H07	MGC	W01C052P14	pDONR221	3401		USP6NL	9712	AAH42943.1	Hs.498661	USP6 N-terminal like			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014688.2	NP_055503.1	VALIDATED	OK	1.000	1.000	828	2487	1	2484	828	1	828
IKAKEN	BC033103	MGC15-H08	MGC	W01C052P15	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC033103	MGC15-H08	MGC	W01C052P16	pDONR221	23759		PMPCA	23203	AAH33103.2	Hs.495471	Peptidase (mitochondrial processing) alpha			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_015160.1	NP_055975.1	PROVISIONAL	OK	1.000	1.000	525	1578	1	1575	525	1	525
IKAKEN	BC031334	MGC15-H09	MGC	W01C052P17	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC031334	MGC15-H09	MGC	W01C052P18	pDONR221	4118		CST6	1474	AAH31334.1	Hs.139389	Cystatin E/M			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001323.2	NP_001314.1	REVIEWED	OK	1.000	1.000	149	450	1	447	149	1	149
IKAKEN	BC033213	MGC15-H10	MGC	W01C052P19	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033213	MGC15-H10	MGC	W01C052P20	pDONR221	638		SAMD11	148398	AAH33213.1	Hs.335293	Sterile alpha motif domain containing 11			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_152486.2	NP_689699.2	VALIDATED	Ps	0.998	0.998	496	1491	1	1488	681	186	681
IKAKEN	BC033195	MGC15-H11	MGC	W01C052P21	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033195	MGC15-H11	MGC	W01C052P22	pDONR221	11717		KIR3DX1	90011	AAH33195	Hs.288520	Killer cell immunoglobulin-like receptor, three domains, X1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_001047605.1	NP_001041070.1	VALIDATED	Pfs	0.438	0.438	16	237	123	170	352	32	47
IKAKEN	BC033073	MGC15-H12	MGC	W01C052P23	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	BC033073	MGC15-H12	MGC	W01C052P24	pDONR221	23787		PGM5	5239	AAH33073.1	Hs.307835	Phosphoglucomutase 5			Lung, large cell carcinoma	NIH_MGC_18	DH10B-R	NM_021965.3	NP_068800.2	VALIDATED	Pgs	0.978	0.981	268	807	1	804	567	82	348
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C053A01	pDONR221															
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C053A02	pDONR221															
IKAKEN	LFL06214	06_01-A02	EST	W01C053A03	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	LFL06214	06_01-A02	EST	W01C053A04	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	MPG01360	06_01-A03	EST	W01C053A05	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG01360	06_01-A03	EST	W01C053A06	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG07704	06_01-A04	EST	W01C053A07	pDONR221															
IKAKEN	MPG07704	06_01-A04	EST	W01C053A08	pDONR221															
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C053A09	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C053A10	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C053A11	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C053A12	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C053A13	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C053A14	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C053A15	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C053A16	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C053A17	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C053A18	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C053A19	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C053A20	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OVT05452	06_01-A11	EST	W01C053A21	pDONR221															
IKAKEN	OVT05452	06_01-A11	EST	W01C053A22	pDONR221															
IKAKEN	RCT01646	06_01-A12	EST	W01C053A23	pDONR221			IGHA1	3493											
IKAKEN	RCT01646	06_01-A12	EST	W01C053A24	pDONR221			IGHA1	3493											
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C053B01	pDONR221															
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C053B02	pDONR221															
IKAKEN	LFL06214	06_01-A02	EST	W01C053B03	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	LFL06214	06_01-A02	EST	W01C053B04	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	MPG01360	06_01-A03	EST	W01C053B05	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG01360	06_01-A03	EST	W01C053B06	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG07704	06_01-A04	EST	W01C053B07	pDONR221															
IKAKEN	MPG07704	06_01-A04	EST	W01C053B08	pDONR221															
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C053B09	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C053B10	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C053B11	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C053B12	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C053B13	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C053B14	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C053B15	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C053B16	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C053B17	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C053B18	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C053B19	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C053B20	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OVT05452	06_01-A11	EST	W01C053B21	pDONR221															
IKAKEN	OVT05452	06_01-A11	EST	W01C053B22	pDONR221															
IKAKEN	RCT01646	06_01-A12	EST	W01C053B23	pDONR221			IGHA1	3493											
IKAKEN	RCT01646	06_01-A12	EST	W01C053B24	pDONR221			IGHA1	3493											
IKAKEN	RCT04146	06_01-B01	EST	W01C053C01	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	RCT04146	06_01-B01	EST	W01C053C02	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	SPL08928	06_01-B02	EST	W01C053C03	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL08928	06_01-B02	EST	W01C053C04	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL09361	06_01-B03	EST	W01C053C05	pDONR221			IGHA1	3493											
IKAKEN	SPL09361	06_01-B03	EST	W01C053C06	pDONR221			IGHA1	3493											
IKAKEN	STM06182	06_01-B04	EST	W01C053C07	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06182	06_01-B04	EST	W01C053C08	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06830	06_01-B05	EST	W01C053C09	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	STM06830	06_01-B05	EST	W01C053C10	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C053C11	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C053C12	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C053C13	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C053C14	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C053C15	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C053C16	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	TST07733	06_01-B09	EST	W01C053C17	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	TST07733	06_01-B09	EST	W01C053C18	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	WMC08458	06_01-B10	EST	W01C053C19	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06_01-B10	EST	W01C053C20	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK001A01	06_01-B11	IMS	W01C053C21	pDONR221															
IKAKEN	SK001A01	06_01-B11	IMS	W01C053C22	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C053C23	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C053C24	pDONR221															
IKAKEN	RCT04146	06_01-B01	EST	W01C053D01	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	RCT04146	06_01-B01	EST	W01C053D02	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	SPL08928	06_01-B02	EST	W01C053D03	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL08928	06_01-B02	EST	W01C053D04	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL09361	06_01-B03	EST	W01C053D05	pDONR221			IGHA1	3493											
IKAKEN	SPL09361	06_01-B03	EST	W01C053D06	pDONR221			IGHA1	3493											
IKAKEN	STM06182	06_01-B04	EST	W01C053D07	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06182	06_01-B04	EST	W01C053D08	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06830	06_01-B05	EST	W01C053D09	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	STM06830	06_01-B05	EST	W01C053D10	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C053D11	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C053D12	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C053D13	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C053D14	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C053D15	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C053D16	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	TST07733	06_01-B09	EST	W01C053D17	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	TST07733	06_01-B09	EST	W01C053D18	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	WMC08458	06_01-B10	EST	W01C053D19	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06_01-B10	EST	W01C053D20	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK001A01	06_01-B11	IMS	W01C053D21	pDONR221															
IKAKEN	SK001A01	06_01-B11	IMS	W01C053D22	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C053D23	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C053D24	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C053E01	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C053E02	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C053E03	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C053E04	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C053E05	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C053E06	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C053E07	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C053E08	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C053E09	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C053E10	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C053E11	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C053E12	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C053E13	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C053E14	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C053E15	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C053E16	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C053E17	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C053E18	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C053E19	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C053E20	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C053E21	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C053E22	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C053E23	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C053E24	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C053F01	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C053F02	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C053F03	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C053F04	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C053F05	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C053F06	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C053F07	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C053F08	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C053F09	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C053F10	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C053F11	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C053F12	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C053F13	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C053F14	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C053F15	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C053F16	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C053F17	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C053F18	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C053F19	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C053F20	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C053F21	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C053F22	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C053F23	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C053F24	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C053G01	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C053G02	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C053G03	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C053G04	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C053G05	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C053G06	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C053G07	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C053G08	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C053G09	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C053G10	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C053G11	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C053G12	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C053G13	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C053G14	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C053G15	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C053G16	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C053G17	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C053G18	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C053G19	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C053G20	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C053G21	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C053G22	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C053G23	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C053G24	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C053H01	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C053H02	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C053H03	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C053H04	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C053H05	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C053H06	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C053H07	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C053H08	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C053H09	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C053H10	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C053H11	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C053H12	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C053H13	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C053H14	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C053H15	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C053H16	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C053H17	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C053H18	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C053H19	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C053H20	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C053H21	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C053H22	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C053H23	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C053H24	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C053I01	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C053I02	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C053I03	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C053I04	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C053I05	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C053I06	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C053I07	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C053I08	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C053I09	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C053I10	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C053I11	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C053I12	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C053I13	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C053I14	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C053I15	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C053I16	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C053I17	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C053I18	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C053I19	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C053I20	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C053I21	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C053I22	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C053I23	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C053I24	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C053J01	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C053J02	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C053J03	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C053J04	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C053J05	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C053J06	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C053J07	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C053J08	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C053J09	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C053J10	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C053J11	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C053J12	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C053J13	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C053J14	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C053J15	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C053J16	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C053J17	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C053J18	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C053J19	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C053J20	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C053J21	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C053J22	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C053J23	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C053J24	pDONR221															
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C053K01	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C053K02	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C053K03	pDONR221			LOC222052	222052											
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C053K04	pDONR221			LOC222052	222052											
IKAKEN	CBL01081	06_01-F03	EST	W01C053K05	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBL01081	06_01-F03	EST	W01C053K06	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBR02422	06_01-F04	EST	W01C053K07	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02422	06_01-F04	EST	W01C053K08	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02670	06_01-F05	EST	W01C053K09	pDONR221															
IKAKEN	CBR02670	06_01-F05	EST	W01C053K10	pDONR221															
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C053K11	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C053K12	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	DAT03661	06_01-F07	EST	W01C053K13	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_01-F07	EST	W01C053K14	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT04650	06_01-F08	EST	W01C053K15	pDONR221															
IKAKEN	DAT04650	06_01-F08	EST	W01C053K16	pDONR221															
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C053K17	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C053K18	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C053K19	pDONR221															
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C053K20	pDONR221															
IKAKEN	HEP00193	06_01-F11	EST	W01C053K21	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP00193	06_01-F11	EST	W01C053K22	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP09077	06_01-F12	EST	W01C053K23	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	HEP09077	06_01-F12	EST	W01C053K24	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C053L01	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C053L02	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C053L03	pDONR221			LOC222052	222052											
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C053L04	pDONR221			LOC222052	222052											
IKAKEN	CBL01081	06_01-F03	EST	W01C053L05	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBL01081	06_01-F03	EST	W01C053L06	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBR02422	06_01-F04	EST	W01C053L07	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02422	06_01-F04	EST	W01C053L08	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02670	06_01-F05	EST	W01C053L09	pDONR221															
IKAKEN	CBR02670	06_01-F05	EST	W01C053L10	pDONR221															
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C053L11	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C053L12	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	DAT03661	06_01-F07	EST	W01C053L13	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_01-F07	EST	W01C053L14	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT04650	06_01-F08	EST	W01C053L15	pDONR221															
IKAKEN	DAT04650	06_01-F08	EST	W01C053L16	pDONR221															
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C053L17	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C053L18	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C053L19	pDONR221															
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C053L20	pDONR221															
IKAKEN	HEP00193	06_01-F11	EST	W01C053L21	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP00193	06_01-F11	EST	W01C053L22	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP09077	06_01-F12	EST	W01C053L23	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	HEP09077	06_01-F12	EST	W01C053L24	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C053M01	pDONR221															
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C053M02	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C053M03	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C053M04	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C053M05	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C053M06	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C053M07	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C053M08	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C053M09	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C053M10	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C053M11	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C053M12	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C053M13	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C053M14	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C053M15	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C053M16	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C053M17	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C053M18	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C053M19	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C053M20	pDONR221															
IKAKEN	JTH07860	06_01-G11	EST	W01C053M21	pDONR221				401322											
IKAKEN	JTH07860	06_01-G11	EST	W01C053M22	pDONR221				401322											
IKAKEN	JTH11146	06_01-G12	EST	W01C053M23	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	JTH11146	06_01-G12	EST	W01C053M24	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C053N01	pDONR221															
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C053N02	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C053N03	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C053N04	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C053N05	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C053N06	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C053N07	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C053N08	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C053N09	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C053N10	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C053N11	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C053N12	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C053N13	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C053N14	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C053N15	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C053N16	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C053N17	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C053N18	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C053N19	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C053N20	pDONR221															
IKAKEN	JTH07860	06_01-G11	EST	W01C053N21	pDONR221				401322											
IKAKEN	JTH07860	06_01-G11	EST	W01C053N22	pDONR221				401322											
IKAKEN	JTH11146	06_01-G12	EST	W01C053N23	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	JTH11146	06_01-G12	EST	W01C053N24	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C053O01	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C053O02	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KDN02467	06_01-H02	EST	W01C053O03	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	06_01-H02	EST	W01C053O04	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C053O05	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C053O06	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C053O07	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C053O08	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C053O09	pDONR221															
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C053O10	pDONR221															
IKAKEN	LFL05785	06_01-H06	EST	W01C053O11	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LFL05785	06_01-H06	EST	W01C053O12	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LNG10447	06_01-H07	EST	W01C053O13	pDONR221				441399											
IKAKEN	LNG10447	06_01-H07	EST	W01C053O14	pDONR221				441399											
IKAKEN	MPG07137	06_01-H08	EST	W01C053O15	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06_01-H08	EST	W01C053O16	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C053O17	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C053O18	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C053O19	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C053O20	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	PCD12917	06_01-H11	EST	W01C053O21	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PCD12917	06_01-H11	EST	W01C053O22	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C053O23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C053O24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C053P01	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C053P02	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KDN02467	06_01-H02	EST	W01C053P03	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	06_01-H02	EST	W01C053P04	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C053P05	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C053P06	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C053P07	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C053P08	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C053P09	pDONR221															
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C053P10	pDONR221															
IKAKEN	LFL05785	06_01-H06	EST	W01C053P11	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LFL05785	06_01-H06	EST	W01C053P12	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LNG10447	06_01-H07	EST	W01C053P13	pDONR221				441399											
IKAKEN	LNG10447	06_01-H07	EST	W01C053P14	pDONR221				441399											
IKAKEN	MPG07137	06_01-H08	EST	W01C053P15	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06_01-H08	EST	W01C053P16	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C053P17	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C053P18	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C053P19	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C053P20	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	PCD12917	06_01-H11	EST	W01C053P21	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PCD12917	06_01-H11	EST	W01C053P22	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C053P23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C053P24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C054A01	pDONR221															
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C054A02	pDONR221															
IKAKEN	LFL06214	06_01-A02	EST	W01C054A03	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	LFL06214	06_01-A02	EST	W01C054A04	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	MPG01360	06_01-A03	EST	W01C054A05	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG01360	06_01-A03	EST	W01C054A06	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG07704	06_01-A04	EST	W01C054A07	pDONR221															
IKAKEN	MPG07704	06_01-A04	EST	W01C054A08	pDONR221															
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C054A09	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C054A10	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C054A11	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C054A12	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C054A13	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C054A14	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C054A15	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C054A16	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C054A17	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C054A18	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C054A19	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C054A20	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OVT05452	06_01-A11	EST	W01C054A21	pDONR221															
IKAKEN	OVT05452	06_01-A11	EST	W01C054A22	pDONR221															
IKAKEN	RCT01646	06_01-A12	EST	W01C054A23	pDONR221			IGHA1	3493											
IKAKEN	RCT01646	06_01-A12	EST	W01C054A24	pDONR221			IGHA1	3493											
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C054B01	pDONR221															
IKAKEN	KMR05554	06_01-A01	EST(RND)	W01C054B02	pDONR221															
IKAKEN	LFL06214	06_01-A02	EST	W01C054B03	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	LFL06214	06_01-A02	EST	W01C054B04	pDONR221			NLRX1	79671		Hs.524082	NLR family member X1						NM_024618.2	NP_078894.2	REVIEWED	OK	1.000	1.000	975	2928	1	2925	975	1	975
IKAKEN	MPG01360	06_01-A03	EST	W01C054B05	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG01360	06_01-A03	EST	W01C054B06	pDONR221			BRCC3	79184		Hs.558537	BRCA1/BRCA2-containing complex, subunit 3						NM_001018055.1	NP_001018065.1	REVIEWED	Cgs	0.979	0.986	291	870	1	867	291	1	291
IKAKEN	MPG07704	06_01-A04	EST	W01C054B07	pDONR221															
IKAKEN	MPG07704	06_01-A04	EST	W01C054B08	pDONR221															
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C054B09	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR02879	06_01-A05	EST(RND)	W01C054B10	pDONR221			C10orf118	55088		Hs.159066	Chromosome 10 open reading frame 118						NM_018017.2	NP_060487.2	VALIDATED	Pfs	0.998	1.000	634	1902	1	1900	898	184	817
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C054B11	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06_01-A06	EST(RND)	W01C054B12	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C054B13	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-A07	EST(RND)	W01C054B14	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C054B15	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07248	06_01-A08	EST(RND)	W01C054B16	pDONR221			NSUN2	54888		Hs.481526	NOL1/NOP2/Sun domain family, member 2						NM_017755.4	NP_060225.4	VALIDATED	OK	1.000	1.000	767	2304	1	2301	767	1	767
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C054B17	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06_01-A09	EST(RND)	W01C054B18	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C054B19	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OFR09463	06_01-A10	EST(RND)	W01C054B20	pDONR221			ARSK	153642		Hs.585051	Arylsulfatase family, member K						NM_198150.2	NP_937793.1	VALIDATED	OK	1.000	1.000	536	1611	1	1608	536	1	536
IKAKEN	OVT05452	06_01-A11	EST	W01C054B21	pDONR221															
IKAKEN	OVT05452	06_01-A11	EST	W01C054B22	pDONR221															
IKAKEN	RCT01646	06_01-A12	EST	W01C054B23	pDONR221			IGHA1	3493											
IKAKEN	RCT01646	06_01-A12	EST	W01C054B24	pDONR221			IGHA1	3493											
IKAKEN	RCT04146	06_01-B01	EST	W01C054C01	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	RCT04146	06_01-B01	EST	W01C054C02	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	SPL08928	06_01-B02	EST	W01C054C03	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL08928	06_01-B02	EST	W01C054C04	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL09361	06_01-B03	EST	W01C054C05	pDONR221			IGHA1	3493											
IKAKEN	SPL09361	06_01-B03	EST	W01C054C06	pDONR221			IGHA1	3493											
IKAKEN	STM06182	06_01-B04	EST	W01C054C07	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06182	06_01-B04	EST	W01C054C08	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06830	06_01-B05	EST	W01C054C09	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	STM06830	06_01-B05	EST	W01C054C10	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C054C11	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C054C12	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C054C13	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C054C14	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C054C15	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C054C16	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	TST07733	06_01-B09	EST	W01C054C17	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	TST07733	06_01-B09	EST	W01C054C18	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	WMC08458	06_01-B10	EST	W01C054C19	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06_01-B10	EST	W01C054C20	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK001A01	06_01-B11	IMS	W01C054C21	pDONR221															
IKAKEN	SK001A01	06_01-B11	IMS	W01C054C22	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C054C23	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C054C24	pDONR221															
IKAKEN	RCT04146	06_01-B01	EST	W01C054D01	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	RCT04146	06_01-B01	EST	W01C054D02	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.292	0.298	48	426	152	295	311	16	62
IKAKEN	SPL08928	06_01-B02	EST	W01C054D03	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL08928	06_01-B02	EST	W01C054D04	pDONR221			C17orf60	284021		Hs.631749	Chromosome 17 open reading frame 60						NM_001085423.1	NP_001078892.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	SPL09361	06_01-B03	EST	W01C054D05	pDONR221			IGHA1	3493											
IKAKEN	SPL09361	06_01-B03	EST	W01C054D06	pDONR221			IGHA1	3493											
IKAKEN	STM06182	06_01-B04	EST	W01C054D07	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06182	06_01-B04	EST	W01C054D08	pDONR221			RAB11FIP1	80223		Hs.696035	RAB11 family interacting protein 1 (class I)						NM_025151.3	NP_079427.3	VALIDATED	Cfs	0.994	0.998	649	1940	1	1937	649	1	649
IKAKEN	STM06830	06_01-B05	EST	W01C054D09	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	STM06830	06_01-B05	EST	W01C054D10	pDONR221			SLC28A2	9153		Hs.367833	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 2						NM_004212.3	NP_004203.2	VALIDATED	OK	1.000	1.000	658	1977	1	1974	658	1	658
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C054D11	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	SZR04146	06_01-B06	EST(RND)	W01C054D12	pDONR221			TSPAN9	10867		Hs.504517	Tetraspanin 9						NM_006675.3	NP_006666.1	REVIEWED	OK	1.000	1.000	239	720	1	717	239	1	239
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C054D13	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	TDR07891	06_01-B07	EST(RND)	W01C054D14	pDONR221			FRRS1	391059		Hs.454779	Ferric-chelate reductase 1						NM_001013660.2	NP_001013682.2	VALIDATED	Pfs	0.985	1.000	592	1779	1	1777	626	1	583
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C054D15	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	THR07790	06_01-B08	EST(RND)	W01C054D16	pDONR221			MARCH6	10299		Hs.432862	Membrane-associated ring finger (C3HC4) 6						NM_005885.2	NP_005876.2	PROVISIONAL	OK	1.000	1.000	910	2733	1	2730	910	1	910
IKAKEN	TST07733	06_01-B09	EST	W01C054D17	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	TST07733	06_01-B09	EST	W01C054D18	pDONR221			FAM69A	388650									NM_001006605.3	NP_001006606.2	REVIEWED	OK	1.000	1.000	428	1287	1	1284	428	1	428
IKAKEN	WMC08458	06_01-B10	EST	W01C054D19	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06_01-B10	EST	W01C054D20	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK001A01	06_01-B11	IMS	W01C054D21	pDONR221															
IKAKEN	SK001A01	06_01-B11	IMS	W01C054D22	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C054D23	pDONR221															
IKAKEN	SK001A03	06_01-B12	IMS	W01C054D24	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C054E01	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C054E02	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C054E03	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C054E04	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C054E05	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C054E06	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C054E07	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C054E08	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C054E09	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C054E10	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C054E11	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C054E12	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C054E13	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C054E14	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C054E15	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C054E16	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C054E17	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C054E18	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C054E19	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C054E20	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C054E21	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C054E22	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C054E23	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C054E24	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C054F01	pDONR221															
IKAKEN	SK001A04	06_01-C01	IMS	W01C054F02	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C054F03	pDONR221															
IKAKEN	SK001B01	06_01-C02	IMS	W01C054F04	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C054F05	pDONR221															
IKAKEN	SK001B02	06_01-C03	IMS	W01C054F06	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C054F07	pDONR221															
IKAKEN	SK001C01	06_01-C04	IMS	W01C054F08	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C054F09	pDONR221															
IKAKEN	SK001C02	06_01-C05	IMS	W01C054F10	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C054F11	pDONR221															
IKAKEN	SK001C03	06_01-C06	IMS	W01C054F12	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C054F13	pDONR221															
IKAKEN	SK001D01	06_01-C07	IMS	W01C054F14	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C054F15	pDONR221															
IKAKEN	SK001D02	06_01-C08	IMS	W01C054F16	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C054F17	pDONR221															
IKAKEN	SK001D03	06_01-C09	IMS	W01C054F18	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C054F19	pDONR221															
IKAKEN	SK001D04	06_01-C10	IMS	W01C054F20	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C054F21	pDONR221															
IKAKEN	SK001E01	06_01-C11	IMS	W01C054F22	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C054F23	pDONR221															
IKAKEN	SK001E02	06_01-C12	IMS	W01C054F24	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C054G01	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C054G02	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C054G03	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C054G04	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C054G05	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C054G06	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C054G07	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C054G08	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C054G09	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C054G10	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C054G11	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C054G12	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C054G13	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C054G14	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C054G15	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C054G16	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C054G17	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C054G18	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C054G19	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C054G20	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C054G21	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C054G22	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C054G23	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C054G24	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C054H01	pDONR221															
IKAKEN	SK001E03	06_01-D01	IMS	W01C054H02	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C054H03	pDONR221															
IKAKEN	SK001F01	06_01-D02	IMS	W01C054H04	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C054H05	pDONR221															
IKAKEN	SK001F02	06_01-D03	IMS	W01C054H06	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C054H07	pDONR221															
IKAKEN	SK001F03	06_01-D04	IMS	W01C054H08	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C054H09	pDONR221															
IKAKEN	SK001F04	06_01-D05	IMS	W01C054H10	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C054H11	pDONR221															
IKAKEN	SK001G01	06_01-D06	IMS	W01C054H12	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C054H13	pDONR221															
IKAKEN	SK001G02	06_01-D07	IMS	W01C054H14	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C054H15	pDONR221															
IKAKEN	SK001G03	06_01-D08	IMS	W01C054H16	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C054H17	pDONR221															
IKAKEN	SK001H01	06_01-D09	IMS	W01C054H18	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C054H19	pDONR221															
IKAKEN	SK001H02	06_01-D10	IMS	W01C054H20	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C054H21	pDONR221															
IKAKEN	SK001H03	06_01-D11	IMS	W01C054H22	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C054H23	pDONR221															
IKAKEN	SK002A01	06_01-D12	IMS	W01C054H24	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C054I01	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C054I02	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C054I03	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C054I04	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C054I05	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C054I06	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C054I07	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C054I08	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C054I09	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C054I10	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C054I11	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C054I12	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C054I13	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C054I14	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C054I15	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C054I16	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C054I17	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C054I18	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C054I19	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C054I20	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C054I21	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C054I22	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C054I23	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C054I24	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C054J01	pDONR221															
IKAKEN	SK002B01	06_01-E01	IMS	W01C054J02	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C054J03	pDONR221															
IKAKEN	SK002B03	06_01-E02	IMS	W01C054J04	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C054J05	pDONR221															
IKAKEN	SK002B05	06_01-E03	IMS	W01C054J06	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C054J07	pDONR221															
IKAKEN	SK002C01	06_01-E04	IMS	W01C054J08	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C054J09	pDONR221															
IKAKEN	SK002D01	06_01-E05	IMS	W01C054J10	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C054J11	pDONR221															
IKAKEN	SK002E01	06_01-E06	IMS	W01C054J12	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C054J13	pDONR221															
IKAKEN	SK002F01	06_01-E07	IMS	W01C054J14	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C054J15	pDONR221															
IKAKEN	SK002F08	06_01-E08	IMS	W01C054J16	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C054J17	pDONR221															
IKAKEN	SK002G01	06_01-E09	IMS	W01C054J18	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C054J19	pDONR221															
IKAKEN	SK001B03	06_01-E10	IMS	W01C054J20	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C054J21	pDONR221															
IKAKEN	SK001C04	06_01-E11	IMS	W01C054J22	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C054J23	pDONR221															
IKAKEN	SK002H01	06_01-E12	IMS	W01C054J24	pDONR221															
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C054K01	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C054K02	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C054K03	pDONR221			LOC222052	222052											
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C054K04	pDONR221			LOC222052	222052											
IKAKEN	CBL01081	06_01-F03	EST	W01C054K05	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBL01081	06_01-F03	EST	W01C054K06	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBR02422	06_01-F04	EST	W01C054K07	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02422	06_01-F04	EST	W01C054K08	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02670	06_01-F05	EST	W01C054K09	pDONR221															
IKAKEN	CBR02670	06_01-F05	EST	W01C054K10	pDONR221															
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C054K11	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C054K12	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	DAT03661	06_01-F07	EST	W01C054K13	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_01-F07	EST	W01C054K14	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT04650	06_01-F08	EST	W01C054K15	pDONR221															
IKAKEN	DAT04650	06_01-F08	EST	W01C054K16	pDONR221															
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C054K17	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C054K18	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C054K19	pDONR221															
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C054K20	pDONR221															
IKAKEN	HEP00193	06_01-F11	EST	W01C054K21	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP00193	06_01-F11	EST	W01C054K22	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP09077	06_01-F12	EST	W01C054K23	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	HEP09077	06_01-F12	EST	W01C054K24	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C054L01	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06_01-F01	EST(RND)	W01C054L02	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C054L03	pDONR221			LOC222052	222052											
IKAKEN	AMR03934	06_01-F02	EST(RND)	W01C054L04	pDONR221			LOC222052	222052											
IKAKEN	CBL01081	06_01-F03	EST	W01C054L05	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBL01081	06_01-F03	EST	W01C054L06	pDONR221			LOC407835	407835		Hs.592273	Mitogen-activated protein kinase kinase 2 pseudogene								
IKAKEN	CBR02422	06_01-F04	EST	W01C054L07	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02422	06_01-F04	EST	W01C054L08	pDONR221			LOC389137	389137		Hs.380752	Hypothetical LOC389137						XM_371655.3	XP_371655.3	MODEL	Cg	0.884	1.000	284	756	1	753	284	1	284
IKAKEN	CBR02670	06_01-F05	EST	W01C054L09	pDONR221															
IKAKEN	CBR02670	06_01-F05	EST	W01C054L10	pDONR221															
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C054L11	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	CNR06682	06_01-F06	EST(RND)	W01C054L12	pDONR221			CLINT1	9685		Hs.711787	Clathrin interactor 1						NM_014666.2	NP_055481.1	VALIDATED	OK	1.000	1.000	625	1878	1	1875	625	1	625
IKAKEN	DAT03661	06_01-F07	EST	W01C054L13	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_01-F07	EST	W01C054L14	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT04650	06_01-F08	EST	W01C054L15	pDONR221															
IKAKEN	DAT04650	06_01-F08	EST	W01C054L16	pDONR221															
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C054L17	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06_01-F09	EST(RND)	W01C054L18	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C054L19	pDONR221															
IKAKEN	HCR04067	06_01-F10	EST(RND)	W01C054L20	pDONR221															
IKAKEN	HEP00193	06_01-F11	EST	W01C054L21	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP00193	06_01-F11	EST	W01C054L22	pDONR221			RP11-484H12.6	283523		Hs.507382	Telomeric repeat binding factor (NIMA-interacting) 1 pseudogene						XM_001732870.1	XP_001732922.1	MODEL	Pfs	0.870	0.937	391	1122	1	1120	395	15	395
IKAKEN	HEP09077	06_01-F12	EST	W01C054L23	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	HEP09077	06_01-F12	EST	W01C054L24	pDONR221			CDC2L1	984		Hs.709182	Cell division cycle 2-like 1 (PITSLRE proteins)						XM_001713748.1	XP_001713800.1	MODEL	C	1.000	1.000	439	1694	375	1691	439	1	439
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C054M01	pDONR221															
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C054M02	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C054M03	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C054M04	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C054M05	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C054M06	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C054M07	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C054M08	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C054M09	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C054M10	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C054M11	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C054M12	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C054M13	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C054M14	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C054M15	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C054M16	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C054M17	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C054M18	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C054M19	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C054M20	pDONR221															
IKAKEN	JTH07860	06_01-G11	EST	W01C054M21	pDONR221				401322											
IKAKEN	JTH07860	06_01-G11	EST	W01C054M22	pDONR221				401322											
IKAKEN	JTH11146	06_01-G12	EST	W01C054M23	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	JTH11146	06_01-G12	EST	W01C054M24	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C054N01	pDONR221															
IKAKEN	HKR12708	06_01-G01	EST(RND)	W01C054N02	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C054N03	pDONR221															
IKAKEN	IMSRT019	06_01-G02	IMS	W01C054N04	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C054N05	pDONR221															
IKAKEN	IMSRT030	06_01-G03	IMS	W01C054N06	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C054N07	pDONR221															
IKAKEN	IMSRT035	06_01-G04	IMS	W01C054N08	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C054N09	pDONR221															
IKAKEN	IMSRT049	06_01-G05	IMS	W01C054N10	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C054N11	pDONR221															
IKAKEN	IMSRT055	06_01-G06	IMS	W01C054N12	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C054N13	pDONR221															
IKAKEN	IMSRT069	06_01-G07	IMS	W01C054N14	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C054N15	pDONR221															
IKAKEN	IMSRT071	06_01-G08	IMS	W01C054N16	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C054N17	pDONR221															
IKAKEN	IMSRT072	06_01-G09	IMS	W01C054N18	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C054N19	pDONR221															
IKAKEN	IMSRT082	06_01-G10	IMS	W01C054N20	pDONR221															
IKAKEN	JTH07860	06_01-G11	EST	W01C054N21	pDONR221				401322											
IKAKEN	JTH07860	06_01-G11	EST	W01C054N22	pDONR221				401322											
IKAKEN	JTH11146	06_01-G12	EST	W01C054N23	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	JTH11146	06_01-G12	EST	W01C054N24	pDONR221			RFT1	91869		Hs.631910	RFT1 homolog (S. cerevisiae)						NM_052859.3	NP_443091.1	REVIEWED	Pfs	0.538	0.538	13	375	327	365	541	488	500
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C054O01	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C054O02	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KDN02467	06_01-H02	EST	W01C054O03	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	06_01-H02	EST	W01C054O04	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C054O05	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C054O06	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C054O07	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C054O08	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C054O09	pDONR221															
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C054O10	pDONR221															
IKAKEN	LFL05785	06_01-H06	EST	W01C054O11	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LFL05785	06_01-H06	EST	W01C054O12	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LNG10447	06_01-H07	EST	W01C054O13	pDONR221				441399											
IKAKEN	LNG10447	06_01-H07	EST	W01C054O14	pDONR221				441399											
IKAKEN	MPG07137	06_01-H08	EST	W01C054O15	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06_01-H08	EST	W01C054O16	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C054O17	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C054O18	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C054O19	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C054O20	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	PCD12917	06_01-H11	EST	W01C054O21	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PCD12917	06_01-H11	EST	W01C054O22	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C054O23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C054O24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C054P01	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR02431	06_01-H01	EST(RND)	W01C054P02	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KDN02467	06_01-H02	EST	W01C054P03	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	06_01-H02	EST	W01C054P04	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C054P05	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06_01-H03	EST(RND)	W01C054P06	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C054P07	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05642	06_01-H04	EST(RND)	W01C054P08	pDONR221			PANK1	53354		Hs.715502	Pantothenate kinase 1						NM_138316.2	NP_612189.2	REVIEWED	OK	1.000	1.000	314	945	1	942	314	1	314
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C054P09	pDONR221															
IKAKEN	KMR05981	06_01-H05	EST(RND)	W01C054P10	pDONR221															
IKAKEN	LFL05785	06_01-H06	EST	W01C054P11	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LFL05785	06_01-H06	EST	W01C054P12	pDONR221			FAM21A	387680		Hs.645272	Family with sequence similarity 21, member A						NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.995	0.996	1090	3273	3	3270	1341	252	1341
IKAKEN	LNG10447	06_01-H07	EST	W01C054P13	pDONR221				441399											
IKAKEN	LNG10447	06_01-H07	EST	W01C054P14	pDONR221				441399											
IKAKEN	MPG07137	06_01-H08	EST	W01C054P15	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06_01-H08	EST	W01C054P16	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C054P17	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06_01-H09	EST(RND)	W01C054P18	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C054P19	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06_01-H10	EST(RND)	W01C054P20	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	PCD12917	06_01-H11	EST	W01C054P21	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PCD12917	06_01-H11	EST	W01C054P22	pDONR221			TNNC2	7125		Hs.182421	Troponin C type 2 (fast)						NM_003279.2	NP_003270.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C054P23	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06_01-H12	EST(RND)	W01C054P24	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PNS00715	06_02-A01	EST	W01C055A01	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	PNS00715	06_02-A01	EST	W01C055A02	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	RCT05896	06_02-A02	EST	W01C055A03	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	RCT05896	06_02-A02	EST	W01C055A04	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	STM01646	06_02-A03	EST	W01C055A05	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	STM01646	06_02-A03	EST	W01C055A06	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	SYN07416	06_02-A04	EST	W01C055A07	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	SYN07416	06_02-A04	EST	W01C055A08	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C055A09	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C055A10	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	UBA01031	06_02-A06	EST	W01C055A11	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	UBA01031	06_02-A06	EST	W01C055A12	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C055A13	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C055A14	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C055A15	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C055A16	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C055A17	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C055A18	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C055A19	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C055A20	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C055A21	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C055A22	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C055A23	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C055A24	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	PNS00715	06_02-A01	EST	W01C055B01	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	PNS00715	06_02-A01	EST	W01C055B02	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	RCT05896	06_02-A02	EST	W01C055B03	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	RCT05896	06_02-A02	EST	W01C055B04	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	STM01646	06_02-A03	EST	W01C055B05	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	STM01646	06_02-A03	EST	W01C055B06	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	SYN07416	06_02-A04	EST	W01C055B07	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	SYN07416	06_02-A04	EST	W01C055B08	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C055B09	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C055B10	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	UBA01031	06_02-A06	EST	W01C055B11	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	UBA01031	06_02-A06	EST	W01C055B12	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C055B13	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C055B14	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C055B15	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C055B16	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C055B17	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C055B18	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C055B19	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C055B20	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C055B21	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C055B22	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C055B23	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C055B24	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C055C01	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C055C02	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C055C03	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C055C04	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C055C05	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C055C06	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C055C07	pDONR221															
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C055C08	pDONR221															
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C055C09	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C055C10	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C055C11	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C055C12	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C055C13	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C055C14	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C055C15	pDONR221															
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C055C16	pDONR221															
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C055C17	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C055C18	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C055C19	pDONR221			KIAA1245	149013											
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C055C20	pDONR221			KIAA1245	149013											
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C055C21	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C055C22	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C055C23	pDONR221															
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C055C24	pDONR221															
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C055D01	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C055D02	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C055D03	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C055D04	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C055D05	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C055D06	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C055D07	pDONR221															
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C055D08	pDONR221															
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C055D09	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C055D10	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C055D11	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C055D12	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C055D13	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C055D14	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C055D15	pDONR221															
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C055D16	pDONR221															
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C055D17	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C055D18	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C055D19	pDONR221			KIAA1245	149013											
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C055D20	pDONR221			KIAA1245	149013											
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C055D21	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C055D22	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C055D23	pDONR221															
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C055D24	pDONR221															
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C055E01	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C055E02	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C055E03	pDONR221															
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C055E04	pDONR221															
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C055E05	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C055E06	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C055E07	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C055E08	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C055E09	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C055E10	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C055E11	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C055E12	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C055E13	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C055E14	pDONR221															
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C055E15	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C055E16	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C055E17	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C055E18	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C055E19	pDONR221			IGLJ3	28831											
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C055E20	pDONR221			IGLJ3	28831											
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C055E21	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C055E22	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C055E23	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C055E24	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C055F01	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C055F02	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C055F03	pDONR221															
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C055F04	pDONR221															
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C055F05	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C055F06	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C055F07	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C055F08	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C055F09	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C055F10	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C055F11	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C055F12	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C055F13	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C055F14	pDONR221															
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C055F15	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C055F16	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C055F17	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C055F18	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C055F19	pDONR221			IGLJ3	28831											
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C055F20	pDONR221			IGLJ3	28831											
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C055F21	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C055F22	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C055F23	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C055F24	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C055G01	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C055G02	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C055G03	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C055G04	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C055G05	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C055G06	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C055G07	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C055G08	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C055G09	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C055G10	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C055G11	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C055G12	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C055G13	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C055G14	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C055G15	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C055G16	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C055G17	pDONR221				440280											
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C055G18	pDONR221				440280											
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C055G19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C055G20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C055G21	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C055G22	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C055G23	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C055G24	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C055H01	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C055H02	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C055H03	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C055H04	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C055H05	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C055H06	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C055H07	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C055H08	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C055H09	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C055H10	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C055H11	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C055H12	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C055H13	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C055H14	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C055H15	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C055H16	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C055H17	pDONR221				440280											
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C055H18	pDONR221				440280											
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C055H19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C055H20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C055H21	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C055H22	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C055H23	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C055H24	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C055I01	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C055I02	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C055I03	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C055I04	pDONR221			TRY6	154754																					
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C055I05	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C055I06	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C055I07	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C055I08	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C055I09	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C055I10	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C055I11	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C055I12	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C055I13	pDONR221															
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C055I14	pDONR221															
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C055I15	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C055I16	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C055I17	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C055I18	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C055I19	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C055I20	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C055I21	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C055I22	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C055I23	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C055I24	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C055J01	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C055J02	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C055J03	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C055J04	pDONR221			TRY6	154754																					
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C055J05	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C055J06	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C055J07	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C055J08	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C055J09	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C055J10	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C055J11	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C055J12	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C055J13	pDONR221															
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C055J14	pDONR221															
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C055J15	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C055J16	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C055J17	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C055J18	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C055J19	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C055J20	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C055J21	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C055J22	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C055J23	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C055J24	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C055K01	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C055K02	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C055K03	pDONR221															
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C055K04	pDONR221															
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C055K05	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C055K06	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C055K07	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C055K08	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C055K09	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C055K10	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	DMC04010	06_02-F06	EST	W01C055K11	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC04010	06_02-F06	EST	W01C055K12	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC05660	06_02-F07	EST	W01C055K13	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05660	06_02-F07	EST	W01C055K14	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC08208	06_02-F08	EST	W01C055K15	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06_02-F08	EST	W01C055K16	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C055K17	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C055K18	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	LFL01807	06_02-F10	EST	W01C055K19	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06_02-F10	EST	W01C055K20	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	CAS12240	06_02-F11	EST	W01C055K21	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	CAS12240	06_02-F11	EST	W01C055K22	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C055K23	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C055K24	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C055L01	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C055L02	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C055L03	pDONR221															
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C055L04	pDONR221															
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C055L05	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C055L06	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C055L07	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C055L08	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C055L09	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C055L10	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	DMC04010	06_02-F06	EST	W01C055L11	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC04010	06_02-F06	EST	W01C055L12	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC05660	06_02-F07	EST	W01C055L13	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05660	06_02-F07	EST	W01C055L14	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC08208	06_02-F08	EST	W01C055L15	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06_02-F08	EST	W01C055L16	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C055L17	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C055L18	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	LFL01807	06_02-F10	EST	W01C055L19	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06_02-F10	EST	W01C055L20	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	CAS12240	06_02-F11	EST	W01C055L21	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	CAS12240	06_02-F11	EST	W01C055L22	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C055L23	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C055L24	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	STM06465	06_02-G01	EST	W01C055M01	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	STM06465	06_02-G01	EST	W01C055M02	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	DAT03661	06_02-G02	EST	W01C055M03	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_02-G02	EST	W01C055M04	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	SLV02550	06_02-G03	EST	W01C055M05	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06_02-G03	EST	W01C055M06	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	TST06995	06_02-G04	EST	W01C055M07	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST06995	06_02-G04	EST	W01C055M08	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST08313	06_02-G05	EST	W01C055M09	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	TST08313	06_02-G05	EST	W01C055M10	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	ARe31B03.ab1	06_02-G06		W01C055M11	pDONR221															
IKAKEN	ARe31B03.ab1	06_02-G06		W01C055M12	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C055M13	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C055M14	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C055M15	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C055M16	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C055M17	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C055M18	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C055M19	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C055M20	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C055M21	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C055M22	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C055M23	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C055M24	pDONR221															
IKAKEN	STM06465	06_02-G01	EST	W01C055N01	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	STM06465	06_02-G01	EST	W01C055N02	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	DAT03661	06_02-G02	EST	W01C055N03	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_02-G02	EST	W01C055N04	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	SLV02550	06_02-G03	EST	W01C055N05	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06_02-G03	EST	W01C055N06	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	TST06995	06_02-G04	EST	W01C055N07	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST06995	06_02-G04	EST	W01C055N08	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST08313	06_02-G05	EST	W01C055N09	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	TST08313	06_02-G05	EST	W01C055N10	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	ARe31B03.ab1	06_02-G06		W01C055N11	pDONR221															
IKAKEN	ARe31B03.ab1	06_02-G06		W01C055N12	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C055N13	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C055N14	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C055N15	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C055N16	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C055N17	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C055N18	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C055N19	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C055N20	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C055N21	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C055N22	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C055N23	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C055N24	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C055O01	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C055O02	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C055O03	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C055O04	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C055O05	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C055O06	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C055O07	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C055O08	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C055O09	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C055O10	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C055O11	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C055O12	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C055O13	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C055O14	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C055O15	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C055O16	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C055O17	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C055O18	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C055O19	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C055O20	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C055O21	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C055O22	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C055O23	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C055O24	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C055P01	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C055P02	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C055P03	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C055P04	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C055P05	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C055P06	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C055P07	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C055P08	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C055P09	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C055P10	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C055P11	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C055P12	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C055P13	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C055P14	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C055P15	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C055P16	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C055P17	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C055P18	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C055P19	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C055P20	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C055P21	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C055P22	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C055P23	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C055P24	pDONR221															
IKAKEN	PNS00715	06_02-A01	EST	W01C056A01	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	PNS00715	06_02-A01	EST	W01C056A02	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	RCT05896	06_02-A02	EST	W01C056A03	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	RCT05896	06_02-A02	EST	W01C056A04	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	STM01646	06_02-A03	EST	W01C056A05	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	STM01646	06_02-A03	EST	W01C056A06	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	SYN07416	06_02-A04	EST	W01C056A07	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	SYN07416	06_02-A04	EST	W01C056A08	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C056A09	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C056A10	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	UBA01031	06_02-A06	EST	W01C056A11	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	UBA01031	06_02-A06	EST	W01C056A12	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C056A13	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C056A14	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C056A15	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C056A16	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C056A17	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C056A18	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C056A19	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C056A20	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C056A21	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C056A22	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C056A23	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C056A24	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	PNS00715	06_02-A01	EST	W01C056B01	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	PNS00715	06_02-A01	EST	W01C056B02	pDONR221			CIR	9541		Hs.632531	CBF1 interacting corepressor						NM_004882.3	NP_004873.3	VALIDATED	Pfs	0.955	1.000	202	609	1	607	450	1	193
IKAKEN	RCT05896	06_02-A02	EST	W01C056B03	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	RCT05896	06_02-A02	EST	W01C056B04	pDONR221			SPCS2	9789		Hs.705711	Signal peptidase complex subunit 2 homolog (S. cerevisiae)						NM_014752.2	NP_055567.2	VALIDATED	Cg	0.974	1.000	232	699	1	696	226	1	226
IKAKEN	STM01646	06_02-A03	EST	W01C056B05	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	STM01646	06_02-A03	EST	W01C056B06	pDONR221			CHIA	27159		Hs.128814	Chitinase, acidic						NM_201653.2	NP_970615.2	VALIDATED	OK	1.000	1.000	476	1431	1	1428	476	1	476
IKAKEN	SYN07416	06_02-A04	EST	W01C056B07	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	SYN07416	06_02-A04	EST	W01C056B08	pDONR221			PTGS1	5742		Hs.201978	Prostaglandin-endoperoxide synthase 1 (prostaglandin G/H synthase and cyclooxygenase)						NM_080591.1	NP_542158.1	REVIEWED	OK	1.000	1.000	562	1689	1	1686	562	1	562
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C056B09	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	THR09367	06_02-A05	EST(RND)	W01C056B10	pDONR221			KIAA1128	54462		Hs.461988	KIAA1128						NM_018999.2	NP_061872.2	VALIDATED	P	1.000	1.000	566	1701	1	1698	834	269	834
IKAKEN	UBA01031	06_02-A06	EST	W01C056B11	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	UBA01031	06_02-A06	EST	W01C056B12	pDONR221			MFAP2	4237		Hs.389137	Microfibrillar-associated protein 2						NM_002403.3	NP_002394.1	REVIEWED	OK	1.000	1.000	183	552	1	549	183	1	183
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C056B13	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRACE3015558	06_02-A07	EST(F-)	W01C056B14	pDONR221			RELN	5649		Hs.655654	Reelin						NM_173054.2	NP_774959.1	REVIEWED	P	1.000	1.000	878	2637	1	2634	3458	2550	3427
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C056B15	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRALZ2006557	06_02-A08	EST(F-)	W01C056B16	pDONR221			DKFZp761P0212	284187											
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C056B17	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06_02-A09	EST(F-)	W01C056B18	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C056B19	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-HLUNG2007494	06_02-A10	EST(F-)	W01C056B20	pDONR221			MMP19	4327		Hs.591033	Matrix metallopeptidase 19						NM_002429.4	NP_002420.1	REVIEWED	Pfs	0.351	0.351	57	258	3	173	508	382	438
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C056B21	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-ACTVT2000141	06_02-A11	EST(F-)	W01C056B22	pDONR221			GVIN1	387751		Hs.494757	GTPase, very large interferon inducible 1						XM_940224.2	XP_945317.1	MODEL										
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C056B23	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06_02-A12	EST(F-)	W01C056B24	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C056C01	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C056C02	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C056C03	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C056C04	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C056C05	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C056C06	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C056C07	pDONR221															
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C056C08	pDONR221															
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C056C09	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C056C10	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C056C11	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C056C12	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C056C13	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C056C14	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C056C15	pDONR221															
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C056C16	pDONR221															
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C056C17	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C056C18	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C056C19	pDONR221			KIAA1245	149013											
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C056C20	pDONR221			KIAA1245	149013											
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C056C21	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C056C22	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C056C23	pDONR221															
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C056C24	pDONR221															
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C056D01	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06_02-B01	EST(F-)	W01C056D02	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C056D03	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-LIVER2009430	06_02-B02	EST(F-)	W01C056D04	pDONR221			tAKR	389932									XM_001715222.1	XP_001715274.1	MODEL		0.977	0.977	128	423	1	384	334	1	128
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C056D05	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE2037207	06_02-B03	EST(F-)	W01C056D06	pDONR221			LOC401431	401431																					
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C056D07	pDONR221															
IKAKEN	F-BRACE3026285	06_02-B04	EST(F-)	W01C056D08	pDONR221															
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C056D09	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-MESAN2012266	06_02-B05	EST(F-)	W01C056D10	pDONR221			RBM15B	29890		Hs.118738	RNA binding motif protein 15B						NM_013286.3	NP_037418.3	VALIDATED	P	1.000	1.000	563	1692	1	1689	890	328	890
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C056D11	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAMY2028898	06_02-B06	EST(F-)	W01C056D12	pDONR221			PCDHB17	54661		Hs.284307	Protocadherin beta 17 pseudogene								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C056D13	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRAWH3030412	06_02-B07	EST(F-)	W01C056D14	pDONR221			C20orf191	149934		Hs.711274	Chromosome 20 open reading frame 191								
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C056D15	pDONR221															
IKAKEN	F-BRHIP2005630	06_02-B08	EST(F-)	W01C056D16	pDONR221															
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C056D17	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06_02-B09	EST(F-)	W01C056D18	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C056D19	pDONR221			KIAA1245	149013											
IKAKEN	F-BRACE3038080	06_02-B10	EST(F-)	W01C056D20	pDONR221			KIAA1245	149013											
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C056D21	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRAWH3012929	06_02-B11	EST(F-)	W01C056D22	pDONR221			HACL1	26061		Hs.63290	2-hydroxyacyl-CoA lyase 1						NM_012260.2	NP_036392.2	VALIDATED	Pfs	0.833	1.000	144	360	1	359	578	1	144
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C056D23	pDONR221															
IKAKEN	F-BRHIP3032243	06_02-B12	EST(F-)	W01C056D24	pDONR221															
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C056E01	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C056E02	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C056E03	pDONR221															
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C056E04	pDONR221															
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C056E05	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C056E06	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C056E07	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C056E08	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C056E09	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C056E10	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C056E11	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C056E12	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C056E13	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C056E14	pDONR221															
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C056E15	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C056E16	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C056E17	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C056E18	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C056E19	pDONR221			IGLJ3	28831											
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C056E20	pDONR221			IGLJ3	28831											
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C056E21	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C056E22	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C056E23	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C056E24	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C056F01	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRACE2008403	06_02-C01	EST(F-)	W01C056F02	pDONR221			KIAA1644	85352		Hs.6829	KIAA1644						NM_001099294.1	NP_001092764.1	PREDICTED	P	1.000	1.000	120	363	1	360	199	80	199
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C056F03	pDONR221															
IKAKEN	F-BRAMY2032461	06_02-C02	EST(F-)	W01C056F04	pDONR221															
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C056F05	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-BRHIP2011791	06_02-C03	EST(F-)	W01C056F06	pDONR221			RPGRIP1L	23322		Hs.298382	RPGRIP1-like						NM_001127897.1	NP_001121369.1	REVIEWED	P	1.000	1.000	1044	3135	1	3132	1235	192	1235
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C056F07	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06_02-C04	EST(F-)	W01C056F08	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C056F09	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C05	EST(F-)	W01C056F10	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C056F11	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C06	EST(F-)	W01C056F12	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C056F13	pDONR221															
IKAKEN	F-CERVX2000844	06_02-C07	EST(F-)	W01C056F14	pDONR221															
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C056F15	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-NT2RI2001067	06_02-C08	EST(F-)	W01C056F16	pDONR221			OR3A1	4994		Hs.647410	Olfactory receptor, family 3, subfamily A, member 1						NM_002550.1	NP_002541.1	PROVISIONAL		0.812	0.812	314	948	1	942	315	1	314
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C056F17	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-PLACE7018402	06_02-C09	EST(F-)	W01C056F18	pDONR221			LOC200261	200261		Hs.352228	Hypothetical LOC200261																		
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C056F19	pDONR221			IGLJ3	28831											
IKAKEN	F-SPLEN2001028	06_02-C10	EST(F-)	W01C056F20	pDONR221			IGLJ3	28831											
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C056F21	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-OCBBF3024129	06_02-C11	EST(F-)	W01C056F22	pDONR221			BAT2L	84726		Hs.495349	HLA-B associated transcript 2-like						NM_013318.3	NP_037450.2	VALIDATED	P	1.000	1.000	673	2022	1	2019	2229	1557	2229
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C056F23	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-PROST2009455	06_02-C12	EST(F-)	W01C056F24	pDONR221			C9orf130	100128782		Hs.652504	Chromosome 9 open reading frame 130						XM_001722853.1	XP_001722905.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C056G01	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C056G02	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C056G03	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C056G04	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C056G05	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C056G06	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C056G07	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C056G08	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C056G09	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C056G10	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C056G11	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C056G12	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C056G13	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C056G14	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C056G15	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C056G16	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C056G17	pDONR221				440280											
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C056G18	pDONR221				440280											
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C056G19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C056G20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C056G21	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C056G22	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C056G23	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C056G24	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C056H01	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D01	EST(F-)	W01C056H02	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C056H03	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-TESTI2041421	06_02-D02	EST(F-)	W01C056H04	pDONR221			LOC285423	285423		Hs.591689	Hypothetical gene supported by BC031092																		
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C056H05	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-PUAEN1000126	06_02-D03	EST(F-)	W01C056H06	pDONR221			HIST1H4D	8360		Hs.248179	Histone cluster 1, H4d						NM_003539.3	NP_003530.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C056H07	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D04	EST(F-)	W01C056H08	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C056H09	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI4043236	06_02-D05	EST(F-)	W01C056H10	pDONR221			GSTTP1	25774		Hs.652490	Glutathione S-transferase theta pseudogene 1								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C056H11	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D06	EST(F-)	W01C056H12	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C056H13	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-TESTI2020499	06_02-D07	EST(F-)	W01C056H14	pDONR221			TTTY1	50858		Hs.584729	Testis-specific transcript, Y-linked 1 (non-protein coding)								
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C056H15	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-NETRP2006424	06_02-D08	EST(F-)	W01C056H16	pDONR221			C11orf21	29125		Hs.559181	Chromosome 11 open reading frame 21						NM_001142946.1	NP_001136418.1	INFERRED	Pfs	0.825	1.000	160	399	2	396	178	19	178
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C056H17	pDONR221				440280											
IKAKEN	F-PLACE7010254	06_02-D09	EST(F-)	W01C056H18	pDONR221				440280											
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C056H19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-SYNOV2007785	06_02-D10	EST(F-)	W01C056H20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.333	0.333	24	423	161	232	311	53	76
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C056H21	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-TESTI4047760	06_02-D11	EST(F-)	W01C056H22	pDONR221			OR4N2	390429		Hs.512490	Olfactory receptor, family 4, subfamily N, member 2						NM_001004723.1	NP_001004723.1	PROVISIONAL	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C056H23	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-NT2RI1000144	06_02-D12	EST(F-)	W01C056H24	pDONR221			EMID2	136227		Hs.654854	EMI domain containing 2						NM_133457.2	NP_597714.2	VALIDATED	Cfs	0.995	1.000	441	1325	1	1322	439	1	439
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C056I01	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C056I02	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C056I03	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C056I04	pDONR221			TRY6	154754																					
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C056I05	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C056I06	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C056I07	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C056I08	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C056I09	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C056I10	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C056I11	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C056I12	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C056I13	pDONR221															
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C056I14	pDONR221															
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C056I15	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C056I16	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C056I17	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C056I18	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C056I19	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C056I20	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C056I21	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C056I22	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C056I23	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C056I24	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C056J01	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-TESTI2010459	06_02-E01	EST(F-)	W01C056J02	pDONR221			HIST1H4B	8366		Hs.143080	Histone cluster 1, H4b						NM_003544.2	NP_003535.1	REVIEWED	OK	1.000	1.000	103	312	1	309	103	1	103
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C056J03	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3032479	06_02-E02	EST(F-)	W01C056J04	pDONR221			TRY6	154754																					
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C056J05	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-TKIDN2006380	06_02-E03	EST(F-)	W01C056J06	pDONR221			KIAA0087	9808		Hs.69749	KIAA0087						XM_001723668.1	XP_001723720.1	MODEL	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C056J07	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-UTERU3022928	06_02-E04	EST(F-)	W01C056J08	pDONR221			RICH2	9912		Hs.499758	Rho-type GTPase-activating protein RICH2						NM_014859.4	NP_055674.4	VALIDATED	Pfs	0.991	1.000	117	348	1	347	818	278	394
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C056J09	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-THYMU3033276	06_02-E05	EST(F-)	W01C056J10	pDONR221			TTTY14	83869		Hs.667793	Testis-specific transcript, Y-linked 14								
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C056J11	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-UTERU2025532	06_02-E06	EST(F-)	W01C056J12	pDONR221			C9orf117	286207		Hs.652519	Chromosome 9 open reading frame 117						NM_001012502.2	NP_001012520.2	PREDICTED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C056J13	pDONR221															
IKAKEN	F-THYMU3036548	06_02-E07	EST(F-)	W01C056J14	pDONR221															
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C056J15	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-TKIDN2013637	06_02-E08	EST(F-)	W01C056J16	pDONR221			ISM1	140862		Hs.559353	Isthmin 1 homolog (zebrafish)						NM_080826.1	NP_543016.1	VALIDATED	OK	1.000	1.000	464	1395	1	1392	464	1	464
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C056J17	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-UTERU2028963	06_02-E09	EST(F-)	W01C056J18	pDONR221			SNX29	92017		Hs.585745	Sorting nexin 29						NM_001080530.2	NP_001073999.2	PROVISIONAL	Pfs	0.364	0.426	55	546	159	323	428	4	50
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C056J19	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TLUNG2000603	06_02-E10	EST(F-)	W01C056J20	pDONR221			CEACAM19	56971		Hs.416925	Carcinoembryonic antigen-related cell adhesion molecule 19						NM_020219.3	NP_064604.2	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C056J21	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E11	EST(F-)	W01C056J22	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Ps	0.990	0.990	385	1362	205	1359	398	14	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C056J23	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-TRACH3027624	06_02-E12	EST(F-)	W01C056J24	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED	Pfs	0.886	0.891	333	1029	34	1026	398	66	398
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C056K01	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C056K02	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C056K03	pDONR221															
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C056K04	pDONR221															
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C056K05	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C056K06	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C056K07	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C056K08	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C056K09	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C056K10	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	DMC04010	06_02-F06	EST	W01C056K11	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC04010	06_02-F06	EST	W01C056K12	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC05660	06_02-F07	EST	W01C056K13	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05660	06_02-F07	EST	W01C056K14	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC08208	06_02-F08	EST	W01C056K15	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06_02-F08	EST	W01C056K16	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C056K17	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C056K18	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	LFL01807	06_02-F10	EST	W01C056K19	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06_02-F10	EST	W01C056K20	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	CAS12240	06_02-F11	EST	W01C056K21	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	CAS12240	06_02-F11	EST	W01C056K22	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C056K23	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C056K24	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C056L01	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-THYMU3041451	06_02-F01	EST(F-)	W01C056L02	pDONR221			CHD2	1106		Hs.220864	Chromodomain helicase DNA binding protein 2						NM_001271.3	NP_001262.3	REVIEWED	P	1.000	1.000	85	258	1	255	1828	1744	1828
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C056L03	pDONR221															
IKAKEN	F-TRACH2015609	06_02-F02	EST(F-)	W01C056L04	pDONR221															
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C056L05	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-THYMU3041667	06_02-F03	EST(F-)	W01C056L06	pDONR221			LRP5L	91355		Hs.634058	Low density lipoprotein receptor-related protein 5-like						NM_182492.2	NP_872298.1	VALIDATED	OK	1.000	1.000	252	759	1	756	252	1	252
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C056L07	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-TRACH3002565	06_02-F04	EST(F-)	W01C056L08	pDONR221			SMCHD1	23347		Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1						NM_015295.2	NP_056110.2	VALIDATED	Ps	0.996	0.996	449	1377	1	1347	2005	1	449
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C056L09	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	F-UTERU2020429	06_02-F05	EST(F-)	W01C056L10	pDONR221			KLK4	9622		Hs.218366	Kallikrein-related peptidase 4						NM_004917.3	NP_004908.3	REVIEWED	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	DMC04010	06_02-F06	EST	W01C056L11	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC04010	06_02-F06	EST	W01C056L12	pDONR221			CSGLCA-T	54480		Hs.647084	Chondroitin sulfate glucuronyltransferase						NM_019015.1	NP_061888.1	PROVISIONAL	OK	1.000	1.000	772	2319	1	2316	772	1	772
IKAKEN	DMC05660	06_02-F07	EST	W01C056L13	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC05660	06_02-F07	EST	W01C056L14	pDONR221			CCNG2	901		Hs.13291	Cyclin G2						NM_004354.2	NP_004345.1	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	DMC08208	06_02-F08	EST	W01C056L15	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06_02-F08	EST	W01C056L16	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C056L17	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	FCC111F05	06_02-F09	TOYOBO	W01C056L18	pDONR221			USP6	9098		Hs.448851	Ubiquitin specific peptidase 6 (Tre-2 oncogene)						NM_004505.2	NP_004496.2	VALIDATED		0.814	0.816	500	1650	1	1500	1406	1	499
IKAKEN	LFL01807	06_02-F10	EST	W01C056L19	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06_02-F10	EST	W01C056L20	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	CAS12240	06_02-F11	EST	W01C056L21	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	CAS12240	06_02-F11	EST	W01C056L22	pDONR221			MTMR10	54893		Hs.30141	Myotubularin related protein 10						NM_017762.2	NP_060232.2	VALIDATED	P	1.000	1.000	191	576	1	573	777	587	777
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C056L23	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	COR02584	06_02-F12	EST(RND)	W01C056L24	pDONR221			MCCC2	64087		Hs.604789	Methylcrotonoyl-Coenzyme A carboxylase 2 (beta)						NM_022132.4	NP_071415.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	STM06465	06_02-G01	EST	W01C056M01	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	STM06465	06_02-G01	EST	W01C056M02	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	DAT03661	06_02-G02	EST	W01C056M03	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_02-G02	EST	W01C056M04	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	SLV02550	06_02-G03	EST	W01C056M05	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06_02-G03	EST	W01C056M06	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	TST06995	06_02-G04	EST	W01C056M07	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST06995	06_02-G04	EST	W01C056M08	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST08313	06_02-G05	EST	W01C056M09	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	TST08313	06_02-G05	EST	W01C056M10	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	ARe31B03.ab1	06_02-G06		W01C056M11	pDONR221															
IKAKEN	ARe31B03.ab1	06_02-G06		W01C056M12	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C056M13	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C056M14	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C056M15	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C056M16	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C056M17	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C056M18	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C056M19	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C056M20	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C056M21	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C056M22	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C056M23	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C056M24	pDONR221															
IKAKEN	STM06465	06_02-G01	EST	W01C056N01	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	STM06465	06_02-G01	EST	W01C056N02	pDONR221			PGC	5225		Hs.1867	Progastricsin (pepsinogen C)						NM_002630.2	NP_002621.1	PROVISIONAL	C	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	DAT03661	06_02-G02	EST	W01C056N03	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_02-G02	EST	W01C056N04	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	SLV02550	06_02-G03	EST	W01C056N05	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06_02-G03	EST	W01C056N06	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	TST06995	06_02-G04	EST	W01C056N07	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST06995	06_02-G04	EST	W01C056N08	pDONR221			C15orf23	90417		Hs.525796	Chromosome 15 open reading frame 23						NM_033286.3	NP_150628.3	VALIDATED	OK	1.000	1.000	316	951	1	948	316	1	316
IKAKEN	TST08313	06_02-G05	EST	W01C056N09	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	TST08313	06_02-G05	EST	W01C056N10	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	ARe31B03.ab1	06_02-G06		W01C056N11	pDONR221															
IKAKEN	ARe31B03.ab1	06_02-G06		W01C056N12	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C056N13	pDONR221															
IKAKEN	ARe49C04.ab1	06_02-G07		W01C056N14	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C056N15	pDONR221															
IKAKEN	ARe17B12.ab1	06_02-G08		W01C056N16	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C056N17	pDONR221															
IKAKEN	HISCO_S01095-103_F08	06_02-G09	hisco_HUVEC	W01C056N18	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C056N19	pDONR221															
IKAKEN	ARe05B05.ab1	06_02-G10		W01C056N20	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C056N21	pDONR221															
IKAKEN	ARe67E02.ab1	06_02-G11		W01C056N22	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C056N23	pDONR221															
IKAKEN	HISCO_S02026A-104_M22	06_02-G12	hisco_OVA	W01C056N24	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C056O01	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C056O02	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C056O03	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C056O04	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C056O05	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C056O06	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C056O07	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C056O08	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C056O09	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C056O10	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C056O11	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C056O12	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C056O13	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C056O14	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C056O15	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C056O16	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C056O17	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C056O18	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C056O19	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C056O20	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C056O21	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C056O22	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C056O23	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C056O24	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C056P01	pDONR221															
IKAKEN	HISCO_S03002-06_M04	06_02-H01	hisco_THY	W01C056P02	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C056P03	pDONR221															
IKAKEN	HISCO_S01095-107_P11	06_02-H02	hisco_HUVEC	W01C056P04	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C056P05	pDONR221															
IKAKEN	HISCO_S01095-107_I18	06_02-H03	hisco_HUVEC	W01C056P06	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C056P07	pDONR221															
IKAKEN	HISCO_S03002-04_P18	06_02-H04	hisco_THY	W01C056P08	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C056P09	pDONR221															
IKAKEN	ARe74H03.ab1	06_02-H05		W01C056P10	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C056P11	pDONR221															
IKAKEN	ARa33G05.ab1	06_02-H06		W01C056P12	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C056P13	pDONR221															
IKAKEN	ARe31B06.ab1	06_02-H07		W01C056P14	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C056P15	pDONR221															
IKAKEN	RBb46H11.ab1	06_02-H08		W01C056P16	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C056P17	pDONR221															
IKAKEN	HISCO_S03002-06_O16	06_02-H09	hisco_THY	W01C056P18	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C056P19	pDONR221															
IKAKEN	ARa67G10.ab1	06_02-H10		W01C056P20	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C056P21	pDONR221															
IKAKEN	ARe70F06.ab1	06_02-H11		W01C056P22	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C056P23	pDONR221															
IKAKEN	ARa29A06.ab1	06_02-H12		W01C056P24	pDONR221															
IKAKEN	ARe35A04.ab1	06_03-A01		W01C057A01	pDONR221															
IKAKEN	ARe35A04.ab1	06_03-A01		W01C057A02	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C057A03	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C057A04	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C057A05	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C057A06	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C057A07	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C057A08	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C057A09	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C057A10	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C057A11	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C057A12	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C057A13	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C057A14	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C057A15	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C057A16	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C057A17	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C057A18	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C057A19	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C057A20	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C057A21	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C057A22	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C057A23	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C057A24	pDONR221															
IKAKEN	ARe35A04.ab1	06_03-A01		W01C057B01	pDONR221															
IKAKEN	ARe35A04.ab1	06_03-A01		W01C057B02	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C057B03	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C057B04	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C057B05	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C057B06	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C057B07	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C057B08	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C057B09	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C057B10	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C057B11	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C057B12	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C057B13	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C057B14	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C057B15	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C057B16	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C057B17	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C057B18	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C057B19	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C057B20	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C057B21	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C057B22	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C057B23	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C057B24	pDONR221															
IKAKEN	ARe03D03.ab1	06_03-B01		W01C057C01	pDONR221															
IKAKEN	ARe03D03.ab1	06_03-B01		W01C057C02	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C057C03	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C057C04	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C057C05	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C057C06	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C057C07	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C057C08	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C057C09	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C057C10	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C057C11	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C057C12	pDONR221															
IKAKEN	HRT03547	06_03-B07	EST	W01C057C13	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	HRT03547	06_03-B07	EST	W01C057C14	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C057C15	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C057C16	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C057C17	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C057C18	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	HRT01923	06_03-B10	EST	W01C057C19	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	HRT01923	06_03-B10	EST	W01C057C20	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C057C21	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C057C22	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C057C23	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C057C24	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	ARe03D03.ab1	06_03-B01		W01C057D01	pDONR221															
IKAKEN	ARe03D03.ab1	06_03-B01		W01C057D02	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C057D03	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C057D04	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C057D05	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C057D06	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C057D07	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C057D08	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C057D09	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C057D10	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C057D11	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C057D12	pDONR221															
IKAKEN	HRT03547	06_03-B07	EST	W01C057D13	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	HRT03547	06_03-B07	EST	W01C057D14	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C057D15	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C057D16	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C057D17	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C057D18	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	HRT01923	06_03-B10	EST	W01C057D19	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	HRT01923	06_03-B10	EST	W01C057D20	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C057D21	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C057D22	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C057D23	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C057D24	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C057E01	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C057E02	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C057E03	pDONR221															
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C057E04	pDONR221															
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C057E05	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C057E06	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C057E07	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C057E08	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C057E09	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C057E10	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C057E11	pDONR221															
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C057E12	pDONR221															
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C057E13	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C057E14	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C057E15	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C057E16	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C057E17	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C057E18	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	AK123389	06_03-C10	FLJ	W01C057E19	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK123389	06_03-C10	FLJ	W01C057E20	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK125754	06_03-C11	FLJ	W01C057E21	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK125754	06_03-C11	FLJ	W01C057E22	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK127376	06_03-C12		W01C057E23	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	AK127376	06_03-C12		W01C057E24	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C057F01	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C057F02	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C057F03	pDONR221															
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C057F04	pDONR221															
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C057F05	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C057F06	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C057F07	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C057F08	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C057F09	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C057F10	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C057F11	pDONR221															
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C057F12	pDONR221															
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C057F13	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C057F14	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C057F15	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C057F16	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C057F17	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C057F18	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	AK123389	06_03-C10	FLJ	W01C057F19	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK123389	06_03-C10	FLJ	W01C057F20	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK125754	06_03-C11	FLJ	W01C057F21	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK125754	06_03-C11	FLJ	W01C057F22	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK127376	06_03-C12		W01C057F23	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	AK127376	06_03-C12		W01C057F24	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	AK127785	06_03-D01	FLJ	W01C057G01	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK127785	06_03-D01	FLJ	W01C057G02	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK126807	06_03-D02		W01C057G03	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	AK126807	06_03-D02		W01C057G04	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	BC007601	06_03-D03		W01C057G05	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	BC007601	06_03-D03		W01C057G06	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	HSI06654	06_03-D04	EST	W01C057G07	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	HSI06654	06_03-D04	EST	W01C057G08	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	RBb16E09.ab1	06_03-D05		W01C057G09	pDONR221															
IKAKEN	RBb16E09.ab1	06_03-D05		W01C057G10	pDONR221															
IKAKEN	FLB02604	06_03-D06	EST	W01C057G11	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	FLB02604	06_03-D06	EST	W01C057G12	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	ARa40D05.ab1	06_03-D07		W01C057G13	pDONR221															
IKAKEN	ARa40D05.ab1	06_03-D07		W01C057G14	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C057G15	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C057G16	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C057G17	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C057G18	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C057G19	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C057G20	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C057G21	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C057G22	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C057G23	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C057G24	pDONR221															
IKAKEN	AK127785	06_03-D01	FLJ	W01C057H01	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK127785	06_03-D01	FLJ	W01C057H02	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK126807	06_03-D02		W01C057H03	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	AK126807	06_03-D02		W01C057H04	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	BC007601	06_03-D03		W01C057H05	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	BC007601	06_03-D03		W01C057H06	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	HSI06654	06_03-D04	EST	W01C057H07	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	HSI06654	06_03-D04	EST	W01C057H08	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	RBb16E09.ab1	06_03-D05		W01C057H09	pDONR221															
IKAKEN	RBb16E09.ab1	06_03-D05		W01C057H10	pDONR221															
IKAKEN	FLB02604	06_03-D06	EST	W01C057H11	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	FLB02604	06_03-D06	EST	W01C057H12	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	ARa40D05.ab1	06_03-D07		W01C057H13	pDONR221															
IKAKEN	ARa40D05.ab1	06_03-D07		W01C057H14	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C057H15	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C057H16	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C057H17	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C057H18	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C057H19	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C057H20	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C057H21	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C057H22	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C057H23	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C057H24	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C057I01	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C057I02	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C057I03	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C057I04	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C057I05	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C057I06	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C057I07	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C057I08	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C057I09	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C057I10	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C057I11	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C057I12	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C057I13	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C057I14	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C057I15	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C057I16	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C057I17	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C057I18	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C057I19	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C057I20	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C057I21	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C057I22	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C057I23	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C057I24	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C057J01	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C057J02	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C057J03	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C057J04	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C057J05	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C057J06	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C057J07	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C057J08	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C057J09	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C057J10	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C057J11	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C057J12	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C057J13	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C057J14	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C057J15	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C057J16	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C057J17	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C057J18	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C057J19	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C057J20	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C057J21	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C057J22	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C057J23	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C057J24	pDONR221															
IKAKEN	SK003F09	06_03-F01	IMS	W01C057K01	pDONR221															
IKAKEN	SK003F09	06_03-F01	IMS	W01C057K02	pDONR221															
IKAKEN	CS0DB003YK08	06_03-F02		W01C057K03	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DB003YK08	06_03-F02		W01C057K04	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DE009YD22	06_03-F03		W01C057K05	pDONR221				392550											
IKAKEN	CS0DE009YD22	06_03-F03		W01C057K06	pDONR221				392550											
IKAKEN	CS0DG006YK13	06_03-F04		W01C057K07	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG006YK13	06_03-F04		W01C057K08	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG001YK07	06_03-F05		W01C057K09	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DG001YK07	06_03-F05		W01C057K10	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DC026YL07	06_03-F06		W01C057K11	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DC026YL07	06_03-F06		W01C057K12	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DI025YJ11	06_03-F07		W01C057K13	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	CS0DI025YJ11	06_03-F07		W01C057K14	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C057K15	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C057K16	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C057K17	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C057K18	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	CS0DL005YK20	06_03-F10		W01C057K19	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DL005YK20	06_03-F10		W01C057K20	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DI056YA22	06_03-F11		W01C057K21	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DI056YA22	06_03-F11		W01C057K22	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DM007YI02	06_03-F12		W01C057K23	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	CS0DM007YI02	06_03-F12		W01C057K24	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	SK003F09	06_03-F01	IMS	W01C057L01	pDONR221															
IKAKEN	SK003F09	06_03-F01	IMS	W01C057L02	pDONR221															
IKAKEN	CS0DB003YK08	06_03-F02		W01C057L03	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DB003YK08	06_03-F02		W01C057L04	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DE009YD22	06_03-F03		W01C057L05	pDONR221				392550											
IKAKEN	CS0DE009YD22	06_03-F03		W01C057L06	pDONR221				392550											
IKAKEN	CS0DG006YK13	06_03-F04		W01C057L07	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG006YK13	06_03-F04		W01C057L08	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG001YK07	06_03-F05		W01C057L09	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DG001YK07	06_03-F05		W01C057L10	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DC026YL07	06_03-F06		W01C057L11	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DC026YL07	06_03-F06		W01C057L12	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DI025YJ11	06_03-F07		W01C057L13	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	CS0DI025YJ11	06_03-F07		W01C057L14	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C057L15	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C057L16	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C057L17	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C057L18	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	CS0DL005YK20	06_03-F10		W01C057L19	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DL005YK20	06_03-F10		W01C057L20	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DI056YA22	06_03-F11		W01C057L21	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DI056YA22	06_03-F11		W01C057L22	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DM007YI02	06_03-F12		W01C057L23	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	CS0DM007YI02	06_03-F12		W01C057L24	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C057M01	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C057M02	pDONR221															
IKAKEN	CS0DM014YC15	06_03-G02		W01C057M03	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DM014YC15	06_03-G02		W01C057M04	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DL006YL05	06_03-G03		W01C057M05	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL006YL05	06_03-G03		W01C057M06	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL001YP01	06_03-G04		W01C057M07	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DL001YP01	06_03-G04		W01C057M08	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DJ013YH23	06_03-G05		W01C057M09	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06_03-G05		W01C057M10	pDONR221			RPL32P20	392271											
IKAKEN	CS0DG004YA07	06_03-G06		W01C057M11	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	CS0DG004YA07	06_03-G06		W01C057M12	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	H033013C12	06_03-G07	Riken	W01C057M13	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033013C12	06_03-G07	Riken	W01C057M14	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033095L03	06_03-G08	Riken	W01C057M15	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	H033095L03	06_03-G08	Riken	W01C057M16	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	CS0DK003YC11	06_03-G09		W01C057M17	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DK003YC11	06_03-G09		W01C057M18	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DI074YC02	06_03-G10		W01C057M19	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DI074YC02	06_03-G10		W01C057M20	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DN001YK13	06_03-G11		W01C057M21	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DN001YK13	06_03-G11		W01C057M22	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DF024YF06	06_03-G12		W01C057M23	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	CS0DF024YF06	06_03-G12		W01C057M24	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C057N01	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C057N02	pDONR221															
IKAKEN	CS0DM014YC15	06_03-G02		W01C057N03	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DM014YC15	06_03-G02		W01C057N04	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DL006YL05	06_03-G03		W01C057N05	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL006YL05	06_03-G03		W01C057N06	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL001YP01	06_03-G04		W01C057N07	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DL001YP01	06_03-G04		W01C057N08	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DJ013YH23	06_03-G05		W01C057N09	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06_03-G05		W01C057N10	pDONR221			RPL32P20	392271											
IKAKEN	CS0DG004YA07	06_03-G06		W01C057N11	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	CS0DG004YA07	06_03-G06		W01C057N12	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	H033013C12	06_03-G07	Riken	W01C057N13	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033013C12	06_03-G07	Riken	W01C057N14	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033095L03	06_03-G08	Riken	W01C057N15	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	H033095L03	06_03-G08	Riken	W01C057N16	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	CS0DK003YC11	06_03-G09		W01C057N17	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DK003YC11	06_03-G09		W01C057N18	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DI074YC02	06_03-G10		W01C057N19	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DI074YC02	06_03-G10		W01C057N20	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DN001YK13	06_03-G11		W01C057N21	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DN001YK13	06_03-G11		W01C057N22	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DF024YF06	06_03-G12		W01C057N23	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	CS0DF024YF06	06_03-G12		W01C057N24	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	CS0DA010YN22	06_03-H01		W01C057O01	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06_03-H01		W01C057O02	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DL006YJ07	06_03-H02		W01C057O03	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DL006YJ07	06_03-H02		W01C057O04	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DE002YA09	06_03-H03		W01C057O05	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DE002YA09	06_03-H03		W01C057O06	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DI081YD08	06_03-H04		W01C057O07	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI081YD08	06_03-H04		W01C057O08	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI039YD13	06_03-H05		W01C057O09	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CS0DI039YD13	06_03-H05		W01C057O10	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CL0BA004ZD09	06_03-H06		W01C057O11	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06_03-H06		W01C057O12	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DB005YB11	06_03-H07		W01C057O13	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DB005YB11	06_03-H07		W01C057O14	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DK007YG10	06_03-H08		W01C057O15	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06_03-H08		W01C057O16	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DC027YF18	06_03-H09		W01C057O17	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DC027YF18	06_03-H09		W01C057O18	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DJ006YP04	06_03-H10		W01C057O19	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DJ006YP04	06_03-H10		W01C057O20	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DF001YG03	06_03-H11		W01C057O21	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DF001YG03	06_03-H11		W01C057O22	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DI081YH12	06_03-H12		W01C057O23	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	CS0DI081YH12	06_03-H12		W01C057O24	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	CS0DA010YN22	06_03-H01		W01C057P01	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06_03-H01		W01C057P02	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DL006YJ07	06_03-H02		W01C057P03	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DL006YJ07	06_03-H02		W01C057P04	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DE002YA09	06_03-H03		W01C057P05	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DE002YA09	06_03-H03		W01C057P06	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DI081YD08	06_03-H04		W01C057P07	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI081YD08	06_03-H04		W01C057P08	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI039YD13	06_03-H05		W01C057P09	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CS0DI039YD13	06_03-H05		W01C057P10	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CL0BA004ZD09	06_03-H06		W01C057P11	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06_03-H06		W01C057P12	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DB005YB11	06_03-H07		W01C057P13	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DB005YB11	06_03-H07		W01C057P14	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DK007YG10	06_03-H08		W01C057P15	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06_03-H08		W01C057P16	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DC027YF18	06_03-H09		W01C057P17	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DC027YF18	06_03-H09		W01C057P18	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DJ006YP04	06_03-H10		W01C057P19	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DJ006YP04	06_03-H10		W01C057P20	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DF001YG03	06_03-H11		W01C057P21	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DF001YG03	06_03-H11		W01C057P22	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DI081YH12	06_03-H12		W01C057P23	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	CS0DI081YH12	06_03-H12		W01C057P24	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	ARe35A04.ab1	06_03-A01		W01C058A01	pDONR221															
IKAKEN	ARe35A04.ab1	06_03-A01		W01C058A02	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C058A03	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C058A04	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C058A05	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C058A06	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C058A07	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C058A08	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C058A09	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C058A10	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C058A11	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C058A12	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C058A13	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C058A14	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C058A15	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C058A16	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C058A17	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C058A18	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C058A19	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C058A20	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C058A21	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C058A22	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C058A23	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C058A24	pDONR221															
IKAKEN	ARe35A04.ab1	06_03-A01		W01C058B01	pDONR221															
IKAKEN	ARe35A04.ab1	06_03-A01		W01C058B02	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C058B03	pDONR221															
IKAKEN	ARa77E03.ab1	06_03-A02		W01C058B04	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C058B05	pDONR221															
IKAKEN	HISCO_S02026A-104_F18	06_03-A03	hisco_OVA	W01C058B06	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C058B07	pDONR221															
IKAKEN	ARa46A08.ab1	06_03-A04		W01C058B08	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C058B09	pDONR221															
IKAKEN	HISCO_S02026A-108_P15	06_03-A05	hisco_OVA	W01C058B10	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C058B11	pDONR221															
IKAKEN	HISCO_S03002-11_G08	06_03-A06	hisco_THY	W01C058B12	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C058B13	pDONR221															
IKAKEN	RBb23C07.ab1	06_03-A07		W01C058B14	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C058B15	pDONR221															
IKAKEN	ARa32B05.ab1	06_03-A08		W01C058B16	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C058B17	pDONR221															
IKAKEN	HISCO_S03002-03_M13	06_03-A09	hisco_THY	W01C058B18	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C058B19	pDONR221															
IKAKEN	RBb08E09.ab1	06_03-A10		W01C058B20	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C058B21	pDONR221															
IKAKEN	ARe63A07.ab1	06_03-A11		W01C058B22	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C058B23	pDONR221															
IKAKEN	ARe98F10.ab1	06_03-A12		W01C058B24	pDONR221															
IKAKEN	ARe03D03.ab1	06_03-B01		W01C058C01	pDONR221															
IKAKEN	ARe03D03.ab1	06_03-B01		W01C058C02	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C058C03	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C058C04	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C058C05	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C058C06	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C058C07	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C058C08	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C058C09	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C058C10	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C058C11	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C058C12	pDONR221															
IKAKEN	HRT03547	06_03-B07	EST	W01C058C13	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	HRT03547	06_03-B07	EST	W01C058C14	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C058C15	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C058C16	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C058C17	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C058C18	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	HRT01923	06_03-B10	EST	W01C058C19	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	HRT01923	06_03-B10	EST	W01C058C20	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C058C21	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C058C22	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C058C23	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C058C24	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	ARe03D03.ab1	06_03-B01		W01C058D01	pDONR221															
IKAKEN	ARe03D03.ab1	06_03-B01		W01C058D02	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C058D03	pDONR221															
IKAKEN	ARe87G04.ab1	06_03-B02		W01C058D04	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C058D05	pDONR221															
IKAKEN	RBb02C04.ab1	06_03-B03		W01C058D06	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C058D07	pDONR221															
IKAKEN	HISCO_S02026A-103_A05	06_03-B04	hisco_OVA	W01C058D08	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C058D09	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-B05		W01C058D10	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C058D11	pDONR221															
IKAKEN	ARe26B04.ab1	06_03-B06		W01C058D12	pDONR221															
IKAKEN	HRT03547	06_03-B07	EST	W01C058D13	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	HRT03547	06_03-B07	EST	W01C058D14	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pfs	1.000	1.000	764	2292	1	2290	1135	1	764
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C058D15	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	KAR06837	06_03-B08	EST(RND)	W01C058D16	pDONR221			OLFM4	10562		Hs.508113	Olfactomedin 4						NM_006418.3	NP_006409.3	REVIEWED	OK	1.000	1.000	510	1533	1	1530	510	1	510
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C058D17	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	THR01667	06_03-B09	EST(RND)	W01C058D18	pDONR221			MARCH1	55016		Hs.696248	Membrane-associated ring finger (C3HC4) 1						NM_017923.2	NP_060393.1	VALIDATED		0.963	0.963	246	870	130	867	272	27	272
IKAKEN	HRT01923	06_03-B10	EST	W01C058D19	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	HRT01923	06_03-B10	EST	W01C058D20	pDONR221			MURC	347273		Hs.99004	Muscle-related coiled-coil protein						NM_001018116.1	NP_001018126.1	VALIDATED	Pg	0.931	1.000	304	852	1	849	364	61	364
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C058D21	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	SMR09368	06_03-B11	EST(RND)	W01C058D22	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	OK	1.000	1.000	475	1428	1	1425	475	1	475
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C058D23	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	60R03821	06_03-B12	EST(RND)	W01C058D24	pDONR221			CLC	1178		Hs.889	Charcot-Leyden crystal protein						NM_001828.4	NP_001819.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C058E01	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C058E02	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C058E03	pDONR221															
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C058E04	pDONR221															
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C058E05	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C058E06	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C058E07	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C058E08	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C058E09	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C058E10	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C058E11	pDONR221															
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C058E12	pDONR221															
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C058E13	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C058E14	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C058E15	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C058E16	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C058E17	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C058E18	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	AK123389	06_03-C10	FLJ	W01C058E19	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK123389	06_03-C10	FLJ	W01C058E20	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK125754	06_03-C11	FLJ	W01C058E21	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK125754	06_03-C11	FLJ	W01C058E22	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK127376	06_03-C12		W01C058E23	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	AK127376	06_03-C12		W01C058E24	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C058F01	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	CNR01230	06_03-C01	EST(RND)	W01C058F02	pDONR221			KIAA0574	23359		Hs.383564	KIAA0574 protein						NM_015307.1	NP_056122.1	VALIDATED	P	1.000	1.000	435	1308	1	1305	539	105	539
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C058F03	pDONR221															
IKAKEN	FBR02611	06_03-C02	EST(RND)	W01C058F04	pDONR221															
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C058F05	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR01210	06_03-C03	EST(RND)	W01C058F06	pDONR221			GPR50	9248		Hs.567390	G protein-coupled receptor 50						NM_004224.2	NP_004215.2	VALIDATED	OK	1.000	1.000	617	1854	1	1851	617	1	617
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C058F07	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HKR09116	06_03-C04	EST(RND)	W01C058F08	pDONR221			ACTBL2	345651		Hs.482167	Actin, beta-like 2						NM_001017992.2	NP_001017992.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C058F09	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	HPR09566	06_03-C05	EST(RND)	W01C058F10	pDONR221			CACNB2	783		Hs.709353	Calcium channel, voltage-dependent, beta 2 subunit						NM_201570.2	NP_963864.1	VALIDATED	OK	1.000	1.000	612	1839	1	1836	612	1	612
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C058F11	pDONR221															
IKAKEN	KAR01783	06_03-C06	EST(RND)	W01C058F12	pDONR221															
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C058F13	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	KMR03544	06_03-C07	EST(RND)	W01C058F14	pDONR221			NOSTRIN	115677		Hs.189780	Nitric oxide synthase trafficker						NM_052946.2	NP_443178.1	PROVISIONAL	Cgs	0.995	0.998	429	1524	235	1521	428	1	428
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C058F15	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_03-C08	EST(RND)	W01C058F16	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C058F17	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	T7R07626	06_03-C09	EST(RND)	W01C058F18	pDONR221			MMACHC	25974		Hs.13024	Methylmalonic aciduria (cobalamin deficiency) cblC type, with homocystinuria						NM_015506.2	NP_056321.2	VALIDATED	OK	1.000	1.000	282	849	1	846	282	1	282
IKAKEN	AK123389	06_03-C10	FLJ	W01C058F19	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK123389	06_03-C10	FLJ	W01C058F20	pDONR221	19296		ANKRD55	79722	BAG53900.1	Hs.436214	Ankyrin repeat domain 55			caudate nucleus	BRCAN2		NM_024669.2	NP_078945.2	VALIDATED	Ps	0.996	0.996	267	807	1	801	614	2	268
IKAKEN	AK125754	06_03-C11	FLJ	W01C058F21	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK125754	06_03-C11	FLJ	W01C058F22	pDONR221	11791		IGFL2	147920	BAC86275.1	Hs.99376	IGF-like family member 2			testis	TESTI2		NM_001135113.1	NP_001128585.1	VALIDATED	OK	1.000	1.000	119	360	1	357	119	1	119
IKAKEN	AK127376	06_03-C12		W01C058F23	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	AK127376	06_03-C12		W01C058F24	pDONR221	8650		NECAB2	54550	BAC86948.1	Hs.140950	N-terminal EF-hand calcium binding protein 2						NM_019065.2	NP_061938.2	PROVISIONAL	OK	1.000	1.000	386	1161	1	1158	386	1	386
IKAKEN	AK127785	06_03-D01	FLJ	W01C058G01	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK127785	06_03-D01	FLJ	W01C058G02	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK126807	06_03-D02		W01C058G03	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	AK126807	06_03-D02		W01C058G04	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	BC007601	06_03-D03		W01C058G05	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	BC007601	06_03-D03		W01C058G06	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	HSI06654	06_03-D04	EST	W01C058G07	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	HSI06654	06_03-D04	EST	W01C058G08	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	RBb16E09.ab1	06_03-D05		W01C058G09	pDONR221															
IKAKEN	RBb16E09.ab1	06_03-D05		W01C058G10	pDONR221															
IKAKEN	FLB02604	06_03-D06	EST	W01C058G11	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	FLB02604	06_03-D06	EST	W01C058G12	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	ARa40D05.ab1	06_03-D07		W01C058G13	pDONR221															
IKAKEN	ARa40D05.ab1	06_03-D07		W01C058G14	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C058G15	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C058G16	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C058G17	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C058G18	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C058G19	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C058G20	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C058G21	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C058G22	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C058G23	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C058G24	pDONR221															
IKAKEN	AK127785	06_03-D01	FLJ	W01C058H01	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK127785	06_03-D01	FLJ	W01C058H02	pDONR221	7507		C14orf43	91748	BAC87133	Hs.656506	Chromosome 14 open reading frame 43			brain	OCBBF3		NM_194278.3	NP_919254.2	VALIDATED	P	1.000	1.000	310	933	1	930	1045	736	1045
IKAKEN	AK126807	06_03-D02		W01C058H03	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	AK126807	06_03-D02		W01C058H04	pDONR221	15047		RIMS4	140730	-	Hs.517065	Regulating synaptic membrane exocytosis 4						NM_182970.2	NP_892015.1	VALIDATED	Cg	0.996	1.000	270	813	1	810	269	1	269
IKAKEN	BC007601	06_03-D03		W01C058H05	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	BC007601	06_03-D03		W01C058H06	pDONR221	12531		ALKBH6	84964	-	Hs.71941	AlkB, alkylation repair homolog 6 (E. coli)						NM_198867.1	NP_942567.1	VALIDATED	Pfs	0.922	1.000	141	423	1	422	161	1	130
IKAKEN	HSI06654	06_03-D04	EST	W01C058H07	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	HSI06654	06_03-D04	EST	W01C058H08	pDONR221			LYN	4067		Hs.699154	V-yes-1 Yamaguchi sarcoma viral related oncogene homolog						NM_002350.2	NP_002341.1	VALIDATED	OK	1.000	1.000	512	1539	1	1536	512	1	512
IKAKEN	RBb16E09.ab1	06_03-D05		W01C058H09	pDONR221															
IKAKEN	RBb16E09.ab1	06_03-D05		W01C058H10	pDONR221															
IKAKEN	FLB02604	06_03-D06	EST	W01C058H11	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	FLB02604	06_03-D06	EST	W01C058H12	pDONR221			ANKS1B	56899		Hs.506458	Ankyrin repeat and sterile alpha motif domain containing 1B						NM_020140.2	NP_064525.1	VALIDATED	Pg	0.858	1.000	450	1371	1	1338	414	1	390
IKAKEN	ARa40D05.ab1	06_03-D07		W01C058H13	pDONR221															
IKAKEN	ARa40D05.ab1	06_03-D07		W01C058H14	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C058H15	pDONR221															
IKAKEN	HISCO_S03002-01_F11	06_03-D08	hisco_THY	W01C058H16	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C058H17	pDONR221															
IKAKEN	RBb46H11.ab1	06_03-D09		W01C058H18	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C058H19	pDONR221															
IKAKEN	ARa54E12.ab1	06_03-D10		W01C058H20	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C058H21	pDONR221															
IKAKEN	HISCO_S02026A-108_M23	06_03-D11	hisco_OVA	W01C058H22	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C058H23	pDONR221															
IKAKEN	SK001B04	06_03-D12	IMS	W01C058H24	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C058I01	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C058I02	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C058I03	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C058I04	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C058I05	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C058I06	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C058I07	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C058I08	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C058I09	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C058I10	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C058I11	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C058I12	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C058I13	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C058I14	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C058I15	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C058I16	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C058I17	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C058I18	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C058I19	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C058I20	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C058I21	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C058I22	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C058I23	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C058I24	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C058J01	pDONR221															
IKAKEN	SK001F11	06_03-E01	IMS	W01C058J02	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C058J03	pDONR221															
IKAKEN	SK002A10	06_03-E02	IMS	W01C058J04	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C058J05	pDONR221															
IKAKEN	SK002C06	06_03-E03	IMS	W01C058J06	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C058J07	pDONR221															
IKAKEN	SK002D04	06_03-E04	IMS	W01C058J08	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C058J09	pDONR221															
IKAKEN	SK002E05	06_03-E05	IMS	W01C058J10	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C058J11	pDONR221															
IKAKEN	SK002E07	06_03-E06	IMS	W01C058J12	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C058J13	pDONR221															
IKAKEN	SK002F04	06_03-E07	IMS	W01C058J14	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C058J15	pDONR221															
IKAKEN	SK002G02	06_03-E08		W01C058J16	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C058J17	pDONR221															
IKAKEN	SK002G05	06_03-E09		W01C058J18	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C058J19	pDONR221															
IKAKEN	SK002G07	06_03-E10	IMS	W01C058J20	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C058J21	pDONR221															
IKAKEN	SK002H09	06_03-E11	IMS	W01C058J22	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C058J23	pDONR221															
IKAKEN	SK003C10	06_03-E12	IMS	W01C058J24	pDONR221															
IKAKEN	SK003F09	06_03-F01	IMS	W01C058K01	pDONR221															
IKAKEN	SK003F09	06_03-F01	IMS	W01C058K02	pDONR221															
IKAKEN	CS0DB003YK08	06_03-F02		W01C058K03	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DB003YK08	06_03-F02		W01C058K04	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DE009YD22	06_03-F03		W01C058K05	pDONR221				392550											
IKAKEN	CS0DE009YD22	06_03-F03		W01C058K06	pDONR221				392550											
IKAKEN	CS0DG006YK13	06_03-F04		W01C058K07	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG006YK13	06_03-F04		W01C058K08	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG001YK07	06_03-F05		W01C058K09	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DG001YK07	06_03-F05		W01C058K10	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DC026YL07	06_03-F06		W01C058K11	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DC026YL07	06_03-F06		W01C058K12	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DI025YJ11	06_03-F07		W01C058K13	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	CS0DI025YJ11	06_03-F07		W01C058K14	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C058K15	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C058K16	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C058K17	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C058K18	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	CS0DL005YK20	06_03-F10		W01C058K19	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DL005YK20	06_03-F10		W01C058K20	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DI056YA22	06_03-F11		W01C058K21	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DI056YA22	06_03-F11		W01C058K22	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DM007YI02	06_03-F12		W01C058K23	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	CS0DM007YI02	06_03-F12		W01C058K24	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	SK003F09	06_03-F01	IMS	W01C058L01	pDONR221															
IKAKEN	SK003F09	06_03-F01	IMS	W01C058L02	pDONR221															
IKAKEN	CS0DB003YK08	06_03-F02		W01C058L03	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DB003YK08	06_03-F02		W01C058L04	pDONR221			USP8	9101		Hs.644563	Ubiquitin specific peptidase 8						NM_001128610.1	NP_001122082.1	VALIDATED	C	1.000	1.000	1118	3357	1	3354	1118	1	1118
IKAKEN	CS0DE009YD22	06_03-F03		W01C058L05	pDONR221				392550											
IKAKEN	CS0DE009YD22	06_03-F03		W01C058L06	pDONR221				392550											
IKAKEN	CS0DG006YK13	06_03-F04		W01C058L07	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG006YK13	06_03-F04		W01C058L08	pDONR221			GPBP1	65056		Hs.444279	GC-rich promoter binding protein 1						NM_022913.2	NP_075064.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	CS0DG001YK07	06_03-F05		W01C058L09	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DG001YK07	06_03-F05		W01C058L10	pDONR221			STIL	6491		Hs.525198	SCL/TAL1 interrupting locus						NM_001048166.1	NP_001041631.1	REVIEWED	Cg	0.949	1.000	1289	3675	1	3672	1288	1	1288
IKAKEN	CS0DC026YL07	06_03-F06		W01C058L11	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DC026YL07	06_03-F06		W01C058L12	pDONR221			SFXN4	119559		Hs.655168	Sideroflexin 4						NM_213649.1	NP_998814.1	VALIDATED	Cg	0.973	1.000	337	987	1	984	337	1	337
IKAKEN	CS0DI025YJ11	06_03-F07		W01C058L13	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	CS0DI025YJ11	06_03-F07		W01C058L14	pDONR221			LOC388931	388931		Hs.407482	Hypothetical protein LOC388931						NM_001080473.1	NP_001073942.1	PREDICTED	Pfs	0.965	0.982	451	1359	3	1335	497	48	497
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C058L15	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX357637 (5' CS0DI028YD18)	06_03-F08		W01C058L16	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	Pfs	0.994	0.994	1182	3546	1	3545	1597	1	1182
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C058L17	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06_03-F09		W01C058L18	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	CS0DL005YK20	06_03-F10		W01C058L19	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DL005YK20	06_03-F10		W01C058L20	pDONR221			RAPGEF1	2889		Hs.127897	Rap guanine nucleotide exchange factor (GEF) 1						NM_005312.2	NP_005303.2	REVIEWED	OK	1.000	1.000	1077	3234	1	3231	1077	1	1077
IKAKEN	CS0DI056YA22	06_03-F11		W01C058L21	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DI056YA22	06_03-F11		W01C058L22	pDONR221			LGALS9	3965		Hs.81337	Lectin, galactoside-binding, soluble, 9						NM_002308.3	NP_002299.2	REVIEWED		0.910	0.945	323	936	1	933	323	1	323
IKAKEN	CS0DM007YI02	06_03-F12		W01C058L23	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	CS0DM007YI02	06_03-F12		W01C058L24	pDONR221			SLC4A1	6521									NM_000342.3	NP_000333.1	REVIEWED	OK	1.000	1.000	911	2736	1	2733	911	1	911
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C058M01	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C058M02	pDONR221															
IKAKEN	CS0DM014YC15	06_03-G02		W01C058M03	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DM014YC15	06_03-G02		W01C058M04	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DL006YL05	06_03-G03		W01C058M05	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL006YL05	06_03-G03		W01C058M06	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL001YP01	06_03-G04		W01C058M07	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DL001YP01	06_03-G04		W01C058M08	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DJ013YH23	06_03-G05		W01C058M09	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06_03-G05		W01C058M10	pDONR221			RPL32P20	392271											
IKAKEN	CS0DG004YA07	06_03-G06		W01C058M11	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	CS0DG004YA07	06_03-G06		W01C058M12	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	H033013C12	06_03-G07	Riken	W01C058M13	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033013C12	06_03-G07	Riken	W01C058M14	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033095L03	06_03-G08	Riken	W01C058M15	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	H033095L03	06_03-G08	Riken	W01C058M16	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	CS0DK003YC11	06_03-G09		W01C058M17	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DK003YC11	06_03-G09		W01C058M18	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DI074YC02	06_03-G10		W01C058M19	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DI074YC02	06_03-G10		W01C058M20	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DN001YK13	06_03-G11		W01C058M21	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DN001YK13	06_03-G11		W01C058M22	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DF024YF06	06_03-G12		W01C058M23	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	CS0DF024YF06	06_03-G12		W01C058M24	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C058N01	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_03-G01		W01C058N02	pDONR221															
IKAKEN	CS0DM014YC15	06_03-G02		W01C058N03	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DM014YC15	06_03-G02		W01C058N04	pDONR221			SMURF1	57154		Hs.189329	SMAD specific E3 ubiquitin protein ligase 1						NM_020429.1	NP_065162.1	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	CS0DL006YL05	06_03-G03		W01C058N05	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL006YL05	06_03-G03		W01C058N06	pDONR221			TIPARP	25976		Hs.719169	TCDD-inducible poly(ADP-ribose) polymerase						NM_015508.3	NP_056323.2	PROVISIONAL	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	CS0DL001YP01	06_03-G04		W01C058N07	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DL001YP01	06_03-G04		W01C058N08	pDONR221			TCF25	22980		Hs.415342	Transcription factor 25 (basic helix-loop-helix)						NM_014972.2	NP_055787.1	VALIDATED	Pfs	0.918	1.000	473	1422	1	1420	676	236	669
IKAKEN	CS0DJ013YH23	06_03-G05		W01C058N09	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06_03-G05		W01C058N10	pDONR221			RPL32P20	392271											
IKAKEN	CS0DG004YA07	06_03-G06		W01C058N11	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	CS0DG004YA07	06_03-G06		W01C058N12	pDONR221			UFD1L	7353		Hs.474213	Ubiquitin fusion degradation 1 like (yeast)						NM_005659.5	NP_005650.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	H033013C12	06_03-G07	Riken	W01C058N13	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033013C12	06_03-G07	Riken	W01C058N14	pDONR221			CDC42	998		Hs.690198	Cell division cycle 42 (GTP binding protein, 25kDa)						NM_044472.2	NP_426359.1	REVIEWED	P	1.000	1.000	156	702	232	699	191	36	191
IKAKEN	H033095L03	06_03-G08	Riken	W01C058N15	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	H033095L03	06_03-G08	Riken	W01C058N16	pDONR221			SNCA	6622		Hs.21374	Synuclein, alpha (non A4 component of amyloid precursor)						NM_000345.3	NP_000336.1	REVIEWED	Cg	0.900	1.000	140	381	1	378	140	1	140
IKAKEN	CS0DK003YC11	06_03-G09		W01C058N17	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DK003YC11	06_03-G09		W01C058N18	pDONR221			PHTF2	57157		Hs.203965	Putative homeodomain transcription factor 2						NM_001127360.1	NP_001120832.1	VALIDATED	P	1.000	1.000	198	1101	1	594	352	138	335
IKAKEN	CS0DI074YC02	06_03-G10		W01C058N19	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DI074YC02	06_03-G10		W01C058N20	pDONR221			C11orf49	79096		Hs.368296	Chromosome 11 open reading frame 49						NM_001003676.1	NP_001003676.1	VALIDATED	P	1.000	1.000	251	927	1	753	274	24	274
IKAKEN	CS0DN001YK13	06_03-G11		W01C058N21	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DN001YK13	06_03-G11		W01C058N22	pDONR221			FOLH1B	219595		Hs.645352	Growth-inhibiting protein 26						NM_153696.2	NP_710163.1	PROVISIONAL	OK	1.000	1.000	442	1329	1	1326	442	1	442
IKAKEN	CS0DF024YF06	06_03-G12		W01C058N23	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	CS0DF024YF06	06_03-G12		W01C058N24	pDONR221			PRKCSH	5589		Hs.610830	Protein kinase C substrate 80K-H						NM_002743.2	NP_002734.2	REVIEWED	OK	1.000	1.000	528	1587	1	1584	528	1	528
IKAKEN	CS0DA010YN22	06_03-H01		W01C058O01	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06_03-H01		W01C058O02	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DL006YJ07	06_03-H02		W01C058O03	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DL006YJ07	06_03-H02		W01C058O04	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DE002YA09	06_03-H03		W01C058O05	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DE002YA09	06_03-H03		W01C058O06	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DI081YD08	06_03-H04		W01C058O07	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI081YD08	06_03-H04		W01C058O08	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI039YD13	06_03-H05		W01C058O09	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CS0DI039YD13	06_03-H05		W01C058O10	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CL0BA004ZD09	06_03-H06		W01C058O11	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06_03-H06		W01C058O12	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DB005YB11	06_03-H07		W01C058O13	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DB005YB11	06_03-H07		W01C058O14	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DK007YG10	06_03-H08		W01C058O15	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06_03-H08		W01C058O16	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DC027YF18	06_03-H09		W01C058O17	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DC027YF18	06_03-H09		W01C058O18	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DJ006YP04	06_03-H10		W01C058O19	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DJ006YP04	06_03-H10		W01C058O20	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DF001YG03	06_03-H11		W01C058O21	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DF001YG03	06_03-H11		W01C058O22	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DI081YH12	06_03-H12		W01C058O23	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	CS0DI081YH12	06_03-H12		W01C058O24	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	CS0DA010YN22	06_03-H01		W01C058P01	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06_03-H01		W01C058P02	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DL006YJ07	06_03-H02		W01C058P03	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DL006YJ07	06_03-H02		W01C058P04	pDONR221			SRM	6723		Hs.76244	Spermidine synthase						NM_003132.2	NP_003123.2	VALIDATED	OK	1.000	1.000	302	909	1	906	302	1	302
IKAKEN	CS0DE002YA09	06_03-H03		W01C058P05	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DE002YA09	06_03-H03		W01C058P06	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	CS0DI081YD08	06_03-H04		W01C058P07	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI081YD08	06_03-H04		W01C058P08	pDONR221			PSG6	5675		Hs.654414	Pregnancy specific beta-1-glycoprotein 6						NM_002782.3	NP_002773.1	PROVISIONAL	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	CS0DI039YD13	06_03-H05		W01C058P09	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CS0DI039YD13	06_03-H05		W01C058P10	pDONR221			C1orf43	25912		Hs.287471	Chromosome 1 open reading frame 43						NM_138740.2	NP_620077.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	CL0BA004ZD09	06_03-H06		W01C058P11	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06_03-H06		W01C058P12	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DB005YB11	06_03-H07		W01C058P13	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DB005YB11	06_03-H07		W01C058P14	pDONR221			NUDT17	200035		Hs.585066	Nudix (nucleoside diphosphate linked moiety X)-type motif 17						NM_001012758.2	NP_001012776.1	VALIDATED	P	1.000	1.000	295	888	1	885	328	1	295
IKAKEN	CS0DK007YG10	06_03-H08		W01C058P15	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06_03-H08		W01C058P16	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DC027YF18	06_03-H09		W01C058P17	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DC027YF18	06_03-H09		W01C058P18	pDONR221			C10orf2	56652		Hs.22678	Chromosome 10 open reading frame 2						NM_021830.3	NP_068602.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	CS0DJ006YP04	06_03-H10		W01C058P19	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DJ006YP04	06_03-H10		W01C058P20	pDONR221			WWOX	51741		Hs.461453	WW domain containing oxidoreductase						NM_016373.1	NP_057457.1	REVIEWED	Pfs	0.992	0.996	240	1059	2	717	414	172	411
IKAKEN	CS0DF001YG03	06_03-H11		W01C058P21	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DF001YG03	06_03-H11		W01C058P22	pDONR221			HN1	51155		Hs.532803	Hematological and neurological expressed 1						NM_001002033.1	NP_001002033.1	VALIDATED	OK	1.000	1.000	108	630	1	324	108	1	108
IKAKEN	CS0DI081YH12	06_03-H12		W01C058P23	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	CS0DI081YH12	06_03-H12		W01C058P24	pDONR221			GLTPD1	80772		Hs.515689	Glycolipid transfer protein domain containing 1						NM_001029885.1	NP_001025056.1	VALIDATED	OK	1.000	1.000	214	645	1	642	214	1	214
IKAKEN	H013023F15	06_04-A01	Riken	W01C059A01	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013023F15	06_04-A01	Riken	W01C059A02	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013038L13	06_04-A02	Riken	W01C059A03	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013038L13	06_04-A02	Riken	W01C059A04	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013048B03	06_04-A03	Riken	W01C059A05	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013048B03	06_04-A03	Riken	W01C059A06	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013060J02	06_04-A04	Riken	W01C059A07	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013060J02	06_04-A04	Riken	W01C059A08	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013067I10	06_04-A05	Riken	W01C059A09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06_04-A05	Riken	W01C059A10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013077D14	06_04-A06	Riken	W01C059A11	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013077D14	06_04-A06	Riken	W01C059A12	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013085D22	06_04-A07	Riken	W01C059A13	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013085D22	06_04-A07	Riken	W01C059A14	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013088L02	06_04-A08	Riken	W01C059A15	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088L02	06_04-A08	Riken	W01C059A16	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088J04	06_04-A09	Riken	W01C059A17	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013088J04	06_04-A09	Riken	W01C059A18	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013095K06	06_04-A10	Riken	W01C059A19	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H013095K06	06_04-A10	Riken	W01C059A20	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H023006E05	06_04-A11	Riken	W01C059A21	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023006E05	06_04-A11	Riken	W01C059A22	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023061J06	06_04-A12	Riken	W01C059A23	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H023061J06	06_04-A12	Riken	W01C059A24	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H013023F15	06_04-A01	Riken	W01C059B01	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013023F15	06_04-A01	Riken	W01C059B02	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013038L13	06_04-A02	Riken	W01C059B03	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013038L13	06_04-A02	Riken	W01C059B04	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013048B03	06_04-A03	Riken	W01C059B05	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013048B03	06_04-A03	Riken	W01C059B06	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013060J02	06_04-A04	Riken	W01C059B07	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013060J02	06_04-A04	Riken	W01C059B08	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013067I10	06_04-A05	Riken	W01C059B09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06_04-A05	Riken	W01C059B10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013077D14	06_04-A06	Riken	W01C059B11	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013077D14	06_04-A06	Riken	W01C059B12	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013085D22	06_04-A07	Riken	W01C059B13	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013085D22	06_04-A07	Riken	W01C059B14	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013088L02	06_04-A08	Riken	W01C059B15	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088L02	06_04-A08	Riken	W01C059B16	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088J04	06_04-A09	Riken	W01C059B17	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013088J04	06_04-A09	Riken	W01C059B18	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013095K06	06_04-A10	Riken	W01C059B19	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H013095K06	06_04-A10	Riken	W01C059B20	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H023006E05	06_04-A11	Riken	W01C059B21	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023006E05	06_04-A11	Riken	W01C059B22	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023061J06	06_04-A12	Riken	W01C059B23	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H023061J06	06_04-A12	Riken	W01C059B24	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H023064J06	06_04-B01	Riken	W01C059C01	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023064J06	06_04-B01	Riken	W01C059C02	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023067B02	06_04-B02	Riken	W01C059C03	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023067B02	06_04-B02	Riken	W01C059C04	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023076K12	06_04-B03	Riken	W01C059C05	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06_04-B03	Riken	W01C059C06	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023078H14	06_04-B04	Riken	W01C059C07	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023078H14	06_04-B04	Riken	W01C059C08	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023090D10	06_04-B05	Riken	W01C059C09	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06_04-B05	Riken	W01C059C10	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023095G07	06_04-B06	Riken	W01C059C11	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H023095G07	06_04-B06	Riken	W01C059C12	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H033011C23	06_04-B07	Riken	W01C059C13	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033011C23	06_04-B07	Riken	W01C059C14	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033069H03	06_04-B08	Riken	W01C059C15	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033069H03	06_04-B08	Riken	W01C059C16	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033076F03	06_04-B09	Riken	W01C059C17	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06_04-B09	Riken	W01C059C18	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06_04-B10	Riken	W01C059C19	pDONR221															
IKAKEN	H033076L09	06_04-B10	Riken	W01C059C20	pDONR221															
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C059C21	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C059C22	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	H013094G13	06_04-B12	Riken	W01C059C23	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06_04-B12	Riken	W01C059C24	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H023064J06	06_04-B01	Riken	W01C059D01	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023064J06	06_04-B01	Riken	W01C059D02	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023067B02	06_04-B02	Riken	W01C059D03	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023067B02	06_04-B02	Riken	W01C059D04	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023076K12	06_04-B03	Riken	W01C059D05	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06_04-B03	Riken	W01C059D06	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023078H14	06_04-B04	Riken	W01C059D07	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023078H14	06_04-B04	Riken	W01C059D08	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023090D10	06_04-B05	Riken	W01C059D09	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06_04-B05	Riken	W01C059D10	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023095G07	06_04-B06	Riken	W01C059D11	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H023095G07	06_04-B06	Riken	W01C059D12	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H033011C23	06_04-B07	Riken	W01C059D13	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033011C23	06_04-B07	Riken	W01C059D14	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033069H03	06_04-B08	Riken	W01C059D15	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033069H03	06_04-B08	Riken	W01C059D16	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033076F03	06_04-B09	Riken	W01C059D17	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06_04-B09	Riken	W01C059D18	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06_04-B10	Riken	W01C059D19	pDONR221															
IKAKEN	H033076L09	06_04-B10	Riken	W01C059D20	pDONR221															
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C059D21	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C059D22	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	H013094G13	06_04-B12	Riken	W01C059D23	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06_04-B12	Riken	W01C059D24	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013097B12	06_04-C01	Riken	W01C059E01	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H013097B12	06_04-C01	Riken	W01C059E02	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H033062B14	06_04-C02	Riken	W01C059E03	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06_04-C02	Riken	W01C059E04	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H013062N19	06_04-C03	Riken	W01C059E05	pDONR221															
IKAKEN	H013062N19	06_04-C03	Riken	W01C059E06	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C059E07	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C059E08	pDONR221															
IKAKEN	H013063A18	06_04-C05	Riken	W01C059E09	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H013063A18	06_04-C05	Riken	W01C059E10	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H023083A18	06_04-C06	Riken	W01C059E11	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	H023083A18	06_04-C06	Riken	W01C059E12	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C059E13	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C059E14	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C059E15	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C059E16	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C059E17	pDONR221															
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C059E18	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C059E19	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C059E20	pDONR221															
IKAKEN	TST08313	06_04-C11	EST	W01C059E21	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06_04-C11	EST	W01C059E22	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004A01	06_04-C12	IMS	W01C059E23	pDONR221															
IKAKEN	SK004A01	06_04-C12	IMS	W01C059E24	pDONR221															
IKAKEN	H013097B12	06_04-C01	Riken	W01C059F01	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H013097B12	06_04-C01	Riken	W01C059F02	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H033062B14	06_04-C02	Riken	W01C059F03	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06_04-C02	Riken	W01C059F04	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H013062N19	06_04-C03	Riken	W01C059F05	pDONR221															
IKAKEN	H013062N19	06_04-C03	Riken	W01C059F06	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C059F07	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C059F08	pDONR221															
IKAKEN	H013063A18	06_04-C05	Riken	W01C059F09	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H013063A18	06_04-C05	Riken	W01C059F10	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H023083A18	06_04-C06	Riken	W01C059F11	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	H023083A18	06_04-C06	Riken	W01C059F12	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C059F13	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C059F14	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C059F15	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C059F16	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C059F17	pDONR221															
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C059F18	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C059F19	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C059F20	pDONR221															
IKAKEN	TST08313	06_04-C11	EST	W01C059F21	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06_04-C11	EST	W01C059F22	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004A01	06_04-C12	IMS	W01C059F23	pDONR221															
IKAKEN	SK004A01	06_04-C12	IMS	W01C059F24	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C059G01	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C059G02	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C059G03	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C059G04	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C059G05	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C059G06	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C059G07	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C059G08	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C059G09	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C059G10	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C059G11	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C059G12	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C059G13	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C059G14	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C059G15	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C059G16	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C059G17	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C059G18	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C059G19	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C059G20	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C059G21	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C059G22	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C059G23	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C059G24	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C059H01	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C059H02	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C059H03	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C059H04	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C059H05	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C059H06	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C059H07	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C059H08	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C059H09	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C059H10	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C059H11	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C059H12	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C059H13	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C059H14	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C059H15	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C059H16	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C059H17	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C059H18	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C059H19	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C059H20	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C059H21	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C059H22	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C059H23	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C059H24	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C059I01	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C059I02	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C059I03	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C059I04	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C059I05	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C059I06	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C059I07	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C059I08	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C059I09	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C059I10	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C059I11	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C059I12	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C059I13	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C059I14	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C059I15	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C059I16	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C059I17	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C059I18	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C059I19	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C059I20	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C059I21	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C059I22	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C059I23	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C059I24	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C059J01	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C059J02	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C059J03	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C059J04	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C059J05	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C059J06	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C059J07	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C059J08	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C059J09	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C059J10	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C059J11	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C059J12	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C059J13	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C059J14	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C059J15	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C059J16	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C059J17	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C059J18	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C059J19	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C059J20	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C059J21	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C059J22	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C059J23	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C059J24	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C059K01	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C059K02	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C059K03	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C059K04	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C059K05	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C059K06	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C059K07	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C059K08	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C059K09	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C059K10	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C059K11	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C059K12	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C059K13	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C059K14	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C059K15	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C059K16	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C059K17	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C059K18	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C059K19	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C059K20	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C059K21	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C059K22	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C059K23	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C059K24	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C059L01	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C059L02	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C059L03	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C059L04	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C059L05	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C059L06	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C059L07	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C059L08	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C059L09	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C059L10	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C059L11	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C059L12	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C059L13	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C059L14	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C059L15	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C059L16	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C059L17	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C059L18	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C059L19	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C059L20	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C059L21	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C059L22	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C059L23	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C059L24	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C059M01	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C059M02	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C059M03	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C059M04	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C059M05	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C059M06	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C059M07	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C059M08	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C059M09	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C059M10	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C059M11	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C059M12	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C059M13	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C059M14	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C059M15	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C059M16	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C059M17	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C059M18	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C059M19	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C059M20	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C059M21	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C059M22	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C059M23	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C059M24	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C059N01	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C059N02	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C059N03	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C059N04	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C059N05	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C059N06	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C059N07	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C059N08	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C059N09	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C059N10	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C059N11	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C059N12	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C059N13	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C059N14	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C059N15	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C059N16	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C059N17	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C059N18	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C059N19	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C059N20	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C059N21	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C059N22	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C059N23	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C059N24	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C059O01	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C059O02	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C059O03	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C059O04	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C059O05	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C059O06	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C059O07	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C059O08	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C059O09	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C059O10	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C059O11	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C059O12	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C059O13	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C059O14	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C059O15	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C059O16	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C059O17	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C059O18	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C059O19	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C059O20	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C059O21	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C059O22	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C059O23	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C059O24	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C059P01	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C059P02	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C059P03	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C059P04	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C059P05	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C059P06	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C059P07	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C059P08	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C059P09	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C059P10	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C059P11	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C059P12	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C059P13	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C059P14	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C059P15	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C059P16	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C059P17	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C059P18	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C059P19	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C059P20	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C059P21	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C059P22	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C059P23	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C059P24	pDONR221															
IKAKEN	H013023F15	06_04-A01	Riken	W01C060A01	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013023F15	06_04-A01	Riken	W01C060A02	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013038L13	06_04-A02	Riken	W01C060A03	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013038L13	06_04-A02	Riken	W01C060A04	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013048B03	06_04-A03	Riken	W01C060A05	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013048B03	06_04-A03	Riken	W01C060A06	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013060J02	06_04-A04	Riken	W01C060A07	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013060J02	06_04-A04	Riken	W01C060A08	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013067I10	06_04-A05	Riken	W01C060A09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06_04-A05	Riken	W01C060A10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013077D14	06_04-A06	Riken	W01C060A11	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013077D14	06_04-A06	Riken	W01C060A12	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013085D22	06_04-A07	Riken	W01C060A13	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013085D22	06_04-A07	Riken	W01C060A14	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013088L02	06_04-A08	Riken	W01C060A15	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088L02	06_04-A08	Riken	W01C060A16	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088J04	06_04-A09	Riken	W01C060A17	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013088J04	06_04-A09	Riken	W01C060A18	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013095K06	06_04-A10	Riken	W01C060A19	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H013095K06	06_04-A10	Riken	W01C060A20	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H023006E05	06_04-A11	Riken	W01C060A21	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023006E05	06_04-A11	Riken	W01C060A22	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023061J06	06_04-A12	Riken	W01C060A23	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H023061J06	06_04-A12	Riken	W01C060A24	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H013023F15	06_04-A01	Riken	W01C060B01	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013023F15	06_04-A01	Riken	W01C060B02	pDONR221			FAM76B	143684		Hs.288304	Family with sequence similarity 76, member B						NM_144664.4	NP_653265.3	VALIDATED	P	1.000	1.000	230	702	1	690	339	1	230
IKAKEN	H013038L13	06_04-A02	Riken	W01C060B03	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013038L13	06_04-A02	Riken	W01C060B04	pDONR221			LRRCC1	85444		Hs.193115	Leucine rich repeat and coiled-coil domain containing 1						NM_033402.3	NP_208325.3	VALIDATED	OK	1.000	1.000	1032	3099	1	3096	1032	1	1032
IKAKEN	H013048B03	06_04-A03	Riken	W01C060B05	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013048B03	06_04-A03	Riken	W01C060B06	pDONR221			TRPC1	7220		Hs.250687	Transient receptor potential cation channel, subfamily C, member 1						NM_003304.4	NP_003295.1	VALIDATED	OK	1.000	1.000	759	2280	1	2277	759	1	759
IKAKEN	H013060J02	06_04-A04	Riken	W01C060B07	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013060J02	06_04-A04	Riken	W01C060B08	pDONR221			TTLL9	164395		Hs.712915	Tubulin tyrosine ligase-like family, member 9						NM_001008409.2	NP_001008409.1	PROVISIONAL	Pfs	0.871	1.000	194	582	1	581	439	51	219
IKAKEN	H013067I10	06_04-A05	Riken	W01C060B09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06_04-A05	Riken	W01C060B10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013077D14	06_04-A06	Riken	W01C060B11	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013077D14	06_04-A06	Riken	W01C060B12	pDONR221			MLF1IP	79682		Hs.575032	MLF1 interacting protein						NM_024629.2	NP_078905.2	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	H013085D22	06_04-A07	Riken	W01C060B13	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013085D22	06_04-A07	Riken	W01C060B14	pDONR221			TNC	3371		Hs.143250	Tenascin C						NM_002160.2	NP_002151.2	VALIDATED		0.496	0.698	2201	4695	1	4689	2201	1	2201
IKAKEN	H013088L02	06_04-A08	Riken	W01C060B15	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088L02	06_04-A08	Riken	W01C060B16	pDONR221			TTTY11	83866		Hs.122396	Testis-specific transcript, Y-linked 11								
IKAKEN	H013088J04	06_04-A09	Riken	W01C060B17	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013088J04	06_04-A09	Riken	W01C060B18	pDONR221			LMBR1	64327		Hs.209989	Limb region 1 homolog (mouse)						NM_022458.3	NP_071903.2	REVIEWED	Pg	0.840	1.000	338	855	1	852	490	153	490
IKAKEN	H013095K06	06_04-A10	Riken	W01C060B19	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H013095K06	06_04-A10	Riken	W01C060B20	pDONR221			C12orf10	60314		Hs.655988	Chromosome 12 open reading frame 10						NM_021640.3	NP_067653.3	VALIDATED	Pgs	0.845	0.996	335	855	1	852	376	42	376
IKAKEN	H023006E05	06_04-A11	Riken	W01C060B21	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023006E05	06_04-A11	Riken	W01C060B22	pDONR221			WDFY1	57590		Hs.708107	WD repeat and FYVE domain containing 1						NM_020830.3	NP_065881.1	REVIEWED	OK	1.000	1.000	410	1233	1	1230	410	1	410
IKAKEN	H023061J06	06_04-A12	Riken	W01C060B23	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H023061J06	06_04-A12	Riken	W01C060B24	pDONR221			PACSIN2	11252									NM_007229.2	NP_009160.2	PROVISIONAL	Cg	0.916	1.000	486	1338	1	1335	486	1	486
IKAKEN	H023064J06	06_04-B01	Riken	W01C060C01	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023064J06	06_04-B01	Riken	W01C060C02	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023067B02	06_04-B02	Riken	W01C060C03	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023067B02	06_04-B02	Riken	W01C060C04	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023076K12	06_04-B03	Riken	W01C060C05	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06_04-B03	Riken	W01C060C06	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023078H14	06_04-B04	Riken	W01C060C07	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023078H14	06_04-B04	Riken	W01C060C08	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023090D10	06_04-B05	Riken	W01C060C09	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06_04-B05	Riken	W01C060C10	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023095G07	06_04-B06	Riken	W01C060C11	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H023095G07	06_04-B06	Riken	W01C060C12	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H033011C23	06_04-B07	Riken	W01C060C13	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033011C23	06_04-B07	Riken	W01C060C14	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033069H03	06_04-B08	Riken	W01C060C15	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033069H03	06_04-B08	Riken	W01C060C16	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033076F03	06_04-B09	Riken	W01C060C17	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06_04-B09	Riken	W01C060C18	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06_04-B10	Riken	W01C060C19	pDONR221															
IKAKEN	H033076L09	06_04-B10	Riken	W01C060C20	pDONR221															
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C060C21	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C060C22	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	H013094G13	06_04-B12	Riken	W01C060C23	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06_04-B12	Riken	W01C060C24	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H023064J06	06_04-B01	Riken	W01C060D01	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023064J06	06_04-B01	Riken	W01C060D02	pDONR221			FZR1	51343		Hs.413133	Fizzy/cell division cycle 20 related 1 (Drosophila)						NM_001136197.1	NP_001129669.1	VALIDATED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	H023067B02	06_04-B02	Riken	W01C060D03	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023067B02	06_04-B02	Riken	W01C060D04	pDONR221			OPA1	4976		Hs.594504	Optic atrophy 1 (autosomal dominant)						NM_130833.2	NP_570846.1	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	H023076K12	06_04-B03	Riken	W01C060D05	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06_04-B03	Riken	W01C060D06	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023078H14	06_04-B04	Riken	W01C060D07	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023078H14	06_04-B04	Riken	W01C060D08	pDONR221			LLGL1	3996		Hs.513983	Lethal giant larvae homolog 1 (Drosophila)						NM_004140.3	NP_004131.3	REVIEWED	Pfs	0.995	0.998	1034	3093	1	3092	1064	1	1034
IKAKEN	H023090D10	06_04-B05	Riken	W01C060D09	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06_04-B05	Riken	W01C060D10	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023095G07	06_04-B06	Riken	W01C060D11	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H023095G07	06_04-B06	Riken	W01C060D12	pDONR221			C10orf54	64115		Hs.47382	Chromosome 10 open reading frame 54						NM_022153.1	NP_071436.1	VALIDATED		0.971	0.971	311	936	1	933	311	1	311
IKAKEN	H033011C23	06_04-B07	Riken	W01C060D13	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033011C23	06_04-B07	Riken	W01C060D14	pDONR221			UNK	85451		Hs.584768	Unkempt homolog (Drosophila)						NM_001080419.1	NP_001073888.1	PROVISIONAL	P	1.000	1.000	810	2433	1	2430	886	77	886
IKAKEN	H033069H03	06_04-B08	Riken	W01C060D15	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033069H03	06_04-B08	Riken	W01C060D16	pDONR221			SYPL1	6856		Hs.80919	Synaptophysin-like 1						NM_182715.1	NP_874384.1	VALIDATED	OK	1.000	1.000	241	726	1	723	241	1	241
IKAKEN	H033076F03	06_04-B09	Riken	W01C060D17	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06_04-B09	Riken	W01C060D18	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06_04-B10	Riken	W01C060D19	pDONR221															
IKAKEN	H033076L09	06_04-B10	Riken	W01C060D20	pDONR221															
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C060D21	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	BX464501 (5' CS0DE002YA09)	06_04-B11		W01C060D22	pDONR221			FILIP1L	11259		Hs.104672	Filamin A interacting protein 1-like						NM_182909.2	NP_878913.2	VALIDATED	Pg	0.982	1.000	767	2260	1	2259	1135	241	1007
IKAKEN	H013094G13	06_04-B12	Riken	W01C060D23	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06_04-B12	Riken	W01C060D24	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013097B12	06_04-C01	Riken	W01C060E01	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H013097B12	06_04-C01	Riken	W01C060E02	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H033062B14	06_04-C02	Riken	W01C060E03	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06_04-C02	Riken	W01C060E04	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H013062N19	06_04-C03	Riken	W01C060E05	pDONR221															
IKAKEN	H013062N19	06_04-C03	Riken	W01C060E06	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C060E07	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C060E08	pDONR221															
IKAKEN	H013063A18	06_04-C05	Riken	W01C060E09	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H013063A18	06_04-C05	Riken	W01C060E10	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H023083A18	06_04-C06	Riken	W01C060E11	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	H023083A18	06_04-C06	Riken	W01C060E12	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C060E13	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C060E14	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C060E15	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C060E16	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C060E17	pDONR221															
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C060E18	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C060E19	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C060E20	pDONR221															
IKAKEN	TST08313	06_04-C11	EST	W01C060E21	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06_04-C11	EST	W01C060E22	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004A01	06_04-C12	IMS	W01C060E23	pDONR221															
IKAKEN	SK004A01	06_04-C12	IMS	W01C060E24	pDONR221															
IKAKEN	H013097B12	06_04-C01	Riken	W01C060F01	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H013097B12	06_04-C01	Riken	W01C060F02	pDONR221			LOC339524	339524		Hs.615291	Hypothetical LOC339524																		
IKAKEN	H033062B14	06_04-C02	Riken	W01C060F03	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06_04-C02	Riken	W01C060F04	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H013062N19	06_04-C03	Riken	W01C060F05	pDONR221															
IKAKEN	H013062N19	06_04-C03	Riken	W01C060F06	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C060F07	pDONR221															
IKAKEN	H013062N19	06_04-C04	Riken	W01C060F08	pDONR221															
IKAKEN	H013063A18	06_04-C05	Riken	W01C060F09	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H013063A18	06_04-C05	Riken	W01C060F10	pDONR221			ZC3H6	376940		Hs.190477	Zinc finger CCCH-type containing 6						NM_198581.2	NP_940983.2	VALIDATED	Pfs	0.991	0.999	929	2786	3	2785	1189	215	1137
IKAKEN	H023083A18	06_04-C06	Riken	W01C060F11	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	H023083A18	06_04-C06	Riken	W01C060F12	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED		0.858	0.858	239	720	1	717	593	355	593
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C060F13	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRACE3017294	06_04-C07	EST(F-)	W01C060F14	pDONR221			CERKL	375298		Hs.715753	Ceramide kinase-like						NM_201548.4	NP_963842.1	VALIDATED	OK	1.000	1.000	532	1599	1	1596	532	1	532
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C060F15	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	F-BRTHA3024509	06_04-C08	EST(F-)	W01C060F16	pDONR221			WDR37	22884		Hs.188495	WD repeat domain 37						NM_014023.3	NP_054742.2	REVIEWED	OK	1.000	1.000	494	1485	1	1482	494	1	494
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C060F17	pDONR221															
IKAKEN	KMR09306	06_04-C09	EST(RND)	W01C060F18	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C060F19	pDONR221															
IKAKEN	KAT09969	06_04-C10	EST	W01C060F20	pDONR221															
IKAKEN	TST08313	06_04-C11	EST	W01C060F21	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06_04-C11	EST	W01C060F22	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004A01	06_04-C12	IMS	W01C060F23	pDONR221															
IKAKEN	SK004A01	06_04-C12	IMS	W01C060F24	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C060G01	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C060G02	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C060G03	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C060G04	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C060G05	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C060G06	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C060G07	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C060G08	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C060G09	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C060G10	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C060G11	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C060G12	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C060G13	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C060G14	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C060G15	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C060G16	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C060G17	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C060G18	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C060G19	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C060G20	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C060G21	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C060G22	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C060G23	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C060G24	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C060H01	pDONR221															
IKAKEN	SK004A02	06_04-D01	IMS	W01C060H02	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C060H03	pDONR221															
IKAKEN	SK004A03	06_04-D02	IMS	W01C060H04	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C060H05	pDONR221															
IKAKEN	SK004A07	06_04-D03	IMS	W01C060H06	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C060H07	pDONR221															
IKAKEN	SK004A10	06_04-D04	IMS	W01C060H08	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C060H09	pDONR221															
IKAKEN	SK004A12	06_04-D05	IMS	W01C060H10	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C060H11	pDONR221															
IKAKEN	SK004B01	06_04-D06	IMS	W01C060H12	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C060H13	pDONR221															
IKAKEN	SK004B02	06_04-D07	IMS	W01C060H14	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C060H15	pDONR221															
IKAKEN	SK004B03	06_04-D08	IMS	W01C060H16	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C060H17	pDONR221															
IKAKEN	SK004B04	06_04-D09	IMS	W01C060H18	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C060H19	pDONR221															
IKAKEN	SK004B06	06_04-D10	IMS	W01C060H20	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C060H21	pDONR221															
IKAKEN	SK004B09	06_04-D11	IMS	W01C060H22	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C060H23	pDONR221															
IKAKEN	SK004B10	06_04-D12	IMS	W01C060H24	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C060I01	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C060I02	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C060I03	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C060I04	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C060I05	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C060I06	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C060I07	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C060I08	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C060I09	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C060I10	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C060I11	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C060I12	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C060I13	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C060I14	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C060I15	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C060I16	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C060I17	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C060I18	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C060I19	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C060I20	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C060I21	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C060I22	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C060I23	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C060I24	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C060J01	pDONR221															
IKAKEN	SK004B11	06_04-E01	IMS	W01C060J02	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C060J03	pDONR221															
IKAKEN	SK004B12	06_04-E02	IMS	W01C060J04	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C060J05	pDONR221															
IKAKEN	SK004C02	06_04-E03	IMS	W01C060J06	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C060J07	pDONR221															
IKAKEN	SK004C03	06_04-E04	IMS	W01C060J08	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C060J09	pDONR221															
IKAKEN	SK004C05	06_04-E05	IMS	W01C060J10	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C060J11	pDONR221															
IKAKEN	SK004C06	06_04-E06	IMS	W01C060J12	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C060J13	pDONR221															
IKAKEN	SK004C07	06_04-E07	IMS	W01C060J14	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C060J15	pDONR221															
IKAKEN	SK004C09	06_04-E08	IMS	W01C060J16	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C060J17	pDONR221															
IKAKEN	SK004D01	06_04-E09	IMS	W01C060J18	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C060J19	pDONR221															
IKAKEN	SK004D02	06_04-E10	IMS	W01C060J20	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C060J21	pDONR221															
IKAKEN	SK004D03	06_04-E11	IMS	W01C060J22	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C060J23	pDONR221															
IKAKEN	SK004D06	06_04-E12	IMS	W01C060J24	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C060K01	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C060K02	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C060K03	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C060K04	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C060K05	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C060K06	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C060K07	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C060K08	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C060K09	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C060K10	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C060K11	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C060K12	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C060K13	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C060K14	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C060K15	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C060K16	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C060K17	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C060K18	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C060K19	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C060K20	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C060K21	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C060K22	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C060K23	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C060K24	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C060L01	pDONR221															
IKAKEN	SK004D06	06_04-F01	IMS	W01C060L02	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C060L03	pDONR221															
IKAKEN	SK004D06	06_04-F02	IMS	W01C060L04	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C060L05	pDONR221															
IKAKEN	SK004D09	06_04-F03	IMS	W01C060L06	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C060L07	pDONR221															
IKAKEN	SK004D10	06_04-F04	IMS	W01C060L08	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C060L09	pDONR221															
IKAKEN	SK004D12	06_04-F05	IMS	W01C060L10	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C060L11	pDONR221															
IKAKEN	SK004E01	06_04-F06	IMS	W01C060L12	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C060L13	pDONR221															
IKAKEN	SK004E02	06_04-F07	IMS	W01C060L14	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C060L15	pDONR221															
IKAKEN	SK004E04	06_04-F08	IMS	W01C060L16	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C060L17	pDONR221															
IKAKEN	SK004E06	06_04-F09	IMS	W01C060L18	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C060L19	pDONR221															
IKAKEN	SK004E07	06_04-F10	IMS	W01C060L20	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C060L21	pDONR221															
IKAKEN	SK004E08	06_04-F11	IMS	W01C060L22	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C060L23	pDONR221															
IKAKEN	SK004E09	06_04-F12	IMS	W01C060L24	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C060M01	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C060M02	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C060M03	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C060M04	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C060M05	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C060M06	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C060M07	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C060M08	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C060M09	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C060M10	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C060M11	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C060M12	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C060M13	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C060M14	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C060M15	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C060M16	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C060M17	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C060M18	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C060M19	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C060M20	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C060M21	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C060M22	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C060M23	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C060M24	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C060N01	pDONR221															
IKAKEN	SK004E09	06_04-G01	IMS	W01C060N02	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C060N03	pDONR221															
IKAKEN	SK004E10	06_04-G02	IMS	W01C060N04	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C060N05	pDONR221															
IKAKEN	SK004E11	06_04-G03	IMS	W01C060N06	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C060N07	pDONR221															
IKAKEN	SK004E12	06_04-G04	IMS	W01C060N08	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C060N09	pDONR221															
IKAKEN	SK004F02	06_04-G05	IMS	W01C060N10	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C060N11	pDONR221															
IKAKEN	SK004F03	06_04-G06	IMS	W01C060N12	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C060N13	pDONR221															
IKAKEN	SK004F04	06_04-G07	IMS	W01C060N14	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C060N15	pDONR221															
IKAKEN	SK004F05	06_04-G08	IMS	W01C060N16	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C060N17	pDONR221															
IKAKEN	SK004F06	06_04-G09	IMS	W01C060N18	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C060N19	pDONR221															
IKAKEN	SK004F08	06_04-G10	IMS	W01C060N20	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C060N21	pDONR221															
IKAKEN	SK004F09	06_04-G11	IMS	W01C060N22	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C060N23	pDONR221															
IKAKEN	SK004F10	06_04-G12	IMS	W01C060N24	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C060O01	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C060O02	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C060O03	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C060O04	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C060O05	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C060O06	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C060O07	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C060O08	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C060O09	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C060O10	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C060O11	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C060O12	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C060O13	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C060O14	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C060O15	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C060O16	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C060O17	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C060O18	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C060O19	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C060O20	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C060O21	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C060O22	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C060O23	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C060O24	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C060P01	pDONR221															
IKAKEN	SK004G02	06_04-H01	IMS	W01C060P02	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C060P03	pDONR221															
IKAKEN	SK004G03	06_04-H02	IMS	W01C060P04	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C060P05	pDONR221															
IKAKEN	SK004G04	06_04-H03	IMS	W01C060P06	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C060P07	pDONR221															
IKAKEN	SK004G05	06_04-H04	IMS	W01C060P08	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C060P09	pDONR221															
IKAKEN	SK004G09	06_04-H05	IMS	W01C060P10	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C060P11	pDONR221															
IKAKEN	SK004G10	06_04-H06	IMS	W01C060P12	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C060P13	pDONR221															
IKAKEN	SK004G12	06_04-H07	IMS	W01C060P14	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C060P15	pDONR221															
IKAKEN	SK004H02	06_04-H08	IMS	W01C060P16	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C060P17	pDONR221															
IKAKEN	SK004H04	06_04-H09	IMS	W01C060P18	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C060P19	pDONR221															
IKAKEN	SK004H05	06_04-H10	IMS	W01C060P20	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C060P21	pDONR221															
IKAKEN	SK004H06	06_04-H11	IMS	W01C060P22	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C060P23	pDONR221															
IKAKEN	SK004H07	06_04-H12	IMS	W01C060P24	pDONR221															
IKAKEN	SK004H07	06_05-A01	IMS	W01C061A01	pDONR221															
IKAKEN	SK004H07	06_05-A01	IMS	W01C061A02	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C061A03	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C061A04	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C061A05	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C061A06	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C061A07	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C061A08	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C061A09	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C061A10	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C061A11	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C061A12	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C061A13	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C061A14	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C061A15	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C061A16	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C061A17	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C061A18	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C061A19	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C061A20	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C061A21	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C061A22	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C061A23	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C061A24	pDONR221															
IKAKEN	SK004H07	06_05-A01	IMS	W01C061B01	pDONR221															
IKAKEN	SK004H07	06_05-A01	IMS	W01C061B02	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C061B03	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C061B04	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C061B05	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C061B06	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C061B07	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C061B08	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C061B09	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C061B10	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C061B11	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C061B12	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C061B13	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C061B14	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C061B15	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C061B16	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C061B17	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C061B18	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C061B19	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C061B20	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C061B21	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C061B22	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C061B23	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C061B24	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C061C01	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C061C02	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C061C03	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C061C04	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C061C05	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C061C06	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C061C07	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C061C08	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C061C09	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C061C10	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C061C11	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C061C12	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C061C13	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C061C14	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C061C15	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C061C16	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C061C17	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C061C18	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C061C19	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C061C20	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C061C21	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C061C22	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C061C23	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C061C24	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C061D01	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C061D02	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C061D03	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C061D04	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C061D05	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C061D06	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C061D07	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C061D08	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C061D09	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C061D10	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C061D11	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C061D12	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C061D13	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C061D14	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C061D15	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C061D16	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C061D17	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C061D18	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C061D19	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C061D20	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C061D21	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C061D22	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C061D23	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C061D24	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C061E01	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C061E02	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C061E03	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C061E04	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C061E05	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C061E06	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C061E07	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C061E08	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C061E09	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C061E10	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C061E11	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C061E12	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C061E13	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C061E14	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C061E15	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C061E16	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C061E17	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C061E18	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C061E19	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C061E20	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C061E21	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C061E22	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C061E23	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C061E24	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C061F01	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C061F02	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C061F03	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C061F04	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C061F05	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C061F06	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C061F07	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C061F08	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C061F09	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C061F10	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C061F11	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C061F12	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C061F13	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C061F14	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C061F15	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C061F16	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C061F17	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C061F18	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C061F19	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C061F20	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C061F21	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C061F22	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C061F23	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C061F24	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C061G01	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C061G02	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C061G03	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C061G04	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C061G05	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C061G06	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C061G07	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C061G08	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C061G09	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C061G10	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C061G11	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C061G12	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C061G13	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C061G14	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C061G15	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C061G16	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C061G17	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C061G18	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C061G19	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C061G20	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C061G21	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C061G22	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C061G23	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C061G24	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C061H01	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C061H02	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C061H03	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C061H04	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C061H05	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C061H06	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C061H07	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C061H08	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C061H09	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C061H10	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C061H11	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C061H12	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C061H13	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C061H14	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C061H15	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C061H16	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C061H17	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C061H18	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C061H19	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C061H20	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C061H21	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C061H22	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C061H23	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C061H24	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C061I01	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C061I02	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C061I03	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C061I04	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C061I05	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C061I06	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C061I07	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C061I08	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C061I09	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C061I10	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C061I11	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C061I12	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C061I13	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C061I14	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C061I15	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C061I16	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C061I17	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C061I18	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C061I19	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C061I20	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C061I21	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C061I22	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C061I23	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C061I24	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C061J01	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C061J02	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C061J03	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C061J04	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C061J05	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C061J06	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C061J07	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C061J08	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C061J09	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C061J10	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C061J11	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C061J12	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C061J13	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C061J14	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C061J15	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C061J16	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C061J17	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C061J18	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C061J19	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C061J20	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C061J21	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C061J22	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C061J23	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C061J24	pDONR221															
IKAKEN	SK004H07	06_05-F01	IMS	W01C061K01	pDONR221															
IKAKEN	SK004H07	06_05-F01	IMS	W01C061K02	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C061K03	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C061K04	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C061K05	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C061K06	pDONR221															
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C061K07	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C061K08	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C061K09	pDONR221															
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C061K10	pDONR221															
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C061K11	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C061K12	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HSI10503	06_05-F07	EST	W01C061K13	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	HSI10503	06_05-F07	EST	W01C061K14	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	JTH11367	06_05-F08	EST	W01C061K15	pDONR221															
IKAKEN	JTH11367	06_05-F08	EST	W01C061K16	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C061K17	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C061K18	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C061K19	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C061K20	pDONR221															
IKAKEN	LFL09410	06_05-F11	EST	W01C061K21	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09410	06_05-F11	EST	W01C061K22	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09693	06_05-F12	EST	W01C061K23	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	LFL09693	06_05-F12	EST	W01C061K24	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	SK004H07	06_05-F01	IMS	W01C061L01	pDONR221															
IKAKEN	SK004H07	06_05-F01	IMS	W01C061L02	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C061L03	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C061L04	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C061L05	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C061L06	pDONR221															
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C061L07	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C061L08	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C061L09	pDONR221															
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C061L10	pDONR221															
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C061L11	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C061L12	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HSI10503	06_05-F07	EST	W01C061L13	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	HSI10503	06_05-F07	EST	W01C061L14	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	JTH11367	06_05-F08	EST	W01C061L15	pDONR221															
IKAKEN	JTH11367	06_05-F08	EST	W01C061L16	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C061L17	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C061L18	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C061L19	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C061L20	pDONR221															
IKAKEN	LFL09410	06_05-F11	EST	W01C061L21	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09410	06_05-F11	EST	W01C061L22	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09693	06_05-F12	EST	W01C061L23	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	LFL09693	06_05-F12	EST	W01C061L24	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C061M01	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C061M02	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	MPG01306	06_05-G02	EST	W01C061M03	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	MPG01306	06_05-G02	EST	W01C061M04	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C061M05	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C061M06	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C061M07	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C061M08	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C061M09	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C061M10	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C061M11	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C061M12	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C061M13	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C061M14	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C061M15	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C061M16	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC033215	06_05-G09	MGC	W01C061M17	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC033215	06_05-G09	MGC	W01C061M18	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC052604	06_05-G10	MGC	W01C061M19	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052604	06_05-G10	MGC	W01C061M20	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052592	06_05-G11	MGC	W01C061M21	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC052592	06_05-G11	MGC	W01C061M22	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC066640	06_05-G12	MGC	W01C061M23	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	BC066640	06_05-G12	MGC	W01C061M24	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C061N01	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C061N02	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	MPG01306	06_05-G02	EST	W01C061N03	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	MPG01306	06_05-G02	EST	W01C061N04	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C061N05	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C061N06	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C061N07	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C061N08	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C061N09	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C061N10	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C061N11	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C061N12	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C061N13	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C061N14	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C061N15	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C061N16	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC033215	06_05-G09	MGC	W01C061N17	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC033215	06_05-G09	MGC	W01C061N18	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC052604	06_05-G10	MGC	W01C061N19	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052604	06_05-G10	MGC	W01C061N20	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052592	06_05-G11	MGC	W01C061N21	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC052592	06_05-G11	MGC	W01C061N22	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC066640	06_05-G12	MGC	W01C061N23	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	BC066640	06_05-G12	MGC	W01C061N24	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	BC062212	06_05-H01	MGC	W01C061O01	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06_05-H01	MGC	W01C061O02	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	AK055679	06_05-H02	FLJ	W01C061O03	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK055679	06_05-H02	FLJ	W01C061O04	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK092963	06_05-H03	FLJ	W01C061O05	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06_05-H03	FLJ	W01C061O06	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK091766	06_05-H04	FLJ	W01C061O07	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK091766	06_05-H04	FLJ	W01C061O08	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK092698	06_05-H05	FLJ	W01C061O09	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK092698	06_05-H05	FLJ	W01C061O10	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK091481	06_05-H06	FLJ	W01C061O11	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK091481	06_05-H06	FLJ	W01C061O12	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK075065	06_05-H07	FLJ	W01C061O13	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075065	06_05-H07	FLJ	W01C061O14	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075136	06_05-H08	FLJ	W01C061O15	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK075136	06_05-H08	FLJ	W01C061O16	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK097054	06_05-H09	FLJ	W01C061O17	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK097054	06_05-H09	FLJ	W01C061O18	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK095614	06_05-H10	FLJ	W01C061O19	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK095614	06_05-H10	FLJ	W01C061O20	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK022629	06_05-H11	FLJ	W01C061O21	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK022629	06_05-H11	FLJ	W01C061O22	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK097091	06_05-H12	FLJ	W01C061O23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_05-H12	FLJ	W01C061O24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	BC062212	06_05-H01	MGC	W01C061P01	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06_05-H01	MGC	W01C061P02	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	AK055679	06_05-H02	FLJ	W01C061P03	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK055679	06_05-H02	FLJ	W01C061P04	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK092963	06_05-H03	FLJ	W01C061P05	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06_05-H03	FLJ	W01C061P06	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK091766	06_05-H04	FLJ	W01C061P07	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK091766	06_05-H04	FLJ	W01C061P08	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK092698	06_05-H05	FLJ	W01C061P09	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK092698	06_05-H05	FLJ	W01C061P10	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK091481	06_05-H06	FLJ	W01C061P11	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK091481	06_05-H06	FLJ	W01C061P12	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK075065	06_05-H07	FLJ	W01C061P13	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075065	06_05-H07	FLJ	W01C061P14	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075136	06_05-H08	FLJ	W01C061P15	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK075136	06_05-H08	FLJ	W01C061P16	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK097054	06_05-H09	FLJ	W01C061P17	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK097054	06_05-H09	FLJ	W01C061P18	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK095614	06_05-H10	FLJ	W01C061P19	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK095614	06_05-H10	FLJ	W01C061P20	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK022629	06_05-H11	FLJ	W01C061P21	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK022629	06_05-H11	FLJ	W01C061P22	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK097091	06_05-H12	FLJ	W01C061P23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_05-H12	FLJ	W01C061P24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	SK004H07	06_05-A01	IMS	W01C062A01	pDONR221															
IKAKEN	SK004H07	06_05-A01	IMS	W01C062A02	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C062A03	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C062A04	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C062A05	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C062A06	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C062A07	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C062A08	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C062A09	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C062A10	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C062A11	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C062A12	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C062A13	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C062A14	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C062A15	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C062A16	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C062A17	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C062A18	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C062A19	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C062A20	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C062A21	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C062A22	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C062A23	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C062A24	pDONR221															
IKAKEN	SK004H07	06_05-A01	IMS	W01C062B01	pDONR221															
IKAKEN	SK004H07	06_05-A01	IMS	W01C062B02	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C062B03	pDONR221															
IKAKEN	SK004H09	06_05-A02	IMS	W01C062B04	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C062B05	pDONR221															
IKAKEN	SK004H10	06_05-A03	IMS	W01C062B06	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C062B07	pDONR221															
IKAKEN	SK004H11	06_05-A04	IMS	W01C062B08	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C062B09	pDONR221															
IKAKEN	SK005A02	06_05-A05	IMS	W01C062B10	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C062B11	pDONR221															
IKAKEN	SK005A03	06_05-A06	IMS	W01C062B12	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C062B13	pDONR221															
IKAKEN	SK005A04	06_05-A07	IMS	W01C062B14	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C062B15	pDONR221															
IKAKEN	SK005A05	06_05-A08	IMS	W01C062B16	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C062B17	pDONR221															
IKAKEN	SK005A06	06_05-A09	IMS	W01C062B18	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C062B19	pDONR221															
IKAKEN	SK005B01	06_05-A10	IMS	W01C062B20	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C062B21	pDONR221															
IKAKEN	SK005B02	06_05-A11	IMS	W01C062B22	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C062B23	pDONR221															
IKAKEN	SK005B03	06_05-A12	IMS	W01C062B24	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C062C01	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C062C02	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C062C03	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C062C04	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C062C05	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C062C06	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C062C07	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C062C08	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C062C09	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C062C10	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C062C11	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C062C12	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C062C13	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C062C14	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C062C15	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C062C16	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C062C17	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C062C18	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C062C19	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C062C20	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C062C21	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C062C22	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C062C23	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C062C24	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C062D01	pDONR221															
IKAKEN	SK005B05	06_05-B01	IMS	W01C062D02	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C062D03	pDONR221															
IKAKEN	SK005B11	06_05-B02	IMS	W01C062D04	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C062D05	pDONR221															
IKAKEN	SK005C03	06_05-B03	IMS	W01C062D06	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C062D07	pDONR221															
IKAKEN	SK005C12	06_05-B04	IMS	W01C062D08	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C062D09	pDONR221															
IKAKEN	SK005D01	06_05-B05	IMS	W01C062D10	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C062D11	pDONR221															
IKAKEN	SK005D03	06_05-B06	IMS	W01C062D12	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C062D13	pDONR221															
IKAKEN	SK005E01	06_05-B07	IMS	W01C062D14	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C062D15	pDONR221															
IKAKEN	SK005E03	06_05-B08	IMS	W01C062D16	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C062D17	pDONR221															
IKAKEN	SK005F03	06_05-B09	IMS	W01C062D18	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C062D19	pDONR221															
IKAKEN	SK005F04	06_05-B10	IMS	W01C062D20	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C062D21	pDONR221															
IKAKEN	SK005F05	06_05-B11	IMS	W01C062D22	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C062D23	pDONR221															
IKAKEN	SK005F12	06_05-B12	IMS	W01C062D24	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C062E01	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C062E02	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C062E03	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C062E04	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C062E05	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C062E06	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C062E07	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C062E08	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C062E09	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C062E10	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C062E11	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C062E12	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C062E13	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C062E14	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C062E15	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C062E16	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C062E17	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C062E18	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C062E19	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C062E20	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C062E21	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C062E22	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C062E23	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C062E24	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C062F01	pDONR221															
IKAKEN	SK005G01	06_05-C01	IMS	W01C062F02	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C062F03	pDONR221															
IKAKEN	SK005G04	06_05-C02	IMS	W01C062F04	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C062F05	pDONR221															
IKAKEN	SK005G05	06_05-C03	IMS	W01C062F06	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C062F07	pDONR221															
IKAKEN	SK005H01	06_05-C04	IMS	W01C062F08	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C062F09	pDONR221															
IKAKEN	SK005H02	06_05-C05	IMS	W01C062F10	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C062F11	pDONR221															
IKAKEN	SK005H03	06_05-C06	IMS	W01C062F12	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C062F13	pDONR221															
IKAKEN	SK005H04	06_05-C07	IMS	W01C062F14	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C062F15	pDONR221															
IKAKEN	SK005H05	06_05-C08	IMS	W01C062F16	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C062F17	pDONR221															
IKAKEN	SK006D01	06_05-C09	IMS	W01C062F18	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C062F19	pDONR221															
IKAKEN	SK006D06	06_05-C10	IMS	W01C062F20	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C062F21	pDONR221															
IKAKEN	SK006E06	06_05-C11	IMS	W01C062F22	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C062F23	pDONR221															
IKAKEN	SK006E11	06_05-C12	IMS	W01C062F24	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C062G01	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C062G02	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C062G03	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C062G04	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C062G05	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C062G06	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C062G07	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C062G08	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C062G09	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C062G10	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C062G11	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C062G12	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C062G13	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C062G14	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C062G15	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C062G16	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C062G17	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C062G18	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C062G19	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C062G20	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C062G21	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C062G22	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C062G23	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C062G24	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C062H01	pDONR221															
IKAKEN	SK006F11	06_05-D01	IMS	W01C062H02	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C062H03	pDONR221															
IKAKEN	SK006G02	06_05-D02	IMS	W01C062H04	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C062H05	pDONR221															
IKAKEN	SK006G03	06_05-D03	IMS	W01C062H06	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C062H07	pDONR221															
IKAKEN	SK006H09	06_05-D04	IMS	W01C062H08	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C062H09	pDONR221															
IKAKEN	SK006B12	06_05-D05	IMS	W01C062H10	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C062H11	pDONR221															
IKAKEN	SK004H12	06_05-D06	IMS	W01C062H12	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C062H13	pDONR221															
IKAKEN	SK006B12	06_05-D07	IMS	W01C062H14	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C062H15	pDONR221															
IKAKEN	SK004D08	06_05-D08	IMS	W01C062H16	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C062H17	pDONR221															
IKAKEN	SK004A01	06_05-D09	IMS	W01C062H18	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C062H19	pDONR221															
IKAKEN	SK004A04	06_05-D10		W01C062H20	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C062H21	pDONR221															
IKAKEN	SK004A05	06_05-D11		W01C062H22	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C062H23	pDONR221															
IKAKEN	SK004A06	06_05-D12		W01C062H24	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C062I01	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C062I02	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C062I03	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C062I04	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C062I05	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C062I06	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C062I07	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C062I08	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C062I09	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C062I10	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C062I11	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C062I12	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C062I13	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C062I14	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C062I15	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C062I16	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C062I17	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C062I18	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C062I19	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C062I20	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C062I21	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C062I22	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C062I23	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C062I24	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C062J01	pDONR221															
IKAKEN	SK004A08	06_05-E01	IMS	W01C062J02	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C062J03	pDONR221															
IKAKEN	SK004A11	06_05-E02		W01C062J04	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C062J05	pDONR221															
IKAKEN	SK004B07	06_05-E03	IMS	W01C062J06	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C062J07	pDONR221															
IKAKEN	SK004B08	06_05-E04	IMS	W01C062J08	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C062J09	pDONR221															
IKAKEN	SK004C01	06_05-E05		W01C062J10	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C062J11	pDONR221															
IKAKEN	SK004C08	06_05-E06		W01C062J12	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C062J13	pDONR221															
IKAKEN	SK004D07	06_05-E07		W01C062J14	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C062J15	pDONR221															
IKAKEN	SK004E03	06_05-E08		W01C062J16	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C062J17	pDONR221															
IKAKEN	SK004F01	06_05-E09		W01C062J18	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C062J19	pDONR221															
IKAKEN	SK004G01	06_05-E10		W01C062J20	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C062J21	pDONR221															
IKAKEN	SK004H01	06_05-E11		W01C062J22	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C062J23	pDONR221															
IKAKEN	SK004H03	06_05-E12		W01C062J24	pDONR221															
IKAKEN	SK004H07	06_05-F01	IMS	W01C062K01	pDONR221															
IKAKEN	SK004H07	06_05-F01	IMS	W01C062K02	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C062K03	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C062K04	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C062K05	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C062K06	pDONR221															
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C062K07	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C062K08	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C062K09	pDONR221															
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C062K10	pDONR221															
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C062K11	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C062K12	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HSI10503	06_05-F07	EST	W01C062K13	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	HSI10503	06_05-F07	EST	W01C062K14	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	JTH11367	06_05-F08	EST	W01C062K15	pDONR221															
IKAKEN	JTH11367	06_05-F08	EST	W01C062K16	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C062K17	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C062K18	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C062K19	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C062K20	pDONR221															
IKAKEN	LFL09410	06_05-F11	EST	W01C062K21	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09410	06_05-F11	EST	W01C062K22	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09693	06_05-F12	EST	W01C062K23	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	LFL09693	06_05-F12	EST	W01C062K24	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	SK004H07	06_05-F01	IMS	W01C062L01	pDONR221															
IKAKEN	SK004H07	06_05-F01	IMS	W01C062L02	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C062L03	pDONR221															
IKAKEN	SK005B06	06_05-F02	IMS	W01C062L04	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C062L05	pDONR221															
IKAKEN	SK005C06	06_05-F03	IMS	W01C062L06	pDONR221															
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C062L07	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	AMR04246	06_05-F04	EST(RND)	W01C062L08	pDONR221			ABLIM1	3983		Hs.538331	Actin binding LIM protein 1						NM_006720.3	NP_006711.3	REVIEWED	Cg	0.853	1.000	470	1251	1	1248	455	1	455
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C062L09	pDONR221															
IKAKEN	FCC144G04	06_05-F05	TOYOBO	W01C062L10	pDONR221															
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C062L11	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06_05-F06	EST(RND)	W01C062L12	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HSI10503	06_05-F07	EST	W01C062L13	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	HSI10503	06_05-F07	EST	W01C062L14	pDONR221			KLHL24	54800		Hs.407709	Kelch-like 24 (Drosophila)						NM_017644.3	NP_060114.2	VALIDATED	Cg	0.688	1.000	600	1242	1	1239	600	1	600
IKAKEN	JTH11367	06_05-F08	EST	W01C062L15	pDONR221															
IKAKEN	JTH11367	06_05-F08	EST	W01C062L16	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C062L17	pDONR221															
IKAKEN	KAT05253	06_05-F09	EST	W01C062L18	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C062L19	pDONR221															
IKAKEN	KAT05282	06_05-F10	EST	W01C062L20	pDONR221															
IKAKEN	LFL09410	06_05-F11	EST	W01C062L21	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09410	06_05-F11	EST	W01C062L22	pDONR221			SMTN	6525		Hs.149098	Smoothelin						NM_134270.1	NP_599032.1	REVIEWED	Cs	0.999	0.999	940	2823	1	2820	940	1	940
IKAKEN	LFL09693	06_05-F12	EST	W01C062L23	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	LFL09693	06_05-F12	EST	W01C062L24	pDONR221			SEC31A	22872		Hs.370024	SEC31 homolog A (S. cerevisiae)						NM_001077206.1	NP_001070674.1	REVIEWED	P	1.000	1.000	512	1539	1	1536	1106	595	1106
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C062M01	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C062M02	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	MPG01306	06_05-G02	EST	W01C062M03	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	MPG01306	06_05-G02	EST	W01C062M04	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C062M05	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C062M06	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C062M07	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C062M08	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C062M09	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C062M10	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C062M11	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C062M12	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C062M13	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C062M14	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C062M15	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C062M16	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC033215	06_05-G09	MGC	W01C062M17	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC033215	06_05-G09	MGC	W01C062M18	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC052604	06_05-G10	MGC	W01C062M19	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052604	06_05-G10	MGC	W01C062M20	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052592	06_05-G11	MGC	W01C062M21	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC052592	06_05-G11	MGC	W01C062M22	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC066640	06_05-G12	MGC	W01C062M23	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	BC066640	06_05-G12	MGC	W01C062M24	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C062N01	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	LVR01238	06_05-G01	EST(RND)	W01C062N02	pDONR221			CFHR1	3078		Hs.575869	Complement factor H-related 1						NM_002113.2	NP_002104.2	VALIDATED	Cgs	0.818	0.996	330	816	1	813	330	1	330
IKAKEN	MPG01306	06_05-G02	EST	W01C062N03	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	MPG01306	06_05-G02	EST	W01C062N04	pDONR221			LY9	4063		Hs.403857	Lymphocyte antigen 9						NM_002348.2	NP_002339.2	VALIDATED	Pg	0.809	1.000	194	474	1	471	655	462	655
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C062N05	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	NRR06427	06_05-G03	EST(RND)	W01C062N06	pDONR221			PCNT	5116		Hs.474069	Pericentrin						NM_006031.5	NP_006022.3	REVIEWED	Pfs	0.973	1.000	259	777	1	776	3336	1	252
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C062N07	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06_05-G04	EST(RND)	W01C062N08	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C062N09	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06_05-G05	EST(RND)	W01C062N10	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C062N11	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06_05-G06	EST(RND)	W01C062N12	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C062N13	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06_05-G07	EST(RND)	W01C062N14	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C062N15	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06_05-G08	EST(RND)	W01C062N16	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC033215	06_05-G09	MGC	W01C062N17	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC033215	06_05-G09	MGC	W01C062N18	pDONR221	18857		MAST4	375449	AAH33215.1	Hs.595458	Microtubule associated serine/threonine kinase family member 4			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_198828.2	NP_942123.1	VALIDATED	OK	1.000	1.000	250	753	1	750	250	1	250
IKAKEN	BC052604	06_05-G10	MGC	W01C062N19	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052604	06_05-G10	MGC	W01C062N20	pDONR221	10462		CENPV	201161	AAH52604.1	Hs.433422	Centromere protein V			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_181716.2	NP_859067.2	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC052592	06_05-G11	MGC	W01C062N21	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC052592	06_05-G11	MGC	W01C062N22	pDONR221	8657		MLYCD	23417	AAH52592.1	Hs.644610	Malonyl-CoA decarboxylase			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_012213.2	NP_036345.2	REVIEWED	OK	1.000	1.000	493	1482	1	1479	493	1	493
IKAKEN	BC066640	06_05-G12	MGC	W01C062N23	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	BC066640	06_05-G12	MGC	W01C062N24	pDONR221	8230		CDAN1	146059	AAH66640.1	Hs.599232	Congenital dyserythropoietic anemia, type I			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_138477.2	NP_612486.2	VALIDATED	Cgs	0.944	0.988	1263	3729	1	3726	1227	1	1227
IKAKEN	BC062212	06_05-H01	MGC	W01C062O01	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06_05-H01	MGC	W01C062O02	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	AK055679	06_05-H02	FLJ	W01C062O03	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK055679	06_05-H02	FLJ	W01C062O04	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK092963	06_05-H03	FLJ	W01C062O05	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06_05-H03	FLJ	W01C062O06	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK091766	06_05-H04	FLJ	W01C062O07	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK091766	06_05-H04	FLJ	W01C062O08	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK092698	06_05-H05	FLJ	W01C062O09	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK092698	06_05-H05	FLJ	W01C062O10	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK091481	06_05-H06	FLJ	W01C062O11	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK091481	06_05-H06	FLJ	W01C062O12	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK075065	06_05-H07	FLJ	W01C062O13	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075065	06_05-H07	FLJ	W01C062O14	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075136	06_05-H08	FLJ	W01C062O15	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK075136	06_05-H08	FLJ	W01C062O16	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK097054	06_05-H09	FLJ	W01C062O17	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK097054	06_05-H09	FLJ	W01C062O18	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK095614	06_05-H10	FLJ	W01C062O19	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK095614	06_05-H10	FLJ	W01C062O20	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK022629	06_05-H11	FLJ	W01C062O21	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK022629	06_05-H11	FLJ	W01C062O22	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK097091	06_05-H12	FLJ	W01C062O23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_05-H12	FLJ	W01C062O24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	BC062212	06_05-H01	MGC	W01C062P01	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06_05-H01	MGC	W01C062P02	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	AK055679	06_05-H02	FLJ	W01C062P03	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK055679	06_05-H02	FLJ	W01C062P04	pDONR221	34059				BAB70982				synoviocytes from rtheumatioid arthritis		HSYRA2				
IKAKEN	AK092963	06_05-H03	FLJ	W01C062P05	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06_05-H03	FLJ	W01C062P06	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK091766	06_05-H04	FLJ	W01C062P07	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK091766	06_05-H04	FLJ	W01C062P08	pDONR221	5467		LOC255480	255480	-	Hs.567915	Hypothetical protein LOC255480			brain	FEBRA2		XM_001719855.1	XP_001719907.1	MODEL	Pfs	0.500	0.500	8	144	84	107	62	51	58
IKAKEN	AK092698	06_05-H05	FLJ	W01C062P09	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK092698	06_05-H05	FLJ	W01C062P10	pDONR221	32547		FLJ35379	729420	BAC03949.1	Hs.586820	Similar to Alu subfamily J sequence contamination warning entry			prostate	PROST2		XM_001722271.1	XP_001722323.1	MODEL	Pfs	0.938	1.000	128	384	1	383	122	1	120
IKAKEN	AK091481	06_05-H06	FLJ	W01C062P11	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK091481	06_05-H06	FLJ	W01C062P12	pDONR221	16779		SEMA5B	54437	-	Hs.210870	Sema domain, seven thrombospondin repeats (type 1 and type 1-like), transmembrane domain (TM) and short cytoplasmic domain, (semaphorin) 5B			brain	FCBBF3		NM_001031702.2	NP_001026872.2	VALIDATED	Pfs	0.960	1.000	1095	3285	1	3284	1151	1	1051
IKAKEN	AK075065	06_05-H07	FLJ	W01C062P13	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075065	06_05-H07	FLJ	W01C062P14	pDONR221	551		NOTCH2NL	388677	BAC11381.1	Hs.709526	Notch homolog 2 (Drosophila) N-terminal like			placenta	PLACE1		NM_203458.3	NP_982283.2	VALIDATED	Ps	0.995	0.995	213	693	1	639	236	1	213
IKAKEN	AK075136	06_05-H08	FLJ	W01C062P15	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK075136	06_05-H08	FLJ	W01C062P16	pDONR221	6416		ITGBL1	9358	-	Hs.696554	Integrin, beta-like 1 (with EGF-like repeat domains)			placenta	PLACE1		NM_004791.1	NP_004782.1	PROVISIONAL	P	1.000	1.000	89	270	1	267	494	406	494
IKAKEN	AK097054	06_05-H09	FLJ	W01C062P17	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK097054	06_05-H09	FLJ	W01C062P18	pDONR221	15927		C22orf36	388886	BAC04937.1	Hs.113314	Chromosome 22 open reading frame 36			small intestine	SMINT2		NM_207644.2	NP_997527.2	VALIDATED	P	1.000	1.000	59	459	1	177	315	1	59
IKAKEN	AK095614	06_05-H10	FLJ	W01C062P19	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK095614	06_05-H10	FLJ	W01C062P20	pDONR221	15228		C21orf34	388815	-	Hs.719301	Chromosome 21 open reading frame 34			brain	FCBBF3		NM_001005732.1	NP_001005732.1	VALIDATED		0.500	0.500	6	75	10	27	74	18	23
IKAKEN	AK022629	06_05-H11	FLJ	W01C062P21	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK022629	06_05-H11	FLJ	W01C062P22	pDONR221	26607		RHOF	54509	BAB14140	Hs.644504	Ras homolog gene family, member F (in filopodia)			whole embryo, mainly body	HEMBB1		NM_019034.2	NP_061907.2	VALIDATED		0.556	0.556	9	273	26	52	211	120	128
IKAKEN	AK097091	06_05-H12	FLJ	W01C062P23	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_05-H12	FLJ	W01C062P24	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_06-A01	FLJ	W01C063A01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_06-A01	FLJ	W01C063A02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097461	06_06-A02	FLJ	W01C063A03	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK097461	06_06-A02	FLJ	W01C063A04	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK098126	06_06-A03	FLJ	W01C063A05	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK098126	06_06-A03	FLJ	W01C063A06	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK122918	06_06-A04	FLJ	W01C063A07	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06_06-A04	FLJ	W01C063A08	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06_06-A05	FLJ	W01C063A09	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06_06-A05	FLJ	W01C063A10	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK026825	06_06-A06		W01C063A11	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK026825	06_06-A06		W01C063A12	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK058162	06_06-A07	FLJ	W01C063A13	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK058162	06_06-A07	FLJ	W01C063A14	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK130082	06_06-A08	FLJ	W01C063A15	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK130082	06_06-A08	FLJ	W01C063A16	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK129567	06_06-A09	FLJ	W01C063A17	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06_06-A09	FLJ	W01C063A18	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129505	06_06-A10		W01C063A19	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK129505	06_06-A10		W01C063A20	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK024591	06_06-A11	FLJ	W01C063A21	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK024591	06_06-A11	FLJ	W01C063A22	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK025706	06_06-A12	FLJ	W01C063A23	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK025706	06_06-A12	FLJ	W01C063A24	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK097091	06_06-A01	FLJ	W01C063B01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_06-A01	FLJ	W01C063B02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097461	06_06-A02	FLJ	W01C063B03	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK097461	06_06-A02	FLJ	W01C063B04	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK098126	06_06-A03	FLJ	W01C063B05	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK098126	06_06-A03	FLJ	W01C063B06	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK122918	06_06-A04	FLJ	W01C063B07	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06_06-A04	FLJ	W01C063B08	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06_06-A05	FLJ	W01C063B09	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06_06-A05	FLJ	W01C063B10	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK026825	06_06-A06		W01C063B11	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK026825	06_06-A06		W01C063B12	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK058162	06_06-A07	FLJ	W01C063B13	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK058162	06_06-A07	FLJ	W01C063B14	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK130082	06_06-A08	FLJ	W01C063B15	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK130082	06_06-A08	FLJ	W01C063B16	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK129567	06_06-A09	FLJ	W01C063B17	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06_06-A09	FLJ	W01C063B18	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129505	06_06-A10		W01C063B19	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK129505	06_06-A10		W01C063B20	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK024591	06_06-A11	FLJ	W01C063B21	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK024591	06_06-A11	FLJ	W01C063B22	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK025706	06_06-A12	FLJ	W01C063B23	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK025706	06_06-A12	FLJ	W01C063B24	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK125363	06_06-B01	FLJ	W01C063C01	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125363	06_06-B01	FLJ	W01C063C02	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125739	06_06-B02	FLJ	W01C063C03	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK125739	06_06-B02	FLJ	W01C063C04	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK122638	06_06-B03	FLJ	W01C063C05	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK122638	06_06-B03	FLJ	W01C063C06	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK124215	06_06-B04	FLJ	W01C063C07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06_06-B04	FLJ	W01C063C08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK125139	06_06-B05	FLJ	W01C063C09	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK125139	06_06-B05	FLJ	W01C063C10	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK126367	06_06-B06	FLJ	W01C063C11	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK126367	06_06-B06	FLJ	W01C063C12	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK124576	06_06-B07	FLJ	W01C063C13	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	06_06-B07	FLJ	W01C063C14	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK126346	06_06-B08	FLJ	W01C063C15	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06_06-B08	FLJ	W01C063C16	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK122630	06_06-B09	FLJ	W01C063C17	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122630	06_06-B09	FLJ	W01C063C18	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122632	06_06-B10	FLJ	W01C063C19	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK122632	06_06-B10	FLJ	W01C063C20	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK125278	06_06-B11	FLJ	W01C063C21	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK125278	06_06-B11	FLJ	W01C063C22	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK124785	06_06-B12	FLJ	W01C063C23	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	06_06-B12	FLJ	W01C063C24	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125363	06_06-B01	FLJ	W01C063D01	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125363	06_06-B01	FLJ	W01C063D02	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125739	06_06-B02	FLJ	W01C063D03	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK125739	06_06-B02	FLJ	W01C063D04	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK122638	06_06-B03	FLJ	W01C063D05	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK122638	06_06-B03	FLJ	W01C063D06	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK124215	06_06-B04	FLJ	W01C063D07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06_06-B04	FLJ	W01C063D08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK125139	06_06-B05	FLJ	W01C063D09	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK125139	06_06-B05	FLJ	W01C063D10	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK126367	06_06-B06	FLJ	W01C063D11	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK126367	06_06-B06	FLJ	W01C063D12	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK124576	06_06-B07	FLJ	W01C063D13	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	06_06-B07	FLJ	W01C063D14	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK126346	06_06-B08	FLJ	W01C063D15	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06_06-B08	FLJ	W01C063D16	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK122630	06_06-B09	FLJ	W01C063D17	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122630	06_06-B09	FLJ	W01C063D18	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122632	06_06-B10	FLJ	W01C063D19	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK122632	06_06-B10	FLJ	W01C063D20	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK125278	06_06-B11	FLJ	W01C063D21	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK125278	06_06-B11	FLJ	W01C063D22	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK124785	06_06-B12	FLJ	W01C063D23	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	06_06-B12	FLJ	W01C063D24	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125885	06_06-C01	FLJ	W01C063E01	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125885	06_06-C01	FLJ	W01C063E02	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125971	06_06-C02	FLJ	W01C063E03	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK125971	06_06-C02	FLJ	W01C063E04	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK126300	06_06-C03	FLJ	W01C063E05	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126300	06_06-C03	FLJ	W01C063E06	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126319	06_06-C04	FLJ	W01C063E07	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126319	06_06-C04	FLJ	W01C063E08	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126023	06_06-C05	FLJ	W01C063E09	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126023	06_06-C05	FLJ	W01C063E10	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126055	06_06-C06	FLJ	W01C063E11	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126055	06_06-C06	FLJ	W01C063E12	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126071	06_06-C07	FLJ	W01C063E13	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK126071	06_06-C07	FLJ	W01C063E14	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK125838	06_06-C08	FLJ	W01C063E15	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK125838	06_06-C08	FLJ	W01C063E16	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK124936	06_06-C09	FLJ	W01C063E17	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK124936	06_06-C09	FLJ	W01C063E18	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK125475	06_06-C10	FLJ	W01C063E19	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK125475	06_06-C10	FLJ	W01C063E20	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK131251	06_06-C11	FLJ	W01C063E21	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131251	06_06-C11	FLJ	W01C063E22	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131274	06_06-C12	FLJ	W01C063E23	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK131274	06_06-C12	FLJ	W01C063E24	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK125885	06_06-C01	FLJ	W01C063F01	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125885	06_06-C01	FLJ	W01C063F02	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125971	06_06-C02	FLJ	W01C063F03	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK125971	06_06-C02	FLJ	W01C063F04	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK126300	06_06-C03	FLJ	W01C063F05	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126300	06_06-C03	FLJ	W01C063F06	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126319	06_06-C04	FLJ	W01C063F07	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126319	06_06-C04	FLJ	W01C063F08	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126023	06_06-C05	FLJ	W01C063F09	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126023	06_06-C05	FLJ	W01C063F10	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126055	06_06-C06	FLJ	W01C063F11	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126055	06_06-C06	FLJ	W01C063F12	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126071	06_06-C07	FLJ	W01C063F13	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK126071	06_06-C07	FLJ	W01C063F14	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK125838	06_06-C08	FLJ	W01C063F15	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK125838	06_06-C08	FLJ	W01C063F16	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK124936	06_06-C09	FLJ	W01C063F17	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK124936	06_06-C09	FLJ	W01C063F18	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK125475	06_06-C10	FLJ	W01C063F19	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK125475	06_06-C10	FLJ	W01C063F20	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK131251	06_06-C11	FLJ	W01C063F21	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131251	06_06-C11	FLJ	W01C063F22	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131274	06_06-C12	FLJ	W01C063F23	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK131274	06_06-C12	FLJ	W01C063F24	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK131339	06_06-D01	FLJ	W01C063G01	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131339	06_06-D01	FLJ	W01C063G02	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131380	06_06-D02	FLJ	W01C063G03	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131380	06_06-D02	FLJ	W01C063G04	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131463	06_06-D03	FLJ	W01C063G05	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06_06-D03	FLJ	W01C063G06	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK127215	06_06-D04	FLJ	W01C063G07	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127215	06_06-D04	FLJ	W01C063G08	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127275	06_06-D05	FLJ	W01C063G09	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127275	06_06-D05	FLJ	W01C063G10	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127277	06_06-D06	FLJ	W01C063G11	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK127277	06_06-D06	FLJ	W01C063G12	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK128717	06_06-D07	FLJ	W01C063G13	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK128717	06_06-D07	FLJ	W01C063G14	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK127487	06_06-D08	FLJ	W01C063G15	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127487	06_06-D08	FLJ	W01C063G16	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127650	06_06-D09	FLJ	W01C063G17	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127650	06_06-D09	FLJ	W01C063G18	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127465	06_06-D10	FLJ	W01C063G19	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127465	06_06-D10	FLJ	W01C063G20	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127643	06_06-D11	FLJ	W01C063G21	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK127643	06_06-D11	FLJ	W01C063G22	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK128583	06_06-D12	FLJ	W01C063G23	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK128583	06_06-D12	FLJ	W01C063G24	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK131339	06_06-D01	FLJ	W01C063H01	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131339	06_06-D01	FLJ	W01C063H02	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131380	06_06-D02	FLJ	W01C063H03	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131380	06_06-D02	FLJ	W01C063H04	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131463	06_06-D03	FLJ	W01C063H05	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06_06-D03	FLJ	W01C063H06	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK127215	06_06-D04	FLJ	W01C063H07	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127215	06_06-D04	FLJ	W01C063H08	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127275	06_06-D05	FLJ	W01C063H09	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127275	06_06-D05	FLJ	W01C063H10	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127277	06_06-D06	FLJ	W01C063H11	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK127277	06_06-D06	FLJ	W01C063H12	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK128717	06_06-D07	FLJ	W01C063H13	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK128717	06_06-D07	FLJ	W01C063H14	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK127487	06_06-D08	FLJ	W01C063H15	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127487	06_06-D08	FLJ	W01C063H16	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127650	06_06-D09	FLJ	W01C063H17	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127650	06_06-D09	FLJ	W01C063H18	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127465	06_06-D10	FLJ	W01C063H19	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127465	06_06-D10	FLJ	W01C063H20	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127643	06_06-D11	FLJ	W01C063H21	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK127643	06_06-D11	FLJ	W01C063H22	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK128583	06_06-D12	FLJ	W01C063H23	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK128583	06_06-D12	FLJ	W01C063H24	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK128639	06_06-E01	FLJ	W01C063I01	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK128639	06_06-E01	FLJ	W01C063I02	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK126887	06_06-E02	FLJ	W01C063I03	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E02	FLJ	W01C063I04	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E03	FLJ	W01C063I05	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK126887	06_06-E03	FLJ	W01C063I06	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK127756	06_06-E04	FLJ	W01C063I07	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK127756	06_06-E04	FLJ	W01C063I08	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK128045	06_06-E05	FLJ	W01C063I09	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128045	06_06-E05	FLJ	W01C063I10	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128060	06_06-E06	FLJ	W01C063I11	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06_06-E06	FLJ	W01C063I12	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128195	06_06-E07	FLJ	W01C063I13	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128195	06_06-E07	FLJ	W01C063I14	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128159	06_06-E08	FLJ	W01C063I15	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK128159	06_06-E08	FLJ	W01C063I16	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK126568	06_06-E09	FLJ	W01C063I17	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK126568	06_06-E09	FLJ	W01C063I18	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK127064	06_06-E10	FLJ	W01C063I19	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06_06-E10	FLJ	W01C063I20	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127381	06_06-E11	FLJ	W01C063I21	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	06_06-E11	FLJ	W01C063I22	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127457	06_06-E12	FLJ	W01C063I23	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK127457	06_06-E12	FLJ	W01C063I24	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK128639	06_06-E01	FLJ	W01C063J01	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK128639	06_06-E01	FLJ	W01C063J02	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK126887	06_06-E02	FLJ	W01C063J03	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E02	FLJ	W01C063J04	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E03	FLJ	W01C063J05	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK126887	06_06-E03	FLJ	W01C063J06	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK127756	06_06-E04	FLJ	W01C063J07	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK127756	06_06-E04	FLJ	W01C063J08	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK128045	06_06-E05	FLJ	W01C063J09	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128045	06_06-E05	FLJ	W01C063J10	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128060	06_06-E06	FLJ	W01C063J11	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06_06-E06	FLJ	W01C063J12	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128195	06_06-E07	FLJ	W01C063J13	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128195	06_06-E07	FLJ	W01C063J14	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128159	06_06-E08	FLJ	W01C063J15	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK128159	06_06-E08	FLJ	W01C063J16	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK126568	06_06-E09	FLJ	W01C063J17	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK126568	06_06-E09	FLJ	W01C063J18	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK127064	06_06-E10	FLJ	W01C063J19	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06_06-E10	FLJ	W01C063J20	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127381	06_06-E11	FLJ	W01C063J21	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	06_06-E11	FLJ	W01C063J22	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127457	06_06-E12	FLJ	W01C063J23	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK127457	06_06-E12	FLJ	W01C063J24	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK128214	06_06-F01	FLJ	W01C063K01	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06_06-F01	FLJ	W01C063K02	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK127089	06_06-F02	FLJ	W01C063K03	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127089	06_06-F02	FLJ	W01C063K04	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127792	06_06-F03	FLJ	W01C063K05	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK127792	06_06-F03	FLJ	W01C063K06	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK128237	06_06-F04	FLJ	W01C063K07	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06_06-F04	FLJ	W01C063K08	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06_06-F05	MGC	W01C063K09	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06_06-F05	MGC	W01C063K10	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC010444	06_06-F06	MGC	W01C063K11	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC010444	06_06-F06	MGC	W01C063K12	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC021714	06_06-F07	MGC	W01C063K13	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	06_06-F07	MGC	W01C063K14	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC028606	06_06-F08	MGC	W01C063K15	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06_06-F08	MGC	W01C063K16	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC033025	06_06-F09	MGC	W01C063K17	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033025	06_06-F09	MGC	W01C063K18	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033582	06_06-F10	MGC	W01C063K19	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC033582	06_06-F10	MGC	W01C063K20	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC028132	06_06-F11	MGC	W01C063K21	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_06-F11	MGC	W01C063K22	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028069	06_06-F12	MGC	W01C063K23	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	BC028069	06_06-F12	MGC	W01C063K24	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	AK128214	06_06-F01	FLJ	W01C063L01	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06_06-F01	FLJ	W01C063L02	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK127089	06_06-F02	FLJ	W01C063L03	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127089	06_06-F02	FLJ	W01C063L04	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127792	06_06-F03	FLJ	W01C063L05	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK127792	06_06-F03	FLJ	W01C063L06	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK128237	06_06-F04	FLJ	W01C063L07	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06_06-F04	FLJ	W01C063L08	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06_06-F05	MGC	W01C063L09	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06_06-F05	MGC	W01C063L10	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC010444	06_06-F06	MGC	W01C063L11	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC010444	06_06-F06	MGC	W01C063L12	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC021714	06_06-F07	MGC	W01C063L13	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	06_06-F07	MGC	W01C063L14	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC028606	06_06-F08	MGC	W01C063L15	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06_06-F08	MGC	W01C063L16	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC033025	06_06-F09	MGC	W01C063L17	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033025	06_06-F09	MGC	W01C063L18	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033582	06_06-F10	MGC	W01C063L19	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC033582	06_06-F10	MGC	W01C063L20	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC028132	06_06-F11	MGC	W01C063L21	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_06-F11	MGC	W01C063L22	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028069	06_06-F12	MGC	W01C063L23	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	BC028069	06_06-F12	MGC	W01C063L24	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	BC034223	06_06-G01	MGC	W01C063M01	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06_06-G01	MGC	W01C063M02	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC031242	06_06-G02	MGC	W01C063M03	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC031242	06_06-G02	MGC	W01C063M04	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC029585	06_06-G03	MGC	W01C063M05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06_06-G03	MGC	W01C063M06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06_06-G04	MGC	W01C063M07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06_06-G04	MGC	W01C063M08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC032706	06_06-G05	MGC	W01C063M09	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC032706	06_06-G05	MGC	W01C063M10	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC035062	06_06-G06		W01C063M11	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC035062	06_06-G06		W01C063M12	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC040904	06_06-G07	MGC	W01C063M13	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06_06-G07	MGC	W01C063M14	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC051717	06_06-G08	MGC	W01C063M15	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_06-G08	MGC	W01C063M16	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC047363	06_06-G09	MGC	W01C063M17	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC047363	06_06-G09	MGC	W01C063M18	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC050069	06_06-G10	MGC	W01C063M19	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06_06-G10	MGC	W01C063M20	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC051694	06_06-G11	MGC	W01C063M21	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC051694	06_06-G11	MGC	W01C063M22	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC052966	06_06-G12	MGC	W01C063M23	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC052966	06_06-G12	MGC	W01C063M24	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC034223	06_06-G01	MGC	W01C063N01	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06_06-G01	MGC	W01C063N02	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC031242	06_06-G02	MGC	W01C063N03	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC031242	06_06-G02	MGC	W01C063N04	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC029585	06_06-G03	MGC	W01C063N05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06_06-G03	MGC	W01C063N06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06_06-G04	MGC	W01C063N07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06_06-G04	MGC	W01C063N08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC032706	06_06-G05	MGC	W01C063N09	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC032706	06_06-G05	MGC	W01C063N10	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC035062	06_06-G06		W01C063N11	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC035062	06_06-G06		W01C063N12	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC040904	06_06-G07	MGC	W01C063N13	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06_06-G07	MGC	W01C063N14	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC051717	06_06-G08	MGC	W01C063N15	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_06-G08	MGC	W01C063N16	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC047363	06_06-G09	MGC	W01C063N17	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC047363	06_06-G09	MGC	W01C063N18	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC050069	06_06-G10	MGC	W01C063N19	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06_06-G10	MGC	W01C063N20	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC051694	06_06-G11	MGC	W01C063N21	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC051694	06_06-G11	MGC	W01C063N22	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC052966	06_06-G12	MGC	W01C063N23	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC052966	06_06-G12	MGC	W01C063N24	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC056606	06_06-H01	MGC	W01C063O01	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H01	MGC	W01C063O02	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C063O03	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C063O04	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC044576	06_06-H03	MGC	W01C063O05	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06_06-H03	MGC	W01C063O06	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC050544	06_06-H04	MGC	W01C063O07	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC050544	06_06-H04	MGC	W01C063O08	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC052982	06_06-H05	MGC	W01C063O09	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06_06-H05	MGC	W01C063O10	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06_06-H06	MGC	W01C063O11	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06_06-H06	MGC	W01C063O12	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC060785	06_06-H07	MGC	W01C063O13	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC060785	06_06-H07	MGC	W01C063O14	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC057847	06_06-H08	MGC	W01C063O15	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06_06-H08	MGC	W01C063O16	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06_06-H09	MGC	W01C063O17	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06_06-H09	MGC	W01C063O18	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC064574	06_06-H10	MGC	W01C063O19	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC064574	06_06-H10	MGC	W01C063O20	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC065540	06_06-H11	MGC	W01C063O21	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC065540	06_06-H11	MGC	W01C063O22	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC064931	06_06-H12	MGC	W01C063O23	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	BC064931	06_06-H12	MGC	W01C063O24	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	BC056606	06_06-H01	MGC	W01C063P01	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H01	MGC	W01C063P02	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C063P03	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C063P04	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC044576	06_06-H03	MGC	W01C063P05	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06_06-H03	MGC	W01C063P06	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC050544	06_06-H04	MGC	W01C063P07	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC050544	06_06-H04	MGC	W01C063P08	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC052982	06_06-H05	MGC	W01C063P09	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06_06-H05	MGC	W01C063P10	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06_06-H06	MGC	W01C063P11	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06_06-H06	MGC	W01C063P12	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC060785	06_06-H07	MGC	W01C063P13	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC060785	06_06-H07	MGC	W01C063P14	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC057847	06_06-H08	MGC	W01C063P15	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06_06-H08	MGC	W01C063P16	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06_06-H09	MGC	W01C063P17	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06_06-H09	MGC	W01C063P18	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC064574	06_06-H10	MGC	W01C063P19	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC064574	06_06-H10	MGC	W01C063P20	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC065540	06_06-H11	MGC	W01C063P21	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC065540	06_06-H11	MGC	W01C063P22	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC064931	06_06-H12	MGC	W01C063P23	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	BC064931	06_06-H12	MGC	W01C063P24	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	AK097091	06_06-A01	FLJ	W01C064A01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_06-A01	FLJ	W01C064A02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097461	06_06-A02	FLJ	W01C064A03	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK097461	06_06-A02	FLJ	W01C064A04	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK098126	06_06-A03	FLJ	W01C064A05	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK098126	06_06-A03	FLJ	W01C064A06	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK122918	06_06-A04	FLJ	W01C064A07	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06_06-A04	FLJ	W01C064A08	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06_06-A05	FLJ	W01C064A09	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06_06-A05	FLJ	W01C064A10	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK026825	06_06-A06		W01C064A11	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK026825	06_06-A06		W01C064A12	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK058162	06_06-A07	FLJ	W01C064A13	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK058162	06_06-A07	FLJ	W01C064A14	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK130082	06_06-A08	FLJ	W01C064A15	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK130082	06_06-A08	FLJ	W01C064A16	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK129567	06_06-A09	FLJ	W01C064A17	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06_06-A09	FLJ	W01C064A18	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129505	06_06-A10		W01C064A19	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK129505	06_06-A10		W01C064A20	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK024591	06_06-A11	FLJ	W01C064A21	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK024591	06_06-A11	FLJ	W01C064A22	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK025706	06_06-A12	FLJ	W01C064A23	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK025706	06_06-A12	FLJ	W01C064A24	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK097091	06_06-A01	FLJ	W01C064B01	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097091	06_06-A01	FLJ	W01C064B02	pDONR221	19021		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			small intestine	SMINT2				
IKAKEN	AK097461	06_06-A02	FLJ	W01C064B03	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK097461	06_06-A02	FLJ	W01C064B04	pDONR221	6063		C12orf76	400073	BAC05063.1	Hs.44817	Chromosome 12 open reading frame 76			testis	TESTI2		NM_207435.1	NP_997318.1	PREDICTED		0.978	0.978	134	531	127	528	135	2	135
IKAKEN	AK098126	06_06-A03	FLJ	W01C064B05	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK098126	06_06-A03	FLJ	W01C064B06	pDONR221	37846				BAC05240					thymus	THYMU2				
IKAKEN	AK122918	06_06-A04	FLJ	W01C064B07	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06_06-A04	FLJ	W01C064B08	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06_06-A05	FLJ	W01C064B09	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06_06-A05	FLJ	W01C064B10	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK026825	06_06-A06		W01C064B11	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK026825	06_06-A06		W01C064B12	pDONR221	16397		FLJ23172	389177	-								XM_941617.1	XP_946710.1	MODEL										
IKAKEN	AK058162	06_06-A07	FLJ	W01C064B13	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK058162	06_06-A07	FLJ	W01C064B14	pDONR221	8285		LOC145814	145814	-	Hs.592021	Hypothetical protein LOC145814			testis	TST		NM_001102612.1	NP_001096082.1	PROVISIONAL	Ps	0.993	0.993	142	429	1	426	196	55	196
IKAKEN	AK130082	06_06-A08	FLJ	W01C064B15	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK130082	06_06-A08	FLJ	W01C064B16	pDONR221	9635		EIF4A1	1973	-	Hs.129673	Eukaryotic translation initiation factor 4A, isoform 1		fibroblast	lung	LNF		NM_001416.2	NP_001407.1	VALIDATED		0.781	0.781	32	99	1	96	406	375	406
IKAKEN	AK129567	06_06-A09	FLJ	W01C064B17	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06_06-A09	FLJ	W01C064B18	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129505	06_06-A10		W01C064B19	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK129505	06_06-A10		W01C064B20	pDONR221	14952		SNX5	27131	-	Hs.316890	Sorting nexin 5						NM_152227.1	NP_689413.1	REVIEWED	OK	1.000	1.000	404	1215	1	1212	404	1	404
IKAKEN	AK024591	06_06-A11	FLJ	W01C064B21	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK024591	06_06-A11	FLJ	W01C064B22	pDONR221	8177		RPS27L	51065	-	Hs.108957	Ribosomal protein S27-like			adipose tissue	ad		NM_015920.3	NP_057004.1	REVIEWED	OK	1.000	1.000	84	255	1	252	84	1	84
IKAKEN	AK025706	06_06-A12	FLJ	W01C064B23	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK025706	06_06-A12	FLJ	W01C064B24	pDONR221	611		AMPD2	271	-	Hs.82927	Adenosine monophosphate deaminase 2 (isoform L)	HepG2	hepatoma		HEP		NM_139156.2	NP_631895.1	VALIDATED	OK	1.000	1.000	798	2397	1	2394	798	1	798
IKAKEN	AK125363	06_06-B01	FLJ	W01C064C01	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125363	06_06-B01	FLJ	W01C064C02	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125739	06_06-B02	FLJ	W01C064C03	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK125739	06_06-B02	FLJ	W01C064C04	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK122638	06_06-B03	FLJ	W01C064C05	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK122638	06_06-B03	FLJ	W01C064C06	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK124215	06_06-B04	FLJ	W01C064C07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06_06-B04	FLJ	W01C064C08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK125139	06_06-B05	FLJ	W01C064C09	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK125139	06_06-B05	FLJ	W01C064C10	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK126367	06_06-B06	FLJ	W01C064C11	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK126367	06_06-B06	FLJ	W01C064C12	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK124576	06_06-B07	FLJ	W01C064C13	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	06_06-B07	FLJ	W01C064C14	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK126346	06_06-B08	FLJ	W01C064C15	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06_06-B08	FLJ	W01C064C16	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK122630	06_06-B09	FLJ	W01C064C17	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122630	06_06-B09	FLJ	W01C064C18	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122632	06_06-B10	FLJ	W01C064C19	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK122632	06_06-B10	FLJ	W01C064C20	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK125278	06_06-B11	FLJ	W01C064C21	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK125278	06_06-B11	FLJ	W01C064C22	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK124785	06_06-B12	FLJ	W01C064C23	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	06_06-B12	FLJ	W01C064C24	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125363	06_06-B01	FLJ	W01C064D01	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125363	06_06-B01	FLJ	W01C064D02	pDONR221	28384		FAM160A1	729830	BAC86147.1	Hs.633810	Family with sequence similarity 160, member A1			tongue	NTONG2		XM_001718535.1	XP_001718587.1	MODEL		0.269	0.580	1066	1494	4	1488	1066	1	1066
IKAKEN	AK125739	06_06-B02	FLJ	W01C064D03	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK125739	06_06-B02	FLJ	W01C064D04	pDONR221	3146		LOC729668	729668	BAC86268	Hs.652158	Golgi autoantigen, golgin subfamily a, 6 pseudogene			testis	TESTI2				
IKAKEN	AK122638	06_06-B03	FLJ	W01C064D05	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK122638	06_06-B03	FLJ	W01C064D06	pDONR221	9645		ZACN	353174	BAC85499	Hs.714919	Zinc activated ligand-gated ion channel			placenta	PLACE6		NM_180990.3	NP_851321.2	VALIDATED	P	1.000	1.000	411	1236	1	1233	412	2	412
IKAKEN	AK124215	06_06-B04	FLJ	W01C064D07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06_06-B04	FLJ	W01C064D08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK125139	06_06-B05	FLJ	W01C064D09	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK125139	06_06-B05	FLJ	W01C064D10	pDONR221	12135		SBNO2	22904	BAG54153.1	Hs.408708	Strawberry notch homolog 2 (Drosophila)			cord Blood	CORDB1		NM_014963.2	NP_055778.2	VALIDATED	Pfs	0.998	0.999	1274	3876	43	3862	1366	93	1366
IKAKEN	AK126367	06_06-B06	FLJ	W01C064D11	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK126367	06_06-B06	FLJ	W01C064D12	pDONR221	5443		UNC119B	84747	BAG54314.1	Hs.127610	Unc-119 homolog B (C. elegans)			trachea	TRACH3		NM_001080533.1	NP_001074002.1	PROVISIONAL		0.937	0.944	253	762	1	759	251	1	251
IKAKEN	AK124576	06_06-B07	FLJ	W01C064D13	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	06_06-B07	FLJ	W01C064D14	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK126346	06_06-B08	FLJ	W01C064D15	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06_06-B08	FLJ	W01C064D16	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK122630	06_06-B09	FLJ	W01C064D17	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122630	06_06-B09	FLJ	W01C064D18	pDONR221	19371		SLC36A2	153201	BAC85496	Hs.483877	Solute carrier family 36 (proton/amino acid symporter), member 2	H4	neuroglioma		BNGH42		NM_181776.2	NP_861441.2	VALIDATED	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	AK122632	06_06-B10	FLJ	W01C064D19	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK122632	06_06-B10	FLJ	W01C064D20	pDONR221	25337		MAP3K15	389840	BAG53631.1	Hs.713701	Mitogen-activated protein kinase kinase kinase 15			kidney	KIDNE2		NM_001001671.2	NP_001001671.2	VALIDATED	P	1.000	1.000	198	597	1	594	788	591	788
IKAKEN	AK125278	06_06-B11	FLJ	W01C064D21	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK125278	06_06-B11	FLJ	W01C064D22	pDONR221	5200		KIAA1467	57613	BAC86111.1	Hs.132660	KIAA1467			kidney	KIDNE2		NM_020853.1	NP_065904.1	VALIDATED	P	1.000	1.000	452	1365	1	1356	622	170	621
IKAKEN	AK124785	06_06-B12	FLJ	W01C064D23	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	06_06-B12	FLJ	W01C064D24	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125885	06_06-C01	FLJ	W01C064E01	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125885	06_06-C01	FLJ	W01C064E02	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125971	06_06-C02	FLJ	W01C064E03	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK125971	06_06-C02	FLJ	W01C064E04	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK126300	06_06-C03	FLJ	W01C064E05	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126300	06_06-C03	FLJ	W01C064E06	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126319	06_06-C04	FLJ	W01C064E07	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126319	06_06-C04	FLJ	W01C064E08	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126023	06_06-C05	FLJ	W01C064E09	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126023	06_06-C05	FLJ	W01C064E10	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126055	06_06-C06	FLJ	W01C064E11	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126055	06_06-C06	FLJ	W01C064E12	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126071	06_06-C07	FLJ	W01C064E13	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK126071	06_06-C07	FLJ	W01C064E14	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK125838	06_06-C08	FLJ	W01C064E15	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK125838	06_06-C08	FLJ	W01C064E16	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK124936	06_06-C09	FLJ	W01C064E17	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK124936	06_06-C09	FLJ	W01C064E18	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK125475	06_06-C10	FLJ	W01C064E19	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK125475	06_06-C10	FLJ	W01C064E20	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK131251	06_06-C11	FLJ	W01C064E21	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131251	06_06-C11	FLJ	W01C064E22	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131274	06_06-C12	FLJ	W01C064E23	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK131274	06_06-C12	FLJ	W01C064E24	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK125885	06_06-C01	FLJ	W01C064F01	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125885	06_06-C01	FLJ	W01C064F02	pDONR221	3966		DNHD1	144132	-	Hs.377188	Dynein heavy chain domain 1			testis	TESTI4		NM_144666.2	NP_653267.2	VALIDATED	Ps	0.998	0.998	999	3027	1	2997	4753	1307	2305
IKAKEN	AK125971	06_06-C02	FLJ	W01C064F03	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK125971	06_06-C02	FLJ	W01C064F04	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.878	0.983	459	1449	1	1368	1427	954	1366
IKAKEN	AK126300	06_06-C03	FLJ	W01C064F05	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126300	06_06-C03	FLJ	W01C064F06	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED	OK	1.000	1.000	331	996	1	993	331	1	331
IKAKEN	AK126319	06_06-C04	FLJ	W01C064F07	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126319	06_06-C04	FLJ	W01C064F08	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pgs	0.979	0.988	326	981	1	978	2223	1901	2223
IKAKEN	AK126023	06_06-C05	FLJ	W01C064F09	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126023	06_06-C05	FLJ	W01C064F10	pDONR221	3926		QSER1	79832	BAC86397.1	Hs.369368	Glutamine and serine rich 1			testis	TESTI4		NM_001076786.1	NP_001070254.1	PROVISIONAL	Pgs	0.861	0.999	1729	4590	1	4470	1735	1	1729
IKAKEN	AK126055	06_06-C06	FLJ	W01C064F11	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126055	06_06-C06	FLJ	W01C064F12	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	P	1.000	1.000	207	624	1	621	1444	1238	1444
IKAKEN	AK126071	06_06-C07	FLJ	W01C064F13	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK126071	06_06-C07	FLJ	W01C064F14	pDONR221	17706		C15orf60	283677		Hs.718617	Chromosome 15 open reading frame 60			testis	TESTI4		NM_001042367.1	NP_001035826.1	PREDICTED	Cgs	0.949	0.989	277	834	1	831	266	1	266
IKAKEN	AK125838	06_06-C08	FLJ	W01C064F15	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK125838	06_06-C08	FLJ	W01C064F16	pDONR221	19767		TDRD6	221400	BAG54254.1	Hs.656983	Tudor domain containing 6			testis	TESTI4		NM_001010870.1	NP_001010870.1	PROVISIONAL	Pfs	0.996	0.999	724	2169	1	2168	2096	1302	2024
IKAKEN	AK124936	06_06-C09	FLJ	W01C064F17	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK124936	06_06-C09	FLJ	W01C064F18	pDONR221	17489		FAM47E	100129583	BAC85998.1					substantia nigra	BRSSN2		XM_001720938.1	XP_001720990.1	MODEL	P	1.000	1.000	240	723	1	720	408	169	408
IKAKEN	AK125475	06_06-C10	FLJ	W01C064F19	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK125475	06_06-C10	FLJ	W01C064F20	pDONR221	5239		DNAH10	196385	BAC86173.1	Hs.622654	Dynein, axonemal, heavy chain 10			brain	OCBBF2		NM_001083900.1	NP_001077369.1	VALIDATED		0.954	0.968	922	2769	1	2760	4471	183	1093
IKAKEN	AK131251	06_06-C11	FLJ	W01C064F21	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131251	06_06-C11	FLJ	W01C064F22	pDONR221	7328		KIAA0831	22863	BAD18430.1	Hs.414809	KIAA0831			corpus callosum	BRCOC2		NM_014924.3	NP_055739.2	PROVISIONAL	P	1.000	1.000	379	1140	1	1137	492	114	492
IKAKEN	AK131274	06_06-C12	FLJ	W01C064F23	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK131274	06_06-C12	FLJ	W01C064F24	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	P	1.000	1.000	324	975	1	972	412	89	412
IKAKEN	AK131339	06_06-D01	FLJ	W01C064G01	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131339	06_06-D01	FLJ	W01C064G02	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131380	06_06-D02	FLJ	W01C064G03	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131380	06_06-D02	FLJ	W01C064G04	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131463	06_06-D03	FLJ	W01C064G05	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06_06-D03	FLJ	W01C064G06	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK127215	06_06-D04	FLJ	W01C064G07	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127215	06_06-D04	FLJ	W01C064G08	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127275	06_06-D05	FLJ	W01C064G09	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127275	06_06-D05	FLJ	W01C064G10	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127277	06_06-D06	FLJ	W01C064G11	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK127277	06_06-D06	FLJ	W01C064G12	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK128717	06_06-D07	FLJ	W01C064G13	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK128717	06_06-D07	FLJ	W01C064G14	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK127487	06_06-D08	FLJ	W01C064G15	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127487	06_06-D08	FLJ	W01C064G16	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127650	06_06-D09	FLJ	W01C064G17	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127650	06_06-D09	FLJ	W01C064G18	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127465	06_06-D10	FLJ	W01C064G19	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127465	06_06-D10	FLJ	W01C064G20	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127643	06_06-D11	FLJ	W01C064G21	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK127643	06_06-D11	FLJ	W01C064G22	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK128583	06_06-D12	FLJ	W01C064G23	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK128583	06_06-D12	FLJ	W01C064G24	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK131339	06_06-D01	FLJ	W01C064H01	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131339	06_06-D01	FLJ	W01C064H02	pDONR221	5529		ZNF705A	440077	BAD18496	Hs.438536	Zinc finger protein 705A		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_001004328.2	NP_001004328.1	VALIDATED	OK	1.000	1.000	300	903	1	900	300	1	300
IKAKEN	AK131380	06_06-D02	FLJ	W01C064H03	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131380	06_06-D02	FLJ	W01C064H04	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.993	0.993	298	906	1	894	842	1	298
IKAKEN	AK131463	06_06-D03	FLJ	W01C064H05	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06_06-D03	FLJ	W01C064H06	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK127215	06_06-D04	FLJ	W01C064H07	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127215	06_06-D04	FLJ	W01C064H08	pDONR221	6660		DOCK9	23348	BAG54454.1	Hs.596105	Dedicator of cytokinesis 9			hippocampus	BRHIP3		NM_015296.2	NP_056111.1	VALIDATED	Pgs	0.936	0.998	595	1794	1	1674	2069	1474	2068
IKAKEN	AK127275	06_06-D05	FLJ	W01C064H09	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127275	06_06-D05	FLJ	W01C064H10	pDONR221	787		LDLRAD2	401944	BAC86913.1	Hs.710255	Low density lipoprotein receptor class A domain containing 2			hippocampus	BRHIP3		NM_001013693.2	NP_001013715.2	VALIDATED	Cg	0.989	1.000	272	810	1	807	272	1	272
IKAKEN	AK127277	06_06-D06	FLJ	W01C064H11	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK127277	06_06-D06	FLJ	W01C064H12	pDONR221	2560		ATRNL1	26033	BAC86914.1	Hs.501127	Attractin-like 1			hippocampus	BRHIP3		NM_207303.2	NP_997186.1	VALIDATED	P	1.000	1.000	1048	3147	1	3144	1379	332	1379
IKAKEN	AK128717	06_06-D07	FLJ	W01C064H13	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK128717	06_06-D07	FLJ	W01C064H14	pDONR221	19977		SLC35F1	222553	BAG54715.1	Hs.654841	Solute carrier family 35, member F1			uterus	UTERU3		NM_001029858.3	NP_001025029.2	VALIDATED	P	1.000	1.000	213	642	1	639	408	196	408
IKAKEN	AK127487	06_06-D08	FLJ	W01C064H15	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127487	06_06-D08	FLJ	W01C064H16	pDONR221	15779		MICAL3	57553	-	Hs.528024	Microtubule associated monoxygenase, calponin and LIM domain containing 3			thalamus	BRTHA3		NM_001122731.1	NP_001116203.1	PROVISIONAL	Pg	0.971	1.000	962	2931	1	2886	966	1	934
IKAKEN	AK127650	06_06-D09	FLJ	W01C064H17	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127650	06_06-D09	FLJ	W01C064H18	pDONR221	2594		WDFY4	57705	BAC87073.1	Hs.287379	WDFY family member 4			kidney	KIDNE2		XM_001124973.2	XP_001124973.2	MODEL	P	1.000	1.000	626	3162	1	1878	654	1	626
IKAKEN	AK127465	06_06-D10	FLJ	W01C064H19	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127465	06_06-D10	FLJ	W01C064H20	pDONR221	3373		C10orf141	642938	BAC86991.1	Hs.613882	Chromosome 10 open reading frame 141			thalamus	BRTHA2		NM_001039762.2	NP_001034851.1	VALIDATED	OK	1.000	1.000	479	1440	1	1437	479	1	479
IKAKEN	AK127643	06_06-D11	FLJ	W01C064H21	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK127643	06_06-D11	FLJ	W01C064H22	pDONR221	9280		UMOD	7369	BAC87070.1	Hs.654425	Uromodulin			kidney	KIDNE2		NM_003361.2	NP_003352.2	REVIEWED	OK	1.000	1.000	640	1923	1	1920	640	1	640
IKAKEN	AK128583	06_06-D12	FLJ	W01C064H23	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK128583	06_06-D12	FLJ	W01C064H24	pDONR221	13804		USP37	57695	-	Hs.166068	Ubiquitin specific peptidase 37			trachea	TRACH3		NM_020935.2	NP_065986.2	VALIDATED	P	1.000	1.000	978	2940	1	2934	979	1	978
IKAKEN	AK128639	06_06-E01	FLJ	W01C064I01	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK128639	06_06-E01	FLJ	W01C064I02	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK126887	06_06-E02	FLJ	W01C064I03	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E02	FLJ	W01C064I04	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E03	FLJ	W01C064I05	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK126887	06_06-E03	FLJ	W01C064I06	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK127756	06_06-E04	FLJ	W01C064I07	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK127756	06_06-E04	FLJ	W01C064I08	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK128045	06_06-E05	FLJ	W01C064I09	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128045	06_06-E05	FLJ	W01C064I10	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128060	06_06-E06	FLJ	W01C064I11	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06_06-E06	FLJ	W01C064I12	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128195	06_06-E07	FLJ	W01C064I13	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128195	06_06-E07	FLJ	W01C064I14	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128159	06_06-E08	FLJ	W01C064I15	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK128159	06_06-E08	FLJ	W01C064I16	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK126568	06_06-E09	FLJ	W01C064I17	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK126568	06_06-E09	FLJ	W01C064I18	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK127064	06_06-E10	FLJ	W01C064I19	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06_06-E10	FLJ	W01C064I20	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127381	06_06-E11	FLJ	W01C064I21	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	06_06-E11	FLJ	W01C064I22	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127457	06_06-E12	FLJ	W01C064I23	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK127457	06_06-E12	FLJ	W01C064I24	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK128639	06_06-E01	FLJ	W01C064J01	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK128639	06_06-E01	FLJ	W01C064J02	pDONR221	21367		PRKAR2B	5577	BAG54705.1	Hs.433068	Protein kinase, cAMP-dependent, regulatory, type II, beta			trachea	TRACH3		NM_002736.2	NP_002727.2	REVIEWED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK126887	06_06-E02	FLJ	W01C064J03	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E02	FLJ	W01C064J04	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06_06-E03	FLJ	W01C064J05	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK126887	06_06-E03	FLJ	W01C064J06	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	Pfs	0.887	0.918	354	1041	2	1040	809	194	542
IKAKEN	AK127756	06_06-E04	FLJ	W01C064J07	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK127756	06_06-E04	FLJ	W01C064J08	pDONR221	2748		VWA2	340706	BAC87116.1	Hs.197741	Von Willebrand factor A domain containing 2			brain	OCBBF2		NM_198496.1	NP_940898.1	PROVISIONAL	OK	1.000	1.000	725	2178	1	2175	725	1	725
IKAKEN	AK128045	06_06-E05	FLJ	W01C064J09	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128045	06_06-E05	FLJ	W01C064J10	pDONR221	8261		RFX7	64864	BAC87248.1	Hs.282855	Regulatory factor X, 7			testis	TESTI4		NM_022841.5	NP_073752.5	VALIDATED	Ps	0.995	0.995	1276	3846	1	3828	1460	98	1373
IKAKEN	AK128060	06_06-E06	FLJ	W01C064J11	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06_06-E06	FLJ	W01C064J12	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128195	06_06-E07	FLJ	W01C064J13	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128195	06_06-E07	FLJ	W01C064J14	pDONR221	5855		FMNL3	91010	BAC87319.1	Hs.179838	Formin-like 3			testis	TESTI4		NM_175736.4	NP_783863.4	VALIDATED	Pfs	0.938	0.999	947	2685	1	2684	1027	1	941
IKAKEN	AK128159	06_06-E08	FLJ	W01C064J15	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK128159	06_06-E08	FLJ	W01C064J16	pDONR221	4830		CCDC73	493860	BAC87304.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	P	1.000	1.000	649	1950	1	1947	1079	431	1079
IKAKEN	AK126568	06_06-E09	FLJ	W01C064J17	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK126568	06_06-E09	FLJ	W01C064J18	pDONR221	26607		TMEM120B	144404	BAG54345.1					uterus	UTERU3		NM_001080825.2	NP_001074294.2	VALIDATED	Cgs	0.974	0.997	347	1044	1	1041	339	1	339
IKAKEN	AK127064	06_06-E10	FLJ	W01C064J19	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06_06-E10	FLJ	W01C064J20	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127381	06_06-E11	FLJ	W01C064J21	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	06_06-E11	FLJ	W01C064J22	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127457	06_06-E12	FLJ	W01C064J23	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK127457	06_06-E12	FLJ	W01C064J24	pDONR221	3622		GRAMD1B	57476	BAG54507.1	Hs.144725	GRAM domain containing 1B			thalamus	BRTHA2		NM_020716.1	NP_065767.1	VALIDATED	Pg	0.995	1.000	730	2337	157	2334	738	9	738
IKAKEN	AK128214	06_06-F01	FLJ	W01C064K01	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06_06-F01	FLJ	W01C064K02	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK127089	06_06-F02	FLJ	W01C064K03	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127089	06_06-F02	FLJ	W01C064K04	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127792	06_06-F03	FLJ	W01C064K05	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK127792	06_06-F03	FLJ	W01C064K06	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK128237	06_06-F04	FLJ	W01C064K07	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06_06-F04	FLJ	W01C064K08	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06_06-F05	MGC	W01C064K09	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06_06-F05	MGC	W01C064K10	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC010444	06_06-F06	MGC	W01C064K11	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC010444	06_06-F06	MGC	W01C064K12	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC021714	06_06-F07	MGC	W01C064K13	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	06_06-F07	MGC	W01C064K14	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC028606	06_06-F08	MGC	W01C064K15	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06_06-F08	MGC	W01C064K16	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC033025	06_06-F09	MGC	W01C064K17	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033025	06_06-F09	MGC	W01C064K18	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033582	06_06-F10	MGC	W01C064K19	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC033582	06_06-F10	MGC	W01C064K20	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC028132	06_06-F11	MGC	W01C064K21	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_06-F11	MGC	W01C064K22	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028069	06_06-F12	MGC	W01C064K23	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	BC028069	06_06-F12	MGC	W01C064K24	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	AK128214	06_06-F01	FLJ	W01C064L01	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06_06-F01	FLJ	W01C064L02	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK127089	06_06-F02	FLJ	W01C064L03	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127089	06_06-F02	FLJ	W01C064L04	pDONR221	19724		MTHFD1L	25902	-	Hs.591343	Methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like			brain	BRAWH3		NM_015440.3	NP_056255.2	VALIDATED	P	1.000	1.000	903	2716	5	2713	978	76	978
IKAKEN	AK127792	06_06-F03	FLJ	W01C064L05	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK127792	06_06-F03	FLJ	W01C064L06	pDONR221	8586		FAM65A	79567	BAC87139.1	Hs.152717	Family with sequence similarity 65, member A			brain	OCBBF3		NM_024519.2	NP_078795.2	VALIDATED	OK	1.000	1.000	1219	3660	1	3657	1219	1	1219
IKAKEN	AK128237	06_06-F04	FLJ	W01C064L07	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06_06-F04	FLJ	W01C064L08	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06_06-F05	MGC	W01C064L09	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06_06-F05	MGC	W01C064L10	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC010444	06_06-F06	MGC	W01C064L11	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC010444	06_06-F06	MGC	W01C064L12	pDONR221	22672		MATN2	4147	AAH10444.1	Hs.189445	Matrilin 2			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_002380.3	NP_002371.3	REVIEWED	Ps	0.997	0.997	941	2826	1	2823	956	1	941
IKAKEN	BC021714	06_06-F07	MGC	W01C064L13	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC021714	06_06-F07	MGC	W01C064L14	pDONR221	3749		PPFIBP2	8495	AAH21714.1	Hs.655714	PTPRF interacting protein, binding protein 2 (liprin beta 2)			Liver	NIH_MGC_76	DH10B	NM_003621.2	NP_003612.2	VALIDATED	Cs	0.999	0.999	876	2631	1	2628	876	1	876
IKAKEN	BC028606	06_06-F08	MGC	W01C064L15	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06_06-F08	MGC	W01C064L16	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC033025	06_06-F09	MGC	W01C064L17	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033025	06_06-F09	MGC	W01C064L18	pDONR221	23051		PPAPDC1B	84513	AAH33025.1	Hs.567619	Phosphatidic acid phosphatase type 2 domain containing 1B			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_001102560.1	NP_001096030.1	VALIDATED	P	1.000	1.000	113	672	1	339	176	42	154
IKAKEN	BC033582	06_06-F10	MGC	W01C064L19	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC033582	06_06-F10	MGC	W01C064L20	pDONR221	16664			646288	AAH33582					Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B			
IKAKEN	BC028132	06_06-F11	MGC	W01C064L21	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_06-F11	MGC	W01C064L22	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028069	06_06-F12	MGC	W01C064L23	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	BC028069	06_06-F12	MGC	W01C064L24	pDONR221	12332		NLRP12	91662	AAH28069.1	Hs.631573	NLR family, pyrin domain containing 12			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_144687.2	NP_653288.1	REVIEWED	Cg	0.946	1.000	1061	3015	1	3012	1061	1	1061
IKAKEN	BC034223	06_06-G01	MGC	W01C064M01	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06_06-G01	MGC	W01C064M02	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC031242	06_06-G02	MGC	W01C064M03	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC031242	06_06-G02	MGC	W01C064M04	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC029585	06_06-G03	MGC	W01C064M05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06_06-G03	MGC	W01C064M06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06_06-G04	MGC	W01C064M07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06_06-G04	MGC	W01C064M08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC032706	06_06-G05	MGC	W01C064M09	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC032706	06_06-G05	MGC	W01C064M10	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC035062	06_06-G06		W01C064M11	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC035062	06_06-G06		W01C064M12	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC040904	06_06-G07	MGC	W01C064M13	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06_06-G07	MGC	W01C064M14	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC051717	06_06-G08	MGC	W01C064M15	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_06-G08	MGC	W01C064M16	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC047363	06_06-G09	MGC	W01C064M17	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC047363	06_06-G09	MGC	W01C064M18	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC050069	06_06-G10	MGC	W01C064M19	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06_06-G10	MGC	W01C064M20	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC051694	06_06-G11	MGC	W01C064M21	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC051694	06_06-G11	MGC	W01C064M22	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC052966	06_06-G12	MGC	W01C064M23	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC052966	06_06-G12	MGC	W01C064M24	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC034223	06_06-G01	MGC	W01C064N01	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06_06-G01	MGC	W01C064N02	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC031242	06_06-G02	MGC	W01C064N03	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC031242	06_06-G02	MGC	W01C064N04	pDONR221	19280		CCDC112	153733	AAH31242.1	Hs.436121	Coiled-coil domain containing 112			Testis	NIH_MGC_97	DH10B	NM_152549.2	NP_689762.2	VALIDATED	OK	1.000	1.000	446	1341	1	1338	446	1	446
IKAKEN	BC029585	06_06-G03	MGC	W01C064N05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06_06-G03	MGC	W01C064N06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06_06-G04	MGC	W01C064N07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06_06-G04	MGC	W01C064N08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC032706	06_06-G05	MGC	W01C064N09	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC032706	06_06-G05	MGC	W01C064N10	pDONR221	20098		C6orf223	221416	AAH32706.1	Hs.531926	Chromosome 6 open reading frame 223			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_153246.3	NP_694978.2	VALIDATED	Ps	0.986	0.986	218	669	13	666	242	25	242
IKAKEN	BC035062	06_06-G06		W01C064N11	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC035062	06_06-G06		W01C064N12	pDONR221	19712		NKAIN2	154215	AAH35062.1	Hs.656604	Na+/K+ transporting ATPase interacting 2						NM_001040214.1	NP_001035304.1	VALIDATED	P	1.000	1.000	190	624	52	621	208	19	208
IKAKEN	BC040904	06_06-G07	MGC	W01C064N13	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06_06-G07	MGC	W01C064N14	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC051717	06_06-G08	MGC	W01C064N15	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_06-G08	MGC	W01C064N16	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC047363	06_06-G09	MGC	W01C064N17	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC047363	06_06-G09	MGC	W01C064N18	pDONR221	92		DNAJC16	23341	AAH47363.1	Hs.655410	DnaJ (Hsp40) homolog, subfamily C, member 16			Brain, hippocampus	NIH_MGC_95	DH10B	NM_015291.2	NP_056106.1	PROVISIONAL	OK	1.000	1.000	782	2349	1	2346	782	1	782
IKAKEN	BC050069	06_06-G10	MGC	W01C064N19	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06_06-G10	MGC	W01C064N20	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC051694	06_06-G11	MGC	W01C064N21	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC051694	06_06-G11	MGC	W01C064N22	pDONR221	17651		KIAA1680	401145	AAH51694.1	Hs.654735	KIAA1680 protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_207491.2	NP_997374.1	VALIDATED	OK	1.000	1.000	677	2034	1	2031	677	1	677
IKAKEN	BC052966	06_06-G12	MGC	W01C064N23	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC052966	06_06-G12	MGC	W01C064N24	pDONR221	3163		PARG	8505	AAH52966.1	Hs.709578	Poly (ADP-ribose) glycohydrolase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_003631.2	NP_003622.2	REVIEWED		0.947	0.975	663	1992	1	1989	976	1	644
IKAKEN	BC056606	06_06-H01	MGC	W01C064O01	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H01	MGC	W01C064O02	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C064O03	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C064O04	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC044576	06_06-H03	MGC	W01C064O05	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06_06-H03	MGC	W01C064O06	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC050544	06_06-H04	MGC	W01C064O07	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC050544	06_06-H04	MGC	W01C064O08	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC052982	06_06-H05	MGC	W01C064O09	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06_06-H05	MGC	W01C064O10	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06_06-H06	MGC	W01C064O11	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06_06-H06	MGC	W01C064O12	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC060785	06_06-H07	MGC	W01C064O13	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC060785	06_06-H07	MGC	W01C064O14	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC057847	06_06-H08	MGC	W01C064O15	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06_06-H08	MGC	W01C064O16	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06_06-H09	MGC	W01C064O17	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06_06-H09	MGC	W01C064O18	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC064574	06_06-H10	MGC	W01C064O19	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC064574	06_06-H10	MGC	W01C064O20	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC065540	06_06-H11	MGC	W01C064O21	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC065540	06_06-H11	MGC	W01C064O22	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC064931	06_06-H12	MGC	W01C064O23	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	BC064931	06_06-H12	MGC	W01C064O24	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	BC056606	06_06-H01	MGC	W01C064P01	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H01	MGC	W01C064P02	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C064P03	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC056606	06_06-H02	MGC	W01C064P04	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.974	1.000	77	314	84	312	172	1	76
IKAKEN	BC044576	06_06-H03	MGC	W01C064P05	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06_06-H03	MGC	W01C064P06	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC050544	06_06-H04	MGC	W01C064P07	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC050544	06_06-H04	MGC	W01C064P08	pDONR221	23443		ADAMTSL2	9719	AAH50544.1	Hs.522543	ADAMTS-like 2			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_001145320.1	NP_001138792.1	REVIEWED	P	1.000	1.000	550	1653	1	1650	951	1	550
IKAKEN	BC052982	06_06-H05	MGC	W01C064P09	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06_06-H05	MGC	W01C064P10	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06_06-H06	MGC	W01C064P11	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06_06-H06	MGC	W01C064P12	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC060785	06_06-H07	MGC	W01C064P13	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC060785	06_06-H07	MGC	W01C064P14	pDONR221	19863		TRIM40	135644	AAH60785.1	Hs.509439	Tripartite motif-containing 40			Testis	NIH_MGC_97	DH10B	NM_138700.3	NP_619645.1	VALIDATED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC057847	06_06-H08	MGC	W01C064P15	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06_06-H08	MGC	W01C064P16	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06_06-H09	MGC	W01C064P17	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06_06-H09	MGC	W01C064P18	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC064574	06_06-H10	MGC	W01C064P19	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC064574	06_06-H10	MGC	W01C064P20	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.917	0.948	396	1191	2	1188	795	413	795
IKAKEN	BC065540	06_06-H11	MGC	W01C064P21	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC065540	06_06-H11	MGC	W01C064P22	pDONR221	1493		PABPC4	8761	AAH65540.1	Hs.169900	Poly(A) binding protein, cytoplasmic 4 (inducible form)			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001135653.1	NP_001129125.1	REVIEWED		0.954	0.954	87	264	1	261	660	574	660
IKAKEN	BC064931	06_06-H12	MGC	W01C064P23	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	BC064931	06_06-H12	MGC	W01C064P24	pDONR221	20031		PRIM2	5558	AAH64931.1	Hs.654580	Primase, DNA, polypeptide 2 (58kDa)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_000947.2	NP_000938.2	REVIEWED		0.964	0.968	223	672	1	669	509	125	346
IKAKEN	BC066962	06_07-A01	MGC	W01C065A01	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066962	06_07-A01	MGC	W01C065A02	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC001801	06_07-A02	MGC	W01C065A03	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06_07-A02	MGC	W01C065A04	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06_07-A03	MGC	W01C065A05	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06_07-A03	MGC	W01C065A06	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06_07-A04	MGC	W01C065A07	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06_07-A04	MGC	W01C065A08	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06_07-A05	MGC	W01C065A09	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06_07-A05	MGC	W01C065A10	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06_07-A06	MGC	W01C065A11	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06_07-A06	MGC	W01C065A12	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06_07-A07	MGC	W01C065A13	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06_07-A07	MGC	W01C065A14	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06_07-A08	MGC	W01C065A15	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06_07-A08	MGC	W01C065A16	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06_07-A09	MGC	W01C065A17	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06_07-A09	MGC	W01C065A18	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06_07-A10	MGC	W01C065A19	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06_07-A10	MGC	W01C065A20	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06_07-A11	MGC	W01C065A21	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06_07-A11	MGC	W01C065A22	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06_07-A12	MGC	W01C065A23	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC019348	06_07-A12	MGC	W01C065A24	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC066962	06_07-A01	MGC	W01C065B01	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066962	06_07-A01	MGC	W01C065B02	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC001801	06_07-A02	MGC	W01C065B03	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06_07-A02	MGC	W01C065B04	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06_07-A03	MGC	W01C065B05	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06_07-A03	MGC	W01C065B06	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06_07-A04	MGC	W01C065B07	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06_07-A04	MGC	W01C065B08	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06_07-A05	MGC	W01C065B09	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06_07-A05	MGC	W01C065B10	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06_07-A06	MGC	W01C065B11	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06_07-A06	MGC	W01C065B12	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06_07-A07	MGC	W01C065B13	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06_07-A07	MGC	W01C065B14	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06_07-A08	MGC	W01C065B15	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06_07-A08	MGC	W01C065B16	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06_07-A09	MGC	W01C065B17	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06_07-A09	MGC	W01C065B18	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06_07-A10	MGC	W01C065B19	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06_07-A10	MGC	W01C065B20	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06_07-A11	MGC	W01C065B21	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06_07-A11	MGC	W01C065B22	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06_07-A12	MGC	W01C065B23	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC019348	06_07-A12	MGC	W01C065B24	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC019348	06_07-B01	MGC	W01C065C01	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B01	MGC	W01C065C02	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C065C03	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C065C04	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06_07-B03	MGC	W01C065C05	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_07-B03	MGC	W01C065C06	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC014475	06_07-B04	MGC	W01C065C07	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06_07-B04	MGC	W01C065C08	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06_07-B05	MGC	W01C065C09	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06_07-B05	MGC	W01C065C10	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06_07-B06	MGC	W01C065C11	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B06	MGC	W01C065C12	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B07	MGC	W01C065C13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06_07-B07	MGC	W01C065C14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06_07-B08	MGC	W01C065C15	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06_07-B08	MGC	W01C065C16	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C065C17	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C065C18	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C065C19	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C065C20	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C065C21	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C065C22	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C065C23	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C065C24	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BC019348	06_07-B01	MGC	W01C065D01	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B01	MGC	W01C065D02	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C065D03	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C065D04	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06_07-B03	MGC	W01C065D05	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_07-B03	MGC	W01C065D06	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC014475	06_07-B04	MGC	W01C065D07	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06_07-B04	MGC	W01C065D08	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06_07-B05	MGC	W01C065D09	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06_07-B05	MGC	W01C065D10	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06_07-B06	MGC	W01C065D11	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B06	MGC	W01C065D12	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B07	MGC	W01C065D13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06_07-B07	MGC	W01C065D14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06_07-B08	MGC	W01C065D15	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06_07-B08	MGC	W01C065D16	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C065D17	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C065D18	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C065D19	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C065D20	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C065D21	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C065D22	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C065D23	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C065D24	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C065E01	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C065E02	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BC015508	06_07-C02	MGC	W01C065E03	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06_07-C02	MGC	W01C065E04	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06_07-C03	MGC	W01C065E05	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06_07-C03	MGC	W01C065E06	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06_07-C04	MGC	W01C065E07	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06_07-C04	MGC	W01C065E08	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06_07-C05	MGC	W01C065E09	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06_07-C05	MGC	W01C065E10	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06_07-C06	MGC	W01C065E11	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06_07-C06	MGC	W01C065E12	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06_07-C07	MGC	W01C065E13	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06_07-C07	MGC	W01C065E14	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	CS0DM013YA17	06_07-C08		W01C065E15	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	CS0DM013YA17	06_07-C08		W01C065E16	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	H013062P13	06_07-C09	Riken	W01C065E17	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	H013062P13	06_07-C09	Riken	W01C065E18	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C065E19	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C065E20	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C065E21	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C065E22	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	H013011E16	06_07-C12	Riken	W01C065E23	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06_07-C12	Riken	W01C065E24	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C065F01	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C065F02	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BC015508	06_07-C02	MGC	W01C065F03	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06_07-C02	MGC	W01C065F04	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06_07-C03	MGC	W01C065F05	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06_07-C03	MGC	W01C065F06	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06_07-C04	MGC	W01C065F07	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06_07-C04	MGC	W01C065F08	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06_07-C05	MGC	W01C065F09	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06_07-C05	MGC	W01C065F10	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06_07-C06	MGC	W01C065F11	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06_07-C06	MGC	W01C065F12	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06_07-C07	MGC	W01C065F13	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06_07-C07	MGC	W01C065F14	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	CS0DM013YA17	06_07-C08		W01C065F15	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	CS0DM013YA17	06_07-C08		W01C065F16	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	H013062P13	06_07-C09	Riken	W01C065F17	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	H013062P13	06_07-C09	Riken	W01C065F18	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C065F19	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C065F20	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C065F21	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C065F22	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	H013011E16	06_07-C12	Riken	W01C065F23	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06_07-C12	Riken	W01C065F24	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013033B02	06_07-D01	Riken	W01C065G01	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013033B02	06_07-D01	Riken	W01C065G02	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013034B19	06_07-D02	Riken	W01C065G03	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013034B19	06_07-D02	Riken	W01C065G04	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013049H10	06_07-D03	Riken	W01C065G05	pDONR221				440289											
IKAKEN	H013049H10	06_07-D03	Riken	W01C065G06	pDONR221				440289											
IKAKEN	H013068D18	06_07-D04	Riken	W01C065G07	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013068D18	06_07-D04	Riken	W01C065G08	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013071G19	06_07-D05	Riken	W01C065G09	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013071G19	06_07-D05	Riken	W01C065G10	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013088F12	06_07-D06	Riken	W01C065G11	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013088F12	06_07-D06	Riken	W01C065G12	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013096M19	06_07-D07	Riken	W01C065G13	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D07	Riken	W01C065G14	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C065G15	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C065G16	pDONR221			GOLGA2LY2	401634											
IKAKEN	H023056D18	06_07-D09	Riken	W01C065G17	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023056D18	06_07-D09	Riken	W01C065G18	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023058H22	06_07-D10	Riken	W01C065G19	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023058H22	06_07-D10	Riken	W01C065G20	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023061J11	06_07-D11	Riken	W01C065G21	pDONR221															
IKAKEN	H023061J11	06_07-D11	Riken	W01C065G22	pDONR221															
IKAKEN	H023062I21	06_07-D12	Riken	W01C065G23	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H023062I21	06_07-D12	Riken	W01C065G24	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H013033B02	06_07-D01	Riken	W01C065H01	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013033B02	06_07-D01	Riken	W01C065H02	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013034B19	06_07-D02	Riken	W01C065H03	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013034B19	06_07-D02	Riken	W01C065H04	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013049H10	06_07-D03	Riken	W01C065H05	pDONR221				440289											
IKAKEN	H013049H10	06_07-D03	Riken	W01C065H06	pDONR221				440289											
IKAKEN	H013068D18	06_07-D04	Riken	W01C065H07	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013068D18	06_07-D04	Riken	W01C065H08	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013071G19	06_07-D05	Riken	W01C065H09	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013071G19	06_07-D05	Riken	W01C065H10	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013088F12	06_07-D06	Riken	W01C065H11	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013088F12	06_07-D06	Riken	W01C065H12	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013096M19	06_07-D07	Riken	W01C065H13	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D07	Riken	W01C065H14	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C065H15	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C065H16	pDONR221			GOLGA2LY2	401634											
IKAKEN	H023056D18	06_07-D09	Riken	W01C065H17	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023056D18	06_07-D09	Riken	W01C065H18	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023058H22	06_07-D10	Riken	W01C065H19	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023058H22	06_07-D10	Riken	W01C065H20	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023061J11	06_07-D11	Riken	W01C065H21	pDONR221															
IKAKEN	H023061J11	06_07-D11	Riken	W01C065H22	pDONR221															
IKAKEN	H023062I21	06_07-D12	Riken	W01C065H23	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H023062I21	06_07-D12	Riken	W01C065H24	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H023069F07	06_07-E01	Riken	W01C065I01	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023069F07	06_07-E01	Riken	W01C065I02	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023076F16	06_07-E02	Riken	W01C065I03	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023076F16	06_07-E02	Riken	W01C065I04	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023086E24	06_07-E03	Riken	W01C065I05	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H023086E24	06_07-E03	Riken	W01C065I06	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H033059F01	06_07-E04	Riken	W01C065I07	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06_07-E04	Riken	W01C065I08	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033067A04	06_07-E05	Riken	W01C065I09	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	H033067A04	06_07-E05	Riken	W01C065I10	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C065I11	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C065I12	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C065I13	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C065I14	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C065I15	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C065I16	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C065I17	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C065I18	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C065I19	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C065I20	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C065I21	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C065I22	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C065I23	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C065I24	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	H023069F07	06_07-E01	Riken	W01C065J01	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023069F07	06_07-E01	Riken	W01C065J02	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023076F16	06_07-E02	Riken	W01C065J03	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023076F16	06_07-E02	Riken	W01C065J04	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023086E24	06_07-E03	Riken	W01C065J05	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H023086E24	06_07-E03	Riken	W01C065J06	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H033059F01	06_07-E04	Riken	W01C065J07	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06_07-E04	Riken	W01C065J08	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033067A04	06_07-E05	Riken	W01C065J09	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	H033067A04	06_07-E05	Riken	W01C065J10	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C065J11	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C065J12	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C065J13	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C065J14	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C065J15	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C065J16	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C065J17	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C065J18	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C065J19	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C065J20	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C065J21	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C065J22	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C065J23	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C065J24	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C065K01	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C065K02	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C065K03	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C065K04	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C065K05	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C065K06	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C065K07	pDONR221															
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C065K08	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C065K09	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C065K10	pDONR221															
IKAKEN	RAM08530	06_07-F06	EST	W01C065K11	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	RAM08530	06_07-F06	EST	W01C065K12	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	SK006G06	06_07-F07	IMS	W01C065K13	pDONR221															
IKAKEN	SK006G06	06_07-F07	IMS	W01C065K14	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C065K15	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C065K16	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C065K17	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C065K18	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C065K19	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C065K20	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C065K21	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C065K22	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C065K23	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C065K24	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C065L01	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C065L02	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C065L03	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C065L04	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C065L05	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C065L06	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C065L07	pDONR221															
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C065L08	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C065L09	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C065L10	pDONR221															
IKAKEN	RAM08530	06_07-F06	EST	W01C065L11	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	RAM08530	06_07-F06	EST	W01C065L12	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	SK006G06	06_07-F07	IMS	W01C065L13	pDONR221															
IKAKEN	SK006G06	06_07-F07	IMS	W01C065L14	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C065L15	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C065L16	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C065L17	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C065L18	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C065L19	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C065L20	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C065L21	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C065L22	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C065L23	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C065L24	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C065M01	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C065M02	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C065M03	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C065M04	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	H023092L01	06_07-G03	Riken	W01C065M05	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H023092L01	06_07-G03	Riken	W01C065M06	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H013087P15	06_07-G04	Riken	W01C065M07	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06_07-G04	Riken	W01C065M08	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013086M14	06_07-G05	Riken	W01C065M09	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06_07-G05	Riken	W01C065M10	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H023092A07	06_07-G06	Riken	W01C065M11	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H023092A07	06_07-G06	Riken	W01C065M12	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H033051H17	06_07-G07	Riken	W01C065M13	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033051H17	06_07-G07	Riken	W01C065M14	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033091K21	06_07-G08	Riken	W01C065M15	pDONR221															
IKAKEN	H033091K21	06_07-G08	Riken	W01C065M16	pDONR221															
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C065M17	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C065M18	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C065M19	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C065M20	pDONR221															
IKAKEN	H013066M09	06_07-G11	Riken	W01C065M21	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H013066M09	06_07-G11	Riken	W01C065M22	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H023059I21	06_07-G12	Riken	W01C065M23	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	H023059I21	06_07-G12	Riken	W01C065M24	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C065N01	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C065N02	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C065N03	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C065N04	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	H023092L01	06_07-G03	Riken	W01C065N05	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H023092L01	06_07-G03	Riken	W01C065N06	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H013087P15	06_07-G04	Riken	W01C065N07	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06_07-G04	Riken	W01C065N08	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013086M14	06_07-G05	Riken	W01C065N09	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06_07-G05	Riken	W01C065N10	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H023092A07	06_07-G06	Riken	W01C065N11	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H023092A07	06_07-G06	Riken	W01C065N12	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H033051H17	06_07-G07	Riken	W01C065N13	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033051H17	06_07-G07	Riken	W01C065N14	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033091K21	06_07-G08	Riken	W01C065N15	pDONR221															
IKAKEN	H033091K21	06_07-G08	Riken	W01C065N16	pDONR221															
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C065N17	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C065N18	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C065N19	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C065N20	pDONR221															
IKAKEN	H013066M09	06_07-G11	Riken	W01C065N21	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H013066M09	06_07-G11	Riken	W01C065N22	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H023059I21	06_07-G12	Riken	W01C065N23	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	H023059I21	06_07-G12	Riken	W01C065N24	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	H023062H21	06_07-H01	Riken	W01C065O01	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023062H21	06_07-H01	Riken	W01C065O02	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023083A18	06_07-H02	Riken	W01C065O03	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H023083A18	06_07-H02	Riken	W01C065O04	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H033011C21	06_07-H03	Riken	W01C065O05	pDONR221															
IKAKEN	H033011C21	06_07-H03	Riken	W01C065O06	pDONR221															
IKAKEN	H033054E06	06_07-H04	Riken	W01C065O07	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033054E06	06_07-H04	Riken	W01C065O08	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033056L19	06_07-H05	Riken	W01C065O09	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033056L19	06_07-H05	Riken	W01C065O10	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033068B12	06_07-H06	Riken	W01C065O11	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033068B12	06_07-H06	Riken	W01C065O12	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033077F05	06_07-H07	Riken	W01C065O13	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	H033077F05	06_07-H07	Riken	W01C065O14	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	SK003D03	06_07-H08	IMS	W01C065O15	pDONR221															
IKAKEN	SK003D03	06_07-H08	IMS	W01C065O16	pDONR221															
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C065O17	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C065O18	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C065O19	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C065O20	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C065O21	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C065O22	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C065O23	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C065O24	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	H023062H21	06_07-H01	Riken	W01C065P01	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023062H21	06_07-H01	Riken	W01C065P02	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023083A18	06_07-H02	Riken	W01C065P03	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H023083A18	06_07-H02	Riken	W01C065P04	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H033011C21	06_07-H03	Riken	W01C065P05	pDONR221															
IKAKEN	H033011C21	06_07-H03	Riken	W01C065P06	pDONR221															
IKAKEN	H033054E06	06_07-H04	Riken	W01C065P07	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033054E06	06_07-H04	Riken	W01C065P08	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033056L19	06_07-H05	Riken	W01C065P09	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033056L19	06_07-H05	Riken	W01C065P10	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033068B12	06_07-H06	Riken	W01C065P11	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033068B12	06_07-H06	Riken	W01C065P12	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033077F05	06_07-H07	Riken	W01C065P13	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	H033077F05	06_07-H07	Riken	W01C065P14	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	SK003D03	06_07-H08	IMS	W01C065P15	pDONR221															
IKAKEN	SK003D03	06_07-H08	IMS	W01C065P16	pDONR221															
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C065P17	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C065P18	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C065P19	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C065P20	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C065P21	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C065P22	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C065P23	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C065P24	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	BC066962	06_07-A01	MGC	W01C066A01	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066962	06_07-A01	MGC	W01C066A02	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC001801	06_07-A02	MGC	W01C066A03	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06_07-A02	MGC	W01C066A04	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06_07-A03	MGC	W01C066A05	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06_07-A03	MGC	W01C066A06	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06_07-A04	MGC	W01C066A07	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06_07-A04	MGC	W01C066A08	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06_07-A05	MGC	W01C066A09	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06_07-A05	MGC	W01C066A10	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06_07-A06	MGC	W01C066A11	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06_07-A06	MGC	W01C066A12	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06_07-A07	MGC	W01C066A13	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06_07-A07	MGC	W01C066A14	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06_07-A08	MGC	W01C066A15	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06_07-A08	MGC	W01C066A16	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06_07-A09	MGC	W01C066A17	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06_07-A09	MGC	W01C066A18	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06_07-A10	MGC	W01C066A19	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06_07-A10	MGC	W01C066A20	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06_07-A11	MGC	W01C066A21	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06_07-A11	MGC	W01C066A22	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06_07-A12	MGC	W01C066A23	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC019348	06_07-A12	MGC	W01C066A24	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC066962	06_07-A01	MGC	W01C066B01	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC066962	06_07-A01	MGC	W01C066B02	pDONR221	15699		SRRD	402055	AAH66962.1	Hs.709914	SRR1 domain containing			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001013694.2	NP_001013716.2	VALIDATED	OK	1.000	1.000	339	1020	1	1017	339	1	339
IKAKEN	BC001801	06_07-A02	MGC	W01C066B03	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06_07-A02	MGC	W01C066B04	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06_07-A03	MGC	W01C066B05	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06_07-A03	MGC	W01C066B06	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06_07-A04	MGC	W01C066B07	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06_07-A04	MGC	W01C066B08	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06_07-A05	MGC	W01C066B09	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06_07-A05	MGC	W01C066B10	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06_07-A06	MGC	W01C066B11	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06_07-A06	MGC	W01C066B12	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06_07-A07	MGC	W01C066B13	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06_07-A07	MGC	W01C066B14	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06_07-A08	MGC	W01C066B15	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06_07-A08	MGC	W01C066B16	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06_07-A09	MGC	W01C066B17	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06_07-A09	MGC	W01C066B18	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06_07-A10	MGC	W01C066B19	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06_07-A10	MGC	W01C066B20	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06_07-A11	MGC	W01C066B21	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06_07-A11	MGC	W01C066B22	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06_07-A12	MGC	W01C066B23	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC019348	06_07-A12	MGC	W01C066B24	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.462	0.462	13	117	19	57	121	5	17
IKAKEN	BC019348	06_07-B01	MGC	W01C066C01	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B01	MGC	W01C066C02	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C066C03	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C066C04	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06_07-B03	MGC	W01C066C05	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_07-B03	MGC	W01C066C06	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC014475	06_07-B04	MGC	W01C066C07	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06_07-B04	MGC	W01C066C08	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06_07-B05	MGC	W01C066C09	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06_07-B05	MGC	W01C066C10	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06_07-B06	MGC	W01C066C11	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B06	MGC	W01C066C12	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B07	MGC	W01C066C13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06_07-B07	MGC	W01C066C14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06_07-B08	MGC	W01C066C15	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06_07-B08	MGC	W01C066C16	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C066C17	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C066C18	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C066C19	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C066C20	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C066C21	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C066C22	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C066C23	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C066C24	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BC019348	06_07-B01	MGC	W01C066D01	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B01	MGC	W01C066D02	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C066D03	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_07-B02	MGC	W01C066D04	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06_07-B03	MGC	W01C066D05	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_07-B03	MGC	W01C066D06	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC014475	06_07-B04	MGC	W01C066D07	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06_07-B04	MGC	W01C066D08	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06_07-B05	MGC	W01C066D09	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06_07-B05	MGC	W01C066D10	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06_07-B06	MGC	W01C066D11	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B06	MGC	W01C066D12	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06_07-B07	MGC	W01C066D13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06_07-B07	MGC	W01C066D14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06_07-B08	MGC	W01C066D15	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06_07-B08	MGC	W01C066D16	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C066D17	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX419459 (5' CS0DF017YO03)	06_07-B09		W01C066D18	pDONR221			LOC442245	442245		Hs.551627	Glutathione S-transferase M1 pseudogene								
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C066D19	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX420136 (5' CS0DF024YO15)	06_07-B10		W01C066D20	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C066D21	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX393401 (5' CS0DB001YE06)	06_07-B11		W01C066D22	pDONR221			RANBP1	5902		Hs.24763	RAN binding protein 1						NM_002882.2	NP_002873.1	REVIEWED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C066D23	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-B12		W01C066D24	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C066E01	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C066E02	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BC015508	06_07-C02	MGC	W01C066E03	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06_07-C02	MGC	W01C066E04	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06_07-C03	MGC	W01C066E05	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06_07-C03	MGC	W01C066E06	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06_07-C04	MGC	W01C066E07	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06_07-C04	MGC	W01C066E08	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06_07-C05	MGC	W01C066E09	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06_07-C05	MGC	W01C066E10	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06_07-C06	MGC	W01C066E11	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06_07-C06	MGC	W01C066E12	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06_07-C07	MGC	W01C066E13	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06_07-C07	MGC	W01C066E14	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	CS0DM013YA17	06_07-C08		W01C066E15	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	CS0DM013YA17	06_07-C08		W01C066E16	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	H013062P13	06_07-C09	Riken	W01C066E17	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	H013062P13	06_07-C09	Riken	W01C066E18	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C066E19	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C066E20	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C066E21	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C066E22	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	H013011E16	06_07-C12	Riken	W01C066E23	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06_07-C12	Riken	W01C066E24	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C066F01	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BX341912 (5' CS0DK006YD24)	06_07-C01		W01C066F02	pDONR221			THAP4	51078		Hs.645463	THAP domain containing 4						NM_015963.4	NP_057047.3	PROVISIONAL	Cs	0.998	0.998	577	1734	1	1731	577	1	577
IKAKEN	BC015508	06_07-C02	MGC	W01C066F03	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06_07-C02	MGC	W01C066F04	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06_07-C03	MGC	W01C066F05	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06_07-C03	MGC	W01C066F06	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06_07-C04	MGC	W01C066F07	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06_07-C04	MGC	W01C066F08	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06_07-C05	MGC	W01C066F09	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06_07-C05	MGC	W01C066F10	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06_07-C06	MGC	W01C066F11	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06_07-C06	MGC	W01C066F12	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06_07-C07	MGC	W01C066F13	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06_07-C07	MGC	W01C066F14	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	CS0DM013YA17	06_07-C08		W01C066F15	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	CS0DM013YA17	06_07-C08		W01C066F16	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	H013062P13	06_07-C09	Riken	W01C066F17	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	H013062P13	06_07-C09	Riken	W01C066F18	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	Pfs	0.985	0.995	194	615	1	578	957	765	957
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C066F19	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX388129 (5' CS0DL002YM22)	06_07-C10		W01C066F20	pDONR221			EPRS	2058		Hs.497788	Glutamyl-prolyl-tRNA synthetase						NM_004446.2	NP_004437.2	REVIEWED	P	1.000	1.000	472	1416	1	1416	1512	1	472
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C066F21	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BX422607 (5' CS0DM012YF14)	06_07-C11		W01C066F22	pDONR221			RAVER2	55225		Hs.591443	Ribonucleoprotein, PTB-binding 2						NM_018211.3	NP_060681.2	VALIDATED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	H013011E16	06_07-C12	Riken	W01C066F23	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06_07-C12	Riken	W01C066F24	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013033B02	06_07-D01	Riken	W01C066G01	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013033B02	06_07-D01	Riken	W01C066G02	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013034B19	06_07-D02	Riken	W01C066G03	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013034B19	06_07-D02	Riken	W01C066G04	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013049H10	06_07-D03	Riken	W01C066G05	pDONR221				440289											
IKAKEN	H013049H10	06_07-D03	Riken	W01C066G06	pDONR221				440289											
IKAKEN	H013068D18	06_07-D04	Riken	W01C066G07	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013068D18	06_07-D04	Riken	W01C066G08	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013071G19	06_07-D05	Riken	W01C066G09	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013071G19	06_07-D05	Riken	W01C066G10	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013088F12	06_07-D06	Riken	W01C066G11	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013088F12	06_07-D06	Riken	W01C066G12	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013096M19	06_07-D07	Riken	W01C066G13	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D07	Riken	W01C066G14	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C066G15	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C066G16	pDONR221			GOLGA2LY2	401634											
IKAKEN	H023056D18	06_07-D09	Riken	W01C066G17	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023056D18	06_07-D09	Riken	W01C066G18	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023058H22	06_07-D10	Riken	W01C066G19	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023058H22	06_07-D10	Riken	W01C066G20	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023061J11	06_07-D11	Riken	W01C066G21	pDONR221															
IKAKEN	H023061J11	06_07-D11	Riken	W01C066G22	pDONR221															
IKAKEN	H023062I21	06_07-D12	Riken	W01C066G23	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H023062I21	06_07-D12	Riken	W01C066G24	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H013033B02	06_07-D01	Riken	W01C066H01	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013033B02	06_07-D01	Riken	W01C066H02	pDONR221			C2orf78	388960		Hs.456833	Chromosome 2 open reading frame 78						NM_001080474.1	NP_001073943.1	PREDICTED	Pg	0.961	1.000	892	2574	1	2571	922	31	922
IKAKEN	H013034B19	06_07-D02	Riken	W01C066H03	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013034B19	06_07-D02	Riken	W01C066H04	pDONR221			TSKS	60385		Hs.515858	Testis-specific serine kinase substrate						NM_021733.1	NP_068379.1	REVIEWED	OK	1.000	1.000	592	1779	1	1776	592	1	592
IKAKEN	H013049H10	06_07-D03	Riken	W01C066H05	pDONR221				440289											
IKAKEN	H013049H10	06_07-D03	Riken	W01C066H06	pDONR221				440289											
IKAKEN	H013068D18	06_07-D04	Riken	W01C066H07	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013068D18	06_07-D04	Riken	W01C066H08	pDONR221			FAM170B	170370		Hs.646291	Family with sequence similarity 170, member B						XM_096317.11	XP_096317.6	MODEL	P	1.000	1.000	283	852	1	849	321	39	321
IKAKEN	H013071G19	06_07-D05	Riken	W01C066H09	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013071G19	06_07-D05	Riken	W01C066H10	pDONR221			C10orf137	26098		Hs.468688	Chromosome 10 open reading frame 137						NM_015608.2	NP_056423.2	VALIDATED	OK	1.000	1.000	1204	3615	1	3612	1204	1	1204
IKAKEN	H013088F12	06_07-D06	Riken	W01C066H11	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013088F12	06_07-D06	Riken	W01C066H12	pDONR221			TDRD12	91646		Hs.646351	Tudor domain containing 12						NM_001110822.1	NP_001104292.1	VALIDATED	Pg	0.917	1.000	396	3384	1	1095	395	1	394
IKAKEN	H013096M19	06_07-D07	Riken	W01C066H13	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D07	Riken	W01C066H14	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C066H15	pDONR221			GOLGA2LY2	401634											
IKAKEN	H013096M19	06_07-D08	Riken	W01C066H16	pDONR221			GOLGA2LY2	401634											
IKAKEN	H023056D18	06_07-D09	Riken	W01C066H17	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023056D18	06_07-D09	Riken	W01C066H18	pDONR221			VWA5B1	127731		Hs.205178	Von Willebrand factor A domain containing 5B1						XM_001722706.1	XP_001722758.1	MODEL	Pg	0.978	1.000	586	1785	1	1719	1215	1	586
IKAKEN	H023058H22	06_07-D10	Riken	W01C066H19	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023058H22	06_07-D10	Riken	W01C066H20	pDONR221			C2orf80	389073		Hs.198416	Chromosome 2 open reading frame 80						NM_001099334.2	NP_001092804.1	VALIDATED	Cgs	0.955	0.995	201	606	1	603	193	1	193
IKAKEN	H023061J11	06_07-D11	Riken	W01C066H21	pDONR221															
IKAKEN	H023061J11	06_07-D11	Riken	W01C066H22	pDONR221															
IKAKEN	H023062I21	06_07-D12	Riken	W01C066H23	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H023062I21	06_07-D12	Riken	W01C066H24	pDONR221			C5orf49	134121		Hs.709979	Chromosome 5 open reading frame 49						NM_001089584.1	NP_001083053.1	PREDICTED	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	H023069F07	06_07-E01	Riken	W01C066I01	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023069F07	06_07-E01	Riken	W01C066I02	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023076F16	06_07-E02	Riken	W01C066I03	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023076F16	06_07-E02	Riken	W01C066I04	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023086E24	06_07-E03	Riken	W01C066I05	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H023086E24	06_07-E03	Riken	W01C066I06	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H033059F01	06_07-E04	Riken	W01C066I07	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06_07-E04	Riken	W01C066I08	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033067A04	06_07-E05	Riken	W01C066I09	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	H033067A04	06_07-E05	Riken	W01C066I10	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C066I11	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C066I12	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C066I13	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C066I14	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C066I15	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C066I16	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C066I17	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C066I18	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C066I19	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C066I20	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C066I21	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C066I22	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C066I23	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C066I24	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	H023069F07	06_07-E01	Riken	W01C066J01	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023069F07	06_07-E01	Riken	W01C066J02	pDONR221			EME2	197342		Hs.7247	Essential meiotic endonuclease 1 homolog 2 (S. pombe)						NM_001010865.1	NP_001010865.1	PROVISIONAL	Pfs	0.857	1.000	266	738	2	735	444	196	444
IKAKEN	H023076F16	06_07-E02	Riken	W01C066J03	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023076F16	06_07-E02	Riken	W01C066J04	pDONR221			TMEM41B	440026		Hs.594563	Transmembrane protein 41B						NM_015012.1	NP_055827.1	VALIDATED	OK	1.000	1.000	291	876	1	873	291	1	291
IKAKEN	H023086E24	06_07-E03	Riken	W01C066J05	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H023086E24	06_07-E03	Riken	W01C066J06	pDONR221			MARCKS	4082		Hs.712721	Myristoylated alanine-rich protein kinase C substrate						NM_002356.5	NP_002347.5	REVIEWED	OK	1.000	1.000	332	999	1	996	332	1	332
IKAKEN	H033059F01	06_07-E04	Riken	W01C066J07	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06_07-E04	Riken	W01C066J08	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033067A04	06_07-E05	Riken	W01C066J09	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	H033067A04	06_07-E05	Riken	W01C066J10	pDONR221			NDUFA10	4705		Hs.277677	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 10, 42kDa						NM_004544.2	NP_004535.1	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C066J11	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-BRALZ2010212	06_07-E06	EST(F-)	W01C066J12	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	Pgs	0.983	0.997	402	1209	1	1206	2294	1899	2294
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C066J13	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-FCBBF3027252	06_07-E07	EST(F-)	W01C066J14	pDONR221			FAM168A	23201		Hs.475334	Family with sequence similarity 168, member A						NM_015159.1	NP_055974.1	PREDICTED	Cg	0.963	1.000	244	735	1	732	235	1	235
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C066J15	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3000421	06_07-E08	EST(F-)	W01C066J16	pDONR221			CDGAP	57514		Hs.668218	Cdc42 GTPase-activating protein						NM_020754.2	NP_065805.2	REVIEWED	OK	1.000	1.000	1444	4335	1	4332	1444	1	1444
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C066J17	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-BRACE3043161	06_07-E09	EST(F-)	W01C066J18	pDONR221			LRRC16B	90668		Hs.26135	Leucine rich repeat containing 16B						NM_138360.3	NP_612369.3	VALIDATED	Pg	0.908	1.000	468	1278	1	1275	1372	905	1372
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C066J19	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI2040689	06_07-E10	EST(F-)	W01C066J20	pDONR221			DSCR8	84677		Hs.192371	Down syndrome critical region gene 8																		
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C066J21	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-TESTI4018079	06_07-E11	EST(F-)	W01C066J22	pDONR221			ADAM29	11086		Hs.126838	ADAM metallopeptidase domain 29						NM_001130704.1	NP_001124176.1	REVIEWED	Ps	0.996	0.996	766	2301	1	2298	820	1	766
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C066J23	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	F-OCBBF3003990	06_07-E12	EST(F-)	W01C066J24	pDONR221			FLJ32810	143872		Hs.269837	Rho-type GTPase-activating protein FLJ32810						XM_001726124.1	XP_001726176.1	MODEL	P	1.000	1.000	55	1878	1711	1875	62	8	62
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C066K01	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C066K02	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C066K03	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C066K04	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C066K05	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C066K06	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C066K07	pDONR221															
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C066K08	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C066K09	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C066K10	pDONR221															
IKAKEN	RAM08530	06_07-F06	EST	W01C066K11	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	RAM08530	06_07-F06	EST	W01C066K12	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	SK006G06	06_07-F07	IMS	W01C066K13	pDONR221															
IKAKEN	SK006G06	06_07-F07	IMS	W01C066K14	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C066K15	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C066K16	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C066K17	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C066K18	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C066K19	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C066K20	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C066K21	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C066K22	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C066K23	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C066K24	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C066L01	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F01	EST(F-)	W01C066L02	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C066L03	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-F02	EST(F-)	W01C066L04	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C066L05	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-TRACH3027624	06_07-F03	EST(F-)	W01C066L06	pDONR221			FAM154B	283726		Hs.459117	Family with sequence similarity 154, member B						NM_001008226.1	NP_001008227.1	PREDICTED		0.296	0.296	27	96	13	93	398	126	152
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C066L07	pDONR221															
IKAKEN	F-UTERU2008076	06_07-F04	EST(F-)	W01C066L08	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C066L09	pDONR221															
IKAKEN	KAT09969	06_07-F05	EST	W01C066L10	pDONR221															
IKAKEN	RAM08530	06_07-F06	EST	W01C066L11	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	RAM08530	06_07-F06	EST	W01C066L12	pDONR221			PSD4	23550		Hs.516306	Pleckstrin and Sec7 domain containing 4						NM_012455.2	NP_036587.2	VALIDATED	Cg	0.999	1.000	1057	3174	1	3171	1056	1	1056
IKAKEN	SK006G06	06_07-F07	IMS	W01C066L13	pDONR221															
IKAKEN	SK006G06	06_07-F07	IMS	W01C066L14	pDONR221															
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C066L15	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	AL514688 (5' CL0BB013ZC02)	06_07-F08		W01C066L16	pDONR221			ZC3H13	23091		Hs.136102	Zinc finger CCCH-type containing 13						NM_015070.3	NP_055885.3	VALIDATED	Pg	0.999	1.000	999	3330	1	2994	1564	560	1558
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C066L17	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	BX391524 (3' CS0DC020YN13)	06_07-F09		W01C066L18	pDONR221			AZI1	22994		Hs.514578	5-azacytidine induced 1						NM_014984.2	NP_055799.2	VALIDATED	Pfs	0.879	1.000	307	813	1	811	1080	681	987
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C066L19	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL524319 (5' CS0DC006YM14)	06_07-F10		W01C066L20	pDONR221			HAUS8	93323		Hs.404088	HAUS augmin-like complex, subunit 8						NM_001011699.1	NP_001011699.1	VALIDATED	Pfs	0.984	1.000	251	753	1	752	409	1	248
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C066L21	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	AL518865 (5' CS0DA011YM19)	06_07-F11		W01C066L22	pDONR221			INTS1	26173		Hs.532188	Integrator complex subunit 1						NM_001080453.2	NP_001073922.2	VALIDATED	Pfs	0.997	1.000	308	1032	1	922	2190	1883	2190
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C066L23	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	BX406635 (5' CS0DM013YA17)	06_07-F12		W01C066L24	pDONR221			RHD	6007		Hs.647623	Rh blood group, D antigen						NM_016124.3	NP_057208.2	REVIEWED	Pfs	0.910	0.914	399	1194	1	1192	417	1	399
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C066M01	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C066M02	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C066M03	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C066M04	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	H023092L01	06_07-G03	Riken	W01C066M05	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H023092L01	06_07-G03	Riken	W01C066M06	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H013087P15	06_07-G04	Riken	W01C066M07	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06_07-G04	Riken	W01C066M08	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013086M14	06_07-G05	Riken	W01C066M09	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06_07-G05	Riken	W01C066M10	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H023092A07	06_07-G06	Riken	W01C066M11	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H023092A07	06_07-G06	Riken	W01C066M12	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H033051H17	06_07-G07	Riken	W01C066M13	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033051H17	06_07-G07	Riken	W01C066M14	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033091K21	06_07-G08	Riken	W01C066M15	pDONR221															
IKAKEN	H033091K21	06_07-G08	Riken	W01C066M16	pDONR221															
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C066M17	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C066M18	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C066M19	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C066M20	pDONR221															
IKAKEN	H013066M09	06_07-G11	Riken	W01C066M21	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H013066M09	06_07-G11	Riken	W01C066M22	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H023059I21	06_07-G12	Riken	W01C066M23	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	H023059I21	06_07-G12	Riken	W01C066M24	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C066N01	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06_07-G01		W01C066N02	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C066N03	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	AL560478 (5' CS0DG006YD10)	06_07-G02		W01C066N04	pDONR221			NUFIP2	57532		Hs.462598	Nuclear fragile X mental retardation protein interacting protein 2						NM_020772.2	NP_065823.1	VALIDATED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	H023092L01	06_07-G03	Riken	W01C066N05	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H023092L01	06_07-G03	Riken	W01C066N06	pDONR221			FNIP2	57600		Hs.709500	Folliculin interacting protein 2						NM_020840.1	NP_065891.1	VALIDATED	OK	1.000	1.000	1114	3345	1	3342	1114	1	1114
IKAKEN	H013087P15	06_07-G04	Riken	W01C066N07	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06_07-G04	Riken	W01C066N08	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013086M14	06_07-G05	Riken	W01C066N09	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06_07-G05	Riken	W01C066N10	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H023092A07	06_07-G06	Riken	W01C066N11	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H023092A07	06_07-G06	Riken	W01C066N12	pDONR221			PMP2	5375		Hs.571512	Peripheral myelin protein 2						NM_002677.3	NP_002668.1	VALIDATED	Ps	0.991	0.991	112	339	1	336	132	21	132
IKAKEN	H033051H17	06_07-G07	Riken	W01C066N13	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033051H17	06_07-G07	Riken	W01C066N14	pDONR221			C14orf45	80127		Hs.644621	Chromosome 14 open reading frame 45						NM_025057.2	NP_079333.2	VALIDATED	Pg	0.995	1.000	193	621	1	579	529	1	192
IKAKEN	H033091K21	06_07-G08	Riken	W01C066N15	pDONR221															
IKAKEN	H033091K21	06_07-G08	Riken	W01C066N16	pDONR221															
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C066N17	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX445713 (5' CS0DG006YA18)	06_07-G09		W01C066N18	pDONR221			OAZ2	4947		Hs.74563	Ornithine decarboxylase antizyme 2						NM_002537.2	NP_002528.1	REVIEWED	Cg	0.995	1.000	189	567	1	564	189	1	189
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C066N19	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06_07-G10		W01C066N20	pDONR221															
IKAKEN	H013066M09	06_07-G11	Riken	W01C066N21	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H013066M09	06_07-G11	Riken	W01C066N22	pDONR221			FKSG2	59347		Hs.651853	Apoptosis inhibitor						NM_021631.2	NP_067644.2	VALIDATED		0.640	0.663	89	3486	1825	2082	127	4	92
IKAKEN	H023059I21	06_07-G12	Riken	W01C066N23	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	H023059I21	06_07-G12	Riken	W01C066N24	pDONR221			PCDH8	5100		Hs.19492	Protocadherin 8						NM_032949.1	NP_116567.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	H023062H21	06_07-H01	Riken	W01C066O01	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023062H21	06_07-H01	Riken	W01C066O02	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023083A18	06_07-H02	Riken	W01C066O03	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H023083A18	06_07-H02	Riken	W01C066O04	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H033011C21	06_07-H03	Riken	W01C066O05	pDONR221															
IKAKEN	H033011C21	06_07-H03	Riken	W01C066O06	pDONR221															
IKAKEN	H033054E06	06_07-H04	Riken	W01C066O07	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033054E06	06_07-H04	Riken	W01C066O08	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033056L19	06_07-H05	Riken	W01C066O09	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033056L19	06_07-H05	Riken	W01C066O10	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033068B12	06_07-H06	Riken	W01C066O11	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033068B12	06_07-H06	Riken	W01C066O12	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033077F05	06_07-H07	Riken	W01C066O13	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	H033077F05	06_07-H07	Riken	W01C066O14	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	SK003D03	06_07-H08	IMS	W01C066O15	pDONR221															
IKAKEN	SK003D03	06_07-H08	IMS	W01C066O16	pDONR221															
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C066O17	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C066O18	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C066O19	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C066O20	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C066O21	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C066O22	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C066O23	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C066O24	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	H023062H21	06_07-H01	Riken	W01C066P01	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023062H21	06_07-H01	Riken	W01C066P02	pDONR221			NRGN	4900		Hs.524116	Neurogranin (protein kinase C substrate, RC3)						NM_001126181.1	NP_001119653.1	REVIEWED	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	H023083A18	06_07-H02	Riken	W01C066P03	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H023083A18	06_07-H02	Riken	W01C066P04	pDONR221			PTPN11	5781		Hs.506852	Protein tyrosine phosphatase, non-receptor type 11						NM_002834.3	NP_002825.3	REVIEWED	OK	1.000	1.000	593	1782	1	1779	593	1	593
IKAKEN	H033011C21	06_07-H03	Riken	W01C066P05	pDONR221															
IKAKEN	H033011C21	06_07-H03	Riken	W01C066P06	pDONR221															
IKAKEN	H033054E06	06_07-H04	Riken	W01C066P07	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033054E06	06_07-H04	Riken	W01C066P08	pDONR221			CS	1431		Hs.715526	Citrate synthase						NM_004077.2	NP_004068.2	REVIEWED	OK	1.000	1.000	466	1401	1	1398	466	1	466
IKAKEN	H033056L19	06_07-H05	Riken	W01C066P09	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033056L19	06_07-H05	Riken	W01C066P10	pDONR221			CIAPIN1	57019		Hs.4900	Cytokine induced apoptosis inhibitor 1						NM_020313.2	NP_064709.2	VALIDATED	Cgs	0.784	0.997	380	1104	1	1101	312	1	312
IKAKEN	H033068B12	06_07-H06	Riken	W01C066P11	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033068B12	06_07-H06	Riken	W01C066P12	pDONR221			PION	54103		Hs.186649	Pigeon homolog (Drosophila)						NM_017439.3	NP_059135.2	VALIDATED	P	1.000	1.000	558	1680	1	1674	854	1	558
IKAKEN	H033077F05	06_07-H07	Riken	W01C066P13	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	H033077F05	06_07-H07	Riken	W01C066P14	pDONR221			RP9P	441212		Hs.648086	Retinitis pigmentosa 9 pseudogene								
IKAKEN	SK003D03	06_07-H08	IMS	W01C066P15	pDONR221															
IKAKEN	SK003D03	06_07-H08	IMS	W01C066P16	pDONR221															
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C066P17	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-BRAWH3030385	06_07-H09	EST(F-)	W01C066P18	pDONR221			CACNA1B	774		Hs.495522	Calcium channel, voltage-dependent, N type, alpha 1B subunit						NM_000718.2	NP_000709.1	VALIDATED	Pfs	0.930	0.998	630	1890	1	1888	2339	1040	1627
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C066P19	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI4039049	06_07-H10	EST(F-)	W01C066P20	pDONR221			WDR42C	347442		Hs.127840	WD repeat domain 42C						NM_001136533.1	NP_001130005.1	PROVISIONAL	Cg	0.932	1.000	631	1767	1	1764	631	1	631
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C066P21	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06_07-H11	EST(F-)	W01C066P22	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C066P23	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	F-UTERU3006397	06_07-H12	EST(F-)	W01C066P24	pDONR221			RNF213	57674		Hs.195642	Ring finger protein 213						NM_020914.3	NP_065965.3	VALIDATED	Pg	0.993	1.000	1442	4329	1	4326	3280	1849	3280
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C067A01	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C067A02	pDONR221			TRY6	154754																					
IKAKEN	JTH01487	06_08-A02	EST	W01C067A03	pDONR221															
IKAKEN	JTH01487	06_08-A02	EST	W01C067A04	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C067A05	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C067A06	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C067A07	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C067A08	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C067A09	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C067A10	pDONR221															
IKAKEN	CBL07919	06_08-A06	EST	W01C067A11	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	CBL07919	06_08-A06	EST	W01C067A12	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	SK004B05	06_08-A07	IMS	W01C067A13	pDONR221															
IKAKEN	SK004B05	06_08-A07	IMS	W01C067A14	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C067A15	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C067A16	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C067A17	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C067A18	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C067A19	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C067A20	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C067A21	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C067A22	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C067A23	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C067A24	pDONR221															
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C067B01	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C067B02	pDONR221			TRY6	154754																					
IKAKEN	JTH01487	06_08-A02	EST	W01C067B03	pDONR221															
IKAKEN	JTH01487	06_08-A02	EST	W01C067B04	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C067B05	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C067B06	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C067B07	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C067B08	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C067B09	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C067B10	pDONR221															
IKAKEN	CBL07919	06_08-A06	EST	W01C067B11	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	CBL07919	06_08-A06	EST	W01C067B12	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	SK004B05	06_08-A07	IMS	W01C067B13	pDONR221															
IKAKEN	SK004B05	06_08-A07	IMS	W01C067B14	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C067B15	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C067B16	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C067B17	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C067B18	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C067B19	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C067B20	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C067B21	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C067B22	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C067B23	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C067B24	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C067C01	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C067C02	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C067C03	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C067C04	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C067C05	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C067C06	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C067C07	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C067C08	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C067C09	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C067C10	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C067C11	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C067C12	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C067C13	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C067C14	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C067C15	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C067C16	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C067C17	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C067C18	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C067C19	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C067C20	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C067C21	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C067C22	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C067C23	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C067C24	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C067D01	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C067D02	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C067D03	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C067D04	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C067D05	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C067D06	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C067D07	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C067D08	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C067D09	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C067D10	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C067D11	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C067D12	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C067D13	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C067D14	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C067D15	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C067D16	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C067D17	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C067D18	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C067D19	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C067D20	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C067D21	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C067D22	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C067D23	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C067D24	pDONR221															
IKAKEN	SK006G06	06_08-C01	IMS	W01C067E01	pDONR221															
IKAKEN	SK006G06	06_08-C01	IMS	W01C067E02	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C067E03	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C067E04	pDONR221															
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C067E05	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C067E06	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C067E07	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C067E08	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C067E09	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C067E10	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C067E11	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C067E12	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C067E13	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C067E14	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C067E15	pDONR221															
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C067E16	pDONR221															
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C067E17	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C067E18	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C067E19	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C067E20	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C067E21	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C067E22	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C067E23	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C067E24	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	SK006G06	06_08-C01	IMS	W01C067F01	pDONR221															
IKAKEN	SK006G06	06_08-C01	IMS	W01C067F02	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C067F03	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C067F04	pDONR221															
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C067F05	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C067F06	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C067F07	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C067F08	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C067F09	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C067F10	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C067F11	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C067F12	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C067F13	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C067F14	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C067F15	pDONR221															
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C067F16	pDONR221															
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C067F17	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C067F18	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C067F19	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C067F20	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C067F21	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C067F22	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C067F23	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C067F24	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C067G01	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C067G02	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C067G03	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C067G04	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK093202	06_08-D03	FLJ	W01C067G05	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK093202	06_08-D03	FLJ	W01C067G06	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK074963	06_08-D04	FLJ	W01C067G07	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06_08-D04	FLJ	W01C067G08	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK097777	06_08-D05	FLJ	W01C067G09	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06_08-D05	FLJ	W01C067G10	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK095608	06_08-D06	FLJ	W01C067G11	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK095608	06_08-D06	FLJ	W01C067G12	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK022880	06_08-D07		W01C067G13	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK022880	06_08-D07		W01C067G14	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK130951	06_08-D08	FLJ	W01C067G15	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130951	06_08-D08	FLJ	W01C067G16	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK124106	06_08-D09	FLJ	W01C067G17	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06_08-D09	FLJ	W01C067G18	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK123682	06_08-D10		W01C067G19	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK123682	06_08-D10		W01C067G20	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK125436	06_08-D11	FLJ	W01C067G21	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_08-D11	FLJ	W01C067G22	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125768	06_08-D12	FLJ	W01C067G23	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	AK125768	06_08-D12	FLJ	W01C067G24	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C067H01	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C067H02	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C067H03	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C067H04	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK093202	06_08-D03	FLJ	W01C067H05	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK093202	06_08-D03	FLJ	W01C067H06	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK074963	06_08-D04	FLJ	W01C067H07	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06_08-D04	FLJ	W01C067H08	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK097777	06_08-D05	FLJ	W01C067H09	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06_08-D05	FLJ	W01C067H10	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK095608	06_08-D06	FLJ	W01C067H11	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK095608	06_08-D06	FLJ	W01C067H12	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK022880	06_08-D07		W01C067H13	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK022880	06_08-D07		W01C067H14	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK130951	06_08-D08	FLJ	W01C067H15	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130951	06_08-D08	FLJ	W01C067H16	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK124106	06_08-D09	FLJ	W01C067H17	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06_08-D09	FLJ	W01C067H18	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK123682	06_08-D10		W01C067H19	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK123682	06_08-D10		W01C067H20	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK125436	06_08-D11	FLJ	W01C067H21	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_08-D11	FLJ	W01C067H22	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125768	06_08-D12	FLJ	W01C067H23	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	AK125768	06_08-D12	FLJ	W01C067H24	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	AK125779	06_08-E01	FLJ	W01C067I01	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK125779	06_08-E01	FLJ	W01C067I02	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK126324	06_08-E02	FLJ	W01C067I03	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06_08-E02	FLJ	W01C067I04	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK131230	06_08-E03	FLJ	W01C067I05	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK131230	06_08-E03	FLJ	W01C067I06	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK127247	06_08-E04	FLJ	W01C067I07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06_08-E04	FLJ	W01C067I08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06_08-E05	FLJ	W01C067I09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06_08-E05	FLJ	W01C067I10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06_08-E06	FLJ	W01C067I11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06_08-E06	FLJ	W01C067I12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127189	06_08-E07	FLJ	W01C067I13	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127189	06_08-E07	FLJ	W01C067I14	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127013	06_08-E08	FLJ	W01C067I15	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06_08-E08	FLJ	W01C067I16	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06_08-E09	FLJ	W01C067I17	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06_08-E09	FLJ	W01C067I18	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC015442	06_08-E10		W01C067I19	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC015442	06_08-E10		W01C067I20	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC026171	06_08-E11	MGC	W01C067I21	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06_08-E11	MGC	W01C067I22	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06_08-E12	MGC	W01C067I23	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06_08-E12	MGC	W01C067I24	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	AK125779	06_08-E01	FLJ	W01C067J01	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK125779	06_08-E01	FLJ	W01C067J02	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK126324	06_08-E02	FLJ	W01C067J03	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06_08-E02	FLJ	W01C067J04	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK131230	06_08-E03	FLJ	W01C067J05	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK131230	06_08-E03	FLJ	W01C067J06	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK127247	06_08-E04	FLJ	W01C067J07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06_08-E04	FLJ	W01C067J08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06_08-E05	FLJ	W01C067J09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06_08-E05	FLJ	W01C067J10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06_08-E06	FLJ	W01C067J11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06_08-E06	FLJ	W01C067J12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127189	06_08-E07	FLJ	W01C067J13	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127189	06_08-E07	FLJ	W01C067J14	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127013	06_08-E08	FLJ	W01C067J15	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06_08-E08	FLJ	W01C067J16	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06_08-E09	FLJ	W01C067J17	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06_08-E09	FLJ	W01C067J18	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC015442	06_08-E10		W01C067J19	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC015442	06_08-E10		W01C067J20	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC026171	06_08-E11	MGC	W01C067J21	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06_08-E11	MGC	W01C067J22	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06_08-E12	MGC	W01C067J23	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06_08-E12	MGC	W01C067J24	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC031603	06_08-F01	MGC	W01C067K01	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC031603	06_08-F01	MGC	W01C067K02	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC028132	06_08-F02	MGC	W01C067K03	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_08-F02	MGC	W01C067K04	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC029590	06_08-F03	MGC	W01C067K05	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC029590	06_08-F03	MGC	W01C067K06	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC039313	06_08-F04	MGC	W01C067K07	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06_08-F04	MGC	W01C067K08	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC032347	06_08-F05	MGC	W01C067K09	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032347	06_08-F05	MGC	W01C067K10	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032035	06_08-F06	MGC	W01C067K11	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC032035	06_08-F06	MGC	W01C067K12	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC036870	06_08-F07	MGC	W01C067K13	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC036870	06_08-F07	MGC	W01C067K14	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC039737	06_08-F08		W01C067K15	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC039737	06_08-F08		W01C067K16	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC058007	06_08-F09	MGC	W01C067K17	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06_08-F09	MGC	W01C067K18	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC050577	06_08-F10	MGC	W01C067K19	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06_08-F10	MGC	W01C067K20	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06_08-F11	MGC	W01C067K21	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06_08-F11	MGC	W01C067K22	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06_08-F12	MGC	W01C067K23	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06_08-F12	MGC	W01C067K24	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC031603	06_08-F01	MGC	W01C067L01	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC031603	06_08-F01	MGC	W01C067L02	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC028132	06_08-F02	MGC	W01C067L03	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_08-F02	MGC	W01C067L04	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC029590	06_08-F03	MGC	W01C067L05	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC029590	06_08-F03	MGC	W01C067L06	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC039313	06_08-F04	MGC	W01C067L07	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06_08-F04	MGC	W01C067L08	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC032347	06_08-F05	MGC	W01C067L09	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032347	06_08-F05	MGC	W01C067L10	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032035	06_08-F06	MGC	W01C067L11	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC032035	06_08-F06	MGC	W01C067L12	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC036870	06_08-F07	MGC	W01C067L13	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC036870	06_08-F07	MGC	W01C067L14	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC039737	06_08-F08		W01C067L15	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC039737	06_08-F08		W01C067L16	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC058007	06_08-F09	MGC	W01C067L17	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06_08-F09	MGC	W01C067L18	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC050577	06_08-F10	MGC	W01C067L19	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06_08-F10	MGC	W01C067L20	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06_08-F11	MGC	W01C067L21	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06_08-F11	MGC	W01C067L22	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06_08-F12	MGC	W01C067L23	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06_08-F12	MGC	W01C067L24	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC000698	06_08-G01	MGC	W01C067M01	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06_08-G01	MGC	W01C067M02	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06_08-G02	MGC	W01C067M03	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06_08-G02	MGC	W01C067M04	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC002725	06_08-G03	MGC	W01C067M05	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC002725	06_08-G03	MGC	W01C067M06	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC005014	06_08-G04	MGC	W01C067M07	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06_08-G04	MGC	W01C067M08	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC009743	06_08-G05		W01C067M09	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC009743	06_08-G05		W01C067M10	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC004540	06_08-G06	MGC	W01C067M11	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC004540	06_08-G06	MGC	W01C067M12	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC005383	06_08-G07		W01C067M13	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC005383	06_08-G07		W01C067M14	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC019348	06_08-G08	MGC	W01C067M15	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_08-G08	MGC	W01C067M16	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC007561	06_08-G09	MGC	W01C067M17	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06_08-G09	MGC	W01C067M18	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06_08-G10	MGC	W01C067M19	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06_08-G10	MGC	W01C067M20	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06_08-G11	MGC	W01C067M21	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06_08-G11	MGC	W01C067M22	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06_08-G12	MGC	W01C067M23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_08-G12	MGC	W01C067M24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC000698	06_08-G01	MGC	W01C067N01	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06_08-G01	MGC	W01C067N02	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06_08-G02	MGC	W01C067N03	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06_08-G02	MGC	W01C067N04	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC002725	06_08-G03	MGC	W01C067N05	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC002725	06_08-G03	MGC	W01C067N06	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC005014	06_08-G04	MGC	W01C067N07	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06_08-G04	MGC	W01C067N08	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC009743	06_08-G05		W01C067N09	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC009743	06_08-G05		W01C067N10	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC004540	06_08-G06	MGC	W01C067N11	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC004540	06_08-G06	MGC	W01C067N12	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC005383	06_08-G07		W01C067N13	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC005383	06_08-G07		W01C067N14	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC019348	06_08-G08	MGC	W01C067N15	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_08-G08	MGC	W01C067N16	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC007561	06_08-G09	MGC	W01C067N17	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06_08-G09	MGC	W01C067N18	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06_08-G10	MGC	W01C067N19	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06_08-G10	MGC	W01C067N20	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06_08-G11	MGC	W01C067N21	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06_08-G11	MGC	W01C067N22	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06_08-G12	MGC	W01C067N23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_08-G12	MGC	W01C067N24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC012161	06_08-H01		W01C067O01	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC012161	06_08-H01		W01C067O02	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC026032	06_08-H02	MGC	W01C067O03	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC026032	06_08-H02	MGC	W01C067O04	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC051717	06_08-H03	MGC	W01C067O05	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_08-H03	MGC	W01C067O06	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06_08-H04	MGC	W01C067O07	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06_08-H04	MGC	W01C067O08	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062680	06_08-H05	MGC	W01C067O09	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H05	MGC	W01C067O10	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H06	MGC	W01C067O11	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06_08-H06	MGC	W01C067O12	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	SK002A06	06_08-H07	IMS	W01C067O13	pDONR221															
IKAKEN	SK002A06	06_08-H07	IMS	W01C067O14	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C067O15	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C067O16	pDONR221															
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C067O17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C067O18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C067O19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C067O20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	SK006C11	06_08-H11		W01C067O21	pDONR221															
IKAKEN	SK006C11	06_08-H11		W01C067O22	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C067O23	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C067O24	pDONR221															
IKAKEN	BC012161	06_08-H01		W01C067P01	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC012161	06_08-H01		W01C067P02	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC026032	06_08-H02	MGC	W01C067P03	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC026032	06_08-H02	MGC	W01C067P04	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC051717	06_08-H03	MGC	W01C067P05	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_08-H03	MGC	W01C067P06	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06_08-H04	MGC	W01C067P07	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06_08-H04	MGC	W01C067P08	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062680	06_08-H05	MGC	W01C067P09	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H05	MGC	W01C067P10	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H06	MGC	W01C067P11	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06_08-H06	MGC	W01C067P12	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	SK002A06	06_08-H07	IMS	W01C067P13	pDONR221															
IKAKEN	SK002A06	06_08-H07	IMS	W01C067P14	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C067P15	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C067P16	pDONR221															
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C067P17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C067P18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C067P19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C067P20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	SK006C11	06_08-H11		W01C067P21	pDONR221															
IKAKEN	SK006C11	06_08-H11		W01C067P22	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C067P23	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C067P24	pDONR221															
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C068A01	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C068A02	pDONR221			TRY6	154754																					
IKAKEN	JTH01487	06_08-A02	EST	W01C068A03	pDONR221															
IKAKEN	JTH01487	06_08-A02	EST	W01C068A04	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C068A05	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C068A06	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C068A07	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C068A08	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C068A09	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C068A10	pDONR221															
IKAKEN	CBL07919	06_08-A06	EST	W01C068A11	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	CBL07919	06_08-A06	EST	W01C068A12	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	SK004B05	06_08-A07	IMS	W01C068A13	pDONR221															
IKAKEN	SK004B05	06_08-A07	IMS	W01C068A14	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C068A15	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C068A16	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C068A17	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C068A18	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C068A19	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C068A20	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C068A21	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C068A22	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C068A23	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C068A24	pDONR221															
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C068B01	pDONR221			TRY6	154754																					
IKAKEN	F-THYMU3047429	06_08-A01	EST(F-)	W01C068B02	pDONR221			TRY6	154754																					
IKAKEN	JTH01487	06_08-A02	EST	W01C068B03	pDONR221															
IKAKEN	JTH01487	06_08-A02	EST	W01C068B04	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C068B05	pDONR221															
IKAKEN	CAS04287	06_08-A03	EST	W01C068B06	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C068B07	pDONR221															
IKAKEN	CAS04287	06_08-A04	EST	W01C068B08	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C068B09	pDONR221															
IKAKEN	CAS04287	06_08-A05	EST	W01C068B10	pDONR221															
IKAKEN	CBL07919	06_08-A06	EST	W01C068B11	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	CBL07919	06_08-A06	EST	W01C068B12	pDONR221			FAM108A5	729495									XM_001721929.1	XP_001721981.1	MODEL	Pg	0.935	1.000	308	867	1	864	403	96	403
IKAKEN	SK004B05	06_08-A07	IMS	W01C068B13	pDONR221															
IKAKEN	SK004B05	06_08-A07	IMS	W01C068B14	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C068B15	pDONR221															
IKAKEN	SK004C04	06_08-A08	IMS	W01C068B16	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C068B17	pDONR221															
IKAKEN	SK004C10	06_08-A09	IMS	W01C068B18	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C068B19	pDONR221															
IKAKEN	SK004C12	06_08-A10	IMS	W01C068B20	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C068B21	pDONR221															
IKAKEN	SK004D04	06_08-A11	IMS	W01C068B22	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C068B23	pDONR221															
IKAKEN	SK004E05	06_08-A12	IMS	W01C068B24	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C068C01	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C068C02	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C068C03	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C068C04	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C068C05	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C068C06	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C068C07	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C068C08	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C068C09	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C068C10	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C068C11	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C068C12	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C068C13	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C068C14	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C068C15	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C068C16	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C068C17	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C068C18	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C068C19	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C068C20	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C068C21	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C068C22	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C068C23	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C068C24	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C068D01	pDONR221															
IKAKEN	SK004G06	06_08-B01	IMS	W01C068D02	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C068D03	pDONR221															
IKAKEN	SK005C04	06_08-B02	IMS	W01C068D04	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C068D05	pDONR221															
IKAKEN	SK005C05	06_08-B03	IMS	W01C068D06	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C068D07	pDONR221															
IKAKEN	SK005C10	06_08-B04	IMS	W01C068D08	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C068D09	pDONR221															
IKAKEN	SK005D09	06_08-B05	IMS	W01C068D10	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C068D11	pDONR221															
IKAKEN	SK005D10	06_08-B06	IMS	W01C068D12	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C068D13	pDONR221															
IKAKEN	SK005F02	06_08-B07	IMS	W01C068D14	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C068D15	pDONR221															
IKAKEN	SK005F04	06_08-B08	IMS	W01C068D16	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C068D17	pDONR221															
IKAKEN	SK006A07	06_08-B09	IMS	W01C068D18	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C068D19	pDONR221															
IKAKEN	SK006B11	06_08-B10	IMS	W01C068D20	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C068D21	pDONR221															
IKAKEN	SK006E01	06_08-B11	IMS	W01C068D22	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C068D23	pDONR221															
IKAKEN	SK006F09	06_08-B12	IMS	W01C068D24	pDONR221															
IKAKEN	SK006G06	06_08-C01	IMS	W01C068E01	pDONR221															
IKAKEN	SK006G06	06_08-C01	IMS	W01C068E02	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C068E03	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C068E04	pDONR221															
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C068E05	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C068E06	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C068E07	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C068E08	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C068E09	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C068E10	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C068E11	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C068E12	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C068E13	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C068E14	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C068E15	pDONR221															
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C068E16	pDONR221															
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C068E17	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C068E18	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C068E19	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C068E20	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C068E21	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C068E22	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C068E23	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C068E24	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	SK006G06	06_08-C01	IMS	W01C068F01	pDONR221															
IKAKEN	SK006G06	06_08-C01	IMS	W01C068F02	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C068F03	pDONR221															
IKAKEN	SK006H06	06_08-C02	IMS	W01C068F04	pDONR221															
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C068F05	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	AL526502 (5' CS0DC014YM16)	06_08-C03		W01C068F06	pDONR221			PAP2D	163404		Hs.483948	Phosphatidic acid phosphatase type 2						NM_001037317.1	NP_001032394.1	REVIEWED	P	1.000	1.000	297	894	1	891	321	25	321
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C068F07	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX328985 (3' CS0DC024YE20)	06_08-C04		W01C068F08	pDONR221			SHISA3	152573		Hs.370904	Shisa homolog 3 (Xenopus laevis)						NM_001080505.1	NP_001073974.1	PROVISIONAL	P	1.000	1.000	91	276	1	273	238	148	238
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C068F09	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX248767 (5' CS0DD009YE24)	06_08-C05		W01C068F10	pDONR221			WDR25	79446		Hs.497600	WD repeat domain 25						NM_024515.3	NP_078791.2	PROVISIONAL	Cgs	0.994	0.996	545	1638	1	1635	544	1	544
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C068F11	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX333171 (5' CS0DC021YK01)	06_08-C06		W01C068F12	pDONR221			SGK493	91461		Hs.408542	Protein kinase-like protein SgK493						NM_138370.2	NP_612379.2	VALIDATED	P	1.000	1.000	160	483	1	480	493	334	493
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C068F13	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06_08-C07		W01C068F14	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C068F15	pDONR221															
IKAKEN	BX335029 (5' CS0DI010YI19)	06_08-C08		W01C068F16	pDONR221															
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C068F17	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	BX384411 (5' CS0DK009YD12)	06_08-C09		W01C068F18	pDONR221			C9orf37	85026		Hs.522520	Chromosome 9 open reading frame 37						NM_032937.4	NP_116326.2	REVIEWED	OK	1.000	1.000	176	622	1	528	176	1	176
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C068F19	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	AL545070 (5' CS0DI013YF06)	06_08-C10		W01C068F20	pDONR221			HSPA12A	259217		Hs.654682	Heat shock 70kDa protein 12A						NM_025015.2	NP_079291.2	VALIDATED	OK	1.000	1.000	675	2028	1	2025	675	1	675
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C068F21	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06_08-C11		W01C068F22	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C068F23	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	BX443072 (5' CS0DG004YC09)	06_08-C12		W01C068F24	pDONR221			PRO0461	652276		Hs.61960	Hypothetical LOC652276																		
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C068G01	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C068G02	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C068G03	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C068G04	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK093202	06_08-D03	FLJ	W01C068G05	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK093202	06_08-D03	FLJ	W01C068G06	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK074963	06_08-D04	FLJ	W01C068G07	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06_08-D04	FLJ	W01C068G08	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK097777	06_08-D05	FLJ	W01C068G09	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06_08-D05	FLJ	W01C068G10	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK095608	06_08-D06	FLJ	W01C068G11	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK095608	06_08-D06	FLJ	W01C068G12	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK022880	06_08-D07		W01C068G13	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK022880	06_08-D07		W01C068G14	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK130951	06_08-D08	FLJ	W01C068G15	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130951	06_08-D08	FLJ	W01C068G16	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK124106	06_08-D09	FLJ	W01C068G17	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06_08-D09	FLJ	W01C068G18	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK123682	06_08-D10		W01C068G19	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK123682	06_08-D10		W01C068G20	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK125436	06_08-D11	FLJ	W01C068G21	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_08-D11	FLJ	W01C068G22	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125768	06_08-D12	FLJ	W01C068G23	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	AK125768	06_08-D12	FLJ	W01C068G24	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C068H01	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX402912 (5' CS0DK003YA09)	06_08-D01		W01C068H02	pDONR221			KLHL17	339451		Hs.109212	Kelch-like 17 (Drosophila)						NM_198317.1	NP_938073.1	PROVISIONAL	OK	1.000	1.000	642	1929	1	1926	642	1	642
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C068H03	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	BX403352 (5' CS0DI011YA01)	06_08-D02		W01C068H04	pDONR221			ALKBH2	121642		Hs.374458	AlkB, alkylation repair homolog 2 (E. coli)						NM_001145375.1	NP_001138847.1	VALIDATED	OK	1.000	1.000	261	786	1	783	261	1	261
IKAKEN	AK093202	06_08-D03	FLJ	W01C068H05	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK093202	06_08-D03	FLJ	W01C068H06	pDONR221	26023		LOC100133616	100133616	BAC04094.1					testis	TESTI2		XM_001722123.1	XP_001722175.1	MODEL		0.964	0.978	140	417	1	414	140	1	140
IKAKEN	AK074963	06_08-D04	FLJ	W01C068H07	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06_08-D04	FLJ	W01C068H08	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK097777	06_08-D05	FLJ	W01C068H09	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06_08-D05	FLJ	W01C068H10	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK095608	06_08-D06	FLJ	W01C068H11	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK095608	06_08-D06	FLJ	W01C068H12	pDONR221	24859		CA5BP	340591		Hs.532326	Carbonic anhydrase VB pseudogene			brain	FCBBF3		XM_001719208.1	XP_001719260.1	MODEL	P	1.000	1.000	59	180	1	177	195	137	195
IKAKEN	AK022880	06_08-D07		W01C068H13	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK022880	06_08-D07		W01C068H14	pDONR221	28218		LOC100009676	100009676	-	Hs.715553	Hypothetical LOC100009676								
IKAKEN	AK130951	06_08-D08	FLJ	W01C068H15	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK130951	06_08-D08	FLJ	W01C068H16	pDONR221	12593		SYCN	342898	-	Hs.124123	Syncollin			umbilical cord	UBA		NM_001080468.2	NP_001073937.1	PROVISIONAL	OK	1.000	1.000	134	405	1	402	134	1	134
IKAKEN	AK124106	06_08-D09	FLJ	W01C068H17	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06_08-D09	FLJ	W01C068H18	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK123682	06_08-D10		W01C068H19	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK123682	06_08-D10		W01C068H20	pDONR221	22728		DPY19L4	286148	BAC85675.1	Hs.567828	Dpy-19-like 4 (C. elegans)						NM_181787.2	NP_861452.2	VALIDATED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	AK125436	06_08-D11	FLJ	W01C068H21	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_08-D11	FLJ	W01C068H22	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125768	06_08-D12	FLJ	W01C068H23	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	AK125768	06_08-D12	FLJ	W01C068H24	pDONR221	13241		CCDC150	284992	-	Hs.132519	Coiled-coil domain containing 150			testis	TESTI2		NM_001080539.1	NP_001074008.1	PROVISIONAL	Pgs	0.967	0.993	305	1278	328	1242	1101	623	919
IKAKEN	AK125779	06_08-E01	FLJ	W01C068I01	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK125779	06_08-E01	FLJ	W01C068I02	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK126324	06_08-E02	FLJ	W01C068I03	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06_08-E02	FLJ	W01C068I04	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK131230	06_08-E03	FLJ	W01C068I05	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK131230	06_08-E03	FLJ	W01C068I06	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK127247	06_08-E04	FLJ	W01C068I07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06_08-E04	FLJ	W01C068I08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06_08-E05	FLJ	W01C068I09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06_08-E05	FLJ	W01C068I10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06_08-E06	FLJ	W01C068I11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06_08-E06	FLJ	W01C068I12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127189	06_08-E07	FLJ	W01C068I13	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127189	06_08-E07	FLJ	W01C068I14	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127013	06_08-E08	FLJ	W01C068I15	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06_08-E08	FLJ	W01C068I16	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06_08-E09	FLJ	W01C068I17	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06_08-E09	FLJ	W01C068I18	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC015442	06_08-E10		W01C068I19	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC015442	06_08-E10		W01C068I20	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC026171	06_08-E11	MGC	W01C068I21	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06_08-E11	MGC	W01C068I22	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06_08-E12	MGC	W01C068I23	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06_08-E12	MGC	W01C068I24	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	AK125779	06_08-E01	FLJ	W01C068J01	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK125779	06_08-E01	FLJ	W01C068J02	pDONR221	17118		LOC401070	401070	BAC86286.1	Hs.452789	FLJ43791 protein			testis	TESTI2				
IKAKEN	AK126324	06_08-E02	FLJ	W01C068J03	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06_08-E02	FLJ	W01C068J04	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK131230	06_08-E03	FLJ	W01C068J05	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK131230	06_08-E03	FLJ	W01C068J06	pDONR221	6183		DBX2	440097	BAD18413.1	Hs.302764	Developing brain homeobox 2	NB69	neuroblastoma		3NB692		NM_001004329.2	NP_001004329.2	VALIDATED		0.914	0.925	339	1008	1	1005	339	1	339
IKAKEN	AK127247	06_08-E04	FLJ	W01C068J07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06_08-E04	FLJ	W01C068J08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06_08-E05	FLJ	W01C068J09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06_08-E05	FLJ	W01C068J10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06_08-E06	FLJ	W01C068J11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06_08-E06	FLJ	W01C068J12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127189	06_08-E07	FLJ	W01C068J13	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127189	06_08-E07	FLJ	W01C068J14	pDONR221	14173		CCDC108	255101	BAC86878.1	Hs.147762	Coiled-coil domain containing 108			hippocampus	BRHIP2		NM_194302.2	NP_919278.2	PROVISIONAL	Pgs	0.987	0.999	816	2472	1	2448	1925	219	1024
IKAKEN	AK127013	06_08-E08	FLJ	W01C068J15	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06_08-E08	FLJ	W01C068J16	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06_08-E09	FLJ	W01C068J17	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06_08-E09	FLJ	W01C068J18	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC015442	06_08-E10		W01C068J19	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC015442	06_08-E10		W01C068J20	pDONR221	12957		DNAH6	1768	AAH15442.1	Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pgs	0.909	0.996	581	1650	1	1590	4158	1980	2560
IKAKEN	BC026171	06_08-E11	MGC	W01C068J21	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06_08-E11	MGC	W01C068J22	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06_08-E12	MGC	W01C068J23	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06_08-E12	MGC	W01C068J24	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC031603	06_08-F01	MGC	W01C068K01	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC031603	06_08-F01	MGC	W01C068K02	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC028132	06_08-F02	MGC	W01C068K03	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_08-F02	MGC	W01C068K04	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC029590	06_08-F03	MGC	W01C068K05	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC029590	06_08-F03	MGC	W01C068K06	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC039313	06_08-F04	MGC	W01C068K07	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06_08-F04	MGC	W01C068K08	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC032347	06_08-F05	MGC	W01C068K09	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032347	06_08-F05	MGC	W01C068K10	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032035	06_08-F06	MGC	W01C068K11	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC032035	06_08-F06	MGC	W01C068K12	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC036870	06_08-F07	MGC	W01C068K13	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC036870	06_08-F07	MGC	W01C068K14	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC039737	06_08-F08		W01C068K15	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC039737	06_08-F08		W01C068K16	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC058007	06_08-F09	MGC	W01C068K17	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06_08-F09	MGC	W01C068K18	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC050577	06_08-F10	MGC	W01C068K19	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06_08-F10	MGC	W01C068K20	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06_08-F11	MGC	W01C068K21	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06_08-F11	MGC	W01C068K22	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06_08-F12	MGC	W01C068K23	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06_08-F12	MGC	W01C068K24	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC031603	06_08-F01	MGC	W01C068L01	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC031603	06_08-F01	MGC	W01C068L02	pDONR221	13817		ALS2CR12	130540	AAH31603.1	Hs.107944	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 12			Brain, adult medulla	NIH_MGC_119	DH10B	NM_139163.2	NP_631902.2	VALIDATED	OK	1.000	1.000	445	1338	1	1335	445	1	445
IKAKEN	BC028132	06_08-F02	MGC	W01C068L03	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC028132	06_08-F02	MGC	W01C068L04	pDONR221	6246		FBXL14	144699	AAH28132.1	Hs.367956	F-box and leucine-rich repeat protein 14			Brain, adult medulla	NIH_MGC_119	DH10B	NM_152441.2	NP_689654.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	BC029590	06_08-F03	MGC	W01C068L05	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC029590	06_08-F03	MGC	W01C068L06	pDONR221	22123		SEMA3D	223117	AAH29590.1	Hs.201340	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3D			Testis	NIH_MGC_97	DH10B	NM_152754.2	NP_689967.2	VALIDATED		0.966	0.969	352	1059	1	1056	777	427	777
IKAKEN	BC039313	06_08-F04	MGC	W01C068L07	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06_08-F04	MGC	W01C068L08	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC032347	06_08-F05	MGC	W01C068L09	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032347	06_08-F05	MGC	W01C068L10	pDONR221	23251		C8orf59	401466	AAH32347.1	Hs.443072	Chromosome 8 open reading frame 59			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_001099673.1	NP_001093143.1	VALIDATED		0.974	0.974	39	135	1	117	100	1	39
IKAKEN	BC032035	06_08-F06	MGC	W01C068L11	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC032035	06_08-F06	MGC	W01C068L12	pDONR221	24301		FAM27E3	100131997	AAH32035.1	Hs.31240	Family with sequence similarity 27, member E3			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_001720463.1	XP_001720515.1	MODEL	Cs	0.991	0.991	113	342	1	339	113	1	113
IKAKEN	BC036870	06_08-F07	MGC	W01C068L13	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC036870	06_08-F07	MGC	W01C068L14	pDONR221	18290		C4orf37	285555	AAH36870.1	Hs.680226	Chromosome 4 open reading frame 37			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_174952.1	NP_777612.1	PREDICTED	Pfs	0.991	1.000	456	1371	1	1369	459	1	452
IKAKEN	BC039737	06_08-F08		W01C068L15	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC039737	06_08-F08		W01C068L16	pDONR221	974		RIMKLA	284716	AAH39737.1	Hs.420244	Ribosomal modification protein rimK-like family member A						NM_173642.3	NP_775913.2	VALIDATED	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC058007	06_08-F09	MGC	W01C068L17	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06_08-F09	MGC	W01C068L18	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC050577	06_08-F10	MGC	W01C068L19	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06_08-F10	MGC	W01C068L20	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06_08-F11	MGC	W01C068L21	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06_08-F11	MGC	W01C068L22	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06_08-F12	MGC	W01C068L23	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06_08-F12	MGC	W01C068L24	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC000698	06_08-G01	MGC	W01C068M01	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06_08-G01	MGC	W01C068M02	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06_08-G02	MGC	W01C068M03	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06_08-G02	MGC	W01C068M04	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC002725	06_08-G03	MGC	W01C068M05	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC002725	06_08-G03	MGC	W01C068M06	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC005014	06_08-G04	MGC	W01C068M07	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06_08-G04	MGC	W01C068M08	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC009743	06_08-G05		W01C068M09	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC009743	06_08-G05		W01C068M10	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC004540	06_08-G06	MGC	W01C068M11	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC004540	06_08-G06	MGC	W01C068M12	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC005383	06_08-G07		W01C068M13	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC005383	06_08-G07		W01C068M14	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC019348	06_08-G08	MGC	W01C068M15	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_08-G08	MGC	W01C068M16	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC007561	06_08-G09	MGC	W01C068M17	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06_08-G09	MGC	W01C068M18	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06_08-G10	MGC	W01C068M19	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06_08-G10	MGC	W01C068M20	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06_08-G11	MGC	W01C068M21	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06_08-G11	MGC	W01C068M22	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06_08-G12	MGC	W01C068M23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_08-G12	MGC	W01C068M24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC000698	06_08-G01	MGC	W01C068N01	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06_08-G01	MGC	W01C068N02	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06_08-G02	MGC	W01C068N03	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06_08-G02	MGC	W01C068N04	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC002725	06_08-G03	MGC	W01C068N05	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC002725	06_08-G03	MGC	W01C068N06	pDONR221	21998		ZCWPW1	55063	AAH02725.1	Hs.105191	Zinc finger, CW type with PWWP domain 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017984.3	NP_060454.3	VALIDATED	Pfs	0.846	0.998	475	1212	1	1211	648	122	595
IKAKEN	BC005014	06_08-G04	MGC	W01C068N07	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06_08-G04	MGC	W01C068N08	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC009743	06_08-G05		W01C068N09	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC009743	06_08-G05		W01C068N10	pDONR221	11875		CCDC9	26093	AAH09743.1	Hs.227782	Coiled-coil domain containing 9						NM_015603.2	NP_056418.1	VALIDATED	OK	1.000	1.000	531	1596	1	1593	531	1	531
IKAKEN	BC004540	06_08-G06	MGC	W01C068N11	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC004540	06_08-G06	MGC	W01C068N12	pDONR221	7496		RPS6KL1	83694	AAH04540.1	Hs.711521	Ribosomal protein S6 kinase-like 1			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_031464.3	NP_113652.1	VALIDATED	Pgs	0.928	0.998	557	1674	1	1671	541	1	518
IKAKEN	BC005383	06_08-G07		W01C068N13	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC005383	06_08-G07		W01C068N14	pDONR221	19418		CETN3	1070	AAH05383.1	Hs.591767	Centrin, EF-hand protein, 3 (CDC31 homolog, yeast)						NM_004365.2	NP_004356.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC019348	06_08-G08	MGC	W01C068N15	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06_08-G08	MGC	W01C068N16	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC007561	06_08-G09	MGC	W01C068N17	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06_08-G09	MGC	W01C068N18	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06_08-G10	MGC	W01C068N19	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06_08-G10	MGC	W01C068N20	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06_08-G11	MGC	W01C068N21	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06_08-G11	MGC	W01C068N22	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06_08-G12	MGC	W01C068N23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06_08-G12	MGC	W01C068N24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC012161	06_08-H01		W01C068O01	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC012161	06_08-H01		W01C068O02	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC026032	06_08-H02	MGC	W01C068O03	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC026032	06_08-H02	MGC	W01C068O04	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC051717	06_08-H03	MGC	W01C068O05	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_08-H03	MGC	W01C068O06	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06_08-H04	MGC	W01C068O07	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06_08-H04	MGC	W01C068O08	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062680	06_08-H05	MGC	W01C068O09	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H05	MGC	W01C068O10	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H06	MGC	W01C068O11	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06_08-H06	MGC	W01C068O12	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	SK002A06	06_08-H07	IMS	W01C068O13	pDONR221															
IKAKEN	SK002A06	06_08-H07	IMS	W01C068O14	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C068O15	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C068O16	pDONR221															
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C068O17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C068O18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C068O19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C068O20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	SK006C11	06_08-H11		W01C068O21	pDONR221															
IKAKEN	SK006C11	06_08-H11		W01C068O22	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C068O23	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C068O24	pDONR221															
IKAKEN	BC012161	06_08-H01		W01C068P01	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC012161	06_08-H01		W01C068P02	pDONR221	9155		SEPT1	1731	AAH12161.1	Hs.632176	Septin 1						NM_052838.2	NP_443070.1	REVIEWED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	BC026032	06_08-H02	MGC	W01C068P03	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC026032	06_08-H02	MGC	W01C068P04	pDONR221	11501		PRRG2	5639	AAH26032.1	Hs.35101	Proline rich Gla (G-carboxyglutamic acid) 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_000951.2	NP_000942.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	BC051717	06_08-H03	MGC	W01C068P05	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06_08-H03	MGC	W01C068P06	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06_08-H04	MGC	W01C068P07	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06_08-H04	MGC	W01C068P08	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062680	06_08-H05	MGC	W01C068P09	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H05	MGC	W01C068P10	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06_08-H06	MGC	W01C068P11	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06_08-H06	MGC	W01C068P12	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	SK002A06	06_08-H07	IMS	W01C068P13	pDONR221															
IKAKEN	SK002A06	06_08-H07	IMS	W01C068P14	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C068P15	pDONR221															
IKAKEN	F-BLADE2000432	06_08-H08	EST(F-)	W01C068P16	pDONR221															
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C068P17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2007785	06_08-H09	EST(F-)	W01C068P18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.259	0.259	27	348	181	261	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C068P19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	F-SYNOV2020216	06_08-H10	EST(F-)	W01C068P20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.323	0.370	31	405	172	264	311	2	28
IKAKEN	SK006C11	06_08-H11		W01C068P21	pDONR221															
IKAKEN	SK006C11	06_08-H11		W01C068P22	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C068P23	pDONR221															
IKAKEN	SK006C11	06_08-H12		W01C068P24	pDONR221															
IKAKEN	H013041G03	06_09-A01	Riken	W01C069A01	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	H013041G03	06_09-A01	Riken	W01C069A02	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C069A03	pDONR221			TRY6	154754																					
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C069A04	pDONR221			TRY6	154754																					
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C069A05	pDONR221				441199											
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C069A06	pDONR221				441199											
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C069A07	pDONR221															
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C069A08	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C069A09	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C069A10	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C069A11	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C069A12	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C069A13	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C069A14	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C069A15	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C069A16	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C069A17	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C069A18	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C069A19	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C069A20	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C069A21	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C069A22	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C069A23	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C069A24	pDONR221															
IKAKEN	H013041G03	06_09-A01	Riken	W01C069B01	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	H013041G03	06_09-A01	Riken	W01C069B02	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C069B03	pDONR221			TRY6	154754																					
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C069B04	pDONR221			TRY6	154754																					
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C069B05	pDONR221				441199											
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C069B06	pDONR221				441199											
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C069B07	pDONR221															
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C069B08	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C069B09	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C069B10	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C069B11	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C069B12	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C069B13	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C069B14	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C069B15	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C069B16	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C069B17	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C069B18	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C069B19	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C069B20	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C069B21	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C069B22	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C069B23	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C069B24	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C069C01	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C069C02	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C069C03	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C069C04	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C069C05	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C069C06	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C069C07	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C069C08	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C069C09	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C069C10	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C069C11	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C069C12	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C069C13	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C069C14	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C069C15	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C069C16	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C069C17	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C069C18	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C069C19	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C069C20	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C069C21	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C069C22	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C069C23	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C069C24	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C069D01	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C069D02	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C069D03	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C069D04	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C069D05	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C069D06	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C069D07	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C069D08	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C069D09	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C069D10	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C069D11	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C069D12	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C069D13	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C069D14	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C069D15	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C069D16	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C069D17	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C069D18	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C069D19	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C069D20	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C069D21	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C069D22	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C069D23	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C069D24	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C069E01	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C069E02	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C069E03	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C069E04	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C069E05	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C069E06	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C069E07	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C069E08	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C069E09	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C069E10	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C069E11	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C069E12	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C069E13	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C069E14	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C069E15	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C069E16	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C069E17	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C069E18	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C069E19	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C069E20	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C069E21	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C069E22	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C069E23	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C069E24	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C069F01	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C069F02	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C069F03	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C069F04	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C069F05	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C069F06	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C069F07	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C069F08	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C069F09	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C069F10	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C069F11	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C069F12	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C069F13	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C069F14	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C069F15	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C069F16	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C069F17	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C069F18	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C069F19	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C069F20	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C069F21	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C069F22	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C069F23	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C069F24	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C069G01	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C069G02	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C069G03	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C069G04	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C069G05	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C069G06	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C069G07	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C069G08	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C069G09	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C069G10	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C069G11	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C069G12	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C069G13	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C069G14	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C069G15	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C069G16	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C069G17	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C069G18	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C069G19	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C069G20	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C069G21	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C069G22	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C069G23	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C069G24	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C069H01	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C069H02	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C069H03	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C069H04	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C069H05	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C069H06	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C069H07	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C069H08	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C069H09	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C069H10	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C069H11	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C069H12	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C069H13	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C069H14	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C069H15	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C069H16	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C069H17	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C069H18	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C069H19	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C069H20	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C069H21	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C069H22	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C069H23	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C069H24	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C069I01	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C069I02	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C069I03	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C069I04	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C069I05	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C069I06	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C069I07	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C069I08	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C069I09	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C069I10	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C069I11	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C069I12	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C069I13	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C069I14	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C069I15	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C069I16	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C069I17	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C069I18	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C069I19	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C069I20	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C069I21	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C069I22	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C069I23	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C069I24	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C069J01	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C069J02	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C069J03	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C069J04	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C069J05	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C069J06	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C069J07	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C069J08	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C069J09	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C069J10	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C069J11	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C069J12	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C069J13	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C069J14	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C069J15	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C069J16	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C069J17	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C069J18	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C069J19	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C069J20	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C069J21	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C069J22	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C069J23	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C069J24	pDONR221															
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C069K01	pDONR221				442031											
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C069K02	pDONR221				442031											
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C069K03	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C069K04	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C069K05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C069K06	pDONR221															
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C069K07	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C069K08	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C069K09	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C069K10	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	AK057394	06_09-F06	FLJ	W01C069K11	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK057394	06_09-F06	FLJ	W01C069K12	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK093100	06_09-F07	FLJ	W01C069K13	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK093100	06_09-F07	FLJ	W01C069K14	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK057500	06_09-F08	FLJ	W01C069K15	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK057500	06_09-F08	FLJ	W01C069K16	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK054745	06_09-F09	FLJ	W01C069K17	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK054745	06_09-F09	FLJ	W01C069K18	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK055465	06_09-F10	FLJ	W01C069K19	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06_09-F10	FLJ	W01C069K20	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06_09-F11	FLJ	W01C069K21	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06_09-F11	FLJ	W01C069K22	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06_09-F12	FLJ	W01C069K23	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06_09-F12	FLJ	W01C069K24	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C069L01	pDONR221				442031											
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C069L02	pDONR221				442031											
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C069L03	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C069L04	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C069L05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C069L06	pDONR221															
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C069L07	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C069L08	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C069L09	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C069L10	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	AK057394	06_09-F06	FLJ	W01C069L11	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK057394	06_09-F06	FLJ	W01C069L12	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK093100	06_09-F07	FLJ	W01C069L13	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK093100	06_09-F07	FLJ	W01C069L14	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK057500	06_09-F08	FLJ	W01C069L15	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK057500	06_09-F08	FLJ	W01C069L16	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK054745	06_09-F09	FLJ	W01C069L17	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK054745	06_09-F09	FLJ	W01C069L18	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK055465	06_09-F10	FLJ	W01C069L19	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06_09-F10	FLJ	W01C069L20	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06_09-F11	FLJ	W01C069L21	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06_09-F11	FLJ	W01C069L22	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06_09-F12	FLJ	W01C069L23	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06_09-F12	FLJ	W01C069L24	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093503	06_09-G01	FLJ	W01C069M01	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK093503	06_09-G01	FLJ	W01C069M02	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK091433	06_09-G02	FLJ	W01C069M03	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091433	06_09-G02	FLJ	W01C069M04	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091491	06_09-G03	FLJ	W01C069M05	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK091491	06_09-G03	FLJ	W01C069M06	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK094821	06_09-G04	FLJ	W01C069M07	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK094821	06_09-G04	FLJ	W01C069M08	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK097510	06_09-G05	FLJ	W01C069M09	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06_09-G05	FLJ	W01C069M10	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097578	06_09-G06	FLJ	W01C069M11	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK097578	06_09-G06	FLJ	W01C069M12	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK001581	06_09-G07	FLJ	W01C069M13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06_09-G07	FLJ	W01C069M14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001686	06_09-G08	FLJ	W01C069M15	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK001686	06_09-G08	FLJ	W01C069M16	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK023367	06_09-G09	FLJ	W01C069M17	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK023367	06_09-G09	FLJ	W01C069M18	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK097903	06_09-G10	FLJ	W01C069M19	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06_09-G10	FLJ	W01C069M20	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06_09-G11	FLJ	W01C069M21	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06_09-G11	FLJ	W01C069M22	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06_09-G12	FLJ	W01C069M23	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06_09-G12	FLJ	W01C069M24	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK093503	06_09-G01	FLJ	W01C069N01	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK093503	06_09-G01	FLJ	W01C069N02	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK091433	06_09-G02	FLJ	W01C069N03	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091433	06_09-G02	FLJ	W01C069N04	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091491	06_09-G03	FLJ	W01C069N05	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK091491	06_09-G03	FLJ	W01C069N06	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK094821	06_09-G04	FLJ	W01C069N07	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK094821	06_09-G04	FLJ	W01C069N08	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK097510	06_09-G05	FLJ	W01C069N09	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06_09-G05	FLJ	W01C069N10	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097578	06_09-G06	FLJ	W01C069N11	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK097578	06_09-G06	FLJ	W01C069N12	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK001581	06_09-G07	FLJ	W01C069N13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06_09-G07	FLJ	W01C069N14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001686	06_09-G08	FLJ	W01C069N15	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK001686	06_09-G08	FLJ	W01C069N16	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK023367	06_09-G09	FLJ	W01C069N17	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK023367	06_09-G09	FLJ	W01C069N18	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK097903	06_09-G10	FLJ	W01C069N19	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06_09-G10	FLJ	W01C069N20	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06_09-G11	FLJ	W01C069N21	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06_09-G11	FLJ	W01C069N22	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06_09-G12	FLJ	W01C069N23	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06_09-G12	FLJ	W01C069N24	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097730	06_09-H01	FLJ	W01C069O01	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06_09-H01	FLJ	W01C069O02	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK122712	06_09-H02	FLJ	W01C069O03	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK122712	06_09-H02	FLJ	W01C069O04	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK075319	06_09-H03	FLJ	W01C069O05	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK075319	06_09-H03	FLJ	W01C069O06	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK098740	06_09-H04	FLJ	W01C069O07	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK098740	06_09-H04	FLJ	W01C069O08	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK026247	06_09-H05	FLJ	W01C069O09	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK026247	06_09-H05	FLJ	W01C069O10	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK025600	06_09-H06	FLJ	W01C069O11	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK025600	06_09-H06	FLJ	W01C069O12	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK123607	06_09-H07	FLJ	W01C069O13	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06_09-H07	FLJ	W01C069O14	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK126104	06_09-H08	FLJ	W01C069O15	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06_09-H08	FLJ	W01C069O16	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06_09-H09	FLJ	W01C069O17	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06_09-H09	FLJ	W01C069O18	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK127686	06_09-H10	FLJ	W01C069O19	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK127686	06_09-H10	FLJ	W01C069O20	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK128169	06_09-H11	FLJ	W01C069O21	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	AK128169	06_09-H11	FLJ	W01C069O22	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	BC029175	06_09-H12	MGC	W01C069O23	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	BC029175	06_09-H12	MGC	W01C069O24	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	AK097730	06_09-H01	FLJ	W01C069P01	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06_09-H01	FLJ	W01C069P02	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK122712	06_09-H02	FLJ	W01C069P03	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK122712	06_09-H02	FLJ	W01C069P04	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK075319	06_09-H03	FLJ	W01C069P05	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK075319	06_09-H03	FLJ	W01C069P06	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK098740	06_09-H04	FLJ	W01C069P07	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK098740	06_09-H04	FLJ	W01C069P08	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK026247	06_09-H05	FLJ	W01C069P09	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK026247	06_09-H05	FLJ	W01C069P10	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK025600	06_09-H06	FLJ	W01C069P11	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK025600	06_09-H06	FLJ	W01C069P12	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK123607	06_09-H07	FLJ	W01C069P13	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06_09-H07	FLJ	W01C069P14	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK126104	06_09-H08	FLJ	W01C069P15	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06_09-H08	FLJ	W01C069P16	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06_09-H09	FLJ	W01C069P17	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06_09-H09	FLJ	W01C069P18	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK127686	06_09-H10	FLJ	W01C069P19	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK127686	06_09-H10	FLJ	W01C069P20	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK128169	06_09-H11	FLJ	W01C069P21	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	AK128169	06_09-H11	FLJ	W01C069P22	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	BC029175	06_09-H12	MGC	W01C069P23	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	BC029175	06_09-H12	MGC	W01C069P24	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	H013041G03	06_09-A01	Riken	W01C070A01	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	H013041G03	06_09-A01	Riken	W01C070A02	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C070A03	pDONR221			TRY6	154754																					
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C070A04	pDONR221			TRY6	154754																					
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C070A05	pDONR221				441199											
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C070A06	pDONR221				441199											
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C070A07	pDONR221															
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C070A08	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C070A09	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C070A10	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C070A11	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C070A12	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C070A13	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C070A14	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C070A15	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C070A16	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C070A17	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C070A18	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C070A19	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C070A20	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C070A21	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C070A22	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C070A23	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C070A24	pDONR221															
IKAKEN	H013041G03	06_09-A01	Riken	W01C070B01	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	H013041G03	06_09-A01	Riken	W01C070B02	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	83	255	7	255	438	2	84
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C070B03	pDONR221			TRY6	154754																					
IKAKEN	F-BLADE2009102	06_09-A02	EST(F-)	W01C070B04	pDONR221			TRY6	154754																					
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C070B05	pDONR221				441199											
IKAKEN	F-TESTI2038091	06_09-A03	EST(F-)	W01C070B06	pDONR221				441199											
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C070B07	pDONR221															
IKAKEN	KMR09306	06_09-A04	EST(RND)	W01C070B08	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C070B09	pDONR221															
IKAKEN	SK005A08	06_09-A05		W01C070B10	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C070B11	pDONR221															
IKAKEN	SK005A09	06_09-A06	IMS	W01C070B12	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C070B13	pDONR221															
IKAKEN	SK005A12	06_09-A07	IMS	W01C070B14	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C070B15	pDONR221															
IKAKEN	SK005B10	06_09-A08		W01C070B16	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C070B17	pDONR221															
IKAKEN	SK005B12	06_09-A09		W01C070B18	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C070B19	pDONR221															
IKAKEN	SK005C07	06_09-A10		W01C070B20	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C070B21	pDONR221															
IKAKEN	SK005C08	06_09-A11		W01C070B22	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C070B23	pDONR221															
IKAKEN	SK005D06	06_09-A12		W01C070B24	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C070C01	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C070C02	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C070C03	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C070C04	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C070C05	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C070C06	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C070C07	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C070C08	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C070C09	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C070C10	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C070C11	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C070C12	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C070C13	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C070C14	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C070C15	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C070C16	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C070C17	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C070C18	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C070C19	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C070C20	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C070C21	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C070C22	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C070C23	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C070C24	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C070D01	pDONR221															
IKAKEN	SK005D07	06_09-B01		W01C070D02	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C070D03	pDONR221															
IKAKEN	SK005D12	06_09-B02		W01C070D04	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C070D05	pDONR221															
IKAKEN	SK005E11	06_09-B03	IMS	W01C070D06	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C070D07	pDONR221															
IKAKEN	SK005E12	06_09-B04	IMS	W01C070D08	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C070D09	pDONR221															
IKAKEN	SK005F08	06_09-B05		W01C070D10	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C070D11	pDONR221															
IKAKEN	SK005F09	06_09-B06	IMS	W01C070D12	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C070D13	pDONR221															
IKAKEN	SK005F10	06_09-B07	IMS	W01C070D14	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C070D15	pDONR221															
IKAKEN	SK005F11	06_09-B08		W01C070D16	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C070D17	pDONR221															
IKAKEN	SK005G09	06_09-B09		W01C070D18	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C070D19	pDONR221															
IKAKEN	SK005G12	06_09-B10	IMS	W01C070D20	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C070D21	pDONR221															
IKAKEN	SK005H09	06_09-B11	IMS	W01C070D22	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C070D23	pDONR221															
IKAKEN	SK005H12	06_09-B12	IMS	W01C070D24	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C070E01	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C070E02	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C070E03	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C070E04	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C070E05	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C070E06	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C070E07	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C070E08	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C070E09	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C070E10	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C070E11	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C070E12	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C070E13	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C070E14	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C070E15	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C070E16	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C070E17	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C070E18	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C070E19	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C070E20	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C070E21	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C070E22	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C070E23	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C070E24	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C070F01	pDONR221															
IKAKEN	SK006A01	06_09-C01		W01C070F02	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C070F03	pDONR221															
IKAKEN	SK006A03	06_09-C02	IMS	W01C070F04	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C070F05	pDONR221															
IKAKEN	SK006A05	06_09-C03		W01C070F06	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C070F07	pDONR221															
IKAKEN	SK006A08	06_09-C04	IMS	W01C070F08	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C070F09	pDONR221															
IKAKEN	SK006A11	06_09-C05	IMS	W01C070F10	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C070F11	pDONR221															
IKAKEN	SK006B04	06_09-C06	IMS	W01C070F12	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C070F13	pDONR221															
IKAKEN	SK006B06	06_09-C07		W01C070F14	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C070F15	pDONR221															
IKAKEN	SK006B08	06_09-C08	IMS	W01C070F16	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C070F17	pDONR221															
IKAKEN	SK006B10	06_09-C09	IMS	W01C070F18	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C070F19	pDONR221															
IKAKEN	SK006C01	06_09-C10	IMS	W01C070F20	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C070F21	pDONR221															
IKAKEN	SK006C04	06_09-C11	IMS	W01C070F22	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C070F23	pDONR221															
IKAKEN	SK006C05	06_09-C12	IMS	W01C070F24	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C070G01	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C070G02	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C070G03	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C070G04	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C070G05	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C070G06	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C070G07	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C070G08	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C070G09	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C070G10	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C070G11	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C070G12	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C070G13	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C070G14	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C070G15	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C070G16	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C070G17	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C070G18	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C070G19	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C070G20	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C070G21	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C070G22	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C070G23	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C070G24	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C070H01	pDONR221															
IKAKEN	SK006C06	06_09-D01	IMS	W01C070H02	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C070H03	pDONR221															
IKAKEN	SK006C07	06_09-D02	IMS	W01C070H04	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C070H05	pDONR221															
IKAKEN	SK006C09	06_09-D03	IMS	W01C070H06	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C070H07	pDONR221															
IKAKEN	SK006C11	06_09-D04		W01C070H08	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C070H09	pDONR221															
IKAKEN	SK006D02	06_09-D05		W01C070H10	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C070H11	pDONR221															
IKAKEN	SK006D03	06_09-D06	IMS	W01C070H12	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C070H13	pDONR221															
IKAKEN	SK006D07	06_09-D07	IMS	W01C070H14	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C070H15	pDONR221															
IKAKEN	SK006D09	06_09-D08	IMS	W01C070H16	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C070H17	pDONR221															
IKAKEN	SK006E02	06_09-D09	IMS	W01C070H18	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C070H19	pDONR221															
IKAKEN	SK006E04	06_09-D10	IMS	W01C070H20	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C070H21	pDONR221															
IKAKEN	SK006E10	06_09-D11	IMS	W01C070H22	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C070H23	pDONR221															
IKAKEN	SK006F01	06_09-D12	IMS	W01C070H24	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C070I01	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C070I02	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C070I03	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C070I04	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C070I05	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C070I06	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C070I07	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C070I08	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C070I09	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C070I10	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C070I11	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C070I12	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C070I13	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C070I14	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C070I15	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C070I16	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C070I17	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C070I18	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C070I19	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C070I20	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C070I21	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C070I22	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C070I23	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C070I24	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C070J01	pDONR221															
IKAKEN	SK006F05	06_09-E01	IMS	W01C070J02	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C070J03	pDONR221															
IKAKEN	SK006F07	06_09-E02		W01C070J04	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C070J05	pDONR221															
IKAKEN	SK006F08	06_09-E03	IMS	W01C070J06	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C070J07	pDONR221															
IKAKEN	SK006F10	06_09-E04	IMS	W01C070J08	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C070J09	pDONR221															
IKAKEN	SK006G01	06_09-E05	IMS	W01C070J10	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C070J11	pDONR221															
IKAKEN	SK006G07	06_09-E06	IMS	W01C070J12	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C070J13	pDONR221															
IKAKEN	SK006G08	06_09-E07	IMS	W01C070J14	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C070J15	pDONR221															
IKAKEN	SK006H02	06_09-E08		W01C070J16	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C070J17	pDONR221															
IKAKEN	SK006H04	06_09-E09	IMS	W01C070J18	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C070J19	pDONR221															
IKAKEN	SK006H05	06_09-E10	IMS	W01C070J20	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C070J21	pDONR221															
IKAKEN	SK006H09	06_09-E11	IMS	W01C070J22	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C070J23	pDONR221															
IKAKEN	SK006H10	06_09-E12		W01C070J24	pDONR221															
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C070K01	pDONR221				442031											
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C070K02	pDONR221				442031											
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C070K03	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C070K04	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C070K05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C070K06	pDONR221															
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C070K07	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C070K08	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C070K09	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C070K10	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	AK057394	06_09-F06	FLJ	W01C070K11	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK057394	06_09-F06	FLJ	W01C070K12	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK093100	06_09-F07	FLJ	W01C070K13	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK093100	06_09-F07	FLJ	W01C070K14	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK057500	06_09-F08	FLJ	W01C070K15	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK057500	06_09-F08	FLJ	W01C070K16	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK054745	06_09-F09	FLJ	W01C070K17	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK054745	06_09-F09	FLJ	W01C070K18	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK055465	06_09-F10	FLJ	W01C070K19	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06_09-F10	FLJ	W01C070K20	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06_09-F11	FLJ	W01C070K21	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06_09-F11	FLJ	W01C070K22	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06_09-F12	FLJ	W01C070K23	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06_09-F12	FLJ	W01C070K24	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C070L01	pDONR221				442031											
IKAKEN	BX336280 (3' CS0DI026YL22)	06_09-F01		W01C070L02	pDONR221				442031											
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C070L03	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX340921 (5' CS0DJ010YF09)	06_09-F02		W01C070L04	pDONR221			CCNL2	81669		Hs.632515	Cyclin L2						NM_001144868.1	NP_001138340.1	VALIDATED	P	1.000	1.000	220	1011	1	660	227	1	220
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C070L05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06_09-F03		W01C070L06	pDONR221															
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C070L07	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX361956 (5' CS0DJ007YI10)	06_09-F04		W01C070L08	pDONR221			KIF7	374654		Hs.513134	Kinesin family member 7						NM_198525.2	NP_940927.2	VALIDATED	P	1.000	1.000	282	846	1	846	1343	104	385
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C070L09	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	BX460831 (5' CS0DF019YD03)	06_09-F05		W01C070L10	pDONR221			LRRC4B	94030		Hs.120873	Leucine rich repeat containing 4B						NM_001080457.1	NP_001073926.1	PROVISIONAL	P	1.000	1.000	421	1263	1	1263	713	216	636
IKAKEN	AK057394	06_09-F06	FLJ	W01C070L11	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK057394	06_09-F06	FLJ	W01C070L12	pDONR221	14123		AHCTF1P	285116	BAB71468.1	Hs.470435	AT hook containing transcription factor 1 pseudogene			testis	TESTI2				
IKAKEN	AK093100	06_09-F07	FLJ	W01C070L13	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK093100	06_09-F07	FLJ	W01C070L14	pDONR221	16396		CEP97	79598	BAC04055.1	Hs.444135	Centrosomal protein 97kDa			testis	TESTI2		NM_024548.2	NP_078824.2	PROVISIONAL	Pg	0.938	1.000	418	1254	1	1254	865	305	696
IKAKEN	AK057500	06_09-F08	FLJ	W01C070L15	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK057500	06_09-F08	FLJ	W01C070L16	pDONR221	3253		C10orf90	118611	BAB71512.1	Hs.587663	Chromosome 10 open reading frame 90			testis	TESTI2		NM_001004298.2	NP_001004298.2	VALIDATED	P	1.000	1.000	662	1992	1	1986	699	1	662
IKAKEN	AK054745	06_09-F09	FLJ	W01C070L17	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK054745	06_09-F09	FLJ	W01C070L18	pDONR221	21294		FAM185A	222234	-	Hs.202543	Family with sequence similarity 185, member A			cerebellum	BRACE2		NM_001145269.1	NP_001138741.1	VALIDATED	Ps	0.988	0.988	84	255	1	252	275	156	239
IKAKEN	AK055465	06_09-F10	FLJ	W01C070L19	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06_09-F10	FLJ	W01C070L20	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06_09-F11	FLJ	W01C070L21	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06_09-F11	FLJ	W01C070L22	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06_09-F12	FLJ	W01C070L23	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06_09-F12	FLJ	W01C070L24	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093503	06_09-G01	FLJ	W01C070M01	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK093503	06_09-G01	FLJ	W01C070M02	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK091433	06_09-G02	FLJ	W01C070M03	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091433	06_09-G02	FLJ	W01C070M04	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091491	06_09-G03	FLJ	W01C070M05	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK091491	06_09-G03	FLJ	W01C070M06	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK094821	06_09-G04	FLJ	W01C070M07	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK094821	06_09-G04	FLJ	W01C070M08	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK097510	06_09-G05	FLJ	W01C070M09	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06_09-G05	FLJ	W01C070M10	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097578	06_09-G06	FLJ	W01C070M11	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK097578	06_09-G06	FLJ	W01C070M12	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK001581	06_09-G07	FLJ	W01C070M13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06_09-G07	FLJ	W01C070M14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001686	06_09-G08	FLJ	W01C070M15	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK001686	06_09-G08	FLJ	W01C070M16	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK023367	06_09-G09	FLJ	W01C070M17	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK023367	06_09-G09	FLJ	W01C070M18	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK097903	06_09-G10	FLJ	W01C070M19	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06_09-G10	FLJ	W01C070M20	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06_09-G11	FLJ	W01C070M21	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06_09-G11	FLJ	W01C070M22	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06_09-G12	FLJ	W01C070M23	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06_09-G12	FLJ	W01C070M24	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK093503	06_09-G01	FLJ	W01C070N01	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK093503	06_09-G01	FLJ	W01C070N02	pDONR221	5236		B4GALNT3	283358	BAC04187.1	Hs.504416	Beta-1,4-N-acetyl-galactosaminyl transferase 3			testis	TESTI2		NM_173593.3	NP_775864.3	VALIDATED	Pgs	0.985	0.991	582	1911	25	1770	998	110	687
IKAKEN	AK091433	06_09-G02	FLJ	W01C070N03	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091433	06_09-G02	FLJ	W01C070N04	pDONR221	22975		FAM135B	51059	-	Hs.126024	Family with sequence similarity 135, member B			brain	FCBBF3		NM_015912.3	NP_056996.2	VALIDATED	Pg	0.998	1.000	862	2588	1	2586	1406	234	1093
IKAKEN	AK091491	06_09-G03	FLJ	W01C070N05	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK091491	06_09-G03	FLJ	W01C070N06	pDONR221	7850		UNC13C	440279	BAC03675.1	Hs.657273	Unc-13 homolog C (C. elegans)			brain	FCBBF3		NM_001080534.1	NP_001074003.1	PROVISIONAL	Pg	0.998	1.000	891	2667	1	2667	2214	1035	1925
IKAKEN	AK094821	06_09-G04	FLJ	W01C070N07	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK094821	06_09-G04	FLJ	W01C070N08	pDONR221	13781		ATAD2B	54454	BAC04429.1	Hs.467862	ATPase family, AAA domain containing 2B			brain	BRAWH2		NM_017552.1	NP_060022.1	VALIDATED	P	1.000	1.000	574	1722	1	1722	1458	1	574
IKAKEN	AK097510	06_09-G05	FLJ	W01C070N09	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06_09-G05	FLJ	W01C070N10	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097578	06_09-G06	FLJ	W01C070N11	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK097578	06_09-G06	FLJ	W01C070N12	pDONR221	4419		IGSF9B	22997	BAC05109.1	Hs.204121	Immunoglobulin superfamily, member 9B			testis	TESTI2		NM_014987.1	NP_055802.1	VALIDATED	Pg	0.993	1.000	604	1812	1	1812	1349	159	758
IKAKEN	AK001581	06_09-G07	FLJ	W01C070N13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06_09-G07	FLJ	W01C070N14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001686	06_09-G08	FLJ	W01C070N15	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK001686	06_09-G08	FLJ	W01C070N16	pDONR221	2751		FAM21A	387680	BAA91836.1	Hs.645272	Family with sequence similarity 21, member A	NT2	teratocarcinoma		NT2RP3		NM_001005751.1	NP_001005751.1	VALIDATED	Pfs	0.998	0.999	913	2793	3	2739	1341	252	1164
IKAKEN	AK023367	06_09-G09	FLJ	W01C070N17	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK023367	06_09-G09	FLJ	W01C070N18	pDONR221	14062		FAM161A	84140	BAB14544.1	Hs.440466	Family with sequence similarity 161, member A			ovary, tumor tissue	OVARC1		NM_032180.2	NP_115556.2	VALIDATED	P	1.000	1.000	436	1308	1	1308	660	110	545
IKAKEN	AK097903	06_09-G10	FLJ	W01C070N19	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06_09-G10	FLJ	W01C070N20	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06_09-G11	FLJ	W01C070N21	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06_09-G11	FLJ	W01C070N22	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06_09-G12	FLJ	W01C070N23	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06_09-G12	FLJ	W01C070N24	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097730	06_09-H01	FLJ	W01C070O01	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06_09-H01	FLJ	W01C070O02	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK122712	06_09-H02	FLJ	W01C070O03	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK122712	06_09-H02	FLJ	W01C070O04	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK075319	06_09-H03	FLJ	W01C070O05	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK075319	06_09-H03	FLJ	W01C070O06	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK098740	06_09-H04	FLJ	W01C070O07	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK098740	06_09-H04	FLJ	W01C070O08	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK026247	06_09-H05	FLJ	W01C070O09	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK026247	06_09-H05	FLJ	W01C070O10	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK025600	06_09-H06	FLJ	W01C070O11	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK025600	06_09-H06	FLJ	W01C070O12	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK123607	06_09-H07	FLJ	W01C070O13	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06_09-H07	FLJ	W01C070O14	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK126104	06_09-H08	FLJ	W01C070O15	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06_09-H08	FLJ	W01C070O16	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06_09-H09	FLJ	W01C070O17	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06_09-H09	FLJ	W01C070O18	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK127686	06_09-H10	FLJ	W01C070O19	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK127686	06_09-H10	FLJ	W01C070O20	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK128169	06_09-H11	FLJ	W01C070O21	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	AK128169	06_09-H11	FLJ	W01C070O22	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	BC029175	06_09-H12	MGC	W01C070O23	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	BC029175	06_09-H12	MGC	W01C070O24	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	AK097730	06_09-H01	FLJ	W01C070P01	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06_09-H01	FLJ	W01C070P02	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK122712	06_09-H02	FLJ	W01C070P03	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK122712	06_09-H02	FLJ	W01C070P04	pDONR221	23954		KIAA0368	23392	BAG53684.1	Hs.368255	KIAA0368			thalamus	BRTHA2		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.997	1.000	709	2127	1	2127	2017	231	937
IKAKEN	AK075319	06_09-H03	FLJ	W01C070P05	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK075319	06_09-H03	FLJ	W01C070P06	pDONR221	7695		FAM63B	54629	BAC11545.1	Hs.591122	Family with sequence similarity 63, member B	Y79	retinoblastoma		Y79AA1		NM_001040450.1	NP_001035540.1	VALIDATED	P	1.000	1.000	605	1815	1	1815	621	1	605
IKAKEN	AK098740	06_09-H04	FLJ	W01C070P07	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK098740	06_09-H04	FLJ	W01C070P08	pDONR221	19370		LOC202051	202051	BAC05400.1	Hs.373612	Hypothetical protein LOC202051			brain	CBR		XM_001721173.1	XP_001721225.1	MODEL	Cfs	0.958	1.000	214	876	1	641	205	1	205
IKAKEN	AK026247	06_09-H05	FLJ	W01C070P09	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK026247	06_09-H05	FLJ	W01C070P10	pDONR221	9555		MPRIP	23164	BAB15410	Hs.462341	Myosin phosphatase Rho interacting protein		primary human renal epithelial cells		HRC		NM_015134.2	NP_055949.2	VALIDATED		0.357	0.357	14	417	303	262	1038	993	1006
IKAKEN	AK025600	06_09-H06	FLJ	W01C070P11	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK025600	06_09-H06	FLJ	W01C070P12	pDONR221	10201		GPATCH8	23131	-	Hs.463129	G patch domain containing 8	HepG2	hepatoma		HEP		NM_001002909.1	NP_001002909.1	VALIDATED	Pgs	0.886	0.998	465	1239	1	1239	1502	215	679
IKAKEN	AK123607	06_09-H07	FLJ	W01C070P13	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06_09-H07	FLJ	W01C070P14	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK126104	06_09-H08	FLJ	W01C070P15	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06_09-H08	FLJ	W01C070P16	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06_09-H09	FLJ	W01C070P17	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06_09-H09	FLJ	W01C070P18	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK127686	06_09-H10	FLJ	W01C070P19	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK127686	06_09-H10	FLJ	W01C070P20	pDONR221	17420		KIAA1109	84162	BAC87084.1	Hs.408142	KIAA1109		neutrophils		NETRP2		NM_015312.2	NP_056127.2	VALIDATED	Pg	0.990	1.000	401	1191	1	1191	5005	1015	1415
IKAKEN	AK128169	06_09-H11	FLJ	W01C070P21	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	AK128169	06_09-H11	FLJ	W01C070P22	pDONR221	11752		CCDC155	147872	BAC87306	Hs.710331	Coiled-coil domain containing 155			testis	TESTI4		NM_144688.3	NP_653289.3	PROVISIONAL		0.500	0.500	12	357	140	175	562	471	482
IKAKEN	BC029175	06_09-H12	MGC	W01C070P23	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	BC029175	06_09-H12	MGC	W01C070P24	pDONR221	21294		FAM185A	222234	AAH29175.1	Hs.202543	Family with sequence similarity 185, member A			Testis	NIH_MGC_97	DH10B	NM_001145268.1	NP_001138740.1	VALIDATED	Ps	0.980	0.980	356	1071	1	1068	392	1	356
IKAKEN	BC061522	06_10-A01	MGC	W01C071A01	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06_10-A01	MGC	W01C071A02	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06_10-A02		W01C071A03	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06_10-A02		W01C071A04	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06_10-A03	MGC	W01C071A05	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A03	MGC	W01C071A06	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06_10-A04	MGC	W01C071A07	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06_10-A04	MGC	W01C071A08	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06_10-A05	MGC	W01C071A09	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06_10-A05	MGC	W01C071A10	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06_10-A06	MGC	W01C071A11	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A06	MGC	W01C071A12	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06_10-A07	MGC	W01C071A13	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06_10-A07	MGC	W01C071A14	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06_10-A08	MGC	W01C071A15	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06_10-A08	MGC	W01C071A16	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C071A17	pDONR221															
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C071A18	pDONR221															
IKAKEN	DMC00978	06_10-A10	EST	W01C071A19	pDONR221				391427											
IKAKEN	DMC00978	06_10-A10	EST	W01C071A20	pDONR221				391427											
IKAKEN	DMC09081	06_10-A11	EST	W01C071A21	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06_10-A11	EST	W01C071A22	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C071A23	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C071A24	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	BC061522	06_10-A01	MGC	W01C071B01	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06_10-A01	MGC	W01C071B02	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06_10-A02		W01C071B03	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06_10-A02		W01C071B04	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06_10-A03	MGC	W01C071B05	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A03	MGC	W01C071B06	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06_10-A04	MGC	W01C071B07	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06_10-A04	MGC	W01C071B08	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06_10-A05	MGC	W01C071B09	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06_10-A05	MGC	W01C071B10	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06_10-A06	MGC	W01C071B11	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A06	MGC	W01C071B12	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06_10-A07	MGC	W01C071B13	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06_10-A07	MGC	W01C071B14	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06_10-A08	MGC	W01C071B15	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06_10-A08	MGC	W01C071B16	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C071B17	pDONR221															
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C071B18	pDONR221															
IKAKEN	DMC00978	06_10-A10	EST	W01C071B19	pDONR221				391427											
IKAKEN	DMC00978	06_10-A10	EST	W01C071B20	pDONR221				391427											
IKAKEN	DMC09081	06_10-A11	EST	W01C071B21	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06_10-A11	EST	W01C071B22	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C071B23	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C071B24	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C071C01	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C071C02	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C071C03	pDONR221				388466											
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C071C04	pDONR221				388466											
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C071C05	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C071C06	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	PCD06645	06_10-B04	EST	W01C071C07	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PCD06645	06_10-B04	EST	W01C071C08	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C071C09	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C071C10	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	RCT10716	06_10-B06	EST	W01C071C11	pDONR221															
IKAKEN	RCT10716	06_10-B06	EST	W01C071C12	pDONR221															
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C071C13	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C071C14	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	SK006H08	06_10-B08	IMS	W01C071C15	pDONR221															
IKAKEN	SK006H08	06_10-B08	IMS	W01C071C16	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C071C17	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C071C18	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C071C19	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C071C20	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C071C21	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C071C22	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C071C23	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C071C24	pDONR221															
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C071D01	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C071D02	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C071D03	pDONR221				388466											
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C071D04	pDONR221				388466											
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C071D05	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C071D06	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	PCD06645	06_10-B04	EST	W01C071D07	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PCD06645	06_10-B04	EST	W01C071D08	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C071D09	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C071D10	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	RCT10716	06_10-B06	EST	W01C071D11	pDONR221															
IKAKEN	RCT10716	06_10-B06	EST	W01C071D12	pDONR221															
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C071D13	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C071D14	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	SK006H08	06_10-B08	IMS	W01C071D15	pDONR221															
IKAKEN	SK006H08	06_10-B08	IMS	W01C071D16	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C071D17	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C071D18	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C071D19	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C071D20	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C071D21	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C071D22	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C071D23	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C071D24	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C071E01	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C071E02	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C071E03	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C071E04	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C071E05	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C071E06	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C071E07	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C071E08	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C071E09	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C071E10	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C071E11	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C071E12	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C071E13	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C071E14	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C071E15	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C071E16	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C071E17	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C071E18	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C071E19	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C071E20	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C071E21	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C071E22	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C071E23	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C071E24	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C071F01	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C071F02	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C071F03	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C071F04	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C071F05	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C071F06	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C071F07	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C071F08	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C071F09	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C071F10	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C071F11	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C071F12	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C071F13	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C071F14	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C071F15	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C071F16	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C071F17	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C071F18	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C071F19	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C071F20	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C071F21	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C071F22	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C071F23	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C071F24	pDONR221															
IKAKEN	SK005G11	06_10-D01	IMS	W01C071G01	pDONR221															
IKAKEN	SK005G11	06_10-D01	IMS	W01C071G02	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C071G03	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C071G04	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C071G05	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C071G06	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C071G07	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C071G08	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C071G09	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C071G10	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C071G11	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C071G12	pDONR221															
IKAKEN	ADB05242	06_10-D07	EST	W01C071G13	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADB05242	06_10-D07	EST	W01C071G14	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADG02834	06_10-D08	EST	W01C071G15	pDONR221			LOC440897	440897											
IKAKEN	ADG02834	06_10-D08	EST	W01C071G16	pDONR221			LOC440897	440897											
IKAKEN	ADG03957	06_10-D09	EST	W01C071G17	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	ADG03957	06_10-D09	EST	W01C071G18	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	CBL07977	06_10-D10	EST	W01C071G19	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBL07977	06_10-D10	EST	W01C071G20	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBR02655	06_10-D11	EST	W01C071G21	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CBR02655	06_10-D11	EST	W01C071G22	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C071G23	pDONR221				389178											
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C071G24	pDONR221				389178											
IKAKEN	SK005G11	06_10-D01	IMS	W01C071H01	pDONR221															
IKAKEN	SK005G11	06_10-D01	IMS	W01C071H02	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C071H03	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C071H04	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C071H05	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C071H06	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C071H07	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C071H08	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C071H09	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C071H10	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C071H11	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C071H12	pDONR221															
IKAKEN	ADB05242	06_10-D07	EST	W01C071H13	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADB05242	06_10-D07	EST	W01C071H14	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADG02834	06_10-D08	EST	W01C071H15	pDONR221			LOC440897	440897											
IKAKEN	ADG02834	06_10-D08	EST	W01C071H16	pDONR221			LOC440897	440897											
IKAKEN	ADG03957	06_10-D09	EST	W01C071H17	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	ADG03957	06_10-D09	EST	W01C071H18	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	CBL07977	06_10-D10	EST	W01C071H19	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBL07977	06_10-D10	EST	W01C071H20	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBR02655	06_10-D11	EST	W01C071H21	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CBR02655	06_10-D11	EST	W01C071H22	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C071H23	pDONR221				389178											
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C071H24	pDONR221				389178											
IKAKEN	COL03020	06_10-E01	EST	W01C071I01	pDONR221															
IKAKEN	COL03020	06_10-E01	EST	W01C071I02	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C071I03	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C071I04	pDONR221															
IKAKEN	COL10044	06_10-E03	EST	W01C071I05	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	COL10044	06_10-E03	EST	W01C071I06	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C071I07	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C071I08	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C071I09	pDONR221															
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C071I10	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C071I11	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C071I12	pDONR221															
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C071I13	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C071I14	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C071I15	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C071I16	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HRC11681	06_10-E09	EST	W01C071I17	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	HRC11681	06_10-E09	EST	W01C071I18	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	IMSRT046	06_10-E10	IMS	W01C071I19	pDONR221															
IKAKEN	IMSRT046	06_10-E10	IMS	W01C071I20	pDONR221															
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C071I21	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C071I22	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAT02253	06_10-E12	EST	W01C071I23	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	KAT02253	06_10-E12	EST	W01C071I24	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	COL03020	06_10-E01	EST	W01C071J01	pDONR221															
IKAKEN	COL03020	06_10-E01	EST	W01C071J02	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C071J03	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C071J04	pDONR221															
IKAKEN	COL10044	06_10-E03	EST	W01C071J05	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	COL10044	06_10-E03	EST	W01C071J06	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C071J07	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C071J08	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C071J09	pDONR221															
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C071J10	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C071J11	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C071J12	pDONR221															
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C071J13	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C071J14	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C071J15	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C071J16	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HRC11681	06_10-E09	EST	W01C071J17	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	HRC11681	06_10-E09	EST	W01C071J18	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	IMSRT046	06_10-E10	IMS	W01C071J19	pDONR221															
IKAKEN	IMSRT046	06_10-E10	IMS	W01C071J20	pDONR221															
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C071J21	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C071J22	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAT02253	06_10-E12	EST	W01C071J23	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	KAT02253	06_10-E12	EST	W01C071J24	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	LFL07236	06_10-F01	EST	W01C071K01	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL07236	06_10-F01	EST	W01C071K02	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL08523	06_10-F02	EST	W01C071K03	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LFL08523	06_10-F02	EST	W01C071K04	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LNG13310	06_10-F03	EST	W01C071K05	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	LNG13310	06_10-F03	EST	W01C071K06	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	MPG08295	06_10-F04	EST	W01C071K07	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	MPG08295	06_10-F04	EST	W01C071K08	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C071K09	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C071K10	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	PRS08411	06_10-F06	EST	W01C071K11	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	PRS08411	06_10-F06	EST	W01C071K12	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	RAM09030	06_10-F07	EST	W01C071K13	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RAM09030	06_10-F07	EST	W01C071K14	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RCT10983	06_10-F08	EST	W01C071K15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06_10-F08	EST	W01C071K16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C071K17	pDONR221															
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C071K18	pDONR221															
IKAKEN	TMS05725	06_10-F10	EST	W01C071K19	pDONR221			IGHA1	3493											
IKAKEN	TMS05725	06_10-F10	EST	W01C071K20	pDONR221			IGHA1	3493											
IKAKEN	TST05652	06_10-F11	EST	W01C071K21	pDONR221															
IKAKEN	TST05652	06_10-F11	EST	W01C071K22	pDONR221															
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C071K23	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C071K24	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	LFL07236	06_10-F01	EST	W01C071L01	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL07236	06_10-F01	EST	W01C071L02	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL08523	06_10-F02	EST	W01C071L03	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LFL08523	06_10-F02	EST	W01C071L04	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LNG13310	06_10-F03	EST	W01C071L05	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	LNG13310	06_10-F03	EST	W01C071L06	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	MPG08295	06_10-F04	EST	W01C071L07	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	MPG08295	06_10-F04	EST	W01C071L08	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C071L09	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C071L10	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	PRS08411	06_10-F06	EST	W01C071L11	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	PRS08411	06_10-F06	EST	W01C071L12	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	RAM09030	06_10-F07	EST	W01C071L13	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RAM09030	06_10-F07	EST	W01C071L14	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RCT10983	06_10-F08	EST	W01C071L15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06_10-F08	EST	W01C071L16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C071L17	pDONR221															
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C071L18	pDONR221															
IKAKEN	TMS05725	06_10-F10	EST	W01C071L19	pDONR221			IGHA1	3493											
IKAKEN	TMS05725	06_10-F10	EST	W01C071L20	pDONR221			IGHA1	3493											
IKAKEN	TST05652	06_10-F11	EST	W01C071L21	pDONR221															
IKAKEN	TST05652	06_10-F11	EST	W01C071L22	pDONR221															
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C071L23	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C071L24	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	CS0DL012YF07	06_10-G01		W01C071M01	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DL012YF07	06_10-G01		W01C071M02	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DJ009YE05	06_10-G02		W01C071M03	pDONR221															
IKAKEN	CS0DJ009YE05	06_10-G02		W01C071M04	pDONR221															
IKAKEN	H013041C16	06_10-G03	Riken	W01C071M05	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H013041C16	06_10-G03	Riken	W01C071M06	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H023072I23	06_10-G04	Riken	W01C071M07	pDONR221															
IKAKEN	H023072I23	06_10-G04	Riken	W01C071M08	pDONR221															
IKAKEN	H023094F23	06_10-G05	Riken	W01C071M09	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	H023094F23	06_10-G05	Riken	W01C071M10	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	SK003H02	06_10-G06	IMS	W01C071M11	pDONR221															
IKAKEN	SK003H02	06_10-G06	IMS	W01C071M12	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C071M13	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C071M14	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C071M15	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C071M16	pDONR221															
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C071M17	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C071M18	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C071M19	pDONR221															
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C071M20	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C071M21	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C071M22	pDONR221															
IKAKEN	DAT03661	06_10-G12	EST	W01C071M23	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_10-G12	EST	W01C071M24	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	CS0DL012YF07	06_10-G01		W01C071N01	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DL012YF07	06_10-G01		W01C071N02	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DJ009YE05	06_10-G02		W01C071N03	pDONR221															
IKAKEN	CS0DJ009YE05	06_10-G02		W01C071N04	pDONR221															
IKAKEN	H013041C16	06_10-G03	Riken	W01C071N05	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H013041C16	06_10-G03	Riken	W01C071N06	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H023072I23	06_10-G04	Riken	W01C071N07	pDONR221															
IKAKEN	H023072I23	06_10-G04	Riken	W01C071N08	pDONR221															
IKAKEN	H023094F23	06_10-G05	Riken	W01C071N09	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	H023094F23	06_10-G05	Riken	W01C071N10	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	SK003H02	06_10-G06	IMS	W01C071N11	pDONR221															
IKAKEN	SK003H02	06_10-G06	IMS	W01C071N12	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C071N13	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C071N14	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C071N15	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C071N16	pDONR221															
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C071N17	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C071N18	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C071N19	pDONR221															
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C071N20	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C071N21	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C071N22	pDONR221															
IKAKEN	DAT03661	06_10-G12	EST	W01C071N23	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_10-G12	EST	W01C071N24	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	SK005C03	06_10-H01	IMS	W01C071O01	pDONR221															
IKAKEN	SK005C03	06_10-H01	IMS	W01C071O02	pDONR221															
IKAKEN	AK095926	06_10-H02		W01C071O03	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK095926	06_10-H02		W01C071O04	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK128212	06_10-H03	FLJ	W01C071O05	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK128212	06_10-H03	FLJ	W01C071O06	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK127072	06_10-H04		W01C071O07	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06_10-H04		W01C071O08	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06_10-H05	MGC	W01C071O09	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06_10-H05	MGC	W01C071O10	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC001865	06_10-H06	MGC	W01C071O11	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06_10-H06	MGC	W01C071O12	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C071O13	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C071O14	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	CS0DL009YO01	06_10-H08		W01C071O15	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	CS0DL009YO01	06_10-H08		W01C071O16	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C071O17	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C071O18	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	HEP08868	06_10-H10	EST	W01C071O19	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	HEP08868	06_10-H10	EST	W01C071O20	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	TMS00322	06_10-H11	EST	W01C071O21	pDONR221				389953											
IKAKEN	TMS00322	06_10-H11	EST	W01C071O22	pDONR221				389953											
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C071O23	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C071O24	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	SK005C03	06_10-H01	IMS	W01C071P01	pDONR221															
IKAKEN	SK005C03	06_10-H01	IMS	W01C071P02	pDONR221															
IKAKEN	AK095926	06_10-H02		W01C071P03	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK095926	06_10-H02		W01C071P04	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK128212	06_10-H03	FLJ	W01C071P05	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK128212	06_10-H03	FLJ	W01C071P06	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK127072	06_10-H04		W01C071P07	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06_10-H04		W01C071P08	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06_10-H05	MGC	W01C071P09	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06_10-H05	MGC	W01C071P10	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC001865	06_10-H06	MGC	W01C071P11	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06_10-H06	MGC	W01C071P12	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C071P13	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C071P14	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	CS0DL009YO01	06_10-H08		W01C071P15	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	CS0DL009YO01	06_10-H08		W01C071P16	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C071P17	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C071P18	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	HEP08868	06_10-H10	EST	W01C071P19	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	HEP08868	06_10-H10	EST	W01C071P20	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	TMS00322	06_10-H11	EST	W01C071P21	pDONR221				389953											
IKAKEN	TMS00322	06_10-H11	EST	W01C071P22	pDONR221				389953											
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C071P23	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C071P24	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	BC061522	06_10-A01	MGC	W01C072A01	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06_10-A01	MGC	W01C072A02	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06_10-A02		W01C072A03	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06_10-A02		W01C072A04	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06_10-A03	MGC	W01C072A05	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A03	MGC	W01C072A06	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06_10-A04	MGC	W01C072A07	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06_10-A04	MGC	W01C072A08	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06_10-A05	MGC	W01C072A09	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06_10-A05	MGC	W01C072A10	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06_10-A06	MGC	W01C072A11	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A06	MGC	W01C072A12	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06_10-A07	MGC	W01C072A13	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06_10-A07	MGC	W01C072A14	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06_10-A08	MGC	W01C072A15	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06_10-A08	MGC	W01C072A16	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C072A17	pDONR221															
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C072A18	pDONR221															
IKAKEN	DMC00978	06_10-A10	EST	W01C072A19	pDONR221				391427											
IKAKEN	DMC00978	06_10-A10	EST	W01C072A20	pDONR221				391427											
IKAKEN	DMC09081	06_10-A11	EST	W01C072A21	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06_10-A11	EST	W01C072A22	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C072A23	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C072A24	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	BC061522	06_10-A01	MGC	W01C072B01	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06_10-A01	MGC	W01C072B02	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06_10-A02		W01C072B03	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06_10-A02		W01C072B04	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06_10-A03	MGC	W01C072B05	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A03	MGC	W01C072B06	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06_10-A04	MGC	W01C072B07	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06_10-A04	MGC	W01C072B08	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06_10-A05	MGC	W01C072B09	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06_10-A05	MGC	W01C072B10	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06_10-A06	MGC	W01C072B11	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06_10-A06	MGC	W01C072B12	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06_10-A07	MGC	W01C072B13	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06_10-A07	MGC	W01C072B14	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06_10-A08	MGC	W01C072B15	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06_10-A08	MGC	W01C072B16	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C072B17	pDONR221															
IKAKEN	CNR05949	06_10-A09	EST(RND)	W01C072B18	pDONR221															
IKAKEN	DMC00978	06_10-A10	EST	W01C072B19	pDONR221				391427											
IKAKEN	DMC00978	06_10-A10	EST	W01C072B20	pDONR221				391427											
IKAKEN	DMC09081	06_10-A11	EST	W01C072B21	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06_10-A11	EST	W01C072B22	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C072B23	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	FBR01202	06_10-A12	EST(RND)	W01C072B24	pDONR221			KIF21B	23046		Hs.169182	Kinesin family member 21B						NM_017596.2	NP_060066.2	PROVISIONAL	Pg	0.997	1.000	582	1746	1	1746	1624	1	580
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C072C01	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C072C02	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C072C03	pDONR221				388466											
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C072C04	pDONR221				388466											
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C072C05	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C072C06	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	PCD06645	06_10-B04	EST	W01C072C07	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PCD06645	06_10-B04	EST	W01C072C08	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C072C09	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C072C10	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	RCT10716	06_10-B06	EST	W01C072C11	pDONR221															
IKAKEN	RCT10716	06_10-B06	EST	W01C072C12	pDONR221															
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C072C13	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C072C14	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	SK006H08	06_10-B08	IMS	W01C072C15	pDONR221															
IKAKEN	SK006H08	06_10-B08	IMS	W01C072C16	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C072C17	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C072C18	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C072C19	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C072C20	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C072C21	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C072C22	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C072C23	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C072C24	pDONR221															
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C072D01	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	FBR05418	06_10-B01	EST(RND)	W01C072D02	pDONR221			FRY	10129		Hs.507669	Furry homolog (Drosophila)						NM_023037.2	NP_075463.2	VALIDATED	P	1.000	1.000	907	2721	1	2721	3013	1	907
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C072D03	pDONR221				388466											
IKAKEN	KGR06582	06_10-B02	EST(RND)	W01C072D04	pDONR221				388466											
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C072D05	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	NRR01988	06_10-B03	EST(RND)	W01C072D06	pDONR221			NBR1	4077		Hs.546264	Neighbor of BRCA1 gene 1						NM_005899.3	NP_005890.2	REVIEWED	Pg	0.917	1.000	839	2307	1	2307	966	80	918
IKAKEN	PCD06645	06_10-B04	EST	W01C072D07	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PCD06645	06_10-B04	EST	W01C072D08	pDONR221			TRDN	10345		Hs.654601	Triadin						NM_006073.2	NP_006064.2	VALIDATED	Pg	0.994	1.000	323	966	1	966	729	67	388
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C072D09	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	PLR06494	06_10-B05	EST(RND)	W01C072D10	pDONR221			AIM1	202		Hs.717199	Absent in melanoma 1						NM_001624.2	NP_001615.1	VALIDATED	Ps	0.995	0.995	392	1248	73	1248	1723	1206	1597
IKAKEN	RCT10716	06_10-B06	EST	W01C072D11	pDONR221															
IKAKEN	RCT10716	06_10-B06	EST	W01C072D12	pDONR221															
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C072D13	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	TIR03644	06_10-B07	EST(RND)	W01C072D14	pDONR221			ZNF609	23060		Hs.719276	Zinc finger protein 609						NM_015042.1	NP_055857.1	PROVISIONAL	P	1.000	1.000	585	1755	1	1755	1411	1	585
IKAKEN	SK006H08	06_10-B08	IMS	W01C072D15	pDONR221															
IKAKEN	SK006H08	06_10-B08	IMS	W01C072D16	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C072D17	pDONR221															
IKAKEN	SK006E09	06_10-B09	IMS	W01C072D18	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C072D19	pDONR221															
IKAKEN	SK001B07	06_10-B10		W01C072D20	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C072D21	pDONR221															
IKAKEN	SK001B11	06_10-B11		W01C072D22	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C072D23	pDONR221															
IKAKEN	SK001C07	06_10-B12		W01C072D24	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C072E01	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C072E02	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C072E03	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C072E04	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C072E05	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C072E06	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C072E07	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C072E08	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C072E09	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C072E10	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C072E11	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C072E12	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C072E13	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C072E14	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C072E15	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C072E16	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C072E17	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C072E18	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C072E19	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C072E20	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C072E21	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C072E22	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C072E23	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C072E24	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C072F01	pDONR221															
IKAKEN	SK001E04	06_10-C01		W01C072F02	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C072F03	pDONR221															
IKAKEN	SK001F06	06_10-C02		W01C072F04	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C072F05	pDONR221															
IKAKEN	SK001G08	06_10-C03		W01C072F06	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C072F07	pDONR221															
IKAKEN	SK002B06	06_10-C04	IMS	W01C072F08	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C072F09	pDONR221															
IKAKEN	SK002D07	06_10-C05		W01C072F10	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C072F11	pDONR221															
IKAKEN	SK002E04	06_10-C06		W01C072F12	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C072F13	pDONR221															
IKAKEN	SK002F03	06_10-C07		W01C072F14	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C072F15	pDONR221															
IKAKEN	SK002G08	06_10-C08		W01C072F16	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C072F17	pDONR221															
IKAKEN	SK002H04	06_10-C09	IMS	W01C072F18	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C072F19	pDONR221															
IKAKEN	SK003F10	06_10-C10	IMS	W01C072F20	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C072F21	pDONR221															
IKAKEN	SK004D05	06_10-C11	IMS	W01C072F22	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C072F23	pDONR221															
IKAKEN	SK005G08	06_10-C12		W01C072F24	pDONR221															
IKAKEN	SK005G11	06_10-D01	IMS	W01C072G01	pDONR221															
IKAKEN	SK005G11	06_10-D01	IMS	W01C072G02	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C072G03	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C072G04	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C072G05	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C072G06	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C072G07	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C072G08	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C072G09	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C072G10	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C072G11	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C072G12	pDONR221															
IKAKEN	ADB05242	06_10-D07	EST	W01C072G13	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADB05242	06_10-D07	EST	W01C072G14	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADG02834	06_10-D08	EST	W01C072G15	pDONR221			LOC440897	440897											
IKAKEN	ADG02834	06_10-D08	EST	W01C072G16	pDONR221			LOC440897	440897											
IKAKEN	ADG03957	06_10-D09	EST	W01C072G17	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	ADG03957	06_10-D09	EST	W01C072G18	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	CBL07977	06_10-D10	EST	W01C072G19	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBL07977	06_10-D10	EST	W01C072G20	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBR02655	06_10-D11	EST	W01C072G21	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CBR02655	06_10-D11	EST	W01C072G22	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C072G23	pDONR221				389178											
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C072G24	pDONR221				389178											
IKAKEN	SK005G11	06_10-D01	IMS	W01C072H01	pDONR221															
IKAKEN	SK005G11	06_10-D01	IMS	W01C072H02	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C072H03	pDONR221															
IKAKEN	SK006A09	06_10-D02	IMS	W01C072H04	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C072H05	pDONR221															
IKAKEN	SK006C03	06_10-D03		W01C072H06	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C072H07	pDONR221															
IKAKEN	SK006D10	06_10-D04	IMS	W01C072H08	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C072H09	pDONR221															
IKAKEN	SK006E08	06_10-D05	IMS	W01C072H10	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C072H11	pDONR221															
IKAKEN	SK006F02	06_10-D06		W01C072H12	pDONR221															
IKAKEN	ADB05242	06_10-D07	EST	W01C072H13	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADB05242	06_10-D07	EST	W01C072H14	pDONR221			PTAR1	375743		Hs.719295	Protein prenyltransferase alpha subunit repeat containing 1						NM_001099666.1	NP_001093136.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	ADG02834	06_10-D08	EST	W01C072H15	pDONR221			LOC440897	440897											
IKAKEN	ADG02834	06_10-D08	EST	W01C072H16	pDONR221			LOC440897	440897											
IKAKEN	ADG03957	06_10-D09	EST	W01C072H17	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	ADG03957	06_10-D09	EST	W01C072H18	pDONR221			TSEN15	116461		Hs.548197	TRNA splicing endonuclease 15 homolog (S. cerevisiae)						NM_052965.2	NP_443197.1	VALIDATED	OK	1.000	1.000	171	516	1	513	171	1	171
IKAKEN	CBL07977	06_10-D10	EST	W01C072H19	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBL07977	06_10-D10	EST	W01C072H20	pDONR221			CCT2	10576		Hs.189772	Chaperonin containing TCP1, subunit 2 (beta)						NM_006431.2	NP_006422.1	REVIEWED	OK	1.000	1.000	535	1608	1	1605	535	1	535
IKAKEN	CBR02655	06_10-D11	EST	W01C072H21	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CBR02655	06_10-D11	EST	W01C072H22	pDONR221			WDR17	116966		Hs.532056	WD repeat domain 17						NM_181265.2	NP_851782.2	REVIEWED		0.971	0.971	102	393	1	306	1298	1	102
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C072H23	pDONR221				389178											
IKAKEN	CCR08353	06_10-D12	EST(RND)	W01C072H24	pDONR221				389178											
IKAKEN	COL03020	06_10-E01	EST	W01C072I01	pDONR221															
IKAKEN	COL03020	06_10-E01	EST	W01C072I02	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C072I03	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C072I04	pDONR221															
IKAKEN	COL10044	06_10-E03	EST	W01C072I05	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	COL10044	06_10-E03	EST	W01C072I06	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C072I07	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C072I08	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C072I09	pDONR221															
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C072I10	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C072I11	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C072I12	pDONR221															
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C072I13	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C072I14	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C072I15	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C072I16	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HRC11681	06_10-E09	EST	W01C072I17	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	HRC11681	06_10-E09	EST	W01C072I18	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	IMSRT046	06_10-E10	IMS	W01C072I19	pDONR221															
IKAKEN	IMSRT046	06_10-E10	IMS	W01C072I20	pDONR221															
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C072I21	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C072I22	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAT02253	06_10-E12	EST	W01C072I23	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	KAT02253	06_10-E12	EST	W01C072I24	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	COL03020	06_10-E01	EST	W01C072J01	pDONR221															
IKAKEN	COL03020	06_10-E01	EST	W01C072J02	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C072J03	pDONR221															
IKAKEN	COL03944	06_10-E02	EST	W01C072J04	pDONR221															
IKAKEN	COL10044	06_10-E03	EST	W01C072J05	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	COL10044	06_10-E03	EST	W01C072J06	pDONR221			SERPINA9	327657		Hs.317970	Serpin peptidase inhibitor, clade A (alpha-1 antiproteinase, antitrypsin), member 9						NM_001042518.1	NP_001035983.1	VALIDATED	OK	1.000	1.000	335	1008	1	1005	335	1	335
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C072J07	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC122G11	06_10-E04	TOYOBO	W01C072J08	pDONR221			FAM162A	26355		Hs.584881	Family with sequence similarity 162, member A						NM_014367.3	NP_055182.3	VALIDATED	Cfs	0.968	0.987	155	561	1	457	154	1	154
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C072J09	pDONR221															
IKAKEN	FCC162A04	06_10-E05	TOYOBO	W01C072J10	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C072J11	pDONR221															
IKAKEN	FCC168E01	06_10-E06	TOYOBO	W01C072J12	pDONR221															
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C072J13	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HKR13221	06_10-E07	EST(RND)	W01C072J14	pDONR221			UBE2CBP	90025		Hs.148609	Ubiquitin-conjugating enzyme E2C binding protein						NM_198920.1	NP_944602.1	PROVISIONAL	OK	1.000	1.000	389	1170	1	1167	389	1	389
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C072J15	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HPR04303	06_10-E08	EST(RND)	W01C072J16	pDONR221			SLC6A17	388662		Hs.128382	Solute carrier family 6, member 17						NM_001010898.2	NP_001010898.1	VALIDATED	Pg	0.999	1.000	696	2085	1	2085	727	1	696
IKAKEN	HRC11681	06_10-E09	EST	W01C072J17	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	HRC11681	06_10-E09	EST	W01C072J18	pDONR221			NIPAL4	348938		Hs.4285	NIPA-like domain containing 4						NM_001099287.1	NP_001092757.1	VALIDATED	P	1.000	1.000	404	1215	1	1212	466	63	466
IKAKEN	IMSRT046	06_10-E10	IMS	W01C072J19	pDONR221															
IKAKEN	IMSRT046	06_10-E10	IMS	W01C072J20	pDONR221															
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C072J21	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAR05662	06_10-E11	EST(RND)	W01C072J22	pDONR221			LYSMD3	116068		Hs.136235	LysM, putative peptidoglycan-binding, domain containing 3						NM_198273.1	NP_938014.1	VALIDATED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	KAT02253	06_10-E12	EST	W01C072J23	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	KAT02253	06_10-E12	EST	W01C072J24	pDONR221			TRPM2	7226		Hs.369759	Transient receptor potential cation channel, subfamily M, member 2						NM_003307.3	NP_003298.1	REVIEWED	P	1.000	1.000	178	555	19	552	1503	1326	1503
IKAKEN	LFL07236	06_10-F01	EST	W01C072K01	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL07236	06_10-F01	EST	W01C072K02	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL08523	06_10-F02	EST	W01C072K03	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LFL08523	06_10-F02	EST	W01C072K04	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LNG13310	06_10-F03	EST	W01C072K05	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	LNG13310	06_10-F03	EST	W01C072K06	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	MPG08295	06_10-F04	EST	W01C072K07	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	MPG08295	06_10-F04	EST	W01C072K08	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C072K09	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C072K10	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	PRS08411	06_10-F06	EST	W01C072K11	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	PRS08411	06_10-F06	EST	W01C072K12	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	RAM09030	06_10-F07	EST	W01C072K13	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RAM09030	06_10-F07	EST	W01C072K14	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RCT10983	06_10-F08	EST	W01C072K15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06_10-F08	EST	W01C072K16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C072K17	pDONR221															
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C072K18	pDONR221															
IKAKEN	TMS05725	06_10-F10	EST	W01C072K19	pDONR221			IGHA1	3493											
IKAKEN	TMS05725	06_10-F10	EST	W01C072K20	pDONR221			IGHA1	3493											
IKAKEN	TST05652	06_10-F11	EST	W01C072K21	pDONR221															
IKAKEN	TST05652	06_10-F11	EST	W01C072K22	pDONR221															
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C072K23	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C072K24	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	LFL07236	06_10-F01	EST	W01C072L01	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL07236	06_10-F01	EST	W01C072L02	pDONR221			CTA-221G9.4	85379		Hs.419171	KIAA1671 protein						NM_001145206.1	NP_001138678.1	VALIDATED	P	1.000	1.000	296	942	52	939	1806	1511	1806
IKAKEN	LFL08523	06_10-F02	EST	W01C072L03	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LFL08523	06_10-F02	EST	W01C072L04	pDONR221			FARP2	9855		Hs.679161	FERM, RhoGEF and pleckstrin domain protein 2						NM_014808.1	NP_055623.1	PROVISIONAL	OK	1.000	1.000	1054	3165	1	3162	1054	1	1054
IKAKEN	LNG13310	06_10-F03	EST	W01C072L05	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	LNG13310	06_10-F03	EST	W01C072L06	pDONR221			INPP5E	56623		Hs.120998	Inositol polyphosphate-5-phosphatase, 72 kDa						NM_019892.3	NP_063945.2	REVIEWED	P	1.000	1.000	130	546	1	390	644	514	643
IKAKEN	MPG08295	06_10-F04	EST	W01C072L07	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	MPG08295	06_10-F04	EST	W01C072L08	pDONR221			KMO	8564		Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)						NM_003679.3	NP_003670.2	VALIDATED	P	1.000	1.000	405	1218	1	1215	486	82	486
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C072L09	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	OFR06149	06_10-F05	EST(RND)	W01C072L10	pDONR221			ERMP1	79956		Hs.591078	Endoplasmic reticulum metallopeptidase 1						NM_024896.2	NP_079172.2	VALIDATED	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	PRS08411	06_10-F06	EST	W01C072L11	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	PRS08411	06_10-F06	EST	W01C072L12	pDONR221			SMS	6611		Hs.715555	Spermine synthase						NM_004595.2	NP_004586.2	REVIEWED	Cs	0.995	0.995	366	1101	1	1098	366	1	366
IKAKEN	RAM09030	06_10-F07	EST	W01C072L13	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RAM09030	06_10-F07	EST	W01C072L14	pDONR221			WASH1	375690		Hs.461200	WAS protein family homolog 1						NM_182905.3	NP_878908.3	VALIDATED	Pfs	0.240	0.261	96	402	326	42	465	244	332
IKAKEN	RCT10983	06_10-F08	EST	W01C072L15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06_10-F08	EST	W01C072L16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C072L17	pDONR221															
IKAKEN	TDR02668	06_10-F09	EST(RND)	W01C072L18	pDONR221															
IKAKEN	TMS05725	06_10-F10	EST	W01C072L19	pDONR221			IGHA1	3493											
IKAKEN	TMS05725	06_10-F10	EST	W01C072L20	pDONR221			IGHA1	3493											
IKAKEN	TST05652	06_10-F11	EST	W01C072L21	pDONR221															
IKAKEN	TST05652	06_10-F11	EST	W01C072L22	pDONR221															
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C072L23	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	BX367676 (5' CS0DJ004YE22)	06_10-F12		W01C072L24	pDONR221			CTAGE5	4253		Hs.540038	CTAGE family, member 5						NM_203354.2	NP_976229.1	VALIDATED	OK	1.000	1.000	792	2379	1	2376	792	1	792
IKAKEN	CS0DL012YF07	06_10-G01		W01C072M01	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DL012YF07	06_10-G01		W01C072M02	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DJ009YE05	06_10-G02		W01C072M03	pDONR221															
IKAKEN	CS0DJ009YE05	06_10-G02		W01C072M04	pDONR221															
IKAKEN	H013041C16	06_10-G03	Riken	W01C072M05	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H013041C16	06_10-G03	Riken	W01C072M06	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H023072I23	06_10-G04	Riken	W01C072M07	pDONR221															
IKAKEN	H023072I23	06_10-G04	Riken	W01C072M08	pDONR221															
IKAKEN	H023094F23	06_10-G05	Riken	W01C072M09	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	H023094F23	06_10-G05	Riken	W01C072M10	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	SK003H02	06_10-G06	IMS	W01C072M11	pDONR221															
IKAKEN	SK003H02	06_10-G06	IMS	W01C072M12	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C072M13	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C072M14	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C072M15	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C072M16	pDONR221															
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C072M17	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C072M18	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C072M19	pDONR221															
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C072M20	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C072M21	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C072M22	pDONR221															
IKAKEN	DAT03661	06_10-G12	EST	W01C072M23	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_10-G12	EST	W01C072M24	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	CS0DL012YF07	06_10-G01		W01C072N01	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DL012YF07	06_10-G01		W01C072N02	pDONR221			NIPA1	123606		Hs.511797	Non imprinted in Prader-Willi/Angelman syndrome 1						NM_144599.4	NP_653200.2	REVIEWED	OK	1.000	1.000	329	990	1	987	329	1	329
IKAKEN	CS0DJ009YE05	06_10-G02		W01C072N03	pDONR221															
IKAKEN	CS0DJ009YE05	06_10-G02		W01C072N04	pDONR221															
IKAKEN	H013041C16	06_10-G03	Riken	W01C072N05	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H013041C16	06_10-G03	Riken	W01C072N06	pDONR221			SNTB2	6645		Hs.461117	Syntrophin, beta 2 (dystrophin-associated protein A1, 59kDa, basic component 2)						NM_006750.3	NP_006741.1	REVIEWED	P	1.000	1.000	265	804	1	795	540	1	265
IKAKEN	H023072I23	06_10-G04	Riken	W01C072N07	pDONR221															
IKAKEN	H023072I23	06_10-G04	Riken	W01C072N08	pDONR221															
IKAKEN	H023094F23	06_10-G05	Riken	W01C072N09	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	H023094F23	06_10-G05	Riken	W01C072N10	pDONR221			MTMR7	9108		Hs.625674	Myotubularin related protein 7						NM_004686.4	NP_004677.3	REVIEWED	Pfs	0.895	1.000	506	1410	3	1362	660	35	540
IKAKEN	SK003H02	06_10-G06	IMS	W01C072N11	pDONR221															
IKAKEN	SK003H02	06_10-G06	IMS	W01C072N12	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C072N13	pDONR221															
IKAKEN	F-BRACE2035853	06_10-G07	EST(F-)	W01C072N14	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C072N15	pDONR221															
IKAKEN	F-FELNG2001623	06_10-G08	EST(F-)	W01C072N16	pDONR221															
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C072N17	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06_10-G09	EST(F-)	W01C072N18	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C072N19	pDONR221															
IKAKEN	F-TESTI4026747	06_10-G10	EST(F-)	W01C072N20	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C072N21	pDONR221															
IKAKEN	STM02553	06_10-G11	EST	W01C072N22	pDONR221															
IKAKEN	DAT03661	06_10-G12	EST	W01C072N23	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	DAT03661	06_10-G12	EST	W01C072N24	pDONR221			MGC21881	389741		Hs.459704	Hypothetical locus MGC21881																		
IKAKEN	SK005C03	06_10-H01	IMS	W01C072O01	pDONR221															
IKAKEN	SK005C03	06_10-H01	IMS	W01C072O02	pDONR221															
IKAKEN	AK095926	06_10-H02		W01C072O03	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK095926	06_10-H02		W01C072O04	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK128212	06_10-H03	FLJ	W01C072O05	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK128212	06_10-H03	FLJ	W01C072O06	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK127072	06_10-H04		W01C072O07	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06_10-H04		W01C072O08	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06_10-H05	MGC	W01C072O09	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06_10-H05	MGC	W01C072O10	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC001865	06_10-H06	MGC	W01C072O11	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06_10-H06	MGC	W01C072O12	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C072O13	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C072O14	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	CS0DL009YO01	06_10-H08		W01C072O15	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	CS0DL009YO01	06_10-H08		W01C072O16	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C072O17	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C072O18	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	HEP08868	06_10-H10	EST	W01C072O19	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	HEP08868	06_10-H10	EST	W01C072O20	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	TMS00322	06_10-H11	EST	W01C072O21	pDONR221				389953											
IKAKEN	TMS00322	06_10-H11	EST	W01C072O22	pDONR221				389953											
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C072O23	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C072O24	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	SK005C03	06_10-H01	IMS	W01C072P01	pDONR221															
IKAKEN	SK005C03	06_10-H01	IMS	W01C072P02	pDONR221															
IKAKEN	AK095926	06_10-H02		W01C072P03	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK095926	06_10-H02		W01C072P04	pDONR221	11437		DAND5	199699	BAC04651.1	Hs.331981	DAN domain family, member 5						NM_152654.2	NP_689867.1	REVIEWED	OK	1.000	1.000	189	570	1	567	189	1	189
IKAKEN	AK128212	06_10-H03	FLJ	W01C072P05	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK128212	06_10-H03	FLJ	W01C072P06	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	P	1.000	1.000	714	2154	1	2142	798	1	714
IKAKEN	AK127072	06_10-H04		W01C072P07	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06_10-H04		W01C072P08	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06_10-H05	MGC	W01C072P09	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06_10-H05	MGC	W01C072P10	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC001865	06_10-H06	MGC	W01C072P11	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06_10-H06	MGC	W01C072P12	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C072P13	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06_10-H07	EST(RND)	W01C072P14	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	CS0DL009YO01	06_10-H08		W01C072P15	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	CS0DL009YO01	06_10-H08		W01C072P16	pDONR221			ADD1	118		Hs.183706	Adducin 1 (alpha)						NM_176801.1	NP_789771.1	REVIEWED	OK	1.000	1.000	662	1989	1	1986	662	1	662
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C072P17	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	KGR08337	06_10-H09	EST(RND)	W01C072P18	pDONR221			CTTN	2017		Hs.596164	Cortactin						NM_005231.3	NP_005222.2	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	HEP08868	06_10-H10	EST	W01C072P19	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	HEP08868	06_10-H10	EST	W01C072P20	pDONR221			MYH16	84176		Hs.621401	Myosin, heavy chain 16 pseudogene								
IKAKEN	TMS00322	06_10-H11	EST	W01C072P21	pDONR221				389953											
IKAKEN	TMS00322	06_10-H11	EST	W01C072P22	pDONR221				389953											
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C072P23	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	F-HCHON2006098	06_10-H12	EST(F-)	W01C072P24	pDONR221			COL14A1	7373		Hs.409662	Collagen, type XIV, alpha 1						NM_021110.1	NP_066933.1	VALIDATED	P	1.000	1.000	486	1458	1	1458	1796	1	486
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C073A01	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C073A02	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C073A03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C073A04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C073A05	pDONR221															
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C073A06	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C073A07	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C073A08	pDONR221															
IKAKEN	H013051I15	06_11-A05	Riken	W01C073A09	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06_11-A05	Riken	W01C073A10	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013058F20	06_11-A06	Riken	W01C073A11	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013058F20	06_11-A06	Riken	W01C073A12	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013068H10	06_11-A07	Riken	W01C073A13	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H013068H10	06_11-A07	Riken	W01C073A14	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H033056P12	06_11-A08	Riken	W01C073A15	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	H033056P12	06_11-A08	Riken	W01C073A16	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	SK001B06	06_11-A09		W01C073A17	pDONR221															
IKAKEN	SK001B06	06_11-A09		W01C073A18	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C073A19	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C073A20	pDONR221															
IKAKEN	CBR09262	06_11-A11	EST	W01C073A21	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	CBR09262	06_11-A11	EST	W01C073A22	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C073A23	pDONR221															
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C073A24	pDONR221															
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C073B01	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C073B02	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C073B03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C073B04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C073B05	pDONR221															
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C073B06	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C073B07	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C073B08	pDONR221															
IKAKEN	H013051I15	06_11-A05	Riken	W01C073B09	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06_11-A05	Riken	W01C073B10	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013058F20	06_11-A06	Riken	W01C073B11	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013058F20	06_11-A06	Riken	W01C073B12	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013068H10	06_11-A07	Riken	W01C073B13	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H013068H10	06_11-A07	Riken	W01C073B14	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H033056P12	06_11-A08	Riken	W01C073B15	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	H033056P12	06_11-A08	Riken	W01C073B16	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	SK001B06	06_11-A09		W01C073B17	pDONR221															
IKAKEN	SK001B06	06_11-A09		W01C073B18	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C073B19	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C073B20	pDONR221															
IKAKEN	CBR09262	06_11-A11	EST	W01C073B21	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	CBR09262	06_11-A11	EST	W01C073B22	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C073B23	pDONR221															
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C073B24	pDONR221															
IKAKEN	HRT02251	06_11-B01	EST	W01C073C01	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	HRT02251	06_11-B01	EST	W01C073C02	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	DAT08701	06_11-B02	EST	W01C073C03	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	DAT08701	06_11-B02	EST	W01C073C04	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	HRT03157	06_11-B03	EST	W01C073C05	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	HRT03157	06_11-B03	EST	W01C073C06	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	CAS11703	06_11-B04	EST	W01C073C07	pDONR221															
IKAKEN	CAS11703	06_11-B04	EST	W01C073C08	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C073C09	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C073C10	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C073C11	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C073C12	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C073C13	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C073C14	pDONR221															
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C073C15	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C073C16	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C073C17	pDONR221															
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C073C18	pDONR221															
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C073C19	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C073C20	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06_11-B11	EST	W01C073C21	pDONR221				442065											
IKAKEN	HEP02866	06_11-B11	EST	W01C073C22	pDONR221				442065											
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C073C23	pDONR221															
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C073C24	pDONR221															
IKAKEN	HRT02251	06_11-B01	EST	W01C073D01	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	HRT02251	06_11-B01	EST	W01C073D02	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	DAT08701	06_11-B02	EST	W01C073D03	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	DAT08701	06_11-B02	EST	W01C073D04	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	HRT03157	06_11-B03	EST	W01C073D05	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	HRT03157	06_11-B03	EST	W01C073D06	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	CAS11703	06_11-B04	EST	W01C073D07	pDONR221															
IKAKEN	CAS11703	06_11-B04	EST	W01C073D08	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C073D09	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C073D10	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C073D11	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C073D12	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C073D13	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C073D14	pDONR221															
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C073D15	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C073D16	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C073D17	pDONR221															
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C073D18	pDONR221															
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C073D19	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C073D20	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06_11-B11	EST	W01C073D21	pDONR221				442065											
IKAKEN	HEP02866	06_11-B11	EST	W01C073D22	pDONR221				442065											
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C073D23	pDONR221															
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C073D24	pDONR221															
IKAKEN	HEP04408	06_11-C01	EST	W01C073E01	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	HEP04408	06_11-C01	EST	W01C073E02	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C073E03	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C073E04	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C073E05	pDONR221															
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C073E06	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C073E07	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C073E08	pDONR221															
IKAKEN	KAT05810	06_11-C05	EST	W01C073E09	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KAT05810	06_11-C05	EST	W01C073E10	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C073E11	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C073E12	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C073E13	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C073E14	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C073E15	pDONR221															
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C073E16	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C073E17	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C073E18	pDONR221															
IKAKEN	RCT03134	06_11-C10	EST	W01C073E19	pDONR221			hCG_1749005	347376											
IKAKEN	RCT03134	06_11-C10	EST	W01C073E20	pDONR221			hCG_1749005	347376											
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C073E21	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C073E22	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	PCD09256	06_11-C12	EST	W01C073E23	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	PCD09256	06_11-C12	EST	W01C073E24	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	HEP04408	06_11-C01	EST	W01C073F01	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	HEP04408	06_11-C01	EST	W01C073F02	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C073F03	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C073F04	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C073F05	pDONR221															
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C073F06	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C073F07	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C073F08	pDONR221															
IKAKEN	KAT05810	06_11-C05	EST	W01C073F09	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KAT05810	06_11-C05	EST	W01C073F10	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C073F11	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C073F12	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C073F13	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C073F14	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C073F15	pDONR221															
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C073F16	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C073F17	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C073F18	pDONR221															
IKAKEN	RCT03134	06_11-C10	EST	W01C073F19	pDONR221			hCG_1749005	347376											
IKAKEN	RCT03134	06_11-C10	EST	W01C073F20	pDONR221			hCG_1749005	347376											
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C073F21	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C073F22	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	PCD09256	06_11-C12	EST	W01C073F23	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	PCD09256	06_11-C12	EST	W01C073F24	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	RCT07046	06_11-D01	EST	W01C073G01	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D01	EST	W01C073G02	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C073G03	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C073G04	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06_11-D03	EST	W01C073G05	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06_11-D03	EST	W01C073G06	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	STM04673	06_11-D04	EST	W01C073G07	pDONR221															
IKAKEN	STM04673	06_11-D04	EST	W01C073G08	pDONR221															
IKAKEN	MPC08423	06_11-D05	EST	W01C073G09	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	MPC08423	06_11-D05	EST	W01C073G10	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C073G11	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C073G12	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C073G13	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C073G14	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C073G15	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C073G16	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C073G17	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C073G18	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	STM06590	06_11-D10	EST	W01C073G19	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	STM06590	06_11-D10	EST	W01C073G20	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	MPE00363	06_11-D11	EST	W01C073G21	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	MPE00363	06_11-D11	EST	W01C073G22	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C073G23	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C073G24	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	RCT07046	06_11-D01	EST	W01C073H01	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D01	EST	W01C073H02	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C073H03	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C073H04	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06_11-D03	EST	W01C073H05	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06_11-D03	EST	W01C073H06	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	STM04673	06_11-D04	EST	W01C073H07	pDONR221															
IKAKEN	STM04673	06_11-D04	EST	W01C073H08	pDONR221															
IKAKEN	MPC08423	06_11-D05	EST	W01C073H09	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	MPC08423	06_11-D05	EST	W01C073H10	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C073H11	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C073H12	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C073H13	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C073H14	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C073H15	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C073H16	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C073H17	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C073H18	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	STM06590	06_11-D10	EST	W01C073H19	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	STM06590	06_11-D10	EST	W01C073H20	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	MPE00363	06_11-D11	EST	W01C073H21	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	MPE00363	06_11-D11	EST	W01C073H22	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C073H23	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C073H24	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SYN02941	06_11-E01	EST	W01C073I01	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	SYN02941	06_11-E01	EST	W01C073I02	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	LFL05860	06_11-E02	EST	W01C073I03	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	LFL05860	06_11-E02	EST	W01C073I04	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	PRS03239	06_11-E03	EST	W01C073I05	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	PRS03239	06_11-E03	EST	W01C073I06	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C073I07	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C073I08	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	STM01505	06_11-E05	EST	W01C073I09	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	STM01505	06_11-E05	EST	W01C073I10	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	WMC08154	06_11-E06	EST	W01C073I11	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	WMC08154	06_11-E06	EST	W01C073I12	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	TMS03482	06_11-E07	EST	W01C073I13	pDONR221			IGHA1	3493											
IKAKEN	TMS03482	06_11-E07	EST	W01C073I14	pDONR221			IGHA1	3493											
IKAKEN	TST06522	06_11-E08	EST	W01C073I15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06_11-E08	EST	W01C073I16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST07837	06_11-E09	EST	W01C073I17	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	TST07837	06_11-E09	EST	W01C073I18	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	IMAGE3685423	06_11-E10		W01C073I19	pDONR221															
IKAKEN	IMAGE3685423	06_11-E10		W01C073I20	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C073I21	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C073I22	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C073I23	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C073I24	pDONR221															
IKAKEN	SYN02941	06_11-E01	EST	W01C073J01	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	SYN02941	06_11-E01	EST	W01C073J02	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	LFL05860	06_11-E02	EST	W01C073J03	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	LFL05860	06_11-E02	EST	W01C073J04	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	PRS03239	06_11-E03	EST	W01C073J05	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	PRS03239	06_11-E03	EST	W01C073J06	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C073J07	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C073J08	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	STM01505	06_11-E05	EST	W01C073J09	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	STM01505	06_11-E05	EST	W01C073J10	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	WMC08154	06_11-E06	EST	W01C073J11	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	WMC08154	06_11-E06	EST	W01C073J12	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	TMS03482	06_11-E07	EST	W01C073J13	pDONR221			IGHA1	3493											
IKAKEN	TMS03482	06_11-E07	EST	W01C073J14	pDONR221			IGHA1	3493											
IKAKEN	TST06522	06_11-E08	EST	W01C073J15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06_11-E08	EST	W01C073J16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST07837	06_11-E09	EST	W01C073J17	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	TST07837	06_11-E09	EST	W01C073J18	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	IMAGE3685423	06_11-E10		W01C073J19	pDONR221															
IKAKEN	IMAGE3685423	06_11-E10		W01C073J20	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C073J21	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C073J22	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C073J23	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C073J24	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C073K01	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C073K02	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C073K03	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C073K04	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C073K05	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C073K06	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C073K07	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C073K08	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C073K09	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C073K10	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C073K11	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C073K12	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C073K13	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C073K14	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C073K15	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C073K16	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C073K17	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C073K18	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C073K19	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C073K20	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C073K21	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C073K22	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C073K23	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C073K24	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C073L01	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C073L02	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C073L03	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C073L04	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C073L05	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C073L06	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C073L07	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C073L08	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C073L09	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C073L10	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C073L11	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C073L12	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C073L13	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C073L14	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C073L15	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C073L16	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C073L17	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C073L18	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C073L19	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C073L20	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C073L21	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C073L22	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C073L23	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C073L24	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C073M01	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C073M02	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C073M03	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C073M04	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C073M05	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C073M06	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C073M07	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C073M08	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C073M09	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C073M10	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C073M11	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C073M12	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C073M13	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C073M14	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C073M15	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C073M16	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C073M17	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C073M18	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C073M19	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C073M20	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C073M21	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C073M22	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C073M23	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C073M24	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C073N01	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C073N02	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C073N03	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C073N04	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C073N05	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C073N06	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C073N07	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C073N08	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C073N09	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C073N10	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C073N11	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C073N12	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C073N13	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C073N14	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C073N15	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C073N16	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C073N17	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C073N18	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C073N19	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C073N20	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C073N21	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C073N22	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C073N23	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C073N24	pDONR221															
IKAKEN	IMAGE4823446	06_11-H01		W01C073O01	pDONR221															
IKAKEN	IMAGE4823446	06_11-H01		W01C073O02	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C073O03	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C073O04	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C073O05	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C073O06	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C073O07	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C073O08	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C073O09	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C073O10	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C073O11	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C073O12	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C073O13	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C073O14	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C073O15	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C073O16	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C073O17	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C073O18	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C073O19	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C073O20	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C073O21	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C073O22	pDONR221															
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C073O23	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C073O24	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	IMAGE4823446	06_11-H01		W01C073P01	pDONR221															
IKAKEN	IMAGE4823446	06_11-H01		W01C073P02	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C073P03	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C073P04	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C073P05	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C073P06	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C073P07	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C073P08	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C073P09	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C073P10	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C073P11	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C073P12	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C073P13	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C073P14	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C073P15	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C073P16	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C073P17	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C073P18	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C073P19	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C073P20	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C073P21	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C073P22	pDONR221															
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C073P23	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C073P24	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C074A01	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C074A02	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C074A03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C074A04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C074A05	pDONR221															
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C074A06	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C074A07	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C074A08	pDONR221															
IKAKEN	H013051I15	06_11-A05	Riken	W01C074A09	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06_11-A05	Riken	W01C074A10	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013058F20	06_11-A06	Riken	W01C074A11	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013058F20	06_11-A06	Riken	W01C074A12	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013068H10	06_11-A07	Riken	W01C074A13	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H013068H10	06_11-A07	Riken	W01C074A14	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H033056P12	06_11-A08	Riken	W01C074A15	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	H033056P12	06_11-A08	Riken	W01C074A16	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	SK001B06	06_11-A09		W01C074A17	pDONR221															
IKAKEN	SK001B06	06_11-A09		W01C074A18	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C074A19	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C074A20	pDONR221															
IKAKEN	CBR09262	06_11-A11	EST	W01C074A21	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	CBR09262	06_11-A11	EST	W01C074A22	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C074A23	pDONR221															
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C074A24	pDONR221															
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C074B01	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX337701 (5' CS0DI048YG01)	06_11-A01		W01C074B02	pDONR221			SERHL	94009		Hs.656672	Serine hydrolase-like						NM_170694.1	NP_733795.1	VALIDATED	P	1.000	1.000	105	537	2	316	203	99	203
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C074B03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06_11-A02		W01C074B04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C074B05	pDONR221															
IKAKEN	BX368301 (3' CS0DI010YN12)	06_11-A03		W01C074B06	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C074B07	pDONR221															
IKAKEN	H013034N23	06_11-A04	Riken	W01C074B08	pDONR221															
IKAKEN	H013051I15	06_11-A05	Riken	W01C074B09	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06_11-A05	Riken	W01C074B10	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013058F20	06_11-A06	Riken	W01C074B11	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013058F20	06_11-A06	Riken	W01C074B12	pDONR221			ARVCF	421									NM_001670.1	NP_001661.1	REVIEWED	OK	1.000	1.000	962	2889	1	2886	962	1	962
IKAKEN	H013068H10	06_11-A07	Riken	W01C074B13	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H013068H10	06_11-A07	Riken	W01C074B14	pDONR221			ZNF800	168850		Hs.159006	Zinc finger protein 800						NM_176814.3	NP_789784.2	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	H033056P12	06_11-A08	Riken	W01C074B15	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	H033056P12	06_11-A08	Riken	W01C074B16	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	Ps	0.999	0.999	845	2538	1	2535	893	49	893
IKAKEN	SK001B06	06_11-A09		W01C074B17	pDONR221															
IKAKEN	SK001B06	06_11-A09		W01C074B18	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C074B19	pDONR221															
IKAKEN	CAS04287	06_11-A10	EST	W01C074B20	pDONR221															
IKAKEN	CBR09262	06_11-A11	EST	W01C074B21	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	CBR09262	06_11-A11	EST	W01C074B22	pDONR221			ATMIN	23300		Hs.589959	ATM interactor						NM_015251.2	NP_056066.2	VALIDATED	Pfs	0.889	0.931	668	1923	1	1920	823	157	823
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C074B23	pDONR221															
IKAKEN	FCC143G12	06_11-A12	TOYOBO	W01C074B24	pDONR221															
IKAKEN	HRT02251	06_11-B01	EST	W01C074C01	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	HRT02251	06_11-B01	EST	W01C074C02	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	DAT08701	06_11-B02	EST	W01C074C03	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	DAT08701	06_11-B02	EST	W01C074C04	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	HRT03157	06_11-B03	EST	W01C074C05	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	HRT03157	06_11-B03	EST	W01C074C06	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	CAS11703	06_11-B04	EST	W01C074C07	pDONR221															
IKAKEN	CAS11703	06_11-B04	EST	W01C074C08	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C074C09	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C074C10	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C074C11	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C074C12	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C074C13	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C074C14	pDONR221															
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C074C15	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C074C16	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C074C17	pDONR221															
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C074C18	pDONR221															
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C074C19	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C074C20	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06_11-B11	EST	W01C074C21	pDONR221				442065											
IKAKEN	HEP02866	06_11-B11	EST	W01C074C22	pDONR221				442065											
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C074C23	pDONR221															
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C074C24	pDONR221															
IKAKEN	HRT02251	06_11-B01	EST	W01C074D01	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	HRT02251	06_11-B01	EST	W01C074D02	pDONR221			SLC38A6	145389		Hs.200738	Solute carrier family 38, member 6						NM_153811.1	NP_722518.1	PROVISIONAL	Cs	0.998	0.998	456	1371	1	1368	456	1	456
IKAKEN	DAT08701	06_11-B02	EST	W01C074D03	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	DAT08701	06_11-B02	EST	W01C074D04	pDONR221			GLOD4	51031		Hs.279061	Glyoxalase domain containing 4						NM_016080.3	NP_057164.3	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	HRT03157	06_11-B03	EST	W01C074D05	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	HRT03157	06_11-B03	EST	W01C074D06	pDONR221			ART3	419		Hs.24976	ADP-ribosyltransferase 3						NM_001130017.1	NP_001123489.1	VALIDATED	OK	1.000	1.000	367	1104	1	1101	367	1	367
IKAKEN	CAS11703	06_11-B04	EST	W01C074D07	pDONR221															
IKAKEN	CAS11703	06_11-B04	EST	W01C074D08	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C074D09	pDONR221															
IKAKEN	CAS11703	06_11-B05	EST	W01C074D10	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C074D11	pDONR221															
IKAKEN	FCC171B07	06_11-B06	TOYOBO	W01C074D12	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C074D13	pDONR221															
IKAKEN	AMR00281	06_11-B07	EST(RND)	W01C074D14	pDONR221															
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C074D15	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	HPR01677	06_11-B08	EST(RND)	W01C074D16	pDONR221			CMAH	8418		Hs.484918	Cytidine monophosphate-N-acetylneuraminic acid hydroxylase (CMP-N-acetylneuraminate monooxygenase) pseudogene																		
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C074D17	pDONR221															
IKAKEN	FCC138C11	06_11-B09	TOYOBO	W01C074D18	pDONR221															
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C074D19	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06_11-B10	EST(RND)	W01C074D20	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06_11-B11	EST	W01C074D21	pDONR221				442065											
IKAKEN	HEP02866	06_11-B11	EST	W01C074D22	pDONR221				442065											
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C074D23	pDONR221															
IKAKEN	FCC138G11	06_11-B12	TOYOBO	W01C074D24	pDONR221															
IKAKEN	HEP04408	06_11-C01	EST	W01C074E01	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	HEP04408	06_11-C01	EST	W01C074E02	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C074E03	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C074E04	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C074E05	pDONR221															
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C074E06	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C074E07	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C074E08	pDONR221															
IKAKEN	KAT05810	06_11-C05	EST	W01C074E09	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KAT05810	06_11-C05	EST	W01C074E10	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C074E11	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C074E12	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C074E13	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C074E14	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C074E15	pDONR221															
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C074E16	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C074E17	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C074E18	pDONR221															
IKAKEN	RCT03134	06_11-C10	EST	W01C074E19	pDONR221			hCG_1749005	347376											
IKAKEN	RCT03134	06_11-C10	EST	W01C074E20	pDONR221			hCG_1749005	347376											
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C074E21	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C074E22	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	PCD09256	06_11-C12	EST	W01C074E23	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	PCD09256	06_11-C12	EST	W01C074E24	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	HEP04408	06_11-C01	EST	W01C074F01	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	HEP04408	06_11-C01	EST	W01C074F02	pDONR221			STARD9	57519		Hs.719567	StAR-related lipid transfer (START) domain containing 9						XM_001717505.1	XP_001717557.1	MODEL	P	1.000	1.000	803	2409	1	2409	4290	709	1511
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C074F03	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06_11-C02	EST(RND)	W01C074F04	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C074F05	pDONR221															
IKAKEN	FCC139A05	06_11-C03	TOYOBO	W01C074F06	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C074F07	pDONR221															
IKAKEN	FCC160G09	06_11-C04	TOYOBO	W01C074F08	pDONR221															
IKAKEN	KAT05810	06_11-C05	EST	W01C074F09	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KAT05810	06_11-C05	EST	W01C074F10	pDONR221			PPIAP19	390006		Hs.527742	Peptidylprolyl isomerase A (cyclophilin A) pseudogene 19						XM_001130327.1	XP_001130327.1	MODEL		0.732	0.769	168	495	1	492	227	63	226
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C074F11	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06_11-C06	EST(RND)	W01C074F12	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C074F13	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	AMR08012	06_11-C07	EST(RND)	W01C074F14	pDONR221			KIF5C	3800		Hs.660699	Kinesin family member 5C						NM_004522.1	NP_004513.1	PROVISIONAL	P	1.000	1.000	426	1278	1	1278	957	181	606
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C074F15	pDONR221															
IKAKEN	FCC160H09	06_11-C08	TOYOBO	W01C074F16	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C074F17	pDONR221															
IKAKEN	PCD03258	06_11-C09	EST	W01C074F18	pDONR221															
IKAKEN	RCT03134	06_11-C10	EST	W01C074F19	pDONR221			hCG_1749005	347376											
IKAKEN	RCT03134	06_11-C10	EST	W01C074F20	pDONR221			hCG_1749005	347376											
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C074F21	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	T7R08759	06_11-C11	EST(RND)	W01C074F22	pDONR221			PSMC3IP	29893		Hs.383019	PSMC3 interacting protein						NM_013290.5	NP_037422.2	VALIDATED	Pfs	0.915	0.973	199	603	1	599	205	1	187
IKAKEN	PCD09256	06_11-C12	EST	W01C074F23	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	PCD09256	06_11-C12	EST	W01C074F24	pDONR221			DDT	1652		Hs.656723	D-dopachrome tautomerase						NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	RCT07046	06_11-D01	EST	W01C074G01	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D01	EST	W01C074G02	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C074G03	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C074G04	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06_11-D03	EST	W01C074G05	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06_11-D03	EST	W01C074G06	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	STM04673	06_11-D04	EST	W01C074G07	pDONR221															
IKAKEN	STM04673	06_11-D04	EST	W01C074G08	pDONR221															
IKAKEN	MPC08423	06_11-D05	EST	W01C074G09	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	MPC08423	06_11-D05	EST	W01C074G10	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C074G11	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C074G12	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C074G13	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C074G14	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C074G15	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C074G16	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C074G17	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C074G18	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	STM06590	06_11-D10	EST	W01C074G19	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	STM06590	06_11-D10	EST	W01C074G20	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	MPE00363	06_11-D11	EST	W01C074G21	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	MPE00363	06_11-D11	EST	W01C074G22	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C074G23	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C074G24	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	RCT07046	06_11-D01	EST	W01C074H01	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D01	EST	W01C074H02	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C074H03	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06_11-D02	EST	W01C074H04	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06_11-D03	EST	W01C074H05	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06_11-D03	EST	W01C074H06	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	STM04673	06_11-D04	EST	W01C074H07	pDONR221															
IKAKEN	STM04673	06_11-D04	EST	W01C074H08	pDONR221															
IKAKEN	MPC08423	06_11-D05	EST	W01C074H09	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	MPC08423	06_11-D05	EST	W01C074H10	pDONR221			LRRK1	79705		Hs.407918	Leucine-rich repeat kinase 1						NM_024652.3	NP_078928.3	VALIDATED	P	1.000	1.000	209	627	1	627	2015	156	364
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C074H11	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D06	EST(RND)	W01C074H12	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C074H13	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06_11-D07	EST(RND)	W01C074H14	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C074H15	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D08	EST(RND)	W01C074H16	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C074H17	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06_11-D09	EST(RND)	W01C074H18	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	STM06590	06_11-D10	EST	W01C074H19	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	STM06590	06_11-D10	EST	W01C074H20	pDONR221			C6orf58	352999		Hs.226268	Chromosome 6 open reading frame 58						NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	MPE00363	06_11-D11	EST	W01C074H21	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	MPE00363	06_11-D11	EST	W01C074H22	pDONR221			TMEM223	79064		Hs.530463	Transmembrane protein 223						NM_001080501.2	NP_001073970.1	VALIDATED	OK	1.000	1.000	202	609	1	606	202	1	202
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C074H23	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06_11-D12	EST(RND)	W01C074H24	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SYN02941	06_11-E01	EST	W01C074I01	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	SYN02941	06_11-E01	EST	W01C074I02	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	LFL05860	06_11-E02	EST	W01C074I03	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	LFL05860	06_11-E02	EST	W01C074I04	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	PRS03239	06_11-E03	EST	W01C074I05	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	PRS03239	06_11-E03	EST	W01C074I06	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C074I07	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C074I08	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	STM01505	06_11-E05	EST	W01C074I09	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	STM01505	06_11-E05	EST	W01C074I10	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	WMC08154	06_11-E06	EST	W01C074I11	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	WMC08154	06_11-E06	EST	W01C074I12	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	TMS03482	06_11-E07	EST	W01C074I13	pDONR221			IGHA1	3493											
IKAKEN	TMS03482	06_11-E07	EST	W01C074I14	pDONR221			IGHA1	3493											
IKAKEN	TST06522	06_11-E08	EST	W01C074I15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06_11-E08	EST	W01C074I16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST07837	06_11-E09	EST	W01C074I17	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	TST07837	06_11-E09	EST	W01C074I18	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	IMAGE3685423	06_11-E10		W01C074I19	pDONR221															
IKAKEN	IMAGE3685423	06_11-E10		W01C074I20	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C074I21	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C074I22	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C074I23	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C074I24	pDONR221															
IKAKEN	SYN02941	06_11-E01	EST	W01C074J01	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	SYN02941	06_11-E01	EST	W01C074J02	pDONR221			ADAM17	6868		Hs.404914	ADAM metallopeptidase domain 17						NM_003183.4	NP_003174.3	REVIEWED		0.268	0.283	56	186	4	171	824	503	555
IKAKEN	LFL05860	06_11-E02	EST	W01C074J03	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	LFL05860	06_11-E02	EST	W01C074J04	pDONR221			ALDH1L2	160428		Hs.42572	Aldehyde dehydrogenase 1 family, member L2						NM_001034173.3	NP_001029345.2	REVIEWED	Cgs	0.994	0.999	928	2787	1	2784	923	1	923
IKAKEN	PRS03239	06_11-E03	EST	W01C074J05	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	PRS03239	06_11-E03	EST	W01C074J06	pDONR221			LOC284861	284861		Hs.645542	Hypothetical gene supported by BC039313						XM_001715905.1	XP_001715957.1	MODEL	Pfs	0.263	0.263	38	384	35	148	442	150	187
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C074J07	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06_11-E04	EST(RND)	W01C074J08	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	STM01505	06_11-E05	EST	W01C074J09	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	STM01505	06_11-E05	EST	W01C074J10	pDONR221			SMYD5	10322		Hs.631882	SMYD family member 5						NM_006062.2	NP_006053.2	VALIDATED	P	1.000	1.000	414	1245	1	1242	418	5	418
IKAKEN	WMC08154	06_11-E06	EST	W01C074J11	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	WMC08154	06_11-E06	EST	W01C074J12	pDONR221			CHD9	80205		Hs.622347	Chromodomain helicase DNA binding protein 9						NM_025134.4	NP_079410.4	VALIDATED	P	1.000	1.000	638	1914	1	1914	2881	1	638
IKAKEN	TMS03482	06_11-E07	EST	W01C074J13	pDONR221			IGHA1	3493											
IKAKEN	TMS03482	06_11-E07	EST	W01C074J14	pDONR221			IGHA1	3493											
IKAKEN	TST06522	06_11-E08	EST	W01C074J15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06_11-E08	EST	W01C074J16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST07837	06_11-E09	EST	W01C074J17	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	TST07837	06_11-E09	EST	W01C074J18	pDONR221			LEMD1	93273		Hs.655520	LEM domain containing 1						NM_001001552.3	NP_001001552.3	VALIDATED	Cfs	0.697	1.000	155	546	1	466	108	1	108
IKAKEN	IMAGE3685423	06_11-E10		W01C074J19	pDONR221															
IKAKEN	IMAGE3685423	06_11-E10		W01C074J20	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C074J21	pDONR221															
IKAKEN	IMAGE4694440	06_11-E11		W01C074J22	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C074J23	pDONR221															
IKAKEN	IMAGE3609162	06_11-E12		W01C074J24	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C074K01	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C074K02	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C074K03	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C074K04	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C074K05	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C074K06	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C074K07	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C074K08	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C074K09	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C074K10	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C074K11	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C074K12	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C074K13	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C074K14	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C074K15	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C074K16	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C074K17	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C074K18	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C074K19	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C074K20	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C074K21	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C074K22	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C074K23	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C074K24	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C074L01	pDONR221															
IKAKEN	IMAGE3638298	06_11-F01		W01C074L02	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C074L03	pDONR221															
IKAKEN	IMAGE4562394	06_11-F02		W01C074L04	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C074L05	pDONR221															
IKAKEN	IMAGE4827116	06_11-F03		W01C074L06	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C074L07	pDONR221															
IKAKEN	IMAGE4540930	06_11-F04		W01C074L08	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C074L09	pDONR221															
IKAKEN	IMAGE795248	06_11-F05		W01C074L10	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C074L11	pDONR221															
IKAKEN	IMAGE3634966	06_11-F06		W01C074L12	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C074L13	pDONR221															
IKAKEN	IMAGE376640	06_11-F07		W01C074L14	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C074L15	pDONR221															
IKAKEN	IMAGE2842588	06_11-F08		W01C074L16	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C074L17	pDONR221															
IKAKEN	IMAGE4650852	06_11-F09		W01C074L18	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C074L19	pDONR221															
IKAKEN	IMAGE2782637	06_11-F10		W01C074L20	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C074L21	pDONR221															
IKAKEN	IMAGE4385273	06_11-F11		W01C074L22	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C074L23	pDONR221															
IKAKEN	IMAGE4747501	06_11-F12		W01C074L24	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C074M01	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C074M02	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C074M03	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C074M04	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C074M05	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C074M06	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C074M07	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C074M08	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C074M09	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C074M10	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C074M11	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C074M12	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C074M13	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C074M14	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C074M15	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C074M16	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C074M17	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C074M18	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C074M19	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C074M20	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C074M21	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C074M22	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C074M23	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C074M24	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C074N01	pDONR221															
IKAKEN	IMAGE796519	06_11-G01		W01C074N02	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C074N03	pDONR221															
IKAKEN	IMAGE4610846	06_11-G02		W01C074N04	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C074N05	pDONR221															
IKAKEN	IMAGE3949589	06_11-G03		W01C074N06	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C074N07	pDONR221															
IKAKEN	IMAGE1455480	06_11-G04		W01C074N08	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C074N09	pDONR221															
IKAKEN	IMAGE1455480	06_11-G05		W01C074N10	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C074N11	pDONR221															
IKAKEN	IMAGE3954399	06_11-G06		W01C074N12	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C074N13	pDONR221															
IKAKEN	IMAGE4830161	06_11-G07		W01C074N14	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C074N15	pDONR221															
IKAKEN	IMAGE4373107	06_11-G08		W01C074N16	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C074N17	pDONR221															
IKAKEN	IMAGE743161	06_11-G09		W01C074N18	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C074N19	pDONR221															
IKAKEN	IMAGE1590213	06_11-G10		W01C074N20	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C074N21	pDONR221															
IKAKEN	IMAGE3138370	06_11-G11		W01C074N22	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C074N23	pDONR221															
IKAKEN	IMAGE4858894	06_11-G12		W01C074N24	pDONR221															
IKAKEN	IMAGE4823446	06_11-H01		W01C074O01	pDONR221															
IKAKEN	IMAGE4823446	06_11-H01		W01C074O02	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C074O03	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C074O04	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C074O05	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C074O06	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C074O07	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C074O08	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C074O09	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C074O10	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C074O11	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C074O12	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C074O13	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C074O14	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C074O15	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C074O16	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C074O17	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C074O18	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C074O19	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C074O20	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C074O21	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C074O22	pDONR221															
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C074O23	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C074O24	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	IMAGE4823446	06_11-H01		W01C074P01	pDONR221															
IKAKEN	IMAGE4823446	06_11-H01		W01C074P02	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C074P03	pDONR221															
IKAKEN	IMAGE3891444	06_11-H02		W01C074P04	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C074P05	pDONR221															
IKAKEN	IMAGE3891444	06_11-H03		W01C074P06	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C074P07	pDONR221															
IKAKEN	IMAGE755105	06_11-H04		W01C074P08	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C074P09	pDONR221															
IKAKEN	IMAGE1636162	06_11-H05		W01C074P10	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C074P11	pDONR221															
IKAKEN	IMAGE4070759	06_11-H06		W01C074P12	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C074P13	pDONR221															
IKAKEN	IMAGE3533146	06_11-H07		W01C074P14	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C074P15	pDONR221															
IKAKEN	IMAGE4299710	06_11-H08		W01C074P16	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C074P17	pDONR221															
IKAKEN	IMAGE4810207	06_11-H09		W01C074P18	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C074P19	pDONR221															
IKAKEN	IMAGE4824842	06_11-H10		W01C074P20	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C074P21	pDONR221															
IKAKEN	IMAGE4539615	06_11-H11		W01C074P22	pDONR221															
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C074P23	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	F-BRHIP2000853	06_11-H12	EST(F-)	W01C074P24	pDONR221			NDST3	9348		Hs.480596	N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 3						NM_004784.2	NP_004775.1	REVIEWED	OK	1.000	1.000	873	2622	1	2619	873	1	873
IKAKEN	BC026336	06-2_01-A01	MGC	W01C075A01	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	06-2_01-A01	MGC	W01C075A02	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC028714	06-2_01-A02	MGC	W01C075A03	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	06-2_01-A02	MGC	W01C075A04	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC035024	06-2_01-A03	MGC	W01C075A05	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	06-2_01-A03	MGC	W01C075A06	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC036012	06-2_01-A04	MGC	W01C075A07	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	06-2_01-A04	MGC	W01C075A08	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC045540	06-2_01-A05	MGC	W01C075A09	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	06-2_01-A05	MGC	W01C075A10	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC060796	06-2_01-A06	MGC	W01C075A11	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	06-2_01-A06	MGC	W01C075A12	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC063289	06-2_01-A07	MGC	W01C075A13	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	06-2_01-A07	MGC	W01C075A14	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC060797	06-2_01-A08	MGC	W01C075A15	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	06-2_01-A08	MGC	W01C075A16	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC018127	06-2_01-A09	MGC	W01C075A17	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	06-2_01-A09	MGC	W01C075A18	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC042674	06-2_01-A10	MGC	W01C075A19	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	06-2_01-A10	MGC	W01C075A20	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC064348	06-2_01-A11	MGC	W01C075A21	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	06-2_01-A11	MGC	W01C075A22	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC009755	06-2_01-A12	MGC	W01C075A23	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	06-2_01-A12	MGC	W01C075A24	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC026336	06-2_01-A01	MGC	W01C075B01	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	06-2_01-A01	MGC	W01C075B02	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC028714	06-2_01-A02	MGC	W01C075B03	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	06-2_01-A02	MGC	W01C075B04	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC035024	06-2_01-A03	MGC	W01C075B05	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	06-2_01-A03	MGC	W01C075B06	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC036012	06-2_01-A04	MGC	W01C075B07	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	06-2_01-A04	MGC	W01C075B08	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC045540	06-2_01-A05	MGC	W01C075B09	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	06-2_01-A05	MGC	W01C075B10	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC060796	06-2_01-A06	MGC	W01C075B11	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	06-2_01-A06	MGC	W01C075B12	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC063289	06-2_01-A07	MGC	W01C075B13	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	06-2_01-A07	MGC	W01C075B14	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC060797	06-2_01-A08	MGC	W01C075B15	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	06-2_01-A08	MGC	W01C075B16	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC018127	06-2_01-A09	MGC	W01C075B17	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	06-2_01-A09	MGC	W01C075B18	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC042674	06-2_01-A10	MGC	W01C075B19	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	06-2_01-A10	MGC	W01C075B20	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC064348	06-2_01-A11	MGC	W01C075B21	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	06-2_01-A11	MGC	W01C075B22	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC009755	06-2_01-A12	MGC	W01C075B23	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	06-2_01-A12	MGC	W01C075B24	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC037287	06-2_01-B01	MGC	W01C075C01	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	06-2_01-B01	MGC	W01C075C02	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC023594	06-2_01-B02	MGC	W01C075C03	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	06-2_01-B02	MGC	W01C075C04	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC032108	06-2_01-B03	MGC	W01C075C05	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	06-2_01-B03	MGC	W01C075C06	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC018771	06-2_01-B04	MGC	W01C075C07	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	06-2_01-B04	MGC	W01C075C08	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC020235	06-2_01-B05	MGC	W01C075C09	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	06-2_01-B05	MGC	W01C075C10	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C075C11	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C075C12	pDONR221	36210									testis	TESTI2				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C075C13	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C075C14	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C075C15	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C075C16	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C075C17	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C075C18	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C075C19	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C075C20	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C075C21	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C075C22	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C075C23	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C075C24	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	BC037287	06-2_01-B01	MGC	W01C075D01	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	06-2_01-B01	MGC	W01C075D02	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC023594	06-2_01-B02	MGC	W01C075D03	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	06-2_01-B02	MGC	W01C075D04	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC032108	06-2_01-B03	MGC	W01C075D05	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	06-2_01-B03	MGC	W01C075D06	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC018771	06-2_01-B04	MGC	W01C075D07	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	06-2_01-B04	MGC	W01C075D08	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC020235	06-2_01-B05	MGC	W01C075D09	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	06-2_01-B05	MGC	W01C075D10	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C075D11	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C075D12	pDONR221	36210									testis	TESTI2				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C075D13	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C075D14	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C075D15	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C075D16	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C075D17	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C075D18	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C075D19	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C075D20	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C075D21	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C075D22	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C075D23	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C075D24	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C075E01	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C075E02	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C075E03	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C075E04	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C075E05	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C075E06	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C075E07	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C075E08	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C075E09	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C075E10	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BC015369	06-2_01-C06	MGC	W01C075E11	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	06-2_01-C06	MGC	W01C075E12	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013770	06-2_01-C07	MGC	W01C075E13	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	06-2_01-C07	MGC	W01C075E14	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC021901	06-2_01-C08	MGC	W01C075E15	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	06-2_01-C08	MGC	W01C075E16	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC024327	06-2_01-C09	MGC	W01C075E17	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	06-2_01-C09	MGC	W01C075E18	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC034530	06-2_01-C10	MGC	W01C075E19	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	06-2_01-C10	MGC	W01C075E20	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	06-2_01-C11	MGC	W01C075E21	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	06-2_01-C11	MGC	W01C075E22	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC053991	06-2_01-C12	MGC	W01C075E23	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	06-2_01-C12	MGC	W01C075E24	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C075F01	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C075F02	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C075F03	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C075F04	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C075F05	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C075F06	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C075F07	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C075F08	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C075F09	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C075F10	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BC015369	06-2_01-C06	MGC	W01C075F11	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	06-2_01-C06	MGC	W01C075F12	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013770	06-2_01-C07	MGC	W01C075F13	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	06-2_01-C07	MGC	W01C075F14	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC021901	06-2_01-C08	MGC	W01C075F15	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	06-2_01-C08	MGC	W01C075F16	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC024327	06-2_01-C09	MGC	W01C075F17	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	06-2_01-C09	MGC	W01C075F18	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC034530	06-2_01-C10	MGC	W01C075F19	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	06-2_01-C10	MGC	W01C075F20	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	06-2_01-C11	MGC	W01C075F21	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	06-2_01-C11	MGC	W01C075F22	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC053991	06-2_01-C12	MGC	W01C075F23	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	06-2_01-C12	MGC	W01C075F24	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC031399	06-2_01-D01	MGC	W01C075G01	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	06-2_01-D01	MGC	W01C075G02	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC042680	06-2_01-D02	MGC	W01C075G03	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	06-2_01-D02	MGC	W01C075G04	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031624	06-2_01-D03	MGC	W01C075G05	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	06-2_01-D03	MGC	W01C075G06	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC044816	06-2_01-D04	MGC	W01C075G07	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	06-2_01-D04	MGC	W01C075G08	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC034582	06-2_01-D05	MGC	W01C075G09	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	06-2_01-D05	MGC	W01C075G10	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC028198	06-2_01-D06	MGC	W01C075G11	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	06-2_01-D06	MGC	W01C075G12	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC061631	06-2_01-D07	MGC	W01C075G13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	06-2_01-D07	MGC	W01C075G14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	06-2_01-D08	MGC	W01C075G15	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	06-2_01-D08	MGC	W01C075G16	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC051360	06-2_01-D09	MGC	W01C075G17	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	06-2_01-D09	MGC	W01C075G18	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC036749	06-2_01-D10	MGC	W01C075G19	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	06-2_01-D10	MGC	W01C075G20	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC062320	06-2_01-D11	MGC	W01C075G21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	06-2_01-D11	MGC	W01C075G22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC035732	06-2_01-D12	MGC	W01C075G23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	06-2_01-D12	MGC	W01C075G24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC031399	06-2_01-D01	MGC	W01C075H01	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	06-2_01-D01	MGC	W01C075H02	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC042680	06-2_01-D02	MGC	W01C075H03	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	06-2_01-D02	MGC	W01C075H04	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031624	06-2_01-D03	MGC	W01C075H05	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	06-2_01-D03	MGC	W01C075H06	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC044816	06-2_01-D04	MGC	W01C075H07	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	06-2_01-D04	MGC	W01C075H08	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC034582	06-2_01-D05	MGC	W01C075H09	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	06-2_01-D05	MGC	W01C075H10	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC028198	06-2_01-D06	MGC	W01C075H11	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	06-2_01-D06	MGC	W01C075H12	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC061631	06-2_01-D07	MGC	W01C075H13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	06-2_01-D07	MGC	W01C075H14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	06-2_01-D08	MGC	W01C075H15	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	06-2_01-D08	MGC	W01C075H16	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC051360	06-2_01-D09	MGC	W01C075H17	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	06-2_01-D09	MGC	W01C075H18	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC036749	06-2_01-D10	MGC	W01C075H19	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	06-2_01-D10	MGC	W01C075H20	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC062320	06-2_01-D11	MGC	W01C075H21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	06-2_01-D11	MGC	W01C075H22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC035732	06-2_01-D12	MGC	W01C075H23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	06-2_01-D12	MGC	W01C075H24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC042923	06-2_01-E01	MGC	W01C075I01	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	06-2_01-E01	MGC	W01C075I02	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC039856	06-2_01-E02	MGC	W01C075I03	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	06-2_01-E02	MGC	W01C075I04	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC044226	06-2_01-E03	MGC	W01C075I05	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	06-2_01-E03	MGC	W01C075I06	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC043345	06-2_01-E04	MGC	W01C075I07	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	06-2_01-E04	MGC	W01C075I08	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC047935	06-2_01-E05	MGC	W01C075I09	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	06-2_01-E05	MGC	W01C075I10	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC053521	06-2_01-E06	MGC	W01C075I11	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	06-2_01-E06	MGC	W01C075I12	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC050462	06-2_01-E07	MGC	W01C075I13	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	06-2_01-E07	MGC	W01C075I14	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC063242	06-2_01-E08	MGC	W01C075I15	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	06-2_01-E08	MGC	W01C075I16	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC054002	06-2_01-E09	MGC	W01C075I17	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	06-2_01-E09	MGC	W01C075I18	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC055285	06-2_01-E10	MGC	W01C075I19	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_01-E10	MGC	W01C075I20	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	06-2_01-E11	MGC	W01C075I21	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	06-2_01-E11	MGC	W01C075I22	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC054036	06-2_01-E12	MGC	W01C075I23	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	06-2_01-E12	MGC	W01C075I24	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC042923	06-2_01-E01	MGC	W01C075J01	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	06-2_01-E01	MGC	W01C075J02	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC039856	06-2_01-E02	MGC	W01C075J03	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	06-2_01-E02	MGC	W01C075J04	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC044226	06-2_01-E03	MGC	W01C075J05	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	06-2_01-E03	MGC	W01C075J06	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC043345	06-2_01-E04	MGC	W01C075J07	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	06-2_01-E04	MGC	W01C075J08	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC047935	06-2_01-E05	MGC	W01C075J09	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	06-2_01-E05	MGC	W01C075J10	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC053521	06-2_01-E06	MGC	W01C075J11	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	06-2_01-E06	MGC	W01C075J12	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC050462	06-2_01-E07	MGC	W01C075J13	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	06-2_01-E07	MGC	W01C075J14	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC063242	06-2_01-E08	MGC	W01C075J15	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	06-2_01-E08	MGC	W01C075J16	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC054002	06-2_01-E09	MGC	W01C075J17	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	06-2_01-E09	MGC	W01C075J18	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC055285	06-2_01-E10	MGC	W01C075J19	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_01-E10	MGC	W01C075J20	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	06-2_01-E11	MGC	W01C075J21	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	06-2_01-E11	MGC	W01C075J22	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC054036	06-2_01-E12	MGC	W01C075J23	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	06-2_01-E12	MGC	W01C075J24	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC063646	06-2_01-F01	MGC	W01C075K01	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	06-2_01-F01	MGC	W01C075K02	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC065510	06-2_01-F02	MGC	W01C075K03	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	06-2_01-F02	MGC	W01C075K04	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC066643	06-2_01-F03	MGC	W01C075K05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	06-2_01-F03	MGC	W01C075K06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC065269	06-2_01-F04	MGC	W01C075K07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	06-2_01-F04	MGC	W01C075K08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065016	06-2_01-F05	MGC	W01C075K09	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	06-2_01-F05	MGC	W01C075K10	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	06-2_01-F06	MGC	W01C075K11	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	06-2_01-F06	MGC	W01C075K12	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC013401	06-2_01-F07	MGC	W01C075K13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	06-2_01-F07	MGC	W01C075K14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC004397	06-2_01-F08	MGC	W01C075K15	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	06-2_01-F08	MGC	W01C075K16	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC011617	06-2_01-F09	MGC	W01C075K17	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	06-2_01-F09	MGC	W01C075K18	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002894	06-2_01-F10	MGC	W01C075K19	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	06-2_01-F10	MGC	W01C075K20	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC030054	06-2_01-F11	MGC	W01C075K21	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	06-2_01-F11	MGC	W01C075K22	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC045110	06-2_01-F12	MGC	W01C075K23	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	06-2_01-F12	MGC	W01C075K24	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC063646	06-2_01-F01	MGC	W01C075L01	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	06-2_01-F01	MGC	W01C075L02	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC065510	06-2_01-F02	MGC	W01C075L03	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	06-2_01-F02	MGC	W01C075L04	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC066643	06-2_01-F03	MGC	W01C075L05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	06-2_01-F03	MGC	W01C075L06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC065269	06-2_01-F04	MGC	W01C075L07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	06-2_01-F04	MGC	W01C075L08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065016	06-2_01-F05	MGC	W01C075L09	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	06-2_01-F05	MGC	W01C075L10	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	06-2_01-F06	MGC	W01C075L11	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	06-2_01-F06	MGC	W01C075L12	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC013401	06-2_01-F07	MGC	W01C075L13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	06-2_01-F07	MGC	W01C075L14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC004397	06-2_01-F08	MGC	W01C075L15	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	06-2_01-F08	MGC	W01C075L16	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC011617	06-2_01-F09	MGC	W01C075L17	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	06-2_01-F09	MGC	W01C075L18	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002894	06-2_01-F10	MGC	W01C075L19	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	06-2_01-F10	MGC	W01C075L20	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC030054	06-2_01-F11	MGC	W01C075L21	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	06-2_01-F11	MGC	W01C075L22	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC045110	06-2_01-F12	MGC	W01C075L23	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	06-2_01-F12	MGC	W01C075L24	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC009373	06-2_01-G01	MGC	W01C075M01	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	06-2_01-G01	MGC	W01C075M02	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC011722	06-2_01-G02	MGC	W01C075M03	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	06-2_01-G02	MGC	W01C075M04	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC034051	06-2_01-G03	MGC	W01C075M05	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	06-2_01-G03	MGC	W01C075M06	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC016753	06-2_01-G04	MGC	W01C075M07	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	06-2_01-G04	MGC	W01C075M08	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC000616	06-2_01-G05	MGC	W01C075M09	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	06-2_01-G05	MGC	W01C075M10	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC014980	06-2_01-G06	MGC	W01C075M11	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	06-2_01-G06	MGC	W01C075M12	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	06-2_01-G07	MGC	W01C075M13	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	06-2_01-G07	MGC	W01C075M14	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	06-2_01-G08	MGC	W01C075M15	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	06-2_01-G08	MGC	W01C075M16	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC021134	06-2_01-G09	MGC	W01C075M17	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	06-2_01-G09	MGC	W01C075M18	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC033082	06-2_01-G10	MGC	W01C075M19	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	06-2_01-G10	MGC	W01C075M20	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC009373	06-2_01-G01	MGC	W01C075N01	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	06-2_01-G01	MGC	W01C075N02	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC011722	06-2_01-G02	MGC	W01C075N03	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	06-2_01-G02	MGC	W01C075N04	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC034051	06-2_01-G03	MGC	W01C075N05	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	06-2_01-G03	MGC	W01C075N06	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC016753	06-2_01-G04	MGC	W01C075N07	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	06-2_01-G04	MGC	W01C075N08	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC000616	06-2_01-G05	MGC	W01C075N09	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	06-2_01-G05	MGC	W01C075N10	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC014980	06-2_01-G06	MGC	W01C075N11	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	06-2_01-G06	MGC	W01C075N12	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	06-2_01-G07	MGC	W01C075N13	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	06-2_01-G07	MGC	W01C075N14	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	06-2_01-G08	MGC	W01C075N15	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	06-2_01-G08	MGC	W01C075N16	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC021134	06-2_01-G09	MGC	W01C075N17	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	06-2_01-G09	MGC	W01C075N18	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC033082	06-2_01-G10	MGC	W01C075N19	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	06-2_01-G10	MGC	W01C075N20	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC026336	06-2_01-A01	MGC	W01C076A01	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	06-2_01-A01	MGC	W01C076A02	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC028714	06-2_01-A02	MGC	W01C076A03	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	06-2_01-A02	MGC	W01C076A04	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC035024	06-2_01-A03	MGC	W01C076A05	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	06-2_01-A03	MGC	W01C076A06	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC036012	06-2_01-A04	MGC	W01C076A07	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	06-2_01-A04	MGC	W01C076A08	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC045540	06-2_01-A05	MGC	W01C076A09	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	06-2_01-A05	MGC	W01C076A10	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC060796	06-2_01-A06	MGC	W01C076A11	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	06-2_01-A06	MGC	W01C076A12	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC063289	06-2_01-A07	MGC	W01C076A13	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	06-2_01-A07	MGC	W01C076A14	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC060797	06-2_01-A08	MGC	W01C076A15	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	06-2_01-A08	MGC	W01C076A16	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC018127	06-2_01-A09	MGC	W01C076A17	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	06-2_01-A09	MGC	W01C076A18	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC042674	06-2_01-A10	MGC	W01C076A19	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	06-2_01-A10	MGC	W01C076A20	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC064348	06-2_01-A11	MGC	W01C076A21	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	06-2_01-A11	MGC	W01C076A22	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC009755	06-2_01-A12	MGC	W01C076A23	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	06-2_01-A12	MGC	W01C076A24	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC026336	06-2_01-A01	MGC	W01C076B01	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC026336	06-2_01-A01	MGC	W01C076B02	pDONR221	2645		NEURL	9148	AAH26336.1	Hs.716382	Neuralized homolog (Drosophila)			Lung	NIH_MGC_77	DH10B	NM_004210.4	NP_004201.3	VALIDATED	OK	1.000	1.000	574	1725	1	1722	574	1	574
IKAKEN	BC028714	06-2_01-A02	MGC	W01C076B03	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC028714	06-2_01-A02	MGC	W01C076B04	pDONR221	7325		ANGEL1	23357	AAH28714.1	Hs.497448	Angel homolog 1 (Drosophila)			Testis	NIH_MGC_97	DH10B	NM_015305.3	NP_056120.2	VALIDATED	OK	1.000	1.000	670	2013	1	2010	670	1	670
IKAKEN	BC035024	06-2_01-A03	MGC	W01C076B05	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC035024	06-2_01-A03	MGC	W01C076B06	pDONR221	8733		C16orf71	146562	AAH35024.1	Hs.602738	Chromosome 16 open reading frame 71			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_139170.2	NP_631909.2	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	BC036012	06-2_01-A04	MGC	W01C076B07	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC036012	06-2_01-A04	MGC	W01C076B08	pDONR221	10218		TRIM37	4591	AAH36012.1	Hs.579079	Tripartite motif-containing 37			Placenta	NIH_MGC_79	DH10B	NM_015294.3	NP_056109.1	REVIEWED	OK	1.000	1.000	964	2895	1	2892	964	1	964
IKAKEN	BC045540	06-2_01-A05	MGC	W01C076B09	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC045540	06-2_01-A05	MGC	W01C076B10	pDONR221	9676		KIAA0195	9772	AAH45540.1	Hs.514474	KIAA0195			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_014738.4	NP_055553.3	VALIDATED	OK	1.000	1.000	1356	4071	1	4068	1356	1	1356
IKAKEN	BC060796	06-2_01-A06	MGC	W01C076B11	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC060796	06-2_01-A06	MGC	W01C076B12	pDONR221	5498		CCDC62	84660	AAH60796.1	Hs.592008	Coiled-coil domain containing 62			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_201435.3	NP_958843.2	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC063289	06-2_01-A07	MGC	W01C076B13	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC063289	06-2_01-A07	MGC	W01C076B14	pDONR221	19751		C4A	720	AAH63289.1	Hs.534847	Complement component 4A (Rodgers blood group)			Placenta, normal	NIH_MGC_147	DH10B	NM_007293.2	NP_009224.2	REVIEWED	Cs	0.994	0.994	1744	5235	1	5232	1744	1	1744
IKAKEN	BC060797	06-2_01-A08	MGC	W01C076B15	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC060797	06-2_01-A08	MGC	W01C076B16	pDONR221	11169		PARD6G	84552	AAH60797.1	Hs.654920	Par-6 partitioning defective 6 homolog gamma (C. elegans)			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_032510.3	NP_115899.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	BC018127	06-2_01-A09	MGC	W01C076B17	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC018127	06-2_01-A09	MGC	W01C076B18	pDONR221	18548		PAM	5066	AAH18127.1	Hs.369430	Peptidylglycine alpha-amidating monooxygenase			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_138821.1	NP_620176.1	REVIEWED	OK	1.000	1.000	866	2601	1	2598	866	1	866
IKAKEN	BC042674	06-2_01-A10	MGC	W01C076B19	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC042674	06-2_01-A10	MGC	W01C076B20	pDONR221	13531		PLB1	151056	AAH42674.1	Hs.444933	Phospholipase B1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_153021.3	NP_694566.3	VALIDATED	P	1.000	1.000	423	1272	1	1269	1458	1036	1458
IKAKEN	BC064348	06-2_01-A11	MGC	W01C076B21	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC064348	06-2_01-A11	MGC	W01C076B22	pDONR221	6670		C13orf23	80209	AAH64348.1	Hs.318526	Chromosome 13 open reading frame 23			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_025138.3	NP_079414.3	VALIDATED	P	1.000	1.000	810	2433	1	2430	944	135	944
IKAKEN	BC009755	06-2_01-A12	MGC	W01C076B23	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC009755	06-2_01-A12	MGC	W01C076B24	pDONR221	6738		ADPRHL1	113622	AAH09755.1	Hs.98669	ADP-ribosylhydrolase like 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_199162.1	NP_954631.1	VALIDATED	OK	1.000	1.000	272	819	1	816	272	1	272
IKAKEN	BC037287	06-2_01-B01	MGC	W01C076C01	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	06-2_01-B01	MGC	W01C076C02	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC023594	06-2_01-B02	MGC	W01C076C03	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	06-2_01-B02	MGC	W01C076C04	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC032108	06-2_01-B03	MGC	W01C076C05	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	06-2_01-B03	MGC	W01C076C06	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC018771	06-2_01-B04	MGC	W01C076C07	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	06-2_01-B04	MGC	W01C076C08	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC020235	06-2_01-B05	MGC	W01C076C09	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	06-2_01-B05	MGC	W01C076C10	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C076C11	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C076C12	pDONR221	36210									testis	TESTI2				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C076C13	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C076C14	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C076C15	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C076C16	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C076C17	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C076C18	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C076C19	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C076C20	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C076C21	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C076C22	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C076C23	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C076C24	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	BC037287	06-2_01-B01	MGC	W01C076D01	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC037287	06-2_01-B01	MGC	W01C076D02	pDONR221	19405		TMEM161B	153396	AAH37287.1	Hs.379972	Transmembrane protein 161B			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_153354.3	NP_699185.1	PROVISIONAL	OK	1.000	1.000	487	1464	1	1461	487	1	487
IKAKEN	BC023594	06-2_01-B02	MGC	W01C076D03	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC023594	06-2_01-B02	MGC	W01C076D04	pDONR221	23473		RPL7A	6130	AAH23594.1	Hs.499839	Ribosomal protein L7a			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000972.2	NP_000963.1	REVIEWED	Cfs	0.801	0.816	266	786	1	783	266	1	266
IKAKEN	BC032108	06-2_01-B03	MGC	W01C076D05	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC032108	06-2_01-B03	MGC	W01C076D06	pDONR221	20583		VPS52	6293	AAH32108.1	Hs.480356	Vacuolar protein sorting 52 homolog (S. cerevisiae)			Skin, squamous cell carcinoma	NCI_CGAP_Skn4	DH10B	NM_022553.4	NP_072047.4	REVIEWED	OK	1.000	1.000	723	2172	1	2169	723	1	723
IKAKEN	BC018771	06-2_01-B04	MGC	W01C076D07	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC018771	06-2_01-B04	MGC	W01C076D08	pDONR221	4630		GDPD5	81544	AAH18771.1	Hs.671860	Glycerophosphodiester phosphodiesterase domain containing 5			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_030792.6	NP_110419.5	VALIDATED	OK	1.000	1.000	605	1818	1	1815	605	1	605
IKAKEN	BC020235	06-2_01-B05	MGC	W01C076D09	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	BC020235	06-2_01-B05	MGC	W01C076D10	pDONR221	24112		HSPA5	3309	AAH20235.1	Hs.716396	Heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa)			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_005347.3	NP_005338.1	VALIDATED		0.902	0.915	655	1944	1	1941	654	1	654
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C076D11	pDONR221	36210									testis	TESTI2				
IKAKEN	AK097660	06-2_01-B06	FLJ	W01C076D12	pDONR221	36210									testis	TESTI2				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C076D13	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK131029	06-2_01-B07	FLJ	W01C076D14	pDONR221	41072		FAM27A	548321	-	Hs.710801	Family with sequence similarity 27, member A			testis	TST				
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C076D15	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK129567	06-2_01-B08	FLJ	W01C076D16	pDONR221	15944		FLJ26056	375127	BAC85185.1	Hs.652126	Hypothetical protein LOC375127			prostate	PRS		XM_001126757.1	XP_001126757.1	MODEL
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C076D17	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK092351	06-2_01-B09	FLJ	W01C076D18	pDONR221	551		NBPF14	25832	-	Hs.607640	Neuroblastoma breakpoint family, member 14	NT2	teratocarcinoma		NT2RP7		NM_015383.1	NP_056198.1	PREDICTED	Pfs	0.985	0.990	206	846	208	821	921	1	206
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C076D19	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK074570	06-2_01-B10	FLJ	W01C076D20	pDONR221	14135		ANKRD36B	57730	BAC11066.1	Hs.532921	Ankyrin repeat domain 36B			whole embryo, mainly head	HEMBA1		NM_025190.2	NP_079466.2	VALIDATED		0.909	0.909	22	735	665	730	1121	1	22
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C076D21	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK025547	06-2_01-B11	FLJ	W01C076D22	pDONR221	12902		MRPL30	51263	-	Hs.590896	Mitochondrial ribosomal protein L30			colon mucosa	ColF		NM_145212.2	NP_660213.1	REVIEWED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C076D23	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK129825	06-2_01-B12	FLJ	W01C076D24	pDONR221	8392		RPS3A	6189	-	Hs.356572	Ribosomal protein S3A			dermoid tumor	DMC		NM_001006.3	NP_000997.1	REVIEWED		0.823	0.828	158	474	1	471	264	1	158
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C076E01	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C076E02	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C076E03	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C076E04	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C076E05	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C076E06	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C076E07	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C076E08	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C076E09	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C076E10	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BC015369	06-2_01-C06	MGC	W01C076E11	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	06-2_01-C06	MGC	W01C076E12	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013770	06-2_01-C07	MGC	W01C076E13	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	06-2_01-C07	MGC	W01C076E14	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC021901	06-2_01-C08	MGC	W01C076E15	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	06-2_01-C08	MGC	W01C076E16	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC024327	06-2_01-C09	MGC	W01C076E17	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	06-2_01-C09	MGC	W01C076E18	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC034530	06-2_01-C10	MGC	W01C076E19	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	06-2_01-C10	MGC	W01C076E20	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	06-2_01-C11	MGC	W01C076E21	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	06-2_01-C11	MGC	W01C076E22	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC053991	06-2_01-C12	MGC	W01C076E23	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	06-2_01-C12	MGC	W01C076E24	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C076F01	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK093262	06-2_01-C01	FLJ	W01C076F02	pDONR221	39630		LOC100127950	100127950	BAC04113.1	Hs.666610	Hypothetical LOC100127950			testis	TESTI2		XM_001725212.1	XP_001725264.1	MODEL	OK	1.000	1.000	122	369	1	366	122	1	122
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C076F03	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK091315	06-2_01-C02	FLJ	W01C076F04	pDONR221	5465		FLJ33996	283401	BAC03635.1	Hs.436550	Hypothetical protein FLJ33996			tongue, tumor tissue	CTONG2														
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C076F05	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	AK074614	06-2_01-C03	FLJ	W01C076F06	pDONR221	4109		IGF2	3481	BAC11090	Hs.718427	Insulin-like growth factor 2 (somatomedin A)			whole embryo, mainly head	HEMBA1		NM_001127598.1	NP_001121070.1	REVIEWED	Pfs	0.214	0.214	56	393	56	223	236	17	72
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C076F07	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX396151 (5' CS0DI012YL19)	06-2_01-C04		W01C076F08	pDONR221			IGFBPL1	347252		Hs.349705	Insulin-like growth factor binding protein-like 1						NM_001007563.1	NP_001007564.1	PROVISIONAL	OK	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C076F09	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BX357637 (5' CS0DI028YD18)	06-2_01-C05		W01C076F10	pDONR221			ARHGEF5	7984		Hs.334	Rho guanine nucleotide exchange factor (GEF) 5						NM_005435.3	NP_005426.2	REVIEWED	P	1.000	1.000	1433	4392	1	4299	1597	1	1433
IKAKEN	BC015369	06-2_01-C06	MGC	W01C076F11	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC015369	06-2_01-C06	MGC	W01C076F12	pDONR221	5426		ORAI1	84876	AAH15369.2	Hs.55148	ORAI calcium release-activated calcium modulator 1			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032790.3	NP_116179.2	REVIEWED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC013770	06-2_01-C07	MGC	W01C076F13	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC013770	06-2_01-C07	MGC	W01C076F14	pDONR221	23476		NTNG2	84628	AAH13770.1	Hs.163642	Netrin G2			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_032536.2	NP_115925.2	VALIDATED	Cgs	0.983	0.998	530	1569	1	1566	530	1	530
IKAKEN	BC021901	06-2_01-C08	MGC	W01C076F15	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC021901	06-2_01-C08	MGC	W01C076F16	pDONR221	5301		RAB21	23011	AAH21901.1	Hs.524590	RAB21, member RAS oncogene family			Testis	NIH_MGC_97	DH10B	NM_014999.2	NP_055814.1	PROVISIONAL	OK	1.000	1.000	225	678	1	675	225	1	225
IKAKEN	BC024327	06-2_01-C09	MGC	W01C076F17	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC024327	06-2_01-C09	MGC	W01C076F18	pDONR221	12700		CDC42EP5	148170	AAH24327.1	Hs.415791	CDC42 effector protein (Rho GTPase binding) 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_145057.2	NP_659494.2	REVIEWED	OK	1.000	1.000	148	447	1	444	148	1	148
IKAKEN	BC034530	06-2_01-C10	MGC	W01C076F19	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC034530	06-2_01-C10	MGC	W01C076F20	pDONR221	25417		FGD1	2245	AAH34530.1	Hs.709201	FYVE, RhoGEF and PH domain containing 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_004463.2	NP_004454.2	REVIEWED	OK	1.000	1.000	961	2886	1	2883	961	1	961
IKAKEN	BC031890	06-2_01-C11	MGC	W01C076F21	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC031890	06-2_01-C11	MGC	W01C076F22	pDONR221	19940		FTSJD2	23070	AAH31890.1	Hs.520102	FtsJ methyltransferase domain containing 2			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015050.2	NP_055865.1	VALIDATED	OK	1.000	1.000	835	2508	1	2505	835	1	835
IKAKEN	BC053991	06-2_01-C12	MGC	W01C076F23	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	06-2_01-C12	MGC	W01C076F24	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC031399	06-2_01-D01	MGC	W01C076G01	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	06-2_01-D01	MGC	W01C076G02	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC042680	06-2_01-D02	MGC	W01C076G03	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	06-2_01-D02	MGC	W01C076G04	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031624	06-2_01-D03	MGC	W01C076G05	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	06-2_01-D03	MGC	W01C076G06	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC044816	06-2_01-D04	MGC	W01C076G07	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	06-2_01-D04	MGC	W01C076G08	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC034582	06-2_01-D05	MGC	W01C076G09	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	06-2_01-D05	MGC	W01C076G10	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC028198	06-2_01-D06	MGC	W01C076G11	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	06-2_01-D06	MGC	W01C076G12	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC061631	06-2_01-D07	MGC	W01C076G13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	06-2_01-D07	MGC	W01C076G14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	06-2_01-D08	MGC	W01C076G15	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	06-2_01-D08	MGC	W01C076G16	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC051360	06-2_01-D09	MGC	W01C076G17	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	06-2_01-D09	MGC	W01C076G18	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC036749	06-2_01-D10	MGC	W01C076G19	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	06-2_01-D10	MGC	W01C076G20	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC062320	06-2_01-D11	MGC	W01C076G21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	06-2_01-D11	MGC	W01C076G22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC035732	06-2_01-D12	MGC	W01C076G23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	06-2_01-D12	MGC	W01C076G24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC031399	06-2_01-D01	MGC	W01C076H01	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC031399	06-2_01-D01	MGC	W01C076H02	pDONR221	5212		B3GNT4	79369	AAH31399.1	Hs.363315	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 4			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_030765.2	NP_110392.1	REVIEWED	C	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	BC042680	06-2_01-D02	MGC	W01C076H03	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC042680	06-2_01-D02	MGC	W01C076H04	pDONR221	9801		FN3K	64122	AAH42680.1	Hs.151135	Fructosamine 3 kinase			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_022158.3	NP_071441.1	VALIDATED	C	1.000	1.000	309	930	1	927	309	1	309
IKAKEN	BC031624	06-2_01-D03	MGC	W01C076H05	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	06-2_01-D03	MGC	W01C076H06	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC044816	06-2_01-D04	MGC	W01C076H07	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC044816	06-2_01-D04	MGC	W01C076H08	pDONR221	10018		C17orf74	201243	-	Hs.380704	Chromosome 17 open reading frame 74			Brain, hippocampus	NIH_MGC_95	DH10B	NM_175734.4	NP_783861.3	VALIDATED	P	1.000	1.000	259	780	1	777	501	243	501
IKAKEN	BC034582	06-2_01-D05	MGC	W01C076H09	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	06-2_01-D05	MGC	W01C076H10	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC028198	06-2_01-D06	MGC	W01C076H11	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	06-2_01-D06	MGC	W01C076H12	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC061631	06-2_01-D07	MGC	W01C076H13	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC061631	06-2_01-D07	MGC	W01C076H14	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Cg	0.998	1.000	1689	5070	1	5067	1686	1	1686
IKAKEN	BC038225	06-2_01-D08	MGC	W01C076H15	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC038225	06-2_01-D08	MGC	W01C076H16	pDONR221	23442		SMC5	23137	AAH38225.1	Hs.534189	Structural maintenance of chromosomes 5			Testis	NIH_MGC_97	DH10B	NM_015110.3	NP_055925.2	VALIDATED	OK	1.000	1.000	1101	3306	1	3303	1101	1	1101
IKAKEN	BC051360	06-2_01-D09	MGC	W01C076H17	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC051360	06-2_01-D09	MGC	W01C076H18	pDONR221	8536		RAB11FIP3	9727	AAH51360.1	Hs.531642	RAB11 family interacting protein 3 (class II)			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_014700.3	NP_055515.1	VALIDATED	OK	1.000	1.000	756	2271	1	2268	756	1	756
IKAKEN	BC036749	06-2_01-D10	MGC	W01C076H19	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC036749	06-2_01-D10	MGC	W01C076H20	pDONR221	9557		ARHGEF15	22899	AAH36749.1	Hs.443109	Rho guanine nucleotide exchange factor (GEF) 15			Brain, hippocampus	NIH_MGC_95	DH10B	NM_173728.2	NP_776089.2	REVIEWED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	BC062320	06-2_01-D11	MGC	W01C076H21	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC062320	06-2_01-D11	MGC	W01C076H22	pDONR221	8347		HAPLN3	145864	AAH62320.1	Hs.447530	Hyaluronan and proteoglycan link protein 3			Eye, normal, pigmented retinal epithelium	NIH_MGC_43	DH10B-R	NM_178232.2	NP_839946.1	REVIEWED	OK	1.000	1.000	360	1083	1	1080	360	1	360
IKAKEN	BC035732	06-2_01-D12	MGC	W01C076H23	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC035732	06-2_01-D12	MGC	W01C076H24	pDONR221	3431		C10orf67	256815	AAH35732.1	Hs.522360	Chromosome 10 open reading frame 67			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_153714.2	NP_714925.2	VALIDATED	P	1.000	1.000	182	621	1	546	185	2	183
IKAKEN	BC042923	06-2_01-E01	MGC	W01C076I01	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	06-2_01-E01	MGC	W01C076I02	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC039856	06-2_01-E02	MGC	W01C076I03	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	06-2_01-E02	MGC	W01C076I04	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC044226	06-2_01-E03	MGC	W01C076I05	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	06-2_01-E03	MGC	W01C076I06	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC043345	06-2_01-E04	MGC	W01C076I07	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	06-2_01-E04	MGC	W01C076I08	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC047935	06-2_01-E05	MGC	W01C076I09	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	06-2_01-E05	MGC	W01C076I10	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC053521	06-2_01-E06	MGC	W01C076I11	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	06-2_01-E06	MGC	W01C076I12	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC050462	06-2_01-E07	MGC	W01C076I13	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	06-2_01-E07	MGC	W01C076I14	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC063242	06-2_01-E08	MGC	W01C076I15	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	06-2_01-E08	MGC	W01C076I16	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC054002	06-2_01-E09	MGC	W01C076I17	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	06-2_01-E09	MGC	W01C076I18	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC055285	06-2_01-E10	MGC	W01C076I19	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_01-E10	MGC	W01C076I20	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	06-2_01-E11	MGC	W01C076I21	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	06-2_01-E11	MGC	W01C076I22	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC054036	06-2_01-E12	MGC	W01C076I23	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	06-2_01-E12	MGC	W01C076I24	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC042923	06-2_01-E01	MGC	W01C076J01	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC042923	06-2_01-E01	MGC	W01C076J02	pDONR221	23971		TLN1	7094	AAH42923.1	Hs.471014	Talin 1			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_006289.3	NP_006280.3	REVIEWED	OK	1.000	1.000	2541	7626	1	7623	2541	1	2541
IKAKEN	BC039856	06-2_01-E02	MGC	W01C076J03	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC039856	06-2_01-E02	MGC	W01C076J04	pDONR221	25202		ARHGEF6	9459	AAH39856.1	Hs.522795	Rac/Cdc42 guanine nucleotide exchange factor (GEF) 6			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_004840.2	NP_004831.1	REVIEWED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	BC044226	06-2_01-E03	MGC	W01C076J05	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC044226	06-2_01-E03	MGC	W01C076J06	pDONR221	2218		MYBPH	4608	AAH44226.1	Hs.927	Myosin binding protein H			Brain, adult medulla	NIH_MGC_119	DH10B	NM_004997.2	NP_004988.2	VALIDATED	OK	1.000	1.000	477	1434	1	1431	477	1	477
IKAKEN	BC043345	06-2_01-E04	MGC	W01C076J07	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC043345	06-2_01-E04	MGC	W01C076J08	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.910	0.917	412	1236	1	1233	1282	1	410
IKAKEN	BC047935	06-2_01-E05	MGC	W01C076J09	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC047935	06-2_01-E05	MGC	W01C076J10	pDONR221	23444		KIAA0649	9858	AAH47935.1	Hs.533260	KIAA0649			Testis	NIH_MGC_97	DH10B	NM_014811.3	NP_055626.3	VALIDATED	C	1.000	1.000	1209	3630	1	3627	1209	1	1209
IKAKEN	BC053521	06-2_01-E06	MGC	W01C076J11	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC053521	06-2_01-E06	MGC	W01C076J12	pDONR221	23494		SPTAN1	6709	AAH53521.1	Hs.372331	Spectrin, alpha, non-erythrocytic 1 (alpha-fodrin)			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_003127.2	NP_003118.2	VALIDATED	C	1.000	1.000	2472	7419	1	7416	2472	1	2472
IKAKEN	BC050462	06-2_01-E07	MGC	W01C076J13	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	06-2_01-E07	MGC	W01C076J14	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC063242	06-2_01-E08	MGC	W01C076J15	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC063242	06-2_01-E08	MGC	W01C076J16	pDONR221	10306		FASN	2194	AAH63242.1	Hs.83190	Fatty acid synthase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004104.4	NP_004095.4	REVIEWED	OK	1.000	1.000	2511	7536	1	7533	2511	1	2511
IKAKEN	BC054002	06-2_01-E09	MGC	W01C076J17	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC054002	06-2_01-E09	MGC	W01C076J18	pDONR221	14757		C20orf177	63939	AAH54002.1	Hs.504920	Chromosome 20 open reading frame 177			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_022106.1	NP_071389.1	PREDICTED	OK	1.000	1.000	383	1152	1	1149	383	1	383
IKAKEN	BC055285	06-2_01-E10	MGC	W01C076J19	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_01-E10	MGC	W01C076J20	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC053584	06-2_01-E11	MGC	W01C076J21	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	06-2_01-E11	MGC	W01C076J22	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC054036	06-2_01-E12	MGC	W01C076J23	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	06-2_01-E12	MGC	W01C076J24	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC063646	06-2_01-F01	MGC	W01C076K01	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	06-2_01-F01	MGC	W01C076K02	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC065510	06-2_01-F02	MGC	W01C076K03	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	06-2_01-F02	MGC	W01C076K04	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC066643	06-2_01-F03	MGC	W01C076K05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	06-2_01-F03	MGC	W01C076K06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC065269	06-2_01-F04	MGC	W01C076K07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	06-2_01-F04	MGC	W01C076K08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065016	06-2_01-F05	MGC	W01C076K09	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	06-2_01-F05	MGC	W01C076K10	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	06-2_01-F06	MGC	W01C076K11	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	06-2_01-F06	MGC	W01C076K12	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC013401	06-2_01-F07	MGC	W01C076K13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	06-2_01-F07	MGC	W01C076K14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC004397	06-2_01-F08	MGC	W01C076K15	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	06-2_01-F08	MGC	W01C076K16	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC011617	06-2_01-F09	MGC	W01C076K17	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	06-2_01-F09	MGC	W01C076K18	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002894	06-2_01-F10	MGC	W01C076K19	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	06-2_01-F10	MGC	W01C076K20	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC030054	06-2_01-F11	MGC	W01C076K21	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	06-2_01-F11	MGC	W01C076K22	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC045110	06-2_01-F12	MGC	W01C076K23	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	06-2_01-F12	MGC	W01C076K24	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC063646	06-2_01-F01	MGC	W01C076L01	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC063646	06-2_01-F01	MGC	W01C076L02	pDONR221	20707		COL9A1	1297	AAH63646.1	Hs.590892	Collagen, type IX, alpha 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_078485.3	NP_511040.2	REVIEWED	OK	1.000	1.000	678	2037	1	2034	678	1	678
IKAKEN	BC065510	06-2_01-F02	MGC	W01C076L03	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC065510	06-2_01-F02	MGC	W01C076L04	pDONR221	13485		CAD	790	AAH65510.1	Hs.377010	Carbamoyl-phosphate synthetase 2, aspartate transcarbamylase, and dihydroorotase			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_004341.3	NP_004332.2	REVIEWED	C	1.000	1.000	2225	6678	1	6675	2225	1	2225
IKAKEN	BC066643	06-2_01-F03	MGC	W01C076L05	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC066643	06-2_01-F03	MGC	W01C076L06	pDONR221	10234		CASKIN2	57513	AAH66643.1	Hs.274408	CASK interacting protein 2			PCR rescued clones	NIH_MGC_195	DH10B	NM_020753.3	NP_065804.2	VALIDATED	OK	1.000	1.000	1202	3609	1	3606	1202	1	1202
IKAKEN	BC065269	06-2_01-F04	MGC	W01C076L07	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065269	06-2_01-F04	MGC	W01C076L08	pDONR221	21895		IGF2BP3	10643	AAH65269.1	Hs.700696	Insulin-like growth factor 2 mRNA binding protein 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_006547.2	NP_006538.2	REVIEWED	Cgs	0.985	0.998	587	1764	1	1761	579	1	579
IKAKEN	BC065016	06-2_01-F05	MGC	W01C076L09	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC065016	06-2_01-F05	MGC	W01C076L10	pDONR221	11265		AFG3L2	10939	AAH65016.1	Hs.528996	AFG3 ATPase family gene 3-like 2 (yeast)			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006796.1	NP_006787.1	REVIEWED	Pfs	0.859	0.873	319	945	1	944	797	1	318
IKAKEN	BC067274	06-2_01-F06	MGC	W01C076L11	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC067274	06-2_01-F06	MGC	W01C076L12	pDONR221	1483		OLFML2B	25903	AAH67274.1	Hs.507515	Olfactomedin-like 2B			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_015441.1	NP_056256.1	PROVISIONAL	P	1.000	1.000	409	1230	1	1227	750	342	750
IKAKEN	BC013401	06-2_01-F07	MGC	W01C076L13	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC013401	06-2_01-F07	MGC	W01C076L14	pDONR221	10656		PHB	5245	AAH13401.1	Hs.514303	Prohibitin			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_002634.2	NP_002625.1	REVIEWED		0.878	0.878	156	471	1	468	272	1	156
IKAKEN	BC004397	06-2_01-F08	MGC	W01C076L15	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004397	06-2_01-F08	MGC	W01C076L16	pDONR221	17707		LOC84740	84740	AAH04397	Hs.663749	Hypothetical LOC84740			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC011617	06-2_01-F09	MGC	W01C076L17	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC011617	06-2_01-F09	MGC	W01C076L18	pDONR221	4894		PC	5091	AAH11617.1	Hs.89890	Pyruvate carboxylase			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_001040716.1	NP_001035806.1	REVIEWED	OK	1.000	1.000	1178	3537	1	3534	1178	1	1178
IKAKEN	BC002894	06-2_01-F10	MGC	W01C076L19	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC002894	06-2_01-F10	MGC	W01C076L20	pDONR221	15598		CRELD2	79174	AAH02894.1	Hs.211282	Cysteine-rich with EGF-like domains 2			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_001135101.1	NP_001128573.1	VALIDATED	Cg	0.799	1.000	402	966	1	963	402	1	402
IKAKEN	BC030054	06-2_01-F11	MGC	W01C076L21	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC030054	06-2_01-F11	MGC	W01C076L22	pDONR221	17739		METAP1	23173	AAH30054.1	Hs.480364	Methionyl aminopeptidase 1			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_015143.2	NP_055958.2	VALIDATED	P	1.000	1.000	272	819	1	816	386	115	386
IKAKEN	BC045110	06-2_01-F12	MGC	W01C076L23	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	06-2_01-F12	MGC	W01C076L24	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC009373	06-2_01-G01	MGC	W01C076M01	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	06-2_01-G01	MGC	W01C076M02	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC011722	06-2_01-G02	MGC	W01C076M03	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	06-2_01-G02	MGC	W01C076M04	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC034051	06-2_01-G03	MGC	W01C076M05	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	06-2_01-G03	MGC	W01C076M06	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC016753	06-2_01-G04	MGC	W01C076M07	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	06-2_01-G04	MGC	W01C076M08	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC000616	06-2_01-G05	MGC	W01C076M09	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	06-2_01-G05	MGC	W01C076M10	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC014980	06-2_01-G06	MGC	W01C076M11	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	06-2_01-G06	MGC	W01C076M12	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	06-2_01-G07	MGC	W01C076M13	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	06-2_01-G07	MGC	W01C076M14	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	06-2_01-G08	MGC	W01C076M15	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	06-2_01-G08	MGC	W01C076M16	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC021134	06-2_01-G09	MGC	W01C076M17	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	06-2_01-G09	MGC	W01C076M18	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC033082	06-2_01-G10	MGC	W01C076M19	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	06-2_01-G10	MGC	W01C076M20	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC009373	06-2_01-G01	MGC	W01C076N01	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC009373	06-2_01-G01	MGC	W01C076N02	pDONR221	23649		PHYHD1	254295	AAH09373.1	Hs.709447	Phytanoyl-CoA dioxygenase domain containing 1			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_174933.3	NP_777593.2	VALIDATED	OK	1.000	1.000	297	894	1	891	297	1	297
IKAKEN	BC011722	06-2_01-G02	MGC	W01C076N03	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC011722	06-2_01-G02	MGC	W01C076N04	pDONR221	12207		ILVBL	10994	AAH11722.1	Hs.78880	IlvB (bacterial acetolactate synthase)-like			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_006844.3	NP_006835.2	REVIEWED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	BC034051	06-2_01-G03	MGC	W01C076N05	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC034051	06-2_01-G03	MGC	W01C076N06	pDONR221	12978		STK11IP	114790	AAH34051.1	Hs.22410	Serine/threonine kinase 11 interacting protein			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_052902.2	NP_443134.2	VALIDATED	P	1.000	1.000	1088	3267	1	3264	1099	12	1099
IKAKEN	BC016753	06-2_01-G04	MGC	W01C076N07	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC016753	06-2_01-G04	MGC	W01C076N08	pDONR221	19837		HSP90AB1	3326	AAH16753.1	Hs.509736	Heat shock protein 90kDa alpha (cytosolic), class B member 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_007355.2	NP_031381.2	PROVISIONAL		0.951	0.956	226	684	1	675	724	1	226
IKAKEN	BC000616	06-2_01-G05	MGC	W01C076N09	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC000616	06-2_01-G05	MGC	W01C076N10	pDONR221	3591		SWAP70	23075	AAH00616.1	Hs.153026	SWAP-70 protein			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_015055.2	NP_055870.2	VALIDATED	OK	1.000	1.000	585	1758	1	1755	585	1	585
IKAKEN	BC014980	06-2_01-G06	MGC	W01C076N11	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC014980	06-2_01-G06	MGC	W01C076N12	pDONR221	24024		HNRNPK	3190	AAH14980.1	Hs.522257	Heterogeneous nuclear ribonucleoprotein K			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_031263.2	NP_112553.1	REVIEWED	Pfs	0.932	0.934	428	1404	1	1281	464	27	454
IKAKEN	BC021557	06-2_01-G07	MGC	W01C076N13	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC021557	06-2_01-G07	MGC	W01C076N14	pDONR221	9096		TMEM8	58986	AAH21557.1	Hs.288940	Transmembrane protein 8 (five membrane-spanning domains)			Testis	NIH_MGC_97	DH10B	NM_021259.2	NP_067082.2	VALIDATED	OK	1.000	1.000	771	2316	1	2313	771	1	771
IKAKEN	BC018722	06-2_01-G08	MGC	W01C076N15	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC018722	06-2_01-G08	MGC	W01C076N16	pDONR221	9759		ASPSCR1	79058	AAH18722.1	Hs.298351	Alveolar soft part sarcoma chromosome region, candidate 1			Brain, glioblastoma	NIH_MGC_57	DH10B	NM_024083.2	NP_076988.1	REVIEWED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC021134	06-2_01-G09	MGC	W01C076N17	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC021134	06-2_01-G09	MGC	W01C076N18	pDONR221	9713		CNTROB	116840	AAH21134.1	Hs.348012	Centrobin, centrosomal BRCA2 interacting protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_053051.2	NP_444279.2	VALIDATED	OK	1.000	1.000	903	2712	1	2709	903	1	903
IKAKEN	BC033082	06-2_01-G10	MGC	W01C076N19	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	BC033082	06-2_01-G10	MGC	W01C076N20	pDONR221	1462		CROCCL2	114819	AAH33082	Hs.597881	Ciliary rootlet coiled-coil, rootletin-like 2			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001714120.1	XP_001714172.1	MODEL	Pfs	0.874	0.980	453	1224	4	1223	798	294	744
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C077A01	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C077A02	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C077A03	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C077A04	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C077A05	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C077A06	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C077A07	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C077A08	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C077A09	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C077A10	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	BC057833	06-2_02-A06	MGC	W01C077A11	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	06-2_02-A06	MGC	W01C077A12	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C077A13	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C077A14	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C077A15	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C077A16	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C077A17	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C077A18	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C077A19	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C077A20	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	UBA06001	06-2_02-A11	EST	W01C077A21	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	06-2_02-A11	EST	W01C077A22	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	06-2_02-A12	EST	W01C077A23	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	06-2_02-A12	EST	W01C077A24	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C077B01	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C077B02	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C077B03	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C077B04	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C077B05	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C077B06	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C077B07	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C077B08	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C077B09	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C077B10	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	BC057833	06-2_02-A06	MGC	W01C077B11	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	06-2_02-A06	MGC	W01C077B12	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C077B13	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C077B14	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C077B15	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C077B16	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C077B17	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C077B18	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C077B19	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C077B20	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	UBA06001	06-2_02-A11	EST	W01C077B21	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	06-2_02-A11	EST	W01C077B22	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	06-2_02-A12	EST	W01C077B23	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	06-2_02-A12	EST	W01C077B24	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C077C01	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C077C02	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C077C03	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C077C04	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C077C05	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C077C06	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC061631	06-2_02-B04	MGC	W01C077C07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	06-2_02-B04	MGC	W01C077C08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	06-2_02-B05	MGC	W01C077C09	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	06-2_02-B05	MGC	W01C077C10	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC043345	06-2_02-B06	MGC	W01C077C11	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	06-2_02-B06	MGC	W01C077C12	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C077C13	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C077C14	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C077C15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C077C16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C077C17	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C077C18	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C077C19	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C077C20	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C077C21	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C077C22	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C077C23	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C077C24	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C077D01	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C077D02	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C077D03	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C077D04	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C077D05	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C077D06	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC061631	06-2_02-B04	MGC	W01C077D07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	06-2_02-B04	MGC	W01C077D08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	06-2_02-B05	MGC	W01C077D09	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	06-2_02-B05	MGC	W01C077D10	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC043345	06-2_02-B06	MGC	W01C077D11	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	06-2_02-B06	MGC	W01C077D12	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C077D13	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C077D14	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C077D15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C077D16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C077D17	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C077D18	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C077D19	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C077D20	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C077D21	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C077D22	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C077D23	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C077D24	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C077E01	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C077E02	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C077E03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C077E04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C077E05	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C077E06	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C077E07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C077E08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C077E09	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C077E10	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C077E11	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C077E12	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C077E13	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C077E14	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C077E15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C077E16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC036263	06-2_02-C09	MGC	W01C077E17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	06-2_02-C09	MGC	W01C077E18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC029775	06-2_02-C10	MGC	W01C077E19	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	06-2_02-C10	MGC	W01C077E20	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C077E21	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C077E22	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C077E23	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C077E24	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C077F01	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C077F02	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C077F03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C077F04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C077F05	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C077F06	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C077F07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C077F08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C077F09	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C077F10	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C077F11	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C077F12	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C077F13	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C077F14	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C077F15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C077F16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC036263	06-2_02-C09	MGC	W01C077F17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	06-2_02-C09	MGC	W01C077F18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC029775	06-2_02-C10	MGC	W01C077F19	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	06-2_02-C10	MGC	W01C077F20	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C077F21	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C077F22	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C077F23	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C077F24	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	BC028364	06-2_02-D01	MGC	W01C077G01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	06-2_02-D01	MGC	W01C077G02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC036263	06-2_02-D02	MGC	W01C077G03	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	06-2_02-D02	MGC	W01C077G04	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC064361	06-2_02-D03	MGC	W01C077G05	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	06-2_02-D03	MGC	W01C077G06	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	06-2_02-D04	MGC	W01C077G07	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	06-2_02-D04	MGC	W01C077G08	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC000385	06-2_02-D05	MGC	W01C077G09	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	06-2_02-D05	MGC	W01C077G10	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC066122	06-2_02-D06	MGC	W01C077G11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	06-2_02-D06	MGC	W01C077G12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC055417	06-2_02-D07	MGC	W01C077G13	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	06-2_02-D07	MGC	W01C077G14	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC035228	06-2_02-D08	MGC	W01C077G15	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	06-2_02-D08	MGC	W01C077G16	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C077G17	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C077G18	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C077G19	pDONR221															
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C077G20	pDONR221															
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C077G21	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C077G22	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC022782	06-2_02-D12	MGC	W01C077G23	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	06-2_02-D12	MGC	W01C077G24	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC028364	06-2_02-D01	MGC	W01C077H01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	06-2_02-D01	MGC	W01C077H02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC036263	06-2_02-D02	MGC	W01C077H03	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	06-2_02-D02	MGC	W01C077H04	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC064361	06-2_02-D03	MGC	W01C077H05	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	06-2_02-D03	MGC	W01C077H06	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	06-2_02-D04	MGC	W01C077H07	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	06-2_02-D04	MGC	W01C077H08	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC000385	06-2_02-D05	MGC	W01C077H09	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	06-2_02-D05	MGC	W01C077H10	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC066122	06-2_02-D06	MGC	W01C077H11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	06-2_02-D06	MGC	W01C077H12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC055417	06-2_02-D07	MGC	W01C077H13	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	06-2_02-D07	MGC	W01C077H14	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC035228	06-2_02-D08	MGC	W01C077H15	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	06-2_02-D08	MGC	W01C077H16	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C077H17	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C077H18	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C077H19	pDONR221															
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C077H20	pDONR221															
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C077H21	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C077H22	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC022782	06-2_02-D12	MGC	W01C077H23	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	06-2_02-D12	MGC	W01C077H24	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC024591	06-2_02-E01	MGC	W01C077I01	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	06-2_02-E01	MGC	W01C077I02	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC013136	06-2_02-E02	MGC	W01C077I03	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	06-2_02-E02	MGC	W01C077I04	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	06-2_02-E03	MGC	W01C077I05	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	06-2_02-E03	MGC	W01C077I06	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	06-2_02-E04	MGC	W01C077I07	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	06-2_02-E04	MGC	W01C077I08	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	06-2_02-E05	MGC	W01C077I09	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	06-2_02-E05	MGC	W01C077I10	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	06-2_02-E06	MGC	W01C077I11	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	06-2_02-E06	MGC	W01C077I12	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	06-2_02-E07	MGC	W01C077I13	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	06-2_02-E07	MGC	W01C077I14	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC061592	06-2_02-E08	MGC	W01C077I15	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	06-2_02-E08	MGC	W01C077I16	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC032948	06-2_02-E09	MGC	W01C077I17	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	06-2_02-E09	MGC	W01C077I18	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC063801	06-2_02-E10	MGC	W01C077I19	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	06-2_02-E10	MGC	W01C077I20	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035013	06-2_02-E11	MGC	W01C077I21	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	06-2_02-E11	MGC	W01C077I22	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC031084	06-2_02-E12	MGC	W01C077I23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	06-2_02-E12	MGC	W01C077I24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC024591	06-2_02-E01	MGC	W01C077J01	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	06-2_02-E01	MGC	W01C077J02	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC013136	06-2_02-E02	MGC	W01C077J03	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	06-2_02-E02	MGC	W01C077J04	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	06-2_02-E03	MGC	W01C077J05	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	06-2_02-E03	MGC	W01C077J06	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	06-2_02-E04	MGC	W01C077J07	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	06-2_02-E04	MGC	W01C077J08	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	06-2_02-E05	MGC	W01C077J09	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	06-2_02-E05	MGC	W01C077J10	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	06-2_02-E06	MGC	W01C077J11	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	06-2_02-E06	MGC	W01C077J12	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	06-2_02-E07	MGC	W01C077J13	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	06-2_02-E07	MGC	W01C077J14	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC061592	06-2_02-E08	MGC	W01C077J15	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	06-2_02-E08	MGC	W01C077J16	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC032948	06-2_02-E09	MGC	W01C077J17	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	06-2_02-E09	MGC	W01C077J18	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC063801	06-2_02-E10	MGC	W01C077J19	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	06-2_02-E10	MGC	W01C077J20	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035013	06-2_02-E11	MGC	W01C077J21	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	06-2_02-E11	MGC	W01C077J22	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC031084	06-2_02-E12	MGC	W01C077J23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	06-2_02-E12	MGC	W01C077J24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC029523	06-2_02-F01	MGC	W01C077K01	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	06-2_02-F01	MGC	W01C077K02	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	06-2_02-F02	MGC	W01C077K03	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	06-2_02-F02	MGC	W01C077K04	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029538	06-2_02-F03	MGC	W01C077K05	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	06-2_02-F03	MGC	W01C077K06	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040521	06-2_02-F04	MGC	W01C077K07	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	06-2_02-F04	MGC	W01C077K08	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC035132	06-2_02-F05	MGC	W01C077K09	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	06-2_02-F05	MGC	W01C077K10	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC062746	06-2_02-F06	MGC	W01C077K11	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	06-2_02-F06	MGC	W01C077K12	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC050291	06-2_02-F07	MGC	W01C077K13	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	06-2_02-F07	MGC	W01C077K14	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC045655	06-2_02-F08	MGC	W01C077K15	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	06-2_02-F08	MGC	W01C077K16	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC062213	06-2_02-F09	MGC	W01C077K17	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	06-2_02-F09	MGC	W01C077K18	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC044577	06-2_02-F10	MGC	W01C077K19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	06-2_02-F10	MGC	W01C077K20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC064696	06-2_02-F11	MGC	W01C077K21	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	06-2_02-F11	MGC	W01C077K22	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063595	06-2_02-F12	MGC	W01C077K23	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	06-2_02-F12	MGC	W01C077K24	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC029523	06-2_02-F01	MGC	W01C077L01	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	06-2_02-F01	MGC	W01C077L02	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	06-2_02-F02	MGC	W01C077L03	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	06-2_02-F02	MGC	W01C077L04	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029538	06-2_02-F03	MGC	W01C077L05	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	06-2_02-F03	MGC	W01C077L06	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040521	06-2_02-F04	MGC	W01C077L07	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	06-2_02-F04	MGC	W01C077L08	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC035132	06-2_02-F05	MGC	W01C077L09	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	06-2_02-F05	MGC	W01C077L10	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC062746	06-2_02-F06	MGC	W01C077L11	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	06-2_02-F06	MGC	W01C077L12	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC050291	06-2_02-F07	MGC	W01C077L13	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	06-2_02-F07	MGC	W01C077L14	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC045655	06-2_02-F08	MGC	W01C077L15	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	06-2_02-F08	MGC	W01C077L16	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC062213	06-2_02-F09	MGC	W01C077L17	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	06-2_02-F09	MGC	W01C077L18	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC044577	06-2_02-F10	MGC	W01C077L19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	06-2_02-F10	MGC	W01C077L20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC064696	06-2_02-F11	MGC	W01C077L21	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	06-2_02-F11	MGC	W01C077L22	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063595	06-2_02-F12	MGC	W01C077L23	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	06-2_02-F12	MGC	W01C077L24	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC057792	06-2_02-G01	MGC	W01C077M01	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	06-2_02-G01	MGC	W01C077M02	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC045108	06-2_02-G02	MGC	W01C077M03	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	06-2_02-G02	MGC	W01C077M04	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015484	06-2_02-G03	MGC	W01C077M05	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	06-2_02-G03	MGC	W01C077M06	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	06-2_02-G04	MGC	W01C077M07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	06-2_02-G04	MGC	W01C077M08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC024043	06-2_02-G05	MGC	W01C077M09	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	06-2_02-G05	MGC	W01C077M10	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC063126	06-2_02-G06	MGC	W01C077M11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	06-2_02-G06	MGC	W01C077M12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC009917	06-2_02-G07	MGC	W01C077M13	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	06-2_02-G07	MGC	W01C077M14	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC007436	06-2_02-G08	MGC	W01C077M15	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	06-2_02-G08	MGC	W01C077M16	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC057792	06-2_02-G01	MGC	W01C077N01	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	06-2_02-G01	MGC	W01C077N02	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC045108	06-2_02-G02	MGC	W01C077N03	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	06-2_02-G02	MGC	W01C077N04	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015484	06-2_02-G03	MGC	W01C077N05	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	06-2_02-G03	MGC	W01C077N06	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	06-2_02-G04	MGC	W01C077N07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	06-2_02-G04	MGC	W01C077N08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC024043	06-2_02-G05	MGC	W01C077N09	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	06-2_02-G05	MGC	W01C077N10	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC063126	06-2_02-G06	MGC	W01C077N11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	06-2_02-G06	MGC	W01C077N12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC009917	06-2_02-G07	MGC	W01C077N13	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	06-2_02-G07	MGC	W01C077N14	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC007436	06-2_02-G08	MGC	W01C077N15	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	06-2_02-G08	MGC	W01C077N16	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C078A01	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C078A02	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C078A03	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C078A04	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C078A05	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C078A06	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C078A07	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C078A08	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C078A09	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C078A10	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	BC057833	06-2_02-A06	MGC	W01C078A11	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	06-2_02-A06	MGC	W01C078A12	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C078A13	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C078A14	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C078A15	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C078A16	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C078A17	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C078A18	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C078A19	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C078A20	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	UBA06001	06-2_02-A11	EST	W01C078A21	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	06-2_02-A11	EST	W01C078A22	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	06-2_02-A12	EST	W01C078A23	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	06-2_02-A12	EST	W01C078A24	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C078B01	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A01	FLJ	W01C078B02	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL		0.878	0.893	303	897	1	894	361	1	303
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C078B03	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK075223	06-2_02-A02	FLJ	W01C078B04	pDONR221	3244		ATAD1	84896	BAC11482.1	Hs.435948	ATPase family, AAA domain containing 1			placenta	PLACE1		NM_032810.2	NP_116199.2	PROVISIONAL	OK	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C078B05	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK130825	06-2_02-A03	FLJ	W01C078B06	pDONR221	1		RPIA	22934	BAC85440	Hs.469264	Ribose 5-phosphate isomerase A			thymus	TMS		NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.245	0.245	53	1455	1040	1198	311	54	106
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C078B07	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK026586	06-2_02-A04	FLJ	W01C078B08	pDONR221	14083		SH3YL1	26751	-	Hs.515951	SH3 domain containing, Ysc84-like 1 (S. cerevisiae)	KATO III	signet-ring cell carcinoma		KAT		NM_015677.2	NP_056492.2	VALIDATED	P	1.000	1.000	245	741	4	738	342	98	342
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C078B09	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	AK027068	06-2_02-A05	FLJ	W01C078B10	pDONR221	14673		BPIL1	80341	-	Hs.257045	Bactericidal/permeability-increasing protein-like 1	HepG2	hepatoma		HEP		NM_025227.1	NP_079503.1	REVIEWED	OK	1.000	1.000	458	1377	1	1374	458	1	458
IKAKEN	BC057833	06-2_02-A06	MGC	W01C078B11	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BC057833	06-2_02-A06	MGC	W01C078B12	pDONR221	4864		ZDHHC24	254359	AAH57833.2	Hs.659933	Zinc finger, DHHC-type containing 24			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_207340.1	NP_997223.1	PROVISIONAL	P	1.000	1.000	202	609	1	606	284	83	284
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C078B13	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX399817 (5' CS0DI083YN02)	06-2_02-A07		W01C078B14	pDONR221			FAM89A	375061		Hs.38516	Family with sequence similarity 89, member A						NM_198552.2	NP_940954.1	VALIDATED	OK	1.000	1.000	184	555	1	552	184	1	184
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C078B15	pDONR221															
IKAKEN	BX382867 (5' CS0DJ001YB05)	06-2_02-A08		W01C078B16	pDONR221															
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C078B17	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	AL530181 (5' CS0DD009YA19)	06-2_02-A09		W01C078B18	pDONR221			CPNE8	144402		Hs.40910	Copine VIII						NM_153634.2	NP_705898.1	REVIEWED	OK	1.000	1.000	564	1695	1	1692	564	1	564
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C078B19	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_02-A10		W01C078B20	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.859	0.885	198	618	37	615	293	97	293
IKAKEN	UBA06001	06-2_02-A11	EST	W01C078B21	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	UBA06001	06-2_02-A11	EST	W01C078B22	pDONR221			HDDC2	51020		Hs.32826	HD domain containing 2						NM_016063.2	NP_057147.2	VALIDATED	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	WMC03658	06-2_02-A12	EST	W01C078B23	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	WMC03658	06-2_02-A12	EST	W01C078B24	pDONR221			CYP2R1	120227		Hs.371427	Cytochrome P450, family 2, subfamily R, polypeptide 1						NM_024514.4	NP_078790.2	REVIEWED	OK	1.000	1.000	501	1506	1	1503	501	1	501
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C078C01	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C078C02	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C078C03	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C078C04	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C078C05	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C078C06	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC061631	06-2_02-B04	MGC	W01C078C07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	06-2_02-B04	MGC	W01C078C08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	06-2_02-B05	MGC	W01C078C09	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	06-2_02-B05	MGC	W01C078C10	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC043345	06-2_02-B06	MGC	W01C078C11	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	06-2_02-B06	MGC	W01C078C12	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C078C13	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C078C14	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C078C15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C078C16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C078C17	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C078C18	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C078C19	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C078C20	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C078C21	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C078C22	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C078C23	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C078C24	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C078D01	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	AMR05817	06-2_02-B01	EST(RND)	W01C078D02	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	P	1.000	1.000	274	825	1	822	5005	1	274
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C078D03	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	CNR09224	06-2_02-B02	EST(RND)	W01C078D04	pDONR221			AMMECR1L	83607		Hs.546449	AMME chromosomal region gene 1-like						NM_031445.2	NP_113633.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C078D05	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	HCR06861	06-2_02-B03	EST(RND)	W01C078D06	pDONR221			C4orf18	51313		Hs.567498	Chromosome 4 open reading frame 18						NM_001128424.1	NP_001121896.1	VALIDATED	OK	1.000	1.000	519	1560	1	1557	519	1	519
IKAKEN	BC061631	06-2_02-B04	MGC	W01C078D07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC061631	06-2_02-B04	MGC	W01C078D08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED	Pfs	0.923	0.931	465	1404	3	1395	1686	1223	1684
IKAKEN	BC036263	06-2_02-B05	MGC	W01C078D09	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC036263	06-2_02-B05	MGC	W01C078D10	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Ps	0.983	0.983	60	183	1	180	678	123	182
IKAKEN	BC043345	06-2_02-B06	MGC	W01C078D11	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BC043345	06-2_02-B06	MGC	W01C078D12	pDONR221	2928		BMS1	9790	AAH43345.1	Hs.10848	BMS1 homolog, ribosome assembly protein (yeast)			Testis	NIH_MGC_97	DH10B	NM_014753.3	NP_055568.3	REVIEWED		0.955	0.955	88	267	1	264	1282	924	1011
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C078D13	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX462494 (5' CS0DH003YI08)	06-2_02-B07		W01C078D14	pDONR221			YDJC	150223		Hs.355952	YdjC homolog (bacterial)						NM_001017964.1	NP_001017964.1	VALIDATED	OK	1.000	1.000	323	972	1	969	323	1	323
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C078D15	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	BX387127 (5' CS0DC023YI18)	06-2_02-B08		W01C078D16	pDONR221			C10orf114	399726		Hs.315568	Chromosome 10 open reading frame 114						NM_001010911.2	NP_001010911.1	VALIDATED	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C078D17	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	AL543376 (5' CS0DI001YB17)	06-2_02-B09		W01C078D18	pDONR221			CCDC6	8030		Hs.591360	Coiled-coil domain containing 6						NM_005436.3	NP_005427.2	VALIDATED	Cfs	0.998	1.000	474	1752	1	1420	474	1	474
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C078D19	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	BX340241 (5' CS0DI084YG16)	06-2_02-B10		W01C078D20	pDONR221			PTPLAD2	401494		Hs.716678	Protein tyrosine phosphatase-like A domain containing 2						NM_001010915.3	NP_001010915.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C078D21	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK074987	06-2_02-B11	FLJ	W01C078D22	pDONR221	16769		HEG1	57493	BAC11336.1	Hs.477420	HEG homolog 1 (zebrafish)	NT2	teratocarcinoma		NT2RP3		NM_020733.1	NP_065784.1	VALIDATED	Pfs	0.267	0.279	45	264	212	78	1381	2	44
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C078D23	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK075564	06-2_02-B12	FLJ	W01C078D24	pDONR221	8289		FAM174B	400451	BAC11703.1	Hs.702316	Family with sequence similarity 174, member B	NT2	teratocarcinoma		NT2RP3		NM_207446.2	NP_997329.2	VALIDATED	Cg	0.987	1.000	159	474	1	471	159	1	159
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C078E01	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C078E02	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C078E03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C078E04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C078E05	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C078E06	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C078E07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C078E08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C078E09	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C078E10	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C078E11	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C078E12	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C078E13	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C078E14	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C078E15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C078E16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC036263	06-2_02-C09	MGC	W01C078E17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	06-2_02-C09	MGC	W01C078E18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC029775	06-2_02-C10	MGC	W01C078E19	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	06-2_02-C10	MGC	W01C078E20	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C078E21	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C078E22	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C078E23	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C078E24	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C078F01	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK129923	06-2_02-C01	FLJ	W01C078F02	pDONR221	22965		C8orf80	389643	BAC85251.1	Hs.370129	Chromosome 8 open reading frame 80			heart	HRT		NM_001010906.1	NP_001010906.1	PREDICTED	P	1.000	1.000	197	594	1	591	796	600	796
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C078F03	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK093017	06-2_02-C02	FLJ	W01C078F04	pDONR221	3920		ATG16L2	89849	BAC04021.1	Hs.653186	ATG16 autophagy related 16-like 2 (S. cerevisiae)			spleen	SPLEN2		NM_033388.1	NP_203746.1	VALIDATED	OK	1.000	1.000	619	1860	1	1857	619	1	619
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C078F05	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK075203	06-2_02-C03	FLJ	W01C078F06	pDONR221	3655		UBASH3B	84959	BAC11468.1	Hs.444075	Ubiquitin associated and SH3 domain containing, B			placenta	PLACE1		NM_032873.4	NP_116262.2	VALIDATED	OK	1.000	1.000	649	1968	19	1965	649	1	649
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C078F07	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK097411	06-2_02-C04	FLJ	W01C078F08	pDONR221	19364		FLJ40092	401196	BAC05040					testis	TESTI2				
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C078F09	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK096772	06-2_02-C05	FLJ	W01C078F10	pDONR221	4792		MUC6	4588	BAC04860.1	Hs.528432	Mucin 6, oligomeric mucus/gel-forming			brain	OCBBF2		NM_005961.2	NP_005952.2	VALIDATED	P	1.000	1.000	577	1734	1	1731	2439	1863	2439
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C078F11	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK023388	06-2_02-C06	FLJ	W01C078F12	pDONR221	7768		EIF3J	8669	BAB14555.1	Hs.404056	Eukaryotic translation initiation factor 3, subunit J			ovary, tumor tissue	OVARC1		NM_003758.2	NP_003749.2	VALIDATED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C078F13	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK094756	06-2_02-C07	FLJ	W01C078F14	pDONR221	23951		SEC16A	9919	BAC04415.1	Hs.668588	SEC16 homolog A (S. cerevisiae)			brain	BRAWH2		NM_014866.1	NP_055681.1	VALIDATED	Pfs	0.819	0.881	326	1158	176	1155	2357	2055	2357
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C078F15	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	AK000731	06-2_02-C08	FLJ	W01C078F16	pDONR221	8211		BTBD1	53339	BAA91345.1	Hs.459149	BTB (POZ) domain containing 1	KATO III	signet-ring cell carcinoma		KAT		NM_025238.3	NP_079514.1	REVIEWED	OK	1.000	1.000	482	1449	1	1446	482	1	482
IKAKEN	BC036263	06-2_02-C09	MGC	W01C078F17	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC036263	06-2_02-C09	MGC	W01C078F18	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.950	0.950	222	666	3	665	678	337	558
IKAKEN	BC029775	06-2_02-C10	MGC	W01C078F19	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	BC029775	06-2_02-C10	MGC	W01C078F20	pDONR221	947		TMEM61	199964	AAH29775.1	Hs.663950	Transmembrane protein 61			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_182532.1	NP_872338.1	PROVISIONAL	C	1.000	1.000	210	633	1	630	210	1	210
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C078F21	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK075561	06-2_02-C11	FLJ	W01C078F22	pDONR221	1892		TTC13	79573	BAC11700.1	Hs.424788	Tetratricopeptide repeat domain 13	NT2	teratocarcinoma		NT2RP3		NM_024525.3	NP_078801.3	VALIDATED	Cg	0.937	1.000	860	2421	1	2418	860	1	860
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C078F23	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	AK127134	06-2_02-C12	FLJ	W01C078F24	pDONR221	9606		CLTC	1213	-	Hs.491351	Clathrin, heavy chain (Hc)			brain	BRAWH3		NM_004859.3	NP_004850.1	REVIEWED	OK	1.000	1.000	1675	5028	1	5025	1675	1	1675
IKAKEN	BC028364	06-2_02-D01	MGC	W01C078G01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	06-2_02-D01	MGC	W01C078G02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC036263	06-2_02-D02	MGC	W01C078G03	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	06-2_02-D02	MGC	W01C078G04	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC064361	06-2_02-D03	MGC	W01C078G05	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	06-2_02-D03	MGC	W01C078G06	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	06-2_02-D04	MGC	W01C078G07	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	06-2_02-D04	MGC	W01C078G08	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC000385	06-2_02-D05	MGC	W01C078G09	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	06-2_02-D05	MGC	W01C078G10	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC066122	06-2_02-D06	MGC	W01C078G11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	06-2_02-D06	MGC	W01C078G12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC055417	06-2_02-D07	MGC	W01C078G13	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	06-2_02-D07	MGC	W01C078G14	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC035228	06-2_02-D08	MGC	W01C078G15	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	06-2_02-D08	MGC	W01C078G16	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C078G17	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C078G18	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C078G19	pDONR221															
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C078G20	pDONR221															
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C078G21	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C078G22	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC022782	06-2_02-D12	MGC	W01C078G23	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	06-2_02-D12	MGC	W01C078G24	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC028364	06-2_02-D01	MGC	W01C078H01	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC028364	06-2_02-D01	MGC	W01C078H02	pDONR221	9955		FBXW10	10517	AAH28364.1	Hs.592128	F-box and WD repeat domain containing 10			Testis	NIH_MGC_97	DH10B	NM_031456.3	NP_113644.3	VALIDATED	Cgs	0.955	0.999	1080	3186	1	3183	1051	1	1051
IKAKEN	BC036263	06-2_02-D02	MGC	W01C078H03	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC036263	06-2_02-D02	MGC	W01C078H04	pDONR221	8619		NPIPL3	23117	AAH36263.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_130464.1	NP_569731.1	VALIDATED	Pfs	0.984	0.988	251	753	1	751	678	217	466
IKAKEN	BC064361	06-2_02-D03	MGC	W01C078H05	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC064361	06-2_02-D03	MGC	W01C078H06	pDONR221	10188		PLEKHM1	9842	AAH64361.1	Hs.514242	Pleckstrin homology domain containing, family M (with RUN domain) member 1			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_014798.1	NP_055613.1	PROVISIONAL	Pfs	0.957	0.970	1058	3174	1	3171	1056	1	1045
IKAKEN	BC066122	06-2_02-D04	MGC	W01C078H07	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC066122	06-2_02-D04	MGC	W01C078H08	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.926	0.926	189	570	1	567	1227	1039	1227
IKAKEN	BC000385	06-2_02-D05	MGC	W01C078H09	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC000385	06-2_02-D05	MGC	W01C078H10	pDONR221	18760		CTNNA1	1495	AAH00385.1	Hs.656653	Catenin (cadherin-associated protein), alpha 1, 102kDa			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001903.2	NP_001894.2	VALIDATED	Pfs	0.879	0.879	141	426	1	423	906	144	284
IKAKEN	BC066122	06-2_02-D06	MGC	W01C078H11	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC066122	06-2_02-D06	MGC	W01C078H12	pDONR221	15537		BCR	613	AAH66122	Hs.715409	Breakpoint cluster region			Placenta, normal	NIH_MGC_147	DH10B	NM_021574.2	NP_067585.2	REVIEWED		0.940	0.940	250	753	1	750	1227	978	1227
IKAKEN	BC055417	06-2_02-D07	MGC	W01C078H13	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC055417	06-2_02-D07	MGC	W01C078H14	pDONR221	6698		DLEU2	8847	AAH55417	Hs.547964	Deleted in lymphocytic leukemia 2 (non-protein coding)			Testis	NIH_MGC_82	DH10B			
IKAKEN	BC035228	06-2_02-D08	MGC	W01C078H15	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	BC035228	06-2_02-D08	MGC	W01C078H16	pDONR221	24216		PTGR1	22949	AAH35228.1	Hs.584864	Prostaglandin reductase 1			Testis	NIH_MGC_97	DH10B	NM_012212.3	NP_036344.2	REVIEWED	Pfs	0.834	0.845	320	957	10	956	329	7	326
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C078H17	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	COR02444	06-2_02-D09	EST(RND)	W01C078H18	pDONR221			LIN28B	389421		Hs.23616	Lin-28 homolog B (C. elegans)						NM_001004317.2	NP_001004317.1	PROVISIONAL	Ps	0.996	0.996	248	828	82	825	250	3	250
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C078H19	pDONR221															
IKAKEN	ADR02862	06-2_02-D10	EST(RND)	W01C078H20	pDONR221															
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C078H21	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	06-2_02-D11	FLJ	W01C078H22	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC022782	06-2_02-D12	MGC	W01C078H23	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC022782	06-2_02-D12	MGC	W01C078H24	pDONR221	7687		BAHD1	22893	AAH22782.1	Hs.22109	Bromo adjacent homology domain containing 1			Colon, adenocarcinoma	NIH_MGC_65	DH10B	NM_014952.3	NP_055767.3	VALIDATED	OK	1.000	1.000	780	2343	1	2340	780	1	780
IKAKEN	BC024591	06-2_02-E01	MGC	W01C078I01	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	06-2_02-E01	MGC	W01C078I02	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC013136	06-2_02-E02	MGC	W01C078I03	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	06-2_02-E02	MGC	W01C078I04	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	06-2_02-E03	MGC	W01C078I05	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	06-2_02-E03	MGC	W01C078I06	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	06-2_02-E04	MGC	W01C078I07	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	06-2_02-E04	MGC	W01C078I08	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	06-2_02-E05	MGC	W01C078I09	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	06-2_02-E05	MGC	W01C078I10	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	06-2_02-E06	MGC	W01C078I11	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	06-2_02-E06	MGC	W01C078I12	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	06-2_02-E07	MGC	W01C078I13	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	06-2_02-E07	MGC	W01C078I14	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC061592	06-2_02-E08	MGC	W01C078I15	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	06-2_02-E08	MGC	W01C078I16	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC032948	06-2_02-E09	MGC	W01C078I17	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	06-2_02-E09	MGC	W01C078I18	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC063801	06-2_02-E10	MGC	W01C078I19	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	06-2_02-E10	MGC	W01C078I20	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035013	06-2_02-E11	MGC	W01C078I21	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	06-2_02-E11	MGC	W01C078I22	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC031084	06-2_02-E12	MGC	W01C078I23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	06-2_02-E12	MGC	W01C078I24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC024591	06-2_02-E01	MGC	W01C078J01	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC024591	06-2_02-E01	MGC	W01C078J02	pDONR221	18484		HISPPD1	23262	AAH24591.1	Hs.212046	Histidine acid phosphatase domain containing 1			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_015216.2	NP_056031.2	PROVISIONAL	Cs	0.998	0.998	1222	3669	1	3666	1222	1	1222
IKAKEN	BC013136	06-2_02-E02	MGC	W01C078J03	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC013136	06-2_02-E02	MGC	W01C078J04	pDONR221	22650		MTBP	27085	AAH13136.1	Hs.657656	Mdm2, transformed 3T3 cell double minute 2, p53 binding protein (mouse) binding protein, 104kDa			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_022045.3	NP_071328.2	PROVISIONAL	OK	1.000	1.000	904	2715	1	2712	904	1	904
IKAKEN	BC039173	06-2_02-E03	MGC	W01C078J05	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	06-2_02-E03	MGC	W01C078J06	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	06-2_02-E04	MGC	W01C078J07	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	06-2_02-E04	MGC	W01C078J08	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	06-2_02-E05	MGC	W01C078J09	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	06-2_02-E05	MGC	W01C078J10	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	06-2_02-E06	MGC	W01C078J11	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	06-2_02-E06	MGC	W01C078J12	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	06-2_02-E07	MGC	W01C078J13	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	06-2_02-E07	MGC	W01C078J14	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC061592	06-2_02-E08	MGC	W01C078J15	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC061592	06-2_02-E08	MGC	W01C078J16	pDONR221	2123		TMEM81	388730	AAH61592.1	Hs.146928	Transmembrane protein 81			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_203376.1	NP_976310.1	VALIDATED	OK	1.000	1.000	255	768	1	765	255	1	255
IKAKEN	BC032948	06-2_02-E09	MGC	W01C078J17	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC032948	06-2_02-E09	MGC	W01C078J18	pDONR221	11880		C19orf63	284361	AAH32948.1	Hs.515550	Chromosome 19 open reading frame 63			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_206538.2	NP_996261.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	BC063801	06-2_02-E10	MGC	W01C078J19	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC063801	06-2_02-E10	MGC	W01C078J20	pDONR221	18029		DGKQ	1609	AAH63801.1	Hs.584858	Diacylglycerol kinase, theta 110kDa			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001347.2	NP_001338.2	REVIEWED	OK	1.000	1.000	942	2829	1	2826	942	1	942
IKAKEN	BC035013	06-2_02-E11	MGC	W01C078J21	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC035013	06-2_02-E11	MGC	W01C078J22	pDONR221	13767		RAB11FIP5	26056	AAH35013.1	Hs.24557	RAB11 family interacting protein 5 (class I)			Testis	NIH_MGC_97	DH10B	NM_015470.2	NP_056285.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	BC031084	06-2_02-E12	MGC	W01C078J23	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC031084	06-2_02-E12	MGC	W01C078J24	pDONR221	8096		PLIN	5346	AAH31084.1	Hs.103253	Perilipin			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001145311.1	NP_001138783.1	REVIEWED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	BC029523	06-2_02-F01	MGC	W01C078K01	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	06-2_02-F01	MGC	W01C078K02	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	06-2_02-F02	MGC	W01C078K03	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	06-2_02-F02	MGC	W01C078K04	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029538	06-2_02-F03	MGC	W01C078K05	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	06-2_02-F03	MGC	W01C078K06	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040521	06-2_02-F04	MGC	W01C078K07	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	06-2_02-F04	MGC	W01C078K08	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC035132	06-2_02-F05	MGC	W01C078K09	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	06-2_02-F05	MGC	W01C078K10	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC062746	06-2_02-F06	MGC	W01C078K11	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	06-2_02-F06	MGC	W01C078K12	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC050291	06-2_02-F07	MGC	W01C078K13	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	06-2_02-F07	MGC	W01C078K14	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC045655	06-2_02-F08	MGC	W01C078K15	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	06-2_02-F08	MGC	W01C078K16	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC062213	06-2_02-F09	MGC	W01C078K17	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	06-2_02-F09	MGC	W01C078K18	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC044577	06-2_02-F10	MGC	W01C078K19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	06-2_02-F10	MGC	W01C078K20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC064696	06-2_02-F11	MGC	W01C078K21	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	06-2_02-F11	MGC	W01C078K22	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063595	06-2_02-F12	MGC	W01C078K23	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	06-2_02-F12	MGC	W01C078K24	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC029523	06-2_02-F01	MGC	W01C078L01	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC029523	06-2_02-F01	MGC	W01C078L02	pDONR221	14286		PFN4	375189	AAH29523.1	Hs.442718	Profilin family, member 4			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199346.1	NP_955378.1	PROVISIONAL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	BC040507	06-2_02-F02	MGC	W01C078L03	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC040507	06-2_02-F02	MGC	W01C078L04	pDONR221	5173		MMP17	4326	AAH40507.2	Hs.709245	Matrix metallopeptidase 17 (membrane-inserted)			Testis	NIH_MGC_97	DH10B	NM_016155.4	NP_057239.4	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	BC029538	06-2_02-F03	MGC	W01C078L05	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC029538	06-2_02-F03	MGC	W01C078L06	pDONR221	1742		C1orf52	148423	AAH29538.1	Hs.26226	Chromosome 1 open reading frame 52			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_198077.3	NP_932343.1	VALIDATED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	BC040521	06-2_02-F04	MGC	W01C078L07	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC040521	06-2_02-F04	MGC	W01C078L08	pDONR221	10254		TEX2	55852	AAH40521.1	Hs.175414	Testis expressed 2			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_018469.3	NP_060939.3	VALIDATED	OK	1.000	1.000	1134	3405	1	3402	1134	1	1134
IKAKEN	BC035132	06-2_02-F05	MGC	W01C078L09	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC035132	06-2_02-F05	MGC	W01C078L10	pDONR221	2764		THNSL1	79896	AAH35132.1	Hs.645274	Threonine synthase-like 1 (S. cerevisiae)			Testis	NIH_MGC_97	DH10B	NM_024838.4	NP_079114.3	VALIDATED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC062746	06-2_02-F06	MGC	W01C078L11	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	06-2_02-F06	MGC	W01C078L12	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC050291	06-2_02-F07	MGC	W01C078L13	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC050291	06-2_02-F07	MGC	W01C078L14	pDONR221	21297		GLCCI1	113263	AAH50291.1	Hs.131673	Glucocorticoid induced transcript 1			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_138426.2	NP_612435.1	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	BC045655	06-2_02-F08	MGC	W01C078L15	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC045655	06-2_02-F08	MGC	W01C078L16	pDONR221	10001		TMEM97	27346	AAH45655.1	Hs.199695	Transmembrane protein 97			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014573.2	NP_055388.2	VALIDATED	P	1.000	1.000	69	210	1	207	176	108	176
IKAKEN	BC062213	06-2_02-F09	MGC	W01C078L17	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	06-2_02-F09	MGC	W01C078L18	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC044577	06-2_02-F10	MGC	W01C078L19	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC044577	06-2_02-F10	MGC	W01C078L20	pDONR221	3600		MICAL2	9645	AAH44577.1	Hs.501928	Microtubule associated monoxygenase, calponin and LIM domain containing 2			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_014632.2	NP_055447.1	PROVISIONAL	C	1.000	1.000	1124	3375	1	3372	1124	1	1124
IKAKEN	BC064696	06-2_02-F11	MGC	W01C078L21	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC064696	06-2_02-F11	MGC	W01C078L22	pDONR221	16739		EPM2AIP1	9852	AAH64696.1	Hs.28020	EPM2A (laforin) interacting protein 1			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_014805.3	NP_055620.1	REVIEWED	OK	1.000	1.000	607	1824	1	1821	607	1	607
IKAKEN	BC063595	06-2_02-F12	MGC	W01C078L23	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063595	06-2_02-F12	MGC	W01C078L24	pDONR221	22948		GSDMC	56169	AAH63595.1	Hs.133244	Gasdermin C			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_031415.2	NP_113603.1	VALIDATED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC057792	06-2_02-G01	MGC	W01C078M01	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	06-2_02-G01	MGC	W01C078M02	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC045108	06-2_02-G02	MGC	W01C078M03	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	06-2_02-G02	MGC	W01C078M04	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015484	06-2_02-G03	MGC	W01C078M05	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	06-2_02-G03	MGC	W01C078M06	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	06-2_02-G04	MGC	W01C078M07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	06-2_02-G04	MGC	W01C078M08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC024043	06-2_02-G05	MGC	W01C078M09	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	06-2_02-G05	MGC	W01C078M10	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC063126	06-2_02-G06	MGC	W01C078M11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	06-2_02-G06	MGC	W01C078M12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC009917	06-2_02-G07	MGC	W01C078M13	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	06-2_02-G07	MGC	W01C078M14	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC007436	06-2_02-G08	MGC	W01C078M15	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	06-2_02-G08	MGC	W01C078M16	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC057792	06-2_02-G01	MGC	W01C078N01	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC057792	06-2_02-G01	MGC	W01C078N02	pDONR221	10048		CA4	762	AAH57792.1	Hs.89485	Carbonic anhydrase IV			Brain, glioblastoma with EGFR amplification	NCI_CGAP_Brn64	DH10B	NM_000717.3	NP_000708.1	REVIEWED	OK	1.000	1.000	312	939	1	936	312	1	312
IKAKEN	BC045108	06-2_02-G02	MGC	W01C078N03	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	06-2_02-G02	MGC	W01C078N04	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC015484	06-2_02-G03	MGC	W01C078N05	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC015484	06-2_02-G03	MGC	W01C078N06	pDONR221	8884		CALB2	794	AAH15484.1	Hs.106857	Calbindin 2			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_001740.3	NP_001731.2	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
IKAKEN	BC042161	06-2_02-G04	MGC	W01C078N07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	06-2_02-G04	MGC	W01C078N08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC024043	06-2_02-G05	MGC	W01C078N09	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC024043	06-2_02-G05	MGC	W01C078N10	pDONR221	5793		PAN2	9924	AAH24043.1	Hs.273397	PAN2 poly(A) specific ribonuclease subunit homolog (S. cerevisiae)			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_014871.3	NP_055686.3	VALIDATED	Cs	0.999	0.999	1198	3597	1	3594	1198	1	1198
IKAKEN	BC063126	06-2_02-G06	MGC	W01C078N11	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	06-2_02-G06	MGC	W01C078N12	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC009917	06-2_02-G07	MGC	W01C078N13	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC009917	06-2_02-G07	MGC	W01C078N14	pDONR221	25288		OTUD5	55593	AAH09917.1	Hs.496098	OTU domain containing 5			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017602.3	NP_060072.1	REVIEWED	OK	1.000	1.000	571	1716	1	1713	571	1	571
IKAKEN	BC007436	06-2_02-G08	MGC	W01C078N15	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	BC007436	06-2_02-G08	MGC	W01C078N16	pDONR221	19402		BOD1	91272	AAH07436.2	Hs.425091	Biorientation of chromosomes in cell division 1			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_138369.2	NP_612378.1	VALIDATED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C079A01	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C079A02	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C079A03	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C079A04	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C079A05	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C079A06	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	WMC08458	06-2_03-A04	EST	W01C079A07	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06-2_03-A04	EST	W01C079A08	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C079A09	pDONR221															
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C079A10	pDONR221															
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C079A11	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C079A12	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	DAT04650	06-2_03-A07	EST	W01C079A13	pDONR221															
IKAKEN	DAT04650	06-2_03-A07	EST	W01C079A14	pDONR221															
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C079A15	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C079A16	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C079A17	pDONR221															
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C079A18	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C079A19	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C079A20	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C079A21	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C079A22	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C079A23	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C079A24	pDONR221															
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C079B01	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C079B02	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C079B03	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C079B04	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C079B05	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C079B06	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	WMC08458	06-2_03-A04	EST	W01C079B07	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06-2_03-A04	EST	W01C079B08	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C079B09	pDONR221															
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C079B10	pDONR221															
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C079B11	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C079B12	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	DAT04650	06-2_03-A07	EST	W01C079B13	pDONR221															
IKAKEN	DAT04650	06-2_03-A07	EST	W01C079B14	pDONR221															
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C079B15	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C079B16	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C079B17	pDONR221															
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C079B18	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C079B19	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C079B20	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C079B21	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C079B22	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C079B23	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C079B24	pDONR221															
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C079C01	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C079C02	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	MPG07137	06-2_03-B02	EST	W01C079C03	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06-2_03-B02	EST	W01C079C04	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C079C05	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C079C06	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C079C07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C079C08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C079C09	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C079C10	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C079C11	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C079C12	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C079C13	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C079C14	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C079C15	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C079C16	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C079C17	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C079C18	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C079C19	pDONR221															
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C079C20	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C079C21	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C079C22	pDONR221															
IKAKEN	DMC08208	06-2_03-B12	EST	W01C079C23	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06-2_03-B12	EST	W01C079C24	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C079D01	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C079D02	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	MPG07137	06-2_03-B02	EST	W01C079D03	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06-2_03-B02	EST	W01C079D04	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C079D05	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C079D06	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C079D07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C079D08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C079D09	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C079D10	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C079D11	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C079D12	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C079D13	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C079D14	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C079D15	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C079D16	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C079D17	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C079D18	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C079D19	pDONR221															
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C079D20	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C079D21	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C079D22	pDONR221															
IKAKEN	DMC08208	06-2_03-B12	EST	W01C079D23	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06-2_03-B12	EST	W01C079D24	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	LFL01807	06-2_03-C01	EST	W01C079E01	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06-2_03-C01	EST	W01C079E02	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	SLV02550	06-2_03-C02	EST	W01C079E03	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06-2_03-C02	EST	W01C079E04	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C079E05	pDONR221															
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C079E06	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C079E07	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C079E08	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C079E09	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C079E10	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C079E11	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C079E12	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C079E13	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C079E14	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C079E15	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C079E16	pDONR221															
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C079E17	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C079E18	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C079E19	pDONR221															
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C079E20	pDONR221															
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C079E21	pDONR221				392550											
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C079E22	pDONR221				392550											
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C079E23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C079E24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	LFL01807	06-2_03-C01	EST	W01C079F01	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06-2_03-C01	EST	W01C079F02	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	SLV02550	06-2_03-C02	EST	W01C079F03	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06-2_03-C02	EST	W01C079F04	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C079F05	pDONR221															
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C079F06	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C079F07	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C079F08	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C079F09	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C079F10	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C079F11	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C079F12	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C079F13	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C079F14	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C079F15	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C079F16	pDONR221															
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C079F17	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C079F18	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C079F19	pDONR221															
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C079F20	pDONR221															
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C079F21	pDONR221				392550											
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C079F22	pDONR221				392550											
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C079F23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C079F24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C079G01	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C079G02	pDONR221			RPL32P20	392271											
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C079G03	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C079G04	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C079G05	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C079G06	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C079G07	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C079G08	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C079G09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C079G10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C079G11	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C079G12	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C079G13	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C079G14	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C079G15	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C079G16	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C079G17	pDONR221															
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C079G18	pDONR221															
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C079G19	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C079G20	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C079G21	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C079G22	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C079G23	pDONR221															
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C079G24	pDONR221															
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C079H01	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C079H02	pDONR221			RPL32P20	392271											
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C079H03	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C079H04	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C079H05	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C079H06	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C079H07	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C079H08	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C079H09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C079H10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C079H11	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C079H12	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C079H13	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C079H14	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C079H15	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C079H16	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C079H17	pDONR221															
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C079H18	pDONR221															
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C079H19	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C079H20	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C079H21	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C079H22	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C079H23	pDONR221															
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C079H24	pDONR221															
IKAKEN	TST08313	06-2_03-E01	EST	W01C079I01	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06-2_03-E01	EST	W01C079I02	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C079I03	pDONR221															
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C079I04	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C079I05	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C079I06	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C079I07	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C079I08	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C079I09	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C079I10	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C079I11	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C079I12	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C079I13	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C079I14	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C079I15	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C079I16	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C079I17	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C079I18	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C079I19	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C079I20	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C079I21	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C079I22	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C079I23	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C079I24	pDONR221															
IKAKEN	TST08313	06-2_03-E01	EST	W01C079J01	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06-2_03-E01	EST	W01C079J02	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C079J03	pDONR221															
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C079J04	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C079J05	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C079J06	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C079J07	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C079J08	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C079J09	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C079J10	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C079J11	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C079J12	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C079J13	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C079J14	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C079J15	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C079J16	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C079J17	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C079J18	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C079J19	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C079J20	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C079J21	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C079J22	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C079J23	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C079J24	pDONR221															
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C079K01	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C079K02	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C079K03	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C079K04	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C079K05	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C079K06	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C079K07	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C079K08	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C079K09	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C079K10	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C079K11	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C079K12	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC062212	06-2_03-F07	MGC	W01C079K13	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06-2_03-F07	MGC	W01C079K14	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C079K15	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C079K16	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C079K17	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C079K18	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C079K19	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C079K20	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C079K21	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C079K22	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C079K23	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C079K24	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C079L01	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C079L02	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C079L03	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C079L04	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C079L05	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C079L06	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C079L07	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C079L08	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C079L09	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C079L10	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C079L11	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C079L12	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC062212	06-2_03-F07	MGC	W01C079L13	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06-2_03-F07	MGC	W01C079L14	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C079L15	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C079L16	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C079L17	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C079L18	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C079L19	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C079L20	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C079L21	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C079L22	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C079L23	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C079L24	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C079M01	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C079M02	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C079M03	pDONR221															
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C079M04	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C079M05	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C079M06	pDONR221															
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C079M07	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C079M08	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C079M09	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C079M10	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C079M11	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C079M12	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C079M13	pDONR221															
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C079M14	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C079M15	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C079M16	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C079M17	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C079M18	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C079M19	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C079M20	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C079M21	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C079M22	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C079M23	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C079M24	pDONR221															
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C079N01	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C079N02	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C079N03	pDONR221															
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C079N04	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C079N05	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C079N06	pDONR221															
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C079N07	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C079N08	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C079N09	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C079N10	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C079N11	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C079N12	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C079N13	pDONR221															
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C079N14	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C079N15	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C079N16	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C079N17	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C079N18	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C079N19	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C079N20	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C079N21	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C079N22	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C079N23	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C079N24	pDONR221															
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C079O01	pDONR221															
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C079O02	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C079O03	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C079O04	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C079O05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C079O06	pDONR221															
IKAKEN	DMC00978	06-2_03-H04	EST	W01C079O07	pDONR221				391427											
IKAKEN	DMC00978	06-2_03-H04	EST	W01C079O08	pDONR221				391427											
IKAKEN	DMC09081	06-2_03-H05	EST	W01C079O09	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06-2_03-H05	EST	W01C079O10	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	RCT10716	06-2_03-H06	EST	W01C079O11	pDONR221															
IKAKEN	RCT10716	06-2_03-H06	EST	W01C079O12	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C079O13	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C079O14	pDONR221															
IKAKEN	RCT10983	06-2_03-H08	EST	W01C079O15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06-2_03-H08	EST	W01C079O16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TST05652	06-2_03-H09	EST	W01C079O17	pDONR221															
IKAKEN	TST05652	06-2_03-H09	EST	W01C079O18	pDONR221															
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C079O19	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C079O20	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C079O21	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C079O22	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	TMS00322	06-2_03-H12	EST	W01C079O23	pDONR221				389953											
IKAKEN	TMS00322	06-2_03-H12	EST	W01C079O24	pDONR221				389953											
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C079P01	pDONR221															
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C079P02	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C079P03	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C079P04	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C079P05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C079P06	pDONR221															
IKAKEN	DMC00978	06-2_03-H04	EST	W01C079P07	pDONR221				391427											
IKAKEN	DMC00978	06-2_03-H04	EST	W01C079P08	pDONR221				391427											
IKAKEN	DMC09081	06-2_03-H05	EST	W01C079P09	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06-2_03-H05	EST	W01C079P10	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	RCT10716	06-2_03-H06	EST	W01C079P11	pDONR221															
IKAKEN	RCT10716	06-2_03-H06	EST	W01C079P12	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C079P13	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C079P14	pDONR221															
IKAKEN	RCT10983	06-2_03-H08	EST	W01C079P15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06-2_03-H08	EST	W01C079P16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TST05652	06-2_03-H09	EST	W01C079P17	pDONR221															
IKAKEN	TST05652	06-2_03-H09	EST	W01C079P18	pDONR221															
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C079P19	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C079P20	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C079P21	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C079P22	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	TMS00322	06-2_03-H12	EST	W01C079P23	pDONR221				389953											
IKAKEN	TMS00322	06-2_03-H12	EST	W01C079P24	pDONR221				389953											
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C080A01	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C080A02	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C080A03	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C080A04	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C080A05	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C080A06	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	WMC08458	06-2_03-A04	EST	W01C080A07	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06-2_03-A04	EST	W01C080A08	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C080A09	pDONR221															
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C080A10	pDONR221															
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C080A11	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C080A12	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	DAT04650	06-2_03-A07	EST	W01C080A13	pDONR221															
IKAKEN	DAT04650	06-2_03-A07	EST	W01C080A14	pDONR221															
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C080A15	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C080A16	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C080A17	pDONR221															
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C080A18	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C080A19	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C080A20	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C080A21	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C080A22	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C080A23	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C080A24	pDONR221															
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C080B01	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR05391	06-2_03-A01	EST(RND)	W01C080B02	pDONR221			FAM5C	339479		Hs.65765	Family with sequence similarity 5, member C						NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C080B03	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR06748	06-2_03-A02	EST(RND)	W01C080B04	pDONR221			IMAA	387254		Hs.664952	SLC7A5 pseudogene								
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C080B05	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	OFR07993	06-2_03-A03	EST(RND)	W01C080B06	pDONR221			BTBD8	284697		Hs.676102	BTB (POZ) domain containing 8						NM_183242.3	NP_899065.2	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	WMC08458	06-2_03-A04	EST	W01C080B07	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	WMC08458	06-2_03-A04	EST	W01C080B08	pDONR221			LDOC1L	84247		Hs.715637	Leucine zipper, down-regulated in cancer 1-like						NM_032287.2	NP_115663.2	VALIDATED	P	1.000	1.000	184	555	1	552	239	56	239
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C080B09	pDONR221															
IKAKEN	SK002C01	06-2_03-A05	IMS	W01C080B10	pDONR221															
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C080B11	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	AMR01210	06-2_03-A06	EST(RND)	W01C080B12	pDONR221			IPCEF1	26034		Hs.146100	Interaction protein for cytohesin exchange factors 1						NM_015553.2	NP_056368.1	VALIDATED	OK	1.000	1.000	437	1314	1	1311	437	1	437
IKAKEN	DAT04650	06-2_03-A07	EST	W01C080B13	pDONR221															
IKAKEN	DAT04650	06-2_03-A07	EST	W01C080B14	pDONR221															
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C080B15	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	FBR02328	06-2_03-A08	EST(RND)	W01C080B16	pDONR221			CACNB4	785		Hs.120725	Calcium channel, voltage-dependent, beta 4 subunit						NM_001005747.2	NP_001005747.1	REVIEWED	Cgs	0.968	0.986	495	1488	1	1485	486	1	486
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C080B17	pDONR221															
IKAKEN	HCR04067	06-2_03-A09	EST(RND)	W01C080B18	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C080B19	pDONR221															
IKAKEN	IMSRT035	06-2_03-A10	IMS	W01C080B20	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C080B21	pDONR221															
IKAKEN	IMSRT055	06-2_03-A11	IMS	W01C080B22	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C080B23	pDONR221															
IKAKEN	IMSRT071	06-2_03-A12	IMS	W01C080B24	pDONR221															
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C080C01	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C080C02	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	MPG07137	06-2_03-B02	EST	W01C080C03	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06-2_03-B02	EST	W01C080C04	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C080C05	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C080C06	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C080C07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C080C08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C080C09	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C080C10	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C080C11	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C080C12	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C080C13	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C080C14	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C080C15	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C080C16	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C080C17	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C080C18	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C080C19	pDONR221															
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C080C20	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C080C21	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C080C22	pDONR221															
IKAKEN	DMC08208	06-2_03-B12	EST	W01C080C23	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06-2_03-B12	EST	W01C080C24	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C080D01	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	KGR03694	06-2_03-B01	EST(RND)	W01C080D02	pDONR221			LOC441066	441066									XM_001724599.1	XP_001724651.1	MODEL		0.708	0.708	24	549	328	399	73	1	24
IKAKEN	MPG07137	06-2_03-B02	EST	W01C080D03	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	MPG07137	06-2_03-B02	EST	W01C080D04	pDONR221			SIGLEC15	284266		Hs.287692	Sialic acid binding Ig-like lectin 15						NM_213602.2	NP_998767.1	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C080D05	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	OFR02517	06-2_03-B03	EST(RND)	W01C080D06	pDONR221			NHLRC3	387921		Hs.507783	NHL repeat containing 3						NM_001012754.2	NP_001012772.1	VALIDATED	OK	1.000	1.000	347	1044	1	1041	347	1	347
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C080D07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	PLR00894	06-2_03-B04	EST(RND)	W01C080D08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	OK	1.000	1.000	378	1137	1	1134	378	1	378
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C080D09	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY2041870	06-2_03-B05	EST(F-)	W01C080D10	pDONR221			CLIC6	54102		Hs.473695	Chloride intracellular channel 6						NM_053277.1	NP_444507.1	REVIEWED	OK	1.000	1.000	686	2061	1	2058	686	1	686
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C080D11	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAMY3014398	06-2_03-B06	EST(F-)	W01C080D12	pDONR221			PPFIA3	8541		Hs.413748	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 3						NM_003660.2	NP_003651.1	REVIEWED	OK	1.000	1.000	1194	3585	1	3582	1194	1	1194
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C080D13	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRAWH3025444	06-2_03-B07	EST(F-)	W01C080D14	pDONR221			KIAA1486	57624		Hs.224409	KIAA1486 protein						NM_020864.1	NP_065915.1	VALIDATED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C080D15	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-BRHIP3013620	06-2_03-B08	EST(F-)	W01C080D16	pDONR221			DNAH6	1768		Hs.249972	Dynein, axonemal, heavy chain 6						NM_001370.1	NP_001361.1	VALIDATED	Pg	0.996	1.000	1356	4071	1	4068	4158	2809	4158
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C080D17	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-NCRRM1000093	06-2_03-B09	EST(F-)	W01C080D18	pDONR221			HELB	92797		Hs.505941	Helicase (DNA) B						NM_033647.2	NP_387467.2	REVIEWED	OK	1.000	1.000	1087	3264	1	3261	1087	1	1087
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C080D19	pDONR221															
IKAKEN	F-CERVX2000844	06-2_03-B10	EST(F-)	W01C080D20	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C080D21	pDONR221															
IKAKEN	F-THYMU3036548	06-2_03-B11	EST(F-)	W01C080D22	pDONR221															
IKAKEN	DMC08208	06-2_03-B12	EST	W01C080D23	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	DMC08208	06-2_03-B12	EST	W01C080D24	pDONR221			COMP	1311		Hs.1584	Cartilage oligomeric matrix protein						NM_000095.2	NP_000086.2	REVIEWED	OK	1.000	1.000	757	2274	1	2271	757	1	757
IKAKEN	LFL01807	06-2_03-C01	EST	W01C080E01	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06-2_03-C01	EST	W01C080E02	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	SLV02550	06-2_03-C02	EST	W01C080E03	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06-2_03-C02	EST	W01C080E04	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C080E05	pDONR221															
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C080E06	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C080E07	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C080E08	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C080E09	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C080E10	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C080E11	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C080E12	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C080E13	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C080E14	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C080E15	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C080E16	pDONR221															
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C080E17	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C080E18	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C080E19	pDONR221															
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C080E20	pDONR221															
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C080E21	pDONR221				392550											
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C080E22	pDONR221				392550											
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C080E23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C080E24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	LFL01807	06-2_03-C01	EST	W01C080F01	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	LFL01807	06-2_03-C01	EST	W01C080F02	pDONR221			C14orf102	55051		Hs.528131	Chromosome 14 open reading frame 102						NM_017970.2	NP_060440.2	VALIDATED	OK	1.000	1.000	1164	3495	1	3492	1164	1	1164
IKAKEN	SLV02550	06-2_03-C02	EST	W01C080F03	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	SLV02550	06-2_03-C02	EST	W01C080F04	pDONR221			KIAA1324	57535		Hs.708190	KIAA1324						NM_020775.2	NP_065826.2	VALIDATED	Cs	0.999	0.999	1013	3042	1	3039	1013	1	1013
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C080F05	pDONR221															
IKAKEN	ARa32B05.ab1	06-2_03-C03		W01C080F06	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C080F07	pDONR221															
IKAKEN	RBb08E09.ab1	06-2_03-C04		W01C080F08	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C080F09	pDONR221															
IKAKEN	ARe03D03.ab1	06-2_03-C05		W01C080F10	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C080F11	pDONR221															
IKAKEN	ARe87G04.ab1	06-2_03-C06		W01C080F12	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C080F13	pDONR221															
IKAKEN	ARa54E12.ab1	06-2_03-C07		W01C080F14	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C080F15	pDONR221															
IKAKEN	KAR01783	06-2_03-C08	EST(RND)	W01C080F16	pDONR221															
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C080F17	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-C09	EST(RND)	W01C080F18	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C080F19	pDONR221															
IKAKEN	SK003C10	06-2_03-C10	IMS	W01C080F20	pDONR221															
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C080F21	pDONR221				392550											
IKAKEN	CS0DE009YD22	06-2_03-C11		W01C080F22	pDONR221				392550											
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C080F23	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	BX405609 (5' CS0DM006YH13)	06-2_03-C12		W01C080F24	pDONR221			KIF18B	146909		Hs.135094	Kinesin family member 18B						NM_001080443.1	NP_001073912.1	PROVISIONAL	Pgs	0.974	0.997	384	1167	1	1152	855	446	820
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C080G01	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C080G02	pDONR221			RPL32P20	392271											
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C080G03	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C080G04	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C080G05	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C080G06	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C080G07	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C080G08	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C080G09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C080G10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C080G11	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C080G12	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C080G13	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C080G14	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C080G15	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C080G16	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C080G17	pDONR221															
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C080G18	pDONR221															
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C080G19	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C080G20	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C080G21	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C080G22	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C080G23	pDONR221															
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C080G24	pDONR221															
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C080H01	pDONR221			RPL32P20	392271											
IKAKEN	CS0DJ013YH23	06-2_03-D01		W01C080H02	pDONR221			RPL32P20	392271											
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C080H03	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CS0DA010YN22	06-2_03-D02		W01C080H04	pDONR221			RP3-402G11.5	83642		Hs.365405	Selenoprotein O						NM_031454.1	NP_113642.1	REVIEWED	P	1.000	1.000	666	2001	1	1998	668	1	666
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C080H05	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CL0BA004ZD09	06-2_03-D03		W01C080H06	pDONR221			C20orf194	25943		Hs.516853	Chromosome 20 open reading frame 194						NM_001009984.1	NP_001009984.1	VALIDATED	Pgs	0.997	0.999	747	2331	1	2238	1177	1	747
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C080H07	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	CS0DK007YG10	06-2_03-D04		W01C080H08	pDONR221			C9orf140	89958		Hs.19322	Chromosome 9 open reading frame 140						NM_178448.3	NP_848543.2	VALIDATED	P	1.000	1.000	389	1170	1	1167	394	6	394
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C080H09	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H013067I10	06-2_03-D05	Riken	W01C080H10	pDONR221			MICALL1	85377		Hs.517610	MICAL-like 1						NM_033386.2	NP_203744.1	VALIDATED	OK	1.000	1.000	863	2592	1	2589	863	1	863
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C080H11	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023076K12	06-2_03-D06	Riken	W01C080H12	pDONR221			FHL1	2273		Hs.435369	Four and a half LIM domains 1						NM_001159703.1	NP_001153175.1	VALIDATED	OK	1.000	1.000	194	585	1	582	194	1	194
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C080H13	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H023090D10	06-2_03-D07	Riken	W01C080H14	pDONR221			FAM98C	147965		Hs.355162	Family with sequence similarity 98, member C						NM_174905.3	NP_777565.3	VALIDATED	Cfs	0.943	1.000	349	1035	1	986	349	1	349
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C080H15	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076F03	06-2_03-D08	Riken	W01C080H16	pDONR221			CTNND2	1501		Hs.314543	Catenin (cadherin-associated protein), delta 2 (neural plakophilin-related arm-repeat protein)						NM_001332.2	NP_001323.1	VALIDATED	Pg	0.952	1.000	1211	3462	1	3459	1225	15	1225
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C080H17	pDONR221															
IKAKEN	H033076L09	06-2_03-D09	Riken	W01C080H18	pDONR221															
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C080H19	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H013094G13	06-2_03-D10	Riken	W01C080H20	pDONR221			SLC36A3	285641		Hs.132482	Solute carrier family 36 (proton/amino acid symporter), member 3						NM_181774.3	NP_861439.3	VALIDATED	OK	1.000	1.000	470	1413	1	1410	470	1	470
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C080H21	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	H033062B14	06-2_03-D11	Riken	W01C080H22	pDONR221			FAM108C1	58489		Hs.459072	Family with sequence similarity 108, member C1						NM_021214.1	NP_067037.1	VALIDATED	P	1.000	1.000	322	969	1	966	329	8	329
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C080H23	pDONR221															
IKAKEN	KMR09306	06-2_03-D12	EST(RND)	W01C080H24	pDONR221															
IKAKEN	TST08313	06-2_03-E01	EST	W01C080I01	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06-2_03-E01	EST	W01C080I02	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C080I03	pDONR221															
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C080I04	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C080I05	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C080I06	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C080I07	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C080I08	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C080I09	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C080I10	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C080I11	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C080I12	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C080I13	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C080I14	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C080I15	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C080I16	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C080I17	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C080I18	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C080I19	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C080I20	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C080I21	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C080I22	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C080I23	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C080I24	pDONR221															
IKAKEN	TST08313	06-2_03-E01	EST	W01C080J01	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	TST08313	06-2_03-E01	EST	W01C080J02	pDONR221			FAM153B	202134		Hs.655683	Family with sequence similarity 153, member B						NM_001079529.2	NP_001072997.2	VALIDATED	Pfs	0.936	0.944	327	1004	2	974	387	3	329
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C080J03	pDONR221															
IKAKEN	SK004B06	06-2_03-E02	IMS	W01C080J04	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C080J05	pDONR221															
IKAKEN	SK004D06	06-2_03-E03	IMS	W01C080J06	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C080J07	pDONR221															
IKAKEN	SK004D06	06-2_03-E04	IMS	W01C080J08	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C080J09	pDONR221															
IKAKEN	SK004D06	06-2_03-E05	IMS	W01C080J10	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C080J11	pDONR221															
IKAKEN	SK004F08	06-2_03-E06	IMS	W01C080J12	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C080J13	pDONR221															
IKAKEN	SK004H06	06-2_03-E07	IMS	W01C080J14	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C080J15	pDONR221															
IKAKEN	SK005B05	06-2_03-E08	IMS	W01C080J16	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C080J17	pDONR221															
IKAKEN	SK005H05	06-2_03-E09	IMS	W01C080J18	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C080J19	pDONR221															
IKAKEN	SK004H12	06-2_03-E10	IMS	W01C080J20	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C080J21	pDONR221															
IKAKEN	SK004A11	06-2_03-E11		W01C080J22	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C080J23	pDONR221															
IKAKEN	SK004C08	06-2_03-E12		W01C080J24	pDONR221															
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C080K01	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C080K02	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C080K03	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C080K04	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C080K05	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C080K06	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C080K07	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C080K08	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C080K09	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C080K10	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C080K11	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C080K12	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC062212	06-2_03-F07	MGC	W01C080K13	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06-2_03-F07	MGC	W01C080K14	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C080K15	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C080K16	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C080K17	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C080K18	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C080K19	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C080K20	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C080K21	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C080K22	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C080K23	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C080K24	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C080L01	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	HER06925	06-2_03-F01	EST(RND)	W01C080L02	pDONR221			RPL18AP4	127545									XM_001724240.1	XP_001724292.1	MODEL	OK	1.000	1.000	175	528	1	525	175	1	175
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C080L03	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	OFR01363	06-2_03-F02	EST(RND)	W01C080L04	pDONR221			ERCC4	2072		Hs.567265	Excision repair cross-complementing rodent repair deficiency, complementation group 4						NM_005236.2	NP_005227.1	REVIEWED	OK	1.000	1.000	916	2751	1	2748	916	1	916
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C080L05	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	PLR07473	06-2_03-F03	EST(RND)	W01C080L06	pDONR221			ACER2	340485		Hs.41379	Alkaline ceramidase 2						NM_001010887.2	NP_001010887.2	VALIDATED	Cg	0.833	1.000	275	690	1	687	275	1	275
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C080L07	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR05788	06-2_03-F04	EST(RND)	W01C080L08	pDONR221			EXPH5	23086		Hs.28540	Exophilin 5						NM_001144765.1	NP_001138237.1	VALIDATED	Cs	0.999	0.999	1801	5970	565	5967	1801	1	1801
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C080L09	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TDR06330	06-2_03-F05	EST(RND)	W01C080L10	pDONR221			LMLN	89782		Hs.518540	Leishmanolysin-like (metallopeptidase M8 family)						NM_033029.3	NP_149018.2	REVIEWED	OK	1.000	1.000	655	1968	1	1965	655	1	655
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C080L11	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	TIR06571	06-2_03-F06	EST(RND)	W01C080L12	pDONR221			TET3	200424		Hs.516107	Tet oncogene family member 3						NM_144993.1	NP_659430.1	PROVISIONAL	P	1.000	1.000	411	1236	1	1233	1660	317	727
IKAKEN	BC062212	06-2_03-F07	MGC	W01C080L13	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	BC062212	06-2_03-F07	MGC	W01C080L14	pDONR221	14980		DEFB119	245932	AAH62212.1	Hs.516998	Defensin, beta 119			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_173460.1	NP_775689.1	VALIDATED	OK	1.000	1.000	43	132	1	129	43	1	43
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C080L15	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H013011E16	06-2_03-F08	Riken	W01C080L16	pDONR221			C1orf175	374977									NM_001039464.2	NP_001034553.2	VALIDATED	Ps	0.999	0.999	988	3093	1	2964	1323	1	988
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C080L17	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	H033059F01	06-2_03-F09	Riken	W01C080L18	pDONR221			RLTPR	146206		Hs.611432	RGD motif, leucine rich repeats, tropomodulin domain and proline-rich containing						NM_001013838.1	NP_001013860.1	PROVISIONAL	Pfs	0.988	0.994	345	1032	1	1028	1435	1007	1351
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C080L19	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-F10	EST(F-)	W01C080L20	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C080L21	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	BX458059 (5' CS0DA009YK08)	06-2_03-F11		W01C080L22	pDONR221			HNRNPC	3183		Hs.508848	Heterogeneous nuclear ribonucleoprotein C (C1/C2)						NM_001077443.1	NP_001070911.1	REVIEWED		0.893	0.923	187	624	79	621	293	107	293
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C080L23	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013087P15	06-2_03-F12	Riken	W01C080L24	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.909	0.921	831	2505	1	2490	1765	1	821
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C080M01	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C080M02	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C080M03	pDONR221															
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C080M04	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C080M05	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C080M06	pDONR221															
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C080M07	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C080M08	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C080M09	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C080M10	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C080M11	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C080M12	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C080M13	pDONR221															
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C080M14	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C080M15	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C080M16	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C080M17	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C080M18	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C080M19	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C080M20	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C080M21	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C080M22	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C080M23	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C080M24	pDONR221															
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C080N01	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H013086M14	06-2_03-G01	Riken	W01C080N02	pDONR221			ACRV1	56		Hs.169222	Acrosomal vesicle protein 1						NM_020111.3	NP_064496.1	REVIEWED	OK	1.000	1.000	170	513	1	510	170	1	170
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C080N03	pDONR221															
IKAKEN	H033091K21	06-2_03-G02	Riken	W01C080N04	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C080N05	pDONR221															
IKAKEN	BX434004 (3' CS0DE001YN14)	06-2_03-G03		W01C080N06	pDONR221															
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C080N07	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	F-TESTI2036327	06-2_03-G04	EST(F-)	W01C080N08	pDONR221			BPY2B	442867		Hs.632848	Basic charge, Y-linked, 2B						NM_001002760.1	NP_001002760.1	REVIEWED	OK	1.000	1.000	106	321	1	318	106	1	106
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C080N09	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX439688 (5' CS0DE013YD13)	06-2_03-G05		W01C080N10	pDONR221			SPIRE2	84501		Hs.461786	Spire homolog 2 (Drosophila)						NM_032451.1	NP_115827.1	VALIDATED	Cg	0.990	1.000	721	2166	1	2163	714	1	714
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C080N11	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	BX359188 (5' CS0DI054YA12)	06-2_03-G06		W01C080N12	pDONR221			P2RX6	9127		Hs.113275	Purinergic receptor P2X, ligand-gated ion channel, 6						NM_005446.3	NP_005437.2	REVIEWED	Pgs	0.993	0.998	433	1302	1	1299	441	11	441
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C080N13	pDONR221															
IKAKEN	SK002A06	06-2_03-G07	IMS	W01C080N14	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C080N15	pDONR221															
IKAKEN	F-BLADE2000432	06-2_03-G08	EST(F-)	W01C080N16	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C080N17	pDONR221															
IKAKEN	SK006C11	06-2_03-G09		W01C080N18	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C080N19	pDONR221															
IKAKEN	KMR09306	06-2_03-G10	EST(RND)	W01C080N20	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C080N21	pDONR221															
IKAKEN	SK006C06	06-2_03-G11	IMS	W01C080N22	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C080N23	pDONR221															
IKAKEN	SK006C09	06-2_03-G12	IMS	W01C080N24	pDONR221															
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C080O01	pDONR221															
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C080O02	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C080O03	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C080O04	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C080O05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C080O06	pDONR221															
IKAKEN	DMC00978	06-2_03-H04	EST	W01C080O07	pDONR221				391427											
IKAKEN	DMC00978	06-2_03-H04	EST	W01C080O08	pDONR221				391427											
IKAKEN	DMC09081	06-2_03-H05	EST	W01C080O09	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06-2_03-H05	EST	W01C080O10	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	RCT10716	06-2_03-H06	EST	W01C080O11	pDONR221															
IKAKEN	RCT10716	06-2_03-H06	EST	W01C080O12	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C080O13	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C080O14	pDONR221															
IKAKEN	RCT10983	06-2_03-H08	EST	W01C080O15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06-2_03-H08	EST	W01C080O16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TST05652	06-2_03-H09	EST	W01C080O17	pDONR221															
IKAKEN	TST05652	06-2_03-H09	EST	W01C080O18	pDONR221															
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C080O19	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C080O20	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C080O21	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C080O22	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	TMS00322	06-2_03-H12	EST	W01C080O23	pDONR221				389953											
IKAKEN	TMS00322	06-2_03-H12	EST	W01C080O24	pDONR221				389953											
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C080P01	pDONR221															
IKAKEN	SK006E04	06-2_03-H01	IMS	W01C080P02	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C080P03	pDONR221															
IKAKEN	SK006H05	06-2_03-H02	IMS	W01C080P04	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C080P05	pDONR221															
IKAKEN	BX362517 (5' CS0DK001YE14)	06-2_03-H03		W01C080P06	pDONR221															
IKAKEN	DMC00978	06-2_03-H04	EST	W01C080P07	pDONR221				391427											
IKAKEN	DMC00978	06-2_03-H04	EST	W01C080P08	pDONR221				391427											
IKAKEN	DMC09081	06-2_03-H05	EST	W01C080P09	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	DMC09081	06-2_03-H05	EST	W01C080P10	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.300	0.300	30	324	132	43	311	7	36
IKAKEN	RCT10716	06-2_03-H06	EST	W01C080P11	pDONR221															
IKAKEN	RCT10716	06-2_03-H06	EST	W01C080P12	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C080P13	pDONR221															
IKAKEN	FCC168E01	06-2_03-H07	TOYOBO	W01C080P14	pDONR221															
IKAKEN	RCT10983	06-2_03-H08	EST	W01C080P15	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	RCT10983	06-2_03-H08	EST	W01C080P16	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.263	0.263	38	435	255	367	311	260	297
IKAKEN	TST05652	06-2_03-H09	EST	W01C080P17	pDONR221															
IKAKEN	TST05652	06-2_03-H09	EST	W01C080P18	pDONR221															
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C080P19	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	F-SYNOV4004386	06-2_03-H10	EST(F-)	W01C080P20	pDONR221			PVT1	5820		Hs.675281	Pvt1 oncogene (non-protein coding)								
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C080P21	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	SMR06522	06-2_03-H11	EST(RND)	W01C080P22	pDONR221			SAR1P3	344988									XM_293671.6	XP_293671.6	MODEL	P	1.000	1.000	189	573	1	567	252	1	189
IKAKEN	TMS00322	06-2_03-H12	EST	W01C080P23	pDONR221				389953											
IKAKEN	TMS00322	06-2_03-H12	EST	W01C080P24	pDONR221				389953											
IKAKEN	AK057328	IMS04-A01	FLJ	W01C081A01	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-A01	FLJ	W01C081A02	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC039173	IMS04-A02	MGC	W01C081A03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS04-A02	MGC	W01C081A04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	IMS04-A03	MGC	W01C081A05	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS04-A03	MGC	W01C081A06	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS04-A04	MGC	W01C081A07	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS04-A04	MGC	W01C081A08	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS04-A05	MGC	W01C081A09	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS04-A05	MGC	W01C081A10	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	IMS04-A06	MGC	W01C081A11	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS04-A06	MGC	W01C081A12	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC031617	IMS04-A07	MGC	W01C081A13	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS04-A07	MGC	W01C081A14	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031624	IMS04-A08	MGC	W01C081A15	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS04-A08	MGC	W01C081A16	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS04-A09	MGC	W01C081A17	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS04-A09	MGC	W01C081A18	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC051704	IMS04-A10	MGC	W01C081A19	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC051704	IMS04-A10	MGC	W01C081A20	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC028119	IMS04-A11	MGC	W01C081A21	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028119	IMS04-A11	MGC	W01C081A22	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028198	IMS04-A12	MGC	W01C081A23	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	IMS04-A12	MGC	W01C081A24	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	AK057328	IMS04-A01	FLJ	W01C081B01	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-A01	FLJ	W01C081B02	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC039173	IMS04-A02	MGC	W01C081B03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS04-A02	MGC	W01C081B04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	IMS04-A03	MGC	W01C081B05	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS04-A03	MGC	W01C081B06	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS04-A04	MGC	W01C081B07	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS04-A04	MGC	W01C081B08	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS04-A05	MGC	W01C081B09	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS04-A05	MGC	W01C081B10	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	IMS04-A06	MGC	W01C081B11	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS04-A06	MGC	W01C081B12	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC031617	IMS04-A07	MGC	W01C081B13	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS04-A07	MGC	W01C081B14	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031624	IMS04-A08	MGC	W01C081B15	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS04-A08	MGC	W01C081B16	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS04-A09	MGC	W01C081B17	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS04-A09	MGC	W01C081B18	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC051704	IMS04-A10	MGC	W01C081B19	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC051704	IMS04-A10	MGC	W01C081B20	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC028119	IMS04-A11	MGC	W01C081B21	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028119	IMS04-A11	MGC	W01C081B22	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028198	IMS04-A12	MGC	W01C081B23	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	IMS04-A12	MGC	W01C081B24	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC040553	IMS04-B01	MGC	W01C081C01	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC040553	IMS04-B01	MGC	W01C081C02	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC033737	IMS04-B02	MGC	W01C081C03	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC033737	IMS04-B02	MGC	W01C081C04	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC052962	IMS04-B03	MGC	W01C081C05	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC052962	IMS04-B03	MGC	W01C081C06	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC048324	IMS04-B04	MGC	W01C081C07	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC048324	IMS04-B04	MGC	W01C081C08	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC050462	IMS04-B05	MGC	W01C081C09	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	IMS04-B05	MGC	W01C081C10	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC054490	IMS04-B06	MGC	W01C081C11	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC054490	IMS04-B06	MGC	W01C081C12	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC053584	IMS04-B07	MGC	W01C081C13	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	IMS04-B07	MGC	W01C081C14	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053557	IMS04-B08	MGC	W01C081C15	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC053557	IMS04-B08	MGC	W01C081C16	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC054036	IMS04-B09	MGC	W01C081C17	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	IMS04-B09	MGC	W01C081C18	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC063489	IMS04-B10	MGC	W01C081C19	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC063489	IMS04-B10	MGC	W01C081C20	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC064579	IMS04-B11	MGC	W01C081C21	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC064579	IMS04-B11	MGC	W01C081C22	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063804	IMS04-B12	MGC	W01C081C23	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC063804	IMS04-B12	MGC	W01C081C24	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC040553	IMS04-B01	MGC	W01C081D01	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC040553	IMS04-B01	MGC	W01C081D02	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC033737	IMS04-B02	MGC	W01C081D03	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC033737	IMS04-B02	MGC	W01C081D04	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC052962	IMS04-B03	MGC	W01C081D05	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC052962	IMS04-B03	MGC	W01C081D06	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC048324	IMS04-B04	MGC	W01C081D07	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC048324	IMS04-B04	MGC	W01C081D08	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC050462	IMS04-B05	MGC	W01C081D09	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	IMS04-B05	MGC	W01C081D10	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC054490	IMS04-B06	MGC	W01C081D11	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC054490	IMS04-B06	MGC	W01C081D12	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC053584	IMS04-B07	MGC	W01C081D13	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	IMS04-B07	MGC	W01C081D14	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053557	IMS04-B08	MGC	W01C081D15	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC053557	IMS04-B08	MGC	W01C081D16	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC054036	IMS04-B09	MGC	W01C081D17	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	IMS04-B09	MGC	W01C081D18	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC063489	IMS04-B10	MGC	W01C081D19	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC063489	IMS04-B10	MGC	W01C081D20	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC064579	IMS04-B11	MGC	W01C081D21	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC064579	IMS04-B11	MGC	W01C081D22	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063804	IMS04-B12	MGC	W01C081D23	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC063804	IMS04-B12	MGC	W01C081D24	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC008792	IMS04-C01	MGC	W01C081E01	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC008792	IMS04-C01	MGC	W01C081E02	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC007758	IMS04-C02	MGC	W01C081E03	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC007758	IMS04-C02	MGC	W01C081E04	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC011705	IMS04-C03	MGC	W01C081E05	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC011705	IMS04-C03	MGC	W01C081E06	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC042161	IMS04-C04	MGC	W01C081E07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	IMS04-C04	MGC	W01C081E08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	IMS04-C05	MGC	W01C081E09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	IMS04-C05	MGC	W01C081E10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041058	IMS04-C06	MGC	W01C081E11	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	IMS04-C06	MGC	W01C081E12	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041594	IMS04-C07	MGC	W01C081E13	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	IMS04-C07	MGC	W01C081E14	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC045108	IMS04-C08	MGC	W01C081E15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	IMS04-C08	MGC	W01C081E16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045110	IMS04-C09	MGC	W01C081E17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	IMS04-C09	MGC	W01C081E18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC042914	IMS04-C10	MGC	W01C081E19	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	IMS04-C10	MGC	W01C081E20	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC041070	IMS04-C11	MGC	W01C081E21	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	IMS04-C11	MGC	W01C081E22	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041608	IMS04-C12	MGC	W01C081E23	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	IMS04-C12	MGC	W01C081E24	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC008792	IMS04-C01	MGC	W01C081F01	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC008792	IMS04-C01	MGC	W01C081F02	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC007758	IMS04-C02	MGC	W01C081F03	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC007758	IMS04-C02	MGC	W01C081F04	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC011705	IMS04-C03	MGC	W01C081F05	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC011705	IMS04-C03	MGC	W01C081F06	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC042161	IMS04-C04	MGC	W01C081F07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	IMS04-C04	MGC	W01C081F08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	IMS04-C05	MGC	W01C081F09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	IMS04-C05	MGC	W01C081F10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041058	IMS04-C06	MGC	W01C081F11	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	IMS04-C06	MGC	W01C081F12	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041594	IMS04-C07	MGC	W01C081F13	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	IMS04-C07	MGC	W01C081F14	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC045108	IMS04-C08	MGC	W01C081F15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	IMS04-C08	MGC	W01C081F16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045110	IMS04-C09	MGC	W01C081F17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	IMS04-C09	MGC	W01C081F18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC042914	IMS04-C10	MGC	W01C081F19	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	IMS04-C10	MGC	W01C081F20	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC041070	IMS04-C11	MGC	W01C081F21	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	IMS04-C11	MGC	W01C081F22	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041608	IMS04-C12	MGC	W01C081F23	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	IMS04-C12	MGC	W01C081F24	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041609	IMS04-D01	MGC	W01C081G01	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	IMS04-D01	MGC	W01C081G02	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC048194	IMS04-D02	MGC	W01C081G03	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	IMS04-D02	MGC	W01C081G04	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC044634	IMS04-D03	MGC	W01C081G05	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	IMS04-D03	MGC	W01C081G06	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC042921	IMS04-D04	MGC	W01C081G07	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	IMS04-D04	MGC	W01C081G08	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC052285	IMS04-D05	MGC	W01C081G09	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	IMS04-D05	MGC	W01C081G10	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052289	IMS04-D06	MGC	W01C081G11	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	IMS04-D06	MGC	W01C081G12	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052581	IMS04-D07	MGC	W01C081G13	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	IMS04-D07	MGC	W01C081G14	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC053991	IMS04-D08	MGC	W01C081G15	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	IMS04-D08	MGC	W01C081G16	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC052293	IMS04-D09	MGC	W01C081G17	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	IMS04-D09	MGC	W01C081G18	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC062213	IMS04-D10	MGC	W01C081G19	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	IMS04-D10	MGC	W01C081G20	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062217	IMS04-D11	MGC	W01C081G21	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	IMS04-D11	MGC	W01C081G22	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065714	IMS04-D12	MGC	W01C081G23	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	IMS04-D12	MGC	W01C081G24	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC041609	IMS04-D01	MGC	W01C081H01	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	IMS04-D01	MGC	W01C081H02	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC048194	IMS04-D02	MGC	W01C081H03	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	IMS04-D02	MGC	W01C081H04	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC044634	IMS04-D03	MGC	W01C081H05	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	IMS04-D03	MGC	W01C081H06	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC042921	IMS04-D04	MGC	W01C081H07	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	IMS04-D04	MGC	W01C081H08	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC052285	IMS04-D05	MGC	W01C081H09	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	IMS04-D05	MGC	W01C081H10	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052289	IMS04-D06	MGC	W01C081H11	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	IMS04-D06	MGC	W01C081H12	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052581	IMS04-D07	MGC	W01C081H13	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	IMS04-D07	MGC	W01C081H14	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC053991	IMS04-D08	MGC	W01C081H15	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	IMS04-D08	MGC	W01C081H16	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC052293	IMS04-D09	MGC	W01C081H17	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	IMS04-D09	MGC	W01C081H18	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC062213	IMS04-D10	MGC	W01C081H19	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	IMS04-D10	MGC	W01C081H20	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062217	IMS04-D11	MGC	W01C081H21	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	IMS04-D11	MGC	W01C081H22	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065714	IMS04-D12	MGC	W01C081H23	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	IMS04-D12	MGC	W01C081H24	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062693	IMS04-E01	MGC	W01C081I01	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	IMS04-E01	MGC	W01C081I02	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062682	IMS04-E02	MGC	W01C081I03	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	IMS04-E02	MGC	W01C081I04	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062712	IMS04-E03	MGC	W01C081I05	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	IMS04-E03	MGC	W01C081I06	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062218	IMS04-E04	MGC	W01C081I07	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	IMS04-E04	MGC	W01C081I08	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062679	IMS04-E05	MGC	W01C081I09	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	IMS04-E05	MGC	W01C081I10	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062678	IMS04-E06	MGC	W01C081I11	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	IMS04-E06	MGC	W01C081I12	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065721	IMS04-E07	MGC	W01C081I13	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC065721	IMS04-E07	MGC	W01C081I14	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC063130	IMS04-E08	MGC	W01C081I15	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	IMS04-E08	MGC	W01C081I16	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063114	IMS04-E09	MGC	W01C081I17	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	IMS04-E09	MGC	W01C081I18	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063126	IMS04-E10	MGC	W01C081I19	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	IMS04-E10	MGC	W01C081I20	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC062423	IMS04-E11	MGC	W01C081I21	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	IMS04-E11	MGC	W01C081I22	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062680	IMS04-E12	MGC	W01C081I23	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	IMS04-E12	MGC	W01C081I24	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062693	IMS04-E01	MGC	W01C081J01	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	IMS04-E01	MGC	W01C081J02	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062682	IMS04-E02	MGC	W01C081J03	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	IMS04-E02	MGC	W01C081J04	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062712	IMS04-E03	MGC	W01C081J05	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	IMS04-E03	MGC	W01C081J06	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062218	IMS04-E04	MGC	W01C081J07	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	IMS04-E04	MGC	W01C081J08	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062679	IMS04-E05	MGC	W01C081J09	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	IMS04-E05	MGC	W01C081J10	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062678	IMS04-E06	MGC	W01C081J11	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	IMS04-E06	MGC	W01C081J12	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065721	IMS04-E07	MGC	W01C081J13	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC065721	IMS04-E07	MGC	W01C081J14	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC063130	IMS04-E08	MGC	W01C081J15	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	IMS04-E08	MGC	W01C081J16	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063114	IMS04-E09	MGC	W01C081J17	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	IMS04-E09	MGC	W01C081J18	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063126	IMS04-E10	MGC	W01C081J19	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	IMS04-E10	MGC	W01C081J20	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC062423	IMS04-E11	MGC	W01C081J21	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	IMS04-E11	MGC	W01C081J22	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062680	IMS04-E12	MGC	W01C081J23	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	IMS04-E12	MGC	W01C081J24	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062776	IMS04-F01	MGC	W01C081K01	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	IMS04-F01	MGC	W01C081K02	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062707	IMS04-F02	MGC	W01C081K03	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	IMS04-F02	MGC	W01C081K04	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062670	IMS04-F03	MGC	W01C081K05	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	IMS04-F03	MGC	W01C081K06	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062746	IMS04-F04	MGC	W01C081K07	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	IMS04-F04	MGC	W01C081K08	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062662	IMS04-F05	MGC	W01C081K09	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	IMS04-F05	MGC	W01C081K10	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062734	IMS04-F06	MGC	W01C081K11	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	IMS04-F06	MGC	W01C081K12	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC065724	IMS04-F07	MGC	W01C081K13	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	IMS04-F07	MGC	W01C081K14	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	AK055685	IMS04-F08	FLJ	W01C081K15	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK055685	IMS04-F08	FLJ	W01C081K16	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK056814	IMS04-F09	FLJ	W01C081K17	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK056814	IMS04-F09	FLJ	W01C081K18	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK057328	IMS04-F10	FLJ	W01C081K19	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-F10	FLJ	W01C081K20	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057381	IMS04-F11	FLJ	W01C081K21	pDONR221	26879									testis	TESTI2				
IKAKEN	AK057381	IMS04-F11	FLJ	W01C081K22	pDONR221	26879									testis	TESTI2				
IKAKEN	AK091373	IMS04-F12	FLJ	W01C081K23	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	AK091373	IMS04-F12	FLJ	W01C081K24	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	BC062776	IMS04-F01	MGC	W01C081L01	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	IMS04-F01	MGC	W01C081L02	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062707	IMS04-F02	MGC	W01C081L03	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	IMS04-F02	MGC	W01C081L04	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062670	IMS04-F03	MGC	W01C081L05	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	IMS04-F03	MGC	W01C081L06	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062746	IMS04-F04	MGC	W01C081L07	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	IMS04-F04	MGC	W01C081L08	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062662	IMS04-F05	MGC	W01C081L09	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	IMS04-F05	MGC	W01C081L10	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062734	IMS04-F06	MGC	W01C081L11	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	IMS04-F06	MGC	W01C081L12	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC065724	IMS04-F07	MGC	W01C081L13	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	IMS04-F07	MGC	W01C081L14	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	AK055685	IMS04-F08	FLJ	W01C081L15	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK055685	IMS04-F08	FLJ	W01C081L16	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK056814	IMS04-F09	FLJ	W01C081L17	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK056814	IMS04-F09	FLJ	W01C081L18	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK057328	IMS04-F10	FLJ	W01C081L19	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-F10	FLJ	W01C081L20	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057381	IMS04-F11	FLJ	W01C081L21	pDONR221	26879									testis	TESTI2				
IKAKEN	AK057381	IMS04-F11	FLJ	W01C081L22	pDONR221	26879									testis	TESTI2				
IKAKEN	AK091373	IMS04-F12	FLJ	W01C081L23	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	AK091373	IMS04-F12	FLJ	W01C081L24	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	AK092096	IMS04-G01	FLJ	W01C081M01	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK092096	IMS04-G01	FLJ	W01C081M02	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK093880	IMS04-G02	FLJ	W01C081M03	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK093880	IMS04-G02	FLJ	W01C081M04	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK091953	IMS04-G03	FLJ	W01C081M05	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK091953	IMS04-G03	FLJ	W01C081M06	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK093019	IMS04-G04	FLJ	W01C081M07	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK093019	IMS04-G04	FLJ	W01C081M08	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK090911	IMS04-G05	FLJ	W01C081M09	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK090911	IMS04-G05	FLJ	W01C081M10	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK054808	IMS04-G06	FLJ	W01C081M11	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK054808	IMS04-G06	FLJ	W01C081M12	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK055377	IMS04-G07	FLJ	W01C081M13	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK055377	IMS04-G07	FLJ	W01C081M14	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK091025	IMS04-G08	FLJ	W01C081M15	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK091025	IMS04-G08	FLJ	W01C081M16	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C081M17	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C081M18	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK074520	IMS04-G10	FLJ	W01C081M19	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074520	IMS04-G10	FLJ	W01C081M20	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074941	IMS04-G11	FLJ	W01C081M21	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074941	IMS04-G11	FLJ	W01C081M22	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK096917	IMS04-G12	FLJ	W01C081M23	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK096917	IMS04-G12	FLJ	W01C081M24	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK092096	IMS04-G01	FLJ	W01C081N01	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK092096	IMS04-G01	FLJ	W01C081N02	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK093880	IMS04-G02	FLJ	W01C081N03	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK093880	IMS04-G02	FLJ	W01C081N04	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK091953	IMS04-G03	FLJ	W01C081N05	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK091953	IMS04-G03	FLJ	W01C081N06	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK093019	IMS04-G04	FLJ	W01C081N07	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK093019	IMS04-G04	FLJ	W01C081N08	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK090911	IMS04-G05	FLJ	W01C081N09	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK090911	IMS04-G05	FLJ	W01C081N10	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK054808	IMS04-G06	FLJ	W01C081N11	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK054808	IMS04-G06	FLJ	W01C081N12	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK055377	IMS04-G07	FLJ	W01C081N13	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK055377	IMS04-G07	FLJ	W01C081N14	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK091025	IMS04-G08	FLJ	W01C081N15	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK091025	IMS04-G08	FLJ	W01C081N16	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C081N17	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C081N18	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK074520	IMS04-G10	FLJ	W01C081N19	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074520	IMS04-G10	FLJ	W01C081N20	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074941	IMS04-G11	FLJ	W01C081N21	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074941	IMS04-G11	FLJ	W01C081N22	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK096917	IMS04-G12	FLJ	W01C081N23	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK096917	IMS04-G12	FLJ	W01C081N24	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK095583	IMS04-H01	FLJ	W01C081O01	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H01	FLJ	W01C081O02	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C081O03	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C081O04	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095826	IMS04-H03	FLJ	W01C081O05	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK095826	IMS04-H03	FLJ	W01C081O06	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK021878	IMS04-H04	FLJ	W01C081O07	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK021878	IMS04-H04	FLJ	W01C081O08	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK022825	IMS04-H05	FLJ	W01C081O09	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK022825	IMS04-H05	FLJ	W01C081O10	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK122875	IMS04-H06	FLJ	W01C081O11	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK122875	IMS04-H06	FLJ	W01C081O12	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK023877	IMS04-H07	FLJ	W01C081O13	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK023877	IMS04-H07	FLJ	W01C081O14	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK097109	IMS04-H08	FLJ	W01C081O15	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097109	IMS04-H08	FLJ	W01C081O16	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097638	IMS04-H09	FLJ	W01C081O17	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097638	IMS04-H09	FLJ	W01C081O18	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097584	IMS04-H10	FLJ	W01C081O19	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK097584	IMS04-H10	FLJ	W01C081O20	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK094860	IMS04-H11	FLJ	W01C081O21	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK094860	IMS04-H11	FLJ	W01C081O22	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK122718	IMS04-H12	FLJ	W01C081O23	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK122718	IMS04-H12	FLJ	W01C081O24	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK095583	IMS04-H01	FLJ	W01C081P01	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H01	FLJ	W01C081P02	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C081P03	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C081P04	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095826	IMS04-H03	FLJ	W01C081P05	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK095826	IMS04-H03	FLJ	W01C081P06	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK021878	IMS04-H04	FLJ	W01C081P07	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK021878	IMS04-H04	FLJ	W01C081P08	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK022825	IMS04-H05	FLJ	W01C081P09	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK022825	IMS04-H05	FLJ	W01C081P10	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK122875	IMS04-H06	FLJ	W01C081P11	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK122875	IMS04-H06	FLJ	W01C081P12	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK023877	IMS04-H07	FLJ	W01C081P13	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK023877	IMS04-H07	FLJ	W01C081P14	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK097109	IMS04-H08	FLJ	W01C081P15	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097109	IMS04-H08	FLJ	W01C081P16	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097638	IMS04-H09	FLJ	W01C081P17	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097638	IMS04-H09	FLJ	W01C081P18	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097584	IMS04-H10	FLJ	W01C081P19	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK097584	IMS04-H10	FLJ	W01C081P20	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK094860	IMS04-H11	FLJ	W01C081P21	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK094860	IMS04-H11	FLJ	W01C081P22	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK122718	IMS04-H12	FLJ	W01C081P23	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK122718	IMS04-H12	FLJ	W01C081P24	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK057328	IMS04-A01	FLJ	W01C082A01	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-A01	FLJ	W01C082A02	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC039173	IMS04-A02	MGC	W01C082A03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS04-A02	MGC	W01C082A04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	IMS04-A03	MGC	W01C082A05	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS04-A03	MGC	W01C082A06	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS04-A04	MGC	W01C082A07	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS04-A04	MGC	W01C082A08	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS04-A05	MGC	W01C082A09	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS04-A05	MGC	W01C082A10	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	IMS04-A06	MGC	W01C082A11	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS04-A06	MGC	W01C082A12	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC031617	IMS04-A07	MGC	W01C082A13	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS04-A07	MGC	W01C082A14	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031624	IMS04-A08	MGC	W01C082A15	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS04-A08	MGC	W01C082A16	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS04-A09	MGC	W01C082A17	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS04-A09	MGC	W01C082A18	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC051704	IMS04-A10	MGC	W01C082A19	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC051704	IMS04-A10	MGC	W01C082A20	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC028119	IMS04-A11	MGC	W01C082A21	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028119	IMS04-A11	MGC	W01C082A22	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028198	IMS04-A12	MGC	W01C082A23	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	IMS04-A12	MGC	W01C082A24	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	AK057328	IMS04-A01	FLJ	W01C082B01	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-A01	FLJ	W01C082B02	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	BC039173	IMS04-A02	MGC	W01C082B03	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC039173	IMS04-A02	MGC	W01C082B04	pDONR221	15063		WFDC5	149708	AAH39173.1	Hs.375031	WAP four-disulfide core domain 5			Brain, adult medulla	NIH_MGC_119	DH10B	NM_145652.2	NP_663627.1	REVIEWED	OK	1.000	1.000	123	372	1	369	123	1	123
IKAKEN	BC031567	IMS04-A03	MGC	W01C082B05	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC031567	IMS04-A03	MGC	W01C082B06	pDONR221	7555		CLEC14A	161198	AAH31567.2	Hs.525307	C-type lectin domain family 14, member A			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_175060.1	NP_778230.1	PROVISIONAL	OK	1.000	1.000	490	1473	1	1470	490	1	490
IKAKEN	BC034376	IMS04-A04	MGC	W01C082B07	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034376	IMS04-A04	MGC	W01C082B08	pDONR221	6		AMPH	273	AAH34376.1	Hs.592182	Amphiphysin			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_001635.2	NP_001626.1	REVIEWED	OK	1.000	1.000	695	2088	1	2085	695	1	695
IKAKEN	BC034390	IMS04-A05	MGC	W01C082B09	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034390	IMS04-A05	MGC	W01C082B10	pDONR221	17685		HTRA3	94031	AAH34390.1	Hs.479119	HtrA serine peptidase 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_053044.2	NP_444272.1	PROVISIONAL	OK	1.000	1.000	453	1362	1	1359	453	1	453
IKAKEN	BC034752	IMS04-A06	MGC	W01C082B11	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC034752	IMS04-A06	MGC	W01C082B12	pDONR221	23791		C9orf62	157927	AAH34752.1	Hs.559511	Chromosome 9 open reading frame 62			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC031617	IMS04-A07	MGC	W01C082B13	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031617	IMS04-A07	MGC	W01C082B14	pDONR221	10020		FAM27L	284123	AAH31617.1	Hs.348578	Family with sequence similarity 27-like			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203392.2	NP_976326.2	PREDICTED	OK	1.000	1.000	92	279	1	276	92	1	92
IKAKEN	BC031624	IMS04-A08	MGC	W01C082B15	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC031624	IMS04-A08	MGC	W01C082B16	pDONR221	25262		RPGR	6103	AAH31624.1	Hs.61438	Retinitis pigmentosa GTPase regulator			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001034853.1	NP_001030025.1	REVIEWED	P	1.000	1.000	472	1443	1	1416	1152	1	472
IKAKEN	BC034582	IMS04-A09	MGC	W01C082B17	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC034582	IMS04-A09	MGC	W01C082B18	pDONR221	10484		KRTAP3-2	83897	AAH34582.1	Hs.307026	Keratin associated protein 3-2			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_031959.2	NP_114165.1	REVIEWED	OK	1.000	1.000	98	297	1	294	98	1	98
IKAKEN	BC051704	IMS04-A10	MGC	W01C082B19	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC051704	IMS04-A10	MGC	W01C082B20	pDONR221	24867		NCRNA00086	399668	AAH51704	Hs.374414	Non-protein coding RNA 86			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	XM_001721183.1	XP_001721235.1	MODEL	OK	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	BC028119	IMS04-A11	MGC	W01C082B21	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028119	IMS04-A11	MGC	W01C082B22	pDONR221	7951		TEX9	374618	AAH28119.1	Hs.511476	Testis expressed 9			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_198524.1	NP_940926.1	PROVISIONAL	OK	1.000	1.000	391	1176	1	1173	391	1	391
IKAKEN	BC028198	IMS04-A12	MGC	W01C082B23	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC028198	IMS04-A12	MGC	W01C082B24	pDONR221	17064		EFHB	151651	AAH28198.1	Hs.670883	EF-hand domain family, member B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_144715.3	NP_653316.3	VALIDATED	P	1.000	1.000	669	2010	1	2007	833	165	833
IKAKEN	BC040553	IMS04-B01	MGC	W01C082C01	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC040553	IMS04-B01	MGC	W01C082C02	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC033737	IMS04-B02	MGC	W01C082C03	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC033737	IMS04-B02	MGC	W01C082C04	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC052962	IMS04-B03	MGC	W01C082C05	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC052962	IMS04-B03	MGC	W01C082C06	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC048324	IMS04-B04	MGC	W01C082C07	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC048324	IMS04-B04	MGC	W01C082C08	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC050462	IMS04-B05	MGC	W01C082C09	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	IMS04-B05	MGC	W01C082C10	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC054490	IMS04-B06	MGC	W01C082C11	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC054490	IMS04-B06	MGC	W01C082C12	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC053584	IMS04-B07	MGC	W01C082C13	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	IMS04-B07	MGC	W01C082C14	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053557	IMS04-B08	MGC	W01C082C15	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC053557	IMS04-B08	MGC	W01C082C16	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC054036	IMS04-B09	MGC	W01C082C17	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	IMS04-B09	MGC	W01C082C18	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC063489	IMS04-B10	MGC	W01C082C19	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC063489	IMS04-B10	MGC	W01C082C20	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC064579	IMS04-B11	MGC	W01C082C21	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC064579	IMS04-B11	MGC	W01C082C22	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063804	IMS04-B12	MGC	W01C082C23	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC063804	IMS04-B12	MGC	W01C082C24	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC040553	IMS04-B01	MGC	W01C082D01	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC040553	IMS04-B01	MGC	W01C082D02	pDONR221	5629		CCDC60	160777	AAH40553.1	Hs.98188	Coiled-coil domain containing 60			Testis	NIH_MGC_97	DH10B	NM_178499.3	NP_848594.2	VALIDATED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BC033737	IMS04-B02	MGC	W01C082D03	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC033737	IMS04-B02	MGC	W01C082D04	pDONR221	3245		OPALIN	93377	AAH33737.1	Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein			Brain, hippocampus	NIH_MGC_95	DH10B	NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC052962	IMS04-B03	MGC	W01C082D05	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC052962	IMS04-B03	MGC	W01C082D06	pDONR221	19262		HEATR7B2	133558	AAH52962.1	Hs.97714	HEAT repeat family member 7B2			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_173489.4	NP_775760.3	VALIDATED	OK	1.000	1.000	1585	4758	1	4755	1585	1	1585
IKAKEN	BC048324	IMS04-B04	MGC	W01C082D07	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC048324	IMS04-B04	MGC	W01C082D08	pDONR221	24091		HEMGN	55363	AAH48324.1	Hs.176626	Hemogen			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_197978.1	NP_932095.1	VALIDATED	OK	1.000	1.000	484	1455	1	1452	484	1	484
IKAKEN	BC050462	IMS04-B05	MGC	W01C082D09	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC050462	IMS04-B05	MGC	W01C082D10	pDONR221	13301		C2orf84	653140	AAH50462.1	Hs.467868	Chromosome 2 open reading frame 84			Peripheral Nervous System, sympathetic	Lupski_sympathetic_trunk	DH10B	NM_001040710.1	NP_001035800.1	PREDICTED	OK	1.000	1.000	206	621	1	618	206	1	206
IKAKEN	BC054490	IMS04-B06	MGC	W01C082D11	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC054490	IMS04-B06	MGC	W01C082D12	pDONR221	1333		RAP1GAP	5909	AAH54490.1	Hs.148178	RAP1 GTPase activating protein			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002885.2	NP_002876.2	VALIDATED	Ps	0.992	0.992	662	1989	1	1986	663	2	663
IKAKEN	BC053584	IMS04-B07	MGC	W01C082D13	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053584	IMS04-B07	MGC	W01C082D14	pDONR221	23459		GDA	9615	AAH53584.1	Hs.494163	Guanine deaminase			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_004293.3	NP_004284.1	VALIDATED	OK	1.000	1.000	454	1365	1	1362	454	1	454
IKAKEN	BC053557	IMS04-B08	MGC	W01C082D15	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC053557	IMS04-B08	MGC	W01C082D16	pDONR221	5469		ZNF740	283337	AAH53557.1	Hs.524458	Zinc finger protein 740			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001004304.3	NP_001004304.1	VALIDATED	Cgs	0.990	0.995	194	585	1	582	193	1	193
IKAKEN	BC054036	IMS04-B09	MGC	W01C082D17	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC054036	IMS04-B09	MGC	W01C082D18	pDONR221	513		CDA	978	AAH54036.1	Hs.466910	Cytidine deaminase			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001785.2	NP_001776.1	REVIEWED	OK	1.000	1.000	146	441	1	438	146	1	146
IKAKEN	BC063489	IMS04-B10	MGC	W01C082D19	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC063489	IMS04-B10	MGC	W01C082D20	pDONR221	9753		TMUB2	79089	AAH63489.1	Hs.181391	Transmembrane and ubiquitin-like domain containing 2			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_177441.2	NP_803190.2	VALIDATED	OK	1.000	1.000	301	906	1	903	301	1	301
IKAKEN	BC064579	IMS04-B11	MGC	W01C082D21	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC064579	IMS04-B11	MGC	W01C082D22	pDONR221	4773		MTL5	9633	AAH64579.1	Hs.145932	Metallothionein-like 5, testis-specific (tesmin)			Placenta, normal	NIH_MGC_147	DH10B	NM_004923.3	NP_004914.2	REVIEWED	OK	1.000	1.000	508	1527	1	1524	508	1	508
IKAKEN	BC063804	IMS04-B12	MGC	W01C082D23	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC063804	IMS04-B12	MGC	W01C082D24	pDONR221	4038		DNAJC24	120526	AAH63804	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC008792	IMS04-C01	MGC	W01C082E01	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC008792	IMS04-C01	MGC	W01C082E02	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC007758	IMS04-C02	MGC	W01C082E03	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC007758	IMS04-C02	MGC	W01C082E04	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC011705	IMS04-C03	MGC	W01C082E05	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC011705	IMS04-C03	MGC	W01C082E06	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC042161	IMS04-C04	MGC	W01C082E07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	IMS04-C04	MGC	W01C082E08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	IMS04-C05	MGC	W01C082E09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	IMS04-C05	MGC	W01C082E10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041058	IMS04-C06	MGC	W01C082E11	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	IMS04-C06	MGC	W01C082E12	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041594	IMS04-C07	MGC	W01C082E13	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	IMS04-C07	MGC	W01C082E14	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC045108	IMS04-C08	MGC	W01C082E15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	IMS04-C08	MGC	W01C082E16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045110	IMS04-C09	MGC	W01C082E17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	IMS04-C09	MGC	W01C082E18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC042914	IMS04-C10	MGC	W01C082E19	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	IMS04-C10	MGC	W01C082E20	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC041070	IMS04-C11	MGC	W01C082E21	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	IMS04-C11	MGC	W01C082E22	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041608	IMS04-C12	MGC	W01C082E23	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	IMS04-C12	MGC	W01C082E24	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC008792	IMS04-C01	MGC	W01C082F01	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC008792	IMS04-C01	MGC	W01C082F02	pDONR221	10230		PSMC3IP	29893	AAH08792.1	Hs.383019	PSMC3 interacting protein			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_013290.5	NP_037422.2	VALIDATED	OK	1.000	1.000	205	618	1	615	205	1	205
IKAKEN	BC007758	IMS04-C02	MGC	W01C082F03	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC007758	IMS04-C02	MGC	W01C082F04	pDONR221	2721		KAZALD1	81621	AAH07758.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC011705	IMS04-C03	MGC	W01C082F05	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC011705	IMS04-C03	MGC	W01C082F06	pDONR221	14783		COL9A3	1299	AAH11705.1	Hs.716639	Collagen, type IX, alpha 3			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001853.3	NP_001844.3	VALIDATED	OK	1.000	1.000	684	2055	1	2052	684	1	684
IKAKEN	BC042161	IMS04-C04	MGC	W01C082F07	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC042161	IMS04-C04	MGC	W01C082F08	pDONR221	11953		TRAPPC5	126003	AAH42161.1	Hs.432413	Trafficking protein particle complex 5			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_174894.1	NP_777554.1	VALIDATED	OK	1.000	1.000	188	567	1	564	188	1	188
IKAKEN	BC041633	IMS04-C05	MGC	W01C082F09	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041633	IMS04-C05	MGC	W01C082F10	pDONR221	2211		C1orf210	149466	AAH41633.1	Hs.158963	Chromosome 1 open reading frame 210			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_182517.2	NP_872323.1	VALIDATED	OK	1.000	1.000	113	342	1	339	113	1	113
IKAKEN	BC041058	IMS04-C06	MGC	W01C082F11	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041058	IMS04-C06	MGC	W01C082F12	pDONR221	10335		ALOX12B	242	AAH41058.1	Hs.136574	Arachidonate 12-lipoxygenase, 12R type			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001139.2	NP_001130.1	REVIEWED	OK	1.000	1.000	701	2106	1	2103	701	1	701
IKAKEN	BC041594	IMS04-C07	MGC	W01C082F13	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC041594	IMS04-C07	MGC	W01C082F14	pDONR221	23489		NOXA1	10811	AAH41594.1	Hs.495554	NADPH oxidase activator 1			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_006647.1	NP_006638.1	PROVISIONAL	OK	1.000	1.000	483	1452	1	1449	483	1	483
IKAKEN	BC045108	IMS04-C08	MGC	W01C082F15	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045108	IMS04-C08	MGC	W01C082F16	pDONR221	10725		PITPNA	5306	AAH45108.1	Hs.429819	Phosphatidylinositol transfer protein, alpha			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_006224.3	NP_006215.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	BC045110	IMS04-C09	MGC	W01C082F17	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC045110	IMS04-C09	MGC	W01C082F18	pDONR221	4914		DUSP8	1850	AAH45110.1	Hs.41688	Dual specificity phosphatase 8			Testis	NIH_MGC_97	DH10B	NM_004420.2	NP_004411.2	REVIEWED		0.917	0.917	218	657	1	654	625	78	295
IKAKEN	BC042914	IMS04-C10	MGC	W01C082F19	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC042914	IMS04-C10	MGC	W01C082F20	pDONR221	16181		SEMA3F	6405	AAH42914.1	Hs.32981	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3F			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004186.3	NP_004177.3	VALIDATED	OK	1.000	1.000	785	2358	1	2355	785	1	785
IKAKEN	BC041070	IMS04-C11	MGC	W01C082F21	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041070	IMS04-C11	MGC	W01C082F22	pDONR221	10735		KRT34	3885	AAH41070.1	Hs.296942	Keratin 34			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_021013.3	NP_066293.2	REVIEWED	OK	1.000	1.000	436	1311	1	1308	436	1	436
IKAKEN	BC041608	IMS04-C12	MGC	W01C082F23	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041608	IMS04-C12	MGC	W01C082F24	pDONR221	792		FAM159A	348378	AAH41608	Hs.424589	Family with sequence similarity 159, member A			Skin, melanoma, amelanotic	NIH_MGC_41	DH10B-R	NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	BC041609	IMS04-D01	MGC	W01C082G01	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	IMS04-D01	MGC	W01C082G02	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC048194	IMS04-D02	MGC	W01C082G03	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	IMS04-D02	MGC	W01C082G04	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC044634	IMS04-D03	MGC	W01C082G05	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	IMS04-D03	MGC	W01C082G06	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC042921	IMS04-D04	MGC	W01C082G07	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	IMS04-D04	MGC	W01C082G08	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC052285	IMS04-D05	MGC	W01C082G09	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	IMS04-D05	MGC	W01C082G10	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052289	IMS04-D06	MGC	W01C082G11	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	IMS04-D06	MGC	W01C082G12	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052581	IMS04-D07	MGC	W01C082G13	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	IMS04-D07	MGC	W01C082G14	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC053991	IMS04-D08	MGC	W01C082G15	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	IMS04-D08	MGC	W01C082G16	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC052293	IMS04-D09	MGC	W01C082G17	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	IMS04-D09	MGC	W01C082G18	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC062213	IMS04-D10	MGC	W01C082G19	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	IMS04-D10	MGC	W01C082G20	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062217	IMS04-D11	MGC	W01C082G21	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	IMS04-D11	MGC	W01C082G22	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065714	IMS04-D12	MGC	W01C082G23	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	IMS04-D12	MGC	W01C082G24	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC041609	IMS04-D01	MGC	W01C082H01	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC041609	IMS04-D01	MGC	W01C082H02	pDONR221	9405		MGC52282	124221	AAH41609	Hs.434388	Transmembrane protease, serine pseudogene			Lymph, lymphoma	NIH_MGC_85	DH10B													
IKAKEN	BC048194	IMS04-D02	MGC	W01C082H03	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC048194	IMS04-D02	MGC	W01C082H04	pDONR221	21316		TRIM56	81844	AAH48194.1	Hs.521092	Tripartite motif-containing 56			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC044634	IMS04-D03	MGC	W01C082H05	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC044634	IMS04-D03	MGC	W01C082H06	pDONR221	12272		CRLF1	9244	AAH44634.1	Hs.114948	Cytokine receptor-like factor 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	BC042921	IMS04-D04	MGC	W01C082H07	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC042921	IMS04-D04	MGC	W01C082H08	pDONR221	11611		PTOV1	53635	AAH42921	Hs.587979	Prostate tumor overexpressed 1			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_017432.3	NP_059128.2	PROVISIONAL	OK	1.000	1.000	416	1251	1	1248	416	1	416
IKAKEN	BC052285	IMS04-D05	MGC	W01C082H09	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052285	IMS04-D05	MGC	W01C082H10	pDONR221	23074		TOP1MT	116447	AAH52285.1	Hs.528574	Topoisomerase (DNA) I, mitochondrial			Ovary, teratocarcinoma	NIH_MGC_109	DH10B-R	NM_052963.1	NP_443195.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	BC052289	IMS04-D06	MGC	W01C082H11	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052289	IMS04-D06	MGC	W01C082H12	pDONR221	21148		CPA4	51200	AAH52289.1	Hs.93764	Carboxypeptidase A4			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_016352.3	NP_057436.2	REVIEWED	C	1.000	1.000	421	1266	1	1263	421	1	421
IKAKEN	BC052581	IMS04-D07	MGC	W01C082H13	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC052581	IMS04-D07	MGC	W01C082H14	pDONR221	12983		SSFA2	6744	AAH52581.1	Hs.591602	Sperm specific antigen 2			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_001130445.1	NP_001123917.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC053991	IMS04-D08	MGC	W01C082H15	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC053991	IMS04-D08	MGC	W01C082H16	pDONR221	10047		NAGLU	4669	AAH53991.1	Hs.50727	N-acetylglucosaminidase, alpha-			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_000263.3	NP_000254.2	REVIEWED	OK	1.000	1.000	743	2232	1	2229	743	1	743
IKAKEN	BC052293	IMS04-D09	MGC	W01C082H17	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC052293	IMS04-D09	MGC	W01C082H18	pDONR221	5817		NT5DC3	51559	AAH52293.1	Hs.48428	5'-nucleotidase domain containing 3			Brain, adult medulla	NIH_MGC_119	DH10B	NM_016575.1	NP_057659.1	VALIDATED	Cs	0.998	0.998	473	1422	1	1419	473	1	473
IKAKEN	BC062213	IMS04-D10	MGC	W01C082H19	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062213	IMS04-D10	MGC	W01C082H20	pDONR221	17499		C4orf7	260436	AAH62213.1	Hs.320147	Chromosome 4 open reading frame 7			Testis	NIH_MGC_82	DH10B	NM_152997.2	NP_694542.1	VALIDATED	OK	1.000	1.000	85	258	1	255	85	1	85
IKAKEN	BC062217	IMS04-D11	MGC	W01C082H21	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC062217	IMS04-D11	MGC	W01C082H22	pDONR221	5975		LACRT	90070	AAH62217.1	Hs.307096	Lacritin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_033277.1	NP_150593.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	BC065714	IMS04-D12	MGC	W01C082H23	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC065714	IMS04-D12	MGC	W01C082H24	pDONR221	15106		CST4	1472	AAH65714.1	Hs.654549	Cystatin S			Pancreas, ductal carcinoma	NIH_MGC_110	DH10B-R	NM_001899.2	NP_001890.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062693	IMS04-E01	MGC	W01C082I01	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	IMS04-E01	MGC	W01C082I02	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062682	IMS04-E02	MGC	W01C082I03	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	IMS04-E02	MGC	W01C082I04	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062712	IMS04-E03	MGC	W01C082I05	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	IMS04-E03	MGC	W01C082I06	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062218	IMS04-E04	MGC	W01C082I07	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	IMS04-E04	MGC	W01C082I08	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062679	IMS04-E05	MGC	W01C082I09	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	IMS04-E05	MGC	W01C082I10	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062678	IMS04-E06	MGC	W01C082I11	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	IMS04-E06	MGC	W01C082I12	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065721	IMS04-E07	MGC	W01C082I13	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC065721	IMS04-E07	MGC	W01C082I14	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC063130	IMS04-E08	MGC	W01C082I15	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	IMS04-E08	MGC	W01C082I16	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063114	IMS04-E09	MGC	W01C082I17	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	IMS04-E09	MGC	W01C082I18	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063126	IMS04-E10	MGC	W01C082I19	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	IMS04-E10	MGC	W01C082I20	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC062423	IMS04-E11	MGC	W01C082I21	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	IMS04-E11	MGC	W01C082I22	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062680	IMS04-E12	MGC	W01C082I23	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	IMS04-E12	MGC	W01C082I24	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062693	IMS04-E01	MGC	W01C082J01	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062693	IMS04-E01	MGC	W01C082J02	pDONR221	3881		SCGB1D1	10648	AAH62693.1	Hs.202686	Secretoglobin, family 1D, member 1			Skin and meninges pool- skin, dura matter,	NIH_MGC_186	DH10B	NM_006552.1	NP_006543.1	REVIEWED	OK	1.000	1.000	90	273	1	270	90	1	90
IKAKEN	BC062682	IMS04-E02	MGC	W01C082J03	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062682	IMS04-E02	MGC	W01C082J04	pDONR221	5947		DCD	117159	AAH62682.1	Hs.350570	Dermcidin			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC062712	IMS04-E03	MGC	W01C082J05	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062712	IMS04-E03	MGC	W01C082J06	pDONR221	20119		C6orf58	352999	AAH62712.2	Hs.226268	Chromosome 6 open reading frame 58			Testis	NIH_MGC_82	DH10B	NM_001010905.1	NP_001010905.1	PREDICTED	OK	1.000	1.000	330	993	1	990	330	1	330
IKAKEN	BC062218	IMS04-E04	MGC	W01C082J07	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062218	IMS04-E04	MGC	W01C082J08	pDONR221	3770		SCGB2A1	4246	AAH62218.1	Hs.97644	Secretoglobin, family 2A, member 1			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_002407.2	NP_002398.1	VALIDATED	OK	1.000	1.000	95	288	1	285	95	1	95
IKAKEN	BC062679	IMS04-E05	MGC	W01C082J09	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062679	IMS04-E05	MGC	W01C082J10	pDONR221	15105		CST2	1470	AAH62679.1	Hs.669305	Cystatin SA			Testis	NIH_MGC_82	DH10B	NM_001322.2	NP_001313.1	REVIEWED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BC062678	IMS04-E06	MGC	W01C082J11	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC062678	IMS04-E06	MGC	W01C082J12	pDONR221	15104		CST5	1473	AAH62678.1	Hs.121489	Cystatin D			Pooled, 40 cell lines	NIH_MGC_126	DH10B	NM_001900.4	NP_001891.2	REVIEWED	OK	1.000	1.000	142	429	1	426	142	1	142
IKAKEN	BC065721	IMS04-E07	MGC	W01C082J13	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC065721	IMS04-E07	MGC	W01C082J14	pDONR221	23803		LCN1	3933	AAH65721.1	Hs.530311	Lipocalin 1 (tear prealbumin)			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_002297.2	NP_002288.1	REVIEWED	OK	1.000	1.000	176	531	1	528	176	1	176
IKAKEN	BC063130	IMS04-E08	MGC	W01C082J15	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063130	IMS04-E08	MGC	W01C082J16	pDONR221	21365		C7orf46	340277	AAH63130.1	Hs.592178	Chromosome 7 open reading frame 46			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_199136.3	NP_954587.2	VALIDATED	OK	1.000	1.000	298	897	1	894	298	1	298
IKAKEN	BC063114	IMS04-E09	MGC	W01C082J17	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063114	IMS04-E09	MGC	W01C082J18	pDONR221	24133		ASPN	54829	AAH63114.1	Hs.435655	Asporin			Placenta, normal	NIH_MGC_147	DH10B	NM_017680.3	NP_060150.3	VALIDATED	C	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC063126	IMS04-E10	MGC	W01C082J19	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC063126	IMS04-E10	MGC	W01C082J20	pDONR221	17974		FAM13A	10144	AAH63126.1	Hs.97270	Family with sequence similarity 13, member A			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_014883.2	NP_055698.2	VALIDATED	Ps	0.995	0.995	202	609	1	606	1023	1	202
IKAKEN	BC062423	IMS04-E11	MGC	W01C082J21	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062423	IMS04-E11	MGC	W01C082J22	pDONR221	21343		C7orf41	222166	AAH62423	Hs.200100	Chromosome 7 open reading frame 41			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_152793.2	NP_690006.2	VALIDATED	P	1.000	1.000	77	297	64	294	131	55	131
IKAKEN	BC062680	IMS04-E12	MGC	W01C082J23	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062680	IMS04-E12	MGC	W01C082J24	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	OK	1.000	1.000	111	336	1	333	111	1	111
IKAKEN	BC062776	IMS04-F01	MGC	W01C082K01	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	IMS04-F01	MGC	W01C082K02	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062707	IMS04-F02	MGC	W01C082K03	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	IMS04-F02	MGC	W01C082K04	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062670	IMS04-F03	MGC	W01C082K05	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	IMS04-F03	MGC	W01C082K06	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062746	IMS04-F04	MGC	W01C082K07	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	IMS04-F04	MGC	W01C082K08	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062662	IMS04-F05	MGC	W01C082K09	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	IMS04-F05	MGC	W01C082K10	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062734	IMS04-F06	MGC	W01C082K11	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	IMS04-F06	MGC	W01C082K12	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC065724	IMS04-F07	MGC	W01C082K13	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	IMS04-F07	MGC	W01C082K14	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	AK055685	IMS04-F08	FLJ	W01C082K15	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK055685	IMS04-F08	FLJ	W01C082K16	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK056814	IMS04-F09	FLJ	W01C082K17	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK056814	IMS04-F09	FLJ	W01C082K18	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK057328	IMS04-F10	FLJ	W01C082K19	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-F10	FLJ	W01C082K20	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057381	IMS04-F11	FLJ	W01C082K21	pDONR221	26879									testis	TESTI2				
IKAKEN	AK057381	IMS04-F11	FLJ	W01C082K22	pDONR221	26879									testis	TESTI2				
IKAKEN	AK091373	IMS04-F12	FLJ	W01C082K23	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	AK091373	IMS04-F12	FLJ	W01C082K24	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	BC062776	IMS04-F01	MGC	W01C082L01	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062776	IMS04-F01	MGC	W01C082L02	pDONR221	2611		AGAP11	119385	AAH62776.1					Placenta	NIH_MGC_79	DH10B	NM_133447.1	NP_597704.1	VALIDATED		0.169	0.169	59	189	179	3	550	175	233
IKAKEN	BC062707	IMS04-F02	MGC	W01C082L03	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062707	IMS04-F02	MGC	W01C082L04	pDONR221	2674		TIMM23	10431	AAH62707.1	Hs.524308	Translocase of inner mitochondrial membrane 23 homolog (yeast)			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_006327.2	NP_006318.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	BC062670	IMS04-F03	MGC	W01C082L05	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062670	IMS04-F03	MGC	W01C082L06	pDONR221	15064		WFDC11	259239	AAH62670.1	Hs.374924	WAP four-disulfide core domain 11			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_147197.2	NP_671730.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC062746	IMS04-F04	MGC	W01C082L07	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062746	IMS04-F04	MGC	W01C082L08	pDONR221	24129		LCN6	158062	AAH62746.1	Hs.522504	Lipocalin 6			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_198946.2	NP_945184.1	VALIDATED	OK	1.000	1.000	163	492	1	489	163	1	163
IKAKEN	BC062662	IMS04-F05	MGC	W01C082L09	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062662	IMS04-F05	MGC	W01C082L10	pDONR221	6017		SYCP3	50511	AAH62662.1	Hs.506504	Synaptonemal complex protein 3			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	BC062734	IMS04-F06	MGC	W01C082L11	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC062734	IMS04-F06	MGC	W01C082L12	pDONR221	8744		MT1E	4493	AAH62734.1	Hs.534330	Metallothionein 1E			Testis, embryonal carcinoma	NIH_MGC_61	DH10B	NM_175617.3	NP_783316.2	VALIDATED	OK	1.000	1.000	61	186	1	183	61	1	61
IKAKEN	BC065724	IMS04-F07	MGC	W01C082L13	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	BC065724	IMS04-F07	MGC	W01C082L14	pDONR221	16586		AADACL2	344752	AAH65724.1	Hs.144710	Arylacetamide deacetylase-like 2			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_207365.3	NP_997248.2	VALIDATED	P	1.000	1.000	379	1140	1	1137	401	23	401
IKAKEN	AK055685	IMS04-F08	FLJ	W01C082L15	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK055685	IMS04-F08	FLJ	W01C082L16	pDONR221	10550		C17orf65	339201	BAG51556.1	Hs.656564	Chromosome 17 open reading frame 65	IMR32	neuroblastoma		IMR322		NM_178542.3	NP_848637.2	VALIDATED	OK	1.000	1.000	193	969	200	778	193	1	193
IKAKEN	AK056814	IMS04-F09	FLJ	W01C082L17	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK056814	IMS04-F09	FLJ	W01C082L18	pDONR221	9287		LOC146336	146336	BAB71289.1	Hs.711752	Hypothetical LOC146336			placenta	PLACE5														
IKAKEN	AK057328	IMS04-F10	FLJ	W01C082L19	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057328	IMS04-F10	FLJ	W01C082L20	pDONR221	13860		TNS1	7145		Hs.471381	Tensin 1			small intestine	SMINT1		NM_022648.4	NP_072174.3	REVIEWED		0.571	0.571	14	309	147	106	1735	651	664
IKAKEN	AK057381	IMS04-F11	FLJ	W01C082L21	pDONR221	26879									testis	TESTI2				
IKAKEN	AK057381	IMS04-F11	FLJ	W01C082L22	pDONR221	26879									testis	TESTI2				
IKAKEN	AK091373	IMS04-F12	FLJ	W01C082L23	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	AK091373	IMS04-F12	FLJ	W01C082L24	pDONR221	24009		KIAA2026	158358		Hs.535060	KIAA2026			brain	FCBBF2		NM_001017969.2	NP_001017969.2	VALIDATED	Ps	0.999	0.999	860	2586	4	2583	2103	1244	2103
IKAKEN	AK092096	IMS04-G01	FLJ	W01C082M01	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK092096	IMS04-G01	FLJ	W01C082M02	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK093880	IMS04-G02	FLJ	W01C082M03	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK093880	IMS04-G02	FLJ	W01C082M04	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK091953	IMS04-G03	FLJ	W01C082M05	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK091953	IMS04-G03	FLJ	W01C082M06	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK093019	IMS04-G04	FLJ	W01C082M07	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK093019	IMS04-G04	FLJ	W01C082M08	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK090911	IMS04-G05	FLJ	W01C082M09	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK090911	IMS04-G05	FLJ	W01C082M10	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK054808	IMS04-G06	FLJ	W01C082M11	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK054808	IMS04-G06	FLJ	W01C082M12	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK055377	IMS04-G07	FLJ	W01C082M13	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK055377	IMS04-G07	FLJ	W01C082M14	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK091025	IMS04-G08	FLJ	W01C082M15	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK091025	IMS04-G08	FLJ	W01C082M16	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C082M17	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C082M18	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK074520	IMS04-G10	FLJ	W01C082M19	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074520	IMS04-G10	FLJ	W01C082M20	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074941	IMS04-G11	FLJ	W01C082M21	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074941	IMS04-G11	FLJ	W01C082M22	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK096917	IMS04-G12	FLJ	W01C082M23	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK096917	IMS04-G12	FLJ	W01C082M24	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK092096	IMS04-G01	FLJ	W01C082N01	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK092096	IMS04-G01	FLJ	W01C082N02	pDONR221	1704		SNHG12	85028	-	Hs.718565	Small nucleolar RNA host gene 12 (non-protein coding)	NT2	teratocarcinoma		NT2NE2		XM_934810.1	XP_939903.1	MODEL										
IKAKEN	AK093880	IMS04-G02	FLJ	W01C082N03	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK093880	IMS04-G02	FLJ	W01C082N04	pDONR221	15635		C22orf15	150248	BAC04241	Hs.116254	Chromosome 22 open reading frame 15			thymus	THYMU2		NM_182520.2	NP_872326.2	VALIDATED	P	1.000	1.000	145	465	1	435	148	1	145
IKAKEN	AK091953	IMS04-G03	FLJ	W01C082N05	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK091953	IMS04-G03	FLJ	W01C082N06	pDONR221	5188		IQSEC3	440073	-	Hs.536319	IQ motif and Sec7 domain 3			kidney	KIDNE2		NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.996	0.997	739	2709	74	2286	759	1	739
IKAKEN	AK093019	IMS04-G04	FLJ	W01C082N07	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK093019	IMS04-G04	FLJ	W01C082N08	pDONR221	19765		FLJ35700	285736	BAC04022					spleen	SPLEN2				
IKAKEN	AK090911	IMS04-G05	FLJ	W01C082N09	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK090911	IMS04-G05	FLJ	W01C082N10	pDONR221	9617		KIF19	124602	BAC03545	Hs.372773	Kinesin family member 19			amygdala	BRAMY2		NM_153209.3	NP_694941.2	VALIDATED		0.978	0.978	134	405	404	3	998	484	617
IKAKEN	AK054808	IMS04-G06	FLJ	W01C082N11	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK054808	IMS04-G06	FLJ	W01C082N12	pDONR221	11738		PLK5P	126520	BAG51426.1	Hs.195352	Polo-like kinase 5 pseudogene			cerebellum	BRACE2														
IKAKEN	AK055377	IMS04-G07	FLJ	W01C082N13	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK055377	IMS04-G07	FLJ	W01C082N14	pDONR221	30064		GPATCH4	54865	-	Hs.193832	G patch domain containing 4			brain	FCBBF2		NM_182679.1	NP_872620.1	VALIDATED	Pfs	0.273	0.292	77	426	357	139	370	233	308
IKAKEN	AK091025	IMS04-G08	FLJ	W01C082N15	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK091025	IMS04-G08	FLJ	W01C082N16	pDONR221	15029		LOC284805	284805	BAC03569.1	Hs.353262	Hypothetical LOC284805			brain	BRAWH2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C082N17	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK093424	IMS04-G09	FLJ	W01C082N18	pDONR221	23165		TMEM75	641384	BAC04160	Hs.629674	Transmembrane protein 75			testis	TESTI2														
IKAKEN	AK074520	IMS04-G10	FLJ	W01C082N19	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074520	IMS04-G10	FLJ	W01C082N20	pDONR221	5962		ERGIC2	51290	BAC11037.1	Hs.339453	ERGIC and golgi 2			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_016570.2	NP_057654.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK074941	IMS04-G11	FLJ	W01C082N21	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK074941	IMS04-G11	FLJ	W01C082N22	pDONR221	11725		GLT25D1	79709	BAC11307.1	Hs.418795	Glycosyltransferase 25 domain containing 1	NT2	teratocarcinoma		NT2RP3		NM_024656.2	NP_078932.2	PROVISIONAL	C	1.000	1.000	622	1869	1	1866	622	1	622
IKAKEN	AK096917	IMS04-G12	FLJ	W01C082N23	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK096917	IMS04-G12	FLJ	W01C082N24	pDONR221	16042			653793	BAC04894					skeletal muscle	SKMUS2				
IKAKEN	AK095583	IMS04-H01	FLJ	W01C082O01	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H01	FLJ	W01C082O02	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C082O03	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C082O04	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095826	IMS04-H03	FLJ	W01C082O05	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK095826	IMS04-H03	FLJ	W01C082O06	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK021878	IMS04-H04	FLJ	W01C082O07	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK021878	IMS04-H04	FLJ	W01C082O08	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK022825	IMS04-H05	FLJ	W01C082O09	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK022825	IMS04-H05	FLJ	W01C082O10	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK122875	IMS04-H06	FLJ	W01C082O11	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK122875	IMS04-H06	FLJ	W01C082O12	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK023877	IMS04-H07	FLJ	W01C082O13	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK023877	IMS04-H07	FLJ	W01C082O14	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK097109	IMS04-H08	FLJ	W01C082O15	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097109	IMS04-H08	FLJ	W01C082O16	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097638	IMS04-H09	FLJ	W01C082O17	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097638	IMS04-H09	FLJ	W01C082O18	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097584	IMS04-H10	FLJ	W01C082O19	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK097584	IMS04-H10	FLJ	W01C082O20	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK094860	IMS04-H11	FLJ	W01C082O21	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK094860	IMS04-H11	FLJ	W01C082O22	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK122718	IMS04-H12	FLJ	W01C082O23	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK122718	IMS04-H12	FLJ	W01C082O24	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK095583	IMS04-H01	FLJ	W01C082P01	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H01	FLJ	W01C082P02	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C082P03	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095583	IMS04-H02	FLJ	W01C082P04	pDONR221	29022				BAC04580					brain	FCBBF1				
IKAKEN	AK095826	IMS04-H03	FLJ	W01C082P05	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK095826	IMS04-H03	FLJ	W01C082P06	pDONR221	16896		VGLL3	389136	-	Hs.435013	Vestigial like 3 (Drosophila)		chondrocytes (HC)		HCHON2		NM_016206.2	NP_057290.2	VALIDATED	Pfs	0.367	0.367	30	1182	525	436	326	114	143
IKAKEN	AK021878	IMS04-H04	FLJ	W01C082P07	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK021878	IMS04-H04	FLJ	W01C082P08	pDONR221	9830		LOC100130950	100130950	-	Hs.668646	Similar to hCG1991536			whole embryo, mainly head	HEMBA1		XM_001720180.1	XP_001720232.1	MODEL	P	1.000	1.000	49	306	157	303	62	14	62
IKAKEN	AK022825	IMS04-H05	FLJ	W01C082P09	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK022825	IMS04-H05	FLJ	W01C082P10	pDONR221	586		LOC149134	149134	-	Hs.417972	Hypothetical LOC149134	NT2	teratocarcinoma		NT2RM4														
IKAKEN	AK122875	IMS04-H06	FLJ	W01C082P11	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK122875	IMS04-H06	FLJ	W01C082P12	pDONR221	8317		FSD2	123722	BAG53773.1	Hs.719372	Fibronectin type III and SPRY domain containing 2			cerebellum	BRACE3		NM_001007122.2	NP_001007123.1	PROVISIONAL	Pgs	0.952	0.993	729	2109	1	2106	749	24	749
IKAKEN	AK023877	IMS04-H07	FLJ	W01C082P13	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK023877	IMS04-H07	FLJ	W01C082P14	pDONR221	1868		SYDE2	84144	BAB14711.1	Hs.670497	Synapse defective 1, Rho GTPase, homolog 2 (C. elegans)			thyroid gland	THYRO1		NM_032184.1	NP_115560.1	VALIDATED	Ps	0.995	0.995	659	2010	1	1977	1194	195	853
IKAKEN	AK097109	IMS04-H08	FLJ	W01C082P15	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097109	IMS04-H08	FLJ	W01C082P16	pDONR221	33536		LOC100131860	100131860	BAC04953	Hs.710056	Hypothetical protein LOC100131860			spleen	SPLEN2		XM_001720708.1	XP_001720760.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK097638	IMS04-H09	FLJ	W01C082P17	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097638	IMS04-H09	FLJ	W01C082P18	pDONR221	10619		C17orf54	283982	BAC05128.1	Hs.464079	Chromosome 17 open reading frame 54			testis	TESTI2														
IKAKEN	AK097584	IMS04-H10	FLJ	W01C082P19	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK097584	IMS04-H10	FLJ	W01C082P20	pDONR221	31250		LOC100128830	100128830	BAC05110	Hs.638406	Hypothetical protein LOC100128830			testis	TESTI2		XM_001716061.1	XP_001716113.1	MODEL	OK	1.000	1.000	337	1014	1	1011	337	1	337
IKAKEN	AK094860	IMS04-H11	FLJ	W01C082P21	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK094860	IMS04-H11	FLJ	W01C082P22	pDONR221	10815		LOC100128288	100128288	BAC04438.1	Hs.549913	Hypothetical protein LOC100128288			caudate nucleus	BRCAN2		XM_001724933.1	XP_001724985.1	MODEL	OK	1.000	1.000	137	414	1	411	137	1	137
IKAKEN	AK122718	IMS04-H12	FLJ	W01C082P23	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK122718	IMS04-H12	FLJ	W01C082P24	pDONR221	23654		PCSK5	5125		Hs.368542	Proprotein convertase subtilisin/kexin type 5			tongue, tumor tissue	CTONG2		NM_006200.3	NP_006191.2	REVIEWED		0.325	0.353	271	1497	301	1074	913	626	887
IKAKEN	AK125818	IMS05-A01	FLJ	W01C083A01	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK125818	IMS05-A01	FLJ	W01C083A02	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK122942	IMS05-A02	FLJ	W01C083A03	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK122942	IMS05-A02	FLJ	W01C083A04	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK130753	IMS05-A03	FLJ	W01C083A05	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK130753	IMS05-A03	FLJ	W01C083A06	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK026541	IMS05-A04	FLJ	W01C083A07	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK026541	IMS05-A04	FLJ	W01C083A08	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK131033	IMS05-A05	FLJ	W01C083A09	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	AK131033	IMS05-A05	FLJ	W01C083A10	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC009623	IMS05-A06	MGC	W01C083A11	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC009623	IMS05-A06	MGC	W01C083A12	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC015802	IMS05-A07	MGC	W01C083A13	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC015802	IMS05-A07	MGC	W01C083A14	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC011952	IMS05-A08	MGC	W01C083A15	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC011952	IMS05-A08	MGC	W01C083A16	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC024325	IMS05-A09	MGC	W01C083A17	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC024325	IMS05-A09	MGC	W01C083A18	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC023087	IMS05-A10	MGC	W01C083A19	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC023087	IMS05-A10	MGC	W01C083A20	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC013166	IMS05-A11	MGC	W01C083A21	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC013166	IMS05-A11	MGC	W01C083A22	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC016673	IMS05-A12	MGC	W01C083A23	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	BC016673	IMS05-A12	MGC	W01C083A24	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	AK125818	IMS05-A01	FLJ	W01C083B01	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK125818	IMS05-A01	FLJ	W01C083B02	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK122942	IMS05-A02	FLJ	W01C083B03	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK122942	IMS05-A02	FLJ	W01C083B04	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK130753	IMS05-A03	FLJ	W01C083B05	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK130753	IMS05-A03	FLJ	W01C083B06	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK026541	IMS05-A04	FLJ	W01C083B07	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK026541	IMS05-A04	FLJ	W01C083B08	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK131033	IMS05-A05	FLJ	W01C083B09	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	AK131033	IMS05-A05	FLJ	W01C083B10	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC009623	IMS05-A06	MGC	W01C083B11	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC009623	IMS05-A06	MGC	W01C083B12	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC015802	IMS05-A07	MGC	W01C083B13	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC015802	IMS05-A07	MGC	W01C083B14	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC011952	IMS05-A08	MGC	W01C083B15	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC011952	IMS05-A08	MGC	W01C083B16	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC024325	IMS05-A09	MGC	W01C083B17	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC024325	IMS05-A09	MGC	W01C083B18	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC023087	IMS05-A10	MGC	W01C083B19	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC023087	IMS05-A10	MGC	W01C083B20	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC013166	IMS05-A11	MGC	W01C083B21	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC013166	IMS05-A11	MGC	W01C083B22	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC016673	IMS05-A12	MGC	W01C083B23	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	BC016673	IMS05-A12	MGC	W01C083B24	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	BC017709	IMS05-B01	MGC	W01C083C01	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC017709	IMS05-B01	MGC	W01C083C02	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC039174	IMS05-B02	MGC	W01C083C03	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC039174	IMS05-B02	MGC	W01C083C04	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC024009	IMS05-B03	MGC	W01C083C05	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC024009	IMS05-B03	MGC	W01C083C06	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC034476	IMS05-B04	MGC	W01C083C07	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC034476	IMS05-B04	MGC	W01C083C08	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC026087	IMS05-B05	MGC	W01C083C09	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC026087	IMS05-B05	MGC	W01C083C10	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC036444	IMS05-B06	MGC	W01C083C11	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC036444	IMS05-B06	MGC	W01C083C12	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC024764	IMS05-B07	MGC	W01C083C13	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B07	MGC	W01C083C14	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B08	MGC	W01C083C15	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC024764	IMS05-B08	MGC	W01C083C16	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC030653	IMS05-B09	MGC	W01C083C17	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC030653	IMS05-B09	MGC	W01C083C18	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC032958	IMS05-B10	MGC	W01C083C19	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC032958	IMS05-B10	MGC	W01C083C20	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC034993	IMS05-B11	MGC	W01C083C21	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC034993	IMS05-B11	MGC	W01C083C22	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC040501	IMS05-B12	MGC	W01C083C23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC040501	IMS05-B12	MGC	W01C083C24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC017709	IMS05-B01	MGC	W01C083D01	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC017709	IMS05-B01	MGC	W01C083D02	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC039174	IMS05-B02	MGC	W01C083D03	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC039174	IMS05-B02	MGC	W01C083D04	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC024009	IMS05-B03	MGC	W01C083D05	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC024009	IMS05-B03	MGC	W01C083D06	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC034476	IMS05-B04	MGC	W01C083D07	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC034476	IMS05-B04	MGC	W01C083D08	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC026087	IMS05-B05	MGC	W01C083D09	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC026087	IMS05-B05	MGC	W01C083D10	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC036444	IMS05-B06	MGC	W01C083D11	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC036444	IMS05-B06	MGC	W01C083D12	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC024764	IMS05-B07	MGC	W01C083D13	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B07	MGC	W01C083D14	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B08	MGC	W01C083D15	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC024764	IMS05-B08	MGC	W01C083D16	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC030653	IMS05-B09	MGC	W01C083D17	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC030653	IMS05-B09	MGC	W01C083D18	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC032958	IMS05-B10	MGC	W01C083D19	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC032958	IMS05-B10	MGC	W01C083D20	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC034993	IMS05-B11	MGC	W01C083D21	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC034993	IMS05-B11	MGC	W01C083D22	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC040501	IMS05-B12	MGC	W01C083D23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC040501	IMS05-B12	MGC	W01C083D24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC027853	IMS05-C01	MGC	W01C083E01	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	IMS05-C01	MGC	W01C083E02	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC034774	IMS05-C02	MGC	W01C083E03	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC034774	IMS05-C02	MGC	W01C083E04	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC029858	IMS05-C03	MGC	W01C083E05	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC029858	IMS05-C03	MGC	W01C083E06	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC033509	IMS05-C04	MGC	W01C083E07	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC033509	IMS05-C04	MGC	W01C083E08	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC027448	IMS05-C05	MGC	W01C083E09	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC027448	IMS05-C05	MGC	W01C083E10	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC034296	IMS05-C06	MGC	W01C083E11	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC034296	IMS05-C06	MGC	W01C083E12	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC031673	IMS05-C07	MGC	W01C083E13	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031673	IMS05-C07	MGC	W01C083E14	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C083E15	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C083E16	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC032236	IMS05-C09	MGC	W01C083E17	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC032236	IMS05-C09	MGC	W01C083E18	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC030295	IMS05-C10	MGC	W01C083E19	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC030295	IMS05-C10	MGC	W01C083E20	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC029574	IMS05-C11	MGC	W01C083E21	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029574	IMS05-C11	MGC	W01C083E22	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029585	IMS05-C12	MGC	W01C083E23	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC029585	IMS05-C12	MGC	W01C083E24	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC027853	IMS05-C01	MGC	W01C083F01	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	IMS05-C01	MGC	W01C083F02	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC034774	IMS05-C02	MGC	W01C083F03	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC034774	IMS05-C02	MGC	W01C083F04	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC029858	IMS05-C03	MGC	W01C083F05	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC029858	IMS05-C03	MGC	W01C083F06	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC033509	IMS05-C04	MGC	W01C083F07	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC033509	IMS05-C04	MGC	W01C083F08	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC027448	IMS05-C05	MGC	W01C083F09	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC027448	IMS05-C05	MGC	W01C083F10	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC034296	IMS05-C06	MGC	W01C083F11	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC034296	IMS05-C06	MGC	W01C083F12	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC031673	IMS05-C07	MGC	W01C083F13	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031673	IMS05-C07	MGC	W01C083F14	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C083F15	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C083F16	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC032236	IMS05-C09	MGC	W01C083F17	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC032236	IMS05-C09	MGC	W01C083F18	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC030295	IMS05-C10	MGC	W01C083F19	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC030295	IMS05-C10	MGC	W01C083F20	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC029574	IMS05-C11	MGC	W01C083F21	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029574	IMS05-C11	MGC	W01C083F22	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029585	IMS05-C12	MGC	W01C083F23	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC029585	IMS05-C12	MGC	W01C083F24	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC029608	IMS05-D01	MGC	W01C083G01	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC029608	IMS05-D01	MGC	W01C083G02	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC032786	IMS05-D02	MGC	W01C083G03	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC032786	IMS05-D02	MGC	W01C083G04	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC039693	IMS05-D03	MGC	W01C083G05	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC039693	IMS05-D03	MGC	W01C083G06	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC053992	IMS05-D04	MGC	W01C083G07	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC053992	IMS05-D04	MGC	W01C083G08	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC032680	IMS05-D05	MGC	W01C083G09	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC032680	IMS05-D05	MGC	W01C083G10	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC040185	IMS05-D06	MGC	W01C083G11	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC040185	IMS05-D06	MGC	W01C083G12	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031958	IMS05-D07	MGC	W01C083G13	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC031958	IMS05-D07	MGC	W01C083G14	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC045671	IMS05-D08	MGC	W01C083G15	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC045671	IMS05-D08	MGC	W01C083G16	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC036837	IMS05-D09	MGC	W01C083G17	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC036837	IMS05-D09	MGC	W01C083G18	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC035838	IMS05-D10	MGC	W01C083G19	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC035838	IMS05-D10	MGC	W01C083G20	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC039006	IMS05-D11	MGC	W01C083G21	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC039006	IMS05-D11	MGC	W01C083G22	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC043528	IMS05-D12	MGC	W01C083G23	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC043528	IMS05-D12	MGC	W01C083G24	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC029608	IMS05-D01	MGC	W01C083H01	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC029608	IMS05-D01	MGC	W01C083H02	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC032786	IMS05-D02	MGC	W01C083H03	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC032786	IMS05-D02	MGC	W01C083H04	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC039693	IMS05-D03	MGC	W01C083H05	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC039693	IMS05-D03	MGC	W01C083H06	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC053992	IMS05-D04	MGC	W01C083H07	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC053992	IMS05-D04	MGC	W01C083H08	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC032680	IMS05-D05	MGC	W01C083H09	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC032680	IMS05-D05	MGC	W01C083H10	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC040185	IMS05-D06	MGC	W01C083H11	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC040185	IMS05-D06	MGC	W01C083H12	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031958	IMS05-D07	MGC	W01C083H13	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC031958	IMS05-D07	MGC	W01C083H14	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC045671	IMS05-D08	MGC	W01C083H15	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC045671	IMS05-D08	MGC	W01C083H16	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC036837	IMS05-D09	MGC	W01C083H17	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC036837	IMS05-D09	MGC	W01C083H18	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC035838	IMS05-D10	MGC	W01C083H19	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC035838	IMS05-D10	MGC	W01C083H20	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC039006	IMS05-D11	MGC	W01C083H21	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC039006	IMS05-D11	MGC	W01C083H22	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC043528	IMS05-D12	MGC	W01C083H23	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC043528	IMS05-D12	MGC	W01C083H24	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC047469	IMS05-E01	MGC	W01C083I01	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC047469	IMS05-E01	MGC	W01C083I02	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC048330	IMS05-E02	MGC	W01C083I03	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E02	MGC	W01C083I04	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C083I05	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C083I06	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048800	IMS05-E04	MGC	W01C083I07	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC048800	IMS05-E04	MGC	W01C083I08	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC046199	IMS05-E05	MGC	W01C083I09	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC046199	IMS05-E05	MGC	W01C083I10	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC057390	IMS05-E06	MGC	W01C083I11	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC057390	IMS05-E06	MGC	W01C083I12	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC053533	IMS05-E07	MGC	W01C083I13	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053533	IMS05-E07	MGC	W01C083I14	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053537	IMS05-E08	MGC	W01C083I15	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053537	IMS05-E08	MGC	W01C083I16	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053997	IMS05-E09	MGC	W01C083I17	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC053997	IMS05-E09	MGC	W01C083I18	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC054033	IMS05-E10	MGC	W01C083I19	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC054033	IMS05-E10	MGC	W01C083I20	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC060811	IMS05-E11	MGC	W01C083I21	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC060811	IMS05-E11	MGC	W01C083I22	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC064693	IMS05-E12	MGC	W01C083I23	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC064693	IMS05-E12	MGC	W01C083I24	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC047469	IMS05-E01	MGC	W01C083J01	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC047469	IMS05-E01	MGC	W01C083J02	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC048330	IMS05-E02	MGC	W01C083J03	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E02	MGC	W01C083J04	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C083J05	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C083J06	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048800	IMS05-E04	MGC	W01C083J07	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC048800	IMS05-E04	MGC	W01C083J08	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC046199	IMS05-E05	MGC	W01C083J09	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC046199	IMS05-E05	MGC	W01C083J10	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC057390	IMS05-E06	MGC	W01C083J11	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC057390	IMS05-E06	MGC	W01C083J12	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC053533	IMS05-E07	MGC	W01C083J13	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053533	IMS05-E07	MGC	W01C083J14	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053537	IMS05-E08	MGC	W01C083J15	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053537	IMS05-E08	MGC	W01C083J16	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053997	IMS05-E09	MGC	W01C083J17	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC053997	IMS05-E09	MGC	W01C083J18	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC054033	IMS05-E10	MGC	W01C083J19	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC054033	IMS05-E10	MGC	W01C083J20	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC060811	IMS05-E11	MGC	W01C083J21	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC060811	IMS05-E11	MGC	W01C083J22	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC064693	IMS05-E12	MGC	W01C083J23	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC064693	IMS05-E12	MGC	W01C083J24	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC060839	IMS05-F01	MGC	W01C083K01	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC060839	IMS05-F01	MGC	W01C083K02	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC063625	IMS05-F02	MGC	W01C083K03	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063625	IMS05-F02	MGC	W01C083K04	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063640	IMS05-F03	MGC	W01C083K05	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063640	IMS05-F03	MGC	W01C083K06	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063561	IMS05-F04	MGC	W01C083K07	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC063561	IMS05-F04	MGC	W01C083K08	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC059947	IMS05-F05	MGC	W01C083K09	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC059947	IMS05-F05	MGC	W01C083K10	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC064574	IMS05-F06	MGC	W01C083K11	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC064574	IMS05-F06	MGC	W01C083K12	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC066647	IMS05-F07	MGC	W01C083K13	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC066647	IMS05-F07	MGC	W01C083K14	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC064028	IMS05-F08	MGC	W01C083K15	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC064028	IMS05-F08	MGC	W01C083K16	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC001083	IMS05-F09	MGC	W01C083K17	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F09	MGC	W01C083K18	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C083K19	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C083K20	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001409	IMS05-F11	MGC	W01C083K21	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC001409	IMS05-F11	MGC	W01C083K22	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC000568	IMS05-F12	MGC	W01C083K23	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC000568	IMS05-F12	MGC	W01C083K24	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC060839	IMS05-F01	MGC	W01C083L01	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC060839	IMS05-F01	MGC	W01C083L02	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC063625	IMS05-F02	MGC	W01C083L03	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063625	IMS05-F02	MGC	W01C083L04	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063640	IMS05-F03	MGC	W01C083L05	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063640	IMS05-F03	MGC	W01C083L06	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063561	IMS05-F04	MGC	W01C083L07	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC063561	IMS05-F04	MGC	W01C083L08	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC059947	IMS05-F05	MGC	W01C083L09	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC059947	IMS05-F05	MGC	W01C083L10	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC064574	IMS05-F06	MGC	W01C083L11	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC064574	IMS05-F06	MGC	W01C083L12	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC066647	IMS05-F07	MGC	W01C083L13	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC066647	IMS05-F07	MGC	W01C083L14	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC064028	IMS05-F08	MGC	W01C083L15	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC064028	IMS05-F08	MGC	W01C083L16	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC001083	IMS05-F09	MGC	W01C083L17	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F09	MGC	W01C083L18	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C083L19	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C083L20	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001409	IMS05-F11	MGC	W01C083L21	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC001409	IMS05-F11	MGC	W01C083L22	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC000568	IMS05-F12	MGC	W01C083L23	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC000568	IMS05-F12	MGC	W01C083L24	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC004353	IMS05-G01	MGC	W01C083M01	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC004353	IMS05-G01	MGC	W01C083M02	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC001794	IMS05-G02	MGC	W01C083M03	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC001794	IMS05-G02	MGC	W01C083M04	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC004894	IMS05-G03	MGC	W01C083M05	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC004894	IMS05-G03	MGC	W01C083M06	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC016299	IMS05-G04	MGC	W01C083M07	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC016299	IMS05-G04	MGC	W01C083M08	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC004995	IMS05-G05	MGC	W01C083M09	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004995	IMS05-G05	MGC	W01C083M10	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007991	IMS05-G06	MGC	W01C083M11	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC007991	IMS05-G06	MGC	W01C083M12	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC001686	IMS05-G07	MGC	W01C083M13	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC001686	IMS05-G07	MGC	W01C083M14	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC003648	IMS05-G08	MGC	W01C083M15	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC003648	IMS05-G08	MGC	W01C083M16	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC002653	IMS05-G09	MGC	W01C083M17	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC002653	IMS05-G09	MGC	W01C083M18	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC020165	IMS05-G10	MGC	W01C083M19	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC020165	IMS05-G10	MGC	W01C083M20	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC005821	IMS05-G11	MGC	W01C083M21	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC005821	IMS05-G11	MGC	W01C083M22	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC009748	IMS05-G12	MGC	W01C083M23	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC009748	IMS05-G12	MGC	W01C083M24	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC004353	IMS05-G01	MGC	W01C083N01	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC004353	IMS05-G01	MGC	W01C083N02	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC001794	IMS05-G02	MGC	W01C083N03	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC001794	IMS05-G02	MGC	W01C083N04	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC004894	IMS05-G03	MGC	W01C083N05	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC004894	IMS05-G03	MGC	W01C083N06	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC016299	IMS05-G04	MGC	W01C083N07	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC016299	IMS05-G04	MGC	W01C083N08	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC004995	IMS05-G05	MGC	W01C083N09	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004995	IMS05-G05	MGC	W01C083N10	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007991	IMS05-G06	MGC	W01C083N11	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC007991	IMS05-G06	MGC	W01C083N12	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC001686	IMS05-G07	MGC	W01C083N13	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC001686	IMS05-G07	MGC	W01C083N14	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC003648	IMS05-G08	MGC	W01C083N15	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC003648	IMS05-G08	MGC	W01C083N16	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC002653	IMS05-G09	MGC	W01C083N17	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC002653	IMS05-G09	MGC	W01C083N18	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC020165	IMS05-G10	MGC	W01C083N19	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC020165	IMS05-G10	MGC	W01C083N20	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC005821	IMS05-G11	MGC	W01C083N21	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC005821	IMS05-G11	MGC	W01C083N22	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC009748	IMS05-G12	MGC	W01C083N23	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC009748	IMS05-G12	MGC	W01C083N24	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC007831	IMS05-H01	MGC	W01C083O01	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007831	IMS05-H01	MGC	W01C083O02	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007913	IMS05-H02	MGC	W01C083O03	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC007913	IMS05-H02	MGC	W01C083O04	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC008360	IMS05-H03	MGC	W01C083O05	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC008360	IMS05-H03	MGC	W01C083O06	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC007354	IMS05-H04	MGC	W01C083O07	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC007354	IMS05-H04	MGC	W01C083O08	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC010056	IMS05-H05	MGC	W01C083O09	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC010056	IMS05-H05	MGC	W01C083O10	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC011581	IMS05-H06	MGC	W01C083O11	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC011581	IMS05-H06	MGC	W01C083O12	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC012096	IMS05-H07	MGC	W01C083O13	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC012096	IMS05-H07	MGC	W01C083O14	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC014311	IMS05-H08	MGC	W01C083O15	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC014311	IMS05-H08	MGC	W01C083O16	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC016318	IMS05-H09	MGC	W01C083O17	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC016318	IMS05-H09	MGC	W01C083O18	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC021275	IMS05-H10	MGC	W01C083O19	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021275	IMS05-H10	MGC	W01C083O20	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021288	IMS05-H11	MGC	W01C083O21	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC021288	IMS05-H11	MGC	W01C083O22	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC029405	IMS05-H12	MGC	W01C083O23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	BC029405	IMS05-H12	MGC	W01C083O24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	BC007831	IMS05-H01	MGC	W01C083P01	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007831	IMS05-H01	MGC	W01C083P02	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007913	IMS05-H02	MGC	W01C083P03	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC007913	IMS05-H02	MGC	W01C083P04	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC008360	IMS05-H03	MGC	W01C083P05	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC008360	IMS05-H03	MGC	W01C083P06	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC007354	IMS05-H04	MGC	W01C083P07	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC007354	IMS05-H04	MGC	W01C083P08	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC010056	IMS05-H05	MGC	W01C083P09	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC010056	IMS05-H05	MGC	W01C083P10	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC011581	IMS05-H06	MGC	W01C083P11	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC011581	IMS05-H06	MGC	W01C083P12	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC012096	IMS05-H07	MGC	W01C083P13	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC012096	IMS05-H07	MGC	W01C083P14	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC014311	IMS05-H08	MGC	W01C083P15	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC014311	IMS05-H08	MGC	W01C083P16	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC016318	IMS05-H09	MGC	W01C083P17	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC016318	IMS05-H09	MGC	W01C083P18	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC021275	IMS05-H10	MGC	W01C083P19	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021275	IMS05-H10	MGC	W01C083P20	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021288	IMS05-H11	MGC	W01C083P21	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC021288	IMS05-H11	MGC	W01C083P22	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC029405	IMS05-H12	MGC	W01C083P23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	BC029405	IMS05-H12	MGC	W01C083P24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	AK125818	IMS05-A01	FLJ	W01C084A01	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK125818	IMS05-A01	FLJ	W01C084A02	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK122942	IMS05-A02	FLJ	W01C084A03	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK122942	IMS05-A02	FLJ	W01C084A04	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK130753	IMS05-A03	FLJ	W01C084A05	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK130753	IMS05-A03	FLJ	W01C084A06	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK026541	IMS05-A04	FLJ	W01C084A07	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK026541	IMS05-A04	FLJ	W01C084A08	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK131033	IMS05-A05	FLJ	W01C084A09	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	AK131033	IMS05-A05	FLJ	W01C084A10	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC009623	IMS05-A06	MGC	W01C084A11	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC009623	IMS05-A06	MGC	W01C084A12	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC015802	IMS05-A07	MGC	W01C084A13	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC015802	IMS05-A07	MGC	W01C084A14	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC011952	IMS05-A08	MGC	W01C084A15	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC011952	IMS05-A08	MGC	W01C084A16	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC024325	IMS05-A09	MGC	W01C084A17	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC024325	IMS05-A09	MGC	W01C084A18	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC023087	IMS05-A10	MGC	W01C084A19	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC023087	IMS05-A10	MGC	W01C084A20	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC013166	IMS05-A11	MGC	W01C084A21	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC013166	IMS05-A11	MGC	W01C084A22	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC016673	IMS05-A12	MGC	W01C084A23	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	BC016673	IMS05-A12	MGC	W01C084A24	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	AK125818	IMS05-A01	FLJ	W01C084B01	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK125818	IMS05-A01	FLJ	W01C084B02	pDONR221	8875		NRN1L	123904		Hs.435464	Neuritin 1-like			testis	TESTI4		NM_198443.1	NP_940845.1	PROVISIONAL	OK	1.000	1.000	165	498	1	495	165	1	165
IKAKEN	AK122942	IMS05-A02	FLJ	W01C084B03	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK122942	IMS05-A02	FLJ	W01C084B04	pDONR221	4550		HNRNPUL2	221092		Hs.714969	Heterogeneous nuclear ribonucleoprotein U-like 2			testis	TESTI4		NM_001079559.1	NP_001073027.1	PROVISIONAL	P	1.000	1.000	629	1890	1	1887	747	119	747
IKAKEN	AK130753	IMS05-A03	FLJ	W01C084B05	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK130753	IMS05-A03	FLJ	W01C084B06	pDONR221	9339		FLJ27243	400539	BAC85422	Hs.514396	FLJ27243 protein			salivary gland	SLV														
IKAKEN	AK026541	IMS05-A04	FLJ	W01C084B07	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK026541	IMS05-A04	FLJ	W01C084B08	pDONR221	22974		FBXL6	26233	BAB15499.1	Hs.12271	F-box and leucine-rich repeat protein 6			ileal mucosa	kaia		NM_012162.1	NP_036294.1	REVIEWED	OK	1.000	1.000	539	1620	1	1617	539	1	539
IKAKEN	AK131033	IMS05-A05	FLJ	W01C084B09	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	AK131033	IMS05-A05	FLJ	W01C084B10	pDONR221	7911		TMEM202	338949	-	Hs.446069	Transmembrane protein 202			testis	TST		NM_001080462.1	NP_001073931.1	PROVISIONAL	OK	1.000	1.000	273	822	1	819	273	1	273
IKAKEN	BC009623	IMS05-A06	MGC	W01C084B11	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC009623	IMS05-A06	MGC	W01C084B12	pDONR221	18526		NPM1	4869	AAH09623.1	Hs.557550	Nucleophosmin (nucleolar phosphoprotein B23, numatrin)			Brain, adult medulla	NIH_MGC_119	DH10B	NM_199185.2	NP_954654.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	BC015802	IMS05-A07	MGC	W01C084B13	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC015802	IMS05-A07	MGC	W01C084B14	pDONR221	19790		RWDD1	51389	AAH15802.1	Hs.532164	RWD domain containing 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_015952.2	NP_057036.2	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	BC011952	IMS05-A08	MGC	W01C084B15	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC011952	IMS05-A08	MGC	W01C084B16	pDONR221	10598		FAM18B2	201158	AAH11952.1					Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_145301.2	NP_660344.2	VALIDATED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	BC024325	IMS05-A09	MGC	W01C084B17	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC024325	IMS05-A09	MGC	W01C084B18	pDONR221	21025		AHCYL2	23382	AAH24325.1	Hs.600789	S-adenosylhomocysteine hydrolase-like 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_015328.2	NP_056143.1	VALIDATED	OK	1.000	1.000	611	1836	1	1833	611	1	611
IKAKEN	BC023087	IMS05-A10	MGC	W01C084B19	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC023087	IMS05-A10	MGC	W01C084B20	pDONR221	478		NBPF15	284565	AAH23087.1	Hs.655246	Neuroblastoma breakpoint family, member 15			Testis	NIH_MGC_97	DH10B	NM_173638.2	NP_775909.1	PREDICTED	Cs	0.999	0.999	670	2013	1	2010	670	1	670
IKAKEN	BC013166	IMS05-A11	MGC	W01C084B21	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC013166	IMS05-A11	MGC	W01C084B22	pDONR221	3884		TRIM44	54765	AAH13166.1	Hs.192103	Tripartite motif-containing 44			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_017583.4	NP_060053.2	REVIEWED	OK	1.000	1.000	344	1035	1	1032	344	1	344
IKAKEN	BC016673	IMS05-A12	MGC	W01C084B23	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	BC016673	IMS05-A12	MGC	W01C084B24	pDONR221	6876			647318	AAH16673					Brain, neuroblastoma	NIH_MGC_19	DH10B-R			
IKAKEN	BC017709	IMS05-B01	MGC	W01C084C01	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC017709	IMS05-B01	MGC	W01C084C02	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC039174	IMS05-B02	MGC	W01C084C03	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC039174	IMS05-B02	MGC	W01C084C04	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC024009	IMS05-B03	MGC	W01C084C05	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC024009	IMS05-B03	MGC	W01C084C06	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC034476	IMS05-B04	MGC	W01C084C07	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC034476	IMS05-B04	MGC	W01C084C08	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC026087	IMS05-B05	MGC	W01C084C09	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC026087	IMS05-B05	MGC	W01C084C10	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC036444	IMS05-B06	MGC	W01C084C11	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC036444	IMS05-B06	MGC	W01C084C12	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC024764	IMS05-B07	MGC	W01C084C13	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B07	MGC	W01C084C14	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B08	MGC	W01C084C15	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC024764	IMS05-B08	MGC	W01C084C16	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC030653	IMS05-B09	MGC	W01C084C17	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC030653	IMS05-B09	MGC	W01C084C18	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC032958	IMS05-B10	MGC	W01C084C19	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC032958	IMS05-B10	MGC	W01C084C20	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC034993	IMS05-B11	MGC	W01C084C21	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC034993	IMS05-B11	MGC	W01C084C22	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC040501	IMS05-B12	MGC	W01C084C23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC040501	IMS05-B12	MGC	W01C084C24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC017709	IMS05-B01	MGC	W01C084D01	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC017709	IMS05-B01	MGC	W01C084D02	pDONR221	3826		API5	8539	AAH17709.1	Hs.435771	Apoptosis inhibitor 5			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006595.3	NP_006586.1	VALIDATED	Pfs	0.872	0.925	296	843	5	840	504	151	446
IKAKEN	BC039174	IMS05-B02	MGC	W01C084D03	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC039174	IMS05-B02	MGC	W01C084D04	pDONR221	2835		VCL	7414	AAH39174.1	Hs.643896	Vinculin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_003373.3	NP_003364.1	REVIEWED	OK	1.000	1.000	1066	3201	1	3198	1066	1	1066
IKAKEN	BC024009	IMS05-B03	MGC	W01C084D05	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC024009	IMS05-B03	MGC	W01C084D06	pDONR221	8818		LRRC50	123872	AAH24009.3	Hs.310164	Leucine rich repeat containing 50			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_178452.4	NP_848547.4	VALIDATED	P	1.000	1.000	638	1917	1	1914	725	88	725
IKAKEN	BC034476	IMS05-B04	MGC	W01C084D07	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC034476	IMS05-B04	MGC	W01C084D08	pDONR221	2610		FRAT1	10023	AAH34476.1	Hs.715785	Frequently rearranged in advanced T-cell lymphomas			brain	CBR		NM_005479.3	NP_005470.2	REVIEWED	OK	1.000	1.000	279	840	1	837	279	1	279
IKAKEN	BC026087	IMS05-B05	MGC	W01C084D09	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC026087	IMS05-B05	MGC	W01C084D10	pDONR221	19963		RNF217	154214	AAH26087.1	Hs.368639	Ring finger protein 217			Testis	NIH_MGC_97	DH10B	NM_152553.2	NP_689766.1	PROVISIONAL	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC036444	IMS05-B06	MGC	W01C084D11	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC036444	IMS05-B06	MGC	W01C084D12	pDONR221	3099		CPEB3	22849	AAH36444.1	Hs.131683	Cytoplasmic polyadenylation element binding protein 3			Brain, hippocampus	NIH_MGC_95	DH10B	NM_014912.3	NP_055727.3	VALIDATED	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC024764	IMS05-B07	MGC	W01C084D13	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B07	MGC	W01C084D14	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED		0.372	0.372	43	558	166	294	759	134	176
IKAKEN	BC024764	IMS05-B08	MGC	W01C084D15	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC024764	IMS05-B08	MGC	W01C084D16	pDONR221	5188		IQSEC3	440073	AAH24764.1	Hs.536319	IQ motif and Sec7 domain 3			Bone, osteosarcoma	NIH_MGC_86	DH10B	NM_015232.1	NP_056047.1	VALIDATED	Pfs	0.280	0.286	93	489	15	290	759	227	318
IKAKEN	BC030653	IMS05-B09	MGC	W01C084D17	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC030653	IMS05-B09	MGC	W01C084D18	pDONR221	8923		CDH13	1012	AAH30653.1	Hs.654386	Cadherin 13, H-cadherin (heart)			Testis	NIH_MGC_97	DH10B	NM_001257.3	NP_001248.1	REVIEWED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	BC032958	IMS05-B10	MGC	W01C084D19	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC032958	IMS05-B10	MGC	W01C084D20	pDONR221	20100		RP4-662A9.2	154089	-	Hs.126165	Hypothetical protein MGC34034			Brain, hippocampus	NIH_MGC_95	DH10B													
IKAKEN	BC034993	IMS05-B11	MGC	W01C084D21	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC034993	IMS05-B11	MGC	W01C084D22	pDONR221	9548		KIF1C	10749	AAH34993.1	Hs.435120	Kinesin family member 1C			Testis	NIH_MGC_97	DH10B	NM_006612.4	NP_006603.2	PROVISIONAL	Pfs	0.777	0.819	355	1014	1	1011	1103	749	1103
IKAKEN	BC040501	IMS05-B12	MGC	W01C084D23	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC040501	IMS05-B12	MGC	W01C084D24	pDONR221	10035		LRRC37A	9884	AAH40501.2	Hs.696401	Leucine rich repeat containing 37A			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_014834.3	NP_055649.3	VALIDATED	Pfs	0.747	0.975	780	1794	1	1793	1700	351	1130
IKAKEN	BC027853	IMS05-C01	MGC	W01C084E01	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	IMS05-C01	MGC	W01C084E02	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC034774	IMS05-C02	MGC	W01C084E03	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC034774	IMS05-C02	MGC	W01C084E04	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC029858	IMS05-C03	MGC	W01C084E05	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC029858	IMS05-C03	MGC	W01C084E06	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC033509	IMS05-C04	MGC	W01C084E07	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC033509	IMS05-C04	MGC	W01C084E08	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC027448	IMS05-C05	MGC	W01C084E09	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC027448	IMS05-C05	MGC	W01C084E10	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC034296	IMS05-C06	MGC	W01C084E11	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC034296	IMS05-C06	MGC	W01C084E12	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC031673	IMS05-C07	MGC	W01C084E13	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031673	IMS05-C07	MGC	W01C084E14	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C084E15	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C084E16	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC032236	IMS05-C09	MGC	W01C084E17	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC032236	IMS05-C09	MGC	W01C084E18	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC030295	IMS05-C10	MGC	W01C084E19	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC030295	IMS05-C10	MGC	W01C084E20	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC029574	IMS05-C11	MGC	W01C084E21	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029574	IMS05-C11	MGC	W01C084E22	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029585	IMS05-C12	MGC	W01C084E23	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC029585	IMS05-C12	MGC	W01C084E24	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC027853	IMS05-C01	MGC	W01C084F01	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC027853	IMS05-C01	MGC	W01C084F02	pDONR221	20348		C6orf123	26238	AAH27853	Hs.520583	Chromosome 6 open reading frame 123			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B													
IKAKEN	BC034774	IMS05-C02	MGC	W01C084F03	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC034774	IMS05-C02	MGC	W01C084F04	pDONR221	20801		C6orf10	10665	AAH34774.1	Hs.567414	Chromosome 6 open reading frame 10			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006781.3	NP_006772.3	VALIDATED	Cfs	0.968	0.991	563	1653	1	1650	563	1	563
IKAKEN	BC029858	IMS05-C03	MGC	W01C084F05	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC029858	IMS05-C03	MGC	W01C084F06	pDONR221	5537		LRRC23	10233	AAH29858.1	Hs.155586	Leucine rich repeat containing 23			Testis	NIH_MGC_97	DH10B	NM_001135217.1	NP_001128689.1	VALIDATED	OK	1.000	1.000	343	1032	1	1029	343	1	343
IKAKEN	BC033509	IMS05-C04	MGC	W01C084F07	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC033509	IMS05-C04	MGC	W01C084F08	pDONR221	14132		MDH1B	130752	AAH33509.1	Hs.147816	Malate dehydrogenase 1B, NAD (soluble)			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_001039845.1	NP_001034934.1	VALIDATED	Pg	0.546	1.000	469	852	1	768	518	1	469
IKAKEN	BC027448	IMS05-C05	MGC	W01C084F09	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC027448	IMS05-C05	MGC	W01C084F10	pDONR221	27967				AAH27448					Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B			
IKAKEN	BC034296	IMS05-C06	MGC	W01C084F11	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC034296	IMS05-C06	MGC	W01C084F12	pDONR221	17691		C4orf22	255119	AAH34296.1	Hs.527104	Chromosome 4 open reading frame 22			Skeletal Muscle	NIH_MGC_81	DH10B	NM_152770.1	NP_689983.1	PREDICTED	Cs	0.996	0.996	233	702	1	699	233	1	233
IKAKEN	BC031673	IMS05-C07	MGC	W01C084F13	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC031673	IMS05-C07	MGC	W01C084F14	pDONR221	17743		LOC389199	389199	AAH31673.1	Hs.375210	Hypothetical gene supported by BC031673			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C084F15	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC028195	IMS05-C08	MGC	W01C084F16	pDONR221	5874		C12orf33	253128	AAH28195.1	Hs.408739	Chromosome 12 open reading frame 33			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B													
IKAKEN	BC032236	IMS05-C09	MGC	W01C084F17	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC032236	IMS05-C09	MGC	W01C084F18	pDONR221	24755		ARMCX4	158947	AAH32236	Hs.709762	Armadillo repeat containing, X-linked 4			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_152583.2	NP_689796.2	NA
IKAKEN	BC030295	IMS05-C10	MGC	W01C084F19	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC030295	IMS05-C10	MGC	W01C084F20	pDONR221	21976		WBSCR27	155368	AAH30295.1	Hs.647042	Williams Beuren syndrome chromosome region 27			Testis	NIH_MGC_97	DH10B	NM_152559.2	NP_689772.2	REVIEWED	OK	1.000	1.000	245	738	1	735	245	1	245
IKAKEN	BC029574	IMS05-C11	MGC	W01C084F21	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029574	IMS05-C11	MGC	W01C084F22	pDONR221	10680		PROCA1	147011	AAH29574.1	Hs.207471	Proline-rich cyclin A1-interacting protein			Testis	NIH_MGC_97	DH10B	NM_152465.1	NP_689678.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC029585	IMS05-C12	MGC	W01C084F23	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC029585	IMS05-C12	MGC	W01C084F24	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	1008	384	827	148	1	148
IKAKEN	BC029608	IMS05-D01	MGC	W01C084G01	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC029608	IMS05-D01	MGC	W01C084G02	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC032786	IMS05-D02	MGC	W01C084G03	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC032786	IMS05-D02	MGC	W01C084G04	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC039693	IMS05-D03	MGC	W01C084G05	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC039693	IMS05-D03	MGC	W01C084G06	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC053992	IMS05-D04	MGC	W01C084G07	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC053992	IMS05-D04	MGC	W01C084G08	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC032680	IMS05-D05	MGC	W01C084G09	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC032680	IMS05-D05	MGC	W01C084G10	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC040185	IMS05-D06	MGC	W01C084G11	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC040185	IMS05-D06	MGC	W01C084G12	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031958	IMS05-D07	MGC	W01C084G13	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC031958	IMS05-D07	MGC	W01C084G14	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC045671	IMS05-D08	MGC	W01C084G15	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC045671	IMS05-D08	MGC	W01C084G16	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC036837	IMS05-D09	MGC	W01C084G17	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC036837	IMS05-D09	MGC	W01C084G18	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC035838	IMS05-D10	MGC	W01C084G19	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC035838	IMS05-D10	MGC	W01C084G20	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC039006	IMS05-D11	MGC	W01C084G21	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC039006	IMS05-D11	MGC	W01C084G22	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC043528	IMS05-D12	MGC	W01C084G23	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC043528	IMS05-D12	MGC	W01C084G24	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC029608	IMS05-D01	MGC	W01C084H01	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC029608	IMS05-D01	MGC	W01C084H02	pDONR221	19137		RICTOR	253260	AAH29608.1	Hs.407926	Rapamycin-insensitive companion of mTOR			Testis	NIH_MGC_97	DH10B	NM_152756.3	NP_689969.2	VALIDATED	Pfs	0.971	1.000	239	765	3	720	1708	20	251
IKAKEN	BC032786	IMS05-D02	MGC	W01C084H03	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC032786	IMS05-D02	MGC	W01C084H04	pDONR221	20715		DDO	8528	AAH32786.3	Hs.591348	D-aspartate oxidase			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_004032.2	NP_004023.2	REVIEWED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	BC039693	IMS05-D03	MGC	W01C084H05	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC039693	IMS05-D03	MGC	W01C084H06	pDONR221	24880		F8A1	8263	AAH39693.1	Hs.533543	Coagulation factor VIII-associated (intronic transcript) 1			Brain, adult medulla	NIH_MGC_119	DH10B	NM_012151.3	NP_036283.2	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	BC053992	IMS05-D04	MGC	W01C084H07	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC053992	IMS05-D04	MGC	W01C084H08	pDONR221	11716		SCAF1	58506	AAH53992.1	Hs.103521	SR-related CTD-associated factor 1			Liver, adenocarcinoma	NIH_MGC_90	DH10B	NM_021228.2	NP_067051.2	VALIDATED	C	1.000	1.000	1312	3939	1	3936	1312	1	1312
IKAKEN	BC032680	IMS05-D05	MGC	W01C084H09	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC032680	IMS05-D05	MGC	W01C084H10	pDONR221	222		ZFYVE9	9372	AAH32680.1	Hs.532345	Zinc finger, FYVE domain containing 9			Testis	NIH_MGC_97	DH10B	NM_007323.1	NP_015562.1	REVIEWED		0.500	0.500	10	579	240	211	762	228	237
IKAKEN	BC040185	IMS05-D06	MGC	W01C084H11	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC040185	IMS05-D06	MGC	W01C084H12	pDONR221	6155		DDX51	317781	AAH40185.1	Hs.445168	DEAD (Asp-Glu-Ala-Asp) box polypeptide 51			Testis	NIH_MGC_97	DH10B	NM_175066.3	NP_778236.2	VALIDATED	OK	1.000	1.000	666	2001	1	1998	666	1	666
IKAKEN	BC031958	IMS05-D07	MGC	W01C084H13	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC031958	IMS05-D07	MGC	W01C084H14	pDONR221	7954		C15orf50	414926	-	Hs.569502	Chromosome 15 open reading frame 50			Lymph, lymphoma	NIH_MGC_85	DH10B			
IKAKEN	BC045671	IMS05-D08	MGC	W01C084H15	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC045671	IMS05-D08	MGC	W01C084H16	pDONR221	14311		C2orf53	339779	AAH45671.1	Hs.136555	Chromosome 2 open reading frame 53			Ovary, pooled from 3 adults	NIH_MGC_125	DH10B	NM_178553.3	NP_848648.2	VALIDATED	OK	1.000	1.000	412	1239	1	1236	412	1	412
IKAKEN	BC036837	IMS05-D09	MGC	W01C084H17	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC036837	IMS05-D09	MGC	W01C084H18	pDONR221	15095		C20orf201	198437	AAH36837.1	Hs.570316	Chromosome 20 open reading frame 201			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001007125.1	NP_001007126.1	PREDICTED	Pfs	0.871	1.000	224	585	1	584	240	1	224
IKAKEN	BC035838	IMS05-D10	MGC	W01C084H19	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC035838	IMS05-D10	MGC	W01C084H20	pDONR221	9740		NT5M	56953	AAH35838.1	Hs.513977	5',3'-nucleotidase, mitochondrial			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_020201.3	NP_064586.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	BC039006	IMS05-D11	MGC	W01C084H21	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC039006	IMS05-D11	MGC	W01C084H22	pDONR221	19449		DPYSL3	1809	AAH39006.1	Hs.519659	Dihydropyrimidinase-like 3			Brain, hippocampus	NIH_MGC_124	DH10B	NM_001387.2	NP_001378.1	VALIDATED	OK	1.000	1.000	570	1713	1	1710	570	1	570
IKAKEN	BC043528	IMS05-D12	MGC	W01C084H23	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC043528	IMS05-D12	MGC	W01C084H24	pDONR221	5438		GLT1D1	144423	AAH43528.1	Hs.655668	Glycosyltransferase 1 domain containing 1			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_144669.1	NP_653270.1	PROVISIONAL	OK	1.000	1.000	266	801	1	798	266	1	266
IKAKEN	BC047469	IMS05-E01	MGC	W01C084I01	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC047469	IMS05-E01	MGC	W01C084I02	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC048330	IMS05-E02	MGC	W01C084I03	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E02	MGC	W01C084I04	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C084I05	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C084I06	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048800	IMS05-E04	MGC	W01C084I07	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC048800	IMS05-E04	MGC	W01C084I08	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC046199	IMS05-E05	MGC	W01C084I09	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC046199	IMS05-E05	MGC	W01C084I10	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC057390	IMS05-E06	MGC	W01C084I11	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC057390	IMS05-E06	MGC	W01C084I12	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC053533	IMS05-E07	MGC	W01C084I13	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053533	IMS05-E07	MGC	W01C084I14	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053537	IMS05-E08	MGC	W01C084I15	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053537	IMS05-E08	MGC	W01C084I16	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053997	IMS05-E09	MGC	W01C084I17	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC053997	IMS05-E09	MGC	W01C084I18	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC054033	IMS05-E10	MGC	W01C084I19	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC054033	IMS05-E10	MGC	W01C084I20	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC060811	IMS05-E11	MGC	W01C084I21	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC060811	IMS05-E11	MGC	W01C084I22	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC064693	IMS05-E12	MGC	W01C084I23	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC064693	IMS05-E12	MGC	W01C084I24	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC047469	IMS05-E01	MGC	W01C084J01	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC047469	IMS05-E01	MGC	W01C084J02	pDONR221	1771		ANGEL2	90806	AAH47469.1	Hs.157078	Angel homolog 2 (Drosophila)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_144567.3	NP_653168.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	BC048330	IMS05-E02	MGC	W01C084J03	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E02	MGC	W01C084J04	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.833	0.939	720	1947	1	1944	725	15	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C084J05	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048330	IMS05-E03	MGC	W01C084J06	pDONR221	986		MST1	4485	AAH48330.1	Hs.512587	Macrophage stimulating 1 (hepatocyte growth factor-like)			Testis	NIH_MGC_97	DH10B	NM_020998.3	NP_066278.3	VALIDATED	Pfs	0.927	0.960	708	2118	3	2115	725	39	725
IKAKEN	BC048800	IMS05-E04	MGC	W01C084J07	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC048800	IMS05-E04	MGC	W01C084J08	pDONR221	2884		C10orf47	254427	AAH48800.1	Hs.435775	Chromosome 10 open reading frame 47			Testis	NIH_MGC_97	DH10B	NM_153256.3	NP_694988.3	VALIDATED	OK	1.000	1.000	435	1308	1	1305	435	1	435
IKAKEN	BC046199	IMS05-E05	MGC	W01C084J09	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC046199	IMS05-E05	MGC	W01C084J10	pDONR221	1223		FAM72B	653820	AAH46199.1	Hs.339665	Family with sequence similarity 72, member B			Eye, retinoblastoma	NIH_MGC_67	DH10B	NM_001100910.1	NP_001094380.1	PREDICTED		0.973	0.973	149	450	1	447	149	1	149
IKAKEN	BC057390	IMS05-E06	MGC	W01C084J11	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC057390	IMS05-E06	MGC	W01C084J12	pDONR221	16811		TMEM158	25907	AAH57390.1	Hs.716411	Transmembrane protein 158			Placenta, normal	NIH_MGC_147	DH10B	NM_015444.2	NP_056259.2	REVIEWED	Cfs	0.997	0.997	300	903	1	900	300	1	300
IKAKEN	BC053533	IMS05-E07	MGC	W01C084J13	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053533	IMS05-E07	MGC	W01C084J14	pDONR221	13960		MTERFD2	130916	AAH53533.2	Hs.159556	MTERF domain containing 2			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_182501.2	NP_872307.2	PROVISIONAL	OK	1.000	1.000	381	1146	1	1143	381	1	381
IKAKEN	BC053537	IMS05-E08	MGC	W01C084J15	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053537	IMS05-E08	MGC	W01C084J16	pDONR221	7581		FBXO33	254170	AAH53537.1	Hs.324342	F-box protein 33			Brain, adult medulla	NIH_MGC_119	DH10B	NM_203301.2	NP_976046.1	VALIDATED	OK	1.000	1.000	555	1668	1	1665	555	1	555
IKAKEN	BC053997	IMS05-E09	MGC	W01C084J17	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC053997	IMS05-E09	MGC	W01C084J18	pDONR221	17753		FRG1	2483	AAH53997.1	Hs.203772	FSHD region gene 1			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_004477.2	NP_004468.1	REVIEWED	OK	1.000	1.000	258	777	1	774	258	1	258
IKAKEN	BC054033	IMS05-E10	MGC	W01C084J19	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC054033	IMS05-E10	MGC	W01C084J20	pDONR221	22553		MSRA	4482	AAH54033.1	Hs.490981	Methionine sulfoxide reductase A			Pooled, 40 cell lines	NIH_MGC_141	DH10B	NM_012331.3	NP_036463.1	REVIEWED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	BC060811	IMS05-E11	MGC	W01C084J21	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC060811	IMS05-E11	MGC	W01C084J22	pDONR221	22465		SCARA3	51435	AAH60811.1	Hs.128856	Scavenger receptor class A, member 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_182826.1	NP_878185.1	REVIEWED	C	1.000	1.000	466	1659	259	1656	466	1	466
IKAKEN	BC064693	IMS05-E12	MGC	W01C084J23	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC064693	IMS05-E12	MGC	W01C084J24	pDONR221	21006		AUTS2	26053	AAH64693.1	Hs.654801	Autism susceptibility candidate 2			Placenta, normal	NIH_MGC_147	DH10B	NM_015570.2	NP_056385.1	VALIDATED	OK	1.000	1.000	1259	3780	1	3777	1259	1	1259
IKAKEN	BC060839	IMS05-F01	MGC	W01C084K01	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC060839	IMS05-F01	MGC	W01C084K02	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC063625	IMS05-F02	MGC	W01C084K03	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063625	IMS05-F02	MGC	W01C084K04	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063640	IMS05-F03	MGC	W01C084K05	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063640	IMS05-F03	MGC	W01C084K06	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063561	IMS05-F04	MGC	W01C084K07	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC063561	IMS05-F04	MGC	W01C084K08	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC059947	IMS05-F05	MGC	W01C084K09	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC059947	IMS05-F05	MGC	W01C084K10	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC064574	IMS05-F06	MGC	W01C084K11	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC064574	IMS05-F06	MGC	W01C084K12	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC066647	IMS05-F07	MGC	W01C084K13	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC066647	IMS05-F07	MGC	W01C084K14	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC064028	IMS05-F08	MGC	W01C084K15	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC064028	IMS05-F08	MGC	W01C084K16	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC001083	IMS05-F09	MGC	W01C084K17	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F09	MGC	W01C084K18	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C084K19	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C084K20	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001409	IMS05-F11	MGC	W01C084K21	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC001409	IMS05-F11	MGC	W01C084K22	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC000568	IMS05-F12	MGC	W01C084K23	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC000568	IMS05-F12	MGC	W01C084K24	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC060839	IMS05-F01	MGC	W01C084L01	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC060839	IMS05-F01	MGC	W01C084L02	pDONR221	16870		PTPLB	201562	AAH60839.1	Hs.705480	Protein tyrosine phosphatase-like (proline instead of catalytic arginine), member b			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_198402.3	NP_940684.1	PROVISIONAL	OK	1.000	1.000	254	765	1	762	254	1	254
IKAKEN	BC063625	IMS05-F02	MGC	W01C084L03	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063625	IMS05-F02	MGC	W01C084L04	pDONR221	10479		KRTAP2-4	85294	AAH63625.1	Hs.560502	Keratin associated protein 2-4			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_033184.2	NP_149440.1	REVIEWED	OK	1.000	1.000	128	387	1	384	128	1	128
IKAKEN	BC063640	IMS05-F03	MGC	W01C084L05	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063640	IMS05-F03	MGC	W01C084L06	pDONR221	12640		SBSN	374897	AAH63640.1	Hs.433484	Suprabasin			Skin, normal	NCI_CGAP_Skn3	DH10B	NM_198538.1	NP_940940.1	PROVISIONAL	C	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BC063561	IMS05-F04	MGC	W01C084L07	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC063561	IMS05-F04	MGC	W01C084L08	pDONR221	6082		PLBD1	79887	AAH63561.1	Hs.131933	Phospholipase B domain containing 1			Kidney, hypernephroma	NIH_MGC_89	DH10B	NM_024829.5	NP_079105.4	VALIDATED	C	1.000	1.000	553	1662	1	1659	553	1	553
IKAKEN	BC059947	IMS05-F05	MGC	W01C084L09	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC059947	IMS05-F05	MGC	W01C084L10	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED	Pg	0.977	1.000	44	135	1	132	78	36	78
IKAKEN	BC064574	IMS05-F06	MGC	W01C084L11	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC064574	IMS05-F06	MGC	W01C084L12	pDONR221	14170		LOC150763	150763	AAH64574	Hs.590914	Hypothetical protein LOC150763			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_207328.2	NP_997211.2	VALIDATED	Pfs	0.914	0.948	397	1194	2	1191	795	413	795
IKAKEN	BC066647	IMS05-F07	MGC	W01C084L13	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC066647	IMS05-F07	MGC	W01C084L14	pDONR221	6938		KIAA0586	9786	AAH66647.2	Hs.232532	KIAA0586			Testis	NIH_MGC_97	DH10B	NM_014749.3	NP_055564.3	VALIDATED	Pg	0.950	1.000	1533	4602	1	4599	1472	16	1472
IKAKEN	BC064028	IMS05-F08	MGC	W01C084L15	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC064028	IMS05-F08	MGC	W01C084L16	pDONR221	23707		IER5L	389792	AAH64028.1	Hs.640233	Immediate early response 5-like			Peripheral Nervous System, dorsal root	Lupski_dorsal_root_ganglion	DH10B	NM_203434.2	NP_982258.2	VALIDATED		0.927	0.927	233	714	1	699	404	1	233
IKAKEN	BC001083	IMS05-F09	MGC	W01C084L17	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F09	MGC	W01C084L18	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C084L19	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001083	IMS05-F10	MGC	W01C084L20	pDONR221	9164		DEXI	28955	AAH01083.2	Hs.592051	Dexamethasone-induced transcript			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014015.3	NP_054734.2	VALIDATED		0.979	0.979	95	288	1	285	95	1	95
IKAKEN	BC001409	IMS05-F11	MGC	W01C084L21	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC001409	IMS05-F11	MGC	W01C084L22	pDONR221	9977		TMEM93	83460	AAH01409.1	Hs.30011	Transmembrane protein 93			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_031298.2	NP_112588.1	VALIDATED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	BC000568	IMS05-F12	MGC	W01C084L23	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC000568	IMS05-F12	MGC	W01C084L24	pDONR221	16135		TMEM108	66000	AAH00568.1	Hs.191616	Transmembrane protein 108			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_001136469.1	NP_001129941.1	VALIDATED	OK	1.000	1.000	575	1728	1	1725	575	1	575
IKAKEN	BC004353	IMS05-G01	MGC	W01C084M01	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC004353	IMS05-G01	MGC	W01C084M02	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC001794	IMS05-G02	MGC	W01C084M03	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC001794	IMS05-G02	MGC	W01C084M04	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC004894	IMS05-G03	MGC	W01C084M05	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC004894	IMS05-G03	MGC	W01C084M06	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC016299	IMS05-G04	MGC	W01C084M07	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC016299	IMS05-G04	MGC	W01C084M08	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC004995	IMS05-G05	MGC	W01C084M09	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004995	IMS05-G05	MGC	W01C084M10	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007991	IMS05-G06	MGC	W01C084M11	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC007991	IMS05-G06	MGC	W01C084M12	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC001686	IMS05-G07	MGC	W01C084M13	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC001686	IMS05-G07	MGC	W01C084M14	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC003648	IMS05-G08	MGC	W01C084M15	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC003648	IMS05-G08	MGC	W01C084M16	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC002653	IMS05-G09	MGC	W01C084M17	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC002653	IMS05-G09	MGC	W01C084M18	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC020165	IMS05-G10	MGC	W01C084M19	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC020165	IMS05-G10	MGC	W01C084M20	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC005821	IMS05-G11	MGC	W01C084M21	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC005821	IMS05-G11	MGC	W01C084M22	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC009748	IMS05-G12	MGC	W01C084M23	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC009748	IMS05-G12	MGC	W01C084M24	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC004353	IMS05-G01	MGC	W01C084N01	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC004353	IMS05-G01	MGC	W01C084N02	pDONR221	8615		HAGHL	84264	AAH04353.1	Hs.124015	Hydroxyacylglutathione hydrolase-like			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_032304.2	NP_115680.1	VALIDATED	Cg	0.966	1.000	292	879	1	876	282	1	282
IKAKEN	BC001794	IMS05-G02	MGC	W01C084N03	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC001794	IMS05-G02	MGC	W01C084N04	pDONR221	12245		NUMBL	9253	-	Hs.326953	Numb homolog (Drosophila)-like			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_004756.3	NP_004747.1	VALIDATED	P	1.000	1.000	568	1707	1	1704	609	42	609
IKAKEN	BC004894	IMS05-G03	MGC	W01C084N05	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC004894	IMS05-G03	MGC	W01C084N06	pDONR221	18187		C4orf14	84273	AAH04894.1	Hs.8715	Chromosome 4 open reading frame 14			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_032313.2	NP_115689.1	PROVISIONAL	C	1.000	1.000	698	2097	1	2094	698	1	698
IKAKEN	BC016299	IMS05-G04	MGC	W01C084N07	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC016299	IMS05-G04	MGC	W01C084N08	pDONR221	23981		ST6GALNAC6	30815	AAH16299.1	Hs.109672	ST6 (alpha-N-acetyl-neuraminyl-2,3-beta-galactosyl-1,3)-N-acetylgalactosaminide alpha-2,6-sialyltransferase 6			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_013443.3	NP_038471.2	PROVISIONAL	OK	1.000	1.000	333	1002	1	999	333	1	333
IKAKEN	BC004995	IMS05-G05	MGC	W01C084N09	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC004995	IMS05-G05	MGC	W01C084N10	pDONR221	2717		MARVELD1	83742	AAH04995	Hs.209614	MARVEL domain containing 1			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007991	IMS05-G06	MGC	W01C084N11	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC007991	IMS05-G06	MGC	W01C084N12	pDONR221	8271		C15orf44	81556	AAH07991.1	Hs.6686	Chromosome 15 open reading frame 44			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_001136043.1	NP_001129515.1	PREDICTED	C	1.000	1.000	439	1557	238	1554	439	1	439
IKAKEN	BC001686	IMS05-G07	MGC	W01C084N13	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC001686	IMS05-G07	MGC	W01C084N14	pDONR221	13464		MAT2A	4144	AAH01686.1	Hs.516157	Methionine adenosyltransferase II, alpha			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_005911.4	NP_005902.1	VALIDATED	OK	1.000	1.000	395	1188	1	1185	395	1	395
IKAKEN	BC003648	IMS05-G08	MGC	W01C084N15	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC003648	IMS05-G08	MGC	W01C084N16	pDONR221	18051		HAUS3	79441	AAH03648.1	Hs.665869	HAUS augmin-like complex, subunit 3			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_024511.5	NP_078787.2	PROVISIONAL	P	1.000	1.000	478	1437	1	1434	603	126	603
IKAKEN	BC002653	IMS05-G09	MGC	W01C084N17	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC002653	IMS05-G09	MGC	W01C084N18	pDONR221	1915		TNNT2	7139	AAH02653.1	Hs.533613	Troponin T type 2 (cardiac)			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_001001432.1	NP_001001432.1	REVIEWED	Cs	0.996	0.996	282	849	1	846	282	1	282
IKAKEN	BC020165	IMS05-G10	MGC	W01C084N19	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC020165	IMS05-G10	MGC	W01C084N20	pDONR221	3123		FRAT2	23401	AAH20165.1	Hs.140720	Frequently rearranged in advanced T-cell lymphomas 2			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R	NM_012083.2	NP_036215.1	REVIEWED	OK	1.000	1.000	233	702	1	699	233	1	233
IKAKEN	BC005821	IMS05-G11	MGC	W01C084N21	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC005821	IMS05-G11	MGC	W01C084N22	pDONR221	2754		PTEN	5728	AAH05821.1	Hs.500466	Phosphatase and tensin homolog			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_000314.4	NP_000305.3	REVIEWED		0.975	0.975	402	1845	637	1842	403	2	403
IKAKEN	BC009748	IMS05-G12	MGC	W01C084N23	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC009748	IMS05-G12	MGC	W01C084N24	pDONR221	17686		DRD5	1816	AAH09748.1	Hs.380681	Dopamine receptor D5			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_000798.4	NP_000789.1	REVIEWED		0.867	0.917	218	624	1	621	477	238	454
IKAKEN	BC007831	IMS05-H01	MGC	W01C084O01	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007831	IMS05-H01	MGC	W01C084O02	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007913	IMS05-H02	MGC	W01C084O03	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC007913	IMS05-H02	MGC	W01C084O04	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC008360	IMS05-H03	MGC	W01C084O05	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC008360	IMS05-H03	MGC	W01C084O06	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC007354	IMS05-H04	MGC	W01C084O07	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC007354	IMS05-H04	MGC	W01C084O08	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC010056	IMS05-H05	MGC	W01C084O09	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC010056	IMS05-H05	MGC	W01C084O10	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC011581	IMS05-H06	MGC	W01C084O11	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC011581	IMS05-H06	MGC	W01C084O12	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC012096	IMS05-H07	MGC	W01C084O13	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC012096	IMS05-H07	MGC	W01C084O14	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC014311	IMS05-H08	MGC	W01C084O15	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC014311	IMS05-H08	MGC	W01C084O16	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC016318	IMS05-H09	MGC	W01C084O17	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC016318	IMS05-H09	MGC	W01C084O18	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC021275	IMS05-H10	MGC	W01C084O19	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021275	IMS05-H10	MGC	W01C084O20	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021288	IMS05-H11	MGC	W01C084O21	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC021288	IMS05-H11	MGC	W01C084O22	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC029405	IMS05-H12	MGC	W01C084O23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	BC029405	IMS05-H12	MGC	W01C084O24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	BC007831	IMS05-H01	MGC	W01C084P01	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007831	IMS05-H01	MGC	W01C084P02	pDONR221	13891		PDE6D	5147	AAH07831.1	Hs.516808	Phosphodiesterase 6D, cGMP-specific, rod, delta			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002601.2	NP_002592.1	VALIDATED	OK	1.000	1.000	150	453	1	450	150	1	150
IKAKEN	BC007913	IMS05-H02	MGC	W01C084P03	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC007913	IMS05-H02	MGC	W01C084P04	pDONR221	8348		UBL7	84993	AAH07913.1	Hs.334713	Ubiquitin-like 7 (bone marrow stromal cell-derived)			Ovary, adenocarcinoma	NIH_MGC_9	DH10B-R	NM_201265.1	NP_957717.1	VALIDATED	OK	1.000	1.000	380	1143	1	1140	380	1	380
IKAKEN	BC008360	IMS05-H03	MGC	W01C084P05	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC008360	IMS05-H03	MGC	W01C084P06	pDONR221	5584		FAM113B	91523	AAH08360.1	Hs.560100	Family with sequence similarity 113, member B			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_138371.1	NP_612380.1	PREDICTED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	BC007354	IMS05-H04	MGC	W01C084P07	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC007354	IMS05-H04	MGC	W01C084P08	pDONR221	21418		MGC16075	84847	AAH07354.1	Hs.488236	Hypothetical protein MGC16075			Pancreas, adenocarcinoma	NIH_MGC_39	DH10B-R													
IKAKEN	BC010056	IMS05-H05	MGC	W01C084P09	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC010056	IMS05-H05	MGC	W01C084P10	pDONR221	16953		MAGEF1	64110	AAH10056.1	Hs.306123	Melanoma antigen family F, 1			Uterus, leiomyosarcoma	NIH_MGC_46	DH10B-R	NM_022149.4	NP_071432.2	REVIEWED	OK	1.000	1.000	307	924	1	921	307	1	307
IKAKEN	BC011581	IMS05-H06	MGC	W01C084P11	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC011581	IMS05-H06	MGC	W01C084P12	pDONR221	4620		OSBP	5007	AAH11581.1	Hs.597091	Oxysterol binding protein			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_002556.2	NP_002547.1	REVIEWED	OK	1.000	1.000	807	2424	1	2421	807	1	807
IKAKEN	BC012096	IMS05-H07	MGC	W01C084P13	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC012096	IMS05-H07	MGC	W01C084P14	pDONR221	24575		ARR3	407	AAH12096.1	Hs.308	Arrestin 3, retinal (X-arrestin)			Primary B-Cells from Tonsils	NIH_MGC_48	DH10B-R	NM_004312.2	NP_004303.2	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC014311	IMS05-H08	MGC	W01C084P15	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC014311	IMS05-H08	MGC	W01C084P16	pDONR221	18764		FCHO2	115548	AAH14311.1	Hs.719247	FCH domain only 2			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_138782.2	NP_620137.2	VALIDATED	P	1.000	1.000	303	1131	1	909	810	3	305
IKAKEN	BC016318	IMS05-H09	MGC	W01C084P17	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC016318	IMS05-H09	MGC	W01C084P18	pDONR221	12391		RRAS	6237	AAH16318.1	Hs.515536	Related RAS viral (r-ras) oncogene homolog			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_006270.3	NP_006261.1	PROVISIONAL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	BC021275	IMS05-H10	MGC	W01C084P19	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021275	IMS05-H10	MGC	W01C084P20	pDONR221	19224		MGC29506	51237	AAH21275.1	Hs.409563	Hypothetical protein MGC29506			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_016459.3	NP_057543.2	VALIDATED	P	1.000	1.000	61	445	1	183	189	129	189
IKAKEN	BC021288	IMS05-H11	MGC	W01C084P21	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC021288	IMS05-H11	MGC	W01C084P22	pDONR221	6450		LAMP1	3916	AAH21288.1	Hs.494419	Lysosomal-associated membrane protein 1			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_005561.3	NP_005552.3	REVIEWED	C	1.000	1.000	417	1254	1	1251	417	1	417
IKAKEN	BC029405	IMS05-H12	MGC	W01C084P23	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	BC029405	IMS05-H12	MGC	W01C084P24	pDONR221	913		H3F3A	3020	AAH29405.1	Hs.546259	H3 histone, family 3A			Brain, adult medulla	NIH_MGC_119	DH10B	NM_002107.3	NP_002098.1	REVIEWED		0.978	0.978	136	411	1	408	136	1	136
IKAKEN	ADB00537	IMS06-A01	EST	W01C085A01	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB00537	IMS06-A01	EST	W01C085A02	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB03716	IMS06-A02	EST	W01C085A03	pDONR221															
IKAKEN	ADB03716	IMS06-A02	EST	W01C085A04	pDONR221															
IKAKEN	ADG00794	IMS06-A03	EST	W01C085A05	pDONR221			TRY6	154754																					
IKAKEN	ADG00794	IMS06-A03	EST	W01C085A06	pDONR221			TRY6	154754																					
IKAKEN	ADG01989	IMS06-A04	EST	W01C085A07	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	ADG01989	IMS06-A04	EST	W01C085A08	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	adSE00312	IMS06-A05	EST	W01C085A09	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	adSE00312	IMS06-A05	EST	W01C085A10	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C085A11	pDONR221				388466											
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C085A12	pDONR221				388466											
IKAKEN	CBL06060	IMS06-A07	EST	W01C085A13	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBL06060	IMS06-A07	EST	W01C085A14	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C085A15	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C085A16	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A09	EST	W01C085A17	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A09	EST	W01C085A18	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A10	EST	W01C085A19	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A10	EST	W01C085A20	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C085A21	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C085A22	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C085A23	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C085A24	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	ADB00537	IMS06-A01	EST	W01C085B01	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB00537	IMS06-A01	EST	W01C085B02	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB03716	IMS06-A02	EST	W01C085B03	pDONR221															
IKAKEN	ADB03716	IMS06-A02	EST	W01C085B04	pDONR221															
IKAKEN	ADG00794	IMS06-A03	EST	W01C085B05	pDONR221			TRY6	154754																					
IKAKEN	ADG00794	IMS06-A03	EST	W01C085B06	pDONR221			TRY6	154754																					
IKAKEN	ADG01989	IMS06-A04	EST	W01C085B07	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	ADG01989	IMS06-A04	EST	W01C085B08	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	adSE00312	IMS06-A05	EST	W01C085B09	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	adSE00312	IMS06-A05	EST	W01C085B10	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C085B11	pDONR221				388466											
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C085B12	pDONR221				388466											
IKAKEN	CBL06060	IMS06-A07	EST	W01C085B13	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBL06060	IMS06-A07	EST	W01C085B14	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C085B15	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C085B16	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A09	EST	W01C085B17	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A09	EST	W01C085B18	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A10	EST	W01C085B19	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A10	EST	W01C085B20	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C085B21	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C085B22	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C085B23	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C085B24	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	DMC01516	IMS06-B01	EST	W01C085C01	pDONR221			TRDD3	28523											
IKAKEN	DMC01516	IMS06-B01	EST	W01C085C02	pDONR221			TRDD3	28523											
IKAKEN	DMC02913	IMS06-B02	EST	W01C085C03	pDONR221															
IKAKEN	DMC02913	IMS06-B02	EST	W01C085C04	pDONR221															
IKAKEN	DMC03158	IMS06-B03	EST	W01C085C05	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03158	IMS06-B03	EST	W01C085C06	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03342	IMS06-B04	EST	W01C085C07	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03342	IMS06-B04	EST	W01C085C08	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C085C09	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C085C10	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC08840	IMS06-B06	EST	W01C085C11	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	DMC08840	IMS06-B06	EST	W01C085C12	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C085C13	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C085C14	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	HEP09638	IMS06-B08	EST	W01C085C15	pDONR221			LOC348162	348162											
IKAKEN	HEP09638	IMS06-B08	EST	W01C085C16	pDONR221			LOC348162	348162											
IKAKEN	HEP09952	IMS06-B09	EST	W01C085C17	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP09952	IMS06-B09	EST	W01C085C18	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP16111	IMS06-B10	EST	W01C085C19	pDONR221															
IKAKEN	HEP16111	IMS06-B10	EST	W01C085C20	pDONR221															
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C085C21	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C085C22	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C085C23	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C085C24	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	DMC01516	IMS06-B01	EST	W01C085D01	pDONR221			TRDD3	28523											
IKAKEN	DMC01516	IMS06-B01	EST	W01C085D02	pDONR221			TRDD3	28523											
IKAKEN	DMC02913	IMS06-B02	EST	W01C085D03	pDONR221															
IKAKEN	DMC02913	IMS06-B02	EST	W01C085D04	pDONR221															
IKAKEN	DMC03158	IMS06-B03	EST	W01C085D05	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03158	IMS06-B03	EST	W01C085D06	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03342	IMS06-B04	EST	W01C085D07	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03342	IMS06-B04	EST	W01C085D08	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C085D09	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C085D10	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC08840	IMS06-B06	EST	W01C085D11	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	DMC08840	IMS06-B06	EST	W01C085D12	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C085D13	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C085D14	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	HEP09638	IMS06-B08	EST	W01C085D15	pDONR221			LOC348162	348162											
IKAKEN	HEP09638	IMS06-B08	EST	W01C085D16	pDONR221			LOC348162	348162											
IKAKEN	HEP09952	IMS06-B09	EST	W01C085D17	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP09952	IMS06-B09	EST	W01C085D18	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP16111	IMS06-B10	EST	W01C085D19	pDONR221															
IKAKEN	HEP16111	IMS06-B10	EST	W01C085D20	pDONR221															
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C085D21	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C085D22	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C085D23	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C085D24	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	HRT01348	IMS06-C01	EST	W01C085E01	pDONR221															
IKAKEN	HRT01348	IMS06-C01	EST	W01C085E02	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C085E03	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C085E04	pDONR221															
IKAKEN	HRT09387	IMS06-C03	EST	W01C085E05	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HRT09387	IMS06-C03	EST	W01C085E06	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HSI03722	IMS06-C04	EST	W01C085E07	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI03722	IMS06-C04	EST	W01C085E08	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI11046	IMS06-C05	EST	W01C085E09	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	HSI11046	IMS06-C05	EST	W01C085E10	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	KAT03886	IMS06-C06	EST	W01C085E11	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT03886	IMS06-C06	EST	W01C085E12	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C085E13	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C085E14	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C085E15	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C085E16	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KDN07647	IMS06-C09	EST	W01C085E17	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KDN07647	IMS06-C09	EST	W01C085E18	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C085E19	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C085E20	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C085E21	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C085E22	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	LNF06445	IMS06-C12	EST	W01C085E23	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	LNF06445	IMS06-C12	EST	W01C085E24	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	HRT01348	IMS06-C01	EST	W01C085F01	pDONR221															
IKAKEN	HRT01348	IMS06-C01	EST	W01C085F02	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C085F03	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C085F04	pDONR221															
IKAKEN	HRT09387	IMS06-C03	EST	W01C085F05	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HRT09387	IMS06-C03	EST	W01C085F06	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HSI03722	IMS06-C04	EST	W01C085F07	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI03722	IMS06-C04	EST	W01C085F08	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI11046	IMS06-C05	EST	W01C085F09	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	HSI11046	IMS06-C05	EST	W01C085F10	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	KAT03886	IMS06-C06	EST	W01C085F11	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT03886	IMS06-C06	EST	W01C085F12	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C085F13	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C085F14	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C085F15	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C085F16	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KDN07647	IMS06-C09	EST	W01C085F17	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KDN07647	IMS06-C09	EST	W01C085F18	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C085F19	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C085F20	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C085F21	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C085F22	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	LNF06445	IMS06-C12	EST	W01C085F23	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	LNF06445	IMS06-C12	EST	W01C085F24	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	MPB09573	IMS06-D01	EST	W01C085G01	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPB09573	IMS06-D01	EST	W01C085G02	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPC08320	IMS06-D02	EST	W01C085G03	pDONR221															
IKAKEN	MPC08320	IMS06-D02	EST	W01C085G04	pDONR221															
IKAKEN	NRB05550	IMS06-D03	EST	W01C085G05	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D03	EST	W01C085G06	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C085G07	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C085G08	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C085G09	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C085G10	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	PCD00388	IMS06-D06	EST	W01C085G11	pDONR221															
IKAKEN	PCD00388	IMS06-D06	EST	W01C085G12	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C085G13	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C085G14	pDONR221															
IKAKEN	PCD02057	IMS06-D08	EST	W01C085G15	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD02057	IMS06-D08	EST	W01C085G16	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD03146	IMS06-D09	EST	W01C085G17	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03146	IMS06-D09	EST	W01C085G18	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03282	IMS06-D10	EST	W01C085G19	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD03282	IMS06-D10	EST	W01C085G20	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD04369	IMS06-D11	EST	W01C085G21	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD04369	IMS06-D11	EST	W01C085G22	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD06251	IMS06-D12	EST	W01C085G23	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	PCD06251	IMS06-D12	EST	W01C085G24	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	MPB09573	IMS06-D01	EST	W01C085H01	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPB09573	IMS06-D01	EST	W01C085H02	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPC08320	IMS06-D02	EST	W01C085H03	pDONR221															
IKAKEN	MPC08320	IMS06-D02	EST	W01C085H04	pDONR221															
IKAKEN	NRB05550	IMS06-D03	EST	W01C085H05	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D03	EST	W01C085H06	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C085H07	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C085H08	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C085H09	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C085H10	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	PCD00388	IMS06-D06	EST	W01C085H11	pDONR221															
IKAKEN	PCD00388	IMS06-D06	EST	W01C085H12	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C085H13	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C085H14	pDONR221															
IKAKEN	PCD02057	IMS06-D08	EST	W01C085H15	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD02057	IMS06-D08	EST	W01C085H16	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD03146	IMS06-D09	EST	W01C085H17	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03146	IMS06-D09	EST	W01C085H18	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03282	IMS06-D10	EST	W01C085H19	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD03282	IMS06-D10	EST	W01C085H20	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD04369	IMS06-D11	EST	W01C085H21	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD04369	IMS06-D11	EST	W01C085H22	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD06251	IMS06-D12	EST	W01C085H23	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	PCD06251	IMS06-D12	EST	W01C085H24	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	PCD07269	IMS06-E01	EST	W01C085I01	pDONR221															
IKAKEN	PCD07269	IMS06-E01	EST	W01C085I02	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C085I03	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C085I04	pDONR221															
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C085I05	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C085I06	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PNC08413	IMS06-E04	EST	W01C085I07	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	PNC08413	IMS06-E04	EST	W01C085I08	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	RCT04040	IMS06-E05	EST	W01C085I09	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT04040	IMS06-E05	EST	W01C085I10	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT11480	IMS06-E06	EST	W01C085I11	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	RCT11480	IMS06-E06	EST	W01C085I12	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	SLV03762	IMS06-E07	EST	W01C085I13	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SLV03762	IMS06-E07	EST	W01C085I14	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SPL08444	IMS06-E08	EST	W01C085I15	pDONR221			TRDD3	28523											
IKAKEN	SPL08444	IMS06-E08	EST	W01C085I16	pDONR221			TRDD3	28523											
IKAKEN	SPL09577	IMS06-E09	EST	W01C085I17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	SPL09577	IMS06-E09	EST	W01C085I18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	STM01370	IMS06-E10	EST	W01C085I19	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM01370	IMS06-E10	EST	W01C085I20	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM03987	IMS06-E11	EST	W01C085I21	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM03987	IMS06-E11	EST	W01C085I22	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM04225	IMS06-E12	EST	W01C085I23	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	STM04225	IMS06-E12	EST	W01C085I24	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	PCD07269	IMS06-E01	EST	W01C085J01	pDONR221															
IKAKEN	PCD07269	IMS06-E01	EST	W01C085J02	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C085J03	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C085J04	pDONR221															
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C085J05	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C085J06	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PNC08413	IMS06-E04	EST	W01C085J07	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	PNC08413	IMS06-E04	EST	W01C085J08	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	RCT04040	IMS06-E05	EST	W01C085J09	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT04040	IMS06-E05	EST	W01C085J10	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT11480	IMS06-E06	EST	W01C085J11	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	RCT11480	IMS06-E06	EST	W01C085J12	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	SLV03762	IMS06-E07	EST	W01C085J13	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SLV03762	IMS06-E07	EST	W01C085J14	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SPL08444	IMS06-E08	EST	W01C085J15	pDONR221			TRDD3	28523											
IKAKEN	SPL08444	IMS06-E08	EST	W01C085J16	pDONR221			TRDD3	28523											
IKAKEN	SPL09577	IMS06-E09	EST	W01C085J17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	SPL09577	IMS06-E09	EST	W01C085J18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	STM01370	IMS06-E10	EST	W01C085J19	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM01370	IMS06-E10	EST	W01C085J20	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM03987	IMS06-E11	EST	W01C085J21	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM03987	IMS06-E11	EST	W01C085J22	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM04225	IMS06-E12	EST	W01C085J23	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	STM04225	IMS06-E12	EST	W01C085J24	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C085K01	pDONR221			CYorf14	55410											
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C085K02	pDONR221			CYorf14	55410											
IKAKEN	TST00713	IMS06-F02	EST	W01C085K03	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST00713	IMS06-F02	EST	W01C085K04	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C085K05	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C085K06	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST02488	IMS06-F04	EST	W01C085K07	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02488	IMS06-F04	EST	W01C085K08	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02623	IMS06-F05	EST	W01C085K09	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST02623	IMS06-F05	EST	W01C085K10	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST04320	IMS06-F06	EST	W01C085K11	pDONR221			COX7AP2	1348											
IKAKEN	TST04320	IMS06-F06	EST	W01C085K12	pDONR221			COX7AP2	1348											
IKAKEN	TST04689	IMS06-F07	EST	W01C085K13	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04689	IMS06-F07	EST	W01C085K14	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04888	IMS06-F08	EST	W01C085K15	pDONR221				151363											
IKAKEN	TST04888	IMS06-F08	EST	W01C085K16	pDONR221				151363											
IKAKEN	TST05174	IMS06-F09	EST	W01C085K17	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST05174	IMS06-F09	EST	W01C085K18	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C085K19	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C085K20	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	UBA08557	IMS06-F11	EST	W01C085K21	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F11	EST	W01C085K22	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C085K23	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C085K24	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C085L01	pDONR221			CYorf14	55410											
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C085L02	pDONR221			CYorf14	55410											
IKAKEN	TST00713	IMS06-F02	EST	W01C085L03	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST00713	IMS06-F02	EST	W01C085L04	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C085L05	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C085L06	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST02488	IMS06-F04	EST	W01C085L07	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02488	IMS06-F04	EST	W01C085L08	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02623	IMS06-F05	EST	W01C085L09	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST02623	IMS06-F05	EST	W01C085L10	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST04320	IMS06-F06	EST	W01C085L11	pDONR221			COX7AP2	1348											
IKAKEN	TST04320	IMS06-F06	EST	W01C085L12	pDONR221			COX7AP2	1348											
IKAKEN	TST04689	IMS06-F07	EST	W01C085L13	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04689	IMS06-F07	EST	W01C085L14	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04888	IMS06-F08	EST	W01C085L15	pDONR221				151363											
IKAKEN	TST04888	IMS06-F08	EST	W01C085L16	pDONR221				151363											
IKAKEN	TST05174	IMS06-F09	EST	W01C085L17	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST05174	IMS06-F09	EST	W01C085L18	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C085L19	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C085L20	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	UBA08557	IMS06-F11	EST	W01C085L21	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F11	EST	W01C085L22	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C085L23	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C085L24	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	UBA08889	IMS06-G01	EST	W01C085M01	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G01	EST	W01C085M02	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G02	EST	W01C085M03	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	UBA08889	IMS06-G02	EST	W01C085M04	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C085M05	pDONR221			NBR2	10230											
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C085M06	pDONR221			NBR2	10230											
IKAKEN	DMC07416	IMS06-G04	EST	W01C085M07	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	DMC07416	IMS06-G04	EST	W01C085M08	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C085M09	pDONR221															
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C085M10	pDONR221															
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C085M11	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C085M12	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C085M13	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C085M14	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	PRS03358	IMS06-G08	EST	W01C085M15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS06-G08	EST	W01C085M16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	REC00781	IMS06-G09	EST	W01C085M17	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	REC00781	IMS06-G09	EST	W01C085M18	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C085M19	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C085M20	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SPL01548	IMS06-G11	EST	W01C085M21	pDONR221			FLJ46026	400627																					
IKAKEN	SPL01548	IMS06-G11	EST	W01C085M22	pDONR221			FLJ46026	400627																					
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C085M23	pDONR221															
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C085M24	pDONR221															
IKAKEN	UBA08889	IMS06-G01	EST	W01C085N01	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G01	EST	W01C085N02	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G02	EST	W01C085N03	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	UBA08889	IMS06-G02	EST	W01C085N04	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C085N05	pDONR221			NBR2	10230											
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C085N06	pDONR221			NBR2	10230											
IKAKEN	DMC07416	IMS06-G04	EST	W01C085N07	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	DMC07416	IMS06-G04	EST	W01C085N08	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C085N09	pDONR221															
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C085N10	pDONR221															
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C085N11	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C085N12	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C085N13	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C085N14	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	PRS03358	IMS06-G08	EST	W01C085N15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS06-G08	EST	W01C085N16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	REC00781	IMS06-G09	EST	W01C085N17	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	REC00781	IMS06-G09	EST	W01C085N18	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C085N19	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C085N20	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SPL01548	IMS06-G11	EST	W01C085N21	pDONR221			FLJ46026	400627																					
IKAKEN	SPL01548	IMS06-G11	EST	W01C085N22	pDONR221			FLJ46026	400627																					
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C085N23	pDONR221															
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C085N24	pDONR221															
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C085O01	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C085O02	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C085O03	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C085O04	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C085O05	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C085O06	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C085O07	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C085O08	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TST00944	IMS06-H05	EST	W01C085O09	pDONR221															
IKAKEN	TST00944	IMS06-H05	EST	W01C085O10	pDONR221															
IKAKEN	TST01729	IMS06-H06	EST	W01C085O11	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST01729	IMS06-H06	EST	W01C085O12	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C085O13	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C085O14	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	H023045L22	IMS06-H08	Riken	W01C085O15	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023045L22	IMS06-H08	Riken	W01C085O16	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023051F19	IMS06-H09	Riken	W01C085O17	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023051F19	IMS06-H09	Riken	W01C085O18	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C085O19	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C085O20	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023068D12	IMS06-H11	Riken	W01C085O21	pDONR221															
IKAKEN	H023068D12	IMS06-H11	Riken	W01C085O22	pDONR221															
IKAKEN	H033063K23	IMS06-H12	Riken	W01C085O23	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	H033063K23	IMS06-H12	Riken	W01C085O24	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C085P01	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C085P02	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C085P03	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C085P04	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C085P05	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C085P06	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C085P07	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C085P08	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TST00944	IMS06-H05	EST	W01C085P09	pDONR221															
IKAKEN	TST00944	IMS06-H05	EST	W01C085P10	pDONR221															
IKAKEN	TST01729	IMS06-H06	EST	W01C085P11	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST01729	IMS06-H06	EST	W01C085P12	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C085P13	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C085P14	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	H023045L22	IMS06-H08	Riken	W01C085P15	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023045L22	IMS06-H08	Riken	W01C085P16	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023051F19	IMS06-H09	Riken	W01C085P17	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023051F19	IMS06-H09	Riken	W01C085P18	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C085P19	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C085P20	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023068D12	IMS06-H11	Riken	W01C085P21	pDONR221															
IKAKEN	H023068D12	IMS06-H11	Riken	W01C085P22	pDONR221															
IKAKEN	H033063K23	IMS06-H12	Riken	W01C085P23	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	H033063K23	IMS06-H12	Riken	W01C085P24	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	ADB00537	IMS06-A01	EST	W01C086A01	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB00537	IMS06-A01	EST	W01C086A02	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB03716	IMS06-A02	EST	W01C086A03	pDONR221															
IKAKEN	ADB03716	IMS06-A02	EST	W01C086A04	pDONR221															
IKAKEN	ADG00794	IMS06-A03	EST	W01C086A05	pDONR221			TRY6	154754																					
IKAKEN	ADG00794	IMS06-A03	EST	W01C086A06	pDONR221			TRY6	154754																					
IKAKEN	ADG01989	IMS06-A04	EST	W01C086A07	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	ADG01989	IMS06-A04	EST	W01C086A08	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	adSE00312	IMS06-A05	EST	W01C086A09	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	adSE00312	IMS06-A05	EST	W01C086A10	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C086A11	pDONR221				388466											
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C086A12	pDONR221				388466											
IKAKEN	CBL06060	IMS06-A07	EST	W01C086A13	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBL06060	IMS06-A07	EST	W01C086A14	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C086A15	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C086A16	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A09	EST	W01C086A17	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A09	EST	W01C086A18	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A10	EST	W01C086A19	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A10	EST	W01C086A20	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C086A21	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C086A22	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C086A23	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C086A24	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	ADB00537	IMS06-A01	EST	W01C086B01	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB00537	IMS06-A01	EST	W01C086B02	pDONR221			CSNK1A1P	161635		Hs.659822	Casein kinase 1, alpha 1 pseudogene								
IKAKEN	ADB03716	IMS06-A02	EST	W01C086B03	pDONR221															
IKAKEN	ADB03716	IMS06-A02	EST	W01C086B04	pDONR221															
IKAKEN	ADG00794	IMS06-A03	EST	W01C086B05	pDONR221			TRY6	154754																					
IKAKEN	ADG00794	IMS06-A03	EST	W01C086B06	pDONR221			TRY6	154754																					
IKAKEN	ADG01989	IMS06-A04	EST	W01C086B07	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	ADG01989	IMS06-A04	EST	W01C086B08	pDONR221			LOC202181	202181		Hs.653052	Hypothetical protein LOC202181						XM_001713848.1	XP_001713900.1	MODEL		0.500	0.500	10	255	49	20	319	163	172
IKAKEN	adSE00312	IMS06-A05	EST	W01C086B09	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	adSE00312	IMS06-A05	EST	W01C086B10	pDONR221			S100A12	6283		Hs.19413	S100 calcium binding protein A12						NM_005621.1	NP_005612.1	REVIEWED	P	1.000	1.000	85	255	1	255	92	1	85
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C086B11	pDONR221				388466											
IKAKEN	AMR06770	IMS06-A06	EST(RND)	W01C086B12	pDONR221				388466											
IKAKEN	CBL06060	IMS06-A07	EST	W01C086B13	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBL06060	IMS06-A07	EST	W01C086B14	pDONR221			C6orf129	154467		Hs.284207	Chromosome 6 open reading frame 129						NM_138493.2	NP_612502.1	VALIDATED	P	1.000	1.000	85	255	1	255	97	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C086B15	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A08	EST	W01C086B16	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.871	0.871	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A09	EST	W01C086B17	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A09	EST	W01C086B18	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.921	0.933	76	231	1	225	89	13	88
IKAKEN	CBR05553	IMS06-A10	EST	W01C086B19	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CBR05553	IMS06-A10	EST	W01C086B20	pDONR221			DYNLL1	8655		Hs.5120	Dynein, light chain, LC8-type 1						NM_003746.2	NP_003737.1	REVIEWED		0.906	0.906	85	255	1	255	89	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C086B21	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	CNR02493	IMS06-A11	EST(RND)	W01C086B22	pDONR221			SMCR5	140771		Hs.352643	Smith-Magenis syndrome chromosome region, candidate 5 (non-protein coding)						XM_001725572.1	XP_001725624.1	MODEL	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C086B23	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	DAT06129	IMS06-A12	EST	W01C086B24	pDONR221			POLR3G	10622		Hs.282387	Polymerase (RNA) III (DNA directed) polypeptide G (32kD)						NM_006467.2	NP_006458.2	VALIDATED		0.895	0.917	86	255	1	255	223	1	85
IKAKEN	DMC01516	IMS06-B01	EST	W01C086C01	pDONR221			TRDD3	28523											
IKAKEN	DMC01516	IMS06-B01	EST	W01C086C02	pDONR221			TRDD3	28523											
IKAKEN	DMC02913	IMS06-B02	EST	W01C086C03	pDONR221															
IKAKEN	DMC02913	IMS06-B02	EST	W01C086C04	pDONR221															
IKAKEN	DMC03158	IMS06-B03	EST	W01C086C05	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03158	IMS06-B03	EST	W01C086C06	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03342	IMS06-B04	EST	W01C086C07	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03342	IMS06-B04	EST	W01C086C08	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C086C09	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C086C10	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC08840	IMS06-B06	EST	W01C086C11	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	DMC08840	IMS06-B06	EST	W01C086C12	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C086C13	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C086C14	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	HEP09638	IMS06-B08	EST	W01C086C15	pDONR221			LOC348162	348162											
IKAKEN	HEP09638	IMS06-B08	EST	W01C086C16	pDONR221			LOC348162	348162											
IKAKEN	HEP09952	IMS06-B09	EST	W01C086C17	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP09952	IMS06-B09	EST	W01C086C18	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP16111	IMS06-B10	EST	W01C086C19	pDONR221															
IKAKEN	HEP16111	IMS06-B10	EST	W01C086C20	pDONR221															
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C086C21	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C086C22	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C086C23	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C086C24	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	DMC01516	IMS06-B01	EST	W01C086D01	pDONR221			TRDD3	28523											
IKAKEN	DMC01516	IMS06-B01	EST	W01C086D02	pDONR221			TRDD3	28523											
IKAKEN	DMC02913	IMS06-B02	EST	W01C086D03	pDONR221															
IKAKEN	DMC02913	IMS06-B02	EST	W01C086D04	pDONR221															
IKAKEN	DMC03158	IMS06-B03	EST	W01C086D05	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03158	IMS06-B03	EST	W01C086D06	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.556	0.556	9	255	114	140	311	39	47
IKAKEN	DMC03342	IMS06-B04	EST	W01C086D07	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03342	IMS06-B04	EST	W01C086D08	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	P	1.000	1.000	85	255	1	255	107	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C086D09	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC03641	IMS06-B05	EST	W01C086D10	pDONR221			KRTAP9-9	81870									NM_030975.1	NP_112237.1	REVIEWED		0.812	0.812	85	255	1	255	154	1	85
IKAKEN	DMC08840	IMS06-B06	EST	W01C086D11	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	DMC08840	IMS06-B06	EST	W01C086D12	pDONR221			LCE3B	353143		Hs.553715	Late cornified envelope 3B						NM_178433.1	NP_848520.1	VALIDATED		0.782	0.810	87	255	1	252	95	1	87
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C086D13	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	FBR02048	IMS06-B07	EST(RND)	W01C086D14	pDONR221			SCHIP1	29970		Hs.134665	Schwannomin interacting protein 1						NM_014575.2	NP_055390.1	PROVISIONAL		0.360	0.375	25	255	170	244	487	170	193
IKAKEN	HEP09638	IMS06-B08	EST	W01C086D15	pDONR221			LOC348162	348162											
IKAKEN	HEP09638	IMS06-B08	EST	W01C086D16	pDONR221			LOC348162	348162											
IKAKEN	HEP09952	IMS06-B09	EST	W01C086D17	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP09952	IMS06-B09	EST	W01C086D18	pDONR221			MTRR	4552		Hs.481551	5-methyltetrahydrofolate-homocysteine methyltransferase reductase						NM_002454.2	NP_002445.2	REVIEWED		0.880	0.880	50	177	1	150	698	1	50
IKAKEN	HEP16111	IMS06-B10	EST	W01C086D19	pDONR221															
IKAKEN	HEP16111	IMS06-B10	EST	W01C086D20	pDONR221															
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C086D21	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HKR02954	IMS06-B11	EST(RND)	W01C086D22	pDONR221			RDM1	201299		Hs.194411	RAD52 motif 1						NM_145654.3	NP_663629.1	REVIEWED	P	1.000	1.000	85	255	1	255	284	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C086D23	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	HRT00667	IMS06-B12	EST	W01C086D24	pDONR221			C9orf123	90871		Hs.7517	Chromosome 9 open reading frame 123						NM_033428.1	NP_219500.1	PREDICTED	P	1.000	1.000	85	255	1	255	112	1	85
IKAKEN	HRT01348	IMS06-C01	EST	W01C086E01	pDONR221															
IKAKEN	HRT01348	IMS06-C01	EST	W01C086E02	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C086E03	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C086E04	pDONR221															
IKAKEN	HRT09387	IMS06-C03	EST	W01C086E05	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HRT09387	IMS06-C03	EST	W01C086E06	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HSI03722	IMS06-C04	EST	W01C086E07	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI03722	IMS06-C04	EST	W01C086E08	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI11046	IMS06-C05	EST	W01C086E09	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	HSI11046	IMS06-C05	EST	W01C086E10	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	KAT03886	IMS06-C06	EST	W01C086E11	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT03886	IMS06-C06	EST	W01C086E12	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C086E13	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C086E14	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C086E15	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C086E16	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KDN07647	IMS06-C09	EST	W01C086E17	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KDN07647	IMS06-C09	EST	W01C086E18	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C086E19	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C086E20	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C086E21	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C086E22	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	LNF06445	IMS06-C12	EST	W01C086E23	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	LNF06445	IMS06-C12	EST	W01C086E24	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	HRT01348	IMS06-C01	EST	W01C086F01	pDONR221															
IKAKEN	HRT01348	IMS06-C01	EST	W01C086F02	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C086F03	pDONR221															
IKAKEN	HRT05580	IMS06-C02	EST	W01C086F04	pDONR221															
IKAKEN	HRT09387	IMS06-C03	EST	W01C086F05	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HRT09387	IMS06-C03	EST	W01C086F06	pDONR221			C3orf43	255798		Hs.631933	Chromosome 3 open reading frame 43						NM_001077657.1	NP_001071125.1	VALIDATED	P	1.000	1.000	85	255	1	255	214	71	155
IKAKEN	HSI03722	IMS06-C04	EST	W01C086F07	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI03722	IMS06-C04	EST	W01C086F08	pDONR221			C17orf91	84981		Hs.597755	Chromosome 17 open reading frame 91						NM_001001870.1	NP_001001870.1	VALIDATED		0.800	0.800	5	72	51	37	57	22	26
IKAKEN	HSI11046	IMS06-C05	EST	W01C086F09	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	HSI11046	IMS06-C05	EST	W01C086F10	pDONR221			C2orf68	388969		Hs.516159	Chromosome 2 open reading frame 68						NM_001013649.3	NP_001013671.2	VALIDATED	P	1.000	1.000	85	255	1	255	166	21	105
IKAKEN	KAT03886	IMS06-C06	EST	W01C086F11	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT03886	IMS06-C06	EST	W01C086F12	pDONR221			RPS23	6228		Hs.527193	Ribosomal protein S23						NM_001025.4	NP_001016.1	REVIEWED	P	1.000	1.000	85	255	1	255	143	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C086F13	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT04390	IMS06-C07	EST	W01C086F14	pDONR221			RPL35	11224		Hs.182825	Ribosomal protein L35						NM_007209.3	NP_009140.1	REVIEWED	P	1.000	1.000	85	255	1	255	123	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C086F15	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KAT06647	IMS06-C08	EST	W01C086F16	pDONR221			HSPE1	3336		Hs.1197	Heat shock 10kDa protein 1 (chaperonin 10)						NM_002157.2	NP_002148.1	REVIEWED	P	1.000	1.000	85	255	1	255	102	1	85
IKAKEN	KDN07647	IMS06-C09	EST	W01C086F17	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KDN07647	IMS06-C09	EST	W01C086F18	pDONR221			NDUFC1	4717		Hs.84549	NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 1, 6kDa						NM_002494.2	NP_002485.1	PROVISIONAL	OK	1.000	1.000	76	231	1	228	76	1	76
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C086F19	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KGR08748	IMS06-C10	EST(RND)	W01C086F20	pDONR221			C14orf23	387978									XM_370758.3	XP_370758.2	MODEL	P	1.000	1.000	36	255	16	123	92	1	36
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C086F21	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	KMR06456	IMS06-C11	EST(RND)	W01C086F22	pDONR221			PDE4DIP	9659		Hs.719077	Phosphodiesterase 4D interacting protein						NM_022359.4	NP_071754.3	VALIDATED	Ps	0.986	0.986	73	255	37	255	310	147	219
IKAKEN	LNF06445	IMS06-C12	EST	W01C086F23	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	LNF06445	IMS06-C12	EST	W01C086F24	pDONR221			MT2A	4502		Hs.647371	Metallothionein 2A						NM_005953.3	NP_005944.1	VALIDATED	Cs	0.984	0.984	61	186	1	183	61	1	61
IKAKEN	MPB09573	IMS06-D01	EST	W01C086G01	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPB09573	IMS06-D01	EST	W01C086G02	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPC08320	IMS06-D02	EST	W01C086G03	pDONR221															
IKAKEN	MPC08320	IMS06-D02	EST	W01C086G04	pDONR221															
IKAKEN	NRB05550	IMS06-D03	EST	W01C086G05	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D03	EST	W01C086G06	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C086G07	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C086G08	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C086G09	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C086G10	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	PCD00388	IMS06-D06	EST	W01C086G11	pDONR221															
IKAKEN	PCD00388	IMS06-D06	EST	W01C086G12	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C086G13	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C086G14	pDONR221															
IKAKEN	PCD02057	IMS06-D08	EST	W01C086G15	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD02057	IMS06-D08	EST	W01C086G16	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD03146	IMS06-D09	EST	W01C086G17	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03146	IMS06-D09	EST	W01C086G18	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03282	IMS06-D10	EST	W01C086G19	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD03282	IMS06-D10	EST	W01C086G20	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD04369	IMS06-D11	EST	W01C086G21	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD04369	IMS06-D11	EST	W01C086G22	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD06251	IMS06-D12	EST	W01C086G23	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	PCD06251	IMS06-D12	EST	W01C086G24	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	MPB09573	IMS06-D01	EST	W01C086H01	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPB09573	IMS06-D01	EST	W01C086H02	pDONR221			C11orf17	56672		Hs.131180	Chromosome 11 open reading frame 17						NM_182901.2	NP_878904.2	VALIDATED	Pg	0.759	1.000	112	255	1	255	210	1	112
IKAKEN	MPC08320	IMS06-D02	EST	W01C086H03	pDONR221															
IKAKEN	MPC08320	IMS06-D02	EST	W01C086H04	pDONR221															
IKAKEN	NRB05550	IMS06-D03	EST	W01C086H05	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D03	EST	W01C086H06	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED		0.882	0.882	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C086H07	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	NRB05550	IMS06-D04	EST	W01C086H08	pDONR221			C7orf64	84060		Hs.21590	Chromosome 7 open reading frame 64						NM_032120.2	NP_115496.2	VALIDATED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C086H09	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	OFR06045	IMS06-D05	EST(RND)	W01C086H10	pDONR221			SCGB1D2	10647		Hs.204096	Secretoglobin, family 1D, member 2						NM_006551.3	NP_006542.1	REVIEWED	P	1.000	1.000	85	255	1	255	90	1	85
IKAKEN	PCD00388	IMS06-D06	EST	W01C086H11	pDONR221															
IKAKEN	PCD00388	IMS06-D06	EST	W01C086H12	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C086H13	pDONR221															
IKAKEN	PCD01295	IMS06-D07	EST	W01C086H14	pDONR221															
IKAKEN	PCD02057	IMS06-D08	EST	W01C086H15	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD02057	IMS06-D08	EST	W01C086H16	pDONR221			INPPL1	3636		Hs.523875	Inositol polyphosphate phosphatase-like 1						NM_001567.3	NP_001558.3	REVIEWED	Pfs	0.988	1.000	85	255	3	255	1258	1136	1220
IKAKEN	PCD03146	IMS06-D09	EST	W01C086H17	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03146	IMS06-D09	EST	W01C086H18	pDONR221			NDUFA11	126328		Hs.406062	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 11, 14.7kDa						NM_175614.2	NP_783313.1	VALIDATED	P	1.000	1.000	85	255	1	255	141	1	85
IKAKEN	PCD03282	IMS06-D10	EST	W01C086H19	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD03282	IMS06-D10	EST	W01C086H20	pDONR221			C11orf31	280636		Hs.719147	Chromosome 11 open reading frame 31						NM_170746.2	NP_734467.1	REVIEWED	Pfs	0.988	1.000	85	255	1	255	121	1	84
IKAKEN	PCD04369	IMS06-D11	EST	W01C086H21	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD04369	IMS06-D11	EST	W01C086H22	pDONR221			RPS21	6227		Hs.190968	Ribosomal protein S21						NM_001024.3	NP_001015.1	REVIEWED	OK	1.000	1.000	83	252	1	249	83	1	83
IKAKEN	PCD06251	IMS06-D12	EST	W01C086H23	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	PCD06251	IMS06-D12	EST	W01C086H24	pDONR221			C7orf59	389541		Hs.406520	Chromosome 7 open reading frame 59						NM_001008395.2	NP_001008396.1	VALIDATED	P	1.000	1.000	85	255	1	255	99	1	85
IKAKEN	PCD07269	IMS06-E01	EST	W01C086I01	pDONR221															
IKAKEN	PCD07269	IMS06-E01	EST	W01C086I02	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C086I03	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C086I04	pDONR221															
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C086I05	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C086I06	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PNC08413	IMS06-E04	EST	W01C086I07	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	PNC08413	IMS06-E04	EST	W01C086I08	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	RCT04040	IMS06-E05	EST	W01C086I09	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT04040	IMS06-E05	EST	W01C086I10	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT11480	IMS06-E06	EST	W01C086I11	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	RCT11480	IMS06-E06	EST	W01C086I12	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	SLV03762	IMS06-E07	EST	W01C086I13	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SLV03762	IMS06-E07	EST	W01C086I14	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SPL08444	IMS06-E08	EST	W01C086I15	pDONR221			TRDD3	28523											
IKAKEN	SPL08444	IMS06-E08	EST	W01C086I16	pDONR221			TRDD3	28523											
IKAKEN	SPL09577	IMS06-E09	EST	W01C086I17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	SPL09577	IMS06-E09	EST	W01C086I18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	STM01370	IMS06-E10	EST	W01C086I19	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM01370	IMS06-E10	EST	W01C086I20	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM03987	IMS06-E11	EST	W01C086I21	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM03987	IMS06-E11	EST	W01C086I22	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM04225	IMS06-E12	EST	W01C086I23	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	STM04225	IMS06-E12	EST	W01C086I24	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	PCD07269	IMS06-E01	EST	W01C086J01	pDONR221															
IKAKEN	PCD07269	IMS06-E01	EST	W01C086J02	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C086J03	pDONR221															
IKAKEN	PCD08094	IMS06-E02	EST	W01C086J04	pDONR221															
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C086J05	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PLR04724	IMS06-E03	EST(RND)	W01C086J06	pDONR221			C21orf84	114038		Hs.592161	Chromosome 21 open reading frame 84																		
IKAKEN	PNC08413	IMS06-E04	EST	W01C086J07	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	PNC08413	IMS06-E04	EST	W01C086J08	pDONR221			CELP	1057		Hs.654361	Carboxyl ester lipase pseudogene								
IKAKEN	RCT04040	IMS06-E05	EST	W01C086J09	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT04040	IMS06-E05	EST	W01C086J10	pDONR221			GLOD5	392465		Hs.437539	Glyoxalase domain containing 5						NM_001080489.1	NP_001073958.1	INFERRED	P	1.000	1.000	76	255	28	255	157	19	94
IKAKEN	RCT11480	IMS06-E06	EST	W01C086J11	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	RCT11480	IMS06-E06	EST	W01C086J12	pDONR221			GNG10	2790		Hs.656890	Guanine nucleotide binding protein (G protein), gamma 10						NM_001017998.2	NP_001017998.1	VALIDATED		0.941	0.941	68	207	1	204	68	1	68
IKAKEN	SLV03762	IMS06-E07	EST	W01C086J13	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SLV03762	IMS06-E07	EST	W01C086J14	pDONR221			NMS	129521		Hs.567676	Neuromedin S						NM_001011717.1	NP_001011717.1	PROVISIONAL	Pfs	0.281	0.281	32	255	130	35	153	29	60
IKAKEN	SPL08444	IMS06-E08	EST	W01C086J15	pDONR221			TRDD3	28523											
IKAKEN	SPL08444	IMS06-E08	EST	W01C086J16	pDONR221			TRDD3	28523											
IKAKEN	SPL09577	IMS06-E09	EST	W01C086J17	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	SPL09577	IMS06-E09	EST	W01C086J18	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.500	0.500	10	255	120	149	311	39	48
IKAKEN	STM01370	IMS06-E10	EST	W01C086J19	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM01370	IMS06-E10	EST	W01C086J20	pDONR221			CXCL17	284340		Hs.445586	Chemokine (C-X-C motif) ligand 17						NM_198477.1	NP_940879.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	119	1	85
IKAKEN	STM03987	IMS06-E11	EST	W01C086J21	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM03987	IMS06-E11	EST	W01C086J22	pDONR221			RBMS1	5937		Hs.470412	RNA binding motif, single stranded interacting protein 1						NM_016836.3	NP_058520.1	REVIEWED	Pfs	0.385	0.385	13	171	87	125	406	101	113
IKAKEN	STM04225	IMS06-E12	EST	W01C086J23	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	STM04225	IMS06-E12	EST	W01C086J24	pDONR221			GKN2	200504		Hs.16757	Gastrokine 2						NM_182536.2	NP_872342.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C086K01	pDONR221			CYorf14	55410											
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C086K02	pDONR221			CYorf14	55410											
IKAKEN	TST00713	IMS06-F02	EST	W01C086K03	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST00713	IMS06-F02	EST	W01C086K04	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C086K05	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C086K06	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST02488	IMS06-F04	EST	W01C086K07	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02488	IMS06-F04	EST	W01C086K08	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02623	IMS06-F05	EST	W01C086K09	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST02623	IMS06-F05	EST	W01C086K10	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST04320	IMS06-F06	EST	W01C086K11	pDONR221			COX7AP2	1348											
IKAKEN	TST04320	IMS06-F06	EST	W01C086K12	pDONR221			COX7AP2	1348											
IKAKEN	TST04689	IMS06-F07	EST	W01C086K13	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04689	IMS06-F07	EST	W01C086K14	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04888	IMS06-F08	EST	W01C086K15	pDONR221				151363											
IKAKEN	TST04888	IMS06-F08	EST	W01C086K16	pDONR221				151363											
IKAKEN	TST05174	IMS06-F09	EST	W01C086K17	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST05174	IMS06-F09	EST	W01C086K18	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C086K19	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C086K20	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	UBA08557	IMS06-F11	EST	W01C086K21	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F11	EST	W01C086K22	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C086K23	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C086K24	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C086L01	pDONR221			CYorf14	55410											
IKAKEN	SZR07171	IMS06-F01	EST(RND)	W01C086L02	pDONR221			CYorf14	55410											
IKAKEN	TST00713	IMS06-F02	EST	W01C086L03	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST00713	IMS06-F02	EST	W01C086L04	pDONR221			C20orf106	200232		Hs.504907	Chromosome 20 open reading frame 106						NM_001012971.3	NP_001012989.2	VALIDATED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C086L05	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST01421	IMS06-F03	EST	W01C086L06	pDONR221			C1orf227	149643		Hs.153274	Chromosome 1 open reading frame 227						NM_001024601.2	NP_001019772.1	PREDICTED	P	1.000	1.000	85	255	1	255	98	1	85
IKAKEN	TST02488	IMS06-F04	EST	W01C086L07	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02488	IMS06-F04	EST	W01C086L08	pDONR221			SERF1A	8293		Hs.559428	Small EDRK-rich factor 1A (telomeric)						NM_022968.1	NP_075257.1	REVIEWED	OK	1.000	1.000	62	189	1	186	62	1	62
IKAKEN	TST02623	IMS06-F05	EST	W01C086L09	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST02623	IMS06-F05	EST	W01C086L10	pDONR221			C1orf100	200159		Hs.442703	Chromosome 1 open reading frame 100						NM_001012970.1	NP_001012988.1	PREDICTED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	TST04320	IMS06-F06	EST	W01C086L11	pDONR221			COX7AP2	1348											
IKAKEN	TST04320	IMS06-F06	EST	W01C086L12	pDONR221			COX7AP2	1348											
IKAKEN	TST04689	IMS06-F07	EST	W01C086L13	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04689	IMS06-F07	EST	W01C086L14	pDONR221			MORN2	729967		Hs.99841	MORN repeat containing 2						NM_001145450.1	NP_001138922.1	VALIDATED	OK	1.000	1.000	79	240	1	237	79	1	79
IKAKEN	TST04888	IMS06-F08	EST	W01C086L15	pDONR221				151363											
IKAKEN	TST04888	IMS06-F08	EST	W01C086L16	pDONR221				151363											
IKAKEN	TST05174	IMS06-F09	EST	W01C086L17	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST05174	IMS06-F09	EST	W01C086L18	pDONR221			DEFB126	81623		Hs.124211	Defensin, beta 126						NM_030931.2	NP_112193.1	REVIEWED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C086L19	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	TST08073	IMS06-F10	EST	W01C086L20	pDONR221			ARL13A	392509		Hs.147237	ADP-ribosylation factor-like 13A						NM_001012990.2	NP_001013008.2	VALIDATED	P	1.000	1.000	85	255	1	255	290	1	85
IKAKEN	UBA08557	IMS06-F11	EST	W01C086L21	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F11	EST	W01C086L22	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL	OK	1.000	1.000	64	195	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C086L23	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	UBA08557	IMS06-F12	EST	W01C086L24	pDONR221			CCDC72	51372		Hs.356440	Coiled-coil domain containing 72						NM_015933.3	NP_057017.1	PROVISIONAL		0.953	0.953	64	213	1	192	64	1	64
IKAKEN	UBA08889	IMS06-G01	EST	W01C086M01	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G01	EST	W01C086M02	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G02	EST	W01C086M03	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	UBA08889	IMS06-G02	EST	W01C086M04	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C086M05	pDONR221			NBR2	10230											
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C086M06	pDONR221			NBR2	10230											
IKAKEN	DMC07416	IMS06-G04	EST	W01C086M07	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	DMC07416	IMS06-G04	EST	W01C086M08	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C086M09	pDONR221															
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C086M10	pDONR221															
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C086M11	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C086M12	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C086M13	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C086M14	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	PRS03358	IMS06-G08	EST	W01C086M15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS06-G08	EST	W01C086M16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	REC00781	IMS06-G09	EST	W01C086M17	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	REC00781	IMS06-G09	EST	W01C086M18	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C086M19	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C086M20	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SPL01548	IMS06-G11	EST	W01C086M21	pDONR221			FLJ46026	400627																					
IKAKEN	SPL01548	IMS06-G11	EST	W01C086M22	pDONR221			FLJ46026	400627																					
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C086M23	pDONR221															
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C086M24	pDONR221															
IKAKEN	UBA08889	IMS06-G01	EST	W01C086N01	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G01	EST	W01C086N02	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED		0.227	0.227	22	243	82	147	1756	1101	1122
IKAKEN	UBA08889	IMS06-G02	EST	W01C086N03	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	UBA08889	IMS06-G02	EST	W01C086N04	pDONR221			RGPD1	400966		Hs.656849	RANBP2-like and GRIP domain containing 1						NM_001024457.2	NP_001019628.2	VALIDATED	Pfs	0.302	0.317	43	243	223	101	1756	785	827
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C086N05	pDONR221			NBR2	10230											
IKAKEN	CCR08468	IMS06-G03	EST(RND)	W01C086N06	pDONR221			NBR2	10230											
IKAKEN	DMC07416	IMS06-G04	EST	W01C086N07	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	DMC07416	IMS06-G04	EST	W01C086N08	pDONR221			ABHD12B	145447		Hs.271896	Abhydrolase domain containing 12B						NM_181533.3	NP_853511.2	VALIDATED	P	1.000	1.000	50	255	106	255	255	6	55
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C086N09	pDONR221															
IKAKEN	KAR06252	IMS06-G05	EST(RND)	W01C086N10	pDONR221															
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C086N11	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	KGR07879	IMS06-G06	EST(RND)	W01C086N12	pDONR221			BMF	90427		Hs.591104	Bcl2 modifying factor						NM_033503.3	NP_277038.1	REVIEWED	P	1.000	1.000	85	255	1	255	184	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C086N13	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	LNF03507	IMS06-G07	EST	W01C086N14	pDONR221			TMEM220	388335		Hs.462230	Transmembrane protein 220						NM_001004313.1	NP_001004313.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	160	1	85
IKAKEN	PRS03358	IMS06-G08	EST	W01C086N15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	IMS06-G08	EST	W01C086N16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	REC00781	IMS06-G09	EST	W01C086N17	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	REC00781	IMS06-G09	EST	W01C086N18	pDONR221			SERPINB7	8710		Hs.138202	Serpin peptidase inhibitor, clade B (ovalbumin), member 7						NM_001040147.1	NP_001035237.1	VALIDATED	P	1.000	1.000	85	255	1	255	380	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C086N19	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SLV07218	IMS06-G10	EST	W01C086N20	pDONR221			LPO	4025		Hs.234742	Lactoperoxidase						NM_006151.2	NP_006142.1	REVIEWED	P	1.000	1.000	85	255	1	255	712	1	85
IKAKEN	SPL01548	IMS06-G11	EST	W01C086N21	pDONR221			FLJ46026	400627																					
IKAKEN	SPL01548	IMS06-G11	EST	W01C086N22	pDONR221			FLJ46026	400627																					
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C086N23	pDONR221															
IKAKEN	T3R09176	IMS06-G12	EST(RND)	W01C086N24	pDONR221															
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C086O01	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C086O02	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C086O03	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C086O04	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C086O05	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C086O06	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C086O07	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C086O08	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TST00944	IMS06-H05	EST	W01C086O09	pDONR221															
IKAKEN	TST00944	IMS06-H05	EST	W01C086O10	pDONR221															
IKAKEN	TST01729	IMS06-H06	EST	W01C086O11	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST01729	IMS06-H06	EST	W01C086O12	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C086O13	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C086O14	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	H023045L22	IMS06-H08	Riken	W01C086O15	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023045L22	IMS06-H08	Riken	W01C086O16	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023051F19	IMS06-H09	Riken	W01C086O17	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023051F19	IMS06-H09	Riken	W01C086O18	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C086O19	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C086O20	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023068D12	IMS06-H11	Riken	W01C086O21	pDONR221															
IKAKEN	H023068D12	IMS06-H11	Riken	W01C086O22	pDONR221															
IKAKEN	H033063K23	IMS06-H12	Riken	W01C086O23	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	H033063K23	IMS06-H12	Riken	W01C086O24	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C086P01	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R03735	IMS06-H01	EST(RND)	W01C086P02	pDONR221			SLC10A7	84068		Hs.659209	Solute carrier family 10 (sodium/bile acid cotransporter family), member 7						NM_032128.3	NP_115504.1	VALIDATED	P	1.000	1.000	14	255	3	44	159	132	145
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C086P03	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	T7R04222	IMS06-H02	EST(RND)	W01C086P04	pDONR221			ABO	28		Hs.654423	ABO blood group (transferase A, alpha 1-3-N-acetylgalactosaminyltransferase; transferase B, alpha 1-3-galactosyltransferase)						NM_020469.2	NP_065202.2	REVIEWED		0.965	0.965	85	255	1	255	354	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C086P05	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TDR09038	IMS06-H03	EST(RND)	W01C086P06	pDONR221			VAMP1	6843		Hs.20021	Vesicle-associated membrane protein 1 (synaptobrevin 1)						NM_199245.1	NP_954740.1	REVIEWED	P	1.000	1.000	85	255	1	255	117	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C086P07	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TGR06587	IMS06-H04	EST(RND)	W01C086P08	pDONR221			WISP1	8840		Hs.492974	WNT1 inducible signaling pathway protein 1						NM_003882.2	NP_003873.1	REVIEWED	P	1.000	1.000	85	255	1	255	367	1	85
IKAKEN	TST00944	IMS06-H05	EST	W01C086P09	pDONR221															
IKAKEN	TST00944	IMS06-H05	EST	W01C086P10	pDONR221															
IKAKEN	TST01729	IMS06-H06	EST	W01C086P11	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST01729	IMS06-H06	EST	W01C086P12	pDONR221			CATSPER3	347732		Hs.631804	Cation channel, sperm associated 3						NM_178019.1	NP_821138.1	VALIDATED	P	1.000	1.000	85	255	1	255	398	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C086P13	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	TST08996	IMS06-H07	EST	W01C086P14	pDONR221			LRP2BP	55805		Hs.558513	LRP2 binding protein						NM_018409.3	NP_060879.2	VALIDATED	P	1.000	1.000	85	255	1	255	347	1	85
IKAKEN	H023045L22	IMS06-H08	Riken	W01C086P15	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023045L22	IMS06-H08	Riken	W01C086P16	pDONR221			PTPN13	5783		Hs.436142	Protein tyrosine phosphatase, non-receptor type 13 (APO-1/CD95 (Fas)-associated phosphatase)						NM_080684.2	NP_542415.1	REVIEWED	P	1.000	1.000	85	255	1	255	2294	2105	2189
IKAKEN	H023051F19	IMS06-H09	Riken	W01C086P17	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023051F19	IMS06-H09	Riken	W01C086P18	pDONR221			PHF20L1	51105		Hs.304362	PHD finger protein 20-like 1						NM_198513.1	NP_940915.1	VALIDATED	P	1.000	1.000	85	255	1	255	285	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C086P19	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023019O04	IMS06-H10	Riken	W01C086P20	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	474	1	85
IKAKEN	H023068D12	IMS06-H11	Riken	W01C086P21	pDONR221															
IKAKEN	H023068D12	IMS06-H11	Riken	W01C086P22	pDONR221															
IKAKEN	H033063K23	IMS06-H12	Riken	W01C086P23	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	H033063K23	IMS06-H12	Riken	W01C086P24	pDONR221			FBLL1	345630									XM_001722529.1	XP_001722581.1	MODEL	P	1.000	1.000	85	255	1	255	239	1	85
IKAKEN	H013034H13	IMS07-A01	Riken	W01C087A01	pDONR221															
IKAKEN	H013034H13	IMS07-A01	Riken	W01C087A02	pDONR221															
IKAKEN	H023055M23	IMS07-A02	Riken	W01C087A03	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H023055M23	IMS07-A02	Riken	W01C087A04	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H013083E23	IMS07-A03	Riken	W01C087A05	pDONR221															
IKAKEN	H013083E23	IMS07-A03	Riken	W01C087A06	pDONR221															
IKAKEN	H013077B16	IMS07-A04	Riken	W01C087A07	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H013077B16	IMS07-A04	Riken	W01C087A08	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H023099O21	IMS07-A05	Riken	W01C087A09	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H023099O21	IMS07-A05	Riken	W01C087A10	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H013033L09	IMS07-A06	Riken	W01C087A11	pDONR221															
IKAKEN	H013033L09	IMS07-A06	Riken	W01C087A12	pDONR221															
IKAKEN	H033037H18	IMS07-A07	Riken	W01C087A13	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H033037H18	IMS07-A07	Riken	W01C087A14	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H023077D12	IMS07-A08	Riken	W01C087A15	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023077D12	IMS07-A08	Riken	W01C087A16	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023092B08	IMS07-A09	Riken	W01C087A17	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H023092B08	IMS07-A09	Riken	W01C087A18	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C087A19	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C087A20	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C087A21	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C087A22	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023072I23	IMS07-A12	Riken	W01C087A23	pDONR221															
IKAKEN	H023072I23	IMS07-A12	Riken	W01C087A24	pDONR221															
IKAKEN	H013034H13	IMS07-A01	Riken	W01C087B01	pDONR221															
IKAKEN	H013034H13	IMS07-A01	Riken	W01C087B02	pDONR221															
IKAKEN	H023055M23	IMS07-A02	Riken	W01C087B03	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H023055M23	IMS07-A02	Riken	W01C087B04	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H013083E23	IMS07-A03	Riken	W01C087B05	pDONR221															
IKAKEN	H013083E23	IMS07-A03	Riken	W01C087B06	pDONR221															
IKAKEN	H013077B16	IMS07-A04	Riken	W01C087B07	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H013077B16	IMS07-A04	Riken	W01C087B08	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H023099O21	IMS07-A05	Riken	W01C087B09	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H023099O21	IMS07-A05	Riken	W01C087B10	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H013033L09	IMS07-A06	Riken	W01C087B11	pDONR221															
IKAKEN	H013033L09	IMS07-A06	Riken	W01C087B12	pDONR221															
IKAKEN	H033037H18	IMS07-A07	Riken	W01C087B13	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H033037H18	IMS07-A07	Riken	W01C087B14	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H023077D12	IMS07-A08	Riken	W01C087B15	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023077D12	IMS07-A08	Riken	W01C087B16	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023092B08	IMS07-A09	Riken	W01C087B17	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H023092B08	IMS07-A09	Riken	W01C087B18	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C087B19	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C087B20	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C087B21	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C087B22	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023072I23	IMS07-A12	Riken	W01C087B23	pDONR221															
IKAKEN	H023072I23	IMS07-A12	Riken	W01C087B24	pDONR221															
IKAKEN	H013094J01	IMS07-B01	Riken	W01C087C01	pDONR221			SERPINA2	390502																					
IKAKEN	H013094J01	IMS07-B01	Riken	W01C087C02	pDONR221			SERPINA2	390502																					
IKAKEN	H013095D11	IMS07-B02	Riken	W01C087C03	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013095D11	IMS07-B02	Riken	W01C087C04	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013088L16	IMS07-B03	Riken	W01C087C05	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H013088L16	IMS07-B03	Riken	W01C087C06	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H023051B17	IMS07-B04	Riken	W01C087C07	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H023051B17	IMS07-B04	Riken	W01C087C08	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H013049H10	IMS07-B05	Riken	W01C087C09	pDONR221				440289											
IKAKEN	H013049H10	IMS07-B05	Riken	W01C087C10	pDONR221				440289											
IKAKEN	H023076D19	IMS07-B06	Riken	W01C087C11	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H023076D19	IMS07-B06	Riken	W01C087C12	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C087C13	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C087C14	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013058O17	IMS07-B08	Riken	W01C087C15	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013058O17	IMS07-B08	Riken	W01C087C16	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013069K21	IMS07-B09	Riken	W01C087C17	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013069K21	IMS07-B09	Riken	W01C087C18	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C087C19	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C087C20	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H033091A13	IMS07-B11	Riken	W01C087C21	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H033091A13	IMS07-B11	Riken	W01C087C22	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H023053L15	IMS07-B12	Riken	W01C087C23	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H023053L15	IMS07-B12	Riken	W01C087C24	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H013094J01	IMS07-B01	Riken	W01C087D01	pDONR221			SERPINA2	390502																					
IKAKEN	H013094J01	IMS07-B01	Riken	W01C087D02	pDONR221			SERPINA2	390502																					
IKAKEN	H013095D11	IMS07-B02	Riken	W01C087D03	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013095D11	IMS07-B02	Riken	W01C087D04	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013088L16	IMS07-B03	Riken	W01C087D05	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H013088L16	IMS07-B03	Riken	W01C087D06	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H023051B17	IMS07-B04	Riken	W01C087D07	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H023051B17	IMS07-B04	Riken	W01C087D08	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H013049H10	IMS07-B05	Riken	W01C087D09	pDONR221				440289											
IKAKEN	H013049H10	IMS07-B05	Riken	W01C087D10	pDONR221				440289											
IKAKEN	H023076D19	IMS07-B06	Riken	W01C087D11	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H023076D19	IMS07-B06	Riken	W01C087D12	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C087D13	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C087D14	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013058O17	IMS07-B08	Riken	W01C087D15	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013058O17	IMS07-B08	Riken	W01C087D16	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013069K21	IMS07-B09	Riken	W01C087D17	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013069K21	IMS07-B09	Riken	W01C087D18	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C087D19	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C087D20	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H033091A13	IMS07-B11	Riken	W01C087D21	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H033091A13	IMS07-B11	Riken	W01C087D22	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H023053L15	IMS07-B12	Riken	W01C087D23	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H023053L15	IMS07-B12	Riken	W01C087D24	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H033020P20	IMS07-C01	Riken	W01C087E01	pDONR221															
IKAKEN	H033020P20	IMS07-C01	Riken	W01C087E02	pDONR221															
IKAKEN	H033090E06	IMS07-C02	Riken	W01C087E03	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H033090E06	IMS07-C02	Riken	W01C087E04	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C087E05	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C087E06	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H013080B13	IMS07-C04	Riken	W01C087E07	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013080B13	IMS07-C04	Riken	W01C087E08	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013046F05	IMS07-C05	Riken	W01C087E09	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013046F05	IMS07-C05	Riken	W01C087E10	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C087E11	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C087E12	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C087E13	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C087E14	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C087E15	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C087E16	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C087E17	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C087E18	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C087E19	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C087E20	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H013090M09	IMS07-C11	Riken	W01C087E21	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H013090M09	IMS07-C11	Riken	W01C087E22	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H023093N18	IMS07-C12	Riken	W01C087E23	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H023093N18	IMS07-C12	Riken	W01C087E24	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H033020P20	IMS07-C01	Riken	W01C087F01	pDONR221															
IKAKEN	H033020P20	IMS07-C01	Riken	W01C087F02	pDONR221															
IKAKEN	H033090E06	IMS07-C02	Riken	W01C087F03	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H033090E06	IMS07-C02	Riken	W01C087F04	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C087F05	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C087F06	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H013080B13	IMS07-C04	Riken	W01C087F07	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013080B13	IMS07-C04	Riken	W01C087F08	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013046F05	IMS07-C05	Riken	W01C087F09	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013046F05	IMS07-C05	Riken	W01C087F10	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C087F11	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C087F12	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C087F13	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C087F14	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C087F15	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C087F16	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C087F17	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C087F18	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C087F19	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C087F20	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H013090M09	IMS07-C11	Riken	W01C087F21	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H013090M09	IMS07-C11	Riken	W01C087F22	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H023093N18	IMS07-C12	Riken	W01C087F23	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H023093N18	IMS07-C12	Riken	W01C087F24	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H023079B18	IMS07-D01	Riken	W01C087G01	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H023079B18	IMS07-D01	Riken	W01C087G02	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C087G03	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C087G04	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C087G05	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C087G06	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C087G07	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C087G08	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C087G09	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C087G10	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C087G11	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C087G12	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H023059H22	IMS07-D07	Riken	W01C087G13	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023059H22	IMS07-D07	Riken	W01C087G14	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023007A20	IMS07-D08	Riken	W01C087G15	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H023007A20	IMS07-D08	Riken	W01C087G16	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H013062K08	IMS07-D09	Riken	W01C087G17	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013062K08	IMS07-D09	Riken	W01C087G18	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C087G19	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C087G20	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C087G21	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C087G22	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C087G23	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C087G24	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	H023079B18	IMS07-D01	Riken	W01C087H01	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H023079B18	IMS07-D01	Riken	W01C087H02	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C087H03	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C087H04	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C087H05	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C087H06	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C087H07	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C087H08	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C087H09	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C087H10	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C087H11	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C087H12	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H023059H22	IMS07-D07	Riken	W01C087H13	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023059H22	IMS07-D07	Riken	W01C087H14	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023007A20	IMS07-D08	Riken	W01C087H15	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H023007A20	IMS07-D08	Riken	W01C087H16	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H013062K08	IMS07-D09	Riken	W01C087H17	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013062K08	IMS07-D09	Riken	W01C087H18	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C087H19	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C087H20	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C087H21	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C087H22	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C087H23	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C087H24	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C087I01	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C087I02	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C087I03	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C087I04	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C087I05	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C087I06	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H033015H03	IMS07-E04	Riken	W01C087I07	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033015H03	IMS07-E04	Riken	W01C087I08	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033072F22	IMS07-E05	Riken	W01C087I09	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072F22	IMS07-E05	Riken	W01C087I10	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C087I11	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C087I12	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C087I13	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C087I14	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C087I15	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C087I16	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C087I17	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C087I18	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C087I19	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C087I20	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	CS0DI012YO22	IMS07-E11		W01C087I21	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	CS0DI012YO22	IMS07-E11		W01C087I22	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	H033094K13	IMS07-E12	Riken	W01C087I23	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	H033094K13	IMS07-E12	Riken	W01C087I24	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C087J01	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C087J02	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C087J03	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C087J04	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C087J05	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C087J06	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H033015H03	IMS07-E04	Riken	W01C087J07	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033015H03	IMS07-E04	Riken	W01C087J08	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033072F22	IMS07-E05	Riken	W01C087J09	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072F22	IMS07-E05	Riken	W01C087J10	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C087J11	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C087J12	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C087J13	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C087J14	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C087J15	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C087J16	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C087J17	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C087J18	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C087J19	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C087J20	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	CS0DI012YO22	IMS07-E11		W01C087J21	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	CS0DI012YO22	IMS07-E11		W01C087J22	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	H033094K13	IMS07-E12	Riken	W01C087J23	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	H033094K13	IMS07-E12	Riken	W01C087J24	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	H013023M10	IMS07-F01	Riken	W01C087K01	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H013023M10	IMS07-F01	Riken	W01C087K02	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H033061B15	IMS07-F02	Riken	W01C087K03	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033061B15	IMS07-F02	Riken	W01C087K04	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C087K05	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C087K06	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H013046P11	IMS07-F04	Riken	W01C087K07	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H013046P11	IMS07-F04	Riken	W01C087K08	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H033045D08	IMS07-F05	Riken	W01C087K09	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H033045D08	IMS07-F05	Riken	W01C087K10	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H013074L12	IMS07-F06	Riken	W01C087K11	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H013074L12	IMS07-F06	Riken	W01C087K12	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C087K13	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C087K14	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C087K15	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C087K16	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C087K17	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C087K18	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C087K19	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C087K20	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C087K21	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C087K22	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C087K23	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C087K24	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H013023M10	IMS07-F01	Riken	W01C087L01	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H013023M10	IMS07-F01	Riken	W01C087L02	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H033061B15	IMS07-F02	Riken	W01C087L03	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033061B15	IMS07-F02	Riken	W01C087L04	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C087L05	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C087L06	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H013046P11	IMS07-F04	Riken	W01C087L07	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H013046P11	IMS07-F04	Riken	W01C087L08	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H033045D08	IMS07-F05	Riken	W01C087L09	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H033045D08	IMS07-F05	Riken	W01C087L10	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H013074L12	IMS07-F06	Riken	W01C087L11	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H013074L12	IMS07-F06	Riken	W01C087L12	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C087L13	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C087L14	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C087L15	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C087L16	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C087L17	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C087L18	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C087L19	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C087L20	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C087L21	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C087L22	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C087L23	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C087L24	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H013062N19	IMS07-G01	Riken	W01C087M01	pDONR221															
IKAKEN	H013062N19	IMS07-G01	Riken	W01C087M02	pDONR221															
IKAKEN	H033084N01	IMS07-G02	Riken	W01C087M03	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H033084N01	IMS07-G02	Riken	W01C087M04	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H013022E02	IMS07-G03	Riken	W01C087M05	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013022E02	IMS07-G03	Riken	W01C087M06	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013032J22	IMS07-G04	Riken	W01C087M07	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	H013032J22	IMS07-G04	Riken	W01C087M08	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	CS0DI028YM15	IMS07-G05		W01C087M09	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	CS0DI028YM15	IMS07-G05		W01C087M10	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	H023026H14	IMS07-G06	Riken	W01C087M11	pDONR221															
IKAKEN	H023026H14	IMS07-G06	Riken	W01C087M12	pDONR221															
IKAKEN	H023085D19	IMS07-G07	Riken	W01C087M13	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H023085D19	IMS07-G07	Riken	W01C087M14	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H013049H10	IMS07-G08	Riken	W01C087M15	pDONR221				440289											
IKAKEN	H013049H10	IMS07-G08	Riken	W01C087M16	pDONR221				440289											
IKAKEN	H013082F22	IMS07-G09	Riken	W01C087M17	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H013082F22	IMS07-G09	Riken	W01C087M18	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H023062I19	IMS07-G10	Riken	W01C087M19	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023062I19	IMS07-G10	Riken	W01C087M20	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023087P05	IMS07-G11	Riken	W01C087M21	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H023087P05	IMS07-G11	Riken	W01C087M22	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C087M23	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C087M24	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H013062N19	IMS07-G01	Riken	W01C087N01	pDONR221															
IKAKEN	H013062N19	IMS07-G01	Riken	W01C087N02	pDONR221															
IKAKEN	H033084N01	IMS07-G02	Riken	W01C087N03	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H033084N01	IMS07-G02	Riken	W01C087N04	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H013022E02	IMS07-G03	Riken	W01C087N05	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013022E02	IMS07-G03	Riken	W01C087N06	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013032J22	IMS07-G04	Riken	W01C087N07	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	H013032J22	IMS07-G04	Riken	W01C087N08	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	CS0DI028YM15	IMS07-G05		W01C087N09	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	CS0DI028YM15	IMS07-G05		W01C087N10	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	H023026H14	IMS07-G06	Riken	W01C087N11	pDONR221															
IKAKEN	H023026H14	IMS07-G06	Riken	W01C087N12	pDONR221															
IKAKEN	H023085D19	IMS07-G07	Riken	W01C087N13	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H023085D19	IMS07-G07	Riken	W01C087N14	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H013049H10	IMS07-G08	Riken	W01C087N15	pDONR221				440289											
IKAKEN	H013049H10	IMS07-G08	Riken	W01C087N16	pDONR221				440289											
IKAKEN	H013082F22	IMS07-G09	Riken	W01C087N17	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H013082F22	IMS07-G09	Riken	W01C087N18	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H023062I19	IMS07-G10	Riken	W01C087N19	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023062I19	IMS07-G10	Riken	W01C087N20	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023087P05	IMS07-G11	Riken	W01C087N21	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H023087P05	IMS07-G11	Riken	W01C087N22	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C087N23	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C087N24	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C087O01	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C087O02	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C087O03	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C087O04	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C087O05	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C087O06	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C087O07	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C087O08	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C087O09	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C087O10	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C087O11	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C087O12	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H033056P12	IMS07-H07	Riken	W01C087O13	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H033056P12	IMS07-H07	Riken	W01C087O14	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H013052L13	IMS07-H08	Riken	W01C087O15	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H013052L13	IMS07-H08	Riken	W01C087O16	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C087O17	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C087O18	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H013002G10	IMS07-H10	Riken	W01C087O19	pDONR221				401026											
IKAKEN	H013002G10	IMS07-H10	Riken	W01C087O20	pDONR221				401026											
IKAKEN	H033070E19	IMS07-H11	Riken	W01C087O21	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H033070E19	IMS07-H11	Riken	W01C087O22	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C087O23	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C087O24	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C087P01	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C087P02	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C087P03	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C087P04	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C087P05	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C087P06	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C087P07	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C087P08	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C087P09	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C087P10	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C087P11	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C087P12	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H033056P12	IMS07-H07	Riken	W01C087P13	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H033056P12	IMS07-H07	Riken	W01C087P14	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H013052L13	IMS07-H08	Riken	W01C087P15	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H013052L13	IMS07-H08	Riken	W01C087P16	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C087P17	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C087P18	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H013002G10	IMS07-H10	Riken	W01C087P19	pDONR221				401026											
IKAKEN	H013002G10	IMS07-H10	Riken	W01C087P20	pDONR221				401026											
IKAKEN	H033070E19	IMS07-H11	Riken	W01C087P21	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H033070E19	IMS07-H11	Riken	W01C087P22	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C087P23	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C087P24	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H013034H13	IMS07-A01	Riken	W01C088A01	pDONR221															
IKAKEN	H013034H13	IMS07-A01	Riken	W01C088A02	pDONR221															
IKAKEN	H023055M23	IMS07-A02	Riken	W01C088A03	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H023055M23	IMS07-A02	Riken	W01C088A04	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H013083E23	IMS07-A03	Riken	W01C088A05	pDONR221															
IKAKEN	H013083E23	IMS07-A03	Riken	W01C088A06	pDONR221															
IKAKEN	H013077B16	IMS07-A04	Riken	W01C088A07	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H013077B16	IMS07-A04	Riken	W01C088A08	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H023099O21	IMS07-A05	Riken	W01C088A09	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H023099O21	IMS07-A05	Riken	W01C088A10	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H013033L09	IMS07-A06	Riken	W01C088A11	pDONR221															
IKAKEN	H013033L09	IMS07-A06	Riken	W01C088A12	pDONR221															
IKAKEN	H033037H18	IMS07-A07	Riken	W01C088A13	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H033037H18	IMS07-A07	Riken	W01C088A14	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H023077D12	IMS07-A08	Riken	W01C088A15	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023077D12	IMS07-A08	Riken	W01C088A16	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023092B08	IMS07-A09	Riken	W01C088A17	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H023092B08	IMS07-A09	Riken	W01C088A18	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C088A19	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C088A20	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C088A21	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C088A22	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023072I23	IMS07-A12	Riken	W01C088A23	pDONR221															
IKAKEN	H023072I23	IMS07-A12	Riken	W01C088A24	pDONR221															
IKAKEN	H013034H13	IMS07-A01	Riken	W01C088B01	pDONR221															
IKAKEN	H013034H13	IMS07-A01	Riken	W01C088B02	pDONR221															
IKAKEN	H023055M23	IMS07-A02	Riken	W01C088B03	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H023055M23	IMS07-A02	Riken	W01C088B04	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	P	1.000	1.000	85	255	1	255	598	1	85
IKAKEN	H013083E23	IMS07-A03	Riken	W01C088B05	pDONR221															
IKAKEN	H013083E23	IMS07-A03	Riken	W01C088B06	pDONR221															
IKAKEN	H013077B16	IMS07-A04	Riken	W01C088B07	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H013077B16	IMS07-A04	Riken	W01C088B08	pDONR221			MARCH11	441061		Hs.662216	Membrane-associated ring finger (C3HC4) 11						NM_001102562.1	NP_001096032.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	226	310
IKAKEN	H023099O21	IMS07-A05	Riken	W01C088B09	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H023099O21	IMS07-A05	Riken	W01C088B10	pDONR221			PWWP2B	170394		Hs.527751	PWWP domain containing 2B						NM_001098637.1	NP_001092107.1	VALIDATED	P	1.000	1.000	85	255	1	255	499	78	162
IKAKEN	H013033L09	IMS07-A06	Riken	W01C088B11	pDONR221															
IKAKEN	H013033L09	IMS07-A06	Riken	W01C088B12	pDONR221															
IKAKEN	H033037H18	IMS07-A07	Riken	W01C088B13	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H033037H18	IMS07-A07	Riken	W01C088B14	pDONR221			BEX5	340542		Hs.47209	Brain expressed, X-linked 5						NM_001159560.1	NP_001153032.1	VALIDATED	P	1.000	1.000	85	255	1	255	111	1	85
IKAKEN	H023077D12	IMS07-A08	Riken	W01C088B15	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023077D12	IMS07-A08	Riken	W01C088B16	pDONR221			TTC7B	145567		Hs.655697	Tetratricopeptide repeat domain 7B						NM_001010854.1	NP_001010854.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	843	103	187
IKAKEN	H023092B08	IMS07-A09	Riken	W01C088B17	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H023092B08	IMS07-A09	Riken	W01C088B18	pDONR221			ADD3	120		Hs.501012	Adducin 3 (gamma)						NM_016824.3	NP_058432.1	REVIEWED	P	1.000	1.000	85	255	1	255	706	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C088B19	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H033061I02	IMS07-A10	Riken	W01C088B20	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	P	1.000	1.000	85	255	1	255	951	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C088B21	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023093F19	IMS07-A11	Riken	W01C088B22	pDONR221			SLC15A4	121260		Hs.699387	Solute carrier family 15, member 4						NM_145648.3	NP_663623.1	VALIDATED	P	1.000	1.000	85	255	1	255	577	1	85
IKAKEN	H023072I23	IMS07-A12	Riken	W01C088B23	pDONR221															
IKAKEN	H023072I23	IMS07-A12	Riken	W01C088B24	pDONR221															
IKAKEN	H013094J01	IMS07-B01	Riken	W01C088C01	pDONR221			SERPINA2	390502																					
IKAKEN	H013094J01	IMS07-B01	Riken	W01C088C02	pDONR221			SERPINA2	390502																					
IKAKEN	H013095D11	IMS07-B02	Riken	W01C088C03	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013095D11	IMS07-B02	Riken	W01C088C04	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013088L16	IMS07-B03	Riken	W01C088C05	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H013088L16	IMS07-B03	Riken	W01C088C06	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H023051B17	IMS07-B04	Riken	W01C088C07	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H023051B17	IMS07-B04	Riken	W01C088C08	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H013049H10	IMS07-B05	Riken	W01C088C09	pDONR221				440289											
IKAKEN	H013049H10	IMS07-B05	Riken	W01C088C10	pDONR221				440289											
IKAKEN	H023076D19	IMS07-B06	Riken	W01C088C11	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H023076D19	IMS07-B06	Riken	W01C088C12	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C088C13	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C088C14	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013058O17	IMS07-B08	Riken	W01C088C15	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013058O17	IMS07-B08	Riken	W01C088C16	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013069K21	IMS07-B09	Riken	W01C088C17	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013069K21	IMS07-B09	Riken	W01C088C18	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C088C19	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C088C20	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H033091A13	IMS07-B11	Riken	W01C088C21	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H033091A13	IMS07-B11	Riken	W01C088C22	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H023053L15	IMS07-B12	Riken	W01C088C23	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H023053L15	IMS07-B12	Riken	W01C088C24	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H013094J01	IMS07-B01	Riken	W01C088D01	pDONR221			SERPINA2	390502																					
IKAKEN	H013094J01	IMS07-B01	Riken	W01C088D02	pDONR221			SERPINA2	390502																					
IKAKEN	H013095D11	IMS07-B02	Riken	W01C088D03	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013095D11	IMS07-B02	Riken	W01C088D04	pDONR221			KIAA0753	9851		Hs.28070	KIAA0753						NM_014804.2	NP_055619.2	VALIDATED	P	1.000	1.000	85	255	1	255	967	1	85
IKAKEN	H013088L16	IMS07-B03	Riken	W01C088D05	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H013088L16	IMS07-B03	Riken	W01C088D06	pDONR221			LRRC37B	114659		Hs.514071	Leucine rich repeat containing 37B						NM_052888.2	NP_443120.2	VALIDATED	Pfs	0.977	0.988	86	255	2	255	947	10	95
IKAKEN	H023051B17	IMS07-B04	Riken	W01C088D07	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H023051B17	IMS07-B04	Riken	W01C088D08	pDONR221			PDE3B	5140		Hs.445711	Phosphodiesterase 3B, cGMP-inhibited						NM_000922.3	NP_000913.2	VALIDATED	P	1.000	1.000	85	255	1	255	1112	1	85
IKAKEN	H013049H10	IMS07-B05	Riken	W01C088D09	pDONR221				440289											
IKAKEN	H013049H10	IMS07-B05	Riken	W01C088D10	pDONR221				440289											
IKAKEN	H023076D19	IMS07-B06	Riken	W01C088D11	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H023076D19	IMS07-B06	Riken	W01C088D12	pDONR221			SF4	57794		Hs.515274	Splicing factor 4						NM_172231.2	NP_757386.2	VALIDATED	P	1.000	1.000	85	255	1	255	645	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C088D13	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013026N16	IMS07-B07	Riken	W01C088D14	pDONR221			DICER1	23405		Hs.87889	Dicer 1, ribonuclease type III						NM_177438.2	NP_803187.1	REVIEWED	P	1.000	1.000	85	255	1	255	1922	1	85
IKAKEN	H013058O17	IMS07-B08	Riken	W01C088D15	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013058O17	IMS07-B08	Riken	W01C088D16	pDONR221			PTCHD3	374308		Hs.631832	Patched domain containing 3						NM_001034842.3	NP_001030014.2	VALIDATED	P	1.000	1.000	85	255	1	255	767	80	164
IKAKEN	H013069K21	IMS07-B09	Riken	W01C088D17	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013069K21	IMS07-B09	Riken	W01C088D18	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	P	1.000	1.000	85	255	1	255	338	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C088D19	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H013098E07	IMS07-B10	Riken	W01C088D20	pDONR221			TMEM18	129787		Hs.43899	Transmembrane protein 18						NM_152834.2	NP_690047.2	VALIDATED	P	1.000	1.000	85	255	1	255	140	1	85
IKAKEN	H033091A13	IMS07-B11	Riken	W01C088D21	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H033091A13	IMS07-B11	Riken	W01C088D22	pDONR221			KIAA1383	54627		Hs.160373	KIAA1383						NM_019090.2	NP_061963.2	VALIDATED	P	1.000	1.000	85	255	1	255	1047	143	227
IKAKEN	H023053L15	IMS07-B12	Riken	W01C088D23	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H023053L15	IMS07-B12	Riken	W01C088D24	pDONR221			SYNGR1	9145		Hs.216226	Synaptogyrin 1						NM_145731.3	NP_663783.1	REVIEWED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	H033020P20	IMS07-C01	Riken	W01C088E01	pDONR221															
IKAKEN	H033020P20	IMS07-C01	Riken	W01C088E02	pDONR221															
IKAKEN	H033090E06	IMS07-C02	Riken	W01C088E03	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H033090E06	IMS07-C02	Riken	W01C088E04	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C088E05	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C088E06	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H013080B13	IMS07-C04	Riken	W01C088E07	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013080B13	IMS07-C04	Riken	W01C088E08	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013046F05	IMS07-C05	Riken	W01C088E09	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013046F05	IMS07-C05	Riken	W01C088E10	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C088E11	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C088E12	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C088E13	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C088E14	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C088E15	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C088E16	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C088E17	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C088E18	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C088E19	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C088E20	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H013090M09	IMS07-C11	Riken	W01C088E21	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H013090M09	IMS07-C11	Riken	W01C088E22	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H023093N18	IMS07-C12	Riken	W01C088E23	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H023093N18	IMS07-C12	Riken	W01C088E24	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H033020P20	IMS07-C01	Riken	W01C088F01	pDONR221															
IKAKEN	H033020P20	IMS07-C01	Riken	W01C088F02	pDONR221															
IKAKEN	H033090E06	IMS07-C02	Riken	W01C088F03	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H033090E06	IMS07-C02	Riken	W01C088F04	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	558	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C088F05	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H023088B04	IMS07-C03	Riken	W01C088F06	pDONR221			PPP4R4	57718		Hs.259599	Protein phosphatase 4, regulatory subunit 4						NM_058237.1	NP_478144.1	REVIEWED	P	1.000	1.000	85	255	1	255	873	1	85
IKAKEN	H013080B13	IMS07-C04	Riken	W01C088F07	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013080B13	IMS07-C04	Riken	W01C088F08	pDONR221			C5orf47	133491		Hs.131469	Chromosome 5 open reading frame 47						XM_941190.2	XP_946283.2	MODEL	P	1.000	1.000	85	255	1	255	278	103	187
IKAKEN	H013046F05	IMS07-C05	Riken	W01C088F09	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013046F05	IMS07-C05	Riken	W01C088F10	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	P	1.000	1.000	85	255	1	255	253	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C088F11	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H013060O19	IMS07-C06	Riken	W01C088F12	pDONR221			SPIRE1	56907		Hs.515283	Spire homolog 1 (Drosophila)						NM_020148.2	NP_064533.3	VALIDATED	P	1.000	1.000	85	255	1	255	742	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C088F13	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023064C16	IMS07-C07	Riken	W01C088F14	pDONR221			STRN	6801		Hs.656726	Striatin, calmodulin binding protein						NM_003162.2	NP_003153.2	VALIDATED	P	1.000	1.000	85	255	1	255	780	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C088F15	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H023090F13	IMS07-C08	Riken	W01C088F16	pDONR221			MAP1D	254042		Hs.298250	Methionine aminopeptidase 1D						NM_199227.1	NP_954697.1	VALIDATED	P	1.000	1.000	85	255	1	255	335	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C088F17	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H033058C16	IMS07-C09	Riken	W01C088F18	pDONR221			FBXL7	23194		Hs.433057	F-box and leucine-rich repeat protein 7						NM_012304.3	NP_036436.1	REVIEWED	P	1.000	1.000	85	255	1	255	491	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C088F19	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H023042I16	IMS07-C10	Riken	W01C088F20	pDONR221			KIAA1429	25962		Hs.202238	KIAA1429						NM_183009.1	NP_892121.1	VALIDATED	P	1.000	1.000	85	255	1	255	1147	1	85
IKAKEN	H013090M09	IMS07-C11	Riken	W01C088F21	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H013090M09	IMS07-C11	Riken	W01C088F22	pDONR221			PEAR1	375033		Hs.142003	Platelet endothelial aggregation receptor 1						NM_001080471.1	NP_001073940.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1037	559	643
IKAKEN	H023093N18	IMS07-C12	Riken	W01C088F23	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H023093N18	IMS07-C12	Riken	W01C088F24	pDONR221			EML6	400954		Hs.656692	Echinoderm microtubule associated protein like 6						XM_001725719.1	XP_001725771.1	MODEL	P	1.000	1.000	85	255	1	255	1935	1458	1542
IKAKEN	H023079B18	IMS07-D01	Riken	W01C088G01	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H023079B18	IMS07-D01	Riken	W01C088G02	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C088G03	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C088G04	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C088G05	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C088G06	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C088G07	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C088G08	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C088G09	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C088G10	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C088G11	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C088G12	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H023059H22	IMS07-D07	Riken	W01C088G13	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023059H22	IMS07-D07	Riken	W01C088G14	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023007A20	IMS07-D08	Riken	W01C088G15	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H023007A20	IMS07-D08	Riken	W01C088G16	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H013062K08	IMS07-D09	Riken	W01C088G17	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013062K08	IMS07-D09	Riken	W01C088G18	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C088G19	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C088G20	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C088G21	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C088G22	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C088G23	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C088G24	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	H023079B18	IMS07-D01	Riken	W01C088H01	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H023079B18	IMS07-D01	Riken	W01C088H02	pDONR221			KCTD8	386617		Hs.719367	Potassium channel tetramerisation domain containing 8						NM_198353.2	NP_938167.1	VALIDATED	P	1.000	1.000	85	255	1	255	473	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C088H03	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013065F09	IMS07-D02	Riken	W01C088H04	pDONR221			NKAPL	222698		Hs.239181	NFKB activating protein-like						NM_001007531.1	NP_001007532.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	402	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C088H05	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H013099M21	IMS07-D03	Riken	W01C088H06	pDONR221			DTX2	113878		Hs.187058	Deltex homolog 2 (Drosophila)						NM_001102595.1	NP_001096065.1	VALIDATED	P	1.000	1.000	85	255	1	255	622	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C088H07	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H023094L15	IMS07-D04	Riken	W01C088H08	pDONR221			MFAP3L	9848		Hs.593942	Microfibrillar-associated protein 3-like						NM_021647.6	NP_067679.6	VALIDATED	P	1.000	1.000	85	255	1	255	409	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C088H09	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013033G19	IMS07-D05	Riken	W01C088H10	pDONR221			CCDC147	159686		Hs.253576	Coiled-coil domain containing 147						NM_001008723.1	NP_001008723.1	VALIDATED	P	1.000	1.000	85	255	1	255	872	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C088H11	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H013089H21	IMS07-D06	Riken	W01C088H12	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003895.1	NP_001003895.1	REVIEWED	P	1.000	1.000	85	255	1	255	554	1	85
IKAKEN	H023059H22	IMS07-D07	Riken	W01C088H13	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023059H22	IMS07-D07	Riken	W01C088H14	pDONR221			SRRT	51593		Hs.111801	Serrate RNA effector molecule homolog (Arabidopsis)						NM_001128854.1	NP_001122326.1	VALIDATED	Pfs	0.988	1.000	85	255	3	255	871	86	170
IKAKEN	H023007A20	IMS07-D08	Riken	W01C088H15	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H023007A20	IMS07-D08	Riken	W01C088H16	pDONR221			DMD	1756		Hs.495912	Dystrophin						NM_004006.2	NP_003997.1	REVIEWED	P	1.000	1.000	78	255	22	255	3685	3076	3153
IKAKEN	H013062K08	IMS07-D09	Riken	W01C088H17	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013062K08	IMS07-D09	Riken	W01C088H18	pDONR221			PLEKHG4	25894		Hs.188781	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4						NM_001129728.1	NP_001123200.1	REVIEWED	P	1.000	1.000	85	255	1	255	1191	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C088H19	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013072G19	IMS07-D10	Riken	W01C088H20	pDONR221			SOCS7	30837		Hs.632261	Suppressor of cytokine signaling 7						NM_014598.1	NP_055413.1	VALIDATED	P	1.000	1.000	85	255	1	255	581	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C088H21	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H013085C24	IMS07-D11	Riken	W01C088H22	pDONR221			VPS37C	55048		Hs.523715	Vacuolar protein sorting 37 homolog C (S. cerevisiae)						NM_017966.4	NP_060436.4	VALIDATED	P	1.000	1.000	85	255	1	255	355	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C088H23	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	H023035C21	IMS07-D12	Riken	W01C088H24	pDONR221			USP11	8237		Hs.171501	Ubiquitin specific peptidase 11						NM_004651.3	NP_004642.2	REVIEWED	P	1.000	1.000	85	255	1	255	963	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C088I01	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C088I02	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C088I03	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C088I04	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C088I05	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C088I06	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H033015H03	IMS07-E04	Riken	W01C088I07	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033015H03	IMS07-E04	Riken	W01C088I08	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033072F22	IMS07-E05	Riken	W01C088I09	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072F22	IMS07-E05	Riken	W01C088I10	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C088I11	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C088I12	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C088I13	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C088I14	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C088I15	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C088I16	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C088I17	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C088I18	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C088I19	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C088I20	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	CS0DI012YO22	IMS07-E11		W01C088I21	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	CS0DI012YO22	IMS07-E11		W01C088I22	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	H033094K13	IMS07-E12	Riken	W01C088I23	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	H033094K13	IMS07-E12	Riken	W01C088I24	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C088J01	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	CS0DE009YJ09	IMS07-E01		W01C088J02	pDONR221			COL1A1	1277		Hs.681002	Collagen, type I, alpha 1						NM_000088.3	NP_000079.2	REVIEWED	P	1.000	1.000	85	255	1	255	1464	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C088J03	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013099D11	IMS07-E02	Riken	W01C088J04	pDONR221			TRMT5	57570		Hs.380159	TRM5 tRNA methyltransferase 5 homolog (S. cerevisiae)						NM_020810.2	NP_065861.2	VALIDATED	P	1.000	1.000	85	255	1	255	509	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C088J05	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H013088H23	IMS07-E03	Riken	W01C088J06	pDONR221			KCTD2	23510		Hs.514468	Potassium channel tetramerisation domain containing 2						NM_015353.1	NP_056168.1	VALIDATED	P	1.000	1.000	85	255	1	255	263	1	85
IKAKEN	H033015H03	IMS07-E04	Riken	W01C088J07	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033015H03	IMS07-E04	Riken	W01C088J08	pDONR221			GARNL1	253959		Hs.113150	GTPase activating Rap/RanGAP domain-like 1						NM_014990.1	NP_055805.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	2036	1745	1829
IKAKEN	H033072F22	IMS07-E05	Riken	W01C088J09	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072F22	IMS07-E05	Riken	W01C088J10	pDONR221			C16orf72	29035		Hs.221497	Chromosome 16 open reading frame 72						NM_014117.2	NP_054836.2	VALIDATED	P	1.000	1.000	85	255	1	255	275	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C088J11	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H033072L06	IMS07-E06	Riken	W01C088J12	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	P	1.000	1.000	85	255	1	255	432	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C088J13	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013090K23	IMS07-E07	Riken	W01C088J14	pDONR221			TBC1D12	23232		Hs.500598	TBC1 domain family, member 12						NM_015188.1	NP_056003.1	VALIDATED	P	1.000	1.000	85	255	1	255	775	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C088J15	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H013082J04	IMS07-E08	Riken	W01C088J16	pDONR221			INO80	54617		Hs.292949	INO80 homolog (S. cerevisiae)						NM_017553.1	NP_060023.1	VALIDATED	P	1.000	1.000	85	255	1	255	1556	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C088J17	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H033005J10	IMS07-E09	Riken	W01C088J18	pDONR221			KIAA0564	23078		Hs.368282	KIAA0564						NM_001009814.1	NP_001009814.1	VALIDATED	P	1.000	1.000	85	255	1	255	1039	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C088J19	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	H013023N18	IMS07-E10	Riken	W01C088J20	pDONR221			CDON	50937		Hs.38034	Cdon homolog (mouse)						NM_016952.4	NP_058648.4	VALIDATED	P	1.000	1.000	85	255	1	255	1264	1	85
IKAKEN	CS0DI012YO22	IMS07-E11		W01C088J21	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	CS0DI012YO22	IMS07-E11		W01C088J22	pDONR221			SAPS1	22870		Hs.515610	SAPS domain family, member 1						NM_014931.3	NP_055746.3	VALIDATED	Pg	0.988	1.000	85	255	1	255	881	128	211
IKAKEN	H033094K13	IMS07-E12	Riken	W01C088J23	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	H033094K13	IMS07-E12	Riken	W01C088J24	pDONR221			CKMT1B	1159		Hs.425633	Creatine kinase, mitochondrial 1B						NM_020990.3	NP_066270.1	REVIEWED	P	1.000	1.000	85	255	1	255	417	1	85
IKAKEN	H013023M10	IMS07-F01	Riken	W01C088K01	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H013023M10	IMS07-F01	Riken	W01C088K02	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H033061B15	IMS07-F02	Riken	W01C088K03	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033061B15	IMS07-F02	Riken	W01C088K04	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C088K05	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C088K06	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H013046P11	IMS07-F04	Riken	W01C088K07	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H013046P11	IMS07-F04	Riken	W01C088K08	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H033045D08	IMS07-F05	Riken	W01C088K09	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H033045D08	IMS07-F05	Riken	W01C088K10	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H013074L12	IMS07-F06	Riken	W01C088K11	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H013074L12	IMS07-F06	Riken	W01C088K12	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C088K13	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C088K14	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C088K15	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C088K16	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C088K17	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C088K18	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C088K19	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C088K20	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C088K21	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C088K22	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C088K23	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C088K24	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H013023M10	IMS07-F01	Riken	W01C088L01	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H013023M10	IMS07-F01	Riken	W01C088L02	pDONR221			C9orf153	389766		Hs.632073	Chromosome 9 open reading frame 153						NM_001010907.1	NP_001010907.1	PREDICTED	P	1.000	1.000	80	255	1	240	101	1	80
IKAKEN	H033061B15	IMS07-F02	Riken	W01C088L03	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033061B15	IMS07-F02	Riken	W01C088L04	pDONR221			DUSP28	285193		Hs.369297	Dual specificity phosphatase 28						NM_001033575.1	NP_001028747.1	VALIDATED	P	1.000	1.000	85	255	1	255	176	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C088L05	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H033035O12	IMS07-F03	Riken	W01C088L06	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	P	1.000	1.000	85	255	1	255	719	1	85
IKAKEN	H013046P11	IMS07-F04	Riken	W01C088L07	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H013046P11	IMS07-F04	Riken	W01C088L08	pDONR221			ESCO2	157570		Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)						NM_001017420.2	NP_001017420.1	REVIEWED	Pfs	1.000	1.000	84	255	3	255	601	44	127
IKAKEN	H033045D08	IMS07-F05	Riken	W01C088L09	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H033045D08	IMS07-F05	Riken	W01C088L10	pDONR221			RBP1	5947		Hs.529571	Retinol binding protein 1, cellular						NM_001130992.1	NP_001124464.1	REVIEWED	P	1.000	1.000	84	255	1	252	157	63	146
IKAKEN	H013074L12	IMS07-F06	Riken	W01C088L11	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H013074L12	IMS07-F06	Riken	W01C088L12	pDONR221			LPCAT1	79888		Hs.368853	Lysophosphatidylcholine acyltransferase 1						NM_024830.3	NP_079106.3	VALIDATED	P	1.000	1.000	85	255	1	255	534	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C088L13	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023072E11	IMS07-F07	Riken	W01C088L14	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	P	1.000	1.000	85	255	1	255	419	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C088L15	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H023064D23	IMS07-F08	Riken	W01C088L16	pDONR221			NAPEPLD	222236		Hs.324271	N-acyl phosphatidylethanolamine phospholipase D						NM_198990.4	NP_945341.3	VALIDATED	P	1.000	1.000	85	255	1	255	393	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C088L17	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013088K09	IMS07-F09	Riken	W01C088L18	pDONR221			HRASLS5	117245		Hs.410316	HRAS-like suppressor family, member 5						NM_001146728.1	NP_001140200.1	VALIDATED	Ps	0.988	0.988	85	255	1	255	253	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C088L19	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013041G03	IMS07-F10	Riken	W01C088L20	pDONR221			DAZ3	57054									NM_020364.2	NP_065097.2	REVIEWED	P	1.000	1.000	85	255	1	255	438	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C088L21	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H013071O04	IMS07-F11	Riken	W01C088L22	pDONR221			PICALM	8301		Hs.163893	Phosphatidylinositol binding clathrin assembly protein						NM_007166.2	NP_009097.2	VALIDATED	P	1.000	1.000	85	255	1	255	652	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C088L23	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H033098F15	IMS07-F12	Riken	W01C088L24	pDONR221			CERK	64781		Hs.200668	Ceramide kinase						NM_022766.5	NP_073603.2	VALIDATED	P	1.000	1.000	85	255	1	255	537	1	85
IKAKEN	H013062N19	IMS07-G01	Riken	W01C088M01	pDONR221															
IKAKEN	H013062N19	IMS07-G01	Riken	W01C088M02	pDONR221															
IKAKEN	H033084N01	IMS07-G02	Riken	W01C088M03	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H033084N01	IMS07-G02	Riken	W01C088M04	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H013022E02	IMS07-G03	Riken	W01C088M05	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013022E02	IMS07-G03	Riken	W01C088M06	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013032J22	IMS07-G04	Riken	W01C088M07	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	H013032J22	IMS07-G04	Riken	W01C088M08	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	CS0DI028YM15	IMS07-G05		W01C088M09	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	CS0DI028YM15	IMS07-G05		W01C088M10	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	H023026H14	IMS07-G06	Riken	W01C088M11	pDONR221															
IKAKEN	H023026H14	IMS07-G06	Riken	W01C088M12	pDONR221															
IKAKEN	H023085D19	IMS07-G07	Riken	W01C088M13	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H023085D19	IMS07-G07	Riken	W01C088M14	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H013049H10	IMS07-G08	Riken	W01C088M15	pDONR221				440289											
IKAKEN	H013049H10	IMS07-G08	Riken	W01C088M16	pDONR221				440289											
IKAKEN	H013082F22	IMS07-G09	Riken	W01C088M17	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H013082F22	IMS07-G09	Riken	W01C088M18	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H023062I19	IMS07-G10	Riken	W01C088M19	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023062I19	IMS07-G10	Riken	W01C088M20	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023087P05	IMS07-G11	Riken	W01C088M21	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H023087P05	IMS07-G11	Riken	W01C088M22	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C088M23	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C088M24	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H013062N19	IMS07-G01	Riken	W01C088N01	pDONR221															
IKAKEN	H013062N19	IMS07-G01	Riken	W01C088N02	pDONR221															
IKAKEN	H033084N01	IMS07-G02	Riken	W01C088N03	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H033084N01	IMS07-G02	Riken	W01C088N04	pDONR221			REEP3	221035		Hs.499833	Receptor accessory protein 3						NM_001001330.1	NP_001001330.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	255	5	89
IKAKEN	H013022E02	IMS07-G03	Riken	W01C088N05	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013022E02	IMS07-G03	Riken	W01C088N06	pDONR221			VPS39	23339		Hs.88025	Vacuolar protein sorting 39 homolog (S. cerevisiae)						NM_015289.2	NP_056104.2	REVIEWED	Pgs	0.859	0.986	85	255	1	255	875	1	74
IKAKEN	H013032J22	IMS07-G04	Riken	W01C088N07	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	H013032J22	IMS07-G04	Riken	W01C088N08	pDONR221			PTPMT1	114971		Hs.700746	Protein tyrosine phosphatase, mitochondrial 1						NM_001143984.1	NP_001137456.1	VALIDATED	P	1.000	1.000	44	204	3	134	151	108	151
IKAKEN	CS0DI028YM15	IMS07-G05		W01C088N09	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	CS0DI028YM15	IMS07-G05		W01C088N10	pDONR221			C14orf37	145407		Hs.535420	Chromosome 14 open reading frame 37						NM_001001872.2	NP_001001872.2	PREDICTED	P	1.000	1.000	85	255	1	255	774	1	85
IKAKEN	H023026H14	IMS07-G06	Riken	W01C088N11	pDONR221															
IKAKEN	H023026H14	IMS07-G06	Riken	W01C088N12	pDONR221															
IKAKEN	H023085D19	IMS07-G07	Riken	W01C088N13	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H023085D19	IMS07-G07	Riken	W01C088N14	pDONR221			KCTD3	51133		Hs.335139	Potassium channel tetramerisation domain containing 3						NM_016121.3	NP_057205.2	VALIDATED	P	1.000	1.000	85	255	1	255	815	1	85
IKAKEN	H013049H10	IMS07-G08	Riken	W01C088N15	pDONR221				440289											
IKAKEN	H013049H10	IMS07-G08	Riken	W01C088N16	pDONR221				440289											
IKAKEN	H013082F22	IMS07-G09	Riken	W01C088N17	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H013082F22	IMS07-G09	Riken	W01C088N18	pDONR221			CNGB1	1258		Hs.147062	Cyclic nucleotide gated channel beta 1						NM_001297.4	NP_001288.3	VALIDATED	P	1.000	1.000	85	255	1	255	1251	1	85
IKAKEN	H023062I19	IMS07-G10	Riken	W01C088N19	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023062I19	IMS07-G10	Riken	W01C088N20	pDONR221			MIDN	90007		Hs.465529	Midnolin						NM_177401.4	NP_796375.3	VALIDATED	P	1.000	1.000	85	255	1	255	468	323	407
IKAKEN	H023087P05	IMS07-G11	Riken	W01C088N21	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H023087P05	IMS07-G11	Riken	W01C088N22	pDONR221			CLIP4	79745		Hs.122927	CAP-GLY domain containing linker protein family, member 4						NM_024692.4	NP_078968.3	VALIDATED	P	1.000	1.000	85	255	1	255	705	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C088N23	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H033052B17	IMS07-G12	Riken	W01C088N24	pDONR221			HOMER2	9455		Hs.578443	Homer homolog 2 (Drosophila)						NM_199330.1	NP_955362.1	REVIEWED	P	1.000	1.000	85	255	1	255	354	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C088O01	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C088O02	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C088O03	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C088O04	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C088O05	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C088O06	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C088O07	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C088O08	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C088O09	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C088O10	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C088O11	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C088O12	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H033056P12	IMS07-H07	Riken	W01C088O13	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H033056P12	IMS07-H07	Riken	W01C088O14	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H013052L13	IMS07-H08	Riken	W01C088O15	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H013052L13	IMS07-H08	Riken	W01C088O16	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C088O17	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C088O18	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H013002G10	IMS07-H10	Riken	W01C088O19	pDONR221				401026											
IKAKEN	H013002G10	IMS07-H10	Riken	W01C088O20	pDONR221				401026											
IKAKEN	H033070E19	IMS07-H11	Riken	W01C088O21	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H033070E19	IMS07-H11	Riken	W01C088O22	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C088O23	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C088O24	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C088P01	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013084H19	IMS07-H01	Riken	W01C088P02	pDONR221			ATP1A4	480		Hs.662219	ATPase, Na+/K+ transporting, alpha 4 polypeptide						NM_144699.3	NP_653300.2	REVIEWED	P	1.000	1.000	85	255	1	255	1029	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C088P03	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H013057G01	IMS07-H02	Riken	W01C088P04	pDONR221			MAP3K2	10746		Hs.145605	Mitogen-activated protein kinase kinase kinase 2						NM_006609.3	NP_006600.3	REVIEWED	P	1.000	1.000	85	255	1	255	619	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C088P05	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023073J06	IMS07-H03	Riken	W01C088P06	pDONR221			LGI3	203190		Hs.33470	Leucine-rich repeat LGI family, member 3						NM_139278.2	NP_644807.1	VALIDATED	P	1.000	1.000	85	255	1	255	548	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C088P07	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023063I18	IMS07-H04	Riken	W01C088P08	pDONR221			VCPIP1	80124		Hs.632066	Valosin containing protein (p97)/p47 complex interacting protein 1						NM_025054.4	NP_079330.2	VALIDATED	P	1.000	1.000	85	255	1	255	1222	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C088P09	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H023062E12	IMS07-H05	Riken	W01C088P10	pDONR221			FAF2	23197		Hs.484242	Fas associated factor family member 2						NM_014613.2	NP_055428.1	REVIEWED	P	1.000	1.000	85	255	1	255	445	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C088P11	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H013092H10	IMS07-H06	Riken	W01C088P12	pDONR221			ADSL	158		Hs.75527	Adenylosuccinate lyase						NM_001123378.1	NP_001116850.1	REVIEWED	P	1.000	1.000	85	255	1	255	425	1	85
IKAKEN	H033056P12	IMS07-H07	Riken	W01C088P13	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H033056P12	IMS07-H07	Riken	W01C088P14	pDONR221			FAM62B	57488		Hs.490795	Family with sequence similarity 62 (C2 domain containing) member B						NM_020728.2	NP_065779.1	VALIDATED	P	1.000	1.000	83	255	7	255	893	70	152
IKAKEN	H013052L13	IMS07-H08	Riken	W01C088P15	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H013052L13	IMS07-H08	Riken	W01C088P16	pDONR221			WDR88	126248		Hs.211046	WD repeat domain 88						NM_173479.3	NP_775750.3	VALIDATED	P	1.000	1.000	85	255	1	255	472	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C088P17	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H023082M17	IMS07-H09	Riken	W01C088P18	pDONR221			EPM2A	7957		Hs.486696	Epilepsy, progressive myoclonus type 2A, Lafora disease (laforin)						NM_001018041.1	NP_001018051.1	REVIEWED	P	1.000	1.000	85	255	1	255	317	1	85
IKAKEN	H013002G10	IMS07-H10	Riken	W01C088P19	pDONR221				401026											
IKAKEN	H013002G10	IMS07-H10	Riken	W01C088P20	pDONR221				401026											
IKAKEN	H033070E19	IMS07-H11	Riken	W01C088P21	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H033070E19	IMS07-H11	Riken	W01C088P22	pDONR221			ARHGAP22	58504		Hs.655672	Rho GTPase activating protein 22						NM_021226.2	NP_067049.2	VALIDATED	P	1.000	1.000	85	255	1	255	698	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C088P23	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H023074N18	IMS07-H12	Riken	W01C088P24	pDONR221			C1QL3	389941		Hs.676792	Complement component 1, q subcomponent-like 3						NM_001010908.1	NP_001010908.1	VALIDATED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H023061J11	IMS08-A01	Riken	W01C089A01	pDONR221															
IKAKEN	H023061J11	IMS08-A01	Riken	W01C089A02	pDONR221															
IKAKEN	H013047J05	IMS08-A02	Riken	W01C089A03	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013047J05	IMS08-A02	Riken	W01C089A04	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013032H08	IMS08-A03	Riken	W01C089A05	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H013032H08	IMS08-A03	Riken	W01C089A06	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H023038D10	IMS08-A04	Riken	W01C089A07	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H023038D10	IMS08-A04	Riken	W01C089A08	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H013027B02	IMS08-A05	Riken	W01C089A09	pDONR221															
IKAKEN	H013027B02	IMS08-A05	Riken	W01C089A10	pDONR221															
IKAKEN	H023092I21	IMS08-A06	Riken	W01C089A11	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	H023092I21	IMS08-A06	Riken	W01C089A12	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	CS0DL008YL22	IMS08-A07		W01C089A13	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	CS0DL008YL22	IMS08-A07		W01C089A14	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	H013020I05	IMS08-A08	Riken	W01C089A15	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013020I05	IMS08-A08	Riken	W01C089A16	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C089A17	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C089A18	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C089A19	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C089A20	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013049L19	IMS08-A11	Riken	W01C089A21	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013049L19	IMS08-A11	Riken	W01C089A22	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013051F06	IMS08-A12	Riken	W01C089A23	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H013051F06	IMS08-A12	Riken	W01C089A24	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H023061J11	IMS08-A01	Riken	W01C089B01	pDONR221															
IKAKEN	H023061J11	IMS08-A01	Riken	W01C089B02	pDONR221															
IKAKEN	H013047J05	IMS08-A02	Riken	W01C089B03	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013047J05	IMS08-A02	Riken	W01C089B04	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013032H08	IMS08-A03	Riken	W01C089B05	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H013032H08	IMS08-A03	Riken	W01C089B06	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H023038D10	IMS08-A04	Riken	W01C089B07	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H023038D10	IMS08-A04	Riken	W01C089B08	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H013027B02	IMS08-A05	Riken	W01C089B09	pDONR221															
IKAKEN	H013027B02	IMS08-A05	Riken	W01C089B10	pDONR221															
IKAKEN	H023092I21	IMS08-A06	Riken	W01C089B11	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	H023092I21	IMS08-A06	Riken	W01C089B12	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	CS0DL008YL22	IMS08-A07		W01C089B13	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	CS0DL008YL22	IMS08-A07		W01C089B14	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	H013020I05	IMS08-A08	Riken	W01C089B15	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013020I05	IMS08-A08	Riken	W01C089B16	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C089B17	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C089B18	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C089B19	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C089B20	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013049L19	IMS08-A11	Riken	W01C089B21	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013049L19	IMS08-A11	Riken	W01C089B22	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013051F06	IMS08-A12	Riken	W01C089B23	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H013051F06	IMS08-A12	Riken	W01C089B24	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H013051E09	IMS08-B01	Riken	W01C089C01	pDONR221															
IKAKEN	H013051E09	IMS08-B01	Riken	W01C089C02	pDONR221															
IKAKEN	H013055P04	IMS08-B02	Riken	W01C089C03	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013055P04	IMS08-B02	Riken	W01C089C04	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013063K02	IMS08-B03	Riken	W01C089C05	pDONR221															
IKAKEN	H013063K02	IMS08-B03	Riken	W01C089C06	pDONR221															
IKAKEN	H013071C16	IMS08-B04	Riken	W01C089C07	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013071C16	IMS08-B04	Riken	W01C089C08	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C089C09	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C089C10	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013082E08	IMS08-B06	Riken	W01C089C11	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013082E08	IMS08-B06	Riken	W01C089C12	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013083F17	IMS08-B07	Riken	W01C089C13	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013083F17	IMS08-B07	Riken	W01C089C14	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013089P16	IMS08-B08	Riken	W01C089C15	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013089P16	IMS08-B08	Riken	W01C089C16	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013090H16	IMS08-B09	Riken	W01C089C17	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013090H16	IMS08-B09	Riken	W01C089C18	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013093J17	IMS08-B10	Riken	W01C089C19	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013093J17	IMS08-B10	Riken	W01C089C20	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013096H21	IMS08-B11	Riken	W01C089C21	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013096H21	IMS08-B11	Riken	W01C089C22	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013099H24	IMS08-B12	Riken	W01C089C23	pDONR221															
IKAKEN	H013099H24	IMS08-B12	Riken	W01C089C24	pDONR221															
IKAKEN	H013051E09	IMS08-B01	Riken	W01C089D01	pDONR221															
IKAKEN	H013051E09	IMS08-B01	Riken	W01C089D02	pDONR221															
IKAKEN	H013055P04	IMS08-B02	Riken	W01C089D03	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013055P04	IMS08-B02	Riken	W01C089D04	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013063K02	IMS08-B03	Riken	W01C089D05	pDONR221															
IKAKEN	H013063K02	IMS08-B03	Riken	W01C089D06	pDONR221															
IKAKEN	H013071C16	IMS08-B04	Riken	W01C089D07	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013071C16	IMS08-B04	Riken	W01C089D08	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C089D09	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C089D10	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013082E08	IMS08-B06	Riken	W01C089D11	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013082E08	IMS08-B06	Riken	W01C089D12	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013083F17	IMS08-B07	Riken	W01C089D13	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013083F17	IMS08-B07	Riken	W01C089D14	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013089P16	IMS08-B08	Riken	W01C089D15	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013089P16	IMS08-B08	Riken	W01C089D16	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013090H16	IMS08-B09	Riken	W01C089D17	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013090H16	IMS08-B09	Riken	W01C089D18	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013093J17	IMS08-B10	Riken	W01C089D19	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013093J17	IMS08-B10	Riken	W01C089D20	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013096H21	IMS08-B11	Riken	W01C089D21	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013096H21	IMS08-B11	Riken	W01C089D22	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013099H24	IMS08-B12	Riken	W01C089D23	pDONR221															
IKAKEN	H013099H24	IMS08-B12	Riken	W01C089D24	pDONR221															
IKAKEN	H023003I03	IMS08-C01	Riken	W01C089E01	pDONR221															
IKAKEN	H023003I03	IMS08-C01	Riken	W01C089E02	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C089E03	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C089E04	pDONR221															
IKAKEN	H023037C05	IMS08-C03	Riken	W01C089E05	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023037C05	IMS08-C03	Riken	W01C089E06	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023051I19	IMS08-C04	Riken	W01C089E07	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C04	Riken	W01C089E08	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C089E09	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C089E10	pDONR221			SNORA66	26782											
IKAKEN	H023062B04	IMS08-C06	Riken	W01C089E11	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023062B04	IMS08-C06	Riken	W01C089E12	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023063H19	IMS08-C07	Riken	W01C089E13	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023063H19	IMS08-C07	Riken	W01C089E14	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023072D22	IMS08-C08	Riken	W01C089E15	pDONR221															
IKAKEN	H023072D22	IMS08-C08	Riken	W01C089E16	pDONR221															
IKAKEN	H023073N12	IMS08-C09	Riken	W01C089E17	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023073N12	IMS08-C09	Riken	W01C089E18	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023092D04	IMS08-C10	Riken	W01C089E19	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023092D04	IMS08-C10	Riken	W01C089E20	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023096O04	IMS08-C11	Riken	W01C089E21	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H023096O04	IMS08-C11	Riken	W01C089E22	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C089E23	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C089E24	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H023003I03	IMS08-C01	Riken	W01C089F01	pDONR221															
IKAKEN	H023003I03	IMS08-C01	Riken	W01C089F02	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C089F03	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C089F04	pDONR221															
IKAKEN	H023037C05	IMS08-C03	Riken	W01C089F05	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023037C05	IMS08-C03	Riken	W01C089F06	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023051I19	IMS08-C04	Riken	W01C089F07	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C04	Riken	W01C089F08	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C089F09	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C089F10	pDONR221			SNORA66	26782											
IKAKEN	H023062B04	IMS08-C06	Riken	W01C089F11	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023062B04	IMS08-C06	Riken	W01C089F12	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023063H19	IMS08-C07	Riken	W01C089F13	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023063H19	IMS08-C07	Riken	W01C089F14	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023072D22	IMS08-C08	Riken	W01C089F15	pDONR221															
IKAKEN	H023072D22	IMS08-C08	Riken	W01C089F16	pDONR221															
IKAKEN	H023073N12	IMS08-C09	Riken	W01C089F17	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023073N12	IMS08-C09	Riken	W01C089F18	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023092D04	IMS08-C10	Riken	W01C089F19	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023092D04	IMS08-C10	Riken	W01C089F20	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023096O04	IMS08-C11	Riken	W01C089F21	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H023096O04	IMS08-C11	Riken	W01C089F22	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C089F23	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C089F24	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H033052L01	IMS08-D01	Riken	W01C089G01	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033052L01	IMS08-D01	Riken	W01C089G02	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033053G06	IMS08-D02	Riken	W01C089G03	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G06	IMS08-D02	Riken	W01C089G04	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G13	IMS08-D03	Riken	W01C089G05	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053G13	IMS08-D03	Riken	W01C089G06	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053N16	IMS08-D04	Riken	W01C089G07	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033053N16	IMS08-D04	Riken	W01C089G08	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033054G03	IMS08-D05	Riken	W01C089G09	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033054G03	IMS08-D05	Riken	W01C089G10	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033062P05	IMS08-D06	Riken	W01C089G11	pDONR221															
IKAKEN	H033062P05	IMS08-D06	Riken	W01C089G12	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C089G13	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C089G14	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C089G15	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C089G16	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C089G17	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C089G18	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C089G19	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C089G20	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C089G21	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C089G22	pDONR221															
IKAKEN	CS0DC002YK04	IMS08-D12		W01C089G23	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	CS0DC002YK04	IMS08-D12		W01C089G24	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	H033052L01	IMS08-D01	Riken	W01C089H01	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033052L01	IMS08-D01	Riken	W01C089H02	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033053G06	IMS08-D02	Riken	W01C089H03	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G06	IMS08-D02	Riken	W01C089H04	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G13	IMS08-D03	Riken	W01C089H05	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053G13	IMS08-D03	Riken	W01C089H06	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053N16	IMS08-D04	Riken	W01C089H07	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033053N16	IMS08-D04	Riken	W01C089H08	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033054G03	IMS08-D05	Riken	W01C089H09	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033054G03	IMS08-D05	Riken	W01C089H10	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033062P05	IMS08-D06	Riken	W01C089H11	pDONR221															
IKAKEN	H033062P05	IMS08-D06	Riken	W01C089H12	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C089H13	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C089H14	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C089H15	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C089H16	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C089H17	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C089H18	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C089H19	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C089H20	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C089H21	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C089H22	pDONR221															
IKAKEN	CS0DC002YK04	IMS08-D12		W01C089H23	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	CS0DC002YK04	IMS08-D12		W01C089H24	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	CS0DE005YP01	IMS08-E01		W01C089I01	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DE005YP01	IMS08-E01		W01C089I02	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DM012YL20	IMS08-E02		W01C089I03	pDONR221			TRA@	6955											
IKAKEN	CS0DM012YL20	IMS08-E02		W01C089I04	pDONR221			TRA@	6955											
IKAKEN	CS0DD006YA23	IMS08-E03		W01C089I05	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DD006YA23	IMS08-E03		W01C089I06	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DC001YC19	IMS08-E04		W01C089I07	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DC001YC19	IMS08-E04		W01C089I08	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C089I09	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C089I10	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DI070YC14	IMS08-E06		W01C089I11	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DI070YC14	IMS08-E06		W01C089I12	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DB001YP17	IMS08-E07		W01C089I13	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DB001YP17	IMS08-E07		W01C089I14	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C089I15	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C089I16	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C089I17	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C089I18	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DC009YK24	IMS08-E10		W01C089I19	pDONR221				390566											
IKAKEN	CS0DC009YK24	IMS08-E10		W01C089I20	pDONR221				390566											
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C089I21	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C089I22	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DE003YD13	IMS08-E12		W01C089I23	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CS0DE003YD13	IMS08-E12		W01C089I24	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CS0DE005YP01	IMS08-E01		W01C089J01	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DE005YP01	IMS08-E01		W01C089J02	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DM012YL20	IMS08-E02		W01C089J03	pDONR221			TRA@	6955											
IKAKEN	CS0DM012YL20	IMS08-E02		W01C089J04	pDONR221			TRA@	6955											
IKAKEN	CS0DD006YA23	IMS08-E03		W01C089J05	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DD006YA23	IMS08-E03		W01C089J06	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DC001YC19	IMS08-E04		W01C089J07	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DC001YC19	IMS08-E04		W01C089J08	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C089J09	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C089J10	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DI070YC14	IMS08-E06		W01C089J11	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DI070YC14	IMS08-E06		W01C089J12	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DB001YP17	IMS08-E07		W01C089J13	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DB001YP17	IMS08-E07		W01C089J14	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C089J15	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C089J16	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C089J17	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C089J18	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DC009YK24	IMS08-E10		W01C089J19	pDONR221				390566											
IKAKEN	CS0DC009YK24	IMS08-E10		W01C089J20	pDONR221				390566											
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C089J21	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C089J22	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DE003YD13	IMS08-E12		W01C089J23	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CS0DE003YD13	IMS08-E12		W01C089J24	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C089K01	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C089K02	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C089K03	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C089K04	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C089K05	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C089K06	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C089K07	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C089K08	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C089K09	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C089K10	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C089K11	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C089K12	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C089K13	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C089K14	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C089K15	pDONR221															
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C089K16	pDONR221															
IKAKEN	CS0DC003YP09	IMS08-F09		W01C089K17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DC003YP09	IMS08-F09		W01C089K18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C089K19	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C089K20	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C089K21	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C089K22	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC022YA12	IMS08-F12		W01C089K23	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CS0DC022YA12	IMS08-F12		W01C089K24	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C089L01	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C089L02	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C089L03	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C089L04	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C089L05	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C089L06	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C089L07	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C089L08	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C089L09	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C089L10	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C089L11	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C089L12	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C089L13	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C089L14	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C089L15	pDONR221															
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C089L16	pDONR221															
IKAKEN	CS0DC003YP09	IMS08-F09		W01C089L17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DC003YP09	IMS08-F09		W01C089L18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C089L19	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C089L20	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C089L21	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C089L22	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC022YA12	IMS08-F12		W01C089L23	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CS0DC022YA12	IMS08-F12		W01C089L24	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CS0DD007YK20	IMS08-G01		W01C089M01	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DD007YK20	IMS08-G01		W01C089M02	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C089M03	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C089M04	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C089M05	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C089M06	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C089M07	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C089M08	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C089M09	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C089M10	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DF029YK03	IMS08-G06		W01C089M11	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DF029YK03	IMS08-G06		W01C089M12	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C089M13	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C089M14	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C089M15	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C089M16	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DN005YL22	IMS08-G09		W01C089M17	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DN005YL22	IMS08-G09		W01C089M18	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DI022YK16	IMS08-G10		W01C089M19	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	CS0DI022YK16	IMS08-G10		W01C089M20	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	SK002H02	IMS08-G11	IMS	W01C089M21	pDONR221															
IKAKEN	SK002H02	IMS08-G11	IMS	W01C089M22	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C089M23	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C089M24	pDONR221															
IKAKEN	CS0DD007YK20	IMS08-G01		W01C089N01	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DD007YK20	IMS08-G01		W01C089N02	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C089N03	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C089N04	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C089N05	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C089N06	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C089N07	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C089N08	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C089N09	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C089N10	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DF029YK03	IMS08-G06		W01C089N11	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DF029YK03	IMS08-G06		W01C089N12	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C089N13	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C089N14	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C089N15	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C089N16	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DN005YL22	IMS08-G09		W01C089N17	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DN005YL22	IMS08-G09		W01C089N18	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DI022YK16	IMS08-G10		W01C089N19	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	CS0DI022YK16	IMS08-G10		W01C089N20	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	SK002H02	IMS08-G11	IMS	W01C089N21	pDONR221															
IKAKEN	SK002H02	IMS08-G11	IMS	W01C089N22	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C089N23	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C089N24	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C089O01	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C089O02	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C089O03	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C089O04	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C089O05	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C089O06	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C089O07	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C089O08	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C089O09	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C089O10	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C089O11	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C089O12	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C089O13	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C089O14	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C089O15	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C089O16	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C089O17	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C089O18	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C089O19	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C089O20	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C089O21	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C089O22	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C089O23	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C089O24	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C089P01	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C089P02	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C089P03	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C089P04	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C089P05	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C089P06	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C089P07	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C089P08	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C089P09	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C089P10	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C089P11	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C089P12	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C089P13	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C089P14	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C089P15	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C089P16	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C089P17	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C089P18	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C089P19	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C089P20	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C089P21	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C089P22	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C089P23	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C089P24	pDONR221															
IKAKEN	H023061J11	IMS08-A01	Riken	W01C090A01	pDONR221															
IKAKEN	H023061J11	IMS08-A01	Riken	W01C090A02	pDONR221															
IKAKEN	H013047J05	IMS08-A02	Riken	W01C090A03	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013047J05	IMS08-A02	Riken	W01C090A04	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013032H08	IMS08-A03	Riken	W01C090A05	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H013032H08	IMS08-A03	Riken	W01C090A06	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H023038D10	IMS08-A04	Riken	W01C090A07	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H023038D10	IMS08-A04	Riken	W01C090A08	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H013027B02	IMS08-A05	Riken	W01C090A09	pDONR221															
IKAKEN	H013027B02	IMS08-A05	Riken	W01C090A10	pDONR221															
IKAKEN	H023092I21	IMS08-A06	Riken	W01C090A11	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	H023092I21	IMS08-A06	Riken	W01C090A12	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	CS0DL008YL22	IMS08-A07		W01C090A13	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	CS0DL008YL22	IMS08-A07		W01C090A14	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	H013020I05	IMS08-A08	Riken	W01C090A15	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013020I05	IMS08-A08	Riken	W01C090A16	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C090A17	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C090A18	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C090A19	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C090A20	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013049L19	IMS08-A11	Riken	W01C090A21	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013049L19	IMS08-A11	Riken	W01C090A22	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013051F06	IMS08-A12	Riken	W01C090A23	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H013051F06	IMS08-A12	Riken	W01C090A24	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H023061J11	IMS08-A01	Riken	W01C090B01	pDONR221															
IKAKEN	H023061J11	IMS08-A01	Riken	W01C090B02	pDONR221															
IKAKEN	H013047J05	IMS08-A02	Riken	W01C090B03	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013047J05	IMS08-A02	Riken	W01C090B04	pDONR221			MED25	81857		Hs.656639	Mediator complex subunit 25						NM_030973.2	NP_112235.2	VALIDATED	P	1.000	1.000	85	255	1	255	747	220	304
IKAKEN	H013032H08	IMS08-A03	Riken	W01C090B05	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H013032H08	IMS08-A03	Riken	W01C090B06	pDONR221			C15orf55	256646		Hs.525769	Chromosome 15 open reading frame 55						NM_175741.1	NP_786883.1	VALIDATED	Ps	0.988	0.988	83	255	7	255	1132	6	88
IKAKEN	H023038D10	IMS08-A04	Riken	W01C090B07	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H023038D10	IMS08-A04	Riken	W01C090B08	pDONR221			SPATA8	145946		Hs.326528	Spermatogenesis associated 8						NM_173499.3	NP_775770.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	105	1	85
IKAKEN	H013027B02	IMS08-A05	Riken	W01C090B09	pDONR221															
IKAKEN	H013027B02	IMS08-A05	Riken	W01C090B10	pDONR221															
IKAKEN	H023092I21	IMS08-A06	Riken	W01C090B11	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	H023092I21	IMS08-A06	Riken	W01C090B12	pDONR221			AKR7A2	8574		Hs.571886	Aldo-keto reductase family 7, member A2 (aflatoxin aldehyde reductase)						NM_003689.2	NP_003680.2	VALIDATED	P	1.000	1.000	85	255	1	255	359	1	85
IKAKEN	CS0DL008YL22	IMS08-A07		W01C090B13	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	CS0DL008YL22	IMS08-A07		W01C090B14	pDONR221			DMWD	1762		Hs.515474	Dystrophia myotonica, WD repeat containing						NM_004943.1	NP_004934.1	VALIDATED	P	1.000	1.000	85	255	1	255	674	16	100
IKAKEN	H013020I05	IMS08-A08	Riken	W01C090B15	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013020I05	IMS08-A08	Riken	W01C090B16	pDONR221			VCY1B	353513									NM_181880.1	NP_870996.1	REVIEWED		0.918	0.918	85	255	1	255	125	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C090B17	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013036C18	IMS08-A09	Riken	W01C090B18	pDONR221			IRAK1BP1	134728		Hs.656212	Interleukin-1 receptor-associated kinase 1 binding protein 1						NM_001010844.1	NP_001010844.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	260	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C090B19	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013047B16	IMS08-A10	Riken	W01C090B20	pDONR221			RANGRF	29098		Hs.408233	RAN guanine nucleotide release factor						NM_016492.3	NP_057576.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	186	1	85
IKAKEN	H013049L19	IMS08-A11	Riken	W01C090B21	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013049L19	IMS08-A11	Riken	W01C090B22	pDONR221			MACROD2	140733		Hs.661576	MACRO domain containing 2						NM_080676.5	NP_542407.2	VALIDATED	P	1.000	1.000	54	183	1	162	425	1	54
IKAKEN	H013051F06	IMS08-A12	Riken	W01C090B23	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H013051F06	IMS08-A12	Riken	W01C090B24	pDONR221			WFDC10A	140832		Hs.199380	WAP four-disulfide core domain 10A						NM_080753.2	NP_542791.1	REVIEWED		0.646	0.699	79	222	1	219	79	1	79
IKAKEN	H013051E09	IMS08-B01	Riken	W01C090C01	pDONR221															
IKAKEN	H013051E09	IMS08-B01	Riken	W01C090C02	pDONR221															
IKAKEN	H013055P04	IMS08-B02	Riken	W01C090C03	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013055P04	IMS08-B02	Riken	W01C090C04	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013063K02	IMS08-B03	Riken	W01C090C05	pDONR221															
IKAKEN	H013063K02	IMS08-B03	Riken	W01C090C06	pDONR221															
IKAKEN	H013071C16	IMS08-B04	Riken	W01C090C07	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013071C16	IMS08-B04	Riken	W01C090C08	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C090C09	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C090C10	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013082E08	IMS08-B06	Riken	W01C090C11	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013082E08	IMS08-B06	Riken	W01C090C12	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013083F17	IMS08-B07	Riken	W01C090C13	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013083F17	IMS08-B07	Riken	W01C090C14	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013089P16	IMS08-B08	Riken	W01C090C15	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013089P16	IMS08-B08	Riken	W01C090C16	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013090H16	IMS08-B09	Riken	W01C090C17	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013090H16	IMS08-B09	Riken	W01C090C18	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013093J17	IMS08-B10	Riken	W01C090C19	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013093J17	IMS08-B10	Riken	W01C090C20	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013096H21	IMS08-B11	Riken	W01C090C21	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013096H21	IMS08-B11	Riken	W01C090C22	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013099H24	IMS08-B12	Riken	W01C090C23	pDONR221															
IKAKEN	H013099H24	IMS08-B12	Riken	W01C090C24	pDONR221															
IKAKEN	H013051E09	IMS08-B01	Riken	W01C090D01	pDONR221															
IKAKEN	H013051E09	IMS08-B01	Riken	W01C090D02	pDONR221															
IKAKEN	H013055P04	IMS08-B02	Riken	W01C090D03	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013055P04	IMS08-B02	Riken	W01C090D04	pDONR221			C20orf107	388799		Hs.287759	Chromosome 20 open reading frame 107						NM_001013646.2	NP_001013668.2	PREDICTED	P	1.000	1.000	85	255	1	255	171	1	85
IKAKEN	H013063K02	IMS08-B03	Riken	W01C090D05	pDONR221															
IKAKEN	H013063K02	IMS08-B03	Riken	W01C090D06	pDONR221															
IKAKEN	H013071C16	IMS08-B04	Riken	W01C090D07	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013071C16	IMS08-B04	Riken	W01C090D08	pDONR221			PPP1R14B	26472		Hs.523760	Protein phosphatase 1, regulatory (inhibitor) subunit 14B						NM_138689.2	NP_619634.1	VALIDATED	P	1.000	1.000	85	255	1	255	147	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C090D09	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013079G16	IMS08-B05	Riken	W01C090D10	pDONR221			SPACA3	124912		Hs.434112	Sperm acrosome associated 3						NM_173847.3	NP_776246.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	215	1	85
IKAKEN	H013082E08	IMS08-B06	Riken	W01C090D11	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013082E08	IMS08-B06	Riken	W01C090D12	pDONR221			SPHAR	10638		Hs.716553	S-phase response (cyclin related)						NM_006542.3	NP_006533.1	VALIDATED	OK	1.000	1.000	63	192	1	189	63	1	63
IKAKEN	H013083F17	IMS08-B07	Riken	W01C090D13	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013083F17	IMS08-B07	Riken	W01C090D14	pDONR221			TMCO2	127391		Hs.406265	Transmembrane and coiled-coil domains 2						NM_001008740.3	NP_001008740.1	VALIDATED	P	1.000	1.000	85	255	1	255	182	1	85
IKAKEN	H013089P16	IMS08-B08	Riken	W01C090D15	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013089P16	IMS08-B08	Riken	W01C090D16	pDONR221			ETNK1	55500		Hs.29464	Ethanolamine kinase 1						NM_018638.4	NP_061108.2	REVIEWED	P	1.000	1.000	85	255	1	255	452	90	174
IKAKEN	H013090H16	IMS08-B09	Riken	W01C090D17	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013090H16	IMS08-B09	Riken	W01C090D18	pDONR221			OAZ3	51686		Hs.713789	Ornithine decarboxylase antizyme 3						NM_001134939.1	NP_001128411.1	REVIEWED	Pfs	0.974	0.974	78	255	19	253	190	10	87
IKAKEN	H013093J17	IMS08-B10	Riken	W01C090D19	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013093J17	IMS08-B10	Riken	W01C090D20	pDONR221			LOC286123	286123		Hs.617172	Hypothetical protein LOC286123								
IKAKEN	H013096H21	IMS08-B11	Riken	W01C090D21	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013096H21	IMS08-B11	Riken	W01C090D22	pDONR221			TTC32	130502		Hs.591547	Tetratricopeptide repeat domain 32						NM_001008237.1	NP_001008238.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	151	1	85
IKAKEN	H013099H24	IMS08-B12	Riken	W01C090D23	pDONR221															
IKAKEN	H013099H24	IMS08-B12	Riken	W01C090D24	pDONR221															
IKAKEN	H023003I03	IMS08-C01	Riken	W01C090E01	pDONR221															
IKAKEN	H023003I03	IMS08-C01	Riken	W01C090E02	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C090E03	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C090E04	pDONR221															
IKAKEN	H023037C05	IMS08-C03	Riken	W01C090E05	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023037C05	IMS08-C03	Riken	W01C090E06	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023051I19	IMS08-C04	Riken	W01C090E07	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C04	Riken	W01C090E08	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C090E09	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C090E10	pDONR221			SNORA66	26782											
IKAKEN	H023062B04	IMS08-C06	Riken	W01C090E11	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023062B04	IMS08-C06	Riken	W01C090E12	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023063H19	IMS08-C07	Riken	W01C090E13	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023063H19	IMS08-C07	Riken	W01C090E14	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023072D22	IMS08-C08	Riken	W01C090E15	pDONR221															
IKAKEN	H023072D22	IMS08-C08	Riken	W01C090E16	pDONR221															
IKAKEN	H023073N12	IMS08-C09	Riken	W01C090E17	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023073N12	IMS08-C09	Riken	W01C090E18	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023092D04	IMS08-C10	Riken	W01C090E19	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023092D04	IMS08-C10	Riken	W01C090E20	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023096O04	IMS08-C11	Riken	W01C090E21	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H023096O04	IMS08-C11	Riken	W01C090E22	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C090E23	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C090E24	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H023003I03	IMS08-C01	Riken	W01C090F01	pDONR221															
IKAKEN	H023003I03	IMS08-C01	Riken	W01C090F02	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C090F03	pDONR221															
IKAKEN	H023014G03	IMS08-C02	Riken	W01C090F04	pDONR221															
IKAKEN	H023037C05	IMS08-C03	Riken	W01C090F05	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023037C05	IMS08-C03	Riken	W01C090F06	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.906	0.906	85	255	1	255	217	1	85
IKAKEN	H023051I19	IMS08-C04	Riken	W01C090F07	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C04	Riken	W01C090F08	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C090F09	pDONR221			SNORA66	26782											
IKAKEN	H023051I19	IMS08-C05	Riken	W01C090F10	pDONR221			SNORA66	26782											
IKAKEN	H023062B04	IMS08-C06	Riken	W01C090F11	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023062B04	IMS08-C06	Riken	W01C090F12	pDONR221			C17orf100	388327		Hs.262480	Chromosome 17 open reading frame 100						NM_001105520.1	NP_001098990.1	VALIDATED	P	1.000	1.000	54	255	94	255	118	1	54
IKAKEN	H023063H19	IMS08-C07	Riken	W01C090F13	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023063H19	IMS08-C07	Riken	W01C090F14	pDONR221			C14orf109	26175		Hs.275352	Chromosome 14 open reading frame 109						NM_015676.1	NP_056491.1	PREDICTED	P	1.000	1.000	85	255	1	255	131	1	85
IKAKEN	H023072D22	IMS08-C08	Riken	W01C090F15	pDONR221															
IKAKEN	H023072D22	IMS08-C08	Riken	W01C090F16	pDONR221															
IKAKEN	H023073N12	IMS08-C09	Riken	W01C090F17	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023073N12	IMS08-C09	Riken	W01C090F18	pDONR221			UBE2S	27338		Hs.396393	Ubiquitin-conjugating enzyme E2S						NM_014501.2	NP_055316.2	REVIEWED	P	1.000	1.000	85	255	1	255	222	1	85
IKAKEN	H023092D04	IMS08-C10	Riken	W01C090F19	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023092D04	IMS08-C10	Riken	W01C090F20	pDONR221			RHBDD2	57414		Hs.488827	Rhomboid domain containing 2						NM_001040456.1	NP_001035546.1	VALIDATED	P	1.000	1.000	59	240	1	177	364	1	59
IKAKEN	H023096O04	IMS08-C11	Riken	W01C090F21	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H023096O04	IMS08-C11	Riken	W01C090F22	pDONR221			CHCHD6	84303		Hs.518119	Coiled-coil-helix-coiled-coil-helix domain containing 6						NM_032343.1	NP_115719.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	235	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C090F23	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H033029L18	IMS08-C12	Riken	W01C090F24	pDONR221			ETFB	2109		Hs.348531	Electron-transfer-flavoprotein, beta polypeptide						NM_001985.2	NP_001976.1	REVIEWED	P	1.000	1.000	85	255	1	255	255	1	85
IKAKEN	H033052L01	IMS08-D01	Riken	W01C090G01	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033052L01	IMS08-D01	Riken	W01C090G02	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033053G06	IMS08-D02	Riken	W01C090G03	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G06	IMS08-D02	Riken	W01C090G04	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G13	IMS08-D03	Riken	W01C090G05	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053G13	IMS08-D03	Riken	W01C090G06	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053N16	IMS08-D04	Riken	W01C090G07	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033053N16	IMS08-D04	Riken	W01C090G08	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033054G03	IMS08-D05	Riken	W01C090G09	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033054G03	IMS08-D05	Riken	W01C090G10	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033062P05	IMS08-D06	Riken	W01C090G11	pDONR221															
IKAKEN	H033062P05	IMS08-D06	Riken	W01C090G12	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C090G13	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C090G14	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C090G15	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C090G16	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C090G17	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C090G18	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C090G19	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C090G20	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C090G21	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C090G22	pDONR221															
IKAKEN	CS0DC002YK04	IMS08-D12		W01C090G23	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	CS0DC002YK04	IMS08-D12		W01C090G24	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	H033052L01	IMS08-D01	Riken	W01C090H01	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033052L01	IMS08-D01	Riken	W01C090H02	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	195	1	85
IKAKEN	H033053G06	IMS08-D02	Riken	W01C090H03	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G06	IMS08-D02	Riken	W01C090H04	pDONR221			C2orf79	391356		Hs.406607	Chromosome 2 open reading frame 79						NM_001013663.1	NP_001013685.1	PREDICTED	P	1.000	1.000	85	255	1	255	140	15	99
IKAKEN	H033053G13	IMS08-D03	Riken	W01C090H05	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053G13	IMS08-D03	Riken	W01C090H06	pDONR221			NFU1	27247		Hs.430439	NFU1 iron-sulfur cluster scaffold homolog (S. cerevisiae)						NM_001002755.1	NP_001002755.1	VALIDATED	P	1.000	1.000	85	255	1	255	254	59	143
IKAKEN	H033053N16	IMS08-D04	Riken	W01C090H07	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033053N16	IMS08-D04	Riken	W01C090H08	pDONR221			RPL14	9045		Hs.719095	Ribosomal protein L14						NM_003973.3	NP_003964.3	REVIEWED		0.812	0.812	85	255	1	255	215	1	85
IKAKEN	H033054G03	IMS08-D05	Riken	W01C090H09	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033054G03	IMS08-D05	Riken	W01C090H10	pDONR221			OAZ1	4946		Hs.446427	Ornithine decarboxylase antizyme 1						NM_004152.2	NP_004143.1	REVIEWED	Pg	0.988	1.000	86	255	1	255	228	1	86
IKAKEN	H033062P05	IMS08-D06	Riken	W01C090H11	pDONR221															
IKAKEN	H033062P05	IMS08-D06	Riken	W01C090H12	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C090H13	pDONR221															
IKAKEN	H033070G08	IMS08-D07	Riken	W01C090H14	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C090H15	pDONR221															
IKAKEN	H033091K21	IMS08-D08	Riken	W01C090H16	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C090H17	pDONR221															
IKAKEN	H033091K21	IMS08-D09	Riken	W01C090H18	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C090H19	pDONR221															
IKAKEN	H033091K21	IMS08-D10	Riken	W01C090H20	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C090H21	pDONR221															
IKAKEN	H023003I03	IMS08-D11	Riken	W01C090H22	pDONR221															
IKAKEN	CS0DC002YK04	IMS08-D12		W01C090H23	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	CS0DC002YK04	IMS08-D12		W01C090H24	pDONR221			SEPT3	55964		Hs.120483	Septin 3						NM_145733.2	NP_663786.2	REVIEWED	P	1.000	1.000	85	255	1	255	358	14	98
IKAKEN	CS0DE005YP01	IMS08-E01		W01C090I01	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DE005YP01	IMS08-E01		W01C090I02	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DM012YL20	IMS08-E02		W01C090I03	pDONR221			TRA@	6955											
IKAKEN	CS0DM012YL20	IMS08-E02		W01C090I04	pDONR221			TRA@	6955											
IKAKEN	CS0DD006YA23	IMS08-E03		W01C090I05	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DD006YA23	IMS08-E03		W01C090I06	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DC001YC19	IMS08-E04		W01C090I07	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DC001YC19	IMS08-E04		W01C090I08	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C090I09	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C090I10	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DI070YC14	IMS08-E06		W01C090I11	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DI070YC14	IMS08-E06		W01C090I12	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DB001YP17	IMS08-E07		W01C090I13	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DB001YP17	IMS08-E07		W01C090I14	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C090I15	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C090I16	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C090I17	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C090I18	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DC009YK24	IMS08-E10		W01C090I19	pDONR221				390566											
IKAKEN	CS0DC009YK24	IMS08-E10		W01C090I20	pDONR221				390566											
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C090I21	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C090I22	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DE003YD13	IMS08-E12		W01C090I23	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CS0DE003YD13	IMS08-E12		W01C090I24	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CS0DE005YP01	IMS08-E01		W01C090J01	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DE005YP01	IMS08-E01		W01C090J02	pDONR221			RAB5B	5869		Hs.567328	RAB5B, member RAS oncogene family						NM_002868.2	NP_002859.1	VALIDATED		0.500	0.500	8	255	140	163	215	206	213
IKAKEN	CS0DM012YL20	IMS08-E02		W01C090J03	pDONR221			TRA@	6955											
IKAKEN	CS0DM012YL20	IMS08-E02		W01C090J04	pDONR221			TRA@	6955											
IKAKEN	CS0DD006YA23	IMS08-E03		W01C090J05	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DD006YA23	IMS08-E03		W01C090J06	pDONR221			LYSMD1	388695		Hs.591482	LysM, putative peptidoglycan-binding, domain containing 1						NM_001136543.1	NP_001130015.1	VALIDATED	P	1.000	1.000	25	255	181	255	179	13	37
IKAKEN	CS0DC001YC19	IMS08-E04		W01C090J07	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DC001YC19	IMS08-E04		W01C090J08	pDONR221			FLJ25076	134111		Hs.126856	Probable ubiquitin-conjugating enzyme E2 FLJ25076						NM_001145161.1	NP_001138633.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	161	1	85
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C090J09	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DJ013YG07	IMS08-E05		W01C090J10	pDONR221			LOC25845	25845		Hs.719132	Hypothetical LOC25845																		
IKAKEN	CS0DI070YC14	IMS08-E06		W01C090J11	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DI070YC14	IMS08-E06		W01C090J12	pDONR221			YRDC	79693		Hs.301564	YrdC domain containing (E. coli)						NM_024640.3	NP_078916.3	VALIDATED	P	1.000	1.000	85	255	1	255	279	10	94
IKAKEN	CS0DB001YP17	IMS08-E07		W01C090J13	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DB001YP17	IMS08-E07		W01C090J14	pDONR221			KCTD12	115207		Hs.644125	Potassium channel tetramerisation domain containing 12						NM_138444.3	NP_612453.1	VALIDATED	P	1.000	1.000	85	255	1	255	325	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C090J15	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF030YO02	IMS08-E08		W01C090J16	pDONR221			ADAT2	134637		Hs.709561	Adenosine deaminase, tRNA-specific 2, TAD2 homolog (S. cerevisiae)						NM_182503.2	NP_872309.2	VALIDATED	P	1.000	1.000	85	255	1	255	191	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C090J17	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DF015YH19	IMS08-E09		W01C090J18	pDONR221			DPYSL4	10570		Hs.100058	Dihydropyrimidinase-like 4						NM_006426.2	NP_006417.2	VALIDATED	P	1.000	1.000	85	255	1	255	572	1	85
IKAKEN	CS0DC009YK24	IMS08-E10		W01C090J19	pDONR221				390566											
IKAKEN	CS0DC009YK24	IMS08-E10		W01C090J20	pDONR221				390566											
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C090J21	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DJ006YP06	IMS08-E11		W01C090J22	pDONR221			FAM78B	149297		Hs.493518	Family with sequence similarity 78, member B						NM_001017961.2	NP_001017961.1	PREDICTED	P	1.000	1.000	57	255	85	255	261	1	57
IKAKEN	CS0DE003YD13	IMS08-E12		W01C090J23	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CS0DE003YD13	IMS08-E12		W01C090J24	pDONR221			CCDC149	91050		Hs.106432	Coiled-coil domain containing 149						NM_001130726.1	NP_001124198.1	VALIDATED	P	1.000	1.000	85	255	1	255	529	56	140
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C090K01	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C090K02	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C090K03	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C090K04	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C090K05	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C090K06	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C090K07	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C090K08	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C090K09	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C090K10	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C090K11	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C090K12	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C090K13	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C090K14	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C090K15	pDONR221															
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C090K16	pDONR221															
IKAKEN	CS0DC003YP09	IMS08-F09		W01C090K17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DC003YP09	IMS08-F09		W01C090K18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C090K19	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C090K20	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C090K21	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C090K22	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC022YA12	IMS08-F12		W01C090K23	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CS0DC022YA12	IMS08-F12		W01C090K24	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C090L01	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BB027ZG09	IMS08-F01		W01C090L02	pDONR221			PRKRIR	5612		Hs.503315	Protein-kinase, interferon-inducible double stranded RNA dependent inhibitor, repressor of (P58 repressor)						NM_004705.2	NP_004696.2	PROVISIONAL	P	1.000	1.000	85	255	1	255	761	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C090L03	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CL0BA008ZB06	IMS08-F02		W01C090L04	pDONR221			AGTRAP	57085		Hs.464438	Angiotensin II receptor-associated protein						NM_001040194.1	NP_001035284.1	REVIEWED	P	1.000	1.000	85	255	1	255	152	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C090L05	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DB005YD19	IMS08-F03		W01C090L06	pDONR221			HTR1E	3354		Hs.1611	5-hydroxytryptamine (serotonin) receptor 1E						NM_000865.2	NP_000856.1	VALIDATED	P	1.000	1.000	85	255	1	255	365	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C090L07	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DI029YH14	IMS08-F04		W01C090L08	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	P	1.000	1.000	85	255	1	255	582	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C090L09	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DL012YG01	IMS08-F05		W01C090L10	pDONR221			TMEM218	219854		Hs.7626	Transmembrane protein 218						NM_001080546.1	NP_001074015.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	115	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C090L11	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DF015YL24	IMS08-F06		W01C090L12	pDONR221			FAM19A1	407738		Hs.655061	Family with sequence similarity 19 (chemokine (C-C motif)-like), member A1						NM_213609.2	NP_998774.2	REVIEWED	P	1.000	1.000	85	255	1	255	133	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C090L13	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DC011YL11	IMS08-F07		W01C090L14	pDONR221			TBC1D9B	23061		Hs.155829	TBC1 domain family, member 9B (with GRAM domain)						NM_198868.2	NP_942568.2	VALIDATED	P	1.000	1.000	85	255	1	255	1250	1	85
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C090L15	pDONR221															
IKAKEN	CS0DI085YJ24	IMS08-F08		W01C090L16	pDONR221															
IKAKEN	CS0DC003YP09	IMS08-F09		W01C090L17	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DC003YP09	IMS08-F09		W01C090L18	pDONR221			PCGF3	10336		Hs.144309	Polycomb group ring finger 3						NM_006315.4	NP_006306.2	REVIEWED	P	1.000	1.000	85	255	1	255	242	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C090L19	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DK007YH03	IMS08-F10		W01C090L20	pDONR221			DFNB31	25861		Hs.93836	Deafness, autosomal recessive 31						NM_015404.2	NP_056219.2	VALIDATED	P	1.000	1.000	85	255	1	255	907	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C090L21	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC007YE05	IMS08-F11		W01C090L22	pDONR221			NUBP1	4682		Hs.81469	Nucleotide binding protein 1 (MinD homolog, E. coli)						NM_002484.2	NP_002475.2	VALIDATED	P	1.000	1.000	85	255	1	255	320	1	85
IKAKEN	CS0DC022YA12	IMS08-F12		W01C090L23	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CS0DC022YA12	IMS08-F12		W01C090L24	pDONR221			DNA2	1763		Hs.532446	DNA replication helicase 2 homolog (yeast)						NM_001080449.1	NP_001073918.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	1146	87	171
IKAKEN	CS0DD007YK20	IMS08-G01		W01C090M01	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DD007YK20	IMS08-G01		W01C090M02	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C090M03	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C090M04	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C090M05	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C090M06	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C090M07	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C090M08	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C090M09	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C090M10	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DF029YK03	IMS08-G06		W01C090M11	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DF029YK03	IMS08-G06		W01C090M12	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C090M13	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C090M14	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C090M15	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C090M16	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DN005YL22	IMS08-G09		W01C090M17	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DN005YL22	IMS08-G09		W01C090M18	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DI022YK16	IMS08-G10		W01C090M19	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	CS0DI022YK16	IMS08-G10		W01C090M20	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	SK002H02	IMS08-G11	IMS	W01C090M21	pDONR221															
IKAKEN	SK002H02	IMS08-G11	IMS	W01C090M22	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C090M23	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C090M24	pDONR221															
IKAKEN	CS0DD007YK20	IMS08-G01		W01C090N01	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DD007YK20	IMS08-G01		W01C090N02	pDONR221			LRCH1	23143		Hs.656722	Leucine-rich repeats and calponin homology (CH) domain containing 1						NM_015116.1	NP_055931.1	PROVISIONAL	P	1.000	1.000	85	255	1	255	728	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C090N03	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI003YE17	IMS08-G02		W01C090N04	pDONR221			SMPDL3B	27293		Hs.123659	Sphingomyelin phosphodiesterase, acid-like 3B						NM_014474.2	NP_055289.2	VALIDATED	P	1.000	1.000	85	255	1	255	455	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C090N05	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DI041YN13	IMS08-G03		W01C090N06	pDONR221			RBM43	375287		Hs.302442	RNA binding motif protein 43						NM_198557.2	NP_940959.1	VALIDATED	P	1.000	1.000	85	255	1	255	357	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C090N07	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DE003YE02	IMS08-G04		W01C090N08	pDONR221			MRM1	79922		Hs.194864	Mitochondrial rRNA methyltransferase 1 homolog (S. cerevisiae)						NM_024864.3	NP_079140.2	VALIDATED	P	1.000	1.000	85	255	1	255	353	1	85
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C090N09	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DA004YJ22	IMS08-G05		W01C090N10	pDONR221			FNTA	2339		Hs.370312	Farnesyltransferase, CAAX box, alpha						NM_001018677.1	NP_001018197.1	REVIEWED	P	1.000	1.000	67	255	1	201	312	1	67
IKAKEN	CS0DF029YK03	IMS08-G06		W01C090N11	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DF029YK03	IMS08-G06		W01C090N12	pDONR221			TENC1	23371		Hs.6147	Tensin like C1 domain containing phosphatase (tensin 2)						NM_198316.1	NP_938072.1	REVIEWED	P	1.000	1.000	85	255	1	255	1285	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C090N13	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DC018YB08	IMS08-G07		W01C090N14	pDONR221			BRAP	8315		Hs.530940	BRCA1 associated protein						NM_006768.3	NP_006759.3	REVIEWED	P	1.000	1.000	85	255	1	255	592	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C090N15	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DF031YJ19	IMS08-G08		W01C090N16	pDONR221			VANGL2	57216		Hs.99477	Vang-like 2 (van gogh, Drosophila)						NM_020335.1	NP_065068.1	VALIDATED	P	1.000	1.000	85	255	1	255	521	1	85
IKAKEN	CS0DN005YL22	IMS08-G09		W01C090N17	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DN005YL22	IMS08-G09		W01C090N18	pDONR221			CMPK2	129607		Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial						NM_207315.2	NP_997198.2	VALIDATED	P	1.000	1.000	59	180	1	177	449	391	449
IKAKEN	CS0DI022YK16	IMS08-G10		W01C090N19	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	CS0DI022YK16	IMS08-G10		W01C090N20	pDONR221			SF3A3	10946		Hs.77897	Splicing factor 3a, subunit 3, 60kDa						NM_006802.2	NP_006793.1	REVIEWED		0.894	0.894	85	255	1	255	501	51	135
IKAKEN	SK002H02	IMS08-G11	IMS	W01C090N21	pDONR221															
IKAKEN	SK002H02	IMS08-G11	IMS	W01C090N22	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C090N23	pDONR221															
IKAKEN	SK001A06	IMS08-G12	IMS	W01C090N24	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C090O01	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C090O02	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C090O03	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C090O04	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C090O05	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C090O06	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C090O07	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C090O08	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C090O09	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C090O10	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C090O11	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C090O12	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C090O13	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C090O14	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C090O15	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C090O16	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C090O17	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C090O18	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C090O19	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C090O20	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C090O21	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C090O22	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C090O23	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C090O24	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C090P01	pDONR221															
IKAKEN	SK001A07	IMS08-H01	IMS	W01C090P02	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C090P03	pDONR221															
IKAKEN	SK001A08	IMS08-H02	IMS	W01C090P04	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C090P05	pDONR221															
IKAKEN	SK001A09	IMS08-H03	IMS	W01C090P06	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C090P07	pDONR221															
IKAKEN	SK001A10	IMS08-H04	IMS	W01C090P08	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C090P09	pDONR221															
IKAKEN	SK001A11	IMS08-H05	IMS	W01C090P10	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C090P11	pDONR221															
IKAKEN	SK001A12	IMS08-H06	IMS	W01C090P12	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C090P13	pDONR221															
IKAKEN	SK001B05	IMS08-H07	IMS	W01C090P14	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C090P15	pDONR221															
IKAKEN	SK001B08	IMS08-H08	IMS	W01C090P16	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C090P17	pDONR221															
IKAKEN	SK001B09	IMS08-H09	IMS	W01C090P18	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C090P19	pDONR221															
IKAKEN	SK001B10	IMS08-H10	IMS	W01C090P20	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C090P21	pDONR221															
IKAKEN	SK001B12	IMS08-H11	IMS	W01C090P22	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C090P23	pDONR221															
IKAKEN	SK001C05	IMS08-H12	IMS	W01C090P24	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C091A01	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C091A02	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C091A03	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C091A04	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C091A05	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C091A06	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C091A07	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C091A08	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C091A09	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C091A10	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C091A11	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C091A12	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C091A13	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C091A14	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C091A15	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C091A16	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C091A17	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C091A18	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C091A19	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C091A20	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C091A21	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C091A22	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C091A23	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C091A24	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C091B01	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C091B02	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C091B03	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C091B04	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C091B05	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C091B06	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C091B07	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C091B08	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C091B09	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C091B10	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C091B11	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C091B12	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C091B13	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C091B14	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C091B15	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C091B16	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C091B17	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C091B18	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C091B19	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C091B20	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C091B21	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C091B22	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C091B23	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C091B24	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C091C01	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C091C02	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C091C03	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C091C04	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C091C05	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C091C06	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C091C07	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C091C08	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C091C09	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C091C10	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C091C11	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C091C12	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C091C13	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C091C14	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C091C15	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C091C16	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C091C17	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C091C18	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C091C19	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C091C20	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C091C21	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C091C22	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C091C23	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C091C24	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C091D01	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C091D02	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C091D03	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C091D04	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C091D05	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C091D06	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C091D07	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C091D08	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C091D09	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C091D10	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C091D11	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C091D12	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C091D13	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C091D14	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C091D15	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C091D16	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C091D17	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C091D18	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C091D19	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C091D20	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C091D21	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C091D22	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C091D23	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C091D24	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C091E01	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C091E02	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C091E03	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C091E04	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C091E05	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C091E06	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C091E07	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C091E08	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C091E09	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C091E10	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C091E11	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C091E12	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C091E13	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C091E14	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C091E15	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C091E16	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C091E17	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C091E18	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C091E19	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C091E20	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C091E21	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C091E22	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C091E23	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C091E24	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C091F01	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C091F02	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C091F03	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C091F04	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C091F05	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C091F06	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C091F07	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C091F08	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C091F09	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C091F10	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C091F11	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C091F12	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C091F13	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C091F14	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C091F15	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C091F16	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C091F17	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C091F18	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C091F19	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C091F20	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C091F21	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C091F22	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C091F23	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C091F24	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C091G01	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C091G02	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C091G03	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C091G04	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C091G05	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C091G06	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C091G07	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C091G08	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C091G09	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C091G10	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C091G11	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C091G12	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C091G13	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C091G14	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C091G15	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C091G16	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C091G17	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C091G18	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C091G19	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C091G20	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C091G21	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C091G22	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C091G23	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C091G24	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C091H01	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C091H02	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C091H03	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C091H04	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C091H05	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C091H06	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C091H07	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C091H08	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C091H09	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C091H10	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C091H11	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C091H12	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C091H13	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C091H14	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C091H15	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C091H16	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C091H17	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C091H18	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C091H19	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C091H20	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C091H21	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C091H22	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C091H23	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C091H24	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C091I01	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C091I02	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C091I03	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C091I04	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C091I05	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C091I06	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C091I07	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C091I08	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C091I09	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C091I10	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C091I11	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C091I12	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C091I13	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C091I14	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C091I15	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C091I16	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C091I17	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C091I18	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C091I19	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C091I20	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C091I21	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C091I22	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C091I23	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C091I24	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C091J01	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C091J02	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C091J03	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C091J04	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C091J05	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C091J06	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C091J07	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C091J08	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C091J09	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C091J10	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C091J11	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C091J12	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C091J13	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C091J14	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C091J15	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C091J16	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C091J17	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C091J18	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C091J19	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C091J20	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C091J21	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C091J22	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C091J23	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C091J24	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C091K01	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C091K02	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C091K03	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C091K04	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C091K05	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C091K06	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C091K07	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C091K08	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C091K09	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C091K10	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C091K11	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C091K12	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C091K13	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C091K14	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C091K15	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C091K16	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C091K17	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C091K18	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C091K19	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C091K20	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C091K21	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C091K22	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C091K23	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C091K24	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C091L01	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C091L02	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C091L03	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C091L04	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C091L05	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C091L06	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C091L07	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C091L08	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C091L09	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C091L10	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C091L11	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C091L12	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C091L13	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C091L14	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C091L15	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C091L16	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C091L17	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C091L18	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C091L19	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C091L20	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C091L21	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C091L22	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C091L23	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C091L24	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C091M01	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C091M02	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C091M03	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C091M04	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C091M05	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C091M06	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C091M07	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C091M08	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C091M09	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C091M10	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C091M11	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C091M12	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C091M13	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C091M14	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C091M15	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C091M16	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C091M17	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C091M18	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C091M19	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C091M20	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C091M21	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C091M22	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C091M23	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C091M24	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C091N01	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C091N02	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C091N03	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C091N04	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C091N05	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C091N06	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C091N07	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C091N08	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C091N09	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C091N10	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C091N11	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C091N12	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C091N13	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C091N14	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C091N15	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C091N16	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C091N17	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C091N18	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C091N19	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C091N20	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C091N21	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C091N22	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C091N23	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C091N24	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C091O01	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C091O02	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C091O03	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C091O04	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C091O05	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C091O06	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C091O07	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C091O08	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C091O09	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C091O10	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C091O11	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C091O12	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C091O13	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C091O14	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C091O15	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C091O16	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C091O17	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C091O18	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C091O19	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C091O20	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C091O21	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C091O22	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C091O23	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C091O24	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C091P01	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C091P02	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C091P03	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C091P04	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C091P05	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C091P06	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C091P07	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C091P08	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C091P09	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C091P10	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C091P11	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C091P12	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C091P13	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C091P14	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C091P15	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C091P16	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C091P17	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C091P18	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C091P19	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C091P20	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C091P21	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C091P22	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C091P23	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C091P24	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C092A01	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C092A02	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C092A03	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C092A04	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C092A05	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C092A06	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C092A07	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C092A08	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C092A09	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C092A10	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C092A11	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C092A12	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C092A13	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C092A14	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C092A15	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C092A16	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C092A17	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C092A18	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C092A19	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C092A20	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C092A21	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C092A22	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C092A23	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C092A24	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C092B01	pDONR221															
IKAKEN	SK001C06	IMS09-A01	IMS	W01C092B02	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C092B03	pDONR221															
IKAKEN	SK001C08	IMS09-A02	IMS	W01C092B04	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C092B05	pDONR221															
IKAKEN	SK001C09	IMS09-A03	IMS	W01C092B06	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C092B07	pDONR221															
IKAKEN	SK001C10	IMS09-A04	IMS	W01C092B08	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C092B09	pDONR221															
IKAKEN	SK001C11	IMS09-A05	IMS	W01C092B10	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C092B11	pDONR221															
IKAKEN	SK001C12	IMS09-A06	IMS	W01C092B12	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C092B13	pDONR221															
IKAKEN	SK001D05	IMS09-A07	IMS	W01C092B14	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C092B15	pDONR221															
IKAKEN	SK001D06	IMS09-A08	IMS	W01C092B16	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C092B17	pDONR221															
IKAKEN	SK001D07	IMS09-A09	IMS	W01C092B18	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C092B19	pDONR221															
IKAKEN	SK001D08	IMS09-A10	IMS	W01C092B20	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C092B21	pDONR221															
IKAKEN	SK001D09	IMS09-A11	IMS	W01C092B22	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C092B23	pDONR221															
IKAKEN	SK001D10	IMS09-A12	IMS	W01C092B24	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C092C01	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C092C02	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C092C03	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C092C04	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C092C05	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C092C06	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C092C07	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C092C08	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C092C09	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C092C10	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C092C11	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C092C12	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C092C13	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C092C14	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C092C15	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C092C16	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C092C17	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C092C18	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C092C19	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C092C20	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C092C21	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C092C22	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C092C23	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C092C24	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C092D01	pDONR221															
IKAKEN	SK001D11	IMS09-B01	IMS	W01C092D02	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C092D03	pDONR221															
IKAKEN	SK001D12	IMS09-B02	IMS	W01C092D04	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C092D05	pDONR221															
IKAKEN	SK001E05	IMS09-B03	IMS	W01C092D06	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C092D07	pDONR221															
IKAKEN	SK001E06	IMS09-B04	IMS	W01C092D08	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C092D09	pDONR221															
IKAKEN	SK001E07	IMS09-B05	IMS	W01C092D10	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C092D11	pDONR221															
IKAKEN	SK001E07	IMS09-B06	IMS	W01C092D12	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C092D13	pDONR221															
IKAKEN	SK001E08	IMS09-B07	IMS	W01C092D14	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C092D15	pDONR221															
IKAKEN	SK001E09	IMS09-B08	IMS	W01C092D16	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C092D17	pDONR221															
IKAKEN	SK001E10	IMS09-B09	IMS	W01C092D18	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C092D19	pDONR221															
IKAKEN	SK001E11	IMS09-B10	IMS	W01C092D20	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C092D21	pDONR221															
IKAKEN	SK001F05	IMS09-B11	IMS	W01C092D22	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C092D23	pDONR221															
IKAKEN	SK001F07	IMS09-B12	IMS	W01C092D24	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C092E01	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C092E02	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C092E03	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C092E04	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C092E05	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C092E06	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C092E07	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C092E08	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C092E09	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C092E10	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C092E11	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C092E12	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C092E13	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C092E14	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C092E15	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C092E16	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C092E17	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C092E18	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C092E19	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C092E20	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C092E21	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C092E22	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C092E23	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C092E24	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C092F01	pDONR221															
IKAKEN	SK001F08	IMS09-C01	IMS	W01C092F02	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C092F03	pDONR221															
IKAKEN	SK001F09	IMS09-C02	IMS	W01C092F04	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C092F05	pDONR221															
IKAKEN	SK001F10	IMS09-C03	IMS	W01C092F06	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C092F07	pDONR221															
IKAKEN	SK001F11	IMS09-C04	IMS	W01C092F08	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C092F09	pDONR221															
IKAKEN	SK001F12	IMS09-C05	IMS	W01C092F10	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C092F11	pDONR221															
IKAKEN	SK001G04	IMS09-C06	IMS	W01C092F12	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C092F13	pDONR221															
IKAKEN	SK001G05	IMS09-C07	IMS	W01C092F14	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C092F15	pDONR221															
IKAKEN	SK001G06	IMS09-C08	IMS	W01C092F16	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C092F17	pDONR221															
IKAKEN	SK001G07	IMS09-C09	IMS	W01C092F18	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C092F19	pDONR221															
IKAKEN	SK001G09	IMS09-C10	IMS	W01C092F20	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C092F21	pDONR221															
IKAKEN	SK001G10	IMS09-C11	IMS	W01C092F22	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C092F23	pDONR221															
IKAKEN	SK001G11	IMS09-C12	IMS	W01C092F24	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C092G01	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C092G02	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C092G03	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C092G04	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C092G05	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C092G06	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C092G07	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C092G08	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C092G09	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C092G10	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C092G11	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C092G12	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C092G13	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C092G14	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C092G15	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C092G16	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C092G17	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C092G18	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C092G19	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C092G20	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C092G21	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C092G22	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C092G23	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C092G24	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C092H01	pDONR221															
IKAKEN	SK001H04	IMS09-D01	IMS	W01C092H02	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C092H03	pDONR221															
IKAKEN	SK001H05	IMS09-D02	IMS	W01C092H04	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C092H05	pDONR221															
IKAKEN	SK001H06	IMS09-D03	IMS	W01C092H06	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C092H07	pDONR221															
IKAKEN	SK001H07	IMS09-D04	IMS	W01C092H08	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C092H09	pDONR221															
IKAKEN	SK001H08	IMS09-D05	IMS	W01C092H10	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C092H11	pDONR221															
IKAKEN	SK001H09	IMS09-D06	IMS	W01C092H12	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C092H13	pDONR221															
IKAKEN	SK001H10	IMS09-D07	IMS	W01C092H14	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C092H15	pDONR221															
IKAKEN	SK001H11	IMS09-D08	IMS	W01C092H16	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C092H17	pDONR221															
IKAKEN	SK001H12	IMS09-D09	IMS	W01C092H18	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C092H19	pDONR221															
IKAKEN	SK002A02	IMS09-D10	IMS	W01C092H20	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C092H21	pDONR221															
IKAKEN	SK002A03	IMS09-D11	IMS	W01C092H22	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C092H23	pDONR221															
IKAKEN	SK002A04	IMS09-D12	IMS	W01C092H24	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C092I01	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C092I02	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C092I03	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C092I04	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C092I05	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C092I06	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C092I07	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C092I08	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C092I09	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C092I10	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C092I11	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C092I12	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C092I13	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C092I14	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C092I15	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C092I16	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C092I17	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C092I18	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C092I19	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C092I20	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C092I21	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C092I22	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C092I23	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C092I24	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C092J01	pDONR221															
IKAKEN	SK002A05	IMS09-E01	IMS	W01C092J02	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C092J03	pDONR221															
IKAKEN	SK002A07	IMS09-E02	IMS	W01C092J04	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C092J05	pDONR221															
IKAKEN	SK002A08	IMS09-E03	IMS	W01C092J06	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C092J07	pDONR221															
IKAKEN	SK002A09	IMS09-E04	IMS	W01C092J08	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C092J09	pDONR221															
IKAKEN	SK002A11	IMS09-E05	IMS	W01C092J10	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C092J11	pDONR221															
IKAKEN	SK002B02	IMS09-E06	IMS	W01C092J12	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C092J13	pDONR221															
IKAKEN	SK002B04	IMS09-E07	IMS	W01C092J14	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C092J15	pDONR221															
IKAKEN	SK002B05	IMS09-E08	IMS	W01C092J16	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C092J17	pDONR221															
IKAKEN	SK002B06	IMS09-E09	IMS	W01C092J18	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C092J19	pDONR221															
IKAKEN	SK002B06	IMS09-E10	IMS	W01C092J20	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C092J21	pDONR221															
IKAKEN	SK002B07	IMS09-E11	IMS	W01C092J22	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C092J23	pDONR221															
IKAKEN	SK002B08	IMS09-E12	IMS	W01C092J24	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C092K01	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C092K02	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C092K03	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C092K04	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C092K05	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C092K06	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C092K07	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C092K08	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C092K09	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C092K10	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C092K11	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C092K12	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C092K13	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C092K14	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C092K15	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C092K16	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C092K17	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C092K18	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C092K19	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C092K20	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C092K21	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C092K22	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C092K23	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C092K24	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C092L01	pDONR221															
IKAKEN	SK002B09	IMS09-F01	IMS	W01C092L02	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C092L03	pDONR221															
IKAKEN	SK002B10	IMS09-F02	IMS	W01C092L04	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C092L05	pDONR221															
IKAKEN	SK002B11	IMS09-F03	IMS	W01C092L06	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C092L07	pDONR221															
IKAKEN	SK002B12	IMS09-F04	IMS	W01C092L08	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C092L09	pDONR221															
IKAKEN	SK002C02	IMS09-F05	IMS	W01C092L10	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C092L11	pDONR221															
IKAKEN	SK002C03	IMS09-F06	IMS	W01C092L12	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C092L13	pDONR221															
IKAKEN	SK002C04	IMS09-F07	IMS	W01C092L14	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C092L15	pDONR221															
IKAKEN	SK002C05	IMS09-F08	IMS	W01C092L16	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C092L17	pDONR221															
IKAKEN	SK002C07	IMS09-F09	IMS	W01C092L18	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C092L19	pDONR221															
IKAKEN	SK002C08	IMS09-F10	IMS	W01C092L20	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C092L21	pDONR221															
IKAKEN	SK002C09	IMS09-F11	IMS	W01C092L22	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C092L23	pDONR221															
IKAKEN	SK002C10	IMS09-F12	IMS	W01C092L24	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C092M01	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C092M02	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C092M03	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C092M04	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C092M05	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C092M06	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C092M07	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C092M08	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C092M09	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C092M10	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C092M11	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C092M12	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C092M13	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C092M14	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C092M15	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C092M16	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C092M17	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C092M18	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C092M19	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C092M20	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C092M21	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C092M22	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C092M23	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C092M24	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C092N01	pDONR221															
IKAKEN	SK002C11	IMS09-G01	IMS	W01C092N02	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C092N03	pDONR221															
IKAKEN	SK002C12	IMS09-G02	IMS	W01C092N04	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C092N05	pDONR221															
IKAKEN	SK002D02	IMS09-G03	IMS	W01C092N06	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C092N07	pDONR221															
IKAKEN	SK002D03	IMS09-G04	IMS	W01C092N08	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C092N09	pDONR221															
IKAKEN	SK002D05	IMS09-G05	IMS	W01C092N10	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C092N11	pDONR221															
IKAKEN	SK002D05	IMS09-G06	IMS	W01C092N12	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C092N13	pDONR221															
IKAKEN	SK002D05	IMS09-G07	IMS	W01C092N14	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C092N15	pDONR221															
IKAKEN	SK002D06	IMS09-G08	IMS	W01C092N16	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C092N17	pDONR221															
IKAKEN	SK002D08	IMS09-G09	IMS	W01C092N18	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C092N19	pDONR221															
IKAKEN	SK002D08	IMS09-G10	IMS	W01C092N20	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C092N21	pDONR221															
IKAKEN	SK002D09	IMS09-G11	IMS	W01C092N22	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C092N23	pDONR221															
IKAKEN	SK002D10	IMS09-G12	IMS	W01C092N24	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C092O01	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C092O02	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C092O03	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C092O04	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C092O05	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C092O06	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C092O07	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C092O08	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C092O09	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C092O10	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C092O11	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C092O12	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C092O13	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C092O14	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C092O15	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C092O16	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C092O17	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C092O18	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C092O19	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C092O20	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C092O21	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C092O22	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C092O23	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C092O24	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C092P01	pDONR221															
IKAKEN	SK002D12	IMS09-H01	IMS	W01C092P02	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C092P03	pDONR221															
IKAKEN	SK002E02	IMS09-H02	IMS	W01C092P04	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C092P05	pDONR221															
IKAKEN	SK002E03	IMS09-H03	IMS	W01C092P06	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C092P07	pDONR221															
IKAKEN	SK002E06	IMS09-H04	IMS	W01C092P08	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C092P09	pDONR221															
IKAKEN	SK002E06	IMS09-H05	IMS	W01C092P10	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C092P11	pDONR221															
IKAKEN	SK002E08	IMS09-H06	IMS	W01C092P12	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C092P13	pDONR221															
IKAKEN	SK002E09	IMS09-H07	IMS	W01C092P14	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C092P15	pDONR221															
IKAKEN	SK002E10	IMS09-H08	IMS	W01C092P16	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C092P17	pDONR221															
IKAKEN	SK002F02	IMS09-H09	IMS	W01C092P18	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C092P19	pDONR221															
IKAKEN	SK002F05	IMS09-H10	IMS	W01C092P20	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C092P21	pDONR221															
IKAKEN	SK002F06	IMS09-H11	IMS	W01C092P22	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C092P23	pDONR221															
IKAKEN	SK002F08	IMS09-H12	IMS	W01C092P24	pDONR221															
IKAKEN	AK123023	IMS10-A01	FLJ	W01C093A01	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK123023	IMS10-A01	FLJ	W01C093A02	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK122666	IMS10-A02	FLJ	W01C093A03	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK122666	IMS10-A02	FLJ	W01C093A04	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK124332	IMS10-A03	FLJ	W01C093A05	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK124332	IMS10-A03	FLJ	W01C093A06	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK123039	IMS10-A04	FLJ	W01C093A07	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK123039	IMS10-A04	FLJ	W01C093A08	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK125341	IMS10-A05	FLJ	W01C093A09	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125341	IMS10-A05	FLJ	W01C093A10	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125722	IMS10-A06	FLJ	W01C093A11	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK125722	IMS10-A06	FLJ	W01C093A12	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK124111	IMS10-A07	FLJ	W01C093A13	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK124111	IMS10-A07	FLJ	W01C093A14	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK125151	IMS10-A08	FLJ	W01C093A15	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK125151	IMS10-A08	FLJ	W01C093A16	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK123041	IMS10-A09	FLJ	W01C093A17	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123041	IMS10-A09	FLJ	W01C093A18	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123974	IMS10-A10	FLJ	W01C093A19	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK123974	IMS10-A10	FLJ	W01C093A20	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK125726	IMS10-A11	FLJ	W01C093A21	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125726	IMS10-A11	FLJ	W01C093A22	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125266	IMS10-A12	FLJ	W01C093A23	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK125266	IMS10-A12	FLJ	W01C093A24	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK123023	IMS10-A01	FLJ	W01C093B01	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK123023	IMS10-A01	FLJ	W01C093B02	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK122666	IMS10-A02	FLJ	W01C093B03	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK122666	IMS10-A02	FLJ	W01C093B04	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK124332	IMS10-A03	FLJ	W01C093B05	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK124332	IMS10-A03	FLJ	W01C093B06	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK123039	IMS10-A04	FLJ	W01C093B07	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK123039	IMS10-A04	FLJ	W01C093B08	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK125341	IMS10-A05	FLJ	W01C093B09	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125341	IMS10-A05	FLJ	W01C093B10	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125722	IMS10-A06	FLJ	W01C093B11	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK125722	IMS10-A06	FLJ	W01C093B12	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK124111	IMS10-A07	FLJ	W01C093B13	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK124111	IMS10-A07	FLJ	W01C093B14	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK125151	IMS10-A08	FLJ	W01C093B15	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK125151	IMS10-A08	FLJ	W01C093B16	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK123041	IMS10-A09	FLJ	W01C093B17	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123041	IMS10-A09	FLJ	W01C093B18	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123974	IMS10-A10	FLJ	W01C093B19	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK123974	IMS10-A10	FLJ	W01C093B20	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK125726	IMS10-A11	FLJ	W01C093B21	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125726	IMS10-A11	FLJ	W01C093B22	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125266	IMS10-A12	FLJ	W01C093B23	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK125266	IMS10-A12	FLJ	W01C093B24	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK123854	IMS10-B01	FLJ	W01C093C01	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK123854	IMS10-B01	FLJ	W01C093C02	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK125364	IMS10-B02	FLJ	W01C093C03	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125364	IMS10-B02	FLJ	W01C093C04	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125535	IMS10-B03	FLJ	W01C093C05	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK125535	IMS10-B03	FLJ	W01C093C06	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK123987	IMS10-B04	FLJ	W01C093C07	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK123987	IMS10-B04	FLJ	W01C093C08	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK124659	IMS10-B05	FLJ	W01C093C09	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK124659	IMS10-B05	FLJ	W01C093C10	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK125206	IMS10-B06	FLJ	W01C093C11	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125206	IMS10-B06	FLJ	W01C093C12	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125227	IMS10-B07	FLJ	W01C093C13	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125227	IMS10-B07	FLJ	W01C093C14	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125347	IMS10-B08	FLJ	W01C093C15	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125347	IMS10-B08	FLJ	W01C093C16	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125353	IMS10-B09	FLJ	W01C093C17	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125353	IMS10-B09	FLJ	W01C093C18	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125494	IMS10-B10	FLJ	W01C093C19	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK125494	IMS10-B10	FLJ	W01C093C20	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK124127	IMS10-B11	FLJ	W01C093C21	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK124127	IMS10-B11	FLJ	W01C093C22	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK125740	IMS10-B12	FLJ	W01C093C23	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK125740	IMS10-B12	FLJ	W01C093C24	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK123854	IMS10-B01	FLJ	W01C093D01	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK123854	IMS10-B01	FLJ	W01C093D02	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK125364	IMS10-B02	FLJ	W01C093D03	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125364	IMS10-B02	FLJ	W01C093D04	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125535	IMS10-B03	FLJ	W01C093D05	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK125535	IMS10-B03	FLJ	W01C093D06	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK123987	IMS10-B04	FLJ	W01C093D07	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK123987	IMS10-B04	FLJ	W01C093D08	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK124659	IMS10-B05	FLJ	W01C093D09	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK124659	IMS10-B05	FLJ	W01C093D10	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK125206	IMS10-B06	FLJ	W01C093D11	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125206	IMS10-B06	FLJ	W01C093D12	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125227	IMS10-B07	FLJ	W01C093D13	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125227	IMS10-B07	FLJ	W01C093D14	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125347	IMS10-B08	FLJ	W01C093D15	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125347	IMS10-B08	FLJ	W01C093D16	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125353	IMS10-B09	FLJ	W01C093D17	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125353	IMS10-B09	FLJ	W01C093D18	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125494	IMS10-B10	FLJ	W01C093D19	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK125494	IMS10-B10	FLJ	W01C093D20	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK124127	IMS10-B11	FLJ	W01C093D21	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK124127	IMS10-B11	FLJ	W01C093D22	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK125740	IMS10-B12	FLJ	W01C093D23	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK125740	IMS10-B12	FLJ	W01C093D24	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK125744	IMS10-C01	FLJ	W01C093E01	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK125744	IMS10-C01	FLJ	W01C093E02	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK124162	IMS10-C02	FLJ	W01C093E03	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK124162	IMS10-C02	FLJ	W01C093E04	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK126134	IMS10-C03	FLJ	W01C093E05	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK126134	IMS10-C03	FLJ	W01C093E06	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK123597	IMS10-C04	FLJ	W01C093E07	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123597	IMS10-C04	FLJ	W01C093E08	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123600	IMS10-C05	FLJ	W01C093E09	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123600	IMS10-C05	FLJ	W01C093E10	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123643	IMS10-C06	FLJ	W01C093E11	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK123643	IMS10-C06	FLJ	W01C093E12	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK125308	IMS10-C07	FLJ	W01C093E13	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK125308	IMS10-C07	FLJ	W01C093E14	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK123995	IMS10-C08	FLJ	W01C093E15	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK123995	IMS10-C08	FLJ	W01C093E16	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C093E17	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C093E18	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124059	IMS10-C10	FLJ	W01C093E19	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124059	IMS10-C10	FLJ	W01C093E20	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124141	IMS10-C11	FLJ	W01C093E21	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124141	IMS10-C11	FLJ	W01C093E22	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C093E23	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C093E24	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK125744	IMS10-C01	FLJ	W01C093F01	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK125744	IMS10-C01	FLJ	W01C093F02	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK124162	IMS10-C02	FLJ	W01C093F03	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK124162	IMS10-C02	FLJ	W01C093F04	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK126134	IMS10-C03	FLJ	W01C093F05	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK126134	IMS10-C03	FLJ	W01C093F06	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK123597	IMS10-C04	FLJ	W01C093F07	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123597	IMS10-C04	FLJ	W01C093F08	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123600	IMS10-C05	FLJ	W01C093F09	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123600	IMS10-C05	FLJ	W01C093F10	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123643	IMS10-C06	FLJ	W01C093F11	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK123643	IMS10-C06	FLJ	W01C093F12	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK125308	IMS10-C07	FLJ	W01C093F13	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK125308	IMS10-C07	FLJ	W01C093F14	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK123995	IMS10-C08	FLJ	W01C093F15	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK123995	IMS10-C08	FLJ	W01C093F16	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C093F17	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C093F18	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124059	IMS10-C10	FLJ	W01C093F19	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124059	IMS10-C10	FLJ	W01C093F20	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124141	IMS10-C11	FLJ	W01C093F21	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124141	IMS10-C11	FLJ	W01C093F22	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C093F23	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C093F24	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK126170	IMS10-D01	FLJ	W01C093G01	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK126170	IMS10-D01	FLJ	W01C093G02	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK124214	IMS10-D02	FLJ	W01C093G03	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK124214	IMS10-D02	FLJ	W01C093G04	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK126174	IMS10-D03	FLJ	W01C093G05	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK126174	IMS10-D03	FLJ	W01C093G06	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK123281	IMS10-D04	FLJ	W01C093G07	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123281	IMS10-D04	FLJ	W01C093G08	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123321	IMS10-D05	FLJ	W01C093G09	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123321	IMS10-D05	FLJ	W01C093G10	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123760	IMS10-D06	FLJ	W01C093G11	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123760	IMS10-D06	FLJ	W01C093G12	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123791	IMS10-D07	FLJ	W01C093G13	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123791	IMS10-D07	FLJ	W01C093G14	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123835	IMS10-D08	FLJ	W01C093G15	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK123835	IMS10-D08	FLJ	W01C093G16	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK125320	IMS10-D09	FLJ	W01C093G17	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125320	IMS10-D09	FLJ	W01C093G18	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125322	IMS10-D10	FLJ	W01C093G19	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125322	IMS10-D10	FLJ	W01C093G20	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125336	IMS10-D11	FLJ	W01C093G21	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK125336	IMS10-D11	FLJ	W01C093G22	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK122760	IMS10-D12	FLJ	W01C093G23	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-D12	FLJ	W01C093G24	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK126170	IMS10-D01	FLJ	W01C093H01	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK126170	IMS10-D01	FLJ	W01C093H02	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK124214	IMS10-D02	FLJ	W01C093H03	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK124214	IMS10-D02	FLJ	W01C093H04	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK126174	IMS10-D03	FLJ	W01C093H05	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK126174	IMS10-D03	FLJ	W01C093H06	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK123281	IMS10-D04	FLJ	W01C093H07	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123281	IMS10-D04	FLJ	W01C093H08	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123321	IMS10-D05	FLJ	W01C093H09	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123321	IMS10-D05	FLJ	W01C093H10	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123760	IMS10-D06	FLJ	W01C093H11	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123760	IMS10-D06	FLJ	W01C093H12	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123791	IMS10-D07	FLJ	W01C093H13	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123791	IMS10-D07	FLJ	W01C093H14	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123835	IMS10-D08	FLJ	W01C093H15	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK123835	IMS10-D08	FLJ	W01C093H16	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK125320	IMS10-D09	FLJ	W01C093H17	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125320	IMS10-D09	FLJ	W01C093H18	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125322	IMS10-D10	FLJ	W01C093H19	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125322	IMS10-D10	FLJ	W01C093H20	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125336	IMS10-D11	FLJ	W01C093H21	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK125336	IMS10-D11	FLJ	W01C093H22	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK122760	IMS10-D12	FLJ	W01C093H23	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-D12	FLJ	W01C093H24	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-E01	FLJ	W01C093I01	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-E01	FLJ	W01C093I02	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK125570	IMS10-E02	FLJ	W01C093I03	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK125570	IMS10-E02	FLJ	W01C093I04	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK124519	IMS10-E03	FLJ	W01C093I05	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124519	IMS10-E03	FLJ	W01C093I06	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124559	IMS10-E04	FLJ	W01C093I07	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124559	IMS10-E04	FLJ	W01C093I08	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124576	IMS10-E05	FLJ	W01C093I09	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	IMS10-E05	FLJ	W01C093I10	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124700	IMS10-E06	FLJ	W01C093I11	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124700	IMS10-E06	FLJ	W01C093I12	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124880	IMS10-E07	FLJ	W01C093I13	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK124880	IMS10-E07	FLJ	W01C093I14	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK125049	IMS10-E08	FLJ	W01C093I15	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125049	IMS10-E08	FLJ	W01C093I16	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125054	IMS10-E09	FLJ	W01C093I17	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125054	IMS10-E09	FLJ	W01C093I18	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125060	IMS10-E10	FLJ	W01C093I19	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125060	IMS10-E10	FLJ	W01C093I20	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125083	IMS10-E11	FLJ	W01C093I21	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125083	IMS10-E11	FLJ	W01C093I22	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125286	IMS10-E12	FLJ	W01C093I23	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK125286	IMS10-E12	FLJ	W01C093I24	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK122760	IMS10-E01	FLJ	W01C093J01	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-E01	FLJ	W01C093J02	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK125570	IMS10-E02	FLJ	W01C093J03	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK125570	IMS10-E02	FLJ	W01C093J04	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK124519	IMS10-E03	FLJ	W01C093J05	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124519	IMS10-E03	FLJ	W01C093J06	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124559	IMS10-E04	FLJ	W01C093J07	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124559	IMS10-E04	FLJ	W01C093J08	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124576	IMS10-E05	FLJ	W01C093J09	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	IMS10-E05	FLJ	W01C093J10	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124700	IMS10-E06	FLJ	W01C093J11	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124700	IMS10-E06	FLJ	W01C093J12	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124880	IMS10-E07	FLJ	W01C093J13	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK124880	IMS10-E07	FLJ	W01C093J14	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK125049	IMS10-E08	FLJ	W01C093J15	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125049	IMS10-E08	FLJ	W01C093J16	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125054	IMS10-E09	FLJ	W01C093J17	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125054	IMS10-E09	FLJ	W01C093J18	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125060	IMS10-E10	FLJ	W01C093J19	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125060	IMS10-E10	FLJ	W01C093J20	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125083	IMS10-E11	FLJ	W01C093J21	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125083	IMS10-E11	FLJ	W01C093J22	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125286	IMS10-E12	FLJ	W01C093J23	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK125286	IMS10-E12	FLJ	W01C093J24	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK122906	IMS10-F01	FLJ	W01C093K01	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK122906	IMS10-F01	FLJ	W01C093K02	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK124614	IMS10-F02	FLJ	W01C093K03	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124614	IMS10-F02	FLJ	W01C093K04	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124616	IMS10-F03	FLJ	W01C093K05	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124616	IMS10-F03	FLJ	W01C093K06	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124640	IMS10-F04	FLJ	W01C093K07	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124640	IMS10-F04	FLJ	W01C093K08	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124899	IMS10-F05	FLJ	W01C093K09	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK124899	IMS10-F05	FLJ	W01C093K10	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK125070	IMS10-F06	FLJ	W01C093K11	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK125070	IMS10-F06	FLJ	W01C093K12	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK126539	IMS10-F07	FLJ	W01C093K13	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126539	IMS10-F07	FLJ	W01C093K14	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C093K15	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C093K16	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK123024	IMS10-F09	FLJ	W01C093K17	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK123024	IMS10-F09	FLJ	W01C093K18	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK124446	IMS10-F10	FLJ	W01C093K19	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK124446	IMS10-F10	FLJ	W01C093K20	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK123348	IMS10-F11	FLJ	W01C093K21	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123348	IMS10-F11	FLJ	W01C093K22	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123957	IMS10-F12	FLJ	W01C093K23	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK123957	IMS10-F12	FLJ	W01C093K24	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK122906	IMS10-F01	FLJ	W01C093L01	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK122906	IMS10-F01	FLJ	W01C093L02	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK124614	IMS10-F02	FLJ	W01C093L03	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124614	IMS10-F02	FLJ	W01C093L04	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124616	IMS10-F03	FLJ	W01C093L05	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124616	IMS10-F03	FLJ	W01C093L06	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124640	IMS10-F04	FLJ	W01C093L07	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124640	IMS10-F04	FLJ	W01C093L08	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124899	IMS10-F05	FLJ	W01C093L09	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK124899	IMS10-F05	FLJ	W01C093L10	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK125070	IMS10-F06	FLJ	W01C093L11	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK125070	IMS10-F06	FLJ	W01C093L12	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK126539	IMS10-F07	FLJ	W01C093L13	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126539	IMS10-F07	FLJ	W01C093L14	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C093L15	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C093L16	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK123024	IMS10-F09	FLJ	W01C093L17	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK123024	IMS10-F09	FLJ	W01C093L18	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK124446	IMS10-F10	FLJ	W01C093L19	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK124446	IMS10-F10	FLJ	W01C093L20	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK123348	IMS10-F11	FLJ	W01C093L21	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123348	IMS10-F11	FLJ	W01C093L22	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123957	IMS10-F12	FLJ	W01C093L23	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK123957	IMS10-F12	FLJ	W01C093L24	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK123383	IMS10-G01	FLJ	W01C093M01	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123383	IMS10-G01	FLJ	W01C093M02	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123547	IMS10-G02	FLJ	W01C093M03	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK123547	IMS10-G02	FLJ	W01C093M04	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK124947	IMS10-G03	FLJ	W01C093M05	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK124947	IMS10-G03	FLJ	W01C093M06	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK123417	IMS10-G04	FLJ	W01C093M07	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123417	IMS10-G04	FLJ	W01C093M08	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123423	IMS10-G05	FLJ	W01C093M09	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK123423	IMS10-G05	FLJ	W01C093M10	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK122706	IMS10-G06	FLJ	W01C093M11	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK122706	IMS10-G06	FLJ	W01C093M12	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK123499	IMS10-G07	FLJ	W01C093M13	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK123499	IMS10-G07	FLJ	W01C093M14	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK124409	IMS10-G08	FLJ	W01C093M15	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124409	IMS10-G08	FLJ	W01C093M16	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124477	IMS10-G09	FLJ	W01C093M17	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK124477	IMS10-G09	FLJ	W01C093M18	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK123184	IMS10-G10	FLJ	W01C093M19	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123184	IMS10-G10	FLJ	W01C093M20	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123718	IMS10-G11	FLJ	W01C093M21	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK123718	IMS10-G11	FLJ	W01C093M22	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK125254	IMS10-G12	FLJ	W01C093M23	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK125254	IMS10-G12	FLJ	W01C093M24	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK123383	IMS10-G01	FLJ	W01C093N01	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123383	IMS10-G01	FLJ	W01C093N02	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123547	IMS10-G02	FLJ	W01C093N03	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK123547	IMS10-G02	FLJ	W01C093N04	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK124947	IMS10-G03	FLJ	W01C093N05	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK124947	IMS10-G03	FLJ	W01C093N06	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK123417	IMS10-G04	FLJ	W01C093N07	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123417	IMS10-G04	FLJ	W01C093N08	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123423	IMS10-G05	FLJ	W01C093N09	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK123423	IMS10-G05	FLJ	W01C093N10	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK122706	IMS10-G06	FLJ	W01C093N11	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK122706	IMS10-G06	FLJ	W01C093N12	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK123499	IMS10-G07	FLJ	W01C093N13	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK123499	IMS10-G07	FLJ	W01C093N14	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK124409	IMS10-G08	FLJ	W01C093N15	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124409	IMS10-G08	FLJ	W01C093N16	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124477	IMS10-G09	FLJ	W01C093N17	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK124477	IMS10-G09	FLJ	W01C093N18	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK123184	IMS10-G10	FLJ	W01C093N19	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123184	IMS10-G10	FLJ	W01C093N20	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123718	IMS10-G11	FLJ	W01C093N21	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK123718	IMS10-G11	FLJ	W01C093N22	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK125254	IMS10-G12	FLJ	W01C093N23	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK125254	IMS10-G12	FLJ	W01C093N24	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK123727	IMS10-H01	FLJ	W01C093O01	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123727	IMS10-H01	FLJ	W01C093O02	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123932	IMS10-H02	FLJ	W01C093O03	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK123932	IMS10-H02	FLJ	W01C093O04	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK124096	IMS10-H03	FLJ	W01C093O05	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124096	IMS10-H03	FLJ	W01C093O06	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C093O07	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C093O08	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C093O09	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C093O10	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C093O11	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C093O12	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK126284	IMS10-H07	FLJ	W01C093O13	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126284	IMS10-H07	FLJ	W01C093O14	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126293	IMS10-H08	FLJ	W01C093O15	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126293	IMS10-H08	FLJ	W01C093O16	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C093O17	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C093O18	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C093O19	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C093O20	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK124915	IMS10-H11	FLJ	W01C093O21	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124915	IMS10-H11	FLJ	W01C093O22	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124384	IMS10-H12	FLJ	W01C093O23	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK124384	IMS10-H12	FLJ	W01C093O24	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK123727	IMS10-H01	FLJ	W01C093P01	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123727	IMS10-H01	FLJ	W01C093P02	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123932	IMS10-H02	FLJ	W01C093P03	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK123932	IMS10-H02	FLJ	W01C093P04	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK124096	IMS10-H03	FLJ	W01C093P05	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124096	IMS10-H03	FLJ	W01C093P06	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C093P07	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C093P08	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C093P09	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C093P10	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C093P11	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C093P12	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK126284	IMS10-H07	FLJ	W01C093P13	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126284	IMS10-H07	FLJ	W01C093P14	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126293	IMS10-H08	FLJ	W01C093P15	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126293	IMS10-H08	FLJ	W01C093P16	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C093P17	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C093P18	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C093P19	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C093P20	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK124915	IMS10-H11	FLJ	W01C093P21	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124915	IMS10-H11	FLJ	W01C093P22	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124384	IMS10-H12	FLJ	W01C093P23	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK124384	IMS10-H12	FLJ	W01C093P24	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK123023	IMS10-A01	FLJ	W01C094A01	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK123023	IMS10-A01	FLJ	W01C094A02	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK122666	IMS10-A02	FLJ	W01C094A03	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK122666	IMS10-A02	FLJ	W01C094A04	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK124332	IMS10-A03	FLJ	W01C094A05	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK124332	IMS10-A03	FLJ	W01C094A06	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK123039	IMS10-A04	FLJ	W01C094A07	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK123039	IMS10-A04	FLJ	W01C094A08	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK125341	IMS10-A05	FLJ	W01C094A09	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125341	IMS10-A05	FLJ	W01C094A10	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125722	IMS10-A06	FLJ	W01C094A11	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK125722	IMS10-A06	FLJ	W01C094A12	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK124111	IMS10-A07	FLJ	W01C094A13	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK124111	IMS10-A07	FLJ	W01C094A14	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK125151	IMS10-A08	FLJ	W01C094A15	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK125151	IMS10-A08	FLJ	W01C094A16	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK123041	IMS10-A09	FLJ	W01C094A17	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123041	IMS10-A09	FLJ	W01C094A18	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123974	IMS10-A10	FLJ	W01C094A19	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK123974	IMS10-A10	FLJ	W01C094A20	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK125726	IMS10-A11	FLJ	W01C094A21	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125726	IMS10-A11	FLJ	W01C094A22	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125266	IMS10-A12	FLJ	W01C094A23	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK125266	IMS10-A12	FLJ	W01C094A24	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK123023	IMS10-A01	FLJ	W01C094B01	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK123023	IMS10-A01	FLJ	W01C094B02	pDONR221	23184		RSPO2	340419	BAG53852.1	Hs.444834	R-spondin 2 homolog (Xenopus laevis)			testis	TESTI4		NM_178565.4	NP_848660.3	VALIDATED	OK	1.000	1.000	243	732	1	729	243	1	243
IKAKEN	AK122666	IMS10-A02	FLJ	W01C094B03	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK122666	IMS10-A02	FLJ	W01C094B04	pDONR221	7899		LOC645106	645106	BAC85502.1	Hs.719641	Similar to kinesin-like motor protein C20orf23	NT2	teratocarcinoma		NT2RP7		XM_001720852.1	XP_001720904.1	MODEL	P	1.000	1.000	205	972	1	615	292	85	289
IKAKEN	AK124332	IMS10-A03	FLJ	W01C094B05	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK124332	IMS10-A03	FLJ	W01C094B06	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	AK123039	IMS10-A04	FLJ	W01C094B07	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK123039	IMS10-A04	FLJ	W01C094B08	pDONR221	4793		SCUBE2	57758	BAC85521.1	Hs.523468	Signal peptide, CUB domain, EGF-like 2			brain	BRAWH2		NM_020974.1	NP_066025.1	PROVISIONAL	Cs	0.999	0.999	999	3000	1	2997	999	1	999
IKAKEN	AK125341	IMS10-A05	FLJ	W01C094B09	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125341	IMS10-A05	FLJ	W01C094B10	pDONR221	34505				BAC86138			NT2	teratocarcinoma		NT2RI3				
IKAKEN	AK125722	IMS10-A06	FLJ	W01C094B11	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK125722	IMS10-A06	FLJ	W01C094B12	pDONR221	7123		C14orf166B	145497	BAC86259.1	Hs.147276	Chromosome 14 open reading frame 166B			breast, tumor tissue	TBAES2		NM_194287.2	NP_919263.2	VALIDATED	Pfs	0.905	1.000	243	660	1	659	488	93	335
IKAKEN	AK124111	IMS10-A07	FLJ	W01C094B13	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK124111	IMS10-A07	FLJ	W01C094B14	pDONR221	17115		C3orf67	200844	BAC85775.1	Hs.368434	Chromosome 3 open reading frame 67			testis	TESTI1		NM_198463.2	NP_940865.1	PREDICTED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK125151	IMS10-A08	FLJ	W01C094B15	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK125151	IMS10-A08	FLJ	W01C094B16	pDONR221	4498		DLG2	1740	BAC86064.1	Hs.654862	Discs, large homolog 2 (Drosophila)			tongue, tumor tissue	CTONG3		NM_001142700.1	NP_001136172.1	REVIEWED	Pfs	0.231	0.237	39	608	62	175	749	550	588
IKAKEN	AK123041	IMS10-A09	FLJ	W01C094B17	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123041	IMS10-A09	FLJ	W01C094B18	pDONR221	13385		LOC400940	400940	BAC85522.1	Hs.378814	Hypothetical LOC400940	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK123974	IMS10-A10	FLJ	W01C094B19	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK123974	IMS10-A10	FLJ	W01C094B20	pDONR221	17658		MYL5	4636	BAC85739	Hs.410970	Myosin, light chain 5, regulatory		pulmonary artery endothelial cells (HPAEC)		PUAEN2		NM_002477.1	NP_002468.1	REVIEWED		0.308	0.308	13	969	214	252	173	7	19
IKAKEN	AK125726	IMS10-A11	FLJ	W01C094B21	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125726	IMS10-A11	FLJ	W01C094B22	pDONR221	16770		LOC100132731	100132731	BAC86260.1	Hs.710652	Hypothetical protein LOC100132731			testis	TESTI2		XM_001724331.1	XP_001724383.1	MODEL	Pgs	0.997	0.998	572	1716	1	1713	608	37	608
IKAKEN	AK125266	IMS10-A12	FLJ	W01C094B23	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK125266	IMS10-A12	FLJ	W01C094B24	pDONR221	8323		FLJ43276	388165	BAC86104.1	Hs.498348	Similar to ubiquitin-conjugating enzyme E2Q 2			lung	HLUNG2														
IKAKEN	AK123854	IMS10-B01	FLJ	W01C094C01	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK123854	IMS10-B01	FLJ	W01C094C02	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK125364	IMS10-B02	FLJ	W01C094C03	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125364	IMS10-B02	FLJ	W01C094C04	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125535	IMS10-B03	FLJ	W01C094C05	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK125535	IMS10-B03	FLJ	W01C094C06	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK123987	IMS10-B04	FLJ	W01C094C07	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK123987	IMS10-B04	FLJ	W01C094C08	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK124659	IMS10-B05	FLJ	W01C094C09	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK124659	IMS10-B05	FLJ	W01C094C10	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK125206	IMS10-B06	FLJ	W01C094C11	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125206	IMS10-B06	FLJ	W01C094C12	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125227	IMS10-B07	FLJ	W01C094C13	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125227	IMS10-B07	FLJ	W01C094C14	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125347	IMS10-B08	FLJ	W01C094C15	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125347	IMS10-B08	FLJ	W01C094C16	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125353	IMS10-B09	FLJ	W01C094C17	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125353	IMS10-B09	FLJ	W01C094C18	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125494	IMS10-B10	FLJ	W01C094C19	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK125494	IMS10-B10	FLJ	W01C094C20	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK124127	IMS10-B11	FLJ	W01C094C21	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK124127	IMS10-B11	FLJ	W01C094C22	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK125740	IMS10-B12	FLJ	W01C094C23	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK125740	IMS10-B12	FLJ	W01C094C24	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK123854	IMS10-B01	FLJ	W01C094D01	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK123854	IMS10-B01	FLJ	W01C094D02	pDONR221	14178		ASB18	401036	BAC85710.1	Hs.639909	Ankyrin repeat and SOCS box-containing 18	NT2	teratocarcinoma		NT2RI3		NM_212556.2	NP_997721.2	PROVISIONAL	Pfs	0.449	0.939	343	579	85	577	466	58	400
IKAKEN	AK125364	IMS10-B02	FLJ	W01C094D03	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125364	IMS10-B02	FLJ	W01C094D04	pDONR221	13397		KLHL30	377007	BAC86148.1	Hs.591595	Kelch-like 30 (Drosophila)			tongue	NTONG2		NM_198582.2	NP_940984.2	VALIDATED	OK	1.000	1.000	560	1683	1	1680	560	1	560
IKAKEN	AK125535	IMS10-B03	FLJ	W01C094D05	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK125535	IMS10-B03	FLJ	W01C094D06	pDONR221	10631		ARHGAP27	201176	BAC86196.1	Hs.463165	Rho GTPase activating protein 27			placenta	PLACE7		NM_199282.2	NP_954976.1	VALIDATED	OK	1.000	1.000	548	1647	1	1644	548	1	548
IKAKEN	AK123987	IMS10-B04	FLJ	W01C094D07	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK123987	IMS10-B04	FLJ	W01C094D08	pDONR221	15937		IL17REL	400935	BAC85743.1	Hs.526712	Interleukin 17 receptor E-like			small intestine	SMINT2		NM_001001694.2	NP_001001694.2	VALIDATED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK124659	IMS10-B05	FLJ	W01C094D09	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK124659	IMS10-B05	FLJ	W01C094D10	pDONR221	13740		NAP5	344148	BAC85920.1	Hs.537329	Nck-associated protein 5			cerebellum	BRACE3		NM_207481.3	NP_997364.3	VALIDATED	P	1.000	1.000	226	879	199	876	590	365	590
IKAKEN	AK125206	IMS10-B06	FLJ	W01C094D11	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125206	IMS10-B06	FLJ	W01C094D12	pDONR221	692		MTR	4548	-	Hs.498187	5-methyltetrahydrofolate-homocysteine methyltransferase			brain	FCBBF3		NM_000254.2	NP_000245.2	REVIEWED		0.400	0.400	10	147	115	86	1265	944	953
IKAKEN	AK125227	IMS10-B07	FLJ	W01C094D13	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125227	IMS10-B07	FLJ	W01C094D14	pDONR221	19378		LHFPL2	10184	BAC86089.1	Hs.79299	Lipoma HMGIC fusion partner-like 2		chondrocytes (HC)		HCHON2		NM_005779.2	NP_005770.1	REVIEWED	OK	1.000	1.000	228	687	1	684	228	1	228
IKAKEN	AK125347	IMS10-B08	FLJ	W01C094D15	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125347	IMS10-B08	FLJ	W01C094D16	pDONR221	22088		WDR86	349136	BAC86140.1	Hs.647083	WD repeat domain 86	NT2	teratocarcinoma		NT2RP7		NM_198285.2	NP_938026.2	VALIDATED	Pfs	0.815	0.995	248	834	1	608	376	129	376
IKAKEN	AK125353	IMS10-B09	FLJ	W01C094D17	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125353	IMS10-B09	FLJ	W01C094D18	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	AK125494	IMS10-B10	FLJ	W01C094D19	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK125494	IMS10-B10	FLJ	W01C094D20	pDONR221	773		FAM177B	400823	BAC86182.1	Hs.697608	Family with sequence similarity 177, member B			brain	OCBBF3		NM_207468.2	NP_997351.2	VALIDATED	P	1.000	1.000	80	363	1	240	158	1	80
IKAKEN	AK124127	IMS10-B11	FLJ	W01C094D21	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK124127	IMS10-B11	FLJ	W01C094D22	pDONR221	14754			400844	BAC85783					testis	TESTI2				
IKAKEN	AK125740	IMS10-B12	FLJ	W01C094D23	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK125740	IMS10-B12	FLJ	W01C094D24	pDONR221	20708		C6orf227	401253	BAC86269.1	Hs.520075	Chromosome 6 open reading frame 227			testis	TESTI2		NM_207497.1	NP_997380.1	PREDICTED	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK125744	IMS10-C01	FLJ	W01C094E01	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK125744	IMS10-C01	FLJ	W01C094E02	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK124162	IMS10-C02	FLJ	W01C094E03	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK124162	IMS10-C02	FLJ	W01C094E04	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK126134	IMS10-C03	FLJ	W01C094E05	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK126134	IMS10-C03	FLJ	W01C094E06	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK123597	IMS10-C04	FLJ	W01C094E07	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123597	IMS10-C04	FLJ	W01C094E08	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123600	IMS10-C05	FLJ	W01C094E09	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123600	IMS10-C05	FLJ	W01C094E10	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123643	IMS10-C06	FLJ	W01C094E11	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK123643	IMS10-C06	FLJ	W01C094E12	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK125308	IMS10-C07	FLJ	W01C094E13	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK125308	IMS10-C07	FLJ	W01C094E14	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK123995	IMS10-C08	FLJ	W01C094E15	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK123995	IMS10-C08	FLJ	W01C094E16	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C094E17	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C094E18	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124059	IMS10-C10	FLJ	W01C094E19	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124059	IMS10-C10	FLJ	W01C094E20	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124141	IMS10-C11	FLJ	W01C094E21	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124141	IMS10-C11	FLJ	W01C094E22	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C094E23	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C094E24	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK125744	IMS10-C01	FLJ	W01C094F01	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK125744	IMS10-C01	FLJ	W01C094F02	pDONR221	13395		FAM179A	165186	BAC86270.1	Hs.525977	Family with sequence similarity 179, member A			testis	TESTI2		NM_199280.2	NP_954974.2	VALIDATED	Ps	0.995	0.995	198	744	22	615	1019	710	907
IKAKEN	AK124162	IMS10-C02	FLJ	W01C094F03	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK124162	IMS10-C02	FLJ	W01C094F04	pDONR221	11837		VMAC	400673	BAG54017.1	Hs.620821	Vimentin-type IF-associated coiled-coil protein			testis	TESTI4		NM_001017921.3	NP_001017921.1	VALIDATED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	AK126134	IMS10-C03	FLJ	W01C094F05	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK126134	IMS10-C03	FLJ	W01C094F06	pDONR221	2834		C10orf129	142827	BAC86458.1	Hs.134229	Chromosome 10 open reading frame 129			testis	TESTI4		NM_207321.2	NP_997204.2	VALIDATED	P	1.000	1.000	176	561	1	528	480	156	331
IKAKEN	AK123597	IMS10-C04	FLJ	W01C094F07	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123597	IMS10-C04	FLJ	W01C094F08	pDONR221	18736		FLJ41603	389337	BAC85655.1	Hs.256206	FLJ41603 protein			colon	COLON2		NM_001001669.2	NP_001001669.2	VALIDATED	P	1.000	1.000	233	702	1	699	675	443	675
IKAKEN	AK123600	IMS10-C05	FLJ	W01C094F09	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123600	IMS10-C05	FLJ	W01C094F10	pDONR221	22066		PAXIP1	22976	BAC85657.1	Hs.443881	PAX interacting (with transcription-activation domain) protein 1			tongue, tumor tissue	CTONG3		NM_007349.3	NP_031375.3	REVIEWED	Ps	0.994	0.994	967	3108	205	3105	1069	103	1069
IKAKEN	AK123643	IMS10-C06	FLJ	W01C094F11	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK123643	IMS10-C06	FLJ	W01C094F12	pDONR221	20704		FLJ41649	401260	BAC85669	Hs.654837	Hypothetical LOC401260			tongue, tumor tissue	CTONG3														
IKAKEN	AK125308	IMS10-C07	FLJ	W01C094F13	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK125308	IMS10-C07	FLJ	W01C094F14	pDONR221	39984		LOC100129484	100129484	BAC86121.1	Hs.587430	Hypothetical LOC100129484	NB9	neuroblastoma		NB9N41		XM_001723177.1	XP_001723229.1	MODEL	OK	1.000	1.000	221	666	1	663	221	1	221
IKAKEN	AK123995	IMS10-C08	FLJ	W01C094F15	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK123995	IMS10-C08	FLJ	W01C094F16	pDONR221	18727		LOC153684	153684	BAC85747.1	Hs.259625	Hypothetical LOC153684			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C094F17	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124001	IMS10-C09	FLJ	W01C094F18	pDONR221	9885		LRRC37B2	147172	BAG53991.1	Hs.568209	Leucine rich repeat containing 37, member B2			spleen	SPLEN2														
IKAKEN	AK124059	IMS10-C10	FLJ	W01C094F19	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124059	IMS10-C10	FLJ	W01C094F20	pDONR221	14578		NPEPL1	79716	BAC85762	Hs.654868	Aminopeptidase-like 1			spleen	SPLEN2		NM_024663.3	NP_078939.3	VALIDATED		0.304	0.368	46	549	131	12	523	75	118
IKAKEN	AK124141	IMS10-C11	FLJ	W01C094F21	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124141	IMS10-C11	FLJ	W01C094F22	pDONR221	4822		LOC399904	399904	BAC85785					testis	TESTI2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C094F23	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK124194	IMS10-C12	FLJ	W01C094F24	pDONR221	15252		FLJ42200	400860	BAC85800.1	Hs.652040	FLJ42200 protein			thymus	THYMU2				
IKAKEN	AK126170	IMS10-D01	FLJ	W01C094G01	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK126170	IMS10-D01	FLJ	W01C094G02	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK124214	IMS10-D02	FLJ	W01C094G03	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK124214	IMS10-D02	FLJ	W01C094G04	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK126174	IMS10-D03	FLJ	W01C094G05	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK126174	IMS10-D03	FLJ	W01C094G06	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK123281	IMS10-D04	FLJ	W01C094G07	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123281	IMS10-D04	FLJ	W01C094G08	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123321	IMS10-D05	FLJ	W01C094G09	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123321	IMS10-D05	FLJ	W01C094G10	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123760	IMS10-D06	FLJ	W01C094G11	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123760	IMS10-D06	FLJ	W01C094G12	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123791	IMS10-D07	FLJ	W01C094G13	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123791	IMS10-D07	FLJ	W01C094G14	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123835	IMS10-D08	FLJ	W01C094G15	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK123835	IMS10-D08	FLJ	W01C094G16	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK125320	IMS10-D09	FLJ	W01C094G17	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125320	IMS10-D09	FLJ	W01C094G18	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125322	IMS10-D10	FLJ	W01C094G19	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125322	IMS10-D10	FLJ	W01C094G20	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125336	IMS10-D11	FLJ	W01C094G21	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK125336	IMS10-D11	FLJ	W01C094G22	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK122760	IMS10-D12	FLJ	W01C094G23	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-D12	FLJ	W01C094G24	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK126170	IMS10-D01	FLJ	W01C094H01	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK126170	IMS10-D01	FLJ	W01C094H02	pDONR221	11840		C19orf20	91978	BAC86469.1	Hs.369613	Chromosome 19 open reading frame 20			thymus	THYMU2		NM_033513.2	NP_277048.2	VALIDATED	P	1.000	1.000	244	735	1	732	290	47	290
IKAKEN	AK124214	IMS10-D02	FLJ	W01C094H03	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK124214	IMS10-D02	FLJ	W01C094H04	pDONR221	7156		FLJ42220	400207	BAC85808	Hs.440174	FLJ42220 protein			thymus	THYMU2														
IKAKEN	AK126174	IMS10-D03	FLJ	W01C094H05	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK126174	IMS10-D03	FLJ	W01C094H06	pDONR221	22095		KLRG2	346689	BAC86473.1	Hs.17572	Killer cell lectin-like receptor subfamily G, member 2			thymus	THYMU2		NM_198508.2	NP_940910.1	VALIDATED	OK	1.000	1.000	409	1230	1	1227	409	1	409
IKAKEN	AK123281	IMS10-D04	FLJ	W01C094H07	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123281	IMS10-D04	FLJ	W01C094H08	pDONR221	8318		TNFAIP8L3	388121	BAC85572.1	Hs.306343	Tumor necrosis factor, alpha-induced protein 8-like 3			alzheimer cortex	BRALZ2		NM_207381.2	NP_997264.2	PROVISIONAL	P	1.000	1.000	204	615	1	612	292	89	292
IKAKEN	AK123321	IMS10-D05	FLJ	W01C094H09	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123321	IMS10-D05	FLJ	W01C094H10	pDONR221	13388		FLJ41327	401045	BAC85579	Hs.712015	FLJ41327 protein			amygdala	BRAMY2														
IKAKEN	AK123760	IMS10-D06	FLJ	W01C094H11	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123760	IMS10-D06	FLJ	W01C094H12	pDONR221	8865		NCRNA00169	400508	BAG53954.1	Hs.578949	Non-protein coding RNA 169			lung	HLUNG2		NM_001101368.1	NP_001094838.1	VALIDATED	OK	1.000	1.000	109	330	1	327	109	1	109
IKAKEN	AK123791	IMS10-D07	FLJ	W01C094H13	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123791	IMS10-D07	FLJ	W01C094H14	pDONR221	25527		LOC645769	645769	BAC85692	Hs.619728	Hypothetical LOC645769	IMR32	neuroblastoma		IMR322														
IKAKEN	AK123835	IMS10-D08	FLJ	W01C094H15	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK123835	IMS10-D08	FLJ	W01C094H16	pDONR221	20705		C6orf138	442213	BAC85703.1	Hs.659409	Chromosome 6 open reading frame 138		normal neural progenitor cells (NHNP5958)		NHNPC2		NM_001013732.2	NP_001013754.2	VALIDATED	Ps	0.990	0.990	290	885	1	870	829	1	290
IKAKEN	AK125320	IMS10-D09	FLJ	W01C094H17	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125320	IMS10-D09	FLJ	W01C094H18	pDONR221	23711		TMEM215	401498	BAC86126.1	Hs.522063	Transmembrane protein 215	NT2	teratocarcinoma		NT2RI2		NM_212558.2	NP_997723.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK125322	IMS10-D10	FLJ	W01C094H19	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125322	IMS10-D10	FLJ	W01C094H20	pDONR221	11203		MYOM1	8736	BAC86128.1	Hs.464469	Myomesin 1, 185kDa	NT2	teratocarcinoma		NT2RI3		NM_003803.3	NP_003794.3	REVIEWED	OK	1.000	1.000	1685	5058	1	5055	1685	1	1685
IKAKEN	AK125336	IMS10-D11	FLJ	W01C094H21	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK125336	IMS10-D11	FLJ	W01C094H22	pDONR221	25342		FRMD7	90167	BAC86135.1	Hs.170776	FERM domain containing 7	NT2	teratocarcinoma		NT2RI3		NM_194277.2	NP_919253.1	REVIEWED	OK	1.000	1.000	714	2145	1	2142	714	1	714
IKAKEN	AK122760	IMS10-D12	FLJ	W01C094H23	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-D12	FLJ	W01C094H24	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-E01	FLJ	W01C094I01	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-E01	FLJ	W01C094I02	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK125570	IMS10-E02	FLJ	W01C094I03	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK125570	IMS10-E02	FLJ	W01C094I04	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK124519	IMS10-E03	FLJ	W01C094I05	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124519	IMS10-E03	FLJ	W01C094I06	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124559	IMS10-E04	FLJ	W01C094I07	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124559	IMS10-E04	FLJ	W01C094I08	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124576	IMS10-E05	FLJ	W01C094I09	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	IMS10-E05	FLJ	W01C094I10	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124700	IMS10-E06	FLJ	W01C094I11	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124700	IMS10-E06	FLJ	W01C094I12	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124880	IMS10-E07	FLJ	W01C094I13	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK124880	IMS10-E07	FLJ	W01C094I14	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK125049	IMS10-E08	FLJ	W01C094I15	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125049	IMS10-E08	FLJ	W01C094I16	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125054	IMS10-E09	FLJ	W01C094I17	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125054	IMS10-E09	FLJ	W01C094I18	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125060	IMS10-E10	FLJ	W01C094I19	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125060	IMS10-E10	FLJ	W01C094I20	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125083	IMS10-E11	FLJ	W01C094I21	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125083	IMS10-E11	FLJ	W01C094I22	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125286	IMS10-E12	FLJ	W01C094I23	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK125286	IMS10-E12	FLJ	W01C094I24	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK122760	IMS10-E01	FLJ	W01C094J01	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK122760	IMS10-E01	FLJ	W01C094J02	pDONR221	1950		CDCP2	200008	BAC85509	Hs.568555	CUB domain containing protein 2			liver	FELIV1		NM_201546.2	NP_963840.2	PROVISIONAL		0.948	0.948	154	474	1	462	449	1	154
IKAKEN	AK125570	IMS10-E02	FLJ	W01C094J03	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK125570	IMS10-E02	FLJ	W01C094J04	pDONR221	23187		C8orf86	389649	BAC86207.1	Hs.546586	Chromosome 8 open reading frame 86			prostate	PROST2		NM_207412.1	NP_997295.1	PREDICTED	OK	1.000	1.000	223	672	1	669	223	1	223
IKAKEN	AK124519	IMS10-E03	FLJ	W01C094J05	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124519	IMS10-E03	FLJ	W01C094J06	pDONR221	769		C1orf130	400746	-	Hs.200253	Chromosome 1 open reading frame 130			cerebellum	BRACE2		NM_001010980.3	NP_001010980.1	PROVISIONAL	OK	1.000	1.000	102	309	1	306	102	1	102
IKAKEN	AK124559	IMS10-E04	FLJ	W01C094J07	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124559	IMS10-E04	FLJ	W01C094J08	pDONR221	13394		ESPNL	339768	BAC85884.1	Hs.127724	Espin-like			cerebellum	BRACE3		NM_194312.2	NP_919288.2	VALIDATED	OK	1.000	1.000	1005	3018	1	3015	1005	1	1005
IKAKEN	AK124576	IMS10-E05	FLJ	W01C094J09	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124576	IMS10-E05	FLJ	W01C094J10	pDONR221	32050									cerebellum	BRACE3				
IKAKEN	AK124700	IMS10-E06	FLJ	W01C094J11	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124700	IMS10-E06	FLJ	W01C094J12	pDONR221	24771		NXF4	55999	BAC85929.1	Hs.454283	Nuclear RNA export factor 4 pseudogene			amygdala	BRAMY2														
IKAKEN	AK124880	IMS10-E07	FLJ	W01C094J13	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK124880	IMS10-E07	FLJ	W01C094J14	pDONR221	20397		KIAA1949	170954	BAG54110.1	Hs.696054	KIAA1949			brain	BRAWH3		NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	3429	1588	3426	613	1	613
IKAKEN	AK125049	IMS10-E08	FLJ	W01C094J15	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125049	IMS10-E08	FLJ	W01C094J16	pDONR221	1443		DOCK7	85440	BAC86032.1	Hs.406156	Dedicator of cytokinesis 7			thalamus	BRTHA2		NM_033407.2	NP_212132.2	VALIDATED	P	1.000	1.000	1520	4563	1	4560	2109	590	2109
IKAKEN	AK125054	IMS10-E09	FLJ	W01C094J17	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125054	IMS10-E09	FLJ	W01C094J18	pDONR221	163		FAM40A	85369	BAC86034.1	Hs.584996	Family with sequence similarity 40, member A			thalamus	BRTHA3		NM_033088.2	NP_149079.2	VALIDATED	Pfs	0.831	1.000	439	1322	1	1316	837	265	629
IKAKEN	AK125060	IMS10-E10	FLJ	W01C094J19	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125060	IMS10-E10	FLJ	W01C094J20	pDONR221	24183		PNPLA7	375775	BAC86036.1	Hs.294147	Patatin-like phospholipase domain containing 7			thalamus	BRTHA3		NM_152286.3	NP_689499.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	AK125083	IMS10-E11	FLJ	W01C094J21	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125083	IMS10-E11	FLJ	W01C094J22	pDONR221	20016		RAB44	401258	BAC86047.1	Hs.485258	RAB44, member RAS oncogene family			thalamus	BRTHA3		XM_001722068.1	XP_001722120.1	MODEL	Ps	0.986	0.986	69	552	3	209	1328	91	159
IKAKEN	AK125286	IMS10-E12	FLJ	W01C094J23	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK125286	IMS10-E12	FLJ	W01C094J24	pDONR221	18683		MST150	85027	BAC86114.1	Hs.29444	MSTP150		normal mesangial cells (NHMC56046-2)		MESAN2		NM_032947.3	NP_116565.2	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK122906	IMS10-F01	FLJ	W01C094K01	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK122906	IMS10-F01	FLJ	W01C094K02	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK124614	IMS10-F02	FLJ	W01C094K03	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124614	IMS10-F02	FLJ	W01C094K04	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124616	IMS10-F03	FLJ	W01C094K05	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124616	IMS10-F03	FLJ	W01C094K06	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124640	IMS10-F04	FLJ	W01C094K07	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124640	IMS10-F04	FLJ	W01C094K08	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124899	IMS10-F05	FLJ	W01C094K09	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK124899	IMS10-F05	FLJ	W01C094K10	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK125070	IMS10-F06	FLJ	W01C094K11	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK125070	IMS10-F06	FLJ	W01C094K12	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK126539	IMS10-F07	FLJ	W01C094K13	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126539	IMS10-F07	FLJ	W01C094K14	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C094K15	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C094K16	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK123024	IMS10-F09	FLJ	W01C094K17	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK123024	IMS10-F09	FLJ	W01C094K18	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK124446	IMS10-F10	FLJ	W01C094K19	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK124446	IMS10-F10	FLJ	W01C094K20	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK123348	IMS10-F11	FLJ	W01C094K21	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123348	IMS10-F11	FLJ	W01C094K22	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123957	IMS10-F12	FLJ	W01C094K23	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK123957	IMS10-F12	FLJ	W01C094K24	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK122906	IMS10-F01	FLJ	W01C094L01	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK122906	IMS10-F01	FLJ	W01C094L02	pDONR221	20015		RFPL4B	442247	BAC85513.1	Hs.448264	Ret finger protein-like 4B			synovial membrane tissue from rheumatioid	SYNOV4		NM_001013734.2	NP_001013756.2	VALIDATED	OK	1.000	1.000	263	792	1	789	263	1	263
IKAKEN	AK124614	IMS10-F02	FLJ	W01C094L03	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124614	IMS10-F02	FLJ	W01C094L04	pDONR221	770		LOC440742	440742	BAC85901.1	Hs.629644	Hypothetical gene supported by AK124614			cerebellum	BRACE3														
IKAKEN	AK124616	IMS10-F03	FLJ	W01C094L05	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124616	IMS10-F03	FLJ	W01C094L06	pDONR221	18018		GPRIN3	285513	BAC85902.1	Hs.605082	GPRIN family member 3			cerebellum	BRACE3		NM_198281.2	NP_938022.2	VALIDATED	OK	1.000	1.000	776	2331	1	2328	776	1	776
IKAKEN	AK124640	IMS10-F04	FLJ	W01C094L07	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124640	IMS10-F04	FLJ	W01C094L08	pDONR221	9567		GARNL4	23108	BAC85912.1	Hs.499659	GTPase activating Rap/RanGAP domain-like 4			cerebellum	BRACE3		NM_015085.4	NP_055900.4	VALIDATED	P	1.000	1.000	711	2136	1	2133	730	20	730
IKAKEN	AK124899	IMS10-F05	FLJ	W01C094L09	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK124899	IMS10-F05	FLJ	W01C094L10	pDONR221	23685		C9orf139	401563	BAC85986.1	Hs.522509	Chromosome 9 open reading frame 139			hippocampus	BRHIP3		NM_207511.1	NP_997394.1	PREDICTED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	AK125070	IMS10-F06	FLJ	W01C094L11	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK125070	IMS10-F06	FLJ	W01C094L12	pDONR221	19376		FLJ43080	642987	BAC86042	Hs.535781	Hypothetical protein LOC642987			thalamus	BRTHA3		NM_001039763.2	NP_001034852.2	PREDICTED	P	1.000	1.000	285	915	19	873	506	201	485
IKAKEN	AK126539	IMS10-F07	FLJ	W01C094L13	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126539	IMS10-F07	FLJ	W01C094L14	pDONR221	9332		LOC400499	400499	BAC86584.1	Hs.459937	Hypothetical LOC400499			uterus	UTERU2														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C094L15	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK126356	IMS10-F08	FLJ	W01C094L16	pDONR221	15650		FLJ44385	400934	BAC86535	Hs.517724	Hypothetical FLJ44385			trachea	TRACH3														
IKAKEN	AK123024	IMS10-F09	FLJ	W01C094L17	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK123024	IMS10-F09	FLJ	W01C094L18	pDONR221	1481		FAM5C	339479	BAG53853.1	Hs.65765	Family with sequence similarity 5, member C			brain	BRAWH1		NM_199051.1	NP_950252.1	PROVISIONAL	OK	1.000	1.000	766	2301	1	2298	766	1	766
IKAKEN	AK124446	IMS10-F10	FLJ	W01C094L19	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK124446	IMS10-F10	FLJ	W01C094L20	pDONR221	23130		NUDT18	79873	BAC85853.1	Hs.718777	Nudix (nucleoside diphosphate linked moiety X)-type motif 18			bladder	BLADE2		NM_024815.3	NP_079091.3	VALIDATED	Cfs	1.000	1.000	323	1622	649	1619	323	1	323
IKAKEN	AK123348	IMS10-F11	FLJ	W01C094L21	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123348	IMS10-F11	FLJ	W01C094L22	pDONR221	16974		C3orf57	165679	BAC85589.1	Hs.711656	Chromosome 3 open reading frame 57			amygdala	BRAMY2		NM_001040100.1	NP_001035189.1	VALIDATED		0.556	0.556	9	693	492	518	76	16	24
IKAKEN	AK123957	IMS10-F12	FLJ	W01C094L23	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK123957	IMS10-F12	FLJ	W01C094L24	pDONR221	24691		TBC1D8B	54885	BAC85735.1	Hs.351798	TBC1 domain family, member 8B (with GRAM domain)			pericardium	PERIC2		NM_198881.1	NP_942582.1	VALIDATED	OK	1.000	1.000	632	1899	1	1896	632	1	632
IKAKEN	AK123383	IMS10-G01	FLJ	W01C094M01	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123383	IMS10-G01	FLJ	W01C094M02	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123547	IMS10-G02	FLJ	W01C094M03	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK123547	IMS10-G02	FLJ	W01C094M04	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK124947	IMS10-G03	FLJ	W01C094M05	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK124947	IMS10-G03	FLJ	W01C094M06	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK123417	IMS10-G04	FLJ	W01C094M07	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123417	IMS10-G04	FLJ	W01C094M08	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123423	IMS10-G05	FLJ	W01C094M09	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK123423	IMS10-G05	FLJ	W01C094M10	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK122706	IMS10-G06	FLJ	W01C094M11	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK122706	IMS10-G06	FLJ	W01C094M12	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK123499	IMS10-G07	FLJ	W01C094M13	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK123499	IMS10-G07	FLJ	W01C094M14	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK124409	IMS10-G08	FLJ	W01C094M15	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124409	IMS10-G08	FLJ	W01C094M16	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124477	IMS10-G09	FLJ	W01C094M17	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK124477	IMS10-G09	FLJ	W01C094M18	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK123184	IMS10-G10	FLJ	W01C094M19	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123184	IMS10-G10	FLJ	W01C094M20	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123718	IMS10-G11	FLJ	W01C094M21	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK123718	IMS10-G11	FLJ	W01C094M22	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK125254	IMS10-G12	FLJ	W01C094M23	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK125254	IMS10-G12	FLJ	W01C094M24	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK123383	IMS10-G01	FLJ	W01C094N01	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123383	IMS10-G01	FLJ	W01C094N02	pDONR221	16018		LOC642648	642648	BAC85601	Hs.631363	Hypothetical LOC642648			brain	BRAWH2				
IKAKEN	AK123547	IMS10-G02	FLJ	W01C094N03	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK123547	IMS10-G02	FLJ	W01C094N04	pDONR221	22727		CLDN23	137075	BAC85642.1	Hs.183617	Claudin 23			colon	COLON2		NM_194284.2	NP_919260.2	VALIDATED		0.960	0.960	149	504	55	501	292	144	292
IKAKEN	AK124947	IMS10-G03	FLJ	W01C094N05	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK124947	IMS10-G03	FLJ	W01C094N06	pDONR221	5511		NCRNA00173	400077	BAC86003.1	Hs.441601	Non-protein coding RNA 173			subthalamic nucleus	BRSTN2		NM_207436.1	NP_997319.1	VALIDATED	C	1.000	1.000	143	432	1	429	143	1	143
IKAKEN	AK123417	IMS10-G04	FLJ	W01C094N07	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123417	IMS10-G04	FLJ	W01C094N08	pDONR221	4015		FLJ41423	399886	BAC85611.1	Hs.559970	Hypothetical LOC399886			corpus callosum	BRCOC2														
IKAKEN	AK123423	IMS10-G05	FLJ	W01C094N09	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK123423	IMS10-G05	FLJ	W01C094N10	pDONR221	2829		CC2D2B	387707	BAC85613	Hs.712014	Coiled-coil and C2 domain containing 2B			hippocampus	BRHIP2		NM_001001732.3	NP_001001732.2	VALIDATED		0.254	0.312	59	489	163	336	322	43	91
IKAKEN	AK122706	IMS10-G06	FLJ	W01C094N11	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK122706	IMS10-G06	FLJ	W01C094N12	pDONR221	22070		KCP	375616	BAC85504.1	Hs.371746	Kielin/chordin-like protein			cerebellum	BRACE3		XM_001715714.1	XP_001715766.1	MODEL	Cfs	0.771	0.968	795	2445	1	2165	706	1	706
IKAKEN	AK123499	IMS10-G07	FLJ	W01C094N13	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK123499	IMS10-G07	FLJ	W01C094N14	pDONR221	11833		LOC400696	400696	BAC85631.1	Hs.456377	Lectin, galactoside-binding, soluble, 14-like			hippocampus	BRHIP2		NM_207646.2	NP_997529.2	VALIDATED	OK	1.000	1.000	151	456	1	453	151	1	151
IKAKEN	AK124409	IMS10-G08	FLJ	W01C094N15	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124409	IMS10-G08	FLJ	W01C094N16	pDONR221	14180		FLJ42418	400941	BAC85847.1	Hs.446195	FLJ42418 protein	GI1	glioma separated from gliosarcoma		BGGI12														
IKAKEN	AK124477	IMS10-G09	FLJ	W01C094N17	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK124477	IMS10-G09	FLJ	W01C094N18	pDONR221	7531		TMEM179	388021	BAC85860.1	Hs.655004	Transmembrane protein 179			cerebellum	BRACE2		NM_207379.1	NP_997262.1	PROVISIONAL	C	1.000	1.000	197	594	1	591	197	1	197
IKAKEN	AK123184	IMS10-G10	FLJ	W01C094N19	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123184	IMS10-G10	FLJ	W01C094N20	pDONR221	11258		CPLX4	339302	BAC85549.1	Hs.449884	Complexin 4			cerebellum	BRACE2		NM_181654.3	NP_857637.1	REVIEWED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK123718	IMS10-G11	FLJ	W01C094N21	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK123718	IMS10-G11	FLJ	W01C094N22	pDONR221	16447		COL29A1	256076	BAC85681.1	Hs.205403	Collagen, type XXIX, alpha 1			brain	FEBRA2		NM_153264.5	NP_694996.5	VALIDATED	P	1.000	1.000	565	1698	1	1695	2526	1962	2526
IKAKEN	AK125254	IMS10-G12	FLJ	W01C094N23	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK125254	IMS10-G12	FLJ	W01C094N24	pDONR221	10630		GJD3	125111	BAC86102.1	Hs.444663	Gap junction protein, delta 3, 31.9kDa		chondrocytes (HC)		HCHON2		NM_152219.3	NP_689343.3	VALIDATED	P	1.000	1.000	245	888	1	735	294	1	245
IKAKEN	AK123727	IMS10-H01	FLJ	W01C094O01	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123727	IMS10-H01	FLJ	W01C094O02	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123932	IMS10-H02	FLJ	W01C094O03	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK123932	IMS10-H02	FLJ	W01C094O04	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK124096	IMS10-H03	FLJ	W01C094O05	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124096	IMS10-H03	FLJ	W01C094O06	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C094O07	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C094O08	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C094O09	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C094O10	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C094O11	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C094O12	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK126284	IMS10-H07	FLJ	W01C094O13	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126284	IMS10-H07	FLJ	W01C094O14	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126293	IMS10-H08	FLJ	W01C094O15	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126293	IMS10-H08	FLJ	W01C094O16	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C094O17	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C094O18	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C094O19	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C094O20	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK124915	IMS10-H11	FLJ	W01C094O21	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124915	IMS10-H11	FLJ	W01C094O22	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124384	IMS10-H12	FLJ	W01C094O23	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK124384	IMS10-H12	FLJ	W01C094O24	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK123727	IMS10-H01	FLJ	W01C094P01	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123727	IMS10-H01	FLJ	W01C094P02	pDONR221	15249		FLJ41733	400870	BAC85684.1	Hs.517320	FLJ41733 protein			lung	HLUNG2														
IKAKEN	AK123932	IMS10-H02	FLJ	W01C094P03	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK123932	IMS10-H02	FLJ	W01C094P04	pDONR221	17088		PAQR9	344838	BAC85729.1	Hs.656111	Progestin and adipoQ receptor family member IX			brain	OCBBF2		NM_198504.2	NP_940906.1	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	AK124096	IMS10-H03	FLJ	W01C094P05	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124096	IMS10-H03	FLJ	W01C094P06	pDONR221	4821		FLJ42102	399923	BAC85771	Hs.128191	FLJ42102 protein			synovial membrane tissue from rheumatioid	SYNOV2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C094P07	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124274	IMS10-H04	FLJ	W01C094P08	pDONR221	22085		FLJ42280	401388	BAC85824.1	Hs.534805	Hypothetical LOC401388			kidney, tumor tissue	TKIDN2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C094P09	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124283	IMS10-H05	FLJ	W01C094P10	pDONR221	8283		FLJ42289	388182	BAC85825.1	Hs.136982	Hypothetical LOC388182			liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C094P11	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK124285	IMS10-H06	FLJ	W01C094P12	pDONR221	22086		FLJ42291	346547	BAC85827.1					liver, tumor tissue	TLIVE2														
IKAKEN	AK126284	IMS10-H07	FLJ	W01C094P13	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126284	IMS10-H07	FLJ	W01C094P14	pDONR221	9331		FAM92B	339145	BAC86515.1	Hs.125713	Family with sequence similarity 92, member B			trachea	TRACH2		NM_198491.1	NP_940893.1	PREDICTED	Cs	0.997	0.997	304	915	1	912	304	1	304
IKAKEN	AK126293	IMS10-H08	FLJ	W01C094P15	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126293	IMS10-H08	FLJ	W01C094P16	pDONR221	11053		FLJ44313	400658	BAC86516.1	Hs.451549	FLJ44313 protein			trachea	TRACH2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C094P17	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126430	IMS10-H09	FLJ	W01C094P18	pDONR221	15938		C22orf34	348645	BAC86548.1	Hs.660314	Chromosome 22 open reading frame 34			uterus, tumor tissue	TUTER2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C094P19	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK126441	IMS10-H10	FLJ	W01C094P20	pDONR221	17664		FLJ44477	401157	BAC86552	Hs.531403	FLJ44477 protein			uterus	UTERU2														
IKAKEN	AK124915	IMS10-H11	FLJ	W01C094P21	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124915	IMS10-H11	FLJ	W01C094P22	pDONR221	24772		LANCL3	347404	BAC85993.1	Hs.521932	LanC lantibiotic synthetase component C-like 3 (bacterial)			hippocampus	BRHIP3		NM_198511.1	NP_940913.1	PROVISIONAL	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	AK124384	IMS10-H12	FLJ	W01C094P23	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK124384	IMS10-H12	FLJ	W01C094P24	pDONR221	16473		FLJ42393	401105	BAC85844.1	Hs.679026	Hypothetical LOC401105			uterus	UTERU1														
IKAKEN	AK123126	IMS11-A01	FLJ	W01C095A01	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK123126	IMS11-A01	FLJ	W01C095A02	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK124452	IMS11-A02	FLJ	W01C095A03	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK124452	IMS11-A02	FLJ	W01C095A04	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK125584	IMS11-A03	FLJ	W01C095A05	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK125584	IMS11-A03	FLJ	W01C095A06	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK126247	IMS11-A04	FLJ	W01C095A07	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126247	IMS11-A04	FLJ	W01C095A08	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126249	IMS11-A05	FLJ	W01C095A09	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK126249	IMS11-A05	FLJ	W01C095A10	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK123544	IMS11-A06	FLJ	W01C095A11	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK123544	IMS11-A06	FLJ	W01C095A12	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK125159	IMS11-A07	FLJ	W01C095A13	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125159	IMS11-A07	FLJ	W01C095A14	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125163	IMS11-A08	FLJ	W01C095A15	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125163	IMS11-A08	FLJ	W01C095A16	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125166	IMS11-A09	FLJ	W01C095A17	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A09	FLJ	W01C095A18	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C095A19	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C095A20	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C095A21	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C095A22	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125178	IMS11-A12	FLJ	W01C095A23	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK125178	IMS11-A12	FLJ	W01C095A24	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK123126	IMS11-A01	FLJ	W01C095B01	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK123126	IMS11-A01	FLJ	W01C095B02	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK124452	IMS11-A02	FLJ	W01C095B03	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK124452	IMS11-A02	FLJ	W01C095B04	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK125584	IMS11-A03	FLJ	W01C095B05	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK125584	IMS11-A03	FLJ	W01C095B06	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK126247	IMS11-A04	FLJ	W01C095B07	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126247	IMS11-A04	FLJ	W01C095B08	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126249	IMS11-A05	FLJ	W01C095B09	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK126249	IMS11-A05	FLJ	W01C095B10	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK123544	IMS11-A06	FLJ	W01C095B11	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK123544	IMS11-A06	FLJ	W01C095B12	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK125159	IMS11-A07	FLJ	W01C095B13	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125159	IMS11-A07	FLJ	W01C095B14	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125163	IMS11-A08	FLJ	W01C095B15	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125163	IMS11-A08	FLJ	W01C095B16	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125166	IMS11-A09	FLJ	W01C095B17	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A09	FLJ	W01C095B18	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C095B19	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C095B20	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C095B21	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C095B22	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125178	IMS11-A12	FLJ	W01C095B23	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK125178	IMS11-A12	FLJ	W01C095B24	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK124744	IMS11-B01	FLJ	W01C095C01	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124744	IMS11-B01	FLJ	W01C095C02	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124773	IMS11-B02	FLJ	W01C095C03	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124773	IMS11-B02	FLJ	W01C095C04	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124785	IMS11-B03	FLJ	W01C095C05	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B03	FLJ	W01C095C06	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C095C07	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C095C08	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C095C09	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C095C10	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125677	IMS11-B06	FLJ	W01C095C11	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125677	IMS11-B06	FLJ	W01C095C12	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125680	IMS11-B07	FLJ	W01C095C13	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125680	IMS11-B07	FLJ	W01C095C14	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125682	IMS11-B08	FLJ	W01C095C15	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125682	IMS11-B08	FLJ	W01C095C16	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125796	IMS11-B09	FLJ	W01C095C17	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125796	IMS11-B09	FLJ	W01C095C18	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125814	IMS11-B10	FLJ	W01C095C19	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125814	IMS11-B10	FLJ	W01C095C20	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125830	IMS11-B11	FLJ	W01C095C21	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125830	IMS11-B11	FLJ	W01C095C22	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125843	IMS11-B12	FLJ	W01C095C23	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK125843	IMS11-B12	FLJ	W01C095C24	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK124744	IMS11-B01	FLJ	W01C095D01	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124744	IMS11-B01	FLJ	W01C095D02	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124773	IMS11-B02	FLJ	W01C095D03	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124773	IMS11-B02	FLJ	W01C095D04	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124785	IMS11-B03	FLJ	W01C095D05	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B03	FLJ	W01C095D06	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C095D07	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C095D08	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C095D09	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C095D10	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125677	IMS11-B06	FLJ	W01C095D11	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125677	IMS11-B06	FLJ	W01C095D12	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125680	IMS11-B07	FLJ	W01C095D13	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125680	IMS11-B07	FLJ	W01C095D14	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125682	IMS11-B08	FLJ	W01C095D15	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125682	IMS11-B08	FLJ	W01C095D16	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125796	IMS11-B09	FLJ	W01C095D17	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125796	IMS11-B09	FLJ	W01C095D18	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125814	IMS11-B10	FLJ	W01C095D19	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125814	IMS11-B10	FLJ	W01C095D20	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125830	IMS11-B11	FLJ	W01C095D21	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125830	IMS11-B11	FLJ	W01C095D22	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125843	IMS11-B12	FLJ	W01C095D23	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK125843	IMS11-B12	FLJ	W01C095D24	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK125845	IMS11-C01	FLJ	W01C095E01	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125845	IMS11-C01	FLJ	W01C095E02	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125847	IMS11-C02	FLJ	W01C095E03	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125847	IMS11-C02	FLJ	W01C095E04	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125848	IMS11-C03	FLJ	W01C095E05	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125848	IMS11-C03	FLJ	W01C095E06	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125851	IMS11-C04	FLJ	W01C095E07	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125851	IMS11-C04	FLJ	W01C095E08	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125858	IMS11-C05	FLJ	W01C095E09	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125858	IMS11-C05	FLJ	W01C095E10	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125894	IMS11-C06	FLJ	W01C095E11	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125894	IMS11-C06	FLJ	W01C095E12	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125905	IMS11-C07	FLJ	W01C095E13	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125905	IMS11-C07	FLJ	W01C095E14	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125921	IMS11-C08	FLJ	W01C095E15	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C08	FLJ	W01C095E16	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C095E17	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C095E18	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125924	IMS11-C10	FLJ	W01C095E19	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125924	IMS11-C10	FLJ	W01C095E20	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125932	IMS11-C11	FLJ	W01C095E21	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125932	IMS11-C11	FLJ	W01C095E22	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125951	IMS11-C12	FLJ	W01C095E23	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125951	IMS11-C12	FLJ	W01C095E24	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125845	IMS11-C01	FLJ	W01C095F01	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125845	IMS11-C01	FLJ	W01C095F02	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125847	IMS11-C02	FLJ	W01C095F03	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125847	IMS11-C02	FLJ	W01C095F04	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125848	IMS11-C03	FLJ	W01C095F05	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125848	IMS11-C03	FLJ	W01C095F06	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125851	IMS11-C04	FLJ	W01C095F07	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125851	IMS11-C04	FLJ	W01C095F08	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125858	IMS11-C05	FLJ	W01C095F09	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125858	IMS11-C05	FLJ	W01C095F10	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125894	IMS11-C06	FLJ	W01C095F11	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125894	IMS11-C06	FLJ	W01C095F12	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125905	IMS11-C07	FLJ	W01C095F13	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125905	IMS11-C07	FLJ	W01C095F14	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125921	IMS11-C08	FLJ	W01C095F15	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C08	FLJ	W01C095F16	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C095F17	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C095F18	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125924	IMS11-C10	FLJ	W01C095F19	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125924	IMS11-C10	FLJ	W01C095F20	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125932	IMS11-C11	FLJ	W01C095F21	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125932	IMS11-C11	FLJ	W01C095F22	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125951	IMS11-C12	FLJ	W01C095F23	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125951	IMS11-C12	FLJ	W01C095F24	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125953	IMS11-D01	FLJ	W01C095G01	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125953	IMS11-D01	FLJ	W01C095G02	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125955	IMS11-D02	FLJ	W01C095G03	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125955	IMS11-D02	FLJ	W01C095G04	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125956	IMS11-D03	FLJ	W01C095G05	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125956	IMS11-D03	FLJ	W01C095G06	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125957	IMS11-D04	FLJ	W01C095G07	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125957	IMS11-D04	FLJ	W01C095G08	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125971	IMS11-D05	FLJ	W01C095G09	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK125971	IMS11-D05	FLJ	W01C095G10	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK126207	IMS11-D06	FLJ	W01C095G11	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126207	IMS11-D06	FLJ	W01C095G12	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126300	IMS11-D07	FLJ	W01C095G13	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126300	IMS11-D07	FLJ	W01C095G14	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126311	IMS11-D08	FLJ	W01C095G15	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126311	IMS11-D08	FLJ	W01C095G16	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126319	IMS11-D09	FLJ	W01C095G17	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK126319	IMS11-D09	FLJ	W01C095G18	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK125978	IMS11-D10	FLJ	W01C095G19	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125978	IMS11-D10	FLJ	W01C095G20	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125984	IMS11-D11	FLJ	W01C095G21	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125984	IMS11-D11	FLJ	W01C095G22	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125993	IMS11-D12	FLJ	W01C095G23	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125993	IMS11-D12	FLJ	W01C095G24	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125953	IMS11-D01	FLJ	W01C095H01	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125953	IMS11-D01	FLJ	W01C095H02	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125955	IMS11-D02	FLJ	W01C095H03	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125955	IMS11-D02	FLJ	W01C095H04	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125956	IMS11-D03	FLJ	W01C095H05	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125956	IMS11-D03	FLJ	W01C095H06	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125957	IMS11-D04	FLJ	W01C095H07	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125957	IMS11-D04	FLJ	W01C095H08	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125971	IMS11-D05	FLJ	W01C095H09	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK125971	IMS11-D05	FLJ	W01C095H10	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK126207	IMS11-D06	FLJ	W01C095H11	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126207	IMS11-D06	FLJ	W01C095H12	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126300	IMS11-D07	FLJ	W01C095H13	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126300	IMS11-D07	FLJ	W01C095H14	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126311	IMS11-D08	FLJ	W01C095H15	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126311	IMS11-D08	FLJ	W01C095H16	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126319	IMS11-D09	FLJ	W01C095H17	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK126319	IMS11-D09	FLJ	W01C095H18	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK125978	IMS11-D10	FLJ	W01C095H19	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125978	IMS11-D10	FLJ	W01C095H20	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125984	IMS11-D11	FLJ	W01C095H21	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125984	IMS11-D11	FLJ	W01C095H22	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125993	IMS11-D12	FLJ	W01C095H23	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125993	IMS11-D12	FLJ	W01C095H24	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125994	IMS11-E01	FLJ	W01C095I01	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK125994	IMS11-E01	FLJ	W01C095I02	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK126018	IMS11-E02	FLJ	W01C095I03	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126018	IMS11-E02	FLJ	W01C095I04	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126032	IMS11-E03	FLJ	W01C095I05	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126032	IMS11-E03	FLJ	W01C095I06	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126035	IMS11-E04	FLJ	W01C095I07	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126035	IMS11-E04	FLJ	W01C095I08	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126038	IMS11-E05	FLJ	W01C095I09	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126038	IMS11-E05	FLJ	W01C095I10	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126042	IMS11-E06	FLJ	W01C095I11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126042	IMS11-E06	FLJ	W01C095I12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126045	IMS11-E07	FLJ	W01C095I13	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E07	FLJ	W01C095I14	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E08	FLJ	W01C095I15	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126045	IMS11-E08	FLJ	W01C095I16	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126048	IMS11-E09	FLJ	W01C095I17	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126048	IMS11-E09	FLJ	W01C095I18	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126051	IMS11-E10	FLJ	W01C095I19	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126051	IMS11-E10	FLJ	W01C095I20	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126055	IMS11-E11	FLJ	W01C095I21	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126055	IMS11-E11	FLJ	W01C095I22	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126064	IMS11-E12	FLJ	W01C095I23	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK126064	IMS11-E12	FLJ	W01C095I24	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK125994	IMS11-E01	FLJ	W01C095J01	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK125994	IMS11-E01	FLJ	W01C095J02	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK126018	IMS11-E02	FLJ	W01C095J03	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126018	IMS11-E02	FLJ	W01C095J04	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126032	IMS11-E03	FLJ	W01C095J05	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126032	IMS11-E03	FLJ	W01C095J06	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126035	IMS11-E04	FLJ	W01C095J07	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126035	IMS11-E04	FLJ	W01C095J08	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126038	IMS11-E05	FLJ	W01C095J09	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126038	IMS11-E05	FLJ	W01C095J10	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126042	IMS11-E06	FLJ	W01C095J11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126042	IMS11-E06	FLJ	W01C095J12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126045	IMS11-E07	FLJ	W01C095J13	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E07	FLJ	W01C095J14	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E08	FLJ	W01C095J15	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126045	IMS11-E08	FLJ	W01C095J16	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126048	IMS11-E09	FLJ	W01C095J17	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126048	IMS11-E09	FLJ	W01C095J18	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126051	IMS11-E10	FLJ	W01C095J19	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126051	IMS11-E10	FLJ	W01C095J20	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126055	IMS11-E11	FLJ	W01C095J21	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126055	IMS11-E11	FLJ	W01C095J22	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126064	IMS11-E12	FLJ	W01C095J23	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK126064	IMS11-E12	FLJ	W01C095J24	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK126066	IMS11-F01	FLJ	W01C095K01	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126066	IMS11-F01	FLJ	W01C095K02	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126070	IMS11-F02	FLJ	W01C095K03	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126070	IMS11-F02	FLJ	W01C095K04	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126100	IMS11-F03	FLJ	W01C095K05	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK126100	IMS11-F03	FLJ	W01C095K06	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK125817	IMS11-F04	FLJ	W01C095K07	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125817	IMS11-F04	FLJ	W01C095K08	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125842	IMS11-F05	FLJ	W01C095K09	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125842	IMS11-F05	FLJ	W01C095K10	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125867	IMS11-F06	FLJ	W01C095K11	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK125867	IMS11-F06	FLJ	W01C095K12	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK124993	IMS11-F07	FLJ	W01C095K13	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK124993	IMS11-F07	FLJ	W01C095K14	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK125794	IMS11-F08	FLJ	W01C095K15	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK125794	IMS11-F08	FLJ	W01C095K16	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK126276	IMS11-F09	FLJ	W01C095K17	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK126276	IMS11-F09	FLJ	W01C095K18	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK122596	IMS11-F10	FLJ	W01C095K19	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122596	IMS11-F10	FLJ	W01C095K20	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122609	IMS11-F11	FLJ	W01C095K21	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK122609	IMS11-F11	FLJ	W01C095K22	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK131211	IMS11-F12	FLJ	W01C095K23	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK131211	IMS11-F12	FLJ	W01C095K24	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK126066	IMS11-F01	FLJ	W01C095L01	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126066	IMS11-F01	FLJ	W01C095L02	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126070	IMS11-F02	FLJ	W01C095L03	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126070	IMS11-F02	FLJ	W01C095L04	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126100	IMS11-F03	FLJ	W01C095L05	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK126100	IMS11-F03	FLJ	W01C095L06	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK125817	IMS11-F04	FLJ	W01C095L07	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125817	IMS11-F04	FLJ	W01C095L08	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125842	IMS11-F05	FLJ	W01C095L09	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125842	IMS11-F05	FLJ	W01C095L10	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125867	IMS11-F06	FLJ	W01C095L11	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK125867	IMS11-F06	FLJ	W01C095L12	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK124993	IMS11-F07	FLJ	W01C095L13	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK124993	IMS11-F07	FLJ	W01C095L14	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK125794	IMS11-F08	FLJ	W01C095L15	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK125794	IMS11-F08	FLJ	W01C095L16	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK126276	IMS11-F09	FLJ	W01C095L17	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK126276	IMS11-F09	FLJ	W01C095L18	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK122596	IMS11-F10	FLJ	W01C095L19	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122596	IMS11-F10	FLJ	W01C095L20	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122609	IMS11-F11	FLJ	W01C095L21	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK122609	IMS11-F11	FLJ	W01C095L22	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK131211	IMS11-F12	FLJ	W01C095L23	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK131211	IMS11-F12	FLJ	W01C095L24	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK131500	IMS11-G01	FLJ	W01C095M01	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131500	IMS11-G01	FLJ	W01C095M02	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131274	IMS11-G02	FLJ	W01C095M03	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131274	IMS11-G02	FLJ	W01C095M04	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131348	IMS11-G03	FLJ	W01C095M05	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131348	IMS11-G03	FLJ	W01C095M06	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131505	IMS11-G04	FLJ	W01C095M07	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131505	IMS11-G04	FLJ	W01C095M08	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131219	IMS11-G05	FLJ	W01C095M09	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131219	IMS11-G05	FLJ	W01C095M10	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131400	IMS11-G06	FLJ	W01C095M11	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131400	IMS11-G06	FLJ	W01C095M12	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131289	IMS11-G07	FLJ	W01C095M13	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131289	IMS11-G07	FLJ	W01C095M14	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131205	IMS11-G08	FLJ	W01C095M15	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131205	IMS11-G08	FLJ	W01C095M16	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131518	IMS11-G09	FLJ	W01C095M17	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131518	IMS11-G09	FLJ	W01C095M18	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131280	IMS11-G10	FLJ	W01C095M19	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131280	IMS11-G10	FLJ	W01C095M20	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131380	IMS11-G11	FLJ	W01C095M21	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131380	IMS11-G11	FLJ	W01C095M22	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131244	IMS11-G12	FLJ	W01C095M23	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131244	IMS11-G12	FLJ	W01C095M24	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131500	IMS11-G01	FLJ	W01C095N01	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131500	IMS11-G01	FLJ	W01C095N02	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131274	IMS11-G02	FLJ	W01C095N03	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131274	IMS11-G02	FLJ	W01C095N04	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131348	IMS11-G03	FLJ	W01C095N05	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131348	IMS11-G03	FLJ	W01C095N06	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131505	IMS11-G04	FLJ	W01C095N07	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131505	IMS11-G04	FLJ	W01C095N08	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131219	IMS11-G05	FLJ	W01C095N09	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131219	IMS11-G05	FLJ	W01C095N10	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131400	IMS11-G06	FLJ	W01C095N11	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131400	IMS11-G06	FLJ	W01C095N12	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131289	IMS11-G07	FLJ	W01C095N13	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131289	IMS11-G07	FLJ	W01C095N14	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131205	IMS11-G08	FLJ	W01C095N15	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131205	IMS11-G08	FLJ	W01C095N16	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131518	IMS11-G09	FLJ	W01C095N17	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131518	IMS11-G09	FLJ	W01C095N18	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131280	IMS11-G10	FLJ	W01C095N19	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131280	IMS11-G10	FLJ	W01C095N20	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131380	IMS11-G11	FLJ	W01C095N21	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131380	IMS11-G11	FLJ	W01C095N22	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131244	IMS11-G12	FLJ	W01C095N23	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131244	IMS11-G12	FLJ	W01C095N24	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131245	IMS11-H01	FLJ	W01C095O01	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131245	IMS11-H01	FLJ	W01C095O02	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131392	IMS11-H02	FLJ	W01C095O03	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131392	IMS11-H02	FLJ	W01C095O04	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131497	IMS11-H03	FLJ	W01C095O05	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H03	FLJ	W01C095O06	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C095O07	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C095O08	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131470	IMS11-H05	FLJ	W01C095O09	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131470	IMS11-H05	FLJ	W01C095O10	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131471	IMS11-H06	FLJ	W01C095O11	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H06	FLJ	W01C095O12	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C095O13	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C095O14	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131195	IMS11-H08	FLJ	W01C095O15	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK131195	IMS11-H08	FLJ	W01C095O16	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK127878	IMS11-H09	FLJ	W01C095O17	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127878	IMS11-H09	FLJ	W01C095O18	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127704	IMS11-H10	FLJ	W01C095O19	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127704	IMS11-H10	FLJ	W01C095O20	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127808	IMS11-H11	FLJ	W01C095O21	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127808	IMS11-H11	FLJ	W01C095O22	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127223	IMS11-H12	FLJ	W01C095O23	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK127223	IMS11-H12	FLJ	W01C095O24	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK131245	IMS11-H01	FLJ	W01C095P01	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131245	IMS11-H01	FLJ	W01C095P02	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131392	IMS11-H02	FLJ	W01C095P03	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131392	IMS11-H02	FLJ	W01C095P04	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131497	IMS11-H03	FLJ	W01C095P05	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H03	FLJ	W01C095P06	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C095P07	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C095P08	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131470	IMS11-H05	FLJ	W01C095P09	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131470	IMS11-H05	FLJ	W01C095P10	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131471	IMS11-H06	FLJ	W01C095P11	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H06	FLJ	W01C095P12	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C095P13	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C095P14	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131195	IMS11-H08	FLJ	W01C095P15	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK131195	IMS11-H08	FLJ	W01C095P16	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK127878	IMS11-H09	FLJ	W01C095P17	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127878	IMS11-H09	FLJ	W01C095P18	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127704	IMS11-H10	FLJ	W01C095P19	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127704	IMS11-H10	FLJ	W01C095P20	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127808	IMS11-H11	FLJ	W01C095P21	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127808	IMS11-H11	FLJ	W01C095P22	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127223	IMS11-H12	FLJ	W01C095P23	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK127223	IMS11-H12	FLJ	W01C095P24	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK123126	IMS11-A01	FLJ	W01C096A01	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK123126	IMS11-A01	FLJ	W01C096A02	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK124452	IMS11-A02	FLJ	W01C096A03	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK124452	IMS11-A02	FLJ	W01C096A04	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK125584	IMS11-A03	FLJ	W01C096A05	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK125584	IMS11-A03	FLJ	W01C096A06	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK126247	IMS11-A04	FLJ	W01C096A07	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126247	IMS11-A04	FLJ	W01C096A08	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126249	IMS11-A05	FLJ	W01C096A09	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK126249	IMS11-A05	FLJ	W01C096A10	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK123544	IMS11-A06	FLJ	W01C096A11	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK123544	IMS11-A06	FLJ	W01C096A12	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK125159	IMS11-A07	FLJ	W01C096A13	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125159	IMS11-A07	FLJ	W01C096A14	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125163	IMS11-A08	FLJ	W01C096A15	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125163	IMS11-A08	FLJ	W01C096A16	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125166	IMS11-A09	FLJ	W01C096A17	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A09	FLJ	W01C096A18	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C096A19	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C096A20	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C096A21	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C096A22	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125178	IMS11-A12	FLJ	W01C096A23	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK125178	IMS11-A12	FLJ	W01C096A24	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK123126	IMS11-A01	FLJ	W01C096B01	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK123126	IMS11-A01	FLJ	W01C096B02	pDONR221	12569		C19orf54	284325	BAC85538.1	Hs.585105	Chromosome 19 open reading frame 54	NT2	teratocarcinoma		NT2RP7		NM_198476.3	NP_940878.3	VALIDATED	Pfs	0.983	1.000	174	513	1	512	351	139	312
IKAKEN	AK124452	IMS11-A02	FLJ	W01C096B03	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK124452	IMS11-A02	FLJ	W01C096B04	pDONR221	9930		SMTNL2	342527	BAC85855.1	Hs.441709	Smoothelin-like 2			cerebellum	BRACE2		NM_198501.2	NP_940903.2	VALIDATED	OK	1.000	1.000	317	954	1	951	317	1	317
IKAKEN	AK125584	IMS11-A03	FLJ	W01C096B05	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK125584	IMS11-A03	FLJ	W01C096B06	pDONR221	10924		LOC348262	348262	BAC86211.1	Hs.514632	Hypothetical protein LOC348262	SK-N-MC	neuroepithelioma		SKNMC2		NM_001093767.1	NP_001087236.1	VALIDATED		0.750	0.750	8	534	243	220	97	15	22
IKAKEN	AK126247	IMS11-A04	FLJ	W01C096B07	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126247	IMS11-A04	FLJ	W01C096B08	pDONR221	11259		C18orf45	85019	BAC86502.1	Hs.137562	Chromosome 18 open reading frame 45			thymus	THYMU3		NM_032933.4	NP_116322.3	VALIDATED	Pfs	0.909	1.000	176	480	1	479	296	1	176
IKAKEN	AK126249	IMS11-A05	FLJ	W01C096B09	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK126249	IMS11-A05	FLJ	W01C096B10	pDONR221	22662		DOCK5	80005	BAC86503.1	Hs.195403	Dedicator of cytokinesis 5			liver, tumor tissue	TLIVE2		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	792	2379	1	2376	1870	1079	1870
IKAKEN	AK123544	IMS11-A06	FLJ	W01C096B11	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK123544	IMS11-A06	FLJ	W01C096B12	pDONR221	14753		C20orf118	140711	BAG53910.1	Hs.472630	Chromosome 20 open reading frame 118			thalamus	BRTHA2		NM_080628.1	NP_542195.1	PREDICTED	P	1.000	1.000	119	360	1	357	215	97	215
IKAKEN	AK125159	IMS11-A07	FLJ	W01C096B13	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125159	IMS11-A07	FLJ	W01C096B14	pDONR221	7157		TMEM63C	57156	BAG54157.1	Hs.22452	Transmembrane protein 63C			brain	FCBBF2		NM_020431.2	NP_065164.2	VALIDATED	OK	1.000	1.000	806	2421	1	2418	806	1	806
IKAKEN	AK125163	IMS11-A08	FLJ	W01C096B15	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125163	IMS11-A08	FLJ	W01C096B16	pDONR221	18541		PLEKHG4B	153478	BAC86068	Hs.535800	Pleckstrin homology domain containing, family G (with RhoGef domain) member 4B			brain	FCBBF3		NM_052909.3	NP_443141.3	VALIDATED	Ps	0.993	0.993	305	963	1	915	1271	810	1114
IKAKEN	AK125166	IMS11-A09	FLJ	W01C096B17	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A09	FLJ	W01C096B18	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C096B19	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A10	FLJ	W01C096B20	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C096B21	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125166	IMS11-A11	FLJ	W01C096B22	pDONR221	21993		LOC441268	441268	BAC86069	Hs.700070	Hypothetical gene supported by BC044942			brain	FCBBF3														
IKAKEN	AK125178	IMS11-A12	FLJ	W01C096B23	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK125178	IMS11-A12	FLJ	W01C096B24	pDONR221	24150		TTLL11	158135	BAC86073.1	Hs.640663	Tubulin tyrosine ligase-like family, member 11			brain	FCBBF3		NM_194252.2	NP_919228.2	VALIDATED	Ps	0.995	0.995	191	708	1	573	538	324	514
IKAKEN	AK124744	IMS11-B01	FLJ	W01C096C01	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124744	IMS11-B01	FLJ	W01C096C02	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124773	IMS11-B02	FLJ	W01C096C03	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124773	IMS11-B02	FLJ	W01C096C04	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124785	IMS11-B03	FLJ	W01C096C05	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B03	FLJ	W01C096C06	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C096C07	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C096C08	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C096C09	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C096C10	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125677	IMS11-B06	FLJ	W01C096C11	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125677	IMS11-B06	FLJ	W01C096C12	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125680	IMS11-B07	FLJ	W01C096C13	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125680	IMS11-B07	FLJ	W01C096C14	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125682	IMS11-B08	FLJ	W01C096C15	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125682	IMS11-B08	FLJ	W01C096C16	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125796	IMS11-B09	FLJ	W01C096C17	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125796	IMS11-B09	FLJ	W01C096C18	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125814	IMS11-B10	FLJ	W01C096C19	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125814	IMS11-B10	FLJ	W01C096C20	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125830	IMS11-B11	FLJ	W01C096C21	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125830	IMS11-B11	FLJ	W01C096C22	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125843	IMS11-B12	FLJ	W01C096C23	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK125843	IMS11-B12	FLJ	W01C096C24	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK124744	IMS11-B01	FLJ	W01C096D01	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124744	IMS11-B01	FLJ	W01C096D02	pDONR221	6002		PPTC7	160760	BAG54087.1	Hs.13854	PTC7 protein phosphatase homolog (S. cerevisiae)			amygdala	BRAMY3		NM_139283.1	NP_644812.1	PROVISIONAL	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK124773	IMS11-B02	FLJ	W01C096D03	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124773	IMS11-B02	FLJ	W01C096D04	pDONR221	21337		C7orf51	222950	BAC85942.1	Hs.320086	Chromosome 7 open reading frame 51			brain	BRAWH3		NM_173564.2	NP_775835.2	PREDICTED	OK	1.000	1.000	841	2526	1	2523	841	1	841
IKAKEN	AK124785	IMS11-B03	FLJ	W01C096D05	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B03	FLJ	W01C096D06	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C096D07	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B04	FLJ	W01C096D08	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C096D09	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK124785	IMS11-B05	FLJ	W01C096D10	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	AK125677	IMS11-B06	FLJ	W01C096D11	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125677	IMS11-B06	FLJ	W01C096D12	pDONR221	15416		LOC441956	441956	BAC86242.1	Hs.535148	Similar to cDNA sequence BC021523			spleen	SPLEN2		NM_001013729.1	NP_001013751.1	MODEL	OK	1.000	1.000	139	420	1	417	139	1	139
IKAKEN	AK125680	IMS11-B07	FLJ	W01C096D13	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125680	IMS11-B07	FLJ	W01C096D14	pDONR221	22091		ARHGEF5L	445328	BAC86243.1	Hs.718740	Rho guanine nucleotide exchange factor (GEF) 5-like			breast, tumor tissue	TBAES2		NM_001003702.1	NP_001003702.1	PROVISIONAL	Cs	0.998	0.998	484	1455	1	1452	484	1	484
IKAKEN	AK125682	IMS11-B08	FLJ	W01C096D15	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125682	IMS11-B08	FLJ	W01C096D16	pDONR221	16472		TPRG1	285386	BAC86245.1	Hs.338851	Tumor protein p63 regulated 1			breast, tumor tissue	TBAES2		NM_198485.3	NP_940887.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK125796	IMS11-B09	FLJ	W01C096D17	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125796	IMS11-B09	FLJ	W01C096D18	pDONR221	32090		DNAH10	196385	BAC86296.1	Hs.622654	Dynein, axonemal, heavy chain 10			testis	TESTI4		NM_001083900.1	NP_001077369.1	VALIDATED	Ps	0.998	0.998	616	1854	1	1848	4471	1518	2133
IKAKEN	AK125814	IMS11-B10	FLJ	W01C096D19	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125814	IMS11-B10	FLJ	W01C096D20	pDONR221	9932		FLJ43826	342666	BAC86303.1					testis	TESTI4														
IKAKEN	AK125830	IMS11-B11	FLJ	W01C096D21	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125830	IMS11-B11	FLJ	W01C096D22	pDONR221	15917		DERL3	91319	BAC86311.1	Hs.593679	Der1-like domain family, member 3			testis	TESTI4		NM_198440.3	NP_940842.2	REVIEWED	Pfs	0.617	0.763	162	678	1	484	205	75	205
IKAKEN	AK125843	IMS11-B12	FLJ	W01C096D23	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK125843	IMS11-B12	FLJ	W01C096D24	pDONR221	9328		SLC6A10P	386757	BAC86314.1	Hs.433146	Solute carrier family 6 (neurotransmitter transporter, creatine), member 10 (pseudogene)			testis	TESTI4														
IKAKEN	AK125845	IMS11-C01	FLJ	W01C096E01	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125845	IMS11-C01	FLJ	W01C096E02	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125847	IMS11-C02	FLJ	W01C096E03	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125847	IMS11-C02	FLJ	W01C096E04	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125848	IMS11-C03	FLJ	W01C096E05	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125848	IMS11-C03	FLJ	W01C096E06	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125851	IMS11-C04	FLJ	W01C096E07	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125851	IMS11-C04	FLJ	W01C096E08	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125858	IMS11-C05	FLJ	W01C096E09	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125858	IMS11-C05	FLJ	W01C096E10	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125894	IMS11-C06	FLJ	W01C096E11	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125894	IMS11-C06	FLJ	W01C096E12	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125905	IMS11-C07	FLJ	W01C096E13	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125905	IMS11-C07	FLJ	W01C096E14	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125921	IMS11-C08	FLJ	W01C096E15	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C08	FLJ	W01C096E16	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C096E17	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C096E18	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125924	IMS11-C10	FLJ	W01C096E19	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125924	IMS11-C10	FLJ	W01C096E20	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125932	IMS11-C11	FLJ	W01C096E21	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125932	IMS11-C11	FLJ	W01C096E22	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125951	IMS11-C12	FLJ	W01C096E23	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125951	IMS11-C12	FLJ	W01C096E24	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125845	IMS11-C01	FLJ	W01C096F01	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125845	IMS11-C01	FLJ	W01C096F02	pDONR221	23682		C9orf79	286234	BAC86315.1	Hs.130672	Chromosome 9 open reading frame 79			testis	TESTI4		NM_178828.4	NP_849150.3	VALIDATED	OK	1.000	1.000	1445	4338	1	4335	1445	1	1445
IKAKEN	AK125847	IMS11-C02	FLJ	W01C096F03	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125847	IMS11-C02	FLJ	W01C096F04	pDONR221	23712		FLJ43859	389761	BAC86316.1					testis	TESTI4		NM_001145197.1	NP_001138669.1	VALIDATED	Cfs	0.998	1.000	917	4338	1	2746	917	1	917
IKAKEN	AK125848	IMS11-C03	FLJ	W01C096F05	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125848	IMS11-C03	FLJ	W01C096F06	pDONR221	23188		FLJ43860	389690	BAC86317.1	Hs.689547	FLJ43860 protein			testis	TESTI4		NM_207414.2	NP_997297.2	VALIDATED	Cfs	0.999	0.999	1318	3957	1	3954	1318	1	1318
IKAKEN	AK125851	IMS11-C04	FLJ	W01C096F07	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125851	IMS11-C04	FLJ	W01C096F08	pDONR221	4020		ACTN3	89	-	Hs.654432	Actinin, alpha 3			testis	TESTI4		NM_001104.1	NP_001095.1	REVIEWED	Cfs	0.996	0.996	901	2706	1	2703	901	1	901
IKAKEN	AK125858	IMS11-C05	FLJ	W01C096F09	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125858	IMS11-C05	FLJ	W01C096F10	pDONR221	11839			400686	BAC86323					testis	TESTI4				
IKAKEN	AK125894	IMS11-C06	FLJ	W01C096F11	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125894	IMS11-C06	FLJ	W01C096F12	pDONR221	4519		C2CD3	26005	BAC86334.1	Hs.694798	C2 calcium-dependent domain containing 3			testis	TESTI4		NM_015531.4	NP_056346.3	VALIDATED	P	1.000	1.000	1224	3675	1	3672	1963	740	1963
IKAKEN	AK125905	IMS11-C07	FLJ	W01C096F13	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125905	IMS11-C07	FLJ	W01C096F14	pDONR221	35918		LOC100129581	100129581	BAC86338	Hs.640189	Hypothetical LOC100129581			testis	TESTI4		XM_001718835.1	XP_001718887.1	MODEL	OK	1.000	1.000	152	459	1	456	152	1	152
IKAKEN	AK125921	IMS11-C08	FLJ	W01C096F15	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C08	FLJ	W01C096F16	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL		0.975	0.975	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C096F17	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125921	IMS11-C09	FLJ	W01C096F18	pDONR221	14187		LOC440905	440905	BAC86344.2	Hs.469918	Hypothetical LOC440905			testis	TESTI4		XM_001723708.1	XP_001723760.1	MODEL	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	AK125924	IMS11-C10	FLJ	W01C096F19	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125924	IMS11-C10	FLJ	W01C096F20	pDONR221	2034		NUP210L	91181	BAC86345.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	Pfs	1.000	1.000	1592	4776	1	4775	1888	277	1868
IKAKEN	AK125932	IMS11-C11	FLJ	W01C096F21	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125932	IMS11-C11	FLJ	W01C096F22	pDONR221	10633		FLJ43944	400593	BAC86349	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK125951	IMS11-C12	FLJ	W01C096F23	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125951	IMS11-C12	FLJ	W01C096F24	pDONR221	17577		FLJ43963	401147	-	Hs.585224	Similar to hypothetical protein			testis	TESTI4		XM_939700.1	XP_944793.1	MODEL										
IKAKEN	AK125953	IMS11-D01	FLJ	W01C096G01	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125953	IMS11-D01	FLJ	W01C096G02	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125955	IMS11-D02	FLJ	W01C096G03	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125955	IMS11-D02	FLJ	W01C096G04	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125956	IMS11-D03	FLJ	W01C096G05	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125956	IMS11-D03	FLJ	W01C096G06	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125957	IMS11-D04	FLJ	W01C096G07	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125957	IMS11-D04	FLJ	W01C096G08	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125971	IMS11-D05	FLJ	W01C096G09	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK125971	IMS11-D05	FLJ	W01C096G10	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK126207	IMS11-D06	FLJ	W01C096G11	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126207	IMS11-D06	FLJ	W01C096G12	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126300	IMS11-D07	FLJ	W01C096G13	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126300	IMS11-D07	FLJ	W01C096G14	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126311	IMS11-D08	FLJ	W01C096G15	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126311	IMS11-D08	FLJ	W01C096G16	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126319	IMS11-D09	FLJ	W01C096G17	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK126319	IMS11-D09	FLJ	W01C096G18	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK125978	IMS11-D10	FLJ	W01C096G19	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125978	IMS11-D10	FLJ	W01C096G20	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125984	IMS11-D11	FLJ	W01C096G21	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125984	IMS11-D11	FLJ	W01C096G22	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125993	IMS11-D12	FLJ	W01C096G23	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125993	IMS11-D12	FLJ	W01C096G24	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125953	IMS11-D01	FLJ	W01C096H01	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125953	IMS11-D01	FLJ	W01C096H02	pDONR221	18194		BEND4	389206	BAC86359.1	Hs.120591	BEN domain containing 4			testis	TESTI4		NM_001159547.1	NP_001153019.1	VALIDATED	Pg	0.954	1.000	346	1203	46	1035	441	94	439
IKAKEN	AK125955	IMS11-D02	FLJ	W01C096H03	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125955	IMS11-D02	FLJ	W01C096H04	pDONR221	7535		C14orf26	400208	-	Hs.660501	Chromosome 14 open reading frame 26			testis	TESTI4				
IKAKEN	AK125956	IMS11-D03	FLJ	W01C096H05	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125956	IMS11-D03	FLJ	W01C096H06	pDONR221	21073		UBN2	254048	BAC86361.1	Hs.624688	Ubinuclein 2			testis	TESTI4		NM_173569.3	NP_775840.3	VALIDATED	P	1.000	1.000	1021	3066	1	3063	1347	327	1347
IKAKEN	AK125957	IMS11-D04	FLJ	W01C096H07	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125957	IMS11-D04	FLJ	W01C096H08	pDONR221	14173		CCDC108	255101	BAC86362.1	Hs.147762	Coiled-coil domain containing 108			testis	TESTI4		NM_194302.2	NP_919278.2	PROVISIONAL	P	1.000	1.000	1215	3648	1	3645	1925	711	1925
IKAKEN	AK125971	IMS11-D05	FLJ	W01C096H09	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK125971	IMS11-D05	FLJ	W01C096H10	pDONR221	34315		CCDC144A	9720	BAC86369.1					testis	TESTI4		NM_014695.1	NP_055510.1	PROVISIONAL	Pgs	0.880	0.981	460	1455	1	1377	1427	954	1367
IKAKEN	AK126207	IMS11-D06	FLJ	W01C096H11	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126207	IMS11-D06	FLJ	W01C096H12	pDONR221	13208		B3GNT7	93010	BAG54296.1	Hs.299329	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7			thymus	THYMU2		NM_145236.2	NP_660279.1	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	AK126300	IMS11-D07	FLJ	W01C096H13	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126300	IMS11-D07	FLJ	W01C096H14	pDONR221	22674		UBXN2B	137886	BAG54305.1	Hs.155572	UBX domain protein 2B			trachea	TRACH2		NM_001077619.1	NP_001071087.1	VALIDATED		0.780	0.936	336	858	1	855	331	1	331
IKAKEN	AK126311	IMS11-D08	FLJ	W01C096H15	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126311	IMS11-D08	FLJ	W01C096H16	pDONR221	18749		NEURL1B	54492	-	Hs.91521	Neuralized homolog 1B (Drosophila)			trachea	TRACH3		XM_001715867.1	XP_001715919.1	MODEL	Pfs	0.320	0.327	50	645	201	347	572	29	78
IKAKEN	AK126319	IMS11-D09	FLJ	W01C096H17	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK126319	IMS11-D09	FLJ	W01C096H18	pDONR221	1964		SPAG17	200162	BAG54308.1	Hs.528821	Sperm associated antigen 17			trachea	TRACH3		NM_206996.2	NP_996879.1	VALIDATED	Pfs	0.977	0.989	355	1068	2	1065	2223	1873	2223
IKAKEN	AK125978	IMS11-D10	FLJ	W01C096H19	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125978	IMS11-D10	FLJ	W01C096H20	pDONR221	7135		TDRD9	122402	BAC86372.1	Hs.21454	Tudor domain containing 9			testis	TESTI4		NM_153046.2	NP_694591.2	VALIDATED	Pfs	0.741	0.897	1097	2721	1	2717	1382	286	1382
IKAKEN	AK125984	IMS11-D11	FLJ	W01C096H21	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125984	IMS11-D11	FLJ	W01C096H22	pDONR221	6784		hCG_2011852	643677	-	Hs.713374	Hypothetical protein LOC643677			testis	TESTI4		XM_001714647.1	XP_001714699.1	MODEL	P	1.000	1.000	507	1524	1	1521	5904	5398	5904
IKAKEN	AK125993	IMS11-D12	FLJ	W01C096H23	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125993	IMS11-D12	FLJ	W01C096H24	pDONR221	2035		NCRNA00083	400797	BAC86382.1	Hs.591460	Non-protein coding RNA 83			testis	TESTI4														
IKAKEN	AK125994	IMS11-E01	FLJ	W01C096I01	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK125994	IMS11-E01	FLJ	W01C096I02	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK126018	IMS11-E02	FLJ	W01C096I03	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126018	IMS11-E02	FLJ	W01C096I04	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126032	IMS11-E03	FLJ	W01C096I05	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126032	IMS11-E03	FLJ	W01C096I06	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126035	IMS11-E04	FLJ	W01C096I07	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126035	IMS11-E04	FLJ	W01C096I08	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126038	IMS11-E05	FLJ	W01C096I09	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126038	IMS11-E05	FLJ	W01C096I10	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126042	IMS11-E06	FLJ	W01C096I11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126042	IMS11-E06	FLJ	W01C096I12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126045	IMS11-E07	FLJ	W01C096I13	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E07	FLJ	W01C096I14	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E08	FLJ	W01C096I15	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126045	IMS11-E08	FLJ	W01C096I16	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126048	IMS11-E09	FLJ	W01C096I17	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126048	IMS11-E09	FLJ	W01C096I18	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126051	IMS11-E10	FLJ	W01C096I19	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126051	IMS11-E10	FLJ	W01C096I20	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126055	IMS11-E11	FLJ	W01C096I21	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126055	IMS11-E11	FLJ	W01C096I22	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126064	IMS11-E12	FLJ	W01C096I23	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK126064	IMS11-E12	FLJ	W01C096I24	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK125994	IMS11-E01	FLJ	W01C096J01	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK125994	IMS11-E01	FLJ	W01C096J02	pDONR221	14188		FLJ44006	400997	BAC86383	Hs.652337	Hypothetical FLJ44006			testis	TESTI4														
IKAKEN	AK126018	IMS11-E02	FLJ	W01C096J03	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126018	IMS11-E02	FLJ	W01C096J04	pDONR221	10546		B3GNTL1	146712	BAC86395	Hs.718480	UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase-like 1			testis	TESTI4		NM_001009905.1	NP_001009905.1	VALIDATED	Pfs	0.375	0.375	40	630	409	528	361	306	345
IKAKEN	AK126032	IMS11-E03	FLJ	W01C096J05	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126032	IMS11-E03	FLJ	W01C096J06	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	AK126035	IMS11-E04	FLJ	W01C096J07	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126035	IMS11-E04	FLJ	W01C096J08	pDONR221	8321		C15orf52	388115	BAC86405.1	Hs.32433	Chromosome 15 open reading frame 52			testis	TESTI4		NM_207380.2	NP_997263.2	VALIDATED	Ps	0.997	0.997	321	975	10	972	534	214	534
IKAKEN	AK126038	IMS11-E05	FLJ	W01C096J09	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126038	IMS11-E05	FLJ	W01C096J10	pDONR221	11225		C18orf34	374864	BAC86407.1	Hs.115461	Chromosome 18 open reading frame 34			testis	TESTI4		NM_198995.2	NP_945346.2	VALIDATED	OK	1.000	1.000	829	2490	1	2487	829	1	829
IKAKEN	AK126042	IMS11-E06	FLJ	W01C096J11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126042	IMS11-E06	FLJ	W01C096J12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	P	1.000	1.000	260	837	55	834	328	69	328
IKAKEN	AK126045	IMS11-E07	FLJ	W01C096J13	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E07	FLJ	W01C096J14	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	P	1.000	1.000	978	2937	1	2934	1417	440	1417
IKAKEN	AK126045	IMS11-E08	FLJ	W01C096J15	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126045	IMS11-E08	FLJ	W01C096J16	pDONR221	778		CCDC18	343099	BAC86410.1	Hs.716682	Coiled-coil domain containing 18			testis	TESTI4		NM_206886.2	NP_996769.2	VALIDATED	Pfs	0.986	0.993	286	855	1	853	1417	824	1109
IKAKEN	AK126048	IMS11-E09	FLJ	W01C096J17	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126048	IMS11-E09	FLJ	W01C096J18	pDONR221	22094		SEPT14	346288	BAC86412.1	Hs.453629	Septin 14			testis	TESTI4		NM_207366.2	NP_997249.2	VALIDATED	P	1.000	1.000	221	666	1	663	432	212	432
IKAKEN	AK126051	IMS11-E10	FLJ	W01C096J19	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126051	IMS11-E10	FLJ	W01C096J20	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	AK126055	IMS11-E11	FLJ	W01C096J21	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126055	IMS11-E11	FLJ	W01C096J22	pDONR221	24201		C9orf84	158401	BAC86417.1	Hs.428209	Chromosome 9 open reading frame 84			testis	TESTI4		NM_173521.3	NP_775792.3	VALIDATED	Pfs	0.990	1.000	100	303	2	300	1444	1346	1444
IKAKEN	AK126064	IMS11-E12	FLJ	W01C096J23	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK126064	IMS11-E12	FLJ	W01C096J24	pDONR221	17122			401080	BAC86421					testis	TESTI4				
IKAKEN	AK126066	IMS11-F01	FLJ	W01C096K01	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126066	IMS11-F01	FLJ	W01C096K02	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126070	IMS11-F02	FLJ	W01C096K03	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126070	IMS11-F02	FLJ	W01C096K04	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126100	IMS11-F03	FLJ	W01C096K05	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK126100	IMS11-F03	FLJ	W01C096K06	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK125817	IMS11-F04	FLJ	W01C096K07	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125817	IMS11-F04	FLJ	W01C096K08	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125842	IMS11-F05	FLJ	W01C096K09	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125842	IMS11-F05	FLJ	W01C096K10	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125867	IMS11-F06	FLJ	W01C096K11	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK125867	IMS11-F06	FLJ	W01C096K12	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK124993	IMS11-F07	FLJ	W01C096K13	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK124993	IMS11-F07	FLJ	W01C096K14	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK125794	IMS11-F08	FLJ	W01C096K15	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK125794	IMS11-F08	FLJ	W01C096K16	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK126276	IMS11-F09	FLJ	W01C096K17	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK126276	IMS11-F09	FLJ	W01C096K18	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK122596	IMS11-F10	FLJ	W01C096K19	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122596	IMS11-F10	FLJ	W01C096K20	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122609	IMS11-F11	FLJ	W01C096K21	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK122609	IMS11-F11	FLJ	W01C096K22	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK131211	IMS11-F12	FLJ	W01C096K23	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK131211	IMS11-F12	FLJ	W01C096K24	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK126066	IMS11-F01	FLJ	W01C096L01	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126066	IMS11-F01	FLJ	W01C096L02	pDONR221	4439		DCDC5	196296	BAC86423	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	P	1.000	1.000	380	1212	1	1140	1258	1	380
IKAKEN	AK126070	IMS11-F02	FLJ	W01C096L03	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126070	IMS11-F02	FLJ	W01C096L04	pDONR221	23714		FLJ44082	389762	BAC86424	Hs.522246	FAM75-like protein FLJ44082			testis	TESTI4		NM_207416.2	NP_997299.2	VALIDATED	P	1.000	1.000	361	1085	1	1083	917	424	784
IKAKEN	AK126100	IMS11-F03	FLJ	W01C096L05	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK126100	IMS11-F03	FLJ	W01C096L06	pDONR221	5518		C12orf63	374467	BAC86439.1	Hs.436197	Chromosome 12 open reading frame 63			testis	TESTI4		NM_198520.2	NP_940922.2	VALIDATED	OK	1.000	1.000	1197	3594	1	3591	1197	1	1197
IKAKEN	AK125817	IMS11-F04	FLJ	W01C096L07	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125817	IMS11-F04	FLJ	W01C096L08	pDONR221	9933		LOC284067	284067	-	Hs.252707	Hypothetical LOC284067			testis	TESTI4		NM_001136483.1	NP_001129955.1	PREDICTED	OK	1.000	1.000	164	495	1	492	164	1	164
IKAKEN	AK125842	IMS11-F05	FLJ	W01C096L09	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125842	IMS11-F05	FLJ	W01C096L10	pDONR221	23624		DENND4C	55667	BAC86313.1	Hs.249591	DENN/MADD domain containing 4C			testis	TESTI4		NM_017925.4	NP_060395.4	PROVISIONAL	P	1.000	1.000	1557	4674	1	4671	1673	117	1673
IKAKEN	AK125867	IMS11-F06	FLJ	W01C096L11	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK125867	IMS11-F06	FLJ	W01C096L12	pDONR221	14185		FLJ43879	401039	BAC86326.1	Hs.516791	FLJ43879 protein			testis	TESTI4														
IKAKEN	AK124993	IMS11-F07	FLJ	W01C096L13	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK124993	IMS11-F07	FLJ	W01C096L14	pDONR221	39982		LOC100128653	100128653	BAC86017.1	Hs.656985	Hypothetical LOC100128653			subthalamic nucleus	BRSTN2		XM_001721042.1	XP_001721094.1	MODEL	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	AK125794	IMS11-F08	FLJ	W01C096L15	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK125794	IMS11-F08	FLJ	W01C096L16	pDONR221	65		RP1-21O18.1	23254	BAC86294					testis	TESTI2		NM_201628.2	NP_963922.2	VALIDATED	P	1.000	1.000	222	669	1	666	775	554	775
IKAKEN	AK126276	IMS11-F09	FLJ	W01C096L17	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK126276	IMS11-F09	FLJ	W01C096L18	pDONR221	17123		DNAH12	201625	BAC86512.1	Hs.201378	Dynein, axonemal, heavy chain 12			liver, tumor tissue	TLIVE2		XM_001134433.1	XP_001134433.1	MODEL										
IKAKEN	AK122596	IMS11-F10	FLJ	W01C096L19	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122596	IMS11-F10	FLJ	W01C096L20	pDONR221	5993		CLEC4C	170482	BAG53616.1	Hs.351812	C-type lectin domain family 4, member C			thymus	TMS		NM_203503.1	NP_987099.1	REVIEWED	OK	1.000	1.000	182	549	1	546	182	1	182
IKAKEN	AK122609	IMS11-F11	FLJ	W01C096L21	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK122609	IMS11-F11	FLJ	W01C096L22	pDONR221	15044		RSPO4	343637	-	Hs.444980	R-spondin family, member 4			lung	HLUNG2		NM_001029871.2	NP_001025042.2	VALIDATED	OK	1.000	1.000	234	705	1	702	234	1	234
IKAKEN	AK131211	IMS11-F12	FLJ	W01C096L23	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK131211	IMS11-F12	FLJ	W01C096L24	pDONR221	16488		TMPRSS7	344805	BAD18401.1	Hs.435490	Transmembrane protease, serine 7			brain	FEBRA2		NM_001042575.2	NP_001036040.2	VALIDATED	P	1.000	1.000	572	1719	1	1716	717	146	717
IKAKEN	AK131500	IMS11-G01	FLJ	W01C096M01	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131500	IMS11-G01	FLJ	W01C096M02	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131274	IMS11-G02	FLJ	W01C096M03	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131274	IMS11-G02	FLJ	W01C096M04	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131348	IMS11-G03	FLJ	W01C096M05	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131348	IMS11-G03	FLJ	W01C096M06	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131505	IMS11-G04	FLJ	W01C096M07	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131505	IMS11-G04	FLJ	W01C096M08	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131219	IMS11-G05	FLJ	W01C096M09	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131219	IMS11-G05	FLJ	W01C096M10	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131400	IMS11-G06	FLJ	W01C096M11	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131400	IMS11-G06	FLJ	W01C096M12	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131289	IMS11-G07	FLJ	W01C096M13	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131289	IMS11-G07	FLJ	W01C096M14	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131205	IMS11-G08	FLJ	W01C096M15	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131205	IMS11-G08	FLJ	W01C096M16	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131518	IMS11-G09	FLJ	W01C096M17	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131518	IMS11-G09	FLJ	W01C096M18	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131280	IMS11-G10	FLJ	W01C096M19	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131280	IMS11-G10	FLJ	W01C096M20	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131380	IMS11-G11	FLJ	W01C096M21	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131380	IMS11-G11	FLJ	W01C096M22	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131244	IMS11-G12	FLJ	W01C096M23	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131244	IMS11-G12	FLJ	W01C096M24	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131500	IMS11-G01	FLJ	W01C096N01	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131500	IMS11-G01	FLJ	W01C096N02	pDONR221	10501		STAC2	342667	BAD18644.1	Hs.145068	SH3 and cysteine rich domain 2			trachea	TRACH3		NM_198993.2	NP_945344.1	VALIDATED	Cgs	0.995	0.998	412	1239	1	1236	411	1	411
IKAKEN	AK131274	IMS11-G02	FLJ	W01C096N03	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131274	IMS11-G02	FLJ	W01C096N04	pDONR221	23197		ZNF704	619279	BAD18451.1	Hs.632067	Zinc finger protein 704			hippocampus	BRHIP3		NM_001033723.1	NP_001028895.1	PROVISIONAL	Pfs	1.000	1.000	343	1035	3	1032	412	70	412
IKAKEN	AK131348	IMS11-G03	FLJ	W01C096N05	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131348	IMS11-G03	FLJ	W01C096N06	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	AK131505	IMS11-G04	FLJ	W01C096N07	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131505	IMS11-G04	FLJ	W01C096N08	pDONR221	22478		DENND3	22898	BAD18649.1	Hs.18166	DENN/MADD domain containing 3			uterus	UTERU2		NM_014957.2	NP_055772.2	VALIDATED	P	1.000	1.000	183	801	1	549	1198	951	1133
IKAKEN	AK131219	IMS11-G05	FLJ	W01C096N09	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131219	IMS11-G05	FLJ	W01C096N10	pDONR221	10648		KRBA2	124751	BAD18406.1	Hs.304604	KRAB-A domain containing 2	NT2	teratocarcinoma		NT2RP7		NM_213597.2	NP_998762.1	PROVISIONAL	P	1.000	1.000	447	1344	1	1341	492	46	492
IKAKEN	AK131400	IMS11-G06	FLJ	W01C096N11	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131400	IMS11-G06	FLJ	W01C096N12	pDONR221	21985		MACC1	346389	BAD18547.1	Hs.598388	Metastasis associated in colon cancer 1			subthalamic nucleus	BRSTN2		NM_182762.3	NP_877439.3	VALIDATED	OK	1.000	1.000	852	2559	1	2556	852	1	852
IKAKEN	AK131289	IMS11-G07	FLJ	W01C096N13	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131289	IMS11-G07	FLJ	W01C096N14	pDONR221	14183		hCG_1645516	731220	BAD18461.1	Hs.662488	Hypothetical protein LOC731220			brain	FEBRA2		NM_001145664.1	NP_001139136.1	VALIDATED	P	1.000	1.000	173	522	1	519	473	301	473
IKAKEN	AK131205	IMS11-G08	FLJ	W01C096N15	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131205	IMS11-G08	FLJ	W01C096N16	pDONR221	2551		KNDC1	85442	BAD18397.1	Hs.530685	Kinase non-catalytic C-lobe domain (KIND) containing 1	NT2	teratocarcinoma		NT2RI2		NM_152643.6	NP_689856.6	VALIDATED	P	1.000	1.000	491	1476	1	1473	1749	1259	1749
IKAKEN	AK131518	IMS11-G09	FLJ	W01C096N17	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131518	IMS11-G09	FLJ	W01C096N18	pDONR221	18065		TMPRSS11A	339967	BAD18660.1	Hs.450110	Transmembrane protease, serine 11A			uterus	UTERU3		NM_001114387.1	NP_001107859.1	VALIDATED	OK	1.000	1.000	418	1257	1	1254	418	1	418
IKAKEN	AK131280	IMS11-G10	FLJ	W01C096N19	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131280	IMS11-G10	FLJ	W01C096N20	pDONR221	9098		ERN2	10595	BAD18455.1	Hs.592041	Endoplasmic reticulum to nucleus signaling 2			tongue, tumor tissue	CTONG3		NM_033266.3	NP_150296.3	VALIDATED	P	1.000	1.000	926	2781	1	2778	974	49	974
IKAKEN	AK131380	IMS11-G11	FLJ	W01C096N21	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131380	IMS11-G11	FLJ	W01C096N22	pDONR221	18543		UNC5A	90249	BAD18531.1	Hs.33191	Unc-5 homolog A (C. elegans)			thymus	THYMU2		NM_133369.2	NP_588610.2	VALIDATED	Ps	0.992	0.992	245	753	7	741	842	54	298
IKAKEN	AK131244	IMS11-G12	FLJ	W01C096N23	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131244	IMS11-G12	FLJ	W01C096N24	pDONR221	20652		AKD1	221264	BAD18424.1	Hs.486169	Adenylate kinase domain containing 2			alzheimer cortex	BRALZ2		NM_001001706.2	NP_001001706.1	PROVISIONAL	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	AK131245	IMS11-H01	FLJ	W01C096O01	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131245	IMS11-H01	FLJ	W01C096O02	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131392	IMS11-H02	FLJ	W01C096O03	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131392	IMS11-H02	FLJ	W01C096O04	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131497	IMS11-H03	FLJ	W01C096O05	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H03	FLJ	W01C096O06	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C096O07	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C096O08	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131470	IMS11-H05	FLJ	W01C096O09	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131470	IMS11-H05	FLJ	W01C096O10	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131471	IMS11-H06	FLJ	W01C096O11	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H06	FLJ	W01C096O12	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C096O13	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C096O14	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131195	IMS11-H08	FLJ	W01C096O15	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK131195	IMS11-H08	FLJ	W01C096O16	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK127878	IMS11-H09	FLJ	W01C096O17	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127878	IMS11-H09	FLJ	W01C096O18	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127704	IMS11-H10	FLJ	W01C096O19	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127704	IMS11-H10	FLJ	W01C096O20	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127808	IMS11-H11	FLJ	W01C096O21	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127808	IMS11-H11	FLJ	W01C096O22	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127223	IMS11-H12	FLJ	W01C096O23	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK127223	IMS11-H12	FLJ	W01C096O24	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK131245	IMS11-H01	FLJ	W01C096P01	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131245	IMS11-H01	FLJ	W01C096P02	pDONR221	11860		PAPL	390928	BAD18425.1	Hs.448934	Purple acid phosphatase long form			caudate nucleus	BRCAN2		NM_001004318.2	NP_001004318.2	VALIDATED	P	1.000	1.000	393	1182	1	1179	438	46	438
IKAKEN	AK131392	IMS11-H02	FLJ	W01C096P03	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131392	IMS11-H02	FLJ	W01C096P04	pDONR221	2067		ETV3L	440695	BAD18543.1	Hs.127138	Ets variant 3-like			brain	BRAWH2		NM_001004341.1	NP_001004341.1	PROVISIONAL	C	1.000	1.000	361	1086	1	1083	361	1	361
IKAKEN	AK131497	IMS11-H03	FLJ	W01C096P05	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H03	FLJ	W01C096P06	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	P	1.000	1.000	801	2406	1	2403	941	141	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C096P07	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131497	IMS11-H04	FLJ	W01C096P08	pDONR221	21827		JHDM1D	80853	BAD18641.1	Hs.308710	Jumonji C domain containing histone demethylase 1 homolog D (S. cerevisiae)			testis	TESTI4		NM_030647.1	NP_085150.1	VALIDATED	Pg	0.976	1.000	499	1464	1	1461	941	443	941
IKAKEN	AK131470	IMS11-H05	FLJ	W01C096P09	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131470	IMS11-H05	FLJ	W01C096P10	pDONR221	4830		CCDC73	493860	BAD18615.1	Hs.706808	Coiled-coil domain containing 73			testis	TESTI4		NM_001008391.2	NP_001008392.2	VALIDATED	Pfs	0.998	1.000	553	1662	2	1659	1079	528	1079
IKAKEN	AK131471	IMS11-H06	FLJ	W01C096P11	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H06	FLJ	W01C096P12	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C096P13	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131471	IMS11-H07	FLJ	W01C096P14	pDONR221	20703		KIF6	221458	BAD18616.1	Hs.588202	Kinesin family member 6			testis	TESTI4		NM_145027.4	NP_659464.3	VALIDATED	OK	1.000	1.000	814	2445	1	2442	814	1	814
IKAKEN	AK131195	IMS11-H08	FLJ	W01C096P15	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK131195	IMS11-H08	FLJ	W01C096P16	pDONR221	12981		GALNT13	114805	BAG54747.1	Hs.470277	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 13 (GalNAc-T13)			Brain, neuroblastoma	NIH_MGC_47	DH10B-R	NM_052917.2	NP_443149.2	VALIDATED	OK	1.000	1.000	556	1671	1	1668	556	1	556
IKAKEN	AK127878	IMS11-H09	FLJ	W01C096P17	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127878	IMS11-H09	FLJ	W01C096P18	pDONR221	2789		STOX1	219736	BAC87173.1	Hs.37636	Storkhead box 1			prostate	PROST2		NM_001130161.1	NP_001123633.1	PROVISIONAL	P	1.000	1.000	609	1830	1	1827	989	381	989
IKAKEN	AK127704	IMS11-H10	FLJ	W01C096P19	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127704	IMS11-H10	FLJ	W01C096P20	pDONR221	18088		DCHS2	54798	BAC87093.1	Hs.712046	Dachsous 2 (Drosophila)		neutrophils		NETRP2		NM_001142552.1	NP_001136024.1	VALIDATED	P	1.000	1.000	1368	4105	1	4104	1369	1	1368
IKAKEN	AK127808	IMS11-H11	FLJ	W01C096P21	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127808	IMS11-H11	FLJ	W01C096P22	pDONR221	12576		RINL	126432	BAC87145.1	Hs.446933	Ras and Rab interactor-like			brain	OCBBF3		NM_198445.2	NP_940847.1	PROVISIONAL	OK	1.000	1.000	452	1359	1	1356	452	1	452
IKAKEN	AK127223	IMS11-H12	FLJ	W01C096P23	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK127223	IMS11-H12	FLJ	W01C096P24	pDONR221	12515		hCG_2039146	729956	BAC86890.1	Hs.6664	UPF0626 protein A			hippocampus	BRHIP3		XM_001719724.1	XP_001719776.1	MODEL		0.417	0.556	24	702	641	588	163	33	56
IKAKEN	AK127233	IMS12-A01	FLJ	W01C097A01	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127233	IMS12-A01	FLJ	W01C097A02	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127236	IMS12-A02	FLJ	W01C097A03	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127236	IMS12-A02	FLJ	W01C097A04	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127261	IMS12-A03	FLJ	W01C097A05	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127261	IMS12-A03	FLJ	W01C097A06	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127960	IMS12-A04	FLJ	W01C097A07	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK127960	IMS12-A04	FLJ	W01C097A08	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK126659	IMS12-A05	FLJ	W01C097A09	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126659	IMS12-A05	FLJ	W01C097A10	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126722	IMS12-A06	FLJ	W01C097A11	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126722	IMS12-A06	FLJ	W01C097A12	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126744	IMS12-A07	FLJ	W01C097A13	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126744	IMS12-A07	FLJ	W01C097A14	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126749	IMS12-A08	FLJ	W01C097A15	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126749	IMS12-A08	FLJ	W01C097A16	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126758	IMS12-A09	FLJ	W01C097A17	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126758	IMS12-A09	FLJ	W01C097A18	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126768	IMS12-A10	FLJ	W01C097A19	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK126768	IMS12-A10	FLJ	W01C097A20	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK128755	IMS12-A11	FLJ	W01C097A21	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A11	FLJ	W01C097A22	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C097A23	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C097A24	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK127233	IMS12-A01	FLJ	W01C097B01	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127233	IMS12-A01	FLJ	W01C097B02	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127236	IMS12-A02	FLJ	W01C097B03	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127236	IMS12-A02	FLJ	W01C097B04	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127261	IMS12-A03	FLJ	W01C097B05	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127261	IMS12-A03	FLJ	W01C097B06	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127960	IMS12-A04	FLJ	W01C097B07	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK127960	IMS12-A04	FLJ	W01C097B08	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK126659	IMS12-A05	FLJ	W01C097B09	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126659	IMS12-A05	FLJ	W01C097B10	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126722	IMS12-A06	FLJ	W01C097B11	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126722	IMS12-A06	FLJ	W01C097B12	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126744	IMS12-A07	FLJ	W01C097B13	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126744	IMS12-A07	FLJ	W01C097B14	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126749	IMS12-A08	FLJ	W01C097B15	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126749	IMS12-A08	FLJ	W01C097B16	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126758	IMS12-A09	FLJ	W01C097B17	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126758	IMS12-A09	FLJ	W01C097B18	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126768	IMS12-A10	FLJ	W01C097B19	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK126768	IMS12-A10	FLJ	W01C097B20	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK128755	IMS12-A11	FLJ	W01C097B21	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A11	FLJ	W01C097B22	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C097B23	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C097B24	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-B01	FLJ	W01C097C01	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-B01	FLJ	W01C097C02	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK127292	IMS12-B02	FLJ	W01C097C03	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127292	IMS12-B02	FLJ	W01C097C04	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127303	IMS12-B03	FLJ	W01C097C05	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127303	IMS12-B03	FLJ	W01C097C06	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127307	IMS12-B04	FLJ	W01C097C07	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127307	IMS12-B04	FLJ	W01C097C08	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127319	IMS12-B05	FLJ	W01C097C09	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK127319	IMS12-B05	FLJ	W01C097C10	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK128691	IMS12-B06	FLJ	W01C097C11	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128691	IMS12-B06	FLJ	W01C097C12	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128700	IMS12-B07	FLJ	W01C097C13	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128700	IMS12-B07	FLJ	W01C097C14	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128026	IMS12-B08	FLJ	W01C097C15	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK128026	IMS12-B08	FLJ	W01C097C16	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK127208	IMS12-B09	FLJ	W01C097C17	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127208	IMS12-B09	FLJ	W01C097C18	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127914	IMS12-B10	FLJ	W01C097C19	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127914	IMS12-B10	FLJ	W01C097C20	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127932	IMS12-B11	FLJ	W01C097C21	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK127932	IMS12-B11	FLJ	W01C097C22	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK126624	IMS12-B12	FLJ	W01C097C23	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK126624	IMS12-B12	FLJ	W01C097C24	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK128755	IMS12-B01	FLJ	W01C097D01	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-B01	FLJ	W01C097D02	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK127292	IMS12-B02	FLJ	W01C097D03	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127292	IMS12-B02	FLJ	W01C097D04	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127303	IMS12-B03	FLJ	W01C097D05	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127303	IMS12-B03	FLJ	W01C097D06	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127307	IMS12-B04	FLJ	W01C097D07	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127307	IMS12-B04	FLJ	W01C097D08	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127319	IMS12-B05	FLJ	W01C097D09	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK127319	IMS12-B05	FLJ	W01C097D10	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK128691	IMS12-B06	FLJ	W01C097D11	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128691	IMS12-B06	FLJ	W01C097D12	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128700	IMS12-B07	FLJ	W01C097D13	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128700	IMS12-B07	FLJ	W01C097D14	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128026	IMS12-B08	FLJ	W01C097D15	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK128026	IMS12-B08	FLJ	W01C097D16	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK127208	IMS12-B09	FLJ	W01C097D17	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127208	IMS12-B09	FLJ	W01C097D18	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127914	IMS12-B10	FLJ	W01C097D19	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127914	IMS12-B10	FLJ	W01C097D20	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127932	IMS12-B11	FLJ	W01C097D21	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK127932	IMS12-B11	FLJ	W01C097D22	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK126624	IMS12-B12	FLJ	W01C097D23	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK126624	IMS12-B12	FLJ	W01C097D24	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK126724	IMS12-C01	FLJ	W01C097E01	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126724	IMS12-C01	FLJ	W01C097E02	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126829	IMS12-C02	FLJ	W01C097E03	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK126829	IMS12-C02	FLJ	W01C097E04	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C097E05	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C097E06	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127709	IMS12-C04	FLJ	W01C097E07	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127709	IMS12-C04	FLJ	W01C097E08	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127809	IMS12-C05	FLJ	W01C097E09	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK127809	IMS12-C05	FLJ	W01C097E10	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK126648	IMS12-C06	FLJ	W01C097E11	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126648	IMS12-C06	FLJ	W01C097E12	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126822	IMS12-C07	FLJ	W01C097E13	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126822	IMS12-C07	FLJ	W01C097E14	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126828	IMS12-C08	FLJ	W01C097E15	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126828	IMS12-C08	FLJ	W01C097E16	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126830	IMS12-C09	FLJ	W01C097E17	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126830	IMS12-C09	FLJ	W01C097E18	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126844	IMS12-C10	FLJ	W01C097E19	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126844	IMS12-C10	FLJ	W01C097E20	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126888	IMS12-C11	FLJ	W01C097E21	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK126888	IMS12-C11	FLJ	W01C097E22	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK127623	IMS12-C12	FLJ	W01C097E23	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK127623	IMS12-C12	FLJ	W01C097E24	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK126724	IMS12-C01	FLJ	W01C097F01	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126724	IMS12-C01	FLJ	W01C097F02	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126829	IMS12-C02	FLJ	W01C097F03	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK126829	IMS12-C02	FLJ	W01C097F04	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C097F05	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C097F06	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127709	IMS12-C04	FLJ	W01C097F07	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127709	IMS12-C04	FLJ	W01C097F08	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127809	IMS12-C05	FLJ	W01C097F09	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK127809	IMS12-C05	FLJ	W01C097F10	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK126648	IMS12-C06	FLJ	W01C097F11	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126648	IMS12-C06	FLJ	W01C097F12	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126822	IMS12-C07	FLJ	W01C097F13	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126822	IMS12-C07	FLJ	W01C097F14	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126828	IMS12-C08	FLJ	W01C097F15	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126828	IMS12-C08	FLJ	W01C097F16	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126830	IMS12-C09	FLJ	W01C097F17	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126830	IMS12-C09	FLJ	W01C097F18	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126844	IMS12-C10	FLJ	W01C097F19	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126844	IMS12-C10	FLJ	W01C097F20	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126888	IMS12-C11	FLJ	W01C097F21	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK126888	IMS12-C11	FLJ	W01C097F22	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK127623	IMS12-C12	FLJ	W01C097F23	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK127623	IMS12-C12	FLJ	W01C097F24	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK127635	IMS12-D01	FLJ	W01C097G01	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127635	IMS12-D01	FLJ	W01C097G02	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127642	IMS12-D02	FLJ	W01C097G03	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127642	IMS12-D02	FLJ	W01C097G04	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127646	IMS12-D03	FLJ	W01C097G05	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127646	IMS12-D03	FLJ	W01C097G06	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127717	IMS12-D04	FLJ	W01C097G07	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127717	IMS12-D04	FLJ	W01C097G08	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127750	IMS12-D05	FLJ	W01C097G09	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127750	IMS12-D05	FLJ	W01C097G10	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127818	IMS12-D06	FLJ	W01C097G11	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127818	IMS12-D06	FLJ	W01C097G12	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127873	IMS12-D07	FLJ	W01C097G13	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127873	IMS12-D07	FLJ	W01C097G14	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127903	IMS12-D08	FLJ	W01C097G15	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127903	IMS12-D08	FLJ	W01C097G16	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C097G17	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C097G18	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127979	IMS12-D10	FLJ	W01C097G19	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127979	IMS12-D10	FLJ	W01C097G20	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127993	IMS12-D11	FLJ	W01C097G21	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127993	IMS12-D11	FLJ	W01C097G22	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127998	IMS12-D12	FLJ	W01C097G23	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK127998	IMS12-D12	FLJ	W01C097G24	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK127635	IMS12-D01	FLJ	W01C097H01	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127635	IMS12-D01	FLJ	W01C097H02	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127642	IMS12-D02	FLJ	W01C097H03	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127642	IMS12-D02	FLJ	W01C097H04	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127646	IMS12-D03	FLJ	W01C097H05	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127646	IMS12-D03	FLJ	W01C097H06	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127717	IMS12-D04	FLJ	W01C097H07	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127717	IMS12-D04	FLJ	W01C097H08	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127750	IMS12-D05	FLJ	W01C097H09	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127750	IMS12-D05	FLJ	W01C097H10	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127818	IMS12-D06	FLJ	W01C097H11	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127818	IMS12-D06	FLJ	W01C097H12	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127873	IMS12-D07	FLJ	W01C097H13	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127873	IMS12-D07	FLJ	W01C097H14	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127903	IMS12-D08	FLJ	W01C097H15	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127903	IMS12-D08	FLJ	W01C097H16	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C097H17	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C097H18	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127979	IMS12-D10	FLJ	W01C097H19	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127979	IMS12-D10	FLJ	W01C097H20	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127993	IMS12-D11	FLJ	W01C097H21	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127993	IMS12-D11	FLJ	W01C097H22	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127998	IMS12-D12	FLJ	W01C097H23	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK127998	IMS12-D12	FLJ	W01C097H24	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK128007	IMS12-E01	FLJ	W01C097I01	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128007	IMS12-E01	FLJ	W01C097I02	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128246	IMS12-E02	FLJ	W01C097I03	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128246	IMS12-E02	FLJ	W01C097I04	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128529	IMS12-E03	FLJ	W01C097I05	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128529	IMS12-E03	FLJ	W01C097I06	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128530	IMS12-E04	FLJ	W01C097I07	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128530	IMS12-E04	FLJ	W01C097I08	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128606	IMS12-E05	FLJ	W01C097I09	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128606	IMS12-E05	FLJ	W01C097I10	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128643	IMS12-E06	FLJ	W01C097I11	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128643	IMS12-E06	FLJ	W01C097I12	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128646	IMS12-E07	FLJ	W01C097I13	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK128646	IMS12-E07	FLJ	W01C097I14	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK126798	IMS12-E08	FLJ	W01C097I15	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126798	IMS12-E08	FLJ	W01C097I16	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126872	IMS12-E09	FLJ	W01C097I17	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK126872	IMS12-E09	FLJ	W01C097I18	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK127343	IMS12-E10	FLJ	W01C097I19	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127343	IMS12-E10	FLJ	W01C097I20	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127362	IMS12-E11	FLJ	W01C097I21	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK127362	IMS12-E11	FLJ	W01C097I22	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK128476	IMS12-E12	FLJ	W01C097I23	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128476	IMS12-E12	FLJ	W01C097I24	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128007	IMS12-E01	FLJ	W01C097J01	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128007	IMS12-E01	FLJ	W01C097J02	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128246	IMS12-E02	FLJ	W01C097J03	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128246	IMS12-E02	FLJ	W01C097J04	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128529	IMS12-E03	FLJ	W01C097J05	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128529	IMS12-E03	FLJ	W01C097J06	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128530	IMS12-E04	FLJ	W01C097J07	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128530	IMS12-E04	FLJ	W01C097J08	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128606	IMS12-E05	FLJ	W01C097J09	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128606	IMS12-E05	FLJ	W01C097J10	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128643	IMS12-E06	FLJ	W01C097J11	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128643	IMS12-E06	FLJ	W01C097J12	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128646	IMS12-E07	FLJ	W01C097J13	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK128646	IMS12-E07	FLJ	W01C097J14	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK126798	IMS12-E08	FLJ	W01C097J15	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126798	IMS12-E08	FLJ	W01C097J16	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126872	IMS12-E09	FLJ	W01C097J17	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK126872	IMS12-E09	FLJ	W01C097J18	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK127343	IMS12-E10	FLJ	W01C097J19	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127343	IMS12-E10	FLJ	W01C097J20	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127362	IMS12-E11	FLJ	W01C097J21	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK127362	IMS12-E11	FLJ	W01C097J22	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK128476	IMS12-E12	FLJ	W01C097J23	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128476	IMS12-E12	FLJ	W01C097J24	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128819	IMS12-F01	FLJ	W01C097K01	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK128819	IMS12-F01	FLJ	W01C097K02	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK127558	IMS12-F02	FLJ	W01C097K03	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK127558	IMS12-F02	FLJ	W01C097K04	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK126574	IMS12-F03	FLJ	W01C097K05	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126574	IMS12-F03	FLJ	W01C097K06	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126577	IMS12-F04	FLJ	W01C097K07	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK126577	IMS12-F04	FLJ	W01C097K08	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK127552	IMS12-F05	FLJ	W01C097K09	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127552	IMS12-F05	FLJ	W01C097K10	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127176	IMS12-F06	FLJ	W01C097K11	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127176	IMS12-F06	FLJ	W01C097K12	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127893	IMS12-F07	FLJ	W01C097K13	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK127893	IMS12-F07	FLJ	W01C097K14	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK128065	IMS12-F08	FLJ	W01C097K15	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128065	IMS12-F08	FLJ	W01C097K16	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128077	IMS12-F09	FLJ	W01C097K17	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128077	IMS12-F09	FLJ	W01C097K18	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128492	IMS12-F10	FLJ	W01C097K19	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK128492	IMS12-F10	FLJ	W01C097K20	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK127722	IMS12-F11	FLJ	W01C097K21	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127722	IMS12-F11	FLJ	W01C097K22	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127731	IMS12-F12	FLJ	W01C097K23	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127731	IMS12-F12	FLJ	W01C097K24	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK128819	IMS12-F01	FLJ	W01C097L01	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK128819	IMS12-F01	FLJ	W01C097L02	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK127558	IMS12-F02	FLJ	W01C097L03	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK127558	IMS12-F02	FLJ	W01C097L04	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK126574	IMS12-F03	FLJ	W01C097L05	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126574	IMS12-F03	FLJ	W01C097L06	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126577	IMS12-F04	FLJ	W01C097L07	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK126577	IMS12-F04	FLJ	W01C097L08	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK127552	IMS12-F05	FLJ	W01C097L09	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127552	IMS12-F05	FLJ	W01C097L10	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127176	IMS12-F06	FLJ	W01C097L11	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127176	IMS12-F06	FLJ	W01C097L12	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127893	IMS12-F07	FLJ	W01C097L13	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK127893	IMS12-F07	FLJ	W01C097L14	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK128065	IMS12-F08	FLJ	W01C097L15	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128065	IMS12-F08	FLJ	W01C097L16	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128077	IMS12-F09	FLJ	W01C097L17	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128077	IMS12-F09	FLJ	W01C097L18	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128492	IMS12-F10	FLJ	W01C097L19	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK128492	IMS12-F10	FLJ	W01C097L20	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK127722	IMS12-F11	FLJ	W01C097L21	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127722	IMS12-F11	FLJ	W01C097L22	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127731	IMS12-F12	FLJ	W01C097L23	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127731	IMS12-F12	FLJ	W01C097L24	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127732	IMS12-G01	FLJ	W01C097M01	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127732	IMS12-G01	FLJ	W01C097M02	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127735	IMS12-G02	FLJ	W01C097M03	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127735	IMS12-G02	FLJ	W01C097M04	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127772	IMS12-G03	FLJ	W01C097M05	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127772	IMS12-G03	FLJ	W01C097M06	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127832	IMS12-G04	FLJ	W01C097M07	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127832	IMS12-G04	FLJ	W01C097M08	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127834	IMS12-G05	FLJ	W01C097M09	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127834	IMS12-G05	FLJ	W01C097M10	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127837	IMS12-G06	FLJ	W01C097M11	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127837	IMS12-G06	FLJ	W01C097M12	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127846	IMS12-G07	FLJ	W01C097M13	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK127846	IMS12-G07	FLJ	W01C097M14	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK128123	IMS12-G08	FLJ	W01C097M15	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128123	IMS12-G08	FLJ	W01C097M16	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128126	IMS12-G09	FLJ	W01C097M17	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128126	IMS12-G09	FLJ	W01C097M18	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128130	IMS12-G10	FLJ	W01C097M19	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128130	IMS12-G10	FLJ	W01C097M20	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128215	IMS12-G11	FLJ	W01C097M21	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128215	IMS12-G11	FLJ	W01C097M22	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128836	IMS12-G12	FLJ	W01C097M23	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK128836	IMS12-G12	FLJ	W01C097M24	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK127732	IMS12-G01	FLJ	W01C097N01	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127732	IMS12-G01	FLJ	W01C097N02	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127735	IMS12-G02	FLJ	W01C097N03	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127735	IMS12-G02	FLJ	W01C097N04	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127772	IMS12-G03	FLJ	W01C097N05	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127772	IMS12-G03	FLJ	W01C097N06	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127832	IMS12-G04	FLJ	W01C097N07	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127832	IMS12-G04	FLJ	W01C097N08	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127834	IMS12-G05	FLJ	W01C097N09	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127834	IMS12-G05	FLJ	W01C097N10	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127837	IMS12-G06	FLJ	W01C097N11	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127837	IMS12-G06	FLJ	W01C097N12	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127846	IMS12-G07	FLJ	W01C097N13	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK127846	IMS12-G07	FLJ	W01C097N14	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK128123	IMS12-G08	FLJ	W01C097N15	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128123	IMS12-G08	FLJ	W01C097N16	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128126	IMS12-G09	FLJ	W01C097N17	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128126	IMS12-G09	FLJ	W01C097N18	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128130	IMS12-G10	FLJ	W01C097N19	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128130	IMS12-G10	FLJ	W01C097N20	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128215	IMS12-G11	FLJ	W01C097N21	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128215	IMS12-G11	FLJ	W01C097N22	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128836	IMS12-G12	FLJ	W01C097N23	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK128836	IMS12-G12	FLJ	W01C097N24	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK127589	IMS12-H01	FLJ	W01C097O01	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK127589	IMS12-H01	FLJ	W01C097O02	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK126811	IMS12-H02	FLJ	W01C097O03	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK126811	IMS12-H02	FLJ	W01C097O04	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK127142	IMS12-H03	FLJ	W01C097O05	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127142	IMS12-H03	FLJ	W01C097O06	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127179	IMS12-H04	FLJ	W01C097O07	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127179	IMS12-H04	FLJ	W01C097O08	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127183	IMS12-H05	FLJ	W01C097O09	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127183	IMS12-H05	FLJ	W01C097O10	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127187	IMS12-H06	FLJ	W01C097O11	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127187	IMS12-H06	FLJ	W01C097O12	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127191	IMS12-H07	FLJ	W01C097O13	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK127191	IMS12-H07	FLJ	W01C097O14	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C097O15	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C097O16	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128203	IMS12-H09	FLJ	W01C097O17	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128203	IMS12-H09	FLJ	W01C097O18	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128212	IMS12-H10	FLJ	W01C097O19	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128212	IMS12-H10	FLJ	W01C097O20	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128108	IMS12-H11	FLJ	W01C097O21	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128108	IMS12-H11	FLJ	W01C097O22	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128136	IMS12-H12	FLJ	W01C097O23	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK128136	IMS12-H12	FLJ	W01C097O24	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK127589	IMS12-H01	FLJ	W01C097P01	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK127589	IMS12-H01	FLJ	W01C097P02	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK126811	IMS12-H02	FLJ	W01C097P03	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK126811	IMS12-H02	FLJ	W01C097P04	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK127142	IMS12-H03	FLJ	W01C097P05	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127142	IMS12-H03	FLJ	W01C097P06	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127179	IMS12-H04	FLJ	W01C097P07	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127179	IMS12-H04	FLJ	W01C097P08	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127183	IMS12-H05	FLJ	W01C097P09	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127183	IMS12-H05	FLJ	W01C097P10	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127187	IMS12-H06	FLJ	W01C097P11	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127187	IMS12-H06	FLJ	W01C097P12	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127191	IMS12-H07	FLJ	W01C097P13	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK127191	IMS12-H07	FLJ	W01C097P14	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C097P15	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C097P16	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128203	IMS12-H09	FLJ	W01C097P17	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128203	IMS12-H09	FLJ	W01C097P18	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128212	IMS12-H10	FLJ	W01C097P19	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128212	IMS12-H10	FLJ	W01C097P20	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128108	IMS12-H11	FLJ	W01C097P21	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128108	IMS12-H11	FLJ	W01C097P22	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128136	IMS12-H12	FLJ	W01C097P23	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK128136	IMS12-H12	FLJ	W01C097P24	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK127233	IMS12-A01	FLJ	W01C098A01	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127233	IMS12-A01	FLJ	W01C098A02	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127236	IMS12-A02	FLJ	W01C098A03	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127236	IMS12-A02	FLJ	W01C098A04	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127261	IMS12-A03	FLJ	W01C098A05	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127261	IMS12-A03	FLJ	W01C098A06	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127960	IMS12-A04	FLJ	W01C098A07	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK127960	IMS12-A04	FLJ	W01C098A08	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK126659	IMS12-A05	FLJ	W01C098A09	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126659	IMS12-A05	FLJ	W01C098A10	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126722	IMS12-A06	FLJ	W01C098A11	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126722	IMS12-A06	FLJ	W01C098A12	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126744	IMS12-A07	FLJ	W01C098A13	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126744	IMS12-A07	FLJ	W01C098A14	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126749	IMS12-A08	FLJ	W01C098A15	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126749	IMS12-A08	FLJ	W01C098A16	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126758	IMS12-A09	FLJ	W01C098A17	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126758	IMS12-A09	FLJ	W01C098A18	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126768	IMS12-A10	FLJ	W01C098A19	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK126768	IMS12-A10	FLJ	W01C098A20	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK128755	IMS12-A11	FLJ	W01C098A21	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A11	FLJ	W01C098A22	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C098A23	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C098A24	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK127233	IMS12-A01	FLJ	W01C098B01	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127233	IMS12-A01	FLJ	W01C098B02	pDONR221	4022			399957	BAC86894					hippocampus	BRHIP3				
IKAKEN	AK127236	IMS12-A02	FLJ	W01C098B03	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127236	IMS12-A02	FLJ	W01C098B04	pDONR221	23668		LCNL1	401562	BAC86897.2	Hs.695210	Lipocalin-like 1			hippocampus	BRHIP3		NM_207510.3	NP_997393.3	VALIDATED	P	1.000	1.000	18	576	522	575	164	1	18
IKAKEN	AK127261	IMS12-A03	FLJ	W01C098B05	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127261	IMS12-A03	FLJ	W01C098B06	pDONR221	23718		LOC401557	401557	BAC86904	Hs.640138	Hypothetical LOC401557			hippocampus	BRHIP3		XM_001719680.1	XP_001719732.1	MODEL	OK	1.000	1.000	129	390	1	387	129	1	129
IKAKEN	AK127960	IMS12-A04	FLJ	W01C098B07	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK127960	IMS12-A04	FLJ	W01C098B08	pDONR221	23080		FAM83H	286077	BAC87207.1	Hs.713170	Family with sequence similarity 83, member H			spleen	SPLEN2		NM_198488.3	NP_940890.3	VALIDATED	P	1.000	1.000	886	2661	1	2658	1179	294	1179
IKAKEN	AK126659	IMS12-A05	FLJ	W01C098B09	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126659	IMS12-A05	FLJ	W01C098B10	pDONR221	6954		MEG3	55384	BAC86632	Hs.655127	Maternally expressed 3 (non-protein coding)			cerebellum	BRACE3														
IKAKEN	AK126722	IMS12-A06	FLJ	W01C098B11	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126722	IMS12-A06	FLJ	W01C098B12	pDONR221	19380		FBXL17	64839	BAC86658.1	Hs.657225	F-box and leucine-rich repeat protein 17			cerebellum	BRACE3		NM_022824.1	NP_073735.1	PROVISIONAL	OK	1.000	1.000	303	912	1	909	303	1	303
IKAKEN	AK126744	IMS12-A07	FLJ	W01C098B13	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126744	IMS12-A07	FLJ	W01C098B14	pDONR221	14762		FLJ44790	400850	BAC86668.1	Hs.711994	Hypothetical FLJ44790			cerebellum	BRACE3														
IKAKEN	AK126749	IMS12-A08	FLJ	W01C098B15	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126749	IMS12-A08	FLJ	W01C098B16	pDONR221	19381		FLJ44796	401209	BAC86670					cerebellum	BRACE3		NM_001001704.1	NP_001001704.1	NA
IKAKEN	AK126758	IMS12-A09	FLJ	W01C098B17	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126758	IMS12-A09	FLJ	W01C098B18	pDONR221	5199		DIP2B	57609	-	Hs.505516	DIP2 disco-interacting protein 2 homolog B (Drosophila)			cerebellum	BRACE3		NM_173602.2	NP_775873.2	VALIDATED	P	1.000	1.000	900	2703	1	2700	1576	677	1576
IKAKEN	AK126768	IMS12-A10	FLJ	W01C098B19	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK126768	IMS12-A10	FLJ	W01C098B20	pDONR221	10634		C17orf102	400591	BAC86680.1	Hs.514090	Chromosome 17 open reading frame 102			cerebellum	BRACE3		NM_207454.2	NP_997337.2	VALIDATED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	AK128755	IMS12-A11	FLJ	W01C098B21	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A11	FLJ	W01C098B22	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C098B23	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-A12	FLJ	W01C098B24	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-B01	FLJ	W01C098C01	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-B01	FLJ	W01C098C02	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK127292	IMS12-B02	FLJ	W01C098C03	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127292	IMS12-B02	FLJ	W01C098C04	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127303	IMS12-B03	FLJ	W01C098C05	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127303	IMS12-B03	FLJ	W01C098C06	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127307	IMS12-B04	FLJ	W01C098C07	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127307	IMS12-B04	FLJ	W01C098C08	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127319	IMS12-B05	FLJ	W01C098C09	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK127319	IMS12-B05	FLJ	W01C098C10	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK128691	IMS12-B06	FLJ	W01C098C11	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128691	IMS12-B06	FLJ	W01C098C12	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128700	IMS12-B07	FLJ	W01C098C13	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128700	IMS12-B07	FLJ	W01C098C14	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128026	IMS12-B08	FLJ	W01C098C15	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK128026	IMS12-B08	FLJ	W01C098C16	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK127208	IMS12-B09	FLJ	W01C098C17	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127208	IMS12-B09	FLJ	W01C098C18	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127914	IMS12-B10	FLJ	W01C098C19	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127914	IMS12-B10	FLJ	W01C098C20	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127932	IMS12-B11	FLJ	W01C098C21	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK127932	IMS12-B11	FLJ	W01C098C22	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK126624	IMS12-B12	FLJ	W01C098C23	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK126624	IMS12-B12	FLJ	W01C098C24	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK128755	IMS12-B01	FLJ	W01C098D01	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK128755	IMS12-B01	FLJ	W01C098D02	pDONR221	22961		TRAPPC9	83696	BAC87600.1	Hs.654911	Trafficking protein particle complex 9			uterus	UTERU3		NM_031466.5	NP_113654.4	VALIDATED	OK	1.000	1.000	1246	3741	1	3738	1246	1	1246
IKAKEN	AK127292	IMS12-B02	FLJ	W01C098D03	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127292	IMS12-B02	FLJ	W01C098D04	pDONR221	6791		FLJ46358	400110	BAC86920.1	Hs.591222	FLJ46358 protein			hippocampus	BRHIP3		XM_001717332.1	XP_001717384.1	MODEL	Pfs	0.720	0.738	82	780	540	779	248	66	147
IKAKEN	AK127303	IMS12-B03	FLJ	W01C098D05	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127303	IMS12-B03	FLJ	W01C098D06	pDONR221	3360		SLC16A12	387700	BAC86925.1	Hs.530338	Solute carrier family 16, member 12 (monocarboxylic acid transporter 12)			hippocampus	BRHIP3		NM_213606.2	NP_998771.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK127307	IMS12-B04	FLJ	W01C098D07	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127307	IMS12-B04	FLJ	W01C098D08	pDONR221	17972		FRYL	285527	BAG54477.1	Hs.631525	FRY-like			hippocampus	BRHIP3		NM_015030.1	NP_055845.1	VALIDATED	Pg	0.995	1.000	1260	3765	1	3762	3013	1754	3013
IKAKEN	AK127319	IMS12-B05	FLJ	W01C098D09	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK127319	IMS12-B05	FLJ	W01C098D10	pDONR221	9937		SLC16A3	9123	BAG54480.1	Hs.500761	Solute carrier family 16, member 3 (monocarboxylic acid transporter 4)			hippocampus	BRHIP3		NM_001042423.1	NP_001035888.1	VALIDATED	C	1.000	1.000	465	1398	1	1395	465	1	465
IKAKEN	AK128691	IMS12-B06	FLJ	W01C098D11	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128691	IMS12-B06	FLJ	W01C098D12	pDONR221	22706		IDO2	169355	BAC87573.1	Hs.676257	Indoleamine 2,3-dioxygenase 2			uterus	UTERU2		NM_194294.2	NP_919270.2	VALIDATED	P	1.000	1.000	158	519	1	474	420	1	158
IKAKEN	AK128700	IMS12-B07	FLJ	W01C098D13	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128700	IMS12-B07	FLJ	W01C098D14	pDONR221	11849		ZNF788	388507	BAC87578.1	Hs.127473	Zinc finger family member 788			uterus	UTERU3														
IKAKEN	AK128026	IMS12-B08	FLJ	W01C098D15	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK128026	IMS12-B08	FLJ	W01C098D16	pDONR221	21340		CCDC129	223075	BAC87235.1	Hs.224269	Coiled-coil domain containing 129			testis	TESTI2		NM_194300.2	NP_919276.2	VALIDATED	Cg	0.858	1.000	1044	2691	1	2688	1044	1	1044
IKAKEN	AK127208	IMS12-B09	FLJ	W01C098D17	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127208	IMS12-B09	FLJ	W01C098D18	pDONR221	33555		LOC100132292	100132292	BAC86884	Hs.616149	Hypothetical protein LOC100132292			hippocampus	BRHIP2		XM_001723683.1	XP_001723735.1	MODEL		0.500	0.500	14	567	493	534	74	61	74
IKAKEN	AK127914	IMS12-B10	FLJ	W01C098D19	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127914	IMS12-B10	FLJ	W01C098D20	pDONR221	43749		RNF213	57674	BAC87188.1	Hs.195642	Ring finger protein 213			spleen	SPLEN2		NM_020914.3	NP_065965.3	VALIDATED	P	1.000	1.000	71	564	238	450	3280	1	71
IKAKEN	AK127932	IMS12-B11	FLJ	W01C098D21	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK127932	IMS12-B11	FLJ	W01C098D22	pDONR221	20468		ZC3H12D	340152	BAC87196.1	Hs.632618	Zinc finger CCCH-type containing 12D			spleen	SPLEN2		NM_207360.1	NP_997243.1	PROVISIONAL		0.977	0.977	221	666	1	663	321	101	321
IKAKEN	AK126624	IMS12-B12	FLJ	W01C098D23	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK126624	IMS12-B12	FLJ	W01C098D24	pDONR221	87		PPFIA4	8497	BAC86617.1	Hs.153648	Protein tyrosine phosphatase, receptor type, f polypeptide (PTPRF), interacting protein (liprin), alpha 4			cerebellum	BRACE2		NM_015053.1	NP_055868.1	VALIDATED	P	1.000	1.000	396	1191	1	1188	701	306	701
IKAKEN	AK126724	IMS12-C01	FLJ	W01C098E01	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126724	IMS12-C01	FLJ	W01C098E02	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126829	IMS12-C02	FLJ	W01C098E03	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK126829	IMS12-C02	FLJ	W01C098E04	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C098E05	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C098E06	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127709	IMS12-C04	FLJ	W01C098E07	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127709	IMS12-C04	FLJ	W01C098E08	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127809	IMS12-C05	FLJ	W01C098E09	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK127809	IMS12-C05	FLJ	W01C098E10	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK126648	IMS12-C06	FLJ	W01C098E11	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126648	IMS12-C06	FLJ	W01C098E12	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126822	IMS12-C07	FLJ	W01C098E13	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126822	IMS12-C07	FLJ	W01C098E14	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126828	IMS12-C08	FLJ	W01C098E15	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126828	IMS12-C08	FLJ	W01C098E16	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126830	IMS12-C09	FLJ	W01C098E17	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126830	IMS12-C09	FLJ	W01C098E18	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126844	IMS12-C10	FLJ	W01C098E19	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126844	IMS12-C10	FLJ	W01C098E20	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126888	IMS12-C11	FLJ	W01C098E21	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK126888	IMS12-C11	FLJ	W01C098E22	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK127623	IMS12-C12	FLJ	W01C098E23	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK127623	IMS12-C12	FLJ	W01C098E24	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK126724	IMS12-C01	FLJ	W01C098F01	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126724	IMS12-C01	FLJ	W01C098F02	pDONR221	35500				BAC86659					cerebellum	BRACE3				
IKAKEN	AK126829	IMS12-C02	FLJ	W01C098F03	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK126829	IMS12-C02	FLJ	W01C098F04	pDONR221	11055		FLJ44881	400661	BAC86711.1	Hs.514963	FLJ44881			amygdala	BRAMY2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C098F05	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127578	IMS12-C03	FLJ	W01C098F06	pDONR221	14196		C2orf46	339789	BAC87041.1	Hs.565619	Chromosome 2 open reading frame 46			tongue, tumor tissue	CTONG2														
IKAKEN	AK127709	IMS12-C04	FLJ	W01C098F07	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127709	IMS12-C04	FLJ	W01C098F08	pDONR221	25326		CXorf23	256643	BAC87094.1	Hs.28896	Chromosome X open reading frame 23	NT2	teratocarcinoma		NT2RI3		NM_198279.2	NP_938020.2	VALIDATED	Pg	0.895	1.000	276	831	1	828	682	436	682
IKAKEN	AK127809	IMS12-C05	FLJ	W01C098F09	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK127809	IMS12-C05	FLJ	W01C098F10	pDONR221	11843		CLEC17A	388512	BAC87146	Hs.567933	C-type lectin domain family 17, member A		peripheral blood mononuclear cells		PEBLM2		NM_207390.2	NP_997273.2	VALIDATED		0.918	0.972	306	921	1	918	289	1	289
IKAKEN	AK126648	IMS12-C06	FLJ	W01C098F11	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126648	IMS12-C06	FLJ	W01C098F12	pDONR221	17666		LRIT3	345193	BAC86628.1	Hs.308127	Leucine-rich repeat, immunoglobulin-like and transmembrane domains 3			cerebellum	BRACE3		NM_198506.2	NP_940908.2	VALIDATED	Ps	0.990	0.990	489	1491	22	1488	634	146	634
IKAKEN	AK126822	IMS12-C07	FLJ	W01C098F13	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126822	IMS12-C07	FLJ	W01C098F14	pDONR221	6173		FLJ44874	399990	BAC86708	Hs.586786	FLJ44874 protein			alzheimer cortex	BRALZ2				
IKAKEN	AK126828	IMS12-C08	FLJ	W01C098F15	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126828	IMS12-C08	FLJ	W01C098F16	pDONR221	11323		LOC647983	647983	BAC86710	Hs.677472	Hypothetical protein LOC647983			amygdala	BRAMY2		XM_001721995.1	XP_001722047.1	MODEL		0.890	0.890	154	513	1	462	158	1	154
IKAKEN	AK126830	IMS12-C09	FLJ	W01C098F17	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126830	IMS12-C09	FLJ	W01C098F18	pDONR221	6790		DLEU7	220107	BAC86712.1	Hs.710878	Deleted in lymphocytic leukemia, 7			amygdala	BRAMY2		NM_198989.2	NP_945340.2	PROVISIONAL	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	AK126844	IMS12-C10	FLJ	W01C098F19	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126844	IMS12-C10	FLJ	W01C098F20	pDONR221	19383		FLJ44896	401166	BAC86718	Hs.711993	FLJ44896 protein			amygdala	BRAMY2														
IKAKEN	AK126888	IMS12-C11	FLJ	W01C098F21	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK126888	IMS12-C11	FLJ	W01C098F22	pDONR221	16716		ANKRD28	23243	BAC86737.1	Hs.335239	Ankyrin repeat domain 28			amygdala	BRAMY3		NM_015199.2	NP_056014.2	PROVISIONAL	P	1.000	1.000	645	2064	127	2061	1053	10	654
IKAKEN	AK127623	IMS12-C12	FLJ	W01C098F23	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK127623	IMS12-C12	FLJ	W01C098F24	pDONR221	18224		FLJ45721	401123	BAC87062	Hs.429441	Hypothetical LOC401123			brain	FCBBF3														
IKAKEN	AK127635	IMS12-D01	FLJ	W01C098G01	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127635	IMS12-D01	FLJ	W01C098G02	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127642	IMS12-D02	FLJ	W01C098G03	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127642	IMS12-D02	FLJ	W01C098G04	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127646	IMS12-D03	FLJ	W01C098G05	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127646	IMS12-D03	FLJ	W01C098G06	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127717	IMS12-D04	FLJ	W01C098G07	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127717	IMS12-D04	FLJ	W01C098G08	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127750	IMS12-D05	FLJ	W01C098G09	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127750	IMS12-D05	FLJ	W01C098G10	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127818	IMS12-D06	FLJ	W01C098G11	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127818	IMS12-D06	FLJ	W01C098G12	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127873	IMS12-D07	FLJ	W01C098G13	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127873	IMS12-D07	FLJ	W01C098G14	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127903	IMS12-D08	FLJ	W01C098G15	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127903	IMS12-D08	FLJ	W01C098G16	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C098G17	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C098G18	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127979	IMS12-D10	FLJ	W01C098G19	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127979	IMS12-D10	FLJ	W01C098G20	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127993	IMS12-D11	FLJ	W01C098G21	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127993	IMS12-D11	FLJ	W01C098G22	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127998	IMS12-D12	FLJ	W01C098G23	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK127998	IMS12-D12	FLJ	W01C098G24	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK127635	IMS12-D01	FLJ	W01C098H01	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127635	IMS12-D01	FLJ	W01C098H02	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	AK127642	IMS12-D02	FLJ	W01C098H03	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127642	IMS12-D02	FLJ	W01C098H04	pDONR221	3374		LOC387720	387720	BAC87069.1	Hs.527750	Hypothetical gene supported by AK127642		synoviocytes from rtheumatioid arthritis		HSYRA2														
IKAKEN	AK127646	IMS12-D03	FLJ	W01C098H05	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127646	IMS12-D03	FLJ	W01C098H06	pDONR221	11554		RGS9BP	388531	BAC87072.1	Hs.528491	Regulator of G protein signaling 9 binding protein			kidney	KIDNE2		NM_207391.2	NP_997274.2	VALIDATED	OK	1.000	1.000	235	708	1	705	235	1	235
IKAKEN	AK127717	IMS12-D04	FLJ	W01C098H07	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127717	IMS12-D04	FLJ	W01C098H08	pDONR221	22098		LOC401433	401433	BAC87097	Hs.714966	Hypothetical gene supported by AK127717	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK127750	IMS12-D05	FLJ	W01C098H09	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127750	IMS12-D05	FLJ	W01C098H10	pDONR221	11812		ZNF324B	388569	BAC87113.1	Hs.186970	Zinc finger protein 324B	NT2	teratocarcinoma		NT2RP8		NM_207395.2	NP_997278.2	VALIDATED	OK	1.000	1.000	544	1635	1	1632	544	1	544
IKAKEN	AK127818	IMS12-D06	FLJ	W01C098H11	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127818	IMS12-D06	FLJ	W01C098H12	pDONR221	11263		ENOSF1	55556	BAC87148.1	Hs.369762	Enolase superfamily member 1		peripheral blood mononuclear cells		PEBLM2		NM_202758.2	NP_974487.1	VALIDATED	OK	1.000	1.000	450	1353	1	1350	450	1	450
IKAKEN	AK127873	IMS12-D07	FLJ	W01C098H13	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127873	IMS12-D07	FLJ	W01C098H14	pDONR221	8320		RBPMS2	348093	BAC87172.1	Hs.436518	RNA binding protein with multiple splicing 2			placenta	PLACE7		NM_194272.1	NP_919248.1	PROVISIONAL	OK	1.000	1.000	209	630	1	627	209	1	209
IKAKEN	AK127903	IMS12-D08	FLJ	W01C098H15	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127903	IMS12-D08	FLJ	W01C098H16	pDONR221	18823		FLJ46010	401191	BAC87183.1	Hs.673805	FLJ46010 protein			small intestine	SMINT2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C098H17	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127913	IMS12-D09	FLJ	W01C098H18	pDONR221	15253		FLJ46020	400863	BAC87187.1	Hs.532855	FLJ46020 protein			spleen	SPLEN2														
IKAKEN	AK127979	IMS12-D10	FLJ	W01C098H19	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127979	IMS12-D10	FLJ	W01C098H20	pDONR221	12495		FAM71E2	284418	-	Hs.528319	Family with sequence similarity 71, member E2			testis	TESTI2		NM_001145402.1	NP_001138874.1	PREDICTED	P	1.000	1.000	575	1728	1	1725	922	348	922
IKAKEN	AK127993	IMS12-D11	FLJ	W01C098H21	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127993	IMS12-D11	FLJ	W01C098H22	pDONR221	4025		FLJ46111	283102	BAC87219.1	Hs.689472	FLJ46111 protein			testis	TESTI2				
IKAKEN	AK127998	IMS12-D12	FLJ	W01C098H23	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK127998	IMS12-D12	FLJ	W01C098H24	pDONR221	17130		LOC389151	389151	BAC87223.1	Hs.531376	Hypothetical gene supported by AK127998			testis	TESTI2		NM_001013650.2	NP_001013672.1	VALIDATED	OK	1.000	1.000	265	798	1	795	265	1	265
IKAKEN	AK128007	IMS12-E01	FLJ	W01C098I01	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128007	IMS12-E01	FLJ	W01C098I02	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128246	IMS12-E02	FLJ	W01C098I03	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128246	IMS12-E02	FLJ	W01C098I04	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128529	IMS12-E03	FLJ	W01C098I05	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128529	IMS12-E03	FLJ	W01C098I06	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128530	IMS12-E04	FLJ	W01C098I07	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128530	IMS12-E04	FLJ	W01C098I08	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128606	IMS12-E05	FLJ	W01C098I09	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128606	IMS12-E05	FLJ	W01C098I10	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128643	IMS12-E06	FLJ	W01C098I11	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128643	IMS12-E06	FLJ	W01C098I12	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128646	IMS12-E07	FLJ	W01C098I13	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK128646	IMS12-E07	FLJ	W01C098I14	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK126798	IMS12-E08	FLJ	W01C098I15	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126798	IMS12-E08	FLJ	W01C098I16	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126872	IMS12-E09	FLJ	W01C098I17	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK126872	IMS12-E09	FLJ	W01C098I18	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK127343	IMS12-E10	FLJ	W01C098I19	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127343	IMS12-E10	FLJ	W01C098I20	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127362	IMS12-E11	FLJ	W01C098I21	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK127362	IMS12-E11	FLJ	W01C098I22	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK128476	IMS12-E12	FLJ	W01C098I23	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128476	IMS12-E12	FLJ	W01C098I24	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128007	IMS12-E01	FLJ	W01C098J01	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128007	IMS12-E01	FLJ	W01C098J02	pDONR221	34519				BAC87229					testis	TESTI2				
IKAKEN	AK128246	IMS12-E02	FLJ	W01C098J03	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128246	IMS12-E02	FLJ	W01C098J04	pDONR221	793		RNF207	388591	BAC87352.1	Hs.716549	Ring finger protein 207			testis	TESTI4		XM_001718203.1	XP_001718255.1	MODEL		0.286	0.286	42	633	278	153	157	2	43
IKAKEN	AK128529	IMS12-E03	FLJ	W01C098J05	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128529	IMS12-E03	FLJ	W01C098J06	pDONR221	23631		UAP1L1	91373	BAC87482.1	Hs.142076	UDP-N-acteylglucosamine pyrophosphorylase 1-like 1			trachea	TRACH3		NM_207309.2	NP_997192.2	VALIDATED	P	1.000	1.000	342	1155	127	1152	507	166	507
IKAKEN	AK128530	IMS12-E04	FLJ	W01C098J07	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128530	IMS12-E04	FLJ	W01C098J08	pDONR221	5522		PLEKHG7	440107	BAC87483.1	Hs.591013	Pleckstrin homology domain containing, family G (with RhoGef domain) member 7			trachea	TRACH3		NM_001004330.2	NP_001004330.1	VALIDATED	OK	1.000	1.000	379	1140	1	1137	379	1	379
IKAKEN	AK128606	IMS12-E05	FLJ	W01C098J09	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128606	IMS12-E05	FLJ	W01C098J10	pDONR221	8840		VWA3A	146177	BAC87526.1	Hs.10697	Von Willebrand factor A domain containing 3A			trachea	TRACH3		NM_173615.3	NP_775886.3	VALIDATED	Ps	0.995	0.995	380	1143	1	1140	1184	805	1184
IKAKEN	AK128643	IMS12-E06	FLJ	W01C098J11	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128643	IMS12-E06	FLJ	W01C098J12	pDONR221	17135		GADL1	339896	BAC87546.1	Hs.657052	Glutamate decarboxylase-like 1			trachea	TRACH3		NM_207359.2	NP_997242.2	VALIDATED	P	1.000	1.000	337	1014	1	1011	521	185	521
IKAKEN	AK128646	IMS12-E07	FLJ	W01C098J13	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK128646	IMS12-E07	FLJ	W01C098J14	pDONR221	15651		LOC400891	400891	BAC87547.1	Hs.291198	Chromosome 14 open reading frame 166B pseudogene			trachea	TRACH3		XM_001716329.1	XP_001716381.1	MODEL		0.351	0.351	57	972	460	630	158	83	139
IKAKEN	AK126798	IMS12-E08	FLJ	W01C098J15	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126798	IMS12-E08	FLJ	W01C098J16	pDONR221	8702		LOC339047	339047	BAC86699	Hs.648395	Hypothetical protein LOC339047			cerebellum	BRACE3		XM_001134445.2	XP_001134445.2	MODEL	Pfs	0.318	0.338	85	2082	735	985	374	263	343
IKAKEN	AK126872	IMS12-E09	FLJ	W01C098J17	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK126872	IMS12-E09	FLJ	W01C098J18	pDONR221	3369		LOC387646	387646	BAC86731.1	Hs.631829	Leucine rich repeat containing 37, member A family pseudogene			amygdala	BRAMY3				
IKAKEN	AK127343	IMS12-E10	FLJ	W01C098J19	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127343	IMS12-E10	FLJ	W01C098J20	pDONR221	3237		FAM53B	9679	BAG54488.1	Hs.129195	Family with sequence similarity 53, member B			hippocampus	BRHIP3		NM_014661.3	NP_055476.3	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	AK127362	IMS12-E11	FLJ	W01C098J21	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK127362	IMS12-E11	FLJ	W01C098J22	pDONR221	4828		C11orf39	399980	BAC86944.1	Hs.683665	Chromosome 11 open reading frame 39			hippocampus	BRHIP3														
IKAKEN	AK128476	IMS12-E12	FLJ	W01C098J23	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128476	IMS12-E12	FLJ	W01C098J24	pDONR221	1		IGHA1	3493	BAC87456.1					kidney, tumor tissue	TKIDN2				
IKAKEN	AK128819	IMS12-F01	FLJ	W01C098K01	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK128819	IMS12-F01	FLJ	W01C098K02	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK127558	IMS12-F02	FLJ	W01C098K03	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK127558	IMS12-F02	FLJ	W01C098K04	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK126574	IMS12-F03	FLJ	W01C098K05	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126574	IMS12-F03	FLJ	W01C098K06	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126577	IMS12-F04	FLJ	W01C098K07	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK126577	IMS12-F04	FLJ	W01C098K08	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK127552	IMS12-F05	FLJ	W01C098K09	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127552	IMS12-F05	FLJ	W01C098K10	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127176	IMS12-F06	FLJ	W01C098K11	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127176	IMS12-F06	FLJ	W01C098K12	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127893	IMS12-F07	FLJ	W01C098K13	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK127893	IMS12-F07	FLJ	W01C098K14	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK128065	IMS12-F08	FLJ	W01C098K15	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128065	IMS12-F08	FLJ	W01C098K16	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128077	IMS12-F09	FLJ	W01C098K17	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128077	IMS12-F09	FLJ	W01C098K18	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128492	IMS12-F10	FLJ	W01C098K19	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK128492	IMS12-F10	FLJ	W01C098K20	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK127722	IMS12-F11	FLJ	W01C098K21	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127722	IMS12-F11	FLJ	W01C098K22	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127731	IMS12-F12	FLJ	W01C098K23	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127731	IMS12-F12	FLJ	W01C098K24	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK128819	IMS12-F01	FLJ	W01C098L01	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK128819	IMS12-F01	FLJ	W01C098L02	pDONR221	23723		C9orf171	389799	BAC87621.1	Hs.201709	Chromosome 9 open reading frame 171			cerebellum	BRACE3		NM_207417.1	NP_997300.1	PREDICTED	C	1.000	1.000	320	963	1	960	320	1	320
IKAKEN	AK127558	IMS12-F02	FLJ	W01C098L03	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK127558	IMS12-F02	FLJ	W01C098L04	pDONR221	8010		PLA2G4E	123745	BAC87034.1	Hs.668060	Phospholipase A2, group IVE			tongue, tumor tissue	CTONG2		NM_001080490.1	NP_001073959.1	PROVISIONAL	Pgs	0.996	0.998	493	1482	1	1479	839	348	839
IKAKEN	AK126574	IMS12-F03	FLJ	W01C098L05	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126574	IMS12-F03	FLJ	W01C098L06	pDONR221	8548		NDRG4	65009	BAC86600.1	Hs.322430	NDRG family member 4			cerebellum	BRACE2		NM_022910.2	NP_075061.1	REVIEWED	OK	1.000	1.000	371	1116	1	1113	371	1	371
IKAKEN	AK126577	IMS12-F04	FLJ	W01C098L07	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK126577	IMS12-F04	FLJ	W01C098L08	pDONR221	5453		FAM101A	144347	BAC86601.1	Hs.432901	Family with sequence similarity 101, member A			cerebellum	BRACE2		NM_181709.3	NP_859060.3	VALIDATED	OK	1.000	1.000	135	408	1	405	135	1	135
IKAKEN	AK127552	IMS12-F05	FLJ	W01C098L09	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127552	IMS12-F05	FLJ	W01C098L10	pDONR221	14195		RBM43	375287	BAC87031.1	Hs.302442	RNA binding motif protein 43			thalamus	BRTHA3		NM_198557.2	NP_940959.1	VALIDATED	OK	1.000	1.000	357	1074	1	1071	357	1	357
IKAKEN	AK127176	IMS12-F06	FLJ	W01C098L11	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127176	IMS12-F06	FLJ	W01C098L12	pDONR221	13233		MFSD6	54842	BAC86869.1	Hs.715029	Major facilitator superfamily domain containing 6			caudate nucleus	BRCAN2		NM_017694.3	NP_060164.3	VALIDATED	OK	1.000	1.000	791	2376	1	2373	791	1	791
IKAKEN	AK127893	IMS12-F07	FLJ	W01C098L13	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK127893	IMS12-F07	FLJ	W01C098L14	pDONR221	32332				BAC87178				pulmonary artery endothelial cells (HPAEC)		PUAEN2				
IKAKEN	AK128065	IMS12-F08	FLJ	W01C098L15	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128065	IMS12-F08	FLJ	W01C098L16	pDONR221	10471		DNAH17	8632	BAC87257	Hs.375975	Dynein, axonemal, heavy chain 17			testis	TESTI4		NM_173628.2	NP_775899.2	MODEL	Pgs	0.973	0.999	1310	3831	1	3828	4485	3176	4485
IKAKEN	AK128077	IMS12-F09	FLJ	W01C098L17	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128077	IMS12-F09	FLJ	W01C098L18	pDONR221	24157		QSOX2	169714	BAC87262.1	Hs.657864	Quiescin Q6 sulfhydryl oxidase 2			testis	TESTI4		NM_181701.3	NP_859052.3	VALIDATED	Pfs	0.993	1.000	578	1731	1	1728	698	123	698
IKAKEN	AK128492	IMS12-F10	FLJ	W01C098L19	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK128492	IMS12-F10	FLJ	W01C098L20	pDONR221	5823		FGD6	55785	BAC87464.1	Hs.506381	FYVE, RhoGEF and PH domain containing 6			lung, tumor tissue	TLUNG2		NM_018351.3	NP_060821.3	VALIDATED	P	1.000	1.000	791	2376	1	2373	1430	640	1430
IKAKEN	AK127722	IMS12-F11	FLJ	W01C098L21	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127722	IMS12-F11	FLJ	W01C098L22	pDONR221	1460		CSMD2	114784	BAC87101.1	Hs.656915	CUB and Sushi multiple domains 2	NT2	teratocarcinoma		NT2RP7		NM_052896.3	NP_443128.2	VALIDATED	Pgs	0.960	0.995	1199	3504	25	3495	3487	1096	2294
IKAKEN	AK127731	IMS12-F12	FLJ	W01C098L23	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127731	IMS12-F12	FLJ	W01C098L24	pDONR221	10640		FLJ45831	400576	BAC87106.1	Hs.446616	Hypothetical FLJ45831	NT2	teratocarcinoma		NT2RP8		NM_001001684.1	NP_001001684.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127732	IMS12-G01	FLJ	W01C098M01	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127732	IMS12-G01	FLJ	W01C098M02	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127735	IMS12-G02	FLJ	W01C098M03	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127735	IMS12-G02	FLJ	W01C098M04	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127772	IMS12-G03	FLJ	W01C098M05	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127772	IMS12-G03	FLJ	W01C098M06	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127832	IMS12-G04	FLJ	W01C098M07	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127832	IMS12-G04	FLJ	W01C098M08	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127834	IMS12-G05	FLJ	W01C098M09	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127834	IMS12-G05	FLJ	W01C098M10	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127837	IMS12-G06	FLJ	W01C098M11	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127837	IMS12-G06	FLJ	W01C098M12	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127846	IMS12-G07	FLJ	W01C098M13	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK127846	IMS12-G07	FLJ	W01C098M14	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK128123	IMS12-G08	FLJ	W01C098M15	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128123	IMS12-G08	FLJ	W01C098M16	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128126	IMS12-G09	FLJ	W01C098M17	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128126	IMS12-G09	FLJ	W01C098M18	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128130	IMS12-G10	FLJ	W01C098M19	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128130	IMS12-G10	FLJ	W01C098M20	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128215	IMS12-G11	FLJ	W01C098M21	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128215	IMS12-G11	FLJ	W01C098M22	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128836	IMS12-G12	FLJ	W01C098M23	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK128836	IMS12-G12	FLJ	W01C098M24	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK127732	IMS12-G01	FLJ	W01C098N01	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127732	IMS12-G01	FLJ	W01C098N02	pDONR221	15051		FLJ45832	400841	BAC87107.1	Hs.516959	FLJ45832 protein	NT2	teratocarcinoma		NT2RP8		NM_207470.1	NP_997353.1	NA
IKAKEN	AK127735	IMS12-G02	FLJ	W01C098N03	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127735	IMS12-G02	FLJ	W01C098N04	pDONR221	11662		CILP2	148113	-	Hs.279574	Cartilage intermediate layer protein 2	NT2	teratocarcinoma		NT2RP8		NM_153221.2	NP_694953.2	VALIDATED	OK	1.000	1.000	1156	3471	1	3468	1156	1	1156
IKAKEN	AK127772	IMS12-G03	FLJ	W01C098N05	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127772	IMS12-G03	FLJ	W01C098N06	pDONR221	12964		NBEAL1	65065	BAC87125.1	Hs.648846	Neurobeachin-like 1			brain	OCBBF2		NM_198945.3	NP_945183.3	VALIDATED	Cg	0.984	1.000	1335	3945	1	3942	1335	1	1335
IKAKEN	AK127832	IMS12-G04	FLJ	W01C098N07	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127832	IMS12-G04	FLJ	W01C098N08	pDONR221	9939		HSD17B1	3292	BAG54583.1	Hs.655222	Hydroxysteroid (17-beta) dehydrogenase 1			placenta	PLACE6		NM_000413.2	NP_000404.2	VALIDATED	OK	1.000	1.000	328	987	1	984	328	1	328
IKAKEN	AK127834	IMS12-G05	FLJ	W01C098N09	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127834	IMS12-G05	FLJ	W01C098N10	pDONR221	8324		C15orf51	196968	BAC87154.1	Hs.585319	Chromosome 15 open reading frame 51			placenta	PLACE7				
IKAKEN	AK127837	IMS12-G06	FLJ	W01C098N11	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127837	IMS12-G06	FLJ	W01C098N12	pDONR221	17004		ZDHHC3	51304	BAC87157	Hs.61430	Zinc finger, DHHC-type containing 3			placenta	PLACE7		NM_001135180.1	NP_001128652.1	VALIDATED	P	1.000	1.000	47	504	362	502	329	248	294
IKAKEN	AK127846	IMS12-G07	FLJ	W01C098N13	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK127846	IMS12-G07	FLJ	W01C098N14	pDONR221	11844		FLJ45949	388560	BAC87158.1					placenta	PLACE7				
IKAKEN	AK128123	IMS12-G08	FLJ	W01C098N15	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128123	IMS12-G08	FLJ	W01C098N16	pDONR221	25346		WDR42B	139425	BAG54633.1	Hs.447365	WD repeat domain 42B			testis	TESTI4		NM_001017930.1	NP_001017930.1	PROVISIONAL	Pfs	0.945	1.000	348	987	1	986	600	107	454
IKAKEN	AK128126	IMS12-G09	FLJ	W01C098N17	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128126	IMS12-G09	FLJ	W01C098N18	pDONR221	9940		EFCAB5	374786	BAC87284.1	Hs.662411	EF-hand calcium binding domain 5			testis	TESTI4		NM_001145053.1	NP_001138525.1	VALIDATED	Ps	0.998	0.998	558	3450	1	1674	856	175	732
IKAKEN	AK128130	IMS12-G10	FLJ	W01C098N19	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128130	IMS12-G10	FLJ	W01C098N20	pDONR221	20023		SYCP2L	221711	BAC87288.1					testis	TESTI4		NM_001040274.1	NP_001035364.1	PROVISIONAL	P	1.000	1.000	291	876	1	873	812	1	291
IKAKEN	AK128215	IMS12-G11	FLJ	W01C098N21	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128215	IMS12-G11	FLJ	W01C098N22	pDONR221	14200		FLJ46347	389064	BAC87331					testis	TESTI4		NM_001005303.1	NP_001005303.1	NA
IKAKEN	AK128836	IMS12-G12	FLJ	W01C098N23	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK128836	IMS12-G12	FLJ	W01C098N24	pDONR221	39684		LOC100132217	100132217	BAC87636.1	Hs.711980	Similar to hCG1793472			testis	TESTI4														
IKAKEN	AK127589	IMS12-H01	FLJ	W01C098O01	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK127589	IMS12-H01	FLJ	W01C098O02	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK126811	IMS12-H02	FLJ	W01C098O03	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK126811	IMS12-H02	FLJ	W01C098O04	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK127142	IMS12-H03	FLJ	W01C098O05	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127142	IMS12-H03	FLJ	W01C098O06	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127179	IMS12-H04	FLJ	W01C098O07	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127179	IMS12-H04	FLJ	W01C098O08	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127183	IMS12-H05	FLJ	W01C098O09	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127183	IMS12-H05	FLJ	W01C098O10	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127187	IMS12-H06	FLJ	W01C098O11	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127187	IMS12-H06	FLJ	W01C098O12	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127191	IMS12-H07	FLJ	W01C098O13	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK127191	IMS12-H07	FLJ	W01C098O14	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C098O15	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C098O16	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128203	IMS12-H09	FLJ	W01C098O17	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128203	IMS12-H09	FLJ	W01C098O18	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128212	IMS12-H10	FLJ	W01C098O19	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128212	IMS12-H10	FLJ	W01C098O20	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128108	IMS12-H11	FLJ	W01C098O21	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128108	IMS12-H11	FLJ	W01C098O22	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128136	IMS12-H12	FLJ	W01C098O23	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK128136	IMS12-H12	FLJ	W01C098O24	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK127589	IMS12-H01	FLJ	W01C098P01	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK127589	IMS12-H01	FLJ	W01C098P02	pDONR221	12581		FLJ45684	400666	BAC87046			TF-1	erythroleukemia		ERLTF2		NM_207462.1	NP_997345.1	NA
IKAKEN	AK126811	IMS12-H02	FLJ	W01C098P03	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK126811	IMS12-H02	FLJ	W01C098P04	pDONR221	9936		LOC388428	388428	BAC86704.1	Hs.591202	Hypothetical LOC388428			cerebellum	BRACE3		NM_207389.1	NP_997272.1	VALIDATED										
IKAKEN	AK127142	IMS12-H03	FLJ	W01C098P05	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127142	IMS12-H03	FLJ	W01C098P06	pDONR221	19374		PLCXD3	345557	BAG54443.1	Hs.145404	Phosphatidylinositol-specific phospholipase C, X domain containing 3			brain	BRAWH3		NM_001005473.2	NP_001005473.1	VALIDATED	OK	1.000	1.000	321	966	1	963	321	1	321
IKAKEN	AK127179	IMS12-H04	FLJ	W01C098P07	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127179	IMS12-H04	FLJ	W01C098P08	pDONR221	7161		FLJ45244	400242	BAC86872.1	Hs.712518	Hypothetical locus FLJ45244			corpus callosum	BRCOC2		NM_207443.1	NP_997326.1	VALIDATED										
IKAKEN	AK127183	IMS12-H05	FLJ	W01C098P09	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127183	IMS12-H05	FLJ	W01C098P10	pDONR221	22733		FLJ45248	401472	BAC86874.1	Hs.224506	FLJ45248 protein			corpus callosum	BRCOC2		NM_207505.1	NP_997388.1	NA
IKAKEN	AK127187	IMS12-H06	FLJ	W01C098P11	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127187	IMS12-H06	FLJ	W01C098P12	pDONR221	13773		AAK1	22848	BAC86877.1	Hs.468878	AP2 associated kinase 1			hippocampus	BRHIP2		NM_014911.3	NP_055726.3	REVIEWED	Pfs	0.419	0.419	31	651	402	494	961	369	399
IKAKEN	AK127191	IMS12-H07	FLJ	W01C098P13	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK127191	IMS12-H07	FLJ	W01C098P14	pDONR221	9334		FLJ45256	400511	BAC86880.1	Hs.592028	Hypothetical LOC400511			hippocampus	BRHIP2														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C098P15	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128037	IMS12-H08	FLJ	W01C098P16	pDONR221	7162		LRRC9	341883	BAC87242.1					testis	TESTI4														
IKAKEN	AK128203	IMS12-H09	FLJ	W01C098P17	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128203	IMS12-H09	FLJ	W01C098P18	pDONR221	24715		RP13-102H20.1	158763	BAC87322.1	Hs.22905	Hypothetical protein FLJ30058			testis	TESTI4		NM_144967.3	NP_659404.2	VALIDATED	OK	1.000	1.000	547	1644	1	1641	547	1	547
IKAKEN	AK128212	IMS12-H10	FLJ	W01C098P19	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128212	IMS12-H10	FLJ	W01C098P20	pDONR221	22941		SLC45A4	57210	BAC87328.1	Hs.372492	Solute carrier family 45, member 4			testis	TESTI4		NM_001080431.1	NP_001073900.1	PROVISIONAL	Pfs	0.999	1.000	691	2085	2	2073	798	25	714
IKAKEN	AK128108	IMS12-H11	FLJ	W01C098P21	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128108	IMS12-H11	FLJ	W01C098P22	pDONR221	2034		NUP210L	91181	BAC87279.1	Hs.67639	Nucleoporin 210kDa-like			testis	TESTI4		NM_207308.2	NP_997191.2	VALIDATED	P	1.000	1.000	1072	3219	1	3216	1888	817	1888
IKAKEN	AK128136	IMS12-H12	FLJ	W01C098P23	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK128136	IMS12-H12	FLJ	W01C098P24	pDONR221	15943		RP11-191L9.1	400932	BAC87291	Hs.561058	FLJ46257 protein			testis	TESTI4														
IKAKEN	AK128176	IMS13-A01	FLJ	W01C099A01	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128176	IMS13-A01	FLJ	W01C099A02	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128180	IMS13-A02	FLJ	W01C099A03	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK128180	IMS13-A02	FLJ	W01C099A04	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK126931	IMS13-A03	FLJ	W01C099A05	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126931	IMS13-A03	FLJ	W01C099A06	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126943	IMS13-A04	FLJ	W01C099A07	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126943	IMS13-A04	FLJ	W01C099A08	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126964	IMS13-A05	FLJ	W01C099A09	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126964	IMS13-A05	FLJ	W01C099A10	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126998	IMS13-A06	FLJ	W01C099A11	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK126998	IMS13-A06	FLJ	W01C099A12	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK127000	IMS13-A07	FLJ	W01C099A13	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A07	FLJ	W01C099A14	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C099A15	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C099A16	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127045	IMS13-A09	FLJ	W01C099A17	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127045	IMS13-A09	FLJ	W01C099A18	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127052	IMS13-A10	FLJ	W01C099A19	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127052	IMS13-A10	FLJ	W01C099A20	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127061	IMS13-A11	FLJ	W01C099A21	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127061	IMS13-A11	FLJ	W01C099A22	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127064	IMS13-A12	FLJ	W01C099A23	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	IMS13-A12	FLJ	W01C099A24	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK128176	IMS13-A01	FLJ	W01C099B01	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128176	IMS13-A01	FLJ	W01C099B02	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128180	IMS13-A02	FLJ	W01C099B03	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK128180	IMS13-A02	FLJ	W01C099B04	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK126931	IMS13-A03	FLJ	W01C099B05	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126931	IMS13-A03	FLJ	W01C099B06	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126943	IMS13-A04	FLJ	W01C099B07	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126943	IMS13-A04	FLJ	W01C099B08	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126964	IMS13-A05	FLJ	W01C099B09	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126964	IMS13-A05	FLJ	W01C099B10	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126998	IMS13-A06	FLJ	W01C099B11	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK126998	IMS13-A06	FLJ	W01C099B12	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK127000	IMS13-A07	FLJ	W01C099B13	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A07	FLJ	W01C099B14	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C099B15	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C099B16	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127045	IMS13-A09	FLJ	W01C099B17	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127045	IMS13-A09	FLJ	W01C099B18	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127052	IMS13-A10	FLJ	W01C099B19	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127052	IMS13-A10	FLJ	W01C099B20	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127061	IMS13-A11	FLJ	W01C099B21	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127061	IMS13-A11	FLJ	W01C099B22	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127064	IMS13-A12	FLJ	W01C099B23	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	IMS13-A12	FLJ	W01C099B24	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127146	IMS13-B01	FLJ	W01C099C01	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127146	IMS13-B01	FLJ	W01C099C02	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127151	IMS13-B02	FLJ	W01C099C03	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B02	FLJ	W01C099C04	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C099C05	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C099C06	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127155	IMS13-B04	FLJ	W01C099C07	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127155	IMS13-B04	FLJ	W01C099C08	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127379	IMS13-B05	FLJ	W01C099C09	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127379	IMS13-B05	FLJ	W01C099C10	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127381	IMS13-B06	FLJ	W01C099C11	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	IMS13-B06	FLJ	W01C099C12	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127398	IMS13-B07	FLJ	W01C099C13	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127398	IMS13-B07	FLJ	W01C099C14	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127413	IMS13-B08	FLJ	W01C099C15	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127413	IMS13-B08	FLJ	W01C099C16	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127436	IMS13-B09	FLJ	W01C099C17	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127436	IMS13-B09	FLJ	W01C099C18	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127438	IMS13-B10	FLJ	W01C099C19	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127438	IMS13-B10	FLJ	W01C099C20	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127445	IMS13-B11	FLJ	W01C099C21	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127445	IMS13-B11	FLJ	W01C099C22	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127450	IMS13-B12	FLJ	W01C099C23	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127450	IMS13-B12	FLJ	W01C099C24	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127146	IMS13-B01	FLJ	W01C099D01	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127146	IMS13-B01	FLJ	W01C099D02	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127151	IMS13-B02	FLJ	W01C099D03	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B02	FLJ	W01C099D04	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C099D05	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C099D06	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127155	IMS13-B04	FLJ	W01C099D07	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127155	IMS13-B04	FLJ	W01C099D08	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127379	IMS13-B05	FLJ	W01C099D09	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127379	IMS13-B05	FLJ	W01C099D10	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127381	IMS13-B06	FLJ	W01C099D11	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	IMS13-B06	FLJ	W01C099D12	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127398	IMS13-B07	FLJ	W01C099D13	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127398	IMS13-B07	FLJ	W01C099D14	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127413	IMS13-B08	FLJ	W01C099D15	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127413	IMS13-B08	FLJ	W01C099D16	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127436	IMS13-B09	FLJ	W01C099D17	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127436	IMS13-B09	FLJ	W01C099D18	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127438	IMS13-B10	FLJ	W01C099D19	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127438	IMS13-B10	FLJ	W01C099D20	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127445	IMS13-B11	FLJ	W01C099D21	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127445	IMS13-B11	FLJ	W01C099D22	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127450	IMS13-B12	FLJ	W01C099D23	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127450	IMS13-B12	FLJ	W01C099D24	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127591	IMS13-C01	FLJ	W01C099E01	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127591	IMS13-C01	FLJ	W01C099E02	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127847	IMS13-C02	FLJ	W01C099E03	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127847	IMS13-C02	FLJ	W01C099E04	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127881	IMS13-C03	FLJ	W01C099E05	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127881	IMS13-C03	FLJ	W01C099E06	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127983	IMS13-C04	FLJ	W01C099E07	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C04	FLJ	W01C099E08	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C099E09	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C099E10	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK128035	IMS13-C06	FLJ	W01C099E11	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C06	FLJ	W01C099E12	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C099E13	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C099E14	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128036	IMS13-C08	FLJ	W01C099E15	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128036	IMS13-C08	FLJ	W01C099E16	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128089	IMS13-C09	FLJ	W01C099E17	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128089	IMS13-C09	FLJ	W01C099E18	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128090	IMS13-C10	FLJ	W01C099E19	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128090	IMS13-C10	FLJ	W01C099E20	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128177	IMS13-C11	FLJ	W01C099E21	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128177	IMS13-C11	FLJ	W01C099E22	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128186	IMS13-C12	FLJ	W01C099E23	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK128186	IMS13-C12	FLJ	W01C099E24	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK127591	IMS13-C01	FLJ	W01C099F01	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127591	IMS13-C01	FLJ	W01C099F02	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127847	IMS13-C02	FLJ	W01C099F03	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127847	IMS13-C02	FLJ	W01C099F04	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127881	IMS13-C03	FLJ	W01C099F05	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127881	IMS13-C03	FLJ	W01C099F06	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127983	IMS13-C04	FLJ	W01C099F07	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C04	FLJ	W01C099F08	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C099F09	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C099F10	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK128035	IMS13-C06	FLJ	W01C099F11	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C06	FLJ	W01C099F12	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C099F13	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C099F14	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128036	IMS13-C08	FLJ	W01C099F15	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128036	IMS13-C08	FLJ	W01C099F16	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128089	IMS13-C09	FLJ	W01C099F17	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128089	IMS13-C09	FLJ	W01C099F18	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128090	IMS13-C10	FLJ	W01C099F19	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128090	IMS13-C10	FLJ	W01C099F20	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128177	IMS13-C11	FLJ	W01C099F21	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128177	IMS13-C11	FLJ	W01C099F22	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128186	IMS13-C12	FLJ	W01C099F23	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK128186	IMS13-C12	FLJ	W01C099F24	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK128831	IMS13-D01	FLJ	W01C099G01	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128831	IMS13-D01	FLJ	W01C099G02	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128275	IMS13-D02	FLJ	W01C099G03	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128275	IMS13-D02	FLJ	W01C099G04	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128332	IMS13-D03	FLJ	W01C099G05	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128332	IMS13-D03	FLJ	W01C099G06	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128339	IMS13-D04	FLJ	W01C099G07	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128339	IMS13-D04	FLJ	W01C099G08	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128347	IMS13-D05	FLJ	W01C099G09	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128347	IMS13-D05	FLJ	W01C099G10	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128390	IMS13-D06	FLJ	W01C099G11	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128390	IMS13-D06	FLJ	W01C099G12	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128393	IMS13-D07	FLJ	W01C099G13	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128393	IMS13-D07	FLJ	W01C099G14	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128418	IMS13-D08	FLJ	W01C099G15	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128418	IMS13-D08	FLJ	W01C099G16	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128444	IMS13-D09	FLJ	W01C099G17	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128444	IMS13-D09	FLJ	W01C099G18	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128460	IMS13-D10	FLJ	W01C099G19	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128460	IMS13-D10	FLJ	W01C099G20	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128465	IMS13-D11	FLJ	W01C099G21	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128465	IMS13-D11	FLJ	W01C099G22	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128673	IMS13-D12	FLJ	W01C099G23	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK128673	IMS13-D12	FLJ	W01C099G24	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK128831	IMS13-D01	FLJ	W01C099H01	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128831	IMS13-D01	FLJ	W01C099H02	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128275	IMS13-D02	FLJ	W01C099H03	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128275	IMS13-D02	FLJ	W01C099H04	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128332	IMS13-D03	FLJ	W01C099H05	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128332	IMS13-D03	FLJ	W01C099H06	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128339	IMS13-D04	FLJ	W01C099H07	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128339	IMS13-D04	FLJ	W01C099H08	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128347	IMS13-D05	FLJ	W01C099H09	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128347	IMS13-D05	FLJ	W01C099H10	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128390	IMS13-D06	FLJ	W01C099H11	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128390	IMS13-D06	FLJ	W01C099H12	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128393	IMS13-D07	FLJ	W01C099H13	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128393	IMS13-D07	FLJ	W01C099H14	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128418	IMS13-D08	FLJ	W01C099H15	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128418	IMS13-D08	FLJ	W01C099H16	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128444	IMS13-D09	FLJ	W01C099H17	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128444	IMS13-D09	FLJ	W01C099H18	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128460	IMS13-D10	FLJ	W01C099H19	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128460	IMS13-D10	FLJ	W01C099H20	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128465	IMS13-D11	FLJ	W01C099H21	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128465	IMS13-D11	FLJ	W01C099H22	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128673	IMS13-D12	FLJ	W01C099H23	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK128673	IMS13-D12	FLJ	W01C099H24	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK127082	IMS13-E01	FLJ	W01C099I01	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127082	IMS13-E01	FLJ	W01C099I02	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127112	IMS13-E02	FLJ	W01C099I03	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127112	IMS13-E02	FLJ	W01C099I04	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127135	IMS13-E03	FLJ	W01C099I05	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127135	IMS13-E03	FLJ	W01C099I06	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127584	IMS13-E04	FLJ	W01C099I07	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127584	IMS13-E04	FLJ	W01C099I08	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127680	IMS13-E05	FLJ	W01C099I09	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127680	IMS13-E05	FLJ	W01C099I10	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127778	IMS13-E06	FLJ	W01C099I11	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127778	IMS13-E06	FLJ	W01C099I12	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127779	IMS13-E07	FLJ	W01C099I13	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127779	IMS13-E07	FLJ	W01C099I14	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127850	IMS13-E08	FLJ	W01C099I15	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127850	IMS13-E08	FLJ	W01C099I16	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127861	IMS13-E09	FLJ	W01C099I17	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127861	IMS13-E09	FLJ	W01C099I18	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127863	IMS13-E10	FLJ	W01C099I19	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127863	IMS13-E10	FLJ	W01C099I20	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127870	IMS13-E11	FLJ	W01C099I21	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK127870	IMS13-E11	FLJ	W01C099I22	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK128220	IMS13-E12	FLJ	W01C099I23	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK128220	IMS13-E12	FLJ	W01C099I24	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK127082	IMS13-E01	FLJ	W01C099J01	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127082	IMS13-E01	FLJ	W01C099J02	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127112	IMS13-E02	FLJ	W01C099J03	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127112	IMS13-E02	FLJ	W01C099J04	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127135	IMS13-E03	FLJ	W01C099J05	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127135	IMS13-E03	FLJ	W01C099J06	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127584	IMS13-E04	FLJ	W01C099J07	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127584	IMS13-E04	FLJ	W01C099J08	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127680	IMS13-E05	FLJ	W01C099J09	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127680	IMS13-E05	FLJ	W01C099J10	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127778	IMS13-E06	FLJ	W01C099J11	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127778	IMS13-E06	FLJ	W01C099J12	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127779	IMS13-E07	FLJ	W01C099J13	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127779	IMS13-E07	FLJ	W01C099J14	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127850	IMS13-E08	FLJ	W01C099J15	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127850	IMS13-E08	FLJ	W01C099J16	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127861	IMS13-E09	FLJ	W01C099J17	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127861	IMS13-E09	FLJ	W01C099J18	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127863	IMS13-E10	FLJ	W01C099J19	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127863	IMS13-E10	FLJ	W01C099J20	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127870	IMS13-E11	FLJ	W01C099J21	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK127870	IMS13-E11	FLJ	W01C099J22	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK128220	IMS13-E12	FLJ	W01C099J23	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK128220	IMS13-E12	FLJ	W01C099J24	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK128228	IMS13-F01	FLJ	W01C099K01	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128228	IMS13-F01	FLJ	W01C099K02	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128229	IMS13-F02	FLJ	W01C099K03	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128229	IMS13-F02	FLJ	W01C099K04	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C099K05	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C099K06	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C099K07	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C099K08	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128243	IMS13-F05	FLJ	W01C099K09	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK128243	IMS13-F05	FLJ	W01C099K10	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK127206	IMS13-F06	FLJ	W01C099K11	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK127206	IMS13-F06	FLJ	W01C099K12	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK128145	IMS13-F07	FLJ	W01C099K13	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128145	IMS13-F07	FLJ	W01C099K14	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128877	IMS13-F08	FLJ	W01C099K15	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK128877	IMS13-F08	FLJ	W01C099K16	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK131528	IMS13-F09	FLJ	W01C099K17	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131528	IMS13-F09	FLJ	W01C099K18	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131571	IMS13-F10	FLJ	W01C099K19	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK131571	IMS13-F10	FLJ	W01C099K20	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK172840	IMS13-F11	FLJ	W01C099K21	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F11	FLJ	W01C099K22	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C099K23	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C099K24	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK128228	IMS13-F01	FLJ	W01C099L01	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128228	IMS13-F01	FLJ	W01C099L02	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128229	IMS13-F02	FLJ	W01C099L03	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128229	IMS13-F02	FLJ	W01C099L04	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C099L05	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C099L06	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C099L07	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C099L08	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128243	IMS13-F05	FLJ	W01C099L09	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK128243	IMS13-F05	FLJ	W01C099L10	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK127206	IMS13-F06	FLJ	W01C099L11	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK127206	IMS13-F06	FLJ	W01C099L12	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK128145	IMS13-F07	FLJ	W01C099L13	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128145	IMS13-F07	FLJ	W01C099L14	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128877	IMS13-F08	FLJ	W01C099L15	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK128877	IMS13-F08	FLJ	W01C099L16	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK131528	IMS13-F09	FLJ	W01C099L17	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131528	IMS13-F09	FLJ	W01C099L18	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131571	IMS13-F10	FLJ	W01C099L19	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK131571	IMS13-F10	FLJ	W01C099L20	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK172840	IMS13-F11	FLJ	W01C099L21	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F11	FLJ	W01C099L22	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C099L23	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C099L24	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-G01	FLJ	W01C099M01	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-G01	FLJ	W01C099M02	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172837	IMS13-G02	FLJ	W01C099M03	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	AK172837	IMS13-G02	FLJ	W01C099M04	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC017708	IMS13-G03	MGC	W01C099M05	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC017708	IMS13-G03	MGC	W01C099M06	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC022521	IMS13-G04	MGC	W01C099M07	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC022521	IMS13-G04	MGC	W01C099M08	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC029527	IMS13-G05	MGC	W01C099M09	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC029527	IMS13-G05	MGC	W01C099M10	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC033708	IMS13-G06	MGC	W01C099M11	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC033708	IMS13-G06	MGC	W01C099M12	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC044799	IMS13-G07	MGC	W01C099M13	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC044799	IMS13-G07	MGC	W01C099M14	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC033965	IMS13-G08	MGC	W01C099M15	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC033965	IMS13-G08	MGC	W01C099M16	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC053688	IMS13-G09	MGC	W01C099M17	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053688	IMS13-G09	MGC	W01C099M18	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053664	IMS13-G10	MGC	W01C099M19	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC053664	IMS13-G10	MGC	W01C099M20	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC067215	IMS13-G11	MGC	W01C099M21	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC067215	IMS13-G11	MGC	W01C099M22	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC005297	IMS13-G12	MGC	W01C099M23	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BC005297	IMS13-G12	MGC	W01C099M24	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK172840	IMS13-G01	FLJ	W01C099N01	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-G01	FLJ	W01C099N02	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172837	IMS13-G02	FLJ	W01C099N03	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	AK172837	IMS13-G02	FLJ	W01C099N04	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC017708	IMS13-G03	MGC	W01C099N05	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC017708	IMS13-G03	MGC	W01C099N06	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC022521	IMS13-G04	MGC	W01C099N07	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC022521	IMS13-G04	MGC	W01C099N08	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC029527	IMS13-G05	MGC	W01C099N09	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC029527	IMS13-G05	MGC	W01C099N10	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC033708	IMS13-G06	MGC	W01C099N11	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC033708	IMS13-G06	MGC	W01C099N12	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC044799	IMS13-G07	MGC	W01C099N13	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC044799	IMS13-G07	MGC	W01C099N14	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC033965	IMS13-G08	MGC	W01C099N15	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC033965	IMS13-G08	MGC	W01C099N16	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC053688	IMS13-G09	MGC	W01C099N17	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053688	IMS13-G09	MGC	W01C099N18	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053664	IMS13-G10	MGC	W01C099N19	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC053664	IMS13-G10	MGC	W01C099N20	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC067215	IMS13-G11	MGC	W01C099N21	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC067215	IMS13-G11	MGC	W01C099N22	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC005297	IMS13-G12	MGC	W01C099N23	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BC005297	IMS13-G12	MGC	W01C099N24	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BC052582	IMS13-H01	MGC	W01C099O01	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	BC052582	IMS13-H01	MGC	W01C099O02	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	SK002F08	IMS13-H02	IMS	W01C099O03	pDONR221															
IKAKEN	SK002F08	IMS13-H02	IMS	W01C099O04	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C099O05	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C099O06	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C099O07	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C099O08	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C099O09	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C099O10	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C099O11	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C099O12	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C099O13	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C099O14	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C099O15	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C099O16	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C099O17	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C099O18	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C099O19	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C099O20	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C099O21	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C099O22	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C099O23	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C099O24	pDONR221															
IKAKEN	BC052582	IMS13-H01	MGC	W01C099P01	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	BC052582	IMS13-H01	MGC	W01C099P02	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	SK002F08	IMS13-H02	IMS	W01C099P03	pDONR221															
IKAKEN	SK002F08	IMS13-H02	IMS	W01C099P04	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C099P05	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C099P06	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C099P07	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C099P08	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C099P09	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C099P10	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C099P11	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C099P12	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C099P13	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C099P14	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C099P15	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C099P16	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C099P17	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C099P18	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C099P19	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C099P20	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C099P21	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C099P22	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C099P23	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C099P24	pDONR221															
IKAKEN	AK128176	IMS13-A01	FLJ	W01C100A01	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128176	IMS13-A01	FLJ	W01C100A02	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128180	IMS13-A02	FLJ	W01C100A03	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK128180	IMS13-A02	FLJ	W01C100A04	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK126931	IMS13-A03	FLJ	W01C100A05	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126931	IMS13-A03	FLJ	W01C100A06	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126943	IMS13-A04	FLJ	W01C100A07	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126943	IMS13-A04	FLJ	W01C100A08	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126964	IMS13-A05	FLJ	W01C100A09	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126964	IMS13-A05	FLJ	W01C100A10	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126998	IMS13-A06	FLJ	W01C100A11	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK126998	IMS13-A06	FLJ	W01C100A12	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK127000	IMS13-A07	FLJ	W01C100A13	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A07	FLJ	W01C100A14	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C100A15	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C100A16	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127045	IMS13-A09	FLJ	W01C100A17	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127045	IMS13-A09	FLJ	W01C100A18	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127052	IMS13-A10	FLJ	W01C100A19	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127052	IMS13-A10	FLJ	W01C100A20	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127061	IMS13-A11	FLJ	W01C100A21	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127061	IMS13-A11	FLJ	W01C100A22	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127064	IMS13-A12	FLJ	W01C100A23	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	IMS13-A12	FLJ	W01C100A24	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK128176	IMS13-A01	FLJ	W01C100B01	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128176	IMS13-A01	FLJ	W01C100B02	pDONR221	16479		KLHDC6	166348	BAC87309.1	Hs.132087	Kelch domain containing 6			testis	TESTI4		NM_207335.2	NP_997218.2	VALIDATED	P	1.000	1.000	176	597	67	594	623	448	623
IKAKEN	AK128180	IMS13-A02	FLJ	W01C100B03	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK128180	IMS13-A02	FLJ	W01C100B04	pDONR221	24441		C9orf144	389715	BAC87313.1	Hs.522093	Chromosome 9 open reading frame 144			testis	TESTI4		XM_001725790.1	XP_001725842.1	MODEL	Pfs	0.326	0.326	43	1671	851	724	123	45	87
IKAKEN	AK126931	IMS13-A03	FLJ	W01C100B05	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126931	IMS13-A03	FLJ	W01C100B06	pDONR221	25286		SPIN4	139886	BAG54402.1	Hs.612782	Spindlin family, member 4			amygdala	BRAMY4		NM_001012968.2	NP_001012986.2	VALIDATED	OK	1.000	1.000	249	750	1	747	249	1	249
IKAKEN	AK126943	IMS13-A04	FLJ	W01C100B07	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126943	IMS13-A04	FLJ	W01C100B08	pDONR221	17451		USP38	84640	BAG54405.1	Hs.480848	Ubiquitin specific peptidase 38			brain	BRAWH3		NM_032557.5	NP_115946.2	VALIDATED	OK	1.000	1.000	1042	3129	1	3126	1042	1	1042
IKAKEN	AK126964	IMS13-A05	FLJ	W01C100B09	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126964	IMS13-A05	FLJ	W01C100B10	pDONR221	2811		JAKMIP3	282973	BAC86766.1	Hs.106254	Janus kinase and microtubule interacting protein 3			brain	BRAWH3		NM_001105521.2	NP_001098991.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	844	507	844
IKAKEN	AK126998	IMS13-A06	FLJ	W01C100B11	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK126998	IMS13-A06	FLJ	W01C100B12	pDONR221	13000		UBR3	130507	BAC86783.1	Hs.379548	Ubiquitin protein ligase E3 component n-recognin 3 (putative)			brain	BRAWH3		NM_172070.3	NP_742067.3	VALIDATED	P	1.000	1.000	741	2226	1	2223	1888	1148	1888
IKAKEN	AK127000	IMS13-A07	FLJ	W01C100B13	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A07	FLJ	W01C100B14	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C100B15	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127000	IMS13-A08	FLJ	W01C100B16	pDONR221	23189		RPL23AP53	644128	-	Hs.652159	Ribosomal protein L23a pseudogene 53			brain	BRAWH3				
IKAKEN	AK127045	IMS13-A09	FLJ	W01C100B17	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127045	IMS13-A09	FLJ	W01C100B18	pDONR221	11367		ARHGEF18	23370	BAC86801.1	Hs.465761	Rho/rac guanine nucleotide exchange factor (GEF) 18			brain	BRAWH3		NM_015318.3	NP_056133.2	REVIEWED	OK	1.000	1.000	1015	3048	1	3045	1015	1	1015
IKAKEN	AK127052	IMS13-A10	FLJ	W01C100B19	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127052	IMS13-A10	FLJ	W01C100B20	pDONR221	7883		LOC283711	283711	BAC86804	Hs.585100	Hypothetical protein LOC283711			brain	BRAWH3				
IKAKEN	AK127061	IMS13-A11	FLJ	W01C100B21	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127061	IMS13-A11	FLJ	W01C100B22	pDONR221	17570		WWC2	80014	BAC86807.1	Hs.333179	WW and C2 domain containing 2			brain	BRAWH3		NM_024949.5	NP_079225.5	VALIDATED	P	1.000	1.000	874	2625	1	2622	1192	319	1192
IKAKEN	AK127064	IMS13-A12	FLJ	W01C100B23	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	IMS13-A12	FLJ	W01C100B24	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127146	IMS13-B01	FLJ	W01C100C01	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127146	IMS13-B01	FLJ	W01C100C02	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127151	IMS13-B02	FLJ	W01C100C03	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B02	FLJ	W01C100C04	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C100C05	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C100C06	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127155	IMS13-B04	FLJ	W01C100C07	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127155	IMS13-B04	FLJ	W01C100C08	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127379	IMS13-B05	FLJ	W01C100C09	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127379	IMS13-B05	FLJ	W01C100C10	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127381	IMS13-B06	FLJ	W01C100C11	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	IMS13-B06	FLJ	W01C100C12	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127398	IMS13-B07	FLJ	W01C100C13	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127398	IMS13-B07	FLJ	W01C100C14	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127413	IMS13-B08	FLJ	W01C100C15	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127413	IMS13-B08	FLJ	W01C100C16	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127436	IMS13-B09	FLJ	W01C100C17	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127436	IMS13-B09	FLJ	W01C100C18	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127438	IMS13-B10	FLJ	W01C100C19	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127438	IMS13-B10	FLJ	W01C100C20	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127445	IMS13-B11	FLJ	W01C100C21	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127445	IMS13-B11	FLJ	W01C100C22	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127450	IMS13-B12	FLJ	W01C100C23	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127450	IMS13-B12	FLJ	W01C100C24	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127146	IMS13-B01	FLJ	W01C100D01	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127146	IMS13-B01	FLJ	W01C100D02	pDONR221	20715		DDO	8528	BAC86851	Hs.591348	D-aspartate oxidase			caudate nucleus	BRCAN2		NM_004032.2	NP_004023.2	REVIEWED		0.364	0.364	11	510	495	463	310	141	151
IKAKEN	AK127151	IMS13-B02	FLJ	W01C100D03	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B02	FLJ	W01C100D04	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C100D05	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127151	IMS13-B03	FLJ	W01C100D06	pDONR221	34999				BAC86855					caudate nucleus	BRCAN2				
IKAKEN	AK127155	IMS13-B04	FLJ	W01C100D07	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127155	IMS13-B04	FLJ	W01C100D08	pDONR221	4826		C11orf55	399879	BAC86858.1	Hs.99443	Chromosome 11 open reading frame 55			caudate nucleus	BRCAN2		NM_207428.2	NP_997311.1	MODEL	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127379	IMS13-B05	FLJ	W01C100D09	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127379	IMS13-B05	FLJ	W01C100D10	pDONR221	9938		FLJ45455	388336	BAC86949.1	Hs.717198	FLJ45455 protein			hippocampus	BRHIP3		XM_001716031.1	XP_001716083.1	MODEL	Pg	0.851	1.000	343	879	1	876	540	198	540
IKAKEN	AK127381	IMS13-B06	FLJ	W01C100D11	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127381	IMS13-B06	FLJ	W01C100D12	pDONR221	788		C1orf122	127687	BAC86950.1	Hs.532749	Chromosome 1 open reading frame 122			subthalamic nucleus	BRSTN2		NM_001142726.1	NP_001136198.1	VALIDATED	C	1.000	1.000	47	471	185	325	47	1	47
IKAKEN	AK127398	IMS13-B07	FLJ	W01C100D13	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127398	IMS13-B07	FLJ	W01C100D14	pDONR221	12574		CAPN12	147968	BAC86959.1	Hs.712632	Calpain 12			subthalamic nucleus	BRSTN2		NM_144691.3	NP_653292.2	VALIDATED	C	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK127413	IMS13-B08	FLJ	W01C100D15	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127413	IMS13-B08	FLJ	W01C100D16	pDONR221	3320		FAM107B	83641	BAC86966.1	Hs.446315	Family with sequence similarity 107, member B			thalamus	BRTHA2		NM_031453.2	NP_113641.2	PREDICTED	OK	1.000	1.000	306	921	1	918	306	1	306
IKAKEN	AK127436	IMS13-B09	FLJ	W01C100D17	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127436	IMS13-B09	FLJ	W01C100D18	pDONR221	3142		SYT15	83849	BAC86979.1	Hs.696346	Synaptotagmin XV			thalamus	BRTHA2		XM_001720092.1	XP_001720144.1	MODEL	Cg	0.996	1.000	252	1425	373	1125	252	1	252
IKAKEN	AK127438	IMS13-B10	FLJ	W01C100D19	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127438	IMS13-B10	FLJ	W01C100D20	pDONR221	9336		C16orf85	400555	BAC86980.1	Hs.120392	Chromosome 16 open reading frame 85			thalamus	BRTHA2		NM_001001682.1	NP_001001682.1	MODEL	OK	1.000	1.000	147	444	1	441	147	1	147
IKAKEN	AK127445	IMS13-B11	FLJ	W01C100D21	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127445	IMS13-B11	FLJ	W01C100D22	pDONR221	23719		C9orf170	401535	BAC86982	Hs.657740	Chromosome 9 open reading frame 170			thalamus	BRTHA2		NM_001001709.2	NP_001001709.1	VALIDATED	OK	1.000	1.000	121	366	1	363	121	1	121
IKAKEN	AK127450	IMS13-B12	FLJ	W01C100D23	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127450	IMS13-B12	FLJ	W01C100D24	pDONR221	31029		LOC439911	439911	BAC86985.1					thalamus	BRTHA2				
IKAKEN	AK127591	IMS13-C01	FLJ	W01C100E01	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127591	IMS13-C01	FLJ	W01C100E02	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127847	IMS13-C02	FLJ	W01C100E03	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127847	IMS13-C02	FLJ	W01C100E04	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127881	IMS13-C03	FLJ	W01C100E05	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127881	IMS13-C03	FLJ	W01C100E06	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127983	IMS13-C04	FLJ	W01C100E07	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C04	FLJ	W01C100E08	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C100E09	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C100E10	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK128035	IMS13-C06	FLJ	W01C100E11	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C06	FLJ	W01C100E12	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C100E13	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C100E14	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128036	IMS13-C08	FLJ	W01C100E15	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128036	IMS13-C08	FLJ	W01C100E16	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128089	IMS13-C09	FLJ	W01C100E17	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128089	IMS13-C09	FLJ	W01C100E18	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128090	IMS13-C10	FLJ	W01C100E19	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128090	IMS13-C10	FLJ	W01C100E20	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128177	IMS13-C11	FLJ	W01C100E21	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128177	IMS13-C11	FLJ	W01C100E22	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128186	IMS13-C12	FLJ	W01C100E23	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK128186	IMS13-C12	FLJ	W01C100E24	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK127591	IMS13-C01	FLJ	W01C100F01	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127591	IMS13-C01	FLJ	W01C100F02	pDONR221	4023		LRRC55	219527	BAC87047.1	Hs.199853	Leucine rich repeat containing 55			brain	FCBBF3		NM_001005210.1	NP_001005210.1	PROVISIONAL	OK	1.000	1.000	341	1026	1	1023	341	1	341
IKAKEN	AK127847	IMS13-C02	FLJ	W01C100F03	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127847	IMS13-C02	FLJ	W01C100F04	pDONR221	4829		FLJ45950	399975	BAC87159.1					placenta	PLACE7				
IKAKEN	AK127881	IMS13-C03	FLJ	W01C100F05	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127881	IMS13-C03	FLJ	W01C100F06	pDONR221	190		LRRC8C	84230	BAG54591.1	Hs.412836	Leucine rich repeat containing 8 family, member C			prostate	PROST2		NM_032270.4	NP_115646.2	VALIDATED	Cs	0.999	0.999	803	2412	1	2409	803	1	803
IKAKEN	AK127983	IMS13-C04	FLJ	W01C100F07	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C04	FLJ	W01C100F08	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C100F09	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK127983	IMS13-C05	FLJ	W01C100F10	pDONR221	14197		CMPK2	129607	BAC87217.1	Hs.7155	Cytidine monophosphate (UMP-CMP) kinase 2, mitochondrial			testis	TESTI2		NM_207315.2	NP_997198.2	VALIDATED	Pfs	0.806	1.000	377	912	1	911	449	1	377
IKAKEN	AK128035	IMS13-C06	FLJ	W01C100F11	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C06	FLJ	W01C100F12	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C100F13	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128035	IMS13-C07	FLJ	W01C100F14	pDONR221	4439		DCDC5	196296	BAC87240.1	Hs.530438	Doublecortin domain containing 5			testis	TESTI4		NM_198462.2	NP_940864.2	MODEL	Pfs	0.995	1.000	651	1947	1	1945	1258	397	1047
IKAKEN	AK128036	IMS13-C08	FLJ	W01C100F15	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128036	IMS13-C08	FLJ	W01C100F16	pDONR221	31511				BAC87241					testis	TESTI4				
IKAKEN	AK128089	IMS13-C09	FLJ	W01C100F17	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128089	IMS13-C09	FLJ	W01C100F18	pDONR221	17133		FLJ46210	389152	BAC87269.1	Hs.531377	FLJ46210 protein			testis	TESTI4		NM_001134657.1	NP_001128129.1	VALIDATED	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	AK128090	IMS13-C10	FLJ	W01C100F19	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128090	IMS13-C10	FLJ	W01C100F20	pDONR221	36953				BAC87270					testis	TESTI4				
IKAKEN	AK128177	IMS13-C11	FLJ	W01C100F21	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128177	IMS13-C11	FLJ	W01C100F22	pDONR221	3376		FLJ46300	399827	BAC87310.1	Hs.523353	FLJ46300 protein			testis	TESTI4														
IKAKEN	AK128186	IMS13-C12	FLJ	W01C100F23	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK128186	IMS13-C12	FLJ	W01C100F24	pDONR221	24780		CNGA2	1260	BAG54645.1	Hs.447360	Cyclic nucleotide gated channel alpha 2			testis	TESTI4		NM_005140.1	NP_005131.1	VALIDATED	OK	1.000	1.000	664	1995	1	1992	664	1	664
IKAKEN	AK128831	IMS13-D01	FLJ	W01C100G01	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128831	IMS13-D01	FLJ	W01C100G02	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128275	IMS13-D02	FLJ	W01C100G03	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128275	IMS13-D02	FLJ	W01C100G04	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128332	IMS13-D03	FLJ	W01C100G05	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128332	IMS13-D03	FLJ	W01C100G06	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128339	IMS13-D04	FLJ	W01C100G07	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128339	IMS13-D04	FLJ	W01C100G08	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128347	IMS13-D05	FLJ	W01C100G09	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128347	IMS13-D05	FLJ	W01C100G10	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128390	IMS13-D06	FLJ	W01C100G11	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128390	IMS13-D06	FLJ	W01C100G12	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128393	IMS13-D07	FLJ	W01C100G13	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128393	IMS13-D07	FLJ	W01C100G14	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128418	IMS13-D08	FLJ	W01C100G15	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128418	IMS13-D08	FLJ	W01C100G16	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128444	IMS13-D09	FLJ	W01C100G17	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128444	IMS13-D09	FLJ	W01C100G18	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128460	IMS13-D10	FLJ	W01C100G19	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128460	IMS13-D10	FLJ	W01C100G20	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128465	IMS13-D11	FLJ	W01C100G21	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128465	IMS13-D11	FLJ	W01C100G22	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128673	IMS13-D12	FLJ	W01C100G23	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK128673	IMS13-D12	FLJ	W01C100G24	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK128831	IMS13-D01	FLJ	W01C100H01	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128831	IMS13-D01	FLJ	W01C100H02	pDONR221	23714		FLJ46321	389763	BAC87631.1	Hs.209545	FAM75-like protein FLJ46321			testis	TESTI4		NM_001001670.2	NP_001001670.1	VALIDATED	OK	1.000	1.000	1576	4731	1	4728	1576	1	1576
IKAKEN	AK128275	IMS13-D02	FLJ	W01C100H03	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128275	IMS13-D02	FLJ	W01C100H04	pDONR221	7470		ATG2B	55102	BAC87363.1	Hs.168241	ATG2 autophagy related 2 homolog B (S. cerevisiae)			thymus	THYMU2		NM_018036.5	NP_060506.5	VALIDATED	Ps	0.999	0.999	909	2730	1	2727	2078	1170	2078
IKAKEN	AK128332	IMS13-D03	FLJ	W01C100H05	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128332	IMS13-D03	FLJ	W01C100H06	pDONR221	10636		FLJ45079	400624	BAC87388.1	Hs.514521	FLJ45079 protein			thymus	THYMU3		NM_001001685.1	NP_001001685.1	PREDICTED	C	1.000	1.000	154	465	1	462	154	1	154
IKAKEN	AK128339	IMS13-D04	FLJ	W01C100H07	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128339	IMS13-D04	FLJ	W01C100H08	pDONR221	18225		C4orf50	389197	BAC87391.1	Hs.479065	Chromosome 4 open reading frame 50			thymus	THYMU3		NM_207405.1	NP_997288.1	PREDICTED	OK	1.000	1.000	276	831	1	828	276	1	276
IKAKEN	AK128347	IMS13-D05	FLJ	W01C100H09	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128347	IMS13-D05	FLJ	W01C100H10	pDONR221	30562				BAC87393					thymus	THYMU3				
IKAKEN	AK128390	IMS13-D06	FLJ	W01C100H11	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128390	IMS13-D06	FLJ	W01C100H12	pDONR221	16897		TESSP5	377047	BAC87415.1	Hs.667712	Testis serine protease 5			thymus	THYMU3		NM_199183.2	NP_954652.2	VALIDATED	Cgs	0.846	0.991	267	804	1	801	228	1	228
IKAKEN	AK128393	IMS13-D07	FLJ	W01C100H13	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128393	IMS13-D07	FLJ	W01C100H14	pDONR221	13410		RUFY4	285180	BAC87417.1	Hs.570069	RUN and FYVE domain containing 4			thymus	THYMU3		NM_198483.2	NP_940885.1	PROVISIONAL	OK	1.000	1.000	398	1197	1	1194	398	1	398
IKAKEN	AK128418	IMS13-D08	FLJ	W01C100H15	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128418	IMS13-D08	FLJ	W01C100H16	pDONR221	13843		hCG_1817306	100130691		Hs.707723	Hypothetical LOC100130691			thymus	THYMU3		XM_001716191.1	XP_001716243.1	MODEL	OK	1.000	1.000	180	543	1	540	180	1	180
IKAKEN	AK128444	IMS13-D09	FLJ	W01C100H17	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128444	IMS13-D09	FLJ	W01C100H18	pDONR221	15246		C21orf125	284836	BAC87443.1	Hs.146127	Chromosome 21 open reading frame 125			thymus	THYMU3														
IKAKEN	AK128460	IMS13-D10	FLJ	W01C100H19	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128460	IMS13-D10	FLJ	W01C100H20	pDONR221	10626		MXRA7	439921	BAC87451.1	Hs.597019	Matrix-remodelling associated 7			thymus	THYMU3		NM_198530.2	NP_940932.2	VALIDATED	Pfs	0.623	0.640	114	642	300	639	170	60	170
IKAKEN	AK128465	IMS13-D11	FLJ	W01C100H21	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128465	IMS13-D11	FLJ	W01C100H22	pDONR221	24781		ZCCHC16	340595	BAC87453.1	Hs.368140	Zinc finger, CCHC domain containing 16			thymus	THYMU3		NM_001004308.2	NP_001004308.2	VALIDATED	OK	1.000	1.000	310	933	1	930	310	1	310
IKAKEN	AK128673	IMS13-D12	FLJ	W01C100H23	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK128673	IMS13-D12	FLJ	W01C100H24	pDONR221	24245		FLJ46836	401554	BAC87564.1	Hs.522437	FLJ46836 protein			trachea	TRACH3														
IKAKEN	AK127082	IMS13-E01	FLJ	W01C100I01	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127082	IMS13-E01	FLJ	W01C100I02	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127112	IMS13-E02	FLJ	W01C100I03	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127112	IMS13-E02	FLJ	W01C100I04	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127135	IMS13-E03	FLJ	W01C100I05	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127135	IMS13-E03	FLJ	W01C100I06	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127584	IMS13-E04	FLJ	W01C100I07	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127584	IMS13-E04	FLJ	W01C100I08	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127680	IMS13-E05	FLJ	W01C100I09	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127680	IMS13-E05	FLJ	W01C100I10	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127778	IMS13-E06	FLJ	W01C100I11	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127778	IMS13-E06	FLJ	W01C100I12	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127779	IMS13-E07	FLJ	W01C100I13	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127779	IMS13-E07	FLJ	W01C100I14	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127850	IMS13-E08	FLJ	W01C100I15	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127850	IMS13-E08	FLJ	W01C100I16	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127861	IMS13-E09	FLJ	W01C100I17	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127861	IMS13-E09	FLJ	W01C100I18	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127863	IMS13-E10	FLJ	W01C100I19	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127863	IMS13-E10	FLJ	W01C100I20	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127870	IMS13-E11	FLJ	W01C100I21	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK127870	IMS13-E11	FLJ	W01C100I22	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK128220	IMS13-E12	FLJ	W01C100I23	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK128220	IMS13-E12	FLJ	W01C100I24	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK127082	IMS13-E01	FLJ	W01C100J01	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127082	IMS13-E01	FLJ	W01C100J02	pDONR221	15417		FLJ45139	400867	BAC86818.1	Hs.689509	FLJ45139 protein			brain	BRAWH3		NM_001001692.1	NP_001001692.1	MODEL	OK	1.000	1.000	136	411	1	408	136	1	136
IKAKEN	AK127112	IMS13-E02	FLJ	W01C100J03	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127112	IMS13-E02	FLJ	W01C100J04	pDONR221	16086		DNAJC13	23317	BAC86835.1	Hs.12707	DnaJ (Hsp40) homolog, subfamily C, member 13			brain	BRAWH3		NM_015268.3	NP_056083.3	VALIDATED	P	1.000	1.000	1626	4881	1	4878	2243	618	2243
IKAKEN	AK127135	IMS13-E03	FLJ	W01C100J05	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127135	IMS13-E03	FLJ	W01C100J06	pDONR221	18544		GALNT10	55568	BAG54441.1	Hs.655011	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 10 (GalNAc-T10)			brain	BRAWH3		NM_198321.2	NP_938080.1	REVIEWED	OK	1.000	1.000	603	1812	1	1809	603	1	603
IKAKEN	AK127584	IMS13-E04	FLJ	W01C100J07	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127584	IMS13-E04	FLJ	W01C100J08	pDONR221	16478		FAM172B	131909	-	Hs.518125	Family with sequence similarity 172, member B pseudogene	TF-1	erythroleukemia		ERLTF1														
IKAKEN	AK127680	IMS13-E05	FLJ	W01C100J09	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127680	IMS13-E05	FLJ	W01C100J10	pDONR221	12582		C19orf35	374872	BAC87082.1	Hs.511803	Chromosome 19 open reading frame 35		lymphoblasts (EB virus transferred B cell)		LYMPB1		NM_198532.2	NP_940934.1	VALIDATED	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127778	IMS13-E06	FLJ	W01C100J11	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127778	IMS13-E06	FLJ	W01C100J12	pDONR221	18103		CXXC4	80319	-	Hs.12248	CXXC finger 4			brain	OCBBF3		NM_025212.1	NP_079488.1	PROVISIONAL	OK	1.000	1.000	198	597	1	594	198	1	198
IKAKEN	AK127779	IMS13-E07	FLJ	W01C100J13	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127779	IMS13-E07	FLJ	W01C100J14	pDONR221	16407		ZNF662	389114	BAC87129.1					brain	OCBBF3		NM_207404.3	NP_997287.2	VALIDATED	OK	1.000	1.000	426	1281	1	1278	426	1	426
IKAKEN	AK127850	IMS13-E08	FLJ	W01C100J15	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127850	IMS13-E08	FLJ	W01C100J16	pDONR221	10639		SP6	80320	BAG54586.1	Hs.253603	Sp6 transcription factor			placenta	PLACE7		NM_199262.2	NP_954871.1	VALIDATED	OK	1.000	1.000	376	1131	1	1128	376	1	376
IKAKEN	AK127861	IMS13-E09	FLJ	W01C100J17	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127861	IMS13-E09	FLJ	W01C100J18	pDONR221	13409		FLJ45964	401040	BAC87165.1	Hs.516794	Hypothetical FLJ45964			placenta	PLACE7														
IKAKEN	AK127863	IMS13-E10	FLJ	W01C100J19	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127863	IMS13-E10	FLJ	W01C100J20	pDONR221	17669			401120	BAC87166					placenta	PLACE7				
IKAKEN	AK127870	IMS13-E11	FLJ	W01C100J21	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK127870	IMS13-E11	FLJ	W01C100J22	pDONR221	22099		FLJ45974	401337	BAC87170.1	Hs.531378	FLJ45974 protein			placenta	PLACE7														
IKAKEN	AK128220	IMS13-E12	FLJ	W01C100J23	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK128220	IMS13-E12	FLJ	W01C100J24	pDONR221	11846		C19orf15	57828	BAC87333.1	Hs.324335	Chromosome 19 open reading frame 15			testis	TESTI4		NM_021185.4	NP_067008.3	VALIDATED	P	1.000	1.000	799	2400	1	2397	1159	361	1159
IKAKEN	AK128228	IMS13-F01	FLJ	W01C100K01	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128228	IMS13-F01	FLJ	W01C100K02	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128229	IMS13-F02	FLJ	W01C100K03	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128229	IMS13-F02	FLJ	W01C100K04	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C100K05	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C100K06	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C100K07	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C100K08	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128243	IMS13-F05	FLJ	W01C100K09	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK128243	IMS13-F05	FLJ	W01C100K10	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK127206	IMS13-F06	FLJ	W01C100K11	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK127206	IMS13-F06	FLJ	W01C100K12	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK128145	IMS13-F07	FLJ	W01C100K13	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128145	IMS13-F07	FLJ	W01C100K14	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128877	IMS13-F08	FLJ	W01C100K15	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK128877	IMS13-F08	FLJ	W01C100K16	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK131528	IMS13-F09	FLJ	W01C100K17	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131528	IMS13-F09	FLJ	W01C100K18	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131571	IMS13-F10	FLJ	W01C100K19	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK131571	IMS13-F10	FLJ	W01C100K20	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK172840	IMS13-F11	FLJ	W01C100K21	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F11	FLJ	W01C100K22	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C100K23	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C100K24	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK128228	IMS13-F01	FLJ	W01C100L01	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128228	IMS13-F01	FLJ	W01C100L02	pDONR221	2838		FLJ46361	375940	BAC87338.1	Hs.650695	Deleted in malignant brain tumors 1 pseudogene			testis	TESTI4				
IKAKEN	AK128229	IMS13-F02	FLJ	W01C100L03	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128229	IMS13-F02	FLJ	W01C100L04	pDONR221	23713		FLJ43950	347127	BAC87339	Hs.215235	FAM75-like protein FLJ46321 pseudogene			testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C100L05	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128232	IMS13-F03	FLJ	W01C100L06	pDONR221	22734		FLJ46365	401459	BAC87342.1					testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C100L07	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128235	IMS13-F04	FLJ	W01C100L08	pDONR221	10633		FLJ43944	400593	BAC87345	Hs.167595	FLJ43944 protein			testis	TESTI4														
IKAKEN	AK128243	IMS13-F05	FLJ	W01C100L09	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK128243	IMS13-F05	FLJ	W01C100L10	pDONR221	5521		CLEC12B	387837	BAC87350.1	Hs.127937	C-type lectin domain family 12, member B			testis	TESTI4		NM_205852.2	NP_995324.2	VALIDATED	OK	1.000	1.000	232	699	1	696	232	1	232
IKAKEN	AK127206	IMS13-F06	FLJ	W01C100L11	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK127206	IMS13-F06	FLJ	W01C100L12	pDONR221	14194		LONRF2	164832	BAC86883.1	Hs.21380	LON peptidase N-terminal domain and ring finger 2			hippocampus	BRHIP2		NM_198461.3	NP_940863.3	VALIDATED	P	1.000	1.000	511	1536	1	1533	754	244	754
IKAKEN	AK128145	IMS13-F07	FLJ	W01C100L13	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128145	IMS13-F07	FLJ	W01C100L14	pDONR221	4027		C11orf88	399949	BAC87297.1	Hs.411600	Chromosome 11 open reading frame 88			testis	TESTI4		NM_207430.2	NP_997313.2	VALIDATED	P	1.000	1.000	178	537	1	534	196	1	178
IKAKEN	AK128877	IMS13-F08	FLJ	W01C100L15	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK128877	IMS13-F08	FLJ	W01C100L16	pDONR221	23725		MORN5	254956	BAC87653.1	Hs.71428	MORN repeat containing 5			testis	TESTI4		NM_198469.2	NP_940871.2	VALIDATED	OK	1.000	1.000	161	486	1	483	161	1	161
IKAKEN	AK131528	IMS13-F09	FLJ	W01C100L17	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131528	IMS13-F09	FLJ	W01C100L18	pDONR221	10944		KIAA0802	23255	BAD18666.1	Hs.650822	KIAA0802			tongue, tumor tissue	CTONG2		NM_015210.3	NP_056025.2	PREDICTED	OK	1.000	1.000	1586	4761	1	4758	1586	1	1586
IKAKEN	AK131571	IMS13-F10	FLJ	W01C100L19	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK131571	IMS13-F10	FLJ	W01C100L20	pDONR221	12598		ADAMTSL5	339366	BAD18703.1	Hs.371674	ADAMTS-like 5			cerebellum	BRACE3		NM_213604.2	NP_998769.2	VALIDATED	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK172840	IMS13-F11	FLJ	W01C100L21	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F11	FLJ	W01C100L22	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C100L23	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-F12	FLJ	W01C100L24	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-G01	FLJ	W01C100M01	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-G01	FLJ	W01C100M02	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172837	IMS13-G02	FLJ	W01C100M03	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	AK172837	IMS13-G02	FLJ	W01C100M04	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC017708	IMS13-G03	MGC	W01C100M05	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC017708	IMS13-G03	MGC	W01C100M06	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC022521	IMS13-G04	MGC	W01C100M07	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC022521	IMS13-G04	MGC	W01C100M08	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC029527	IMS13-G05	MGC	W01C100M09	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC029527	IMS13-G05	MGC	W01C100M10	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC033708	IMS13-G06	MGC	W01C100M11	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC033708	IMS13-G06	MGC	W01C100M12	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC044799	IMS13-G07	MGC	W01C100M13	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC044799	IMS13-G07	MGC	W01C100M14	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC033965	IMS13-G08	MGC	W01C100M15	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC033965	IMS13-G08	MGC	W01C100M16	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC053688	IMS13-G09	MGC	W01C100M17	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053688	IMS13-G09	MGC	W01C100M18	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053664	IMS13-G10	MGC	W01C100M19	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC053664	IMS13-G10	MGC	W01C100M20	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC067215	IMS13-G11	MGC	W01C100M21	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC067215	IMS13-G11	MGC	W01C100M22	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC005297	IMS13-G12	MGC	W01C100M23	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BC005297	IMS13-G12	MGC	W01C100M24	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	AK172840	IMS13-G01	FLJ	W01C100N01	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172840	IMS13-G01	FLJ	W01C100N02	pDONR221	21214		OR2A9P	441295	-					human small intestine	HSI				
IKAKEN	AK172837	IMS13-G02	FLJ	W01C100N03	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	AK172837	IMS13-G02	FLJ	W01C100N04	pDONR221	16491		OSTalpha	200931	BAD18802.1	Hs.630585	Organic solute transporter alpha			uterus	UTERU2		NM_152672.5	NP_689885.4	VALIDATED	OK	1.000	1.000	340	1023	1	1020	340	1	340
IKAKEN	BC017708	IMS13-G03	MGC	W01C100N05	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC017708	IMS13-G03	MGC	W01C100N06	pDONR221	7825		UBE2Q2	92912	AAH17708.1	Hs.23033	Ubiquitin-conjugating enzyme E2Q family member 2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_173469.2	NP_775740.1	VALIDATED	OK	1.000	1.000	375	1128	1	1125	375	1	375
IKAKEN	BC022521	IMS13-G04	MGC	W01C100N07	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC022521	IMS13-G04	MGC	W01C100N08	pDONR221	23777		NXNL2	158046	AAH22521.1	Hs.668937	Nucleoredoxin-like 2			Lung	NIH_MGC_77	DH10B	NM_145283.1	NP_660326.1	PROVISIONAL	Cs	0.993	0.993	135	408	1	405	135	1	135
IKAKEN	BC029527	IMS13-G05	MGC	W01C100N09	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC029527	IMS13-G05	MGC	W01C100N10	pDONR221	10635		C17orf103	256302	AAH29527.1	Hs.654713	Chromosome 17 open reading frame 103			Testis	NIH_MGC_97	DH10B	NM_152914.2	NP_690878.2	VALIDATED	Cgs	0.956	0.982	113	333	1	330	113	1	113
IKAKEN	BC033708	IMS13-G06	MGC	W01C100N11	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC033708	IMS13-G06	MGC	W01C100N12	pDONR221	23436		RALGPS1	9649	AAH33708.1	Hs.648175	Ral GEF with PH domain and SH3 binding motif 1			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_014636.1	NP_055451.1	PROVISIONAL		0.839	0.891	380	1155	1	1140	557	1	358
IKAKEN	BC044799	IMS13-G07	MGC	W01C100N13	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC044799	IMS13-G07	MGC	W01C100N14	pDONR221	18141		C4orf21	55345	AAH44799.1	Hs.380346	Chromosome 4 open reading frame 21			Brain, adult medulla	NIH_MGC_119	DH10B	NM_018392.3	NP_060862.2	PREDICTED	Cs	0.998	0.998	1062	3189	1	3186	1062	1	1062
IKAKEN	BC033965	IMS13-G08	MGC	W01C100N15	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC033965	IMS13-G08	MGC	W01C100N16	pDONR221	13841		NDUFAF2	91942	AAH33965.1	Hs.591757	NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, assembly factor 2			Brain, adult medulla	NIH_MGC_119	DH10B	NM_174889.4	NP_777549.1	REVIEWED	OK	1.000	1.000	169	510	1	507	169	1	169
IKAKEN	BC053688	IMS13-G09	MGC	W01C100N17	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053688	IMS13-G09	MGC	W01C100N18	pDONR221	2036		ARHGAP30	257106	AAH53688.1	Hs.389374	Rho GTPase activating protein 30			Brain, Lung, Testis, adult, pooled whole	NIH_MGC_115	DH10B	NM_181720.2	NP_859071.2	VALIDATED	OK	1.000	1.000	890	2673	1	2670	890	1	890
IKAKEN	BC053664	IMS13-G10	MGC	W01C100N19	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC053664	IMS13-G10	MGC	W01C100N20	pDONR221	18001		ZFYVE28	57732	AAH53664.1	Hs.292056	Zinc finger, FYVE domain containing 28			Brain, adult medulla	NIH_MGC_119	DH10B	NM_020972.1	NP_066023.1	PROVISIONAL	Pgs	0.987	0.992	237	864	1	711	887	2	237
IKAKEN	BC067215	IMS13-G11	MGC	W01C100N21	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC067215	IMS13-G11	MGC	W01C100N22	pDONR221	12909		EHBP1	23301	AAH67215.1	Hs.271667	EH domain binding protein 1			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_001142616.1	NP_001136088.1	VALIDATED	OK	1.000	1.000	1160	3483	1	3480	1160	1	1160
IKAKEN	BC005297	IMS13-G12	MGC	W01C100N23	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BC005297	IMS13-G12	MGC	W01C100N24	pDONR221	306		KMO	8564	AAH05297.1	Hs.409081	Kynurenine 3-monooxygenase (kynurenine 3-hydroxylase)			Bladder, carcinoma	NIH_MGC_53	DH10B	NM_003679.3	NP_003670.2	VALIDATED	OK	1.000	1.000	486	1461	1	1458	486	1	486
IKAKEN	BC052582	IMS13-H01	MGC	W01C100O01	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	BC052582	IMS13-H01	MGC	W01C100O02	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	SK002F08	IMS13-H02	IMS	W01C100O03	pDONR221															
IKAKEN	SK002F08	IMS13-H02	IMS	W01C100O04	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C100O05	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C100O06	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C100O07	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C100O08	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C100O09	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C100O10	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C100O11	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C100O12	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C100O13	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C100O14	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C100O15	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C100O16	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C100O17	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C100O18	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C100O19	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C100O20	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C100O21	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C100O22	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C100O23	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C100O24	pDONR221															
IKAKEN	BC052582	IMS13-H01	MGC	W01C100P01	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	BC052582	IMS13-H01	MGC	W01C100P02	pDONR221	20391		NCR3	259197	AAH52582.1	Hs.509513	Natural cytotoxicity triggering receptor 3			Blood, natural killer cell	NIH_MGC_106	DH10B-R	NM_147130.2	NP_667341.1	VALIDATED	Cg	0.876	1.000	201	531	1	528	201	1	201
IKAKEN	SK002F08	IMS13-H02	IMS	W01C100P03	pDONR221															
IKAKEN	SK002F08	IMS13-H02	IMS	W01C100P04	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C100P05	pDONR221															
IKAKEN	SK002F08	IMS13-H03	IMS	W01C100P06	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C100P07	pDONR221															
IKAKEN	SK002F09	IMS13-H04	IMS	W01C100P08	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C100P09	pDONR221															
IKAKEN	SK002F11	IMS13-H05	IMS	W01C100P10	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C100P11	pDONR221															
IKAKEN	SK002F12	IMS13-H06	IMS	W01C100P12	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C100P13	pDONR221															
IKAKEN	SK002G03	IMS13-H07	IMS	W01C100P14	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C100P15	pDONR221															
IKAKEN	SK002G06	IMS13-H08	IMS	W01C100P16	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C100P17	pDONR221															
IKAKEN	SK002G09	IMS13-H09	IMS	W01C100P18	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C100P19	pDONR221															
IKAKEN	SK002G10	IMS13-H10	IMS	W01C100P20	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C100P21	pDONR221															
IKAKEN	SK002G11	IMS13-H11	IMS	W01C100P22	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C100P23	pDONR221															
IKAKEN	SK002G12	IMS13-H12	IMS	W01C100P24	pDONR221															
IKAKEN	SK002H03	IMS14-A01	IMS	W01C101A01	pDONR221															
IKAKEN	SK002H03	IMS14-A01	IMS	W01C101A02	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C101A03	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C101A04	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C101A05	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C101A06	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C101A07	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C101A08	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C101A09	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C101A10	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C101A11	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C101A12	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C101A13	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C101A14	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C101A15	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C101A16	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C101A17	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C101A18	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C101A19	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C101A20	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C101A21	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C101A22	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C101A23	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C101A24	pDONR221															
IKAKEN	SK002H03	IMS14-A01	IMS	W01C101B01	pDONR221															
IKAKEN	SK002H03	IMS14-A01	IMS	W01C101B02	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C101B03	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C101B04	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C101B05	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C101B06	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C101B07	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C101B08	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C101B09	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C101B10	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C101B11	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C101B12	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C101B13	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C101B14	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C101B15	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C101B16	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C101B17	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C101B18	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C101B19	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C101B20	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C101B21	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C101B22	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C101B23	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C101B24	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C101C01	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C101C02	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C101C03	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C101C04	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C101C05	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C101C06	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C101C07	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C101C08	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C101C09	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C101C10	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C101C11	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C101C12	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C101C13	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C101C14	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C101C15	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C101C16	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C101C17	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C101C18	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C101C19	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C101C20	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C101C21	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C101C22	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C101C23	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C101C24	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C101D01	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C101D02	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C101D03	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C101D04	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C101D05	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C101D06	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C101D07	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C101D08	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C101D09	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C101D10	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C101D11	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C101D12	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C101D13	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C101D14	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C101D15	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C101D16	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C101D17	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C101D18	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C101D19	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C101D20	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C101D21	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C101D22	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C101D23	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C101D24	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C101E01	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C101E02	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C101E03	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C101E04	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C101E05	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C101E06	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C101E07	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C101E08	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C101E09	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C101E10	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C101E11	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C101E12	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C101E13	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C101E14	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C101E15	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C101E16	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C101E17	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C101E18	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C101E19	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C101E20	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C101E21	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C101E22	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C101E23	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C101E24	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C101F01	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C101F02	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C101F03	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C101F04	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C101F05	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C101F06	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C101F07	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C101F08	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C101F09	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C101F10	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C101F11	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C101F12	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C101F13	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C101F14	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C101F15	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C101F16	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C101F17	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C101F18	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C101F19	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C101F20	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C101F21	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C101F22	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C101F23	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C101F24	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C101G01	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C101G02	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C101G03	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C101G04	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C101G05	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C101G06	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C101G07	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C101G08	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C101G09	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C101G10	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C101G11	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C101G12	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C101G13	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C101G14	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C101G15	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C101G16	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C101G17	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C101G18	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C101G19	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C101G20	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C101G21	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C101G22	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C101G23	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C101G24	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C101H01	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C101H02	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C101H03	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C101H04	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C101H05	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C101H06	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C101H07	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C101H08	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C101H09	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C101H10	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C101H11	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C101H12	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C101H13	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C101H14	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C101H15	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C101H16	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C101H17	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C101H18	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C101H19	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C101H20	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C101H21	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C101H22	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C101H23	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C101H24	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C101I01	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C101I02	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C101I03	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C101I04	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C101I05	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C101I06	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C101I07	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C101I08	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C101I09	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C101I10	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C101I11	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C101I12	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C101I13	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C101I14	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C101I15	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C101I16	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C101I17	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C101I18	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C101I19	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C101I20	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C101I21	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C101I22	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C101I23	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C101I24	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C101J01	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C101J02	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C101J03	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C101J04	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C101J05	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C101J06	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C101J07	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C101J08	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C101J09	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C101J10	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C101J11	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C101J12	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C101J13	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C101J14	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C101J15	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C101J16	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C101J17	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C101J18	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C101J19	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C101J20	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C101J21	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C101J22	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C101J23	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C101J24	pDONR221															
IKAKEN	SK003H06	IMS14-F01	IMS	W01C101K01	pDONR221															
IKAKEN	SK003H06	IMS14-F01	IMS	W01C101K02	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C101K03	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C101K04	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C101K05	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C101K06	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C101K07	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C101K08	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C101K09	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C101K10	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C101K11	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C101K12	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C101K13	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C101K14	pDONR221															
IKAKEN	H033051D14	IMS14-F08	Riken	W01C101K15	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	H033051D14	IMS14-F08	Riken	W01C101K16	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	CBR02670	IMS14-F09	EST	W01C101K17	pDONR221															
IKAKEN	CBR02670	IMS14-F09	EST	W01C101K18	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C101K19	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C101K20	pDONR221															
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C101K21	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C101K22	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C101K23	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C101K24	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	SK003H06	IMS14-F01	IMS	W01C101L01	pDONR221															
IKAKEN	SK003H06	IMS14-F01	IMS	W01C101L02	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C101L03	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C101L04	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C101L05	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C101L06	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C101L07	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C101L08	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C101L09	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C101L10	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C101L11	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C101L12	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C101L13	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C101L14	pDONR221															
IKAKEN	H033051D14	IMS14-F08	Riken	W01C101L15	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	H033051D14	IMS14-F08	Riken	W01C101L16	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	CBR02670	IMS14-F09	EST	W01C101L17	pDONR221															
IKAKEN	CBR02670	IMS14-F09	EST	W01C101L18	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C101L19	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C101L20	pDONR221															
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C101L21	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C101L22	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C101L23	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C101L24	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C101M01	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C101M02	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C101M03	pDONR221															
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C101M04	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C101M05	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C101M06	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C101M07	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C101M08	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C101M09	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C101M10	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C101M11	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C101M12	pDONR221															
IKAKEN	FLB08849	IMS14-G07	EST	W01C101M13	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FLB08849	IMS14-G07	EST	W01C101M14	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C101M15	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C101M16	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	HEP00546	IMS14-G09	EST	W01C101M17	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP00546	IMS14-G09	EST	W01C101M18	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP02878	IMS14-G10	EST	W01C101M19	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP02878	IMS14-G10	EST	W01C101M20	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP10707	IMS14-G11	EST	W01C101M21	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP10707	IMS14-G11	EST	W01C101M22	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP12493	IMS14-G12	EST	W01C101M23	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	HEP12493	IMS14-G12	EST	W01C101M24	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C101N01	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C101N02	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C101N03	pDONR221															
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C101N04	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C101N05	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C101N06	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C101N07	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C101N08	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C101N09	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C101N10	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C101N11	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C101N12	pDONR221															
IKAKEN	FLB08849	IMS14-G07	EST	W01C101N13	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FLB08849	IMS14-G07	EST	W01C101N14	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C101N15	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C101N16	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	HEP00546	IMS14-G09	EST	W01C101N17	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP00546	IMS14-G09	EST	W01C101N18	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP02878	IMS14-G10	EST	W01C101N19	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP02878	IMS14-G10	EST	W01C101N20	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP10707	IMS14-G11	EST	W01C101N21	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP10707	IMS14-G11	EST	W01C101N22	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP12493	IMS14-G12	EST	W01C101N23	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	HEP12493	IMS14-G12	EST	W01C101N24	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C101O01	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C101O02	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HRT08816	IMS14-H02	EST	W01C101O03	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HRT08816	IMS14-H02	EST	W01C101O04	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HSI05269	IMS14-H03	EST	W01C101O05	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI05269	IMS14-H03	EST	W01C101O06	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI13995	IMS14-H04	EST	W01C101O07	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	HSI13995	IMS14-H04	EST	W01C101O08	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	JTH07448	IMS14-H05	EST	W01C101O09	pDONR221															
IKAKEN	JTH07448	IMS14-H05	EST	W01C101O10	pDONR221															
IKAKEN	KAT03648	IMS14-H06	EST	W01C101O11	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT03648	IMS14-H06	EST	W01C101O12	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT09190	IMS14-H07	EST	W01C101O13	pDONR221															
IKAKEN	KAT09190	IMS14-H07	EST	W01C101O14	pDONR221															
IKAKEN	KAT10933	IMS14-H08	EST	W01C101O15	pDONR221			ATP8	4509											
IKAKEN	KAT10933	IMS14-H08	EST	W01C101O16	pDONR221			ATP8	4509											
IKAKEN	KDN02467	IMS14-H09	EST	W01C101O17	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	IMS14-H09	EST	W01C101O18	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C101O19	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C101O20	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C101O21	pDONR221				388466											
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C101O22	pDONR221				388466											
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C101O23	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C101O24	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C101P01	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C101P02	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HRT08816	IMS14-H02	EST	W01C101P03	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HRT08816	IMS14-H02	EST	W01C101P04	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HSI05269	IMS14-H03	EST	W01C101P05	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI05269	IMS14-H03	EST	W01C101P06	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI13995	IMS14-H04	EST	W01C101P07	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	HSI13995	IMS14-H04	EST	W01C101P08	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	JTH07448	IMS14-H05	EST	W01C101P09	pDONR221															
IKAKEN	JTH07448	IMS14-H05	EST	W01C101P10	pDONR221															
IKAKEN	KAT03648	IMS14-H06	EST	W01C101P11	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT03648	IMS14-H06	EST	W01C101P12	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT09190	IMS14-H07	EST	W01C101P13	pDONR221															
IKAKEN	KAT09190	IMS14-H07	EST	W01C101P14	pDONR221															
IKAKEN	KAT10933	IMS14-H08	EST	W01C101P15	pDONR221			ATP8	4509											
IKAKEN	KAT10933	IMS14-H08	EST	W01C101P16	pDONR221			ATP8	4509											
IKAKEN	KDN02467	IMS14-H09	EST	W01C101P17	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	IMS14-H09	EST	W01C101P18	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C101P19	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C101P20	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C101P21	pDONR221				388466											
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C101P22	pDONR221				388466											
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C101P23	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C101P24	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	SK002H03	IMS14-A01	IMS	W01C102A01	pDONR221															
IKAKEN	SK002H03	IMS14-A01	IMS	W01C102A02	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C102A03	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C102A04	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C102A05	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C102A06	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C102A07	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C102A08	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C102A09	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C102A10	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C102A11	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C102A12	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C102A13	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C102A14	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C102A15	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C102A16	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C102A17	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C102A18	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C102A19	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C102A20	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C102A21	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C102A22	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C102A23	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C102A24	pDONR221															
IKAKEN	SK002H03	IMS14-A01	IMS	W01C102B01	pDONR221															
IKAKEN	SK002H03	IMS14-A01	IMS	W01C102B02	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C102B03	pDONR221															
IKAKEN	SK002H06	IMS14-A02	IMS	W01C102B04	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C102B05	pDONR221															
IKAKEN	SK002H07	IMS14-A03	IMS	W01C102B06	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C102B07	pDONR221															
IKAKEN	SK002H08	IMS14-A04	IMS	W01C102B08	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C102B09	pDONR221															
IKAKEN	SK002H10	IMS14-A05	IMS	W01C102B10	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C102B11	pDONR221															
IKAKEN	SK002H11	IMS14-A06	IMS	W01C102B12	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C102B13	pDONR221															
IKAKEN	SK002H12	IMS14-A07	IMS	W01C102B14	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C102B15	pDONR221															
IKAKEN	SK003A01	IMS14-A08	IMS	W01C102B16	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C102B17	pDONR221															
IKAKEN	SK003A02	IMS14-A09	IMS	W01C102B18	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C102B19	pDONR221															
IKAKEN	SK003A03	IMS14-A10	IMS	W01C102B20	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C102B21	pDONR221															
IKAKEN	SK003A04	IMS14-A11	IMS	W01C102B22	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C102B23	pDONR221															
IKAKEN	SK003A08	IMS14-A12	IMS	W01C102B24	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C102C01	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C102C02	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C102C03	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C102C04	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C102C05	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C102C06	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C102C07	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C102C08	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C102C09	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C102C10	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C102C11	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C102C12	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C102C13	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C102C14	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C102C15	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C102C16	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C102C17	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C102C18	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C102C19	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C102C20	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C102C21	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C102C22	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C102C23	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C102C24	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C102D01	pDONR221															
IKAKEN	SK003A10	IMS14-B01	IMS	W01C102D02	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C102D03	pDONR221															
IKAKEN	SK003B01	IMS14-B02	IMS	W01C102D04	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C102D05	pDONR221															
IKAKEN	SK003B01	IMS14-B03	IMS	W01C102D06	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C102D07	pDONR221															
IKAKEN	SK003B01	IMS14-B04	IMS	W01C102D08	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C102D09	pDONR221															
IKAKEN	SK003B03	IMS14-B05	IMS	W01C102D10	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C102D11	pDONR221															
IKAKEN	SK003B04	IMS14-B06	IMS	W01C102D12	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C102D13	pDONR221															
IKAKEN	SK003B08	IMS14-B07	IMS	W01C102D14	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C102D15	pDONR221															
IKAKEN	SK003B10	IMS14-B08	IMS	W01C102D16	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C102D17	pDONR221															
IKAKEN	SK003C01	IMS14-B09	IMS	W01C102D18	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C102D19	pDONR221															
IKAKEN	SK003C01	IMS14-B10	IMS	W01C102D20	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C102D21	pDONR221															
IKAKEN	SK003C01	IMS14-B11	IMS	W01C102D22	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C102D23	pDONR221															
IKAKEN	SK003C02	IMS14-B12	IMS	W01C102D24	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C102E01	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C102E02	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C102E03	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C102E04	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C102E05	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C102E06	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C102E07	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C102E08	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C102E09	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C102E10	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C102E11	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C102E12	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C102E13	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C102E14	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C102E15	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C102E16	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C102E17	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C102E18	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C102E19	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C102E20	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C102E21	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C102E22	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C102E23	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C102E24	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C102F01	pDONR221															
IKAKEN	SK003C03	IMS14-C01	IMS	W01C102F02	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C102F03	pDONR221															
IKAKEN	SK003C04	IMS14-C02	IMS	W01C102F04	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C102F05	pDONR221															
IKAKEN	SK003C06	IMS14-C03	IMS	W01C102F06	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C102F07	pDONR221															
IKAKEN	SK003C08	IMS14-C04	IMS	W01C102F08	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C102F09	pDONR221															
IKAKEN	SK003D01	IMS14-C05	IMS	W01C102F10	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C102F11	pDONR221															
IKAKEN	SK003D01	IMS14-C06	IMS	W01C102F12	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C102F13	pDONR221															
IKAKEN	SK003D01	IMS14-C07	IMS	W01C102F14	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C102F15	pDONR221															
IKAKEN	SK003D05	IMS14-C08	IMS	W01C102F16	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C102F17	pDONR221															
IKAKEN	SK003D06	IMS14-C09	IMS	W01C102F18	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C102F19	pDONR221															
IKAKEN	SK003D07	IMS14-C10	IMS	W01C102F20	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C102F21	pDONR221															
IKAKEN	SK003D08	IMS14-C11	IMS	W01C102F22	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C102F23	pDONR221															
IKAKEN	SK003D09	IMS14-C12	IMS	W01C102F24	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C102G01	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C102G02	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C102G03	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C102G04	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C102G05	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C102G06	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C102G07	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C102G08	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C102G09	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C102G10	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C102G11	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C102G12	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C102G13	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C102G14	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C102G15	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C102G16	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C102G17	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C102G18	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C102G19	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C102G20	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C102G21	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C102G22	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C102G23	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C102G24	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C102H01	pDONR221															
IKAKEN	SK003D10	IMS14-D01	IMS	W01C102H02	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C102H03	pDONR221															
IKAKEN	SK003E01	IMS14-D02	IMS	W01C102H04	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C102H05	pDONR221															
IKAKEN	SK003E01	IMS14-D03	IMS	W01C102H06	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C102H07	pDONR221															
IKAKEN	SK003E04	IMS14-D04	IMS	W01C102H08	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C102H09	pDONR221															
IKAKEN	SK003E05	IMS14-D05	IMS	W01C102H10	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C102H11	pDONR221															
IKAKEN	SK003E07	IMS14-D06	IMS	W01C102H12	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C102H13	pDONR221															
IKAKEN	SK003E08	IMS14-D07	IMS	W01C102H14	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C102H15	pDONR221															
IKAKEN	SK003E09	IMS14-D08	IMS	W01C102H16	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C102H17	pDONR221															
IKAKEN	SK003E10	IMS14-D09	IMS	W01C102H18	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C102H19	pDONR221															
IKAKEN	SK003F02	IMS14-D10	IMS	W01C102H20	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C102H21	pDONR221															
IKAKEN	SK003F03	IMS14-D11	IMS	W01C102H22	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C102H23	pDONR221															
IKAKEN	SK003F04	IMS14-D12	IMS	W01C102H24	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C102I01	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C102I02	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C102I03	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C102I04	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C102I05	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C102I06	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C102I07	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C102I08	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C102I09	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C102I10	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C102I11	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C102I12	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C102I13	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C102I14	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C102I15	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C102I16	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C102I17	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C102I18	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C102I19	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C102I20	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C102I21	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C102I22	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C102I23	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C102I24	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C102J01	pDONR221															
IKAKEN	SK003F05	IMS14-E01	IMS	W01C102J02	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C102J03	pDONR221															
IKAKEN	SK003F06	IMS14-E02	IMS	W01C102J04	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C102J05	pDONR221															
IKAKEN	SK003F08	IMS14-E03	IMS	W01C102J06	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C102J07	pDONR221															
IKAKEN	SK003G01	IMS14-E04	IMS	W01C102J08	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C102J09	pDONR221															
IKAKEN	SK003G03	IMS14-E05	IMS	W01C102J10	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C102J11	pDONR221															
IKAKEN	SK003G04	IMS14-E06	IMS	W01C102J12	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C102J13	pDONR221															
IKAKEN	SK003G07	IMS14-E07	IMS	W01C102J14	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C102J15	pDONR221															
IKAKEN	SK003G08	IMS14-E08	IMS	W01C102J16	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C102J17	pDONR221															
IKAKEN	SK003G09	IMS14-E09	IMS	W01C102J18	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C102J19	pDONR221															
IKAKEN	SK003G10	IMS14-E10	IMS	W01C102J20	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C102J21	pDONR221															
IKAKEN	SK003H01	IMS14-E11	IMS	W01C102J22	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C102J23	pDONR221															
IKAKEN	SK003H04	IMS14-E12	IMS	W01C102J24	pDONR221															
IKAKEN	SK003H06	IMS14-F01	IMS	W01C102K01	pDONR221															
IKAKEN	SK003H06	IMS14-F01	IMS	W01C102K02	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C102K03	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C102K04	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C102K05	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C102K06	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C102K07	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C102K08	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C102K09	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C102K10	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C102K11	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C102K12	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C102K13	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C102K14	pDONR221															
IKAKEN	H033051D14	IMS14-F08	Riken	W01C102K15	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	H033051D14	IMS14-F08	Riken	W01C102K16	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	CBR02670	IMS14-F09	EST	W01C102K17	pDONR221															
IKAKEN	CBR02670	IMS14-F09	EST	W01C102K18	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C102K19	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C102K20	pDONR221															
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C102K21	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C102K22	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C102K23	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C102K24	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	SK003H06	IMS14-F01	IMS	W01C102L01	pDONR221															
IKAKEN	SK003H06	IMS14-F01	IMS	W01C102L02	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C102L03	pDONR221															
IKAKEN	SK003H07	IMS14-F02	IMS	W01C102L04	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C102L05	pDONR221															
IKAKEN	SK003H08	IMS14-F03	IMS	W01C102L06	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C102L07	pDONR221															
IKAKEN	SK003H09	IMS14-F04	IMS	W01C102L08	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C102L09	pDONR221															
IKAKEN	SK003H10	IMS14-F05	IMS	W01C102L10	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C102L11	pDONR221															
IKAKEN	SK003H10	IMS14-F06	IMS	W01C102L12	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C102L13	pDONR221															
IKAKEN	SK003H10	IMS14-F07	IMS	W01C102L14	pDONR221															
IKAKEN	H033051D14	IMS14-F08	Riken	W01C102L15	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	H033051D14	IMS14-F08	Riken	W01C102L16	pDONR221			MOBP	4336		Hs.121333	Myelin-associated oligodendrocyte basic protein						NM_182935.2	NP_891980.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	CBR02670	IMS14-F09	EST	W01C102L17	pDONR221															
IKAKEN	CBR02670	IMS14-F09	EST	W01C102L18	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C102L19	pDONR221															
IKAKEN	CBR02670	IMS14-F10	EST	W01C102L20	pDONR221															
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C102L21	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	CCR00776	IMS14-F11	EST(RND)	W01C102L22	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C102L23	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	FBR07513	IMS14-F12	EST(RND)	W01C102L24	pDONR221			LRRTM3	347731		Hs.652155	Leucine rich repeat transmembrane neuronal 3						NM_178011.3	NP_821079.3	VALIDATED	OK	1.000	1.000	581	1746	1	1743	581	1	581
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C102M01	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C102M02	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C102M03	pDONR221															
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C102M04	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C102M05	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C102M06	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C102M07	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C102M08	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C102M09	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C102M10	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C102M11	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C102M12	pDONR221															
IKAKEN	FLB08849	IMS14-G07	EST	W01C102M13	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FLB08849	IMS14-G07	EST	W01C102M14	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C102M15	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C102M16	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	HEP00546	IMS14-G09	EST	W01C102M17	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP00546	IMS14-G09	EST	W01C102M18	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP02878	IMS14-G10	EST	W01C102M19	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP02878	IMS14-G10	EST	W01C102M20	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP10707	IMS14-G11	EST	W01C102M21	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP10707	IMS14-G11	EST	W01C102M22	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP12493	IMS14-G12	EST	W01C102M23	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	HEP12493	IMS14-G12	EST	W01C102M24	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C102N01	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC117F04	IMS14-G01	TOYOBO	W01C102N02	pDONR221			TFF3	7033		Hs.82961	Trefoil factor 3 (intestinal)						NM_003226.2	NP_003217.2	REVIEWED	OK	1.000	1.000	130	393	1	390	130	1	130
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C102N03	pDONR221															
IKAKEN	FCC167H10	IMS14-G02	TOYOBO	W01C102N04	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C102N05	pDONR221															
IKAKEN	FCC169E05	IMS14-G03	TOYOBO	W01C102N06	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C102N07	pDONR221															
IKAKEN	FCC173G10	IMS14-G04	TOYOBO	W01C102N08	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C102N09	pDONR221															
IKAKEN	FCC174E01	IMS14-G05	TOYOBO	W01C102N10	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C102N11	pDONR221															
IKAKEN	FCC174F01	IMS14-G06	TOYOBO	W01C102N12	pDONR221															
IKAKEN	FLB08849	IMS14-G07	EST	W01C102N13	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FLB08849	IMS14-G07	EST	W01C102N14	pDONR221			LRFN2	57497		Hs.250015	Leucine rich repeat and fibronectin type III domain containing 2						NM_020737.1	NP_065788.1	PROVISIONAL	C	1.000	1.000	789	2601	232	2598	789	1	789
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C102N15	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	FMR06549	IMS14-G08	EST(RND)	W01C102N16	pDONR221			ENTPD4	9583		Hs.444389	Ectonucleoside triphosphate diphosphohydrolase 4						NM_004901.3	NP_004892.1	VALIDATED	OK	1.000	1.000	616	1851	1	1848	616	1	616
IKAKEN	HEP00546	IMS14-G09	EST	W01C102N17	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP00546	IMS14-G09	EST	W01C102N18	pDONR221			NUBPL	80224		Hs.288981	Nucleotide binding protein-like						NM_025152.2	NP_079428.2	VALIDATED	OK	1.000	1.000	319	960	1	957	319	1	319
IKAKEN	HEP02878	IMS14-G10	EST	W01C102N19	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP02878	IMS14-G10	EST	W01C102N20	pDONR221			SR140	23350		Hs.596572	U2-associated SR140 protein						NM_001080415.1	NP_001073884.1	PROVISIONAL	Cs	0.998	0.998	1029	3090	1	3087	1029	1	1029
IKAKEN	HEP10707	IMS14-G11	EST	W01C102N21	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP10707	IMS14-G11	EST	W01C102N22	pDONR221			ARFIP1	27236		Hs.416089	ADP-ribosylation factor interacting protein 1						NM_001025595.1	NP_001020766.1	VALIDATED	OK	1.000	1.000	373	1122	1	1119	373	1	373
IKAKEN	HEP12493	IMS14-G12	EST	W01C102N23	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	HEP12493	IMS14-G12	EST	W01C102N24	pDONR221			ARSI	340075		Hs.591252	Arylsulfatase family, member I						NM_001012301.2	NP_001012301.1	VALIDATED	Pfs	0.995	0.998	427	1278	1	1277	569	1	427
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C102O01	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C102O02	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HRT08816	IMS14-H02	EST	W01C102O03	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HRT08816	IMS14-H02	EST	W01C102O04	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HSI05269	IMS14-H03	EST	W01C102O05	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI05269	IMS14-H03	EST	W01C102O06	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI13995	IMS14-H04	EST	W01C102O07	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	HSI13995	IMS14-H04	EST	W01C102O08	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	JTH07448	IMS14-H05	EST	W01C102O09	pDONR221															
IKAKEN	JTH07448	IMS14-H05	EST	W01C102O10	pDONR221															
IKAKEN	KAT03648	IMS14-H06	EST	W01C102O11	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT03648	IMS14-H06	EST	W01C102O12	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT09190	IMS14-H07	EST	W01C102O13	pDONR221															
IKAKEN	KAT09190	IMS14-H07	EST	W01C102O14	pDONR221															
IKAKEN	KAT10933	IMS14-H08	EST	W01C102O15	pDONR221			ATP8	4509											
IKAKEN	KAT10933	IMS14-H08	EST	W01C102O16	pDONR221			ATP8	4509											
IKAKEN	KDN02467	IMS14-H09	EST	W01C102O17	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	IMS14-H09	EST	W01C102O18	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C102O19	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C102O20	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C102O21	pDONR221				388466											
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C102O22	pDONR221				388466											
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C102O23	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C102O24	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C102P01	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HPR08555	IMS14-H01	EST(RND)	W01C102P02	pDONR221			CLCN6	1185		Hs.193043	Chloride channel 6						NM_001286.2	NP_001277.1	REVIEWED	Cs	0.999	0.999	869	2610	1	2607	869	1	869
IKAKEN	HRT08816	IMS14-H02	EST	W01C102P03	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HRT08816	IMS14-H02	EST	W01C102P04	pDONR221			OLFML1	283298		Hs.503500	Olfactomedin-like 1						NM_198474.2	NP_940876.1	PROVISIONAL	Cs	0.998	0.998	402	1209	1	1206	402	1	402
IKAKEN	HSI05269	IMS14-H03	EST	W01C102P05	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI05269	IMS14-H03	EST	W01C102P06	pDONR221			PLA2G4F	255189		Hs.231873	Phospholipase A2, group IVF						NM_213600.2	NP_998765.2	PROVISIONAL	P	1.000	1.000	432	1365	1	1296	849	1	432
IKAKEN	HSI13995	IMS14-H04	EST	W01C102P07	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	HSI13995	IMS14-H04	EST	W01C102P08	pDONR221			TMIGD1	388364		Hs.371005	Transmembrane and immunoglobulin domain containing 1						NM_206832.1	NP_996663.1	PROVISIONAL	OK	1.000	1.000	262	789	1	786	262	1	262
IKAKEN	JTH07448	IMS14-H05	EST	W01C102P09	pDONR221															
IKAKEN	JTH07448	IMS14-H05	EST	W01C102P10	pDONR221															
IKAKEN	KAT03648	IMS14-H06	EST	W01C102P11	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT03648	IMS14-H06	EST	W01C102P12	pDONR221			SDCCAG8	10806		Hs.591530	Serologically defined colon cancer antigen 8						NM_006642.2	NP_006633.1	VALIDATED	OK	1.000	1.000	713	2142	1	2139	713	1	713
IKAKEN	KAT09190	IMS14-H07	EST	W01C102P13	pDONR221															
IKAKEN	KAT09190	IMS14-H07	EST	W01C102P14	pDONR221															
IKAKEN	KAT10933	IMS14-H08	EST	W01C102P15	pDONR221			ATP8	4509											
IKAKEN	KAT10933	IMS14-H08	EST	W01C102P16	pDONR221			ATP8	4509											
IKAKEN	KDN02467	IMS14-H09	EST	W01C102P17	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KDN02467	IMS14-H09	EST	W01C102P18	pDONR221			SLC28A1	9154		Hs.459187	Solute carrier family 28 (sodium-coupled nucleoside transporter), member 1						NM_004213.3	NP_004204.3	VALIDATED	C	1.000	1.000	649	1950	1	1947	649	1	649
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C102P19	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR03584	IMS14-H10	EST(RND)	W01C102P20	pDONR221			SFT2D2	375035		Hs.645435	SFT2 domain containing 2						NM_199344.2	NP_955376.1	VALIDATED	OK	1.000	1.000	160	483	1	480	160	1	160
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C102P21	pDONR221				388466											
IKAKEN	KGR06582	IMS14-H11	EST(RND)	W01C102P22	pDONR221				388466											
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C102P23	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	KMR04257	IMS14-H12	EST(RND)	W01C102P24	pDONR221			PGGT1B	5229		Hs.254006	Protein geranylgeranyltransferase type I, beta subunit						NM_005023.3	NP_005014.2	VALIDATED	OK	1.000	1.000	377	1134	1	1131	377	1	377
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C103A01	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C103A02	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C103A03	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C103A04	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C103A05	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C103A06	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C103A07	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C103A08	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C103A09	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C103A10	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	PRS00368	06_12-A06	EST	W01C103A11	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	PRS00368	06_12-A06	EST	W01C103A12	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	IMAGE795451	06_12-A07		W01C103A13	pDONR221															
IKAKEN	IMAGE795451	06_12-A07		W01C103A14	pDONR221															
IKAKEN	MPE08818	06_12-A08	EST	W01C103A15	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	MPE08818	06_12-A08	EST	W01C103A16	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	IMAGE4521185	06_12-A09		W01C103A17	pDONR221															
IKAKEN	IMAGE4521185	06_12-A09		W01C103A18	pDONR221															
IKAKEN	HRT07615	06_12-A10	EST	W01C103A19	pDONR221				389550											
IKAKEN	HRT07615	06_12-A10	EST	W01C103A20	pDONR221				389550											
IKAKEN	IMAGE4750606	06_12-A11		W01C103A21	pDONR221															
IKAKEN	IMAGE4750606	06_12-A11		W01C103A22	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C103A23	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C103A24	pDONR221															
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C103B01	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C103B02	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C103B03	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C103B04	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C103B05	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C103B06	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C103B07	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C103B08	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C103B09	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C103B10	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	PRS00368	06_12-A06	EST	W01C103B11	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	PRS00368	06_12-A06	EST	W01C103B12	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	IMAGE795451	06_12-A07		W01C103B13	pDONR221															
IKAKEN	IMAGE795451	06_12-A07		W01C103B14	pDONR221															
IKAKEN	MPE08818	06_12-A08	EST	W01C103B15	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	MPE08818	06_12-A08	EST	W01C103B16	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	IMAGE4521185	06_12-A09		W01C103B17	pDONR221															
IKAKEN	IMAGE4521185	06_12-A09		W01C103B18	pDONR221															
IKAKEN	HRT07615	06_12-A10	EST	W01C103B19	pDONR221				389550											
IKAKEN	HRT07615	06_12-A10	EST	W01C103B20	pDONR221				389550											
IKAKEN	IMAGE4750606	06_12-A11		W01C103B21	pDONR221															
IKAKEN	IMAGE4750606	06_12-A11		W01C103B22	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C103B23	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C103B24	pDONR221															
IKAKEN	SK003G09	06_12-B01	IMS	W01C103C01	pDONR221															
IKAKEN	SK003G09	06_12-B01	IMS	W01C103C02	pDONR221															
IKAKEN	AK130796	06_12-B02	FLJ	W01C103C03	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK130796	06_12-B02	FLJ	W01C103C04	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK125223	06_12-B03	FLJ	W01C103C05	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06_12-B03	FLJ	W01C103C06	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06_12-B04	FLJ	W01C103C07	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06_12-B04	FLJ	W01C103C08	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK123302	06_12-B05	FLJ	W01C103C09	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK123302	06_12-B05	FLJ	W01C103C10	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK126042	06_12-B06	FLJ	W01C103C11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK126042	06_12-B06	FLJ	W01C103C12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK131340	06_12-B07	FLJ	W01C103C13	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK131340	06_12-B07	FLJ	W01C103C14	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127390	06_12-B08	FLJ	W01C103C15	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK127390	06_12-B08	FLJ	W01C103C16	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK172862	06_12-B09	FLJ	W01C103C17	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06_12-B09	FLJ	W01C103C18	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06_12-B10		W01C103C19	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06_12-B10		W01C103C20	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC029104	06_12-B11	MGC	W01C103C21	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC029104	06_12-B11	MGC	W01C103C22	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC015931	06_12-B12		W01C103C23	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC015931	06_12-B12		W01C103C24	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	SK003G09	06_12-B01	IMS	W01C103D01	pDONR221															
IKAKEN	SK003G09	06_12-B01	IMS	W01C103D02	pDONR221															
IKAKEN	AK130796	06_12-B02	FLJ	W01C103D03	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK130796	06_12-B02	FLJ	W01C103D04	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK125223	06_12-B03	FLJ	W01C103D05	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06_12-B03	FLJ	W01C103D06	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06_12-B04	FLJ	W01C103D07	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06_12-B04	FLJ	W01C103D08	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK123302	06_12-B05	FLJ	W01C103D09	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK123302	06_12-B05	FLJ	W01C103D10	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK126042	06_12-B06	FLJ	W01C103D11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK126042	06_12-B06	FLJ	W01C103D12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK131340	06_12-B07	FLJ	W01C103D13	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK131340	06_12-B07	FLJ	W01C103D14	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127390	06_12-B08	FLJ	W01C103D15	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK127390	06_12-B08	FLJ	W01C103D16	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK172862	06_12-B09	FLJ	W01C103D17	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06_12-B09	FLJ	W01C103D18	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06_12-B10		W01C103D19	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06_12-B10		W01C103D20	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC029104	06_12-B11	MGC	W01C103D21	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC029104	06_12-B11	MGC	W01C103D22	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC015931	06_12-B12		W01C103D23	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC015931	06_12-B12		W01C103D24	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC022014	06_12-C01	MGC	W01C103E01	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC022014	06_12-C01	MGC	W01C103E02	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC028626	06_12-C02	MGC	W01C103E03	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC028626	06_12-C02	MGC	W01C103E04	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC025709	06_12-C03	MGC	W01C103E05	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC025709	06_12-C03	MGC	W01C103E06	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC040105	06_12-C04	MGC	W01C103E07	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC040105	06_12-C04	MGC	W01C103E08	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC044931	06_12-C05	MGC	W01C103E09	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC044931	06_12-C05	MGC	W01C103E10	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC047240	06_12-C06	MGC	W01C103E11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06_12-C06	MGC	W01C103E12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06_12-C07	MGC	W01C103E13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06_12-C07	MGC	W01C103E14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06_12-C08	MGC	W01C103E15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06_12-C08	MGC	W01C103E16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06_12-C09	MGC	W01C103E17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06_12-C09	MGC	W01C103E18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC006170	06_12-C10	MGC	W01C103E19	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	06_12-C10	MGC	W01C103E20	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC013376	06_12-C11	MGC	W01C103E21	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC013376	06_12-C11	MGC	W01C103E22	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC067366	06_12-C12		W01C103E23	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06_12-C12		W01C103E24	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC022014	06_12-C01	MGC	W01C103F01	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC022014	06_12-C01	MGC	W01C103F02	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC028626	06_12-C02	MGC	W01C103F03	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC028626	06_12-C02	MGC	W01C103F04	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC025709	06_12-C03	MGC	W01C103F05	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC025709	06_12-C03	MGC	W01C103F06	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC040105	06_12-C04	MGC	W01C103F07	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC040105	06_12-C04	MGC	W01C103F08	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC044931	06_12-C05	MGC	W01C103F09	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC044931	06_12-C05	MGC	W01C103F10	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC047240	06_12-C06	MGC	W01C103F11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06_12-C06	MGC	W01C103F12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06_12-C07	MGC	W01C103F13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06_12-C07	MGC	W01C103F14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06_12-C08	MGC	W01C103F15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06_12-C08	MGC	W01C103F16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06_12-C09	MGC	W01C103F17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06_12-C09	MGC	W01C103F18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC006170	06_12-C10	MGC	W01C103F19	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	06_12-C10	MGC	W01C103F20	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC013376	06_12-C11	MGC	W01C103F21	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC013376	06_12-C11	MGC	W01C103F22	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC067366	06_12-C12		W01C103F23	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06_12-C12		W01C103F24	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C103G01	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C103G02	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C103G03	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C103G04	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C103G05	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C103G06	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C103G07	pDONR221															
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C103G08	pDONR221															
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C103G09	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C103G10	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C103G11	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C103G12	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK054668	06_12-D07	FLJ	W01C103G13	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK054668	06_12-D07	FLJ	W01C103G14	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK090993	06_12-D08	FLJ	W01C103G15	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK090993	06_12-D08	FLJ	W01C103G16	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK021849	06_12-D09	FLJ	W01C103G17	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK021849	06_12-D09	FLJ	W01C103G18	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK022932	06_12-D10	FLJ	W01C103G19	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK022932	06_12-D10	FLJ	W01C103G20	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK094713	06_12-D11	FLJ	W01C103G21	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK094713	06_12-D11	FLJ	W01C103G22	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK096380	06_12-D12	FLJ	W01C103G23	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096380	06_12-D12	FLJ	W01C103G24	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C103H01	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C103H02	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C103H03	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C103H04	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C103H05	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C103H06	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C103H07	pDONR221															
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C103H08	pDONR221															
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C103H09	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C103H10	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C103H11	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C103H12	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK054668	06_12-D07	FLJ	W01C103H13	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK054668	06_12-D07	FLJ	W01C103H14	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK090993	06_12-D08	FLJ	W01C103H15	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK090993	06_12-D08	FLJ	W01C103H16	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK021849	06_12-D09	FLJ	W01C103H17	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK021849	06_12-D09	FLJ	W01C103H18	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK022932	06_12-D10	FLJ	W01C103H19	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK022932	06_12-D10	FLJ	W01C103H20	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK094713	06_12-D11	FLJ	W01C103H21	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK094713	06_12-D11	FLJ	W01C103H22	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK096380	06_12-D12	FLJ	W01C103H23	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096380	06_12-D12	FLJ	W01C103H24	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK125524	06_12-E01	FLJ	W01C103I01	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK125524	06_12-E01	FLJ	W01C103I02	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK127973	06_12-E02	FLJ	W01C103I03	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127973	06_12-E02	FLJ	W01C103I04	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127987	06_12-E03	FLJ	W01C103I05	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06_12-E03	FLJ	W01C103I06	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	BC040074	06_12-E04	MGC	W01C103I07	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	BC040074	06_12-E04	MGC	W01C103I08	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	AK091837	06_12-E05	FLJ	W01C103I09	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06_12-E05	FLJ	W01C103I10	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C103I11	pDONR221															
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C103I12	pDONR221															
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C103I13	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C103I14	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C103I15	pDONR221															
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C103I16	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C103I17	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C103I18	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C103I19	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C103I20	pDONR221															
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C103I21	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C103I22	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C103I23	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C103I24	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	AK125524	06_12-E01	FLJ	W01C103J01	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK125524	06_12-E01	FLJ	W01C103J02	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK127973	06_12-E02	FLJ	W01C103J03	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127973	06_12-E02	FLJ	W01C103J04	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127987	06_12-E03	FLJ	W01C103J05	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06_12-E03	FLJ	W01C103J06	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	BC040074	06_12-E04	MGC	W01C103J07	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	BC040074	06_12-E04	MGC	W01C103J08	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	AK091837	06_12-E05	FLJ	W01C103J09	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06_12-E05	FLJ	W01C103J10	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C103J11	pDONR221															
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C103J12	pDONR221															
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C103J13	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C103J14	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C103J15	pDONR221															
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C103J16	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C103J17	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C103J18	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C103J19	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C103J20	pDONR221															
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C103J21	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C103J22	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C103J23	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C103J24	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C103K01	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C103K02	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	TST08264	06_12-F02	EST	W01C103K03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	TST08264	06_12-F02	EST	W01C103K04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C103K05	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C103K06	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C103K07	pDONR221				442093											
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C103K08	pDONR221				442093											
IKAKEN	H05D073J18	06_12-F05	Riken	W01C103K09	pDONR221															
IKAKEN	H05D073J18	06_12-F05	Riken	W01C103K10	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C103K11	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C103K12	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C103K13	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C103K14	pDONR221															
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C103K15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C103K16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H013071C07	06_12-F09	Riken	W01C103K17	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	H013071C07	06_12-F09	Riken	W01C103K18	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C103K19	pDONR221															
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C103K20	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C103K21	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C103K22	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C103K23	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C103K24	pDONR221															
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C103L01	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C103L02	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	TST08264	06_12-F02	EST	W01C103L03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	TST08264	06_12-F02	EST	W01C103L04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C103L05	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C103L06	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C103L07	pDONR221				442093											
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C103L08	pDONR221				442093											
IKAKEN	H05D073J18	06_12-F05	Riken	W01C103L09	pDONR221															
IKAKEN	H05D073J18	06_12-F05	Riken	W01C103L10	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C103L11	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C103L12	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C103L13	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C103L14	pDONR221															
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C103L15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C103L16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H013071C07	06_12-F09	Riken	W01C103L17	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	H013071C07	06_12-F09	Riken	W01C103L18	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C103L19	pDONR221															
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C103L20	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C103L21	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C103L22	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C103L23	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C103L24	pDONR221															
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C103M01	pDONR221															
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C103M02	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C103M03	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C103M04	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C103M05	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C103M06	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C103M07	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C103M08	pDONR221															
IKAKEN	H013043O09	06_12-G05	Riken	W01C103M09	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	H013043O09	06_12-G05	Riken	W01C103M10	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C103M11	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C103M12	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	H04D014L14	06_12-G07	Riken	W01C103M13	pDONR221															
IKAKEN	H04D014L14	06_12-G07	Riken	W01C103M14	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C103M15	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C103M16	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C103M17	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C103M18	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C103M19	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C103M20	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C103M21	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C103M22	pDONR221															
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C103M23	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C103M24	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C103N01	pDONR221															
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C103N02	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C103N03	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C103N04	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C103N05	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C103N06	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C103N07	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C103N08	pDONR221															
IKAKEN	H013043O09	06_12-G05	Riken	W01C103N09	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	H013043O09	06_12-G05	Riken	W01C103N10	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C103N11	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C103N12	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	H04D014L14	06_12-G07	Riken	W01C103N13	pDONR221															
IKAKEN	H04D014L14	06_12-G07	Riken	W01C103N14	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C103N15	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C103N16	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C103N17	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C103N18	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C103N19	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C103N20	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C103N21	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C103N22	pDONR221															
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C103N23	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C103N24	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	H06D054A05	06_12-H01	Riken	W01C103O01	pDONR221															
IKAKEN	H06D054A05	06_12-H01	Riken	W01C103O02	pDONR221															
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C103O03	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C103O04	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H07D030K21	06_12-H03	Riken	W01C103O05	pDONR221															
IKAKEN	H07D030K21	06_12-H03	Riken	W01C103O06	pDONR221															
IKAKEN	H013030A10	06_12-H04	Riken	W01C103O07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06_12-H04	Riken	W01C103O08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H023070A07	06_12-H05	Riken	W01C103O09	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	H023070A07	06_12-H05	Riken	W01C103O10	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C103O11	pDONR221															
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C103O12	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C103O13	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C103O14	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C103O15	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C103O16	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C103O17	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C103O18	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C103O19	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C103O20	pDONR221															
IKAKEN	H013050H19	06_12-H11	Riken	W01C103O21	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06_12-H11	Riken	W01C103O22	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06_12-H12	EST	W01C103O23	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06_12-H12	EST	W01C103O24	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	H06D054A05	06_12-H01	Riken	W01C103P01	pDONR221															
IKAKEN	H06D054A05	06_12-H01	Riken	W01C103P02	pDONR221															
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C103P03	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C103P04	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H07D030K21	06_12-H03	Riken	W01C103P05	pDONR221															
IKAKEN	H07D030K21	06_12-H03	Riken	W01C103P06	pDONR221															
IKAKEN	H013030A10	06_12-H04	Riken	W01C103P07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06_12-H04	Riken	W01C103P08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H023070A07	06_12-H05	Riken	W01C103P09	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	H023070A07	06_12-H05	Riken	W01C103P10	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C103P11	pDONR221															
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C103P12	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C103P13	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C103P14	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C103P15	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C103P16	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C103P17	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C103P18	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C103P19	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C103P20	pDONR221															
IKAKEN	H013050H19	06_12-H11	Riken	W01C103P21	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06_12-H11	Riken	W01C103P22	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06_12-H12	EST	W01C103P23	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06_12-H12	EST	W01C103P24	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C104A01	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C104A02	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C104A03	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C104A04	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C104A05	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C104A06	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C104A07	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C104A08	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C104A09	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C104A10	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	PRS00368	06_12-A06	EST	W01C104A11	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	PRS00368	06_12-A06	EST	W01C104A12	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	IMAGE795451	06_12-A07		W01C104A13	pDONR221															
IKAKEN	IMAGE795451	06_12-A07		W01C104A14	pDONR221															
IKAKEN	MPE08818	06_12-A08	EST	W01C104A15	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	MPE08818	06_12-A08	EST	W01C104A16	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	IMAGE4521185	06_12-A09		W01C104A17	pDONR221															
IKAKEN	IMAGE4521185	06_12-A09		W01C104A18	pDONR221															
IKAKEN	HRT07615	06_12-A10	EST	W01C104A19	pDONR221				389550											
IKAKEN	HRT07615	06_12-A10	EST	W01C104A20	pDONR221				389550											
IKAKEN	IMAGE4750606	06_12-A11		W01C104A21	pDONR221															
IKAKEN	IMAGE4750606	06_12-A11		W01C104A22	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C104A23	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C104A24	pDONR221															
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C104B01	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06_12-A01	EST(F-)	W01C104B02	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C104B03	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRAMY2037112	06_12-A02	EST(F-)	W01C104B04	pDONR221			EIF2A	83939		Hs.655782	Eukaryotic translation initiation factor 2A, 65kDa						NM_032025.3	NP_114414.2	VALIDATED	Cg	0.998	1.000	586	1826	66	1823	585	1	585
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C104B05	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06_12-A03	EST(F-)	W01C104B06	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C104B07	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	F-COLON2000733	06_12-A04	EST(F-)	W01C104B08	pDONR221			CCDC101	112869		Hs.655476	Coiled-coil domain containing 101						NM_138414.2	NP_612423.1	VALIDATED	Pfs	0.391	0.391	23	1317	567	499	293	131	153
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C104B09	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	OFR02033	06_12-A05	EST(RND)	W01C104B10	pDONR221			DCD	117159		Hs.350570	Dermcidin						NM_053283.2	NP_444513.1	REVIEWED	OK	1.000	1.000	110	333	1	330	110	1	110
IKAKEN	PRS00368	06_12-A06	EST	W01C104B11	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	PRS00368	06_12-A06	EST	W01C104B12	pDONR221			SYCP3	50511		Hs.506504	Synaptonemal complex protein 3						NM_153694.3	NP_710161.1	VALIDATED	OK	1.000	1.000	236	711	1	708	236	1	236
IKAKEN	IMAGE795451	06_12-A07		W01C104B13	pDONR221															
IKAKEN	IMAGE795451	06_12-A07		W01C104B14	pDONR221															
IKAKEN	MPE08818	06_12-A08	EST	W01C104B15	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	MPE08818	06_12-A08	EST	W01C104B16	pDONR221			LGALS2	3957		Hs.531776	Lectin, galactoside-binding, soluble, 2						NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	IMAGE4521185	06_12-A09		W01C104B17	pDONR221															
IKAKEN	IMAGE4521185	06_12-A09		W01C104B18	pDONR221															
IKAKEN	HRT07615	06_12-A10	EST	W01C104B19	pDONR221				389550											
IKAKEN	HRT07615	06_12-A10	EST	W01C104B20	pDONR221				389550											
IKAKEN	IMAGE4750606	06_12-A11		W01C104B21	pDONR221															
IKAKEN	IMAGE4750606	06_12-A11		W01C104B22	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C104B23	pDONR221															
IKAKEN	SK003E04	06_12-A12	IMS	W01C104B24	pDONR221															
IKAKEN	SK003G09	06_12-B01	IMS	W01C104C01	pDONR221															
IKAKEN	SK003G09	06_12-B01	IMS	W01C104C02	pDONR221															
IKAKEN	AK130796	06_12-B02	FLJ	W01C104C03	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK130796	06_12-B02	FLJ	W01C104C04	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK125223	06_12-B03	FLJ	W01C104C05	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06_12-B03	FLJ	W01C104C06	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06_12-B04	FLJ	W01C104C07	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06_12-B04	FLJ	W01C104C08	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK123302	06_12-B05	FLJ	W01C104C09	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK123302	06_12-B05	FLJ	W01C104C10	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK126042	06_12-B06	FLJ	W01C104C11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK126042	06_12-B06	FLJ	W01C104C12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK131340	06_12-B07	FLJ	W01C104C13	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK131340	06_12-B07	FLJ	W01C104C14	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127390	06_12-B08	FLJ	W01C104C15	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK127390	06_12-B08	FLJ	W01C104C16	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK172862	06_12-B09	FLJ	W01C104C17	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06_12-B09	FLJ	W01C104C18	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06_12-B10		W01C104C19	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06_12-B10		W01C104C20	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC029104	06_12-B11	MGC	W01C104C21	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC029104	06_12-B11	MGC	W01C104C22	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC015931	06_12-B12		W01C104C23	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC015931	06_12-B12		W01C104C24	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	SK003G09	06_12-B01	IMS	W01C104D01	pDONR221															
IKAKEN	SK003G09	06_12-B01	IMS	W01C104D02	pDONR221															
IKAKEN	AK130796	06_12-B02	FLJ	W01C104D03	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK130796	06_12-B02	FLJ	W01C104D04	pDONR221	1		IGHA1	3493	BAC85432.1					thymus	TMS				
IKAKEN	AK125223	06_12-B03	FLJ	W01C104D05	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06_12-B03	FLJ	W01C104D06	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06_12-B04	FLJ	W01C104D07	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06_12-B04	FLJ	W01C104D08	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK123302	06_12-B05	FLJ	W01C104D09	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK123302	06_12-B05	FLJ	W01C104D10	pDONR221	25515		NCRNA00087	644596	-	Hs.656427	Non-protein coding RNA 87			amygdala	BRAMY2		XM_927710.3	XP_932803.1	MODEL	C	1.000	1.000	78	237	1	234	78	1	78
IKAKEN	AK126042	06_12-B06	FLJ	W01C104D11	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK126042	06_12-B06	FLJ	W01C104D12	pDONR221	6788		FLJ44054	643365	BAC86409.1	Hs.680435	Hypothetical protein LOC643365			testis	TESTI4		XM_001722970.1	XP_001723022.1	MODEL	Pfs	0.989	0.989	264	798	3	795	328	65	328
IKAKEN	AK131340	06_12-B07	FLJ	W01C104D13	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK131340	06_12-B07	FLJ	W01C104D14	pDONR221	15588		RGL4	266747	BAD18497.1	Hs.658997	Ral guanine nucleotide dissociation stimulator-like 4			testis	TESTI4		NM_153615.1	NP_705843.1	PROVISIONAL	OK	1.000	1.000	473	1422	1	1419	473	1	473
IKAKEN	AK127390	06_12-B08	FLJ	W01C104D15	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK127390	06_12-B08	FLJ	W01C104D16	pDONR221	41011				BAC86955					subthalamic nucleus	BRSTN2				
IKAKEN	AK172862	06_12-B09	FLJ	W01C104D17	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06_12-B09	FLJ	W01C104D18	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06_12-B10		W01C104D19	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06_12-B10		W01C104D20	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC029104	06_12-B11	MGC	W01C104D21	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC029104	06_12-B11	MGC	W01C104D22	pDONR221	11641		CPT1C	126129	AAH29104.1	Hs.112195	Carnitine palmitoyltransferase 1C			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_001136052.1	NP_001129524.1	PROVISIONAL	Pg	0.807	1.000	460	1116	1	1113	792	333	792
IKAKEN	BC015931	06_12-B12		W01C104D23	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC015931	06_12-B12		W01C104D24	pDONR221	6021		RAB35	11021	AAH15931.1	Hs.524788	RAB35, member RAS oncogene family						NM_006861.4	NP_006852.1	VALIDATED	OK	1.000	1.000	201	606	1	603	201	1	201
IKAKEN	BC022014	06_12-C01	MGC	W01C104E01	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC022014	06_12-C01	MGC	W01C104E02	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC028626	06_12-C02	MGC	W01C104E03	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC028626	06_12-C02	MGC	W01C104E04	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC025709	06_12-C03	MGC	W01C104E05	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC025709	06_12-C03	MGC	W01C104E06	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC040105	06_12-C04	MGC	W01C104E07	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC040105	06_12-C04	MGC	W01C104E08	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC044931	06_12-C05	MGC	W01C104E09	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC044931	06_12-C05	MGC	W01C104E10	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC047240	06_12-C06	MGC	W01C104E11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06_12-C06	MGC	W01C104E12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06_12-C07	MGC	W01C104E13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06_12-C07	MGC	W01C104E14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06_12-C08	MGC	W01C104E15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06_12-C08	MGC	W01C104E16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06_12-C09	MGC	W01C104E17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06_12-C09	MGC	W01C104E18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC006170	06_12-C10	MGC	W01C104E19	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	06_12-C10	MGC	W01C104E20	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC013376	06_12-C11	MGC	W01C104E21	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC013376	06_12-C11	MGC	W01C104E22	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC067366	06_12-C12		W01C104E23	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06_12-C12		W01C104E24	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC022014	06_12-C01	MGC	W01C104F01	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC022014	06_12-C01	MGC	W01C104F02	pDONR221	20338		PARK2	5071	AAH22014.1	Hs.716168	Parkinson disease (autosomal recessive, juvenile) 2, parkin			Testis	NIH_MGC_97	DH10B	NM_013987.2	NP_054642.2	REVIEWED	Pgs	0.874	0.997	381	1164	1	1143	437	1	334
IKAKEN	BC028626	06_12-C02	MGC	W01C104F03	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC028626	06_12-C02	MGC	W01C104F04	pDONR221	15501		TNRC6B	23112	AAH28626.1	Hs.372082	Trinucleotide repeat containing 6B			Brain, hippocampus	NIH_MGC_95	DH10B	NM_001024843.1	NP_001020014.1	VALIDATED	Cg	0.993	1.000	1030	3075	1	3072	1029	1	1029
IKAKEN	BC025709	06_12-C03	MGC	W01C104F05	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC025709	06_12-C03	MGC	W01C104F06	pDONR221	1555		AKR7A3	22977	AAH25709.1	Hs.6980	Aldo-keto reductase family 7, member A3 (aflatoxin aldehyde reductase)			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_012067.2	NP_036199.2	VALIDATED	Ps	0.994	0.994	315	948	1	945	331	17	331
IKAKEN	BC040105	06_12-C04	MGC	W01C104F07	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC040105	06_12-C04	MGC	W01C104F08	pDONR221	4442		NOX4	50507	AAH40105.1	Hs.371036	NADPH oxidase 4			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	NM_001143836.1	NP_001137308.1	REVIEWED	Cs	0.994	0.994	538	1617	1	1614	538	1	538
IKAKEN	BC044931	06_12-C05	MGC	W01C104F09	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC044931	06_12-C05	MGC	W01C104F10	pDONR221	4038		DNAJC24	120526	-	Hs.718544	DnaJ (Hsp40) homolog, subfamily C, member 24			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_181706.4	NP_859057.4	VALIDATED	P	1.000	1.000	148	447	1	444	149	2	149
IKAKEN	BC047240	06_12-C06	MGC	W01C104F11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06_12-C06	MGC	W01C104F12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06_12-C07	MGC	W01C104F13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06_12-C07	MGC	W01C104F14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06_12-C08	MGC	W01C104F15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06_12-C08	MGC	W01C104F16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06_12-C09	MGC	W01C104F17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06_12-C09	MGC	W01C104F18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC006170	06_12-C10	MGC	W01C104F19	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC006170	06_12-C10	MGC	W01C104F20	pDONR221	24870		IDS	3423	AAH06170.1	Hs.460960	Iduronate 2-sulfatase			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_006123.3	NP_006114.1	REVIEWED		0.977	0.977	301	939	1	903	343	1	301
IKAKEN	BC013376	06_12-C11	MGC	W01C104F21	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC013376	06_12-C11	MGC	W01C104F22	pDONR221	8814		MARVELD3	91862	AAH13376.1	Hs.513706	MARVEL domain containing 3			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_052858.3	NP_443090.2	VALIDATED	OK	1.000	1.000	401	1206	1	1203	401	1	401
IKAKEN	BC067366	06_12-C12		W01C104F23	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06_12-C12		W01C104F24	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C104G01	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C104G02	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C104G03	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C104G04	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C104G05	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C104G06	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C104G07	pDONR221															
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C104G08	pDONR221															
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C104G09	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C104G10	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C104G11	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C104G12	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK054668	06_12-D07	FLJ	W01C104G13	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK054668	06_12-D07	FLJ	W01C104G14	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK090993	06_12-D08	FLJ	W01C104G15	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK090993	06_12-D08	FLJ	W01C104G16	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK021849	06_12-D09	FLJ	W01C104G17	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK021849	06_12-D09	FLJ	W01C104G18	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK022932	06_12-D10	FLJ	W01C104G19	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK022932	06_12-D10	FLJ	W01C104G20	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK094713	06_12-D11	FLJ	W01C104G21	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK094713	06_12-D11	FLJ	W01C104G22	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK096380	06_12-D12	FLJ	W01C104G23	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096380	06_12-D12	FLJ	W01C104G24	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C104H01	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRTHA2022924	06_12-D01	EST(F-)	W01C104H02	pDONR221			SEMA3E	9723		Hs.528721	Sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3E						NM_012431.1	NP_036563.1	PROVISIONAL	C	1.000	1.000	775	2328	1	2325	775	1	775
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C104H03	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-BRHIP3004937	06_12-D02	EST(F-)	W01C104H04	pDONR221			WWC1	23286		Hs.484047	WW and C2 domain containing 1						NM_015238.1	NP_056053.1	PROVISIONAL	C	1.000	1.000	1113	3342	1	3339	1113	1	1113
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C104H05	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06_12-D03	EST(F-)	W01C104H06	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C104H07	pDONR221															
IKAKEN	FBR02611	06_12-D04	EST(RND)	W01C104H08	pDONR221															
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C104H09	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	FLR01792	06_12-D05	EST(RND)	W01C104H10	pDONR221			C14orf28	122525		Hs.82098	Chromosome 14 open reading frame 28						NM_001017923.1	NP_001017923.1	VALIDATED	P	1.000	1.000	236	708	1	708	310	64	299
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C104H11	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06_12-D06	EST(RND)	W01C104H12	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK054668	06_12-D07	FLJ	W01C104H13	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK054668	06_12-D07	FLJ	W01C104H14	pDONR221	9853		SLFN5	162394	BAB70788.1	Hs.709347	Schlafen family member 5			adrenal gland	ADRGL2		NM_144975.3	NP_659412.3	VALIDATED	P	1.000	1.000	782	2346	1	2346	891	1	782
IKAKEN	AK090993	06_12-D08	FLJ	W01C104H15	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK090993	06_12-D08	FLJ	W01C104H16	pDONR221	17080		PRRT3	285368	BAC03564.1	Hs.598147	Proline-rich transmembrane protein 3			amygdala	BRAMY2		NM_207351.3	NP_997234.3	VALIDATED	P	1.000	1.000	666	1998	1	1998	981	1	666
IKAKEN	AK021849	06_12-D09	FLJ	W01C104H17	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK021849	06_12-D09	FLJ	W01C104H18	pDONR221	11217		DSEL	92126	BAB13912.1	Hs.124673	Dermatan sulfate epimerase-like			whole embryo, mainly head	HEMBA1		NM_032160.2	NP_115536.1	VALIDATED	Ps	0.995	0.995	197	942	1	591	1222	1	197
IKAKEN	AK022932	06_12-D10	FLJ	W01C104H19	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK022932	06_12-D10	FLJ	W01C104H20	pDONR221	13235		RIF1	55183	BAB14313.1	Hs.655671	RAP1 interacting factor homolog (yeast)	NT2	teratocarcinoma		NT2RP2		NM_018151.3	NP_060621.3	VALIDATED	Pg	0.994	1.000	843	2529	1	2529	2472	177	1014
IKAKEN	AK094713	06_12-D11	FLJ	W01C104H21	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK094713	06_12-D11	FLJ	W01C104H22	pDONR221	18545		RGNEF	64283	BAC04405.1	Hs.482521	Rho-guanine nucleotide exchange factor			amygdala	BRAMY2		NM_001080479.1	NP_001073948.1	PROVISIONAL	P	1.000	1.000	932	2796	1	2796	1651	14	945
IKAKEN	AK096380	06_12-D12	FLJ	W01C104H23	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK096380	06_12-D12	FLJ	W01C104H24	pDONR221	13365		FLJ39061	165057	BAC04773.1	Hs.686898	Hypothetical protein FLJ39061	NT2	teratocarcinoma		NT2RP7														
IKAKEN	AK125524	06_12-E01	FLJ	W01C104I01	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK125524	06_12-E01	FLJ	W01C104I02	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK127973	06_12-E02	FLJ	W01C104I03	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127973	06_12-E02	FLJ	W01C104I04	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127987	06_12-E03	FLJ	W01C104I05	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06_12-E03	FLJ	W01C104I06	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	BC040074	06_12-E04	MGC	W01C104I07	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	BC040074	06_12-E04	MGC	W01C104I08	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	AK091837	06_12-E05	FLJ	W01C104I09	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06_12-E05	FLJ	W01C104I10	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C104I11	pDONR221															
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C104I12	pDONR221															
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C104I13	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C104I14	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C104I15	pDONR221															
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C104I16	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C104I17	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C104I18	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C104I19	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C104I20	pDONR221															
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C104I21	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C104I22	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C104I23	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C104I24	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	AK125524	06_12-E01	FLJ	W01C104J01	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK125524	06_12-E01	FLJ	W01C104J02	pDONR221	3660		DYNC2H1	79659	BAC86194.1	Hs.503721	Dynein, cytoplasmic 2, heavy chain 1		peripheral blood mononuclear cells		PEBLM2		NM_001080463.1	NP_001073932.1	PROVISIONAL	P	1.000	1.000	1088	3264	1	3264	4314	1	1088
IKAKEN	AK127973	06_12-E02	FLJ	W01C104J03	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127973	06_12-E02	FLJ	W01C104J04	pDONR221	3963		CCDC67	159989	BAC87213.1	Hs.436625	Coiled-coil domain containing 67			testis	TESTI1		NM_181645.3	NP_857596.2	VALIDATED	Pfs	0.994	0.994	538	1699	1	1613	604	9	546
IKAKEN	AK127987	06_12-E03	FLJ	W01C104J05	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06_12-E03	FLJ	W01C104J06	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	BC040074	06_12-E04	MGC	W01C104J07	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	BC040074	06_12-E04	MGC	W01C104J08	pDONR221	21243		FAM20C	56975	AAH40074.1	Hs.134742	Family with sequence similarity 20, member C			Testis, embryonal carcinoma	NIH_MGC_92	DH10B	NM_020223.2	NP_064608.2	VALIDATED	P	1.000	1.000	247	742	1	741	584	15	261
IKAKEN	AK091837	06_12-E05	FLJ	W01C104J09	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06_12-E05	FLJ	W01C104J10	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C104J11	pDONR221															
IKAKEN	COR00625	06_12-E06	EST(RND)	W01C104J12	pDONR221															
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C104J13	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06_12-E07	EST(RND)	W01C104J14	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C104J15	pDONR221															
IKAKEN	SZR03924	06_12-E08	EST(RND)	W01C104J16	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C104J17	pDONR221															
IKAKEN	FMR04876	06_12-E09	EST(RND)	W01C104J18	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C104J19	pDONR221															
IKAKEN	CAS03318	06_12-E10	EST	W01C104J20	pDONR221															
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C104J21	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06_12-E11	EST(RND)	W01C104J22	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C104J23	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	KMR04674	06_12-E12	EST(RND)	W01C104J24	pDONR221			CAMSAP1	157922		Hs.522493	Calmodulin regulated spectrin-associated protein 1						NM_015447.3	NP_056262.3	VALIDATED	Pfs	0.995	0.997	385	1152	1	1151	1602	320	704
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C104K01	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C104K02	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	TST08264	06_12-F02	EST	W01C104K03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	TST08264	06_12-F02	EST	W01C104K04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C104K05	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C104K06	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C104K07	pDONR221				442093											
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C104K08	pDONR221				442093											
IKAKEN	H05D073J18	06_12-F05	Riken	W01C104K09	pDONR221															
IKAKEN	H05D073J18	06_12-F05	Riken	W01C104K10	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C104K11	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C104K12	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C104K13	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C104K14	pDONR221															
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C104K15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C104K16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H013071C07	06_12-F09	Riken	W01C104K17	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	H013071C07	06_12-F09	Riken	W01C104K18	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C104K19	pDONR221															
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C104K20	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C104K21	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C104K22	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C104K23	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C104K24	pDONR221															
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C104L01	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	THR07746	06_12-F01	EST(RND)	W01C104L02	pDONR221			HAPLN4	404037		Hs.367829	Hyaluronan and proteoglycan link protein 4						NM_023002.2	NP_075378.1	VALIDATED	OK	1.000	1.000	402	1209	1	1206	402	1	402
IKAKEN	TST08264	06_12-F02	EST	W01C104L03	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	TST08264	06_12-F02	EST	W01C104L04	pDONR221			CYLC1	1538		Hs.444230	Cylicin, basic protein of sperm head cytoskeleton 1						NM_021118.1	NP_066941.1	PROVISIONAL	Cg	0.998	1.000	651	1953	1	1950	651	1	651
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C104L05	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06_12-F03	EST(RND)	W01C104L06	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C104L07	pDONR221				442093											
IKAKEN	TGR05436	06_12-F04	EST(RND)	W01C104L08	pDONR221				442093											
IKAKEN	H05D073J18	06_12-F05	Riken	W01C104L09	pDONR221															
IKAKEN	H05D073J18	06_12-F05	Riken	W01C104L10	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C104L11	pDONR221															
IKAKEN	H04D082L08	06_12-F06	Riken	W01C104L12	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C104L13	pDONR221															
IKAKEN	H07D018L21	06_12-F07	Riken	W01C104L14	pDONR221															
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C104L15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06_12-F08	TOYOBO	W01C104L16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H013071C07	06_12-F09	Riken	W01C104L17	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	H013071C07	06_12-F09	Riken	W01C104L18	pDONR221			RPGRIP1	57096		Hs.126035	Retinitis pigmentosa GTPase regulator interacting protein 1						NM_020366.3	NP_065099.3	REVIEWED	Pfs	0.246	0.378	905	1842	70	1837	1286	382	1286
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C104L19	pDONR221															
IKAKEN	RBd-S105_K09	06_12-F10	Unknown	W01C104L20	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C104L21	pDONR221															
IKAKEN	H06D014I18	06_12-F11	Riken	W01C104L22	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C104L23	pDONR221															
IKAKEN	H04D067M21	06_12-F12	Riken	W01C104L24	pDONR221															
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C104M01	pDONR221															
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C104M02	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C104M03	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C104M04	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C104M05	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C104M06	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C104M07	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C104M08	pDONR221															
IKAKEN	H013043O09	06_12-G05	Riken	W01C104M09	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	H013043O09	06_12-G05	Riken	W01C104M10	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C104M11	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C104M12	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	H04D014L14	06_12-G07	Riken	W01C104M13	pDONR221															
IKAKEN	H04D014L14	06_12-G07	Riken	W01C104M14	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C104M15	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C104M16	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C104M17	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C104M18	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C104M19	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C104M20	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C104M21	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C104M22	pDONR221															
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C104M23	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C104M24	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C104N01	pDONR221															
IKAKEN	FCC161C10	06_12-G01	TOYOBO	W01C104N02	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C104N03	pDONR221															
IKAKEN	RBd69_E07	06_12-G02	Unknown	W01C104N04	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C104N05	pDONR221															
IKAKEN	H04D013H22	06_12-G03	Riken	W01C104N06	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C104N07	pDONR221															
IKAKEN	FMR03954	06_12-G04	EST(RND)	W01C104N08	pDONR221															
IKAKEN	H013043O09	06_12-G05	Riken	W01C104N09	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	H013043O09	06_12-G05	Riken	W01C104N10	pDONR221			SYCE2	256126		Hs.655173	Synaptonemal complex central element protein 2						NM_001105578.1	NP_001099048.1	VALIDATED	OK	1.000	1.000	218	657	1	654	218	1	218
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C104N11	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06_12-G06	TOYOBO	W01C104N12	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	H04D014L14	06_12-G07	Riken	W01C104N13	pDONR221															
IKAKEN	H04D014L14	06_12-G07	Riken	W01C104N14	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C104N15	pDONR221															
IKAKEN	FCC157C03	06_12-G08	TOYOBO	W01C104N16	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C104N17	pDONR221															
IKAKEN	H04D034O21	06_12-G09	Riken	W01C104N18	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C104N19	pDONR221															
IKAKEN	H04D088K09	06_12-G10	Riken	W01C104N20	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C104N21	pDONR221															
IKAKEN	ARi-S008_N04	06_12-G11	Unknown	W01C104N22	pDONR221															
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C104N23	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06_12-G12	TOYOBO	W01C104N24	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	H06D054A05	06_12-H01	Riken	W01C104O01	pDONR221															
IKAKEN	H06D054A05	06_12-H01	Riken	W01C104O02	pDONR221															
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C104O03	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C104O04	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H07D030K21	06_12-H03	Riken	W01C104O05	pDONR221															
IKAKEN	H07D030K21	06_12-H03	Riken	W01C104O06	pDONR221															
IKAKEN	H013030A10	06_12-H04	Riken	W01C104O07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06_12-H04	Riken	W01C104O08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H023070A07	06_12-H05	Riken	W01C104O09	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	H023070A07	06_12-H05	Riken	W01C104O10	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C104O11	pDONR221															
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C104O12	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C104O13	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C104O14	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C104O15	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C104O16	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C104O17	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C104O18	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C104O19	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C104O20	pDONR221															
IKAKEN	H013050H19	06_12-H11	Riken	W01C104O21	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06_12-H11	Riken	W01C104O22	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06_12-H12	EST	W01C104O23	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06_12-H12	EST	W01C104O24	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	H06D054A05	06_12-H01	Riken	W01C104P01	pDONR221															
IKAKEN	H06D054A05	06_12-H01	Riken	W01C104P02	pDONR221															
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C104P03	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06_12-H02	TOYOBO	W01C104P04	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H07D030K21	06_12-H03	Riken	W01C104P05	pDONR221															
IKAKEN	H07D030K21	06_12-H03	Riken	W01C104P06	pDONR221															
IKAKEN	H013030A10	06_12-H04	Riken	W01C104P07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06_12-H04	Riken	W01C104P08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H023070A07	06_12-H05	Riken	W01C104P09	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	H023070A07	06_12-H05	Riken	W01C104P10	pDONR221			USP19	10869		Hs.255596	Ubiquitin specific peptidase 19						NM_006677.1	NP_006668.1	PROVISIONAL	Pfs	0.992	0.992	369	1209	1	1106	1318	880	1248
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C104P11	pDONR221															
IKAKEN	RBd69_G05	06_12-H06	Unknown	W01C104P12	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C104P13	pDONR221															
IKAKEN	H04D065F10	06_12-H07	Riken	W01C104P14	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C104P15	pDONR221															
IKAKEN	H05D080K05	06_12-H08	Riken	W01C104P16	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C104P17	pDONR221															
IKAKEN	ARi34A02	06_12-H09	Unknown	W01C104P18	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C104P19	pDONR221															
IKAKEN	H05D080K05	06_12-H10	Riken	W01C104P20	pDONR221															
IKAKEN	H013050H19	06_12-H11	Riken	W01C104P21	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06_12-H11	Riken	W01C104P22	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06_12-H12	EST	W01C104P23	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06_12-H12	EST	W01C104P24	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	H06D008A11	06_13-A01	Riken	W01C105A01	pDONR221															
IKAKEN	H06D008A11	06_13-A01	Riken	W01C105A02	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C105A03	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C105A04	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C105A05	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C105A06	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C105A07	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C105A08	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C105A09	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C105A10	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C105A11	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C105A12	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C105A13	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C105A14	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C105A15	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C105A16	pDONR221															
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C105A17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C105A18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H04D093E02	06_13-A10	Riken	W01C105A19	pDONR221															
IKAKEN	H04D093E02	06_13-A10	Riken	W01C105A20	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C105A21	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C105A22	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C105A23	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C105A24	pDONR221															
IKAKEN	H06D008A11	06_13-A01	Riken	W01C105B01	pDONR221															
IKAKEN	H06D008A11	06_13-A01	Riken	W01C105B02	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C105B03	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C105B04	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C105B05	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C105B06	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C105B07	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C105B08	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C105B09	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C105B10	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C105B11	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C105B12	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C105B13	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C105B14	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C105B15	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C105B16	pDONR221															
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C105B17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C105B18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H04D093E02	06_13-A10	Riken	W01C105B19	pDONR221															
IKAKEN	H04D093E02	06_13-A10	Riken	W01C105B20	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C105B21	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C105B22	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C105B23	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C105B24	pDONR221															
IKAKEN	H013085D17	06_13-B01	Riken	W01C105C01	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06_13-B01	Riken	W01C105C02	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C105C03	pDONR221															
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C105C04	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C105C05	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C105C06	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C105C07	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C105C08	pDONR221															
IKAKEN	TST01191	06_13-B05	EST	W01C105C09	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	TST01191	06_13-B05	EST	W01C105C10	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C105C11	pDONR221															
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C105C12	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C105C13	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C105C14	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C105C15	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C105C16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C105C17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C105C18	pDONR221															
IKAKEN	RCT06775	06_13-B10	EST	W01C105C19	pDONR221			IGHA1	3493											
IKAKEN	RCT06775	06_13-B10	EST	W01C105C20	pDONR221			IGHA1	3493											
IKAKEN	SYN08912	06_13-B11	EST	W01C105C21	pDONR221															
IKAKEN	SYN08912	06_13-B11	EST	W01C105C22	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C105C23	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C105C24	pDONR221															
IKAKEN	H013085D17	06_13-B01	Riken	W01C105D01	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06_13-B01	Riken	W01C105D02	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C105D03	pDONR221															
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C105D04	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C105D05	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C105D06	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C105D07	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C105D08	pDONR221															
IKAKEN	TST01191	06_13-B05	EST	W01C105D09	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	TST01191	06_13-B05	EST	W01C105D10	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C105D11	pDONR221															
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C105D12	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C105D13	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C105D14	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C105D15	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C105D16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C105D17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C105D18	pDONR221															
IKAKEN	RCT06775	06_13-B10	EST	W01C105D19	pDONR221			IGHA1	3493											
IKAKEN	RCT06775	06_13-B10	EST	W01C105D20	pDONR221			IGHA1	3493											
IKAKEN	SYN08912	06_13-B11	EST	W01C105D21	pDONR221															
IKAKEN	SYN08912	06_13-B11	EST	W01C105D22	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C105D23	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C105D24	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C105E01	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C105E02	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C105E03	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C105E04	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C105E05	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C105E06	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C105E07	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C105E08	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C105E09	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C105E10	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C105E11	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C105E12	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C105E13	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C105E14	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C105E15	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C105E16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C105E17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C105E18	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C105E19	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C105E20	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C105E21	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C105E22	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C105E23	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C105E24	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C105F01	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C105F02	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C105F03	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C105F04	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C105F05	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C105F06	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C105F07	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C105F08	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C105F09	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C105F10	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C105F11	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C105F12	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C105F13	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C105F14	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C105F15	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C105F16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C105F17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C105F18	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C105F19	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C105F20	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C105F21	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C105F22	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C105F23	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C105F24	pDONR221															
IKAKEN	ARa58D08.ab1	06_13-D01		W01C105G01	pDONR221															
IKAKEN	ARa58D08.ab1	06_13-D01		W01C105G02	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C105G03	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C105G04	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C105G05	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C105G06	pDONR221															
IKAKEN	MPE08838	06_13-D04	EST	W01C105G07	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	MPE08838	06_13-D04	EST	W01C105G08	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	RBb48F12.ab1	06_13-D05		W01C105G09	pDONR221															
IKAKEN	RBb48F12.ab1	06_13-D05		W01C105G10	pDONR221															
IKAKEN	PCD09058	06_13-D06	EST	W01C105G11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06_13-D06	EST	W01C105G12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	HSI01702	06_13-D07	EST	W01C105G13	pDONR221			TRDD3	28523											
IKAKEN	HSI01702	06_13-D07	EST	W01C105G14	pDONR221			TRDD3	28523											
IKAKEN	PCD01835	06_13-D08	EST	W01C105G15	pDONR221															
IKAKEN	PCD01835	06_13-D08	EST	W01C105G16	pDONR221															
IKAKEN	PCD07975	06_13-D09	EST	W01C105G17	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	PCD07975	06_13-D09	EST	W01C105G18	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	KAT04487	06_13-D10	EST	W01C105G19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-D10	EST	W01C105G20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06_13-D11	EST	W01C105G21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D11	EST	W01C105G22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C105G23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C105G24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	ARa58D08.ab1	06_13-D01		W01C105H01	pDONR221															
IKAKEN	ARa58D08.ab1	06_13-D01		W01C105H02	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C105H03	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C105H04	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C105H05	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C105H06	pDONR221															
IKAKEN	MPE08838	06_13-D04	EST	W01C105H07	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	MPE08838	06_13-D04	EST	W01C105H08	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	RBb48F12.ab1	06_13-D05		W01C105H09	pDONR221															
IKAKEN	RBb48F12.ab1	06_13-D05		W01C105H10	pDONR221															
IKAKEN	PCD09058	06_13-D06	EST	W01C105H11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06_13-D06	EST	W01C105H12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	HSI01702	06_13-D07	EST	W01C105H13	pDONR221			TRDD3	28523											
IKAKEN	HSI01702	06_13-D07	EST	W01C105H14	pDONR221			TRDD3	28523											
IKAKEN	PCD01835	06_13-D08	EST	W01C105H15	pDONR221															
IKAKEN	PCD01835	06_13-D08	EST	W01C105H16	pDONR221															
IKAKEN	PCD07975	06_13-D09	EST	W01C105H17	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	PCD07975	06_13-D09	EST	W01C105H18	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	KAT04487	06_13-D10	EST	W01C105H19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-D10	EST	W01C105H20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06_13-D11	EST	W01C105H21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D11	EST	W01C105H22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C105H23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C105H24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C105I01	pDONR221															
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C105I02	pDONR221															
IKAKEN	KAT04487	06_13-E02	EST	W01C105I03	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-E02	EST	W01C105I04	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	ARe24G10.ab1	06_13-E03		W01C105I05	pDONR221															
IKAKEN	ARe24G10.ab1	06_13-E03		W01C105I06	pDONR221															
IKAKEN	NRB08993	06_13-E04	EST	W01C105I07	pDONR221				391014											
IKAKEN	NRB08993	06_13-E04	EST	W01C105I08	pDONR221				391014											
IKAKEN	RCT08006	06_13-E05	EST	W01C105I09	pDONR221			IGHA1	3493											
IKAKEN	RCT08006	06_13-E05	EST	W01C105I10	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C105I11	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C105I12	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06_13-E07	EST	W01C105I13	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06_13-E07	EST	W01C105I14	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	RBb66F11.ab1	06_13-E08		W01C105I15	pDONR221															
IKAKEN	RBb66F11.ab1	06_13-E08		W01C105I16	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C105I17	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C105I18	pDONR221															
IKAKEN	AK127748	06_13-E10		W01C105I19	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK127748	06_13-E10		W01C105I20	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	H023096O15	06_13-E11	Riken	W01C105I21	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	H023096O15	06_13-E11	Riken	W01C105I22	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	AK056717	06_13-E12		W01C105I23	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06_13-E12		W01C105I24	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C105J01	pDONR221															
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C105J02	pDONR221															
IKAKEN	KAT04487	06_13-E02	EST	W01C105J03	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-E02	EST	W01C105J04	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	ARe24G10.ab1	06_13-E03		W01C105J05	pDONR221															
IKAKEN	ARe24G10.ab1	06_13-E03		W01C105J06	pDONR221															
IKAKEN	NRB08993	06_13-E04	EST	W01C105J07	pDONR221				391014											
IKAKEN	NRB08993	06_13-E04	EST	W01C105J08	pDONR221				391014											
IKAKEN	RCT08006	06_13-E05	EST	W01C105J09	pDONR221			IGHA1	3493											
IKAKEN	RCT08006	06_13-E05	EST	W01C105J10	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C105J11	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C105J12	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06_13-E07	EST	W01C105J13	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06_13-E07	EST	W01C105J14	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	RBb66F11.ab1	06_13-E08		W01C105J15	pDONR221															
IKAKEN	RBb66F11.ab1	06_13-E08		W01C105J16	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C105J17	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C105J18	pDONR221															
IKAKEN	AK127748	06_13-E10		W01C105J19	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK127748	06_13-E10		W01C105J20	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	H023096O15	06_13-E11	Riken	W01C105J21	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	H023096O15	06_13-E11	Riken	W01C105J22	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	AK056717	06_13-E12		W01C105J23	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06_13-E12		W01C105J24	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C105K01	pDONR221															
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C105K02	pDONR221															
IKAKEN	AK098343	06_13-F02		W01C105K03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06_13-F02		W01C105K04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK126947	06_13-F03		W01C105K05	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK126947	06_13-F03		W01C105K06	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK125436	06_13-F04	FLJ	W01C105K07	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_13-F04	FLJ	W01C105K08	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	H013056J18	06_13-F05	Riken	W01C105K09	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	H013056J18	06_13-F05	Riken	W01C105K10	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	AK091096	06_13-F06	FLJ	W01C105K11	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	AK091096	06_13-F06	FLJ	W01C105K12	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	CL0BA001ZG12	06_13-F07		W01C105K13	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	CL0BA001ZG12	06_13-F07		W01C105K14	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	AK074769	06_13-F08		W01C105K15	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	AK074769	06_13-F08		W01C105K16	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	BC059947	06_13-F09	MGC	W01C105K17	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06_13-F09	MGC	W01C105K18	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK001856	06_13-F10		W01C105K19	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK001856	06_13-F10		W01C105K20	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK074628	06_13-F11	FLJ	W01C105K21	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06_13-F11	FLJ	W01C105K22	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK002082	06_13-F12		W01C105K23	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	AK002082	06_13-F12		W01C105K24	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C105L01	pDONR221															
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C105L02	pDONR221															
IKAKEN	AK098343	06_13-F02		W01C105L03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06_13-F02		W01C105L04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK126947	06_13-F03		W01C105L05	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK126947	06_13-F03		W01C105L06	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK125436	06_13-F04	FLJ	W01C105L07	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_13-F04	FLJ	W01C105L08	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	H013056J18	06_13-F05	Riken	W01C105L09	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	H013056J18	06_13-F05	Riken	W01C105L10	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	AK091096	06_13-F06	FLJ	W01C105L11	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	AK091096	06_13-F06	FLJ	W01C105L12	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	CL0BA001ZG12	06_13-F07		W01C105L13	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	CL0BA001ZG12	06_13-F07		W01C105L14	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	AK074769	06_13-F08		W01C105L15	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	AK074769	06_13-F08		W01C105L16	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	BC059947	06_13-F09	MGC	W01C105L17	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06_13-F09	MGC	W01C105L18	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK001856	06_13-F10		W01C105L19	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK001856	06_13-F10		W01C105L20	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK074628	06_13-F11	FLJ	W01C105L21	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06_13-F11	FLJ	W01C105L22	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK002082	06_13-F12		W01C105L23	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	AK002082	06_13-F12		W01C105L24	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	AK128014	06_13-G01	FLJ	W01C105M01	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	AK128014	06_13-G01	FLJ	W01C105M02	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	BC005238	06_13-G02		W01C105M03	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC005238	06_13-G02		W01C105M04	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C105M05	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C105M06	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	BC008794	06_13-G04	MGC	W01C105M07	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06_13-G04	MGC	W01C105M08	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06_13-G05	Riken	W01C105M09	pDONR221															
IKAKEN	H023072I23	06_13-G05	Riken	W01C105M10	pDONR221															
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C105M11	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C105M12	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	BC010076	06_13-G07	MGC	W01C105M13	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC010076	06_13-G07	MGC	W01C105M14	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC027925	06_13-G08	MGC	W01C105M15	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC027925	06_13-G08	MGC	W01C105M16	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC030201	06_13-G09	MGC	W01C105M17	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC030201	06_13-G09	MGC	W01C105M18	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC015799	06_13-G10	MGC	W01C105M19	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC015799	06_13-G10	MGC	W01C105M20	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C105M21	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C105M22	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC033167	06_13-G12	MGC	W01C105M23	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC033167	06_13-G12	MGC	W01C105M24	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK128014	06_13-G01	FLJ	W01C105N01	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	AK128014	06_13-G01	FLJ	W01C105N02	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	BC005238	06_13-G02		W01C105N03	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC005238	06_13-G02		W01C105N04	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C105N05	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C105N06	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	BC008794	06_13-G04	MGC	W01C105N07	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06_13-G04	MGC	W01C105N08	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06_13-G05	Riken	W01C105N09	pDONR221															
IKAKEN	H023072I23	06_13-G05	Riken	W01C105N10	pDONR221															
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C105N11	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C105N12	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	BC010076	06_13-G07	MGC	W01C105N13	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC010076	06_13-G07	MGC	W01C105N14	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC027925	06_13-G08	MGC	W01C105N15	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC027925	06_13-G08	MGC	W01C105N16	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC030201	06_13-G09	MGC	W01C105N17	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC030201	06_13-G09	MGC	W01C105N18	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC015799	06_13-G10	MGC	W01C105N19	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC015799	06_13-G10	MGC	W01C105N20	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C105N21	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C105N22	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC033167	06_13-G12	MGC	W01C105N23	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC033167	06_13-G12	MGC	W01C105N24	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	H033052K23	06_13-H01	Riken	W01C105O01	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H033052K23	06_13-H01	Riken	W01C105O02	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H07D029H09	06_13-H02	Riken	W01C105O03	pDONR221															
IKAKEN	H07D029H09	06_13-H02	Riken	W01C105O04	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C105O05	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C105O06	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C105O07	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C105O08	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C105O09	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C105O10	pDONR221															
IKAKEN	WMD01757	06_13-H06	EST	W01C105O11	pDONR221				392487											
IKAKEN	WMD01757	06_13-H06	EST	W01C105O12	pDONR221				392487											
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C105O13	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C105O14	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	SPL09685	06_13-H08	EST	W01C105O15	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06_13-H08	EST	W01C105O16	pDONR221			IGHA1	3493											
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C105O17	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C105O18	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	DMC07943	06_13-H10	EST	W01C105O19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06_13-H10	EST	W01C105O20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C105O21	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C105O22	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C105O23	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C105O24	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H033052K23	06_13-H01	Riken	W01C105P01	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H033052K23	06_13-H01	Riken	W01C105P02	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H07D029H09	06_13-H02	Riken	W01C105P03	pDONR221															
IKAKEN	H07D029H09	06_13-H02	Riken	W01C105P04	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C105P05	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C105P06	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C105P07	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C105P08	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C105P09	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C105P10	pDONR221															
IKAKEN	WMD01757	06_13-H06	EST	W01C105P11	pDONR221				392487											
IKAKEN	WMD01757	06_13-H06	EST	W01C105P12	pDONR221				392487											
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C105P13	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C105P14	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	SPL09685	06_13-H08	EST	W01C105P15	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06_13-H08	EST	W01C105P16	pDONR221			IGHA1	3493											
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C105P17	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C105P18	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	DMC07943	06_13-H10	EST	W01C105P19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06_13-H10	EST	W01C105P20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C105P21	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C105P22	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C105P23	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C105P24	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H06D008A11	06_13-A01	Riken	W01C106A01	pDONR221															
IKAKEN	H06D008A11	06_13-A01	Riken	W01C106A02	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C106A03	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C106A04	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C106A05	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C106A06	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C106A07	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C106A08	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C106A09	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C106A10	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C106A11	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C106A12	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C106A13	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C106A14	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C106A15	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C106A16	pDONR221															
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C106A17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C106A18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H04D093E02	06_13-A10	Riken	W01C106A19	pDONR221															
IKAKEN	H04D093E02	06_13-A10	Riken	W01C106A20	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C106A21	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C106A22	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C106A23	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C106A24	pDONR221															
IKAKEN	H06D008A11	06_13-A01	Riken	W01C106B01	pDONR221															
IKAKEN	H06D008A11	06_13-A01	Riken	W01C106B02	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C106B03	pDONR221															
IKAKEN	RBd69_D02	06_13-A02	Unknown	W01C106B04	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C106B05	pDONR221															
IKAKEN	H04D008G15	06_13-A03	Riken	W01C106B06	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C106B07	pDONR221															
IKAKEN	H04D082L08	06_13-A04	Riken	W01C106B08	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C106B09	pDONR221															
IKAKEN	RBd-S075_G16	06_13-A05	Unknown	W01C106B10	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C106B11	pDONR221															
IKAKEN	RBd58_A06	06_13-A06	Unknown	W01C106B12	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C106B13	pDONR221															
IKAKEN	H04D074L02	06_13-A07	Riken	W01C106B14	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C106B15	pDONR221															
IKAKEN	H04D017H02	06_13-A08	Riken	W01C106B16	pDONR221															
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C106B17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06_13-A09	HITACHI	W01C106B18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H04D093E02	06_13-A10	Riken	W01C106B19	pDONR221															
IKAKEN	H04D093E02	06_13-A10	Riken	W01C106B20	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C106B21	pDONR221															
IKAKEN	ATa-S067_K04	06_13-A11		W01C106B22	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C106B23	pDONR221															
IKAKEN	RBd98_B11	06_13-A12	Unknown	W01C106B24	pDONR221															
IKAKEN	H013085D17	06_13-B01	Riken	W01C106C01	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06_13-B01	Riken	W01C106C02	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C106C03	pDONR221															
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C106C04	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C106C05	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C106C06	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C106C07	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C106C08	pDONR221															
IKAKEN	TST01191	06_13-B05	EST	W01C106C09	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	TST01191	06_13-B05	EST	W01C106C10	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C106C11	pDONR221															
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C106C12	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C106C13	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C106C14	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C106C15	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C106C16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C106C17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C106C18	pDONR221															
IKAKEN	RCT06775	06_13-B10	EST	W01C106C19	pDONR221			IGHA1	3493											
IKAKEN	RCT06775	06_13-B10	EST	W01C106C20	pDONR221			IGHA1	3493											
IKAKEN	SYN08912	06_13-B11	EST	W01C106C21	pDONR221															
IKAKEN	SYN08912	06_13-B11	EST	W01C106C22	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C106C23	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C106C24	pDONR221															
IKAKEN	H013085D17	06_13-B01	Riken	W01C106D01	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06_13-B01	Riken	W01C106D02	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C106D03	pDONR221															
IKAKEN	HISCO_S03002-13_E15	06_13-B02	hisco_THY	W01C106D04	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C106D05	pDONR221															
IKAKEN	ARa51F05.ab1	06_13-B03		W01C106D06	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C106D07	pDONR221															
IKAKEN	NTa04E11.ab1	06_13-B04		W01C106D08	pDONR221															
IKAKEN	TST01191	06_13-B05	EST	W01C106D09	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	TST01191	06_13-B05	EST	W01C106D10	pDONR221			RP1-199H16.1	388900		Hs.454921	Hypothetical LOC388900						XM_940238.1	XP_945331.1	MODEL										
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C106D11	pDONR221															
IKAKEN	HISCO_S03002-01_N15	06_13-B06	hisco_THY	W01C106D12	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C106D13	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06_13-B07	hisco_HUVEC	W01C106D14	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C106D15	pDONR221															
IKAKEN	HISCO_S03002-09_A06	06_13-B08	hisco_THY	W01C106D16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C106D17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-B09		W01C106D18	pDONR221															
IKAKEN	RCT06775	06_13-B10	EST	W01C106D19	pDONR221			IGHA1	3493											
IKAKEN	RCT06775	06_13-B10	EST	W01C106D20	pDONR221			IGHA1	3493											
IKAKEN	SYN08912	06_13-B11	EST	W01C106D21	pDONR221															
IKAKEN	SYN08912	06_13-B11	EST	W01C106D22	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C106D23	pDONR221															
IKAKEN	ARa43E02.ab1	06_13-B12		W01C106D24	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C106E01	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C106E02	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C106E03	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C106E04	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C106E05	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C106E06	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C106E07	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C106E08	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C106E09	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C106E10	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C106E11	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C106E12	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C106E13	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C106E14	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C106E15	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C106E16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C106E17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C106E18	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C106E19	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C106E20	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C106E21	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C106E22	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C106E23	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C106E24	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C106F01	pDONR221															
IKAKEN	HISCO_S02026A-107_I19	06_13-C01	hisco_OVA	W01C106F02	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C106F03	pDONR221															
IKAKEN	HISCO_S01095-102_N10	06_13-C02	hisco_HUVEC	W01C106F04	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C106F05	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06_13-C03	hisco_HUVEC	W01C106F06	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C106F07	pDONR221															
IKAKEN	HISCO_S01095-112_C02	06_13-C04	hisco_HUVEC	W01C106F08	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C106F09	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06_13-C05	hisco_THY	W01C106F10	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C106F11	pDONR221															
IKAKEN	ARe05D06.ab1	06_13-C06		W01C106F12	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C106F13	pDONR221															
IKAKEN	ARe07G02.ab1	06_13-C07		W01C106F14	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C106F15	pDONR221															
IKAKEN	HISCO_S01095-101_A22	06_13-C08	hisco_HUVEC	W01C106F16	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C106F17	pDONR221															
IKAKEN	ARa76H01.ab1	06_13-C09		W01C106F18	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C106F19	pDONR221															
IKAKEN	ARe63E03.ab1	06_13-C10		W01C106F20	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C106F21	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06_13-C11	hisco_OVA	W01C106F22	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C106F23	pDONR221															
IKAKEN	RBb16E09.ab1	06_13-C12		W01C106F24	pDONR221															
IKAKEN	ARa58D08.ab1	06_13-D01		W01C106G01	pDONR221															
IKAKEN	ARa58D08.ab1	06_13-D01		W01C106G02	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C106G03	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C106G04	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C106G05	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C106G06	pDONR221															
IKAKEN	MPE08838	06_13-D04	EST	W01C106G07	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	MPE08838	06_13-D04	EST	W01C106G08	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	RBb48F12.ab1	06_13-D05		W01C106G09	pDONR221															
IKAKEN	RBb48F12.ab1	06_13-D05		W01C106G10	pDONR221															
IKAKEN	PCD09058	06_13-D06	EST	W01C106G11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06_13-D06	EST	W01C106G12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	HSI01702	06_13-D07	EST	W01C106G13	pDONR221			TRDD3	28523											
IKAKEN	HSI01702	06_13-D07	EST	W01C106G14	pDONR221			TRDD3	28523											
IKAKEN	PCD01835	06_13-D08	EST	W01C106G15	pDONR221															
IKAKEN	PCD01835	06_13-D08	EST	W01C106G16	pDONR221															
IKAKEN	PCD07975	06_13-D09	EST	W01C106G17	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	PCD07975	06_13-D09	EST	W01C106G18	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	KAT04487	06_13-D10	EST	W01C106G19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-D10	EST	W01C106G20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06_13-D11	EST	W01C106G21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D11	EST	W01C106G22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C106G23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C106G24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	ARa58D08.ab1	06_13-D01		W01C106H01	pDONR221															
IKAKEN	ARa58D08.ab1	06_13-D01		W01C106H02	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C106H03	pDONR221															
IKAKEN	HISCO_S01095-105_L13	06_13-D02	hisco_HUVEC	W01C106H04	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C106H05	pDONR221															
IKAKEN	ARa69F11.ab1	06_13-D03		W01C106H06	pDONR221															
IKAKEN	MPE08838	06_13-D04	EST	W01C106H07	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	MPE08838	06_13-D04	EST	W01C106H08	pDONR221			KCTD9	54793		Hs.72071	Potassium channel tetramerisation domain containing 9						NM_017634.2	NP_060104.2	VALIDATED		0.828	0.944	389	1026	1	1023	389	1	389
IKAKEN	RBb48F12.ab1	06_13-D05		W01C106H09	pDONR221															
IKAKEN	RBb48F12.ab1	06_13-D05		W01C106H10	pDONR221															
IKAKEN	PCD09058	06_13-D06	EST	W01C106H11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06_13-D06	EST	W01C106H12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	HSI01702	06_13-D07	EST	W01C106H13	pDONR221			TRDD3	28523											
IKAKEN	HSI01702	06_13-D07	EST	W01C106H14	pDONR221			TRDD3	28523											
IKAKEN	PCD01835	06_13-D08	EST	W01C106H15	pDONR221															
IKAKEN	PCD01835	06_13-D08	EST	W01C106H16	pDONR221															
IKAKEN	PCD07975	06_13-D09	EST	W01C106H17	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	PCD07975	06_13-D09	EST	W01C106H18	pDONR221			C6orf115	58527		Hs.600861	Chromosome 6 open reading frame 115						NM_021243.2	NP_067066.1	VALIDATED	OK	1.000	1.000	81	246	1	243	81	1	81
IKAKEN	KAT04487	06_13-D10	EST	W01C106H19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-D10	EST	W01C106H20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06_13-D11	EST	W01C106H21	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D11	EST	W01C106H22	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C106H23	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06_13-D12	EST	W01C106H24	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C106I01	pDONR221															
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C106I02	pDONR221															
IKAKEN	KAT04487	06_13-E02	EST	W01C106I03	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-E02	EST	W01C106I04	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	ARe24G10.ab1	06_13-E03		W01C106I05	pDONR221															
IKAKEN	ARe24G10.ab1	06_13-E03		W01C106I06	pDONR221															
IKAKEN	NRB08993	06_13-E04	EST	W01C106I07	pDONR221				391014											
IKAKEN	NRB08993	06_13-E04	EST	W01C106I08	pDONR221				391014											
IKAKEN	RCT08006	06_13-E05	EST	W01C106I09	pDONR221			IGHA1	3493											
IKAKEN	RCT08006	06_13-E05	EST	W01C106I10	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C106I11	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C106I12	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06_13-E07	EST	W01C106I13	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06_13-E07	EST	W01C106I14	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	RBb66F11.ab1	06_13-E08		W01C106I15	pDONR221															
IKAKEN	RBb66F11.ab1	06_13-E08		W01C106I16	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C106I17	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C106I18	pDONR221															
IKAKEN	AK127748	06_13-E10		W01C106I19	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK127748	06_13-E10		W01C106I20	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	H023096O15	06_13-E11	Riken	W01C106I21	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	H023096O15	06_13-E11	Riken	W01C106I22	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	AK056717	06_13-E12		W01C106I23	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06_13-E12		W01C106I24	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C106J01	pDONR221															
IKAKEN	HPR03249	06_13-E01	EST(RND)	W01C106J02	pDONR221															
IKAKEN	KAT04487	06_13-E02	EST	W01C106J03	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06_13-E02	EST	W01C106J04	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	ARe24G10.ab1	06_13-E03		W01C106J05	pDONR221															
IKAKEN	ARe24G10.ab1	06_13-E03		W01C106J06	pDONR221															
IKAKEN	NRB08993	06_13-E04	EST	W01C106J07	pDONR221				391014											
IKAKEN	NRB08993	06_13-E04	EST	W01C106J08	pDONR221				391014											
IKAKEN	RCT08006	06_13-E05	EST	W01C106J09	pDONR221			IGHA1	3493											
IKAKEN	RCT08006	06_13-E05	EST	W01C106J10	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C106J11	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06_13-E06	EST	W01C106J12	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06_13-E07	EST	W01C106J13	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06_13-E07	EST	W01C106J14	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	RBb66F11.ab1	06_13-E08		W01C106J15	pDONR221															
IKAKEN	RBb66F11.ab1	06_13-E08		W01C106J16	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C106J17	pDONR221															
IKAKEN	ARe86F10.ab1	06_13-E09		W01C106J18	pDONR221															
IKAKEN	AK127748	06_13-E10		W01C106J19	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	AK127748	06_13-E10		W01C106J20	pDONR221	10641		ACCN1	40	BAG54565.1	Hs.368417	Amiloride-sensitive cation channel 1, neuronal						NM_183377.1	NP_899233.1	REVIEWED	OK	1.000	1.000	563	1692	1	1689	563	1	563
IKAKEN	H023096O15	06_13-E11	Riken	W01C106J21	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	H023096O15	06_13-E11	Riken	W01C106J22	pDONR221			OLFM3	118427		Hs.484475	Olfactomedin 3						NM_058170.2	NP_477518.2	VALIDATED	P	1.000	1.000	435	1437	130	1434	458	24	458
IKAKEN	AK056717	06_13-E12		W01C106J23	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06_13-E12		W01C106J24	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C106K01	pDONR221															
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C106K02	pDONR221															
IKAKEN	AK098343	06_13-F02		W01C106K03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06_13-F02		W01C106K04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK126947	06_13-F03		W01C106K05	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK126947	06_13-F03		W01C106K06	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK125436	06_13-F04	FLJ	W01C106K07	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_13-F04	FLJ	W01C106K08	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	H013056J18	06_13-F05	Riken	W01C106K09	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	H013056J18	06_13-F05	Riken	W01C106K10	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	AK091096	06_13-F06	FLJ	W01C106K11	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	AK091096	06_13-F06	FLJ	W01C106K12	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	CL0BA001ZG12	06_13-F07		W01C106K13	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	CL0BA001ZG12	06_13-F07		W01C106K14	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	AK074769	06_13-F08		W01C106K15	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	AK074769	06_13-F08		W01C106K16	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	BC059947	06_13-F09	MGC	W01C106K17	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06_13-F09	MGC	W01C106K18	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK001856	06_13-F10		W01C106K19	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK001856	06_13-F10		W01C106K20	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK074628	06_13-F11	FLJ	W01C106K21	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06_13-F11	FLJ	W01C106K22	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK002082	06_13-F12		W01C106K23	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	AK002082	06_13-F12		W01C106K24	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C106L01	pDONR221															
IKAKEN	F-NESOP2000206	06_13-F01	EST(F-)	W01C106L02	pDONR221															
IKAKEN	AK098343	06_13-F02		W01C106L03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06_13-F02		W01C106L04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK126947	06_13-F03		W01C106L05	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK126947	06_13-F03		W01C106L06	pDONR221	6488		HS6ST3	266722	BAG54407.1	Hs.171001	Heparan sulfate 6-O-sulfotransferase 3						XM_001720419.1	XP_001720471.1	MODEL	OK	1.000	1.000	471	1416	1	1413	471	1	471
IKAKEN	AK125436	06_13-F04	FLJ	W01C106L07	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	AK125436	06_13-F04	FLJ	W01C106L08	pDONR221	27004		LOC440297	440297	BAC86164.1	Hs.498322	Chondroitin sulfate proteoglycan 4 pseudogene			tongue	NTONG2				
IKAKEN	H013056J18	06_13-F05	Riken	W01C106L09	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	H013056J18	06_13-F05	Riken	W01C106L10	pDONR221			RNF17	56163		Hs.97464	Ring finger protein 17						NM_031277.2	NP_112567.2	REVIEWED	Pfs	0.979	0.979	424	1350	1	1273	1623	1	424
IKAKEN	AK091096	06_13-F06	FLJ	W01C106L11	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	AK091096	06_13-F06	FLJ	W01C106L12	pDONR221	5463		PDZRN4	29951	-	Hs.380044	PDZ domain containing ring finger 4			brain	BRAWH2		NM_013377.3	NP_037509.3	VALIDATED	OK	1.000	1.000	778	2337	1	2334	778	1	778
IKAKEN	CL0BA001ZG12	06_13-F07		W01C106L13	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	CL0BA001ZG12	06_13-F07		W01C106L14	pDONR221			PSG3	5671		Hs.654413	Pregnancy specific beta-1-glycoprotein 3						NM_021016.3	NP_066296.2	VALIDATED		0.915	0.915	414	1281	1	1242	428	1	414
IKAKEN	AK074769	06_13-F08		W01C106L15	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	AK074769	06_13-F08		W01C106L16	pDONR221	3853		JAM3	83700	BAC11195.1	Hs.150718	Junctional adhesion molecule 3						NM_032801.3	NP_116190.2	REVIEWED	OK	1.000	1.000	355	1068	1	1065	355	1	355
IKAKEN	BC059947	06_13-F09	MGC	W01C106L17	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06_13-F09	MGC	W01C106L18	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK001856	06_13-F10		W01C106L19	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK001856	06_13-F10		W01C106L20	pDONR221	13247		LOC654433	654433	-	Hs.656660	Hypothetical LOC654433																		
IKAKEN	AK074628	06_13-F11	FLJ	W01C106L21	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06_13-F11	FLJ	W01C106L22	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK002082	06_13-F12		W01C106L23	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	AK002082	06_13-F12		W01C106L24	pDONR221	1844		RSBN1	54665	BAA92075.1	Hs.486285	Round spermatid basic protein 1						NM_018364.3	NP_060834.2	VALIDATED	OK	1.000	1.000	802	2409	1	2406	802	1	802
IKAKEN	AK128014	06_13-G01	FLJ	W01C106M01	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	AK128014	06_13-G01	FLJ	W01C106M02	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	BC005238	06_13-G02		W01C106M03	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC005238	06_13-G02		W01C106M04	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C106M05	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C106M06	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	BC008794	06_13-G04	MGC	W01C106M07	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06_13-G04	MGC	W01C106M08	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06_13-G05	Riken	W01C106M09	pDONR221															
IKAKEN	H023072I23	06_13-G05	Riken	W01C106M10	pDONR221															
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C106M11	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C106M12	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	BC010076	06_13-G07	MGC	W01C106M13	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC010076	06_13-G07	MGC	W01C106M14	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC027925	06_13-G08	MGC	W01C106M15	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC027925	06_13-G08	MGC	W01C106M16	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC030201	06_13-G09	MGC	W01C106M17	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC030201	06_13-G09	MGC	W01C106M18	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC015799	06_13-G10	MGC	W01C106M19	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC015799	06_13-G10	MGC	W01C106M20	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C106M21	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C106M22	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC033167	06_13-G12	MGC	W01C106M23	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC033167	06_13-G12	MGC	W01C106M24	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	AK128014	06_13-G01	FLJ	W01C106N01	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	AK128014	06_13-G01	FLJ	W01C106N02	pDONR221	2047		YOD1	55432	BAC87233.1	Hs.711982	YOD1 OTU deubiquinating enzyme 1 homolog (S. cerevisiae)			testis	TESTI2		NM_018566.3	NP_061036.3	VALIDATED	P	1.000	1.000	303	912	1	909	348	46	348
IKAKEN	BC005238	06_13-G02		W01C106N03	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	BC005238	06_13-G02		W01C106N04	pDONR221	11925		FXYD3	5349	AAH05238.1	Hs.301350	FXYD domain containing ion transport regulator 3						NM_001136011.1	NP_001129483.1	REVIEWED	OK	1.000	1.000	87	264	1	261	87	1	87
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C106N05	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	F-OCBBF2006511	06_13-G03	EST(F-)	W01C106N06	pDONR221			KIAA1109	84162		Hs.408142	KIAA1109						NM_015312.2	NP_056127.2	VALIDATED	Ps	0.997	0.997	327	1140	1	981	5005	606	932
IKAKEN	BC008794	06_13-G04	MGC	W01C106N07	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06_13-G04	MGC	W01C106N08	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06_13-G05	Riken	W01C106N09	pDONR221															
IKAKEN	H023072I23	06_13-G05	Riken	W01C106N10	pDONR221															
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C106N11	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	COR00221	06_13-G06	EST(RND)	W01C106N12	pDONR221			ZDBF2	57683		Hs.110489	Zinc finger, DBF-type containing 2						NM_020923.1	NP_065974.1	VALIDATED	P	1.000	1.000	762	2289	1	2286	2354	1593	2354
IKAKEN	BC010076	06_13-G07	MGC	W01C106N13	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC010076	06_13-G07	MGC	W01C106N14	pDONR221	15170		MRPS6	64968	AAH10076.1	Hs.302742	Mitochondrial ribosomal protein S6			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_032476.3	NP_115865.1	REVIEWED	OK	1.000	1.000	125	378	1	375	125	1	125
IKAKEN	BC027925	06_13-G08	MGC	W01C106N15	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC027925	06_13-G08	MGC	W01C106N16	pDONR221	25163		DCX	1641	AAH27925.1	Hs.34780	Doublecortin			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_000555.2	NP_000546.2	REVIEWED	OK	1.000	1.000	441	1326	1	1323	441	1	441
IKAKEN	BC030201	06_13-G09	MGC	W01C106N17	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC030201	06_13-G09	MGC	W01C106N18	pDONR221	5329		CABP1	9478	AAH30201.2	Hs.458482	Calcium binding protein 1			Lung, Spleen, fetal, pooled	NIH_MGC_122	DH10B	NM_004276.3	NP_004267.2	REVIEWED	OK	1.000	1.000	167	504	1	501	167	1	167
IKAKEN	BC015799	06_13-G10	MGC	W01C106N19	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	BC015799	06_13-G10	MGC	W01C106N20	pDONR221	2847		CASP7	840	AAH15799.1	Hs.9216	Caspase 7, apoptosis-related cysteine peptidase			Skin, melanotic melanoma, high MDR.	NIH_MGC_49	DH10B-R	NM_033338.4	NP_203124.1	REVIEWED	OK	1.000	1.000	336	1011	1	1008	336	1	336
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C106N21	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	F-TESTI2031682	06_13-G11	EST(F-)	W01C106N22	pDONR221			C4orf6	10141		Hs.177972	Chromosome 4 open reading frame 6						NM_005750.2	NP_005741.1	REVIEWED	OK	1.000	1.000	93	282	1	279	93	1	93
IKAKEN	BC033167	06_13-G12	MGC	W01C106N23	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	BC033167	06_13-G12	MGC	W01C106N24	pDONR221	4052		CABP4	57010	AAH33167.1	Hs.143036	Calcium binding protein 4			Brain, astrocytoma, grade IV	NIH_MGC_98	DH10B	NM_145200.2	NP_660201.1	VALIDATED	OK	1.000	1.000	275	828	1	825	275	1	275
IKAKEN	H033052K23	06_13-H01	Riken	W01C106O01	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H033052K23	06_13-H01	Riken	W01C106O02	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H07D029H09	06_13-H02	Riken	W01C106O03	pDONR221															
IKAKEN	H07D029H09	06_13-H02	Riken	W01C106O04	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C106O05	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C106O06	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C106O07	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C106O08	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C106O09	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C106O10	pDONR221															
IKAKEN	WMD01757	06_13-H06	EST	W01C106O11	pDONR221				392487											
IKAKEN	WMD01757	06_13-H06	EST	W01C106O12	pDONR221				392487											
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C106O13	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C106O14	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	SPL09685	06_13-H08	EST	W01C106O15	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06_13-H08	EST	W01C106O16	pDONR221			IGHA1	3493											
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C106O17	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C106O18	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	DMC07943	06_13-H10	EST	W01C106O19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06_13-H10	EST	W01C106O20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C106O21	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C106O22	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C106O23	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C106O24	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H033052K23	06_13-H01	Riken	W01C106P01	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H033052K23	06_13-H01	Riken	W01C106P02	pDONR221			CHADL	150356		Hs.714982	Chondroadherin-like						XM_377720.2	XP_377720.2	MODEL										
IKAKEN	H07D029H09	06_13-H02	Riken	W01C106P03	pDONR221															
IKAKEN	H07D029H09	06_13-H02	Riken	W01C106P04	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C106P05	pDONR221															
IKAKEN	H07D029H09	06_13-H03	Riken	W01C106P06	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C106P07	pDONR221															
IKAKEN	H07D059B18	06_13-H04	Riken	W01C106P08	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C106P09	pDONR221															
IKAKEN	H04D036L05	06_13-H05	Riken	W01C106P10	pDONR221															
IKAKEN	WMD01757	06_13-H06	EST	W01C106P11	pDONR221				392487											
IKAKEN	WMD01757	06_13-H06	EST	W01C106P12	pDONR221				392487											
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C106P13	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	FBR06993	06_13-H07	EST(RND)	W01C106P14	pDONR221			C10orf18	54906		Hs.699500	Chromosome 10 open reading frame 18						NM_017782.3	NP_060252.3	VALIDATED	P	1.000	1.000	749	2247	1	2247	2430	358	1106
IKAKEN	SPL09685	06_13-H08	EST	W01C106P15	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06_13-H08	EST	W01C106P16	pDONR221			IGHA1	3493											
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C106P17	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	HPR01435	06_13-H09	EST(RND)	W01C106P18	pDONR221			MUM1	84939		Hs.515016	Melanoma associated antigen (mutated) 1						NM_032853.3	NP_116242.2	VALIDATED	Pfs	0.991	1.000	227	738	64	738	711	73	299
IKAKEN	DMC07943	06_13-H10	EST	W01C106P19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06_13-H10	EST	W01C106P20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C106P21	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	CNR06661	06_13-H11	EST(RND)	W01C106P22	pDONR221			PCNXL2	80003		Hs.370605	Pecanex-like 2 (Drosophila)						NM_014801.3	NP_055616.3	VALIDATED	P	1.000	1.000	391	1173	1	1173	2137	1	391
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C106P23	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06_13-H12	EST(RND)	W01C106P24	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H04D047E22	06_14-A01	Riken	W01C107A01	pDONR221															
IKAKEN	H04D047E22	06_14-A01	Riken	W01C107A02	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C107A03	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C107A04	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C107A05	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C107A06	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C107A07	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C107A08	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C107A09	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C107A10	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C107A11	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C107A12	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C107A13	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C107A14	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C107A15	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C107A16	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C107A17	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C107A18	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C107A19	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C107A20	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C107A21	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C107A22	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C107A23	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C107A24	pDONR221															
IKAKEN	H04D047E22	06_14-A01	Riken	W01C107B01	pDONR221															
IKAKEN	H04D047E22	06_14-A01	Riken	W01C107B02	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C107B03	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C107B04	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C107B05	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C107B06	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C107B07	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C107B08	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C107B09	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C107B10	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C107B11	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C107B12	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C107B13	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C107B14	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C107B15	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C107B16	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C107B17	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C107B18	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C107B19	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C107B20	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C107B21	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C107B22	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C107B23	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C107B24	pDONR221															
IKAKEN	H05D035C09	06_14-B01	Riken	W01C107C01	pDONR221															
IKAKEN	H05D035C09	06_14-B01	Riken	W01C107C02	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C107C03	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C107C04	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C107C05	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C107C06	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C107C07	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C107C08	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C107C09	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C107C10	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C107C11	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C107C12	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C107C13	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C107C14	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C107C15	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C107C16	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C107C17	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C107C18	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C107C19	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C107C20	pDONR221															
IKAKEN	H013002L21	06_14-B11	Riken	W01C107C21	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06_14-B11	Riken	W01C107C22	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023093H14	06_14-B12	Riken	W01C107C23	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H023093H14	06_14-B12	Riken	W01C107C24	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H05D035C09	06_14-B01	Riken	W01C107D01	pDONR221															
IKAKEN	H05D035C09	06_14-B01	Riken	W01C107D02	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C107D03	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C107D04	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C107D05	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C107D06	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C107D07	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C107D08	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C107D09	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C107D10	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C107D11	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C107D12	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C107D13	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C107D14	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C107D15	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C107D16	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C107D17	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C107D18	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C107D19	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C107D20	pDONR221															
IKAKEN	H013002L21	06_14-B11	Riken	W01C107D21	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06_14-B11	Riken	W01C107D22	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023093H14	06_14-B12	Riken	W01C107D23	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H023093H14	06_14-B12	Riken	W01C107D24	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H023099P08	06_14-C01	Riken	W01C107E01	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06_14-C01	Riken	W01C107E02	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H033085J19	06_14-C02	Riken	W01C107E03	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H033085J19	06_14-C02	Riken	W01C107E04	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H04D006G23	06_14-C03	Riken	W01C107E05	pDONR221															
IKAKEN	H04D006G23	06_14-C03	Riken	W01C107E06	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C107E07	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C107E08	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C107E09	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C107E10	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C107E11	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C107E12	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C107E13	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C107E14	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C107E15	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C107E16	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C107E17	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C107E18	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C107E19	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C107E20	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C107E21	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C107E22	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C107E23	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C107E24	pDONR221															
IKAKEN	H023099P08	06_14-C01	Riken	W01C107F01	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06_14-C01	Riken	W01C107F02	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H033085J19	06_14-C02	Riken	W01C107F03	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H033085J19	06_14-C02	Riken	W01C107F04	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H04D006G23	06_14-C03	Riken	W01C107F05	pDONR221															
IKAKEN	H04D006G23	06_14-C03	Riken	W01C107F06	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C107F07	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C107F08	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C107F09	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C107F10	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C107F11	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C107F12	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C107F13	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C107F14	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C107F15	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C107F16	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C107F17	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C107F18	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C107F19	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C107F20	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C107F21	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C107F22	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C107F23	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C107F24	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C107G01	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C107G02	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C107G03	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C107G04	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C107G05	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C107G06	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C107G07	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C107G08	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C107G09	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C107G10	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C107G11	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C107G12	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C107G13	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C107G14	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C107G15	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C107G16	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C107G17	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C107G18	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C107G19	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C107G20	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C107G21	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C107G22	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C107G23	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C107G24	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C107H01	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C107H02	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C107H03	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C107H04	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C107H05	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C107H06	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C107H07	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C107H08	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C107H09	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C107H10	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C107H11	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C107H12	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C107H13	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C107H14	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C107H15	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C107H16	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C107H17	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C107H18	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C107H19	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C107H20	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C107H21	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C107H22	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C107H23	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C107H24	pDONR221															
IKAKEN	SK007C01	06_14-E01		W01C107I01	pDONR221															
IKAKEN	SK007C01	06_14-E01		W01C107I02	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C107I03	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C107I04	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C107I05	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C107I06	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C107I07	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C107I08	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C107I09	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C107I10	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C107I11	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C107I12	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C107I13	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C107I14	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C107I15	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C107I16	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C107I17	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C107I18	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C107I19	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C107I20	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C107I21	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C107I22	pDONR221															
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C107I23	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C107I24	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	SK007C01	06_14-E01		W01C107J01	pDONR221															
IKAKEN	SK007C01	06_14-E01		W01C107J02	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C107J03	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C107J04	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C107J05	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C107J06	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C107J07	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C107J08	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C107J09	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C107J10	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C107J11	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C107J12	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C107J13	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C107J14	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C107J15	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C107J16	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C107J17	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C107J18	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C107J19	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C107J20	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C107J21	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C107J22	pDONR221															
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C107J23	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C107J24	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	HSI12469	06_14-F01	EST	W01C107K01	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06_14-F01	EST	W01C107K02	pDONR221			LOC392217	392217											
IKAKEN	NRB03282	06_14-F02	EST	W01C107K03	pDONR221															
IKAKEN	NRB03282	06_14-F02	EST	W01C107K04	pDONR221															
IKAKEN	AK125949	06_14-F03		W01C107K05	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	AK125949	06_14-F03		W01C107K06	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C107K07	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C107K08	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	AK123860	06_14-F05	FLJ	W01C107K09	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	AK123860	06_14-F05	FLJ	W01C107K10	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	H013094N20	06_14-F06	Riken	W01C107K11	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	H013094N20	06_14-F06	Riken	W01C107K12	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	STM00905	06_14-F07	EST	W01C107K13	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	STM00905	06_14-F07	EST	W01C107K14	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C107K15	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C107K16	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C107K17	pDONR221															
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C107K18	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C107K19	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C107K20	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C107K21	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C107K22	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C107K23	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C107K24	pDONR221															
IKAKEN	HSI12469	06_14-F01	EST	W01C107L01	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06_14-F01	EST	W01C107L02	pDONR221			LOC392217	392217											
IKAKEN	NRB03282	06_14-F02	EST	W01C107L03	pDONR221															
IKAKEN	NRB03282	06_14-F02	EST	W01C107L04	pDONR221															
IKAKEN	AK125949	06_14-F03		W01C107L05	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	AK125949	06_14-F03		W01C107L06	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C107L07	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C107L08	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	AK123860	06_14-F05	FLJ	W01C107L09	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	AK123860	06_14-F05	FLJ	W01C107L10	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	H013094N20	06_14-F06	Riken	W01C107L11	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	H013094N20	06_14-F06	Riken	W01C107L12	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	STM00905	06_14-F07	EST	W01C107L13	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	STM00905	06_14-F07	EST	W01C107L14	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C107L15	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C107L16	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C107L17	pDONR221															
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C107L18	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C107L19	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C107L20	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C107L21	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C107L22	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C107L23	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C107L24	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C107M01	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C107M02	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C107M03	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C107M04	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C107M05	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C107M06	pDONR221															
IKAKEN	HRT08911	06_14-G04	EST	W01C107M07	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	HRT08911	06_14-G04	EST	W01C107M08	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	H013097F20	06_14-G05	Riken	W01C107M09	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	H013097F20	06_14-G05	Riken	W01C107M10	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C107M11	pDONR221															
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C107M12	pDONR221															
IKAKEN	H013099B11	06_14-G07	Riken	W01C107M13	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H013099B11	06_14-G07	Riken	W01C107M14	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H05D098C17	06_14-G08	Riken	W01C107M15	pDONR221															
IKAKEN	H05D098C17	06_14-G08	Riken	W01C107M16	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C107M17	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C107M18	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C107M19	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C107M20	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C107M21	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C107M22	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C107M23	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C107M24	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C107N01	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C107N02	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C107N03	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C107N04	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C107N05	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C107N06	pDONR221															
IKAKEN	HRT08911	06_14-G04	EST	W01C107N07	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	HRT08911	06_14-G04	EST	W01C107N08	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	H013097F20	06_14-G05	Riken	W01C107N09	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	H013097F20	06_14-G05	Riken	W01C107N10	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C107N11	pDONR221															
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C107N12	pDONR221															
IKAKEN	H013099B11	06_14-G07	Riken	W01C107N13	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H013099B11	06_14-G07	Riken	W01C107N14	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H05D098C17	06_14-G08	Riken	W01C107N15	pDONR221															
IKAKEN	H05D098C17	06_14-G08	Riken	W01C107N16	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C107N17	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C107N18	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C107N19	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C107N20	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C107N21	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C107N22	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C107N23	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C107N24	pDONR221															
IKAKEN	H04D077C20	06_14-H01	Riken	W01C107O01	pDONR221															
IKAKEN	H04D077C20	06_14-H01	Riken	W01C107O02	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C107O03	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C107O04	pDONR221															
IKAKEN	BC003688	06_14-H03		W01C107O05	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC003688	06_14-H03		W01C107O06	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C107O07	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C107O08	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C107O09	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C107O10	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C107O11	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C107O12	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C107O13	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C107O14	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	H013045P06	06_14-H08	Riken	W01C107O15	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H013045P06	06_14-H08	Riken	W01C107O16	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H023062J08	06_14-H09	Riken	W01C107O17	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	H023062J08	06_14-H09	Riken	W01C107O18	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	AK056949	06_14-H10		W01C107O19	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK056949	06_14-H10		W01C107O20	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK127226	06_14-H11	FLJ	W01C107O21	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	AK127226	06_14-H11	FLJ	W01C107O22	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	BC014374	06_14-H12	MGC	W01C107O23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	06_14-H12	MGC	W01C107O24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	H04D077C20	06_14-H01	Riken	W01C107P01	pDONR221															
IKAKEN	H04D077C20	06_14-H01	Riken	W01C107P02	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C107P03	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C107P04	pDONR221															
IKAKEN	BC003688	06_14-H03		W01C107P05	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC003688	06_14-H03		W01C107P06	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C107P07	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C107P08	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C107P09	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C107P10	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C107P11	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C107P12	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C107P13	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C107P14	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	H013045P06	06_14-H08	Riken	W01C107P15	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H013045P06	06_14-H08	Riken	W01C107P16	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H023062J08	06_14-H09	Riken	W01C107P17	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	H023062J08	06_14-H09	Riken	W01C107P18	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	AK056949	06_14-H10		W01C107P19	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK056949	06_14-H10		W01C107P20	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK127226	06_14-H11	FLJ	W01C107P21	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	AK127226	06_14-H11	FLJ	W01C107P22	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	BC014374	06_14-H12	MGC	W01C107P23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	06_14-H12	MGC	W01C107P24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	H04D047E22	06_14-A01	Riken	W01C108A01	pDONR221															
IKAKEN	H04D047E22	06_14-A01	Riken	W01C108A02	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C108A03	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C108A04	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C108A05	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C108A06	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C108A07	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C108A08	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C108A09	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C108A10	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C108A11	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C108A12	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C108A13	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C108A14	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C108A15	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C108A16	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C108A17	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C108A18	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C108A19	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C108A20	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C108A21	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C108A22	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C108A23	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C108A24	pDONR221															
IKAKEN	H04D047E22	06_14-A01	Riken	W01C108B01	pDONR221															
IKAKEN	H04D047E22	06_14-A01	Riken	W01C108B02	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C108B03	pDONR221															
IKAKEN	H04D047E22	06_14-A02	Riken	W01C108B04	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C108B05	pDONR221															
IKAKEN	H05D006B16	06_14-A03	Riken	W01C108B06	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C108B07	pDONR221															
IKAKEN	H04D053K20	06_14-A04	Riken	W01C108B08	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C108B09	pDONR221															
IKAKEN	H04D054G15	06_14-A05	Riken	W01C108B10	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C108B11	pDONR221															
IKAKEN	H04D055N18	06_14-A06	Riken	W01C108B12	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C108B13	pDONR221															
IKAKEN	H04D056G11	06_14-A07	Riken	W01C108B14	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C108B15	pDONR221															
IKAKEN	H04D056M24	06_14-A08	Riken	W01C108B16	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C108B17	pDONR221															
IKAKEN	H04D059D06	06_14-A09	Riken	W01C108B18	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C108B19	pDONR221															
IKAKEN	H04D060I19	06_14-A10	Riken	W01C108B20	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C108B21	pDONR221															
IKAKEN	H04D061C22	06_14-A11	Riken	W01C108B22	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C108B23	pDONR221															
IKAKEN	H04D062M01	06_14-A12	Riken	W01C108B24	pDONR221															
IKAKEN	H05D035C09	06_14-B01	Riken	W01C108C01	pDONR221															
IKAKEN	H05D035C09	06_14-B01	Riken	W01C108C02	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C108C03	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C108C04	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C108C05	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C108C06	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C108C07	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C108C08	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C108C09	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C108C10	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C108C11	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C108C12	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C108C13	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C108C14	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C108C15	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C108C16	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C108C17	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C108C18	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C108C19	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C108C20	pDONR221															
IKAKEN	H013002L21	06_14-B11	Riken	W01C108C21	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06_14-B11	Riken	W01C108C22	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023093H14	06_14-B12	Riken	W01C108C23	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H023093H14	06_14-B12	Riken	W01C108C24	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H05D035C09	06_14-B01	Riken	W01C108D01	pDONR221															
IKAKEN	H05D035C09	06_14-B01	Riken	W01C108D02	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C108D03	pDONR221															
IKAKEN	H05D045A17	06_14-B02	Riken	W01C108D04	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C108D05	pDONR221															
IKAKEN	H05D056F11	06_14-B03	Riken	W01C108D06	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C108D07	pDONR221															
IKAKEN	H06D081L09	06_14-B04	Riken	W01C108D08	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C108D09	pDONR221															
IKAKEN	H06D077B16	06_14-B05	Riken	W01C108D10	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C108D11	pDONR221															
IKAKEN	H06D082L14	06_14-B06	Riken	W01C108D12	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C108D13	pDONR221															
IKAKEN	H06D092M12	06_14-B07	Riken	W01C108D14	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C108D15	pDONR221															
IKAKEN	H06D093D10	06_14-B08	Riken	W01C108D16	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C108D17	pDONR221															
IKAKEN	H07D010D06	06_14-B09	Riken	W01C108D18	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C108D19	pDONR221															
IKAKEN	H07D013M03	06_14-B10	Riken	W01C108D20	pDONR221															
IKAKEN	H013002L21	06_14-B11	Riken	W01C108D21	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06_14-B11	Riken	W01C108D22	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023093H14	06_14-B12	Riken	W01C108D23	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H023093H14	06_14-B12	Riken	W01C108D24	pDONR221			LOC339674	339674		Hs.517656	Hypothetical LOC339674						XM_001726822.1	XP_001726874.1	MODEL	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H023099P08	06_14-C01	Riken	W01C108E01	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06_14-C01	Riken	W01C108E02	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H033085J19	06_14-C02	Riken	W01C108E03	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H033085J19	06_14-C02	Riken	W01C108E04	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H04D006G23	06_14-C03	Riken	W01C108E05	pDONR221															
IKAKEN	H04D006G23	06_14-C03	Riken	W01C108E06	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C108E07	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C108E08	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C108E09	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C108E10	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C108E11	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C108E12	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C108E13	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C108E14	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C108E15	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C108E16	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C108E17	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C108E18	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C108E19	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C108E20	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C108E21	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C108E22	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C108E23	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C108E24	pDONR221															
IKAKEN	H023099P08	06_14-C01	Riken	W01C108F01	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06_14-C01	Riken	W01C108F02	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H033085J19	06_14-C02	Riken	W01C108F03	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H033085J19	06_14-C02	Riken	W01C108F04	pDONR221			CRLF1	9244		Hs.114948	Cytokine receptor-like factor 1						NM_004750.3	NP_004741.1	VALIDATED	OK	1.000	1.000	422	1269	1	1266	422	1	422
IKAKEN	H04D006G23	06_14-C03	Riken	W01C108F05	pDONR221															
IKAKEN	H04D006G23	06_14-C03	Riken	W01C108F06	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C108F07	pDONR221															
IKAKEN	H04D015B10	06_14-C04	Riken	W01C108F08	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C108F09	pDONR221															
IKAKEN	H04D015D18	06_14-C05	Riken	W01C108F10	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C108F11	pDONR221															
IKAKEN	H04D017C10	06_14-C06	Riken	W01C108F12	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C108F13	pDONR221															
IKAKEN	H04D039G19	06_14-C07	Riken	W01C108F14	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C108F15	pDONR221															
IKAKEN	H04D049J01	06_14-C08	Riken	W01C108F16	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C108F17	pDONR221															
IKAKEN	H04D056D23	06_14-C09	Riken	W01C108F18	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C108F19	pDONR221															
IKAKEN	H04D057J16	06_14-C10	Riken	W01C108F20	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C108F21	pDONR221															
IKAKEN	H05D092E09	06_14-C11	Riken	W01C108F22	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C108F23	pDONR221															
IKAKEN	H06D085A11	06_14-C12	Riken	W01C108F24	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C108G01	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C108G02	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C108G03	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C108G04	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C108G05	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C108G06	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C108G07	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C108G08	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C108G09	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C108G10	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C108G11	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C108G12	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C108G13	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C108G14	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C108G15	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C108G16	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C108G17	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C108G18	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C108G19	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C108G20	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C108G21	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C108G22	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C108G23	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C108G24	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C108H01	pDONR221															
IKAKEN	H04D056D23	06_14-D01	Riken	W01C108H02	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C108H03	pDONR221															
IKAKEN	H07D002I11	06_14-D02	Riken	W01C108H04	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C108H05	pDONR221															
IKAKEN	H013028F10	06_14-D03	Riken	W01C108H06	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C108H07	pDONR221															
IKAKEN	SK007A04	06_14-D04		W01C108H08	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C108H09	pDONR221															
IKAKEN	SK007C04	06_14-D05		W01C108H10	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C108H11	pDONR221															
IKAKEN	SK007E03	06_14-D06		W01C108H12	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C108H13	pDONR221															
IKAKEN	SK007A01	06_14-D07		W01C108H14	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C108H15	pDONR221															
IKAKEN	SK007A03	06_14-D08		W01C108H16	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C108H17	pDONR221															
IKAKEN	SK007A06	06_14-D09		W01C108H18	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C108H19	pDONR221															
IKAKEN	SK007B02	06_14-D10		W01C108H20	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C108H21	pDONR221															
IKAKEN	SK007B03	06_14-D11		W01C108H22	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C108H23	pDONR221															
IKAKEN	SK007B06	06_14-D12		W01C108H24	pDONR221															
IKAKEN	SK007C01	06_14-E01		W01C108I01	pDONR221															
IKAKEN	SK007C01	06_14-E01		W01C108I02	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C108I03	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C108I04	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C108I05	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C108I06	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C108I07	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C108I08	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C108I09	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C108I10	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C108I11	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C108I12	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C108I13	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C108I14	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C108I15	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C108I16	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C108I17	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C108I18	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C108I19	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C108I20	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C108I21	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C108I22	pDONR221															
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C108I23	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C108I24	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	SK007C01	06_14-E01		W01C108J01	pDONR221															
IKAKEN	SK007C01	06_14-E01		W01C108J02	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C108J03	pDONR221															
IKAKEN	SK007C02	06_14-E02		W01C108J04	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C108J05	pDONR221															
IKAKEN	SK007C03	06_14-E03		W01C108J06	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C108J07	pDONR221															
IKAKEN	SK007D01	06_14-E04		W01C108J08	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C108J09	pDONR221															
IKAKEN	SK007D02	06_14-E05		W01C108J10	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C108J11	pDONR221															
IKAKEN	SK007D03	06_14-E06		W01C108J12	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C108J13	pDONR221															
IKAKEN	SK007E02	06_14-E07		W01C108J14	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C108J15	pDONR221															
IKAKEN	SK007F01	06_14-E08		W01C108J16	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C108J17	pDONR221															
IKAKEN	SK007F02	06_14-E09		W01C108J18	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C108J19	pDONR221															
IKAKEN	SK007G01	06_14-E10		W01C108J20	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C108J21	pDONR221															
IKAKEN	SK007H02	06_14-E11		W01C108J22	pDONR221															
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C108J23	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	KGR06648	06_14-E12	EST(RND)	W01C108J24	pDONR221			C9orf102	375748		Hs.432364	Chromosome 9 open reading frame 102						NM_001034155.1	NP_001029327.1	VALIDATED	P	1.000	1.000	135	1749	1144	1548	146	1	135
IKAKEN	HSI12469	06_14-F01	EST	W01C108K01	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06_14-F01	EST	W01C108K02	pDONR221			LOC392217	392217											
IKAKEN	NRB03282	06_14-F02	EST	W01C108K03	pDONR221															
IKAKEN	NRB03282	06_14-F02	EST	W01C108K04	pDONR221															
IKAKEN	AK125949	06_14-F03		W01C108K05	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	AK125949	06_14-F03		W01C108K06	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C108K07	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C108K08	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	AK123860	06_14-F05	FLJ	W01C108K09	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	AK123860	06_14-F05	FLJ	W01C108K10	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	H013094N20	06_14-F06	Riken	W01C108K11	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	H013094N20	06_14-F06	Riken	W01C108K12	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	STM00905	06_14-F07	EST	W01C108K13	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	STM00905	06_14-F07	EST	W01C108K14	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C108K15	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C108K16	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C108K17	pDONR221															
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C108K18	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C108K19	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C108K20	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C108K21	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C108K22	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C108K23	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C108K24	pDONR221															
IKAKEN	HSI12469	06_14-F01	EST	W01C108L01	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06_14-F01	EST	W01C108L02	pDONR221			LOC392217	392217											
IKAKEN	NRB03282	06_14-F02	EST	W01C108L03	pDONR221															
IKAKEN	NRB03282	06_14-F02	EST	W01C108L04	pDONR221															
IKAKEN	AK125949	06_14-F03		W01C108L05	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	AK125949	06_14-F03		W01C108L06	pDONR221	41180		C9orf144B	259308	BAC86357.1								NM_001141917.1	NP_001135389.1	VALIDATED	P	1.000	1.000	556	1668	1	1668	1335	271	826
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C108L07	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	BX438043 (5' CS0DA003YG15)	06_14-F04		W01C108L08	pDONR221			STYXL1	51657		Hs.11615	Serine/threonine/tyrosine interacting-like 1						NM_016086.2	NP_057170.1	VALIDATED	Cfs	0.879	1.000	313	954	1	826	313	1	313
IKAKEN	AK123860	06_14-F05	FLJ	W01C108L09	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	AK123860	06_14-F05	FLJ	W01C108L10	pDONR221	16915		WDR82	80335	-	Hs.194110	WD repeat domain 82			tongue	NTONG2		NM_025222.3	NP_079498.2	VALIDATED		0.939	0.939	310	930	1	930	313	1	310
IKAKEN	H013094N20	06_14-F06	Riken	W01C108L11	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	H013094N20	06_14-F06	Riken	W01C108L12	pDONR221			USP28	57646		Hs.503891	Ubiquitin specific peptidase 28						NM_020886.2	NP_065937.1	VALIDATED	Pg	0.959	1.000	790	2277	1	2274	1077	288	1077
IKAKEN	STM00905	06_14-F07	EST	W01C108L13	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	STM00905	06_14-F07	EST	W01C108L14	pDONR221			FAM55B	120406		Hs.446760	Family with sequence similarity 55, member B						XM_001725989.1	XP_001726041.1	MODEL	P	1.000	1.000	309	1122	1	927	559	1	309
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C108L15	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ADR09456	06_14-F08	EST(RND)	W01C108L16	pDONR221			NEBL	10529		Hs.5025	Nebulette						NM_213569.2	NP_998734.1	VALIDATED	OK	1.000	1.000	270	813	1	810	270	1	270
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C108L17	pDONR221															
IKAKEN	ARi-S161_M01.ab1	06_14-F09		W01C108L18	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C108L19	pDONR221															
IKAKEN	H07D039P20	06_14-F10	Riken	W01C108L20	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C108L21	pDONR221															
IKAKEN	H05D098J10	06_14-F11	Riken	W01C108L22	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C108L23	pDONR221															
IKAKEN	H05D075I18	06_14-F12	Riken	W01C108L24	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C108M01	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C108M02	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C108M03	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C108M04	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C108M05	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C108M06	pDONR221															
IKAKEN	HRT08911	06_14-G04	EST	W01C108M07	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	HRT08911	06_14-G04	EST	W01C108M08	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	H013097F20	06_14-G05	Riken	W01C108M09	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	H013097F20	06_14-G05	Riken	W01C108M10	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C108M11	pDONR221															
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C108M12	pDONR221															
IKAKEN	H013099B11	06_14-G07	Riken	W01C108M13	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H013099B11	06_14-G07	Riken	W01C108M14	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H05D098C17	06_14-G08	Riken	W01C108M15	pDONR221															
IKAKEN	H05D098C17	06_14-G08	Riken	W01C108M16	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C108M17	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C108M18	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C108M19	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C108M20	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C108M21	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C108M22	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C108M23	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C108M24	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C108N01	pDONR221															
IKAKEN	H05D075I18	06_14-G01	Riken	W01C108N02	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C108N03	pDONR221															
IKAKEN	RBd-S013_P01.ab1	06_14-G02		W01C108N04	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C108N05	pDONR221															
IKAKEN	H04D086F08	06_14-G03	Riken	W01C108N06	pDONR221															
IKAKEN	HRT08911	06_14-G04	EST	W01C108N07	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	HRT08911	06_14-G04	EST	W01C108N08	pDONR221			PPP1R1C	151242		Hs.10941	Protein phosphatase 1, regulatory (inhibitor) subunit 1C						NM_001080545.1	NP_001074014.1	PROVISIONAL	Cg	0.940	1.000	116	351	1	348	109	1	109
IKAKEN	H013097F20	06_14-G05	Riken	W01C108N09	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	H013097F20	06_14-G05	Riken	W01C108N10	pDONR221			KIAA0895	23366		Hs.6224	KIAA0895						NM_001100425.1	NP_001093895.1	VALIDATED	OK	1.000	1.000	520	1563	1	1560	520	1	520
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C108N11	pDONR221															
IKAKEN	FCC159B08	06_14-G06	TOYOBO	W01C108N12	pDONR221															
IKAKEN	H013099B11	06_14-G07	Riken	W01C108N13	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H013099B11	06_14-G07	Riken	W01C108N14	pDONR221			KIAA1370	56204		Hs.152385	KIAA1370						NM_019600.2	NP_062546.2	VALIDATED	Cg	0.989	1.000	1088	3267	1	3264	1076	1	1076
IKAKEN	H05D098C17	06_14-G08	Riken	W01C108N15	pDONR221															
IKAKEN	H05D098C17	06_14-G08	Riken	W01C108N16	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C108N17	pDONR221															
IKAKEN	H04D013O19	06_14-G09	Riken	W01C108N18	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C108N19	pDONR221															
IKAKEN	H033021D10	06_14-G10	Riken	W01C108N20	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C108N21	pDONR221															
IKAKEN	RBd13C03.ab1	06_14-G11		W01C108N22	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C108N23	pDONR221															
IKAKEN	H05D001C14	06_14-G12	Riken	W01C108N24	pDONR221															
IKAKEN	H04D077C20	06_14-H01	Riken	W01C108O01	pDONR221															
IKAKEN	H04D077C20	06_14-H01	Riken	W01C108O02	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C108O03	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C108O04	pDONR221															
IKAKEN	BC003688	06_14-H03		W01C108O05	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC003688	06_14-H03		W01C108O06	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C108O07	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C108O08	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C108O09	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C108O10	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C108O11	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C108O12	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C108O13	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C108O14	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	H013045P06	06_14-H08	Riken	W01C108O15	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H013045P06	06_14-H08	Riken	W01C108O16	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H023062J08	06_14-H09	Riken	W01C108O17	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	H023062J08	06_14-H09	Riken	W01C108O18	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	AK056949	06_14-H10		W01C108O19	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK056949	06_14-H10		W01C108O20	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK127226	06_14-H11	FLJ	W01C108O21	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	AK127226	06_14-H11	FLJ	W01C108O22	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	BC014374	06_14-H12	MGC	W01C108O23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	06_14-H12	MGC	W01C108O24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	H04D077C20	06_14-H01	Riken	W01C108P01	pDONR221															
IKAKEN	H04D077C20	06_14-H01	Riken	W01C108P02	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C108P03	pDONR221															
IKAKEN	H04D027F06	06_14-H02	Riken	W01C108P04	pDONR221															
IKAKEN	BC003688	06_14-H03		W01C108P05	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BC003688	06_14-H03		W01C108P06	pDONR221	21783		PTCD1	26024	AAH03688.2	Hs.632313	Pentatricopeptide repeat domain 1						NM_015545.2	NP_056360.2	VALIDATED	OK	1.000	1.000	700	2103	1	2100	700	1	700
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C108P07	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX424075 (5' CS0DE003YA13)	06_14-H04		W01C108P08	pDONR221			CHMP1A	5119		Hs.589427	Chromatin modifying protein 1A						NM_002768.2	NP_002759.2	VALIDATED	C	1.000	1.000	196	958	216	803	196	1	196
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C108P09	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX363467 (5' CS0DL001YC16)	06_14-H05		W01C108P10	pDONR221			C16orf35	8131		Hs.19699	Chromosome 16 open reading frame 35						NM_001039476.1	NP_001034565.1	VALIDATED	Cfs	1.000	1.000	390	1709	538	1706	390	1	390
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C108P11	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX355232 (5' CS0DD003YC12)	06_14-H06		W01C108P12	pDONR221			BCL7A	605		Hs.530970	B-cell CLL/lymphoma 7A						NM_001024808.1	NP_001019979.1	REVIEWED	P	1.000	1.000	187	625	1	561	210	1	187
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C108P13	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	BX339281 (5' CS0DI070YO12)	06_14-H07		W01C108P14	pDONR221			MAN1C1	57134		Hs.197043	Mannosidase, alpha, class 1C, member 1						NM_020379.2	NP_065112.1	VALIDATED	Cfs	0.998	0.998	630	1892	1	1889	630	1	630
IKAKEN	H013045P06	06_14-H08	Riken	W01C108P15	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H013045P06	06_14-H08	Riken	W01C108P16	pDONR221			CD300LG	146894		Hs.657365	CD300 molecule-like family member g						NM_145273.2	NP_660316.1	PROVISIONAL		0.698	0.972	301	702	1	648	332	1	301
IKAKEN	H023062J08	06_14-H09	Riken	W01C108P17	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	H023062J08	06_14-H09	Riken	W01C108P18	pDONR221			BTBD3	22903		Hs.709366	BTB (POZ) domain containing 3						NM_014962.2	NP_055777.1	VALIDATED	OK	1.000	1.000	522	1569	1	1566	522	1	522
IKAKEN	AK056949	06_14-H10		W01C108P19	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK056949	06_14-H10		W01C108P20	pDONR221	2743		C10orf71	118461	BAB71321.1	Hs.709928	Chromosome 10 open reading frame 71						NM_001135196.1	NP_001128668.1	VALIDATED	P	1.000	1.000	423	1270	1	1269	1435	872	1294
IKAKEN	AK127226	06_14-H11	FLJ	W01C108P21	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	AK127226	06_14-H11	FLJ	W01C108P22	pDONR221	13404		CTNNA2	1496	BAG54457.1	Hs.167368	Catenin (cadherin-associated protein), alpha 2			hippocampus	BRHIP3		NM_004389.2	NP_004380.2	VALIDATED	P	1.000	1.000	553	1755	94	1752	905	353	905
IKAKEN	BC014374	06_14-H12	MGC	W01C108P23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC014374	06_14-H12	MGC	W01C108P24	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	BC015664	06_15-A01	MGC	W01C109A01	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC015664	06_15-A01	MGC	W01C109A02	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC016633	06_15-A02		W01C109A03	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC016633	06_15-A02		W01C109A04	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC030237	06_15-A03	MGC	W01C109A05	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC030237	06_15-A03	MGC	W01C109A06	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC037207	06_15-A04	MGC	W01C109A07	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	BC037207	06_15-A04	MGC	W01C109A08	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C109A09	pDONR221				442362											
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C109A10	pDONR221				442362											
IKAKEN	AK054997	06_15-A06	FLJ	W01C109A11	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	AK054997	06_15-A06	FLJ	W01C109A12	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	BC022079	06_15-A07	MGC	W01C109A13	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC022079	06_15-A07	MGC	W01C109A14	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC005341	06_15-A08	MGC	W01C109A15	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	BC005341	06_15-A08	MGC	W01C109A16	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	AK094486	06_15-A09	FLJ	W01C109A17	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	AK094486	06_15-A09	FLJ	W01C109A18	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	BC035914	06_15-A10	MGC	W01C109A19	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	BC035914	06_15-A10	MGC	W01C109A20	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	UBA13157	06_15-A11	EST	W01C109A21	pDONR221															
IKAKEN	UBA13157	06_15-A11	EST	W01C109A22	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C109A23	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C109A24	pDONR221															
IKAKEN	BC015664	06_15-A01	MGC	W01C109B01	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC015664	06_15-A01	MGC	W01C109B02	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC016633	06_15-A02		W01C109B03	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC016633	06_15-A02		W01C109B04	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC030237	06_15-A03	MGC	W01C109B05	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC030237	06_15-A03	MGC	W01C109B06	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC037207	06_15-A04	MGC	W01C109B07	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	BC037207	06_15-A04	MGC	W01C109B08	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C109B09	pDONR221				442362											
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C109B10	pDONR221				442362											
IKAKEN	AK054997	06_15-A06	FLJ	W01C109B11	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	AK054997	06_15-A06	FLJ	W01C109B12	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	BC022079	06_15-A07	MGC	W01C109B13	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC022079	06_15-A07	MGC	W01C109B14	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC005341	06_15-A08	MGC	W01C109B15	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	BC005341	06_15-A08	MGC	W01C109B16	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	AK094486	06_15-A09	FLJ	W01C109B17	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	AK094486	06_15-A09	FLJ	W01C109B18	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	BC035914	06_15-A10	MGC	W01C109B19	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	BC035914	06_15-A10	MGC	W01C109B20	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	UBA13157	06_15-A11	EST	W01C109B21	pDONR221															
IKAKEN	UBA13157	06_15-A11	EST	W01C109B22	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C109B23	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C109B24	pDONR221															
IKAKEN	H013076I23	06_15-B01	Riken	W01C109C01	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	H013076I23	06_15-B01	Riken	W01C109C02	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	DMC07192	06_15-B02	EST	W01C109C03	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	DMC07192	06_15-B02	EST	W01C109C04	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	H013087P15	06_15-B03	Riken	W01C109C05	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	H013087P15	06_15-B03	Riken	W01C109C06	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C109C07	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C109C08	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C109C09	pDONR221															
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C109C10	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C109C11	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C109C12	pDONR221															
IKAKEN	AK123204	06_15-B07	FLJ	W01C109C13	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK123204	06_15-B07	FLJ	W01C109C14	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK128236	06_15-B08	FLJ	W01C109C15	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128236	06_15-B08	FLJ	W01C109C16	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128550	06_15-B09		W01C109C17	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK128550	06_15-B09		W01C109C18	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK024974	06_15-B10	FLJ	W01C109C19	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	AK024974	06_15-B10	FLJ	W01C109C20	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	BC029611	06_15-B11		W01C109C21	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC029611	06_15-B11		W01C109C22	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC015179	06_15-B12	MGC	W01C109C23	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	BC015179	06_15-B12	MGC	W01C109C24	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	H013076I23	06_15-B01	Riken	W01C109D01	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	H013076I23	06_15-B01	Riken	W01C109D02	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	DMC07192	06_15-B02	EST	W01C109D03	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	DMC07192	06_15-B02	EST	W01C109D04	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	H013087P15	06_15-B03	Riken	W01C109D05	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	H013087P15	06_15-B03	Riken	W01C109D06	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C109D07	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C109D08	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C109D09	pDONR221															
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C109D10	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C109D11	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C109D12	pDONR221															
IKAKEN	AK123204	06_15-B07	FLJ	W01C109D13	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK123204	06_15-B07	FLJ	W01C109D14	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK128236	06_15-B08	FLJ	W01C109D15	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128236	06_15-B08	FLJ	W01C109D16	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128550	06_15-B09		W01C109D17	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK128550	06_15-B09		W01C109D18	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK024974	06_15-B10	FLJ	W01C109D19	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	AK024974	06_15-B10	FLJ	W01C109D20	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	BC029611	06_15-B11		W01C109D21	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC029611	06_15-B11		W01C109D22	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC015179	06_15-B12	MGC	W01C109D23	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	BC015179	06_15-B12	MGC	W01C109D24	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	AK125546	06_15-C01		W01C109E01	pDONR221	12060			646545											
IKAKEN	AK125546	06_15-C01		W01C109E02	pDONR221	12060			646545											
IKAKEN	BC034694	06_15-C02	MGC	W01C109E03	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC034694	06_15-C02	MGC	W01C109E04	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC062637	06_15-C03	MGC	W01C109E05	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	BC062637	06_15-C03	MGC	W01C109E06	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	TST01228	06_15-C04	EST	W01C109E07	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	TST01228	06_15-C04	EST	W01C109E08	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	SYN03596	06_15-C05	EST	W01C109E09	pDONR221															
IKAKEN	SYN03596	06_15-C05	EST	W01C109E10	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C109E11	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C109E12	pDONR221															
IKAKEN	H023056K23	06_15-C07	Riken	W01C109E13	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H023056K23	06_15-C07	Riken	W01C109E14	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H04D022O17	06_15-C08	Riken	W01C109E15	pDONR221															
IKAKEN	H04D022O17	06_15-C08	Riken	W01C109E16	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C109E17	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C109E18	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C109E19	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C109E20	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C109E21	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C109E22	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C109E23	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C109E24	pDONR221															
IKAKEN	AK125546	06_15-C01		W01C109F01	pDONR221	12060			646545											
IKAKEN	AK125546	06_15-C01		W01C109F02	pDONR221	12060			646545											
IKAKEN	BC034694	06_15-C02	MGC	W01C109F03	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC034694	06_15-C02	MGC	W01C109F04	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC062637	06_15-C03	MGC	W01C109F05	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	BC062637	06_15-C03	MGC	W01C109F06	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	TST01228	06_15-C04	EST	W01C109F07	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	TST01228	06_15-C04	EST	W01C109F08	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	SYN03596	06_15-C05	EST	W01C109F09	pDONR221															
IKAKEN	SYN03596	06_15-C05	EST	W01C109F10	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C109F11	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C109F12	pDONR221															
IKAKEN	H023056K23	06_15-C07	Riken	W01C109F13	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H023056K23	06_15-C07	Riken	W01C109F14	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H04D022O17	06_15-C08	Riken	W01C109F15	pDONR221															
IKAKEN	H04D022O17	06_15-C08	Riken	W01C109F16	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C109F17	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C109F18	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C109F19	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C109F20	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C109F21	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C109F22	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C109F23	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C109F24	pDONR221															
IKAKEN	TST03309	06_15-D01	EST	W01C109G01	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	TST03309	06_15-D01	EST	W01C109G02	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	H06D087N24	06_15-D02	Riken	W01C109G03	pDONR221															
IKAKEN	H06D087N24	06_15-D02	Riken	W01C109G04	pDONR221															
IKAKEN	PCD03083	06_15-D03	EST	W01C109G05	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	PCD03083	06_15-D03	EST	W01C109G06	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	H013046G23	06_15-D04		W01C109G07	pDONR221															
IKAKEN	H013046G23	06_15-D04		W01C109G08	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C109G09	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C109G10	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C109G11	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C109G12	pDONR221															
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C109G13	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C109G14	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	PCD07444	06_15-D08		W01C109G15	pDONR221															
IKAKEN	PCD07444	06_15-D08		W01C109G16	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C109G17	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C109G18	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C109G19	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C109G20	pDONR221															
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C109G21	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C109G22	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	RBb27D12.ab1	06_15-D12		W01C109G23	pDONR221															
IKAKEN	RBb27D12.ab1	06_15-D12		W01C109G24	pDONR221															
IKAKEN	TST03309	06_15-D01	EST	W01C109H01	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	TST03309	06_15-D01	EST	W01C109H02	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	H06D087N24	06_15-D02	Riken	W01C109H03	pDONR221															
IKAKEN	H06D087N24	06_15-D02	Riken	W01C109H04	pDONR221															
IKAKEN	PCD03083	06_15-D03	EST	W01C109H05	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	PCD03083	06_15-D03	EST	W01C109H06	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	H013046G23	06_15-D04		W01C109H07	pDONR221															
IKAKEN	H013046G23	06_15-D04		W01C109H08	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C109H09	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C109H10	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C109H11	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C109H12	pDONR221															
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C109H13	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C109H14	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	PCD07444	06_15-D08		W01C109H15	pDONR221															
IKAKEN	PCD07444	06_15-D08		W01C109H16	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C109H17	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C109H18	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C109H19	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C109H20	pDONR221															
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C109H21	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C109H22	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	RBb27D12.ab1	06_15-D12		W01C109H23	pDONR221															
IKAKEN	RBb27D12.ab1	06_15-D12		W01C109H24	pDONR221															
IKAKEN	KAT09302	06_15-E01	EST	W01C109I01	pDONR221															
IKAKEN	KAT09302	06_15-E01	EST	W01C109I02	pDONR221															
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C109I03	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C109I04	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	PNC04756	06_15-E03	EST	W01C109I05	pDONR221															
IKAKEN	PNC04756	06_15-E03	EST	W01C109I06	pDONR221															
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C109I07	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C109I08	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C109I09	pDONR221															
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C109I10	pDONR221															
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C109I11	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C109I12	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C109I13	pDONR221															
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C109I14	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C109I15	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C109I16	pDONR221															
IKAKEN	H013074C13	06_15-E09	Riken	W01C109I17	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013074C13	06_15-E09	Riken	W01C109I18	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013040D23	06_15-E10	Riken	W01C109I19	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H013040D23	06_15-E10	Riken	W01C109I20	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H04D013M04	06_15-E11	Riken	W01C109I21	pDONR221															
IKAKEN	H04D013M04	06_15-E11	Riken	W01C109I22	pDONR221															
IKAKEN	H013091A12	06_15-E12	Riken	W01C109I23	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	H013091A12	06_15-E12	Riken	W01C109I24	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	KAT09302	06_15-E01	EST	W01C109J01	pDONR221															
IKAKEN	KAT09302	06_15-E01	EST	W01C109J02	pDONR221															
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C109J03	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C109J04	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	PNC04756	06_15-E03	EST	W01C109J05	pDONR221															
IKAKEN	PNC04756	06_15-E03	EST	W01C109J06	pDONR221															
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C109J07	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C109J08	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C109J09	pDONR221															
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C109J10	pDONR221															
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C109J11	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C109J12	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C109J13	pDONR221															
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C109J14	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C109J15	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C109J16	pDONR221															
IKAKEN	H013074C13	06_15-E09	Riken	W01C109J17	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013074C13	06_15-E09	Riken	W01C109J18	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013040D23	06_15-E10	Riken	W01C109J19	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H013040D23	06_15-E10	Riken	W01C109J20	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H04D013M04	06_15-E11	Riken	W01C109J21	pDONR221															
IKAKEN	H04D013M04	06_15-E11	Riken	W01C109J22	pDONR221															
IKAKEN	H013091A12	06_15-E12	Riken	W01C109J23	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	H013091A12	06_15-E12	Riken	W01C109J24	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	H033093L24	06_15-F01	Riken	W01C109K01	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	H033093L24	06_15-F01	Riken	W01C109K02	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C109K03	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C109K04	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C109K05	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C109K06	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C109K07	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C109K08	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C109K09	pDONR221															
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C109K10	pDONR221															
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C109K11	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C109K12	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C109K13	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C109K14	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C109K15	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C109K16	pDONR221															
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C109K17	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C109K18	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C109K19	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C109K20	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	H06D085N19	06_15-F11	Riken	W01C109K21	pDONR221															
IKAKEN	H06D085N19	06_15-F11	Riken	W01C109K22	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C109K23	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C109K24	pDONR221															
IKAKEN	H033093L24	06_15-F01	Riken	W01C109L01	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	H033093L24	06_15-F01	Riken	W01C109L02	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C109L03	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C109L04	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C109L05	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C109L06	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C109L07	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C109L08	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C109L09	pDONR221															
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C109L10	pDONR221															
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C109L11	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C109L12	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C109L13	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C109L14	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C109L15	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C109L16	pDONR221															
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C109L17	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C109L18	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C109L19	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C109L20	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	H06D085N19	06_15-F11	Riken	W01C109L21	pDONR221															
IKAKEN	H06D085N19	06_15-F11	Riken	W01C109L22	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C109L23	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C109L24	pDONR221															
IKAKEN	H04D056H16	06_15-G01	Riken	W01C109M01	pDONR221															
IKAKEN	H04D056H16	06_15-G01	Riken	W01C109M02	pDONR221															
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C109M03	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C109M04	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	H04D056H16	06_15-G01	Riken	W01C109N01	pDONR221															
IKAKEN	H04D056H16	06_15-G01	Riken	W01C109N02	pDONR221															
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C109N03	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C109N04	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	BC015664	06_15-A01	MGC	W01C110A01	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC015664	06_15-A01	MGC	W01C110A02	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC016633	06_15-A02		W01C110A03	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC016633	06_15-A02		W01C110A04	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC030237	06_15-A03	MGC	W01C110A05	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC030237	06_15-A03	MGC	W01C110A06	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC037207	06_15-A04	MGC	W01C110A07	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	BC037207	06_15-A04	MGC	W01C110A08	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C110A09	pDONR221				442362											
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C110A10	pDONR221				442362											
IKAKEN	AK054997	06_15-A06	FLJ	W01C110A11	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	AK054997	06_15-A06	FLJ	W01C110A12	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	BC022079	06_15-A07	MGC	W01C110A13	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC022079	06_15-A07	MGC	W01C110A14	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC005341	06_15-A08	MGC	W01C110A15	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	BC005341	06_15-A08	MGC	W01C110A16	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	AK094486	06_15-A09	FLJ	W01C110A17	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	AK094486	06_15-A09	FLJ	W01C110A18	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	BC035914	06_15-A10	MGC	W01C110A19	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	BC035914	06_15-A10	MGC	W01C110A20	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	UBA13157	06_15-A11	EST	W01C110A21	pDONR221															
IKAKEN	UBA13157	06_15-A11	EST	W01C110A22	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C110A23	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C110A24	pDONR221															
IKAKEN	BC015664	06_15-A01	MGC	W01C110B01	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC015664	06_15-A01	MGC	W01C110B02	pDONR221	4614		INTS4	92105	AAH15664.1	Hs.533723	Integrator complex subunit 4			Lymph, lymphoma	NIH_MGC_99	DH10B	NM_033547.3	NP_291025.3	VALIDATED	Ps	0.984	0.984	378	1296	160	1293	963	264	641
IKAKEN	BC016633	06_15-A02		W01C110B03	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC016633	06_15-A02		W01C110B04	pDONR221	22488		C8orf79	57604	AAH16633.2	Hs.202521	Chromosome 8 open reading frame 79						NM_001099677.1	NP_001093147.1	VALIDATED	C	1.000	1.000	328	1104	118	1101	328	1	328
IKAKEN	BC030237	06_15-A03	MGC	W01C110B05	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC030237	06_15-A03	MGC	W01C110B06	pDONR221	4544		SLC22A18AS	5003	AAH30237.1	Hs.300076	Solute carrier family 22 (organic cation transporter), member 18 antisense			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_007105.2	NP_009036.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	BC037207	06_15-A04	MGC	W01C110B07	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	BC037207	06_15-A04	MGC	W01C110B08	pDONR221	2593		FAM160B1	57700	AAH37207.1	Hs.192619	Family with sequence similarity 160, member B1			Pancreas, Spleen, adult pooled	NIH_MGC_120	DH10B	NM_020940.3	NP_065991.3	VALIDATED	OK	1.000	1.000	765	2298	1	2295	765	1	765
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C110B09	pDONR221				442362											
IKAKEN	ADR01876	06_15-A05	EST(RND)	W01C110B10	pDONR221				442362											
IKAKEN	AK054997	06_15-A06	FLJ	W01C110B11	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	AK054997	06_15-A06	FLJ	W01C110B12	pDONR221	23599		KGFLP1	387628	-	Hs.439341	Keratinocyte growth factor-like protein 1			cerebellum	BRACE2				
IKAKEN	BC022079	06_15-A07	MGC	W01C110B13	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC022079	06_15-A07	MGC	W01C110B14	pDONR221	18118		NHEDC1	150159	AAH22079	Hs.666728	Na+/H+ exchanger domain containing 1			Lymph, lymphoma	NIH_MGC_85	DH10B	NM_001100874.1	NP_001094344.1	REVIEWED		0.939	0.939	165	851	147	641	475	276	440
IKAKEN	BC005341	06_15-A08	MGC	W01C110B15	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	BC005341	06_15-A08	MGC	W01C110B16	pDONR221	13211		LIMS1	3987	AAH05341.1	Hs.613268	LIM and senescent cell antigen-like domains 1			Liver	NIH_MGC_76	DH10B	NM_004987.3	NP_004978.2	REVIEWED		0.953	0.953	232	696	1	696	325	86	317
IKAKEN	AK094486	06_15-A09	FLJ	W01C110B17	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	AK094486	06_15-A09	FLJ	W01C110B18	pDONR221	16757		C3orf63	23272	-	Hs.116877	Chromosome 3 open reading frame 63			cerebellum	BRACE2		NM_001112736.1	NP_001106207.1	VALIDATED		0.948	0.948	115	536	1	345	1512	1	115
IKAKEN	BC035914	06_15-A10	MGC	W01C110B19	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	BC035914	06_15-A10	MGC	W01C110B20	pDONR221	7346		CCDC88C	440193	AAH35914.1	Hs.525536	Coiled-coil domain containing 88C			Bladder, transitional cell papilloma	NIH_MGC_93	DH10B	NM_001080414.2	NP_001073883.2	VALIDATED	P	1.000	1.000	181	591	49	591	2028	1567	1747
IKAKEN	UBA13157	06_15-A11	EST	W01C110B21	pDONR221															
IKAKEN	UBA13157	06_15-A11	EST	W01C110B22	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C110B23	pDONR221															
IKAKEN	STM02553	06_15-A12	EST	W01C110B24	pDONR221															
IKAKEN	H013076I23	06_15-B01	Riken	W01C110C01	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	H013076I23	06_15-B01	Riken	W01C110C02	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	DMC07192	06_15-B02	EST	W01C110C03	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	DMC07192	06_15-B02	EST	W01C110C04	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	H013087P15	06_15-B03	Riken	W01C110C05	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	H013087P15	06_15-B03	Riken	W01C110C06	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C110C07	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C110C08	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C110C09	pDONR221															
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C110C10	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C110C11	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C110C12	pDONR221															
IKAKEN	AK123204	06_15-B07	FLJ	W01C110C13	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK123204	06_15-B07	FLJ	W01C110C14	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK128236	06_15-B08	FLJ	W01C110C15	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128236	06_15-B08	FLJ	W01C110C16	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128550	06_15-B09		W01C110C17	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK128550	06_15-B09		W01C110C18	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK024974	06_15-B10	FLJ	W01C110C19	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	AK024974	06_15-B10	FLJ	W01C110C20	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	BC029611	06_15-B11		W01C110C21	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC029611	06_15-B11		W01C110C22	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC015179	06_15-B12	MGC	W01C110C23	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	BC015179	06_15-B12	MGC	W01C110C24	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	H013076I23	06_15-B01	Riken	W01C110D01	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	H013076I23	06_15-B01	Riken	W01C110D02	pDONR221			RBM38	55544		Hs.236361	RNA binding motif protein 38						NM_183425.1	NP_906270.1	VALIDATED	P	1.000	1.000	98	372	1	294	121	24	121
IKAKEN	DMC07192	06_15-B02	EST	W01C110D03	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	DMC07192	06_15-B02	EST	W01C110D04	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED		0.429	0.444	28	387	261	178	311	17	43
IKAKEN	H013087P15	06_15-B03	Riken	W01C110D05	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	H013087P15	06_15-B03	Riken	W01C110D06	pDONR221			RGPD5	84220		Hs.469630	RANBP2-like and GRIP domain containing 5						NM_005054.2	NP_005045.2	REVIEWED		0.901	0.905	212	663	1	633	1765	1	212
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C110D07	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	F-TESTI4031350	06_15-B04	EST(F-)	W01C110D08	pDONR221			DUSP21	63904		Hs.534478	Dual specificity phosphatase 21						NM_022076.3	NP_071359.3	REVIEWED	OK	1.000	1.000	190	573	1	570	190	1	190
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C110D09	pDONR221															
IKAKEN	HISCO_S02026A-107_I14	06_15-B05	hisco_OVA	W01C110D10	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C110D11	pDONR221															
IKAKEN	HISCO_S01095-112_F02	06_15-B06	hisco_HUVEC	W01C110D12	pDONR221															
IKAKEN	AK123204	06_15-B07	FLJ	W01C110D13	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK123204	06_15-B07	FLJ	W01C110D14	pDONR221	14128		PLEKHM3	389072	BAC85557.1	Hs.709906	Pleckstrin homology domain containing, family M, member 3			cerebellum	BRACE2		XM_001725073.1	XP_001725125.1	MODEL		0.318	0.318	22	330	202	267	53	1	22
IKAKEN	AK128236	06_15-B08	FLJ	W01C110D15	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128236	06_15-B08	FLJ	W01C110D16	pDONR221	792		FAM159A	348378	BAC87346.1	Hs.424589	Family with sequence similarity 159, member A			testis	TESTI4		NM_001042693.1	NP_001036158.1	VALIDATED		0.968	0.968	63	219	1	189	190	1	63
IKAKEN	AK128550	06_15-B09		W01C110D17	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK128550	06_15-B09		W01C110D18	pDONR221	15326		C2CD2	25966	BAG54693.1	Hs.675058	C2 calcium-dependent domain containing 2						NM_199050.2	NP_950251.1	VALIDATED	OK	1.000	1.000	541	1626	1	1623	541	1	541
IKAKEN	AK024974	06_15-B10	FLJ	W01C110D19	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	AK024974	06_15-B10	FLJ	W01C110D20	pDONR221	33244		TCF12	6938		Hs.511504	Transcription factor 12			adipose tissue	ad		NM_207036.1	NP_996919.1	REVIEWED	Pfs	0.417	0.417	24	282	151	80	706	106	129
IKAKEN	BC029611	06_15-B11		W01C110D21	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC029611	06_15-B11		W01C110D22	pDONR221	13813		ALS2CR4	65062	AAH29611.1	Hs.12319	Amyotrophic lateral sclerosis 2 (juvenile) chromosome region, candidate 4						NM_152388.2	NP_689601.2	VALIDATED	Cs	0.998	0.998	400	1297	95	1294	400	1	400
IKAKEN	BC015179	06_15-B12	MGC	W01C110D23	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	BC015179	06_15-B12	MGC	W01C110D24	pDONR221	20384		SNX3	8724	AAH15179.1	Hs.12102	Sorting nexin 3			Brain, primitive neuroectodermal	NIH_MGC_56	DH10B	NM_003795.4	NP_003786.1	REVIEWED	P	1.000	1.000	86	342	1	258	162	1	86
IKAKEN	AK125546	06_15-C01		W01C110E01	pDONR221	12060			646545											
IKAKEN	AK125546	06_15-C01		W01C110E02	pDONR221	12060			646545											
IKAKEN	BC034694	06_15-C02	MGC	W01C110E03	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC034694	06_15-C02	MGC	W01C110E04	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC062637	06_15-C03	MGC	W01C110E05	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	BC062637	06_15-C03	MGC	W01C110E06	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	TST01228	06_15-C04	EST	W01C110E07	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	TST01228	06_15-C04	EST	W01C110E08	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	SYN03596	06_15-C05	EST	W01C110E09	pDONR221															
IKAKEN	SYN03596	06_15-C05	EST	W01C110E10	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C110E11	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C110E12	pDONR221															
IKAKEN	H023056K23	06_15-C07	Riken	W01C110E13	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H023056K23	06_15-C07	Riken	W01C110E14	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H04D022O17	06_15-C08	Riken	W01C110E15	pDONR221															
IKAKEN	H04D022O17	06_15-C08	Riken	W01C110E16	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C110E17	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C110E18	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C110E19	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C110E20	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C110E21	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C110E22	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C110E23	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C110E24	pDONR221															
IKAKEN	AK125546	06_15-C01		W01C110F01	pDONR221	12060			646545											
IKAKEN	AK125546	06_15-C01		W01C110F02	pDONR221	12060			646545											
IKAKEN	BC034694	06_15-C02	MGC	W01C110F03	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC034694	06_15-C02	MGC	W01C110F04	pDONR221	11807		SULT2B1	6820	AAH34694.1	Hs.369331	Sulfotransferase family, cytosolic, 2B, member 1			Testis	NIH_MGC_97	DH10B	NM_177973.1	NP_814444.1	REVIEWED	P	1.000	1.000	77	255	25	255	365	24	100
IKAKEN	BC062637	06_15-C03	MGC	W01C110F05	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	BC062637	06_15-C03	MGC	W01C110F06	pDONR221	1389		KIAA0907	22889	AAH62637.1	Hs.719258	KIAA0907			Lung, epidermoid carcinoma	NIH_MGC_101	DH10B	NM_014949.2	NP_055764.2	PREDICTED	P	1.000	1.000	85	255	1	255	614	1	85
IKAKEN	TST01228	06_15-C04	EST	W01C110F07	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	TST01228	06_15-C04	EST	W01C110F08	pDONR221			CDC10L	285961		Hs.406568	CDC10 cell division cycle 10 homolog (S. cerevisiae)-like								
IKAKEN	SYN03596	06_15-C05	EST	W01C110F09	pDONR221															
IKAKEN	SYN03596	06_15-C05	EST	W01C110F10	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C110F11	pDONR221															
IKAKEN	HKR10035	06_15-C06	EST(RND)	W01C110F12	pDONR221															
IKAKEN	H023056K23	06_15-C07	Riken	W01C110F13	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H023056K23	06_15-C07	Riken	W01C110F14	pDONR221			C20orf71	128861		Hs.360989	Chromosome 20 open reading frame 71						NM_178466.3	NP_848561.2	VALIDATED	P	1.000	1.000	207	633	1	621	254	1	207
IKAKEN	H04D022O17	06_15-C08	Riken	W01C110F15	pDONR221															
IKAKEN	H04D022O17	06_15-C08	Riken	W01C110F16	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C110F17	pDONR221															
IKAKEN	RBd-S081_G01.ab1	06_15-C09		W01C110F18	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C110F19	pDONR221															
IKAKEN	H07D015H01	06_15-C10	Riken	W01C110F20	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C110F21	pDONR221															
IKAKEN	H07D048I22	06_15-C11	Riken	W01C110F22	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C110F23	pDONR221															
IKAKEN	COR01523	06_15-C12	EST(RND)	W01C110F24	pDONR221															
IKAKEN	TST03309	06_15-D01	EST	W01C110G01	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	TST03309	06_15-D01	EST	W01C110G02	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	H06D087N24	06_15-D02	Riken	W01C110G03	pDONR221															
IKAKEN	H06D087N24	06_15-D02	Riken	W01C110G04	pDONR221															
IKAKEN	PCD03083	06_15-D03	EST	W01C110G05	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	PCD03083	06_15-D03	EST	W01C110G06	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	H013046G23	06_15-D04		W01C110G07	pDONR221															
IKAKEN	H013046G23	06_15-D04		W01C110G08	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C110G09	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C110G10	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C110G11	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C110G12	pDONR221															
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C110G13	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C110G14	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	PCD07444	06_15-D08		W01C110G15	pDONR221															
IKAKEN	PCD07444	06_15-D08		W01C110G16	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C110G17	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C110G18	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C110G19	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C110G20	pDONR221															
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C110G21	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C110G22	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	RBb27D12.ab1	06_15-D12		W01C110G23	pDONR221															
IKAKEN	RBb27D12.ab1	06_15-D12		W01C110G24	pDONR221															
IKAKEN	TST03309	06_15-D01	EST	W01C110H01	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	TST03309	06_15-D01	EST	W01C110H02	pDONR221			ANTXRL	195977		Hs.538515	Anthrax toxin receptor-like																		
IKAKEN	H06D087N24	06_15-D02	Riken	W01C110H03	pDONR221															
IKAKEN	H06D087N24	06_15-D02	Riken	W01C110H04	pDONR221															
IKAKEN	PCD03083	06_15-D03	EST	W01C110H05	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	PCD03083	06_15-D03	EST	W01C110H06	pDONR221			TSPAN11	441631		Hs.505141	Tetraspanin 11						NM_001080509.2	NP_001073978.1	VALIDATED	P	1.000	1.000	182	549	1	546	253	72	253
IKAKEN	H013046G23	06_15-D04		W01C110H07	pDONR221															
IKAKEN	H013046G23	06_15-D04		W01C110H08	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C110H09	pDONR221															
IKAKEN	H013046G23	06_15-D05		W01C110H10	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C110H11	pDONR221															
IKAKEN	H04D054N10	06_15-D06	Riken	W01C110H12	pDONR221															
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C110H13	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	BX375927 (5' CS0DC020YE19)	06_15-D07		W01C110H14	pDONR221			COCH	1690		Hs.21016	Coagulation factor C homolog, cochlin (Limulus polyphemus)						NM_004086.2	NP_004077.1	REVIEWED	OK	1.000	1.000	550	1653	1	1650	550	1	550
IKAKEN	PCD07444	06_15-D08		W01C110H15	pDONR221															
IKAKEN	PCD07444	06_15-D08		W01C110H16	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C110H17	pDONR221															
IKAKEN	H07D046O16	06_15-D09	Riken	W01C110H18	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C110H19	pDONR221															
IKAKEN	H05D019E04	06_15-D10	Riken	W01C110H20	pDONR221															
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C110H21	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	BX399881 (5' CS0DI085YA24)	06_15-D11		W01C110H22	pDONR221			IGSF5	150084		Hs.422120	Immunoglobulin superfamily, member 5						NM_001080444.1	NP_001073913.1	PROVISIONAL	P	1.000	1.000	338	1017	1	1014	407	70	407
IKAKEN	RBb27D12.ab1	06_15-D12		W01C110H23	pDONR221															
IKAKEN	RBb27D12.ab1	06_15-D12		W01C110H24	pDONR221															
IKAKEN	KAT09302	06_15-E01	EST	W01C110I01	pDONR221															
IKAKEN	KAT09302	06_15-E01	EST	W01C110I02	pDONR221															
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C110I03	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C110I04	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	PNC04756	06_15-E03	EST	W01C110I05	pDONR221															
IKAKEN	PNC04756	06_15-E03	EST	W01C110I06	pDONR221															
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C110I07	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C110I08	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C110I09	pDONR221															
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C110I10	pDONR221															
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C110I11	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C110I12	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C110I13	pDONR221															
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C110I14	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C110I15	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C110I16	pDONR221															
IKAKEN	H013074C13	06_15-E09	Riken	W01C110I17	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013074C13	06_15-E09	Riken	W01C110I18	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013040D23	06_15-E10	Riken	W01C110I19	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H013040D23	06_15-E10	Riken	W01C110I20	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H04D013M04	06_15-E11	Riken	W01C110I21	pDONR221															
IKAKEN	H04D013M04	06_15-E11	Riken	W01C110I22	pDONR221															
IKAKEN	H013091A12	06_15-E12	Riken	W01C110I23	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	H013091A12	06_15-E12	Riken	W01C110I24	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	KAT09302	06_15-E01	EST	W01C110J01	pDONR221															
IKAKEN	KAT09302	06_15-E01	EST	W01C110J02	pDONR221															
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C110J03	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	TIR00689	06_15-E02	EST(RND)	W01C110J04	pDONR221			EPGN	255324		Hs.401237	Epithelial mitogen homolog (mouse)						NM_001013442.1	NP_001013460.1	PROVISIONAL		0.915	0.977	141	465	1	423	133	1	132
IKAKEN	PNC04756	06_15-E03	EST	W01C110J05	pDONR221															
IKAKEN	PNC04756	06_15-E03	EST	W01C110J06	pDONR221															
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C110J07	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	AL560968 (5' CS0DL006YC03)	06_15-E04		W01C110J08	pDONR221			POLR2J4	84820		Hs.657028	Polymerase (RNA) II (DNA directed) polypeptide J4, pseudogene																		
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C110J09	pDONR221															
IKAKEN	ATa-S038.P07.ab1	06_15-E05		W01C110J10	pDONR221															
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C110J11	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	AL524858 (5' CS0DC008YF23)	06_15-E06		W01C110J12	pDONR221			VPS18	57617		Hs.23876	Vacuolar protein sorting 18 homolog (S. cerevisiae)						NM_020857.2	NP_065908.1	REVIEWED	OK	1.000	1.000	973	2922	1	2919	973	1	973
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C110J13	pDONR221															
IKAKEN	FCC148B05	06_15-E07	TOYOBO	W01C110J14	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C110J15	pDONR221															
IKAKEN	H07D001D22	06_15-E08	Riken	W01C110J16	pDONR221															
IKAKEN	H013074C13	06_15-E09	Riken	W01C110J17	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013074C13	06_15-E09	Riken	W01C110J18	pDONR221			MTX3	345778		Hs.531418	Metaxin 3						NM_001010891.3	NP_001010891.3	VALIDATED	P	1.000	1.000	251	756	1	753	312	62	312
IKAKEN	H013040D23	06_15-E10	Riken	W01C110J19	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H013040D23	06_15-E10	Riken	W01C110J20	pDONR221			PLB1	151056		Hs.444933	Phospholipase B1						NM_153021.3	NP_694566.3	VALIDATED	Pgs	0.977	0.985	782	2352	1	2346	1458	57	832
IKAKEN	H04D013M04	06_15-E11	Riken	W01C110J21	pDONR221															
IKAKEN	H04D013M04	06_15-E11	Riken	W01C110J22	pDONR221															
IKAKEN	H013091A12	06_15-E12	Riken	W01C110J23	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	H013091A12	06_15-E12	Riken	W01C110J24	pDONR221			SEC31B	25956		Hs.18889	SEC31 homolog B (S. cerevisiae)						NM_015490.3	NP_056305.1	REVIEWED	Ps	0.997	0.997	349	1050	1	1047	1179	1	349
IKAKEN	H033093L24	06_15-F01	Riken	W01C110K01	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	H033093L24	06_15-F01	Riken	W01C110K02	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C110K03	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C110K04	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C110K05	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C110K06	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C110K07	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C110K08	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C110K09	pDONR221															
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C110K10	pDONR221															
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C110K11	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C110K12	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C110K13	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C110K14	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C110K15	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C110K16	pDONR221															
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C110K17	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C110K18	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C110K19	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C110K20	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	H06D085N19	06_15-F11	Riken	W01C110K21	pDONR221															
IKAKEN	H06D085N19	06_15-F11	Riken	W01C110K22	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C110K23	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C110K24	pDONR221															
IKAKEN	H033093L24	06_15-F01	Riken	W01C110L01	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	H033093L24	06_15-F01	Riken	W01C110L02	pDONR221			AATK	9625		Hs.514575	Apoptosis-associated tyrosine kinase						XM_001714082.1	XP_001714134.1	MODEL	P	1.000	1.000	102	4047	424	729	243	1	102
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C110L03	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX464696 (5' CL0BB005ZE11)	06_15-F02		W01C110L04	pDONR221			GALNTL6	442117		Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6						NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	237	711	1	711	601	195	431
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C110L05	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX350109 (3' CS0DI040YK23)	06_15-F03		W01C110L06	pDONR221			RIMKLB	57494		Hs.504670	Ribosomal modification protein rimK-like family member B						NM_020734.2	NP_065785.2	VALIDATED		0.935	0.935	323	972	1	969	386	46	368
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C110L07	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX423903 (5' CS0DN003YB09)	06_15-F04		W01C110L08	pDONR221			OPALIN	93377		Hs.12449	Oligodendrocytic myelin paranodal and inner loop protein						NM_033207.3	NP_149984.1	VALIDATED	OK	1.000	1.000	141	426	1	423	141	1	141
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C110L09	pDONR221															
IKAKEN	BX376880 (5' CS0DD007YH01)	06_15-F05		W01C110L10	pDONR221															
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C110L11	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX428151 (5' CS0DN005YM12)	06_15-F06		W01C110L12	pDONR221			SUCLG2	8801		Hs.655250	Succinate-CoA ligase, GDP-forming, beta subunit						NM_003848.2	NP_003839.2	VALIDATED	Pg	0.572	1.000	313	540	1	537	432	120	432
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C110L13	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F07		W01C110L14	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C110L15	pDONR221															
IKAKEN	BX438661 (5' CS0DA012YP10)	06_15-F08		W01C110L16	pDONR221															
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C110L17	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	COR07360	06_15-F09	EST(RND)	W01C110L18	pDONR221			DKFZp686O24166	374383		Hs.146274	Hypothetical protein DKFZp686O24166						XM_001716694.1	XP_001716746.1	MODEL	P	1.000	1.000	454	1365	1	1362	626	173	626
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C110L19	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	AL529115 (5' CS0DD004YG04)	06_15-F10		W01C110L20	pDONR221			KIRREL2	84063		Hs.145729	Kin of IRRE like 2 (Drosophila)						NM_199179.2	NP_954648.2	VALIDATED	OK	1.000	1.000	583	1752	1	1749	583	1	583
IKAKEN	H06D085N19	06_15-F11	Riken	W01C110L21	pDONR221															
IKAKEN	H06D085N19	06_15-F11	Riken	W01C110L22	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C110L23	pDONR221															
IKAKEN	H04D056H16	06_15-F12	Riken	W01C110L24	pDONR221															
IKAKEN	H04D056H16	06_15-G01	Riken	W01C110M01	pDONR221															
IKAKEN	H04D056H16	06_15-G01	Riken	W01C110M02	pDONR221															
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C110M03	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C110M04	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	H04D056H16	06_15-G01	Riken	W01C110N01	pDONR221															
IKAKEN	H04D056H16	06_15-G01	Riken	W01C110N02	pDONR221															
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C110N03	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	SZR07864	06_15-G02	EST(RND)	W01C110N04	pDONR221			TRIM56	81844		Hs.521092	Tripartite motif-containing 56						NM_030961.1	NP_112223.1	PROVISIONAL	C	1.000	1.000	755	2268	1	2265	755	1	755
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C111A01	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C111A02	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C111A03	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C111A04	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C111A05	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C111A06	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C111A07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C111A08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C111A09	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C111A10	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C111A11	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C111A12	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C111A13	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C111A14	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C111A15	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C111A16	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C111A17	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C111A18	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C111A19	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C111A20	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C111A21	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C111A22	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06-2_04-A12	MGC	W01C111A23	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06-2_04-A12	MGC	W01C111A24	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C111B01	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C111B02	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C111B03	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C111B04	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C111B05	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C111B06	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C111B07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C111B08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C111B09	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C111B10	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C111B11	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C111B12	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C111B13	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C111B14	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C111B15	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C111B16	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C111B17	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C111B18	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C111B19	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C111B20	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C111B21	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C111B22	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06-2_04-A12	MGC	W01C111B23	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06-2_04-A12	MGC	W01C111B24	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC028606	06-2_04-B01	MGC	W01C111C01	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06-2_04-B01	MGC	W01C111C02	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC034223	06-2_04-B02	MGC	W01C111C03	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06-2_04-B02	MGC	W01C111C04	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC029585	06-2_04-B03	MGC	W01C111C05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06-2_04-B03	MGC	W01C111C06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06-2_04-B04	MGC	W01C111C07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06-2_04-B04	MGC	W01C111C08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC040904	06-2_04-B05	MGC	W01C111C09	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06-2_04-B05	MGC	W01C111C10	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC050069	06-2_04-B06	MGC	W01C111C11	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06-2_04-B06	MGC	W01C111C12	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC056606	06-2_04-B07	MGC	W01C111C13	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06-2_04-B07	MGC	W01C111C14	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC044576	06-2_04-B08	MGC	W01C111C15	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06-2_04-B08	MGC	W01C111C16	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC052982	06-2_04-B09	MGC	W01C111C17	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06-2_04-B09	MGC	W01C111C18	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06-2_04-B10	MGC	W01C111C19	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06-2_04-B10	MGC	W01C111C20	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC057847	06-2_04-B11	MGC	W01C111C21	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06-2_04-B11	MGC	W01C111C22	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06-2_04-B12	MGC	W01C111C23	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06-2_04-B12	MGC	W01C111C24	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC028606	06-2_04-B01	MGC	W01C111D01	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06-2_04-B01	MGC	W01C111D02	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC034223	06-2_04-B02	MGC	W01C111D03	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06-2_04-B02	MGC	W01C111D04	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC029585	06-2_04-B03	MGC	W01C111D05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06-2_04-B03	MGC	W01C111D06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06-2_04-B04	MGC	W01C111D07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06-2_04-B04	MGC	W01C111D08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC040904	06-2_04-B05	MGC	W01C111D09	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06-2_04-B05	MGC	W01C111D10	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC050069	06-2_04-B06	MGC	W01C111D11	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06-2_04-B06	MGC	W01C111D12	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC056606	06-2_04-B07	MGC	W01C111D13	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06-2_04-B07	MGC	W01C111D14	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC044576	06-2_04-B08	MGC	W01C111D15	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06-2_04-B08	MGC	W01C111D16	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC052982	06-2_04-B09	MGC	W01C111D17	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06-2_04-B09	MGC	W01C111D18	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06-2_04-B10	MGC	W01C111D19	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06-2_04-B10	MGC	W01C111D20	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC057847	06-2_04-B11	MGC	W01C111D21	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06-2_04-B11	MGC	W01C111D22	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06-2_04-B12	MGC	W01C111D23	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06-2_04-B12	MGC	W01C111D24	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC001801	06-2_04-C01	MGC	W01C111E01	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06-2_04-C01	MGC	W01C111E02	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06-2_04-C02	MGC	W01C111E03	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06-2_04-C02	MGC	W01C111E04	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06-2_04-C03	MGC	W01C111E05	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06-2_04-C03	MGC	W01C111E06	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06-2_04-C04	MGC	W01C111E07	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06-2_04-C04	MGC	W01C111E08	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06-2_04-C05	MGC	W01C111E09	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06-2_04-C05	MGC	W01C111E10	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06-2_04-C06	MGC	W01C111E11	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06-2_04-C06	MGC	W01C111E12	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06-2_04-C07	MGC	W01C111E13	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06-2_04-C07	MGC	W01C111E14	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06-2_04-C08	MGC	W01C111E15	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06-2_04-C08	MGC	W01C111E16	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06-2_04-C09	MGC	W01C111E17	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06-2_04-C09	MGC	W01C111E18	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06-2_04-C10	MGC	W01C111E19	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06-2_04-C10	MGC	W01C111E20	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06-2_04-C11	MGC	W01C111E21	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06-2_04-C11	MGC	W01C111E22	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06-2_04-C12	MGC	W01C111E23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-C12	MGC	W01C111E24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC001801	06-2_04-C01	MGC	W01C111F01	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06-2_04-C01	MGC	W01C111F02	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06-2_04-C02	MGC	W01C111F03	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06-2_04-C02	MGC	W01C111F04	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06-2_04-C03	MGC	W01C111F05	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06-2_04-C03	MGC	W01C111F06	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06-2_04-C04	MGC	W01C111F07	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06-2_04-C04	MGC	W01C111F08	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06-2_04-C05	MGC	W01C111F09	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06-2_04-C05	MGC	W01C111F10	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06-2_04-C06	MGC	W01C111F11	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06-2_04-C06	MGC	W01C111F12	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06-2_04-C07	MGC	W01C111F13	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06-2_04-C07	MGC	W01C111F14	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06-2_04-C08	MGC	W01C111F15	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06-2_04-C08	MGC	W01C111F16	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06-2_04-C09	MGC	W01C111F17	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06-2_04-C09	MGC	W01C111F18	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06-2_04-C10	MGC	W01C111F19	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06-2_04-C10	MGC	W01C111F20	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06-2_04-C11	MGC	W01C111F21	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06-2_04-C11	MGC	W01C111F22	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06-2_04-C12	MGC	W01C111F23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-C12	MGC	W01C111F24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC014475	06-2_04-D01	MGC	W01C111G01	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06-2_04-D01	MGC	W01C111G02	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06-2_04-D02	MGC	W01C111G03	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06-2_04-D02	MGC	W01C111G04	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06-2_04-D03	MGC	W01C111G05	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D03	MGC	W01C111G06	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D04	MGC	W01C111G07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06-2_04-D04	MGC	W01C111G08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06-2_04-D05	MGC	W01C111G09	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06-2_04-D05	MGC	W01C111G10	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC015508	06-2_04-D06	MGC	W01C111G11	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06-2_04-D06	MGC	W01C111G12	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06-2_04-D07	MGC	W01C111G13	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06-2_04-D07	MGC	W01C111G14	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06-2_04-D08	MGC	W01C111G15	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06-2_04-D08	MGC	W01C111G16	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06-2_04-D09	MGC	W01C111G17	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_04-D09	MGC	W01C111G18	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06-2_04-D10	MGC	W01C111G19	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06-2_04-D10	MGC	W01C111G20	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06-2_04-D11	MGC	W01C111G21	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06-2_04-D11	MGC	W01C111G22	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C111G23	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C111G24	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	BC014475	06-2_04-D01	MGC	W01C111H01	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06-2_04-D01	MGC	W01C111H02	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06-2_04-D02	MGC	W01C111H03	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06-2_04-D02	MGC	W01C111H04	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06-2_04-D03	MGC	W01C111H05	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D03	MGC	W01C111H06	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D04	MGC	W01C111H07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06-2_04-D04	MGC	W01C111H08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06-2_04-D05	MGC	W01C111H09	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06-2_04-D05	MGC	W01C111H10	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC015508	06-2_04-D06	MGC	W01C111H11	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06-2_04-D06	MGC	W01C111H12	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06-2_04-D07	MGC	W01C111H13	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06-2_04-D07	MGC	W01C111H14	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06-2_04-D08	MGC	W01C111H15	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06-2_04-D08	MGC	W01C111H16	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06-2_04-D09	MGC	W01C111H17	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_04-D09	MGC	W01C111H18	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06-2_04-D10	MGC	W01C111H19	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06-2_04-D10	MGC	W01C111H20	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06-2_04-D11	MGC	W01C111H21	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06-2_04-D11	MGC	W01C111H22	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C111H23	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C111H24	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C111I01	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C111I02	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C111I03	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C111I04	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C111I05	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C111I06	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C111I07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C111I08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C111I09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C111I10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C111I11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C111I12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C111I13	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C111I14	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C111I15	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C111I16	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC026171	06-2_04-E09	MGC	W01C111I17	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06-2_04-E09	MGC	W01C111I18	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06-2_04-E10	MGC	W01C111I19	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06-2_04-E10	MGC	W01C111I20	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC039313	06-2_04-E11	MGC	W01C111I21	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06-2_04-E11	MGC	W01C111I22	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC058007	06-2_04-E12	MGC	W01C111I23	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06-2_04-E12	MGC	W01C111I24	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C111J01	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C111J02	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C111J03	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C111J04	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C111J05	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C111J06	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C111J07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C111J08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C111J09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C111J10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C111J11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C111J12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C111J13	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C111J14	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C111J15	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C111J16	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC026171	06-2_04-E09	MGC	W01C111J17	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06-2_04-E09	MGC	W01C111J18	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06-2_04-E10	MGC	W01C111J19	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06-2_04-E10	MGC	W01C111J20	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC039313	06-2_04-E11	MGC	W01C111J21	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06-2_04-E11	MGC	W01C111J22	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC058007	06-2_04-E12	MGC	W01C111J23	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06-2_04-E12	MGC	W01C111J24	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC050577	06-2_04-F01	MGC	W01C111K01	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06-2_04-F01	MGC	W01C111K02	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06-2_04-F02	MGC	W01C111K03	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06-2_04-F02	MGC	W01C111K04	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06-2_04-F03	MGC	W01C111K05	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06-2_04-F03	MGC	W01C111K06	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC000698	06-2_04-F04	MGC	W01C111K07	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06-2_04-F04	MGC	W01C111K08	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06-2_04-F05	MGC	W01C111K09	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06-2_04-F05	MGC	W01C111K10	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC005014	06-2_04-F06	MGC	W01C111K11	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06-2_04-F06	MGC	W01C111K12	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC007561	06-2_04-F07	MGC	W01C111K13	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06-2_04-F07	MGC	W01C111K14	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06-2_04-F08	MGC	W01C111K15	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06-2_04-F08	MGC	W01C111K16	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06-2_04-F09	MGC	W01C111K17	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06-2_04-F09	MGC	W01C111K18	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06-2_04-F10	MGC	W01C111K19	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-F10	MGC	W01C111K20	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC051717	06-2_04-F11	MGC	W01C111K21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06-2_04-F11	MGC	W01C111K22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06-2_04-F12	MGC	W01C111K23	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06-2_04-F12	MGC	W01C111K24	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC050577	06-2_04-F01	MGC	W01C111L01	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06-2_04-F01	MGC	W01C111L02	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06-2_04-F02	MGC	W01C111L03	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06-2_04-F02	MGC	W01C111L04	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06-2_04-F03	MGC	W01C111L05	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06-2_04-F03	MGC	W01C111L06	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC000698	06-2_04-F04	MGC	W01C111L07	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06-2_04-F04	MGC	W01C111L08	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06-2_04-F05	MGC	W01C111L09	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06-2_04-F05	MGC	W01C111L10	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC005014	06-2_04-F06	MGC	W01C111L11	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06-2_04-F06	MGC	W01C111L12	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC007561	06-2_04-F07	MGC	W01C111L13	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06-2_04-F07	MGC	W01C111L14	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06-2_04-F08	MGC	W01C111L15	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06-2_04-F08	MGC	W01C111L16	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06-2_04-F09	MGC	W01C111L17	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06-2_04-F09	MGC	W01C111L18	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06-2_04-F10	MGC	W01C111L19	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-F10	MGC	W01C111L20	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC051717	06-2_04-F11	MGC	W01C111L21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06-2_04-F11	MGC	W01C111L22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06-2_04-F12	MGC	W01C111L23	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06-2_04-F12	MGC	W01C111L24	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062680	06-2_04-G01	MGC	W01C111M01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G01	MGC	W01C111M02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C111M03	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C111M04	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C111M05	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C111M06	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C111M07	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C111M08	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C111M09	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C111M10	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C111M11	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C111M12	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C111M13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C111M14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C111M15	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C111M16	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C111M17	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C111M18	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C111M19	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C111M20	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C111M21	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C111M22	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C111M23	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C111M24	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	BC062680	06-2_04-G01	MGC	W01C111N01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G01	MGC	W01C111N02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C111N03	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C111N04	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C111N05	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C111N06	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C111N07	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C111N08	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C111N09	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C111N10	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C111N11	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C111N12	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C111N13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C111N14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C111N15	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C111N16	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C111N17	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C111N18	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C111N19	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C111N20	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C111N21	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C111N22	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C111N23	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C111N24	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C111O01	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C111O02	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C111O03	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C111O04	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	BC061522	06-2_04-H03	MGC	W01C111O05	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06-2_04-H03	MGC	W01C111O06	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06-2_04-H04		W01C111O07	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06-2_04-H04		W01C111O08	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06-2_04-H05	MGC	W01C111O09	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H05	MGC	W01C111O10	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06-2_04-H06	MGC	W01C111O11	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06-2_04-H06	MGC	W01C111O12	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06-2_04-H07	MGC	W01C111O13	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06-2_04-H07	MGC	W01C111O14	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06-2_04-H08	MGC	W01C111O15	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H08	MGC	W01C111O16	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06-2_04-H09	MGC	W01C111O17	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06-2_04-H09	MGC	W01C111O18	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06-2_04-H10	MGC	W01C111O19	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06-2_04-H10	MGC	W01C111O20	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	AK127072	06-2_04-H11		W01C111O21	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06-2_04-H11		W01C111O22	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06-2_04-H12	MGC	W01C111O23	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06-2_04-H12	MGC	W01C111O24	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C111P01	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C111P02	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C111P03	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C111P04	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	BC061522	06-2_04-H03	MGC	W01C111P05	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06-2_04-H03	MGC	W01C111P06	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06-2_04-H04		W01C111P07	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06-2_04-H04		W01C111P08	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06-2_04-H05	MGC	W01C111P09	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H05	MGC	W01C111P10	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06-2_04-H06	MGC	W01C111P11	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06-2_04-H06	MGC	W01C111P12	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06-2_04-H07	MGC	W01C111P13	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06-2_04-H07	MGC	W01C111P14	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06-2_04-H08	MGC	W01C111P15	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H08	MGC	W01C111P16	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06-2_04-H09	MGC	W01C111P17	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06-2_04-H09	MGC	W01C111P18	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06-2_04-H10	MGC	W01C111P19	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06-2_04-H10	MGC	W01C111P20	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	AK127072	06-2_04-H11		W01C111P21	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06-2_04-H11		W01C111P22	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06-2_04-H12	MGC	W01C111P23	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06-2_04-H12	MGC	W01C111P24	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C112A01	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C112A02	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C112A03	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C112A04	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C112A05	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C112A06	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C112A07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C112A08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C112A09	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C112A10	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C112A11	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C112A12	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C112A13	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C112A14	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C112A15	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C112A16	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C112A17	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C112A18	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C112A19	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C112A20	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C112A21	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C112A22	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06-2_04-A12	MGC	W01C112A23	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06-2_04-A12	MGC	W01C112A24	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C112B01	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK092963	06-2_04-A01	FLJ	W01C112B02	pDONR221	169		RPL5	6125	-	Hs.532359	Ribosomal protein L5			spleen	SPLEN2		NM_000969.3	NP_000960.2	REVIEWED		0.813	0.832	171	504	1	501	297	51	221
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C112B03	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK122918	06-2_04-A02	FLJ	W01C112B04	pDONR221	19723		UHRF1BP1	54887	-	Hs.700656	UHRF1 binding protein 1			testis	TESTI4		NM_017754.3	NP_060224.3	VALIDATED	Pg	0.730	1.000	623	1368	1	1365	1440	818	1440
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C112B05	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK123006	06-2_04-A03	FLJ	W01C112B06	pDONR221	2377		PPIAL4G	644591	-	Hs.534674	Peptidylprolyl isomerase A (cyclophilin A)-like 4G			brain	BRAWH3		XM_927706.2	XP_932799.1	MODEL	Pfs	0.837	0.844	123	420	4	368	164	42	164
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C112B07	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK124215	06-2_04-A04	FLJ	W01C112B08	pDONR221	22594		ESCO2	157570	BAG54021.1	Hs.99480	Establishment of cohesion 1 homolog 2 (S. cerevisiae)			thymus	THYMU2		NM_001017420.2	NP_001017420.1	REVIEWED	OK	1.000	1.000	601	1806	1	1803	601	1	601
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C112B09	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK126346	06-2_04-A05	FLJ	W01C112B10	pDONR221	18139		RASSF6	166824	BAC86530.1	Hs.590920	Ras association (RalGDS/AF-6) domain family member 6			trachea	TRACH3		NM_177532.3	NP_803876.1	VALIDATED		0.951	0.951	306	978	58	975	337	32	337
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C112B11	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK131463	06-2_04-A06	FLJ	W01C112B12	pDONR221	13745		PREPL	9581	BAD18608.1	Hs.719111	Prolyl endopeptidase-like			tongue, tumor tissue	CTONG3		NM_006036.3	NP_006027.2	VALIDATED	Ps	0.995	0.995	658	2080	104	2077	727	70	727
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C112B13	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK126887	06-2_04-A07	FLJ	W01C112B14	pDONR221	7718		WHAMM	123720	-	Hs.377360	WAS protein homolog associated with actin, golgi membranes and microtubules			amygdala	BRAMY3		NM_001080435.1	NP_001073904.1	PROVISIONAL	OK	1.000	1.000	809	2430	1	2427	809	1	809
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C112B15	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK128060	06-2_04-A08	FLJ	W01C112B16	pDONR221	20717		C6orf167	253714	BAC87254.1	Hs.444292	Chromosome 6 open reading frame 167			testis	TESTI4		NM_198468.2	NP_940870.2	PREDICTED	OK	1.000	1.000	1243	3732	1	3729	1243	1	1243
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C112B17	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK127064	06-2_04-A09	FLJ	W01C112B18	pDONR221	8870		FLJ45121	400556	BAC86809.2					brain	BRAWH3		NM_207451.1	NP_997334.1	NA
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C112B19	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128214	06-2_04-A10	FLJ	W01C112B20	pDONR221	4029		OTOG	340990	BAC87330.1	Hs.688380	Otogelin			testis	TESTI4		XM_291816.6	XP_291816.6	MODEL	Pfs	0.869	0.998	1704	4455	2	4449	2925	940	2643
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C112B21	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	AK128237	06-2_04-A11	FLJ	W01C112B22	pDONR221	11733		TJP3	27134	BAG54652.1	Hs.25527	Tight junction protein 3 (zona occludens 3)			testis	TESTI4		NM_014428.1	NP_055243.1	PROVISIONAL	OK	1.000	1.000	952	2859	1	2856	952	1	952
IKAKEN	BC003413	06-2_04-A12	MGC	W01C112B23	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC003413	06-2_04-A12	MGC	W01C112B24	pDONR221	17567		GAR1	54433	AAH03413.1	Hs.69851	GAR1 ribonucleoprotein homolog (yeast)			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_032993.2	NP_127460.1	REVIEWED	OK	1.000	1.000	217	654	1	651	217	1	217
IKAKEN	BC028606	06-2_04-B01	MGC	W01C112C01	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06-2_04-B01	MGC	W01C112C02	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC034223	06-2_04-B02	MGC	W01C112C03	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06-2_04-B02	MGC	W01C112C04	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC029585	06-2_04-B03	MGC	W01C112C05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06-2_04-B03	MGC	W01C112C06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06-2_04-B04	MGC	W01C112C07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06-2_04-B04	MGC	W01C112C08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC040904	06-2_04-B05	MGC	W01C112C09	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06-2_04-B05	MGC	W01C112C10	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC050069	06-2_04-B06	MGC	W01C112C11	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06-2_04-B06	MGC	W01C112C12	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC056606	06-2_04-B07	MGC	W01C112C13	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06-2_04-B07	MGC	W01C112C14	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC044576	06-2_04-B08	MGC	W01C112C15	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06-2_04-B08	MGC	W01C112C16	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC052982	06-2_04-B09	MGC	W01C112C17	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06-2_04-B09	MGC	W01C112C18	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06-2_04-B10	MGC	W01C112C19	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06-2_04-B10	MGC	W01C112C20	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC057847	06-2_04-B11	MGC	W01C112C21	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06-2_04-B11	MGC	W01C112C22	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06-2_04-B12	MGC	W01C112C23	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06-2_04-B12	MGC	W01C112C24	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC028606	06-2_04-B01	MGC	W01C112D01	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC028606	06-2_04-B01	MGC	W01C112D02	pDONR221	18652		FAM153B	202134	AAH28606.1	Hs.655683	Family with sequence similarity 153, member B			Testis	NIH_MGC_97	DH10B	NM_001079529.2	NP_001072997.2	VALIDATED		0.979	0.979	329	1017	1	987	387	1	329
IKAKEN	BC034223	06-2_04-B02	MGC	W01C112D03	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC034223	06-2_04-B02	MGC	W01C112D04	pDONR221	3385		C10orf92	54777	AAH34223.1	Hs.298038	Chromosome 10 open reading frame 92			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_017609.4	NP_060079.4	VALIDATED	P	1.000	1.000	876	2631	1	2628	2441	1566	2441
IKAKEN	BC029585	06-2_04-B03	MGC	W01C112D05	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC029585	06-2_04-B03	MGC	W01C112D06	pDONR221	12712		C19orf34	255193	AAH29585.2	Hs.374717	Chromosome 19 open reading frame 34			Testis	NIH_MGC_97	DH10B	NM_152771.2	NP_689984.2	PROVISIONAL	C	1.000	1.000	148	870	246	689	148	1	148
IKAKEN	BC046932	06-2_04-B04	MGC	W01C112D07	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC046932	06-2_04-B04	MGC	W01C112D08	pDONR221	22158		FAM3C	10447	AAH46932.1	Hs.434053	Family with sequence similarity 3, member C			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_001040020.1	NP_001035109.1	REVIEWED	Cg	0.978	1.000	232	699	1	696	227	1	227
IKAKEN	BC040904	06-2_04-B05	MGC	W01C112D09	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC040904	06-2_04-B05	MGC	W01C112D10	pDONR221	15097		GGTLC1	92086	AAH40904.1	Hs.355394	Gamma-glutamyltransferase light chain 1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_178311.2	NP_842563.1	REVIEWED	Cfs	0.884	0.926	225	648	1	645	225	1	225
IKAKEN	BC050069	06-2_04-B06	MGC	W01C112D11	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC050069	06-2_04-B06	MGC	W01C112D12	pDONR221	5406		DDX11	1663	AAH50069.1	Hs.443960	DEAD/H (Asp-Glu-Ala-Asp/His) box polypeptide 11 (CHL1-like helicase homolog, S. cerevisiae)			Brain, hypothalamus	NIH_MGC_96	DH10B	NM_030653.3	NP_085911.2	REVIEWED	P	1.000	1.000	536	1609	1	1608	906	323	858
IKAKEN	BC056606	06-2_04-B07	MGC	W01C112D13	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC056606	06-2_04-B07	MGC	W01C112D14	pDONR221	21462		SPDYE3	441272	AAH56606.1	Hs.709266	Speedy homolog E3 (Xenopus laevis)			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_001004351.3	NP_001004351.2	PROVISIONAL	Pfs	0.909	0.933	77	402	172	400	172	1	76
IKAKEN	BC044576	06-2_04-B08	MGC	W01C112D15	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC044576	06-2_04-B08	MGC	W01C112D16	pDONR221	24105		FAM108B1	51104	AAH44576.1	Hs.380389	Family with sequence similarity 108, member B1			Uterus, leiomyosarcoma	NIH_MGC_71	DH10B	NM_001025780.1	NP_001020951.1	VALIDATED	OK	1.000	1.000	288	867	1	864	288	1	288
IKAKEN	BC052982	06-2_04-B09	MGC	W01C112D17	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC052982	06-2_04-B09	MGC	W01C112D18	pDONR221	15846		ST13	6767	AAH52982.1	Hs.712713	Suppression of tumorigenicity 13 (colon carcinoma) (Hsp70 interacting protein)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_003932.3	NP_003923.2	REVIEWED		0.880	0.886	167	504	1	498	369	15	181
IKAKEN	BC053600	06-2_04-B10	MGC	W01C112D19	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC053600	06-2_04-B10	MGC	W01C112D20	pDONR221	2043		TMCO4	255104	AAH53600.1	Hs.656313	Transmembrane and coiled-coil domains 4			Blood, adult leukocytes	NIH_MGC_118	DH10B	NM_181719.4	NP_859070.3	VALIDATED	Cg	0.937	1.000	634	1785	1	1782	634	1	634
IKAKEN	BC057847	06-2_04-B11	MGC	W01C112D21	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC057847	06-2_04-B11	MGC	W01C112D22	pDONR221	24706		CXorf39	139231	AAH57847.1	Hs.592223	Chromosome X open reading frame 39			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_207318.2	NP_997201.1	VALIDATED	OK	1.000	1.000	388	1167	1	1164	388	1	388
IKAKEN	BC066644	06-2_04-B12	MGC	W01C112D23	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC066644	06-2_04-B12	MGC	W01C112D24	pDONR221	20397		KIAA1949	170954	AAH66644.1	Hs.696054	KIAA1949			PCR rescued clones	NIH_MGC_195	DH10B	NM_133471.3	NP_597728.1	VALIDATED	Cs	0.998	0.998	613	1842	1	1839	613	1	613
IKAKEN	BC001801	06-2_04-C01	MGC	W01C112E01	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06-2_04-C01	MGC	W01C112E02	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06-2_04-C02	MGC	W01C112E03	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06-2_04-C02	MGC	W01C112E04	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06-2_04-C03	MGC	W01C112E05	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06-2_04-C03	MGC	W01C112E06	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06-2_04-C04	MGC	W01C112E07	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06-2_04-C04	MGC	W01C112E08	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06-2_04-C05	MGC	W01C112E09	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06-2_04-C05	MGC	W01C112E10	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06-2_04-C06	MGC	W01C112E11	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06-2_04-C06	MGC	W01C112E12	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06-2_04-C07	MGC	W01C112E13	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06-2_04-C07	MGC	W01C112E14	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06-2_04-C08	MGC	W01C112E15	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06-2_04-C08	MGC	W01C112E16	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06-2_04-C09	MGC	W01C112E17	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06-2_04-C09	MGC	W01C112E18	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06-2_04-C10	MGC	W01C112E19	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06-2_04-C10	MGC	W01C112E20	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06-2_04-C11	MGC	W01C112E21	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06-2_04-C11	MGC	W01C112E22	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06-2_04-C12	MGC	W01C112E23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-C12	MGC	W01C112E24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC001801	06-2_04-C01	MGC	W01C112F01	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC001801	06-2_04-C01	MGC	W01C112F02	pDONR221	15964		LOC284912	284912	AAH01801.1	Hs.306978	Hypothetical gene supported by BC001801			Eye, retinoblastoma	NIH_MGC_16	DH10B-R													
IKAKEN	BC004994	06-2_04-C02	MGC	W01C112F03	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC004994	06-2_04-C02	MGC	W01C112F04	pDONR221	11066		MYL12B	103910	AAH04994.1	Hs.464472	Myosin, light chain 12B, regulatory			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_001144944.1	NP_001138416.1	VALIDATED		0.910	0.910	133	402	1	399	172	40	172
IKAKEN	BC001077	06-2_04-C03	MGC	W01C112F05	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC001077	06-2_04-C03	MGC	W01C112F06	pDONR221	6773		A2LD1	87769	AAH01077.2	Hs.350868	AIG2-like domain 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_033110.1	NP_149101.1	PROVISIONAL	OK	1.000	1.000	153	462	1	459	153	1	153
IKAKEN	BC003178	06-2_04-C04	MGC	W01C112F07	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC003178	06-2_04-C04	MGC	W01C112F08	pDONR221	1398		MUTYH	4595	AAH03178.1	Hs.271353	MutY homolog (E. coli)			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_012222.2	NP_036354.1	REVIEWED	OK	1.000	1.000	546	1641	1	1638	546	1	546
IKAKEN	BC000354	06-2_04-C05	MGC	W01C112F09	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC000354	06-2_04-C05	MGC	W01C112F10	pDONR221	4158		RPS28	6234	AAH00354.1	Hs.719103	Ribosomal protein S28			Eye, retinoblastoma	NIH_MGC_16	DH10B-R	NM_001031.4	NP_001022.1	REVIEWED	P	1.000	1.000	35	108	1	105	69	35	69
IKAKEN	BC006290	06-2_04-C06	MGC	W01C112F11	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC006290	06-2_04-C06	MGC	W01C112F12	pDONR221	11928		CGB5	93659	AAH06290.1	Hs.590955	Chorionic gonadotropin, beta polypeptide 5			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_033043.1	NP_149032.1	REVIEWED	P	1.000	1.000	161	507	22	504	165	5	165
IKAKEN	BC007057	06-2_04-C07	MGC	W01C112F13	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC007057	06-2_04-C07	MGC	W01C112F14	pDONR221	6653		CPB2	1361	AAH07057.1	Hs.512937	Carboxypeptidase B2 (plasma)			Lung, mucoepidermoid carcinoma	NIH_MGC_59	DH10B	NM_016413.3	NP_057497.3	REVIEWED	Cs	0.997	0.997	360	1083	1	1080	360	1	360
IKAKEN	BC025415	06-2_04-C08	MGC	W01C112F15	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC025415	06-2_04-C08	MGC	W01C112F16	pDONR221	7244		GCH1	2643	AAH25415.1	Hs.86724	GTP cyclohydrolase 1			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001024071.1	NP_001019242.1	REVIEWED	Ps	0.982	0.982	110	390	1	330	213	102	211
IKAKEN	BC006332	06-2_04-C09	MGC	W01C112F17	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC006332	06-2_04-C09	MGC	W01C112F18	pDONR221	19419		CLTB	1212	AAH06332.1	Hs.484241	Clathrin, light chain (Lcb)			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_007097.2	NP_009028.1	REVIEWED	OK	1.000	1.000	229	690	1	687	229	1	229
IKAKEN	BC021216	06-2_04-C10	MGC	W01C112F19	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC021216	06-2_04-C10	MGC	W01C112F20	pDONR221	19219		KCTD9	54793	AAH21216.2	Hs.72071	Potassium channel tetramerisation domain containing 9			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_017634.2	NP_060104.2	VALIDATED		0.898	0.943	275	789	1	786	389	115	389
IKAKEN	BC019348	06-2_04-C11	MGC	W01C112F21	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC019348	06-2_04-C11	MGC	W01C112F22	pDONR221	15662		RPL23AP82	284942	AAH19348	Hs.406135	Ribosomal protein L23a pseudogene 82			Lung, small cell carcinoma	NIH_MGC_7	DH10B-R	NM_203302.2	NP_976047.1	VALIDATED		0.545	0.545	11	117	25	57	121	7	17
IKAKEN	BC030137	06-2_04-C12	MGC	W01C112F23	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-C12	MGC	W01C112F24	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC014475	06-2_04-D01	MGC	W01C112G01	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06-2_04-D01	MGC	W01C112G02	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06-2_04-D02	MGC	W01C112G03	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06-2_04-D02	MGC	W01C112G04	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06-2_04-D03	MGC	W01C112G05	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D03	MGC	W01C112G06	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D04	MGC	W01C112G07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06-2_04-D04	MGC	W01C112G08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06-2_04-D05	MGC	W01C112G09	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06-2_04-D05	MGC	W01C112G10	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC015508	06-2_04-D06	MGC	W01C112G11	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06-2_04-D06	MGC	W01C112G12	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06-2_04-D07	MGC	W01C112G13	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06-2_04-D07	MGC	W01C112G14	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06-2_04-D08	MGC	W01C112G15	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06-2_04-D08	MGC	W01C112G16	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06-2_04-D09	MGC	W01C112G17	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_04-D09	MGC	W01C112G18	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06-2_04-D10	MGC	W01C112G19	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06-2_04-D10	MGC	W01C112G20	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06-2_04-D11	MGC	W01C112G21	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06-2_04-D11	MGC	W01C112G22	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C112G23	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C112G24	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	BC014475	06-2_04-D01	MGC	W01C112H01	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC014475	06-2_04-D01	MGC	W01C112H02	pDONR221	14656		BIRC7	79444	AAH14475.1	Hs.256126	Baculoviral IAP repeat-containing 7			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_022161.2	NP_071444.1	REVIEWED	OK	1.000	1.000	280	843	1	840	280	1	280
IKAKEN	BC034143	06-2_04-D02	MGC	W01C112H03	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC034143	06-2_04-D02	MGC	W01C112H04	pDONR221	12650		TNNT1	7138	AAH34143.1	Hs.631558	Troponin T type 1 (skeletal, slow)			Ovary, adenocarcinoma	NIH_MGC_66	DH10B	NM_003283.4	NP_003274.3	REVIEWED	C	1.000	1.000	278	837	1	834	278	1	278
IKAKEN	BC061631	06-2_04-D03	MGC	W01C112H05	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D03	MGC	W01C112H06	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.883	0.887	469	1416	7	1410	1686	1218	1685
IKAKEN	BC061631	06-2_04-D04	MGC	W01C112H07	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC061631	06-2_04-D04	MGC	W01C112H08	pDONR221	8192		ADAMTS7	11173	AAH61631.1	Hs.16441	ADAM metallopeptidase with thrombospondin type 1 motif, 7			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_014272.3	NP_055087.2	REVIEWED		0.896	0.896	96	345	7	294	1686	112	207
IKAKEN	BC056261	06-2_04-D05	MGC	W01C112H09	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC056261	06-2_04-D05	MGC	W01C112H10	pDONR221	4578		SPTY2D1	144108	AAH56261.1	Hs.719399	SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae)			Brain, hippocampus	NIH_MGC_95	DH10B	NM_194285.2	NP_919261.2	VALIDATED	Ps	0.991	0.991	326	1095	1	978	685	1	326
IKAKEN	BC015508	06-2_04-D06	MGC	W01C112H11	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC015508	06-2_04-D06	MGC	W01C112H12	pDONR221	15966		DDT	1652	AAH15508.1	Hs.656723	D-dopachrome tautomerase			Cervix, carcinoma	NIH_MGC_12	DH10B	NM_001355.3	NP_001346.1	REVIEWED	OK	1.000	1.000	118	357	1	354	118	1	118
IKAKEN	BC034769	06-2_04-D07	MGC	W01C112H13	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC034769	06-2_04-D07	MGC	W01C112H14	pDONR221	12197		IZUMO1	284359	AAH34769.1	Hs.714990	Izumo sperm-egg fusion 1			Skin, melanotic melanoma.	NIH_MGC_72	DH10B	NM_182575.2	NP_872381.2	VALIDATED	OK	1.000	1.000	350	1053	1	1050	350	1	350
IKAKEN	BC029594	06-2_04-D08	MGC	W01C112H15	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC029594	06-2_04-D08	MGC	W01C112H16	pDONR221	14805		ADIG	149685	-	Hs.368028	Adipogenin			Testis	NIH_MGC_97	DH10B	NM_001018082.1	NP_001018092.1	VALIDATED	P	1.000	1.000	34	357	3	104	80	47	80
IKAKEN	BC055285	06-2_04-D09	MGC	W01C112H17	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC055285	06-2_04-D09	MGC	W01C112H18	pDONR221	24005		AKNA	80709	AAH55285.1	Hs.494895	AT-hook transcription factor			Placenta, choriocarcinoma	NIH_MGC_10	DH10B	NM_030767.4	NP_110394.3	VALIDATED	OK	1.000	1.000	1439	4320	1	4317	1439	1	1439
IKAKEN	BC059782	06-2_04-D10	MGC	W01C112H19	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC059782	06-2_04-D10	MGC	W01C112H20	pDONR221	15982		LGALS2	3957	AAH59782.1	Hs.531776	Lectin, galactoside-binding, soluble, 2			Pooled, 40 cell lines	NIH_MGC_142	DH10B	NM_006498.2	NP_006489.1	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	BC062635	06-2_04-D11	MGC	W01C112H21	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	BC062635	06-2_04-D11	MGC	W01C112H22	pDONR221	20375		XPO5	57510	AAH62635.1	Hs.203206	Exportin 5			Colon, Kidney, Stomach, adult, whole pooled	NIH_MGC_116	DH10B	NM_020750.2	NP_065801.1	VALIDATED	Cg	0.999	1.000	1205	3618	1	3615	1204	1	1204
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C112H23	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK074963	06-2_04-D12	FLJ	W01C112H24	pDONR221	19173		C5orf15	56951	BAC11319.1	Hs.716457	Chromosome 5 open reading frame 15	NT2	teratocarcinoma		NT2RP3		NM_020199.2	NP_064584.1	VALIDATED		0.867	0.887	271	828	1	813	265	1	265
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C112I01	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C112I02	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C112I03	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C112I04	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C112I05	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C112I06	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C112I07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C112I08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C112I09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C112I10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C112I11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C112I12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C112I13	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C112I14	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C112I15	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C112I16	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC026171	06-2_04-E09	MGC	W01C112I17	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06-2_04-E09	MGC	W01C112I18	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06-2_04-E10	MGC	W01C112I19	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06-2_04-E10	MGC	W01C112I20	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC039313	06-2_04-E11	MGC	W01C112I21	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06-2_04-E11	MGC	W01C112I22	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC058007	06-2_04-E12	MGC	W01C112I23	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06-2_04-E12	MGC	W01C112I24	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C112J01	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK097777	06-2_04-E01	FLJ	W01C112J02	pDONR221	6924		LOC26080	26080	-	Hs.448583	Hypothetical LOC26080			testis	TESTI2														
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C112J03	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK124106	06-2_04-E02	FLJ	W01C112J04	pDONR221	27209		FAM18A	780776	-	Hs.371576	Family with sequence similarity 18, member A			esophageal, tumor tissue	TESOP2		NM_001079512.2	NP_001072980.1	PREDICTED	OK	1.000	1.000	213	642	1	639	213	1	213
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C112J05	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK126324	06-2_04-E03	FLJ	W01C112J06	pDONR221	10942		SMCHD1	23347	BAC86525.1	Hs.8118	Structural maintenance of chromosomes flexible hinge domain containing 1			trachea	TRACH3		NM_015295.2	NP_056110.2	VALIDATED	P	1.000	1.000	844	2535	1	2532	2005	1155	1998
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C112J07	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127247	06-2_04-E04	FLJ	W01C112J08	pDONR221	23954		KIAA0368	23392	BAG54464.1	Hs.368255	KIAA0368			hippocampus	BRHIP3		NM_001080398.1	NP_001073867.1	PROVISIONAL	Pg	0.999	1.000	1450	4353	1	4350	2017	569	2017
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C112J09	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK127470	06-2_04-E05	FLJ	W01C112J10	pDONR221	2042		C1orf173	127254	BAC86994.1	Hs.531182	Chromosome 1 open reading frame 173			thalamus	BRTHA3		NM_001002912.3	NP_001002912.3	PREDICTED	Pgs	0.992	0.999	977	2958	1	2931	1530	207	1176
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C112J11	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK126665	06-2_04-E06	FLJ	W01C112J12	pDONR221	10251		SNIP	80725	BAC86634.1	Hs.448872	SNAP25-interacting protein			cerebellum	BRACE3		NM_025248.2	NP_079524.2	VALIDATED	Ps	0.992	0.992	1013	3168	127	3165	1183	171	1183
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C112J13	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127013	06-2_04-E07	FLJ	W01C112J14	pDONR221	23673		SNX30	401548	-	Hs.522350	Sorting nexin family member 30			brain	BRAWH3		NM_001012994.1	NP_001013012.1	VALIDATED	Pg	0.979	1.000	340	1023	1	1020	437	105	437
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C112J15	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	AK127387	06-2_04-E08	FLJ	W01C112J16	pDONR221	25651		CYorf15A	246126	BAC86953.1	Hs.522863	Chromosome Y open reading frame 15A			subthalamic nucleus	BRSTN2		NM_001005852.2	NP_001005852.2	VALIDATED	Cfs	0.985	1.000	131	543	1	389	131	1	131
IKAKEN	BC026171	06-2_04-E09	MGC	W01C112J17	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC026171	06-2_04-E09	MGC	W01C112J18	pDONR221	25411		FAM47A	158724	AAH26171.1	Hs.143268	Family with sequence similarity 47, member A			Brain, hippocampus	NIH_MGC_95	DH10B	NM_203408.2	NP_981953.2	PREDICTED	Cgs	0.819	0.998	791	1950	1	1947	791	1	791
IKAKEN	BC036669	06-2_04-E10	MGC	W01C112J19	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC036669	06-2_04-E10	MGC	W01C112J20	pDONR221	18105		COL25A1	84570	AAH36669.1	Hs.658842	Collagen, type XXV, alpha 1			Brain, hippocampus	NIH_MGC_95	DH10B	NM_198721.1	NP_942014.1	VALIDATED	Pfs	0.879	0.997	331	924	1	922	654	256	571
IKAKEN	BC039313	06-2_04-E11	MGC	W01C112J21	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC039313	06-2_04-E11	MGC	W01C112J22	pDONR221	36726		LOC284861	284861	-	Hs.645542	Hypothetical gene supported by BC039313			Brain, adult medulla	NIH_MGC_119	DH10B	XM_001715190.1	XP_001715242.1	MODEL	Pfs	0.784	0.791	305	915	1	906	547	1	305
IKAKEN	BC058007	06-2_04-E12	MGC	W01C112J23	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC058007	06-2_04-E12	MGC	W01C112J24	pDONR221	4702		MUC15	143662	AAH58007.1	Hs.407152	Mucin 15, cell surface associated			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_145650.3	NP_663625.2	VALIDATED	Cg	0.850	1.000	334	855	1	852	334	1	334
IKAKEN	BC050577	06-2_04-F01	MGC	W01C112K01	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06-2_04-F01	MGC	W01C112K02	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06-2_04-F02	MGC	W01C112K03	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06-2_04-F02	MGC	W01C112K04	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06-2_04-F03	MGC	W01C112K05	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06-2_04-F03	MGC	W01C112K06	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC000698	06-2_04-F04	MGC	W01C112K07	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06-2_04-F04	MGC	W01C112K08	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06-2_04-F05	MGC	W01C112K09	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06-2_04-F05	MGC	W01C112K10	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC005014	06-2_04-F06	MGC	W01C112K11	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06-2_04-F06	MGC	W01C112K12	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC007561	06-2_04-F07	MGC	W01C112K13	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06-2_04-F07	MGC	W01C112K14	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06-2_04-F08	MGC	W01C112K15	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06-2_04-F08	MGC	W01C112K16	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06-2_04-F09	MGC	W01C112K17	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06-2_04-F09	MGC	W01C112K18	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06-2_04-F10	MGC	W01C112K19	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-F10	MGC	W01C112K20	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC051717	06-2_04-F11	MGC	W01C112K21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06-2_04-F11	MGC	W01C112K22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06-2_04-F12	MGC	W01C112K23	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06-2_04-F12	MGC	W01C112K24	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC050577	06-2_04-F01	MGC	W01C112L01	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC050577	06-2_04-F01	MGC	W01C112L02	pDONR221	14902		KIF16B	55614	AAH50577	Hs.101774	Kinesin family member 16B			Duodenum, adenocarcinoma	NIH_MGC_88	DH10B	NM_024704.3	NP_078980.3	VALIDATED	OK	1.000	1.000	1317	3954	1	3951	1317	1	1317
IKAKEN	BC051337	06-2_04-F02	MGC	W01C112L03	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC051337	06-2_04-F02	MGC	W01C112L04	pDONR221	24862		IL9R	3581	AAH51337	Hs.406228	Interleukin 9 receptor			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R	NM_002186.2	NP_002177.2	REVIEWED	Pfs	0.793	0.863	285	846	1	813	521	22	297
IKAKEN	BC002480	06-2_04-F03	MGC	W01C112L05	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC002480	06-2_04-F03	MGC	W01C112L06	pDONR221	17597		SRD5A3	79644	AAH02480.1	Hs.39311	Steroid 5 alpha-reductase 3			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_024592.3	NP_078868.1	VALIDATED		0.811	0.827	318	939	1	936	318	1	318
IKAKEN	BC000698	06-2_04-F04	MGC	W01C112L07	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC000698	06-2_04-F04	MGC	W01C112L08	pDONR221	5524		KRT18	3875	AAH00698.1	Hs.406013	Keratin 18			Testis	NIH_MGC_97	DH10B	NM_199187.1	NP_954657.1	REVIEWED		0.817	0.829	208	618	1	615	430	48	255
IKAKEN	BC001862	06-2_04-F05	MGC	W01C112L09	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC001862	06-2_04-F05	MGC	W01C112L10	pDONR221	3875		TRIM48	79097	AAH01862.1	Hs.195715	Tripartite motif-containing 48			Colon, adenocarcinoma	NIH_MGC_15	DH10B-R	NM_024114.3	NP_077019.2	VALIDATED		0.636	0.864	280	1347	1	840	224	17	222
IKAKEN	BC005014	06-2_04-F06	MGC	W01C112L11	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC005014	06-2_04-F06	MGC	W01C112L12	pDONR221	4086		SPRYD5	84767	AAH05014.1	Hs.326734	SPRY domain containing 5			Kidney, renal cell adenocarcinoma	NIH_MGC_14	DH10B-R	NM_032681.3	NP_116070.2	VALIDATED		0.878	0.884	295	888	1	885	452	160	452
IKAKEN	BC007561	06-2_04-F07	MGC	W01C112L13	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC007561	06-2_04-F07	MGC	W01C112L14	pDONR221	5569		PA2G4	5036	AAH07561.1	Hs.715674	Proliferation-associated 2G4, 38kDa			mammary gland	MAMMA1		NM_006191.2	NP_006182.2	REVIEWED		0.827	0.897	358	993	1	990	394	1	358
IKAKEN	BC013357	06-2_04-F08	MGC	W01C112L15	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC013357	06-2_04-F08	MGC	W01C112L16	pDONR221	25178		RLIM	51132	AAH13357.1	Hs.653288	Ring finger protein, LIM domain interacting			Muscle, rhabdomyosarcoma	NIH_MGC_17	DH10B-R	NM_016120.3	NP_057204.2	REVIEWED	Cfs	0.870	0.936	624	1743	1	1740	624	1	624
IKAKEN	BC007394	06-2_04-F09	MGC	W01C112L17	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC007394	06-2_04-F09	MGC	W01C112L18	pDONR221	2793		LOC84856	84856	AAH07394	Hs.55977	Hypothetical LOC84856			Skin, melanotic melanoma.	NIH_MGC_20	DH10B-R													
IKAKEN	BC030137	06-2_04-F10	MGC	W01C112L19	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC030137	06-2_04-F10	MGC	W01C112L20	pDONR221	12586		EID2	163126	AAH30137.3	Hs.18949	EP300 interacting inhibitor of differentiation 2			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_153232.3	NP_694964.3	VALIDATED	P	1.000	1.000	174	525	1	522	236	63	236
IKAKEN	BC051717	06-2_04-F11	MGC	W01C112L21	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC051717	06-2_04-F11	MGC	W01C112L22	pDONR221	3163		AGAP8	728404	AAH51717	Hs.536192	ArfGAP with GTPase domain, ankyrin repeat and PH domain 8			Skin, melanoma, melanotic	NIH_MGC_112	DH10B-R	NM_001077686.1	NP_001071154.1	PROVISIONAL		0.928	0.958	608	1899	76	1896	663	74	663
IKAKEN	BC062319	06-2_04-F12	MGC	W01C112L23	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062319	06-2_04-F12	MGC	W01C112L24	pDONR221	9414		RAB43	339122	AAH62319.1	Hs.709807	RAB43, member RAS oncogene family			Pancreas, epithelioid carcinoma	NIH_MGC_42	DH10B-R	NM_198490.1	NP_940892.1	VALIDATED	P	1.000	1.000	180	546	4	543	212	33	212
IKAKEN	BC062680	06-2_04-G01	MGC	W01C112M01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G01	MGC	W01C112M02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C112M03	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C112M04	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C112M05	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C112M06	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C112M07	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C112M08	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C112M09	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C112M10	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C112M11	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C112M12	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C112M13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C112M14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C112M15	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C112M16	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C112M17	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C112M18	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C112M19	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C112M20	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C112M21	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C112M22	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C112M23	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C112M24	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	BC062680	06-2_04-G01	MGC	W01C112N01	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G01	MGC	W01C112N02	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED	Pfs	0.620	0.713	108	294	10	291	111	4	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C112N03	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	BC062680	06-2_04-G02	MGC	W01C112N04	pDONR221	25230		XAGE3	170626	AAH62680.1	Hs.43879	X antigen family, member 3			Glandular pool- thyroid, parathyroid,	NIH_MGC_184	DH10B	NM_133179.2	NP_573440.1	REVIEWED		0.775	0.887	111	294	1	291	111	1	111
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C112N05	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK055465	06-2_04-G03	FLJ	W01C112N06	pDONR221	6422		LMO7	4008	-	Hs.207631	LIM domain 7			brain	FEBRA2		NM_015842.2	NP_056667.2	REVIEWED	P	1.000	1.000	929	2787	1	2787	1385	218	1146
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C112N07	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK091816	06-2_04-G04	FLJ	W01C112N08	pDONR221	1964		SPAG17	200162	BAC03753.1	Hs.528821	Sperm associated antigen 17			lung	HLUNG2		NM_206996.2	NP_996879.1	VALIDATED	P	1.000	1.000	922	2766	1	2766	2223	1	922
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C112N09	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK093476	06-2_04-G05	FLJ	W01C112N10	pDONR221	16448		LOC375337	375337	BAC04180.1	Hs.132125	Hypothetical protein LOC375337			testis	TESTI2		NM_001145030.1	NP_001138502.1	VALIDATED	P	1.000	1.000	696	2088	1	2088	1692	1	696
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C112N11	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK097510	06-2_04-G06	FLJ	W01C112N12	pDONR221	19365		ANKRD31	256006	BAC05081.1	Hs.711809	Ankyrin repeat domain 31			testis	TESTI2		XM_001714469.1	XP_001714521.1	MODEL	P	1.000	1.000	724	2172	1	2172	1147	1	724
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C112N13	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK001581	06-2_04-G07	FLJ	W01C112N14	pDONR221	7713		FANCI	55215	BAA91770.1	Hs.513126	Fanconi anemia, complementation group I	NT2	teratocarcinoma		NT2RP2		NM_018193.2	NP_060663.2	REVIEWED	P	1.000	1.000	1085	3255	1	3255	1268	180	1264
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C112N15	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097903	06-2_04-G08	FLJ	W01C112N16	pDONR221	20681		TSEPA	387357	BAC05194.1	Hs.661756	Thymocyte selection pathway associated			thymus	THYMU2		NM_001010923.1	NP_001010923.1	VALIDATED	P	1.000	1.000	631	1896	1	1893	641	1	631
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C112N17	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097481	06-2_04-G09	FLJ	W01C112N18	pDONR221	9322		KCTD19	146212	BAC05072.1	Hs.299127	Potassium channel tetramerisation domain containing 19			testis	TESTI2		NM_001100915.1	NP_001094385.1	PROVISIONAL	P	1.000	1.000	608	1824	1	1824	926	1	608
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C112N19	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097495	06-2_04-G10	FLJ	W01C112N20	pDONR221	6784		hCG_2011852	643677	BAC05076.1	Hs.713374	Hypothetical protein LOC643677			testis	TESTI2		NM_001146197.1	NP_001139669.1	PREDICTED	P	1.000	1.000	728	2184	1	2184	7081	4630	5357
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C112N21	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK097730	06-2_04-G11	FLJ	W01C112N22	pDONR221	13376		RBM44	375316	BAC05154.1					testis	TESTI2		NM_001080504.2	NP_001073973.2	VALIDATED	Ps	0.998	0.998	641	1929	1	1923	1052	1	641
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C112N23	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK123607	06-2_04-G12	FLJ	W01C112N24	pDONR221	22662		DOCK5	80005	BAC85660.1	Hs.195403	Dedicator of cytokinesis 5			tongue, tumor tissue	CTONG3		NM_024940.6	NP_079216.4	VALIDATED	P	1.000	1.000	1228	3684	1	3684	1870	1	1228
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C112O01	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C112O02	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C112O03	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C112O04	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	BC061522	06-2_04-H03	MGC	W01C112O05	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06-2_04-H03	MGC	W01C112O06	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06-2_04-H04		W01C112O07	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06-2_04-H04		W01C112O08	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06-2_04-H05	MGC	W01C112O09	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H05	MGC	W01C112O10	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06-2_04-H06	MGC	W01C112O11	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06-2_04-H06	MGC	W01C112O12	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06-2_04-H07	MGC	W01C112O13	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06-2_04-H07	MGC	W01C112O14	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06-2_04-H08	MGC	W01C112O15	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H08	MGC	W01C112O16	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06-2_04-H09	MGC	W01C112O17	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06-2_04-H09	MGC	W01C112O18	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06-2_04-H10	MGC	W01C112O19	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06-2_04-H10	MGC	W01C112O20	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	AK127072	06-2_04-H11		W01C112O21	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06-2_04-H11		W01C112O22	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06-2_04-H12	MGC	W01C112O23	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06-2_04-H12	MGC	W01C112O24	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C112P01	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK126104	06-2_04-H01	FLJ	W01C112P02	pDONR221	13401		FLJ44048	401024	BAC86442.1	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	Pfs	0.214	0.226	154	2928	2868	2427	1605	642	794
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C112P03	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	AK128826	06-2_04-H02	FLJ	W01C112P04	pDONR221	12589		WDR87	83889	BAC87627.1	Hs.664194	WD repeat domain 87			testis	TESTI2		XM_371164.5	XP_371164.5	MODEL	P	1.000	1.000	1201	3603	1	3603	2873	150	1350
IKAKEN	BC061522	06-2_04-H03	MGC	W01C112P05	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC061522	06-2_04-H03	MGC	W01C112P06	pDONR221	8805		NPIPL3	23117	AAH61522.1	Hs.632865	Nuclear pore complex interacting protein-like 3			Placenta, pre-eclamptic	NIH_MGC_148	DH10B	NM_130464.1	NP_569731.1	VALIDATED	Pgs	0.898	0.998	451	1218	1	1218	678	217	667
IKAKEN	BC056865	06-2_04-H04		W01C112P07	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC056865	06-2_04-H04		W01C112P08	pDONR221	10666		MPP3	4356	AAH56865.1	Hs.396566	Membrane protein, palmitoylated 3 (MAGUK p55 subfamily member 3)						NM_001932.3	NP_001923.2	REVIEWED	Cfs	0.993	1.000	589	2027	1	1768	585	1	585
IKAKEN	BC062556	06-2_04-H05	MGC	W01C112P09	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H05	MGC	W01C112P10	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC007198	06-2_04-H06	MGC	W01C112P11	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC007198	06-2_04-H06	MGC	W01C112P12	pDONR221	3744		C11orf2	738	AAH07198.1	Hs.277517	Chromosome 11 open reading frame2			Bone marrow, acute myelogenous leukemia	NIH_MGC_55	DH10B	NM_013265.2	NP_037397.2	PROVISIONAL		0.847	0.855	118	351	1	351	782	1	118
IKAKEN	BC022045	06-2_04-H07	MGC	W01C112P13	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC022045	06-2_04-H07	MGC	W01C112P14	pDONR221	6807		MRPS31	10240	AAH22045.1	Hs.154655	Mitochondrial ribosomal protein S31			Testis	NIH_MGC_97	DH10B	NM_005830.3	NP_005821.2	REVIEWED		0.773	0.876	128	387	1	384	395	208	320
IKAKEN	BC062556	06-2_04-H08	MGC	W01C112P15	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC062556	06-2_04-H08	MGC	W01C112P16	pDONR221	9092		BCAR1	9564	AAH62556.1	Hs.479747	Breast cancer anti-estrogen resistance 1			Placenta, choriocarcinoma	NIH_MGC_21	DH10B-R	NM_014567.2	NP_055382.2	VALIDATED		0.976	0.976	212	639	1	636	870	1	212
IKAKEN	BC063653	06-2_04-H09	MGC	W01C112P17	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC063653	06-2_04-H09	MGC	W01C112P18	pDONR221	22184		LOC441239	441239	AAH63653.1	Hs.632019	Hypothetical gene supported by BC063653			Brain, anaplastic oligodendroglioma with	NCI_CGAP_Brn67	DH10B	XM_499305.3	XP_499305.3	MODEL	P	1.000	1.000	233	699	1	699	301	1	233
IKAKEN	BC044793	06-2_04-H10	MGC	W01C112P19	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	BC044793	06-2_04-H10	MGC	W01C112P20	pDONR221	17574		GALNTL6	442117	AAH44793	Hs.386236	UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase-like 6			Brain, adult medulla	NIH_MGC_119	DH10B	NM_001034845.2	NP_001030017.2	VALIDATED	P	1.000	1.000	51	159	1	153	601	134	184
IKAKEN	AK127072	06-2_04-H11		W01C112P21	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	AK127072	06-2_04-H11		W01C112P22	pDONR221	15940		C22orf40	150383	BAC86813	Hs.592209	Chromosome 22 open reading frame 40						NM_207327.4	NP_997210.3	VALIDATED		0.357	0.357	14	471	55	96	123	10	23
IKAKEN	BC057852	06-2_04-H12	MGC	W01C112P23	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC057852	06-2_04-H12	MGC	W01C112P24	pDONR221	8645		CMTM1	113540	AAH57852.2	Hs.710181	CKLF-like MARVEL transmembrane domain containing 1			Placenta, normal	NIH_MGC_147	DH10B	NM_052999.3	NP_443725.3	REVIEWED	P	1.000	1.000	123	375	1	369	286	108	230
IKAKEN	BC001865	06-2_05-A01	MGC	W01C113A01	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06-2_05-A01	MGC	W01C113A02	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C113A03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C113A04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C113A05	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C113A06	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C113A07	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C113A08	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06-2_05-A05	EST	W01C113A09	pDONR221				442065											
IKAKEN	HEP02866	06-2_05-A05	EST	W01C113A10	pDONR221				442065											
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C113A11	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C113A12	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C113A13	pDONR221															
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C113A14	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C113A15	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C113A16	pDONR221															
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C113A17	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C113A18	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	PCD03258	06-2_05-A10	EST	W01C113A19	pDONR221															
IKAKEN	PCD03258	06-2_05-A10	EST	W01C113A20	pDONR221															
IKAKEN	RCT07046	06-2_05-A11	EST	W01C113A21	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06-2_05-A11	EST	W01C113A22	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06-2_05-A12	EST	W01C113A23	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06-2_05-A12	EST	W01C113A24	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	BC001865	06-2_05-A01	MGC	W01C113B01	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06-2_05-A01	MGC	W01C113B02	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C113B03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C113B04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C113B05	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C113B06	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C113B07	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C113B08	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06-2_05-A05	EST	W01C113B09	pDONR221				442065											
IKAKEN	HEP02866	06-2_05-A05	EST	W01C113B10	pDONR221				442065											
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C113B11	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C113B12	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C113B13	pDONR221															
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C113B14	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C113B15	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C113B16	pDONR221															
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C113B17	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C113B18	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	PCD03258	06-2_05-A10	EST	W01C113B19	pDONR221															
IKAKEN	PCD03258	06-2_05-A10	EST	W01C113B20	pDONR221															
IKAKEN	RCT07046	06-2_05-A11	EST	W01C113B21	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06-2_05-A11	EST	W01C113B22	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06-2_05-A12	EST	W01C113B23	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06-2_05-A12	EST	W01C113B24	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	STM04673	06-2_05-B01	EST	W01C113C01	pDONR221															
IKAKEN	STM04673	06-2_05-B01	EST	W01C113C02	pDONR221															
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C113C03	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C113C04	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C113C05	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C113C06	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C113C07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C113C08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C113C09	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C113C10	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C113C11	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C113C12	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C113C13	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C113C14	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	TST06522	06-2_05-B08	EST	W01C113C15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06-2_05-B08	EST	W01C113C16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	IMAGE1636162	06-2_05-B09		W01C113C17	pDONR221															
IKAKEN	IMAGE1636162	06-2_05-B09		W01C113C18	pDONR221															
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C113C19	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C113C20	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C113C21	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C113C22	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C113C23	pDONR221															
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C113C24	pDONR221															
IKAKEN	STM04673	06-2_05-B01	EST	W01C113D01	pDONR221															
IKAKEN	STM04673	06-2_05-B01	EST	W01C113D02	pDONR221															
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C113D03	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C113D04	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C113D05	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C113D06	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C113D07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C113D08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C113D09	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C113D10	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C113D11	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C113D12	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C113D13	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C113D14	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	TST06522	06-2_05-B08	EST	W01C113D15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06-2_05-B08	EST	W01C113D16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	IMAGE1636162	06-2_05-B09		W01C113D17	pDONR221															
IKAKEN	IMAGE1636162	06-2_05-B09		W01C113D18	pDONR221															
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C113D19	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C113D20	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C113D21	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C113D22	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C113D23	pDONR221															
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C113D24	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C113E01	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C113E02	pDONR221															
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C113E03	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C113E04	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C113E05	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C113E06	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C113E07	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C113E08	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06-2_05-C05		W01C113E09	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06-2_05-C05		W01C113E10	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC047240	06-2_05-C06	MGC	W01C113E11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06-2_05-C06	MGC	W01C113E12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06-2_05-C07	MGC	W01C113E13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06-2_05-C07	MGC	W01C113E14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06-2_05-C08	MGC	W01C113E15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06-2_05-C08	MGC	W01C113E16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06-2_05-C09	MGC	W01C113E17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06-2_05-C09	MGC	W01C113E18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC067366	06-2_05-C10		W01C113E19	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06-2_05-C10		W01C113E20	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C113E21	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C113E22	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C113E23	pDONR221															
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C113E24	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C113F01	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C113F02	pDONR221															
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C113F03	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C113F04	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C113F05	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C113F06	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C113F07	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C113F08	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06-2_05-C05		W01C113F09	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06-2_05-C05		W01C113F10	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC047240	06-2_05-C06	MGC	W01C113F11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06-2_05-C06	MGC	W01C113F12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06-2_05-C07	MGC	W01C113F13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06-2_05-C07	MGC	W01C113F14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06-2_05-C08	MGC	W01C113F15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06-2_05-C08	MGC	W01C113F16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06-2_05-C09	MGC	W01C113F17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06-2_05-C09	MGC	W01C113F18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC067366	06-2_05-C10		W01C113F19	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06-2_05-C10		W01C113F20	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C113F21	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C113F22	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C113F23	pDONR221															
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C113F24	pDONR221															
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C113G01	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C113G02	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C113G03	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C113G04	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C113G05	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C113G06	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C113G07	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C113G08	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C113G09	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C113G10	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C113G11	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C113G12	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C113G13	pDONR221															
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C113G14	pDONR221															
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C113G15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C113G16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C113G17	pDONR221															
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C113G18	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C113G19	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C113G20	pDONR221															
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C113G21	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C113G22	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C113G23	pDONR221															
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C113G24	pDONR221															
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C113H01	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C113H02	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C113H03	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C113H04	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C113H05	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C113H06	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C113H07	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C113H08	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C113H09	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C113H10	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C113H11	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C113H12	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C113H13	pDONR221															
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C113H14	pDONR221															
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C113H15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C113H16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C113H17	pDONR221															
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C113H18	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C113H19	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C113H20	pDONR221															
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C113H21	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C113H22	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C113H23	pDONR221															
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C113H24	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C113I01	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C113I02	pDONR221															
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C113I03	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C113I04	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C113I05	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C113I06	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C113I07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C113I08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C113I09	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C113I10	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06-2_05-E06	EST	W01C113I11	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06-2_05-E06	EST	W01C113I12	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C113I13	pDONR221															
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C113I14	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C113I15	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C113I16	pDONR221															
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C113I17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C113I18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C113I19	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C113I20	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C113I21	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C113I22	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C113I23	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C113I24	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C113J01	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C113J02	pDONR221															
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C113J03	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C113J04	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C113J05	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C113J06	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C113J07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C113J08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C113J09	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C113J10	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06-2_05-E06	EST	W01C113J11	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06-2_05-E06	EST	W01C113J12	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C113J13	pDONR221															
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C113J14	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C113J15	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C113J16	pDONR221															
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C113J17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C113J18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C113J19	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C113J20	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C113J21	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C113J22	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C113J23	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C113J24	pDONR221															
IKAKEN	SYN08912	06-2_05-F01	EST	W01C113K01	pDONR221															
IKAKEN	SYN08912	06-2_05-F01	EST	W01C113K02	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C113K03	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C113K04	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C113K05	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C113K06	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C113K07	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C113K08	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C113K09	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C113K10	pDONR221															
IKAKEN	PCD09058	06-2_05-F06	EST	W01C113K11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06-2_05-F06	EST	W01C113K12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	KAT04487	06-2_05-F07	EST	W01C113K13	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F07	EST	W01C113K14	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06-2_05-F08	EST	W01C113K15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F08	EST	W01C113K16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C113K17	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C113K18	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	KAT04487	06-2_05-F10	EST	W01C113K19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F10	EST	W01C113K20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	DMC08550	06-2_05-F11	EST	W01C113K21	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06-2_05-F11	EST	W01C113K22	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06-2_05-F12	EST	W01C113K23	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06-2_05-F12	EST	W01C113K24	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	SYN08912	06-2_05-F01	EST	W01C113L01	pDONR221															
IKAKEN	SYN08912	06-2_05-F01	EST	W01C113L02	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C113L03	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C113L04	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C113L05	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C113L06	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C113L07	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C113L08	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C113L09	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C113L10	pDONR221															
IKAKEN	PCD09058	06-2_05-F06	EST	W01C113L11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06-2_05-F06	EST	W01C113L12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	KAT04487	06-2_05-F07	EST	W01C113L13	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F07	EST	W01C113L14	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06-2_05-F08	EST	W01C113L15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F08	EST	W01C113L16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C113L17	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C113L18	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	KAT04487	06-2_05-F10	EST	W01C113L19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F10	EST	W01C113L20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	DMC08550	06-2_05-F11	EST	W01C113L21	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06-2_05-F11	EST	W01C113L22	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06-2_05-F12	EST	W01C113L23	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06-2_05-F12	EST	W01C113L24	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	AK056717	06-2_05-G01		W01C113M01	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06-2_05-G01		W01C113M02	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK098343	06-2_05-G02		W01C113M03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06-2_05-G02		W01C113M04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	BC059947	06-2_05-G03	MGC	W01C113M05	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06-2_05-G03	MGC	W01C113M06	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C113M07	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C113M08	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC008794	06-2_05-G05	MGC	W01C113M09	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06-2_05-G05	MGC	W01C113M10	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C113M11	pDONR221															
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C113M12	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C113M13	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C113M14	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C113M15	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C113M16	pDONR221															
IKAKEN	SPL09685	06-2_05-G09	EST	W01C113M17	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06-2_05-G09	EST	W01C113M18	pDONR221			IGHA1	3493											
IKAKEN	DMC07943	06-2_05-G10	EST	W01C113M19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06-2_05-G10	EST	W01C113M20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C113M21	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C113M22	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C113M23	pDONR221															
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C113M24	pDONR221															
IKAKEN	AK056717	06-2_05-G01		W01C113N01	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06-2_05-G01		W01C113N02	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK098343	06-2_05-G02		W01C113N03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06-2_05-G02		W01C113N04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	BC059947	06-2_05-G03	MGC	W01C113N05	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06-2_05-G03	MGC	W01C113N06	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C113N07	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C113N08	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC008794	06-2_05-G05	MGC	W01C113N09	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06-2_05-G05	MGC	W01C113N10	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C113N11	pDONR221															
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C113N12	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C113N13	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C113N14	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C113N15	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C113N16	pDONR221															
IKAKEN	SPL09685	06-2_05-G09	EST	W01C113N17	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06-2_05-G09	EST	W01C113N18	pDONR221			IGHA1	3493											
IKAKEN	DMC07943	06-2_05-G10	EST	W01C113N19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06-2_05-G10	EST	W01C113N20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C113N21	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C113N22	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C113N23	pDONR221															
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C113N24	pDONR221															
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C113O01	pDONR221															
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C113O02	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C113O03	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C113O04	pDONR221															
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C113O05	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C113O06	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C113O07	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C113O08	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C113O09	pDONR221															
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C113O10	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C113O11	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C113O12	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C113O13	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C113O14	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C113O15	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C113O16	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C113O17	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C113O18	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C113O19	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C113O20	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C113O21	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C113O22	pDONR221															
IKAKEN	HSI12469	06-2_05-H12	EST	W01C113O23	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06-2_05-H12	EST	W01C113O24	pDONR221			LOC392217	392217											
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C113P01	pDONR221															
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C113P02	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C113P03	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C113P04	pDONR221															
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C113P05	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C113P06	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C113P07	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C113P08	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C113P09	pDONR221															
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C113P10	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C113P11	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C113P12	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C113P13	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C113P14	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C113P15	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C113P16	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C113P17	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C113P18	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C113P19	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C113P20	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C113P21	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C113P22	pDONR221															
IKAKEN	HSI12469	06-2_05-H12	EST	W01C113P23	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06-2_05-H12	EST	W01C113P24	pDONR221			LOC392217	392217											
IKAKEN	BC001865	06-2_05-A01	MGC	W01C114A01	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06-2_05-A01	MGC	W01C114A02	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C114A03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C114A04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C114A05	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C114A06	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C114A07	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C114A08	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06-2_05-A05	EST	W01C114A09	pDONR221				442065											
IKAKEN	HEP02866	06-2_05-A05	EST	W01C114A10	pDONR221				442065											
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C114A11	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C114A12	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C114A13	pDONR221															
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C114A14	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C114A15	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C114A16	pDONR221															
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C114A17	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C114A18	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	PCD03258	06-2_05-A10	EST	W01C114A19	pDONR221															
IKAKEN	PCD03258	06-2_05-A10	EST	W01C114A20	pDONR221															
IKAKEN	RCT07046	06-2_05-A11	EST	W01C114A21	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06-2_05-A11	EST	W01C114A22	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06-2_05-A12	EST	W01C114A23	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06-2_05-A12	EST	W01C114A24	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	BC001865	06-2_05-A01	MGC	W01C114B01	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BC001865	06-2_05-A01	MGC	W01C114B02	pDONR221										Eye, retinoblastoma	NIH_MGC_16	DH10B-R			
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C114B03	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	BX361594 (5' CS0DI087YN06)	06-2_05-A02		W01C114B04	pDONR221			INPP5D	3635		Hs.601911	Inositol polyphosphate-5-phosphatase, 145kDa						NM_005541.3	NP_005532.2	REVIEWED	P	1.000	1.000	221	699	1	663	1188	1	221
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C114B05	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	H013051I15	06-2_05-A03	Riken	W01C114B06	pDONR221			SFI1	9814		Hs.62209	Sfi1 homolog, spindle assembly associated (yeast)						NM_014775.2	NP_055590.2	VALIDATED	OK	1.000	1.000	1211	3684	49	3681	1211	1	1211
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C114B07	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	FMR04135	06-2_05-A04	EST(RND)	W01C114B08	pDONR221			HEATR2	54919		Hs.535896	HEAT repeat containing 2						NM_017802.3	NP_060272.3	VALIDATED	Ps	0.997	0.997	653	1962	1	1959	855	203	855
IKAKEN	HEP02866	06-2_05-A05	EST	W01C114B09	pDONR221				442065											
IKAKEN	HEP02866	06-2_05-A05	EST	W01C114B10	pDONR221				442065											
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C114B11	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	ADR02648	06-2_05-A06	EST(RND)	W01C114B12	pDONR221			DOCK4	9732		Hs.654652	Dedicator of cytokinesis 4						NM_014705.3	NP_055520.3	REVIEWED	Pfs	0.930	1.000	823	2298	2	2295	1966	1144	1966
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C114B13	pDONR221															
IKAKEN	FCC139A05	06-2_05-A07	TOYOBO	W01C114B14	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C114B15	pDONR221															
IKAKEN	FCC160G09	06-2_05-A08	TOYOBO	W01C114B16	pDONR221															
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C114B17	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	KGR01128	06-2_05-A09	EST(RND)	W01C114B18	pDONR221			FN1	2335		Hs.203717	Fibronectin 1						NM_054034.2	NP_473375.2	REVIEWED	OK	1.000	1.000	657	1974	1	1971	657	1	657
IKAKEN	PCD03258	06-2_05-A10	EST	W01C114B19	pDONR221															
IKAKEN	PCD03258	06-2_05-A10	EST	W01C114B20	pDONR221															
IKAKEN	RCT07046	06-2_05-A11	EST	W01C114B21	pDONR221			IGHA1	3493											
IKAKEN	RCT07046	06-2_05-A11	EST	W01C114B22	pDONR221			IGHA1	3493											
IKAKEN	SLV03122	06-2_05-A12	EST	W01C114B23	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	SLV03122	06-2_05-A12	EST	W01C114B24	pDONR221			CTSL3	392360		Hs.690450	Cathepsin L family member 3						NM_001023564.2	NP_001018858.2	VALIDATED	Pfs	0.400	0.400	10	384	61	32	218	133	142
IKAKEN	STM04673	06-2_05-B01	EST	W01C114C01	pDONR221															
IKAKEN	STM04673	06-2_05-B01	EST	W01C114C02	pDONR221															
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C114C03	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C114C04	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C114C05	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C114C06	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C114C07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C114C08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C114C09	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C114C10	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C114C11	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C114C12	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C114C13	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C114C14	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	TST06522	06-2_05-B08	EST	W01C114C15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06-2_05-B08	EST	W01C114C16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	IMAGE1636162	06-2_05-B09		W01C114C17	pDONR221															
IKAKEN	IMAGE1636162	06-2_05-B09		W01C114C18	pDONR221															
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C114C19	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C114C20	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C114C21	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C114C22	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C114C23	pDONR221															
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C114C24	pDONR221															
IKAKEN	STM04673	06-2_05-B01	EST	W01C114D01	pDONR221															
IKAKEN	STM04673	06-2_05-B01	EST	W01C114D02	pDONR221															
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C114D03	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B02	EST(RND)	W01C114D04	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	P	1.000	1.000	492	1503	1	1476	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C114D05	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	OFR07196	06-2_05-B03	EST(RND)	W01C114D06	pDONR221			MIA3	375056		Hs.118474	Melanoma inhibitory activity family, member 3						NM_198551.2	NP_940953.2	VALIDATED	Pfs	0.996	0.998	492	1501	1	1474	1907	1	492
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C114D07	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B04	EST(RND)	W01C114D08	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED	Cgs	0.730	0.982	378	846	1	843	378	1	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C114D09	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	PLR00894	06-2_05-B05	EST(RND)	W01C114D10	pDONR221			HNRNPA3	220988		Hs.516539	Heterogeneous nuclear ribonucleoprotein A3						NM_194247.2	NP_919223.1	VALIDATED		0.599	0.878	312	642	1	639	378	67	378
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C114D11	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	SMR00336	06-2_05-B06	EST(RND)	W01C114D12	pDONR221			TNIP3	79931		Hs.208206	TNFAIP3 interacting protein 3						NM_001128843.1	NP_001122315.1	VALIDATED	Pfs	0.987	0.991	319	969	1	953	325	1	319
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C114D13	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	T7R01362	06-2_05-B07	EST(RND)	W01C114D14	pDONR221			TMEM180	79847		Hs.309069	Transmembrane protein 180						NM_024789.3	NP_079065.2	VALIDATED	OK	1.000	1.000	517	1554	1	1551	517	1	517
IKAKEN	TST06522	06-2_05-B08	EST	W01C114D15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	TST06522	06-2_05-B08	EST	W01C114D16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	IMAGE1636162	06-2_05-B09		W01C114D17	pDONR221															
IKAKEN	IMAGE1636162	06-2_05-B09		W01C114D18	pDONR221															
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C114D19	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-FCBBF3022215	06-2_05-B10	EST(F-)	W01C114D20	pDONR221			LOC284214	284214		Hs.594640	Hypothetical protein LOC284214								
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C114D21	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	F-BRTHA2034892	06-2_05-B11	EST(F-)	W01C114D22	pDONR221			GRIK1	2897		Hs.706747	Glutamate receptor, ionotropic, kainate 1						NM_000830.3	NP_000821.1	REVIEWED	Cg	0.999	1.000	919	2760	1	2757	918	1	918
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C114D23	pDONR221															
IKAKEN	SK003E04	06-2_05-B12	IMS	W01C114D24	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C114E01	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C114E02	pDONR221															
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C114E03	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C114E04	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C114E05	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C114E06	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C114E07	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C114E08	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06-2_05-C05		W01C114E09	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06-2_05-C05		W01C114E10	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC047240	06-2_05-C06	MGC	W01C114E11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06-2_05-C06	MGC	W01C114E12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06-2_05-C07	MGC	W01C114E13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06-2_05-C07	MGC	W01C114E14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06-2_05-C08	MGC	W01C114E15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06-2_05-C08	MGC	W01C114E16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06-2_05-C09	MGC	W01C114E17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06-2_05-C09	MGC	W01C114E18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC067366	06-2_05-C10		W01C114E19	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06-2_05-C10		W01C114E20	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C114E21	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C114E22	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C114E23	pDONR221															
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C114E24	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C114F01	pDONR221															
IKAKEN	SK003G09	06-2_05-C01	IMS	W01C114F02	pDONR221															
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C114F03	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125223	06-2_05-C02	FLJ	W01C114F04	pDONR221	17653		IDUA	3425	BAG54168.1	Hs.89560	Iduronidase, alpha-L-			brain	FEBRA2		NM_000203.3	NP_000194.2	REVIEWED	OK	1.000	1.000	653	1962	1	1959	653	1	653
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C114F05	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK125619	06-2_05-C03	FLJ	W01C114F06	pDONR221	1341		RP11-345P4.4	728661	BAG54222.1	Hs.655255	Similar to solute carrier family 35, member E2			small intestine	SMINT2		NM_001110781.1	NP_001104251.1	VALIDATED		0.957	0.957	345	1164	1	1035	405	1	345
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C114F07	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	AK172862	06-2_05-C04	FLJ	W01C114F08	pDONR221	2721		KAZALD1	81621	BAD18818.1	Hs.632079	Kazal-type serine peptidase inhibitor domain 1			ileal mucosa	kaia		NM_030929.4	NP_112191.2	REVIEWED	OK	1.000	1.000	304	915	1	912	304	1	304
IKAKEN	BC008200	06-2_05-C05		W01C114F09	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC008200	06-2_05-C05		W01C114F10	pDONR221	6185		KRT8	3856	AAH08200.1	Hs.708445	Keratin 8						NM_002273.3	NP_002264.1	REVIEWED	Pfs	0.839	0.868	322	960	1	957	483	84	397
IKAKEN	BC047240	06-2_05-C06	MGC	W01C114F11	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC047240	06-2_05-C06	MGC	W01C114F12	pDONR221	21263		HEATR2	54919	AAH47240.1	Hs.535896	HEAT repeat containing 2			Breast, mammary adenocarcinoma.	NIH_MGC_87	DH10B	NM_017802.3	NP_060272.3	VALIDATED	Cs	0.998	0.998	855	2568	1	2565	855	1	855
IKAKEN	BC059402	06-2_05-C07	MGC	W01C114F13	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC059402	06-2_05-C07	MGC	W01C114F14	pDONR221	21357		RSBN1L	222194	AAH59402.1	Hs.592289	Round spermatid basic protein 1-like			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_198467.2	NP_940869.2	VALIDATED	Cg	0.995	1.000	846	2529	1	2526	846	1	846
IKAKEN	BC060804	06-2_05-C08	MGC	W01C114F15	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC060804	06-2_05-C08	MGC	W01C114F16	pDONR221	3172		ADAM12	8038	AAH60804.1	Hs.594537	ADAM metallopeptidase domain 12			Brain, hippocampus	NIH_MGC_95	DH10B	NM_021641.3	NP_067673.2	REVIEWED	OK	1.000	1.000	738	2217	1	2214	738	1	738
IKAKEN	BC002862	06-2_05-C09	MGC	W01C114F17	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC002862	06-2_05-C09	MGC	W01C114F18	pDONR221	2575		AKR1CL2	83592	AAH02862.1	Hs.657944	Aldo-keto reductase family 1, member C-like 2			Lymph, Burkitt lymphoma	NIH_MGC_8	DH10B-R	NM_001040177.1	NP_001035267.1	PROVISIONAL	Cg	0.822	1.000	320	792	1	789	320	1	320
IKAKEN	BC067366	06-2_05-C10		W01C114F19	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	BC067366	06-2_05-C10		W01C114F20	pDONR221	24034		FAM129B	64855	AAH67366	Hs.522401	Family with sequence similarity 129, member B						NM_001035534.1	NP_001030611.1	VALIDATED	OK	1.000	1.000	733	2202	1	2199	733	1	733
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C114F21	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	F-TESTI4014307	06-2_05-C11	EST(F-)	W01C114F22	pDONR221			LOC166994	166994									XM_496798.2	XP_496798.2	MODEL
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C114F23	pDONR221															
IKAKEN	FBR02611	06-2_05-C12	EST(RND)	W01C114F24	pDONR221															
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C114G01	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C114G02	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C114G03	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C114G04	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C114G05	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C114G06	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C114G07	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C114G08	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C114G09	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C114G10	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C114G11	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C114G12	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C114G13	pDONR221															
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C114G14	pDONR221															
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C114G15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C114G16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C114G17	pDONR221															
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C114G18	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C114G19	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C114G20	pDONR221															
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C114G21	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C114G22	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C114G23	pDONR221															
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C114G24	pDONR221															
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C114H01	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	SMR09368	06-2_05-D01	EST(RND)	W01C114H02	pDONR221			ZCCHC5	203430		Hs.134873	Zinc finger, CCHC domain containing 5						NM_152694.1	NP_689907.1	PROVISIONAL	Pfs	0.240	0.250	154	1329	546	1002	475	31	179
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C114H03	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK127987	06-2_05-D02	FLJ	W01C114H04	pDONR221	4764		UBQLNL	143630	BAC87218	Hs.10688	Ubiquilin-like			testis	TESTI2		NM_145053.4	NP_659490.4	VALIDATED		0.222	0.222	36	454	55	162	475	349	384
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C114H05	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	AK091837	06-2_05-D03	FLJ	W01C114H06	pDONR221	15896		LOC91316	91316	-	Hs.148656	Glucuronidase, beta/ immunoglobulin lambda-like polypeptide 1 pseudogene			lung	HLUNG2		XM_001717599.1	XP_001717651.1	MODEL		0.316	0.316	19	225	48	104	271	105	123
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C114H07	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR03425	06-2_05-D04	EST(RND)	W01C114H08	pDONR221			PDPR	55066		Hs.461183	Pyruvate dehydrogenase phosphatase regulatory subunit						NM_017990.3	NP_060460.4	VALIDATED		0.975	0.980	648	1944	1	1935	879	37	684
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C114H09	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	KGR01315	06-2_05-D05	EST(RND)	W01C114H10	pDONR221			DNMBP	23268		Hs.500771	Dynamin binding protein						NM_015221.2	NP_056036.1	VALIDATED	Pg	0.996	1.000	1424	4257	1	4254	1577	154	1577
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C114H11	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	OFR09267	06-2_05-D06	EST(RND)	W01C114H12	pDONR221			C3orf63	23272		Hs.116877	Chromosome 3 open reading frame 63						NM_001112736.1	NP_001106207.1	VALIDATED	Pg	0.934	1.000	920	3108	1	2577	1512	575	1494
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C114H13	pDONR221															
IKAKEN	H05D073J18	06-2_05-D07	Riken	W01C114H14	pDONR221															
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C114H15	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	FCC126F06	06-2_05-D08	TOYOBO	W01C114H16	pDONR221			MBNL2	10150		Hs.657347	Muscleblind-like 2 (Drosophila)						NM_207304.1	NP_997187.1	REVIEWED	P	1.000	1.000	94	285	1	282	361	268	361
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C114H17	pDONR221															
IKAKEN	H04D013H22	06-2_05-D09	Riken	W01C114H18	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C114H19	pDONR221															
IKAKEN	FMR03954	06-2_05-D10	EST(RND)	W01C114H20	pDONR221															
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C114H21	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC104G08	06-2_05-D11	TOYOBO	W01C114H22	pDONR221			RHBG	57127		Hs.131835	Rh family, B glycoprotein (gene/pseudogene)						NM_020407.3	NP_065140.3	REVIEWED	Cg	0.998	1.000	458	1374	1	1371	458	1	458
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C114H23	pDONR221															
IKAKEN	FCC157C03	06-2_05-D12	TOYOBO	W01C114H24	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C114I01	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C114I02	pDONR221															
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C114I03	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C114I04	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C114I05	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C114I06	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C114I07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C114I08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C114I09	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C114I10	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06-2_05-E06	EST	W01C114I11	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06-2_05-E06	EST	W01C114I12	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C114I13	pDONR221															
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C114I14	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C114I15	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C114I16	pDONR221															
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C114I17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C114I18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C114I19	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C114I20	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C114I21	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C114I22	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C114I23	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C114I24	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C114J01	pDONR221															
IKAKEN	ARi-S008_N04	06-2_05-E01	Unknown	W01C114J02	pDONR221															
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C114J03	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC119D04	06-2_05-E02	TOYOBO	W01C114J04	pDONR221			ITIH3	3699		Hs.76716	Inter-alpha (globulin) inhibitor H3						NM_002217.3	NP_002208.3	VALIDATED	Pfs	0.995	1.000	886	2649	2	2646	890	5	890
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C114J05	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	FCC130H05	06-2_05-E03	TOYOBO	W01C114J06	pDONR221			FBXO11	80204		Hs.352677	F-box protein 11						NM_025133.3	NP_079409.3	REVIEWED	OK	1.000	1.000	843	2532	1	2529	843	1	843
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C114J07	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013030A10	06-2_05-E04	Riken	W01C114J08	pDONR221			NIPBL	25836		Hs.481927	Nipped-B homolog (Drosophila)						NM_015384.4	NP_056199.2	REVIEWED	Ps	0.998	0.998	1171	3519	1	3513	2697	1	1171
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C114J09	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	H013050H19	06-2_05-E05	Riken	W01C114J10	pDONR221			NOL8	55035		Hs.442199	Nucleolar protein 8						NM_017948.5	NP_060418.4	VALIDATED	Cgs	0.994	0.999	1173	3522	1	3519	1167	1	1167
IKAKEN	SLV03339	06-2_05-E06	EST	W01C114J11	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	SLV03339	06-2_05-E06	EST	W01C114J12	pDONR221			AMY1A	276		Hs.655232	Amylase, alpha 1A (salivary)						NM_004038.3	NP_004029.2	REVIEWED	OK	1.000	1.000	511	1536	1	1533	511	1	511
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C114J13	pDONR221															
IKAKEN	RBd69_D02	06-2_05-E07	Unknown	W01C114J14	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C114J15	pDONR221															
IKAKEN	H04D074L02	06-2_05-E08	Riken	W01C114J16	pDONR221															
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C114J17	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	S01066-10_E08	06-2_05-E09	HITACHI	W01C114J18	pDONR221			MASP2	10747		Hs.655645	Mannan-binding lectin serine peptidase 2						NM_139208.1	NP_631947.1	REVIEWED	OK	1.000	1.000	185	558	1	555	185	1	185
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C114J19	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	H013085D17	06-2_05-E10	Riken	W01C114J20	pDONR221			AOX1	316		Hs.406238	Aldehyde oxidase 1						NM_001159.3	NP_001150.3	REVIEWED	OK	1.000	1.000	1338	4017	1	4014	1338	1	1338
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C114J21	pDONR221															
IKAKEN	HISCO_S01095-109_J14	06-2_05-E11	hisco_HUVEC	W01C114J22	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C114J23	pDONR221															
IKAKEN	ARa76H01.ab1	06-2_05-E12		W01C114J24	pDONR221															
IKAKEN	SYN08912	06-2_05-F01	EST	W01C114K01	pDONR221															
IKAKEN	SYN08912	06-2_05-F01	EST	W01C114K02	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C114K03	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C114K04	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C114K05	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C114K06	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C114K07	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C114K08	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C114K09	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C114K10	pDONR221															
IKAKEN	PCD09058	06-2_05-F06	EST	W01C114K11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06-2_05-F06	EST	W01C114K12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	KAT04487	06-2_05-F07	EST	W01C114K13	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F07	EST	W01C114K14	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06-2_05-F08	EST	W01C114K15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F08	EST	W01C114K16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C114K17	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C114K18	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	KAT04487	06-2_05-F10	EST	W01C114K19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F10	EST	W01C114K20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	DMC08550	06-2_05-F11	EST	W01C114K21	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06-2_05-F11	EST	W01C114K22	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06-2_05-F12	EST	W01C114K23	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06-2_05-F12	EST	W01C114K24	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	SYN08912	06-2_05-F01	EST	W01C114L01	pDONR221															
IKAKEN	SYN08912	06-2_05-F01	EST	W01C114L02	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C114L03	pDONR221															
IKAKEN	HISCO_S01095-101_N17	06-2_05-F02	hisco_HUVEC	W01C114L04	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C114L05	pDONR221															
IKAKEN	HISCO_S03002-12_H21	06-2_05-F03	hisco_THY	W01C114L06	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C114L07	pDONR221															
IKAKEN	HISCO_S02026A-102_B10	06-2_05-F04	hisco_OVA	W01C114L08	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C114L09	pDONR221															
IKAKEN	RBb16E09.ab1	06-2_05-F05		W01C114L10	pDONR221															
IKAKEN	PCD09058	06-2_05-F06	EST	W01C114L11	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	PCD09058	06-2_05-F06	EST	W01C114L12	pDONR221			C20orf199	441951		Hs.356766	Chromosome 20 open reading frame 199																		
IKAKEN	KAT04487	06-2_05-F07	EST	W01C114L13	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F07	EST	W01C114L14	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	PRS03358	06-2_05-F08	EST	W01C114L15	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F08	EST	W01C114L16	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C114L17	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	PRS03358	06-2_05-F09	EST	W01C114L18	pDONR221			POM121L9P	29774		Hs.534980	POM121 membrane glycoprotein-like 9 (rat) pseudogene								
IKAKEN	KAT04487	06-2_05-F10	EST	W01C114L19	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	KAT04487	06-2_05-F10	EST	W01C114L20	pDONR221			RPL26	6154		Hs.644794	Ribosomal protein L26						NM_000987.3	NP_000978.1	REVIEWED		0.873	0.873	79	240	1	237	145	47	125
IKAKEN	DMC08550	06-2_05-F11	EST	W01C114L21	pDONR221			IGHA1	3493											
IKAKEN	DMC08550	06-2_05-F11	EST	W01C114L22	pDONR221			IGHA1	3493											
IKAKEN	FLB06440	06-2_05-F12	EST	W01C114L23	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	FLB06440	06-2_05-F12	EST	W01C114L24	pDONR221			ZRANB1	54764		Hs.595158	Zinc finger, RAN-binding domain containing 1						NM_017580.2	NP_060050.2	VALIDATED	Ps	0.999	0.999	707	2127	1	2121	708	1	707
IKAKEN	AK056717	06-2_05-G01		W01C114M01	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06-2_05-G01		W01C114M02	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK098343	06-2_05-G02		W01C114M03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06-2_05-G02		W01C114M04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	BC059947	06-2_05-G03	MGC	W01C114M05	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06-2_05-G03	MGC	W01C114M06	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C114M07	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C114M08	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC008794	06-2_05-G05	MGC	W01C114M09	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06-2_05-G05	MGC	W01C114M10	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C114M11	pDONR221															
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C114M12	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C114M13	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C114M14	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C114M15	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C114M16	pDONR221															
IKAKEN	SPL09685	06-2_05-G09	EST	W01C114M17	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06-2_05-G09	EST	W01C114M18	pDONR221			IGHA1	3493											
IKAKEN	DMC07943	06-2_05-G10	EST	W01C114M19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06-2_05-G10	EST	W01C114M20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C114M21	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C114M22	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C114M23	pDONR221															
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C114M24	pDONR221															
IKAKEN	AK056717	06-2_05-G01		W01C114N01	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK056717	06-2_05-G01		W01C114N02	pDONR221	10555		ABHD15	116236	-	Hs.106510	Abhydrolase domain containing 15						NM_198147.1	NP_937790.1	PROVISIONAL	Cs	0.998	0.998	468	1407	1	1404	468	1	468
IKAKEN	AK098343	06-2_05-G02		W01C114N03	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	AK098343	06-2_05-G02		W01C114N04	pDONR221	6757		FAM123A	219287	BAC05288.1	Hs.528335	Family with sequence similarity 123A						NM_152704.2	NP_689917.2	VALIDATED	OK	1.000	1.000	671	2016	1	2013	671	1	671
IKAKEN	BC059947	06-2_05-G03	MGC	W01C114N05	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	BC059947	06-2_05-G03	MGC	W01C114N06	pDONR221	24637		CSAG1	158511	AAH59947.1	Hs.423718	Chondrosarcoma associated gene 1			Placenta, normal	NIH_MGC_147	DH10B	NM_001102576.1	NP_001096046.1	REVIEWED		0.890	0.890	73	333	112	330	78	6	78
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C114N07	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	AK074628	06-2_05-G04	FLJ	W01C114N08	pDONR221	20511		SFRS18	25957	BAC11098.1	Hs.520287	Splicing factor, arginine/serine-rich 18			whole embryo, mainly body	HEMBB1		NM_032870.2	NP_116259.2	VALIDATED	OK	1.000	1.000	805	2418	1	2415	805	1	805
IKAKEN	BC008794	06-2_05-G05	MGC	W01C114N09	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	BC008794	06-2_05-G05	MGC	W01C114N10	pDONR221	21013		POM121	9883	AAH08794.1	Hs.655217	POM121 membrane glycoprotein (rat)			Uterus, endometrium adenocarcinoma	NIH_MGC_44	DH10B-R	NM_172020.1	NP_742017.1	REVIEWED		0.975	0.978	987	3690	727	3687	984	1	984
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C114N11	pDONR221															
IKAKEN	H023072I23	06-2_05-G06	Riken	W01C114N12	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C114N13	pDONR221															
IKAKEN	H07D029H09	06-2_05-G07	Riken	W01C114N14	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C114N15	pDONR221															
IKAKEN	H07D029H09	06-2_05-G08	Riken	W01C114N16	pDONR221															
IKAKEN	SPL09685	06-2_05-G09	EST	W01C114N17	pDONR221			IGHA1	3493											
IKAKEN	SPL09685	06-2_05-G09	EST	W01C114N18	pDONR221			IGHA1	3493											
IKAKEN	DMC07943	06-2_05-G10	EST	W01C114N19	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	DMC07943	06-2_05-G10	EST	W01C114N20	pDONR221			RPIA	22934		Hs.469264	Ribose 5-phosphate isomerase A						NM_144563.2	NP_653164.2	VALIDATED	Pfs	0.200	0.204	50	348	239	93	311	234	283
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C114N21	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	NRR03871	06-2_05-G11	EST(RND)	W01C114N22	pDONR221			NAP5	344148		Hs.537329	Nck-associated protein 5						NM_207363.2	NP_997246.2	VALIDATED	P	1.000	1.000	406	1218	1	1218	1909	162	567
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C114N23	pDONR221															
IKAKEN	H04D047E22	06-2_05-G12	Riken	W01C114N24	pDONR221															
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C114O01	pDONR221															
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C114O02	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C114O03	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C114O04	pDONR221															
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C114O05	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C114O06	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C114O07	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C114O08	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C114O09	pDONR221															
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C114O10	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C114O11	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C114O12	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C114O13	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C114O14	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C114O15	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C114O16	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C114O17	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C114O18	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C114O19	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C114O20	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C114O21	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C114O22	pDONR221															
IKAKEN	HSI12469	06-2_05-H12	EST	W01C114O23	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06-2_05-H12	EST	W01C114O24	pDONR221			LOC392217	392217											
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C114P01	pDONR221															
IKAKEN	H04D061C22	06-2_05-H01	Riken	W01C114P02	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C114P03	pDONR221															
IKAKEN	H05D045A17	06-2_05-H02	Riken	W01C114P04	pDONR221															
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C114P05	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H013002L21	06-2_05-H03	Riken	W01C114P06	pDONR221			CCDC99	54908		Hs.368710	Coiled-coil domain containing 99						NM_017785.4	NP_060255.3	VALIDATED	Cgs	0.846	0.998	605	1542	1	1539	605	1	605
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C114P07	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H023099P08	06-2_05-H04	Riken	W01C114P08	pDONR221			PPM1J	333926		Hs.655231	Protein phosphatase 1J (PP2C domain containing)						NM_005167.5	NP_005158.5	REVIEWED	Pg	0.885	1.000	338	900	1	897	505	168	505
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C114P09	pDONR221															
IKAKEN	H04D049J01	06-2_05-H05	Riken	W01C114P10	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C114P11	pDONR221															
IKAKEN	H04D056D23	06-2_05-H06	Riken	W01C114P12	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C114P13	pDONR221															
IKAKEN	H04D057J16	06-2_05-H07	Riken	W01C114P14	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C114P15	pDONR221															
IKAKEN	H06D085A11	06-2_05-H08	Riken	W01C114P16	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C114P17	pDONR221															
IKAKEN	H04D056D23	06-2_05-H09	Riken	W01C114P18	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C114P19	pDONR221															
IKAKEN	SK007A03	06-2_05-H10		W01C114P20	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C114P21	pDONR221															
IKAKEN	SK007D01	06-2_05-H11		W01C114P22	pDONR221															
IKAKEN	HSI12469	06-2_05-H12	EST	W01C114P23	pDONR221			LOC392217	392217											
IKAKEN	HSI12469	06-2_05-H12	EST	W01C114P24	pDONR221			LOC392217	392217											
IKAKEN	AK094021	1_5-A01	FLJ	W01C115A01	pDONR221	28636		SMA4	11039	-	Hs.654588	Glucuronidase, beta pseudogene			uterus	UTERU2				
IKAKEN	BC047690	1_5-A02	MGC	W01C115A03	pDONR221	16207		MRAS	22808	AAH47690	Hs.527021	Muscle RAS oncogene homolog			Brain, adult, 6 pooled whole brains	NIH_MGC_114	DH10B	NM_012219.3	NP_036351.3	VALIDATED	OK	1.000	1.000	208	627	1	624	208	1	208
IKAKEN	BX379100 (5' CS0DI029YH14)	1_5-A03		W01C115A05	pDONR221			FAM149B1	317662		Hs.408577	Family with sequence similarity 149, member B1						NM_173348.1	NP_775483.1	VALIDATED	Pfs	0.267	0.286	75	423	3	212	582	496	570
IKAKEN	BX420136 (5' CS0DF024YO15)	1_5-A04		W01C115A07	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AK097693	1_5-A05	FLJ	W01C115A09	pDONR221	748		PLA2G5	5322	BAG53516.1	Hs.319438	Phospholipase A2, group V			testis	TESTI2		NM_000929.2	NP_000920.1	REVIEWED	OK	1.000	1.000	138	417	1	414	138	1	138
IKAKEN	AK000274	1_5-A06	FLJ	W01C115A11	pDONR221	17491		LARP7	51574	-	Hs.713663	La ribonucleoprotein domain family, member 7						NM_015454.1	NP_056269.1	VALIDATED	P	1.000	1.000	332	999	1	996	582	251	582
IKAKEN	AK126032	1_5-A07	FLJ	W01C115A13	pDONR221	13400		FER1L5	90342	BAC86403.1	Hs.534025	Fer-1-like 5 (C. elegans)			testis	TESTI4		NM_001077400.1	NP_001070868.1	PROVISIONAL	Pfs	0.263	0.268	57	636	392	559	802	400	456
IKAKEN	CCR00776	1_5-A08	EST(RND)	W01C115A15	pDONR221			C21orf62	56245		Hs.517235	Chromosome 21 open reading frame 62						NM_019596.3	NP_062542.3	VALIDATED	OK	1.000	1.000	247	744	1	741	247	1	247
IKAKEN	BX420136 (5' CS0DF024YO15)	1_5-A09		W01C115A17	pDONR221			SCRT1	83482		Hs.31746	Scratch homolog 1, zinc finger protein (Drosophila)						NM_031309.4	NP_112599.1	REVIEWED		0.562	0.562	16	351	264	217	348	330	345
IKAKEN	AK025079	1_5-A10	FLJ	W01C115A19	pDONR221	18156		FABP2	2169	-	Hs.282265	Fatty acid binding protein 2, intestinal			colon	COL		NM_000134.3	NP_000125.2	REVIEWED	OK	1.000	1.000	132	399	1	396	132	1	132
IKAKEN	AK131348	1_5-A11	FLJ	W01C115A21	pDONR221	14759		MACROD2	140733	BAD18504.1	Hs.661576	MACRO domain containing 2			testis	TESTI4		NM_001033087.1	NP_001028259.1	VALIDATED	P	1.000	1.000	58	324	150	323	213	24	81
IKAKEN	BC014374	1_5-A12	MGC	W01C115A23	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	AK074672	2_5-A01	FLJ	W01C116A01	pDONR221	23666		PPAPDC2	403313	BAC11126	Hs.107510	Phosphatidic acid phosphatase type 2 domain containing 2			mammary gland	MAMMA1		NM_203453.2	NP_982278.3	VALIDATED	P	1.000	1.000	288	867	1	864	295	8	295
IKAKEN	BC014374	2_5-A02	MGC	W01C116A03	pDONR221	13486		OR7E91P	79315	AAH14374	Hs.327033	Olfactory receptor, family 7, subfamily E, member 91 pseudogene			Bladder, carcinoma	NIH_MGC_53	DH10B			
IKAKEN	DMC03342	2_5-A03	EST	W01C116A05	pDONR221			DAPL1	92196		Hs.59761	Death associated protein-like 1						NM_001017920.2	NP_001017920.2	VALIDATED	OK	1.000	1.000	107	324	1	321	107	1	107
IKAKEN	H013046F05	2_5-A04	Riken	W01C116A07	pDONR221			DNAJC8	22826		Hs.433540	DnaJ (Hsp40) homolog, subfamily C, member 8						NM_014280.2	NP_055095.2	VALIDATED	OK	1.000	1.000	253	762	1	759	253	1	253
IKAKEN	SK003A01	2_5-A05	IMS	W01C116A09	pDONR221															
IKAKEN	BC006140	2_5-A06	MGC	W01C116A11	pDONR221	1705		HYI	81888	AAH06140.1	Hs.709864	Hydroxypyruvate isomerase homolog (E. coli)			Brain, neuroblastoma	NIH_MGC_19	DH10B-R	NM_031207.2	NP_112484.1	PROVISIONAL	OK	1.000	1.000	204	615	1	612	204	1	204
IKAKEN	TST04320	2_5-A07	EST	W01C116A13	pDONR221			COX7AP2	1348											
IKAKEN	H023037C05	2_5-A08	Riken	W01C116A15	pDONR221			RPL10A	4736		Hs.546269	Ribosomal protein L10a						NM_007104.4	NP_009035.3	REVIEWED		0.625	0.625	8	588	293	316	217	192	199
IKAKEN	AK12820	2_5-A09		W01C116A17	pDONR221															
IKAKEN	AK124332	2_5-A10	FLJ	W01C116A19	pDONR221	26746		LOC100190939	100190939	BAC85835.1	Hs.375766	Hypothetical LOC100190939			liver, tumor tissue	TLIVE2				
IKAKEN	BX374745 (5' CS0DC001YH05)	2_5-A11		W01C116A21	pDONR221			C4orf49	84709		Hs.710036	Chromosome 4 open reading frame 49						NM_032623.3	NP_116012.2	VALIDATED	OK	1.000	1.000	240	805	1	720	240	1	240
IKAKEN	H023072D22	2_5-A12	Riken	W01C116A23	pDONR221															
IKAKEN	AK021522	3_5-A01	FLJ	W01C117A01	pDONR221	10475		VAMP2	6844	-	Hs.25348	Vesicle-associated membrane protein 2 (synaptobrevin 2)	NT2	teratocarcinoma		NT2RP4		NM_014232.2	NP_055047.2	REVIEWED	P	1.000	1.000	111	342	1	333	116	1	111
IKAKEN	AK125353	3_5-A02	FLJ	W01C117A03	pDONR221	18221		CCDC149	91050	BAC86142.1	Hs.106432	Coiled-coil domain containing 149	NT2	teratocarcinoma		NT2RP7		NM_173463.3	NP_775734.1	VALIDATED	Cg	0.996	1.000	268	807	1	804	267	1	267
IKAKEN	H033052L01	3_5-A03	Riken	W01C117A05	pDONR221			PXMP2	5827		Hs.430299	Peroxisomal membrane protein 2, 22kDa						NM_018663.1	NP_061133.1	PROVISIONAL	C	1.000	1.000	195	588	1	585	195	1	195
IKAKEN	AK057662	3_5-A04	FLJ	W01C117A07	pDONR221	18271		C4orf36	132989		Hs.339646	Chromosome 4 open reading frame 36			trachea	TRACH2		NM_144645.3	NP_653246.1	VALIDATED	Cs	0.991	0.991	117	354	1	351	117	1	117
IKAKEN	AK124785	3_5-A05	FLJ	W01C117A09	pDONR221	10474		LOC220594	220594	-	Hs.462475	TL132 protein			brain	BRAWH3				
IKAKEN	BC040050	3_5-A06	MGC	W01C117A11	pDONR221	17658		MYL5	4636	AAH40050.1	Hs.410970	Myosin, light chain 5, regulatory			Pancreas, epithelioid carcinoma	NIH_MGC_70	DH10B	NM_002477.1	NP_002468.1	REVIEWED	OK	1.000	1.000	173	522	1	519	173	1	173
IKAKEN	AK024619	3_5-A07	FLJ	W01C117A13	pDONR221	9083		GGA2	23062	-	Hs.460336	Golgi associated, gamma adaptin ear containing, ARF binding protein 2			adipose tissue	ad		NM_015044.3	NP_055859.1	REVIEWED	OK	1.000	1.000	613	1842	1	1839	613	1	613
IKAKEN	AK074446	3_5-A08	FLJ	W01C117A15	pDONR221	17073		RFTN1	23180	-	Hs.98910	Raftlin, lipid raft linker 1		primary endothelial cells of human umbilical		HUV		NM_015150.1	NP_055965.1	VALIDATED	OK	1.000	1.000	578	1737	1	1734	578	1	578
IKAKEN	BX385952 (5' CS0DI021YA10)	3_5-A09		W01C117A17	pDONR221			C9orf91	203197		Hs.522357	Chromosome 9 open reading frame 91						NM_153045.3	NP_694590.2	VALIDATED	OK	1.000	1.000	342	1029	1	1026	342	1	342
IKAKEN	H023072E11	3_5-A10	Riken	W01C117A19	pDONR221			RNF130	55819		Hs.484363	Ring finger protein 130						NM_018434.4	NP_060904.2	REVIEWED	OK	1.000	1.000	419	1260	1	1257	419	1	419
IKAKEN	BC056904	3_5-A11	MGC	W01C117A21	pDONR221	641		GPATCH4	54865	AAH56904	Hs.193832	G patch domain containing 4			Brain, fetal, whole pooled	NIH_MGC_121	DH10B	NM_182679.1	NP_872620.1	VALIDATED	OK	1.000	1.000	370	1113	1	1110	370	1	370
IKAKEN	H013069K21	3_5-A12	Riken	W01C117A23	pDONR221			ZPBP2	124626		Hs.367245	Zona pellucida binding protein 2						NM_199321.2	NP_955353.1	VALIDATED	OK	1.000	1.000	338	1017	1	1014	338	1	338
IKAKEN	H013062N19	4_5-A01	Riken	W01C118A01	pDONR221															
IKAKEN	H033090E06	4_5-A02	Riken	W01C118A03	pDONR221			LIN9	286826		Hs.120817	Lin-9 homolog (C. elegans)						NM_173083.2	NP_775106.2	PROVISIONAL	OK	1.000	1.000	558	1677	1	1674	558	1	558
IKAKEN	AK127635	4_5-A03	FLJ	W01C118A05	pDONR221	19705		FNDC1	84624	BAG54537.1	Hs.520525	Fibronectin type III domain containing 1		coronary artery smooth muscle cells (HCASMC)		HCASM2		NM_032532.2	NP_115921.2	VALIDATED	P	1.000	1.000	367	1104	1	1101	1894	1528	1894
IKAKEN	H013089H21	4_5-A04	Riken	W01C118A07	pDONR221			CDY1B	253175		Hs.562095	Chromodomain protein, Y-linked, 1B						NM_001003894.1	NP_001003894.1	REVIEWED	Cgs	0.980	0.981	541	1626	1	1623	540	1	540
IKAKEN	H023019O04	4_5-A05	Riken	W01C118A09	pDONR221			RBM45	129831		Hs.377257	RNA binding motif protein 45						NM_152945.2	NP_694453.2	PROVISIONAL	Pfs	0.998	1.000	434	1302	1	1300	474	1	434
IKAKEN	H033072L06	4_5-A06	Riken	W01C118A11	pDONR221			NPTX1	4884		Hs.719680	Neuronal pentraxin I						NM_002522.3	NP_002513.2	REVIEWED	OK	1.000	1.000	432	1299	1	1296	432	1	432
IKAKEN	H023055M23	4_5-A07	Riken	W01C118A13	pDONR221			WBSCR17	64409		Hs.488591	Williams-Beuren syndrome chromosome region 17						NM_022479.1	NP_071924.1	REVIEWED	OK	1.000	1.000	598	1797	1	1794	598	1	598
IKAKEN	AK074833	4_5-A08	FLJ	W01C118A15	pDONR221	21961		LRCH4	4034	BAG52011.1	Hs.125742	Leucine-rich repeats and calponin homology (CH) domain containing 4	NT2	teratocarcinoma		NT2RP2		NM_002319.3	NP_002310.2	REVIEWED	OK	1.000	1.000	683	2052	1	2049	683	1	683
IKAKEN	AK075262	4_5-A09	FLJ	W01C118A17	pDONR221	11520		CLPTM1	1209	-	Hs.444441	Cleft lip and palate associated transmembrane protein 1			placenta	PLACE1		NM_001294.1	NP_001285.1	PROVISIONAL	C	1.000	1.000	669	2010	1	2007	669	1	669
IKAKEN	H033061I02	4_5-A10	Riken	W01C118A19	pDONR221			LGR4	55366		Hs.502176	Leucine-rich repeat-containing G protein-coupled receptor 4						NM_018490.2	NP_060960.2	VALIDATED	Cg	0.996	1.000	955	2868	1	2865	951	1	951
IKAKEN	H033035O12	4_5-A11	Riken	W01C118A21	pDONR221			SLCO6A1	133482		Hs.388874	Solute carrier organic anion transporter family, member 6A1						NM_173488.3	NP_775759.3	VALIDATED	OK	1.000	1.000	719	2160	1	2157	719	1	719
IKAKEN	AK126051	4_5-A12	FLJ	W01C118A23	pDONR221	13401		FLJ44048	401024	BAC86413	Hs.98025	FLJ44048 protein			testis	TESTI4		NM_207482.2	NP_997365.2	MODEL	P	1.000	1.000	1012	3039	1	3036	1605	594	1605
IKAKEN	BX421216 (5' CS0DG002YJ01)	5_5-A01		W01C119A01	pDONR221			OAS3	4940		Hs.528634	2'-5'-oligoadenylate synthetase 3, 100kDa						NM_006187.2	NP_006178.2	REVIEWED	C	1.000	1.000	1087	3264	1	3261	1087	1	1087
RIKEN	-	NM_000522.3_HOXA13	Codon Devices	W01F001A01	pENTR3C	22151		HOXA13	3209	NP_000513.2	Hs.592172	Homeobox A13						NM_000522.4	NP_000513.2	REVIEWED	C	1.000	1.000	388	1167	1	1164	388	1	388
RIKEN	-	NM_001001890.1_RUNX1	Codon Devices	W01F001A03	pENTR3C	15414		RUNX1	861	NP_001001890.1	Hs.149261	Runt-related transcription factor 1						NM_001001890.2	NP_001001890.1	REVIEWED	OK	1.000	1.000	453	1362	1	1359	453	1	453
RIKEN	-	NM_001048201.1_UHRF1	Codon Devices	W01F001A05	pENTR3C			UHRF1	29128	NP_001041666.1	Hs.108106	Ubiquitin-like with PHD and ring finger domains 1						NM_001048201.1	NP_001041666.1	REVIEWED	OK	1.000	1.000	793	2382	1	2379	793	1	793
RIKEN	-	NM_001080547.1_SPI1	Codon Devices	W01F001A07	pENTR3C			SPI1	6688	NP_001074016.1	Hs.502511	Spleen focus forming virus (SFFV) proviral integration oncogene spi1						NM_001080547.1	NP_001074016.1	REVIEWED	OK	1.000	1.000	271	816	1	813	271	1	271
RIKEN	-	NM_001572.3_IRF7	Codon Devices	W01F001A09	pENTR3C	4563		IRF7	3665	NP_001563.2	Hs.166120	Interferon regulatory factor 7						NM_001572.3	NP_001563.2	REVIEWED	C	1.000	1.000	503	1512	1	1509	503	1	503
RIKEN	-	NM_001754.3_RUNX1	Codon Devices	W01F001A11	pENTR3C	15414		RUNX1	861	NP_001745.2	Hs.149261	Runt-related transcription factor 1						NM_001754.4	NP_001745.2	REVIEWED	OK	1.000	1.000	480	1443	1	1440	480	1	480
RIKEN	-	NM_002467.3_MYC	Codon Devices	W01F001A13	pENTR3C	22768		MYC	4609	NP_002458.2								NM_002467.3	NP_002458.2	REVIEWED	C	1.000	1.000	454	1365	1	1362	454	1	454
RIKEN	-	NM_003120.2_SPI1	Codon Devices	W01F001A15	pENTR3C	4950		SPI1	6688	NP_003111.2	Hs.502511	Spleen focus forming virus (SFFV) proviral integration oncogene spi1						NM_003120.2	NP_003111.2	REVIEWED	OK	1.000	1.000	270	813	1	810	270	1	270
RIKEN	-	NM_003204.1_NFE2L1	Codon Devices	W01F001A17	pENTR3C	9886		NFE2L1	4779	NP_003195.1	Hs.514284	Nuclear factor (erythroid-derived 2)-like 1						NM_003204.2	NP_003195.1	VALIDATED	OK	1.000	1.000	772	2319	1	2316	772	1	772
RIKEN	-	NM_004029.2_IRF7	Codon Devices	W01F001A19	pENTR3C	4563		IRF7	3665	NP_004020.1	Hs.166120	Interferon regulatory factor 7						NM_004029.2	NP_004020.1	REVIEWED	C	1.000	1.000	474	1425	1	1422	474	1	474
RIKEN	-	NM_004031.2_IRF7	Codon Devices	W01F001A21	pENTR3C	4563		IRF7	3665	NP_004022.2	Hs.166120	Interferon regulatory factor 7						NM_004031.2	NP_004022.2	REVIEWED	C	1.000	1.000	516	1551	1	1548	516	1	516
RIKEN	-	NM_004364.2_CEBPA	Codon Devices	W01F001A23	pENTR3C	12706		CEBPA	1050	NP_004355.2	Hs.719494	CCAAT/enhancer binding protein (C/EBP), alpha						NM_004364.3	NP_004355.2	REVIEWED	OK	1.000	1.000	358	1077	1	1074	358	1	358
RIKEN	-	NM_004472.2_FOXD1	Codon Devices	W01F001C01	pENTR3C	19477		FOXD1	2297	NP_004463.1	Hs.519385	Forkhead box D1						NM_004472.2	NP_004463.1	REVIEWED	C	1.000	1.000	465	1398	1	1395	465	1	465
RIKEN	-	NM_005195.3_CEBPD	Codon Devices	W01F001C03	pENTR3C	23277		CEBPD	1052	NP_005186.2	Hs.440829	CCAAT/enhancer binding protein (C/EBP), delta						NM_005195.3	NP_005186.2	REVIEWED	C	1.000	1.000	269	810	1	807	269	1	269
RIKEN	-	NM_006526.2_ZNF217	Codon Devices	W01F001C05	pENTR3C	14932		ZNF217	7764	NP_006517.1	Hs.711564	Zinc finger protein 217						NM_006526.2	NP_006517.1	VALIDATED	OK	1.000	1.000	1048	3147	1	3144	1048	1	1048
RIKEN	-	NM_006602.2_TCFL5	Codon Devices	W01F001C07	pENTR3C	14867		TCFL5	10732	NP_006593.2	Hs.126248	Transcription factor-like 5 (basic helix-loop-helix)						NM_006602.2	NP_006593.2	VALIDATED	OK	1.000	1.000	500	1503	1	1500	500	1	500
RIKEN	-	NM_013282.3_UHRF1	Codon Devices	W01F001C09	pENTR3C	5628		UHRF1	29128	NP_037414.3	Hs.108106	Ubiquitin-like with PHD and ring finger domains 1						NM_013282.3	NP_037414.3	REVIEWED	OK	1.000	1.000	806	2421	1	2418	806	1	806
RIKEN	-	NM_014947.3_FOXJ3	Codon Devices	W01F001C11	pENTR3C	1404		FOXJ3	22887	NP_055762.3	Hs.26023	Forkhead box J3						NM_014947.3	NP_055762.3	VALIDATED	C	1.000	1.000	622	1869	1	1866	622	1	622
RIKEN	-	NM_018951.3_HOXA10	Codon Devices	W01F001C13	pENTR3C	22146		HOXA10	3206	NP_061824.3	Hs.110637	Homeobox A10						NM_018951.3	NP_061824.3	REVIEWED	P	1.000	1.000	393	1182	1	1179	410	18	410
RIKEN	-	NM_024336.1_IRX3	Codon Devices	W01F001C15	pENTR3C	9358		IRX3	79191	NP_077312.2	Hs.499205	Iroquois homeobox 3						NM_024336.2	NP_077312.2	VALIDATED	Cs	0.998	0.998	501	1506	1	1503	501	1	501
RIKEN	-	NM_153715.2_HOXA10	Codon Devices	W01F001C17	pENTR3C	22146		HOXA10	3206	NP_714926.1	Hs.110637	Homeobox A10						NM_153715.3	NP_714926.1	REVIEWED	OK	1.000	1.000	94	285	1	282	94	1	94
RIKEN	-	NM_178310.3_SNAI3	Codon Devices	W01F001C19	pENTR3C	9404		SNAI3	333929	NP_840101.1	Hs.673548	Snail homolog 3 (Drosophila)						NM_178310.3	NP_840101.1	VALIDATED	OK	1.000	1.000	292	879	1	876	292	1	292
RIKEN	-	NM_005933.2_MLL	Codon Devices	W01F001C21	pENTR3C	3693		MLL	4297	NP_005924.2	Hs.258855	Myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila)						NM_005933.2	NP_005924.2	VALIDATED	C	1.000	1.000	3969	11910	1	11907	3969	1	3969
RIKEN	-	NM_017617.3_NOTCH1	Codon Devices	W01F001C23	pENTR3C	24033		NOTCH1	4851	NP_060087.3	Hs.495473	Notch homolog 1, translocation-associated (Drosophila)						NM_017617.3	NP_060087.3	REVIEWED	C	1.000	1.000	2555	7668	1	7665	2555	1	2555
RIKEN	NM_032199	1_NM_032199	Invitrogen(GeneMaker)	W01G001A01	pDONR221	2763		ARID5B	84159	NP_115575.1	Hs.535297	AT rich interactive domain 5B (MRF1-like)						NM_032199.1	NP_115575.1	VALIDATED	C	1.000	1.000	1188	3573	6	3569	1188	1	1188
RIKEN	NM_001008496	2_NM_001008496.2	Invitrogen(GeneMaker)	W01G001A03	pDONR221	15807		PIWIL3	440822	NP_001008496.2	Hs.448343	Piwi-like 3 (Drosophila)						NM_001008496.2	NP_001008496.2	VALIDATED	C	1.000	1.000	882	2655	6	2651	882	1	882
RIKEN	NM_012154	3_NM_012154	Invitrogen(GeneMaker)	W01G001A05	pDONR221	23029		EIF2C2	27161	NP_036286.2	Hs.449415	Eukaryotic translation initiation factor 2C, 2						NM_012154.2	NP_036286.2	REVIEWED	C	1.000	1.000	859	2586	6	2582	859	1	859
RIKEN	NM_001955	5_NM_001955	Invitrogen(GeneMaker)	W01G001A07	pDONR221	20079		EDN1	1906	NP_001946.3	Hs.713645	Endothelin 1						NM_001955.3	NP_001946.3	VALIDATED	C	1.000	1.000	212	645	6	641	212	1	212
RIKEN	NM_003483	6_NM_003483	Invitrogen(GeneMaker)	W01G001A09	pDONR221	5261		HMGA2	8091	NP_003474.1	Hs.505924	High mobility group AT-hook 2						NM_003483.4	NP_003474.1	REVIEWED	C	1.000	1.000	109	336	6	332	109	1	109
RIKEN	NM_000722	7_NM_000722	Invitrogen(GeneMaker)	W01G001A11	pDONR221	22183		CACNA2D1	781	NP_000713.2	Hs.282151	Calcium channel, voltage-dependent, alpha 2/delta subunit 1						NM_000722.2	NP_000713.2	REVIEWED	C	1.000	1.000	1091	3282	6	3278	1091	1	1091
RIKEN	NM_021975	8_NM_021975.2	Invitrogen(GeneMaker)	W01G001A13	pDONR221	4893		RELA	5970	NP_068810.3	Hs.502875	V-rel reticuloendotheliosis viral oncogene homolog A (avian)						NM_021975.3	NP_068810.3	VALIDATED	Cs	0.998	0.998	551	1662	6	1658	551	1	551
RIKEN	NM_001913	10_NM_001913	Invitrogen(GeneMaker)	W01G001A15	pDONR221	21068		CUX1	1523	NP_001904.2	Hs.654389	Cut-like homeobox 1						NM_001913.2	NP_001904.2	REVIEWED	C	1.000	1.000	678	2043	6	2039	678	1	678
RIKEN	NM_001042492	11_NM_001042492	Invitrogen(GeneMaker)	W01G001A17	pDONR221			NF1	4763	NP_001035957.1	Hs.113577	Neurofibromin 1						NM_001042492.1	NP_001035957.1	REVIEWED	OK	1.000	1.000	2839	8520	1	8517	2839	1	2839
RIKEN	NM_013235	4_NM_013235.4	Invitrogen(GeneMaker)	W01H001A01	pENTR223.1LC	19155		RNASEN	29102	NP_037367.3	Hs.97997	Ribonuclease type III, nuclear						NM_013235.4	NP_037367.3	VALIDATED	C	1.000	1.000	1374	4131	6	4127	1374	1	1374
RIKEN	NM_000378	9_NM_000378	Invitrogen(GeneMaker)	W01H001A03	pENTR223.1LC	4797		WT1	7490	NP_000369.3	Hs.591980	Wilms tumor 1						NM_000378.3	NP_000369.3	REVIEWED	Cs	0.998	0.998	497	1500	6	1496	497	1	497
Funakoshi	BC160067	OHS4559-99855949	OpenBiosystems(on_gateway)	W01I001A01	pENTR223.1			DPPA3	359787	AAI60067.1	Hs.131358	Developmental pluripotency associated 3					DH10B	NM_199286.2	NP_954980.1	REVIEWED	C	1.000	1.000	159	541	35	511	159	1	159
Funakoshi	BC160187	OHS4559-99856157	OpenBiosystems(on_gateway)	W01I001A03	pENTR223.1			NANOG	79923	AAI60187.1	Hs.661360	Nanog homeobox					DH10B	NM_024865.2	NP_079141.2	VALIDATED	C	1.000	1.000	305	979	35	949	305	1	305
Funakoshi	BC166624	OHS4559-99856192	OpenBiosystems(on_gateway)	W01I001A05	pENTR223.1			UTF1	8433	AAI66624.1	Hs.458406	Undifferentiated embryonic cell transcription factor 1					DH10B	NM_003577.2	NP_003568.2	PROVISIONAL	C	1.000	1.000	341	1087	35	1057	341	1	341
Funakoshi	BC146551	OHS4559-99620436	OpenBiosystems(on_gateway)	W01I001A07	pENTR223.1			POU3F4	5456	AAI46552.1	Hs.2229	POU class 3 homeobox 4					DH10B	NM_000307.3	NP_000298.2	REVIEWED	C	1	1	361	1147	35	1117	361	1	361
Funakoshi	BC111592	OHS4559-99620513	OpenBiosystems(on_gateway)	W01I001A09	pENTR223.1			PDX1	3651	AAI11593.1	Hs.32938	Pancreatic and duodenal homeobox 1					DH10B	NM_000209.3	NP_000200.1	REVIEWED	C	1	1	283	913	35	883	283	1	283
Funakoshi	BC160030	OHS4559-99855912	OpenBiosystems(on_gateway)	W01I001A11	pENTR223.1			NKX6-1	4825	AAI60030.1	Hs.546270	NK6 homeobox 1					DH10B	NM_006168.2	NP_006159.2	VALIDATED	C	1	1	367	1165	35	1135	367	1	367
Funakoshi	BC160126	OHS4559-99856038	OpenBiosystems(on_gateway)	W01I001A13	pENTR223.1			MNX1	3110	AAI60126.1	Hs.37035	Motor neuron and pancreas homeobox 1					DH10B	NM_005515.3	NP_005506.3	VALIDATED	C	1	1	401	1267	35	1237	401	1	401
Funakoshi	BC156603	OHS4559-99848543	OpenBiosystems(on_gateway)	W01I001A15	pENTR223.1			MEF2C	4208	AAI56604.1	Hs.653394	Myocyte enhancer factor 2C					DH10B	NM_002397.3	NP_002388.2	VALIDATED	C	1	1	473	1483	35	1453	473	1	473
Funakoshi	BC168363	OHS4559-99856544	OpenBiosystems(on_gateway)	W01I001A17	pENTR223.1			PRDM16	63976	AAI68363.1	Hs.99500	PR domain containing 16					DH10B	NM_199454.1	NP_955533.1	REVIEWED	C	1	1	1256	3832	35	3802	1256	1	1256
Funakoshi	BC160119	OHS4559-99856024	OpenBiosystems(on_gateway)	W01I001A19	pENTR223.1			SOX11	6664	AAI60119.1	Hs.432638	SRY (sex determining region Y)-box 11					DH10B	NM_003108.3	NP_003099.1	REVIEWED	C	1	1	441	1387	35	1357	441	1	441
Funakoshi	BC168360	OHS4559-99856538	OpenBiosystems(on_gateway)	W01I001A21	pENTR223.1			HIPK2	28996	AAI68360.1	Hs.397465	Homeodomain interacting protein kinase 2					DH10B	NM_022740.4	NP_073577.3	VALIDATED	P	1.000	1.000	815	2509	35	2479	1198	384	1198
Funakoshi	BC140298	OHS4559-99620577	OpenBiosystems(on_gateway)	W01I001A23	pENTR223.1			MPL	4352	AAI40299.1	Hs.82906	Myeloproliferative leukemia virus oncogene					DH10B	NM_005373.2	NP_005364.1	REVIEWED	C	1.000	1.000	635	1969	35	1939	635	1	635
Funakoshi	DQ892661	OHS4559-99857263	OpenBiosystems(on_gateway)	W01J001A01	pENTR221			GDF3	9573	ABM83587.1	Hs.86232	Growth differentiation factor 3					DH5alpha	NM_020634.1	NP_065685.1	REVIEWED	Cs	0.997	0.997	364	1135	23	1114	364	1	364
Funakoshi	DQ891225	OHS4559-99858140	OpenBiosystems(on_gateway)	W01J001A03	pENTR221			DPPA4	55211	ABM82151.1	Hs.317659	Developmental pluripotency associated 4					DH5alpha	NM_018189.3	NP_060659.3	VALIDATED	Ps	0.983	0.983	298	925	11	904	304	7	304
Funakoshi	DQ892177	OHS4559-99858946	OpenBiosystems(on_gateway)	W01J001A05	pENTR221			DNMT3L	29947	ABM83103.1	Hs.592165	DNA (cytosine-5-)-methyltransferase 3-like					DH5alpha	NM_175867.1	NP_787063.1	REVIEWED	Cs	0.997	0.997	386	1201	23	1180	386	1	386
Funakoshi	DQ891496	OHS4559-99857777	OpenBiosystems(on_gateway)	W01J001A07	pENTR221			TBL2	26608	ABM82422.1	Hs.647044	Transducin (beta)-like 2					DH5alpha	NM_012453.2	NP_036585.1	REVIEWED	Ps	0.991	0.991	444	1381	23	1354	447	1	444
Funakoshi	DQ891564	OHS4559-99857768	OpenBiosystems(on_gateway)	W01J001A09	pENTR221			RB1	5925	ABM82490.1	Hs.408528	Retinoblastoma 1					DH5alpha	NM_000321.2	NP_000312.2	REVIEWED	C	1	1	928	2827	23	2806	928	1	928
Funakoshi	DQ890664	OHS4559-99858986	OpenBiosystems(on_gateway)	W01J001A11	pENTR221			HCLS1	3059	ABM81590.1	Hs.14601	Hematopoietic cell-specific Lyn substrate 1					DH5alpha	NM_005335.4	NP_005326.2	VALIDATED	Cs	0.998	0.998	486	1501	23	1480	486	1	486
Funakoshi	DQ891131	OHS4559-99857135	OpenBiosystems(on_gateway)	W01J001A13	pENTR221			CREG1	8804	ABM82057.1	Hs.5710	Cellular repressor of E1A-stimulated genes 1					DH5alpha	NM_003851.2	NP_003842.1	REVIEWED	C	1	1	220	703	23	682	220	1	220
Funakoshi	DQ891576	OHS4559-99857513	OpenBiosystems(on_gateway)	W01J001A15	pENTR221			HBP1	26959	ABM82502.1	Hs.162032	HMG-box transcription factor 1					DH5alpha	NM_012257.3	NP_036389.2	VALIDATED	C	1	1	514	1585	23	1564	514	1	514
Funakoshi	DQ893531	OHS4559-99857155	OpenBiosystems(on_gateway)	W01J001A17	pENTR221			RARA	5914	ABM84457.1	Hs.654583	Retinoic acid receptor, alpha					DH5alpha	NM_001145301.1	NP_001138773.1	VALIDATED	C	1	1	462	1429	23	1408	462	1	462
Funakoshi	DQ892512	OHS4559-99857887	OpenBiosystems(on_gateway)	W01J001A19	pENTR221			THRA	7067	ABM83438.1	Hs.724	Thyroid hormone receptor, alpha (erythroblastic leukemia viral (v-erb-a) oncogene homolog, avian)					DH5alpha	NM_003250.4	NP_003241.2	REVIEWED	C	1	1	490	1513	23	1492	490	1	490
Funakoshi	DQ893264	OHS4559-99858028	OpenBiosystems(on_gateway)	W01J001A21	pENTR221			DTX2	113878	ABM84190.1	Hs.187058	Deltex homolog 2 (Drosophila)					DH10B	NM_020892.2	NP_065943.2	VALIDATED	Cs	0.998	0.998	622	1909	23	1888	622	1	622
Funakoshi	DQ892504	OHS4559-99857893	OpenBiosystems(on_gateway)	W01J001A23	pENTR221			ID3	3399	ABM83430.1	Hs.76884	Inhibitor of DNA binding 3, dominant negative helix-loop-helix protein					DH10B	NM_002167.3	NP_002158.3	VALIDATED	Cs	0.992	0.992	119	400	23	379	119	1	119
Funakoshi	DQ891062	OHS4559-99856721	OpenBiosystems(on_gateway)	W01J001C01	pENTR221			IFI16	3428	ABM81988.1	Hs.380250	Interferon, gamma-inducible protein 16					DH10B	NM_005531.2	NP_005522.2	REVIEWED	Cs	0.996	0.996	729	2230	23	2209	729	1	729
Funakoshi	DQ891440	OHS4559-99859134	OpenBiosystems(on_gateway)	W01J001C03	pENTR221			SDPR	8436	ABM82366.1	Hs.26530	Serum deprivation response (phosphatidylserine binding protein)					DH10B	NM_004657.4	NP_004648.1	REVIEWED	C	1.000	1.000	425	1318	23	1297	425	1	425
Funakoshi	DQ890989	OHS4559-99859217	OpenBiosystems(on_gateway)	W01J001C05	pENTR221			XBP1	7494	ABM81915.1	Hs.437638	X-box binding protein 1					DH10B	NM_005080.3	NP_005071.2	REVIEWED	C	1.000	1.000	261	826	23	805	261	1	261
Funakoshi	BC105949	OHS4559-100070354	OpenBiosystems(on_gateway)	W01J001C07	pENTR221	1022		BTG2	7832	AAI05950.1	Hs.519162	BTG family, member 2		NM_006763.2	NP_006754.1	REVIEWED	C	1.000	1.000	158	1429	46	519	158	1	158
Funakoshi	EU446704	OHS4559-101208972	OpenBiosystems(on_gateway)	W01J001C09	pENTR221			HLTF	6596	ABZ92233.1	Hs.3068	Helicase-like transcription factor					DH5alpha	NM_139048.2	NP_620636.1	REVIEWED	Cgs	0.998	0.999	1009	3067	23	3046	1009	1	1009
RIKEN	NM_001025290	IPS	Operon	W01K001A01	pENTR3C Dual Selection	20856		DPPA5	340168	NP_001020461.1	Hs.125331	Developmental pluripotency associated 5					DH10B	NM_001025290.1	NP_001020461.1	PROVISIONAL	OK	1	1	116	612	6	353	116	1	116
RIKEN	NM_001110822	IPS	Operon	W01K001A03	pENTR3C Dual Selection			TDRD12	91646	NP_001104292.1	Hs.646351	Tudor domain containing 12					DH10B	NM_001110822.1	NP_001104292.1	VALIDATED	OK	1	1	395	1617	301	1485	395	1	395
RIKEN	NM_138815	IPS	Operon	W01K001A05	pENTR3C Dual Selection	17159		DPPA2	151871	NP_620170.3	Hs.351113	Developmental pluripotency associated 2					DH10B	NM_138815.3	NP_620170.3	VALIDATED	OK	1	1	298	1393	248	1141	298	1	298
RIKEN	NM_001017361	IPS	Operon	W01K001A07	pENTR3C Dual Selection	19755		C6orf221	154288	NP_001017361.1	Hs.128326	Chromosome 6 open reading frame 221					DH10B	NM_001017361.2	NP_001017361.1	VALIDATED	OK	1	1	217	1027	54	704	217	1	217
RIKEN	NM_181532	IPS	Operon	W01K001A09	pENTR3C Dual Selection	24540		ERAS	3266	NP_853510.1	Hs.447330	ES cell expressed Ras					DH10B	NM_181532.2	NP_853510.1	PROVISIONAL	OK	1	1	233	1266	252	950	233	1	233
RIKEN	NM_020436	IPS	Operon	W01K001A11	pENTR3C Dual Selection	15002		SALL4	57167	NP_065169.1	Hs.517113	Sal-like 4 (Drosophila)					DH10B	NM_020436.3	NP_065169.1	REVIEWED	OK	1	1	1053	3487	102	3260	1053	1	1053
RIKEN	NM_021193	MSC	Operon	W01K001A13	pENTR3C Dual Selection	13545		HOXD12	3238	NP_067016.3	Hs.450028	Homeobox D12					DH10B	NM_021193.3	NP_067016.3	REVIEWED	OK	1	1	270	813	1	810	270	1	270
RIKEN	NM_000545	beta	Operon	W01K001A15	pENTR3C Dual Selection	5655		HNF1A	6927	NP_000536.5	Hs.654455	HNF1 homeobox A					DH10B	NM_000545.5	NP_000536.5	REVIEWED	Cs	0.998	0.998	631	3241	24	1916	631	1	631
RIKEN	NM_002196	beta	Operon	W01K001A17	pENTR3C Dual Selection	14827		INSM1	3642	NP_002187.1	Hs.89584	Insulinoma-associated 1					DH10B	NM_002196.2	NP_002187.1	REVIEWED	OK	1	1	510	2838	148	1677	510	1	510
RIKEN	NM_004498	beta	Operon	W01K001A19	pENTR3C Dual Selection	8396		ONECUT1	3175	NP_004489.1	Hs.658573	One cut homeobox 1					DH10B	NM_004498.1	NP_004489.1	PROVISIONAL	OK	1	1	465	1925	129	1523	465	1	465
RIKEN	NM_018723	beta	Operon	W01K001A21	pENTR3C Dual Selection	8600		A2BP1	54715	NP_061193.2	Hs.459842	Ataxin 2-binding protein 1					DH10B	NM_018723.3	NP_061193.2	REVIEWED	OK	1	1	397	4775	989	2179	397	1	397
RIKEN	NM_005257	CARDIO	Operon	W01K001A23	pENTR3C Dual Selection	11059		GATA6	2627	NP_005248.2	Hs.514746	GATA binding protein 6					DH10B	NM_005257.3	NP_005248.2	VALIDATED	OK	1	1	595	3494	266	2050	595	1	595
RIKEN	NM_016270	MON	Operon	W01K001C01	pENTR3C Dual Selection	11576		KLF2	10365	NP_057354.1	Hs.107740	Kruppel-like factor 2 (lung)					DH10B	NM_016270.2	NP_057354.1	VALIDATED	OK	1	1	355	1655	85	1149	355	1	355
RIKEN	NM_016010	MSC	Operon	W01K001C03	pENTR3C Dual Selection	22568		FAM164A	51101	NP_057094.2	Hs.271876	Family with sequence similarity 164, member A					DH10B	NM_016010.2	NP_057094.2	VALIDATED	OK	1	1	325	3352	103	1077	325	1	325
RIKEN	NM_002025	MSC	Operon	W01K001C05	pENTR3C Dual Selection	24541		AFF2	2334	NP_002016.2	Hs.496911	AF4/FMR2 family, member 2					DH10B	NM_002025.3	NP_002016.2	REVIEWED	OK	1	1	1311	13746	480	4412	1311	1	1311
RIKEN	NM_152262	MSC	Operon	W01K001C07	pENTR3C Dual Selection	11734		ZNF439	90594	NP_689475.1	Hs.528731	Zinc finger protein 439					DH10B	NM_152262.2	NP_689475.1	PROVISIONAL	OK	1	1	499	2566	129	1625	499	1	499
RIKEN	NM_005069	MSC	Operon	W01K001C09	pENTR3C Dual Selection	15232		SIM2	6493	NP_005060.1	Hs.146186	Single-minded homolog 2 (Drosophila)					DH10B	NM_005069.3	NP_005060.1	REVIEWED	OK	1	1	667	4177	57	2057	667	1	667
RIKEN	NM_005604	Neuron	Operon	W01K001C11	pENTR3C Dual Selection	20002		POU3F2	5454	NP_005595.2	Hs.182505	POU class 3 homeobox 2					DH10B	NM_005604.2	NP_005595.2	VALIDATED	OK	1	1	443	4172	171	1499	443	1	443
RIKEN	NM_201589	beta	Operon	W01K001C13	pENTR3C Dual Selection	23290		MAFA	389692	NP_963883.2	Hs.670866	V-maf musculoaponeurotic fibrosarcoma oncogene homolog A (avian)					DH10B	NM_201589.2	NP_963883.2	VALIDATED	OK	1	1	353	1062	1	1059	353	1	353
RIKEN	NM_178161	beta	Operon	W01K001C15	pENTR3C Dual Selection	2954		PTF1A	256297	NP_835455.1	Hs.351503	Pancreas specific transcription factor, 1a					DH10B	NM_178161.2	NP_835455.1	REVIEWED	OK	1	1	328	1339	1	984	328	1	328
RIKEN	NM_024936	CARDIO	Operon	W01K001C17	pENTR3C Dual Selection			ZCCHC4	29063	NP_079212.2	Hs.278945	Zinc finger, CCHC domain containing 4					DH10B	NM_024936.2	NP_079212.2	VALIDATED	OK	1	1	513	2814	37	1575	513	1	513
RIKEN	NM_002052	CARDIO	Operon	W01K001C19	pENTR3C Dual Selection	22599		GATA4	2626	NP_002043.2	Hs.243987	GATA binding protein 4					DH10B	NM_002052.3	NP_002043.2	REVIEWED	OK	1	1	442	3419	555	1880	442	1	442
RIKEN	NM_001143766	MON	Operon	W01K001C21	pENTR3C Dual Selection			ZNF438	220929	NP_001137238.1	Hs.660642	Zinc finger protein 438					DH10B	NM_001143766.1	NP_001137238.1	VALIDATED	OK	1	1	828	3306	484	2967	828	1	828
RIKEN	NM_018419	MSC	Operon	W01K001C23	pENTR3C Dual Selection	14891		SOX18	54345	NP_060889.1	Hs.8619	SRY (sex determining region Y)-box 18					DH10B	NM_018419.2	NP_060889.1	REVIEWED	OK	1	1	384	1718	111	1262	384	1	384
RIKEN	NM_001080508	MSC	Operon	W01K001E01	pENTR3C Dual Selection			TBX18	9096	NP_001073977.1	Hs.251830	T-box 18					DH10B	NM_001080508.1	NP_001073977.1	PROVISIONAL	OK	1	1	607	4070	1	1821	607	1	607
RIKEN	NM_033512	MSC	Operon	W01K001E03	pENTR3C Dual Selection	22954		TSPYL5	85453	NP_277047.2	Hs.173094	TSPY-like 5					DH10B	NM_033512.2	NP_277047.2	VALIDATED	OK	1	1	417	4478	105	1355	417	1	417
RIKEN	NM_004956	MSC	Operon	W01K001E05	pENTR3C Dual Selection	21850		ETV1	2115	NP_004947.2	Hs.22634	Ets variant 1					DH10B	NM_004956.4	NP_004947.2	VALIDATED	OK	1	1	477	6824	740	2170	477	1	477
RIKEN	NM_002763	beta	Operon	W01K001E07	pENTR3C Dual Selection	939		PROX1	5629	NP_002754.2	Hs.585369	Prospero homeobox 1					DH10B	NM_002763.3	NP_002754.2	PROVISIONAL	OK	1	1	737	3088	273	2483	737	1	737
RIKEN	NM_013449	CARDIO	Operon	W01K001E09	pENTR3C Dual Selection	5772		BAZ2A	11176	NP_038477.2	Hs.314263	Bromodomain adjacent to zinc finger domain, 2A					DH10B	NM_013449.3	NP_038477.2	VALIDATED	OK	1	1	1905	8934	195	5909	1905	1	1905
RIKEN	NM_012298	CARDIO	Operon	W01K001E11	pENTR3C Dual Selection			CAND2	23066	NP_036430.1	Hs.343664	Cullin-associated and neddylation-dissociated 2 (putative)					DH10B	NM_012298.2	NP_036430.1	VALIDATED	OK	1	1	1119	4229	50	3406	1119	1	1119
RIKEN	NM_006618	CARDIO	Operon	W01K001E13	pENTR3C Dual Selection	776		KDM5B	10765	NP_006609.3	Hs.443650	Lysine (K)-specific demethylase 5B					DH10B	NM_006618.3	NP_006609.3	VALIDATED	OK	1	1	1544	6393	117	4748	1544	1	1544
RIKEN	NM_004689	CARDIO	Operon	W01K001E15	pENTR3C Dual Selection	6985		MTA1	9112	NP_004680.2	Hs.525629	Metastasis associated 1					DH10B	NM_004689.3	NP_004680.2	REVIEWED	OK	1	1	715	2856	188	2332	715	1	715
RIKEN	NM_006473	CARDIO	Operon	W01K001E17	pENTR3C Dual Selection	3766		TAF6L	10629	NP_006464.1	Hs.714400	TAF6-like RNA polymerase II, p300/CBP-associated factor (PCAF)-associated factor, 65kDa					DH10B	NM_006473.2	NP_006464.1	REVIEWED	OK	1	1	622	2016	102	1967	622	1	622
RIKEN	NM_006037	MON	Operon	W01K001E19	pENTR3C Dual Selection	13742		HDAC4	9759	NP_006028.2	Hs.20516	Histone deacetylase 4					DH10B	NM_006037.3	NP_006028.2	REVIEWED	OK	1	1	1084	8980	793	4044	1084	1	1084
RIKEN	NM_016374	MSC	Operon	W01K001E21	pENTR3C Dual Selection	1530		ARID4B	51742	NP_057458.4	Hs.575782	AT rich interactive domain 4B (RBP1-like)					DH10B	NM_016374.5	NP_057458.4	REVIEWED	OK	1	1	1312	6067	499	4434	1312	1	1312
RIKEN	NM_001042474	MSC	Operon	W01K001E23	pENTR3C Dual Selection			ZNF565	147929	NP_001035939.1	Hs.596338	Zinc finger protein 565					DH10B	NM_001042474.1	NP_001035939.1	VALIDATED	OK	1	1	499	1950	263	1759	499	1	499
RIKEN	NM_002360	CARDIO	Operon	W01K001G01	pENTR3C Dual Selection	21126		MAFK	7975	NP_002351.1	Hs.520612	V-maf musculoaponeurotic fibrosarcoma oncogene homolog K (avian)					DH10B	NM_002360.3	NP_002351.1	VALIDATED	OK	1	1	156	3350	212	679	156	1	156
RIKEN	NM_015478	CARDIO	Operon	W01K001G03	pENTR3C Dual Selection	14542		L3MBTL1	26013	NP_056293.4	Hs.709356	L(3)mbt-like (Drosophila)					DH10B	NM_015478.6	NP_056293.4	REVIEWED	C	1	1	772	3228	133	2448	772	1	772
RIKEN	NM_005904	MSC	Operon	W01K001G05	pENTR3C Dual Selection	11188		SMAD7	4092	NP_005895.1	Hs.465087	SMAD family member 7					DH10B	NM_001190822.1	NP_001177751.1	REVIEWED	C	1	1	211	3103	933	1565	211	1	211
RIKEN	NM_015025	Neuron	Operon	W01K001G07	pENTR3C Dual Selection	13774		MYT1L	23040	NP_055840.2	Hs.669852	Myelin transcription factor 1-like					DH10B	NM_015025.2	NP_055840.2	VALIDATED	OK	1	1	1184	7152	828	4379	1184	1	1184
RIKEN	NM_138713	MSC	Operon	W01K001G09	pENTR3C Dual Selection	8544		NFAT5	10725	NP_619727.2	Hs.371987	Nuclear factor of activated T-cells 5, tonicity-responsive					DH10B	NM_138713.2	NP_619727.2	REVIEWED	OK	1	1	1549	14177	1209	5855	1549	1	1549
RIKEN	NM_015069	MSC	Operon	W01K001G11	pENTR3C Dual Selection	9074		ZNF423	23090	NP_055884.2	Hs.530930	Zinc finger protein 423					DH10B	NM_015069.2	NP_055884.2	REVIEWED	OK	1	1	1284	4846	299	4150	1284	1	1284
RIKEN	NM_020999	beta	Operon	W01K001G13	pENTR3C Dual Selection	3447		NEUROG3	50674	NP_066279.2	Hs.532682	Neurogenin 3					DH10B	NM_020999.3	NP_066279.2	REVIEWED	OK	1	1	214	1167	159	800	214	1	214
RIKEN	NM_002509	beta	Operon	W01K001G15	pENTR3C Dual Selection	15110		NKX2-2	4821	NP_002500.1	Hs.725591	NK2 homeobox 2					DH10B	NM_002509.2	NP_002500.1	REVIEWED	OK	1	1	273	2092	358	1176	273	1	273
RIKEN	NM_006044	CARDIO	Operon	W01K001G17	pENTR3C Dual Selection	24507		HDAC6	10013	NP_006035.2	Hs.6764	Histone deacetylase 6					DH10B	NM_006044.2	NP_006035.2	REVIEWED	OK	1	1	1215	4099	94	3738	1215	1	1215
RIKEN	NM_014159	CARDIO	Operon	W01K001G19	pENTR3C Dual Selection	16792		SETD2	29072	NP_054878.5	Hs.517941	SET domain containing 2					DH10B	NM_014159.6	NP_054878.5	REVIEWED	OK	1	1	2564	8452	54	7745	2564	1	2564
RIKEN	NM_003308	CARDIO	Operon	W01K001G21	pENTR3C Dual Selection	25668		TSPY1	7258	NP_003299.2	Hs.647494	Testis specific protein, Y-linked 1					DH10B	NM_003308.3	NP_003299.2	VALIDATED	OK	1	1	308	1171	47	970	308	1	308
RIKEN	NM_015559	MSC	Operon	W01K001G23	pENTR3C Dual Selection	10938		SETBP1	26040	NP_056374.2	Hs.435458	SET binding protein 1					DH10B	NM_015559.2	NP_056374.2	REVIEWED	OK	1	1	1596	9899	297	5084	1596	1	1596
Funakoshi	BC023144	OHS1770-9379402	OpenBiosystems(on_gateway)	W01L001A01	pDONR223	17394		SMARCA5	8467	AAH23144.1	Hs.558422	SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 5						NM_003601.2	NP_003592.2	REVIEWED	Cs	0.999	0.999	1052	3617	214	3369	1052	1	1052